Allele ID	Allele Symbol	Phenotypes
MGI:4419470	1110059G10Rik<tm1a(KOMP)Wtsi>	MP:0003036,vertebral transformation
MGI:3578166	12aex	MP:0000914,exencephaly|MP:0011089,perinatal lethality, complete penetrance
MGI:6276858	1500009L16Rik<em1(IMPC)Mbp>	MP:0000063,decreased bone mineral density|MP:0000194,increased circulating calcium level|MP:0002965,increased circulating serum albumin level|MP:0005343,increased circulating aspartate transaminase level|MP:0005553,increased circulating creatinine level
MGI:6194257	1600014C10Rik<em1(IMPC)J>	MP:0000849,abnormal cerebellum morphology|MP:0000880,decreased Purkinje cell number|MP:0001405,impaired coordination|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002229,neurodegeneration|MP:0003225,axonal dystrophy|MP:0003243,abnormal dopaminergic neuron morphology|MP:0004077,abnormal striatum morphology|MP:0005277,abnormal brainstem morphology|MP:0006035,abnormal mitochondrial morphology|MP:0006082,CNS inflammation|MP:0008493,alpha-synuclein inclusion body|MP:0008571,abnormal synaptic bouton morphology|MP:0008918,microgliosis|MP:0010047,axonal spheroids|MP:0011630,increased mitochondrial size|MP:0014812,abnormal brain physiology|MP:0020352,abnormal endoplasmic reticulum physiology|MP:0020365,increased brain iron level|MP:0031686,abnormal smooth endoplasmic reticulum morphology
MGI:5613647	1600029I14Rik<tm1b(KOMP)Wtsi>	MP:0002135,abnormal kidney morphology|MP:0004930,small epididymis
MGI:5548659	1700003F12Rik<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4451336	1700008O03Rik<tm1a(KOMP)Wtsi>	MP:0002073,abnormal hair growth|MP:0002608,increased hematocrit
MGI:6382049	1700008P02Rik<em1(IMPC)J>	MP:0001556,increased circulating HDL cholesterol level|MP:0001566,increased circulating phosphate level|MP:0005178,increased circulating cholesterol level|MP:0010024,increased total body fat amount
MGI:6361158	1700010B08Rik<em1Osb>	MP:0005389,reproductive system phenotype
MGI:7531506	1700010I14Rik<em1Osb>	MP:0001922,reduced male fertility|MP:0009282,decreased hyperactivated sperm motility|MP:0014803,abnormal flagellar waveform|MP:0020451,decreased sperm progressive motility
MGI:5548527	1700010I14Rik<tm2b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:6110839	1700012B09Rik<tm1.1Gos>	MP:0002169,no abnormal phenotype detected
MGI:5613646	1700012B09Rik<tm1.1(KOMP)Wtsi>	MP:0003020,decreased circulating chloride level|MP:0005419,decreased circulating serum albumin level|MP:0011239,abnormal skin coloration
MGI:6467466	1700013H16Rik<em11Juhu>	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype
MGI:6467465	1700013H16Rik<em1Juhu>	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype
MGI:6257713	1700016H13Rik<em1(IMPC)Bay>	MP:0005534,decreased body temperature
MGI:3057163	1700016L21Rik<Tg(Itgax-HBEGF/EGFP)57Lan>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0001793,abnormal susceptibility to infection|MP:0001828,abnormal T cell activation|MP:0002083,premature death|MP:0002411,decreased susceptibility to bacterial infection|MP:0002412,increased susceptibility to bacterial infection|MP:0002452,abnormal professional antigen presenting cell physiology|MP:0003884,decreased macrophage cell number|MP:0004031,insulitis|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005018,decreased T cell number|MP:0005025,abnormal response to infection|MP:0005044,sepsis|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005150,cachexia|MP:0005379,endocrine/exocrine gland phenotype|MP:0005387,immune system phenotype|MP:0008040,decreased NK T cell number|MP:0008042,abnormal NK T cell physiology|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008127,decreased dendritic cell number|MP:0008245,abnormal alveolar macrophage morphology|MP:0008347,decreased gamma-delta T cell number|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0008618,decreased circulating interleukin-12 level|MP:0008670,decreased interleukin-12b secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008719,impaired neutrophil recruitment|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010210,abnormal circulating cytokine level|MP:0010766,abnormal NK cell physiology|MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:5766052	1700019D03Rik<tm1.1(NCOM)Mfgc>	MP:0000702,enlarged lymph nodes|MP:0005505,thrombocytosis|MP:0005562,decreased mean corpuscular hemoglobin
MGI:7507198	1700020A23Rik<em1(IMPC)Mbp>	MP:0000367,abnormal coat/ hair morphology
MGI:7543963	1700020L13Rik<em1(IMPC)Bay>	MP:0001392,abnormal locomotor behavior
MGI:7865137	1700021F13Rik<em1Smoc>	MP:0000267,abnormal heart development|MP:0002652,thin myocardium|MP:0002740,heart hypoplasia|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0010633,myocardium hypertrophy|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011925,abnormal heart echocardiography feature|MP:0031611,decreased fetal cardiomyocyte number
MGI:6140113	1700025G04Rik<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001293,anophthalmia|MP:0001529,abnormal vocalization|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0002590,increased mean corpuscular volume|MP:0005344,increased circulating bilirubin level|MP:0010067,increased red blood cell distribution width
MGI:6402900	1700028K03Rik<em1Jzc>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0004805,absent oocytes|MP:0005159,azoospermia|MP:0005431,decreased oocyte number|MP:0008261,arrest of male meiosis|MP:0010767,abnormal female meiosis I arrest|MP:0010948,abnormal double-strand DNA break repair|MP:0014052,increased male germ cell apoptosis
MGI:5692659	1700029F12Rik<tm1b(EUCOMM)Hmgu>	MP:0003020,decreased circulating chloride level
MGI:6362055	1700030J22Rik<em1(IMPC)J>	MP:0005559,increased circulating glucose level|MP:0005635,decreased circulating bilirubin level
MGI:7425476	1700030K09Rik<em1(IMPC)Bay>	MP:0000063,decreased bone mineral density|MP:0010124,decreased bone mineral content
MGI:6140114	1700034E13Rik<em1(IMPC)Mbp>	MP:0000274,enlarged heart|MP:0000470,abnormal stomach morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001126,abnormal ovary morphology|MP:0001293,anophthalmia|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002968,increased circulating alkaline phosphatase level
MGI:6194641	1700034J05Rik<tm1b(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:8204801	1700052I22Rik<em1Bcgen>	MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0009230,abnormal sperm head morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014634,decreased round spermatid number|MP:0014636,decreased elongated spermatid number
MGI:5289829	1700067K01Rik<tm2a(KOMP)Wtsi>	MP:0000783,abnormal forebrain morphology|MP:0001175,abnormal lung morphology|MP:0003230,abnormal umbilical artery morphology|MP:0003584,bifid ureter|MP:0003826,abnormal Mullerian duct morphology|MP:0004111,abnormal coronary artery morphology|MP:0004613,fusion of vertebral arches|MP:0006093,arteriovenous malformation|MP:0008922,abnormal cervical rib|MP:0011100,preweaning lethality, complete penetrance|MP:0011683,dual inferior vena cava|MP:0012303,umbilical vein stenosis|MP:0013840,absent segment of posterior cerebral artery|MP:0013842,ductus venosus stenosis|MP:0013843,hepatic portal vein stenosis|MP:0013876,absent ductus venosus valve|MP:0013971,blood in lymph vessels|MP:0013985,abnormal umbilical vein topology|MP:0013986,abnormal vitelline vein topology|MP:0013987,absent intrahepatic inferior vena cava segment|MP:0014001,abnormal vertebral artery topology
MGI:6140115	1700069L16Rik<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus
MGI:5620909	1700088E04Rik<tm1.1(KOMP)Vlcg>	MP:0001325,abnormal retina morphology
MGI:5618825	1700093K21Rik<b2b3025Clo>	MP:0000644,dextrocardia|MP:0003047,abnormal thoracic vertebrae morphology|MP:0004133,heterotaxia|MP:0006063,abnormal inferior vena cava morphology|MP:0010808,right-sided stomach|MP:0011250,abdominal situs ambiguus
MGI:6278519	1700093K21Rik<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001566,increased circulating phosphate level
MGI:6194887	1700093K21Rik<tm1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6514855	1700102P08Rik<em1Feis>	MP:0001147,small testis|MP:0001925,male infertility|MP:0004930,small epididymis|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:6430726	1700121C10Rik<em1Smoc>	MP:0005389,reproductive system phenotype
MGI:4434270	1700123O20Rik<tm1a(EUCOMM)Wtsi>	MP:0008810,increased circulating iron level
MGI:6388367	1810055G02Rik<em1(IMPC)Hmgu>	MP:0002098,abnormal vibrissa morphology
MGI:7310331	2010003K11Rik<em1Cya>	MP:0001260,increased body weight|MP:0001552,increased circulating triglyceride level|MP:0002079,increased circulating insulin level|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005342,abnormal intestinal lipid absorption|MP:0005658,increased susceptibility to diet-induced obesity|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0013279,increased fasting circulating glucose level|MP:0031269,increased susceptibility to diet-induced hepatic steatosis
MGI:5692716	2210408I21Rik<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001102,small superior vagus ganglion|MP:0002135,abnormal kidney morphology|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0009709,hydrometra|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5006990	2300002M23Rik<tm1Lex>	MP:0001262,decreased body weight|MP:0010025,decreased total body fat amount
MGI:7507200	2310011J03Rik<em1(IMPC)Mbp>	MP:0000367,abnormal coat/ hair morphology|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0014586,decreased egg cylinder size
MGI:4436328	2310022B05Rik<tm1a(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0005014,increased B cell number|MP:0010052,increased grip strength
MGI:3530127	2310039L15Rik<Tg(Prnp-SNCA*A53T)23Mkle>	MP:0000753,paralysis|MP:0000955,abnormal spinal cord morphology|MP:0001393,ataxia|MP:0001523,impaired righting response|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0002574,increased vertical activity|MP:0002882,abnormal neuron morphology|MP:0003244,loss of dopaminergic neurons|MP:0003354,astrocytosis|MP:0003632,abnormal nervous system morphology|MP:0004191,neuronal intranuclear inclusions|MP:0005156,bradykinesia|MP:0005323,dystonia|MP:0031391,increased locomotor activity
MGI:7582056	2310057M21Rik<em1Cya>	MP:0002792,abnormal retina vasculature morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:6404493	2310061I04Rik<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:7855590	2310061I04Rik<m1Ifd>	MP:0000774,decreased brain size|MP:0000953,abnormal oligodendrocyte morphology|MP:0001393,ataxia|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology|MP:0008225,abnormal anterior commissure morphology|MP:0013438,dysmyelination
MGI:7645199	2310065F04Rik<em1Boet>	MP:0000730,increased satellite cell number
MGI:7645198	2310065F04Rik<tm1.1Boet>	MP:0000730,increased satellite cell number|MP:0000759,abnormal skeletal muscle morphology|MP:0001260,increased body weight|MP:0002106,abnormal muscle physiology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004818,increased skeletal muscle mass|MP:0009461,skeletal muscle hypertrophy|MP:0010238,increased skeletal muscle weight|MP:0031323,increased skeletal muscle satellite cell proliferation
MGI:3923455	2500002B13Rik<Gt(Ayu21-T167)Imeg>	MP:0004215,abnormal myocardial fiber physiology|MP:0004485,increased response of heart to induced stress|MP:0006036,abnormal mitochondrial physiology
MGI:6782388	2500002B13Rik<tm1(CAG-2500002B13Rik)Yo>	MP:0004486,decreased response of heart to induced stress|MP:0011628,increased mitochondrial number
MGI:5583064	2510002D24Rik<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002169,no abnormal phenotype detected|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis
MGI:6147529	2510009E07Rik<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000367,abnormal coat/ hair morphology|MP:0000443,abnormal snout morphology|MP:0000639,abnormal adrenal gland morphology|MP:0000642,enlarged adrenal glands|MP:0001325,abnormal retina morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney
MGI:3526861	2610005L07Rik<Gt(ROSA)73Sor>	MP:0000074,abnormal neurocranium morphology|MP:0000091,short premaxilla|MP:0000097,short maxilla|MP:0000107,abnormal frontal bone morphology|MP:0000157,abnormal sternum morphology|MP:0000445,short snout|MP:0004471,short nasal bone|MP:0005508,abnormal skeleton morphology|MP:0008146,asymmetric sternocostal joints|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011709,increased fibroblast cell migration|MP:0030189,broad snout
MGI:6316124	2610008E11Rik<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0003068,enlarged kidney
MGI:6382413	2610028H24Rik<em1(IMPC)Mbp>	MP:0001304,cataract|MP:0002699,abnormal vitreous body morphology
MGI:7541281	2610035D17Rik<em1Zhgn>	MP:0010768,mortality/aging
MGI:5548598	2610318N02Rik<tm1b(EUCOMM)Wtsi>	MP:0005554,decreased circulating creatinine level
MGI:5287574	2700049A03Rik<tm1.1Arte>	MP:0000547,short limbs|MP:0000554,abnormal carpal bone morphology|MP:0000562,polydactyly|MP:0002110,abnormal digit morphology|MP:0002113,abnormal skeleton development|MP:0002544,brachydactyly|MP:0002764,short tibia|MP:0002765,short fibula|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0004083,polysyndactyly|MP:0004340,short scapula|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004576,abnormal embryonic autopod plate morphology|MP:0004686,decreased length of long bones|MP:0006280,abnormal digit development|MP:0008272,abnormal endochondral bone ossification|MP:0011261,abnormal limb mesenchyme morphology|MP:0011708,decreased fibroblast cell migration|MP:0013202,abnormal cilium morphology
MGI:5287585	2700049A03Rik<tm1.2Arte>	MP:0001706,abnormal left-right axis patterning|MP:0001730,embryonic growth arrest|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0003742,narrow head|MP:0004132,absent embryonic cilia|MP:0004252,abnormal direction of heart looping|MP:0009902,abnormal lateral nasal prominence morphology|MP:0009903,abnormal medial nasal prominence morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0030943,abnormal centrosome morphology
MGI:5749516	2700049A03Rik<tm1Blnw>	MP:0013202,abnormal cilium morphology|MP:0031682,abnormal centriole morphology
MGI:5755102	2700054A10Rik<em2(IMPC)Mbp>	MP:0001293,anophthalmia|MP:0001402,decreased locomotor activity|MP:0001566,increased circulating phosphate level|MP:0002092,abnormal eye morphology
MGI:4431683	2810408A11Rik<tm1a(EUCOMM)Wtsi>	MP:0001260,increased body weight|MP:0001513,limb grasping|MP:0002833,increased heart weight|MP:0002896,abnormal bone mineralization|MP:0003795,abnormal bone structure|MP:0008044,increased NK cell number|MP:0008045,decreased NK cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number
MGI:4435426	2900026A02Rik<tm1a(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0002092,abnormal eye morphology
MGI:6194700	2900092C05Rik<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:3578167	31bex	MP:0000914,exencephaly|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012138,decreased forebrain size
MGI:7716459	3425401B19Rik<em1Liyu>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000280,thin ventricular wall|MP:0001625,cardiac hypertrophy|MP:0002188,small heart|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002834,decreased heart weight|MP:0003141,cardiac fibrosis|MP:0004090,abnormal sarcomere morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0004937,dilated heart|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011925,abnormal heart echocardiography feature|MP:0011952,decreased cardiac stroke volume|MP:0014518,myocardial hypertrabeculation
MGI:6147530	3425401B19Rik<em2(IMPC)Ccpcz>	MP:0003961,decreased lean body mass|MP:0005011,increased eosinophil cell number|MP:0005628,decreased circulating potassium level|MP:0010053,decreased grip strength|MP:0013772,increased effector memory T-helper cell number
MGI:3578549	38dlp	MP:0001688,abnormal somite development|MP:0001730,embryonic growth arrest|MP:0010117,abnormal lateral plate mesoderm morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7624488	3930402G23Rik<em1.1Gonz>	MP:0000598,abnormal liver morphology|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0010359,increased liver free fatty acids level|MP:0031265,increased susceptibility to hepatic steatosis
MGI:6694243	4833411C07Rik<em1Cecad>	MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level
MGI:6140117	4833420G17Rik<em1(IMPC)Mbp>	MP:0001258,decreased body length|MP:0002092,abnormal eye morphology|MP:0004931,enlarged epididymis|MP:0005344,increased circulating bilirubin level
MGI:5523316	4921509C19Rik<tm1.1(KOMP)Vlcg>	MP:0005562,decreased mean corpuscular hemoglobin|MP:0005633,increased circulating sodium level|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:4363036	4921536K21Rik<tm1a(KOMP)Wtsi>	MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength
MGI:6830917	4921539E11Rik<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:5050148	4930404H24Rik<tm1a(KOMP)Wtsi>	MP:0002599,increased mean platelet volume|MP:0005419,decreased circulating serum albumin level
MGI:7512899	4930444P10Rik<em1(IMPC)Tcp>	MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0005012,decreased eosinophil cell number|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5823358	4930447C04Rik<em1Amp>	MP:0001126,abnormal ovary morphology|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001930,abnormal meiosis|MP:0001931,abnormal oogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0004805,absent oocytes|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis|MP:0008871,abnormal ovarian follicle number|MP:0008966,abnormal chiasmata formation|MP:0009451,abnormal chromosomal synapsis|MP:0011751,abnormal X-Y chromosome synapsis during male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:6257636	4930447C04Rik<em1(IMPC)Bay>	MP:0000063,decreased bone mineral density|MP:0001925,male infertility|MP:0001926,female infertility|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:6477600	4930447F04Rik<em1Utr>	MP:0005389,reproductive system phenotype
MGI:7327525	4930451I11Rik<em1Nino>	MP:0001922,reduced male fertility|MP:0009647,decreased fertilization frequency
MGI:6460465	4930451I11Rik<em1Osb>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0005389,reproductive system phenotype
MGI:6460467	4930451I11Rik<em2Osb>	MP:0000242,impaired fertilization
MGI:5609355	4930451I11Rik<tm1.1(KOMP)Wtsi>	MP:0001925,male infertility|MP:0001926,female infertility
MGI:1856802	4930453N24Rik<din>	MP:0000018,small ears|MP:0000120,malocclusion|MP:0000121,failure of tooth eruption|MP:0000372,irregular coat pigmentation|MP:0001732,postnatal growth retardation|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0002818,abnormal dentin morphology|MP:0005358,abnormal incisor morphology|MP:0030542,abnormal dentin development
MGI:7382753	4930463O16Rik<em1Bmpe>	MP:0002674,abnormal sperm motility|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0031426,increased sperm motility|MP:0031427,increased sperm progressive motility
MGI:7261402	4930522H14Rik<em1Kher>	MP:0005389,reproductive system phenotype
MGI:6194701	4930522H14Rik<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6140118	4930524B15Rik<em1(IMPC)Mbp>	MP:0001402,decreased locomotor activity|MP:0003795,abnormal bone structure|MP:0005084,abnormal gallbladder morphology
MGI:6739918	4930524B15Rik<em1Qsh>	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:6307020	4930558K02Rik<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology
MGI:5630071	4930563E22Rik<tm1.1(KOMP)Vlcg>	MP:0013278,decreased fasting circulating glucose level
MGI:6717350	4930568D16Rik<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6272669	4930579F01Rik<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0005655,increased aggression
MGI:6753386	4930579G24Rik<em1Qsh>	MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype
MGI:7444374	4930590J08Rik<em1Qsh>	MP:0000242,impaired fertilization|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001729,impaired embryo implantation|MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0002660,abnormal caput epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004542,impaired acrosome reaction|MP:0004543,abnormal sperm physiology|MP:0004884,abnormal testis physiology|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0009647,decreased fertilization frequency|MP:0010954,abnormal cellular respiration|MP:0010959,abnormal oxidative phosphorylation|MP:0013601,increased testis apoptosis|MP:0020451,decreased sperm progressive motility|MP:0030978,impaired binding of sperm to zona pellucida
MGI:4882021	4930590J08Rik<tm1a(EUCOMM)Wtsi>	MP:0001925,male infertility
MGI:4944391	4930591A17Rik<tm1a(KOMP)Wtsi>	MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010123,increased bone mineral content
MGI:5637051	4931406C07Rik<tm1b(EUCOMM)Wtsi>	MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003928,increased heart rate variability|MP:0011960,abnormal eye anterior chamber depth
MGI:6360260	4931414P19Rik<em1Lych>	MP:0003503,decreased activity of thyroid gland|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005471,decreased thyroxine level|MP:0005473,decreased triiodothyronine level
MGI:5692703	4931422A03Rik<tm1b(EUCOMM)Wtsi>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0001257,increased body length|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia
MGI:4460419	4931429L15Rik<tm1a(EUCOMM)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0005565,increased blood urea nitrogen level
MGI:6275630	4933402J07Rik<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0005292,improved glucose tolerance
MGI:7544859	4933402N03Rik<em1Ctu>	MP:0005389,reproductive system phenotype
MGI:4820121	4933402N03Rik<tm2a(KOMP)Wtsi>	MP:0000194,increased circulating calcium level|MP:0000438,abnormal cranium morphology|MP:0002073,abnormal hair growth|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level
MGI:6740198	4933411K16Rik<em1(IMPC)J>	MP:0005632,decreased circulating aspartate transaminase level
MGI:7641893	4933411K16Rik<em1Osb>	MP:0005389,reproductive system phenotype
MGI:7266255	4933425B07Rik<Tn(pb-Act-RFP)1.1Zhu>	MP:0000516,abnormal renal/urinary system morphology|MP:0000519,hydronephrosis|MP:0000524,decreased renal tubule number|MP:0001948,vesicoureteral reflux|MP:0002135,abnormal kidney morphology|MP:0003446,renal hypoplasia|MP:0004017,duplex kidney|MP:0004505,decreased renal glomerulus number|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0011457,abnormal metanephric ureteric bud development
MGI:5515778	4933427D14Rik<tm1.1(KOMP)Vlcg>	MP:0000269,abnormal heart looping|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001787,pericardial edema|MP:0003984,embryonic growth retardation|MP:0013203,abnormal primary cilium morphology|MP:0013214,decreased embryonic neuroepithelium primary cilium number|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:5695921	4933428G20Rik<tm1.1(KOMP)Vlcg>	MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0010123,increased bone mineral content
MGI:4432117	4933430I17Rik<tm1a(EUCOMM)Wtsi>	MP:0001944,abnormal pancreas morphology|MP:0002590,increased mean corpuscular volume
MGI:5548894	4933430I17Rik<tm1b(EUCOMM)Wtsi>	MP:0002764,short tibia|MP:0002941,increased circulating alanine transaminase level|MP:0005599,increased cardiac muscle contractility
MGI:4432969	4933434E20Rik<tm1a(EUCOMM)Wtsi>	MP:0000141,abnormal vertebral body morphology|MP:0000186,decreased circulating HDL cholesterol level|MP:0000273,overriding aortic valve|MP:0000282,abnormal interatrial septum morphology|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000602,dilated liver sinusoidal space|MP:0000632,abnormal pineal gland morphology|MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000841,abnormal hindbrain morphology|MP:0000963,fused dorsal root ganglion|MP:0001015,small superior cervical ganglion|MP:0001303,abnormal lens morphology|MP:0002249,abnormal larynx morphology|MP:0002941,increased circulating alanine transaminase level|MP:0003105,abnormal heart atrium morphology|MP:0003130,anal atresia|MP:0003262,intestinal/bowel diverticulum|MP:0003617,urinary bladder hypoplasia|MP:0003686,abnormal eye muscle morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0003922,abnormal heart right atrium morphology|MP:0004158,right aortic arch|MP:0004160,retroesophageal right subclavian artery|MP:0004599,abnormal vertebral arch morphology|MP:0004603,absent vertebral arch|MP:0004613,fusion of vertebral arches|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0006065,abnormal heart position or orientation|MP:0006093,arteriovenous malformation|MP:0006408,dorsal root ganglion hypoplasia|MP:0008128,abnormal brain internal capsule morphology|MP:0010088,decreased circulating fructosamine level|MP:0010200,enlarged lymphatic vessel|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010490,abnormal inferior vena cava valve morphology|MP:0010496,abnormal pectinate muscle morphology|MP:0010595,abnormal aortic valve cusp morphology|MP:0010602,abnormal pulmonary valve cusp morphology|MP:0010912,herniated liver|MP:0011100,preweaning lethality, complete penetrance|MP:0011493,double ureter|MP:0013826,absent hypoglossal canal|MP:0013834,thin hypoglossal nerve|MP:0013835,absent hypoglossal nerve|MP:0013836,abnormal hypoglossal nerve topology|MP:0013840,absent segment of posterior cerebral artery|MP:0013848,subcutaneous edema|MP:0013859,abnormal vitelline vein connection|MP:0013876,absent ductus venosus valve|MP:0013877,abnormal ductus venosus valve morphology|MP:0013878,abnormal ductus venosus valve topology|MP:0013913,absent costovertebral joint|MP:0013924,abnormal dural venous sinus morphology|MP:0013937,decreased thyroid gland lobe number|MP:0013952,retroesophageal left subclavian artery|MP:0013967,abnormal infrahyoid muscle connection|MP:0013969,reduced sympathetic cervical ganglion size|MP:0013971,blood in lymph vessels|MP:0014001,abnormal vertebral artery topology|MP:0014017,abnormal Wolffian duct connection|MP:0014019,embryo cyst|MP:0014021,heterochrony|MP:0020500,persistent trigeminal artery
MGI:6477605	4933436I01Rik<em1Utr>	MP:0005389,reproductive system phenotype
MGI:7507202	5031439G07Rik<em1(IMPC)Mbp>	MP:0009141,increased prepulse inhibition
MGI:6256959	5430431A17Rik<em1Doca>	MP:0000275,heart hyperplasia|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003649,decreased heart right ventricle size|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0010580,decreased heart left ventricle size
MGI:7309177	5730403I07Rik<em8Gpt>	MP:0001846,increased inflammatory response|MP:0002444,abnormal T cell physiology|MP:0003447,decreased tumor growth/size|MP:0004946,abnormal regulatory T cell physiology|MP:0006387,abnormal T cell number|MP:0008566,increased interferon-gamma secretion
MGI:7507203	5730455P16Rik<em1(IMPC)Mbp>	MP:0002699,abnormal vitreous body morphology|MP:0005561,increased mean corpuscular hemoglobin
MGI:5007001	6030468B19Rik<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:6276870	6430548M08Rik<em1(IMPC)Mbp>	MP:0000194,increased circulating calcium level|MP:0000702,enlarged lymph nodes|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003068,enlarged kidney
MGI:7507204	6820408C15Rik<em1(IMPC)Mbp>	MP:0000494,abnormal cecum morphology|MP:0009476,enlarged cecum
MGI:3584380	7630403G23Rik<Tg(Th-cre)1Tmd>	MP:0005386,behavior/neurological phenotype|MP:0030586,impaired behavioral response to amphetamine
MGI:3578177	7a6ex	MP:0000914,exencephaly|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012138,decreased forebrain size
MGI:6392887	9030622O22Rik<em1Eem>	MP:0001861,lung inflammation|MP:0002281,abnormal respiratory mucosa goblet cell morphology|MP:0005165,increased susceptibility to injury
MGI:3620956	917M	MP:0000135,decreased compact bone thickness|MP:0000558,abnormal tibia morphology|MP:0003795,abnormal bone structure|MP:0010124,decreased bone mineral content|MP:0030439,decreased osteoblast proliferation
MGI:5007003	9430015G10Rik<tm1Lex>	MP:0001973,increased thermal nociceptive threshold|MP:0005014,increased B cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:6158415	9630013A20Rik<em1Qrlu>	MP:0000953,abnormal oligodendrocyte morphology|MP:0003631,nervous system phenotype|MP:0013438,dysmyelination
MGI:3578153	97c2	MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0011089,perinatal lethality, complete penetrance
MGI:5613660	9930012K11Rik<tm2b(EUCOMM)Hmgu>	MP:0003733,abnormal retina inner nuclear layer morphology|MP:0011239,abnormal skin coloration|MP:0011964,increased total retina thickness
MGI:1855937	a	MP:0002075,abnormal coat/hair pigmentation|MP:0005379,endocrine/exocrine gland phenotype|MP:0005409,darkened coat color
MGI:1856464	A	MP:0001186,pigmentation phenotype|MP:0002169,no abnormal phenotype detected
MGI:2384104	a<10R>	MP:0002075,abnormal coat/hair pigmentation
MGI:2384105	a<11R>	MP:0002075,abnormal coat/hair pigmentation
MGI:2384106	a<12R>	MP:0002075,abnormal coat/hair pigmentation
MGI:5299219	a<13H>	MP:0002075,abnormal coat/hair pigmentation|MP:0009928,abnormal pinna hair pigmentation
MGI:2384107	a<13R>	MP:0002075,abnormal coat/hair pigmentation
MGI:2384108	a<14R>	MP:0002075,abnormal coat/hair pigmentation
MGI:2384109	a<15R>	MP:0002075,abnormal coat/hair pigmentation
MGI:1855950	a<16H>	MP:0002080,prenatal lethality
MGI:2384110	a<16R>	MP:0002075,abnormal coat/hair pigmentation
MGI:5299220	a<17H>	MP:0002075,abnormal coat/hair pigmentation|MP:0009928,abnormal pinna hair pigmentation
MGI:2384111	a<17R>	MP:0002075,abnormal coat/hair pigmentation
MGI:2384112	a<18R>	MP:0002075,abnormal coat/hair pigmentation
MGI:5299225	a<19H>	MP:0002075,abnormal coat/hair pigmentation|MP:0009928,abnormal pinna hair pigmentation
MGI:2384113	a<19R>	MP:0002075,abnormal coat/hair pigmentation
MGI:3050453	A1cf<Tg(Myh6-cre/Esr1*)1Jmk>	MP:0002795,dilated cardiomyopathy|MP:0005140,decreased cardiac muscle contractility|MP:0005329,abnormal myocardium layer morphology|MP:0010768,mortality/aging
MGI:5523232	A1cf<tm1b(EUCOMM)Hmgu>	MP:0002833,increased heart weight|MP:0005561,increased mean corpuscular hemoglobin|MP:0005633,increased circulating sodium level|MP:0010052,increased grip strength
MGI:6384908	A1cf<tm1c(EUCOMM)Hmgu>	MP:0001552,increased circulating triglyceride level|MP:0002139,abnormal hepatobiliary system physiology|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0003458,decreased circulating ketone body level|MP:0005178,increased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009356,decreased liver triglyceride level|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0010400,increased liver glycogen level|MP:0011424,decreased urine uric acid level|MP:0013278,decreased fasting circulating glucose level|MP:0030973,impaired gluconeogenesis
MGI:3690371	A1cf<tm1Ddsn>	MP:0000352,decreased cell proliferation|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2384121	a<1R>	MP:0002075,abnormal coat/hair pigmentation
MGI:5299228	a<20H>	MP:0002075,abnormal coat/hair pigmentation|MP:0009928,abnormal pinna hair pigmentation|MP:0009933,abnormal tail hair pigmentation
MGI:2384114	a<20R>	MP:0002075,abnormal coat/hair pigmentation
MGI:2384115	a<21R>	MP:0002075,abnormal coat/hair pigmentation
MGI:2384116	a<22R>	MP:0002075,abnormal coat/hair pigmentation
MGI:2384117	a<23R>	MP:0002075,abnormal coat/hair pigmentation
MGI:2384118	a<24R>	MP:0002075,abnormal coat/hair pigmentation
MGI:2384119	a<25R>	MP:0002075,abnormal coat/hair pigmentation
MGI:6257801	A2ml1<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000689,abnormal spleen morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2384097	a<2R>	MP:0002075,abnormal coat/hair pigmentation
MGI:3707000	A3galt2<tm1.1Hjg>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype
MGI:2384098	a<3R>	MP:0002075,abnormal coat/hair pigmentation
MGI:4419175	A430005L14Rik<tm1a(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:3624807	A4galt<tm1Kfk>	MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009747,impaired behavioral response to xenobiotic|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:5425954	A4gnt<tm1Jnaka>	MP:0000351,increased cell proliferation|MP:0001663,abnormal digestive system physiology|MP:0001873,stomach inflammation|MP:0003721,increased tumor growth/size|MP:0005493,stomach epithelial hyperplasia|MP:0005601,increased angiogenesis|MP:0008010,increased gastric adenocarcinoma incidence|MP:0010792,abnormal stomach mucosa morphology
MGI:2384122	a<4R>	MP:0002075,abnormal coat/hair pigmentation
MGI:1856427	a<5mnu>	MP:0001510,abnormal coat appearance|MP:0005409,darkened coat color
MGI:2384099	a<5R>	MP:0002075,abnormal coat/hair pigmentation
MGI:3051139	a<6H>	MP:0005409,darkened coat color|MP:0009928,abnormal pinna hair pigmentation
MGI:2384100	a<6R>	MP:0002075,abnormal coat/hair pigmentation
MGI:2384101	a<7R>	MP:0002075,abnormal coat/hair pigmentation
MGI:7507205	A830018L16Rik<em1(IMPC)Mbp>	MP:0013279,increased fasting circulating glucose level
MGI:4820036	A830019P07Rik<tm1a(KOMP)Wtsi>	MP:0005376,homeostasis/metabolism phenotype
MGI:5812929	A830031A19Rik<tm1b(KOMP)Wtsi>	MP:0006358,absent pinna reflex
MGI:2384102	a<8R>	MP:0002075,abnormal coat/hair pigmentation
MGI:5307017	A930011O12Rik/Mir124a-1<tm1Tfur>	MP:0000774,decreased brain size|MP:0001006,abnormal retina cone cell morphology|MP:0001513,limb grasping|MP:0002175,decreased brain weight|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0004022,abnormal cone electrophysiology|MP:0006072,abnormal retina apoptosis|MP:0008446,decreased retina cone cell number|MP:0009938,abnormal hippocampus granule cell morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:7311693	A930024E05Rik<em2Zfa>	MP:0002412,increased susceptibility to bacterial infection|MP:0005387,immune system phenotype|MP:0008568,abnormal interleukin secretion|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0013893,decreased common lymphocyte progenitor cell number
MGI:2384103	a<9R>	MP:0002075,abnormal coat/hair pigmentation
MGI:6404506	AA986860<em1(IMPC)Mbp>	MP:0001325,abnormal retina morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0004738,abnormal auditory brainstem response
MGI:3621812	Aaas<tm1Ahue>	MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001516,abnormal motor coordination/balance|MP:0001926,female infertility|MP:0003631,nervous system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005384,cellular phenotype
MGI:3042398	Aabpr<NZB/Slc>	MP:0005154,increased B cell proliferation
MGI:5898379	Aacs<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:6140121	Aadac<em1(IMPC)Mbp>	MP:0000538,abnormal urinary bladder morphology|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney
MGI:7541405	Aadacl4<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002060,abnormal skin morphology|MP:0002591,decreased mean corpuscular volume|MP:0003020,decreased circulating chloride level|MP:0003917,increased kidney weight|MP:0003961,decreased lean body mass|MP:0005634,decreased circulating sodium level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0009453,enhanced contextual conditioning behavior|MP:0010024,increased total body fat amount|MP:0020420,abnormal freezing behavior
MGI:3052711	Aadat<tm1Tag>	MP:0001399,hyperactivity|MP:0001525,impaired balance|MP:0002862,abnormal righting response|MP:0002882,abnormal neuron morphology|MP:0003153,early eyelid opening
MGI:7481201	Aagab<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:3573908	Aaj1<A/J>	MP:0001363,increased anxiety-related response
MGI:3573910	Aaj2<A/J>	MP:0001363,increased anxiety-related response
MGI:3573912	Aaj3<A/J>	MP:0001363,increased anxiety-related response
MGI:3573914	Aaj4<A/J>	MP:0001363,increased anxiety-related response
MGI:5766745	Aak1<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0001469,abnormal contextual conditioning behavior|MP:0001489,decreased startle reflex|MP:0002574,increased vertical activity|MP:0002764,short tibia|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003795,abnormal bone structure|MP:0003921,abnormal heart left ventricle morphology|MP:0004738,abnormal auditory brainstem response|MP:0005179,decreased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0009141,increased prepulse inhibition|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1889306	Aal	MP:0002798,abnormal active avoidance behavior
MGI:6208836	Aamp<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2180134	Aanat<rs216509331-A>	MP:0011728,abnormal pineal gland physiology|MP:0011729,abnormal pineal gland melatonin secretion
MGI:2680912	Aaom1<MRL/MpJ>	MP:0001864,vascular inflammation
MGI:6201045	Aap<b>	MP:0002798,abnormal active avoidance behavior
MGI:1889307	Aap<d>	MP:0002798,abnormal active avoidance behavior
MGI:2159395	Aaq1<C57BL/6J>	MP:0001425,abnormal alcohol consumption
MGI:7537199	Aars1<em1(IMPC)Bay>	MP:0000432,abnormal head morphology|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0011999,abnormal tail length
MGI:3618596	Aars1<sti>	MP:0000418,focal hair loss|MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0001393,ataxia|MP:0001511,disheveled coat|MP:0001525,impaired balance|MP:0003413,hair follicle degeneration|MP:0003631,nervous system phenotype|MP:0003809,abnormal hair shaft morphology|MP:0010688,hair follicle outer root sheath hyperplasia
MGI:5614439	Aars1<tm1.1Slac>	MP:0000876,Purkinje cell degeneration|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6368036	Aars2<tm1.1Htyy>	MP:0001698,decreased embryo size|MP:0002169,no abnormal phenotype detected|MP:0011092,embryonic lethality, complete penetrance
MGI:4419134	Aars2<tm1(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0001529,abnormal vocalization|MP:0002606,increased basophil cell number|MP:0003921,abnormal heart left ventricle morphology|MP:0005011,increased eosinophil cell number|MP:0006243,impaired pupillary reflex|MP:0010068,decreased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance
MGI:6368037	Aars2<tm2.1Htyy>	MP:0001698,decreased embryo size|MP:0002169,no abnormal phenotype detected|MP:0011092,embryonic lethality, complete penetrance
MGI:6358625	Aasdh<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0002092,abnormal eye morphology|MP:0002941,increased circulating alanine transaminase level
MGI:5700041	Aasdhppt<tm1.1(KOMP)Vlcg>	MP:0005102,abnormal iris pigmentation|MP:0005292,improved glucose tolerance|MP:0010053,decreased grip strength|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6156438	Aass<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000702,enlarged lymph nodes|MP:0011874,enlarged urinary bladder
MGI:6361005	Aatf<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001728,failure of embryo implantation|MP:0001730,embryonic growth arrest|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2176283	Aatf<Gt(pGT1.8geo)3Pgr>	MP:0000352,decreased cell proliferation|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002663,absent blastocoele|MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012111,failure of morula compaction|MP:0012129,failure of blastocyst formation|MP:0014238,abnormal ribosome morphology|MP:0014239,abnormal intracellular organelle morphology
MGI:5428170	Aatk<tm1Shhi>	MP:0000774,decreased brain size|MP:0004768,abnormal axonal transport|MP:0005404,abnormal axon morphology|MP:0008415,abnormal neurite morphology
MGI:5695961	AB124611<tm1.1(KOMP)Vlcg>	MP:0002135,abnormal kidney morphology|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0010393,shortened QRS complex duration
MGI:6257435	Abat<em2(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:7443008	Abat<tm1c(EUCOMM)Hmgu>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008397,abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology|MP:0010221,abnormal T-helper 17 cell differentiation
MGI:3026899	Abbp1<C57BL/6>	MP:0002842,increased systemic arterial blood pressure
MGI:3026901	Abbp2<C57BL/6>	MP:0002842,increased systemic arterial blood pressure
MGI:3026903	Abbp3<C57BL/6>	MP:0002842,increased systemic arterial blood pressure
MGI:3026905	Abbp4<C57BL/6>	MP:0002842,increased systemic arterial blood pressure
MGI:4461044	Abca12<el12>	MP:0001198,tight skin|MP:0001218,thin epidermis|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001238,thin epidermis stratum spinosum|MP:0001242,hyperkeratosis|MP:0001429,dehydration|MP:0001435,absent suckling reflex|MP:0002060,abnormal skin morphology|MP:0002118,abnormal lipid homeostasis|MP:0002796,impaired skin barrier function|MP:0003193,decreased cholesterol efflux|MP:0003941,abnormal skin development|MP:0003982,increased cholesterol level|MP:0004200,decreased fetal size|MP:0009594,abnormal corneocyte envelope morphology|MP:0009599,thick epidermis stratum granulosum|MP:0009608,abnormal epidermal lamellar body morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:6294780	Abca12<em1(IMPC)J>	MP:0001785,edema|MP:0002177,abnormal outer ear morphology|MP:0003743,abnormal facial morphology|MP:0009931,abnormal skin appearance|MP:0011100,preweaning lethality, complete penetrance
MGI:6188327	Abca12<smsk>	MP:0001196,shiny skin|MP:0001198,tight skin|MP:0001201,translucent skin|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001238,thin epidermis stratum spinosum|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001429,dehydration|MP:0002796,impaired skin barrier function|MP:0003427,parakeratosis|MP:0003453,abnormal keratinocyte physiology|MP:0003853,dry skin|MP:0003941,abnormal skin development|MP:0009597,impaired stratum corneum desquamation|MP:0009599,thick epidermis stratum granulosum|MP:0009608,abnormal epidermal lamellar body morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:3528440	Abca12<tm1Lex>	MP:0001230,epidermal desquamation|MP:0001242,hyperkeratosis|MP:0002118,abnormal lipid homeostasis|MP:0002796,impaired skin barrier function|MP:0003427,parakeratosis|MP:0009608,abnormal epidermal lamellar body morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:3809668	Abca12<tm1Shzu>	MP:0001177,atelectasis|MP:0001179,thick pulmonary interalveolar septum|MP:0001190,reddish skin|MP:0001192,scaly skin|MP:0001196,shiny skin|MP:0001198,tight skin|MP:0001212,skin lesions|MP:0001216,abnormal epidermal layer morphology|MP:0001242,hyperkeratosis|MP:0001429,dehydration|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002796,impaired skin barrier function|MP:0003773,eclabion|MP:0003941,abnormal skin development|MP:0004780,abnormal surfactant secretion|MP:0009431,decreased fetal weight|MP:0009608,abnormal epidermal lamellar body morphology|MP:0009674,decreased birth weight|MP:0010018,pulmonary vascular congestion|MP:0010814,absent alveolar lamellar bodies|MP:0011087,neonatal lethality, complete penetrance|MP:0014659,increased skin stiffness
MGI:7330391	Abca13<em1Kueda>	MP:0004811,abnormal neuron physiology|MP:0005386,behavior/neurological phenotype|MP:0009142,decreased prepulse inhibition|MP:0021013,abnormal synaptic vesicle endocytosis
MGI:5603352	Abca13<tm1b(EUCOMM)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0002966,decreased circulating alkaline phosphatase level|MP:0009142,decreased prepulse inhibition|MP:0009198,abnormal male genitalia morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:5659623	Abca16<em1(IMPC)J>	MP:0001303,abnormal lens morphology|MP:0001312,abnormal cornea morphology|MP:0001513,limb grasping|MP:0005343,increased circulating aspartate transaminase level|MP:0005634,decreased circulating sodium level|MP:0010052,increased grip strength
MGI:5692866	Abca17<tm1b(EUCOMM)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005628,decreased circulating potassium level
MGI:3848340	Abca1<m4620Dajl>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level
MGI:5792044	Abca1<mpc227H>	MP:0005179,decreased circulating cholesterol level
MGI:3577725	Abca1<tm1.1Jp>	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0006084,abnormal circulating phospholipid level
MGI:5548975	Abca1<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0001491,unresponsive to tactile stimuli|MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance
MGI:3525100	Abca1<tm1Blt>	MP:0005464,abnormal platelet physiology
MGI:1935192	Abca1<tm1Jdm>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000642,enlarged adrenal glands|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0001154,seminiferous tubule degeneration|MP:0001175,abnormal lung morphology|MP:0001262,decreased body weight|MP:0001712,abnormal placenta development|MP:0001798,impaired macrophage phagocytosis|MP:0001914,hemorrhage|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0002118,abnormal lipid homeostasis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002646,increased intestinal cholesterol absorption|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0002786,abnormal Leydig cell morphology|MP:0003179,thrombocytopenia|MP:0003192,increased cholesterol efflux|MP:0003193,decreased cholesterol efflux|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005376,homeostasis/metabolism phenotype|MP:0005401,abnormal fat-soluble vitamin level|MP:0006084,abnormal circulating phospholipid level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011385,abnormal testosterone level|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0031205,decreased circulating phytosterol level
MGI:3577723	Abca1<tm1Jp>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0003193,decreased cholesterol efflux|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0006084,abnormal circulating phospholipid level|MP:0008882,abnormal enterocyte physiology
MGI:1935193	Abca1<tm1Wpfl>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000276,heart right ventricle hypertrophy|MP:0000521,abnormal kidney cortex morphology|MP:0000639,abnormal adrenal gland morphology|MP:0000703,abnormal thymus morphology|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001182,lung hemorrhage|MP:0001265,decreased body size|MP:0001716,abnormal placenta labyrinth morphology|MP:0001730,embryonic growth arrest|MP:0001923,reduced female fertility|MP:0001954,respiratory distress|MP:0002625,heart left ventricle hypertrophy|MP:0002647,decreased intestinal cholesterol absorption|MP:0002743,glomerulonephritis|MP:0002784,abnormal Sertoli cell morphology|MP:0003984,embryonic growth retardation|MP:0005179,decreased circulating cholesterol level|MP:0005181,decreased circulating estradiol level|MP:0005185,decreased circulating progesterone level|MP:0005264,glomerulosclerosis|MP:0005330,cardiomyopathy|MP:0009080,uterus inflammation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0020519,renal glomerular immunoglobulin deposits|MP:0030975,placenta hemorrhage|MP:0031115,macrovesicular hepatic steatosis
MGI:6273493	Abca2<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001566,increased circulating phosphate level|MP:0010053,decreased grip strength|MP:0010123,increased bone mineral content
MGI:3697467	Abca2<tm1Kdt>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001488,increased startle reflex|MP:0001516,abnormal motor coordination/balance|MP:0002574,increased vertical activity|MP:0003459,increased fear-related response|MP:0003858,enhanced coordination|MP:0003871,abnormal myelin sheath morphology|MP:0031391,increased locomotor activity
MGI:3719855	Abca2<tm1Nina>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001525,impaired balance|MP:0001547,abnormal lipid level|MP:0001923,reduced female fertility|MP:0002572,abnormal emotion/affect behavior|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5581732	Abca3<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:3757572	Abca3<tm1Dgen>	MP:0001176,abnormal lung development|MP:0001179,thick pulmonary interalveolar septum|MP:0002270,abnormal pulmonary alveolus morphology|MP:0004780,abnormal surfactant secretion|MP:0004782,abnormal surfactant physiology|MP:0010814,absent alveolar lamellar bodies|MP:0010890,decreased alveolar lamellar body number|MP:0011087,neonatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3706347	Abca3<tm1Frm>	MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002118,abnormal lipid homeostasis|MP:0004780,abnormal surfactant secretion|MP:0005202,lethargy|MP:0005367,renal/urinary system phenotype|MP:0010814,absent alveolar lamellar bodies|MP:0010819,primary atelectasis|MP:0010909,pulmonary alveolar hemorrhage|MP:0011087,neonatal lethality, complete penetrance
MGI:3716562	Abca3<tm1Holz>	MP:0001177,atelectasis|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002275,abnormal type II pneumocyte morphology|MP:0004782,abnormal surfactant physiology|MP:0005202,lethargy|MP:0010813,abnormal alveolar lamellar body morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3709991	Abca3<tm1Nina>	MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002275,abnormal type II pneumocyte morphology|MP:0004781,abnormal surfactant composition|MP:0010018,pulmonary vascular congestion|MP:0010813,abnormal alveolar lamellar body morphology|MP:0010814,absent alveolar lamellar bodies|MP:0010817,absent type I pneumocytes|MP:0010825,abnormal lung saccule morphology|MP:0010897,abnormal bronchiole epithelium morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011143,thick lung-associated mesenchyme|MP:0011163,increased wet-to-dry lung weight ratio
MGI:6159285	Abca4<tm1.1Rsmy>	MP:0005201,abnormal retina pigment epithelium morphology|MP:0005253,abnormal eye physiology
MGI:4441732	Abca4<tm1a(EUCOMM)Wtsi>	MP:0004609,vertebral fusion|MP:0005561,increased mean corpuscular hemoglobin
MGI:1857860	Abca4<tm1Ght>	MP:0003011,delayed dark adaptation|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology|MP:0005253,abnormal eye physiology|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008584,photoreceptor outer segment degeneration|MP:0011232,abnormal vitamin A level
MGI:5752222	Abca4<tm2.1Kpal>	MP:0005391,vision/eye phenotype|MP:0008842,lipofuscinosis
MGI:7425480	Abca5<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0003068,enlarged kidney
MGI:3581814	Abca5<tm1Akya>	MP:0000598,abnormal liver morphology|MP:0000609,abnormal liver physiology|MP:0000745,tremors|MP:0001785,edema|MP:0002083,premature death|MP:0002750,exophthalmos|MP:0002795,dilated cardiomyopathy|MP:0003503,decreased activity of thyroid gland|MP:0004566,myocardial fiber degeneration|MP:0004696,abnormal thyroid follicle morphology|MP:0005314,absent thyroid gland|MP:0010017,visceral vascular congestion|MP:0020409,abnormal cardiac thrombosis
MGI:7256952	Abca6<em1Nju>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype
MGI:5513737	Abca6<tm2b(KOMP)Wtsi>	MP:0002608,increased hematocrit|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:3574592	Abca7<tm1Frm>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001783,decreased white adipose tissue amount|MP:0002989,small kidney|MP:0005179,decreased circulating cholesterol level
MGI:5605763	Abca7<tm2b(EUCOMM)Hmgu>	MP:0004151,decreased circulating iron level|MP:0005560,decreased circulating glucose level|MP:0011396,abnormal sleep behavior|MP:0013279,increased fasting circulating glucose level
MGI:6294772	Abca8a<em1(IMPC)J>	MP:0002098,abnormal vibrissa morphology|MP:0002608,increased hematocrit|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4432962	Abca8b<tm1a(EUCOMM)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level
MGI:5649019	Abca9<em1(IMPC)J>	MP:0020870,decreased thigmotaxis
MGI:5708657	Abcb10<tm1.2Tafu>	MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0001588,abnormal hemoglobin|MP:0001770,abnormal iron level|MP:0003396,abnormal embryonic hematopoiesis|MP:0003674,oxidative stress|MP:0003717,pallor|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013657,abnormal blood cell morphology
MGI:5445808	Abcb10<tm1Lex>	MP:0003674,oxidative stress|MP:0004485,increased response of heart to induced stress|MP:0005385,cardiovascular system phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0011092,embryonic lethality, complete penetrance
MGI:4434682	Abcb11<tm1a(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0005343,increased circulating aspartate transaminase level|MP:0005627,increased circulating potassium level
MGI:5548476	Abcb11<tm1b(EUCOMM)Hmgu>	MP:0001175,abnormal lung morphology|MP:0001402,decreased locomotor activity|MP:0002644,decreased circulating triglyceride level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0008806,increased circulating amylase level|MP:0010087,increased circulating fructosamine level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011896,increased circulating unsaturated transferrin level
MGI:2136289	Abcb11<tm1Wng>	MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0003982,increased cholesterol level|MP:0004772,abnormal bile secretion|MP:0004774,abnormal bile salt level|MP:0004777,abnormal phospholipid level|MP:0004789,increased bile salt level|MP:0005415,intrahepatic cholestasis|MP:0008991,abnormal bile canaliculus morphology|MP:0010398,decreased liver glycogen level
MGI:3044239	Abcb1a<mds>	MP:0000745,tremors|MP:0000811,hippocampal neuron degeneration|MP:0002083,premature death|MP:0002822,catalepsy|MP:0005011,increased eosinophil cell number|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:2180054	Abcb1a<tm1Bor>	MP:0000488,abnormal intestinal epithelium morphology|MP:0000491,crypts of Lieberkuhn abscesses|MP:0000511,abnormal intestinal mucosa morphology|MP:0000512,intestinal ulcer|MP:0002461,increased immunoglobulin level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0002816,colitis|MP:0003304,large intestinal inflammation|MP:0003945,abnormal lymphocyte physiology|MP:0004611,increased susceptibility to ototoxicity-induced hearing loss|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0004999,abnormal blood-inner ear barrier function|MP:0005037,mucous diarrhea|MP:0005150,cachexia|MP:0008351,decreased gamma-delta intraepithelial T cell number|MP:0008401,abnormal CD8 positive, alpha-beta intraepithelial T cell morphology|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0013803,increased IgG2 level|MP:0031384,impaired blood-brain barrier function
MGI:2155889	Abcb1b<tm2Bor>	MP:0008875,abnormal xenobiotic pharmacokinetics
MGI:6356812	Abcb4<em1(IMPC)H>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0002606,increased basophil cell number|MP:0002874,decreased hemoglobin content|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0004952,increased spleen weight|MP:0005013,increased lymphocyte cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005505,thrombocytosis|MP:0005553,increased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005627,increased circulating potassium level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010067,increased red blood cell distribution width
MGI:1857236	Abcb4<tm1Bor>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000195,decreased circulating calcium level|MP:0000202,abnormal circulating alkaline phosphatase level|MP:0000203,abnormal circulating aspartate transaminase level|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0000610,cholestasis|MP:0000691,enlarged spleen|MP:0001263,weight loss|MP:0001566,increased circulating phosphate level|MP:0001569,abnormal circulating bilirubin level|MP:0001570,abnormal circulating enzyme level|MP:0001573,abnormal circulating alanine transaminase level|MP:0001654,hepatic necrosis|MP:0001656,focal hepatic necrosis|MP:0001860,liver inflammation|MP:0001923,reduced female fertility|MP:0002118,abnormal lipid homeostasis|MP:0002138,abnormal hepatobiliary system morphology|MP:0002139,abnormal hepatobiliary system physiology|MP:0002647,decreased intestinal cholesterol absorption|MP:0002830,gallstones|MP:0002928,abnormal bile duct morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0002998,abnormal bone remodeling|MP:0003046,liver cirrhosis|MP:0003253,dilated bile duct|MP:0003254,bile duct inflammation|MP:0003255,bile duct proliferation|MP:0003256,biliary cirrhosis|MP:0003328,portal hypertension|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003333,liver fibrosis|MP:0003797,abnormal compact bone morphology|MP:0003888,liver hemorrhage|MP:0004772,abnormal bile secretion|MP:0004773,abnormal bile composition|MP:0004789,increased bile salt level|MP:0005179,decreased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005376,homeostasis/metabolism phenotype|MP:0005415,intrahepatic cholestasis|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0008837,increased transforming growth factor beta level|MP:0008991,abnormal bile canaliculus morphology|MP:0008993,abnormal portal triad morphology|MP:0009642,abnormal blood homeostasis|MP:0010124,decreased bone mineral content|MP:0010155,abnormal intestine physiology|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0010877,abnormal trabecular bone volume|MP:0010933,decreased trabecular bone connectivity density|MP:0011584,increased alkaline phosphatase activity|MP:0011977,abnormal sodium ion homeostasis|MP:0012336,decreased vitamin D level|MP:0014476,abnormal feces lipid level|MP:0014479,decreased feces bile salt level|MP:0020010,decreased bone mineral density of femur|MP:0020134,abnormal gallbladder size|MP:0021029,increased tumor necrosis factor (ligand) superfamily member 11 level
MGI:5637593	Abcb5<tm1.2Nyf>	MP:0000351,increased cell proliferation|MP:0001312,abnormal cornea morphology|MP:0001325,abnormal retina morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005253,abnormal eye physiology|MP:0006000,abnormal cornea epithelium morphology|MP:0020858,cornea epithelium hypoplasia|MP:0020861,abnormal cornea wound healing
MGI:4362220	Abcb6<tm1a(KOMP)Wtsi>	MP:0002098,abnormal vibrissa morphology
MGI:5426703	Abcb6<tm1Jsch>	MP:0003656,abnormal erythrocyte physiology|MP:0006036,abnormal mitochondrial physiology|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010831,lethality, incomplete penetrance|MP:0031276,abnormal stress erythropoiesis
MGI:5463225	Abcb6<tm1Pkr>	MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3628655	Abcb7<tm1.1Mdf>	MP:0002080,prenatal lethality|MP:0003121,genetic imprinting
MGI:3628654	Abcb7<tm1Mdf>	MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0001570,abnormal circulating enzyme level|MP:0001914,hemorrhage|MP:0003631,nervous system phenotype|MP:0003984,embryonic growth retardation|MP:0005032,abnormal ectoplacental cone morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005639,hemosiderosis|MP:0010768,mortality/aging|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0014341,abnormal hepatocyte mitochondrial morphology|MP:0014682,increased polyploid hepatocyte number
MGI:5315860	Abcb8<tm1Hard>	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003393,decreased cardiac output|MP:0003822,decreased left ventricle systolic pressure|MP:0004084,abnormal cardiac muscle relaxation|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0010579,increased heart left ventricle size|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0020367,increased heart iron level
MGI:5513738	Abcb9<tm1b(KOMP)Wtsi>	MP:0000702,enlarged lymph nodes|MP:0002768,small adrenal glands|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength
MGI:7425481	Abcc10<em1(IMPC)Bay>	MP:0000063,decreased bone mineral density|MP:0010124,decreased bone mineral content
MGI:5013608	Abcc10<tm1Eah>	MP:0000221,decreased leukocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0000692,small spleen|MP:0000711,thymus cortex hypoplasia|MP:0001262,decreased body weight|MP:0002356,abnormal spleen red pulp morphology|MP:0008479,decreased spleen white pulp amount|MP:0008482,decreased spleen germinal center number|MP:0008484,decreased spleen germinal center size|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:8233518	Abcc12<em1Yinc>	MP:0000598,abnormal liver morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003252,abnormal bile duct physiology|MP:0003333,liver fibrosis|MP:0005344,increased circulating bilirubin level|MP:0005376,homeostasis/metabolism phenotype|MP:0009497,abnormal intrahepatic bile duct morphology|MP:0010180,increased susceptibility to weight loss|MP:0012237,increased cholangiocyte apoptosis
MGI:2653091	Abcc1<tm1Acs>	MP:0001764,abnormal homeostasis|MP:0005397,hematopoietic system phenotype|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:2155908	Abcc1<tm1Bor>	MP:0001876,decreased inflammatory response|MP:0002423,abnormal mast cell physiology|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010768,mortality/aging
MGI:5609256	Abcc2<tm1.1(ABCC2)Arte>	MP:0005376,homeostasis/metabolism phenotype
MGI:3621934	Abcc2<tm1Ahs>	MP:0000609,abnormal liver physiology|MP:0002136,abnormal kidney physiology|MP:0002874,decreased hemoglobin content|MP:0002981,increased liver weight|MP:0004772,abnormal bile secretion|MP:0005344,increased circulating bilirubin level|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0009642,abnormal blood homeostasis|MP:0011464,bilirubinuria
MGI:3790671	Abcc2<tm1Dgen>	MP:0000609,abnormal liver physiology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0004772,abnormal bile secretion|MP:0004773,abnormal bile composition|MP:0005178,increased circulating cholesterol level|MP:0005344,increased circulating bilirubin level
MGI:5548478	Abcc2<tm2b(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0001556,increased circulating HDL cholesterol level|MP:0002591,decreased mean corpuscular volume|MP:0002941,increased circulating alanine transaminase level|MP:0003917,increased kidney weight|MP:0005016,decreased lymphocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008935,decreased mean platelet volume
MGI:3582301	Abcc3<tm1Bor>	MP:0001982,decreased chemically-elicited antinociception|MP:0005365,abnormal bile salt homeostasis|MP:0008875,abnormal xenobiotic pharmacokinetics
MGI:3689906	Abcc3<tm1Kruh>	MP:0004774,abnormal bile salt level|MP:0005344,increased circulating bilirubin level|MP:0005370,liver/biliary system phenotype
MGI:3526359	Abcc4<Gt(RRC212)Byg>	MP:0001973,increased thermal nociceptive threshold|MP:0008531,increased chemical nociceptive threshold|MP:0009815,decreased prostaglandin level
MGI:3047326	Abcc4<tm1Jsch>	MP:0005167,abnormal blood-brain barrier function|MP:0006088,abnormal blood-cerebrospinal fluid barrier function|MP:0006272,abnormal urine organic anion level
MGI:3697373	Abcc4<tm1Kruh>	MP:0000496,abnormal small intestine morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000692,small spleen|MP:0000711,thymus cortex hypoplasia|MP:0001263,weight loss|MP:0001858,intestinal inflammation|MP:0002356,abnormal spleen red pulp morphology|MP:0003306,small intestinal inflammation|MP:0005167,abnormal blood-brain barrier function|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008537,increased susceptibility to induced colitis|MP:0009642,abnormal blood homeostasis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0014263,decreased spleen B cell follicle number|MP:0014348,decreased spleen B cell follicle size
MGI:5749845	Abcc5<em1(IMPC)H>	MP:0000195,decreased circulating calcium level|MP:0000221,decreased leukocyte cell number|MP:0001488,increased startle reflex|MP:0001513,limb grasping|MP:0005012,decreased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005293,impaired glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level
MGI:3794119	Abcc5<tm1Bor>	MP:0005384,cellular phenotype
MGI:3639103	Abcc6<Dyscalc1-C3H/HeNCrl>	MP:0002839,increased susceptibility to dystrophic cardiac calcinosis
MGI:2384504	Abcc6<Dyscalc1-C57BL/10>	MP:0002838,decreased susceptibility to dystrophic cardiac calcinosis
MGI:2156661	Abcc6<Dyscalc1-C57BL/6J>	MP:0002838,decreased susceptibility to dystrophic cardiac calcinosis
MGI:2156733	Abcc6<Dyscalc1-DBA/2J>	MP:0002839,increased susceptibility to dystrophic cardiac calcinosis
MGI:2156660	Abcc6<rs32756904-T>	MP:0002839,increased susceptibility to dystrophic cardiac calcinosis
MGI:3614409	Abcc6<tm1Aabb>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000530,abnormal kidney vasculature morphology|MP:0003196,calcified skin|MP:0005239,abnormal Bruch membrane morphology|MP:0005553,increased circulating creatinine level|MP:0006133,calcified artery
MGI:6195711	Abcc6<tm1c(EUCOMM)Wtsi>	MP:0003195,calcinosis|MP:0003196,calcified skin|MP:0010771,integument phenotype|MP:0030533,abnormal snout skin morphology
MGI:3045236	Abcc6<tm1Jfk>	MP:0003195,calcinosis|MP:0003196,calcified skin|MP:0003197,nephrocalcinosis|MP:0006133,calcified artery|MP:0006188,calcified retina|MP:0010234,abnormal vibrissa follicle morphology|MP:0030533,abnormal snout skin morphology
MGI:6273498	Abcc8<em1(IMPC)J>	MP:0003960,increased lean body mass|MP:0005293,impaired glucose tolerance
MGI:5568409	Abcc8<tm1.1Fmas>	MP:0003058,increased insulin secretion|MP:0003059,decreased insulin secretion|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005559,increased circulating glucose level|MP:0005560,decreased circulating glucose level
MGI:2388392	Abcc8<tm1.1Mgn>	MP:0000189,hypoglycemia|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance
MGI:2386677	Abcc8<tm1Jbry>	MP:0000189,hypoglycemia|MP:0003059,decreased insulin secretion|MP:0003564,abnormal insulin secretion|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0005560,decreased circulating glucose level
MGI:6304244	Abcc9<em1(IMPC)H>	MP:0000220,increased monocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0010052,increased grip strength
MGI:6389010	Abcc9<em1Nich>	MP:0000249,abnormal blood vessel physiology|MP:0000274,enlarged heart|MP:0001596,hypotension|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0003394,increased cardiac output|MP:0003484,abnormal channel response|MP:0005590,increased vasodilation|MP:0005595,abnormal vascular smooth muscle physiology|MP:0006047,aortic valve regurgitation|MP:0008770,decreased survivor rate|MP:0010468,abnormal thoracic aorta morphology|MP:0010575,aortic arch dilation|MP:0011925,abnormal heart echocardiography feature|MP:0011951,increased cardiac stroke volume
MGI:6389242	Abcc9<em2Nich>	MP:0002753,dilated heart left ventricle|MP:0002842,increased systemic arterial blood pressure|MP:0003484,abnormal channel response|MP:0003646,increased muscle fatigability|MP:0005386,behavior/neurological phenotype|MP:0011925,abnormal heart echocardiography feature|MP:0031633,decreased heart left ventricle muscle contractility
MGI:6822330	Abcc9<em3Nich>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0003137,abnormal impulse conducting system conduction|MP:0004937,dilated heart|MP:0005385,cardiovascular system phenotype|MP:0008872,abnormal physiological response to xenobiotic|MP:0009865,abnormal aorta smooth muscle morphology|MP:0010574,dilated aorta|MP:0020345,abnormal myocardial fiber currents
MGI:5646147	Abcc9<tm1.1Mcn>	MP:0000274,enlarged heart|MP:0002833,increased heart weight|MP:0003674,oxidative stress|MP:0005039,hypoxia|MP:0005140,decreased cardiac muscle contractility|MP:0005290,decreased oxygen consumption|MP:0005330,cardiomyopathy|MP:0005376,homeostasis/metabolism phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011390,abnormal fetal cardiomyocyte physiology|MP:0011631,decreased mitochondrial size|MP:0014172,decreased fatty acid oxidation|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:2155916	Abcc9<tm1Cfb>	MP:0000189,hypoglycemia|MP:0000230,abnormal systemic arterial blood pressure|MP:0000231,hypertension|MP:0002083,premature death|MP:0002891,increased insulin sensitivity|MP:0003897,abnormal ST segment|MP:0005292,improved glucose tolerance|MP:0005595,abnormal vascular smooth muscle physiology|MP:0006135,artery stenosis|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008489,slow postnatal weight gain|MP:0031192,coronary artery spasm|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:4433571	Abcd1<tm1a(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002169,no abnormal phenotype detected
MGI:1861771	Abcd1<tm1Kan>	MP:0001921,reduced fertility|MP:0002118,abnormal lipid homeostasis|MP:0005281,increased fatty acids level
MGI:2155926	Abcd1<tm1Kds>	MP:0000136,abnormal microglial cell morphology|MP:0000920,abnormal myelination|MP:0000955,abnormal spinal cord morphology|MP:0001106,abnormal Schwann cell morphology|MP:0001405,impaired coordination|MP:0001516,abnormal motor coordination/balance|MP:0002118,abnormal lipid homeostasis|MP:0002182,abnormal astrocyte morphology|MP:0002757,decreased vertical activity|MP:0003313,abnormal locomotor activation|MP:0003354,astrocytosis|MP:0003633,abnormal nervous system physiology|MP:0005281,increased fatty acids level|MP:0005284,increased saturated fatty acids level|MP:0005403,abnormal nerve conduction|MP:0005405,axon degeneration|MP:0008288,abnormal adrenal cortex morphology|MP:0008294,abnormal adrenal gland zona fasciculata morphology|MP:0008295,abnormal adrenal gland zona reticularis morphology
MGI:2429945	Abcd1<tm1Ymd>	MP:0002118,abnormal lipid homeostasis
MGI:3612442	Abcd2<tm1Apuj>	MP:0000136,abnormal microglial cell morphology|MP:0000745,tremors|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000952,abnormal CNS glial cell morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001392,abnormal locomotor behavior|MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001504,abnormal posture|MP:0001516,abnormal motor coordination/balance|MP:0001525,impaired balance|MP:0002182,abnormal astrocyte morphology|MP:0002183,gliosis|MP:0002272,abnormal nervous system electrophysiology|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0003633,abnormal nervous system physiology|MP:0005281,increased fatty acids level|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration
MGI:5803796	Abcd3<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0000194,increased circulating calcium level|MP:0000367,abnormal coat/ hair morphology|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002075,abnormal coat/hair pigmentation|MP:0002644,decreased circulating triglyceride level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0005278,abnormal cholesterol homeostasis|MP:0005292,improved glucose tolerance|MP:0005568,increased circulating total protein level|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0013279,increased fasting circulating glucose level
MGI:5695545	Abcd3<tm1Safe>	MP:0000599,enlarged liver|MP:0004773,abnormal bile composition|MP:0009642,abnormal blood homeostasis|MP:0014010,abnormal peroxisome morphology
MGI:4434636	Abcd4<tm1a(EUCOMM)Hmgu>	MP:0001413,abnormal response to new environment|MP:0005316,abnormal response to tactile stimuli
MGI:5287492	Abce1<Tg(Tyr)2295G-2b3Ove>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5696882	Abce1<tm1.1(KOMP)Vlcg>	MP:0000219,increased neutrophil cell number|MP:0000702,enlarged lymph nodes|MP:0002059,abnormal seminal vesicle morphology|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:6120699	Abce1<tm1b(EUCOMM)Hmgu>	MP:0001293,anophthalmia|MP:0005554,decreased circulating creatinine level|MP:0011100,preweaning lethality, complete penetrance|MP:0012362,increased large unstained cell number|MP:0013292,embryonic lethality prior to organogenesis
MGI:4127483	Abcf1<Gt(XK097)Byg>	MP:0013292,embryonic lethality prior to organogenesis
MGI:3715323	Abcg1<tm1Asch>	MP:0000189,hypoglycemia|MP:0002971,abnormal brown adipose tissue morphology|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005533,increased body temperature|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009115,abnormal fat cell morphology|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis|MP:0031391,increased locomotor activity
MGI:3695417	Abcg1<tm1Dgen>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0001175,abnormal lung morphology|MP:0001183,overexpanded pulmonary alveolus|MP:0001547,abnormal lipid level|MP:0001861,lung inflammation|MP:0002446,abnormal macrophage morphology|MP:0002451,abnormal macrophage physiology|MP:0002628,hepatic steatosis|MP:0003009,abnormal cytokine secretion|MP:0003193,decreased cholesterol efflux|MP:0004777,abnormal phospholipid level|MP:0004778,increased macrophage derived foam cell number|MP:0004780,abnormal surfactant secretion|MP:0005011,increased eosinophil cell number|MP:0005014,increased B cell number|MP:0005317,increased triglyceride level|MP:0005367,renal/urinary system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008112,abnormal monocyte differentiation|MP:0008126,increased dendritic cell number|MP:0008246,abnormal leukocyte morphology|MP:0008570,lipidosis|MP:0008722,abnormal chemokine secretion|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0031632,increased lung cholesterol level
MGI:6726365	Abcg2<em1Omw>	MP:0002079,increased circulating insulin level|MP:0002136,abnormal kidney physiology|MP:0002628,hepatic steatosis|MP:0004702,increased circulating insulin-like growth factor I level|MP:0005528,decreased renal glomerular filtration rate|MP:0005559,increased circulating glucose level|MP:0005627,increased circulating potassium level|MP:0006316,increased urine sodium level|MP:0008055,increased urine osmolality|MP:0008821,increased blood uric acid level|MP:0010155,abnormal intestine physiology
MGI:5505632	Abcg2<tm1.1(KOMP)Vlcg>	MP:0001307,fused cornea and lens|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005566,decreased blood urea nitrogen level
MGI:5506750	Abcg2<tm1.1Ssf>	MP:0000607,abnormal hepatocyte morphology|MP:0001860,liver inflammation|MP:0002078,abnormal glucose homeostasis|MP:0002398,abnormal bone marrow cell morphology/development|MP:0003674,oxidative stress|MP:0004147,increased porphyrin level|MP:0005293,impaired glucose tolerance|MP:0006036,abnormal mitochondrial physiology|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0010398,decreased liver glycogen level|MP:0010955,abnormal respiratory electron transport chain|MP:0010959,abnormal oxidative phosphorylation|MP:0011635,abnormal mitochondrial crista morphology|MP:0014341,abnormal hepatocyte mitochondrial morphology
MGI:2447196	Abcg2<tm1Ahs>	MP:0000341,abnormal bile color|MP:0001764,abnormal homeostasis|MP:0005344,increased circulating bilirubin level|MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0005653,phototoxicity|MP:0005654,porphyria|MP:0008821,increased blood uric acid level|MP:0009810,increased urine uric acid level
MGI:3578727	Abcg2<tm1Bsor>	MP:0002396,abnormal hematopoietic system morphology/development|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:5444690	Abcg2<tm3.1(cre/ERT2)Bsor>	MP:0002169,no abnormal phenotype detected
MGI:3795864	Abcg4<tm1Dgen>	MP:0001547,abnormal lipid level
MGI:2687002	Abcg5<tm1Plo>	MP:0000599,enlarged liver|MP:0000609,abnormal liver physiology|MP:0001552,increased circulating triglyceride level|MP:0001783,decreased white adipose tissue amount|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002118,abnormal lipid homeostasis|MP:0002981,increased liver weight|MP:0003975,increased circulating VLDL triglyceride level|MP:0003983,decreased cholesterol level|MP:0004772,abnormal bile secretion|MP:0004777,abnormal phospholipid level|MP:0005179,decreased circulating cholesterol level|MP:0005266,abnormal metabolism|MP:0005278,abnormal cholesterol homeostasis|MP:0009269,decreased fat cell size|MP:0010078,increased circulating phytosterol level
MGI:2156990	Abcg5<trac>	MP:0000180,abnormal circulating cholesterol level|MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000229,abnormal megakaryocyte differentiation|MP:0001156,abnormal spermatogenesis|MP:0001265,decreased body size|MP:0001505,hunched posture|MP:0001585,hemolytic anemia|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002083,premature death|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002417,abnormal megakaryocyte morphology|MP:0002599,increased mean platelet volume|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0003141,cardiac fibrosis|MP:0003179,thrombocytopenia|MP:0003949,abnormal circulating lipid level|MP:0004720,abnormal platelet morphology|MP:0005065,abnormal neutrophil morphology|MP:0005330,cardiomyopathy|MP:0005606,increased bleeding time|MP:0006298,abnormal platelet activation|MP:0008254,increased megakaryocyte cell number|MP:0009549,decreased platelet aggregation|MP:0010074,stomatocytosis|MP:0014060,abnormal platelet alpha-granule morphology|MP:0030025,giant platelets|MP:0031085,increased erythrocyte osmotic fragility
MGI:5810735	Abcg8<tm1b(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001523,impaired righting response|MP:0001552,increased circulating triglyceride level|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002591,decreased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002874,decreased hemoglobin content|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003921,abnormal heart left ventricle morphology|MP:0004151,decreased circulating iron level|MP:0005018,decreased T cell number|MP:0005178,increased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005343,increased circulating aspartate transaminase level|MP:0005387,immune system phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005599,increased cardiac muscle contractility|MP:0005627,increased circulating potassium level|MP:0005634,decreased circulating sodium level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008040,decreased NK T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008207,decreased B-2 B cell number|MP:0010067,increased red blood cell distribution width|MP:0010097,abnormal retina blood vessel morphology|MP:0011044,increased lung elastance|MP:0013510,decreased CD4-negative NK T cell number|MP:0013513,decreased memory-marker CD4-negative NK T cell number
MGI:3514037	Abcg8<tm1Elk>	MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001783,decreased white adipose tissue amount|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002139,abnormal hepatobiliary system physiology|MP:0003983,decreased cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0009269,decreased fat cell size|MP:0010078,increased circulating phytosterol level
MGI:6140122	Abhd10<em1(IMPC)Mbp>	MP:0001925,male infertility|MP:0002606,increased basophil cell number|MP:0005011,increased eosinophil cell number
MGI:6158461	Abhd11<em1(IMPC)Mbp>	MP:0000538,abnormal urinary bladder morphology|MP:0001297,microphthalmia|MP:0001399,hyperactivity|MP:0002092,abnormal eye morphology
MGI:6471012	Abhd11<tm1Esco>	MP:0001262,decreased body weight|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002001,blindness|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003867,increased defecation amount|MP:0004222,iris synechia|MP:0005194,abnormal anterior uvea morphology|MP:0005292,improved glucose tolerance|MP:0005386,behavior/neurological phenotype|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009287,decreased abdominal fat pad weight|MP:0014476,abnormal feces lipid level
MGI:6274349	Abhd12b<em1(IMPC)J>	MP:0013279,increased fasting circulating glucose level
MGI:5487621	Abhd12<tm1Crv>	MP:0000747,muscle weakness|MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001489,decreased startle reflex|MP:0004777,abnormal phospholipid level|MP:0005391,vision/eye phenotype|MP:0006325,impaired hearing|MP:0006359,absent startle reflex|MP:0008918,microgliosis|MP:0011579,decreased lipoprotein lipase activity|MP:0014740,increased auditory brainstem response wave peak latency|MP:0014742,increased auditory brainstem response wave interpeak latency
MGI:6140123	Abhd13<em1(IMPC)Mbp>	MP:0001415,increased exploration in new environment|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002092,abnormal eye morphology|MP:0004953,decreased spleen weight|MP:0020421,increased freezing behavior
MGI:4842383	Abhd14a<tm2a(EUCOMM)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0005292,improved glucose tolerance
MGI:6274308	Abhd14b<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001513,limb grasping
MGI:8226233	Abhd15<em1Dejs>	MP:0000603,pale liver|MP:0001554,increased circulating free fatty acids level|MP:0002971,abnormal brown adipose tissue morphology|MP:0005318,decreased triglyceride level|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005670,abnormal white adipose tissue physiology|MP:0008033,impaired lipolysis|MP:0008034,enhanced lipolysis|MP:0008469,abnormal protein level|MP:0009355,increased liver triglyceride level|MP:0011698,abnormal brown adipose tissue physiology
MGI:8226234	Abhd15<em2Dejs>	MP:0000603,pale liver|MP:0001554,increased circulating free fatty acids level|MP:0002971,abnormal brown adipose tissue morphology|MP:0005318,decreased triglyceride level|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005670,abnormal white adipose tissue physiology|MP:0008033,impaired lipolysis|MP:0008034,enhanced lipolysis|MP:0008469,abnormal protein level|MP:0009355,increased liver triglyceride level|MP:0011698,abnormal brown adipose tissue physiology
MGI:8226235	Abhd15<em3Dejs>	MP:0000603,pale liver|MP:0001554,increased circulating free fatty acids level|MP:0002971,abnormal brown adipose tissue morphology|MP:0005318,decreased triglyceride level|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005670,abnormal white adipose tissue physiology|MP:0008033,impaired lipolysis|MP:0008034,enhanced lipolysis|MP:0008469,abnormal protein level|MP:0009355,increased liver triglyceride level|MP:0011698,abnormal brown adipose tissue physiology
MGI:6281436	Abhd15<tm1.1Jgbs>	MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0003926,decreased cellular glucose uptake|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005559,increased circulating glucose level|MP:0005670,abnormal white adipose tissue physiology|MP:0008034,enhanced lipolysis|MP:0008469,abnormal protein level|MP:0009133,decreased white fat cell size|MP:0009295,decreased interscapular fat pad weight|MP:0014146,decreased white adipose tissue mass|MP:0020868,decreased lipogenesis|MP:0030017,decreased adipocyte glucose uptake|MP:0030020,decreased cardiac muscle cell glucose uptake|MP:0030968,decreased circulating adiponectin level
MGI:5692674	Abhd15<tm1b(KOMP)Wtsi>	MP:0001488,increased startle reflex|MP:0010052,increased grip strength|MP:0011960,abnormal eye anterior chamber depth
MGI:6281435	Abhd15<tm1Jgbs>	MP:0003960,increased lean body mass|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0008034,enhanced lipolysis|MP:0008469,abnormal protein level|MP:0010379,decreased respiratory quotient|MP:0013245,abnormal lipid metabolism|MP:0014143,decreased body fat mass|MP:0030968,decreased circulating adiponectin level
MGI:4820220	Abhd16a<tm1a(EUCOMM)Wtsi>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001925,male infertility|MP:0002451,abnormal macrophage physiology|MP:0003960,increased lean body mass|MP:0004777,abnormal phospholipid level|MP:0005386,behavior/neurological phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008561,decreased tumor necrosis factor secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008706,decreased interleukin-6 secretion|MP:0010025,decreased total body fat amount|MP:0010093,decreased circulating magnesium level|MP:0011079,decreased macrophage cytokine production|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:7639938	Abhd17a<em1Eko>	MP:0004811,abnormal neuron physiology
MGI:5013744	Abhd17a<tm1a(KOMP)Wtsi>	MP:0005292,improved glucose tolerance
MGI:5696235	Abhd17b<em1(IMPC)J>	MP:0001312,abnormal cornea morphology|MP:0001325,abnormal retina morphology|MP:0002546,mydriasis|MP:0020870,decreased thigmotaxis
MGI:6276853	Abhd17c<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001297,microphthalmia|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002188,small heart|MP:0002339,abnormal lymph node morphology|MP:0002942,decreased circulating alanine transaminase level|MP:0002989,small kidney|MP:0009552,urinary bladder obstruction
MGI:7257779	Abhd2<em1Lshko>	MP:0001126,abnormal ovary morphology|MP:0001130,abnormal ovarian folliculogenesis|MP:0001927,abnormal estrous cycle|MP:0002681,increased corpora lutea number|MP:0005389,reproductive system phenotype|MP:0008870,increased mature ovarian follicle number|MP:0009012,short diestrus|MP:0009015,short proestrus|MP:0009017,prolonged estrus|MP:0011129,decreased tertiary ovarian follicle number|MP:0013508,increased granulosa cell apoptosis|MP:0031239,increased atretic ovarian follicle number|MP:0031421,increased superovulation rate
MGI:3531515	Abhd2<Gt(pUHachi)8025Imeg>	MP:0003091,abnormal cell migration|MP:0004883,abnormal vascular wound healing
MGI:6273658	Abhd4<em1(IMPC)J>	MP:0001417,decreased exploration in new environment
MGI:6343190	Abhd4<tm1Crv>	MP:0002118,abnormal lipid homeostasis|MP:0005386,behavior/neurological phenotype|MP:0005584,abnormal enzyme/coenzyme activity
MGI:5523003	Abhd5<tm1.1Lqyu>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0001547,abnormal lipid level|MP:0001860,liver inflammation|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003333,liver fibrosis|MP:0003674,oxidative stress|MP:0004777,abnormal phospholipid level|MP:0005343,increased circulating aspartate transaminase level|MP:0005376,homeostasis/metabolism phenotype|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0010359,increased liver free fatty acids level|MP:0011582,decreased triglyceride lipase activity|MP:0014172,decreased fatty acid oxidation|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis
MGI:4456205	Abhd5<tm1.1Rze>	MP:0001242,hyperkeratosis|MP:0001258,decreased body length|MP:0001547,abnormal lipid level|MP:0002058,neonatal lethality|MP:0002118,abnormal lipid homeostasis|MP:0002441,abnormal granulocyte morphology|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0003941,abnormal skin development|MP:0005282,decreased fatty acids level|MP:0005317,increased triglyceride level|MP:0005501,abnormal skin physiology|MP:0005560,decreased circulating glucose level|MP:0008033,impaired lipolysis|MP:0009355,increased liver triglyceride level|MP:0009611,epidermis stratum spinosum hyperplasia|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0011582,decreased triglyceride lipase activity
MGI:4364049	Abhd5<tm1a(KOMP)Wtsi>	MP:0000455,abnormal maxilla morphology|MP:0001262,decreased body weight|MP:0002784,abnormal Sertoli cell morphology|MP:0009347,increased trabecular bone thickness|MP:0010869,decreased bone trabecula number
MGI:5906416	Abhd5<tm1Murm>	MP:0005317,increased triglyceride level|MP:0012232,abnormal ceramide level
MGI:5502402	Abhd5<tm1Rze>	MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002833,increased heart weight|MP:0003915,increased heart left ventricle weight|MP:0003921,abnormal heart left ventricle morphology|MP:0005290,decreased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005560,decreased circulating glucose level|MP:0008033,impaired lipolysis|MP:0009356,decreased liver triglyceride level|MP:0010378,increased respiratory quotient|MP:0010535,myocardium steatosis|MP:0011579,decreased lipoprotein lipase activity|MP:0030018,increased cardiac muscle cell glucose uptake|MP:0031415,increased skeletal muscle triglyceride level|MP:0031418,increased cardiac muscle triglyceride level|MP:0031633,decreased heart left ventricle muscle contractility
MGI:6140124	Abhd6<em1(IMPC)Mbp>	MP:0002699,abnormal vitreous body morphology
MGI:4458703	Abhd6<tm1a(EUCOMM)Hmgu>	MP:0000003,abnormal adipose tissue morphology|MP:0000598,abnormal liver morphology|MP:0001262,decreased body weight|MP:0001547,abnormal lipid level|MP:0001777,abnormal body temperature homeostasis|MP:0002079,increased circulating insulin level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003058,increased insulin secretion|MP:0003059,decreased insulin secretion|MP:0003402,decreased liver weight|MP:0003562,abnormal pancreatic beta cell physiology|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009133,decreased white fat cell size|MP:0009136,decreased brown fat cell size|MP:0009356,decreased liver triglyceride level|MP:0011940,decreased food intake|MP:0014143,decreased body fat mass|MP:0014173,increased fatty acid beta-oxidation|MP:0014574,decreased circulating resistin level|MP:0020521,browned white adipose tissue morphology|MP:0030016,increased adipocyte glucose uptake|MP:0031391,increased locomotor activity|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:5907201	Abhd6<tm1c(EUCOMM)Hmgu>	MP:0002079,increased circulating insulin level|MP:0003058,increased insulin secretion|MP:0005292,improved glucose tolerance
MGI:5612824	Abhd8<tm1b(EUCOMM)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0003020,decreased circulating chloride level|MP:0005179,decreased circulating cholesterol level|MP:0005627,increased circulating potassium level|MP:0010024,increased total body fat amount
MGI:4950558	Abi1<tm1.2Lko>	MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0000930,wavy neural tube|MP:0001787,pericardial edema|MP:0003984,embryonic growth retardation|MP:0004937,dilated heart|MP:0010395,abnormal pharyngeal arch development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012270,cardiac edema
MGI:3613611	Abi1<tm1Pen>	MP:0001622,abnormal vasculogenesis|MP:0001634,internal hemorrhage|MP:0001785,edema|MP:0002190,disorganized myocardium|MP:0002836,abnormal chorion morphology|MP:0003057,abnormal epicardium morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003974,abnormal endocardium morphology|MP:0003984,embryonic growth retardation|MP:0005602,decreased angiogenesis|MP:0009657,failure of chorioallantoic fusion|MP:0010545,abnormal heart layer morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012095,increased Reichert's membrane thickness
MGI:5760383	Abi2<tm1b(EUCOMM)Wtsi>	MP:0001147,small testis|MP:0001312,abnormal cornea morphology|MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0002059,abnormal seminal vesicle morphology|MP:0002941,increased circulating alanine transaminase level|MP:0005102,abnormal iris pigmentation|MP:0009142,decreased prepulse inhibition|MP:0009252,absent urinary bladder
MGI:3526871	Abi2<tm1Pen>	MP:0000780,abnormal corpus callosum morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001469,abnormal contextual conditioning behavior|MP:0002579,disorganized secondary lens fibers|MP:0003236,abnormal lens capsule morphology|MP:0005545,abnormal lens development|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0009969,abnormal cerebral cortex pyramidal cell morphology
MGI:6359786	Abi3bp<tm1.1Smoc>	MP:0002006,neoplasm|MP:0002797,increased thigmotaxis|MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype
MGI:5605816	Abi3bp<tm1e.1(KOMP)Mbp>	MP:0002100,abnormal tooth morphology|MP:0002599,increased mean platelet volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0010053,decreased grip strength|MP:0010067,increased red blood cell distribution width|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6356821	Abi3bp<tm1Tac>	MP:0000351,increased cell proliferation|MP:0005076,abnormal cell differentiation|MP:0031217,increased susceptibility to myocardial ischemic injury|MP:0031633,decreased heart left ventricle muscle contractility
MGI:6150877	Abitram<tm1b(EUCOMM)Wtsi>	MP:0002792,abnormal retina vasculature morphology|MP:0005599,increased cardiac muscle contractility|MP:0010123,increased bone mineral content|MP:0011965,decreased total retina thickness
MGI:1856663	Abl1<m1>	MP:0000689,abnormal spleen morphology|MP:0000694,spleen hypoplasia|MP:0000703,abnormal thymus morphology|MP:0000711,thymus cortex hypoplasia|MP:0000715,decreased thymocyte number|MP:0000716,abnormal immune system cell morphology|MP:0001262,decreased body weight|MP:0001302,eyelids open at birth|MP:0001304,cataract|MP:0001823,thymus hypoplasia|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0002169,no abnormal phenotype detected|MP:0002357,abnormal spleen white pulp morphology|MP:0002359,abnormal spleen germinal center morphology|MP:0002401,abnormal lymphopoiesis|MP:0002406,increased susceptibility to infection|MP:0002722,abnormal immune system organ morphology|MP:0006387,abnormal T cell number|MP:0008082,increased single-positive T cell number|MP:0008083,decreased single-positive T cell number|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008525,decreased cranium height|MP:0009278,abnormal bone marrow cell physiology|MP:0009333,abnormal splenocyte physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0014469,abnormal B cell calcium ion homeostasis
MGI:4939889	Abl1<tm1.1Gcos>	MP:0000729,abnormal myogenesis|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:4421532	Abl1<tm1.1Goff>	MP:0002169,no abnormal phenotype detected
MGI:3525886	Abl1<tm1Ajk>	MP:0003631,nervous system phenotype|MP:0005166,decreased susceptibility to injury|MP:0005386,behavior/neurological phenotype
MGI:4421531	Abl1<tm1Goff>	MP:0000274,enlarged heart|MP:0000275,heart hyperplasia|MP:0002953,thick ventricular wall|MP:0005294,abnormal heart ventricle morphology|MP:0005385,cardiovascular system phenotype|MP:0011087,neonatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:2153718	Abl1<tm1Mlg>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000275,heart hyperplasia|MP:0000278,abnormal myocardial fiber morphology|MP:0000333,decreased bone marrow cell number|MP:0000493,rectal prolapse|MP:0000607,abnormal hepatocyte morphology|MP:0000689,abnormal spleen morphology|MP:0000715,decreased thymocyte number|MP:0001265,decreased body size|MP:0001861,lung inflammation|MP:0002092,abnormal eye morphology|MP:0002406,increased susceptibility to infection|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0003140,dilated heart atrium|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0004056,abnormal myocardium compact layer morphology|MP:0004067,abnormal trabecula carnea morphology|MP:0004545,enlarged esophagus|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005150,cachexia|MP:0005294,abnormal heart ventricle morphology|MP:0005385,cardiovascular system phenotype|MP:0006321,increased myocardial fiber number|MP:0008525,decreased cranium height|MP:0008770,decreased survivor rate|MP:0008772,increased heart ventricle size|MP:0010724,thick interventricular septum|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011394,increased fetal cardiomyocyte proliferation|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0031131,myocardial fiber disarray
MGI:4850041	Abl1<tm2.2Goff>	MP:0000854,abnormal cerebellum development|MP:0000857,abnormal cerebellar foliation|MP:0001265,decreased body size|MP:0002762,ectopic cerebellar granule cells|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4458329	Abl2<Gt(kin)Byg>	MP:0003631,nervous system phenotype|MP:0004179,transmission ratio distortion
MGI:2153719	Abl2<tm1Ajk>	MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001489,decreased startle reflex|MP:0001516,abnormal motor coordination/balance|MP:0001921,reduced fertility|MP:0005357,novel environmental response-related retropulsion|MP:0005656,decreased aggression|MP:0006359,absent startle reflex|MP:0009969,abnormal cerebral cortex pyramidal cell morphology
MGI:2676007	Ablim1<tm1Tili>	MP:0002169,no abnormal phenotype detected
MGI:6284829	Ablim2<em1(IMPC)J>	MP:0010053,decreased grip strength
MGI:6257511	Ablim3<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001258,decreased body length|MP:0001293,anophthalmia|MP:0001417,decreased exploration in new environment|MP:0002607,decreased basophil cell number|MP:0002608,increased hematocrit|MP:0005013,increased lymphocyte cell number|MP:0020421,increased freezing behavior
MGI:3521889	Ablp<BALB/cJ>	MP:0005319,abnormal enzyme/coenzyme level
MGI:3032987	Abmm<DBA/2J>	MP:0001856,myocarditis
MGI:1856660	abn	MP:0000111,cleft palate|MP:0000435,shortened head|MP:0000547,short limbs|MP:0000599,enlarged liver|MP:0009908,protruding tongue|MP:0011091,prenatal lethality, complete penetrance
MGI:5548732	Abo<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002060,abnormal skin morphology
MGI:4881716	Abra<tm1Eno>	MP:0003410,abnormal artery development|MP:0005165,increased susceptibility to injury
MGI:6296766	Abraxas1<tm1.1Bwng>	MP:0001658,increased mortality induced by gamma-irradiation|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002020,increased tumor incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002083,premature death|MP:0004029,spontaneous chromosome breakage|MP:0009321,increased histiocytic sarcoma incidence|MP:0012431,increased lymphoma incidence|MP:0014040,increased cellular sensitivity to DNA damaging agent induced cell death|MP:0014764,impaired double-strand DNA break repair|MP:0031678,increased micronucleus incidence
MGI:7867252	Abraxas2<tm1.2Bwng>	MP:0000691,enlarged spleen|MP:0001846,increased inflammatory response|MP:0002020,increased tumor incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002083,premature death|MP:0003111,abnormal cell nucleus morphology|MP:0003702,abnormal chromosome morphology|MP:0004046,abnormal mitosis|MP:0005384,cellular phenotype|MP:0008057,abnormal DNA replication|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008866,chromosomal instability|MP:0012431,increased lymphoma incidence|MP:0013374,increased sebaceous gland tumor incidence|MP:0014040,increased cellular sensitivity to DNA damaging agent induced cell death|MP:0031678,increased micronucleus incidence
MGI:7545513	Abraxas2<tm1Nju>	MP:0001876,decreased inflammatory response|MP:0002451,abnormal macrophage physiology|MP:0005387,immune system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008658,decreased interleukin-1 beta secretion|MP:0008685,decreased interleukin-18 secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0014788,decreased protein level
MGI:2388713	Abr<tm1Jhg>	MP:0002169,no abnormal phenotype detected
MGI:3829729	Abshq1<PWK/PhJ>	MP:0009230,abnormal sperm head morphology
MGI:3829731	Abshq2<PWK/PhJ>	MP:0009230,abnormal sperm head morphology
MGI:3829733	Abshq3<PWK/PhJ>	MP:0009230,abnormal sperm head morphology
MGI:3829734	Abshq4<PWK/PhJ>	MP:0009230,abnormal sperm head morphology
MGI:3829737	Abshq5<PWK/PhJ>	MP:0009230,abnormal sperm head morphology
MGI:3829739	Abshq6<PWK/PhJ>	MP:0009230,abnormal sperm head morphology
MGI:3829741	Abshq7<PWK/PhJ>	MP:0009230,abnormal sperm head morphology
MGI:6341888	Abtb1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002060,abnormal skin morphology|MP:0013279,increased fasting circulating glucose level
MGI:4451397	Abtb2<tm1a(KOMP)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0010052,increased grip strength
MGI:6359867	Abtb2<tm1Zgwg>	MP:0005517,impaired liver regeneration|MP:0020148,abnormal susceptibility to induced morbidity/mortality
MGI:7493862	Abtb3<tm1c(EUCOMM)Wtsi>	MP:0001364,decreased anxiety-related response|MP:0001415,increased exploration in new environment|MP:0002272,abnormal nervous system electrophysiology|MP:0002574,increased vertical activity|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0009746,enhanced behavioral response to xenobiotic|MP:0014376,decreased miniature excitatory postsynaptic current frequency|MP:0020422,decreased freezing behavior|MP:0020551,abnormal postsynaptic density morphology|MP:0021010,impaired synaptic physiology
MGI:5752853	Aby	MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0002081,perinatal lethality|MP:0009743,preaxial polydactyly
MGI:1856647	ac	MP:0002196,absent corpus callosum
MGI:5702328	Aca71	MP:0001306,small lens
MGI:8245457	Acaa1a<em1Syki>	MP:0002169,no abnormal phenotype detected
MGI:3617359	Acaa1b<tm1Vnf>	MP:0002169,no abnormal phenotype detected
MGI:7539663	Acaa2<em1(IMPC)Bay>	MP:0001417,decreased exploration in new environment
MGI:3700955	Acaca<tm1.1Jkus>	MP:0003984,embryonic growth retardation|MP:0006207,embryonic lethality during organogenesis
MGI:5618483	Acaca<tm1Dejs>	MP:0002444,abnormal T cell physiology|MP:0005018,decreased T cell number|MP:0005387,immune system phenotype|MP:0008050,decreased memory T cell number|MP:0013245,abnormal lipid metabolism
MGI:3700954	Acaca<tm1Jkus>	MP:0002118,abnormal lipid homeostasis|MP:0005343,increased circulating aspartate transaminase level|MP:0009356,decreased liver triglyceride level
MGI:3603457	Acaca<tm1Sjw>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3641125	Acaca<tm2Sjw>	MP:0000609,abnormal liver physiology|MP:0001547,abnormal lipid level|MP:0001554,increased circulating free fatty acids level|MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002310,decreased susceptibility to hepatic steatosis|MP:0002702,decreased circulating free fatty acids level|MP:0003458,decreased circulating ketone body level|MP:0005282,decreased fatty acids level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009356,decreased liver triglyceride level
MGI:4430244	Acacb<tm1.1Dejs>	MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0010401,increased skeletal muscle glycogen level|MP:0010957,abnormal aerobic respiration|MP:0014171,increased fatty acid oxidation
MGI:4450932	Acacb<tm1.1Lowl>	MP:0002169,no abnormal phenotype detected
MGI:4450934	Acacb<tm1.2Lowl>	MP:0002079,increased circulating insulin level|MP:0002188,small heart|MP:0004924,abnormal behavior|MP:0005289,increased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0010379,decreased respiratory quotient|MP:0014777,decreased heart enzyme/coenzyme level
MGI:2679547	Acacb<tm1Sjw>	MP:0001262,decreased body weight|MP:0001433,polyphagia|MP:0001552,increased circulating triglyceride level|MP:0002118,abnormal lipid homeostasis|MP:0002575,increased circulating ketone body level|MP:0002702,decreased circulating free fatty acids level|MP:0005282,decreased fatty acids level|MP:0005450,abnormal energy expenditure|MP:0005560,decreased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009356,decreased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0010398,decreased liver glycogen level|MP:0014171,increased fatty acid oxidation|MP:0014173,increased fatty acid beta-oxidation|MP:0014775,decreased skeletal muscle enzyme/coenzyme level|MP:0014777,decreased heart enzyme/coenzyme level
MGI:6156439	Acad10<em1(IMPC)Tcp>	MP:0000689,abnormal spleen morphology
MGI:6284513	Acad11<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response|MP:0010052,increased grip strength|MP:0010393,shortened QRS complex duration
MGI:6120791	Acad12<tm1b(EUCOMM)Wtsi>	MP:0002079,increased circulating insulin level
MGI:5693896	Acad8<m1Ytc>	MP:0001570,abnormal circulating enzyme level|MP:0003978,decreased circulating carnitine level|MP:0005289,increased oxygen consumption|MP:0005311,abnormal circulating amino acid level|MP:0005376,homeostasis/metabolism phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0009125,decreased brown fat cell lipid droplet size|MP:0009643,abnormal urine homeostasis|MP:0011049,impaired adaptive thermogenesis|MP:0011635,abnormal mitochondrial crista morphology|MP:0011637,abnormal mitochondrial matrix morphology|MP:0014341,abnormal hepatocyte mitochondrial morphology|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis
MGI:4944332	Acad9<tm1a(KOMP)Wtsi>	MP:0011091,prenatal lethality, complete penetrance
MGI:7327433	Acad9<tm1c(KOMP)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000747,muscle weakness|MP:0002082,postnatal lethality|MP:0002108,abnormal muscle morphology|MP:0002953,thick ventricular wall|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0006036,abnormal mitochondrial physiology|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0012106,impaired exercise endurance|MP:0012552,lactic acidosis|MP:0031131,myocardial fiber disarray
MGI:2180079	Acadl<tm1Uab>	MP:0000189,hypoglycemia|MP:0000266,abnormal heart morphology|MP:0001554,increased circulating free fatty acids level|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0003141,cardiac fibrosis|MP:0003979,increased circulating carnitine level|MP:0004773,abnormal bile composition|MP:0005281,increased fatty acids level|MP:0005283,increased unsaturated fatty acids level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008570,lipidosis|MP:0011019,abnormal adaptive thermogenesis|MP:0011101,prenatal lethality, incomplete penetrance|MP:0030613,dicarboxylic aciduria|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis
MGI:5637194	Acadm<tm1b(EUCOMM)Hmgu>	MP:0002098,abnormal vibrissa morphology|MP:0002764,short tibia|MP:0010052,increased grip strength
MGI:3692446	Acadm<tm1Uab>	MP:0000278,abnormal myocardial fiber morphology|MP:0003141,cardiac fibrosis|MP:0003979,increased circulating carnitine level|MP:0004566,myocardial fiber degeneration|MP:0005330,cardiomyopathy|MP:0005560,decreased circulating glucose level|MP:0009642,abnormal blood homeostasis|MP:0009862,abnormal aorta elastic tissue morphology|MP:0011049,impaired adaptive thermogenesis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis
MGI:5795947	Acadsb<em1(IMPC)J>	MP:0000452,abnormal mouth morphology|MP:0001303,abnormal lens morphology|MP:0001399,hyperactivity|MP:0002075,abnormal coat/hair pigmentation|MP:0002098,abnormal vibrissa morphology|MP:0004222,iris synechia|MP:0020870,decreased thigmotaxis
MGI:3029768	Acads<del-J>	MP:0000189,hypoglycemia|MP:0000759,abnormal skeletal muscle morphology|MP:0001423,abnormal liquid preference|MP:0001432,abnormal food preference|MP:0001556,increased circulating HDL cholesterol level|MP:0002628,hepatic steatosis|MP:0003978,decreased circulating carnitine level|MP:0010953,abnormal fatty acid oxidation|MP:0011019,abnormal adaptive thermogenesis|MP:0030612,organic aciduria|MP:0030615,ethylmalonic aciduria|MP:0030656,decreased circulating glycine level
MGI:7425484	Acads<em1(IMPC)Hmgu>	MP:0001406,abnormal gait|MP:0002757,decreased vertical activity|MP:0011965,decreased total retina thickness
MGI:3038140	Acads<Hdlq8-C57BL/6J>	MP:0000186,decreased circulating HDL cholesterol level
MGI:3038141	Acads<Hdlq8-NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:6449034	Acadvl<em1(IMPC)H>	MP:0005293,impaired glucose tolerance|MP:0013278,decreased fasting circulating glucose level
MGI:2180080	Acadvl<tm1Uab>	MP:0000266,abnormal heart morphology|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0003979,increased circulating carnitine level|MP:0005584,abnormal enzyme/coenzyme activity
MGI:3606688	Acadvl<tm1Vje>	MP:0000003,abnormal adipose tissue morphology|MP:0000189,hypoglycemia|MP:0000278,abnormal myocardial fiber morphology|MP:0001260,increased body weight|MP:0001636,irregular heartbeat|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0002899,fatigue|MP:0002971,abnormal brown adipose tissue morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004566,myocardial fiber degeneration|MP:0005293,impaired glucose tolerance|MP:0005330,cardiomyopathy|MP:0005332,abnormal amino acid level|MP:0005333,decreased heart rate|MP:0005439,decreased glycogen level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010954,abnormal cellular respiration|MP:0011049,impaired adaptive thermogenesis|MP:0011698,abnormal brown adipose tissue physiology|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0031115,macrovesicular hepatic steatosis
MGI:5578174	Acadvl<tm1Zkhu>	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003921,abnormal heart left ventricle morphology|MP:0005202,lethargy|MP:0005333,decreased heart rate|MP:0005560,decreased circulating glucose level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010379,decreased respiratory quotient|MP:0011014,decreased core body temperature|MP:0011019,abnormal adaptive thermogenesis|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5297419	Acan<b2b183Clo>	MP:0000111,cleft palate|MP:0001625,cardiac hypertrophy|MP:0002427,disproportionate dwarf|MP:0002772,brachypodia|MP:0005330,cardiomyopathy
MGI:1856465	Acan<cmd>	MP:0000042,abnormal organ of Corti morphology|MP:0000111,cleft palate|MP:0000130,abnormal trabecular bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000141,abnormal vertebral body morphology|MP:0000150,abnormal rib morphology|MP:0000160,kyphosis|MP:0000162,lordosis|MP:0000164,abnormal cartilage development|MP:0000166,abnormal chondrocyte morphology|MP:0000445,short snout|MP:0000447,flattened snout|MP:0000599,enlarged liver|MP:0000955,abnormal spinal cord morphology|MP:0001175,abnormal lung morphology|MP:0001178,pulmonary hypoplasia|MP:0001270,distended abdomen|MP:0001406,abnormal gait|MP:0001438,aphagia|MP:0001954,respiratory distress|MP:0001967,deafness|MP:0002083,premature death|MP:0002109,abnormal limb morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002427,disproportionate dwarf|MP:0002544,brachydactyly|MP:0003109,short femur|MP:0003120,abnormal tracheal cartilage morphology|MP:0004020,polyhydramnios|MP:0004173,abnormal intervertebral disk morphology|MP:0004351,short humerus|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004403,absent cochlear outer hair cells|MP:0004653,absent caudal vertebrae|MP:0004684,intervertebral disk degeneration|MP:0004686,decreased length of long bones|MP:0004704,short vertebral column|MP:0004734,small thoracic cavity|MP:0004746,abnormal cochlear IHC afferent innervation pattern|MP:0009908,protruding tongue|MP:0011087,neonatal lethality, complete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014605,dark liver|MP:0030420,short basicranium
MGI:1855999	Acan<cmd-Bc>	MP:0000111,cleft palate|MP:0000445,short snout|MP:0000547,short limbs|MP:0001178,pulmonary hypoplasia|MP:0001270,distended abdomen|MP:0001953,respiratory failure|MP:0004734,small thoracic cavity|MP:0006279,abnormal limb development|MP:0009908,protruding tongue|MP:0011087,neonatal lethality, complete penetrance
MGI:6760644	Acan<m1Btlr>	MP:0002764,short tibia|MP:0003109,short femur
MGI:6760645	Acan<m2Btlr>	MP:0002764,short tibia|MP:0003109,short femur
MGI:5792073	Acan<mpc227H>	MP:0001261,obese|MP:0002932,abnormal joint morphology
MGI:3577026	Acan<tm1Afos>	MP:0002169,no abnormal phenotype detected
MGI:6120825	Acan<tm1b(EUCOMM)Hmgu>	MP:0002606,increased basophil cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:4420223	Acan<tm1(cre/ERT2)Crm>	MP:0002169,no abnormal phenotype detected
MGI:3713763	Acan<tm2Afos>	MP:0003436,decreased susceptibility to induced arthritis
MGI:5585643	Acap1<tm1.1(KOMP)Vlcg>	MP:0005560,decreased circulating glucose level
MGI:6149965	Acap2<em1(IMPC)J>	MP:0001529,abnormal vocalization
MGI:4436565	Acap3<tm1a(EUCOMM)Hmgu>	MP:0001258,decreased body length
MGI:6361038	Acat1<em1(IMPC)J>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity
MGI:5548912	Acat2<tm1b(KOMP)Wtsi>	MP:0001257,increased body length|MP:0001491,unresponsive to tactile stimuli|MP:0001697,abnormal embryo size|MP:0003019,increased circulating chloride level|MP:0003385,abnormal body wall morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5548778	Acbd3<tm1b(EUCOMM)Hmgu>	MP:0001488,increased startle reflex|MP:0002590,increased mean corpuscular volume|MP:0002644,decreased circulating triglyceride level|MP:0005343,increased circulating aspartate transaminase level|MP:0011100,preweaning lethality, complete penetrance
MGI:4842354	Acbd5<tm1a(EUCOMM)Wtsi>	MP:0000136,abnormal microglial cell morphology|MP:0000160,kyphosis|MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000921,demyelination|MP:0001262,decreased body weight|MP:0001326,retina degeneration|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001847,brain inflammation|MP:0001921,reduced fertility|MP:0002118,abnormal lipid homeostasis|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0003439,abnormal glycerol level|MP:0005281,increased fatty acids level|MP:0005404,abnormal axon morphology|MP:0011940,decreased food intake|MP:0012220,abnormal ether lipid level|MP:0014010,abnormal peroxisome morphology
MGI:5637073	Acbd5<tm1b(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0001257,increased body length|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002599,increased mean platelet volume|MP:0002644,decreased circulating triglyceride level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0003960,increased lean body mass|MP:0005292,improved glucose tolerance|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0010869,decreased bone trabecula number|MP:0013630,increased bone trabecular spacing
MGI:1856662	Acc	MP:0001314,cornea opacity|MP:0001317,abnormal pupil morphology|MP:0010259,anterior polar cataract|MP:0010261,sutural cataract|MP:0011091,prenatal lethality, complete penetrance
MGI:1856658	Acd<acd>	MP:0000416,sparse hair|MP:0000424,retarded hair growth|MP:0000562,polydactyly|MP:0000585,kinked tail|MP:0000639,abnormal adrenal gland morphology|MP:0000640,adrenal gland hypoplasia|MP:0001188,hyperpigmentation|MP:0001274,curly vibrissae|MP:0001282,short vibrissae|MP:0001921,reduced fertility|MP:0002074,abnormal hair texture|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002665,decreased circulating corticosterone level|MP:0002768,small adrenal glands|MP:0003963,abnormal corticosterone level|MP:0003965,abnormal pituitary hormone level|MP:0003966,abnormal adrenocorticotropin level|MP:0005129,increased adrenocorticotropin level|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation
MGI:4462417	Acd<tm1.1Blas>	MP:0000367,abnormal coat/ hair morphology|MP:0000378,absent hair follicles|MP:0000648,absent sebaceous gland|MP:0001192,scaly skin|MP:0001216,abnormal epidermal layer morphology|MP:0001438,aphagia|MP:0001732,postnatal growth retardation|MP:0002009,preneoplasia|MP:0002060,abnormal skin morphology|MP:0002796,impaired skin barrier function|MP:0003077,abnormal cell cycle|MP:0003111,abnormal cell nucleus morphology|MP:0003704,abnormal hair follicle development|MP:0003745,abnormal oral mucosa morphology|MP:0003853,dry skin|MP:0004025,polyploidy|MP:0004045,abnormal cell cycle checkpoint function|MP:0004046,abnormal mitosis|MP:0009931,abnormal skin appearance|MP:0011085,postnatal lethality, complete penetrance|MP:0030926,increased skin pigmentation|MP:0030927,decreased telomere length
MGI:4456177	Acd<tm1.1Cek>	MP:0003702,abnormal chromosome morphology|MP:0004025,polyploidy|MP:0005621,abnormal cell physiology|MP:0008008,early cellular replicative senescence
MGI:4456178	Acd<tm1.2Cek>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:8250890	Ace2<em1(ACE2)Dfl>	MP:0020949,increased susceptibility to Coronaviridae infection
MGI:6431336	Ace2<em1(ACE2)Yowa>	MP:0001179,thick pulmonary interalveolar septum|MP:0001182,lung hemorrhage|MP:0001862,interstitial pneumonia|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0008577,increased circulating interferon-gamma level|MP:0008629,increased circulating interleukin-9 level|MP:0010210,abnormal circulating cytokine level|MP:0020949,increased susceptibility to Coronaviridae infection
MGI:6500740	Ace2<em1Cya>	MP:0000477,abnormal intestine morphology|MP:0001858,intestinal inflammation|MP:0003288,intestinal edema|MP:0003292,melena|MP:0003674,oxidative stress|MP:0003868,abnormal feces composition|MP:0008537,increased susceptibility to induced colitis|MP:0010155,abnormal intestine physiology|MP:0010180,increased susceptibility to weight loss|MP:0013956,decreased colon length|MP:0031319,impaired intestine regeneration
MGI:7425486	Ace2<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0003961,decreased lean body mass|MP:0009709,hydrometra|MP:0010024,increased total body fat amount
MGI:6406963	Ace2<em1Shyy>	MP:0003548,pulmonary hypertension
MGI:6452442	Ace2<em2(ACE2)Gpt>	MP:0001861,lung inflammation|MP:0010180,increased susceptibility to weight loss|MP:0020949,increased susceptibility to Coronaviridae infection
MGI:6406965	Ace2<em2Shyy>	MP:0004013,decreased pulmonary artery pressure
MGI:5752578	Ace2<em#Yngh>	MP:0005036,diarrhea|MP:0008537,increased susceptibility to induced colitis|MP:0010180,increased susceptibility to weight loss|MP:0013956,decreased colon length
MGI:4820112	Ace2<tm1a(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0001861,lung inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss
MGI:3665270	Ace2<tm1Cof>	MP:0000231,hypertension|MP:0001313,increased incidence of corneal inflammation|MP:0001314,cornea opacity|MP:0005333,decreased heart rate|MP:0005385,cardiovascular system phenotype|MP:0005542,cornea vascularization|MP:0006000,abnormal cornea epithelium morphology|MP:0006144,increased systemic arterial systolic blood pressure|MP:0020861,abnormal cornea wound healing|MP:0031229,increased angiotensin II level|MP:0031232,increased circulating angiotensin II level
MGI:3794966	Ace2<tm1Hira>	MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0005630,increased lung weight|MP:0006138,congestive heart failure|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010018,pulmonary vascular congestion|MP:0031229,increased angiotensin II level|MP:0031232,increased circulating angiotensin II level
MGI:5007005	Ace2<tm1Lex>	MP:0001861,lung inflammation|MP:0003136,yellow coat color|MP:0003184,increased angiotensin I-converting enzyme activity|MP:0005573,increased pulmonary respiratory rate|MP:0005584,abnormal enzyme/coenzyme activity
MGI:2661723	Ace2<tm1Pngr>	MP:0000219,increased neutrophil cell number|MP:0001544,abnormal cardiovascular system physiology|MP:0001596,hypotension|MP:0001625,cardiac hypertrophy|MP:0001853,heart inflammation|MP:0001861,lung inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003070,increased vascular permeability|MP:0003674,oxidative stress|MP:0003819,increased left ventricle diastolic pressure|MP:0003828,pulmonary edema|MP:0005140,decreased cardiac muscle contractility|MP:0005165,increased susceptibility to injury|MP:0005385,cardiovascular system phenotype|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0008713,abnormal cytokine level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0011044,increased lung elastance|MP:0011925,abnormal heart echocardiography feature|MP:0012041,increased susceptibility to pulmonary hyaline membrane formation|MP:0020344,abnormal susceptibility to injury induced morbidity/mortality|MP:0020446,increased NAD(P)H oxidase activity|MP:0020946,increased susceptibility to Orthomyxoviridae infection|MP:0020950,decreased susceptibility to Coronaviridae infection|MP:0021158,decreased heart left ventricle wall thickness|MP:0031046,increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality|MP:0031229,increased angiotensin II level|MP:0031232,increased circulating angiotensin II level
MGI:4459895	Ace3<tm1Osb>	MP:0005389,reproductive system phenotype
MGI:4432648	Acer1<tm1a(EUCOMM)Wtsi>	MP:0000367,abnormal coat/ hair morphology|MP:0000377,abnormal hair follicle morphology|MP:0000400,abnormal awl hair morphology|MP:0000402,abnormal zigzag hair morphology|MP:0000414,alopecia|MP:0000652,enlarged sebaceous gland|MP:0001192,scaly skin|MP:0001222,epidermal hyperplasia|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001245,thick dermal layer|MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0001547,abnormal lipid level|MP:0002073,abnormal hair growth|MP:0002796,impaired skin barrier function|MP:0003704,abnormal hair follicle development|MP:0003809,abnormal hair shaft morphology|MP:0003810,abnormal hair cuticle|MP:0003853,dry skin|MP:0004889,increased energy expenditure|MP:0004947,skin inflammation|MP:0005011,increased eosinophil cell number|MP:0006042,increased apoptosis|MP:0008965,increased basal metabolism|MP:0009125,decreased brown fat cell lipid droplet size|MP:0009288,increased epididymal fat pad weight|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009441,delayed skin barrier formation|MP:0009535,abnormal skin sebaceous gland morphology|MP:0009583,increased keratinocyte proliferation|MP:0009602,abnormal keratohyalin granule morphology|MP:0009759,abnormal hair follicle bulge morphology|MP:0009823,abnormal sphingomyelin level|MP:0010682,abnormal hair follicle infundibulum morphology|MP:0010683,dilated hair follicle infundibulum|MP:0011939,increased food intake|MP:0012232,abnormal ceramide level|MP:0013375,abnormal sebocyte morphology|MP:0014169,decreased brown adipose tissue mass|MP:0020117,decreased sphingosine level
MGI:5085811	Acer1<tm1(KOMP)Vlcg>	MP:0000414,alopecia|MP:0000427,abnormal hair cycle|MP:0001263,weight loss|MP:0002992,abnormal sebaceous lipid secretion|MP:0003941,abnormal skin development|MP:0005501,abnormal skin physiology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008858,abnormal hair cycle anagen phase|MP:0008860,abnormal hair cycle telogen phase|MP:0009793,sebaceous gland hypertrophy|MP:0010683,dilated hair follicle infundibulum|MP:0010768,mortality/aging|MP:0011194,abnormal hair follicle physiology|MP:0030570,abnormal piliary canal morphology
MGI:5883755	Acer2<em1Mvw>	MP:0005397,hematopoietic system phenotype|MP:0012230,abnormal sphingolipid level
MGI:6115367	Acer3<tm1Cmao>	MP:0000876,Purkinje cell degeneration|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002757,decreased vertical activity|MP:0005389,reproductive system phenotype|MP:0009823,abnormal sphingomyelin level|MP:0010768,mortality/aging|MP:0012230,abnormal sphingolipid level|MP:0012232,abnormal ceramide level|MP:0020116,increased sphingosine level
MGI:5708267	Ace<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001697,abnormal embryo size|MP:0002606,increased basophil cell number|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:2155954	Ace<tm1Keb>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000519,hydronephrosis|MP:0001762,polyuria|MP:0001859,kidney inflammation|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002626,increased heart rate|MP:0002988,decreased urine osmolality|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003918,decreased kidney weight|MP:0004193,abnormal kidney papilla morphology|MP:0005385,cardiovascular system phenotype|MP:0005553,increased circulating creatinine level|MP:0005582,increased renin activity|MP:0005619,increased urine potassium level|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0009643,abnormal urine homeostasis|MP:0010768,mortality/aging|MP:0011304,kidney papillary atrophy|MP:0011305,dilated kidney calyx|MP:0011309,abnormal kidney arterial blood vessel morphology|MP:0011317,abnormal renal artery morphology|MP:0011376,abnormal kidney corticomedullary boundary morphology|MP:0011422,kidney medulla atrophy|MP:0011541,decreased urine aldosterone level
MGI:2155955	Ace<tm1Mcf>	MP:0000530,abnormal kidney vasculature morphology|MP:0001859,kidney inflammation|MP:0002988,decreased urine osmolality|MP:0003014,abnormal kidney medulla morphology|MP:0003670,dilated renal glomerular capsule|MP:0004194,abnormal kidney pelvis morphology|MP:0005389,reproductive system phenotype|MP:0005565,increased blood urea nitrogen level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011307,kidney medulla cyst|MP:0011347,abnormal kidney medullary ray morphology|MP:0011405,tubulointerstitial nephritis|MP:0011423,kidney cortex atrophy
MGI:1857115	Ace<tm1Unc>	MP:0000242,impaired fertilization|MP:0000530,abnormal kidney vasculature morphology|MP:0001260,increased body weight|MP:0001596,hypotension|MP:0001859,kidney inflammation|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002626,increased heart rate|MP:0002833,increased heart weight|MP:0003058,increased insulin secretion|MP:0005166,decreased susceptibility to injury|MP:0005325,abnormal renal glomerulus morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0006319,abnormal epididymal fat pad morphology|MP:0009647,decreased fertilization frequency|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011346,renal tubule atrophy|MP:0011423,kidney cortex atrophy|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031012,impaired sperm migration in female genital tract|MP:0031228,decreased angiotensin II level|MP:0031231,decreased circulating angiotensin II level
MGI:2155953	Ace<tm2Keb>	MP:0001762,polyuria|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002988,decreased urine osmolality|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0011305,dilated kidney calyx|MP:0011309,abnormal kidney arterial blood vessel morphology|MP:0011501,increased glomerular capsule space
MGI:1857116	Ace<tm2Unc>	MP:0000530,abnormal kidney vasculature morphology|MP:0004970,kidney atrophy|MP:0005389,reproductive system phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2657140	Ace<tm3Keb>	MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005385,cardiovascular system phenotype
MGI:2155951	Ace<tm3Unc>	MP:0000521,abnormal kidney cortex morphology|MP:0001262,decreased body weight|MP:0002834,decreased heart weight|MP:0002842,increased systemic arterial blood pressure|MP:0002871,albuminuria|MP:0003059,decreased insulin secretion|MP:0005325,abnormal renal glomerulus morphology|MP:0005333,decreased heart rate|MP:0006319,abnormal epididymal fat pad morphology|MP:0011939,increased food intake
MGI:2665017	Ace<tm4Keb>	MP:0000208,decreased hematocrit|MP:0000530,abnormal kidney vasculature morphology|MP:0002135,abnormal kidney morphology|MP:0002988,decreased urine osmolality|MP:0003626,kidney medulla hypoplasia|MP:0003918,decreased kidney weight|MP:0004194,abnormal kidney pelvis morphology|MP:0006264,decreased systemic arterial systolic blood pressure
MGI:3042130	Ace<tm5Keb>	MP:0003184,increased angiotensin I-converting enzyme activity|MP:0003185,decreased angiotensin I-converting enzyme activity|MP:0005166,decreased susceptibility to injury|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:3713781	Ace<tm6Keb>	MP:0003447,decreased tumor growth/size|MP:0003448,abnormal tumor morphology|MP:0005015,increased T cell number|MP:0008751,abnormal interleukin level
MGI:3783350	Ace<tm7Keb>	MP:0002083,premature death|MP:0004937,dilated heart|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0008543,atrial fibrillation|MP:0008725,increased heart atrium size|MP:0008770,decreased survivor rate
MGI:4830151	Ace<tm8.1Keb>	MP:0000230,abnormal systemic arterial blood pressure|MP:0002988,decreased urine osmolality|MP:0003185,decreased angiotensin I-converting enzyme activity|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005416,abnormal circulating protein level|MP:0005582,increased renin activity|MP:0013254,abnormal angiotensin I-converting enzyme activity|MP:0031231,decreased circulating angiotensin II level
MGI:4830150	Ace<tm8Keb>	MP:0001544,abnormal cardiovascular system physiology|MP:0001764,abnormal homeostasis|MP:0002135,abnormal kidney morphology
MGI:5430660	Ace<tm9Keb>	MP:0000230,abnormal systemic arterial blood pressure|MP:0001762,polyuria|MP:0001859,kidney inflammation|MP:0002987,abnormal urine osmolality|MP:0002988,decreased urine osmolality|MP:0003014,abnormal kidney medulla morphology|MP:0003185,decreased angiotensin I-converting enzyme activity|MP:0004194,abnormal kidney pelvis morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005582,increased renin activity|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006373,abnormal circulating angiotensinogen level|MP:0006376,decreased circulating angiotensinogen level|MP:0011317,abnormal renal artery morphology|MP:0011941,increased fluid intake
MGI:6276916	Ache<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000266,abnormal heart morphology|MP:0001404,no spontaneous movement|MP:0001914,hemorrhage|MP:0002188,small heart|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3814333	Ache<tm1.1Hssh>	MP:0000745,tremors|MP:0001777,abnormal body temperature homeostasis|MP:0001783,decreased white adipose tissue amount|MP:0002083,premature death|MP:0004183,abnormal sympathetic nervous system physiology|MP:0005375,adipose tissue phenotype|MP:0005534,decreased body temperature|MP:0008489,slow postnatal weight gain|MP:0008770,decreased survivor rate
MGI:3778298	Ache<tm1.1Pata>	MP:0000745,tremors|MP:0000747,muscle weakness|MP:0001262,decreased body weight|MP:0001943,abnormal respiration|MP:0002327,abnormal respiratory function|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0005464,abnormal platelet physiology|MP:0005534,decreased body temperature|MP:0005575,increased pulmonary ventilation|MP:0005576,decreased pulmonary ventilation|MP:0005585,increased tidal volume|MP:0005586,decreased tidal volume|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:2179948	Ache<tm1Loc>	MP:0000054,delayed ear emergence|MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001394,circling|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001523,impaired righting response|MP:0005176,eyelids fail to open|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008872,abnormal physiological response to xenobiotic|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3778300	Ache<tm2Pata>	MP:0000745,tremors|MP:0000747,muscle weakness|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype
MGI:3842443	Ache<tm3Pata>	MP:0000746,weakness|MP:0001265,decreased body size|MP:0001529,abnormal vocalization
MGI:3842445	Ache<tm4.1Pata>	MP:0000747,muscle weakness|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype
MGI:3842444	Ache<tm4Pata>	MP:0000746,weakness|MP:0000747,muscle weakness|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001504,abnormal posture|MP:0001505,hunched posture|MP:0001529,abnormal vocalization|MP:0001924,infertility|MP:0001943,abnormal respiration|MP:0002064,seizures|MP:0002327,abnormal respiratory function|MP:0003492,abnormal involuntary movement|MP:0005534,decreased body temperature|MP:0005575,increased pulmonary ventilation|MP:0005585,increased tidal volume|MP:0005586,decreased tidal volume|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0010053,decreased grip strength|MP:0012106,impaired exercise endurance
MGI:2386436	Ackr1<tm1Pogo>	MP:0000065,abnormal bone marrow cavity morphology|MP:0010879,decreased trabecular bone volume|MP:0013615,increased volumetric bone mineral density
MGI:1888977	Ackr1<tm1Scp>	MP:0001846,increased inflammatory response|MP:0010209,abnormal circulating chemokine level
MGI:2656980	Ackr1<tm1Skmz>	MP:0001764,abnormal homeostasis|MP:0008721,abnormal chemokine level
MGI:3623613	Ackr2<tm1Gjg>	MP:0001194,dermatitis|MP:0001846,increased inflammatory response|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:3778916	Ackr3<tm1.1Fma>	MP:0000273,overriding aortic valve|MP:0000297,abnormal atrioventricular cushion morphology|MP:0002083,premature death|MP:0002754,dilated heart right ventricle|MP:0003631,nervous system phenotype|MP:0005381,digestive/alimentary phenotype|MP:0006116,calcified aortic valve|MP:0006126,abnormal cardiac outflow tract development|MP:0008182,decreased marginal zone B cell number|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010484,bicuspid aortic valve|MP:0010527,bicuspid pulmonary valve|MP:0010593,thick aortic valve cusps|MP:0010595,abnormal aortic valve cusp morphology|MP:0010596,unicuspid aortic valve|MP:0010602,abnormal pulmonary valve cusp morphology|MP:0010603,unicuspid pulmonary valve|MP:0010605,thick pulmonary valve cusps|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4838088	Ackr3<tm1.1Rodb>	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:4881712	Ackr3<tm1.1Twb>	MP:0000273,overriding aortic valve|MP:0000274,enlarged heart|MP:0000297,abnormal atrioventricular cushion morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001575,cyanosis|MP:0001914,hemorrhage|MP:0001954,respiratory distress|MP:0002746,abnormal semilunar valve morphology|MP:0003140,dilated heart atrium|MP:0006117,aortic valve stenosis|MP:0006128,pulmonary valve stenosis|MP:0010418,perimembraneous ventricular septal defect|MP:0010426,abnormal heart and great artery attachment|MP:0010594,thick aortic valve|MP:0010601,thick pulmonary valve|MP:0011087,neonatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3722943	Ackr3<tm1Fma>	MP:0002754,dilated heart right ventricle|MP:0010484,bicuspid aortic valve|MP:0010527,bicuspid pulmonary valve|MP:0010593,thick aortic valve cusps|MP:0010595,abnormal aortic valve cusp morphology|MP:0010596,unicuspid aortic valve|MP:0010602,abnormal pulmonary valve cusp morphology|MP:0010603,unicuspid pulmonary valve|MP:0010605,thick pulmonary valve cusps
MGI:3796065	Ackr3<tm1Jgo>	MP:0000275,heart hyperplasia|MP:0001855,abnormal atrial thrombosis|MP:0001861,lung inflammation|MP:0003141,cardiac fibrosis|MP:0004566,myocardial fiber degeneration|MP:0006050,pulmonary fibrosis|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3801080	Ackr3<tm1Litt>	MP:0000281,abnormal interventricular septum morphology|MP:0002746,abnormal semilunar valve morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:5502184	Ackr3<tm1Yzo>	MP:0001614,abnormal blood vessel morphology|MP:0003631,nervous system phenotype
MGI:5692583	Ackr3<tm2b(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness
MGI:4847614	Ackr4<tm1.1Rjbn>	MP:0000693,spleen hyperplasia|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005095,decreased T cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008073,abnormal CD4-positive, alpha-beta T cell number|MP:0008690,increased interleukin-23 secretion|MP:0008721,abnormal chemokine level|MP:0010209,abnormal circulating chemokine level|MP:0010219,increased T-helper 17 cell number|MP:0010221,abnormal T-helper 17 cell differentiation
MGI:5316751	Ackr4<tm1Ccbl>	MP:0002169,no abnormal phenotype detected
MGI:3604505	Ackr4<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3625695	Acla1<BXSB/Slc>	MP:0003725,increased autoantibody level
MGI:3625698	Acla2<BXSB/Slc>	MP:0003725,increased autoantibody level
MGI:3036686	Acly<Gt(NPX098)Byg>	MP:0005376,homeostasis/metabolism phenotype|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:5287022	Acly<TgTn(sb-cHS4,Tyr)2517BOve>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5692813	Acmsd<tm1b(EUCOMM)Hmgu>	MP:0000062,increased bone mineral density|MP:0001417,decreased exploration in new environment|MP:0002599,increased mean platelet volume|MP:0005635,decreased circulating bilirubin level
MGI:6361231	Acnat2<em1(IMPC)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:6273484	Aco1<em1(IMPC)J>	MP:0001325,abnormal retina morphology|MP:0002591,decreased mean corpuscular volume
MGI:3613495	Aco1<tm1.1Mwh>	MP:0002169,no abnormal phenotype detected
MGI:3613519	Aco1<tm1.2Mwh>	MP:0002169,no abnormal phenotype detected|MP:0010768,mortality/aging
MGI:3613021	Aco1<tm1Mwh>	MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3029223	Aco1<tm1Roua>	MP:0005637,abnormal iron homeostasis
MGI:6402258	Aco2<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:5775820	Acod1<em1(IMPC)J>	MP:0010053,decreased grip strength
MGI:4362443	Acod1<tm1a(KOMP)Wtsi>	MP:0002451,abnormal macrophage physiology
MGI:5317949	Acot11<tm1Deco>	MP:0000005,increased brown adipose tissue amount|MP:0000186,decreased circulating HDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0001876,decreased inflammatory response|MP:0002971,abnormal brown adipose tissue morphology|MP:0003961,decreased lean body mass|MP:0004889,increased energy expenditure|MP:0005179,decreased circulating cholesterol level|MP:0005281,increased fatty acids level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009116,abnormal brown fat cell morphology|MP:0009125,decreased brown fat cell lipid droplet size|MP:0010378,increased respiratory quotient|MP:0011698,abnormal brown adipose tissue physiology|MP:0011699,abnormal brown adipose tissue thermogenesis|MP:0011939,increased food intake|MP:0014171,increased fatty acid oxidation|MP:0030016,increased adipocyte glucose uptake|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:7485922	Acot12<em1Ejj>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0001260,increased body weight|MP:0002981,increased liver weight|MP:0005293,impaired glucose tolerance|MP:0005319,abnormal enzyme/coenzyme level|MP:0005331,insulin resistance|MP:0008546,abnormal vesicle-mediated transport|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0010359,increased liver free fatty acids level|MP:0020867,increased lipogenesis|MP:0031265,increased susceptibility to hepatic steatosis
MGI:7485925	Acot12<em1Holi>	MP:0001765,abnormal ion homeostasis|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003333,liver fibrosis|MP:0003721,increased tumor growth/size|MP:0003980,increased circulating phospholipid level|MP:0004499,increased incidence of tumors by chemical induction|MP:0004777,abnormal phospholipid level|MP:0005178,increased circulating cholesterol level|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level
MGI:6403702	Acot12<em1(IMPC)Hmgu>	MP:0001529,abnormal vocalization|MP:0002753,dilated heart left ventricle|MP:0005140,decreased cardiac muscle contractility
MGI:5437122	Acot13<tm1Deco>	MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001431,abnormal eating behavior|MP:0001547,abnormal lipid level|MP:0001783,decreased white adipose tissue amount|MP:0002078,abnormal glucose homeostasis|MP:0002702,decreased circulating free fatty acids level|MP:0003383,abnormal gluconeogenesis|MP:0003458,decreased circulating ketone body level|MP:0003960,increased lean body mass|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005290,decreased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009125,decreased brown fat cell lipid droplet size|MP:0009289,decreased epididymal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level|MP:0010378,increased respiratory quotient|MP:0010379,decreased respiratory quotient|MP:0011016,increased core body temperature|MP:0011019,abnormal adaptive thermogenesis|MP:0011020,abnormal circadian temperature homeostasis|MP:0011939,increased food intake|MP:0011940,decreased food intake|MP:0014476,abnormal feces lipid level|MP:0020234,decreased basal metabolism|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5763009	Acot2<em1(IMPC)J>	MP:0002591,decreased mean corpuscular volume|MP:0010053,decreased grip strength
MGI:6276909	Acot3<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0001417,decreased exploration in new environment|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney
MGI:5548768	Acot4<tm1b(KOMP)Wtsi>	MP:0002135,abnormal kidney morphology
MGI:4364061	Acot5<tm1a(KOMP)Wtsi>	MP:0001552,increased circulating triglyceride level|MP:0010067,increased red blood cell distribution width
MGI:4362231	Acot6<tm1a(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5528815	Acot7<tm1.1Mwol>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002118,abnormal lipid homeostasis|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0002628,hepatic steatosis|MP:0003949,abnormal circulating lipid level|MP:0003961,decreased lean body mass|MP:0004777,abnormal phospholipid level|MP:0004889,increased energy expenditure|MP:0004924,abnormal behavior|MP:0005281,increased fatty acids level|MP:0005317,increased triglyceride level|MP:0005386,behavior/neurological phenotype|MP:0008948,decreased neuron number|MP:0009142,decreased prepulse inhibition|MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0010024,increased total body fat amount|MP:0014814,increased brain glucose metabolism|MP:0020523,decreased susceptibility to induced hypothermia
MGI:6402892	Acot8<em1(IMPC)Bay>	MP:0001257,increased body length
MGI:7425487	Acox1<em1(IMPC)Bay>	MP:0000063,decreased bone mineral density|MP:0000598,abnormal liver morphology|MP:0001258,decreased body length|MP:0001925,male infertility|MP:0001926,female infertility|MP:0010052,increased grip strength|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020870,decreased thigmotaxis
MGI:6682059	Acox1<em1Wum>	MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype
MGI:5285926	Acox1<lampe1>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0001732,postnatal growth retardation|MP:0001860,liver inflammation|MP:0001921,reduced fertility|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003331,increased hepatocellular carcinoma incidence|MP:0031116,microvesicular hepatic steatosis
MGI:1857811	Acox1<tm1Jkr>	MP:0000603,pale liver|MP:0000609,abnormal liver physiology|MP:0001127,small ovary|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001548,hyperlipidemia|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002658,abnormal liver regeneration|MP:0002981,increased liver weight|MP:0003331,increased hepatocellular carcinoma incidence|MP:0005536,decreased Leydig cell number|MP:0010264,increased hepatoma incidence|MP:0014634,decreased round spermatid number|MP:0031116,microvesicular hepatic steatosis
MGI:7447406	Acox2<em1(IMPC)Bay>	MP:0001392,abnormal locomotor behavior
MGI:7263204	Acox2<em1Jynz>	MP:0001860,liver inflammation|MP:0003255,bile duct proliferation|MP:0008019,increased liver tumor incidence
MGI:5910374	Acox3<em1(IMPC)J>	MP:0001304,cataract|MP:0005293,impaired glucose tolerance|MP:0005565,increased blood urea nitrogen level
MGI:6140125	Acoxl<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000266,abnormal heart morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000639,abnormal adrenal gland morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002188,small heart|MP:0002339,abnormal lymph node morphology|MP:0005016,decreased lymphocyte cell number|MP:0005292,improved glucose tolerance
MGI:4130291	Acp1<Gt(RRK222)Byg>	MP:0001262,decreased body weight|MP:0003223,decreased cardiomyocyte apoptosis|MP:0004486,decreased response of heart to induced stress
MGI:5007006	Acp1<tm1Lex>	MP:0001265,decreased body size|MP:0008705,increased interleukin-6 secretion|MP:0011703,increased fibroblast proliferation
MGI:3574793	Acp2<nax>	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000422,delayed hair appearance|MP:0000745,tremors|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000873,thin external granule cell layer|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000885,ectopic Purkinje cell|MP:0000888,absent cerebellar granule layer|MP:0000889,abnormal cerebellar molecular layer|MP:0000952,abnormal CNS glial cell morphology|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001243,abnormal dermal layer morphology|MP:0001255,decreased body height|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001732,postnatal growth retardation|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0009351,thin hair shaft
MGI:4431704	Acp2<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001262,decreased body weight|MP:0002875,decreased erythrocyte cell number|MP:0002896,abnormal bone mineralization|MP:0003795,abnormal bone structure|MP:0004924,abnormal behavior|MP:0005014,increased B cell number|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:2180084	Acp2<tm1Psa>	MP:0000069,kyphoscoliosis|MP:0000136,abnormal microglial cell morphology|MP:0000141,abnormal vertebral body morphology|MP:0000160,kyphosis|MP:0000162,lordosis|MP:0003354,astrocytosis|MP:0003797,abnormal compact bone morphology|MP:0003997,tonic-clonic seizures|MP:0004604,abnormal vertebral pedicle morphology|MP:0004703,abnormal vertebral column morphology|MP:0005058,abnormal lysosome morphology|MP:0005060,accumulation of giant lysosomes in kidney/renal tubule cells|MP:0005386,behavior/neurological phenotype|MP:0010932,increased trabecular bone connectivity density|MP:0020137,decreased bone mineralization
MGI:3849300	Acp3<tm1Pivi>	MP:0001168,abnormal prostate gland epithelium morphology|MP:0003177,allodynia|MP:0003998,decreased thermal nociceptive threshold|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0009381,abnormal prostate gland dorsolateral lobe morphology|MP:0031369,prostate gland dorsolateral lobe hyperplasia
MGI:6715233	Acp4<em1Jcch>	MP:0002576,abnormal enamel morphology
MGI:2180086	Acp5<tm1Ahdm>	MP:0000062,increased bone mineral density|MP:0000067,osteopetrosis|MP:0000130,abnormal trabecular bone morphology|MP:0000132,thickened long bone epiphysis|MP:0000133,abnormal long bone metaphysis morphology|MP:0000137,abnormal vertebrae morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000547,short limbs|MP:0000558,abnormal tibia morphology|MP:0001541,abnormal osteoclast physiology|MP:0002109,abnormal limb morphology|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0002896,abnormal bone mineralization|MP:0002998,abnormal bone remodeling|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003723,abnormal long bone morphology|MP:0004686,decreased length of long bones|MP:0006394,abnormal vertebral epiphyseal plate morphology|MP:0006397,disorganized long bone epiphyseal plate|MP:0006398,increased long bone epiphyseal plate size|MP:0008151,increased diameter of long bones|MP:0008272,abnormal endochondral bone ossification|MP:0020080,increased bone mineralization|MP:0030791,club-shaped femur
MGI:6449047	Acp6<em1(IMPC)Hmgu>	MP:0002965,increased circulating serum albumin level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4295303	Acp6<Gt(OST365230)Lex>	MP:0002169,no abnormal phenotype detected
MGI:6118116	Acrbp<tm1Tba>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0002674,abnormal sperm motility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0004542,impaired acrosome reaction|MP:0005389,reproductive system phenotype|MP:0008898,abnormal acrosome morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009282,decreased hyperactivated sperm motility|MP:0009647,decreased fertilization frequency|MP:0009831,abnormal sperm midpiece morphology|MP:0020451,decreased sperm progressive motility|MP:0020869,immotile sperm|MP:0030977,impaired sperm-egg recognition|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031009,abnormal sperm-egg fusion|MP:0031012,impaired sperm migration in female genital tract|MP:0031354,abnormal acrosome assembly
MGI:3606887	Acrbp<tm1Wen>	MP:0000242,impaired fertilization|MP:0005411,delayed fertilization
MGI:2180087	Acr<tm1Tba>	MP:0005411,delayed fertilization
MGI:2429958	Acr<tm1Wen>	MP:0005411,delayed fertilization
MGI:7641822	Acrv1<em1Osb>	MP:0005389,reproductive system phenotype
MGI:3851593	Acsbg1<tm1Mld>	MP:0002781,increased circulating testosterone level|MP:0002786,abnormal Leydig cell morphology|MP:0004884,abnormal testis physiology|MP:0005281,increased fatty acids level|MP:0005282,decreased fatty acids level|MP:0005389,reproductive system phenotype
MGI:5085893	Acsbg2<Gt(OST346159)Lex>	MP:0002169,no abnormal phenotype detected
MGI:4432785	Acsbg2<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0010052,increased grip strength
MGI:5085892	Acsf2<Gt(OST182478)Lex>	MP:0002169,no abnormal phenotype detected
MGI:5554927	Acsf2<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0002590,increased mean corpuscular volume|MP:0005561,increased mean corpuscular hemoglobin|MP:0011396,abnormal sleep behavior
MGI:7425488	Acsf3<em1(IMPC)Hmgu>	MP:0008810,increased circulating iron level
MGI:4417846	Acsl1<tm1Rcol>	MP:0000189,hypoglycemia|MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002118,abnormal lipid homeostasis|MP:0003442,decreased circulating glycerol level|MP:0005281,increased fatty acids level|MP:0005317,increased triglyceride level|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0009285,increased gonadal fat pad weight|MP:0009288,increased epididymal fat pad weight|MP:0011049,impaired adaptive thermogenesis|MP:0011579,decreased lipoprotein lipase activity|MP:0014142,increased body fat mass|MP:0014172,decreased fatty acid oxidation
MGI:3529071	Acsl3<Gt(OST148301)Lex>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001800,abnormal humoral immune response|MP:0002089,abnormal postnatal growth/weight/body size|MP:0003961,decreased lean body mass|MP:0005017,decreased B cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number
MGI:4431605	Acsl4<tm1a(EUCOMM)Wtsi>	MP:0000558,abnormal tibia morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002834,decreased heart weight|MP:0003179,thrombocytopenia|MP:0003961,decreased lean body mass|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2182854	Acsl4<tm1Tty>	MP:0001119,abnormal female reproductive system morphology|MP:0001123,dilated uterus|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002169,no abnormal phenotype detected|MP:0002681,increased corpora lutea number|MP:0004832,enlarged ovary|MP:0004896,abnormal endometrium morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0009082,uterus cyst|MP:0009671,abnormal uterus physiology|MP:0009814,increased prostaglandin level
MGI:5548610	Acsl5<tm1.1(KOMP)Vlcg>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001303,abnormal lens morphology|MP:0001314,cornea opacity|MP:0002644,decreased circulating triglyceride level|MP:0002833,increased heart weight|MP:0003402,decreased liver weight|MP:0004952,increased spleen weight|MP:0005179,decreased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0005560,decreased circulating glucose level|MP:0005567,decreased circulating total protein level|MP:0006203,eye hemorrhage|MP:0010393,shortened QRS complex duration
MGI:5007008	Acsl5<tm1Lex>	MP:0000063,decreased bone mineral density|MP:0003179,thrombocytopenia|MP:0005376,homeostasis/metabolism phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0010124,decreased bone mineral content
MGI:6268795	Acsl6<tm1.1Jeme>	MP:0001405,impaired coordination|MP:0001489,decreased startle reflex|MP:0003806,abnormal nucleotide metabolism|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0010762,abnormal microglial cell activation|MP:0013242,abnormal amino acid metabolism|MP:0013243,abnormal carbohydrate metabolism|MP:0020866,abnormal lipogenesis|MP:0020867,increased lipogenesis|MP:0020868,decreased lipogenesis
MGI:6268794	Acsl6<tm1Jeme>	MP:0020868,decreased lipogenesis
MGI:7425489	Acsm1<em1(IMPC)Mhzh>	MP:0000280,thin ventricular wall|MP:0001417,decreased exploration in new environment|MP:0002606,increased basophil cell number|MP:0005011,increased eosinophil cell number
MGI:5554928	Acsm2<tm1.1(KOMP)Vlcg>	MP:0001510,abnormal coat appearance|MP:0003020,decreased circulating chloride level|MP:0005560,decreased circulating glucose level
MGI:8246909	Acsm3<em1Wayb>	MP:0000182,increased circulating LDL cholesterol level|MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001556,increased circulating HDL cholesterol level|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003103,liver degeneration|MP:0003674,oxidative stress|MP:0005178,increased circulating cholesterol level|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005343,increased circulating aspartate transaminase level|MP:0006036,abnormal mitochondrial physiology|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0010080,abnormal hepatocyte physiology|MP:0010359,increased liver free fatty acids level|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake|MP:0014246,decreased cellular ATP level|MP:0014341,abnormal hepatocyte mitochondrial morphology|MP:0014783,decreased liver enzyme/coenzyme level
MGI:3608776	Acsm3<tm1Njs>	MP:0002169,no abnormal phenotype detected
MGI:2385461	Acsns1<A/J>	MP:0005026,decreased susceptibility to parasitic infection
MGI:2389048	Acsns2<SM/J>	MP:0005027,increased susceptibility to parasitic infection
MGI:2389050	Acsns3<SM/J>	MP:0005027,increased susceptibility to parasitic infection
MGI:3838396	Acss1<tm1Jsak>	MP:0000189,hypoglycemia|MP:0001553,abnormal circulating free fatty acids level|MP:0001732,postnatal growth retardation|MP:0001777,abnormal body temperature homeostasis|MP:0002083,premature death|MP:0002332,abnormal exercise endurance|MP:0002865,increased growth rate|MP:0003860,abnormal carbon dioxide level|MP:0005449,abnormal food intake|MP:0005668,decreased circulating leptin level|MP:0009642,abnormal blood homeostasis|MP:0010180,increased susceptibility to weight loss|MP:0010957,abnormal aerobic respiration|MP:0011049,impaired adaptive thermogenesis
MGI:7309378	Acss2<em22Gpt>	MP:0000521,abnormal kidney cortex morphology|MP:0005554,decreased circulating creatinine level|MP:0005566,decreased blood urea nitrogen level|MP:0008658,decreased interleukin-1 beta secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0014364,decreased pyroptosis
MGI:7431353	Acss3<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001293,anophthalmia|MP:0002092,abnormal eye morphology|MP:0003961,decreased lean body mass|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013772,increased effector memory T-helper cell number
MGI:1856800	act	MP:0001304,cataract
MGI:5424775	Acta1<tm1Hrd>	MP:0001262,decreased body weight|MP:0001344,blepharoptosis|MP:0001349,excessive tearing|MP:0001402,decreased locomotor activity|MP:0002083,premature death|MP:0004087,abnormal muscle fiber morphology|MP:0004090,abnormal sarcomere morphology|MP:0004232,decreased muscle weight|MP:0010053,decreased grip strength|MP:0030140,facial muscle atrophy
MGI:2183817	Acta1<tm1Jll>	MP:0000161,scoliosis|MP:0000733,abnormal muscle development|MP:0000747,muscle weakness|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001780,decreased brown adipose tissue amount|MP:0002106,abnormal muscle physiology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0005439,decreased glycogen level|MP:0009402,decreased skeletal muscle fiber diameter|MP:0010398,decreased liver glycogen level|MP:0010399,decreased skeletal muscle glycogen level|MP:0011085,postnatal lethality, complete penetrance
MGI:6402026	Acta2<em1(IMPC)H>	MP:0002591,decreased mean corpuscular volume|MP:0002607,decreased basophil cell number|MP:0002834,decreased heart weight|MP:0005016,decreased lymphocyte cell number
MGI:8250493	Acta2<tm1.1Dmmz>	MP:0000272,abnormal aorta morphology|MP:0002843,decreased systemic arterial blood pressure|MP:0010768,mortality/aging
MGI:3665248	Acta2<tm1Rjs>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000233,abnormal blood flow velocity|MP:0000272,abnormal aorta morphology|MP:0003026,decreased vasoconstriction|MP:0003070,increased vascular permeability|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0009862,abnormal aorta elastic tissue morphology
MGI:6209780	Actb<em1Erv>	MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0004531,short outer hair cell stereocilia|MP:0004748,increased susceptibility to age-related hearing loss|MP:0005369,muscle phenotype|MP:0006325,impaired hearing
MGI:7447019	Actbl2<em1(IMPC)J>	MP:0000063,decreased bone mineral density
MGI:4881824	Actb<tm1.1Erv>	MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004524,short cochlear hair cell stereocilia|MP:0004748,increased susceptibility to age-related hearing loss|MP:0005377,hearing/vestibular/ear phenotype|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5439159	Actb<tm1.1(tetO-COP4*/EYFP)Kftnk>	MP:0004811,abnormal neuron physiology|MP:0008916,abnormal astrocyte physiology
MGI:2448648	Actb<tm1Alj>	MP:0011091,prenatal lethality, complete penetrance
MGI:2180089	Actb<tm1Bhr>	MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3796617	Actb<tm1Dost>	MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:3770046	Actb<tm1Npa>	MP:0001262,decreased body weight|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3032612	Actb<tm1(PyVT)Arge>	MP:0001883,increased mammary adenocarcinoma incidence|MP:0002083,premature death|MP:0002947,increased hemangioma incidence|MP:0005140,decreased cardiac muscle contractility|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5438548	Actb<tm1Rsin>	MP:0002169,no abnormal phenotype detected
MGI:3769438	Actb<tm2Npa>	MP:0001265,decreased body size
MGI:3032619	Actb<tm2(Tag)Arge>	MP:0000767,abnormal smooth muscle morphology|MP:0001120,abnormal uterus morphology|MP:0002032,increased sarcoma incidence|MP:0002035,increased leiomyosarcoma incidence|MP:0002997,enlarged seminal vesicle|MP:0009342,enlarged gallbladder
MGI:4456082	Actb<tm3.1(Sirt1)Npa>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001262,decreased body weight|MP:0001516,abnormal motor coordination/balance|MP:0002683,delayed fertility|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005668,decreased circulating leptin level|MP:0009289,decreased epididymal fat pad weight|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011939,increased food intake|MP:0013278,decreased fasting circulating glucose level|MP:0030968,decreased circulating adiponectin level
MGI:7642224	Actc1dt<tm1Kwan>	MP:0002833,increased heart weight|MP:0003038,decreased myocardial infarct size|MP:0004215,abnormal myocardial fiber physiology|MP:0004565,decreased myocardial fiber size|MP:0006321,increased myocardial fiber number|MP:0031216,decreased susceptibility to myocardial ischemic injury
MGI:6276989	Actc1<em1(IMPC)Mbp>	MP:0011100,preweaning lethality, complete penetrance
MGI:3029177	Actc1<tm1.1Buck>	MP:0002169,no abnormal phenotype detected
MGI:2180072	Actc1<tm1Jll>	MP:0000274,enlarged heart|MP:0001265,decreased body size|MP:0002190,disorganized myocardium|MP:0004090,abnormal sarcomere morphology|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011392,increased fetal cardiomyocyte apoptosis|MP:0012082,delayed heart development|MP:0031609,increased fetal cardiomyocyte size|MP:0031613,fetal cardiomyocyte disarray
MGI:2153871	Actd1<C57BL/6J>	MP:0001399,hyperactivity
MGI:2153872	Actd1<DBA/2J>	MP:0001402,decreased locomotor activity
MGI:2156055	Actd2<C57BL/6J>	MP:0001399,hyperactivity
MGI:2156056	Actd2<DBA/2J>	MP:0001402,decreased locomotor activity
MGI:2156058	Actd3<C57BL/6J>	MP:0001399,hyperactivity
MGI:2156059	Actd3<DBA/2J>	MP:0001402,decreased locomotor activity
MGI:2157191	Actd4<DBA/2J>	MP:0001399,hyperactivity
MGI:3849834	Actg1<tm1.1Erv>	MP:0001262,decreased body weight|MP:0001967,deafness|MP:0002083,premature death|MP:0004529,decreased outer hair cell stereocilia number|MP:0005381,digestive/alimentary phenotype|MP:0006325,impaired hearing|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5692873	Actg1<tm1.1(KOMP)Vlcg>	MP:0000428,abnormal craniofacial morphology|MP:0001297,microphthalmia|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003054,spina bifida|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4881925	Actg1<tm1.2Erv>	MP:0001402,decreased locomotor activity|MP:0001513,limb grasping|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004091,abnormal Z line morphology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004748,increased susceptibility to age-related hearing loss|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3664246	Actg1<tm1Erv>	MP:0001402,decreased locomotor activity|MP:0001513,limb grasping|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004091,abnormal Z line morphology|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:5807486	Actg2<em1(IMPC)J>	MP:0001304,cataract|MP:0002098,abnormal vibrissa morphology|MP:0005553,increased circulating creatinine level
MGI:7593716	Actg2<em1Yiwan>	MP:0000495,abnormal colon morphology|MP:0000496,abnormal small intestine morphology|MP:0000539,distended urinary bladder|MP:0003620,oliguria|MP:0006001,abnormal intestinal transit time|MP:0010155,abnormal intestine physiology|MP:0011923,abnormal bladder urine volume
MGI:5473172	Actl10<tm1a(EUCOMM)Wtsi>	MP:0010088,decreased circulating fructosamine level
MGI:6377435	Actl6a<em1(IMPC)J>	MP:0000198,decreased circulating phosphate level|MP:0001417,decreased exploration in new environment|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005635,decreased circulating bilirubin level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5427581	Actl6a<tm1.1Grc>	MP:0000221,decreased leukocyte cell number|MP:0000223,decreased monocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0000334,decreased granulocyte number|MP:0001577,anemia|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002872,polycythemia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0003884,decreased macrophage cell number|MP:0004810,decreased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0008255,decreased megakaryocyte cell number|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0009278,abnormal bone marrow cell physiology|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011178,increased erythroblast number|MP:0011903,decreased hematopoietic stem cell proliferation
MGI:5427582	Actl6a<tm1.2Grc>	MP:0011092,embryonic lethality, complete penetrance
MGI:6361975	Actl6b<em1(IMPC)J>	MP:0001926,female infertility|MP:0004738,abnormal auditory brainstem response|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3775841	Actl6b<tm1Grc>	MP:0000920,abnormal myelination|MP:0001399,hyperactivity|MP:0004998,decreased CNS synapse formation|MP:0008143,abnormal dendrite morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6827375	Actl7a<em1Fzh>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0005389,reproductive system phenotype|MP:0008898,abnormal acrosome morphology|MP:0009231,detached acrosome
MGI:5620312	Actl7b<tm1.1(KOMP)Vlcg>	MP:0000538,abnormal urinary bladder morphology|MP:0001925,male infertility
MGI:4399183	Actl7b<tm1(KOMP)Vlcg>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004929,decreased epididymis weight|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009830,abnormal sperm connecting piece morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009833,absent sperm mitochondrial sheath|MP:0009834,abnormal sperm annulus morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014052,increased male germ cell apoptosis|MP:0020451,decreased sperm progressive motility|MP:0031356,abnormal outer dense fiber morphology
MGI:6693352	Actl9<em1Glin>	MP:0000242,impaired fertilization|MP:0006380,abnormal spermatid morphology|MP:0008898,abnormal acrosome morphology|MP:0009231,detached acrosome|MP:0031354,abnormal acrosome assembly|MP:0031355,abnormal proacrosomal vesicle fusion
MGI:6831070	Actmap<em1Nki>	MP:0000747,muscle weakness|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010053,decreased grip strength|MP:0010768,mortality/aging|MP:0020849,abnormal actin cytoskeleton morphology
MGI:7482516	Actn2<em1Kage>	MP:0000266,abnormal heart morphology|MP:0000486,abnormal pulmonary trunk morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0002748,abnormal pulmonary valve morphology|MP:0003920,abnormal heart right ventricle morphology|MP:0003923,abnormal heart left atrium morphology|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0005369,muscle phenotype|MP:0005385,cardiovascular system phenotype|MP:0010418,perimembraneous ventricular septal defect|MP:0010463,aorta stenosis|MP:0010605,thick pulmonary valve cusps|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011390,abnormal fetal cardiomyocyte physiology|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0021158,decreased heart left ventricle wall thickness
MGI:3760255	Actn3<tm1Knno>	MP:0000759,abnormal skeletal muscle morphology|MP:0002106,abnormal muscle physiology|MP:0003060,increased aerobic running capacity
MGI:3767564	Actn4<tm1.1Mrpk>	MP:0002962,increased urine protein level|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0008140,podocyte foot process effacement|MP:0011090,perinatal lethality, incomplete penetrance
MGI:4441842	Actn4<tm1a(EUCOMM)Wtsi>	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000445,short snout|MP:0000602,dilated liver sinusoidal space|MP:0000783,abnormal forebrain morphology|MP:0001014,absent superior cervical ganglion|MP:0001015,small superior cervical ganglion|MP:0001325,abnormal retina morphology|MP:0002725,abnormal vein morphology|MP:0002833,increased heart weight|MP:0003237,abnormal lens epithelium morphology|MP:0003266,biliary cyst|MP:0003686,abnormal eye muscle morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0004269,abnormal optic cup morphology|MP:0004666,absent stapedial artery|MP:0005244,hemopericardium|MP:0006063,abnormal inferior vena cava morphology|MP:0006093,arteriovenous malformation|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013824,abnormal hypoglossal canal morphology|MP:0013825,small hypoglossal canal|MP:0013826,absent hypoglossal canal|MP:0013834,thin hypoglossal nerve|MP:0013835,absent hypoglossal nerve|MP:0013836,abnormal hypoglossal nerve topology|MP:0013848,subcutaneous edema|MP:0013875,increased trigeminal neuroma incidence|MP:0013876,absent ductus venosus valve|MP:0013877,abnormal ductus venosus valve morphology|MP:0013878,abnormal ductus venosus valve topology|MP:0013967,abnormal infrahyoid muscle connection|MP:0013968,multiple persisting craniopharyngeal ducts|MP:0013971,blood in lymph vessels|MP:0013975,abnormal coronary sinus connection|MP:0013992,persistent dorsal ophthalmic artery|MP:0014018,embryo tumor|MP:0014021,heterochrony|MP:0014023,abnormal intestine placement
MGI:2664917	Actn4<tm1Mrpk>	MP:0000523,cortical renal glomerulopathies|MP:0001263,weight loss|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002705,dilated renal tubule|MP:0002871,albuminuria|MP:0002959,increased urine microalbumin level|MP:0002962,increased urine protein level|MP:0002989,small kidney|MP:0003606,kidney failure|MP:0004969,pale kidney|MP:0005264,glomerulosclerosis|MP:0005265,abnormal blood urea nitrogen level|MP:0008140,podocyte foot process effacement|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011320,abnormal glomerular capillary morphology|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011402,renal cast|MP:0011753,decreased podocyte number|MP:0011826,abnormal lymphocyte chemotaxis|MP:0011864,abnormal podocyte adhesion|MP:0011869,detached podocyte
MGI:6423413	Actr3b<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0020870,decreased thigmotaxis
MGI:3765916	Actr3<Gt(A009F03)Vau>	MP:0001730,embryonic growth arrest|MP:0004957,abnormal blastocyst morphology|MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:6120757	Actr5<tm2b(EUCOMM)Wtsi>	MP:0001415,increased exploration in new environment|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0003232,abnormal forebrain development|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4434280	Actr6<tm1a(EUCOMM)Wtsi>	MP:0003443,increased circulating glycerol level|MP:0011100,preweaning lethality, complete penetrance
MGI:5554924	Actr8<tm1.1(KOMP)Vlcg>	MP:0000208,decreased hematocrit|MP:0001399,hyperactivity|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005633,increased circulating sodium level|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:2153874	Actre1<C57BL/6J>	MP:0002629,hyperactivity elicited by ethanol administration
MGI:2153873	Actre1<DBA/2J>	MP:0002629,hyperactivity elicited by ethanol administration
MGI:2154487	Actre2<C57BL/6J>	MP:0002629,hyperactivity elicited by ethanol administration
MGI:3694237	Actre5<BALB/cJ>	MP:0002629,hyperactivity elicited by ethanol administration
MGI:3694240	Actre6<LP/J>	MP:0001402,decreased locomotor activity
MGI:6765445	Actrt1<em1Xwei>	MP:0001922,reduced male fertility|MP:0006380,abnormal spermatid morphology|MP:0009234,absent sperm head
MGI:5632529	Actrt3<tm1.1(KOMP)Vlcg>	MP:0000367,abnormal coat/ hair morphology|MP:0001399,hyperactivity|MP:0010097,abnormal retina blood vessel morphology
MGI:5000108	Acvr1b<tm1.1Gsu>	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000427,abnormal hair cycle|MP:0000652,enlarged sebaceous gland|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001732,postnatal growth retardation|MP:0002073,abnormal hair growth|MP:0003414,epidermal cyst|MP:0003815,hairless|MP:0003875,abnormal hair follicle regression|MP:0005381,digestive/alimentary phenotype|MP:0005389,reproductive system phenotype|MP:0005501,abnormal skin physiology|MP:0009535,abnormal skin sebaceous gland morphology|MP:0009715,thick epidermis stratum basale|MP:0010096,abnormal incisor color|MP:0010680,abnormal skin adnexa physiology|MP:0010699,dilated hair follicle|MP:0030136,abnormal lower incisor morphology
MGI:5548443	Acvr1b<tm1.1(KOMP)Vlcg>	MP:0000367,abnormal coat/ hair morphology|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001147,small testis|MP:0002768,small adrenal glands|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5441233	Acvr1b<tm1.1Pbe>	MP:0011092,embryonic lethality, complete penetrance
MGI:1857710	Acvr1b<tm1Enl>	MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001694,absent egg cylinders|MP:0001730,embryonic growth arrest|MP:0002582,disorganized extraembryonic tissue|MP:0003886,abnormal embryonic epiblast morphology|MP:0005076,abnormal cell differentiation|MP:0010126,abnormal distal visceral endoderm morphology|MP:0010736,abnormal extraembryonic ectoderm morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011186,abnormal visceral endoderm morphology
MGI:5544768	Acvr1b<tm2.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:5634946	Acvr1c<tm1b(EUCOMM)Hmgu>	MP:0001402,decreased locomotor activity|MP:0002833,increased heart weight|MP:0010025,decreased total body fat amount
MGI:3512292	Acvr1c<tm1Cfi>	MP:0002169,no abnormal phenotype detected
MGI:5548914	Acvr1<tm1.1(KOMP)Vlcg>	MP:0005568,increased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6414911	Acvr1<tm1.1Mak>	MP:0001672,abnormal embryo development|MP:0011091,prenatal lethality, complete penetrance
MGI:3696672	Acvr1<tm1.1Vk>	MP:0001680,abnormal mesoderm development|MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002231,abnormal primitive streak morphology|MP:0003886,abnormal embryonic epiblast morphology
MGI:1931734	Acvr1<tm1Bhr>	MP:0001680,abnormal mesoderm development|MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002230,abnormal primitive streak formation|MP:0002231,abnormal primitive streak morphology|MP:0003087,absent allantois|MP:0003886,abnormal embryonic epiblast morphology|MP:0003988,disorganized embryonic tissue|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5471642	Acvr1<tm1Emsh>	MP:0001785,edema|MP:0001846,increased inflammatory response|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002932,abnormal joint morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0004609,vertebral fusion|MP:0004635,short metatarsal bones|MP:0005306,abnormal phalanx morphology|MP:0006042,increased apoptosis|MP:0008069,abnormal joint mobility|MP:0008149,abnormal costovertebral joint morphology|MP:0009415,skeletal muscle degeneration|MP:0010079,increased osteochondroma incidence|MP:0011087,neonatal lethality, complete penetrance|MP:0014167,ectopic bone|MP:0030793,short femur neck|MP:0030794,broad femur neck
MGI:1857711	Acvr1<tm1Enl>	MP:0001672,abnormal embryo development|MP:0001675,abnormal ectoderm development|MP:0001683,absent mesoderm|MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0001710,absent amniotic folds|MP:0002230,abnormal primitive streak formation|MP:0003087,absent allantois|MP:0005030,absent amnion|MP:0009593,absent chorion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011190,thick embryonic epiblast
MGI:6140231	Acvr1<tm1Glh>	MP:0005390,skeleton phenotype
MGI:6414907	Acvr1<tm1Mak>	MP:0000743,muscle spasm|MP:0000913,abnormal brain development|MP:0001393,ataxia|MP:0002006,neoplasm|MP:0003690,abnormal glial cell physiology|MP:0005277,abnormal brainstem morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5763014	Acvr1<tm2.1Vlcg>	MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002110,abnormal digit morphology|MP:0002113,abnormal skeleton development|MP:0002764,short tibia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0004351,short humerus|MP:0004355,short radius|MP:0004686,decreased length of long bones|MP:0014100,increased chondrocyte proliferation|MP:0020039,increased bone ossification
MGI:5548333	Acvr2a<tm1.1(KOMP)Vlcg>	MP:0000222,decreased neutrophil cell number|MP:0000428,abnormal craniofacial morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001697,abnormal embryo size|MP:0002797,increased thigmotaxis|MP:0004924,abnormal behavior|MP:0005012,decreased eosinophil cell number|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2179547	Acvr2a<tm1Hsch>	MP:0000460,mandible hypoplasia|MP:0001695,abnormal gastrulation|MP:0001923,reduced female fertility|MP:0003830,abnormal testis development|MP:0005163,cyclopia|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:1861779	Acvr2a<tm1Zuk>	MP:0000111,cleft palate|MP:0000125,absent incisors|MP:0000460,mandible hypoplasia|MP:0001126,abnormal ovary morphology|MP:0001134,absent corpus luteum|MP:0001147,small testis|MP:0001340,abnormal eyelid morphology|MP:0001749,suppressed circulating follicle stimulating hormone level|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0002116,abnormal craniofacial bone morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005250,decreased Sertoli cell number|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0008975,delayed male fertility|MP:0009081,thin uterus|MP:0011087,neonatal lethality, complete penetrance|MP:0014617,decreased spermatogonia number|MP:0014634,decreased round spermatid number|MP:0031239,increased atretic ovarian follicle number
MGI:5548915	Acvr2b<tm1.1(KOMP)Vlcg>	MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0008528,polycystic kidney|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3697600	Acvr2b<tm1.1Spo>	MP:0003036,vertebral transformation
MGI:5441718	Acvr2b<tm1.1Zuk>	MP:0010238,increased skeletal muscle weight
MGI:1857709	Acvr2b<tm1Enl>	MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000267,abnormal heart development|MP:0000520,absent kidney|MP:0000531,right pulmonary isomerism|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001575,cyanosis|MP:0001706,abnormal left-right axis patterning|MP:0002264,abnormal bronchus morphology|MP:0003036,vertebral transformation|MP:0003446,renal hypoplasia|MP:0003604,single kidney|MP:0004110,transposition of great arteries|MP:0004252,abnormal direction of heart looping|MP:0004616,lumbar vertebral transformation|MP:0004617,sacral vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004651,increased thoracic vertebrae number|MP:0006061,right atrial isomerism|MP:0006065,abnormal heart position or orientation|MP:0006126,abnormal cardiac outflow tract development|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3690298	Acvr2b<tm1Spo>	MP:0000531,right pulmonary isomerism|MP:0001706,abnormal left-right axis patterning|MP:0003036,vertebral transformation|MP:0004110,transposition of great arteries|MP:0004616,lumbar vertebral transformation
MGI:3604490	Acvrl1<tm1Dgen>	MP:0000262,poor arterial differentiation|MP:0000266,abnormal heart morphology|MP:0000272,abnormal aorta morphology|MP:0000274,enlarged heart|MP:0001718,abnormal visceral yolk sac morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004067,abnormal trabecula carnea morphology|MP:0004076,abnormal vitelline vascular remodeling|MP:0004787,abnormal dorsal aorta morphology|MP:0005312,pericardial effusion|MP:0009577,abnormal developmental vascular remodeling|MP:0010545,abnormal heart layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2155981	Acvrl1<tm1Dyl>	MP:0000260,abnormal angiogenesis|MP:0000298,absent atrioventricular cushions|MP:0001730,embryonic growth arrest|MP:0002123,abnormal definitive hematopoiesis|MP:0002169,no abnormal phenotype detected|MP:0002740,heart hypoplasia|MP:0003229,abnormal vitelline vasculature morphology|MP:0004068,dilated dorsal aorta|MP:0004076,abnormal vitelline vascular remodeling|MP:0004783,abnormal cardinal vein morphology|MP:0004784,abnormal anterior cardinal vein morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0005590,increased vasodilation|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006093,arteriovenous malformation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2155980	Acvrl1<tm1Enl>	MP:0000231,hypertension|MP:0000260,abnormal angiogenesis|MP:0000291,enlarged pericardium|MP:0000433,microcephaly|MP:0000465,gastrointestinal hemorrhage|MP:0000599,enlarged liver|MP:0000602,dilated liver sinusoidal space|MP:0001038,abnormal cholinergic neuron morphology|MP:0001614,abnormal blood vessel morphology|MP:0001914,hemorrhage|MP:0002083,premature death|MP:0002138,abnormal hepatobiliary system morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003974,abnormal endocardium morphology|MP:0003984,embryonic growth retardation|MP:0004068,dilated dorsal aorta|MP:0004175,telangiectasia|MP:0004183,abnormal sympathetic nervous system physiology|MP:0004938,dilated vasculature|MP:0005329,abnormal myocardium layer morphology|MP:0005367,renal/urinary system phenotype|MP:0005385,cardiovascular system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005592,abnormal vascular smooth muscle morphology|MP:0005662,increased circulating adrenaline level|MP:0005665,increased circulating noradrenaline level|MP:0006093,arteriovenous malformation|MP:0008872,abnormal physiological response to xenobiotic|MP:0011022,abnormal circadian regulation of systemic arterial blood pressure|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012253,abnormal intersomitic vessel morphology|MP:0012494,dilated pharyngeal arch artery|MP:0012676,dilated brain ventricle|MP:0031231,decreased circulating angiotensin II level
MGI:2680088	Acvrl1<tm1Spo>	MP:0000259,abnormal vascular development|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4398901	Acvrl1<tm2.1Spo>	MP:0000208,decreased hematocrit|MP:0000274,enlarged heart|MP:0000465,gastrointestinal hemorrhage|MP:0001182,lung hemorrhage|MP:0001577,anemia|MP:0001614,abnormal blood vessel morphology|MP:0001634,internal hemorrhage|MP:0001914,hemorrhage|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0003292,melena|MP:0004007,abnormal lung vasculature morphology|MP:0004883,abnormal vascular wound healing|MP:0004950,abnormal brain vasculature morphology|MP:0005150,cachexia|MP:0005385,cardiovascular system phenotype|MP:0006093,arteriovenous malformation|MP:0010480,pulmonary arteriovenous malformation|MP:0010530,cerebral arteriovenous malformation|MP:0010531,gastrointestinal arteriovenous malformation|MP:0013139,moribund|MP:0031156,large intestine hemorrhage
MGI:4398902	Acvrl1<tm2.2Spo>	MP:0001719,absent vitelline blood vessels|MP:0001914,hemorrhage|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4398904	Acvrl1<tm2Spo>	MP:0002976,vascular smooth muscle hypotrophy|MP:0003229,abnormal vitelline vasculature morphology|MP:0004007,abnormal lung vasculature morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0004938,dilated vasculature|MP:0006093,arteriovenous malformation|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5784639	Acy1<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001406,abnormal gait|MP:0001486,abnormal startle reflex|MP:0002075,abnormal coat/hair pigmentation|MP:0004122,abnormal sinus arrhythmia|MP:0005344,increased circulating bilirubin level|MP:0010053,decreased grip strength
MGI:5810346	Acy3<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0005278,abnormal cholesterol homeostasis|MP:0005553,increased circulating creatinine level|MP:0005567,decreased circulating total protein level|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:6414762	Acyp1<em1(IMPC)J>	MP:0003960,increased lean body mass|MP:0005559,increased circulating glucose level
MGI:1856650	Ad	MP:0000008,increased white adipose tissue amount|MP:0000010,abnormal abdominal fat pad morphology|MP:0000598,abnormal liver morphology|MP:0001261,obese|MP:0002079,increased circulating insulin level|MP:0006094,increased fat cell size|MP:0008469,abnormal protein level|MP:0010024,increased total body fat amount|MP:0020411,increased abdominal adipose tissue amount
MGI:1855938	a<da>	MP:0005409,darkened coat color|MP:0008238,abnormal dorsoventral coat patterning|MP:0009928,abnormal pinna hair pigmentation
MGI:5616653	Adad1<em1(IMPC)J>	MP:0003020,decreased circulating chloride level|MP:0004151,decreased circulating iron level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7495727	Adad1<em1Osb>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis
MGI:3574372	Adad1<tm1Reb>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia
MGI:5565206	Adad2<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001925,male infertility|MP:0001926,female infertility|MP:0003064,decreased coping response|MP:0005560,decreased circulating glucose level
MGI:7495729	Adad2<em1Osb>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0004901,decreased male germ cell number|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0006379,abnormal spermatocyte morphology|MP:0006380,abnormal spermatid morphology|MP:0009230,abnormal sperm head morphology
MGI:7450907	Adad2<em1Shnk>	MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0008279,arrest of spermiogenesis|MP:0008898,abnormal acrosome morphology
MGI:7495733	Adad2<em2Osb>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0008279,arrest of spermiogenesis|MP:0020550,multinucleated giant male germ cells
MGI:7450908	Adad2<em2Shnk>	MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0008279,arrest of spermiogenesis|MP:0008898,abnormal acrosome morphology
MGI:5604765	Adad2<em3(IMPC)J>	MP:0001925,male infertility|MP:0005159,azoospermia|MP:0006380,abnormal spermatid morphology|MP:0014636,decreased elongated spermatid number
MGI:5302350	Adal<tm1a(EUCOMM)Wtsi>	MP:0003179,thrombocytopenia|MP:0010124,decreased bone mineral content
MGI:4438892	Adam10<tm1.1Dhc>	MP:0002144,abnormal B cell differentiation|MP:0008173,increased follicular B cell number|MP:0008183,absent marginal zone B cells|MP:0009922,increased transitional stage T1 B cell number|MP:0009926,decreased transitional stage T2 B cell number
MGI:5305451	Adam10<tm1.1Khr>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000706,small thymus|MP:0001823,thymus hypoplasia|MP:0002123,abnormal definitive hematopoiesis|MP:0002145,abnormal T cell differentiation|MP:0002169,no abnormal phenotype detected|MP:0002397,abnormal bone marrow morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004809,increased hematopoietic stem cell number|MP:0004952,increased spleen weight|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008111,abnormal granulocyte differentiation|MP:0008476,increased spleen red pulp amount|MP:0010373,myeloid hyperplasia
MGI:3809599	Adam10<tm1.1Zhu>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4839221	Adam10<tm1Beni>	MP:0005464,abnormal platelet physiology
MGI:3522353	Adam10<tm1Psa>	MP:0000264,failure of vascular branching|MP:0000292,distended pericardium|MP:0000844,abnormal pontine flexure morphology|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0001725,abnormal umbilical cord morphology|MP:0002151,abnormal neural tube morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0006341,small first pharyngeal arch|MP:0008029,abnormal paraxial mesoderm morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012082,delayed heart development|MP:0012254,absent intersomitic vessels
MGI:3809598	Adam10<tm1Zhu>	MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:4838238	Adam10<tm2Psa>	MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0001614,abnormal blood vessel morphology|MP:0001727,abnormal embryo implantation|MP:0001729,impaired embryo implantation|MP:0001915,intracranial hemorrhage|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0002169,no abnormal phenotype detected|MP:0003845,abnormal decidualization|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0005381,digestive/alimentary phenotype|MP:0006056,increased vascular endothelial cell number|MP:0009661,abnormal pregnancy|MP:0009664,abnormal luminal closure|MP:0009667,abnormal embryo invasion|MP:0011090,perinatal lethality, incomplete penetrance|MP:0013577,forestomach hypoplasia
MGI:5694165	Adam11<tm1b(KOMP)Mbp>	MP:0001392,abnormal locomotor behavior
MGI:3625523	Adam11<tm1Sag>	MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning
MGI:2448241	Adam12<tm1Asf>	MP:0000759,abnormal skeletal muscle morphology|MP:0001780,decreased brown adipose tissue amount|MP:0009408,decreased skeletal muscle fiber density|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2672997	Adam15<tm1Bbl>	MP:0002052,decreased tumor incidence|MP:0002166,abnormal tumor susceptibility|MP:0003447,decreased tumor growth/size|MP:0009660,abnormal induced retina neovascularization
MGI:3804711	Adam15<tm1Dgen>	MP:0003434,decreased susceptibility to induced choroidal neovascularization|MP:0009660,abnormal induced retina neovascularization
MGI:5616076	Adam15<tm2.1Bbl>	MP:0001325,abnormal retina morphology|MP:0002052,decreased tumor incidence|MP:0002166,abnormal tumor susceptibility|MP:0003447,decreased tumor growth/size|MP:0009392,retina gliosis|MP:0010235,abnormal retina inner limiting membrane morphology
MGI:4835996	Adam17<m1Btlr>	MP:0000410,waved hair|MP:0001263,weight loss|MP:0008537,increased susceptibility to induced colitis|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008770,decreased survivor rate|MP:0008838,decreased transforming growth factor beta level
MGI:3713366	Adam17<tm1.1Bbl>	MP:0001302,eyelids open at birth|MP:0002081,perinatal lethality|MP:0002624,abnormal tricuspid valve morphology|MP:0002747,abnormal aortic valve morphology|MP:0002748,abnormal pulmonary valve morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0009264,failure of eyelid fusion|MP:0010591,enlarged aortic valve|MP:0010593,thick aortic valve cusps|MP:0010605,thick pulmonary valve cusps|MP:0010626,thick tricuspid valve cusps|MP:0011085,postnatal lethality, complete penetrance
MGI:4822480	Adam17<tm1.1Srj>	MP:0000384,distorted hair follicle pattern|MP:0001302,eyelids open at birth|MP:0004947,skin inflammation|MP:0005381,digestive/alimentary phenotype|MP:0005464,abnormal platelet physiology|MP:0008537,increased susceptibility to induced colitis|MP:0008568,abnormal interleukin secretion|MP:0008660,increased interleukin-10 secretion|MP:0008721,abnormal chemokine level|MP:0008883,abnormal enterocyte proliferation|MP:0009503,abnormal mammary gland duct morphology|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009859,eye opacity|MP:0010180,increased susceptibility to weight loss|MP:0010579,increased heart left ventricle size|MP:0010614,abnormal mitral valve cusp morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5571391	Adam17<tm1.1Wesh>	MP:0000274,enlarged heart|MP:0000352,decreased cell proliferation|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002652,thin myocardium|MP:0004007,abnormal lung vasculature morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005388,respiratory system phenotype|MP:0006382,abnormal lung epithelium morphology|MP:0010768,mortality/aging|MP:0010825,abnormal lung saccule morphology|MP:0011143,thick lung-associated mesenchyme
MGI:4354847	Adam17<tm1.2Bbl>	MP:0000065,abnormal bone marrow cavity morphology|MP:0000066,osteoporosis|MP:0000135,decreased compact bone thickness|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000321,increased bone marrow cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001191,abnormal skin condition|MP:0001194,dermatitis|MP:0001216,abnormal epidermal layer morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0002060,abnormal skin morphology|MP:0002073,abnormal hair growth|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002497,increased IgE level|MP:0002796,impaired skin barrier function|MP:0002998,abnormal bone remodeling|MP:0003109,short femur|MP:0003153,early eyelid opening|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003853,dry skin|MP:0004016,decreased bone mass|MP:0004686,decreased length of long bones|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005425,increased macrophage cell number|MP:0005505,thrombocytosis|MP:0005564,increased hemoglobin content|MP:0008086,increased T-helper 1 cell number|MP:0008090,increased T-helper 2 cell number|MP:0008476,increased spleen red pulp amount|MP:0008614,increased circulating interleukin-17 level|MP:0008681,increased interleukin-17 secretion|MP:0009346,decreased trabecular bone thickness|MP:0010072,increased pruritus|MP:0010209,abnormal circulating chemokine level|MP:0010219,increased T-helper 17 cell number
MGI:5478752	Adam17<tm1.2Rain>	MP:0002745,abnormal atrioventricular valve morphology|MP:0002833,increased heart weight|MP:0011089,perinatal lethality, complete penetrance|MP:0031580,enlarged semilunar valve
MGI:5571392	Adam17<tm1.2Wesh>	MP:0001178,pulmonary hypoplasia|MP:0001302,eyelids open at birth|MP:0008772,increased heart ventricle size|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4434074	Adam17<tm1a(EUCOMM)Wtsi>	MP:0001260,increased body weight|MP:0002098,abnormal vibrissa morphology|MP:0003131,increased erythrocyte cell number|MP:0010123,increased bone mineral content|MP:0010373,myeloid hyperplasia|MP:0010831,lethality, incomplete penetrance
MGI:3713365	Adam17<tm1Bbl>	MP:0002169,no abnormal phenotype detected|MP:0002451,abnormal macrophage physiology|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008734,decreased susceptibility to endotoxin shock
MGI:3807283	Adam17<tm1Ckww>	MP:0002376,abnormal dendritic cell physiology|MP:0010768,mortality/aging
MGI:1857753	Adam17<tm1Imx>	MP:0000274,enlarged heart|MP:0000377,abnormal hair follicle morphology|MP:0000383,abnormal hair follicle orientation|MP:0000496,abnormal small intestine morphology|MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001178,pulmonary hypoplasia|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001274,curly vibrissae|MP:0001282,short vibrissae|MP:0001302,eyelids open at birth|MP:0001312,abnormal cornea morphology|MP:0001313,increased incidence of corneal inflammation|MP:0001575,cyanosis|MP:0001614,abnormal blood vessel morphology|MP:0001634,internal hemorrhage|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0002085,abnormal embryonic tissue morphology|MP:0002092,abnormal eye morphology|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0004007,abnormal lung vasculature morphology|MP:0004067,abnormal trabecula carnea morphology|MP:0004391,abnormal respiratory conducting tube morphology|MP:0004950,abnormal brain vasculature morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0006382,abnormal lung epithelium morphology|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009264,failure of eyelid fusion|MP:0009431,decreased fetal weight|MP:0010402,ventricular septal defect|MP:0010591,enlarged aortic valve|MP:0010594,thick aortic valve|MP:0010600,enlarged pulmonary valve|MP:0010825,abnormal lung saccule morphology|MP:0010856,dilated respiratory conducting tube|MP:0010887,pale lung|MP:0010897,abnormal bronchiole epithelium morphology|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011143,thick lung-associated mesenchyme|MP:0011394,increased fetal cardiomyocyte proliferation|MP:0012099,decreased spongiotrophoblast size|MP:0012269,nuchal edema|MP:0013744,abnormal conjunctival sac morphology|MP:0020333,enhanced leukocyte tethering or rolling|MP:0031570,enlarged atrioventricular valve|MP:0031580,enlarged semilunar valve|MP:0031609,increased fetal cardiomyocyte size
MGI:5284875	Adam17<tm1Rain>	MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0020333,enhanced leukocyte tethering or rolling
MGI:4822481	Adam17<tm1Srj>	MP:0002083,premature death
MGI:3625359	Adam17<woe>	MP:0000274,enlarged heart|MP:0000285,abnormal heart valve morphology|MP:0000410,waved hair|MP:0001194,dermatitis|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001302,eyelids open at birth|MP:0001304,cataract|MP:0001312,abnormal cornea morphology|MP:0001313,increased incidence of corneal inflammation|MP:0001314,cornea opacity|MP:0001316,cornea scarring|MP:0001325,abnormal retina morphology|MP:0003078,aphakia|MP:0003704,abnormal hair follicle development|MP:0003711,pathological neovascularization|MP:0004226,absent Schlemm's canal|MP:0004283,absent cornea endothelium|MP:0004285,absent Descemet membrane|MP:0004545,enlarged esophagus|MP:0005193,abnormal anterior eye segment morphology|MP:0005204,abnormal canal of Schlemm morphology|MP:0005381,digestive/alimentary phenotype|MP:0005543,decreased cornea thickness|MP:0006000,abnormal cornea epithelium morphology|MP:0006236,absent Meibomian glands|MP:0009264,failure of eyelid fusion|MP:0010591,enlarged aortic valve|MP:0010594,thick aortic valve|MP:0010600,enlarged pulmonary valve|MP:0010601,thick pulmonary valve|MP:0011481,anterior iris synechia|MP:0011697,lens vacuoles|MP:0013745,abnormal eyelid margin morphology|MP:0031563,pulmonary valve hypertrophy|MP:0031569,aortic valve hypertrophy
MGI:5007009	Adam18<tm1Lex>	MP:0003858,enhanced coordination
MGI:6194894	Adam18<tm1Osb>	MP:0002169,no abnormal phenotype detected
MGI:3028702	Adam19<Gt(Betageo)1Bbl>	MP:0000273,overriding aortic valve|MP:0000285,abnormal heart valve morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002624,abnormal tricuspid valve morphology|MP:0002754,dilated heart right ventricle|MP:0005294,abnormal heart ventricle morphology|MP:0005390,skeleton phenotype|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006055,abnormal vascular endothelial cell morphology|MP:0006117,aortic valve stenosis|MP:0006126,abnormal cardiac outflow tract development|MP:0006128,pulmonary valve stenosis|MP:0008028,pregnancy-related premature death|MP:0010403,atrial septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010423,heart right ventricle aneurysm|MP:0010593,thick aortic valve cusps|MP:0010594,thick aortic valve|MP:0010605,thick pulmonary valve cusps|MP:0010629,thick tricuspid valve|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3620562	Adam19<tm1Asf>	MP:0000273,overriding aortic valve|MP:0000276,heart right ventricle hypertrophy|MP:0000286,abnormal mitral valve morphology|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000301,decreased atrioventricular cushion size|MP:0000639,abnormal adrenal gland morphology|MP:0000759,abnormal skeletal muscle morphology|MP:0000761,thin diaphragm muscle|MP:0002624,abnormal tricuspid valve morphology|MP:0010418,perimembraneous ventricular septal defect|MP:0010455,aortopulmonary window|MP:0010563,increased heart right ventricle size|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031554,abnormal aortic valve development|MP:0031555,abnormal pulmonary valve development
MGI:3052660	Adam1a<tm1Tba>	MP:0001925,male infertility|MP:0005410,abnormal fertilization|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031012,impaired sperm migration in female genital tract
MGI:3628759	Adam1b<tm1Tba>	MP:0002169,no abnormal phenotype detected
MGI:5637118	Adam20<tm1b(EUCOMM)Hmgu>	MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity
MGI:7294347	Adam21<em1Liwe>	MP:0002169,no abnormal phenotype detected
MGI:3663320	Adam21<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:4441313	Adam22<tm1.1Mejr>	MP:0000920,abnormal myelination|MP:0002882,abnormal neuron morphology|MP:0003631,nervous system phenotype
MGI:3584137	Adam22<tm1Sag>	MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0000947,convulsive seizures|MP:0001106,abnormal Schwann cell morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0002882,abnormal neuron morphology|MP:0003634,abnormal glial cell morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2156200	Adam23<Gt(KST021)Byg>	MP:0000745,tremors|MP:0001393,ataxia|MP:0011085,postnatal lethality, complete penetrance
MGI:5613204	Adam23<tm1.1Mejr>	MP:0001406,abnormal gait|MP:0002882,abnormal neuron morphology|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology
MGI:5613205	Adam23<tm1.2Mejr>	MP:0000745,tremors|MP:0001732,postnatal growth retardation|MP:0003631,nervous system phenotype|MP:0011085,postnatal lethality, complete penetrance
MGI:5636978	Adam23<tm1b(EUCOMM)Hmgu>	MP:0002100,abnormal tooth morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4437125	Adam24<tm1Pmkf>	MP:0001922,reduced male fertility|MP:0031014,polyspermy
MGI:5569036	Adam26a<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0012125,decreased bronchoconstrictive response
MGI:6460278	Adam28<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6488446	Adam28<tm1.2Dica>	MP:0002021,increased incidence of induced tumors|MP:0002619,abnormal lymphocyte morphology|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0012762,abnormal alpha-beta T cell morphology
MGI:7710881	Adam29<em1Otin>	MP:0000198,decreased circulating phosphate level|MP:0000607,abnormal hepatocyte morphology|MP:0001846,increased inflammatory response|MP:0002724,enhanced wound healing|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008963,increased carbon dioxide production|MP:0010378,increased respiratory quotient|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:1857764	Adam2<tm1Dgm>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031012,impaired sperm migration in female genital tract
MGI:5634295	Adam32<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0003961,decreased lean body mass|MP:0006243,impaired pupillary reflex|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:3664558	Adam33<tm1.1Chch>	MP:0002169,no abnormal phenotype detected
MGI:6279890	Adam33<tm1b(EUCOMM)Hmgu>	MP:0005553,increased circulating creatinine level|MP:0005627,increased circulating potassium level
MGI:2156166	Adam3<tm1Ihgg>	MP:0001925,male infertility|MP:0005389,reproductive system phenotype|MP:0030978,impaired binding of sperm to zona pellucida
MGI:6358812	Adam3<tm1Osb>	MP:0001925,male infertility
MGI:2156167	Adam3<tm1Pmkf>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0030978,impaired binding of sperm to zona pellucida
MGI:6260210	Adam5<em1(IMPC)J>	MP:0001925,male infertility|MP:0002591,decreased mean corpuscular volume
MGI:7425492	Adam7<em1(IMPC)Ccpcz>	MP:0001293,anophthalmia|MP:0002092,abnormal eye morphology|MP:0005599,increased cardiac muscle contractility
MGI:5804545	Adam7<tm1Tigm>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0002631,abnormal epididymis morphology|MP:0002660,abnormal caput epididymis morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0002674,abnormal sperm motility|MP:0004933,abnormal epididymis epithelium morphology|MP:0005389,reproductive system phenotype|MP:0009237,kinked sperm flagellum|MP:0009824,spermatic granuloma
MGI:4418309	Adam8<tm1.1Mdz>	MP:0003436,decreased susceptibility to induced arthritis|MP:0005387,immune system phenotype
MGI:5009706	Adam8<tm1.1Rood>	MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005390,skeleton phenotype|MP:0008396,abnormal osteoclast differentiation
MGI:3527133	Adam8<tm1Bbl>	MP:0002169,no abnormal phenotype detected
MGI:2180096	Adam9<tm1Bbl>	MP:0002169,no abnormal phenotype detected|MP:0002724,enhanced wound healing|MP:0003447,decreased tumor growth/size|MP:0003727,abnormal retina layer morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0006069,abnormal retina neuronal layer morphology|MP:0009660,abnormal induced retina neovascularization|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0012193,increased keratinocyte migration|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:6509014	Adamdec1<tm1Dgen>	MP:0000219,increased neutrophil cell number|MP:0001858,intestinal inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0005381,digestive/alimentary phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0008594,decreased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0013298,increased susceptibility to colitis induced morbidity/mortality|MP:0013956,decreased colon length
MGI:6258768	Adamts10<em1Cbal>	MP:0000759,abnormal skeletal muscle morphology|MP:0001200,thick skin|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004686,decreased length of long bones|MP:0004818,increased skeletal muscle mass|MP:0005099,abnormal ciliary body morphology|MP:0009400,decreased skeletal muscle fiber size|MP:0009405,increased skeletal muscle fiber number|MP:0011159,abnormal epidermal-dermal junction morphology|MP:0014164,abnormal ciliary process morphology|MP:0014176,abnormal cilary zonule morphology
MGI:6783437	Adamts10<em1Jku>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002699,abnormal vitreous body morphology|MP:0005391,vision/eye phenotype|MP:0010768,mortality/aging|MP:0011962,increased cornea thickness|MP:0014176,abnormal cilary zonule morphology|MP:0031212,decreased eye anterior chamber depth
MGI:6355992	Adamts10<tm1Dgen>	MP:0001262,decreased body weight|MP:0002271,abnormal pulmonary alveolar duct morphology|MP:0002699,abnormal vitreous body morphology|MP:0004348,long femur|MP:0004370,long ulna|MP:0005385,cardiovascular system phenotype|MP:0005390,skeleton phenotype|MP:0008770,decreased survivor rate|MP:0011101,prenatal lethality, incomplete penetrance|MP:0014176,abnormal cilary zonule morphology|MP:0014659,increased skin stiffness|MP:0020414,abnormal fibroblast physiology|MP:0031212,decreased eye anterior chamber depth
MGI:6430654	Adamts12<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001304,cataract|MP:0002699,abnormal vitreous body morphology
MGI:4457760	Adamts12<tm1Agno>	MP:0003721,increased tumor growth/size|MP:0005601,increased angiogenesis|MP:0010144,abnormal tumor vascularization
MGI:3579136	Adamts13<s>	MP:0031121,increased susceptibility to induced thrombosis
MGI:3605825	Adamts13<tm1Dgi>	MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002412,increased susceptibility to bacterial infection|MP:0002447,abnormal erythrocyte morphology|MP:0003179,thrombocytopenia|MP:0005048,abnormal thrombosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology|MP:0010768,mortality/aging|MP:0031121,increased susceptibility to induced thrombosis|MP:0031165,increased circulating von Willebrand factor level
MGI:3763820	Adamts13<tm1Myta>	MP:0002551,abnormal blood coagulation|MP:0005048,abnormal thrombosis|MP:0006298,abnormal platelet activation
MGI:3708852	Adamts13<tm2Dgi>	MP:0002169,no abnormal phenotype detected
MGI:5763135	Adamts14<em1(IMPC)J>	MP:0001304,cataract
MGI:4954752	Adamts14<Gt(511E11)Cmhd>	MP:0002169,no abnormal phenotype detected|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005391,vision/eye phenotype|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion|MP:0010771,integument phenotype
MGI:5569072	Adamts15<tm1.1(KOMP)Vlcg>	MP:0001925,male infertility|MP:0002079,increased circulating insulin level|MP:0004738,abnormal auditory brainstem response|MP:0004931,enlarged epididymis
MGI:6377449	Adamts16<em1Amc>	MP:0005388,respiratory system phenotype
MGI:6140148	Adamts16<em1(IMPC)H>	MP:0000222,decreased neutrophil cell number|MP:0000745,tremors|MP:0001556,increased circulating HDL cholesterol level|MP:0004852,decreased testis weight|MP:0005012,decreased eosinophil cell number|MP:0005389,reproductive system phenotype|MP:0005628,decreased circulating potassium level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:6140145	Adamts16<em2(IMPC)H>	MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype
MGI:6466716	Adamts17<tm1.1Taks>	MP:0000137,abnormal vertebrae morphology|MP:0004686,decreased length of long bones|MP:0008525,decreased cranium height
MGI:6466717	Adamts17<tm1.2Taks>	MP:0000137,abnormal vertebrae morphology|MP:0001200,thick skin|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002113,abnormal skeleton development|MP:0002543,brachyphalangia|MP:0002544,brachydactyly|MP:0002764,short tibia|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0004351,short humerus|MP:0004634,short metacarpal bones|MP:0004686,decreased length of long bones|MP:0005501,abnormal skin physiology|MP:0008525,decreased cranium height|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0011101,prenatal lethality, incomplete penetrance|MP:0014106,delayed chondrocyte differentiation|MP:0020253,increased collagen level
MGI:5548810	Adamts18<tm1.1(KOMP)Vlcg>	MP:0001304,cataract|MP:0002590,increased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0002699,abnormal vitreous body morphology|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:6148036	Adamts18<tm1.1Wzha>	MP:0001183,overexpanded pulmonary alveolus|MP:0001265,decreased body size|MP:0001286,abnormal eye development|MP:0004499,increased incidence of tumors by chemical induction|MP:0005088,increased acute inflammation|MP:0008537,increased susceptibility to induced colitis|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0013956,decreased colon length|MP:0014222,decreased colon goblet cell number
MGI:4452851	Adamts18<tm1(KOMP)Vlcg>	MP:0000527,abnormal kidney development|MP:0001176,abnormal lung development|MP:0001942,abnormal lung volume|MP:0003068,enlarged kidney|MP:0003641,small lung|MP:0009571,abnormal right lung accessory lobe morphology|MP:0010975,abnormal lung lobe morphology|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011289,abnormal nephron number|MP:0011493,double ureter
MGI:5308778	Adamts18<tm1Zdl>	MP:0001919,abnormal reproductive system physiology
MGI:5527601	Adamts19<tm4a(EUCOMM)Wtsi>	MP:0002747,abnormal aortic valve morphology|MP:0006047,aortic valve regurgitation|MP:0006117,aortic valve stenosis|MP:0010593,thick aortic valve cusps|MP:0010594,thick aortic valve|MP:0010595,abnormal aortic valve cusp morphology|MP:0010598,abnormal aortic valve annulus morphology|MP:0011929,abnormal aortic valve flow|MP:0031166,abnormal aortic valve commissure morphology
MGI:6416159	Adamts19<tm4b(EUCOMM)Wtsi>	MP:0002747,abnormal aortic valve morphology|MP:0006047,aortic valve regurgitation|MP:0006117,aortic valve stenosis|MP:0010593,thick aortic valve cusps|MP:0010594,thick aortic valve|MP:0010595,abnormal aortic valve cusp morphology|MP:0010598,abnormal aortic valve annulus morphology|MP:0011929,abnormal aortic valve flow|MP:0031166,abnormal aortic valve commissure morphology
MGI:6277032	Adamts1<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001404,no spontaneous movement|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0002092,abnormal eye morphology|MP:0002111,abnormal tail morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003231,abnormal placenta vasculature|MP:0003385,abnormal body wall morphology|MP:0006203,eye hemorrhage|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5427602	Adamts1<tm1Dgen>	MP:0000519,hydronephrosis|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003917,increased kidney weight|MP:0011423,kidney cortex atrophy
MGI:2156168	Adamts1<tm1Hku>	MP:0000534,abnormal ureter morphology|MP:0001123,dilated uterus|MP:0001262,decreased body weight|MP:0001729,impaired embryo implantation|MP:0001762,polyuria|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002682,decreased mature ovarian follicle number|MP:0005376,homeostasis/metabolism phenotype|MP:0005618,decreased urine potassium level|MP:0006317,decreased urine sodium level|MP:0008289,abnormal adrenal medulla morphology|MP:0009082,uterus cyst|MP:0010025,decreased total body fat amount|MP:0011303,absent kidney papilla|MP:0011305,dilated kidney calyx|MP:0011376,abnormal kidney corticomedullary boundary morphology|MP:0011460,decreased urine chloride ion level|MP:0011487,abnormal ureteropelvic junction morphology|MP:0011491,ureteropelvic junction obstruction|MP:0011565,kidney papillary hypoplasia
MGI:3574351	Adamts1<tm1Mapr>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002135,abnormal kidney morphology|MP:0003355,decreased ovulation rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011305,dilated kidney calyx|MP:0011422,kidney medulla atrophy|MP:0011423,kidney cortex atrophy
MGI:3609982	Adamts1<tm1Mlia>	MP:0001262,decreased body weight|MP:0002135,abnormal kidney morphology|MP:0003587,ureter obstruction|MP:0011090,perinatal lethality, incomplete penetrance
MGI:1856473	Adamts20<bt>	MP:0002671,belted|MP:0009555,abnormal hair follicle melanin granule distribution
MGI:5617471	Adamts20<bt-10J>	MP:0002671,belted
MGI:2448696	Adamts20<bt-1R>	MP:0002095,abnormal skin pigmentation|MP:0002671,belted
MGI:3766915	Adamts20<bt-2H>	MP:0001186,pigmentation phenotype|MP:0002671,belted|MP:0002938,white spotting|MP:0009784,abnormal melanoblast migration
MGI:2448689	Adamts20<bt-2R>	MP:0002095,abnormal skin pigmentation|MP:0002671,belted
MGI:1856482	Adamts20<bt-4J>	MP:0002075,abnormal coat/hair pigmentation|MP:0002671,belted|MP:0002938,white spotting
MGI:1856483	Adamts20<bt-5J>	MP:0002075,abnormal coat/hair pigmentation|MP:0002671,belted|MP:0002938,white spotting
MGI:1857586	Adamts20<bt-8J>	MP:0002671,belted
MGI:2673334	Adamts20<bt-Bei1>	MP:0000564,syndactyly|MP:0000571,interdigital webbing|MP:0001891,hydrocephaly|MP:0002671,belted
MGI:2675831	Adamts20<bt-J>	MP:0002671,belted|MP:0004381,abnormal hair follicle melanocyte morphology|MP:0009784,abnormal melanoblast migration
MGI:2673336	Adamts20<bt-Mri1>	MP:0002671,belted
MGI:3847117	Adamts20<hip>	MP:0002671,belted|MP:0002938,white spotting
MGI:3835192	Adamts20<m2Btlr>	MP:0002671,belted
MGI:5607745	Adamts20<m3Btlr>	MP:0002671,belted
MGI:5632160	Adamts20<m4Btlr>	MP:0002671,belted
MGI:5632162	Adamts20<m5Btlr>	MP:0002671,belted
MGI:5789560	Adamts20<m6Btlr>	MP:0002671,belted
MGI:5806454	Adamts20<m7Btlr>	MP:0002671,belted
MGI:6198347	Adamts20<m8Btlr>	MP:0002671,belted
MGI:6268396	Adamts20<m9Btlr>	MP:0000373,belly spot|MP:0002940,variable body spotting
MGI:3774131	Adamts20<sp2>	MP:0000373,belly spot|MP:0002671,belted
MGI:5427636	Adamts2<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:2388161	Adamts2<tm1Prc>	MP:0000159,abnormal xiphoid process morphology|MP:0000377,abnormal hair follicle morphology|MP:0000420,ruffled hair|MP:0000445,short snout|MP:0001156,abnormal spermatogenesis|MP:0001199,thin skin|MP:0001764,abnormal homeostasis|MP:0001925,male infertility|MP:0001958,emphysema|MP:0002687,oligozoospermia|MP:0002689,abnormal molar morphology|MP:0003089,decreased skin tensile strength|MP:0005376,homeostasis/metabolism phenotype|MP:0005391,vision/eye phenotype|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0008566,increased interferon-gamma secretion|MP:0010771,integument phenotype|MP:0011643,abnormal tendon collagen fibril morphology|MP:0012546,triangular face
MGI:6189557	Adamts3<tm1.2Itl>	MP:0000601,small liver|MP:0001716,abnormal placenta labyrinth morphology|MP:0001786,skin edema|MP:0002447,abnormal erythrocyte morphology|MP:0003103,liver degeneration|MP:0003717,pallor|MP:0003887,increased hepatocyte apoptosis|MP:0005390,skeleton phenotype|MP:0008778,abnormal lymphangiogenesis|MP:0010194,absent lymphatic vessels|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011526,abnormal placenta fetal blood space morphology
MGI:5585728	Adamts3<tm1b(KOMP)Wtsi>	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0000783,abnormal forebrain morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000826,abnormal third ventricle morphology|MP:0000828,abnormal fourth ventricle morphology|MP:0000841,abnormal hindbrain morphology|MP:0002947,increased hemangioma incidence|MP:0003387,aorta coarctation|MP:0003584,bifid ureter|MP:0003586,dilated ureter|MP:0003826,abnormal Mullerian duct morphology|MP:0003827,abnormal Wolffian duct morphology|MP:0004163,abnormal adenohypophysis morphology|MP:0004463,basisphenoid bone foramen|MP:0004613,fusion of vertebral arches|MP:0004666,absent stapedial artery|MP:0005244,hemopericardium|MP:0008922,abnormal cervical rib|MP:0008923,thoracoschisis|MP:0008986,abnormal liver parenchyma morphology|MP:0009770,abnormal optic chiasm morphology|MP:0010418,perimembraneous ventricular septal defect|MP:0011100,preweaning lethality, complete penetrance|MP:0011513,abnormal vertebral artery morphology|MP:0011683,dual inferior vena cava|MP:0013186,abnormal basilar artery morphology|MP:0013823,absent segment of anterior cerebral artery|MP:0013847,retropleural edema|MP:0013848,subcutaneous edema|MP:0013852,abnormal Mullerian duct topology|MP:0013859,abnormal vitelline vein connection|MP:0013875,increased trigeminal neuroma incidence|MP:0013876,absent ductus venosus valve|MP:0013877,abnormal ductus venosus valve morphology|MP:0013878,abnormal ductus venosus valve topology|MP:0013968,multiple persisting craniopharyngeal ducts|MP:0013986,abnormal vitelline vein topology|MP:0013992,persistent dorsal ophthalmic artery|MP:0014019,embryo cyst|MP:0014021,heterochrony|MP:0020483,abnormal brain artery topology|MP:0020500,persistent trigeminal artery
MGI:5009124	Adamts4<tm1.1Boer>	MP:0002169,no abnormal phenotype detected
MGI:3578001	Adamts4<tm1.1Eam>	MP:0002169,no abnormal phenotype detected
MGI:3617790	Adamts4<tm1.1Lex>	MP:0005390,skeleton phenotype
MGI:5692620	Adamts4<tm1b(EUCOMM)Hmgu>	MP:0003795,abnormal bone structure|MP:0010052,increased grip strength
MGI:3604481	Adamts4<tm1Dgen>	MP:0001405,impaired coordination|MP:0002906,increased susceptibility to pharmacologically induced seizures
MGI:4454664	Adamts4<tm1Dqp>	MP:0000877,abnormal Purkinje cell morphology|MP:0002183,gliosis
MGI:3529049	Adamts4<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:3576786	Adamts5<tm1.1Eam>	MP:0003436,decreased susceptibility to induced arthritis
MGI:3710194	Adamts5<tm1.1Lex>	MP:0005390,skeleton phenotype
MGI:3604488	Adamts5<tm1Dgen>	MP:0000564,syndactyly|MP:0000571,interdigital webbing
MGI:3577938	Adamts5<tm1Eam>	MP:0002169,no abnormal phenotype detected
MGI:3529332	Adamts5<tm1Lex>	MP:0003560,osteoarthritis
MGI:5285450	Adamts5<tm2.2Lex>	MP:0001970,abnormal pain threshold|MP:0003436,decreased susceptibility to induced arthritis
MGI:5476179	Adamts6<b2b1879.1Clo>	MP:0000111,cleft palate|MP:0000137,abnormal vertebrae morphology|MP:0000273,overriding aortic valve|MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0000556,abnormal hindlimb morphology|MP:0001823,thymus hypoplasia|MP:0002192,hydrops fetalis|MP:0002625,heart left ventricle hypertrophy|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5487287	Adamts6<b2b2029Clo>	MP:0000111,cleft palate|MP:0000137,abnormal vertebrae morphology|MP:0000273,overriding aortic valve|MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0000556,abnormal hindlimb morphology|MP:0001823,thymus hypoplasia|MP:0002192,hydrops fetalis|MP:0002625,heart left ventricle hypertrophy|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5491254	Adamts6<b2b2182Clo>	MP:0000111,cleft palate|MP:0000137,abnormal vertebrae morphology|MP:0000273,overriding aortic valve|MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0000556,abnormal hindlimb morphology|MP:0001823,thymus hypoplasia|MP:0002192,hydrops fetalis|MP:0002625,heart left ventricle hypertrophy|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5547743	Adamts6<b2b2187.1Clo>	MP:0000111,cleft palate|MP:0000137,abnormal vertebrae morphology|MP:0000273,overriding aortic valve|MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0000556,abnormal hindlimb morphology|MP:0001823,thymus hypoplasia|MP:0002192,hydrops fetalis|MP:0002625,heart left ventricle hypertrophy|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5491258	Adamts6<b2b2228Clo>	MP:0000111,cleft palate|MP:0000137,abnormal vertebrae morphology|MP:0000273,overriding aortic valve|MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0000556,abnormal hindlimb morphology|MP:0001823,thymus hypoplasia|MP:0002192,hydrops fetalis|MP:0002625,heart left ventricle hypertrophy|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5560144	Adamts6<b2b2405Clo>	MP:0000111,cleft palate|MP:0000137,abnormal vertebrae morphology|MP:0000273,overriding aortic valve|MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0000556,abnormal hindlimb morphology|MP:0001823,thymus hypoplasia|MP:0002192,hydrops fetalis|MP:0002625,heart left ventricle hypertrophy|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5560143	Adamts6<b2b2407Clo>	MP:0000111,cleft palate|MP:0000137,abnormal vertebrae morphology|MP:0000273,overriding aortic valve|MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0000556,abnormal hindlimb morphology|MP:0001823,thymus hypoplasia|MP:0002192,hydrops fetalis|MP:0002625,heart left ventricle hypertrophy|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5560500	Adamts6<b2b2744Clo>	MP:0000111,cleft palate|MP:0000137,abnormal vertebrae morphology|MP:0000273,overriding aortic valve|MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0000556,abnormal hindlimb morphology|MP:0001823,thymus hypoplasia|MP:0002192,hydrops fetalis|MP:0002625,heart left ventricle hypertrophy|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5646302	Adamts6<b2b2966.2Clo>	MP:0000111,cleft palate|MP:0000445,short snout|MP:0000556,abnormal hindlimb morphology|MP:0001625,cardiac hypertrophy|MP:0001823,thymus hypoplasia|MP:0002192,hydrops fetalis|MP:0010082,sternebra fusion|MP:0010412,atrioventricular septal defect|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:6404504	Adamts6<em1(IMPC)Mbp>	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0002109,abnormal limb morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0003231,abnormal placenta vasculature|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape
MGI:4363113	Adamts7<tm1a(KOMP)Wtsi>	MP:0000187,abnormal triglyceride level|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001586,abnormal erythrocyte cell number|MP:0002309,abnormal vital capacity|MP:0003544,abnormal vascular endothelial cell migration|MP:0004001,decreased hepatocyte proliferation|MP:0004883,abnormal vascular wound healing|MP:0005164,abnormal response to injury|MP:0005289,increased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005585,increased tidal volume|MP:0010042,abnormal oval cell physiology|MP:0010896,decreased lung compliance|MP:0010936,decreased airway resistance|MP:0010937,increased total lung capacity|MP:0014275,increased respiration|MP:0020253,increased collagen level|MP:0020316,decreased vascular endothelial cell proliferation
MGI:3530329	Adamts9<Mhdaund3>	MP:0005174,abnormal tail pigmentation|MP:0009387,abnormal epidermal pigmentation
MGI:5629512	Adamts9<Mhdaund4>	MP:0005174,abnormal tail pigmentation|MP:0009387,abnormal epidermal pigmentation|MP:0009783,abnormal melanoblast morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5603199	Adamts9<tm1.1Apte>	MP:0000564,syndactyly|MP:0000571,interdigital webbing|MP:0002169,no abnormal phenotype detected
MGI:6163814	Adamts9<tm1.1Cvrk>	MP:0001186,pigmentation phenotype|MP:0005174,abnormal tail pigmentation
MGI:5603304	Adamts9<tm1.2Apte>	MP:0000285,abnormal heart valve morphology|MP:0001683,absent mesoderm|MP:0001695,abnormal gastrulation|MP:0002092,abnormal eye morphology|MP:0002582,disorganized extraembryonic tissue|MP:0003886,abnormal embryonic epiblast morphology|MP:0003988,disorganized embryonic tissue|MP:0005371,limbs/digits/tail phenotype|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0014134,abnormal embryo morphology
MGI:6163820	Adamts9<tm1.2Cvrk>	MP:0005174,abnormal tail pigmentation
MGI:5766163	Adamts9<tm1b(KOMP)Wtsi>	MP:0001697,abnormal embryo size|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:4418751	Adamts9<tm1Dgen>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:1857056	Adamtsl2<stb>	MP:0000130,abnormal trabecular bone morphology|MP:0000164,abnormal cartilage development|MP:0000440,domed cranium|MP:0000547,short limbs|MP:0000588,thick tail|MP:0000592,short tail|MP:0001147,small testis|MP:0001258,decreased body length|MP:0001259,abnormal body weight|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0002114,abnormal axial skeleton morphology|MP:0002427,disproportionate dwarf|MP:0002566,abnormal sexual interaction|MP:0002673,abnormal sperm number|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003956,abnormal body size|MP:0004686,decreased length of long bones|MP:0006396,decreased long bone epiphyseal plate size|MP:0008525,decreased cranium height|MP:0009856,failure of ejaculation|MP:0031628,abnormal intromission|MP:0031646,impotence
MGI:4362645	Adamtsl2<tm1a(KOMP)Wtsi>	MP:0001732,postnatal growth retardation|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5696789	Adamtsl2<tm1b(KOMP)Wtsi>	MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002058,neonatal lethality|MP:0005369,muscle phenotype|MP:0010943,abnormal bronchus epithelium morphology|MP:0014274,decreased respiration
MGI:6369410	Adamtsl2<tm1c(KOMP)Wtsi>	MP:0000133,abnormal long bone metaphysis morphology|MP:0000572,abnormal autopod morphology|MP:0002115,abnormal limb bone morphology|MP:0002764,short tibia|MP:0004214,abnormal long bone diaphysis morphology|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004635,short metatarsal bones|MP:0011643,abnormal tendon collagen fibril morphology|MP:0030775,abnormal calcaneal tendon morphology|MP:0030803,abnormal tendon cell morphology
MGI:8243400	Adamtsl2<tm1Mtek>	MP:0000438,abnormal cranium morphology|MP:0001262,decreased body weight|MP:0002543,brachyphalangia|MP:0003109,short femur|MP:0005385,cardiovascular system phenotype|MP:0010768,mortality/aging
MGI:8243401	Adamtsl2<tm2Mtek>	MP:0000438,abnormal cranium morphology|MP:0000445,short snout|MP:0001175,abnormal lung morphology|MP:0001625,cardiac hypertrophy|MP:0001861,lung inflammation|MP:0002297,abnormal forced expiratory flow rates|MP:0002327,abnormal respiratory function|MP:0002543,brachyphalangia|MP:0002747,abnormal aortic valve morphology|MP:0003109,short femur|MP:0004471,short nasal bone|MP:0005329,abnormal myocardium layer morphology|MP:0005330,cardiomyopathy|MP:0005608,cardiac interstitial fibrosis|MP:0008489,slow postnatal weight gain|MP:0010493,abnormal atrium myocardium morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011925,abnormal heart echocardiography feature
MGI:7427743	Adamtsl3<em1Apte>	MP:0002833,increased heart weight|MP:0004357,long tibia|MP:0004485,increased response of heart to induced stress|MP:0010768,mortality/aging
MGI:6156440	Adamtsl3<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000274,enlarged heart|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0001126,abnormal ovary morphology|MP:0002637,small uterus|MP:0011874,enlarged urinary bladder
MGI:5795948	Adamtsl4<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001284,absent vibrissae|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0001319,irregularly shaped pupil|MP:0001325,abnormal retina morphology|MP:0001486,abnormal startle reflex|MP:0002098,abnormal vibrissa morphology|MP:0003131,increased erythrocyte cell number|MP:0006241,abnormal placement of pupils|MP:0010052,increased grip strength|MP:0010053,decreased grip strength
MGI:5902816	Adamtsl4<tvrm267>	MP:0002092,abnormal eye morphology|MP:0002864,abnormal ocular fundus morphology|MP:0005103,abnormal retina pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0012040,abnormal c-wave shape|MP:0031428,lens dislocation
MGI:5692660	Adamtsl5<tm1b(EUCOMM)Hmgu>	MP:0010052,increased grip strength
MGI:7425227	Adap1<tm1.1Ryya>	MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008414,abnormal spatial reference memory|MP:0009936,abnormal dendritic spine morphology|MP:0020338,abnormal hippocampal pyramidal neuron dendrite morphology|MP:0020507,increased dendritic spine density
MGI:4944490	Adap1<tm1a(EUCOMM)Wtsi>	MP:0008044,increased NK cell number|MP:0013426,decreased memory-marker NK cell number
MGI:3830729	Adarb1<tm1.1Eme>	MP:0002169,no abnormal phenotype detected
MGI:4840554	Adarb1<tm1.1Skwa>	MP:0000938,motor neuron degeneration|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001056,abnormal cranial nerve morphology|MP:0001071,abnormal facial nerve morphology|MP:0001076,abnormal hypoglossal nerve morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001504,abnormal posture|MP:0002083,premature death|MP:0002184,abnormal innervation|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003993,abnormal ventral spinal root morphology|MP:0004263,abnormal limb posture|MP:0005113,decreased spinal cord ventral horn cell number|MP:0005386,behavior/neurological phenotype|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009413,skeletal muscle fiber atrophy|MP:0010053,decreased grip strength
MGI:2178079	Adarb1<tm1Phs>	MP:0002064,seizures|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0011085,postnatal lethality, complete penetrance
MGI:5754576	Adarb2<em1(IMPC)Tcp>	MP:0000063,decreased bone mineral density|MP:0000367,abnormal coat/ hair morphology|MP:0000689,abnormal spleen morphology|MP:0001147,small testis|MP:0001513,limb grasping|MP:0002989,small kidney
MGI:6257878	Adarb2<tm1b(KOMP)Mbp>	MP:0001363,increased anxiety-related response|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior
MGI:7281512	Adar<em1Stsn>	MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0010768,mortality/aging
MGI:7484719	Adar<em2Qwan>	MP:0005378,growth/size/body region phenotype|MP:0005387,immune system phenotype
MGI:7484703	Adar<em3Qwan>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0005387,immune system phenotype|MP:0008591,increased circulating interleukin-1 level|MP:0008596,increased circulating interleukin-6 level|MP:0008614,increased circulating interleukin-17 level|MP:0008721,abnormal chemokine level|MP:0031226,increased CXCL10 level
MGI:3032487	Adar<tm1.1Knk>	MP:0001634,internal hemorrhage|MP:0001648,abnormal apoptosis|MP:0001722,pale yolk sac|MP:0003887,increased hepatocyte apoptosis|MP:0005397,hematopoietic system phenotype|MP:0008943,increased sensitivity to induced cell death|MP:0010768,mortality/aging|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5474756	Adar<tm1b(EUCOMM)Wtsi>	MP:0001697,abnormal embryo size|MP:0001722,pale yolk sac|MP:0003717,pallor|MP:0003720,abnormal neural tube closure|MP:0004258,abnormal placenta size|MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance
MGI:3032439	Adar<tm1Knk>	MP:0000598,abnormal liver morphology|MP:0001265,decreased body size|MP:0001559,hyperglycemia|MP:0001570,abnormal circulating enzyme level|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003887,increased hepatocyte apoptosis|MP:0005343,increased circulating aspartate transaminase level|MP:0005397,hematopoietic system phenotype|MP:0011971,increased circulating lactate dehydrogenase level
MGI:4941203	Adar<tm1Olds>	MP:0005621,abnormal cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0020946,increased susceptibility to Orthomyxoviridae infection|MP:0020952,increased susceptibility to Paramyxoviridae infection
MGI:3029789	Adar<tm1Phs>	MP:0000239,absent common myeloid progenitor cells|MP:0000596,abnormal liver development|MP:0000601,small liver|MP:0001606,impaired hematopoiesis|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5436438	Adar<tm2Knk>	MP:0000596,abnormal liver development|MP:0004229,abnormal embryonic erythropoiesis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3029862	Adar<tm2Phs>	MP:0000239,absent common myeloid progenitor cells|MP:0000596,abnormal liver development|MP:0000601,small liver|MP:0001606,impaired hematopoiesis|MP:0003984,embryonic growth retardation|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0008550,abnormal circulating interferon-beta level|MP:0008573,increased circulating interferon-alpha level|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7408173	Adat2<em1(IMPC)J>	MP:0002075,abnormal coat/hair pigmentation|MP:0011100,preweaning lethality, complete penetrance
MGI:1857117	Ada<tm1Mw>	MP:0000276,heart right ventricle hypertrophy|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000606,decreased hepatocyte number|MP:0000607,abnormal hepatocyte morphology|MP:0001262,decreased body weight|MP:0001379,abnormal penile erection|MP:0001575,cyanosis|MP:0001654,hepatic necrosis|MP:0001711,abnormal placenta morphology|MP:0002336,abnormal pulmonary gas exchange|MP:0002376,abnormal dendritic cell physiology|MP:0002975,vascular smooth muscle hypertrophy|MP:0003231,abnormal placenta vasculature|MP:0003415,priapism|MP:0003548,pulmonary hypertension|MP:0003718,maternal effect|MP:0003806,abnormal nucleotide metabolism|MP:0004007,abnormal lung vasculature morphology|MP:0004259,small placenta|MP:0004921,decreased placenta weight|MP:0005018,decreased T cell number|MP:0005319,abnormal enzyme/coenzyme level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0008126,increased dendritic cell number|MP:0010758,increased right ventricle systolic pressure|MP:0010896,decreased lung compliance|MP:0010899,abnormal pulmonary alveolar system morphology|MP:0010935,increased airway resistance|MP:0011044,increased lung elastance|MP:0011087,neonatal lethality, complete penetrance|MP:0020427,increased hepatocyte karyomegaly|MP:0031510,increased vascular smooth muscle cell proliferation
MGI:2155977	Ada<tm1Vlr>	MP:0000240,extramedullary hematopoiesis|MP:0000496,abnormal small intestine morphology|MP:0001177,atelectasis|MP:0001575,cyanosis|MP:0001654,hepatic necrosis|MP:0002270,abnormal pulmonary alveolus morphology|MP:0005415,intrahepatic cholestasis|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2155606	Adaz1<NZM2328/J>	MP:0004762,increased anti-double stranded DNA antibody level
MGI:3525664	Adbg1<LG/J>	MP:0001731,abnormal postnatal growth|MP:0002758,long tail
MGI:5754577	Adck1<em2(IMPC)Tcp>	MP:0000702,enlarged lymph nodes
MGI:5529498	Adck2<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0002804,abnormal motor learning|MP:0005627,increased circulating potassium level
MGI:4399318	Adck2<tm1(KOMP)Vlcg>	MP:0001405,impaired coordination|MP:0001764,abnormal homeostasis|MP:0002106,abnormal muscle physiology|MP:0002702,decreased circulating free fatty acids level|MP:0003440,decreased glycerol level|MP:0003978,decreased circulating carnitine level|MP:0005281,increased fatty acids level|MP:0005289,increased oxygen consumption|MP:0005319,abnormal enzyme/coenzyme level|MP:0005452,abnormal adipose tissue amount|MP:0006036,abnormal mitochondrial physiology|MP:0006038,increased mitochondrial fission|MP:0008489,slow postnatal weight gain|MP:0008963,increased carbon dioxide production|MP:0009403,increased variability of skeletal muscle fiber size|MP:0010053,decreased grip strength|MP:0010359,increased liver free fatty acids level|MP:0010378,increased respiratory quotient|MP:0012106,impaired exercise endurance|MP:0013405,increased circulating lactate level|MP:0014174,decreased fatty acid beta-oxidation|MP:0014775,decreased skeletal muscle enzyme/coenzyme level|MP:0030612,organic aciduria|MP:0031115,macrovesicular hepatic steatosis
MGI:5609360	Adck5<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0002959,increased urine microalbumin level
MGI:5779519	Adcy10<tm1.2Geno>	MP:0001925,male infertility
MGI:3529121	Adcy10<tm1Lex>	MP:0001925,male infertility|MP:0002626,increased heart rate|MP:0002674,abnormal sperm motility|MP:0002675,asthenozoospermia|MP:0003666,impaired sperm capacitation|MP:0005178,increased circulating cholesterol level|MP:0005317,increased triglyceride level|MP:0005410,abnormal fertilization|MP:0005578,teratozoospermia|MP:0009237,kinked sperm flagellum|MP:0009243,hairpin sperm flagellum
MGI:1857405	Adcy1<brl>	MP:0000861,disorganized barrel cortex|MP:0000862,absent barrels in primary somatosensory cortex|MP:0001900,impaired synaptic plasticity|MP:0001908,abnormal somatosensory cortex physiology|MP:0002910,abnormal excitatory postsynaptic currents
MGI:3798842	Adcy1<tm1.1Ito>	MP:0000832,abnormal thalamus morphology|MP:0000862,absent barrels in primary somatosensory cortex|MP:0002206,abnormal CNS synaptic transmission
MGI:5780575	Adcy1<tm1b(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001566,increased circulating phosphate level|MP:0002075,abnormal coat/hair pigmentation|MP:0002590,increased mean corpuscular volume|MP:0005292,improved glucose tolerance|MP:0010090,increased circulating creatine kinase level
MGI:1857775	Adcy1<tm1Drs>	MP:0001463,abnormal spatial learning|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0005498,hyporesponsive to tactile stimuli|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008531,increased chemical nociceptive threshold
MGI:8246800	Adcy2<em1Jde>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001473,reduced long-term potentiation|MP:0003062,abnormal coping response|MP:0003461,abnormal response to novel object|MP:0008432,abnormal long-term spatial reference memory|MP:0012315,impaired learning|MP:0014375,increased miniature excitatory postsynaptic current frequency|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0020876,increased nervous system dopamine level|MP:0030585,enhanced behavioral response to amphetamine
MGI:4451651	Adcy2<tm1a(KOMP)Wtsi>	MP:0001556,increased circulating HDL cholesterol level
MGI:5574448	Adcy3<Jll>	MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0002727,decreased circulating insulin level|MP:0005289,increased oxygen consumption|MP:0005459,decreased percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0009133,decreased white fat cell size|MP:0009136,decreased brown fat cell size|MP:0010025,decreased total body fat amount|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:8215533	Adcy3<m1Btlr>	MP:0001261,obese|MP:0001433,polyphagia
MGI:5606199	Adcy3<tm1.1Dek>	MP:0005367,renal/urinary system phenotype
MGI:5461479	Adcy3<tm1.1Hazh>	MP:0001983,abnormal olfactory system physiology
MGI:4432916	Adcy3<tm1a(EUCOMM)Wtsi>	MP:0002608,increased hematocrit|MP:0003961,decreased lean body mass|MP:0005564,increased hemoglobin content|MP:0010024,increased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3604495	Adcy3<tm1Dgen>	MP:0002169,no abnormal phenotype detected|MP:0011085,postnatal lethality, complete penetrance
MGI:2661086	Adcy3<tm1Drs>	MP:0000242,impaired fertilization|MP:0000774,decreased brain size|MP:0000819,abnormal olfactory bulb morphology|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001413,abnormal response to new environment|MP:0001433,polyphagia|MP:0001442,decreased grooming behavior|MP:0001447,abnormal nest building behavior|MP:0001458,abnormal object recognition memory|MP:0001473,reduced long-term potentiation|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0001984,abnormal olfaction|MP:0002161,abnormal fertility/fecundity|MP:0002175,decreased brain weight|MP:0002206,abnormal CNS synaptic transmission|MP:0002573,behavioral despair|MP:0002675,asthenozoospermia|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003353,decreased circulating renin level|MP:0003360,abnormal depression-related behavior|MP:0003666,impaired sperm capacitation|MP:0004512,anosmia|MP:0004811,abnormal neuron physiology|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005528,decreased renal glomerular filtration rate|MP:0005553,increased circulating creatinine level|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008283,small hippocampus|MP:0008432,abnormal long-term spatial reference memory|MP:0008544,impaired olfaction|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012014,abnormal olfactory neuron innervation pattern|MP:0012287,increased frequency of paradoxical sleep|MP:0012289,abnormal non-rapid eye movement sleep pattern|MP:0012307,impaired spatial learning|MP:0012460,decreased dentate gyrus size|MP:0013288,premature acrosome reaction|MP:0020083,decreased hippocampus volume|MP:0021090,abnormal dendrite arborization pattern|MP:0031392,hypoactivity
MGI:7260104	Adcy3<tm2.1Drs>	MP:0001413,abnormal response to new environment|MP:0001442,decreased grooming behavior|MP:0001447,abnormal nest building behavior|MP:0001458,abnormal object recognition memory|MP:0001745,increased circulating corticosterone level|MP:0002573,behavioral despair|MP:0003360,abnormal depression-related behavior|MP:0008432,abnormal long-term spatial reference memory|MP:0012289,abnormal non-rapid eye movement sleep pattern|MP:0012307,impaired spatial learning|MP:0020478,abnormal circadian sleep/wake cycle|MP:0031392,hypoactivity
MGI:5618272	Adcy4<tm1.1Dek>	MP:0002169,no abnormal phenotype detected
MGI:3604519	Adcy4<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:2387896	Adcy5<tm1Plhn>	MP:0009747,impaired behavioral response to xenobiotic
MGI:2662295	Adcy5<tm1Yish>	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002757,decreased vertical activity|MP:0005156,bradykinesia|MP:0005584,abnormal enzyme/coenzyme activity
MGI:5490599	Adcy6<tm1.1Dek>	MP:0002988,decreased urine osmolality
MGI:5708268	Adcy6<tm1.1(KOMP)Vlcg>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005565,increased blood urea nitrogen level
MGI:3830298	Adcy6<tm1Hkh>	MP:0004231,abnormal calcium ion homeostasis|MP:0010754,abnormal heart left ventricle pressure|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4459915	Adcy6<tm1Yich>	MP:0001762,polyuria|MP:0002988,decreased urine osmolality|MP:0005558,decreased creatinine clearance|MP:0005618,decreased urine potassium level|MP:0006317,decreased urine sodium level|MP:0010108,abnormal renal water reabsorption|MP:0011460,decreased urine chloride ion level|MP:0011467,decreased urine urea nitrogen level|MP:0011941,increased fluid intake
MGI:4459917	Adcy6<tm2Yich>	MP:0001762,polyuria|MP:0002988,decreased urine osmolality|MP:0005618,decreased urine potassium level|MP:0006317,decreased urine sodium level|MP:0010108,abnormal renal water reabsorption|MP:0011460,decreased urine chloride ion level|MP:0011467,decreased urine urea nitrogen level|MP:0011471,decreased urine creatinine level|MP:0011941,increased fluid intake
MGI:5470143	Adcy7<tm1.1Pcst>	MP:0003303,peritoneal inflammation|MP:0008560,increased tumor necrosis factor secretion
MGI:3693867	Adcy7<tm1Btab>	MP:0003360,abnormal depression-related behavior|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3604498	Adcy7<tm1Dgen>	MP:0011085,postnatal lethality, complete penetrance
MGI:2176596	Adcy8<tm1Ljm>	MP:0001265,decreased body size|MP:0001364,decreased anxiety-related response|MP:0001899,absent long-term depression|MP:0003463,abnormal single cell response|MP:0003963,abnormal corticosterone level|MP:0005394,taste/olfaction phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008531,increased chemical nociceptive threshold
MGI:3529525	Adcy9<Gt(OST193739)Lex>	MP:0001544,abnormal cardiovascular system physiology|MP:0005333,decreased heart rate|MP:0008499,increased IgG1 level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5636912	Adcy9<tm1b(EUCOMM)Wtsi>	MP:0000497,abnormal small intestine placement|MP:0000602,dilated liver sinusoidal space|MP:0001015,small superior cervical ganglion|MP:0001711,abnormal placenta morphology|MP:0002079,increased circulating insulin level|MP:0002169,no abnormal phenotype detected|MP:0003020,decreased circulating chloride level|MP:0003826,abnormal Mullerian duct morphology|MP:0003888,liver hemorrhage|MP:0004666,absent stapedial artery|MP:0005272,abnormal temporal bone morphology|MP:0009571,abnormal right lung accessory lobe morphology|MP:0010418,perimembraneous ventricular septal defect|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011683,dual inferior vena cava|MP:0013840,absent segment of posterior cerebral artery|MP:0013847,retropleural edema|MP:0013852,abnormal Mullerian duct topology|MP:0013876,absent ductus venosus valve|MP:0013877,abnormal ductus venosus valve morphology|MP:0013971,blood in lymph vessels|MP:0013985,abnormal umbilical vein topology|MP:0014001,abnormal vertebral artery topology|MP:0014003,additional anastomosis between intracranial vertebral arteries|MP:0014087,retrolental blood
MGI:2180119	Adcyap1r1<tm1.1Gsc>	MP:0001364,decreased anxiety-related response|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0002574,increased vertical activity|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031391,increased locomotor activity
MGI:2180120	Adcyap1r1<tm1.2Gsc>	MP:0001469,abnormal contextual conditioning behavior|MP:0002169,no abnormal phenotype detected
MGI:2386283	Adcyap1r1<tm1Aba>	MP:0002169,no abnormal phenotype detected
MGI:2180097	Adcyap1r1<tm1Bbt>	MP:0001262,decreased body weight|MP:0001923,reduced female fertility|MP:0002079,increased circulating insulin level|MP:0002412,increased susceptibility to bacterial infection|MP:0002727,decreased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0009006,prolonged estrous cycle|MP:0009011,prolonged diestrus|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020470,shortened circadian behavior period|MP:0020475,delayed circadian behavior phase
MGI:6324159	Adcyap1r1<tm1e.1(KOMP)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:2182878	Adcyap1<tm1Aba>	MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001442,decreased grooming behavior|MP:0001921,reduced fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002574,increased vertical activity|MP:0006000,abnormal cornea epithelium morphology|MP:0009326,absent maternal crouching|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014602,decreased female mating frequency|MP:0020220,decreased tear production
MGI:3521845	Adcyap1<tm1Clw>	MP:0001828,abnormal T cell activation|MP:0004946,abnormal regulatory T cell physiology|MP:0010219,increased T-helper 17 cell number|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011448,decreased dopaminergic neuron number|MP:0011451,increased susceptibility to dopaminergic neuron neurotoxicity|MP:0020448,increased microglial cell activation|MP:0020470,shortened circadian behavior period|MP:0020473,abnormal circadian behavior phase|MP:0031391,increased locomotor activity
MGI:2159730	Adcyap1<tm1Eid>	MP:0000189,hypoglycemia|MP:0003631,nervous system phenotype|MP:0005661,decreased circulating adrenaline level|MP:0030762,decreased adrenaline level
MGI:2386973	Adcyap1<tm1Nms>	MP:0000189,hypoglycemia|MP:0000759,abnormal skeletal muscle morphology|MP:0001263,weight loss|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001729,impaired embryo implantation|MP:0001745,increased circulating corticosterone level|MP:0001783,decreased white adipose tissue amount|MP:0001923,reduced female fertility|MP:0002079,increased circulating insulin level|MP:0002566,abnormal sexual interaction|MP:0002575,increased circulating ketone body level|MP:0005121,decreased circulating prolactin level|MP:0005178,increased circulating cholesterol level|MP:0005185,decreased circulating progesterone level|MP:0008489,slow postnatal weight gain|MP:0010398,decreased liver glycogen level|MP:0011049,impaired adaptive thermogenesis|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031116,microvesicular hepatic steatosis
MGI:3799499	Add1<tm1Llp>	MP:0000208,decreased hematocrit|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001585,hemolytic anemia|MP:0001893,non-obstructive hydrocephaly|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002812,spherocytosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0005505,thrombocytosis|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008850,increased hemoglobin concentration distribution width|MP:0008935,decreased mean platelet volume|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2149087	Add2<tm1Feb>	MP:0000208,decreased hematocrit|MP:0000231,hypertension|MP:0001577,anemia|MP:0002640,reticulocytosis|MP:0002643,poikilocytosis|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0004952,increased spleen weight|MP:0005344,increased circulating bilirubin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0006265,increased pulse pressure|MP:0031085,increased erythrocyte osmotic fragility
MGI:2149065	Add2<tm1Llp>	MP:0000208,decreased hematocrit|MP:0000691,enlarged spleen|MP:0001454,abnormal cued conditioning behavior|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0001577,anemia|MP:0001900,impaired synaptic plasticity|MP:0002206,abnormal CNS synaptic transmission|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002812,spherocytosis|MP:0002813,microcytosis|MP:0002919,enhanced paired-pulse facilitation|MP:0002923,increased post-tetanic potentiation|MP:0003656,abnormal erythrocyte physiology|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008807,increased liver iron level|MP:0008809,increased spleen iron level|MP:0010375,increased kidney iron level|MP:0031085,increased erythrocyte osmotic fragility
MGI:4462017	Add3<tm1.2Llp>	MP:0002169,no abnormal phenotype detected|MP:0005385,cardiovascular system phenotype
MGI:6140126	Adgb<em1(IMPC)Mbp>	MP:0001404,no spontaneous movement|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0004818,increased skeletal muscle mass|MP:0005011,increased eosinophil cell number|MP:0020421,increased freezing behavior
MGI:7311625	Adgb<tm1d(KOMP)Wtsi>	MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology
MGI:5688779	Adgra1<em1(IMPC)J>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:7425047	Adgra1<tm1.1Zgwg>	MP:0001262,decreased body weight|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0003502,increased activity of thyroid gland|MP:0003961,decreased lean body mass|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005386,behavior/neurological phenotype|MP:0008963,increased carbon dioxide production|MP:0009125,decreased brown fat cell lipid droplet size|MP:0009133,decreased white fat cell size|MP:0010025,decreased total body fat amount|MP:0011019,abnormal adaptive thermogenesis|MP:0013278,decreased fasting circulating glucose level
MGI:5642368	Adgra1<tm1b(EUCOMM)Hmgu>	MP:0005292,improved glucose tolerance|MP:0010123,increased bone mineral content
MGI:4940060	Adgra2<tm1.1Vlcg>	MP:0000111,cleft palate|MP:0000260,abnormal angiogenesis|MP:0000434,megacephaly|MP:0001614,abnormal blood vessel morphology|MP:0001914,hemorrhage|MP:0003631,nervous system phenotype|MP:0003641,small lung|MP:0004950,abnormal brain vasculature morphology|MP:0008535,enlarged lateral ventricles|MP:0009890,cleft secondary palate|MP:0011089,perinatal lethality, complete penetrance
MGI:4949903	Adgra2<tm1.2Bstc>	MP:0000787,abnormal telencephalon morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000934,abnormal telencephalon development|MP:0001614,abnormal blood vessel morphology|MP:0001891,hydrocephaly|MP:0001915,intracranial hemorrhage|MP:0001917,intraventricular hemorrhage|MP:0003227,abnormal vascular branching morphogenesis|MP:0004171,abnormal pallium development|MP:0004950,abnormal brain vasculature morphology|MP:0006054,spinal hemorrhage|MP:0006088,abnormal blood-cerebrospinal fluid barrier function|MP:0008535,enlarged lateral ventricles|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0031384,impaired blood-brain barrier function
MGI:4840264	Adgra2<tm1Cjku>	MP:0000260,abnormal angiogenesis|MP:0000787,abnormal telencephalon morphology|MP:0001614,abnormal blood vessel morphology|MP:0001634,internal hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0003227,abnormal vascular branching morphogenesis|MP:0003633,abnormal nervous system physiology|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012732,abnormal perineural vascular plexus morphology
MGI:5544776	Adgra2<tm2.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:3763371	Adgra3<tm1Rafi>	MP:0002169,no abnormal phenotype detected
MGI:5755487	Adgrb1<tm1Egvm>	MP:0001475,reduced long-term depression|MP:0001900,impaired synaptic plasticity|MP:0002063,abnormal learning/memory/conditioning|MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008469,abnormal protein level|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0012307,impaired spatial learning|MP:0020551,abnormal postsynaptic density morphology
MGI:5006776	Adgrb1<tm2a(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0001413,abnormal response to new environment|MP:0002079,increased circulating insulin level|MP:0003019,increased circulating chloride level|MP:0005419,decreased circulating serum albumin level
MGI:5616366	Adgrb2<tm1b(KOMP)Mbp>	MP:0001399,hyperactivity
MGI:3604512	Adgrb2<tm1Dgen>	MP:0003063,increased coping response
MGI:5708582	Adgrb2<tm1Yazu>	MP:0003631,nervous system phenotype
MGI:6257783	Adgrb3<em1(IMPC)Bay>	MP:0000195,decreased circulating calcium level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5708584	Adgrb3<tm1Ksak>	MP:0001899,absent long-term depression|MP:0002804,abnormal motor learning|MP:0002882,abnormal neuron morphology|MP:0003412,abnormal afterhyperpolarization|MP:0003463,abnormal single cell response|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:5548892	Adgrd1<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001926,female infertility|MP:0003699,abnormal female reproductive system physiology|MP:0004794,increased anti-nuclear antigen antibody level|MP:0010124,decreased bone mineral content
MGI:3793322	Adgre1<m1Btlr>	MP:0005387,immune system phenotype
MGI:5478734	Adgre1<m2Btlr>	MP:0002451,abnormal macrophage physiology|MP:0003884,decreased macrophage cell number
MGI:5789555	Adgre1<m3Btlr>	MP:0002451,abnormal macrophage physiology|MP:0003884,decreased macrophage cell number
MGI:6113851	Adgre1<M4Btlr>	MP:0003884,decreased macrophage cell number
MGI:3582333	Adgre1<tm1Stst>	MP:0004946,abnormal regulatory T cell physiology|MP:0005000,abnormal immune tolerance
MGI:3814838	Adgre5<tm1.1Joha>	MP:0000322,increased granulocyte number|MP:0005387,immune system phenotype
MGI:3604535	Adgre5<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3700734	Adgre5<tm1Kake>	MP:0000322,increased granulocyte number|MP:0002411,decreased susceptibility to bacterial infection|MP:0005387,immune system phenotype|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:7425493	Adgrf1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology
MGI:5439102	Adgrf1<tm1Tcam>	MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:7545665	Adgrf2<em1Iwto>	MP:0030450,abnormal enamel mineralization
MGI:5439104	Adgrf2<tm1Tcam>	MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:7641825	Adgrf3<em1Kzt>	MP:0005389,reproductive system phenotype
MGI:5439106	Adgrf4<tm1Tcam>	MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:5692752	Adgrf4<tm2b(EUCOMM)Wtsi>	MP:0011962,increased cornea thickness
MGI:5690210	Adgrf5<m1Btlr>	MP:0005559,increased circulating glucose level
MGI:5490511	Adgrf5<tm1.2Bstc>	MP:0001262,decreased body weight|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002275,abnormal type II pneumocyte morphology|MP:0004777,abnormal phospholipid level|MP:0004778,increased macrophage derived foam cell number|MP:0004782,abnormal surfactant physiology|MP:0010891,increased alveolar lamellar body number|MP:0010992,increased surfactant secretion|MP:0010998,pulmonary alveolar proteinosis|MP:0031632,increased lung cholesterol level
MGI:5697003	Adgrf5<tm1.2Jpbs>	MP:0001175,abnormal lung morphology|MP:0001943,abnormal respiration|MP:0001954,respiratory distress|MP:0002133,abnormal respiratory system physiology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0004781,abnormal surfactant composition|MP:0004782,abnormal surfactant physiology|MP:0005378,growth/size/body region phenotype|MP:0005426,tachypnea|MP:0008245,abnormal alveolar macrophage morphology|MP:0010992,increased surfactant secretion
MGI:5513786	Adgrf5<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000223,decreased monocyte cell number|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0005016,decreased lymphocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010052,increased grip strength|MP:0010067,increased red blood cell distribution width|MP:0010124,decreased bone mineral content|MP:0013279,increased fasting circulating glucose level
MGI:5547987	Adgrf5<tm1Shiro>	MP:0001958,emphysema|MP:0002270,abnormal pulmonary alveolus morphology|MP:0005425,increased macrophage cell number|MP:0005630,increased lung weight|MP:0008245,abnormal alveolar macrophage morphology|MP:0010810,increased type II pneumocyte number|MP:0010992,increased surfactant secretion
MGI:7541406	Adgrg1<em1(IMPC)Bay>	MP:0010053,decreased grip strength
MGI:7519106	Adgrg1<em1(IMPC)Hmgu>	MP:0001147,small testis
MGI:5427671	Adgrg1<tm1Dgen>	MP:0001392,abnormal locomotor behavior|MP:0003998,decreased thermal nociceptive threshold|MP:0004097,abnormal cerebellar cortex morphology
MGI:3796624	Adgrg1<tm1Lex>	MP:0000788,abnormal cerebral cortex morphology|MP:0000885,ectopic Purkinje cell|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001405,impaired coordination|MP:0001922,reduced male fertility|MP:0002182,abnormal astrocyte morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0002762,ectopic cerebellar granule cells|MP:0002763,ectopic Bergmann glia cells|MP:0002784,abnormal Sertoli cell morphology|MP:0003648,abnormal radial glial cell morphology|MP:0004097,abnormal cerebellar cortex morphology|MP:0004272,abnormal basement membrane morphology|MP:0004901,decreased male germ cell number|MP:0006419,disorganized testis cords|MP:0008030,abnormal Cajal-Retzius cell morphology|MP:0009964,abnormal cerebellum lobule morphology|MP:0009977,abnormal cerebellar granule cell migration|MP:0014552,enhanced neuronal migration|MP:0020560,abnormal pontine nuclei morphology
MGI:3056121	Adgrg2<tm1Bend>	MP:0001148,enlarged testis|MP:0001156,abnormal spermatogenesis|MP:0001784,abnormal fluid regulation|MP:0001922,reduced male fertility|MP:0002662,abnormal cauda epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004929,decreased epididymis weight|MP:0004930,small epididymis|MP:0005578,teratozoospermia|MP:0009140,dilated efferent ductule of testis|MP:0009234,absent sperm head|MP:0009237,kinked sperm flagellum|MP:0009257,dilated seminiferous tubule
MGI:3579990	Adgrg3<tm1Fwa>	MP:0005387,immune system phenotype
MGI:5704321	Adgrg3<tm1Zgwg>	MP:0000685,abnormal immune system morphology|MP:0000689,abnormal spleen morphology|MP:0001790,abnormal immune system physiology|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002362,abnormal spleen marginal zone morphology|MP:0002490,abnormal immunoglobulin level|MP:0004939,abnormal B cell morphology|MP:0005387,immune system phenotype|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008211,decreased mature B cell number|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008782,increased B cell apoptosis|MP:0009923,decreased transitional stage T1 B cell number|MP:0009925,increased transitional stage T2 B cell number|MP:0013802,abnormal IgG2 level|MP:0014351,abnormal spleen B cell follicle shape|MP:0020174,abnormal IgG level|MP:0020175,abnormal IgG1 level
MGI:5805686	Adgrg5<tm1b(EUCOMM)Wtsi>	MP:0001258,decreased body length|MP:0008806,increased circulating amylase level
MGI:7438175	Adgrg6<em1Jlp>	MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000920,abnormal myelination|MP:0001265,decreased body size|MP:0001392,abnormal locomotor behavior|MP:0001516,abnormal motor coordination/balance|MP:0003861,abnormal nervous system development|MP:0005385,cardiovascular system phenotype|MP:0010768,mortality/aging|MP:0030798,joint contracture
MGI:7438176	Adgrg6<em2Jlp>	MP:0000267,abnormal heart development|MP:0000280,thin ventricular wall|MP:0000281,abnormal interventricular septum morphology|MP:0002189,abnormal myocardial trabeculae morphology|MP:0004057,thin myocardium compact layer|MP:0005031,abnormal trophoblast layer morphology|MP:0008022,dilated heart ventricle|MP:0008958,abnormal trophoblast glycogen cell morphology|MP:0010038,abnormal placenta physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011527,disorganized placental labyrinth|MP:0011529,increased placenta intervillous maternal lacunae size|MP:0012726,abnormal uterine spiral artery morphology|MP:0012727,abnormal uterine spiral artery remodeling|MP:0030975,placenta hemorrhage
MGI:7438177	Adgrg6<em3Jlp>	MP:0001265,decreased body size|MP:0002169,no abnormal phenotype detected|MP:0002188,small heart|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0030798,joint contracture
MGI:4878918	Adgrg6<tm1Apr>	MP:0001634,internal hemorrhage|MP:0001785,edema|MP:0002128,abnormal blood circulation|MP:0002652,thin myocardium|MP:0008022,dilated heart ventricle|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5819097	Adgrg6<tm1Arte>	MP:0000157,abnormal sternum morphology|MP:0000161,scoliosis|MP:0004173,abnormal intervertebral disk morphology|MP:0005390,skeleton phenotype|MP:0006392,abnormal nucleus pulposus morphology|MP:0014103,increased chondrocyte apoptosis|MP:0030802,abnormal tendon physiology
MGI:3528728	Adgrg6<tm1Lex>	MP:0000920,abnormal myelination|MP:0001106,abnormal Schwann cell morphology|MP:0001265,decreased body size|MP:0001524,impaired limb coordination|MP:0001732,postnatal growth retardation|MP:0002651,abnormal sciatic nerve morphology|MP:0002690,akinesia|MP:0002752,abnormal somatic nervous system morphology|MP:0004716,abnormal cochlear nerve morphology|MP:0005404,abnormal axon morphology|MP:0009450,abnormal axon fasciculation|MP:0010503,myocardial trabeculae hypoplasia|MP:0011100,preweaning lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0020452,abnormal axon radial sorting|MP:0030798,joint contracture
MGI:5521368	Adgrg6<tm1Taki>	MP:0000280,thin ventricular wall|MP:0001787,pericardial edema|MP:0002189,abnormal myocardial trabeculae morphology|MP:0003974,abnormal endocardium morphology|MP:0005385,cardiovascular system phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011633,abnormal mitochondrial shape|MP:0011635,abnormal mitochondrial crista morphology|MP:0031418,increased cardiac muscle triglyceride level|MP:0031607,abnormal fetal cardiomyocyte mitochondrial morphology
MGI:5692818	Adgrg7<tm1b(EUCOMM)Hmgu>	MP:0002834,decreased heart weight|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0011960,abnormal eye anterior chamber depth|MP:0011965,decreased total retina thickness
MGI:6116519	Adgrg7<tm1Wfro>	MP:0001262,decreased body weight|MP:0003291,interstinal hyperperistalsis|MP:0008489,slow postnatal weight gain
MGI:3691022	Adgrl1<tm1Sud>	MP:0001386,abnormal maternal nurturing|MP:0004495,decreased synaptic glutamate release|MP:0014812,abnormal brain physiology
MGI:6491650	Adgrl2<tm1b(EUCOMM)Hmgu>	MP:0000267,abnormal heart development|MP:0003920,abnormal heart right ventricle morphology|MP:0003922,abnormal heart right atrium morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0010432,common ventricle|MP:0010580,decreased heart left ventricle size|MP:0011091,prenatal lethality, complete penetrance
MGI:5427677	Adgrl2<tm1Dgen>	MP:0001402,decreased locomotor activity|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4973916	Adgrl3<Gt(S17-5H1)Sor>	MP:0000195,decreased circulating calcium level|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001409,increased stereotypic behavior|MP:0001431,abnormal eating behavior|MP:0001906,increased dopamine level|MP:0002572,abnormal emotion/affect behavior|MP:0005386,behavior/neurological phenotype|MP:0008415,abnormal neurite morphology|MP:0008911,induced hyperactivity|MP:0009754,enhanced behavioral response to cocaine|MP:0010069,increased serotonin level|MP:0031391,increased locomotor activity
MGI:5603353	Adgrl3<tm1.1(KOMP)Vlcg>	MP:0002060,abnormal skin morphology
MGI:5605017	Adgrl3<tm1Sud>	MP:0002169,no abnormal phenotype detected
MGI:6423067	Adgrl4<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002574,increased vertical activity|MP:0002591,decreased mean corpuscular volume|MP:0002699,abnormal vitreous body morphology|MP:0005562,decreased mean corpuscular hemoglobin|MP:0006203,eye hemorrhage
MGI:7407284	Adgrl4<tm1Adbg>	MP:0002006,neoplasm|MP:0005385,cardiovascular system phenotype|MP:0010144,abnormal tumor vascularization
MGI:5427665	Adgrl4<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:2389570	Adgrv1<frings>	MP:0001496,audiogenic seizures|MP:0001967,deafness|MP:0002857,cochlear ganglion degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004748,increased susceptibility to age-related hearing loss|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6508388	Adgrv1<m1>	MP:0000043,organ of Corti degeneration|MP:0001967,deafness|MP:0003637,cochlear ganglion hypoplasia|MP:0004529,decreased outer hair cell stereocilia number|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5792019	Adgrv1<mpc188H>	MP:0001967,deafness
MGI:3708270	Adgrv1<rueda>	MP:0001489,decreased startle reflex|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5695890	Adgrv1<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001399,hyperactivity|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0002764,short tibia|MP:0004738,abnormal auditory brainstem response|MP:0009142,decreased prepulse inhibition
MGI:3527179	Adgrv1<tm1Msat>	MP:0001496,audiogenic seizures|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004582,absent cochlear hair bundle ankle links|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3046273	Adgrv1<tm1Pwh>	MP:0000043,organ of Corti degeneration|MP:0001496,audiogenic seizures|MP:0001967,deafness|MP:0002090,abnormal vision|MP:0004022,abnormal cone electrophysiology|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004582,absent cochlear hair bundle ankle links|MP:0004586,pillar cell degeneration|MP:0004737,absent distortion product otoacoustic emissions|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3718538	Adgrv1<tm2Msat>	MP:0003146,absent cochlear ganglion|MP:0004404,cochlear outer hair cell degeneration|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004577,abnormal cochlear hair cell inter-stereocilial links morphology|MP:0004737,absent distortion product otoacoustic emissions|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2180100	Adh1<tm1Gdu>	MP:0005443,abnormal ethanol metabolism|MP:0005444,abnormal retinol metabolism|MP:0009751,enhanced behavioral response to alcohol
MGI:2180099	Adh1<tm2Gdu>	MP:0001263,weight loss|MP:0005444,abnormal retinol metabolism|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5049924	Adh5<tm1.1Llli>	MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010768,mortality/aging
MGI:5548916	Adh5<tm1b(EUCOMM)Wtsi>	MP:0001417,decreased exploration in new environment|MP:0001529,abnormal vocalization
MGI:2180101	Adh5<tm1Gdu>	MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:3033711	Adh5<tm1Stam>	MP:0002412,increased susceptibility to bacterial infection|MP:0002843,decreased systemic arterial blood pressure|MP:0005266,abnormal metabolism|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:2180102	Adh7<tm1Gdu>	MP:0000819,abnormal olfactory bulb morphology|MP:0000836,abnormal substantia nigra morphology|MP:0001262,decreased body weight|MP:0001392,abnormal locomotor behavior|MP:0001906,increased dopamine level|MP:0002757,decreased vertical activity|MP:0005386,behavior/neurological phenotype|MP:0005443,abnormal ethanol metabolism|MP:0005444,abnormal retinol metabolism|MP:0008544,impaired olfaction|MP:0009746,enhanced behavioral response to xenobiotic|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011232,abnormal vitamin A level
MGI:5548852	Adig<tm1.1(KOMP)Vlcg>	MP:0002727,decreased circulating insulin level|MP:0002874,decreased hemoglobin content|MP:0002891,increased insulin sensitivity|MP:0004889,increased energy expenditure|MP:0005292,improved glucose tolerance|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0005670,abnormal white adipose tissue physiology|MP:0006203,eye hemorrhage|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0011167,abnormal adipose tissue development|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3614959	Adip10<SM/J>	MP:0009292,increased inguinal fat pad weight|MP:0009304,increased retroperitoneal fat pad weight
MGI:3614969	Adip11<SM/J>	MP:0009292,increased inguinal fat pad weight|MP:0009304,increased retroperitoneal fat pad weight
MGI:3614974	Adip12<SM/J>	MP:0009298,increased mesenteric fat pad weight
MGI:3614982	Adip13<NZB/BlNJ>	MP:0009285,increased gonadal fat pad weight
MGI:3615001	Adip16<SM/J>	MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight
MGI:3615111	Adip17<SM/J>	MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009304,increased retroperitoneal fat pad weight
MGI:3615116	Adip18<NZB/BlNJ>	MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight
MGI:2153875	Adip1<LG/J>	MP:0000008,increased white adipose tissue amount
MGI:2670698	Adip20<129P3/J>	MP:0000008,increased white adipose tissue amount|MP:0005334,abnormal fat pad morphology|MP:0009285,increased gonadal fat pad weight|MP:0009304,increased retroperitoneal fat pad weight
MGI:2670699	Adip20<C57BL/6ByJ>	MP:0001257,increased body length|MP:0001260,increased body weight
MGI:2156452	Adip2<LG/J>	MP:0000008,increased white adipose tissue amount
MGI:2156714	Adip3<LG/J>	MP:0000008,increased white adipose tissue amount
MGI:2157025	Adip4<LG/J>	MP:0000008,increased white adipose tissue amount|MP:0002758,long tail
MGI:2157326	Adip5<LG/J>	MP:0001783,decreased white adipose tissue amount
MGI:2157329	Adip6<LG/J>	MP:0010025,decreased total body fat amount
MGI:2157332	Adip7<LG/J>	MP:0000008,increased white adipose tissue amount
MGI:2157334	Adip8<LG/J>	MP:0000008,increased white adipose tissue amount
MGI:2670701	Adip9<C57BL/6ByJ>	MP:0000008,increased white adipose tissue amount
MGI:5605738	Adipoq<tm1b(KOMP)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0005576,decreased pulmonary ventilation
MGI:2388007	Adipoq<tm1Chan>	MP:0000218,increased leukocyte cell number|MP:0001260,increased body weight|MP:0002118,abnormal lipid homeostasis|MP:0002442,abnormal leukocyte physiology|MP:0002871,albuminuria|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003674,oxidative stress|MP:0003957,abnormal nitric oxide homeostasis|MP:0005376,homeostasis/metabolism phenotype|MP:0008139,fused podocyte foot processes|MP:0014174,decreased fatty acid beta-oxidation|MP:0020318,increased vascular endothelial cell adhesion|MP:0030968,decreased circulating adiponectin level
MGI:3663753	Adipoq<tm1Far>	MP:0001260,increased body weight|MP:0005293,impaired glucose tolerance|MP:0005458,increased percent body fat/body weight|MP:0005559,increased circulating glucose level|MP:0009355,increased liver triglyceride level|MP:0010024,increased total body fat amount|MP:0031269,increased susceptibility to diet-induced hepatic steatosis
MGI:2387344	Adipoq<tm1Ish>	MP:0000010,abnormal abdominal fat pad morphology|MP:0000062,increased bone mineral density|MP:0000063,decreased bone mineral density|MP:0001262,decreased body weight|MP:0001533,abnormal skeleton physiology|MP:0001544,abnormal cardiovascular system physiology|MP:0001547,abnormal lipid level|MP:0001554,increased circulating free fatty acids level|MP:0001559,hyperglycemia|MP:0001613,abnormal vasodilation|MP:0001625,cardiac hypertrophy|MP:0001914,hemorrhage|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002127,abnormal cardiovascular system morphology|MP:0002753,dilated heart left ventricle|MP:0002843,decreased systemic arterial blood pressure|MP:0002970,abnormal white adipose tissue morphology|MP:0003059,decreased insulin secretion|MP:0003674,oxidative stress|MP:0003828,pulmonary edema|MP:0003948,abnormal gas homeostasis|MP:0003953,abnormal hormone level|MP:0004016,decreased bone mass|MP:0004148,increased compact bone thickness|MP:0004149,increased bone strength|MP:0004883,abnormal vascular wound healing|MP:0004889,increased energy expenditure|MP:0004892,increased adiponectin level|MP:0004982,abnormal osteoclast morphology|MP:0004988,increased osteoblast cell number|MP:0004989,decreased osteoblast cell number|MP:0005006,abnormal osteoblast physiology|MP:0005289,increased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005333,decreased heart rate|MP:0005369,muscle phenotype|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0005413,vascular restenosis|MP:0005448,abnormal energy homeostasis|MP:0005508,abnormal skeleton morphology|MP:0005559,increased circulating glucose level|MP:0005605,increased bone mass|MP:0005658,increased susceptibility to diet-induced obesity|MP:0006138,congestive heart failure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008907,decreased total fat pad weight|MP:0008963,increased carbon dioxide production|MP:0009643,abnormal urine homeostasis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010018,pulmonary vascular congestion|MP:0010869,decreased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0010879,decreased trabecular bone volume|MP:0011940,decreased food intake|MP:0012575,increased noradrenaline level|MP:0020039,increased bone ossification|MP:0020040,decreased bone ossification|MP:0030770,increased urine adrenaline level|MP:0030969,increased circulating adiponectin level|MP:0030984,increased circulating osteocalcin level|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3623488	Adipoq<tm1Pesch>	MP:0003383,abnormal gluconeogenesis|MP:0003718,maternal effect|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005336,abnormal inguinal fat pad morphology|MP:0010955,abnormal respiratory electron transport chain|MP:0011016,increased core body temperature|MP:0020523,decreased susceptibility to induced hypothermia
MGI:2384094	Adipoq<tm1Tka>	MP:0001552,increased circulating triglyceride level|MP:0004883,abnormal vascular wound healing|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance
MGI:5519975	Adipor1<tm1.1Kry>	MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype
MGI:5692722	Adipor1<tm1b(EUCOMM)Hmgu>	MP:0000195,decreased circulating calcium level|MP:0000219,increased neutrophil cell number|MP:0001325,abnormal retina morphology|MP:0001417,decreased exploration in new environment|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0001566,increased circulating phosphate level|MP:0002874,decreased hemoglobin content|MP:0002941,increased circulating alanine transaminase level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004738,abnormal auditory brainstem response|MP:0005016,decreased lymphocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0005543,decreased cornea thickness|MP:0005565,increased blood urea nitrogen level|MP:0008806,increased circulating amylase level|MP:0010067,increased red blood cell distribution width|MP:0011965,decreased total retina thickness
MGI:3604517	Adipor1<tm1Dgen>	MP:0000005,increased brown adipose tissue amount|MP:0000008,increased white adipose tissue amount|MP:0001402,decreased locomotor activity|MP:0002118,abnormal lipid homeostasis|MP:0002169,no abnormal phenotype detected|MP:0004890,decreased energy expenditure|MP:0004893,decreased adiponectin level|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005455,increased susceptibility to weight gain|MP:0005458,increased percent body fat/body weight|MP:0005669,increased circulating leptin level|MP:0009355,increased liver triglyceride level|MP:0011019,abnormal adaptive thermogenesis|MP:0011049,impaired adaptive thermogenesis|MP:0030968,decreased circulating adiponectin level
MGI:3698268	Adipor1<tm1Tka>	MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0005584,abnormal enzyme/coenzyme activity
MGI:4457490	Adipor1<tm2Tka>	MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0003674,oxidative stress|MP:0005290,decreased oxygen consumption|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0012106,impaired exercise endurance|MP:0014389,decreased skeletal muscle fiber mitochondrial DNA content|MP:0031415,increased skeletal muscle triglyceride level
MGI:5519976	Adipor2<tm1.1Kry>	MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype
MGI:5692885	Adipor2<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0001147,small testis|MP:0001513,limb grasping|MP:0001925,male infertility|MP:0005016,decreased lymphocyte cell number|MP:0010053,decreased grip strength
MGI:3604502	Adipor2<tm1Dgen>	MP:0000010,abnormal abdominal fat pad morphology|MP:0000186,decreased circulating HDL cholesterol level|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0002118,abnormal lipid homeostasis|MP:0002176,increased brain weight|MP:0002687,oligozoospermia|MP:0002727,decreased circulating insulin level|MP:0003953,abnormal hormone level|MP:0003961,decreased lean body mass|MP:0004852,decreased testis weight|MP:0004889,increased energy expenditure|MP:0004929,decreased epididymis weight|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009116,abnormal brown fat cell morphology|MP:0009269,decreased fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0009303,decreased renal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0011019,abnormal adaptive thermogenesis|MP:0011049,impaired adaptive thermogenesis|MP:0011939,increased food intake|MP:0014169,decreased brown adipose tissue mass|MP:0020550,multinucleated giant male germ cells|MP:0030969,increased circulating adiponectin level|MP:0031391,increased locomotor activity
MGI:3698269	Adipor2<tm1Tka>	MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance
MGI:3770154	Adipor2<tm2Dgen>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0002078,abnormal glucose homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0003339,decreased pancreatic beta cell number|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005559,increased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0030969,increased circulating adiponectin level
MGI:7432545	Adissp<tm1c(EUCOMM)Hmgu>	MP:0002970,abnormal white adipose tissue morphology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005386,behavior/neurological phenotype|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005666,abnormal adipose tissue physiology|MP:0009115,abnormal fat cell morphology|MP:0009118,increased white fat cell size|MP:0011049,impaired adaptive thermogenesis|MP:0013279,increased fasting circulating glucose level|MP:0014145,increased white adipose tissue mass|MP:0020426,abnormal beige fat cell physiology|MP:0030017,decreased adipocyte glucose uptake
MGI:6341908	Adk<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001175,abnormal lung morphology|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0004174,abnormal spine curvature|MP:0004882,enlarged lung|MP:0011047,increased lung tissue damping|MP:0011100,preweaning lethality, complete penetrance
MGI:2449557	Adk<tm1Bois>	MP:0000603,pale liver|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001290,delayed eyelid opening|MP:0001732,postnatal growth retardation|MP:0001764,abnormal homeostasis|MP:0001777,abnormal body temperature homeostasis|MP:0001957,apnea|MP:0002628,hepatic steatosis|MP:0003806,abnormal nucleotide metabolism|MP:0011085,postnatal lethality, complete penetrance|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis
MGI:5816711	Adk<tm2Bois>	MP:0000947,convulsive seizures|MP:0002062,abnormal associative learning|MP:0002206,abnormal CNS synaptic transmission|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003008,enhanced long-term potentiation|MP:0004859,abnormal synaptic plasticity|MP:0009358,environmentally induced seizures|MP:0009454,impaired contextual conditioning behavior
MGI:6382308	Adm2<em1Zhan>	MP:0001175,abnormal lung morphology|MP:0001846,increased inflammatory response|MP:0001860,liver inflammation|MP:0002135,abnormal kidney morphology|MP:0002406,increased susceptibility to infection|MP:0003070,increased vascular permeability|MP:0005165,increased susceptibility to injury|MP:0011350,abnormal proximal convoluted tubule brush border morphology|MP:0011824,increased cell chemotaxis|MP:0013022,increased Ly6C high monocyte number|MP:0020344,abnormal susceptibility to injury induced morbidity/mortality
MGI:5695957	Adm2<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0008725,increased heart atrium size
MGI:3811634	Adm<tm1.1Mtnz>	MP:0011091,prenatal lethality, complete penetrance
MGI:3043324	Adm<tm1Hku>	MP:0001182,lung hemorrhage|MP:0001625,cardiac hypertrophy|MP:0001711,abnormal placenta morphology|MP:0001914,hemorrhage|MP:0002191,abnormal artery morphology|MP:0002192,hydrops fetalis|MP:0002842,increased systemic arterial blood pressure|MP:0003044,impaired basement membrane formation|MP:0003229,abnormal vitelline vasculature morphology|MP:0003620,oliguria|MP:0003888,liver hemorrhage|MP:0004921,decreased placenta weight|MP:0005264,glomerulosclerosis|MP:0005312,pericardial effusion|MP:0005558,decreased creatinine clearance|MP:0005598,decreased heart ventricle muscle contractility|MP:0006055,abnormal vascular endothelial cell morphology|MP:0009820,abnormal liver vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011514,skin hemorrhage|MP:0011942,decreased fluid intake|MP:0012302,umbilical artery stenosis|MP:0012303,umbilical vein stenosis|MP:0021157,increased heart left ventricle wall thickness
MGI:5517672	Adm<tm1Kmca>	MP:0005389,reproductive system phenotype|MP:0009394,increased uterine NK cell number
MGI:3811632	Adm<tm1Mtnz>	MP:0001363,increased anxiety-related response|MP:0001405,impaired coordination|MP:0001409,increased stereotypic behavior|MP:0002574,increased vertical activity|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0031391,increased locomotor activity
MGI:3609557	Adm<tm1Tfjt>	MP:0001863,blood vessel inflammation|MP:0003674,oxidative stress|MP:0004111,abnormal coronary artery morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:2176598	Adm<tm1Unc>	MP:0001716,abnormal placenta labyrinth morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001785,edema|MP:0002188,small heart|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002190,disorganized myocardium|MP:0002191,abnormal artery morphology|MP:0002192,hydrops fetalis|MP:0002450,abnormal lymph organ development|MP:0003222,increased cardiomyocyte apoptosis|MP:0003390,lymphedema|MP:0003921,abnormal heart left ventricle morphology|MP:0005385,cardiovascular system phenotype|MP:0008876,decreased uterine NK cell number|MP:0009658,increased placenta apoptosis|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011525,abnormal placenta intervillous maternal lacunae morphology|MP:0011526,abnormal placenta fetal blood space morphology|MP:0012727,abnormal uterine spiral artery remodeling
MGI:3763612	Adm<tm2Unc>	MP:0005385,cardiovascular system phenotype
MGI:5754578	Adnp2<em3(IMPC)Tcp>	MP:0000063,decreased bone mineral density|MP:0000157,abnormal sternum morphology|MP:0000598,abnormal liver morphology|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001175,abnormal lung morphology|MP:0001258,decreased body length|MP:0001417,decreased exploration in new environment|MP:0002637,small uterus|MP:0002764,short tibia|MP:0002768,small adrenal glands|MP:0002989,small kidney|MP:0003795,abnormal bone structure|MP:0005313,absent adrenal gland|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6416397	Adnp<em1Ant>	MP:0001363,increased anxiety-related response|MP:0001409,increased stereotypic behavior|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012307,impaired spatial learning
MGI:7867540	Adnp<em1Goz>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001290,delayed eyelid opening|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001441,increased grooming behavior|MP:0001485,abnormal pinna reflex|MP:0001486,abnormal startle reflex|MP:0001529,abnormal vocalization|MP:0001961,abnormal reflex|MP:0001963,abnormal hearing physiology|MP:0001984,abnormal olfaction|MP:0002862,abnormal righting response|MP:0003998,decreased thermal nociceptive threshold|MP:0004250,tau protein deposits|MP:0009538,abnormal synapse morphology|MP:0010377,abnormal gut flora balance|MP:0010540,long stride length|MP:0010748,abnormal visual evoked potential|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014367,impaired long-term object recognition memory|MP:0020351,decreased vocalization|MP:0020508,decreased dendritic spine density|MP:0020863,abnormal suckling reflex|MP:0021112,impaired social recognition
MGI:2674108	Adnp<tm1Goz>	MP:0000928,incomplete rostral neuropore closure|MP:0002085,abnormal embryonic tissue morphology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:2180136	Adora1<tm1Bbf>	MP:0001363,increased anxiety-related response|MP:0001777,abnormal body temperature homeostasis|MP:0002206,abnormal CNS synaptic transmission|MP:0002314,abnormal respiratory mechanics|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002917,decreased synaptic depression|MP:0003177,allodynia|MP:0003998,decreased thermal nociceptive threshold|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005407,hyperalgesia
MGI:5634953	Adora1<tm1b(KOMP)Wtsi>	MP:0001415,increased exploration in new environment|MP:0002574,increased vertical activity|MP:0003960,increased lean body mass|MP:0005561,increased mean corpuscular hemoglobin
MGI:2388340	Adora1<tm1Jgsc>	MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004041,increased susceptibility to kidney reperfusion injury|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005553,increased circulating creatinine level|MP:0011297,absent tubuloglomerular feedback response
MGI:3712214	Adora1<tm1Rgrn>	MP:0002169,no abnormal phenotype detected|MP:0002272,abnormal nervous system electrophysiology|MP:0002912,abnormal excitatory postsynaptic potential
MGI:6315517	Adora2a<em1(IMPC)H>	MP:0000219,increased neutrophil cell number|MP:0001402,decreased locomotor activity|MP:0002874,decreased hemoglobin content|MP:0002941,increased circulating alanine transaminase level|MP:0003961,decreased lean body mass|MP:0005016,decreased lymphocyte cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005559,increased circulating glucose level|MP:0010024,increased total body fat amount|MP:0020421,increased freezing behavior
MGI:3611746	Adora2a<tm1Dyj>	MP:0003313,abnormal locomotor activation
MGI:2155985	Adora2a<tm1Jfc>	MP:0000276,heart right ventricle hypertrophy|MP:0000484,abnormal pulmonary artery morphology|MP:0001402,decreased locomotor activity|MP:0002698,abnormal sclera morphology|MP:0002975,vascular smooth muscle hypertrophy|MP:0003100,myopia|MP:0003313,abnormal locomotor activation|MP:0003548,pulmonary hypertension|MP:0003631,nervous system phenotype|MP:0004007,abnormal lung vasculature morphology|MP:0005385,cardiovascular system phenotype|MP:0005391,vision/eye phenotype|MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009750,impaired behavioral response to addictive substance|MP:0010758,increased right ventricle systolic pressure
MGI:2152583	Adora2a<tm1Map>	MP:0001354,increased aggression towards male mice|MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001423,abnormal liquid preference|MP:0001544,abnormal cardiovascular system physiology|MP:0001973,increased thermal nociceptive threshold|MP:0002626,increased heart rate|MP:0002842,increased systemic arterial blood pressure|MP:0003043,hypoalgesia|MP:0003313,abnormal locomotor activation|MP:0006087,increased body mass index|MP:0008661,decreased interleukin-10 secretion|MP:0009586,increased platelet aggregation|MP:0009755,impaired behavioral response to alcohol
MGI:5445790	Adora2b<tm1.1(KOMP)Vlcg>	MP:0000947,convulsive seizures|MP:0002968,increased circulating alkaline phosphatase level|MP:0005560,decreased circulating glucose level|MP:0010097,abnormal retina blood vessel morphology|MP:0013279,increased fasting circulating glucose level
MGI:4941886	Adora2b<tm1.1Msit>	MP:0002451,abnormal macrophage physiology|MP:0002626,increased heart rate|MP:0004875,increased mean systemic arterial blood pressure|MP:0005165,increased susceptibility to injury|MP:0005166,decreased susceptibility to injury|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008560,increased tumor necrosis factor secretion|MP:0008705,increased interleukin-6 secretion|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:3773754	Adora2b<tm1Dgen>	MP:0000343,abnormal response to cardiac infarction|MP:0001379,abnormal penile erection|MP:0002376,abnormal dendritic cell physiology|MP:0003070,increased vascular permeability|MP:0005164,abnormal response to injury|MP:0005166,decreased susceptibility to injury|MP:0008661,decreased interleukin-10 secretion
MGI:3665133	Adora2b<tm1Kra>	MP:0001845,abnormal inflammatory response|MP:0003156,abnormal leukocyte migration|MP:0003628,abnormal leukocyte adhesion|MP:0005385,cardiovascular system phenotype|MP:0008596,increased circulating interleukin-6 level|MP:0008661,decreased interleukin-10 secretion|MP:0008713,abnormal cytokine level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0020333,enhanced leukocyte tethering or rolling
MGI:4941885	Adora2b<tm1Msit>	MP:0005165,increased susceptibility to injury|MP:0005166,decreased susceptibility to injury|MP:0005376,homeostasis/metabolism phenotype
MGI:3759856	Adora2b<tm1Till>	MP:0005376,homeostasis/metabolism phenotype|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008705,increased interleukin-6 secretion|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009858,abnormal cellular extravasation|MP:0011049,impaired adaptive thermogenesis
MGI:3613017	Adora3<tm1(ADORA3)Msth>	MP:0002423,abnormal mast cell physiology|MP:0008765,decreased mast cell degranulation
MGI:2155986	Adora3<tm1Jbsn>	MP:0002335,decreased airway responsiveness|MP:0002423,abnormal mast cell physiology|MP:0002736,abnormal nociception after inflammation|MP:0002843,decreased systemic arterial blood pressure|MP:0003022,increased coronary flow rate|MP:0003038,decreased myocardial infarct size|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0005087,decreased acute inflammation|MP:0005260,ocular hypotension|MP:0005554,decreased circulating creatinine level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008719,impaired neutrophil recruitment|MP:0008763,abnormal mast cell degranulation
MGI:4840602	Adpgk<tm2a(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content
MGI:6140149	Adprhl1<em1(IMPC)H>	MP:0020421,increased freezing behavior
MGI:3719093	Adprh<tm1Jlms>	MP:0002406,increased susceptibility to infection
MGI:5811623	Adprm<tm1b(EUCOMM)Hmgu>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0004924,abnormal behavior|MP:0010379,decreased respiratory quotient|MP:0020870,decreased thigmotaxis
MGI:6140089	Adprs<em1(IMPC)Wtsi>	MP:0000062,increased bone mineral density|MP:0001257,increased body length|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:6455175	Adprs<tm1.2Jlms>	MP:0003076,increased susceptibility to ischemic brain injury|MP:0020344,abnormal susceptibility to injury induced morbidity/mortality
MGI:2387663	Adra1a<tm1Pcs>	MP:0001596,hypotension|MP:0003026,decreased vasoconstriction|MP:0003929,decreased heart rate variability
MGI:2148638	Adra1b<tm1Cta>	MP:0000230,abnormal systemic arterial blood pressure|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001157,small seminal vesicle|MP:0001415,increased exploration in new environment|MP:0001417,decreased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0001559,hyperglycemia|MP:0001751,increased circulating luteinizing hormone level|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002063,abnormal learning/memory/conditioning|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002216,abnormal seminiferous tubule morphology|MP:0002702,decreased circulating free fatty acids level|MP:0002780,decreased circulating testosterone level|MP:0002784,abnormal Sertoli cell morphology|MP:0002843,decreased systemic arterial blood pressure|MP:0003026,decreased vasoconstriction|MP:0003461,abnormal response to novel object|MP:0003562,abnormal pancreatic beta cell physiology|MP:0003921,abnormal heart left ventricle morphology|MP:0004000,impaired passive avoidance behavior|MP:0004184,abnormal baroreceptor physiology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005140,decreased cardiac muscle contractility|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005333,decreased heart rate|MP:0005389,reproductive system phenotype|MP:0005458,increased percent body fat/body weight|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0008280,abnormal male germ cell apoptosis|MP:0009712,impaired conditioned place preference behavior|MP:0009750,impaired behavioral response to addictive substance|MP:0010399,decreased skeletal muscle glycogen level|MP:0010400,increased liver glycogen level|MP:0014269,decreased testes secretion
MGI:2182469	Adra1d<tm1Gzt>	MP:0001489,decreased startle reflex|MP:0001544,abnormal cardiovascular system physiology|MP:0001596,hypotension|MP:0002843,decreased systemic arterial blood pressure|MP:0003088,abnormal prepulse inhibition|MP:0003858,enhanced coordination|MP:0004142,abnormal muscle tone|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0008428,abnormal spatial working memory
MGI:3612161	Adra1d<tm1Jabl>	MP:0002757,decreased vertical activity|MP:0003313,abnormal locomotor activation|MP:0009750,impaired behavioral response to addictive substance
MGI:6269429	Adra2a<m1Btlr>	MP:0002079,increased circulating insulin level|MP:0005560,decreased circulating glucose level
MGI:6269434	Adra2a<m2Btlr>	MP:0005560,decreased circulating glucose level
MGI:5695965	Adra2a<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001399,hyperactivity|MP:0001489,decreased startle reflex|MP:0005292,improved glucose tolerance|MP:0009142,decreased prepulse inhibition|MP:0013278,decreased fasting circulating glucose level
MGI:2179108	Adra2a<tm1Bkk>	MP:0000189,hypoglycemia|MP:0000230,abnormal systemic arterial blood pressure|MP:0002078,abnormal glucose homeostasis|MP:0002626,increased heart rate|MP:0005447,abnormal synaptic norepinephrine release|MP:0008840,abnormal spike wave discharge
MGI:1857459	Adra2a<tm1Lel>	MP:0000230,abnormal systemic arterial blood pressure
MGI:3849302	Adra2a<tm1Qiwa>	MP:0002169,no abnormal phenotype detected
MGI:1857118	Adra2b<tm1Gsb>	MP:0000250,abnormal vasoconstriction|MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001179,thick pulmonary interalveolar septum|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002082,postnatal lethality|MP:0002161,abnormal fertility/fecundity|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002754,dilated heart right ventricle|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005397,hematopoietic system phenotype|MP:0005631,decreased lung weight|MP:0008489,slow postnatal weight gain|MP:0009674,decreased birth weight|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011147,increased mesenchymal cell proliferation involved in lung development
MGI:1857119	Adra2c<tm1Gsb>	MP:0001488,increased startle reflex|MP:0003063,increased coping response|MP:0003631,nervous system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory
MGI:1857120	Adrb1<tm1Bkk>	MP:0001544,abnormal cardiovascular system physiology|MP:0005385,cardiovascular system phenotype|MP:0008872,abnormal physiological response to xenobiotic|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6423068	Adrb2<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0004738,abnormal auditory brainstem response
MGI:1859675	Adrb2<tm1Bkk>	MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0001541,abnormal osteoclast physiology|MP:0001629,abnormal heart rate|MP:0002842,increased systemic arterial blood pressure|MP:0004876,decreased mean systemic arterial blood pressure|MP:0004945,abnormal bone resorption|MP:0004982,abnormal osteoclast morphology|MP:0004993,decreased bone resorption|MP:0005006,abnormal osteoblast physiology|MP:0005241,abnormal retina ganglion layer morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005547,abnormal Muller cell morphology|MP:0005605,increased bone mass|MP:0006309,decreased retina ganglion cell number|MP:0006319,abnormal epididymal fat pad morphology|MP:0008396,abnormal osteoclast differentiation|MP:0008560,increased tumor necrosis factor secretion|MP:0010379,decreased respiratory quotient|MP:0010875,increased bone volume|MP:0012029,abnormal electroretinogram waveform feature|MP:0012107,enhanced exercise endurance|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0030005,increased retina apoptosis
MGI:3837346	Adrb2<tm1Kry>	MP:0002079,increased circulating insulin level|MP:0003564,abnormal insulin secretion|MP:0005560,decreased circulating glucose level
MGI:5784772	Adrb3<em1(IMPC)Krb>	MP:0013886,increased CD4-negative, CD25-positive NK T cell number
MGI:2387777	Adrb3<tm1Jpg>	MP:0001433,polyphagia|MP:0005376,homeostasis/metabolism phenotype|MP:0005455,increased susceptibility to weight gain|MP:0005458,increased percent body fat/body weight|MP:0010024,increased total body fat amount
MGI:1860610	Adrb3<tm1Lowl>	MP:0008872,abnormal physiological response to xenobiotic|MP:0009300,increased parametrial fat pad weight|MP:0010024,increased total body fat amount
MGI:3612071	Adre<BALB/cBy>	MP:0020865,delayed suckling reflex loss
MGI:3612070	Adre<C57BL/6By>	MP:0020864,premature suckling reflex loss
MGI:4196174	Adrm1<Gt(OST128063)Lex>	MP:0000010,abnormal abdominal fat pad morphology|MP:0000708,thymus hyperplasia|MP:0000709,enlarged thymus|MP:0001125,abnormal oocyte morphology|MP:0001126,abnormal ovary morphology|MP:0001131,abnormal ovarian follicle morphology|MP:0001134,absent corpus luteum|MP:0001153,small seminiferous tubules|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002082,postnatal lethality|MP:0004924,abnormal behavior|MP:0005123,increased circulating growth hormone level|MP:0005159,azoospermia|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005387,immune system phenotype|MP:0005431,decreased oocyte number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008081,abnormal single-positive T cell number|MP:0008280,abnormal male germ cell apoptosis|MP:0009444,ovarian follicular cyst|MP:0009674,decreased birth weight|MP:0010024,increased total body fat amount|MP:0011122,absent primordial ovarian follicles
MGI:3620167	Ads1<NZB>	MP:0004762,increased anti-double stranded DNA antibody level|MP:0005350,increased susceptibility to autoimmune disorder
MGI:3620169	Ads2<NZB>	MP:0004762,increased anti-double stranded DNA antibody level|MP:0005350,increased susceptibility to autoimmune disorder
MGI:3620172	Ads3<NZW>	MP:0002490,abnormal immunoglobulin level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005350,increased susceptibility to autoimmune disorder
MGI:3620173	Ads4<NZB>	MP:0002962,increased urine protein level|MP:0004798,decreased anti-double stranded DNA antibody level
MGI:3620174	Ads4<NZW>	MP:0002490,abnormal immunoglobulin level|MP:0005350,increased susceptibility to autoimmune disorder
MGI:6720350	Adsl<em1Svap>	MP:0013242,abnormal amino acid metabolism
MGI:5548339	Adsl<tm1b(KOMP)Wtsi>	MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5617796	Adss2<tm1b(EUCOMM)Wtsi>	MP:0001556,increased circulating HDL cholesterol level|MP:0005012,decreased eosinophil cell number|MP:0005554,decreased circulating creatinine level|MP:0005566,decreased blood urea nitrogen level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6257443	Adtrp<em1(IMPC)Bay>	MP:0000280,thin ventricular wall
MGI:6488487	Adtrp<em1Sagh>	MP:0005281,increased fatty acids level|MP:0010768,mortality/aging|MP:0013245,abnormal lipid metabolism
MGI:6460464	Adtrp<tm1.1Clu>	MP:0000324,increased mast cell number|MP:0001786,skin edema|MP:0001846,increased inflammatory response|MP:0001914,hemorrhage|MP:0004272,abnormal basement membrane morphology|MP:0005385,cardiovascular system phenotype|MP:0005606,increased bleeding time|MP:0006055,abnormal vascular endothelial cell morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013258,abnormal extracellular matrix morphology|MP:0014264,abnormal perivascular vein cell coverage|MP:0020326,dilated capillary|MP:0020327,abnormal capillary branching pattern|MP:0020331,increased capillary tortuosity
MGI:1855939	a<e>	MP:0002075,abnormal coat/hair pigmentation|MP:0005409,darkened coat color
MGI:5696883	Aebp1<tm1.1(KOMP)Wtsi>	MP:0001402,decreased locomotor activity|MP:0002111,abnormal tail morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:3758183	Aebp1<tm1Hsro>	MP:0001262,decreased body weight|MP:0001382,abnormal nursing|MP:0001732,postnatal growth retardation|MP:0001783,decreased white adipose tissue amount|MP:0002644,decreased circulating triglyceride level|MP:0002970,abnormal white adipose tissue morphology|MP:0005179,decreased circulating cholesterol level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0006271,abnormal involution of the mammary gland|MP:0009115,abnormal fat cell morphology|MP:0010025,decreased total body fat amount|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2180115	Aebp1<tm1Mdl>	MP:0000352,decreased cell proliferation|MP:0000477,abnormal intestine morphology|MP:0000585,kinked tail|MP:0000598,abnormal liver morphology|MP:0000757,herniated abdominal wall|MP:0001212,skin lesions|MP:0001792,impaired wound healing|MP:0003051,curly tail|MP:0008770,decreased survivor rate|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3871767	Aebp2<Gt(BC0681)Wtsi>	MP:0001270,distended abdomen|MP:0001489,decreased startle reflex|MP:0002926,aganglionic megacolon|MP:0003289,abnormal intestinal peristalsis|MP:0003866,abnormal defecation|MP:0005175,non-pigmented tail tip|MP:0005408,hypopigmentation|MP:0011092,embryonic lethality, complete penetrance
MGI:6423852	a<em1(IMPC)Mbp>	MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002574,increased vertical activity|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney
MGI:2156720	Aem2<C57BL/6>	MP:0003726,decreased autoantibody level
MGI:2157943	Aem3<C57BL/6>	MP:0001790,abnormal immune system physiology
MGI:2680914	Aevm1<MRL/MpJ>	MP:0001864,vascular inflammation
MGI:2680916	Aevm2<MRL/MpJ>	MP:0001864,vascular inflammation
MGI:5705576	Aey30	MP:0001147,small testis|MP:0002687,oligozoospermia|MP:0002864,abnormal ocular fundus morphology
MGI:2156123	Aeyo<C57BL/6By>	MP:0001290,delayed eyelid opening
MGI:5694611	Afap1l2<tm1.1Mliu>	MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0005164,abnormal response to injury|MP:0005376,homeostasis/metabolism phenotype
MGI:5548752	Afap1l2<tm1b(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0000367,abnormal coat/ hair morphology|MP:0000689,abnormal spleen morphology|MP:0001402,decreased locomotor activity|MP:0001488,increased startle reflex|MP:0002968,increased circulating alkaline phosphatase level|MP:0004738,abnormal auditory brainstem response|MP:0005292,improved glucose tolerance|MP:0005333,decreased heart rate|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0010392,prolonged QRS complex duration|MP:0010506,prolonged RR interval
MGI:5707264	Afap1<tm1.2Ycho>	MP:0001382,abnormal nursing|MP:0001882,abnormal lactation|MP:0003718,maternal effect|MP:0004047,abnormal milk composition|MP:0006271,abnormal involution of the mammary gland|MP:0009506,abnormal mammary gland alveolus morphology|MP:0009546,absent gastric milk in neonates
MGI:6277063	Afdn<em1(IMPC)Mbp>	MP:0000494,abnormal cecum morphology|MP:0000538,abnormal urinary bladder morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0002339,abnormal lymph node morphology|MP:0002608,increased hematocrit|MP:0003068,enlarged kidney|MP:0003720,abnormal neural tube closure|MP:0004953,decreased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0005084,abnormal gallbladder morphology|MP:0005564,increased hemoglobin content|MP:0006108,abnormal hindbrain development|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0011625,cystolithiasis|MP:0013292,embryonic lethality prior to organogenesis
MGI:5308214	Afdn<tm1.1Lfr>	MP:0002912,abnormal excitatory postsynaptic potential|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0009538,abnormal synapse morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0010011,ectopic hippocampus pyramidal cells
MGI:5607284	Afdn<tm1c(EUCOMM)Hmgu>	MP:0000778,abnormal nervous system tract morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000807,abnormal hippocampus morphology|MP:0000934,abnormal telencephalon development|MP:0003077,abnormal cell cycle|MP:0003648,abnormal radial glial cell morphology|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004980,increased neuronal precursor cell number|MP:0005238,increased brain size|MP:0008441,thin cortical plate|MP:0008458,abnormal cortical ventricular zone morphology|MP:0008547,abnormal neocortex morphology|MP:0011723,ectopic neuron|MP:0020067,increased neocortex size|MP:0020389,increased radial glial cell number
MGI:3525467	Afdn<tm1Mrcr>	MP:0000932,absent notochord|MP:0001674,abnormal germ layer development|MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0003087,absent allantois|MP:0003885,abnormal rostral-caudal body axis extension|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0006386,absent somites|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012165,absent neural folds
MGI:3623108	Afdn<tm1Ytk>	MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0002151,abnormal neural tube morphology|MP:0003087,absent allantois|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011199,abnormal amniotic cavity morphology|MP:0011200,abnormal extraembryonic coelom morphology|MP:0011388,absent heart
MGI:4354298	Afdn<tm2Ytk>	MP:0009538,abnormal synapse morphology
MGI:1862020	Aff1<Rob>	MP:0000849,abnormal cerebellum morphology|MP:0000876,Purkinje cell degeneration|MP:0000890,thin cerebellar molecular layer|MP:0001265,decreased body size|MP:0001304,cataract|MP:0001388,abnormal stationary movement|MP:0001393,ataxia|MP:0001525,impaired balance|MP:0001823,thymus hypoplasia|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0002183,gliosis|MP:0002407,abnormal double-negative T cell morphology|MP:0004956,decreased thymus weight|MP:0005424,jerky movement|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2386161	Aff1<tm1Cim>	MP:0000716,abnormal immune system cell morphology|MP:0001265,decreased body size|MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0002722,abnormal immune system organ morphology|MP:0005017,decreased B cell number|MP:0005092,decreased double-positive T cell number|MP:0008083,decreased single-positive T cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0011086,postnatal lethality, incomplete penetrance
MGI:7425494	Aff2<em1(IMPC)Hmgu>	MP:0004156,abnormal QT variability|MP:0010097,abnormal retina blood vessel morphology
MGI:2182641	Aff2<tm1Dln>	MP:0001265,decreased body size|MP:0001454,abnormal cued conditioning behavior|MP:0001463,abnormal spatial learning|MP:0002083,premature death|MP:0002206,abnormal CNS synaptic transmission|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003008,enhanced long-term potentiation|MP:0003998,decreased thermal nociceptive threshold
MGI:7266365	Aff3<em1Andg>	MP:0000060,delayed bone ossification|MP:0000428,abnormal craniofacial morphology|MP:0000477,abnormal intestine morphology|MP:0000558,abnormal tibia morphology|MP:0000562,polydactyly|MP:0002080,prenatal lethality|MP:0002187,abnormal fibula morphology|MP:0003633,abnormal nervous system physiology|MP:0004200,decreased fetal size|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004686,decreased length of long bones
MGI:7266450	Aff3<em1Xen>	MP:0002080,prenatal lethality
MGI:4434291	Aff3<tm1a(EUCOMM)Wtsi>	MP:0000443,abnormal snout morphology|MP:0000781,decreased corpus callosum size|MP:0002100,abnormal tooth morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003019,increased circulating chloride level|MP:0003036,vertebral transformation|MP:0004599,abnormal vertebral arch morphology|MP:0004613,fusion of vertebral arches|MP:0005358,abnormal incisor morphology|MP:0005419,decreased circulating serum albumin level|MP:0008535,enlarged lateral ventricles|MP:0010053,decreased grip strength|MP:0010088,decreased circulating fructosamine level
MGI:6382405	Aff4<em1(IMPC)Mbp>	MP:0000428,abnormal craniofacial morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0002989,small kidney|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0020421,increased freezing behavior
MGI:3586991	Aff4<tm1Nosa>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001260,increased body weight|MP:0001377,abnormal mating frequency|MP:0001925,male infertility|MP:0001943,abnormal respiration|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003984,embryonic growth retardation|MP:0004909,increased seminal vesicle weight|MP:0004930,small epididymis|MP:0005159,azoospermia|MP:0005397,hematopoietic system phenotype|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:6336108	Afg1l<em1(IMPC)Kmpc>	MP:0000367,abnormal coat/ hair morphology|MP:0001399,hyperactivity|MP:0002075,abnormal coat/hair pigmentation|MP:0002833,increased heart weight
MGI:5605804	Afg2a<tm1b(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7426002	Afg2b<em1(IMPC)Bay>	MP:0000702,enlarged lymph nodes|MP:0001402,decreased locomotor activity|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011100,preweaning lethality, complete penetrance|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:5817724	Afg3l1<tm1.1Arte>	MP:0002169,no abnormal phenotype detected
MGI:3775617	Afg3l2<Emv66>	MP:0000748,progressive muscle weakness|MP:0000753,paralysis|MP:0000876,Purkinje cell degeneration|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000890,thin cerebellar molecular layer|MP:0000920,abnormal myelination|MP:0000956,decreased spinal cord size|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0002183,gliosis|MP:0002882,abnormal neuron morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003313,abnormal locomotor activation|MP:0003354,astrocytosis|MP:0003674,oxidative stress|MP:0004098,abnormal cerebellar granule cell morphology|MP:0005370,liver/biliary system phenotype|MP:0005384,cellular phenotype|MP:0005404,abnormal axon morphology|MP:0006035,abnormal mitochondrial morphology|MP:0006099,thin cerebellar granule layer|MP:0008027,abnormal spinal cord white matter morphology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0009400,decreased skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010955,abnormal respiratory electron transport chain|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011085,postnatal lethality, complete penetrance|MP:0011630,increased mitochondrial size|MP:0011635,abnormal mitochondrial crista morphology|MP:0014345,abnormal neuron mitochondrial morphology
MGI:1856984	Afg3l2<par>	MP:0000745,tremors|MP:0000747,muscle weakness|MP:0000748,progressive muscle weakness|MP:0000753,paralysis|MP:0000920,abnormal myelination|MP:0000937,abnormal motor neuron morphology|MP:0000939,decreased motor neuron number|MP:0000956,decreased spinal cord size|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001523,impaired righting response|MP:0001961,abnormal reflex|MP:0002269,muscular atrophy|MP:0002882,abnormal neuron morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003871,abnormal myelin sheath morphology|MP:0004835,abnormal miniature endplate potential|MP:0005370,liver/biliary system phenotype|MP:0005384,cellular phenotype|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0008027,abnormal spinal cord white matter morphology|MP:0009400,decreased skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009684,abnormal spinal cord lateral motor column morphology|MP:0010955,abnormal respiratory electron transport chain|MP:0011085,postnatal lethality, complete penetrance
MGI:5476783	Afg3l2<tm1Arte>	MP:0000876,Purkinje cell degeneration|MP:0000953,abnormal oligodendrocyte morphology|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0002229,neurodegeneration|MP:0003354,astrocytosis|MP:0005378,growth/size/body region phenotype|MP:0005405,axon degeneration|MP:0008027,abnormal spinal cord white matter morphology|MP:0008918,microgliosis|MP:0008948,decreased neuron number|MP:0010387,abnormal Bergmann glial cell morphology|MP:0010954,abnormal cellular respiration|MP:0011630,increased mitochondrial size|MP:0011635,abnormal mitochondrial crista morphology|MP:0011730,increased myelin sheath thickness|MP:0011731,decreased myelin sheath thickness|MP:0013438,dysmyelination|MP:0014331,abnormal Purkinje cell mitochondrial morphology
MGI:6259101	Afmid<em1Llp>	MP:0001399,hyperactivity|MP:0010053,decreased grip strength
MGI:4432070	Afmid<tm1a(EUCOMM)Wtsi>	MP:0001426,polydipsia|MP:0001559,hyperglycemia|MP:0001762,polyuria
MGI:5548841	Afmid<tm1b(EUCOMM)Wtsi>	MP:0001399,hyperactivity|MP:0002590,increased mean corpuscular volume|MP:0003059,decreased insulin secretion|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005559,increased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0009168,decreased pancreatic islet number|MP:0009643,abnormal urine homeostasis|MP:0010087,increased circulating fructosamine level
MGI:4455621	Afm<tm1a(KOMP)Wtsi>	MP:0000565,oligodactyly|MP:0003062,abnormal coping response|MP:0005564,increased hemoglobin content
MGI:2155737	Afpq11<DU6i>	MP:0000010,abnormal abdominal fat pad morphology
MGI:2156702	Afpq9<DU6i>	MP:0000010,abnormal abdominal fat pad morphology
MGI:3610508	Afp<tm1(Cebpa)Ndw>	MP:0004502,decreased incidence of tumors by chemical induction|MP:0010400,increased liver glycogen level
MGI:2388722	Afp<tm1Ibmm>	MP:0001126,abnormal ovary morphology|MP:0001134,absent corpus luteum|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001926,female infertility|MP:0002566,abnormal sexual interaction|MP:0005185,decreased circulating progesterone level|MP:0008869,anovulation|MP:0009009,absent estrous cycle|MP:0009092,endometrium hyperplasia|MP:0030983,failure of copulatory plug deposition
MGI:2388723	Afp<tm2Ibmm>	MP:0001126,abnormal ovary morphology|MP:0001134,absent corpus luteum|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001926,female infertility|MP:0002566,abnormal sexual interaction|MP:0005185,decreased circulating progesterone level|MP:0008869,anovulation|MP:0009009,absent estrous cycle|MP:0009092,endometrium hyperplasia|MP:0030983,failure of copulatory plug deposition
MGI:1856589	Aft	MP:0000379,decreased hair follicle number|MP:0000414,alopecia|MP:0000564,syndactyly|MP:0000571,interdigital webbing|MP:0000585,kinked tail|MP:0001212,skin lesions|MP:0001511,disheveled coat|MP:0009932,skin fibrosis|MP:0010206,pigment incontinence
MGI:3716511	Afteq1<ISS>	MP:0005443,abnormal ethanol metabolism
MGI:3716512	Afteq2<ILS>	MP:0005443,abnormal ethanol metabolism
MGI:3716513	Afteq2<ISS>	MP:0005443,abnormal ethanol metabolism
MGI:6342500	Aftph<em1(IMPC)J>	MP:0000198,decreased circulating phosphate level|MP:0003131,increased erythrocyte cell number|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2155285	Afw12<DU6i>	MP:0000010,abnormal abdominal fat pad morphology
MGI:5586546	Afw13<PWK>	MP:0000010,abnormal abdominal fat pad morphology
MGI:2155735	Afw14<DU6i>	MP:0000010,abnormal abdominal fat pad morphology
MGI:2156040	Afw15<DU6i>	MP:0000010,abnormal abdominal fat pad morphology
MGI:5586558	Afw16<C57BL/6>	MP:0000010,abnormal abdominal fat pad morphology
MGI:2679844	Afw18<DU6i>	MP:0000010,abnormal abdominal fat pad morphology
MGI:2429618	Afw19<DU6i>	MP:0000010,abnormal abdominal fat pad morphology
MGI:5586532	Afw1<DU6>	MP:0000010,abnormal abdominal fat pad morphology
MGI:5586548	Afw2<DU6>	MP:0000010,abnormal abdominal fat pad morphology
MGI:2156053	Afw3<DU6>	MP:0000010,abnormal abdominal fat pad morphology
MGI:2446910	Afw5<DU6>	MP:0000010,abnormal abdominal fat pad morphology
MGI:2156705	Afw9<DU6i>	MP:0000010,abnormal abdominal fat pad morphology
MGI:1856653	ag	MP:0000745,tremors|MP:0000849,abnormal cerebellum morphology|MP:0000876,Purkinje cell degeneration|MP:0000880,decreased Purkinje cell number|MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0003492,abnormal involuntary movement|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005150,cachexia|MP:0009674,decreased birth weight
MGI:4820274	Agap1<tm1a(EUCOMM)Wtsi>	MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001307,fused cornea and lens|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001322,abnormal iris morphology|MP:0002100,abnormal tooth morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0004738,abnormal auditory brainstem response|MP:0005627,increased circulating potassium level|MP:0006358,absent pinna reflex|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration
MGI:4439325	Agap2<tm1.1Kye>	MP:0001559,hyperglycemia|MP:0002891,increased insulin sensitivity|MP:0003383,abnormal gluconeogenesis|MP:0004047,abnormal milk composition|MP:0005331,insulin resistance|MP:0006270,abnormal mammary gland growth during lactation|MP:0009506,abnormal mammary gland alveolus morphology|MP:0010174,decreased mammary gland epithelial cell proliferation|MP:0010249,lactation failure|MP:0014126,increased mammary gland apoptosis
MGI:4439322	Agap2<tm1Kye>	MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0002644,decreased circulating triglyceride level|MP:0003383,abnormal gluconeogenesis|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level|MP:0010360,decreased liver free fatty acids level
MGI:6719547	Agap3<tm1.1Ygi>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031391,increased locomotor activity
MGI:6719542	Agap3<tm1Ygi>	MP:0000812,abnormal dentate gyrus morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001399,hyperactivity|MP:0008948,decreased neuron number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031391,increased locomotor activity
MGI:2156980	Aga<tm1Pltn>	MP:0000822,abnormal brain ventricle morphology|MP:0001260,increased body weight|MP:0001463,abnormal spatial learning|MP:0005058,abnormal lysosome morphology|MP:0005386,behavior/neurological phenotype|MP:0008540,abnormal cerebral hemisphere morphology|MP:0011380,enlarged brain ventricles|MP:0011516,aspartylglucosaminuria
MGI:1861793	Aga<tm1Vk>	MP:0000519,hydronephrosis|MP:0000539,distended urinary bladder|MP:0000540,abnormal urinary bladder urothelium morphology|MP:0000849,abnormal cerebellum morphology|MP:0000876,Purkinje cell degeneration|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0001511,disheveled coat|MP:0001524,impaired limb coordination|MP:0001525,impaired balance|MP:0001655,multifocal hepatic necrosis|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0003215,renal interstitial fibrosis|MP:0003354,astrocytosis|MP:0003624,anuria|MP:0004195,abnormal kidney calyx morphology|MP:0004970,kidney atrophy|MP:0005058,abnormal lysosome morphology|MP:0005302,neurogenic bladder|MP:0005325,abnormal renal glomerulus morphology|MP:0005404,abnormal axon morphology|MP:0009643,abnormal urine homeostasis|MP:0011346,renal tubule atrophy|MP:0011413,colorless urine|MP:0011516,aspartylglucosaminuria
MGI:5882076	Agbl1<em1(IMPC)J>	MP:0001284,absent vibrissae|MP:0001402,decreased locomotor activity|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002075,abnormal coat/hair pigmentation|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount
MGI:5787965	Agbl1<em1Zfa>	MP:0005387,immune system phenotype
MGI:7425495	Agbl2<em1(IMPC)H>	MP:0010052,increased grip strength
MGI:5787967	Agbl2<em1Zfa>	MP:0005387,immune system phenotype
MGI:5608873	Agbl2<tm1.2Ics>	MP:0005389,reproductive system phenotype
MGI:5787968	Agbl3<em1Zfa>	MP:0005387,immune system phenotype
MGI:5608874	Agbl3<tm1.2Ics>	MP:0005389,reproductive system phenotype
MGI:6140127	Agbl4<em1(IMPC)Mbp>	MP:0000220,increased monocyte cell number|MP:0005344,increased circulating bilirubin level|MP:0020421,increased freezing behavior
MGI:5788002	Agbl4<Tn(pb-Act-RFP)1.080115015-HRAZhu>	MP:0000229,abnormal megakaryocyte differentiation|MP:0000689,abnormal spleen morphology|MP:0002417,abnormal megakaryocyte morphology|MP:0003405,abnormal platelet shape|MP:0004720,abnormal platelet morphology|MP:0004952,increased spleen weight|MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology|MP:0005505,thrombocytosis|MP:0005606,increased bleeding time|MP:0008254,increased megakaryocyte cell number|MP:0009549,decreased platelet aggregation|MP:0009676,abnormal hemostasis|MP:0014060,abnormal platelet alpha-granule morphology|MP:0020431,decreased platelet alpha-granule number|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020928,increased susceptibility to Poxviridae infection|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality|MP:0031034,increased susceptibility to Poxviridae infection induced morbidity/mortality
MGI:5787969	Agbl5<em1Zfa>	MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020928,increased susceptibility to Poxviridae infection|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality|MP:0031034,increased susceptibility to Poxviridae infection induced morbidity/mortality
MGI:6287427	Agbl5<tm1.1Ics>	MP:0001932,abnormal spermiogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009243,hairpin sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0031373,abnormal manchette perinuclear ring morphology|MP:0031374,abnormal manchette assembly
MGI:6887875	Agbl5<tm1.2Ics>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002660,abnormal caput epididymis morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008545,absent sperm flagellum|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009239,short sperm flagellum|MP:0009376,abnormal manchette morphology|MP:0009833,absent sperm mitochondrial sheath|MP:0009838,abnormal sperm axoneme morphology|MP:0014636,decreased elongated spermatid number|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0031373,abnormal manchette perinuclear ring morphology|MP:0031374,abnormal manchette assembly|MP:0031375,abnormal manchette disassembly
MGI:2451038	Ager<tm1.1Arnd>	MP:0001790,abnormal immune system physiology|MP:0002707,abnormal kidney weight|MP:0002733,abnormal thermal nociception|MP:0004149,increased bone strength|MP:0004883,abnormal vascular wound healing|MP:0004985,decreased osteoclast cell number|MP:0004993,decreased bone resorption|MP:0005325,abnormal renal glomerulus morphology|MP:0005559,increased circulating glucose level|MP:0005595,abnormal vascular smooth muscle physiology|MP:0005605,increased bone mass|MP:0008597,decreased circulating interleukin-6 level|MP:0009347,increased trabecular bone thickness|MP:0010123,increased bone mineral content|MP:0010878,increased trabecular bone volume|MP:0011338,abnormal mesangial matrix morphology|MP:0011349,abnormal renal glomerulus basement membrane thickness|MP:0013623,increased femur compact bone thickness|MP:0013631,decreased bone trabecular spacing|MP:0020011,increased bone mineral density of femur|MP:0020416,decreased fibroblast chemotaxis|MP:0031509,decreased vascular smooth muscle cell proliferation
MGI:3692766	Ager<tm1.1Hyam>	MP:0000260,abnormal angiogenesis|MP:0000350,abnormal cell proliferation|MP:0001262,decreased body weight|MP:0002169,no abnormal phenotype detected|MP:0005559,increased circulating glucose level|MP:0006043,decreased apoptosis|MP:0009642,abnormal blood homeostasis
MGI:3698956	Ager<tm1Arnd>	MP:0002169,no abnormal phenotype detected
MGI:5427971	Ager<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:2182772	Agfg1<tm1Jvd>	MP:0000242,impaired fertilization|MP:0001919,abnormal reproductive system physiology|MP:0001925,male infertility|MP:0001929,abnormal gametogenesis|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0008279,arrest of spermiogenesis|MP:0008839,absent acrosome|MP:0008898,abnormal acrosome morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009233,enlarged sperm head|MP:0009376,abnormal manchette morphology|MP:0009377,ectopic manchette|MP:0009830,abnormal sperm connecting piece morphology|MP:0009833,absent sperm mitochondrial sheath|MP:0009838,abnormal sperm axoneme morphology|MP:0009839,multiflagellated sperm|MP:0030980,abnormal acroplaxome morphology|MP:0031355,abnormal proacrosomal vesicle fusion|MP:0031386,elongated manchette|MP:0031682,abnormal centriole morphology
MGI:5816161	Agfg2<em1(IMPC)J>	MP:0005562,decreased mean corpuscular hemoglobin
MGI:4122569	Aggf1<Gt(PT036)Byg>	MP:0000259,abnormal vascular development|MP:0001182,lung hemorrhage|MP:0001634,internal hemorrhage|MP:0001915,intracranial hemorrhage|MP:0002052,decreased tumor incidence|MP:0002083,premature death|MP:0002899,fatigue|MP:0003070,increased vascular permeability|MP:0003229,abnormal vitelline vasculature morphology|MP:0004003,abnormal vascular endothelial cell physiology|MP:0004007,abnormal lung vasculature morphology|MP:0004950,abnormal brain vasculature morphology|MP:0010144,abnormal tumor vascularization|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011134,decreased lung endothelial cell migration|MP:0013292,embryonic lethality prior to organogenesis
MGI:5882327	Aggf1<tm1Qkw>	MP:0000259,abnormal vascular development|MP:0001182,lung hemorrhage|MP:0001634,internal hemorrhage|MP:0002052,decreased tumor incidence|MP:0003070,increased vascular permeability|MP:0003229,abnormal vitelline vasculature morphology|MP:0004003,abnormal vascular endothelial cell physiology|MP:0010144,abnormal tumor vascularization|MP:0011102,embryonic lethality, incomplete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2179250	Aggr1<NZB/BlNJ>	MP:0001353,increased aggression towards mice
MGI:2179252	Aggr2<NZB/BlNJ>	MP:0001353,increased aggression towards mice
MGI:7610741	Agk<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6381662	Agk<em1Qiz>	MP:0002083,premature death|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005397,hematopoietic system phenotype|MP:0010851,decreased effector memory CD8-positive, alpha-beta T cell number
MGI:6381660	Agk<tm1.1Smoc>	MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0010851,decreased effector memory CD8-positive, alpha-beta T cell number
MGI:5811085	Aglna	MP:0001829,increased activated T cell number|MP:0002362,abnormal spleen marginal zone morphology
MGI:4432988	Agl<tm1a(EUCOMM)Wtsi>	MP:0000189,hypoglycemia|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0000747,muscle weakness|MP:0001402,decreased locomotor activity|MP:0002083,premature death|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003333,liver fibrosis|MP:0005343,increased circulating aspartate transaminase level|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0010400,increased liver glycogen level|MP:0010401,increased skeletal muscle glycogen level|MP:0014071,increased cardiac muscle glycogen level
MGI:5548686	Agl<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000745,tremors|MP:0001304,cataract|MP:0001406,abnormal gait|MP:0002833,increased heart weight|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003917,increased kidney weight|MP:0003960,increased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005560,decreased circulating glucose level|MP:0008806,increased circulating amylase level|MP:0008810,increased circulating iron level|MP:0010025,decreased total body fat amount|MP:0010090,increased circulating creatine kinase level|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:5661387	Agl<tm1Geno>	MP:0000160,kyphosis|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005440,increased glycogen level|MP:0005560,decreased circulating glucose level|MP:0005573,increased pulmonary respiratory rate|MP:0010090,increased circulating creatine kinase level|MP:0010400,increased liver glycogen level|MP:0010401,increased skeletal muscle glycogen level|MP:0012106,impaired exercise endurance|MP:0013278,decreased fasting circulating glucose level|MP:0014071,increased cardiac muscle glycogen level|MP:0014074,increased brain glycogen level|MP:0014605,dark liver
MGI:7425496	Agmo<em1(IMPC)Bay>	MP:0011959,abnormal eye posterior chamber depth
MGI:7256325	Agmo<tm2a(EUCOMM)Wtsi>	MP:0005179,decreased circulating cholesterol level|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0010768,mortality/aging|MP:0012220,abnormal ether lipid level
MGI:7254848	Agmo<tm2c(EUCOMM)Wtsi>	MP:0005378,growth/size/body region phenotype
MGI:7254849	Agmo<tm2d(EUCOMM)Wtsi>	MP:0005378,growth/size/body region phenotype|MP:0005584,abnormal enzyme/coenzyme activity
MGI:3582420	Agnm1<MRL/MpJ>	MP:0002743,glomerulonephritis|MP:0004801,increased susceptibility to systemic lupus erythematosus
MGI:3582422	Agnm2<MRL/MpJ>	MP:0002743,glomerulonephritis|MP:0004801,increased susceptibility to systemic lupus erythematosus
MGI:3582424	Agnm3<MRL/MpJ>	MP:0002743,glomerulonephritis|MP:0004801,increased susceptibility to systemic lupus erythematosus
MGI:5319524	Ago1<tm1.1Tara>	MP:0002169,no abnormal phenotype detected
MGI:4362358	Ago1<tm1a(KOMP)Wtsi>	MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0004924,abnormal behavior|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3711987	Ago2<Gt(XE344)Byg>	MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0005384,cellular phenotype|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4839762	Ago2<tm1.1Tara>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002169,no abnormal phenotype detected|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003339,decreased pancreatic beta cell number|MP:0003656,abnormal erythrocyte physiology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005562,decreased mean corpuscular hemoglobin|MP:0009114,decreased pancreatic beta cell mass|MP:0010067,increased red blood cell distribution width|MP:0011171,increased number of Heinz bodies|MP:0011820,decreased pancreatic beta cell proliferation
MGI:3056454	Ago2<tm1Ghan>	MP:0000274,enlarged heart|MP:0000929,open neural tube|MP:0000930,wavy neural tube|MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001787,pericardial edema|MP:0003232,abnormal forebrain development|MP:0003984,embryonic growth retardation|MP:0011091,prenatal lethality, complete penetrance
MGI:4462371	Ago2<tm3.1Ghan>	MP:0002416,abnormal proerythroblast morphology|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0011087,neonatal lethality, complete penetrance
MGI:4880894	Ago3<tm1a(KOMP)Wtsi>	MP:0010052,increased grip strength
MGI:5438526	Ago4<tm1.1Peco>	MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0006362,abnormal male germ cell morphology|MP:0009452,abnormal synaptonemal complex|MP:0014052,increased male germ cell apoptosis
MGI:3620205	Agp1<NZB>	MP:0005615,increased susceptibility to type III hypersensitivity reaction
MGI:3620208	Agp2<NZW>	MP:0005615,increased susceptibility to type III hypersensitivity reaction
MGI:7516677	Agpat1<em1Andm>	MP:0001265,decreased body size|MP:0011085,postnatal lethality, complete penetrance
MGI:5554916	Agpat1<tm1.1(KOMP)Vlcg>	MP:0000195,decreased circulating calcium level|MP:0001759,increased urine glucose level|MP:0002941,increased circulating alanine transaminase level|MP:0002959,increased urine microalbumin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003020,decreased circulating chloride level|MP:0005560,decreased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005627,increased circulating potassium level|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6343539	Agpat1<tm1Garg>	MP:0000189,hypoglycemia|MP:0000807,abnormal hippocampus morphology|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001496,audiogenic seizures|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0002083,premature death|MP:0002574,increased vertical activity|MP:0003355,decreased ovulation rate|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005668,decreased circulating leptin level|MP:0006319,abnormal epididymal fat pad morphology|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0008489,slow postnatal weight gain|MP:0009011,prolonged diestrus|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011128,increased tertiary ovarian follicle number|MP:0014633,decreased spermatid number|MP:0014634,decreased round spermatid number|MP:0014636,decreased elongated spermatid number|MP:0030973,impaired gluconeogenesis|MP:0031391,increased locomotor activity
MGI:7425497	Agpat2<em1(IMPC)Ccpcz>	MP:0000470,abnormal stomach morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001404,no spontaneous movement|MP:0002135,abnormal kidney morphology|MP:0002965,increased circulating serum albumin level|MP:0003068,enlarged kidney|MP:0003883,enlarged stomach|MP:0004599,abnormal vertebral arch morphology|MP:0004906,enlarged uterus|MP:0005568,increased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance
MGI:4317356	Agpat2<Gt(OST438470)Lex>	MP:0000129,ameloblast degeneration|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0001559,hyperglycemia|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0001860,liver inflammation|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002500,granulomatous inflammation|MP:0002577,reduced enamel thickness|MP:0002971,abnormal brown adipose tissue morphology|MP:0003645,increased pancreatic beta cell number|MP:0005358,abnormal incisor morphology|MP:0005559,increased circulating glucose level|MP:0009117,abnormal white fat cell morphology|MP:0009131,decreased white fat cell number|MP:0009133,decreased white fat cell size|MP:0009171,enlarged pancreatic islets|MP:0010179,rough coat|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011174,lipodystrophy|MP:0013249,adipose tissue necrosis|MP:0030542,abnormal dentin development|MP:0030827,femur fracture|MP:0031116,microvesicular hepatic steatosis|MP:0031603,brown adipose tissue inflammation
MGI:3838346	Agpat2<tm1Garg>	MP:0000010,abnormal abdominal fat pad morphology|MP:0000496,abnormal small intestine morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001426,polydipsia|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0002702,decreased circulating free fatty acids level|MP:0002981,increased liver weight|MP:0003917,increased kidney weight|MP:0003948,abnormal gas homeostasis|MP:0004777,abnormal phospholipid level|MP:0004952,increased spleen weight|MP:0005178,increased circulating cholesterol level|MP:0005280,abnormal fatty acids level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005534,decreased body temperature|MP:0005559,increased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0008770,decreased survivor rate|MP:0008843,absent subcutaneous adipose tissue|MP:0008963,increased carbon dioxide production|MP:0009113,increased pancreatic beta cell mass|MP:0009171,enlarged pancreatic islets|MP:0009355,increased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0010379,decreased respiratory quotient|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011939,increased food intake|MP:0011941,increased fluid intake
MGI:4432492	Agpat3<tm1a(EUCOMM)Wtsi>	MP:0000242,impaired fertilization|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0001925,male infertility|MP:0002090,abnormal vision|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0002942,decreased circulating alanine transaminase level|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0004777,abnormal phospholipid level|MP:0005571,decreased lactate dehydrogenase level|MP:0005578,teratozoospermia|MP:0005632,decreased circulating aspartate transaminase level|MP:0008515,thin retina outer nuclear layer|MP:0008581,disorganized photoreceptor inner segment|MP:0008582,short photoreceptor inner segment|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0009230,abnormal sperm head morphology|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0020813,abnormal photoreceptor outer segment disc membrane morphology
MGI:5637031	Agpat4<tm1b(KOMP)Wtsi>	MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0013279,increased fasting circulating glucose level
MGI:5007015	Agpat4<tm1Lex>	MP:0002169,no abnormal phenotype detected|MP:0004777,abnormal phospholipid level
MGI:6358072	Agpat5<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001157,small seminal vesicle|MP:0002059,abnormal seminal vesicle morphology|MP:0003961,decreased lean body mass
MGI:3529976	Agpat5<Gt(OST62319)Lex>	MP:0002628,hepatic steatosis
MGI:3777322	Agps<bs2>	MP:0001147,small testis|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001547,abnormal lipid level|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002579,disorganized secondary lens fibers|MP:0002840,abnormal lens fiber morphology|MP:0005159,azoospermia|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5494472	Agr2<tm1.1Lex>	MP:0000351,increased cell proliferation|MP:0000473,abnormal stomach glandular epithelium morphology|MP:0000489,abnormal large intestine morphology|MP:0000496,abnormal small intestine morphology|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0002083,premature death|MP:0003270,intestinal obstruction|MP:0003699,abnormal female reproductive system physiology|MP:0003883,enlarged stomach|MP:0004139,abnormal gastric parietal cell morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0005419,decreased circulating serum albumin level|MP:0008907,decreased total fat pad weight|MP:0010155,abnormal intestine physiology|MP:0010799,stomach mucosa hyperplasia|MP:0010803,abnormal stomach enteroendocrine cell morphology
MGI:4421687	Agr2<tm1.1Lpkn>	MP:0000479,abnormal enterocyte morphology|MP:0002816,colitis|MP:0003449,abnormal intestine goblet cell morphology|MP:0008883,abnormal enterocyte proliferation|MP:0008885,increased enterocyte apoptosis|MP:0013485,increased Paneth cell number
MGI:3844570	Agr2<tm1.2Erle>	MP:0000324,increased mast cell number|MP:0000493,rectal prolapse|MP:0000511,abnormal intestinal mucosa morphology|MP:0008537,increased susceptibility to induced colitis
MGI:4421689	Agr2<tm1.2Lpkn>	MP:0000479,abnormal enterocyte morphology|MP:0002389,abnormal Peyer's patch follicle morphology|MP:0002816,colitis|MP:0003449,abnormal intestine goblet cell morphology|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0009482,ileum inflammation|MP:0013485,increased Paneth cell number
MGI:5051097	Agr2<tm1(KOMP)Vlcg>	MP:0000462,abnormal digestive system morphology|MP:0001262,decreased body weight|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5494471	Agr2<tm1Lex>	MP:0000351,increased cell proliferation
MGI:2136176	Agrn<Gt(Ex192)Byg>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0005367,renal/urinary system phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:3614578	Agrn<nmf380>	MP:0000556,abnormal hindlimb morphology|MP:0000743,muscle spasm|MP:0000745,tremors|MP:0000751,myopathy|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001265,decreased body size|MP:0001513,limb grasping|MP:0001524,impaired limb coordination|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0003631,nervous system phenotype|MP:0003807,camptodactyly|MP:0005369,muscle phenotype|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009417,skeletal muscle atrophy|MP:0009434,paraparesis|MP:0010768,mortality/aging
MGI:1929777	Agrn<tm1Jrs>	MP:0001052,abnormal innervation pattern to muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0002058,neonatal lethality|MP:0002184,abnormal innervation|MP:0002923,increased post-tetanic potentiation|MP:0003631,nervous system phenotype|MP:0004807,abnormal paired-pulse inhibition|MP:0004998,decreased CNS synapse formation|MP:0005404,abnormal axon morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:3579476	Agrn<tm1Rwb>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0001614,abnormal blood vessel morphology|MP:0002279,abnormal diaphragm morphology|MP:0003631,nervous system phenotype|MP:0005367,renal/urinary system phenotype|MP:0011089,perinatal lethality, complete penetrance|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011409,increased renal glomerulus basement membrane thickness
MGI:1930978	Agrn<tm2Jrs>	MP:0002169,no abnormal phenotype detected
MGI:1930979	Agrn<tm3Jrs>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0001404,no spontaneous movement|MP:0002184,abnormal innervation|MP:0010819,primary atelectasis|MP:0011089,perinatal lethality, complete penetrance
MGI:2663725	Agrn<tm4Jrs>	MP:0001054,failure of neuromuscular synapse presynaptic differentiation|MP:0005367,renal/urinary system phenotype
MGI:3578923	Agrn<tm5Jrs>	MP:0003631,nervous system phenotype|MP:0010768,mortality/aging
MGI:5526035	Agrp<tm1Dgen>	MP:0000609,abnormal liver physiology|MP:0003458,decreased circulating ketone body level|MP:0003961,decreased lean body mass|MP:0003976,decreased circulating VLDL triglyceride level|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0009356,decreased liver triglyceride level|MP:0010180,increased susceptibility to weight loss|MP:0012575,increased noradrenaline level
MGI:3696694	Agrp<tm1Mws>	MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0003983,decreased cholesterol level|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005449,abnormal food intake|MP:0005450,abnormal energy expenditure|MP:0005477,increased circulating thyroxine level|MP:0005480,increased circulating triiodothyronine level|MP:0005668,decreased circulating leptin level|MP:0009642,abnormal blood homeostasis|MP:0010025,decreased total body fat amount|MP:0010379,decreased respiratory quotient|MP:0011016,increased core body temperature
MGI:2183577	Agrp<tm1Sqn>	MP:0001260,increased body weight|MP:0001661,extended life span|MP:0002169,no abnormal phenotype detected|MP:0003961,decreased lean body mass|MP:0005450,abnormal energy expenditure|MP:0011049,impaired adaptive thermogenesis|MP:0011939,increased food intake
MGI:3527177	Agrp<tm2(HBEGF)Rpa>	MP:0001262,decreased body weight|MP:0001431,abnormal eating behavior|MP:0001657,abnormal induced morbidity/mortality|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0005111,hyperdipsia|MP:0011940,decreased food intake
MGI:3612160	Agtpbp1<atms>	MP:0000689,abnormal spleen morphology|MP:0000694,spleen hypoplasia|MP:0000717,abnormal lymphocyte cell number|MP:0001393,ataxia|MP:0002145,abnormal T cell differentiation|MP:0002444,abnormal T cell physiology|MP:0003944,abnormal T cell subpopulation ratio|MP:0004953,decreased spleen weight|MP:0005017,decreased B cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:3847121	Agtpbp1<babe>	MP:0001393,ataxia|MP:0009434,paraparesis
MGI:4442903	Agtpbp1<m2Btlr>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0009280,decreased activated sperm motility
MGI:6199620	Agtpbp1<m3Btlr>	MP:0001262,decreased body weight|MP:0001405,impaired coordination
MGI:1856535	Agtpbp1<pcd>	MP:0000819,abnormal olfactory bulb morphology|MP:0000832,abnormal thalamus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000890,thin cerebellar molecular layer|MP:0001005,abnormal retina rod cell morphology|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001442,decreased grooming behavior|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002757,decreased vertical activity|MP:0003203,increased neuron apoptosis|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003734,abnormal retina inner plexiform layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0006362,abnormal male germ cell morphology|MP:0008106,decreased amacrine cell number|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0012490,abnormal cochlear VIII nucleus morphology|MP:0014059,abnormal photoreceptor connecting cilium morphology|MP:0014367,impaired long-term object recognition memory|MP:0021111,decreased social investigation
MGI:1856536	Agtpbp1<pcd-2J>	MP:0001393,ataxia|MP:0001516,abnormal motor coordination/balance|MP:0001922,reduced male fertility|MP:0003631,nervous system phenotype
MGI:1857523	Agtpbp1<pcd-3J>	MP:0000832,abnormal thalamus morphology|MP:0000876,Purkinje cell degeneration|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001393,ataxia|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0006362,abnormal male germ cell morphology|MP:0008450,retina photoreceptor degeneration|MP:0009954,abnormal mitral cell morphology
MGI:2384178	Agtpbp1<pcd-4J>	MP:0000876,Purkinje cell degeneration|MP:0001393,ataxia
MGI:2388491	Agtpbp1<pcd-5J>	MP:0000852,small cerebellum|MP:0000876,Purkinje cell degeneration|MP:0001326,retina degeneration|MP:0001393,ataxia|MP:0001925,male infertility|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0008515,thin retina outer nuclear layer
MGI:3521973	Agtpbp1<pcd-6J>	MP:0000819,abnormal olfactory bulb morphology|MP:0000876,Purkinje cell degeneration|MP:0001326,retina degeneration|MP:0001393,ataxia|MP:0001921,reduced fertility|MP:0001924,infertility|MP:0003205,testicular atrophy|MP:0003993,abnormal ventral spinal root morphology|MP:0005159,azoospermia|MP:0009400,decreased skeletal muscle fiber size
MGI:3573876	Agtpbp1<pcd-7J>	MP:0000876,Purkinje cell degeneration|MP:0001393,ataxia|MP:0004738,abnormal auditory brainstem response|MP:0008282,enlarged hippocampus
MGI:3772649	Agtpbp1<pcd-8J>	MP:0000880,decreased Purkinje cell number|MP:0001265,decreased body size|MP:0001326,retina degeneration|MP:0001393,ataxia|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0003727,abnormal retina layer morphology|MP:0006362,abnormal male germ cell morphology
MGI:3774134	Agtpbp1<pcd-Btlr>	MP:0000876,Purkinje cell degeneration|MP:0001393,ataxia|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0003631,nervous system phenotype|MP:0005578,teratozoospermia|MP:0008450,retina photoreceptor degeneration
MGI:1856129	Agtpbp1<pcd-Tg(Dhfr)1Jwg>	MP:0000819,abnormal olfactory bulb morphology|MP:0000876,Purkinje cell degeneration|MP:0001393,ataxia|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0005159,azoospermia|MP:0008450,retina photoreceptor degeneration
MGI:6270378	Agtpbp1<tm1.2Ics>	MP:0020850,abnormal microtubule cytoskeleton morphology
MGI:6156120	Agtr1a<em1(IMPC)Rbrc>	MP:0000208,decreased hematocrit|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002135,abnormal kidney morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004952,increased spleen weight|MP:0005505,thrombocytosis|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008528,polycystic kidney|MP:0010067,increased red blood cell distribution width
MGI:5007680	Agtr1a<tm1.1Cof>	MP:0005528,decreased renal glomerular filtration rate|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0010108,abnormal renal water reabsorption
MGI:5468252	Agtr1a<tm1.1Uky>	MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0009118,increased white fat cell size|MP:0009131,decreased white fat cell number|MP:0011167,abnormal adipose tissue development
MGI:2156487	Agtr1a<tm1Afu>	MP:0001596,hypotension|MP:0003352,increased circulating renin level|MP:0005166,decreased susceptibility to injury|MP:0005376,homeostasis/metabolism phenotype|MP:0005582,increased renin activity|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0011425,abnormal kidney interstitium morphology|MP:0011941,increased fluid intake
MGI:3721911	Agtr1a<tm1Ecl>	MP:0000530,abnormal kidney vasculature morphology|MP:0001262,decreased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0002136,abnormal kidney physiology|MP:0002593,high mean erythrocyte cell number|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003353,decreased circulating renin level|MP:0003620,oliguria|MP:0003921,abnormal heart left ventricle morphology|MP:0003985,renal fibrosis|MP:0005564,increased hemoglobin content|MP:0005565,increased blood urea nitrogen level|MP:0005608,cardiac interstitial fibrosis|MP:0005618,decreased urine potassium level|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008055,increased urine osmolality|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009642,abnormal blood homeostasis|MP:0011471,decreased urine creatinine level|MP:0031231,decreased circulating angiotensin II level
MGI:2183541	Agtr1a<tm1Tma>	MP:0002829,abnormal juxtaglomerular apparatus morphology|MP:0002842,increased systemic arterial blood pressure|MP:0011301,juxtaglomerular cell hyperplasia|MP:0011316,abnormal kidney interlobular artery morphology
MGI:4946096	Agtr1a<tm1Uky>	MP:0005385,cardiovascular system phenotype
MGI:1857147	Agtr1a<tm1Unc>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000818,abnormal amygdala morphology|MP:0000832,abnormal thalamus morphology|MP:0001629,abnormal heart rate|MP:0002834,decreased heart weight|MP:0002843,decreased systemic arterial blood pressure|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005333,decreased heart rate|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0008872,abnormal physiological response to xenobiotic
MGI:2183543	Agtr1a<tm2Tma>	MP:0002829,abnormal juxtaglomerular apparatus morphology|MP:0011301,juxtaglomerular cell hyperplasia|MP:0011316,abnormal kidney interlobular artery morphology
MGI:5883021	Agtr1a<tm3Tma>	MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype
MGI:4433535	Agtr2<tm1a(EUCOMM)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0001262,decreased body weight|MP:0002942,decreased circulating alanine transaminase level
MGI:1857123	Agtr2<tm1Gsb>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000250,abnormal vasoconstriction|MP:0000343,abnormal response to cardiac infarction|MP:0001402,decreased locomotor activity|MP:0001622,abnormal vasculogenesis|MP:0002753,dilated heart left ventricle|MP:0002975,vascular smooth muscle hypertrophy|MP:0003025,increased vasoconstriction|MP:0005165,increased susceptibility to injury|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006144,increased systemic arterial systolic blood pressure|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011941,increased fluid intake|MP:0011947,abnormal fluid intake
MGI:2178475	Agtr2<tm1Tin>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000278,abnormal myocardial fiber morphology|MP:0000343,abnormal response to cardiac infarction|MP:0000516,abnormal renal/urinary system morphology|MP:0000519,hydronephrosis|MP:0000520,absent kidney|MP:0000521,abnormal kidney cortex morphology|MP:0000527,abnormal kidney development|MP:0000534,abnormal ureter morphology|MP:0000536,hydroureter|MP:0000818,abnormal amygdala morphology|MP:0000832,abnormal thalamus morphology|MP:0001417,decreased exploration in new environment|MP:0001431,abnormal eating behavior|MP:0001489,decreased startle reflex|MP:0001560,abnormal circulating insulin level|MP:0001629,abnormal heart rate|MP:0001745,increased circulating corticosterone level|MP:0001748,increased circulating adrenocorticotropin level|MP:0001944,abnormal pancreas morphology|MP:0001948,vesicoureteral reflux|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002135,abnormal kidney morphology|MP:0002834,decreased heart weight|MP:0002842,increased systemic arterial blood pressure|MP:0002891,increased insulin sensitivity|MP:0003043,hypoalgesia|MP:0003141,cardiac fibrosis|MP:0003215,renal interstitial fibrosis|MP:0003334,pancreas fibrosis|MP:0003446,renal hypoplasia|MP:0003459,increased fear-related response|MP:0003585,large ureter|MP:0003586,dilated ureter|MP:0003600,ectopic kidney|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003672,abnormal ureter development|MP:0003916,decreased heart left ventricle weight|MP:0003918,decreased kidney weight|MP:0003921,abnormal heart left ventricle morphology|MP:0003963,abnormal corticosterone level|MP:0004082,abnormal habenula morphology|MP:0004129,abnormal respiratory quotient|MP:0004184,abnormal baroreceptor physiology|MP:0004486,decreased response of heart to induced stress|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004875,increased mean systemic arterial blood pressure|MP:0004889,increased energy expenditure|MP:0005502,abnormal renal/urinary system physiology|MP:0005526,decreased renal plasma flow rate|MP:0005531,increased renal vascular resistance|MP:0005534,decreased body temperature|MP:0005601,increased angiogenesis|MP:0005602,decreased angiogenesis|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005667,abnormal circulating leptin level|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0006274,abnormal urine sodium level|MP:0006319,abnormal epididymal fat pad morphology|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008265,abnormal hippocampus CA2 region morphology|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0008528,polycystic kidney|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009109,decreased pancreas weight|MP:0009130,increased white fat cell number|MP:0009133,decreased white fat cell size|MP:0009150,pancreatic acinar cell atrophy|MP:0009347,increased trabecular bone thickness|MP:0009643,abnormal urine homeostasis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010009,abnormal piriform cortex morphology|MP:0010182,decreased susceptibility to weight gain|MP:0010725,thin interventricular septum|MP:0010867,abnormal bone trabecula morphology|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume|MP:0010932,increased trabecular bone connectivity density|MP:0011371,decreased kidney apoptosis|MP:0011415,abnormal aldosterone level|MP:0011489,ureteropelvic junction atresia|MP:0011490,ureteropelvic junction stenosis|MP:0011492,ureterovesical junction obstruction|MP:0011493,double ureter|MP:0012575,increased noradrenaline level|MP:0014316,decreased heart left ventricle posterior wall thickness|MP:0030761,increased adrenaline level|MP:0031413,abnormal skeletal muscle triglyceride level
MGI:7484784	Agtrap<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0002590,increased mean corpuscular volume|MP:0002606,increased basophil cell number|MP:0020421,increased freezing behavior
MGI:4126022	Agtrap<Gt(XE129)Byg>	MP:0001762,polyuria|MP:0004875,increased mean systemic arterial blood pressure|MP:0005376,homeostasis/metabolism phenotype|MP:0006144,increased systemic arterial systolic blood pressure|MP:0009350,decreased urine pH|MP:0009642,abnormal blood homeostasis|MP:0010127,hypervolemia
MGI:6511094	Agtrap<tm1Tamk>	MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002079,increased circulating insulin level|MP:0002446,abnormal macrophage morphology|MP:0002965,increased circulating serum albumin level|MP:0002970,abnormal white adipose tissue morphology|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0006094,increased fat cell size|MP:0009288,increased epididymal fat pad weight
MGI:5305952	Agt<tm1.1Itl>	MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006376,decreased circulating angiotensinogen level
MGI:2136636	Agt<tm1Afu>	MP:0000519,hydronephrosis|MP:0000530,abnormal kidney vasculature morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001426,polydipsia|MP:0001596,hypotension|MP:0001762,polyuria|MP:0002135,abnormal kidney morphology|MP:0002667,decreased circulating aldosterone level|MP:0002829,abnormal juxtaglomerular apparatus morphology|MP:0002843,decreased systemic arterial blood pressure|MP:0002988,decreased urine osmolality|MP:0003352,increased circulating renin level|MP:0003917,increased kidney weight|MP:0004505,decreased renal glomerulus number|MP:0005319,abnormal enzyme/coenzyme level|MP:0005489,vascular smooth muscle hyperplasia|MP:0005558,decreased creatinine clearance|MP:0005610,increased circulating antidiuretic hormone level|MP:0005618,decreased urine potassium level|MP:0006263,decreased systemic arterial diastolic blood pressure|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006317,decreased urine sodium level|MP:0006376,decreased circulating angiotensinogen level|MP:0008285,abnormal hippocampus granule cell layer|MP:0008489,slow postnatal weight gain|MP:0009269,decreased fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009642,abnormal blood homeostasis|MP:0010025,decreased total body fat amount|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011304,kidney papillary atrophy|MP:0011312,abnormal kidney afferent arteriole morphology|MP:0011316,abnormal kidney interlobular artery morphology|MP:0011333,abnormal kidney inner medulla morphology|MP:0011346,renal tubule atrophy|MP:0011405,tubulointerstitial nephritis|MP:0011422,kidney medulla atrophy|MP:0011541,decreased urine aldosterone level|MP:0011543,increased urine antidiuretic hormone level|MP:0031384,impaired blood-brain barrier function|MP:0031391,increased locomotor activity
MGI:2183545	Agt<tm1Ii>	MP:0000519,hydronephrosis|MP:0000521,abnormal kidney cortex morphology|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0002834,decreased heart weight|MP:0002843,decreased systemic arterial blood pressure|MP:0002988,decreased urine osmolality|MP:0003215,renal interstitial fibrosis|MP:0003402,decreased liver weight|MP:0004860,dilated kidney collecting duct|MP:0005325,abnormal renal glomerulus morphology|MP:0005502,abnormal renal/urinary system physiology|MP:0005553,increased circulating creatinine level|MP:0005556,abnormal renal filtration rate|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0011304,kidney papillary atrophy|MP:0011312,abnormal kidney afferent arteriole morphology|MP:0011314,abnormal kidney cortex artery morphology|MP:0011316,abnormal kidney interlobular artery morphology|MP:0011353,expanded mesangial matrix|MP:0011431,increased urine flow rate|MP:0011565,kidney papillary hypoplasia|MP:0011941,increased fluid intake
MGI:1857121	Agt<tm1Unc>	MP:0000530,abnormal kidney vasculature morphology|MP:0002843,decreased systemic arterial blood pressure|MP:0003215,renal interstitial fibrosis|MP:0003352,increased circulating renin level|MP:0004970,kidney atrophy|MP:0005367,renal/urinary system phenotype|MP:0005389,reproductive system phenotype|MP:0005525,increased renal plasma flow rate|MP:0006376,decreased circulating angiotensinogen level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011316,abnormal kidney interlobular artery morphology|MP:0011346,renal tubule atrophy|MP:0011405,tubulointerstitial nephritis|MP:0011423,kidney cortex atrophy
MGI:1857122	Agt<tm2Unc>	MP:0002842,increased systemic arterial blood pressure|MP:0005367,renal/urinary system phenotype|MP:0006375,increased circulating angiotensinogen level|MP:0031420,decreased superovulation rate
MGI:6450144	Agxt2<em1(IMPC)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:5560668	Agxt2<tm1Lex>	MP:0000231,hypertension|MP:0005367,renal/urinary system phenotype|MP:0005590,increased vasodilation|MP:0020836,increased circulating citrulline level
MGI:3526219	Agxt<tm1Ull>	MP:0003197,nephrocalcinosis|MP:0003606,kidney failure|MP:0005360,urolithiasis|MP:0005558,decreased creatinine clearance|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009645,crystalluria|MP:0011517,hyperoxaluria
MGI:1856661	aha	MP:0001585,hemolytic anemia
MGI:6384598	Ahctf1<em1(IMPC)Hmgu>	MP:0002699,abnormal vitreous body morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:3578224	Ahctf1<tm1Taga>	MP:0002718,abnormal inner cell mass morphology|MP:0010380,abnormal inner cell mass apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:6838413	Ahcy<em1Cya>	MP:0001613,abnormal vasodilation|MP:0003674,oxidative stress|MP:0003957,abnormal nitric oxide homeostasis
MGI:5635096	Ahcyl1<tm1.1Smua>	MP:0010148,abnormal exocrine pancreas physiology
MGI:4431930	Ahcyl1<tm1a(EUCOMM)Wtsi>	MP:0001312,abnormal cornea morphology|MP:0001325,abnormal retina morphology|MP:0002599,increased mean platelet volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0005477,increased circulating thyroxine level|MP:0010123,increased bone mineral content
MGI:5605830	Ahcy<tm1b(EUCOMM)Hmgu>	MP:0002606,increased basophil cell number|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:7595527	Ahdc1<em#Oro>	MP:0000081,premature cranial suture closure|MP:0000259,abnormal vascular development|MP:0000428,abnormal craniofacial morphology|MP:0000445,short snout|MP:0001293,anophthalmia|MP:0001302,eyelids open at birth|MP:0002060,abnormal skin morphology|MP:0003052,omphalocele|MP:0004200,decreased fetal size|MP:0009827,skin detachment|MP:0011089,perinatal lethality, complete penetrance|MP:0011160,dermal-epidermal separation
MGI:5517460	Ahi1<tm1.1Xjl>	MP:0001392,abnormal locomotor behavior|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0008489,slow postnatal weight gain
MGI:4367773	Ahi1<tm1Jgg>	MP:0000774,decreased brain size|MP:0000851,cerebellum hypoplasia|MP:0000864,abnormal cerebellum vermis morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001859,kidney inflammation|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002136,abnormal kidney physiology|MP:0002705,dilated renal tubule|MP:0002989,small kidney|MP:0003675,kidney cyst|MP:0003985,renal fibrosis|MP:0004272,abnormal basement membrane morphology|MP:0005164,abnormal response to injury|MP:0005391,vision/eye phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0006072,abnormal retina apoptosis|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008585,absent photoreceptor outer segment|MP:0009719,reduced cerebellar foliation|MP:0009959,abnormal cerebellar hemisphere morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013305,isosthenuria
MGI:4360696	Ahi1<tm1Rujf>	MP:0013202,abnormal cilium morphology
MGI:4849287	Ahi1<tm1Xjl>	MP:0002573,behavioral despair|MP:0005386,behavior/neurological phenotype
MGI:2662446	Ahl2<NOD/ShiLtJ>	MP:0004748,increased susceptibility to age-related hearing loss
MGI:3526113	Ahl3<MSM>	MP:0004766,decreased susceptibility to age-related hearing loss
MGI:5586731	ahlg	MP:0001265,decreased body size|MP:0001513,limb grasping|MP:0003055,abnormal long bone epiphyseal plate morphology
MGI:5636950	Ahnak<tm1b(KOMP)Mbp>	MP:0000220,increased monocyte cell number|MP:0005292,improved glucose tolerance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012362,increased large unstained cell number
MGI:3053964	Ahnak<tm1Tak>	MP:0002169,no abnormal phenotype detected
MGI:3040870	Ahnak<tm1Vtm>	MP:0001828,abnormal T cell activation|MP:0005027,increased susceptibility to parasitic infection|MP:0005095,decreased T cell proliferation|MP:0005465,abnormal T-helper 1 physiology|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion
MGI:4868713	Ahnak<tm1Ysb>	MP:0001262,decreased body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0010025,decreased total body fat amount
MGI:2667308	Ahr<b-1>	MP:0001790,abnormal immune system physiology|MP:0001846,increased inflammatory response|MP:0005376,homeostasis/metabolism phenotype|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:2667355	Ahr<b-2>	MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:2667538	Ahr<b-3>	MP:0005376,homeostasis/metabolism phenotype
MGI:2667196	Ahr<d>	MP:0004499,increased incidence of tumors by chemical induction|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:5443922	Ahrr<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001325,abnormal retina morphology|MP:0004738,abnormal auditory brainstem response|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:3772082	Ahrr<tm1Yfk>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:5571477	Ahr<tm1.2Arte>	MP:0001154,seminiferous tubule degeneration|MP:0002662,abnormal cauda epididymis morphology|MP:0004852,decreased testis weight|MP:0004929,decreased epididymis weight|MP:0005578,teratozoospermia|MP:0008280,abnormal male germ cell apoptosis|MP:0009230,abnormal sperm head morphology|MP:0009238,coiled sperm flagellum|MP:0009647,decreased fertilization frequency|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014684,impaired spermiation|MP:0020550,multinucleated giant male germ cells
MGI:3776466	Ahr<tm1(AHR)Mym>	MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:1857427	Ahr<tm1Bra>	MP:0000240,extramedullary hematopoiesis|MP:0000530,abnormal kidney vasculature morphology|MP:0000601,small liver|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0000662,abnormal branching of the mammary ductal tree|MP:0000691,enlarged spleen|MP:0001127,small ovary|MP:0001130,abnormal ovarian folliculogenesis|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001861,lung inflammation|MP:0001928,abnormal ovulation|MP:0002209,decreased germ cell number|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002680,decreased corpora lutea number|MP:0003009,abnormal cytokine secretion|MP:0003402,decreased liver weight|MP:0003453,abnormal keratinocyte physiology|MP:0003507,abnormal ovary physiology|MP:0003828,pulmonary edema|MP:0004004,patent ductus venosus|MP:0004856,decreased ovary weight|MP:0004910,decreased seminal vesicle weight|MP:0005141,liver hyperplasia|MP:0005362,abnormal Langerhans cell physiology|MP:0005418,abnormal circulating hormone level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008117,abnormal Langerhans cell morphology|MP:0008484,decreased spleen germinal center size|MP:0008713,abnormal cytokine level|MP:0008721,abnormal chemokine level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008989,abnormal liver sinusoid morphology|MP:0010894,pulmonary alveolar edema|MP:0011120,increased primordial ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0012538,persistent hyaloid artery|MP:0014600,increased susceptibility to hyperoxia-induced injury|MP:0031116,microvesicular hepatic steatosis|MP:0031346,abnormal eye vasculature morphology|MP:0031359,decreased prostate gland anterior lobe weight|MP:0031366,decreased prostate gland dorsolateral lobe weight|MP:0031381,decreased secondary ovarian follicle number|MP:0031420,decreased superovulation rate
MGI:2151800	Ahr<tm1Gonz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000367,abnormal coat/ hair morphology|MP:0000376,folliculitis|MP:0000377,abnormal hair follicle morphology|MP:0000405,abnormal auchene hair morphology|MP:0000414,alopecia|MP:0000493,rectal prolapse|MP:0000495,abnormal colon morphology|MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0001120,abnormal uterus morphology|MP:0001191,abnormal skin condition|MP:0001192,scaly skin|MP:0001200,thick skin|MP:0001209,spontaneous skin ulceration|MP:0001212,skin lesions|MP:0001216,abnormal epidermal layer morphology|MP:0001263,weight loss|MP:0001614,abnormal blood vessel morphology|MP:0001665,chronic diarrhea|MP:0001732,postnatal growth retardation|MP:0001846,increased inflammatory response|MP:0001853,heart inflammation|MP:0001855,abnormal atrial thrombosis|MP:0001874,acanthosis|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002356,abnormal spleen red pulp morphology|MP:0002816,colitis|MP:0002833,increased heart weight|MP:0002975,vascular smooth muscle hypertrophy|MP:0003141,cardiac fibrosis|MP:0003254,bile duct inflammation|MP:0003299,gastric polyps|MP:0003324,increased liver adenoma incidence|MP:0003333,liver fibrosis|MP:0003402,decreased liver weight|MP:0003809,abnormal hair shaft morphology|MP:0004111,abnormal coronary artery morphology|MP:0005048,abnormal thrombosis|MP:0005389,reproductive system phenotype|MP:0008479,decreased spleen white pulp amount|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009600,hypergranulosis|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0010264,increased hepatoma incidence|MP:0010785,abnormal stomach pyloric region morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0030571,dilated piliary canal
MGI:2657000	Ahr<tm1Yfk>	MP:0000538,abnormal urinary bladder morphology|MP:0000540,abnormal urinary bladder urothelium morphology|MP:0001328,disorganized retina layers|MP:0001732,postnatal growth retardation|MP:0003631,nervous system phenotype|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0009550,increased urinary bladder carcinoma incidence|MP:0009646,urinary bladder inflammation|MP:0009810,increased urine uric acid level|MP:0011042,abnormal horizontal vestibuloocular reflex|MP:0011625,cystolithiasis|MP:0011769,urinary bladder fibrosis|MP:0011773,abnormal urinary bladder vasculature morphology|MP:0014645,decreased optokinetic reflex
MGI:2663776	Ahr<tm2Bra>	MP:0002833,increased heart weight|MP:0003402,decreased liver weight|MP:0004004,patent ductus venosus|MP:0004952,increased spleen weight|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3612477	Ahr<tm3.1Bra>	MP:0001326,retina degeneration|MP:0003634,abnormal glial cell morphology|MP:0004004,patent ductus venosus|MP:0004021,abnormal rod electrophysiology|MP:0004980,increased neuronal precursor cell number|MP:0005385,cardiovascular system phenotype|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0008450,retina photoreceptor degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0008587,short photoreceptor outer segment|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0030005,increased retina apoptosis
MGI:3521676	Ahr<tm3Bra>	MP:0004004,patent ductus venosus|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3821486	Ahr<tm4.1Bra>	MP:0000274,enlarged heart|MP:0000601,small liver|MP:0000691,enlarged spleen|MP:0004004,patent ductus venosus|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0031116,microvesicular hepatic steatosis
MGI:5804023	Ahsa1<em1(IMPC)J>	MP:0008259,abnormal optic disk morphology
MGI:5548571	Ahsa2<tm1b(EUCOMM)Wtsi>	MP:0001312,abnormal cornea morphology|MP:0011965,decreased total retina thickness
MGI:5548370	Ahsg<tm1.1(KOMP)Vlcg>	MP:0000062,increased bone mineral density|MP:0001314,cornea opacity|MP:0002764,short tibia|MP:0004222,iris synechia|MP:0004738,abnormal auditory brainstem response
MGI:2180147	Ahsg<tm1Mbl>	MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003199,calcified muscle|MP:0005292,improved glucose tolerance|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009642,abnormal blood homeostasis|MP:0010182,decreased susceptibility to weight gain
MGI:3769235	Ahsp<tm1.1Mjwe>	MP:0000208,decreased hematocrit|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001588,abnormal hemoglobin|MP:0002123,abnormal definitive hematopoiesis|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0003135,increased erythroid progenitor cell number|MP:0003674,oxidative stress|MP:0005097,polychromatophilia|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005563,abnormal hemoglobin content|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0008850,increased hemoglobin concentration distribution width|MP:0010067,increased red blood cell distribution width|MP:0010175,leptocytosis|MP:0010177,acanthocytosis|MP:0011171,increased number of Heinz bodies
MGI:2449154	Ahsp<tm1Mjwe>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001588,abnormal hemoglobin|MP:0002123,abnormal definitive hematopoiesis|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002642,anisocytosis|MP:0003135,increased erythroid progenitor cell number|MP:0003674,oxidative stress|MP:0005097,polychromatophilia|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005563,abnormal hemoglobin content|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0008850,increased hemoglobin concentration distribution width|MP:0010175,leptocytosis|MP:0010177,acanthocytosis|MP:0011171,increased number of Heinz bodies
MGI:1855945	A<hvy>	MP:0002075,abnormal coat/hair pigmentation
MGI:5609357	AI467606<tm2b(EUCOMM)Wtsi>	MP:0005553,increased circulating creatinine level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3620160	Aia1<NZB/Omr>	MP:0004827,increased susceptibility to autoimmune hemolytic anemia
MGI:1856403	A<iapy>	MP:0000372,irregular coat pigmentation|MP:0000421,mottled coat|MP:0001261,obese|MP:0002075,abnormal coat/hair pigmentation|MP:0003136,yellow coat color|MP:0003718,maternal effect|MP:0010768,mortality/aging
MGI:3045756	Aibl<C57BL/10SnJ>	MP:0001257,increased body length
MGI:7511620	Aicda<em1Jaych>	MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002494,increased IgM level|MP:0004816,abnormal class switch recombination|MP:0005397,hematopoietic system phenotype|MP:0008826,abnormal splenic cell ratio|MP:0008828,abnormal lymph node cell ratio
MGI:6199978	Aicda<m1Btlr>	MP:0001800,abnormal humoral immune response|MP:0002492,decreased IgE level|MP:0002494,increased IgM level
MGI:6199982	Aicda<m2Btlr>	MP:0001800,abnormal humoral immune response|MP:0002492,decreased IgE level|MP:0002494,increased IgM level
MGI:4437052	Aicda<tm1.1(cre/ERT2)Crey>	MP:0002169,no abnormal phenotype detected
MGI:5566773	Aicda<tm1.1Fwa>	MP:0004815,abnormal somatic hypermutation frequency|MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype
MGI:5636974	Aicda<tm1b(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008174,decreased follicular B cell number|MP:0008177,increased germinal center B cell number|MP:0013684,increased early germinal center B cell number|MP:0013685,decreased late germinal center B cell number
MGI:2156156	Aicda<tm1Hon>	MP:0001805,decreased IgG level|MP:0001807,decreased IgA level|MP:0002494,increased IgM level|MP:0004815,abnormal somatic hypermutation frequency|MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype|MP:0008177,increased germinal center B cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:4942397	Aicda<tm2.1Hon>	MP:0002412,increased susceptibility to bacterial infection|MP:0004815,abnormal somatic hypermutation frequency|MP:0005387,immune system phenotype|MP:0008177,increased germinal center B cell number|MP:0008495,decreased IgG1 level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010377,abnormal gut flora balance
MGI:3796170	Aicda<tm2Mnz>	MP:0005387,immune system phenotype|MP:0008866,chromosomal instability
MGI:3839329	Aicda<tm3.1Mnz>	MP:0004815,abnormal somatic hypermutation frequency|MP:0004816,abnormal class switch recombination
MGI:3818466	Aicda<tm3Mnz>	MP:0004815,abnormal somatic hypermutation frequency|MP:0004816,abnormal class switch recombination
MGI:3839323	Aicda<tm4.1Mnz>	MP:0004815,abnormal somatic hypermutation frequency|MP:0004816,abnormal class switch recombination
MGI:3818467	Aicda<tm4Mnz>	MP:0004815,abnormal somatic hypermutation frequency|MP:0004816,abnormal class switch recombination
MGI:6401842	Aida<tm1.1Scli>	MP:0000008,increased white adipose tissue amount|MP:0000479,abnormal enterocyte morphology|MP:0001261,obese|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0002981,increased liver weight|MP:0005317,increased triglyceride level|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0008882,abnormal enterocyte physiology|MP:0009118,increased white fat cell size|MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0010378,increased respiratory quotient|MP:0010400,increased liver glycogen level|MP:0031269,increased susceptibility to diet-induced hepatic steatosis
MGI:5548618	Aif1l<tm1b(EUCOMM)Wtsi>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000706,small thymus|MP:0002060,abnormal skin morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004952,increased spleen weight
MGI:5613637	Aif1<tm1.1(KOMP)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0002699,abnormal vitreous body morphology|MP:0003961,decreased lean body mass|MP:0005566,decreased blood urea nitrogen level|MP:0008259,abnormal optic disk morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:3526421	Aif1<tm1Nsib>	MP:0003179,thrombocytopenia|MP:0003436,decreased susceptibility to induced arthritis|MP:0004953,decreased spleen weight
MGI:1861097	Aifm1<Hq>	MP:0000343,abnormal response to cardiac infarction|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000418,focal hair loss|MP:0000745,tremors|MP:0000852,small cerebellum|MP:0000876,Purkinje cell degeneration|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000950,abnormal seizure response to pharmacological agent|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001333,absent optic nerve|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002127,abnormal cardiovascular system morphology|MP:0002753,dilated heart left ventricle|MP:0003037,increased myocardial infarct size|MP:0003077,abnormal cell cycle|MP:0003222,increased cardiomyocyte apoptosis|MP:0003631,nervous system phenotype|MP:0003674,oxidative stress|MP:0004097,abnormal cerebellar cortex morphology|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005386,behavior/neurological phenotype|MP:0005551,abnormal eye electrophysiology|MP:0008067,retina ganglion cell degeneration|MP:0008103,amacrine cell degeneration|MP:0008236,decreased susceptibility to neuronal excitotoxicity|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0008513,thin retina inner plexiform layer|MP:0008519,thin retina outer plexiform layer|MP:0009674,decreased birth weight|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010955,abnormal respiratory electron transport chain|MP:0011593,increased catalase activity|MP:0012660,increased superoxide dismutase level|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:2159372	Aifm1<tm1Pngr>	MP:0005621,abnormal cell physiology
MGI:3851178	Aifm1<tm2.1Pngr>	MP:0000774,decreased brain size|MP:0001698,decreased embryo size|MP:0010955,abnormal respiratory electron transport chain|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011732,decreased somite size|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3686777	Aifm1<tm2Pngr>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000749,muscle degeneration|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001625,cardiac hypertrophy|MP:0002078,abnormal glucose homeostasis|MP:0002269,muscular atrophy|MP:0002795,dilated cardiomyopathy|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003203,increased neuron apoptosis|MP:0003204,decreased neuron apoptosis|MP:0003674,oxidative stress|MP:0003953,abnormal hormone level|MP:0003984,embryonic growth retardation|MP:0004564,increased myocardial fiber size|MP:0004819,decreased skeletal muscle mass|MP:0005140,decreased cardiac muscle contractility|MP:0005202,lethargy|MP:0005319,abnormal enzyme/coenzyme level|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006039,decreased mitochondrial fission|MP:0006254,thin cerebral cortex|MP:0008775,abnormal heart ventricle pressure|MP:0009401,increased skeletal muscle fiber diameter|MP:0010955,abnormal respiratory electron transport chain|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0010957,abnormal aerobic respiration|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011594,decreased catalase activity|MP:0011628,increased mitochondrial number|MP:0011635,abnormal mitochondrial crista morphology|MP:0013405,increased circulating lactate level|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:5428887	Aifm2<tm1Avm>	MP:0005389,reproductive system phenotype
MGI:3619528	Aifm2<tm1Hbsh>	MP:0000350,abnormal cell proliferation|MP:0002006,neoplasm
MGI:6156121	Aifm3<em1(IMPC)Rbrc>	MP:0000181,abnormal circulating LDL cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005343,increased circulating aspartate transaminase level|MP:0013279,increased fasting circulating glucose level
MGI:7660785	Aifm3<em1Jgg>	MP:0003631,nervous system phenotype
MGI:7660786	Aifm3<em2Jgg>	MP:0003631,nervous system phenotype
MGI:6488486	Aig1<em1Sagh>	MP:0005376,homeostasis/metabolism phenotype|MP:0013245,abnormal lipid metabolism
MGI:6341916	Aim2<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002965,increased circulating serum albumin level|MP:0005084,abnormal gallbladder morphology|MP:0005568,increased circulating total protein level|MP:0009342,enlarged gallbladder
MGI:3877800	Aim2<Gt(CSG445)Byg>	MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0005387,immune system phenotype|MP:0008045,decreased NK cell number|MP:0008555,abnormal interferon secretion|MP:0008564,increased interferon-beta secretion|MP:0008636,decreased circulating interleukin-18 level|MP:0008658,decreased interleukin-1 beta secretion|MP:0008685,decreased interleukin-18 secretion|MP:0011081,decreased macrophage apoptosis|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020928,increased susceptibility to Poxviridae infection
MGI:5428935	Aim2<tm1.1Vmd>	MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0003009,abnormal cytokine secretion|MP:0008560,increased tumor necrosis factor secretion|MP:0008564,increased interferon-beta secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008685,decreased interleukin-18 secretion
MGI:5441076	Aim2<tm1Ktak>	MP:0002412,increased susceptibility to bacterial infection|MP:0008567,decreased interferon-gamma secretion|MP:0008636,decreased circulating interleukin-18 level|MP:0008658,decreased interleukin-1 beta secretion|MP:0008685,decreased interleukin-18 secretion|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:6156422	Aimp1<em1(IMPC)Tcp>	MP:0000691,enlarged spleen|MP:0001697,abnormal embryo size|MP:0001925,male infertility|MP:0003642,absent seminal vesicle|MP:0009709,hydrometra|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3531206	Aimp1<Gt(OST58507)Lex>	MP:0001876,decreased inflammatory response|MP:0002908,delayed wound healing
MGI:3497919	Aimp2<Gt(OST7994)Lex>	MP:0002082,postnatal lethality
MGI:4128743	Aip<Gt(RRI002)Byg>	MP:0002041,increased pituitary adenoma incidence|MP:0003505,increased prolactinoma incidence|MP:0009078,adrenal gland hyperplasia|MP:0011091,prenatal lethality, complete penetrance
MGI:3524971	Aipl1<tm1Mad>	MP:0001006,abnormal retina cone cell morphology|MP:0001327,decreased retina photoreceptor cell number|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0005547,abnormal Muller cell morphology|MP:0006069,abnormal retina neuronal layer morphology|MP:0006073,abnormal retina bipolar cell morphology|MP:0008446,decreased retina cone cell number|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008515,thin retina outer nuclear layer
MGI:3054784	Aipl1<tm1Tili>	MP:0005551,abnormal eye electrophysiology|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:3054793	Aipl1<tm1Visu>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001326,retina degeneration|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0005551,abnormal eye electrophysiology
MGI:5810589	Aipl1<tvrm119>	MP:0008450,retina photoreceptor degeneration|MP:0010748,abnormal visual evoked potential|MP:0012029,abnormal electroretinogram waveform feature
MGI:5810590	Aipl1<tvrm127>	MP:0008450,retina photoreceptor degeneration|MP:0010748,abnormal visual evoked potential|MP:0010749,absent visual evoked potential
MGI:3819941	Aip<tm1Bra>	MP:0000284,double outlet right ventricle|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0003052,omphalocele|MP:0003229,abnormal vitelline vasculature morphology|MP:0003402,decreased liver weight|MP:0003717,pallor|MP:0004004,patent ductus venosus|MP:0008816,petechiae|MP:0010128,hypovolemia|MP:0010402,ventricular septal defect|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:4867827	Aip<tm2Bra>	MP:0003402,decreased liver weight|MP:0004004,patent ductus venosus
MGI:5296650	Aire<tm1.1(cre)Ghr>	MP:0004974,decreased regulatory T cell number|MP:0008126,increased dendritic cell number|MP:0008127,decreased dendritic cell number
MGI:2661910	Aire<tm1.1Doi>	MP:0001313,increased incidence of corneal inflammation|MP:0001326,retina degeneration|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001868,ovary inflammation|MP:0001869,pancreas inflammation|MP:0001870,salivary gland inflammation|MP:0001873,stomach inflammation|MP:0002083,premature death|MP:0002375,abnormal thymus medulla morphology|MP:0003341,chronic pancreas inflammation|MP:0003504,thyroid gland inflammation|MP:0003608,prostate gland inflammation|MP:0003725,increased autoantibody level|MP:0004031,insulitis|MP:0005015,increased T cell number|MP:0005150,cachexia|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005381,digestive/alimentary phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005515,uveitis|MP:0008880,lacrimal gland inflammation
MGI:5766149	Aire<tm1.1(NCOM)Mfgc>	MP:0000220,increased monocyte cell number|MP:0001325,abnormal retina morphology|MP:0002092,abnormal eye morphology|MP:0005278,abnormal cholesterol homeostasis|MP:0009142,decreased prepulse inhibition
MGI:3793464	Aire<tm1Mand>	MP:0000753,paralysis|MP:0000755,hindlimb paralysis|MP:0000921,demyelination|MP:0001513,limb grasping|MP:0001846,increased inflammatory response|MP:0001851,eye inflammation|MP:0001870,salivary gland inflammation|MP:0002651,abnormal sciatic nerve morphology|MP:0003341,chronic pancreas inflammation|MP:0003504,thyroid gland inflammation|MP:0003632,abnormal nervous system morphology|MP:0003725,increased autoantibody level|MP:0004031,insulitis|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0006082,CNS inflammation|MP:0008721,abnormal chemokine level|MP:0008880,lacrimal gland inflammation|MP:0031226,increased CXCL10 level
MGI:3573749	Aire<tm1Mmat>	MP:0001844,autoimmune response|MP:0001869,pancreas inflammation|MP:0001870,salivary gland inflammation|MP:0001873,stomach inflammation|MP:0001921,reduced fertility|MP:0003725,increased autoantibody level|MP:0005379,endocrine/exocrine gland phenotype|MP:0008879,submandibular gland inflammation|MP:0008880,lacrimal gland inflammation|MP:0010792,abnormal stomach mucosa morphology|MP:0013367,parotid gland inflammation|MP:0020220,decreased tear production
MGI:2182940	Aire<tm1Pltn>	MP:0000220,increased monocyte cell number|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001601,abnormal myelopoiesis|MP:0001860,liver inflammation|MP:0001921,reduced fertility|MP:0001924,infertility|MP:0002023,increased B cell derived lymphoma incidence|MP:0002123,abnormal definitive hematopoiesis|MP:0002362,abnormal spleen marginal zone morphology|MP:0003644,thymus atrophy|MP:0003725,increased autoantibody level|MP:0004952,increased spleen weight|MP:0005014,increased B cell number|MP:0005313,absent adrenal gland|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0008037,abnormal T cell morphology|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008241,abnormal metallophilic macrophage morphology
MGI:3722595	Aire<tm1Ptsn>	MP:0001828,abnormal T cell activation|MP:0001873,stomach inflammation|MP:0001922,reduced male fertility|MP:0002375,abnormal thymus medulla morphology|MP:0002420,abnormal adaptive immunity|MP:0003725,increased autoantibody level|MP:0004946,abnormal regulatory T cell physiology|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005398,decreased susceptibility to fungal infection|MP:0005399,increased susceptibility to fungal infection|MP:0005465,abnormal T-helper 1 physiology|MP:0005515,uveitis|MP:0006201,vitreous body inflammation|MP:0008560,increased tumor necrosis factor secretion|MP:0008663,increased interleukin-12 secretion|MP:0008690,increased interleukin-23 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008713,abnormal cytokine level|MP:0010222,abnormal T-helper 17 cell physiology|MP:0013367,parotid gland inflammation|MP:0013533,sublingual gland inflammation
MGI:3818933	Aire<tm2Mmat>	MP:0000703,abnormal thymus morphology|MP:0001844,autoimmune response|MP:0003763,abnormal thymus physiology|MP:0009540,absent Hassall's corpuscle
MGI:4454265	Aire<tm3(cre)Mmat>	MP:0002169,no abnormal phenotype detected
MGI:2677157	Airn<tm1Dpb>	MP:0001262,decreased body weight|MP:0002089,abnormal postnatal growth/weight/body size|MP:0003122,maternal imprinting
MGI:5426385	Airn<tm2.1Dpb>	MP:0001923,reduced female fertility|MP:0003718,maternal effect|MP:0005389,reproductive system phenotype|MP:0008877,abnormal DNA methylation
MGI:1855933	A<iy>	MP:0000421,mottled coat|MP:0001261,obese|MP:0002075,abnormal coat/hair pigmentation|MP:0003136,yellow coat color
MGI:5502312	Ajap1<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0002941,increased circulating alanine transaminase level|MP:0003019,increased circulating chloride level|MP:0003631,nervous system phenotype|MP:0003795,abnormal bone structure|MP:0004924,abnormal behavior|MP:0005343,increased circulating aspartate transaminase level|MP:0005568,increased circulating total protein level|MP:0005627,increased circulating potassium level|MP:0005633,increased circulating sodium level|MP:0010124,decreased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:1856429	a<jl10>	MP:0002080,prenatal lethality
MGI:1856430	a<jl41>	MP:0002080,prenatal lethality
MGI:1856431	a<jl85>	MP:0002080,prenatal lethality
MGI:6257429	Ajuba<em1(IMPC)H>	MP:0000219,increased neutrophil cell number|MP:0000572,abnormal autopod morphology|MP:0002110,abnormal digit morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0004952,increased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0010052,increased grip strength|MP:0020421,increased freezing behavior
MGI:7425350	Ajuba<em1Strka>	MP:0011092,embryonic lethality, complete penetrance
MGI:3578221	Ajuba<tm1Gdl>	MP:0003091,abnormal cell migration
MGI:2389509	Ak1<tm1Bew>	MP:0000343,abnormal response to cardiac infarction|MP:0002078,abnormal glucose homeostasis|MP:0002106,abnormal muscle physiology|MP:0003806,abnormal nucleotide metabolism|MP:0005450,abnormal energy expenditure|MP:0010958,abnormal tricarboxylic acid cycle
MGI:6711698	Ak2<em1.1Dze>	MP:0005266,abnormal metabolism|MP:0008022,dilated heart ventricle|MP:0011925,abnormal heart echocardiography feature|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3529816	Ak2<Gt(OST495245)Lex>	MP:0006035,abnormal mitochondrial morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011636,disorganized mitochondrial cristae
MGI:6284316	Ak3<em1(IMPC)J>	MP:0010053,decreased grip strength
MGI:6336109	Ak4<em1(IMPC)Kmpc>	MP:0000182,increased circulating LDL cholesterol level|MP:0000367,abnormal coat/ hair morphology|MP:0001399,hyperactivity|MP:0002059,abnormal seminal vesicle morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002581,abnormal ileum morphology|MP:0003271,abnormal duodenum morphology|MP:0005178,increased circulating cholesterol level|MP:0005333,decreased heart rate|MP:0010123,increased bone mineral content|MP:0010124,decreased bone mineral content|MP:0010506,prolonged RR interval
MGI:7858964	Ak6<tm1.1Zhexf>	MP:0000609,abnormal liver physiology|MP:0002136,abnormal kidney physiology|MP:0011091,prenatal lethality, complete penetrance|MP:0013272,abnormal translation|MP:0014242,abnormal ribosome biogenesis
MGI:6367967	Ak7<em1(IMPC)Ccpcz>	MP:0000160,kyphosis|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002060,abnormal skin morphology|MP:0004174,abnormal spine curvature|MP:0005628,decreased circulating potassium level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4315923	Ak7<Gt(OST434404)Lex>	MP:0001155,arrest of spermatogenesis|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002083,premature death|MP:0002687,oligozoospermia|MP:0005378,growth/size/body region phenotype|MP:0010752,impaired mucociliary clearance|MP:0011495,abnormal head shape|MP:0030118,rhinosinusitis
MGI:5431002	Ak7<Tg(tetO-Hmox1)67Sami>	MP:0000849,abnormal cerebellum morphology|MP:0001732,postnatal growth retardation|MP:0001867,rhinitis|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002083,premature death|MP:0002405,respiratory system inflammation|MP:0005159,azoospermia|MP:0005367,renal/urinary system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0006254,thin cerebral cortex|MP:0008535,enlarged lateral ventricles|MP:0009230,abnormal sperm head morphology|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011055,abnormal respiratory motile cilium physiology
MGI:5429197	Ak8<Gt(OST16378)Lex>	MP:0000825,dilated lateral ventricle|MP:0001891,hydrocephaly|MP:0005378,growth/size/body region phenotype|MP:0005382,craniofacial phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0008283,small hippocampus
MGI:7540710	Ak9<em1Lnl>	MP:0001925,male infertility|MP:0002675,asthenozoospermia
MGI:7607935	Ak9<em1Mdj>	MP:0001525,impaired balance|MP:0001924,infertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002674,abnormal sperm motility|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0011056,abnormal brain ependyma motile cilium morphology|MP:0011069,abnormal brain ependyma motile cilium physiology|MP:0011380,enlarged brain ventricles|MP:0030964,decreased brain ependyma motile cilium length
MGI:3712925	Akap10<Gt(RRC139)Byg>	MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0003928,increased heart rate variability|MP:0004070,abnormal P wave|MP:0004122,abnormal sinus arrhythmia|MP:0004184,abnormal baroreceptor physiology|MP:0005333,decreased heart rate|MP:0006142,abnormal sinoatrial node conduction|MP:0010519,atrioventricular block|MP:0010768,mortality/aging
MGI:5574598	Akap10<tm1.1(KOMP)Vlcg>	MP:0002608,increased hematocrit|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5751858	Akap11<tm1.2Jsco>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002764,short tibia|MP:0002797,increased thigmotaxis|MP:0004754,abnormal kidney collecting duct morphology|MP:0008055,increased urine osmolality|MP:0020211,slow movement
MGI:5503137	Akap11<tm1b(EUCOMM)Hmgu>	MP:0000221,decreased leukocyte cell number
MGI:2388095	Akap12<Gt(ble-lacZ)15Brr>	MP:0002169,no abnormal phenotype detected
MGI:4126493	Akap12<Gt(XE450)Byg>	MP:0000278,abnormal myocardial fiber morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0006113,abnormal heart septum morphology|MP:0011951,increased cardiac stroke volume|MP:0031635,increased heart left ventricle muscle contractility
MGI:5286076	Akap12<tm1Ihg>	MP:0000274,enlarged heart|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0001158,abnormal prostate gland morphology|MP:0001175,abnormal lung morphology|MP:0001513,limb grasping|MP:0001860,liver inflammation|MP:0001924,infertility|MP:0002083,premature death|MP:0002683,delayed fertility|MP:0003607,abnormal prostate gland physiology|MP:0004961,increased prostate gland weight|MP:0005305,prostate gland anterior lobe hyperplasia|MP:0005386,behavior/neurological phenotype|MP:0008476,increased spleen red pulp amount|MP:0008975,delayed male fertility|MP:0008976,delayed female fertility|MP:0031365,prostate gland ventral lobe hyperplasia
MGI:6430644	Akap13<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000702,enlarged lymph nodes|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0002699,abnormal vitreous body morphology|MP:0005292,improved glucose tolerance
MGI:4345910	Akap13<Gt(AG0213)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:3880720	Akap13<Gt(CSJ288)Byg>	MP:0002169,no abnormal phenotype detected
MGI:3880669	Akap13<Gt(CSJ306)Byg>	MP:0004484,abnormal response of heart to induced stress|MP:0005608,cardiac interstitial fibrosis|MP:0010768,mortality/aging|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5308769	Akap13<tm1Segj>	MP:0000267,abnormal heart development|MP:0000274,enlarged heart|MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0001921,reduced fertility|MP:0002652,thin myocardium|MP:0003945,abnormal lymphocyte physiology|MP:0003984,embryonic growth retardation|MP:0004090,abnormal sarcomere morphology|MP:0004953,decreased spleen weight|MP:0005017,decreased B cell number|MP:0005312,pericardial effusion|MP:0006341,small first pharyngeal arch|MP:0008495,decreased IgG1 level|MP:0009333,abnormal splenocyte physiology|MP:0009339,decreased splenocyte number|MP:0009922,increased transitional stage T1 B cell number|MP:0009926,decreased transitional stage T2 B cell number|MP:0010503,myocardial trabeculae hypoplasia|MP:0011091,prenatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012138,decreased forebrain size|MP:0012723,abnormal nuchal region morphology|MP:0014348,decreased spleen B cell follicle size
MGI:4129850	Akap17b<Gt(RRI131)Byg>	MP:0000432,abnormal head morphology|MP:0001698,decreased embryo size|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0005385,cardiovascular system phenotype|MP:0009657,failure of chorioallantoic fusion|MP:0009768,impaired somite development|MP:0011732,decreased somite size
MGI:3620561	Akap1<tm1Gsm>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0005168,abnormal female meiosis
MGI:6867043	Akap3<em1Hqi>	MP:0001925,male infertility|MP:0008892,abnormal sperm flagellum morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009282,decreased hyperactivated sperm motility|MP:0009836,abnormal sperm principal piece morphology
MGI:7707395	Akap4<em1Bbw>	MP:0001922,reduced male fertility|MP:0002687,oligozoospermia|MP:0009237,kinked sperm flagellum|MP:0009239,short sperm flagellum|MP:0009836,abnormal sperm principal piece morphology|MP:0020451,decreased sperm progressive motility|MP:0030590,abnormal sperm fibrous sheath morphology
MGI:6867044	Akap4<em1Hqi>	MP:0001925,male infertility|MP:0008892,abnormal sperm flagellum morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009282,decreased hyperactivated sperm motility|MP:0009836,abnormal sperm principal piece morphology
MGI:2684287	Akap4<tm1Eddy>	MP:0001925,male infertility|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009280,decreased activated sperm motility|MP:0009282,decreased hyperactivated sperm motility|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009836,abnormal sperm principal piece morphology|MP:0009837,abnormal sperm end piece morphology|MP:0014464,decreased sperm mitochondrial sheath size
MGI:3809938	Akap5<tm1.1Jsco>	MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001475,reduced long-term depression|MP:0002727,decreased circulating insulin level|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005292,improved glucose tolerance
MGI:3765995	Akap5<tm1Gsm>	MP:0001473,reduced long-term potentiation|MP:0002727,decreased circulating insulin level|MP:0005376,homeostasis/metabolism phenotype
MGI:3809936	Akap5<tm1Jsco>	MP:0002727,decreased circulating insulin level|MP:0003058,increased insulin secretion|MP:0005293,impaired glucose tolerance
MGI:5448682	Akap5<tm1Mdaq>	MP:0001475,reduced long-term depression|MP:0001899,absent long-term depression|MP:0002727,decreased circulating insulin level|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0002891,increased insulin sensitivity|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003008,enhanced long-term potentiation|MP:0003059,decreased insulin secretion|MP:0003631,nervous system phenotype|MP:0004859,abnormal synaptic plasticity|MP:0005292,improved glucose tolerance
MGI:5635498	Akap5<tm2Mdaq>	MP:0004859,abnormal synaptic plasticity
MGI:5588705	Akap6<tm1.1Mskf>	MP:0002169,no abnormal phenotype detected|MP:0002625,heart left ventricle hypertrophy|MP:0003222,increased cardiomyocyte apoptosis|MP:0003915,increased heart left ventricle weight|MP:0004564,increased myocardial fiber size|MP:0005333,decreased heart rate|MP:0005608,cardiac interstitial fibrosis|MP:0011915,increased heart left atrium weight|MP:0012688,abnormal heart ventricles weight|MP:0021157,increased heart left ventricle wall thickness
MGI:5603562	Akap6<tm1.2Mskf>	MP:0002058,neonatal lethality
MGI:3711141	Akap6<tm1Jsco>	MP:0000428,abnormal craniofacial morphology|MP:0001262,decreased body weight|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5451048	Akap7<tm1.1Gsm>	MP:0002169,no abnormal phenotype detected
MGI:5612823	Akap7<tm2b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level
MGI:3694775	Akap8<Gt(XG068)Byg>	MP:0002169,no abnormal phenotype detected
MGI:6231175	Akap8l<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0002941,increased circulating alanine transaminase level|MP:0003179,thrombocytopenia
MGI:3050560	Akap9<mei2-5>	MP:0001146,abnormal testis morphology|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0004109,abnormal Sertoli cell development|MP:0005159,azoospermia|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis
MGI:3512933	Akap9<repro12>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004910,decreased seminal vesicle weight
MGI:4362642	Akap9<tm1a(KOMP)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0000432,abnormal head morphology|MP:0001262,decreased body weight|MP:0002100,abnormal tooth morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004647,decreased lumbar vertebrae number|MP:0004889,increased energy expenditure|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005419,decreased circulating serum albumin level|MP:0005459,decreased percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0005567,decreased circulating total protein level|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008211,decreased mature B cell number|MP:0008963,increased carbon dioxide production|MP:0010025,decreased total body fat amount|MP:0010087,increased circulating fructosamine level|MP:0010088,decreased circulating fructosamine level|MP:0010831,lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5516002	Akap9<tm1b(KOMP)Wtsi>	MP:0001925,male infertility
MGI:7327293	Akip1<em1Cya>	MP:0002410,decreased susceptibility to viral infection|MP:0005607,decreased bleeding time|MP:0008734,decreased susceptibility to endotoxin shock|MP:0012355,decreased prothrombin time
MGI:3796164	Akirin1<tm1.1Aki>	MP:0002169,no abnormal phenotype detected
MGI:3796163	Akirin2<tm1.1Aki>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5788727	Akna<tm1Mak>	MP:0000219,increased neutrophil cell number|MP:0000746,weakness|MP:0001265,decreased body size|MP:0001861,lung inflammation|MP:0005088,increased acute inflammation|MP:0005399,increased susceptibility to fungal infection|MP:0010922,alveolitis|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5788924	Akna<tm2Mak>	MP:0005399,increased susceptibility to fungal infection|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2680530	Akp3<tm1Jlm>	MP:0001260,increased body weight|MP:0001547,abnormal lipid level|MP:0001552,increased circulating triglyceride level|MP:0005342,abnormal intestinal lipid absorption
MGI:4239556	Akr1a1<Gt(OST222400)Lex>	MP:0000061,fragile skeleton|MP:0000066,osteoporosis|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0001541,abnormal osteoclast physiology|MP:0001926,female infertility|MP:0002244,abnormal turbinate morphology|MP:0003311,aminoaciduria|MP:0004984,increased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0005006,abnormal osteoblast physiology|MP:0008395,abnormal osteoblast differentiation|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0011229,abnormal vitamin C level
MGI:5439954	Akr1a1<tm1Maka>	MP:0005584,abnormal enzyme/coenzyme activity|MP:0011229,abnormal vitamin C level
MGI:5008171	Akr1b1<tm1.1Kgab>	MP:0011229,abnormal vitamin C level
MGI:2183239	Akr1b1<tm1Skc>	MP:0001426,polydipsia|MP:0001762,polyuria|MP:0002986,decreased urine calcium level|MP:0002988,decreased urine osmolality|MP:0004860,dilated kidney collecting duct|MP:0005376,homeostasis/metabolism phenotype|MP:0005618,decreased urine potassium level|MP:0006317,decreased urine sodium level|MP:0010108,abnormal renal water reabsorption|MP:0011333,abnormal kidney inner medulla morphology|MP:0011460,decreased urine chloride ion level|MP:0011467,decreased urine urea nitrogen level|MP:0011471,decreased urine creatinine level
MGI:3689185	Akr1b1<tm1Tona>	MP:0000194,increased circulating calcium level|MP:0001263,weight loss|MP:0001762,polyuria|MP:0002988,decreased urine osmolality|MP:0005441,increased urine calcium level|MP:0010092,increased circulating magnesium level
MGI:5568561	Akr1b7<tm1.1Anm>	MP:0000008,increased white adipose tissue amount|MP:0001260,increased body weight|MP:0001552,increased circulating triglyceride level|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0003443,increased circulating glycerol level|MP:0004890,decreased energy expenditure|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0005670,abnormal white adipose tissue physiology|MP:0009118,increased white fat cell size|MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake|MP:0030969,increased circulating adiponectin level
MGI:3629297	Akr1b7<tm1.1Fth>	MP:0005185,decreased circulating progesterone level|MP:0005186,increased circulating progesterone level|MP:0005389,reproductive system phenotype
MGI:5523271	Akr1b8<tm1.1(KOMP)Vlcg>	MP:0001488,increased startle reflex|MP:0005560,decreased circulating glucose level|MP:0005568,increased circulating total protein level|MP:0010052,increased grip strength|MP:0013278,decreased fasting circulating glucose level
MGI:6690900	Akr1b8<tm1Dgen>	MP:0003674,oxidative stress|MP:0004499,increased incidence of tumors by chemical induction|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0008537,increased susceptibility to induced colitis|MP:0008750,abnormal interferon level|MP:0008751,abnormal interleukin level|MP:0010155,abnormal intestine physiology|MP:0020868,decreased lipogenesis|MP:0031319,impaired intestine regeneration
MGI:5692634	Akr1c12<tm1b(KOMP)Wtsi>	MP:0004738,abnormal auditory brainstem response
MGI:7310293	Akr1c14<tm1.1Penn>	MP:0001364,decreased anxiety-related response|MP:0001409,increased stereotypic behavior|MP:0002557,abnormal social/conspecific interaction behavior|MP:0003858,enhanced coordination|MP:0005386,behavior/neurological phenotype|MP:0009808,decreased oligodendrocyte number|MP:0010050,hypermyelination|MP:0010160,increased oligodendrocyte number|MP:0010540,long stride length|MP:0013438,dysmyelination|MP:0020351,decreased vocalization
MGI:3527218	Akr1c18<tm1Jni>	MP:0002293,long gestation period|MP:0005386,behavior/neurological phenotype|MP:0005397,hematopoietic system phenotype|MP:0012010,parturition failure
MGI:3774264	Akr1c18<tm1Mni>	MP:0001935,decreased litter size|MP:0002293,long gestation period|MP:0005186,increased circulating progesterone level|MP:0009006,prolonged estrous cycle|MP:0009011,prolonged diestrus
MGI:5907829	Akr1c19<em1(IMPC)J>	MP:0002169,no abnormal phenotype detected|MP:0003131,increased erythrocyte cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0020870,decreased thigmotaxis
MGI:7639885	Akr1c21<em1Wany>	MP:0001861,lung inflammation|MP:0003674,oxidative stress|MP:0005088,increased acute inflammation|MP:0014437,increased interleukin level
MGI:5550435	Akr1d1<tm1.1(KOMP)Vlcg>	MP:0001289,persistence of hyaloid vascular system|MP:0001399,hyperactivity|MP:0010052,increased grip strength|MP:0013278,decreased fasting circulating glucose level
MGI:5617786	Akr7a5<tm1b(EUCOMM)Hmgu>	MP:0001488,increased startle reflex|MP:0003795,abnormal bone structure|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3794786	Akt1<Gt1Pnt>	MP:0002169,no abnormal phenotype detected
MGI:5769980	Akt1s1<tm1.1Rrth>	MP:0003076,increased susceptibility to ischemic brain injury|MP:0006060,increased cerebral infarct size
MGI:6460342	Akt1<tm1.1Mjl>	MP:0000630,mammary gland hyperplasia|MP:0001222,epidermal hyperplasia|MP:0001614,abnormal blood vessel morphology|MP:0001884,mammary gland alveolar hyperplasia|MP:0003253,dilated bile duct|MP:0003266,biliary cyst|MP:0009503,abnormal mammary gland duct morphology|MP:0014057,abnormal mammary gland stroma morphology
MGI:2675202	Akt1<tm1Hem>	MP:0000382,underdeveloped hair follicles|MP:0000746,weakness|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001711,abnormal placenta morphology|MP:0001712,abnormal placenta development|MP:0001732,postnatal growth retardation|MP:0001935,decreased litter size|MP:0003231,abnormal placenta vasculature|MP:0003717,pallor|MP:0004126,thin hypodermis|MP:0004200,decreased fetal size|MP:0004256,abnormal maternal decidual layer morphology|MP:0004259,small placenta|MP:0004921,decreased placenta weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011521,decreased placental labyrinth size|MP:0012099,decreased spongiotrophoblast size|MP:0012109,decreased trophoblast glycogen cell number
MGI:2180150	Akt1<tm1Mbb>	MP:0000606,decreased hepatocyte number|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002152,abnormal brain morphology|MP:0003961,decreased lean body mass|MP:0004565,decreased myocardial fiber size|MP:0005289,increased oxygen consumption|MP:0005386,behavior/neurological phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008963,increased carbon dioxide production|MP:0008965,increased basal metabolism|MP:0009142,decreased prepulse inhibition|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6460299	Akt1<tm1Mjl>	MP:0000630,mammary gland hyperplasia|MP:0001614,abnormal blood vessel morphology|MP:0001884,mammary gland alveolar hyperplasia|MP:0003253,dilated bile duct|MP:0003266,biliary cyst|MP:0009503,abnormal mammary gland duct morphology|MP:0014057,abnormal mammary gland stroma morphology
MGI:2181580	Akt1<tm1Nhy>	MP:0000703,abnormal thymus morphology|MP:0001146,abnormal testis morphology|MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002083,premature death|MP:0002687,oligozoospermia|MP:0020550,multinucleated giant male germ cells
MGI:3794787	Akt1<tm1Pnt>	MP:0002169,no abnormal phenotype detected
MGI:5317890	Akt1<tm2.1Mbb>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001399,hyperactivity|MP:0002078,abnormal glucose homeostasis|MP:0002891,increased insulin sensitivity|MP:0003383,abnormal gluconeogenesis|MP:0003961,decreased lean body mass|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005459,decreased percent body fat/body weight|MP:0005478,decreased circulating thyroxine level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008963,increased carbon dioxide production|MP:0008965,increased basal metabolism|MP:0009356,decreased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0010379,decreased respiratory quotient|MP:0014171,increased fatty acid oxidation|MP:0030969,increased circulating adiponectin level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5603754	Akt1<tm2.2Mbb>	MP:0002169,no abnormal phenotype detected
MGI:5317852	Akt1<tm2Mbb>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype
MGI:2158456	Akt2<tm1.1Mbb>	MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005387,immune system phenotype|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009167,increased pancreatic islet number|MP:0009356,decreased liver triglyceride level|MP:0030017,decreased adipocyte glucose uptake|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:4889113	Akt2<tm1.2Mbb>	MP:0005378,growth/size/body region phenotype|MP:0009356,decreased liver triglyceride level
MGI:3690020	Akt2<tm1Hem>	MP:0001126,abnormal ovary morphology|MP:0001559,hyperglycemia|MP:0002016,ovary cyst|MP:0002079,increased circulating insulin level|MP:0002680,decreased corpora lutea number|MP:0002781,increased circulating testosterone level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0009371,increased theca cell number
MGI:2664498	Akt2<tm1Rsg>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002727,decreased circulating insulin level|MP:0003339,decreased pancreatic beta cell number|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005668,decreased circulating leptin level|MP:0009171,enlarged pancreatic islets|MP:0014146,decreased white adipose tissue mass|MP:0014169,decreased brown adipose tissue mass
MGI:4941186	Akt3<Nmf350>	MP:0000951,sporadic seizures|MP:0001650,abnormal seizure response to electrical stimulation|MP:0002176,increased brain weight|MP:0002194,maximal tonic hindlimb extension seizures|MP:0002196,absent corpus callosum|MP:0002762,ectopic cerebellar granule cells|MP:0002882,abnormal neuron morphology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003997,tonic-clonic seizures|MP:0005238,increased brain size|MP:0008282,enlarged hippocampus
MGI:3580101	Akt3<tm1Hem>	MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0000822,abnormal brain ventricle morphology|MP:0002175,decreased brain weight|MP:0008235,increased susceptibility to neuronal excitotoxicity
MGI:3574346	Akt3<tm1Mbb>	MP:0000774,decreased brain size|MP:0001650,abnormal seizure response to electrical stimulation|MP:0002194,maximal tonic hindlimb extension seizures|MP:0003997,tonic-clonic seizures|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0008414,abnormal spatial reference memory|MP:0012296,impaired discrimination learning|MP:0031391,increased locomotor activity
MGI:4435660	Aktip<tm1a(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000160,kyphosis|MP:0000266,abnormal heart morphology|MP:0000428,abnormal craniofacial morphology|MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0002006,neoplasm|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002188,small heart|MP:0002764,short tibia|MP:0003109,short femur|MP:0004652,small caudal vertebrae|MP:0005390,skeleton phenotype|MP:0005508,abnormal skeleton morphology|MP:0006394,abnormal vertebral epiphyseal plate morphology|MP:0006396,decreased long bone epiphyseal plate size|MP:0008409,increased cellular sensitivity to hydroxyurea induced cell death|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0010025,decreased total body fat amount|MP:0011704,decreased fibroblast proliferation|MP:0014040,increased cellular sensitivity to DNA damaging agent induced cell death
MGI:5513742	Aktip<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0005343,increased circulating aspartate transaminase level|MP:0010124,decreased bone mineral content
MGI:1855940	a<l>	MP:0002080,prenatal lethality
MGI:1856590	Al	MP:0000414,alopecia|MP:0000418,focal hair loss|MP:0001510,abnormal coat appearance|MP:0002074,abnormal hair texture
MGI:2670679	Alaa1<C3H/HeJ>	MP:0000414,alopecia
MGI:6156441	Alad<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000598,abnormal liver morphology|MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0001552,increased circulating triglyceride level|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002768,small adrenal glands|MP:0010053,decreased grip strength|MP:0010068,decreased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:2155721	Alan2<B10.O20/Dem>	MP:0001790,abnormal immune system physiology
MGI:6449017	Alas1<em1(IMPC)Mbp>	MP:0001126,abnormal ovary morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0004832,enlarged ovary|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:4440831	Alas1<tm1.1Mym>	MP:0003984,embryonic growth retardation|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:2180151	Alas2<tm1Mym>	MP:0001577,anemia|MP:0001770,abnormal iron level|MP:0003396,abnormal embryonic hematopoiesis|MP:0003717,pallor|MP:0004229,abnormal embryonic erythropoiesis|MP:0005152,pancytopenia|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5494601	Alb<em8Mvw>	MP:0005419,decreased circulating serum albumin level
MGI:5424985	Alb<Mhdabcl001>	MP:0000195,decreased circulating calcium level|MP:0002968,increased circulating alkaline phosphatase level
MGI:5424986	Alb<Mhdabcl002>	MP:0000195,decreased circulating calcium level|MP:0005419,decreased circulating serum albumin level|MP:0011584,increased alkaline phosphatase activity
MGI:3794628	Albq1<A/J>	MP:0002871,albuminuria
MGI:3762839	Albq5<DBA/2J>	MP:0002871,albuminuria
MGI:3762841	Albq6<DBA/2J>	MP:0002871,albuminuria
MGI:3762843	Albq7<DBA/2J>	MP:0002871,albuminuria
MGI:3052812	Alb<tm1(cre/ERT2)Mtz>	MP:0002169,no abnormal phenotype detected
MGI:3056579	Alcam<tm1Jawe>	MP:0000940,abnormal motor neuron innervation pattern|MP:0001325,abnormal retina morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0005241,abnormal retina ganglion layer morphology
MGI:3050680	Alcdp1<DBA/2J>	MP:0009775,increased behavioral withdrawal response
MGI:3050685	Alcdp2<DBA/2J>	MP:0009775,increased behavioral withdrawal response
MGI:2158135	Alcp19<A/J>	MP:0001425,abnormal alcohol consumption
MGI:2155189	Alcp1<C57BL/6J>	MP:0001425,abnormal alcohol consumption
MGI:2155190	Alcp1<DBA/2J>	MP:0001987,alcohol preference
MGI:2153878	Alcp25<C57BL/6Ibg>	MP:0001987,alcohol preference
MGI:2153877	Alcp25<DBA/2Ibg>	MP:0001987,alcohol preference
MGI:2154972	Alcp26<C57BL/6Ibg>	MP:0001987,alcohol preference
MGI:2154973	Alcp26<DBA/2Ibg>	MP:0001987,alcohol preference
MGI:3032990	Alcp2<C57BL/6J>	MP:0003545,increased alcohol consumption
MGI:2155374	Alcp3<C57BL/6J>	MP:0001987,alcohol preference
MGI:2155375	Alcp3<DBA/2J>	MP:0001987,alcohol preference
MGI:2153880	Alcp4<C57BL/6J>	MP:0001987,alcohol preference
MGI:2153881	Alcp4<DBA/2J>	MP:0001987,alcohol preference
MGI:2153883	Alcw1<C57BL/6J>	MP:0009755,impaired behavioral response to alcohol
MGI:2153882	Alcw1<DBA/2J>	MP:0009751,enhanced behavioral response to alcohol
MGI:2155929	Alcw2<C57BL/6J>	MP:0002272,abnormal nervous system electrophysiology|MP:0009755,impaired behavioral response to alcohol|MP:0009776,decreased behavioral withdrawal response
MGI:2155928	Alcw2<DBA/2J>	MP:0009775,increased behavioral withdrawal response
MGI:2159389	Alcw3<C57BL/6J>	MP:0009751,enhanced behavioral response to alcohol
MGI:2159390	Alcw3<DBA/2J>	MP:0009755,impaired behavioral response to alcohol
MGI:2159374	Alcw4<C57BL/6J>	MP:0009751,enhanced behavioral response to alcohol
MGI:2159375	Alcw4<DBA/2J>	MP:0009751,enhanced behavioral response to alcohol
MGI:3580125	Alcw9<DBA/1J>	MP:0005443,abnormal ethanol metabolism
MGI:4432547	Aldh16a1<tm1a(EUCOMM)Wtsi>	MP:0001325,abnormal retina morphology|MP:0001765,abnormal ion homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0003020,decreased circulating chloride level|MP:0005634,decreased circulating sodium level
MGI:4363671	Aldh18a1<tm1a(KOMP)Wtsi>	MP:0004947,skin inflammation|MP:0009932,skin fibrosis|MP:0011100,preweaning lethality, complete penetrance|MP:0011156,abnormal hypodermis fat layer morphology
MGI:3609477	Aldh1a1<tm1.1Ngb>	MP:0002169,no abnormal phenotype detected
MGI:2667220	Aldh1a1<tm1Gdu>	MP:0002139,abnormal hepatobiliary system physiology|MP:0005391,vision/eye phenotype
MGI:3609476	Aldh1a1<tm1Nbg>	MP:0002169,no abnormal phenotype detected
MGI:5004939	Aldh1a2<grim>	MP:0000259,abnormal vascular development|MP:0000270,abnormal heart tube morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001096,abnormal glossopharyngeal ganglion morphology|MP:0001100,abnormal vagus ganglion morphology|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001730,embryonic growth arrest|MP:0002884,abnormal pharyngeal arch morphology|MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0003861,abnormal nervous system development|MP:0003874,absent pharyngeal arches|MP:0004251,failure of heart looping|MP:0004310,small otic vesicle|MP:0006337,abnormal first pharyngeal arch morphology|MP:0006341,small first pharyngeal arch|MP:0009806,abnormal otic vesicle morphology|MP:0010642,absent third pharyngeal arch|MP:0010643,absent fourth pharyngeal arch|MP:0010939,abnormal mandibular prominence morphology|MP:0010940,abnormal maxillary prominence morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011233,abnormal vitamin A metabolism|MP:0011732,decreased somite size|MP:0012493,absent pharyngeal arch arteries|MP:0013165,absent forelimb buds|MP:0013166,small forelimb buds
MGI:2451316	Aldh1a2<tm1Dll>	MP:0001265,decreased body size|MP:0001575,cyanosis|MP:0002191,abnormal artery morphology|MP:0004161,cervical aortic arch|MP:0004550,short trachea|MP:0004551,decreased tracheal cartilage ring number|MP:0010454,abnormal truncus arteriosus septation|MP:0010464,abnormal aortic arch and aortic arch branch attachment|MP:0010465,aberrant origin of the right subclavian artery|MP:0010488,abnormal left subclavian artery morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012729,abnormal common carotid artery morphology
MGI:2180721	Aldh1a2<tm1Gdu>	MP:0000267,abnormal heart development|MP:0001258,decreased body length|MP:0001698,decreased embryo size|MP:0003446,renal hypoplasia|MP:0004251,failure of heart looping|MP:0004310,small otic vesicle|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0006345,absent second pharyngeal arch|MP:0010642,absent third pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011732,decreased somite size
MGI:1857891	Aldh1a2<tm1Ipc>	MP:0000267,abnormal heart development|MP:0000274,enlarged heart|MP:0000293,absent myocardial trabeculae|MP:0000298,absent atrioventricular cushions|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0002085,abnormal embryonic tissue morphology|MP:0002151,abnormal neural tube morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0004073,caudal body truncation|MP:0004251,failure of heart looping|MP:0004311,otic vesicle hypoplasia|MP:0005329,abnormal myocardium layer morphology|MP:0006107,abnormal fetal atrioventricular canal morphology|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0009073,absent Wolffian ducts|MP:0010656,thick myocardium|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011732,decreased somite size|MP:0012707,incomplete caudal neuropore closure|MP:0013168,absent hindlimb buds|MP:0013283,failure of ventral body wall closure|MP:0030249,small frontonasal prominence
MGI:3665178	Aldh1a2<tm1Soc>	MP:0011092,embryonic lethality, complete penetrance
MGI:3043947	Aldh1a3<tm1.1Pcn>	MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002237,abnormal nasal cavity morphology|MP:0004054,abnormal periocular mesenchyme morphology|MP:0008881,absent Harderian gland|MP:0008970,choanal atresia|MP:0008972,ethmoturbinate hypoplasia|MP:0010706,ventral rotation of lens|MP:0010707,decreased ventral retina size|MP:0010711,persistent hyperplastic primary vitreous|MP:0010712,absent nasolacrimal duct|MP:0011087,neonatal lethality, complete penetrance|MP:0030093,absent maxillary sinus|MP:0030181,persistent nasal fins|MP:0030326,decreased periocular mesenchyme apoptosis
MGI:5634954	Aldh1a3<tm1b(KOMP)Wtsi>	MP:0001297,microphthalmia|MP:0001399,hyperactivity|MP:0002968,increased circulating alkaline phosphatase level|MP:0011100,preweaning lethality, complete penetrance
MGI:3512079	Aldh1a3<tm1Gdu>	MP:0002699,abnormal vitreous body morphology|MP:0005367,renal/urinary system phenotype|MP:0010711,persistent hyperplastic primary vitreous|MP:0011087,neonatal lethality, complete penetrance|MP:0011964,increased total retina thickness
MGI:3043945	Aldh1a3<tm1Pcn>	MP:0002169,no abnormal phenotype detected
MGI:5792875	Aldh1b1<tm1.1(KOMP)Vlcg>	MP:0001559,hyperglycemia|MP:0002710,increased glucagon secretion|MP:0003058,increased insulin secretion|MP:0003059,decreased insulin secretion|MP:0003674,oxidative stress|MP:0003934,abnormal pancreas development|MP:0004231,abnormal calcium ion homeostasis|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0009113,increased pancreatic beta cell mass|MP:0009175,abnormal pancreatic beta cell differentiation|MP:0009176,increased pancreatic alpha cell number|MP:0009180,increased pancreatic delta cell number|MP:0011819,increased pancreatic beta cell proliferation|MP:0014117,increased pancreatic beta cell apoptosis|MP:0014121,increased pancreatic islet cell apoptosis
MGI:5779307	Aldh1b1<tm1Vvas>	MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0013279,increased fasting circulating glucose level
MGI:4840594	Aldh1b1<tm2a(EUCOMM)Wtsi>	MP:0010052,increased grip strength
MGI:4364886	Aldh1l1<tm1a(KOMP)Wtsi>	MP:0001764,abnormal homeostasis|MP:0011230,abnormal folic acid level|MP:0030659,decreased glycine level|MP:0030691,increased serine level
MGI:5548445	Aldh1l1<tm1b(KOMP)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:5784761	Aldh1l2<em1(IMPC)Kmpc>	MP:0008167,increased B-1a cell number|MP:0013890,increased CD8-positive, CD25-positive alpha-beta T cell number
MGI:4451568	Aldh1l2<tm2e(KOMP)Wtsi>	MP:0002628,hepatic steatosis|MP:0003631,nervous system phenotype|MP:0005266,abnormal metabolism|MP:0005319,abnormal enzyme/coenzyme level|MP:0005332,abnormal amino acid level|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0005621,abnormal cell physiology|MP:0010768,mortality/aging|MP:0011229,abnormal vitamin C level|MP:0011230,abnormal folic acid level|MP:0012604,decreased glutathione level|MP:0014174,decreased fatty acid beta-oxidation|MP:0030623,decreased cysteine level|MP:0030685,decreased cystathionine level
MGI:3530243	Aldh2<Gt(OST7285)Lex>	MP:0003546,decreased alcohol consumption|MP:0009751,enhanced behavioral response to alcohol
MGI:5701667	Aldh2<tm1.1Mak>	MP:0000221,decreased leukocyte cell number|MP:0001188,hyperpigmentation|MP:0001262,decreased body weight|MP:0003887,increased hepatocyte apoptosis|MP:0004499,increased incidence of tumors by chemical induction|MP:0005443,abnormal ethanol metabolism|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009751,enhanced behavioral response to alcohol|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010308,decreased tumor latency
MGI:4431566	Aldh2<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001486,abnormal startle reflex|MP:0001554,increased circulating free fatty acids level|MP:0001756,abnormal urination|MP:0001935,decreased litter size|MP:0002896,abnormal bone mineralization|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005018,decreased T cell number|MP:0005179,decreased circulating cholesterol level|MP:0005316,abnormal response to tactile stimuli|MP:0005567,decreased circulating total protein level|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:6515832	Aldh2<tm1Bcgen>	MP:0000807,abnormal hippocampus morphology|MP:0003461,abnormal response to novel object|MP:0008428,abnormal spatial working memory
MGI:5695134	Aldh2<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology
MGI:5608796	Aldh2<tm1Dmro>	MP:0001625,cardiac hypertrophy|MP:0001627,abnormal cardiac output|MP:0001629,abnormal heart rate|MP:0002736,abnormal nociception after inflammation|MP:0005140,decreased cardiac muscle contractility|MP:0005407,hyperalgesia|MP:0005418,abnormal circulating hormone level|MP:0005443,abnormal ethanol metabolism|MP:0006138,congestive heart failure|MP:0012106,impaired exercise endurance
MGI:2157245	Aldh2<tm1Kaw>	MP:0005584,abnormal enzyme/coenzyme activity|MP:0010954,abnormal cellular respiration
MGI:2180794	Aldh3a1<tm1Jpi>	MP:0002169,no abnormal phenotype detected
MGI:4432633	Aldh3a2<tm1a(EUCOMM)Wtsi>	MP:0002590,increased mean corpuscular volume|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004924,abnormal behavior|MP:0009142,decreased prepulse inhibition
MGI:5803882	Aldh3a2<tm1b(EUCOMM)Wtsi>	MP:0001231,abnormal epidermis stratum basale morphology|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0003453,abnormal keratinocyte physiology|MP:0003674,oxidative stress|MP:0004777,abnormal phospholipid level|MP:0009441,delayed skin barrier formation|MP:0009583,increased keratinocyte proliferation|MP:0011939,increased food intake|MP:0013245,abnormal lipid metabolism|MP:0020016,decreased aldehyde dehydrogenase activity
MGI:5548549	Aldh3b1<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0003961,decreased lean body mass|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7367353	Aldh3b2<em1Akih>	MP:0002169,no abnormal phenotype detected
MGI:7510084	Aldh4a1<em1(IMPC)Bay>	MP:0001392,abnormal locomotor behavior|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2180159	Aldh5a1<tm1Kmg>	MP:0000243,myoclonus|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0002183,gliosis|MP:0002826,tonic seizures|MP:0003216,absence seizures|MP:0004994,abnormal brain wave pattern|MP:0005332,abnormal amino acid level|MP:0005376,homeostasis/metabolism phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0030707,decreased glutamine level|MP:0030730,increased beta-alanine level|MP:0030732,increased gamma-aminobutyric acid level|MP:0030734,increased urine gamma-aminobutyric acid level
MGI:3530146	Aldh7a1<Gt(OST281597)Lex>	MP:0002169,no abnormal phenotype detected
MGI:6491215	Aldh7a1<tm1d(EUCOMM)Hmgu>	MP:0002064,seizures|MP:0003674,oxidative stress|MP:0005332,abnormal amino acid level|MP:0005386,behavior/neurological phenotype|MP:0005400,abnormal vitamin level|MP:0005665,increased circulating noradrenaline level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013242,abnormal amino acid metabolism|MP:0020237,increased proline level|MP:0030647,increased ornithine level|MP:0030659,decreased glycine level|MP:0030691,increased serine level|MP:0030697,increased phenylalanine level|MP:0030722,decreased lysine level|MP:0030747,increased leucine level
MGI:5572027	Aldh9a1<tm1b(KOMP)Wtsi>	MP:0002060,abnormal skin morphology|MP:0002874,decreased hemoglobin content
MGI:5605831	Aldoa<tm1.1(KOMP)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness|MP:0020870,decreased thigmotaxis
MGI:4951216	Aldob<tm1(KOMP)Vlcg>	MP:0000598,abnormal liver morphology|MP:0000603,pale liver|MP:0001265,decreased body size|MP:0001860,liver inflammation|MP:0002628,hepatic steatosis|MP:0003333,liver fibrosis|MP:0008993,abnormal portal triad morphology|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5606345	Aldob<tm2b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0003921,abnormal heart left ventricle morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5548322	Aldoc<tm1.1(KOMP)Vlcg>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001399,hyperactivity|MP:0001552,increased circulating triglyceride level|MP:0002135,abnormal kidney morphology|MP:0002644,decreased circulating triglyceride level|MP:0004738,abnormal auditory brainstem response|MP:0005179,decreased circulating cholesterol level|MP:0005573,increased pulmonary respiratory rate|MP:0005576,decreased pulmonary ventilation
MGI:5620954	Aldoc<tm2Ksak>	MP:0002169,no abnormal phenotype detected
MGI:2671810	Alg10<nse5>	MP:0001967,deafness|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004402,decreased cochlear outer hair cell number|MP:0004404,cochlear outer hair cell degeneration|MP:0004413,absent cochlear microphonics|MP:0004737,absent distortion product otoacoustic emissions|MP:0005377,hearing/vestibular/ear phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5704519	Alg11<tm1.1(KOMP)Vlcg>	MP:0001289,persistence of hyaloid vascular system|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7425011	Alg12<em1(IMPC)J>	MP:0000745,tremors
MGI:6358168	Alg13<em1Bayu>	MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003240,loss of hippocampal neurons|MP:0003354,astrocytosis|MP:0004859,abnormal synaptic plasticity|MP:0009358,environmentally induced seizures|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:4351478	Alg13<Gt(P035H04)Wrst>	MP:0002084,abnormal developmental patterning|MP:0004180,failure of initiation of embryo turning|MP:0004187,cardia bifida|MP:0008762,embryonic lethality
MGI:3864932	Alg13<Gt(P088H08)Wrst>	MP:0001696,failure to gastrulate
MGI:4841293	Alg13<tm1a(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5692664	Alg14<tm2b(EUCOMM)Hmgu>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0008527,embryonic lethality at implantation|MP:0011100,preweaning lethality, complete penetrance|MP:0011962,increased cornea thickness|MP:0013292,embryonic lethality prior to organogenesis
MGI:5698866	Alg1<tm1b(KOMP)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0002075,abnormal coat/hair pigmentation|MP:0002606,increased basophil cell number|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005278,abnormal cholesterol homeostasis|MP:0011100,preweaning lethality, complete penetrance
MGI:5523411	Alg2<tm1.1(KOMP)Vlcg>	MP:0001523,impaired righting response|MP:0002079,increased circulating insulin level|MP:0002110,abnormal digit morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level|MP:0013292,embryonic lethality prior to organogenesis
MGI:5007020	Alg2<tm1Lex>	MP:0011100,preweaning lethality, complete penetrance|MP:0011806,decreased dermal fibroblast proliferation
MGI:6194900	Alg3<em1(IMPC)J>	MP:0000266,abnormal heart morphology|MP:0000592,short tail|MP:0000783,abnormal forebrain morphology|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001915,intracranial hemorrhage|MP:0002080,prenatal lethality|MP:0003984,embryonic growth retardation|MP:0005031,abnormal trophoblast layer morphology|MP:0006301,abnormal mesenchyme morphology|MP:0009698,heart hemorrhage|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0012098,increased spongiotrophoblast size|MP:0013176,abnormal tail position or orientation
MGI:3578146	Alg5<nero>	MP:0001701,incomplete embryo turning|MP:0001706,abnormal left-right axis patterning|MP:0001730,embryonic growth arrest|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:6156575	Alg6<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001417,decreased exploration in new environment|MP:0001672,abnormal embryo development|MP:0001697,abnormal embryo size|MP:0001726,abnormal allantois morphology|MP:0002060,abnormal skin morphology|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5825112	Alg8<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001399,hyperactivity|MP:0001556,increased circulating HDL cholesterol level|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0002075,abnormal coat/hair pigmentation|MP:0002098,abnormal vibrissa morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0003961,decreased lean body mass|MP:0003984,embryonic growth retardation|MP:0005178,increased circulating cholesterol level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5823410	Alg9<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0002075,abnormal coat/hair pigmentation|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2178601	Aliq4<A/J>	MP:0005165,increased susceptibility to injury
MGI:2178600	Aliq4<C57BL/6J>	MP:0005166,decreased susceptibility to injury
MGI:7328421	Alkal2<em1(IMPC)J>	MP:0001314,cornea opacity|MP:0002060,abnormal skin morphology|MP:0002750,exophthalmos|MP:0005287,narrow eye opening|MP:0010053,decreased grip strength
MGI:5472661	Alkal2<tm1a(EUCOMM)Hmgu>	MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001783,decreased white adipose tissue amount|MP:0002891,increased insulin sensitivity|MP:0003960,increased lean body mass|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008489,slow postnatal weight gain|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008963,increased carbon dioxide production|MP:0009133,decreased white fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0010378,increased respiratory quotient|MP:0012575,increased noradrenaline level|MP:0013138,thin body|MP:0020521,browned white adipose tissue morphology
MGI:7578836	Alkal2<tm1Schl>	MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001783,decreased white adipose tissue amount|MP:0002891,increased insulin sensitivity|MP:0003960,increased lean body mass|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005459,decreased percent body fat/body weight|MP:0008489,slow postnatal weight gain|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008963,increased carbon dioxide production|MP:0009133,decreased white fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0010378,increased respiratory quotient|MP:0011941,increased fluid intake|MP:0011942,decreased fluid intake|MP:0011957,decreased compensatory feeding amount|MP:0012297,hyperactivity elicited by feed restriction|MP:0012575,increased noradrenaline level|MP:0013138,thin body|MP:0020521,browned white adipose tissue morphology
MGI:3774031	Alkbh1<tm1.1Lpkn>	MP:0001713,decreased trophoblast giant cell number|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0004266,pale placenta|MP:0004921,decreased placenta weight|MP:0008957,abnormal placenta junctional zone morphology|MP:0009674,decreased birth weight|MP:0011521,decreased placental labyrinth size|MP:0012109,decreased trophoblast glycogen cell number|MP:0030989,decreased spongiotrophoblast cell number
MGI:5695126	Alkbh1<tm1b(EUCOMM)Hmgu>	MP:0000598,abnormal liver morphology|MP:0000627,abnormal mammary gland morphology|MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0002098,abnormal vibrissa morphology|MP:0002135,abnormal kidney morphology|MP:0002581,abnormal ileum morphology|MP:0003866,abnormal defecation|MP:0011100,preweaning lethality, complete penetrance
MGI:4868224	Alkbh1<tm1Klng>	MP:0000077,abnormal interparietal bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000109,abnormal parietal bone morphology|MP:0000116,abnormal tooth development|MP:0000157,abnormal sternum morphology|MP:0000445,short snout|MP:0000458,abnormal mandible morphology|MP:0000914,exencephaly|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001326,retina degeneration|MP:0001328,disorganized retina layers|MP:0001732,postnatal growth retardation|MP:0001915,intracranial hemorrhage|MP:0001935,decreased litter size|MP:0002092,abnormal eye morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0002840,abnormal lens fiber morphology|MP:0003072,abnormal metatarsal bone morphology|MP:0003078,aphakia|MP:0003420,delayed intramembranous bone ossification|MP:0003720,abnormal neural tube closure|MP:0004200,decreased fetal size|MP:0004380,short frontal bone|MP:0004471,short nasal bone|MP:0004473,absent nasal bone|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005306,abnormal phalanx morphology|MP:0005621,abnormal cell physiology|MP:0008277,abnormal sternum ossification|MP:0008770,decreased survivor rate|MP:0010743,delayed cranial suture closure|MP:0010769,abnormal survival|MP:0012101,acoria|MP:0020040,decreased bone ossification|MP:0030029,wide cranial sutures|MP:0030189,broad snout|MP:0031428,lens dislocation
MGI:3774030	Alkbh1<tm1Lpkn>	MP:0005389,reproductive system phenotype
MGI:3714064	Alkbh2<tm1Klng>	MP:0010768,mortality/aging|MP:0014760,impaired DNA repair
MGI:3714065	Alkbh3<tm1Klng>	MP:0002169,no abnormal phenotype detected
MGI:5549955	Alkbh4<tm1.1Geno>	MP:0011100,preweaning lethality, complete penetrance
MGI:5549954	Alkbh4<tm1Geno>	MP:0003707,increased cell nucleus count|MP:0011708,decreased fibroblast cell migration|MP:0013289,abnormal mitotic cytokinesis|MP:0030943,abnormal centrosome morphology
MGI:5473894	Alkbh5<tm1.1Klng>	MP:0001147,small testis|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005578,teratozoospermia|MP:0008280,abnormal male germ cell apoptosis
MGI:6120771	Alkbh6<tm1b(EUCOMM)Hmgu>	MP:0002092,abnormal eye morphology|MP:0002941,increased circulating alanine transaminase level|MP:0005553,increased circulating creatinine level
MGI:6492321	Alkbh7<tm1.1Klng>	MP:0001261,obese|MP:0001402,decreased locomotor activity|MP:0001764,abnormal homeostasis|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002833,increased heart weight|MP:0002891,increased insulin sensitivity|MP:0002981,increased liver weight|MP:0003037,increased myocardial infarct size|MP:0003038,decreased myocardial infarct size|MP:0003961,decreased lean body mass|MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0005458,increased percent body fat/body weight|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0006036,abnormal mitochondrial physiology|MP:0006094,increased fat cell size|MP:0008403,decreased cellular sensitivity to alkylating agent induced cell death|MP:0008405,decreased cellular sensitivity to methylmethanesulfonate induced cell death|MP:0008407,decreased cellular sensitivity to hydrogen peroxide|MP:0008944,decreased sensitivity to induced cell death|MP:0009286,increased abdominal fat pad weight|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010953,abnormal fatty acid oxidation|MP:0010957,abnormal aerobic respiration|MP:0011940,decreased food intake|MP:0013245,abnormal lipid metabolism|MP:0013278,decreased fasting circulating glucose level|MP:0014142,increased body fat mass|MP:0020102,increased hepatic glucose production|MP:0030968,decreased circulating adiponectin level
MGI:5692677	Alkbh8<tm1b(EUCOMM)Hmgu>	MP:0002135,abnormal kidney morphology|MP:0002590,increased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002968,increased circulating alkaline phosphatase level
MGI:4822190	Alkbh8<tm1Klng>	MP:0002169,no abnormal phenotype detected
MGI:6476969	Alk<tm1.1(ALK*F1174L)Heno>	MP:0001008,abnormal sympathetic ganglion morphology|MP:0001013,enlarged superior cervical ganglion|MP:0001017,abnormal stellate ganglion morphology|MP:0002006,neoplasm|MP:0002169,no abnormal phenotype detected
MGI:5705324	Alk<tm1.1Ics>	MP:0001013,enlarged superior cervical ganglion|MP:0001017,abnormal stellate ganglion morphology
MGI:5700375	Alk<tm1.1Rhp>	MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001752,abnormal hypothalamus secretion|MP:0001938,delayed sexual maturation|MP:0002216,abnormal seminiferous tubule morphology|MP:0002673,abnormal sperm number|MP:0002780,decreased circulating testosterone level|MP:0004852,decreased testis weight|MP:0005250,decreased Sertoli cell number|MP:0005389,reproductive system phenotype|MP:0006362,abnormal male germ cell morphology|MP:0008489,slow postnatal weight gain|MP:0008940,delayed balanopreputial separation|MP:0008975,delayed male fertility|MP:0013601,increased testis apoptosis|MP:0014592,decreased gonadotropin-releasing hormone neuron number
MGI:5700377	Alk<tm1Swm>	MP:0003545,increased alcohol consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0009751,enhanced behavioral response to alcohol
MGI:5705326	Alk<tm2.1Ics>	MP:0000422,delayed hair appearance|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001011,abnormal superior cervical ganglion morphology|MP:0001013,enlarged superior cervical ganglion|MP:0001017,abnormal stellate ganglion morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001957,apnea|MP:0002092,abnormal eye morphology|MP:0002757,decreased vertical activity|MP:0002968,increased circulating alkaline phosphatase level|MP:0003019,increased circulating chloride level|MP:0003631,nervous system phenotype|MP:0004214,abnormal long bone diaphysis morphology|MP:0004924,abnormal behavior|MP:0005379,endocrine/exocrine gland phenotype|MP:0010052,increased grip strength|MP:0010232,delayed skin pigmentation appearance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011940,decreased food intake
MGI:6459757	Allc<em1Osb>	MP:0005389,reproductive system phenotype
MGI:1856649	Alm	MP:0000373,belly spot|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001307,fused cornea and lens|MP:0001314,cornea opacity|MP:0001322,abnormal iris morphology|MP:0001924,infertility|MP:0002794,lenticonus|MP:0010263,total cataract|MP:0011100,preweaning lethality, complete penetrance
MGI:3611799	Alms1<bbb>	MP:0001116,small gonad|MP:0001261,obese|MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0005253,abnormal eye physiology|MP:0006325,impaired hearing
MGI:3621984	Alms1<foz>	MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0003333,liver fibrosis|MP:0005331,insulin resistance|MP:0011939,increased food intake
MGI:3576051	Alms1<Gt(XH152)Byg>	MP:0000008,increased white adipose tissue amount|MP:0001116,small gonad|MP:0001260,increased body weight|MP:0001261,obese|MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0002216,abnormal seminiferous tubule morphology|MP:0002871,albuminuria|MP:0002981,increased liver weight|MP:0003068,enlarged kidney|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003917,increased kidney weight|MP:0005178,increased circulating cholesterol level|MP:0005384,cellular phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0005551,abnormal eye electrophysiology|MP:0009050,dilated proximal convoluted tubule|MP:0009255,degranulated pancreatic beta cells|MP:0009645,crystalluria|MP:0011405,tubulointerstitial nephritis|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis
MGI:3699224	Alms1<L2131X>	MP:0000180,abnormal circulating cholesterol level|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002705,dilated renal tubule|MP:0002962,increased urine protein level|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005253,abnormal eye physiology|MP:0005455,increased susceptibility to weight gain|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0010024,increased total body fat amount|MP:0011066,abnormal renal tubule epithelial cell primary cilium morphology|MP:0011368,increased kidney apoptosis|MP:0011440,increased kidney cell proliferation
MGI:5619129	Alms1<m1Btlr>	MP:0001260,increased body weight
MGI:6197903	Alms1<m2Btlr>	MP:0005293,impaired glucose tolerance
MGI:6197908	Alms1<m3Btlr>	MP:0001260,increased body weight|MP:0001264,increased body size|MP:0002079,increased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0013279,increased fasting circulating glucose level
MGI:6268762	Alms1<m4Btlr>	MP:0001260,increased body weight
MGI:6269388	Alms1<m5Btlr>	MP:0001260,increased body weight
MGI:6305831	Alms1<m6Btlr>	MP:0001260,increased body weight
MGI:5796935	Alms1<tm1b(EUCOMM)Hmgu>	MP:0001392,abnormal locomotor behavior|MP:0008806,increased circulating amylase level
MGI:5810779	Alms1<tvrm102>	MP:0001261,obese|MP:0005548,retina pigment epithelium atrophy|MP:0008450,retina photoreceptor degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:3641309	Alo1	MP:0000240,extramedullary hematopoiesis|MP:0000321,increased bone marrow cell number|MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000648,absent sebaceous gland|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001190,reddish skin|MP:0001195,flaky skin|MP:0001200,thick skin|MP:0001212,skin lesions|MP:0001219,thick epidermis|MP:0001243,abnormal dermal layer morphology|MP:0001246,mixed cellular infiltration to dermis|MP:0002339,abnormal lymph node morphology|MP:0031052,lymph node necrosis
MGI:3641310	Alo2	MP:0000240,extramedullary hematopoiesis|MP:0000321,increased bone marrow cell number|MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000648,absent sebaceous gland|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001190,reddish skin|MP:0001195,flaky skin|MP:0001200,thick skin|MP:0001212,skin lesions|MP:0001219,thick epidermis|MP:0001243,abnormal dermal layer morphology|MP:0001246,mixed cellular infiltration to dermis|MP:0002339,abnormal lymph node morphology|MP:0003705,abnormal hypodermis morphology|MP:0031052,lymph node necrosis
MGI:3655496	Alox12b<mmy>	MP:0001190,reddish skin|MP:0001192,scaly skin|MP:0001196,shiny skin|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001429,dehydration|MP:0002796,impaired skin barrier function|MP:0003853,dry skin|MP:0011087,neonatal lethality, complete penetrance
MGI:3795936	Alox12b<tm1.1Krie>	MP:0001190,reddish skin|MP:0001191,abnormal skin condition|MP:0001196,shiny skin|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001429,dehydration|MP:0001547,abnormal lipid level|MP:0002796,impaired skin barrier function|MP:0011087,neonatal lethality, complete penetrance
MGI:1932927	Alox12<tm1Fun>	MP:0002796,impaired skin barrier function|MP:0005387,immune system phenotype|MP:0009586,increased platelet aggregation|MP:0031121,increased susceptibility to induced thrombosis
MGI:4889210	Alox15<tm1.1Nadl>	MP:0002693,abnormal pancreas physiology|MP:0003058,increased insulin secretion|MP:0003186,abnormal redox activity|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005292,improved glucose tolerance|MP:0005319,abnormal enzyme/coenzyme level|MP:0005378,growth/size/body region phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0009113,increased pancreatic beta cell mass|MP:0020088,decreased susceptibility to non-insulin-dependent diabetes
MGI:5563793	Alox15<tm1.2Nadl>	MP:0000230,abnormal systemic arterial blood pressure|MP:0005385,cardiovascular system phenotype
MGI:5696932	Alox15<tm1b(KOMP)Mbp>	MP:0001289,persistence of hyaloid vascular system|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1857428	Alox15<tm1Fun>	MP:0000172,abnormal bone marrow cell number|MP:0000218,increased leukocyte cell number|MP:0001194,dermatitis|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0001790,abnormal immune system physiology|MP:0002083,premature death|MP:0002339,abnormal lymph node morphology|MP:0002356,abnormal spleen red pulp morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002414,abnormal myeloblast morphology/development|MP:0002606,increased basophil cell number|MP:0004952,increased spleen weight|MP:0005379,endocrine/exocrine gland phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005481,increased chronic myelocytic leukemia incidence|MP:0008475,intermingled spleen red and white pulp|MP:0014263,decreased spleen B cell follicle number
MGI:2156546	Alox5ap<tm1Bhk>	MP:0005087,decreased acute inflammation|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0008719,impaired neutrophil recruitment|MP:0009814,increased prostaglandin level|MP:0009817,decreased leukotriene level|MP:0009818,abnormal thromboxane level
MGI:1857167	Alox5ap<tm1Jdm>	MP:0001876,decreased inflammatory response|MP:0003436,decreased susceptibility to induced arthritis|MP:0005387,immune system phenotype|MP:0009811,abnormal prostaglandin level|MP:0009813,abnormal leukotriene level|MP:0009817,decreased leukotriene level
MGI:7425505	Alox5<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0008935,decreased mean platelet volume|MP:0010099,abnormal thoracic cage shape
MGI:1933120	Alox5<tm1Bhk>	MP:0001845,abnormal inflammatory response|MP:0002463,abnormal neutrophil physiology|MP:0005087,decreased acute inflammation|MP:0005397,hematopoietic system phenotype|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0008719,impaired neutrophil recruitment|MP:0008720,impaired neutrophil chemotaxis|MP:0009814,increased prostaglandin level|MP:0009817,decreased leukotriene level|MP:0009818,abnormal thromboxane level
MGI:1857125	Alox5<tm1Fun>	MP:0000062,increased bone mineral density|MP:0000692,small spleen|MP:0001790,abnormal immune system physiology|MP:0001876,decreased inflammatory response|MP:0004822,decreased susceptibility to experimental autoimmune uveoretinitis|MP:0005145,increased circulating VLDL cholesterol level|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005669,increased circulating leptin level|MP:0008908,increased total fat pad weight
MGI:4362187	Alox8<tm1a(KOMP)Wtsi>	MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001861,lung inflammation|MP:0005534,decreased body temperature|MP:0008705,increased interleukin-6 secretion|MP:0010857,pulmonary necrosis|MP:0020945,abnormal susceptibility to Orthomyxoviridae infection
MGI:6276993	Aloxe3<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0001297,microphthalmia|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001914,hemorrhage|MP:0002339,abnormal lymph node morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:5496904	Aloxe3<tm1.2Krie>	MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001263,weight loss|MP:0001429,dehydration|MP:0001547,abnormal lipid level|MP:0002796,impaired skin barrier function|MP:0009597,impaired stratum corneum desquamation|MP:0011087,neonatal lethality, complete penetrance
MGI:1856659	alp	MP:0000414,alopecia|MP:0000746,weakness|MP:0001262,decreased body weight|MP:0001382,abnormal nursing|MP:0001731,abnormal postnatal growth|MP:0002083,premature death|MP:0011049,impaired adaptive thermogenesis
MGI:5901883	Alpk2<em1(IMPC)J>	MP:0003961,decreased lean body mass|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:4206048	Alpk3<Gt(OST149512)Lex>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0003393,decreased cardiac output|MP:0005140,decreased cardiac muscle contractility|MP:0005329,abnormal myocardium layer morphology|MP:0005330,cardiomyopathy|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006267,abnormal intercalated disk morphology|MP:0010545,abnormal heart layer morphology|MP:0010633,myocardium hypertrophy|MP:0010724,thick interventricular septum|MP:0010754,abnormal heart left ventricle pressure|MP:0011952,decreased cardiac stroke volume|MP:0014731,disorganized myocardial fiber myofibrils|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5698072	Alpk3<tm1b(EUCOMM)Hmgu>	MP:0000274,enlarged heart|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0005140,decreased cardiac muscle contractility|MP:0010579,increased heart left ventricle size|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5438641	Alpl<ALPLD1>	MP:0002966,decreased circulating alkaline phosphatase level
MGI:5424920	Alpl<BAP023>	MP:0002966,decreased circulating alkaline phosphatase level
MGI:7621902	Alpl<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0004122,abnormal sinus arrhythmia|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3051587	Alpl<Hpp>	MP:0002966,decreased circulating alkaline phosphatase level
MGI:5424919	Alpl<Mhdabap020>	MP:0002966,decreased circulating alkaline phosphatase level
MGI:5424922	Alpl<Mhdabap26>	MP:0002966,decreased circulating alkaline phosphatase level
MGI:5424923	Alpl<Mhdabap27>	MP:0002966,decreased circulating alkaline phosphatase level
MGI:5424924	Alpl<Mhdabap32>	MP:0002966,decreased circulating alkaline phosphatase level
MGI:5425009	Alpl<SAP007>	MP:0002966,decreased circulating alkaline phosphatase level
MGI:2183411	Alpl<tm1Jlm>	MP:0000061,fragile skeleton|MP:0000063,decreased bone mineral density|MP:0000116,abnormal tooth development|MP:0000133,abnormal long bone metaphysis morphology|MP:0000221,decreased leukocyte cell number|MP:0000496,abnormal small intestine morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000746,weakness|MP:0001077,abnormal spinal nerve morphology|MP:0001182,lung hemorrhage|MP:0001405,impaired coordination|MP:0001634,internal hemorrhage|MP:0001664,abnormal digestion|MP:0001915,intracranial hemorrhage|MP:0001957,apnea|MP:0002064,seizures|MP:0002108,abnormal muscle morphology|MP:0002371,abnormal thymus cortex morphology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003933,abnormal cementum morphology|MP:0004189,abnormal alveolar process morphology|MP:0004986,abnormal osteoblast morphology|MP:0005006,abnormal osteoblast physiology|MP:0005150,cachexia|MP:0006396,decreased long bone epiphyseal plate size|MP:0009246,pale spleen|MP:0010025,decreased total body fat amount|MP:0011085,postnatal lethality, complete penetrance|MP:0011165,abnormal tooth root development|MP:0020137,decreased bone mineralization|MP:0030281,thin parietal bone|MP:0030451,abnormal dentin mineralization|MP:0030453,abnormal odontoblast morphology|MP:0030493,abnormal tooth root morphology|MP:0030497,short tooth root|MP:0030562,enlarged dental pulp chamber
MGI:1857124	Alpl<tm1Sor>	MP:0001265,decreased body size|MP:0002064,seizures|MP:0002100,abnormal tooth morphology|MP:0009642,abnormal blood homeostasis|MP:0011085,postnatal lethality, complete penetrance
MGI:5818891	Alpl<tm2.1Jlm>	MP:0000109,abnormal parietal bone morphology|MP:0004189,abnormal alveolar process morphology|MP:0004992,increased bone resorption|MP:0009346,decreased trabecular bone thickness|MP:0010868,increased bone trabecula number|MP:0011585,decreased alkaline phosphatase activity|MP:0020137,decreased bone mineralization|MP:0020138,delayed bone mineralization|MP:0030452,abnormal cementum mineralization|MP:0030545,abnormal acellular cementum morphology|MP:0030546,abnormal cellular cementum morphology
MGI:2183412	Alppl2<tm1Jlm>	MP:0001935,decreased litter size|MP:0002169,no abnormal phenotype detected|MP:0002293,long gestation period|MP:0003984,embryonic growth retardation|MP:0009781,abnormal preimplantation embryo development|MP:0011104,embryonic lethality before implantation, incomplete penetrance
MGI:3046822	Alprf<BALB/cJ>	MP:0001987,alcohol preference
MGI:6117095	Als2cl<em1(IMPC)J>	MP:0002941,increased circulating alanine transaminase level
MGI:3522476	Als2<tm1Cai>	MP:0001260,increased body weight|MP:0001363,increased anxiety-related response|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0002804,abnormal motor learning|MP:0003631,nervous system phenotype|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:3770658	Als2<tm1Deng>	MP:0001405,impaired coordination|MP:0002229,neurodegeneration|MP:0002878,abnormal corticospinal tract morphology
MGI:3807480	Als2<tm1Garo>	MP:0001405,impaired coordination|MP:0002878,abnormal corticospinal tract morphology|MP:0003993,abnormal ventral spinal root morphology|MP:0004262,abnormal physical strength|MP:0004768,abnormal axonal transport|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration
MGI:3653518	Als2<tm1Hay>	MP:0000937,abnormal motor neuron morphology|MP:0001402,decreased locomotor activity|MP:0002882,abnormal neuron morphology
MGI:3612978	Als2<tm1Jei>	MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000939,decreased motor neuron number|MP:0000940,abnormal motor neuron innervation pattern|MP:0001053,abnormal neuromuscular synapse morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003354,astrocytosis|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential|MP:0006082,CNS inflammation|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009413,skeletal muscle fiber atrophy
MGI:7562294	Altre<tm1.1Hbgl>	MP:0000598,abnormal liver morphology|MP:0002083,premature death|MP:0002941,increased circulating alanine transaminase level|MP:0003333,liver fibrosis|MP:0004946,abnormal regulatory T cell physiology|MP:0004974,decreased regulatory T cell number|MP:0005018,decreased T cell number|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0008019,increased liver tumor incidence|MP:0008049,increased memory T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008681,increased interleukin-17 secretion|MP:0011631,decreased mitochondrial size|MP:0012188,increased regulatory T cell apoptosis|MP:0031269,increased susceptibility to diet-induced hepatic steatosis
MGI:7258422	Alx1<em1Jian>	MP:0000111,cleft palate|MP:0000445,short snout|MP:0000449,broad nasal bridge|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001302,eyelids open at birth|MP:0002235,abnormal external nares morphology|MP:0003631,nervous system phenotype|MP:0004054,abnormal periocular mesenchyme morphology|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0004450,presphenoid bone hypoplasia|MP:0004538,abnormal maxillary shelf morphology|MP:0004871,premaxilla hypoplasia|MP:0009902,abnormal lateral nasal prominence morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011266,abnormal frontonasal mesenchyme morphology|MP:0012085,midface hypoplasia|MP:0030034,depressed nasal bridge|MP:0030193,short philtrum|MP:0031441,increased periocular mesenchyme apoptosis|MP:0031445,midline cleft upper lip|MP:0031449,abnormal nasal cartilage morphology
MGI:1857553	Alx1<tm1Crm>	MP:0000075,absent neurocranium|MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000435,shortened head|MP:0000783,abnormal forebrain morphology|MP:0000929,open neural tube|MP:0001302,eyelids open at birth|MP:0001575,cyanosis|MP:0002778,meroanencephaly|MP:0003104,acrania|MP:0003108,short zygomatic bone|MP:0004377,small frontal bone|MP:0004383,absent interparietal bone|MP:0004418,small parietal bone|MP:0004444,small supraoccipital bone|MP:0004449,absent presphenoid bone|MP:0004459,small alisphenoid bone|MP:0004508,abnormal pectoral girdle bone morphology|MP:0004726,abnormal nasal capsule morphology|MP:0005249,abnormal palatine bone morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005382,craniofacial phenotype|MP:0005390,skeleton phenotype|MP:0009546,absent gastric milk in neonates|MP:0011087,neonatal lethality, complete penetrance|MP:0011862,decreased cranium length|MP:0012702,increased embryonic neuroepithelium thickness|MP:0030066,short face|MP:0030121,small temporal bone squamous part|MP:0031449,abnormal nasal cartilage morphology
MGI:2151910	Alx3<tm1Hubr>	MP:0000108,midline facial cleft|MP:0000313,abnormal cell death|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001923,reduced female fertility|MP:0002079,increased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0003935,abnormal craniofacial development|MP:0003984,embryonic growth retardation|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0005559,increased circulating glucose level|MP:0009114,decreased pancreatic beta cell mass|MP:0009172,small pancreatic islets|MP:0009264,failure of eyelid fusion|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011260,abnormal head mesenchyme morphology|MP:0013279,increased fasting circulating glucose level|MP:0014117,increased pancreatic beta cell apoptosis
MGI:3829369	Alx4<Lst-2J>	MP:0000074,abnormal neurocranium morphology|MP:0000107,abnormal frontal bone morphology|MP:0000414,alopecia|MP:0000445,short snout|MP:0000562,polydactyly|MP:0001300,ocular hypertelorism|MP:0001302,eyelids open at birth|MP:0001304,cataract|MP:0005382,craniofacial phenotype|MP:0009264,failure of eyelid fusion|MP:0009743,preaxial polydactyly|MP:0011090,perinatal lethality, incomplete penetrance
MGI:1857503	Alx4<lst-Alb>	MP:0002109,abnormal limb morphology|MP:0009743,preaxial polydactyly|MP:0011091,prenatal lethality, complete penetrance
MGI:1856069	Alx4<lst-J>	MP:0004692,small pubis
MGI:3774135	Alx4<m1Btlr>	MP:0000422,delayed hair appearance|MP:0000445,short snout|MP:0006411,upturned snout|MP:0009743,preaxial polydactyly|MP:0010202,focal dorsal hair loss
MGI:5502864	Alx4<M1Yzcm>	MP:0000414,alopecia|MP:0000757,herniated abdominal wall|MP:0001199,thin skin|MP:0001302,eyelids open at birth|MP:0002108,abnormal muscle morphology|MP:0002764,short tibia|MP:0003052,omphalocele|MP:0003257,abnormal abdominal wall morphology|MP:0004418,small parietal bone|MP:0004691,absent pubis|MP:0009743,preaxial polydactyly|MP:0011088,neonatal lethality, incomplete penetrance
MGI:1857484	Alx4<tm1Rwi>	MP:0000109,abnormal parietal bone morphology|MP:0000562,polydactyly|MP:0000757,herniated abdominal wall|MP:0002169,no abnormal phenotype detected|MP:0011090,perinatal lethality, incomplete penetrance|MP:0012528,abnormal zone of polarizing activity morphology
MGI:1856665	am	MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000137,abnormal vertebrae morphology|MP:0000138,absent vertebrae|MP:0000154,rib fusion|MP:0000346,broad head|MP:0000435,shortened head|MP:0000445,short snout|MP:0000547,short limbs|MP:0000550,abnormal forelimb morphology|MP:0001258,decreased body length|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001785,edema|MP:0003456,absent tail|MP:0003566,abnormal cell adhesion|MP:0003885,abnormal rostral-caudal body axis extension|MP:0004612,fusion of vertebral bodies|MP:0005229,abnormal intervertebral disk development|MP:0006029,abnormal sclerotome morphology|MP:0006281,abnormal tail development|MP:0006306,abnormal nasal pit morphology|MP:0008029,abnormal paraxial mesoderm morphology|MP:0009652,abnormal palatal rugae morphology|MP:0009768,impaired somite development|MP:0009883,palatal shelf hypoplasia|MP:0009890,cleft secondary palate|MP:0010048,abnormal primitive streak regression|MP:0011087,neonatal lethality, complete penetrance|MP:0011266,abnormal frontonasal mesenchyme morphology|MP:0011495,abnormal head shape|MP:0011732,decreased somite size|MP:0013351,abnormal Rathke's pouch development
MGI:3056107	am3	MP:0003931,absent molars
MGI:3044171	Amacr<tm1Jkh>	MP:0000180,abnormal circulating cholesterol level|MP:0000599,enlarged liver|MP:0001654,hepatic necrosis|MP:0002968,increased circulating alkaline phosphatase level|MP:0004773,abnormal bile composition|MP:0005281,increased fatty acids level|MP:0005282,decreased fatty acids level|MP:0005318,decreased triglyceride level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010025,decreased total body fat amount|MP:0010180,increased susceptibility to weight loss
MGI:6277050	Ambn<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003068,enlarged kidney
MGI:3525231	Ambn<tm1Nid>	MP:0000454,abnormal jaw morphology|MP:0002020,increased tumor incidence|MP:0002100,abnormal tooth morphology|MP:0002650,abnormal ameloblast morphology|MP:0003404,absent enamel|MP:0003932,abnormal molar crown morphology|MP:0005358,abnormal incisor morphology|MP:0010096,abnormal incisor color|MP:0030459,abnormal tooth attrition
MGI:2388018	Ambp<tm1Kkm>	MP:0000242,impaired fertilization|MP:0001125,abnormal oocyte morphology|MP:0001386,abnormal maternal nurturing|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0003406,failure of zygotic cell division|MP:0009374,absent cumulus expansion
MGI:2180160	Ambp<tm1Miya>	MP:0001125,abnormal oocyte morphology|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0003697,absent zona pellucida|MP:0009648,abnormal superovulation
MGI:6257521	Ambra1<em1(IMPC)Bay>	MP:0000438,abnormal cranium morphology|MP:0000841,abnormal hindbrain morphology|MP:0000897,abnormal midbrain morphology|MP:0001325,abnormal retina morphology|MP:0002080,prenatal lethality|MP:0002111,abnormal tail morphology|MP:0003054,spina bifida|MP:0003720,abnormal neural tube closure|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0008797,facial cleft|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0011960,abnormal eye anterior chamber depth|MP:0011964,increased total retina thickness
MGI:3715977	Ambra1<Gt(pGT1.8geo)1Fcec>	MP:0000351,increased cell proliferation|MP:0000914,exencephaly|MP:0000934,abnormal telencephalon development|MP:0002809,increased spinal cord size|MP:0003054,spina bifida|MP:0004837,abnormal neural fold formation|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012701,increased embryonic neuroepithelium apoptosis|MP:0012705,increased embryonic neuroepithelial cell proliferation|MP:0030940,impaired autophagy
MGI:3586494	Amd1<tm1Kiga>	MP:0001730,embryonic growth arrest|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3835836	amd<A/J>	MP:0001856,myocarditis
MGI:3835839	amd<DBA/2J>	MP:0001856,myocarditis
MGI:5609350	Amdhd1<tm2b(EUCOMM)Hmgu>	MP:0005013,increased lymphocyte cell number
MGI:7708049	Amdhd2<em1(IMPC)Mbp>	MP:0005293,impaired glucose tolerance|MP:0009453,enhanced contextual conditioning behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0020421,increased freezing behavior
MGI:7276144	Amdhd2<em#Msde>	MP:0011091,prenatal lethality, complete penetrance
MGI:3695450	Amdt1<C57BL/6J>	MP:0008911,induced hyperactivity
MGI:3695452	Amdt2<C57BL/6J>	MP:0008911,induced hyperactivity
MGI:6341952	Amelx<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000470,abnormal stomach morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0001262,decreased body weight|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002100,abnormal tooth morphology|MP:0002339,abnormal lymph node morphology|MP:0003036,vertebral transformation|MP:0003883,enlarged stomach|MP:0004599,abnormal vertebral arch morphology|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005270,abnormal zygomatic bone morphology|MP:0011047,increased lung tissue damping|MP:0013129,abnormal tooth color|MP:0030610,absent teeth
MGI:3807977	Amelx<Rgsc888>	MP:0000116,abnormal tooth development|MP:0000126,brittle teeth|MP:0000458,abnormal mandible morphology|MP:0002576,abnormal enamel morphology|MP:0002577,reduced enamel thickness|MP:0002649,abnormal enamel rod pattern|MP:0002650,abnormal ameloblast morphology|MP:0002689,abnormal molar morphology|MP:0004830,short incisors|MP:0005358,abnormal incisor morphology|MP:0010096,abnormal incisor color|MP:0030050,large mandible|MP:0030089,short lower incisors|MP:0030090,short upper incisors|MP:0030450,abnormal enamel mineralization|MP:0030457,abnormal molar cusp morphology|MP:0030458,abnormal tooth wear|MP:0030460,enamel pits
MGI:2177294	Amelx<tm1Kul>	MP:0000126,brittle teeth|MP:0002100,abnormal tooth morphology|MP:0002577,reduced enamel thickness|MP:0002649,abnormal enamel rod pattern
MGI:3694786	Amelx<tm1Msnd>	MP:0000126,brittle teeth|MP:0002576,abnormal enamel morphology|MP:0002577,reduced enamel thickness|MP:0002649,abnormal enamel rod pattern|MP:0002650,abnormal ameloblast morphology|MP:0030457,abnormal molar cusp morphology|MP:0030458,abnormal tooth wear|MP:0030513,short Tomes' process
MGI:3694787	Amelx<tm2Msnd>	MP:0000126,brittle teeth|MP:0002576,abnormal enamel morphology|MP:0002577,reduced enamel thickness|MP:0002649,abnormal enamel rod pattern|MP:0002650,abnormal ameloblast morphology|MP:0003932,abnormal molar crown morphology|MP:0030458,abnormal tooth wear|MP:0030513,short Tomes' process
MGI:4948587	Amelx<tm3Msnd>	MP:0002577,reduced enamel thickness
MGI:5086003	Amer1<tm1.1Nbar>	MP:0000130,abnormal trabecular bone morphology|MP:0000157,abnormal sternum morphology|MP:0002113,abnormal skeleton development|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0003797,abnormal compact bone morphology|MP:0004353,abnormal deltoid tuberosity morphology|MP:0004988,increased osteoblast cell number|MP:0005390,skeleton phenotype|MP:0005422,osteosclerosis|MP:0008277,abnormal sternum ossification|MP:0008395,abnormal osteoblast differentiation|MP:0009115,abnormal fat cell morphology|MP:0009250,abnormal appendicular skeleton morphology|MP:0009347,increased trabecular bone thickness|MP:0010875,increased bone volume|MP:0011168,abnormal fat cell differentiation|MP:0020039,increased bone ossification|MP:0020080,increased bone mineralization|MP:0020138,delayed bone mineralization|MP:0030388,large fontanelles|MP:0030393,delayed fontanelle closure
MGI:5086004	Amer1<tm1.2Nbar>	MP:0000062,increased bone mineral density|MP:0000074,abnormal neurocranium morphology|MP:0000157,abnormal sternum morphology|MP:0000274,enlarged heart|MP:0000439,enlarged cranium|MP:0000441,increased cranium width|MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000694,spleen hypoplasia|MP:0001575,cyanosis|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0002135,abnormal kidney morphology|MP:0002833,increased heart weight|MP:0002835,abnormal cranial suture morphology|MP:0002896,abnormal bone mineralization|MP:0003068,enlarged kidney|MP:0003419,delayed endochondral bone ossification|MP:0003420,delayed intramembranous bone ossification|MP:0003604,single kidney|MP:0003723,abnormal long bone morphology|MP:0003797,abnormal compact bone morphology|MP:0003827,abnormal Wolffian duct morphology|MP:0004199,increased fetal size|MP:0004353,abnormal deltoid tuberosity morphology|MP:0004354,absent deltoid tuberosity|MP:0004361,bowed ulna|MP:0004374,bowed radius|MP:0005108,abnormal ulna morphology|MP:0005422,osteosclerosis|MP:0005508,abnormal skeleton morphology|MP:0006032,abnormal ureteric bud morphology|MP:0008272,abnormal endochondral bone ossification|MP:0008273,abnormal intramembranous bone ossification|MP:0008277,abnormal sternum ossification|MP:0009432,increased fetal weight|MP:0010025,decreased total body fat amount|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011386,increased metanephric mesenchyme apoptosis|MP:0030316,enlarged neurocranium|MP:0030885,increased radius size
MGI:4093875	Amfr<Gt(IST12797A11)Tigm>	MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0001261,obese|MP:0001860,liver inflammation|MP:0002628,hepatic steatosis|MP:0003046,liver cirrhosis|MP:0003333,liver fibrosis|MP:0008019,increased liver tumor incidence|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:5509334	Amfr<tm1.1Amw>	MP:0005384,cellular phenotype
MGI:4362704	Amfr<tm1a(KOMP)Wtsi>	MP:0002942,decreased circulating alanine transaminase level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005567,decreased circulating total protein level|MP:0005571,decreased lactate dehydrogenase level|MP:0005632,decreased circulating aspartate transaminase level|MP:0010088,decreased circulating fructosamine level
MGI:2682758	A<mhdadcc4>	MP:0005409,darkened coat color
MGI:2156555	Amhr2<tm1Bhr>	MP:0001152,increased Leydig cell number|MP:0001154,seminiferous tubule degeneration|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001939,secondary sex reversal|MP:0002784,abnormal Sertoli cell morphology|MP:0002789,male pseudohermaphroditism|MP:0005389,reproductive system phenotype|MP:0009139,failure of Mullerian duct regression
MGI:3042214	Amhr2<tm3(cre)Bhr>	MP:0001939,secondary sex reversal|MP:0002789,male pseudohermaphroditism
MGI:1857126	Amh<tm1Bhr>	MP:0001152,increased Leydig cell number|MP:0001749,suppressed circulating follicle stimulating hormone level|MP:0001922,reduced male fertility|MP:0001939,secondary sex reversal|MP:0002789,male pseudohermaphroditism|MP:0004855,increased ovary weight|MP:0005389,reproductive system phenotype|MP:0011121,decreased primordial ovarian follicle number|MP:0011128,increased tertiary ovarian follicle number|MP:0031383,increased secondary ovarian follicle number
MGI:2156548	Amh<tm2.1Bhr>	MP:0005389,reproductive system phenotype
MGI:2156547	Amh<tm2Bhr>	MP:0001939,secondary sex reversal|MP:0002789,male pseudohermaphroditism
MGI:2156550	Amh<tm3.1Bhr>	MP:0001939,secondary sex reversal|MP:0002789,male pseudohermaphroditism
MGI:2156552	Amh<tm4.1Bhr>	MP:0001939,secondary sex reversal|MP:0002789,male pseudohermaphroditism
MGI:2156554	Amh<tm5.1Bhr>	MP:0005389,reproductive system phenotype
MGI:2156553	Amh<tm5Bhr>	MP:0001939,secondary sex reversal|MP:0002789,male pseudohermaphroditism
MGI:5634962	Amigo1<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0005391,vision/eye phenotype|MP:0006068,abnormal retina horizontal cell morphology|MP:0006074,abnormal retina rod bipolar cell morphology
MGI:6380687	Amigo2<em1(IMPC)J>	MP:0010052,increased grip strength
MGI:6478808	Amigo2<em#Dke>	MP:0005391,vision/eye phenotype|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0008056,abnormal retina ganglion cell morphology|MP:0020376,abnormal starburst amacrine cell morphology
MGI:5548832	Amigo3<tm1.1(KOMP)Vlcg>	MP:0000274,enlarged heart
MGI:5049960	amiko	MP:0001730,embryonic growth arrest
MGI:1855948	a<m-J>	MP:0000421,mottled coat|MP:0003122,maternal imprinting
MGI:4127412	Ammecr1<Gt(XK571)Byg>	MP:0005379,endocrine/exocrine gland phenotype
MGI:6336110	Ammecr1l<em1(IMPC)Kmpc>	MP:0001404,no spontaneous movement|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2135304	Amn<amn>	MP:0000932,absent notochord|MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0001683,absent mesoderm|MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0002230,abnormal primitive streak formation|MP:0002231,abnormal primitive streak morphology|MP:0003861,abnormal nervous system development|MP:0004073,caudal body truncation|MP:0005030,absent amnion|MP:0005380,embryo phenotype|MP:0006386,absent somites|MP:0009331,absent primitive node|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5614775	Amn<b2b2259Clo>	MP:0000157,abnormal sternum morphology|MP:0000484,abnormal pulmonary artery morphology|MP:0001297,microphthalmia|MP:0001625,cardiac hypertrophy|MP:0004158,right aortic arch|MP:0010466,vascular ring|MP:0010488,abnormal left subclavian artery morphology|MP:0011666,double outlet right ventricle, ventricular defect committed to aorta
MGI:2135454	Amn<tm1Ehl>	MP:0001730,embryonic growth arrest|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:6276189	Amotl1<em1Rstot>	MP:0005382,craniofacial phenotype|MP:0005385,cardiovascular system phenotype|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6276196	Amotl1<em2Rstot>	MP:0002169,no abnormal phenotype detected
MGI:6276197	Amotl1<em3Rstot>	MP:0002169,no abnormal phenotype detected
MGI:6356823	Amotl1<tm1Laho>	MP:0010144,abnormal tumor vascularization
MGI:7484785	Amotl2<em1(IMPC)Mbp>	MP:0000220,increased monocyte cell number|MP:0001258,decreased body length|MP:0001303,abnormal lens morphology|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0002092,abnormal eye morphology|MP:0002750,exophthalmos|MP:0004222,iris synechia|MP:0005542,cornea vascularization|MP:0006243,impaired pupillary reflex|MP:0009142,decreased prepulse inhibition
MGI:6120889	Amotl2<tm1.1Laho>	MP:0000272,abnormal aorta morphology|MP:0005385,cardiovascular system phenotype|MP:0006055,abnormal vascular endothelial cell morphology|MP:0010463,aorta stenosis
MGI:2656627	Amot<tm1Bhr>	MP:0000260,abnormal angiogenesis|MP:0001698,decreased embryo size|MP:0001914,hemorrhage|MP:0002084,abnormal developmental patterning|MP:0003229,abnormal vitelline vasculature morphology|MP:0003658,abnormal capillary morphology|MP:0003984,embryonic growth retardation|MP:0004259,small placenta|MP:0004938,dilated vasculature|MP:0004950,abnormal brain vasculature morphology|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011255,abnormal anterior visceral endoderm cell migration
MGI:2155697	Amp1<C57BL/6J>	MP:0020467,abnormal circadian behavior
MGI:2153884	Amp2<BALB/cJ>	MP:0020467,abnormal circadian behavior
MGI:5548917	Ampd1<tm1b(KOMP)Wtsi>	MP:0000222,decreased neutrophil cell number|MP:0000702,enlarged lymph nodes|MP:0002599,increased mean platelet volume|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6157956	Ampd1<tm1Tm>	MP:0003806,abnormal nucleotide metabolism|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0030604,abnormal ammonia homeostasis
MGI:3848348	Ampd2<m4521Dajl>	MP:0000182,increased circulating LDL cholesterol level|MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0005178,increased circulating cholesterol level
MGI:6120811	Ampd2<tm1b(EUCOMM)Hmgu>	MP:0000208,decreased hematocrit|MP:0001556,increased circulating HDL cholesterol level|MP:0002599,increased mean platelet volume|MP:0005178,increased circulating cholesterol level|MP:0005505,thrombocytosis|MP:0005627,increased circulating potassium level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008806,increased circulating amylase level|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5490144	Ampd2<tm1Tm>	MP:0002703,abnormal renal tubule morphology|MP:0002962,increased urine protein level|MP:0005387,immune system phenotype|MP:0008140,podocyte foot process effacement
MGI:5529271	Ampd3<tm1Tm>	MP:0001861,lung inflammation|MP:0002590,increased mean corpuscular volume|MP:0003656,abnormal erythrocyte physiology|MP:0031085,increased erythrocyte osmotic fragility
MGI:4364610	Ampd3<tm2a(KOMP)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0003806,abnormal nucleotide metabolism|MP:0004924,abnormal behavior|MP:0005288,abnormal oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005584,abnormal enzyme/coenzyme activity
MGI:2388118	Amph<tm1Pdc>	MP:0001454,abnormal cued conditioning behavior|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001932,abnormal spermiogenesis|MP:0002083,premature death|MP:0002784,abnormal Sertoli cell morphology|MP:0002826,tonic seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0004770,abnormal synaptic vesicle recycling|MP:0014633,decreased spermatid number|MP:0014684,impaired spermiation
MGI:7425507	Amt<em1(IMPC)Tcp>	MP:0000111,cleft palate|MP:0000914,exencephaly|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001697,abnormal embryo size|MP:0002109,abnormal limb morphology|MP:0002764,short tibia|MP:0002792,abnormal retina vasculature morphology|MP:0003054,spina bifida|MP:0003131,increased erythrocyte cell number|MP:0003257,abnormal abdominal wall morphology|MP:0003743,abnormal facial morphology|MP:0004258,abnormal placenta size|MP:0005016,decreased lymphocyte cell number|MP:0008797,facial cleft|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0011496,abnormal head size
MGI:4218349	Amt<Gt(OST181110)Lex>	MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0002080,prenatal lethality|MP:0002151,abnormal neural tube morphology|MP:0008784,craniorachischisis
MGI:6276835	Amtn<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0002989,small kidney
MGI:5896933	Amtn<tm1Tigm>	MP:0002576,abnormal enamel morphology|MP:0002650,abnormal ameloblast morphology|MP:0010096,abnormal incisor color|MP:0030450,abnormal enamel mineralization
MGI:5568076	anan	MP:0004794,increased anti-nuclear antigen antibody level
MGI:6203658	Anapc10<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0012000,abnormal limb position
MGI:5606343	Anapc13<tm2b(EUCOMM)Wtsi>	MP:0001510,abnormal coat appearance|MP:0002590,increased mean corpuscular volume|MP:0005419,decreased circulating serum albumin level|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration|MP:0013292,embryonic lethality prior to organogenesis
MGI:5561049	Anapc15<tm1.1(KOMP)Vlcg>	MP:0000428,abnormal craniofacial morphology|MP:0000783,abnormal forebrain morphology|MP:0000841,abnormal hindbrain morphology|MP:0000897,abnormal midbrain morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001556,increased circulating HDL cholesterol level|MP:0001697,abnormal embryo size|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0003717,pallor|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration|MP:0011495,abnormal head shape
MGI:5825199	Anapc1<em1(IMPC)J>	MP:0001303,abnormal lens morphology|MP:0001488,increased startle reflex|MP:0002968,increased circulating alkaline phosphatase level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5300909	Anapc2<tm1Hez>	MP:0002169,no abnormal phenotype detected
MGI:3029825	Anapc2<tm1Kna>	MP:0000607,abnormal hepatocyte morphology|MP:0002083,premature death|MP:0003326,liver failure|MP:0003893,increased hepatocyte proliferation
MGI:3029826	Anapc2<tm2Kna>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5548397	Anapc4<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:7709701	Anapc4<tm1c(EUCOMM)Wtsi>	MP:0008415,abnormal neurite morphology
MGI:7425508	Anapc5<em1(IMPC)Bay>	MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:6385663	Anapc7<em1(IMPC)J>	MP:0000208,decreased hematocrit|MP:0001402,decreased locomotor activity|MP:0001926,female infertility|MP:0002591,decreased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0003795,abnormal bone structure|MP:0005293,impaired glucose tolerance|MP:0005333,decreased heart rate|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6887761	Anapc7<tm1.1Azbi>	MP:0001402,decreased locomotor activity|MP:0001516,abnormal motor coordination/balance|MP:0001522,impaired swimming|MP:0001732,postnatal growth retardation|MP:0005386,behavior/neurological phenotype|MP:0020421,increased freezing behavior
MGI:5568096	anaya	MP:0004794,increased anti-nuclear antigen antibody level
MGI:3803643	Anb	MP:0000562,polydactyly
MGI:5568106	andra	MP:0004794,increased anti-nuclear antigen antibody level
MGI:5704082	anem	MP:0000218,increased leukocyte cell number|MP:0001577,anemia|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002640,reticulocytosis|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:5695964	Ang6<tm1.1(KOMP)Vlcg>	MP:0010378,increased respiratory quotient
MGI:4839199	Angel1<tm1(NCOM)Cmhd>	MP:0002608,increased hematocrit|MP:0005554,decreased circulating creatinine level|MP:0005564,increased hemoglobin content
MGI:7309788	Angel2<em1Gpt>	MP:0005266,abnormal metabolism|MP:0010768,mortality/aging|MP:0010955,abnormal respiratory electron transport chain|MP:0010959,abnormal oxidative phosphorylation|MP:0013272,abnormal translation
MGI:5585457	Angpt1<tm1.1Yona>	MP:0003070,increased vascular permeability|MP:0010097,abnormal retina blood vessel morphology|MP:0012049,increased susceptilbility to retina ischemic injury|MP:0012066,decreased astrocyte number
MGI:2180143	Angpt1<tm1Sato>	MP:0000259,abnormal vascular development|MP:0000264,failure of vascular branching|MP:0000293,absent myocardial trabeculae|MP:0003229,abnormal vitelline vasculature morphology|MP:0003974,abnormal endocardium morphology|MP:0005602,decreased angiogenesis|MP:0006055,abnormal vascular endothelial cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012082,delayed heart development
MGI:2180145	Angpt1<tm2Sato>	MP:0000259,abnormal vascular development|MP:0000264,failure of vascular branching|MP:0000293,absent myocardial trabeculae|MP:0003229,abnormal vitelline vasculature morphology|MP:0003974,abnormal endocardium morphology|MP:0005602,decreased angiogenesis|MP:0006055,abnormal vascular endothelial cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012082,delayed heart development
MGI:6158462	Angpt2<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0001157,small seminal vesicle|MP:0002339,abnormal lymph node morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3040929	Angpt2<tm1Gdy>	MP:0000364,abnormal vascular regression|MP:0001201,translucent skin|MP:0001289,persistence of hyaloid vascular system|MP:0001786,skin edema|MP:0001879,abnormal lymphatic vessel morphology|MP:0002792,abnormal retina vasculature morphology|MP:0005324,ascites|MP:0008108,abnormal small intestinal villus morphology|MP:0008852,retina neovascularization|MP:0011085,postnatal lethality, complete penetrance|MP:0012080,chylous ascites|MP:0012684,abnormal pleural cavity morphology
MGI:3040930	Angpt2<tm2(Angpt1)Gdy>	MP:0000260,abnormal angiogenesis|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype
MGI:3721928	Angptl1<tm1Hung>	MP:0002169,no abnormal phenotype detected
MGI:6188495	Angptl1<tm4b(KOMP)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001399,hyperactivity|MP:0001566,increased circulating phosphate level|MP:0005565,increased blood urea nitrogen level
MGI:4359444	Angptl2<tm1Yo>	MP:0001262,decreased body weight|MP:0002891,increased insulin sensitivity|MP:0003799,impaired macrophage chemotaxis|MP:0005292,improved glucose tolerance|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0010025,decreased total body fat amount|MP:0010379,decreased respiratory quotient
MGI:2384031	Angptl3<hypl>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005318,decreased triglyceride level|MP:0009283,decreased gonadal fat pad weight|MP:0011578,increased lipoprotein lipase activity
MGI:3610614	Angptl3<tm1Akos>	MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0005375,adipose tissue phenotype|MP:0011578,increased lipoprotein lipase activity
MGI:3623491	Angptl3<tm1Kfuj>	MP:0000609,abnormal liver physiology|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002981,increased liver weight|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0009289,decreased epididymal fat pad weight
MGI:3849576	Angptl3<tm1Lex>	MP:0002644,decreased circulating triglyceride level
MGI:6120717	Angptl3<tm2b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000702,enlarged lymph nodes|MP:0002644,decreased circulating triglyceride level|MP:0004906,enlarged uterus|MP:0005179,decreased circulating cholesterol level|MP:0009709,hydrometra|MP:0013279,increased fasting circulating glucose level
MGI:3716687	Angptl4<Gt(OST352973)Lex>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000511,abnormal intestinal mucosa morphology|MP:0001879,abnormal lymphatic vessel morphology|MP:0002082,postnatal lethality|MP:0002118,abnormal lipid homeostasis|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005232,abnormal mesenteric lymph node morphology|MP:0005318,decreased triglyceride level|MP:0008034,enhanced lipolysis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0012080,chylous ascites
MGI:3610613	Angptl4<tm1Akos>	MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0005375,adipose tissue phenotype|MP:0011578,increased lipoprotein lipase activity
MGI:5637000	Angptl4<tm1b(EUCOMM)Hmgu>	MP:0001333,absent optic nerve|MP:0002644,decreased circulating triglyceride level
MGI:3505565	Angptl4<tm1Jig>	MP:0005666,abnormal adipose tissue physiology|MP:0010025,decreased total body fat amount
MGI:3716688	Angptl4<tm1Lex>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000511,abnormal intestinal mucosa morphology|MP:0001879,abnormal lymphatic vessel morphology|MP:0002082,postnatal lethality|MP:0002644,decreased circulating triglyceride level|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005232,abnormal mesenteric lymph node morphology|MP:0005318,decreased triglyceride level|MP:0008034,enhanced lipolysis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0012080,chylous ascites
MGI:5302391	Angptl4<tm1Vlcg>	MP:0002725,abnormal vein morphology|MP:0003070,increased vascular permeability|MP:0003658,abnormal capillary morphology|MP:0003719,abnormal pericyte morphology|MP:0005602,decreased angiogenesis|MP:0009660,abnormal induced retina neovascularization|MP:0010097,abnormal retina blood vessel morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3849577	Angptl4<tm2Lex>	MP:0005318,decreased triglyceride level
MGI:3576787	Angptl6<tm1Yo>	MP:0001261,obese|MP:0001554,increased circulating free fatty acids level|MP:0001559,hyperglycemia|MP:0001718,abnormal visceral yolk sac morphology|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0002925,abnormal cardiovascular development|MP:0002970,abnormal white adipose tissue morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0005178,increased circulating cholesterol level|MP:0005290,decreased oxygen consumption|MP:0005331,insulin resistance|MP:0005669,increased circulating leptin level|MP:0010024,increased total body fat amount|MP:0011014,decreased core body temperature|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:6712191	Angptl7<em1Pli>	MP:0004810,decreased hematopoietic stem cell number|MP:0011246,abnormal fetal liver hematopoietic progenitor cell morphology|MP:0013697,decreased granulocyte monocyte progenitor cell number
MGI:5292942	Angptl8<tm1(KOMP)Vlcg>	MP:0001262,decreased body weight|MP:0002644,decreased circulating triglyceride level|MP:0003976,decreased circulating VLDL triglyceride level|MP:0005282,decreased fatty acids level|MP:0005376,homeostasis/metabolism phenotype|MP:0005459,decreased percent body fat/body weight|MP:0008489,slow postnatal weight gain|MP:0010025,decreased total body fat amount|MP:0011578,increased lipoprotein lipase activity|MP:0013245,abnormal lipid metabolism
MGI:5007159	Angptl8<tm1Lex>	MP:0002644,decreased circulating triglyceride level
MGI:5695966	Ang<tm1.1(KOMP)Vlcg>	MP:0001488,increased startle reflex|MP:0005011,increased eosinophil cell number
MGI:6267403	Ang<tm1Dats>	MP:0000221,decreased leukocyte cell number|MP:0001545,abnormal hematopoietic system physiology|MP:0001658,increased mortality induced by gamma-irradiation|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0004809,increased hematopoietic stem cell number|MP:0005013,increased lymphocyte cell number|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011182,decreased hematopoietic cell number|MP:0011902,increased hematopoietic stem cell proliferation|MP:0013694,abnormal granulocyte monocyte progenitor cell morphology|MP:0013702,abnormal megakaryocyte-erythroid progenitor cell morphology
MGI:5502651	Ank1<ity16>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000611,jaundice|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001585,hemolytic anemia|MP:0002412,increased susceptibility to bacterial infection|MP:0002447,abnormal erythrocyte morphology|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002743,glomerulonephritis|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0003131,increased erythrocyte cell number|MP:0003332,liver abscess|MP:0003917,increased kidney weight|MP:0005013,increased lymphocyte cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005565,increased blood urea nitrogen level|MP:0008807,increased liver iron level|MP:0008808,decreased spleen iron level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010375,increased kidney iron level|MP:0011339,abnormal glomerular mesangium morphology
MGI:5528853	Ank1<M1Btlr>	MP:0000240,extramedullary hematopoiesis|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002812,spherocytosis|MP:0002813,microcytosis|MP:0003131,increased erythrocyte cell number|MP:0005344,increased circulating bilirubin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008809,increased spleen iron level|MP:0010074,stomatocytosis|MP:0010163,hemolysis|MP:0011285,increased circulating erythropoietin level|MP:0031085,increased erythrocyte osmotic fragility
MGI:4947988	Ank1<M1Wlst>	MP:0000208,decreased hematocrit|MP:0000217,abnormal leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000274,enlarged heart|MP:0000611,jaundice|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001585,hemolytic anemia|MP:0001601,abnormal myelopoiesis|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002812,spherocytosis|MP:0002830,gallstones|MP:0002874,decreased hemoglobin content|MP:0003131,increased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0003717,pallor|MP:0005096,erythroblastosis|MP:0005097,polychromatophilia|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008813,decreased common myeloid progenitor cell number|MP:0008956,decreased cellular hemoglobin content|MP:0009395,increased nucleated erythrocyte cell number|MP:0009431,decreased fetal weight|MP:0009674,decreased birth weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0031085,increased erythrocyte osmotic fragility
MGI:5438699	Ank1<MRI23420>	MP:0000611,jaundice|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002643,poikilocytosis|MP:0002812,spherocytosis|MP:0002813,microcytosis|MP:0002814,hyperchromasia|MP:0002872,polycythemia|MP:0003131,increased erythrocyte cell number|MP:0004952,increased spleen weight|MP:0005026,decreased susceptibility to parasitic infection|MP:0005505,thrombocytosis|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008809,increased spleen iron level|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0031085,increased erythrocyte osmotic fragility
MGI:1856298	Ank1<nb>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000314,schistocytosis|MP:0000599,enlarged liver|MP:0000611,jaundice|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000704,abnormal thymus development|MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0001265,decreased body size|MP:0001525,impaired balance|MP:0001585,hemolytic anemia|MP:0001625,cardiac hypertrophy|MP:0001924,infertility|MP:0002095,abnormal skin pigmentation|MP:0002397,abnormal bone marrow morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002594,low mean erythrocyte cell number|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002810,microcytic anemia|MP:0002812,spherocytosis|MP:0002813,microcytosis|MP:0002830,gallstones|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003656,abnormal erythrocyte physiology|MP:0005026,decreased susceptibility to parasitic infection|MP:0005344,increased circulating bilirubin level|MP:0005637,abnormal iron homeostasis|MP:0005639,hemosiderosis|MP:0008387,hypochromic anemia|MP:0008742,abnormal kidney iron level|MP:0008807,increased liver iron level|MP:0009395,increased nucleated erythrocyte cell number|MP:0010035,increased erythrocyte clearance|MP:0010074,stomatocytosis|MP:0010163,hemolysis|MP:0010177,acanthocytosis|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011188,increased erythrocyte protoporphyrin level|MP:0020409,abnormal cardiac thrombosis|MP:0031085,increased erythrocyte osmotic fragility
MGI:4367449	Ank1<pale>	MP:0001265,decreased body size|MP:0002095,abnormal skin pigmentation|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3844284	Ank1<Rbc2>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000611,jaundice|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002083,premature death|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002812,spherocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003656,abnormal erythrocyte physiology|MP:0005026,decreased susceptibility to parasitic infection|MP:0005344,increased circulating bilirubin level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008807,increased liver iron level|MP:0008850,increased hemoglobin concentration distribution width|MP:0009395,increased nucleated erythrocyte cell number|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0031085,increased erythrocyte osmotic fragility
MGI:5695219	Ank1<tm1Vso>	MP:0000751,myopathy|MP:0002279,abnormal diaphragm morphology|MP:0002841,impaired skeletal muscle contractility|MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0004121,abnormal sarcolemma morphology|MP:0004145,abnormal muscle electrophysiology|MP:0004231,abnormal calcium ion homeostasis|MP:0004246,abnormal extensor digitorum longus morphology|MP:0009411,abnormal skeletal muscle fiber triad morphology|MP:0009412,skeletal muscle fiber degeneration|MP:0012106,impaired exercise endurance
MGI:6784038	Ank2<em1Bnt>	MP:0001402,decreased locomotor activity|MP:0001441,increased grooming behavior|MP:0002152,abnormal brain morphology|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002920,decreased paired-pulse facilitation|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype|MP:0005404,abnormal axon morphology|MP:0012306,enhanced spatial learning|MP:0014373,increased miniature excitatory postsynaptic current amplitude|MP:0014375,increased miniature excitatory postsynaptic current frequency|MP:0020351,decreased vocalization|MP:0020357,abnormal excitatory synapse morphology
MGI:7513830	Ank2<em1Melr>	MP:0001636,irregular heartbeat|MP:0003141,cardiac fibrosis|MP:0003233,prolonged QT interval|MP:0004215,abnormal myocardial fiber physiology|MP:0004485,increased response of heart to induced stress|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval|MP:0010637,sinus bradycardia|MP:0011925,abnormal heart echocardiography feature
MGI:2179754	Ank2<tm1Bnt>	MP:0000781,decreased corpus callosum size|MP:0001262,decreased body weight|MP:0001392,abnormal locomotor behavior|MP:0001525,impaired balance|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002579,disorganized secondary lens fibers|MP:0003631,nervous system phenotype|MP:0003928,increased heart rate variability|MP:0005404,abnormal axon morphology|MP:0006142,abnormal sinoatrial node conduction|MP:0006219,optic nerve degeneration|MP:0008535,enlarged lateral ventricles|MP:0008872,abnormal physiological response to xenobiotic|MP:0009682,abnormal anterior corticospinal tract morphology|MP:0009683,abnormal lateral corticospinal tract morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011168,abnormal fat cell differentiation|MP:0012306,enhanced spatial learning|MP:0012462,decreased brain internal capsule size|MP:0020351,decreased vocalization|MP:0030017,decreased adipocyte glucose uptake
MGI:5646021	Ank2<tm2.1Bnt>	MP:0001260,increased body weight|MP:0001554,increased circulating free fatty acids level|MP:0002083,premature death|MP:0003212,increased susceptibility to age related obesity|MP:0003383,abnormal gluconeogenesis|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0006094,increased fat cell size|MP:0009288,increased epididymal fat pad weight|MP:0011168,abnormal fat cell differentiation|MP:0030016,increased adipocyte glucose uptake|MP:0031269,increased susceptibility to diet-induced hepatic steatosis
MGI:5646022	Ank2<tm3.1Bnt>	MP:0001260,increased body weight|MP:0001554,increased circulating free fatty acids level|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003212,increased susceptibility to age related obesity|MP:0003383,abnormal gluconeogenesis|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0006094,increased fat cell size|MP:0009288,increased epididymal fat pad weight|MP:0010024,increased total body fat amount|MP:0011168,abnormal fat cell differentiation|MP:0030016,increased adipocyte glucose uptake|MP:0030017,decreased adipocyte glucose uptake|MP:0031269,increased susceptibility to diet-induced hepatic steatosis|MP:0031618,decreased skeletal muscle cell glucose uptake|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:6784039	Ank2<tm4.1Bnt>	MP:0002557,abnormal social/conspecific interaction behavior|MP:0005404,abnormal axon morphology|MP:0012306,enhanced spatial learning|MP:0020351,decreased vocalization
MGI:7425509	Ank3<em1(IMPC)Bay>	MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:2179751	Ank3<tm1Bnt>	MP:0000745,tremors|MP:0000852,small cerebellum|MP:0000876,Purkinje cell degeneration|MP:0000880,decreased Purkinje cell number|MP:0000890,thin cerebellar molecular layer|MP:0000947,convulsive seizures|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0002578,impaired ability to fire action potentials
MGI:5538265	Ank3<tm2.1Bnt>	MP:0002081,perinatal lethality|MP:0005404,abnormal axon morphology
MGI:5538266	Ank3<tm2.2Bnt>	MP:0010943,abnormal bronchus epithelium morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011843,abnormal kidney collecting duct epithelium morphology
MGI:5829748	Ank3<tm3Bnt>	MP:0002082,postnatal lethality|MP:0002272,abnormal nervous system electrophysiology|MP:0004994,abnormal brain wave pattern|MP:0005402,abnormal action potential|MP:0005404,abnormal axon morphology|MP:0009939,abnormal hippocampus neuron morphology|MP:0010732,abnormal node of Ranvier morphology|MP:0010733,abnormal axon initial segment morphology|MP:0010735,abnormal paranodal axoglial junction morphology|MP:0014329,abnormal Purkinje cell axon morphology|MP:0014621,abnormal brain alpha wave pattern
MGI:1856651	Ank<ank>	MP:0000160,kyphosis|MP:0000163,abnormal cartilage morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000559,abnormal femur morphology|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001765,abnormal ion homeostasis|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002083,premature death|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0002932,abnormal joint morphology|MP:0002993,autoimmune arthritis|MP:0003189,fused joints|MP:0003198,calcified tendon|MP:0003200,calcified joint|MP:0003930,abnormal tooth hard tissue morphology|MP:0003933,abnormal cementum morphology|MP:0004173,abnormal intervertebral disk morphology|MP:0004685,calcified intervertebral disk|MP:0005006,abnormal osteoblast physiology|MP:0005503,abnormal tendon morphology|MP:0005504,abnormal ligament morphology|MP:0005508,abnormal skeleton morphology|MP:0009005,abnormal sesamoid bone of gastrocnemius morphology|MP:0010053,decreased grip strength|MP:0010522,calcified aorta|MP:0030841,abnormal transverse acetabular ligament morphology|MP:0030863,decreased joint mobility|MP:0030865,abnormal synovial joint cavity morphology
MGI:2183465	Ankfn1<nmf9>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0001522,impaired swimming|MP:0004742,abnormal vestibular system physiology|MP:0004924,abnormal behavior|MP:0005191,head tilt|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype|MP:0009456,impaired cued conditioning behavior|MP:0009712,impaired conditioned place preference behavior|MP:0020467,abnormal circadian behavior|MP:0020468,abnormal circadian behavior period|MP:0020470,shortened circadian behavior period
MGI:4127244	Ankfy1<Gt(RRE069)Byg>	MP:0000160,kyphosis|MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000774,decreased brain size|MP:0000852,small cerebellum|MP:0000876,Purkinje cell degeneration|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002183,gliosis|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0012051,spasticity|MP:0014178,increased brain apoptosis
MGI:5696889	Ankfy1<tm1b(KOMP)Mbp>	MP:0000220,increased monocyte cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4847680	Ankhd1<tm1a(KOMP)Wtsi>	MP:0002079,increased circulating insulin level|MP:0008806,increased circulating amylase level
MGI:5698069	Ankib1<tm1b(EUCOMM)Hmgu>	MP:0001513,limb grasping|MP:0001566,increased circulating phosphate level|MP:0002764,short tibia|MP:0002968,increased circulating alkaline phosphatase level|MP:0013279,increased fasting circulating glucose level
MGI:5827621	Ankle1<tm1.1(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5827623	Ankle1<tm1.2(KOMP)Wtsi>	MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4363814	Ankle1<tm1(KOMP)Wtsi>	MP:0001402,decreased locomotor activity|MP:0002075,abnormal coat/hair pigmentation|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6257450	Ankle2<em1(IMPC)Bay>	MP:0000280,thin ventricular wall|MP:0001415,increased exploration in new environment|MP:0002792,abnormal retina vasculature morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6404514	Ankmy2<em1(IMPC)Bay>	MP:0000266,abnormal heart morphology|MP:0001672,abnormal embryo development|MP:0001691,abnormal somite shape|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001712,abnormal placenta development|MP:0002151,abnormal neural tube morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0003717,pallor|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:4841499	Ankmy2<tm1a(EUCOMM)Hmgu>	MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:6488662	Ankmy2<tm1b(EUCOMM)Hmgu>	MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0008784,craniorachischisis|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:5692732	Ankrd10<tm2b(EUCOMM)Hmgu>	MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:5548681	Ankrd11<tm1b(EUCOMM)Wtsi>	MP:0001258,decreased body length|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0001556,increased circulating HDL cholesterol level|MP:0001672,abnormal embryo development|MP:0002699,abnormal vitreous body morphology|MP:0004738,abnormal auditory brainstem response|MP:0005178,increased circulating cholesterol level|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:6885539	Ankrd11<tm1c(EUCOMM)Wtsi>	MP:0000074,abnormal neurocranium morphology|MP:0000085,large anterior fontanelle|MP:0000105,impaired ossification of basisphenoid bone|MP:0000107,abnormal frontal bone morphology|MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0000432,abnormal head morphology|MP:0000440,domed cranium|MP:0000458,abnormal mandible morphology|MP:0001302,eyelids open at birth|MP:0002233,abnormal nose morphology|MP:0002639,micrognathia|MP:0002998,abnormal bone remodeling|MP:0003420,delayed intramembranous bone ossification|MP:0004282,retrognathia|MP:0004377,small frontal bone|MP:0004418,small parietal bone|MP:0004453,abnormal pterygoid bone morphology|MP:0004454,absent pterygoid process|MP:0004592,small mandible|MP:0004869,frontal bone hypoplasia|MP:0004985,decreased osteoclast cell number|MP:0004993,decreased bone resorption|MP:0005249,abnormal palatine bone morphology|MP:0005408,hypopigmentation|MP:0008273,abnormal intramembranous bone ossification|MP:0008753,abnormal osteocyte morphology|MP:0009883,palatal shelf hypoplasia|MP:0009888,palatal shelves fail to meet at midline|MP:0009904,tongue hypoplasia|MP:0009907,decreased tongue size|MP:0010029,abnormal basicranium morphology|MP:0010768,mortality/aging|MP:0010869,decreased bone trabecula number|MP:0011089,perinatal lethality, complete penetrance|MP:0011642,abnormal bone collagen fibril morphology|MP:0012085,midface hypoplasia|MP:0012546,triangular face|MP:0013545,cleft hard palate|MP:0014012,abnormal cranial blood vasculature morphology|MP:0020040,decreased bone ossification|MP:0020301,short tongue|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0030067,narrow face|MP:0030095,abnormal midface morphology|MP:0030316,enlarged neurocranium|MP:0030431,wide metopic suture|MP:0030533,abnormal snout skin morphology|MP:0031460,abnormal palatal shelf morphology
MGI:3797584	Ankrd11<Yod>	MP:0000102,abnormal nasal bone morphology|MP:0000160,kyphosis|MP:0000440,domed cranium|MP:0000441,increased cranium width|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001698,decreased embryo size|MP:0002116,abnormal craniofacial bone morphology|MP:0003795,abnormal bone structure|MP:0003842,abnormal metopic suture morphology|MP:0004016,decreased bone mass|MP:0004180,failure of initiation of embryo turning|MP:0004380,short frontal bone|MP:0004421,enlarged parietal bone|MP:0004471,short nasal bone|MP:0004985,decreased osteoclast cell number|MP:0005668,decreased circulating leptin level|MP:0010043,abnormal frontonasal suture morphology|MP:0010968,decreased compact bone area|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0020010,decreased bone mineral density of femur|MP:0030066,short face|MP:0030069,broad face
MGI:6856778	Ankrd13c<em1(IMPC)Tcp>	MP:0001325,abnormal retina morphology|MP:0001944,abnormal pancreas morphology|MP:0002060,abnormal skin morphology|MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin
MGI:6197500	Ankrd16<tm1.1Slac>	MP:0002169,no abnormal phenotype detected
MGI:2155467	Ankrd17<Gt(PT1-ATG)114Wrst>	MP:0002169,no abnormal phenotype detected
MGI:4360512	Ankrd17<tm1.1Yty>	MP:0000259,abnormal vascular development|MP:0000267,abnormal heart development|MP:0000292,distended pericardium|MP:0000295,trabecula carnea hypoplasia|MP:0001614,abnormal blood vessel morphology|MP:0001634,internal hemorrhage|MP:0001722,pale yolk sac|MP:0001915,intracranial hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0002652,thin myocardium|MP:0003070,increased vascular permeability|MP:0003658,abnormal capillary morphology|MP:0003984,embryonic growth retardation|MP:0005244,hemopericardium|MP:0005592,abnormal vascular smooth muscle morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011264,abnormal cardiac mesenchyme morphology
MGI:5707274	Ankrd1<tm1.1Jmda>	MP:0002169,no abnormal phenotype detected
MGI:5707279	Ankrd1<tm1.2Jmda>	MP:0001220,epidermal necrosis|MP:0001731,abnormal postnatal growth|MP:0001792,impaired wound healing|MP:0002908,delayed wound healing|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0012688,abnormal heart ventricles weight
MGI:3760783	Ankrd1<tm1Krc>	MP:0002169,no abnormal phenotype detected
MGI:3760785	Ankrd23<tm1Krc>	MP:0002169,no abnormal phenotype detected
MGI:6274400	Ankrd24<em1(IMPC)J>	MP:0001489,decreased startle reflex|MP:0004738,abnormal auditory brainstem response
MGI:3774418	Ankrd26<Gt(XK525)Byg>	MP:0000005,increased brown adipose tissue amount|MP:0000008,increased white adipose tissue amount|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001261,obese|MP:0001433,polyphagia|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002079,increased circulating insulin level|MP:0002833,increased heart weight|MP:0003917,increased kidney weight|MP:0003960,increased lean body mass|MP:0005331,insulin resistance|MP:0005450,abnormal energy expenditure|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size
MGI:5612827	Ankrd27<tm1b(EUCOMM)Hmgu>	MP:0002764,short tibia|MP:0011965,decreased total retina thickness
MGI:6149988	Ankrd28<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia
MGI:3760784	Ankrd2<tm1Krc>	MP:0000759,abnormal skeletal muscle morphology|MP:0001845,abnormal inflammatory response|MP:0005385,cardiovascular system phenotype|MP:0010768,mortality/aging
MGI:6343192	Ankrd31<em1Atot>	MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001930,abnormal meiosis|MP:0002216,abnormal seminiferous tubule morphology|MP:0004852,decreased testis weight|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0005431,decreased oocyte number|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0008967,absent chiasmata formation|MP:0008995,early reproductive senescence|MP:0009451,abnormal chromosomal synapsis|MP:0009452,abnormal synaptonemal complex|MP:0010948,abnormal double-strand DNA break repair|MP:0011751,abnormal X-Y chromosome synapsis during male meiosis|MP:0014052,increased male germ cell apoptosis|MP:0031474,increased female germ cell apoptosis
MGI:6831182	Ankrd31<em1Flor>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0020451,decreased sperm progressive motility
MGI:7512901	Ankrd31<em1(IMPC)Hmgu>	MP:0000689,abnormal spleen morphology
MGI:6343226	Ankrd31<em1Sky>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0001931,abnormal oogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002777,absent ovarian follicles|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0005431,decreased oocyte number|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0008967,absent chiasmata formation|MP:0009451,abnormal chromosomal synapsis|MP:0010948,abnormal double-strand DNA break repair|MP:0011121,decreased primordial ovarian follicle number|MP:0011751,abnormal X-Y chromosome synapsis during male meiosis|MP:0014052,increased male germ cell apoptosis|MP:0031020,premature ovarian failure
MGI:6343193	Ankrd31<em2Atot>	MP:0001923,reduced female fertility|MP:0001925,male infertility
MGI:6831183	Ankrd31<em2Flor>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0020451,decreased sperm progressive motility
MGI:6343227	Ankrd31<em2Sky>	MP:0004852,decreased testis weight
MGI:6831229	Ankrd31<em3Flor>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0020451,decreased sperm progressive motility
MGI:5810098	Ankrd35<em1(IMPC)J>	MP:0001312,abnormal cornea morphology
MGI:7539152	Ankrd42<em1(IMPC)J>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6406438	Ankrd44<em1(IMPC)J>	MP:0003179,thrombocytopenia|MP:0011496,abnormal head size
MGI:5812890	Ankrd45<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:7568029	Ankrd46<em1(IMPC)Mbp>	MP:0000220,increased monocyte cell number|MP:0002699,abnormal vitreous body morphology
MGI:7550753	Ankrd46<em1Tmg>	MP:0001265,decreased body size
MGI:6257592	Ankrd48<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0002060,abnormal skin morphology|MP:0003883,enlarged stomach|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7616789	Ankrd49<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0004085,abnormal heartbeat|MP:0011100,preweaning lethality, complete penetrance
MGI:7425511	Ankrd50<em1(IMPC)Bay>	MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6161380	Ankrd52<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001529,abnormal vocalization|MP:0001697,abnormal embryo size|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:7384345	Ankrd60<em1(IMPC)J>	MP:0000194,increased circulating calcium level|MP:0000221,decreased leukocyte cell number|MP:0010052,increased grip strength
MGI:4419461	Ankrd65<tm1(KOMP)Wtsi>	MP:0001417,decreased exploration in new environment
MGI:5661416	Ankrd6<tm1Pche>	MP:0002623,abnormal vestibular hair cell morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype
MGI:6361159	Ankrd7<em1Osb>	MP:0005389,reproductive system phenotype
MGI:4419197	Ankrd9<tm1(KOMP)Wtsi>	MP:0001257,increased body length|MP:0002875,decreased erythrocyte cell number|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:5896631	Anks1b<tm1b(KOMP)Wtsi>	MP:0001409,increased stereotypic behavior|MP:0009142,decreased prepulse inhibition|MP:0009746,enhanced behavioral response to xenobiotic|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031391,increased locomotor activity
MGI:5779292	Anks1b<tm1Bnaj>	MP:0001475,reduced long-term depression|MP:0001900,impaired synaptic plasticity|MP:0003631,nervous system phenotype|MP:0011274,short excitatory postsynaptic current decay time
MGI:7425512	Anks1<em1(IMPC)Bay>	MP:0001513,limb grasping|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3867137	Anks1<Gt(CF0537)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:6120799	Anks1<tm1b(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0000280,thin ventricular wall|MP:0010097,abnormal retina blood vessel morphology|MP:0010123,increased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:5763008	Anks3<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:4433863	Anks4b<tm2a(EUCOMM)Wtsi>	MP:0002098,abnormal vibrissa morphology
MGI:5463579	Anks6<b2b1801.1Clo>	MP:0000273,overriding aortic valve|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0004133,heterotaxia|MP:0006061,right atrial isomerism|MP:0006063,abnormal inferior vena cava morphology|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0011683,dual inferior vena cava
MGI:5637085	Anks6<tm1b(KOMP)Wtsi>	MP:0000282,abnormal interatrial septum morphology|MP:0001175,abnormal lung morphology|MP:0002747,abnormal aortic valve morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0003827,abnormal Wolffian duct morphology|MP:0004110,transposition of great arteries|MP:0004201,fetal growth retardation|MP:0010406,common atrium|MP:0010418,perimembraneous ventricular septal defect|MP:0010440,anomalous pulmonary venous connection|MP:0010607,common atrioventricular valve|MP:0010854,lung situs inversus|MP:0011100,preweaning lethality, complete penetrance|MP:0011249,abdominal situs inversus|MP:0011683,dual inferior vena cava|MP:0013876,absent ductus venosus valve|MP:0013975,abnormal coronary sinus connection|MP:0013977,symmetric azygos veins
MGI:6727369	Anks6<tm1d(KOMP)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000273,overriding aortic valve|MP:0000531,right pulmonary isomerism|MP:0000601,small liver|MP:0001654,hepatic necrosis|MP:0002766,situs inversus|MP:0002767,situs ambiguus|MP:0002928,abnormal bile duct morphology|MP:0002929,abnormal bile duct development|MP:0003253,dilated bile duct|MP:0003333,liver fibrosis|MP:0003943,abnormal hepatobiliary system development|MP:0004133,heterotaxia|MP:0005294,abnormal heart ventricle morphology|MP:0008992,abnormal portal lobule morphology|MP:0010412,atrioventricular septal defect|MP:0011089,perinatal lethality, complete penetrance|MP:0011249,abdominal situs inversus|MP:0011682,renal glomerulus cyst|MP:0012238,abnormal cholangiocyte primary cilium morphology|MP:0013611,abnormal bile duct epithelium morphology
MGI:4889192	Ank<tm1.1Ejr>	MP:0000062,increased bone mineral density|MP:0000559,abnormal femur morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001570,abnormal circulating enzyme level|MP:0002083,premature death|MP:0002116,abnormal craniofacial bone morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003109,short femur|MP:0003795,abnormal bone structure|MP:0005105,abnormal middle ear ossicle morphology|MP:0005508,abnormal skeleton morphology|MP:0008158,increased diameter of femur|MP:0008396,abnormal osteoclast differentiation|MP:0010053,decreased grip strength|MP:0010123,increased bone mineral content|MP:0010941,abnormal foramen magnum morphology|MP:0030110,incudomalleolar fusion|MP:0030222,hyperostosis|MP:0030223,mandibular hyperostosis|MP:0030278,thick neurocranium|MP:0030310,abnormal cranial foramen morphology|MP:0030382,absent paranasal sinus|MP:0030417,craniofacial hyperostosis|MP:0030791,club-shaped femur|MP:0030863,decreased joint mobility
MGI:3715331	Ank<tm1.1Kng>	MP:0000079,abnormal basioccipital bone morphology|MP:0000135,decreased compact bone thickness|MP:0000438,abnormal cranium morphology|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0002896,abnormal bone mineralization|MP:0002932,abnormal joint morphology|MP:0003189,fused joints|MP:0003740,fusion of middle ear ossicles|MP:0003930,abnormal tooth hard tissue morphology|MP:0003933,abnormal cementum morphology|MP:0010879,decreased trabecular bone volume|MP:0010933,decreased trabecular bone connectivity density|MP:0030094,foramen magnum stenosis|MP:0030160,abnormal auditory bulla morphology|MP:0030319,abnormal temporal bone petrous part morphology|MP:0030863,decreased joint mobility
MGI:3715330	Ank<tm1Kng>	MP:0002932,abnormal joint morphology|MP:0003189,fused joints|MP:0003933,abnormal cementum morphology|MP:0006433,abnormal articular cartilage morphology|MP:0030863,decreased joint mobility
MGI:5708256	Ankub1<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0010123,increased bone mineral content
MGI:7425513	Anln<em1(IMPC)Bay>	MP:0001672,abnormal embryo development|MP:0003984,embryonic growth retardation|MP:0010124,decreased bone mineral content|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011959,abnormal eye posterior chamber depth
MGI:6358611	Anln<tm1c(EUCOMM)Wtsi>	MP:0000920,abnormal myelination|MP:0003631,nervous system phenotype|MP:0008814,decreased nerve conduction velocity|MP:0012674,tomacula
MGI:6151400	Ano10<tm1Jrr>	MP:0014208,decreased intestinal epithelial chloride transmembrane transport
MGI:5588146	Ano1<tm1.1Cahb>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000249,abnormal blood vessel physiology|MP:0003026,decreased vasoconstriction|MP:0003719,abnormal pericyte morphology|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005592,abnormal vascular smooth muscle morphology
MGI:5461852	Ano1<tm1.1Jwo>	MP:0000965,abnormal sensory neuron morphology|MP:0001973,increased thermal nociceptive threshold|MP:0005386,behavior/neurological phenotype|MP:0010771,integument phenotype
MGI:5588154	Ano1<tm1.2Cahb>	MP:0003120,abnormal tracheal cartilage morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:3809591	Ano1<tm1Bdh>	MP:0001262,decreased body weight|MP:0001575,cyanosis|MP:0002282,abnormal trachea morphology|MP:0002284,abnormal tracheal smooth muscle morphology|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0008489,slow postnatal weight gain|MP:0010988,abnormal bronchial cartilage morphology|MP:0010994,aerophagia|MP:0011085,postnatal lethality, complete penetrance
MGI:5442019	Ano1<tm1Jrr>	MP:0002962,increased urine protein level|MP:0009640,abnormal renal tubule epithelium morphology
MGI:5569641	Ano1<tm2Jrr>	MP:0002666,increased circulating aldosterone level|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0003352,increased circulating renin level|MP:0005367,renal/urinary system phenotype|MP:0005618,decreased urine potassium level|MP:0006317,decreased urine sodium level|MP:0009640,abnormal renal tubule epithelium morphology|MP:0011460,decreased urine chloride ion level|MP:0014208,decreased intestinal epithelial chloride transmembrane transport
MGI:7425514	Ano2<em1(IMPC)Ccpcz>	MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0002110,abnormal digit morphology|MP:0002339,abnormal lymph node morphology|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:5052299	Ano2<tm1.1Tjj>	MP:0001983,abnormal olfactory system physiology
MGI:6158463	Ano3<em2(IMPC)Mbp>	MP:0002942,decreased circulating alanine transaminase level
MGI:6790221	Ano3<tm1.1Lyj>	MP:0001777,abnormal body temperature homeostasis|MP:0009358,environmentally induced seizures
MGI:7461419	Ano4<em1(IMPC)Kmpc>	MP:0001399,hyperactivity|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010124,decreased bone mineral content
MGI:6489964	Ano5<em1Huyi>	MP:0000062,increased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000558,abnormal tibia morphology|MP:0000759,abnormal skeletal muscle morphology|MP:0001922,reduced male fertility|MP:0002818,abnormal dentin morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003668,abnormal periodontal ligament morphology|MP:0004148,increased compact bone thickness|MP:0004214,abnormal long bone diaphysis morphology|MP:0004358,bowed tibia|MP:0005006,abnormal osteoblast physiology|MP:0005422,osteosclerosis|MP:0005508,abnormal skeleton morphology|MP:0005601,increased angiogenesis|MP:0009346,decreased trabecular bone thickness|MP:0010090,increased circulating creatine kinase level|MP:0010123,increased bone mineral content|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0013630,increased bone trabecular spacing|MP:0030050,large mandible|MP:0030132,periodontium inflammation|MP:0030223,mandibular hyperostosis
MGI:7491944	Ano5<em2Huyi>	MP:0000062,increased bone mineral density|MP:0000458,abnormal mandible morphology|MP:0001541,abnormal osteoclast physiology|MP:0001921,reduced fertility|MP:0002968,increased circulating alkaline phosphatase level|MP:0004148,increased compact bone thickness|MP:0004358,bowed tibia|MP:0004985,decreased osteoclast cell number|MP:0004991,decreased bone strength|MP:0005190,osteomyelitis|MP:0005422,osteosclerosis|MP:0009346,decreased trabecular bone thickness|MP:0010123,increased bone mineral content|MP:0010869,decreased bone trabecula number|MP:0010932,increased trabecular bone connectivity density|MP:0011642,abnormal bone collagen fibril morphology|MP:0011710,enhanced osteoblast differentiation|MP:0013630,increased bone trabecular spacing|MP:0020039,increased bone ossification|MP:0030050,large mandible
MGI:6148084	Ano5<tm1.2Naga>	MP:0001922,reduced male fertility|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0009280,decreased activated sperm motility|MP:0020451,decreased sperm progressive motility
MGI:6149153	Ano5<tm1Lrk>	MP:0000759,abnormal skeletal muscle morphology|MP:0002279,abnormal diaphragm morphology|MP:0003082,abnormal gastrocnemius morphology|MP:0003083,abnormal tibialis anterior morphology|MP:0003646,increased muscle fatigability|MP:0005369,muscle phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009414,skeletal muscle fiber necrosis|MP:0010090,increased circulating creatine kinase level|MP:0013239,impaired skeletal muscle regeneration|MP:0014344,abnormal skeletal muscle fiber mitochondrial morphology|MP:0031328,delayed skeletal muscle regeneration
MGI:5754582	Ano6<em3(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0005278,abnormal cholesterol homeostasis|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011954,shortened PQ interval
MGI:4127698	Ano6<Gt(RRF355)Byg>	MP:0000547,short limbs|MP:0004200,decreased fetal size|MP:0004672,short ribs|MP:0005508,abnormal skeleton morphology|MP:0010099,abnormal thoracic cage shape|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization|MP:0020138,delayed bone mineralization|MP:0030029,wide cranial sutures|MP:0030857,absent olecranon
MGI:5441003	Ano6<tm1.2Lyj>	MP:0002417,abnormal megakaryocyte morphology|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0031120,decreased susceptibility to induced thrombosis
MGI:5486205	Ano6<tm1Avor>	MP:0000130,abnormal trabecular bone morphology|MP:0000547,short limbs|MP:0004200,decreased fetal size|MP:0004672,short ribs|MP:0005006,abnormal osteoblast physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005606,increased bleeding time|MP:0009445,osteomalacia|MP:0010099,abnormal thoracic cage shape|MP:0010926,increased osteoid volume|MP:0010929,increased osteoid thickness|MP:0011088,neonatal lethality, incomplete penetrance|MP:0020040,decreased bone ossification|MP:0020138,delayed bone mineralization|MP:0030029,wide cranial sutures|MP:0030857,absent olecranon
MGI:5775821	Ano7<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology
MGI:5776201	Ano8<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001523,impaired righting response|MP:0002075,abnormal coat/hair pigmentation|MP:0005178,increased circulating cholesterol level|MP:0010124,decreased bone mineral content
MGI:7428505	Ano9<em1Uoh>	MP:0020852,abnormal olfactory behavior
MGI:3043774	Anp32a<tm1Hzo>	MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype
MGI:4949091	Anp32a<tm1Mak>	MP:0005384,cellular phenotype|MP:0010768,mortality/aging
MGI:5003050	Anp32b<tm1Mak>	MP:0000026,abnormal inner ear morphology|MP:0000111,cleft palate|MP:0000160,kyphosis|MP:0000186,decreased circulating HDL cholesterol level|MP:0000428,abnormal craniofacial morphology|MP:0000536,hydroureter|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002731,megacolon|MP:0003786,premature aging|MP:0004025,polyploidy|MP:0004499,increased incidence of tumors by chemical induction|MP:0005179,decreased circulating cholesterol level|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0005567,decreased circulating total protein level|MP:0005635,decreased circulating bilirubin level|MP:0008817,hematoma|MP:0010819,primary atelectasis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011380,enlarged brain ventricles
MGI:4129176	Anp32e<Gt(RRK001)Byg>	MP:0001405,impaired coordination|MP:0001513,limb grasping
MGI:4867888	Anp32e<tm1Mak>	MP:0002169,no abnormal phenotype detected
MGI:6367953	Anpep<em1(IMPC)Hmgu>	MP:0001312,abnormal cornea morphology|MP:0005544,cornea deposits|MP:0005599,increased cardiac muscle contractility
MGI:4830680	Anpep<tm1.1Lsha>	MP:0002451,abnormal macrophage physiology|MP:0005387,immune system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number
MGI:5582781	Anpep<tm1Afk>	MP:0012075,impaired mammary gland growth during pregnancy
MGI:3702506	Anpep<tm1Sid>	MP:0003711,pathological neovascularization|MP:0005389,reproductive system phenotype|MP:0008852,retina neovascularization
MGI:5758945	Anta	MP:0002743,glomerulonephritis|MP:0004794,increased anti-nuclear antigen antibody level
MGI:3609202	Anth2<CBA/J>	MP:0002411,decreased susceptibility to bacterial infection
MGI:3608860	Anth<C3H/HeNCrj>	MP:0002411,decreased susceptibility to bacterial infection
MGI:5692805	Antkmt<tm1.1(KOMP)Vlcg>	MP:0001120,abnormal uterus morphology|MP:0001399,hyperactivity|MP:0002941,increased circulating alanine transaminase level|MP:0004924,abnormal behavior|MP:0005343,increased circulating aspartate transaminase level|MP:0009709,hydrometra|MP:0020870,decreased thigmotaxis
MGI:4353383	Antxr1<tm1.2Bstc>	MP:0000116,abnormal tooth development|MP:0000120,malocclusion|MP:0000133,abnormal long bone metaphysis morphology|MP:0000137,abnormal vertebrae morphology|MP:0001126,abnormal ovary morphology|MP:0002835,abnormal cranial suture morphology|MP:0003447,decreased tumor growth/size|MP:0003668,abnormal periodontal ligament morphology|MP:0005385,cardiovascular system phenotype|MP:0010747,abnormal enamel organ morphology|MP:0013258,abnormal extracellular matrix morphology|MP:0030083,long upper incisors|MP:0030541,misaligned incisors
MGI:4352941	Antxr1<tm1.2Lepp>	MP:0001926,female infertility|MP:0005387,immune system phenotype|MP:0008944,decreased sensitivity to induced cell death|MP:0010768,mortality/aging|MP:0030541,misaligned incisors
MGI:6153738	Antxr2<em1(IMPC)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010067,increased red blood cell distribution width
MGI:5437300	Antxr2<tm1.1Jkit>	MP:0001120,abnormal uterus morphology|MP:0001135,abnormal uterine cervix morphology|MP:0001926,female infertility|MP:0004038,lymphangiectasis|MP:0004938,dilated vasculature|MP:0005389,reproductive system phenotype|MP:0006042,increased apoptosis|MP:0008028,pregnancy-related premature death|MP:0008256,abnormal myometrium morphology|MP:0009209,abnormal internal female genitalia morphology|MP:0009671,abnormal uterus physiology|MP:0012010,parturition failure|MP:0031434,increased miscarriage rate
MGI:4352943	Antxr2<tm1.1Lepp>	MP:0010768,mortality/aging
MGI:4352944	Antxr2<tm1.2Lepp>	MP:0001926,female infertility|MP:0008944,decreased sensitivity to induced cell death|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:1856657	anx	MP:0000189,hypoglycemia|MP:0000436,abnormal head movements|MP:0000462,abnormal digestive system morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001436,abnormal suckling behavior|MP:0001845,abnormal inflammatory response|MP:0002083,premature death|MP:0002176,increased brain weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0004950,abnormal brain vasculature morphology|MP:0004953,decreased spleen weight|MP:0004955,increased thymus weight|MP:0005150,cachexia|MP:0005178,increased circulating cholesterol level|MP:0005534,decreased body temperature|MP:0005565,increased blood urea nitrogen level|MP:0008821,increased blood uric acid level|MP:0009246,pale spleen|MP:0011940,decreased food intake
MGI:5888868	Anxa10<em1Siag>	MP:0003718,maternal effect|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype
MGI:8243872	Anxa11<em1Lcu>	MP:0000743,muscle spasm|MP:0000751,myopathy|MP:0000752,dystrophic muscle|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002269,muscular atrophy|MP:0003354,astrocytosis|MP:0004087,abnormal muscle fiber morphology|MP:0004091,abnormal Z line morphology|MP:0004145,abnormal muscle electrophysiology|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential|MP:0006082,CNS inflammation|MP:0010053,decreased grip strength|MP:0011975,neuronal cytoplasmic inclusions|MP:0030940,impaired autophagy
MGI:6336111	Anxa13<em1(IMPC)Kmpc>	MP:0001146,abnormal testis morphology|MP:0002764,short tibia|MP:0002997,enlarged seminal vesicle|MP:0020421,increased freezing behavior
MGI:6367957	Anxa1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0002631,abnormal epididymis morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002989,small kidney|MP:0004151,decreased circulating iron level|MP:0004906,enlarged uterus|MP:0004931,enlarged epididymis|MP:0010935,increased airway resistance
MGI:2449710	Anxa1<tm1Rjf>	MP:0000003,abnormal adipose tissue morphology|MP:0000062,increased bone mineral density|MP:0000074,abnormal neurocranium morphology|MP:0000107,abnormal frontal bone morphology|MP:0000438,abnormal cranium morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000495,abnormal colon morphology|MP:0001263,weight loss|MP:0001273,decreased metastatic potential|MP:0001739,abnormal adrenal gland secretion|MP:0001798,impaired macrophage phagocytosis|MP:0001846,increased inflammatory response|MP:0002079,increased circulating insulin level|MP:0002442,abnormal leukocyte physiology|MP:0002908,delayed wound healing|MP:0003447,decreased tumor growth/size|MP:0003544,abnormal vascular endothelial cell migration|MP:0003843,abnormal sagittal suture morphology|MP:0004003,abnormal vascular endothelial cell physiology|MP:0005129,increased adrenocorticotropin level|MP:0005249,abnormal palatine bone morphology|MP:0005334,abnormal fat pad morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005666,abnormal adipose tissue physiology|MP:0008302,thin adrenal cortex|MP:0008322,abnormal somatotroph morphology|MP:0008323,abnormal lactotroph morphology|MP:0008325,abnormal gonadotroph morphology|MP:0008327,abnormal corticotroph morphology|MP:0008427,decreased corticotroph cell size|MP:0008537,increased susceptibility to induced colitis|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010144,abnormal tumor vascularization|MP:0013341,abnormal folliculo-stellate cell morphology|MP:0014166,ectopic cranial bone|MP:0020316,decreased vascular endothelial cell proliferation
MGI:3028929	Anxa2<tm1Kah>	MP:0000259,abnormal vascular development|MP:0000260,abnormal angiogenesis|MP:0001262,decreased body weight|MP:0001545,abnormal hematopoietic system physiology|MP:0002551,abnormal blood coagulation|MP:0031121,increased susceptibility to induced thrombosis
MGI:6416299	Anxa3<tm1c(EUCOMM)Hmgu>	MP:0010097,abnormal retina blood vessel morphology|MP:0010098,abnormal retina blood vessel pattern
MGI:3530283	Anxa4<Gt(OST134786)Lex>	MP:0001386,abnormal maternal nurturing|MP:0005367,renal/urinary system phenotype
MGI:2655676	Anxa5<tm1Epo>	MP:0001845,abnormal inflammatory response|MP:0002169,no abnormal phenotype detected|MP:0003009,abnormal cytokine secretion|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction
MGI:4432672	Anxa6<tm1a(EUCOMM)Wtsi>	MP:0002098,abnormal vibrissa morphology|MP:0002697,abnormal eye size
MGI:2159012	Anxa6<tm1Moss>	MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005600,increased heart ventricle muscle contractility
MGI:4839130	Anxa6<tm1(NCOM)Cmhd>	MP:0001262,decreased body weight|MP:0005633,increased circulating sodium level
MGI:2159006	Anxa7<tm1Ngl>	MP:0001765,abnormal ion homeostasis|MP:0002447,abnormal erythrocyte morphology|MP:0005379,endocrine/exocrine gland phenotype|MP:0005390,skeleton phenotype|MP:0005397,hematopoietic system phenotype|MP:0005505,thrombocytosis|MP:0008916,abnormal astrocyte physiology|MP:0009548,abnormal platelet aggregation|MP:0010768,mortality/aging
MGI:2159005	Anxa7<tm1Pll>	MP:0001260,increased body weight|MP:0001264,increased body size|MP:0001544,abnormal cardiovascular system physiology|MP:0001727,abnormal embryo implantation|MP:0001765,abnormal ion homeostasis|MP:0001869,pancreas inflammation|MP:0001917,intraventricular hemorrhage|MP:0001934,increased litter size|MP:0002020,increased tumor incidence|MP:0002865,increased growth rate|MP:0003059,decreased insulin secretion|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003562,abnormal pancreatic beta cell physiology|MP:0004028,chromosome breakage|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0009171,enlarged pancreatic islets|MP:0009662,abnormal uterine receptivity|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012431,increased lymphoma incidence
MGI:5705281	Anxa8<tm1Resc>	MP:0020332,impaired leukocyte tethering or rolling
MGI:2686971	Anxty<NZB>	MP:0001363,increased anxiety-related response
MGI:1856654	ao	MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000647,abnormal sebaceous gland morphology|MP:0002073,abnormal hair growth|MP:0005409,darkened coat color|MP:0010179,rough coat
MGI:3044108	Aoah<tm1Rsm>	MP:0001800,abnormal humoral immune response
MGI:5708264	Aoc1l1<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5548670	Aoc1<tm1b(EUCOMM)Hmgu>	MP:0000198,decreased circulating phosphate level|MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002941,increased circulating alanine transaminase level|MP:0003921,abnormal heart left ventricle morphology
MGI:3528069	Aoc3<tm1Salm>	MP:0001876,decreased inflammatory response|MP:0003156,abnormal leukocyte migration|MP:0003628,abnormal leukocyte adhesion|MP:0009858,abnormal cellular extravasation|MP:0020332,impaired leukocyte tethering or rolling
MGI:2664522	Aod1a<A/J>	MP:0001868,ovary inflammation
MGI:2664523	Aod1b<C57BL/6J>	MP:0001868,ovary inflammation
MGI:2670906	Aod3<A/J>	MP:0001868,ovary inflammation|MP:0004833,ovary atrophy
MGI:2670907	Aod4<A/J>	MP:0004833,ovary atrophy
MGI:3693920	aol	MP:0000163,abnormal cartilage morphology|MP:0000754,paresis|MP:0000997,abnormal synovial joint capsule morphology|MP:0001406,abnormal gait|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0002936,joint swelling|MP:0003189,fused joints|MP:0003560,osteoarthritis|MP:0003869,ectopic cartilage|MP:0008919,fused tarsal bones|MP:0030835,abnormal ankle joint morphology|MP:0030866,abnormal synovial joint membrane morphology
MGI:4357693	Aopep<Gt(GT411)Lmf>	MP:0002169,no abnormal phenotype detected
MGI:6209550	Aopep<tm1b(KOMP)Wtsi>	MP:0000538,abnormal urinary bladder morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0008935,decreased mean platelet volume|MP:0020421,increased freezing behavior
MGI:3037011	Aorls1<DBA/2J>	MP:0005338,atherosclerotic lesions
MGI:3037012	Aorls2<C57BL/6J>	MP:0005338,atherosclerotic lesions
MGI:3833684	Aox4<tm1Enga>	MP:0001219,thick epidermis|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1856655	ap	MP:0000367,abnormal coat/ hair morphology|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000417,short hair|MP:0001192,scaly skin|MP:0001282,short vibrissae|MP:0001382,abnormal nursing|MP:0002073,abnormal hair growth|MP:0002075,abnormal coat/hair pigmentation|MP:0002111,abnormal tail morphology|MP:0003853,dry skin|MP:0006162,thick eyelids|MP:0009931,abnormal skin appearance|MP:0013178,tail necrosis|MP:0013897,decreased eyelid cilium number|MP:0013898,short eyelid cilia
MGI:5695127	Ap1ar<tm2b(EUCOMM)Hmgu>	MP:0001510,abnormal coat appearance|MP:0002833,increased heart weight|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003960,increased lean body mass|MP:0005567,decreased circulating total protein level|MP:0010123,increased bone mineral content|MP:0011965,decreased total retina thickness
MGI:5433323	Ap1b1<b2b1660Clo>	MP:0000690,absent spleen|MP:0000694,spleen hypoplasia|MP:0003178,left pulmonary isomerism|MP:0004133,heterotaxia|MP:0004624,abnormal thoracic cage morphology|MP:0006063,abnormal inferior vena cava morphology|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia
MGI:5755140	Ap1g1<fgt>	MP:0000043,organ of Corti degeneration|MP:0000681,abnormal thyroid gland morphology|MP:0001262,decreased body weight|MP:0001394,circling|MP:0001522,impaired swimming|MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004324,vestibular hair cell degeneration|MP:0004328,decreased vestibular hair cell number|MP:0004402,decreased cochlear outer hair cell number|MP:0004404,cochlear outer hair cell degeneration|MP:0004696,abnormal thyroid follicle morphology|MP:0004697,abnormal thyroid follicular cell morphology|MP:0004901,decreased male germ cell number|MP:0005191,head tilt|MP:0005307,head tossing|MP:0005478,decreased circulating thyroxine level|MP:0005546,choroidal neovascularization|MP:0009237,kinked sperm flagellum|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012671,retina spots|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:5638688	Ap1g1<tm1b(EUCOMM)Hmgu>	MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0003961,decreased lean body mass|MP:0008259,abnormal optic disk morphology|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2180169	Ap1g1<tm1Schu>	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008489,slow postnatal weight gain|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:7425515	Ap1g2<em1(IMPC)Bay>	MP:0000063,decreased bone mineral density|MP:0003961,decreased lean body mass
MGI:2180171	Ap1m1<tm1Schu>	MP:0001914,hemorrhage|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5704433	Ap1m2<tm1.1Ohno>	MP:0000488,abnormal intestinal epithelium morphology|MP:0000496,abnormal small intestine morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0005178,increased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0008012,duodenum polyps|MP:0008108,abnormal small intestinal villus morphology|MP:0008109,abnormal small intestinal microvillus morphology|MP:0010155,abnormal intestine physiology|MP:0010157,abnormal small intestinal crypt cell proliferation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011882,enlarged duodenum|MP:0013482,abnormal duodenum crypts of Lieberkuhn morphology|MP:0013483,abnormal jejunum crypts of Lieberkuhn morphology|MP:0014082,decreased small intestinal villus height
MGI:2153885	Ap1q<C57BL/6J>	MP:0001987,alcohol preference
MGI:5585400	Ap1s1<tm1.1(KOMP)Vlcg>	MP:0011100,preweaning lethality, complete penetrance
MGI:6276968	Ap1s2<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0002092,abnormal eye morphology|MP:0002574,increased vertical activity|MP:0006243,impaired pupillary reflex|MP:0013278,decreased fasting circulating glucose level
MGI:5620801	Ap1s2<tm1Pschu>	MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001525,impaired balance|MP:0003107,abnormal response to novelty|MP:0004769,abnormal synaptic vesicle morphology|MP:0004770,abnormal synaptic vesicle recycling|MP:0004792,abnormal synaptic vesicle number|MP:0004793,abnormal synaptic vesicle clustering|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0006320,abnormal interscapular fat pad morphology|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009289,decreased epididymal fat pad weight|MP:0010025,decreased total body fat amount|MP:0011167,abnormal adipose tissue development|MP:0011168,abnormal fat cell differentiation|MP:0011174,lipodystrophy|MP:0012307,impaired spatial learning
MGI:6404503	Ap1s3<em1(IMPC)Bay>	MP:0003233,prolonged QT interval
MGI:6153953	Ap2a1<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002591,decreased mean corpuscular volume|MP:0005292,improved glucose tolerance|MP:0005554,decreased circulating creatinine level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010053,decreased grip strength
MGI:6153278	Ap2a2<em1(IMPC)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7612025	Ap2a2<tm1.1Momk>	MP:0001780,decreased brown adipose tissue amount|MP:0001876,decreased inflammatory response|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0002971,abnormal brown adipose tissue morphology|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005448,abnormal energy homeostasis|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0005670,abnormal white adipose tissue physiology|MP:0006036,abnormal mitochondrial physiology|MP:0008963,increased carbon dioxide production|MP:0009133,decreased white fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0011049,impaired adaptive thermogenesis|MP:0011628,increased mitochondrial number|MP:0013278,decreased fasting circulating glucose level|MP:0014171,increased fatty acid oxidation|MP:0014172,decreased fatty acid oxidation|MP:0014397,increased fat cell mitochondrial DNA content|MP:0020423,abnormal mitochondrial biogenesis|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5548327	Ap2a2<tm1b(EUCOMM)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0001554,increased circulating free fatty acids level|MP:0001556,increased circulating HDL cholesterol level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0006358,absent pinna reflex|MP:0008810,increased circulating iron level|MP:0010088,decreased circulating fructosamine level
MGI:5552944	Ap2b1<b2b2321Clo>	MP:0000111,cleft palate|MP:0000273,overriding aortic valve|MP:0000276,heart right ventricle hypertrophy|MP:0001823,thymus hypoplasia|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia|MP:0004113,abnormal aortic arch morphology|MP:0004158,right aortic arch|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0011667,double outlet right ventricle with atrioventricular septal defect|MP:0011668,double outlet right ventricle, Taussig bing type
MGI:5776619	Ap2b1<em1(IMPC)J>	MP:0000111,cleft palate|MP:0001697,abnormal embryo size|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:5792018	Ap2b1<mpc187H>	MP:0001399,hyperactivity
MGI:5287248	Ap2b1<TgTn(sb-cHS4,Tyr)2343AOve>	MP:0000111,cleft palate
MGI:5295975	Ap2b1<Tg(Tyr)427Ove>	MP:0000111,cleft palate|MP:0009887,abnormal palatal shelf fusion at midline
MGI:3608896	Ap2m1<tm1Ohno>	MP:0005621,abnormal cell physiology|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2155112	Ap2q<C57BL/6J>	MP:0001987,alcohol preference
MGI:5754583	Ap2s1<em1(IMPC)Tcp>	MP:0000494,abnormal cecum morphology|MP:0001258,decreased body length|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0009331,absent primitive node|MP:0009476,enlarged cecum|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014586,decreased egg cylinder size
MGI:6401510	Ap2s1<m3Rvt>	MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:3776785	Ap3b1<m1Btlr>	MP:0000371,diluted coat color|MP:0009379,abnormal foot pigmentation|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:6197805	Ap3b1<m2Btlr>	MP:0000371,diluted coat color
MGI:1856989	Ap3b1<pe>	MP:0000371,diluted coat color|MP:0000783,abnormal forebrain morphology|MP:0000805,abnormal visual cortex morphology|MP:0000904,abnormal superior colliculus morphology|MP:0001121,uterus hypoplasia|MP:0001182,lung hemorrhage|MP:0001183,overexpanded pulmonary alveolus|MP:0001386,abnormal maternal nurturing|MP:0001389,abnormal eye movement|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0002075,abnormal coat/hair pigmentation|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002090,abnormal vision|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002551,abnormal blood coagulation|MP:0002637,small uterus|MP:0002938,white spotting|MP:0003173,decreased lysosomal enzyme secretion|MP:0004165,abnormal lateral geniculate nucleus morphology|MP:0004267,abnormal optic tract morphology|MP:0004721,abnormal platelet dense granule morphology|MP:0004725,decreased platelet serotonin level|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005058,abnormal lysosome morphology|MP:0005060,accumulation of giant lysosomes in kidney/renal tubule cells|MP:0005075,abnormal melanosome morphology|MP:0005172,decreased eye pigmentation|MP:0005319,abnormal enzyme/coenzyme level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005606,increased bleeding time|MP:0006103,abnormal midbrain roof plate morphology|MP:0006298,abnormal platelet activation|MP:0008028,pregnancy-related premature death|MP:0008258,thin endometrium|MP:0009088,thin uterine horn|MP:0009089,short uterine horn|MP:0009446,abnormal platelet dense granule physiology|MP:0009448,decreased platelet ATP level|MP:0009549,decreased platelet aggregation|MP:0009557,decreased platelet ADP level|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014780,increased kidney enzyme/coenzyme level|MP:0020432,decreased platelet dense granule number
MGI:1857884	Ap3b1<pe-10J>	MP:0000371,diluted coat color|MP:0002075,abnormal coat/hair pigmentation|MP:0005172,decreased eye pigmentation
MGI:1857892	Ap3b1<pe-11J>	MP:0000371,diluted coat color
MGI:3526709	Ap3b1<pe-13J>	MP:0000371,diluted coat color
MGI:3574762	Ap3b1<pe-14J>	MP:0000371,diluted coat color|MP:0002095,abnormal skin pigmentation
MGI:3606217	Ap3b1<pe-15J>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0002095,abnormal skin pigmentation|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:3606778	Ap3b1<pe-16J>	MP:0000371,diluted coat color|MP:0009379,abnormal foot pigmentation|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:1859842	Ap3b1<pe-5J>	MP:0002075,abnormal coat/hair pigmentation
MGI:1861610	Ap3b1<pe-7J>	MP:0000371,diluted coat color
MGI:1857676	Ap3b1<pe-8J>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0002075,abnormal coat/hair pigmentation
MGI:1857352	Ap3b1<pe-rim2>	MP:0001293,anophthalmia|MP:0001304,cataract|MP:0005172,decreased eye pigmentation|MP:0005408,hypopigmentation|MP:0009446,abnormal platelet dense granule physiology|MP:0009448,decreased platelet ATP level|MP:0009549,decreased platelet aggregation|MP:0009557,decreased platelet ADP level
MGI:3525672	Ap3b1<tm1.1Sms>	MP:0000371,diluted coat color|MP:0005386,behavior/neurological phenotype
MGI:2684535	Ap3b1<tm1Sms>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0005058,abnormal lysosome morphology|MP:0005075,abnormal melanosome morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0005408,hypopigmentation|MP:0005606,increased bleeding time|MP:0005636,abnormal mineral homeostasis|MP:0009618,increased brain zinc level
MGI:5302660	Ap3b2<m1J>	MP:0001399,hyperactivity|MP:0003492,abnormal involuntary movement|MP:0003997,tonic-clonic seizures
MGI:5449877	Ap3b2<m2J>	MP:0003997,tonic-clonic seizures|MP:0005391,vision/eye phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3513518	Ap3b2<tm1Bur>	MP:0001399,hyperactivity|MP:0003997,tonic-clonic seizures|MP:0009617,decreased brain zinc level|MP:0010771,integument phenotype
MGI:5528707	Ap3d1<m1Btlr>	MP:0000371,diluted coat color
MGI:1856083	Ap3d1<mh>	MP:0000026,abnormal inner ear morphology|MP:0000034,abnormal inner ear vestibule morphology|MP:0000043,organ of Corti degeneration|MP:0000048,abnormal stria vascularis morphology|MP:0000371,diluted coat color|MP:0001399,hyperactivity|MP:0001732,postnatal growth retardation|MP:0001963,abnormal hearing physiology|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002082,postnatal lethality|MP:0002161,abnormal fertility/fecundity|MP:0002857,cochlear ganglion degeneration|MP:0002894,abnormal otolith morphology|MP:0002978,absent otoliths|MP:0003173,decreased lysosomal enzyme secretion|MP:0003889,enhanced sensorimotor gating|MP:0004721,abnormal platelet dense granule morphology|MP:0004725,decreased platelet serotonin level|MP:0004738,abnormal auditory brainstem response|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004813,absent linear vestibular evoked potential|MP:0004994,abnormal brain wave pattern|MP:0005172,decreased eye pigmentation|MP:0005191,head tilt|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005397,hematopoietic system phenotype|MP:0005606,increased bleeding time|MP:0008840,abnormal spike wave discharge|MP:0009549,decreased platelet aggregation|MP:0009617,decreased brain zinc level|MP:0010149,abnormal synaptic dopamine release|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014623,abnormal brain theta wave pattern|MP:0020432,decreased platelet dense granule number
MGI:1856084	Ap3d1<mh-2J>	MP:0000371,diluted coat color|MP:0001399,hyperactivity|MP:0003631,nervous system phenotype|MP:0004738,abnormal auditory brainstem response|MP:0005377,hearing/vestibular/ear phenotype|MP:0008840,abnormal spike wave discharge
MGI:5484771	Ap3d1<mh-4J>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0005191,head tilt|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6149217	Ap3m2<em2(IMPC)H>	MP:0002953,thick ventricular wall
MGI:3497921	Ap3m2<tm1Ohno>	MP:0000807,abnormal hippocampus morphology|MP:0000948,nonconvulsive seizures|MP:0001499,abnormal kindling response|MP:0002064,seizures|MP:0002272,abnormal nervous system electrophysiology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003008,enhanced long-term potentiation|MP:0003990,decreased neurotransmitter release|MP:0004769,abnormal synaptic vesicle morphology
MGI:2155848	Ap3q<C57BL/6J>	MP:0001987,alcohol preference
MGI:5548436	Ap3s1<tm1b(EUCOMM)Hmgu>	MP:0002968,increased circulating alkaline phosphatase level|MP:0013279,increased fasting circulating glucose level
MGI:5548435	Ap3s2<tm1b(EUCOMM)Hmgu>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001566,increased circulating phosphate level|MP:0004924,abnormal behavior|MP:0010088,decreased circulating fructosamine level|MP:0020870,decreased thigmotaxis
MGI:3529172	Ap4b1<tm1Lex>	MP:0000877,abnormal Purkinje cell morphology|MP:0001405,impaired coordination|MP:0003631,nervous system phenotype
MGI:6257699	Ap4e1<em1(IMPC)Bay>	MP:0001491,unresponsive to tactile stimuli|MP:0001510,abnormal coat appearance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5638898	Ap4e1<em1(IMPC)J>	MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0001554,increased circulating free fatty acids level|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002757,decreased vertical activity|MP:0005560,decreased circulating glucose level|MP:0005633,increased circulating sodium level|MP:0011396,abnormal sleep behavior
MGI:6158468	Ap4e1<em2(IMPC)Mbp>	MP:0005278,abnormal cholesterol homeostasis|MP:0005343,increased circulating aspartate transaminase level
MGI:4362509	Ap4e1<tm1a(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0000559,abnormal femur morphology|MP:0000781,decreased corpus callosum size|MP:0001577,anemia|MP:0002757,decreased vertical activity|MP:0002874,decreased hemoglobin content|MP:0003960,increased lean body mass|MP:0004924,abnormal behavior|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008535,enlarged lateral ventricles
MGI:5548434	Ap4e1<tm1b(KOMP)Wtsi>	MP:0000137,abnormal vertebrae morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001303,abnormal lens morphology|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001488,increased startle reflex|MP:0001513,limb grasping|MP:0002135,abnormal kidney morphology|MP:0002311,abnormal inspiratory capacity|MP:0002608,increased hematocrit|MP:0002757,decreased vertical activity|MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0003020,decreased circulating chloride level|MP:0003131,increased erythrocyte cell number|MP:0003393,decreased cardiac output|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003917,increased kidney weight|MP:0003929,decreased heart rate variability|MP:0003960,increased lean body mass|MP:0004122,abnormal sinus arrhythmia|MP:0004599,abnormal vertebral arch morphology|MP:0004924,abnormal behavior|MP:0005293,impaired glucose tolerance|MP:0005333,decreased heart rate|MP:0005343,increased circulating aspartate transaminase level|MP:0005385,cardiovascular system phenotype|MP:0005560,decreased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0005599,increased cardiac muscle contractility|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008806,increased circulating amylase level|MP:0009141,increased prepulse inhibition|MP:0009142,decreased prepulse inhibition|MP:0009454,impaired contextual conditioning behavior|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010053,decreased grip strength|MP:0010067,increased red blood cell distribution width|MP:0010090,increased circulating creatine kinase level|MP:0010123,increased bone mineral content|MP:0010379,decreased respiratory quotient|MP:0010895,increased lung compliance|MP:0011396,abnormal sleep behavior|MP:0011965,decreased total retina thickness|MP:0013279,increased fasting circulating glucose level|MP:0020420,abnormal freezing behavior|MP:0020870,decreased thigmotaxis
MGI:5636962	Ap4m1<tm1b(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0002608,increased hematocrit|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0008810,increased circulating iron level
MGI:2157430	Ap4q<C57BL/6J>	MP:0001987,alcohol preference
MGI:7708051	Ap5b1<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0001488,increased startle reflex|MP:0002092,abnormal eye morphology
MGI:6277068	Ap5m1<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001402,decreased locomotor activity|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology|MP:0002965,increased circulating serum albumin level|MP:0005568,increased circulating total protein level|MP:0020421,increased freezing behavior
MGI:2157427	Ap5q<C57BL/6J>	MP:0001987,alcohol preference
MGI:4460281	Ap5z1<tm1(KOMP)Wtsi>	MP:0000432,abnormal head morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001406,abnormal gait|MP:0002878,abnormal corticospinal tract morphology|MP:0003172,abnormal lysosome physiology|MP:0003354,astrocytosis|MP:0005386,behavior/neurological phenotype|MP:0005405,axon degeneration|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0010047,axonal spheroids|MP:0011743,abnormal Golgi apparatus morphology|MP:0014329,abnormal Purkinje cell axon morphology|MP:0030940,impaired autophagy|MP:0030949,abnormal Golgi vesicle transport|MP:0030952,abnormal Golgi stack morphology
MGI:2155427	Ap6q<C57BL/6J>	MP:0001987,alcohol preference
MGI:2668895	Ap7q<C57BL/6ByJ>	MP:0001425,abnormal alcohol consumption
MGI:2668897	Ap8q<C57BL/6ByJ>	MP:0001425,abnormal alcohol consumption|MP:0001987,alcohol preference
MGI:1888997	Apaf1<fog>	MP:0000074,abnormal neurocranium morphology|MP:0000108,midline facial cleft|MP:0000438,abnormal cranium morphology|MP:0000445,short snout|MP:0000585,kinked tail|MP:0000783,abnormal forebrain morphology|MP:0000787,abnormal telencephalon morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000914,exencephaly|MP:0001916,intracerebral hemorrhage|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002621,delayed neural tube closure|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0003631,nervous system phenotype|MP:0004203,abnormal cranial flexure morphology|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005297,spina bifida occulta|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0030045,abnormal forehead shape
MGI:1857868	Apaf1<Gt(IRESBetageo)XIX18Pgr>	MP:0000075,absent neurocranium|MP:0000099,absent vomer bone|MP:0000101,absent ethmoid bone|MP:0000105,impaired ossification of basisphenoid bone|MP:0000108,midline facial cleft|MP:0000571,interdigital webbing|MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0000792,abnormal cortical marginal zone morphology|MP:0000821,choroid plexus hyperplasia|MP:0000831,diencephalon hyperplasia|MP:0000839,hypothalamus hyperplasia|MP:0000898,midbrain hyperplasia|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0000935,abnormal folding of telencephalic vesicles|MP:0000936,small embryonic telencephalon|MP:0001289,persistence of hyaloid vascular system|MP:0001306,small lens|MP:0001308,abnormal lens polarity|MP:0001329,retina hyperplasia|MP:0001648,abnormal apoptosis|MP:0001891,hydrocephaly|MP:0002085,abnormal embryonic tissue morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002152,abnormal brain morphology|MP:0002882,abnormal neuron morphology|MP:0003203,increased neuron apoptosis|MP:0003204,decreased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology|MP:0009889,persistence of medial edge epithelium during palatal shelf fusion|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0013502,decreased fibroblast apoptosis|MP:0021107,retina fold
MGI:1860245	Apaf1<tm1Her>	MP:0000822,abnormal brain ventricle morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000914,exencephaly|MP:0000919,cranioschisis|MP:0000929,open neural tube|MP:0001399,hyperactivity|MP:0001891,hydrocephaly|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002006,neoplasm|MP:0002083,premature death|MP:0002216,abnormal seminiferous tubule morphology|MP:0002239,abnormal nasal septum morphology|MP:0003204,decreased neuron apoptosis|MP:0003755,abnormal palate morphology|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0005159,azoospermia|MP:0005274,abnormal viscerocranium morphology|MP:0006030,abnormal otic vesicle development|MP:0006069,abnormal retina neuronal layer morphology|MP:0006378,abnormal spermatogonia morphology|MP:0009937,abnormal neuron differentiation|MP:0011090,perinatal lethality, incomplete penetrance|MP:0012702,increased embryonic neuroepithelium thickness|MP:0013500,abnormal fibroblast apoptosis|MP:0014551,impaired neuronal migration|MP:0031391,increased locomotor activity
MGI:5300913	Apaf1<tm1Hez>	MP:0002169,no abnormal phenotype detected
MGI:1928692	Apaf1<tm1Mak>	MP:0000107,abnormal frontal bone morphology|MP:0000351,increased cell proliferation|MP:0000428,abnormal craniofacial morphology|MP:0000433,microcephaly|MP:0000571,interdigital webbing|MP:0000783,abnormal forebrain morphology|MP:0000789,thickened cerebral cortex|MP:0000821,choroid plexus hyperplasia|MP:0000826,abnormal third ventricle morphology|MP:0000832,abnormal thalamus morphology|MP:0000833,thalamus hyperplasia|MP:0000837,abnormal hypothalamus morphology|MP:0000839,hypothalamus hyperplasia|MP:0000841,abnormal hindbrain morphology|MP:0000914,exencephaly|MP:0001891,hydrocephaly|MP:0002110,abnormal digit morphology|MP:0002882,abnormal neuron morphology|MP:0003631,nervous system phenotype|MP:0003743,abnormal facial morphology|MP:0004811,abnormal neuron physiology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005387,immune system phenotype|MP:0006043,decreased apoptosis|MP:0008944,decreased sensitivity to induced cell death|MP:0010955,abnormal respiratory electron transport chain|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011495,abnormal head shape|MP:0012174,flat head
MGI:5490757	Apaf1<ytj>	MP:0000107,abnormal frontal bone morphology|MP:0000108,midline facial cleft|MP:0000428,abnormal craniofacial morphology|MP:0000455,abnormal maxilla morphology|MP:0000571,interdigital webbing|MP:0000914,exencephaly|MP:0003232,abnormal forebrain development|MP:0003631,nervous system phenotype|MP:0004383,absent interparietal bone|MP:0004419,absent parietal bone|MP:0004443,absent supraoccipital bone|MP:0004448,abnormal presphenoid bone morphology|MP:0004449,absent presphenoid bone|MP:0009264,failure of eyelid fusion|MP:0011089,perinatal lethality, complete penetrance|MP:0030251,broad frontonasal prominence
MGI:2450729	Apba1<tm1.1Sud>	MP:0001265,decreased body size|MP:0001393,ataxia|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003631,nervous system phenotype
MGI:3609568	Apba1<tm1Amor>	MP:0001905,abnormal dopamine level|MP:0004924,abnormal behavior|MP:0009750,impaired behavioral response to addictive substance
MGI:3694702	Apba2<tm1.1Sud>	MP:0002169,no abnormal phenotype detected
MGI:3697454	Apba2<tm1Tsuz>	MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001413,abnormal response to new environment|MP:0001431,abnormal eating behavior|MP:0001777,abnormal body temperature homeostasis|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0003862,decreased aggression towards male mice|MP:0005386,behavior/neurological phenotype|MP:0010069,increased serotonin level
MGI:5293146	Apba3<tm1.1Ski>	MP:0008734,decreased susceptibility to endotoxin shock|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:3694704	Apba3<tm1.1Sud>	MP:0002169,no abnormal phenotype detected
MGI:5293147	Apba3<tm1.2Ski>	MP:0002451,abnormal macrophage physiology|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008618,decreased circulating interleukin-12 level|MP:0008664,decreased interleukin-12 secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:6341869	Apbb1ip<em1(IMPC)Ccpcz>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0002599,increased mean platelet volume|MP:0003917,increased kidney weight|MP:0004952,increased spleen weight|MP:0005011,increased eosinophil cell number|MP:0005554,decreased circulating creatinine level|MP:0005566,decreased blood urea nitrogen level|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008810,increased circulating iron level|MP:0010067,increased red blood cell distribution width|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0010935,increased airway resistance|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:5085540	Apbb1ip<tm1(KOMP)Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:3615373	Apbb1<tm1Her>	MP:0002169,no abnormal phenotype detected
MGI:3514266	Apbb1<tm1Quhu>	MP:0001463,abnormal spatial learning|MP:0002799,abnormal passive avoidance behavior
MGI:3699106	Apbb1<tm1Trus>	MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0005621,abnormal cell physiology
MGI:6199157	Apbb2<M1Btlr>	MP:0005293,impaired glucose tolerance
MGI:6199162	Apbb2<m2Btlr>	MP:0005293,impaired glucose tolerance
MGI:5574593	Apbb2<tm1.1(KOMP)Vlcg>	MP:0001914,hemorrhage|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002941,increased circulating alanine transaminase level|MP:0003054,spina bifida|MP:0005343,increased circulating aspartate transaminase level|MP:0005630,increased lung weight|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3615374	Apbb2<tm1Her>	MP:0002169,no abnormal phenotype detected
MGI:5428211	Apc2<tm1Mno>	MP:0000790,abnormal stratification in cerebral cortex|MP:0000812,abnormal dentate gyrus morphology|MP:0000813,abnormal hippocampus layer morphology|MP:0000885,ectopic Purkinje cell|MP:0001405,impaired coordination|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002161,abnormal fertility/fecundity|MP:0002762,ectopic cerebellar granule cells|MP:0003203,increased neuron apoptosis|MP:0003241,loss of cortex neurons|MP:0006009,abnormal neuronal migration|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008285,abnormal hippocampus granule cell layer|MP:0009946,abnormal olfactory bulb layer morphology|MP:0009951,abnormal olfactory bulb mitral cell layer morphology|MP:0009956,abnormal cerebellar layer morphology|MP:0009977,abnormal cerebellar granule cell migration|MP:0010011,ectopic hippocampus pyramidal cells|MP:0010540,long stride length
MGI:6449050	Apcdd1<em1(IMPC)Mbp>	MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0009141,increased prepulse inhibition|MP:0010123,increased bone mineral content
MGI:3837809	Apcdd1<tm1Hsav>	MP:0010098,abnormal retina blood vessel pattern
MGI:4122552	Apc<Gt(XA018)Byg>	MP:0002044,increased colon adenoma incidence|MP:0002404,increased intestinal adenoma incidence|MP:0003447,decreased tumor growth/size|MP:0003721,increased tumor growth/size|MP:0008011,intestine polyps
MGI:5620880	Apc<M1Tno>	MP:0001883,increased mammary adenocarcinoma incidence|MP:0002013,increased pilomatricoma incidence|MP:0002083,premature death|MP:0002732,increased trichoepithelioma incidence|MP:0003789,increased osteosarcoma incidence|MP:0010299,increased mammary gland tumor incidence|MP:0010300,increased skin tumor incidence|MP:0010313,increased osteoma incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1856318	Apc<Min>	MP:0000208,decreased hematocrit|MP:0000493,rectal prolapse|MP:0000511,abnormal intestinal mucosa morphology|MP:0000628,abnormal mammary gland development|MP:0000630,mammary gland hyperplasia|MP:0001130,abnormal ovarian folliculogenesis|MP:0001131,abnormal ovarian follicle morphology|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001140,abnormal vagina epithelium morphology|MP:0001262,decreased body weight|MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001577,anemia|MP:0001661,extended life span|MP:0001672,abnormal embryo development|MP:0001697,abnormal embryo size|MP:0001698,decreased embryo size|MP:0001732,postnatal growth retardation|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002006,neoplasm|MP:0002021,increased incidence of induced tumors|MP:0002044,increased colon adenoma incidence|MP:0002083,premature death|MP:0002404,increased intestinal adenoma incidence|MP:0002435,abnormal effector T cell morphology|MP:0002628,hepatic steatosis|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0003085,abnormal egg cylinder morphology|MP:0003269,colon polyps|MP:0003270,intestinal obstruction|MP:0003292,melena|MP:0003447,decreased tumor growth/size|MP:0003449,abnormal intestine goblet cell morphology|MP:0003884,decreased macrophage cell number|MP:0004024,aneuploidy|MP:0004499,increased incidence of tumors by chemical induction|MP:0004833,ovary atrophy|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0004894,uterus atrophy|MP:0005018,decreased T cell number|MP:0005389,reproductive system phenotype|MP:0005621,abnormal cell physiology|MP:0008011,intestine polyps|MP:0008045,decreased NK cell number|MP:0008102,lymph node hyperplasia|MP:0008466,enlarged mesenteric lymph nodes|MP:0008568,abnormal interleukin secretion|MP:0008883,abnormal enterocyte proliferation|MP:0009078,adrenal gland hyperplasia|MP:0009339,decreased splenocyte number|MP:0009661,abnormal pregnancy|MP:0009733,absent nipple|MP:0009814,increased prostaglandin level|MP:0009850,embryonic lethality between implantation and placentation|MP:0010299,increased mammary gland tumor incidence|MP:0010639,abnormal tumor pathology|MP:0011092,embryonic lethality, complete penetrance|MP:0012434,decreased intestinal adenoma incidence|MP:0014756,decreased tumor cell proliferation
MGI:2138028	Apcs<tm1Mpe>	MP:0000689,abnormal spleen morphology|MP:0002135,abnormal kidney morphology|MP:0002169,no abnormal phenotype detected|MP:0002356,abnormal spleen red pulp morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002411,decreased susceptibility to bacterial infection|MP:0002743,glomerulonephritis|MP:0003725,increased autoantibody level|MP:0005387,immune system phenotype|MP:0008478,increased spleen white pulp amount|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0020519,renal glomerular immunoglobulin deposits
MGI:2388056	Apcs<tm1Smae>	MP:0000604,amyloidosis|MP:0003725,increased autoantibody level|MP:0005367,renal/urinary system phenotype|MP:0008734,decreased susceptibility to endotoxin shock
MGI:5305725	Apc<tm1.1Alew>	MP:0000351,increased cell proliferation|MP:0001577,anemia|MP:0002083,premature death|MP:0002404,increased intestinal adenoma incidence|MP:0003448,abnormal tumor morphology|MP:0006042,increased apoptosis|MP:0010352,gastrointestinal tract polyps|MP:0010383,increased adenoma incidence|MP:0011091,prenatal lethality, complete penetrance
MGI:5431889	Apc<tm1.1Klne>	MP:0003269,colon polyps|MP:0003299,gastric polyps|MP:0008883,abnormal enterocyte proliferation
MGI:3848480	Apc<tm1.1Rsmi>	MP:0001577,anemia|MP:0002083,premature death|MP:0002404,increased intestinal adenoma incidence|MP:0003270,intestinal obstruction|MP:0009309,increased small intestine adenocarcinoma incidence|MP:0009310,increased large intestine adenocarcinoma incidence|MP:0010279,increased gastrointestinal tumor incidence|MP:0010338,increased desmoid tumor incidence|MP:0031309,skin cyst
MGI:3764940	Apc<tm1.1Tno>	MP:0000465,gastrointestinal hemorrhage|MP:0001577,anemia|MP:0002083,premature death|MP:0002404,increased intestinal adenoma incidence|MP:0003270,intestinal obstruction|MP:0008011,intestine polyps
MGI:4461178	Apc<tm1.1Tyj>	MP:0001577,anemia|MP:0002044,increased colon adenoma incidence|MP:0002083,premature death|MP:0002404,increased intestinal adenoma incidence|MP:0003721,increased tumor growth/size
MGI:3513416	Apc<tm1Cip>	MP:0000493,rectal prolapse|MP:0001577,anemia|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002044,increased colon adenoma incidence|MP:0002083,premature death|MP:0002404,increased intestinal adenoma incidence|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0003293,rectal hemorrhage|MP:0011091,prenatal lethality, complete penetrance
MGI:2387050	Apc<tm1Hsa>	MP:0000462,abnormal digestive system morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0001577,anemia|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002083,premature death|MP:0003269,colon polyps|MP:0010279,increased gastrointestinal tumor incidence|MP:0010299,increased mammary gland tumor incidence|MP:0010301,increased stomach tumor incidence|MP:0011091,prenatal lethality, complete penetrance|MP:0031154,intestinal hemorrhage
MGI:3589207	Apc<tm1Kk>	MP:0000324,increased mast cell number|MP:0000511,abnormal intestinal mucosa morphology|MP:0000706,small thymus|MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002404,increased intestinal adenoma incidence|MP:0005090,increased double-negative T cell number|MP:0008011,intestine polyps|MP:0008553,increased circulating tumor necrosis factor level
MGI:1857957	Apc<tm1Mmt>	MP:0002404,increased intestinal adenoma incidence|MP:0008011,intestine polyps|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance
MGI:1857951	Apc<tm1Rak>	MP:0002083,premature death|MP:0002404,increased intestinal adenoma incidence|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0003269,colon polyps|MP:0003293,rectal hemorrhage|MP:0003299,gastric polyps|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003414,epidermal cyst|MP:0008011,intestine polyps|MP:0010279,increased gastrointestinal tumor incidence|MP:0010301,increased stomach tumor incidence|MP:0010338,increased desmoid tumor incidence|MP:0011092,embryonic lethality, complete penetrance|MP:0014237,decreased tumor-free survival time
MGI:1858101	Apc<tm1Rfo>	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002006,neoplasm|MP:0005384,cellular phenotype|MP:0006401,absent male preputial gland|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031309,skin cyst
MGI:3848479	Apc<tm1Rsmi>	MP:0000150,abnormal rib morphology|MP:0000158,absent sternum|MP:0000164,abnormal cartilage development|MP:0000166,abnormal chondrocyte morphology|MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0000458,abnormal mandible morphology|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0001208,blistering|MP:0001258,decreased body length|MP:0002006,neoplasm|MP:0002016,ovary cyst|MP:0002113,abnormal skeleton development|MP:0002169,no abnormal phenotype detected|MP:0002404,increased intestinal adenoma incidence|MP:0002896,abnormal bone mineralization|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0003257,abnormal abdominal wall morphology|MP:0003574,abnormal oviduct morphology|MP:0004200,decreased fetal size|MP:0004344,scapular bone hypoplasia|MP:0004672,short ribs|MP:0004733,abnormal thoracic cavity morphology|MP:0005296,abnormal humerus morphology|MP:0006279,abnormal limb development|MP:0008000,increased ovary tumor incidence|MP:0008272,abnormal endochondral bone ossification|MP:0009092,endometrium hyperplasia|MP:0009209,abnormal internal female genitalia morphology|MP:0009309,increased small intestine adenocarcinoma incidence|MP:0009310,increased large intestine adenocarcinoma incidence|MP:0010279,increased gastrointestinal tumor incidence|MP:0010287,increased reproductive system tumor incidence|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011710,enhanced osteoblast differentiation|MP:0012411,increased granulosa cell tumor incidence|MP:0014236,increased tumor-free survival time|MP:0014321,short forelimb|MP:0014322,short hindlimb
MGI:1857966	Apc<tm1Tno>	MP:0000208,decreased hematocrit|MP:0000493,rectal prolapse|MP:0000540,abnormal urinary bladder urothelium morphology|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001167,prostate gland epithelial hyperplasia|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002006,neoplasm|MP:0002020,increased tumor incidence|MP:0002044,increased colon adenoma incidence|MP:0002045,increased renal cystadenoma incidence|MP:0002083,premature death|MP:0002404,increased intestinal adenoma incidence|MP:0003068,enlarged kidney|MP:0003270,intestinal obstruction|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003675,kidney cyst|MP:0004499,increased incidence of tumors by chemical induction|MP:0005565,increased blood urea nitrogen level|MP:0008011,intestine polyps|MP:0008528,polycystic kidney|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0009309,increased small intestine adenocarcinoma incidence|MP:0010279,increased gastrointestinal tumor incidence|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance
MGI:3829069	Apc<tm1Tyj>	MP:0002044,increased colon adenoma incidence|MP:0002169,no abnormal phenotype detected|MP:0002404,increased intestinal adenoma incidence
MGI:5305728	Apc<tm2.1Alew>	MP:0001505,hunched posture|MP:0001577,anemia|MP:0002404,increased intestinal adenoma incidence|MP:0010352,gastrointestinal tract polyps|MP:0010383,increased adenoma incidence|MP:0010639,abnormal tumor pathology|MP:0011091,prenatal lethality, complete penetrance
MGI:3521822	Apc<tm2.1Cip>	MP:0000488,abnormal intestinal epithelium morphology|MP:0000493,rectal prolapse|MP:0000495,abnormal colon morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0001860,liver inflammation|MP:0002006,neoplasm|MP:0002044,increased colon adenoma incidence|MP:0002083,premature death|MP:0002404,increased intestinal adenoma incidence|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003449,abnormal intestine goblet cell morphology|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0005141,liver hyperplasia|MP:0005150,cachexia|MP:0008011,intestine polyps|MP:0008040,decreased NK T cell number|MP:0008042,abnormal NK T cell physiology|MP:0008260,abnormal autophagy|MP:0008566,increased interferon-gamma secretion|MP:0008699,increased interleukin-4 secretion|MP:0008800,increased small intestinal crypt cell apoptosis|MP:0010158,abnormal intestine development|MP:0010377,abnormal gut flora balance|MP:0014237,decreased tumor-free survival time
MGI:3688437	Apc<tm2.1Rak>	MP:0001382,abnormal nursing|MP:0001577,anemia|MP:0002083,premature death|MP:0002404,increased intestinal adenoma incidence|MP:0003293,rectal hemorrhage|MP:0010279,increased gastrointestinal tumor incidence
MGI:2449941	Apc<tm2Mmt>	MP:0002404,increased intestinal adenoma incidence|MP:0008762,embryonic lethality
MGI:3688435	Apc<tm2Rak>	MP:0000022,abnormal ear shape|MP:0000116,abnormal tooth development|MP:0000208,decreased hematocrit|MP:0000350,abnormal cell proliferation|MP:0000377,abnormal hair follicle morphology|MP:0000382,underdeveloped hair follicles|MP:0000383,abnormal hair follicle orientation|MP:0000417,short hair|MP:0000422,delayed hair appearance|MP:0000493,rectal prolapse|MP:0000619,salivary gland epithelial hyperplasia|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001192,scaly skin|MP:0001210,skin ridges|MP:0001211,wrinkled skin|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001282,short vibrissae|MP:0001344,blepharoptosis|MP:0001577,anemia|MP:0002006,neoplasm|MP:0002038,increased carcinoma incidence|MP:0002044,increased colon adenoma incidence|MP:0002083,premature death|MP:0002095,abnormal skin pigmentation|MP:0002404,increased intestinal adenoma incidence|MP:0002656,abnormal keratinocyte differentiation|MP:0002691,small stomach|MP:0003269,colon polyps|MP:0003272,duodenal atresia|MP:0003292,melena|MP:0003704,abnormal hair follicle development|MP:0003934,abnormal pancreas development|MP:0004499,increased incidence of tumors by chemical induction|MP:0004790,absent upper incisors|MP:0005202,lethargy|MP:0005376,homeostasis/metabolism phenotype|MP:0009114,decreased pancreatic beta cell mass|MP:0009168,decreased pancreatic islet number|MP:0009539,abnormal Hassall's corpuscle morphology|MP:0010158,abnormal intestine development|MP:0010274,increased organ/body region tumor incidence|MP:0010681,abnormal hair follicle bulb morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011278,increased ear pigmentation|MP:0013443,Harderian gland hyperplasia|MP:0020857,cornea epithelium hyperplasia|MP:0030053,increased forehead pigmentation|MP:0030610,absent teeth
MGI:4360657	Apc<tm2Rfo>	MP:0001272,increased metastatic potential|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0003414,epidermal cyst|MP:0008019,increased liver tumor incidence|MP:0010279,increased gastrointestinal tumor incidence|MP:0010299,increased mammary gland tumor incidence|MP:0010338,increased desmoid tumor incidence|MP:0011085,postnatal lethality, complete penetrance
MGI:2678005	Apc<tm2Tno>	MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002083,premature death|MP:0002404,increased intestinal adenoma incidence|MP:0002628,hepatic steatosis|MP:0005178,increased circulating cholesterol level|MP:0008011,intestine polyps
MGI:2449944	Apc<tm3Mmt>	MP:0000474,abnormal foregut morphology|MP:0000913,abnormal brain development|MP:0000925,abnormal floor plate morphology|MP:0001701,incomplete embryo turning|MP:0002084,abnormal developmental patterning|MP:0002151,abnormal neural tube morphology|MP:0002404,increased intestinal adenoma incidence|MP:0004066,abnormal primitive node morphology|MP:0004187,cardia bifida|MP:0004713,split notochord|MP:0006108,abnormal hindbrain development|MP:0008011,intestine polyps|MP:0008533,abnormal anterior visceral endoderm morphology|MP:0009266,abnormal mesendoderm development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012087,absent midbrain|MP:0012135,embryonic-extraembryonic boundary constriction|MP:0012136,absent forebrain|MP:0012156,rostral-caudal axis duplication|MP:0012157,rostral body truncation|MP:0012165,absent neural folds|MP:0012176,abnormal head development|MP:0012700,abnormal endocardial heart tube morphology
MGI:3605472	Apc<tm4Mmt>	MP:0002404,increased intestinal adenoma incidence|MP:0008011,intestine polyps|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5637196	Apeh<tm2b(EUCOMM)Hmgu>	MP:0001510,abnormal coat appearance|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength
MGI:7424870	Apela<em1Shx>	MP:0002169,no abnormal phenotype detected
MGI:6118179	Apela<tm1.2Brre>	MP:0000259,abnormal vascular development|MP:0000260,abnormal angiogenesis|MP:0000270,abnormal heart tube morphology|MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0001722,pale yolk sac|MP:0001787,pericardial edema|MP:0001933,abnormal litter size|MP:0002127,abnormal cardiovascular system morphology|MP:0002842,increased systemic arterial blood pressure|MP:0002962,increased urine protein level|MP:0003718,maternal effect|MP:0003984,embryonic growth retardation|MP:0004787,abnormal dorsal aorta morphology|MP:0005367,renal/urinary system phenotype|MP:0005380,embryo phenotype|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009429,decreased embryo weight|MP:0009658,increased placenta apoptosis|MP:0010662,abnormal intersomitic artery morphology|MP:0010831,lethality, incomplete penetrance|MP:0011433,glomerular capillary congestion|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011455,absent glomerular endothelium fenestra|MP:0011523,thin placenta labyrinth|MP:0011531,abnormal syncytiotrophoblast morphology|MP:0014044,absent cardiac outflow tract|MP:0020518,renal glomerular protein deposits
MGI:1857956	Apex1<tm1Cur>	MP:0001672,abnormal embryo development|MP:0003025,increased vasoconstriction|MP:0003026,decreased vasoconstriction|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003957,abnormal nitric oxide homeostasis|MP:0004875,increased mean systemic arterial blood pressure|MP:0004883,abnormal vascular wound healing|MP:0005591,decreased vasodilation|MP:0005595,abnormal vascular smooth muscle physiology|MP:0008593,increased circulating interleukin-10 level|MP:0008638,increased circulating interleukin-1 alpha level|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:1857955	Apex1<tm1Djc>	MP:0000598,abnormal liver morphology|MP:0001672,abnormal embryo development|MP:0001718,abnormal visceral yolk sac morphology|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002216,abnormal seminiferous tubule morphology|MP:0003886,abnormal embryonic epiblast morphology|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011191,increased embryonic epiblast cell apoptosis
MGI:2652193	Apex1<tm1Ecf>	MP:0000313,abnormal cell death|MP:0001853,heart inflammation|MP:0001856,myocarditis|MP:0001857,pericarditis|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002038,increased carcinoma incidence|MP:0003141,cardiac fibrosis|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012431,increased lymphoma incidence
MGI:2664368	Apex1<tm2Cur>	MP:0002169,no abnormal phenotype detected
MGI:6324179	Apex2<em1(IMPC)H>	MP:0000219,increased neutrophil cell number|MP:0000443,abnormal snout morphology|MP:0001402,decreased locomotor activity|MP:0002075,abnormal coat/hair pigmentation|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0005016,decreased lymphocyte cell number
MGI:3526443	Apex2<tm1Yun>	MP:0000221,decreased leukocyte cell number|MP:0000715,decreased thymocyte number|MP:0001732,postnatal growth retardation|MP:0002875,decreased erythrocyte cell number|MP:0002879,increased cellular sensitivity to X-ray irradiation induced cell death|MP:0003644,thymus atrophy|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0009335,decreased splenocyte proliferation|MP:0009674,decreased birth weight
MGI:3530440	Aph1a<tm1.1Bdes>	MP:0000292,distended pericardium|MP:0000934,abnormal telencephalon development|MP:0001680,abnormal mesoderm development|MP:0001688,abnormal somite development|MP:0001691,abnormal somite shape|MP:0001698,decreased embryo size|MP:0003227,abnormal vascular branching morphogenesis|MP:0003400,kinked neural tube|MP:0004076,abnormal vitelline vascular remodeling|MP:0004206,abnormal dermomyotome development|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0006029,abnormal sclerotome morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011732,decreased somite size|MP:0012701,increased embryonic neuroepithelium apoptosis
MGI:3522625	Aph1a<tm1Bdes>	MP:0002169,no abnormal phenotype detected
MGI:5692808	Aph1a<tm1b(KOMP)Mbp>	MP:0001399,hyperactivity|MP:0001510,abnormal coat appearance|MP:0001697,abnormal embryo size|MP:0001722,pale yolk sac|MP:0003717,pallor|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration|MP:0011965,decreased total retina thickness|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3527942	Aph1a<tm1Pcw>	MP:0000267,abnormal heart development|MP:0000292,distended pericardium|MP:0001688,abnormal somite development|MP:0001730,embryonic growth arrest|MP:0003229,abnormal vitelline vasculature morphology|MP:0003400,kinked neural tube|MP:0006341,small first pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3522628	Aph1b<tm1Bdes>	MP:0002169,no abnormal phenotype detected
MGI:3530442	Aph1c<tm1.1Bdes>	MP:0002169,no abnormal phenotype detected
MGI:3530441	Aph1c<tm1Bdes>	MP:0002169,no abnormal phenotype detected
MGI:5548561	Aph1c<tm1b(KOMP)Wtsi>	MP:0002075,abnormal coat/hair pigmentation|MP:0009141,increased prepulse inhibition|MP:0010053,decreased grip strength
MGI:4836501	aphl	MP:0000416,sparse hair|MP:0001191,abnormal skin condition|MP:0002073,abnormal hair growth
MGI:5637096	Apip<tm1b(EUCOMM)Wtsi>	MP:0005419,decreased circulating serum albumin level
MGI:4128102	Aplf<Gt(RRF189)Byg>	MP:0004816,abnormal class switch recombination|MP:0008058,abnormal DNA repair
MGI:5569042	Aplnr<tm1.1(KOMP)Vlcg>	MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002631,abnormal epididymis morphology|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5775395	Aplnr<tm1.1Path>	MP:0000276,heart right ventricle hypertrophy|MP:0002725,abnormal vein morphology|MP:0003828,pulmonary edema|MP:0004012,increased pulmonary artery pressure|MP:0006137,venoocclusion
MGI:4367882	Aplnr<tm1.1Tq>	MP:0000267,abnormal heart development|MP:0001730,embryonic growth arrest|MP:0001935,decreased litter size|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0008779,abnormal maternal behavior|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012106,impaired exercise endurance
MGI:3047284	Aplnr<tm1Afu>	MP:0000230,abnormal systemic arterial blood pressure|MP:0005385,cardiovascular system phenotype
MGI:5433631	Aplnr<tm1Dgen>	MP:0001262,decreased body weight|MP:0001756,abnormal urination|MP:0002988,decreased urine osmolality|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011942,decreased fluid intake
MGI:5775391	Aplnr<tm1Path>	MP:0000276,heart right ventricle hypertrophy|MP:0002725,abnormal vein morphology|MP:0003828,pulmonary edema|MP:0004012,increased pulmonary artery pressure|MP:0006137,venoocclusion
MGI:3775290	Apln<tm1Ntak>	MP:0001263,weight loss|MP:0001293,anophthalmia|MP:0005380,embryo phenotype|MP:0005412,vascular stenosis|MP:0020329,decreased capillary density
MGI:3813940	Apln<tm1Pngr>	MP:0004485,increased response of heart to induced stress|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3776530	Apln<tm1Tq>	MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005290,decreased oxygen consumption|MP:0012106,impaired exercise endurance
MGI:2154545	Aplp1<tm1Umu>	MP:0001262,decreased body weight
MGI:4822176	Aplp2<tm1.1Umu>	MP:0002169,no abnormal phenotype detected
MGI:2137246	Aplp2<tm1Dbo>	MP:0002169,no abnormal phenotype detected
MGI:2138038	Aplp2<tm1Min>	MP:0003984,embryonic growth retardation|MP:0011092,embryonic lethality, complete penetrance
MGI:5572038	Aplp2<tm2b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0002591,decreased mean corpuscular volume|MP:0002764,short tibia
MGI:5825060	Apmap<em1(IMPC)J>	MP:0000452,abnormal mouth morphology|MP:0001303,abnormal lens morphology|MP:0001486,abnormal startle reflex|MP:0001556,increased circulating HDL cholesterol level|MP:0001566,increased circulating phosphate level|MP:0002098,abnormal vibrissa morphology|MP:0002941,increased circulating alanine transaminase level|MP:0003961,decreased lean body mass|MP:0004222,iris synechia|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength
MGI:6343493	Apmap<tm1.2Jgbs>	MP:0002891,increased insulin sensitivity|MP:0002970,abnormal white adipose tissue morphology|MP:0005292,improved glucose tolerance|MP:0005370,liver/biliary system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype|MP:0005560,decreased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0005669,increased circulating leptin level|MP:0005670,abnormal white adipose tissue physiology|MP:0009130,increased white fat cell number|MP:0009133,decreased white fat cell size|MP:0010378,increased respiratory quotient|MP:0011939,increased food intake|MP:0013258,abnormal extracellular matrix morphology|MP:0014146,decreased white adipose tissue mass|MP:0014169,decreased brown adipose tissue mass|MP:0020254,decreased collagen level
MGI:4363051	Apmap<tm1a(KOMP)Wtsi>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008414,abnormal spatial reference memory
MGI:2157320	Apmt1<FVB/NJ>	MP:0010299,increased mammary gland tumor incidence
MGI:2157319	Apmt2<I/LnJ>	MP:0010299,increased mammary gland tumor incidence
MGI:1856666	Apo	MP:0001286,abnormal eye development|MP:0001304,cataract|MP:0001314,cornea opacity|MP:0001318,pupil opacity|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001935,decreased litter size|MP:0010259,anterior polar cataract|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2451255	Apoa1<tm1(APOA1)Prli>	MP:0005376,homeostasis/metabolism phenotype
MGI:2180783	Apoa1<tm1Bres>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0003193,decreased cholesterol efflux|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:1857127	Apoa1<tm1Unc>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0003191,abnormal cellular cholesterol metabolism|MP:0003193,decreased cholesterol efflux|MP:0003981,decreased circulating phospholipid level|MP:0004883,abnormal vascular wound healing|MP:0005178,increased circulating cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:2451256	Apoa1<tm2(APOA1)Prli>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000609,abnormal liver physiology|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis
MGI:3043616	Apoa2<a>	MP:0000604,amyloidosis
MGI:3043622	Apoa2<b>	MP:0000604,amyloidosis|MP:0005178,increased circulating cholesterol level
MGI:3043623	Apoa2<c>	MP:0000604,amyloidosis
MGI:2157148	Apoa2<tm1Bres>	MP:0000186,decreased circulating HDL cholesterol level|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005560,decreased circulating glucose level
MGI:2157162	Apoa4<tm1Bres>	MP:0000186,decreased circulating HDL cholesterol level|MP:0002118,abnormal lipid homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0003976,decreased circulating VLDL triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0008537,increased susceptibility to induced colitis|MP:0011939,increased food intake
MGI:3586505	Apoa5<tm1Hgc>	MP:0001552,increased circulating triglyceride level|MP:0005145,increased circulating VLDL cholesterol level
MGI:6367947	Apobec1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001399,hyperactivity|MP:0001489,decreased startle reflex|MP:0002060,abnormal skin morphology|MP:0002110,abnormal digit morphology
MGI:2157210	Apobec1<tm1Chan>	MP:0000186,decreased circulating HDL cholesterol level
MGI:2157186	Apobec1<tm1Ddsn>	MP:0000187,abnormal triglyceride level|MP:0002118,abnormal lipid homeostasis|MP:0002169,no abnormal phenotype detected
MGI:3664540	Apobec1<tm1Ishi>	MP:0003982,increased cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:2157378	Apobec1<tm1Rub>	MP:0000182,increased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0002118,abnormal lipid homeostasis
MGI:3529527	Apobec2<Gt(OST259634)Lex>	MP:0000063,decreased bone mineral density|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0010124,decreased bone mineral content
MGI:3701835	Apobec2<tm1Msn>	MP:0000751,myopathy|MP:0001262,decreased body weight|MP:0002169,no abnormal phenotype detected|MP:0003081,abnormal soleus morphology|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009426,decreased soleus weight|MP:0009428,decreased tibialis anterior weight
MGI:3700142	Apobec3<Gt(XN450)Byg>	MP:0002490,abnormal immunoglobulin level|MP:0020934,increased susceptibility to Retroviridae infection
MGI:3809767	Apobec3<Rfv3-r>	MP:0003448,abnormal tumor morphology|MP:0005387,immune system phenotype|MP:0020935,decreased susceptibility to Retroviridae infection
MGI:3701836	Apobec3<tm1Msn>	MP:0002169,no abnormal phenotype detected
MGI:2183298	Apob<tm1.1Zc>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0005146,decreased circulating VLDL cholesterol level|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2157090	Apob<tm1Bres>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0011091,prenatal lethality, complete penetrance|MP:0030976,impaired sperm penetration of zona pellucida
MGI:3665449	Apob<tm1Mae>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000184,abnormal circulating HDL cholesterol level|MP:0000187,abnormal triglyceride level|MP:0000914,exencephaly|MP:0001891,hydrocephaly|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0010332,abnormal circulating apolipoprotein level
MGI:3581824	Apob<tm1Meh>	MP:0005376,homeostasis/metabolism phenotype
MGI:1857303	Apob<tm1Sgy>	MP:0000183,decreased circulating LDL cholesterol level|MP:0002644,decreased circulating triglyceride level
MGI:1857141	Apob<tm1Unc>	MP:0000180,abnormal circulating cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000914,exencephaly|MP:0001891,hydrocephaly|MP:0002644,decreased circulating triglyceride level
MGI:2183299	Apob<tm1Zc>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1857304	Apob<tm2Sgy>	MP:0000182,increased circulating LDL cholesterol level|MP:0001552,increased circulating triglyceride level
MGI:1857625	Apob<tm3Sgy>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000914,exencephaly|MP:0001672,abnormal embryo development|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0020515,abnormal visceral yolk sac endoderm morphology
MGI:2157775	Apob<tm4Sgy>	MP:0000914,exencephaly|MP:0001698,decreased embryo size|MP:0001914,hemorrhage|MP:0010912,herniated liver|MP:0011091,prenatal lethality, complete penetrance
MGI:2157108	Apob<tm5Sgy>	MP:0000183,decreased circulating LDL cholesterol level|MP:0002082,postnatal lethality|MP:0005146,decreased circulating VLDL cholesterol level
MGI:2157218	Apoc1<tm1Lmh>	MP:0000180,abnormal circulating cholesterol level|MP:0001547,abnormal lipid level|MP:0001552,increased circulating triglyceride level|MP:0003982,increased cholesterol level|MP:0004773,abnormal bile composition|MP:0005178,increased circulating cholesterol level|MP:0009355,increased liver triglyceride level
MGI:5763016	Apoc2<em1Arem>	MP:0000180,abnormal circulating cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0003975,increased circulating VLDL triglyceride level|MP:0009642,abnormal blood homeostasis|MP:0010329,abnormal lipoprotein level
MGI:5763017	Apoc2<em2Arem>	MP:0000180,abnormal circulating cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0003975,increased circulating VLDL triglyceride level|MP:0009642,abnormal blood homeostasis|MP:0010329,abnormal lipoprotein level
MGI:1857128	Apoc3<tm1Unc>	MP:0000008,increased white adipose tissue amount|MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0002118,abnormal lipid homeostasis|MP:0002575,increased circulating ketone body level|MP:0002644,decreased circulating triglyceride level|MP:0004890,decreased energy expenditure|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0008570,lipidosis|MP:0009642,abnormal blood homeostasis|MP:0011939,increased food intake
MGI:5613668	Apoc4<tm1.1(KOMP)Mbp>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000218,increased leukocyte cell number|MP:0001303,abnormal lens morphology|MP:0001552,increased circulating triglyceride level|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003020,decreased circulating chloride level|MP:0005179,decreased circulating cholesterol level|MP:0005293,impaired glucose tolerance
MGI:2152880	Apoca	MP:0001304,cataract|MP:0001314,cornea opacity|MP:0001317,abnormal pupil morphology|MP:0001935,decreased litter size|MP:0004222,iris synechia|MP:0010259,anterior polar cataract|MP:0011100,preweaning lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011481,anterior iris synechia
MGI:3528149	Apod<tm1Bres>	MP:0000343,abnormal response to cardiac infarction|MP:0003037,increased myocardial infarct size|MP:0005377,hearing/vestibular/ear phenotype|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3829240	Apod<tm1Dsan>	MP:0001402,decreased locomotor activity|MP:0001463,abnormal spatial learning|MP:0002118,abnormal lipid homeostasis|MP:0002757,decreased vertical activity|MP:0002804,abnormal motor learning|MP:0008414,abnormal spatial reference memory|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0014812,abnormal brain physiology
MGI:6452938	Apoe<em1Gpt>	MP:0000272,abnormal aorta morphology|MP:0005339,increased susceptibility to atherosclerosis|MP:0005341,decreased susceptibility to atherosclerosis|MP:0005376,homeostasis/metabolism phenotype|MP:0010957,abnormal aerobic respiration|MP:0010958,abnormal tricarboxylic acid cycle|MP:0012167,abnormal epigenetic regulation of gene expression
MGI:3574899	Apoe<shl>	MP:0000414,alopecia|MP:0001382,abnormal nursing|MP:0002083,premature death|MP:0003692,xanthoma|MP:0005178,increased circulating cholesterol level|MP:0005338,atherosclerotic lesions|MP:0005339,increased susceptibility to atherosclerosis
MGI:3798877	Apoe<Tg(rtTA)1Gaga>	MP:0005178,increased circulating cholesterol level|MP:0005339,increased susceptibility to atherosclerosis
MGI:2447431	Apoe<tm1.1Khw>	MP:0005376,homeostasis/metabolism phenotype
MGI:5703874	Apoe<tm1.1Mae>	MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003884,decreased macrophage cell number|MP:0003982,increased cholesterol level|MP:0003983,decreased cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005318,decreased triglyceride level|MP:0005425,increased macrophage cell number|MP:0005560,decreased circulating glucose level|MP:0009122,decreased white fat cell lipid droplet size|MP:0009133,decreased white fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level|MP:0031414,decreased skeletal muscle triglyceride level|MP:0031417,decreased cardiac muscle triglyceride level
MGI:2158396	Apoe<tm1(APOE*2)Mae>	MP:0001326,retina degeneration|MP:0001547,abnormal lipid level|MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0002118,abnormal lipid homeostasis|MP:0003692,xanthoma|MP:0005178,increased circulating cholesterol level|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology|MP:0005338,atherosclerotic lesions|MP:0005339,increased susceptibility to atherosclerosis|MP:0005370,liver/biliary system phenotype
MGI:2385931	Apoe<tm1(APOE_i4)Sfu>	MP:0000180,abnormal circulating cholesterol level|MP:0000182,increased circulating LDL cholesterol level|MP:0002152,abnormal brain morphology|MP:0003075,abnormal response to CNS ischemic injury|MP:0003950,abnormal plasma membrane morphology|MP:0004777,abnormal phospholipid level|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0010161,decreased brain cholesterol level
MGI:2137814	Apoe<tm1Bres>	MP:0000180,abnormal circulating cholesterol level|MP:0000181,abnormal circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0001552,increased circulating triglyceride level|MP:0001663,abnormal digestive system physiology|MP:0002882,abnormal neuron morphology|MP:0003692,xanthoma|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005317,increased triglyceride level|MP:0005338,atherosclerotic lesions|MP:0005339,increased susceptibility to atherosclerosis
MGI:2447429	Apoe<tm1Khw>	MP:0000182,increased circulating LDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:2152302	Apoe<tm1Lmh>	MP:0001556,increased circulating HDL cholesterol level|MP:0002118,abnormal lipid homeostasis|MP:0003692,xanthoma|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005338,atherosclerotic lesions
MGI:1857129	Apoe<tm1Unc>	MP:0000031,abnormal cochlea morphology|MP:0000043,organ of Corti degeneration|MP:0000048,abnormal stria vascularis morphology|MP:0000180,abnormal circulating cholesterol level|MP:0000182,increased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000208,decreased hematocrit|MP:0000233,abnormal blood flow velocity|MP:0000249,abnormal blood vessel physiology|MP:0000609,abnormal liver physiology|MP:0000639,abnormal adrenal gland morphology|MP:0000685,abnormal immune system morphology|MP:0001212,skin lesions|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001413,abnormal response to new environment|MP:0001417,decreased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0001488,increased startle reflex|MP:0001489,decreased startle reflex|MP:0001499,abnormal kindling response|MP:0001533,abnormal skeleton physiology|MP:0001547,abnormal lipid level|MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0001613,abnormal vasodilation|MP:0001625,cardiac hypertrophy|MP:0001744,hypersecretion of corticosterone|MP:0001745,increased circulating corticosterone level|MP:0001790,abnormal immune system physiology|MP:0001861,lung inflammation|MP:0001863,blood vessel inflammation|MP:0001942,abnormal lung volume|MP:0001967,deafness|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002164,abnormal gland physiology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002376,abnormal dendritic cell physiology|MP:0002421,abnormal cell-mediated immunity|MP:0002461,increased immunoglobulin level|MP:0002494,increased IgM level|MP:0002644,decreased circulating triglyceride level|MP:0002651,abnormal sciatic nerve morphology|MP:0002723,abnormal immune serum protein physiology|MP:0002733,abnormal thermal nociception|MP:0002757,decreased vertical activity|MP:0002797,increased thigmotaxis|MP:0002833,increased heart weight|MP:0002857,cochlear ganglion degeneration|MP:0003149,abnormal tectorial membrane morphology|MP:0003157,impaired muscle relaxation|MP:0003192,increased cholesterol efflux|MP:0003348,hypopituitarism|MP:0003394,increased cardiac output|MP:0003631,nervous system phenotype|MP:0003674,oxidative stress|MP:0003692,xanthoma|MP:0003725,increased autoantibody level|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003795,abnormal bone structure|MP:0003806,abnormal nucleotide metabolism|MP:0003871,abnormal myelin sheath morphology|MP:0003957,abnormal nitric oxide homeostasis|MP:0003980,increased circulating phospholipid level|MP:0003991,arteriosclerosis|MP:0004148,increased compact bone thickness|MP:0004308,abnormal basilar membrane morphology|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004629,abnormal spiral modiolar artery morphology|MP:0004630,spiral modiolar artery stenosis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004769,abnormal synaptic vesicle morphology|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004879,decreased systemic vascular resistance|MP:0004952,increased spleen weight|MP:0005006,abnormal osteoblast physiology|MP:0005014,increased B cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005325,abnormal renal glomerulus morphology|MP:0005338,atherosclerotic lesions|MP:0005339,increased susceptibility to atherosclerosis|MP:0005340,abnormal susceptibility to atherosclerosis|MP:0005341,decreased susceptibility to atherosclerosis|MP:0005386,behavior/neurological phenotype|MP:0005412,vascular stenosis|MP:0005416,abnormal circulating protein level|MP:0005455,increased susceptibility to weight gain|MP:0005551,abnormal eye electrophysiology|MP:0005560,decreased circulating glucose level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005591,decreased vasodilation|MP:0005595,abnormal vascular smooth muscle physiology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0005668,decreased circulating leptin level|MP:0006058,decreased cerebral infarct size|MP:0006387,abnormal T cell number|MP:0008073,abnormal CD4-positive, alpha-beta T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008090,increased T-helper 2 cell number|MP:0008143,abnormal dendrite morphology|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008217,abnormal B cell activation|MP:0008288,abnormal adrenal cortex morphology|MP:0008289,abnormal adrenal medulla morphology|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008544,impaired olfaction|MP:0008567,decreased interferon-gamma secretion|MP:0008916,abnormal astrocyte physiology|MP:0009289,decreased epididymal fat pad weight|MP:0009538,abnormal synapse morphology|MP:0009814,increased prostaglandin level|MP:0009866,abnormal aorta wall morphology|MP:0010451,kidney microaneurysm|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume|MP:0010878,increased trabecular bone volume|MP:0010895,increased lung compliance|MP:0010935,increased airway resistance|MP:0010950,abnormal lung hysteresivity|MP:0011309,abnormal kidney arterial blood vessel morphology|MP:0011353,expanded mesangial matrix|MP:0011430,mesangiolysis|MP:0011508,abnormal glomerular capillary thrombosis|MP:0011509,dilated glomerular capillary|MP:0011561,renal glomerulus lipidosis|MP:0011939,increased food intake|MP:0011941,increased fluid intake|MP:0011951,increased cardiac stroke volume|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012334,decreased circulating homocysteine level|MP:0014169,decreased brown adipose tissue mass|MP:0021187,increased bone mineral density of vertebrae|MP:0031384,impaired blood-brain barrier function
MGI:2157240	Apoe<tm2(APOE*3)Mae>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000187,abnormal triglyceride level|MP:0001415,increased exploration in new environment|MP:0001547,abnormal lipid level|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0002118,abnormal lipid homeostasis|MP:0003976,decreased circulating VLDL triglyceride level|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005338,atherosclerotic lesions|MP:0005339,increased susceptibility to atherosclerosis|MP:0005341,decreased susceptibility to atherosclerosis|MP:0008561,decreased tumor necrosis factor secretion|MP:0008706,decreased interleukin-6 secretion
MGI:3613513	Apoe<tm2(APOE_i2)Sfu>	MP:0003075,abnormal response to CNS ischemic injury|MP:0005179,decreased circulating cholesterol level
MGI:2158398	Apoe<tm3(APOE*4)Mae>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001314,cornea opacity|MP:0001326,retina degeneration|MP:0001547,abnormal lipid level|MP:0001731,abnormal postnatal growth|MP:0002078,abnormal glucose homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0003329,amyloid beta deposits|MP:0003949,abnormal circulating lipid level|MP:0003975,increased circulating VLDL triglyceride level|MP:0005025,abnormal response to infection|MP:0005145,increased circulating VLDL cholesterol level|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology|MP:0005293,impaired glucose tolerance|MP:0005339,increased susceptibility to atherosclerosis|MP:0005548,retina pigment epithelium atrophy|MP:0006319,abnormal epididymal fat pad morphology|MP:0008414,abnormal spatial reference memory|MP:0008428,abnormal spatial working memory|MP:0008515,thin retina outer nuclear layer|MP:0008560,increased tumor necrosis factor secretion|MP:0008705,increased interleukin-6 secretion|MP:0008852,retina neovascularization|MP:0009115,abnormal fat cell morphology
MGI:3610994	Apoe<tm3(APOE_i3)Sfu>	MP:0003075,abnormal response to CNS ischemic injury|MP:0005179,decreased circulating cholesterol level|MP:0005376,homeostasis/metabolism phenotype
MGI:5007656	Apoe<tm4Mae>	MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0003949,abnormal circulating lipid level|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005341,decreased susceptibility to atherosclerosis
MGI:5560008	Apof<tm1.1(KOMP)Vlcg>	MP:0000367,abnormal coat/ hair morphology|MP:0002606,increased basophil cell number
MGI:3800154	Apof<tm1(KOMP)Vlcg>	MP:0001556,increased circulating HDL cholesterol level|MP:0002644,decreased circulating triglyceride level|MP:0003193,decreased cholesterol efflux|MP:0005278,abnormal cholesterol homeostasis|MP:0010027,increased liver cholesterol level
MGI:2157224	Apoh<tm1Krl>	MP:0009642,abnormal blood homeostasis|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5692859	Apol10b<tm1b(KOMP)Wtsi>	MP:0010579,increased heart left ventricle size
MGI:7578884	Apol6<em1Hsul>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001262,decreased body weight|MP:0001554,increased circulating free fatty acids level|MP:0001876,decreased inflammatory response|MP:0002644,decreased circulating triglyceride level|MP:0002891,increased insulin sensitivity|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008034,enhanced lipolysis|MP:0009133,decreased white fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009303,decreased renal fat pad weight|MP:0011168,abnormal fat cell differentiation|MP:0014143,decreased body fat mass|MP:0014146,decreased white adipose tissue mass
MGI:8205014	Apol7c<em4Gpt>	MP:0002376,abnormal dendritic cell physiology|MP:0002455,abnormal dendritic cell antigen presentation
MGI:6511000	Apold1<tm1Pfw>	MP:0006059,decreased susceptibility to ischemic brain injury
MGI:5574605	Apom<tm1.1(KOMP)Vlcg>	MP:0001120,abnormal uterus morphology|MP:0002941,increased circulating alanine transaminase level|MP:0004931,enlarged epididymis|MP:0009709,hydrometra
MGI:3772574	Apom<tm1Cchr>	MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level
MGI:3806679	Apom<tm1Stf>	MP:0000186,decreased circulating HDL cholesterol level
MGI:3876457	Apool<Gt(AC0470)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5637032	Apoo<tm1b(KOMP)Wtsi>	MP:0008810,increased circulating iron level
MGI:6164048	Appbp2<em1(IMPC)J>	MP:0000432,abnormal head morphology|MP:0000443,abnormal snout morphology|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4332126	Appl1<Gt(RRS819)Byg>	MP:0001399,hyperactivity|MP:0002079,increased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0011016,increased core body temperature|MP:0011698,abnormal brown adipose tissue physiology|MP:0013279,increased fasting circulating glucose level|MP:0020101,abnormal hepatic glucose production
MGI:4128359	Appl1<Gt(XM073)Byg>	MP:0005348,increased T cell proliferation|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype
MGI:4454678	Appl1<tm1.2Test>	MP:0002608,increased hematocrit|MP:0005348,increased T cell proliferation|MP:0005384,cellular phenotype|MP:0005397,hematopoietic system phenotype|MP:0005621,abnormal cell physiology|MP:0008943,increased sensitivity to induced cell death|MP:0011708,decreased fibroblast cell migration
MGI:5461700	Appl1<tm1Ymli>	MP:0003025,increased vasoconstriction|MP:0005591,decreased vasodilation
MGI:5703918	Appl2<tm1.1Test>	MP:0002590,increased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0005397,hematopoietic system phenotype|MP:0005621,abnormal cell physiology|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011708,decreased fibroblast cell migration
MGI:5762674	Appl2<tm1Smoc>	MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:2652346	App<tm1.1Cep>	MP:0005621,abnormal cell physiology
MGI:5637815	App<tm1.1Tcs>	MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype
MGI:5906910	App<tm1.1Tlyp>	MP:0000790,abnormal stratification in cerebral cortex
MGI:5903308	App<tm1.1Wevn>	MP:0001916,intracerebral hemorrhage|MP:0008817,hematoma|MP:0031121,increased susceptibility to induced thrombosis
MGI:6111357	App<tm1.2Tlyp>	MP:0003631,nervous system phenotype
MGI:5692874	App<tm1b(KOMP)Wtsi>	MP:0000194,increased circulating calcium level|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0002764,short tibia|MP:0005565,increased blood urea nitrogen level|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011962,increased cornea thickness|MP:0011965,decreased total retina thickness
MGI:2652342	App<tm1Cep>	MP:0005621,abnormal cell physiology
MGI:3609234	App<tm1Ck>	MP:0001363,increased anxiety-related response|MP:0002152,abnormal brain morphology
MGI:2154522	App<tm1Cwe>	MP:0000781,decreased corpus callosum size|MP:0001262,decreased body weight|MP:0001417,decreased exploration in new environment|MP:0001454,abnormal cued conditioning behavior|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001522,impaired swimming|MP:0002063,abnormal learning/memory/conditioning|MP:0002065,abnormal fear/anxiety-related behavior|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002175,decreased brain weight|MP:0002196,absent corpus callosum|MP:0002199,abnormal brain commissure morphology|MP:0002572,abnormal emotion/affect behavior|MP:0002797,increased thigmotaxis|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0008222,decreased hippocampal commissure size|MP:0008226,decreased anterior commissure size|MP:0008414,abnormal spatial reference memory|MP:0010053,decreased grip strength|MP:0020467,abnormal circadian behavior
MGI:2136847	App<tm1Dbo>	MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001463,abnormal spatial learning|MP:0001916,intracerebral hemorrhage|MP:0002183,gliosis|MP:0002207,abnormal long-term potentiation|MP:0002798,abnormal active avoidance behavior|MP:0002882,abnormal neuron morphology|MP:0003313,abnormal locomotor activation|MP:0003354,astrocytosis|MP:0008817,hematoma|MP:0010053,decreased grip strength|MP:0031121,increased susceptibility to induced thrombosis
MGI:3044176	App<tm1Ini>	MP:0000787,abnormal telencephalon morphology|MP:0001392,abnormal locomotor behavior|MP:0001463,abnormal spatial learning|MP:0002063,abnormal learning/memory/conditioning|MP:0002083,premature death|MP:0002801,abnormal long-term object recognition memory|MP:0003329,amyloid beta deposits|MP:0031391,increased locomotor activity
MGI:3764842	App<tm1Somm>	MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0002910,abnormal excitatory postsynaptic currents|MP:0004000,impaired passive avoidance behavior|MP:0010053,decreased grip strength
MGI:3783884	App<tm1Sud>	MP:0002169,no abnormal phenotype detected
MGI:3693885	App<tm1Tsuz>	MP:0003631,nervous system phenotype
MGI:3718442	App<tm1Umu>	MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype
MGI:4868765	App<tm2.1Ldad>	MP:0000749,muscle degeneration|MP:0003631,nervous system phenotype|MP:0004510,myositis|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:5637816	App<tm2.1Tcs>	MP:0000604,amyloidosis|MP:0002063,abnormal learning/memory/conditioning|MP:0003329,amyloid beta deposits|MP:0003354,astrocytosis|MP:0008918,microgliosis|MP:0009538,abnormal synapse morphology
MGI:4838049	App<tm2.1Zhe>	MP:0002169,no abnormal phenotype detected
MGI:2154535	App<tm2Cwe>	MP:0000781,decreased corpus callosum size|MP:0002175,decreased brain weight|MP:0002196,absent corpus callosum|MP:0002199,abnormal brain commissure morphology|MP:0008222,decreased hippocampal commissure size|MP:0008226,decreased anterior commissure size
MGI:3718443	App<tm2Umu>	MP:0002175,decreased brain weight|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype
MGI:5637817	App<tm3.1Tcs>	MP:0000604,amyloidosis|MP:0002063,abnormal learning/memory/conditioning|MP:0003329,amyloid beta deposits|MP:0003354,astrocytosis|MP:0008918,microgliosis|MP:0009538,abnormal synapse morphology
MGI:4822174	App<tm3.1Umu>	MP:0002169,no abnormal phenotype detected
MGI:4847574	App<tm3.1Zhe>	MP:0002169,no abnormal phenotype detected
MGI:6377200	Aprt<em1(IMPC)Hmgu>	MP:0001325,abnormal retina morphology|MP:0010378,increased respiratory quotient|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2429961	Aprt<tm1Dwm>	MP:0000519,hydronephrosis|MP:0000538,abnormal urinary bladder morphology|MP:0001265,decreased body size|MP:0001505,hunched posture|MP:0001510,abnormal coat appearance|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0002708,nephrolithiasis|MP:0002989,small kidney|MP:0003014,abnormal kidney medulla morphology|MP:0003215,renal interstitial fibrosis|MP:0003311,aminoaciduria|MP:0003670,dilated renal glomerular capsule|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0009643,abnormal urine homeostasis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011402,renal cast|MP:0011403,pyelonephritis|MP:0011413,colorless urine|MP:0011422,kidney medulla atrophy|MP:0011423,kidney cortex atrophy|MP:0011477,abnormal urine nucleoside level
MGI:1857278	Aprt<tm1Jat>	MP:0000208,decreased hematocrit|MP:0001263,weight loss|MP:0001505,hunched posture|MP:0001511,disheveled coat|MP:0001762,polyuria|MP:0001859,kidney inflammation|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0002705,dilated renal tubule|MP:0002708,nephrolithiasis|MP:0003215,renal interstitial fibrosis|MP:0003918,decreased kidney weight|MP:0003985,renal fibrosis|MP:0004154,renal tubular necrosis|MP:0004970,kidney atrophy|MP:0005389,reproductive system phenotype|MP:0005558,decreased creatinine clearance|MP:0005565,increased blood urea nitrogen level|MP:0009645,crystalluria|MP:0011346,renal tubule atrophy|MP:0011424,decreased urine uric acid level|MP:0011477,abnormal urine nucleoside level|MP:0011625,cystolithiasis|MP:0011844,kidney collecting duct atrophy|MP:0011941,increased fluid intake
MGI:2654615	Aprt<tm1Vri>	MP:0001265,decreased body size|MP:0001429,dehydration|MP:0001505,hunched posture|MP:0001859,kidney inflammation|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002708,nephrolithiasis|MP:0003606,kidney failure|MP:0003985,renal fibrosis|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5634963	Aptx<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0002941,increased circulating alanine transaminase level|MP:0010124,decreased bone mineral content
MGI:3686875	Aptx<tm1Pmc>	MP:0008058,abnormal DNA repair|MP:0014768,impaired single-strand DNA break repair
MGI:1889609	Aqp11<sjds>	MP:0000521,abnormal kidney cortex morphology|MP:0001262,decreased body weight|MP:0002703,abnormal renal tubule morphology|MP:0002988,decreased urine osmolality|MP:0003606,kidney failure|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004969,pale kidney|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0009640,abnormal renal tubule epithelium morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011352,proximal convoluted tubule brush border loss
MGI:5615647	Aqp11<tm1.1(KOMP)Vlcg>	MP:0000221,decreased leukocyte cell number|MP:0002546,mydriasis|MP:0011436,decreased urine magnesium level
MGI:5485013	Aqp11<tm1.1Nlsn>	MP:0000607,abnormal hepatocyte morphology|MP:0001556,increased circulating HDL cholesterol level|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0003442,decreased circulating glycerol level|MP:0003458,decreased circulating ketone body level|MP:0005343,increased circulating aspartate transaminase level|MP:0005376,homeostasis/metabolism phenotype|MP:0005566,decreased blood urea nitrogen level|MP:0009378,abnormal endoplasmic reticulum morphology
MGI:3528447	Aqp11<tm1Lex>	MP:0000521,abnormal kidney cortex morphology|MP:0000522,kidney cortex cyst|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002703,abnormal renal tubule morphology|MP:0002988,decreased urine osmolality|MP:0003068,enlarged kidney|MP:0003606,kidney failure|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004969,pale kidney|MP:0005565,increased blood urea nitrogen level
MGI:5692844	Aqp12<tm1.1(KOMP)Vlcg>	MP:0003179,thrombocytopenia|MP:0005343,increased circulating aspartate transaminase level
MGI:4418194	Aqp12<tm1Rai>	MP:0003982,increased cholesterol level|MP:0004761,increased susceptibility to induced pancreatitis|MP:0009160,abnormal pancreatic acinar cell zymogen granule morphology
MGI:1857807	Aqp1<tm1Ask>	MP:0001262,decreased body weight|MP:0001429,dehydration|MP:0001732,postnatal growth retardation|MP:0002133,abnormal respiratory system physiology|MP:0002988,decreased urine osmolality|MP:0003071,decreased vascular permeability|MP:0003631,nervous system phenotype|MP:0004215,abnormal myocardial fiber physiology|MP:0005202,lethargy|MP:0005377,hearing/vestibular/ear phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0006317,decreased urine sodium level|MP:0006423,dilated rete testis|MP:0008997,increased blood osmolality|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011443,abnormal renal water transport
MGI:5692545	Aqp1<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000219,increased neutrophil cell number|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001556,increased circulating HDL cholesterol level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003020,decreased circulating chloride level|MP:0003960,increased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005553,increased circulating creatinine level|MP:0005568,increased circulating total protein level|MP:0008806,increased circulating amylase level|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:1856830	Aqp2<cph>	MP:0000414,alopecia|MP:0000519,hydronephrosis|MP:0000536,hydroureter|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0001732,postnatal growth retardation|MP:0001762,polyuria|MP:0001921,reduced fertility|MP:0001924,infertility|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0004192,abnormal kidney pyramid morphology|MP:0004194,abnormal kidney pelvis morphology|MP:0004860,dilated kidney collecting duct|MP:0005202,lethargy|MP:0005565,increased blood urea nitrogen level|MP:0008997,increased blood osmolality|MP:0009643,abnormal urine homeostasis|MP:0011304,kidney papillary atrophy|MP:0011305,dilated kidney calyx|MP:0011413,colorless urine|MP:0011422,kidney medulla atrophy|MP:0011492,ureterovesical junction obstruction|MP:0011844,kidney collecting duct atrophy
MGI:3616876	Aqp2<F204V>	MP:0000519,hydronephrosis|MP:0001426,polydipsia|MP:0001762,polyuria|MP:0002136,abnormal kidney physiology|MP:0002988,decreased urine osmolality|MP:0010768,mortality/aging
MGI:3511258	Aqp2<tm1.1Ask>	MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0002988,decreased urine osmolality|MP:0003014,abnormal kidney medulla morphology|MP:0005565,increased blood urea nitrogen level|MP:0011085,postnatal lethality, complete penetrance|MP:0011304,kidney papillary atrophy
MGI:3624697	Aqp2<tm1.1Nlsn>	MP:0000519,hydronephrosis|MP:0001732,postnatal growth retardation|MP:0011085,postnatal lethality, complete penetrance|MP:0011304,kidney papillary atrophy
MGI:3687866	Aqp2<tm1(AQP2)Suc>	MP:0001263,weight loss|MP:0001762,polyuria|MP:0002988,decreased urine osmolality
MGI:3511443	Aqp2<tm1Ask>	MP:0001429,dehydration|MP:0001762,polyuria|MP:0002135,abnormal kidney morphology|MP:0002988,decreased urine osmolality|MP:0004860,dilated kidney collecting duct|MP:0005565,increased blood urea nitrogen level|MP:0008997,increased blood osmolality|MP:0011085,postnatal lethality, complete penetrance|MP:0011304,kidney papillary atrophy|MP:0011307,kidney medulla cyst|MP:0011422,kidney medulla atrophy
MGI:3653759	Aqp2<tm1Bxy>	MP:0000536,hydroureter|MP:0000538,abnormal urinary bladder morphology|MP:0001762,polyuria|MP:0002987,abnormal urine osmolality|MP:0002988,decreased urine osmolality|MP:0004860,dilated kidney collecting duct|MP:0011422,kidney medulla atrophy
MGI:3711456	Aqp2<tm1(cre)Blyg>	MP:0000519,hydronephrosis|MP:0001262,decreased body weight|MP:0001426,polydipsia|MP:0001429,dehydration|MP:0001510,abnormal coat appearance|MP:0001762,polyuria|MP:0002083,premature death|MP:0002608,increased hematocrit|MP:0002987,abnormal urine osmolality|MP:0002988,decreased urine osmolality|MP:0003215,renal interstitial fibrosis|MP:0003853,dry skin|MP:0004860,dilated kidney collecting duct|MP:0005389,reproductive system phenotype|MP:0005565,increased blood urea nitrogen level|MP:0011304,kidney papillary atrophy
MGI:3624696	Aqp2<tm1Nlsn>	MP:0000519,hydronephrosis|MP:0001762,polyuria|MP:0002988,decreased urine osmolality|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011304,kidney papillary atrophy
MGI:4366758	Aqp3<m1Btlr>	MP:0002378,abnormal gut-associated lymphoid tissue morphology|MP:0008537,increased susceptibility to induced colitis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0031154,intestinal hemorrhage
MGI:2150021	Aqp3<tm1Ask>	MP:0001426,polydipsia|MP:0001762,polyuria|MP:0002644,decreased circulating triglyceride level|MP:0002988,decreased urine osmolality|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0008789,abnormal olfactory epithelium morphology|MP:0008997,increased blood osmolality|MP:0011443,abnormal renal water transport
MGI:5636956	Aqp3<tm2b(EUCOMM)Wtsi>	MP:0000194,increased circulating calcium level|MP:0001556,increased circulating HDL cholesterol level|MP:0002965,increased circulating serum albumin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005568,increased circulating total protein level
MGI:5297539	Aqp4<tm1.1Geno>	MP:0005167,abnormal blood-brain barrier function
MGI:4946403	Aqp4<tm1.1Lmno>	MP:0005027,increased susceptibility to parasitic infection|MP:0005167,abnormal blood-brain barrier function|MP:0008916,abnormal astrocyte physiology|MP:0010750,increased susceptibility to parasitic infection induced morbidity/mortality|MP:0011854,cerebral edema
MGI:5613228	Aqp4<tm1.1Mysi>	MP:0003691,abnormal microglial cell physiology
MGI:3848919	Aqp4<tm1.1Tsna>	MP:0003690,abnormal glial cell physiology
MGI:1857808	Aqp4<tm1Ask>	MP:0001784,abnormal fluid regulation|MP:0001967,deafness|MP:0002988,decreased urine osmolality|MP:0003631,nervous system phenotype|MP:0004699,unilateral deafness|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0006190,retina ischemia|MP:0006325,impaired hearing|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0011443,abnormal renal water transport|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:7261160	Aqp4<tm1Gghu>	MP:0001129,impaired ovarian folliculogenesis|MP:0001906,increased dopamine level|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002637,small uterus|MP:0002680,decreased corpora lutea number|MP:0004080,abnormal nucleus accumbens morphology|MP:0004856,decreased ovary weight|MP:0004905,decreased uterus weight|MP:0008258,thin endometrium|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009671,abnormal uterus physiology|MP:0009758,impaired behavioral response to cocaine|MP:0011129,decreased tertiary ovarian follicle number|MP:0031420,decreased superovulation rate
MGI:7310129	Aqp5<em1Cya>	MP:0001337,dry eyes|MP:0001346,abnormal lacrimal gland morphology|MP:0006000,abnormal cornea epithelium morphology|MP:0020220,decreased tear production
MGI:2655164	Aqp5<tm1Amn>	MP:0000623,decreased salivation|MP:0001262,decreased body weight|MP:0001784,abnormal fluid regulation|MP:0001952,increased airway responsiveness|MP:0005310,abnormal salivary gland physiology|MP:0005369,muscle phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging|MP:0010896,decreased lung compliance|MP:0010935,increased airway resistance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012124,increased bronchoconstrictive response
MGI:2150059	Aqp5<tm1Ask>	MP:0000623,decreased salivation|MP:0001732,postnatal growth retardation|MP:0005310,abnormal salivary gland physiology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5636970	Aqp6<tm1b(EUCOMM)Hmgu>	MP:0002135,abnormal kidney morphology|MP:0003019,increased circulating chloride level|MP:0011964,increased total retina thickness
MGI:3608967	Aqp7<tm1.1Suc>	MP:0001759,increased urine glucose level|MP:0002136,abnormal kidney physiology|MP:0005389,reproductive system phenotype
MGI:3580002	Aqp7<tm1Ask>	MP:0001258,decreased body length|MP:0005670,abnormal white adipose tissue physiology|MP:0006094,increased fat cell size|MP:0009285,increased gonadal fat pad weight
MGI:3723644	Aqp7<tm1Chan>	MP:0002079,increased circulating insulin level|MP:0003058,increased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0003441,increased glycerol level|MP:0003927,increased cellular glucose import|MP:0005215,abnormal pancreatic islet morphology|MP:0005375,adipose tissue phenotype|MP:0009172,small pancreatic islets|MP:0009177,decreased pancreatic alpha cell number|MP:0009186,decreased PP cell number
MGI:3841695	Aqp7<tm1Nlsn>	MP:0004543,abnormal sperm physiology|MP:0030781,decreased urine glycerol level
MGI:3526441	Aqp7<tm1Tfun>	MP:0000189,hypoglycemia|MP:0003441,increased glycerol level|MP:0003442,decreased circulating glycerol level
MGI:3613030	Aqp8<tm1Ask>	MP:0001130,abnormal ovarian folliculogenesis|MP:0001148,enlarged testis|MP:0001156,abnormal spermatogenesis|MP:0001552,increased circulating triglyceride level|MP:0001784,abnormal fluid regulation|MP:0001928,abnormal ovulation|MP:0001934,increased litter size|MP:0002681,increased corpora lutea number|MP:0004851,increased testis weight|MP:0005178,increased circulating cholesterol level|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0031016,decreased granulosa cell apoptosis|MP:0031411,increased ovulation rate|MP:0031421,increased superovulation rate|MP:0031424,enhanced female fertility
MGI:6120726	Aqp9<tm1b(KOMP)Wtsi>	MP:0000558,abnormal tibia morphology|MP:0002764,short tibia|MP:0004738,abnormal auditory brainstem response|MP:0005278,abnormal cholesterol homeostasis
MGI:3719452	Aqp9<tm1Nlsn>	MP:0001552,increased circulating triglyceride level|MP:0003443,increased circulating glycerol level|MP:0003656,abnormal erythrocyte physiology|MP:0005026,decreased susceptibility to parasitic infection|MP:0031084,decreased erythrocyte osmotic fragility
MGI:3045413	Aqr<Gt(PT1-ATG)193Wrst>	MP:0002169,no abnormal phenotype detected
MGI:2678463	Aqr<Gt(pT1Betageo)1Ruiz>	MP:0002169,no abnormal phenotype detected
MGI:2180180	Araf<tm1Mmc>	MP:0000492,abnormal rectum morphology|MP:0000706,small thymus|MP:0000745,tremors|MP:0000746,weakness|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001362,abnormal anxiety-related response|MP:0001436,abnormal suckling behavior|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0001527,athetotic walking movements|MP:0002108,abnormal muscle morphology|MP:0002731,megacolon|MP:0004263,abnormal limb posture|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5548590	Arap1<tm1b(EUCOMM)Wtsi>	MP:0001325,abnormal retina morphology|MP:0001529,abnormal vocalization|MP:0002764,short tibia|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005574,decreased pulmonary respiratory rate|MP:0005576,decreased pulmonary ventilation
MGI:4839133	Arap1<tm1(NCOM)Cmhd>	MP:0003961,decreased lean body mass
MGI:5688575	Arap3<em1(IMPC)J>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0002098,abnormal vibrissa morphology|MP:0006243,impaired pupillary reflex|MP:0020870,decreased thigmotaxis
MGI:5428754	Arap3<tm1.2Sve>	MP:0000260,abnormal angiogenesis|MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0001722,pale yolk sac|MP:0001730,embryonic growth arrest|MP:0003227,abnormal vascular branching morphogenesis|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0003717,pallor|MP:0004076,abnormal vitelline vascular remodeling|MP:0004950,abnormal brain vasculature morphology|MP:0009577,abnormal developmental vascular remodeling|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011205,excessive folding of visceral yolk sac|MP:0011521,decreased placental labyrinth size
MGI:5428755	Arap3<tm2.1Sve>	MP:0001698,decreased embryo size|MP:0003227,abnormal vascular branching morphogenesis|MP:0003229,abnormal vitelline vasculature morphology|MP:0003717,pallor|MP:0004950,abnormal brain vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011205,excessive folding of visceral yolk sac
MGI:6147534	Arb2a<em2(IMPC)Ccpcz>	MP:0000598,abnormal liver morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0003402,decreased liver weight|MP:0005343,increased circulating aspartate transaminase level|MP:0013678,decreased Ly6C-positive NK T cell number|MP:0020420,abnormal freezing behavior
MGI:7429117	Arb2a<Tg(Tyr)TpNpln>	MP:0000111,cleft palate|MP:0000266,abnormal heart morphology|MP:0000352,decreased cell proliferation|MP:0000428,abnormal craniofacial morphology|MP:0000914,exencephaly|MP:0001056,abnormal cranial nerve morphology|MP:0001071,abnormal facial nerve morphology|MP:0001157,small seminal vesicle|MP:0001344,blepharoptosis|MP:0001394,circling|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0001891,hydrocephaly|MP:0001921,reduced fertility|MP:0002177,abnormal outer ear morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0002252,abnormal oropharynx morphology|MP:0002286,cryptorchism|MP:0002428,abnormal semicircular canal morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002636,delayed vaginal opening|MP:0002833,increased heart weight|MP:0002939,head spot|MP:0002950,abnormal neural crest cell migration|MP:0003446,renal hypoplasia|MP:0005171,absent coat pigmentation|MP:0005188,small penis|MP:0005381,digestive/alimentary phenotype|MP:0005652,sex reversal|MP:0008544,impaired olfaction|MP:0009085,abnormal uterine horn morphology|MP:0010059,olfactory bulb hypoplasia|MP:0010715,retina coloboma|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012741,decreased neural crest cell proliferation|MP:0012744,increased neural crest cell apoptosis|MP:0030099,facial asymmetry|MP:0030393,delayed fontanelle closure
MGI:6356322	Arc<em1Pfw>	MP:0005386,behavior/neurological phenotype|MP:0008414,abnormal spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior
MGI:6304924	Arcn1<m1Btlr>	MP:0000371,diluted coat color
MGI:2671790	Arcn1<nur17>	MP:0000371,diluted coat color|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0003214,neurofibrillary tangles|MP:0004924,abnormal behavior|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008733,abnormal hair shaft melanin granule distribution|MP:0009992,abnormal cerebellum vermis lobule IX morphology|MP:0009994,abnormal cerebellum vermis lobule VI morphology|MP:0009995,abnormal cerebellum vermis lobule VII morphology|MP:0009997,abnormal cerebellum vermis lobule X morphology|MP:0030949,abnormal Golgi vesicle transport
MGI:5004971	arco	MP:0001081,abnormal cranial ganglia morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001096,abnormal glossopharyngeal ganglion morphology|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0003861,abnormal nervous system development|MP:0006344,small second pharyngeal arch|MP:0006346,small pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3716713	Arc<tm1.1Kuhl>	MP:0001454,abnormal cued conditioning behavior|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0002805,abnormal conditioned taste aversion behavior|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0003008,enhanced long-term potentiation|MP:0003460,decreased fear-related response|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0014367,impaired long-term object recognition memory
MGI:2386454	Arc<tm1Amt>	MP:0001672,abnormal embryo development|MP:0001683,absent mesoderm|MP:0001696,failure to gastrulate|MP:0001705,abnormal proximal-distal axis patterning|MP:0001730,embryonic growth arrest|MP:0002582,disorganized extraembryonic tissue|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0003984,embryonic growth retardation|MP:0003988,disorganized embryonic tissue|MP:0004264,abnormal extraembryonic tissue physiology|MP:0010736,abnormal extraembryonic ectoderm morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology
MGI:3694120	Arc<tm1Stl>	MP:0002272,abnormal nervous system electrophysiology|MP:0003633,abnormal nervous system physiology
MGI:2176531	Areg<tm1Dle>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0005385,cardiovascular system phenotype|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0013716,hypolactation
MGI:5637197	Areg<tm2b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment|MP:0002590,increased mean corpuscular volume
MGI:5806473	Areg<tm2c(EUCOMM)Hmgu>	MP:0005387,immune system phenotype|MP:0010768,mortality/aging|MP:0011015,decreased body surface temperature|MP:0020946,increased susceptibility to Orthomyxoviridae infection|MP:0031068,decreased blood oxygen saturation level
MGI:6392853	Arel1<em1Bbc>	MP:0005087,decreased acute inflammation|MP:0020001,decreased response to antigen
MGI:5605782	Arel1<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0013279,increased fasting circulating glucose level
MGI:5523591	Ar<em1Liuy>	MP:0001147,small testis|MP:0001939,secondary sex reversal
MGI:5697481	Arf1<tm1.1Towa>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5529068	Arf2<tm1.1(KOMP)Wtsi>	MP:0001523,impaired righting response|MP:0002075,abnormal coat/hair pigmentation|MP:0003795,abnormal bone structure|MP:0010052,increased grip strength|MP:0013278,decreased fasting circulating glucose level
MGI:5614714	Arf3<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology
MGI:3857506	Arf4<Gt(AY0614)Wtsi>	MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0005380,embryo phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011186,abnormal visceral endoderm morphology
MGI:3879059	Arf4<Gt(CSH658)Byg>	MP:0003107,abnormal response to novelty|MP:0005386,behavior/neurological phenotype|MP:0011092,embryonic lethality, complete penetrance|MP:0014372,decreased miniature excitatory postsynaptic current amplitude|MP:0020508,decreased dendritic spine density
MGI:6368996	Arf4<tm1.1Tsdk>	MP:0011092,embryonic lethality, complete penetrance
MGI:5572044	Arf4<tm1b(KOMP)Wtsi>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0004952,increased spleen weight|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6369002	Arf5<tm1.1Tsdk>	MP:0002169,no abnormal phenotype detected
MGI:3662650	Arf6<tm1Yaka>	MP:0000596,abnormal liver development|MP:0000598,abnormal liver morphology|MP:0000600,liver hypoplasia|MP:0000603,pale liver|MP:0001577,anemia|MP:0001914,hemorrhage|MP:0002192,hydrops fetalis|MP:0003402,decreased liver weight|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012246,abnormal hepatic cord morphology
MGI:8163548	Arfgap2<tm1c(EUCOMM)Hmgu>	MP:0001841,decreased level of surface class I molecules|MP:0005387,immune system phenotype|MP:0008565,decreased interferon-beta secretion|MP:0008706,decreased interleukin-6 secretion|MP:0010539,decreased level of surface class II molecules|MP:0011075,abnormal macrophage activation involved in immune response|MP:0011079,decreased macrophage cytokine production
MGI:6423073	Arfgef1<em1(IMPC)Hmgu>	MP:0001402,decreased locomotor activity|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance
MGI:3878593	Arfgef1<Gt(CSH465)Byg>	MP:0000774,decreased brain size|MP:0000780,abnormal corpus callosum morphology|MP:0000852,small cerebellum|MP:0002946,delayed axon extension|MP:0002961,abnormal axon guidance|MP:0003203,increased neuron apoptosis|MP:0003247,abnormal glutaminergic neuron morphology|MP:0003651,abnormal axon extension|MP:0006254,thin cerebral cortex|MP:0008227,absent anterior commissure|MP:0008283,small hippocampus|MP:0008535,enlarged lateral ventricles|MP:0009546,absent gastric milk in neonates|MP:0009937,abnormal neuron differentiation|MP:0011087,neonatal lethality, complete penetrance|MP:0020069,decreased neocortex size
MGI:4833878	Arfgef2<Gt(pMS1)16Wen>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5440903	Arfgef2<tm1Itl>	MP:0000788,abnormal cerebral cortex morphology|MP:0000914,exencephaly|MP:0003257,abnormal abdominal wall morphology|MP:0003631,nervous system phenotype|MP:0006009,abnormal neuronal migration|MP:0011723,ectopic neuron
MGI:7519107	Arfgef3<em1(IMPC)Hmgu>	MP:0011886,increased circulating lipase level
MGI:5614350	Arfgef3<tm1Hong>	MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0003058,increased insulin secretion|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:6276923	Arfip1<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002339,abnormal lymph node morphology|MP:0010123,increased bone mineral content
MGI:7611851	Arfip2<tm1d(EUCOMM)Wtsi>	MP:0002871,albuminuria|MP:0005367,renal/urinary system phenotype|MP:0008059,abnormal podocyte foot process morphology|MP:0008060,abnormal podocyte slit diaphragm morphology|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0030940,impaired autophagy
MGI:2159671	Arfrp1<tm1Asch>	MP:0003085,abnormal egg cylinder morphology|MP:0005621,abnormal cell physiology|MP:0011091,prenatal lethality, complete penetrance|MP:0011207,absent ectoplacental cavity|MP:0011209,absent extraembryonic coelom|MP:0014586,decreased egg cylinder size
MGI:3821725	Arfrp1<tm2Asch>	MP:0005621,abnormal cell physiology
MGI:4453214	Arg1<tm1.1Lky>	MP:0002169,no abnormal phenotype detected
MGI:3826848	Arg1<tm1.1Pmu>	MP:0002082,postnatal lethality|MP:0011076,increased macrophage nitric oxide production
MGI:5426515	Arg1<tm1Ekoe>	MP:0002451,abnormal macrophage physiology|MP:0009642,abnormal blood homeostasis
MGI:3826847	Arg1<tm1Pmu>	MP:0002411,decreased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0003957,abnormal nitric oxide homeostasis|MP:0005026,decreased susceptibility to parasitic infection|MP:0011076,increased macrophage nitric oxide production
MGI:2660809	Arg1<tm1Rki>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0001764,abnormal homeostasis|MP:0002138,abnormal hepatobiliary system morphology|MP:0003631,nervous system phenotype|MP:0005309,increased circulating ammonia level|MP:0005311,abnormal circulating amino acid level|MP:0011085,postnatal lethality, complete penetrance|MP:0011652,increased circulating histidine level|MP:0020836,increased circulating citrulline level|MP:0030651,decreased circulating ornithine level|MP:0030661,increased circulating arginine level|MP:0030668,decreased circulating proline level
MGI:6367956	Arg2<em1(IMPC)Ccpcz>	MP:0000160,kyphosis|MP:0000162,lordosis|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000277,abnormal heart shape|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001417,decreased exploration in new environment|MP:0004174,abnormal spine curvature
MGI:2180319	Arg2<tm1Weo>	MP:0005376,homeostasis/metabolism phenotype|MP:0030661,increased circulating arginine level
MGI:6208886	Arglu1<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:4457552	Arglu1<tm1a(EUCOMM)Hmgu>	MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014178,increased brain apoptosis
MGI:6281939	Arhgap10<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000702,enlarged lymph nodes|MP:0001126,abnormal ovary morphology|MP:0001258,decreased body length|MP:0002060,abnormal skin morphology|MP:0002599,increased mean platelet volume|MP:0003795,abnormal bone structure
MGI:5563425	Arhgap10<m1Anu>	MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002566,abnormal sexual interaction|MP:0009434,paraparesis
MGI:7328429	Arhgap11a<em2(ARHGAP11B)Wbh>	MP:0001364,decreased anxiety-related response|MP:0002063,abnormal learning/memory/conditioning|MP:0003861,abnormal nervous system development|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0005386,behavior/neurological phenotype|MP:0008439,abnormal cortical plate morphology|MP:0008457,abnormal cortical intermediate zone morphology|MP:0008947,increased neuron number|MP:0020067,increased neocortex size
MGI:3529984	Arhgap12<Gt(OST237375)Lex>	MP:0002169,no abnormal phenotype detected
MGI:5142283	Arhgap15<tm1Ehi>	MP:0000217,abnormal leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0002411,decreased susceptibility to bacterial infection|MP:0002446,abnormal macrophage morphology|MP:0002463,abnormal neutrophil physiology|MP:0003884,decreased macrophage cell number|MP:0005016,decreased lymphocyte cell number|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008246,abnormal leukocyte morphology
MGI:4329627	Arhgap17<Gt(RRN062)Byg>	MP:0000488,abnormal intestinal epithelium morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0005381,digestive/alimentary phenotype|MP:0008489,slow postnatal weight gain|MP:0008537,increased susceptibility to induced colitis|MP:0008560,increased tumor necrosis factor secretion|MP:0008882,abnormal enterocyte physiology|MP:0010180,increased susceptibility to weight loss|MP:0011942,decreased fluid intake|MP:0013797,abnormal ileal goblet cell morphology|MP:0013956,decreased colon length|MP:0014201,abnormal intestinal epithelium physiology
MGI:5637047	Arhgap17<tm1b(EUCOMM)Wtsi>	MP:0003795,abnormal bone structure|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0008168,decreased B-1a cell number|MP:0008174,decreased follicular B cell number|MP:0008211,decreased mature B cell number|MP:0009922,increased transitional stage T1 B cell number|MP:0010088,decreased circulating fructosamine level|MP:0010124,decreased bone mineral content
MGI:4363220	Arhgap18<tm1a(KOMP)Wtsi>	MP:0000194,increased circulating calcium level|MP:0001257,increased body length|MP:0002792,abnormal retina vasculature morphology|MP:0003026,decreased vasoconstriction|MP:0003721,increased tumor growth/size|MP:0005385,cardiovascular system phenotype|MP:0005595,abnormal vascular smooth muscle physiology|MP:0005601,increased angiogenesis|MP:0009862,abnormal aorta elastic tissue morphology|MP:0009866,abnormal aorta wall morphology|MP:0009867,abnormal ascending aorta morphology|MP:0009870,abnormal abdominal aorta morphology|MP:0009871,abnormal aorta tunica adventitia morphology|MP:0009873,abnormal aorta tunica media morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0010144,abnormal tumor vascularization|MP:0020849,abnormal actin cytoskeleton morphology|MP:0031274,increased susceptibility to induced aneurysm formation|MP:0031281,increased susceptibility to aneurysm induced morbidity/mortality
MGI:3878285	Arhgap19<Gt(YHD020)Byg>	MP:0002169,no abnormal phenotype detected
MGI:5569051	Arhgap19<tm1b(KOMP)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3606252	Arhgap1<tm1Yizh>	MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000141,abnormal vertebral body morphology|MP:0000160,kyphosis|MP:0000333,decreased bone marrow cell number|MP:0000358,abnormal cell morphology|MP:0000600,liver hypoplasia|MP:0000694,spleen hypoplasia|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0001732,postnatal growth retardation|MP:0001792,impaired wound healing|MP:0001823,thymus hypoplasia|MP:0001921,reduced fertility|MP:0002073,abnormal hair growth|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0002396,abnormal hematopoietic system morphology/development|MP:0003203,increased neuron apoptosis|MP:0003446,renal hypoplasia|MP:0003702,abnormal chromosome morphology|MP:0003786,premature aging|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0006042,increased apoptosis|MP:0008479,decreased spleen white pulp amount|MP:0008843,absent subcutaneous adipose tissue|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0013501,increased fibroblast apoptosis|MP:0013624,decreased femur compact bone thickness|MP:0014760,impaired DNA repair|MP:0020010,decreased bone mineral density of femur|MP:0031253,lordokyphosis
MGI:6266926	Arhgap20<em1(IMPC)J>	MP:0005278,abnormal cholesterol homeostasis
MGI:6149757	Arhgap21<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0003385,abnormal body wall morphology|MP:0003961,decreased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4330478	Arhgap21<Gt(RRR629)Byg>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0004810,decreased hematopoietic stem cell number|MP:0005165,increased susceptibility to injury|MP:0008254,increased megakaryocyte cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0020463,increased megakaryocyte progenitor cell number
MGI:4363166	Arhgap22<tm1a(KOMP)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0005561,increased mean corpuscular hemoglobin
MGI:5605828	Arhgap23<tm1b(EUCOMM)Wtsi>	MP:0000198,decreased circulating phosphate level|MP:0005419,decreased circulating serum albumin level
MGI:5694178	Arhgap24<tm1b(KOMP)Wtsi>	MP:0001402,decreased locomotor activity|MP:0010579,increased heart left ventricle size|MP:0011960,abnormal eye anterior chamber depth
MGI:4362243	Arhgap25<tm1a(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0002463,abnormal neutrophil physiology|MP:0005088,increased acute inflammation|MP:0005103,abnormal retina pigmentation|MP:0005397,hematopoietic system phenotype|MP:0005561,increased mean corpuscular hemoglobin|MP:0009858,abnormal cellular extravasation|MP:0020213,enhanced leukocyte migration|MP:0020333,enhanced leukocyte tethering or rolling
MGI:4199843	Arhgap26<Gt(OST135790)Lex>	MP:0009400,decreased skeletal muscle fiber size|MP:0010053,decreased grip strength|MP:0013239,impaired skeletal muscle regeneration|MP:0030959,abnormal myoblast fusion
MGI:6199115	Arhgap26<tm1b(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0001566,increased circulating phosphate level
MGI:6148068	Arhgap28<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0001404,no spontaneous movement|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001914,hemorrhage|MP:0002989,small kidney|MP:0003231,abnormal placenta vasculature|MP:0004258,abnormal placenta size|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4451570	Arhgap28<tm2a(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5750967	Arhgap28<tm2b(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:7582400	Arhgap29<em1Cya>	MP:0000111,cleft palate|MP:0000116,abnormal tooth development|MP:0000266,abnormal heart morphology|MP:0000277,abnormal heart shape|MP:0000452,abnormal mouth morphology|MP:0000585,kinked tail|MP:0001297,microphthalmia|MP:0002576,abnormal enamel morphology|MP:0005230,ectrodactyly|MP:0009653,abnormal palate development|MP:0009703,decreased birth body size|MP:0010402,ventricular septal defect|MP:0011086,postnatal lethality, incomplete penetrance|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0031460,abnormal palatal shelf morphology|MP:0031532,abnormal heart ventricle wall morphology
MGI:5749747	Arhgap29<em1(IMPC)J>	MP:0002941,increased circulating alanine transaminase level|MP:0004738,abnormal auditory brainstem response|MP:0005343,increased circulating aspartate transaminase level|MP:0009884,palatal shelf fusion with tongue or mandible|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0030179,abnormal oral epithelium morphology
MGI:6150826	Arhgap29<tm1Murr>	MP:0009884,palatal shelf fusion with tongue or mandible|MP:0009886,failure of palatal shelf elevation|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0013530,abnormal periderm morphology|MP:0030179,abnormal oral epithelium morphology
MGI:4433173	Arhgap30<tm1a(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0002599,increased mean platelet volume|MP:0005419,decreased circulating serum albumin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008806,increased circulating amylase level|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level
MGI:6257558	Arhgap31<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0001914,hemorrhage|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6343385	Arhgap31<tm1.2Itl>	MP:0000259,abnormal vascular development|MP:0000603,pale liver|MP:0001614,abnormal blood vessel morphology|MP:0005602,decreased angiogenesis|MP:0009022,abnormal brain meninges morphology|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0013848,subcutaneous edema|MP:0031152,subcutaneous hemorrhage
MGI:3694810	Arhgap32<tm1Taki>	MP:0001360,abnormal social investigation|MP:0001405,impaired coordination|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001513,limb grasping|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003863,decreased aggression towards mice|MP:0005389,reproductive system phenotype|MP:0009937,abnormal neuron differentiation|MP:0011622,abnormal habituation to a novel odor|MP:0012315,impaired learning|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude|MP:0020351,decreased vocalization|MP:0020395,abnormal response to social novelty|MP:0021117,abnormal huddling behavior
MGI:5431233	Arhgap33<tm1.1Wbm>	MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000794,abnormal parietal lobe morphology|MP:0000805,abnormal visual cortex morphology|MP:0000859,abnormal somatosensory cortex morphology|MP:0002882,abnormal neuron morphology|MP:0004631,abnormal auditory cortex morphology|MP:0006254,thin cerebral cortex|MP:0008143,abnormal dendrite morphology|MP:0008547,abnormal neocortex morphology
MGI:5582443	Arhgap33<tm1b(KOMP)Wtsi>	MP:0001491,unresponsive to tactile stimuli|MP:0002834,decreased heart weight|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5789382	Arhgap35<m1Bchd>	MP:0000522,kidney cortex cyst|MP:0000914,exencephaly|MP:0002135,abnormal kidney morphology|MP:0003054,spina bifida|MP:0003446,renal hypoplasia|MP:0003604,single kidney|MP:0003670,dilated renal glomerular capsule|MP:0003720,abnormal neural tube closure|MP:0009050,dilated proximal convoluted tubule|MP:0011066,abnormal renal tubule epithelial cell primary cilium morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011682,renal glomerulus cyst|MP:0012026,abnormal S-shaped body morphology|MP:0013202,abnormal cilium morphology
MGI:2448591	Arhgap35<tm1Jset>	MP:0000790,abnormal stratification in cerebral cortex|MP:0000826,abnormal third ventricle morphology|MP:0000914,exencephaly|MP:0000923,abnormal roof plate morphology|MP:0000925,abnormal floor plate morphology|MP:0000928,incomplete rostral neuropore closure|MP:0001056,abnormal cranial nerve morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0001071,abnormal facial nerve morphology|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0001076,abnormal hypoglossal nerve morphology|MP:0001100,abnormal vagus ganglion morphology|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001698,decreased embryo size|MP:0002135,abnormal kidney morphology|MP:0002184,abnormal innervation|MP:0002196,absent corpus callosum|MP:0002199,abnormal brain commissure morphology|MP:0003052,omphalocele|MP:0003054,spina bifida|MP:0003446,renal hypoplasia|MP:0003604,single kidney|MP:0003720,abnormal neural tube closure|MP:0005262,coloboma|MP:0005549,retina pigment epithelium hyperplasia|MP:0008223,absent hippocampal commissure|MP:0008227,absent anterior commissure|MP:0010860,abnormal anterior commissure pars posterior morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011682,renal glomerulus cyst|MP:0012535,abnormal optic fissure closure|MP:0021107,retina fold
MGI:4453472	Arhgap35<tm2Jset>	MP:0001672,abnormal embryo development|MP:0002081,perinatal lethality|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0003861,abnormal nervous system development
MGI:6357898	Arhgap36<em1Seul>	MP:0003631,nervous system phenotype|MP:0009684,abnormal spinal cord lateral motor column morphology
MGI:5612828	Arhgap40<tm1b(KOMP)Wtsi>	MP:0002753,dilated heart left ventricle
MGI:6157659	Arhgap42<em1(IMPC)H>	MP:0005567,decreased circulating total protein level
MGI:3871380	Arhgap42<Gt(CE0477)Wtsi>	MP:0002842,increased systemic arterial blood pressure|MP:0003025,increased vasoconstriction|MP:0004875,increased mean systemic arterial blood pressure|MP:0005367,renal/urinary system phenotype|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure
MGI:5806663	Arhgap44<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system
MGI:3852684	Arhgap44<Gt(RRZ340)Byg>	MP:0001402,decreased locomotor activity|MP:0001441,increased grooming behavior|MP:0002176,increased brain weight|MP:0002804,abnormal motor learning|MP:0003461,abnormal response to novel object|MP:0009936,abnormal dendritic spine morphology|MP:0020512,abnormal dendritic mushroom spine morphology|MP:0020513,abnormal dendritic stubby spine morphology
MGI:6806175	Arhgap45<em1Ciphe>	MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005380,embryo phenotype|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008101,lymph node hypoplasia|MP:0008185,decreased naive B cell number|MP:0010130,decreased DN1 thymic pro-T cell number|MP:0010768,mortality/aging|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0031207,decreased lymphocyte chemotaxis
MGI:2179998	Arhgap5<tm1Jset>	MP:0000628,abnormal mammary gland development|MP:0000706,small thymus|MP:0000781,decreased corpus callosum size|MP:0000825,dilated lateral ventricle|MP:0001265,decreased body size|MP:0001943,abnormal respiration|MP:0002199,abnormal brain commissure morphology|MP:0005666,abnormal adipose tissue physiology|MP:0006254,thin cerebral cortex|MP:0008226,decreased anterior commissure size|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0011089,perinatal lethality, complete penetrance
MGI:2447298	Arhgap6/Hccs/Mid1<tm1Hzo>	MP:0001672,abnormal embryo development|MP:0001695,abnormal gastrulation|MP:0002169,no abnormal phenotype detected|MP:0003984,embryonic growth retardation|MP:0011091,prenatal lethality, complete penetrance
MGI:3580071	Arhgap6/Hccs/Mid1<tm1Hzo>	MP:0001672,abnormal embryo development|MP:0001695,abnormal gastrulation|MP:0002169,no abnormal phenotype detected|MP:0003984,embryonic growth retardation|MP:0011091,prenatal lethality, complete penetrance
MGI:3580072	Arhgap6/Hccs/Mid1<tm1Hzo>	MP:0001672,abnormal embryo development|MP:0001695,abnormal gastrulation|MP:0002169,no abnormal phenotype detected|MP:0003984,embryonic growth retardation|MP:0011091,prenatal lethality, complete penetrance
MGI:2447302	Arhgap6<tm1Hzo>	MP:0002169,no abnormal phenotype detected
MGI:5776203	Arhgap8<em1(IMPC)J>	MP:0001304,cataract|MP:0002574,increased vertical activity
MGI:3613573	Arhgdia<tm1Ytk>	MP:0000242,impaired fertilization|MP:0000746,weakness|MP:0001762,polyuria|MP:0001919,abnormal reproductive system physiology|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002160,abnormal reproductive system morphology|MP:0002161,abnormal fertility/fecundity|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0002705,dilated renal tubule|MP:0002962,increased urine protein level|MP:0003606,kidney failure|MP:0003675,kidney cyst|MP:0004014,abnormal uterine environment|MP:0004757,abnormal distal convoluted tubule morphology|MP:0004860,dilated kidney collecting duct|MP:0005018,decreased T cell number|MP:0005178,increased circulating cholesterol level|MP:0005264,glomerulosclerosis|MP:0005326,abnormal podocyte morphology|MP:0005389,reproductive system phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005502,abnormal renal/urinary system physiology|MP:0005553,increased circulating creatinine level|MP:0005558,decreased creatinine clearance|MP:0005565,increased blood urea nitrogen level|MP:0008137,absent podocytes|MP:0009640,abnormal renal tubule epithelium morphology|MP:0009642,abnormal blood homeostasis|MP:0011320,abnormal glomerular capillary morphology|MP:0011339,abnormal glomerular mesangium morphology|MP:0011402,renal cast|MP:0011405,tubulointerstitial nephritis|MP:0011428,decreased mesangial cell number|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0031420,decreased superovulation rate
MGI:2180327	Arhgdib<tm1Len>	MP:0005154,increased B cell proliferation|MP:0005387,immune system phenotype
MGI:3814585	Arhgdib<tm1Miyo>	MP:0001156,abnormal spermatogenesis|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number
MGI:3588412	Arhgdig<tm1Caw>	MP:0002169,no abnormal phenotype detected
MGI:6293909	Arhgef10l<em1(IMPC)J>	MP:0003960,increased lean body mass
MGI:5488782	Arhgef10<tm1.1(KOMP)Vlcg>	MP:0002941,increased circulating alanine transaminase level|MP:0005560,decreased circulating glucose level|MP:0005627,increased circulating potassium level
MGI:6287205	Arhgef10<tm1.1Ssfg>	MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001906,increased dopamine level|MP:0003063,increased coping response|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0010069,increased serotonin level|MP:0012575,increased noradrenaline level|MP:0012636,decreased monoamine oxidase activity|MP:0020395,abnormal response to social novelty|MP:0031391,increased locomotor activity
MGI:5788572	Arhgef11<tm1.1Mak>	MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001409,increased stereotypic behavior|MP:0002078,abnormal glucose homeostasis|MP:0005289,increased oxygen consumption|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005670,abnormal white adipose tissue physiology|MP:0009131,decreased white fat cell number|MP:0010378,increased respiratory quotient|MP:0011169,abnormal white fat cell differentation|MP:0014146,decreased white adipose tissue mass|MP:0020090,decreased susceptibility to diet-induced non-insulin dependent diabetes
MGI:5548801	Arhgef11<tm1b(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0005655,increased aggression
MGI:5505410	Arhgef11<tm1Sgkd>	MP:0002169,no abnormal phenotype detected
MGI:3849180	Arhgef12<tm1.1Wet>	MP:0005094,abnormal T cell proliferation
MGI:5614703	Arhgef12<tm1b(KOMP)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000277,abnormal heart shape|MP:0001402,decreased locomotor activity|MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0009141,increased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5505411	Arhgef12<tm1Sgkd>	MP:0011101,prenatal lethality, incomplete penetrance
MGI:3819185	Arhgef12<tm1Soff>	MP:0002843,decreased systemic arterial blood pressure|MP:0003026,decreased vasoconstriction|MP:0005385,cardiovascular system phenotype
MGI:5583080	Arhgef15<tm1.1(KOMP)Vlcg>	MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002152,abnormal brain morphology|MP:0010067,increased red blood cell distribution width|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4882034	Arhgef15<tm1.1Meg>	MP:0009936,abnormal dendritic spine morphology
MGI:3812708	Arhgef15<tm1(KOMP)Vlcg>	MP:0000364,abnormal vascular regression|MP:0002006,neoplasm|MP:0002792,abnormal retina vasculature morphology
MGI:5464934	Arhgef15<tm1Nmoc>	MP:0002792,abnormal retina vasculature morphology
MGI:6148069	Arhgef16<em1(IMPC)Mbp>	MP:0000220,increased monocyte cell number|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0010123,increased bone mineral content|MP:0020421,increased freezing behavior
MGI:6257654	Arhgef17<em1(IMPC)Bay>	MP:0002953,thick ventricular wall|MP:0003068,enlarged kidney|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3531196	Arhgef18<Gt(OSTGST002860)Lex>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6148227	Arhgef18<tm1b(KOMP)Mbp>	MP:0001325,abnormal retina morphology|MP:0008806,increased circulating amylase level|MP:0011100,preweaning lethality, complete penetrance
MGI:3686863	Arhgef1<tm1.1Rmt>	MP:0001806,decreased IgM level|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008193,abnormal marginal zone B cell physiology
MGI:4434048	Arhgef1<tm1a(EUCOMM)Wtsi>	MP:0000220,increased monocyte cell number|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0005564,increased hemoglobin content|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008127,decreased dendritic cell number|MP:0008182,decreased marginal zone B cell number|MP:0008346,increased gamma-delta T cell number|MP:0008524,increased plasmacytoid dendritic cell number|MP:0010835,increased CD4-positive, alpha-beta memory T cell number|MP:0010838,increased CD8-positive, alpha-beta memory T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012767,increased KLRG1-positive NK cell number|MP:0013025,increased Ly6C low monocyte number|MP:0013417,decreased memory-marker gamma-delta T cell number|MP:0013433,increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0013522,decreased memory-marker CD4-positive NK T cell number|MP:0013666,decreased immature NK cell number|MP:0013669,decreased Ly6C-positive immature NK cell number|MP:0013673,increased mature NK cell number|MP:0013679,increased Ly6C-positive NK T cell number
MGI:3769502	Arhgef1<tm1Djle>	MP:0000218,increased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0002463,abnormal neutrophil physiology|MP:0008177,increased germinal center B cell number
MGI:3582489	Arhgef1<tm1Kdf>	MP:0000717,abnormal lymphocyte cell number|MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0003945,abnormal lymphocyte physiology|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0005348,increased T cell proliferation|MP:0008182,decreased marginal zone B cell number
MGI:4442362	Arhgef1<tm1Rmt>	MP:0000230,abnormal systemic arterial blood pressure|MP:0001625,cardiac hypertrophy|MP:0003026,decreased vasoconstriction|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009866,abnormal aorta wall morphology
MGI:5426693	Arhgef25<tm1.1Xya>	MP:0002169,no abnormal phenotype detected|MP:0005385,cardiovascular system phenotype|MP:0010768,mortality/aging
MGI:5500046	Arhgef26<tm1.1Kbur>	MP:0004003,abnormal vascular endothelial cell physiology|MP:0006055,abnormal vascular endothelial cell morphology
MGI:5638671	Arhgef28<tm1.1Ddsr>	MP:0002865,increased growth rate|MP:0005389,reproductive system phenotype|MP:0009703,decreased birth body size|MP:0011708,decreased fibroblast cell migration
MGI:5548458	Arhgef28<tm1b(EUCOMM)Wtsi>	MP:0003795,abnormal bone structure
MGI:5638669	Arhgef28<tm1Ddsr>	MP:0002169,no abnormal phenotype detected
MGI:6430657	Arhgef2<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000774,decreased brain size|MP:0001325,abnormal retina morphology|MP:0002060,abnormal skin morphology|MP:0002152,abnormal brain morphology|MP:0002965,increased circulating serum albumin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0005568,increased circulating total protein level|MP:0010053,decreased grip strength
MGI:5200558	Arhgef2<Gt(IST13976A8)Tigm>	MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000849,abnormal cerebellum morphology|MP:0002451,abnormal macrophage physiology|MP:0005277,abnormal brainstem morphology|MP:0005387,immune system phenotype|MP:0006009,abnormal neuronal migration|MP:0008565,decreased interferon-beta secretion|MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:6388389	Arhgef33<em1(IMPC)Tcp>	MP:0000745,tremors|MP:0001399,hyperactivity|MP:0001510,abnormal coat appearance|MP:0002574,increased vertical activity
MGI:4949326	Arhgef38<tm1a(KOMP)Wtsi>	MP:0005178,increased circulating cholesterol level
MGI:6712019	Arhgef3<em1Chej>	MP:0005369,muscle phenotype|MP:0005620,abnormal muscle contractility|MP:0013161,enhanced muscle regeneration
MGI:4419295	Arhgef3<tm1(KOMP)Wtsi>	MP:0002599,increased mean platelet volume|MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology
MGI:6257774	Arhgef40<em1(IMPC)Bay>	MP:0011964,increased total retina thickness
MGI:4364388	Arhgef4<tm1a(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0002492,decreased IgE level|MP:0002644,decreased circulating triglyceride level|MP:0002874,decreased hemoglobin content|MP:0002968,increased circulating alkaline phosphatase level|MP:0005018,decreased T cell number|MP:0005316,abnormal response to tactile stimuli|MP:0005568,increased circulating total protein level|MP:0008210,increased mature B cell number|MP:0008495,decreased IgG1 level
MGI:4453566	Arhgef4<tm1Taki>	MP:0002169,no abnormal phenotype detected|MP:0003447,decreased tumor growth/size|MP:0003448,abnormal tumor morphology|MP:0003544,abnormal vascular endothelial cell migration|MP:0004003,abnormal vascular endothelial cell physiology|MP:0005602,decreased angiogenesis|MP:0010144,abnormal tumor vascularization
MGI:4437666	Arhgef5<tm1.1Dwu>	MP:0002376,abnormal dendritic cell physiology|MP:0005012,decreased eosinophil cell number|MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008700,decreased interleukin-4 secretion
MGI:4882035	Arhgef5<tm1.2Meg>	MP:0004997,increased CNS synapse formation
MGI:3799061	Arhgef6<tm1Kdf>	MP:0001800,abnormal humoral immune response|MP:0002444,abnormal T cell physiology|MP:0002458,abnormal B cell number|MP:0005016,decreased lymphocyte cell number|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008211,decreased mature B cell number|MP:0008688,decreased interleukin-2 secretion|MP:0014471,enhanced B cell migration
MGI:5305716	Arhgef6<tm1Kkut>	MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001898,abnormal long-term depression|MP:0003461,abnormal response to novel object|MP:0005386,behavior/neurological phenotype|MP:0008143,abnormal dendrite morphology|MP:0009538,abnormal synapse morphology|MP:0009936,abnormal dendritic spine morphology
MGI:5766158	Arhgef6<tm2e.1(EUCOMM)Wtsi>	MP:0000702,enlarged lymph nodes|MP:0005016,decreased lymphocyte cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005627,increased circulating potassium level
MGI:5009652	Arhgef7<tm1a(EUCOMM)Wtsi>	MP:0001711,abnormal placenta morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:6501601	Arhgef7<tm1c(EUCOMM)Wtsi>	MP:0002231,abnormal primitive streak morphology|MP:0005380,embryo phenotype|MP:0011255,abnormal anterior visceral endoderm cell migration
MGI:6501603	Arhgef7<tm1d(EUCOMM)Wtsi>	MP:0001672,abnormal embryo development|MP:0002231,abnormal primitive streak morphology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011255,abnormal anterior visceral endoderm cell migration
MGI:6402582	Arhgef7<tm1Dprk>	MP:0000928,incomplete rostral neuropore closure|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001726,abnormal allantois morphology|MP:0002836,abnormal chorion morphology|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011709,increased fibroblast cell migration|MP:0020416,decreased fibroblast chemotaxis
MGI:8174718	Arhgef9<em1Frk>	MP:0000243,myoclonus|MP:0002064,seizures|MP:0002578,impaired ability to fire action potentials|MP:0002635,reduced sensorimotor gating|MP:0002826,tonic seizures|MP:0003216,absence seizures|MP:0003997,tonic-clonic seizures|MP:0005604,hyperekplexia|MP:0009939,abnormal hippocampus neuron morphology|MP:0012006,abnormal hippocampus physiology|MP:0014373,increased miniature excitatory postsynaptic current amplitude|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude|MP:0014620,abnormal interictal brain wave pattern|MP:0020338,abnormal hippocampal pyramidal neuron dendrite morphology|MP:0020357,abnormal excitatory synapse morphology|MP:0020551,abnormal postsynaptic density morphology
MGI:3757650	Arhgef9<tm1.1Betz>	MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0001475,reduced long-term depression|MP:0002797,increased thigmotaxis|MP:0002882,abnormal neuron morphology|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003008,enhanced long-term potentiation|MP:0004859,abnormal synaptic plasticity
MGI:3820313	Arhgef9<tm1Betz>	MP:0002882,abnormal neuron morphology
MGI:2137663	ari	MP:0001304,cataract|MP:0002699,abnormal vitreous body morphology|MP:0005099,abnormal ciliary body morphology|MP:0005193,abnormal anterior eye segment morphology|MP:0021107,retina fold
MGI:5469314	Arid1a<m1Mag>	MP:0000259,abnormal vascular development|MP:0000293,absent myocardial trabeculae|MP:0000784,forebrain hypoplasia|MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001722,pale yolk sac|MP:0001730,embryonic growth arrest|MP:0001914,hemorrhage|MP:0004086,absent heartbeat|MP:0004259,small placenta|MP:0004269,abnormal optic cup morphology|MP:0005312,pericardial effusion|MP:0005333,decreased heart rate|MP:0005397,hematopoietic system phenotype|MP:0010402,ventricular septal defect|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012098,increased spongiotrophoblast size
MGI:5469315	Arid1a<m2Mag>	MP:0002169,no abnormal phenotype detected
MGI:4836625	Arid1a<tm1.1Gusa>	MP:0001545,abnormal hematopoietic system physiology|MP:0004809,increased hematopoietic stem cell number|MP:0011087,neonatal lethality, complete penetrance
MGI:5708705	Arid1a<tm1.1Mag>	MP:0000024,lowered ear position|MP:0000074,abnormal neurocranium morphology|MP:0000091,short premaxilla|MP:0000281,abnormal interventricular septum morphology|MP:0000433,microcephaly|MP:0000438,abnormal cranium morphology|MP:0000445,short snout|MP:0001299,abnormal eye distance/ position|MP:0001614,abnormal blood vessel morphology|MP:0002633,persistent truncus arteriosus|MP:0005249,abnormal palatine bone morphology|MP:0005451,abnormal body composition|MP:0006126,abnormal cardiac outflow tract development|MP:0006198,enophthalmos|MP:0006337,abnormal first pharyngeal arch morphology|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0006355,abnormal sixth pharyngeal arch artery morphology|MP:0006356,abnormal third pharyngeal arch artery morphology|MP:0010565,absent fetal ductus arteriosus|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012747,abnormal cardiac neural crest cell morphology|MP:0012752,abnormal cardiac neural crest cell migration|MP:0030121,small temporal bone squamous part|MP:0031554,abnormal aortic valve development|MP:0031555,abnormal pulmonary valve development
MGI:3796520	Arid1a<tm1.2Zhwa>	MP:0001683,absent mesoderm|MP:0001696,failure to gastrulate|MP:0001730,embryonic growth arrest|MP:0002399,abnormal pluripotent precursor cell morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6116819	Arid1b<em1Hzhu>	MP:0000747,muscle weakness|MP:0000781,decreased corpus callosum size|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001363,increased anxiety-related response|MP:0001441,increased grooming behavior|MP:0001529,abnormal vocalization|MP:0001732,postnatal growth retardation|MP:0001764,abnormal homeostasis|MP:0001891,hydrocephaly|MP:0002188,small heart|MP:0002834,decreased heart weight|MP:0002989,small kidney|MP:0003918,decreased kidney weight|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005386,behavior/neurological phenotype|MP:0005645,abnormal hypothalamus physiology|MP:0006254,thin cerebral cortex|MP:0008831,abnormal insulin-like growth factor I level|MP:0008948,decreased neuron number|MP:0009703,decreased birth body size|MP:0010053,decreased grip strength|MP:0011089,perinatal lethality, complete penetrance|MP:0012460,decreased dentate gyrus size|MP:0020395,abnormal response to social novelty|MP:0020594,decreased cerebral cortex cell number|MP:0030981,abnormal dentate gyrus subgranular zone morphology
MGI:6286071	Arid1b<em1Iha>	MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001405,impaired coordination|MP:0001409,increased stereotypic behavior|MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0001891,hydrocephaly|MP:0001973,increased thermal nociceptive threshold|MP:0003459,increased fear-related response|MP:0004950,abnormal brain vasculature morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008432,abnormal long-term spatial reference memory|MP:0008535,enlarged lateral ventricles|MP:0009142,decreased prepulse inhibition|MP:0009455,enhanced cued conditioning behavior|MP:0010053,decreased grip strength|MP:0011400,lethality, complete penetrance|MP:0012318,slow extinction of fear memory|MP:0014115,cognitive inflexibility
MGI:6156423	Arid1b<em1(IMPC)Tcp>	MP:0000689,abnormal spleen morphology|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001785,edema|MP:0005553,increased circulating creatinine level|MP:0009142,decreased prepulse inhibition|MP:0009456,impaired cued conditioning behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level|MP:0020420,abnormal freezing behavior|MP:0020421,increased freezing behavior
MGI:5771994	Arid1b<tm1b(EUCOMM)Hmgu>	MP:0000788,abnormal cerebral cortex morphology|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001441,increased grooming behavior|MP:0001458,abnormal object recognition memory|MP:0001925,male infertility|MP:0002797,increased thigmotaxis|MP:0002804,abnormal motor learning|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003064,decreased coping response|MP:0003203,increased neuron apoptosis|MP:0004101,abnormal brain interneuron morphology|MP:0004276,abnormal medial ganglionic eminence morphology|MP:0004277,abnormal lateral ganglionic eminence morphology|MP:0008432,abnormal long-term spatial reference memory|MP:0009538,abnormal synapse morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012307,impaired spatial learning|MP:0014416,decreased social novelty preference|MP:0020358,abnormal inhibitory synapse morphology|MP:0020361,abnormal symmetric synapse morphology|MP:0020394,decreased neuronal precursor proliferation|MP:0020551,abnormal postsynaptic density morphology|MP:0021111,decreased social investigation
MGI:6115546	Arid1b<tm1c(EUCOMM)Hmgu>	MP:0001363,increased anxiety-related response|MP:0001441,increased grooming behavior|MP:0001458,abnormal object recognition memory|MP:0004101,abnormal brain interneuron morphology|MP:0008415,abnormal neurite morphology|MP:0014416,decreased social novelty preference|MP:0021111,decreased social investigation
MGI:4433303	Arid2<tm1a(EUCOMM)Wtsi>	MP:0000260,abnormal angiogenesis|MP:0000284,double outlet right ventricle|MP:0001544,abnormal cardiovascular system physiology|MP:0001914,hemorrhage|MP:0002745,abnormal atrioventricular valve morphology|MP:0004057,thin myocardium compact layer|MP:0004111,abnormal coronary artery morphology|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0010419,inlet ventricular septal defect|MP:0010607,common atrioventricular valve|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0013848,subcutaneous edema
MGI:5448531	Arid3a<tm1b(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0001303,abnormal lens morphology|MP:0001552,increased circulating triglyceride level|MP:0001697,abnormal embryo size|MP:0001711,abnormal placenta morphology|MP:0001914,hemorrhage|MP:0002079,increased circulating insulin level|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005561,increased mean corpuscular hemoglobin|MP:0005650,abnormal limb bud morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:4941793	Arid3a<tm1Pwt>	MP:0000245,abnormal erythropoiesis|MP:0000600,liver hypoplasia|MP:0001265,decreased body size|MP:0001722,pale yolk sac|MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0003717,pallor|MP:0004057,thin myocardium compact layer|MP:0004229,abnormal embryonic erythropoiesis|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0004816,abnormal class switch recombination|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005621,abnormal cell physiology|MP:0008168,decreased B-1a cell number|MP:0008182,decreased marginal zone B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008207,decreased B-2 B cell number|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008495,decreased IgG1 level|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0009923,decreased transitional stage T1 B cell number|MP:0009926,decreased transitional stage T2 B cell number|MP:0010831,lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4129312	Arid3b<Gt(RRJ028)Byg>	MP:0011092,embryonic lethality, complete penetrance
MGI:5812005	Arid3b<tm1c(KOMP)Wtsi>	MP:0002144,abnormal B cell differentiation|MP:0005017,decreased B cell number|MP:0005397,hematopoietic system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008167,increased B-1a cell number|MP:0008170,decreased B-1b cell number|MP:0008173,increased follicular B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008215,decreased immature B cell number|MP:0011816,decreased pre-pro B cell number|MP:0013893,decreased common lymphocyte progenitor cell number
MGI:3625143	Arid3b<tm1Take>	MP:0000267,abnormal heart development|MP:0000364,abnormal vascular regression|MP:0000432,abnormal head morphology|MP:0000930,wavy neural tube|MP:0003984,embryonic growth retardation|MP:0004937,dilated heart|MP:0006042,increased apoptosis|MP:0006346,small pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7783477	Arid3c<em1Fclo>	MP:0001392,abnormal locomotor behavior|MP:0003631,nervous system phenotype|MP:0031391,increased locomotor activity
MGI:7428738	Arid3c<em1(IMPC)J>	MP:0000194,increased circulating calcium level|MP:0000221,decreased leukocyte cell number
MGI:6761445	Arid4a<em1Btlr>	MP:0002764,short tibia|MP:0003109,short femur|MP:0004692,small pubis
MGI:6761440	Arid4a<m1Btlr>	MP:0002764,short tibia|MP:0003109,short femur|MP:0004692,small pubis
MGI:4432398	Arid4a<tm1a(EUCOMM)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3687004	Arid4a<tm1Alb>	MP:0000218,increased leukocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000420,ruffled hair|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001402,decreased locomotor activity|MP:0001577,anemia|MP:0001935,decreased litter size|MP:0002026,increased leukemia incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002397,abnormal bone marrow morphology|MP:0002445,abnormal mononuclear cell differentiation|MP:0002643,poikilocytosis|MP:0002875,decreased erythrocyte cell number|MP:0003121,genetic imprinting|MP:0003131,increased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0003179,thrombocytopenia|MP:0004809,increased hematopoietic stem cell number|MP:0004834,ovary hemorrhage|MP:0005015,increased T cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005573,increased pulmonary respiratory rate|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0011747,myelofibrosis
MGI:3687005	Arid4b<tm1Alb>	MP:0003121,genetic imprinting|MP:0011092,embryonic lethality, complete penetrance
MGI:5692772	Arid4b<tm1b(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0002797,increased thigmotaxis|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5519212	Arid5a<tm1Rnis>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005015,increased T cell number|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008597,decreased circulating interleukin-6 level|MP:0010220,decreased T-helper 17 cell number
MGI:3526852	Arid5b<Gt(ROSA)75Sor>	MP:0000074,abnormal neurocranium morphology|MP:0000091,short premaxilla|MP:0000097,short maxilla|MP:0000107,abnormal frontal bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000157,abnormal sternum morphology|MP:0000445,short snout|MP:0000767,abnormal smooth muscle morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001859,kidney inflammation|MP:0002082,postnatal lethality|MP:0002135,abnormal kidney morphology|MP:0002136,abnormal kidney physiology|MP:0002989,small kidney|MP:0003091,abnormal cell migration|MP:0003755,abnormal palate morphology|MP:0004471,short nasal bone|MP:0004599,abnormal vertebral arch morphology|MP:0004969,pale kidney|MP:0005325,abnormal renal glomerulus morphology|MP:0005508,abnormal skeleton morphology|MP:0005565,increased blood urea nitrogen level|MP:0008146,asymmetric sternocostal joints|MP:0009895,decreased palatine bone horizontal plate size|MP:0011708,decreased fibroblast cell migration|MP:0030189,broad snout|MP:0030383,small presphenoid bone
MGI:2445941	Arid5b<tm1Pjh>	MP:0000333,decreased bone marrow cell number|MP:0000694,spleen hypoplasia|MP:0000711,thymus cortex hypoplasia|MP:0001119,abnormal female reproductive system morphology|MP:0001126,abnormal ovary morphology|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001145,abnormal male reproductive system morphology|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001376,abnormal mating receptivity|MP:0001380,decreased male mating frequency|MP:0001443,poor grooming|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0002161,abnormal fertility/fecundity|MP:0002286,cryptorchism|MP:0002401,abnormal lymphopoiesis|MP:0002637,small uterus|MP:0002722,abnormal immune system organ morphology|MP:0005092,decreased double-positive T cell number|MP:0008082,increased single-positive T cell number|MP:0008208,decreased pro-B cell number|MP:0008295,abnormal adrenal gland zona reticularis morphology|MP:0009396,small endometrial glands|MP:0011090,perinatal lethality, incomplete penetrance|MP:0031286,unilateral cryptorchism|MP:0031287,bilateral cryptorchism
MGI:3771593	Arid5b<tm1Whit>	MP:0000003,abnormal adipose tissue morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0002764,short tibia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008272,abnormal endochondral bone ossification|MP:0008489,slow postnatal weight gain|MP:0009115,abnormal fat cell morphology|MP:0009137,decreased brown fat lipid droplet number|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011939,increased food intake|MP:0011940,decreased food intake
MGI:3524946	Arigg10<BALB/cByJ>	MP:0004797,increased anti-erythrocyte antigen antibody level
MGI:3524888	Arigg1<NZB/BlNJ>	MP:0004797,increased anti-erythrocyte antigen antibody level
MGI:3524891	Arigg2<NZB/BlNJ>	MP:0004797,increased anti-erythrocyte antigen antibody level
MGI:3524894	Arigg3<NZB/BlNJ>	MP:0004797,increased anti-erythrocyte antigen antibody level
MGI:3524896	Arigg4<NZB/BlNJ>	MP:0004797,increased anti-erythrocyte antigen antibody level
MGI:3524898	Arigg5<NZB/BlNJ>	MP:0004797,increased anti-erythrocyte antigen antibody level
MGI:3524904	Arigg6<NZB/BlNJ>	MP:0004797,increased anti-erythrocyte antigen antibody level
MGI:3524912	Arigg7<NZB/BlNJ>	MP:0004797,increased anti-erythrocyte antigen antibody level
MGI:3524923	Arigg8<BALB/cByJ>	MP:0004797,increased anti-erythrocyte antigen antibody level
MGI:3524929	Arigg9<NZB/BlNJ>	MP:0004797,increased anti-erythrocyte antigen antibody level
MGI:3524884	Arigm1<BALB/cByJ>	MP:0002494,increased IgM level
MGI:3524915	Arigm2<NZB/BlNJ>	MP:0002494,increased IgM level
MGI:3524917	Arigm3<NZB/BlNJ>	MP:0002494,increased IgM level
MGI:3524919	Arigm4<NZB/BlNJ>	MP:0002494,increased IgM level
MGI:3524934	Arigm5<NZB/BlNJ>	MP:0002494,increased IgM level
MGI:3524936	Arigm6<NZB/BlNJ>	MP:0002494,increased IgM level
MGI:3524940	Arigm7<NZB/BlNJ>	MP:0002494,increased IgM level
MGI:6156459	Arih1<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013292,embryonic lethality prior to organogenesis
MGI:7408549	Arih1<em3Gpt>	MP:0005387,immune system phenotype|MP:0008565,decreased interferon-beta secretion|MP:0008576,decreased circulating interferon-beta level|MP:0008597,decreased circulating interleukin-6 level|MP:0008706,decreased interleukin-6 secretion|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:5695900	Arih2<tm1.1(KOMP)Vlcg>	MP:0000538,abnormal urinary bladder morphology|MP:0001697,abnormal embryo size|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0003984,embryonic growth retardation|MP:0008528,polycystic kidney|MP:0011100,preweaning lethality, complete penetrance|MP:0011625,cystolithiasis
MGI:5463664	Arih2<tm1Mak>	MP:0000600,liver hypoplasia|MP:0000609,abnormal liver physiology|MP:0001194,dermatitis|MP:0001265,decreased body size|MP:0001846,increased inflammatory response|MP:0001853,heart inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002376,abnormal dendritic cell physiology|MP:0005150,cachexia|MP:0006042,increased apoptosis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5516581	Ark2c<Gt(P9-3F)Sor>	MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000572,abnormal autopod morphology|MP:0000940,abnormal motor neuron innervation pattern|MP:0001265,decreased body size|MP:0001429,dehydration|MP:0001438,aphagia|MP:0001575,cyanosis|MP:0001732,postnatal growth retardation|MP:0003631,nervous system phenotype|MP:0003651,abnormal axon extension|MP:0003956,abnormal body size|MP:0005039,hypoxia|MP:0008069,abnormal joint mobility|MP:0009417,skeletal muscle atrophy|MP:0010053,decreased grip strength|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012055,abnormal phrenic nerve innervation pattern to diaphragm|MP:0013405,increased circulating lactate level
MGI:7384485	Ark2n<em1Wehi>	MP:0000266,abnormal heart morphology|MP:0002106,abnormal muscle physiology|MP:0002841,impaired skeletal muscle contractility|MP:0003961,decreased lean body mass|MP:0005376,homeostasis/metabolism phenotype|MP:0009400,decreased skeletal muscle fiber size|MP:0010024,increased total body fat amount|MP:0012106,impaired exercise endurance|MP:0014145,increased white adipose tissue mass
MGI:5548718	Arl10<tm1.1(KOMP)Vlcg>	MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:3578151	Arl13b<hnn>	MP:0000926,absent floor plate|MP:0001706,abnormal left-right axis patterning|MP:0003054,spina bifida|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6107225	Arl13b<tm1.1Tc>	MP:0002864,abnormal ocular fundus morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0008450,retina photoreceptor degeneration|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment|MP:0009772,abnormal retina development|MP:0011965,decreased total retina thickness|MP:0012029,abnormal electroretinogram waveform feature|MP:0014059,abnormal photoreceptor connecting cilium morphology|MP:0020813,abnormal photoreceptor outer segment disc membrane morphology
MGI:5907220	Arl13b<tm1c(EUCOMM)Wtsi>	MP:0000522,kidney cortex cyst|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0003068,enlarged kidney|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0003675,kidney cyst|MP:0003917,increased kidney weight|MP:0003985,renal fibrosis|MP:0004860,dilated kidney collecting duct|MP:0005565,increased blood urea nitrogen level|MP:0008528,polycystic kidney|MP:0011307,kidney medulla cyst|MP:0011440,increased kidney cell proliferation|MP:0020384,absent kidney epithelial cell primary cilium
MGI:6740188	Arl14<em1(IMPC)J>	MP:0005632,decreased circulating aspartate transaminase level
MGI:6149188	Arl15<em1(IMPC)H>	MP:0000757,herniated abdominal wall|MP:0002764,short tibia|MP:0005553,increased circulating creatinine level|MP:0011100,preweaning lethality, complete penetrance
MGI:7425521	Arl16<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0000759,abnormal skeletal muscle morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002110,abnormal digit morphology|MP:0004083,polysyndactyly
MGI:5825297	Arl2bp<em1(IMPC)J>	MP:0000443,abnormal snout morphology|MP:0001417,decreased exploration in new environment|MP:0003795,abnormal bone structure|MP:0008259,abnormal optic disk morphology|MP:0010124,decreased bone mineral content
MGI:6376642	Arl2bp<em1Visu>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0002766,situs inversus|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004133,heterotaxia|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0008586,disorganized photoreceptor outer segment|MP:0008892,abnormal sperm flagellum morphology|MP:0008893,detached sperm flagellum|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0011102,embryonic lethality, incomplete penetrance|MP:0012143,decreased a-wave amplitude|MP:0013203,abnormal primary cilium morphology|MP:0014059,abnormal photoreceptor connecting cilium morphology|MP:0014684,impaired spermiation|MP:0020813,abnormal photoreceptor outer segment disc membrane morphology|MP:0020869,immotile sperm|MP:0030590,abnormal sperm fibrous sheath morphology
MGI:6386241	Arl3<Gt(EUCJ0159b07)1.1Hmgu>	MP:0001326,retina degeneration|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008451,retina rod cell degeneration|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0008511,thin retina inner nuclear layer|MP:0008587,short photoreceptor outer segment|MP:0011965,decreased total retina thickness|MP:0014059,abnormal photoreceptor connecting cilium morphology|MP:0014645,decreased optokinetic reflex
MGI:4875141	Arl3<Gt(EUCJ0159b07)Hmgu>	MP:0011085,postnatal lethality, complete penetrance
MGI:3623141	Arl3<Gt(OST263303)Lex>	MP:0000527,abnormal kidney development|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0001944,abnormal pancreas morphology|MP:0002705,dilated renal tubule|MP:0002928,abnormal bile duct morphology|MP:0002929,abnormal bile duct development|MP:0003068,enlarged kidney|MP:0003254,bile duct inflammation|MP:0003336,pancreas cyst|MP:0003675,kidney cyst|MP:0004247,small pancreas|MP:0008518,retina outer nuclear layer degeneration|MP:0008585,absent photoreceptor outer segment|MP:0009343,dilated gallbladder|MP:0009498,abnormal extrahepatic bile duct morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2181269	Arl4a<tm1Asch>	MP:0001156,abnormal spermatogenesis|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype
MGI:4432430	Arl4d<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000150,abnormal rib morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002444,abnormal T cell physiology|MP:0003345,decreased rib number|MP:0003961,decreased lean body mass|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004647,decreased lumbar vertebrae number|MP:0004648,decreased thoracic vertebrae number|MP:0004973,increased regulatory T cell number|MP:0005387,immune system phenotype|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008539,decreased susceptibility to induced colitis|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion|MP:0010101,increased sacral vertebrae number|MP:0010124,decreased bone mineral content|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0013154,increased KLRG1+ CD8 alpha-beta T cell number
MGI:7398103	Arl4d<tm1c(EUCOMM)Wtsi>	MP:0002444,abnormal T cell physiology|MP:0005387,immune system phenotype|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008687,increased interleukin-2 secretion|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
MGI:6275185	Arl5a<em1(IMPC)J>	MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval
MGI:5558161	Arl5c<tm1.1(KOMP)Vlcg>	MP:0000195,decreased circulating calcium level|MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology|MP:0005419,decreased circulating serum albumin level|MP:0005554,decreased circulating creatinine level|MP:0005567,decreased circulating total protein level
MGI:5698068	Arl6ip1<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002591,decreased mean corpuscular volume
MGI:5437297	Arl6ip5<tm1.1Jwzh>	MP:0002169,no abnormal phenotype detected
MGI:5437298	Arl6ip5<tm1.2Jwzh>	MP:0000066,osteoporosis|MP:0000160,kyphosis|MP:0001262,decreased body weight|MP:0002006,neoplasm|MP:0002722,abnormal immune system organ morphology|MP:0003453,abnormal keratinocyte physiology|MP:0004502,decreased incidence of tumors by chemical induction|MP:0014756,decreased tumor cell proliferation
MGI:5315599	Arl6ip5<tm1Tnkk>	MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0002804,abnormal motor learning|MP:0003186,abnormal redox activity|MP:0003631,nervous system phenotype|MP:0003858,enhanced coordination|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory
MGI:7425522	Arl6ip6<em1(IMPC)Bay>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology
MGI:4442928	Arl6<tm1Vcs>	MP:0005378,growth/size/body region phenotype|MP:0008581,disorganized photoreceptor inner segment
MGI:5310744	Arl6<tm2Vcs>	MP:0000079,abnormal basioccipital bone morphology|MP:0000098,abnormal vomer bone morphology|MP:0000104,abnormal sphenoid bone morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000111,cleft palate|MP:0000116,abnormal tooth development|MP:0000440,domed cranium|MP:0000787,abnormal telencephalon morphology|MP:0001004,abnormal retina photoreceptor morphology|MP:0001575,cyanosis|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0001954,respiratory distress|MP:0002200,abnormal brain ventricular system morphology|MP:0002626,increased heart rate|MP:0002820,abnormal premaxilla morphology|MP:0002842,increased systemic arterial blood pressure|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004183,abnormal sympathetic nervous system physiology|MP:0004449,absent presphenoid bone|MP:0004450,presphenoid bone hypoplasia|MP:0004463,basisphenoid bone foramen|MP:0005170,cleft upper lip|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype|MP:0005391,vision/eye phenotype|MP:0005458,increased percent body fat/body weight|MP:0006069,abnormal retina neuronal layer morphology|MP:0006254,thin cerebral cortex|MP:0006302,abnormal ectomesenchyme morphology|MP:0008283,small hippocampus|MP:0008545,absent sperm flagellum|MP:0008583,absent photoreceptor inner segment|MP:0008585,absent photoreceptor outer segment|MP:0009890,cleft secondary palate|MP:0010029,abnormal basicranium morphology|MP:0010082,sternebra fusion|MP:0010413,complete atrioventricular septal defect|MP:0011056,abnormal brain ependyma motile cilium morphology|MP:0011069,abnormal brain ependyma motile cilium physiology|MP:0011087,neonatal lethality, complete penetrance|MP:0012085,midface hypoplasia|MP:0012468,decreased striatum size|MP:0030029,wide cranial sutures|MP:0030137,abnormal upper incisor morphology|MP:0030197,small nasal septum|MP:0030420,short basicranium|MP:0030443,abnormal cranial synchondrosis|MP:0030445,abnormal sphenooccipital synchondrosis|MP:0030447,abnormal presphenoid synchondrosis|MP:0030498,abnormal dental lamina morphology|MP:0030966,decreased brain ependyma motile cilium number
MGI:3852843	Arl8b<Gt(AK0793)Wtsi>	MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0004264,abnormal extraembryonic tissue physiology|MP:0011089,perinatal lethality, complete penetrance|MP:0020515,abnormal visceral yolk sac endoderm morphology
MGI:5766134	Arl8b<tm1.1(NCOM)Mfgc>	MP:0004509,abnormal pelvic girdle bone morphology|MP:0005565,increased blood urea nitrogen level|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:6107941	Arl8b<tm1Kkon>	MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0004264,abnormal extraembryonic tissue physiology|MP:0005332,abnormal amino acid level|MP:0008932,abnormal embryonic tissue physiology|MP:0020515,abnormal visceral yolk sac endoderm morphology
MGI:7507199	Arln<em1(IMPC)Mbp>	MP:0002606,increased basophil cell number
MGI:6512469	Armc12<em1Osb>	MP:0001925,male infertility|MP:0005389,reproductive system phenotype|MP:0009237,kinked sperm flagellum|MP:0009647,decreased fertilization frequency|MP:0014468,disorganized sperm mitochondrial sheath|MP:0020451,decreased sperm progressive motility|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031012,impaired sperm migration in female genital tract
MGI:6512490	Armc12<em2Osb>	MP:0005389,reproductive system phenotype
MGI:6512491	Armc12<em3Osb>	MP:0001925,male infertility|MP:0009237,kinked sperm flagellum|MP:0009832,abnormal sperm mitochondrial sheath morphology
MGI:6368816	Armc2<em1Pfr>	MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009241,thick sperm flagellum|MP:0020869,immotile sperm|MP:0031352,absent sperm axonemal central pair
MGI:6148226	Armc2<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0010088,decreased circulating fructosamine level|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6343228	Armc3<em1(IMPC)J>	MP:0001925,male infertility|MP:0005178,increased circulating cholesterol level
MGI:6828763	Armc3<em1Lukf>	MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0006380,abnormal spermatid morphology|MP:0020869,immotile sperm|MP:0030940,impaired autophagy
MGI:6157645	Armc5<tm1Stra>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001683,absent mesoderm|MP:0001696,failure to gastrulate|MP:0001745,increased circulating corticosterone level|MP:0002665,decreased circulating corticosterone level|MP:0005129,increased adrenocorticotropin level|MP:0008288,abnormal adrenal cortex morphology|MP:0008294,abnormal adrenal gland zona fasciculata morphology|MP:0008302,thin adrenal cortex|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5548858	Armc7<tm1.1(KOMP)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6277018	Armcx1<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001417,decreased exploration in new environment|MP:0002339,abnormal lymph node morphology
MGI:7612011	Armcx3<tm1.1Eso>	MP:0002079,increased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0002942,decreased circulating alanine transaminase level|MP:0003448,abnormal tumor morphology|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0010025,decreased total body fat amount|MP:0011939,increased food intake|MP:0014757,increased tumor cell death|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:4455980	Armh3<tm1a(EUCOMM)Wtsi>	MP:0002836,abnormal chorion morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0010052,increased grip strength|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5749842	Armh4<em1(IMPC)H>	MP:0000691,enlarged spleen|MP:0001406,abnormal gait|MP:0010052,increased grip strength
MGI:6272392	Arnt2<em1Btlr>	MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001264,increased body size|MP:0001433,polyphagia|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0005293,impaired glucose tolerance|MP:0010024,increased total body fat amount|MP:0013279,increased fasting circulating glucose level
MGI:6272391	Arnt2<M1Btlr>	MP:0001260,increased body weight
MGI:2180386	Arnt2<tm1Mcs>	MP:0000837,abnormal hypothalamus morphology|MP:0003631,nervous system phenotype|MP:0005621,abnormal cell physiology|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:2178831	Arnt2<tm1Yfk>	MP:0001746,abnormal pituitary secretion|MP:0003965,abnormal pituitary hormone level|MP:0004164,abnormal neurohypophysis morphology|MP:0008536,enlarged third ventricle|MP:0008845,abnormal paraventricular hypothalamic nucleus morphology|MP:0008846,abnormal supraoptic nucleus morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:6386299	Arnt<em1(IMPC)H>	MP:0011100,preweaning lethality, complete penetrance
MGI:2679359	Arnt<tm1.1Gonz>	MP:0000208,decreased hematocrit|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004151,decreased circulating iron level
MGI:3042111	Arnt<tm1Bra>	MP:0001926,female infertility|MP:0004004,patent ductus venosus|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2176696	Arnt<tm1Gonz>	MP:0001131,abnormal ovarian follicle morphology|MP:0001882,abnormal lactation|MP:0001935,decreased litter size|MP:0002169,no abnormal phenotype detected|MP:0005389,reproductive system phenotype|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0011121,decreased primordial ovarian follicle number
MGI:1857680	Arnt<tm1Mcs>	MP:0000260,abnormal angiogenesis|MP:0001606,impaired hematopoiesis|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0001723,disorganized yolk sac vascular plexus|MP:0003403,absent placental labyrinth|MP:0003984,embryonic growth retardation|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004560,abnormal chorionic plate morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0005384,cellular phenotype|MP:0005385,cardiovascular system phenotype|MP:0011092,embryonic lethality, complete penetrance
MGI:1932111	Arnt<tm1Oha>	MP:0000435,shortened head|MP:0000784,forebrain hypoplasia|MP:0001711,abnormal placenta morphology|MP:0002151,abnormal neural tube morphology|MP:0002169,no abnormal phenotype detected|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0004188,delayed embryo turning|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0030975,placenta hemorrhage
MGI:1861621	Arp<BALB/c>	MP:0000693,spleen hyperplasia|MP:0000696,abnormal Peyer's patch morphology|MP:0000708,thymus hyperplasia|MP:0002339,abnormal lymph node morphology|MP:0008101,lymph node hypoplasia
MGI:6275161	Arpc1a<em1(IMPC)J>	MP:0000267,abnormal heart development|MP:0000928,incomplete rostral neuropore closure|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001787,pericardial edema|MP:0002884,abnormal pharyngeal arch morphology|MP:0003720,abnormal neural tube closure|MP:0005031,abnormal trophoblast layer morphology|MP:0006031,abnormal pharyngeal pouch morphology|MP:0010124,decreased bone mineral content|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0012098,increased spongiotrophoblast size|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014134,abnormal embryo morphology
MGI:4431851	Arpc1b<tm1a(EUCOMM)Wtsi>	MP:0000194,increased circulating calcium level|MP:0000218,increased leukocyte cell number|MP:0001258,decreased body length|MP:0002599,increased mean platelet volume|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003884,decreased macrophage cell number|MP:0004609,vertebral fusion|MP:0004613,fusion of vertebral arches|MP:0005419,decreased circulating serum albumin level|MP:0005505,thrombocytosis|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005568,increased circulating total protein level|MP:0008045,decreased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008097,increased plasma cell number|MP:0009926,decreased transitional stage T2 B cell number|MP:0009932,skin fibrosis|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010206,pigment incontinence|MP:0010835,increased CD4-positive, alpha-beta memory T cell number|MP:0012768,decreased KLRG1-positive NK cell number|MP:0013157,increased KLRG1+ CD4 alpha-beta T cell number|MP:0013427,increased memory-marker NK cell number|MP:0013430,increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0013433,increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0013514,increased memory-marker CD4-negative NK T cell number|MP:0013654,increased CD103-positive CD11b-low dendritic cell number|MP:0013667,increased immature NK cell number|MP:0013672,decreased mature NK cell number|MP:0013675,decreased Ly6C-positive mature NK cell number|MP:0013768,decreased marginal zone precursor B cell number|MP:0013772,increased effector memory T-helper cell number|MP:0013775,increased KLRG1-positive T-helper cell number
MGI:4431694	Arpc2<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0002075,abnormal coat/hair pigmentation|MP:0005561,increased mean corpuscular hemoglobin|MP:0010025,decreased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:4125947	Arpc3<Gt(XG476)Byg>	MP:0001792,impaired wound healing|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011707,impaired fibroblast cell migration|MP:0020414,abnormal fibroblast physiology|MP:0020415,abnormal fibroblast chemotaxis
MGI:4842449	Arpc3<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5509154	Arpc3<tm1Ssod>	MP:0001399,hyperactivity|MP:0001409,increased stereotypic behavior|MP:0001458,abnormal object recognition memory|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002574,increased vertical activity|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory|MP:0009142,decreased prepulse inhibition|MP:0009538,abnormal synapse morphology|MP:0009936,abnormal dendritic spine morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0014365,impaired short-term object recognition memory|MP:0014367,impaired long-term object recognition memory
MGI:3613188	Arpc3<Tn(sb-lacZ,GFP)T5.117Jtak>	MP:0000358,abnormal cell morphology|MP:0001265,decreased body size|MP:0002718,abnormal inner cell mass morphology|MP:0004957,abnormal blastocyst morphology|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4433308	Arpc4<tm1a(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0002074,abnormal hair texture|MP:0002590,increased mean corpuscular volume|MP:0005567,decreased circulating total protein level|MP:0010088,decreased circulating fructosamine level
MGI:6111539	Arpc4<tm1c(EUCOMM)Wtsi>	MP:0000379,decreased hair follicle number|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000648,absent sebaceous gland|MP:0001192,scaly skin|MP:0001193,psoriasis|MP:0001194,dermatitis|MP:0001212,skin lesions|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001874,acanthosis|MP:0002169,no abnormal phenotype detected|MP:0002656,abnormal keratinocyte differentiation|MP:0003427,parakeratosis|MP:0003853,dry skin|MP:0005501,abnormal skin physiology|MP:0009931,abnormal skin appearance|MP:0030529,abnormal head skin morphology
MGI:7450686	Arpc5<em1.1Mway>	MP:0000928,incomplete rostral neuropore closure|MP:0003874,absent pharyngeal arches|MP:0004180,failure of initiation of embryo turning|MP:0009768,impaired somite development|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012707,incomplete caudal neuropore closure|MP:0014044,absent cardiac outflow tract
MGI:5634586	Arpc5l<tm1.1(KOMP)Vlcg>	MP:0001406,abnormal gait|MP:0002075,abnormal coat/hair pigmentation|MP:0002941,increased circulating alanine transaminase level|MP:0013278,decreased fasting circulating glucose level
MGI:8187429	Arpin<em1Cya>	MP:0001175,abnormal lung morphology|MP:0003070,increased vascular permeability|MP:0003828,pulmonary edema|MP:0004125,abnormal venule morphology|MP:0010899,abnormal pulmonary alveolar system morphology|MP:0010909,pulmonary alveolar hemorrhage
MGI:6342463	Arpp19<tm1d(KOMP)Mbp>	MP:0001672,abnormal embryo development|MP:0001696,failure to gastrulate|MP:0001730,embryonic growth arrest|MP:0011091,prenatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3529328	Arpp21<tm1Lex>	MP:0003484,abnormal channel response
MGI:5688598	Arr3<em1(IMPC)J>	MP:0002644,decreased circulating triglyceride level|MP:0002968,increased circulating alkaline phosphatase level|MP:0006243,impaired pupillary reflex
MGI:3527130	Arr3<tm1Chcr>	MP:0005391,vision/eye phenotype
MGI:5477806	Arrb1<tm1b(KOMP)Wtsi>	MP:0002833,increased heart weight|MP:0003179,thrombocytopenia|MP:0005561,increased mean corpuscular hemoglobin|MP:0009142,decreased prepulse inhibition
MGI:2157962	Arrb1<tm1Jse>	MP:0001544,abnormal cardiovascular system physiology|MP:0002626,increased heart rate|MP:0031635,increased heart left ventricle muscle contractility
MGI:5445919	Arrb2<tm1.1(KOMP)Vlcg>	MP:0001554,increased circulating free fatty acids level|MP:0001556,increased circulating HDL cholesterol level|MP:0001566,increased circulating phosphate level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0010052,increased grip strength
MGI:2157960	Arrb2<tm1Rjl>	MP:0001777,abnormal body temperature homeostasis|MP:0001981,increased chemically-elicited antinociception|MP:0003945,abnormal lymphocyte physiology|MP:0005088,increased acute inflammation|MP:0008552,abnormal circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008596,increased circulating interleukin-6 level|MP:0008669,increased interleukin-12b secretion|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock
MGI:2664153	Arrd1<C57BL/6J>	MP:0031605,decreased susceptibility to age-related retinal degeneration
MGI:2664155	Arrd2<C57BL/6J>	MP:0031605,decreased susceptibility to age-related retinal degeneration
MGI:2664156	Arrd3<BALB/cByJ>	MP:0031605,decreased susceptibility to age-related retinal degeneration
MGI:3700833	Arrd4<C57BL/6J>	MP:0031605,decreased susceptibility to age-related retinal degeneration
MGI:5445677	Arrdc1<tm1.1(KOMP)Vlcg>	MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0001489,decreased startle reflex|MP:0002941,increased circulating alanine transaminase level|MP:0013279,increased fasting circulating glucose level
MGI:5051234	Arrdc1<tm1(KOMP)Vlcg>	MP:0005621,abnormal cell physiology
MGI:5638565	Arrdc2<tm1b(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0005333,decreased heart rate|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3877613	Arrdc3<Gt(CSE151)Byg>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002310,decreased susceptibility to hepatic steatosis|MP:0002575,increased circulating ketone body level|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003213,decreased susceptibility to age related obesity|MP:0003953,abnormal hormone level|MP:0005289,increased oxygen consumption|MP:0005448,abnormal energy homeostasis|MP:0005459,decreased percent body fat/body weight|MP:0005479,decreased circulating triiodothyronine level|MP:0005560,decreased circulating glucose level|MP:0005661,decreased circulating adrenaline level|MP:0005668,decreased circulating leptin level|MP:0008965,increased basal metabolism|MP:0009116,abnormal brown fat cell morphology|MP:0009133,decreased white fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0011090,perinatal lethality, incomplete penetrance|MP:0020523,decreased susceptibility to induced hypothermia
MGI:3883794	Arrdc3<Gt(CSE513)Byg>	MP:0001199,thin skin|MP:0001265,decreased body size|MP:0003213,decreased susceptibility to age related obesity|MP:0011092,embryonic lethality, complete penetrance
MGI:6856856	Arrdc4<em1(IMPC)Tcp>	MP:0000220,increased monocyte cell number|MP:0000702,enlarged lymph nodes|MP:0010067,increased red blood cell distribution width|MP:0011874,enlarged urinary bladder
MGI:5286528	Arrdc4<tm1(KOMP)Vlcg>	MP:0005621,abnormal cell physiology
MGI:7543366	Arrdc5<em1Oat>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0003666,impaired sperm capacitation|MP:0004542,impaired acrosome reaction|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008898,abnormal acrosome morphology|MP:0009233,enlarged sperm head|MP:0030976,impaired sperm penetration of zona pellucida
MGI:5637088	Arrdc5<tm1b(EUCOMM)Wtsi>	MP:0001325,abnormal retina morphology|MP:0001925,male infertility|MP:0002968,increased circulating alkaline phosphatase level|MP:0005561,increased mean corpuscular hemoglobin|MP:0010087,increased circulating fructosamine level
MGI:3844242	Arrh1<C57BL/6JJcl>	MP:0020467,abnormal circadian behavior
MGI:2180363	Arsa<tm1Gie>	MP:0000136,abnormal microglial cell morphology|MP:0000242,impaired fertilization|MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001106,abnormal Schwann cell morphology|MP:0001146,abnormal testis morphology|MP:0001156,abnormal spermatogenesis|MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001463,abnormal spatial learning|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0001922,reduced male fertility|MP:0001967,deafness|MP:0002092,abnormal eye morphology|MP:0002118,abnormal lipid homeostasis|MP:0002631,abnormal epididymis morphology|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0002799,abnormal passive avoidance behavior|MP:0002856,abnormal vestibular ganglion morphology|MP:0002857,cochlear ganglion degeneration|MP:0002882,abnormal neuron morphology|MP:0003354,astrocytosis|MP:0004852,decreased testis weight|MP:0005058,abnormal lysosome morphology|MP:0005404,abnormal axon morphology|MP:0005578,teratozoospermia|MP:0006362,abnormal male germ cell morphology|MP:0006380,abnormal spermatid morphology|MP:0008026,abnormal brain white matter morphology|MP:0008128,abnormal brain internal capsule morphology|MP:0009230,abnormal sperm head morphology|MP:0009238,coiled sperm flagellum|MP:0009853,decreased Sertoli cell phagocytosis|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014052,increased male germ cell apoptosis|MP:0030978,impaired binding of sperm to zona pellucida
MGI:6760610	Arsb<m1Btlr>	MP:0002764,short tibia|MP:0003109,short femur
MGI:3800577	Arsb<m1J>	MP:0000062,increased bone mineral density|MP:0000097,short maxilla|MP:0000445,short snout|MP:0000547,short limbs|MP:0000588,thick tail|MP:0000958,peripheral nervous system degeneration|MP:0001265,decreased body size|MP:0001300,ocular hypertelorism|MP:0001406,abnormal gait|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002110,abnormal digit morphology|MP:0003172,abnormal lysosome physiology|MP:0005459,decreased percent body fat/body weight|MP:0009415,skeletal muscle degeneration|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2180365	Arsb<tm1Cptr>	MP:0000097,short maxilla|MP:0000150,abnormal rib morphology|MP:0000163,abnormal cartilage morphology|MP:0000285,abnormal heart valve morphology|MP:0000346,broad head|MP:0000358,abnormal cell morphology|MP:0000441,increased cranium width|MP:0000445,short snout|MP:0000547,short limbs|MP:0001262,decreased body weight|MP:0001312,abnormal cornea morphology|MP:0002429,abnormal blood cell morphology/development|MP:0002843,decreased systemic arterial blood pressure|MP:0003120,abnormal tracheal cartilage morphology|MP:0003393,decreased cardiac output|MP:0003958,heart valve hyperplasia|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004686,decreased length of long bones|MP:0005140,decreased cardiac muscle contractility|MP:0006000,abnormal cornea epithelium morphology|MP:0006045,mitral valve regurgitation|MP:0006397,disorganized long bone epiphyseal plate|MP:0006398,increased long bone epiphyseal plate size|MP:0006433,abnormal articular cartilage morphology|MP:0010620,thick mitral valve|MP:0011473,increased urine glycosaminoglycan level|MP:0020242,increased autopod size|MP:0020855,decreased cornea epithelium thickness|MP:0020859,disorganized cornea epithelium|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5430640	Arsg<tm1Tdi>	MP:0000136,abnormal microglial cell morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0001417,decreased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0002063,abnormal learning/memory/conditioning|MP:0002135,abnormal kidney morphology|MP:0002446,abnormal macrophage morphology|MP:0002882,abnormal neuron morphology|MP:0003354,astrocytosis|MP:0004000,impaired passive avoidance behavior|MP:0004967,abnormal kidney epithelium morphology|MP:0005059,lysosomal protein accumulation|MP:0008242,abnormal perivascular macrophage morphology|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment|MP:0008918,microgliosis|MP:0009939,abnormal hippocampus neuron morphology|MP:0010369,abnormal thalamus neuron morphology|MP:0011475,abnormal glycosaminoglycan level|MP:0011965,decreased total retina thickness|MP:0031148,abnormal liver sinusoidal endothelial cell morphology
MGI:6394013	Arsj<em1(IMPC)J>	MP:0000062,increased bone mineral density|MP:0001488,increased startle reflex|MP:0002626,increased heart rate|MP:0002833,increased heart weight|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0010507,shortened RR interval
MGI:5446134	Arsk<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001325,abnormal retina morphology|MP:0002557,abnormal social/conspecific interaction behavior|MP:0003172,abnormal lysosome physiology|MP:0003631,nervous system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008414,abnormal spatial reference memory|MP:0011333,abnormal kidney inner medulla morphology|MP:0011378,abnormal kidney outer medulla inner stripe morphology|MP:0011475,abnormal glycosaminoglycan level
MGI:5696877	Art1<tm1b(EUCOMM)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0000702,enlarged lymph nodes|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002606,increased basophil cell number|MP:0002941,increased circulating alanine transaminase level|MP:0005634,decreased circulating sodium level|MP:0010053,decreased grip strength
MGI:2180366	Art2a<null>	MP:0002169,no abnormal phenotype detected
MGI:4363180	Art4<tm1a(KOMP)Wtsi>	MP:0010052,increased grip strength|MP:0010067,increased red blood cell distribution width
MGI:7490376	Art5<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0002075,abnormal coat/hair pigmentation
MGI:1856319	Ar<Tfm>	MP:0000172,abnormal bone marrow cell number|MP:0000245,abnormal erythropoiesis|MP:0001119,abnormal female reproductive system morphology|MP:0001144,vagina atresia|MP:0001145,abnormal male reproductive system morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001156,abnormal spermatogenesis|MP:0001929,abnormal gametogenesis|MP:0001939,secondary sex reversal|MP:0002212,abnormal secondary sex determination|MP:0002216,abnormal seminiferous tubule morphology|MP:0002286,cryptorchism|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002789,male pseudohermaphroditism|MP:0003557,absent vas deferens|MP:0004727,absent epididymis|MP:0005189,abnormal anogenital distance|MP:0006262,increased testis tumor incidence|MP:0006308,enlarged seminiferous tubules|MP:0008214,increased immature B cell number|MP:0008250,abnormal myeloid leukocyte morphology|MP:0008261,arrest of male meiosis|MP:0013598,Leydig cell hypertrophy|MP:0013604,abnormal adult Leydig cell differentiation|MP:0014491,abnormal mammary gland sensory innervation pattern
MGI:1856477	Ar<Tfm-Jms>	MP:0001147,small testis|MP:0001260,increased body weight|MP:0001926,female infertility|MP:0001939,secondary sex reversal|MP:0002212,abnormal secondary sex determination
MGI:2153860	Artles<C57BL/6J>	MP:0002079,increased circulating insulin level|MP:0005339,increased susceptibility to atherosclerosis
MGI:2156399	Artles<CAST/EiJ>	MP:0002727,decreased circulating insulin level|MP:0005341,decreased susceptibility to atherosclerosis
MGI:2687199	Ar<tm1.1Chc>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001159,absent prostate gland|MP:0001751,increased circulating luteinizing hormone level|MP:0002009,preneoplasia|MP:0002780,decreased circulating testosterone level|MP:0003642,absent seminal vesicle|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004727,absent epididymis|MP:0014756,decreased tumor cell proliferation|MP:0014757,increased tumor cell death
MGI:3716756	Ar<tm1.1Jdz>	MP:0001145,abnormal male reproductive system morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001159,absent prostate gland|MP:0001262,decreased body weight|MP:0001939,secondary sex reversal|MP:0002286,cryptorchism|MP:0002670,absent scrotum|MP:0002780,decreased circulating testosterone level|MP:0003550,short perineum|MP:0003642,absent seminal vesicle|MP:0004727,absent epididymis|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005378,growth/size/body region phenotype|MP:0008261,arrest of male meiosis
MGI:3714992	Ar<tm1.1Reb>	MP:0001147,small testis|MP:0001939,secondary sex reversal|MP:0002286,cryptorchism|MP:0002789,male pseudohermaphroditism|MP:0008261,arrest of male meiosis
MGI:3034099	Ar<tm1.1Verh>	MP:0001145,abnormal male reproductive system morphology|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001731,abnormal postnatal growth|MP:0001751,increased circulating luteinizing hormone level|MP:0001939,secondary sex reversal|MP:0002212,abnormal secondary sex determination|MP:0002286,cryptorchism|MP:0003557,absent vas deferens|MP:0003642,absent seminal vesicle|MP:0004727,absent epididymis|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005536,decreased Leydig cell number|MP:0006420,abnormal peritubular myoid cell morphology|MP:0009073,absent Wolffian ducts|MP:0014052,increased male germ cell apoptosis
MGI:3628485	Ar<tm1(AR)Dmr>	MP:0001260,increased body weight|MP:0005458,increased percent body fat/body weight
MGI:2451025	Ar<tm1Chc>	MP:0000008,increased white adipose tissue amount|MP:0000130,abnormal trabecular bone morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001158,abnormal prostate gland morphology|MP:0001159,absent prostate gland|MP:0001168,abnormal prostate gland epithelium morphology|MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001925,male infertility|MP:0001930,abnormal meiosis|MP:0001935,decreased litter size|MP:0001940,testis hypoplasia|MP:0002079,increased circulating insulin level|MP:0002169,no abnormal phenotype detected|MP:0002216,abnormal seminiferous tubule morphology|MP:0002286,cryptorchism|MP:0002669,abnormal scrotum morphology|MP:0002780,decreased circulating testosterone level|MP:0002784,abnormal Sertoli cell morphology|MP:0003124,hypospadia|MP:0003205,testicular atrophy|MP:0003557,absent vas deferens|MP:0003642,absent seminal vesicle|MP:0004727,absent epididymis|MP:0004852,decreased testis weight|MP:0004893,decreased adiponectin level|MP:0004901,decreased male germ cell number|MP:0004984,increased osteoclast cell number|MP:0005159,azoospermia|MP:0005188,small penis|MP:0005189,abnormal anogenital distance|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005455,increased susceptibility to weight gain|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0009115,abnormal fat cell morphology|MP:0009199,abnormal external male genitalia morphology|MP:0009204,absent external male genitalia|MP:0009285,increased gonadal fat pad weight|MP:0009302,increased renal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0013598,Leydig cell hypertrophy|MP:0014441,decreased response to leptin|MP:0014617,decreased spermatogonia number|MP:0020039,increased bone ossification|MP:0031357,enlarged prostate gland ventral lobe|MP:0031415,increased skeletal muscle triglyceride level
MGI:3706240	Ar<tm1Fcl>	MP:0001153,small seminiferous tubules|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002169,no abnormal phenotype detected|MP:0002209,decreased germ cell number|MP:0004852,decreased testis weight|MP:0004910,decreased seminal vesicle weight|MP:0004929,decreased epididymis weight|MP:0005250,decreased Sertoli cell number|MP:0031359,decreased prostate gland anterior lobe weight|MP:0031362,decreased prostate gland ventral lobe weight
MGI:3717246	Ar<tm1Jdz>	MP:0000242,impaired fertilization|MP:0000661,small prostate gland ventral lobe|MP:0000664,small prostate gland anterior lobe|MP:0001146,abnormal testis morphology|MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001157,small seminal vesicle|MP:0001158,abnormal prostate gland morphology|MP:0001163,abnormal prostate gland anterior lobe morphology|MP:0001168,abnormal prostate gland epithelium morphology|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002059,abnormal seminal vesicle morphology|MP:0002169,no abnormal phenotype detected|MP:0002661,abnormal corpus epididymis morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0002673,abnormal sperm number|MP:0002774,small prostate gland|MP:0002786,abnormal Leydig cell morphology|MP:0004852,decreased testis weight|MP:0004910,decreased seminal vesicle weight|MP:0004929,decreased epididymis weight|MP:0004962,decreased prostate gland weight|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009243,hairpin sperm flagellum|MP:0013288,premature acrosome reaction|MP:0013598,Leydig cell hypertrophy|MP:0013899,abnormal seminal vesicle epithelium morphology|MP:0013904,abnormal seminal vesicle muscle layer morphology|MP:0031435,abnormal copulatory plug biosynthesis|MP:0031436,decreased copulatory plug deposition
MGI:3841391	Ar<tm1Rax>	MP:0002169,no abnormal phenotype detected
MGI:3044436	Ar<tm1Reb>	MP:0001146,abnormal testis morphology|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0002781,increased circulating testosterone level|MP:0004852,decreased testis weight|MP:0004910,decreased seminal vesicle weight|MP:0005117,increased circulating pituitary hormone level|MP:0005159,azoospermia|MP:0005386,behavior/neurological phenotype|MP:0020356,abnormal Sertoli cell barrier function
MGI:2681507	Ar<tm1Ska>	MP:0000008,increased white adipose tissue amount|MP:0000278,abnormal myocardial fiber morphology|MP:0001155,arrest of spermatogenesis|MP:0001159,absent prostate gland|MP:0001259,abnormal body weight|MP:0001261,obese|MP:0001732,postnatal growth retardation|MP:0001919,abnormal reproductive system physiology|MP:0001939,secondary sex reversal|MP:0002188,small heart|MP:0002286,cryptorchism|MP:0002834,decreased heart weight|MP:0003534,blind vagina|MP:0003557,absent vas deferens|MP:0003642,absent seminal vesicle|MP:0003921,abnormal heart left ventricle morphology|MP:0004565,decreased myocardial fiber size|MP:0004727,absent epididymis|MP:0005187,abnormal penis morphology|MP:0005608,cardiac interstitial fibrosis|MP:0013600,testis degeneration|MP:0021158,decreased heart left ventricle wall thickness|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3034098	Ar<tm1Verh>	MP:0000005,increased brown adipose tissue amount|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001148,enlarged testis|MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001875,testis inflammation|MP:0001925,male infertility|MP:0002079,increased circulating insulin level|MP:0002631,abnormal epididymis morphology|MP:0002660,abnormal caput epididymis morphology|MP:0002786,abnormal Leydig cell morphology|MP:0003205,testicular atrophy|MP:0003698,abnormal male reproductive system physiology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0004929,decreased epididymis weight|MP:0004933,abnormal epididymis epithelium morphology|MP:0004934,epididymis epithelium degeneration|MP:0005159,azoospermia|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0005452,abnormal adipose tissue amount|MP:0005536,decreased Leydig cell number|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0009198,abnormal male genitalia morphology|MP:0009283,decreased gonadal fat pad weight|MP:0009294,increased interscapular fat pad weight|MP:0009298,increased mesenteric fat pad weight|MP:0010045,increased omental fat pad weight|MP:0010182,decreased susceptibility to weight gain|MP:0014052,increased male germ cell apoptosis|MP:0014634,decreased round spermatid number|MP:0014636,decreased elongated spermatid number
MGI:5431884	Ar<tm2.1Reb>	MP:0020355,abnormal Sertoli cell barrier morphology|MP:0020356,abnormal Sertoli cell barrier function
MGI:3628489	Ar<tm2(AR)Dmr>	MP:0005389,reproductive system phenotype
MGI:4461236	Ar<tm2Ska>	MP:0003553,abnormal foreskin morphology|MP:0003936,abnormal reproductive system development|MP:0005369,muscle phenotype|MP:0005389,reproductive system phenotype|MP:0009199,abnormal external male genitalia morphology|MP:0010053,decreased grip strength
MGI:4946660	Ar<tm3.1(AR)Ska>	MP:0001153,small seminiferous tubules|MP:0001921,reduced fertility|MP:0002774,small prostate gland|MP:0002781,increased circulating testosterone level|MP:0003607,abnormal prostate gland physiology|MP:0004961,increased prostate gland weight|MP:0004962,decreased prostate gland weight|MP:0031364,increased prostate gland ventral lobe weight
MGI:3628492	Ar<tm3(AR)Dmr>	MP:0001260,increased body weight|MP:0003631,nervous system phenotype|MP:0005369,muscle phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005458,increased percent body fat/body weight
MGI:3612537	Ar<tm4(AR)Dmr>	MP:0000539,distended urinary bladder|MP:0000747,muscle weakness|MP:0000748,progressive muscle weakness|MP:0000751,myopathy|MP:0000938,motor neuron degeneration|MP:0000955,abnormal spinal cord morphology|MP:0001146,abnormal testis morphology|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001751,increased circulating luteinizing hormone level|MP:0001922,reduced male fertility|MP:0002083,premature death|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0002780,decreased circulating testosterone level|MP:0002781,increased circulating testosterone level|MP:0002784,abnormal Sertoli cell morphology|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003157,impaired muscle relaxation|MP:0003205,testicular atrophy|MP:0004145,abnormal muscle electrophysiology|MP:0004852,decreased testis weight|MP:0005378,growth/size/body region phenotype|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009413,skeletal muscle fiber atrophy|MP:0009642,abnormal blood homeostasis|MP:0010053,decreased grip strength|MP:0010768,mortality/aging|MP:0011532,decreased urine major urinary protein level|MP:0011533,increased urine major urinary protein level|MP:0020378,abnormal cell cytoskeleton morphology
MGI:3588388	Artmd1<MRL/MpJ>	MP:0002936,joint swelling|MP:0003189,fused joints
MGI:3588389	Artmd2<DBA/1Crlj>	MP:0002936,joint swelling|MP:0003189,fused joints
MGI:2183554	Artn<tm1Jmi>	MP:0001008,abnormal sympathetic ganglion morphology|MP:0001011,abnormal superior cervical ganglion morphology|MP:0001015,small superior cervical ganglion|MP:0001025,abnormal sympathetic neuron morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001344,blepharoptosis
MGI:5810348	Arv1<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001304,cataract|MP:0001399,hyperactivity|MP:0002797,increased thigmotaxis|MP:0004738,abnormal auditory brainstem response|MP:0005333,decreased heart rate|MP:0010052,increased grip strength|MP:0010506,prolonged RR interval
MGI:6356538	Arv1<tm1.2Geno>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000609,abnormal liver physiology|MP:0001386,abnormal maternal nurturing|MP:0001405,impaired coordination|MP:0001556,increased circulating HDL cholesterol level|MP:0001780,decreased brown adipose tissue amount|MP:0002064,seizures|MP:0002083,premature death|MP:0002644,decreased circulating triglyceride level|MP:0002891,increased insulin sensitivity|MP:0002968,increased circulating alkaline phosphatase level|MP:0003868,abnormal feces composition|MP:0003961,decreased lean body mass|MP:0004789,increased bile salt level|MP:0004889,increased energy expenditure|MP:0005178,increased circulating cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005283,increased unsaturated fatty acids level|MP:0005284,increased saturated fatty acids level|MP:0005285,decreased unsaturated fatty acids level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005365,abnormal bile salt homeostasis|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0005565,increased blood urea nitrogen level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008770,decreased survivor rate|MP:0008963,increased carbon dioxide production|MP:0008965,increased basal metabolism|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level|MP:0010155,abnormal intestine physiology|MP:0010360,decreased liver free fatty acids level|MP:0011612,increased circulating ghrelin level|MP:0011939,increased food intake|MP:0011972,decreased circulating lactate dehydrogenase level|MP:0013278,decreased fasting circulating glucose level|MP:0014143,decreased body fat mass|MP:0014783,decreased liver enzyme/coenzyme level|MP:0030969,increased circulating adiponectin level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis|MP:0031391,increased locomotor activity
MGI:6149717	Arv1<tm1.2Radr>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000189,hypoglycemia|MP:0001399,hyperactivity|MP:0001633,poor circulation|MP:0001783,decreased white adipose tissue amount|MP:0001926,female infertility|MP:0002083,premature death|MP:0003949,abnormal circulating lipid level|MP:0003961,decreased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005370,liver/biliary system phenotype|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005668,decreased circulating leptin level|MP:0008489,slow postnatal weight gain|MP:0008770,decreased survivor rate|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008963,increased carbon dioxide production|MP:0008965,increased basal metabolism|MP:0009133,decreased white fat cell size|MP:0010379,decreased respiratory quotient|MP:0011939,increased food intake|MP:0013139,moribund|MP:0013245,abnormal lipid metabolism|MP:0013278,decreased fasting circulating glucose level|MP:0014143,decreased body fat mass|MP:0014171,increased fatty acid oxidation|MP:0030969,increased circulating adiponectin level
MGI:4433370	Arvcf<tm1a(EUCOMM)Wtsi>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0004924,abnormal behavior
MGI:4432634	Arvcf<tm1e(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000745,tremors|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001406,abnormal gait|MP:0002599,increased mean platelet volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0006415,absent testes|MP:0008259,abnormal optic disk morphology|MP:0010053,decreased grip strength|MP:0011965,decreased total retina thickness
MGI:2155751	Arvm1<MRL/MpJ>	MP:0001864,vascular inflammation
MGI:2155753	Arvm2<MRL/MpJ>	MP:0001790,abnormal immune system physiology
MGI:6195852	Arx<tm1.1Ics>	MP:0000743,muscle spasm|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0002272,abnormal nervous system electrophysiology|MP:0002574,increased vertical activity|MP:0003491,abnormal voluntary movement|MP:0003858,enhanced coordination|MP:0004101,abnormal brain interneuron morphology|MP:0006009,abnormal neuronal migration|MP:0008948,decreased neuron number|MP:0009454,impaired contextual conditioning behavior|MP:0031391,increased locomotor activity
MGI:4353222	Arx<tm1.1Jno>	MP:0000243,myoclonus|MP:0000788,abnormal cerebral cortex morphology|MP:0000859,abnormal somatosensory cortex morphology|MP:0001364,decreased anxiety-related response|MP:0002062,abnormal associative learning|MP:0002064,seizures|MP:0003858,enhanced coordination|MP:0003863,decreased aggression towards mice|MP:0003996,clonic seizures|MP:0003997,tonic-clonic seizures|MP:0003998,decreased thermal nociceptive threshold|MP:0004077,abnormal striatum morphology|MP:0004101,abnormal brain interneuron morphology|MP:0004994,abnormal brain wave pattern|MP:0005379,endocrine/exocrine gland phenotype|MP:0008269,abnormal hippocampus CA4 region morphology|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior
MGI:3803178	Arx<tm1Gldn>	MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000947,convulsive seizures|MP:0000951,sporadic seizures|MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0003996,clonic seizures|MP:0003997,tonic-clonic seizures|MP:0004101,abnormal brain interneuron morphology|MP:0004994,abnormal brain wave pattern|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014623,abnormal brain theta wave pattern|MP:0014624,abnormal brain delta wave pattern
MGI:2429693	Arx<tm1Kki>	MP:0000774,decreased brain size|MP:0000778,abnormal nervous system tract morphology|MP:0000780,abnormal corpus callosum morphology|MP:0000787,abnormal telencephalon morphology|MP:0000792,abnormal cortical marginal zone morphology|MP:0000808,abnormal hippocampus development|MP:0000812,abnormal dentate gyrus morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000832,abnormal thalamus morphology|MP:0000934,abnormal telencephalon development|MP:0001147,small testis|MP:0002741,small olfactory bulb|MP:0003232,abnormal forebrain development|MP:0003247,abnormal glutaminergic neuron morphology|MP:0005148,seminal vesicle hypoplasia|MP:0006308,enlarged seminiferous tubules|MP:0008128,abnormal brain internal capsule morphology|MP:0008223,absent hippocampal commissure|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0008439,abnormal cortical plate morphology|MP:0008441,thin cortical plate|MP:0008536,enlarged third ventricle|MP:0008547,abnormal neocortex morphology|MP:0008929,abnormal central medial nucleus morphology|MP:0009324,absent hippocampal fimbria|MP:0011087,neonatal lethality, complete penetrance|MP:0013603,abnormal fetal Leydig cell differentiation|MP:0014551,impaired neuronal migration|MP:0014558,decreased cortical ventricular zone thickness
MGI:2679972	Arx<tm1Pgr>	MP:0000189,hypoglycemia|MP:0000746,weakness|MP:0001429,dehydration|MP:0001732,postnatal growth retardation|MP:0003645,increased pancreatic beta cell number|MP:0005218,abnormal pancreatic delta cell morphology|MP:0009178,absent pancreatic alpha cells|MP:0009180,increased pancreatic delta cell number|MP:0011085,postnatal lethality, complete penetrance
MGI:4359175	Arx<tm2Kki>	MP:0000774,decreased brain size|MP:0002741,small olfactory bulb|MP:0004103,abnormal ventral striatum morphology|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0006009,abnormal neuronal migration|MP:0008441,thin cortical plate|MP:0011087,neonatal lethality, complete penetrance
MGI:4359176	Arx<tm3Kki>	MP:0001038,abnormal cholinergic neuron morphology|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003246,loss of GABAergic neurons|MP:0004000,impaired passive avoidance behavior|MP:0006009,abnormal neuronal migration|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010768,mortality/aging
MGI:4359177	Arx<tm4Kki>	MP:0000243,myoclonus|MP:0001038,abnormal cholinergic neuron morphology|MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001361,social withdrawal|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001415,increased exploration in new environment|MP:0001417,decreased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0002064,seizures|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002826,tonic seizures|MP:0003246,loss of GABAergic neurons|MP:0003460,decreased fear-related response|MP:0004000,impaired passive avoidance behavior|MP:0006009,abnormal neuronal migration|MP:0008840,abnormal spike wave discharge|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012307,impaired spatial learning|MP:0020395,abnormal response to social novelty
MGI:5559563	Arx<tm5Kki>	MP:0000243,myoclonus|MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001361,social withdrawal|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001415,increased exploration in new environment|MP:0001417,decreased exploration in new environment|MP:0002064,seizures|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0003460,decreased fear-related response|MP:0003631,nervous system phenotype|MP:0004101,abnormal brain interneuron morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012307,impaired spatial learning|MP:0020395,abnormal response to social novelty
MGI:4818883	As3mt<tm1Djth>	MP:0000609,abnormal liver physiology|MP:0008875,abnormal xenobiotic pharmacokinetics
MGI:1856804	asa	MP:0001856,myocarditis|MP:0003725,increased autoantibody level
MGI:5523898	Asah1<tm1.1Jhkh>	MP:0003360,abnormal depression-related behavior|MP:0008872,abnormal physiological response to xenobiotic|MP:0009937,abnormal neuron differentiation|MP:0012232,abnormal ceramide level
MGI:8275162	Asah1<tm1.1Medin>	MP:0000160,kyphosis|MP:0000539,distended urinary bladder|MP:0000540,abnormal urinary bladder urothelium morphology|MP:0000745,tremors|MP:0000748,progressive muscle weakness|MP:0000755,hindlimb paralysis|MP:0000921,demyelination|MP:0001263,weight loss|MP:0001406,abnormal gait|MP:0001524,impaired limb coordination|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003103,liver degeneration|MP:0003280,urinary incontinence|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0003643,spleen atrophy|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0008027,abnormal spinal cord white matter morphology|MP:0008242,abnormal perivascular macrophage morphology|MP:0011774,abnormal urinary bladder detrusor smooth muscle morphology|MP:0012230,abnormal sphingolipid level|MP:0012712,spinal cord degeneration|MP:0014431,increased chemokine level|MP:0020116,increased sphingosine level|MP:0020582,increased ceramide level|MP:0020955,increased mechanical nociceptive threshold|MP:0031392,hypoactivity
MGI:6401408	Asah1<tm1.2Geno>	MP:0000161,scoliosis|MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000322,increased granulocyte number|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000752,dystrophic muscle|MP:0001263,weight loss|MP:0001406,abnormal gait|MP:0001861,lung inflammation|MP:0002083,premature death|MP:0002339,abnormal lymph node morphology|MP:0002591,decreased mean corpuscular volume|MP:0002941,increased circulating alanine transaminase level|MP:0003131,increased erythrocyte cell number|MP:0003333,liver fibrosis|MP:0003354,astrocytosis|MP:0004778,increased macrophage derived foam cell number|MP:0004809,increased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005425,increased macrophage cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0009339,decreased splenocyte number|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009413,skeletal muscle fiber atrophy|MP:0009823,abnormal sphingomyelin level|MP:0010090,increased circulating creatine kinase level|MP:0010210,abnormal circulating cytokine level|MP:0011971,increased circulating lactate dehydrogenase level|MP:0020116,increased sphingosine level|MP:0020582,increased ceramide level|MP:0030837,abnormal knee joint morphology|MP:0031220,increased circulating CXCL10 level
MGI:2180367	Asah1<tm1Esc>	MP:0000598,abnormal liver morphology|MP:0000603,pale liver|MP:0002118,abnormal lipid homeostasis|MP:0011092,embryonic lethality, complete penetrance
MGI:5792731	Asah1<tm1Medin>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0001127,small ovary|MP:0001263,weight loss|MP:0001513,limb grasping|MP:0001654,hepatic necrosis|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003131,increased erythrocyte cell number|MP:0004778,increased macrophage derived foam cell number|MP:0004952,increased spleen weight|MP:0005011,increased eosinophil cell number|MP:0005058,abnormal lysosome morphology|MP:0005150,cachexia|MP:0005202,lethargy|MP:0005564,increased hemoglobin content|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006396,decreased long bone epiphyseal plate size|MP:0008272,abnormal endochondral bone ossification|MP:0008647,increased circulating interleukin-12b level|MP:0008722,abnormal chemokine secretion|MP:0009105,penis prolapse|MP:0009246,pale spleen|MP:0009283,decreased gonadal fat pad weight|MP:0010209,abnormal circulating chemokine level|MP:0010894,pulmonary alveolar edema|MP:0011129,decreased tertiary ovarian follicle number|MP:0012232,abnormal ceramide level|MP:0012676,dilated brain ventricle
MGI:3641171	Asah2<tm1Rlp>	MP:0001547,abnormal lipid level
MGI:6281937	Asap1<em1(IMPC)Wtsi>	MP:0002599,increased mean platelet volume|MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4332097	Asap1<Gt(RRS873)Byg>	MP:0000107,abnormal frontal bone morphology|MP:0000458,abnormal mandible morphology|MP:0000556,abnormal hindlimb morphology|MP:0001262,decreased body weight|MP:0002006,neoplasm|MP:0002820,abnormal premaxilla morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003109,short femur|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003420,delayed intramembranous bone ossification|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0005076,abnormal cell differentiation|MP:0005306,abnormal phalanx morphology|MP:0005385,cardiovascular system phenotype|MP:0005574,decreased pulmonary respiratory rate|MP:0006397,disorganized long bone epiphyseal plate|MP:0008152,decreased diameter of femur|MP:0008489,slow postnatal weight gain|MP:0008525,decreased cranium height|MP:0008770,decreased survivor rate|MP:0009131,decreased white fat cell number|MP:0009133,decreased white fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0009431,decreased fetal weight|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011167,abnormal adipose tissue development|MP:0011168,abnormal fat cell differentiation|MP:0014107,premature chondrocyte differentiation|MP:0020040,decreased bone ossification
MGI:6281940	Asap2<em1(IMPC)Wtsi>	MP:0009142,decreased prepulse inhibition
MGI:6200307	Asap3<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation
MGI:5463965	Asb10<tm2b(KOMP)Wtsi>	MP:0002608,increased hematocrit|MP:0002833,increased heart weight|MP:0005564,increased hemoglobin content
MGI:7310252	Asb12<em1Mngx>	MP:0005389,reproductive system phenotype
MGI:6341953	Asb16<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000277,abnormal heart shape|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus
MGI:7314167	Asb17<em1Bzhg>	MP:0002687,oligozoospermia|MP:0004884,abnormal testis physiology|MP:0005389,reproductive system phenotype|MP:0014685,spermiation failure|MP:0031389,abnormal ectoplasmic specialization morphology
MGI:5755382	Asb18<em1(IMPC)J>	MP:0005344,increased circulating bilirubin level
MGI:6341847	Asb1<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002060,abnormal skin morphology|MP:0005554,decreased circulating creatinine level|MP:0005627,increased circulating potassium level
MGI:2178847	Asb1<tm1Wehi>	MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0001146,abnormal testis morphology|MP:0001156,abnormal spermatogenesis|MP:0001219,thick epidermis|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype
MGI:5517670	Asb2<tm1.1Lutz>	MP:0002376,abnormal dendritic cell physiology
MGI:5776369	Asb2<tm2b(KOMP)Wtsi>	MP:0000288,abnormal pericardium morphology|MP:0001697,abnormal embryo size|MP:0001722,pale yolk sac|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0005015,increased T cell number|MP:0010025,decreased total body fat amount|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013669,decreased Ly6C-positive immature NK cell number|MP:0013670,increased Ly6C-positive immature NK cell number
MGI:6341911	Asb4<em1(IMPC)Ccpcz>	MP:0000367,abnormal coat/ hair morphology|MP:0000689,abnormal spleen morphology|MP:0001146,abnormal testis morphology|MP:0002631,abnormal epididymis morphology|MP:0010935,increased airway resistance
MGI:5629538	Asb4<tm1.2Cpat>	MP:0000231,hypertension|MP:0001713,decreased trophoblast giant cell number|MP:0001716,abnormal placenta labyrinth morphology|MP:0001730,embryonic growth arrest|MP:0001935,decreased litter size|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002871,albuminuria|MP:0003231,abnormal placenta vasculature|MP:0009661,abnormal pregnancy|MP:0010695,abnormal blood pressure regulation|MP:0011320,abnormal glomerular capillary morphology|MP:0011339,abnormal glomerular mesangium morphology|MP:0020153,abnormal urine albumin level
MGI:6341940	Asb5<em1(IMPC)Ccpcz>	MP:0000137,abnormal vertebrae morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0005634,decreased circulating sodium level
MGI:6341901	Asb7<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001120,abnormal uterus morphology|MP:0001293,anophthalmia|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002311,abnormal inspiratory capacity|MP:0002968,increased circulating alkaline phosphatase level|MP:0003917,increased kidney weight|MP:0004906,enlarged uterus|MP:0005599,increased cardiac muscle contractility|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0009455,enhanced cued conditioning behavior|MP:0010053,decreased grip strength|MP:0010574,dilated aorta|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013279,increased fasting circulating glucose level
MGI:2389196	Asbb1<BALB/c>	MP:0004801,increased susceptibility to systemic lupus erythematosus
MGI:2389197	Asbb2<C57BL/6J>	MP:0004801,increased susceptibility to systemic lupus erythematosus
MGI:2389200	Asbb3<C57BL/6J>	MP:0004801,increased susceptibility to systemic lupus erythematosus
MGI:1860252	Asc1	MP:0001303,abnormal lens morphology|MP:0001317,abnormal pupil morphology|MP:0010259,anterior polar cataract
MGI:1860253	Asc2	MP:0001303,abnormal lens morphology|MP:0001317,abnormal pupil morphology|MP:0010259,anterior polar cataract
MGI:6257661	Ascc1<em1(IMPC)Bay>	MP:0002953,thick ventricular wall|MP:0003385,abnormal body wall morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011962,increased cornea thickness
MGI:5008937	Ascc2<tm1a(EUCOMM)Wtsi>	MP:0000691,enlarged spleen|MP:0001512,trunk curl|MP:0011100,preweaning lethality, complete penetrance
MGI:5548657	Ascc2<tm1b(EUCOMM)Wtsi>	MP:0003019,increased circulating chloride level|MP:0010580,decreased heart left ventricle size|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7425524	Ascc3<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:4436301	Ascc3<tm1a(EUCOMM)Hmgu>	MP:0000198,decreased circulating phosphate level|MP:0001566,increased circulating phosphate level|MP:0004357,long tibia
MGI:4452601	Ascl1<tm1.1(cre/ERT2)Jejo>	MP:0002169,no abnormal phenotype detected|MP:0003861,abnormal nervous system development|MP:0011087,neonatal lethality, complete penetrance
MGI:1857470	Ascl1<tm1And>	MP:0000934,abnormal telencephalon development|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001034,abnormal parasympathetic ganglion morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001048,absent enteric neurons|MP:0001176,abnormal lung development|MP:0001954,respiratory distress|MP:0002095,abnormal skin pigmentation|MP:0003202,abnormal neuron apoptosis|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0008789,abnormal olfactory epithelium morphology|MP:0009546,absent gastric milk in neonates|MP:0010916,decreased solitary pulmonary neuroendocrine cell number|MP:0010917,absent solitary pulmonary neuroendocrine cells|MP:0010920,decreased number of pulmonary neuroendocrine bodies|MP:0010921,absent pulmonary neuroendocrine bodies|MP:0011087,neonatal lethality, complete penetrance|MP:0011827,impaired neuron differentiation|MP:0020394,decreased neuronal precursor proliferation|MP:0021091,abnormal dorsal interneuron morphology|MP:0021093,abnormal dorsal interneuron 2 morphology|MP:0021094,abnormal dorsal interneuron 3 morphology|MP:0021095,abnormal dorsal interneuron 4 morphology|MP:0021096,abnormal dorsal interneuron 5 morphology|MP:0021097,abnormal dorsal interneuron 6 morphology|MP:0021104,abnormal ventral interneuron 2 morphology
MGI:3639318	Ascl1<tm1Cbm>	MP:0012069,abnormal horizontal basal cell of olfactory epithelium morphology
MGI:2388165	Ascl1<tm1(Neurog2)Fgu>	MP:0003202,abnormal neuron apoptosis|MP:0003661,abnormal locus ceruleus morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0021093,abnormal dorsal interneuron 2 morphology|MP:0021094,abnormal dorsal interneuron 3 morphology|MP:0021099,abnormal dorsal interneuron LA morphology|MP:0021104,abnormal ventral interneuron 2 morphology
MGI:5141455	Ascl1<tm2Fgu>	MP:0006009,abnormal neuronal migration
MGI:3846671	Ascl2<tm1.1Cle>	MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0008800,increased small intestinal crypt cell apoptosis
MGI:2155757	Ascl2<tm1.1Nagy>	MP:0030989,decreased spongiotrophoblast cell number
MGI:2153832	Ascl2<tm1Alj>	MP:0001712,abnormal placenta development|MP:0002836,abnormal chorion morphology|MP:0003123,paternal imprinting|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012100,absent spongiotrophoblast layer
MGI:4399141	Ascl2<tm2Nagy>	MP:0002169,no abnormal phenotype detected
MGI:5520171	Ascl3<tm1.1(EGFP/cre)Ovi>	MP:0002169,no abnormal phenotype detected
MGI:3808720	Ascl3<tm1(EGFP/cre)Ovi>	MP:0002169,no abnormal phenotype detected
MGI:6273154	Ascl4<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0001284,absent vibrissae
MGI:7425525	Ascl5<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002060,abnormal skin morphology|MP:0010090,increased circulating creatine kinase level
MGI:3613550	Ascla1<FVB/N>	MP:0005339,increased susceptibility to atherosclerosis
MGI:3613621	Ascla2<FVB/N>	MP:0005339,increased susceptibility to atherosclerosis
MGI:3613622	Ascla3<C57BL/6J>	MP:0005339,increased susceptibility to atherosclerosis
MGI:3613624	Ascla4<C57BL/6J>	MP:0005339,increased susceptibility to atherosclerosis
MGI:3613626	Ascla5<C57BL/6J>	MP:0005339,increased susceptibility to atherosclerosis
MGI:3613628	Ascla6<C57BL/6J>	MP:0005339,increased susceptibility to atherosclerosis
MGI:3619572	Asdq1<129T2/SvEms>	MP:0000282,abnormal interatrial septum morphology
MGI:3619574	Asdq2<129T2/SvEms>	MP:0000282,abnormal interatrial septum morphology
MGI:3619576	Asdq3<129T2/SvEms>	MP:0000282,abnormal interatrial septum morphology
MGI:3619578	Asdq4<129T2/SvEms>	MP:0000282,abnormal interatrial septum morphology
MGI:3619580	Asdq5<129T2/SvEms>	MP:0000282,abnormal interatrial septum morphology
MGI:3619582	Asdq6<129T2/SvEms>	MP:0000282,abnormal interatrial septum morphology
MGI:3619584	Asdq7<129T2/SvEms>	MP:0000282,abnormal interatrial septum morphology
MGI:4345510	Asf1a<Gt(AL0673)Wtsi>	MP:0011092,embryonic lethality, complete penetrance
MGI:5471306	Asf1a<tm1b(KOMP)Wtsi>	MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0002079,increased circulating insulin level|MP:0002151,abnormal neural tube morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0020870,decreased thigmotaxis
MGI:6268351	Asf1b<m1Btlr>	MP:0002497,increased IgE level
MGI:5424890	Asgr1<Mhdabap005>	MP:0002968,increased circulating alkaline phosphatase level
MGI:2180369	Asgr1<tm1Ishi>	MP:0000609,abnormal liver physiology
MGI:3798982	Asgr1<tm1Sau>	MP:0002412,increased susceptibility to bacterial infection|MP:0005607,decreased bleeding time|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:1857130	Asgr2<tm1Her>	MP:0001764,abnormal homeostasis|MP:0002412,increased susceptibility to bacterial infection|MP:0005376,homeostasis/metabolism phenotype|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3852878	Ash1l<Gt(AL0395)Wtsi>	MP:0000157,abnormal sternum morphology|MP:0000480,increased rib number|MP:0001120,abnormal uterus morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0002631,abnormal epididymis morphology|MP:0002637,small uterus|MP:0002662,abnormal cauda epididymis morphology|MP:0002673,abnormal sperm number|MP:0002769,abnormal vas deferens morphology|MP:0003845,abnormal decidualization|MP:0005251,blepharitis|MP:0006000,abnormal cornea epithelium morphology|MP:0006236,absent Meibomian glands|MP:0008146,asymmetric sternocostal joints|MP:0008258,thin endometrium|MP:0008770,decreased survivor rate|MP:0008853,decreased abdominal adipose tissue amount|MP:0009096,decreased endometrial gland number|MP:0009669,abnormal postimplantation uterine environment|MP:0013192,decreased sebaceous gland number
MGI:5605812	Ash1l<tm2b(EUCOMM)Hmgu>	MP:0001510,abnormal coat appearance|MP:0002606,increased basophil cell number|MP:0002833,increased heart weight|MP:0005011,increased eosinophil cell number|MP:0006243,impaired pupillary reflex|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:5563008	Ash1l<Tn(pb-Act-RFP)1.AF0-180T25Zhu>	MP:0002412,increased susceptibility to bacterial infection|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002743,glomerulonephritis|MP:0003724,increased susceptibility to induced arthritis|MP:0003725,increased autoantibody level|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005387,immune system phenotype|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008596,increased circulating interleukin-6 level|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010855,pulmonary hyperemia
MGI:4130694	Ash2l<Gt(S3-11A1)Sor>	MP:0005621,abnormal cell physiology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:5696892	Ash2l<tm1b(EUCOMM)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0001510,abnormal coat appearance|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration|MP:0013292,embryonic lethality prior to organogenesis
MGI:6276975	Asic1<em1(IMPC)Mbp>	MP:0001489,decreased startle reflex|MP:0001552,increased circulating triglyceride level|MP:0009454,impaired contextual conditioning behavior
MGI:5490899	Asic1<tm1.1Ccli>	MP:0002206,abnormal CNS synaptic transmission|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:2179834	Asic1<tm1Wsh>	MP:0001463,abnormal spatial learning|MP:0002207,abnormal long-term potentiation|MP:0002807,abnormal eye blink conditioning behavior|MP:0002912,abnormal excitatory postsynaptic potential|MP:0008432,abnormal long-term spatial reference memory|MP:0009244,abnormal acid-activated cation-mediated receptor currents
MGI:6276843	Asic2<em1(IMPC)Mbp>	MP:0000692,small spleen|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0020421,increased freezing behavior
MGI:3043849	Asic2<tm1.1Lzd>	MP:0001326,retina degeneration|MP:0005277,abnormal brainstem morphology|MP:0005551,abnormal eye electrophysiology
MGI:2180111	Asic2<tm1Wsh>	MP:0000249,abnormal blood vessel physiology|MP:0002272,abnormal nervous system electrophysiology|MP:0003026,decreased vasoconstriction|MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype|MP:0006335,abnormal hearing electrophysiology
MGI:7425526	Asic3<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001258,decreased body length|MP:0004738,abnormal auditory brainstem response|MP:0005084,abnormal gallbladder morphology|MP:0009142,decreased prepulse inhibition|MP:0009342,enlarged gallbladder
MGI:4353615	Asic3<tm1Pho>	MP:0000965,abnormal sensory neuron morphology|MP:0004021,abnormal rod electrophysiology|MP:0005277,abnormal brainstem morphology|MP:0005551,abnormal eye electrophysiology|MP:0006072,abnormal retina apoptosis|MP:0008067,retina ganglion cell degeneration|MP:0008103,amacrine cell degeneration|MP:0008512,disorganized retina inner nuclear layer|MP:0008516,disorganized retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008519,thin retina outer plexiform layer|MP:0008580,photoreceptor inner segment degeneration|MP:0008584,photoreceptor outer segment degeneration
MGI:2451051	Asic3<tm1Pig>	MP:0002734,abnormal mechanical nociception|MP:0002738,hyperresponsive to tactile stimuli|MP:0003631,nervous system phenotype|MP:0003998,decreased thermal nociceptive threshold|MP:0005386,behavior/neurological phenotype|MP:0008532,decreased chemical nociceptive threshold
MGI:2429689	Asic3<tm1Wsh>	MP:0002272,abnormal nervous system electrophysiology|MP:0002734,abnormal mechanical nociception|MP:0005407,hyperalgesia|MP:0005498,hyporesponsive to tactile stimuli|MP:0008872,abnormal physiological response to xenobiotic|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5293878	Asic4<tm1a(KOMP)Mbp>	MP:0003631,nervous system phenotype
MGI:5583077	Asic4<tm1b(KOMP)Mbp>	MP:0001258,decreased body length
MGI:4847709	Asic5<tm2a(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5308971	Asl<tm1.1Brle>	MP:0002169,no abnormal phenotype detected
MGI:5308970	Asl<tm1Brle>	MP:0000278,abnormal myocardial fiber morphology|MP:0000367,abnormal coat/ hair morphology|MP:0000377,abnormal hair follicle morphology|MP:0000380,small hair follicles|MP:0000711,thymus cortex hypoplasia|MP:0001221,epidermal atrophy|MP:0001243,abnormal dermal layer morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002447,abnormal erythrocyte morphology|MP:0002942,decreased circulating alanine transaminase level|MP:0003957,abnormal nitric oxide homeostasis|MP:0005016,decreased lymphocyte cell number|MP:0005309,increased circulating ammonia level|MP:0005325,abnormal renal glomerulus morphology|MP:0005425,increased macrophage cell number|MP:0005558,decreased creatinine clearance|MP:0005591,decreased vasodilation|MP:0005632,decreased circulating aspartate transaminase level|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008476,increased spleen red pulp amount|MP:0008482,decreased spleen germinal center number|MP:0010177,acanthocytosis|MP:0020836,increased circulating citrulline level|MP:0030662,decreased circulating arginine level
MGI:3604881	Asl<tm1Wjc>	MP:0005202,lethargy|MP:0005309,increased circulating ammonia level|MP:0005311,abnormal circulating amino acid level|MP:0005376,homeostasis/metabolism phenotype|MP:0005449,abnormal food intake|MP:0005584,abnormal enzyme/coenzyme activity|MP:0011085,postnatal lethality, complete penetrance|MP:0020836,increased circulating citrulline level|MP:0030662,decreased circulating arginine level|MP:0030709,increased circulating glutamine level
MGI:2157890	Asm1<MRL/MpJ>	MP:0001790,abnormal immune system physiology
MGI:2155726	Asm2<MRL/MpJ>	MP:0001870,salivary gland inflammation
MGI:6144036	Asmt<C57BL/6JJcl>	MP:0004851,increased testis weight|MP:0011729,abnormal pineal gland melatonin secretion
MGI:4324901	Asnsd1<Gt(OST460318)Lex>	MP:0000747,muscle weakness|MP:0000751,myopathy|MP:0002941,increased circulating alanine transaminase level|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003961,decreased lean body mass|MP:0004819,decreased skeletal muscle mass|MP:0005076,abnormal cell differentiation|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005458,increased percent body fat/body weight|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0009358,environmentally induced seizures|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009412,skeletal muscle fiber degeneration|MP:0009414,skeletal muscle fiber necrosis|MP:0010053,decreased grip strength|MP:0011084,lethality at weaning, incomplete penetrance|MP:0021206,abnormal limb muscle morphology|MP:0031318,enhanced skeletal muscle regeneration
MGI:4441742	Asns<tm1a(EUCOMM)Wtsi>	MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0002874,decreased hemoglobin content|MP:0004924,abnormal behavior|MP:0005386,behavior/neurological phenotype|MP:0006254,thin cerebral cortex|MP:0008535,enlarged lateral ventricles|MP:0014365,impaired short-term object recognition memory|MP:0014367,impaired long-term object recognition memory
MGI:1889100	Asp1	MP:0001399,hyperactivity|MP:0001496,audiogenic seizures|MP:0002083,premature death
MGI:1856806	Asp2	MP:0001496,audiogenic seizures|MP:0002083,premature death|MP:0031391,increased locomotor activity
MGI:1856807	Asp3<DBA/2J>	MP:0001496,audiogenic seizures|MP:0002083,premature death|MP:0031391,increased locomotor activity
MGI:5787576	Aspa<deaf14>	MP:0000745,tremors|MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001489,decreased startle reflex|MP:0002654,spongiform encephalopathy|MP:0005386,behavior/neurological phenotype|MP:0008025,brain vacuoles|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:2671733	Aspa<nur7>	MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0002064,seizures|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002654,spongiform encephalopathy|MP:0002757,decreased vertical activity|MP:0003354,astrocytosis|MP:0005202,lethargy|MP:0005319,abnormal enzyme/coenzyme level|MP:0005405,axon degeneration|MP:0008025,brain vacuoles|MP:0008026,abnormal brain white matter morphology|MP:0008535,enlarged lateral ventricles|MP:0012230,abnormal sphingolipid level
MGI:4434258	Aspa<tm1a(EUCOMM)Wtsi>	MP:0000747,muscle weakness|MP:0000753,paralysis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0002183,gliosis|MP:0002654,spongiform encephalopathy|MP:0004142,abnormal muscle tone|MP:0004143,muscle hypertonia|MP:0005424,jerky movement
MGI:5614710	Aspa<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0001513,limb grasping|MP:0002590,increased mean corpuscular volume|MP:0002757,decreased vertical activity|MP:0002968,increased circulating alkaline phosphatase level|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake|MP:0013279,increased fasting circulating glucose level
MGI:5008602	Aspa<tm1c(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:3038539	Aspa<tm1Mata>	MP:0000063,decreased bone mineral density|MP:0000434,megacephaly|MP:0000745,tremors|MP:0000830,abnormal diencephalon morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001970,abnormal pain threshold|MP:0002083,premature death|MP:0002204,abnormal synaptic neurotransmitter level|MP:0002654,spongiform encephalopathy|MP:0005202,lethargy|MP:0005241,abnormal retina ganglion layer morphology|MP:0005277,abnormal brainstem morphology|MP:0006303,abnormal retina nerve fiber layer morphology|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance|MP:0021190,decreased bone mineral density of lumbar vertebrae|MP:0030733,decreased gamma-aminobutyric acid level|MP:0030737,decreased glutamic acid level|MP:0030742,increased aspartic acid level
MGI:4457210	aspb	MP:0000755,hindlimb paralysis|MP:0001513,limb grasping|MP:0010047,axonal spheroids
MGI:6156553	Aspg<em1(IMPC)Tcp>	MP:0002060,abnormal skin morphology|MP:0002591,decreased mean corpuscular volume|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:7425527	Asphd1<em1(IMPC)Ccpcz>	MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0002100,abnormal tooth morphology|MP:0002111,abnormal tail morphology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005333,decreased heart rate
MGI:3774139	Asph<tm1Egk>	MP:0001629,abnormal heart rate|MP:0002083,premature death|MP:0004215,abnormal myocardial fiber physiology|MP:0004484,abnormal response of heart to induced stress|MP:0005385,cardiovascular system phenotype|MP:0005599,increased cardiac muscle contractility|MP:0006141,abnormal atrioventricular node conduction|MP:0008950,ventricular tachycardia
MGI:2179287	Asph<tm1Jed>	MP:0000111,cleft palate|MP:0000445,short snout|MP:0000564,syndactyly|MP:0001923,reduced female fertility|MP:0001935,decreased litter size
MGI:7661142	Aspm<em1Mama>	MP:0002175,decreased brain weight|MP:0005384,cellular phenotype|MP:0008547,abnormal neocortex morphology|MP:0020362,abnormal male germ cell physiology
MGI:4345319	Aspm<Gt(AA0137)Wtsi>	MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0001262,decreased body weight|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002175,decreased brain weight|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0008547,abnormal neocortex morphology|MP:0009235,small sperm head
MGI:4345389	Aspm<Gt(AJ0069)Wtsi>	MP:0000433,microcephaly|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002175,decreased brain weight|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0008547,abnormal neocortex morphology|MP:0009235,small sperm head
MGI:5573152	Aspm<tm1.2Kxi>	MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001154,seminiferous tubule degeneration|MP:0002175,decreased brain weight|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0003989,abnormal barrel cortex morphology|MP:0006254,thin cerebral cortex|MP:0008535,enlarged lateral ventricles|MP:0008540,abnormal cerebral hemisphere morphology
MGI:4362345	Aspm<tm1a(KOMP)Wtsi>	MP:0001556,increased circulating HDL cholesterol level|MP:0003179,thrombocytopenia|MP:0003443,increased circulating glycerol level|MP:0003961,decreased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0010024,increased total body fat amount
MGI:5753079	Aspm<tm1(cre)Mrc>	MP:0000433,microcephaly|MP:0000913,abnormal brain development|MP:0002175,decreased brain weight|MP:0002182,abnormal astrocyte morphology|MP:0003077,abnormal cell cycle|MP:0004981,decreased neuronal precursor cell number|MP:0006254,thin cerebral cortex
MGI:7564244	Aspn<tm1.2Mmac>	MP:0002060,abnormal skin morphology|MP:0005275,abnormal skin tensile strength|MP:0005386,behavior/neurological phenotype|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0011475,abnormal glycosaminoglycan level
MGI:5548526	Aspn<tm1b(EUCOMM)Hmgu>	MP:0000198,decreased circulating phosphate level|MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0001556,increased circulating HDL cholesterol level|MP:0002591,decreased mean corpuscular volume|MP:0002699,abnormal vitreous body morphology|MP:0004738,abnormal auditory brainstem response|MP:0005178,increased circulating cholesterol level
MGI:3699318	Asprv1<tm1Tmts>	MP:0001211,wrinkled skin|MP:0001510,abnormal coat appearance
MGI:6156481	Aspscr1<em1(IMPC)Tcp>	MP:0000222,decreased neutrophil cell number|MP:0000494,abnormal cecum morphology|MP:0000598,abnormal liver morphology|MP:0000702,enlarged lymph nodes|MP:0001417,decreased exploration in new environment|MP:0005013,increased lymphocyte cell number|MP:0020421,increased freezing behavior
MGI:7645890	Aspscr1<tm1.1Jsbo>	MP:0000008,increased white adipose tissue amount|MP:0000759,abnormal skeletal muscle morphology|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0004890,decreased energy expenditure|MP:0005290,decreased oxygen consumption|MP:0005386,behavior/neurological phenotype|MP:0005455,increased susceptibility to weight gain|MP:0005658,increased susceptibility to diet-induced obesity|MP:0008964,decreased carbon dioxide production|MP:0010401,increased skeletal muscle glycogen level|MP:0011636,disorganized mitochondrial cristae|MP:0011939,increased food intake|MP:0011941,increased fluid intake|MP:0013278,decreased fasting circulating glucose level|MP:0013279,increased fasting circulating glucose level|MP:0014142,increased body fat mass|MP:0014172,decreased fatty acid oxidation|MP:0014652,increased skeletal muscle fiber mitochondrial size|MP:0031415,increased skeletal muscle triglyceride level|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:3768255	Asq1<IQI>	MP:0001870,salivary gland inflammation
MGI:6867218	Asrgl1<em1Xjz>	MP:0003728,abnormal retina photoreceptor layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008446,decreased retina cone cell number|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0030005,increased retina apoptosis
MGI:4838083	Ass1<bar>	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000745,tremors|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001258,decreased body length|MP:0001394,circling|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0005309,increased circulating ammonia level|MP:0005311,abnormal circulating amino acid level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009977,abnormal cerebellar granule cell migration|MP:0010387,abnormal Bergmann glial cell morphology|MP:0020836,increased circulating citrulline level
MGI:3696404	Ass1<fold>	MP:0000377,abnormal hair follicle morphology|MP:0000416,sparse hair|MP:0000422,delayed hair appearance|MP:0000745,tremors|MP:0001211,wrinkled skin|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0003674,oxidative stress|MP:0003704,abnormal hair follicle development|MP:0003809,abnormal hair shaft morphology|MP:0005309,increased circulating ammonia level|MP:0005311,abnormal circulating amino acid level|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009977,abnormal cerebellar granule cell migration|MP:0020836,increased circulating citrulline level
MGI:5529834	Ass1<tm1.1Ekoe>	MP:0000479,abnormal enterocyte morphology|MP:0002169,no abnormal phenotype detected|MP:0005311,abnormal circulating amino acid level|MP:0005332,abnormal amino acid level|MP:0005378,growth/size/body region phenotype|MP:0005387,immune system phenotype|MP:0010771,integument phenotype|MP:0020836,increased circulating citrulline level|MP:0030638,increased circulating taurine level|MP:0030639,decreased circulating taurine level|MP:0030650,increased circulating ornithine level|MP:0030651,decreased circulating ornithine level|MP:0030662,decreased circulating arginine level
MGI:5529836	Ass1<tm1.2Ekoe>	MP:0011087,neonatal lethality, complete penetrance
MGI:1857131	Ass1<tm1Bay>	MP:0005309,increased circulating ammonia level|MP:0005311,abnormal circulating amino acid level|MP:0011087,neonatal lethality, complete penetrance|MP:0020836,increased circulating citrulline level|MP:0030662,decreased circulating arginine level
MGI:4364811	Aste1<tm1a(KOMP)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0004924,abnormal behavior
MGI:3032996	Asthm1<BALB/c>	MP:0001952,increased airway responsiveness
MGI:3032997	Asthm2<BP2>	MP:0001952,increased airway responsiveness
MGI:5427881	Astl<tm1Dean>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size
MGI:5316737	Astl<tm1Lex>	MP:0001923,reduced female fertility
MGI:2445955	Astn1<tm1Hatn>	MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0001405,impaired coordination|MP:0002762,ectopic cerebellar granule cells|MP:0003203,increased neuron apoptosis|MP:0004098,abnormal cerebellar granule cell morphology|MP:0006099,thin cerebellar granule layer|MP:0009977,abnormal cerebellar granule cell migration
MGI:5575656	Asxl1<tm1.1Iaai>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000333,decreased bone marrow cell number|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0002123,abnormal definitive hematopoiesis|MP:0002874,decreased hemoglobin content|MP:0003135,increased erythroid progenitor cell number|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004809,increased hematopoietic stem cell number|MP:0008211,decreased mature B cell number|MP:0009339,decreased splenocyte number|MP:0009395,increased nucleated erythrocyte cell number
MGI:5575668	Asxl1<tm1.1Mjxu>	MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000321,increased bone marrow cell number|MP:0000351,increased cell proliferation|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001293,anophthalmia|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0001606,impaired hematopoiesis|MP:0002018,increased malignant tumor incidence|MP:0002026,increased leukemia incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002357,abnormal spleen white pulp morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002417,abnormal megakaryocyte morphology|MP:0002429,abnormal blood cell morphology/development|MP:0002463,abnormal neutrophil physiology|MP:0003179,thrombocytopenia|MP:0003643,spleen atrophy|MP:0004809,increased hematopoietic stem cell number|MP:0004810,decreased hematopoietic stem cell number|MP:0004953,decreased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005065,abnormal neutrophil morphology|MP:0005097,polychromatophilia|MP:0006042,increased apoptosis|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008082,increased single-positive T cell number|MP:0008246,abnormal leukocyte morphology|MP:0008477,decreased spleen red pulp amount|MP:0008973,decreased erythroid progenitor cell number|MP:0010178,increased number of Howell-Jolly bodies|MP:0010373,myeloid hyperplasia|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5575657	Asxl1<tm1.2Iaai>	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0000460,mandible hypoplasia|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0003036,vertebral transformation|MP:0003056,abnormal hyoid bone morphology|MP:0005508,abnormal skeleton morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4431878	Asxl1<tm1a(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0002644,decreased circulating triglyceride level|MP:0002700,increased opacity of vitreous body|MP:0002702,decreased circulating free fatty acids level|MP:0002874,decreased hemoglobin content|MP:0002968,increased circulating alkaline phosphatase level|MP:0003062,abnormal coping response|MP:0004609,vertebral fusion|MP:0004647,decreased lumbar vertebrae number|MP:0005017,decreased B cell number|MP:0005560,decreased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008810,increased circulating iron level|MP:0008821,increased blood uric acid level|MP:0009859,eye opacity|MP:0010101,increased sacral vertebrae number|MP:0011400,lethality, complete penetrance
MGI:4418244	Asxl1<tm1Bc>	MP:0000240,extramedullary hematopoiesis|MP:0000333,decreased bone marrow cell number|MP:0000693,spleen hyperplasia|MP:0000703,abnormal thymus morphology|MP:0000716,abnormal immune system cell morphology|MP:0002401,abnormal lymphopoiesis|MP:0002429,abnormal blood cell morphology/development|MP:0002722,abnormal immune system organ morphology|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005090,increased double-negative T cell number|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008209,decreased pre-B cell number
MGI:3840841	Asxl2<Gt(AQ0356)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0003050,abnormal sacral vertebrae morphology|MP:0004616,lumbar vertebral transformation|MP:0004617,sacral vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004687,split vertebrae|MP:0005202,lethargy|MP:0005608,cardiac interstitial fibrosis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5605793	Asxl2<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0002591,decreased mean corpuscular volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010052,increased grip strength|MP:0010392,prolonged QRS complex duration|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1855935	A<sy>	MP:0003136,yellow coat color
MGI:4357768	Asz1<tm1Zuk>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005169,abnormal male meiosis|MP:0006379,abnormal spermatocyte morphology|MP:0008866,chromosomal instability|MP:0008878,abnormal DNA methylation during gametogenesis
MGI:1855941	a<t>	MP:0002075,abnormal coat/hair pigmentation|MP:0008238,abnormal dorsoventral coat patterning
MGI:1856668	at	MP:0000416,sparse hair|MP:0001116,small gonad|MP:0001127,small ovary|MP:0001147,small testis|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0004901,decreased male germ cell number|MP:0005431,decreased oocyte number|MP:0011411,abnormal gonadal ridge morphology|MP:0020152,abnormal oocyte number
MGI:2651789	a<t-2Gso>	MP:0002075,abnormal coat/hair pigmentation
MGI:1855949	a<t-33J>	MP:0008238,abnormal dorsoventral coat patterning
MGI:1856432	a<t-41J>	MP:0001510,abnormal coat appearance|MP:0008237,abnormal ventral coat pigmentation
MGI:2657305	a<t-42J>	MP:0002075,abnormal coat/hair pigmentation|MP:0008237,abnormal ventral coat pigmentation
MGI:1856433	a<t-43J>	MP:0001510,abnormal coat appearance|MP:0008237,abnormal ventral coat pigmentation
MGI:1856383	a<t-44J>	MP:0002075,abnormal coat/hair pigmentation|MP:0008237,abnormal ventral coat pigmentation
MGI:5085323	Atad1<tm1.1Vdaw>	MP:0001265,decreased body size|MP:0001899,absent long-term depression|MP:0002064,seizures|MP:0002083,premature death|MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype|MP:0011002,enhanced AMPA-mediated synaptic currents|MP:0014373,increased miniature excitatory postsynaptic current amplitude
MGI:5085322	Atad1<tm1Vdaw>	MP:0002064,seizures|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory|MP:0008431,abnormal short-term spatial reference memory
MGI:5287273	Atad2b<Tg(Tyr)2295B-4Ove>	MP:0001265,decreased body size|MP:0001923,reduced female fertility
MGI:5548831	Atad2b<tm1b(EUCOMM)Hmgu>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0001469,abnormal contextual conditioning behavior|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002135,abnormal kidney morphology|MP:0004357,long tibia|MP:0004738,abnormal auditory brainstem response|MP:0005179,decreased circulating cholesterol level|MP:0008040,decreased NK T cell number
MGI:3896084	Atad3a<Gt(E118D03)Wrst>	MP:0001672,abnormal embryo development|MP:0001675,abnormal ectoderm development|MP:0001685,abnormal endoderm development|MP:0001696,failure to gastrulate|MP:0001705,abnormal proximal-distal axis patterning|MP:0001717,absent ectoplacental cone|MP:0002084,abnormal developmental patterning|MP:0002583,absent extraembryonic ectoderm|MP:0003984,embryonic growth retardation|MP:0005028,abnormal trophectoderm morphology|MP:0005032,abnormal ectoplacental cone morphology|MP:0010736,abnormal extraembryonic ectoderm morphology|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011189,small embryonic epiblast
MGI:4364878	Atad3a<tm1a(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0011100,preweaning lethality, complete penetrance
MGI:6197790	Atad3a<tm1c(KOMP)Wtsi>	MP:0000160,kyphosis|MP:0000746,weakness|MP:0001402,decreased locomotor activity|MP:0001516,abnormal motor coordination/balance|MP:0004087,abnormal muscle fiber morphology|MP:0005150,cachexia|MP:0005278,abnormal cholesterol homeostasis|MP:0005378,growth/size/body region phenotype|MP:0009412,skeletal muscle fiber degeneration|MP:0009413,skeletal muscle fiber atrophy|MP:0010053,decreased grip strength|MP:0010239,decreased skeletal muscle weight|MP:0010959,abnormal oxidative phosphorylation|MP:0011631,decreased mitochondrial size|MP:0011635,abnormal mitochondrial crista morphology|MP:0011636,disorganized mitochondrial cristae|MP:0014342,abnormal muscle fiber mitochondrial morphology|MP:0014389,decreased skeletal muscle fiber mitochondrial DNA content
MGI:6257796	Atad5<em1(IMPC)Bay>	MP:0010579,increased heart left ventricle size|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:4127920	Atad5<Gt(RRF055)Byg>	MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0002640,reticulocytosis|MP:0003667,increased hemangiosarcoma incidence|MP:0004024,aneuploidy|MP:0005621,abnormal cell physiology|MP:0008058,abnormal DNA repair|MP:0008714,increased lung carcinoma incidence|MP:0008866,chromosomal instability|MP:0009591,increased liver adenocarcinoma incidence|MP:0010288,increased gland tumor incidence|MP:0010367,increased spindle cell carcinoma incidence|MP:0011091,prenatal lethality, complete penetrance|MP:0012411,increased granulosa cell tumor incidence|MP:0012431,increased lymphoma incidence|MP:0014128,increased Harderian gland adenocarcinoma incidence|MP:0014237,decreased tumor-free survival time
MGI:5549959	Atat1<tm1.1Phep>	MP:0002169,no abnormal phenotype detected
MGI:5549960	Atat1<tm1.2Phep>	MP:0000358,abnormal cell morphology|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002797,increased thigmotaxis|MP:0004852,decreased testis weight|MP:0004929,decreased epididymis weight|MP:0005386,behavior/neurological phenotype|MP:0005397,hematopoietic system phenotype|MP:0005578,teratozoospermia|MP:0009239,short sperm flagellum|MP:0009834,abnormal sperm annulus morphology|MP:0010768,mortality/aging|MP:0010771,integument phenotype|MP:0014052,increased male germ cell apoptosis
MGI:4453011	Atat1<tm1(KOMP)Vlcg>	MP:0000812,abnormal dentate gyrus morphology|MP:0000825,dilated lateral ventricle|MP:0005621,abnormal cell physiology
MGI:7425528	Atcay<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:1856574	Atcay<ji>	MP:0000703,abnormal thymus morphology|MP:0000743,muscle spasm|MP:0000938,motor neuron degeneration|MP:0001393,ataxia|MP:0001429,dehydration|MP:0001523,impaired righting response|MP:0002064,seizures|MP:0002083,premature death|MP:0002371,abnormal thymus cortex morphology|MP:0002375,abnormal thymus medulla morphology|MP:0002876,abnormal thyroid gland physiology|MP:0004163,abnormal adenohypophysis morphology|MP:0004696,abnormal thyroid follicle morphology|MP:0005323,dystonia|MP:0008026,abnormal brain white matter morphology
MGI:1856898	Atcay<ji-hes>	MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0001922,reduced male fertility|MP:0005323,dystonia
MGI:1856713	Atcay<ji-hes2J>	MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance
MGI:3776916	Atcay<m1Btlr>	MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001523,impaired righting response|MP:0003314,dysmetria
MGI:6400428	Atcayos<em1Bbr>	MP:0003916,decreased heart left ventricle weight|MP:0005385,cardiovascular system phenotype
MGI:2679221	Atcay<swd>	MP:0004924,abnormal behavior
MGI:1855942	a<td>	MP:0002075,abnormal coat/hair pigmentation|MP:0008237,abnormal ventral coat pigmentation|MP:0008238,abnormal dorsoventral coat patterning
MGI:7425529	Ate1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001697,abnormal embryo size|MP:0001944,abnormal pancreas morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3836440	Ate1<tm1Akas>	MP:0001730,embryonic growth arrest|MP:0001914,hemorrhage|MP:0002652,thin myocardium|MP:0003717,pallor|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0006267,abnormal intercalated disk morphology|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0014729,abnormal myocardial fiber myofibril maturation|MP:0014730,abnormal myocardial fiber myofibril morphology
MGI:2183428	Ate1<tm1Avar>	MP:0000364,abnormal vascular regression|MP:0001614,abnormal blood vessel morphology|MP:0001730,embryonic growth arrest|MP:0001786,skin edema|MP:0001914,hemorrhage|MP:0002633,persistent truncus arteriosus|MP:0003105,abnormal heart atrium morphology|MP:0003717,pallor|MP:0008489,slow postnatal weight gain|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010502,ventricle myocardium hypoplasia|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4414839	Ate1<tm2.1Akas>	MP:0001921,reduced fertility|MP:0001935,decreased litter size
MGI:5470067	Atf1<tm1.1Arte>	MP:0005387,immune system phenotype
MGI:2445229	Atf1<tm1Gsc>	MP:0002169,no abnormal phenotype detected
MGI:3696689	Atf2<Tg(Gzma-Klra1)7Wum>	MP:0001272,increased metastatic potential|MP:0003410,abnormal artery development|MP:0005387,immune system phenotype|MP:0008040,decreased NK T cell number|MP:0008045,decreased NK cell number|MP:0008578,decreased circulating interferon-gamma level|MP:0010766,abnormal NK cell physiology
MGI:6149896	Atf2<tm1b(EUCOMM)Hmgu>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000538,abnormal urinary bladder morphology|MP:0000689,abnormal spleen morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0003020,decreased circulating chloride level|MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level|MP:0008935,decreased mean platelet volume|MP:0013279,increased fasting circulating glucose level
MGI:1857283	Atf2<tm1Glm>	MP:0000166,abnormal chondrocyte morphology|MP:0000745,tremors|MP:0000774,decreased brain size|MP:0000880,decreased Purkinje cell number|MP:0000885,ectopic Purkinje cell|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0001524,impaired limb coordination|MP:0001851,eye inflammation|MP:0002082,postnatal lethality|MP:0002412,increased susceptibility to bacterial infection|MP:0002657,chondrodystrophy|MP:0002730,head shaking|MP:0002856,abnormal vestibular ganglion morphology|MP:0003009,abnormal cytokine secretion|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003144,decreased otolith number|MP:0004328,decreased vestibular hair cell number|MP:0004330,abnormal vestibular saccular macula morphology|MP:0004333,abnormal utricular macula morphology|MP:0004517,decreased vestibular hair cell stereocilia number|MP:0005307,head tossing|MP:0005387,immune system phenotype|MP:0006325,impaired hearing|MP:0006396,decreased long bone epiphyseal plate size|MP:0006397,disorganized long bone epiphyseal plate|MP:0008735,increased susceptibility to endotoxin shock|MP:0008974,proportional dwarf|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011380,enlarged brain ventricles|MP:0014288,rhizomelic limb|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020937,increased susceptibility to Picornaviridae infection
MGI:3720850	Atf2<tm1Nicj>	MP:0001575,cyanosis|MP:0011087,neonatal lethality, complete penetrance
MGI:3842320	Atf2<tm1Sis>	MP:0001175,abnormal lung morphology|MP:0001575,cyanosis|MP:0001716,abnormal placenta labyrinth morphology|MP:0001953,respiratory failure|MP:0003231,abnormal placenta vasculature|MP:0005039,hypoxia|MP:0011087,neonatal lethality, complete penetrance
MGI:3720851	Atf2<tm2Nicj>	MP:0001575,cyanosis|MP:0011087,neonatal lethality, complete penetrance
MGI:3774771	Atf2<tm3Nicj>	MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0002051,increased skin papilloma incidence|MP:0002169,no abnormal phenotype detected
MGI:5547956	Atf3<tm1.1Hai>	MP:0001273,decreased metastatic potential
MGI:5775935	Atf3<tm1.2Kitab>	MP:0001262,decreased body weight|MP:0001783,decreased white adipose tissue amount|MP:0002891,increased insulin sensitivity|MP:0004183,abnormal sympathetic nervous system physiology|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005533,increased body temperature|MP:0005560,decreased circulating glucose level|MP:0005645,abnormal hypothalamus physiology|MP:0005670,abnormal white adipose tissue physiology|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008853,decreased abdominal adipose tissue amount|MP:0008963,increased carbon dioxide production|MP:0008965,increased basal metabolism|MP:0009117,abnormal white fat cell morphology|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0010378,increased respiratory quotient|MP:0011940,decreased food intake
MGI:3531501	Atf3<tm1Dron>	MP:0001273,decreased metastatic potential|MP:0001861,lung inflammation|MP:0002006,neoplasm|MP:0005215,abnormal pancreatic islet morphology|MP:0005466,abnormal T-helper 2 physiology|MP:0008496,decreased IgG2a level|MP:0008672,increased interleukin-13 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion
MGI:5636919	Atf3<tm2b(EUCOMM)Wtsi>	MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity
MGI:5550363	Atf4<tm1.1Cmad>	MP:0000272,abnormal aorta morphology|MP:0004064,decreased susceptibility to induced muscular atrophy|MP:0004231,abnormal calcium ion homeostasis|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype
MGI:2445679	Atf4<tm1Aki>	MP:0001297,microphthalmia|MP:0001922,reduced male fertility|MP:0002769,abnormal vas deferens morphology|MP:0002840,abnormal lens fiber morphology|MP:0008794,increased lens epithelium apoptosis|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2180371	Atf4<tm1Jml>	MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001322,abnormal iris morphology|MP:0003078,aphakia|MP:0004200,decreased fetal size|MP:0005099,abnormal ciliary body morphology|MP:0005176,eyelids fail to open|MP:0011090,perinatal lethality, incomplete penetrance
MGI:4888784	Atf4<tm1(KOMP)Mbp>	MP:0000223,decreased monocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0011100,preweaning lethality, complete penetrance
MGI:4360484	Atf4<tm1Kry>	MP:0001262,decreased body weight|MP:0002078,abnormal glucose homeostasis|MP:0002891,increased insulin sensitivity|MP:0003058,increased insulin secretion|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005438,abnormal glycogen homeostasis|MP:0005560,decreased circulating glucose level|MP:0030973,impaired gluconeogenesis
MGI:2180373	Atf4<tm1Tow>	MP:0000063,decreased bone mineral density|MP:0000074,abnormal neurocranium morphology|MP:0000107,abnormal frontal bone morphology|MP:0000109,abnormal parietal bone morphology|MP:0000208,decreased hematocrit|MP:0000239,absent common myeloid progenitor cells|MP:0000352,decreased cell proliferation|MP:0000420,ruffled hair|MP:0000422,delayed hair appearance|MP:0000603,pale liver|MP:0000606,decreased hepatocyte number|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001944,abnormal pancreas morphology|MP:0002079,increased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0002896,abnormal bone mineralization|MP:0003058,increased insulin secretion|MP:0005292,improved glucose tolerance|MP:0005298,abnormal clavicle morphology|MP:0005492,exocrine pancreas hypoplasia|MP:0005560,decreased circulating glucose level|MP:0008271,abnormal bone ossification|MP:0008395,abnormal osteoblast differentiation|MP:0008907,decreased total fat pad weight|MP:0009113,increased pancreatic beta cell mass|MP:0009145,abnormal pancreatic acinus morphology|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009160,abnormal pancreatic acinar cell zymogen granule morphology|MP:0010867,abnormal bone trabecula morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011819,increased pancreatic beta cell proliferation|MP:0030388,large fontanelles|MP:0030973,impaired gluconeogenesis
MGI:4399238	Atf5<tm1(KOMP)Vlcg>	MP:0006092,abnormal olfactory sensory neuron morphology|MP:0008770,decreased survivor rate
MGI:5467393	Atf5<tm1Mrgr>	MP:0001262,decreased body weight|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0008789,abnormal olfactory epithelium morphology|MP:0009546,absent gastric milk in neonates|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5548360	Atf6b<tm1.1(KOMP)Vlcg>	MP:0001192,scaly skin|MP:0002060,abnormal skin morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3839241	Atf6b<tm1Kamo>	MP:0008943,increased sensitivity to induced cell death
MGI:3723526	Atf6<tm1.1Rjk>	MP:0000352,decreased cell proliferation|MP:0002628,hepatic steatosis|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005621,abnormal cell physiology|MP:0008518,retina outer nuclear layer degeneration|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0012029,abnormal electroretinogram waveform feature|MP:0012144,decreased b-wave amplitude|MP:0020352,abnormal endoplasmic reticulum physiology|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:5614122	Atf6<tm1Hota>	MP:0002891,increased insulin sensitivity|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0014121,increased pancreatic islet cell apoptosis
MGI:3839240	Atf6<tm1Kamo>	MP:0008943,increased sensitivity to induced cell death
MGI:8259262	Atf7ip2<em1Shnk>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0008261,arrest of male meiosis|MP:0009451,abnormal chromosomal synapsis|MP:0011751,abnormal X-Y chromosome synapsis during male meiosis|MP:0014633,decreased spermatid number
MGI:3720869	Atf7<tm1Nicj>	MP:0002169,no abnormal phenotype detected
MGI:4421144	Atf7<tm1Sis>	MP:0001363,increased anxiety-related response|MP:0001488,increased startle reflex|MP:0005386,behavior/neurological phenotype|MP:0009142,decreased prepulse inhibition
MGI:5614707	Atf7<tm2b(EUCOMM)Hmgu>	MP:0000062,increased bone mineral density|MP:0001289,persistence of hyaloid vascular system|MP:0001488,increased startle reflex|MP:0009142,decreased prepulse inhibition
MGI:6508992	Atg101<em1Nmz>	MP:0002118,abnormal lipid homeostasis|MP:0003641,small lung|MP:0004200,decreased fetal size|MP:0010813,abnormal alveolar lamellar body morphology|MP:0010865,prenatal growth retardation|MP:0010889,small alveolar lamellar bodies|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5784706	Atg12<tm1.1Jdth>	MP:0001260,increased body weight|MP:0001402,decreased locomotor activity|MP:0003631,nervous system phenotype|MP:0005293,impaired glucose tolerance|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0008260,abnormal autophagy|MP:0010024,increased total body fat amount|MP:0011087,neonatal lethality, complete penetrance|MP:0011939,increased food intake|MP:0014142,increased body fat mass
MGI:5784707	Atg12<tm1.2Jdth>	MP:0011087,neonatal lethality, complete penetrance
MGI:6158453	Atg13<em1Nmz>	MP:0000280,thin ventricular wall|MP:0005380,embryo phenotype|MP:0010865,prenatal growth retardation|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3871189	Atg13<Gt(DD0507)Wtsi>	MP:0000280,thin ventricular wall|MP:0005380,embryo phenotype|MP:0010865,prenatal growth retardation|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5805683	Atg13<tm2b(EUCOMM)Hmgu>	MP:0001697,abnormal embryo size|MP:0002764,short tibia|MP:0011100,preweaning lethality, complete penetrance
MGI:6449042	Atg14<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002699,abnormal vitreous body morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5569340	Atg14<tm1Aki>	MP:0000479,abnormal enterocyte morphology
MGI:3818574	Atg16l1<Gt(BC0122)Wtsi>	MP:0004843,abnormal Paneth cell morphology|MP:0005389,reproductive system phenotype|MP:0030940,impaired autophagy
MGI:3818575	Atg16l1<Gt(XR0164)Wtsi>	MP:0004843,abnormal Paneth cell morphology|MP:0030940,impaired autophagy
MGI:5605964	Atg16l1<tm1.1Mvlc>	MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype|MP:0008641,increased circulating interleukin-1 beta level|MP:0011078,increased macrophage cytokine production|MP:0030940,impaired autophagy
MGI:4432181	Atg16l1<tm1a(EUCOMM)Wtsi>	MP:0000273,overriding aortic valve|MP:0002080,prenatal lethality|MP:0002965,increased circulating serum albumin level|MP:0003686,abnormal eye muscle morphology|MP:0005561,increased mean corpuscular hemoglobin|MP:0008923,thoracoschisis|MP:0010418,perimembraneous ventricular septal defect|MP:0010439,abnormal hepatic vein morphology|MP:0010490,abnormal inferior vena cava valve morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013830,abnormal intrathoracic topology of vagus nerve|MP:0013835,absent hypoglossal nerve|MP:0013836,abnormal hypoglossal nerve topology|MP:0013840,absent segment of posterior cerebral artery|MP:0013848,subcutaneous edema|MP:0013876,absent ductus venosus valve|MP:0013936,abnormal thymus topology|MP:0013970,absent connection between subcutaneous lymph vessels and lymph sac|MP:0013971,blood in lymph vessels|MP:0013986,abnormal vitelline vein topology
MGI:3818483	Atg16l1<tm1Aki>	MP:0002451,abnormal macrophage physiology|MP:0008537,increased susceptibility to induced colitis|MP:0008657,increased interleukin-1 beta secretion|MP:0008684,increased interleukin-18 secretion|MP:0011087,neonatal lethality, complete penetrance|MP:0030939,abnormal autophagosome formation|MP:0030940,impaired autophagy
MGI:5638694	Atg16l1<tm1c(EUCOMM)Wtsi>	MP:0001729,impaired embryo implantation|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002412,increased susceptibility to bacterial infection|MP:0003845,abnormal decidualization|MP:0004843,abnormal Paneth cell morphology|MP:0005384,cellular phenotype|MP:0005387,immune system phenotype|MP:0005425,increased macrophage cell number|MP:0008260,abnormal autophagy|MP:0008537,increased susceptibility to induced colitis|MP:0008588,abnormal circulating interleukin level|MP:0008596,increased circulating interleukin-6 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008713,abnormal cytokine level|MP:0008721,abnormal chemokine level|MP:0009481,cecum inflammation|MP:0010155,abnormal intestine physiology|MP:0013298,increased susceptibility to colitis induced morbidity/mortality|MP:0013486,decreased Paneth cell number
MGI:5559372	Atg16l1<tm1Kuv>	MP:0000479,abnormal enterocyte morphology|MP:0001262,decreased body weight|MP:0003306,small intestinal inflammation|MP:0004843,abnormal Paneth cell morphology|MP:0008260,abnormal autophagy|MP:0008537,increased susceptibility to induced colitis|MP:0008882,abnormal enterocyte physiology|MP:0008885,increased enterocyte apoptosis
MGI:5605965	Atg16l1<tm2.1Mvlc>	MP:0030940,impaired autophagy
MGI:5563511	Atg16l2<m1Anu>	MP:0005016,decreased lymphocyte cell number
MGI:6275189	Atg2b<em1(IMPC)J>	MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002797,increased thigmotaxis|MP:0002833,increased heart weight|MP:0004738,abnormal auditory brainstem response|MP:0005178,increased circulating cholesterol level
MGI:5009305	Atg3<tm1.1Ywh>	MP:0000694,spleen hypoplasia|MP:0001823,thymus hypoplasia|MP:0003674,oxidative stress|MP:0005095,decreased T cell proliferation|MP:0006413,increased T cell apoptosis|MP:0008037,abnormal T cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0030940,impaired autophagy
MGI:5548550	Atg3<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:5609520	Atg3<tm1Kmts>	MP:0005311,abnormal circulating amino acid level|MP:0008260,abnormal autophagy|MP:0009674,decreased birth weight|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011087,neonatal lethality, complete penetrance|MP:0030939,abnormal autophagosome formation
MGI:4123150	Atg4b<Gt(A029E06)Wrst>	MP:0001394,circling|MP:0001405,impaired coordination|MP:0001522,impaired swimming|MP:0002118,abnormal lipid homeostasis|MP:0002894,abnormal otolith morphology|MP:0002978,absent otoliths|MP:0003143,enlarged otoliths|MP:0003631,nervous system phenotype|MP:0004330,abnormal vestibular saccular macula morphology|MP:0005191,head tilt|MP:0006090,abnormal utricle morphology|MP:0030940,impaired autophagy
MGI:4256475	Atg4b<Gt(OST264114)Lex>	MP:0001405,impaired coordination|MP:0002804,abnormal motor learning|MP:0003631,nervous system phenotype|MP:0009979,abnormal cerebellum deep nucleus morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6336219	Atg4b<tm1b(EUCOMM)Hmgu>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000218,increased leukocyte cell number|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001513,limb grasping|MP:0002100,abnormal tooth morphology|MP:0002599,increased mean platelet volume|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0003961,decreased lean body mass|MP:0005013,increased lymphocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0009142,decreased prepulse inhibition|MP:0010067,increased red blood cell distribution width
MGI:3718523	Atg4c<tm1Otin>	MP:0001402,decreased locomotor activity|MP:0004499,increased incidence of tumors by chemical induction|MP:0030940,impaired autophagy
MGI:6358045	Atg5<em1Smoc>	MP:0003447,decreased tumor growth/size|MP:0003448,abnormal tumor morphology
MGI:3035932	Atg5<Gt(IRESBetageo)4Pgr>	MP:0002169,no abnormal phenotype detected
MGI:3663625	Atg5<tm1Myok>	MP:0000598,abnormal liver morphology|MP:0000745,tremors|MP:0000776,abnormal inferior colliculus morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000832,abnormal thalamus morphology|MP:0000876,Purkinje cell degeneration|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0001436,abnormal suckling behavior|MP:0001513,limb grasping|MP:0001544,abnormal cardiovascular system physiology|MP:0001732,postnatal growth retardation|MP:0001759,increased urine glucose level|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002169,no abnormal phenotype detected|MP:0002662,abnormal cauda epididymis morphology|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0002972,abnormal cardiac muscle contractility|MP:0003224,neuron degeneration|MP:0003311,aminoaciduria|MP:0003449,abnormal intestine goblet cell morphology|MP:0003631,nervous system phenotype|MP:0003917,increased kidney weight|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004191,neuronal intranuclear inclusions|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004843,abnormal Paneth cell morphology|MP:0004852,decreased testis weight|MP:0004884,abnormal testis physiology|MP:0004924,abnormal behavior|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0005391,vision/eye phenotype|MP:0005404,abnormal axon morphology|MP:0005578,teratozoospermia|MP:0005621,abnormal cell physiology|MP:0005630,increased lung weight|MP:0006138,congestive heart failure|MP:0008260,abnormal autophagy|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009239,short sperm flagellum|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009837,abnormal sperm end piece morphology|MP:0009974,decreased cerebral cortex pyramidal cell number|MP:0010053,decreased grip strength|MP:0010768,mortality/aging|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0014684,impaired spermiation|MP:0020406,hyperthreoninuria|MP:0020550,multinucleated giant male germ cells|MP:0020869,immotile sperm|MP:0030591,absent sperm fibrous sheath|MP:0030618,tryptophanuria|MP:0030620,valinuria|MP:0030940,impaired autophagy|MP:0031354,abnormal acrosome assembly|MP:0031372,abnormal sperm individualization|MP:0031409,double-headed sperm|MP:0031641,alaninuria
MGI:3612279	Atg5<tm1Nmz>	MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000639,abnormal adrenal gland morphology|MP:0002152,abnormal brain morphology|MP:0002371,abnormal thymus cortex morphology|MP:0002444,abnormal T cell physiology|MP:0002978,absent otoliths|MP:0003143,enlarged otoliths|MP:0003674,oxidative stress|MP:0003897,abnormal ST segment|MP:0003944,abnormal T cell subpopulation ratio|MP:0004163,abnormal adenohypophysis morphology|MP:0004191,neuronal intranuclear inclusions|MP:0005018,decreased T cell number|MP:0005058,abnormal lysosome morphology|MP:0005095,decreased T cell proliferation|MP:0005311,abnormal circulating amino acid level|MP:0005332,abnormal amino acid level|MP:0005388,respiratory system phenotype|MP:0005391,vision/eye phenotype|MP:0005397,hematopoietic system phenotype|MP:0006090,abnormal utricle morphology|MP:0008037,abnormal T cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0009546,absent gastric milk in neonates|MP:0011087,neonatal lethality, complete penetrance|MP:0011630,increased mitochondrial size|MP:0030940,impaired autophagy
MGI:6341910	Atg7<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000627,abnormal mammary gland morphology|MP:0001325,abnormal retina morphology|MP:0001404,no spontaneous movement|MP:0001697,abnormal embryo size|MP:0002060,abnormal skin morphology|MP:0002965,increased circulating serum albumin level|MP:0005568,increased circulating total protein level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3587771	Atg7<tm1.1Tchi>	MP:0001262,decreased body weight|MP:0005311,abnormal circulating amino acid level|MP:0011087,neonatal lethality, complete penetrance|MP:0014239,abnormal intracellular organelle morphology
MGI:3587769	Atg7<tm1Tchi>	MP:0000221,decreased leukocyte cell number|MP:0000242,impaired fertilization|MP:0000333,decreased bone marrow cell number|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0000937,abnormal motor neuron morphology|MP:0000965,abnormal sensory neuron morphology|MP:0001147,small testis|MP:0001263,weight loss|MP:0001360,abnormal social investigation|MP:0001392,abnormal locomotor behavior|MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001570,abnormal circulating enzyme level|MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002183,gliosis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002229,neurodegeneration|MP:0002662,abnormal cauda epididymis morphology|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0002882,abnormal neuron morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0002981,increased liver weight|MP:0003051,curly tail|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration|MP:0003325,decreased liver function|MP:0003354,astrocytosis|MP:0003449,abnormal intestine goblet cell morphology|MP:0003631,nervous system phenotype|MP:0003674,oxidative stress|MP:0003893,increased hepatocyte proliferation|MP:0004542,impaired acrosome reaction|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0004852,decreased testis weight|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005075,abnormal melanosome morphology|MP:0005156,bradykinesia|MP:0005332,abnormal amino acid level|MP:0005343,increased circulating aspartate transaminase level|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0005405,axon degeneration|MP:0005643,decreased dopamine level|MP:0008008,early cellular replicative senescence|MP:0008045,decreased NK cell number|MP:0008246,abnormal leukocyte morphology|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008260,abnormal autophagy|MP:0008770,decreased survivor rate|MP:0008813,decreased common myeloid progenitor cell number|MP:0008898,abnormal acrosome morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009387,abnormal epidermal pigmentation|MP:0009388,abnormal epidermal melanocyte morphology|MP:0009936,abnormal dendritic spine morphology|MP:0009972,absent hippocampus pyramidal cells|MP:0009975,absent cerebral cortex pyramidal cells|MP:0010741,abnormal melanocyte proliferation|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011277,decreased tail pigmentation|MP:0011568,decreased foot pigmentation|MP:0011632,dilated mitochondrion|MP:0013219,abnormal substantia nigra pars compacta morphology|MP:0014052,increased male germ cell apoptosis|MP:0014341,abnormal hepatocyte mitochondrial morphology|MP:0014812,abnormal brain physiology|MP:0020395,abnormal response to social novelty|MP:0030939,abnormal autophagosome formation|MP:0030940,impaired autophagy|MP:0031354,abnormal acrosome assembly|MP:0031355,abnormal proacrosomal vesicle fusion
MGI:4417824	Atg9a<tm1Aki>	MP:0002419,abnormal innate immunity|MP:0008564,increased interferon-beta secretion|MP:0008705,increased interleukin-6 secretion|MP:0011087,neonatal lethality, complete penetrance|MP:0030939,abnormal autophagosome formation|MP:0030940,impaired autophagy
MGI:5569076	Atg9b<tm1b(KOMP)Mbp>	MP:0001293,anophthalmia|MP:0001333,absent optic nerve|MP:0002092,abnormal eye morphology|MP:0002941,increased circulating alanine transaminase level
MGI:2386544	Ath11<FVB/NCr>	MP:0000266,abnormal heart morphology
MGI:2386546	Ath13<C57BL/6J>	MP:0000266,abnormal heart morphology
MGI:2386548	Ath16<FVB/NCr>	MP:0000266,abnormal heart morphology
MGI:3038666	Ath17<C57BL/6J>	MP:0005341,decreased susceptibility to atherosclerosis
MGI:3618891	Ath22<DBA/2J>	MP:0005339,increased susceptibility to atherosclerosis
MGI:3618898	Ath23<AKR/J>	MP:0005339,increased susceptibility to atherosclerosis
MGI:3618899	Ath24<DBA/2J>	MP:0005339,increased susceptibility to atherosclerosis
MGI:3618904	Ath26<AKR/J>	MP:0005339,increased susceptibility to atherosclerosis
MGI:3618911	Ath28<DBA/2J>	MP:0005339,increased susceptibility to atherosclerosis
MGI:3628448	Ath29<C3H/HeJ>	MP:0005338,atherosclerotic lesions|MP:0005341,decreased susceptibility to atherosclerosis
MGI:3628449	Ath29<C57BL/6J>	MP:0005338,atherosclerotic lesions
MGI:3044381	Ath6<C57BLKS/J>	MP:0005338,atherosclerotic lesions
MGI:3528304	Ath8<SM/J>	MP:0005338,atherosclerotic lesions|MP:0005339,increased susceptibility to atherosclerosis
MGI:2386542	Ath9<FVB/NCr>	MP:0001556,increased circulating HDL cholesterol level
MGI:3528042	Athla1<C57BL/6J>	MP:0005338,atherosclerotic lesions
MGI:2155675	Athsq1<MOLF/Ei>	MP:0005339,increased susceptibility to atherosclerosis
MGI:2156388	Athsq2<C57BL/6J>	MP:0005339,increased susceptibility to atherosclerosis
MGI:7510093	Atic<tm1c(EUCOMM)Hmgu>	MP:0003077,abnormal cell cycle|MP:0004883,abnormal vascular wound healing|MP:0005376,homeostasis/metabolism phenotype|MP:0031509,decreased vascular smooth muscle cell proliferation
MGI:5471512	a<tl>	MP:0002075,abnormal coat/hair pigmentation|MP:0005409,darkened coat color
MGI:7463984	Atl1<tm1.1Cbla>	MP:0002878,abnormal corticospinal tract morphology|MP:0005386,behavior/neurological phenotype|MP:0009378,abnormal endoplasmic reticulum morphology
MGI:7463986	Atl1<tm1.2Cbla>	MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003871,abnormal myelin sheath morphology|MP:0009517,abnormal salivary gland duct morphology
MGI:5429535	Atl1<tm1Jfnk>	MP:0001406,abnormal gait|MP:0014320,abnormal autopod rotation
MGI:5698071	Atl2<tm2b(EUCOMM)Hmgu>	MP:0000222,decreased neutrophil cell number|MP:0002591,decreased mean corpuscular volume|MP:0003961,decreased lean body mass|MP:0004953,decreased spleen weight|MP:0005013,increased lymphocyte cell number|MP:0005564,increased hemoglobin content|MP:0010024,increased total body fat amount|MP:0010068,decreased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5754584	Atl3<em1(IMPC)Tcp>	MP:0000598,abnormal liver morphology|MP:0000702,enlarged lymph nodes|MP:0002768,small adrenal glands|MP:0002989,small kidney|MP:0004958,enlarged prostate gland|MP:0011874,enlarged urinary bladder
MGI:3842513	A<tm1Brd>	MP:0001186,pigmentation phenotype|MP:0010771,integument phenotype
MGI:3640783	Atmin<gpg6>	MP:0000428,abnormal craniofacial morphology|MP:0000531,right pulmonary isomerism|MP:0000914,exencephaly|MP:0001181,absent lungs|MP:0001297,microphthalmia|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0002639,micrognathia|MP:0002766,situs inversus|MP:0002989,small kidney|MP:0003054,spina bifida|MP:0003178,left pulmonary isomerism|MP:0003641,small lung|MP:0004131,abnormal motile primary cilium morphology|MP:0004157,interrupted aortic arch|MP:0004158,right aortic arch|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0004967,abnormal kidney epithelium morphology|MP:0005262,coloboma|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0006126,abnormal cardiac outflow tract development|MP:0010454,abnormal truncus arteriosus septation|MP:0011998,decreased embryonic cilium length|MP:0013203,abnormal primary cilium morphology|MP:0013213,abnormal embryonic neuroepithelium primary cilium morphology|MP:0030169,thick upper lip
MGI:5620361	Atmin<m1H>	MP:0000914,exencephaly|MP:0001181,absent lungs|MP:0001297,microphthalmia|MP:0001785,edema|MP:0003178,left pulmonary isomerism|MP:0003641,small lung|MP:0005262,coloboma|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0030169,thick upper lip
MGI:4868762	Atmin<tm1.1Axbe>	MP:0000352,decreased cell proliferation|MP:0000428,abnormal craniofacial morphology|MP:0000914,exencephaly|MP:0005621,abnormal cell physiology|MP:0008008,early cellular replicative senescence|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4881337	Atmin<tm1.1Jhh>	MP:0000914,exencephaly|MP:0001181,absent lungs|MP:0001823,thymus hypoplasia|MP:0002006,neoplasm|MP:0003115,abnormal respiratory system development|MP:0004201,fetal growth retardation|MP:0005017,decreased B cell number|MP:0005384,cellular phenotype|MP:0005397,hematopoietic system phenotype|MP:0006065,abnormal heart position or orientation|MP:0008008,early cellular replicative senescence|MP:0008215,decreased immature B cell number|MP:0008404,increased cellular sensitivity to methylmethanesulfonate induced cell death|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0008495,decreased IgG1 level|MP:0008782,increased B cell apoptosis|MP:0009431,decreased fetal weight|MP:0009796,abnormal base-excision repair|MP:0010885,absent trachea|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0013496,abnormal trachea development
MGI:5463937	Atmin<tm1.2Jhh>	MP:0000692,small spleen|MP:0002144,abnormal B cell differentiation|MP:0002459,abnormal B cell physiology|MP:0002875,decreased erythrocyte cell number|MP:0004953,decreased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number
MGI:4868760	Atmin<tm1Axbe>	MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0003244,loss of dopaminergic neurons|MP:0003354,astrocytosis|MP:0008948,decreased neuron number
MGI:6200331	Atm<m1Btlr>	MP:0002494,increased IgM level|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0020001,decreased response to antigen|MP:0020154,impaired humoral immune response
MGI:6200335	Atm<m2Btlr>	MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6285924	Atm<m3Btlr>	MP:0005425,increased macrophage cell number|MP:0008167,increased B-1a cell number
MGI:6285928	Atm<M4Btlr>	MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation
MGI:6285932	Atm<m5Btlr>	MP:0001798,impaired macrophage phagocytosis|MP:0002619,abnormal lymphocyte morphology|MP:0004977,increased B-1 B cell number|MP:0008658,decreased interleukin-1 beta secretion
MGI:6305816	Atm<m6Btlr>	MP:0002145,abnormal T cell differentiation|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0010838,increased CD8-positive, alpha-beta memory T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:5806239	Atm<tm1.1Mmpl>	MP:0000352,decreased cell proliferation|MP:0001393,ataxia|MP:0002024,increased T cell derived lymphoma incidence|MP:0003631,nervous system phenotype|MP:0005014,increased B cell number|MP:0005018,decreased T cell number|MP:0008058,abnormal DNA repair|MP:0008944,decreased sensitivity to induced cell death|MP:0010831,lethality, incomplete penetrance
MGI:5463773	Atm<tm1.1Shzh>	MP:0011092,embryonic lethality, complete penetrance
MGI:1857132	Atm<tm1Awb>	MP:0000877,abnormal Purkinje cell morphology|MP:0001119,abnormal female reproductive system morphology|MP:0001120,abnormal uterus morphology|MP:0001127,small ovary|MP:0001145,abnormal male reproductive system morphology|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0001658,increased mortality induced by gamma-irradiation|MP:0001830,decreased activated T cell number|MP:0001919,abnormal reproductive system physiology|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001929,abnormal gametogenesis|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002019,abnormal tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0002166,abnormal tumor susceptibility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002757,decreased vertical activity|MP:0002777,absent ovarian follicles|MP:0003077,abnormal cell cycle|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003631,nervous system phenotype|MP:0003674,oxidative stress|MP:0003702,abnormal chromosome morphology|MP:0004028,chromosome breakage|MP:0004029,spontaneous chromosome breakage|MP:0004045,abnormal cell cycle checkpoint function|MP:0004805,absent oocytes|MP:0004816,abnormal class switch recombination|MP:0005014,increased B cell number|MP:0005018,decreased T cell number|MP:0005058,abnormal lysosome morphology|MP:0005091,increased double-positive T cell number|MP:0005092,decreased double-positive T cell number|MP:0005159,azoospermia|MP:0005384,cellular phenotype|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0009009,absent estrous cycle|MP:0009021,absent estrus|MP:0010768,mortality/aging|MP:0010831,lethality, incomplete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:1926343	Atm<tm1Bal>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0000876,Purkinje cell degeneration|MP:0000889,abnormal cerebellar molecular layer|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001805,decreased IgG level|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002024,increased T cell derived lymphoma incidence|MP:0002444,abnormal T cell physiology|MP:0002777,absent ovarian follicles|MP:0003224,neuron degeneration|MP:0003691,abnormal microglial cell physiology|MP:0004045,abnormal cell cycle checkpoint function|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004805,absent oocytes|MP:0005168,abnormal female meiosis|MP:0005386,behavior/neurological phenotype|MP:0008209,decreased pre-B cell number|MP:0008261,arrest of male meiosis|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0011704,decreased fibroblast proliferation|MP:0013236,ovary degeneration|MP:0014237,decreased tumor-free survival time
MGI:1933748	Atm<tm1Fwa>	MP:0000715,decreased thymocyte number|MP:0000885,ectopic Purkinje cell|MP:0000890,thin cerebellar molecular layer|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0002804,abnormal motor learning|MP:0004816,abnormal class switch recombination|MP:0005016,decreased lymphocyte cell number|MP:0005018,decreased T cell number|MP:0008209,decreased pre-B cell number|MP:0008215,decreased immature B cell number|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008866,chromosomal instability|MP:0009339,decreased splenocyte number|MP:0010768,mortality/aging|MP:0014329,abnormal Purkinje cell axon morphology
MGI:1926875	Atm<tm1Led>	MP:0000706,small thymus|MP:0000711,thymus cortex hypoplasia|MP:0000877,abnormal Purkinje cell morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001925,male infertility|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0003702,abnormal chromosome morphology|MP:0004028,chromosome breakage|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0005091,increased double-positive T cell number|MP:0005159,azoospermia|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0014127,increased thymoma incidence
MGI:2181756	Atm<tm1Mfl>	MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0000716,abnormal immune system cell morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001929,abnormal gametogenesis|MP:0001931,abnormal oogenesis|MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0002217,small lymph nodes|MP:0002722,abnormal immune system organ morphology|MP:0003631,nervous system phenotype|MP:0003702,abnormal chromosome morphology|MP:0003830,abnormal testis development|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0005090,increased double-negative T cell number|MP:0006379,abnormal spermatocyte morphology|MP:0008000,increased ovary tumor incidence|MP:0008082,increased single-positive T cell number|MP:0010383,increased adenoma incidence|MP:0012431,increased lymphoma incidence|MP:0014633,decreased spermatid number
MGI:1933746	Atm<tm1Pmc>	MP:0000013,abnormal adipose tissue distribution|MP:0001924,infertility|MP:0003077,abnormal cell cycle|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0004045,abnormal cell cycle checkpoint function|MP:0004228,decreased cellular sensitivity to ionizing radiation induced cell death|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005668,decreased circulating leptin level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0011168,abnormal fat cell differentiation|MP:0011939,increased food intake|MP:0012431,increased lymphoma incidence|MP:0030968,decreased circulating adiponectin level
MGI:3851145	Atm<tm2.1Fwa>	MP:0000715,decreased thymocyte number|MP:0002024,increased T cell derived lymphoma incidence|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number
MGI:6714060	Atm<tm2.1Mfgc>	MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0005018,decreased T cell number|MP:0005386,behavior/neurological phenotype|MP:0008770,decreased survivor rate|MP:0014127,increased thymoma incidence
MGI:5316210	Atm<tm2Pmc>	MP:0004228,decreased cellular sensitivity to ionizing radiation induced cell death
MGI:3709882	Atn1<tm1.1Asp>	MP:0002169,no abnormal phenotype detected
MGI:5548352	Atn1<tm1b(EUCOMM)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000266,abnormal heart morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0001552,increased circulating triglyceride level|MP:0002060,abnormal skin morphology|MP:0002875,decreased erythrocyte cell number|MP:0003928,increased heart rate variability|MP:0004122,abnormal sinus arrhythmia|MP:0005016,decreased lymphocyte cell number|MP:0005385,cardiovascular system phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005561,increased mean corpuscular hemoglobin
MGI:4360645	Atn1<tm1Rexu>	MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001922,reduced male fertility|MP:0002083,premature death|MP:0002673,abnormal sperm number|MP:0003631,nervous system phenotype|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011940,decreased food intake
MGI:3849084	Atoh1<tm1(cre/ERT2)Mhos>	MP:0003247,abnormal glutaminergic neuron morphology|MP:0012490,abnormal cochlear VIII nucleus morphology
MGI:4455013	Atoh1<tm1(cre)Gan>	MP:0011087,neonatal lethality, complete penetrance
MGI:2155984	Atoh1<tm1Hzo>	MP:0000852,small cerebellum|MP:0000853,absent cerebellar foliation|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0011087,neonatal lethality, complete penetrance
MGI:2155983	Atoh1<tm2Hzo>	MP:0000852,small cerebellum|MP:0000853,absent cerebellar foliation|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0003631,nervous system phenotype|MP:0004325,absent vestibular hair cells|MP:0004405,absent cochlear hair cells|MP:0005574,decreased pulmonary respiratory rate|MP:0006108,abnormal hindbrain development|MP:0011087,neonatal lethality, complete penetrance
MGI:3767172	Atoh1<tm3Hzo>	MP:0005376,homeostasis/metabolism phenotype|MP:0014076,absent Paneth cells|MP:0020394,decreased neuronal precursor proliferation
MGI:4420925	Atoh1<tm6.1Hzo>	MP:0002169,no abnormal phenotype detected
MGI:2656758	Atoh1<trhl>	MP:0000852,small cerebellum|MP:0000853,absent cerebellar foliation|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0001406,abnormal gait|MP:0001485,abnormal pinna reflex|MP:0001967,deafness|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004529,decreased outer hair cell stereocilia number|MP:0004534,decreased inner hair cell stereocilia number|MP:0004736,abnormal distortion product otoacoustic emission|MP:0006325,impaired hearing|MP:0010768,mortality/aging|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5529126	Atoh7<tm1.1(Ascl1)Nlbr>	MP:0001333,absent optic nerve|MP:0002792,abnormal retina vasculature morphology|MP:0005547,abnormal Muller cell morphology|MP:0006073,abnormal retina bipolar cell morphology|MP:0006309,decreased retina ganglion cell number|MP:0008445,increased retina cone cell number|MP:0011965,decreased total retina thickness
MGI:4353889	Atoh7<tm1.1Xmu>	MP:0002169,no abnormal phenotype detected
MGI:2159013	Atoh7<tm1Gan>	MP:0001325,abnormal retina morphology|MP:0001333,absent optic nerve|MP:0005389,reproductive system phenotype|MP:0005547,abnormal Muller cell morphology|MP:0005551,abnormal eye electrophysiology|MP:0006075,abnormal retina cone bipolar cell morphology|MP:0006221,optic nerve hypoplasia|MP:0006309,decreased retina ganglion cell number|MP:0008056,abnormal retina ganglion cell morphology|MP:0008068,absent retina ganglion cell|MP:0008105,increased amacrine cell number|MP:0030005,increased retina apoptosis
MGI:2159015	Atoh7<tm1Gla>	MP:0001006,abnormal retina cone cell morphology|MP:0001286,abnormal eye development|MP:0001325,abnormal retina morphology|MP:0001333,absent optic nerve|MP:0001334,absent optic tract|MP:0001614,abnormal blood vessel morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003077,abnormal cell cycle|MP:0003425,abnormal optic vesicle formation|MP:0005240,abnormal amacrine cell morphology|MP:0005241,abnormal retina ganglion layer morphology|MP:0005551,abnormal eye electrophysiology|MP:0006073,abnormal retina bipolar cell morphology|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0006075,abnormal retina cone bipolar cell morphology|MP:0006303,abnormal retina nerve fiber layer morphology|MP:0008068,absent retina ganglion cell|MP:0008445,increased retina cone cell number|MP:0008453,decreased retina rod cell number|MP:0008510,absent retina ganglion layer|MP:0008511,thin retina inner nuclear layer|MP:0008513,thin retina inner plexiform layer|MP:0008515,thin retina outer nuclear layer|MP:0008519,thin retina outer plexiform layer|MP:0011965,decreased total retina thickness|MP:0020476,abnormal circardian behavior entrainment
MGI:2159014	Atoh7<tm2Gan>	MP:0001325,abnormal retina morphology|MP:0001330,abnormal optic nerve morphology|MP:0004021,abnormal rod electrophysiology|MP:0005389,reproductive system phenotype|MP:0006303,abnormal retina nerve fiber layer morphology|MP:0006309,decreased retina ganglion cell number|MP:0008056,abnormal retina ganglion cell morphology|MP:0011965,decreased total retina thickness|MP:0020548,decreased optic chiasm size
MGI:3514047	Atoh7<tm3(cre)Gan>	MP:0005391,vision/eye phenotype|MP:0006309,decreased retina ganglion cell number
MGI:5532929	Atoh8<tm1.1Mlkn>	MP:0010768,mortality/aging
MGI:3799350	Atoh8<tm1(EGFP/cre)Gasa>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5532930	Atoh8<tm2.1Mlkn>	MP:0010768,mortality/aging
MGI:5532931	Atoh8<tm3Mlkn>	MP:0010768,mortality/aging
MGI:2158341	Atox1<Gt(IRESBetageo)3Pgr>	MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001402,decreased locomotor activity|MP:0001634,internal hemorrhage|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0003067,decreased liver copper level|MP:0003632,abnormal nervous system morphology|MP:0003718,maternal effect|MP:0003951,abnormal copper homeostasis|MP:0005408,hypopigmentation|MP:0005421,loose skin|MP:0005534,decreased body temperature|MP:0005584,abnormal enzyme/coenzyme activity|MP:0010909,pulmonary alveolar hemorrhage|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011215,decreased brain copper level
MGI:7464990	Atp10a<em1(IMPC)Tcp>	MP:0001126,abnormal ovary morphology|MP:0001925,male infertility|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:7610141	Atp10a<em1Vtrg>	MP:0000609,abnormal liver physiology|MP:0001258,decreased body length|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001556,increased circulating HDL cholesterol level|MP:0003949,abnormal circulating lipid level|MP:0003975,increased circulating VLDL triglyceride level|MP:0003980,increased circulating phospholipid level|MP:0004777,abnormal phospholipid level|MP:0005178,increased circulating cholesterol level|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005448,abnormal energy homeostasis|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0010360,decreased liver free fatty acids level|MP:0011940,decreased food intake|MP:0012230,abnormal sphingolipid level|MP:0012338,decreased bile salt level|MP:0013245,abnormal lipid metabolism|MP:0013279,increased fasting circulating glucose level|MP:0014448,increased enzyme/coenzyme level|MP:0031115,macrovesicular hepatic steatosis
MGI:5563515	Atp10a<m1Anu>	MP:0005387,immune system phenotype
MGI:4363953	Atp11a<tm1a(KOMP)Wtsi>	MP:0000273,overriding aortic valve|MP:0000480,increased rib number|MP:0000600,liver hypoplasia|MP:0000602,dilated liver sinusoidal space|MP:0000703,abnormal thymus morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000914,exencephaly|MP:0001015,small superior cervical ganglion|MP:0002092,abnormal eye morphology|MP:0002191,abnormal artery morphology|MP:0002237,abnormal nasal cavity morphology|MP:0002249,abnormal larynx morphology|MP:0003078,aphakia|MP:0003387,aorta coarctation|MP:0003686,abnormal eye muscle morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0004057,thin myocardium compact layer|MP:0004163,abnormal adenohypophysis morphology|MP:0004181,abnormal carotid artery morphology|MP:0004259,small placenta|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0005236,abnormal olfactory nerve morphology|MP:0005287,narrow eye opening|MP:0005587,abnormal Meckel's cartilage morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010912,herniated liver|MP:0011100,preweaning lethality, complete penetrance|MP:0011513,abnormal vertebral artery morphology|MP:0012303,umbilical vein stenosis|MP:0013809,absent pectinate muscle|MP:0013833,absent olfactory nerve|MP:0013848,subcutaneous edema|MP:0013875,increased trigeminal neuroma incidence|MP:0013876,absent ductus venosus valve|MP:0013945,abnormal elbow joint morphology|MP:0013968,multiple persisting craniopharyngeal ducts|MP:0013969,reduced sympathetic cervical ganglion size|MP:0013975,abnormal coronary sinus connection|MP:0013985,abnormal umbilical vein topology|MP:0013986,abnormal vitelline vein topology|MP:0014003,additional anastomosis between intracranial vertebral arteries|MP:0014021,heterochrony|MP:0020500,persistent trigeminal artery|MP:0030975,placenta hemorrhage
MGI:6188633	Atp11a<tm1c(KOMP)Wtsi>	MP:0005369,muscle phenotype|MP:0011808,abnormal myoblast differentiation|MP:0013237,abnormal skeletal muscle regeneration
MGI:6379555	Atp11b<em1(IMPC)Tcp>	MP:0001289,persistence of hyaloid vascular system|MP:0004832,enlarged ovary|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:4456247	Atp11c<ambr>	MP:0000221,decreased leukocyte cell number|MP:0001577,anemia|MP:0001800,abnormal humoral immune response|MP:0002144,abnormal B cell differentiation|MP:0002875,decreased erythrocyte cell number|MP:0003331,increased hepatocellular carcinoma incidence|MP:0004978,decreased B-1 B cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005344,increased circulating bilirubin level|MP:0005397,hematopoietic system phenotype|MP:0008168,decreased B-1a cell number|MP:0008170,decreased B-1b cell number|MP:0008174,decreased follicular B cell number|MP:0008207,decreased B-2 B cell number|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number
MGI:6114795	Atp11c<em1(IMPC)J>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0001556,increased circulating HDL cholesterol level|MP:0002590,increased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005344,increased circulating bilirubin level|MP:0005561,increased mean corpuscular hemoglobin
MGI:4329541	Atp11c<Gt(RRM203)Byg>	MP:0002169,no abnormal phenotype detected
MGI:4843273	Atp11c<m1Btlr>	MP:0001802,arrested B cell differentiation|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005344,increased circulating bilirubin level|MP:0005387,immune system phenotype|MP:0008175,absent follicular B cells|MP:0008190,decreased transitional stage B cell number|MP:0008207,decreased B-2 B cell number|MP:0008215,decreased immature B cell number|MP:0008495,decreased IgG1 level|MP:0009923,decreased transitional stage T1 B cell number|MP:0009926,decreased transitional stage T2 B cell number|MP:0010228,decreased transitional stage T3 B cell number
MGI:5006936	Atp11c<m2Anu>	MP:0005017,decreased B cell number
MGI:4843275	Atp11c<m2Btlr>	MP:0005017,decreased B cell number|MP:0005387,immune system phenotype
MGI:2177160	Atp12a<tm1Ges>	MP:0003866,abnormal defecation|MP:0003917,increased kidney weight|MP:0005619,increased urine potassium level|MP:0005628,decreased circulating potassium level|MP:0010180,increased susceptibility to weight loss
MGI:6385269	Atp13a1<em1(IMPC)Tcp>	MP:0000428,abnormal craniofacial morphology|MP:0000914,exencephaly|MP:0001293,anophthalmia|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0011496,abnormal head size
MGI:5642333	Atp13a2<tm1.2Wtd>	MP:0001402,decreased locomotor activity|MP:0001513,limb grasping|MP:0002183,gliosis|MP:0002882,abnormal neuron morphology|MP:0003172,abnormal lysosome physiology|MP:0003354,astrocytosis|MP:0005058,abnormal lysosome morphology|MP:0005059,lysosomal protein accumulation|MP:0008842,lipofuscinosis|MP:0030940,impaired autophagy
MGI:5472135	Atp13a2<tm1Pjsch>	MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001447,abnormal nest building behavior|MP:0001463,abnormal spatial learning|MP:0001516,abnormal motor coordination/balance|MP:0002882,abnormal neuron morphology|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008493,alpha-synuclein inclusion body|MP:0008842,lipofuscinosis
MGI:6314147	Atp13a3<em1(IMPC)J>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000218,increased leukocyte cell number|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0001925,male infertility|MP:0002591,decreased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0002644,decreased circulating triglyceride level|MP:0002833,increased heart weight|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003131,increased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005292,improved glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005566,decreased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0010097,abnormal retina blood vessel morphology|MP:0010123,increased bone mineral content|MP:0011239,abnormal skin coloration|MP:0013278,decreased fasting circulating glucose level
MGI:6450011	Atp13a3<em2H>	MP:0000276,heart right ventricle hypertrophy|MP:0000278,abnormal myocardial fiber morphology|MP:0000484,abnormal pulmonary artery morphology|MP:0003548,pulmonary hypertension|MP:0004012,increased pulmonary artery pressure|MP:0005608,cardiac interstitial fibrosis|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011925,abnormal heart echocardiography feature
MGI:6257413	Atp13a4<em1(IMPC)Bay>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0011965,decreased total retina thickness
MGI:5007030	Atp13a5<tm1Lex>	MP:0002635,reduced sensorimotor gating|MP:0008045,decreased NK cell number
MGI:6389079	Atp1a1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0000759,abnormal skeletal muscle morphology|MP:0001120,abnormal uterus morphology|MP:0002060,abnormal skin morphology|MP:0002110,abnormal digit morphology|MP:0002339,abnormal lymph node morphology|MP:0002953,thick ventricular wall|MP:0005333,decreased heart rate|MP:0005564,increased hemoglobin content|MP:0010579,increased heart left ventricle size|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3530009	Atp1a1<Gt(OST31117)Lex>	MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0011100,preweaning lethality, complete penetrance
MGI:2451290	Atp1a1<tm1Ling>	MP:0000738,impaired muscle contractility|MP:0001745,increased circulating corticosterone level|MP:0003313,abnormal locomotor activation|MP:0005140,decreased cardiac muscle contractility|MP:0009749,enhanced behavioral response to addictive substance|MP:0011100,preweaning lethality, complete penetrance
MGI:6729893	Atp1a2<tm1.1Gica>	MP:0001363,increased anxiety-related response|MP:0001413,abnormal response to new environment|MP:0002272,abnormal nervous system electrophysiology|MP:0003459,increased fear-related response|MP:0011087,neonatal lethality, complete penetrance
MGI:6187668	Atp1a2<tm1.1Tmklh>	MP:0001260,increased body weight|MP:0001360,abnormal social investigation|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001441,increased grooming behavior|MP:0001488,increased startle reflex|MP:0002272,abnormal nervous system electrophysiology|MP:0002572,abnormal emotion/affect behavior|MP:0002573,behavioral despair|MP:0009710,anhedonia|MP:0010698,abnormal impulsive behavior control|MP:0011087,neonatal lethality, complete penetrance|MP:0012006,abnormal hippocampus physiology|MP:0013140,excessive vocalization|MP:0030736,increased glutamic acid level
MGI:2664907	Atp1a2<tm1Kwk>	MP:0000818,abnormal amygdala morphology|MP:0002065,abnormal fear/anxiety-related behavior|MP:0005267,abnormal olfactory cortex morphology|MP:0005380,embryo phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:3522421	Atp1a2<tm2Kwk>	MP:0001404,no spontaneous movement|MP:0001491,unresponsive to tactile stimuli|MP:0001953,respiratory failure|MP:0002169,no abnormal phenotype detected|MP:0002204,abnormal synaptic neurotransmitter level|MP:0002272,abnormal nervous system electrophysiology|MP:0005402,abnormal action potential|MP:0005423,abnormal somatic nervous system physiology|MP:0011087,neonatal lethality, complete penetrance|MP:0030732,increased gamma-aminobutyric acid level
MGI:2451291	Atp1a2<tm2Ling>	MP:0001363,increased anxiety-related response|MP:0001463,abnormal spatial learning|MP:0005140,decreased cardiac muscle contractility|MP:0005376,homeostasis/metabolism phenotype|MP:0005620,abnormal muscle contractility|MP:0011087,neonatal lethality, complete penetrance
MGI:3027260	Atp1a2<tm3Ling>	MP:0002972,abnormal cardiac muscle contractility|MP:0005385,cardiovascular system phenotype
MGI:5296814	Atp1a2<tm4.1Ling>	MP:0000230,abnormal systemic arterial blood pressure|MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0005385,cardiovascular system phenotype
MGI:4356167	Atp1a3<Myk>	MP:0000801,abnormal temporal lobe morphology|MP:0000947,convulsive seizures|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001486,abnormal startle reflex|MP:0001501,abnormal sleep pattern|MP:0002083,premature death|MP:0002634,abnormal sensorimotor gating|MP:0002797,increased thigmotaxis|MP:0003354,astrocytosis|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology|MP:0004924,abnormal behavior|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008840,abnormal spike wave discharge|MP:0008918,microgliosis|MP:0009142,decreased prepulse inhibition|MP:0009357,abnormal seizure response to inducing agent|MP:0009358,environmentally induced seizures|MP:0009454,impaired contextual conditioning behavior|MP:0009713,enhanced conditioned place preference behavior|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011617,abnormal habituation|MP:0011624,abnormal sensitization to xenobiotic|MP:0012286,decreased frequency of paradoxical sleep|MP:0012288,abnormal paradoxical sleep pattern|MP:0012289,abnormal non-rapid eye movement sleep pattern|MP:0020469,prolonged circadian behavior period|MP:0031391,increased locomotor activity
MGI:5572809	Atp1a3<tm1.1Kwk>	MP:0001399,hyperactivity|MP:0002206,abnormal CNS synaptic transmission|MP:0002327,abnormal respiratory function|MP:0003631,nervous system phenotype|MP:0003858,enhanced coordination|MP:0005323,dystonia|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0011087,neonatal lethality, complete penetrance|MP:0014382,increased miniature inhibitory postsynaptic current frequency
MGI:6163502	Atp1a3<tm1.1Tmklh>	MP:0000812,abnormal dentate gyrus morphology|MP:0001399,hyperactivity|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003631,nervous system phenotype|MP:0004000,impaired passive avoidance behavior|MP:0004924,abnormal behavior|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0009938,abnormal hippocampus granule cell morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011620,abnormal habituation to a new environment|MP:0012307,impaired spatial learning
MGI:5692876	Atp1a3<tm1b(EUCOMM)Hmgu>	MP:0001364,decreased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0005292,improved glucose tolerance|MP:0011100,preweaning lethality, complete penetrance
MGI:3696954	Atp1a3<tm1Ling>	MP:0001399,hyperactivity|MP:0001463,abnormal spatial learning|MP:0005376,homeostasis/metabolism phenotype|MP:0009749,enhanced behavioral response to addictive substance|MP:0011087,neonatal lethality, complete penetrance
MGI:6197036	Atp1a3<tm1Mika>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0002064,seizures|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002801,abnormal long-term object recognition memory|MP:0003461,abnormal response to novel object|MP:0005323,dystonia|MP:0009357,abnormal seizure response to inducing agent|MP:0020424,increased kindling response|MP:0031202,hemiplegia
MGI:6162645	Atp1a3<tm1Ute>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0001973,increased thermal nociceptive threshold|MP:0002064,seizures|MP:0002083,premature death|MP:0002206,abnormal CNS synaptic transmission|MP:0002801,abnormal long-term object recognition memory|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0004924,abnormal behavior|MP:0005323,dystonia|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0020424,increased kindling response|MP:0031201,hemiparesis|MP:0031202,hemiplegia
MGI:5694169	Atp1a4<tm1b(KOMP)Wtsi>	MP:0001925,male infertility
MGI:5528797	Atp1a4<tm1Blac>	MP:0001925,male infertility|MP:0005389,reproductive system phenotype|MP:0009237,kinked sperm flagellum|MP:0009282,decreased hyperactivated sperm motility
MGI:4941050	Atp1a4<tm1Itl>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0003666,impaired sperm capacitation|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0009237,kinked sperm flagellum
MGI:7425530	Atp1b1<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000277,abnormal heart shape|MP:0000585,kinked tail|MP:0000783,abnormal forebrain morphology|MP:0000928,incomplete rostral neuropore closure|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001488,increased startle reflex|MP:0001691,abnormal somite shape|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001701,incomplete embryo turning|MP:0001718,abnormal visceral yolk sac morphology|MP:0001787,pericardial edema|MP:0002060,abnormal skin morphology|MP:0002151,abnormal neural tube morphology|MP:0002699,abnormal vitreous body morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003400,kinked neural tube|MP:0003425,abnormal optic vesicle formation|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0004180,failure of initiation of embryo turning|MP:0005380,embryo phenotype|MP:0006203,eye hemorrhage|MP:0010393,shortened QRS complex duration|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0012708,delayed rostral neuropore closure|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:4360184	Atp1b1<tm1.1Akra>	MP:0001625,cardiac hypertrophy|MP:0002169,no abnormal phenotype detected|MP:0002833,increased heart weight|MP:0002972,abnormal cardiac muscle contractility|MP:0004215,abnormal myocardial fiber physiology|MP:0004485,increased response of heart to induced stress|MP:0005598,decreased heart ventricle muscle contractility|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5787934	Atp1b1<tm1.1Zboro>	MP:0005388,respiratory system phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0014181,abnormal respiratory epithelial sodium ion transmembrane transport|MP:0014525,impaired pulmonary alveolar fluid clearance
MGI:2157777	Atp1b2<tm1(Atp1b1)Mtg>	MP:0001004,abnormal retina photoreceptor morphology|MP:0003631,nervous system phenotype|MP:0006069,abnormal retina neuronal layer morphology|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment|MP:0030005,increased retina apoptosis
MGI:2157776	Atp1b2<tm1Msch>	MP:0000745,tremors|MP:0000756,forelimb paralysis|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001004,abnormal retina photoreceptor morphology|MP:0001326,retina degeneration|MP:0001405,impaired coordination|MP:0001523,impaired righting response|MP:0003631,nervous system phenotype|MP:0005176,eyelids fail to open|MP:0005277,abnormal brainstem morphology|MP:0005391,vision/eye phenotype|MP:0005449,abnormal food intake|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment|MP:0011085,postnatal lethality, complete penetrance
MGI:6257693	Atp1b3<em1(IMPC)Bay>	MP:0001399,hyperactivity|MP:0001691,abnormal somite shape|MP:0002151,abnormal neural tube morphology|MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0004924,abnormal behavior|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0020870,decreased thigmotaxis
MGI:7294249	Atp23<em1Cya>	MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003641,small lung|MP:0003717,pallor|MP:0004200,decreased fetal size|MP:0004782,abnormal surfactant physiology|MP:0006027,impaired lung alveolus development|MP:0010887,pale lung|MP:0010890,decreased alveolar lamellar body number|MP:0011089,perinatal lethality, complete penetrance|MP:0011143,thick lung-associated mesenchyme
MGI:5692558	Atp2a1<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:2656945	Atp2a1<tm1Dhm>	MP:0001175,abnormal lung morphology|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002106,abnormal muscle physiology|MP:0002279,abnormal diaphragm morphology|MP:0002841,impaired skeletal muscle contractility|MP:0003157,impaired muscle relaxation|MP:0003646,increased muscle fatigability|MP:0011087,neonatal lethality, complete penetrance
MGI:4415164	Atp2a2<tm1.1Iemr>	MP:0000274,enlarged heart|MP:0001544,abnormal cardiovascular system physiology|MP:0003140,dilated heart atrium|MP:0003393,decreased cardiac output|MP:0003923,abnormal heart left atrium morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0005385,cardiovascular system phenotype|MP:0005665,increased circulating noradrenaline level|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0010754,abnormal heart left ventricle pressure|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5660869	Atp2a2<tm1.1Raco>	MP:0000259,abnormal vascular development|MP:0001698,decreased embryo size|MP:0002128,abnormal blood circulation|MP:0003544,abnormal vascular endothelial cell migration|MP:0003710,abnormal physiological neovascularization|MP:0004003,abnormal vascular endothelial cell physiology|MP:0004231,abnormal calcium ion homeostasis|MP:0005602,decreased angiogenesis|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:5548918	Atp2a2<tm1b(EUCOMM)Hmgu>	MP:0002966,decreased circulating alkaline phosphatase level|MP:0008935,decreased mean platelet volume|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:3653502	Atp2a2<tm1Fwuy>	MP:0001262,decreased body weight|MP:0001523,impaired righting response|MP:0001625,cardiac hypertrophy|MP:0001935,decreased litter size|MP:0002625,heart left ventricle hypertrophy|MP:0002754,dilated heart right ventricle|MP:0002833,increased heart weight|MP:0002899,fatigue|MP:0003141,cardiac fibrosis|MP:0003313,abnormal locomotor activation|MP:0003387,aorta coarctation|MP:0004084,abnormal cardiac muscle relaxation|MP:0004231,abnormal calcium ion homeostasis|MP:0005140,decreased cardiac muscle contractility|MP:0005156,bradykinesia|MP:0005608,cardiac interstitial fibrosis|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010469,ascending aorta hypoplasia|MP:0010556,thin ventricle myocardium compact layer|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0021161,increased heart left ventricle posterior wall thickness|MP:0021163,increased heart left ventricle septal wall thickness|MP:0031511,globular heart
MGI:2158235	Atp2a2<tm1Ges>	MP:0000466,esophageal epithelium hyperplasia|MP:0000582,toenail hyperkeratosis|MP:0001242,hyperkeratosis|MP:0001625,cardiac hypertrophy|MP:0002020,increased tumor incidence|MP:0002051,increased skin papilloma incidence|MP:0002083,premature death|MP:0002625,heart left ventricle hypertrophy|MP:0002753,dilated heart left ventricle|MP:0002843,decreased systemic arterial blood pressure|MP:0003141,cardiac fibrosis|MP:0003277,increased esophageal papilloma incidence|MP:0003819,increased left ventricle diastolic pressure|MP:0003822,decreased left ventricle systolic pressure|MP:0003828,pulmonary edema|MP:0004084,abnormal cardiac muscle relaxation|MP:0004207,increased squamous cell carcinoma incidence|MP:0004231,abnormal calcium ion homeostasis|MP:0004485,increased response of heart to induced stress|MP:0005150,cachexia|MP:0005202,lethargy|MP:0005493,stomach epithelial hyperplasia|MP:0005598,decreased heart ventricle muscle contractility|MP:0006138,congestive heart failure|MP:0008396,abnormal osteoclast differentiation|MP:0009105,penis prolapse|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011091,prenatal lethality, complete penetrance|MP:0021161,increased heart left ventricle posterior wall thickness|MP:0030257,increased tongue papilloma incidence|MP:0031633,decreased heart left ventricle muscle contractility
MGI:2180376	Atp2a3<tm1Ges>	MP:0004003,abnormal vascular endothelial cell physiology|MP:0004036,abnormal muscle relaxation
MGI:6278934	Atp2b1<Tg(Thy1-CHMP2B*)1Rene>	MP:0000745,tremors|MP:0000746,weakness|MP:0000753,paralysis|MP:0000755,hindlimb paralysis|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002083,premature death|MP:0002183,gliosis|MP:0002651,abnormal sciatic nerve morphology|MP:0002757,decreased vertical activity|MP:0003354,astrocytosis|MP:0004145,abnormal muscle electrophysiology|MP:0005307,head tossing|MP:0005424,jerky movement|MP:0009849,increased vertical stereotypic behavior|MP:0011939,increased food intake|MP:0011975,neuronal cytoplasmic inclusions|MP:0012347,low sweet preference|MP:0013189,abnormal exploration in a new environment|MP:0030214,muscle fasciculation
MGI:5703955	Atp2b1<tm1.1Hiraw>	MP:0003025,increased vasoconstriction|MP:0004231,abnormal calcium ion homeostasis|MP:0004875,increased mean systemic arterial blood pressure|MP:0005378,growth/size/body region phenotype|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure
MGI:5888894	Atp2b1<tm1.1Raku>	MP:0000063,decreased bone mineral density|MP:0001265,decreased body size|MP:0002900,abnormal urine phosphate level|MP:0002986,decreased urine calcium level|MP:0009703,decreased birth body size|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011221,decreased intestinal calcium absorption|MP:0020010,decreased bone mineral density of femur|MP:0020137,decreased bone mineralization
MGI:5605735	Atp2b1<tm1b(KOMP)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0001284,absent vibrissae|MP:0002098,abnormal vibrissa morphology|MP:0002631,abnormal epididymis morphology|MP:0004738,abnormal auditory brainstem response|MP:0004931,enlarged epididymis|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011185,absent primitive endoderm|MP:0012102,absent trophectoderm|MP:0013292,embryonic lethality prior to organogenesis
MGI:3051541	Atp2b1<tm1Ges>	MP:0011091,prenatal lethality, complete penetrance
MGI:5505456	Atp2b2<Deaf11>	MP:0001489,decreased startle reflex|MP:0004362,cochlear hair cell degeneration|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5505458	Atp2b2<Deaf13>	MP:0001489,decreased startle reflex|MP:0004362,cochlear hair cell degeneration|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856799	Atp2b2<dfw>	MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0001967,deafness|MP:0002855,abnormal cochlear ganglion morphology|MP:0002857,cochlear ganglion degeneration|MP:0004231,abnormal calcium ion homeostasis|MP:0004362,cochlear hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004412,abnormal cochlear microphonics|MP:0004415,abnormal cochlear nerve compound action potential|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0004432,abnormal cochlear hair cell physiology|MP:0004438,abnormal vestibular hair cell physiology|MP:0004530,absent outer hair cell stereocilia|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004737,absent distortion product otoacoustic emissions|MP:0005386,behavior/neurological phenotype|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012490,abnormal cochlear VIII nucleus morphology|MP:0014406,increased or absent distortion product otoacoustic emission threshold|MP:0014409,decreased distortion product otoacoustic emission amplitude|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:1857396	Atp2b2<dfw-2J>	MP:0000745,tremors|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0001522,impaired swimming|MP:0001924,infertility|MP:0001961,abnormal reflex|MP:0001967,deafness|MP:0004748,increased susceptibility to age-related hearing loss|MP:0004813,absent linear vestibular evoked potential|MP:0004814,reduced linear vestibular evoked potential|MP:0005202,lethargy|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1934613	Atp2b2<dfw-3J>	MP:0000745,tremors|MP:0001516,abnormal motor coordination/balance|MP:0001967,deafness|MP:0004738,abnormal auditory brainstem response
MGI:5636635	Atp2b2<dfw-i5>	MP:0001394,circling|MP:0001405,impaired coordination|MP:0001408,stereotypic behavior|MP:0001516,abnormal motor coordination/balance|MP:0001525,impaired balance|MP:0001963,abnormal hearing physiology|MP:0001967,deafness|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0005307,head tossing|MP:0005386,behavior/neurological phenotype|MP:0011968,decreased threshold for auditory brainstem response
MGI:5554594	Atp2b2<Elfin>	MP:0000034,abnormal inner ear vestibule morphology|MP:0000043,organ of Corti degeneration|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001513,limb grasping|MP:0001525,impaired balance|MP:0002857,cochlear ganglion degeneration|MP:0004325,absent vestibular hair cells|MP:0004404,cochlear outer hair cell degeneration|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0006089,abnormal vestibular saccule morphology|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3664103	Atp2b2<jog>	MP:0000313,abnormal cell death|MP:0000745,tremors|MP:0000852,small cerebellum|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0001524,impaired limb coordination
MGI:5640789	Atp2b2<m1Btlr>	MP:0000745,tremors|MP:0001393,ataxia|MP:0001410,head bobbing|MP:0001513,limb grasping
MGI:6283636	Atp2b2<m2Btlr>	MP:0001262,decreased body weight
MGI:4355879	Atp2b2<Obv>	MP:0000043,organ of Corti degeneration|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001394,circling|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0001961,abnormal reflex|MP:0001967,deafness|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004438,abnormal vestibular hair cell physiology|MP:0004586,pillar cell degeneration|MP:0004742,abnormal vestibular system physiology|MP:0005307,head tossing|MP:0006325,impaired hearing|MP:0006358,absent pinna reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1857876	Atp2b2<tm1Ges>	MP:0000026,abnormal inner ear morphology|MP:0000034,abnormal inner ear vestibule morphology|MP:0000042,abnormal organ of Corti morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000849,abnormal cerebellum morphology|MP:0000879,increased Purkinje cell number|MP:0000890,thin cerebellar molecular layer|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0001961,abnormal reflex|MP:0001967,deafness|MP:0002978,absent otoliths|MP:0003151,absent tunnel of Corti|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004231,abnormal calcium ion homeostasis|MP:0004301,absent organ of Corti supporting cells|MP:0004312,absent pillar cells|MP:0004405,absent cochlear hair cells|MP:0004408,decreased cochlear hair cell number|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0004432,abnormal cochlear hair cell physiology|MP:0004438,abnormal vestibular hair cell physiology|MP:0004497,decreased organ of Corti supporting cell number|MP:0004597,increased susceptibility to noise-induced hearing loss|MP:0004631,abnormal auditory cortex morphology|MP:0004716,abnormal cochlear nerve morphology|MP:0004737,absent distortion product otoacoustic emissions|MP:0004738,abnormal auditory brainstem response|MP:0004740,sensorineural hearing loss|MP:0004748,increased susceptibility to age-related hearing loss|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2158375	Atp2b2<Tmy>	MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001967,deafness|MP:0004748,increased susceptibility to age-related hearing loss|MP:0004750,syndromic hearing loss|MP:0005377,hearing/vestibular/ear phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1857092	Atp2b2<wri>	MP:0000032,cochlear degeneration|MP:0000745,tremors|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0001967,deafness|MP:0002857,cochlear ganglion degeneration|MP:0002980,abnormal postural reflex|MP:0003894,abnormal Purkinje cell innervation|MP:0004329,vestibular saccular degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0006089,abnormal vestibular saccule morphology|MP:0008579,abnormal Purkinje cell differentiation|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5805216	Atp2b3<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001510,abnormal coat appearance|MP:0002075,abnormal coat/hair pigmentation|MP:0002757,decreased vertical activity|MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval|MP:0020870,decreased thigmotaxis
MGI:7425531	Atp2b4<em1(IMPC)Bay>	MP:0001925,male infertility
MGI:3051542	Atp2b4<tm1Ges>	MP:0001412,excessive scratching|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002742,enlarged submandibular lymph nodes|MP:0003026,decreased vasoconstriction
MGI:3709898	Atp2b4<tm1Ksch>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:3722875	Atp2c1<tm1Ges>	MP:0000358,abnormal cell morphology|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0002051,increased skin papilloma incidence|MP:0003277,increased esophageal papilloma incidence|MP:0003984,embryonic growth retardation|MP:0004207,increased squamous cell carcinoma incidence|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011743,abnormal Golgi apparatus morphology|MP:0012505,increased neural tube apoptosis|MP:0013199,increased head mesenchyme apoptosis|MP:0031685,abnormal rough endoplasmic reticulum morphology|MP:0031688,dilated rough endoplasmic reticulum
MGI:6156482	Atp2c2<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000208,decreased hematocrit|MP:0000702,enlarged lymph nodes|MP:0002059,abnormal seminal vesicle morphology
MGI:4839212	Atp4a<m1Btlr>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000470,abnormal stomach morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002874,decreased hemoglobin content|MP:0003135,increased erythroid progenitor cell number|MP:0003883,enlarged stomach|MP:0004151,decreased circulating iron level|MP:0005397,hematopoietic system phenotype|MP:0005505,thrombocytosis|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005637,abnormal iron homeostasis|MP:0008006,increased stomach pH|MP:0008387,hypochromic anemia|MP:0010067,increased red blood cell distribution width|MP:0010768,mortality/aging|MP:0010787,gastric cyst|MP:0011285,increased circulating erythropoietin level|MP:0031084,decreased erythrocyte osmotic fragility
MGI:6118153	Atp4a<tm1.1Ocalv>	MP:0000470,abnormal stomach morphology|MP:0001577,anemia|MP:0002006,neoplasm|MP:0003892,abnormal gastric gland morphology|MP:0004139,abnormal gastric parietal cell morphology|MP:0004731,increased circulating gastrin level|MP:0005213,gastric metaplasia|MP:0008003,achlorhydria|MP:0008006,increased stomach pH|MP:0010783,abnormal stomach wall morphology|MP:0010787,gastric cyst|MP:0010792,abnormal stomach mucosa morphology|MP:0011891,decreased circulating ferritin level|MP:0013578,abnormal stomach glandular region morphology
MGI:2158246	Atp4a<tm1Ges>	MP:0003892,abnormal gastric gland morphology|MP:0004139,abnormal gastric parietal cell morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0004731,increased circulating gastrin level|MP:0005213,gastric metaplasia|MP:0008003,achlorhydria|MP:0010803,abnormal stomach enteroendocrine cell morphology|MP:0013566,dilated gastric gland
MGI:2158258	Atp4b<tm1Ird>	MP:0003892,abnormal gastric gland morphology|MP:0004139,abnormal gastric parietal cell morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0004731,increased circulating gastrin level|MP:0005211,increased stomach mucosa thickness|MP:0008006,increased stomach pH|MP:0010792,abnormal stomach mucosa morphology
MGI:4432141	Atp5f1a<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0003961,decreased lean body mass
MGI:7431358	Atp5f1b<em1(IMPC)Ccpcz>	MP:0000186,decreased circulating HDL cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0005553,increased circulating creatinine level
MGI:5513743	Atp5f1b<tm1b(EUCOMM)Hmgu>	MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6257672	Atp5f1d<em1(IMPC)Bay>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011100,preweaning lethality, complete penetrance|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:5636990	Atp5f1e<tm1b(EUCOMM)Wtsi>	MP:0010067,increased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6792081	Atp5if1<em1Jpy>	MP:0000222,decreased neutrophil cell number|MP:0000479,abnormal enterocyte morphology|MP:0000495,abnormal colon morphology|MP:0001402,decreased locomotor activity|MP:0002981,increased liver weight|MP:0004890,decreased energy expenditure|MP:0005292,improved glucose tolerance|MP:0005331,insulin resistance|MP:0005397,hematopoietic system phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0009288,increased epididymal fat pad weight|MP:0011631,decreased mitochondrial size|MP:0011637,abnormal mitochondrial matrix morphology|MP:0013299,decreased susceptibility to colitis induced morbidity/mortality|MP:0014046,abnormal mitophagy|MP:0014234,decreased enterocyte apoptosis
MGI:4433166	Atp5if1<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0002942,decreased circulating alanine transaminase level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0010025,decreased total body fat amount
MGI:6358582	Atp5if1<tm1Ksuj>	MP:0002972,abnormal cardiac muscle contractility|MP:0004486,decreased response of heart to induced stress|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype
MGI:5588276	Atp5mc2<tm2b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness|MP:0013279,increased fasting circulating glucose level
MGI:6257697	Atp5mc3<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity
MGI:5636982	Atp5mg<tm1b(EUCOMM)Hmgu>	MP:0000274,enlarged heart|MP:0000691,enlarged spleen|MP:0001406,abnormal gait|MP:0002965,increased circulating serum albumin level|MP:0005012,decreased eosinophil cell number|MP:0005561,increased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0011100,preweaning lethality, complete penetrance
MGI:5692650	Atp5mk<tm1b(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0001406,abnormal gait|MP:0001566,increased circulating phosphate level|MP:0002590,increased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0008806,increased circulating amylase level
MGI:5636929	Atp5pb<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5700038	Atp5po<tm1.1(KOMP)Vlcg>	MP:0005292,improved glucose tolerance|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:4365734	Atp6ap1<tm1Gjmm>	MP:0011091,prenatal lethality, complete penetrance
MGI:5638540	Atp6ap1<tm1Mhzh>	MP:0001672,abnormal embryo development|MP:0002081,perinatal lethality|MP:0002152,abnormal brain morphology|MP:0003224,neuron degeneration|MP:0011380,enlarged brain ventricles
MGI:7490116	Atp6ap2<em1Nira>	MP:0001262,decreased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0001925,male infertility|MP:0003402,decreased liver weight|MP:0003915,increased heart left ventricle weight|MP:0003918,decreased kidney weight|MP:0003960,increased lean body mass|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006376,decreased circulating angiotensinogen level|MP:0009289,decreased epididymal fat pad weight|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0011951,increased cardiac stroke volume|MP:0012046,decreased susceptibility to hypertension|MP:0031358,decreased urine output
MGI:4836029	Atp6ap2<tm1.1Aich>	MP:0000266,abnormal heart morphology|MP:0000521,abnormal kidney cortex morphology|MP:0000522,kidney cortex cyst|MP:0000527,abnormal kidney development|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0001325,abnormal retina morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001762,polyuria|MP:0002871,albuminuria|MP:0002988,decreased urine osmolality|MP:0002989,small kidney|MP:0003446,renal hypoplasia|MP:0003675,kidney cyst|MP:0003727,abnormal retina layer morphology|MP:0003881,abnormal nephron morphology|MP:0003918,decreased kidney weight|MP:0004754,abnormal kidney collecting duct morphology|MP:0004857,abnormal heart weight|MP:0004860,dilated kidney collecting duct|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005553,increased circulating creatinine level|MP:0005598,decreased heart ventricle muscle contractility|MP:0006032,abnormal ureteric bud morphology|MP:0008140,podocyte foot process effacement|MP:0008450,retina photoreceptor degeneration|MP:0009349,increased urine pH|MP:0010080,abnormal hepatocyte physiology|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011290,decreased nephron number|MP:0011307,kidney medulla cyst|MP:0011334,abnormal nephrogenic zone morphology|MP:0011457,abnormal metanephric ureteric bud development|MP:0011965,decreased total retina thickness|MP:0012024,abnormal nephron morphogenesis|MP:0012025,abnormal comma shaped body morphology|MP:0012026,abnormal S-shaped body morphology|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0030940,impaired autophagy
MGI:5776594	Atp6ap2<tm1.1Ics>	MP:0002705,dilated renal tubule|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0005178,increased circulating cholesterol level|MP:0005326,abnormal podocyte morphology|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008140,podocyte foot process effacement|MP:0009640,abnormal renal tubule epithelium morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011282,increased podocyte apoptosis|MP:0011351,absent proximal convoluted tubule brush border|MP:0011402,renal cast|MP:0020378,abnormal cell cytoskeleton morphology|MP:0030940,impaired autophagy
MGI:6711345	Atp6v0a1<em1Hisa>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:6711346	Atp6v0a1<em2Hisa>	MP:0000111,cleft palate|MP:0000774,decreased brain size|MP:0000812,abnormal dentate gyrus morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001523,impaired righting response|MP:0003203,increased neuron apoptosis|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004769,abnormal synaptic vesicle morphology|MP:0004998,decreased CNS synapse formation|MP:0005058,abnormal lysosome morphology|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0009546,absent gastric milk in neonates|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0009974,decreased cerebral cortex pyramidal cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0020357,abnormal excitatory synapse morphology|MP:0030940,impaired autophagy
MGI:6711347	Atp6v0a1<em3Hisa>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:5513745	Atp6v0a1<tm1b(EUCOMM)Hmgu>	MP:0005627,increased circulating potassium level|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6303630	Atp6v0a2<tm1Kdb>	MP:0000628,abnormal mammary gland development|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001272,increased metastatic potential|MP:0001882,abnormal lactation|MP:0002021,increased incidence of induced tumors|MP:0002436,abnormal CD8-positive, alpha-beta cytotoxic T cell morphology|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0009503,abnormal mammary gland duct morphology|MP:0009504,abnormal mammary gland epithelium morphology|MP:0010308,decreased tumor latency|MP:0012075,impaired mammary gland growth during pregnancy|MP:0012765,decreased alpha-beta T cell number|MP:0013782,abnormal mammary duct terminal end bud morphology
MGI:5563513	Atp6v0a4<m1Anu>	MP:0002083,premature death
MGI:5441584	Atp6v0a4<tm1.1Fekf>	MP:0000026,abnormal inner ear morphology|MP:0000063,decreased bone mineral density|MP:0000519,hydronephrosis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001394,circling|MP:0001426,polydipsia|MP:0001429,dehydration|MP:0001516,abnormal motor coordination/balance|MP:0001762,polyuria|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002083,premature death|MP:0002703,abnormal renal tubule morphology|MP:0002978,absent otoliths|MP:0003019,increased circulating chloride level|MP:0003031,acidosis|MP:0003197,nephrocalcinosis|MP:0004119,hypokalemia|MP:0004410,absent endocochlear potential|MP:0005191,head tilt|MP:0005376,homeostasis/metabolism phenotype|MP:0005565,increased blood urea nitrogen level|MP:0006012,dilated endolymphatic duct|MP:0006325,impaired hearing|MP:0006358,absent pinna reflex|MP:0008309,dilated scala media|MP:0008544,impaired olfaction|MP:0008997,increased blood osmolality|MP:0009350,decreased urine pH|MP:0009643,abnormal urine homeostasis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011625,cystolithiasis|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5051197	Atp6v0a4<tm1(KOMP)Vlcg>	MP:0011100,preweaning lethality, complete penetrance
MGI:6402781	Atp6v0b<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002608,increased hematocrit|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0004924,abnormal behavior|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:1931846	Atp6v0c<tm1Hka>	MP:0002085,abnormal embryonic tissue morphology|MP:0002718,abnormal inner cell mass morphology|MP:0003406,failure of zygotic cell division|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:7616526	Atp6v0d1<em1Nju>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001544,abnormal cardiovascular system physiology|MP:0001554,increased circulating free fatty acids level|MP:0001625,cardiac hypertrophy|MP:0001780,decreased brown adipose tissue amount|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002981,increased liver weight|MP:0003141,cardiac fibrosis|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005178,increased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005331,insulin resistance|MP:0005343,increased circulating aspartate transaminase level|MP:0005378,growth/size/body region phenotype|MP:0005668,decreased circulating leptin level|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0010027,increased liver cholesterol level|MP:0010359,increased liver free fatty acids level|MP:0011174,lipodystrophy|MP:0011703,increased fibroblast proliferation|MP:0011925,abnormal heart echocardiography feature|MP:0030968,decreased circulating adiponectin level
MGI:5605751	Atp6v0d1<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0002059,abnormal seminal vesicle morphology|MP:0002135,abnormal kidney morphology|MP:0002764,short tibia|MP:0005016,decreased lymphocyte cell number|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3698147	Atp6v0d2<tm1Ywc>	MP:0000067,osteopetrosis|MP:0004982,abnormal osteoclast morphology|MP:0004993,decreased bone resorption|MP:0008396,abnormal osteoclast differentiation|MP:0031073,decreased circulating type I collagen C-terminal telopeptide level
MGI:7512902	Atp6v0e2<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance
MGI:6279916	Atp6v1a<em1(IMPC)Bay>	MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:5569034	Atp6v1b1<tm1.1(KOMP)Vlcg>	MP:0002941,increased circulating alanine transaminase level
MGI:2673510	Atp6v1b1<tm1Choo>	MP:0001983,abnormal olfactory system physiology|MP:0002985,abnormal urine calcium level|MP:0002988,decreased urine osmolality|MP:0003017,decreased circulating bicarbonate level|MP:0003031,acidosis|MP:0003462,abnormal response to novel odor|MP:0004043,abnormal pH regulation|MP:0005377,hearing/vestibular/ear phenotype|MP:0005390,skeleton phenotype|MP:0009349,increased urine pH|MP:0011417,abnormal renal transport
MGI:5469980	Atp6v1b1<vtx>	MP:0000031,abnormal cochlea morphology|MP:0000035,abnormal membranous labyrinth morphology|MP:0000042,abnormal organ of Corti morphology|MP:0001395,bidirectional circling|MP:0002986,decreased urine calcium level|MP:0003144,decreased otolith number|MP:0004287,abnormal spiral limbus morphology|MP:0004292,abnormal spiral ligament fibrocyte morphology|MP:0004293,abnormal type I spiral ligament fibrocytes|MP:0004295,abnormal type III spiral ligament fibrocytes|MP:0004402,decreased cochlear outer hair cell number|MP:0004411,decreased endocochlear potential|MP:0004862,small scala tympani|MP:0004863,thin spiral ligament|MP:0005191,head tilt|MP:0005377,hearing/vestibular/ear phenotype|MP:0006012,dilated endolymphatic duct|MP:0006021,abnormal Reissner membrane morphology|MP:0006403,abnormal cochlear endolymph ionic homeostasis|MP:0008309,dilated scala media|MP:0009349,increased urine pH|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:7567698	Atp6v1b2<em1Pcamp>	MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003631,nervous system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0009358,environmentally induced seizures|MP:0009701,abnormal birth body size|MP:0010768,mortality/aging|MP:0020870,decreased thigmotaxis|MP:0031391,increased locomotor activity
MGI:5513747	Atp6v1b2<tm1b(KOMP)Wtsi>	MP:0002217,small lymph nodes|MP:0002591,decreased mean corpuscular volume|MP:0002768,small adrenal glands|MP:0002874,decreased hemoglobin content|MP:0002968,increased circulating alkaline phosphatase level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6358819	Atp6v1b2<tm1Yoyu>	MP:0004000,impaired passive avoidance behavior|MP:0005377,hearing/vestibular/ear phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008489,slow postnatal weight gain|MP:0009358,environmentally induced seizures|MP:0014365,impaired short-term object recognition memory
MGI:5766173	Atp6v1c1<tm1b(NCOM)Mfgc>	MP:0000218,increased leukocyte cell number|MP:0001417,decreased exploration in new environment|MP:0002590,increased mean corpuscular volume|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5513749	Atp6v1d<tm1b(EUCOMM)Hmgu>	MP:0001402,decreased locomotor activity|MP:0003928,increased heart rate variability|MP:0003960,increased lean body mass|MP:0004122,abnormal sinus arrhythmia|MP:0005385,cardiovascular system phenotype|MP:0005505,thrombocytosis|MP:0008935,decreased mean platelet volume|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6148313	Atp6v1e1<em1(IMPC)Rbrc>	MP:0011100,preweaning lethality, complete penetrance
MGI:6362956	Atp6v1f<em1(IMPC)J>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6148314	Atp6v1g2<em1(IMPC)Rbrc>	MP:0001399,hyperactivity
MGI:5649304	Atp6v1g2<tm1.1Ywd>	MP:0010768,mortality/aging
MGI:6257747	Atp6v1h<em1(IMPC)Bay>	MP:0002792,abnormal retina vasculature morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5828914	Atp6v1h<em1Xhd>	MP:0000066,osteoporosis|MP:0000164,abnormal cartilage development|MP:0000194,increased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0001541,abnormal osteoclast physiology|MP:0002968,increased circulating alkaline phosphatase level|MP:0004016,decreased bone mass|MP:0004986,abnormal osteoblast morphology|MP:0004989,decreased osteoblast cell number|MP:0005397,hematopoietic system phenotype|MP:0008396,abnormal osteoclast differentiation|MP:0009346,decreased trabecular bone thickness|MP:0010876,decreased bone volume|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011585,decreased alkaline phosphatase activity|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization
MGI:6195300	Atp7a<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation
MGI:1856096	Atp7a<Mo>	MP:0001274,curly vibrissae|MP:0001935,decreased litter size|MP:0002075,abnormal coat/hair pigmentation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1856322	Atp7a<Mo-10H>	MP:0001274,curly vibrissae|MP:0001405,impaired coordination|MP:0005171,absent coat pigmentation|MP:0005366,variegated coat color|MP:0011085,postnatal lethality, complete penetrance
MGI:1856323	Atp7a<Mo-11H>	MP:0005366,variegated coat color|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance
MGI:2387948	Atp7a<Mo-12DFiOD>	MP:0011091,prenatal lethality, complete penetrance
MGI:1856324	Atp7a<Mo-12H>	MP:0001274,curly vibrissae|MP:0001405,impaired coordination|MP:0001525,impaired balance|MP:0002115,abnormal limb bone morphology|MP:0005366,variegated coat color|MP:0011100,preweaning lethality, complete penetrance
MGI:1856325	Atp7a<Mo-13H>	MP:0011085,postnatal lethality, complete penetrance
MGI:1858103	Atp7a<Mo-14H>	MP:0002080,prenatal lethality
MGI:2387454	Atp7a<Mo-16H>	MP:0005366,variegated coat color
MGI:2387458	Atp7a<Mo-17H>	MP:0005366,variegated coat color
MGI:5304930	Atp7a<Mo-18H>	MP:0000421,mottled coat|MP:0001274,curly vibrissae|MP:0001284,absent vibrissae|MP:0002080,prenatal lethality
MGI:2387944	Atp7a<Mo-1Pub>	MP:0011091,prenatal lethality, complete penetrance
MGI:2387947	Atp7a<Mo-2Acre>	MP:0011085,postnatal lethality, complete penetrance
MGI:3806010	Atp7a<Mo-2Btlr>	MP:0001186,pigmentation phenotype|MP:0005171,absent coat pigmentation|MP:0010389,mosaic coat color|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4366761	Atp7a<Mo-3Btlr>	MP:0002075,abnormal coat/hair pigmentation|MP:0005363,decreased susceptibility to prion infection|MP:0010771,integument phenotype|MP:0011215,decreased brain copper level
MGI:2387843	Atp7a<Mo-4R>	MP:0000421,mottled coat|MP:0001278,kinked vibrissae|MP:0011091,prenatal lethality, complete penetrance
MGI:1856320	Atp7a<Mo-5J>	MP:0001510,abnormal coat appearance|MP:0002075,abnormal coat/hair pigmentation|MP:0010389,mosaic coat color|MP:0011100,preweaning lethality, complete penetrance
MGI:2387952	Atp7a<Mo-7ENURF>	MP:0011091,prenatal lethality, complete penetrance
MGI:2387950	Atp7a<Mo-7R>	MP:0011091,prenatal lethality, complete penetrance
MGI:1856321	Atp7a<Mo-8J>	MP:0000371,diluted coat color|MP:0000372,irregular coat pigmentation|MP:0000755,hindlimb paralysis|MP:0001279,wavy vibrissae|MP:0002075,abnormal coat/hair pigmentation|MP:0002082,postnatal lethality|MP:0010389,mosaic coat color
MGI:2387949	Atp7a<Mo-8R>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857583	Atp7a<Mo-9J>	MP:0000421,mottled coat|MP:0001274,curly vibrissae|MP:0002075,abnormal coat/hair pigmentation|MP:0011091,prenatal lethality, complete penetrance
MGI:1856097	Atp7a<Mo-blo>	MP:0000163,abnormal cartilage morphology|MP:0000272,abnormal aorta morphology|MP:0000358,abnormal cell morphology|MP:0000371,diluted coat color|MP:0000556,abnormal hindlimb morphology|MP:0000745,tremors|MP:0001265,decreased body size|MP:0001274,curly vibrissae|MP:0001402,decreased locomotor activity|MP:0001505,hunched posture|MP:0001765,abnormal ion homeostasis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001951,abnormal breathing pattern|MP:0002083,premature death|MP:0002133,abnormal respiratory system physiology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002832,coarse hair|MP:0003067,decreased liver copper level|MP:0003211,abnormal aorta elastic fiber morphology|MP:0003279,aneurysm|MP:0003415,priapism|MP:0003560,osteoarthritis|MP:0003674,oxidative stress|MP:0003907,decreased aorta elastin content|MP:0003951,abnormal copper homeostasis|MP:0003964,abnormal noradrenaline level|MP:0004882,enlarged lung|MP:0005150,cachexia|MP:0005202,lethargy|MP:0005243,hemothorax|MP:0005389,reproductive system phenotype|MP:0005435,hemoperitoneum|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006278,aortic aneurysm|MP:0010243,increased kidney copper level|MP:0010247,increased intestine copper level|MP:0010470,dilated ascending aorta|MP:0010574,dilated aorta|MP:0010768,mortality/aging|MP:0010856,dilated respiratory conducting tube|MP:0010895,increased lung compliance|MP:0010900,abnormal pulmonary interalveolar septum morphology|MP:0010908,dilated pulmonary alveolar duct|MP:0010937,increased total lung capacity|MP:0011215,decreased brain copper level|MP:0031200,increased aortic weight
MGI:1856098	Atp7a<Mo-br>	MP:0003067,decreased liver copper level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006349,decreased circulating copper level|MP:0010247,increased intestine copper level|MP:0011215,decreased brain copper level|MP:0012574,decreased noradrenaline level
MGI:1856103	Atp7a<Mo-brJ>	MP:0000421,mottled coat|MP:0000745,tremors|MP:0001406,abnormal gait|MP:0002075,abnormal coat/hair pigmentation|MP:0002082,postnatal lethality|MP:0003067,decreased liver copper level|MP:0005376,homeostasis/metabolism phenotype|MP:0010247,increased intestine copper level
MGI:3777914	Atp7a<Mo-Btlr>	MP:0010389,mosaic coat color|MP:0011089,perinatal lethality, complete penetrance|MP:0011091,prenatal lethality, complete penetrance
MGI:2387450	Atp7a<Mo-ca>	MP:0001274,curly vibrissae|MP:0011091,prenatal lethality, complete penetrance
MGI:1856099	Atp7a<Mo-dp>	MP:0000150,abnormal rib morphology|MP:0000576,clubfoot|MP:0001274,curly vibrissae|MP:0002115,abnormal limb bone morphology|MP:0004508,abnormal pectoral girdle bone morphology|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004676,wide ribs|MP:0005366,variegated coat color|MP:0005508,abnormal skeleton morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006208,lethality throughout fetal growth and development|MP:0006278,aortic aneurysm|MP:0011089,perinatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011215,decreased brain copper level|MP:0012574,decreased noradrenaline level
MGI:2447843	Atp7a<Mo-dp2>	MP:0000137,abnormal vertebrae morphology|MP:0000410,waved hair|MP:0000421,mottled coat|MP:0000572,abnormal autopod morphology|MP:0001274,curly vibrissae|MP:0001524,impaired limb coordination|MP:0001722,pale yolk sac|MP:0002074,abnormal hair texture|MP:0002075,abnormal coat/hair pigmentation|MP:0002082,postnatal lethality|MP:0003198,calcified tendon|MP:0005508,abnormal skeleton morphology|MP:0008731,abnormal hair shaft melanin granule morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1856466	Atp7a<Mo-ml>	MP:0000489,abnormal large intestine morphology|MP:0001274,curly vibrissae|MP:0001393,ataxia|MP:0001731,abnormal postnatal growth|MP:0002075,abnormal coat/hair pigmentation|MP:0002826,tonic seizures|MP:0003067,decreased liver copper level|MP:0004953,decreased spleen weight|MP:0005150,cachexia|MP:0005171,absent coat pigmentation|MP:0005376,homeostasis/metabolism phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0010016,variable depigmentation|MP:0010243,increased kidney copper level|MP:0010247,increased intestine copper level|MP:0010769,abnormal survival|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011215,decreased brain copper level|MP:0011218,decreased brainstem copper level|MP:0014540,decreased copper level
MGI:1856100	Atp7a<Mo-ms>	MP:0000367,abnormal coat/ hair morphology|MP:0000371,diluted coat color|MP:0000400,abnormal awl hair morphology|MP:0000402,abnormal zigzag hair morphology|MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0001263,weight loss|MP:0001274,curly vibrissae|MP:0001393,ataxia|MP:0002098,abnormal vibrissa morphology|MP:0002703,abnormal renal tubule morphology|MP:0003067,decreased liver copper level|MP:0003203,increased neuron apoptosis|MP:0003918,decreased kidney weight|MP:0003951,abnormal copper homeostasis|MP:0003952,abnormal copper level|MP:0004505,decreased renal glomerulus number|MP:0010243,increased kidney copper level|MP:0010247,increased intestine copper level|MP:0011085,postnatal lethality, complete penetrance|MP:0011215,decreased brain copper level|MP:0012661,decreased circulating ceruloplasmin level|MP:0031204,hindlimb paresis
MGI:1856479	Atp7a<Mo-N>	MP:0001274,curly vibrissae|MP:0005366,variegated coat color|MP:0011091,prenatal lethality, complete penetrance
MGI:1856104	Atp7a<Mo-pew>	MP:0000371,diluted coat color|MP:0000372,irregular coat pigmentation|MP:0000421,mottled coat|MP:0002075,abnormal coat/hair pigmentation|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:1856105	Atp7a<Mo-pew2J>	MP:0000371,diluted coat color|MP:0000372,irregular coat pigmentation|MP:0000421,mottled coat|MP:0002075,abnormal coat/hair pigmentation|MP:0010768,mortality/aging
MGI:3037036	Atp7a<Mo-pew3J>	MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death
MGI:2387468	Atp7a<Mo-spot>	MP:0005366,variegated coat color
MGI:1856101	Atp7a<Mo-to>	MP:0001279,wavy vibrissae|MP:0002074,abnormal hair texture|MP:0002080,prenatal lethality|MP:0002115,abnormal limb bone morphology|MP:0003809,abnormal hair shaft morphology|MP:0005366,variegated coat color|MP:0006278,aortic aneurysm|MP:0010247,increased intestine copper level
MGI:3588774	Atp7a<Mo-Tohm>	MP:0000421,mottled coat|MP:0000788,abnormal cerebral cortex morphology|MP:0000815,abnormal Ammon gyrus morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001732,postnatal growth retardation|MP:0001914,hemorrhage|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003211,abnormal aorta elastic fiber morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0004076,abnormal vitelline vascular remodeling|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011215,decreased brain copper level|MP:0014178,increased brain apoptosis|MP:0014539,increased copper level
MGI:1856102	Atp7a<Mo-vbr>	MP:0000272,abnormal aorta morphology|MP:0001191,abnormal skin condition|MP:0001925,male infertility|MP:0002075,abnormal coat/hair pigmentation|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0003089,decreased skin tensile strength|MP:0003211,abnormal aorta elastic fiber morphology|MP:0004043,abnormal pH regulation|MP:0005376,homeostasis/metabolism phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006036,abnormal mitochondrial physiology|MP:0006278,aortic aneurysm|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0010062,decreased creatine level|MP:0020308,decreased creatine kinase activity|MP:0031200,increased aortic weight
MGI:1858104	Atp7a<Mo-Xm>	MP:0011091,prenatal lethality, complete penetrance
MGI:5447640	Atp7a<tm1.1Mjp>	MP:0000938,motor neuron degeneration|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001274,curly vibrissae|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002269,muscular atrophy|MP:0002861,abnormal tail bud morphology|MP:0003717,pallor|MP:0003952,abnormal copper level|MP:0004819,decreased skeletal muscle mass|MP:0005335,abnormal gonadal fat pad morphology|MP:0005408,hypopigmentation|MP:0009901,abnormal frontonasal prominence morphology|MP:0010053,decreased grip strength|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6393654	Atp7a<tm1.2Mlke>	MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003631,nervous system phenotype|MP:0003952,abnormal copper level|MP:0005386,behavior/neurological phenotype|MP:0005621,abnormal cell physiology|MP:0009401,increased skeletal muscle fiber diameter|MP:0011214,increased brain copper level
MGI:6113858	Atp7b<m1Btlr>	MP:0001569,abnormal circulating bilirubin level
MGI:2158253	Atp7b<tm1Tcg>	MP:0000598,abnormal liver morphology|MP:0000745,tremors|MP:0001392,abnormal locomotor behavior|MP:0001393,ataxia|MP:0001732,postnatal growth retardation|MP:0001881,abnormal mammary gland physiology|MP:0003046,liver cirrhosis|MP:0003065,abnormal liver copper level|MP:0003952,abnormal copper level|MP:0005370,liver/biliary system phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1856220	Atp7b<tx>	MP:0000371,diluted coat color|MP:0000607,abnormal hepatocyte morphology|MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001274,curly vibrissae|MP:0001393,ataxia|MP:0001511,disheveled coat|MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0002082,postnatal lethality|MP:0002106,abnormal muscle physiology|MP:0003046,liver cirrhosis|MP:0003066,increased liver copper level|MP:0003067,decreased liver copper level|MP:0003718,maternal effect|MP:0003952,abnormal copper level|MP:0005379,endocrine/exocrine gland phenotype|MP:0005408,hypopigmentation|MP:0006349,decreased circulating copper level|MP:0006350,increased circulating copper level|MP:0009618,increased brain zinc level|MP:0010243,increased kidney copper level|MP:0011085,postnatal lethality, complete penetrance|MP:0011214,increased brain copper level|MP:0014549,increased zinc level
MGI:1856221	Atp7b<tx-J>	MP:0000371,diluted coat color|MP:0000598,abnormal liver morphology|MP:0000794,abnormal parietal lobe morphology|MP:0000798,abnormal frontal lobe morphology|MP:0000804,abnormal occipital lobe morphology|MP:0001274,curly vibrissae|MP:0002152,abnormal brain morphology|MP:0003046,liver cirrhosis|MP:0003224,neuron degeneration|MP:0003718,maternal effect|MP:0005011,increased eosinophil cell number|MP:0008540,abnormal cerebral hemisphere morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011214,increased brain copper level
MGI:4434463	Atp8a1<tm1a(EUCOMM)Wtsi>	MP:0001260,increased body weight|MP:0002875,decreased erythrocyte cell number|MP:0005565,increased blood urea nitrogen level|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:3663343	Atp8a1<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:2670333	Atp8a2<agil>	MP:0000920,abnormal myelination|MP:0001393,ataxia|MP:0001732,postnatal growth retardation|MP:0003225,axonal dystrophy|MP:0008027,abnormal spinal cord white matter morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:3805719	Atp8a2<agil-2J>	MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0003225,axonal dystrophy|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0008025,brain vacuoles|MP:0008027,abnormal spinal cord white matter morphology
MGI:4837728	Atp8a2<agil-3J>	MP:0000479,abnormal enterocyte morphology|MP:0001393,ataxia|MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality|MP:0003225,axonal dystrophy|MP:0008027,abnormal spinal cord white matter morphology|MP:0009148,pancreas necrosis
MGI:6273815	Atp8a2<em1(IMPC)J>	MP:0005559,increased circulating glucose level
MGI:5588356	Atp8a2<tm1Rsmy>	MP:0001265,decreased body size|MP:0001327,decreased retina photoreceptor cell number|MP:0001513,limb grasping|MP:0002083,premature death|MP:0003491,abnormal voluntary movement|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005391,vision/eye phenotype|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment
MGI:1856271	Atp8a2<wl>	MP:0000189,hypoglycemia|MP:0000745,tremors|MP:0000921,demyelination|MP:0001262,decreased body weight|MP:0001327,decreased retina photoreceptor cell number|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001489,decreased startle reflex|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0001524,impaired limb coordination|MP:0001961,abnormal reflex|MP:0002857,cochlear ganglion degeneration|MP:0003631,nervous system phenotype|MP:0005311,abnormal circulating amino acid level|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006219,optic nerve degeneration|MP:0008587,short photoreceptor outer segment|MP:0011083,lethality at weaning, complete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013722,abnormal circulating tyrosine level|MP:0030670,increased circulating phenylalanine level
MGI:1856272	Atp8a2<wl-2J>	MP:0001516,abnormal motor coordination/balance|MP:0001961,abnormal reflex|MP:0011100,preweaning lethality, complete penetrance
MGI:1856413	Atp8a2<wl-3J>	MP:0000921,demyelination|MP:0001393,ataxia|MP:0011084,lethality at weaning, incomplete penetrance
MGI:1856273	Atp8a2<wl-vmd>	MP:0000745,tremors|MP:0000938,motor neuron degeneration|MP:0001265,decreased body size|MP:0001431,abnormal eating behavior|MP:0001486,abnormal startle reflex|MP:0001505,hunched posture|MP:0001511,disheveled coat|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002883,chromatolysis|MP:0003225,axonal dystrophy|MP:0005150,cachexia|MP:0008587,short photoreceptor outer segment|MP:0014333,short retina cone cell outer segment
MGI:6156424	Atp8b1<em1(IMPC)Tcp>	MP:0000063,decreased bone mineral density|MP:0000186,decreased circulating HDL cholesterol level|MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0001157,small seminal vesicle|MP:0001293,anophthalmia|MP:0001314,cornea opacity|MP:0001325,abnormal retina morphology|MP:0001417,decreased exploration in new environment|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0001944,abnormal pancreas morphology|MP:0002092,abnormal eye morphology|MP:0002591,decreased mean corpuscular volume|MP:0002631,abnormal epididymis morphology|MP:0002644,decreased circulating triglyceride level|MP:0002792,abnormal retina vasculature morphology|MP:0002834,decreased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003068,enlarged kidney|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0004357,long tibia|MP:0004738,abnormal auditory brainstem response|MP:0005292,improved glucose tolerance|MP:0005333,decreased heart rate|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005560,decreased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005627,increased circulating potassium level|MP:0008528,polycystic kidney|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010053,decreased grip strength|MP:0010097,abnormal retina blood vessel morphology|MP:0010124,decreased bone mineral content|MP:0010506,prolonged RR interval|MP:0011874,enlarged urinary bladder|MP:0013278,decreased fasting circulating glucose level
MGI:3043815	Atp8b1<tm1Nbf>	MP:0000031,abnormal cochlea morphology|MP:0000043,organ of Corti degeneration|MP:0000599,enlarged liver|MP:0000609,abnormal liver physiology|MP:0001732,postnatal growth retardation|MP:0002855,abnormal cochlear ganglion morphology|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004465,degeneration of organ of Corti supporting cells|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004772,abnormal bile secretion|MP:0004774,abnormal bile salt level|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0010180,increased susceptibility to weight loss|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4419232	Atp8b2<tm1a(KOMP)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005419,decreased circulating serum albumin level|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7425532	Atp8b3<em1(IMPC)Hmgu>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3039498	Atp8b3<tm1Gar>	MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0004542,impaired acrosome reaction|MP:0005410,abnormal fertilization
MGI:7425533	Atp8b4<em1(IMPC)Bay>	MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0010123,increased bone mineral content
MGI:7641834	Atp8b5<em1Kzt>	MP:0005389,reproductive system phenotype
MGI:7580494	Atp9a<em1Bcgen>	MP:0001399,hyperactivity|MP:0001924,infertility|MP:0002083,premature death|MP:0002206,abnormal CNS synaptic transmission|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008414,abnormal spatial reference memory|MP:0008415,abnormal neurite morphology|MP:0010053,decreased grip strength|MP:0012307,impaired spatial learning|MP:0020508,decreased dendritic spine density|MP:0021090,abnormal dendrite arborization pattern
MGI:5704515	Atp9a<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0010097,abnormal retina blood vessel morphology
MGI:6120511	Atp9b<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation
MGI:7792241	Atpaf1<em1Cya>	MP:0001265,decreased body size|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003674,oxidative stress|MP:0004564,increased myocardial fiber size|MP:0005386,behavior/neurological phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006036,abnormal mitochondrial physiology|MP:0006138,congestive heart failure|MP:0008489,slow postnatal weight gain|MP:0010954,abnormal cellular respiration|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0010959,abnormal oxidative phosphorylation|MP:0011631,decreased mitochondrial size|MP:0011632,dilated mitochondrion|MP:0011635,abnormal mitochondrial crista morphology|MP:0013405,increased circulating lactate level|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014777,decreased heart enzyme/coenzyme level|MP:0030940,impaired autophagy|MP:0031633,decreased heart left ventricle muscle contractility|MP:0031645,increased myocardial fiber apoptosis
MGI:7792242	Atpaf2<em1Cya>	MP:0011091,prenatal lethality, complete penetrance
MGI:4362266	Atpaf2<tm1a(KOMP)Wtsi>	MP:0000137,abnormal vertebrae morphology|MP:0000455,abnormal maxilla morphology|MP:0001262,decreased body weight|MP:0003345,decreased rib number|MP:0004648,decreased thoracic vertebrae number|MP:0011100,preweaning lethality, complete penetrance
MGI:6278547	Atpsckmt<em1(IMPC)J>	MP:0001973,increased thermal nociceptive threshold|MP:0002272,abnormal nervous system electrophysiology|MP:0002736,abnormal nociception after inflammation|MP:0005386,behavior/neurological phenotype|MP:0020879,abnormal calcium level|MP:0020955,increased mechanical nociceptive threshold
MGI:4146072	Atraid<Gt(OST23679)Lex>	MP:0001304,cataract
MGI:6501143	Atrip<tm1.1Pof>	MP:0000433,microcephaly|MP:0000851,cerebellum hypoplasia|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0002840,abnormal lens fiber morphology|MP:0003078,aphakia|MP:0003237,abnormal lens epithelium morphology|MP:0003727,abnormal retina layer morphology|MP:0004046,abnormal mitosis|MP:0005253,abnormal eye physiology|MP:0005391,vision/eye phenotype|MP:0005621,abnormal cell physiology|MP:0006071,abnormal retina progenitor cell morphology|MP:0006149,decreased visual acuity|MP:0008450,retina photoreceptor degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0008794,increased lens epithelium apoptosis|MP:0009674,decreased birth weight|MP:0010768,mortality/aging|MP:0011100,preweaning lethality, complete penetrance|MP:0020596,decreased cerebral cortex total cell area|MP:0020621,decreased dorsal striatum total cell area|MP:0030004,hippocampus hypoplasia|MP:0030005,increased retina apoptosis
MGI:5473356	Atrip<tm1b(KOMP)Wtsi>	MP:0003019,increased circulating chloride level|MP:0005633,increased circulating sodium level|MP:0011100,preweaning lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level|MP:0013292,embryonic lethality prior to organogenesis
MGI:2156204	Atrn<Gt(PST112)Byg>	MP:0000920,abnormal myelination|MP:0005409,darkened coat color|MP:0008025,brain vacuoles
MGI:7425534	Atrnl1<em1(IMPC)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:3773080	Atrnl1<tm1Gsb>	MP:0003631,nervous system phenotype|MP:0010771,integument phenotype
MGI:1856081	Atrn<mg>	MP:0001732,postnatal growth retardation|MP:0002075,abnormal coat/hair pigmentation|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005409,darkened coat color|MP:0008025,brain vacuoles|MP:0010025,decreased total body fat amount|MP:0031391,increased locomotor activity
MGI:1856082	Atrn<mg-3J>	MP:0000745,tremors|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002075,abnormal coat/hair pigmentation|MP:0002106,abnormal muscle physiology|MP:0002152,abnormal brain morphology|MP:0002654,spongiform encephalopathy|MP:0003354,astrocytosis|MP:0005409,darkened coat color|MP:0008025,brain vacuoles|MP:0010025,decreased total body fat amount|MP:0031391,increased locomotor activity
MGI:2657306	Atrn<mg-6J>	MP:0000745,tremors|MP:0000788,abnormal cerebral cortex morphology|MP:0000832,abnormal thalamus morphology|MP:0000846,abnormal medulla oblongata morphology|MP:0000849,abnormal cerebellum morphology|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002882,abnormal neuron morphology|MP:0005409,darkened coat color|MP:0008025,brain vacuoles|MP:0008026,abnormal brain white matter morphology|MP:0008027,abnormal spinal cord white matter morphology
MGI:2156486	Atrn<mg-L>	MP:0002075,abnormal coat/hair pigmentation|MP:0008025,brain vacuoles
MGI:5708188	Atrn<tm1.1(KOMP)Vlcg>	MP:0002092,abnormal eye morphology|MP:0002590,increased mean corpuscular volume|MP:0005561,increased mean corpuscular hemoglobin|MP:0010053,decreased grip strength|MP:0010123,increased bone mineral content
MGI:3851821	Atr<tm1.1Twgl>	MP:0002169,no abnormal phenotype detected
MGI:2176604	Atr<tm1Akl>	MP:0002006,neoplasm|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2176600	Atr<tm1Bal>	MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5471285	Atr<tm1b(KOMP)Wtsi>	MP:0000955,abnormal spinal cord morphology|MP:0001488,increased startle reflex|MP:0002833,increased heart weight|MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4355008	Atr<tm1Ofc>	MP:0000066,osteoporosis|MP:0000084,abnormal fontanelle morphology|MP:0000120,malocclusion|MP:0000160,kyphosis|MP:0000333,decreased bone marrow cell number|MP:0000379,decreased hair follicle number|MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0001129,impaired ovarian folliculogenesis|MP:0001131,abnormal ovarian follicle morphology|MP:0001218,thin epidermis|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001711,abnormal placenta morphology|MP:0001931,abnormal oogenesis|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002175,decreased brain weight|MP:0002182,abnormal astrocyte morphology|MP:0002196,absent corpus callosum|MP:0002233,abnormal nose morphology|MP:0002397,abnormal bone marrow morphology|MP:0002639,micrognathia|MP:0002835,abnormal cranial suture morphology|MP:0003077,abnormal cell cycle|MP:0003402,decreased liver weight|MP:0003786,premature aging|MP:0004029,spontaneous chromosome breakage|MP:0004734,small thoracic cavity|MP:0004805,absent oocytes|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight|MP:0005150,cachexia|MP:0005152,pancytopenia|MP:0005168,abnormal female meiosis|MP:0005631,decreased lung weight|MP:0006042,increased apoptosis|MP:0008008,early cellular replicative senescence|MP:0008057,abnormal DNA replication|MP:0008404,increased cellular sensitivity to methylmethanesulfonate induced cell death|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008974,proportional dwarf|MP:0009362,abnormal primary ovarian follicle morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011120,increased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number|MP:0011495,abnormal head shape|MP:0011496,abnormal head size|MP:0013501,increased fibroblast apoptosis|MP:0013508,increased granulosa cell apoptosis|MP:0030048,sloping forehead|MP:0031018,decreased granulosa cell proliferation|MP:0031019,increased granulosa cell proliferation|MP:0031381,decreased secondary ovarian follicle number
MGI:3851820	Atr<tm1Twgl>	MP:0004030,induced chromosome breakage|MP:0004759,decreased mitotic index
MGI:2656567	Atr<tm2Bal>	MP:0000774,decreased brain size|MP:0000780,abnormal corpus callosum morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000854,abnormal cerebellum development|MP:0000885,ectopic Purkinje cell|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0003203,increased neuron apoptosis|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0008924,decreased cerebellar granule cell number|MP:0009949,abnormal olfactory bulb granule cell layer morphology|MP:0009967,abnormal neuron proliferation|MP:0011085,postnatal lethality, complete penetrance|MP:0012525,abnormal rhombic lip morphology|MP:0013551,decreased cerebellar granule cell precursor proliferation|MP:0030004,hippocampus hypoplasia
MGI:4355009	Atr<tm2Ofc>	MP:0005378,growth/size/body region phenotype|MP:0005382,craniofacial phenotype
MGI:3895501	Atrx<Gt(E085A04)Wrst>	MP:0002084,abnormal developmental patterning|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4351062	Atrx<Gt(P034C09)Wrst>	MP:0002084,abnormal developmental patterning
MGI:4351061	Atrx<Gt(P034D09)Wrst>	MP:0000266,abnormal heart morphology|MP:0002084,abnormal developmental patterning
MGI:4888669	Atrx<tm1Enl>	MP:0001262,decreased body weight|MP:0001473,reduced long-term potentiation|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3528480	Atrx<tm1Rjg>	MP:0000352,decreased cell proliferation|MP:0000814,absent dentate gyrus|MP:0001325,abnormal retina morphology|MP:0001436,abnormal suckling behavior|MP:0001698,decreased embryo size|MP:0001713,decreased trophoblast giant cell number|MP:0001919,abnormal reproductive system physiology|MP:0002582,disorganized extraembryonic tissue|MP:0002584,small ectoplacental cone|MP:0003240,loss of hippocampal neurons|MP:0003241,loss of cortex neurons|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003787,abnormal imprinting|MP:0003984,embryonic growth retardation|MP:0004924,abnormal behavior|MP:0005028,abnormal trophectoderm morphology|MP:0005032,abnormal ectoplacental cone morphology|MP:0005241,abnormal retina ganglion layer morphology|MP:0005551,abnormal eye electrophysiology|MP:0006068,abnormal retina horizontal cell morphology|MP:0008106,decreased amacrine cell number|MP:0009546,absent gastric milk in neonates|MP:0009703,decreased birth body size|MP:0009971,decreased hippocampus pyramidal cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:1859844	a<twp>	MP:0002075,abnormal coat/hair pigmentation|MP:0008237,abnormal ventral coat pigmentation
MGI:4220264	Atxn10<Gt(OST184877)Lex>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:4245397	Atxn10<Gt(OST237477)Lex>	MP:0002169,no abnormal phenotype detected|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:5636994	Atxn10<tm1b(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5301616	Atxn1l<tm2.1Hzo>	MP:0000160,kyphosis|MP:0000440,domed cranium|MP:0001265,decreased body size|MP:0001575,cyanosis|MP:0001891,hydrocephaly|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003052,omphalocele|MP:0005150,cachexia|MP:0005202,lethargy|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0010902,abnormal pulmonary alveolar sac morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2429435	Atxn1<tm1Hzo>	MP:0000160,kyphosis|MP:0000749,muscle degeneration|MP:0000880,decreased Purkinje cell number|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001454,abnormal cued conditioning behavior|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001513,limb grasping|MP:0002062,abnormal associative learning|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002912,abnormal excitatory postsynaptic potential|MP:0004191,neuronal intranuclear inclusions|MP:0005150,cachexia|MP:0008489,slow postnatal weight gain|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0012676,dilated brain ventricle
MGI:2181805	Atxn1<tm2Hzo>	MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0002920,decreased paired-pulse facilitation|MP:0008428,abnormal spatial working memory
MGI:2386669	Atxn1<tm2Zuk>	MP:0001405,impaired coordination
MGI:6458736	Atxn2l<em1Aub>	MP:0000358,abnormal cell morphology|MP:0003203,increased neuron apoptosis|MP:0004201,fetal growth retardation|MP:0006254,thin cerebral cortex|MP:0009431,decreased fetal weight|MP:0011100,preweaning lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3793867	Atxn2<tm1.1Aub>	MP:0001399,hyperactivity|MP:0001547,abnormal lipid level|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0003058,increased insulin secretion|MP:0003645,increased pancreatic beta cell number|MP:0005178,increased circulating cholesterol level|MP:0005455,increased susceptibility to weight gain|MP:0005491,pancreatic islet hyperplasia|MP:0005560,decreased circulating glucose level|MP:0009285,increased gonadal fat pad weight|MP:0010400,increased liver glycogen level|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3611805	Atxn2<tm1Plt>	MP:0000010,abnormal abdominal fat pad morphology|MP:0001260,increased body weight|MP:0001405,impaired coordination|MP:0002628,hepatic steatosis|MP:0002997,enlarged seminal vesicle|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005415,intrahepatic cholestasis
MGI:5467982	Atxn2<tm2.1Aub>	MP:0000877,abnormal Purkinje cell morphology|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0005386,behavior/neurological phenotype
MGI:7570176	Atxn3<em1Jhus>	MP:0000160,kyphosis|MP:0000880,decreased Purkinje cell number|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0003858,enhanced coordination|MP:0004191,neuronal intranuclear inclusions
MGI:7570177	Atxn3<em2Jhus>	MP:0002169,no abnormal phenotype detected
MGI:5288414	Atxn3<tm1.1(ATXN3)Mfig>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:4363482	Atxn3<tm1a(KOMP)Wtsi>	MP:0004794,increased anti-nuclear antigen antibody level|MP:0005343,increased circulating aspartate transaminase level|MP:0010088,decreased circulating fructosamine level
MGI:5493478	Atxn3<tm1Hlp>	MP:0004191,neuronal intranuclear inclusions|MP:0005386,behavior/neurological phenotype|MP:0011975,neuronal cytoplasmic inclusions
MGI:3833681	Atxn3<tm1Isch>	MP:0001417,decreased exploration in new environment|MP:0002757,decreased vertical activity|MP:0005386,behavior/neurological phenotype
MGI:5708157	Atxn3<tm2.1(ATXN3*)Mfig>	MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0001405,impaired coordination|MP:0002229,neurodegeneration|MP:0003354,astrocytosis|MP:0004191,neuronal intranuclear inclusions|MP:0011975,neuronal cytoplasmic inclusions|MP:0014327,decreased Purkinje cell size
MGI:6384613	Atxn7<em1(IMPC)Bay>	MP:0003795,abnormal bone structure|MP:0010123,increased bone mineral content
MGI:6727371	Atxn7l1<em1(IMPC)J>	MP:0000745,tremors|MP:0001392,abnormal locomotor behavior|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex
MGI:6148070	Atxn7l2<em1(IMPC)Mbp>	MP:0000194,increased circulating calcium level|MP:0001556,increased circulating HDL cholesterol level|MP:0002092,abnormal eye morphology|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content|MP:0020421,increased freezing behavior
MGI:5548884	Atxn7l3<tm1.1(KOMP)Wtsi>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002764,short tibia|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness
MGI:4364787	Atxn7l3<tm1(KOMP)Wtsi>	MP:0005621,abnormal cell physiology
MGI:2651378	Atxn7<tm1Hzo>	MP:0000160,kyphosis|MP:0000243,myoclonus|MP:0000745,tremors|MP:0000774,decreased brain size|MP:0000849,abnormal cerebellum morphology|MP:0000864,abnormal cerebellum vermis morphology|MP:0001005,abnormal retina rod cell morphology|MP:0001263,weight loss|MP:0001327,decreased retina photoreceptor cell number|MP:0001344,blepharoptosis|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002083,premature death|MP:0002922,decreased post-tetanic potentiation|MP:0005386,behavior/neurological phenotype|MP:0008450,retina photoreceptor degeneration|MP:0008513,thin retina inner plexiform layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008587,short photoreceptor outer segment|MP:0010387,abnormal Bergmann glial cell morphology|MP:0014327,decreased Purkinje cell size
MGI:1855943	a<u>	MP:0002075,abnormal coat/hair pigmentation
MGI:5582437	AU021092<tm1b(KOMP)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000538,abnormal urinary bladder morphology|MP:0001399,hyperactivity|MP:0002135,abnormal kidney morphology|MP:0002833,increased heart weight|MP:0005560,decreased circulating glucose level
MGI:5803696	AU040320<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001284,absent vibrissae|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001486,abnormal startle reflex|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001925,male infertility|MP:0002075,abnormal coat/hair pigmentation|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:6111779	AU040320<tm1b(EUCOMM)Wtsi>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0008839,absent acrosome|MP:0008898,abnormal acrosome morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009235,small sperm head|MP:0009238,coiled sperm flagellum|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0014465,abnormal sperm mitochondrial morphology|MP:0020869,immotile sperm|MP:0031354,abnormal acrosome assembly|MP:0031355,abnormal proacrosomal vesicle fusion
MGI:6156458	Auh<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0002941,increased circulating alanine transaminase level|MP:0005011,increased eosinophil cell number
MGI:3826513	Aurka<Gt(XQ0149)Wtsi>	MP:0001730,embryonic growth arrest|MP:0002020,increased tumor incidence|MP:0004024,aneuploidy|MP:0004046,abnormal mitosis|MP:0004207,increased squamous cell carcinoma incidence|MP:0006204,embryonic lethality before implantation|MP:0008714,increased lung carcinoma incidence|MP:0008866,chromosomal instability|MP:0009760,abnormal mitotic spindle morphology|MP:0010264,increased hepatoma incidence|MP:0012431,increased lymphoma incidence
MGI:6257513	Aurkaip1<em1(IMPC)Bay>	MP:0000195,decreased circulating calcium level|MP:0005419,decreased circulating serum albumin level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3836420	Aurka<tm1.1Tvd>	MP:0001147,small testis|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0002674,abnormal sperm motility|MP:0002687,oligozoospermia|MP:0004046,abnormal mitosis|MP:0004543,abnormal sperm physiology|MP:0004760,increased mitotic index|MP:0004806,absent germ cells|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005578,teratozoospermia|MP:0006042,increased apoptosis|MP:0009230,abnormal sperm head morphology|MP:0009237,kinked sperm flagellum|MP:0009831,abnormal sperm midpiece morphology|MP:0009839,multiflagellated sperm|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014052,increased male germ cell apoptosis|MP:0031427,increased sperm progressive motility
MGI:5498678	Aurka<tm1.2Sbsn>	MP:0001698,decreased embryo size|MP:0002718,abnormal inner cell mass morphology|MP:0003111,abnormal cell nucleus morphology|MP:0003984,embryonic growth retardation|MP:0004046,abnormal mitosis|MP:0004965,inner cell mass degeneration|MP:0009760,abnormal mitotic spindle morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:3836423	Aurka<tm1.2Tvd>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0004760,increased mitotic index|MP:0009760,abnormal mitotic spindle morphology|MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5529637	Aurka<tm1b(EUCOMM)Hmgu>	MP:0000221,decreased leukocyte cell number|MP:0003795,abnormal bone structure|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0012121,sclerocornea|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6718894	Aurka<tm1c(EUCOMM)Hmgu>	MP:0001926,female infertility|MP:0002680,decreased corpora lutea number|MP:0009761,abnormal meiotic spindle morphology|MP:0010767,abnormal female meiosis I arrest
MGI:5056426	Aurkb<tm1.1Mama>	MP:0000358,abnormal cell morphology|MP:0003707,increased cell nucleus count|MP:0004025,polyploidy|MP:0004046,abnormal mitosis|MP:0009760,abnormal mitotic spindle morphology|MP:0013501,increased fibroblast apoptosis|MP:0031678,increased micronucleus incidence
MGI:5056428	Aurkb<tm1.2Mama>	MP:0002020,increased tumor incidence|MP:0002051,increased skin papilloma incidence|MP:0002083,premature death|MP:0002687,oligozoospermia|MP:0009308,increased adenocarcinoma incidence|MP:0009591,increased liver adenocarcinoma incidence
MGI:3529317	Aurkc<tm1Lex>	MP:0001935,decreased litter size|MP:0005389,reproductive system phenotype|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology
MGI:6153281	Auts2<em1(IMPC)Wtsi>	MP:0000282,abnormal interatrial septum morphology|MP:0001258,decreased body length|MP:0002947,increased hemangioma incidence|MP:0003266,biliary cyst|MP:0003960,increased lean body mass|MP:0006063,abnormal inferior vena cava morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013836,abnormal hypoglossal nerve topology|MP:0013840,absent segment of posterior cerebral artery|MP:0013852,abnormal Mullerian duct topology|MP:0013877,abnormal ductus venosus valve morphology|MP:0014018,embryo tumor
MGI:5697527	Auts2<tm1.1Dare>	MP:0001258,decreased body length|MP:0001523,impaired righting response|MP:0005356,positive geotaxis|MP:0011940,decreased food intake|MP:0020351,decreased vocalization
MGI:6156949	Auts2<tm1.1Mhos>	MP:0003651,abnormal axon extension|MP:0006009,abnormal neuronal migration
MGI:6156950	Auts2<tm1.2Mhos>	MP:0003651,abnormal axon extension|MP:0006009,abnormal neuronal migration|MP:0010726,abnormal collateral sprouting|MP:0011087,neonatal lethality, complete penetrance
MGI:6156948	Auts2<tm1Mhos>	MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0005386,behavior/neurological phenotype|MP:0006009,abnormal neuronal migration|MP:0009456,impaired cued conditioning behavior|MP:0011087,neonatal lethality, complete penetrance|MP:0011620,abnormal habituation to a new environment|MP:0014367,impaired long-term object recognition memory
MGI:4821826	avc2	MP:0002081,perinatal lethality|MP:0009743,preaxial polydactyly|MP:0010404,ostium primum atrial septal defect
MGI:4821827	avc3	MP:0002081,perinatal lethality|MP:0004056,abnormal myocardium compact layer morphology|MP:0010413,complete atrioventricular septal defect|MP:0011102,embryonic lethality, incomplete penetrance
MGI:6403699	Aven<em1(IMPC)Hmgu>	MP:0009142,decreased prepulse inhibition
MGI:5317759	Aven<tm1.1Zrng>	MP:0001648,abnormal apoptosis
MGI:3774413	Avil<tm1(ALPP)Fawa>	MP:0008770,decreased survivor rate|MP:0011101,prenatal lethality, incomplete penetrance|MP:0030012,impaired central nervous system regeneration
MGI:4459942	Avil<tm2(cre)Fawa>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0002734,abnormal mechanical nociception|MP:0003177,allodynia|MP:0003651,abnormal axon extension|MP:0003998,decreased thermal nociceptive threshold|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0008415,abnormal neurite morphology
MGI:6307018	Avl9<em1(IMPC)J>	MP:0010392,prolonged QRS complex duration
MGI:5548586	Avpi1<tm1b(EUCOMM)Hmgu>	MP:0004738,abnormal auditory brainstem response|MP:0005599,increased cardiac muscle contractility
MGI:6208800	Avpr1a<em1(IMPC)J>	MP:0010053,decreased grip strength
MGI:3604506	Avpr1a<tm1Dgen>	MP:0009142,decreased prepulse inhibition
MGI:3623418	Avpr1a<tm1Gzt>	MP:0000250,abnormal vasoconstriction|MP:0000639,abnormal adrenal gland morphology|MP:0001596,hypotension|MP:0001629,abnormal heart rate|MP:0001633,poor circulation|MP:0004184,abnormal baroreceptor physiology|MP:0005345,abnormal circulating corticosterone level|MP:0005523,decreased circulating atrial natriuretic factor|MP:0008432,abnormal long-term spatial reference memory
MGI:5430761	Avpr1a<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:3603461	Avpr1a<tm1Sbhu>	MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0002144,abnormal B cell differentiation|MP:0002490,abnormal immunoglobulin level|MP:0008167,increased B-1a cell number|MP:0008497,decreased IgG2b level|MP:0008500,increased IgG2a level
MGI:3604516	Avpr1b<tm1Dgen>	MP:0002906,increased susceptibility to pharmacologically induced seizures
MGI:3029988	Avpr1b<tm1Gzt>	MP:0002664,decreased circulating adrenocorticotropin level|MP:0002665,decreased circulating corticosterone level|MP:0002768,small adrenal glands
MGI:3522438	Avpr1b<tm1Wsy>	MP:0001360,abnormal social investigation|MP:0002781,increased circulating testosterone level|MP:0005656,decreased aggression
MGI:2150344	Avpr2<tm1Jwe>	MP:0000189,hypoglycemia|MP:0000519,hydronephrosis|MP:0001262,decreased body weight|MP:0001426,polydipsia|MP:0001762,polyuria|MP:0002136,abnormal kidney physiology|MP:0002608,increased hematocrit|MP:0002988,decreased urine osmolality|MP:0003019,increased circulating chloride level|MP:0003853,dry skin|MP:0005633,increased circulating sodium level|MP:0011085,postnatal lethality, complete penetrance
MGI:7282271	Avpr2<tm2.1Jwe>	MP:0000519,hydronephrosis|MP:0001262,decreased body weight|MP:0001426,polydipsia|MP:0001762,polyuria|MP:0002988,decreased urine osmolality|MP:0005528,decreased renal glomerular filtration rate|MP:0005618,decreased urine potassium level|MP:0006317,decreased urine sodium level|MP:0011467,decreased urine urea nitrogen level|MP:0011471,decreased urine creatinine level
MGI:5522761	Avp<tm1.1(cre)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5637198	Avp<tm1b(EUCOMM)Wtsi>	MP:0000222,decreased neutrophil cell number|MP:0001523,impaired righting response|MP:0005013,increased lymphocyte cell number|MP:0005568,increased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance|MP:0012361,decreased large unstained cell number
MGI:6153120	Avp<tm1Chron>	MP:0011085,postnatal lethality, complete penetrance
MGI:3843456	Avp<tm1Hari>	MP:0001429,dehydration|MP:0001762,polyuria|MP:0002988,decreased urine osmolality|MP:0003953,abnormal hormone level|MP:0008846,abnormal supraoptic nucleus morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011941,increased fluid intake
MGI:3843457	Avp<tm1Lja>	MP:0000837,abnormal hypothalamus morphology|MP:0001762,polyuria|MP:0005418,abnormal circulating hormone level|MP:0005645,abnormal hypothalamus physiology|MP:0011085,postnatal lethality, complete penetrance|MP:0011941,increased fluid intake
MGI:3843458	Avp<tm2Lja>	MP:0002169,no abnormal phenotype detected
MGI:1855930	A<vy>	MP:0002006,neoplasm|MP:0002075,abnormal coat/hair pigmentation
MGI:1855936	A<w>	MP:0003136,yellow coat color|MP:0005379,endocrine/exocrine gland phenotype|MP:0008237,abnormal ventral coat pigmentation|MP:0008296,abnormal adrenal gland x-zone morphology
MGI:6358209	AW112010<em2Flv>	MP:0002412,increased susceptibility to bacterial infection|MP:0008539,decreased susceptibility to induced colitis|MP:0008597,decreased circulating interleukin-6 level|MP:0008648,decreased circulating interleukin-12b level|MP:0008670,decreased interleukin-12b secretion|MP:0008706,decreased interleukin-6 secretion|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:7573108	AW209491<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology
MGI:1856452	A<w-34J>	MP:0005171,absent coat pigmentation
MGI:1856453	A<w-35J>	MP:0005171,absent coat pigmentation
MGI:1856454	A<w-36J>	MP:0005171,absent coat pigmentation
MGI:1856455	A<w-37J>	MP:0005171,absent coat pigmentation
MGI:1856456	A<w-38J>	MP:0005171,absent coat pigmentation
MGI:1856457	A<w-39J>	MP:0005171,absent coat pigmentation
MGI:1856458	A<w-40J>	MP:0005171,absent coat pigmentation
MGI:1856459	A<w-41J>	MP:0005171,absent coat pigmentation
MGI:1856460	A<w-42J>	MP:0005171,absent coat pigmentation
MGI:1856461	A<w-43J>	MP:0005171,absent coat pigmentation
MGI:2181392	A<w-46J>	MP:0002075,abnormal coat/hair pigmentation|MP:0002095,abnormal skin pigmentation
MGI:2181393	A<w-47J>	MP:0002075,abnormal coat/hair pigmentation|MP:0002095,abnormal skin pigmentation
MGI:7367579	Awat1<em1Akih>	MP:0001337,dry eyes|MP:0001994,increased blinking frequency|MP:0005252,abnormal Meibomian gland morphology|MP:0013391,abnormal Meibomian gland physiology|MP:0014131,abnormal tear film morphology
MGI:5698074	Awat1<tm1b(KOMP)Wtsi>	MP:0010570,prolonged ST segment
MGI:7367580	Awat2<em1Akih>	MP:0001312,abnormal cornea morphology|MP:0001337,dry eyes|MP:0001349,excessive tearing|MP:0001994,increased blinking frequency|MP:0005252,abnormal Meibomian gland morphology|MP:0013386,enlarged Meibomian gland|MP:0013391,abnormal Meibomian gland physiology|MP:0014131,abnormal tear film morphology
MGI:6148071	Awat2<em1(IMPC)Mbp>	MP:0000538,abnormal urinary bladder morphology|MP:0001340,abnormal eyelid morphology|MP:0001944,abnormal pancreas morphology|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0006203,eye hemorrhage
MGI:6729716	Awat2<tm1.2Golc>	MP:0000649,sebaceous gland atrophy|MP:0001192,scaly skin|MP:0001212,skin lesions|MP:0001219,thick epidermis|MP:0001310,abnormal conjunctiva morphology|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001322,abnormal iris morphology|MP:0001337,dry eyes|MP:0001340,abnormal eyelid morphology|MP:0001851,eye inflammation|MP:0003853,dry skin|MP:0004222,iris synechia|MP:0005251,blepharitis|MP:0005252,abnormal Meibomian gland morphology|MP:0005300,abnormal cornea stroma morphology|MP:0005542,cornea vascularization|MP:0006000,abnormal cornea epithelium morphology|MP:0006193,conjunctival telangiectasia|MP:0008778,abnormal lymphangiogenesis|MP:0009935,abnormal Meibomian gland acinus morphology|MP:0010202,focal dorsal hair loss|MP:0010699,dilated hair follicle|MP:0011962,increased cornea thickness|MP:0013145,eye discharge|MP:0013192,decreased sebaceous gland number|MP:0013375,abnormal sebocyte morphology|MP:0013391,abnormal Meibomian gland physiology|MP:0014131,abnormal tear film morphology|MP:0014154,Meibomian gland degeneration
MGI:1889309	awg<Tg(GBts1env)832Pkw>	MP:0000745,tremors|MP:0000938,motor neuron degeneration|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002083,premature death|MP:0003644,thymus atrophy
MGI:1855946	A<w-J>	MP:0004382,abnormal hair follicle melanogenesis|MP:0005118,decreased circulating pituitary hormone level|MP:0008237,abnormal ventral coat pigmentation
MGI:1855944	a<x>	MP:0003984,embryonic growth retardation|MP:0008762,embryonic lethality|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:1856670	Axd	MP:0000352,decreased cell proliferation|MP:0000929,open neural tube|MP:0001672,abnormal embryo development|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002111,abnormal tail morphology|MP:0002151,abnormal neural tube morphology|MP:0002169,no abnormal phenotype detected|MP:0002621,delayed neural tube closure|MP:0002632,vestigial tail|MP:0003051,curly tail|MP:0003720,abnormal neural tube closure|MP:0009264,failure of eyelid fusion|MP:0009265,delayed eyelid fusion|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012544,abnormal caudal neuropore morphology|MP:0012547,spina bifida cystica|MP:0012707,incomplete caudal neuropore closure
MGI:7490386	Axdnd1<em1(IMPC)J>	MP:0002098,abnormal vibrissa morphology
MGI:7310205	Axdnd1<em1Ktmr>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0009230,abnormal sperm head morphology|MP:0009376,abnormal manchette morphology|MP:0014052,increased male germ cell apoptosis
MGI:1856035	Axin1<Fu>	MP:0000137,abnormal vertebrae morphology|MP:0000151,absent ribs|MP:0000154,rib fusion|MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000556,abnormal hindlimb morphology|MP:0000592,short tail|MP:0001394,circling|MP:0001539,decreased caudal vertebrae number|MP:0001967,deafness|MP:0002111,abnormal tail morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002169,no abnormal phenotype detected|MP:0002759,abnormal caudal vertebrae morphology|MP:0003121,genetic imprinting|MP:0003122,maternal imprinting|MP:0003123,paternal imprinting|MP:0003176,reversion by viral sequence excision|MP:0003591,urethra atresia|MP:0003718,maternal effect|MP:0003722,absent ureter|MP:0011775,rectal atresia|MP:0011999,abnormal tail length|MP:0013175,bifurcated tail
MGI:1856037	Axin1<Fu-kb>	MP:0000585,kinked tail|MP:0001675,abnormal ectoderm development|MP:0002084,abnormal developmental patterning|MP:0009352,impaired spacing of implantation sites|MP:0009353,twin decidual capsule|MP:0011092,embryonic lethality, complete penetrance|MP:0012104,small amniotic cavity
MGI:1856036	Axin1<Fu-ki>	MP:0000137,abnormal vertebrae morphology|MP:0000154,rib fusion|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001539,decreased caudal vertebrae number|MP:0001726,abnormal allantois morphology|MP:0002080,prenatal lethality|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0003988,disorganized embryonic tissue|MP:0004619,caudal vertebral fusion|MP:0004621,lumbar vertebral fusion|MP:0004622,sacral vertebral fusion|MP:0004623,thoracic vertebral fusion|MP:0004713,split notochord|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011259,abnormal cephalic neural fold morphology|MP:0012062,small tail bud|MP:0012156,rostral-caudal axis duplication|MP:0013175,bifurcated tail
MGI:1857546	Axin1<Fu-Tg1>	MP:0000291,enlarged pericardium|MP:0000435,shortened head|MP:0000784,forebrain hypoplasia|MP:0000928,incomplete rostral neuropore closure|MP:0001684,abnormal axial mesoderm morphology|MP:0001698,decreased embryo size|MP:0001726,abnormal allantois morphology|MP:0002085,abnormal embryonic tissue morphology|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0004187,cardia bifida|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011199,abnormal amniotic cavity morphology|MP:0012136,absent forebrain|MP:0012156,rostral-caudal axis duplication
MGI:4941940	Axin1<tm1.1Dic>	MP:0002169,no abnormal phenotype detected
MGI:4941943	Axin1<tm1.2Dic>	MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0008762,embryonic lethality
MGI:3580422	Axin1<tm1(Axin2)Cos>	MP:0002169,no abnormal phenotype detected
MGI:3580423	Axin1<tm2Cos>	MP:0002169,no abnormal phenotype detected
MGI:3840236	Axin1<tm3Cos>	MP:0000291,enlarged pericardium|MP:0000435,shortened head|MP:0000928,incomplete rostral neuropore closure|MP:0001258,decreased body length|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0004187,cardia bifida|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3840238	Axin1<tm4Cos>	MP:0000291,enlarged pericardium|MP:0000435,shortened head|MP:0000928,incomplete rostral neuropore closure|MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0004187,cardia bifida|MP:0011092,embryonic lethality, complete penetrance
MGI:5006982	Axin2<canp>	MP:0000266,abnormal heart morphology|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001730,embryonic growth arrest|MP:0002111,abnormal tail morphology|MP:0002231,abnormal primitive streak morphology|MP:0004187,cardia bifida|MP:0005657,abnormal neural plate morphology|MP:0006281,abnormal tail development|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:6111808	Axin2<em1Fstl>	MP:0001732,postnatal growth retardation|MP:0003051,curly tail
MGI:5563343	Axin2<M1J>	MP:0000585,kinked tail|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5692597	Axin2<tm1b(KOMP)Wtsi>	MP:0000562,polydactyly|MP:0001258,decreased body length|MP:0001289,persistence of hyaloid vascular system|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001491,unresponsive to tactile stimuli|MP:0001672,abnormal embryo development|MP:0001697,abnormal embryo size|MP:0002109,abnormal limb morphology|MP:0003385,abnormal body wall morphology|MP:0003743,abnormal facial morphology|MP:0005565,increased blood urea nitrogen level|MP:0009263,abnormal eyelid fusion|MP:0009908,protruding tongue|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration|MP:0011495,abnormal head shape
MGI:3579503	Axin2<tm1Wbm>	MP:0000074,abnormal neurocranium morphology|MP:0000435,shortened head|MP:0000438,abnormal cranium morphology|MP:0002092,abnormal eye morphology|MP:0002113,abnormal skeleton development|MP:0003418,premature intramembranous bone ossification|MP:0005006,abnormal osteoblast physiology|MP:0008525,decreased cranium height|MP:0011710,enhanced osteoblast differentiation|MP:0030367,premature metopic suture closure|MP:0030370,absent jugum limitans|MP:0030438,increased osteoblast proliferation
MGI:3604510	Axl<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:2387750	Axl<tm1Grl>	MP:0003070,increased vascular permeability|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:3041610	Axtofa10<L2/Ibg>	MP:0001402,decreased locomotor activity
MGI:3041577	Axtofa1<L1/Ibg>	MP:0001402,decreased locomotor activity
MGI:3041591	Axtofa3<L1/Ibg>	MP:0001399,hyperactivity
MGI:3041609	Axtofa5<L1/Ibg>	MP:0001402,decreased locomotor activity
MGI:3041614	Axtofa6<L2/Ibg>	MP:0001402,decreased locomotor activity
MGI:3041618	Axtofa7<L2/Ibg>	MP:0031391,increased locomotor activity
MGI:3041578	Axtofa8<L2/Ibg>	MP:0001402,decreased locomotor activity
MGI:3041592	Axtofa9<L2/Ibg>	MP:0001399,hyperactivity
MGI:3041581	Axtofd1<L1/Ibg>	MP:0001362,abnormal anxiety-related response
MGI:3041595	Axtofd3<L1/Ibg>	MP:0001362,abnormal anxiety-related response
MGI:3041622	Axtofd4<L2/Ibg>	MP:0001362,abnormal anxiety-related response
MGI:3041582	Axtofd5<L2/Ibg>	MP:0001362,abnormal anxiety-related response
MGI:3041596	Axtofd6<L2/Ibg>	MP:0001362,abnormal anxiety-related response
MGI:1856798	A<y>	MP:0003718,maternal effect|MP:0008762,embryonic lethality|MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:1856451	A<y-J>	MP:0003136,yellow coat color
MGI:5431920	Azgp1<tm1.1Sbah>	MP:0000691,enlarged spleen|MP:0001260,increased body weight|MP:0005666,abnormal adipose tissue physiology|MP:0008033,impaired lipolysis
MGI:5544312	Azi2<tm1Aki>	MP:0002376,abnormal dendritic cell physiology|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0008115,abnormal dendritic cell differentiation|MP:0008561,decreased tumor necrosis factor secretion|MP:0008563,decreased interferon-alpha secretion|MP:0008706,decreased interleukin-6 secretion|MP:0009278,abnormal bone marrow cell physiology
MGI:3838345	Azin1<Gt(Ayu17-689)Imeg>	MP:0008986,abnormal liver parenchyma morphology|MP:0009674,decreased birth weight|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4075460	Azin2<Gt(IST12418H6)Tigm>	MP:0002727,decreased circulating insulin level
MGI:7573109	B230219D22Rik<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0005542,cornea vascularization|MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:5316785	b2b1060Clo	MP:0000438,abnormal cranium morphology|MP:0002633,persistent truncus arteriosus|MP:0011660,ectopia cordis
MGI:5437731	b2b1117.1Clo	MP:0002639,micrognathia|MP:0006130,pulmonary valve atresia|MP:0008797,facial cleft|MP:0010402,ventricular septal defect|MP:0011674,multiple major aortopulmonary collateral arteries
MGI:5437732	b2b1117.2Clo	MP:0000276,heart right ventricle hypertrophy|MP:0002625,heart left ventricle hypertrophy
MGI:5437730	b2b1117Clo	MP:0000276,heart right ventricle hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia|MP:0006130,pulmonary valve atresia|MP:0008797,facial cleft|MP:0010402,ventricular septal defect|MP:0011674,multiple major aortopulmonary collateral arteries
MGI:5437084	b2b1146Clo	MP:0000531,right pulmonary isomerism|MP:0000644,dextrocardia|MP:0003178,left pulmonary isomerism|MP:0003675,kidney cyst|MP:0004133,heterotaxia|MP:0008528,polycystic kidney|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011649,immotile respiratory cilia|MP:0011665,d-loop transposition of the great arteries|MP:0011668,double outlet right ventricle, Taussig bing type
MGI:5433410	b2b1163.2Clo	MP:0000276,heart right ventricle hypertrophy|MP:0002625,heart left ventricle hypertrophy
MGI:5433408	b2b1163Clo	MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0002625,heart left ventricle hypertrophy|MP:0004133,heterotaxia|MP:0004157,interrupted aortic arch|MP:0008528,polycystic kidney|MP:0010412,atrioventricular septal defect|MP:0010422,heart right ventricle hypoplasia
MGI:5437103	b2b1200.2Clo	MP:0000276,heart right ventricle hypertrophy|MP:0000519,hydronephrosis|MP:0002625,heart left ventricle hypertrophy|MP:0003675,kidney cyst|MP:0008528,polycystic kidney
MGI:5437101	b2b1200Clo	MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0000519,hydronephrosis|MP:0002625,heart left ventricle hypertrophy|MP:0003675,kidney cyst|MP:0004017,duplex kidney|MP:0004133,heterotaxia|MP:0008528,polycystic kidney|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010422,heart right ventricle hypoplasia|MP:0010466,vascular ring|MP:0010485,aortic arch hypoplasia
MGI:5313715	b2b1247Clo	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002952,ventricular cardiomyopathy|MP:0005329,abnormal myocardium layer morphology|MP:0010413,complete atrioventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010499,abnormal ventricle myocardium morphology
MGI:5311391	b2b1249Clo	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0000562,polydactyly|MP:0001178,pulmonary hypoplasia|MP:0001823,thymus hypoplasia|MP:0003345,decreased rib number|MP:0003446,renal hypoplasia|MP:0003922,abnormal heart right atrium morphology|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0006061,right atrial isomerism|MP:0010460,pulmonary artery hypoplasia|MP:0010466,vascular ring|MP:0010487,abnormal right subclavian artery morphology|MP:0011659,interrupted aortic arch, type b
MGI:5437087	b2b1291.2Clo	MP:0000519,hydronephrosis|MP:0004017,duplex kidney|MP:0008528,polycystic kidney
MGI:5437085	b2b1291Clo	MP:0000519,hydronephrosis|MP:0004017,duplex kidney|MP:0004133,heterotaxia|MP:0008528,polycystic kidney|MP:0010808,right-sided stomach|MP:0011253,situs inversus with levocardia
MGI:5438057	b2b1297Clo	MP:0000284,double outlet right ventricle|MP:0000598,abnormal liver morphology|MP:0003327,liver cyst|MP:0006128,pulmonary valve stenosis|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010593,thick aortic valve cusps|MP:0011648,thick heart valve cusps
MGI:5437729	b2b1298Clo	MP:0000284,double outlet right ventricle|MP:0000519,hydronephrosis|MP:0000536,hydroureter|MP:0004157,interrupted aortic arch|MP:0010471,supravalvar aortic stenosis|MP:0010476,coronary fistula|MP:0010485,aortic arch hypoplasia|MP:0011667,double outlet right ventricle with atrioventricular septal defect|MP:0011682,renal glomerulus cyst
MGI:5297417	b2b134Clo	MP:0000519,hydronephrosis|MP:0008528,polycystic kidney|MP:0010460,pulmonary artery hypoplasia|MP:0010476,coronary fistula|MP:0010485,aortic arch hypoplasia|MP:0011666,double outlet right ventricle, ventricular defect committed to aorta
MGI:5446156	b2b1430Clo	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0000519,hydronephrosis|MP:0000520,absent kidney|MP:0003446,renal hypoplasia|MP:0003675,kidney cyst|MP:0004158,right aortic arch|MP:0010446,heart left ventricle hypoplasia|MP:0010580,decreased heart left ventricle size|MP:0011665,d-loop transposition of the great arteries
MGI:5445346	b2b1432Clo	MP:0000284,double outlet right ventricle|MP:0000286,abnormal mitral valve morphology|MP:0000445,short snout|MP:0002747,abnormal aortic valve morphology|MP:0010446,heart left ventricle hypoplasia|MP:0010463,aorta stenosis|MP:0010580,decreased heart left ventricle size|MP:0031523,mitral valve hypoplasia
MGI:5431500	b2b1436Clo	MP:0004133,heterotaxia|MP:0010412,atrioventricular septal defect|MP:0011252,situs inversus totalis|MP:0011665,d-loop transposition of the great arteries
MGI:5463441	b2b1456Clo	MP:0000644,dextrocardia|MP:0003178,left pulmonary isomerism|MP:0004133,heterotaxia|MP:0010412,atrioventricular septal defect|MP:0011252,situs inversus totalis
MGI:5297418	b2b145Clo	MP:0002135,abnormal kidney morphology|MP:0004158,right aortic arch|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect
MGI:5696350	b2b1468Clo	MP:0000284,double outlet right ventricle|MP:0000519,hydronephrosis|MP:0000536,hydroureter|MP:0000644,dextrocardia|MP:0001297,microphthalmia|MP:0002766,situs inversus|MP:0004200,decreased fetal size|MP:0004860,dilated kidney collecting duct|MP:0008528,polycystic kidney|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010422,heart right ventricle hypoplasia|MP:0010457,pulmonary artery stenosis|MP:0011649,immotile respiratory cilia
MGI:5430054	b2b1470Clo	MP:0000111,cleft palate|MP:0000562,polydactyly|MP:0000564,syndactyly
MGI:5491229	b2b1511.1Clo	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0000519,hydronephrosis|MP:0000536,hydroureter|MP:0000562,polydactyly|MP:0001297,microphthalmia|MP:0003675,kidney cyst|MP:0004017,duplex kidney|MP:0008797,facial cleft|MP:0010402,ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect
MGI:5491230	b2b1511.2Clo	MP:0000111,cleft palate|MP:0000276,heart right ventricle hypertrophy|MP:0001293,anophthalmia|MP:0002625,heart left ventricle hypertrophy
MGI:5491228	b2b1511Clo	MP:0000111,cleft palate|MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0000519,hydronephrosis|MP:0000536,hydroureter|MP:0000562,polydactyly|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002625,heart left ventricle hypertrophy|MP:0003675,kidney cyst|MP:0004017,duplex kidney|MP:0008797,facial cleft|MP:0010402,ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect
MGI:5433294	b2b1519Clo	MP:0000284,double outlet right ventricle|MP:0000644,dextrocardia|MP:0003178,left pulmonary isomerism|MP:0004133,heterotaxia|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010422,heart right ventricle hypoplasia|MP:0010466,vascular ring|MP:0011252,situs inversus totalis|MP:0011680,tricuspid valve hypoplasia
MGI:5429777	b2b1528Clo	MP:0003924,diaphragmatic hernia
MGI:5429851	b2b1555Clo	MP:0000111,cleft palate
MGI:5433324	b2b1580Clo	MP:0004158,right aortic arch|MP:0006128,pulmonary valve stenosis|MP:0006130,pulmonary valve atresia|MP:0010412,atrioventricular septal defect
MGI:5442115	b2b1594Clo	MP:0000111,cleft palate|MP:0000276,heart right ventricle hypertrophy|MP:0000564,syndactyly|MP:0000576,clubfoot|MP:0002544,brachydactyly|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia|MP:0010464,abnormal aortic arch and aortic arch branch attachment|MP:0010466,vascular ring
MGI:5437728	b2b1596Clo	MP:0000445,short snout|MP:0002639,micrognathia|MP:0030273,mandibular retrognathia
MGI:5438060	b2b1625Clo	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0001293,anophthalmia|MP:0003052,omphalocele|MP:0004017,duplex kidney|MP:0010412,atrioventricular septal defect|MP:0010466,vascular ring|MP:0011661,persistent truncus arteriosus type i
MGI:5438061	b2b1639Clo	MP:0000276,heart right ventricle hypertrophy|MP:0010422,heart right ventricle hypoplasia|MP:0011680,tricuspid valve hypoplasia
MGI:5438063	b2b1700Clo	MP:0000284,double outlet right ventricle|MP:0000462,abnormal digestive system morphology|MP:0000644,dextrocardia|MP:0004133,heterotaxia|MP:0010403,atrial septal defect|MP:0010466,vascular ring|MP:0011649,immotile respiratory cilia|MP:0011665,d-loop transposition of the great arteries
MGI:5696518	b2b1702Clo	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0000531,right pulmonary isomerism|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0000694,spleen hypoplasia|MP:0000757,herniated abdominal wall|MP:0001265,decreased body size|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001823,thymus hypoplasia|MP:0002192,hydrops fetalis|MP:0002639,micrognathia|MP:0003052,omphalocele|MP:0004110,transposition of great arteries|MP:0004133,heterotaxia|MP:0008772,increased heart ventricle size|MP:0008816,petechiae|MP:0010412,atrioventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010476,coronary fistula|MP:0010808,right-sided stomach|MP:0010975,abnormal lung lobe morphology|MP:0011666,double outlet right ventricle, ventricular defect committed to aorta|MP:0011668,double outlet right ventricle, Taussig bing type
MGI:5438064	b2b1709Clo	MP:0000273,overriding aortic valve|MP:0000428,abnormal craniofacial morphology|MP:0000433,microcephaly|MP:0001293,anophthalmia|MP:0005157,holoprosencephaly|MP:0005163,cyclopia|MP:0010402,ventricular septal defect|MP:0010446,heart left ventricle hypoplasia|MP:0010466,vascular ring|MP:0010476,coronary fistula|MP:0010485,aortic arch hypoplasia|MP:0010580,decreased heart left ventricle size|MP:0031522,small mitral valve|MP:0031523,mitral valve hypoplasia
MGI:5438065	b2b1714Clo	MP:0000276,heart right ventricle hypertrophy|MP:0002625,heart left ventricle hypertrophy
MGI:5442116	b2b1723Clo	MP:0000111,cleft palate|MP:0000273,overriding aortic valve|MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia|MP:0010476,coronary fistula
MGI:5463581	b2b1801.2Clo	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0010402,ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010485,aortic arch hypoplasia|MP:0010526,aortic arch coarctation
MGI:5446159	b2b1801Clo	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0004133,heterotaxia|MP:0006061,right atrial isomerism|MP:0006063,abnormal inferior vena cava morphology|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010485,aortic arch hypoplasia|MP:0010526,aortic arch coarctation|MP:0011683,dual inferior vena cava
MGI:5438069	b2b1827Clo	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0001297,microphthalmia|MP:0004158,right aortic arch|MP:0010403,atrial septal defect|MP:0010460,pulmonary artery hypoplasia
MGI:5446160	b2b1835Clo	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0002952,ventricular cardiomyopathy|MP:0010412,atrioventricular septal defect
MGI:5446161	b2b1854Clo	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0005170,cleft upper lip|MP:0011664,persistent truncus arteriosus type iv
MGI:5476172	b2b1876Clo	MP:0000284,double outlet right ventricle|MP:0004056,abnormal myocardium compact layer morphology|MP:0010412,atrioventricular septal defect
MGI:5476180	b2b1879.2Clo	MP:0000520,absent kidney
MGI:5476173	b2b1879Clo	MP:0000111,cleft palate|MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0000520,absent kidney|MP:0002625,heart left ventricle hypertrophy|MP:0002633,persistent truncus arteriosus|MP:0002639,micrognathia|MP:0004056,abnormal myocardium compact layer morphology|MP:0010420,muscular ventricular septal defect|MP:0011661,persistent truncus arteriosus type i
MGI:5297421	b2b191Clo	MP:0000111,cleft palate|MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0004158,right aortic arch|MP:0010402,ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010449,heart right ventricle outflow tract stenosis|MP:0010457,pulmonary artery stenosis|MP:0010464,abnormal aortic arch and aortic arch branch attachment|MP:0010476,coronary fistula|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5476174	b2b1929Clo	MP:0000284,double outlet right ventricle|MP:0001181,absent lungs|MP:0006130,pulmonary valve atresia|MP:0010412,atrioventricular septal defect|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011252,situs inversus totalis|MP:0011683,dual inferior vena cava
MGI:5446162	b2b1941Clo	MP:0000111,cleft palate|MP:0000519,hydronephrosis|MP:0000705,athymia|MP:0001297,microphthalmia|MP:0002639,micrognathia|MP:0003321,tracheoesophageal fistula|MP:0004017,duplex kidney|MP:0006130,pulmonary valve atresia|MP:0010412,atrioventricular septal defect|MP:0010466,vascular ring|MP:0011664,persistent truncus arteriosus type iv|MP:0011665,d-loop transposition of the great arteries|MP:0011674,multiple major aortopulmonary collateral arteries
MGI:5467354	b2b1963Clo	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0000914,exencephaly|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002639,micrognathia|MP:0010446,heart left ventricle hypoplasia|MP:0010485,aortic arch hypoplasia|MP:0010580,decreased heart left ventricle size
MGI:5491232	b2b2012.1Clo	MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002639,micrognathia|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect
MGI:5491233	b2b2012.2Clo	MP:0000453,absent mouth|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001625,cardiac hypertrophy|MP:0002639,micrognathia|MP:0004158,right aortic arch|MP:0005157,holoprosencephaly|MP:0005163,cyclopia
MGI:5491231	b2b2012Clo	MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0000453,absent mouth|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001625,cardiac hypertrophy|MP:0002639,micrognathia|MP:0004158,right aortic arch|MP:0005157,holoprosencephaly|MP:0005163,cyclopia|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect
MGI:5554445	b2b2025.2Clo	MP:0000284,double outlet right ventricle|MP:0000564,syndactyly|MP:0000572,abnormal autopod morphology|MP:0001297,microphthalmia|MP:0004056,abnormal myocardium compact layer morphology|MP:0004113,abnormal aortic arch morphology|MP:0004158,right aortic arch|MP:0010412,atrioventricular septal defect|MP:0010460,pulmonary artery hypoplasia|MP:0010466,vascular ring|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5491236	b2b2025Clo	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000564,syndactyly|MP:0000572,abnormal autopod morphology|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0000690,absent spleen|MP:0000694,spleen hypoplasia|MP:0001297,microphthalmia|MP:0003178,left pulmonary isomerism|MP:0004056,abnormal myocardium compact layer morphology|MP:0004113,abnormal aortic arch morphology|MP:0004133,heterotaxia|MP:0004157,interrupted aortic arch|MP:0004158,right aortic arch|MP:0006061,right atrial isomerism|MP:0006063,abnormal inferior vena cava morphology|MP:0008461,left atrial isomerism|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010460,pulmonary artery hypoplasia|MP:0010466,vascular ring|MP:0010808,right-sided stomach|MP:0011254,superior-inferior ventricles|MP:0011667,double outlet right ventricle with atrioventricular septal defect|MP:0011668,double outlet right ventricle, Taussig bing type|MP:0011683,dual inferior vena cava|MP:0031515,l-loop transposition of the great arteries
MGI:5491238	b2b2059Clo	MP:0000273,overriding aortic valve|MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0000644,dextrocardia|MP:0000694,spleen hypoplasia|MP:0002625,heart left ventricle hypertrophy|MP:0003178,left pulmonary isomerism|MP:0004133,heterotaxia|MP:0006063,abnormal inferior vena cava morphology|MP:0008461,left atrial isomerism|MP:0008528,polycystic kidney|MP:0010412,atrioventricular septal defect|MP:0010808,right-sided stomach|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011252,situs inversus totalis|MP:0011665,d-loop transposition of the great arteries|MP:0011667,double outlet right ventricle with atrioventricular septal defect|MP:0011683,dual inferior vena cava
MGI:5560802	b2b2101Clo	MP:0000284,double outlet right ventricle|MP:0001297,microphthalmia|MP:0004113,abnormal aortic arch morphology|MP:0004157,interrupted aortic arch|MP:0004158,right aortic arch|MP:0006061,right atrial isomerism|MP:0010402,ventricular septal defect|MP:0010466,vascular ring|MP:0011683,dual inferior vena cava
MGI:5498494	b2b2110.1Clo	MP:0000284,double outlet right ventricle|MP:0010485,aortic arch hypoplasia
MGI:5498499	b2b2110.2Clo	MP:0000087,absent mandible|MP:0000111,cleft palate|MP:0000276,heart right ventricle hypertrophy|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia
MGI:5498488	b2b2110Clo	MP:0000087,absent mandible|MP:0000111,cleft palate|MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia|MP:0010485,aortic arch hypoplasia
MGI:5560901	b2b2140Clo	MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0000562,polydactyly|MP:0000572,abnormal autopod morphology|MP:0000694,spleen hypoplasia|MP:0002625,heart left ventricle hypertrophy|MP:0002633,persistent truncus arteriosus|MP:0002639,micrognathia|MP:0003446,renal hypoplasia|MP:0003675,kidney cyst|MP:0003924,diaphragmatic hernia|MP:0004113,abnormal aortic arch morphology|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0005170,cleft upper lip|MP:0010412,atrioventricular septal defect|MP:0010460,pulmonary artery hypoplasia|MP:0010466,vascular ring|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5516008	b2b2153.1Clo	MP:0000111,cleft palate|MP:0000276,heart right ventricle hypertrophy|MP:0002092,abnormal eye morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia|MP:0010402,ventricular septal defect|MP:0011666,double outlet right ventricle, ventricular defect committed to aorta
MGI:5516009	b2b2153.2Clo	MP:0000024,lowered ear position|MP:0000111,cleft palate|MP:0000276,heart right ventricle hypertrophy|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia|MP:0003051,curly tail|MP:0006198,enophthalmos
MGI:5491242	b2b2153Clo	MP:0000024,lowered ear position|MP:0000111,cleft palate|MP:0000276,heart right ventricle hypertrophy|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia|MP:0003051,curly tail|MP:0006198,enophthalmos|MP:0010402,ventricular septal defect|MP:0011666,double outlet right ventricle, ventricular defect committed to aorta
MGI:5547744	b2b2187.2Clo	MP:0000111,cleft palate|MP:0000276,heart right ventricle hypertrophy|MP:0001297,microphthalmia|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia
MGI:5491256	b2b2187Clo	MP:0000111,cleft palate|MP:0000157,abnormal sternum morphology|MP:0000273,overriding aortic valve|MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0000519,hydronephrosis|MP:0000556,abnormal hindlimb morphology|MP:0001297,microphthalmia|MP:0001823,thymus hypoplasia|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia|MP:0003675,kidney cyst|MP:0006128,pulmonary valve stenosis|MP:0010402,ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect
MGI:5437100	b2b227.2Clo	MP:0000276,heart right ventricle hypertrophy|MP:0002625,heart left ventricle hypertrophy
MGI:5437098	b2b227Clo	MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0000694,spleen hypoplasia|MP:0001943,abnormal respiration|MP:0002625,heart left ventricle hypertrophy|MP:0004133,heterotaxia|MP:0004880,lung cyst|MP:0005330,cardiomyopathy|MP:0010402,ventricular septal defect|MP:0010808,right-sided stomach|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia
MGI:5510163	b2b2289Clo	MP:0000284,double outlet right ventricle|MP:0000519,hydronephrosis|MP:0003675,kidney cyst|MP:0004113,abnormal aortic arch morphology|MP:0004158,right aortic arch|MP:0010485,aortic arch hypoplasia
MGI:5491275	b2b2350Clo	MP:0000284,double outlet right ventricle|MP:0000519,hydronephrosis|MP:0000644,dextrocardia|MP:0003178,left pulmonary isomerism|MP:0003675,kidney cyst|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0004159,double aortic arch|MP:0006063,abnormal inferior vena cava morphology|MP:0010412,atrioventricular septal defect|MP:0011252,situs inversus totalis|MP:0011254,superior-inferior ventricles|MP:0011667,double outlet right ventricle with atrioventricular septal defect|MP:0011668,double outlet right ventricle, Taussig bing type|MP:0011683,dual inferior vena cava
MGI:5560157	b2b2362.2Clo	MP:0000111,cleft palate|MP:0000276,heart right ventricle hypertrophy|MP:0000445,short snout|MP:0000757,herniated abdominal wall|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia|MP:0005170,cleft upper lip|MP:0008797,facial cleft|MP:0011495,abnormal head shape
MGI:5560155	b2b2362Clo	MP:0000111,cleft palate|MP:0000276,heart right ventricle hypertrophy|MP:0000445,short snout|MP:0000757,herniated abdominal wall|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia|MP:0003446,renal hypoplasia|MP:0005170,cleft upper lip|MP:0008797,facial cleft|MP:0010402,ventricular septal defect|MP:0011495,abnormal head shape|MP:0011660,ectopia cordis|MP:0011667,double outlet right ventricle with atrioventricular septal defect|MP:0011668,double outlet right ventricle, Taussig bing type|MP:0011682,renal glomerulus cyst|MP:0014518,myocardial hypertrabeculation
MGI:5430050	b2b243.1Clo	MP:0002633,persistent truncus arteriosus|MP:0004158,right aortic arch
MGI:5430051	b2b243.2Clo	MP:0000519,hydronephrosis|MP:0008528,polycystic kidney
MGI:5430049	b2b243Clo	MP:0000519,hydronephrosis|MP:0002633,persistent truncus arteriosus|MP:0004158,right aortic arch|MP:0008528,polycystic kidney
MGI:5560903	b2b2459Clo	MP:0000284,double outlet right ventricle|MP:0003675,kidney cyst|MP:0004056,abnormal myocardium compact layer morphology|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5560904	b2b2463Clo	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0001823,thymus hypoplasia|MP:0010402,ventricular septal defect
MGI:5313711	b2b246Clo	MP:0004056,abnormal myocardium compact layer morphology|MP:0005157,holoprosencephaly|MP:0006128,pulmonary valve stenosis|MP:0010402,ventricular septal defect|MP:0010460,pulmonary artery hypoplasia|MP:0010607,common atrioventricular valve|MP:0011666,double outlet right ventricle, ventricular defect committed to aorta
MGI:5313696	b2b251Clo	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0001175,abnormal lung morphology|MP:0003387,aorta coarctation|MP:0004113,abnormal aortic arch morphology|MP:0004880,lung cyst|MP:0010418,perimembraneous ventricular septal defect|MP:0010419,inlet ventricular septal defect|MP:0010543,aorta tubular hypoplasia
MGI:5560906	b2b2588Clo	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0000757,herniated abdominal wall|MP:0001823,thymus hypoplasia|MP:0003052,omphalocele|MP:0003675,kidney cyst|MP:0004113,abnormal aortic arch morphology|MP:0004158,right aortic arch|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010488,abnormal left subclavian artery morphology|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5620186	b2b2696.1Clo	MP:0000284,double outlet right ventricle|MP:0000477,abnormal intestine morphology|MP:0000644,dextrocardia|MP:0000690,absent spleen|MP:0001625,cardiac hypertrophy|MP:0004133,heterotaxia|MP:0006063,abnormal inferior vena cava morphology|MP:0010412,atrioventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010441,total anomalous pulmonary venous connection|MP:0011250,abdominal situs ambiguus
MGI:5620188	b2b2696.2Clo	MP:0000024,lowered ear position|MP:0000108,midline facial cleft|MP:0000536,hydroureter|MP:0001293,anophthalmia|MP:0001823,thymus hypoplasia|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia|MP:0004017,duplex kidney|MP:0004158,right aortic arch|MP:0010412,atrioventricular septal defect|MP:0010466,vascular ring
MGI:5620185	b2b2696Clo	MP:0000284,double outlet right ventricle|MP:0000477,abnormal intestine morphology|MP:0000644,dextrocardia|MP:0000690,absent spleen|MP:0001625,cardiac hypertrophy|MP:0004133,heterotaxia|MP:0006063,abnormal inferior vena cava morphology|MP:0010412,atrioventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010441,total anomalous pulmonary venous connection|MP:0011250,abdominal situs ambiguus
MGI:5560812	b2b2736.2Clo	MP:0000111,cleft palate|MP:0000564,syndactyly|MP:0001178,pulmonary hypoplasia|MP:0001297,microphthalmia|MP:0001823,thymus hypoplasia|MP:0002639,micrognathia|MP:0003446,renal hypoplasia|MP:0004113,abnormal aortic arch morphology|MP:0004158,right aortic arch|MP:0010412,atrioventricular septal defect|MP:0010466,vascular ring|MP:0010488,abnormal left subclavian artery morphology|MP:0011661,persistent truncus arteriosus type i
MGI:5560813	b2b2736Clo	MP:0000111,cleft palate|MP:0000531,right pulmonary isomerism|MP:0000542,left-sided isomerism|MP:0000564,syndactyly|MP:0000694,spleen hypoplasia|MP:0001178,pulmonary hypoplasia|MP:0001297,microphthalmia|MP:0001823,thymus hypoplasia|MP:0002639,micrognathia|MP:0003342,accessory spleen|MP:0003446,renal hypoplasia|MP:0004113,abnormal aortic arch morphology|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0010402,ventricular septal defect|MP:0010406,common atrium|MP:0010412,atrioventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010422,heart right ventricle hypoplasia|MP:0010443,total anomalous pulmonary venous connection, intracardiac|MP:0010466,vascular ring|MP:0010487,abnormal right subclavian artery morphology|MP:0010488,abnormal left subclavian artery morphology|MP:0010808,right-sided stomach|MP:0011254,superior-inferior ventricles|MP:0011661,persistent truncus arteriosus type i|MP:0011665,d-loop transposition of the great arteries
MGI:5560909	b2b2738Clo	MP:0000024,lowered ear position|MP:0000087,absent mandible|MP:0000276,heart right ventricle hypertrophy|MP:0000520,absent kidney|MP:0000565,oligodactyly|MP:0000585,kinked tail|MP:0000849,abnormal cerebellum morphology|MP:0001293,anophthalmia|MP:0002625,heart left ventricle hypertrophy|MP:0004113,abnormal aortic arch morphology|MP:0004158,right aortic arch|MP:0010464,abnormal aortic arch and aortic arch branch attachment
MGI:5560910	b2b2739Clo	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0001265,decreased body size|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002639,micrognathia|MP:0004056,abnormal myocardium compact layer morphology|MP:0004113,abnormal aortic arch morphology|MP:0004158,right aortic arch|MP:0005170,cleft upper lip|MP:0008816,petechiae|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010466,vascular ring|MP:0010488,abnormal left subclavian artery morphology|MP:0011667,double outlet right ventricle with atrioventricular septal defect|MP:0011668,double outlet right ventricle, Taussig bing type
MGI:5616525	b2b2815Clo	MP:0000024,lowered ear position|MP:0000087,absent mandible|MP:0000111,cleft palate|MP:0000273,overriding aortic valve|MP:0000445,short snout|MP:0001293,anophthalmia|MP:0001625,cardiac hypertrophy|MP:0002135,abnormal kidney morphology|MP:0002639,micrognathia|MP:0010418,perimembraneous ventricular septal defect
MGI:5570109	b2b2821Clo	MP:0000111,cleft palate|MP:0000531,right pulmonary isomerism|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0001823,thymus hypoplasia|MP:0004113,abnormal aortic arch morphology|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0006063,abnormal inferior vena cava morphology|MP:0010406,common atrium|MP:0010412,atrioventricular septal defect|MP:0010441,total anomalous pulmonary venous connection|MP:0010466,vascular ring|MP:0010488,abnormal left subclavian artery morphology|MP:0010808,right-sided stomach|MP:0011250,abdominal situs ambiguus|MP:0011254,superior-inferior ventricles|MP:0011665,d-loop transposition of the great arteries
MGI:5646292	b2b2966Clo	MP:0000024,lowered ear position|MP:0000284,double outlet right ventricle|MP:0000484,abnormal pulmonary artery morphology|MP:0000520,absent kidney|MP:0000564,syndactyly|MP:0000572,abnormal autopod morphology|MP:0000650,mesocardia|MP:0000914,exencephaly|MP:0001265,decreased body size|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001823,thymus hypoplasia|MP:0002633,persistent truncus arteriosus|MP:0002705,dilated renal tubule|MP:0003051,curly tail|MP:0003178,left pulmonary isomerism|MP:0003675,kidney cyst|MP:0004157,interrupted aortic arch|MP:0004158,right aortic arch|MP:0004733,abnormal thoracic cavity morphology|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010460,pulmonary artery hypoplasia|MP:0010466,vascular ring|MP:0010487,abnormal right subclavian artery morphology
MGI:5646614	b2b3077.2Clo	MP:0000111,cleft palate|MP:0000286,abnormal mitral valve morphology|MP:0000445,short snout|MP:0000477,abnormal intestine morphology|MP:0000564,syndactyly|MP:0000572,abnormal autopod morphology|MP:0001178,pulmonary hypoplasia|MP:0001823,thymus hypoplasia|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0002135,abnormal kidney morphology|MP:0002639,micrognathia|MP:0004733,abnormal thoracic cavity morphology|MP:0005170,cleft upper lip|MP:0006115,aortic valve atresia|MP:0010446,heart left ventricle hypoplasia
MGI:5646612	b2b3077Clo	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0000286,abnormal mitral valve morphology|MP:0000445,short snout|MP:0000477,abnormal intestine morphology|MP:0000564,syndactyly|MP:0000572,abnormal autopod morphology|MP:0001178,pulmonary hypoplasia|MP:0001823,thymus hypoplasia|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0002135,abnormal kidney morphology|MP:0002633,persistent truncus arteriosus|MP:0002639,micrognathia|MP:0004733,abnormal thoracic cavity morphology|MP:0005170,cleft upper lip|MP:0006115,aortic valve atresia|MP:0010412,atrioventricular septal defect|MP:0010446,heart left ventricle hypoplasia|MP:0010460,pulmonary artery hypoplasia
MGI:5648003	b2b3121.2Clo	MP:0001891,hydrocephaly|MP:0010530,cerebral arteriovenous malformation
MGI:5647996	b2b3121Clo	MP:0000111,cleft palate|MP:0000642,enlarged adrenal glands|MP:0001823,thymus hypoplasia|MP:0001891,hydrocephaly|MP:0002925,abnormal cardiovascular development|MP:0010484,bicuspid aortic valve|MP:0010527,bicuspid pulmonary valve|MP:0010530,cerebral arteriovenous malformation
MGI:6161436	b2b3183Clo	MP:0004113,abnormal aortic arch morphology|MP:0010412,atrioventricular septal defect|MP:0010446,heart left ventricle hypoplasia|MP:0010463,aorta stenosis|MP:0010485,aortic arch hypoplasia|MP:0010607,common atrioventricular valve
MGI:5648208	b2b3260.2Clo	MP:0000111,cleft palate|MP:0000703,abnormal thymus morphology|MP:0001823,thymus hypoplasia|MP:0003675,kidney cyst|MP:0004056,abnormal myocardium compact layer morphology|MP:0004110,transposition of great arteries|MP:0010412,atrioventricular septal defect
MGI:5648202	b2b3260Clo	MP:0000111,cleft palate|MP:0000445,short snout|MP:0000703,abnormal thymus morphology|MP:0000914,exencephaly|MP:0001823,thymus hypoplasia|MP:0002135,abnormal kidney morphology|MP:0002633,persistent truncus arteriosus|MP:0002746,abnormal semilunar valve morphology|MP:0003675,kidney cyst|MP:0004056,abnormal myocardium compact layer morphology|MP:0004110,transposition of great arteries|MP:0009743,preaxial polydactyly|MP:0010412,atrioventricular septal defect
MGI:5313523	b2b370.1Clo	MP:0000453,absent mouth|MP:0002639,micrognathia|MP:0004158,right aortic arch|MP:0005157,holoprosencephaly|MP:0006290,proboscis|MP:0010469,ascending aorta hypoplasia|MP:0010663,abnormal brachiocephalic trunk morphology
MGI:5311366	b2b370Clo	MP:0000276,heart right ventricle hypertrophy|MP:0000452,abnormal mouth morphology|MP:0000453,absent mouth|MP:0001614,abnormal blood vessel morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia|MP:0003924,diaphragmatic hernia|MP:0004113,abnormal aortic arch morphology|MP:0004158,right aortic arch|MP:0005157,holoprosencephaly|MP:0006290,proboscis|MP:0010457,pulmonary artery stenosis|MP:0010464,abnormal aortic arch and aortic arch branch attachment|MP:0010469,ascending aorta hypoplasia|MP:0010471,supravalvar aortic stenosis|MP:0010663,abnormal brachiocephalic trunk morphology
MGI:5431636	b2b383Clo	MP:0000273,overriding aortic valve|MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0000453,absent mouth|MP:0001297,microphthalmia|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia|MP:0004158,right aortic arch|MP:0005157,holoprosencephaly|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0013791,absent external nares
MGI:5605963	b2b386.1Clo	MP:0000284,double outlet right ventricle|MP:0000690,absent spleen|MP:0003178,left pulmonary isomerism|MP:0004133,heterotaxia|MP:0006063,abnormal inferior vena cava morphology|MP:0010402,ventricular septal defect|MP:0010406,common atrium|MP:0010412,atrioventricular septal defect|MP:0010476,coronary fistula|MP:0011250,abdominal situs ambiguus|MP:0011667,double outlet right ventricle with atrioventricular septal defect|MP:0014518,myocardial hypertrabeculation
MGI:5605971	b2b386.2Clo	MP:0000111,cleft palate|MP:0000519,hydronephrosis|MP:0000598,abnormal liver morphology|MP:0002135,abnormal kidney morphology|MP:0002639,micrognathia|MP:0004113,abnormal aortic arch morphology|MP:0004157,interrupted aortic arch|MP:0004703,abnormal vertebral column morphology
MGI:5297423	b2b386Clo	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0000519,hydronephrosis|MP:0000598,abnormal liver morphology|MP:0000690,absent spleen|MP:0002135,abnormal kidney morphology|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002639,micrognathia|MP:0003178,left pulmonary isomerism|MP:0004113,abnormal aortic arch morphology|MP:0004133,heterotaxia|MP:0004157,interrupted aortic arch|MP:0004703,abnormal vertebral column morphology|MP:0006063,abnormal inferior vena cava morphology|MP:0010402,ventricular septal defect|MP:0010406,common atrium|MP:0010412,atrioventricular septal defect|MP:0010476,coronary fistula|MP:0011250,abdominal situs ambiguus|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5297424	b2b464Clo	MP:0000284,double outlet right ventricle|MP:0006122,mitral valve stenosis|MP:0010403,atrial septal defect|MP:0010446,heart left ventricle hypoplasia|MP:0010485,aortic arch hypoplasia|MP:0010541,aorta hypoplasia|MP:0010580,decreased heart left ventricle size|MP:0031523,mitral valve hypoplasia|MP:0031567,aortic valve hypoplasia
MGI:5313713	b2b498Clo	MP:0001178,pulmonary hypoplasia|MP:0006130,pulmonary valve atresia|MP:0010402,ventricular septal defect|MP:0010865,prenatal growth retardation|MP:0011674,multiple major aortopulmonary collateral arteries
MGI:5313992	b2b508.2Clo	MP:0001293,anophthalmia|MP:0002639,micrognathia|MP:0005157,holoprosencephaly|MP:0009579,acephaly|MP:0009880,decreased mouth size|MP:0010402,ventricular septal defect
MGI:5313714	b2b508Clo	MP:0000284,double outlet right ventricle|MP:0000433,microcephaly|MP:0001293,anophthalmia|MP:0002639,micrognathia|MP:0005157,holoprosencephaly|MP:0009579,acephaly|MP:0009880,decreased mouth size|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010413,complete atrioventricular septal defect|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5316778	b2b520Clo	MP:0004158,right aortic arch|MP:0010422,heart right ventricle hypoplasia|MP:0010460,pulmonary artery hypoplasia|MP:0011680,tricuspid valve hypoplasia
MGI:5316779	b2b540Clo	MP:0002633,persistent truncus arteriosus
MGI:5430052	b2b576Clo	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle
MGI:5311367	b2b635Clo	MP:0000267,abnormal heart development|MP:0000284,double outlet right ventricle|MP:0000452,abnormal mouth morphology|MP:0000585,kinked tail|MP:0002639,micrognathia|MP:0004225,patent cardiac foramen ovale|MP:0006115,aortic valve atresia|MP:0006122,mitral valve stenosis|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0010426,abnormal heart and great artery attachment|MP:0010446,heart left ventricle hypoplasia|MP:0010468,abnormal thoracic aorta morphology|MP:0010469,ascending aorta hypoplasia|MP:0031523,mitral valve hypoplasia|MP:0031567,aortic valve hypoplasia|MP:0031607,abnormal fetal cardiomyocyte mitochondrial morphology
MGI:5446154	b2b773Clo	MP:0002747,abnormal aortic valve morphology|MP:0011665,d-loop transposition of the great arteries|MP:0011684,coronary-cameral fistula to heart right ventricle
MGI:5696171	b2b811.2Clo	MP:0001625,cardiac hypertrophy|MP:0010418,perimembraneous ventricular septal defect
MGI:5696169	b2b811Clo	MP:0000157,abnormal sternum morphology|MP:0000273,overriding aortic valve|MP:0000644,dextrocardia|MP:0001625,cardiac hypertrophy|MP:0004133,heterotaxia|MP:0006061,right atrial isomerism|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010476,coronary fistula|MP:0011250,abdominal situs ambiguus|MP:0011252,situs inversus totalis|MP:0011665,d-loop transposition of the great arteries
MGI:5317766	b2b827Clo	MP:0000111,cleft palate|MP:0001293,anophthalmia|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia|MP:0005170,cleft upper lip|MP:0010402,ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect
MGI:5317767	b2b842Clo	MP:0000111,cleft palate|MP:0000276,heart right ventricle hypertrophy|MP:0000520,absent kidney|MP:0002625,heart left ventricle hypertrophy|MP:0008797,facial cleft|MP:0010420,muscular ventricular septal defect
MGI:5431495	b2b904.1Clo	MP:0002189,abnormal myocardial trabeculae morphology|MP:0005329,abnormal myocardium layer morphology|MP:0008022,dilated heart ventricle
MGI:5431496	b2b904.2Clo	MP:0000276,heart right ventricle hypertrophy|MP:0002625,heart left ventricle hypertrophy
MGI:5431494	b2b904Clo	MP:0000276,heart right ventricle hypertrophy|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002625,heart left ventricle hypertrophy|MP:0005329,abnormal myocardium layer morphology|MP:0008022,dilated heart ventricle
MGI:5316782	b2b913Clo	MP:0000276,heart right ventricle hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0010422,heart right ventricle hypoplasia|MP:0010458,pulmonary trunk hypoplasia|MP:0011680,tricuspid valve hypoplasia
MGI:5431498	b2b918Clo	MP:0000276,heart right ventricle hypertrophy|MP:0002625,heart left ventricle hypertrophy
MGI:5316783	b2b940Clo	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0001293,anophthalmia|MP:0004158,right aortic arch|MP:0010402,ventricular septal defect|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5311377	b2b942Clo	MP:0000284,double outlet right ventricle|MP:0010406,common atrium|MP:0010412,atrioventricular septal defect|MP:0010457,pulmonary artery stenosis|MP:0011250,abdominal situs ambiguus
MGI:5311368	b2b954Clo	MP:0001823,thymus hypoplasia|MP:0001914,hemorrhage|MP:0002633,persistent truncus arteriosus|MP:0004158,right aortic arch|MP:0010402,ventricular septal defect|MP:0010466,vascular ring
MGI:5318330	b2b972Clo	MP:0000284,double outlet right ventricle|MP:0001293,anophthalmia|MP:0002189,abnormal myocardial trabeculae morphology|MP:0004113,abnormal aortic arch morphology|MP:0004157,interrupted aortic arch|MP:0010402,ventricular septal defect
MGI:5318333	b2b977Clo	MP:0000284,double outlet right ventricle|MP:0002189,abnormal myocardial trabeculae morphology|MP:0004113,abnormal aortic arch morphology|MP:0004157,interrupted aortic arch|MP:0004158,right aortic arch|MP:0011665,d-loop transposition of the great arteries
MGI:5311380	b2b997Clo	MP:0000284,double outlet right ventricle|MP:0000531,right pulmonary isomerism|MP:0001175,abnormal lung morphology|MP:0004133,heterotaxia|MP:0010402,ventricular septal defect|MP:0010406,common atrium|MP:0011250,abdominal situs ambiguus|MP:0011665,d-loop transposition of the great arteries|MP:0011667,double outlet right ventricle with atrioventricular septal defect|MP:0011673,unbalanced complete common atrioventricular canal
MGI:5446155	b2b999Clo	MP:0000276,heart right ventricle hypertrophy|MP:0000286,abnormal mitral valve morphology|MP:0002624,abnormal tricuspid valve morphology|MP:0002625,heart left ventricle hypertrophy|MP:0006128,pulmonary valve stenosis
MGI:5692877	B2m<tm1b(EUCOMM)Wtsi>	MP:0001102,small superior vagus ganglion|MP:0001566,increased circulating phosphate level|MP:0002060,abnormal skin morphology|MP:0009709,hydrometra|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:1927183	B2m<tm1Jae>	MP:0002436,abnormal CD8-positive, alpha-beta cytotoxic T cell morphology|MP:0004165,abnormal lateral geniculate nucleus morphology|MP:0005026,decreased susceptibility to parasitic infection|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005638,hemochromatosis|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008346,increased gamma-delta T cell number|MP:0008350,increased gamma-delta intraepithelial T cell number|MP:0008560,increased tumor necrosis factor secretion|MP:0008696,increased interleukin-3 secretion|MP:0008700,decreased interleukin-4 secretion
MGI:1857133	B2m<tm1Unc>	MP:0000727,absent CD8-positive, alpha-beta T cells|MP:0001805,decreased IgG level|MP:0001841,decreased level of surface class I molecules|MP:0001944,abnormal pancreas morphology|MP:0002411,decreased susceptibility to bacterial infection|MP:0002494,increased IgM level|MP:0004031,insulitis|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005419,decreased circulating serum albumin level|MP:0006387,abnormal T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008086,increased T-helper 1 cell number|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0009787,increased susceptibility to infection induced morbidity/mortality
MGI:3604458	B3galnt1<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:2183036	B3galnt1<tm1Led>	MP:0001728,failure of embryo implantation|MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:5883341	B3galnt2<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001697,abnormal embryo size|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:5696895	B3galt2<tm1.1(KOMP)Vlcg>	MP:0000062,increased bone mineral density|MP:0001399,hyperactivity|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0005016,decreased lymphocyte cell number|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3604457	B3galt2<tm1Dgen>	MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001488,increased startle reflex|MP:0003064,decreased coping response|MP:0031391,increased locomotor activity
MGI:3604460	B3galt5<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:5754562	B3galt6<em2(IMPC)Tcp>	MP:0002092,abnormal eye morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3759445	B3gat1<tm1Tkaw>	MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0005386,behavior/neurological phenotype
MGI:6115601	B3gat2<tm1Shok>	MP:0003631,nervous system phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:6761401	B3gat3<m1Btlr>	MP:0002764,short tibia|MP:0003109,short femur
MGI:6761402	B3gat3<m2Btlr>	MP:0002764,short tibia|MP:0003109,short femur
MGI:5697553	B3gat3<tm1Hkit>	MP:0006204,embryonic lethality before implantation|MP:0011475,abnormal glycosaminoglycan level|MP:0013289,abnormal mitotic cytokinesis
MGI:6277079	B3glct<tm1.2Nari>	MP:0000074,abnormal neurocranium morphology|MP:0000102,abnormal nasal bone morphology|MP:0000104,abnormal sphenoid bone morphology|MP:0000441,increased cranium width|MP:0001265,decreased body size|MP:0001300,ocular hypertelorism|MP:0001891,hydrocephaly|MP:0002544,brachydactyly|MP:0002938,white spotting|MP:0004379,wide frontal bone|MP:0004380,short frontal bone|MP:0004472,broad nasal bone|MP:0004686,decreased length of long bones|MP:0005391,vision/eye phenotype|MP:0006396,decreased long bone epiphyseal plate size|MP:0008273,abnormal intramembranous bone ossification|MP:0010031,abnormal cranium size|MP:0011861,increased cranium height|MP:0030066,short face|MP:0030099,facial asymmetry|MP:0030316,enlarged neurocranium|MP:0030384,short facial bone|MP:0030420,short basicranium
MGI:4820079	B3glct<tm1a(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:6274693	B3glct<tm1b(KOMP)Wtsi>	MP:0000102,abnormal nasal bone morphology|MP:0000104,abnormal sphenoid bone morphology|MP:0000564,syndactyly|MP:0001265,decreased body size|MP:0001300,ocular hypertelorism|MP:0002938,white spotting|MP:0004379,wide frontal bone|MP:0004380,short frontal bone|MP:0004472,broad nasal bone|MP:0005391,vision/eye phenotype|MP:0008273,abnormal intramembranous bone ossification|MP:0030099,facial asymmetry|MP:0030316,enlarged neurocranium|MP:0030384,short facial bone
MGI:6315841	B3glct<tm1d(KOMP)Wtsi>	MP:0000428,abnormal craniofacial morphology|MP:0005508,abnormal skeleton morphology
MGI:3576265	B3gnt2<Gt(KST308)Byg>	MP:0001003,abnormal olfactory receptor morphology|MP:0001984,abnormal olfaction|MP:0003203,increased neuron apoptosis|MP:0005394,taste/olfaction phenotype|MP:0008789,abnormal olfactory epithelium morphology
MGI:3529146	B3gnt2<Gt(OST237555)Lex>	MP:0002451,abnormal macrophage physiology|MP:0005348,increased T cell proliferation|MP:0008560,increased tumor necrosis factor secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008705,increased interleukin-6 secretion
MGI:3604461	B3gnt2<tm1Dgen>	MP:0001364,decreased anxiety-related response|MP:0002573,behavioral despair
MGI:3604463	B3gnt3<tm1Dgen>	MP:0003998,decreased thermal nociceptive threshold
MGI:4867401	B3gnt5<tm1Big>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001261,obese|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002359,abnormal spleen germinal center morphology|MP:0005017,decreased B cell number|MP:0008028,pregnancy-related premature death|MP:0008234,absent spleen marginal zone|MP:0008475,intermingled spleen red and white pulp|MP:0008478,increased spleen white pulp amount|MP:0008770,decreased survivor rate|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4459891	B3gnt5<tm1Nari>	MP:0002493,increased IgG level|MP:0004939,abnormal B cell morphology|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0010768,mortality/aging
MGI:3830631	B3gnt5<tm1Then>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4867403	B3gnt5<tm2.1Big>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001261,obese|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002359,abnormal spleen germinal center morphology|MP:0005017,decreased B cell number|MP:0008028,pregnancy-related premature death|MP:0008234,absent spleen marginal zone|MP:0008475,intermingled spleen red and white pulp|MP:0008478,increased spleen white pulp amount|MP:0008770,decreased survivor rate|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5447022	B3gnt6<tm1Lx>	MP:0000220,increased monocyte cell number|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000512,intestinal ulcer|MP:0002038,increased carcinoma incidence|MP:0002404,increased intestinal adenoma incidence|MP:0003293,rectal hemorrhage|MP:0003721,increased tumor growth/size|MP:0004499,increased incidence of tumors by chemical induction|MP:0005015,increased T cell number|MP:0005036,diarrhea|MP:0005425,increased macrophage cell number|MP:0008537,increased susceptibility to induced colitis|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion|MP:0008883,abnormal enterocyte proliferation|MP:0009308,increased adenocarcinoma incidence|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0010279,increased gastrointestinal tumor incidence|MP:0013956,decreased colon length
MGI:6160920	B3gnt7<tm1Akam>	MP:0001312,abnormal cornea morphology|MP:0003092,decreased cornea stroma thickness|MP:0005543,decreased cornea thickness
MGI:5548784	B3gnt7<tm1e.1(KOMP)Wtsi>	MP:0000274,enlarged heart|MP:0000691,enlarged spleen|MP:0002574,increased vertical activity
MGI:7708053	B3gntl1<em1(IMPC)Mbp>	MP:0010052,increased grip strength
MGI:2158349	B4galnt1<tm1Rlp>	MP:0001154,seminiferous tubule degeneration|MP:0001925,male infertility
MGI:2158348	B4galnt1<tm1Sia>	MP:0003633,abnormal nervous system physiology
MGI:3618460	B4galnt2<tm1Jbl>	MP:0000219,increased neutrophil cell number|MP:0001488,increased startle reflex|MP:0002458,abnormal B cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0006143,increased systemic arterial diastolic blood pressure
MGI:4434237	B4galnt3<tm1a(EUCOMM)Wtsi>	MP:0001391,abnormal tail movements|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:7344348	B4galnt4<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2178779	B4galt1<tm1Shur>	MP:0000379,decreased hair follicle number|MP:0000416,sparse hair|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001179,thick pulmonary interalveolar septum|MP:0001199,thin skin|MP:0001429,dehydration|MP:0001732,postnatal growth retardation|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002293,long gestation period|MP:0002674,abnormal sperm motility|MP:0002768,small adrenal glands|MP:0004514,dystocia|MP:0004542,impaired acrosome reaction|MP:0004543,abnormal sperm physiology|MP:0005381,digestive/alimentary phenotype|MP:0005410,abnormal fertilization|MP:0005478,decreased circulating thyroxine level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008288,abnormal adrenal cortex morphology|MP:0008294,abnormal adrenal gland zona fasciculata morphology|MP:0008295,abnormal adrenal gland zona reticularis morphology|MP:0008321,small adenohypophysis|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0010249,lactation failure|MP:0010899,abnormal pulmonary alveolar system morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0013337,abnormal adenohypophysis development
MGI:2450889	B4galt1<tm1Yiw>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000488,abnormal intestinal epithelium morphology|MP:0000496,abnormal small intestine morphology|MP:0000691,enlarged spleen|MP:0001212,skin lesions|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001874,acanthosis|MP:0001935,decreased litter size|MP:0002006,neoplasm|MP:0002083,premature death|MP:0002416,abnormal proerythroblast morphology|MP:0002442,abnormal leukocyte physiology|MP:0002463,abnormal neutrophil physiology|MP:0002495,increased IgA level|MP:0002743,glomerulonephritis|MP:0002871,albuminuria|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002908,delayed wound healing|MP:0003710,abnormal physiological neovascularization|MP:0003799,impaired macrophage chemotaxis|MP:0004047,abnormal milk composition|MP:0004760,increased mitotic index|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0005013,increased lymphocyte cell number|MP:0005087,decreased acute inflammation|MP:0005161,hematuria|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008719,impaired neutrophil recruitment|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011339,abnormal glomerular mesangium morphology|MP:0011353,expanded mesangial matrix|MP:0020180,abnormal IgM level
MGI:3771315	B4galt1<tm2Shur>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0004047,abnormal milk composition|MP:0004542,impaired acrosome reaction|MP:0005376,homeostasis/metabolism phenotype|MP:0005410,abnormal fertilization|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006269,abnormal mammary gland growth during pregnancy
MGI:3849305	B4galt2<tm1Masn>	MP:0000880,decreased Purkinje cell number|MP:0000885,ectopic Purkinje cell|MP:0001392,abnormal locomotor behavior|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0002175,decreased brain weight|MP:0006097,abnormal cerebellar lobule formation|MP:0006254,thin cerebral cortex|MP:0008535,enlarged lateral ventricles
MGI:7780011	B4galt3<em1Masn>	MP:0002436,abnormal CD8-positive, alpha-beta cytotoxic T cell morphology|MP:0003447,decreased tumor growth/size|MP:0004974,decreased regulatory T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:7411374	B4galt4<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number
MGI:7780013	B4galt4<em1Masn>	MP:0002006,neoplasm
MGI:6435667	B4galt5<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001697,abnormal embryo size|MP:0002060,abnormal skin morphology|MP:0002941,increased circulating alanine transaminase level|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3530090	B4galt5<Gt(OST202518)Lex>	MP:0001363,increased anxiety-related response|MP:0001698,decreased embryo size|MP:0010166,increased response to stress-induced hyperthermia|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:3529464	B4galt6<Gt(OST126901)Lex>	MP:0002169,no abnormal phenotype detected
MGI:6151125	B4galt6<tm1Kfk>	MP:0005376,homeostasis/metabolism phenotype|MP:0005621,abnormal cell physiology
MGI:5470461	B4gat1<m1Ddg>	MP:0000752,dystrophic muscle|MP:0000778,abnormal nervous system tract morphology|MP:0002961,abnormal axon guidance|MP:0009450,abnormal axon fasciculation|MP:0009677,abnormal spinal cord dorsal column morphology
MGI:5583065	B4gat1<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0014586,decreased egg cylinder size
MGI:4399423	B4gat1<tm1(KOMP)Vlcg>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3710015	B4gat1<tm1Mifu>	MP:0005387,immune system phenotype|MP:0008828,abnormal lymph node cell ratio|MP:0020332,impaired leukocyte tethering or rolling
MGI:4432284	B9d1<tm1a(EUCOMM)Wtsi>	MP:0000111,cleft palate|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0000785,telencephalon hypoplasia|MP:0000914,exencephaly|MP:0001260,increased body weight|MP:0001297,microphthalmia|MP:0001486,abnormal startle reflex|MP:0002135,abnormal kidney morphology|MP:0002652,thin myocardium|MP:0002929,abnormal bile duct development|MP:0003068,enlarged kidney|MP:0003743,abnormal facial morphology|MP:0004839,bile duct hyperplasia|MP:0005157,holoprosencephaly|MP:0005316,abnormal response to tactile stimuli|MP:0008528,polycystic kidney|MP:0009743,preaxial polydactyly|MP:0010402,ventricular septal defect|MP:0011066,abnormal renal tubule epithelial cell primary cilium morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011293,dilated nephron|MP:0011408,renal tubule hypertrophy|MP:0011998,decreased embryonic cilium length|MP:0013197,decreased embryonic cilium number
MGI:5301332	B9d1<tm1d(EUCOMM)Wtsi>	MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0001297,microphthalmia|MP:0001614,abnormal blood vessel morphology|MP:0001672,abnormal embryo development|MP:0002109,abnormal limb morphology|MP:0002127,abnormal cardiovascular system morphology|MP:0002135,abnormal kidney morphology|MP:0002138,abnormal hepatobiliary system morphology|MP:0003861,abnormal nervous system development|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:3719581	B9d2/Tgfb1<tm1Flv>	MP:0004946,abnormal regulatory T cell physiology|MP:0008119,decreased Langerhans cell number
MGI:3719621	B9d2/Tgfb1<tm1Flv>	MP:0001845,abnormal inflammatory response|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002145,abnormal T cell differentiation|MP:0002816,colitis|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004946,abnormal regulatory T cell physiology|MP:0004973,increased regulatory T cell number|MP:0005150,cachexia|MP:0005378,growth/size/body region phenotype|MP:0005387,immune system phenotype|MP:0008086,increased T-helper 1 cell number|MP:0008119,decreased Langerhans cell number|MP:0008883,abnormal enterocyte proliferation|MP:0010220,decreased T-helper 17 cell number|MP:0010221,abnormal T-helper 17 cell differentiation
MGI:4441794	B9d2<tm1a(EUCOMM)Wtsi>	MP:0000141,abnormal vertebral body morphology|MP:0000150,abnormal rib morphology|MP:0000282,abnormal interatrial septum morphology|MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000455,abnormal maxilla morphology|MP:0000562,polydactyly|MP:0000598,abnormal liver morphology|MP:0000639,abnormal adrenal gland morphology|MP:0000692,small spleen|MP:0000764,abnormal tongue epithelium morphology|MP:0000783,abnormal forebrain morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000841,abnormal hindbrain morphology|MP:0000955,abnormal spinal cord morphology|MP:0001015,small superior cervical ganglion|MP:0001062,absent oculomotor nerve|MP:0001102,small superior vagus ganglion|MP:0001126,abnormal ovary morphology|MP:0001944,abnormal pancreas morphology|MP:0002152,abnormal brain morphology|MP:0002239,abnormal nasal septum morphology|MP:0002279,abnormal diaphragm morphology|MP:0002947,increased hemangioma incidence|MP:0003078,aphakia|MP:0003178,left pulmonary isomerism|MP:0003262,intestinal/bowel diverticulum|MP:0003342,accessory spleen|MP:0003584,bifid ureter|MP:0003686,abnormal eye muscle morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0004110,transposition of great arteries|MP:0004133,heterotaxia|MP:0004163,abnormal adenohypophysis morphology|MP:0004164,abnormal neurohypophysis morphology|MP:0004247,small pancreas|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004613,fusion of vertebral arches|MP:0004790,absent upper incisors|MP:0004950,abnormal brain vasculature morphology|MP:0005358,abnormal incisor morphology|MP:0006065,abnormal heart position or orientation|MP:0008128,abnormal brain internal capsule morphology|MP:0008320,absent adenohypophysis|MP:0008923,thoracoschisis|MP:0009770,abnormal optic chiasm morphology|MP:0010200,enlarged lymphatic vessel|MP:0010406,common atrium|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010427,double outlet left ventricle|MP:0010433,double inlet heart left ventricle|MP:0010439,abnormal hepatic vein morphology|MP:0010440,anomalous pulmonary venous connection|MP:0010496,abnormal pectinate muscle morphology|MP:0010526,aortic arch coarctation|MP:0010527,bicuspid pulmonary valve|MP:0010572,persistent right dorsal aorta|MP:0010614,abnormal mitral valve cusp morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011250,abdominal situs ambiguus|MP:0011380,enlarged brain ventricles|MP:0011493,double ureter|MP:0011513,abnormal vertebral artery morphology|MP:0011683,dual inferior vena cava|MP:0011727,ectopic ovary|MP:0013823,absent segment of anterior cerebral artery|MP:0013827,thin oculomotor nerve|MP:0013830,abnormal intrathoracic topology of vagus nerve|MP:0013836,abnormal hypoglossal nerve topology|MP:0013840,absent segment of posterior cerebral artery|MP:0013842,ductus venosus stenosis|MP:0013848,subcutaneous edema|MP:0013874,abnormal ductus venosus topology|MP:0013876,absent ductus venosus valve|MP:0013878,abnormal ductus venosus valve topology|MP:0013917,persistent right 6th pharyngeal arch artery|MP:0013928,thin motoric part of trigeminal nerve|MP:0013936,abnormal thymus topology|MP:0013967,abnormal infrahyoid muscle connection|MP:0013969,reduced sympathetic cervical ganglion size|MP:0013971,blood in lymph vessels|MP:0013977,symmetric azygos veins|MP:0013979,abnormal subclavian artery origin|MP:0013982,inverse situs of great intrathoracic arteries|MP:0013985,abnormal umbilical vein topology|MP:0013986,abnormal vitelline vein topology|MP:0013987,absent intrahepatic inferior vena cava segment|MP:0014000,anastomosis between internal carotid artery and basilar artery|MP:0014001,abnormal vertebral artery topology|MP:0014003,additional anastomosis between intracranial vertebral arteries|MP:0014017,abnormal Wolffian duct connection|MP:0014018,embryo tumor|MP:0014019,embryo cyst|MP:0014023,abnormal intestine placement|MP:0020301,short tongue|MP:0020494,left sided inferior vena cava
MGI:1856678	ba	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000417,short hair|MP:0000422,delayed hair appearance|MP:0000427,abnormal hair cycle|MP:0000652,enlarged sebaceous gland|MP:0001219,thick epidermis|MP:0001245,thick dermal layer|MP:0001284,absent vibrissae|MP:0001732,postnatal growth retardation|MP:0002001,blindness|MP:0002060,abnormal skin morphology|MP:0003704,abnormal hair follicle development|MP:0003809,abnormal hair shaft morphology|MP:0003815,hairless|MP:0004127,thick hypodermis|MP:0008858,abnormal hair cycle anagen phase|MP:0009351,thin hair shaft
MGI:6148072	Baat<em1(IMPC)Mbp>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001304,cataract|MP:0001552,increased circulating triglyceride level|MP:0002339,abnormal lymph node morphology|MP:0002590,increased mean corpuscular volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance
MGI:7425537	Babam1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000432,abnormal head morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001293,anophthalmia|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0002989,small kidney|MP:0003604,single kidney|MP:0005011,increased eosinophil cell number|MP:0008040,decreased NK T cell number|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0020421,increased freezing behavior
MGI:3994220	Babam1<Gt(IST11207B9)Tigm>	MP:0000321,increased bone marrow cell number|MP:0003077,abnormal cell cycle|MP:0004809,increased hematopoietic stem cell number|MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology|MP:0005505,thrombocytosis|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011902,increased hematopoietic stem cell proliferation
MGI:4432635	Babam2<tm1a(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0001406,abnormal gait|MP:0002896,abnormal bone mineralization
MGI:5898381	Babam2<tm1b(EUCOMM)Wtsi>	MP:0005389,reproductive system phenotype|MP:0008008,early cellular replicative senescence|MP:0011704,decreased fibroblast proliferation|MP:0013501,increased fibroblast apoptosis|MP:0014760,impaired DNA repair
MGI:5603349	Bacc1<tm1.1(KOMP)Vlcg>	MP:0001488,increased startle reflex|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2181644	Bace1<tm1.1Slr>	MP:0002169,no abnormal phenotype detected
MGI:3042562	Bace1<tm1Bux>	MP:0002169,no abnormal phenotype detected
MGI:2684825	Bace1<tm1Cdi>	MP:0001362,abnormal anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0002106,abnormal muscle physiology|MP:0002863,improved righting response
MGI:3588406	Bace1<tm1Nn>	MP:0005621,abnormal cell physiology
MGI:2389228	Bace1<tm1Pcw>	MP:0000920,abnormal myelination|MP:0001364,decreased anxiety-related response|MP:0001463,abnormal spatial learning|MP:0001486,abnormal startle reflex|MP:0001898,abnormal long-term depression|MP:0002919,enhanced paired-pulse facilitation|MP:0003313,abnormal locomotor activation|MP:0003461,abnormal response to novel object|MP:0003871,abnormal myelin sheath morphology|MP:0003998,decreased thermal nociceptive threshold|MP:0004000,impaired passive avoidance behavior|MP:0008414,abnormal spatial reference memory|MP:0008428,abnormal spatial working memory|MP:0009142,decreased prepulse inhibition|MP:0009746,enhanced behavioral response to xenobiotic|MP:0009936,abnormal dendritic spine morphology|MP:0010053,decreased grip strength|MP:0011619,abnormal dishabituation
MGI:3603141	Bace1<tm1Psa>	MP:0000921,demyelination|MP:0001186,pigmentation phenotype|MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0003484,abnormal channel response|MP:0003633,abnormal nervous system physiology|MP:0004069,abnormal muscle spindle morphology|MP:0005150,cachexia|MP:0008486,decreased muscle spindle number|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2180468	Bace1<tm1Vas>	MP:0002169,no abnormal phenotype detected
MGI:3603597	Bace1<tm2Psa>	MP:0001364,decreased anxiety-related response|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031391,increased locomotor activity
MGI:2181645	Bace1<tm2Slr>	MP:0002169,no abnormal phenotype detected
MGI:3603144	Bace2<tm1Bdes>	MP:0000371,diluted coat color|MP:0005075,abnormal melanosome morphology|MP:0005077,abnormal melanogenesis|MP:0005621,abnormal cell physiology|MP:0009388,abnormal epidermal melanocyte morphology|MP:0010192,abnormal retina melanin granule morphology
MGI:6120724	Bace2<tm1b(EUCOMM)Wtsi>	MP:0000194,increased circulating calcium level|MP:0001325,abnormal retina morphology|MP:0011962,increased cornea thickness
MGI:5471267	Bach1<tm1.1(KOMP)Vlcg>	MP:0000062,increased bone mineral density|MP:0002833,increased heart weight|MP:0003928,increased heart rate variability|MP:0005385,cardiovascular system phenotype|MP:0005633,increased circulating sodium level|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:3590153	Bach1<tm1Igar>	MP:0000230,abnormal systemic arterial blood pressure|MP:0002169,no abnormal phenotype detected|MP:0003223,decreased cardiomyocyte apoptosis|MP:0005164,abnormal response to injury|MP:0005592,abnormal vascular smooth muscle morphology
MGI:6283665	Bach2<M1Btlr>	MP:0004977,increased B-1 B cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:5056539	Bach2<m1Ccg>	MP:0005017,decreased B cell number|MP:0008182,decreased marginal zone B cell number|MP:0010373,myeloid hyperplasia
MGI:5563501	Bach2<m2Anu>	MP:0002494,increased IgM level|MP:0008211,decreased mature B cell number|MP:0008214,increased immature B cell number
MGI:4882014	Bach2<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0003795,abnormal bone structure|MP:0004974,decreased regulatory T cell number|MP:0005011,increased eosinophil cell number|MP:0005017,decreased B cell number|MP:0005425,increased macrophage cell number|MP:0005505,thrombocytosis|MP:0005554,decreased circulating creatinine level|MP:0008044,increased NK cell number|MP:0008174,decreased follicular B cell number|MP:0008211,decreased mature B cell number|MP:0008214,increased immature B cell number|MP:0008810,increased circulating iron level|MP:0010124,decreased bone mineral content|MP:0010835,increased CD4-positive, alpha-beta memory T cell number|MP:0010838,increased CD8-positive, alpha-beta memory T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0010851,decreased effector memory CD8-positive, alpha-beta T cell number|MP:0012767,increased KLRG1-positive NK cell number|MP:0013022,increased Ly6C high monocyte number|MP:0013025,increased Ly6C low monocyte number|MP:0013154,increased KLRG1+ CD8 alpha-beta T cell number|MP:0013157,increased KLRG1+ CD4 alpha-beta T cell number|MP:0013424,increased KLRG1-positive gamma-delta T cell number|MP:0013426,decreased memory-marker NK cell number|MP:0013427,increased memory-marker NK cell number|MP:0013430,increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0013433,increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0013514,increased memory-marker CD4-negative NK T cell number|MP:0013517,increased KLRG1-positive CD4-negative NK T cell number|MP:0013649,decreased CD11b-high dendritic cell number|MP:0013651,increased CD11b-low dendritic cell number|MP:0013654,increased CD103-positive CD11b-low dendritic cell number|MP:0013772,increased effector memory T-helper cell number
MGI:5605836	Bach2<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0002757,decreased vertical activity|MP:0002764,short tibia|MP:0002968,increased circulating alkaline phosphatase level|MP:0005011,increased eosinophil cell number|MP:0005017,decreased B cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005387,immune system phenotype|MP:0005554,decreased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005573,increased pulmonary respiratory rate|MP:0008039,increased NK T cell number|MP:0008040,decreased NK T cell number|MP:0008045,decreased NK cell number|MP:0008168,decreased B-1a cell number|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008207,decreased B-2 B cell number|MP:0008259,abnormal optic disk morphology|MP:0008806,increased circulating amylase level|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0010379,decreased respiratory quotient|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0011896,increased circulating unsaturated transferrin level|MP:0011940,decreased food intake|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0013510,decreased CD4-negative NK T cell number|MP:0013513,decreased memory-marker CD4-negative NK T cell number|MP:0013514,increased memory-marker CD4-negative NK T cell number|MP:0013649,decreased CD11b-high dendritic cell number|MP:0013669,decreased Ly6C-positive immature NK cell number|MP:0013675,decreased Ly6C-positive mature NK cell number
MGI:3047541	Bach2<tm1Igar>	MP:0000694,spleen hypoplasia|MP:0001805,decreased IgG level|MP:0001807,decreased IgA level|MP:0002144,abnormal B cell differentiation|MP:0002459,abnormal B cell physiology|MP:0002494,increased IgM level|MP:0004815,abnormal somatic hypermutation frequency|MP:0004816,abnormal class switch recombination|MP:0005017,decreased B cell number|MP:0008179,absent germinal center B cells|MP:0008211,decreased mature B cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:3029528	Bad<tm1Meg>	MP:0000706,small thymus|MP:0001259,abnormal body weight|MP:0001648,abnormal apoptosis|MP:0001823,thymus hypoplasia|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0004956,decreased thymus weight|MP:0005559,increased circulating glucose level|MP:0008208,decreased pro-B cell number|MP:0008211,decreased mature B cell number|MP:0009172,small pancreatic islets|MP:0014117,increased pancreatic beta cell apoptosis
MGI:2675966	Bad<tm1Sjk>	MP:0000188,abnormal circulating glucose level|MP:0000716,abnormal immune system cell morphology|MP:0000807,abnormal hippocampus morphology|MP:0001146,abnormal testis morphology|MP:0001648,abnormal apoptosis|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002160,abnormal reproductive system morphology|MP:0002183,gliosis|MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005387,immune system phenotype|MP:0009167,increased pancreatic islet number|MP:0012431,increased lymphoma incidence|MP:0020550,multinucleated giant male germ cells
MGI:3783745	Bad<tm2Meg>	MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance
MGI:4434714	Bag1<tm1a(EUCOMM)Hmgu>	MP:0002591,decreased mean corpuscular volume|MP:0005564,increased hemoglobin content
MGI:3528234	Bag1<tm1Msd>	MP:0000600,liver hypoplasia|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6294108	Bag2<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001566,increased circulating phosphate level|MP:0013279,increased fasting circulating glucose level
MGI:3530294	Bag3<Gt(OST16086)Lex>	MP:0000759,abnormal skeletal muscle morphology|MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality|MP:0002427,disproportionate dwarf|MP:0003828,pulmonary edema|MP:0004091,abnormal Z line morphology|MP:0004566,myocardial fiber degeneration|MP:0009412,skeletal muscle fiber degeneration|MP:0031645,increased myocardial fiber apoptosis
MGI:6107852	Bag3<tm1.1Chen>	MP:0001732,postnatal growth retardation|MP:0002083,premature death
MGI:3831334	Bag3<tm1.1Jhl>	MP:0000189,hypoglycemia|MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000603,pale liver|MP:0000694,spleen hypoplasia|MP:0001263,weight loss|MP:0001823,thymus hypoplasia|MP:0002575,increased circulating ketone body level|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0003402,decreased liver weight|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight|MP:0005016,decreased lymphocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009283,decreased gonadal fat pad weight|MP:0011085,postnatal lethality, complete penetrance
MGI:4436101	Bag3<tm1a(EUCOMM)Hmgu>	MP:0001260,increased body weight|MP:0010052,increased grip strength
MGI:5548479	Bag3<tm1b(EUCOMM)Hmgu>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0005566,decreased blood urea nitrogen level|MP:0011100,preweaning lethality, complete penetrance
MGI:5760384	Bag3<tm1c(EUCOMM)Hmgu>	MP:0000274,enlarged heart|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0006138,congestive heart failure|MP:0011390,abnormal fetal cardiomyocyte physiology|MP:0011925,abnormal heart echocardiography feature|MP:0030939,abnormal autophagosome formation|MP:0030940,impaired autophagy
MGI:2677764	Bag4<tm1Kpf>	MP:0002169,no abnormal phenotype detected
MGI:2663613	Bag4<tm1Yeh>	MP:0000694,spleen hypoplasia|MP:0001823,thymus hypoplasia|MP:0001846,increased inflammatory response|MP:0002451,abnormal macrophage physiology|MP:0008596,increased circulating interleukin-6 level|MP:0008705,increased interleukin-6 secretion
MGI:7327648	Bag5<em1Asay>	MP:0000278,abnormal myocardial fiber morphology|MP:0002753,dilated heart left ventricle|MP:0004215,abnormal myocardial fiber physiology|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010018,pulmonary vascular congestion|MP:0011925,abnormal heart echocardiography feature|MP:0031633,decreased heart left ventricle muscle contractility
MGI:6452193	Bag5<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001293,anophthalmia|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001925,male infertility|MP:0002092,abnormal eye morphology|MP:0002152,abnormal brain morphology|MP:0002699,abnormal vitreous body morphology
MGI:3705047	Bag6<tm1Pmc>	MP:0000527,abnormal kidney development|MP:0000787,abnormal telencephalon morphology|MP:0000897,abnormal midbrain morphology|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0001178,pulmonary hypoplasia|MP:0001785,edema|MP:0001953,respiratory failure|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0003446,renal hypoplasia|MP:0003604,single kidney|MP:0004505,decreased renal glomerulus number|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0006027,impaired lung alveolus development|MP:0006032,abnormal ureteric bud morphology|MP:0008236,decreased susceptibility to neuronal excitotoxicity|MP:0010979,small ureteric bud|MP:0010982,abnormal ureteric bud elongation|MP:0011032,impaired branching involved in terminal bronchiole morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011294,renal glomerulus hypertrophy|MP:0011368,increased kidney apoptosis|MP:0011440,increased kidney cell proliferation
MGI:3663684	Bahcc1<tm1Mnkm>	MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0005156,bradykinesia|MP:0011090,perinatal lethality, incomplete penetrance
MGI:4941896	Bahd1<tm1.1Ics>	MP:0002411,decreased susceptibility to bacterial infection
MGI:5699601	Bahd1<tm2b(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0001402,decreased locomotor activity|MP:0001488,increased startle reflex|MP:0005015,increased T cell number|MP:0005016,decreased lymphocyte cell number|MP:0008039,increased NK T cell number|MP:0008044,increased NK cell number|MP:0010851,decreased effector memory CD8-positive, alpha-beta T cell number|MP:0011965,decreased total retina thickness|MP:0013511,increased CD4-negative NK T cell number|MP:0013514,increased memory-marker CD4-negative NK T cell number
MGI:3835373	Baiap2<Gt(XG757)Byg>	MP:0000079,abnormal basioccipital bone morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000280,thin ventricular wall|MP:0000281,abnormal interventricular septum morphology|MP:0000297,abnormal atrioventricular cushion morphology|MP:0001458,abnormal object recognition memory|MP:0001463,abnormal spatial learning|MP:0001787,pericardial edema|MP:0002206,abnormal CNS synaptic transmission|MP:0003008,enhanced long-term potentiation|MP:0003227,abnormal vascular branching morphogenesis|MP:0003649,decreased heart right ventricle size|MP:0003920,abnormal heart right ventricle morphology|MP:0003984,embryonic growth retardation|MP:0004200,decreased fetal size|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0005385,cardiovascular system phenotype|MP:0005508,abnormal skeleton morphology|MP:0008770,decreased survivor rate|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0010402,ventricular septal defect|MP:0010498,abnormal interventricular septum muscular part morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011514,skin hemorrhage|MP:0012099,decreased spongiotrophoblast size|MP:0013848,subcutaneous edema|MP:0014280,forelimb oligodactyly|MP:0030975,placenta hemorrhage|MP:0031589,detached epicardium|MP:0031591,detached endocardium
MGI:6355370	Baiap2l1<tm1.1Arte>	MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype
MGI:5828650	Baiap2l1<tm1Zgh>	MP:0002079,increased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0013279,increased fasting circulating glucose level|MP:0020102,increased hepatic glucose production
MGI:6714004	Baiap2l2<em1Pgg>	MP:0001963,abnormal hearing physiology|MP:0002102,abnormal ear morphology|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0004431,abnormal hair cell mechanoelectric transduction
MGI:4435406	Baiap2l2<tm1a(EUCOMM)Hmgu>	MP:0001489,decreased startle reflex|MP:0004738,abnormal auditory brainstem response|MP:0005344,increased circulating bilirubin level|MP:0005599,increased cardiac muscle contractility|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength
MGI:5548844	Baiap2l2<tm1b(EUCOMM)Hmgu>	MP:0000208,decreased hematocrit|MP:0001406,abnormal gait|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0001967,deafness|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0004529,decreased outer hair cell stereocilia number|MP:0004534,decreased inner hair cell stereocilia number|MP:0004738,abnormal auditory brainstem response|MP:0006325,impaired hearing|MP:0009142,decreased prepulse inhibition|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014406,increased or absent distortion product otoacoustic emission threshold
MGI:5605808	Baiap2<tm1b(KOMP)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001785,edema|MP:0003179,thrombocytopenia|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5644306	Baiap3<tm1Smwk>	MP:0001363,increased anxiety-related response|MP:0002797,increased thigmotaxis|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003107,abnormal response to novelty|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential|MP:0009745,abnormal behavioral response to xenobiotic|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude
MGI:2159364	Bak1<tm1Thsn>	MP:0002169,no abnormal phenotype detected|MP:0005464,abnormal platelet physiology|MP:0005505,thrombocytosis
MGI:2448980	baln	MP:0001395,bidirectional circling|MP:0001525,impaired balance|MP:0005191,head tilt
MGI:2448981	baln2	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0001512,trunk curl|MP:0001525,impaired balance|MP:0005191,head tilt
MGI:2448983	baln3	MP:0000852,small cerebellum|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001410,head bobbing|MP:0001512,trunk curl
MGI:2670817	baln4	MP:0001265,decreased body size|MP:0001525,impaired balance|MP:0001921,reduced fertility
MGI:3053570	baln5	MP:0001265,decreased body size|MP:0001525,impaired balance
MGI:3758817	Bambi<tm1.1Jian>	MP:0001262,decreased body weight|MP:0005371,limbs/digits/tail phenotype|MP:0005382,craniofacial phenotype|MP:0005390,skeleton phenotype
MGI:5569047	Bambi<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3758816	Bambi<tm1Jian>	MP:0002169,no abnormal phenotype detected
MGI:4437820	Bambi<tm1Mahu>	MP:0001970,abnormal pain threshold|MP:0001973,increased thermal nociceptive threshold|MP:0005498,hyporesponsive to tactile stimuli|MP:0008531,increased chemical nociceptive threshold
MGI:6836771	Banf1<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001510,abnormal coat appearance|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011100,preweaning lethality, complete penetrance|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6361160	Banf2<em1Osb>	MP:0005389,reproductive system phenotype
MGI:3686872	Bank1<tm1Kuro>	MP:0002359,abnormal spleen germinal center morphology|MP:0002459,abnormal B cell physiology|MP:0002494,increased IgM level|MP:0003945,abnormal lymphocyte physiology|MP:0005154,increased B cell proliferation|MP:0008167,increased B-1a cell number|MP:0008210,increased mature B cell number|MP:0008481,increased spleen germinal center number|MP:0008483,increased spleen germinal center size|MP:0008500,increased IgG2a level|MP:0008826,abnormal splenic cell ratio
MGI:6316626	Banp<em1(IMPC)J>	MP:0005178,increased circulating cholesterol level|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5424902	BAP008	MP:0002968,increased circulating alkaline phosphatase level
MGI:5424904	BAP011	MP:0002968,increased circulating alkaline phosphatase level
MGI:5424905	BAP013	MP:0002968,increased circulating alkaline phosphatase level
MGI:5424914	BAP028	MP:0001265,decreased body size|MP:0002966,decreased circulating alkaline phosphatase level
MGI:5424915	BAP029	MP:0002966,decreased circulating alkaline phosphatase level
MGI:5424916	BAP030	MP:0001265,decreased body size|MP:0002966,decreased circulating alkaline phosphatase level
MGI:5424917	BAP031	MP:0002966,decreased circulating alkaline phosphatase level
MGI:5638884	Bap1<em1Test>	MP:0001883,increased mammary adenocarcinoma incidence|MP:0004207,increased squamous cell carcinoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0005397,hematopoietic system phenotype|MP:0008000,increased ovary tumor incidence|MP:0008714,increased lung carcinoma incidence|MP:0008877,abnormal DNA methylation|MP:0010300,increased skin tumor incidence|MP:0010309,increased mesothelioma incidence|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0012167,abnormal epigenetic regulation of gene expression|MP:0012411,increased granulosa cell tumor incidence|MP:0012436,increased colon tumor incidence
MGI:5817986	Bap1<em2Test>	MP:0001883,increased mammary adenocarcinoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0008000,increased ovary tumor incidence|MP:0008714,increased lung carcinoma incidence|MP:0010300,increased skin tumor incidence|MP:0010309,increased mesothelioma incidence|MP:0010348,increased pancreatic islet cell carcinoma incidence|MP:0012411,increased granulosa cell tumor incidence
MGI:5817987	Bap1<em3Test>	MP:0001883,increased mammary adenocarcinoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0008000,increased ovary tumor incidence|MP:0008714,increased lung carcinoma incidence|MP:0010300,increased skin tumor incidence|MP:0012411,increased granulosa cell tumor incidence|MP:0012431,increased lymphoma incidence
MGI:5439652	Bap1<tm1.1Geno>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0001853,heart inflammation|MP:0002026,increased leukemia incidence|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002441,abnormal granulocyte morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002641,anisopoikilocytosis|MP:0003179,thrombocytopenia|MP:0004809,increased hematopoietic stem cell number|MP:0005065,abnormal neutrophil morphology|MP:0009278,abnormal bone marrow cell physiology|MP:0009395,increased nucleated erythrocyte cell number|MP:0010373,myeloid hyperplasia|MP:0010632,cardiac muscle necrosis|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0014713,abnormal erythrocyte basophilic stippling|MP:0020409,abnormal cardiac thrombosis|MP:0030025,giant platelets
MGI:5439653	Bap1<tm1.2Geno>	MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4436674	Bap1<tm1a(EUCOMM)Hmgu>	MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0002098,abnormal vibrissa morphology|MP:0002836,abnormal chorion morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:6399949	Bard1<tm1.1Rjbr>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002006,neoplasm|MP:0004901,decreased male germ cell number|MP:0008057,abnormal DNA replication|MP:0014040,increased cellular sensitivity to DNA damaging agent induced cell death
MGI:2668394	Bard1<tm1Thl>	MP:0001695,abnormal gastrulation|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0004965,inner cell mass degeneration|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6399951	Bard1<tm2.1Rjbr>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002006,neoplasm|MP:0004901,decreased male germ cell number|MP:0008057,abnormal DNA replication|MP:0014040,increased cellular sensitivity to DNA damaging agent induced cell death
MGI:3790742	Bard1<tm2Thl>	MP:0001883,increased mammary adenocarcinoma incidence|MP:0002169,no abnormal phenotype detected
MGI:6399953	Bard1<tm3.1Rjbr>	MP:0011091,prenatal lethality, complete penetrance
MGI:6399960	Bard1<tm4.2Rjbr>	MP:0011091,prenatal lethality, complete penetrance
MGI:2181383	Barhl1<tm1Xia>	MP:0001489,decreased startle reflex|MP:0001967,deafness|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004748,increased susceptibility to age-related hearing loss|MP:0005386,behavior/neurological phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3841416	Barhl2<tm1Gan>	MP:0001286,abnormal eye development|MP:0001330,abnormal optic nerve morphology|MP:0001405,impaired coordination|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005241,abnormal retina ganglion layer morphology|MP:0005551,abnormal eye electrophysiology|MP:0006309,decreased retina ganglion cell number|MP:0008105,increased amacrine cell number|MP:0008106,decreased amacrine cell number|MP:0008489,slow postnatal weight gain|MP:0008507,thin retina ganglion layer|MP:0008511,thin retina inner nuclear layer|MP:0011085,postnatal lethality, complete penetrance
MGI:3578634	Barx1<tm1Shiv>	MP:0000111,cleft palate|MP:0000116,abnormal tooth development|MP:0000118,arrest of tooth development|MP:0000351,increased cell proliferation|MP:0000352,decreased cell proliferation|MP:0000470,abnormal stomach morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5548392	Barx2<tm1b(EUCOMM)Hmgu>	MP:0000137,abnormal vertebrae morphology|MP:0001284,absent vibrissae|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001340,abnormal eyelid morphology|MP:0001406,abnormal gait|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0002111,abnormal tail morphology|MP:0005176,eyelids fail to open|MP:0005287,narrow eye opening|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005542,cornea vascularization|MP:0008806,increased circulating amylase level|MP:0010090,increased circulating creatine kinase level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3574438	Barx2<tm1Rsd>	MP:0000414,alopecia|MP:0000417,short hair|MP:0000427,abnormal hair cycle|MP:0000652,enlarged sebaceous gland|MP:0000759,abnormal skeletal muscle morphology|MP:0000761,thin diaphragm muscle|MP:0001262,decreased body weight|MP:0001282,short vibrissae|MP:0001302,eyelids open at birth|MP:0001406,abnormal gait|MP:0001511,disheveled coat|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002095,abnormal skin pigmentation|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004087,abnormal muscle fiber morphology|MP:0004174,abnormal spine curvature|MP:0004819,decreased skeletal muscle mass|MP:0008489,slow postnatal weight gain|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009413,skeletal muscle fiber atrophy|MP:0009419,skeletal muscle fibrosis|MP:0010239,decreased skeletal muscle weight|MP:0013239,impaired skeletal muscle regeneration
MGI:2429495	Basp1<tm1Crni>	MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001106,abnormal Schwann cell morphology|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0002882,abnormal neuron morphology|MP:0003651,abnormal axon extension|MP:0004243,abnormal motor nerve collateral sprouting|MP:0005404,abnormal axon morphology|MP:0008415,abnormal neurite morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011380,enlarged brain ventricles
MGI:2429496	Basp1<tm2(Gap43)Crni>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0004243,abnormal motor nerve collateral sprouting
MGI:5435553	Batf2<tm1Kmm>	MP:0010750,increased susceptibility to parasitic infection induced morbidity/mortality
MGI:3817232	Batf3<tm1Kmm>	MP:0001790,abnormal immune system physiology|MP:0002376,abnormal dendritic cell physiology|MP:0002455,abnormal dendritic cell antigen presentation|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005387,immune system phenotype|MP:0008050,decreased memory T cell number|MP:0008115,abnormal dendritic cell differentiation|MP:0008122,decreased myeloid dendritic cell number
MGI:4459733	Batf<tm1.1Ejt>	MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002492,decreased IgE level|MP:0004816,abnormal class switch recombination|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008179,absent germinal center B cells|MP:0008495,decreased IgG1 level|MP:0008682,decreased interleukin-17 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008897,decreased IgG2c level|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010187,decreased T follicular helper cell number|MP:0010220,decreased T-helper 17 cell number
MGI:3851385	Batf<tm1.1Kmm>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008682,decreased interleukin-17 secretion|MP:0009058,decreased interleukin-21 secretion
MGI:2153893	Batq1<MH>	MP:0000005,increased brown adipose tissue amount
MGI:2155576	Batq2<MH>	MP:0000005,increased brown adipose tissue amount
MGI:3042545	baw	MP:0000371,diluted coat color|MP:0000372,irregular coat pigmentation
MGI:2158306	Bax<tm1Dlo>	MP:0003204,decreased neuron apoptosis|MP:0006043,decreased apoptosis
MGI:3613737	Bax<tm1Ofxa>	MP:0003204,decreased neuron apoptosis
MGI:1857429	Bax<tm1Sjk>	MP:0000691,enlarged spleen|MP:0000714,increased thymocyte number|MP:0000909,abnormal facial motor nucleus morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001011,abnormal superior cervical ganglion morphology|MP:0001025,abnormal sympathetic neuron morphology|MP:0001078,abnormal phrenic nerve morphology|MP:0001130,abnormal ovarian folliculogenesis|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0003204,decreased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0003651,abnormal axon extension|MP:0004297,abnormal proprioceptive neuron morphology|MP:0004852,decreased testis weight|MP:0005014,increased B cell number|MP:0005159,azoospermia|MP:0005192,increased motor neuron number|MP:0006006,increased sensory neuron number|MP:0008261,arrest of male meiosis|MP:0008870,increased mature ovarian follicle number|MP:0009083,uterus hypertrophy|MP:0014052,increased male germ cell apoptosis|MP:0031239,increased atretic ovarian follicle number
MGI:5698832	Baz1a<tm1.1Sky>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002660,abnormal caput epididymis morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004543,abnormal sperm physiology|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009238,coiled sperm flagellum|MP:0009831,abnormal sperm midpiece morphology|MP:0009834,abnormal sperm annulus morphology|MP:0010768,mortality/aging|MP:0013601,increased testis apoptosis|MP:0014685,spermiation failure|MP:0020550,multinucleated giant male germ cells|MP:0031410,biflagellated sperm
MGI:5513751	Baz1a<tm1b(EUCOMM)Hmgu>	MP:0000470,abnormal stomach morphology|MP:0001417,decreased exploration in new environment|MP:0001925,male infertility|MP:0002599,increased mean platelet volume|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010052,increased grip strength
MGI:3821601	Baz1b<MommeD10>	MP:0000088,short mandible|MP:0000120,malocclusion|MP:0000445,short snout|MP:0000460,mandible hypoplasia|MP:0001265,decreased body size|MP:0001935,decreased litter size|MP:0002082,postnatal lethality|MP:0004200,decreased fetal size|MP:0004418,small parietal bone|MP:0004471,short nasal bone|MP:0005249,abnormal palatine bone morphology|MP:0006411,upturned snout|MP:0030049,prominent forehead
MGI:3850079	Baz1b<tm1Ska>	MP:0000194,increased circulating calcium level|MP:0000266,abnormal heart morphology|MP:0000284,double outlet right ventricle|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0003387,aorta coarctation|MP:0005329,abnormal myocardium layer morphology|MP:0005384,cellular phenotype|MP:0009703,decreased birth body size|MP:0010403,atrial septal defect|MP:0010420,muscular ventricular septal defect|MP:0010563,increased heart right ventricle size|MP:0010579,increased heart left ventricle size|MP:0011085,postnatal lethality, complete penetrance|MP:0013270,fourth pharyngeal arch hypoplasia|MP:0014764,impaired double-strand DNA break repair
MGI:4363543	Baz1b<tm2a(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001262,decreased body weight|MP:0005179,decreased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0005567,decreased circulating total protein level
MGI:5754585	Baz2a<em1(IMPC)Tcp>	MP:0000689,abnormal spleen morphology|MP:0001147,small testis|MP:0002060,abnormal skin morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0002989,small kidney|MP:0004930,small epididymis|MP:0005565,increased blood urea nitrogen level|MP:0005633,increased circulating sodium level|MP:0013278,decreased fasting circulating glucose level
MGI:7312211	Baz2b<em1Hzhu>	MP:0002942,decreased circulating alanine transaminase level|MP:0005516,enhanced liver regeneration|MP:0005632,decreased circulating aspartate transaminase level
MGI:6153283	Baz2b<em1(IMPC)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0001258,decreased body length|MP:0002075,abnormal coat/hair pigmentation|MP:0002968,increased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0005560,decreased circulating glucose level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:3028666	Bbaa10<C3H/HeN>	MP:0001846,increased inflammatory response
MGI:2447009	Bbaa11<C3H/HeN>	MP:0001846,increased inflammatory response
MGI:2447011	Bbaa12<C3H/HeN>	MP:0001846,increased inflammatory response
MGI:3028668	Bbaa13<C3H/HeN>	MP:0001846,increased inflammatory response
MGI:2389400	Bbaa14<C3H/HeJ>	MP:0001846,increased inflammatory response|MP:0002493,increased IgG level
MGI:2447041	Bbaa15<C3H/HeN>	MP:0002493,increased IgG level
MGI:3028670	Bbaa16<C3H/HeN>	MP:0001846,increased inflammatory response
MGI:3028672	Bbaa17<C3H/HeN>	MP:0001846,increased inflammatory response
MGI:3028674	Bbaa18<C3H/HeN>	MP:0001846,increased inflammatory response
MGI:2429556	Bbaa19<C3H/HeN>	MP:0002493,increased IgG level
MGI:2155831	Bbaa1<C3H/HeNCr>	MP:0001845,abnormal inflammatory response
MGI:3028676	Bbaa20<C3H/HeJ>	MP:0001846,increased inflammatory response
MGI:2389331	Bbaa21<C3H/HeN>	MP:0002412,increased susceptibility to bacterial infection
MGI:2389398	Bbaa22<C3H/HeN>	MP:0001846,increased inflammatory response
MGI:3028678	Bbaa23<C3H/HeN>	MP:0001846,increased inflammatory response
MGI:2156192	Bbaa2<C3H/HeNCr>	MP:0001790,abnormal immune system physiology
MGI:2156195	Bbaa3<C3H/HeNCr>	MP:0001845,abnormal inflammatory response
MGI:2156535	Bbaa5<C57BL/6NCr>	MP:0002494,increased IgM level
MGI:2157405	Bbaa9<C57BL/6NCr>	MP:0002490,abnormal immunoglobulin level
MGI:2681654	Bbc3<tm1Ast>	MP:0000218,increased leukocyte cell number|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004811,abnormal neuron physiology|MP:0005387,immune system phenotype|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008826,abnormal splenic cell ratio|MP:0008944,decreased sensitivity to induced cell death
MGI:3692386	Bbc3<tm1Gpz>	MP:0000313,abnormal cell death|MP:0003038,decreased myocardial infarct size|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0003633,abnormal nervous system physiology|MP:0003823,increased left ventricle developed pressure|MP:0005397,hematopoietic system phenotype|MP:0005571,decreased lactate dehydrogenase level|MP:0006043,decreased apoptosis|MP:0010754,abnormal heart left ventricle pressure
MGI:6341833	Bbip1<em1(IMPC)Ccpcz>	MP:0000160,kyphosis|MP:0001404,no spontaneous movement|MP:0001944,abnormal pancreas morphology|MP:0002060,abnormal skin morphology|MP:0002591,decreased mean corpuscular volume|MP:0004174,abnormal spine curvature|MP:0010379,decreased respiratory quotient|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5563473	Bbip1<tm1.1Gne>	MP:0000837,abnormal hypothalamus morphology|MP:0001261,obese|MP:0001326,retina degeneration|MP:0001433,polyphagia|MP:0001925,male infertility|MP:0011085,postnatal lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011939,increased food intake
MGI:4419262	Bbln<tm1(KOMP)Wtsi>	MP:0000559,abnormal femur morphology|MP:0004984,increased osteoclast cell number|MP:0004992,increased bone resorption|MP:0005390,skeleton phenotype|MP:0008396,abnormal osteoclast differentiation|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0013630,increased bone trabecular spacing
MGI:3044541	Bbn	MP:0001394,circling|MP:0001410,head bobbing|MP:0001967,deafness
MGI:7541199	Bbof1<em1Liwe>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0005389,reproductive system phenotype|MP:0009838,abnormal sperm axoneme morphology|MP:0013209,abnormal motile cilium physiology|MP:0020451,decreased sperm progressive motility
MGI:5426649	Bbox1<tm1a(KOMP)Wtsi>	MP:0001925,male infertility
MGI:5561563	Bbox1<tm1b(KOMP)Wtsi>	MP:0000274,enlarged heart|MP:0000428,abnormal craniofacial morphology|MP:0000783,abnormal forebrain morphology|MP:0000841,abnormal hindbrain morphology|MP:0000897,abnormal midbrain morphology|MP:0001325,abnormal retina morphology|MP:0001491,unresponsive to tactile stimuli|MP:0002792,abnormal retina vasculature morphology|MP:0002833,increased heart weight|MP:0003720,abnormal neural tube closure|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5515782	Bbs10<tm1.1(KOMP)Vlcg>	MP:0005633,increased circulating sodium level|MP:0011100,preweaning lethality, complete penetrance
MGI:5788679	Bbs10<tm1.1Vmar>	MP:0002169,no abnormal phenotype detected
MGI:5788680	Bbs10<tm1.2Vmar>	MP:0001260,increased body weight|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001326,retina degeneration|MP:0001433,polyphagia|MP:0001762,polyuria|MP:0002959,increased urine microalbumin level|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0005291,abnormal glucose tolerance|MP:0005375,adipose tissue phenotype|MP:0005610,increased circulating antidiuretic hormone level|MP:0005669,increased circulating leptin level|MP:0006072,abnormal retina apoptosis|MP:0008138,absent podocyte foot process|MP:0008450,retina photoreceptor degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0008580,photoreceptor inner segment degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0009640,abnormal renal tubule epithelium morphology|MP:0011431,increased urine flow rate|MP:0011859,decreased renal glomerulus basement membrane thickness|MP:0011965,decreased total retina thickness
MGI:7425539	Bbs12<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001404,no spontaneous movement|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5444297	Bbs12<tm1.1Vmar>	MP:0001261,obese|MP:0001326,retina degeneration|MP:0001431,abnormal eating behavior|MP:0001876,decreased inflammatory response|MP:0002397,abnormal bone marrow morphology|MP:0002702,decreased circulating free fatty acids level|MP:0002891,increased insulin sensitivity|MP:0005367,renal/urinary system phenotype|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0008515,thin retina outer nuclear layer|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008584,photoreceptor outer segment degeneration|MP:0008597,decreased circulating interleukin-6 level|MP:0009115,abnormal fat cell morphology|MP:0009288,increased epididymal fat pad weight|MP:0009703,decreased birth body size|MP:0030016,increased adipocyte glucose uptake|MP:0030969,increased circulating adiponectin level
MGI:6276922	Bbs1<em1(IMPC)Mbp>	MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0003231,abnormal placenta vasculature|MP:0011100,preweaning lethality, complete penetrance
MGI:3055491	Bbs1<Gt1Nk>	MP:0001261,obese|MP:0001326,retina degeneration|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0009703,decreased birth body size|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011281,abnormal olfactory epithelium cilium morphology
MGI:3767672	Bbs1<tm1Vcs>	MP:0000005,increased brown adipose tissue amount|MP:0000825,dilated lateral ventricle|MP:0001004,abnormal retina photoreceptor morphology|MP:0001261,obese|MP:0001402,decreased locomotor activity|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002626,increased heart rate|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003863,decreased aggression towards mice|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0004948,abnormal neuronal precursor proliferation|MP:0005334,abnormal fat pad morphology|MP:0005367,renal/urinary system phenotype|MP:0005371,limbs/digits/tail phenotype|MP:0005551,abnormal eye electrophysiology|MP:0005669,increased circulating leptin level|MP:0006254,thin cerebral cortex|MP:0008283,small hippocampus|MP:0008518,retina outer nuclear layer degeneration|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0008544,impaired olfaction|MP:0008545,absent sperm flagellum|MP:0008580,photoreceptor inner segment degeneration|MP:0008581,disorganized photoreceptor inner segment|MP:0008586,disorganized photoreceptor outer segment|MP:0010024,increased total body fat amount|MP:0010768,mortality/aging|MP:0011059,abnormal ependyma motile cilium morphology|MP:0011939,increased food intake|MP:0012468,decreased striatum size|MP:0012676,dilated brain ventricle|MP:0020508,decreased dendritic spine density
MGI:5474481	Bbs1<tm2Vcs>	MP:0001891,hydrocephaly|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0020394,decreased neuronal precursor proliferation
MGI:6153765	Bbs2<em2(IMPC)Wtsi>	MP:0003961,decreased lean body mass|MP:0010123,increased bone mineral content
MGI:6471956	Bbs2<tm1.1Huss>	MP:0001261,obese|MP:0001433,polyphagia|MP:0001552,increased circulating triglyceride level|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0004512,anosmia|MP:0005367,renal/urinary system phenotype|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0008446,decreased retina cone cell number|MP:0008453,decreased retina rod cell number|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008789,abnormal olfactory epithelium morphology|MP:0009703,decreased birth body size|MP:0010024,increased total body fat amount|MP:0011281,abnormal olfactory epithelium cilium morphology|MP:0013203,abnormal primary cilium morphology|MP:0020582,increased ceramide level
MGI:3521669	Bbs2<tm1Vcs>	MP:0000010,abnormal abdominal fat pad morphology|MP:0000623,decreased salivation|MP:0001260,increased body weight|MP:0001265,decreased body size|MP:0001433,polyphagia|MP:0001489,decreased startle reflex|MP:0001526,abnormal placing response|MP:0001925,male infertility|MP:0001984,abnormal olfaction|MP:0002628,hepatic steatosis|MP:0003675,kidney cyst|MP:0005371,limbs/digits/tail phenotype|MP:0005498,hyporesponsive to tactile stimuli|MP:0005551,abnormal eye electrophysiology|MP:0005656,decreased aggression|MP:0006007,abnormal basal ganglion morphology|MP:0006087,increased body mass index|MP:0006254,thin cerebral cortex|MP:0008283,small hippocampus|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0008545,absent sperm flagellum|MP:0008586,disorganized photoreceptor outer segment|MP:0009703,decreased birth body size|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:3055492	Bbs4<Gt1Nk>	MP:0000182,increased circulating LDL cholesterol level|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000609,abnormal liver physiology|MP:0001059,optic nerve atrophy|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0001363,increased anxiety-related response|MP:0001556,increased circulating HDL cholesterol level|MP:0001984,abnormal olfaction|MP:0002079,increased circulating insulin level|MP:0002151,abnormal neural tube morphology|MP:0002461,increased immunoglobulin level|MP:0002628,hepatic steatosis|MP:0002792,abnormal retina vasculature morphology|MP:0002797,increased thigmotaxis|MP:0002864,abnormal ocular fundus morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003212,increased susceptibility to age related obesity|MP:0003537,hydrometrocolpos|MP:0003675,kidney cyst|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0003863,decreased aggression towards mice|MP:0003949,abnormal circulating lipid level|MP:0004022,abnormal cone electrophysiology|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005195,abnormal posterior eye segment morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005418,abnormal circulating hormone level|MP:0005551,abnormal eye electrophysiology|MP:0005559,increased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0005633,increased circulating sodium level|MP:0005669,increased circulating leptin level|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0006357,abnormal circulating mineral level|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0009642,abnormal blood homeostasis|MP:0009703,decreased birth body size|MP:0010090,increased circulating creatine kinase level|MP:0010092,increased circulating magnesium level|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011281,abnormal olfactory epithelium cilium morphology|MP:0011682,renal glomerulus cyst|MP:0011971,increased circulating lactate dehydrogenase level|MP:0020411,increased abdominal adipose tissue amount|MP:0020508,decreased dendritic spine density|MP:0020511,decreased dendritic spine length|MP:0030941,enhanced autophagy
MGI:5554915	Bbs4<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020870,decreased thigmotaxis
MGI:3045473	Bbs4<tm1Vcs>	MP:0000623,decreased salivation|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001433,polyphagia|MP:0001526,abnormal placing response|MP:0001925,male infertility|MP:0001984,abnormal olfaction|MP:0005498,hyporesponsive to tactile stimuli|MP:0005656,decreased aggression|MP:0006007,abnormal basal ganglion morphology|MP:0006254,thin cerebral cortex|MP:0008283,small hippocampus|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0008545,absent sperm flagellum|MP:0009703,decreased birth body size|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0011066,abnormal renal tubule epithelial cell primary cilium morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:4433255	Bbs5<tm1a(EUCOMM)Wtsi>	MP:0000633,abnormal pituitary gland morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0001261,obese|MP:0001732,postnatal growth retardation|MP:0001924,infertility|MP:0002116,abnormal craniofacial bone morphology|MP:0004686,decreased length of long bones|MP:0005361,small pituitary gland|MP:0005367,renal/urinary system phenotype|MP:0005380,embryo phenotype|MP:0005388,respiratory system phenotype|MP:0005508,abnormal skeleton morphology|MP:0008535,enlarged lateral ventricles|MP:0008545,absent sperm flagellum|MP:0010029,abnormal basicranium morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011862,decreased cranium length
MGI:5548622	Bbs5<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000745,tremors|MP:0001325,abnormal retina morphology|MP:0001406,abnormal gait|MP:0002590,increased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0002644,decreased circulating triglyceride level|MP:0002764,short tibia|MP:0002834,decreased heart weight|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0004953,decreased spleen weight|MP:0005013,increased lymphocyte cell number|MP:0005293,impaired glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005559,increased circulating glucose level|MP:0005564,increased hemoglobin content|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010087,increased circulating fructosamine level|MP:0010124,decreased bone mineral content|MP:0010379,decreased respiratory quotient|MP:0013279,increased fasting circulating glucose level|MP:0020508,decreased dendritic spine density|MP:0020511,decreased dendritic spine length
MGI:5554939	Bbs7<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0002941,increased circulating alanine transaminase level|MP:0005633,increased circulating sodium level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5315475	Bbs7<tm1Vcs>	MP:0001260,increased body weight|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001326,retina degeneration|MP:0001925,male infertility|MP:0003631,nervous system phenotype|MP:0005367,renal/urinary system phenotype|MP:0005371,limbs/digits/tail phenotype|MP:0005384,cellular phenotype|MP:0005391,vision/eye phenotype|MP:0005394,taste/olfaction phenotype|MP:0006254,thin cerebral cortex|MP:0008283,small hippocampus|MP:0008518,retina outer nuclear layer degeneration|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0008545,absent sperm flagellum|MP:0008580,photoreceptor inner segment degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0008892,abnormal sperm flagellum morphology|MP:0009703,decreased birth body size|MP:0009836,abnormal sperm principal piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0011056,abnormal brain ependyma motile cilium morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011939,increased food intake|MP:0012468,decreased striatum size|MP:0013202,abnormal cilium morphology|MP:0030964,decreased brain ependyma motile cilium length|MP:0030966,decreased brain ependyma motile cilium number|MP:0031356,abnormal outer dense fiber morphology
MGI:7574679	Bbs9<em1(IMPC)Bay>	MP:0000218,increased leukocyte cell number|MP:0001556,increased circulating HDL cholesterol level|MP:0011100,preweaning lethality, complete penetrance
MGI:6200219	Bbs9<m1Btlr>	MP:0001260,increased body weight|MP:0002764,short tibia|MP:0004509,abnormal pelvic girdle bone morphology|MP:0014142,increased body fat mass
MGI:4432372	Bbx<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000438,abnormal cranium morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002100,abnormal tooth morphology|MP:0002495,increased IgA level|MP:0002834,decreased heart weight|MP:0003961,decreased lean body mass|MP:0004686,decreased length of long bones|MP:0004991,decreased bone strength|MP:0010124,decreased bone mineral content
MGI:7336199	BC004004<em1Nju>	MP:0005058,abnormal lysosome morphology|MP:0005166,decreased susceptibility to injury|MP:0005584,abnormal enzyme/coenzyme activity|MP:0011807,decreased lung fibroblast proliferation|MP:0013501,increased fibroblast apoptosis|MP:0020254,decreased collagen level|MP:0020414,abnormal fibroblast physiology|MP:0030679,decreased hydroxyproline level|MP:0030939,abnormal autophagosome formation|MP:0030941,enhanced autophagy
MGI:4259010	BC004004<Gt(OST273008)Lex>	MP:0002169,no abnormal phenotype detected
MGI:6429948	BC028528<tm1.1Smoc>	MP:0005165,increased susceptibility to injury|MP:0005367,renal/urinary system phenotype|MP:0020344,abnormal susceptibility to injury induced morbidity/mortality
MGI:7425536	BC031181<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5692865	BC048562<tm1b(KOMP)Wtsi>	MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0013278,decreased fasting circulating glucose level|MP:0020421,increased freezing behavior
MGI:7573111	BC048671<em1(IMPC)Mbp>	MP:0002699,abnormal vitreous body morphology
MGI:7641899	BC048671<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5696929	BC049715<tm1b(KOMP)Mbp>	MP:0000208,decreased hematocrit|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number
MGI:2677614	Bc1<tm1Jbro>	MP:0003631,nervous system phenotype
MGI:3529350	Bcam<Gt(OST423981)Lex>	MP:0002169,no abnormal phenotype detected
MGI:3771876	Bcam<tm1Ics>	MP:0000495,abnormal colon morphology|MP:0001260,increased body weight|MP:0004002,abnormal jejunum morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0005367,renal/urinary system phenotype|MP:0006087,increased body mass index|MP:0011320,abnormal glomerular capillary morphology
MGI:3822736	Bcam<tm1Jhm>	MP:0003631,nervous system phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:2388924	Bcan<tm1Ref>	MP:0000807,abnormal hippocampus morphology|MP:0002207,abnormal long-term potentiation|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:6294895	Bcap29<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0010097,abnormal retina blood vessel morphology|MP:0010124,decreased bone mineral content
MGI:6368552	Bcap31<tm1.1Bwang>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0001828,abnormal T cell activation|MP:0001846,increased inflammatory response|MP:0004956,decreased thymus weight|MP:0005095,decreased T cell proliferation|MP:0005319,abnormal enzyme/coenzyme level|MP:0005386,behavior/neurological phenotype|MP:0008083,decreased single-positive T cell number|MP:0008414,abnormal spatial reference memory|MP:0008560,increased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008948,decreased neuron number|MP:0009541,increased thymocyte apoptosis|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0013772,increased effector memory T-helper cell number|MP:0020448,increased microglial cell activation
MGI:2181166	Bcar1<tm1Hhi>	MP:0000255,blood vessel congestion|MP:0000267,abnormal heart development|MP:0000358,abnormal cell morphology|MP:0000601,small liver|MP:0002652,thin myocardium|MP:0003984,embryonic growth retardation|MP:0004091,abnormal Z line morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005590,increased vasodilation|MP:0005621,abnormal cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014731,disorganized myocardial fiber myofibrils
MGI:5494134	Bcar1<tm2.1Homy>	MP:0005369,muscle phenotype
MGI:6362810	Bcar3<em1(IMPC)Mbp>	MP:0000194,increased circulating calcium level|MP:0001258,decreased body length|MP:0001304,cataract|MP:0002079,increased circulating insulin level|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002606,increased basophil cell number|MP:0002989,small kidney
MGI:4359826	Bcar3<tm1Lern>	MP:0001304,cataract|MP:0001322,abnormal iris morphology|MP:0002840,abnormal lens fiber morphology|MP:0004222,iris synechia|MP:0005195,abnormal posterior eye segment morphology|MP:0005205,abnormal eye anterior chamber morphology|MP:0005391,vision/eye phenotype|MP:0006309,decreased retina ganglion cell number|MP:0008841,ruptured lens capsule|MP:0011697,lens vacuoles|MP:0031213,increased eye anterior chamber depth
MGI:5754586	Bcas1<em1(IMPC)Tcp>	MP:0001175,abnormal lung morphology
MGI:6343403	Bcas1<tm1Himo>	MP:0001364,decreased anxiety-related response|MP:0001847,brain inflammation|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0009142,decreased prepulse inhibition|MP:0011731,decreased myelin sheath thickness|MP:0013438,dysmyelination
MGI:5909974	Bcas2<tm1.1Lil>	MP:0000242,impaired fertilization|MP:0001125,abnormal oocyte morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0003718,maternal effect|MP:0005168,abnormal female meiosis|MP:0010768,mortality/aging|MP:0011124,increased primary ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0031383,increased secondary ovarian follicle number|MP:0031420,decreased superovulation rate
MGI:5909977	Bcas2<tm1Lil>	MP:0011400,lethality, complete penetrance
MGI:6195663	Bcas3<tm1.1Msin>	MP:0000259,abnormal vascular development|MP:0000266,abnormal heart morphology|MP:0000432,abnormal head morphology|MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001722,pale yolk sac|MP:0001723,disorganized yolk sac vascular plexus|MP:0002188,small heart|MP:0003227,abnormal vascular branching morphogenesis|MP:0003658,abnormal capillary morphology|MP:0003794,delayed somite formation|MP:0003974,abnormal endocardium morphology|MP:0003984,embryonic growth retardation|MP:0004560,abnormal chorionic plate morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0005602,decreased angiogenesis|MP:0006055,abnormal vascular endothelial cell morphology|MP:0009489,abnormal blood vessel endothelium morphology|MP:0010412,atrioventricular septal defect|MP:0010551,abnormal coronary vessel morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance|MP:0011521,decreased placental labyrinth size|MP:0011805,decreased cell migration|MP:0012253,abnormal intersomitic vessel morphology
MGI:6195662	Bcas3<tm1Msin>	MP:0000259,abnormal vascular development|MP:0000432,abnormal head morphology|MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0002188,small heart|MP:0003227,abnormal vascular branching morphogenesis|MP:0003658,abnormal capillary morphology|MP:0003974,abnormal endocardium morphology|MP:0004259,small placenta|MP:0004787,abnormal dorsal aorta morphology|MP:0005602,decreased angiogenesis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012253,abnormal intersomitic vessel morphology
MGI:5660825	Bcat1<tm1.2Eaa>	MP:0002444,abnormal T cell physiology
MGI:3028726	Bcat2<m1Ytc>	MP:0000416,sparse hair|MP:0000746,weakness|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002893,ketoaciduria|MP:0005156,bradykinesia|MP:0005311,abnormal circulating amino acid level|MP:0009351,thin hair shaft|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5791978	Bcat2<mpc91H>	MP:0002083,premature death
MGI:3772355	Bcat2<tm1.2Clyn>	MP:0001262,decreased body weight|MP:0001432,abnormal food preference|MP:0001762,polyuria|MP:0001764,abnormal homeostasis|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003068,enlarged kidney|MP:0003458,decreased circulating ketone body level|MP:0003960,increased lean body mass|MP:0004889,increased energy expenditure|MP:0005292,improved glucose tolerance|MP:0005311,abnormal circulating amino acid level|MP:0005386,behavior/neurological phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0009289,decreased epididymal fat pad weight|MP:0011016,increased core body temperature|MP:0011468,abnormal urine amino acid level|MP:0011471,decreased urine creatinine level|MP:0011939,increased food intake|MP:0014574,decreased circulating resistin level|MP:0030968,decreased circulating adiponectin level
MGI:5548513	Bccip<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001417,decreased exploration in new environment|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:6489524	Bccip<tm1d(EUCOMM)Hmgu>	MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000691,enlarged spleen|MP:0001654,hepatic necrosis|MP:0002023,increased B cell derived lymphoma incidence|MP:0002499,chronic inflammation|MP:0003331,increased hepatocellular carcinoma incidence|MP:0005386,behavior/neurological phenotype|MP:0008477,decreased spleen red pulp amount|MP:0010768,mortality/aging|MP:0011092,embryonic lethality, complete penetrance|MP:0014045,Mallory bodies|MP:0014755,increased tumor cell proliferation|MP:0031301,chronic liver inflammation
MGI:5424972	BCH001	MP:0000194,increased circulating calcium level
MGI:5424973	BCH005	MP:0000194,increased circulating calcium level
MGI:5424978	BCH012	MP:0000194,increased circulating calcium level
MGI:3723049	Bche<tm1Loc>	MP:0005389,reproductive system phenotype|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:6156450	Bckdha<em1(IMPC)Tcp>	MP:0000219,increased neutrophil cell number|MP:0001157,small seminal vesicle|MP:0005016,decreased lymphocyte cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:4843858	Bckdha<tm1a(EUCOMM)Hmgu>	MP:0001260,increased body weight|MP:0002981,increased liver weight|MP:0003829,impaired febrile response|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005386,behavior/neurological phenotype|MP:0009355,increased liver triglyceride level|MP:0010024,increased total body fat amount|MP:0011014,decreased core body temperature|MP:0011049,impaired adaptive thermogenesis|MP:0011698,abnormal brown adipose tissue physiology|MP:0013242,abnormal amino acid metabolism|MP:0014172,decreased fatty acid oxidation
MGI:5825325	Bckdhb<em1(IMPC)J>	MP:0001732,postnatal growth retardation|MP:0005311,abnormal circulating amino acid level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0010024,increased total body fat amount|MP:0011085,postnatal lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0030674,decreased circulating alanine level|MP:0030727,increased circulating valine level|MP:0030750,increased circulating leucine level
MGI:4176423	Bckdk<Gt(OST79912)Lex>	MP:0001360,abnormal social investigation|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0002757,decreased vertical activity|MP:0003631,nervous system phenotype|MP:0004924,abnormal behavior|MP:0005311,abnormal circulating amino acid level|MP:0005332,abnormal amino acid level|MP:0013242,abnormal amino acid metabolism|MP:0014383,decreased miniature inhibitory postsynaptic current frequency
MGI:3699162	Bckdk<Gt(VICT48)710Lex>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001510,abnormal coat appearance|MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0001961,abnormal reflex|MP:0002064,seizures|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002981,increased liver weight|MP:0003860,abnormal carbon dioxide level|MP:0003917,increased kidney weight|MP:0003997,tonic-clonic seizures|MP:0004232,decreased muscle weight|MP:0005311,abnormal circulating amino acid level|MP:0005332,abnormal amino acid level|MP:0010025,decreased total body fat amount|MP:0011084,lethality at weaning, incomplete penetrance
MGI:6199632	Bcl10<m1Btlr>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0002494,increased IgM level|MP:0002497,increased IgE level|MP:0004978,decreased B-1 B cell number|MP:0005015,increased T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number
MGI:2158304	Bcl10<tm1Mak>	MP:0000715,decreased thymocyte number|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001819,abnormal immune cell physiology|MP:0001828,abnormal T cell activation|MP:0001830,decreased activated T cell number|MP:0002145,abnormal T cell differentiation|MP:0002376,abnormal dendritic cell physiology|MP:0002406,increased susceptibility to infection|MP:0002460,decreased immunoglobulin level|MP:0004838,abnormal neural fold elevation formation|MP:0005025,abnormal response to infection|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005384,cellular phenotype|MP:0011090,perinatal lethality, incomplete penetrance|MP:0012261,increased hindbrain apoptosis
MGI:2674989	Bcl10<tm1Swm>	MP:0000914,exencephaly|MP:0001800,abnormal humoral immune response|MP:0002144,abnormal B cell differentiation|MP:0002376,abnormal dendritic cell physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0003009,abnormal cytokine secretion|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008193,abnormal marginal zone B cell physiology|MP:0008211,decreased mature B cell number|MP:0011090,perinatal lethality, incomplete penetrance
MGI:4358088	Bcl11a<tm1.1Pwt>	MP:0000245,abnormal erythropoiesis|MP:0005563,abnormal hemoglobin content
MGI:5320881	Bcl11a<tm1.1Sbri>	MP:0011087,neonatal lethality, complete penetrance
MGI:2663941	Bcl11a<tm1Ngc>	MP:0000706,small thymus|MP:0000726,absent lymphocyte|MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0003790,absent CD4-positive, alpha-beta T cells|MP:0004810,decreased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0005018,decreased T cell number|MP:0005090,increased double-negative T cell number|MP:0008071,absent B cells|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008115,abnormal dendritic cell differentiation|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008346,increased gamma-delta T cell number|MP:0008760,abnormal immunoglobulin heavy chain V(D)J recombination|MP:0010132,decreased DN2 thymocyte number|MP:0011087,neonatal lethality, complete penetrance
MGI:5475335	Bcl11a<tm1Peli>	MP:0005397,hematopoietic system phenotype
MGI:4358087	Bcl11a<tm1Pwt>	MP:0000221,decreased leukocyte cell number|MP:0004810,decreased hematopoietic stem cell number|MP:0005017,decreased B cell number|MP:0005397,hematopoietic system phenotype|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0008574,decreased circulating interferon-alpha level
MGI:5320880	Bcl11a<tm1Sbri>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0005404,abnormal axon morphology|MP:0006282,abnormal spinal cord dorsal horn morphology|MP:0008415,abnormal neurite morphology|MP:0009937,abnormal neuron differentiation
MGI:5475336	Bcl11a<tm2.1Peli>	MP:0000685,abnormal immune system morphology|MP:0002145,abnormal T cell differentiation|MP:0004810,decreased hematopoietic stem cell number|MP:0005017,decreased B cell number|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008215,decreased immature B cell number|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008782,increased B cell apoptosis|MP:0010132,decreased DN2 thymocyte number|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:5529616	Bcl11b<tm1.1(KOMP)Vlcg>	MP:0002574,increased vertical activity|MP:0003743,abnormal facial morphology|MP:0003795,abnormal bone structure|MP:0009263,abnormal eyelid fusion|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:3839576	Bcl11b<tm1.1Leid>	MP:0001216,abnormal epidermal layer morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0002796,impaired skin barrier function
MGI:3839578	Bcl11b<tm1.2Leid>	MP:0000116,abnormal tooth development|MP:0001216,abnormal epidermal layer morphology|MP:0001218,thin epidermis|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001302,eyelids open at birth|MP:0001436,abnormal suckling behavior|MP:0001823,thymus hypoplasia|MP:0002650,abnormal ameloblast morphology|MP:0002796,impaired skin barrier function|MP:0005358,abnormal incisor morphology|MP:0006402,small molars|MP:0008070,absent T cells|MP:0010864,abnormal enamel knot morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0030079,small incisors|MP:0030453,abnormal odontoblast morphology|MP:0030471,abnormal ameloblast differentiation|MP:0030518,abnormal outer dental epithelium morphology|MP:0030522,abnormal stellate reticulum morphology|MP:0030526,abnormal enamel cord morphology|MP:0030605,abnormal corneocyte morphology
MGI:3767620	Bcl11b<tm1Avram>	MP:0000693,spleen hyperplasia|MP:0001823,thymus hypoplasia|MP:0003850,abnormal thymocyte activation|MP:0004919,abnormal positive T cell selection|MP:0004952,increased spleen weight|MP:0005014,increased B cell number|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008044,increased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008126,increased dendritic cell number|MP:0008246,abnormal leukocyte morphology|MP:0008346,increased gamma-delta T cell number|MP:0008466,enlarged mesenteric lymph nodes
MGI:2663971	Bcl11b<tm1Jpk>	MP:0001302,eyelids open at birth|MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0002371,abnormal thymus cortex morphology|MP:0002375,abnormal thymus medulla morphology|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008037,abnormal T cell morphology|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008758,abnormal T cell receptor beta chain V(D)J recombination|MP:0009541,increased thymocyte apoptosis|MP:0009546,absent gastric milk in neonates|MP:0011087,neonatal lethality, complete penetrance|MP:0013741,absent thymus corticomedullary boundary
MGI:4818771	Bcl11b<tm1Peli>	MP:0001273,decreased metastatic potential|MP:0008053,abnormal NK cell differentiation
MGI:5571289	Bcl11b<tm2.1Jpk>	MP:0000715,decreased thymocyte number|MP:0003077,abnormal cell cycle|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0006387,abnormal T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0012431,increased lymphoma incidence
MGI:2656326	Bcl2a1a<tm1Prys>	MP:0001876,decreased inflammatory response|MP:0002463,abnormal neutrophil physiology|MP:0005026,decreased susceptibility to parasitic infection|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:2158426	Bcl2a1a<tm1Sen>	MP:0000418,focal hair loss|MP:0002463,abnormal neutrophil physiology
MGI:3844731	Bcl2<drn>	MP:0000371,diluted coat color|MP:0000372,irregular coat pigmentation
MGI:2387943	Bcl2l10<tm1Pmc>	MP:0002169,no abnormal phenotype detected
MGI:6399901	Bcl2l11<em1(IMPC)H>	MP:0000218,increased leukocyte cell number|MP:0003131,increased erythrocyte cell number|MP:0004952,increased spleen weight|MP:0005013,increased lymphocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005627,increased circulating potassium level|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0012362,increased large unstained cell number
MGI:2156498	Bcl2l11<tm1.1Ast>	MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0001025,abnormal sympathetic neuron morphology|MP:0001846,increased inflammatory response|MP:0001864,vascular inflammation|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002439,abnormal plasma cell morphology|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002705,dilated renal tubule|MP:0002743,glomerulonephritis|MP:0003179,thrombocytopenia|MP:0003631,nervous system phenotype|MP:0003725,increased autoantibody level|MP:0003945,abnormal lymphocyte physiology|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004796,increased anti-histone antibody level|MP:0004939,abnormal B cell morphology|MP:0004952,increased spleen weight|MP:0004973,increased regulatory T cell number|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005016,decreased lymphocyte cell number|MP:0005025,abnormal response to infection|MP:0005068,abnormal NK cell morphology|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005153,abnormal B cell proliferation|MP:0005325,abnormal renal glomerulus morphology|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005460,abnormal leukopoiesis|MP:0005565,increased blood urea nitrogen level|MP:0006043,decreased apoptosis|MP:0006271,abnormal involution of the mammary gland|MP:0006414,decreased T cell apoptosis|MP:0008044,increased NK cell number|MP:0008073,abnormal CD4-positive, alpha-beta T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008173,increased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008189,increased transitional stage B cell number|MP:0008210,increased mature B cell number|MP:0008214,increased immature B cell number|MP:0008783,decreased B cell apoptosis|MP:0008826,abnormal splenic cell ratio|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009338,increased splenocyte number|MP:0009341,decreased splenocyte apoptosis|MP:0009542,decreased thymocyte apoptosis|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011353,expanded mesangial matrix|MP:0011369,increased renal glomerulus apoptosis|MP:0011402,renal cast|MP:0011506,glomerular crescent|MP:0020519,renal glomerular immunoglobulin deposits
MGI:4366749	Bcl2l11<tm1.1Boui>	MP:0000218,increased leukocyte cell number|MP:0004952,increased spleen weight|MP:0005387,immune system phenotype
MGI:2156483	Bcl2l11<tm1.1Jad>	MP:0000628,abnormal mammary gland development|MP:0002169,no abnormal phenotype detected|MP:0009503,abnormal mammary gland duct morphology
MGI:2156494	Bcl2l11<tm1Ast>	MP:0000807,abnormal hippocampus morphology|MP:0002183,gliosis
MGI:3589204	Bcl2l11<tm1Sjk>	MP:0002362,abnormal spleen marginal zone morphology|MP:0002459,abnormal B cell physiology|MP:0002461,increased immunoglobulin level|MP:0005014,increased B cell number|MP:0008173,increased follicular B cell number|MP:0008189,increased transitional stage B cell number|MP:0008206,increased B-2 B cell number
MGI:4366751	Bcl2l11<tm2.1Boui>	MP:0000218,increased leukocyte cell number|MP:0004952,increased spleen weight|MP:0005387,immune system phenotype
MGI:3800457	Bcl2l11<tm2Rjd>	MP:0013501,increased fibroblast apoptosis
MGI:4366756	Bcl2l11<tm3.1Boui>	MP:0000218,increased leukocyte cell number|MP:0004952,increased spleen weight|MP:0005387,immune system phenotype
MGI:3800462	Bcl2l11<tm3Rjd>	MP:0005014,increased B cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0009338,increased splenocyte number|MP:0009542,decreased thymocyte apoptosis
MGI:5527367	Bcl2l11<tm4Boul>	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:3800472	Bcl2l11<tm4Rjd>	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0013501,increased fibroblast apoptosis
MGI:5527368	Bcl2l11<tm5Boul>	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:5562690	Bcl2l11<tm6.1Boui>	MP:0004973,increased regulatory T cell number
MGI:5708226	Bcl2l12<tm1.1(KOMP)Vlcg>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002608,increased hematocrit|MP:0004952,increased spleen weight|MP:0010123,increased bone mineral content
MGI:7594050	Bcl2l13<em1Lrsn>	MP:0002169,no abnormal phenotype detected
MGI:8242671	Bcl2l13<tm1.2Otsu>	MP:0000278,abnormal myocardial fiber morphology|MP:0003674,oxidative stress|MP:0004215,abnormal myocardial fiber physiology|MP:0004484,abnormal response of heart to induced stress|MP:0006036,abnormal mitochondrial physiology|MP:0006039,decreased mitochondrial fission|MP:0011925,abnormal heart echocardiography feature|MP:0014046,abnormal mitophagy|MP:0014246,decreased cellular ATP level|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0031633,decreased heart left ventricle muscle contractility
MGI:8206330	Bcl2l13<tm2.1Otsu>	MP:0000278,abnormal myocardial fiber morphology|MP:0003141,cardiac fibrosis|MP:0004484,abnormal response of heart to induced stress|MP:0014046,abnormal mitophagy|MP:0014246,decreased cellular ATP level|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:6470550	Bcl2l14<tm1.1Boui>	MP:0002169,no abnormal phenotype detected|MP:0004499,increased incidence of tumors by chemical induction|MP:0005381,digestive/alimentary phenotype|MP:0010155,abnormal intestine physiology|MP:0013296,abnormal susceptibility to induced colitis
MGI:5637171	Bcl2l15<tm1b(EUCOMM)Hmgu>	MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0002874,decreased hemoglobin content|MP:0005344,increased circulating bilirubin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005568,increased circulating total protein level|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:3847886	Bcl2l1<Plt16>	MP:0003179,thrombocytopenia|MP:0005464,abnormal platelet physiology|MP:0008254,increased megakaryocyte cell number|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3847887	Bcl2l1<Plt20>	MP:0000240,extramedullary hematopoiesis|MP:0003179,thrombocytopenia|MP:0005464,abnormal platelet physiology|MP:0008254,increased megakaryocyte cell number
MGI:2176700	Bcl2l1<tm1.1Mam>	MP:0001262,decreased body weight|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002175,decreased brain weight|MP:0003661,abnormal locus ceruleus morphology|MP:0005643,decreased dopamine level|MP:0020543,decreased substantia nigra size
MGI:2672833	Bcl2l1<tm1Cant>	MP:0002444,abnormal T cell physiology|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005095,decreased T cell proliferation|MP:0008050,decreased memory T cell number|MP:0008051,abnormal memory T cell physiology|MP:0008688,decreased interleukin-2 secretion
MGI:2158303	Bcl2l1<tm1Dlo>	MP:0003179,thrombocytopenia|MP:0003203,increased neuron apoptosis|MP:0005464,abnormal platelet physiology|MP:0006042,increased apoptosis
MGI:2176699	Bcl2l1<tm1Mam>	MP:0001147,small testis|MP:0001648,abnormal apoptosis|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0008392,decreased primordial germ cell number|MP:0011121,decreased primordial ovarian follicle number
MGI:2654939	Bcl2l1<tm1Tak>	MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0009580,increased keratinocyte apoptosis|MP:0030578,decreased keratinocyte adhesion
MGI:3581620	Bcl2l1<tm1Ywh>	MP:0000715,decreased thymocyte number|MP:0005092,decreased double-positive T cell number
MGI:1857389	Bcl2l2<Gt(ROSA)41Sor>	MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001153,small seminiferous tubules|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001925,male infertility|MP:0002209,decreased germ cell number|MP:0002216,abnormal seminiferous tubule morphology|MP:0002785,absent Leydig cells|MP:0002804,abnormal motor learning|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0004910,decreased seminal vesicle weight|MP:0004996,abnormal CNS synapse formation|MP:0005250,decreased Sertoli cell number|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0014331,abnormal Purkinje cell mitochondrial morphology|MP:0020355,abnormal Sertoli cell barrier morphology
MGI:2158430	Bcl2l2<tm1Sco>	MP:0001153,small seminiferous tubules|MP:0001925,male infertility|MP:0002160,abnormal reproductive system morphology|MP:0005159,azoospermia|MP:0005250,decreased Sertoli cell number|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014052,increased male germ cell apoptosis|MP:0020550,multinucleated giant male germ cells
MGI:2156165	Bcl2<tm1Dlo>	MP:0000018,small ears|MP:0000521,abnormal kidney cortex morphology|MP:0000527,abnormal kidney development|MP:0000530,abnormal kidney vasculature morphology|MP:0000715,decreased thymocyte number|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002145,abnormal T cell differentiation|MP:0002705,dilated renal tubule|MP:0002989,small kidney|MP:0003014,abnormal kidney medulla morphology|MP:0003446,renal hypoplasia|MP:0003606,kidney failure|MP:0003643,spleen atrophy|MP:0003675,kidney cyst|MP:0003918,decreased kidney weight|MP:0003945,abnormal lymphocyte physiology|MP:0004505,decreased renal glomerulus number|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0004953,decreased spleen weight|MP:0004969,pale kidney|MP:0005016,decreased lymphocyte cell number|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005460,abnormal leukopoiesis|MP:0006413,increased T cell apoptosis|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008140,podocyte foot process effacement|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008479,decreased spleen white pulp amount|MP:0008528,polycystic kidney|MP:0008782,increased B cell apoptosis|MP:0009322,increased splenocyte apoptosis|MP:0009640,abnormal renal tubule epithelium morphology|MP:0009641,kidney degeneration|MP:0010979,small ureteric bud|MP:0010982,abnormal ureteric bud elongation|MP:0010985,abnormal kidney mesenchyme morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011290,decreased nephron number|MP:0011294,renal glomerulus hypertrophy|MP:0011334,abnormal nephrogenic zone morphology|MP:0011353,expanded mesangial matrix|MP:0011365,small metanephros|MP:0011368,increased kidney apoptosis|MP:0011369,increased renal glomerulus apoptosis|MP:0011376,abnormal kidney corticomedullary boundary morphology|MP:0011408,renal tubule hypertrophy|MP:0011430,mesangiolysis|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011483,renal glomerular synechia|MP:0011498,abnormal glomerular capsule parietal layer morphology|MP:0011500,decreased glomerular capsule space|MP:0011871,podocyte hypertrophy|MP:0020084,short ears|MP:0030188,round snout
MGI:3830735	Bcl2<tm1Irt>	MP:0011080,increased macrophage apoptosis
MGI:3690216	Bcl2<tm1Lbox>	MP:0002144,abnormal B cell differentiation|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008217,abnormal B cell activation|MP:0008782,increased B cell apoptosis
MGI:1857430	Bcl2<tm1Mpin>	MP:0000909,abnormal facial motor nucleus morphology|MP:0000938,motor neuron degeneration|MP:0000966,decreased sensory neuron number|MP:0001011,abnormal superior cervical ganglion morphology|MP:0001025,abnormal sympathetic neuron morphology|MP:0001265,decreased body size|MP:0001330,abnormal optic nerve morphology|MP:0002083,premature death|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0006405,abnormal L3 dorsal root ganglion morphology|MP:0008067,retina ganglion cell degeneration|MP:0008528,polycystic kidney
MGI:1857134	Bcl2<tm1Sjk>	MP:0000018,small ears|MP:0000445,short snout|MP:0000522,kidney cortex cyst|MP:0000528,delayed kidney development|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001824,abnormal thymus involution|MP:0002083,premature death|MP:0002356,abnormal spleen red pulp morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002722,abnormal immune system organ morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002955,increased compensatory renal growth|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0003446,renal hypoplasia|MP:0003566,abnormal cell adhesion|MP:0003606,kidney failure|MP:0003675,kidney cyst|MP:0003719,abnormal pericyte morphology|MP:0003918,decreased kidney weight|MP:0004505,decreased renal glomerulus number|MP:0004805,absent oocytes|MP:0004969,pale kidney|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005150,cachexia|MP:0005325,abnormal renal glomerulus morphology|MP:0005408,hypopigmentation|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0006057,decreased vascular endothelial cell number|MP:0006413,increased T cell apoptosis|MP:0008528,polycystic kidney|MP:0009050,dilated proximal convoluted tubule|MP:0009051,dilated distal convoluted tubule|MP:0009361,abnormal primordial ovarian follicle morphology|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009640,abnormal renal tubule epithelium morphology|MP:0009660,abnormal induced retina neovascularization|MP:0009783,abnormal melanoblast morphology|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011290,decreased nephron number|MP:0011307,kidney medulla cyst|MP:0011334,abnormal nephrogenic zone morphology|MP:0011365,small metanephros|MP:0011368,increased kidney apoptosis|MP:0011386,increased metanephric mesenchyme apoptosis|MP:0011425,abnormal kidney interstitium morphology|MP:0011440,increased kidney cell proliferation|MP:0011457,abnormal metanephric ureteric bud development|MP:0011502,parietal capsular epithelium metaplasia|MP:0030188,round snout
MGI:2158305	Bcl2<tm1Tsu>	MP:0000018,small ears|MP:0000394,absent hair follicle melanin granules|MP:0000496,abnormal small intestine morphology|MP:0000692,small spleen|MP:0000706,small thymus|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002444,abnormal T cell physiology|MP:0002619,abnormal lymphocyte morphology|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0004505,decreased renal glomerulus number|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0004969,pale kidney|MP:0005408,hypopigmentation|MP:0008108,abnormal small intestinal villus morphology|MP:0008528,polycystic kidney|MP:0009050,dilated proximal convoluted tubule|MP:0009051,dilated distal convoluted tubule|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014082,decreased small intestinal villus height
MGI:5288478	Bcl2<tm2.1Lbox>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0002459,abnormal B cell physiology|MP:0003132,increased pre-B cell number|MP:0005014,increased B cell number|MP:0008210,increased mature B cell number|MP:0008214,increased immature B cell number|MP:0009317,increased follicular lymphoma incidence
MGI:8257378	Bcl3<em1Dvs>	MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:6114031	Bcl3<m1Btlr>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0002492,decreased IgE level|MP:0004977,increased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005425,increased macrophage cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008170,decreased B-1b cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number
MGI:6199063	Bcl3<m2Btlr>	MP:0002491,decreased IgD level|MP:0002494,increased IgM level|MP:0004977,increased B-1 B cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0010838,increased CD8-positive, alpha-beta memory T cell number
MGI:6305105	Bcl3<m3Btlr>	MP:0010848,decreased central memory CD8 positive, alpha-beta T cell number
MGI:5806268	Bcl3<tm1b(EUCOMM)Wtsi>	MP:0000443,abnormal snout morphology|MP:0003179,thrombocytopenia|MP:0004952,increased spleen weight
MGI:2675475	Bcl3<tm1Rie>	MP:0000696,abnormal Peyer's patch morphology|MP:0002389,abnormal Peyer's patch follicle morphology|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002392,abnormal Peyer's patch T cell area morphology|MP:0005017,decreased B cell number|MP:0006173,abnormal myeloid dendritic cell morphology|MP:0008125,abnormal dendritic cell number|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0008196,abnormal follicular dendritic cell morphology|MP:0008524,increased plasmacytoid dendritic cell number
MGI:3695737	Bcl3<tm1Rsch>	MP:0002412,increased susceptibility to bacterial infection|MP:0002419,abnormal innate immunity|MP:0002451,abnormal macrophage physiology|MP:0003009,abnormal cytokine secretion|MP:0005584,abnormal enzyme/coenzyme activity
MGI:2158443	Bcl3<tm1Sbn>	MP:0002144,abnormal B cell differentiation|MP:0002344,abnormal lymph node B cell domain morphology|MP:0002459,abnormal B cell physiology|MP:0002619,abnormal lymphocyte morphology|MP:0003884,decreased macrophage cell number|MP:0003957,abnormal nitric oxide homeostasis|MP:0004816,abnormal class switch recombination|MP:0005017,decreased B cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005093,decreased B cell proliferation|MP:0005154,increased B cell proliferation|MP:0008101,lymph node hypoplasia|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008240,abnormal spleen marginal zone macrophage morphology|MP:0008241,abnormal metallophilic macrophage morphology|MP:0008474,absent spleen germinal center|MP:0008475,intermingled spleen red and white pulp|MP:0008484,decreased spleen germinal center size|MP:0008496,decreased IgG2a level|MP:0008567,decreased interferon-gamma secretion|MP:0008664,decreased interleukin-12 secretion|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009923,decreased transitional stage T1 B cell number|MP:0009926,decreased transitional stage T2 B cell number|MP:0014350,disorganized spleen B cell follicle
MGI:1861796	Bcl3<tm1Ver>	MP:0001800,abnormal humoral immune response|MP:0002412,increased susceptibility to bacterial infection|MP:0005387,immune system phenotype|MP:0008474,absent spleen germinal center
MGI:3584139	Bcl6b<tm1Dtf>	MP:0005025,abnormal response to infection|MP:0005095,decreased T cell proliferation|MP:0008050,decreased memory T cell number
MGI:3497910	Bcl6b<tm1Tto>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology
MGI:3719094	Bcl6b<tm2Dent>	MP:0000220,increased monocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0002429,abnormal blood cell morphology/development|MP:0003131,increased erythrocyte cell number
MGI:5518542	Bcl6<tm1.1Dent>	MP:0001805,decreased IgG level|MP:0002169,no abnormal phenotype detected|MP:0008178,decreased germinal center B cell number|MP:0008660,increased interleukin-10 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0010187,decreased T follicular helper cell number|MP:0010188,abnormal T follicular helper cell differentiation
MGI:5449732	Bcl6<tm1.1Jwan>	MP:0004815,abnormal somatic hypermutation frequency|MP:0005387,immune system phenotype
MGI:5502178	Bcl6<tm1.1Meln>	MP:0001805,decreased IgG level|MP:0002359,abnormal spleen germinal center morphology|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002420,abnormal adaptive immunity|MP:0002452,abnormal professional antigen presenting cell physiology|MP:0002722,abnormal immune system organ morphology|MP:0005378,growth/size/body region phenotype|MP:0005387,immune system phenotype|MP:0008192,abnormal germinal center B cell physiology|MP:0008482,decreased spleen germinal center number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0010187,decreased T follicular helper cell number|MP:0010768,mortality/aging
MGI:5461311	Bcl6<tm1.1Mtto>	MP:0001800,abnormal humoral immune response|MP:0002440,abnormal memory B cell morphology|MP:0004815,abnormal somatic hypermutation frequency|MP:0005387,immune system phenotype|MP:0008178,decreased germinal center B cell number|MP:0008179,absent germinal center B cells|MP:0008194,abnormal memory B cell physiology|MP:0010187,decreased T follicular helper cell number
MGI:5140802	Bcl6<tm1.1Toka>	MP:0000696,abnormal Peyer's patch morphology|MP:0005387,immune system phenotype|MP:0008178,decreased germinal center B cell number|MP:0010187,decreased T follicular helper cell number
MGI:6293908	Bcl6<tm1Gdba>	MP:0000008,increased white adipose tissue amount|MP:0001547,abnormal lipid level|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0005335,abnormal gonadal fat pad morphology|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0009118,increased white fat cell size|MP:0009356,decreased liver triglyceride level|MP:0010379,decreased respiratory quotient|MP:0010934,increased subcutaneous adipose tissue amount|MP:0013278,decreased fasting circulating glucose level|MP:0014142,increased body fat mass|MP:0020583,decreased ceramide level|MP:0020867,increased lipogenesis|MP:0030016,increased adipocyte glucose uptake|MP:0030017,decreased adipocyte glucose uptake|MP:0030969,increased circulating adiponectin level|MP:0030973,impaired gluconeogenesis|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis|MP:0031602,white adipose tissue inflammation|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:2158436	Bcl6<tm1Htno>	MP:0000280,thin ventricular wall|MP:0000689,abnormal spleen morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001648,abnormal apoptosis|MP:0001856,myocarditis|MP:0001861,lung inflammation|MP:0001922,reduced male fertility|MP:0002083,premature death|MP:0002687,oligozoospermia|MP:0004566,myocardial fiber degeneration|MP:0005608,cardiac interstitial fibrosis|MP:0008022,dilated heart ventricle|MP:0009647,decreased fertilization frequency|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014052,increased male germ cell apoptosis
MGI:2158437	Bcl6<tm1Rdf>	MP:0000685,abnormal immune system morphology|MP:0000693,spleen hyperplasia|MP:0000706,small thymus|MP:0001732,postnatal growth retardation|MP:0001790,abnormal immune system physiology|MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001846,increased inflammatory response|MP:0001853,heart inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002459,abnormal B cell physiology|MP:0005011,increased eosinophil cell number|MP:0005466,abnormal T-helper 2 physiology|MP:0008474,absent spleen germinal center|MP:0008523,absent lymph node germinal center
MGI:2158439	Bcl6<tm1Sdt>	MP:0000333,decreased bone marrow cell number|MP:0000694,spleen hypoplasia|MP:0001732,postnatal growth retardation|MP:0001790,abnormal immune system physiology|MP:0002429,abnormal blood cell morphology/development|MP:0008721,abnormal chemokine level|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2158438	Bcl6<tm2Rdf>	MP:0000685,abnormal immune system morphology|MP:0000693,spleen hyperplasia|MP:0000706,small thymus|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001790,abnormal immune system physiology|MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001846,increased inflammatory response|MP:0001853,heart inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002459,abnormal B cell physiology|MP:0005011,increased eosinophil cell number|MP:0005093,decreased B cell proliferation|MP:0005466,abnormal T-helper 2 physiology|MP:0008474,absent spleen germinal center|MP:0008523,absent lymph node germinal center|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6361907	Bcl7a<tm1.1Ban>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6361906	Bcl7a<tm1Ban>	MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001522,impaired swimming|MP:0005386,behavior/neurological phenotype|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:5616361	Bcl7a<tm1b(EUCOMM)Wtsi>	MP:0001491,unresponsive to tactile stimuli|MP:0001697,abnormal embryo size|MP:0002574,increased vertical activity|MP:0002833,increased heart weight|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration|MP:0011965,decreased total retina thickness
MGI:6361910	Bcl7b<tm1.1Ban>	MP:0002169,no abnormal phenotype detected
MGI:5614695	Bcl7b<tm1b(EUCOMM)Wtsi>	MP:0001399,hyperactivity|MP:0002833,increased heart weight|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:6362049	Bcl7c<em1(IMPC)J>	MP:0000195,decreased circulating calcium level
MGI:7425541	Bcl9<em1(IMPC)Bay>	MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6257736	Bcl9l<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6781769	Bcl9l<tm1Taki>	MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0001722,pale yolk sac|MP:0001730,embryonic growth arrest|MP:0004266,pale placenta|MP:0004560,abnormal chorionic plate morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5520175	Bclaf1<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001399,hyperactivity|MP:0001575,cyanosis|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:4438380	Bclaf1<tm1Raz>	MP:0000562,polydactyly|MP:0001176,abnormal lung development|MP:0001265,decreased body size|MP:0005014,increased B cell number|MP:0005095,decreased T cell proliferation|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0009546,absent gastric milk in neonates|MP:0011085,postnatal lethality, complete penetrance|MP:0011143,thick lung-associated mesenchyme|MP:0011145,abnormal mesenchymal cell differentiation involved in lung development
MGI:3865259	Bclaf3<Gt(P078F05)Wrst>	MP:0002169,no abnormal phenotype detected
MGI:4123143	Bclaf3<Gt(W069B04)Wrst>	MP:0002169,no abnormal phenotype detected
MGI:2389406	Bcmd2<CAST/EiJ>	MP:0000324,increased mast cell number
MGI:3767552	Bco1<tm1Dnp>	MP:0001554,increased circulating free fatty acids level|MP:0002941,increased circulating alanine transaminase level|MP:0004019,abnormal vitamin homeostasis|MP:0005178,increased circulating cholesterol level|MP:0005376,homeostasis/metabolism phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0011232,abnormal vitamin A level|MP:0031115,macrovesicular hepatic steatosis
MGI:4840382	Bco2<tm1Dnp>	MP:0000003,abnormal adipose tissue morphology|MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0001147,small testis|MP:0001764,abnormal homeostasis|MP:0004852,decreased testis weight|MP:0004910,decreased seminal vesicle weight|MP:0004952,increased spleen weight|MP:0009355,increased liver triglyceride level|MP:0009642,abnormal blood homeostasis|MP:0010080,abnormal hepatocyte physiology|MP:0010957,abnormal aerobic respiration|MP:0031115,macrovesicular hepatic steatosis
MGI:4335462	Bcor<Gt(A20062)Wrst>	MP:0001695,abnormal gastrulation
MGI:3870923	Bcor<Gt(DB0053)Wtsi>	MP:0000433,microcephaly|MP:0001689,incomplete somite formation|MP:0003232,abnormal forebrain development|MP:0004251,failure of heart looping|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3897494	Bcor<Gt(P101H07)Wrst>	MP:0001700,abnormal embryo turning|MP:0002084,abnormal developmental patterning
MGI:4334028	Bcor<Gt(W096D07)Wrst>	MP:0001695,abnormal gastrulation
MGI:4126230	Bcor<Gt(XE541)Byg>	MP:0000269,abnormal heart looping|MP:0000433,microcephaly|MP:0001689,incomplete somite formation|MP:0003232,abnormal forebrain development
MGI:7256769	Bcorl1<em1(IMPC)Tcp>	MP:0000063,decreased bone mineral density|MP:0000186,decreased circulating HDL cholesterol level|MP:0000208,decreased hematocrit|MP:0000443,abnormal snout morphology|MP:0001258,decreased body length|MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002100,abnormal tooth morphology|MP:0002599,increased mean platelet volume|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0005179,decreased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0010097,abnormal retina blood vessel morphology|MP:0010124,decreased bone mineral content|MP:0030610,absent teeth
MGI:6764605	Bcorl1<em1Nju>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0009832,abnormal sperm mitochondrial sheath morphology
MGI:5925306	Bcor<tm1.1Vjba>	MP:0000088,short mandible|MP:0000111,cleft palate|MP:0000160,kyphosis|MP:0000219,increased neutrophil cell number|MP:0000351,increased cell proliferation|MP:0000564,syndactyly|MP:0000585,kinked tail|MP:0000762,abnormal tongue morphology|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001344,blepharoptosis|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0002633,persistent truncus arteriosus|MP:0003717,pallor|MP:0003792,abnormal major salivary gland morphology|MP:0003984,embryonic growth retardation|MP:0004113,abnormal aortic arch morphology|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0005385,cardiovascular system phenotype|MP:0006020,decreased tympanic ring size|MP:0006208,lethality throughout fetal growth and development|MP:0008862,asymmetric snout|MP:0009278,abnormal bone marrow cell physiology|MP:0009397,increased trophoblast giant cell number|MP:0009546,absent gastric milk in neonates|MP:0009886,failure of palatal shelf elevation|MP:0009909,bifid tongue|MP:0010418,perimembraneous ventricular septal defect|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011523,thin placenta labyrinth|MP:0012138,decreased forebrain size|MP:0013264,tongue ankylosis|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0013933,short Meckel's cartilage|MP:0021213,complete cleft palate|MP:0030189,broad snout|MP:0031443,abnormal tongue position
MGI:5524984	Bcr<tm1(BCR/ABL)Tsr>	MP:0002169,no abnormal phenotype detected|MP:0004810,decreased hematopoietic stem cell number|MP:0009278,abnormal bone marrow cell physiology
MGI:2154396	Bcr<tm1Hkp>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0001263,weight loss|MP:0002123,abnormal definitive hematopoiesis|MP:0002463,abnormal neutrophil physiology|MP:0002581,abnormal ileum morphology|MP:0002941,increased circulating alanine transaminase level|MP:0003288,intestinal edema|MP:0003946,renal necrosis|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005044,sepsis|MP:0005325,abnormal renal glomerulus morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0005565,increased blood urea nitrogen level|MP:0008735,increased susceptibility to endotoxin shock|MP:0008986,abnormal liver parenchyma morphology|MP:0011971,increased circulating lactate dehydrogenase level
MGI:5569046	Bcs1l<tm1.1(KOMP)Vlcg>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014586,decreased egg cylinder size
MGI:5446796	Bcs1l<tm1.1Levp>	MP:0000219,increased neutrophil cell number|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001505,hunched posture|MP:0001654,hepatic necrosis|MP:0001860,liver inflammation|MP:0002083,premature death|MP:0002446,abnormal macrophage morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003333,liver fibrosis|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005425,increased macrophage cell number|MP:0005536,decreased Leydig cell number|MP:0005560,decreased circulating glucose level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006036,abnormal mitochondrial physiology|MP:0008489,slow postnatal weight gain|MP:0008807,increased liver iron level|MP:0008993,abnormal portal triad morphology|MP:0010398,decreased liver glycogen level|MP:0010954,abnormal cellular respiration|MP:0011630,increased mitochondrial size|MP:0011635,abnormal mitochondrial crista morphology|MP:0013405,increased circulating lactate level|MP:0014341,abnormal hepatocyte mitochondrial morphology|MP:0020836,increased circulating citrulline level|MP:0030650,increased circulating ornithine level|MP:0030662,decreased circulating arginine level|MP:0030970,ketosis|MP:0031116,microvesicular hepatic steatosis
MGI:1856683	bd	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001958,emphysema|MP:0002705,dilated renal tubule|MP:0003154,abnormal soft palate morphology|MP:0005150,cachexia|MP:0005574,decreased pulmonary respiratory rate|MP:0008489,slow postnatal weight gain|MP:0008727,increased heart right atrium size|MP:0009247,meteorism|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031443,abnormal tongue position
MGI:1856682	Bda	MP:0000416,sparse hair|MP:0001406,abnormal gait|MP:0001923,reduced female fertility|MP:0002109,abnormal limb morphology|MP:0003815,hairless
MGI:3770627	bdd	MP:0001265,decreased body size|MP:0001312,abnormal cornea morphology|MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0004173,abnormal intervertebral disk morphology|MP:0004509,abnormal pelvic girdle bone morphology|MP:0009079,prolapsed intervertebral disk|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6297074	Bdh1<tm1c(EUCOMM)Wtsi>	MP:0003921,abnormal heart left ventricle morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4433163	Bdh2<tm1a(EUCOMM)Wtsi>	MP:0005561,increased mean corpuscular hemoglobin
MGI:6140144	Bdkrb1<em1(IMPC)H>	MP:0002968,increased circulating alkaline phosphatase level|MP:0010052,increased grip strength
MGI:3795262	Bdkrb1<tm1(BDKRB1)Jfh>	MP:0002169,no abnormal phenotype detected
MGI:2158501	Bdkrb1<tm1Bdr>	MP:0001982,decreased chemically-elicited antinociception|MP:0002498,abnormal acute inflammation|MP:0002733,abnormal thermal nociception|MP:0002734,abnormal mechanical nociception|MP:0003043,hypoalgesia|MP:0005385,cardiovascular system phenotype|MP:0008734,decreased susceptibility to endotoxin shock
MGI:3604513	Bdkrb1<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:1857135	Bdkrb2<tm1Jfh>	MP:0000063,decreased bone mineral density|MP:0000521,abnormal kidney cortex morphology|MP:0000522,kidney cortex cyst|MP:0000527,abnormal kidney development|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002136,abnormal kidney physiology|MP:0002169,no abnormal phenotype detected|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002786,abnormal Leydig cell morphology|MP:0002829,abnormal juxtaglomerular apparatus morphology|MP:0003881,abnormal nephron morphology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005566,decreased blood urea nitrogen level|MP:0009640,abnormal renal tubule epithelium morphology|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011300,abnormal juxtaglomerular cell morphology|MP:0011320,abnormal glomerular capillary morphology|MP:0011347,abnormal kidney medullary ray morphology|MP:0011501,increased glomerular capsule space|MP:0011638,abnormal mitochondrial chromosome morphology|MP:0011742,decreased urine nitrite level
MGI:2446859	Bdln1<M. spretus>	MP:0001257,increased body length
MGI:2670691	Bdln3<C57BL/6ByJ>	MP:0001257,increased body length
MGI:2670693	Bdln4<C57BL/6ByJ>	MP:0001257,increased body length
MGI:2670695	Bdln5<C57BL/6ByJ>	MP:0001257,increased body length
MGI:2670696	Bdln6<129P3/J>	MP:0001257,increased body length
MGI:3698779	Bdlnq7<CAST/EiJ>	MP:0001258,decreased body length
MGI:3586682	Bdmsq<EF>	MP:0001260,increased body weight
MGI:5427360	Bdnf<tm1.1Krj>	MP:0003631,nervous system phenotype|MP:0009936,abnormal dendritic spine morphology|MP:0014491,abnormal mammary gland sensory innervation pattern
MGI:3809491	Bdnf<tm1.1Meg>	MP:0008960,abnormal axon pruning
MGI:3836989	Bdnf<tm1.1Tes>	MP:0002169,no abnormal phenotype detected
MGI:7545595	Bdnf<tm1.1Tmiz>	MP:0001260,increased body weight|MP:0001447,abnormal nest building behavior|MP:0002573,behavioral despair|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0011939,increased food intake
MGI:3842639	Bdnf<tm1Bail>	MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003633,abnormal nervous system physiology|MP:0004101,abnormal brain interneuron morphology|MP:0004859,abnormal synaptic plasticity
MGI:3664862	Bdnf<tm1Flee>	MP:0000812,abnormal dentate gyrus morphology|MP:0001260,increased body weight|MP:0001354,increased aggression towards male mice|MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001469,abnormal contextual conditioning behavior|MP:0004811,abnormal neuron physiology|MP:0008143,abnormal dendrite morphology|MP:0020083,decreased hippocampus volume
MGI:1930038	Bdnf<tm1Gdy>	MP:0000774,decreased brain size|MP:0000966,decreased sensory neuron number|MP:0001085,small petrosal ganglion|MP:0001088,small nodose ganglion|MP:0001093,small trigeminal ganglion|MP:0001399,hyperactivity|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0001732,postnatal growth retardation|MP:0003987,small vestibular ganglion|MP:0004298,vestibular ganglion degeneration|MP:0004747,abnormal cochlear OHC afferent innervation pattern|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014490,abnormal inner ear vestibular sensory neuron innervation pattern
MGI:1857136	Bdnf<tm1Jae>	MP:0000907,small mesencephalic trigeminal nucleus|MP:0000966,decreased sensory neuron number|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001021,small L4 dorsal root ganglion|MP:0001065,abnormal trigeminal nerve morphology|MP:0001083,small geniculate ganglion|MP:0001085,small petrosal ganglion|MP:0001088,small nodose ganglion|MP:0001093,small trigeminal ganglion|MP:0001265,decreased body size|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0001411,spinning|MP:0001524,impaired limb coordination|MP:0001525,impaired balance|MP:0001967,deafness|MP:0002855,abnormal cochlear ganglion morphology|MP:0002856,abnormal vestibular ganglion morphology|MP:0002882,abnormal neuron morphology|MP:0003202,abnormal neuron apoptosis|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0003987,small vestibular ganglion|MP:0004249,abnormal crista ampullaris morphology|MP:0004428,abnormal type I vestibular cell|MP:0005191,head tilt|MP:0005377,hearing/vestibular/ear phenotype|MP:0006257,abnormal fungiform papillae morphology|MP:0006260,abnormal gustatory papilla taste bud morphology|MP:0008947,increased neuron number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014490,abnormal inner ear vestibular sensory neuron innervation pattern
MGI:2663046	Bdnf<tm1Jben>	MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0002882,abnormal neuron morphology|MP:0004077,abnormal striatum morphology
MGI:3582638	Bdnf<tm1Krj>	MP:0002272,abnormal nervous system electrophysiology|MP:0003245,abnormal GABAergic neuron morphology|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0008143,abnormal dendrite morphology|MP:0014812,abnormal brain physiology
MGI:1930110	Bdnf<tm1Lfr>	MP:0000435,shortened head|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000907,small mesencephalic trigeminal nucleus|MP:0000959,abnormal somatic sensory system morphology|MP:0000960,abnormal sensory ganglion morphology|MP:0000964,small dorsal root ganglion|MP:0000966,decreased sensory neuron number|MP:0001081,abnormal cranial ganglia morphology|MP:0001083,small geniculate ganglion|MP:0001085,small petrosal ganglion|MP:0001088,small nodose ganglion|MP:0001261,obese|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001411,spinning|MP:0001505,hunched posture|MP:0001523,impaired righting response|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002856,abnormal vestibular ganglion morphology|MP:0003313,abnormal locomotor activation|MP:0005574,decreased pulmonary respiratory rate|MP:0006257,abnormal fungiform papillae morphology|MP:0006258,abnormal circumvallate papillae morphology|MP:0006260,abnormal gustatory papilla taste bud morphology|MP:0009937,abnormal neuron differentiation|MP:0011085,postnatal lethality, complete penetrance|MP:0020301,short tongue
MGI:3770141	Bdnf<tm1Limm>	MP:0001423,abnormal liquid preference|MP:0003360,abnormal depression-related behavior|MP:0031391,increased locomotor activity
MGI:3774518	Bdnf<tm1Msd>	MP:0001473,reduced long-term potentiation|MP:0003631,nervous system phenotype|MP:0010768,mortality/aging
MGI:2655761	Bdnf<tm1(Ntf3)Pern>	MP:0000031,abnormal cochlea morphology|MP:0000965,abnormal sensory neuron morphology|MP:0001082,abnormal geniculate ganglion morphology|MP:0001088,small nodose ganglion|MP:0001260,increased body weight|MP:0001405,impaired coordination|MP:0001525,impaired balance|MP:0002083,premature death|MP:0002184,abnormal innervation|MP:0002856,abnormal vestibular ganglion morphology|MP:0004249,abnormal crista ampullaris morphology|MP:0004298,vestibular ganglion degeneration|MP:0005377,hearing/vestibular/ear phenotype|MP:0005500,abnormal gustatory system morphology|MP:0006257,abnormal fungiform papillae morphology|MP:0014490,abnormal inner ear vestibular sensory neuron innervation pattern
MGI:1929986	Bdnf<tm1Par>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0000964,small dorsal root ganglion|MP:0000966,decreased sensory neuron number|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001021,small L4 dorsal root ganglion|MP:0001083,small geniculate ganglion|MP:0001085,small petrosal ganglion|MP:0001088,small nodose ganglion|MP:0001093,small trigeminal ganglion|MP:0001260,increased body weight|MP:0001354,increased aggression towards male mice|MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001433,polyphagia|MP:0002079,increased circulating insulin level|MP:0002206,abnormal CNS synaptic transmission|MP:0002752,abnormal somatic nervous system morphology|MP:0002757,decreased vertical activity|MP:0003203,increased neuron apoptosis|MP:0003212,increased susceptibility to age related obesity|MP:0003313,abnormal locomotor activation|MP:0003877,abnormal serotonergic neuron morphology|MP:0003989,abnormal barrel cortex morphology|MP:0005322,abnormal serotonin level|MP:0011085,postnatal lethality, complete penetrance|MP:0020083,decreased hippocampus volume
MGI:2678286	Bdnf<tm1Sieg>	MP:0001473,reduced long-term potentiation|MP:0002169,no abnormal phenotype detected
MGI:1891516	Bdnf<tm1Tbn>	MP:0000427,abnormal hair cycle|MP:0000477,abnormal intestine morphology|MP:0000495,abnormal colon morphology|MP:0000964,small dorsal root ganglion|MP:0000966,decreased sensory neuron number|MP:0001007,abnormal sympathetic system morphology|MP:0001026,abnormal adrenergic neuron morphology|MP:0001262,decreased body weight|MP:0001473,reduced long-term potentiation|MP:0001524,impaired limb coordination|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0001900,impaired synaptic plasticity|MP:0002184,abnormal innervation|MP:0002655,abnormal keratinocyte morphology|MP:0002912,abnormal excitatory postsynaptic potential|MP:0004747,abnormal cochlear OHC afferent innervation pattern|MP:0011085,postnatal lethality, complete penetrance|MP:0013795,abnormal colon goblet cell morphology
MGI:4443014	Bdnf<tm1Yab>	MP:0000774,decreased brain size|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001330,abnormal optic nerve morphology|MP:0001363,increased anxiety-related response|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0002175,decreased brain weight|MP:0002882,abnormal neuron morphology|MP:0003313,abnormal locomotor activation|MP:0008143,abnormal dendrite morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0012468,decreased striatum size
MGI:1929985	Bdnf<tm2(Ntf5)Jae>	MP:0001262,decreased body weight|MP:0001412,excessive scratching|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0003631,nervous system phenotype
MGI:2176750	Bdnf<tm3Jae>	MP:0000819,abnormal olfactory bulb morphology|MP:0001257,increased body length|MP:0001261,obese|MP:0001354,increased aggression towards male mice|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001433,polyphagia|MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0001499,abnormal kindling response|MP:0001513,limb grasping|MP:0001764,abnormal homeostasis|MP:0001923,reduced female fertility|MP:0002079,increased circulating insulin level|MP:0002169,no abnormal phenotype detected|MP:0002175,decreased brain weight|MP:0003982,increased cholesterol level|MP:0005331,insulin resistance|MP:0005386,behavior/neurological phenotype|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0008265,abnormal hippocampus CA2 region morphology|MP:0009456,impaired cued conditioning behavior|MP:0009747,impaired behavioral response to xenobiotic
MGI:6156463	Bdp1<em1(IMPC)Tcp>	MP:0000222,decreased neutrophil cell number|MP:0000689,abnormal spleen morphology|MP:0005013,increased lymphocyte cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:2156404	Bdt3<DBA/2J>	MP:0000062,increased bone mineral density|MP:0005145,increased circulating VLDL cholesterol level|MP:0005669,increased circulating leptin level|MP:0008908,increased total fat pad weight
MGI:3589629	Bdw1<FGS/Kist>	MP:0001262,decreased body weight
MGI:3778074	Bdwtq<129S1/SvImJ>	MP:0001262,decreased body weight|MP:0005334,abnormal fat pad morphology|MP:0009283,decreased gonadal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight
MGI:3528052	Bdywt<C57BL/6J>	MP:0001260,increased body weight
MGI:6293842	Bean1<em1(IMPC)H>	MP:0001406,abnormal gait|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number
MGI:5605284	Bean1<tm1Shkr>	MP:0002169,no abnormal phenotype detected
MGI:5527250	Becn1<tm1.1Bflu>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005095,decreased T cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0006413,increased T cell apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:5308733	Becn1<tm1.1Ebr>	MP:0001126,abnormal ovary morphology
MGI:5548507	Becn1<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000218,increased leukocyte cell number|MP:0001488,increased startle reflex|MP:0003961,decreased lean body mass|MP:0005344,increased circulating bilirubin level|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:2683696	Becn1<tm1Blev>	MP:0000685,abnormal immune system morphology|MP:0002018,increased malignant tumor incidence|MP:0002020,increased tumor incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0003037,increased myocardial infarct size|MP:0003038,decreased myocardial infarct size|MP:0003331,increased hepatocellular carcinoma incidence|MP:0008481,increased spleen germinal center number|MP:0008483,increased spleen germinal center size|MP:0008714,increased lung carcinoma incidence|MP:0009317,increased follicular lymphoma incidence|MP:0009321,increased histiocytic sarcoma incidence|MP:0009503,abnormal mammary gland duct morphology|MP:0010286,increased plasmacytoma incidence|MP:0010299,increased mammary gland tumor incidence|MP:0011091,prenatal lethality, complete penetrance|MP:0012431,increased lymphoma incidence|MP:0014237,decreased tumor-free survival time|MP:0030940,impaired autophagy
MGI:5308732	Becn1<tm1Ebr>	MP:0000267,abnormal heart development|MP:0000913,abnormal brain development|MP:0001127,small ovary|MP:0002081,perinatal lethality|MP:0009361,abnormal primordial ovarian follicle morphology|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011121,decreased primordial ovarian follicle number
MGI:2683833	Becn1<tm1Htz>	MP:0001698,decreased embryo size|MP:0001710,absent amniotic folds|MP:0001730,embryonic growth arrest|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0005029,abnormal amnion morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis|MP:0030940,impaired autophagy
MGI:6715552	Becn1<tm1Smoc>	MP:0004946,abnormal regulatory T cell physiology
MGI:6156896	Becn1<tm2.1Blev>	MP:0002169,no abnormal phenotype detected
MGI:5550535	Becn2<tm1.1Blev>	MP:0001260,increased body weight|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011939,increased food intake|MP:0030940,impaired autophagy
MGI:5818151	Begain<tm1.1Tayk>	MP:0001970,abnormal pain threshold|MP:0002910,abnormal excitatory postsynaptic currents|MP:0008432,abnormal long-term spatial reference memory|MP:0011271,prolonged excitatory postsynaptic current rise time|MP:0012319,fast extinction of fear memory
MGI:5297598	bella	MP:0001393,ataxia|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0003203,increased neuron apoptosis|MP:0008924,decreased cerebellar granule cell number|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:3785460	Belr1<BALB/cJ>	MP:0005026,decreased susceptibility to parasitic infection
MGI:7314760	Bend2<em1Hncs>	MP:0001147,small testis|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:7314790	Bend2<em3Hncs>	MP:0001147,small testis|MP:0001925,male infertility
MGI:5707440	Bend3<tm1b(KOMP)Mbp>	MP:0002075,abnormal coat/hair pigmentation|MP:0011100,preweaning lethality, complete penetrance
MGI:6275204	Bend6<em1(IMPC)J>	MP:0001513,limb grasping
MGI:5692828	Bend7<tm1b(EUCOMM)Wtsi>	MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level
MGI:2669995	Berr1<WLA/Pas>	MP:0005026,decreased susceptibility to parasitic infection
MGI:2670003	Berr2<WLA/Pas>	MP:0005026,decreased susceptibility to parasitic infection
MGI:4443333	Best1<tm1.1Amar>	MP:0003099,retina detachment|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005253,abnormal eye physiology|MP:0005551,abnormal eye electrophysiology
MGI:3795281	Best1<tm1Lmar>	MP:0005253,abnormal eye physiology|MP:0005551,abnormal eye electrophysiology
MGI:5752938	Best1<tm1Web>	MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0004543,abnormal sperm physiology|MP:0005391,vision/eye phenotype|MP:0008839,absent acrosome|MP:0008892,abnormal sperm flagellum morphology|MP:0008893,detached sperm flagellum|MP:0008898,abnormal acrosome morphology|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009325,necrospermia
MGI:6378540	Best1<tm2.1Web>	MP:0000242,impaired fertilization|MP:0002675,asthenozoospermia|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype
MGI:5642358	Best2<tm1b(EUCOMM)Hmgu>	MP:0005544,cornea deposits|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3796232	Best2<tm1Dgen>	MP:0005257,abnormal intraocular pressure|MP:0005260,ocular hypotension|MP:0005381,digestive/alimentary phenotype|MP:0005394,taste/olfaction phenotype|MP:0008872,abnormal physiological response to xenobiotic
MGI:7532855	Best3<tm1.1Zhoj>	MP:0000272,abnormal aorta morphology|MP:0001634,internal hemorrhage|MP:0002083,premature death|MP:0004044,aortic dissection|MP:0005385,cardiovascular system phenotype|MP:0005595,abnormal vascular smooth muscle physiology|MP:0006042,increased apoptosis|MP:0006278,aortic aneurysm|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009862,abnormal aorta elastic tissue morphology|MP:0009866,abnormal aorta wall morphology|MP:0009873,abnormal aorta tunica media morphology|MP:0010139,aortitis|MP:0010470,dilated ascending aorta|MP:0010473,descending aorta dilation|MP:0010658,thoracic aorta aneurysm|MP:0010659,abdominal aorta aneurysm|MP:0010997,decreased aorta wall thickness
MGI:6281721	Betalinc1<tm1Suss>	MP:0002079,increased circulating insulin level|MP:0003339,decreased pancreatic beta cell number|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0009177,decreased pancreatic alpha cell number|MP:0009180,increased pancreatic delta cell number|MP:0009191,decreased pancreatic epsilon cell number|MP:0011932,abnormal endocrine pancreas development
MGI:3764914	Bex1<Gt(OST125186)Lex>	MP:0012106,impaired exercise endurance|MP:0013237,abnormal skeletal muscle regeneration
MGI:5614697	Bex2<tm1b(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001488,increased startle reflex|MP:0002075,abnormal coat/hair pigmentation|MP:0009142,decreased prepulse inhibition|MP:0010068,decreased red blood cell distribution width|MP:0010097,abnormal retina blood vessel morphology
MGI:6302823	Bex2<tm1Kami>	MP:0002169,no abnormal phenotype detected
MGI:6430672	Bex3<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0003068,enlarged kidney
MGI:7430934	Bex3<em1Jjcar>	MP:0000788,abnormal cerebral cortex morphology|MP:0000822,abnormal brain ventricle morphology|MP:0000852,small cerebellum|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001447,abnormal nest building behavior|MP:0002801,abnormal long-term object recognition memory|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004000,impaired passive avoidance behavior|MP:0004101,abnormal brain interneuron morphology|MP:0004375,enlarged frontal bone|MP:0005386,behavior/neurological phenotype|MP:0006212,large orbits|MP:0008428,abnormal spatial working memory|MP:0009141,increased prepulse inhibition|MP:0011151,abnormal hippocampus stratum radiatum morphology|MP:0012676,dilated brain ventricle|MP:0014379,decreased excitatory postsynaptic current frequency|MP:0020395,abnormal response to social novelty
MGI:7430936	Bex3<em2Jjcar>	MP:0000788,abnormal cerebral cortex morphology|MP:0000822,abnormal brain ventricle morphology|MP:0000852,small cerebellum|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0004375,enlarged frontal bone|MP:0005386,behavior/neurological phenotype|MP:0006212,large orbits|MP:0008428,abnormal spatial working memory|MP:0009141,increased prepulse inhibition|MP:0012676,dilated brain ventricle|MP:0020395,abnormal response to social novelty
MGI:5634964	Bex6<tm1.1(KOMP)Vlcg>	MP:0000218,increased leukocyte cell number|MP:0001399,hyperactivity|MP:0002591,decreased mean corpuscular volume|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:1889298	Bey	MP:0000081,premature cranial suture closure|MP:0000097,short maxilla|MP:0000107,abnormal frontal bone morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000457,maxilla hypoplasia|MP:0001300,ocular hypertelorism|MP:0002750,exophthalmos|MP:0003743,abnormal facial morphology|MP:0004471,short nasal bone|MP:0030350,premature coronal suture closure|MP:0030354,premature sagittal suture closure|MP:0030356,premature lambdoid suture closure|MP:0030367,premature metopic suture closure|MP:0030415,premature intermaxillary suture closure
MGI:1889299	Bfo	MP:0001928,abnormal ovulation
MGI:2155179	Bfq1<LP/J>	MP:0001262,decreased body weight|MP:0002727,decreased circulating insulin level|MP:0005459,decreased percent body fat/body weight|MP:0009305,decreased retroperitoneal fat pad weight
MGI:5696874	Bfsp1<tm1b(EUCOMM)Wtsi>	MP:0001102,small superior vagus ganglion|MP:0001488,increased startle reflex|MP:0002092,abnormal eye morphology|MP:0004906,enlarged uterus
MGI:3641549	Bfsp1<tm1Pgf>	MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology
MGI:2671074	Bfsp2<Dundee>	MP:0002840,abnormal lens fiber morphology|MP:0020378,abnormal cell cytoskeleton morphology
MGI:3624777	Bfsp2<tm1Pgf>	MP:0001304,cataract
MGI:2653265	Bfsp2<tm1Raq>	MP:0002090,abnormal vision|MP:0002840,abnormal lens fiber morphology|MP:0003096,increased corneal light-scattering|MP:0020378,abnormal cell cytoskeleton morphology
MGI:3603628	bgby	MP:0006087,increased body mass index
MGI:2153895	Bgeq1<LG/J>	MP:0002089,abnormal postnatal growth/weight/body size
MGI:2153896	Bgeq1<SM/J>	MP:0002089,abnormal postnatal growth/weight/body size
MGI:2154961	Bgeq2<SM/J>	MP:0002865,increased growth rate
MGI:4949088	Bglap/Bglap2<tm3.1Kry>	MP:0001147,small testis|MP:0002687,oligozoospermia|MP:0002780,decreased circulating testosterone level|MP:0004852,decreased testis weight|MP:0004910,decreased seminal vesicle weight|MP:0004929,decreased epididymis weight|MP:0005389,reproductive system phenotype
MGI:4949089	Bglap/Bglap2<tm3.1Kry>	MP:0001147,small testis|MP:0002687,oligozoospermia|MP:0002780,decreased circulating testosterone level|MP:0004852,decreased testis weight|MP:0004910,decreased seminal vesicle weight|MP:0004929,decreased epididymis weight|MP:0005389,reproductive system phenotype
MGI:2156463	Bglq5<LG/J>	MP:0002865,increased growth rate
MGI:2157510	Bglq7<LG/J>	MP:0002865,increased growth rate
MGI:2157518	Bglq8<SM/J>	MP:0002865,increased growth rate
MGI:2157520	Bglq9<SM/J>	MP:0002865,increased growth rate
MGI:3812560	Bglu10<NZB/BlNJ>	MP:0005559,increased circulating glucose level
MGI:2154951	Bglu1<C57BL/6Slc>	MP:0001559,hyperglycemia
MGI:2389255	Bglu2<C57BL/6Slc>	MP:0001559,hyperglycemia
MGI:3624637	Bglu3<C3H/HeJ>	MP:0001260,increased body weight|MP:0005559,increased circulating glucose level
MGI:3812542	Bglu4<NZB/BlNJ>	MP:0005559,increased circulating glucose level
MGI:3812545	Bglu5<NZW/LacJ>	MP:0005559,increased circulating glucose level
MGI:3812546	Bglu6<NZB/BlNJ>	MP:0005559,increased circulating glucose level
MGI:3812550	Bglu7<NZW/LacJ>	MP:0005559,increased circulating glucose level
MGI:3812552	Bglu8<NZB/BlNJ>	MP:0005559,increased circulating glucose level
MGI:3812553	Bglu8<NZW/LacJ>	MP:0005559,increased circulating glucose level
MGI:5701726	Bgn<tm1.1(KOMP)Vlcg>	MP:0001258,decreased body length
MGI:2153057	Bgn<tm1Mfy>	MP:0000066,osteoporosis|MP:0000130,abnormal trabecular bone morphology|MP:0000131,abnormal long bone epiphysis morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000135,decreased compact bone thickness|MP:0000559,abnormal femur morphology|MP:0001244,thin dermal layer|MP:0001262,decreased body weight|MP:0003109,short femur|MP:0003560,osteoarthritis|MP:0004214,abnormal long bone diaphysis morphology|MP:0004989,decreased osteoblast cell number|MP:0005390,skeleton phenotype|MP:0008271,abnormal bone ossification|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0010124,decreased bone mineral content|MP:0010771,integument phenotype|MP:0011642,abnormal bone collagen fibril morphology|MP:0011643,abnormal tendon collagen fibril morphology|MP:0020254,decreased collagen level
MGI:1856677	bh	MP:0000074,abnormal neurocranium morphology|MP:0000435,shortened head|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001891,hydrocephaly|MP:0002135,abnormal kidney morphology|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002840,abnormal lens fiber morphology|MP:0002962,increased urine protein level|MP:0003311,aminoaciduria|MP:0005325,abnormal renal glomerulus morphology|MP:0008528,polycystic kidney|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008770,decreased survivor rate|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2155362	Bh4p<C57BL/6By>	MP:0004262,abnormal physical strength
MGI:1856591	Bhd	MP:0000346,broad head|MP:0002082,postnatal lethality|MP:0010768,mortality/aging|MP:0030189,broad snout
MGI:2671869	bhe	MP:0002499,chronic inflammation
MGI:2182768	Bhlha15<tm1Skz>	MP:0000473,abnormal stomach glandular epithelium morphology|MP:0001944,abnormal pancreas morphology|MP:0003334,pancreas fibrosis|MP:0003335,exocrine pancreatic insufficiency|MP:0004140,abnormal gastric chief cell morphology|MP:0005220,abnormal exocrine pancreas morphology|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0006270,abnormal mammary gland growth during lactation|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009160,abnormal pancreatic acinar cell zymogen granule morphology|MP:0009506,abnormal mammary gland alveolus morphology|MP:0010172,abnormal mammary gland epithelium physiology|MP:0013317,abnormal seminal vesicle development|MP:0013594,abnormal parotid gland acinus morphology|MP:0013781,abnormal mammary gland luminal epithelium morphology|MP:0013899,abnormal seminal vesicle epithelium morphology|MP:0013900,seminal vesicle epithelium degeneration|MP:0013903,abnormal seminal vesicle fluid composition|MP:0014126,increased mammary gland apoptosis
MGI:3615274	Bhlha15<tm2(Kras)Skz>	MP:0000599,enlarged liver|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0005150,cachexia|MP:0005220,abnormal exocrine pancreas morphology|MP:0008780,increased pancreatic acinar cell carcinoma incidence|MP:0009043,increased pancreas adenoma incidence|MP:0009155,pancreatic acinar hyperplasia|MP:0013184,hemorrhagic ascites
MGI:3821734	Bhlha15<tm3(cre/ERT2)Skz>	MP:0008260,abnormal autophagy|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009147,abnormal pancreatic acinar cell physiology|MP:0009160,abnormal pancreatic acinar cell zymogen granule morphology|MP:0014098,decreased pancreatic amylase secretion
MGI:5585727	Bhlha9<tm1.1(KOMP)Vlcg>	MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology
MGI:5604430	Bhlha9<tm1Nba>	MP:0000564,syndactyly|MP:0000571,interdigital webbing|MP:0009874,abnormal interdigital cell death
MGI:3707409	Bhlhe22<tm1Gan>	MP:0000774,decreased brain size|MP:0000778,abnormal nervous system tract morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000859,abnormal somatosensory cortex morphology|MP:0000861,disorganized barrel cortex|MP:0000937,abnormal motor neuron morphology|MP:0001212,skin lesions|MP:0001262,decreased body weight|MP:0002878,abnormal corticospinal tract morphology|MP:0006075,abnormal retina cone bipolar cell morphology|MP:0008106,decreased amacrine cell number|MP:0008511,thin retina inner nuclear layer|MP:0009681,abnormal pyramidal decussation morphology|MP:0009682,abnormal anterior corticospinal tract morphology
MGI:4440742	Bhlhe22<tm1Meg>	MP:0001212,skin lesions|MP:0001412,excessive scratching|MP:0001516,abnormal motor coordination/balance|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002196,absent corpus callosum|MP:0002735,abnormal chemical nociception|MP:0003631,nervous system phenotype|MP:0003633,abnormal nervous system physiology|MP:0004924,abnormal behavior|MP:0008223,absent hippocampal commissure|MP:0008227,absent anterior commissure|MP:0009682,abnormal anterior corticospinal tract morphology|MP:0014747,abnormal motor neuron axon guidance
MGI:4440744	Bhlhe22<tm2.1Meg>	MP:0001212,skin lesions|MP:0001412,excessive scratching|MP:0002196,absent corpus callosum|MP:0002735,abnormal chemical nociception|MP:0005386,behavior/neurological phenotype|MP:0008223,absent hippocampal commissure|MP:0009682,abnormal anterior corticospinal tract morphology|MP:0010771,integument phenotype
MGI:3054837	Bhlhe23<tm1Dbra>	MP:0005551,abnormal eye electrophysiology|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0030005,increased retina apoptosis
MGI:3775803	Bhlhe40<tm1.1Rhli>	MP:0002906,increased susceptibility to pharmacologically induced seizures
MGI:5583057	Bhlhe40<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0002833,increased heart weight|MP:0003019,increased circulating chloride level|MP:0003442,decreased circulating glycerol level|MP:0005179,decreased circulating cholesterol level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0008810,increased circulating iron level|MP:0010087,increased circulating fructosamine level|MP:0013278,decreased fasting circulating glucose level
MGI:2180488	Bhlhe40<tm1Tan>	MP:0000693,spleen hyperplasia|MP:0000708,thymus hyperplasia|MP:0000716,abnormal immune system cell morphology|MP:0001790,abnormal immune system physiology|MP:0001828,abnormal T cell activation|MP:0002425,abnormal susceptibility to autoimmune disorder|MP:0002497,increased IgE level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0005325,abnormal renal glomerulus morphology|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008102,lymph node hyperplasia|MP:0008478,increased spleen white pulp amount|MP:0008481,increased spleen germinal center number|MP:0008499,increased IgG1 level|MP:0008522,abnormal lymph node germinal center morphology|MP:0008688,decreased interleukin-2 secretion|MP:0020475,delayed circadian behavior phase
MGI:7627403	Bhlhe41<tm1.2Cdon>	MP:0000222,decreased neutrophil cell number|MP:0000717,abnormal lymphocyte cell number|MP:0003884,decreased macrophage cell number|MP:0005012,decreased eosinophil cell number|MP:0005095,decreased T cell proliferation|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008567,decreased interferon-gamma secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008681,increased interleukin-17 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion
MGI:3805461	Bhlhe41<tm1Mjro>	MP:0020475,delayed circadian behavior phase
MGI:5297083	Bhmt<tm1.2Zei>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000598,abnormal liver morphology|MP:0001547,abnormal lipid level|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003949,abnormal circulating lipid level|MP:0003981,decreased circulating phospholipid level|MP:0004777,abnormal phospholipid level|MP:0005179,decreased circulating cholesterol level|MP:0005317,increased triglyceride level|MP:0008019,increased liver tumor incidence|MP:0008489,slow postnatal weight gain|MP:0009643,abnormal urine homeostasis|MP:0021133,increased amino acid betaine level|MP:0030753,decreased choline level
MGI:5582429	Bhmt<tm1b(EUCOMM)Hmgu>	MP:0002874,decreased hemoglobin content|MP:0003960,increased lean body mass|MP:0004952,increased spleen weight|MP:0005566,decreased blood urea nitrogen level|MP:0010025,decreased total body fat amount
MGI:2156474	Bhr5<A/J>	MP:0001952,increased airway responsiveness
MGI:3764934	Bhrd	MP:0000416,sparse hair|MP:0000418,focal hair loss|MP:0001510,abnormal coat appearance|MP:0002073,abnormal hair growth
MGI:5646491	Bhv11	MP:0000428,abnormal craniofacial morphology
MGI:5646243	Bhv26	MP:0008428,abnormal spatial working memory
MGI:5308750	Bhv31	MP:0001363,increased anxiety-related response
MGI:5646449	Bhv32	MP:0001410,head bobbing|MP:0031391,increased locomotor activity
MGI:6241405	bhv4	MP:0000373,belly spot|MP:0002939,head spot|MP:0005174,abnormal tail pigmentation
MGI:5646493	Bhv43	MP:0008428,abnormal spatial working memory
MGI:5285079	Bicc1<b2b222Clo>	MP:0000284,double outlet right ventricle|MP:0000644,dextrocardia|MP:0004133,heterotaxia|MP:0008528,polycystic kidney|MP:0010412,atrioventricular septal defect|MP:0011252,situs inversus totalis|MP:0011665,d-loop transposition of the great arteries
MGI:6276939	Bicc1<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0001402,decreased locomotor activity|MP:0001614,abnormal blood vessel morphology|MP:0001700,abnormal embryo turning|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003231,abnormal placenta vasculature|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1856920	Bicc1<jcpk>	MP:0000522,kidney cortex cyst|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0002928,abnormal bile duct morphology|MP:0003253,dilated bile duct|MP:0003675,kidney cyst|MP:0008993,abnormal portal triad morphology|MP:0009144,dilated pancreatic duct|MP:0009342,enlarged gallbladder|MP:0011085,postnatal lethality, complete penetrance|MP:0011501,increased glomerular capsule space
MGI:1856693	Bicc1<jcpk-bpk>	MP:0000598,abnormal liver morphology|MP:0000603,pale liver|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0002083,premature death|MP:0003068,enlarged kidney|MP:0003606,kidney failure|MP:0003675,kidney cyst|MP:0004839,bile duct hyperplasia|MP:0005202,lethargy|MP:0005565,increased blood urea nitrogen level|MP:0009343,dilated gallbladder|MP:0011085,postnatal lethality, complete penetrance|MP:0011501,increased glomerular capsule space
MGI:5427468	Bicc1<m1006Lja>	MP:0003675,kidney cyst
MGI:3776918	Bicc1<m1Btlr>	MP:0001924,infertility|MP:0002083,premature death|MP:0005565,increased blood urea nitrogen level|MP:0008528,polycystic kidney
MGI:4356450	Bicc1<tm1Bdc>	MP:0002766,situs inversus|MP:0002767,situs ambiguus|MP:0003606,kidney failure|MP:0008933,abnormal motile primary cilium physiology|MP:0010402,ventricular septal defect|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012027,abnormal embryonic cilium location or orientation
MGI:3711021	Bicc1<tm1Emdr>	MP:0003068,enlarged kidney|MP:0003266,biliary cyst|MP:0003336,pancreas cyst|MP:0008528,polycystic kidney|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011334,abnormal nephrogenic zone morphology
MGI:5605749	Bicd1<tm1.1(KOMP)Wtsi>	MP:0001489,decreased startle reflex|MP:0004738,abnormal auditory brainstem response|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength
MGI:5618154	Bicd2<tm1.1Hgrd>	MP:0000440,domed cranium|MP:0000790,abnormal stratification in cerebral cortex|MP:0000813,abnormal hippocampus layer morphology|MP:0000852,small cerebellum|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000888,absent cerebellar granule layer|MP:0000889,abnormal cerebellar molecular layer|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002958,cerebral aqueductal stenosis|MP:0006254,thin cerebral cortex|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008535,enlarged lateral ventricles|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0009512,abnormal cerebellar Golgi cell morphology|MP:0009956,abnormal cerebellar layer morphology|MP:0009977,abnormal cerebellar granule cell migration|MP:0009978,abnormal cerebellum white matter morphology|MP:0010152,abnormal brain ependyma morphology|MP:0010540,long stride length|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012004,abnormal septum pellucidum morphology|MP:0012508,forebrain atrophy|MP:0013258,abnormal extracellular matrix morphology|MP:0030003,hippocampus atrophy|MP:0030986,striatum atrophy
MGI:5618153	Bicd2<tm1Hgrd>	MP:0000781,decreased corpus callosum size|MP:0000790,abnormal stratification in cerebral cortex|MP:0000813,abnormal hippocampus layer morphology|MP:0000888,absent cerebellar granule layer|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0006009,abnormal neuronal migration|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0009956,abnormal cerebellar layer morphology|MP:0009977,abnormal cerebellar granule cell migration|MP:0020141,decreased brain external capsule size
MGI:5603351	Bicdl1<tm2b(EUCOMM)Wtsi>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001491,unresponsive to tactile stimuli|MP:0002757,decreased vertical activity|MP:0002764,short tibia|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003928,increased heart rate variability|MP:0005385,cardiovascular system phenotype|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:6276907	Bicdl2<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney
MGI:7488659	Bicra<em1Hzhg>	MP:0000280,thin ventricular wall|MP:0000284,double outlet right ventricle|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0001787,pericardial edema|MP:0002188,small heart|MP:0003137,abnormal impulse conducting system conduction|MP:0003984,embryonic growth retardation|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0005136,decreased growth hormone level|MP:0010402,ventricular septal defect|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:6460366	Bicra<em1(IMPC)J>	MP:0001297,microphthalmia|MP:0001914,hemorrhage|MP:0002111,abnormal tail morphology|MP:0002590,increased mean corpuscular volume|MP:0003385,abnormal body wall morphology|MP:0005561,increased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance
MGI:7488660	Bicra<em2Hzhg>	MP:0000280,thin ventricular wall|MP:0000284,double outlet right ventricle|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0001787,pericardial edema|MP:0002188,small heart|MP:0003137,abnormal impulse conducting system conduction|MP:0003984,embryonic growth retardation|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0005136,decreased growth hormone level|MP:0010402,ventricular septal defect|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:7488661	Bicra<em3Hzhg>	MP:0000266,abnormal heart morphology|MP:0000284,double outlet right ventricle|MP:0001265,decreased body size|MP:0002083,premature death|MP:0003393,decreased cardiac output|MP:0005385,cardiovascular system phenotype|MP:0006111,abnormal coronary circulation|MP:0010402,ventricular septal defect|MP:0010768,mortality/aging|MP:0011088,neonatal lethality, incomplete penetrance|MP:0031634,decreased heart right ventricle muscle contractility
MGI:6468335	Bicral<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001325,abnormal retina morphology|MP:0001488,increased startle reflex|MP:0001925,male infertility|MP:0002590,increased mean corpuscular volume|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005561,increased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5306775	Bicral<Gt(M019E03)Wrst>	MP:0001625,cardiac hypertrophy|MP:0001700,abnormal embryo turning|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4440571	Bid<tm1.1Ast>	MP:0005166,decreased susceptibility to injury|MP:0005384,cellular phenotype|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:5428930	Bid<tm1.1Atgr>	MP:0003992,increased mortality induced by ionizing radiation|MP:0009278,abnormal bone marrow cell physiology|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:2158671	Bid<tm1Sjk>	MP:0000807,abnormal hippocampus morphology|MP:0001175,abnormal lung morphology|MP:0002183,gliosis|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0005166,decreased susceptibility to injury|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005388,respiratory system phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0006043,decreased apoptosis|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:3580288	biga1	MP:0005551,abnormal eye electrophysiology
MGI:3612275	Bik<tm1Ast>	MP:0002169,no abnormal phenotype detected
MGI:2664484	Bin1<tm1Gcp>	MP:0001436,abnormal suckling behavior|MP:0002190,disorganized myocardium|MP:0002952,ventricular cardiomyopathy|MP:0002953,thick ventricular wall|MP:0004090,abnormal sarcomere morphology|MP:0004093,diffuse Z line|MP:0005384,cellular phenotype|MP:0005387,immune system phenotype|MP:0011087,neonatal lethality, complete penetrance|MP:0014731,disorganized myocardial fiber myofibrils|MP:0030566,abnormal A band morphology
MGI:3512133	Bin1<tm2Gcp>	MP:0004499,increased incidence of tumors by chemical induction|MP:0010299,increased mammary gland tumor incidence
MGI:6153285	Bin2<em1(IMPC)Wtsi>	MP:0002599,increased mean platelet volume|MP:0003179,thrombocytopenia|MP:0005562,decreased mean corpuscular hemoglobin|MP:0006358,absent pinna reflex
MGI:6508532	Bin2<tm1.1Beni>	MP:0004865,abnormal platelet calcium level|MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0006298,abnormal platelet activation|MP:0009549,decreased platelet aggregation|MP:0031120,decreased susceptibility to induced thrombosis
MGI:6508533	Bin2<tm1.2Beni>	MP:0002169,no abnormal phenotype detected
MGI:3512131	Bin3<tm1Gcp>	MP:0000240,extramedullary hematopoiesis|MP:0000607,abnormal hepatocyte morphology|MP:0000691,enlarged spleen|MP:0001304,cataract|MP:0001577,anemia|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002027,increased lung adenocarcinoma incidence|MP:0002840,abnormal lens fiber morphology|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0012431,increased lymphoma incidence
MGI:3576924	Birc2<tm1Jda>	MP:0005016,decreased lymphocyte cell number
MGI:5501232	Birc2<tm2.1Jda>	MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0008566,increased interferon-gamma secretion
MGI:4887220	Birc3<tm1Jda>	MP:0000717,abnormal lymphocyte cell number|MP:0002378,abnormal gut-associated lymphoid tissue morphology|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005154,increased B cell proliferation|MP:0005348,increased T cell proliferation|MP:0008102,lymph node hyperplasia|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008215,decreased immature B cell number|MP:0008466,enlarged mesenteric lymph nodes|MP:0008495,decreased IgG1 level|MP:0008502,increased IgG3 level|MP:0008566,increased interferon-gamma secretion|MP:0008783,decreased B cell apoptosis
MGI:3830313	Birc3<tm1Rgk>	MP:0000217,abnormal leukocyte cell number|MP:0001819,abnormal immune cell physiology|MP:0002444,abnormal T cell physiology|MP:0002451,abnormal macrophage physiology|MP:0003009,abnormal cytokine secretion|MP:0003884,decreased macrophage cell number|MP:0008556,abnormal tumor necrosis factor secretion|MP:0008656,abnormal interleukin-1 beta secretion|MP:0008662,abnormal interleukin-12 secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:2384336	Birc5<tm1Emc>	MP:0001648,abnormal apoptosis|MP:0005165,increased susceptibility to injury|MP:0010959,abnormal oxidative phosphorylation|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3046203	Birc5<tm1Mak>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0002169,no abnormal phenotype detected|MP:0003077,abnormal cell cycle|MP:0005089,decreased double-negative T cell number|MP:0006413,increased T cell apoptosis|MP:0008037,abnormal T cell morphology|MP:0009543,abnormal thymus corticomedullary boundary morphology
MGI:2681348	Birc5<tm1Vaux>	MP:0001714,absent trophoblast giant cells|MP:0002085,abnormal embryonic tissue morphology|MP:0002663,absent blastocoele|MP:0003077,abnormal cell cycle|MP:0003111,abnormal cell nucleus morphology|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0003706,abnormal cell nucleus count|MP:0003708,binucleate|MP:0004965,inner cell mass degeneration|MP:0009760,abnormal mitotic spindle morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0014693,abnormal cell nucleus size|MP:0031678,increased micronucleus incidence
MGI:6341866	Birc6<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001325,abnormal retina morphology|MP:0001404,no spontaneous movement|MP:0001785,edema|MP:0010090,increased circulating creatine kinase level|MP:0011100,preweaning lethality, complete penetrance
MGI:2156197	Birc6<Gt(Ex54)Byg>	MP:0011087,neonatal lethality, complete penetrance
MGI:2678441	Birc6<Gt(pT1Betageo)2Ruiz>	MP:0002169,no abnormal phenotype detected
MGI:2678436	Birc6<Gt(pT1Betageo)45Flo>	MP:0001711,abnormal placenta morphology
MGI:5563506	Birc6<m1Anu>	MP:0008762,embryonic lethality
MGI:3573859	Birc6<tm1Nai>	MP:0000260,abnormal angiogenesis|MP:0000606,decreased hepatocyte number|MP:0001785,edema|MP:0003077,abnormal cell cycle|MP:0004200,decreased fetal size|MP:0009541,increased thymocyte apoptosis|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0013501,increased fibroblast apoptosis
MGI:3512417	Birc6<tm1Sjen>	MP:0000352,decreased cell proliferation|MP:0001716,abnormal placenta labyrinth morphology|MP:0001914,hemorrhage|MP:0001917,intraventricular hemorrhage|MP:0002123,abnormal definitive hematopoiesis|MP:0003231,abnormal placenta vasculature|MP:0003396,abnormal embryonic hematopoiesis|MP:0003717,pallor|MP:0004201,fetal growth retardation|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004259,small placenta|MP:0005031,abnormal trophoblast layer morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:5796180	Birc7<tm1Gne>	MP:0005391,vision/eye phenotype
MGI:2159255	Bis1<C57BL/6J>	MP:0000950,abnormal seizure response to pharmacological agent
MGI:2156751	Bis4<A/J>	MP:0000950,abnormal seizure response to pharmacological agent
MGI:2154793	Bits1<NZB/BlNJ>	MP:0004210,abnormal bitter taste sensitivity
MGI:2158271	Bits3<NZB/BlNJ>	MP:0004210,abnormal bitter taste sensitivity
MGI:2158273	Bits4<NZB/BlNJ>	MP:0004210,abnormal bitter taste sensitivity
MGI:5637122	Bivm<tm1b(KOMP)Wtsi>	MP:0005560,decreased circulating glucose level|MP:0013406,abnormal epidermal immune compartment
MGI:3700018	Blacv1<DBA/2J>	MP:0000818,abnormal amygdala morphology
MGI:2671843	blb2	MP:0001261,obese
MGI:6849809	Blcap<em1(IMPC)J>	MP:0002966,decreased circulating alkaline phosphatase level|MP:0013279,increased fasting circulating glucose level
MGI:1856686	Bld	MP:0001297,microphthalmia|MP:0001302,eyelids open at birth|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001307,fused cornea and lens|MP:0001312,abnormal cornea morphology|MP:0001313,increased incidence of corneal inflammation|MP:0001314,cornea opacity|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0001680,abnormal mesoderm development|MP:0001685,abnormal endoderm development|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0001724,abnormal extraembryonic endoderm formation|MP:0001727,abnormal embryo implantation|MP:0002001,blindness|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002092,abnormal eye morphology|MP:0002230,abnormal primitive streak formation|MP:0003078,aphakia|MP:0003984,embryonic growth retardation|MP:0005542,cornea vascularization|MP:0006221,optic nerve hypoplasia|MP:0008770,decreased survivor rate|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011697,lens vacuoles|MP:0011962,increased cornea thickness|MP:0020857,cornea epithelium hyperplasia|MP:0021107,retina fold
MGI:4821358	Blff	MP:0009930,fuzzy hair
MGI:3847096	Blite	MP:0000372,irregular coat pigmentation|MP:0002192,hydrops fetalis|MP:0005171,absent coat pigmentation|MP:0008762,embryonic lethality
MGI:8268541	Blk<em1Hxzh>	MP:0001876,decreased inflammatory response|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:6113863	Blk<m1Btlr>	MP:0002497,increased IgE level|MP:0008657,increased interleukin-1 beta secretion
MGI:5695967	Blk<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis
MGI:2386868	Blk<tm1Tara>	MP:0002169,no abnormal phenotype detected
MGI:1861798	Blmh<tm1Geh>	MP:0001192,scaly skin|MP:0001194,dermatitis|MP:0001219,thick epidermis|MP:0001265,decreased body size|MP:0002111,abnormal tail morphology|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2668891	Blmpf1<C57BL/6J>	MP:0006050,pulmonary fibrosis
MGI:2668892	Blmpf2<C3H/Kam>	MP:0001175,abnormal lung morphology
MGI:2668894	Blmpf2<C57BL/6J>	MP:0006050,pulmonary fibrosis
MGI:3606264	Blmpf3<A/J>	MP:0006050,pulmonary fibrosis
MGI:3606266	Blmpf4<A/J>	MP:0006050,pulmonary fibrosis
MGI:3606268	Blmpf5<A/J>	MP:0006050,pulmonary fibrosis
MGI:1857708	Blm<tm1Ches>	MP:0000245,abnormal erythropoiesis|MP:0000248,macrocytosis|MP:0000358,abnormal cell morphology|MP:0001577,anemia|MP:0001599,abnormal blood volume|MP:0001648,abnormal apoptosis|MP:0001698,decreased embryo size|MP:0002416,abnormal proerythroblast morphology|MP:0002424,abnormal reticulocyte morphology|MP:0002447,abnormal erythrocyte morphology|MP:0003984,embryonic growth retardation|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2388038	Blm<tm1Grdn>	MP:0002021,increased incidence of induced tumors|MP:0004028,chromosome breakage
MGI:2158669	Blm<tm2Brd>	MP:0002080,prenatal lethality
MGI:2158670	Blm<tm3Brd>	MP:0001806,decreased IgM level|MP:0002020,increased tumor incidence|MP:0012431,increased lymphoma incidence
MGI:2683764	Blm<tm3Ches>	MP:0001698,decreased embryo size|MP:0001732,postnatal growth retardation|MP:0002447,abnormal erythrocyte morphology|MP:0002641,anisopoikilocytosis|MP:0003717,pallor|MP:0011092,embryonic lethality, complete penetrance
MGI:6322956	Blnk<em1(IMPC)H>	MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0000692,small spleen|MP:0002607,decreased basophil cell number|MP:0004953,decreased spleen weight|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number
MGI:4442912	Blnk<m1Btlr>	MP:0001802,arrested B cell differentiation|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0005387,immune system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008211,decreased mature B cell number
MGI:2389137	Blnk<tm1Achn>	MP:0001802,arrested B cell differentiation|MP:0002144,abnormal B cell differentiation|MP:0002460,decreased immunoglobulin level|MP:0005093,decreased B cell proliferation|MP:0005385,cardiovascular system phenotype|MP:0008168,decreased B-1a cell number|MP:0008171,abnormal mature B cell morphology|MP:0008186,increased pro-B cell number|MP:0008204,absent B-1b cells|MP:0008211,decreased mature B cell number|MP:0009339,decreased splenocyte number
MGI:2665856	Blnk<tm1Dkit>	MP:0001802,arrested B cell differentiation|MP:0001806,decreased IgM level|MP:0002026,increased leukemia incidence|MP:0002144,abnormal B cell differentiation|MP:0002403,abnormal pre-B cell morphology|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005022,abnormal immature B cell morphology|MP:0008099,abnormal plasma cell differentiation|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008498,decreased IgG3 level|MP:0008781,abnormal B cell apoptosis|MP:0008782,increased B cell apoptosis
MGI:2386672	Blnk<tm1Kplm>	MP:0000694,spleen hypoplasia|MP:0002144,abnormal B cell differentiation|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0008186,increased pro-B cell number|MP:0008203,absent B-1a cells|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008217,abnormal B cell activation|MP:0008782,increased B cell apoptosis
MGI:2447161	Blnk<tm1Pjln>	MP:0000691,enlarged spleen|MP:0001802,arrested B cell differentiation|MP:0001806,decreased IgM level|MP:0002020,increased tumor incidence|MP:0002403,abnormal pre-B cell morphology|MP:0003132,increased pre-B cell number|MP:0008210,increased mature B cell number|MP:0008211,decreased mature B cell number|MP:0008498,decreased IgG3 level
MGI:5544207	blnt	MP:0000592,short tail|MP:0005174,abnormal tail pigmentation|MP:0006281,abnormal tail development|MP:0013177,abnormal tail tip morphology
MGI:5824712	Bloc1s1<tm1.1Wli>	MP:0005058,abnormal lysosome morphology|MP:0005384,cellular phenotype|MP:0008260,abnormal autophagy|MP:0008480,absent eye pigmentation|MP:0008546,abnormal vesicle-mediated transport|MP:0011091,prenatal lethality, complete penetrance
MGI:4434990	Bloc1s1<tm1a(EUCOMM)Hmgu>	MP:0005178,increased circulating cholesterol level|MP:0006036,abnormal mitochondrial physiology|MP:0008260,abnormal autophagy|MP:0011092,embryonic lethality, complete penetrance|MP:0014046,abnormal mitophagy
MGI:5490495	Bloc1s2<tm1.1(KOMP)Mbp>	MP:0000288,abnormal pericardium morphology|MP:0000428,abnormal craniofacial morphology|MP:0000603,pale liver|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002702,decreased circulating free fatty acids level|MP:0002941,increased circulating alanine transaminase level|MP:0003179,thrombocytopenia|MP:0004258,abnormal placenta size|MP:0005650,abnormal limb bud morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5824713	Bloc1s2<tm1Wli>	MP:0000428,abnormal craniofacial morphology|MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0001606,impaired hematopoiesis|MP:0003172,abnormal lysosome physiology|MP:0003241,loss of cortex neurons|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004809,increased hematopoietic stem cell number|MP:0005058,abnormal lysosome morphology|MP:0006254,thin cerebral cortex|MP:0008441,thin cortical plate|MP:0008457,abnormal cortical intermediate zone morphology|MP:0008480,absent eye pigmentation|MP:0008535,enlarged lateral ventricles|MP:0008546,abnormal vesicle-mediated transport|MP:0011087,neonatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011827,impaired neuron differentiation|MP:0011902,increased hematopoietic stem cell proliferation|MP:0013697,decreased granulocyte monocyte progenitor cell number|MP:0020389,increased radial glial cell number|MP:0020393,increased neuronal precursor proliferation
MGI:1857021	Bloc1s3<rp>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0003172,abnormal lysosome physiology|MP:0005075,abnormal melanosome morphology|MP:0008731,abnormal hair shaft melanin granule morphology|MP:0009779,enhanced behavioral response to anesthetic|MP:0010766,abnormal NK cell physiology|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:2449643	Bloc1s4<cno>	MP:0000371,diluted coat color|MP:0000609,abnormal liver physiology|MP:0001525,impaired balance|MP:0002136,abnormal kidney physiology|MP:0002980,abnormal postural reflex|MP:0003173,decreased lysosomal enzyme secretion|MP:0004725,decreased platelet serotonin level|MP:0004867,decreased platelet calcium level|MP:0005075,abnormal melanosome morphology|MP:0005077,abnormal melanogenesis|MP:0005098,abnormal optic choroid morphology|MP:0005100,abnormal choroid pigmentation|MP:0005103,abnormal retina pigmentation|MP:0005172,decreased eye pigmentation|MP:0005191,head tilt|MP:0005388,respiratory system phenotype|MP:0005408,hypopigmentation|MP:0005606,increased bleeding time|MP:0008546,abnormal vesicle-mediated transport|MP:0009446,abnormal platelet dense granule physiology|MP:0009448,decreased platelet ATP level|MP:0009549,decreased platelet aggregation|MP:0020432,decreased platelet dense granule number|MP:0030915,abnormal melanosome maturation|MP:0030916,abnormal melanosome size|MP:0030918,small melanosome
MGI:7484786	Bloc1s4<em1(IMPC)Mbp>	MP:0000220,increased monocyte cell number|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0005567,decreased circulating total protein level
MGI:7425543	Bloc1s5<em1(IMPC)Tcp>	MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0005102,abnormal iris pigmentation|MP:0010097,abnormal retina blood vessel morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration
MGI:1856106	Bloc1s5<mu>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0001522,impaired swimming|MP:0002894,abnormal otolith morphology|MP:0002963,decreased urine protein level|MP:0002978,absent otoliths|MP:0002980,abnormal postural reflex|MP:0003173,decreased lysosomal enzyme secretion|MP:0004721,abnormal platelet dense granule morphology|MP:0004725,decreased platelet serotonin level|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004812,abnormal linear vestibular evoked potential|MP:0005059,lysosomal protein accumulation|MP:0005075,abnormal melanosome morphology|MP:0005172,decreased eye pigmentation|MP:0005191,head tilt|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005397,hematopoietic system phenotype|MP:0005408,hypopigmentation|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0009446,abnormal platelet dense granule physiology|MP:0009448,decreased platelet ATP level|MP:0009549,decreased platelet aggregation|MP:0020432,decreased platelet dense granule number
MGI:3799687	Bloc1s5<mu-Btlr>	MP:0000371,diluted coat color|MP:0005191,head tilt|MP:0005387,immune system phenotype
MGI:6277008	Bloc1s6<em1(IMPC)Mbp>	MP:0001399,hyperactivity|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0002965,increased circulating serum albumin level
MGI:1856982	Bloc1s6<pa>	MP:0000371,diluted coat color|MP:0001175,abnormal lung morphology|MP:0001260,increased body weight|MP:0001393,ataxia|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0001760,abnormal urine enzyme level|MP:0001861,lung inflammation|MP:0001942,abnormal lung volume|MP:0001958,emphysema|MP:0002083,premature death|MP:0002133,abnormal respiratory system physiology|MP:0002136,abnormal kidney physiology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002276,abnormal lung interstitium morphology|MP:0002314,abnormal respiratory mechanics|MP:0002826,tonic seizures|MP:0002894,abnormal otolith morphology|MP:0003172,abnormal lysosome physiology|MP:0003718,maternal effect|MP:0003828,pulmonary edema|MP:0004725,decreased platelet serotonin level|MP:0004812,abnormal linear vestibular evoked potential|MP:0005075,abnormal melanosome morphology|MP:0005172,decreased eye pigmentation|MP:0005191,head tilt|MP:0005384,cellular phenotype|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0006159,ocular albinism|MP:0006298,abnormal platelet activation|MP:0009448,decreased platelet ATP level|MP:0009549,decreased platelet aggregation|MP:0009557,decreased platelet ADP level|MP:0009642,abnormal blood homeostasis|MP:0010766,abnormal NK cell physiology|MP:0010771,integument phenotype|MP:0010898,abnormal pulmonary alveolus epithelium morphology|MP:0020432,decreased platelet dense granule number
MGI:3851199	blst	MP:0000371,diluted coat color
MGI:5613665	Bltp1<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001488,increased startle reflex|MP:0001697,abnormal embryo size|MP:0001914,hemorrhage|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002797,increased thigmotaxis|MP:0002833,increased heart weight|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004924,abnormal behavior|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:6203636	Bltp2<em1(IMPC)J>	MP:0000266,abnormal heart morphology|MP:0001284,absent vibrissae|MP:0001312,abnormal cornea morphology|MP:0001392,abnormal locomotor behavior|MP:0001417,decreased exploration in new environment|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001914,hemorrhage|MP:0002075,abnormal coat/hair pigmentation|MP:0002833,increased heart weight|MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0012099,decreased spongiotrophoblast size|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014134,abnormal embryo morphology
MGI:6317373	Bltp3b<em1(IMPC)J>	MP:0005178,increased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level
MGI:7398535	Blvra<tm1.1Rsto>	MP:0000341,abnormal bile color|MP:0002591,decreased mean corpuscular volume|MP:0002593,high mean erythrocyte cell number|MP:0003674,oxidative stress|MP:0004773,abnormal bile composition|MP:0005084,abnormal gallbladder morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:5816874	Blvra<tm1c(EUCOMM)Hmgu>	MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0005281,increased fatty acids level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0009355,increased liver triglyceride level|MP:0010398,decreased liver glycogen level|MP:0013279,increased fasting circulating glucose level|MP:0014174,decreased fatty acid beta-oxidation
MGI:4419545	Blvrb<tm1(KOMP)Wtsi>	MP:0000280,thin ventricular wall|MP:0004738,abnormal auditory brainstem response|MP:0005553,increased circulating creatinine level
MGI:7488133	Bmal1<em1Bwu>	MP:0002451,abnormal macrophage physiology|MP:0010155,abnormal intestine physiology
MGI:5440061	Bmal1<tm1.1Ljm>	MP:0001402,decreased locomotor activity|MP:0002907,abnormal parturition|MP:0005376,homeostasis/metabolism phenotype|MP:0012008,delayed parturition|MP:0012009,early parturition|MP:0020467,abnormal circadian behavior
MGI:5613362	Bmal1<tm1.1Shbi>	MP:0005369,muscle phenotype|MP:0005370,liver/biliary system phenotype|MP:0005386,behavior/neurological phenotype
MGI:3720979	Bmal1<tm1.1Weit>	MP:0020467,abnormal circadian behavior
MGI:5613363	Bmal1<tm1.2Shbi>	MP:0000182,increased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001262,decreased body weight|MP:0001345,Meibomian gland atrophy|MP:0001547,abnormal lipid level|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001556,increased circulating HDL cholesterol level|MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003383,abnormal gluconeogenesis|MP:0003976,decreased circulating VLDL triglyceride level|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009133,decreased white fat cell size|MP:0009171,enlarged pancreatic islets|MP:0009355,increased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0010378,increased respiratory quotient|MP:0013373,increased sebum secretion|MP:0020477,abnormal locomotor circadian rhythm|MP:0031269,increased susceptibility to diet-induced hepatic steatosis|MP:0031415,increased skeletal muscle triglyceride level
MGI:2180361	Bmal1<tm1Bra>	MP:0000066,osteoporosis|MP:0000150,abnormal rib morphology|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000424,retarded hair growth|MP:0000427,abnormal hair cycle|MP:0001157,small seminal vesicle|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001312,abnormal cornea morphology|MP:0001313,increased incidence of corneal inflammation|MP:0001391,abnormal tail movements|MP:0001406,abnormal gait|MP:0001429,dehydration|MP:0001501,abnormal sleep pattern|MP:0001504,abnormal posture|MP:0001523,impaired righting response|MP:0001596,hypotension|MP:0001728,failure of embryo implantation|MP:0001732,postnatal growth retardation|MP:0001792,impaired wound healing|MP:0001924,infertility|MP:0001926,female infertility|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002144,abnormal B cell differentiation|MP:0002607,decreased basophil cell number|MP:0002834,decreased heart weight|MP:0002840,abnormal lens fiber morphology|MP:0002891,increased insulin sensitivity|MP:0002941,increased circulating alanine transaminase level|MP:0003025,increased vasoconstriction|MP:0003059,decreased insulin secretion|MP:0003189,fused joints|MP:0003198,calcified tendon|MP:0003200,calcified joint|MP:0003313,abnormal locomotor activation|MP:0003415,priapism|MP:0003786,premature aging|MP:0003918,decreased kidney weight|MP:0003944,abnormal T cell subpopulation ratio|MP:0003957,abnormal nitric oxide homeostasis|MP:0004232,decreased muscle weight|MP:0004622,sacral vertebral fusion|MP:0004623,thoracic vertebral fusion|MP:0004624,abnormal thoracic cage morphology|MP:0004685,calcified intervertebral disk|MP:0004703,abnormal vertebral column morphology|MP:0004852,decreased testis weight|MP:0004876,decreased mean systemic arterial blood pressure|MP:0004905,decreased uterus weight|MP:0004953,decreased spleen weight|MP:0004988,increased osteoblast cell number|MP:0004992,increased bone resorption|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005164,abnormal response to injury|MP:0005185,decreased circulating progesterone level|MP:0005266,abnormal metabolism|MP:0005300,abnormal cornea stroma morphology|MP:0005333,decreased heart rate|MP:0005343,increased circulating aspartate transaminase level|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0005391,vision/eye phenotype|MP:0005397,hematopoietic system phenotype|MP:0005416,abnormal circulating protein level|MP:0005489,vascular smooth muscle hyperplasia|MP:0005504,abnormal ligament morphology|MP:0005505,thrombocytosis|MP:0005542,cornea vascularization|MP:0005551,abnormal eye electrophysiology|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0005591,decreased vasodilation|MP:0005595,abnormal vascular smooth muscle physiology|MP:0005626,decreased plasma anion gap|MP:0005631,decreased lung weight|MP:0005660,abnormal circulating adrenaline level|MP:0005661,decreased circulating adrenaline level|MP:0005664,decreased circulating noradrenaline level|MP:0006432,abnormal costal cartilage morphology|MP:0008174,decreased follicular B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008254,increased megakaryocyte cell number|MP:0008495,decreased IgG1 level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008853,decreased abdominal adipose tissue amount|MP:0008858,abnormal hair cycle anagen phase|MP:0008908,increased total fat pad weight|MP:0009006,prolonged estrous cycle|MP:0009168,decreased pancreatic islet number|MP:0009436,fragmentation of sleep/wake states|MP:0010025,decreased total body fat amount|MP:0010686,abnormal hair follicle matrix region morphology|MP:0011021,abnormal circadian regulation of heart rate|MP:0011022,abnormal circadian regulation of systemic arterial blood pressure|MP:0012329,increased circulating factor VIII level|MP:0012331,increased circulating fibrinogen level|MP:0012355,decreased prothrombin time|MP:0012359,increased partial thromboplastin time|MP:0014167,ectopic bone|MP:0020332,impaired leukocyte tethering or rolling|MP:0020467,abnormal circadian behavior|MP:0020472,arrhythmic circadian behavior persistence|MP:0020473,abnormal circadian behavior phase|MP:0020475,delayed circadian behavior phase|MP:0020478,abnormal circadian sleep/wake cycle|MP:0020857,cornea epithelium hyperplasia|MP:0030776,calcified calcaneal tendon|MP:0030837,abnormal knee joint morphology|MP:0030973,impaired gluconeogenesis|MP:0030984,increased circulating osteocalcin level|MP:0031121,increased susceptibility to induced thrombosis|MP:0031158,abnormal venous thrombosis|MP:0031214,hypercoagulability
MGI:3720808	Bmal1<tm1Weit>	MP:0005551,abnormal eye electrophysiology|MP:0020470,shortened circadian behavior period
MGI:4819968	Bmal1<tm2Bra>	MP:0001402,decreased locomotor activity|MP:0001559,hyperglycemia|MP:0002626,increased heart rate|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005164,abnormal response to injury|MP:0005293,impaired glucose tolerance|MP:0005386,behavior/neurological phenotype|MP:0008469,abnormal protein level
MGI:3052790	Bmca<AKR/J>	MP:0004773,abnormal bile composition
MGI:3511320	Bmch1<C3H/HeJ>	MP:0001542,abnormal bone strength
MGI:3511322	Bmch2<C3H/HeJ>	MP:0001542,abnormal bone strength
MGI:3511325	Bmch3<DBA/2J>	MP:0004149,increased bone strength
MGI:3511326	Bmch4<C3H/HeJ>	MP:0001542,abnormal bone strength
MGI:3511330	Bmch5<BALB/cJ>	MP:0004149,increased bone strength
MGI:3511328	Bmch5<C3H/HeJ>	MP:0001542,abnormal bone strength
MGI:3511332	Bmch6<BALB/cJ>	MP:0004149,increased bone strength
MGI:3511334	Bmch7<C3H/HeJ>	MP:0001542,abnormal bone strength
MGI:2389163	Bmd10<C3H/HeJ>	MP:0021186,decreased bone mineral density of vertebrae
MGI:2389166	Bmd11<C3H/HeJ>	MP:0020011,increased bone mineral density of femur|MP:0021187,increased bone mineral density of vertebrae
MGI:2389168	Bmd12<C3H/HeJ>	MP:0020010,decreased bone mineral density of femur
MGI:2389170	Bmd13<C3H/HeJ>	MP:0000062,increased bone mineral density|MP:0002998,abnormal bone remodeling
MGI:2389172	Bmd14<C3H/HeJ>	MP:0020011,increased bone mineral density of femur|MP:0021187,increased bone mineral density of vertebrae
MGI:2389176	Bmd15<C3H/HeJ>	MP:0000062,increased bone mineral density
MGI:2389179	Bmd16<C3H/HeJ>	MP:0001260,increased body weight|MP:0004991,decreased bone strength|MP:0010968,decreased compact bone area|MP:0020011,increased bone mineral density of femur|MP:0021187,increased bone mineral density of vertebrae
MGI:3033017	Bmd19<C3H/HeJ>	MP:0020011,increased bone mineral density of femur
MGI:3619595	Bmd1a<CAST/EiJ>	MP:0000062,increased bone mineral density|MP:0001262,decreased body weight|MP:0003795,abnormal bone structure
MGI:3619597	Bmd1b<CAST/EiJ>	MP:0000062,increased bone mineral density|MP:0001260,increased body weight|MP:0003795,abnormal bone structure|MP:0013615,increased volumetric bone mineral density
MGI:2153899	Bmd1<CAST/EiJ>	MP:0000062,increased bone mineral density
MGI:3619599	Bmd1c<CAST/EiJ>	MP:0000063,decreased bone mineral density|MP:0001262,decreased body weight|MP:0003795,abnormal bone structure
MGI:3619542	Bmd20<129S1/SvImJ>	MP:0000062,increased bone mineral density|MP:0021187,increased bone mineral density of vertebrae
MGI:3619543	Bmd21<C57BL/6J>	MP:0000062,increased bone mineral density
MGI:3619546	Bmd22<129S1/SvImJ>	MP:0000062,increased bone mineral density|MP:0021187,increased bone mineral density of vertebrae
MGI:2156068	Bmd2<C57BL/6J>	MP:0000062,increased bone mineral density
MGI:3698500	Bmd37<CASA/Rk>	MP:0000063,decreased bone mineral density
MGI:3699724	Bmd38<CAST/EiJ>	MP:0020011,increased bone mineral density of femur
MGI:3719114	Bmd39<C3H/HeJ>	MP:0002998,abnormal bone remodeling
MGI:2681001	Bmd3<C3H/HeJ>	MP:0020011,increased bone mineral density of femur
MGI:3830037	Bmd5a<C3H/HeJ>	MP:0010875,increased bone volume|MP:0013623,increased femur compact bone thickness|MP:0013624,decreased femur compact bone thickness|MP:0020010,decreased bone mineral density of femur|MP:0020011,increased bone mineral density of femur
MGI:3830040	Bmd5b<C3H/HeJ>	MP:0010875,increased bone volume
MGI:2389153	Bmd5<C3H/HeJ>	MP:0001260,increased body weight|MP:0002998,abnormal bone remodeling|MP:0010968,decreased compact bone area|MP:0020011,increased bone mineral density of femur|MP:0021187,increased bone mineral density of vertebrae
MGI:2681002	Bmd5<CAST/EiJ>	MP:0008151,increased diameter of long bones|MP:0020011,increased bone mineral density of femur
MGI:3830042	Bmd5c<C3H/HeJ>	MP:0000130,abnormal trabecular bone morphology
MGI:2447014	Bmd6<C3H/HeJ>	MP:0000062,increased bone mineral density
MGI:2389157	Bmd7<C3H/HeJ>	MP:0004149,increased bone strength|MP:0020011,increased bone mineral density of femur|MP:0020039,increased bone ossification|MP:0021183,increased femoral compact bone area|MP:0021187,increased bone mineral density of vertebrae
MGI:2389159	Bmd8<C3H/HeJ>	MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0004991,decreased bone strength|MP:0013616,decreased volumetric bone mineral density|MP:0020010,decreased bone mineral density of femur
MGI:2389161	Bmd9<C3H/HeJ>	MP:0021186,decreased bone mineral density of vertebrae
MGI:2389160	Bmd9<C57BL/6J>	MP:0021187,increased bone mineral density of vertebrae
MGI:6152702	Bmerb1<em1(IMPC)Ccpcz>	MP:0000538,abnormal urinary bladder morphology|MP:0000613,abnormal salivary gland morphology|MP:0000639,abnormal adrenal gland morphology|MP:0000642,enlarged adrenal glands
MGI:3778610	Bmf<tm1.1Ast>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000716,abnormal immune system cell morphology|MP:0002006,neoplasm|MP:0002024,increased T cell derived lymphoma incidence|MP:0002461,increased immunoglobulin level|MP:0003132,increased pre-B cell number|MP:0004939,abnormal B cell morphology|MP:0006271,abnormal involution of the mammary gland|MP:0006414,decreased T cell apoptosis|MP:0008173,increased follicular B cell number|MP:0008189,increased transitional stage B cell number|MP:0008210,increased mature B cell number|MP:0008214,increased immature B cell number|MP:0008783,decreased B cell apoptosis
MGI:4421178	Bmf<tm1Rjd>	MP:0000691,enlarged spleen|MP:0001144,vagina atresia|MP:0003537,hydrometrocolpos|MP:0005014,increased B cell number|MP:0006414,decreased T cell apoptosis|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0009338,increased splenocyte number
MGI:4421179	Bmf<tm2.1Rjd>	MP:0002169,no abnormal phenotype detected
MGI:4421180	Bmf<tm3.1Rjd>	MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:5695968	Bmi1<tm1.1(KOMP)Vlcg>	MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5532395	Bmi1<tm1.1Lees>	MP:0002169,no abnormal phenotype detected
MGI:1857632	Bmi1<tm1Brn>	MP:0000137,abnormal vertebrae morphology|MP:0000333,decreased bone marrow cell number|MP:0000352,decreased cell proliferation|MP:0000692,small spleen|MP:0000711,thymus cortex hypoplasia|MP:0000715,decreased thymocyte number|MP:0000745,tremors|MP:0000780,abnormal corpus callosum morphology|MP:0000811,hippocampal neuron degeneration|MP:0000851,cerebellum hypoplasia|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000890,thin cerebellar molecular layer|MP:0000951,sporadic seizures|MP:0001127,small ovary|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0001806,decreased IgM level|MP:0001824,abnormal thymus involution|MP:0001861,lung inflammation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002183,gliosis|MP:0002356,abnormal spleen red pulp morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002407,abnormal double-negative T cell morphology|MP:0002631,abnormal epididymis morphology|MP:0002636,delayed vaginal opening|MP:0002682,decreased mature ovarian follicle number|MP:0002687,oligozoospermia|MP:0002780,decreased circulating testosterone level|MP:0003036,vertebral transformation|MP:0003077,abnormal cell cycle|MP:0003406,failure of zygotic cell division|MP:0003507,abnormal ovary physiology|MP:0003582,abnormal ovary development|MP:0003674,oxidative stress|MP:0004599,abnormal vertebral arch morphology|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0004884,abnormal testis physiology|MP:0004901,decreased male germ cell number|MP:0005092,decreased double-positive T cell number|MP:0005319,abnormal enzyme/coenzyme level|MP:0005431,decreased oocyte number|MP:0005536,decreased Leydig cell number|MP:0005578,teratozoospermia|MP:0006035,abnormal mitochondrial morphology|MP:0008008,early cellular replicative senescence|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0009011,prolonged diestrus|MP:0009015,short proestrus|MP:0009018,short estrus|MP:0009020,prolonged metestrus|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009233,enlarged sperm head|MP:0009335,decreased splenocyte proliferation|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009956,abnormal cerebellar layer morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011121,decreased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number|MP:0011182,decreased hematopoietic cell number|MP:0011629,decreased mitochondrial number|MP:0011635,abnormal mitochondrial crista morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0012659,decreased superoxide dismutase level|MP:0013508,increased granulosa cell apoptosis|MP:0014052,increased male germ cell apoptosis|MP:0014269,decreased testes secretion|MP:0020362,abnormal male germ cell physiology|MP:0031018,decreased granulosa cell proliferation|MP:0031239,increased atretic ovarian follicle number|MP:0031381,decreased secondary ovarian follicle number|MP:0031420,decreased superovulation rate
MGI:3806975	Bmi1<tm1Ilw>	MP:0002169,no abnormal phenotype detected
MGI:5644155	Bmi1<tm1Sgon>	MP:0000245,abnormal erythropoiesis|MP:0000333,decreased bone marrow cell number|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0000716,abnormal immune system cell morphology|MP:0002083,premature death|MP:0002357,abnormal spleen white pulp morphology|MP:0002358,abnormal spleen periarteriolar lymphoid sheath morphology|MP:0002722,abnormal immune system organ morphology|MP:0003644,thymus atrophy|MP:0004810,decreased hematopoietic stem cell number|MP:0004953,decreased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008474,absent spleen germinal center|MP:0008477,decreased spleen red pulp amount|MP:0008479,decreased spleen white pulp amount|MP:0008813,decreased common myeloid progenitor cell number|MP:0010768,mortality/aging|MP:0013662,decreased myeloid cell number|MP:0013693,abnormal hemopoiesis|MP:0013892,increased common lymphocyte progenitor cell number
MGI:3806976	Bmi1<tm2Ilw>	MP:0002169,no abnormal phenotype detected
MGI:6358171	Bmncr<tm1.1Xhl>	MP:0004016,decreased bone mass|MP:0004989,decreased osteoblast cell number|MP:0010879,decreased trabecular bone volume|MP:0013624,decreased femur compact bone thickness|MP:0020010,decreased bone mineral density of femur|MP:0020040,decreased bone ossification|MP:0030009,increased bone marrow adipose tissue amount
MGI:3698187	Bmnx<C57BL/6J>	MP:0006087,increased body mass index
MGI:5616117	Bmp10<b2b2711Clo>	MP:0000284,double outlet right ventricle|MP:0001823,thymus hypoplasia|MP:0003051,curly tail|MP:0008528,polycystic kidney|MP:0008816,petechiae|MP:0010417,subarterial ventricular septal defect|MP:0010460,pulmonary artery hypoplasia
MGI:5703977	Bmp10<tm1.1(Gdf2)Minh>	MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000274,enlarged heart|MP:0000277,abnormal heart shape|MP:0000280,thin ventricular wall|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0002169,no abnormal phenotype detected|MP:0002192,hydrops fetalis|MP:0002740,heart hypoplasia|MP:0005380,embryo phenotype|MP:0005385,cardiovascular system phenotype|MP:0010402,ventricular septal defect|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation
MGI:3042354	Bmp10<tm1Shou>	MP:0000259,abnormal vascular development|MP:0000279,ventricular hypoplasia|MP:0000291,enlarged pericardium|MP:0000295,trabecula carnea hypoplasia|MP:0000298,absent atrioventricular cushions|MP:0001698,decreased embryo size|MP:0001719,absent vitelline blood vessels|MP:0001730,embryonic growth arrest|MP:0004068,dilated dorsal aorta|MP:0004076,abnormal vitelline vascular remodeling|MP:0004783,abnormal cardinal vein morphology|MP:0005333,decreased heart rate|MP:0006093,arteriovenous malformation|MP:0010586,absent conotruncal ridges|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5694168	Bmp10<tm3b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment|MP:0005292,improved glucose tolerance|MP:0005554,decreased circulating creatinine level|MP:0011100,preweaning lethality, complete penetrance
MGI:2450734	Bmp15<tm1Zuk>	MP:0001125,abnormal oocyte morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001130,abnormal ovarian folliculogenesis|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002016,ovary cyst|MP:0003696,abnormal zona pellucida morphology|MP:0005389,reproductive system phenotype|MP:0005431,decreased oocyte number|MP:0031420,decreased superovulation rate
MGI:6257458	Bmp1<em1(IMPC)Bay>	MP:0003385,abnormal body wall morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:1857952	Bmp1<tm1Blh>	MP:0000477,abnormal intestine morphology|MP:0000757,herniated abdominal wall|MP:0002085,abnormal embryonic tissue morphology|MP:0004377,small frontal bone|MP:0004384,small interparietal bone|MP:0004418,small parietal bone|MP:0005029,abnormal amnion morphology|MP:0005380,embryo phenotype|MP:0005390,skeleton phenotype|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5584154	Bmp2k<em1(IMPC)J>	MP:0001303,abnormal lens morphology|MP:0011436,decreased urine magnesium level
MGI:3620971	Bmp2<tm1.1Jfm>	MP:0000267,abnormal heart development|MP:0002151,abnormal neural tube morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:5572019	Bmp2<tm1.2Mis>	MP:0000267,abnormal heart development
MGI:1857894	Bmp2<tm1Brd>	MP:0000267,abnormal heart development|MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0002836,abnormal chorion morphology|MP:0004558,delayed allantois development|MP:0006065,abnormal heart position or orientation|MP:0011092,embryonic lethality, complete penetrance|MP:0011197,abnormal proamniotic cavity morphology|MP:0012082,delayed heart development
MGI:3699309	Bmp2<tm1Cjt>	MP:0000149,abnormal scapula morphology|MP:0000564,syndactyly
MGI:3583785	Bmp2<tm1Jfm>	MP:0000088,short mandible|MP:0000104,abnormal sphenoid bone morphology|MP:0000428,abnormal craniofacial morphology|MP:0000454,abnormal jaw morphology|MP:0000457,maxilla hypoplasia|MP:0000460,mandible hypoplasia|MP:0002116,abnormal craniofacial bone morphology|MP:0002169,no abnormal phenotype detected|MP:0002639,micrognathia|MP:0003984,embryonic growth retardation|MP:0004448,abnormal presphenoid bone morphology|MP:0004467,absent zygomatic bone|MP:0004538,abnormal maxillary shelf morphology|MP:0004592,small mandible|MP:0004912,absent mandibular coronoid process|MP:0005312,pericardial effusion|MP:0005329,abnormal myocardium layer morphology|MP:0005382,craniofacial phenotype|MP:0006107,abnormal fetal atrioventricular canal morphology|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0009382,abnormal cardiac jelly morphology|MP:0009886,failure of palatal shelf elevation|MP:0011089,perinatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011495,abnormal head shape|MP:0021213,complete cleft palate|MP:0030026,small Meckel's cartilage|MP:0030261,abnormal temporal bone zygomatic process morphology|MP:0030302,abnormal maxillary zygomatic process morphology|MP:0031443,abnormal tongue position
MGI:4460567	Bmp2<tm1(KOMP)Vlcg>	MP:0001258,decreased body length|MP:0003345,decreased rib number|MP:0010124,decreased bone mineral content|MP:0010876,decreased bone volume|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3641368	Bmp2<tm1Vrs>	MP:0000267,abnormal heart development|MP:0000298,absent atrioventricular cushions|MP:0001698,decreased embryo size|MP:0005312,pericardial effusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012270,cardiac edema
MGI:2448071	Bmp3<tm1Kml>	MP:0005390,skeleton phenotype|MP:0010878,increased trabecular bone volume|MP:0020011,increased bone mineral density of femur
MGI:3714059	Bmp4<tm1.1Jlch>	MP:0000550,abnormal forelimb morphology|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0003345,decreased rib number|MP:0004672,short ribs|MP:0008392,decreased primordial germ cell number|MP:0009743,preaxial polydactyly
MGI:5699604	Bmp4<tm1b(EUCOMM)Hmgu>	MP:0000266,abnormal heart morphology|MP:0001297,microphthalmia|MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001672,abnormal embryo development|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001726,abnormal allantois morphology|MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0005176,eyelids fail to open|MP:0006108,abnormal hindbrain development|MP:0008259,abnormal optic disk morphology|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0011960,abnormal eye anterior chamber depth|MP:0011965,decreased total retina thickness|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:1857137	Bmp4<tm1Blh>	MP:0000037,abnormal lateral semicircular canal morphology|MP:0000042,abnormal organ of Corti morphology|MP:0000269,abnormal heart looping|MP:0000519,hydronephrosis|MP:0000562,polydactyly|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001145,abnormal male reproductive system morphology|MP:0001163,abnormal prostate gland anterior lobe morphology|MP:0001262,decreased body weight|MP:0001288,abnormal lens induction|MP:0001289,persistence of hyaloid vascular system|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001319,irregularly shaped pupil|MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0001330,abnormal optic nerve morphology|MP:0001333,absent optic nerve|MP:0001394,circling|MP:0001680,abnormal mesoderm development|MP:0001693,failure of primitive streak formation|MP:0001718,abnormal visceral yolk sac morphology|MP:0001721,absent visceral yolk sac blood islands|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002092,abnormal eye morphology|MP:0002161,abnormal fertility/fecundity|MP:0002216,abnormal seminiferous tubule morphology|MP:0002546,mydriasis|MP:0002697,abnormal eye size|MP:0002699,abnormal vitreous body morphology|MP:0002700,increased opacity of vitreous body|MP:0002875,decreased erythrocyte cell number|MP:0003087,absent allantois|MP:0003099,retina detachment|MP:0003161,absent lateral semicircular canal|MP:0003162,decreased lateral semicircular canal size|MP:0003604,single kidney|MP:0003675,kidney cyst|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003938,abnormal ear development|MP:0003984,embryonic growth retardation|MP:0004066,abnormal primitive node morphology|MP:0004221,abnormal iridocorneal angle|MP:0004223,hypoplastic trabecular meshwork|MP:0004224,absent trabecular meshwork|MP:0004226,absent Schlemm's canal|MP:0004380,short frontal bone|MP:0004471,short nasal bone|MP:0004517,decreased vestibular hair cell stereocilia number|MP:0004970,kidney atrophy|MP:0005193,abnormal anterior eye segment morphology|MP:0005195,abnormal posterior eye segment morphology|MP:0005204,abnormal canal of Schlemm morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005258,ocular hypertension|MP:0005325,abnormal renal glomerulus morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0005543,decreased cornea thickness|MP:0005551,abnormal eye electrophysiology|MP:0005559,increased circulating glucose level|MP:0006226,iris hypoplasia|MP:0006241,abnormal placement of pupils|MP:0006250,abnormal line of Schwalbe morphology|MP:0006323,abnormal extraembryonic mesoderm development|MP:0006325,impaired hearing|MP:0006377,abnormal vestibulocollic reflex|MP:0008259,abnormal optic disk morphology|MP:0008392,decreased primordial germ cell number|MP:0008393,absent primordial germ cells|MP:0008507,thin retina ganglion layer|MP:0008511,thin retina inner nuclear layer|MP:0009274,buphthalmos|MP:0010098,abnormal retina blood vessel pattern|MP:0010117,abnormal lateral plate mesoderm morphology|MP:0010252,anterior subcapsular cataract|MP:0010256,anterior cortical cataract|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011199,abnormal amniotic cavity morphology|MP:0011481,anterior iris synechia|MP:0011759,absent Rathke's pouch|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012740,abnormal posterior primitive streak morphology|MP:0020516,abnormal visceral yolk sac mesenchyme morphology
MGI:3041440	Bmp4<tm1Jfm>	MP:0000085,large anterior fontanelle|MP:0000458,abnormal mandible morphology|MP:0000562,polydactyly|MP:0004384,small interparietal bone|MP:0006126,abnormal cardiac outflow tract development|MP:0010426,abnormal heart and great artery attachment|MP:0010454,abnormal truncus arteriosus septation|MP:0011711,impaired osteoblast differentiation
MGI:2158495	Bmp4<tm2Blh>	MP:0000260,abnormal angiogenesis|MP:0000276,heart right ventricle hypertrophy|MP:0000474,abnormal foregut morphology|MP:0000516,abnormal renal/urinary system morphology|MP:0000519,hydronephrosis|MP:0000527,abnormal kidney development|MP:0000534,abnormal ureter morphology|MP:0000536,hydroureter|MP:0000597,delayed hepatic development|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002191,abnormal artery morphology|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0003087,absent allantois|MP:0003345,decreased rib number|MP:0003446,renal hypoplasia|MP:0003584,bifid ureter|MP:0003586,dilated ureter|MP:0003672,abnormal ureter development|MP:0003675,kidney cyst|MP:0003827,abnormal Wolffian duct morphology|MP:0003984,embryonic growth retardation|MP:0004003,abnormal vascular endothelial cell physiology|MP:0004017,duplex kidney|MP:0004601,abnormal vertebral spinous process morphology|MP:0004620,cervical vertebral fusion|MP:0004623,thoracic vertebral fusion|MP:0004672,short ribs|MP:0005592,abnormal vascular smooth muscle morphology|MP:0008392,decreased primordial germ cell number|MP:0008393,absent primordial germ cells|MP:0008528,polycystic kidney|MP:0010418,perimembraneous ventricular septal defect|MP:0010755,abnormal heart right ventricle pressure|MP:0010980,ectopic ureteric bud|MP:0010982,abnormal ureteric bud elongation|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0010985,abnormal kidney mesenchyme morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011305,dilated kidney calyx|MP:0011334,abnormal nephrogenic zone morphology|MP:0011386,increased metanephric mesenchyme apoptosis|MP:0011426,abnormal ureter smooth muscle morphology|MP:0011486,ectopic ureter|MP:0011488,abnormal ureterovesical junction morphology|MP:0011783,abnormal ureteral orifice morphology|MP:0012235,abnormal liver bud morphology
MGI:4941211	Bmp4<tm2(tetO-Bmp4,lacZ)Jfm>	MP:0011260,abnormal head mesenchyme morphology|MP:0011264,abnormal cardiac mesenchyme morphology
MGI:2181190	Bmp4<tm3.1Blh>	MP:0001175,abnormal lung morphology|MP:0002081,perinatal lethality|MP:0002092,abnormal eye morphology|MP:0002133,abnormal respiratory system physiology|MP:0005385,cardiovascular system phenotype|MP:0010403,atrial septal defect
MGI:2181188	Bmp4<tm3Blh>	MP:0000443,abnormal snout morphology|MP:0001286,abnormal eye development|MP:0001394,circling|MP:0002082,postnatal lethality|MP:0002092,abnormal eye morphology|MP:0003631,nervous system phenotype|MP:0004282,retrognathia|MP:0005176,eyelids fail to open|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0030313,abnormal face development
MGI:3797048	Bmp4<tm4Blh>	MP:0000516,abnormal renal/urinary system morphology|MP:0002187,abnormal fibula morphology|MP:0003126,abnormal external female genitalia morphology|MP:0003445,sirenomelia|MP:0003446,renal hypoplasia|MP:0006279,abnormal limb development|MP:0009052,anal stenosis|MP:0009203,external male genitalia hypoplasia|MP:0009252,absent urinary bladder|MP:0011851,abnormal embryonic cloaca development|MP:0013167,abnormal hindlimb bud morphology
MGI:4460795	Bmp4<tm5.1Bhr>	MP:0003984,embryonic growth retardation|MP:0011091,prenatal lethality, complete penetrance
MGI:3510601	Bmp5<cfe-se6J>	MP:0000018,small ears|MP:0000022,abnormal ear shape
MGI:2679550	Bmp5<cfe-se7J>	MP:0000022,abnormal ear shape|MP:0000024,lowered ear position|MP:0000063,decreased bone mineral density|MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000438,abnormal cranium morphology|MP:0000445,short snout|MP:0002233,abnormal nose morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005390,skeleton phenotype|MP:0008525,decreased cranium height|MP:0010031,abnormal cranium size|MP:0010124,decreased bone mineral content|MP:0011862,decreased cranium length|MP:0013618,decreased areal bone mineral density|MP:0020084,short ears
MGI:3521993	Bmp5<cfe-se8J>	MP:0000018,small ears|MP:0000022,abnormal ear shape|MP:0005390,skeleton phenotype
MGI:1856150	Bmp5<se>	MP:0000018,small ears|MP:0000019,thick ears|MP:0000022,abnormal ear shape|MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000164,abnormal cartilage development|MP:0000272,abnormal aorta morphology|MP:0000438,abnormal cranium morphology|MP:0000441,increased cranium width|MP:0000519,hydronephrosis|MP:0000536,hydroureter|MP:0000550,abnormal forelimb morphology|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0000592,short tail|MP:0000598,abnormal liver morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002085,abnormal embryonic tissue morphology|MP:0002115,abnormal limb bone morphology|MP:0002135,abnormal kidney morphology|MP:0002177,abnormal outer ear morphology|MP:0002187,abnormal fibula morphology|MP:0002191,abnormal artery morphology|MP:0002249,abnormal larynx morphology|MP:0002256,abnormal laryngeal cartilage morphology|MP:0002500,granulomatous inflammation|MP:0002823,abnormal rib development|MP:0002999,abnormal bone healing|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003109,short femur|MP:0003345,decreased rib number|MP:0003402,decreased liver weight|MP:0003723,abnormal long bone morphology|MP:0004322,abnormal sternebra morphology|MP:0004350,long humerus|MP:0004351,short humerus|MP:0004357,long tibia|MP:0004359,short ulna|MP:0004360,absent ulna|MP:0004471,short nasal bone|MP:0004601,abnormal vertebral spinous process morphology|MP:0004678,split xiphoid process|MP:0004695,increased length of long bones|MP:0004880,lung cyst|MP:0005296,abnormal humerus morphology|MP:0005352,small cranium|MP:0008150,decreased diameter of long bones|MP:0008154,decreased diameter of humerus|MP:0008271,abnormal bone ossification|MP:0009005,abnormal sesamoid bone of gastrocnemius morphology|MP:0009914,abnormal hyoid bone lesser horn morphology|MP:0010113,abnormal sacrum morphology|MP:0010146,umbilical hernia|MP:0011318,abnormal right renal artery morphology|MP:0011727,ectopic ovary|MP:0011835,abnormal urogenital fold morphology|MP:0011872,absent xiphoid process|MP:0020084,short ears|MP:0030422,abnormal outer ear cartilage morphology|MP:0030867,small thyroid cartilage|MP:0030872,small cricoid cartilage|MP:0031286,unilateral cryptorchism
MGI:2153987	Bmp5<se-15THO-I>	MP:0000018,small ears|MP:0020084,short ears
MGI:5299230	Bmp5<se-19H>	MP:0000018,small ears|MP:0010768,mortality/aging|MP:0020084,short ears
MGI:2153905	Bmp5<se-207K>	MP:0011091,prenatal lethality, complete penetrance
MGI:5299231	Bmp5<se-20H>	MP:0002080,prenatal lethality|MP:0010768,mortality/aging|MP:0020084,short ears
MGI:1858106	Bmp5<se-2OZb>	MP:0000018,small ears|MP:0000159,abnormal xiphoid process morphology|MP:0003345,decreased rib number|MP:0005508,abnormal skeleton morphology
MGI:1857398	Bmp5<se-30DThWb>	MP:0000018,small ears
MGI:2153910	Bmp5<se-32DTD>	MP:0011091,prenatal lethality, complete penetrance
MGI:1930367	Bmp5<se-38DSD>	MP:0000018,small ears
MGI:1857399	Bmp5<se-4CHLd>	MP:0000018,small ears
MGI:1856154	Bmp5<se-4J>	MP:0000018,small ears|MP:0000022,abnormal ear shape|MP:0002102,abnormal ear morphology|MP:0002177,abnormal outer ear morphology
MGI:2153906	Bmp5<se-52CoS>	MP:0011091,prenatal lethality, complete penetrance
MGI:2153907	Bmp5<se-5RD300H>	MP:0001683,absent mesoderm|MP:0001698,decreased embryo size|MP:0009397,increased trophoblast giant cell number|MP:0010736,abnormal extraembryonic ectoderm morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:2153908	Bmp5<se-70FBFo>	MP:0011091,prenatal lethality, complete penetrance
MGI:3587789	Bmp5<se-Ca>	MP:0000462,abnormal digestive system morphology|MP:0000519,hydronephrosis|MP:0000536,hydroureter|MP:0000550,abnormal forelimb morphology|MP:0000598,abnormal liver morphology|MP:0002085,abnormal embryonic tissue morphology|MP:0002500,granulomatous inflammation|MP:0003109,short femur|MP:0003230,abnormal umbilical artery morphology|MP:0003585,large ureter|MP:0004351,short humerus|MP:0004880,lung cyst|MP:0005367,renal/urinary system phenotype|MP:0005380,embryo phenotype|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0011318,abnormal right renal artery morphology|MP:0011727,ectopic ovary|MP:0031286,unilateral cryptorchism
MGI:1856153	Bmp5<se-x>	MP:0000018,small ears
MGI:1857400	Bmp5<T27H>	MP:0011091,prenatal lethality, complete penetrance
MGI:6358085	Bmp6<em1(IMPC)Ccpcz>	MP:0000160,kyphosis|MP:0000613,abnormal salivary gland morphology|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001944,abnormal pancreas morphology|MP:0002060,abnormal skin morphology|MP:0002152,abnormal brain morphology|MP:0002590,increased mean corpuscular volume|MP:0002941,increased circulating alanine transaminase level|MP:0004174,abnormal spine curvature|MP:0005238,increased brain size|MP:0005333,decreased heart rate|MP:0005343,increased circulating aspartate transaminase level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008810,increased circulating iron level
MGI:3529157	Bmp6<tm1Lex>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size
MGI:2136985	Bmp6<tm1Rob>	MP:0008277,abnormal sternum ossification|MP:0008785,abnormal sternum manubrium morphology
MGI:2158467	Bmp7<Tg(BCL2)114Cro>	MP:0000060,delayed bone ossification|MP:0000063,decreased bone mineral density|MP:0000137,abnormal vertebrae morphology|MP:0000154,rib fusion|MP:0000527,abnormal kidney development|MP:0000562,polydactyly|MP:0000585,kinked tail|MP:0000745,tremors|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0002989,small kidney|MP:0003050,abnormal sacral vertebrae morphology|MP:0003078,aphakia|MP:0004463,basisphenoid bone foramen|MP:0004612,fusion of vertebral bodies|MP:0004647,decreased lumbar vertebrae number|MP:0004679,xiphoid process foramen|MP:0004757,abnormal distal convoluted tubule morphology|MP:0005103,abnormal retina pigmentation|MP:0005176,eyelids fail to open|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005508,abnormal skeleton morphology|MP:0008528,polycystic kidney|MP:0009674,decreased birth weight|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011290,decreased nephron number
MGI:3847797	Bmp7<tm1.1Dgra>	MP:0000074,abnormal neurocranium morphology|MP:0000102,abnormal nasal bone morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0000163,abnormal cartilage morphology|MP:0000443,abnormal snout morphology|MP:0001943,abnormal respiration|MP:0001957,apnea|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002244,abnormal turbinate morphology|MP:0002932,abnormal joint morphology|MP:0002933,joint inflammation|MP:0003560,osteoarthritis|MP:0004471,short nasal bone|MP:0005290,decreased oxygen consumption|MP:0005534,decreased body temperature|MP:0005574,decreased pulmonary respiratory rate|MP:0009782,abnormal basicranium angle|MP:0012085,midface hypoplasia|MP:0012106,impaired exercise endurance|MP:0030199,deviated nasal septum|MP:0030262,frontal bossing|MP:0030313,abnormal face development|MP:0030420,short basicranium|MP:0030681,increased circulating hydroxyproline level|MP:0031101,nasal obstruction
MGI:3847798	Bmp7<tm1.2Dgra>	MP:0000031,abnormal cochlea morphology|MP:0000079,abnormal basioccipital bone morphology|MP:0000111,cleft palate|MP:0000128,growth retardation of molars|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000157,abnormal sternum morphology|MP:0000377,abnormal hair follicle morphology|MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0001286,abnormal eye development|MP:0001292,abnormal lens vesicle development|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002098,abnormal vibrissa morphology|MP:0002100,abnormal tooth morphology|MP:0002258,abnormal cricoid cartilage morphology|MP:0002260,abnormal thyroid cartilage morphology|MP:0002428,abnormal semicircular canal morphology|MP:0002689,abnormal molar morphology|MP:0003056,abnormal hyoid bone morphology|MP:0003154,abnormal soft palate morphology|MP:0003446,renal hypoplasia|MP:0003670,dilated renal glomerular capsule|MP:0003756,abnormal hard palate morphology|MP:0003935,abnormal craniofacial development|MP:0004200,decreased fetal size|MP:0004538,abnormal maxillary shelf morphology|MP:0004726,abnormal nasal capsule morphology|MP:0004790,absent upper incisors|MP:0005105,abnormal middle ear ossicle morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0005548,retina pigment epithelium atrophy|MP:0006400,decreased molar number|MP:0009003,abnormal vibrissa number|MP:0009883,palatal shelf hypoplasia|MP:0009888,palatal shelves fail to meet at midline|MP:0010688,hair follicle outer root sheath hyperplasia|MP:0010985,abnormal kidney mesenchyme morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0012173,short rostral-caudal axis|MP:0030026,small Meckel's cartilage|MP:0030136,abnormal lower incisor morphology|MP:0030200,abnormal nasal septum cartilage morphology|MP:0030319,abnormal temporal bone petrous part morphology|MP:0030868,absent thyroid cartilage|MP:0030873,absent cricoid cartilage
MGI:4436150	Bmp7<tm1a(EUCOMM)Hmgu>	MP:0000220,increased monocyte cell number|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number
MGI:1934010	Bmp7<tm1Kry>	MP:0000106,abnormal basisphenoid bone morphology|MP:0000154,rib fusion|MP:0000159,abnormal xiphoid process morphology|MP:0000536,hydroureter|MP:0000562,polydactyly|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001292,abnormal lens vesicle development|MP:0001293,anophthalmia|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0002110,abnormal digit morphology|MP:0002989,small kidney|MP:0003078,aphakia|MP:0003235,abnormal alisphenoid bone morphology|MP:0003345,decreased rib number|MP:0004456,small pterygoid bone|MP:0004462,small basisphenoid bone|MP:0004463,basisphenoid bone foramen|MP:0004505,decreased renal glomerulus number|MP:0004574,broad limb buds|MP:0005385,cardiovascular system phenotype|MP:0005390,skeleton phenotype|MP:0008146,asymmetric sternocostal joints|MP:0011085,postnatal lethality, complete penetrance|MP:0011387,absent metanephric mesenchyme
MGI:1857654	Bmp7<tm1Rob>	MP:0000438,abnormal cranium morphology|MP:0000527,abnormal kidney development|MP:0000536,hydroureter|MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002114,abnormal axial skeleton morphology|MP:0008148,abnormal sternocostal joint morphology|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2136986	Bmp7<tm2Rob>	MP:0000527,abnormal kidney development|MP:0000536,hydroureter|MP:0003675,kidney cyst
MGI:1857953	Bmp8a<tm1Blh>	MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0002500,granulomatous inflammation|MP:0002631,abnormal epididymis morphology|MP:0004934,epididymis epithelium degeneration|MP:0006362,abnormal male germ cell morphology|MP:0014052,increased male germ cell apoptosis
MGI:1857954	Bmp8b<tm1Blh>	MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001726,abnormal allantois morphology|MP:0001919,abnormal reproductive system physiology|MP:0001925,male infertility|MP:0002685,abnormal spermatogonia proliferation|MP:0003087,absent allantois|MP:0003984,embryonic growth retardation|MP:0004188,delayed embryo turning|MP:0004558,delayed allantois development|MP:0004559,small allantois|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005076,abnormal cell differentiation|MP:0006362,abnormal male germ cell morphology|MP:0008391,abnormal primordial germ cell morphology|MP:0008392,decreased primordial germ cell number|MP:0008393,absent primordial germ cells|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0013600,testis degeneration|MP:0014052,increased male germ cell apoptosis
MGI:3840517	Bmper<tm1Cpat>	MP:0001176,abnormal lung development|MP:0001672,abnormal embryo development|MP:0009660,abnormal induced retina neovascularization|MP:0010810,increased type II pneumocyte number|MP:0010825,abnormal lung saccule morphology|MP:0010827,small lung saccule|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011143,thick lung-associated mesenchyme
MGI:3711028	Bmper<tm1Emdr>	MP:0000030,abnormal tympanic ring morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0000592,short tail|MP:0000914,exencephaly|MP:0001297,microphthalmia|MP:0001953,respiratory failure|MP:0002282,abnormal trachea morphology|MP:0003345,decreased rib number|MP:0004354,absent deltoid tuberosity|MP:0004553,absent tracheal cartilage rings|MP:0004599,abnormal vertebral arch morphology|MP:0004610,small vertebrae|MP:0004618,thoracic vertebral transformation|MP:0004703,abnormal vertebral column morphology|MP:0005508,abnormal skeleton morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3691854	Bmper<tm1Ysas>	MP:0000149,abnormal scapula morphology|MP:0000163,abnormal cartilage morphology|MP:0000164,abnormal cartilage development|MP:0000438,abnormal cranium morphology|MP:0000592,short tail|MP:0000914,exencephaly|MP:0001258,decreased body length|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003051,curly tail|MP:0003345,decreased rib number|MP:0004200,decreased fetal size|MP:0004342,scapular bone foramen|MP:0004343,small scapula|MP:0004354,absent deltoid tuberosity|MP:0004384,small interparietal bone|MP:0004444,small supraoccipital bone|MP:0004463,basisphenoid bone foramen|MP:0004505,decreased renal glomerulus number|MP:0004553,absent tracheal cartilage rings|MP:0004603,absent vertebral arch|MP:0004670,small vertebral body|MP:0004915,abnormal Reichert's cartilage morphology|MP:0005225,abnormal vertebrae development|MP:0005226,abnormal vertebral arch development|MP:0005227,abnormal vertebral body development|MP:0009575,abnormal pubic symphysis morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011290,decreased nephron number|MP:0030120,absent retrotympanic process|MP:0030431,wide metopic suture|MP:0030844,abnormal pubis body morphology|MP:0030867,small thyroid cartilage|MP:0030872,small cricoid cartilage
MGI:3691855	Bmper<tm2Ysas>	MP:0000149,abnormal scapula morphology|MP:0000163,abnormal cartilage morphology|MP:0000164,abnormal cartilage development|MP:0000438,abnormal cranium morphology|MP:0000592,short tail|MP:0000914,exencephaly|MP:0001258,decreased body length|MP:0002135,abnormal kidney morphology|MP:0002258,abnormal cricoid cartilage morphology|MP:0002260,abnormal thyroid cartilage morphology|MP:0002989,small kidney|MP:0003051,curly tail|MP:0003120,abnormal tracheal cartilage morphology|MP:0003345,decreased rib number|MP:0003842,abnormal metopic suture morphology|MP:0004200,decreased fetal size|MP:0004342,scapular bone foramen|MP:0004343,small scapula|MP:0004354,absent deltoid tuberosity|MP:0004384,small interparietal bone|MP:0004423,abnormal temporal bone squamous part morphology|MP:0004444,small supraoccipital bone|MP:0004463,basisphenoid bone foramen|MP:0004505,decreased renal glomerulus number|MP:0004506,abnormal pubis morphology|MP:0004670,small vertebral body|MP:0004915,abnormal Reichert's cartilage morphology|MP:0005225,abnormal vertebrae development|MP:0005226,abnormal vertebral arch development|MP:0005227,abnormal vertebral body development|MP:0011087,neonatal lethality, complete penetrance|MP:0011290,decreased nephron number
MGI:2158342	Bmpr1a<tm1Bhr>	MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0002111,abnormal tail morphology|MP:0002151,abnormal neural tube morphology|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011190,thick embryonic epiblast|MP:0011191,increased embryonic epiblast cell apoptosis|MP:0011192,decreased embryonic epiblast cell proliferation
MGI:2158390	Bmpr1a<tm2.1Bhr>	MP:0000060,delayed bone ossification|MP:0000259,abnormal vascular development|MP:0000298,absent atrioventricular cushions|MP:0000414,alopecia|MP:0000471,abnormal stomach epithelium morphology|MP:0001175,abnormal lung morphology|MP:0001533,abnormal skeleton physiology|MP:0001541,abnormal osteoclast physiology|MP:0001634,internal hemorrhage|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0001722,pale yolk sac|MP:0001730,embryonic growth arrest|MP:0001873,stomach inflammation|MP:0001914,hemorrhage|MP:0001954,respiratory distress|MP:0002006,neoplasm|MP:0002082,postnatal lethality|MP:0002169,no abnormal phenotype detected|MP:0002188,small heart|MP:0002657,chondrodystrophy|MP:0002725,abnormal vein morphology|MP:0003227,abnormal vascular branching morphogenesis|MP:0003229,abnormal vitelline vasculature morphology|MP:0003299,gastric polyps|MP:0003717,pallor|MP:0003795,abnormal bone structure|MP:0003814,vascular smooth muscle hypoplasia|MP:0003892,abnormal gastric gland morphology|MP:0004421,enlarged parietal bone|MP:0004686,decreased length of long bones|MP:0004985,decreased osteoclast cell number|MP:0005312,pericardial effusion|MP:0005388,respiratory system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005508,abnormal skeleton morphology|MP:0005605,increased bone mass|MP:0008396,abnormal osteoclast differentiation|MP:0010099,abnormal thoracic cage shape|MP:0010103,small thoracic cage|MP:0010797,abnormal pyloric gastric gland morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0014033,abnormal submucosal gland morphology|MP:0020040,decreased bone ossification|MP:0020080,increased bone mineralization
MGI:2181295	Bmpr1a<tm2.2Bhr>	MP:0002080,prenatal lethality
MGI:2158343	Bmpr1a<tm2Bhr>	MP:0000116,abnormal tooth development|MP:0000377,abnormal hair follicle morphology|MP:0000380,small hair follicles|MP:0000383,abnormal hair follicle orientation|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000452,abnormal mouth morphology|MP:0000557,absent hindlimb|MP:0000579,abnormal nail morphology|MP:0001265,decreased body size|MP:0001302,eyelids open at birth|MP:0001436,abnormal suckling behavior|MP:0002009,preneoplasia|MP:0002073,abnormal hair growth|MP:0002083,premature death|MP:0002100,abnormal tooth morphology|MP:0003809,abnormal hair shaft morphology|MP:0003813,abnormal hair follicle dermal papilla morphology|MP:0003875,abnormal hair follicle regression|MP:0011085,postnatal lethality, complete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0012110,increased hair follicle number|MP:0030610,absent teeth
MGI:7425544	Bmpr1b<em1(IMPC)Mbp>	MP:0000572,abnormal autopod morphology|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0001304,cataract|MP:0001319,irregularly shaped pupil|MP:0001566,increased circulating phosphate level|MP:0001926,female infertility|MP:0002059,abnormal seminal vesicle morphology|MP:0002699,abnormal vitreous body morphology|MP:0003795,abnormal bone structure|MP:0008259,abnormal optic disk morphology|MP:0010053,decreased grip strength|MP:0020421,increased freezing behavior
MGI:2158498	Bmpr1b<Tg(ACTB-FLP)4917Dym>	MP:0000164,abnormal cartilage development|MP:0000352,decreased cell proliferation|MP:0002110,abnormal digit morphology|MP:0002115,abnormal limb bone morphology|MP:0002169,no abnormal phenotype detected|MP:0002544,brachydactyly|MP:0003072,abnormal metatarsal bone morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0004642,fused metatarsal bones|MP:0005306,abnormal phalanx morphology|MP:0006042,increased apoptosis
MGI:2158497	Bmpr1b<tm1Kml>	MP:0000164,abnormal cartilage development|MP:0000554,abnormal carpal bone morphology|MP:0001919,abnormal reproductive system physiology|MP:0001926,female infertility|MP:0002115,abnormal limb bone morphology|MP:0002543,brachyphalangia|MP:0002544,brachydactyly|MP:0002932,abnormal joint morphology|MP:0004634,short metacarpal bones|MP:0004635,short metatarsal bones|MP:0005306,abnormal phalanx morphology|MP:0006280,abnormal digit development|MP:0008056,abnormal retina ganglion cell morphology|MP:0008258,thin endometrium|MP:0008730,fused phalanges|MP:0009011,prolonged diestrus|MP:0009097,absent endometrial glands|MP:0009374,absent cumulus expansion|MP:0009728,abnormal calcaneum morphology|MP:0012281,decreased sternebra size|MP:0013400,abnormal endometrial gland development|MP:0014105,abnormal chondrocyte differentiation|MP:0014750,abnormal retinal ganglion cell axon guidance|MP:0030005,increased retina apoptosis|MP:0030843,elbow dislocation
MGI:4836989	Bmpr1b<Tn(sb-lacZ,GFP)IR3.PV50Jtak>	MP:0001926,female infertility|MP:0009250,abnormal appendicular skeleton morphology
MGI:5560496	Bmpr2<b2b2556Clo>	MP:0000519,hydronephrosis|MP:0002746,abnormal semilunar valve morphology|MP:0004056,abnormal myocardium compact layer morphology|MP:0010412,atrioventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011661,persistent truncus arteriosus type i|MP:0011664,persistent truncus arteriosus type iv
MGI:3574812	Bmpr2<tm1.1Enl>	MP:0000276,heart right ventricle hypertrophy|MP:0000484,abnormal pulmonary artery morphology|MP:0002169,no abnormal phenotype detected|MP:0003548,pulmonary hypertension|MP:0003812,abnormal hair medulla|MP:0004007,abnormal lung vasculature morphology|MP:0004012,increased pulmonary artery pressure|MP:0006134,artery occlusion|MP:0008733,abnormal hair shaft melanin granule distribution|MP:0008767,abnormal hair medullary septa cells|MP:0010771,integument phenotype|MP:0011139,increased lung endothelial cell proliferation|MP:0031167,abnormal lung thrombosis|MP:0031510,increased vascular smooth muscle cell proliferation
MGI:5568728	Bmpr2<tm1.1Pley>	MP:0005385,cardiovascular system phenotype|MP:0011105,embryonic lethality between implantation and placentation, incomplete penetrance
MGI:3574813	Bmpr2<tm1.2Enl>	MP:0003984,embryonic growth retardation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:8255475	Bmpr2<tm1.2Nwm>	MP:0002271,abnormal pulmonary alveolar duct morphology|MP:0005385,cardiovascular system phenotype
MGI:3574811	Bmpr2<tm1Enl>	MP:0002169,no abnormal phenotype detected
MGI:2158503	Bmpr2<tm1Kmi>	MP:0000484,abnormal pulmonary artery morphology|MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001730,embryonic growth arrest|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002442,abnormal leukocyte physiology|MP:0002582,disorganized extraembryonic tissue|MP:0003025,increased vasoconstriction|MP:0003034,increased pulmonary vascular resistance|MP:0003036,vertebral transformation|MP:0003548,pulmonary hypertension|MP:0003886,abnormal embryonic epiblast morphology|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0003984,embryonic growth retardation|MP:0003988,disorganized embryonic tissue|MP:0004007,abnormal lung vasculature morphology|MP:0004012,increased pulmonary artery pressure|MP:0005221,abnormal rostral-caudal axis patterning|MP:0008148,abnormal sternocostal joint morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0014586,decreased egg cylinder size
MGI:2445437	Bmpr2<tm1Kml>	MP:0000060,delayed bone ossification|MP:0000281,abnormal interventricular septum morphology|MP:0001719,absent vitelline blood vessels|MP:0002746,abnormal semilunar valve morphology|MP:0003345,decreased rib number|MP:0004157,interrupted aortic arch|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5776726	Bmpr2<tm1Mmue>	MP:0000484,abnormal pulmonary artery morphology|MP:0003070,increased vascular permeability|MP:0003548,pulmonary hypertension|MP:0010758,increased right ventricle systolic pressure|MP:0011400,lethality, complete penetrance
MGI:3699876	Bmrbc1<C57BL/6Ola>	MP:0003131,increased erythrocyte cell number
MGI:3699877	Bmrbc2<CBA/HOla>	MP:0003131,increased erythrocyte cell number
MGI:3699880	Bmrbc3<C57BL/6Ola>	MP:0003131,increased erythrocyte cell number
MGI:3699882	Bmrbc4<C57BL/6Ola>	MP:0003131,increased erythrocyte cell number
MGI:3699881	Bmrbc4<CBA/HOla>	MP:0003131,increased erythrocyte cell number
MGI:5548836	Bms1<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0005634,decreased circulating sodium level|MP:0011100,preweaning lethality, complete penetrance
MGI:5013470	Bmx<tm1.1Npa>	MP:0005390,skeleton phenotype
MGI:2660714	Bmx<tm1Ali>	MP:0002169,no abnormal phenotype detected|MP:0003436,decreased susceptibility to induced arthritis
MGI:5466677	Bmyc<tm1Mpo>	MP:0001154,seminiferous tubule degeneration|MP:0001262,decreased body weight|MP:0001751,increased circulating luteinizing hormone level|MP:0002006,neoplasm|MP:0004852,decreased testis weight|MP:0004929,decreased epididymis weight|MP:0005389,reproductive system phenotype|MP:0009248,small caput epididymis|MP:0010831,lethality, incomplete penetrance|MP:0011385,abnormal testosterone level|MP:0014052,increased male germ cell apoptosis
MGI:6257580	Bnc1<em1(IMPC)H>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000367,abnormal coat/ hair morphology|MP:0000689,abnormal spleen morphology|MP:0001147,small testis|MP:0001926,female infertility|MP:0002059,abnormal seminal vesicle morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002941,increased circulating alanine transaminase level|MP:0005013,increased lymphocyte cell number|MP:0010123,increased bone mineral content
MGI:8190270	Bnc1<tm1.1Nju>	MP:0001127,small ovary|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001923,reduced female fertility|MP:0005181,decreased circulating estradiol level|MP:0008871,abnormal ovarian follicle number|MP:0011121,decreased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0031381,decreased secondary ovarian follicle number
MGI:3771811	Bnc1<tm1.1Tsen>	MP:0020855,decreased cornea epithelium thickness|MP:0020858,cornea epithelium hypoplasia|MP:0020861,abnormal cornea wound healing
MGI:3639337	Bnc2<Gt(pU21)18Imeg>	MP:0000433,microcephaly|MP:0004420,parietal bone hypoplasia|MP:0004452,abnormal pterygoid process morphology|MP:0004459,small alisphenoid bone|MP:0004476,absent palatine bone|MP:0004538,abnormal maxillary shelf morphology|MP:0004869,frontal bone hypoplasia|MP:0009247,meteorism|MP:0009653,abnormal palate development|MP:0009703,decreased birth body size|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0009907,decreased tongue size|MP:0011087,neonatal lethality, complete penetrance|MP:0030353,wide sagittal suture|MP:0030387,large posterior fontanelle
MGI:6120794	Bnc2<tm1b(KOMP)Wtsi>	MP:0001417,decreased exploration in new environment|MP:0011962,increased cornea thickness
MGI:5695117	Bnip1<tm2b(KOMP)Wtsi>	MP:0001417,decreased exploration in new environment|MP:0005011,increased eosinophil cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:5636917	Bnip2<tm1b(EUCOMM)Wtsi>	MP:0000438,abnormal cranium morphology|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0002875,decreased erythrocyte cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0005561,increased mean corpuscular hemoglobin|MP:0010052,increased grip strength|MP:0010096,abnormal incisor color
MGI:6277037	Bnip3<em1(IMPC)Mbp>	MP:0001325,abnormal retina morphology|MP:0001333,absent optic nerve|MP:0002079,increased circulating insulin level|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance
MGI:3802624	Bnip3l<Gt(XT0573)Wtsi>	MP:0002424,abnormal reticulocyte morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002875,decreased erythrocyte cell number|MP:0003656,abnormal erythrocyte physiology|MP:0005097,polychromatophilia|MP:0031085,increased erythrocyte osmotic fragility
MGI:3819954	Bnip3l<tm1.1Gwd>	MP:0000172,abnormal bone marrow cell number|MP:0000228,abnormal thrombopoiesis|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002123,abnormal definitive hematopoiesis|MP:0002447,abnormal erythrocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0005097,polychromatophilia|MP:0005385,cardiovascular system phenotype|MP:0008476,increased spleen red pulp amount|MP:0011177,abnormal erythroblast number
MGI:3841600	Bnip3l<tm1Gwd>	MP:0003141,cardiac fibrosis|MP:0003223,decreased cardiomyocyte apoptosis|MP:0003921,abnormal heart left ventricle morphology|MP:0004484,abnormal response of heart to induced stress|MP:0005599,increased cardiac muscle contractility
MGI:3819930	Bnip3l<tm1Ney>	MP:0000208,decreased hematocrit|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0001577,anemia|MP:0002123,abnormal definitive hematopoiesis|MP:0002447,abnormal erythrocyte morphology|MP:0002640,reticulocytosis|MP:0002643,poikilocytosis|MP:0002812,spherocytosis|MP:0002875,decreased erythrocyte cell number|MP:0005097,polychromatophilia|MP:0014046,abnormal mitophagy
MGI:3764664	Bnip3<tm1Gwd>	MP:0003223,decreased cardiomyocyte apoptosis|MP:0004484,abnormal response of heart to induced stress|MP:0005385,cardiovascular system phenotype|MP:0005397,hematopoietic system phenotype
MGI:5695936	Bnip5<tm1.1(KOMP)Vlcg>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0002941,increased circulating alanine transaminase level
MGI:7709795	Bnipl<em1(IMPC)Mbp>	MP:0001417,decreased exploration in new environment|MP:0010393,shortened QRS complex duration|MP:0020421,increased freezing behavior
MGI:3618848	Bnszq2<C3H>	MP:0000135,decreased compact bone thickness
MGI:3578901	Bntq1<C57BL/6J>	MP:0000558,abnormal tibia morphology|MP:0008158,increased diameter of femur
MGI:3578902	Bntq1<DBA/2J>	MP:0000008,increased white adipose tissue amount
MGI:3692939	Boc<tm1Aok>	MP:0002184,abnormal innervation|MP:0003631,nervous system phenotype|MP:0005382,craniofacial phenotype
MGI:5548758	Boc<tm1b(KOMP)Wtsi>	MP:0000198,decreased circulating phosphate level|MP:0001488,increased startle reflex|MP:0001552,increased circulating triglyceride level|MP:0002606,increased basophil cell number|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level
MGI:5000228	Boc<tm1Rsk>	MP:0002169,no abnormal phenotype detected
MGI:5000229	Boc<tm2Rsk>	MP:0002169,no abnormal phenotype detected
MGI:7506247	Bod1l<em1Bltn>	MP:0001805,decreased IgG level|MP:0004816,abnormal class switch recombination|MP:0008495,decreased IgG1 level
MGI:5694175	Bod1<tm1b(KOMP)Wtsi>	MP:0002606,increased basophil cell number|MP:0002833,increased heart weight|MP:0004738,abnormal auditory brainstem response|MP:0005011,increased eosinophil cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:3624644	Bodwt1<C3H/HeJ>	MP:0000180,abnormal circulating cholesterol level|MP:0001260,increased body weight|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level
MGI:3624646	Bodwt2<C3H/HeJ>	MP:0001260,increased body weight
MGI:5527387	Bok<tm1.1Ast>	MP:0004952,increased spleen weight|MP:0004955,increased thymus weight|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:5605768	Bok<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment|MP:0002606,increased basophil cell number|MP:0005011,increased eosinophil cell number|MP:0005278,abnormal cholesterol homeostasis
MGI:5749451	Bola1<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010124,decreased bone mineral content
MGI:4419429	Bola2<tm1(KOMP)Wtsi>	MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0002075,abnormal coat/hair pigmentation|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0004151,decreased circulating iron level|MP:0005292,improved glucose tolerance|MP:0008283,small hippocampus|MP:0012478,decreased secondary somatosensory cortex size|MP:0013909,small third ventricle
MGI:4842419	Bola3<tm1a(EUCOMM)Wtsi>	MP:0004890,decreased energy expenditure|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005455,increased susceptibility to weight gain|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006036,abnormal mitochondrial physiology|MP:0011698,abnormal brown adipose tissue physiology|MP:0011699,abnormal brown adipose tissue thermogenesis|MP:0014145,increased white adipose tissue mass|MP:0030017,decreased adipocyte glucose uptake
MGI:4457699	Boll<tm1Eyx>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0008279,arrest of spermiogenesis|MP:0008280,abnormal male germ cell apoptosis|MP:0020550,multinucleated giant male germ cells
MGI:3689312	Bolt	MP:0000556,abnormal hindlimb morphology|MP:0000585,kinked tail|MP:0003049,abnormal lumbar vertebrae morphology|MP:0004704,short vertebral column|MP:0005391,vision/eye phenotype
MGI:2155343	Bomb1<NSF/N>	MP:0003132,increased pre-B cell number|MP:0012431,increased lymphoma incidence
MGI:2155342	Bomb1<SL/Kh>	MP:0003132,increased pre-B cell number|MP:0012431,increased lymphoma incidence
MGI:2178274	Bomd3<DBA/2>	MP:0000062,increased bone mineral density
MGI:2178276	Bomd4<DBA/2>	MP:0000062,increased bone mineral density
MGI:3583585	Bomd5<DBA/2J>	MP:0000062,increased bone mineral density
MGI:3583587	Bomd6<DBA/2J>	MP:0000062,increased bone mineral density
MGI:3583588	Bomd7<C57BL/6J>	MP:0000062,increased bone mineral density
MGI:3708457	bona	MP:0001489,decreased startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3778078	Boneq<129S1/SvImJ>	MP:0000063,decreased bone mineral density|MP:0003795,abnormal bone structure
MGI:6437040	Borcs5<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance
MGI:6510587	Borcs5<em1Jusb>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0003631,nervous system phenotype|MP:0005058,abnormal lysosome morphology|MP:0005404,abnormal axon morphology|MP:0010819,primary atelectasis|MP:0011089,perinatal lethality, complete penetrance
MGI:5750742	Borcs6<tm1.1(KOMP)Vlcg>	MP:0000194,increased circulating calcium level|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0002230,abnormal primitive streak formation|MP:0003085,abnormal egg cylinder morphology|MP:0003886,abnormal embryonic epiblast morphology|MP:0005058,abnormal lysosome morphology|MP:0008546,abnormal vesicle-mediated transport|MP:0009331,absent primitive node|MP:0010024,increased total body fat amount|MP:0010126,abnormal distal visceral endoderm morphology|MP:0010736,abnormal extraembryonic ectoderm morphology|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011189,small embryonic epiblast|MP:0011192,decreased embryonic epiblast cell proliferation|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0013504,increased embryonic tissue cell apoptosis|MP:0014134,abnormal embryo morphology|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance|MP:0014586,decreased egg cylinder size|MP:0014693,abnormal cell nucleus size
MGI:7512903	Borcs7<em1(IMPC)Hmgu>	MP:0000745,tremors|MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:6281438	Borcs7<Q87X>	MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001463,abnormal spatial learning|MP:0001489,decreased startle reflex|MP:0001513,limb grasping|MP:0001922,reduced male fertility|MP:0002757,decreased vertical activity|MP:0003225,axonal dystrophy|MP:0004768,abnormal axonal transport|MP:0005058,abnormal lysosome morphology|MP:0010053,decreased grip strength
MGI:6280949	Borcs7<tm1Bhk>	MP:0004768,abnormal axonal transport|MP:0005058,abnormal lysosome morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:6150873	Borcs8<tm1b(EUCOMM)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3688712	bpck	MP:0001127,small ovary|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0001577,anemia|MP:0001891,hydrocephaly|MP:0005370,liver/biliary system phenotype|MP:0005371,limbs/digits/tail phenotype|MP:0005380,embryo phenotype|MP:0005565,increased blood urea nitrogen level|MP:0008528,polycystic kidney|MP:0011065,abnormal kidney epithelial cell primary cilium morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0020382,increased kidney epithelial cell primary cilium length
MGI:6506869	Bpgm<m1Pgrs>	MP:0000245,abnormal erythropoiesis|MP:0000248,macrocytosis|MP:0000691,enlarged spleen|MP:0002608,increased hematocrit|MP:0002640,reticulocytosis|MP:0002872,polycythemia|MP:0003656,abnormal erythrocyte physiology|MP:0005387,immune system phenotype|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality|MP:0011178,increased erythroblast number|MP:0011236,increased blood oxygen capacity|MP:0011285,increased circulating erythropoietin level|MP:0011913,abnormal reticulocyte cell number|MP:0031276,abnormal stress erythropoiesis
MGI:4363424	Bpgm<tm1a(KOMP)Wtsi>	MP:0005553,increased circulating creatinine level
MGI:5548556	Bphl<tm1b(EUCOMM)Hmgu>	MP:0020420,abnormal freezing behavior
MGI:5510863	Bpifa1<m1Ingm>	MP:0001850,increased susceptibility to otitis media|MP:0001861,lung inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0005388,respiratory system phenotype|MP:0008560,increased tumor necrosis factor secretion|MP:0008654,increased interleukin-1 alpha secretion|MP:0008657,increased interleukin-1 beta secretion
MGI:6200793	Bpifa1<tm1.1Jpst>	MP:0020946,increased susceptibility to Orthomyxoviridae infection|MP:0031046,increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:6200800	Bpifa1<tm1.2Jpst>	MP:0020946,increased susceptibility to Orthomyxoviridae infection|MP:0031046,increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:3847456	Bpifa1<tm1(KOMP)Vlcg>	MP:0002412,increased susceptibility to bacterial infection
MGI:6148073	Bpifa2<em1(IMPC)Mbp>	MP:0001402,decreased locomotor activity|MP:0002631,abnormal epididymis morphology|MP:0004924,abnormal behavior|MP:0004931,enlarged epididymis|MP:0020870,decreased thigmotaxis
MGI:6361147	Bpifa3<em1Osb>	MP:0005389,reproductive system phenotype
MGI:4363898	Bpifa3<tm1a(KOMP)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:4880889	Bpifb1<tm1a(KOMP)Wtsi>	MP:0002133,abnormal respiratory system physiology|MP:0004179,transmission ratio distortion
MGI:5583068	Bpifb1<tm1b(KOMP)Wtsi>	MP:0005343,increased circulating aspartate transaminase level
MGI:3604377	Bpifb3<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:7447043	Bpifb6<em1(IMPC)J>	MP:0001258,decreased body length|MP:0002098,abnormal vibrissa morphology
MGI:6275202	Bpifc<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0005293,impaired glucose tolerance|MP:0005655,increased aggression
MGI:7623758	Bpi<tm1.1Buls>	MP:0001819,abnormal immune cell physiology|MP:0005015,increased T cell number|MP:0005387,immune system phenotype|MP:0008466,enlarged mesenteric lymph nodes|MP:0008537,increased susceptibility to induced colitis|MP:0008568,abnormal interleukin secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0008588,abnormal circulating interleukin level
MGI:5424987	BPL001	MP:0000198,decreased circulating phosphate level
MGI:5424988	BPL002	MP:0000198,decreased circulating phosphate level
MGI:5424989	BPL003	MP:0000198,decreased circulating phosphate level
MGI:5424990	BPL004	MP:0000198,decreased circulating phosphate level
MGI:5424991	BPL005	MP:0000198,decreased circulating phosphate level
MGI:5424993	BPL006	MP:0000198,decreased circulating phosphate level|MP:0001265,decreased body size
MGI:5424994	BPL007	MP:0000198,decreased circulating phosphate level|MP:0001265,decreased body size
MGI:5424995	BPL008	MP:0000198,decreased circulating phosphate level|MP:0001265,decreased body size
MGI:5424996	BPL009	MP:0000198,decreased circulating phosphate level
MGI:5424997	BPL010	MP:0000198,decreased circulating phosphate level
MGI:5424998	BPL011	MP:0000198,decreased circulating phosphate level
MGI:5424999	BPL012	MP:0000198,decreased circulating phosphate level
MGI:5425001	BPL013	MP:0000198,decreased circulating phosphate level
MGI:5425002	BPL014	MP:0000198,decreased circulating phosphate level
MGI:2159705	Bplpf1<C57BL/6J>	MP:0006050,pulmonary fibrosis
MGI:4818342	Bpnt1<tm1Yrk>	MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0001570,abnormal circulating enzyme level|MP:0002083,premature death|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003983,decreased cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005416,abnormal circulating protein level|MP:0005419,decreased circulating serum albumin level|MP:0010332,abnormal circulating apolipoprotein level|MP:0010333,abnormal circulating apolipoprotein E level|MP:0011738,anasarca|MP:0014341,abnormal hepatocyte mitochondrial morphology
MGI:3806990	Bpnt2<Gt(KST245)Byg>	MP:0000071,axial skeleton hypoplasia|MP:0000164,abnormal cartilage development|MP:0000435,shortened head|MP:0000547,short limbs|MP:0002081,perinatal lethality|MP:0002114,abnormal axial skeleton morphology|MP:0002427,disproportionate dwarf|MP:0002932,abnormal joint morphology|MP:0004624,abnormal thoracic cage morphology|MP:0005390,skeleton phenotype|MP:0006397,disorganized long bone epiphyseal plate|MP:0009890,cleft secondary palate|MP:0030245,round head|MP:0030837,abnormal knee joint morphology
MGI:3810994	Bpnt2<Gt(RST634)Byg>	MP:0000071,axial skeleton hypoplasia|MP:0000164,abnormal cartilage development|MP:0000445,short snout|MP:0000547,short limbs|MP:0001177,atelectasis|MP:0001954,respiratory distress|MP:0002133,abnormal respiratory system physiology|MP:0004321,short sternum|MP:0004340,short scapula|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004624,abnormal thoracic cage morphology|MP:0004672,short ribs|MP:0006397,disorganized long bone epiphyseal plate|MP:0011087,neonatal lethality, complete penetrance
MGI:6287461	Bpnt2<tm1.1Aros>	MP:0005508,abnormal skeleton morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:6287463	Bpnt2<tm1.2Aros>	MP:0000071,axial skeleton hypoplasia|MP:0000111,cleft palate|MP:0000547,short limbs|MP:0002764,short tibia|MP:0002765,short fibula|MP:0003109,short femur|MP:0004321,short sternum|MP:0004624,abnormal thoracic cage morphology|MP:0005508,abnormal skeleton morphology|MP:0009703,decreased birth body size|MP:0011089,perinatal lethality, complete penetrance
MGI:4363750	Bpnt2<tm1a(KOMP)Wtsi>	MP:0001260,increased body weight
MGI:2153901	Bpq1<C57BL/6J>	MP:0004217,salt-sensitive hypertension
MGI:2153903	Bpq2<C57BL/6J>	MP:0004217,salt-sensitive hypertension
MGI:2662863	Bpq31<CBA/CaJ>	MP:0000231,hypertension
MGI:2155724	Bpq3<C57BL/6J>	MP:0004217,salt-sensitive hypertension
MGI:2156034	Bpq4<C57BL/6J>	MP:0004217,salt-sensitive hypertension
MGI:2156438	Bpq5<C57BL/6J>	MP:0004217,salt-sensitive hypertension
MGI:2662867	Bpq7<BALB/cJ>	MP:0000231,hypertension
MGI:3041270	Bpq8<SWR/J>	MP:0002842,increased systemic arterial blood pressure
MGI:3041273	Bpq9<C3H/HeJ>	MP:0002842,increased systemic arterial blood pressure
MGI:3041272	Bpq9<SWR/J>	MP:0002842,increased systemic arterial blood pressure
MGI:6257533	Bptf<em1(IMPC)Bay>	MP:0001258,decreased body length|MP:0003795,abnormal bone structure|MP:0004609,vertebral fusion|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6364856	Bptf<em1Zfa>	MP:0002412,increased susceptibility to bacterial infection|MP:0003119,abnormal digestive system development|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0013893,decreased common lymphocyte progenitor cell number
MGI:3823037	Bptf<Gt(A012C04)Wrst>	MP:0001698,decreased embryo size|MP:0001705,abnormal proximal-distal axis patterning|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002230,abnormal primitive streak formation|MP:0002584,small ectoplacental cone|MP:0002836,abnormal chorion morphology|MP:0003085,abnormal egg cylinder morphology|MP:0003984,embryonic growth retardation|MP:0005221,abnormal rostral-caudal axis patterning|MP:0009593,absent chorion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011190,thick embryonic epiblast|MP:0012685,abnormal primitive streak elongation
MGI:3841299	Bptf<Gt(XG023)Byg>	MP:0000352,decreased cell proliferation|MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001730,embryonic growth arrest|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012159,absent anterior visceral endoderm|MP:0012161,absent distal visceral endoderm
MGI:3841297	Bptf<tm1.1Cwu>	MP:0000784,forebrain hypoplasia|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0001262,decreased body weight|MP:0002175,decreased brain weight|MP:0002948,abnormal neuron specification|MP:0003203,increased neuron apoptosis|MP:0004948,abnormal neuronal precursor proliferation|MP:0004981,decreased neuronal precursor cell number|MP:0005386,behavior/neurological phenotype|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0008918,microgliosis|MP:0010768,mortality/aging|MP:0011089,perinatal lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0012138,decreased forebrain size
MGI:3841298	Bptf<tm1.2Cwu>	MP:0001675,abnormal ectoderm development|MP:0001683,absent mesoderm|MP:0001685,abnormal endoderm development|MP:0001698,decreased embryo size|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:1856675	Br	MP:0000074,abnormal neurocranium morphology|MP:0000091,short premaxilla|MP:0000108,midline facial cleft|MP:0000120,malocclusion|MP:0000445,short snout|MP:0000521,abnormal kidney cortex morphology|MP:0000527,abnormal kidney development|MP:0000530,abnormal kidney vasculature morphology|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002116,abnormal craniofacial bone morphology|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0002989,small kidney|MP:0003446,renal hypoplasia|MP:0003675,kidney cyst|MP:0003760,decreased palatal length|MP:0003881,abnormal nephron morphology|MP:0004592,small mandible|MP:0004594,abnormal mandibular coronoid process morphology|MP:0004831,long incisors|MP:0004969,pale kidney|MP:0008528,polycystic kidney|MP:0009050,dilated proximal convoluted tubule|MP:0009655,abnormal secondary palate development|MP:0009857,absent kidney cortex|MP:0009886,failure of palatal shelf elevation|MP:0009888,palatal shelves fail to meet at midline|MP:0009889,persistence of medial edge epithelium during palatal shelf fusion|MP:0009890,cleft secondary palate|MP:0010029,abnormal basicranium morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0012085,midface hypoplasia|MP:0030258,small mandibular condyloid process|MP:0030283,small mandibular coronoid process|MP:0030284,short mandibular coronoid process|MP:0030458,abnormal tooth wear|MP:0031445,midline cleft upper lip|MP:0031462,decreased palatal shelf size
MGI:5527388	Braf<tm1.1Brd>	MP:0000488,abnormal intestinal epithelium morphology|MP:0000489,abnormal large intestine morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000496,abnormal small intestine morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0002038,increased carcinoma incidence|MP:0002404,increased intestinal adenoma incidence|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0008011,intestine polyps|MP:0008108,abnormal small intestinal villus morphology|MP:0010279,increased gastrointestinal tumor incidence|MP:0013957,increased small intestine length|MP:0013959,increased large intestine length|MP:0014081,branched small intestinal villi
MGI:4888303	Braf<tm1.1Eyc>	MP:0005386,behavior/neurological phenotype
MGI:3622462	Braf<tm1.1Sva>	MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0003203,increased neuron apoptosis|MP:0003984,embryonic growth retardation|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3711007	Braf<tm1.1Wds>	MP:0003203,increased neuron apoptosis|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3664469	Braf<tm1(ARAF)Urr>	MP:0000790,abnormal stratification in cerebral cortex|MP:0000805,abnormal visual cortex morphology|MP:0000859,abnormal somatosensory cortex morphology|MP:0000934,abnormal telencephalon development|MP:0001262,decreased body weight|MP:0001698,decreased embryo size|MP:0002083,premature death|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight|MP:0006042,increased apoptosis|MP:0006254,thin cerebral cortex|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4946645	Braf<tm1Bbd>	MP:0000074,abnormal neurocranium morphology|MP:0000107,abnormal frontal bone morphology|MP:0000109,abnormal parietal bone morphology|MP:0000274,enlarged heart|MP:0000275,heart hyperplasia|MP:0000358,abnormal cell morphology|MP:0000435,shortened head|MP:0000703,abnormal thymus morphology|MP:0000715,decreased thymocyte number|MP:0000947,convulsive seizures|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001272,increased metastatic potential|MP:0001304,cataract|MP:0001380,decreased male mating frequency|MP:0001399,hyperactivity|MP:0001783,decreased white adipose tissue amount|MP:0001790,abnormal immune system physiology|MP:0002048,increased lung adenoma incidence|MP:0002050,increased pheochromocytoma incidence|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002182,abnormal astrocyte morphology|MP:0003620,oliguria|MP:0003644,thymus atrophy|MP:0005426,tachypnea|MP:0005558,decreased creatinine clearance|MP:0005599,increased cardiac muscle contractility|MP:0005665,increased circulating noradrenaline level|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009322,increased splenocyte apoptosis|MP:0009386,abnormal dermal melanocyte morphology|MP:0009535,abnormal skin sebaceous gland morphology|MP:0009541,increased thymocyte apoptosis|MP:0010029,abnormal basicranium morphology|MP:0010288,increased gland tumor incidence|MP:0011086,postnatal lethality, incomplete penetrance|MP:0030245,round head|MP:0031391,increased locomotor activity
MGI:3612533	Braf<tm1Cpri>	MP:0000221,decreased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000333,decreased bone marrow cell number|MP:0000351,increased cell proliferation|MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001188,hyperpigmentation|MP:0001209,spontaneous skin ulceration|MP:0001212,skin lesions|MP:0001262,decreased body weight|MP:0001412,excessive scratching|MP:0002026,increased leukemia incidence|MP:0002048,increased lung adenoma incidence|MP:0002083,premature death|MP:0002184,abnormal innervation|MP:0002272,abnormal nervous system electrophysiology|MP:0002875,decreased erythrocyte cell number|MP:0003503,decreased activity of thyroid gland|MP:0004811,abnormal neuron physiology|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005386,behavior/neurological phenotype|MP:0005477,increased circulating thyroxine level|MP:0008014,increased lung tumor incidence|MP:0009746,enhanced behavioral response to xenobiotic|MP:0010275,increased melanoma incidence|MP:0010300,increased skin tumor incidence|MP:0010316,increased thyroid tumor incidence|MP:0010346,increased thyroid carcinoma incidence|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011703,increased fibroblast proliferation|MP:0014660,increased skin nevi incidence
MGI:3711771	Braf<tm1Mmcm>	MP:0000681,abnormal thyroid gland morphology|MP:0000702,enlarged lymph nodes|MP:0001212,skin lesions|MP:0001577,anemia|MP:0001846,increased inflammatory response|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001953,respiratory failure|MP:0002006,neoplasm|MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002500,granulomatous inflammation|MP:0002877,abnormal melanocyte morphology|MP:0003503,decreased activity of thyroid gland|MP:0004696,abnormal thyroid follicle morphology|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005355,enlarged thyroid gland|MP:0005478,decreased circulating thyroxine level|MP:0008014,increased lung tumor incidence|MP:0008126,increased dendritic cell number|MP:0009674,decreased birth weight|MP:0010346,increased thyroid carcinoma incidence|MP:0010945,lung epithelium hyperplasia|MP:0031058,hepatosplenomegaly|MP:0031066,cytokine storm
MGI:4458346	Braf<tm1Rima>	MP:0001186,pigmentation phenotype|MP:0002006,neoplasm
MGI:3620008	Braf<tm1Sva>	MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0002062,abnormal associative learning|MP:0002169,no abnormal phenotype detected
MGI:5902220	Braf<tm1Tumg>	MP:0000160,kyphosis|MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000274,enlarged heart|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000416,sparse hair|MP:0000420,ruffled hair|MP:0000460,mandible hypoplasia|MP:0000562,polydactyly|MP:0000601,small liver|MP:0001392,abnormal locomotor behavior|MP:0001575,cyanosis|MP:0001654,hepatic necrosis|MP:0001732,postnatal growth retardation|MP:0001785,edema|MP:0001914,hemorrhage|MP:0001926,female infertility|MP:0002016,ovary cyst|MP:0002083,premature death|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002450,abnormal lymph organ development|MP:0002757,decreased vertical activity|MP:0002833,increased heart weight|MP:0003057,abnormal epicardium morphology|MP:0003402,decreased liver weight|MP:0004057,thin myocardium compact layer|MP:0004111,abnormal coronary artery morphology|MP:0004225,patent cardiac foramen ovale|MP:0006128,pulmonary valve stenosis|MP:0008489,slow postnatal weight gain|MP:0009454,impaired contextual conditioning behavior|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010405,ostium secundum atrial septal defect|MP:0010600,enlarged pulmonary valve|MP:0010601,thick pulmonary valve|MP:0010602,abnormal pulmonary valve cusp morphology|MP:0010605,thick pulmonary valve cusps|MP:0010617,thick mitral valve cusps|MP:0010629,thick tricuspid valve|MP:0010909,pulmonary alveolar hemorrhage|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011862,decreased cranium length|MP:0011940,decreased food intake|MP:0012400,nail dystrophy|MP:0012401,long nails|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0030245,round head|MP:0031559,tricuspid valve hypertrophy|MP:0031563,pulmonary valve hypertrophy|MP:0031564,mitral valve hypertrophy
MGI:1857579	Braf<tm1Zim>	MP:0000272,abnormal aorta morphology|MP:0000432,abnormal head morphology|MP:0000934,abnormal telencephalon development|MP:0001614,abnormal blood vessel morphology|MP:0001633,poor circulation|MP:0001648,abnormal apoptosis|MP:0001914,hemorrhage|MP:0001917,intraventricular hemorrhage|MP:0002882,abnormal neuron morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0004783,abnormal cardinal vein morphology|MP:0005244,hemopericardium|MP:0005333,decreased heart rate|MP:0006055,abnormal vascular endothelial cell morphology|MP:0006056,increased vascular endothelial cell number|MP:0008817,hematoma|MP:0009429,decreased embryo weight|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4888305	Braf<tm2.1Eyc>	MP:0005386,behavior/neurological phenotype|MP:0014367,impaired long-term object recognition memory
MGI:5512688	Braf<tm2.1Urr>	MP:0000849,abnormal cerebellum morphology|MP:0000851,cerebellum hypoplasia|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000889,abnormal cerebellar molecular layer|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001525,impaired balance|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002175,decreased brain weight|MP:0005655,increased aggression|MP:0008285,abnormal hippocampus granule cell layer|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0009957,abnormal cerebellum vermis lobule morphology|MP:0009988,abnormal cerebellum vermis lobule I morphology|MP:0009989,abnormal cerebellum vermis lobule II morphology|MP:0009990,abnormal cerebellum vermis lobule III morphology|MP:0009993,abnormal cerebellum vermis lobule V morphology|MP:0009995,abnormal cerebellum vermis lobule VII morphology|MP:0009997,abnormal cerebellum vermis lobule X morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011827,impaired neuron differentiation|MP:0020393,increased neuronal precursor proliferation
MGI:5512689	Braf<tm2.2Urr>	MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0004259,small placenta|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5440045	Braf<tm2Cpri>	MP:0000274,enlarged heart|MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0001255,decreased body height|MP:0001262,decreased body weight|MP:0001304,cataract|MP:0001625,cardiac hypertrophy|MP:0002051,increased skin papilloma incidence|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0002404,increased intestinal adenoma incidence|MP:0002953,thick ventricular wall|MP:0003076,increased susceptibility to ischemic brain injury|MP:0003743,abnormal facial morphology|MP:0004564,increased myocardial fiber size|MP:0004831,long incisors|MP:0004952,increased spleen weight|MP:0005384,cellular phenotype|MP:0005388,respiratory system phenotype|MP:0005577,uterus prolapse|MP:0008011,intestine polyps|MP:0008256,abnormal myometrium morphology|MP:0010724,thick interventricular septum
MGI:5512687	Braf<tm2Urr>	MP:0000849,abnormal cerebellum morphology|MP:0000851,cerebellum hypoplasia|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000889,abnormal cerebellar molecular layer|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001525,impaired balance|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002175,decreased brain weight|MP:0004948,abnormal neuronal precursor proliferation|MP:0005655,increased aggression|MP:0008285,abnormal hippocampus granule cell layer|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0009957,abnormal cerebellum vermis lobule morphology|MP:0009988,abnormal cerebellum vermis lobule I morphology|MP:0009989,abnormal cerebellum vermis lobule II morphology|MP:0009990,abnormal cerebellum vermis lobule III morphology|MP:0009993,abnormal cerebellum vermis lobule V morphology|MP:0009995,abnormal cerebellum vermis lobule VII morphology|MP:0009997,abnormal cerebellum vermis lobule X morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011827,impaired neuron differentiation
MGI:6276845	Brap<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001614,abnormal blood vessel morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0002339,abnormal lymph node morphology|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation|MP:0020421,increased freezing behavior
MGI:5515812	Brap<tm1.1Yfng>	MP:0004046,abnormal mitosis|MP:0005378,growth/size/body region phenotype|MP:0006207,embryonic lethality during organogenesis
MGI:7425545	Brat1<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3762184	Brca1<tm1.1Brn>	MP:0011091,prenatal lethality, complete penetrance
MGI:5307254	Brca1<tm1.1Jjon>	MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3706167	Brca1<tm1Aash>	MP:0000621,increased salivary adenocarcinoma incidence|MP:0002169,no abnormal phenotype detected|MP:0010299,increased mammary gland tumor incidence
MGI:1930613	Brca1<tm1Arge>	MP:0001683,absent mesoderm|MP:0001710,absent amniotic folds|MP:0002085,abnormal embryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0003085,abnormal egg cylinder morphology|MP:0003984,embryonic growth retardation|MP:0009687,empty decidua capsularis|MP:0011092,embryonic lethality, complete penetrance
MGI:1857931	Brca1<tm1Bhk>	MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001262,decreased body weight|MP:0001698,decreased embryo size|MP:0002169,no abnormal phenotype detected|MP:0003054,spina bifida|MP:0008008,early cellular replicative senescence|MP:0010174,decreased mammary gland epithelial cell proliferation|MP:0010299,increased mammary gland tumor incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3696057	Brca1<tm1Brn>	MP:0000313,abnormal cell death|MP:0000352,decreased cell proliferation|MP:0001126,abnormal ovary morphology|MP:0002006,neoplasm
MGI:1930612	Brca1<tm1Cxd>	MP:0001684,abnormal axial mesoderm morphology|MP:0001698,decreased embryo size|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002085,abnormal embryonic tissue morphology|MP:0002230,abnormal primitive streak formation|MP:0004023,abnormal chromosome number|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0014764,impaired double-strand DNA break repair
MGI:1858108	Brca1<tm1Mak>	MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001698,decreased embryo size|MP:0001714,absent trophoblast giant cells|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0002582,disorganized extraembryonic tissue|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0003984,embryonic growth retardation|MP:0005031,abnormal trophoblast layer morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011187,abnormal parietal endoderm morphology
MGI:2178447	Brca1<tm1Rfo>	MP:0000267,abnormal heart development|MP:0001689,incomplete somite formation|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0003401,enlarged tail bud|MP:0003984,embryonic growth retardation|MP:0006042,increased apoptosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3790741	Brca1<tm1Thl>	MP:0001883,increased mammary adenocarcinoma incidence|MP:0002169,no abnormal phenotype detected
MGI:1858107	Brca1<tm1Whl>	MP:0000352,decreased cell proliferation|MP:0001683,absent mesoderm|MP:0001694,absent egg cylinders|MP:0001698,decreased embryo size|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0003984,embryonic growth retardation|MP:0003988,disorganized embryonic tissue|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2182470	Brca1<tm2.1Cxd>	MP:0000313,abnormal cell death|MP:0000914,exencephaly|MP:0001698,decreased embryo size|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0003091,abnormal cell migration|MP:0003632,abnormal nervous system morphology|MP:0006042,increased apoptosis|MP:0008008,early cellular replicative senescence|MP:0008866,chromosomal instability|MP:0011091,prenatal lethality, complete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0014699,increased fibroblast adhesion|MP:0030943,abnormal centrosome morphology
MGI:2177209	Brca1<tm2Arge>	MP:0000585,kinked tail|MP:0001155,arrest of spermatogenesis|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0002020,increased tumor incidence|MP:0002095,abnormal skin pigmentation|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010299,increased mammary gland tumor incidence|MP:0011101,prenatal lethality, incomplete penetrance|MP:0014764,impaired double-strand DNA break repair
MGI:1931238	Brca1<tm2Cxd>	MP:0001884,mammary gland alveolar hyperplasia|MP:0002016,ovary cyst|MP:0002169,no abnormal phenotype detected|MP:0003587,ureter obstruction|MP:0003675,kidney cyst|MP:0004028,chromosome breakage|MP:0009503,abnormal mammary gland duct morphology|MP:0010173,increased mammary gland epithelial cell proliferation|MP:0010299,increased mammary gland tumor incidence
MGI:2429692	Brca1<tm2Mak>	MP:0000313,abnormal cell death|MP:0000715,decreased thymocyte number|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002020,increased tumor incidence|MP:0002722,abnormal immune system organ morphology|MP:0004045,abnormal cell cycle checkpoint function|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0006387,abnormal T cell number|MP:0008083,decreased single-positive T cell number|MP:0010299,increased mammary gland tumor incidence
MGI:5494434	Brca1<tm2Rjbr>	MP:0001925,male infertility|MP:0002020,increased tumor incidence|MP:0008008,early cellular replicative senescence|MP:0010768,mortality/aging|MP:0011704,decreased fibroblast proliferation|MP:0030943,abnormal centrosome morphology
MGI:5494435	Brca1<tm3.1Rjbr>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0002006,neoplasm|MP:0005159,azoospermia|MP:0005384,cellular phenotype|MP:0010768,mortality/aging
MGI:3513253	Brca1<tm3Cxd>	MP:0000400,abnormal awl hair morphology|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001126,abnormal ovary morphology|MP:0001260,increased body weight|MP:0002020,increased tumor incidence|MP:0002676,uterus hyperplasia|MP:0003077,abnormal cell cycle|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0010264,increased hepatoma incidence|MP:0010299,increased mammary gland tumor incidence|MP:0010343,increased lipoma incidence|MP:0012431,increased lymphoma incidence
MGI:5494436	Brca1<tm4.1Rjbr>	MP:0005389,reproductive system phenotype
MGI:3665173	Brca1<tm4Cxd>	MP:0000627,abnormal mammary gland morphology|MP:0000630,mammary gland hyperplasia|MP:0001138,abnormal uterine cervix squamous epithelium morphology|MP:0001885,mammary gland duct hyperplasia|MP:0003077,abnormal cell cycle|MP:0009092,endometrium hyperplasia|MP:0009503,abnormal mammary gland duct morphology|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009508,increased mammary gland ductal carcinoma incidence|MP:0010299,increased mammary gland tumor incidence|MP:0010768,mortality/aging|MP:0030943,abnormal centrosome morphology
MGI:4418211	Brca1<tm5.1Cxd>	MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000628,abnormal mammary gland development|MP:0000630,mammary gland hyperplasia|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001194,dermatitis|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001658,increased mortality induced by gamma-irradiation|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002024,increased T cell derived lymphoma incidence|MP:0002073,abnormal hair growth|MP:0002075,abnormal coat/hair pigmentation|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0008019,increased liver tumor incidence|MP:0008108,abnormal small intestinal villus morphology|MP:0008770,decreased survivor rate|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009505,abnormal mammary gland lobule morphology|MP:0010173,increased mammary gland epithelial cell proliferation|MP:0010299,increased mammary gland tumor incidence|MP:0012431,increased lymphoma incidence|MP:0014082,decreased small intestinal villus height|MP:0014126,increased mammary gland apoptosis
MGI:2156644	Brca2<tm1.1Brn>	MP:0001672,abnormal embryo development|MP:0003984,embryonic growth retardation|MP:0011092,embryonic lethality, complete penetrance
MGI:5438023	Brca2<tm1.1Sks>	MP:0005389,reproductive system phenotype
MGI:1930615	Brca2<tm1Arge>	MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0002006,neoplasm|MP:0002086,abnormal extraembryonic tissue morphology|MP:0004556,enlarged allantois|MP:0005029,abnormal amnion morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011197,abnormal proamniotic cavity morphology
MGI:2177233	Brca2<tm1Brd>	MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0011091,prenatal lethality, complete penetrance
MGI:2156556	Brca2<tm1Brn>	MP:0000659,prostate gland hyperplasia|MP:0002169,no abnormal phenotype detected|MP:0003607,abnormal prostate gland physiology|MP:0003631,nervous system phenotype|MP:0004028,chromosome breakage|MP:0009219,increased prostate intraepithelial neoplasia incidence
MGI:1930616	Brca2<tm1Cam>	MP:0001925,male infertility|MP:0001926,female infertility|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0002114,abnormal axial skeleton morphology|MP:0003984,embryonic growth retardation|MP:0004046,abnormal mitosis|MP:0004806,absent germ cells|MP:0004955,increased thymus weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:2177226	Brca2<tm1Cbl>	MP:0000150,abnormal rib morphology|MP:0000157,abnormal sternum morphology|MP:0000585,kinked tail|MP:0001127,small ovary|MP:0001147,small testis|MP:0001216,abnormal epidermal layer morphology|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001241,absent epidermis stratum corneum|MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0002024,increased T cell derived lymphoma incidence|MP:0002060,abnormal skin morphology|MP:0002083,premature death|MP:0002777,absent ovarian follicles|MP:0004201,fetal growth retardation|MP:0005159,azoospermia|MP:0009431,decreased fetal weight|MP:0009674,decreased birth weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0013236,ovary degeneration|MP:0014764,impaired double-strand DNA break repair
MGI:2653913	Brca2<tm1Hst>	MP:0002038,increased carcinoma incidence|MP:0002083,premature death|MP:0005044,sepsis|MP:0010308,decreased tumor latency|MP:0012431,increased lymphoma incidence
MGI:2448890	Brca2<tm1Kamc>	MP:0000333,decreased bone marrow cell number|MP:0000662,abnormal branching of the mammary ductal tree|MP:0000694,spleen hypoplasia|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001606,impaired hematopoiesis|MP:0002006,neoplasm|MP:0002020,increased tumor incidence|MP:0002396,abnormal hematopoietic system morphology/development|MP:0003702,abnormal chromosome morphology|MP:0003992,increased mortality induced by ionizing radiation|MP:0005389,reproductive system phenotype|MP:0008058,abnormal DNA repair|MP:0008770,decreased survivor rate|MP:0008813,decreased common myeloid progenitor cell number|MP:0008943,increased sensitivity to induced cell death|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:2387337	Brca2<tm1Mbn>	MP:0000929,open neural tube|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003984,embryonic growth retardation|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0009078,adrenal gland hyperplasia|MP:0010299,increased mammary gland tumor incidence|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3055613	Brca2<tm1Mhun>	MP:0002052,decreased tumor incidence|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005621,abnormal cell physiology|MP:0006042,increased apoptosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7278767	Brca2<tm2.1Sks>	MP:0001698,decreased embryo size|MP:0002006,neoplasm|MP:0005376,homeostasis/metabolism phenotype|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2177211	Brca2<tm2Arge>	MP:0001883,increased mammary adenocarcinoma incidence
MGI:2653914	Brca2<tm2Hst>	MP:0011092,embryonic lethality, complete penetrance
MGI:2429691	Brca2<tm2Mak>	MP:0002169,no abnormal phenotype detected
MGI:6403852	Brcc3dc<em1(IMPC)J>	MP:0005293,impaired glucose tolerance
MGI:7545514	Brcc3<em1Bcgen>	MP:0001876,decreased inflammatory response|MP:0002451,abnormal macrophage physiology|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008656,abnormal interleukin-1 beta secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0010768,mortality/aging
MGI:6149150	Brcc3<em1(IMPC)Wtsi>	MP:0005505,thrombocytosis
MGI:5296490	Brd1<tm1Hko>	MP:0000245,abnormal erythropoiesis|MP:0000601,small liver|MP:0000929,open neural tube|MP:0001303,abnormal lens morphology|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0003396,abnormal embryonic hematopoiesis|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004229,abnormal embryonic erythropoiesis|MP:0004269,abnormal optic cup morphology|MP:0006042,increased apoptosis|MP:0008973,decreased erythroid progenitor cell number|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011179,decreased erythroblast number|MP:0011246,abnormal fetal liver hematopoietic progenitor cell morphology|MP:0012243,decreased hepatoblast number
MGI:6147548	Brd2<em1(IMPC)Wtsi>	MP:0000141,abnormal vertebral body morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000161,scoliosis|MP:0000274,enlarged heart|MP:0000282,abnormal interatrial septum morphology|MP:0000284,double outlet right ventricle|MP:0000480,increased rib number|MP:0000602,dilated liver sinusoidal space|MP:0000632,abnormal pineal gland morphology|MP:0000706,small thymus|MP:0000783,abnormal forebrain morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000914,exencephaly|MP:0001014,absent superior cervical ganglion|MP:0001100,abnormal vagus ganglion morphology|MP:0001914,hemorrhage|MP:0002239,abnormal nasal septum morphology|MP:0002633,persistent truncus arteriosus|MP:0002746,abnormal semilunar valve morphology|MP:0002747,abnormal aortic valve morphology|MP:0002748,abnormal pulmonary valve morphology|MP:0002951,small thyroid gland|MP:0002989,small kidney|MP:0003078,aphakia|MP:0003345,decreased rib number|MP:0003387,aorta coarctation|MP:0004057,thin myocardium compact layer|MP:0004110,transposition of great arteries|MP:0004160,retroesophageal right subclavian artery|MP:0004163,abnormal adenohypophysis morphology|MP:0004201,fetal growth retardation|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0004463,basisphenoid bone foramen|MP:0004571,absent vagus nerve|MP:0004599,abnormal vertebral arch morphology|MP:0004603,absent vertebral arch|MP:0004613,fusion of vertebral arches|MP:0004738,abnormal auditory brainstem response|MP:0005084,abnormal gallbladder morphology|MP:0005105,abnormal middle ear ossicle morphology|MP:0005236,abnormal olfactory nerve morphology|MP:0005561,increased mean corpuscular hemoglobin|MP:0006135,artery stenosis|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008923,thoracoschisis|MP:0009770,abnormal optic chiasm morphology|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010496,abnormal pectinate muscle morphology|MP:0010572,persistent right dorsal aorta|MP:0010589,common truncal valve|MP:0010853,abnormal lung position or orientation|MP:0011100,preweaning lethality, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0011659,interrupted aortic arch, type b|MP:0011683,dual inferior vena cava|MP:0012548,myelocele|MP:0012729,abnormal common carotid artery morphology|MP:0013809,absent pectinate muscle|MP:0013814,abnormal hepatic portal vein connection|MP:0013836,abnormal hypoglossal nerve topology|MP:0013847,retropleural edema|MP:0013848,subcutaneous edema|MP:0013852,abnormal Mullerian duct topology|MP:0013873,abnormal ductus venosus morphology|MP:0013874,abnormal ductus venosus topology|MP:0013879,duplication of ductus venosus|MP:0013913,absent costovertebral joint|MP:0013929,absent eye muscles|MP:0013936,abnormal thymus topology|MP:0013969,reduced sympathetic cervical ganglion size|MP:0013970,absent connection between subcutaneous lymph vessels and lymph sac|MP:0013971,blood in lymph vessels|MP:0013985,abnormal umbilical vein topology|MP:0013995,abnormal external carotid artery origin|MP:0014001,abnormal vertebral artery topology|MP:0014021,heterochrony|MP:0020483,abnormal brain artery topology|MP:0020500,persistent trigeminal artery|MP:0020502,abnormal physiological umbilical hernia morphology
MGI:3840071	Brd2<Gt(RRE050)Byg>	MP:0000313,abnormal cell death|MP:0000352,decreased cell proliferation|MP:0001697,abnormal embryo size|MP:0001698,decreased embryo size|MP:0003077,abnormal cell cycle|MP:0003720,abnormal neural tube closure|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:4340588	Brd2<Gt(RRT234)Byg>	MP:0000003,abnormal adipose tissue morphology|MP:0001261,obese|MP:0001431,abnormal eating behavior|MP:0001552,increased circulating triglyceride level|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002712,increased circulating glucagon level|MP:0003645,increased pancreatic beta cell number|MP:0003949,abnormal circulating lipid level|MP:0004129,abnormal respiratory quotient|MP:0005178,increased circulating cholesterol level|MP:0005215,abnormal pancreatic islet morphology|MP:0005292,improved glucose tolerance|MP:0005491,pancreatic islet hyperplasia|MP:0005560,decreased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0008553,increased circulating tumor necrosis factor level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008965,increased basal metabolism|MP:0009167,increased pancreatic islet number|MP:0009288,increased epididymal fat pad weight|MP:0009294,increased interscapular fat pad weight|MP:0009642,abnormal blood homeostasis|MP:0010024,increased total body fat amount|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0030969,increased circulating adiponectin level
MGI:6388678	Brd3<em1(IMPC)J>	MP:0002075,abnormal coat/hair pigmentation|MP:0010052,increased grip strength|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2674141	Brd4<Gt(pGT1.8TM)ST132Nimr>	MP:0000088,short mandible|MP:0000091,short premaxilla|MP:0000607,abnormal hepatocyte morphology|MP:0001156,abnormal spermatogenesis|MP:0001219,thick epidermis|MP:0001246,mixed cellular infiltration to dermis|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001732,postnatal growth retardation|MP:0002116,abnormal craniofacial bone morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0002769,abnormal vas deferens morphology|MP:0003984,embryonic growth retardation|MP:0004471,short nasal bone|MP:0004933,abnormal epididymis epithelium morphology|MP:0004965,inner cell mass degeneration|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance
MGI:6355946	Brd4<M1Rvt>	MP:0003197,nephrocalcinosis|MP:0005376,homeostasis/metabolism phenotype
MGI:5776368	Brd4<tm1b(EUCOMM)Wtsi>	MP:0000438,abnormal cranium morphology|MP:0002764,short tibia|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011959,abnormal eye posterior chamber depth|MP:0011965,decreased total retina thickness|MP:0013292,embryonic lethality prior to organogenesis
MGI:5755484	Brd7<tm1.2Ligy>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002686,globozoospermia|MP:0002801,abnormal long-term object recognition memory|MP:0003631,nervous system phenotype|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0006380,abnormal spermatid morphology|MP:0008143,abnormal dendrite morphology|MP:0008839,absent acrosome|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0012307,impaired spatial learning|MP:0014052,increased male germ cell apoptosis|MP:0014365,impaired short-term object recognition memory
MGI:4842893	Brd7<tm2a(EUCOMM)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000367,abnormal coat/ hair morphology|MP:0000745,tremors|MP:0001539,decreased caudal vertebrae number|MP:0001614,abnormal blood vessel morphology|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0004924,abnormal behavior|MP:0008821,increased blood uric acid level|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012531,delayed limb development
MGI:4433628	Brd8<tm1a(EUCOMM)Wtsi>	MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance
MGI:6156554	Brd9<em1(IMPC)Tcp>	MP:0000219,increased neutrophil cell number|MP:0001556,increased circulating HDL cholesterol level|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002637,small uterus|MP:0002768,small adrenal glands|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder
MGI:4455954	Brdt<tm1a(EUCOMM)Wtsi>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001938,delayed sexual maturation|MP:0002216,abnormal seminiferous tubule morphology|MP:0002780,decreased circulating testosterone level|MP:0004647,decreased lumbar vertebrae number|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0006379,abnormal spermatocyte morphology|MP:0006380,abnormal spermatid morphology|MP:0008261,arrest of male meiosis|MP:0010101,increased sacral vertebrae number|MP:0013330,abnormal male accessory sex gland morphology|MP:0014052,increased male germ cell apoptosis|MP:0014634,decreased round spermatid number
MGI:3765973	Brdt<tm1Djw>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0031354,abnormal acrosome assembly
MGI:6403352	Brf1<tm1.1Arte>	MP:0003695,delayed blastocyst hatching from the zona pellucida|MP:0011092,embryonic lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012129,failure of blastocyst formation
MGI:6403351	Brf1<tm1Arte>	MP:0000601,small liver|MP:0001262,decreased body weight|MP:0001654,hepatic necrosis|MP:0001860,liver inflammation|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003887,increased hepatocyte apoptosis|MP:0005344,increased circulating bilirubin level|MP:0005379,endocrine/exocrine gland phenotype|MP:0013272,abnormal translation
MGI:7573112	Bri3bp<em1(IMPC)Mbp>	MP:0002092,abnormal eye morphology
MGI:6257820	Bri3<em1(IMPC)Bay>	MP:0001314,cornea opacity
MGI:5604542	Brinp1<tm1.1Pib>	MP:0000807,abnormal hippocampus morphology|MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001399,hyperactivity|MP:0001408,stereotypic behavior|MP:0001442,decreased grooming behavior|MP:0001529,abnormal vocalization|MP:0001732,postnatal growth retardation|MP:0002574,increased vertical activity|MP:0004101,abnormal brain interneuron morphology|MP:0005386,behavior/neurological phenotype|MP:0008431,abnormal short-term spatial reference memory|MP:0008489,slow postnatal weight gain|MP:0008547,abnormal neocortex morphology|MP:0009546,absent gastric milk in neonates|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013189,abnormal exploration in a new environment|MP:0031391,increased locomotor activity
MGI:5698819	Brinp1<tm1Imts>	MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0004101,abnormal brain interneuron morphology|MP:0004980,increased neuronal precursor cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008428,abnormal spatial working memory|MP:0011827,impaired neuron differentiation|MP:0030981,abnormal dentate gyrus subgranular zone morphology|MP:0031391,increased locomotor activity
MGI:6286377	Brinp2<em1(IMPC)Wtsi>	MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001529,abnormal vocalization|MP:0005333,decreased heart rate
MGI:7425546	Brinp3<em1(IMPC)Ccpcz>	MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000162,lordosis|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000538,abnormal urinary bladder morphology|MP:0001262,decreased body weight|MP:0002135,abnormal kidney morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004924,abnormal behavior
MGI:5823287	Brip1<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001304,cataract|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0002075,abnormal coat/hair pigmentation|MP:0002590,increased mean corpuscular volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0010053,decreased grip strength|MP:0012000,abnormal limb position
MGI:4129733	Brip1<Gt(RRI409)Byg>	MP:0000352,decreased cell proliferation|MP:0001147,small testis|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0001940,testis hypoplasia|MP:0002016,ovary cyst|MP:0002020,increased tumor incidence|MP:0002041,increased pituitary adenoma incidence|MP:0002216,abnormal seminiferous tubule morphology|MP:0002628,hepatic steatosis|MP:0002685,abnormal spermatogonia proliferation|MP:0002687,oligozoospermia|MP:0002776,increased Sertoli cell number|MP:0003205,testicular atrophy|MP:0003582,abnormal ovary development|MP:0003702,abnormal chromosome morphology|MP:0004030,induced chromosome breakage|MP:0004852,decreased testis weight|MP:0005621,abnormal cell physiology|MP:0008008,early cellular replicative senescence|MP:0008057,abnormal DNA replication|MP:0008392,decreased primordial germ cell number|MP:0008866,chromosomal instability|MP:0008966,abnormal chiasmata formation|MP:0009092,endometrium hyperplasia|MP:0009308,increased adenocarcinoma incidence|MP:0010383,increased adenoma incidence|MP:0010948,abnormal double-strand DNA break repair|MP:0011125,decreased primary ovarian follicle number|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0011751,abnormal X-Y chromosome synapsis during male meiosis|MP:0012431,increased lymphoma incidence|MP:0013538,increased Harderian gland adenoma incidence|MP:0014040,increased cellular sensitivity to DNA damaging agent induced cell death|MP:0014617,decreased spermatogonia number|MP:0030934,decreased primordial germ cell proliferation|MP:0030935,increased primordial germ cell apoptosis
MGI:7524674	Brix1<tm1b(KOMP)Mbp>	MP:0001488,increased startle reflex|MP:0002606,increased basophil cell number|MP:0005011,increased eosinophil cell number
MGI:7573113	Brk1<em1(IMPC)Mbp>	MP:0011100,preweaning lethality, complete penetrance
MGI:3872157	Brk1<Gt(DC0002)Wtsi>	MP:0001728,failure of embryo implantation|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0003984,embryonic growth retardation|MP:0003988,disorganized embryonic tissue|MP:0004957,abnormal blastocyst morphology|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0020849,abnormal actin cytoskeleton morphology
MGI:7281853	Brme1<em1Amp>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0008871,abnormal ovarian follicle number|MP:0009451,abnormal chromosomal synapsis
MGI:6456788	Brme1<em1Hirok>	MP:0001147,small testis|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0008966,abnormal chiasmata formation|MP:0009451,abnormal chromosomal synapsis|MP:0010948,abnormal double-strand DNA break repair|MP:0011751,abnormal X-Y chromosome synapsis during male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:6273508	Brme1<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior
MGI:6460292	Brme1<em1Zhal>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0006379,abnormal spermatocyte morphology|MP:0010948,abnormal double-strand DNA break repair|MP:0014052,increased male germ cell apoptosis|MP:0014633,decreased spermatid number|MP:0014634,decreased round spermatid number|MP:0014636,decreased elongated spermatid number
MGI:7281854	Brme1<em2Amp>	MP:0005389,reproductive system phenotype
MGI:3694935	Brml1<C57BL/6J>	MP:0000062,increased bone mineral density|MP:0013615,increased volumetric bone mineral density
MGI:3694938	Brml2<C3H/HeJ>	MP:0004148,increased compact bone thickness|MP:0013615,increased volumetric bone mineral density
MGI:3694943	Brml3<C57BL/6J>	MP:0003795,abnormal bone structure
MGI:5927711	Brms1l<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0003795,abnormal bone structure|MP:0005655,increased aggression|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5529063	Brms1<tm1.1(KOMP)Vlcg>	MP:0001488,increased startle reflex|MP:0003019,increased circulating chloride level|MP:0005633,increased circulating sodium level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3778080	Brnwq<129S1/SvImJ>	MP:0002175,decreased brain weight
MGI:3708460	bro	MP:0001489,decreased startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4433631	Brpf1<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000220,increased monocyte cell number|MP:0001262,decreased body weight|MP:0002169,no abnormal phenotype detected|MP:0005018,decreased T cell number|MP:0011092,embryonic lethality, complete penetrance
MGI:5705128	Brpf1<tm1b(EUCOMM)Wtsi>	MP:0001730,embryonic growth arrest|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014134,abnormal embryo morphology
MGI:5705131	Brpf1<tm1c(EUCOMM)Wtsi>	MP:0000780,abnormal corpus callosum morphology|MP:0000781,decreased corpus callosum size|MP:0000807,abnormal hippocampus morphology|MP:0000808,abnormal hippocampus development|MP:0000812,abnormal dentate gyrus morphology|MP:0001265,decreased body size|MP:0001447,abnormal nest building behavior|MP:0001513,limb grasping|MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0003631,nervous system phenotype|MP:0003648,abnormal radial glial cell morphology|MP:0004045,abnormal cell cycle checkpoint function|MP:0004924,abnormal behavior|MP:0004981,decreased neuronal precursor cell number|MP:0005621,abnormal cell physiology|MP:0008262,abnormal hippocampus region morphology|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008441,thin cortical plate|MP:0008547,abnormal neocortex morphology|MP:0009939,abnormal hippocampus neuron morphology|MP:0010865,prenatal growth retardation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011940,decreased food intake|MP:0012203,abnormal neuronal stem cell morphology|MP:0012460,decreased dentate gyrus size|MP:0014744,abnormal hippocampal mossy fiber suprapyramidal bundle morphology|MP:0020069,decreased neocortex size|MP:0020388,decreased radial glial cell number|MP:0020394,decreased neuronal precursor proliferation|MP:0020536,increased subiculum size|MP:0030956,abnormal neuronal precursor cell migration
MGI:5705132	Brpf1<tm1d(EUCOMM)Wtsi>	MP:0005621,abnormal cell physiology|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4432544	Brpf3<tm1a(EUCOMM)Wtsi>	MP:0005560,decreased circulating glucose level|MP:0005628,decreased circulating potassium level
MGI:6159126	Brpf3<tm1b(EUCOMM)Wtsi>	MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:6159284	Brpf3<tm1d(EUCOMM)Wtsi>	MP:0005376,homeostasis/metabolism phenotype|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0010768,mortality/aging
MGI:2387858	Brs3<tm1Hoh>	MP:0000008,increased white adipose tissue amount|MP:0001261,obese|MP:0001433,polyphagia|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002842,increased systemic arterial blood pressure|MP:0005120,decreased circulating growth hormone level|MP:0005290,decreased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005669,increased circulating leptin level|MP:0011942,decreased fluid intake|MP:0014441,decreased response to leptin
MGI:2657217	Brs3<tm1Jfb>	MP:0000005,increased brown adipose tissue amount|MP:0000008,increased white adipose tissue amount|MP:0001260,increased body weight|MP:0002079,increased circulating insulin level|MP:0005375,adipose tissue phenotype|MP:0005449,abnormal food intake|MP:0005669,increased circulating leptin level|MP:0006319,abnormal epididymal fat pad morphology|MP:0011939,increased food intake
MGI:5429001	Brs3<tm1Lex>	MP:0005458,increased percent body fat/body weight
MGI:3575112	Brsk1<tm1Jrs>	MP:0002169,no abnormal phenotype detected
MGI:3575113	Brsk2<tm1Jrs>	MP:0002169,no abnormal phenotype detected
MGI:5524054	Brsk2<tm2.1Jrs>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0003631,nervous system phenotype|MP:0003651,abnormal axon extension|MP:0004297,abnormal proprioceptive neuron morphology|MP:0005156,bradykinesia|MP:0009546,absent gastric milk in neonates|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2448679	brwd	MP:0002075,abnormal coat/hair pigmentation
MGI:6156470	Brwd1<em1(IMPC)Tcp>	MP:0000689,abnormal spleen morphology|MP:0001147,small testis|MP:0001556,increased circulating HDL cholesterol level|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0005178,increased circulating cholesterol level
MGI:3795157	Brwd1<Gt(AW0417)Wtsi>	MP:0004901,decreased male germ cell number|MP:0005168,abnormal female meiosis|MP:0006362,abnormal male germ cell morphology
MGI:3512929	Brwd1<repro5>	MP:0000242,impaired fertilization|MP:0001125,abnormal oocyte morphology|MP:0001919,abnormal reproductive system physiology|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001932,abnormal spermiogenesis|MP:0002160,abnormal reproductive system morphology|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0005168,abnormal female meiosis|MP:0005578,teratozoospermia|MP:0006362,abnormal male germ cell morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009325,necrospermia|MP:0009831,abnormal sperm midpiece morphology
MGI:3867498	Brwd3<Gt(RHA090)Byg>	MP:0000433,microcephaly|MP:0003984,embryonic growth retardation|MP:0012062,small tail bud
MGI:3698801	Brwq1<CAST/EiJ>	MP:0002175,decreased brain weight
MGI:3691694	Brwt1<C57BL/6J>	MP:0002176,increased brain weight
MGI:3691696	Brwt2<C57BL/6J>	MP:0002176,increased brain weight
MGI:3691698	Brwt3<C57BL/6J>	MP:0002176,increased brain weight
MGI:3691700	Brwt4<C57BL/6J>	MP:0002176,increased brain weight
MGI:3051768	Bsbob2<SPRET/EiJ>	MP:0001260,increased body weight|MP:0001781,abnormal white adipose tissue amount|MP:0005458,increased percent body fat/body weight
MGI:3051776	Bsbob5<SPRET/EiJ>	MP:0005459,decreased percent body fat/body weight
MGI:3045762	Bsbob<SPRET/EiJ>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001783,decreased white adipose tissue amount|MP:0005334,abnormal fat pad morphology|MP:0005449,abnormal food intake|MP:0005450,abnormal energy expenditure|MP:0005459,decreased percent body fat/body weight|MP:0006319,abnormal epididymal fat pad morphology|MP:0009283,decreased gonadal fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0010025,decreased total body fat amount
MGI:2157859	Bsc1<C57BL/6J>	MP:0002176,increased brain weight|MP:0005238,increased brain size
MGI:5629937	Bscl2<tm1.1Gliu>	MP:0001146,abnormal testis morphology|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002079,increased circulating insulin level|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004777,abnormal phospholipid level|MP:0005178,increased circulating cholesterol level|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006362,abnormal male germ cell morphology|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0011174,lipodystrophy
MGI:5426998	Bscl2<tm1.1Lchan>	MP:0000274,enlarged heart|MP:0000496,abnormal small intestine morphology|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001433,polyphagia|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001780,decreased brown adipose tissue amount|MP:0001781,abnormal white adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002970,abnormal white adipose tissue morphology|MP:0003068,enlarged kidney|MP:0003442,decreased circulating glycerol level|MP:0003443,increased circulating glycerol level|MP:0003960,increased lean body mass|MP:0005331,insulin resistance|MP:0005334,abnormal fat pad morphology|MP:0005559,increased circulating glucose level|MP:0005560,decreased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0005670,abnormal white adipose tissue physiology|MP:0006319,abnormal epididymal fat pad morphology|MP:0008034,enhanced lipolysis|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009117,abnormal white fat cell morphology|MP:0009131,decreased white fat cell number|MP:0009133,decreased white fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0009295,decreased interscapular fat pad weight|MP:0009303,decreased renal fat pad weight|MP:0010025,decreased total body fat amount|MP:0010954,abnormal cellular respiration|MP:0010957,abnormal aerobic respiration|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011168,abnormal fat cell differentiation|MP:0013245,abnormal lipid metabolism|MP:0030968,decreased circulating adiponectin level
MGI:5014325	Bscl2<tm1.2Gliu>	MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001146,abnormal testis morphology|MP:0001156,abnormal spermatogenesis|MP:0001265,decreased body size|MP:0001552,increased circulating triglyceride level|MP:0001780,decreased brown adipose tissue amount|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002079,increased circulating insulin level|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004777,abnormal phospholipid level|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005370,liver/biliary system phenotype|MP:0005533,increased body temperature|MP:0005559,increased circulating glucose level|MP:0005578,teratozoospermia|MP:0005668,decreased circulating leptin level|MP:0006319,abnormal epididymal fat pad morphology|MP:0006362,abnormal male germ cell morphology|MP:0006380,abnormal spermatid morphology|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009283,decreased gonadal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0011156,abnormal hypodermis fat layer morphology|MP:0011169,abnormal white fat cell differentation|MP:0011174,lipodystrophy|MP:0014634,decreased round spermatid number|MP:0030968,decreased circulating adiponectin level|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis
MGI:6120702	Bscl2<tm1b(EUCOMM)Hmgu>	MP:0000194,increased circulating calcium level|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0001258,decreased body length|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001556,increased circulating HDL cholesterol level|MP:0001566,increased circulating phosphate level|MP:0002590,increased mean corpuscular volume|MP:0002764,short tibia|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0002965,increased circulating serum albumin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005559,increased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005568,increased circulating total protein level|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010379,decreased respiratory quotient|MP:0011939,increased food intake|MP:0011941,increased fluid intake|MP:0011962,increased cornea thickness|MP:0011965,decreased total retina thickness|MP:0012362,increased large unstained cell number|MP:0013279,increased fasting circulating glucose level
MGI:6159699	Bscl2<tm1c(EUCOMM)Hmgu>	MP:0000187,abnormal triglyceride level|MP:0001402,decreased locomotor activity|MP:0001783,decreased white adipose tissue amount|MP:0002970,abnormal white adipose tissue morphology|MP:0002971,abnormal brown adipose tissue morphology|MP:0003960,increased lean body mass|MP:0005376,homeostasis/metabolism phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009355,increased liver triglyceride level|MP:0010378,increased respiratory quotient|MP:0010379,decreased respiratory quotient|MP:0011174,lipodystrophy|MP:0014143,decreased body fat mass|MP:0014169,decreased brown adipose tissue mass|MP:0020521,browned white adipose tissue morphology|MP:0030880,abnormal infrapatellar fat pad morphology|MP:0030968,decreased circulating adiponectin level|MP:0031008,decreased bone marrow adipose tissue amount
MGI:5519934	Bscl2<tm1Geno>	MP:0000005,increased brown adipose tissue amount|MP:0000477,abnormal intestine morphology|MP:0000599,enlarged liver|MP:0001262,decreased body weight|MP:0001556,increased circulating HDL cholesterol level|MP:0001559,hyperglycemia|MP:0001925,male infertility|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0002631,abnormal epididymis morphology|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002981,increased liver weight|MP:0004890,decreased energy expenditure|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005559,increased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0008034,enhanced lipolysis|MP:0008964,decreased carbon dioxide production|MP:0009283,decreased gonadal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009295,decreased interscapular fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0009355,increased liver triglyceride level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011167,abnormal adipose tissue development|MP:0011174,lipodystrophy|MP:0011939,increased food intake|MP:0030968,decreased circulating adiponectin level
MGI:8250889	Bsg<em1(BSG)Dfl>	MP:0020949,increased susceptibility to Coronaviridae infection
MGI:5587937	Bsg<tm1.1Znc>	MP:0000715,decreased thymocyte number|MP:0001828,abnormal T cell activation|MP:0004956,decreased thymus weight|MP:0005092,decreased double-positive T cell number|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0008083,decreased single-positive T cell number
MGI:6467013	Bsg<tm1Itl>	MP:0003631,nervous system phenotype|MP:0005369,muscle phenotype
MGI:2177802	Bsg<tm1Tmu>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001862,interstitial pneumonia|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001954,respiratory distress|MP:0002216,abnormal seminiferous tubule morphology|MP:0002631,abnormal epididymis morphology|MP:0002743,glomerulonephritis|MP:0002871,albuminuria|MP:0003917,increased kidney weight|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0004728,abnormal efferent ductules of testis morphology|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0004952,increased spleen weight|MP:0005159,azoospermia|MP:0005325,abnormal renal glomerulus morphology|MP:0005391,vision/eye phenotype|MP:0006379,abnormal spermatocyte morphology|MP:0006428,ectopic Sertoli cells|MP:0008261,arrest of male meiosis|MP:0008447,absent retina cone cells|MP:0008450,retina photoreceptor degeneration|MP:0008454,absent retina rod cells|MP:0008515,thin retina outer nuclear layer|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0009338,increased splenocyte number|MP:0010219,increased T-helper 17 cell number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011103,embryonic lethality at implantation, incomplete penetrance|MP:0011353,expanded mesangial matrix|MP:0011427,increased mesangial cell number|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0012144,decreased b-wave amplitude|MP:0012153,increased b-wave latency|MP:0014052,increased male germ cell apoptosis|MP:0020216,decreased circulating complement protein level|MP:0020355,abnormal Sertoli cell barrier morphology|MP:0020550,multinucleated giant male germ cells|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:2682366	Bslm4<C57BL/6J>	MP:0001399,hyperactivity
MGI:5285211	Bsnd<tm1.1Suc>	MP:0001762,polyuria|MP:0002136,abnormal kidney physiology|MP:0002843,decreased systemic arterial blood pressure|MP:0003016,increased circulating bicarbonate level|MP:0003020,decreased circulating chloride level|MP:0003028,alkalosis|MP:0004119,hypokalemia|MP:0005376,homeostasis/metabolism phenotype|MP:0005634,decreased circulating sodium level|MP:0006317,decreased urine sodium level|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3826850	Bsnd<tm1.1Tjj>	MP:0001429,dehydration|MP:0011085,postnatal lethality, complete penetrance
MGI:5285212	Bsnd<tm1Suc>	MP:0000519,hydronephrosis|MP:0001265,decreased body size|MP:0001762,polyuria|MP:0002608,increased hematocrit|MP:0002666,increased circulating aldosterone level|MP:0002988,decreased urine osmolality|MP:0003016,increased circulating bicarbonate level|MP:0003020,decreased circulating chloride level|MP:0003028,alkalosis|MP:0004119,hypokalemia|MP:0005554,decreased circulating creatinine level
MGI:3826849	Bsnd<tm1Tjj>	MP:0000048,abnormal stria vascularis morphology|MP:0001429,dehydration|MP:0004363,stria vascularis degeneration|MP:0004364,thin stria vascularis|MP:0004404,cochlear outer hair cell degeneration|MP:0004411,decreased endocochlear potential|MP:0004737,absent distortion product otoacoustic emissions|MP:0006024,collapsed Reissner membrane|MP:0011039,abnormal vestibuloocular dark reflex|MP:0011085,postnatal lethality, complete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4880009	Bsn<Gt(OST486029)Lex>	MP:0004562,abnormal inner hair cell synaptic ribbon morphology|MP:0006325,impaired hearing
MGI:2652946	Bsn<tm1Gund>	MP:0000243,myoclonus|MP:0000947,convulsive seizures|MP:0001005,abnormal retina rod cell morphology|MP:0001393,ataxia|MP:0001523,impaired righting response|MP:0002083,premature death|MP:0002206,abnormal CNS synaptic transmission|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002917,decreased synaptic depression|MP:0003635,abnormal synaptic transmission|MP:0003996,clonic seizures|MP:0004417,decreased cochlear nerve compound action potential|MP:0004433,abnormal cochlear inner hair cell physiology|MP:0004562,abnormal inner hair cell synaptic ribbon morphology|MP:0004563,absent active-zone-anchored inner hair cell synaptic ribbon|MP:0004738,abnormal auditory brainstem response|MP:0004994,abnormal brain wave pattern|MP:0005423,abnormal somatic nervous system physiology|MP:0006325,impaired hearing|MP:0014711,decreased synaptic vesicle readily releasable pool size
MGI:1889301	Bsp	MP:0000689,abnormal spleen morphology|MP:0008842,lipofuscinosis
MGI:3663800	Bst1<tm1Thir>	MP:0001800,abnormal humoral immune response|MP:0001807,decreased IgA level|MP:0002459,abnormal B cell physiology|MP:0004978,decreased B-1 B cell number|MP:0005014,increased B cell number|MP:0005387,immune system phenotype|MP:0008215,decreased immature B cell number|MP:0008498,decreased IgG3 level
MGI:6430643	Bst2<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney
MGI:5308812	Bst2<tm1.1Bsz>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0005621,abnormal cell physiology|MP:0020934,increased susceptibility to Retroviridae infection
MGI:5308660	Bstk	MP:0002075,abnormal coat/hair pigmentation|MP:0004034,belly blaze|MP:0008762,embryonic lethality
MGI:2152777	Bswt	MP:0000373,belly spot|MP:0005174,abnormal tail pigmentation|MP:0009379,abnormal foot pigmentation
MGI:3719242	Bsx<tm1Aoh>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0003718,maternal effect|MP:0006270,abnormal mammary gland growth during lactation|MP:0006271,abnormal involution of the mammary gland|MP:0010249,lactation failure|MP:0014126,increased mammary gland apoptosis
MGI:3716209	Bsx<tm1Tre>	MP:0001402,decreased locomotor activity|MP:0005376,homeostasis/metabolism phenotype|MP:0005449,abnormal food intake|MP:0005458,increased percent body fat/body weight|MP:0010379,decreased respiratory quotient|MP:0011020,abnormal circadian temperature homeostasis
MGI:3719245	Bsx<tm2Aoh>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0003718,maternal effect|MP:0006270,abnormal mammary gland growth during lactation|MP:0006271,abnormal involution of the mammary gland|MP:0010249,lactation failure|MP:0014126,increased mammary gland apoptosis
MGI:3716210	Bsx<tm2Tre>	MP:0002169,no abnormal phenotype detected
MGI:1856690	bt2	MP:0002671,belted
MGI:7278797	bt3	MP:0000438,abnormal cranium morphology|MP:0002671,belted
MGI:4127718	Btaf1<Gt(RRF308)Byg>	MP:0003984,embryonic growth retardation
MGI:5050316	Btaf1<m1Fme>	MP:0000913,abnormal brain development|MP:0001785,edema|MP:0002128,abnormal blood circulation|MP:0003984,embryonic growth retardation|MP:0010503,myocardial trabeculae hypoplasia|MP:0012177,delayed head development
MGI:6399906	Btbd10<em1(IMPC)Hmgu>	MP:0002574,increased vertical activity|MP:0004738,abnormal auditory brainstem response
MGI:5581735	Btbd16<tm2b(EUCOMM)Hmgu>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002644,decreased circulating triglyceride level|MP:0004952,increased spleen weight|MP:0011239,abnormal skin coloration
MGI:6148074	Btbd17<em1(IMPC)Mbp>	MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis
MGI:6341842	Btbd18<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0001175,abnormal lung morphology|MP:0002874,decreased hemoglobin content|MP:0003641,small lung
MGI:5888779	Btbd18<tm1Dean>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0001929,abnormal gametogenesis|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005380,embryo phenotype|MP:0008279,arrest of spermiogenesis|MP:0013601,increased testis apoptosis|MP:0014052,increased male germ cell apoptosis|MP:0014634,decreased round spermatid number
MGI:7523295	Btbd19<em1(IMPC)Hmgu>	MP:0000745,tremors
MGI:4419700	Btbd1<tm1a(KOMP)Wtsi>	MP:0002135,abnormal kidney morphology|MP:0003604,single kidney|MP:0005567,decreased circulating total protein level|MP:0013436,increased CD8-positive, naive alpha-beta T cell number
MGI:6276952	Btbd2<em1(IMPC)Mbp>	MP:0000194,increased circulating calcium level|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000702,enlarged lymph nodes|MP:0001488,increased startle reflex|MP:0001513,limb grasping|MP:0002339,abnormal lymph node morphology|MP:0002590,increased mean corpuscular volume
MGI:6446945	Btbd3<em1Dul>	MP:0001362,abnormal anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001447,abnormal nest building behavior|MP:0002757,decreased vertical activity|MP:0002797,increased thigmotaxis|MP:0011620,abnormal habituation to a new environment|MP:0031391,increased locomotor activity
MGI:5588286	Btbd3<tm1b(EUCOMM)Hmgu>	MP:0000137,abnormal vertebrae morphology|MP:0000681,abnormal thyroid gland morphology|MP:0001262,decreased body weight|MP:0004599,abnormal vertebral arch morphology|MP:0005355,enlarged thyroid gland|MP:0008935,decreased mean platelet volume|MP:0013890,increased CD8-positive, CD25-positive alpha-beta T cell number
MGI:6385277	Btbd7<em1(IMPC)Ccpcz>	MP:0000162,lordosis|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001399,hyperactivity|MP:0002059,abnormal seminal vesicle morphology|MP:0002092,abnormal eye morphology|MP:0002311,abnormal inspiratory capacity|MP:0002953,thick ventricular wall|MP:0009141,increased prepulse inhibition|MP:0009709,hydrometra|MP:0010895,increased lung compliance|MP:0011045,decreased lung elastance
MGI:6259681	Btbd7<tm1.1Kmy>	MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005379,endocrine/exocrine gland phenotype|MP:0009520,decreased submandibular gland size|MP:0010865,prenatal growth retardation|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011085,postnatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011805,decreased cell migration|MP:0013541,abnormal submandibular gland development|MP:0013542,abnormal submandibular gland branching morphogenesis
MGI:6341849	Btbd8<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0003020,decreased circulating chloride level
MGI:7660970	Btbd8<em1Lych>	MP:0008539,decreased susceptibility to induced colitis|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008882,abnormal enterocyte physiology|MP:0010155,abnormal intestine physiology|MP:0011079,decreased macrophage cytokine production|MP:0014201,abnormal intestinal epithelium physiology|MP:0014221,increased colon goblet cell number
MGI:4127237	Btbd9<Gt(RRE078)Byg>	MP:0001396,unidirectional circling|MP:0001501,abnormal sleep pattern|MP:0003008,enhanced long-term potentiation|MP:0003663,abnormal thermosensation|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004859,abnormal synaptic plasticity|MP:0005266,abnormal metabolism|MP:0008810,increased circulating iron level|MP:0009453,enhanced contextual conditioning behavior|MP:0009455,enhanced cued conditioning behavior|MP:0014254,increased paired-pulse ratio|MP:0014812,abnormal brain physiology|MP:0031391,increased locomotor activity
MGI:5548584	Btbd9<tm1b(EUCOMM)Wtsi>	MP:0001258,decreased body length|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0010053,decreased grip strength|MP:0013279,increased fasting circulating glucose level
MGI:6384248	Btbd9<tm1c(EUCOMM)Wtsi>	MP:0000860,abnormal primary somatosensory cortex morphology|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001973,increased thermal nociceptive threshold|MP:0011396,abnormal sleep behavior|MP:0012448,abnormal primary motor cortex morphology|MP:0031391,increased locomotor activity
MGI:6488232	Btbd9<tm1d(EUCOMM)Wtsi>	MP:0000877,abnormal Purkinje cell morphology|MP:0001405,impaired coordination|MP:0002272,abnormal nervous system electrophysiology|MP:0002919,enhanced paired-pulse facilitation|MP:0004859,abnormal synaptic plasticity|MP:0014327,decreased Purkinje cell size
MGI:6276951	Btc<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology
MGI:2665044	Btc<tm1Dcl>	MP:0002169,no abnormal phenotype detected
MGI:4888510	Btd<tm1Bwol>	MP:0000414,alopecia|MP:0000745,tremors|MP:0000746,weakness|MP:0000755,hindlimb paralysis|MP:0000756,forelimb paralysis|MP:0001263,weight loss|MP:0001406,abnormal gait|MP:0001505,hunched posture|MP:0002075,abnormal coat/hair pigmentation|MP:0004016,decreased bone mass|MP:0004144,hypotonia|MP:0004924,abnormal behavior|MP:0005202,lethargy|MP:0005253,abnormal eye physiology|MP:0005309,increased circulating ammonia level|MP:0009643,abnormal urine homeostasis
MGI:6414548	Btf3<em1(IMPC)Tcp>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000702,enlarged lymph nodes|MP:0002092,abnormal eye morphology|MP:0002591,decreased mean corpuscular volume|MP:0005016,decreased lymphocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013292,embryonic lethality prior to organogenesis
MGI:3688730	Btf3<Gt(ROSA)1Bhr>	MP:0009687,empty decidua capsularis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6148075	Btg1<em1(IMPC)Mbp>	MP:0000691,enlarged spleen|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002590,increased mean corpuscular volume|MP:0002606,increased basophil cell number|MP:0002833,increased heart weight|MP:0003068,enlarged kidney|MP:0004832,enlarged ovary|MP:0004906,enlarged uterus|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005561,increased mean corpuscular hemoglobin
MGI:5825483	Btg1<tm1Ftir>	MP:0000812,abnormal dentate gyrus morphology|MP:0001469,abnormal contextual conditioning behavior|MP:0003203,increased neuron apoptosis|MP:0012307,impaired spatial learning|MP:0020394,decreased neuronal precursor proliferation
MGI:5472170	Btg2<tm1b(KOMP)Mbp>	MP:0001399,hyperactivity|MP:0002590,increased mean corpuscular volume|MP:0004906,enlarged uterus|MP:0005561,increased mean corpuscular hemoglobin|MP:0013279,increased fasting circulating glucose level
MGI:3525505	Btg2<tm1Spo>	MP:0003036,vertebral transformation|MP:0004615,cervical vertebral transformation|MP:0004618,thoracic vertebral transformation
MGI:3038949	Btg2<tm1Wbh>	MP:0003631,nervous system phenotype
MGI:3848525	Btg3<tm1Tya>	MP:0002048,increased lung adenoma incidence|MP:0008014,increased lung tumor incidence|MP:0008714,increased lung carcinoma incidence|MP:0014167,ectopic bone
MGI:6276544	Btg4<em1Hyfn>	MP:0001926,female infertility|MP:0002006,neoplasm|MP:0003718,maternal effect|MP:0005266,abnormal metabolism|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype
MGI:6276546	Btg4<em2Hyfn>	MP:0001926,female infertility|MP:0003718,maternal effect
MGI:5563504	Btk<m1Anu>	MP:0005017,decreased B cell number
MGI:5563503	Btk<m2Anu>	MP:0002494,increased IgM level|MP:0008214,increased immature B cell number
MGI:4434935	Btk<tm1a(EUCOMM)Hmgu>	MP:0001262,decreased body weight|MP:0008074,increased CD4-positive, alpha-beta T cell number
MGI:2449487	Btk<tm1Gsv>	MP:0001790,abnormal immune system physiology|MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0002460,decreased immunoglobulin level|MP:0005017,decreased B cell number|MP:0008203,absent B-1a cells|MP:0008211,decreased mature B cell number|MP:0008212,absent mature B cells|MP:0008215,decreased immature B cell number|MP:0008498,decreased IgG3 level|MP:0014469,abnormal B cell calcium ion homeostasis
MGI:1857138	Btk<tm1Wk>	MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0005093,decreased B cell proliferation|MP:0008186,increased pro-B cell number|MP:0008211,decreased mature B cell number|MP:0008217,abnormal B cell activation|MP:0008482,decreased spleen germinal center number|MP:0008484,decreased spleen germinal center size|MP:0008498,decreased IgG3 level|MP:0008522,abnormal lymph node germinal center morphology
MGI:4820731	Btk<vila>	MP:0002491,decreased IgD level|MP:0002493,increased IgG level|MP:0002497,increased IgE level|MP:0005017,decreased B cell number|MP:0008246,abnormal leukocyte morphology
MGI:1856317	Btk<xid>	MP:0000172,abnormal bone marrow cell number|MP:0000222,decreased neutrophil cell number|MP:0000694,spleen hypoplasia|MP:0001602,impaired myelopoiesis|MP:0001806,decreased IgM level|MP:0001844,autoimmune response|MP:0002401,abnormal lymphopoiesis|MP:0002403,abnormal pre-B cell morphology|MP:0002451,abnormal macrophage physiology|MP:0002459,abnormal B cell physiology|MP:0002463,abnormal neutrophil physiology|MP:0002467,impaired neutrophil phagocytosis|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005087,decreased acute inflammation|MP:0005093,decreased B cell proliferation|MP:0005153,abnormal B cell proliferation|MP:0005387,immune system phenotype|MP:0008174,decreased follicular B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008211,decreased mature B cell number|MP:0008498,decreased IgG3 level|MP:0008537,increased susceptibility to induced colitis|MP:0009339,decreased splenocyte number|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:3842627	Btla<tm1Dgra>	MP:0001828,abnormal T cell activation|MP:0008749,abnormal peripheral T cell anergy
MGI:3045408	Btla<tm1Kay>	MP:0001828,abnormal T cell activation
MGI:3027713	Btla<tm1Kmm>	MP:0001800,abnormal humoral immune response|MP:0001828,abnormal T cell activation|MP:0004751,increased length of allograft survival|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005095,decreased T cell proliferation|MP:0005154,increased B cell proliferation|MP:0005348,increased T cell proliferation|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion
MGI:3050155	Btn1a1<tm1Ihm>	MP:0000627,abnormal mammary gland morphology|MP:0001882,abnormal lactation|MP:0004047,abnormal milk composition
MGI:3050156	Btn1a1<tm2Ihm>	MP:0000627,abnormal mammary gland morphology|MP:0001882,abnormal lactation|MP:0004047,abnormal milk composition
MGI:6158673	Btn2a2<tm1.2Wrth>	MP:0002166,abnormal tumor susceptibility|MP:0002493,increased IgG level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0008499,increased IgG1 level|MP:0008896,increased IgG2c level|MP:0020002,increased response to antigen
MGI:6445624	Btnl1<em1Ahay>	MP:0008351,decreased gamma-delta intraepithelial T cell number|MP:0008401,abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
MGI:6690612	Btnl1<em4Ahay>	MP:0005387,immune system phenotype
MGI:5287743	Btnl1<tm1(KOMP)Mbp>	MP:0008351,decreased gamma-delta intraepithelial T cell number|MP:0008401,abnormal CD8 positive, alpha-beta intraepithelial T cell morphology
MGI:6885845	Btnl2<em1Wche>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0002006,neoplasm|MP:0003304,large intestinal inflammation|MP:0008343,abnormal gamma-delta T cell morphology|MP:0008713,abnormal cytokine level
MGI:6156508	Btnl4<em1(IMPC)Tcp>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002060,abnormal skin morphology|MP:0003233,prolonged QT interval|MP:0010506,prolonged RR interval|MP:0010570,prolonged ST segment
MGI:5014557	Btnl4<tm1(KOMP)Mbp>	MP:0005387,immune system phenotype
MGI:6690614	Btnl6<em1.1Ahay>	MP:0008359,decreased CD4-positive, gamma-delta intraepithelial T cell number
MGI:6690613	Btnl6<em1Ahay>	MP:0008359,decreased CD4-positive, gamma-delta intraepithelial T cell number
MGI:3847258	Btnt	MP:0008237,abnormal ventral coat pigmentation
MGI:5487551	Btnt2	MP:0008237,abnormal ventral coat pigmentation
MGI:5548441	Btrc<tm1b(KOMP)Wtsi>	MP:0000220,increased monocyte cell number|MP:0002590,increased mean corpuscular volume|MP:0002941,increased circulating alanine transaminase level
MGI:2669949	Btrc<tm1Kin>	MP:0000358,abnormal cell morphology|MP:0002006,neoplasm|MP:0002619,abnormal lymphocyte morphology|MP:0004025,polyploidy|MP:0011704,decreased fibroblast proliferation|MP:0013501,increased fibroblast apoptosis
MGI:3055737	Btrc<tm1Paga>	MP:0001922,reduced male fertility|MP:0002687,oligozoospermia|MP:0004046,abnormal mitosis|MP:0005169,abnormal male meiosis|MP:0009760,abnormal mitotic spindle morphology|MP:0009761,abnormal meiotic spindle morphology|MP:0010768,mortality/aging|MP:0030943,abnormal centrosome morphology
MGI:2155068	Bts1<C57BL/6JShi>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:2155069	Bts1<NON/Shi>	MP:0002020,increased tumor incidence
MGI:2156536	Bts2<C57BL/6JShi>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:2156537	Bts2<NON/Shi>	MP:0002020,increased tumor incidence
MGI:3606255	Btts<C57BL/6J>	MP:0004210,abnormal bitter taste sensitivity
MGI:3033386	Bub1b<Gt(neo-btk)1Dai>	MP:0000229,abnormal megakaryocyte differentiation|MP:0000239,absent common myeloid progenitor cells|MP:0000691,enlarged spleen|MP:0002044,increased colon adenoma incidence|MP:0002123,abnormal definitive hematopoiesis|MP:0002875,decreased erythrocyte cell number|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0004957,abnormal blastocyst morphology|MP:0005380,embryo phenotype|MP:0009762,abnormal mitotic spindle assembly checkpoint|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5543300	Bub1b<tm1.1Hsl>	MP:0000691,enlarged spleen|MP:0001672,abnormal embryo development|MP:0002021,increased incidence of induced tumors|MP:0002023,increased B cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003667,increased hemangiosarcoma incidence|MP:0003984,embryonic growth retardation|MP:0004024,aneuploidy|MP:0004046,abnormal mitosis|MP:0005154,increased B cell proliferation|MP:0006042,increased apoptosis|MP:0008478,increased spleen white pulp amount|MP:0009308,increased adenocarcinoma incidence|MP:0009315,increased rectum adenocarcinoma incidence|MP:0009762,abnormal mitotic spindle assembly checkpoint|MP:0010363,increased fibrosarcoma incidence|MP:0010768,mortality/aging|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012431,increased lymphoma incidence|MP:0031678,increased micronucleus incidence
MGI:3046581	Bub1b<tm1.1Jvd>	MP:0002006,neoplasm|MP:0002083,premature death|MP:0003721,increased tumor growth/size|MP:0004024,aneuploidy|MP:0004045,abnormal cell cycle checkpoint function|MP:0004046,abnormal mitosis|MP:0009762,abnormal mitotic spindle assembly checkpoint|MP:0010308,decreased tumor latency|MP:0011092,embryonic lethality, complete penetrance
MGI:3046580	Bub1b<tm1Jvd>	MP:0000160,kyphosis|MP:0000189,hypoglycemia|MP:0001244,thin dermal layer|MP:0001304,cataract|MP:0001732,postnatal growth retardation|MP:0001792,impaired wound healing|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0002687,oligozoospermia|MP:0002891,increased insulin sensitivity|MP:0003786,premature aging|MP:0004024,aneuploidy|MP:0004028,chromosome breakage|MP:0004045,abnormal cell cycle checkpoint function|MP:0004046,abnormal mitosis|MP:0004485,increased response of heart to induced stress|MP:0005150,cachexia|MP:0005292,improved glucose tolerance|MP:0005621,abnormal cell physiology|MP:0008007,abnormal cellular replicative senescence|MP:0008008,early cellular replicative senescence|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009269,decreased fat cell size|MP:0009413,skeletal muscle fiber atrophy|MP:0009760,abnormal mitotic spindle morphology|MP:0009762,abnormal mitotic spindle assembly checkpoint|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010080,abnormal hepatocyte physiology|MP:0011174,lipodystrophy|MP:0012106,impaired exercise endurance|MP:0031253,lordokyphosis
MGI:5487826	Bub1b<tm2.1Jvd>	MP:0001262,decreased body weight|MP:0001304,cataract|MP:0002006,neoplasm|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0003721,increased tumor growth/size|MP:0003786,premature aging|MP:0004023,abnormal chromosome number|MP:0004024,aneuploidy|MP:0004046,abnormal mitosis|MP:0005334,abnormal fat pad morphology|MP:0005385,cardiovascular system phenotype|MP:0005390,skeleton phenotype|MP:0008008,early cellular replicative senescence|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009269,decreased fat cell size|MP:0009293,decreased inguinal fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009760,abnormal mitotic spindle morphology|MP:0009762,abnormal mitotic spindle assembly checkpoint|MP:0010025,decreased total body fat amount|MP:0012106,impaired exercise endurance|MP:0031253,lordokyphosis
MGI:6478925	Bub1b<tm3.1Jvd>	MP:0002006,neoplasm|MP:0003721,increased tumor growth/size|MP:0004023,abnormal chromosome number|MP:0004024,aneuploidy|MP:0004046,abnormal mitosis|MP:0009760,abnormal mitotic spindle morphology|MP:0009762,abnormal mitotic spindle assembly checkpoint|MP:0010308,decreased tumor latency|MP:0010768,mortality/aging
MGI:6257501	Bub1<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3830862	Bub1<Gt(XG453)Byg>	MP:0003718,maternal effect
MGI:3793293	Bub1<tm1.1Jvd>	MP:0002052,decreased tumor incidence|MP:0004024,aneuploidy|MP:0004045,abnormal cell cycle checkpoint function|MP:0004046,abnormal mitosis|MP:0004499,increased incidence of tumors by chemical induction|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0013502,decreased fibroblast apoptosis
MGI:3767633	Bub1<tm1.1Ssta>	MP:0011092,embryonic lethality, complete penetrance
MGI:3830859	Bub1<tm1.1Tvd>	MP:0000218,increased leukocyte cell number|MP:0000603,pale liver|MP:0001577,anemia|MP:0001654,hepatic necrosis|MP:0002021,increased incidence of induced tumors|MP:0003077,abnormal cell cycle|MP:0004024,aneuploidy|MP:0004045,abnormal cell cycle checkpoint function|MP:0008008,early cellular replicative senescence|MP:0008014,increased lung tumor incidence|MP:0008019,increased liver tumor incidence|MP:0009277,increased brain tumor incidence|MP:0009674,decreased birth weight|MP:0009760,abnormal mitotic spindle morphology|MP:0009762,abnormal mitotic spindle assembly checkpoint|MP:0010768,mortality/aging|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:3767632	Bub1<tm1Ssta>	MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0004759,decreased mitotic index|MP:0004852,decreased testis weight
MGI:3830858	Bub1<tm1Tvd>	MP:0002169,no abnormal phenotype detected
MGI:3793294	Bub1<tm2Jvd>	MP:0002032,increased sarcoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0004024,aneuploidy|MP:0004045,abnormal cell cycle checkpoint function|MP:0004046,abnormal mitosis|MP:0010308,decreased tumor latency|MP:0013502,decreased fibroblast apoptosis
MGI:5478548	Bub1<tm3.1Jvd>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002006,neoplasm|MP:0002687,oligozoospermia|MP:0004024,aneuploidy|MP:0004045,abnormal cell cycle checkpoint function|MP:0004852,decreased testis weight|MP:0008866,chromosomal instability
MGI:5478549	Bub1<tm4.1Jvd>	MP:0000313,abnormal cell death
MGI:3619247	Bub3<tm1Jvd>	MP:0004024,aneuploidy|MP:0004045,abnormal cell cycle checkpoint function|MP:0004046,abnormal mitosis|MP:0004499,increased incidence of tumors by chemical induction|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2180502	Bub3<tm1Khac>	MP:0003111,abnormal cell nucleus morphology|MP:0003702,abnormal chromosome morphology|MP:0004965,inner cell mass degeneration|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0031678,increased micronucleus incidence
MGI:7431359	Bud13<em1(IMPC)Ccpcz>	MP:0000470,abnormal stomach morphology|MP:0000689,abnormal spleen morphology|MP:0003961,decreased lean body mass|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6690826	Bud23<em1Asil>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0010959,abnormal oxidative phosphorylation|MP:0011092,embryonic lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011628,increased mitochondrial number
MGI:6690827	Bud23<em2Asil>	MP:0000274,enlarged heart|MP:0000280,thin ventricular wall|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003674,oxidative stress|MP:0003900,shortened QT interval|MP:0005140,decreased cardiac muscle contractility|MP:0005319,abnormal enzyme/coenzyme level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006035,abnormal mitochondrial morphology|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0008469,abnormal protein level|MP:0010393,shortened QRS complex duration|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0010959,abnormal oxidative phosphorylation|MP:0011629,decreased mitochondrial number|MP:0014390,decreased myocardial fiber mitochondrial DNA content
MGI:6153866	Bud23<em2(IMPC)H>	MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2155610	Bulb1<C57BL/6J>	MP:0000819,abnormal olfactory bulb morphology
MGI:2156397	Bulb2<C57BL/6J>	MP:0000819,abnormal olfactory bulb morphology
MGI:2158240	Bulb3<DBA/2J>	MP:0000819,abnormal olfactory bulb morphology
MGI:2429630	Bulb4<DBA/2J>	MP:0000819,abnormal olfactory bulb morphology
MGI:4889057	bumpy	MP:0000592,short tail|MP:0000783,abnormal forebrain morphology|MP:0003651,abnormal axon extension|MP:0009450,abnormal axon fasciculation|MP:0011085,postnatal lethality, complete penetrance
MGI:2446918	Bw10<DU6>	MP:0001260,increased body weight
MGI:2156045	Bw13<DU6i>	MP:0001260,increased body weight
MGI:2156707	Bw14<DU6i>	MP:0001260,increased body weight
MGI:3033019	Bw15<DU6i>	MP:0001262,decreased body weight
MGI:3033021	Bw16<DU6i>	MP:0001260,increased body weight
MGI:2153913	Bw17<A/J>	MP:0001260,increased body weight
MGI:2153912	Bw17<SM/J>	MP:0001262,decreased body weight
MGI:2156445	Bw18<A/J>	MP:0001260,increased body weight
MGI:2156446	Bw18<SM/J>	MP:0001262,decreased body weight
MGI:2446878	Bw19<HI>	MP:0001257,increased body length|MP:0002758,long tail|MP:0002865,increased growth rate|MP:0011939,increased food intake
MGI:2153919	Bw36<DU6i>	MP:0001260,increased body weight
MGI:2155731	Bw37<DU6i>	MP:0001260,increased body weight
MGI:2158215	Bw4<DU6>	MP:0001260,increased body weight
MGI:2153914	Bw5<DU6>	MP:0001260,increased body weight
MGI:2681290	Bw8q1<C57BL/6J>	MP:0001262,decreased body weight|MP:0031391,increased locomotor activity
MGI:2681292	Bw8q2<C57BL/6J>	MP:0001260,increased body weight
MGI:2156130	Bwefm<NZB/BlNJ>	MP:0001260,increased body weight
MGI:2156134	Bwem1<NZB/BlNJ>	MP:0001260,increased body weight
MGI:2157990	Bwem2<C57BL/6By>	MP:0001260,increased body weight
MGI:3497868	Bwnd2wk2<NMRI8/Fbn>	MP:0001260,increased body weight
MGI:3510144	Bwnd2wk5<NMRI8/Fbn>	MP:0001260,increased body weight
MGI:3510214	Bwnd2wk7<NMRI8/Fbn>	MP:0001260,increased body weight
MGI:3510148	Bwnd3wk1<NMRI8/Fbn>	MP:0001260,increased body weight
MGI:3510152	Bwnd4wk4<NMRI8/Fbn>	MP:0001260,increased body weight
MGI:3510218	Bwnd4wk7<NMRI8/Fbn>	MP:0001260,increased body weight
MGI:3497894	Bwnd5wk3<NMRI8/Fbn>	MP:0001260,increased body weight
MGI:3510222	Bwnd5wk7<NMRI8/Fbn>	MP:0001260,increased body weight
MGI:2156592	Bwq2<KK>	MP:0001260,increased body weight
MGI:2156992	Bwq3<SM/J>	MP:0001260,increased body weight
MGI:2445552	Bwq4<SM/J>	MP:0001260,increased body weight
MGI:2670686	Bwq5<C57BL/6ByJ>	MP:0001260,increased body weight
MGI:2670689	Bwq6<C57BL/6ByJ>	MP:0001260,increased body weight
MGI:3525689	Bwtn1<SM/J>	MP:0001260,increased body weight
MGI:3614877	Bwtq10<NZB/BlNJ>	MP:0001260,increased body weight
MGI:3614881	Bwtq11<NZB/BlNJ>	MP:0001260,increased body weight
MGI:3614885	Bwtq12<NZB/BlNJ>	MP:0001260,increased body weight
MGI:3614869	Bwtq8<NZB/BlNJ>	MP:0001260,increased body weight
MGI:3614871	Bwtq9<NZB/BlNJ>	MP:0001260,increased body weight
MGI:3836289	Bxs6<BXSB/MpJ>	MP:0001844,autoimmune response|MP:0002743,glomerulonephritis|MP:0003725,increased autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level
MGI:3664544	BY367451<tm1.1Mdk>	MP:0000890,thin cerebellar molecular layer|MP:0001405,impaired coordination|MP:0001406,abnormal gait
MGI:3664539	BY367451<tm1Mdk>	MP:0000890,thin cerebellar molecular layer|MP:0001405,impaired coordination
MGI:6341843	Bysl<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0002060,abnormal skin morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002953,thick ventricular wall|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3697441	Bysl<tm1Mfu>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5763137	Bzw1<em1(IMPC)J>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0001925,male infertility|MP:0004738,abnormal auditory brainstem response
MGI:5463964	Bzw2<tm1b(KOMP)Mbp>	MP:0001303,abnormal lens morphology|MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0004151,decreased circulating iron level|MP:0005179,decreased circulating cholesterol level|MP:0005560,decreased circulating glucose level
MGI:2157244	C10bw2<M. m. castaneus>	MP:0001262,decreased body weight
MGI:2157307	C10bw3<M. m. castaneus>	MP:0001262,decreased body weight
MGI:2157309	C10bw4<M. m. castaneus>	MP:0001262,decreased body weight
MGI:2157313	C10bw6<M. m. castaneus>	MP:0001262,decreased body weight
MGI:6451110	C1d<em1(IMPC)H>	MP:0002965,increased circulating serum albumin level|MP:0011100,preweaning lethality, complete penetrance
MGI:4459541	C1galt1c1<tm1.2Rdcu>	MP:0001614,abnormal blood vessel morphology|MP:0001634,internal hemorrhage|MP:0001732,postnatal growth retardation|MP:0001914,hemorrhage|MP:0003984,embryonic growth retardation|MP:0006054,spinal hemorrhage|MP:0011085,postnatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:6273946	C1galt1<em1(IMPC)Hmgu>	MP:0000194,increased circulating calcium level|MP:0011100,preweaning lethality, complete penetrance
MGI:3693890	C1galt1<ptl1>	MP:0000228,abnormal thrombopoiesis|MP:0001262,decreased body weight|MP:0001859,kidney inflammation|MP:0002083,premature death|MP:0002599,increased mean platelet volume|MP:0002743,glomerulonephritis|MP:0002828,abnormal renal glomerular capsule morphology|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0003179,thrombocytopenia|MP:0004505,decreased renal glomerulus number|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0011402,renal cast|MP:0011423,kidney cortex atrophy
MGI:3713768	C1galt1<tm1.1Rpmc>	MP:0000260,abnormal angiogenesis|MP:0001914,hemorrhage|MP:0005389,reproductive system phenotype
MGI:3714051	C1galt1<tm1.2Rpmc>	MP:0003696,abnormal zona pellucida morphology|MP:0009375,thin zona pellucida
MGI:5524267	C1galt1<tm1.2Staka>	MP:0001914,hemorrhage|MP:0011092,embryonic lethality, complete penetrance
MGI:3531503	C1galt1<tm1Rpmc>	MP:0001577,anemia|MP:0001915,intracranial hemorrhage|MP:0003227,abnormal vascular branching morphogenesis|MP:0003658,abnormal capillary morphology|MP:0006054,spinal hemorrhage|MP:0006055,abnormal vascular endothelial cell morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0020326,dilated capillary
MGI:3796996	C1qa<tm1.1Tenn>	MP:0002169,no abnormal phenotype detected
MGI:5488784	C1qa<tm1b(EUCOMM)Wtsi>	MP:0003019,increased circulating chloride level|MP:0005560,decreased circulating glucose level|MP:0005566,decreased blood urea nitrogen level
MGI:2158701	C1qa<tm1Mjw>	MP:0002064,seizures|MP:0002083,premature death|MP:0002412,increased susceptibility to bacterial infection|MP:0002743,glomerulonephritis|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003216,absence seizures|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004796,increased anti-histone antibody level|MP:0005387,immune system phenotype|MP:0008571,abnormal synaptic bouton morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0011369,increased renal glomerulus apoptosis|MP:0011506,glomerular crescent|MP:0014375,increased miniature excitatory postsynaptic current frequency|MP:0014378,increased excitatory postsynaptic current frequency
MGI:5487822	C1qbp<tm1.1Tuch>	MP:0000352,decreased cell proliferation|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0010955,abnormal respiratory electron transport chain|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5779860	C1qc<em1(IMPC)J>	MP:0000194,increased circulating calcium level|MP:0000572,abnormal autopod morphology|MP:0001284,absent vibrissae|MP:0001486,abnormal startle reflex|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005568,increased circulating total protein level|MP:0010053,decreased grip strength
MGI:5708580	C1ql1<tm1.1Yuza>	MP:0001899,absent long-term depression|MP:0002804,abnormal motor learning|MP:0002882,abnormal neuron morphology|MP:0003412,abnormal afterhyperpolarization|MP:0003463,abnormal single cell response|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:6276964	C1ql2<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0001926,female infertility|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney
MGI:6437046	C1ql3<em1(IMPC)H>	MP:0000221,decreased leukocyte cell number|MP:0000223,decreased monocyte cell number|MP:0005012,decreased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005565,increased blood urea nitrogen level
MGI:5779427	C1ql3<tm1.1Sud>	MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior
MGI:5779516	C1ql3<tm1.2Sud>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0002805,abnormal conditioned taste aversion behavior|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0009712,impaired conditioned place preference behavior|MP:0020357,abnormal excitatory synapse morphology
MGI:7618529	C1ql4<tm1Lex>	MP:0000221,decreased leukocyte cell number|MP:0001402,decreased locomotor activity|MP:0002575,increased circulating ketone body level|MP:0002608,increased hematocrit|MP:0002640,reticulocytosis|MP:0004889,increased energy expenditure|MP:0005016,decreased lymphocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005564,increased hemoglobin content|MP:0005658,increased susceptibility to diet-induced obesity|MP:0009292,increased inguinal fat pad weight|MP:0010053,decreased grip strength|MP:0011957,decreased compensatory feeding amount|MP:0014142,increased body fat mass
MGI:6158501	C1qtnf12<em1(IMPC)Mbp>	MP:0001148,enlarged testis|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0002188,small heart|MP:0002989,small kidney
MGI:6164618	C1qtnf12<tm1Gww>	MP:0001552,increased circulating triglyceride level|MP:0002575,increased circulating ketone body level|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0003975,increased circulating VLDL triglyceride level|MP:0003976,decreased circulating VLDL triglyceride level|MP:0005331,insulin resistance|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0014171,increased fatty acid oxidation|MP:0014424,increased liver triglyceride secretion|MP:0014425,decreased liver triglyceride secretion|MP:0031269,increased susceptibility to diet-induced hepatic steatosis
MGI:6277058	C1qtnf1<em1(IMPC)Mbp>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000494,abnormal cecum morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001126,abnormal ovary morphology|MP:0001297,microphthalmia|MP:0001402,decreased locomotor activity|MP:0001486,abnormal startle reflex|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002644,decreased circulating triglyceride level|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0005179,decreased circulating cholesterol level|MP:0009476,enlarged cecum
MGI:5007035	C1qtnf1<tm1Lex>	MP:0001399,hyperactivity|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009283,decreased gonadal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level|MP:0014143,decreased body fat mass
MGI:5007036	C1qtnf2<tm1Lex>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000601,small liver|MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001783,decreased white adipose tissue amount|MP:0003443,increased circulating glycerol level|MP:0003961,decreased lean body mass|MP:0003975,increased circulating VLDL triglyceride level|MP:0003983,decreased cholesterol level|MP:0004777,abnormal phospholipid level|MP:0004889,increased energy expenditure|MP:0005145,increased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0008034,enhanced lipolysis|MP:0008963,increased carbon dioxide production|MP:0008965,increased basal metabolism|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level|MP:0010379,decreased respiratory quotient|MP:0014143,decreased body fat mass
MGI:5578157	C1qtnf3<tm1Yiw>	MP:0002493,increased IgG level|MP:0002933,joint inflammation|MP:0003724,increased susceptibility to induced arthritis|MP:0005387,immune system phenotype
MGI:6379554	C1qtnf3<tm2b(EUCOMM)Wtsi>	MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0010090,increased circulating creatine kinase level
MGI:6194706	C1qtnf4<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6729707	C1qtnf4<em1Smoc>	MP:0008113,abnormal macrophage differentiation|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008596,increased circulating interleukin-6 level|MP:0008635,increased circulating interleukin-18 level|MP:0008735,increased susceptibility to endotoxin shock|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5309003	C1qtnf5<tm1.1Geno>	MP:0002169,no abnormal phenotype detected
MGI:4949224	C1qtnf5<tm1.1Itl>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001006,abnormal retina cone cell morphology|MP:0002864,abnormal ocular fundus morphology|MP:0003070,increased vascular permeability|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology|MP:0005551,abnormal eye electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008446,decreased retina cone cell number|MP:0008448,abnormal retina cone cell inner segment morphology|MP:0008455,abnormal retina rod cell inner segment morphology|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment|MP:0011965,decreased total retina thickness|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:5443923	C1qtnf5<tm1.1(KOMP)Vlcg>	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0013279,increased fasting circulating glucose level|MP:0031212,decreased eye anterior chamber depth
MGI:4460570	C1qtnf5<tm1(KOMP)Vlcg>	MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003058,increased insulin secretion|MP:0005292,improved glucose tolerance|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0009356,decreased liver triglyceride level|MP:0011940,decreased food intake|MP:0013278,decreased fasting circulating glucose level|MP:0030973,impaired gluconeogenesis|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:6343246	C1qtnf6<tm1Yiw>	MP:0002471,abnormal complement pathway|MP:0002493,increased IgG level|MP:0003724,increased susceptibility to induced arthritis|MP:0003725,increased autoantibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005014,increased B cell number|MP:0005367,renal/urinary system phenotype|MP:0005387,immune system phenotype|MP:0005615,increased susceptibility to type III hypersensitivity reaction|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011566,abnormal complement protein level|MP:0020217,increased circulating complement protein level
MGI:4452854	C1qtnf7<tm1(KOMP)Vlcg>	MP:0003402,decreased liver weight|MP:0005166,decreased susceptibility to injury|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005425,increased macrophage cell number|MP:0005560,decreased circulating glucose level
MGI:4415477	C1qtnf9<tm1(KOMP)Vlcg>	MP:0000609,abnormal liver physiology|MP:0000759,abnormal skeletal muscle morphology|MP:0001260,increased body weight|MP:0001261,obese|MP:0002079,increased circulating insulin level|MP:0002106,abnormal muscle physiology|MP:0002628,hepatic steatosis|MP:0003058,increased insulin secretion|MP:0003961,decreased lean body mass|MP:0005331,insulin resistance|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005458,increased percent body fat/body weight|MP:0005645,abnormal hypothalamus physiology|MP:0005669,increased circulating leptin level|MP:0009355,increased liver triglyceride level|MP:0011939,increased food intake|MP:0014573,increased circulating resistin level
MGI:5695904	C1ra<tm1.1(KOMP)Vlcg>	MP:0002282,abnormal trachea morphology|MP:0002699,abnormal vitreous body morphology
MGI:5548846	C1rl<tm1b(EUCOMM)Hmgu>	MP:0000558,abnormal tibia morphology|MP:0002932,abnormal joint morphology|MP:0003961,decreased lean body mass|MP:0004509,abnormal pelvic girdle bone morphology
MGI:5817198	C2cd2<em1(IMPC)J>	MP:0000195,decreased circulating calcium level
MGI:6275144	C2cd2l<em1(IMPC)J>	MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0004738,abnormal auditory brainstem response
MGI:6887610	C2cd3<em1Brgm>	MP:0000269,abnormal heart looping|MP:0000914,exencephaly|MP:0001787,pericardial edema|MP:0002084,abnormal developmental patterning|MP:0004203,abnormal cranial flexure morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013203,abnormal primary cilium morphology
MGI:6257547	C2cd3<em1(IMPC)Tcp>	MP:0000219,increased neutrophil cell number|MP:0001120,abnormal uterus morphology|MP:0001399,hyperactivity|MP:0001697,abnormal embryo size|MP:0002060,abnormal skin morphology|MP:0003984,embryonic growth retardation|MP:0005016,decreased lymphocyte cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6887618	C2cd3<em2Brgm>	MP:0000060,delayed bone ossification|MP:0000111,cleft palate|MP:0000762,abnormal tongue morphology|MP:0013208,abnormal cilium physiology
MGI:3836403	C2cd3<Gt(AG0177)Wtsi>	MP:0000914,exencephaly|MP:0000925,abnormal floor plate morphology|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0004132,absent embryonic cilia|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3836402	C2cd3<hty>	MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0000925,abnormal floor plate morphology|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0001706,abnormal left-right axis patterning|MP:0001787,pericardial edema|MP:0003885,abnormal rostral-caudal body axis extension|MP:0004132,absent embryonic cilia|MP:0004203,abnormal cranial flexure morphology|MP:0004252,abnormal direction of heart looping|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4842681	C2cd3<tm1a(EUCOMM)Wtsi>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6887626	C2cd3<tm1c(EUCOMM)Wtsi>	MP:0000060,delayed bone ossification|MP:0000111,cleft palate|MP:0003743,abnormal facial morphology|MP:0009904,tongue hypoplasia|MP:0013208,abnormal cilium physiology
MGI:6144265	C2cd4a<em1(IMPC)H>	MP:0010392,prolonged QRS complex duration
MGI:6153289	C2cd4b<em1(IMPC)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0002599,increased mean platelet volume|MP:0002644,decreased circulating triglyceride level|MP:0002874,decreased hemoglobin content|MP:0005179,decreased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0010067,increased red blood cell distribution width
MGI:7425549	C2cd4c<em1(IMPC)Hmgu>	MP:0000063,decreased bone mineral density|MP:0002135,abnormal kidney morphology
MGI:4456628	C2cd4c<tm1(KOMP)Mbp>	MP:0001262,decreased body weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:7464991	C2cd5<em1(IMPC)Tcp>	MP:0001325,abnormal retina morphology|MP:0002591,decreased mean corpuscular volume|MP:0002792,abnormal retina vasculature morphology|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010097,abnormal retina blood vessel morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4044687	C2cd5<Gt(IST12020E4)Tigm>	MP:0001261,obese|MP:0001739,abnormal adrenal gland secretion|MP:0002078,abnormal glucose homeostasis|MP:0002628,hepatic steatosis|MP:0002702,decreased circulating free fatty acids level|MP:0002757,decreased vertical activity|MP:0003212,increased susceptibility to age related obesity|MP:0004890,decreased energy expenditure|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005661,decreased circulating adrenaline level|MP:0008033,impaired lipolysis|MP:0009118,increased white fat cell size|MP:0009124,increased brown fat cell lipid droplet size|MP:0009138,increased brown fat lipid droplet number|MP:0009355,increased liver triglyceride level|MP:0011014,decreased core body temperature|MP:0011049,impaired adaptive thermogenesis|MP:0011699,abnormal brown adipose tissue thermogenesis|MP:0012575,increased noradrenaline level|MP:0013279,increased fasting circulating glucose level|MP:0014172,decreased fatty acid oxidation|MP:0020103,decreased hepatic glucose production|MP:0020234,decreased basal metabolism|MP:0020426,abnormal beige fat cell physiology|MP:0020867,increased lipogenesis|MP:0030017,decreased adipocyte glucose uptake|MP:0030020,decreased cardiac muscle cell glucose uptake|MP:0030761,increased adrenaline level|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:6842332	C2cd6<tm1Jw>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009282,decreased hyperactivated sperm motility
MGI:8224028	C2<em1Lgmo>	MP:0002083,premature death
MGI:5696879	C3ar1<tm1.1(KOMP)Vlcg>	MP:0002135,abnormal kidney morphology|MP:0008528,polycystic kidney
MGI:2158678	C3ar1<tm1Cge>	MP:0002335,decreased airway responsiveness|MP:0002702,decreased circulating free fatty acids level|MP:0003981,decreased circulating phospholipid level|MP:0004985,decreased osteoclast cell number|MP:0006068,abnormal retina horizontal cell morphology|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008516,disorganized retina outer nuclear layer|MP:0008597,decreased circulating interleukin-6 level|MP:0010768,mortality/aging|MP:0012040,abnormal c-wave shape|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0030005,increased retina apoptosis|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:3785865	C3ar1<tm1Dgen>	MP:0003959,abnormal lean body mass|MP:0005334,abnormal fat pad morphology
MGI:2158707	C3ar1<tm1Raw>	MP:0000222,decreased neutrophil cell number|MP:0000921,demyelination|MP:0001790,abnormal immune system physiology|MP:0002281,abnormal respiratory mucosa goblet cell morphology|MP:0002335,decreased airway responsiveness|MP:0002420,abnormal adaptive immunity|MP:0002465,abnormal eosinophil physiology|MP:0002492,decreased IgE level|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005012,decreased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005397,hematopoietic system phenotype|MP:0005466,abnormal T-helper 2 physiology|MP:0005517,impaired liver regeneration|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008495,decreased IgG1 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008700,decreased interleukin-4 secretion|MP:0008719,impaired neutrophil recruitment|MP:0008735,increased susceptibility to endotoxin shock|MP:0008751,abnormal interleukin level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010768,mortality/aging
MGI:1861799	C3<tm1Crr>	MP:0000222,decreased neutrophil cell number|MP:0000336,decreased mast cell number|MP:0000477,abnormal intestine morphology|MP:0000598,abnormal liver morphology|MP:0000609,abnormal liver physiology|MP:0000685,abnormal immune system morphology|MP:0001364,decreased anxiety-related response|MP:0001656,focal hepatic necrosis|MP:0001657,abnormal induced morbidity/mortality|MP:0001729,impaired embryo implantation|MP:0001790,abnormal immune system physiology|MP:0001800,abnormal humoral immune response|MP:0001845,abnormal inflammatory response|MP:0001847,brain inflammation|MP:0001860,liver inflammation|MP:0002359,abnormal spleen germinal center morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002421,abnormal cell-mediated immunity|MP:0002423,abnormal mast cell physiology|MP:0002551,abnormal blood coagulation|MP:0002628,hepatic steatosis|MP:0002702,decreased circulating free fatty acids level|MP:0002743,glomerulonephritis|MP:0002919,enhanced paired-pulse facilitation|MP:0002941,increased circulating alanine transaminase level|MP:0002942,decreased circulating alanine transaminase level|MP:0003008,enhanced long-term potentiation|MP:0003071,decreased vascular permeability|MP:0003699,abnormal female reproductive system physiology|MP:0004001,decreased hepatocyte proliferation|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0004259,small placenta|MP:0004792,abnormal synaptic vesicle number|MP:0004828,decreased susceptibility to autoimmune hemolytic anemia|MP:0004859,abnormal synaptic plasticity|MP:0004957,abnormal blastocyst morphology|MP:0004985,decreased osteoclast cell number|MP:0005065,abnormal neutrophil morphology|MP:0005166,decreased susceptibility to injury|MP:0005344,increased circulating bilirubin level|MP:0005387,immune system phenotype|MP:0005391,vision/eye phenotype|MP:0005517,impaired liver regeneration|MP:0005540,decreased urine albumin level|MP:0005551,abnormal eye electrophysiology|MP:0006058,decreased cerebral infarct size|MP:0006068,abnormal retina horizontal cell morphology|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0008428,abnormal spatial working memory|MP:0008482,decreased spleen germinal center number|MP:0008484,decreased spleen germinal center size|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008597,decreased circulating interleukin-6 level|MP:0008752,abnormal tumor necrosis factor level|MP:0008947,increased neuron number|MP:0009006,prolonged estrous cycle|MP:0009431,decreased fetal weight|MP:0009453,enhanced contextual conditioning behavior|MP:0009642,abnormal blood homeostasis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0009936,abnormal dendritic spine morphology|MP:0011521,decreased placental labyrinth size|MP:0012040,abnormal c-wave shape|MP:0012099,decreased spongiotrophoblast size|MP:0012144,decreased b-wave amplitude|MP:0012306,enhanced spatial learning|MP:0014783,decreased liver enzyme/coenzyme level|MP:0020950,decreased susceptibility to Coronaviridae infection|MP:0030013,enhanced central nervous system regeneration|MP:0031266,decreased susceptibility to alcohol-induced hepatic steatosis
MGI:2158703	C3<tm1Hrc>	MP:0000005,increased brown adipose tissue amount|MP:0001262,decreased body weight|MP:0001433,polyphagia|MP:0001554,increased circulating free fatty acids level|MP:0001783,decreased white adipose tissue amount|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002412,increased susceptibility to bacterial infection|MP:0002472,impaired complement alternative pathway|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0005317,increased triglyceride level|MP:0005342,abnormal intestinal lipid absorption|MP:0005450,abnormal energy expenditure|MP:0005517,impaired liver regeneration|MP:0005560,decreased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0010025,decreased total body fat amount
MGI:2386266	C3<tm1Pkna>	MP:0002169,no abnormal phenotype detected|MP:0003436,decreased susceptibility to induced arthritis
MGI:8224027	C3<tm2(C3)Lgmo>	MP:0000315,hemoglobinuria|MP:0001860,liver inflammation|MP:0002083,premature death|MP:0002703,abnormal renal tubule morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003606,kidney failure|MP:0004154,renal tubular necrosis|MP:0004839,bile duct hyperplasia|MP:0005161,hematuria|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005327,abnormal mesangial cell morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0005505,thrombocytosis|MP:0005565,increased blood urea nitrogen level|MP:0008059,abnormal podocyte foot process morphology|MP:0008140,podocyte foot process effacement|MP:0011339,abnormal glomerular mesangium morphology|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011353,expanded mesangial matrix|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011454,abnormal glomerular endothelium fenestra morphology|MP:0011506,glomerular crescent|MP:0011566,abnormal complement protein level|MP:0012610,increased complement C5 level|MP:0020153,abnormal urine albumin level|MP:0020519,renal glomerular immunoglobulin deposits
MGI:6144264	C4b<em1(IMPC)H>	MP:0003961,decreased lean body mass|MP:0020421,increased freezing behavior
MGI:6120812	C4bp<tm1b(KOMP)Wtsi>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:7414030	C4bp<tm1Raw>	MP:0005389,reproductive system phenotype|MP:0008596,increased circulating interleukin-6 level
MGI:1889070	C4b<tm1Crr>	MP:0000219,increased neutrophil cell number|MP:0000477,abnormal intestine morphology|MP:0001790,abnormal immune system physiology|MP:0001800,abnormal humoral immune response|MP:0001860,liver inflammation|MP:0002359,abnormal spleen germinal center morphology|MP:0002411,decreased susceptibility to bacterial infection|MP:0002551,abnormal blood coagulation|MP:0002743,glomerulonephritis|MP:0003071,decreased vascular permeability|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004952,increased spleen weight|MP:0005325,abnormal renal glomerulus morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005425,increased macrophage cell number|MP:0008481,increased spleen germinal center number|MP:0008482,decreased spleen germinal center number|MP:0008484,decreased spleen germinal center size|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0020518,renal glomerular protein deposits|MP:0020950,decreased susceptibility to Coronaviridae infection
MGI:1934246	C5ar1<tm1Cge>	MP:0001800,abnormal humoral immune response|MP:0002412,increased susceptibility to bacterial infection|MP:0002702,decreased circulating free fatty acids level|MP:0004985,decreased osteoclast cell number|MP:0008597,decreased circulating interleukin-6 level|MP:0008719,impaired neutrophil recruitment|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0012040,abnormal c-wave shape
MGI:3028524	C5ar1<tm1Raw>	MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0008481,increased spleen germinal center number
MGI:5426685	C5ar1<tm1Song>	MP:0002463,abnormal neutrophil physiology
MGI:6717141	C5ar2<em1(IMPC)H>	MP:0000219,increased neutrophil cell number|MP:0005012,decreased eosinophil cell number
MGI:3612426	C5ar2<tm1Cge>	MP:0001819,abnormal immune cell physiology|MP:0001846,increased inflammatory response
MGI:3721065	C5ar2<tm1Gdy>	MP:0000598,abnormal liver morphology|MP:0001656,focal hepatic necrosis|MP:0001657,abnormal induced morbidity/mortality|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005666,abnormal adipose tissue physiology|MP:0009115,abnormal fat cell morphology|MP:0010954,abnormal cellular respiration|MP:0011939,increased food intake|MP:0014171,increased fatty acid oxidation
MGI:3714381	C6<Q0>	MP:0005166,decreased susceptibility to injury
MGI:5823284	C7<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0000432,abnormal head morphology|MP:0001303,abnormal lens morphology|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002075,abnormal coat/hair pigmentation
MGI:5605820	C8a<tm1b(EUCOMM)Hmgu>	MP:0000062,increased bone mineral density|MP:0001417,decreased exploration in new environment|MP:0005013,increased lymphocyte cell number
MGI:3721517	C8b<0>	MP:0001545,abnormal hematopoietic system physiology
MGI:5637199	C8b<tm1b(EUCOMM)Hmgu>	MP:0010068,decreased red blood cell distribution width
MGI:6514830	C9<em1Sjlg>	MP:0002473,impaired complement classical pathway|MP:0008658,decreased interleukin-1 beta secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:6118174	C9orf72<em1Eggn>	MP:0000208,decreased hematocrit|MP:0000691,enlarged spleen|MP:0002083,premature death|MP:0004762,increased anti-double stranded DNA antibody level|MP:0008542,enlarged cervical lymph nodes
MGI:5751186	C9orf72<em5Lutzy>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002451,abnormal macrophage physiology|MP:0003631,nervous system phenotype|MP:0003691,abnormal microglial cell physiology|MP:0005059,lysosomal protein accumulation|MP:0005386,behavior/neurological phenotype|MP:0008027,abnormal spinal cord white matter morphology|MP:0008503,abnormal spinal cord grey matter morphology
MGI:5883590	C9orf72<tm1.1Eggn>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001194,dermatitis|MP:0001847,brain inflammation|MP:0001860,liver inflammation|MP:0001953,respiratory failure|MP:0002083,premature death|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002591,decreased mean corpuscular volume|MP:0002619,abnormal lymphocyte morphology|MP:0002810,microcytic anemia|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0003631,nervous system phenotype|MP:0003725,increased autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005150,cachexia|MP:0005350,increased susceptibility to autoimmune disorder|MP:0008588,abnormal circulating interleukin level|MP:0008600,decreased circulating interleukin-2 level|MP:0009338,increased splenocyte number|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010210,abnormal circulating cytokine level
MGI:5548633	C9orf72<tm1.1(KOMP)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001147,small testis|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0004599,abnormal vertebral arch morphology|MP:0004952,increased spleen weight|MP:0010025,decreased total body fat amount
MGI:5883587	C9orf72<tm1Eggn>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001194,dermatitis|MP:0001393,ataxia|MP:0001634,internal hemorrhage|MP:0001953,respiratory failure|MP:0002083,premature death|MP:0002591,decreased mean corpuscular volume|MP:0002619,abnormal lymphocyte morphology|MP:0002810,microcytic anemia|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005150,cachexia|MP:0005350,increased susceptibility to autoimmune disorder|MP:0008542,enlarged cervical lymph nodes|MP:0010210,abnormal circulating cytokine level
MGI:5779391	C9orf72<tm1Lagi>	MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0002351,abnormal cervical lymph node morphology|MP:0002874,decreased hemoglobin content|MP:0005016,decreased lymphocyte cell number|MP:0008542,enlarged cervical lymph nodes|MP:0008828,abnormal lymph node cell ratio|MP:0009626,abnormal celiac lymph node morphology
MGI:5494473	C9<tm1.1(KOMP)Vlcg>	MP:0001488,increased startle reflex|MP:0002833,increased heart weight|MP:0005633,increased circulating sodium level
MGI:4830597	CA001	MP:0000195,decreased circulating calcium level
MGI:7573114	Caap1<em1(IMPC)Mbp>	MP:0000538,abnormal urinary bladder morphology|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0011874,enlarged urinary bladder
MGI:6492224	Caap1<em1Jcbs>	MP:0002169,no abnormal phenotype detected
MGI:1856812	cab	MP:0000189,hypoglycemia|MP:0000598,abnormal liver morphology|MP:0001177,atelectasis|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002078,abnormal glucose homeostasis|MP:0003105,abnormal heart atrium morphology|MP:0003806,abnormal nucleotide metabolism|MP:0005156,bradykinesia|MP:0005294,abnormal heart ventricle morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005439,decreased glycogen level|MP:0006382,abnormal lung epithelium morphology|MP:0008817,hematoma|MP:0011089,perinatal lethality, complete penetrance
MGI:7615150	Cab39<em1(IMPC)Tcp>	MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0001697,abnormal embryo size|MP:0002764,short tibia|MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0005016,decreased lymphocyte cell number|MP:0005565,increased blood urea nitrogen level|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance
MGI:5637018	Cab39l<tm1b(EUCOMM)Wtsi>	MP:0000274,enlarged heart|MP:0002591,decreased mean corpuscular volume
MGI:7665327	Cab39l<tm1d(EUCOMM)Wtsi>	MP:0000540,abnormal urinary bladder urothelium morphology|MP:0004499,increased incidence of tumors by chemical induction
MGI:7594038	Cabcoco1<em1Gaof>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum
MGI:4365217	Cabcoco1<tm1a(KOMP)Wtsi>	MP:0001925,male infertility|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level
MGI:7425551	Cabin1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0011045,decreased lung elastance|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2429675	Cabin1<tm1.1Che>	MP:0001800,abnormal humoral immune response|MP:0002497,increased IgE level|MP:0003009,abnormal cytokine secretion|MP:0005387,immune system phenotype|MP:0008499,increased IgG1 level|MP:0008501,increased IgG2b level
MGI:2429669	Cabin1<tm1Che>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5581467	Cables1<Tg(CAG-rtTA,CAG-tTS)138Utr>	MP:0000783,abnormal forebrain morphology|MP:0000952,abnormal CNS glial cell morphology|MP:0001394,circling|MP:0002196,absent corpus callosum|MP:0008222,decreased hippocampal commissure size|MP:0008226,decreased anterior commissure size|MP:0008535,enlarged lateral ventricles
MGI:3027499	Cables1<tm1Lrz>	MP:0001123,dilated uterus|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0004868,increased endometrial carcinoma incidence|MP:0004896,abnormal endometrium morphology|MP:0004906,enlarged uterus|MP:0009092,endometrium hyperplasia|MP:0009094,abnormal endometrial gland morphology
MGI:5581469	Cables1<tm1Utr>	MP:0003631,nervous system phenotype
MGI:6761760	Cables2<em2Utr>	MP:0002169,no abnormal phenotype detected
MGI:4951297	Cables2<tm1(KOMP)Vlcg>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0003984,embryonic growth retardation|MP:0006042,increased apoptosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5618492	Cabp1<tm1Alee>	MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology
MGI:5548480	Cabp1<tm1b(EUCOMM)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001510,abnormal coat appearance|MP:0004952,increased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0010025,decreased total body fat amount
MGI:6195841	Cabp2<em1(IMPC)J>	MP:0001489,decreased startle reflex|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0004738,abnormal auditory brainstem response
MGI:6120904	Cabp2<tm1b(KOMP)Mbp>	MP:0004433,abnormal cochlear inner hair cell physiology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0006335,abnormal hearing electrophysiology|MP:0010768,mortality/aging|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:6157024	Cabp2<tm1Fha>	MP:0003631,nervous system phenotype|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology
MGI:5577270	Cabp4<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology
MGI:3056615	Cabp4<tm1Kpal>	MP:0001005,abnormal retina rod cell morphology|MP:0001006,abnormal retina cone cell morphology|MP:0001325,abnormal retina morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005253,abnormal eye physiology|MP:0005551,abnormal eye electrophysiology|MP:0006069,abnormal retina neuronal layer morphology|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0008515,thin retina outer nuclear layer|MP:0008519,thin retina outer plexiform layer|MP:0014336,short retina rod cell outer segment
MGI:6120713	Cabp5<tm1b(KOMP)Wtsi>	MP:0002100,abnormal tooth morphology|MP:0005293,impaired glucose tolerance
MGI:6369037	Cabp5<tm1Fha>	MP:0005253,abnormal eye physiology|MP:0005391,vision/eye phenotype
MGI:6694874	Cabs1<em1Ntu>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0009237,kinked sperm flagellum|MP:0009834,abnormal sperm annulus morphology|MP:0009835,absent sperm annulus
MGI:6459768	Cabs1<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6152666	Cabyr<em1Osb>	MP:0001922,reduced male fertility|MP:0002674,abnormal sperm motility|MP:0003666,impaired sperm capacitation|MP:0003698,abnormal male reproductive system physiology|MP:0008892,abnormal sperm flagellum morphology|MP:0009280,decreased activated sperm motility|MP:0009836,abnormal sperm principal piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0020451,decreased sperm progressive motility|MP:0030590,abnormal sperm fibrous sheath morphology
MGI:1856813	cac	MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology|MP:0003236,abnormal lens capsule morphology
MGI:5427429	Cacfd1<tm1.1Geno>	MP:0000352,decreased cell proliferation|MP:0004502,decreased incidence of tumors by chemical induction|MP:0006042,increased apoptosis|MP:0009828,increased tumor latency
MGI:5007000	Cacfd1<tm1Lex>	MP:0001489,decreased startle reflex|MP:0001552,increased circulating triglyceride level|MP:0005178,increased circulating cholesterol level
MGI:5795757	Cachd1<em1(IMPC)J>	MP:0000194,increased circulating calcium level|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6827308	Cachd1<em1Kjn>	MP:0000026,abnormal inner ear morphology|MP:0000035,abnormal membranous labyrinth morphology|MP:0000042,abnormal organ of Corti morphology|MP:0001394,circling|MP:0003144,decreased otolith number|MP:0003149,abnormal tectorial membrane morphology|MP:0003169,abnormal scala media morphology|MP:0004402,decreased cochlear outer hair cell number|MP:0004411,decreased endocochlear potential|MP:0004422,small temporal bone|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004885,abnormal endolymph physiology|MP:0004886,increased endolymph production|MP:0005191,head tilt|MP:0006012,dilated endolymphatic duct|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology|MP:0006403,abnormal cochlear endolymph ionic homeostasis|MP:0011238,abnormal inner ear development|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6827187	Cachd1<tow>	MP:0000026,abnormal inner ear morphology|MP:0001394,circling|MP:0001522,impaired swimming|MP:0003144,decreased otolith number|MP:0005191,head tilt|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology|MP:0011238,abnormal inner ear development|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:7518212	Cacna1a<em1Andm>	MP:0001393,ataxia
MGI:6257534	Cacna1a<em1(IMPC)H>	MP:0011110,preweaning lethality, incomplete penetrance|MP:0020421,increased freezing behavior
MGI:6269366	Cacna1a<m1Btlr>	MP:0001405,impaired coordination|MP:0001525,impaired balance
MGI:2154404	Cacna1a<rkr>	MP:0000745,tremors|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0003216,absence seizures|MP:0003312,abnormal locomotor coordination|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:5499996	Cacna1a<smrl>	MP:0001393,ataxia|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0001524,impaired limb coordination|MP:0001525,impaired balance|MP:0001935,decreased litter size|MP:0005391,vision/eye phenotype|MP:0008770,decreased survivor rate|MP:0010769,abnormal survival|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:1856209	Cacna1a<tg>	MP:0000951,sporadic seizures|MP:0001262,decreased body weight|MP:0001386,abnormal maternal nurturing|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001522,impaired swimming|MP:0001524,impaired limb coordination|MP:0001908,abnormal somatosensory cortex physiology|MP:0001921,reduced fertility|MP:0001924,infertility|MP:0002064,seizures|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002206,abnormal CNS synaptic transmission|MP:0002272,abnormal nervous system electrophysiology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003635,abnormal synaptic transmission|MP:0004145,abnormal muscle electrophysiology|MP:0004807,abnormal paired-pulse inhibition|MP:0005323,dystonia|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0014812,abnormal brain physiology
MGI:2155892	Cacna1a<tg-4J>	MP:0001393,ataxia|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002272,abnormal nervous system electrophysiology|MP:0003216,absence seizures|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0014327,decreased Purkinje cell size|MP:0014329,abnormal Purkinje cell axon morphology
MGI:2181625	Cacna1a<Tg-5J>	MP:0000877,abnormal Purkinje cell morphology|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0002083,premature death|MP:0002272,abnormal nervous system electrophysiology|MP:0005404,abnormal axon morphology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3588961	Cacna1a<tg-6J>	MP:0000333,decreased bone marrow cell number|MP:0001265,decreased body size|MP:0001513,limb grasping|MP:0001524,impaired limb coordination|MP:0002356,abnormal spleen red pulp morphology|MP:0003644,thymus atrophy
MGI:4456266	Cacna1a<Tg-7J>	MP:0001393,ataxia|MP:0001406,abnormal gait
MGI:1856210	Cacna1a<tg-la>	MP:0003477,abnormal nerve fiber response|MP:0003481,decreased nerve fiber response intensity|MP:0003484,abnormal channel response|MP:0003631,nervous system phenotype|MP:0003998,decreased thermal nociceptive threshold|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential|MP:0005498,hyporesponsive to tactile stimuli
MGI:1856211	Cacna1a<tg-rol>	MP:0000746,weakness|MP:0000747,muscle weakness|MP:0000849,abnormal cerebellum morphology|MP:0000851,cerebellum hypoplasia|MP:0000852,small cerebellum|MP:0001262,decreased body weight|MP:0001382,abnormal nursing|MP:0001393,ataxia|MP:0001524,impaired limb coordination|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002206,abnormal CNS synaptic transmission|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002919,enhanced paired-pulse facilitation|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004145,abnormal muscle electrophysiology|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005266,abnormal metabolism|MP:0005277,abnormal brainstem morphology|MP:0006042,increased apoptosis|MP:0010768,mortality/aging|MP:0011273,prolonged excitatory postsynaptic current decay time|MP:0012575,increased noradrenaline level|MP:0012590,decreased choline O-acetyltransferase activity|MP:0014185,cerebellum atrophy|MP:0014814,increased brain glucose metabolism|MP:0020076,increased brain tyrosine 3-monooxygenase activity|MP:0030635,increased taurine level|MP:0030658,increased glycine level|MP:0030737,decreased glutamic acid level
MGI:3718033	Cacna1a<tm1.1(CACNA1A)Ttan>	MP:0001393,ataxia|MP:0005323,dystonia|MP:0011083,lethality at weaning, complete penetrance
MGI:5704132	Cacna1a<tm1.1Ehess>	MP:0003484,abnormal channel response|MP:0005386,behavior/neurological phenotype
MGI:5467731	Cacna1a<tm1.1Kewa>	MP:0002169,no abnormal phenotype detected
MGI:4949728	Cacna1a<tm1.1Sher>	MP:0000852,small cerebellum|MP:0000890,thin cerebellar molecular layer|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0002169,no abnormal phenotype detected|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003216,absence seizures|MP:0003484,abnormal channel response|MP:0005402,abnormal action potential|MP:0006099,thin cerebellar granule layer|MP:0008840,abnormal spike wave discharge|MP:0009357,abnormal seizure response to inducing agent|MP:0009358,environmentally induced seizures|MP:0010053,decreased grip strength
MGI:4949729	Cacna1a<tm1.2Sher>	MP:0001265,decreased body size|MP:0001393,ataxia|MP:0002064,seizures|MP:0002083,premature death|MP:0002945,abnormal inhibitory postsynaptic currents
MGI:3718032	Cacna1a<tm1(CACNA1A)Ttan>	MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0005323,dystonia|MP:0011083,lethality at weaning, complete penetrance
MGI:2180190	Cacna1a<tm1Fcr>	MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002152,abnormal brain morphology|MP:0003633,abnormal nervous system physiology
MGI:2181384	Cacna1a<tm1Hssh>	MP:0000743,muscle spasm|MP:0000852,small cerebellum|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0002083,premature death|MP:0002206,abnormal CNS synaptic transmission|MP:0002882,abnormal neuron morphology|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003484,abnormal channel response|MP:0004994,abnormal brain wave pattern|MP:0005404,abnormal axon morphology|MP:0008840,abnormal spike wave discharge|MP:0009538,abnormal synapse morphology
MGI:3810386	Cacna1a<tm1Hzo>	MP:0003484,abnormal channel response|MP:0005386,behavior/neurological phenotype
MGI:5140539	Cacna1a<tm1Kano>	MP:0000852,small cerebellum|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0002206,abnormal CNS synaptic transmission|MP:0002882,abnormal neuron morphology|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008921,increased neurotransmitter release|MP:0011267,abnormal excitatory postsynaptic current amplitude|MP:0011271,prolonged excitatory postsynaptic current rise time|MP:0011273,prolonged excitatory postsynaptic current decay time
MGI:6226076	Cacna1a<tm1Lory>	MP:0000889,abnormal cerebellar molecular layer|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002757,decreased vertical activity|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003216,absence seizures|MP:0003894,abnormal Purkinje cell innervation|MP:0005402,abnormal action potential|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008925,increased cerebellar granule cell number|MP:0009538,abnormal synapse morphology|MP:0010053,decreased grip strength|MP:0011085,postnatal lethality, complete penetrance|MP:0011269,increased excitatory postsynaptic current amplitude|MP:0011270,decreased excitatory postsynaptic current amplitude
MGI:3037859	Cacna1a<tm1Maag>	MP:0001394,circling|MP:0001504,abnormal posture|MP:0002206,abnormal CNS synaptic transmission|MP:0002272,abnormal nervous system electrophysiology|MP:0002913,abnormal PNS synaptic transmission|MP:0003076,increased susceptibility to ischemic brain injury|MP:0003484,abnormal channel response|MP:0004835,abnormal miniature endplate potential|MP:0004836,abnormal synaptic acetylcholine release|MP:0006060,increased cerebral infarct size|MP:0008872,abnormal physiological response to xenobiotic|MP:0009746,enhanced behavioral response to xenobiotic|MP:0031202,hemiplegia
MGI:4415271	Cacna1a<tm1Nobs>	MP:0001393,ataxia|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death
MGI:3718035	Cacna1a<tm2.1(CACNA1A)Ttan>	MP:0001393,ataxia|MP:0005323,dystonia|MP:0011083,lethality at weaning, complete penetrance
MGI:5467732	Cacna1a<tm2.1Kewa>	MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001516,abnormal motor coordination/balance|MP:0002272,abnormal nervous system electrophysiology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0014327,decreased Purkinje cell size|MP:0014331,abnormal Purkinje cell mitochondrial morphology
MGI:3696966	Cacna1a<tm2.1Maag>	MP:0000745,tremors|MP:0000849,abnormal cerebellum morphology|MP:0000876,Purkinje cell degeneration|MP:0000889,abnormal cerebellar molecular layer|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0002169,no abnormal phenotype detected|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004101,abnormal brain interneuron morphology
MGI:3718034	Cacna1a<tm2(CACNA1A)Ttan>	MP:0011083,lethality at weaning, complete penetrance
MGI:3810387	Cacna1a<tm2Hzo>	MP:0003484,abnormal channel response|MP:0005386,behavior/neurological phenotype
MGI:4415272	Cacna1a<tm2Nobs>	MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0003216,absence seizures|MP:0003996,clonic seizures|MP:0008840,abnormal spike wave discharge|MP:0010768,mortality/aging|MP:0014185,cerebellum atrophy
MGI:3810388	Cacna1a<tm3Hzo>	MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000890,thin cerebellar molecular layer|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001511,disheveled coat|MP:0001525,impaired balance|MP:0002882,abnormal neuron morphology|MP:0003484,abnormal channel response|MP:0003631,nervous system phenotype
MGI:3836195	Cacna1a<tm3Maag>	MP:0001394,circling|MP:0001405,impaired coordination|MP:0001504,abnormal posture|MP:0001953,respiratory failure|MP:0002064,seizures|MP:0002272,abnormal nervous system electrophysiology|MP:0003076,increased susceptibility to ischemic brain injury|MP:0006060,increased cerebral infarct size|MP:0008872,abnormal physiological response to xenobiotic|MP:0009746,enhanced behavioral response to xenobiotic|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0031202,hemiplegia
MGI:3706667	Cacna1a<Wb>	MP:0000890,thin cerebellar molecular layer|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001523,impaired righting response|MP:0002083,premature death|MP:0003631,nervous system phenotype|MP:0005323,dystonia|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0010053,decreased grip strength|MP:0010768,mortality/aging|MP:0014185,cerebellum atrophy|MP:0014587,impaired fine motor coordination
MGI:4838018	Cacna1b<tm1.1Dili>	MP:0003463,abnormal single cell response|MP:0005386,behavior/neurological phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5572039	Cacna1b<tm1b(KOMP)Wtsi>	MP:0001364,decreased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001415,increased exploration in new environment|MP:0004924,abnormal behavior|MP:0010053,decreased grip strength|MP:0013278,decreased fasting circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:2388140	Cacna1b<tm1Hssh>	MP:0001353,increased aggression towards mice|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001752,abnormal hypothalamus secretion|MP:0001973,increased thermal nociceptive threshold|MP:0002063,abnormal learning/memory/conditioning|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002272,abnormal nervous system electrophysiology|MP:0002570,alcohol aversion|MP:0002802,abnormal discrimination learning|MP:0002805,abnormal conditioned taste aversion behavior|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0002969,impaired social transmission of food preference|MP:0003463,abnormal single cell response|MP:0003470,abnormal summary potential|MP:0003484,abnormal channel response|MP:0003546,decreased alcohol consumption|MP:0003631,nervous system phenotype|MP:0003635,abnormal synaptic transmission|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005498,hyporesponsive to tactile stimuli|MP:0008432,abnormal long-term spatial reference memory|MP:0008531,increased chemical nociceptive threshold|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0009712,impaired conditioned place preference behavior|MP:0009751,enhanced behavioral response to alcohol|MP:0009755,impaired behavioral response to alcohol
MGI:2180187	Cacna1b<tm1Ksw>	MP:0000231,hypertension|MP:0001399,hyperactivity|MP:0001501,abnormal sleep pattern|MP:0001547,abnormal lipid level|MP:0001973,increased thermal nociceptive threshold|MP:0002626,increased heart rate|MP:0002644,decreased circulating triglyceride level|MP:0002696,decreased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0003194,abnormal frequency of paradoxical sleep|MP:0003484,abnormal channel response|MP:0004183,abnormal sympathetic nervous system physiology|MP:0004184,abnormal baroreceptor physiology|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005386,behavior/neurological phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008531,increased chemical nociceptive threshold|MP:0009436,fragmentation of sleep/wake states|MP:0014639,decreased sleep duration
MGI:2387803	Cacna1b<tm1Ttan>	MP:0001364,decreased anxiety-related response|MP:0001489,decreased startle reflex|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0005498,hyporesponsive to tactile stimuli|MP:0008531,increased chemical nociceptive threshold|MP:0009745,abnormal behavioral response to xenobiotic|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4838019	Cacna1b<tm2.1Dili>	MP:0001982,decreased chemically-elicited antinociception|MP:0003463,abnormal single cell response
MGI:8265024	Cacna1c<em1Gsp>	MP:0000189,hypoglycemia|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001426,polydipsia|MP:0001759,increased urine glucose level|MP:0002575,increased circulating ketone body level|MP:0002696,decreased circulating glucagon level|MP:0002711,decreased glucagon secretion|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003017,decreased circulating bicarbonate level|MP:0003030,acidemia|MP:0003233,prolonged QT interval|MP:0003484,abnormal channel response|MP:0005292,improved glucose tolerance|MP:0005379,endocrine/exocrine gland phenotype|MP:0005452,abnormal adipose tissue amount|MP:0005662,increased circulating adrenaline level|MP:0005668,decreased circulating leptin level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011091,prenatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011940,decreased food intake|MP:0030588,decreased pancreatic alpha cell mass
MGI:6362815	Cacna1c<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001402,decreased locomotor activity|MP:0001711,abnormal placenta morphology|MP:0002135,abnormal kidney morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0002989,small kidney|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation|MP:0020421,increased freezing behavior
MGI:4462362	Cacna1c<tm1.1Knt>	MP:0002063,abnormal learning/memory/conditioning|MP:0005386,behavior/neurological phenotype|MP:0008531,increased chemical nociceptive threshold
MGI:5528791	Cacna1c<tm1.1Wac>	MP:0001625,cardiac hypertrophy|MP:0002972,abnormal cardiac muscle contractility|MP:0003061,decreased aerobic running capacity|MP:0004145,abnormal muscle electrophysiology|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005389,reproductive system phenotype
MGI:3604527	Cacna1c<tm1Dgen>	MP:0000458,abnormal mandible morphology|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002797,increased thigmotaxis|MP:0005378,growth/size/body region phenotype|MP:0011100,preweaning lethality, complete penetrance
MGI:5446616	Cacna1c<tm1Ggm>	MP:0002083,premature death|MP:0005140,decreased cardiac muscle contractility|MP:0008022,dilated heart ventricle|MP:0008432,abnormal long-term spatial reference memory
MGI:2674113	Cacna1c<tm1Hfm>	MP:0002085,abnormal embryonic tissue morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4949646	Cacna1c<tm1Itl>	MP:0000276,heart right ventricle hypertrophy|MP:0001625,cardiac hypertrophy|MP:0001634,internal hemorrhage|MP:0002833,increased heart weight|MP:0003139,patent ductus arteriosus|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0004811,abnormal neuron physiology|MP:0006138,congestive heart failure|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3047071	Cacna1c<tm1Jst>	MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002206,abnormal CNS synaptic transmission|MP:0002573,behavioral despair|MP:0003633,abnormal nervous system physiology|MP:0004215,abnormal myocardial fiber physiology
MGI:3829031	Cacna1c<tm1Msmg>	MP:0005385,cardiovascular system phenotype
MGI:5662550	Cacna1c<tm2.1Wac>	MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0003061,decreased aerobic running capacity|MP:0004215,abnormal myocardial fiber physiology|MP:0004231,abnormal calcium ion homeostasis|MP:0005140,decreased cardiac muscle contractility|MP:0011390,abnormal fetal cardiomyocyte physiology|MP:0012557,decreased calcium uptake by cardiac muscle
MGI:2674114	Cacna1c<tm2Hfm>	MP:0002085,abnormal embryonic tissue morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5296904	Cacna1c<tm2Itl>	MP:0001194,dermatitis|MP:0001360,abnormal social investigation|MP:0001409,increased stereotypic behavior|MP:0001412,excessive scratching|MP:0001417,decreased exploration in new environment|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0005386,behavior/neurological phenotype|MP:0008535,enlarged lateral ventricles|MP:0009453,enhanced contextual conditioning behavior|MP:0009455,enhanced cued conditioning behavior|MP:0011085,postnatal lethality, complete penetrance|MP:0020351,decreased vocalization
MGI:2674119	Cacna1c<tm3Hfm>	MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level
MGI:5293799	Cacna1c<tm5.1Hfm>	MP:0001636,irregular heartbeat|MP:0004215,abnormal myocardial fiber physiology|MP:0005333,decreased heart rate|MP:0011085,postnatal lethality, complete penetrance
MGI:7520869	Cacna1d<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:5431126	Cacna1d<tm1Hgn>	MP:0000848,abnormal pons morphology|MP:0004736,abnormal distortion product otoacoustic emission|MP:0008948,decreased neuron number|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0014406,increased or absent distortion product otoacoustic emission threshold|MP:0031671,decreased auditory brainstem response wave amplitude|MP:0031672,increased auditory brainstem response wave amplitude
MGI:2180138	Cacna1d<tm1Hssh>	MP:0001262,decreased body weight|MP:0001967,deafness|MP:0002727,decreased circulating insulin level|MP:0002857,cochlear ganglion degeneration|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0003562,abnormal pancreatic beta cell physiology|MP:0004231,abnormal calcium ion homeostasis|MP:0004404,cochlear outer hair cell degeneration|MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004530,absent outer hair cell stereocilia|MP:0004737,absent distortion product otoacoustic emissions|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0006358,absent pinna reflex|MP:0009114,decreased pancreatic beta cell mass|MP:0009168,decreased pancreatic islet number|MP:0009175,abnormal pancreatic beta cell differentiation|MP:0009176,increased pancreatic alpha cell number|MP:0011820,decreased pancreatic beta cell proliferation|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2180141	Cacna1d<tm1Jst>	MP:0001262,decreased body weight|MP:0001629,abnormal heart rate|MP:0001967,deafness|MP:0002626,increased heart rate|MP:0002857,cochlear ganglion degeneration|MP:0003631,nervous system phenotype|MP:0003896,prolonged PR interval|MP:0003928,increased heart rate variability|MP:0004122,abnormal sinus arrhythmia|MP:0004215,abnormal myocardial fiber physiology|MP:0004231,abnormal calcium ion homeostasis|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004433,abnormal cochlear inner hair cell physiology|MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004562,abnormal inner hair cell synaptic ribbon morphology|MP:0004563,absent active-zone-anchored inner hair cell synaptic ribbon|MP:0004633,abnormal cochlear IHC efferent innervation pattern|MP:0004716,abnormal cochlear nerve morphology|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004740,sensorineural hearing loss|MP:0004746,abnormal cochlear IHC afferent innervation pattern|MP:0005333,decreased heart rate|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential|MP:0006142,abnormal sinoatrial node conduction|MP:0006358,absent pinna reflex|MP:0008543,atrial fibrillation|MP:0010506,prolonged RR interval|MP:0010519,atrioventricular block|MP:0010559,heart block|MP:0010637,sinus bradycardia|MP:0010768,mortality/aging|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3619022	Cacna1e<tm1.1Beck>	MP:0003488,decreased channel response intensity|MP:0003489,increased channel response threshold
MGI:3526823	Cacna1e<tm1.1Tsch>	MP:0001260,increased body weight|MP:0001559,hyperglycemia|MP:0002696,decreased circulating glucagon level|MP:0002711,decreased glucagon secretion|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0003565,abnormal glucagon secretion|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009177,decreased pancreatic alpha cell number
MGI:2451031	Cacna1e<tm1Hssh>	MP:0002065,abnormal fear/anxiety-related behavior|MP:0002797,increased thigmotaxis|MP:0003484,abnormal channel response
MGI:2180170	Cacna1e<tm1Rjml>	MP:0002169,no abnormal phenotype detected
MGI:3526822	Cacna1e<tm1Tsch>	MP:0002169,no abnormal phenotype detected
MGI:2179732	Cacna1e<tm1Ttan>	MP:0002065,abnormal fear/anxiety-related behavior|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002067,abnormal sensory capabilities/reflexes/nociception
MGI:3605845	Cacna1f<nob2>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0006068,abnormal retina horizontal cell morphology|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0008056,abnormal retina ganglion cell morphology|MP:0008520,disorganized retina outer plexiform layer
MGI:5817401	Cacna1f<nob9>	MP:0001006,abnormal retina cone cell morphology|MP:0002864,abnormal ocular fundus morphology|MP:0004022,abnormal cone electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008446,decreased retina cone cell number|MP:0008519,thin retina outer plexiform layer|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0012671,retina spots|MP:0020439,absent b-wave
MGI:5708191	Cacna1f<tm1.1(KOMP)Vlcg>	MP:0001333,absent optic nerve|MP:0001399,hyperactivity|MP:0002079,increased circulating insulin level|MP:0002092,abnormal eye morphology|MP:0005553,increased circulating creatinine level
MGI:3838717	Cacna1f<tm1.1Sdie>	MP:0001006,abnormal retina cone cell morphology|MP:0001325,abnormal retina morphology|MP:0002001,blindness|MP:0002090,abnormal vision|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0003734,abnormal retina inner plexiform layer morphology|MP:0004811,abnormal neuron physiology|MP:0005253,abnormal eye physiology|MP:0006068,abnormal retina horizontal cell morphology|MP:0006072,abnormal retina apoptosis|MP:0006073,abnormal retina bipolar cell morphology|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008519,thin retina outer plexiform layer|MP:0009392,retina gliosis|MP:0009538,abnormal synapse morphology|MP:0012029,abnormal electroretinogram waveform feature|MP:0012034,abnormal a-wave shape|MP:0012035,abnormal b-wave shape|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:5317193	Cacna1f<tm1.2Sdie>	MP:0004811,abnormal neuron physiology|MP:0005253,abnormal eye physiology|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008515,thin retina outer nuclear layer|MP:0009538,abnormal synapse morphology|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0030005,increased retina apoptosis
MGI:3609549	Cacna1f<tm1Ntbh>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0005551,abnormal eye electrophysiology|MP:0006068,abnormal retina horizontal cell morphology|MP:0006069,abnormal retina neuronal layer morphology|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0008519,thin retina outer plexiform layer|MP:0010749,absent visual evoked potential|MP:0012029,abnormal electroretinogram waveform feature
MGI:6400521	Cacna1g<em1Ftan>	MP:0000876,Purkinje cell degeneration|MP:0000890,thin cerebellar molecular layer|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0002229,neurodegeneration|MP:0003354,astrocytosis|MP:0003412,abnormal afterhyperpolarization|MP:0003484,abnormal channel response|MP:0004097,abnormal cerebellar cortex morphology|MP:0004811,abnormal neuron physiology
MGI:6276856	Cacna1g<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0001148,enlarged testis|MP:0001415,increased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney
MGI:3530501	Cacna1g<tm1.1Stl>	MP:0001402,decreased locomotor activity|MP:0001501,abnormal sleep pattern|MP:0002578,impaired ability to fire action potentials|MP:0005402,abnormal action potential|MP:0009436,fragmentation of sleep/wake states|MP:0014639,decreased sleep duration
MGI:4354305	Cacna1g<tm1.3Ksak>	MP:0003463,abnormal single cell response|MP:0009747,impaired behavioral response to xenobiotic
MGI:3851330	Cacna1g<tm1Dgen>	MP:0001399,hyperactivity|MP:0005659,decreased susceptibility to diet-induced obesity
MGI:2182962	Cacna1g<tm1Hssh>	MP:0000745,tremors|MP:0001405,impaired coordination|MP:0001544,abnormal cardiovascular system physiology|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0003633,abnormal nervous system physiology|MP:0005333,decreased heart rate|MP:0005402,abnormal action potential|MP:0006141,abnormal atrioventricular node conduction|MP:0006142,abnormal sinoatrial node conduction|MP:0008840,abnormal spike wave discharge|MP:0011953,prolonged PQ interval
MGI:3530499	Cacna1g<tm1Stl>	MP:0001501,abnormal sleep pattern|MP:0005386,behavior/neurological phenotype|MP:0009436,fragmentation of sleep/wake states
MGI:2682015	Cacna1h<tm1Kcam>	MP:0000164,abnormal cartilage development|MP:0000278,abnormal myocardial fiber morphology|MP:0001265,decreased body size|MP:0001529,abnormal vocalization|MP:0001614,abnormal blood vessel morphology|MP:0002127,abnormal cardiovascular system morphology|MP:0003025,increased vasoconstriction|MP:0003120,abnormal tracheal cartilage morphology|MP:0003141,cardiac fibrosis|MP:0003484,abnormal channel response|MP:0004112,abnormal arteriole morphology|MP:0010883,trachea stenosis
MGI:6704921	Cacna1i<em1Jqp>	MP:0002272,abnormal nervous system electrophysiology|MP:0003412,abnormal afterhyperpolarization|MP:0003463,abnormal single cell response|MP:0004994,abnormal brain wave pattern|MP:0005402,abnormal action potential
MGI:6704922	Cacna1i<em2Jqp>	MP:0002272,abnormal nervous system electrophysiology|MP:0003412,abnormal afterhyperpolarization|MP:0003463,abnormal single cell response|MP:0005402,abnormal action potential
MGI:5548772	Cacna1i<tm1b(KOMP)Wtsi>	MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0001402,decreased locomotor activity|MP:0001944,abnormal pancreas morphology|MP:0002188,small heart|MP:0002833,increased heart weight|MP:0003019,increased circulating chloride level
MGI:1856326	Cacna1s<mdg>	MP:0000005,increased brown adipose tissue amount|MP:0000088,short mandible|MP:0000150,abnormal rib morphology|MP:0000157,abnormal sternum morphology|MP:0000160,kyphosis|MP:0000163,abnormal cartilage morphology|MP:0000435,shortened head|MP:0000458,abnormal mandible morphology|MP:0000733,abnormal muscle development|MP:0000738,impaired muscle contractility|MP:0000749,muscle degeneration|MP:0000761,thin diaphragm muscle|MP:0000762,abnormal tongue morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001052,abnormal innervation pattern to muscle|MP:0001078,abnormal phrenic nerve morphology|MP:0001404,no spontaneous movement|MP:0001513,limb grasping|MP:0001785,edema|MP:0002106,abnormal muscle physiology|MP:0002108,abnormal muscle morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002279,abnormal diaphragm morphology|MP:0002639,micrognathia|MP:0002841,impaired skeletal muscle contractility|MP:0002932,abnormal joint morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003201,extremity edema|MP:0004087,abnormal muscle fiber morphology|MP:0004089,dilated sarcoplasmic reticulum|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0004136,abnormal tongue muscle morphology|MP:0004174,abnormal spine curvature|MP:0004198,abnormal fetal size|MP:0004321,short sternum|MP:0004322,abnormal sternebra morphology|MP:0004338,small clavicle|MP:0004343,small scapula|MP:0004354,absent deltoid tuberosity|MP:0004386,enlarged interparietal bone|MP:0004620,cervical vertebral fusion|MP:0004623,thoracic vertebral fusion|MP:0004671,long ribs|MP:0004674,thin ribs|MP:0004703,abnormal vertebral column morphology|MP:0004733,abnormal thoracic cavity morphology|MP:0004819,decreased skeletal muscle mass|MP:0004846,absent skeletal muscle|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005421,loose skin|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008150,decreased diameter of long bones|MP:0009890,cleft secondary palate|MP:0009907,decreased tongue size|MP:0010082,sternebra fusion|MP:0011089,perinatal lethality, complete penetrance|MP:0014652,increased skeletal muscle fiber mitochondrial size|MP:0030258,small mandibular condyloid process|MP:0030283,small mandibular coronoid process|MP:0030287,enlarged occipital bone
MGI:5819113	Cacna1s<tm1.1Arte>	MP:0002106,abnormal muscle physiology|MP:0002841,impaired skeletal muscle contractility|MP:0003061,decreased aerobic running capacity|MP:0004145,abnormal muscle electrophysiology|MP:0004231,abnormal calcium ion homeostasis|MP:0005369,muscle phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006036,abnormal mitochondrial physiology|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0010053,decreased grip strength|MP:0011629,decreased mitochondrial number|MP:0011631,decreased mitochondrial size|MP:0011632,dilated mitochondrion|MP:0014344,abnormal skeletal muscle fiber mitochondrial morphology
MGI:5473902	Cacna1s<tm1.1Cann>	MP:0000751,myopathy|MP:0002106,abnormal muscle physiology|MP:0004089,dilated sarcoplasmic reticulum|MP:0005620,abnormal muscle contractility|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010053,decreased grip strength
MGI:5494476	Cacna1s<tm1.1(KOMP)Vlcg>	MP:0001491,unresponsive to tactile stimuli|MP:0001575,cyanosis|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003231,abnormal placenta vasculature|MP:0003743,abnormal facial morphology|MP:0005388,respiratory system phenotype|MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance
MGI:6276924	Cacna2d1<em1(IMPC)Mbp>	MP:0000220,increased monocyte cell number|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0002968,increased circulating alkaline phosphatase level|MP:0005293,impaired glucose tolerance|MP:0009142,decreased prepulse inhibition|MP:0009453,enhanced contextual conditioning behavior|MP:0010124,decreased bone mineral content|MP:0013279,increased fasting circulating glucose level|MP:0020420,abnormal freezing behavior|MP:0020421,increased freezing behavior
MGI:4353680	Cacna2d1<tm1Aschw>	MP:0000539,distended urinary bladder|MP:0003488,decreased channel response intensity|MP:0003489,increased channel response threshold|MP:0004145,abnormal muscle electrophysiology|MP:0005140,decreased cardiac muscle contractility
MGI:3622078	Cacna2d1<tm1Cptl>	MP:0002206,abnormal CNS synaptic transmission|MP:0009747,impaired behavioral response to xenobiotic
MGI:1856022	Cacna2d2<du>	MP:0000755,hindlimb paralysis|MP:0000841,abnormal hindbrain morphology|MP:0000846,abnormal medulla oblongata morphology|MP:0000852,small cerebellum|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000920,abnormal myelination|MP:0000937,abnormal motor neuron morphology|MP:0000952,abnormal CNS glial cell morphology|MP:0000955,abnormal spinal cord morphology|MP:0000956,decreased spinal cord size|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001077,abnormal spinal nerve morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001388,abnormal stationary movement|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002064,seizures|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002882,abnormal neuron morphology|MP:0003225,axonal dystrophy|MP:0003631,nervous system phenotype|MP:0003690,abnormal glial cell physiology|MP:0003990,decreased neurotransmitter release|MP:0003993,abnormal ventral spinal root morphology|MP:0003994,abnormal dorsal spinal root morphology|MP:0004703,abnormal vertebral column morphology|MP:0004706,short vertebral body|MP:0004835,abnormal miniature endplate potential|MP:0005379,endocrine/exocrine gland phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006108,abnormal hindbrain development|MP:0008027,abnormal spinal cord white matter morphology|MP:0008770,decreased survivor rate|MP:0008911,induced hyperactivity|MP:0008948,decreased neuron number|MP:0009460,skeletal muscle hypoplasia|MP:0020533,decreased pons size
MGI:2149331	Cacna2d2<du-2J>	MP:0000849,abnormal cerebellum morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0001393,ataxia|MP:0002206,abnormal CNS synaptic transmission|MP:0002272,abnormal nervous system electrophysiology|MP:0003216,absence seizures|MP:0003492,abnormal involuntary movement|MP:0003631,nervous system phenotype|MP:0004994,abnormal brain wave pattern|MP:0005404,abnormal axon morphology|MP:0008840,abnormal spike wave discharge|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0014327,decreased Purkinje cell size
MGI:3051588	Cacna2d2<du-3J>	MP:0000243,myoclonus|MP:0000745,tremors|MP:0001265,decreased body size|MP:0001516,abnormal motor coordination/balance|MP:0002083,premature death|MP:0005389,reproductive system phenotype
MGI:1856023	Cacna2d2<du-td>	MP:0000633,abnormal pituitary gland morphology|MP:0000745,tremors|MP:0001134,absent corpus luteum|MP:0001732,postnatal growth retardation|MP:0001824,abnormal thymus involution|MP:0001921,reduced fertility|MP:0001923,reduced female fertility|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0005202,lethargy|MP:0008333,absent lactotrophs
MGI:6386301	Cacna2d2<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000745,tremors|MP:0001146,abnormal testis morphology|MP:0001157,small seminal vesicle|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001404,no spontaneous movement|MP:0001406,abnormal gait|MP:0001711,abnormal placenta morphology|MP:0001926,female infertility|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002188,small heart|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0003960,increased lean body mass|MP:0004952,increased spleen weight|MP:0010025,decreased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3038918	Cacna2d2<ent>	MP:0001120,abnormal uterus morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001392,abnormal locomotor behavior|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001926,female infertility|MP:0002064,seizures|MP:0002566,abnormal sexual interaction|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology|MP:0004994,abnormal brain wave pattern|MP:0008035,behavioral arrest|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5688505	Cacna2d2<m1Btlr>	MP:0001262,decreased body weight
MGI:5707604	Cacna2d2<m1Mhda>	MP:0002169,no abnormal phenotype detected
MGI:3055290	Cacna2d2<tm1Svi>	MP:0000243,myoclonus|MP:0000849,abnormal cerebellum morphology|MP:0000866,cerebellum vermis hypoplasia|MP:0000876,Purkinje cell degeneration|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001429,dehydration|MP:0001431,abnormal eating behavior|MP:0001513,limb grasping|MP:0001629,abnormal heart rate|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0001867,rhinitis|MP:0002064,seizures|MP:0002083,premature death|MP:0002826,tonic seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0005333,decreased heart rate
MGI:5477798	Cacna2d3<tm1b(KOMP)Wtsi>	MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0005560,decreased circulating glucose level|MP:0005633,increased circulating sodium level
MGI:3604520	Cacna2d3<tm1Dgen>	MP:0001399,hyperactivity|MP:0001489,decreased startle reflex|MP:0005655,increased aggression
MGI:4887240	Cacna2d3<tm1Pngr>	MP:0001973,increased thermal nociceptive threshold|MP:0002736,abnormal nociception after inflammation|MP:0005386,behavior/neurological phenotype|MP:0014812,abnormal brain physiology
MGI:6287969	Cacna2d3<Tn(pb-Act-RFP)1.1Zhu>	MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0014538,decreased calcium level|MP:0030940,impaired autophagy
MGI:5925303	Cacna2d4<em1(IMPC)J>	MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0010097,abnormal retina blood vessel morphology
MGI:3665263	Cacna2d4<lob>	MP:0003727,abnormal retina layer morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0003734,abnormal retina inner plexiform layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0008519,thin retina outer plexiform layer
MGI:2181804	Cacnb1<tm1Rgg>	MP:0001504,abnormal posture|MP:0002106,abnormal muscle physiology|MP:0002109,abnormal limb morphology|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004174,abnormal spine curvature|MP:0004819,decreased skeletal muscle mass|MP:0011089,perinatal lethality, complete penetrance|MP:0031495,absent prenatal movement
MGI:5695970	Cacnb2<tm1.1(KOMP)Vlcg>	MP:0000538,abnormal urinary bladder morphology|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level
MGI:2429694	Cacnb2<tm1Rgg>	MP:0001544,abnormal cardiovascular system physiology|MP:0005391,vision/eye phenotype|MP:0011092,embryonic lethality, complete penetrance
MGI:2389248	Cacnb3<tm1Acv>	MP:0000274,enlarged heart|MP:0002833,increased heart weight|MP:0002842,increased systemic arterial blood pressure|MP:0002975,vascular smooth muscle hypertrophy|MP:0004231,abnormal calcium ion homeostasis|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005592,abnormal vascular smooth muscle morphology|MP:0005595,abnormal vascular smooth muscle physiology|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008567,decreased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion
MGI:2180537	Cacnb3<tm1Hssh>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0002802,abnormal discrimination learning|MP:0003008,enhanced long-term potentiation|MP:0003234,enhanced NMDA-mediated synaptic currents|MP:0003484,abnormal channel response|MP:0003631,nervous system phenotype|MP:0004267,abnormal optic tract morphology|MP:0005391,vision/eye phenotype|MP:0009453,enhanced contextual conditioning behavior|MP:0014368,enhanced long-term object recognition memory
MGI:1856936	Cacnb4<lh>	MP:0000635,pituitary gland hyperplasia|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0000706,small thymus|MP:0000937,abnormal motor neuron morphology|MP:0000947,convulsive seizures|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001134,absent corpus luteum|MP:0001393,ataxia|MP:0001394,circling|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001523,impaired righting response|MP:0001732,postnatal growth retardation|MP:0001824,abnormal thymus involution|MP:0001921,reduced fertility|MP:0002064,seizures|MP:0002065,abnormal fear/anxiety-related behavior|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002206,abnormal CNS synaptic transmission|MP:0002339,abnormal lymph node morphology|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002826,tonic seizures|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0003996,clonic seizures|MP:0004751,increased length of allograft survival|MP:0004924,abnormal behavior|MP:0004994,abnormal brain wave pattern|MP:0005016,decreased lymphocyte cell number|MP:0005036,diarrhea|MP:0005092,decreased double-positive T cell number|MP:0005150,cachexia|MP:0005202,lethargy|MP:0005391,vision/eye phenotype|MP:0005403,abnormal nerve conduction|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005551,abnormal eye electrophysiology|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0008499,increased IgG1 level|MP:0008567,decreased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008814,decreased nerve conduction velocity|MP:0009747,impaired behavioral response to xenobiotic|MP:0013741,absent thymus corticomedullary boundary|MP:0030143,facial muscle spasm
MGI:2155890	Cacnb4<lh-2J>	MP:0001524,impaired limb coordination|MP:0002064,seizures
MGI:2684216	Cacnb4<lh-3J>	MP:0000436,abnormal head movements|MP:0001265,decreased body size|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0005202,lethargy
MGI:3712356	Cacnb4<lh-4J>	MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001925,male infertility|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype
MGI:3838110	Cacng1<tm1Rgg>	MP:0004145,abnormal muscle electrophysiology
MGI:2180153	Cacng1<tm1Vfz>	MP:0004145,abnormal muscle electrophysiology
MGI:6505622	Cacng2<em1Tern>	MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0014372,decreased miniature excitatory postsynaptic current amplitude|MP:0014376,decreased miniature excitatory postsynaptic current frequency
MGI:1856548	Cacng2<stg>	MP:0000832,abnormal thalamus morphology|MP:0000937,abnormal motor neuron morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001408,stereotypic behavior|MP:0001410,head bobbing|MP:0001489,decreased startle reflex|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0001925,male infertility|MP:0002184,abnormal innervation|MP:0002206,abnormal CNS synaptic transmission|MP:0002623,abnormal vestibular hair cell morphology|MP:0002730,head shaking|MP:0002757,decreased vertical activity|MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0003216,absence seizures|MP:0003240,loss of hippocampal neurons|MP:0003631,nervous system phenotype|MP:0003894,abnormal Purkinje cell innervation|MP:0004249,abnormal crista ampullaris morphology|MP:0004428,abnormal type I vestibular cell|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004769,abnormal synaptic vesicle morphology|MP:0004792,abnormal synaptic vesicle number|MP:0004994,abnormal brain wave pattern|MP:0004996,abnormal CNS synapse formation|MP:0004998,decreased CNS synapse formation|MP:0005307,head tossing|MP:0009538,abnormal synapse morphology|MP:0009937,abnormal neuron differentiation|MP:0011001,absence of AMPA-mediated synaptic currents|MP:0011003,reduced AMPA-mediated synaptic currents|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2155891	Cacng2<stg-3J>	MP:0003631,nervous system phenotype
MGI:1856386	Cacng2<stg-wag>	MP:0003216,absence seizures
MGI:4821763	Cacng2<tm1.1Mwa>	MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0003312,abnormal locomotor coordination|MP:0011003,reduced AMPA-mediated synaptic currents|MP:0011270,decreased excitatory postsynaptic current amplitude
MGI:4822223	Cacng2<tm1.1Suto>	MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0003631,nervous system phenotype|MP:0014373,increased miniature excitatory postsynaptic current amplitude
MGI:5707431	Cacng2<tm1b(KOMP)Mbp>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:4822224	Cacng2<tm2.1Suto>	MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0003631,nervous system phenotype|MP:0014372,decreased miniature excitatory postsynaptic current amplitude
MGI:7520872	Cacng3<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3604524	Cacng3<tm1Dgen>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3810416	Cacng3<tm1Ran>	MP:0002169,no abnormal phenotype detected
MGI:3604526	Cacng4<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3521945	Cacng4<tm1Frk>	MP:0002169,no abnormal phenotype detected
MGI:5285084	Cacng4<tm1Ran>	MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0014372,decreased miniature excitatory postsynaptic current amplitude
MGI:6324177	Cacng5<em1(IMPC)H>	MP:0001392,abnormal locomotor behavior
MGI:3530062	Cacng6<Gt(OST322893)Lex>	MP:0002169,no abnormal phenotype detected
MGI:7431360	Cacng7<em1(IMPC)Bay>	MP:0010053,decreased grip strength|MP:0011964,increased total retina thickness
MGI:4821765	Cacng7<tm1.1Mwa>	MP:0002169,no abnormal phenotype detected
MGI:3696717	Cacng8<tm1.1Mwa>	MP:0009940,abnormal hippocampus pyramidal cell morphology
MGI:5307062	Cacng8<tm1.1Suto>	MP:0001919,abnormal reproductive system physiology|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0010768,mortality/aging
MGI:3609205	Cacng8<tm1Ran>	MP:0001353,increased aggression towards mice|MP:0001415,increased exploration in new environment|MP:0001447,abnormal nest building behavior|MP:0001473,reduced long-term potentiation|MP:0002572,abnormal emotion/affect behavior|MP:0003461,abnormal response to novel object|MP:0003635,abnormal synaptic transmission|MP:0004924,abnormal behavior|MP:0005655,increased aggression|MP:0010698,abnormal impulsive behavior control|MP:0012293,impaired active avoidance behavior|MP:0014372,decreased miniature excitatory postsynaptic current amplitude|MP:0020395,abnormal response to social novelty
MGI:7425552	Cactin<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002059,abnormal seminal vesicle morphology|MP:0002997,enlarged seminal vesicle|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3530884	Cacybp<GT(OST39970)Lex>	MP:0000694,spleen hypoplasia|MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0002357,abnormal spleen white pulp morphology|MP:0004045,abnormal cell cycle checkpoint function|MP:0008037,abnormal T cell morphology|MP:0011703,increased fibroblast proliferation|MP:0013588,small thymus medulla
MGI:5605753	Cacybp<tm1b(EUCOMM)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0002941,increased circulating alanine transaminase level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6276915	Cad<em1(IMPC)Mbp>	MP:0001513,limb grasping|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2156461	Cadfar<C57BL/6NCrl>	MP:0000550,abnormal forelimb morphology
MGI:3923695	Cadm1<Gt(Ayu21-W34)Imeg>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002145,abnormal T cell differentiation|MP:0004200,decreased fetal size|MP:0005091,increased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008754,abnormal T cell receptor V(D)J recombination
MGI:3712182	Cadm1<Gt(XI486)Byg>	MP:0000807,abnormal hippocampus morphology|MP:0002152,abnormal brain morphology|MP:0002182,abnormal astrocyte morphology|MP:0008547,abnormal neocortex morphology
MGI:3625157	Cadm1<tm1.1Brd>	MP:0002169,no abnormal phenotype detected
MGI:3625158	Cadm1<tm1.2Brd>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0003645,increased pancreatic beta cell number|MP:0005379,endocrine/exocrine gland phenotype|MP:0005578,teratozoospermia|MP:0009113,increased pancreatic beta cell mass|MP:0011819,increased pancreatic beta cell proliferation
MGI:4432825	Cadm1<tm1a(EUCOMM)Wtsi>	MP:0001391,abnormal tail movements|MP:0004924,abnormal behavior
MGI:3769418	Cadm1<tm1Momo>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0003631,nervous system phenotype|MP:0004850,abnormal testis weight|MP:0004901,decreased male germ cell number|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008279,arrest of spermiogenesis|MP:0014636,decreased elongated spermatid number
MGI:3625113	Cadm1<tm1Mrkm>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005578,teratozoospermia|MP:0009239,short sperm flagellum|MP:0009839,multiflagellated sperm
MGI:5528799	Cadm2<tm1.1Pele>	MP:0003631,nervous system phenotype
MGI:5528800	Cadm3<tm1.1Pele>	MP:0003631,nervous system phenotype
MGI:3829883	Cadm3<tm1Qiu>	MP:0000920,abnormal myelination
MGI:5528801	Cadm4<tm1.1Pele>	MP:0000920,abnormal myelination|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0003871,abnormal myelin sheath morphology|MP:0004263,abnormal limb posture|MP:0008814,decreased nerve conduction velocity|MP:0010734,abnormal paranode morphology
MGI:5518469	Cadm4<tm1(cre/ERT2)Qiu>	MP:0003631,nervous system phenotype
MGI:6156123	Cadps2<em1(IMPC)Rbrc>	MP:0000202,abnormal circulating alkaline phosphatase level|MP:0000613,abnormal salivary gland morphology|MP:0000702,enlarged lymph nodes|MP:0001944,abnormal pancreas morphology|MP:0002339,abnormal lymph node morphology|MP:0002581,abnormal ileum morphology|MP:0003271,abnormal duodenum morphology|MP:0004002,abnormal jejunum morphology|MP:0008806,increased circulating amylase level
MGI:3774018	Cadps2<tm1Bros>	MP:0002710,increased glucagon secretion|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005293,impaired glucose tolerance|MP:0008953,abnormal pancreatic somatostatin secretion
MGI:3707315	Cadps2<tm1Tfr>	MP:0000849,abnormal cerebellum morphology|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000880,decreased Purkinje cell number|MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001386,abnormal maternal nurturing|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0001501,abnormal sleep pattern|MP:0002152,abnormal brain morphology|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002572,abnormal emotion/affect behavior|MP:0002918,abnormal paired-pulse facilitation|MP:0002948,abnormal neuron specification|MP:0003461,abnormal response to novel object|MP:0004101,abnormal brain interneuron morphology|MP:0008414,abnormal spatial reference memory|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0009267,abnormal cerebellum fissure morphology|MP:0009977,abnormal cerebellar granule cell migration|MP:0014647,decreased horizontal optokinetic reflex|MP:0020467,abnormal circadian behavior
MGI:3583931	Cadps<tm1Bros>	MP:0001739,abnormal adrenal gland secretion|MP:0001953,respiratory failure|MP:0002882,abnormal neuron morphology|MP:0002909,abnormal adrenal gland physiology|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology|MP:0011087,neonatal lethality, complete penetrance|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0014372,decreased miniature excitatory postsynaptic current amplitude|MP:0014376,decreased miniature excitatory postsynaptic current frequency
MGI:6376189	Cad<tm1c(KOMP)Wtsi>	MP:0005378,growth/size/body region phenotype|MP:0009133,decreased white fat cell size
MGI:2182803	Cal	MP:0000410,waved hair|MP:0001274,curly vibrissae
MGI:2182804	Cal2	MP:0000410,waved hair|MP:0001274,curly vibrissae
MGI:3043215	Cal3	MP:0000410,waved hair|MP:0001274,curly vibrissae
MGI:3045703	Cal5	MP:0000377,abnormal hair follicle morphology|MP:0000410,waved hair|MP:0001214,skin hyperplasia|MP:0001278,kinked vibrissae|MP:0005377,hearing/vestibular/ear phenotype
MGI:3047107	Cal6	MP:0000410,waved hair|MP:0001278,kinked vibrissae
MGI:3521996	Cal7	MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0005172,decreased eye pigmentation|MP:0009379,abnormal foot pigmentation|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:5780086	Cal8	MP:0000410,waved hair|MP:0001279,wavy vibrissae
MGI:7425553	Calb1<em1(IMPC)Ccpcz>	MP:0000137,abnormal vertebrae morphology|MP:0000160,kyphosis|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001325,abnormal retina morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004174,abnormal spine curvature|MP:0004599,abnormal vertebral arch morphology|MP:0005599,increased cardiac muscle contractility|MP:0009709,hydrometra
MGI:5522769	Calb1<tm1.1(folA/cre)Hze>	MP:0002169,no abnormal phenotype detected
MGI:1857460	Calb1<tm1Mpin>	MP:0001393,ataxia|MP:0002272,abnormal nervous system electrophysiology|MP:0005377,hearing/vestibular/ear phenotype
MGI:2181196	Calb1<tm2.1Mpin>	MP:0001524,impaired limb coordination|MP:0001961,abnormal reflex|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology|MP:0004844,abnormal vestibuloocular reflex|MP:0005386,behavior/neurological phenotype
MGI:4365736	Calb2<tm1(cre)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:2158756	Calb2<tm1Map>	MP:0001405,impaired coordination|MP:0002207,abnormal long-term potentiation|MP:0002272,abnormal nervous system electrophysiology|MP:0005386,behavior/neurological phenotype
MGI:4880758	Calb2<tm2.1(cre/ERT2)Zjh>	MP:0001405,impaired coordination|MP:0001473,reduced long-term potentiation|MP:0002169,no abnormal phenotype detected|MP:0002272,abnormal nervous system electrophysiology
MGI:5559692	Calca<tm1.1(cre/EGFP)Rpa>	MP:0002910,abnormal excitatory postsynaptic currents|MP:0011940,decreased food intake
MGI:5437493	Calca<tm1.1(EGFP/HBEGF)Mjz>	MP:0002169,no abnormal phenotype detected
MGI:2148538	Calca<tm1Eme>	MP:0003631,nervous system phenotype|MP:0004738,abnormal auditory brainstem response|MP:0004746,abnormal cochlear IHC afferent innervation pattern|MP:0005333,decreased heart rate|MP:0006263,decreased systemic arterial diastolic blood pressure
MGI:2445489	Calca<tm1Hku>	MP:0002335,decreased airway responsiveness|MP:0002626,increased heart rate|MP:0003929,decreased heart rate variability|MP:0004183,abnormal sympathetic nervous system physiology|MP:0004875,increased mean systemic arterial blood pressure|MP:0004878,increased systemic vascular resistance|MP:0011478,abnormal urine catecholamine level
MGI:2148771	Calca<tm1Jpc>	MP:0001980,abnormal chemically-elicited antinociception|MP:0008531,increased chemical nociceptive threshold|MP:0009747,impaired behavioral response to xenobiotic|MP:0009752,enhanced behavioral response to nicotine|MP:0009776,decreased behavioral withdrawal response
MGI:3527257	Calca<tm1Rfg>	MP:0000062,increased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0001562,abnormal circulating calcium level|MP:0001771,abnormal circulating magnesium level|MP:0002896,abnormal bone mineralization|MP:0004991,decreased bone strength|MP:0005006,abnormal osteoblast physiology|MP:0005380,embryo phenotype|MP:0009643,abnormal urine homeostasis
MGI:5696919	Calcb<tm1.1(KOMP)Vlcg>	MP:0000955,abnormal spinal cord morphology|MP:0001944,abnormal pancreas morphology|MP:0002135,abnormal kidney morphology|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis
MGI:6305721	Calcoco1<em1(IMPC)H>	MP:0000062,increased bone mineral density|MP:0000198,decreased circulating phosphate level|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001392,abnormal locomotor behavior|MP:0001486,abnormal startle reflex|MP:0003068,enlarged kidney|MP:0005567,decreased circulating total protein level|MP:0011874,enlarged urinary bladder
MGI:4419466	Calcoco2<tm1(KOMP)Wtsi>	MP:0004509,abnormal pelvic girdle bone morphology
MGI:6148315	Calcr<em1(IMPC)Rbrc>	MP:0000202,abnormal circulating alkaline phosphatase level|MP:0001562,abnormal circulating calcium level
MGI:3623122	Calcrl<tm1Kmca>	MP:0001191,abnormal skin condition|MP:0001716,abnormal placenta labyrinth morphology|MP:0001785,edema|MP:0002188,small heart|MP:0002190,disorganized myocardium|MP:0002192,hydrops fetalis|MP:0002450,abnormal lymph organ development|MP:0003288,intestinal edema|MP:0003390,lymphedema|MP:0003814,vascular smooth muscle hypoplasia|MP:0004056,abnormal myocardium compact layer morphology|MP:0004057,thin myocardium compact layer|MP:0005329,abnormal myocardium layer morphology|MP:0005592,abnormal vascular smooth muscle morphology|MP:0008876,decreased uterine NK cell number|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011392,increased fetal cardiomyocyte apoptosis|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0012727,abnormal uterine spiral artery remodeling
MGI:3038975	Calcr<tm1Dgal>	MP:0000062,increased bone mineral density|MP:0005605,increased bone mass|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0020039,increased bone ossification
MGI:3604511	Calcr<tm1Dgen>	MP:0002169,no abnormal phenotype detected|MP:0005386,behavior/neurological phenotype
MGI:4352932	Calcr<tm1Rda>	MP:0001541,abnormal osteoclast physiology|MP:0001562,abnormal circulating calcium level|MP:0003109,short femur|MP:0005418,abnormal circulating hormone level|MP:0009345,abnormal trabecular bone thickness|MP:0010867,abnormal bone trabecula morphology|MP:0010872,increased trabecular bone mass|MP:0011091,prenatal lethality, complete penetrance
MGI:5552739	Cald1<tm1Chac>	MP:0010386,abnormal urinary bladder physiology|MP:0011100,preweaning lethality, complete penetrance|MP:0011774,abnormal urinary bladder detrusor smooth muscle morphology|MP:0011799,increased urinary bladder weight
MGI:3576365	Cald1<tm1Claw>	MP:0003052,omphalocele|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5432529	Calhm1<tm1Geno>	MP:0001985,abnormal gustatory system physiology|MP:0004811,abnormal neuron physiology
MGI:8219395	Calhm2<em1Zyu>	MP:0001473,reduced long-term potentiation|MP:0002573,behavioral despair|MP:0002912,abnormal excitatory postsynaptic potential|MP:0008916,abnormal astrocyte physiology|MP:0009710,anhedonia|MP:0012307,impaired spatial learning|MP:0014367,impaired long-term object recognition memory|MP:0014370,impaired spatial working memory|MP:0020379,abnormal sucrose solution preference|MP:0020508,decreased dendritic spine density|MP:0021018,decreased dendritic spine number
MGI:5696912	Calhm2<tm1b(KOMP)Mbp>	MP:0001289,persistence of hyaloid vascular system|MP:0001944,abnormal pancreas morphology|MP:0003450,enlarged pancreas
MGI:6307099	Calhm3<em1Jkf>	MP:0001985,abnormal gustatory system physiology|MP:0004209,abnormal sweet taste sensitivity|MP:0004210,abnormal bitter taste sensitivity|MP:0004212,abnormal salty taste sensitivity|MP:0004213,abnormal umami taste sensitivity|MP:0005394,taste/olfaction phenotype
MGI:7425554	Calhm4<em1(IMPC)Tcp>	MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:6120789	Calhm6<tm2b(EUCOMM)Wtsi>	MP:0003928,increased heart rate variability
MGI:7623971	Calm1<em1Allg>	MP:0001265,decreased body size|MP:0001636,irregular heartbeat|MP:0003233,prolonged QT interval|MP:0003928,increased heart rate variability|MP:0004085,abnormal heartbeat|MP:0004215,abnormal myocardial fiber physiology|MP:0004484,abnormal response of heart to induced stress|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0010392,prolonged QRS complex duration|MP:0010506,prolonged RR interval|MP:0010637,sinus bradycardia|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:6315239	Calm1<em1Gkim>	MP:0001260,increased body weight|MP:0001265,decreased body size|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002626,increased heart rate|MP:0003060,increased aerobic running capacity|MP:0003961,decreased lean body mass|MP:0005386,behavior/neurological phenotype|MP:0014142,increased body fat mass
MGI:7623972	Calm2<em1Allg>	MP:0001636,irregular heartbeat|MP:0004215,abnormal myocardial fiber physiology|MP:0009732,ventricular premature beat|MP:0010506,prolonged RR interval|MP:0010637,sinus bradycardia
MGI:6887651	Calm4<tm1Mso>	MP:0002169,no abnormal phenotype detected
MGI:7510163	Caln1<em1Mrkr>	MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0009939,abnormal hippocampus neuron morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0011149,abnormal hippocampus stratum lacunosum morphology|MP:0020338,abnormal hippocampal pyramidal neuron dendrite morphology|MP:0020508,decreased dendritic spine density
MGI:4946941	Calr3<tm1Osb>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0005389,reproductive system phenotype|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031012,impaired sperm migration in female genital tract
MGI:3584007	calre	MP:0000402,abnormal zigzag hair morphology|MP:0000410,waved hair|MP:0000414,alopecia|MP:0001274,curly vibrissae|MP:0001284,absent vibrissae|MP:0001510,abnormal coat appearance|MP:0010771,integument phenotype
MGI:6144082	Calr<tm1.1Osb>	MP:0020414,abnormal fibroblast physiology
MGI:2176266	Calr<tm1Mlk>	MP:0000278,abnormal myocardial fiber morphology|MP:0000280,thin ventricular wall|MP:0000295,trabecula carnea hypoplasia|MP:0002188,small heart|MP:0003052,omphalocele|MP:0004057,thin myocardium compact layer|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0004231,abnormal calcium ion homeostasis|MP:0004567,decreased myocardial fiber number|MP:0006267,abnormal intercalated disk morphology|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0014071,increased cardiac muscle glycogen level|MP:0014731,disorganized myocardial fiber myofibrils|MP:0014737,decreased myocardial fiber myofibril thickness
MGI:2183263	Calr<tm1Star>	MP:0000280,thin ventricular wall|MP:0000295,trabecula carnea hypoplasia|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0002952,ventricular cardiomyopathy|MP:0003052,omphalocele|MP:0003091,abnormal cell migration|MP:0003222,increased cardiomyocyte apoptosis|MP:0005621,abnormal cell physiology|MP:0010498,abnormal interventricular septum muscular part morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0013283,failure of ventral body wall closure|MP:0014698,decreased fibroblast adhesion
MGI:6286371	Calu<em1(IMPC)Tcp>	MP:0000428,abnormal craniofacial morphology|MP:0000841,abnormal hindbrain morphology|MP:0000897,abnormal midbrain morphology|MP:0001697,abnormal embryo size|MP:0002217,small lymph nodes|MP:0003257,abnormal abdominal wall morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:3838019	Caly<tm1.1Cber>	MP:0001899,absent long-term depression|MP:0004770,abnormal synaptic vesicle recycling
MGI:3838018	Caly<tm1Cber>	MP:0002169,no abnormal phenotype detected
MGI:6148079	Camk1d<em1(IMPC)Mbp>	MP:0000063,decreased bone mineral density|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001417,decreased exploration in new environment|MP:0002092,abnormal eye morphology|MP:0002834,decreased heart weight|MP:0003450,enlarged pancreas|MP:0003961,decreased lean body mass|MP:0005565,increased blood urea nitrogen level|MP:0009709,hydrometra|MP:0010024,increased total body fat amount|MP:0010052,increased grip strength
MGI:3851326	Camk1g<tm1(cre/PGR)Hbto>	MP:0008143,abnormal dendrite morphology
MGI:5574594	Camk1<tm2b(EUCOMM)Hmgu>	MP:0000745,tremors|MP:0002942,decreased circulating alanine transaminase level|MP:0003960,increased lean body mass|MP:0009142,decreased prepulse inhibition|MP:0013278,decreased fasting circulating glucose level
MGI:5811610	Camk2a<em1Rjco>	MP:0001394,circling|MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002574,increased vertical activity|MP:0002797,increased thigmotaxis|MP:0020395,abnormal response to social novelty
MGI:6199624	Camk2a<m1Btlr>	MP:0001399,hyperactivity
MGI:3849851	Camk2a<tm1.1Oyam>	MP:0000951,sporadic seizures|MP:0001399,hyperactivity|MP:0001462,abnormal avoidance learning behavior|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0002083,premature death|MP:0002882,abnormal neuron morphology|MP:0008431,abnormal short-term spatial reference memory|MP:0008770,decreased survivor rate
MGI:5662417	Camk2a<tm1.1Yelg>	MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0012307,impaired spatial learning
MGI:5613814	Camk2a<tm1Kub>	MP:0001899,absent long-term depression
MGI:2389309	Camk2a<tm1Mllr>	MP:0001454,abnormal cued conditioning behavior|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0002207,abnormal long-term potentiation|MP:0014367,impaired long-term object recognition memory
MGI:1857279	Camk2a<tm1Sva>	MP:0000351,increased cell proliferation|MP:0000812,abnormal dentate gyrus morphology|MP:0001262,decreased body weight|MP:0001353,increased aggression towards mice|MP:0001364,decreased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001473,reduced long-term potentiation|MP:0001475,reduced long-term depression|MP:0002206,abnormal CNS synaptic transmission|MP:0002920,decreased paired-pulse facilitation|MP:0003631,nervous system phenotype|MP:0004769,abnormal synaptic vesicle morphology|MP:0004811,abnormal neuron physiology|MP:0006060,increased cerebral infarct size|MP:0009538,abnormal synapse morphology|MP:0009938,abnormal hippocampus granule cell morphology|MP:0014370,impaired spatial working memory|MP:0014413,decreased depression-related behavior|MP:0020551,abnormal postsynaptic density morphology|MP:0031391,increased locomotor activity
MGI:2655688	Camk2a<tm1Vyb>	MP:0002206,abnormal CNS synaptic transmission|MP:0003635,abnormal synaptic transmission
MGI:2158733	Camk2a<tm2Sva>	MP:0000973,abnormal cutaneous/subcutaneous mechanoreceptor morphology|MP:0001191,abnormal skin condition|MP:0001473,reduced long-term potentiation|MP:0001899,absent long-term depression|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0008143,abnormal dendrite morphology
MGI:2389262	Camk2a<tm3Sva>	MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0002912,abnormal excitatory postsynaptic potential|MP:0004769,abnormal synaptic vesicle morphology|MP:0004792,abnormal synaptic vesicle number|MP:0004859,abnormal synaptic plasticity
MGI:2389254	Camk2a<tm4Sva>	MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0002064,seizures|MP:0002207,abnormal long-term potentiation|MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype|MP:0003858,enhanced coordination
MGI:2389272	Camk2a<tm5Sva>	MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0001898,abnormal long-term depression|MP:0002064,seizures|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:5638541	Camk2b<tm1.1Ics>	MP:0001265,decreased body size|MP:0001364,decreased anxiety-related response|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001447,abnormal nest building behavior|MP:0001458,abnormal object recognition memory|MP:0001525,impaired balance|MP:0003491,abnormal voluntary movement|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005458,increased percent body fat/body weight|MP:0008489,slow postnatal weight gain|MP:0010053,decreased grip strength
MGI:5431628	Camk2b<tm1.1Ksak>	MP:0003631,nervous system phenotype
MGI:6120813	Camk2b<tm1b(EUCOMM)Hmgu>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0002757,decreased vertical activity|MP:0004924,abnormal behavior|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020870,decreased thigmotaxis
MGI:4359775	Camk2b<tm1Yelg>	MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001473,reduced long-term potentiation|MP:0001898,abnormal long-term depression|MP:0002207,abnormal long-term potentiation|MP:0003631,nervous system phenotype|MP:0004859,abnormal synaptic plasticity|MP:0009454,impaired contextual conditioning behavior
MGI:5285573	Camk2b<tm2.1Yelg>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:7628184	Camk2d<em1Mean>	MP:0005333,decreased heart rate
MGI:5476688	Camk2d<tm1.1Jhb>	MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0004486,decreased response of heart to induced stress
MGI:5555902	Camk2d<tm1.1Mean>	MP:0000343,abnormal response to cardiac infarction|MP:0003674,oxidative stress|MP:0006043,decreased apoptosis|MP:0006142,abnormal sinoatrial node conduction|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:3837728	Camk2d<tm1.2Eno>	MP:0004486,decreased response of heart to induced stress
MGI:4398829	Camk2g<tm1.1Irt>	MP:0001926,female infertility|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005166,decreased susceptibility to injury|MP:0008537,increased susceptibility to induced colitis|MP:0011081,decreased macrophage apoptosis|MP:0013298,increased susceptibility to colitis induced morbidity/mortality
MGI:7645440	Camk2n1<em1Lyg>	MP:0001636,irregular heartbeat|MP:0003037,increased myocardial infarct size|MP:0003141,cardiac fibrosis|MP:0006110,ventricular fibrillation|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0031217,increased susceptibility to myocardial ischemic injury|MP:0031252,abnormal physiological response to hypoxia
MGI:6358082	Camk4<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0002100,abnormal tooth morphology
MGI:2158694	Camk4<tm1Arm>	MP:0000745,tremors|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0001119,abnormal female reproductive system morphology|MP:0001131,abnormal ovarian follicle morphology|MP:0001134,absent corpus luteum|MP:0001145,abnormal male reproductive system morphology|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001919,abnormal reproductive system physiology|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001929,abnormal gametogenesis|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002160,abnormal reproductive system morphology|MP:0002687,oligozoospermia|MP:0002757,decreased vertical activity|MP:0002915,abnormal synaptic depression|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005578,teratozoospermia|MP:0008869,anovulation|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009433,polyovular ovarian follicle|MP:0011269,increased excitatory postsynaptic current amplitude|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0014633,decreased spermatid number
MGI:2181436	Camk4<tm1Gsc>	MP:0009754,enhanced behavioral response to cocaine
MGI:1888972	Camk4<tm1Tch>	MP:0000062,increased bone mineral density|MP:0001475,reduced long-term depression|MP:0001982,decreased chemically-elicited antinociception|MP:0002063,abnormal learning/memory/conditioning|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0002998,abnormal bone remodeling|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0004985,decreased osteoclast cell number|MP:0005386,behavior/neurological phenotype|MP:0008396,abnormal osteoclast differentiation|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0009712,impaired conditioned place preference behavior|MP:0010875,increased bone volume|MP:0014379,decreased excitatory postsynaptic current frequency
MGI:4442999	Camk4<tm1Tsmi>	MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0004924,abnormal behavior|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior
MGI:2388343	Camk4<tm2Arm>	MP:0002169,no abnormal phenotype detected
MGI:3697455	Camkk1<tm1Tch>	MP:0001469,abnormal contextual conditioning behavior|MP:0003631,nervous system phenotype|MP:0005389,reproductive system phenotype
MGI:3796172	Camkk2<tm1.1Arm>	MP:0000005,increased brown adipose tissue amount|MP:0002078,abnormal glucose homeostasis|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005292,improved glucose tolerance|MP:0005458,increased percent body fat/body weight|MP:0005533,increased body temperature|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0010025,decreased total body fat amount|MP:0011940,decreased food intake|MP:0011957,decreased compensatory feeding amount
MGI:2681319	Camkk2<tm1Kpg>	MP:0001463,abnormal spatial learning|MP:0002207,abnormal long-term potentiation|MP:0002969,impaired social transmission of food preference|MP:0005376,homeostasis/metabolism phenotype
MGI:4946516	Camkk2<tm2Kpg>	MP:0005386,behavior/neurological phenotype
MGI:5637069	Camkmt<tm1b(EUCOMM)Wtsi>	MP:0002599,increased mean platelet volume|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005633,increased circulating sodium level|MP:0010025,decreased total body fat amount
MGI:5804590	Camkmt<tm1Rpav>	MP:0000751,myopathy|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0004000,impaired passive avoidance behavior|MP:0004924,abnormal behavior|MP:0005367,renal/urinary system phenotype|MP:0005369,muscle phenotype|MP:0005386,behavior/neurological phenotype|MP:0009403,increased variability of skeletal muscle fiber size|MP:0010053,decreased grip strength|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0021165,behavioral developmental delay
MGI:6149004	Camkv<em1(IMPC)Mbp>	MP:0000494,abnormal cecum morphology|MP:0009476,enlarged cecum|MP:0020421,increased freezing behavior
MGI:2678819	Caml<tm1Rjb>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5515888	Camp<tm1.1Jimw>	MP:0008127,decreased dendritic cell number|MP:0011518,abnormal cell chemotaxis
MGI:2182791	Camp<tm1Rlg>	MP:0000219,increased neutrophil cell number|MP:0001313,increased incidence of corneal inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0005399,increased susceptibility to fungal infection|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:6361950	Camsap1<em1(IMPC)J>	MP:0001566,increased circulating phosphate level|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:6467782	Camsap1<tm1Wem>	MP:0000774,decreased brain size|MP:0000934,abnormal telencephalon development|MP:0002064,seizures|MP:0006009,abnormal neuronal migration|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0020581,abnormal neuron polarity|MP:0020850,abnormal microtubule cytoskeleton morphology
MGI:6355951	Camsap2<tm1Ltm>	MP:0000774,decreased brain size|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0008143,abnormal dendrite morphology
MGI:5912533	Camsap3<tm1.1Ltm>	MP:0000774,decreased brain size|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0005404,abnormal axon morphology|MP:0008108,abnormal small intestinal villus morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020581,abnormal neuron polarity|MP:0020850,abnormal microtubule cytoskeleton morphology
MGI:4431915	Camsap3<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000186,decreased circulating HDL cholesterol level|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000783,abnormal forebrain morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001258,decreased body length|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001306,small lens|MP:0001307,fused cornea and lens|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001512,trunk curl|MP:0001711,abnormal placenta morphology|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002169,no abnormal phenotype detected|MP:0002874,decreased hemoglobin content|MP:0002968,increased circulating alkaline phosphatase level|MP:0003019,increased circulating chloride level|MP:0003443,increased circulating glycerol level|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005179,decreased circulating cholesterol level|MP:0005404,abnormal axon morphology|MP:0005477,increased circulating thyroxine level|MP:0005560,decreased circulating glucose level|MP:0005566,decreased blood urea nitrogen level|MP:0005633,increased circulating sodium level|MP:0006063,abnormal inferior vena cava morphology|MP:0006358,absent pinna reflex|MP:0008346,increased gamma-delta T cell number|MP:0008922,abnormal cervical rib|MP:0008986,abnormal liver parenchyma morphology|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010484,bicuspid aortic valve|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013877,abnormal ductus venosus valve morphology|MP:0014087,retrolental blood|MP:0020581,abnormal neuron polarity
MGI:5637357	Camta1<tm1.1Eno>	MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000890,thin cerebellar molecular layer|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001921,reduced fertility|MP:0006099,thin cerebellar granule layer|MP:0010768,mortality/aging|MP:0014185,cerebellum atrophy
MGI:5637358	Camta1<tm1.2Eno>	MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001504,abnormal posture|MP:0002006,neoplasm|MP:0002169,no abnormal phenotype detected|MP:0011085,postnatal lethality, complete penetrance
MGI:3692751	Camta2<tm1Eno>	MP:0004486,decreased response of heart to induced stress
MGI:1856814	can	MP:0000097,short maxilla|MP:0000120,malocclusion|MP:0000150,abnormal rib morphology|MP:0000161,scoliosis|MP:0000164,abnormal cartilage development|MP:0000166,abnormal chondrocyte morphology|MP:0000440,domed cranium|MP:0000547,short limbs|MP:0001262,decreased body weight|MP:0001270,distended abdomen|MP:0002082,postnatal lethality|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0003199,calcified muscle|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004200,decreased fetal size|MP:0004672,short ribs|MP:0006395,abnormal epiphyseal plate morphology|MP:0006396,decreased long bone epiphyseal plate size|MP:0008489,slow postnatal weight gain|MP:0008525,decreased cranium height|MP:0009250,abnormal appendicular skeleton morphology|MP:0009674,decreased birth weight|MP:0010099,abnormal thoracic cage shape|MP:0010103,small thoracic cage|MP:0011692,increased chondrocyte number|MP:0030427,abnormal neck muscle morphology
MGI:6149007	Cand1<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000428,abnormal craniofacial morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001147,small testis|MP:0001297,microphthalmia|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002188,small heart|MP:0002339,abnormal lymph node morphology|MP:0002591,decreased mean corpuscular volume|MP:0002989,small kidney|MP:0003984,embryonic growth retardation|MP:0005084,abnormal gallbladder morphology|MP:0005333,decreased heart rate|MP:0009342,enlarged gallbladder|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:7614261	Cand1<em1Zpan>	MP:0004485,increased response of heart to induced stress|MP:0011091,prenatal lethality, complete penetrance|MP:0020344,abnormal susceptibility to injury induced morbidity/mortality
MGI:4432020	Cand2<tm1a(EUCOMM)Wtsi>	MP:0003960,increased lean body mass|MP:0004151,decreased circulating iron level|MP:0004486,decreased response of heart to induced stress|MP:0005478,decreased circulating thyroxine level|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width
MGI:5499480	Candy	MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level
MGI:5499481	Candy2	MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level
MGI:5499491	Candy3	MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level
MGI:5499492	Candy4	MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level
MGI:4830605	Candy5	MP:0001559,hyperglycemia|MP:0001566,increased circulating phosphate level
MGI:7264666	Cant1<tm1.1Aros>	MP:0000160,kyphosis|MP:0001265,decreased body size|MP:0005306,abnormal phalanx morphology
MGI:7264674	Cant1<tm1.2Aros>	MP:0000160,kyphosis|MP:0000163,abnormal cartilage morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000166,abnormal chondrocyte morphology|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002657,chondrodystrophy|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003419,delayed endochondral bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0005306,abnormal phalanx morphology|MP:0005354,abnormal ilium morphology|MP:0008152,decreased diameter of femur|MP:0008156,decreased diameter of tibia|MP:0008272,abnormal endochondral bone ossification|MP:0009780,abnormal chondrocyte physiology|MP:0014100,increased chondrocyte proliferation|MP:0014103,increased chondrocyte apoptosis|MP:0030848,short ilium
MGI:5612825	Cant1<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0001488,increased startle reflex|MP:0002111,abnormal tail morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0008259,abnormal optic disk morphology|MP:0008806,increased circulating amylase level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011886,increased circulating lipase level|MP:0011999,abnormal tail length
MGI:7425555	Canx<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0000759,abnormal skeletal muscle morphology|MP:0001120,abnormal uterus morphology|MP:0001404,no spontaneous movement|MP:0004906,enlarged uterus|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4123998	Canx<Gt(KST286)Byg>	MP:0000745,tremors|MP:0000780,abnormal corpus callosum morphology|MP:0000921,demyelination|MP:0000955,abnormal spinal cord morphology|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0003871,abnormal myelin sheath morphology|MP:0005387,immune system phenotype|MP:0008128,abnormal brain internal capsule morphology|MP:0008814,decreased nerve conduction velocity|MP:0009976,abnormal cerebellar peduncle morphology|MP:0010768,mortality/aging
MGI:2388910	Canx<tm1.1Den>	MP:0001265,decreased body size|MP:0001393,ataxia|MP:0002082,postnatal lethality|MP:0003632,abnormal nervous system morphology|MP:0005356,positive geotaxis|MP:0005357,novel environmental response-related retropulsion
MGI:3798916	Canx<tm1.1Osb>	MP:0001147,small testis|MP:0001732,postnatal growth retardation|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2388893	Canx<tm1Den>	MP:0001265,decreased body size|MP:0001393,ataxia|MP:0003632,abnormal nervous system morphology|MP:0005356,positive geotaxis|MP:0005357,novel environmental response-related retropulsion|MP:0011086,postnatal lethality, incomplete penetrance
MGI:7443056	Cap1<tm1.1Mbrst>	MP:0000807,abnormal hippocampus morphology|MP:0000815,abnormal Ammon gyrus morphology|MP:0008415,abnormal neurite morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011827,impaired neuron differentiation
MGI:4431970	Cap2<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001320,small pupil|MP:0001732,postnatal growth retardation|MP:0001851,eye inflammation|MP:0002083,premature death|MP:0002406,increased susceptibility to infection|MP:0002644,decreased circulating triglyceride level|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003061,decreased aerobic running capacity|MP:0003137,abnormal impulse conducting system conduction|MP:0003233,prolonged QT interval|MP:0003313,abnormal locomotor activation|MP:0005376,homeostasis/metabolism phenotype|MP:0005608,cardiac interstitial fibrosis|MP:0006138,congestive heart failure|MP:0008770,decreased survivor rate|MP:0010053,decreased grip strength|MP:0010392,prolonged QRS complex duration|MP:0010553,prolonged HV interval|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5692670	Cap2<tm1b(EUCOMM)Wtsi>	MP:0005562,decreased mean corpuscular hemoglobin|MP:0010067,increased red blood cell distribution width|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5806472	Cap2<tm1c(EUCOMM)Wtsi>	MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0003137,abnormal impulse conducting system conduction|MP:0005333,decreased heart rate|MP:0005385,cardiovascular system phenotype|MP:0010392,prolonged QRS complex duration|MP:0010506,prolonged RR interval|MP:0010519,atrioventricular block|MP:0010553,prolonged HV interval|MP:0010637,sinus bradycardia
MGI:5776537	Cap2<tm1e(EUCOMM)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0003140,dilated heart atrium|MP:0003141,cardiac fibrosis|MP:0003233,prolonged QT interval|MP:0004062,dilated heart right atrium|MP:0004090,abnormal sarcomere morphology|MP:0004094,abnormal M line morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004567,decreased myocardial fiber number|MP:0005329,abnormal myocardium layer morphology|MP:0005333,decreased heart rate|MP:0008022,dilated heart ventricle|MP:0010392,prolonged QRS complex duration|MP:0010499,abnormal ventricle myocardium morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011953,prolonged PQ interval|MP:0014730,abnormal myocardial fiber myofibril morphology|MP:0030567,abnormal I band morphology
MGI:2680796	Capg<tm1Djk>	MP:0001798,impaired macrophage phagocytosis|MP:0002376,abnormal dendritic cell physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0008720,impaired neutrophil chemotaxis
MGI:6209549	Capn10<tm1b(EUCOMM)Wtsi>	MP:0001399,hyperactivity|MP:0001566,increased circulating phosphate level|MP:0002764,short tibia|MP:0005278,abnormal cholesterol homeostasis|MP:0005344,increased circulating bilirubin level
MGI:3721096	Capn10<tm1Ksp>	MP:0002693,abnormal pancreas physiology
MGI:5692635	Capn11<tm1b(EUCOMM)Wtsi>	MP:0005293,impaired glucose tolerance
MGI:6194895	Capn11<tm1Osb>	MP:0002169,no abnormal phenotype detected
MGI:5605772	Capn12<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001417,decreased exploration in new environment|MP:0002699,abnormal vitreous body morphology|MP:0005559,increased circulating glucose level|MP:0008806,increased circulating amylase level|MP:0011886,increased circulating lipase level
MGI:6489917	Capn15<tm2d(EUCOMM)Hmgu>	MP:0001262,decreased body weight|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5445809	Capn1<tm1.1Arte>	MP:0005464,abnormal platelet physiology
MGI:2180538	Capn1<tm1Ahc>	MP:0002551,abnormal blood coagulation|MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology|MP:0009446,abnormal platelet dense granule physiology|MP:0009549,decreased platelet aggregation
MGI:5319092	Capn1<tm1Dgen>	MP:0003628,abnormal leukocyte adhesion|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3628453	Capn2<tm1Pag>	MP:0004179,transmission ratio distortion|MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5292734	Capn2<tm1Tcs>	MP:0000259,abnormal vascular development|MP:0000280,thin ventricular wall|MP:0002128,abnormal blood circulation|MP:0004266,pale placenta|MP:0011091,prenatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3046866	Capn3<Gt(OST141731)Lex>	MP:0001262,decreased body weight|MP:0002108,abnormal muscle morphology|MP:0002279,abnormal diaphragm morphology|MP:0003081,abnormal soleus morphology|MP:0003082,abnormal gastrocnemius morphology|MP:0003083,abnormal tibialis anterior morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004819,decreased skeletal muscle mass|MP:0014344,abnormal skeletal muscle fiber mitochondrial morphology|MP:0030566,abnormal A band morphology
MGI:4829966	Capn3<tm1.1Hiso>	MP:0000752,dystrophic muscle|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009415,skeletal muscle degeneration|MP:0010090,increased circulating creatine kinase level
MGI:2177929	Capn3<tm1Jsb>	MP:0000752,dystrophic muscle|MP:0004121,abnormal sarcolemma morphology|MP:0004179,transmission ratio distortion
MGI:4436604	Capn5<tm1a(EUCOMM)Hmgu>	MP:0001260,increased body weight
MGI:3604529	Capn5<tm1Dgen>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3029041	Capn5<tm1Nde>	MP:0001265,decreased body size|MP:0002083,premature death|MP:0005387,immune system phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5544425	Capn6<tm1Hiso>	MP:0000729,abnormal myogenesis|MP:0004136,abnormal tongue muscle morphology|MP:0031318,enhanced skeletal muscle regeneration
MGI:3604530	Capn7<tm1Dgen>	MP:0001262,decreased body weight|MP:0001973,increased thermal nociceptive threshold|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4822421	Capn8<tm1Hiso>	MP:0005165,increased susceptibility to injury|MP:0005381,digestive/alimentary phenotype
MGI:4822422	Capn8<tm2.1Hiso>	MP:0005165,increased susceptibility to injury
MGI:4822423	Capn9<tm1Hiso>	MP:0005165,increased susceptibility to injury|MP:0005381,digestive/alimentary phenotype
MGI:5293309	Capns1<tm1.1Otsu>	MP:0002753,dilated heart left ventricle|MP:0003141,cardiac fibrosis|MP:0003921,abnormal heart left ventricle morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004485,increased response of heart to induced stress|MP:0005140,decreased cardiac muscle contractility|MP:0005630,increased lung weight|MP:0006138,congestive heart failure
MGI:5619296	Capns1<tm1Kraj>	MP:0006207,embryonic lethality during organogenesis
MGI:2179226	Capns1<tm1Pag>	MP:0000267,abnormal heart development|MP:0001622,abnormal vasculogenesis|MP:0001914,hemorrhage|MP:0002950,abnormal neural crest cell migration|MP:0003228,abnormal sinus venosus morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0009395,increased nucleated erythrocyte cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3640691	Capns1<tm1Ujz>	MP:0011092,embryonic lethality, complete penetrance
MGI:3663675	Capns1<tm2.1Pag>	MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3044388	Capop<NOD>	MP:0006414,decreased T cell apoptosis
MGI:4838547	Caprin1<tm1Mtok>	MP:0001504,abnormal posture|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0003203,increased neuron apoptosis|MP:0004200,decreased fetal size|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004811,abnormal neuron physiology|MP:0008143,abnormal dendrite morphology|MP:0009538,abnormal synapse morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:8254854	Caprin2<em1Nshi>	MP:0001303,abnormal lens morphology|MP:0013272,abnormal translation
MGI:4434168	Caprin2<tm2a(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001314,cornea opacity|MP:0002840,abnormal lens fiber morphology|MP:0010713,corneal-lenticular stalk
MGI:8190488	Capsl<em1Xjz>	MP:0000260,abnormal angiogenesis|MP:0000364,abnormal vascular regression|MP:0002792,abnormal retina vasculature morphology|MP:0003544,abnormal vascular endothelial cell migration|MP:0010097,abnormal retina blood vessel morphology|MP:0012201,decreased endothelial cell proliferation|MP:0012537,abnormal hyaloid artery morphology
MGI:2680367	Capsq1<KJR/Ms>	MP:0001986,abnormal taste sensitivity
MGI:2680370	Capsq2<KJR/Ms>	MP:0001986,abnormal taste sensitivity
MGI:2680374	Capsq3<KJR/Ms>	MP:0001986,abnormal taste sensitivity
MGI:6432322	Capza1<em1(IMPC)Tcp>	MP:0000208,decreased hematocrit|MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002111,abnormal tail morphology|MP:0002591,decreased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0003179,thrombocytopenia|MP:0005016,decreased lymphocyte cell number
MGI:7792458	Capza2<em1Cya>	MP:0001363,increased anxiety-related response|MP:0001405,impaired coordination|MP:0001458,abnormal object recognition memory|MP:0002882,abnormal neuron morphology|MP:0008432,abnormal long-term spatial reference memory|MP:0009936,abnormal dendritic spine morphology|MP:0009937,abnormal neuron differentiation|MP:0012307,impaired spatial learning|MP:0014370,impaired spatial working memory|MP:0014416,decreased social novelty preference|MP:0020335,abnormal dentate gyrus neuron dendrite morphology|MP:0020507,increased dendritic spine density|MP:0020508,decreased dendritic spine density|MP:0020510,increased dendritic spine length|MP:0021018,decreased dendritic spine number|MP:0021019,increased dendritic spine number|MP:0021111,decreased social investigation|MP:0031391,increased locomotor activity
MGI:8250452	Capza2<em1Yoch>	MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001458,abnormal object recognition memory|MP:0002152,abnormal brain morphology|MP:0008432,abnormal long-term spatial reference memory|MP:0009538,abnormal synapse morphology|MP:0009937,abnormal neuron differentiation|MP:0009939,abnormal hippocampus neuron morphology|MP:0012307,impaired spatial learning|MP:0014370,impaired spatial working memory|MP:0014416,decreased social novelty preference|MP:0020507,increased dendritic spine density|MP:0020508,decreased dendritic spine density|MP:0021018,decreased dendritic spine number|MP:0021111,decreased social investigation
MGI:5638561	Capza2<tm1b(KOMP)Wtsi>	MP:0000602,dilated liver sinusoidal space|MP:0002169,no abnormal phenotype detected|MP:0002599,increased mean platelet volume|MP:0003266,biliary cyst|MP:0004613,fusion of vertebral arches|MP:0005553,increased circulating creatinine level|MP:0010420,muscular ventricular septal defect|MP:0010484,bicuspid aortic valve|MP:0010602,abnormal pulmonary valve cusp morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013834,thin hypoglossal nerve|MP:0013835,absent hypoglossal nerve|MP:0013836,abnormal hypoglossal nerve topology|MP:0013875,increased trigeminal neuroma incidence|MP:0013877,abnormal ductus venosus valve morphology|MP:0013968,multiple persisting craniopharyngeal ducts|MP:0013971,blood in lymph vessels|MP:0013973,abnormal hepatic vein connection|MP:0014001,abnormal vertebral artery topology
MGI:3590195	Capza3<repro32>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology
MGI:5925338	Capzb<tm1c(EUCOMM)Wtsi>	MP:0002730,head shaking|MP:0004737,absent distortion product otoacoustic emissions|MP:0004742,abnormal vestibular system physiology|MP:0004813,absent linear vestibular evoked potential|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3526109	Car12<Tn(sb-T2/GT2/tTA)4563.1Dla>	MP:0002083,premature death
MGI:5695123	Car13<tm1b(KOMP)Wtsi>	MP:0005293,impaired glucose tolerance
MGI:6120708	Car14<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake|MP:0011965,decreased total retina thickness
MGI:3611771	Car14<tm1Sly>	MP:0002169,no abnormal phenotype detected
MGI:7718420	Car1<tm1.1Nju>	MP:0001363,increased anxiety-related response|MP:0003008,enhanced long-term potentiation|MP:0008269,abnormal hippocampus CA4 region morphology|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude|MP:0014414,increased depression-related behavior|MP:0021009,abnormal synaptic physiology
MGI:2135646	Car2<n>	MP:0000525,renal tubular acidosis|MP:0001663,abnormal digestive system physiology|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0003017,decreased circulating bicarbonate level|MP:0003271,abnormal duodenum morphology|MP:0005390,skeleton phenotype|MP:0005493,stomach epithelial hyperplasia|MP:0006423,dilated rete testis|MP:0009140,dilated efferent ductule of testis|MP:0010787,gastric cyst|MP:0012550,respiratory acidosis
MGI:3808366	Car2<tm1(KOMP)Vlcg>	MP:0000525,renal tubular acidosis|MP:0001265,decreased body size|MP:0002412,increased susceptibility to bacterial infection|MP:0003017,decreased circulating bicarbonate level|MP:0003027,abnormal blood pH regulation|MP:0004119,hypokalemia|MP:0009349,increased urine pH|MP:0011403,pyelonephritis|MP:0011754,abnormal kidney collecting duct intercalated cell morphology|MP:0012551,metabolic acidosis
MGI:7425556	Car3<em1(IMPC)Hmgu>	MP:0001523,impaired righting response
MGI:3511866	Car3<tm1Gkim>	MP:0005620,abnormal muscle contractility
MGI:5548394	Car4<tm1b(EUCOMM)Wtsi>	MP:0000194,increased circulating calcium level|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3611770	Car4<tm1Sly>	MP:0002082,postnatal lethality
MGI:5425618	Car5a<tm1Sly>	MP:0001265,decreased body size|MP:0001764,abnormal homeostasis|MP:0005309,increased circulating ammonia level|MP:0005376,homeostasis/metabolism phenotype|MP:0010768,mortality/aging
MGI:5314752	Car5b<tm1Sly>	MP:0005376,homeostasis/metabolism phenotype|MP:0010768,mortality/aging
MGI:7425557	Car6<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001325,abnormal retina morphology|MP:0001552,increased circulating triglyceride level|MP:0002110,abnormal digit morphology|MP:0002339,abnormal lymph node morphology|MP:0005011,increased eosinophil cell number|MP:0008045,decreased NK cell number|MP:0009142,decreased prepulse inhibition|MP:0011045,decreased lung elastance|MP:0013129,abnormal tooth color
MGI:5013650	Car6<tm1Pwp>	MP:0002389,abnormal Peyer's patch follicle morphology|MP:0005381,digestive/alimentary phenotype
MGI:5543604	Car7<tm1.1Kkai>	MP:0004008,abnormal GABA-mediated receptor currents|MP:0009358,environmentally induced seizures
MGI:5498767	Car7<tm1b(KOMP)Wtsi>	MP:0001554,increased circulating free fatty acids level|MP:0002833,increased heart weight|MP:0005633,increased circulating sodium level
MGI:7610742	Car8<em1(IMPC)Bay>	MP:0001406,abnormal gait|MP:0010053,decreased grip strength
MGI:2449035	Car8<wdl>	MP:0000745,tremors|MP:0000849,abnormal cerebellum morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0002184,abnormal innervation|MP:0002804,abnormal motor learning|MP:0004738,abnormal auditory brainstem response|MP:0004811,abnormal neuron physiology
MGI:5007043	Car9<tm1Lex>	MP:0008210,increased mature B cell number
MGI:2448129	Car9<tm1Spas>	MP:0001663,abnormal digestive system physiology|MP:0002580,duodenal lesions|MP:0004139,abnormal gastric parietal cell morphology|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0005381,digestive/alimentary phenotype|MP:0005493,stomach epithelial hyperplasia|MP:0010792,abnormal stomach mucosa morphology|MP:0013567,gastric gland atrophy
MGI:2154530	Cara1<C57BL/6J>	MP:0002089,abnormal postnatal growth/weight/body size
MGI:2678054	Cara2<C57BL/6J>	MP:0002089,abnormal postnatal growth/weight/body size
MGI:2429714	Cara3<C57BL/6J>	MP:0002089,abnormal postnatal growth/weight/body size
MGI:5704084	carc	MP:0000367,abnormal coat/ hair morphology|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000427,abnormal hair cycle|MP:0001200,thick skin|MP:0010771,integument phenotype
MGI:3710003	Card10<tm1Xlin>	MP:0001890,anencephaly|MP:0011090,perinatal lethality, incomplete penetrance
MGI:6367964	Card11<em1(IMPC)Ccpcz>	MP:0000218,increased leukocyte cell number|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002966,decreased circulating alkaline phosphatase level|MP:0004953,decreased spleen weight|MP:0005013,increased lymphocyte cell number|MP:0005015,increased T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0009709,hydrometra|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010851,decreased effector memory CD8-positive, alpha-beta T cell number|MP:0013436,increased CD8-positive, naive alpha-beta T cell number|MP:0013763,increased T-helper cell number|MP:0013771,decreased effector memory T-helper cell number
MGI:6491988	Card11<em1Welu>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0004978,decreased B-1 B cell number|MP:0005093,decreased B cell proliferation|MP:0008099,abnormal plasma cell differentiation|MP:0008168,decreased B-1a cell number|MP:0008173,increased follicular B cell number|MP:0008176,abnormal germinal center B cell morphology|MP:0008178,decreased germinal center B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008209,decreased pre-B cell number|MP:0009923,decreased transitional stage T1 B cell number|MP:0009925,increased transitional stage T2 B cell number|MP:0010228,decreased transitional stage T3 B cell number|MP:0020154,impaired humoral immune response
MGI:6491989	Card11<em2Welu>	MP:0000691,enlarged spleen|MP:0003132,increased pre-B cell number|MP:0004977,increased B-1 B cell number|MP:0005154,increased B cell proliferation|MP:0008099,abnormal plasma cell differentiation|MP:0008167,increased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0008177,increased germinal center B cell number|MP:0008181,increased marginal zone B cell number|MP:0008211,decreased mature B cell number|MP:0009925,increased transitional stage T2 B cell number
MGI:6491990	Card11<em3Welu>	MP:0004978,decreased B-1 B cell number|MP:0008182,decreased marginal zone B cell number
MGI:3805728	Card11<m1Btlr>	MP:0001194,dermatitis|MP:0001806,decreased IgM level|MP:0001828,abnormal T cell activation|MP:0002407,abnormal double-negative T cell morphology|MP:0002460,decreased immunoglobulin level|MP:0003009,abnormal cytokine secretion|MP:0004974,decreased regulatory T cell number|MP:0004978,decreased B-1 B cell number|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008040,decreased NK T cell number|MP:0008045,decreased NK cell number|MP:0008050,decreased memory T cell number|MP:0008211,decreased mature B cell number|MP:0008347,decreased gamma-delta T cell number|MP:0008397,abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008897,decreased IgG2c level|MP:0010766,abnormal NK cell physiology
MGI:5497995	Card11<M2Btlr>	MP:0001806,decreased IgM level
MGI:5640756	Card11<m3Btlr>	MP:0008167,increased B-1a cell number
MGI:6113504	Card11<M4Btlr>	MP:0001806,decreased IgM level|MP:0008168,decreased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0020154,impaired humoral immune response
MGI:6113551	Card11<M5Btlr>	MP:0001806,decreased IgM level|MP:0004977,increased B-1 B cell number|MP:0008167,increased B-1a cell number|MP:0020154,impaired humoral immune response
MGI:6283989	Card11<M6Btlr>	MP:0012764,increased alpha-beta T cell number
MGI:6304449	Card11<M7Btlr>	MP:0002145,abnormal T cell differentiation|MP:0004978,decreased B-1 B cell number|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010842,decreased central memory CD4-positive, alpha-beta T cell number|MP:0010845,decreased effector memory CD4-positive, alpha-beta T cell number|MP:0010851,decreased effector memory CD8-positive, alpha-beta T cell number
MGI:6305368	Card11<m8Btlr>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0008039,increased NK T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008168,decreased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0010851,decreased effector memory CD8-positive, alpha-beta T cell number|MP:0020001,decreased response to antigen|MP:0020154,impaired humoral immune response
MGI:5307006	Card11<tm1.1Litt>	MP:0001828,abnormal T cell activation|MP:0002405,respiratory system inflammation|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype
MGI:3039682	Card11<tm1Litt>	MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0001828,abnormal T cell activation|MP:0002145,abnormal T cell differentiation|MP:0002407,abnormal double-negative T cell morphology|MP:0002460,decreased immunoglobulin level|MP:0005094,abnormal T cell proliferation|MP:0005153,abnormal B cell proliferation|MP:0008203,absent B-1a cells|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:3045950	Card11<tm1Pngr>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0001828,abnormal T cell activation|MP:0002144,abnormal B cell differentiation|MP:0002459,abnormal B cell physiology|MP:0002460,decreased immunoglobulin level|MP:0002492,decreased IgE level|MP:0002619,abnormal lymphocyte morphology|MP:0005093,decreased B cell proliferation|MP:0005387,immune system phenotype|MP:0008045,decreased NK cell number|MP:0008203,absent B-1a cells|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008686,abnormal interleukin-2 secretion
MGI:3528226	Card11<tm1Vmd>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002459,abnormal B cell physiology|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0008213,absent immature B cells|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:3776490	Card11<tm1Xav>	MP:0001828,abnormal T cell activation|MP:0001861,lung inflammation|MP:0002335,decreased airway responsiveness|MP:0002492,decreased IgE level|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008603,decreased circulating interleukin-4 level|MP:0008627,decreased circulating interleukin-5 level
MGI:3045963	Card11<unm>	MP:0000693,spleen hyperplasia|MP:0001194,dermatitis|MP:0001790,abnormal immune system physiology|MP:0001806,decreased IgM level|MP:0001828,abnormal T cell activation|MP:0001846,increased inflammatory response|MP:0002144,abnormal B cell differentiation|MP:0002460,decreased immunoglobulin level|MP:0002461,increased immunoglobulin level|MP:0002497,increased IgE level|MP:0003454,erythroderma|MP:0004978,decreased B-1 B cell number|MP:0008102,lymph node hyperplasia|MP:0008498,decreased IgG3 level
MGI:7425558	Card14<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002792,abnormal retina vasculature morphology|MP:0003961,decreased lean body mass
MGI:7861304	Card14<em1Maak>	MP:0000377,abnormal hair follicle morphology|MP:0001192,scaly skin|MP:0001212,skin lesions|MP:0001242,hyperkeratosis|MP:0001874,acanthosis|MP:0002796,impaired skin barrier function|MP:0003427,parakeratosis|MP:0004947,skin inflammation|MP:0008489,slow postnatal weight gain|MP:0010699,dilated hair follicle|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6441135	Card14<em1Tshu>	MP:0012573,decreased susceptibility to chemically induced skin inflammation
MGI:6441136	Card14<em2Tshu>	MP:0001193,psoriasis|MP:0001219,thick epidermis|MP:0001874,acanthosis|MP:0004947,skin inflammation|MP:0008345,abnormal gamma-delta T cell number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012764,increased alpha-beta T cell number
MGI:6441137	Card14<em3Tshu>	MP:0001193,psoriasis|MP:0001219,thick epidermis|MP:0004947,skin inflammation
MGI:6164625	Card14<em9Lutzy>	MP:0001193,psoriasis|MP:0001195,flaky skin|MP:0001212,skin lesions|MP:0001214,skin hyperplasia|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001265,decreased body size|MP:0001614,abnormal blood vessel morphology|MP:0001874,acanthosis|MP:0003427,parakeratosis|MP:0003853,dry skin|MP:0004947,skin inflammation|MP:0009583,increased keratinocyte proliferation|MP:0009675,orthokeratosis|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3528483	Card14<tm1Lex>	MP:0012573,decreased susceptibility to chemically induced skin inflammation
MGI:7514948	Card19<tm1Rwen>	MP:0003726,decreased autoantibody level|MP:0005387,immune system phenotype
MGI:3776908	Card6<tm1.1Aldu>	MP:0005387,immune system phenotype
MGI:3663486	Card9<tm1Jrld>	MP:0002376,abnormal dendritic cell physiology|MP:0005399,increased susceptibility to fungal infection
MGI:3715521	Card9<tm1Tks>	MP:0002376,abnormal dendritic cell physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0003009,abnormal cytokine secretion|MP:0005387,immune system phenotype|MP:0008561,decreased tumor necrosis factor secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008670,decreased interleukin-12b secretion|MP:0008691,decreased interleukin-23 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion
MGI:3698412	Card9<tm1Xlin>	MP:0002412,increased susceptibility to bacterial infection|MP:0002419,abnormal innate immunity|MP:0002451,abnormal macrophage physiology|MP:0008713,abnormal cytokine level
MGI:2156016	Carfhg1<CAST/EiJ>	MP:0010024,increased total body fat amount
MGI:2157111	Carfhg2<CAST/EiJ>	MP:0010024,increased total body fat amount
MGI:4461230	Carf<tm1.1Aew>	MP:0001458,abnormal object recognition memory|MP:0008414,abnormal spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0014365,impaired short-term object recognition memory
MGI:5529500	Carf<tm1.1(KOMP)Vlcg>	MP:0003019,increased circulating chloride level|MP:0005633,increased circulating sodium level|MP:0010570,prolonged ST segment
MGI:7507543	Carhsp1<em1(IMPC)J>	MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount
MGI:5505489	Carm1<m9Bei>	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0000428,abnormal craniofacial morphology|MP:0000780,abnormal corpus callosum morphology|MP:0001698,decreased embryo size|MP:0002109,abnormal limb morphology|MP:0002633,persistent truncus arteriosus|MP:0003052,omphalocele|MP:0003808,increased atrioventricular cushion size|MP:0003923,abnormal heart left atrium morphology|MP:0005243,hemothorax|MP:0008727,increased heart right atrium size|MP:0009698,heart hemorrhage|MP:0010402,ventricular septal defect|MP:0010647,heart left atrium hypoplasia|MP:0011100,preweaning lethality, complete penetrance
MGI:6276271	Carm1<tm1.1Mtb>	MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0002662,abnormal cauda epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0009230,abnormal sperm head morphology|MP:0009234,absent sperm head|MP:0009831,abnormal sperm midpiece morphology|MP:0014636,decreased elongated spermatid number
MGI:5605773	Carm1<tm1b(EUCOMM)Hmgu>	MP:0005016,decreased lymphocyte cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:2663959	Carm1<tm1Mtb>	MP:0000284,double outlet right ventricle|MP:0001175,abnormal lung morphology|MP:0001825,arrested T cell differentiation|MP:0001953,respiratory failure|MP:0002633,persistent truncus arteriosus|MP:0004200,decreased fetal size|MP:0005243,hemothorax|MP:0010402,ventricular septal defect|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011167,abnormal adipose tissue development
MGI:4454543	Carm1<tm2.1Mtb>	MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0004200,decreased fetal size|MP:0011087,neonatal lethality, complete penetrance|MP:0011167,abnormal adipose tissue development
MGI:5636628	carmelo	MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality
MGI:4362921	Carmil1<tm1a(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5547539	Carmil2<bas>	MP:0000709,enlarged thymus|MP:0004974,decreased regulatory T cell number|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion
MGI:5692851	Carmil2<tm1b(KOMP)Mbp>	MP:0002075,abnormal coat/hair pigmentation|MP:0005278,abnormal cholesterol homeostasis|MP:0005559,increased circulating glucose level
MGI:6276894	Carmil3<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology
MGI:7541262	Carnmt1<em1Yshk>	MP:0003984,embryonic growth retardation|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011111,lethality during fetal growth through weaning, complete penetrance
MGI:7541268	Carnmt1<em2Yshk>	MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011111,lethality during fetal growth through weaning, complete penetrance
MGI:6489595	Carns1<tm1.2Meck>	MP:0005369,muscle phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0008544,impaired olfaction|MP:0010768,mortality/aging|MP:0020348,decreased olfactory sensory neuron number
MGI:2154528	Carp1<C57BL/6J>	MP:0002089,abnormal postnatal growth/weight/body size
MGI:2678062	Carp2<C57BL/6J>	MP:0002089,abnormal postnatal growth/weight/body size
MGI:2678063	Carp2<CAST/EiJ>	MP:0001257,increased body length|MP:0001260,increased body weight|MP:0002865,increased growth rate|MP:0005458,increased percent body fat/body weight|MP:0008908,increased total fat pad weight
MGI:2429716	Carp3<C57BL/6J>	MP:0002089,abnormal postnatal growth/weight/body size
MGI:7716916	Cars1<em1(IMPC)Tcp>	MP:0011100,preweaning lethality, complete penetrance
MGI:6368616	Cars2<em1Akai>	MP:0002080,prenatal lethality|MP:0006036,abnormal mitochondrial physiology
MGI:7425559	Cars2<em1(IMPC)Bay>	MP:0000266,abnormal heart morphology|MP:0001513,limb grasping|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001914,hemorrhage|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6368617	Cars2<em2Akai>	MP:0006036,abnormal mitochondrial physiology
MGI:4840539	Cars2<m1Btlr>	MP:0000745,tremors|MP:0001410,head bobbing|MP:0003631,nervous system phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0008911,induced hyperactivity
MGI:6316119	Cartpt<em1(IMPC)Mbp>	MP:0000494,abnormal cecum morphology|MP:0001304,cataract|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0009453,enhanced contextual conditioning behavior
MGI:3612125	Cartpt<tm1Amgn>	MP:0001260,increased body weight|MP:0002079,increased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance
MGI:3576858	Cartpt<tm1Hmh>	MP:0004016,decreased bone mass|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0005449,abnormal food intake|MP:0005658,increased susceptibility to diet-induced obesity|MP:0010024,increased total body fat amount
MGI:4338383	Casc3<Gt(RRU345)Byg>	MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0011111,lethality during fetal growth through weaning, complete penetrance|MP:0012531,delayed limb development
MGI:5548776	Casc3<tm1.1(KOMP)Vlcg>	MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0005566,decreased blood urea nitrogen level|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012724,absent head fold
MGI:4452843	Casc3<tm1(KOMP)Vlcg>	MP:0001698,decreased embryo size|MP:0002169,no abnormal phenotype detected|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014134,abnormal embryo morphology
MGI:6152419	Caskin1<em1(IMPC)Mbp>	MP:0001402,decreased locomotor activity|MP:0009142,decreased prepulse inhibition
MGI:6364869	Caskin1<tm1.1Tayk>	MP:0001262,decreased body weight|MP:0001362,abnormal anxiety-related response|MP:0001406,abnormal gait|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002734,abnormal mechanical nociception|MP:0002757,decreased vertical activity|MP:0003360,abnormal depression-related behavior|MP:0003908,decreased stereotypic behavior|MP:0003998,decreased thermal nociceptive threshold|MP:0005407,hyperalgesia|MP:0005534,decreased body temperature|MP:0008432,abnormal long-term spatial reference memory|MP:0009453,enhanced contextual conditioning behavior|MP:0009455,enhanced cued conditioning behavior|MP:0031391,increased locomotor activity
MGI:5583073	Caskin1<tm1b(KOMP)Wtsi>	MP:0000538,abnormal urinary bladder morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002631,abnormal epididymis morphology|MP:0010378,increased respiratory quotient|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011625,cystolithiasis
MGI:5548764	Caskin2<tm1.1(KOMP)Vlcg>	MP:0000062,increased bone mineral density|MP:0003917,increased kidney weight|MP:0009142,decreased prepulse inhibition
MGI:2180543	Cask<Tg(Bnlf1)1Wln>	MP:0000088,short mandible|MP:0000378,absent hair follicles|MP:0000418,focal hair loss|MP:0000433,microcephaly|MP:0000448,pointed snout|MP:0000455,abnormal maxilla morphology|MP:0000585,kinked tail|MP:0001211,wrinkled skin|MP:0001222,epidermal hyperplasia|MP:0001290,delayed eyelid opening|MP:0001436,abnormal suckling behavior|MP:0001505,hunched posture|MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0004174,abnormal spine curvature|MP:0009655,abnormal secondary palate development|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance|MP:0030273,mandibular retrognathia|MP:0031460,abnormal palatal shelf morphology|MP:0031462,decreased palatal shelf size
MGI:3699428	Cask<tm1.1Sud>	MP:0011087,neonatal lethality, complete penetrance
MGI:3693354	Cask<tm1Sud>	MP:0001265,decreased body size
MGI:3604507	Casp12<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3832547	Casp12<tm1Dwni>	MP:0002411,decreased susceptibility to bacterial infection|MP:0008566,increased interferon-gamma secretion|MP:0008635,increased circulating interleukin-18 level|MP:0008657,increased interleukin-1 beta secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:2159367	Casp12<tm1Yuan>	MP:0002006,neoplasm|MP:0005384,cellular phenotype|MP:0008236,decreased susceptibility to neuronal excitotoxicity|MP:0008944,decreased sensitivity to induced cell death
MGI:6341907	Casp14<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002060,abnormal skin morphology|MP:0005627,increased circulating potassium level|MP:0011239,abnormal skin coloration
MGI:3770173	Casp14<tm1Wdec>	MP:0001196,shiny skin|MP:0001203,increased sensitivity to skin irradiation|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001429,dehydration|MP:0002796,impaired skin barrier function|MP:0010771,integument phenotype
MGI:2158744	Casp1<tm1Flv>	MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype
MGI:6449043	Casp2<em1(IMPC)Mbp>	MP:0000494,abnormal cecum morphology|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001488,increased startle reflex|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0005238,increased brain size|MP:0009476,enlarged cecum
MGI:3609949	Casp2<tm1Vaux>	MP:0005384,cellular phenotype
MGI:2159368	Casp2<tm1Yuan>	MP:0000909,abnormal facial motor nucleus morphology|MP:0001025,abnormal sympathetic neuron morphology|MP:0001125,abnormal oocyte morphology|MP:0001648,abnormal apoptosis|MP:0003202,abnormal neuron apoptosis|MP:0006361,abnormal female germ cell morphology|MP:0008781,abnormal B cell apoptosis|MP:0011120,increased primordial ovarian follicle number
MGI:5056374	Casp3<hith2>	MP:0000111,cleft palate|MP:0001406,abnormal gait|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012260,encephalomeningocele
MGI:5646608	Casp3<m1H>	MP:0006043,decreased apoptosis
MGI:4366356	Casp3<mldy>	MP:0001967,deafness|MP:0002622,abnormal cochlear hair cell morphology|MP:0002857,cochlear ganglion degeneration|MP:0004362,cochlear hair cell degeneration|MP:0006359,absent startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0030263,cranial bossing
MGI:2651856	Casp3<tm1Dsp>	MP:0000819,abnormal olfactory bulb morphology|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002739,abnormal olfactory bulb development|MP:0003204,decreased neuron apoptosis|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0011090,perinatal lethality, incomplete penetrance
MGI:2158753	Casp3<tm1Flv>	MP:0000032,cochlear degeneration|MP:0000042,abnormal organ of Corti morphology|MP:0000060,delayed bone ossification|MP:0000063,decreased bone mineral density|MP:0000168,abnormal bone marrow development|MP:0000715,decreased thymocyte number|MP:0000783,abnormal forebrain morphology|MP:0000830,abnormal diencephalon morphology|MP:0000854,abnormal cerebellum development|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0000919,cranioschisis|MP:0001265,decreased body size|MP:0001286,abnormal eye development|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001541,abnormal osteoclast physiology|MP:0001614,abnormal blood vessel morphology|MP:0001648,abnormal apoptosis|MP:0001891,hydrocephaly|MP:0001967,deafness|MP:0002092,abnormal eye morphology|MP:0002102,abnormal ear morphology|MP:0002113,abnormal skeleton development|MP:0002152,abnormal brain morphology|MP:0002857,cochlear ganglion degeneration|MP:0002998,abnormal bone remodeling|MP:0003222,increased cardiomyocyte apoptosis|MP:0003237,abnormal lens epithelium morphology|MP:0003453,abnormal keratinocyte physiology|MP:0003631,nervous system phenotype|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003843,abnormal sagittal suture morphology|MP:0004268,abnormal optic stalk morphology|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004528,fused outer hair cell stereocilia|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005277,abnormal brainstem morphology|MP:0005367,renal/urinary system phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005384,cellular phenotype|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0005545,abnormal lens development|MP:0006043,decreased apoptosis|MP:0008271,abnormal bone ossification|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008868,abnormal granulosa cell morphology|MP:0008943,increased sensitivity to induced cell death|MP:0008944,decreased sensitivity to induced cell death|MP:0009346,decreased trabecular bone thickness|MP:0009581,decreased keratinocyte apoptosis|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013502,decreased fibroblast apoptosis|MP:0021107,retina fold|MP:0031239,increased atretic ovarian follicle number
MGI:2684608	Casp3<tm1Kin>	MP:0002857,cochlear ganglion degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004737,absent distortion product otoacoustic emissions|MP:0006358,absent pinna reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2178778	Casp3<tm1Mak>	MP:0001876,decreased inflammatory response|MP:0002083,premature death|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5468949	Casp4<tm1.1Vmd>	MP:0008636,decreased circulating interleukin-18 level|MP:0008639,decreased circulating interleukin-1 alpha level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008655,decreased interleukin-1 alpha secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0011081,decreased macrophage apoptosis
MGI:5548377	Casp4<tm1b(KOMP)Wtsi>	MP:0000194,increased circulating calcium level|MP:0002079,increased circulating insulin level|MP:0005344,increased circulating bilirubin level|MP:0005559,increased circulating glucose level|MP:0005576,decreased pulmonary ventilation
MGI:2159366	Casp4<tm1Yuan>	MP:0008639,decreased circulating interleukin-1 alpha level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008658,decreased interleukin-1 beta secretion|MP:0008685,decreased interleukin-18 secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:5426933	Casp6<tm1.2Xen>	MP:0000788,abnormal cerebral cortex morphology|MP:0001402,decreased locomotor activity|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology|MP:0008236,decreased susceptibility to neuronal excitotoxicity|MP:0012467,increased striatum size
MGI:3603318	Casp6<tm1Flv>	MP:0005384,cellular phenotype|MP:0005391,vision/eye phenotype|MP:0005545,abnormal lens development
MGI:5308651	Casp7<tm1.1Acau>	MP:0005387,immune system phenotype
MGI:3603317	Casp7<tm1Flv>	MP:0005387,immune system phenotype|MP:0005391,vision/eye phenotype|MP:0013502,decreased fibroblast apoptosis
MGI:5311557	Casp8ap2<Gt(SGT207T1)Tigm>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:7572923	Casp8<em1Hbz>	MP:0000691,enlarged spleen|MP:0002942,decreased circulating alanine transaminase level|MP:0005397,hematopoietic system phenotype|MP:0005632,decreased circulating aspartate transaminase level|MP:0006043,decreased apoptosis|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010768,mortality/aging
MGI:6385274	Casp8<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0002135,abnormal kidney morphology|MP:0002953,thick ventricular wall|MP:0002989,small kidney|MP:0010579,increased heart left ventricle size|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5563498	Casp8<kuche>	MP:0000601,small liver|MP:0001606,impaired hematopoiesis
MGI:6113870	Casp8<m1Btlr>	MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6286116	Casp8<M2Btlr>	MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number
MGI:5546196	Casp8<tm1.1Raz>	MP:0000930,wavy neural tube|MP:0002128,abnormal blood circulation|MP:0003229,abnormal vitelline vasculature morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:5614580	Casp8<tm1.1Vmd>	MP:0011092,embryonic lethality, complete penetrance
MGI:2176089	Casp8<tm1.1Yuan>	MP:0001698,decreased embryo size|MP:0002128,abnormal blood circulation|MP:0002396,abnormal hematopoietic system morphology/development|MP:0005329,abnormal myocardium layer morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:4461018	Casp8<tm1Clie>	MP:0001570,abnormal circulating enzyme level|MP:0001860,liver inflammation|MP:0005165,increased susceptibility to injury|MP:0005166,decreased susceptibility to injury
MGI:3696985	Casp8<tm1Hed>	MP:0000324,increased mast cell number|MP:0000694,spleen hypoplasia|MP:0001192,scaly skin|MP:0001194,dermatitis|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001786,skin edema|MP:0001874,acanthosis|MP:0002060,abnormal skin morphology|MP:0002083,premature death|MP:0002420,abnormal adaptive immunity|MP:0002444,abnormal T cell physiology|MP:0002490,abnormal immunoglobulin level|MP:0002497,increased IgE level|MP:0002655,abnormal keratinocyte morphology|MP:0002796,impaired skin barrier function|MP:0003853,dry skin|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0006042,increased apoptosis|MP:0008182,decreased marginal zone B cell number|MP:0008499,increased IgG1 level|MP:0009795,epidermal spongiosis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014273,abnormal skin vasculature morphology
MGI:2655730	Casp8<tm1Raz>	MP:0000221,decreased leukocyte cell number|MP:0000598,abnormal liver morphology|MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001175,abnormal lung morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001828,abnormal T cell activation|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002444,abnormal T cell physiology|MP:0002619,abnormal lymphocyte morphology|MP:0003944,abnormal T cell subpopulation ratio|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005013,increased lymphocyte cell number|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005018,decreased T cell number|MP:0005094,abnormal T cell proliferation|MP:0005095,decreased T cell proliferation|MP:0006414,decreased T cell apoptosis|MP:0008037,abnormal T cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3609638	Casp8<tm1Syon>	MP:0000266,abnormal heart morphology|MP:0001722,pale yolk sac|MP:0003396,abnormal embryonic hematopoiesis|MP:0003400,kinked neural tube|MP:0004076,abnormal vitelline vascular remodeling|MP:0005244,hemopericardium|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011392,increased fetal cardiomyocyte apoptosis
MGI:2159369	Casp8<tm1Yuan>	MP:0000313,abnormal cell death|MP:0001698,decreased embryo size|MP:0002128,abnormal blood circulation|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002429,abnormal blood cell morphology/development|MP:0002652,thin myocardium|MP:0003131,increased erythrocyte cell number|MP:0005294,abnormal heart ventricle morphology|MP:0005329,abnormal myocardium layer morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:2158755	Casp9<tm1Flv>	MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0000787,abnormal telencephalon morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000826,abnormal third ventricle morphology|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0000934,abnormal telencephalon development|MP:0001648,abnormal apoptosis|MP:0002081,perinatal lethality|MP:0002152,abnormal brain morphology|MP:0003204,decreased neuron apoptosis|MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0006414,decreased T cell apoptosis|MP:0008789,abnormal olfactory epithelium morphology|MP:0009258,abnormal thymocyte apoptosis|MP:0011090,perinatal lethality, incomplete penetrance|MP:0012091,increased midbrain size|MP:0012132,abnormal midbrain-hindbrain boundary morphology|MP:0012540,abnormal lamina terminalis morphology|MP:0013228,brain ventricle stenosis
MGI:2158754	Casp9<tm1Mak>	MP:0000788,abnormal cerebral cortex morphology|MP:0000822,abnormal brain ventricle morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0001265,decreased body size|MP:0001891,hydrocephaly|MP:0001916,intracerebral hemorrhage|MP:0002196,absent corpus callosum|MP:0002199,abnormal brain commissure morphology|MP:0003204,decreased neuron apoptosis|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0003232,abnormal forebrain development|MP:0005387,immune system phenotype|MP:0005621,abnormal cell physiology|MP:0006043,decreased apoptosis|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008944,decreased sensitivity to induced cell death|MP:0009258,abnormal thymocyte apoptosis|MP:0009340,abnormal splenocyte apoptosis|MP:0009703,decreased birth body size|MP:0010955,abnormal respiratory electron transport chain|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3530841	Casq1<Gt(OST82566)Lex>	MP:0001262,decreased body weight|MP:0002106,abnormal muscle physiology|MP:0002269,muscular atrophy|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003157,impaired muscle relaxation|MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0004090,abnormal sarcomere morphology|MP:0004145,abnormal muscle electrophysiology
MGI:5692603	Casq1<tm1b(EUCOMM)Wtsi>	MP:0005278,abnormal cholesterol homeostasis|MP:0005554,decreased circulating creatinine level|MP:0005568,increased circulating total protein level|MP:0010053,decreased grip strength|MP:0020420,abnormal freezing behavior
MGI:4354204	Casq2<tm1.1Sgp>	MP:0000278,abnormal myocardial fiber morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat
MGI:5548421	Casq2<tm1b(KOMP)Wtsi>	MP:0001785,edema|MP:0003929,decreased heart rate variability|MP:0004122,abnormal sinus arrhythmia|MP:0005385,cardiovascular system phenotype|MP:0011100,preweaning lethality, complete penetrance
MGI:3721900	Casq2<tm1Jse>	MP:0001625,cardiac hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0004122,abnormal sinus arrhythmia|MP:0004215,abnormal myocardial fiber physiology|MP:0004485,increased response of heart to induced stress|MP:0005333,decreased heart rate|MP:0008725,increased heart atrium size|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3690019	Casq2<tm1Kpfe>	MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0004215,abnormal myocardial fiber physiology|MP:0005333,decreased heart rate|MP:0008950,ventricular tachycardia
MGI:5587007	Casq2<tm2.1Sgp>	MP:0000278,abnormal myocardial fiber morphology|MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0008950,ventricular tachycardia
MGI:3721902	Casq2<tm2Jse>	MP:0001625,cardiac hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0004122,abnormal sinus arrhythmia|MP:0004215,abnormal myocardial fiber physiology|MP:0004485,increased response of heart to induced stress|MP:0005333,decreased heart rate|MP:0008725,increased heart atrium size|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5424979	Casr<BCH002>	MP:0000194,increased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0001265,decreased body size|MP:0002075,abnormal coat/hair pigmentation
MGI:5424980	Casr<BCH003>	MP:0000194,increased circulating calcium level
MGI:5424981	Casr<BCH004>	MP:0000194,increased circulating calcium level
MGI:5424982	Casr<BCH007>	MP:0000194,increased circulating calcium level|MP:0001265,decreased body size
MGI:5424983	Casr<BCH011>	MP:0000194,increased circulating calcium level
MGI:5424984	Casr<BCH013>	MP:0000194,increased circulating calcium level
MGI:3054788	Casr<Nuf>	MP:0000195,decreased circulating calcium level|MP:0001304,cataract|MP:0001566,increased circulating phosphate level|MP:0002083,premature death|MP:0002902,decreased urine phosphate level|MP:0002905,decreased circulating parathyroid hormone level|MP:0002986,decreased urine calcium level|MP:0003195,calcinosis|MP:0003197,nephrocalcinosis|MP:0003199,calcified muscle|MP:0030129,tongue inflammation
MGI:5620314	Casr<tm1b(KOMP)Mbp>	MP:0000194,increased circulating calcium level|MP:0001102,small superior vagus ganglion|MP:0001566,increased circulating phosphate level|MP:0001785,edema|MP:0001944,abnormal pancreas morphology|MP:0004906,enlarged uterus|MP:0011100,preweaning lethality, complete penetrance
MGI:2176758	Casr<tm1Ces>	MP:0000060,delayed bone ossification|MP:0000063,decreased bone mineral density|MP:0000069,kyphoscoliosis|MP:0000194,increased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001429,dehydration|MP:0001438,aphagia|MP:0001504,abnormal posture|MP:0001732,postnatal growth retardation|MP:0002608,increased hematocrit|MP:0002896,abnormal bone mineralization|MP:0002904,increased circulating parathyroid hormone level|MP:0002980,abnormal postural reflex|MP:0002986,decreased urine calcium level|MP:0003112,enlarged parathyroid gland|MP:0003114,pigmented parathyroid gland|MP:0003116,rickets|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003493,parathyroid gland hyperplasia|MP:0005202,lethargy|MP:0005367,renal/urinary system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005390,skeleton phenotype|MP:0005397,hematopoietic system phenotype|MP:0010092,increased circulating magnesium level|MP:0011085,postnatal lethality, complete penetrance|MP:0013572,abnormal parathyroid gland chief cell morphology
MGI:5306665	Casr<tm1Wch>	MP:0000061,fragile skeleton|MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000194,increased circulating calcium level|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002113,abnormal skeleton development|MP:0002904,increased circulating parathyroid hormone level|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005390,skeleton phenotype|MP:0005441,increased urine calcium level|MP:0005508,abnormal skeleton morphology|MP:0008883,abnormal enterocyte proliferation|MP:0009346,decreased trabecular bone thickness|MP:0010124,decreased bone mineral content|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0010933,decreased trabecular bone connectivity density|MP:0010965,decreased compact bone volume|MP:0011085,postnatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0020137,decreased bone mineralization
MGI:5708214	Castor1<tm1.1(KOMP)Vlcg>	MP:0002060,abnormal skin morphology
MGI:5488495	Cast<tm1.1(KOMP)Vlcg>	MP:0000579,abnormal nail morphology|MP:0001406,abnormal gait|MP:0001489,decreased startle reflex|MP:0001566,increased circulating phosphate level|MP:0002110,abnormal digit morphology|MP:0002833,increased heart weight|MP:0002941,increased circulating alanine transaminase level|MP:0005633,increased circulating sodium level|MP:0012000,abnormal limb position|MP:0013278,decreased fasting circulating glucose level
MGI:3641275	Cast<tm1Tcs>	MP:0008235,increased susceptibility to neuronal excitotoxicity
MGI:3870873	Casz1<Gt(CJ0565)Wtsi>	MP:0000267,abnormal heart development|MP:0000281,abnormal interventricular septum morphology|MP:0001879,abnormal lymphatic vessel morphology|MP:0002128,abnormal blood circulation|MP:0002652,thin myocardium|MP:0004056,abnormal myocardium compact layer morphology|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0006138,congestive heart failure|MP:0010019,liver vascular congestion|MP:0010200,enlarged lymphatic vessel|MP:0010402,ventricular septal defect|MP:0010500,myocardium hypoplasia|MP:0010640,ventricular myocardium compact layer hypoplasia|MP:0010725,thin interventricular septum|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0012269,nuchal edema|MP:0013848,subcutaneous edema|MP:0031511,globular heart|MP:0031613,fetal cardiomyocyte disarray
MGI:5638931	Casz1<tm1.1Flc>	MP:0000267,abnormal heart development|MP:0000277,abnormal heart shape|MP:0000280,thin ventricular wall|MP:0000281,abnormal interventricular septum morphology|MP:0000292,distended pericardium|MP:0000295,trabecula carnea hypoplasia|MP:0001633,poor circulation|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002169,no abnormal phenotype detected|MP:0002652,thin myocardium|MP:0002740,heart hypoplasia|MP:0003920,abnormal heart right ventricle morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004045,abnormal cell cycle checkpoint function|MP:0004062,dilated heart right atrium|MP:0004759,decreased mitotic index|MP:0005294,abnormal heart ventricle morphology|MP:0008727,increased heart right atrium size|MP:0010402,ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010422,heart right ventricle hypoplasia|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011390,abnormal fetal cardiomyocyte physiology|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0012515,abnormal heart apex morphology|MP:0031611,decreased fetal cardiomyocyte number
MGI:5636932	Casz1<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0003900,shortened QT interval|MP:0011100,preweaning lethality, complete penetrance
MGI:5638932	Casz1<tm2(cre/ERT2)Flc>	MP:0002169,no abnormal phenotype detected
MGI:1856492	Cat2<no2>	MP:0001304,cataract
MGI:1855997	Cat3<vao>	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001320,small pupil|MP:0001322,abnormal iris morphology|MP:0011697,lens vacuoles
MGI:1855998	Cat3<vl>	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001320,small pupil|MP:0001322,abnormal iris morphology|MP:0005253,abnormal eye physiology|MP:0008841,ruptured lens capsule|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011697,lens vacuoles
MGI:1856586	Cat4<Apcat1-2>	MP:0001286,abnormal eye development|MP:0001304,cataract|MP:0001314,cornea opacity|MP:0001319,irregularly shaped pupil|MP:0002638,abnormal pupillary reflex|MP:0006240,anisocoria|MP:0010259,anterior polar cataract|MP:0011100,preweaning lethality, complete penetrance
MGI:1856587	Cat4<Apcat1-3>	MP:0001297,microphthalmia|MP:0001314,cornea opacity|MP:0001322,abnormal iris morphology|MP:0010259,anterior polar cataract|MP:0011100,preweaning lethality, complete penetrance
MGI:1856588	Cat4<Apcat1-4>	MP:0001314,cornea opacity|MP:0010259,anterior polar cataract|MP:0011100,preweaning lethality, complete penetrance
MGI:2137391	Cat5<To2>	MP:0010263,total cataract
MGI:3688852	Cat6<1R>	MP:0001304,cataract
MGI:3053604	Cat<b>	MP:0002644,decreased circulating triglyceride level|MP:0003186,abnormal redox activity|MP:0004499,increased incidence of tumors by chemical induction|MP:0005179,decreased circulating cholesterol level|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0010264,increased hepatoma incidence|MP:0010269,decreased mammary gland tumor incidence|MP:0011592,abnormal catalase activity
MGI:3615894	Cat<c>	MP:0003186,abnormal redox activity|MP:0011592,abnormal catalase activity
MGI:3615901	Cat<d>	MP:0003186,abnormal redox activity|MP:0011592,abnormal catalase activity
MGI:3615923	Cat<e>	MP:0003186,abnormal redox activity|MP:0011592,abnormal catalase activity
MGI:3615931	Cat<f>	MP:0003186,abnormal redox activity|MP:0011592,abnormal catalase activity
MGI:5637170	Catip<tm1b(KOMP)Wtsi>	MP:0001925,male infertility|MP:0002599,increased mean platelet volume
MGI:2387461	Catsper1<tm1Clph>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002674,abnormal sperm motility|MP:0002675,asthenozoospermia|MP:0004231,abnormal calcium ion homeostasis|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0030976,impaired sperm penetration of zona pellucida
MGI:7464994	Catsper2<em1(IMPC)Mbp>	MP:0001925,male infertility
MGI:2683843	Catsper2<tm1Gar>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002674,abnormal sperm motility|MP:0002675,asthenozoospermia|MP:0004543,abnormal sperm physiology|MP:0030976,impaired sperm penetration of zona pellucida
MGI:6152421	Catsper3<em2(IMPC)Mbp>	MP:0000639,abnormal adrenal gland morphology|MP:0000642,enlarged adrenal glands|MP:0001925,male infertility|MP:0002092,abnormal eye morphology
MGI:5695932	Catsper3<tm1.1(KOMP)Vlcg>	MP:0001925,male infertility|MP:0005576,decreased pulmonary ventilation
MGI:3694352	Catsper3<tm1Clph>	MP:0001925,male infertility|MP:0002674,abnormal sperm motility|MP:0002675,asthenozoospermia|MP:0003666,impaired sperm capacitation|MP:0004543,abnormal sperm physiology|MP:0005578,teratozoospermia
MGI:3720684	Catsper3<tm1Wyan>	MP:0001925,male infertility|MP:0002674,abnormal sperm motility
MGI:3694354	Catsper4<tm1Clph>	MP:0001925,male infertility|MP:0002674,abnormal sperm motility|MP:0002675,asthenozoospermia|MP:0003666,impaired sperm capacitation|MP:0004543,abnormal sperm physiology|MP:0005578,teratozoospermia
MGI:3720685	Catsper4<tm1Wyan>	MP:0001925,male infertility|MP:0002674,abnormal sperm motility
MGI:5315769	Catsperd<tm1.1Clph>	MP:0001919,abnormal reproductive system physiology|MP:0001925,male infertility|MP:0002208,abnormal germ cell morphology|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0009282,decreased hyperactivated sperm motility
MGI:5617262	Catsperz<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002546,mydriasis|MP:0002833,increased heart weight|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:4454032	Catsperz<tm1(KOMP)Mbp>	MP:0001919,abnormal reproductive system physiology|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0009282,decreased hyperactivated sperm motility|MP:0031011,abnormal sperm migration in female genital tract
MGI:3051232	Cat<tm1Ysh>	MP:0010957,abnormal aerobic respiration
MGI:3618864	Catys1<CBA/Nov>	MP:0002822,catalepsy
MGI:6336100	Cav1<em2(IMPC)Ics>	MP:0001556,increased circulating HDL cholesterol level|MP:0002590,increased mean corpuscular volume|MP:0002626,increased heart rate|MP:0005140,decreased cardiac muscle contractility|MP:0005178,increased circulating cholesterol level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0010053,decreased grip strength
MGI:5141474	Cav1<tm1.1Aia>	MP:0002006,neoplasm|MP:0002016,ovary cyst|MP:0005389,reproductive system phenotype|MP:0009082,uterus cyst|MP:0009251,enlarged endometrial glands|MP:0009671,abnormal uterus physiology|MP:0013401,increased endometrial gland number
MGI:2386787	Cav1<tm1Krc>	MP:0000276,heart right ventricle hypertrophy|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0003548,pulmonary hypertension|MP:0003915,increased heart left ventricle weight|MP:0003957,abnormal nitric oxide homeostasis|MP:0004150,absent caveolae|MP:0005598,decreased heart ventricle muscle contractility|MP:0010725,thin interventricular septum|MP:0014316,decreased heart left ventricle posterior wall thickness|MP:0031636,increased heart right ventricle muscle contractility
MGI:2154537	Cav1<tm1Kur>	MP:0000250,abnormal vasoconstriction|MP:0000609,abnormal liver physiology|MP:0001179,thick pulmonary interalveolar septum|MP:0001547,abnormal lipid level|MP:0002275,abnormal type II pneumocyte morphology|MP:0003426,pulmonary interstitial fibrosis|MP:0004001,decreased hepatocyte proliferation|MP:0004150,absent caveolae|MP:0004697,abnormal thyroid follicular cell morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005384,cellular phenotype|MP:0005517,impaired liver regeneration|MP:0005590,increased vasodilation|MP:0009356,decreased liver triglyceride level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011139,increased lung endothelial cell proliferation|MP:0012106,impaired exercise endurance
MGI:2180364	Cav1<tm1Mls>	MP:0000005,increased brown adipose tissue amount|MP:0000130,abnormal trabecular bone morphology|MP:0000131,abnormal long bone epiphysis morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000187,abnormal triglyceride level|MP:0000250,abnormal vasoconstriction|MP:0000358,abnormal cell morphology|MP:0000609,abnormal liver physiology|MP:0000627,abnormal mammary gland morphology|MP:0000630,mammary gland hyperplasia|MP:0000759,abnormal skeletal muscle morphology|MP:0000774,decreased brain size|MP:0000811,hippocampal neuron degeneration|MP:0000812,abnormal dentate gyrus morphology|MP:0000952,abnormal CNS glial cell morphology|MP:0001175,abnormal lung morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001222,epidermal hyperplasia|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0001552,increased circulating triglyceride level|MP:0001553,abnormal circulating free fatty acids level|MP:0001559,hyperglycemia|MP:0001613,abnormal vasodilation|MP:0001625,cardiac hypertrophy|MP:0001663,abnormal digestive system physiology|MP:0001764,abnormal homeostasis|MP:0001783,decreased white adipose tissue amount|MP:0001792,impaired wound healing|MP:0001861,lung inflammation|MP:0001882,abnormal lactation|MP:0001885,mammary gland duct hyperplasia|MP:0001921,reduced fertility|MP:0002006,neoplasm|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002175,decreased brain weight|MP:0002182,abnormal astrocyte morphology|MP:0002314,abnormal respiratory mechanics|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology|MP:0002625,heart left ventricle hypertrophy|MP:0002754,dilated heart right ventricle|MP:0002842,increased systemic arterial blood pressure|MP:0002896,abnormal bone mineralization|MP:0002981,increased liver weight|MP:0003026,decreased vasoconstriction|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003070,increased vascular permeability|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003141,cardiac fibrosis|MP:0003180,abnormal pulmonary endothelial cell surface|MP:0003191,abnormal cellular cholesterol metabolism|MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0003329,amyloid beta deposits|MP:0003354,astrocytosis|MP:0003416,premature bone ossification|MP:0003443,increased circulating glycerol level|MP:0003492,abnormal involuntary movement|MP:0003548,pulmonary hypertension|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003797,abnormal compact bone morphology|MP:0003828,pulmonary edema|MP:0003957,abnormal nitric oxide homeostasis|MP:0003975,increased circulating VLDL triglyceride level|MP:0004007,abnormal lung vasculature morphology|MP:0004129,abnormal respiratory quotient|MP:0004149,increased bone strength|MP:0004150,absent caveolae|MP:0004250,tau protein deposits|MP:0004499,increased incidence of tumors by chemical induction|MP:0004697,abnormal thyroid follicular cell morphology|MP:0004883,abnormal vascular wound healing|MP:0004950,abnormal brain vasculature morphology|MP:0004982,abnormal osteoclast morphology|MP:0004998,decreased CNS synapse formation|MP:0005140,decreased cardiac muscle contractility|MP:0005282,decreased fatty acids level|MP:0005289,increased oxygen consumption|MP:0005311,abnormal circulating amino acid level|MP:0005317,increased triglyceride level|MP:0005329,abnormal myocardium layer morphology|MP:0005331,insulin resistance|MP:0005335,abnormal gonadal fat pad morphology|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005565,increased blood urea nitrogen level|MP:0005590,increased vasodilation|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005666,abnormal adipose tissue physiology|MP:0005668,decreased circulating leptin level|MP:0006055,abnormal vascular endothelial cell morphology|MP:0006060,increased cerebral infarct size|MP:0006080,brain ischemia|MP:0006138,congestive heart failure|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0006398,increased long bone epiphyseal plate size|MP:0006429,abnormal hyaline cartilage morphology|MP:0008033,impaired lipolysis|MP:0008034,enhanced lipolysis|MP:0008128,abnormal brain internal capsule morphology|MP:0008143,abnormal dendrite morphology|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008489,slow postnatal weight gain|MP:0008546,abnormal vesicle-mediated transport|MP:0008553,increased circulating tumor necrosis factor level|MP:0008577,increased circulating interferon-gamma level|MP:0008596,increased circulating interleukin-6 level|MP:0008713,abnormal cytokine level|MP:0008719,impaired neutrophil recruitment|MP:0008722,abnormal chemokine secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008843,absent subcutaneous adipose tissue|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008904,abnormal mammary fat pad morphology|MP:0009115,abnormal fat cell morphology|MP:0009116,abnormal brown fat cell morphology|MP:0009122,decreased white fat cell lipid droplet size|MP:0009124,increased brown fat cell lipid droplet size|MP:0009347,increased trabecular bone thickness|MP:0009503,abnormal mammary gland duct morphology|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009642,abnormal blood homeostasis|MP:0009780,abnormal chondrocyte physiology|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010299,increased mammary gland tumor incidence|MP:0010358,abnormal free fatty acids level|MP:0010378,increased respiratory quotient|MP:0010398,decreased liver glycogen level|MP:0010400,increased liver glycogen level|MP:0010724,thick interventricular septum|MP:0010855,pulmonary hyperemia|MP:0010867,abnormal bone trabecula morphology|MP:0010868,increased bone trabecula number|MP:0010896,decreased lung compliance|MP:0010901,abnormal pulmonary alveolar parenchyma morphology|MP:0010935,increased airway resistance|MP:0010954,abnormal cellular respiration|MP:0010955,abnormal respiratory electron transport chain|MP:0011014,decreased core body temperature|MP:0011044,increased lung elastance|MP:0011049,impaired adaptive thermogenesis|MP:0011939,increased food intake|MP:0012106,impaired exercise endurance|MP:0020378,abnormal cell cytoskeleton morphology|MP:0020415,abnormal fibroblast chemotaxis|MP:0020416,decreased fibroblast chemotaxis|MP:0020849,abnormal actin cytoskeleton morphology|MP:0021157,increased heart left ventricle wall thickness|MP:0021183,increased femoral compact bone area|MP:0030876,abnormal costochondral joint morphology|MP:0030942,abnormal microtubule organizing center morphology|MP:0030968,decreased circulating adiponectin level|MP:0030974,enhanced gluconeogenesis|MP:0031131,myocardial fiber disarray|MP:0031220,increased circulating CXCL10 level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5316847	Cav1<tm1Pesch>	MP:0003442,decreased circulating glycerol level|MP:0005370,liver/biliary system phenotype|MP:0005560,decreased circulating glucose level
MGI:2654177	Cav1<tm1Tt>	MP:0003917,increased kidney weight|MP:0005360,urolithiasis|MP:0005367,renal/urinary system phenotype|MP:0005441,increased urine calcium level|MP:0010111,abnormal renal calcium reabsorption
MGI:6156271	Cav2<em1(IMPC)Kmpc>	MP:0002092,abnormal eye morphology
MGI:4950154	Cav2<tm1(KOMP)Mbp>	MP:0003447,decreased tumor growth/size|MP:0003448,abnormal tumor morphology|MP:0010144,abnormal tumor vascularization|MP:0010537,tumor regression|MP:0014756,decreased tumor cell proliferation|MP:0014757,increased tumor cell death
MGI:2180372	Cav2<tm1Mls>	MP:0000730,increased satellite cell number|MP:0000750,abnormal muscle regeneration|MP:0001175,abnormal lung morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004272,abnormal basement membrane morphology|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005384,cellular phenotype|MP:0005385,cardiovascular system phenotype|MP:0009399,increased skeletal muscle fiber size|MP:0012106,impaired exercise endurance|MP:0014344,abnormal skeletal muscle fiber mitochondrial morphology
MGI:6156274	Cav3<em1(IMPC)Kmpc>	MP:0001126,abnormal ovary morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0009141,increased prepulse inhibition|MP:0011239,abnormal skin coloration|MP:0011877,absent liver
MGI:2180558	Cav3<tm1Mls>	MP:0000278,abnormal myocardial fiber morphology|MP:0000751,myopathy|MP:0000752,dystrophic muscle|MP:0001625,cardiac hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0002753,dilated heart left ventricle|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003141,cardiac fibrosis|MP:0004121,abnormal sarcolemma morphology|MP:0004150,absent caveolae|MP:0005330,cardiomyopathy|MP:0005369,muscle phenotype|MP:0005598,decreased heart ventricle muscle contractility|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009414,skeletal muscle fiber necrosis|MP:0010090,increased circulating creatine kinase level|MP:0010724,thick interventricular septum|MP:0021157,increased heart left ventricle wall thickness
MGI:2684578	Cav3<tm1Ncnp>	MP:0000733,abnormal muscle development|MP:0000749,muscle degeneration|MP:0002953,thick ventricular wall|MP:0003105,abnormal heart atrium morphology|MP:0004087,abnormal muscle fiber morphology|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010581,abnormal atrium myocardial trabeculae morphology|MP:0031131,myocardial fiber disarray
MGI:7615151	Cavin1<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3829005	Cavin1<tm1Pfp>	MP:0000741,impaired contractility of urinary bladder detrusor smooth muscle|MP:0001175,abnormal lung morphology|MP:0001402,decreased locomotor activity|MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002079,increased circulating insulin level|MP:0003548,pulmonary hypertension|MP:0003913,increased heart right ventricle weight|MP:0003949,abnormal circulating lipid level|MP:0003960,increased lean body mass|MP:0004007,abnormal lung vasculature morphology|MP:0004150,absent caveolae|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005418,abnormal circulating hormone level|MP:0005668,decreased circulating leptin level|MP:0006055,abnormal vascular endothelial cell morphology|MP:0010758,increased right ventricle systolic pressure|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011774,abnormal urinary bladder detrusor smooth muscle morphology|MP:0011799,increased urinary bladder weight|MP:0020234,decreased basal metabolism
MGI:4415387	Cavin2<tm1(KOMP)Vlcg>	MP:0003180,abnormal pulmonary endothelial cell surface|MP:0003950,abnormal plasma membrane morphology|MP:0004007,abnormal lung vasculature morphology|MP:0006055,abnormal vascular endothelial cell morphology|MP:0009115,abnormal fat cell morphology
MGI:5696914	Cavin3<tm1.1(KOMP)Vlcg>	MP:0002599,increased mean platelet volume|MP:0005561,increased mean corpuscular hemoglobin|MP:0010067,increased red blood cell distribution width
MGI:3847505	Cavin3<tm1(KOMP)Vlcg>	MP:0005384,cellular phenotype|MP:0005385,cardiovascular system phenotype
MGI:5518819	Cavin3<tm1Pemi>	MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0005150,cachexia|MP:0010954,abnormal cellular respiration|MP:0011174,lipodystrophy
MGI:5607305	Cavin4<tm1.2Tue>	MP:0004486,decreased response of heart to induced stress|MP:0005385,cardiovascular system phenotype
MGI:1856701	cb	MP:0000819,abnormal olfactory bulb morphology|MP:0001891,hydrocephaly|MP:0001924,infertility|MP:0002082,postnatal lethality|MP:0002233,abnormal nose morphology|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0008540,abnormal cerebral hemisphere morphology
MGI:6508393	Cbarp<em1Dsb>	MP:0004077,abnormal striatum morphology|MP:0010149,abnormal synaptic dopamine release
MGI:6508391	Cbarp<tm1.1Yamo>	MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002757,decreased vertical activity|MP:0002797,increased thigmotaxis|MP:0003908,decreased stereotypic behavior|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory|MP:0009141,increased prepulse inhibition|MP:0009456,impaired cued conditioning behavior|MP:0010053,decreased grip strength|MP:0010771,integument phenotype|MP:0020395,abnormal response to social novelty
MGI:6324149	Cbarp<tm2e.1(EUCOMM)Hmgu>	MP:0001258,decreased body length|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002757,decreased vertical activity|MP:0002797,increased thigmotaxis|MP:0003795,abnormal bone structure|MP:0004924,abnormal behavior|MP:0010124,decreased bone mineral content|MP:0011960,abnormal eye anterior chamber depth
MGI:5811012	Cbfa2t2<em1Dare>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002777,absent ovarian follicles|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005158,ovary hypoplasia|MP:0008391,abnormal primordial germ cell morphology|MP:0008392,decreased primordial germ cell number|MP:0012167,abnormal epigenetic regulation of gene expression|MP:0030978,impaired binding of sperm to zona pellucida
MGI:3607923	Cbfa2t2<tm1Swh>	MP:0000488,abnormal intestinal epithelium morphology|MP:0000496,abnormal small intestine morphology|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0003306,small intestinal inflammation|MP:0003449,abnormal intestine goblet cell morphology|MP:0009431,decreased fetal weight|MP:0010802,abnormal intestinal enteroendocrine cell morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013486,decreased Paneth cell number
MGI:3815201	Cbfa2t3<tm1.1Swh>	MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002640,reticulocytosis|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008215,decreased immature B cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0010178,increased number of Howell-Jolly bodies|MP:0031276,abnormal stress erythropoiesis
MGI:5287108	Cbfb<TgTn(sb-cHS4,Tyr)2512E-2Ove>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5698722	Cbfb<tm1.1Ddg>	MP:0002169,no abnormal phenotype detected
MGI:3761812	Cbfb<tm1Itan>	MP:0000060,delayed bone ossification|MP:0000063,decreased bone mineral density|MP:0000116,abnormal tooth development|MP:0000125,absent incisors|MP:0000438,abnormal cranium morphology|MP:0000458,abnormal mandible morphology|MP:0000547,short limbs|MP:0000715,decreased thymocyte number|MP:0001255,decreased body height|MP:0001861,lung inflammation|MP:0002100,abnormal tooth morphology|MP:0002113,abnormal skeleton development|MP:0002145,abnormal T cell differentiation|MP:0002258,abnormal cricoid cartilage morphology|MP:0002260,abnormal thyroid cartilage morphology|MP:0002408,abnormal double-positive T cell morphology|MP:0002461,increased immunoglobulin level|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0002689,abnormal molar morphology|MP:0003056,abnormal hyoid bone morphology|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003420,delayed intramembranous bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003723,abnormal long bone morphology|MP:0004033,supernumerary teeth|MP:0004337,clavicle hypoplasia|MP:0004989,decreased osteoblast cell number|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005091,increased double-positive T cell number|MP:0006396,decreased long bone epiphyseal plate size|MP:0006397,disorganized long bone epiphyseal plate|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008077,abnormal CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008499,increased IgG1 level|MP:0009653,abnormal palate development|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0011615,submucous cleft palate|MP:0011711,impaired osteoblast differentiation|MP:0014609,abnormal bone marrow cavity size|MP:0020010,decreased bone mineral density of femur|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization|MP:0021214,anterior cleft palate|MP:0030273,mandibular retrognathia
MGI:3579250	Cbfb<tm1Lhc>	MP:0000218,increased leukocyte cell number|MP:0000229,abnormal megakaryocyte differentiation|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0001606,impaired hematopoiesis|MP:0003179,thrombocytopenia|MP:0004809,increased hematopoietic stem cell number|MP:0011092,embryonic lethality, complete penetrance
MGI:2388355	Cbfb<tm1Ppl>	MP:0000240,extramedullary hematopoiesis|MP:0000601,small liver|MP:0000603,pale liver|MP:0001606,impaired hematopoiesis|MP:0001634,internal hemorrhage|MP:0001915,intracranial hemorrhage|MP:0001917,intraventricular hemorrhage|MP:0005244,hemopericardium|MP:0005435,hemoperitoneum|MP:0006042,increased apoptosis|MP:0006051,brainstem hemorrhage|MP:0006054,spinal hemorrhage|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1934195	Cbfb<tm1Spe>	MP:0001606,impaired hematopoiesis|MP:0001785,edema|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0001917,intraventricular hemorrhage|MP:0002414,abnormal myeloblast morphology/development|MP:0003658,abnormal capillary morphology|MP:0006042,increased apoptosis|MP:0006054,spinal hemorrhage|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011179,decreased erythroblast number
MGI:1933624	Cbfb<tm1Tno>	MP:0000596,abnormal liver development|MP:0001917,intraventricular hemorrhage|MP:0002123,abnormal definitive hematopoiesis|MP:0003396,abnormal embryonic hematopoiesis|MP:0006054,spinal hemorrhage|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1857593	Cbfb<tm1Tok>	MP:0000603,pale liver|MP:0001722,pale yolk sac|MP:0001915,intracranial hemorrhage|MP:0002123,abnormal definitive hematopoiesis|MP:0003717,pallor|MP:0006054,spinal hemorrhage|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5698728	Cbfb<tm2.1Ddg>	MP:0002081,perinatal lethality|MP:0003935,abnormal craniofacial development
MGI:3721277	Cbfb<tm2.1Spe>	MP:0000074,abnormal neurocranium morphology|MP:0000149,abnormal scapula morphology|MP:0000150,abnormal rib morphology|MP:0000157,abnormal sternum morphology|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0000703,abnormal thymus morphology|MP:0001823,thymus hypoplasia|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0002115,abnormal limb bone morphology|MP:0002145,abnormal T cell differentiation|MP:0003072,abnormal metatarsal bone morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0004214,abnormal long bone diaphysis morphology|MP:0004508,abnormal pectoral girdle bone morphology|MP:0005092,decreased double-positive T cell number|MP:0005225,abnormal vertebrae development|MP:0005298,abnormal clavicle morphology|MP:0005306,abnormal phalanx morphology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008826,abnormal splenic cell ratio|MP:0008827,abnormal thymus cell ratio|MP:0011087,neonatal lethality, complete penetrance
MGI:4939676	Cbfb<tm2Itan>	MP:0002450,abnormal lymph organ development|MP:0002831,absent Peyer's patches|MP:0008133,decreased Peyer's patch number|MP:0008463,abnormal peripheral lymph node morphology
MGI:2447293	Cbfb<tm2Ppl>	MP:0000060,delayed bone ossification|MP:0000166,abnormal chondrocyte morphology|MP:0002764,short tibia|MP:0011087,neonatal lethality, complete penetrance
MGI:4461804	Cbfb<tm3Ppl>	MP:0000603,pale liver|MP:0001634,internal hemorrhage|MP:0004810,decreased hematopoietic stem cell number|MP:0005397,hematopoietic system phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4461805	Cbfb<tm4Ppl>	MP:0000603,pale liver|MP:0002398,abnormal bone marrow cell morphology/development|MP:0008253,absent megakaryocytes
MGI:5469976	Cbfb<tm5Ppl>	MP:0001606,impaired hematopoiesis|MP:0001915,intracranial hemorrhage|MP:0002006,neoplasm|MP:0002445,abnormal mononuclear cell differentiation|MP:0010373,myeloid hyperplasia|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6407110	Cbfb<tm6Ppl>	MP:0001606,impaired hematopoiesis|MP:0001634,internal hemorrhage|MP:0002006,neoplasm|MP:0005017,decreased B cell number|MP:0005397,hematopoietic system phenotype|MP:0011092,embryonic lethality, complete penetrance|MP:0013663,increased myeloid cell number
MGI:2180572	Cblb<tm1Hua>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005348,increased T cell proliferation|MP:0008687,increased interleukin-2 secretion
MGI:2180570	Cblb<tm1Pngr>	MP:0002423,abnormal mast cell physiology|MP:0005348,increased T cell proliferation|MP:0008560,increased tumor necrosis factor secretion|MP:0008705,increased interleukin-6 secretion
MGI:3762926	Cblb<tm1Wlan>	MP:0002423,abnormal mast cell physiology|MP:0008560,increased tumor necrosis factor secretion|MP:0008705,increased interleukin-6 secretion
MGI:2680200	Cblc<tm1Pngr>	MP:0002169,no abnormal phenotype detected
MGI:4363945	Cblif<tm1a(KOMP)Wtsi>	MP:0000240,extramedullary hematopoiesis|MP:0000607,abnormal hepatocyte morphology|MP:0001262,decreased body weight|MP:0002412,increased susceptibility to bacterial infection|MP:0002417,abnormal megakaryocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0003442,decreased circulating glycerol level|MP:0003718,maternal effect|MP:0004151,decreased circulating iron level|MP:0005015,increased T cell number|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010330,abnormal circulating lipoprotein level|MP:0011227,abnormal vitamin B12 level
MGI:3771564	Cbll<Tg(Alb-KL)7-2Mhos>	MP:0000745,tremors|MP:0000850,absent cerebellum|MP:0000873,thin external granule cell layer|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0003245,abnormal GABAergic neuron morphology|MP:0003247,abnormal glutaminergic neuron morphology|MP:0003684,abnormal inferior olivary complex morphology|MP:0006098,absent cerebellar lobules|MP:0008579,abnormal Purkinje cell differentiation
MGI:6798141	Cbln1os<em1Xis>	MP:0000852,small cerebellum|MP:0000880,decreased Purkinje cell number|MP:0000952,abnormal CNS glial cell morphology|MP:0001405,impaired coordination|MP:0002804,abnormal motor learning|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0004792,abnormal synaptic vesicle number|MP:0004998,decreased CNS synapse formation|MP:0005378,growth/size/body region phenotype|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0012525,abnormal rhombic lip morphology|MP:0014379,decreased excitatory postsynaptic current frequency|MP:0014558,decreased cortical ventricular zone thickness
MGI:4839623	Cbln1<tm1.1Mmsh>	MP:0009538,abnormal synapse morphology
MGI:4839626	Cbln1<tm1.2Mmsh>	MP:0009538,abnormal synapse morphology
MGI:3609188	Cbln1<tm1Jim>	MP:0000886,abnormal cerebellar granule layer morphology|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001898,abnormal long-term depression|MP:0003894,abnormal Purkinje cell innervation|MP:0011270,decreased excitatory postsynaptic current amplitude
MGI:5316017	Cbln2<tm1Jim>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:5443924	Cbln3<tm1.1(KOMP)Vlcg>	MP:0004738,abnormal auditory brainstem response|MP:0011396,abnormal sleep behavior
MGI:3697442	Cbln3<tm1Jim>	MP:0002169,no abnormal phenotype detected
MGI:5426853	Cbln4<tm1Jim>	MP:0002169,no abnormal phenotype detected
MGI:5766762	Cbl<tm1b(EUCOMM)Hmgu>	MP:0002953,thick ventricular wall|MP:0003896,prolonged PR interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2180578	Cbl<tm1Ddlb>	MP:0000240,extramedullary hematopoiesis|MP:0000662,abnormal branching of the mammary ductal tree|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0001260,increased body weight|MP:0001433,polyphagia|MP:0001783,decreased white adipose tissue amount|MP:0002078,abnormal glucose homeostasis|MP:0002106,abnormal muscle physiology|MP:0002118,abnormal lipid homeostasis|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002414,abnormal myeloblast morphology/development|MP:0002444,abnormal T cell physiology|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003948,abnormal gas homeostasis|MP:0003960,increased lean body mass|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005390,skeleton phenotype|MP:0005505,thrombocytosis|MP:0005533,increased body temperature|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008476,increased spleen red pulp amount|MP:0008826,abnormal splenic cell ratio|MP:0008827,abnormal thymus cell ratio|MP:0008828,abnormal lymph node cell ratio|MP:0008904,abnormal mammary fat pad morphology|MP:0009115,abnormal fat cell morphology|MP:0009356,decreased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0010379,decreased respiratory quotient|MP:0011630,increased mitochondrial size|MP:0031391,increased locomotor activity|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:3709884	Cbl<tm1Dejs>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype
MGI:4354652	Cbl<tm1Soga>	MP:0000691,enlarged spleen|MP:0004809,increased hematopoietic stem cell number
MGI:2451336	Cbl<tm1Wlan>	MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0001123,dilated uterus|MP:0002082,postnatal lethality|MP:0002414,abnormal myeloblast morphology/development|MP:0002444,abnormal T cell physiology|MP:0008476,increased spleen red pulp amount|MP:0009069,dilated oviduct|MP:0010373,myeloid hyperplasia
MGI:3610727	Cbl<tm2Wlan>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000703,abnormal thymus morphology|MP:0001823,thymus hypoplasia|MP:0002364,abnormal thymus size|MP:0005409,darkened coat color|MP:0008476,increased spleen red pulp amount|MP:0009379,abnormal foot pigmentation|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation
MGI:2153927	Cbm1<C57BL/6J>	MP:0000774,decreased brain size|MP:0002175,decreased brain weight
MGI:2156995	Cbm2<C57BL/6J>	MP:0000774,decreased brain size|MP:0002175,decreased brain weight
MGI:2389344	Cbm3<C57BL/6J>	MP:0000849,abnormal cerebellum morphology
MGI:2446798	Cbm4<C57BL/6J>	MP:0000849,abnormal cerebellum morphology
MGI:2446800	Cbm5<C57BL/6J>	MP:0000849,abnormal cerebellum morphology
MGI:5692567	Cbr2<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0008805,decreased circulating amylase level|MP:0010088,decreased circulating fructosamine level
MGI:6324164	Cbr3<em1(IMPC)Ics>	MP:0000063,decreased bone mineral density|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002757,decreased vertical activity|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:6361214	Cbr4<em1(IMPC)Bay>	MP:0000062,increased bone mineral density|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:1857139	Cbs<tm1Unc>	MP:0000069,kyphoscoliosis|MP:0000160,kyphosis|MP:0000164,abnormal cartilage development|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000240,extramedullary hematopoiesis|MP:0000255,blood vessel congestion|MP:0000267,abnormal heart development|MP:0000377,abnormal hair follicle morphology|MP:0000448,pointed snout|MP:0000528,delayed kidney development|MP:0000585,kinked tail|MP:0000592,short tail|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0000652,enlarged sebaceous gland|MP:0001176,abnormal lung development|MP:0001211,wrinkled skin|MP:0001237,enlarged spinous cells|MP:0001242,hyperkeratosis|MP:0001244,thin dermal layer|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001286,abnormal eye development|MP:0001290,delayed eyelid opening|MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001510,abnormal coat appearance|MP:0001613,abnormal vasodilation|MP:0001732,postnatal growth retardation|MP:0001860,liver inflammation|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0002073,abnormal hair growth|MP:0002083,premature death|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0002182,abnormal astrocyte morphology|MP:0002628,hepatic steatosis|MP:0002656,abnormal keratinocyte differentiation|MP:0002699,abnormal vitreous body morphology|MP:0002764,short tibia|MP:0002792,abnormal retina vasculature morphology|MP:0003070,increased vascular permeability|MP:0003109,short femur|MP:0003333,liver fibrosis|MP:0003419,delayed endochondral bone ossification|MP:0003674,oxidative stress|MP:0003719,abnormal pericyte morphology|MP:0003743,abnormal facial morphology|MP:0003845,abnormal decidualization|MP:0003887,increased hepatocyte apoptosis|MP:0004003,abnormal vascular endothelial cell physiology|MP:0004014,abnormal uterine environment|MP:0004125,abnormal venule morphology|MP:0004126,thin hypodermis|MP:0004174,abnormal spine curvature|MP:0004256,abnormal maternal decidual layer morphology|MP:0004351,short humerus|MP:0004359,short ulna|MP:0004610,small vertebrae|MP:0004686,decreased length of long bones|MP:0004903,abnormal uterus weight|MP:0004921,decreased placenta weight|MP:0005186,increased circulating progesterone level|MP:0005311,abnormal circulating amino acid level|MP:0005332,abnormal amino acid level|MP:0005386,behavior/neurological phenotype|MP:0005547,abnormal Muller cell morphology|MP:0005639,hemosiderosis|MP:0006076,abnormal circulating homocysteine level|MP:0006190,retina ischemia|MP:0006296,arachnodactyly|MP:0006397,disorganized long bone epiphyseal plate|MP:0006398,increased long bone epiphyseal plate size|MP:0008047,absent uterine NK cells|MP:0008489,slow postnatal weight gain|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0008852,retina neovascularization|MP:0008871,abnormal ovarian follicle number|MP:0008876,decreased uterine NK cell number|MP:0008957,abnormal placenta junctional zone morphology|MP:0009007,short estrous cycle|MP:0009012,short diestrus|MP:0009018,short estrus|MP:0009020,prolonged metestrus|MP:0009392,retina gliosis|MP:0009661,abnormal pregnancy|MP:0010097,abnormal retina blood vessel morphology|MP:0010098,abnormal retina blood vessel pattern|MP:0010452,retina microaneurysm|MP:0010771,integument phenotype|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011520,increased placental labyrinth size|MP:0012065,increased astrocyte number|MP:0012110,increased hair follicle number|MP:0012335,increased circulating homocysteine level|MP:0012602,increased alpha-fetoprotein level|MP:0014179,abnormal blood-retina barrier function|MP:0014682,increased polyploid hepatocyte number|MP:0030639,decreased circulating taurine level|MP:0031116,microvesicular hepatic steatosis
MGI:7431361	Cbx1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0002135,abnormal kidney morphology|MP:0003233,prolonged QT interval|MP:0003795,abnormal bone structure|MP:0005553,increased circulating creatinine level|MP:0008528,polycystic kidney|MP:0010570,prolonged ST segment|MP:0011100,preweaning lethality, complete penetrance|MP:0013129,abnormal tooth color
MGI:2678420	Cbx1<Gt(U3Betageo)1Ruiz>	MP:0002169,no abnormal phenotype detected
MGI:4432508	Cbx1<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5548919	Cbx2<tm1b(KOMP)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:1857631	Cbx2<tm1Cim>	MP:0000149,abnormal scapula morphology|MP:0001259,abnormal body weight|MP:0001825,arrested T cell differentiation|MP:0001939,secondary sex reversal|MP:0002083,premature death|MP:0003036,vertebral transformation|MP:0003345,decreased rib number|MP:0004607,abnormal cervical atlas morphology|MP:0005508,abnormal skeleton morphology|MP:0009335,decreased splenocyte proliferation|MP:0010728,fusion of atlas and occipital bones|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0012283,decreased sternebra number
MGI:2181776	Cbx2<tm1Ykf>	MP:0000120,malocclusion|MP:0000495,abnormal colon morphology|MP:0001127,small ovary|MP:0001259,abnormal body weight|MP:0001939,secondary sex reversal|MP:0002083,premature death|MP:0002211,abnormal primary sex determination|MP:0002212,abnormal secondary sex determination|MP:0002213,true hermaphroditism|MP:0003036,vertebral transformation|MP:0005644,agonadal|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3762749	Cbx3<Gt(ROSANBetageo)10C2Masn>	MP:0001924,infertility|MP:0005380,embryo phenotype
MGI:5438243	Cbx3<tm1Ics>	MP:0005387,immune system phenotype
MGI:5433765	Cbx3<tm1Pbs>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5489931	Cbx4<tm1.1Gxu>	MP:0005397,hematopoietic system phenotype
MGI:5548407	Cbx4<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001697,abnormal embryo size|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:5489932	Cbx4<tm1.2Gxu>	MP:0000704,abnormal thymus development|MP:0001823,thymus hypoplasia|MP:0003763,abnormal thymus physiology|MP:0005397,hematopoietic system phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:7425560	Cbx5<em1(IMPC)Ccpcz>	MP:0000220,increased monocyte cell number|MP:0002599,increased mean platelet volume
MGI:5431105	Cbx5<Gt(ROSA)11Sor>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:4336248	Cbx5<Gt(W205C07)Wrst>	MP:0002169,no abnormal phenotype detected
MGI:5438242	Cbx5<tm1.1Ics>	MP:0005387,immune system phenotype|MP:0005466,abnormal T-helper 2 physiology
MGI:4441648	Cbx5<tm1a(EUCOMM)Wtsi>	MP:0003036,vertebral transformation|MP:0004609,vertebral fusion|MP:0004613,fusion of vertebral arches|MP:0005560,decreased circulating glucose level|MP:0010052,increased grip strength
MGI:4441849	Cbx6<tm1a(EUCOMM)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000558,abnormal tibia morphology|MP:0001262,decreased body weight|MP:0002928,abnormal bile duct morphology|MP:0002947,increased hemangioma incidence|MP:0003019,increased circulating chloride level|MP:0003826,abnormal Mullerian duct morphology|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005553,increased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0005633,increased circulating sodium level|MP:0008806,increased circulating amylase level|MP:0008935,decreased mean platelet volume|MP:0009820,abnormal liver vasculature morphology|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0010418,perimembraneous ventricular septal defect|MP:0013278,decreased fasting circulating glucose level|MP:0013835,absent hypoglossal nerve|MP:0013852,abnormal Mullerian duct topology|MP:0013967,abnormal infrahyoid muscle connection|MP:0013971,blood in lymph vessels|MP:0013986,abnormal vitelline vein topology|MP:0014001,abnormal vertebral artery topology|MP:0014021,heterochrony
MGI:5427591	Cbx7<tm1Afus>	MP:0000313,abnormal cell death|MP:0001257,increased body length|MP:0002020,increased tumor incidence|MP:0002038,increased carcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0003077,abnormal cell cycle|MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0008014,increased lung tumor incidence|MP:0008019,increased liver tumor incidence|MP:0008714,increased lung carcinoma incidence|MP:0011703,increased fibroblast proliferation
MGI:4363230	Cbx7<tm1a(KOMP)Wtsi>	MP:0012725,small sebaceous gland
MGI:5306630	Cbx8<tm1.1Hko>	MP:0005397,hematopoietic system phenotype|MP:0005621,abnormal cell physiology|MP:0010768,mortality/aging
MGI:5306629	Cbx8<tm1Hko>	MP:0005397,hematopoietic system phenotype|MP:0005621,abnormal cell physiology
MGI:1856815	cby	MP:0000130,abnormal trabecular bone morphology|MP:0000131,abnormal long bone epiphysis morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000163,abnormal cartilage morphology|MP:0000164,abnormal cartilage development|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000435,shortened head|MP:0000445,short snout|MP:0001935,decreased litter size|MP:0002427,disproportionate dwarf|MP:0002544,brachydactyly|MP:0002764,short tibia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004686,decreased length of long bones|MP:0008272,abnormal endochondral bone ossification|MP:0008525,decreased cranium height|MP:0014289,decreased distal limb length
MGI:3714454	Cby1<tm1Ktkm>	MP:0000208,decreased hematocrit|MP:0001178,pulmonary hypoplasia|MP:0001183,overexpanded pulmonary alveolus|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001850,increased susceptibility to otitis media|MP:0001872,sinus inflammation|MP:0001925,male infertility|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0002274,abnormal type I pneumocyte morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002314,abnormal respiratory mechanics|MP:0002412,increased susceptibility to bacterial infection|MP:0004391,abnormal respiratory conducting tube morphology|MP:0005380,embryo phenotype|MP:0006027,impaired lung alveolus development|MP:0008489,slow postnatal weight gain|MP:0008770,decreased survivor rate|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0010752,impaired mucociliary clearance|MP:0010809,abnormal club cell morphology|MP:0010891,increased alveolar lamellar body number|MP:0010896,decreased lung compliance|MP:0010901,abnormal pulmonary alveolar parenchyma morphology|MP:0010902,abnormal pulmonary alveolar sac morphology|MP:0010936,decreased airway resistance|MP:0010942,abnormal respiratory epithelium morphology|MP:0010950,abnormal lung hysteresivity|MP:0011044,increased lung elastance|MP:0011047,increased lung tissue damping|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011053,decreased respiratory motile cilia number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011168,abnormal fat cell differentiation
MGI:6830919	Cby2<em1Osb>	MP:0005389,reproductive system phenotype
MGI:8172321	Cby3<tm1b(EUCOMM)Hmgu>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009237,kinked sperm flagellum|MP:0009282,decreased hyperactivated sperm motility|MP:0009834,abnormal sperm annulus morphology|MP:0009835,absent sperm annulus
MGI:6458916	Cc2d1a<tm1.1Thkn>	MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002169,no abnormal phenotype detected|MP:0005381,digestive/alimentary phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:6458917	Cc2d1a<tm1.2Thkn>	MP:0000358,abnormal cell morphology|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0011087,neonatal lethality, complete penetrance
MGI:4362979	Cc2d1a<tm1a(KOMP)Wtsi>	MP:0008565,decreased interferon-beta secretion|MP:0008706,decreased interleukin-6 secretion
MGI:5426910	Cc2d1a<tm1Bisu>	MP:0001262,decreased body weight|MP:0001505,hunched posture|MP:0001954,respiratory distress|MP:0004811,abnormal neuron physiology|MP:0004950,abnormal brain vasculature morphology|MP:0004998,decreased CNS synapse formation|MP:0008143,abnormal dendrite morphology|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3829256	Cc2d1a<tm1Zjc>	MP:0002910,abnormal excitatory postsynaptic currents|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004770,abnormal synaptic vesicle recycling|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0011089,perinatal lethality, complete penetrance|MP:0014381,abnormal miniature inhibitory postsynaptic current frequency|MP:0014384,increased miniature inhibitory postsynaptic current amplitude
MGI:4362981	Cc2d1b<tm1a(KOMP)Wtsi>	MP:0000198,decreased circulating phosphate level|MP:0001262,decreased body weight|MP:0002169,no abnormal phenotype detected|MP:0002702,decreased circulating free fatty acids level|MP:0004924,abnormal behavior
MGI:6459258	Cc2d1b<tm1c(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5311382	Cc2d2a<b2b1035Clo>	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002633,persistent truncus arteriosus|MP:0003675,kidney cyst|MP:0004017,duplex kidney|MP:0004133,heterotaxia|MP:0006123,tricuspid valve atresia|MP:0006130,pulmonary valve atresia|MP:0008528,polycystic kidney|MP:0009743,preaxial polydactyly|MP:0010402,ventricular septal defect|MP:0010406,common atrium|MP:0010412,atrioventricular septal defect|MP:0010413,complete atrioventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010865,prenatal growth retardation|MP:0011254,superior-inferior ventricles|MP:0011510,biventricular, discordant atrioventricular connection|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:4344514	Cc2d2a<Gt(AA0274)Wtsi>	MP:0001297,microphthalmia|MP:0001706,abnormal left-right axis patterning|MP:0005157,holoprosencephaly|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005384,cellular phenotype
MGI:4431801	Cc2d2a<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight
MGI:5708063	Cc2d2a<tm1Asw>	MP:0000562,polydactyly|MP:0000644,dextrocardia|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0001914,hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0002766,situs inversus|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004066,abnormal primitive node morphology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0005202,lethargy|MP:0005551,abnormal eye electrophysiology|MP:0008546,abnormal vesicle-mediated transport|MP:0009743,preaxial polydactyly|MP:0010202,focal dorsal hair loss|MP:0011053,decreased respiratory motile cilia number|MP:0011060,abnormal kinocilium morphology|MP:0011066,abnormal renal tubule epithelial cell primary cilium morphology|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0013197,decreased embryonic cilium number|MP:0013203,abnormal primary cilium morphology|MP:0013205,abnormal nonmotile primary cilium morphology|MP:0013214,decreased embryonic neuroepithelium primary cilium number
MGI:4129528	Ccar2<Gt(XN876)Byg>	MP:0000609,abnormal liver physiology|MP:0008561,decreased tumor necrosis factor secretion|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5776716	Ccar2<tm1Dac>	MP:0001402,decreased locomotor activity|MP:0002006,neoplasm|MP:0002079,increased circulating insulin level|MP:0004890,decreased energy expenditure|MP:0005283,increased unsaturated fatty acids level|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005455,increased susceptibility to weight gain|MP:0005658,increased susceptibility to diet-induced obesity|MP:0010024,increased total body fat amount|MP:0020102,increased hepatic glucose production
MGI:6430660	Ccbe1<em1(IMPC)Mbp>	MP:0000428,abnormal craniofacial morphology|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000603,pale liver|MP:0001120,abnormal uterus morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0004906,enlarged uterus|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5007046	Ccbe1<tm1Lex>	MP:0001785,edema|MP:0008778,abnormal lymphangiogenesis|MP:0010194,absent lymphatic vessels|MP:0011091,prenatal lethality, complete penetrance
MGI:5495674	Ccbe1<tm1Mlkn>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001577,anemia|MP:0001785,edema|MP:0002080,prenatal lethality|MP:0002451,abnormal macrophage physiology|MP:0003717,pallor|MP:0003884,decreased macrophage cell number|MP:0006042,increased apoptosis|MP:0009395,increased nucleated erythrocyte cell number|MP:0010194,absent lymphatic vessels|MP:0011243,decreased fetal derived definitive erythrocyte cell number
MGI:5495677	Ccbe1<tm2.1Mlkn>	MP:0002169,no abnormal phenotype detected|MP:0005397,hematopoietic system phenotype
MGI:1861187	Ccd	MP:0000074,abnormal neurocranium morphology|MP:0000077,abnormal interparietal bone morphology|MP:0000084,abnormal fontanelle morphology|MP:0000137,abnormal vertebrae morphology|MP:0000149,abnormal scapula morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000438,abnormal cranium morphology|MP:0002114,abnormal axial skeleton morphology|MP:0004354,absent deltoid tuberosity|MP:0004423,abnormal temporal bone squamous part morphology|MP:0004473,absent nasal bone|MP:0004506,abnormal pubis morphology|MP:0004507,abnormal ischium morphology|MP:0004508,abnormal pectoral girdle bone morphology|MP:0004509,abnormal pelvic girdle bone morphology|MP:0005296,abnormal humerus morphology|MP:0005298,abnormal clavicle morphology|MP:0008274,failure of bone ossification|MP:0009575,abnormal pubic symphysis morphology|MP:0010030,abnormal orbit morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:7519108	Ccdc102a<em1(IMPC)Hmgu>	MP:0002135,abnormal kidney morphology
MGI:6355922	Ccdc103<em4(IMPC)H>	MP:0003961,decreased lean body mass|MP:0008806,increased circulating amylase level|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:6275206	Ccdc107<em1(IMPC)J>	MP:0010053,decreased grip strength
MGI:7425562	Ccdc110<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001146,abnormal testis morphology
MGI:5695933	Ccdc116<tm1.1(KOMP)Vlcg>	MP:0005293,impaired glucose tolerance
MGI:6269391	Ccdc117<em1(IMPC)J>	MP:0001488,increased startle reflex|MP:0002968,increased circulating alkaline phosphatase level|MP:0004738,abnormal auditory brainstem response|MP:0010052,increased grip strength
MGI:5445789	Ccdc120<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001554,increased circulating free fatty acids level|MP:0005560,decreased circulating glucose level|MP:0013279,increased fasting circulating glucose level
MGI:4363388	Ccdc122<tm1a(KOMP)Wtsi>	MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level|MP:0010378,increased respiratory quotient|MP:0011939,increased food intake
MGI:5605783	Ccdc124<tm1b(KOMP)Wtsi>	MP:0000601,small liver|MP:0000692,small spleen|MP:0000774,decreased brain size|MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0002188,small heart|MP:0003641,small lung
MGI:6377203	Ccdc125<em1(IMPC)Hmgu>	MP:0011965,decreased total retina thickness
MGI:5637023	Ccdc127<tm1b(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0003960,increased lean body mass|MP:0010088,decreased circulating fructosamine level
MGI:6117856	Ccdc134<tm1.2Jhua>	MP:0000259,abnormal vascular development|MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0001577,anemia|MP:0001614,abnormal blood vessel morphology|MP:0001625,cardiac hypertrophy|MP:0001698,decreased embryo size|MP:0001915,intracranial hemorrhage|MP:0002152,abnormal brain morphology|MP:0004001,decreased hepatocyte proliferation|MP:0004259,small placenta|MP:0004950,abnormal brain vasculature morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011526,abnormal placenta fetal blood space morphology
MGI:4362536	Ccdc134<tm1a(KOMP)Wtsi>	MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6161253	Ccdc136<em1Smoc>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0009232,abnormal sperm nucleus morphology|MP:0009647,decreased fertilization frequency|MP:0020451,decreased sperm progressive motility
MGI:4363458	Ccdc137<tm1a(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:7608139	Ccdc13<em1(IMPC)J>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5692717	Ccdc141<tm1.1(KOMP)Wtsi>	MP:0001402,decreased locomotor activity
MGI:6148229	Ccdc141<tm1.1Ygi>	MP:0001363,increased anxiety-related response|MP:0001442,decreased grooming behavior|MP:0002184,abnormal innervation|MP:0002573,behavioral despair|MP:0002574,increased vertical activity|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0003998,decreased thermal nociceptive threshold|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0006009,abnormal neuronal migration|MP:0010768,mortality/aging|MP:0031391,increased locomotor activity
MGI:7577422	Ccdc146<em1Cya>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009376,abnormal manchette morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0020869,immotile sperm|MP:0031356,abnormal outer dense fiber morphology|MP:0031373,abnormal manchette perinuclear ring morphology|MP:0031386,elongated manchette
MGI:5788754	Ccdc146<em1(IMPC)J>	MP:0001304,cataract
MGI:7425563	Ccdc148<em1(IMPC)Bay>	MP:0002574,increased vertical activity
MGI:8273657	Ccdc152<em1Ktmr>	MP:0001153,small seminiferous tubules|MP:0004852,decreased testis weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia
MGI:5702426	Ccdc154<ntl>	MP:0000062,increased bone mineral density|MP:0000065,abnormal bone marrow cavity morphology|MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000135,decreased compact bone thickness|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001265,decreased body size|MP:0002083,premature death|MP:0004993,decreased bone resorption|MP:0009347,increased trabecular bone thickness|MP:0011165,abnormal tooth root development|MP:0011166,absent molar root|MP:0013631,decreased bone trabecular spacing
MGI:7616768	Ccdc157<em1Ymxi>	MP:0001385,pup cannibalization|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004910,decreased seminal vesicle weight|MP:0004929,decreased epididymis weight|MP:0008898,abnormal acrosome morphology|MP:0008975,delayed male fertility|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009234,absent sperm head|MP:0014684,impaired spermiation|MP:0030980,abnormal acroplaxome morphology|MP:0031354,abnormal acrosome assembly
MGI:7703515	Ccdc159<em1Yingz>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0005389,reproductive system phenotype|MP:0006042,increased apoptosis|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0008893,detached sperm flagellum|MP:0008898,abnormal acrosome morphology|MP:0009830,abnormal sperm connecting piece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0014468,disorganized sperm mitochondrial sheath|MP:0014632,increased spermatid number|MP:0014635,increased round spermatid number|MP:0014637,increased elongated spermatid number|MP:0030591,absent sperm fibrous sheath
MGI:4419403	Ccdc159<tm1a(KOMP)Wtsi>	MP:0001925,male infertility
MGI:3856076	Ccdc160<Gt(179B2)Cmhd>	MP:0000292,distended pericardium|MP:0000928,incomplete rostral neuropore closure|MP:0000929,open neural tube|MP:0002151,abnormal neural tube morphology|MP:0003400,kinked neural tube|MP:0004073,caudal body truncation|MP:0009328,delayed heart looping|MP:0009657,failure of chorioallantoic fusion
MGI:6391231	Ccdc166<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0004738,abnormal auditory brainstem response
MGI:6157335	Ccdc170<em1(IMPC)J>	MP:0001529,abnormal vocalization
MGI:5570360	Ccdc171<m1Anu>	MP:0002491,decreased IgD level|MP:0002494,increased IgM level|MP:0008211,decreased mature B cell number
MGI:6257702	Ccdc174<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5286656	Ccdc174<Tg(Tyr)2401AOve>	MP:0006205,embryonic lethality between implantation and somite formation
MGI:6194708	Ccdc178<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:8216644	Ccdc178<em1Wli>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0008893,detached sperm flagellum|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009376,abnormal manchette morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0030980,abnormal acroplaxome morphology|MP:0031374,abnormal manchette assembly|MP:0031386,elongated manchette|MP:0031387,abnormal intramanchette transport|MP:0031389,abnormal ectoplasmic specialization morphology
MGI:6120746	Ccdc178<tm1b(EUCOMM)Wtsi>	MP:0001314,cornea opacity
MGI:5695129	Ccdc180<tm1b(KOMP)Wtsi>	MP:0001925,male infertility|MP:0001926,female infertility|MP:0005543,decreased cornea thickness
MGI:7785523	Ccdc181<em1Qsh>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0014052,increased male germ cell apoptosis|MP:0030980,abnormal acroplaxome morphology|MP:0031386,elongated manchette
MGI:5550595	Ccdc181<tm1b(EUCOMM)Hmgu>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0011965,decreased total retina thickness
MGI:7425565	Ccdc183<em1(IMPC)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0002060,abnormal skin morphology|MP:0003131,increased erythrocyte cell number|MP:0005564,increased hemoglobin content
MGI:7621683	Ccdc183<em1Osb>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009241,thick sperm flagellum|MP:0009376,abnormal manchette morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009836,abnormal sperm principal piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0014684,impaired spermiation|MP:0020451,decreased sperm progressive motility|MP:0020869,immotile sperm|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0030591,absent sperm fibrous sheath|MP:0031356,abnormal outer dense fiber morphology
MGI:7330216	Ccdc184<em1(IMPC)J>	MP:0001284,absent vibrissae
MGI:6152423	Ccdc186<em1(IMPC)Mbp>	MP:0000428,abnormal craniofacial morphology|MP:0001297,microphthalmia|MP:0001404,no spontaneous movement|MP:0001417,decreased exploration in new environment|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002092,abnormal eye morphology|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:7869471	Ccdc188<em1Osb>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0008893,detached sperm flagellum|MP:0009230,abnormal sperm head morphology|MP:0009234,absent sperm head|MP:0009239,short sperm flagellum|MP:0009830,abnormal sperm connecting piece morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0009833,absent sperm mitochondrial sheath
MGI:7425564	Ccdc18<em1(IMPC)Ccpcz>	MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology
MGI:4460455	Ccdc18<tm1a(EUCOMM)Wtsi>	MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003443,increased circulating glycerol level|MP:0005568,increased circulating total protein level|MP:0005633,increased circulating sodium level
MGI:5911509	Ccdc191<em1(IMPC)J>	MP:0001925,male infertility|MP:0002546,mydriasis
MGI:7481232	Ccdc198<em1Iad>	MP:0000601,small liver|MP:0001260,increased body weight|MP:0001402,decreased locomotor activity|MP:0001672,abnormal embryo development|MP:0001780,decreased brown adipose tissue amount|MP:0002768,small adrenal glands|MP:0002871,albuminuria|MP:0002989,small kidney|MP:0003179,thrombocytopenia|MP:0003960,increased lean body mass|MP:0004890,decreased energy expenditure|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0011891,decreased circulating ferritin level|MP:0011940,decreased food intake|MP:0011957,decreased compensatory feeding amount|MP:0012298,hypoactivity in response to feed restriction
MGI:6442544	Ccdc198<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0002110,abnormal digit morphology|MP:0002631,abnormal epididymis morphology|MP:0002757,decreased vertical activity|MP:0003961,decreased lean body mass|MP:0004889,increased energy expenditure|MP:0005012,decreased eosinophil cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0011045,decreased lung elastance|MP:0011939,increased food intake
MGI:6279920	Ccdc25<em1(IMPC)Mbp>	MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000692,small spleen|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001333,absent optic nerve|MP:0001404,no spontaneous movement|MP:0001711,abnormal placenta morphology|MP:0002699,abnormal vitreous body morphology|MP:0003231,abnormal placenta vasculature|MP:0005293,impaired glucose tolerance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7490402	Ccdc27<em1(IMPC)J>	MP:0001417,decreased exploration in new environment
MGI:7664574	Ccdc28a<em1Lwa>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009235,small sperm head|MP:0020451,decreased sperm progressive motility|MP:0030980,abnormal acroplaxome morphology
MGI:5634966	Ccdc28a<tm3b(EUCOMM)Wtsi>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001513,limb grasping|MP:0001925,male infertility|MP:0002757,decreased vertical activity|MP:0003960,increased lean body mass|MP:0005102,abnormal iris pigmentation|MP:0010052,increased grip strength|MP:0010506,prolonged RR interval
MGI:7481203	Ccdc28b<em1(IMPC)Bay>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology
MGI:7576205	Ccdc28b<em1Jlba>	MP:0001360,abnormal social investigation|MP:0001409,increased stereotypic behavior|MP:0002152,abnormal brain morphology|MP:0002566,abnormal sexual interaction|MP:0002574,increased vertical activity|MP:0005291,abnormal glucose tolerance|MP:0005378,growth/size/body region phenotype|MP:0005391,vision/eye phenotype|MP:0005559,increased circulating glucose level|MP:0013202,abnormal cilium morphology
MGI:5755389	Ccdc30<em1(IMPC)J>	MP:0009142,decreased prepulse inhibition
MGI:7378567	Ccdc32<em1(IMPC)J>	MP:0000194,increased circulating calcium level|MP:0000221,decreased leukocyte cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:5548652	Ccdc33<tm1.1(KOMP)Vlcg>	MP:0002764,short tibia|MP:0005630,increased lung weight
MGI:7442138	Ccdc34<em1Fzg>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0009838,abnormal sperm axoneme morphology|MP:0014052,increased male germ cell apoptosis|MP:0031356,abnormal outer dense fiber morphology
MGI:6376240	Ccdc34<em1(IMPC)J>	MP:0001925,male infertility|MP:0008259,abnormal optic disk morphology
MGI:7287391	Ccdc38<em1Cya>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004884,abnormal testis physiology|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009242,thin sperm flagellum|MP:0009377,ectopic manchette|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0031356,abnormal outer dense fiber morphology|MP:0031386,elongated manchette
MGI:5316786	Ccdc39<b2b1304Clo>	MP:0000519,hydronephrosis|MP:0000644,dextrocardia|MP:0008528,polycystic kidney|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia
MGI:5438066	Ccdc39<b2b1735Clo>	MP:0000284,double outlet right ventricle|MP:0000644,dextrocardia|MP:0002639,micrognathia|MP:0003178,left pulmonary isomerism|MP:0004133,heterotaxia|MP:0010403,atrial septal defect|MP:0010466,vascular ring|MP:0011249,abdominal situs inversus|MP:0011250,abdominal situs ambiguus|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia
MGI:5554444	Ccdc39<b2b2025.1Clo>	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0000690,absent spleen|MP:0000694,spleen hypoplasia|MP:0003178,left pulmonary isomerism|MP:0004113,abnormal aortic arch morphology|MP:0004133,heterotaxia|MP:0004157,interrupted aortic arch|MP:0006061,right atrial isomerism|MP:0006063,abnormal inferior vena cava morphology|MP:0008461,left atrial isomerism|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010466,vascular ring|MP:0010808,right-sided stomach|MP:0011254,superior-inferior ventricles|MP:0011667,double outlet right ventricle with atrioventricular septal defect|MP:0011668,double outlet right ventricle, Taussig bing type|MP:0011683,dual inferior vena cava|MP:0031515,l-loop transposition of the great arteries
MGI:5056368	Ccdc39<prh>	MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0000913,abnormal brain development|MP:0001262,decreased body weight|MP:0001891,hydrocephaly|MP:0002183,gliosis|MP:0002741,small olfactory bulb|MP:0004133,heterotaxia|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0008458,abnormal cortical ventricular zone morphology|MP:0010808,right-sided stomach|MP:0011056,abnormal brain ependyma motile cilium morphology|MP:0011069,abnormal brain ependyma motile cilium physiology|MP:0011085,postnatal lethality, complete penetrance|MP:0011252,situs inversus totalis|MP:0011380,enlarged brain ventricles|MP:0013438,dysmyelination|MP:0013907,abnormal cerebrospinal fluid flow
MGI:5605755	Ccdc39<tm2b(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5749736	Ccdc3<tm1Ish>	MP:0001263,weight loss|MP:0002078,abnormal glucose homeostasis|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0005334,abnormal fat pad morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005559,increased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009133,decreased white fat cell size|MP:0009356,decreased liver triglyceride level|MP:0031270,decreased susceptibility to age-related hepatic steatosis
MGI:6382545	Ccdc40<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0001925,male infertility|MP:0002941,increased circulating alanine transaminase level
MGI:3662904	Ccdc40<lnks>	MP:0000542,left-sided isomerism|MP:0001891,hydrocephaly|MP:0002766,situs inversus|MP:0003178,left pulmonary isomerism|MP:0004131,abnormal motile primary cilium morphology|MP:0004133,heterotaxia|MP:0005367,renal/urinary system phenotype|MP:0010854,lung situs inversus|MP:0011085,postnatal lethality, complete penetrance
MGI:3800251	Ccdc42<tm1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002631,abnormal epididymis morphology|MP:0005159,azoospermia|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009830,abnormal sperm connecting piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0014685,spermiation failure
MGI:3722141	Ccdc47<tm1Hta>	MP:0005621,abnormal cell physiology|MP:0011087,neonatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013501,increased fibroblast apoptosis
MGI:7638801	Ccdc50<em2Gpt>	MP:0005379,endocrine/exocrine gland phenotype|MP:0008564,increased interferon-beta secretion|MP:0008575,increased circulating interferon-beta level|MP:0020917,decreased susceptibility to Herpesvirales infection|MP:0031025,decreased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:5692675	Ccdc50<tm1b(EUCOMM)Hmgu>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010052,increased grip strength
MGI:6276291	Ccdc51<em1(IMPC)J>	MP:0005561,increased mean corpuscular hemoglobin|MP:0013279,increased fasting circulating glucose level
MGI:6368872	Ccdc51<tm1.1Geno>	MP:0004485,increased response of heart to induced stress|MP:0006036,abnormal mitochondrial physiology
MGI:4431914	Ccdc57<tm1a(EUCOMM)Wtsi>	MP:0000438,abnormal cranium morphology|MP:0001262,decreased body weight|MP:0005560,decreased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005628,decreased circulating potassium level|MP:0005633,increased circulating sodium level
MGI:5804139	Ccdc59<em1(IMPC)J>	MP:0001304,cataract|MP:0001693,failure of primitive streak formation|MP:0001694,absent egg cylinders|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002591,decreased mean corpuscular volume|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013241,embryo tissue necrosis|MP:0013292,embryonic lethality prior to organogenesis
MGI:6116688	Ccdc62<em1Jxia>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0009230,abnormal sperm head morphology|MP:0009831,abnormal sperm midpiece morphology
MGI:3590192	Ccdc62<repro29>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004910,decreased seminal vesicle weight|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008839,absent acrosome|MP:0009230,abnormal sperm head morphology|MP:0009831,abnormal sperm midpiece morphology
MGI:6343353	Ccdc63<em1Osb>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009239,short sperm flagellum
MGI:7296395	Ccdc65<em11Gpt>	MP:0000434,megacephaly|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology|MP:0004499,increased incidence of tumors by chemical induction|MP:0008535,enlarged lateral ventricles|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013907,abnormal cerebrospinal fluid flow
MGI:6152425	Ccdc65<em1(IMPC)Mbp>	MP:0001325,abnormal retina morphology|MP:0001404,no spontaneous movement|MP:0009709,hydrometra|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7484787	Ccdc66<em1(IMPC)Mbp>	MP:0002608,increased hematocrit|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:3893603	Ccdc66<Gt(E021F10)Wrst>	MP:0001005,abnormal retina rod cell morphology|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008515,thin retina outer nuclear layer
MGI:6153244	Ccdc6<em1(IMPC)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6714085	Ccdc6<tm1Afus>	MP:0003077,abnormal cell cycle|MP:0003498,thyroid gland hyperplasia|MP:0005134,decreased thyroid-stimulating hormone level|MP:0005470,increased thyroxine level|MP:0005474,increased triiodothyronine level|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0013501,increased fibroblast apoptosis
MGI:6188296	Ccdc73<em1Qsh>	MP:0005389,reproductive system phenotype
MGI:4432801	Ccdc77<tm1a(EUCOMM)Wtsi>	MP:0000182,increased circulating LDL cholesterol level
MGI:5649017	Ccdc78<em1(IMPC)J>	MP:0000195,decreased circulating calcium level
MGI:5553098	Ccdc7a<Tg(Prnp-Sirt1)10Imai>	MP:0001399,hyperactivity|MP:0001661,extended life span|MP:0002574,increased vertical activity|MP:0004811,abnormal neuron physiology|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005533,increased body temperature|MP:0011614,slow aging|MP:0011698,abnormal brown adipose tissue physiology|MP:0011939,increased food intake|MP:0012289,abnormal non-rapid eye movement sleep pattern|MP:0012297,hyperactivity elicited by feed restriction
MGI:5662451	Ccdc80<tm1.1Ftk>	MP:0003331,increased hepatocellular carcinoma incidence|MP:0005381,digestive/alimentary phenotype|MP:0010768,mortality/aging
MGI:5662449	Ccdc80<tm1Ftk>	MP:0002169,no abnormal phenotype detected
MGI:5445519	Ccdc80<tm1Ftrm>	MP:0001554,increased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0003058,increased insulin secretion|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005449,abnormal food intake|MP:0005455,increased susceptibility to weight gain|MP:0005491,pancreatic islet hyperplasia|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0008034,enhanced lipolysis|MP:0010024,increased total body fat amount|MP:0011939,increased food intake
MGI:5706809	Ccdc80<tm1Ppal>	MP:0001272,increased metastatic potential|MP:0003496,increased thyroid adenoma incidence|MP:0003579,increased ovarian carcinoma incidence|MP:0011703,increased fibroblast proliferation|MP:0013502,decreased fibroblast apoptosis
MGI:6294708	Ccdc85a<em1(IMPC)J>	MP:0010052,increased grip strength
MGI:3505575	Ccdc85c<hhy>	MP:0000788,abnormal cerebral cortex morphology|MP:0000804,abnormal occipital lobe morphology|MP:0000825,dilated lateral ventricle|MP:0000849,abnormal cerebellum morphology|MP:0000897,abnormal midbrain morphology|MP:0001891,hydrocephaly|MP:0001915,intracranial hemorrhage|MP:0002083,premature death|MP:0002183,gliosis|MP:0002958,cerebral aqueductal stenosis|MP:0003632,abnormal nervous system morphology|MP:0003633,abnormal nervous system physiology
MGI:4356276	Ccdc86<tm1Hfuj>	MP:0006414,decreased T cell apoptosis|MP:0008037,abnormal T cell morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:3812849	Ccdc87<tm1(KOMP)Vlcg>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0002674,abnormal sperm motility|MP:0004542,impaired acrosome reaction|MP:0005389,reproductive system phenotype|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009647,decreased fertilization frequency|MP:0031354,abnormal acrosome assembly
MGI:3835852	Ccdc88a<tm1Mat>	MP:0000774,decreased brain size|MP:0000819,abnormal olfactory bulb morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001473,reduced long-term potentiation|MP:0002083,premature death|MP:0002739,abnormal olfactory bulb development|MP:0002741,small olfactory bulb|MP:0002792,abnormal retina vasculature morphology|MP:0002801,abnormal long-term object recognition memory|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003245,abnormal GABAergic neuron morphology|MP:0003631,nervous system phenotype|MP:0004279,abnormal rostral migratory stream morphology|MP:0005602,decreased angiogenesis|MP:0008547,abnormal neocortex morphology|MP:0008948,decreased neuron number|MP:0009454,impaired contextual conditioning behavior|MP:0009937,abnormal neuron differentiation|MP:0009948,abnormal olfactory bulb glomerular layer morphology|MP:0009949,abnormal olfactory bulb granule cell layer morphology|MP:0009951,abnormal olfactory bulb mitral cell layer morphology|MP:0009952,abnormal olfactory bulb subventricular zone morphology|MP:0012307,impaired spatial learning|MP:0030956,abnormal neuronal precursor cell migration
MGI:5140603	Ccdc88a<tm2.1Mat>	MP:0001473,reduced long-term potentiation|MP:0002635,reduced sensorimotor gating|MP:0002910,abnormal excitatory postsynaptic currents|MP:0005378,growth/size/body region phenotype|MP:0009142,decreased prepulse inhibition|MP:0009454,impaired contextual conditioning behavior|MP:0009936,abnormal dendritic spine morphology|MP:0010768,mortality/aging|MP:0011620,abnormal habituation to a new environment|MP:0012307,impaired spatial learning|MP:0014367,impaired long-term object recognition memory
MGI:5140605	Ccdc88a<tm3.1Mat>	MP:0001263,weight loss|MP:0002083,premature death|MP:0002739,abnormal olfactory bulb development|MP:0004279,abnormal rostral migratory stream morphology|MP:0030956,abnormal neuronal precursor cell migration
MGI:5449207	Ccdc88a<tm4.1Mat>	MP:0000812,abnormal dentate gyrus morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001732,postnatal growth retardation|MP:0002741,small olfactory bulb|MP:0004279,abnormal rostral migratory stream morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:6156502	Ccdc88b<em1(IMPC)Tcp>	MP:0000221,decreased leukocyte cell number|MP:0000702,enlarged lymph nodes|MP:0005016,decreased lymphocyte cell number|MP:0008528,polycystic kidney|MP:0013278,decreased fasting circulating glucose level
MGI:5523920	Ccdc88b<m1Pgrs>	MP:0005026,decreased susceptibility to parasitic infection|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality|MP:0013663,increased myeloid cell number
MGI:5548562	Ccdc88c<tm1.1(KOMP)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0004738,abnormal auditory brainstem response
MGI:5141808	Ccdc88c<tm1(KOMP)Mbp>	MP:0010152,abnormal brain ependyma morphology|MP:0030963,abnormal brain ependyma motile cilium location or orientation
MGI:6470667	Ccdc88c<tm1Mat>	MP:0001263,weight loss|MP:0001792,impaired wound healing
MGI:6156595	Ccdc8<em1(IMPC)Tcp>	MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:6695964	Ccdc8<tm1.2Yxi>	MP:0001712,abnormal placenta development|MP:0004200,decreased fetal size|MP:0005384,cellular phenotype|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009431,decreased fetal weight|MP:0010865,prenatal growth retardation|MP:0011089,perinatal lethality, complete penetrance|MP:0011523,thin placenta labyrinth|MP:0011525,abnormal placenta intervillous maternal lacunae morphology|MP:0011708,decreased fibroblast cell migration
MGI:7378824	Ccdc90b<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0002100,abnormal tooth morphology|MP:0005635,decreased circulating bilirubin level|MP:0010052,increased grip strength
MGI:4455380	Ccdc92<tm1a(KOMP)Mbp>	MP:0000062,increased bone mineral density|MP:0000183,decreased circulating LDL cholesterol level|MP:0001876,decreased inflammatory response|MP:0002644,decreased circulating triglyceride level|MP:0002891,increased insulin sensitivity|MP:0002965,increased circulating serum albumin level|MP:0002970,abnormal white adipose tissue morphology|MP:0003402,decreased liver weight|MP:0003884,decreased macrophage cell number|MP:0004889,increased energy expenditure|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005565,increased blood urea nitrogen level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0005670,abnormal white adipose tissue physiology|MP:0008636,decreased circulating interleukin-18 level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009127,increased brown fat cell number|MP:0009133,decreased white fat cell size|MP:0009136,decreased brown fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0011168,abnormal fat cell differentiation|MP:0011699,abnormal brown adipose tissue thermogenesis|MP:0020868,decreased lipogenesis|MP:0030969,increased circulating adiponectin level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis|MP:0031391,increased locomotor activity
MGI:5692564	Ccdc92<tm1b(KOMP)Mbp>	MP:0002175,decreased brain weight|MP:0004738,abnormal auditory brainstem response|MP:0005179,decreased circulating cholesterol level|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7427746	Ccdc93<em1(IMPC)J>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0002582,disorganized extraembryonic tissue|MP:0002834,decreased heart weight|MP:0003984,embryonic growth retardation|MP:0010024,increased total body fat amount|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis|MP:0014586,decreased egg cylinder size
MGI:5754574	Ccdc9b<em1(IMPC)Tcp>	MP:0001417,decreased exploration in new environment|MP:0009142,decreased prepulse inhibition
MGI:8237793	Ccer1<em1Zbhu>	MP:0001925,male infertility|MP:0005389,reproductive system phenotype
MGI:8237976	Ccer1<em2Zbhu>	MP:0001925,male infertility|MP:0005389,reproductive system phenotype
MGI:8237977	Ccer1<em3Zbhu>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004182,abnormal spermiation|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009647,decreased fertilization frequency|MP:0012167,abnormal epigenetic regulation of gene expression|MP:0014631,abnormal elongated spermatid morphology|MP:0014685,spermiation failure|MP:0020451,decreased sperm progressive motility
MGI:6394064	Cchcr1<em1Aoka>	MP:0000414,alopecia|MP:0003809,abnormal hair shaft morphology|MP:0003810,abnormal hair cuticle|MP:0003848,brittle hair|MP:0005387,immune system phenotype|MP:0010771,integument phenotype
MGI:6377492	Cchcr1<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0002574,increased vertical activity
MGI:7296421	Ccin<em2Gpt>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0014052,increased male germ cell apoptosis
MGI:6120823	Cckar<tm1b(EUCOMM)Hmgu>	MP:0005343,increased circulating aspartate transaminase level|MP:0011874,enlarged urinary bladder
MGI:3051882	Cckar<tm1Kpn>	MP:0000783,abnormal forebrain morphology|MP:0002646,increased intestinal cholesterol absorption|MP:0002830,gallstones|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004279,abnormal rostral migratory stream morphology|MP:0004773,abnormal bile composition|MP:0004981,decreased neuronal precursor cell number|MP:0005278,abnormal cholesterol homeostasis|MP:0005365,abnormal bile salt homeostasis|MP:0005449,abnormal food intake|MP:0006002,abnormal small intestinal transit time|MP:0006009,abnormal neuronal migration|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0020132,increased gallbladder volume
MGI:3529601	Cckar<tm1Kym>	MP:0001399,hyperactivity|MP:0001777,abnormal body temperature homeostasis|MP:0002694,abnormal pancreas secretion|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005386,behavior/neurological phenotype
MGI:6157678	Cckbr<em1(IMPC)H>	MP:0000572,abnormal autopod morphology
MGI:2180591	Cckbr<tm1Kpn>	MP:0003892,abnormal gastric gland morphology|MP:0004139,abnormal gastric parietal cell morphology|MP:0004731,increased circulating gastrin level|MP:0005218,abnormal pancreatic delta cell morphology|MP:0008006,increased stomach pH|MP:0010803,abnormal stomach enteroendocrine cell morphology
MGI:2384535	Cckbr<tm1Tom>	MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001431,abnormal eating behavior|MP:0001442,decreased grooming behavior|MP:0001663,abnormal digestive system physiology|MP:0002128,abnormal blood circulation|MP:0002691,small stomach|MP:0002736,abnormal nociception after inflammation|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003829,impaired febrile response|MP:0004152,abnormal circulating iron level|MP:0004731,increased circulating gastrin level|MP:0004889,increased energy expenditure|MP:0004924,abnormal behavior|MP:0005376,homeostasis/metabolism phenotype|MP:0005498,hyporesponsive to tactile stimuli|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008807,increased liver iron level|MP:0008872,abnormal physiological response to xenobiotic|MP:0009749,enhanced behavioral response to addictive substance|MP:0009753,enhanced behavioral response to morphine|MP:0009758,impaired behavioral response to cocaine|MP:0009854,impaired gastric peristalsis|MP:0010792,abnormal stomach mucosa morphology|MP:0011891,decreased circulating ferritin level|MP:0011897,decreased circulating unsaturated transferrin level|MP:0011939,increased food intake|MP:0011941,increased fluid intake
MGI:3604503	Cck<tm1Dgen>	MP:0009142,decreased prepulse inhibition
MGI:2180568	Cck<tm1Lcs>	MP:0002693,abnormal pancreas physiology|MP:0005319,abnormal enzyme/coenzyme level
MGI:5572040	Cck<tm2b(EUCOMM)Hmgu>	MP:0002135,abnormal kidney morphology
MGI:2384431	Ccl11<tm1Brv>	MP:0002169,no abnormal phenotype detected
MGI:2384435	Ccl11<tm1Mer>	MP:0005012,decreased eosinophil cell number|MP:0008723,impaired eosinophil recruitment
MGI:3712152	Ccl12<tm1.1Ifc>	MP:0005387,immune system phenotype
MGI:3712151	Ccl12<tm1Ifc>	MP:0005387,immune system phenotype
MGI:6356806	Ccl17<em1(IMPC)H>	MP:0004952,increased spleen weight
MGI:4441162	Ccl17<tm1.1Ifo>	MP:0004751,increased length of allograft survival|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction
MGI:3762257	Ccl19<tm1Cys>	MP:0000685,abnormal immune system morphology|MP:0005018,decreased T cell number|MP:0005387,immune system phenotype
MGI:3809665	Ccl1<tm1Sman>	MP:0001845,abnormal inflammatory response|MP:0004946,abnormal regulatory T cell physiology
MGI:6149979	Ccl21a<tm1Yout>	MP:0000689,abnormal spleen morphology|MP:0000715,decreased thymocyte number|MP:0004918,abnormal negative T cell selection|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0008880,lacrimal gland inflammation|MP:0012765,decreased alpha-beta T cell number|MP:0013588,small thymus medulla|MP:0020220,decreased tear production
MGI:4441963	Ccl22<tm1a(EUCOMM)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:4881184	Ccl22<tm1(KOMP)Vlcg>	MP:0002376,abnormal dendritic cell physiology
MGI:3606463	Ccl24<tm1Mer>	MP:0001790,abnormal immune system physiology
MGI:6284268	Ccl25<em1(IMPC)H>	MP:0000691,enlarged spleen|MP:0002941,increased circulating alanine transaminase level|MP:0004952,increased spleen weight|MP:0010052,increased grip strength|MP:0013278,decreased fasting circulating glucose level
MGI:3797365	Ccl25<tm1.1Mal>	MP:0003944,abnormal T cell subpopulation ratio|MP:0005232,abnormal mesenteric lymph node morphology|MP:0008345,abnormal gamma-delta T cell number|MP:0008351,decreased gamma-delta intraepithelial T cell number
MGI:3529266	Ccl25<tm1Lex>	MP:0010024,increased total body fat amount
MGI:5529064	Ccl26<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0005292,improved glucose tolerance|MP:0005561,increased mean corpuscular hemoglobin|MP:0011396,abnormal sleep behavior
MGI:5695899	Ccl27a<tm1.1(KOMP)Vlcg>	MP:0004974,decreased regulatory T cell number|MP:0005387,immune system phenotype
MGI:6358078	Ccl28<em1(IMPC)Ccpcz>	MP:0000160,kyphosis|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002941,increased circulating alanine transaminase level|MP:0009709,hydrometra|MP:0010052,increased grip strength
MGI:6367826	Ccl28<tm1Takna>	MP:0000495,abnormal colon morphology|MP:0000716,abnormal immune system cell morphology|MP:0001807,decreased IgA level|MP:0002493,increased IgG level|MP:0003091,abnormal cell migration|MP:0008537,increased susceptibility to induced colitis|MP:0010377,abnormal gut flora balance
MGI:4950271	Ccl2<tm1.1Pame>	MP:0002412,increased susceptibility to bacterial infection|MP:0003156,abnormal leukocyte migration|MP:0005387,immune system phenotype
MGI:4355946	Ccl2<tm1.1Tyos>	MP:0002376,abnormal dendritic cell physiology|MP:0002463,abnormal neutrophil physiology|MP:0003799,impaired macrophage chemotaxis|MP:0008127,decreased dendritic cell number|MP:0008721,abnormal chemokine level|MP:0008722,abnormal chemokine secretion|MP:0010740,abnormal dendritic cell chemotaxis
MGI:5507824	Ccl2<tm1.2Tyos>	MP:0002169,no abnormal phenotype detected
MGI:5462245	Ccl2<tm1Lex>	MP:0003799,impaired macrophage chemotaxis
MGI:2175911	Ccl2<tm1Rol>	MP:0000122,premature tooth eruption|MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0000343,abnormal response to cardiac infarction|MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0001504,abnormal posture|MP:0001523,impaired righting response|MP:0001876,decreased inflammatory response|MP:0001968,abnormal touch/nociception|MP:0001987,alcohol preference|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002128,abnormal blood circulation|MP:0002444,abnormal T cell physiology|MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology|MP:0002493,increased IgG level|MP:0002570,alcohol aversion|MP:0002620,abnormal monocyte morphology|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002805,abnormal conditioned taste aversion behavior|MP:0002891,increased insulin sensitivity|MP:0002908,delayed wound healing|MP:0003009,abnormal cytokine secretion|MP:0003156,abnormal leukocyte migration|MP:0003383,abnormal gluconeogenesis|MP:0003397,increased muscle weight|MP:0003545,increased alcohol consumption|MP:0003546,decreased alcohol consumption|MP:0003691,abnormal microglial cell physiology|MP:0003710,abnormal physiological neovascularization|MP:0003799,impaired macrophage chemotaxis|MP:0003852,skeletal muscle necrosis|MP:0003884,decreased macrophage cell number|MP:0003921,abnormal heart left ventricle morphology|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004811,abnormal neuron physiology|MP:0004892,increased adiponectin level|MP:0004893,decreased adiponectin level|MP:0004984,increased osteoclast cell number|MP:0005016,decreased lymphocyte cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005098,abnormal optic choroid morphology|MP:0005164,abnormal response to injury|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology|MP:0005292,improved glucose tolerance|MP:0005293,impaired glucose tolerance|MP:0005335,abnormal gonadal fat pad morphology|MP:0005402,abnormal action potential|MP:0005458,increased percent body fat/body weight|MP:0005546,choroidal neovascularization|MP:0005559,increased circulating glucose level|MP:0005590,increased vasodilation|MP:0005602,decreased angiogenesis|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0006187,retina deposits|MP:0006238,abnormal choriocapillaris morphology|MP:0006319,abnormal epididymal fat pad morphology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008236,decreased susceptibility to neuronal excitotoxicity|MP:0008450,retina photoreceptor degeneration|MP:0008499,increased IgG1 level|MP:0008518,retina outer nuclear layer degeneration|MP:0008539,decreased susceptibility to induced colitis|MP:0008553,increased circulating tumor necrosis factor level|MP:0008567,decreased interferon-gamma secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008593,increased circulating interleukin-10 level|MP:0008658,decreased interleukin-1 beta secretion|MP:0008660,increased interleukin-10 secretion|MP:0008670,decreased interleukin-12b secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0008721,abnormal chemokine level|MP:0008722,abnormal chemokine secretion|MP:0008842,lipofuscinosis|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008908,increased total fat pad weight|MP:0009269,decreased fat cell size|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0009787,increased susceptibility to infection induced morbidity/mortality|MP:0010760,abnormal macrophage chemotaxis|MP:0011941,increased fluid intake|MP:0013239,impaired skeletal muscle regeneration|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:4355945	Ccl2<tm1Tyos>	MP:0008721,abnormal chemokine level|MP:0008722,abnormal chemokine secretion
MGI:6355940	Ccl3<em1(IMPC)H>	MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level
MGI:1857243	Ccl3<tm1Unc>	MP:0000222,decreased neutrophil cell number|MP:0001463,abnormal spatial learning|MP:0001523,impaired righting response|MP:0002411,decreased susceptibility to bacterial infection|MP:0002570,alcohol aversion|MP:0002805,abnormal conditioned taste aversion behavior|MP:0003546,decreased alcohol consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005614,decreased susceptibility to type III hypersensitivity reaction|MP:0008432,abnormal long-term spatial reference memory|MP:0008916,abnormal astrocyte physiology|MP:0009481,cecum inflammation|MP:0011941,increased fluid intake|MP:0020449,decreased microglial cell activation|MP:0020938,decreased susceptibility to Picornaviridae infection|MP:0020945,abnormal susceptibility to Orthomyxoviridae infection|MP:0020947,decreased susceptibility to Orthomyxoviridae infection
MGI:7447407	Ccl4<em1(IMPC)Bay>	MP:0000550,abnormal forelimb morphology|MP:0012000,abnormal limb position
MGI:7621875	Ccl4<em1Narl>	MP:0001876,decreased inflammatory response|MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:2180195	Ccl5<tm1Hso>	MP:0005095,decreased T cell proliferation|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion
MGI:3712065	Ccl7<tm1Ifc>	MP:0002620,abnormal monocyte morphology
MGI:4452877	Ccl9<tm1(KOMP)Vlcg>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3512761	Ccm2<Gt(RRG051)Byg>	MP:0001622,abnormal vasculogenesis|MP:0001633,poor circulation|MP:0001787,pericardial edema|MP:0001915,intracranial hemorrhage|MP:0002127,abnormal cardiovascular system morphology|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003542,abnormal vascular endothelial cell development|MP:0003984,embryonic growth retardation|MP:0004068,dilated dorsal aorta|MP:0004076,abnormal vitelline vascular remodeling|MP:0004783,abnormal cardinal vein morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0004950,abnormal brain vasculature morphology|MP:0005244,hemopericardium|MP:0005602,decreased angiogenesis|MP:0005621,abnormal cell physiology|MP:0006356,abnormal third pharyngeal arch artery morphology|MP:0010355,abnormal first pharyngeal arch artery morphology|MP:0010356,abnormal second pharyngeal arch artery morphology|MP:0010463,aorta stenosis|MP:0011091,prenatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012511,dilated aortic sac
MGI:5439489	Ccm2l<tm1Mlkn>	MP:0001273,decreased metastatic potential|MP:0002908,delayed wound healing|MP:0003447,decreased tumor growth/size|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010144,abnormal tumor vascularization|MP:0010768,mortality/aging
MGI:3837686	Ccm2<tm1.1Etl>	MP:0001722,pale yolk sac|MP:0001787,pericardial edema|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011205,excessive folding of visceral yolk sac|MP:0012082,delayed heart development
MGI:3817970	Ccm2<tm1.1Kwhi>	MP:0001633,poor circulation|MP:0002127,abnormal cardiovascular system morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0004068,dilated dorsal aorta|MP:0004076,abnormal vitelline vascular remodeling|MP:0005602,decreased angiogenesis|MP:0006337,abnormal first pharyngeal arch morphology|MP:0006338,abnormal second pharyngeal arch morphology|MP:0006339,abnormal third pharyngeal arch morphology|MP:0010463,aorta stenosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3837678	Ccm2<tm1Etl>	MP:0000274,enlarged heart|MP:0000280,thin ventricular wall|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000820,abnormal choroid plexus morphology|MP:0001688,abnormal somite development|MP:0001719,absent vitelline blood vessels|MP:0001722,pale yolk sac|MP:0001730,embryonic growth arrest|MP:0001787,pericardial edema|MP:0002169,no abnormal phenotype detected|MP:0002582,disorganized extraembryonic tissue|MP:0003228,abnormal sinus venosus morphology|MP:0004266,pale placenta|MP:0004783,abnormal cardinal vein morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0004950,abnormal brain vasculature morphology|MP:0006055,abnormal vascular endothelial cell morphology|MP:0008725,increased heart atrium size|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3817969	Ccm2<tm1Kwhi>	MP:0002169,no abnormal phenotype detected
MGI:5439490	Ccm2<tm1Mlkn>	MP:0002652,thin myocardium|MP:0004950,abnormal brain vasculature morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0031593,decreased cardiac jelly amount
MGI:5085314	Ccm2<tm1Sbn>	MP:0000260,abnormal angiogenesis|MP:0000267,abnormal heart development|MP:0001787,pericardial edema|MP:0003227,abnormal vascular branching morphogenesis|MP:0003410,abnormal artery development|MP:0004076,abnormal vitelline vascular remodeling|MP:0004251,failure of heart looping|MP:0005592,abnormal vascular smooth muscle morphology|MP:0009577,abnormal developmental vascular remodeling|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0030044,short forehead
MGI:5085315	Ccm2<tm2.1Sbn>	MP:0000267,abnormal heart development|MP:0001393,ataxia|MP:0001915,intracranial hemorrhage|MP:0001916,intracerebral hemorrhage|MP:0002064,seizures|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology|MP:0003227,abnormal vascular branching morphogenesis|MP:0003410,abnormal artery development|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004251,failure of heart looping|MP:0004787,abnormal dorsal aorta morphology|MP:0004950,abnormal brain vasculature morphology|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006052,cerebellum hemorrhage|MP:0008918,microgliosis|MP:0009577,abnormal developmental vascular remodeling|MP:0031384,impaired blood-brain barrier function
MGI:2446577	Ccn1<tm1Lfl>	MP:0000267,abnormal heart development|MP:0000281,abnormal interventricular septum morphology|MP:0000286,abnormal mitral valve morphology|MP:0000299,failure of atrioventricular cushion closure|MP:0001648,abnormal apoptosis|MP:0001711,abnormal placenta morphology|MP:0001914,hemorrhage|MP:0002191,abnormal artery morphology|MP:0004068,dilated dorsal aorta|MP:0004225,patent cardiac foramen ovale|MP:0004266,pale placenta|MP:0004560,abnormal chorionic plate morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009657,failure of chorioallantoic fusion|MP:0010402,ventricular septal defect|MP:0010404,ostium primum atrial septal defect|MP:0010413,complete atrioventricular septal defect|MP:0010607,common atrioventricular valve|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3715733	Ccn1<tm2Lfl>	MP:0005165,increased susceptibility to injury|MP:0006043,decreased apoptosis
MGI:5529625	Ccn1<tm3.1Lfl>	MP:0003333,liver fibrosis|MP:0005165,increased susceptibility to injury|MP:0005370,liver/biliary system phenotype|MP:0008007,abnormal cellular replicative senescence
MGI:4949916	Ccn2<tm1.1Alea>	MP:0005501,abnormal skin physiology|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5702703	Ccn2<tm1.1(folA/cre)Hze>	MP:0002169,no abnormal phenotype detected
MGI:4822056	Ccn2<tm1.1Vlcg>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0002169,no abnormal phenotype detected
MGI:2663631	Ccn2<tm1Kml>	MP:0000088,short mandible|MP:0000101,absent ethmoid bone|MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000163,abnormal cartilage morphology|MP:0000164,abnormal cartilage development|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000440,domed cranium|MP:0001176,abnormal lung development|MP:0001178,pulmonary hypoplasia|MP:0001953,respiratory failure|MP:0002114,abnormal axial skeleton morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002657,chondrodystrophy|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003641,small lung|MP:0003723,abnormal long bone morphology|MP:0004321,short sternum|MP:0004322,abnormal sternebra morphology|MP:0004358,bowed tibia|MP:0004361,bowed ulna|MP:0004372,bowed fibula|MP:0004374,bowed radius|MP:0004391,abnormal respiratory conducting tube morphology|MP:0004607,abnormal cervical atlas morphology|MP:0004624,abnormal thoracic cage morphology|MP:0004703,abnormal vertebral column morphology|MP:0004734,small thoracic cavity|MP:0005385,cardiovascular system phenotype|MP:0005587,abnormal Meckel's cartilage morphology|MP:0005602,decreased angiogenesis|MP:0005631,decreased lung weight|MP:0006397,disorganized long bone epiphyseal plate|MP:0006398,increased long bone epiphyseal plate size|MP:0009250,abnormal appendicular skeleton morphology|MP:0009346,decreased trabecular bone thickness|MP:0009780,abnormal chondrocyte physiology|MP:0009886,failure of palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0010827,small lung saccule|MP:0010889,small alveolar lamellar bodies|MP:0011087,neonatal lethality, complete penetrance|MP:0011148,decreased mesenchymal cell proliferation involved in lung development|MP:0012514,pectus excavatum|MP:0020010,decreased bone mineral density of femur|MP:0031449,abnormal nasal cartilage morphology
MGI:4838151	Ccn2<tm1Mae>	MP:0011087,neonatal lethality, complete penetrance
MGI:3840270	Ccn2<tm1Mga>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000157,abnormal sternum morphology|MP:0000260,abnormal angiogenesis|MP:0001953,respiratory failure|MP:0002657,chondrodystrophy|MP:0008271,abnormal bone ossification|MP:0011087,neonatal lethality, complete penetrance
MGI:4838152	Ccn2<tm2Mae>	MP:0000018,small ears|MP:0000108,midline facial cleft|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001286,abnormal eye development|MP:0001622,abnormal vasculogenesis|MP:0001698,decreased embryo size|MP:0002169,no abnormal phenotype detected|MP:0003743,abnormal facial morphology|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0003984,embryonic growth retardation|MP:0008797,facial cleft|MP:0008798,lateral facial cleft|MP:0010124,decreased bone mineral content|MP:0010395,abnormal pharyngeal arch development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0030066,short face
MGI:6279924	Ccn3<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0001293,anophthalmia|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0003068,enlarged kidney
MGI:4440613	Ccn3<tm1.1Ecan>	MP:0001533,abnormal skeleton physiology|MP:0001541,abnormal osteoclast physiology|MP:0004148,increased compact bone thickness|MP:0004348,long femur|MP:0005006,abnormal osteoblast physiology|MP:0005375,adipose tissue phenotype|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype|MP:0005508,abnormal skeleton morphology|MP:0008271,abnormal bone ossification|MP:0008396,abnormal osteoclast differentiation|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume
MGI:3794783	Ccn3<tm1Cabo>	MP:0000164,abnormal cartilage development|MP:0000166,abnormal chondrocyte morphology|MP:0000281,abnormal interventricular septum morphology|MP:0000439,enlarged cranium|MP:0000532,kidney vascular congestion|MP:0000554,abnormal carpal bone morphology|MP:0000585,kinked tail|MP:0001268,barrel chest|MP:0001304,cataract|MP:0001506,limp posture|MP:0002269,muscular atrophy|MP:0002759,abnormal caudal vertebrae morphology|MP:0002837,dystrophic cardiac calcinosis|MP:0002952,ventricular cardiomyopathy|MP:0003385,abnormal body wall morphology|MP:0003419,delayed endochondral bone ossification|MP:0003795,abnormal bone structure|MP:0003808,increased atrioventricular cushion size|MP:0004695,increased length of long bones|MP:0005353,abnormal patella morphology|MP:0005508,abnormal skeleton morphology|MP:0006137,venoocclusion|MP:0008069,abnormal joint mobility|MP:0008271,abnormal bone ossification|MP:0008770,decreased survivor rate|MP:0008919,fused tarsal bones|MP:0010019,liver vascular congestion|MP:0011102,embryonic lethality, incomplete penetrance|MP:0030796,hip dislocation
MGI:5004902	Ccn3<tm1Hko>	MP:0004883,abnormal vascular wound healing|MP:0031510,increased vascular smooth muscle cell proliferation
MGI:5430817	Ccn4<tm1Lex>	MP:0001405,impaired coordination
MGI:5548427	Ccn5<tm1.1(KOMP)Vlcg>	MP:0004738,abnormal auditory brainstem response
MGI:4399364	Ccn5<tm1(KOMP)Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:6093469	Ccn6<tm1.1Cgkl>	MP:0000627,abnormal mammary gland morphology|MP:0001272,increased metastatic potential|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001885,mammary gland duct hyperplasia|MP:0006271,abnormal involution of the mammary gland|MP:0009503,abnormal mammary gland duct morphology|MP:0013782,abnormal mammary duct terminal end bud morphology
MGI:5302829	Ccn6<tm1(cre)Mawa>	MP:0002169,no abnormal phenotype detected
MGI:3525361	Ccn6<tm2Mawa>	MP:0002169,no abnormal phenotype detected
MGI:3038977	Ccna1<tm1Coll>	MP:0001155,arrest of spermatogenesis|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0020550,multinucleated giant male germ cells
MGI:2180633	Ccna1<tm1Djw>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis|MP:0020550,multinucleated giant male germ cells
MGI:4461954	Ccna2<tm1.1Pisc>	MP:0002083,premature death|MP:0003077,abnormal cell cycle
MGI:4461956	Ccna2<tm1.2Pisc>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2180634	Ccna2<tm1Sot>	MP:0001672,abnormal embryo development|MP:0001730,embryonic growth arrest|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5754587	Ccnb1ip1<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001402,decreased locomotor activity|MP:0001925,male infertility|MP:0001926,female infertility
MGI:3050548	Ccnb1ip1<mei4>	MP:0001125,abnormal oocyte morphology|MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001924,infertility|MP:0001929,abnormal gametogenesis|MP:0001930,abnormal meiosis|MP:0002216,abnormal seminiferous tubule morphology|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005431,decreased oocyte number|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0008967,absent chiasmata formation
MGI:5637200	Ccnb1<tm1b(KOMP)Wtsi>	MP:0000745,tremors|MP:0009552,urinary bladder obstruction|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2429976	Ccnb1<tm1Thnt>	MP:0011092,embryonic lethality, complete penetrance
MGI:2429974	Ccnb2<tm1Thnt>	MP:0000706,small thymus|MP:0001262,decreased body weight|MP:0001935,decreased litter size|MP:0005090,increased double-negative T cell number|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6287726	Ccnb3<em1Sky>	MP:0001926,female infertility|MP:0005168,abnormal female meiosis|MP:0005389,reproductive system phenotype|MP:0012736,abnormal polar body morphology
MGI:5697676	Ccnc<tm1.1Pisc>	MP:0002006,neoplasm
MGI:5697678	Ccnc<tm1.2Pisc>	MP:0001715,placental labyrinth hypoplasia|MP:0003077,abnormal cell cycle|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2385629	Ccnd1<tm1(CCNE)Pisc>	MP:0001325,abnormal retina morphology|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005551,abnormal eye electrophysiology|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0010768,mortality/aging
MGI:2180640	Ccnd1<tm1Dsn>	MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0001265,decreased body size|MP:0001328,disorganized retina layers|MP:0001385,pup cannibalization|MP:0001513,limb grasping|MP:0002984,retina hypoplasia|MP:0004831,long incisors|MP:0005384,cellular phenotype|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0006270,abnormal mammary gland growth during lactation|MP:0008507,thin retina ganglion layer|MP:0008509,disorganized retina ganglion layer|MP:0010249,lactation failure|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011965,decreased total retina thickness|MP:0030541,misaligned incisors
MGI:3614415	Ccnd1<tm1Phin>	MP:0001325,abnormal retina morphology|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0005389,reproductive system phenotype|MP:0005551,abnormal eye electrophysiology
MGI:1857280	Ccnd1<tm1Wbg>	MP:0001382,abnormal nursing|MP:0001513,limb grasping|MP:0001663,abnormal digestive system physiology|MP:0001732,postnatal growth retardation|MP:0002984,retina hypoplasia|MP:0005379,endocrine/exocrine gland phenotype|MP:0005551,abnormal eye electrophysiology|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0010249,lactation failure|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3530077	Ccnd1<tm2(Ccnd2)Pisc>	MP:0001262,decreased body weight|MP:0001513,limb grasping|MP:0005389,reproductive system phenotype|MP:0005551,abnormal eye electrophysiology
MGI:3722105	Ccnd1<tm2Phin>	MP:0002169,no abnormal phenotype detected
MGI:4421800	Ccnd1<tm3Pisc>	MP:0002169,no abnormal phenotype detected
MGI:4421801	Ccnd1<tm4Pisc>	MP:0002169,no abnormal phenotype detected
MGI:5468336	Ccnd1<tm5.1Pisc>	MP:0002169,no abnormal phenotype detected
MGI:6120814	Ccnd2<tm1b(KOMP)Mbp>	MP:0000438,abnormal cranium morphology|MP:0001147,small testis|MP:0001399,hyperactivity|MP:0001512,trunk curl|MP:0001566,increased circulating phosphate level|MP:0002590,increased mean corpuscular volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0004174,abnormal spine curvature|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0008810,increased circulating iron level|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0013279,increased fasting circulating glucose level
MGI:2180642	Ccnd2<tm1Wbg>	MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000873,thin external granule cell layer|MP:0000877,abnormal Purkinje cell morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001130,abnormal ovarian folliculogenesis|MP:0001926,female infertility|MP:0001928,abnormal ovulation|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:5468556	Ccnd3<tm1.1(Ccnd2)Iaai>	MP:0000333,decreased bone marrow cell number|MP:0000706,small thymus|MP:0001823,thymus hypoplasia|MP:0005092,decreased double-positive T cell number|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0008209,decreased pre-B cell number|MP:0009278,abnormal bone marrow cell physiology
MGI:2448172	Ccnd3<tm1Pisc>	MP:0000333,decreased bone marrow cell number|MP:0000706,small thymus|MP:0001823,thymus hypoplasia|MP:0005016,decreased lymphocyte cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0008209,decreased pre-B cell number
MGI:5468337	Ccnd3<tm2.1Pisc>	MP:0000221,decreased leukocyte cell number|MP:0000706,small thymus|MP:0002169,no abnormal phenotype detected|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002875,decreased erythrocyte cell number|MP:0005092,decreased double-positive T cell number|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:3711012	Ccndbp1<tm1Riet>	MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0004001,decreased hepatocyte proliferation|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0031324,delayed liver regeneration
MGI:3797100	Ccne1<tm1Clur>	MP:0000245,abnormal erythropoiesis|MP:0000321,increased bone marrow cell number|MP:0000488,abnormal intestinal epithelium morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0001577,anemia|MP:0002356,abnormal spleen red pulp morphology|MP:0002397,abnormal bone marrow morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002641,anisopoikilocytosis|MP:0003135,increased erythroid progenitor cell number|MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0006271,abnormal involution of the mammary gland|MP:0008250,abnormal myeloid leukocyte morphology|MP:0010173,increased mammary gland epithelial cell proliferation|MP:0014126,increased mammary gland apoptosis
MGI:3584133	Ccne1<tm1Jro>	MP:0000240,extramedullary hematopoiesis|MP:0000488,abnormal intestinal epithelium morphology|MP:0004952,increased spleen weight|MP:0005381,digestive/alimentary phenotype|MP:0005389,reproductive system phenotype|MP:0005621,abnormal cell physiology|MP:0009336,increased splenocyte proliferation|MP:0010173,increased mammary gland epithelial cell proliferation|MP:0014126,increased mammary gland apoptosis
MGI:2675473	Ccne1<tm1Pisc>	MP:0002169,no abnormal phenotype detected
MGI:2677700	Ccne2<tm1Boa>	MP:0001147,small testis|MP:0001922,reduced male fertility|MP:0002160,abnormal reproductive system morphology|MP:0002161,abnormal fertility/fecundity|MP:0002687,oligozoospermia
MGI:2675474	Ccne2<tm1Pisc>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002160,abnormal reproductive system morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0003205,testicular atrophy|MP:0005169,abnormal male meiosis|MP:0020550,multinucleated giant male germ cells
MGI:3040863	Ccnf<tm1.1Sje>	MP:0000352,decreased cell proliferation|MP:0000784,forebrain hypoplasia|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001712,abnormal placenta development|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0001723,disorganized yolk sac vascular plexus|MP:0001726,abnormal allantois morphology|MP:0001889,delayed brain development|MP:0003077,abnormal cell cycle|MP:0003229,abnormal vitelline vasculature morphology|MP:0003400,kinked neural tube|MP:0003720,abnormal neural tube closure|MP:0004076,abnormal vitelline vascular remodeling|MP:0005221,abnormal rostral-caudal axis patterning|MP:0006108,abnormal hindbrain development|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012090,midbrain hypoplasia|MP:0013169,small hindlimb buds
MGI:3619512	Ccng1<tm1Noj>	MP:0000511,abnormal intestinal mucosa morphology|MP:0001658,increased mortality induced by gamma-irradiation|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death
MGI:3619024	Ccng1<tm1Sst>	MP:0002053,decreased incidence of induced tumors|MP:0002658,abnormal liver regeneration|MP:0003402,decreased liver weight|MP:0010264,increased hepatoma incidence|MP:0010265,decreased hepatoma incidence
MGI:3693371	Ccni<tm1Jro>	MP:0002962,increased urine protein level|MP:0003606,kidney failure|MP:0005264,glomerulosclerosis|MP:0005553,increased circulating creatinine level|MP:0011282,increased podocyte apoptosis|MP:0011369,increased renal glomerulus apoptosis|MP:0011753,decreased podocyte number
MGI:6214844	Ccnj<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment
MGI:4348808	Ccnk<Gt(Q016B07)Wrst>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:6362812	Ccno<em1(IMPC)Mbp>	MP:0002135,abnormal kidney morphology|MP:0002989,small kidney
MGI:5792813	Ccno<tm1b(EUCOMM)Wtsi>	MP:0000432,abnormal head morphology|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0005387,immune system phenotype|MP:0006254,thin cerebral cortex|MP:0011100,preweaning lethality, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0031101,nasal obstruction
MGI:5708212	Ccnq<tm1.1(KOMP)Vlcg>	MP:0001552,increased circulating triglyceride level|MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6342504	Ccnt1<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0001289,persistence of hyaloid vascular system|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005567,decreased circulating total protein level
MGI:4330764	Ccnt1<Gt(RRR115)Byg>	MP:0001844,autoimmune response|MP:0001870,salivary gland inflammation|MP:0003763,abnormal thymus physiology|MP:0005387,immune system phenotype|MP:0008880,lacrimal gland inflammation
MGI:3849580	Ccnt2<Gt(W048F02)Wrst>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5637066	Ccnt2<tm1b(EUCOMM)Wtsi>	MP:0001491,unresponsive to tactile stimuli|MP:0001925,male infertility|MP:0001926,female infertility|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration|MP:0011965,decreased total retina thickness
MGI:4432945	Ccnyl1<tm1a(EUCOMM)Wtsi>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0009833,absent sperm mitochondrial sheath|MP:0009834,abnormal sperm annulus morphology|MP:0020451,decreased sperm progressive motility
MGI:5688373	Ccny<tm1.1Smoc>	MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0003960,increased lean body mass|MP:0004889,increased energy expenditure|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005334,abnormal fat pad morphology|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0008963,increased carbon dioxide production|MP:0009133,decreased white fat cell size|MP:0009293,decreased inguinal fat pad weight|MP:0009303,decreased renal fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0010378,increased respiratory quotient|MP:0011168,abnormal fat cell differentiation|MP:0011698,abnormal brown adipose tissue physiology
MGI:5816715	Ccp110<tm1.2Asw>	MP:0000111,cleft palate|MP:0000163,abnormal cartilage morphology|MP:0000266,abnormal heart morphology|MP:0000358,abnormal cell morphology|MP:0000562,polydactyly|MP:0000822,abnormal brain ventricle morphology|MP:0000925,abnormal floor plate morphology|MP:0001265,decreased body size|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0002151,abnormal neural tube morphology|MP:0002633,persistent truncus arteriosus|MP:0003052,omphalocele|MP:0003072,abnormal metatarsal bone morphology|MP:0003077,abnormal cell cycle|MP:0004024,aneuploidy|MP:0004025,polyploidy|MP:0004029,spontaneous chromosome breakage|MP:0004200,decreased fetal size|MP:0004672,short ribs|MP:0004734,small thoracic cavity|MP:0004760,increased mitotic index|MP:0005262,coloboma|MP:0005306,abnormal phalanx morphology|MP:0005508,abnormal skeleton morphology|MP:0009743,preaxial polydactyly|MP:0009760,abnormal mitotic spindle morphology|MP:0009882,absent palatal shelf|MP:0010082,sternebra fusion|MP:0010103,small thoracic cage|MP:0010152,abnormal brain ependyma morphology|MP:0010402,ventricular septal defect|MP:0011056,abnormal brain ependyma motile cilium morphology|MP:0011065,abnormal kidney epithelial cell primary cilium morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0013202,abnormal cilium morphology|MP:0013214,decreased embryonic neuroepithelium primary cilium number|MP:0020137,decreased bone mineralization|MP:0030320,abnormal temporal bone tympanic part morphology
MGI:5000356	Ccpg1<tm1a(EUCOMM)Hmgu>	MP:0001869,pancreas inflammation|MP:0001944,abnormal pancreas morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009147,abnormal pancreatic acinar cell physiology|MP:0009148,pancreas necrosis|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0010148,abnormal exocrine pancreas physiology|MP:0020354,increased endoplasmic reticulum stress|MP:0030938,abnormal reticulophagy
MGI:5588268	Ccpg1<tm1b(EUCOMM)Hmgu>	MP:0001944,abnormal pancreas morphology|MP:0008259,abnormal optic disk morphology|MP:0008806,increased circulating amylase level|MP:0011886,increased circulating lipase level
MGI:2384080	Ccr10/Cntnap1<tm1Bhat>	MP:0000160,kyphosis|MP:0000743,muscle spasm|MP:0000745,tremors|MP:0000746,weakness|MP:0000754,paresis|MP:0000877,abnormal Purkinje cell morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0002083,premature death|MP:0003871,abnormal myelin sheath morphology|MP:0005402,abnormal action potential|MP:0005403,abnormal nerve conduction|MP:0005404,abnormal axon morphology|MP:0008814,decreased nerve conduction velocity|MP:0010050,hypermyelination|MP:0011084,lethality at weaning, incomplete penetrance|MP:0013438,dysmyelination|MP:0014185,cerebellum atrophy|MP:0014329,abnormal Purkinje cell axon morphology|MP:0014587,impaired fine motor coordination
MGI:3822136	Ccr10/Cntnap1<tm1Bhat>	MP:0000160,kyphosis|MP:0000743,muscle spasm|MP:0000745,tremors|MP:0000746,weakness|MP:0000754,paresis|MP:0000877,abnormal Purkinje cell morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0002083,premature death|MP:0003871,abnormal myelin sheath morphology|MP:0005402,abnormal action potential|MP:0005403,abnormal nerve conduction|MP:0005404,abnormal axon morphology|MP:0008814,decreased nerve conduction velocity|MP:0010050,hypermyelination|MP:0011084,lethality at weaning, incomplete penetrance|MP:0013438,dysmyelination|MP:0014329,abnormal Purkinje cell axon morphology|MP:0014587,impaired fine motor coordination
MGI:4837004	Ccr10<tm1.1Nax>	MP:0008351,decreased gamma-delta intraepithelial T cell number
MGI:3036706	Ccr10<tm1Cge>	MP:0001807,decreased IgA level|MP:0002169,no abnormal phenotype detected|MP:0002439,abnormal plasma cell morphology|MP:0003156,abnormal leukocyte migration|MP:0004047,abnormal milk composition
MGI:6714045	Ccr1l1<em1Semp>	MP:0005387,immune system phenotype
MGI:6714048	Ccr1l1<em2Semp>	MP:0005387,immune system phenotype
MGI:3604539	Ccr1l1<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:1931849	Ccr1<tm1Cge>	MP:0001861,lung inflammation|MP:0002335,decreased airway responsiveness|MP:0002411,decreased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002743,glomerulonephritis|MP:0002962,increased urine protein level|MP:0004751,increased length of allograft survival|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005387,immune system phenotype|MP:0005565,increased blood urea nitrogen level|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008500,increased IgG2a level|MP:0008560,increased tumor necrosis factor secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0008661,decreased interleukin-10 secretion|MP:0008663,increased interleukin-12 secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008719,impaired neutrophil recruitment|MP:0008722,abnormal chemokine secretion|MP:0009481,cecum inflammation|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0010209,abnormal circulating chemokine level|MP:0011076,increased macrophage nitric oxide production|MP:0011506,glomerular crescent|MP:0020914,decreased susceptibility to Riboviria infection
MGI:1931850	Ccr1<tm1Gao>	MP:0000336,decreased mast cell number|MP:0000343,abnormal response to cardiac infarction|MP:0001606,impaired hematopoiesis|MP:0002463,abnormal neutrophil physiology|MP:0002500,granulomatous inflammation|MP:0003628,abnormal leukocyte adhesion|MP:0005027,increased susceptibility to parasitic infection|MP:0005387,immune system phenotype|MP:0005399,increased susceptibility to fungal infection|MP:0005614,decreased susceptibility to type III hypersensitivity reaction|MP:0008114,abnormal Kupffer cell morphology|MP:0009858,abnormal cellular extravasation|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality|MP:0031054,bronchiolitis
MGI:6278509	Ccr2<em1(IMPC)H>	MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000274,enlarged heart|MP:0001406,abnormal gait|MP:0003921,abnormal heart left ventricle morphology|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005599,increased cardiac muscle contractility
MGI:5552734	Ccr2<tm1.1(CCR2)Rodb>	MP:0002078,abnormal glucose homeostasis|MP:0002446,abnormal macrophage morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005387,immune system phenotype|MP:0006315,abnormal urine protein level|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:5660875	Ccr2<tm1.1Dnc>	MP:0008126,increased dendritic cell number|MP:0010740,abnormal dendritic cell chemotaxis|MP:0013648,increased CD11b-high dendritic cell number|MP:0013649,decreased CD11b-high dendritic cell number
MGI:5444250	Ccr2<tm1.1Mpa>	MP:0000223,decreased monocyte cell number|MP:0003884,decreased macrophage cell number|MP:0005023,abnormal wound healing
MGI:3613374	Ccr2<tm1Blck>	MP:0000343,abnormal response to cardiac infarction|MP:0003628,abnormal leukocyte adhesion|MP:0009858,abnormal cellular extravasation
MGI:3664108	Ccr2<tm1Brv>	MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001655,multifocal hepatic necrosis|MP:0001860,liver inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0003799,impaired macrophage chemotaxis|MP:0005011,increased eosinophil cell number
MGI:2158213	Ccr2<tm1Ifc>	MP:0000130,abnormal trabecular bone morphology|MP:0001541,abnormal osteoclast physiology|MP:0001654,hepatic necrosis|MP:0001876,decreased inflammatory response|MP:0002118,abnormal lipid homeostasis|MP:0002335,decreased airway responsiveness|MP:0002442,abnormal leukocyte physiology|MP:0002620,abnormal monocyte morphology|MP:0002723,abnormal immune serum protein physiology|MP:0002941,increased circulating alanine transaminase level|MP:0003156,abnormal leukocyte migration|MP:0003447,decreased tumor growth/size|MP:0003691,abnormal microglial cell physiology|MP:0003799,impaired macrophage chemotaxis|MP:0003887,increased hepatocyte apoptosis|MP:0003888,liver hemorrhage|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004883,abnormal vascular wound healing|MP:0004983,abnormal osteoclast cell number|MP:0004985,decreased osteoclast cell number|MP:0005087,decreased acute inflammation|MP:0005095,decreased T cell proliferation|MP:0005278,abnormal cholesterol homeostasis|MP:0005362,abnormal Langerhans cell physiology|MP:0005387,immune system phenotype|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0008396,abnormal osteoclast differentiation|MP:0008539,decreased susceptibility to induced colitis|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008813,decreased common myeloid progenitor cell number|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009335,decreased splenocyte proliferation|MP:0009347,increased trabecular bone thickness|MP:0009878,decreased susceptibility to bone fracture|MP:0010119,abnormal bone mineral density|MP:0010760,abnormal macrophage chemotaxis|MP:0010867,abnormal bone trabecula morphology|MP:0010878,increased trabecular bone volume|MP:0020332,impaired leukocyte tethering or rolling|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:2158345	Ccr2<tm1Mae>	MP:0000222,decreased neutrophil cell number|MP:0001263,weight loss|MP:0001876,decreased inflammatory response|MP:0002442,abnormal leukocyte physiology|MP:0002493,increased IgG level|MP:0002570,alcohol aversion|MP:0002805,abnormal conditioned taste aversion behavior|MP:0002942,decreased circulating alanine transaminase level|MP:0003009,abnormal cytokine secretion|MP:0003156,abnormal leukocyte migration|MP:0003545,increased alcohol consumption|MP:0003546,decreased alcohol consumption|MP:0003799,impaired macrophage chemotaxis|MP:0003884,decreased macrophage cell number|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0005014,increased B cell number|MP:0005036,diarrhea|MP:0005098,abnormal optic choroid morphology|MP:0005166,decreased susceptibility to injury|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology|MP:0005546,choroidal neovascularization|MP:0005554,decreased circulating creatinine level|MP:0006187,retina deposits|MP:0006238,abnormal choriocapillaris morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008450,retina photoreceptor degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0008537,increased susceptibility to induced colitis|MP:0008722,abnormal chemokine secretion|MP:0008842,lipofuscinosis|MP:0011941,increased fluid intake|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031054,bronchiolitis|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:5444249	Ccr2<tm1Mpa>	MP:0003884,decreased macrophage cell number|MP:0005023,abnormal wound healing
MGI:6399890	Ccr3<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001312,abnormal cornea morphology
MGI:2448180	Ccr3<tm1Cge>	MP:0000223,decreased monocyte cell number|MP:0001952,increased airway responsiveness|MP:0002133,abnormal respiratory system physiology|MP:0002334,abnormal airway responsiveness|MP:0002423,abnormal mast cell physiology|MP:0002465,abnormal eosinophil physiology|MP:0002602,abnormal eosinophil cell number|MP:0005011,increased eosinophil cell number|MP:0005012,decreased eosinophil cell number|MP:0005397,hematopoietic system phenotype|MP:0008603,decreased circulating interleukin-4 level|MP:0008723,impaired eosinophil recruitment|MP:0008724,impaired eosinophil chemotaxis|MP:0008764,increased mast cell degranulation|MP:0009676,abnormal hemostasis
MGI:2136258	Ccr4<tm1Pwr>	MP:0000219,increased neutrophil cell number|MP:0002492,decreased IgE level|MP:0002497,increased IgE level|MP:0003009,abnormal cytokine secretion|MP:0003884,decreased macrophage cell number|MP:0004751,increased length of allograft survival|MP:0005012,decreased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005387,immune system phenotype|MP:0005398,decreased susceptibility to fungal infection|MP:0005425,increased macrophage cell number|MP:0008039,increased NK T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008499,increased IgG1 level|MP:0008560,increased tumor necrosis factor secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008660,increased interleukin-10 secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0008722,abnormal chemokine secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009333,abnormal splenocyte physiology|MP:0010935,increased airway resistance|MP:0010936,decreased airway resistance
MGI:3613371	Ccr5<tm1Blck>	MP:0000343,abnormal response to cardiac infarction|MP:0003628,abnormal leukocyte adhesion|MP:0004751,increased length of allograft survival|MP:0009858,abnormal cellular extravasation
MGI:2429994	Ccr5<tm1Brv>	MP:0002412,increased susceptibility to bacterial infection|MP:0003009,abnormal cytokine secretion|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008499,increased IgG1 level|MP:0008566,increased interferon-gamma secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008699,increased interleukin-4 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:5774771	Ccr5<tm1(CCR5)Pfi>	MP:0005385,cardiovascular system phenotype|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:1861911	Ccr5<tm1Kuz>	MP:0001273,decreased metastatic potential|MP:0001392,abnormal locomotor behavior|MP:0001463,abnormal spatial learning|MP:0001544,abnormal cardiovascular system physiology|MP:0001876,decreased inflammatory response|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002805,abnormal conditioned taste aversion behavior|MP:0003326,liver failure|MP:0003545,increased alcohol consumption|MP:0003631,nervous system phenotype|MP:0003633,abnormal nervous system physiology|MP:0003690,abnormal glial cell physiology|MP:0003799,impaired macrophage chemotaxis|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005166,decreased susceptibility to injury|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005399,increased susceptibility to fungal infection|MP:0005406,abnormal heart size|MP:0005542,cornea vascularization|MP:0008039,increased NK T cell number|MP:0008042,abnormal NK T cell physiology|MP:0008045,decreased NK cell number|MP:0008114,abnormal Kupffer cell morphology|MP:0008432,abnormal long-term spatial reference memory|MP:0008539,decreased susceptibility to induced colitis|MP:0008713,abnormal cytokine level|MP:0008916,abnormal astrocyte physiology|MP:0008990,abnormal Ito cell morphology|MP:0010080,abnormal hepatocyte physiology|MP:0010399,decreased skeletal muscle glycogen level|MP:0010759,decreased right ventricle systolic pressure|MP:0010768,mortality/aging|MP:0011941,increased fluid intake|MP:0012106,impaired exercise endurance|MP:0020449,decreased microglial cell activation|MP:0020935,decreased susceptibility to Retroviridae infection|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031054,bronchiolitis
MGI:3522335	Ccr5<tm1Sush>	MP:0002442,abnormal leukocyte physiology|MP:0005095,decreased T cell proliferation
MGI:4359772	Ccr6<tm1.1Jmf>	MP:0001876,decreased inflammatory response|MP:0002376,abnormal dendritic cell physiology|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008568,abnormal interleukin secretion
MGI:5696887	Ccr6<tm1.1(KOMP)Vlcg>	MP:0000689,abnormal spleen morphology|MP:0001399,hyperactivity|MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval
MGI:3604541	Ccr6<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:2179543	Ccr6<tm1(EGFP)Irw>	MP:0000696,abnormal Peyer's patch morphology|MP:0002378,abnormal gut-associated lymphoid tissue morphology|MP:0002411,decreased susceptibility to bacterial infection|MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0005017,decreased B cell number|MP:0005348,increased T cell proliferation|MP:0008133,decreased Peyer's patch number|MP:0008197,abnormal follicular dendritic cell physiology|MP:0008399,abnormal alpha-beta intraepithelial T cell morphology|MP:0008400,abnormal CD4-positive, alpha-beta intraepithelial T cell morphology|MP:0008401,abnormal CD8 positive, alpha-beta intraepithelial T cell morphology|MP:0008561,decreased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0014472,impaired B cell migration
MGI:2179613	Ccr6<tm1Gma>	MP:0000218,increased leukocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000696,abnormal Peyer's patch morphology|MP:0001876,decreased inflammatory response|MP:0002389,abnormal Peyer's patch follicle morphology|MP:0002435,abnormal effector T cell morphology|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0006173,abnormal myeloid dendritic cell morphology
MGI:2179552	Ccr6<tm1Lira>	MP:0000696,abnormal Peyer's patch morphology|MP:0000820,abnormal choroid plexus morphology|MP:0001807,decreased IgA level|MP:0001829,increased activated T cell number|MP:0001876,decreased inflammatory response|MP:0002378,abnormal gut-associated lymphoid tissue morphology|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002392,abnormal Peyer's patch T cell area morphology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002444,abnormal T cell physiology|MP:0002451,abnormal macrophage physiology|MP:0002492,decreased IgE level|MP:0002494,increased IgM level|MP:0002619,abnormal lymphocyte morphology|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004977,increased B-1 B cell number|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005091,increased double-positive T cell number|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0006173,abnormal myeloid dendritic cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008198,abnormal follicular dendritic cell antigen presentation|MP:0008244,abnormal peritoneal macrophage morphology|MP:0008498,decreased IgG3 level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0008723,impaired eosinophil recruitment|MP:0008895,abnormal intraepithelial T cell number|MP:0011077,decreased macrophage nitric oxide production|MP:0011079,decreased macrophage cytokine production|MP:0020913,increased susceptibility to Riboviria infection
MGI:4458322	Ccr7<Gt(hpk)Byg>	MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype
MGI:5640785	Ccr7<m1Btlr>	MP:0003884,decreased macrophage cell number|MP:0008082,increased single-positive T cell number
MGI:3604543	Ccr7<tm1Dgen>	MP:0002499,chronic inflammation
MGI:2180679	Ccr7<tm1Rfor>	MP:0000691,enlarged spleen|MP:0001346,abnormal lacrimal gland morphology|MP:0001800,abnormal humoral immune response|MP:0001846,increased inflammatory response|MP:0001870,salivary gland inflammation|MP:0002217,small lymph nodes|MP:0002343,abnormal lymph node cortex morphology|MP:0002347,abnormal lymph node T cell domain morphology|MP:0002356,abnormal spleen red pulp morphology|MP:0002358,abnormal spleen periarteriolar lymphoid sheath morphology|MP:0002363,abnormal spleen marginal sinus morphology|MP:0002371,abnormal thymus cortex morphology|MP:0002376,abnormal dendritic cell physiology|MP:0002392,abnormal Peyer's patch T cell area morphology|MP:0002411,decreased susceptibility to bacterial infection|MP:0002444,abnormal T cell physiology|MP:0002497,increased IgE level|MP:0003156,abnormal leukocyte migration|MP:0003452,abnormal parotid gland morphology|MP:0003793,abnormal submandibular gland morphology|MP:0004816,abnormal class switch recombination|MP:0005015,increased T cell number|MP:0005018,decreased T cell number|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005387,immune system phenotype|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008127,decreased dendritic cell number|MP:0008135,small Peyer's patches|MP:0008217,abnormal B cell activation|MP:0008498,decreased IgG3 level|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008522,abnormal lymph node germinal center morphology|MP:0008872,abnormal physiological response to xenobiotic|MP:0008879,submandibular gland inflammation|MP:0008880,lacrimal gland inflammation|MP:0010740,abnormal dendritic cell chemotaxis|MP:0013367,parotid gland inflammation|MP:0013558,abnormal exocrine gland morphology|MP:0013588,small thymus medulla|MP:0013649,decreased CD11b-high dendritic cell number|MP:0013655,decreased CD103-positive CD11b-low dendritic cell number|MP:0014472,impaired B cell migration
MGI:6277049	Ccr8<em1(IMPC)Mbp>	MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002092,abnormal eye morphology|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:2450726	Ccr8<tm1Gma>	MP:0002169,no abnormal phenotype detected
MGI:2447888	Ccr8<tm1Lira>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis
MGI:2447885	Ccr8<tm1Vnk>	MP:0002169,no abnormal phenotype detected
MGI:6717154	Ccr9<em1(IMPC)H>	MP:0005293,impaired glucose tolerance
MGI:2181004	Ccr9<tm1.1Mal>	MP:0000217,abnormal leukocyte cell number|MP:0002145,abnormal T cell differentiation|MP:0003944,abnormal T cell subpopulation ratio|MP:0005015,increased T cell number|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0005232,abnormal mesenteric lymph node morphology|MP:0008208,decreased pro-B cell number|MP:0008345,abnormal gamma-delta T cell number|MP:0008351,decreased gamma-delta intraepithelial T cell number
MGI:3521585	Ccr9<tm1Ccb>	MP:0000715,decreased thymocyte number|MP:0002145,abnormal T cell differentiation
MGI:5009291	Ccr9<tm1Dgen>	MP:0001405,impaired coordination
MGI:3654108	Ccr9<tm1Lov>	MP:0005016,decreased lymphocyte cell number|MP:0008346,increased gamma-delta T cell number|MP:0008349,abnormal gamma-delta intraepithelial T cell morphology|MP:0008363,decreased CD8-positive, gamma-delta intraepithelial T cell number
MGI:3604544	Ccrl2<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3812407	Ccrl2<tm1Lex>	MP:0005597,decreased susceptibility to type I hypersensitivity reaction
MGI:4839219	Ccrl2<tm1Ssoz>	MP:0002148,abnormal hypersensitivity reaction|MP:0005466,abnormal T-helper 2 physiology|MP:0008101,lymph node hypoplasia|MP:0008673,decreased interleukin-13 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0010740,abnormal dendritic cell chemotaxis
MGI:2153934	Ccrs1<C57BL/6By>	MP:0000780,abnormal corpus callosum morphology
MGI:2155837	Ccrs2<NZB/BlNJ>	MP:0000780,abnormal corpus callosum morphology
MGI:3828828	Ccrs3<BTBR T-+- Itpr3-tf/J>	MP:0002196,absent corpus callosum
MGI:3828830	Ccrs4<BTBR T-+- Itpr3-tf/J>	MP:0002196,absent corpus callosum
MGI:3618099	Ccs1<C57BL/6Ha>	MP:0002052,decreased tumor incidence
MGI:3618098	Ccs1<ICR/Ha>	MP:0002020,increased tumor incidence
MGI:6220921	Ccsap<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0009142,decreased prepulse inhibition
MGI:7481241	Ccser2<em1Skpk>	MP:0000788,abnormal cerebral cortex morphology|MP:0006009,abnormal neuronal migration|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2446505	Ccs<tm1Pcw>	MP:0001131,abnormal ovarian follicle morphology|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002680,decreased corpora lutea number|MP:0002682,decreased mature ovarian follicle number|MP:0003951,abnormal copper homeostasis|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008412,increased cellular sensitivity to oxidative stress
MGI:7782498	Cct2<em1Tiwata>	MP:0005391,vision/eye phenotype|MP:0011091,prenatal lethality, complete penetrance
MGI:7782499	Cct2<em2Tiwata>	MP:0008450,retina photoreceptor degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0012029,abnormal electroretinogram waveform feature|MP:0012034,abnormal a-wave shape|MP:0014059,abnormal photoreceptor connecting cilium morphology
MGI:6369355	Cct3<em1(IMPC)Tcp>	MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0002599,increased mean platelet volume|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5286663	Cct3<Tg(Tyr)2423AOve>	MP:0006206,embryonic lethality between somite formation and embryo turning
MGI:6156448	Cct5<em1(IMPC)Tcp>	MP:0001120,abnormal uterus morphology|MP:0001325,abnormal retina morphology|MP:0001417,decreased exploration in new environment|MP:0001697,abnormal embryo size|MP:0002060,abnormal skin morphology|MP:0002110,abnormal digit morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6724571	Cct6b<em1Jsha>	MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0020451,decreased sperm progressive motility
MGI:7261404	Cct6b<em1Kher>	MP:0005389,reproductive system phenotype
MGI:6361161	Cct6b<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6367820	Cct7<em1(IMPC)J>	MP:0002757,decreased vertical activity|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6836735	Cct8<em1(IMPC)J>	MP:0001728,failure of embryo implantation|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:1861669	Ccw	MP:0001274,curly vibrissae|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5288503	Cd101<tm1.1Dil>	MP:0000334,decreased granulocyte number
MGI:5605817	Cd109<tm1.1(KOMP)Vlcg>	MP:0001284,absent vibrissae|MP:0006203,eye hemorrhage
MGI:5443927	Cd109<tm1Mat>	MP:0000416,sparse hair|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0002073,abnormal hair growth|MP:0003809,abnormal hair shaft morphology|MP:0004947,skin inflammation|MP:0009612,thick epidermis suprabasal layer|MP:0009715,thick epidermis stratum basale|MP:0009794,sebaceous gland hyperplasia|MP:0010678,abnormal skin adnexa morphology|MP:0010682,abnormal hair follicle infundibulum morphology|MP:0010699,dilated hair follicle
MGI:3581425	Cd14<hdl>	MP:0008555,abnormal interferon secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0020913,increased susceptibility to Riboviria infection
MGI:1934009	Cd14<tm1Frm>	MP:0000062,increased bone mineral density|MP:0003009,abnormal cytokine secretion|MP:0003828,pulmonary edema|MP:0003960,increased lean body mass|MP:0005605,increased bone mass|MP:0008555,abnormal interferon secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008713,abnormal cytokine level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0009878,decreased susceptibility to bone fracture|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0020913,increased susceptibility to Riboviria infection
MGI:1857977	Cd14<tm1Smg>	MP:0002411,decreased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008597,decreased circulating interleukin-6 level|MP:0008706,decreased interleukin-6 secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008752,abnormal tumor necrosis factor level|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:3050539	Cd151<tm1Lka>	MP:0000172,abnormal bone marrow cell number|MP:0001785,edema|MP:0002083,premature death|MP:0002705,dilated renal tubule|MP:0002962,increased urine protein level|MP:0003068,enlarged kidney|MP:0003606,kidney failure|MP:0005094,abnormal T cell proliferation|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005367,renal/urinary system phenotype|MP:0005606,increased bleeding time|MP:0008140,podocyte foot process effacement|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011353,expanded mesangial matrix|MP:0011402,renal cast|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011483,renal glomerular synechia|MP:0011534,granular kidney|MP:0011753,decreased podocyte number|MP:0012194,decreased keratinocyte migration
MGI:3819817	Cd151<tm1Mhe>	MP:0002053,decreased incidence of induced tumors|MP:0003544,abnormal vascular endothelial cell migration|MP:0004003,abnormal vascular endothelial cell physiology|MP:0005385,cardiovascular system phenotype|MP:0005602,decreased angiogenesis
MGI:3691076	Cd151<tm1Nki>	MP:0001263,weight loss|MP:0002135,abnormal kidney morphology|MP:0002828,abnormal renal glomerular capsule morphology|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004970,kidney atrophy|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0008061,absent podocyte slit diaphragm|MP:0008138,absent podocyte foot process|MP:0008140,podocyte foot process effacement|MP:0009050,dilated proximal convoluted tubule|MP:0009641,kidney degeneration|MP:0010771,integument phenotype|MP:0011320,abnormal glomerular capillary morphology|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011353,expanded mesangial matrix|MP:0011402,renal cast|MP:0011405,tubulointerstitial nephritis|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011427,increased mesangial cell number|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011454,abnormal glomerular endothelium fenestra morphology|MP:0011483,renal glomerular synechia|MP:0011506,glomerular crescent|MP:0011534,granular kidney
MGI:4950443	Cd151<tm2Nki>	MP:0000377,abnormal hair follicle morphology|MP:0001218,thin epidermis|MP:0003447,decreased tumor growth/size|MP:0004502,decreased incidence of tumors by chemical induction|MP:0009584,decreased keratinocyte proliferation|MP:0012193,increased keratinocyte migration|MP:0014754,abnormal tumor progression
MGI:6438194	Cd160<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:5698520	Cd160<tm1Yxf>	MP:0003721,increased tumor growth/size|MP:0008567,decreased interferon-gamma secretion
MGI:3799792	Cd163<tm1(KOMP)Vlcg>	MP:0001861,lung inflammation|MP:0002281,abnormal respiratory mucosa goblet cell morphology|MP:0003060,increased aerobic running capacity|MP:0003082,abnormal gastrocnemius morphology|MP:0009410,abnormal skeletal muscle satellite cell proliferation|MP:0010098,abnormal retina blood vessel pattern|MP:0010210,abnormal circulating cytokine level|MP:0010760,abnormal macrophage chemotaxis|MP:0010957,abnormal aerobic respiration|MP:0031318,enhanced skeletal muscle regeneration
MGI:4415421	Cd177<tm1(KOMP)Vlcg>	MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0002463,abnormal neutrophil physiology|MP:0005387,immune system phenotype
MGI:3581654	Cd180<tm1Kmiy>	MP:0001800,abnormal humoral immune response|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:6324165	Cd19<em2(IMPC)Ics>	MP:0000220,increased monocyte cell number|MP:0005016,decreased lymphocyte cell number
MGI:5521189	Cd19<tm1.1Oao>	MP:0002169,no abnormal phenotype detected
MGI:1931143	Cd19<tm1(cre)Cgn>	MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0002459,abnormal B cell physiology|MP:0002490,abnormal immunoglobulin level|MP:0002492,decreased IgE level|MP:0004978,decreased B-1 B cell number|MP:0008474,absent spleen germinal center|MP:0008495,decreased IgG1 level
MGI:2180685	Cd19<tm1Tft>	MP:0000222,decreased neutrophil cell number|MP:0000921,demyelination|MP:0001245,thick dermal layer|MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002459,abnormal B cell physiology|MP:0004795,decreased anti-nuclear antigen antibody level|MP:0004798,decreased anti-double stranded DNA antibody level|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0005165,increased susceptibility to injury|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0008594,decreased circulating interleukin-10 level|MP:0008597,decreased circulating interleukin-6 level|MP:0008603,decreased circulating interleukin-4 level|MP:0008661,decreased interleukin-10 secretion|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009932,skin fibrosis
MGI:7425567	Cd1d1<em1(IMPC)H>	MP:0002606,increased basophil cell number|MP:0008806,increased circulating amylase level|MP:0010068,decreased red blood cell distribution width
MGI:5056283	Cd1d1<tm1.1Aben>	MP:0005387,immune system phenotype|MP:0008040,decreased NK T cell number|MP:0008567,decreased interferon-gamma secretion|MP:0008700,decreased interleukin-4 secretion
MGI:4355877	Cd1d1<tm1.1Boes>	MP:0002455,abnormal dendritic cell antigen presentation|MP:0008036,abnormal NK T cell morphology|MP:0008040,decreased NK T cell number|MP:0008042,abnormal NK T cell physiology|MP:0008688,decreased interleukin-2 secretion|MP:0008698,abnormal interleukin-4 secretion
MGI:5085993	Cd1d1<tm1.2Aben>	MP:0001828,abnormal T cell activation|MP:0001861,lung inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0003076,increased susceptibility to ischemic brain injury|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:2180713	Cd1d1<tm1Crw>	MP:0001805,decreased IgG level|MP:0003436,decreased susceptibility to induced arthritis|MP:0008040,decreased NK T cell number
MGI:2180711	Cd1d1<tm1Luc>	MP:0000598,abnormal liver morphology|MP:0001825,arrested T cell differentiation|MP:0001844,autoimmune response|MP:0001859,kidney inflammation|MP:0002743,glomerulonephritis|MP:0002962,increased urine protein level|MP:0003215,renal interstitial fibrosis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004974,decreased regulatory T cell number|MP:0005087,decreased acute inflammation|MP:0005264,glomerulosclerosis|MP:0005565,increased blood urea nitrogen level|MP:0008040,decreased NK T cell number|MP:0008502,increased IgG3 level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0011346,renal tubule atrophy|MP:0011506,glomerular crescent
MGI:5056289	Cd1d1<tm2Aben>	MP:0001835,abnormal antigen presentation|MP:0008040,decreased NK T cell number
MGI:1857482	Cd1<tm1Gru>	MP:0001273,decreased metastatic potential|MP:0001856,myocarditis|MP:0002334,abnormal airway responsiveness|MP:0002602,abnormal eosinophil cell number|MP:0003434,decreased susceptibility to induced choroidal neovascularization|MP:0005387,immune system phenotype|MP:0008041,absent NK T cells|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008700,decreased interleukin-4 secretion|MP:0009786,decreased susceptibility to infection induced morbidity/mortality
MGI:7334726	Cd200l2<tm1.1Hkar>	MP:0002736,abnormal nociception after inflammation|MP:0020954,decreased mechanical nociceptive threshold
MGI:3790100	Cd200r1<tm1.1Rmgo>	MP:0002376,abnormal dendritic cell physiology|MP:0002452,abnormal professional antigen presenting cell physiology|MP:0005671,abnormal response to transplant|MP:0008560,increased tumor necrosis factor secretion|MP:0008669,increased interleukin-12b secretion
MGI:5472130	Cd200r1<tm1Eakj>	MP:0002451,abnormal macrophage physiology|MP:0002736,abnormal nociception after inflammation|MP:0008565,decreased interferon-beta secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008706,decreased interleukin-6 secretion|MP:0020917,decreased susceptibility to Herpesvirales infection|MP:0020954,decreased mechanical nociceptive threshold|MP:0031025,decreased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:5692856	Cd200r4<tm1.1(KOMP)Wtsi>	MP:0002135,abnormal kidney morphology
MGI:4362965	Cd200<tm1a(KOMP)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0010052,increased grip strength
MGI:2429651	Cd200<tm1Jods>	MP:0000136,abnormal microglial cell morphology|MP:0000702,enlarged lymph nodes|MP:0001790,abnormal immune system physiology|MP:0002339,abnormal lymph node morphology|MP:0002451,abnormal macrophage physiology|MP:0002722,abnormal immune system organ morphology|MP:0003691,abnormal microglial cell physiology|MP:0003724,increased susceptibility to induced arthritis|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004821,increased susceptibility to experimental autoimmune uveoretinitis|MP:0005386,behavior/neurological phenotype|MP:0005425,increased macrophage cell number|MP:0006042,increased apoptosis|MP:0008476,increased spleen red pulp amount|MP:0008713,abnormal cytokine level
MGI:5052167	Cd207<tm1.1Cfg>	MP:0000696,abnormal Peyer's patch morphology|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008498,decreased IgG3 level
MGI:3800754	Cd207<tm1(Hbegf/EGFP)Bjec>	MP:0002534,abnormal type IV hypersensitivity reaction|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008118,absent Langerhans cell|MP:0008127,decreased dendritic cell number|MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:3526083	Cd207<tm1Mal>	MP:0008117,abnormal Langerhans cell morphology
MGI:5308064	Cd207<tm2.1(cre)Bjec>	MP:0005387,immune system phenotype
MGI:5052165	Cd209a<tm1.1Cfg>	MP:0000220,increased monocyte cell number|MP:0001846,increased inflammatory response|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005013,increased lymphocyte cell number|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0005566,decreased blood urea nitrogen level|MP:0008097,increased plasma cell number|MP:0008210,increased mature B cell number|MP:0008483,increased spleen germinal center size|MP:0008497,decreased IgG2b level|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:4366040	Cd209a<tm1Olne>	MP:0005387,immune system phenotype
MGI:5052161	Cd209b<tm1.1Cfg>	MP:0001798,impaired macrophage phagocytosis|MP:0002412,increased susceptibility to bacterial infection|MP:0002494,increased IgM level|MP:0005011,increased eosinophil cell number|MP:0005387,immune system phenotype|MP:0005425,increased macrophage cell number|MP:0005635,decreased circulating bilirubin level|MP:0008211,decreased mature B cell number|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level|MP:0009646,urinary bladder inflammation|MP:0011339,abnormal glomerular mesangium morphology
MGI:3522018	Cd209b<tm1Anjm>	MP:0001798,impaired macrophage phagocytosis|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0005387,immune system phenotype|MP:0008539,decreased susceptibility to induced colitis|MP:0008658,decreased interleukin-1 beta secretion|MP:0008685,decreased interleukin-18 secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:7425568	Cd209c<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002059,abnormal seminal vesicle morphology
MGI:5052162	Cd209d<tm1.1Cfg>	MP:0002412,increased susceptibility to bacterial infection|MP:0005014,increased B cell number|MP:0005154,increased B cell proliferation|MP:0008553,increased circulating tumor necrosis factor level|MP:0009115,abnormal fat cell morphology
MGI:6120780	Cd209e<tm1b(KOMP)Wtsi>	MP:0002965,increased circulating serum albumin level
MGI:4454325	Cd226<tm1.1Cln>	MP:0001272,increased metastatic potential|MP:0001876,decreased inflammatory response|MP:0002166,abnormal tumor susceptibility|MP:0003721,increased tumor growth/size|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005095,decreased T cell proliferation
MGI:4838287	Cd226<tm1Shib>	MP:0001790,abnormal immune system physiology|MP:0002021,increased incidence of induced tumors|MP:0004499,increased incidence of tumors by chemical induction|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5009050	Cd22<m1Anu>	MP:0001802,arrested B cell differentiation|MP:0005017,decreased B cell number
MGI:5009700	Cd22<m1Btlr>	MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0005387,immune system phenotype
MGI:5607164	Cd22<m2Btlr>	MP:0002144,abnormal B cell differentiation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology
MGI:5632158	Cd22<m3Btlr>	MP:0005017,decreased B cell number|MP:0008167,increased B-1a cell number
MGI:5688497	Cd22<m4Btlr>	MP:0005017,decreased B cell number|MP:0008167,increased B-1a cell number|MP:0008207,decreased B-2 B cell number|MP:0008729,decreased memory B cell number
MGI:6113421	Cd22<m5Btlr>	MP:0005017,decreased B cell number|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010838,increased CD8-positive, alpha-beta memory T cell number
MGI:5446371	Cd22<tm1.1(CD22)Lnit>	MP:0002459,abnormal B cell physiology|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0008182,decreased marginal zone B cell number|MP:0009923,decreased transitional stage T1 B cell number|MP:0009926,decreased transitional stage T2 B cell number|MP:0014469,abnormal B cell calcium ion homeostasis|MP:0014472,impaired B cell migration
MGI:5696933	Cd22<tm1b(EUCOMM)Wtsi>	MP:0000220,increased monocyte cell number|MP:0001488,increased startle reflex|MP:0005178,increased circulating cholesterol level
MGI:2180680	Cd22<tm1Eac>	MP:0001806,decreased IgM level|MP:0005153,abnormal B cell proliferation|MP:0008171,abnormal mature B cell morphology|MP:0008182,decreased marginal zone B cell number|MP:0008188,abnormal transitional stage B cell morphology|MP:0008211,decreased mature B cell number|MP:0008217,abnormal B cell activation|MP:0008495,decreased IgG1 level|MP:0008498,decreased IgG3 level|MP:0008729,decreased memory B cell number|MP:0008782,increased B cell apoptosis
MGI:2180698	Cd22<tm1Lam>	MP:0008182,decreased marginal zone B cell number|MP:0008211,decreased mature B cell number|MP:0008217,abnormal B cell activation
MGI:5526055	Cd22<tm1Lnit>	MP:0005387,immune system phenotype|MP:0008182,decreased marginal zone B cell number
MGI:2180701	Cd22<tm1Msn>	MP:0001790,abnormal immune system physiology|MP:0002083,premature death|MP:0002490,abnormal immunoglobulin level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004977,increased B-1 B cell number|MP:0008171,abnormal mature B cell morphology|MP:0008217,abnormal B cell activation|MP:0008500,increased IgG2a level|MP:0014469,abnormal B cell calcium ion homeostasis
MGI:2180700	Cd22<tm1Tft>	MP:0005017,decreased B cell number|MP:0005154,increased B cell proliferation|MP:0008182,decreased marginal zone B cell number|MP:0008211,decreased mature B cell number
MGI:5526056	Cd22<tm2Lnit>	MP:0001844,autoimmune response|MP:0005387,immune system phenotype|MP:0008182,decreased marginal zone B cell number|MP:0008212,absent mature B cells
MGI:3054883	Cd22<tm2Tft>	MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0005154,increased B cell proliferation|MP:0008746,abnormal peripheral B cell anergy|MP:0010674,increased activation-induced B cell apoptosis
MGI:5526058	Cd22<tm3Lnit>	MP:0000685,abnormal immune system morphology|MP:0001790,abnormal immune system physiology|MP:0001844,autoimmune response|MP:0002459,abnormal B cell physiology|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0008182,decreased marginal zone B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008212,absent mature B cells|MP:0008499,increased IgG1 level|MP:0008782,increased B cell apoptosis|MP:0011805,decreased cell migration
MGI:3054888	Cd22<tm3Tft>	MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0005154,increased B cell proliferation
MGI:5491497	Cd244a<Chip>	MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0010766,abnormal NK cell physiology
MGI:3055564	Cd244a<tm1Kmle>	MP:0003080,increased natural killer cell mediated cytotoxicity|MP:0005070,impaired natural killer cell mediated cytotoxicity
MGI:5297360	Cd247<m1Btlr>	MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology
MGI:1857142	Cd247<tm1Lov>	MP:0000715,decreased thymocyte number|MP:0000904,abnormal superior colliculus morphology|MP:0001475,reduced long-term depression|MP:0001898,abnormal long-term depression|MP:0001899,absent long-term depression|MP:0002152,abnormal brain morphology|MP:0002206,abnormal CNS synaptic transmission|MP:0002433,abnormal T-helper 1 cell morphology|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003008,enhanced long-term potentiation|MP:0004165,abnormal lateral geniculate nucleus morphology|MP:0005092,decreased double-positive T cell number|MP:0005465,abnormal T-helper 1 physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008081,abnormal single-positive T cell number|MP:0008352,absent gamma-delta intraepithelial T cell|MP:0008535,enlarged lateral ventricles
MGI:2180466	Cd247<tm1Mal>	MP:0000715,decreased thymocyte number|MP:0002145,abnormal T cell differentiation|MP:0002407,abnormal double-negative T cell morphology|MP:0003850,abnormal thymocyte activation|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008037,abnormal T cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0008894,abnormal intraepithelial T cell morphology
MGI:2180467	Cd247<tm1Mhu>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0009335,decreased splenocyte proliferation|MP:0013588,small thymus medulla|MP:0013593,enlarged thymus cortex
MGI:2180484	Cd247<tm1Tks>	MP:0000715,decreased thymocyte number|MP:0003080,increased natural killer cell mediated cytotoxicity|MP:0005068,abnormal NK cell morphology|MP:0005092,decreased double-positive T cell number|MP:0005094,abnormal T cell proliferation|MP:0008040,decreased NK T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0008399,abnormal alpha-beta intraepithelial T cell morphology|MP:0008566,increased interferon-gamma secretion|MP:0010766,abnormal NK cell physiology|MP:0013588,small thymus medulla
MGI:5468025	Cd247<tm2.1Lov>	MP:0000715,decreased thymocyte number|MP:0002145,abnormal T cell differentiation|MP:0002444,abnormal T cell physiology|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004946,abnormal regulatory T cell physiology|MP:0004973,increased regulatory T cell number|MP:0005387,immune system phenotype|MP:0008036,abnormal NK T cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008356,abnormal gamma-delta T cell differentiation|MP:0009278,abnormal bone marrow cell physiology|MP:0009542,decreased thymocyte apoptosis
MGI:5468024	Cd247<tm2Lov>	MP:0002169,no abnormal phenotype detected
MGI:2446976	Cd247<tm2Tks>	MP:0011085,postnatal lethality, complete penetrance
MGI:4950376	Cd248<tm1.1Isyu>	MP:0002169,no abnormal phenotype detected
MGI:5569050	Cd248<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001258,decreased body length|MP:0002060,abnormal skin morphology|MP:0002079,increased circulating insulin level
MGI:3625491	Cd248<tm1Huso>	MP:0003447,decreased tumor growth/size|MP:0005387,immune system phenotype
MGI:2179996	Cd24a<tm1Pjln>	MP:0001935,decreased litter size|MP:0002144,abnormal B cell differentiation|MP:0004179,transmission ratio distortion|MP:0005027,increased susceptibility to parasitic infection|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008209,decreased pre-B cell number|MP:0008215,decreased immature B cell number|MP:0010035,increased erythrocyte clearance|MP:0014606,dark spleen|MP:0020455,increased erythrocyte aggregation|MP:0031063,increased erythrocyte sedimentation rate|MP:0031085,increased erythrocyte osmotic fragility
MGI:3762770	Cd274<tm1.1Lex>	MP:0003009,abnormal cytokine secretion|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:5562292	Cd274<tm1Igu>	MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3043876	Cd274<tm1Lpc>	MP:0001829,increased activated T cell number|MP:0002376,abnormal dendritic cell physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002738,hyperresponsive to tactile stimuli|MP:0003724,increased susceptibility to induced arthritis|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004946,abnormal regulatory T cell physiology|MP:0005015,increased T cell number|MP:0005165,increased susceptibility to injury|MP:0005348,increased T cell proliferation|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0006414,decreased T cell apoptosis|MP:0008037,abnormal T cell morphology|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008087,decreased T helper 1 cell number|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008098,decreased plasma cell number|MP:0008178,decreased germinal center B cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008499,increased IgG1 level|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008687,increased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008722,abnormal chemokine secretion|MP:0008896,increased IgG2c level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010189,abnormal T follicular helper cell physiology|MP:0010220,decreased T-helper 17 cell number|MP:0020914,decreased susceptibility to Riboviria infection|MP:0031023,decreased susceptibility to Riboviria infection induced morbidity/mortality
MGI:3050803	Cd274<tm1Shr>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0008566,increased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion
MGI:3050804	Cd274<tm2Shr>	MP:0003009,abnormal cytokine secretion|MP:0005026,decreased susceptibility to parasitic infection
MGI:5818965	Cd276<tm1Lpc>	MP:0003436,decreased susceptibility to induced arthritis|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0010222,abnormal T-helper 17 cell physiology
MGI:3033707	Cd276<tm1Mak>	MP:0001846,increased inflammatory response|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0005465,abnormal T-helper 1 physiology|MP:0008566,increased interferon-gamma secretion
MGI:3527215	Cd276<tm1Wwh>	MP:0003009,abnormal cytokine secretion|MP:0005671,abnormal response to transplant
MGI:5812924	Cd276<tm2b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0002591,decreased mean corpuscular volume|MP:0005568,increased circulating total protein level
MGI:7425569	Cd27<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0002059,abnormal seminal vesicle morphology|MP:0002110,abnormal digit morphology|MP:0009141,increased prepulse inhibition|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
MGI:2385835	Cd27<tm1Jbo>	MP:0000218,increased leukocyte cell number|MP:0002444,abnormal T cell physiology|MP:0004974,decreased regulatory T cell number|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005387,immune system phenotype|MP:0005460,abnormal leukopoiesis|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0006413,increased T cell apoptosis
MGI:5461540	Cd28<tm1.1Huen>	MP:0004946,abnormal regulatory T cell physiology|MP:0004974,decreased regulatory T cell number
MGI:4435635	Cd28<tm1a(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0005018,decreased T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number
MGI:3722546	Cd28<tm1Jmg>	MP:0002401,abnormal lymphopoiesis|MP:0002460,decreased immunoglobulin level|MP:0003009,abnormal cytokine secretion|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008192,abnormal germinal center B cell physiology|MP:0008688,decreased interleukin-2 secretion
MGI:5485211	Cd28<tm1Ltu>	MP:0000418,focal hair loss|MP:0000420,ruffled hair|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001212,skin lesions|MP:0001340,abnormal eyelid morphology|MP:0001402,decreased locomotor activity|MP:0001505,hunched posture|MP:0001829,increased activated T cell number|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004947,skin inflammation|MP:0004974,decreased regulatory T cell number|MP:0005014,increased B cell number|MP:0005095,decreased T cell proliferation|MP:0005350,increased susceptibility to autoimmune disorder
MGI:1857150	Cd28<tm1Mak>	MP:0000709,enlarged thymus|MP:0001847,brain inflammation|MP:0002460,decreased immunoglobulin level|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0004816,abnormal class switch recombination|MP:0004946,abnormal regulatory T cell physiology|MP:0004974,decreased regulatory T cell number|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005095,decreased T cell proliferation|MP:0005348,increased T cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0005671,abnormal response to transplant|MP:0006413,increased T cell apoptosis|MP:0008482,decreased spleen germinal center number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008500,increased IgG2a level|MP:0008566,increased interferon-gamma secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0008603,decreased circulating interleukin-4 level|MP:0008688,decreased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0010766,abnormal NK cell physiology
MGI:2664380	Cd28<tm1Pjl>	MP:0001806,decreased IgM level|MP:0002490,abnormal immunoglobulin level|MP:0004816,abnormal class switch recombination|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008664,decreased interleukin-12 secretion|MP:0009336,increased splenocyte proliferation
MGI:3721239	Cd28<tm1Shr>	MP:0005095,decreased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008688,decreased interleukin-2 secretion
MGI:3850854	Cd28<tm2.1Jmg>	MP:0002169,no abnormal phenotype detected
MGI:6257815	Cd2ap<em1(IMPC)Bay>	MP:0010053,decreased grip strength
MGI:6476759	Cd2ap<em1Irgu>	MP:0001732,postnatal growth retardation|MP:0001859,kidney inflammation|MP:0002083,premature death|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0003606,kidney failure|MP:0005264,glomerulosclerosis|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0011346,renal tubule atrophy
MGI:2664945	Cd2ap<tm1Shaw>	MP:0000274,enlarged heart|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002136,abnormal kidney physiology|MP:0002962,increased urine protein level|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0005095,decreased T cell proliferation|MP:0005165,increased susceptibility to injury|MP:0005264,glomerulosclerosis|MP:0005324,ascites|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0011294,renal glomerulus hypertrophy|MP:0011353,expanded mesangial matrix|MP:0011427,increased mesangial cell number
MGI:6392026	Cd2bp2<tm1.1Tbh>	MP:0001263,weight loss|MP:0001730,embryonic growth arrest|MP:0001798,impaired macrophage phagocytosis|MP:0001914,hemorrhage|MP:0002083,premature death|MP:0002962,increased urine protein level|MP:0005264,glomerulosclerosis|MP:0008140,podocyte foot process effacement|MP:0010666,abnormal vitelline vein morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011402,renal cast|MP:0011427,increased mesangial cell number
MGI:6392027	Cd2bp2<tm1.2Tbh>	MP:0001701,incomplete embryo turning|MP:0001730,embryonic growth arrest|MP:0001914,hemorrhage|MP:0010666,abnormal vitelline vein morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012131,small visceral yolk sac
MGI:2158301	Cd2<tm1Litt>	MP:0002169,no abnormal phenotype detected
MGI:5692830	Cd300a<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0001406,abnormal gait|MP:0002599,increased mean platelet volume|MP:0005012,decreased eosinophil cell number|MP:0010052,increased grip strength
MGI:5445723	Cd300a<tm1Shib>	MP:0000219,increased neutrophil cell number|MP:0002423,abnormal mast cell physiology|MP:0005166,decreased susceptibility to injury|MP:0008560,increased tumor necrosis factor secretion|MP:0008660,increased interleukin-10 secretion|MP:0008672,increased interleukin-13 secretion|MP:0008722,abnormal chemokine secretion|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:5296504	Cd300c2<tm1Shib>	MP:0005154,increased B cell proliferation
MGI:6140159	Cd300c<em1(IMPC)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0001258,decreased body length
MGI:5692814	Cd300e<tm1.1(KOMP)Vlcg>	MP:0000274,enlarged heart|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0005560,decreased circulating glucose level
MGI:4829592	Cd300lb<tm1Toki>	MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0005387,immune system phenotype
MGI:6153296	Cd300ld2<em1(IMPC)Wtsi>	MP:0002941,increased circulating alanine transaminase level|MP:0003960,increased lean body mass|MP:0005343,increased circulating aspartate transaminase level|MP:0010090,increased circulating creatine kinase level
MGI:6140160	Cd300ld<em1(IMPC)Wtsi>	MP:0005343,increased circulating aspartate transaminase level
MGI:4421781	Cd300lf<tm1Gne>	MP:0000921,demyelination|MP:0003957,abnormal nitric oxide homeostasis|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005387,immune system phenotype|MP:0008654,increased interleukin-1 alpha secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008663,increased interleukin-12 secretion
MGI:5467158	Cd300lf<tm1Toki>	MP:0002405,respiratory system inflammation|MP:0002423,abnormal mast cell physiology|MP:0005387,immune system phenotype|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008568,abnormal interleukin secretion|MP:0008672,increased interleukin-13 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion
MGI:4364847	Cd300lg<tm1a(KOMP)Wtsi>	MP:0003960,increased lean body mass|MP:0004509,abnormal pelvic girdle bone morphology|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0011939,increased food intake
MGI:5007052	Cd300lg<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:6724312	Cd302<tm1.1Dnjh>	MP:0002376,abnormal dendritic cell physiology|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005387,immune system phenotype|MP:0008127,decreased dendritic cell number
MGI:6279931	Cd320<em1(IMPC)Bay>	MP:0011959,abnormal eye posterior chamber depth
MGI:3858540	Cd320<Gt(CC0426)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0001935,decreased litter size|MP:0004019,abnormal vitamin homeostasis|MP:0005397,hematopoietic system phenotype|MP:0011227,abnormal vitamin B12 level|MP:0012335,increased circulating homocysteine level|MP:0030628,increased methylmalonic acid level|MP:0030630,increased circulating methylmalonic acid level
MGI:4187820	Cd320<Gt(OST110882)Lex>	MP:0002792,abnormal retina vasculature morphology
MGI:5471218	Cd33<tm1.1(KOMP)Vlcg>	MP:0013279,increased fasting circulating glucose level
MGI:2664507	Cd33<tm1Avrk>	MP:0001586,abnormal erythrocyte cell number|MP:0001876,decreased inflammatory response|MP:0005343,increased circulating aspartate transaminase level
MGI:2180758	Cd34<tm1Lal>	MP:0002123,abnormal definitive hematopoiesis|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008973,decreased erythroid progenitor cell number|MP:0009339,decreased splenocyte number
MGI:2180755	Cd34<tm1Szk>	MP:0000352,decreased cell proliferation|MP:0000377,abnormal hair follicle morphology|MP:0001216,abnormal epidermal layer morphology|MP:0001231,abnormal epidermis stratum basale morphology|MP:0002051,increased skin papilloma incidence|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005012,decreased eosinophil cell number|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010771,integument phenotype
MGI:6276959	Cd36<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000774,decreased brain size|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002152,abnormal brain morphology|MP:0002644,decreased circulating triglyceride level|MP:0002699,abnormal vitreous body morphology|MP:0002833,increased heart weight|MP:0003795,abnormal bone structure|MP:0006203,eye hemorrhage|MP:0013278,decreased fasting circulating glucose level
MGI:3573941	Cd36<obl>	MP:0001984,abnormal olfaction|MP:0002412,increased susceptibility to bacterial infection|MP:0002421,abnormal cell-mediated immunity|MP:0002451,abnormal macrophage physiology|MP:0003664,ocular pterygium|MP:0003665,endophthalmitis|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:2447190	Cd36<tm1Frm>	MP:0000288,abnormal pericardium morphology|MP:0001798,impaired macrophage phagocytosis|MP:0002135,abnormal kidney morphology|MP:0002451,abnormal macrophage physiology|MP:0003691,abnormal microglial cell physiology|MP:0005025,abnormal response to infection|MP:0005044,sepsis|MP:0008561,decreased tumor necrosis factor secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008721,abnormal chemokine level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:1931790	Cd36<tm1Mfe>	MP:0000187,abnormal triglyceride level|MP:0000343,abnormal response to cardiac infarction|MP:0000496,abnormal small intestine morphology|MP:0000609,abnormal liver physiology|MP:0000920,abnormal myelination|MP:0001004,abnormal retina photoreceptor morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001432,abnormal food preference|MP:0001544,abnormal cardiovascular system physiology|MP:0001547,abnormal lipid level|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001556,increased circulating HDL cholesterol level|MP:0001625,cardiac hypertrophy|MP:0001666,abnormal intestinal absorption|MP:0001764,abnormal homeostasis|MP:0001780,decreased brown adipose tissue amount|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002078,abnormal glucose homeostasis|MP:0002106,abnormal muscle physiology|MP:0002118,abnormal lipid homeostasis|MP:0002460,decreased immunoglobulin level|MP:0002575,increased circulating ketone body level|MP:0002644,decreased circulating triglyceride level|MP:0002647,decreased intestinal cholesterol absorption|MP:0003383,abnormal gluconeogenesis|MP:0003949,abnormal circulating lipid level|MP:0003953,abnormal hormone level|MP:0003975,increased circulating VLDL triglyceride level|MP:0004016,decreased bone mass|MP:0004220,abnormal peripheral nervous system regeneration|MP:0004939,abnormal B cell morphology|MP:0005178,increased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005280,abnormal fatty acids level|MP:0005281,increased fatty acids level|MP:0005282,decreased fatty acids level|MP:0005334,abnormal fat pad morphology|MP:0005342,abnormal intestinal lipid absorption|MP:0005376,homeostasis/metabolism phenotype|MP:0005449,abnormal food intake|MP:0005459,decreased percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0006238,abnormal choriocapillaris morphology|MP:0008099,abnormal plasma cell differentiation|MP:0008189,increased transitional stage B cell number|MP:0008489,slow postnatal weight gain|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008515,thin retina outer nuclear layer|MP:0008516,disorganized retina outer nuclear layer|MP:0008586,disorganized photoreceptor outer segment|MP:0008897,decreased IgG2c level|MP:0008961,abnormal basal metabolism|MP:0009355,increased liver triglyceride level|MP:0009356,decreased liver triglyceride level|MP:0010148,abnormal exocrine pancreas physiology|MP:0010360,decreased liver free fatty acids level|MP:0010399,decreased skeletal muscle glycogen level|MP:0010695,abnormal blood pressure regulation|MP:0010760,abnormal macrophage chemotaxis|MP:0011049,impaired adaptive thermogenesis|MP:0011698,abnormal brown adipose tissue physiology|MP:0013278,decreased fasting circulating glucose level|MP:0013758,increased intestinal glucose absorption|MP:0014072,decreased cardiac muscle glycogen level|MP:0030017,decreased adipocyte glucose uptake|MP:0030018,increased cardiac muscle cell glucose uptake|MP:0030968,decreased circulating adiponectin level|MP:0031120,decreased susceptibility to induced thrombosis|MP:0031417,decreased cardiac muscle triglyceride level|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:5703985	Cd36<tm2.1Mfe>	MP:0000343,abnormal response to cardiac infarction|MP:0002078,abnormal glucose homeostasis|MP:0005282,decreased fatty acids level|MP:0005385,cardiovascular system phenotype|MP:0014172,decreased fatty acid oxidation|MP:0031417,decreased cardiac muscle triglyceride level
MGI:2386160	Cd37<tm1Hor>	MP:0001800,abnormal humoral immune response|MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype|MP:0008482,decreased spleen germinal center number|MP:0008484,decreased spleen germinal center size|MP:0008495,decreased IgG1 level|MP:0008522,abnormal lymph node germinal center morphology
MGI:6385272	Cd38<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002941,increased circulating alanine transaminase level|MP:0008040,decreased NK T cell number|MP:0008044,increased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013519,decreased CD4-positive NK T cell number|MP:0013522,decreased memory-marker CD4-positive NK T cell number|MP:0013764,decreased T-helper cell number|MP:0013771,decreased effector memory T-helper cell number
MGI:1861803	Cd38<tm1Lnd>	MP:0001800,abnormal humoral immune response|MP:0004031,insulitis|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006413,increased T cell apoptosis|MP:0009114,decreased pancreatic beta cell mass|MP:0009254,disorganized pancreatic islets|MP:0014121,increased pancreatic islet cell apoptosis
MGI:2680868	Cd38<tm1Okam>	MP:0002727,decreased circulating insulin level|MP:0005293,impaired glucose tolerance
MGI:2180760	Cd3d<tm1Kap>	MP:0001825,arrested T cell differentiation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3776477	Cd3e<m1Btlr>	MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0001825,arrested T cell differentiation|MP:0002064,seizures|MP:0004816,abnormal class switch recombination|MP:0006413,increased T cell apoptosis|MP:0008070,absent T cells
MGI:6305303	Cd3e<m2Btlr>	MP:0002145,abnormal T cell differentiation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:5474199	Cd3e<tm1.1Geno>	MP:0002145,abnormal T cell differentiation|MP:0002408,abnormal double-positive T cell morphology|MP:0006387,abnormal T cell number|MP:0010133,increased DN3 thymocyte number
MGI:2384123	Cd3e<tm1.1Lov>	MP:0001825,arrested T cell differentiation|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008037,abnormal T cell morphology
MGI:2155671	Cd3e<tm1Cpt>	MP:0001823,thymus hypoplasia|MP:0005092,decreased double-positive T cell number|MP:0008070,absent T cells
MGI:2384120	Cd3e<tm1Lov>	MP:0001825,arrested T cell differentiation|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008037,abnormal T cell morphology
MGI:2155092	Cd3e<tm1Mal>	MP:0000727,absent CD8-positive, alpha-beta T cells|MP:0001825,arrested T cell differentiation|MP:0002407,abnormal double-negative T cell morphology|MP:0003790,absent CD4-positive, alpha-beta T cells|MP:0004939,abnormal B cell morphology|MP:0004946,abnormal regulatory T cell physiology|MP:0008070,absent T cells|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:4398866	Cd3g<tm1.1Cage>	MP:0000694,spleen hypoplasia|MP:0000715,decreased thymocyte number|MP:0005025,abnormal response to infection|MP:0006413,increased T cell apoptosis|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:2180763	Cd3g<tm1Amk>	MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0001828,abnormal T cell activation|MP:0002145,abnormal T cell differentiation|MP:0002444,abnormal T cell physiology|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005094,abnormal T cell proliferation|MP:0008101,lymph node hypoplasia
MGI:2673301	Cd3g<tm2Amk>	MP:0005387,immune system phenotype
MGI:4819117	Cd40lg<m1Btlr>	MP:0001805,decreased IgG level|MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype
MGI:2182733	Cd40lg<tm1Flv>	MP:0000685,abnormal immune system morphology|MP:0001790,abnormal immune system physiology|MP:0001807,decreased IgA level|MP:0002145,abnormal T cell differentiation|MP:0002420,abnormal adaptive immunity|MP:0002460,decreased immunoglobulin level|MP:0002491,decreased IgD level|MP:0002492,decreased IgE level|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0004816,abnormal class switch recombination|MP:0004974,decreased regulatory T cell number|MP:0005092,decreased double-positive T cell number|MP:0005466,abnormal T-helper 2 physiology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008396,abnormal osteoclast differentiation|MP:0008474,absent spleen germinal center|MP:0008495,decreased IgG1 level|MP:0008498,decreased IgG3 level
MGI:1857145	Cd40lg<tm1Imx>	MP:0000063,decreased bone mineral density|MP:0000832,abnormal thalamus morphology|MP:0001790,abnormal immune system physiology|MP:0001807,decreased IgA level|MP:0001835,abnormal antigen presentation|MP:0002229,neurodegeneration|MP:0002339,abnormal lymph node morphology|MP:0002460,decreased immunoglobulin level|MP:0002492,decreased IgE level|MP:0002551,abnormal blood coagulation|MP:0002654,spongiform encephalopathy|MP:0002722,abnormal immune system organ morphology|MP:0003241,loss of cortex neurons|MP:0003628,abnormal leukocyte adhesion|MP:0003633,abnormal nervous system physiology|MP:0004816,abnormal class switch recombination|MP:0005002,abnormal T cell clonal deletion|MP:0005048,abnormal thrombosis|MP:0005364,increased susceptibility to prion infection|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005606,increased bleeding time|MP:0006055,abnormal vascular endothelial cell morphology|MP:0006058,decreased cerebral infarct size|MP:0008101,lymph node hypoplasia|MP:0008474,absent spleen germinal center|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008523,absent lymph node germinal center|MP:0008918,microgliosis|MP:0009549,decreased platelet aggregation|MP:0010873,decreased trabecular bone mass|MP:0010962,decreased compact bone mass
MGI:5306631	Cd40lg<tm1Parl>	MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0003179,thrombocytopenia|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008498,decreased IgG3 level|MP:0008499,increased IgG1 level
MGI:5640773	Cd40<m1Btlr>	MP:0020154,impaired humoral immune response
MGI:6113439	Cd40<m2Btlr>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level
MGI:3707600	Cd40<tm1Arah>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002490,abnormal immunoglobulin level|MP:0002492,decreased IgE level|MP:0002494,increased IgM level|MP:0005671,abnormal response to transplant|MP:0008474,absent spleen germinal center|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008502,increased IgG3 level
MGI:2655321	Cd40<tm1Geha>	MP:0001807,decreased IgA level|MP:0008482,decreased spleen germinal center number|MP:0008484,decreased spleen germinal center size|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008522,abnormal lymph node germinal center morphology
MGI:1857457	Cd40<tm1Kik>	MP:0000063,decreased bone mineral density|MP:0000222,decreased neutrophil cell number|MP:0001800,abnormal humoral immune response|MP:0001807,decreased IgA level|MP:0002376,abnormal dendritic cell physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002460,decreased immunoglobulin level|MP:0002492,decreased IgE level|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005612,decreased susceptibility to type II hypersensitivity reaction|MP:0006058,decreased cerebral infarct size|MP:0008179,absent germinal center B cells|MP:0008474,absent spleen germinal center|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0009549,decreased platelet aggregation|MP:0010873,decreased trabecular bone mass|MP:0010962,decreased compact bone mass
MGI:6268367	Cd44<M1Btlr>	MP:0000414,alopecia|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010842,decreased central memory CD4-positive, alpha-beta T cell number|MP:0010845,decreased effector memory CD4-positive, alpha-beta T cell number|MP:0010848,decreased central memory CD8 positive, alpha-beta T cell number|MP:0012765,decreased alpha-beta T cell number
MGI:2679706	Cd44<tm1.1Ugu>	MP:0001663,abnormal digestive system physiology|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology
MGI:1934008	Cd44<tm1Hbg>	MP:0000336,decreased mast cell number|MP:0000343,abnormal response to cardiac infarction|MP:0000362,decreased mast cell histamine storage|MP:0001218,thin epidermis|MP:0001547,abnormal lipid level|MP:0001792,impaired wound healing|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002463,abnormal neutrophil physiology|MP:0002764,short tibia|MP:0002796,impaired skin barrier function|MP:0003156,abnormal leukocyte migration|MP:0003983,decreased cholesterol level|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005025,abnormal response to infection|MP:0005088,increased acute inflammation|MP:0005397,hematopoietic system phenotype|MP:0005546,choroidal neovascularization|MP:0008162,increased diameter of tibia|MP:0008396,abnormal osteoclast differentiation|MP:0009608,abnormal epidermal lamellar body morphology
MGI:2181292	Cd44<tm1Mak>	MP:0000358,abnormal cell morphology|MP:0001622,abnormal vasculogenesis|MP:0001798,impaired macrophage phagocytosis|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002123,abnormal definitive hematopoiesis|MP:0002908,delayed wound healing|MP:0003038,decreased myocardial infarct size|MP:0003156,abnormal leukocyte migration|MP:0003303,peritoneal inflammation|MP:0003447,decreased tumor growth/size|MP:0003710,abnormal physiological neovascularization|MP:0003724,increased susceptibility to induced arthritis|MP:0003858,enhanced coordination|MP:0004003,abnormal vascular endothelial cell physiology|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004875,increased mean systemic arterial blood pressure|MP:0005027,increased susceptibility to parasitic infection|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005087,decreased acute inflammation|MP:0005387,immune system phenotype|MP:0005554,decreased circulating creatinine level|MP:0005566,decreased blood urea nitrogen level|MP:0005595,abnormal vascular smooth muscle physiology|MP:0005602,decreased angiogenesis|MP:0005621,abnormal cell physiology|MP:0006055,abnormal vascular endothelial cell morphology|MP:0008553,increased circulating tumor necrosis factor level|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008568,abnormal interleukin secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008599,increased circulating interleukin-2 level|MP:0008657,increased interleukin-1 beta secretion|MP:0008660,increased interleukin-10 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0008838,decreased transforming growth factor beta level|MP:0008944,decreased sensitivity to induced cell death|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010209,abnormal circulating chemokine level|MP:0010210,abnormal circulating cytokine level|MP:0010677,decreased activation-induced cell death of T cells|MP:0011630,increased mitochondrial size|MP:0011635,abnormal mitochondrial crista morphology|MP:0011704,decreased fibroblast proliferation|MP:0014373,increased miniature excitatory postsynaptic current amplitude|MP:0014376,decreased miniature excitatory postsynaptic current frequency
MGI:5544103	Cd44<tm1Stpa>	MP:0005381,digestive/alimentary phenotype
MGI:2679704	Cd44<tm1Ugu>	MP:0001663,abnormal digestive system physiology|MP:0005387,immune system phenotype|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology
MGI:4835490	Cd44<tm2.1Ugu>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005095,decreased T cell proliferation
MGI:2178950	Cd44<tm2Kmz>	MP:0001120,abnormal uterus morphology|MP:0003436,decreased susceptibility to induced arthritis|MP:0003628,abnormal leukocyte adhesion|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0006271,abnormal involution of the mammary gland|MP:0008719,impaired neutrophil recruitment|MP:0020332,impaired leukocyte tethering or rolling
MGI:5544104	Cd44<tm2Stpa>	MP:0005381,digestive/alimentary phenotype
MGI:3588663	Cd44<tm2Ugu>	MP:0002169,no abnormal phenotype detected
MGI:5586970	Cd46<tm1Atk>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001325,abnormal retina morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005098,abnormal optic choroid morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology|MP:0005389,reproductive system phenotype|MP:0006238,abnormal choriocapillaris morphology|MP:0008450,retina photoreceptor degeneration|MP:0011557,increased susceptibility to induced choroid neovascularization|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:2654215	Cd46<tm1Osb>	MP:0001934,increased litter size|MP:0005389,reproductive system phenotype|MP:0005410,abnormal fertilization
MGI:1861955	Cd47<tm1Fpl>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000245,abnormal erythropoiesis|MP:0000321,increased bone marrow cell number|MP:0000556,abnormal hindlimb morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001204,decreased sensitivity to skin irradiation|MP:0001533,abnormal skeleton physiology|MP:0001585,hemolytic anemia|MP:0002052,decreased tumor incidence|MP:0002083,premature death|MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0002467,impaired neutrophil phagocytosis|MP:0002573,behavioral despair|MP:0002626,increased heart rate|MP:0002640,reticulocytosis|MP:0002799,abnormal passive avoidance behavior|MP:0002874,decreased hemoglobin content|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003179,thrombocytopenia|MP:0003631,nervous system phenotype|MP:0003710,abnormal physiological neovascularization|MP:0003795,abnormal bone structure|MP:0004087,abnormal muscle fiber morphology|MP:0004875,increased mean systemic arterial blood pressure|MP:0004985,decreased osteoclast cell number|MP:0004993,decreased bone resorption|MP:0005018,decreased T cell number|MP:0005074,impaired granulocyte bactericidal activity|MP:0005369,muscle phenotype|MP:0005391,vision/eye phenotype|MP:0005404,abnormal axon morphology|MP:0005464,abnormal platelet physiology|MP:0005501,abnormal skin physiology|MP:0006036,abnormal mitochondrial physiology|MP:0006080,brain ischemia|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008143,abnormal dendrite morphology|MP:0008396,abnormal osteoclast differentiation|MP:0008713,abnormal cytokine level|MP:0008719,impaired neutrophil recruitment|MP:0008720,impaired neutrophil chemotaxis|MP:0008752,abnormal tumor necrosis factor level|MP:0008826,abnormal splenic cell ratio|MP:0009347,increased trabecular bone thickness|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0010334,pleural effusion|MP:0010771,integument phenotype|MP:0010878,increased trabecular bone volume
MGI:2180770	Cd48<tm1Rsr>	MP:0001828,abnormal T cell activation|MP:0005095,decreased T cell proliferation|MP:0008074,increased CD4-positive, alpha-beta T cell number
MGI:3664575	Cd4<del>	MP:0000689,abnormal spleen morphology|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002347,abnormal lymph node T cell domain morphology|MP:0002460,decreased immunoglobulin level|MP:0002722,abnormal immune system organ morphology|MP:0003790,absent CD4-positive, alpha-beta T cells|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:6220669	Cd4<em1Litt>	MP:0005387,immune system phenotype
MGI:5582497	Cd4<m1Btlr>	MP:0003790,absent CD4-positive, alpha-beta T cells|MP:0020154,impaired humoral immune response
MGI:4819382	Cd4<maat>	MP:0002408,abnormal double-positive T cell morphology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:4819228	Cd4<sesh>	MP:0002408,abnormal double-positive T cell morphology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0005018,decreased T cell number
MGI:4819162	Cd4<thth>	MP:0003790,absent CD4-positive, alpha-beta T cells
MGI:3639344	Cd4<tm1Jrp>	MP:0002145,abnormal T cell differentiation|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:1857143	Cd4<tm1Knw>	MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005027,increased susceptibility to parasitic infection|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:1857281	Cd4<tm1Litt>	MP:0003790,absent CD4-positive, alpha-beta T cells|MP:0005095,decreased T cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:1857144	Cd4<tm1Mak>	MP:0000921,demyelination|MP:0001847,brain inflammation|MP:0004774,abnormal bile salt level|MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008100,absent plasma cells|MP:0020937,increased susceptibility to Picornaviridae infection
MGI:2654930	Cd4<tm1Nik>	MP:0004946,abnormal regulatory T cell physiology
MGI:2673472	Cd4ts1<BALB/c>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology
MGI:3589124	Cd4ts2<DBA/2>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology
MGI:2673486	Cd4ts3<BALB/c>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology
MGI:3589128	Cd4ts4<C3H>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology
MGI:2673495	Cd4ts5<BALB/c>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology
MGI:2673496	Cd4ts5<C57BL/6>	MP:0008049,increased memory T cell number
MGI:3589133	Cd4ts6<DBA/2>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology
MGI:3589136	Cd4vts1<DBA/2>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology
MGI:7490160	Cd52<em1(IMPC)Ccpcz>	MP:0005559,increased circulating glucose level|MP:0008040,decreased NK T cell number
MGI:3822524	Cd52<tm1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6151126	Cd53<tm1.1Nmg>	MP:0002459,abnormal B cell physiology
MGI:4868034	Cd55b<tm1a(KOMP)Wtsi>	MP:0005505,thrombocytosis|MP:0005553,increased circulating creatinine level|MP:0010052,increased grip strength
MGI:5692553	Cd55<tm1b(EUCOMM)Hmgu>	MP:0000198,decreased circulating phosphate level
MGI:2383980	Cd55<tm1Mme>	MP:0002871,albuminuria|MP:0004823,increased susceptibility to experimental autoimmune myasthenia gravis|MP:0005165,increased susceptibility to injury|MP:0005326,abnormal podocyte morphology
MGI:2387405	Cd55<tm1Song>	MP:0002471,abnormal complement pathway|MP:0002472,impaired complement alternative pathway|MP:0002473,impaired complement classical pathway|MP:0004823,increased susceptibility to experimental autoimmune myasthenia gravis|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0010053,decreased grip strength
MGI:2180771	Cd59a<tm1Bpm>	MP:0000219,increased neutrophil cell number|MP:0000315,hemoglobinuria|MP:0000332,hemoglobinemia|MP:0000921,demyelination|MP:0001262,decreased body weight|MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001861,lung inflammation|MP:0002471,abnormal complement pathway|MP:0002640,reticulocytosis|MP:0003724,increased susceptibility to induced arthritis|MP:0004041,increased susceptibility to kidney reperfusion injury|MP:0004153,increased renal tubule apoptosis|MP:0004510,myositis|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004823,increased susceptibility to experimental autoimmune myasthenia gravis|MP:0005091,increased double-positive T cell number|MP:0005093,decreased B cell proliferation|MP:0005165,increased susceptibility to injury|MP:0005348,increased T cell proliferation|MP:0005425,increased macrophage cell number|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005546,choroidal neovascularization|MP:0006050,pulmonary fibrosis|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008098,decreased plasma cell number|MP:0010053,decreased grip strength|MP:0010180,increased susceptibility to weight loss|MP:0010653,abnormal Wallerian degeneration|MP:0020929,decreased susceptibility to Poxviridae infection|MP:0020946,increased susceptibility to Orthomyxoviridae infection|MP:0031085,increased erythrocyte osmotic fragility
MGI:2675293	Cd59a<tm1Song>	MP:0002471,abnormal complement pathway
MGI:2653298	Cd59b<tm1Jha>	MP:0000208,decreased hematocrit|MP:0000256,echinocytosis|MP:0000314,schistocytosis|MP:0000315,hemoglobinuria|MP:0000327,hemosiderinuria|MP:0000332,hemoglobinemia|MP:0001585,hemolytic anemia|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005096,erythroblastosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005464,abnormal platelet physiology|MP:0006362,abnormal male germ cell morphology|MP:0008995,early reproductive senescence|MP:0009230,abnormal sperm head morphology|MP:0009234,absent sperm head|MP:0009325,necrospermia|MP:0014052,increased male germ cell apoptosis|MP:0020550,multinucleated giant male germ cells
MGI:5636957	Cd5l<tm1b(KOMP)Mbp>	MP:0000062,increased bone mineral density|MP:0000579,abnormal nail morphology|MP:0001417,decreased exploration in new environment|MP:0005560,decreased circulating glucose level
MGI:2653296	Cd5l<tm1Nto>	MP:0000715,decreased thymocyte number|MP:0002408,abnormal double-positive T cell morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0005387,immune system phenotype
MGI:5447646	Cd5<tm1.1Chra>	MP:0002444,abnormal T cell physiology|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005017,decreased B cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0005348,increased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008174,decreased follicular B cell number|MP:0008747,abnormal T cell anergy|MP:0010220,decreased T-helper 17 cell number
MGI:5583082	Cd5<tm1.1(KOMP)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001120,abnormal uterus morphology|MP:0002060,abnormal skin morphology|MP:0004952,increased spleen weight
MGI:1857148	Cd5<tm1Cgn>	MP:0002169,no abnormal phenotype detected|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004973,increased regulatory T cell number|MP:0005348,increased T cell proliferation|MP:0008747,abnormal T cell anergy
MGI:3840228	Cd63<tm1Psa>	MP:0001426,polydipsia|MP:0001762,polyuria|MP:0001784,abnormal fluid regulation|MP:0002988,decreased urine osmolality|MP:0009643,abnormal urine homeostasis|MP:0011757,abnormal kidney collecting duct principal cell morphology|MP:0014483,increased feces water content
MGI:7425572	Cd68<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5285208	Cd68<tm1Shnd>	MP:0002455,abnormal dendritic cell antigen presentation
MGI:5297542	Cd68<tm1Xfen>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0001541,abnormal osteoclast physiology|MP:0004982,abnormal osteoclast morphology|MP:0004993,decreased bone resorption|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume|MP:0020080,increased bone mineralization
MGI:2180772	Cd69<tm1Fsm>	MP:0001800,abnormal humoral immune response|MP:0002144,abnormal B cell differentiation|MP:0002494,increased IgM level|MP:0003132,increased pre-B cell number|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008214,increased immature B cell number|MP:0008500,increased IgG2a level
MGI:2675144	Cd69<tm1Naka>	MP:0001800,abnormal humoral immune response|MP:0002444,abnormal T cell physiology|MP:0003436,decreased susceptibility to induced arthritis|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008051,abnormal memory T cell physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008719,impaired neutrophil recruitment|MP:0008720,impaired neutrophil chemotaxis
MGI:5824697	Cd6<tm1Linf>	MP:0001806,decreased IgM level|MP:0002459,abnormal B cell physiology|MP:0004978,decreased B-1 B cell number|MP:0005093,decreased B cell proliferation|MP:0005166,decreased susceptibility to injury|MP:0008167,increased B-1a cell number|MP:0008168,decreased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0008706,decreased interleukin-6 secretion
MGI:5475220	Cd70<tm1.1Jda>	MP:0001790,abnormal immune system physiology|MP:0002444,abnormal T cell physiology|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005387,immune system phenotype|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0020913,increased susceptibility to Riboviria infection
MGI:5514249	Cd70<tm1(cre)Jbo>	MP:0004974,decreased regulatory T cell number|MP:0005387,immune system phenotype
MGI:5563235	Cd72<c>	MP:0005154,increased B cell proliferation|MP:0005387,immune system phenotype
MGI:2180786	Cd72<tm1Jrp>	MP:0002144,abnormal B cell differentiation|MP:0002494,increased IgM level|MP:0003132,increased pre-B cell number|MP:0004977,increased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005154,increased B cell proliferation|MP:0008167,increased B-1a cell number|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008186,increased pro-B cell number|MP:0008207,decreased B-2 B cell number|MP:0008211,decreased mature B cell number|MP:0008214,increased immature B cell number|MP:0008217,abnormal B cell activation|MP:0014469,abnormal B cell calcium ion homeostasis
MGI:5563226	Cd72<tm1Tsub>	MP:0001861,lung inflammation|MP:0002743,glomerulonephritis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004829,increased anti-chromatin antibody level|MP:0004952,increased spleen weight|MP:0005154,increased B cell proliferation|MP:0005387,immune system phenotype|MP:0020519,renal glomerular immunoglobulin deposits
MGI:6322958	Cd74<em1(IMPC)H>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number
MGI:1927205	Cd74<tm1Doi>	MP:0001835,abnormal antigen presentation|MP:0002455,abnormal dendritic cell antigen presentation|MP:0005042,abnormal level of surface class II molecules|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:1927544	Cd74<tm1Eae>	MP:0000352,decreased cell proliferation|MP:0001802,arrested B cell differentiation|MP:0001806,decreased IgM level|MP:0003037,increased myocardial infarct size|MP:0005042,abnormal level of surface class II molecules|MP:0005093,decreased B cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008828,abnormal lymph node cell ratio|MP:0031217,increased susceptibility to myocardial ischemic injury
MGI:1927530	Cd74<tm1Liz>	MP:0001265,decreased body size|MP:0001835,abnormal antigen presentation|MP:0002144,abnormal B cell differentiation|MP:0002452,abnormal professional antigen presenting cell physiology|MP:0002455,abnormal dendritic cell antigen presentation|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004919,abnormal positive T cell selection|MP:0005017,decreased B cell number|MP:0005041,abnormal antigen presentation via MHC class II|MP:0005042,abnormal level of surface class II molecules|MP:0005043,defective assembly of class II molecules|MP:0005094,abnormal T cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005150,cachexia|MP:0005397,hematopoietic system phenotype|MP:0005465,abnormal T-helper 1 physiology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008214,increased immature B cell number|MP:0008567,decreased interferon-gamma secretion
MGI:1857190	Cd74<tm2Liz>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0008688,decreased interleukin-2 secretion
MGI:2656764	Cd74<tm3Liz>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005041,abnormal antigen presentation via MHC class II|MP:0005042,abnormal level of surface class II molecules|MP:0005043,defective assembly of class II molecules|MP:0005387,immune system phenotype|MP:0008688,decreased interleukin-2 secretion
MGI:5006856	Cd79a<m1Anu>	MP:0000238,absent pre-B cells|MP:0001805,decreased IgG level
MGI:5056357	Cd79a<m1Btlr>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0004816,abnormal class switch recombination|MP:0005017,decreased B cell number
MGI:6113480	Cd79a<m2Btlr>	MP:0001806,decreased IgM level|MP:0004978,decreased B-1 B cell number|MP:0020154,impaired humoral immune response
MGI:2384631	Cd79a<tm1.1(BAP31N-EGFP)Pld>	MP:0000716,abnormal immune system cell morphology
MGI:2388326	Cd79a<tm1.1Cgn>	MP:0004978,decreased B-1 B cell number|MP:0008168,decreased B-1a cell number|MP:0008182,decreased marginal zone B cell number|MP:0008211,decreased mature B cell number|MP:0008217,abnormal B cell activation|MP:0008495,decreased IgG1 level
MGI:5301876	Cd79a<tm1.1Rsky>	MP:0001800,abnormal humoral immune response|MP:0003132,increased pre-B cell number|MP:0004771,increased anti-single stranded DNA antibody level|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008182,decreased marginal zone B cell number|MP:0008189,increased transitional stage B cell number|MP:0008211,decreased mature B cell number|MP:0008214,increased immature B cell number|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008501,increased IgG2b level|MP:0008896,increased IgG2c level|MP:0008897,decreased IgG2c level|MP:0009922,increased transitional stage T1 B cell number|MP:0009925,increased transitional stage T2 B cell number|MP:0010229,increased transitional stage T3 B cell number
MGI:2384630	Cd79a<tm1(BAP31N-EGFP)Pld>	MP:0002169,no abnormal phenotype detected
MGI:3687451	Cd79a<tm1(cre)Reth>	MP:0002169,no abnormal phenotype detected
MGI:2447454	Cd79a<tm2Cgn>	MP:0002460,decreased immunoglobulin level|MP:0005017,decreased B cell number|MP:0008186,increased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number
MGI:2687365	Cd79a<tm2Pld>	MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0005092,decreased double-positive T cell number|MP:0008212,absent mature B cells
MGI:3038712	Cd79a<tm3Cgn>	MP:0002356,abnormal spleen red pulp morphology|MP:0005017,decreased B cell number|MP:0008240,abnormal spleen marginal zone macrophage morphology|MP:0008241,abnormal metallophilic macrophage morphology
MGI:3047537	Cd79a<tm4.1Cgn>	MP:0002144,abnormal B cell differentiation
MGI:3047539	Cd79a<tm5.1Cgn>	MP:0002144,abnormal B cell differentiation|MP:0004939,abnormal B cell morphology|MP:0005018,decreased T cell number|MP:0008168,decreased B-1a cell number|MP:0008186,increased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number
MGI:3687009	Cd79a<tm6Cgn>	MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0002458,abnormal B cell number|MP:0002459,abnormal B cell physiology|MP:0002490,abnormal immunoglobulin level|MP:0003077,abnormal cell cycle|MP:0004046,abnormal mitosis|MP:0005093,decreased B cell proliferation|MP:0005387,immune system phenotype|MP:0008168,decreased B-1a cell number|MP:0008189,increased transitional stage B cell number|MP:0008496,decreased IgG2a level|MP:0008498,decreased IgG3 level
MGI:3687010	Cd79a<tm7Cgn>	MP:0001790,abnormal immune system physiology
MGI:6268742	Cd79b<m1Btlr>	MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0008045,decreased NK cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0012764,increased alpha-beta T cell number
MGI:3829352	Cd79b<m1Ghost>	MP:0001802,arrested B cell differentiation|MP:0001805,decreased IgG level|MP:0001807,decreased IgA level|MP:0002144,abnormal B cell differentiation|MP:0002831,absent Peyer's patches|MP:0008071,absent B cells
MGI:6286293	Cd79b<M2Btlr>	MP:0002619,abnormal lymphocyte morphology|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number
MGI:3720567	Cd79b<tm168Mnz>	MP:0002169,no abnormal phenotype detected
MGI:3722155	Cd79b<tm1Gzmn>	MP:0001790,abnormal immune system physiology|MP:0002494,increased IgM level|MP:0002496,increased IgD level|MP:0008168,decreased B-1a cell number|MP:0008495,decreased IgG1 level
MGI:2387024	Cd79b<tm1Mnz>	MP:0001802,arrested B cell differentiation|MP:0005432,abnormal pro-B cell morphology|MP:0008233,abnormal pro-B cell differentiation
MGI:2447121	Cd79b<tm2.1Mnz>	MP:0001802,arrested B cell differentiation|MP:0008186,increased pro-B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008217,abnormal B cell activation
MGI:3768659	Cd79b<tm3Mnz>	MP:0001790,abnormal immune system physiology|MP:0002459,abnormal B cell physiology|MP:0005017,decreased B cell number|MP:0005022,abnormal immature B cell morphology|MP:0005093,decreased B cell proliferation|MP:0008168,decreased B-1a cell number|MP:0008181,increased marginal zone B cell number|MP:0008186,increased pro-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number
MGI:2180804	Cd7<tm1Bfh>	MP:0000714,increased thymocyte number|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005091,increased double-positive T cell number|MP:0005387,immune system phenotype|MP:0008567,decreased interferon-gamma secretion
MGI:5766763	Cd7<tm1b(KOMP)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract
MGI:3700571	Cd7<tm1Fabo>	MP:0005387,immune system phenotype
MGI:3653492	Cd80<tm1Lbgn>	MP:0002444,abnormal T cell physiology
MGI:1861804	Cd80<tm1Shr>	MP:0002490,abnormal immunoglobulin level|MP:0005093,decreased B cell proliferation
MGI:2180813	Cd81<tm1Geha>	MP:0001402,decreased locomotor activity|MP:0001906,increased dopamine level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0004080,abnormal nucleus accumbens morphology|MP:0004939,abnormal B cell morphology|MP:0004978,decreased B-1 B cell number|MP:0005154,increased B cell proliferation|MP:0008168,decreased B-1a cell number|MP:0008502,increased IgG3 level|MP:0009758,impaired behavioral response to cocaine
MGI:2180805	Cd81<tm1Lvy>	MP:0000136,abnormal microglial cell morphology|MP:0000780,abnormal corpus callosum morphology|MP:0000789,thickened cerebral cortex|MP:0000807,abnormal hippocampus morphology|MP:0000952,abnormal CNS glial cell morphology|MP:0001805,decreased IgG level|MP:0002176,increased brain weight|MP:0002882,abnormal neuron morphology|MP:0003631,nervous system phenotype|MP:0004939,abnormal B cell morphology|MP:0005026,decreased susceptibility to parasitic infection|MP:0005466,abnormal T-helper 2 physiology|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008495,decreased IgG1 level|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0012065,increased astrocyte number|MP:0020082,increased hippocampus volume
MGI:2665072	Cd81<tm1Tmiy>	MP:0000716,abnormal immune system cell morphology|MP:0002144,abnormal B cell differentiation|MP:0002451,abnormal macrophage physiology|MP:0004978,decreased B-1 B cell number|MP:0005093,decreased B cell proliferation|MP:0005094,abnormal T cell proliferation|MP:0005154,increased B cell proliferation
MGI:5790985	Cd82<tm1.1Xaz>	MP:0000343,abnormal response to cardiac infarction|MP:0003544,abnormal vascular endothelial cell migration|MP:0005601,increased angiogenesis|MP:0009660,abnormal induced retina neovascularization|MP:0010144,abnormal tumor vascularization
MGI:7312064	Cd82<tm1Kjbr>	MP:0000219,increased neutrophil cell number|MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0005425,increased macrophage cell number|MP:0008113,abnormal macrophage differentiation|MP:0009858,abnormal cellular extravasation|MP:0012049,increased susceptilbility to retina ischemic injury|MP:0020332,impaired leukocyte tethering or rolling
MGI:3819968	Cd83<anu>	MP:0004939,abnormal B cell morphology|MP:0005461,abnormal dendritic cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:3055293	Cd83<lcd4>	MP:0005095,decreased T cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008076,abnormal CD4-positive T cell differentiation
MGI:5819103	Cd83<tm1.1Lnjt>	MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:5548426	Cd83<tm1b(KOMP)Wtsi>	MP:0001944,abnormal pancreas morphology|MP:0002059,abnormal seminal vesicle morphology
MGI:3809654	Cd83<tm1Mak>	MP:0002169,no abnormal phenotype detected
MGI:2676282	Cd83<tm1Tft>	MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0001825,arrested T cell differentiation|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:5753066	Cd84<tm1Beni>	MP:0002169,no abnormal phenotype detected
MGI:5515779	Cd84<tm1b(KOMP)Mbp>	MP:0001488,increased startle reflex|MP:0005633,increased circulating sodium level
MGI:4438772	Cd84<tm1Pls>	MP:0001805,decreased IgG level|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008178,decreased germinal center B cell number|MP:0008484,decreased spleen germinal center size|MP:0009058,decreased interleukin-21 secretion|MP:0010084,abnormal long lived plasma cell morphology
MGI:1861805	Cd86<tm1Shr>	MP:0000754,paresis|MP:0000755,hindlimb paralysis|MP:0000921,demyelination|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0002269,muscular atrophy|MP:0003632,abnormal nervous system morphology|MP:0003725,increased autoantibody level|MP:0003871,abnormal myelin sheath morphology|MP:0003993,abnormal ventral spinal root morphology|MP:0003994,abnormal dorsal spinal root morphology|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0004974,decreased regulatory T cell number|MP:0005094,abnormal T cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005402,abnormal action potential|MP:0005403,abnormal nerve conduction|MP:0008474,absent spleen germinal center|MP:0008566,increased interferon-gamma secretion|MP:0008814,decreased nerve conduction velocity|MP:0010053,decreased grip strength
MGI:5640751	Cd8a<m1Btlr>	MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:5806327	Cd8a<m2Btlr>	MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0011822,increased CD8-positive, alpha-beta memory T cell proliferation
MGI:5294414	Cd8a<tm1.1(cre)Koni>	MP:0002169,no abnormal phenotype detected|MP:0005397,hematopoietic system phenotype|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3630292	Cd8a<tm1.1Kio>	MP:0008076,abnormal CD4-positive T cell differentiation
MGI:3584478	Cd8a<tm1.1Litt>	MP:0005010,abnormal CD8-positive, alpha beta T cell morphology
MGI:3664646	Cd8a<tm1.1Welm>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype
MGI:3760403	Cd8a<tm1Asin>	MP:0002408,abnormal double-positive T cell morphology
MGI:1857149	Cd8a<tm1Mak>	MP:0000727,absent CD8-positive, alpha-beta T cells|MP:0000921,demyelination|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005387,immune system phenotype|MP:0005671,abnormal response to transplant|MP:0020937,increased susceptibility to Picornaviridae infection
MGI:6113877	Cd8b1<M1Btlr>	MP:0002493,increased IgG level|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0020155,enhanced humoral immune response
MGI:6304443	Cd8b1<m2Btlr>	MP:0002144,abnormal B cell differentiation|MP:0005018,decreased T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:3654103	Cd8b1<tm1Litt>	MP:0000715,decreased thymocyte number|MP:0003944,abnormal T cell subpopulation ratio|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:2158830	Cd8b1<tm1Wpfl>	MP:0000715,decreased thymocyte number|MP:0003944,abnormal T cell subpopulation ratio|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005387,immune system phenotype|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation
MGI:3589139	Cd8mts1<DBA/2>	MP:0008049,increased memory T cell number
MGI:2673469	Cd8mts2<BALB/c>	MP:0008049,increased memory T cell number
MGI:2673470	Cd8mts3<C57BL/6>	MP:0008049,increased memory T cell number
MGI:3589144	Cd8mts4<DBA/2>	MP:0008049,increased memory T cell number
MGI:2673505	Cd8mts5<BALB/c>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology
MGI:2673506	Cd8mts5<C57BL/6>	MP:0008049,increased memory T cell number
MGI:3589150	Cd8mts6<C3H>	MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:3589152	Cd8ts1<DBA/2>	MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:2673490	Cd8ts2<C57BL/6>	MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:3589157	Cd8ts3<C3H>	MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:3589156	Cd8ts3<DBA/2>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology
MGI:3038703	Cd93<tm1Mbo>	MP:0001798,impaired macrophage phagocytosis
MGI:6140170	Cd96<em1(IMPC)Wtsi>	MP:0000218,increased leukocyte cell number
MGI:5617136	Cd96<tm1.1Mjs>	MP:0001273,decreased metastatic potential|MP:0001846,increased inflammatory response|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005379,endocrine/exocrine gland phenotype|MP:0005380,embryo phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008735,increased susceptibility to endotoxin shock|MP:0010766,abnormal NK cell physiology
MGI:3923395	Cd99<Gt(Ayu21-B6T44)Imeg>	MP:0005387,immune system phenotype|MP:0009333,abnormal splenocyte physiology
MGI:6116872	Cd99l2<tm1.1Dvst>	MP:0005384,cellular phenotype|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0009858,abnormal cellular extravasation
MGI:6117037	Cd99l2<tm1.2Dvst>	MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0009858,abnormal cellular extravasation
MGI:2180795	Cd9<tm1Bcx>	MP:0000242,impaired fertilization|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0008976,delayed female fertility
MGI:2180798	Cd9<tm1Kudo>	MP:0000242,impaired fertilization|MP:0001926,female infertility|MP:0005389,reproductive system phenotype
MGI:2181695	Cd9<tm1Mek>	MP:0001125,abnormal oocyte morphology|MP:0001926,female infertility|MP:0002123,abnormal definitive hematopoiesis
MGI:8261286	Cdadc1<em1Boch>	MP:0002169,no abnormal phenotype detected
MGI:8240199	Cdadc1<em1Jmdn>	MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:8240200	Cdadc1<em2Jmdn>	MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:4125912	Cdan1<Gt(XG571)Byg>	MP:0002169,no abnormal phenotype detected|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5572030	Cdan1<tm1b(KOMP)Wtsi>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001697,abnormal embryo size|MP:0002941,increased circulating alanine transaminase level|MP:0003179,thrombocytopenia|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:7442520	Cda<tm1d(EUCOMM)Wtsi>	MP:0002006,neoplasm|MP:0003447,decreased tumor growth/size|MP:0003701,elevated level of mitotic sister chromatid exchange|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005386,behavior/neurological phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005621,abnormal cell physiology|MP:0008866,chromosomal instability
MGI:5548737	Cdc123<tm1b(KOMP)Wtsi>	MP:0001488,increased startle reflex|MP:0002075,abnormal coat/hair pigmentation|MP:0002792,abnormal retina vasculature morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:6693771	Cdc14a<em1Jgao>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0004408,decreased cochlear hair cell number|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006325,impaired hearing|MP:0008261,arrest of male meiosis|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009234,absent sperm head|MP:0009238,coiled sperm flagellum|MP:0010723,paternal effect|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0020451,decreased sperm progressive motility
MGI:5810960	Cdc14a<em1Tbf>	MP:0001154,seminiferous tubule degeneration|MP:0001925,male infertility|MP:0001967,deafness|MP:0002687,oligozoospermia|MP:0004362,cochlear hair cell degeneration|MP:0004528,fused outer hair cell stereocilia|MP:0004533,fused inner hair cell stereocilia|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4456717	Cdc14a<tm1a(EUCOMM)Hmgu>	MP:0001967,deafness|MP:0004737,absent distortion product otoacoustic emissions|MP:0004740,sensorineural hearing loss|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5779857	Cdc14a<tm1b(EUCOMM)Hmgu>	MP:0001154,seminiferous tubule degeneration|MP:0001925,male infertility|MP:0001967,deafness|MP:0002687,oligozoospermia|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004528,fused outer hair cell stereocilia|MP:0004533,fused inner hair cell stereocilia|MP:0004737,absent distortion product otoacoustic emissions|MP:0004740,sensorineural hearing loss|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5779859	Cdc14a<tm1d(EUCOMM)Hmgu>	MP:0001154,seminiferous tubule degeneration|MP:0001925,male infertility|MP:0001967,deafness|MP:0002687,oligozoospermia|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004528,fused outer hair cell stereocilia|MP:0004533,fused inner hair cell stereocilia|MP:0004737,absent distortion product otoacoustic emissions|MP:0004740,sensorineural hearing loss|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5634967	Cdc14a<tm1e.1(EUCOMM)Hmgu>	MP:0001304,cataract|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5550277	Cdc14b<tm1.1Mama>	MP:0005384,cellular phenotype
MGI:4948253	Cdc14b<tm1.2Pzg>	MP:0000160,kyphosis|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001921,reduced fertility|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0003786,premature aging|MP:0005377,hearing/vestibular/ear phenotype|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0008008,early cellular replicative senescence|MP:0009454,impaired contextual conditioning behavior|MP:0011962,increased cornea thickness|MP:0014760,impaired DNA repair
MGI:6257489	Cdc16<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:6153297	Cdc20b<em1(IMPC)Wtsi>	MP:0001552,increased circulating triglyceride level|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number
MGI:3711105	Cdc20<Gt(XE368)Byg>	MP:0003702,abnormal chromosome morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance
MGI:5445785	Cdc20<tm1.1(KOMP)Vlcg>	MP:0002833,increased heart weight|MP:0005292,improved glucose tolerance|MP:0005559,increased circulating glucose level|MP:0005560,decreased circulating glucose level|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3851133	Cdc20<tm1.1Pzg>	MP:0000313,abnormal cell death|MP:0000352,decreased cell proliferation|MP:0001698,decreased embryo size|MP:0002020,increased tumor incidence|MP:0004024,aneuploidy|MP:0004046,abnormal mitosis|MP:0010264,increased hepatoma incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012431,increased lymphoma incidence|MP:0013504,increased embryonic tissue cell apoptosis
MGI:4887574	Cdc20<tm1.2Mama>	MP:0003406,failure of zygotic cell division|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4838294	Cdc20<tm1Jvd>	MP:0005389,reproductive system phenotype
MGI:6157342	Cdc23<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7608105	Cdc23<em1Lwa>	MP:0001926,female infertility|MP:0010767,abnormal female meiosis I arrest
MGI:3530222	Cdc25a<Gt(OST186277)Lex>	MP:0000130,abnormal trabecular bone morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:2445422	Cdc25a<m1Rfp>	MP:0000245,abnormal erythropoiesis|MP:0000351,increased cell proliferation|MP:0004045,abnormal cell cycle checkpoint function|MP:0005584,abnormal enzyme/coenzyme activity
MGI:3836586	Cdc25a<tm1.1Hpw>	MP:0002718,abnormal inner cell mass morphology|MP:0003984,embryonic growth retardation|MP:0006042,increased apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3831687	Cdc25a<tm1Dvb>	MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0004024,aneuploidy|MP:0004046,abnormal mitosis|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0030943,abnormal centrosome morphology
MGI:3836585	Cdc25a<tm1Hpw>	MP:0002169,no abnormal phenotype detected
MGI:3717591	Cdc25a<tm1Kiyo>	MP:0003693,abnormal blastocyst hatching|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2682953	Cdc25b<tm1Pjd>	MP:0001125,abnormal oocyte morphology|MP:0001919,abnormal reproductive system physiology|MP:0001926,female infertility|MP:0005168,abnormal female meiosis
MGI:2180791	Cdc25c<tm1Hpw>	MP:0002169,no abnormal phenotype detected
MGI:5548520	Cdc26<tm1b(EUCOMM)Hmgu>	MP:0005599,increased cardiac muscle contractility|MP:0011100,preweaning lethality, complete penetrance
MGI:6324187	Cdc27<tm1dIcs>	MP:0001417,decreased exploration in new environment|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount
MGI:5532536	Cdc34<tm1.1(KOMP)Mbp>	MP:0000579,abnormal nail morphology|MP:0001925,male infertility|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:6361011	Cdc37<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0002968,increased circulating alkaline phosphatase level|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:5788403	Cdc37l1<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001304,cataract|MP:0001399,hyperactivity|MP:0004738,abnormal auditory brainstem response
MGI:6404505	Cdc40<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:6509468	Cdc40<em1Jgg>	MP:0003631,nervous system phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:6509469	Cdc40<em2Jgg>	MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:5812907	Cdc42bpb<em1(IMPC)J>	MP:0001697,abnormal embryo size|MP:0003717,pallor|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7384726	Cdc42ep1<tm1Yxz>	MP:0000260,abnormal angiogenesis|MP:0000266,abnormal heart morphology|MP:0000280,thin ventricular wall|MP:0001262,decreased body weight|MP:0001614,abnormal blood vessel morphology|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0010097,abnormal retina blood vessel morphology|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011805,decreased cell migration|MP:0020329,decreased capillary density
MGI:6152427	Cdc42ep3<em1(IMPC)Mbp>	MP:0005343,increased circulating aspartate transaminase level
MGI:5910399	Cdc42ep4<tm1.1Ksh>	MP:0002804,abnormal motor learning|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003312,abnormal locomotor coordination|MP:0003631,nervous system phenotype|MP:0003635,abnormal synaptic transmission|MP:0011002,enhanced AMPA-mediated synaptic currents|MP:0011273,prolonged excitatory postsynaptic current decay time
MGI:4419249	Cdc42ep5<tm1(KOMP)Wtsi>	MP:0002075,abnormal coat/hair pigmentation|MP:0002606,increased basophil cell number|MP:0003961,decreased lean body mass|MP:0005011,increased eosinophil cell number
MGI:2156185	Cdc42<Gt(Ex160)Byg>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5320442	Cdc42<tm1.1Ayam>	MP:0000091,short premaxilla|MP:0000097,short maxilla|MP:0000102,abnormal nasal bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000111,cleft palate|MP:0000159,abnormal xiphoid process morphology|MP:0000164,abnormal cartilage development|MP:0000445,short snout|MP:0000458,abnormal mandible morphology|MP:0000547,short limbs|MP:0000564,syndactyly|MP:0000571,interdigital webbing|MP:0000572,abnormal autopod morphology|MP:0000746,weakness|MP:0001258,decreased body length|MP:0001436,abnormal suckling behavior|MP:0001915,intracranial hemorrhage|MP:0002109,abnormal limb morphology|MP:0002115,abnormal limb bone morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002239,abnormal nasal septum morphology|MP:0002544,brachydactyly|MP:0002820,abnormal premaxilla morphology|MP:0002932,abnormal joint morphology|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0004320,split sternum|MP:0004639,fused metacarpal bones|MP:0006397,disorganized long bone epiphyseal plate|MP:0008273,abnormal intramembranous bone ossification|MP:0008730,fused phalanges|MP:0008797,facial cleft|MP:0009546,absent gastric milk in neonates|MP:0009655,abnormal secondary palate development|MP:0009703,decreased birth body size|MP:0009874,abnormal interdigital cell death|MP:0009882,absent palatal shelf|MP:0009886,failure of palatal shelf elevation|MP:0009896,palatine bone horizontal plate hypoplasia|MP:0009898,maxillary shelf hypoplasia|MP:0009903,abnormal medial nasal prominence morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0030393,delayed fontanelle closure|MP:0030806,abnormal autopod joint morphology|MP:0031460,abnormal palatal shelf morphology
MGI:5495277	Cdc42<tm1.1Rac>	MP:0000440,domed cranium|MP:0000788,abnormal cerebral cortex morphology|MP:0000822,abnormal brain ventricle morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000826,abnormal third ventricle morphology|MP:0001402,decreased locomotor activity|MP:0001891,hydrocephaly|MP:0001917,intraventricular hemorrhage|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002741,small olfactory bulb|MP:0002958,cerebral aqueductal stenosis|MP:0003111,abnormal cell nucleus morphology|MP:0003634,abnormal glial cell morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0004981,decreased neuronal precursor cell number|MP:0005537,abnormal cerebral aqueduct morphology|MP:0006254,thin cerebral cortex|MP:0008439,abnormal cortical plate morphology|MP:0008458,abnormal cortical ventricular zone morphology|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0008547,abnormal neocortex morphology|MP:0009546,absent gastric milk in neonates|MP:0009688,abnormal spinal cord central canal morphology|MP:0010152,abnormal brain ependyma morphology|MP:0011057,absent brain ependyma motile cilia|MP:0011085,postnatal lethality, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0014561,decreased cortical ventricular zone cell density
MGI:5140986	Cdc42<tm1.1Yizh>	MP:0005598,decreased heart ventricle muscle contractility
MGI:5636900	Cdc42<tm1b(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000438,abnormal cranium morphology|MP:0001314,cornea opacity|MP:0001325,abnormal retina morphology|MP:0001556,increased circulating HDL cholesterol level|MP:0002874,decreased hemoglobin content|MP:0002968,increased circulating alkaline phosphatase level|MP:0003068,enlarged kidney|MP:0005013,increased lymphocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010067,increased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3619134	Cdc42<tm1Brak>	MP:0000377,abnormal hair follicle morphology|MP:0000388,absent hair follicle inner root sheath|MP:0000477,abnormal intestine morphology|MP:0000479,abnormal enterocyte morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000521,abnormal kidney cortex morphology|MP:0000524,decreased renal tubule number|MP:0000527,abnormal kidney development|MP:0001216,abnormal epidermal layer morphology|MP:0001222,epidermal hyperplasia|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001247,dermal cyst|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002655,abnormal keratinocyte morphology|MP:0003179,thrombocytopenia|MP:0003288,intestinal edema|MP:0003446,renal hypoplasia|MP:0003449,abnormal intestine goblet cell morphology|MP:0003624,anuria|MP:0003809,abnormal hair shaft morphology|MP:0003866,abnormal defecation|MP:0003871,abnormal myelin sheath morphology|MP:0004041,increased susceptibility to kidney reperfusion injury|MP:0004193,abnormal kidney papilla morphology|MP:0004505,decreased renal glomerulus number|MP:0004720,abnormal platelet morphology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005034,abnormal anus morphology|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0006298,abnormal platelet activation|MP:0008800,increased small intestinal crypt cell apoptosis|MP:0009446,abnormal platelet dense granule physiology|MP:0009586,increased platelet aggregation|MP:0009640,abnormal renal tubule epithelium morphology|MP:0010155,abnormal intestine physiology|MP:0010156,abnormal small intestinal crypt cell physiology|MP:0010686,abnormal hair follicle matrix region morphology|MP:0010802,abnormal intestinal enteroendocrine cell morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011334,abnormal nephrogenic zone morphology|MP:0013486,decreased Paneth cell number|MP:0014076,absent Paneth cells|MP:0031121,increased susceptibility to induced thrombosis
MGI:2156460	Cdc42<tm1Fwa>	MP:0001698,decreased embryo size|MP:0003988,disorganized embryonic tissue|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011184,absent embryonic epiblast|MP:0020849,abnormal actin cytoskeleton morphology
MGI:3693320	Cdc42<tm1Yizh>	MP:0000934,abnormal telencephalon development|MP:0000935,abnormal folding of telencephalic vesicles|MP:0000936,small embryonic telencephalon|MP:0001286,abnormal eye development|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005157,holoprosencephaly|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:6257721	Cdc45<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:2180780	Cdc45<tm1Dta>	MP:0002169,no abnormal phenotype detected|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:6305208	Cdc5l<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3794028	Cdc73<Gt(RRE190)Byg>	MP:0000194,increased circulating calcium level|MP:0000454,abnormal jaw morphology|MP:0001728,failure of embryo implantation|MP:0002083,premature death|MP:0002904,increased circulating parathyroid hormone level|MP:0003432,increased activity of parathyroid|MP:0003495,increased parathyroid adenoma incidence|MP:0008256,abnormal myometrium morphology|MP:0009082,uterus cyst|MP:0009092,endometrium hyperplasia|MP:0009222,increased uterus tumor incidence|MP:0010321,increased parathyroid gland tumor incidence|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012114,absent inner cell mass proliferation|MP:0012118,absent trophectoderm cell proliferation
MGI:3794032	Cdc73<tm1.1Btt>	MP:0011092,embryonic lethality, complete penetrance
MGI:3794030	Cdc73<tm1Btt>	MP:0000194,increased circulating calcium level|MP:0000352,decreased cell proliferation|MP:0000462,abnormal digestive system morphology|MP:0000601,small liver|MP:0000618,small salivary gland|MP:0000692,small spleen|MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001654,hepatic necrosis|MP:0001698,decreased embryo size|MP:0001961,abnormal reflex|MP:0002083,premature death|MP:0002164,abnormal gland physiology|MP:0002188,small heart|MP:0002691,small stomach|MP:0002989,small kidney|MP:0003495,increased parathyroid adenoma incidence|MP:0003641,small lung|MP:0003861,abnormal nervous system development|MP:0003946,renal necrosis|MP:0004819,decreased skeletal muscle mass|MP:0005324,ascites|MP:0005574,decreased pulmonary respiratory rate|MP:0006042,increased apoptosis|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008853,decreased abdominal adipose tissue amount|MP:0010321,increased parathyroid gland tumor incidence|MP:0011091,prenatal lethality, complete penetrance|MP:0013501,increased fibroblast apoptosis
MGI:5695891	Cdc7<tm1.1(KOMP)Vlcg>	MP:0000222,decreased neutrophil cell number|MP:0002060,abnormal skin morphology|MP:0005013,increased lymphocyte cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2183930	Cdc7<tm1Hmas>	MP:0004965,inner cell mass degeneration|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5576039	Cdca5<tm1.1(KOMP)Vlcg>	MP:0001303,abnormal lens morphology|MP:0002941,increased circulating alanine transaminase level|MP:0003019,increased circulating chloride level|MP:0004738,abnormal auditory brainstem response|MP:0005633,increased circulating sodium level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:7614313	Cdca7<em1Ldax>	MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0008877,abnormal DNA methylation|MP:0010768,mortality/aging
MGI:6158515	Cdca7l<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002989,small kidney|MP:0005178,increased circulating cholesterol level|MP:0009142,decreased prepulse inhibition
MGI:4362476	Cdca8<tm1a(KOMP)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0001973,increased thermal nociceptive threshold|MP:0002968,increased circulating alkaline phosphatase level|MP:0003019,increased circulating chloride level|MP:0003020,decreased circulating chloride level
MGI:3795253	Cdca8<tm1Tatn>	MP:0003111,abnormal cell nucleus morphology|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0003707,increased cell nucleus count|MP:0004046,abnormal mitosis|MP:0006042,increased apoptosis|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0014694,anisokaryosis|MP:0031678,increased micronucleus incidence
MGI:5442762	Cdcp1<tm1.1Moas>	MP:0002169,no abnormal phenotype detected
MGI:5442763	Cdcp1<tm1.2Moas>	MP:0002169,no abnormal phenotype detected
MGI:6276891	Cdcp2<em1(IMPC)Mbp>	MP:0000692,small spleen
MGI:6140120	Cdcp3<em1(IMPC)Mbp>	MP:0002092,abnormal eye morphology|MP:0002111,abnormal tail morphology
MGI:2388742	Cdcs10<C3H/HeJBir>	MP:0001858,intestinal inflammation
MGI:2159154	Cdcs1<C3H/HeJBir>	MP:0000462,abnormal digestive system morphology|MP:0001790,abnormal immune system physiology
MGI:2159156	Cdcs2<C3H/HeJBir>	MP:0001858,intestinal inflammation
MGI:2159159	Cdcs3<C3H/HeJBir>	MP:0001858,intestinal inflammation
MGI:2159163	Cdcs4<C57BL/6J>	MP:0001858,intestinal inflammation
MGI:2159175	Cdcs5<C57BL/6J>	MP:0001858,intestinal inflammation
MGI:2159179	Cdcs6<C57BL/6J>	MP:0001858,intestinal inflammation
MGI:2388736	Cdcs7<C3H/HeJBir>	MP:0001858,intestinal inflammation
MGI:2388739	Cdcs8<C57BL/6J>	MP:0001858,intestinal inflammation
MGI:2388741	Cdcs9<C3H/HeJBir>	MP:0001858,intestinal inflammation
MGI:5548371	Cdh10<tm2b(KOMP)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0001297,microphthalmia|MP:0003960,increased lean body mass|MP:0005013,increased lymphocyte cell number
MGI:6276836	Cdh11<em1(IMPC)Mbp>	MP:0000432,abnormal head morphology|MP:0000443,abnormal snout morphology|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001258,decreased body length|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003068,enlarged kidney|MP:0004924,abnormal behavior|MP:0010053,decreased grip strength|MP:0011496,abnormal head size|MP:0020870,decreased thigmotaxis
MGI:1861184	Cdh11<tm1Mta>	MP:0005380,embryo phenotype
MGI:6293911	Cdh12<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology
MGI:5519977	Cdh13<tm1.1Kry>	MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype
MGI:5612831	Cdh13<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0003900,shortened QT interval|MP:0010053,decreased grip strength
MGI:3778287	Cdh13<tm1Brns>	MP:0002006,neoplasm|MP:0005389,reproductive system phenotype|MP:0008852,retina neovascularization|MP:0030969,increased circulating adiponectin level
MGI:2663004	Cdh15<tm1Hha>	MP:0002169,no abnormal phenotype detected
MGI:6283871	Cdh17<M1Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:3573870	Cdh17<tm1Ohn>	MP:0001805,decreased IgG level|MP:0002362,abnormal spleen marginal zone morphology|MP:0003132,increased pre-B cell number|MP:0005017,decreased B cell number|MP:0008168,decreased B-1a cell number|MP:0008178,decreased germinal center B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008186,increased pro-B cell number|MP:0008211,decreased mature B cell number|MP:0008484,decreased spleen germinal center size
MGI:6382060	Cdh18<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001417,decreased exploration in new environment
MGI:4432826	Cdh19<tm1a(EUCOMM)Wtsi>	MP:0003961,decreased lean body mass|MP:0010124,decreased bone mineral content
MGI:4821988	Cdh1<tm1.1Mpst>	MP:0001711,abnormal placenta morphology|MP:0001715,placental labyrinth hypoplasia|MP:0001722,pale yolk sac|MP:0001730,embryonic growth arrest|MP:0003717,pallor|MP:0005031,abnormal trophoblast layer morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0010038,abnormal placenta physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011521,decreased placental labyrinth size
MGI:4432805	Cdh1<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:2182564	Cdh1<tm1Cbm>	MP:0002663,absent blastocoele|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0009781,abnormal preimplantation embryo development|MP:0011092,embryonic lethality, complete penetrance|MP:0012111,failure of morula compaction
MGI:3693661	Cdh1<tm1Jjon>	MP:0002006,neoplasm|MP:0002169,no abnormal phenotype detected|MP:0013716,hypolactation
MGI:1857282	Cdh1<tm1Kem>	MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002663,absent blastocoele|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012102,absent trophectoderm
MGI:3822550	Cdh1<tm1Mlec>	MP:0002412,increased susceptibility to bacterial infection|MP:0008882,abnormal enterocyte physiology
MGI:5426968	Cdh1<tm2.1Mpst>	MP:0002663,absent blastocoele|MP:0012102,absent trophectoderm|MP:0012119,increased trophectoderm apoptosis
MGI:2389020	Cdh1<tm2Kem>	MP:0001614,abnormal blood vessel morphology|MP:0003059,decreased insulin secretion|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005378,growth/size/body region phenotype|MP:0009113,increased pancreatic beta cell mass|MP:0011819,increased pancreatic beta cell proliferation
MGI:3574479	Cdh1<tm3.1Kem>	MP:0002080,prenatal lethality
MGI:5426969	Cdh1<tm3.1Mpst>	MP:0005028,abnormal trophectoderm morphology
MGI:3574481	Cdh1<tm3.2Kem>	MP:0011091,prenatal lethality, complete penetrance
MGI:3574476	Cdh1<tm3Kem>	MP:0011091,prenatal lethality, complete penetrance
MGI:3696711	Cdh1<tm4(Cdh2)Kem>	MP:0001672,abnormal embryo development|MP:0009687,empty decidua capsularis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3696713	Cdh1<tm5(Cdh2)Kem>	MP:0002085,abnormal embryonic tissue morphology|MP:0002663,absent blastocoele|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0009687,empty decidua capsularis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012102,absent trophectoderm
MGI:6404179	Cdh20<em1(IMPC)J>	MP:0002574,increased vertical activity|MP:0005635,decreased circulating bilirubin level
MGI:4453135	Cdh23<12J>	MP:0000043,organ of Corti degeneration|MP:0001967,deafness|MP:0004362,cochlear hair cell degeneration|MP:0004396,decreased cochlear inner hair cell number|MP:0004398,cochlear inner hair cell degeneration|MP:0004402,decreased cochlear outer hair cell number|MP:0004404,cochlear outer hair cell degeneration|MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004523,decreased cochlear hair cell stereocilia number|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004578,abnormal cochlear hair bundle tip links morphology|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004737,absent distortion product otoacoustic emissions|MP:0004738,abnormal auditory brainstem response|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0006325,impaired hearing|MP:0006358,absent pinna reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3028349	Cdh23<ahl>	MP:0000043,organ of Corti degeneration|MP:0003637,cochlear ganglion hypoplasia|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004748,increased susceptibility to age-related hearing loss
MGI:5140884	Cdh23<Jera>	MP:0000042,abnormal organ of Corti morphology|MP:0000043,organ of Corti degeneration|MP:0002855,abnormal cochlear ganglion morphology|MP:0004362,cochlear hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5513006	Cdh23<m1Btlr>	MP:0001410,head bobbing
MGI:6268401	Cdh23<m2Btlr>	MP:0001262,decreased body weight|MP:0001394,circling
MGI:3708379	Cdh23<sals>	MP:0000043,organ of Corti degeneration|MP:0001489,decreased startle reflex|MP:0001963,abnormal hearing physiology|MP:0002622,abnormal cochlear hair cell morphology|MP:0002857,cochlear ganglion degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004432,abnormal cochlear hair cell physiology|MP:0004578,abnormal cochlear hair bundle tip links morphology|MP:0004737,absent distortion product otoacoustic emissions|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5897899	Cdh23<tm1.1Kjn>	MP:0004396,decreased cochlear inner hair cell number|MP:0004402,decreased cochlear outer hair cell number|MP:0004408,decreased cochlear hair cell number|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4361286	Cdh23<tm1.1Ugds>	MP:0004413,absent cochlear microphonics|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0004531,short outer hair cell stereocilia|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004534,decreased inner hair cell stereocilia number|MP:0004536,short inner hair cell stereocilia|MP:0004578,abnormal cochlear hair bundle tip links morphology|MP:0004737,absent distortion product otoacoustic emissions|MP:0005386,behavior/neurological phenotype|MP:0006325,impaired hearing|MP:0006335,abnormal hearing electrophysiology|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4441515	Cdh23<tm1.2Ugds>	MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0004527,abnormal outer hair cell stereociliary bundle morphology
MGI:5897995	Cdh23<tm2.1Kjn>	MP:0005377,hearing/vestibular/ear phenotype
MGI:5775000	Cdh23<tm2b(EUCOMM)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0000221,decreased leukocyte cell number|MP:0001258,decreased body length|MP:0001406,abnormal gait|MP:0001408,stereotypic behavior|MP:0001512,trunk curl|MP:0001523,impaired righting response|MP:0003019,increased circulating chloride level|MP:0003960,increased lean body mass|MP:0005560,decreased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005633,increased circulating sodium level|MP:0006358,absent pinna reflex|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:1856228	Cdh23<v>	MP:0000745,tremors|MP:0001388,abnormal stationary movement|MP:0001392,abnormal locomotor behavior|MP:0001394,circling|MP:0001406,abnormal gait|MP:0001442,decreased grooming behavior|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0002730,head shaking|MP:0002757,decreased vertical activity|MP:0002857,cochlear ganglion degeneration|MP:0003107,abnormal response to novelty|MP:0003866,abnormal defecation|MP:0004331,vestibular saccular macula degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004396,decreased cochlear inner hair cell number|MP:0004402,decreased cochlear outer hair cell number|MP:0004415,abnormal cochlear nerve compound action potential|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004597,increased susceptibility to noise-induced hearing loss|MP:0004748,increased susceptibility to age-related hearing loss|MP:0005376,homeostasis/metabolism phenotype|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology|MP:0006325,impaired hearing|MP:0006358,absent pinna reflex
MGI:3032511	Cdh23<v-10J>	MP:0001388,abnormal stationary movement|MP:0001394,circling|MP:0001967,deafness|MP:0004738,abnormal auditory brainstem response|MP:0005191,head tilt
MGI:3772667	Cdh23<v-11J>	MP:0000043,organ of Corti degeneration|MP:0001394,circling|MP:0001410,head bobbing|MP:0001967,deafness|MP:0005391,vision/eye phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2154548	Cdh23<v-2J>	MP:0001394,circling|MP:0001522,impaired swimming|MP:0001961,abnormal reflex|MP:0002102,abnormal ear morphology|MP:0003878,abnormal ear physiology|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004432,abnormal cochlear hair cell physiology|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0004530,absent outer hair cell stereocilia|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004577,abnormal cochlear hair cell inter-stereocilial links morphology|MP:0004578,abnormal cochlear hair bundle tip links morphology|MP:0004748,increased susceptibility to age-related hearing loss|MP:0004813,absent linear vestibular evoked potential|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology|MP:0006358,absent pinna reflex|MP:0011061,abnormal inner hair cell kinocilium morphology|MP:0011062,abnormal outer hair cell kinocilium morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012148,decreased a-wave implicit time|MP:0012149,decreased b-wave implicit time
MGI:2657145	Cdh23<v-3J>	MP:0001393,ataxia|MP:0004742,abnormal vestibular system physiology|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1857519	Cdh23<v-4J>	MP:0001394,circling|MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0001967,deafness
MGI:1857520	Cdh23<v-5J>	MP:0001394,circling|MP:0001410,head bobbing|MP:0001967,deafness
MGI:2154547	Cdh23<v-6J>	MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2154258	Cdh23<v-7J>	MP:0000026,abnormal inner ear morphology|MP:0000043,organ of Corti degeneration|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001967,deafness|MP:0002857,cochlear ganglion degeneration|MP:0004329,vestibular saccular degeneration|MP:0004363,stria vascularis degeneration|MP:0005307,head tossing
MGI:2663947	Cdh23<v-8J>	MP:0001394,circling|MP:0001967,deafness|MP:0004738,abnormal auditory brainstem response|MP:0005191,head tilt
MGI:2680541	Cdh23<v-9J>	MP:0001394,circling|MP:0001967,deafness|MP:0004738,abnormal auditory brainstem response
MGI:1857310	Cdh23<v-Alb>	MP:0001395,bidirectional circling|MP:0001399,hyperactivity|MP:0001935,decreased litter size|MP:0001967,deafness|MP:0002102,abnormal ear morphology|MP:0003878,abnormal ear physiology|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0004530,absent outer hair cell stereocilia|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0005307,head tossing|MP:0005391,vision/eye phenotype|MP:0030961,abnormal outer hair cell kinocilium location or orientation
MGI:1856681	Cdh23<v-bus>	MP:0000031,abnormal cochlea morphology|MP:0000042,abnormal organ of Corti morphology|MP:0001386,abnormal maternal nurturing|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001486,abnormal startle reflex|MP:0002622,abnormal cochlear hair cell morphology|MP:0002855,abnormal cochlear ganglion morphology|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0004408,decreased cochlear hair cell number|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004492,abnormal orientation of inner hair cell stereociliary bundles|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0005191,head tilt|MP:0005307,head tossing|MP:0006359,absent startle reflex
MGI:1856229	Cdh23<v-df>	MP:0000023,abnormal ear position|MP:0000043,organ of Corti degeneration|MP:0000048,abnormal stria vascularis morphology|MP:0001967,deafness|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002855,abnormal cochlear ganglion morphology|MP:0006358,absent pinna reflex
MGI:1856412	Cdh23<v-J>	MP:0001393,ataxia|MP:0002894,abnormal otolith morphology|MP:0005307,head tossing|MP:0005357,novel environmental response-related retropulsion|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2154549	Cdh23<v-ngt>	MP:0001394,circling|MP:0001967,deafness|MP:0002730,head shaking|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0006358,absent pinna reflex
MGI:5695960	Cdh26<tm1.1(KOMP)Vlcg>	MP:0005575,increased pulmonary ventilation|MP:0005576,decreased pulmonary ventilation|MP:0005586,decreased tidal volume|MP:0006203,eye hemorrhage|MP:0012125,decreased bronchoconstrictive response
MGI:7432734	Cdh2<em1Obir>	MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0001900,impaired synaptic plasticity|MP:0002634,abnormal sensorimotor gating|MP:0003088,abnormal prepulse inhibition|MP:0003862,decreased aggression towards male mice|MP:0003990,decreased neurotransmitter release|MP:0004770,abnormal synaptic vesicle recycling|MP:0004793,abnormal synaptic vesicle clustering|MP:0009538,abnormal synapse morphology|MP:0011448,decreased dopaminergic neuron number|MP:0014376,decreased miniature excitatory postsynaptic current frequency|MP:0014711,decreased synaptic vesicle readily releasable pool size|MP:0020875,decreased nervous system dopamine level
MGI:7432736	Cdh2<em2Obir>	MP:0001399,hyperactivity
MGI:3525642	Cdh2<Gt(OST49160)Lex>	MP:0000270,abnormal heart tube morphology|MP:0000913,abnormal brain development|MP:0001787,pericardial edema|MP:0011091,prenatal lethality, complete penetrance
MGI:7639718	Cdh2<tm1.1Ayki>	MP:0002206,abnormal CNS synaptic transmission|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0009455,enhanced cued conditioning behavior|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0014369,enhanced spatial working memory|MP:0020360,abnormal asymmetric synapse morphology|MP:0020551,abnormal postsynaptic density morphology
MGI:3522469	Cdh2<tm1Glr>	MP:0000778,abnormal nervous system tract morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000789,thickened cerebral cortex|MP:0000955,abnormal spinal cord morphology|MP:0003648,abnormal radial glial cell morphology|MP:0004980,increased neuronal precursor cell number|MP:0006009,abnormal neuronal migration|MP:0008458,abnormal cortical ventricular zone morphology|MP:0008547,abnormal neocortex morphology|MP:0009685,abnormal spinal cord motor column morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011723,ectopic neuron
MGI:1861181	Cdh2<tm1Hyn>	MP:0000270,abnormal heart tube morphology|MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000292,distended pericardium|MP:0000930,wavy neural tube|MP:0001691,abnormal somite shape|MP:0001700,abnormal embryo turning|MP:0001718,abnormal visceral yolk sac morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0005329,abnormal myocardium layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1857943	Cdh3<tm1Hyn>	MP:0000627,abnormal mammary gland morphology|MP:0000628,abnormal mammary gland development|MP:0000630,mammary gland hyperplasia|MP:0001884,mammary gland alveolar hyperplasia|MP:0001885,mammary gland duct hyperplasia
MGI:5571352	Cdh4<tm1b(EUCOMM)Wtsi>	MP:0001516,abnormal motor coordination/balance|MP:0002757,decreased vertical activity|MP:0005568,increased circulating total protein level|MP:0005633,increased circulating sodium level
MGI:2180782	Cdh4<tm1Semb>	MP:0000527,abnormal kidney development|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005367,renal/urinary system phenotype|MP:0006032,abnormal ureteric bud morphology|MP:0009050,dilated proximal convoluted tubule|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0011386,increased metanephric mesenchyme apoptosis
MGI:5647997	Cdh5<tm1.1Ics>	MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001785,edema|MP:0002016,ovary cyst|MP:0003070,increased vascular permeability|MP:0004832,enlarged ovary|MP:0004906,enlarged uterus|MP:0006055,abnormal vascular endothelial cell morphology|MP:0009083,uterus hypertrophy|MP:0009251,enlarged endometrial glands|MP:0009444,ovarian follicular cyst|MP:0013398,uterus fibrosis|MP:0013607,ovary fibrosis
MGI:2148548	Cdh5<tm1.1Pec>	MP:0000259,abnormal vascular development|MP:0000260,abnormal angiogenesis|MP:0001622,abnormal vasculogenesis|MP:0001688,abnormal somite development|MP:0001730,embryonic growth arrest|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0003411,abnormal vein development|MP:0003542,abnormal vascular endothelial cell development|MP:0005397,hematopoietic system phenotype|MP:0006042,increased apoptosis|MP:0006126,abnormal cardiac outflow tract development|MP:0006346,small pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012082,delayed heart development|MP:0012253,abnormal intersomitic vessel morphology
MGI:5294807	Cdh5<tm1Dvst>	MP:0001914,hemorrhage|MP:0002792,abnormal retina vasculature morphology|MP:0005601,increased angiogenesis|MP:0005602,decreased angiogenesis|MP:0009772,abnormal retina development
MGI:1857669	Cdh5<tm1Hub>	MP:0000292,distended pericardium|MP:0000313,abnormal cell death|MP:0001622,abnormal vasculogenesis|MP:0001636,irregular heartbeat|MP:0001689,incomplete somite formation|MP:0001701,incomplete embryo turning|MP:0001719,absent vitelline blood vessels|MP:0003230,abnormal umbilical artery morphology|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004068,dilated dorsal aorta|MP:0005602,decreased angiogenesis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011204,abnormal visceral yolk sac blood island morphology|MP:0012253,abnormal intersomitic vessel morphology|MP:0012300,abnormal umbilical cord blood vessel morphology
MGI:2148547	Cdh5<tm1Pec>	MP:0000259,abnormal vascular development|MP:0000260,abnormal angiogenesis|MP:0001622,abnormal vasculogenesis|MP:0001688,abnormal somite development|MP:0001730,embryonic growth arrest|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0003411,abnormal vein development|MP:0003542,abnormal vascular endothelial cell development|MP:0005397,hematopoietic system phenotype|MP:0006042,increased apoptosis|MP:0006126,abnormal cardiac outflow tract development|MP:0006346,small pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012082,delayed heart development|MP:0012253,abnormal intersomitic vessel morphology
MGI:5294795	Cdh5<tm2(Cdh5)Dvst>	MP:0002169,no abnormal phenotype detected
MGI:2148549	Cdh5<tm2Pec>	MP:0000259,abnormal vascular development|MP:0000260,abnormal angiogenesis|MP:0001622,abnormal vasculogenesis|MP:0001688,abnormal somite development|MP:0001730,embryonic growth arrest|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0003411,abnormal vein development|MP:0003542,abnormal vascular endothelial cell development|MP:0005397,hematopoietic system phenotype|MP:0006042,increased apoptosis|MP:0006126,abnormal cardiac outflow tract development|MP:0006346,small pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012082,delayed heart development|MP:0012253,abnormal intersomitic vessel morphology
MGI:5294790	Cdh5<tm3(Cdh5/Ctnna1)Dvst>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0001619,abnormal vascular permeability|MP:0001879,abnormal lymphatic vessel morphology|MP:0002123,abnormal definitive hematopoiesis|MP:0003156,abnormal leukocyte migration|MP:0003390,lymphedema|MP:0003402,decreased liver weight|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005501,abnormal skin physiology|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0009858,abnormal cellular extravasation|MP:0010195,abnormal lymphatic vessel endothelium morphology|MP:0010197,abnormal lymphatic vessel endothelial cell morphology|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011092,embryonic lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014400,increased hematopoietic precursor cell number
MGI:5305106	Cdh5<tm4(Cdh5/Fkbp,Ptprb/Mtor*)Dvst>	MP:0003071,decreased vascular permeability|MP:0008719,impaired neutrophil recruitment|MP:0009858,abnormal cellular extravasation
MGI:5617005	Cdh5<tm5Dvst>	MP:0009858,abnormal cellular extravasation
MGI:5617006	Cdh5<tm6Dvst>	MP:0009858,abnormal cellular extravasation
MGI:5621267	Cdh5<tm7Dvst>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5621268	Cdh5<tm8Dvst>	MP:0005370,liver/biliary system phenotype
MGI:2387681	Cdh6<tm1Nosu>	MP:0003631,nervous system phenotype
MGI:1861807	Cdh6<tm1Sma>	MP:0000527,abnormal kidney development|MP:0011290,decreased nephron number|MP:0011291,nephron necrosis
MGI:5909204	Cdh7<em1(IMPC)J>	MP:0001304,cataract
MGI:3707077	Cdh8<tm1Mta>	MP:0001391,abnormal tail movements|MP:0002206,abnormal CNS synaptic transmission|MP:0002733,abnormal thermal nociception|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005391,vision/eye phenotype
MGI:6147663	Cdh9<tm1b(KOMP)Wtsi>	MP:0003631,nervous system phenotype|MP:0005178,increased circulating cholesterol level|MP:0005391,vision/eye phenotype|MP:0006073,abnormal retina bipolar cell morphology|MP:0010053,decreased grip strength
MGI:4360873	Cdhr1<tm1(cre)Kbal>	MP:0002169,no abnormal phenotype detected
MGI:3046299	Cdhr1<tm1Nat>	MP:0001325,abnormal retina morphology|MP:0005551,abnormal eye electrophysiology|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:6363535	Cdhr2<tm1c(EUCOMM)Hmgu>	MP:0000479,abnormal enterocyte morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0004002,abnormal jejunum morphology|MP:0008109,abnormal small intestinal microvillus morphology|MP:0008882,abnormal enterocyte physiology|MP:0013482,abnormal duodenum crypts of Lieberkuhn morphology|MP:0014082,decreased small intestinal villus height
MGI:6333009	Cdhr3<em1(IMPC)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0001510,abnormal coat appearance|MP:0005016,decreased lymphocyte cell number
MGI:5007056	Cdhr5<tm1Lex>	MP:0002006,neoplasm|MP:0005381,digestive/alimentary phenotype|MP:0008883,abnormal enterocyte proliferation
MGI:5749789	Cdin1<em1(IMPC)J>	MP:0001486,abnormal startle reflex|MP:0002941,increased circulating alanine transaminase level|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:4071535	Cdip1<Gt(IST12371A7)Tigm>	MP:0006043,decreased apoptosis
MGI:5565610	Cdip1<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0020870,decreased thigmotaxis
MGI:7663892	Cdiptos<em1Sunb>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:5548363	Cdipt<tm1b(EUCOMM)Wtsi>	MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0011972,decreased circulating lactate dehydrogenase level|MP:0013292,embryonic lethality prior to organogenesis
MGI:6201331	Cdk10<tm1.2Kald>	MP:0000266,abnormal heart morphology|MP:0000460,mandible hypoplasia|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001732,postnatal growth retardation|MP:0002108,abnormal muscle morphology|MP:0002135,abnormal kidney morphology|MP:0002267,abnormal bronchiole morphology|MP:0002703,abnormal renal tubule morphology|MP:0003109,short femur|MP:0004154,renal tubular necrosis|MP:0004201,fetal growth retardation|MP:0009640,abnormal renal tubule epithelium morphology|MP:0010702,split cervical atlas|MP:0010703,split cervical axis|MP:0010730,absent odontoid process|MP:0010819,primary atelectasis|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011346,renal tubule atrophy|MP:0020137,decreased bone mineralization
MGI:3759055	Cdk11b<Gt(XG836)Byg>	MP:0001219,thick epidermis|MP:0002051,increased skin papilloma incidence|MP:0002060,abnormal skin morphology
MGI:3043373	Cdk11b<tm1Vjk>	MP:0000352,decreased cell proliferation|MP:0001730,embryonic growth arrest|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5754588	Cdk12<em1(IMPC)Tcp>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000208,decreased hematocrit|MP:0000538,abnormal urinary bladder morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001417,decreased exploration in new environment|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004952,increased spleen weight|MP:0010067,increased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5906608	Cdk12<tm1.2Mjfn>	MP:0002718,abnormal inner cell mass morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0006042,increased apoptosis|MP:0008866,chromosomal instability|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4842225	Cdk13<tm1a(EUCOMM)Hmgu>	MP:0000233,abnormal blood flow velocity|MP:0000266,abnormal heart morphology|MP:0000280,thin ventricular wall|MP:0000528,delayed kidney development|MP:0000601,small liver|MP:0000774,decreased brain size|MP:0001636,irregular heartbeat|MP:0001698,decreased embryo size|MP:0001889,delayed brain development|MP:0002652,thin myocardium|MP:0002989,small kidney|MP:0003641,small lung|MP:0003658,abnormal capillary morphology|MP:0003984,embryonic growth retardation|MP:0005312,pericardial effusion|MP:0005329,abnormal myocardium layer morphology|MP:0009653,abnormal palate development|MP:0009655,abnormal secondary palate development|MP:0009890,cleft secondary palate|MP:0010545,abnormal heart layer morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012269,nuchal edema|MP:0013580,abnormal nasal gland morphology
MGI:5588278	Cdk13<tm1b(EUCOMM)Hmgu>	MP:0001488,increased startle reflex|MP:0011100,preweaning lethality, complete penetrance
MGI:6451101	Cdk13<tm1d(EUCOMM)Hmgu>	MP:0000108,midline facial cleft|MP:0000527,abnormal kidney development|MP:0000596,abnormal liver development|MP:0000601,small liver|MP:0001698,decreased embryo size|MP:0002188,small heart|MP:0002989,small kidney|MP:0003743,abnormal facial morphology|MP:0003984,embryonic growth retardation|MP:0005294,abnormal heart ventricle morphology|MP:0005312,pericardial effusion|MP:0012085,midface hypoplasia|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4362247	Cdk14<tm1a(KOMP)Wtsi>	MP:0010093,decreased circulating magnesium level
MGI:7547243	Cdk14<tm1Dsp>	MP:0002946,delayed axon extension
MGI:5498771	Cdk15<tm1b(KOMP)Wtsi>	MP:0002702,decreased circulating free fatty acids level|MP:0002833,increased heart weight
MGI:5319210	Cdk16<tm1.2Stge>	MP:0001146,abnormal testis morphology|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002208,abnormal germ cell morphology|MP:0002675,asthenozoospermia|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009834,abnormal sperm annulus morphology
MGI:5912110	Cdk17<em1(IMPC)J>	MP:0000443,abnormal snout morphology|MP:0001399,hyperactivity|MP:0001697,abnormal embryo size|MP:0002574,increased vertical activity|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5911515	Cdk18<em1(IMPC)J>	MP:0005553,increased circulating creatinine level
MGI:5607862	Cdk19<em1(IMPC)J>	MP:0002833,increased heart weight|MP:0010052,increased grip strength
MGI:7261165	Cdk19<em1Smoc>	MP:0004809,increased hematopoietic stem cell number|MP:0005397,hematopoietic system phenotype|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011903,decreased hematopoietic stem cell proliferation|MP:0013705,decreased megakaryocyte-erythroid progenitor cell number
MGI:3722849	Cdk1<Gt(P009F08)Bbd>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3722851	Cdk1<Gt(pGT1-3)1Bbd>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3818306	Cdk1<tm1(Cdk2)Kald>	MP:0002169,no abnormal phenotype detected|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5604426	Cdk1<tm1Eddy>	MP:0002840,abnormal lens fiber morphology|MP:0003237,abnormal lens epithelium morphology|MP:0005545,abnormal lens development
MGI:5318085	Cdk1<tm2.1Kald>	MP:0000352,decreased cell proliferation|MP:0000606,decreased hepatocyte number|MP:0000607,abnormal hepatocyte morphology|MP:0002053,decreased incidence of induced tumors|MP:0003447,decreased tumor growth/size|MP:0004001,decreased hepatocyte proliferation|MP:0004025,polyploidy|MP:0004046,abnormal mitosis|MP:0005164,abnormal response to injury|MP:0008008,early cellular replicative senescence|MP:0008057,abnormal DNA replication
MGI:5318086	Cdk1<tm2.2Kald>	MP:0003111,abnormal cell nucleus morphology|MP:0003406,failure of zygotic cell division|MP:0003706,abnormal cell nucleus count|MP:0004957,abnormal blastocyst morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:6201517	Cdk1<tm3.1Kald>	MP:0011092,embryonic lethality, complete penetrance
MGI:6160101	Cdk1<tm3Kald>	MP:0001147,small testis|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis
MGI:6257424	Cdk20<em1(IMPC)Bay>	MP:0000111,cleft palate|MP:0000562,polydactyly|MP:0001293,anophthalmia|MP:0001697,abnormal embryo size|MP:0003385,abnormal body wall morphology|MP:0003743,abnormal facial morphology|MP:0008797,facial cleft|MP:0011100,preweaning lethality, complete penetrance
MGI:6113512	Cdk20<tm1.1Jegg>	MP:0000111,cleft palate|MP:0000552,abnormal radius morphology|MP:0000914,exencephaly|MP:0000925,abnormal floor plate morphology|MP:0000926,absent floor plate|MP:0000929,open neural tube|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0002151,abnormal neural tube morphology|MP:0005108,abnormal ulna morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0009743,preaxial polydactyly|MP:0013202,abnormal cilium morphology|MP:0013210,abnormal primary cilium physiology|MP:0013213,abnormal embryonic neuroepithelium primary cilium morphology
MGI:4419942	Cdk20<tm1a(KOMP)Wtsi>	MP:0000111,cleft palate|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0014134,abnormal embryo morphology
MGI:3512185	Cdk2ap1<tm1Dtw>	MP:0000445,short snout|MP:0005380,embryo phenotype|MP:0005621,abnormal cell physiology|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0030046,round forehead
MGI:5910604	Cdk2ap2<em1(IMPC)J>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0005562,decreased mean corpuscular hemoglobin
MGI:5319654	Cdk2<tm1.1Jro>	MP:0001262,decreased body weight|MP:0001922,reduced male fertility|MP:0003205,testicular atrophy|MP:0005159,azoospermia|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2679913	Cdk2<tm1Kald>	MP:0001126,abnormal ovary morphology|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001265,decreased body size|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0003077,abnormal cell cycle|MP:0004001,decreased hepatocyte proliferation|MP:0004805,absent oocytes|MP:0004833,ovary atrophy|MP:0004894,uterus atrophy|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011122,absent primordial ovarian follicles
MGI:2675585	Cdk2<tm1Sgo>	MP:0001119,abnormal female reproductive system morphology|MP:0001125,abnormal oocyte morphology|MP:0001134,absent corpus luteum|MP:0001145,abnormal male reproductive system morphology|MP:0001924,infertility|MP:0001929,abnormal gametogenesis|MP:0001930,abnormal meiosis|MP:0001932,abnormal spermiogenesis|MP:0002161,abnormal fertility/fecundity|MP:0002216,abnormal seminiferous tubule morphology|MP:0002777,absent ovarian follicles|MP:0003205,testicular atrophy|MP:0004833,ovary atrophy
MGI:5697686	Cdk3<rs27030777-A>	MP:0002169,no abnormal phenotype detected
MGI:2154521	Cdk4<tm1.1Bbd>	MP:0001152,increased Leydig cell number|MP:0001260,increased body weight|MP:0002006,neoplasm|MP:0003645,increased pancreatic beta cell number|MP:0005376,homeostasis/metabolism phenotype
MGI:2154520	Cdk4<tm1Bbd>	MP:0001119,abnormal female reproductive system morphology|MP:0001127,small ovary|MP:0001145,abnormal male reproductive system morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001426,polydipsia|MP:0001524,impaired limb coordination|MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level|MP:0001762,polyuria|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0002082,postnatal lethality|MP:0002216,abnormal seminiferous tubule morphology|MP:0002679,abnormal corpus luteum morphology|MP:0002687,oligozoospermia|MP:0002727,decreased circulating insulin level|MP:0002784,abnormal Sertoli cell morphology|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0002893,ketoaciduria|MP:0003077,abnormal cell cycle|MP:0003698,abnormal male reproductive system physiology|MP:0003699,abnormal female reproductive system physiology|MP:0004852,decreased testis weight|MP:0005185,decreased circulating progesterone level|MP:0005215,abnormal pancreatic islet morphology|MP:0005536,decreased Leydig cell number|MP:0009172,small pancreatic islets|MP:0031419,delayed estrus
MGI:5766181	Cdk4<tm1b(NCOM)Mfgc>	MP:0000438,abnormal cranium morphology|MP:0001258,decreased body length|MP:0001297,microphthalmia|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002590,increased mean corpuscular volume|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2149587	Cdk4<tm1Kiyo>	MP:0001119,abnormal female reproductive system morphology|MP:0001145,abnormal male reproductive system morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001759,increased urine glucose level|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002161,abnormal fertility/fecundity|MP:0002679,abnormal corpus luteum morphology|MP:0002687,oligozoospermia|MP:0002785,absent Leydig cells|MP:0003356,impaired luteinization|MP:0005159,azoospermia|MP:0005215,abnormal pancreatic islet morphology|MP:0008332,decreased lactotroph cell number|MP:0008365,adenohypophysis hypoplasia|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5705761	Cdk4<tm2.2Bbd>	MP:0002169,no abnormal phenotype detected
MGI:5009264	Cdk4<wnch>	MP:0002078,abnormal glucose homeostasis
MGI:2683302	Cdk5r1<tm1Ivi>	MP:0000790,abnormal stratification in cerebral cortex|MP:0000849,abnormal cerebellum morphology|MP:0000884,delaminated Purkinje cell layer|MP:0002762,ectopic cerebellar granule cells
MGI:1931885	Cdk5r1<tm1Lht>	MP:0000781,decreased corpus callosum size|MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000813,abnormal hippocampus layer morphology|MP:0000825,dilated lateral ventricle|MP:0000885,ectopic Purkinje cell|MP:0000889,abnormal cerebellar molecular layer|MP:0001399,hyperactivity|MP:0001473,reduced long-term potentiation|MP:0002064,seizures|MP:0002083,premature death|MP:0002184,abnormal innervation|MP:0002739,abnormal olfactory bulb development|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003232,abnormal forebrain development|MP:0003651,abnormal axon extension|MP:0003927,increased cellular glucose import|MP:0004077,abnormal striatum morphology|MP:0008440,abnormal subplate morphology|MP:0008441,thin cortical plate|MP:0008872,abnormal physiological response to xenobiotic|MP:0009745,abnormal behavioral response to xenobiotic|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0010069,increased serotonin level|MP:0011624,abnormal sensitization to xenobiotic|MP:0012468,decreased striatum size
MGI:2680652	Cdk5r1<tm1Ohsh>	MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001475,reduced long-term depression|MP:0001973,increased thermal nociceptive threshold|MP:0009938,abnormal hippocampus granule cell morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology
MGI:5560495	Cdk5r1<tm2.1Lht>	MP:0001898,abnormal long-term depression|MP:0002912,abnormal excitatory postsynaptic potential|MP:0012318,slow extinction of fear memory
MGI:5660032	Cdk5r1<tm2Ohsh>	MP:0001405,impaired coordination|MP:0001473,reduced long-term potentiation|MP:0001899,absent long-term depression|MP:0001900,impaired synaptic plasticity|MP:0003631,nervous system phenotype
MGI:2387662	Cdk5r2<tm1Lht>	MP:0002169,no abnormal phenotype detected
MGI:5750452	Cdk5rap1<tm1.2Tomik>	MP:0001625,cardiac hypertrophy|MP:0003674,oxidative stress|MP:0004485,increased response of heart to induced stress|MP:0005140,decreased cardiac muscle contractility|MP:0005290,decreased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005560,decreased circulating glucose level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005621,abnormal cell physiology|MP:0006036,abnormal mitochondrial physiology|MP:0010955,abnormal respiratory electron transport chain|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0010959,abnormal oxidative phosphorylation|MP:0011630,increased mitochondrial size|MP:0011635,abnormal mitochondrial crista morphology|MP:0012106,impaired exercise endurance|MP:0012557,decreased calcium uptake by cardiac muscle|MP:0013272,abnormal translation|MP:0014046,abnormal mitophagy|MP:0014394,increased skeletal muscle fiber mitochondrial DNA content
MGI:1856646	Cdk5rap2<an>	MP:0000160,kyphosis|MP:0000221,decreased leukocyte cell number|MP:0000245,abnormal erythropoiesis|MP:0000248,macrocytosis|MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0001156,abnormal spermatogenesis|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001921,reduced fertility|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002209,decreased germ cell number|MP:0002447,abnormal erythrocyte morphology|MP:0002642,anisocytosis|MP:0002741,small olfactory bulb|MP:0002811,macrocytic anemia|MP:0003203,increased neuron apoptosis|MP:0003232,abnormal forebrain development|MP:0003241,loss of cortex neurons|MP:0004046,abnormal mitosis|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0005114,premature hair loss|MP:0005431,decreased oocyte number|MP:0006254,thin cerebral cortex|MP:0008283,small hippocampus|MP:0008941,reticulocytopenia|MP:0009760,abnormal mitotic spindle morphology|MP:0009859,eye opacity|MP:0009967,abnormal neuron proliferation|MP:0011380,enlarged brain ventricles|MP:0013539,increased ovary adenoma incidence
MGI:7661143	Cdk5rap2<em1Mama>	MP:0001297,microphthalmia|MP:0002175,decreased brain weight|MP:0005384,cellular phenotype|MP:0008547,abnormal neocortex morphology|MP:0009772,abnormal retina development|MP:0020362,abnormal male germ cell physiology
MGI:4129121	Cdk5rap2<Gt(RRF465)Byg>	MP:0001925,male infertility|MP:0003950,abnormal plasma membrane morphology|MP:0004046,abnormal mitosis|MP:0008008,early cellular replicative senescence|MP:0009760,abnormal mitotic spindle morphology|MP:0014693,abnormal cell nucleus size|MP:0030943,abnormal centrosome morphology|MP:0030944,abnormal pericentriolar material morphology|MP:0031682,abnormal centriole morphology
MGI:4329471	Cdk5rap2<Gt(RRO242)Byg>	MP:0000221,decreased leukocyte cell number
MGI:4338479	Cdk5rap2<Gt(RRU031)Byg>	MP:0005384,cellular phenotype|MP:0030943,abnormal centrosome morphology|MP:0030944,abnormal pericentriolar material morphology
MGI:4433427	Cdk5rap2<tm1a(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0000432,abnormal head morphology|MP:0000438,abnormal cranium morphology|MP:0001262,decreased body weight|MP:0002590,increased mean corpuscular volume|MP:0003961,decreased lean body mass|MP:0005561,increased mean corpuscular hemoglobin|MP:0010124,decreased bone mineral content
MGI:5548726	Cdk5rap3<tm1b(EUCOMM)Hmgu>	MP:0000245,abnormal erythropoiesis|MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0000609,abnormal liver physiology|MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001417,decreased exploration in new environment|MP:0001577,anemia|MP:0001914,hemorrhage|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003402,decreased liver weight|MP:0004001,decreased hepatocyte proliferation|MP:0004201,fetal growth retardation|MP:0004810,decreased hematopoietic stem cell number|MP:0009395,increased nucleated erythrocyte cell number|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011111,lethality during fetal growth through weaning, complete penetrance|MP:0011952,decreased cardiac stroke volume|MP:0012236,abnormal cholangiocyte morphology|MP:0012242,abnormal hepatoblast differentiation|MP:0013279,increased fasting circulating glucose level
MGI:6294784	Cdk5rap3<tm1c(EUCOMM)Hmgu>	MP:0000189,hypoglycemia|MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0000607,abnormal hepatocyte morphology|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002644,decreased circulating triglyceride level|MP:0002941,increased circulating alanine transaminase level|MP:0003402,decreased liver weight|MP:0005179,decreased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0005370,liver/biliary system phenotype|MP:0010080,abnormal hepatocyte physiology|MP:0010768,mortality/aging|MP:0012246,abnormal hepatic cord morphology|MP:0013278,decreased fasting circulating glucose level|MP:0013693,abnormal hemopoiesis
MGI:3720892	Cdk5<tm1Bibb>	MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0002207,abnormal long-term potentiation|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002923,increased post-tetanic potentiation|MP:0004859,abnormal synaptic plasticity
MGI:1861809	Cdk5<tm1Kul>	MP:0000746,weakness|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000812,abnormal dentate gyrus morphology|MP:0000813,abnormal hippocampus layer morphology|MP:0000857,abnormal cerebellar foliation|MP:0000937,abnormal motor neuron morphology|MP:0001071,abnormal facial nerve morphology|MP:0001076,abnormal hypoglossal nerve morphology|MP:0001392,abnormal locomotor behavior|MP:0001435,absent suckling reflex|MP:0001491,unresponsive to tactile stimuli|MP:0001575,cyanosis|MP:0001956,hypopnea|MP:0002739,abnormal olfactory bulb development|MP:0002883,chromatolysis|MP:0004097,abnormal cerebellar cortex morphology|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0008439,abnormal cortical plate morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:3043819	Cdk5<tm2Kul>	MP:0000808,abnormal hippocampus development|MP:0000854,abnormal cerebellum development|MP:0000913,abnormal brain development|MP:0002169,no abnormal phenotype detected|MP:0002739,abnormal olfactory bulb development
MGI:3833566	Cdk6<tm1.1Phin>	MP:0005387,immune system phenotype
MGI:3053975	Cdk6<tm1Bbd>	MP:0000221,decreased leukocyte cell number|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0000703,abnormal thymus morphology|MP:0001262,decreased body weight|MP:0001823,thymus hypoplasia|MP:0001923,reduced female fertility|MP:0002123,abnormal definitive hematopoiesis|MP:0002356,abnormal spleen red pulp morphology|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002447,abnormal erythrocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002682,decreased mature ovarian follicle number|MP:0002875,decreased erythrocyte cell number|MP:0005095,decreased T cell proliferation|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008082,increased single-positive T cell number|MP:0008255,decreased megakaryocyte cell number|MP:0013585,thymus cortex atrophy
MGI:5696886	Cdk6<tm1b(EUCOMM)Wtsi>	MP:0001102,small superior vagus ganglion|MP:0002092,abnormal eye morphology|MP:0002590,increased mean corpuscular volume|MP:0005561,increased mean corpuscular hemoglobin
MGI:3833563	Cdk6<tm1Phin>	MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0002401,abnormal lymphopoiesis|MP:0003644,thymus atrophy|MP:0003850,abnormal thymocyte activation|MP:0004810,decreased hematopoietic stem cell number|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0009542,decreased thymocyte apoptosis|MP:0010130,decreased DN1 thymic pro-T cell number|MP:0010132,decreased DN2 thymocyte number|MP:0010133,increased DN3 thymocyte number|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:5141514	Cdk6<tm2.1Phin>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0002145,abnormal T cell differentiation|MP:0004810,decreased hematopoietic stem cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010130,decreased DN1 thymic pro-T cell number|MP:0010132,decreased DN2 thymocyte number|MP:0010133,increased DN3 thymocyte number|MP:0010136,decreased DN4 thymocyte number|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:5141515	Cdk6<tm3.1Phin>	MP:0000709,enlarged thymus|MP:0000714,increased thymocyte number|MP:0002145,abnormal T cell differentiation|MP:0004809,increased hematopoietic stem cell number|MP:0005387,immune system phenotype|MP:0006413,increased T cell apoptosis|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0010129,increased DN1 thymic pro-T cell number|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:5141516	Cdk6<tm4.1Phin>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0002145,abnormal T cell differentiation|MP:0004809,increased hematopoietic stem cell number|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010130,decreased DN1 thymic pro-T cell number|MP:0010132,decreased DN2 thymocyte number|MP:0010133,increased DN3 thymocyte number|MP:0010136,decreased DN4 thymocyte number|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:5429213	Cdk7<Gt(D032B11)1.1Wrst>	MP:0000160,kyphosis|MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0001192,scaly skin|MP:0001216,abnormal epidermal layer morphology|MP:0001233,abnormal epidermis suprabasal layer morphology|MP:0001244,thin dermal layer|MP:0001263,weight loss|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002135,abnormal kidney morphology|MP:0002397,abnormal bone marrow morphology|MP:0002655,abnormal keratinocyte morphology|MP:0003197,nephrocalcinosis|MP:0003786,premature aging|MP:0003941,abnormal skin development|MP:0004810,decreased hematopoietic stem cell number|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0008142,decreased small intestinal villus size|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009613,thin epidermis suprabasal layer|MP:0009703,decreased birth body size|MP:0009759,abnormal hair follicle bulge morphology|MP:0010124,decreased bone mineral content|MP:0010873,decreased trabecular bone mass|MP:0011085,postnatal lethality, complete penetrance|MP:0011705,absent fibroblast proliferation|MP:0030927,decreased telomere length
MGI:3873807	Cdk7<Gt(D032B11)Wrst>	MP:0005031,abnormal trophoblast layer morphology|MP:0010380,abnormal inner cell mass apoptosis|MP:0011092,embryonic lethality, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3760076	Cdk8<GT(RRS314)Byg>	MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012111,failure of morula compaction
MGI:4842014	Cdk8<tm1a(EUCOMM)Hmgu>	MP:0001262,decreased body weight|MP:0002727,decreased circulating insulin level|MP:0003058,increased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005292,improved glucose tolerance|MP:0005559,increased circulating glucose level|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0009114,decreased pancreatic beta cell mass|MP:0014117,increased pancreatic beta cell apoptosis
MGI:5548408	Cdk8<tm1b(EUCOMM)Hmgu>	MP:0000266,abnormal heart morphology|MP:0001417,decreased exploration in new environment|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0003720,abnormal neural tube closure|MP:0011100,preweaning lethality, complete penetrance|MP:0020420,abnormal freezing behavior
MGI:5695892	Cdk9<tm1.1(KOMP)Vlcg>	MP:0002574,increased vertical activity|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5484736	Cdkal1<Gt(6062)Tgen>	MP:0001262,decreased body weight|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005560,decreased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009287,decreased abdominal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0009356,decreased liver triglyceride level|MP:0011940,decreased food intake|MP:0031414,decreased skeletal muscle triglyceride level|MP:0031415,increased skeletal muscle triglyceride level
MGI:5301441	Cdkal1<tm1.1Tomik>	MP:0002169,no abnormal phenotype detected|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0003564,abnormal insulin secretion|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level
MGI:5301443	Cdkal1<tm1.2Tomik>	MP:0005621,abnormal cell physiology
MGI:5548648	Cdkal1<tm2b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001415,increased exploration in new environment
MGI:7539030	Cdkl1<em1(IMPC)J>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002834,decreased heart weight
MGI:5581415	Cdkl2<tm1b(EUCOMM)Hmgu>	MP:0000198,decreased circulating phosphate level|MP:0000689,abnormal spleen morphology|MP:0005628,decreased circulating potassium level|MP:0005632,decreased circulating aspartate transaminase level|MP:0010124,decreased bone mineral content
MGI:5700371	Cdkl4<tm1.1(KOMP)Vlcg>	MP:0001304,cataract|MP:0002968,increased circulating alkaline phosphatase level
MGI:5573232	Cdkl5<tm1.1Cogr>	MP:0001402,decreased locomotor activity|MP:0001513,limb grasping|MP:0005386,behavior/neurological phenotype
MGI:5475468	Cdkl5<tm1.1Joez>	MP:0001361,social withdrawal|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001447,abnormal nest building behavior|MP:0001513,limb grasping|MP:0002272,abnormal nervous system electrophysiology|MP:0003631,nervous system phenotype|MP:0005394,taste/olfaction phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior
MGI:5573238	Cdkl5<tm1.2Cogr>	MP:0000813,abnormal hippocampus layer morphology|MP:0001402,decreased locomotor activity|MP:0001513,limb grasping|MP:0002064,seizures|MP:0006254,thin cerebral cortex|MP:0008143,abnormal dendrite morphology|MP:0009357,abnormal seizure response to inducing agent|MP:0010748,abnormal visual evoked potential|MP:0012444,thin hippocampus molecular cell layer|MP:0012446,thin hippocampus stratum oriens
MGI:5573245	Cdkl5<tm1.3Cogr>	MP:0004924,abnormal behavior
MGI:7432923	Cdkl5<tm1dIcs>	MP:0010379,decreased respiratory quotient
MGI:5695874	Cdkn1a<tm1.1(KOMP)Vlcg>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis
MGI:3039362	Cdkn1a<tm1(HBsAg)Xya>	MP:0002628,hepatic steatosis|MP:0003331,increased hepatocellular carcinoma incidence
MGI:5285186	Cdkn1a<tm1Hpw>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype
MGI:1888950	Cdkn1a<tm1Led>	MP:0000400,abnormal awl hair morphology|MP:0000405,abnormal auchene hair morphology|MP:0002006,neoplasm|MP:0002019,abnormal tumor incidence|MP:0002083,premature death|MP:0003077,abnormal cell cycle|MP:0003725,increased autoantibody level|MP:0004023,abnormal chromosome number|MP:0004045,abnormal cell cycle checkpoint function|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004796,increased anti-histone antibody level|MP:0005348,increased T cell proliferation|MP:0008538,decreased zigzag hair amount|MP:0010268,decreased lymphoma incidence|MP:0011703,increased fibroblast proliferation
MGI:1933751	Cdkn1a<tm1Tyj>	MP:0000005,increased brown adipose tissue amount|MP:0000223,decreased monocyte cell number|MP:0000351,increased cell proliferation|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0001204,decreased sensitivity to skin irradiation|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001272,increased metastatic potential|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002018,increased malignant tumor incidence|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002038,increased carcinoma incidence|MP:0002083,premature death|MP:0002176,increased brain weight|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002743,glomerulonephritis|MP:0002962,increased urine protein level|MP:0003010,decreased mortality induced by ionizing radiation|MP:0003075,abnormal response to CNS ischemic injury|MP:0003436,decreased susceptibility to induced arthritis|MP:0003453,abnormal keratinocyte physiology|MP:0003606,kidney failure|MP:0003667,increased hemangiosarcoma incidence|MP:0003763,abnormal thymus physiology|MP:0003799,impaired macrophage chemotaxis|MP:0003917,increased kidney weight|MP:0004207,increased squamous cell carcinoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0004503,decreased incidence of tumors by ionizing radiation induction|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004796,increased anti-histone antibody level|MP:0004809,increased hematopoietic stem cell number|MP:0004910,decreased seminal vesicle weight|MP:0004948,abnormal neuronal precursor proliferation|MP:0004952,increased spleen weight|MP:0004980,increased neuronal precursor cell number|MP:0005005,abnormal self tolerance|MP:0005014,increased B cell number|MP:0005178,increased circulating cholesterol level|MP:0005348,increased T cell proliferation|MP:0005377,hearing/vestibular/ear phenotype|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005501,abnormal skin physiology|MP:0005621,abnormal cell physiology|MP:0008009,delayed cellular replicative senescence|MP:0008049,increased memory T cell number|MP:0008102,lymph node hyperplasia|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008499,increased IgG1 level|MP:0008542,enlarged cervical lymph nodes|MP:0008714,increased lung carcinoma incidence|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008943,increased sensitivity to induced cell death|MP:0008947,increased neuron number|MP:0009130,increased white fat cell number|MP:0009292,increased inguinal fat pad weight|MP:0009300,increased parametrial fat pad weight|MP:0009321,increased histiocytic sarcoma incidence|MP:0009381,abnormal prostate gland dorsolateral lobe morphology|MP:0009592,increased Leydig cell tumor incidence|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010289,increased urinary system tumor incidence|MP:0010300,increased skin tumor incidence|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0013383,increased sebaceous gland adenoma incidence|MP:0021085,increased DNA replication|MP:0030516,abnormal junctional epithelium morphology|MP:0031366,decreased prostate gland dorsolateral lobe weight
MGI:3039363	Cdkn1a<tm2(HBx)Xya>	MP:0002628,hepatic steatosis|MP:0003331,increased hepatocellular carcinoma incidence
MGI:1888808	Cdkn1b<tm1Ako>	MP:0000005,increased brown adipose tissue amount|MP:0000274,enlarged heart|MP:0000275,heart hyperplasia|MP:0000714,increased thymocyte number|MP:0001260,increased body weight|MP:0001926,female infertility|MP:0002027,increased lung adenocarcinoma incidence|MP:0002100,abnormal tooth morphology|MP:0002176,increased brain weight|MP:0002679,abnormal corpus luteum morphology|MP:0002780,decreased circulating testosterone level|MP:0002833,increased heart weight|MP:0003567,abnormal fetal cardiomyocyte proliferation|MP:0003607,abnormal prostate gland physiology|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003917,increased kidney weight|MP:0004565,decreased myocardial fiber size|MP:0004952,increased spleen weight|MP:0004955,increased thymus weight|MP:0005178,increased circulating cholesterol level|MP:0006321,increased myocardial fiber number|MP:0008000,increased ovary tumor incidence|MP:0008130,abnormal pituitary intermediate lobe morphology|MP:0008371,pituitary intermediate lobe hyperplasia|MP:0009006,prolonged estrous cycle|MP:0009017,prolonged estrus|MP:0009130,increased white fat cell number|MP:0009292,increased inguinal fat pad weight|MP:0009300,increased parametrial fat pad weight|MP:0009381,abnormal prostate gland dorsolateral lobe morphology|MP:0010320,increased pituitary gland tumor incidence
MGI:2387694	Cdkn1b<tm1Jro>	MP:0000352,decreased cell proliferation|MP:0001260,increased body weight|MP:0002908,delayed wound healing|MP:0005095,decreased T cell proliferation|MP:0009584,decreased keratinocyte proliferation
MGI:1888790	Cdkn1b<tm1Kin>	MP:0000642,enlarged adrenal glands|MP:0000691,enlarged spleen|MP:0000708,thymus hyperplasia|MP:0000709,enlarged thymus|MP:0001004,abnormal retina photoreceptor morphology|MP:0001120,abnormal uterus morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001131,abnormal ovarian follicle morphology|MP:0001134,absent corpus luteum|MP:0001148,enlarged testis|MP:0001149,testicular hyperplasia|MP:0001260,increased body weight|MP:0001264,increased body size|MP:0001328,disorganized retina layers|MP:0001926,female infertility|MP:0002041,increased pituitary adenoma incidence|MP:0004832,enlarged ovary|MP:0004958,enlarged prostate gland|MP:0005015,increased T cell number|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005547,abnormal Muller cell morphology|MP:0005551,abnormal eye electrophysiology|MP:0008105,increased amacrine cell number|MP:0008130,abnormal pituitary intermediate lobe morphology|MP:0008301,adrenal medulla hyperplasia|MP:0008371,pituitary intermediate lobe hyperplasia|MP:0008868,abnormal granulosa cell morphology|MP:0008939,increased pituitary gland weight|MP:0009092,endometrium hyperplasia|MP:0010236,abnormal retina outer limiting membrane morphology|MP:0011130,absent tertiary ovarian follicles
MGI:1857146	Cdkn1b<tm1Mlf>	MP:0000042,abnormal organ of Corti morphology|MP:0000350,abnormal cell proliferation|MP:0000607,abnormal hepatocyte morphology|MP:0000635,pituitary gland hyperplasia|MP:0000636,enlarged pituitary gland|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000694,spleen hypoplasia|MP:0000703,abnormal thymus morphology|MP:0000708,thymus hyperplasia|MP:0000709,enlarged thymus|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000840,abnormal epithalamus morphology|MP:0001134,absent corpus luteum|MP:0001260,increased body weight|MP:0001264,increased body size|MP:0001328,disorganized retina layers|MP:0001926,female infertility|MP:0002041,increased pituitary adenoma incidence|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0003825,abnormal pillar cell morphology|MP:0004395,increased cochlear inner hair cell number|MP:0004401,increased cochlear outer hair cell number|MP:0004407,increased cochlear hair cell number|MP:0004498,increased organ of Corti supporting cell number|MP:0004499,increased incidence of tumors by chemical induction|MP:0005348,increased T cell proliferation|MP:0005386,behavior/neurological phenotype|MP:0006069,abnormal retina neuronal layer morphology|MP:0006325,impaired hearing|MP:0009937,abnormal neuron differentiation|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014551,impaired neuronal migration
MGI:3624666	Cdkn1b<tm2.1Mlf>	MP:0002083,premature death
MGI:3611831	Cdkn1b<tm2Jro>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:3623439	Cdkn1b<tm2Mlf>	MP:0002083,premature death|MP:0010320,increased pituitary gland tumor incidence
MGI:3611833	Cdkn1b<tm3Jro>	MP:0000691,enlarged spleen|MP:0000709,enlarged thymus|MP:0001260,increased body weight|MP:0001264,increased body size
MGI:3623441	Cdkn1b<tm3Mlf>	MP:0001264,increased body size|MP:0002052,decreased tumor incidence|MP:0002083,premature death|MP:0010320,increased pituitary gland tumor incidence
MGI:3840687	Cdkn1c<tm1.1(Cdkn1b*)Kei>	MP:0000642,enlarged adrenal glands|MP:0001711,abnormal placenta morphology|MP:0003052,omphalocele|MP:0003123,paternal imprinting|MP:0003257,abnormal abdominal wall morphology|MP:0003568,uterus atresia|MP:0004193,abnormal kidney papilla morphology|MP:0004894,uterus atrophy|MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005390,skeleton phenotype|MP:0005391,vision/eye phenotype|MP:0005397,hematopoietic system phenotype|MP:0010768,mortality/aging
MGI:5695875	Cdkn1c<tm1.1(KOMP)Vlcg>	MP:0001785,edema|MP:0011100,preweaning lethality, complete penetrance
MGI:1933757	Cdkn1c<tm1Bbd>	MP:0000111,cleft palate|MP:0000131,abnormal long bone epiphysis morphology|MP:0000462,abnormal digestive system morphology|MP:0000477,abnormal intestine morphology|MP:0000498,absent jejunum|MP:0000547,short limbs|MP:0000897,abnormal midbrain morphology|MP:0001436,abnormal suckling behavior|MP:0002113,abnormal skeleton development|MP:0002115,abnormal limb bone morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002581,abnormal ileum morphology|MP:0003119,abnormal digestive system development|MP:0003123,paternal imprinting|MP:0003154,abnormal soft palate morphology|MP:0003271,abnormal duodenum morphology|MP:0003419,delayed endochondral bone ossification|MP:0003756,abnormal hard palate morphology|MP:0008271,abnormal bone ossification|MP:0009247,meteorism|MP:0009546,absent gastric milk in neonates|MP:0009888,palatal shelves fail to meet at midline|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012503,increased midbrain apoptosis
MGI:1933758	Cdkn1c<tm1Kat>	MP:0000060,delayed bone ossification|MP:0000111,cleft palate|MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000477,abnormal intestine morphology|MP:0000523,cortical renal glomerulopathies|MP:0000642,enlarged adrenal glands|MP:0001119,abnormal female reproductive system morphology|MP:0001144,vagina atresia|MP:0001145,abnormal male reproductive system morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001304,cataract|MP:0001575,cyanosis|MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0001732,postnatal growth retardation|MP:0001926,female infertility|MP:0001938,delayed sexual maturation|MP:0001954,respiratory distress|MP:0002135,abnormal kidney morphology|MP:0002161,abnormal fertility/fecundity|MP:0002163,abnormal gland morphology|MP:0002294,short gestation period|MP:0002357,abnormal spleen white pulp morphology|MP:0002703,abnormal renal tubule morphology|MP:0002842,increased systemic arterial blood pressure|MP:0002962,increased urine protein level|MP:0003052,omphalocele|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003123,paternal imprinting|MP:0003158,dysphagia|MP:0003179,thrombocytopenia|MP:0003257,abnormal abdominal wall morphology|MP:0003568,uterus atresia|MP:0003572,abnormal uterus development|MP:0003830,abnormal testis development|MP:0003984,embryonic growth retardation|MP:0004193,abnormal kidney papilla morphology|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004260,enlarged placenta|MP:0004686,decreased length of long bones|MP:0004894,uterus atrophy|MP:0004920,increased placenta weight|MP:0005033,abnormal trophoblast giant cell morphology|MP:0005296,abnormal humerus morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0005545,abnormal lens development|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008272,abnormal endochondral bone ossification|MP:0008273,abnormal intramembranous bone ossification|MP:0009247,meteorism|MP:0009546,absent gastric milk in neonates|MP:0009709,hydrometra|MP:0009735,abnormal prostate gland development|MP:0009890,cleft secondary palate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0013317,abnormal seminal vesicle development|MP:0031239,increased atretic ovarian follicle number
MGI:1861811	Cdkn1c<tm1Sje>	MP:0000131,abnormal long bone epiphysis morphology|MP:0000526,small inner medullary pyramid|MP:0000642,enlarged adrenal glands|MP:0000757,herniated abdominal wall|MP:0000759,abnormal skeletal muscle morphology|MP:0001325,abnormal retina morphology|MP:0001780,decreased brown adipose tissue amount|MP:0001954,respiratory distress|MP:0002581,abnormal ileum morphology|MP:0002971,abnormal brown adipose tissue morphology|MP:0003052,omphalocele|MP:0003123,paternal imprinting|MP:0003237,abnormal lens epithelium morphology|MP:0003613,abnormal kidney medulla development|MP:0003723,abnormal long bone morphology|MP:0004002,abnormal jejunum morphology|MP:0004200,decreased fetal size|MP:0004320,split sternum|MP:0004686,decreased length of long bones|MP:0005367,renal/urinary system phenotype|MP:0006320,abnormal interscapular fat pad morphology|MP:0008151,increased diameter of long bones|MP:0008794,increased lens epithelium apoptosis|MP:0009247,meteorism|MP:0009888,palatal shelves fail to meet at midline|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011697,lens vacuoles
MGI:5294426	Cdkn1c<tm2.1Kei>	MP:0002169,no abnormal phenotype detected|MP:0004810,decreased hematopoietic stem cell number|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011304,kidney papillary atrophy
MGI:6114043	Cdkn2a<em1Cjs>	MP:0004851,increased testis weight|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0010336,increased acute lymphoblastic leukemia incidence
MGI:6113939	Cdkn2a<em2Cjs>	MP:0002006,neoplasm|MP:0002687,oligozoospermia|MP:0003099,retina detachment|MP:0006148,binocular blindness|MP:0006379,abnormal spermatocyte morphology|MP:0010711,persistent hyperplastic primary vitreous
MGI:6403878	Cdkn2aip<em1(IMPC)J>	MP:0001488,increased startle reflex|MP:0002968,increased circulating alkaline phosphatase level|MP:0005565,increased blood urea nitrogen level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3036106	Cdkn2a<Pctr1-DBA/2N>	MP:0002052,decreased tumor incidence
MGI:2384165	Cdkn2a<tm1.1Brn>	MP:0002006,neoplasm|MP:0004502,decreased incidence of tumors by chemical induction
MGI:5502377	Cdkn2a<tm1.1Gsu>	MP:0002006,neoplasm
MGI:4460436	Cdkn2a<tm1a(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract
MGI:1926877	Cdkn2a<tm1Cjs>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001272,increased metastatic potential|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0002001,blindness|MP:0002014,increased papilloma incidence|MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002037,increased fibrohistocytoma incidence|MP:0002038,increased carcinoma incidence|MP:0002687,oligozoospermia|MP:0003099,retina detachment|MP:0003205,testicular atrophy|MP:0003236,abnormal lens capsule morphology|MP:0003721,increased tumor growth/size|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0004207,increased squamous cell carcinoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0004852,decreased testis weight|MP:0005241,abnormal retina ganglion layer morphology|MP:0005391,vision/eye phenotype|MP:0005621,abnormal cell physiology|MP:0006148,binocular blindness|MP:0006379,abnormal spermatocyte morphology|MP:0009621,primary vitreous hyperplasia|MP:0010336,increased acute lymphoblastic leukemia incidence|MP:0010363,increased fibrosarcoma incidence|MP:0010711,persistent hyperplastic primary vitreous|MP:0011703,increased fibroblast proliferation|MP:0012431,increased lymphoma incidence|MP:0021107,retina fold
MGI:2684603	Cdkn2a<tm1(GFP)Cjs>	MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0003667,increased hemangiosarcoma incidence|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0009321,increased histiocytic sarcoma incidence|MP:0009515,increased gastrointestinal stromal tumor incidence|MP:0012431,increased lymphoma incidence
MGI:2677722	Cdkn2a<tm1Nesh>	MP:0000755,hindlimb paralysis|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002064,seizures|MP:0003789,increased osteosarcoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0005621,abnormal cell physiology|MP:0008714,increased lung carcinoma incidence|MP:0009319,increased small lymphocytic lymphoma incidence
MGI:1857942	Cdkn2a<tm1Rdp>	MP:0000240,extramedullary hematopoiesis|MP:0000689,abnormal spleen morphology|MP:0001004,abnormal retina photoreceptor morphology|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002032,increased sarcoma incidence|MP:0002356,abnormal spleen red pulp morphology|MP:0003077,abnormal cell cycle|MP:0003453,abnormal keratinocyte physiology|MP:0003667,increased hemangiosarcoma incidence|MP:0004207,increased squamous cell carcinoma incidence|MP:0005195,abnormal posterior eye segment morphology|MP:0005501,abnormal skin physiology|MP:0005545,abnormal lens development|MP:0005621,abnormal cell physiology|MP:0006069,abnormal retina neuronal layer morphology|MP:0008009,delayed cellular replicative senescence|MP:0008478,increased spleen white pulp amount|MP:0009277,increased brain tumor incidence|MP:0010322,increased cutaneous melanoma incidence|MP:0010363,increased fibrosarcoma incidence|MP:0010711,persistent hyperplastic primary vitreous|MP:0011703,increased fibroblast proliferation|MP:0012431,increased lymphoma incidence|MP:0014237,decreased tumor-free survival time|MP:0021107,retina fold
MGI:3848992	Cdkn2a<tm1Sxs>	MP:0002019,abnormal tumor incidence|MP:0002092,abnormal eye morphology|MP:0009621,primary vitreous hyperplasia
MGI:2384164	Cdkn2a<tm2.1Brn>	MP:0001272,increased metastatic potential|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002038,increased carcinoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0010275,increased melanoma incidence|MP:0012431,increased lymphoma incidence
MGI:2384177	Cdkn2a<tm2.1Rdp>	MP:0000708,thymus hyperplasia|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0003789,increased osteosarcoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0004955,increased thymus weight|MP:0005091,increased double-positive T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0009319,increased small lymphocytic lymphoma incidence|MP:0009336,increased splenocyte proliferation|MP:0012431,increased lymphoma incidence
MGI:3842628	Cdkn2a<tm3(cre)Cjs>	MP:0001925,male infertility
MGI:3842647	Cdkn2a<tm4Cjs>	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0002001,blindness|MP:0002006,neoplasm|MP:0021107,retina fold
MGI:2687203	Cdkn2a<tm4Rdp>	MP:0002006,neoplasm
MGI:1933760	Cdkn2b<tm1Bbd>	MP:0000240,extramedullary hematopoiesis|MP:0000688,lymphoid hyperplasia|MP:0000689,abnormal spleen morphology|MP:0000693,spleen hyperplasia|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002346,abnormal lymph node secondary follicle morphology|MP:0002362,abnormal spleen marginal zone morphology|MP:0002619,abnormal lymphocyte morphology|MP:0005621,abnormal cell physiology|MP:0008102,lymph node hyperplasia|MP:0008210,increased mature B cell number|MP:0008522,abnormal lymph node germinal center morphology|MP:0009308,increased adenocarcinoma incidence|MP:0011703,increased fibroblast proliferation
MGI:4829849	Cdkn2b<tm1Wff>	MP:0000220,increased monocyte cell number|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008973,decreased erythroid progenitor cell number|MP:0010373,myeloid hyperplasia
MGI:1933761	Cdkn2c<tm1Bbd>	MP:0000522,kidney cortex cyst|MP:0000523,cortical renal glomerulopathies|MP:0000630,mammary gland hyperplasia|MP:0000635,pituitary gland hyperplasia|MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000889,abnormal cerebellar molecular layer|MP:0001148,enlarged testis|MP:0001152,increased Leydig cell number|MP:0001260,increased body weight|MP:0001264,increased body size|MP:0001648,abnormal apoptosis|MP:0002006,neoplasm|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002041,increased pituitary adenoma incidence|MP:0002050,increased pheochromocytoma incidence|MP:0002348,abnormal lymph node medulla morphology|MP:0002780,decreased circulating testosterone level|MP:0003667,increased hemangiosarcoma incidence|MP:0003675,kidney cyst|MP:0006009,abnormal neuronal migration|MP:0006262,increased testis tumor incidence|MP:0008478,increased spleen white pulp amount|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009937,abnormal neuron differentiation|MP:0010384,increased renal carcinoma incidence|MP:0013602,abnormal Leydig cell differentiation|MP:0014237,decreased tumor-free survival time
MGI:1933762	Cdkn2c<tm1Yxi>	MP:0000321,increased bone marrow cell number|MP:0000627,abnormal mammary gland morphology|MP:0000635,pituitary gland hyperplasia|MP:0000636,enlarged pituitary gland|MP:0000642,enlarged adrenal glands|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000708,thymus hyperplasia|MP:0001147,small testis|MP:0001260,increased body weight|MP:0001263,weight loss|MP:0001264,increased body size|MP:0001393,ataxia|MP:0001429,dehydration|MP:0002027,increased lung adenocarcinoma incidence|MP:0002041,increased pituitary adenoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002364,abnormal thymus size|MP:0002444,abnormal T cell physiology|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0008014,increased lung tumor incidence|MP:0008130,abnormal pituitary intermediate lobe morphology|MP:0010299,increased mammary gland tumor incidence|MP:0010829,increased bronchioalveolar stem cell number
MGI:1927668	Cdkn2d<tm1Maro>	MP:0001156,abnormal spermatogenesis|MP:0001648,abnormal apoptosis|MP:0001750,increased circulating follicle stimulating hormone level|MP:0002687,oligozoospermia|MP:0003205,testicular atrophy|MP:0004362,cochlear hair cell degeneration|MP:0004396,decreased cochlear inner hair cell number|MP:0004398,cochlear inner hair cell degeneration|MP:0004402,decreased cochlear outer hair cell number|MP:0004404,cochlear outer hair cell degeneration|MP:0004432,abnormal cochlear hair cell physiology|MP:0004737,absent distortion product otoacoustic emissions|MP:0004740,sensorineural hearing loss|MP:0004749,nonsyndromic hearing loss|MP:0005169,abnormal male meiosis|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014052,increased male germ cell apoptosis|MP:0020550,multinucleated giant male germ cells
MGI:5788504	Cdkn3<em1(IMPC)J>	MP:0002968,increased circulating alkaline phosphatase level|MP:0010053,decreased grip strength
MGI:1856816	cdm	MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:7443053	Cdnf<em1(IMPC)Hmgu>	MP:0001325,abnormal retina morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology
MGI:6394118	Cdnf<tm1.1Uhb>	MP:0001046,abnormal enteric neuron morphology|MP:0001905,abnormal dopamine level|MP:0002229,neurodegeneration|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0010800,abnormal submucous nerve plexus morphology|MP:0020876,increased nervous system dopamine level|MP:0030585,enhanced behavioral response to amphetamine|MP:0030941,enhanced autophagy
MGI:6394117	Cdnf<tm1Uhb>	MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012134,absent umbilical cord|MP:0012299,hydropic allantois
MGI:5315594	Cdo1<tm1.1Mhst>	MP:0000063,decreased bone mineral density|MP:0000102,abnormal nasal bone morphology|MP:0000120,malocclusion|MP:0000160,kyphosis|MP:0000438,abnormal cranium morphology|MP:0000484,abnormal pulmonary artery morphology|MP:0000550,abnormal forelimb morphology|MP:0001258,decreased body length|MP:0001290,delayed eyelid opening|MP:0001340,abnormal eyelid morphology|MP:0001348,abnormal lacrimal gland physiology|MP:0001402,decreased locomotor activity|MP:0001925,male infertility|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002110,abnormal digit morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002161,abnormal fertility/fecundity|MP:0002177,abnormal outer ear morphology|MP:0002233,abnormal nose morphology|MP:0004263,abnormal limb posture|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005287,narrow eye opening|MP:0005560,decreased circulating glucose level|MP:0008489,slow postnatal weight gain|MP:0009674,decreased birth weight|MP:0010899,abnormal pulmonary alveolar system morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011641,abnormal pulmonary collagen fibril morphology|MP:0011939,increased food intake|MP:0030622,increased cysteine level|MP:0030625,increased circulating cysteine level|MP:0030636,decreased taurine level
MGI:5315591	Cdo1<tm1Mhst>	MP:0001764,abnormal homeostasis|MP:0009642,abnormal blood homeostasis|MP:0030623,decreased cysteine level|MP:0030626,decreased circulating cysteine level
MGI:3692942	Cdon<tm1Aok>	MP:0003631,nervous system phenotype
MGI:5804647	Cdon<tm1b(EUCOMM)Hmgu>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:2653120	Cdon<tm1Rsk>	MP:0000428,abnormal craniofacial morphology|MP:0000430,absent maxillary shelf|MP:0000440,domed cranium|MP:0000455,abnormal maxilla morphology|MP:0000746,weakness|MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000822,abnormal brain ventricle morphology|MP:0001265,decreased body size|MP:0001614,abnormal blood vessel morphology|MP:0001891,hydrocephaly|MP:0001914,hemorrhage|MP:0002083,premature death|MP:0002233,abnormal nose morphology|MP:0002820,abnormal premaxilla morphology|MP:0003935,abnormal craniofacial development|MP:0004462,small basisphenoid bone|MP:0004463,basisphenoid bone foramen|MP:0004538,abnormal maxillary shelf morphology|MP:0004790,absent upper incisors|MP:0004948,abnormal neuronal precursor proliferation|MP:0005157,holoprosencephaly|MP:0006254,thin cerebral cortex|MP:0008535,enlarged lateral ventricles|MP:0009653,abnormal palate development|MP:0009897,decreased maxillary shelf size|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0012256,abnormal philtrum morphology|MP:0012541,absent lamina terminalis|MP:0030137,abnormal upper incisor morphology|MP:0030197,small nasal septum|MP:0030201,absent nasal septum cartilage|MP:0030202,nasal septum cartilage hypoplasia|MP:0030218,piriform aperture stenosis|MP:0030314,absent primary palate
MGI:2653132	Cdon<tm2Rsk>	MP:0000428,abnormal craniofacial morphology|MP:0000440,domed cranium|MP:0000746,weakness|MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000822,abnormal brain ventricle morphology|MP:0001265,decreased body size|MP:0001614,abnormal blood vessel morphology|MP:0001891,hydrocephaly|MP:0001914,hemorrhage|MP:0002083,premature death|MP:0002233,abnormal nose morphology|MP:0002820,abnormal premaxilla morphology|MP:0004462,small basisphenoid bone|MP:0004463,basisphenoid bone foramen|MP:0004790,absent upper incisors|MP:0004948,abnormal neuronal precursor proliferation|MP:0005157,holoprosencephaly|MP:0006254,thin cerebral cortex|MP:0008535,enlarged lateral ventricles|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0012256,abnormal philtrum morphology|MP:0012541,absent lamina terminalis|MP:0030137,abnormal upper incisor morphology|MP:0030197,small nasal septum|MP:0030201,absent nasal septum cartilage|MP:0030202,nasal septum cartilage hypoplasia|MP:0030218,piriform aperture stenosis|MP:0030314,absent primary palate
MGI:6296601	Cdr1os<em1Dpbl>	MP:0002169,no abnormal phenotype detected
MGI:6107169	Cdr1os<em1Nikr>	MP:0005402,abnormal action potential|MP:0009142,decreased prepulse inhibition|MP:0014375,increased miniature excitatory postsynaptic current frequency
MGI:6296602	Cdr1os<em2Dpbl>	MP:0002169,no abnormal phenotype detected
MGI:3840617	Cdr2<tm1Rbd>	MP:0002169,no abnormal phenotype detected
MGI:6277013	Cds1<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0001925,male infertility|MP:0002092,abnormal eye morphology
MGI:3529169	Cds2<Gt(OST184358)Lex>	MP:0003889,enhanced sensorimotor gating|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:4363703	Cds2<tm1a(KOMP)Wtsi>	MP:0001262,decreased body weight|MP:0011100,preweaning lethality, complete penetrance
MGI:4365388	Cdsn<tm1.1Ics>	MP:0001191,abnormal skin condition|MP:0001192,scaly skin|MP:0001209,spontaneous skin ulceration|MP:0001216,abnormal epidermal layer morphology|MP:0001222,epidermal hyperplasia|MP:0001241,absent epidermis stratum corneum|MP:0001242,hyperkeratosis|MP:0001246,mixed cellular infiltration to dermis|MP:0001247,dermal cyst|MP:0001263,weight loss|MP:0001874,acanthosis|MP:0002051,increased skin papilloma incidence|MP:0002083,premature death|MP:0002796,impaired skin barrier function|MP:0003089,decreased skin tensile strength|MP:0003413,hair follicle degeneration|MP:0003427,parakeratosis|MP:0003815,hairless|MP:0004947,skin inflammation|MP:0009793,sebaceous gland hypertrophy|MP:0010699,dilated hair follicle|MP:0011087,neonatal lethality, complete penetrance
MGI:5637180	Cdsn<tm1b(EUCOMM)Hmgu>	MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0011964,increased total retina thickness
MGI:3790339	Cdsn<tm1Mmat>	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0001193,psoriasis|MP:0001216,abnormal epidermal layer morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001246,mixed cellular infiltration to dermis|MP:0001874,acanthosis|MP:0003427,parakeratosis|MP:0003658,abnormal capillary morphology|MP:0003809,abnormal hair shaft morphology|MP:0004938,dilated vasculature|MP:0010771,integument phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:5697668	Cdt1<del>	MP:0002169,no abnormal phenotype detected
MGI:3817874	Cdx1<tm1Lhn>	MP:0000079,abnormal basioccipital bone morphology|MP:0000154,rib fusion|MP:0004615,cervical vertebral transformation|MP:0010728,fusion of atlas and occipital bones
MGI:2154514	Cdx1<tm1Pgr>	MP:0000079,abnormal basioccipital bone morphology|MP:0000080,abnormal exoccipital bone morphology|MP:0000150,abnormal rib morphology|MP:0000151,absent ribs|MP:0000154,rib fusion|MP:0003036,vertebral transformation|MP:0003345,decreased rib number|MP:0004229,abnormal embryonic erythropoiesis|MP:0004599,abnormal vertebral arch morphology|MP:0004601,abnormal vertebral spinous process morphology|MP:0004613,fusion of vertebral arches|MP:0004615,cervical vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004658,abnormal ventral tubercle of atlas morphology|MP:0005269,abnormal occipital bone morphology|MP:0030282,broad supraoccipital bone
MGI:3837941	Cdx1<tm2Lhn>	MP:0000150,abnormal rib morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004607,abnormal cervical atlas morphology|MP:0004615,cervical vertebral transformation|MP:0005269,abnormal occipital bone morphology
MGI:3837942	Cdx1<tm3Lhn>	MP:0004599,abnormal vertebral arch morphology|MP:0004607,abnormal cervical atlas morphology|MP:0004615,cervical vertebral transformation|MP:0005269,abnormal occipital bone morphology
MGI:3848699	Cdx1<tm4.1(Cdx2)Lhn>	MP:0002169,no abnormal phenotype detected
MGI:5445743	Cdx2<tm1.1Aral>	MP:0005389,reproductive system phenotype
MGI:4415130	Cdx2<tm1.1Lhn>	MP:0000592,short tail|MP:0001680,abnormal mesoderm development|MP:0003445,sirenomelia|MP:0003456,absent tail|MP:0009768,impaired somite development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011732,decreased somite size|MP:0012173,short rostral-caudal axis|MP:0012182,abnormal presomitic mesoderm morphology|MP:0013168,absent hindlimb buds
MGI:1857928	Cdx2<tm1Fbe>	MP:0000150,abnormal rib morphology|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001262,decreased body weight|MP:0001714,absent trophoblast giant cells|MP:0001716,abnormal placenta labyrinth morphology|MP:0001728,failure of embryo implantation|MP:0002044,increased colon adenoma incidence|MP:0002404,increased intestinal adenoma incidence|MP:0003036,vertebral transformation|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0004615,cervical vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004957,abnormal blastocyst morphology|MP:0004963,abnormal blastocoele morphology|MP:0005028,abnormal trophectoderm morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0009657,failure of chorioallantoic fusion|MP:0010380,abnormal inner cell mass apoptosis|MP:0011092,embryonic lethality, complete penetrance|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012119,increased trophectoderm apoptosis
MGI:3848929	Cdx2<tm1Khk>	MP:0000477,abnormal intestine morphology|MP:0000487,absent enterocytes|MP:0000488,abnormal intestinal epithelium morphology|MP:0000494,abnormal cecum morphology|MP:0002169,no abnormal phenotype detected|MP:0003119,abnormal digestive system development|MP:0003271,abnormal duodenum morphology|MP:0003449,abnormal intestine goblet cell morphology|MP:0004141,abnormal enteroendocrine cell morphology|MP:0008142,decreased small intestinal villus size|MP:0008786,abnormal hindgut morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011881,distended duodenum|MP:0011884,absent colon
MGI:1926374	Cdx2<tm1Mmt>	MP:0000150,abnormal rib morphology|MP:0000494,abnormal cecum morphology|MP:0000495,abnormal colon morphology|MP:0000496,abnormal small intestine morphology|MP:0001265,decreased body size|MP:0002043,increased colon hamartoma incidence|MP:0003036,vertebral transformation|MP:0003269,colon polyps|MP:0003702,abnormal chromosome morphology|MP:0004045,abnormal cell cycle checkpoint function|MP:0006042,increased apoptosis|MP:0006043,decreased apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:5431579	Cdx2<tm1Yxz>	MP:0002169,no abnormal phenotype detected
MGI:5308967	Cdx2<tm2.1Fbe>	MP:0008011,intestine polyps
MGI:5308966	Cdx2<tm2Fbe>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0002581,abnormal ileum morphology|MP:0003091,abnormal cell migration|MP:0008013,cecum polyps|MP:0008108,abnormal small intestinal villus morphology|MP:0010155,abnormal intestine physiology|MP:0013485,increased Paneth cell number|MP:0013487,abnormal Paneth cell physiology
MGI:3796742	Cdx4<tm1.1Gqda>	MP:0004229,abnormal embryonic erythropoiesis
MGI:3612959	Cdx4<tm1.1Jdes>	MP:0004618,thoracic vertebral transformation
MGI:3612958	Cdx4<tm1Jdes>	MP:0002169,no abnormal phenotype detected
MGI:6316169	Cdyl2<em1(IMPC)Tcp>	MP:0001258,decreased body length|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002875,decreased erythrocyte cell number|MP:0020421,increased freezing behavior
MGI:6121103	Cdyl<tm1.1Yuw>	MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0005386,behavior/neurological phenotype|MP:0006009,abnormal neuronal migration
MGI:2448242	Ceacam10<tm1Wzm>	MP:0001935,decreased litter size
MGI:6140174	Ceacam11<em1(IMPC)Wtsi>	MP:0010123,increased bone mineral content
MGI:5517676	Ceacam16<tm1.1(KOMP)Wtsi>	MP:0002702,decreased circulating free fatty acids level|MP:0005633,increased circulating sodium level|MP:0012121,sclerocornea
MGI:4363974	Ceacam16<tm1(KOMP)Wtsi>	MP:0006336,abnormal otoacoustic response|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013962,absent Hensen stripe|MP:0014091,abnormal tectorial membrane striated-sheet matrix morphology
MGI:5437595	Ceacam16<tm1Wzm>	MP:0004749,nonsyndromic hearing loss|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014407,decreased distortion product otoacoustic emission threshold|MP:0014409,decreased distortion product otoacoustic emission amplitude
MGI:3053078	Ceacam1<Hv2-r>	MP:0002410,decreased susceptibility to viral infection|MP:0020950,decreased susceptibility to Coronaviridae infection
MGI:3027072	Ceacam1<Hv2-s>	MP:0005387,immune system phenotype
MGI:5496530	Ceacam1<tm1.1Fta>	MP:0020950,decreased susceptibility to Coronaviridae infection|MP:0031047,decreased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:2180785	Ceacam1<tm1Bcn>	MP:0031047,decreased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:5560663	Ceacam1<tm1Geno>	MP:0004883,abnormal vascular wound healing
MGI:3693674	Ceacam1<tm1Rsb>	MP:0003009,abnormal cytokine secretion|MP:0005348,increased T cell proliferation|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion
MGI:3053071	Ceacam1<tm2Bcn>	MP:0000495,abnormal colon morphology|MP:0004499,increased incidence of tumors by chemical induction|MP:0020950,decreased susceptibility to Coronaviridae infection
MGI:6140197	Ceacam23<em1(IMPC)Wtsi>	MP:0001556,increased circulating HDL cholesterol level
MGI:5314388	Ceacam2<tm1Snaj>	MP:0001261,obese|MP:0001433,polyphagia|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002644,decreased circulating triglyceride level|MP:0003058,increased insulin secretion|MP:0003960,increased lean body mass|MP:0004890,decreased energy expenditure|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005438,abnormal glycogen homeostasis|MP:0005669,increased circulating leptin level|MP:0008964,decreased carbon dioxide production|MP:0009286,increased abdominal fat pad weight|MP:0010024,increased total body fat amount|MP:0010379,decreased respiratory quotient|MP:0014172,decreased fatty acid oxidation|MP:0031415,increased skeletal muscle triglyceride level|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:7790450	Ceacam3<em1Btlr>	MP:0005387,immune system phenotype
MGI:6152736	Ceacam3<em1(IMPC)Wtsi>	MP:0005567,decreased circulating total protein level|MP:0008806,increased circulating amylase level|MP:0010088,decreased circulating fructosamine level
MGI:6153302	Ceacam5<em1(IMPC)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0002599,increased mean platelet volume|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:2183316	Ceacam9<tm1Wzm>	MP:0002169,no abnormal phenotype detected
MGI:3526131	Ceat1<NOD>	MP:0002876,abnormal thyroid gland physiology|MP:0004825,increased susceptibility to experimental autoimmune thyroiditis
MGI:3848341	Cebpa<m4443Dajl>	MP:0000182,increased circulating LDL cholesterol level|MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:2183333	Cebpa<tm1.1(Cebpb)Ylee>	MP:0000005,increased brown adipose tissue amount|MP:0001545,abnormal hematopoietic system physiology|MP:0001783,decreased white adipose tissue amount|MP:0002970,abnormal white adipose tissue morphology|MP:0002971,abnormal brown adipose tissue morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005668,decreased circulating leptin level|MP:0009115,abnormal fat cell morphology|MP:0011939,increased food intake
MGI:4867437	Cebpa<tm1.1(cre)Touw>	MP:0005397,hematopoietic system phenotype
MGI:2177135	Cebpa<tm1.1Gonz>	MP:0002081,perinatal lethality
MGI:3617752	Cebpa<tm1Btp>	MP:0002169,no abnormal phenotype detected
MGI:3522010	Cebpa<tm1Dgt>	MP:0000334,decreased granulocyte number|MP:0001601,abnormal myelopoiesis|MP:0001603,failure of myelopoiesis|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0004780,abnormal surfactant secretion|MP:0005044,sepsis|MP:0005370,liver/biliary system phenotype|MP:0005397,hematopoietic system phenotype|MP:0010812,absent type II pneumocytes|MP:0010814,absent alveolar lamellar bodies|MP:0010817,absent type I pneumocytes|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014473,increased pulmonary alveolus wall thickness
MGI:2177053	Cebpa<tm1Gjd>	MP:0000189,hypoglycemia|MP:0000239,absent common myeloid progenitor cells|MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0001175,abnormal lung morphology|MP:0001262,decreased body weight|MP:0001603,failure of myelopoiesis|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003383,abnormal gluconeogenesis|MP:0004780,abnormal surfactant secretion|MP:0005202,lethargy|MP:0005336,abnormal inguinal fat pad morphology|MP:0005379,endocrine/exocrine gland phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005389,reproductive system phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005438,abnormal glycogen homeostasis|MP:0005450,abnormal energy expenditure|MP:0008489,slow postnatal weight gain|MP:0009546,absent gastric milk in neonates|MP:0010398,decreased liver glycogen level|MP:0010810,increased type II pneumocyte number|MP:0010903,abnormal pulmonary alveolus wall morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0013723,increased circulating tyrosine level
MGI:2177133	Cebpa<tm1Gonz>	MP:0001177,atelectasis|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001554,increased circulating free fatty acids level|MP:0001954,respiratory distress|MP:0002051,increased skin papilloma incidence|MP:0002274,abnormal type I pneumocyte morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0003721,increased tumor growth/size|MP:0004007,abnormal lung vasculature morphology|MP:0004207,increased squamous cell carcinoma incidence|MP:0004780,abnormal surfactant secretion|MP:0009583,increased keratinocyte proliferation|MP:0010018,pulmonary vascular congestion|MP:0010300,increased skin tumor incidence|MP:0010771,integument phenotype|MP:0010817,absent type I pneumocytes|MP:0010825,abnormal lung saccule morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:2177068	Cebpa<tm1Kgx>	MP:0000189,hypoglycemia|MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0001176,abnormal lung development|MP:0001195,flaky skin|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0001934,increased litter size|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002276,abnormal lung interstitium morphology|MP:0005202,lethargy|MP:0006027,impaired lung alveolus development|MP:0008489,slow postnatal weight gain|MP:0008991,abnormal bile canaliculus morphology|MP:0009546,absent gastric milk in neonates|MP:0009674,decreased birth weight|MP:0010398,decreased liver glycogen level|MP:0010810,increased type II pneumocyte number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2387091	Cebpa<tm1Nerl>	MP:0002169,no abnormal phenotype detected|MP:0005375,adipose tissue phenotype|MP:0005387,immune system phenotype
MGI:4837200	Cebpa<tm1Timc>	MP:0001552,increased circulating triglyceride level|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0004001,decreased hepatocyte proliferation|MP:0004499,increased incidence of tumors by chemical induction|MP:0005343,increased circulating aspartate transaminase level|MP:0005560,decreased circulating glucose level
MGI:5438639	Cebpa<tm2Btp>	MP:0000222,decreased neutrophil cell number|MP:0000691,enlarged spleen|MP:0001601,abnormal myelopoiesis|MP:0002123,abnormal definitive hematopoiesis|MP:0002398,abnormal bone marrow cell morphology/development|MP:0003135,increased erythroid progenitor cell number|MP:0004809,increased hematopoietic stem cell number|MP:0005397,hematopoietic system phenotype
MGI:2387093	Cebpa<tm2Nerl>	MP:0000334,decreased granulocyte number|MP:0001783,decreased white adipose tissue amount|MP:0002083,premature death|MP:0002441,abnormal granulocyte morphology|MP:0005335,abnormal gonadal fat pad morphology|MP:0005387,immune system phenotype
MGI:2387094	Cebpa<tm3Nerl>	MP:0005375,adipose tissue phenotype|MP:0005387,immune system phenotype
MGI:2387095	Cebpa<tm4Nerl>	MP:0000334,decreased granulocyte number|MP:0001783,decreased white adipose tissue amount|MP:0002083,premature death|MP:0002441,abnormal granulocyte morphology|MP:0005335,abnormal gonadal fat pad morphology|MP:0005387,immune system phenotype
MGI:3707189	Cebpa<tm5Nerl>	MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0005370,liver/biliary system phenotype|MP:0005375,adipose tissue phenotype|MP:0009355,increased liver triglyceride level
MGI:3707191	Cebpa<tm6Nerl>	MP:0000609,abnormal liver physiology|MP:0001560,abnormal circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005375,adipose tissue phenotype|MP:0005388,respiratory system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005559,increased circulating glucose level|MP:0010398,decreased liver glycogen level|MP:0030017,decreased adipocyte glucose uptake|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:3796230	Cebpa<tm8.1Nerl>	MP:0000189,hypoglycemia|MP:0000208,decreased hematocrit|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000334,decreased granulocyte number|MP:0000606,decreased hepatocyte number|MP:0000691,enlarged spleen|MP:0001860,liver inflammation|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002441,abnormal granulocyte morphology|MP:0003326,liver failure|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008246,abnormal leukocyte morphology|MP:0008250,abnormal myeloid leukocyte morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3849861	Cebpb<tm1.1Acle>	MP:0001541,abnormal osteoclast physiology|MP:0004982,abnormal osteoclast morphology|MP:0004992,increased bone resorption|MP:0005006,abnormal osteoblast physiology|MP:0005508,abnormal skeleton morphology|MP:0008396,abnormal osteoclast differentiation|MP:0010867,abnormal bone trabecula morphology|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011710,enhanced osteoblast differentiation|MP:0020039,increased bone ossification|MP:0020080,increased bone mineralization
MGI:6195224	Cebpb<tm1.1Elgaz>	MP:0002411,decreased susceptibility to bacterial infection|MP:0008553,increased circulating tumor necrosis factor level|MP:0008594,decreased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008838,decreased transforming growth factor beta level|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0013661,abnormal myeloid cell number
MGI:4421439	Cebpb<tm1.1Maka>	MP:0003058,increased insulin secretion|MP:0005376,homeostasis/metabolism phenotype
MGI:4362073	Cebpb<tm1Aki>	MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002500,granulomatous inflammation|MP:0005465,abnormal T-helper 1 physiology|MP:0008734,decreased susceptibility to endotoxin shock
MGI:3623142	Cebpb<tm1Es>	MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0002656,abnormal keratinocyte differentiation|MP:0004502,decreased incidence of tumors by chemical induction|MP:0009580,increased keratinocyte apoptosis|MP:0009583,increased keratinocyte proliferation|MP:0010771,integument phenotype
MGI:2180848	Cebpb<tm1Kish>	MP:0001798,impaired macrophage phagocytosis|MP:0001926,female infertility|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002971,abnormal brown adipose tissue morphology|MP:0004469,abnormal zygomatic arch morphology|MP:0004624,abnormal thoracic cage morphology|MP:0004817,abnormal skeletal muscle mass|MP:0005076,abnormal cell differentiation|MP:0005298,abnormal clavicle morphology|MP:0008663,increased interleukin-12 secretion|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:4366801	Cebpb<tm1Nerl>	MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype
MGI:2181982	Cebpb<tm1Pfj>	MP:0000628,abnormal mammary gland development|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001129,impaired ovarian folliculogenesis|MP:0001134,absent corpus luteum|MP:0001541,abnormal osteoclast physiology|MP:0001882,abnormal lactation|MP:0001926,female infertility|MP:0002053,decreased incidence of induced tumors|MP:0003356,impaired luteinization|MP:0003357,impaired granulosa cell differentiation|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004982,abnormal osteoclast morphology|MP:0004992,increased bone resorption|MP:0005006,abnormal osteoblast physiology|MP:0005389,reproductive system phenotype|MP:0005508,abnormal skeleton morphology|MP:0008396,abnormal osteoclast differentiation|MP:0008752,abnormal tumor necrosis factor level|MP:0009009,absent estrous cycle|MP:0009346,decreased trabecular bone thickness|MP:0009580,increased keratinocyte apoptosis|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0011101,prenatal lethality, incomplete penetrance|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization|MP:0031420,decreased superovulation rate
MGI:2149329	Cebpb<tm1Vpo>	MP:0000189,hypoglycemia|MP:0000240,extramedullary hematopoiesis|MP:0000321,increased bone marrow cell number|MP:0000628,abnormal mammary gland development|MP:0000662,abnormal branching of the mammary ductal tree|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001212,skin lesions|MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0001553,abnormal circulating free fatty acids level|MP:0001745,increased circulating corticosterone level|MP:0001780,decreased brown adipose tissue amount|MP:0001800,abnormal humoral immune response|MP:0001926,female infertility|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002123,abnormal definitive hematopoiesis|MP:0002343,abnormal lymph node cortex morphology|MP:0002344,abnormal lymph node B cell domain morphology|MP:0002346,abnormal lymph node secondary follicle morphology|MP:0002347,abnormal lymph node T cell domain morphology|MP:0002348,abnormal lymph node medulla morphology|MP:0002356,abnormal spleen red pulp morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002377,abnormal mucosa-associated lymphoid tissue morphology|MP:0002419,abnormal innate immunity|MP:0002421,abnormal cell-mediated immunity|MP:0002439,abnormal plasma cell morphology|MP:0002451,abnormal macrophage physiology|MP:0002493,increased IgG level|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002715,decreased glycogen catabolism rate|MP:0002727,decreased circulating insulin level|MP:0002742,enlarged submandibular lymph nodes|MP:0002743,glomerulonephritis|MP:0002891,increased insulin sensitivity|MP:0003383,abnormal gluconeogenesis|MP:0005318,decreased triglyceride level|MP:0005319,abnormal enzyme/coenzyme level|MP:0005399,increased susceptibility to fungal infection|MP:0005459,decreased percent body fat/body weight|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0005517,impaired liver regeneration|MP:0005559,increased circulating glucose level|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0005639,hemosiderosis|MP:0005666,abnormal adipose tissue physiology|MP:0005668,decreased circulating leptin level|MP:0008033,impaired lipolysis|MP:0008466,enlarged mesenteric lymph nodes|MP:0008472,abnormal spleen secondary B follicle morphology|MP:0008596,increased circulating interleukin-6 level|MP:0008618,decreased circulating interleukin-12 level|MP:0008944,decreased sensitivity to induced cell death|MP:0009283,decreased gonadal fat pad weight|MP:0009289,decreased epididymal fat pad weight|MP:0009307,decreased uterine fat pad weight|MP:0009503,abnormal mammary gland duct morphology|MP:0009623,enlarged inguinal lymph nodes|MP:0009631,enlarged axillary lymph nodes|MP:0010172,abnormal mammary gland epithelium physiology|MP:0011049,impaired adaptive thermogenesis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011224,abnormal lymph node medullary cord morphology|MP:0011294,renal glomerulus hypertrophy|MP:0011353,expanded mesangial matrix|MP:0011427,increased mesangial cell number|MP:0011579,decreased lipoprotein lipase activity|MP:0011698,abnormal brown adipose tissue physiology|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:4418931	Cebpb<tm2.1Acle>	MP:0000352,decreased cell proliferation|MP:0004982,abnormal osteoclast morphology|MP:0004985,decreased osteoclast cell number|MP:0005389,reproductive system phenotype|MP:0005517,impaired liver regeneration|MP:0008596,increased circulating interleukin-6 level|MP:0009347,increased trabecular bone thickness|MP:0010875,increased bone volume
MGI:4418936	Cebpb<tm3.1Acle>	MP:0002169,no abnormal phenotype detected
MGI:4366861	Cebpb<tm3Nerl>	MP:0003199,calcified muscle|MP:0004510,myositis|MP:0005389,reproductive system phenotype|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009400,decreased skeletal muscle fiber size|MP:0009419,skeletal muscle fibrosis|MP:0013239,impaired skeletal muscle regeneration
MGI:2180837	Cebpd<tm1Aki>	MP:0002971,abnormal brown adipose tissue morphology|MP:0005076,abnormal cell differentiation|MP:0006319,abnormal epididymal fat pad morphology|MP:0010768,mortality/aging
MGI:2180841	Cebpd<tm1Pfj>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0001469,abnormal contextual conditioning behavior|MP:0001876,decreased inflammatory response|MP:0002133,abnormal respiratory system physiology|MP:0005166,decreased susceptibility to injury|MP:0008713,abnormal cytokine level|MP:0008822,decreased blood uric acid level|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009643,abnormal urine homeostasis|MP:0009810,increased urine uric acid level|MP:0010173,increased mammary gland epithelial cell proliferation|MP:0010768,mortality/aging|MP:0013404,decreased circulating lactate level
MGI:2178607	Cebpe<tm1Kgx>	MP:0000240,extramedullary hematopoiesis|MP:0000321,increased bone marrow cell number|MP:0000334,decreased granulocyte number|MP:0000702,enlarged lymph nodes|MP:0001601,abnormal myelopoiesis|MP:0001602,impaired myelopoiesis|MP:0001846,increased inflammatory response|MP:0001852,conjunctivitis|MP:0001861,lung inflammation|MP:0001867,rhinitis|MP:0002060,abnormal skin morphology|MP:0002083,premature death|MP:0002397,abnormal bone marrow morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002412,increased susceptibility to bacterial infection|MP:0002415,abnormal neutrophil differentiation|MP:0002443,abnormal eosinophil differentiation|MP:0002463,abnormal neutrophil physiology|MP:0002816,colitis|MP:0003303,peritoneal inflammation|MP:0005012,decreased eosinophil cell number|MP:0005065,abnormal neutrophil morphology|MP:0005190,osteomyelitis|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008097,increased plasma cell number|MP:0008111,abnormal granulocyte differentiation|MP:0031053,pleuritis
MGI:2180824	Cebpg<tm1Aki>	MP:0001183,overexpanded pulmonary alveolus|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0010766,abnormal NK cell physiology|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5812915	Cebpz<tm1b(EUCOMM)Hmgu>	MP:0010024,increased total body fat amount
MGI:3574034	Cecr2<Gt(pGT1)1Hemc>	MP:0000914,exencephaly|MP:0001341,absent eyelids|MP:0002151,abnormal neural tube morphology|MP:0002621,delayed neural tube closure|MP:0003631,nervous system phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0011090,perinatal lethality, incomplete penetrance
MGI:4829945	Cecr2<tm1.1Hemc>	MP:0000108,midline facial cleft|MP:0000914,exencephaly|MP:0002083,premature death|MP:0012260,encephalomeningocele
MGI:5605798	Cecr2<tm2b(EUCOMM)Hmgu>	MP:0000428,abnormal craniofacial morphology|MP:0000702,enlarged lymph nodes|MP:0000783,abnormal forebrain morphology|MP:0000841,abnormal hindbrain morphology|MP:0000897,abnormal midbrain morphology|MP:0001417,decreased exploration in new environment|MP:0002968,increased circulating alkaline phosphatase level|MP:0003720,abnormal neural tube closure|MP:0004156,abnormal QT variability|MP:0011100,preweaning lethality, complete penetrance
MGI:6359441	Cela1<em1Rjv>	MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0010899,abnormal pulmonary alveolar system morphology|MP:0011044,increased lung elastance|MP:0011163,increased wet-to-dry lung weight ratio
MGI:6313718	Cela2a<tm1Bdr>	MP:0003393,decreased cardiac output|MP:0003631,nervous system phenotype|MP:0003649,decreased heart right ventricle size|MP:0004085,abnormal heartbeat|MP:0004183,abnormal sympathetic nervous system physiology|MP:0005333,decreased heart rate|MP:0005385,cardiovascular system phenotype|MP:0006277,abnormal parasympathetic nervous system physiology|MP:0010580,decreased heart left ventricle size|MP:0011952,decreased cardiac stroke volume
MGI:8254863	Cel<em1(CEL)Zlia>	MP:0002169,no abnormal phenotype detected
MGI:8254864	Cel<em2(CEL/CELP)Zlia>	MP:0001869,pancreas inflammation|MP:0001944,abnormal pancreas morphology|MP:0003334,pancreas fibrosis|MP:0004761,increased susceptibility to induced pancreatitis|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009150,pancreatic acinar cell atrophy|MP:0013220,increased pancreas apoptosis|MP:0013295,pancreas atrophy|MP:0020354,increased endoplasmic reticulum stress|MP:0030941,enhanced autophagy
MGI:6257535	Celf1<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance
MGI:3700209	Celf1<tm1Cba>	MP:0001155,arrest of spermatogenesis|MP:0001265,decreased body size|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0004201,fetal growth retardation|MP:0004921,decreased placenta weight|MP:0008489,slow postnatal weight gain|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6306985	Celf2<tm1.1Yjin>	MP:0003651,abnormal axon extension|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5779676	Celf2<tm1b(EUCOMM)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6306984	Celf2<tm1Yjin>	MP:0001265,decreased body size|MP:0004811,abnormal neuron physiology
MGI:3767553	Celf3<tm1Ade>	MP:0002674,abnormal sperm motility|MP:0002687,oligozoospermia
MGI:3037035	Celf4<Ff>	MP:0001260,increased body weight|MP:0001265,decreased body size|MP:0001399,hyperactivity|MP:0001650,abnormal seizure response to electrical stimulation|MP:0002064,seizures|MP:0002083,premature death|MP:0003216,absence seizures|MP:0003997,tonic-clonic seizures|MP:0005455,increased susceptibility to weight gain|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5425629	Celf4<tm1.1Frk>	MP:0000947,convulsive seizures|MP:0008840,abnormal spike wave discharge|MP:0012348,decreased susceptibility to induction of seizure by inducing agent|MP:0012349,increased susceptibility to induction of seizure by inducing agent
MGI:5425630	Celf4<tm1.2Frk>	MP:0001265,decreased body size|MP:0002064,seizures|MP:0003216,absence seizures|MP:0003997,tonic-clonic seizures|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008840,abnormal spike wave discharge|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4433345	Celf4<tm1a(EUCOMM)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0002079,increased circulating insulin level|MP:0002169,no abnormal phenotype detected|MP:0002928,abnormal bile duct morphology|MP:0003686,abnormal eye muscle morphology|MP:0004201,fetal growth retardation|MP:0005179,decreased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0011100,preweaning lethality, complete penetrance|MP:0011683,dual inferior vena cava|MP:0013877,abnormal ductus venosus valve morphology|MP:0013971,blood in lymph vessels|MP:0013986,abnormal vitelline vein topology|MP:0014004,absent basilar artery segment
MGI:5696217	Celf6<tm1.1Jdd>	MP:0002169,no abnormal phenotype detected
MGI:5494708	Celf6<tm1.2Jdd>	MP:0002572,abnormal emotion/affect behavior|MP:0003462,abnormal response to novel odor|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005643,decreased dopamine level|MP:0010070,decreased serotonin level|MP:0012574,decreased noradrenaline level|MP:0020351,decreased vocalization
MGI:5563535	Celrr<tm1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:2668337	Celsr1<Crsh>	MP:0000928,incomplete rostral neuropore closure|MP:0000929,open neural tube|MP:0001175,abnormal lung morphology|MP:0001178,pulmonary hypoplasia|MP:0001341,absent eyelids|MP:0001411,spinning|MP:0002621,delayed neural tube closure|MP:0002730,head shaking|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0003641,small lung|MP:0004391,abnormal respiratory conducting tube morphology|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0005657,abnormal neural plate morphology|MP:0006026,dilated terminal bronchiole tube|MP:0006382,abnormal lung epithelium morphology|MP:0008784,craniorachischisis|MP:0010825,abnormal lung saccule morphology|MP:0010975,abnormal lung lobe morphology|MP:0010976,small lung lobe|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011032,impaired branching involved in terminal bronchiole morphogenesis|MP:0011089,perinatal lethality, complete penetrance|MP:0011143,thick lung-associated mesenchyme|MP:0030961,abnormal outer hair cell kinocilium location or orientation
MGI:5577174	Celsr1<ctb>	MP:0000420,ruffled hair|MP:0001265,decreased body size|MP:0001394,circling|MP:0001510,abnormal coat appearance|MP:0001850,increased susceptibility to otitis media|MP:0001891,hydrocephaly|MP:0001921,reduced fertility|MP:0001967,deafness|MP:0003051,curly tail|MP:0003205,testicular atrophy|MP:0005307,head tossing|MP:0006325,impaired hearing|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5613368	Celsr1<ctb-2J>	MP:0000420,ruffled hair|MP:0001265,decreased body size|MP:0001394,circling|MP:0001510,abnormal coat appearance|MP:0001850,increased susceptibility to otitis media|MP:0001891,hydrocephaly|MP:0001921,reduced fertility|MP:0001967,deafness|MP:0002080,prenatal lethality|MP:0003051,curly tail|MP:0003205,testicular atrophy|MP:0005307,head tossing|MP:0006325,impaired hearing|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6423825	Celsr1<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001404,no spontaneous movement|MP:0001711,abnormal placenta morphology|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002060,abnormal skin morphology|MP:0002111,abnormal tail morphology|MP:0002152,abnormal brain morphology|MP:0002699,abnormal vitreous body morphology|MP:0005238,increased brain size|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1862019	Celsr1<Scy>	MP:0000928,incomplete rostral neuropore closure|MP:0001341,absent eyelids|MP:0001410,head bobbing|MP:0001411,spinning|MP:0002730,head shaking|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0003492,abnormal involuntary movement|MP:0004300,abnormal organ of Corti supporting cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0008784,craniorachischisis|MP:0011089,perinatal lethality, complete penetrance|MP:0030961,abnormal outer hair cell kinocilium location or orientation
MGI:4430218	Celsr1<tm1.1Fati>	MP:0000383,abnormal hair follicle orientation|MP:0000585,kinked tail|MP:0000919,cranioschisis|MP:0003720,abnormal neural tube closure|MP:0009457,whorled hair|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4430217	Celsr1<tm1Fati>	MP:0009457,whorled hair
MGI:3604518	Celsr2<tm1Dgen>	MP:0000825,dilated lateral ventricle
MGI:5429210	Celsr2<tm1Lex>	MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype
MGI:3578665	Celsr3<tm1Agof>	MP:0000778,abnormal nervous system tract morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000792,abnormal cortical marginal zone morphology|MP:0001177,atelectasis|MP:0001405,impaired coordination|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002152,abnormal brain morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002961,abnormal axon guidance|MP:0004081,abnormal globus pallidus morphology|MP:0008129,absent brain internal capsule|MP:0008227,absent anterior commissure|MP:0009247,meteorism|MP:0011087,neonatal lethality, complete penetrance|MP:0011881,distended duodenum|MP:0012484,decreased corticospinal tract size
MGI:3849321	Celsr3<tm1Mrc>	MP:0002184,abnormal innervation|MP:0003631,nervous system phenotype|MP:0004081,abnormal globus pallidus morphology|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0014551,impaired neuronal migration
MGI:2180867	Cel<tm1Dyh>	MP:0005342,abnormal intestinal lipid absorption
MGI:2180869	Cel<tm1Eaf>	MP:0005342,abnormal intestinal lipid absorption
MGI:6854703	Cemip2<tm1.1Cya>	MP:0000065,abnormal bone marrow cavity morphology|MP:0001243,abnormal dermal layer morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002339,abnormal lymph node morphology|MP:0002827,abnormal renal corpuscle morphology|MP:0005266,abnormal metabolism|MP:0008989,abnormal liver sinusoid morphology|MP:0014427,increased circulating hyaluronic acid level|MP:0014429,increased hyaluronic acid level
MGI:7311628	Cemip<tm1.1Okda>	MP:0002764,short tibia|MP:0003109,short femur|MP:0004985,decreased osteoclast cell number|MP:0005602,decreased angiogenesis|MP:0006398,increased long bone epiphyseal plate size|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6117713	Cemip<tm1.1Tac>	MP:0000920,abnormal myelination|MP:0011904,abnormal Schwann cell physiology|MP:0014650,decreased susceptibility to nerve crush injury
MGI:4831137	Cend1<tm1.1Rmat>	MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000890,thin cerebellar molecular layer|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0009967,abnormal neuron proliferation|MP:0009977,abnormal cerebellar granule cell migration|MP:0010540,long stride length
MGI:2180885	Cenpa<tm1Khac>	MP:0004046,abnormal mitosis|MP:0004965,inner cell mass degeneration|MP:0005028,abnormal trophectoderm morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2670429	Cenpa<tm2Khac>	MP:0000266,abnormal heart morphology|MP:0000783,abnormal forebrain morphology|MP:0001648,abnormal apoptosis|MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0002151,abnormal neural tube morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003111,abnormal cell nucleus morphology|MP:0003702,abnormal chromosome morphology|MP:0003984,embryonic growth retardation|MP:0004024,aneuploidy|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2386968	Cenpb<tm1Gmay>	MP:0002169,no abnormal phenotype detected|MP:0005384,cellular phenotype
MGI:2181521	Cenpb<tm1Khac>	MP:0001119,abnormal female reproductive system morphology|MP:0001120,abnormal uterus morphology|MP:0001121,uterus hypoplasia|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001923,reduced female fertility|MP:0002161,abnormal fertility/fecundity|MP:0002292,abnormal gestational length|MP:0002687,oligozoospermia|MP:0003699,abnormal female reproductive system physiology|MP:0004014,abnormal uterine environment|MP:0004896,abnormal endometrium morphology|MP:0008028,pregnancy-related premature death|MP:0009096,decreased endometrial gland number|MP:0012008,delayed parturition
MGI:1932104	Cenpb<tm1Rpe>	MP:0002169,no abnormal phenotype detected|MP:0005389,reproductive system phenotype
MGI:2181526	Cenpb<tm2Khac>	MP:0001262,decreased body weight
MGI:2180846	Cenpc1<tm1Khac>	MP:0003702,abnormal chromosome morphology|MP:0003984,embryonic growth retardation|MP:0004046,abnormal mitosis|MP:0011092,embryonic lethality, complete penetrance|MP:0014693,abnormal cell nucleus size
MGI:5548395	Cenpe<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0011100,preweaning lethality, complete penetrance|MP:0011886,increased circulating lipase level|MP:0013279,increased fasting circulating glucose level
MGI:2449007	Cenpe<tm1Dwc>	MP:0004046,abnormal mitosis|MP:0004966,abnormal inner cell mass proliferation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2449008	Cenpe<tm2Dwc>	MP:0002658,abnormal liver regeneration|MP:0004046,abnormal mitosis|MP:0008866,chromosomal instability
MGI:6287437	Cenpf<em1Bko>	MP:0002169,no abnormal phenotype detected
MGI:6287440	Cenpf<em2Bko>	MP:0002169,no abnormal phenotype detected
MGI:6287441	Cenpf<em3Bko>	MP:0002169,no abnormal phenotype detected
MGI:5467564	Cenpf<tm1Dbdr>	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0000280,thin ventricular wall|MP:0001265,decreased body size|MP:0001544,abnormal cardiovascular system physiology|MP:0002083,premature death|MP:0002188,small heart|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002834,decreased heart weight|MP:0003057,abnormal epicardium morphology|MP:0003105,abnormal heart atrium morphology|MP:0003141,cardiac fibrosis|MP:0003896,prolonged PR interval|MP:0004071,prolonged P wave|MP:0004215,abnormal myocardial fiber physiology|MP:0004567,decreased myocardial fiber number|MP:0005294,abnormal heart ventricle morphology|MP:0005385,cardiovascular system phenotype|MP:0006267,abnormal intercalated disk morphology|MP:0010503,myocardial trabeculae hypoplasia|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0011395,decreased fetal cardiomyocyte proliferation
MGI:5588273	Cenph<tm1b(EUCOMM)Hmgu>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001303,abnormal lens morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5637046	Cenpl<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5463969	Cenpo<tm1b(KOMP)Mbp>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0001303,abnormal lens morphology|MP:0001399,hyperactivity|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002833,increased heart weight|MP:0004151,decreased circulating iron level|MP:0005179,decreased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0005566,decreased blood urea nitrogen level|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014586,decreased egg cylinder size
MGI:6257760	Cenpt<em1(IMPC)Bay>	MP:0001417,decreased exploration in new environment|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011962,increased cornea thickness|MP:0013292,embryonic lethality prior to organogenesis
MGI:5522669	Cenpu<tm1Hluo>	MP:0001698,decreased embryo size|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011186,abnormal visceral endoderm morphology
MGI:6838381	Cenpv<tm1c(EUCOMM)Hmgu>	MP:0005168,abnormal female meiosis|MP:0014443,impaired polar body extrusion
MGI:6838384	Cenpv<tm1d(EUCOMM)Hmgu>	MP:0001923,reduced female fertility|MP:0005168,abnormal female meiosis|MP:0005389,reproductive system phenotype|MP:0009761,abnormal meiotic spindle morphology|MP:0014443,impaired polar body extrusion
MGI:6404500	Cenpx<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity
MGI:7510085	Cep104<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7481204	Cep112<em1(IMPC)Bay>	MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount
MGI:5749514	Cep120<tm1.2Blnw>	MP:0000358,abnormal cell morphology|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0004252,abnormal direction of heart looping|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013202,abnormal cilium morphology
MGI:5688207	Cep126<tm1b(KOMP)Mbp>	MP:0001925,male infertility|MP:0006243,impaired pupillary reflex|MP:0013279,increased fasting circulating glucose level
MGI:7261352	Cep128<em1Fzh>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0020451,decreased sperm progressive motility
MGI:6336112	Cep128<em1(IMPC)Kmpc>	MP:0001402,decreased locomotor activity|MP:0001404,no spontaneous movement|MP:0001489,decreased startle reflex|MP:0004738,abnormal auditory brainstem response|MP:0005292,improved glucose tolerance|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength
MGI:7261353	Cep128<em2Fzh>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0020451,decreased sperm progressive motility
MGI:7261354	Cep128<em3Fzh>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0009243,hairpin sperm flagellum|MP:0009647,decreased fertilization frequency|MP:0009838,abnormal sperm axoneme morphology
MGI:3870375	Cep131<Gt(CC0635)Wtsi>	MP:0001146,abnormal testis morphology|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001929,abnormal gametogenesis|MP:0001932,abnormal spermiogenesis|MP:0002631,abnormal epididymis morphology|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005367,renal/urinary system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0005388,respiratory system phenotype|MP:0005391,vision/eye phenotype|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009239,short sperm flagellum|MP:0009830,abnormal sperm connecting piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014052,increased male germ cell apoptosis
MGI:5805217	Cep135<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0000428,abnormal craniofacial morphology|MP:0000432,abnormal head morphology|MP:0000562,polydactyly|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001785,edema|MP:0005419,decreased circulating serum albumin level|MP:0005568,increased circulating total protein level|MP:0008797,facial cleft|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape
MGI:7661140	Cep135<em1Mama>	MP:0000433,microcephaly|MP:0005384,cellular phenotype|MP:0020069,decreased neocortex size
MGI:7661141	Cep135<em2Mama>	MP:0000352,decreased cell proliferation|MP:0000433,microcephaly|MP:0000511,abnormal intestinal mucosa morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0001176,abnormal lung development|MP:0001325,abnormal retina morphology|MP:0001698,decreased embryo size|MP:0002175,decreased brain weight|MP:0003077,abnormal cell cycle|MP:0004024,aneuploidy|MP:0004046,abnormal mitosis|MP:0008458,abnormal cortical ventricular zone morphology|MP:0008866,chromosomal instability|MP:0009760,abnormal mitotic spindle morphology|MP:0010158,abnormal intestine development|MP:0010792,abnormal stomach mucosa morphology|MP:0010995,abnormal lung alveolus development|MP:0011087,neonatal lethality, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis|MP:0014693,abnormal cell nucleus size|MP:0020069,decreased neocortex size|MP:0020394,decreased neuronal precursor proliferation|MP:0030943,abnormal centrosome morphology|MP:0031682,abnormal centriole morphology
MGI:4432204	Cep152<tm1a(EUCOMM)Wtsi>	MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0006042,increased apoptosis|MP:0013214,decreased embryonic neuroepithelium primary cilium number|MP:0030943,abnormal centrosome morphology
MGI:5637049	Cep15<tm1b(KOMP)Wtsi>	MP:0010067,increased red blood cell distribution width
MGI:4432075	Cep164<tm1a(EUCOMM)Wtsi>	MP:0000269,abnormal heart looping|MP:0001787,pericardial edema|MP:0004073,caudal body truncation|MP:0005157,holoprosencephaly|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013203,abnormal primary cilium morphology|MP:0013214,decreased embryonic neuroepithelium primary cilium number
MGI:5637128	Cep164<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6281982	Cep164<tm1c(EUCOMM)Wtsi>	MP:0000440,domed cranium|MP:0001154,seminiferous tubule degeneration|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0002687,oligozoospermia|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004543,abnormal sperm physiology|MP:0004728,abnormal efferent ductules of testis morphology|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006308,enlarged seminiferous tubules|MP:0006417,rete testis obstruction|MP:0006423,dilated rete testis|MP:0008535,enlarged lateral ventricles|MP:0008892,abnormal sperm flagellum morphology|MP:0009140,dilated efferent ductule of testis|MP:0009234,absent sperm head|MP:0009257,dilated seminiferous tubule|MP:0010752,impaired mucociliary clearance|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011053,decreased respiratory motile cilia number|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011281,abnormal olfactory epithelium cilium morphology|MP:0011644,abnormal oviduct epithelium motile cilium morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0030963,abnormal brain ependyma motile cilium location or orientation|MP:0030966,decreased brain ependyma motile cilium number|MP:0031088,coughing|MP:0031089,sneezing
MGI:6403701	Cep170b<em1(IMPC)Hmgu>	MP:0001364,decreased anxiety-related response|MP:0001489,decreased startle reflex|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:5576737	Cep19<tm1.1Jmgi>	MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001261,obese|MP:0001402,decreased locomotor activity|MP:0001433,polyphagia|MP:0005290,decreased oxygen consumption|MP:0005458,increased percent body fat/body weight|MP:0010024,increased total body fat amount|MP:0010378,increased respiratory quotient
MGI:5792556	Cep19<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0001510,abnormal coat appearance|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002834,decreased heart weight|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005292,improved glucose tolerance|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011965,decreased total retina thickness
MGI:5576738	Cep19<tm2.1Jmgi>	MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001261,obese|MP:0001552,increased circulating triglyceride level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005458,increased percent body fat/body weight|MP:0005559,increased circulating glucose level|MP:0010024,increased total body fat amount
MGI:7263004	Cep20<tm1.1(KOMP)Vlcg>	MP:0000260,abnormal angiogenesis|MP:0000267,abnormal heart development|MP:0000291,enlarged pericardium|MP:0001698,decreased embryo size|MP:0001706,abnormal left-right axis patterning|MP:0001730,embryonic growth arrest|MP:0001787,pericardial edema|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004066,abnormal primitive node morphology|MP:0004073,caudal body truncation|MP:0004132,absent embryonic cilia|MP:0004180,failure of initiation of embryo turning|MP:0004252,abnormal direction of heart looping|MP:0009577,abnormal developmental vascular remodeling|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011199,abnormal amniotic cavity morphology
MGI:7327530	Cep250<em1Glvr>	MP:0001147,small testis|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis|MP:0030943,abnormal centrosome morphology
MGI:4431949	Cep250<tm1a(EUCOMM)Wtsi>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0004738,abnormal auditory brainstem response|MP:0004901,decreased male germ cell number|MP:0006358,absent pinna reflex|MP:0010024,increased total body fat amount
MGI:7444339	Cep250<tm1b(EUCOMM)Wtsi>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0004856,decreased ovary weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0005431,decreased oocyte number|MP:0030943,abnormal centrosome morphology
MGI:6356300	Cep250<tm1Jzb>	MP:0001326,retina degeneration|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0010097,abnormal retina blood vessel morphology|MP:0011965,decreased total retina thickness|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:5437082	Cep290<b2b1454Clo>	MP:0000284,double outlet right ventricle|MP:0000542,left-sided isomerism|MP:0000694,spleen hypoplasia|MP:0002639,micrognathia|MP:0003342,accessory spleen|MP:0003675,kidney cyst|MP:0004133,heterotaxia|MP:0006063,abnormal inferior vena cava morphology|MP:0008528,polycystic kidney|MP:0010412,atrioventricular septal defect|MP:0010419,inlet ventricular septal defect|MP:0011682,renal glomerulus cyst|MP:0011683,dual inferior vena cava
MGI:5438068	Cep290<b2b1752Clo>	MP:0000694,spleen hypoplasia|MP:0004133,heterotaxia|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010412,atrioventricular septal defect|MP:0011665,d-loop transposition of the great arteries
MGI:6277014	Cep290<em1(IMPC)Mbp>	MP:0001404,no spontaneous movement|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001914,hemorrhage|MP:0003743,abnormal facial morphology|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011495,abnormal head shape
MGI:3870362	Cep290<Gt(CC0582)Wtsi>	MP:0000522,kidney cortex cyst|MP:0001426,polydipsia|MP:0001762,polyuria|MP:0001891,hydrocephaly|MP:0003111,abnormal cell nucleus morphology|MP:0003631,nervous system phenotype|MP:0003675,kidney cyst|MP:0004754,abnormal kidney collecting duct morphology|MP:0005370,liver/biliary system phenotype|MP:0008057,abnormal DNA replication|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008580,photoreceptor inner segment degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0010768,mortality/aging|MP:0010948,abnormal double-strand DNA break repair|MP:0011066,abnormal renal tubule epithelial cell primary cilium morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0020384,absent kidney epithelial cell primary cilium|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:3624136	Cep290<rd16>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001326,retina degeneration|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0004512,anosmia|MP:0005201,abnormal retina pigment epithelium morphology|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008580,photoreceptor inner segment degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0008587,short photoreceptor outer segment|MP:0008789,abnormal olfactory epithelium morphology|MP:0012671,retina spots|MP:0013202,abnormal cilium morphology
MGI:4835226	Cep290<tm1.1Jgg>	MP:0000849,abnormal cerebellum morphology|MP:0000864,abnormal cerebellum vermis morphology|MP:0001265,decreased body size|MP:0001326,retina degeneration|MP:0001925,male infertility|MP:0001926,female infertility|MP:0008489,slow postnatal weight gain|MP:0009719,reduced cerebellar foliation
MGI:5578355	Cep290<tm1.1Rwjc>	MP:0002169,no abnormal phenotype detected
MGI:5578357	Cep290<tm2.1Rwjc>	MP:0002169,no abnormal phenotype detected
MGI:7425576	Cep295<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0001925,male infertility|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5558038	Cep295nl<tm1.1(KOMP)Vlcg>	MP:0005633,increased circulating sodium level
MGI:6149747	Cep350<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0010053,decreased grip strength
MGI:3820227	Cep41<Gt(AW0157)Wtsi>	MP:0000288,abnormal pericardium morphology|MP:0000841,abnormal hindbrain morphology|MP:0000914,exencephaly|MP:0001700,abnormal embryo turning|MP:0001915,intracranial hemorrhage|MP:0005380,embryo phenotype|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4432442	Cep41<tm1a(EUCOMM)Wtsi>	MP:0001925,male infertility
MGI:5548654	Cep43<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001516,abnormal motor coordination/balance|MP:0002591,decreased mean corpuscular volume|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:7608263	Cep55<em1.1Hyli>	MP:0000352,decreased cell proliferation|MP:0000807,abnormal hippocampus morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000822,abnormal brain ventricle morphology|MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0000832,abnormal thalamus morphology|MP:0000852,small cerebellum|MP:0001891,hydrocephaly|MP:0003077,abnormal cell cycle|MP:0003675,kidney cyst|MP:0004102,abnormal dorsal striatum morphology|MP:0005371,limbs/digits/tail phenotype|MP:0005382,craniofacial phenotype|MP:0006254,thin cerebral cortex|MP:0011085,postnatal lethality, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0011682,renal glomerulus cyst|MP:0013203,abnormal primary cilium morphology|MP:0013213,abnormal embryonic neuroepithelium primary cilium morphology|MP:0020382,increased kidney epithelial cell primary cilium length|MP:0030965,increased brain ependyma motile cilium length
MGI:6156491	Cep55<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0001126,abnormal ovary morphology|MP:0002637,small uterus|MP:0002989,small kidney|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4951017	Cep55<tm1a(EUCOMM)Hmgu>	MP:0000433,microcephaly|MP:0000438,abnormal cranium morphology|MP:0000521,abnormal kidney cortex morphology|MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002175,decreased brain weight|MP:0003203,increased neuron apoptosis|MP:0003707,increased cell nucleus count|MP:0003717,pallor|MP:0004981,decreased neuronal precursor cell number|MP:0005325,abnormal renal glomerulus morphology|MP:0006254,thin cerebral cortex|MP:0009546,absent gastric milk in neonates|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013289,abnormal mitotic cytokinesis|MP:0020600,decreased cerebral cortex cell density
MGI:6458053	Cep55<tm1c(EUCOMM)Hmgu>	MP:0003707,increased cell nucleus count|MP:0005381,digestive/alimentary phenotype
MGI:6208802	Cep57<em1Jvd>	MP:0000358,abnormal cell morphology|MP:0000592,short tail|MP:0002020,increased tumor incidence|MP:0002048,increased lung adenoma incidence|MP:0003051,curly tail|MP:0004024,aneuploidy|MP:0004499,increased incidence of tumors by chemical induction|MP:0004604,abnormal vertebral pedicle morphology|MP:0004610,small vertebrae|MP:0004703,abnormal vertebral column morphology|MP:0005227,abnormal vertebral body development|MP:0008271,abnormal bone ossification|MP:0009760,abnormal mitotic spindle morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:6208812	Cep57<em2Jvd>	MP:0002020,increased tumor incidence|MP:0002048,increased lung adenoma incidence|MP:0004024,aneuploidy|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:5634968	Cep57l1<tm1b(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level|MP:0013292,embryonic lethality prior to organogenesis
MGI:7594043	Cep63<em1(IMPC)Bay>	MP:0001529,abnormal vocalization|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0011965,decreased total retina thickness
MGI:4377328	Cep63<Gt(EUCE0251h11)Hmgu>	MP:0000433,microcephaly|MP:0000788,abnormal cerebral cortex morphology|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001940,testis hypoplasia|MP:0003830,abnormal testis development|MP:0004025,polyploidy|MP:0004046,abnormal mitosis|MP:0004852,decreased testis weight|MP:0004981,decreased neuronal precursor cell number|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0005431,decreased oocyte number|MP:0006254,thin cerebral cortex|MP:0006378,abnormal spermatogonia morphology|MP:0006379,abnormal spermatocyte morphology|MP:0008458,abnormal cortical ventricular zone morphology|MP:0009452,abnormal synaptonemal complex|MP:0009760,abnormal mitotic spindle morphology|MP:0010207,abnormal telomere morphology|MP:0012138,decreased forebrain size|MP:0012504,increased forebrain apoptosis|MP:0013601,increased testis apoptosis|MP:0014633,decreased spermatid number|MP:0014764,impaired double-strand DNA break repair
MGI:6284517	Cep68<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0001925,male infertility|MP:0002833,increased heart weight
MGI:6404516	Cep70<em1(IMPC)Bay>	MP:0001926,female infertility
MGI:7439755	Cep70<em1Qiao>	MP:0001147,small testis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008279,arrest of spermiogenesis|MP:0008898,abnormal acrosome morphology|MP:0009235,small sperm head|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0014052,increased male germ cell apoptosis
MGI:7398570	Cep72<em1Lmgg>	MP:0001932,abnormal spermiogenesis|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008839,absent acrosome|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009234,absent sperm head|MP:0009238,coiled sperm flagellum|MP:0009836,abnormal sperm principal piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0031356,abnormal outer dense fiber morphology
MGI:5561564	Cep76<tm1b(EUCOMM)Hmgu>	MP:0000689,abnormal spleen morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0011965,decreased total retina thickness
MGI:6294897	Cep78<em1(IMPC)J>	MP:0001925,male infertility|MP:0004085,abnormal heartbeat
MGI:7486489	Cep78<em1Xjg>	MP:0001006,abnormal retina cone cell morphology|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002660,abnormal caput epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008515,thin retina outer nuclear layer|MP:0008545,absent sperm flagellum|MP:0008586,disorganized photoreceptor outer segment|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009830,abnormal sperm connecting piece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0009839,multiflagellated sperm|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0014059,abnormal photoreceptor connecting cilium morphology|MP:0020451,decreased sperm progressive motility|MP:0031354,abnormal acrosome assembly|MP:0031356,abnormal outer dense fiber morphology|MP:0031373,abnormal manchette perinuclear ring morphology|MP:0031374,abnormal manchette assembly|MP:0031386,elongated manchette
MGI:7296812	Cep78<em2Gpt>	MP:0001326,retina degeneration|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004737,absent distortion product otoacoustic emissions|MP:0005578,teratozoospermia|MP:0008449,abnormal retina cone cell outer segment morphology|MP:0008545,absent sperm flagellum|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009239,short sperm flagellum|MP:0009647,decreased fertilization frequency|MP:0009831,abnormal sperm midpiece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:5695934	Cep83<tm1.1(KOMP)Vlcg>	MP:0000288,abnormal pericardium morphology|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6362813	Cep85l<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001364,decreased anxiety-related response|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0003068,enlarged kidney|MP:0004738,abnormal auditory brainstem response|MP:0004924,abnormal behavior|MP:0009142,decreased prepulse inhibition|MP:0020870,decreased thigmotaxis
MGI:6336113	Cep89<em1(IMPC)Kmpc>	MP:0000063,decreased bone mineral density|MP:0003961,decreased lean body mass|MP:0004924,abnormal behavior|MP:0005278,abnormal cholesterol homeostasis|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:6111956	Cep95<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:5708221	Cep97<tm1.1(KOMP)Vlcg>	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0001297,microphthalmia|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003054,spina bifida|MP:0008854,bleb|MP:0011100,preweaning lethality, complete penetrance
MGI:6117770	Cept1<tm1.1Sem>	MP:0000747,muscle weakness|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005384,cellular phenotype|MP:0005560,decreased circulating glucose level|MP:0010053,decreased grip strength|MP:0010378,increased respiratory quotient|MP:0010954,abnormal cellular respiration
MGI:7425577	Cer1<em1(IMPC)Ccpcz>	MP:0000137,abnormal vertebrae morphology|MP:0000160,kyphosis|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0003036,vertebral transformation|MP:0004599,abnormal vertebral arch morphology
MGI:2445492	Cer1<tm1.1Rph>	MP:0002169,no abnormal phenotype detected
MGI:2445497	Cer1<tm1Belo>	MP:0002169,no abnormal phenotype detected
MGI:2178818	Cer1<tm1Bhr>	MP:0002169,no abnormal phenotype detected
MGI:3604536	Cer1<tm1Dgen>	MP:0001260,increased body weight|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0003063,increased coping response
MGI:5049959	cerbo	MP:0012269,nuchal edema|MP:0012270,cardiac edema
MGI:6758642	Cerkl<em1Gmar>	MP:0011092,embryonic lethality, complete penetrance
MGI:5461515	Cerkl<tm1.1Geno>	MP:0005551,abnormal eye electrophysiology|MP:0030005,increased retina apoptosis
MGI:5779908	Cerkl<tm1.1Npa>	MP:0005391,vision/eye phenotype
MGI:3774547	Cerk<tm1Fbor>	MP:0000218,increased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000334,decreased granulocyte number|MP:0001262,decreased body weight|MP:0002412,increased susceptibility to bacterial infection|MP:0005387,immune system phenotype|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0012232,abnormal ceramide level
MGI:3764485	Cerk<tm1Yiga>	MP:0001406,abnormal gait|MP:0003867,increased defecation amount
MGI:4867029	Cers1<fln>	MP:0000876,Purkinje cell degeneration|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0001547,abnormal lipid level|MP:0002118,abnormal lipid homeostasis|MP:0003224,neuron degeneration|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008842,lipofuscinosis|MP:0010768,mortality/aging
MGI:5475110	Cers1<tm1.1Kwi>	MP:0000866,cerebellum vermis hypoplasia|MP:0000876,Purkinje cell degeneration|MP:0000880,decreased Purkinje cell number|MP:0001362,abnormal anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001547,abnormal lipid level|MP:0002118,abnormal lipid homeostasis|MP:0002804,abnormal motor learning|MP:0003203,increased neuron apoptosis|MP:0003354,astrocytosis|MP:0003461,abnormal response to novel object|MP:0008428,abnormal spatial working memory|MP:0008842,lipofuscinosis|MP:0009719,reduced cerebellar foliation|MP:0014185,cerebellum atrophy
MGI:6163775	Cers1<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2653507	Cers1<to>	MP:0000745,tremors|MP:0000852,small cerebellum|MP:0000876,Purkinje cell degeneration|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001525,impaired balance|MP:0002064,seizures|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002183,gliosis|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:4346044	Cers2<Gt(S16-4B1)Sor>	MP:0000886,abnormal cerebellar granule layer morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0002118,abnormal lipid homeostasis|MP:0003005,abnormal hippocampal fimbria morphology|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003871,abnormal myelin sheath morphology|MP:0008019,increased liver tumor incidence|MP:0008026,abnormal brain white matter morphology|MP:0010771,integument phenotype
MGI:5307225	Cers3<tm1.1Rsnd>	MP:0001190,reddish skin|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001429,dehydration|MP:0001547,abnormal lipid level|MP:0002796,impaired skin barrier function|MP:0003453,abnormal keratinocyte physiology|MP:0003941,abnormal skin development|MP:0005399,increased susceptibility to fungal infection|MP:0009546,absent gastric milk in neonates|MP:0009596,abnormal stratum corneum lipid matrix formation|MP:0009597,impaired stratum corneum desquamation|MP:0009608,abnormal epidermal lamellar body morphology|MP:0009931,abnormal skin appearance|MP:0011087,neonatal lethality, complete penetrance
MGI:5638668	Cers4<tm1.1Kwi>	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000652,enlarged sebaceous gland|MP:0001219,thick epidermis|MP:0002074,abnormal hair texture|MP:0002992,abnormal sebaceous lipid secretion|MP:0003413,hair follicle degeneration|MP:0009004,progressive hair loss|MP:0009823,abnormal sphingomyelin level|MP:0012232,abnormal ceramide level|MP:0030571,dilated piliary canal
MGI:7296822	Cers5<em1Gpt>	MP:0000609,abnormal liver physiology|MP:0003333,liver fibrosis|MP:0005165,increased susceptibility to injury|MP:0005365,abnormal bile salt homeostasis
MGI:5490496	Cers5<tm2b(KOMP)Mbp>	MP:0000063,decreased bone mineral density|MP:0001417,decreased exploration in new environment|MP:0001516,abnormal motor coordination/balance|MP:0003795,abnormal bone structure|MP:0005633,increased circulating sodium level|MP:0010124,decreased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:5607417	Cers6<tm1.1Arte>	MP:0001876,decreased inflammatory response|MP:0002727,decreased circulating insulin level|MP:0004889,increased energy expenditure|MP:0005292,improved glucose tolerance|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008034,enhanced lipolysis|MP:0009125,decreased brown fat cell lipid droplet size|MP:0009269,decreased fat cell size|MP:0010025,decreased total body fat amount|MP:0010954,abnormal cellular respiration|MP:0012232,abnormal ceramide level|MP:0014171,increased fatty acid oxidation
MGI:5523623	Cers6<tm1.1Kwi>	MP:0000807,abnormal hippocampus morphology|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002118,abnormal lipid homeostasis|MP:0002574,increased vertical activity|MP:0005386,behavior/neurological phenotype|MP:0008912,nervous|MP:0008918,microgliosis|MP:0011620,abnormal habituation to a new environment|MP:0031391,increased locomotor activity
MGI:5607416	Cers6<tm1Arte>	MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0012232,abnormal ceramide level
MGI:3837565	Cert1<Gt(RRF047)Byg>	MP:0000266,abnormal heart morphology|MP:0000280,thin ventricular wall|MP:0000352,decreased cell proliferation|MP:0001544,abnormal cardiovascular system physiology|MP:0001698,decreased embryo size|MP:0002118,abnormal lipid homeostasis|MP:0005384,cellular phenotype|MP:0005598,decreased heart ventricle muscle contractility|MP:0005621,abnormal cell physiology|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006126,abnormal cardiac outflow tract development|MP:0008772,increased heart ventricle size|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0031594,increased cardiac jelly amount
MGI:5301370	Cert1<tm1.1Jsau>	MP:0000733,abnormal muscle development|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype
MGI:5287775	Cert1<tm1a(KOMP)Wtsi>	MP:0000284,double outlet right ventricle|MP:0000783,abnormal forebrain morphology|MP:0001711,abnormal placenta morphology|MP:0002237,abnormal nasal cavity morphology|MP:0002428,abnormal semicircular canal morphology|MP:0002633,persistent truncus arteriosus|MP:0002728,absent tibia|MP:0003078,aphakia|MP:0004201,fetal growth retardation|MP:0004259,small placenta|MP:0004269,abnormal optic cup morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004612,fusion of vertebral bodies|MP:0004613,fusion of vertebral arches|MP:0004646,decreased cervical vertebrae number|MP:0005031,abnormal trophoblast layer morphology|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0008922,abnormal cervical rib|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010496,abnormal pectinate muscle morphology|MP:0010572,persistent right dorsal aorta|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013247,placenta necrosis|MP:0013985,abnormal umbilical vein topology|MP:0014001,abnormal vertebral artery topology|MP:0014021,heterochrony|MP:0020500,persistent trigeminal artery|MP:0030975,placenta hemorrhage
MGI:5692869	Ces1a<tm1b(KOMP)Wtsi>	MP:0003394,increased cardiac output
MGI:7425578	Ces1c<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002059,abnormal seminal vesicle morphology|MP:0002339,abnormal lymph node morphology|MP:0002997,enlarged seminal vesicle|MP:0010935,increased airway resistance
MGI:4938302	Ces1c<tm1.1Loc>	MP:0005534,decreased body temperature|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:6158484	Ces1d<em1(IMPC)Mbp>	MP:0002135,abnormal kidney morphology|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0008528,polycystic kidney
MGI:4440967	Ces1d<tm1Reli>	MP:0000008,increased white adipose tissue amount|MP:0001399,hyperactivity|MP:0001431,abnormal eating behavior|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0003442,decreased circulating glycerol level|MP:0003949,abnormal circulating lipid level|MP:0003976,decreased circulating VLDL triglyceride level|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0009118,increased white fat cell size|MP:0009172,small pancreatic islets|MP:0009356,decreased liver triglyceride level|MP:0010080,abnormal hepatocyte physiology|MP:0010378,increased respiratory quotient|MP:0030968,decreased circulating adiponectin level
MGI:5752553	Ces1f<tm1b(KOMP)Wtsi>	MP:0002590,increased mean corpuscular volume|MP:0004738,abnormal auditory brainstem response|MP:0011239,abnormal skin coloration
MGI:6164718	Ces1g<tm1Reli>	MP:0001260,increased body weight|MP:0001261,obese|MP:0001399,hyperactivity|MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0002891,increased insulin sensitivity|MP:0002971,abnormal brown adipose tissue morphology|MP:0003103,liver degeneration|MP:0003975,increased circulating VLDL triglyceride level|MP:0003980,increased circulating phospholipid level|MP:0004890,decreased energy expenditure|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005283,increased unsaturated fatty acids level|MP:0005286,decreased saturated fatty acids level|MP:0005290,decreased oxygen consumption|MP:0005331,insulin resistance|MP:0005455,increased susceptibility to weight gain|MP:0008964,decreased carbon dioxide production|MP:0009118,increased white fat cell size|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0010080,abnormal hepatocyte physiology|MP:0010331,abnormal apolipoprotein level|MP:0010332,abnormal circulating apolipoprotein level|MP:0010333,abnormal circulating apolipoprotein E level|MP:0010378,increased respiratory quotient|MP:0010379,decreased respiratory quotient|MP:0011049,impaired adaptive thermogenesis|MP:0013278,decreased fasting circulating glucose level|MP:0014145,increased white adipose tissue mass|MP:0014169,decreased brown adipose tissue mass
MGI:4399394	Ces2a<tm1(KOMP)Vlcg>	MP:0000013,abnormal adipose tissue distribution|MP:0001260,increased body weight|MP:0001860,liver inflammation|MP:0002079,increased circulating insulin level|MP:0002644,decreased circulating triglyceride level|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003333,liver fibrosis|MP:0003982,increased cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005343,increased circulating aspartate transaminase level|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0014142,increased body fat mass|MP:0014170,increased brown adipose tissue mass|MP:0020582,increased ceramide level|MP:0031269,increased susceptibility to diet-induced hepatic steatosis
MGI:5792024	Ces2f<mpc200H>	MP:0001242,hyperkeratosis
MGI:5707434	Ces2f<tm1b(KOMP)Wtsi>	MP:0005505,thrombocytosis|MP:0010067,increased red blood cell distribution width
MGI:6281171	Ces3b<em1(IMPC)J>	MP:0005278,abnormal cholesterol homeostasis
MGI:6278540	Ces5a<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001399,hyperactivity|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:6693654	Ces5a<em1Zuk>	MP:0001922,reduced male fertility|MP:0002631,abnormal epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0020451,decreased sperm progressive motility
MGI:6324193	Cetn1<tm1.1Wbae>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009239,short sperm flagellum|MP:0009831,abnormal sperm midpiece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0014685,spermiation failure|MP:0020869,immotile sperm|MP:0031354,abnormal acrosome assembly|MP:0031682,abnormal centriole morphology
MGI:6324192	Cetn1<tm1Wbae>	MP:0005391,vision/eye phenotype
MGI:5634782	Cetn2<tm1.1Wbae>	MP:0000440,domed cranium|MP:0000825,dilated lateral ventricle|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0005384,cellular phenotype|MP:0005391,vision/eye phenotype|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0008544,impaired olfaction|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011281,abnormal olfactory epithelium cilium morphology|MP:0012676,dilated brain ventricle|MP:0013907,abnormal cerebrospinal fluid flow|MP:0030963,abnormal brain ependyma motile cilium location or orientation|MP:0030988,dysosmia
MGI:4842368	Cetn3<tm1a(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:6324197	Cetn3<tm1d(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:7343883	Cfap107<em1(IMPC)J>	MP:0005635,decreased circulating bilirubin level
MGI:7594036	Cfap119<em1Gaof>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005384,cellular phenotype|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0014465,abnormal sperm mitochondrial morphology|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0031374,abnormal manchette assembly|MP:0031386,elongated manchette
MGI:7594037	Cfap119<em2Gaof>	MP:0005389,reproductive system phenotype
MGI:5548862	Cfap119<tm1b(EUCOMM)Hmgu>	MP:0001402,decreased locomotor activity|MP:0001556,increased circulating HDL cholesterol level|MP:0001925,male infertility|MP:0002757,decreased vertical activity|MP:0005178,increased circulating cholesterol level
MGI:5308442	Cfap126<tm1.1(icre)Heli>	MP:0002169,no abnormal phenotype detected
MGI:6336088	Cfap144<tm1.2Arte>	MP:0002169,no abnormal phenotype detected
MGI:5907281	Cfap157<tm1b(EUCOMM)Hmgu>	MP:0000358,abnormal cell morphology|MP:0001925,male infertility|MP:0002662,abnormal cauda epididymis morphology|MP:0002674,abnormal sperm motility|MP:0004901,decreased male germ cell number|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009234,absent sperm head|MP:0009282,decreased hyperactivated sperm motility|MP:0009831,abnormal sperm midpiece morphology
MGI:5907283	Cfap157<tm1d(EUCOMM)Hmgu>	MP:0000358,abnormal cell morphology|MP:0001925,male infertility|MP:0002662,abnormal cauda epididymis morphology|MP:0002674,abnormal sperm motility|MP:0004901,decreased male germ cell number|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009234,absent sperm head|MP:0009282,decreased hyperactivated sperm motility|MP:0009831,abnormal sperm midpiece morphology
MGI:6152704	Cfap161<em1(IMPC)Ccpcz>	MP:0000452,abnormal mouth morphology|MP:0000627,abnormal mammary gland morphology|MP:0000681,abnormal thyroid gland morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0005355,enlarged thyroid gland|MP:0010025,decreased total body fat amount
MGI:6783445	Cfap161<tm1.2Gos>	MP:0002169,no abnormal phenotype detected
MGI:6152428	Cfap206<em1(IMPC)Mbp>	MP:0001304,cataract|MP:0001404,no spontaneous movement|MP:0001925,male infertility|MP:0001926,female infertility
MGI:6771469	Cfap206<em1Yxc>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0003631,nervous system phenotype|MP:0005389,reproductive system phenotype|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009647,decreased fertilization frequency|MP:0009781,abnormal preimplantation embryo development|MP:0009838,abnormal sperm axoneme morphology|MP:0020451,decreased sperm progressive motility|MP:0031352,absent sperm axonemal central pair|MP:0031356,abnormal outer dense fiber morphology
MGI:6466698	Cfap206<tm1.2Gos>	MP:0000822,abnormal brain ventricle morphology|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002237,abnormal nasal cavity morphology|MP:0002675,asthenozoospermia|MP:0002958,cerebral aqueductal stenosis|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0010752,impaired mucociliary clearance|MP:0011380,enlarged brain ventricles|MP:0012676,dilated brain ventricle|MP:0013228,brain ventricle stenosis|MP:0030316,enlarged neurocranium|MP:0031438,abnormal sperm radial spoke morphology
MGI:7430786	Cfap20dc<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0002834,decreased heart weight
MGI:6390920	Cfap276<em1Fuxi>	MP:0000921,demyelination|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0002651,abnormal sciatic nerve morphology|MP:0003871,abnormal myelin sheath morphology|MP:0005402,abnormal action potential|MP:0005405,axon degeneration|MP:0009417,skeletal muscle atrophy|MP:0009434,paraparesis|MP:0010053,decreased grip strength|MP:0010738,abnormal internode morphology|MP:0011730,increased myelin sheath thickness
MGI:7641836	Cfap276<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6473223	Cfap276<em2.1Fuxi>	MP:0000921,demyelination|MP:0000939,decreased motor neuron number|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001729,impaired embryo implantation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002269,muscular atrophy|MP:0002651,abnormal sciatic nerve morphology|MP:0003871,abnormal myelin sheath morphology|MP:0004262,abnormal physical strength|MP:0005402,abnormal action potential|MP:0005405,axon degeneration|MP:0005498,hyporesponsive to tactile stimuli|MP:0008814,decreased nerve conduction velocity|MP:0009413,skeletal muscle fiber atrophy|MP:0010053,decreased grip strength|MP:0010738,abnormal internode morphology|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011730,increased myelin sheath thickness
MGI:5548582	Cfap299<tm1b(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:6414474	Cfap300<em1(IMPC)Bay>	MP:0003795,abnormal bone structure|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:4433419	Cfap36<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005633,increased circulating sodium level
MGI:6294893	Cfap418<em1(IMPC)J>	MP:0001417,decreased exploration in new environment
MGI:6157829	Cfap418<em1Jyang>	MP:0005378,growth/size/body region phenotype|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0012147,increased a-wave implicit time
MGI:6157830	Cfap418<em2Jyang>	MP:0005378,growth/size/body region phenotype|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0012147,increased a-wave implicit time
MGI:6157831	Cfap418<em3Jyang>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001326,retina degeneration|MP:0001327,decreased retina photoreceptor cell number|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005367,renal/urinary system phenotype|MP:0005371,limbs/digits/tail phenotype|MP:0005378,growth/size/body region phenotype|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment|MP:0011965,decreased total retina thickness|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0012147,increased a-wave implicit time|MP:0012150,increased b-wave implicit time
MGI:6258949	Cfap43<em1Fzh>	MP:0001925,male infertility|MP:0002662,abnormal cauda epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0031351,abnormal sperm flagellum thickness|MP:0031352,absent sperm axonemal central pair|MP:0031356,abnormal outer dense fiber morphology
MGI:6140013	Cfap43<em1Pfr>	MP:0001925,male infertility|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009241,thick sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0020451,decreased sperm progressive motility|MP:0020869,immotile sperm|MP:0031352,absent sperm axonemal central pair|MP:0031438,abnormal sperm radial spoke morphology
MGI:6457568	Cfap43<em1Sono>	MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0001891,hydrocephaly|MP:0008892,abnormal sperm flagellum morphology|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013206,abnormal motile cilium morphology
MGI:6258950	Cfap43<em2Fzh>	MP:0001925,male infertility|MP:0002662,abnormal cauda epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0031351,abnormal sperm flagellum thickness|MP:0031352,absent sperm axonemal central pair|MP:0031356,abnormal outer dense fiber morphology
MGI:6258948	Cfap44<em1Fzh>	MP:0001925,male infertility|MP:0002662,abnormal cauda epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0031352,absent sperm axonemal central pair|MP:0031356,abnormal outer dense fiber morphology
MGI:6140014	Cfap44<em1Pfr>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0005578,teratozoospermia|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009836,abnormal sperm principal piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0031356,abnormal outer dense fiber morphology
MGI:4431950	Cfap44<tm1a(EUCOMM)Wtsi>	MP:0001925,male infertility|MP:0005419,decreased circulating serum albumin level
MGI:6509073	Cfap45<em1Hmd>	MP:0000440,domed cranium|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0001265,decreased body size|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002083,premature death|MP:0002675,asthenozoospermia|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0005389,reproductive system phenotype|MP:0008933,abnormal motile primary cilium physiology|MP:0009282,decreased hyperactivated sperm motility|MP:0010808,right-sided stomach|MP:0010854,lung situs inversus|MP:0011252,situs inversus totalis|MP:0013858,abnormal azygos vein topology|MP:0020494,left sided inferior vena cava
MGI:6727102	Cfap47<em1Fzh>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0009237,kinked sperm flagellum|MP:0030590,abnormal sperm fibrous sheath morphology
MGI:7425580	Cfap47<em1(IMPC)Hmgu>	MP:0001340,abnormal eyelid morphology|MP:0003961,decreased lean body mass|MP:0004953,decreased spleen weight|MP:0010024,increased total body fat amount
MGI:7582946	Cfap52<em1Cya>	MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002083,premature death|MP:0002675,asthenozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0020451,decreased sperm progressive motility
MGI:6724260	Cfap53<em1Cya>	MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002083,premature death|MP:0002687,oligozoospermia|MP:0002766,situs inversus|MP:0005389,reproductive system phenotype|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011252,situs inversus totalis|MP:0031386,elongated manchette
MGI:6153305	Cfap53<em1(IMPC)Wtsi>	MP:0000598,abnormal liver morphology|MP:0000602,dilated liver sinusoidal space|MP:0000692,small spleen|MP:0001015,small superior cervical ganglion|MP:0001711,abnormal placenta morphology|MP:0002767,situs ambiguus|MP:0003178,left pulmonary isomerism|MP:0003414,epidermal cyst|MP:0003826,abnormal Mullerian duct morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0008923,thoracoschisis|MP:0010052,increased grip strength|MP:0010406,common atrium|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010427,double outlet left ventricle|MP:0010434,double inlet heart right ventricle|MP:0010440,anomalous pulmonary venous connection|MP:0010490,abnormal inferior vena cava valve morphology|MP:0010912,herniated liver|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011250,abdominal situs ambiguus|MP:0011252,situs inversus totalis|MP:0011683,dual inferior vena cava|MP:0013247,placenta necrosis|MP:0013830,abnormal intrathoracic topology of vagus nerve|MP:0013836,abnormal hypoglossal nerve topology|MP:0013843,hepatic portal vein stenosis|MP:0013847,retropleural edema|MP:0013848,subcutaneous edema|MP:0013858,abnormal azygos vein topology|MP:0013868,abnormal ventral pancreas topology|MP:0013876,absent ductus venosus valve|MP:0013877,abnormal ductus venosus valve morphology|MP:0013936,abnormal thymus topology|MP:0013971,blood in lymph vessels|MP:0013977,symmetric azygos veins|MP:0013982,inverse situs of great intrathoracic arteries|MP:0013987,absent intrahepatic inferior vena cava segment|MP:0014001,abnormal vertebral artery topology|MP:0020491,abnormal ovary topology|MP:0020492,abnormal superior mesenteric vein topology|MP:0030975,placenta hemorrhage
MGI:3942561	Cfap54<Gt(IST10309B2)Tigm>	MP:0000440,domed cranium|MP:0000788,abnormal cerebral cortex morphology|MP:0000825,dilated lateral ventricle|MP:0001891,hydrocephaly|MP:0001917,intraventricular hemorrhage|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002083,premature death|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0002687,oligozoospermia|MP:0003631,nervous system phenotype|MP:0006380,abnormal spermatid morphology|MP:0008026,abnormal brain white matter morphology|MP:0008545,absent sperm flagellum|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0010752,impaired mucociliary clearance|MP:0010768,mortality/aging|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011057,absent brain ependyma motile cilia|MP:0011069,abnormal brain ependyma motile cilium physiology
MGI:6152429	Cfap57<em1(IMPC)Mbp>	MP:0000759,abnormal skeletal muscle morphology|MP:0000955,abnormal spinal cord morphology|MP:0001417,decreased exploration in new environment|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002152,abnormal brain morphology
MGI:7529021	Cfap57<em1Qsh>	MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0020869,immotile sperm
MGI:6477396	Cfap58<em1Fzh>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0014636,decreased elongated spermatid number|MP:0020869,immotile sperm
MGI:6864090	Cfap61<em1Mngx>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009241,thick sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0020869,immotile sperm|MP:0031438,abnormal sperm radial spoke morphology
MGI:7448443	Cfap61<em1Yqt>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0013601,increased testis apoptosis|MP:0020451,decreased sperm progressive motility|MP:0031356,abnormal outer dense fiber morphology
MGI:5527609	Cfap61<tm2a(EUCOMM)Wtsi>	MP:0001925,male infertility|MP:0005565,increased blood urea nitrogen level|MP:0010124,decreased bone mineral content
MGI:6451090	Cfap65<em1Fzh>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0008545,absent sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0014052,increased male germ cell apoptosis|MP:0031352,absent sperm axonemal central pair
MGI:7316618	Cfap65<em1Yqt>	MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008545,absent sperm flagellum|MP:0008839,absent acrosome|MP:0008892,abnormal sperm flagellum morphology|MP:0008893,detached sperm flagellum|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009377,ectopic manchette|MP:0009830,abnormal sperm connecting piece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0014052,increased male germ cell apoptosis|MP:0020869,immotile sperm|MP:0031351,abnormal sperm flagellum thickness|MP:0031352,absent sperm axonemal central pair|MP:0031354,abnormal acrosome assembly|MP:0031356,abnormal outer dense fiber morphology|MP:0031374,abnormal manchette assembly|MP:0031386,elongated manchette|MP:0031438,abnormal sperm radial spoke morphology
MGI:7641905	Cfap68<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6431857	Cfap69<em1Fzh>	MP:0001925,male infertility|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0020869,immotile sperm|MP:0031356,abnormal outer dense fiber morphology
MGI:5548820	Cfap69<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0005389,reproductive system phenotype|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009239,short sperm flagellum|MP:0009377,ectopic manchette|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009836,abnormal sperm principal piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020869,immotile sperm|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0030591,absent sperm fibrous sheath|MP:0031356,abnormal outer dense fiber morphology
MGI:5906136	Cfap69<tm1c(KOMP)Wtsi>	MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype|MP:0008544,impaired olfaction|MP:0011677,abnormal olfactory sensory neuron physiology
MGI:7587719	Cfap70<em1Chnsr>	MP:0000440,domed cranium|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0011056,abnormal brain ependyma motile cilium morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011380,enlarged brain ventricles|MP:0030966,decreased brain ependyma motile cilium number|MP:0031356,abnormal outer dense fiber morphology
MGI:7587720	Cfap70<em2Chnsr>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0031352,absent sperm axonemal central pair
MGI:7641835	Cfap90<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6152510	Cfap91<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001925,male infertility|MP:0002092,abnormal eye morphology|MP:0002152,abnormal brain morphology|MP:0005238,increased brain size
MGI:6469464	Cfap97d1<em1Osb>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0005389,reproductive system phenotype|MP:0009838,abnormal sperm axoneme morphology|MP:0030976,impaired sperm penetration of zona pellucida
MGI:4947739	Cfap97d1<tm1a(KOMP)Wtsi>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0005389,reproductive system phenotype|MP:0030976,impaired sperm penetration of zona pellucida
MGI:5548656	Cfap97d1<tm1b(KOMP)Wtsi>	MP:0009142,decreased prepulse inhibition|MP:0010097,abnormal retina blood vessel morphology
MGI:5529069	Cfb<tm1.1(KOMP)Wtsi>	MP:0000198,decreased circulating phosphate level|MP:0002135,abnormal kidney morphology|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0005564,increased hemoglobin content|MP:0013279,increased fasting circulating glucose level
MGI:1861129	Cfb<tm1Hrc>	MP:0001921,reduced fertility|MP:0002471,abnormal complement pathway|MP:0002472,impaired complement alternative pathway|MP:0002473,impaired complement classical pathway|MP:0020950,decreased susceptibility to Coronaviridae infection
MGI:2158706	Cfb<tm1Mbo>	MP:0002412,increased susceptibility to bacterial infection
MGI:3038803	Cfb<tm1Pkna>	MP:0003436,decreased susceptibility to induced arthritis
MGI:2661709	Cfbw1<C57BL/6J>	MP:0001260,increased body weight
MGI:2661711	Cfbw2<C57BL/6J>	MP:0001260,increased body weight
MGI:2661712	Cfbw3<BALB/cJ>	MP:0001260,increased body weight
MGI:2661715	Cfbw4<C57BL/6J>	MP:0001260,increased body weight
MGI:2661717	Cfbw5<C57BL/6J>	MP:0001260,increased body weight
MGI:5560815	Cfc1<b2b2736.1Clo>	MP:0000531,right pulmonary isomerism|MP:0000542,left-sided isomerism|MP:0000694,spleen hypoplasia|MP:0003342,accessory spleen|MP:0004113,abnormal aortic arch morphology|MP:0004133,heterotaxia|MP:0010402,ventricular septal defect|MP:0010406,common atrium|MP:0010412,atrioventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010422,heart right ventricle hypoplasia|MP:0010443,total anomalous pulmonary venous connection, intracardiac|MP:0010466,vascular ring|MP:0010487,abnormal right subclavian artery morphology|MP:0010808,right-sided stomach|MP:0011254,superior-inferior ventricles|MP:0011665,d-loop transposition of the great arteries
MGI:5311378	Cfc1<b2b970Clo>	MP:0000531,right pulmonary isomerism|MP:0000650,mesocardia|MP:0004110,transposition of great arteries|MP:0004133,heterotaxia|MP:0006063,abnormal inferior vena cava morphology|MP:0010808,right-sided stomach|MP:0011673,unbalanced complete common atrioventricular canal
MGI:2181718	Cfc1<tm1Cbm>	MP:0000267,abnormal heart development|MP:0000284,double outlet right ventricle|MP:0000531,right pulmonary isomerism|MP:0000644,dextrocardia|MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0004110,transposition of great arteries|MP:0006113,abnormal heart septum morphology|MP:0010402,ventricular septal defect|MP:0010406,common atrium|MP:0010426,abnormal heart and great artery attachment|MP:0010454,abnormal truncus arteriosus septation|MP:0010808,right-sided stomach|MP:0011085,postnatal lethality, complete penetrance
MGI:2179530	Cfc1<tm1Mms>	MP:0000284,double outlet right ventricle|MP:0000531,right pulmonary isomerism|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0000690,absent spleen|MP:0001706,abnormal left-right axis patterning|MP:0002083,premature death|MP:0002766,situs inversus|MP:0004158,right aortic arch|MP:0004190,abnormal direction of embryo turning|MP:0004252,abnormal direction of heart looping|MP:0005390,skeleton phenotype|MP:0010403,atrial septal defect|MP:0010808,right-sided stomach|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011569,abnormal azygos vein morphology
MGI:7425581	Cfd<em1(IMPC)Mbp>	MP:0000639,abnormal adrenal gland morphology|MP:0002135,abnormal kidney morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0002768,small adrenal glands|MP:0002989,small kidney
MGI:6307726	Cfdp1<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2156994	Cfd<tm1Yxu>	MP:0002412,increased susceptibility to bacterial infection|MP:0002472,impaired complement alternative pathway
MGI:7425582	Cfhr1<em1(IMPC)Bay>	MP:0001513,limb grasping
MGI:8276744	Cfhr1<em1Wli>	MP:0000322,increased granulocyte number|MP:0002136,abnormal kidney physiology|MP:0002471,abnormal complement pathway|MP:0002875,decreased erythrocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0005088,increased acute inflammation|MP:0005387,immune system phenotype|MP:0008553,increased circulating tumor necrosis factor level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008735,increased susceptibility to endotoxin shock|MP:0012609,decreased complement C5 level|MP:0012610,increased complement C5 level|MP:0020217,increased circulating complement protein level
MGI:6314797	Cfh<tm1.1Song>	MP:0000530,abnormal kidney vasculature morphology|MP:0000755,hindlimb paralysis|MP:0001265,decreased body size|MP:0001325,abnormal retina morphology|MP:0001394,circling|MP:0001577,anemia|MP:0001916,intracerebral hemorrhage|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002551,abnormal blood coagulation|MP:0002640,reticulocytosis|MP:0002792,abnormal retina vasculature morphology|MP:0002874,decreased hemoglobin content|MP:0003099,retina detachment|MP:0003157,impaired muscle relaxation|MP:0003179,thrombocytopenia|MP:0004924,abnormal behavior|MP:0005048,abnormal thrombosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005565,increased blood urea nitrogen level|MP:0006080,brain ischemia|MP:0006134,artery occlusion|MP:0006242,white pupil|MP:0009642,abnormal blood homeostasis|MP:0010061,increased creatine level|MP:0011320,abnormal glomerular capillary morphology|MP:0011339,abnormal glomerular mesangium morphology|MP:0011353,expanded mesangial matrix|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011507,abnormal kidney thrombosis|MP:0011508,abnormal glomerular capillary thrombosis|MP:0012049,increased susceptilbility to retina ischemic injury|MP:0012553,decreased serum complement activity|MP:0012609,decreased complement C5 level|MP:0020216,decreased circulating complement protein level|MP:0031159,abnormal hepatic portal vein thrombosis|MP:0031161,abnormal kidney venous thrombosis|MP:0031167,abnormal lung thrombosis|MP:0031168,abnormal brain thrombosis
MGI:4434438	Cfh<tm1a(EUCOMM)Wtsi>	MP:0005561,increased mean corpuscular hemoglobin
MGI:2384179	Cfh<tm1Mbo>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001325,abnormal retina morphology|MP:0002083,premature death|MP:0002743,glomerulonephritis|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0003329,amyloid beta deposits|MP:0003727,abnormal retina layer morphology|MP:0005161,hematuria|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0005615,increased susceptibility to type III hypersensitivity reaction|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0006149,decreased visual acuity|MP:0008586,disorganized photoreceptor outer segment|MP:0011310,abnormal kidney capillary morphology|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011353,expanded mesangial matrix|MP:0011427,increased mesangial cell number|MP:0011512,mesangial cell interposition|MP:0011566,abnormal complement protein level|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0020216,decreased circulating complement protein level|MP:0020518,renal glomerular protein deposits|MP:0020519,renal glomerular immunoglobulin deposits
MGI:2670717	Cfid<BALB/cJ>	MP:0000477,abnormal intestine morphology|MP:0002083,premature death
MGI:7507065	Cfi<em1Jiwe>	MP:0002472,impaired complement alternative pathway|MP:0011427,increased mesangial cell number|MP:0011566,abnormal complement protein level
MGI:5636899	Cfi<tm1b(EUCOMM)Hmgu>	MP:0001402,decreased locomotor activity|MP:0002941,increased circulating alanine transaminase level|MP:0003179,thrombocytopenia
MGI:3773693	Cfi<tm1Mcp>	MP:0005325,abnormal renal glomerulus morphology|MP:0011353,expanded mesangial matrix|MP:0020216,decreased circulating complement protein level|MP:0020518,renal glomerular protein deposits
MGI:5473701	Cfl1<c5>	MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0000930,wavy neural tube|MP:0001787,pericardial edema|MP:0006126,abnormal cardiac outflow tract development
MGI:3529175	Cfl1<Gt(OST252839)Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:3574398	Cfl1<tm1.1Wit>	MP:0000788,abnormal cerebral cortex morphology|MP:0001393,ataxia|MP:0001511,disheveled coat|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002083,premature death|MP:0002962,increased urine protein level|MP:0003424,premature neuronal precursor differentiation|MP:0003651,abnormal axon extension|MP:0004948,abnormal neuronal precursor proliferation|MP:0005164,abnormal response to injury|MP:0005324,ascites|MP:0005367,renal/urinary system phenotype|MP:0005553,increased circulating creatinine level|MP:0008059,abnormal podocyte foot process morphology|MP:0008415,abnormal neurite morphology|MP:0009937,abnormal neuron differentiation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011380,enlarged brain ventricles|MP:0011868,podocyte microvillus transformation
MGI:3574399	Cfl1<tm1.2Wit>	MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0000930,wavy neural tube|MP:0001286,abnormal eye development|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0002151,abnormal neural tube morphology|MP:0002950,abnormal neural crest cell migration|MP:0005657,abnormal neural plate morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0011091,prenatal lethality, complete penetrance|MP:0012703,decreased embryonic neuroepithelium thickness|MP:0012706,decreased embryonic neuroepithelial cell proliferation|MP:0012728,abnormal somite border morphology|MP:0012746,abnormal neural crest cell delamination|MP:0013198,absent head mesenchyme
MGI:5316057	Cfl2<tm1.1Itl>	MP:0000747,muscle weakness|MP:0000759,abnormal skeletal muscle morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001436,abnormal suckling behavior|MP:0001523,impaired righting response|MP:0001732,postnatal growth retardation|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0004090,abnormal sarcomere morphology|MP:0005449,abnormal food intake|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009412,skeletal muscle fiber degeneration|MP:0011085,postnatal lethality, complete penetrance
MGI:5316051	Cfl2<tm1Itl>	MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002083,premature death|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0009412,skeletal muscle fiber degeneration|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5804644	Cflar<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:2159361	Cflar<tm1Mak>	MP:0000292,distended pericardium|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002652,thin myocardium|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012082,delayed heart development|MP:0013501,increased fibroblast apoptosis
MGI:3589399	Cflar<tm1Ywh>	MP:0008083,decreased single-positive T cell number|MP:0009541,increased thymocyte apoptosis
MGI:2661737	Cfld1<BALB/cJ>	MP:0006050,pulmonary fibrosis
MGI:2661740	Cfld2<BALB/cJ>	MP:0006050,pulmonary fibrosis
MGI:2661743	Cfld3<C57BL/6J>	MP:0006050,pulmonary fibrosis
MGI:2661744	Cfld4<BALB/cJ>	MP:0006050,pulmonary fibrosis
MGI:3771611	Cfp<tm1.1Song>	MP:0002169,no abnormal phenotype detected
MGI:3774548	Cfp<tm1Cmst>	MP:0001544,abnormal cardiovascular system physiology|MP:0005044,sepsis|MP:0005166,decreased susceptibility to injury|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3771610	Cfp<tm1Song>	MP:0002471,abnormal complement pathway|MP:0002472,impaired complement alternative pathway|MP:0002473,impaired complement classical pathway|MP:0003436,decreased susceptibility to induced arthritis
MGI:4838300	Cfp<tm2.1Song>	MP:0002472,impaired complement alternative pathway|MP:0003436,decreased susceptibility to induced arthritis
MGI:2670722	Cfsw1<BALB/cJ>	MP:0002082,postnatal lethality
MGI:2670725	Cfsw2<BALB/cJ>	MP:0002082,postnatal lethality
MGI:2670728	Cfsw3<C57BL/6J>	MP:0002082,postnatal lethality
MGI:6192450	Cftr<em3Cwr>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0003270,intestinal obstruction|MP:0008770,decreased survivor rate
MGI:3822761	Cftr<tm1.1Cwr>	MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0003270,intestinal obstruction|MP:0003449,abnormal intestine goblet cell morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014028,decreased respiratory epithelial chloride transmembrane transport|MP:0014208,decreased intestinal epithelial chloride transmembrane transport|MP:0014231,intestinal mucus accumulation
MGI:7263374	Cftr<tm1.1Sdw>	MP:0001511,disheveled coat|MP:0002083,premature death|MP:0003270,intestinal obstruction|MP:0003449,abnormal intestine goblet cell morphology|MP:0005388,respiratory system phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014230,dilated crypt of Lieberkuhn
MGI:1857897	Cftr<tm1Bay>	MP:0000477,abnormal intestine morphology|MP:0000491,crypts of Lieberkuhn abscesses|MP:0000495,abnormal colon morphology|MP:0000512,intestinal ulcer|MP:0001263,weight loss|MP:0001270,distended abdomen|MP:0001438,aphagia|MP:0001732,postnatal growth retardation|MP:0002163,abnormal gland morphology|MP:0003270,intestinal obstruction|MP:0003340,acute pancreas inflammation|MP:0003449,abnormal intestine goblet cell morphology|MP:0005150,cachexia|MP:0009150,pancreatic acinar cell atrophy|MP:0009342,enlarged gallbladder|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013455,lacrimal gland atrophy|MP:0014028,decreased respiratory epithelial chloride transmembrane transport|MP:0014208,decreased intestinal epithelial chloride transmembrane transport|MP:0014230,dilated crypt of Lieberkuhn|MP:0014231,intestinal mucus accumulation
MGI:1857544	Cftr<tm1Cam>	MP:0000477,abnormal intestine morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000495,abnormal colon morphology|MP:0000496,abnormal small intestine morphology|MP:0001262,decreased body weight|MP:0001346,abnormal lacrimal gland morphology|MP:0002083,premature death|MP:0002406,increased susceptibility to infection|MP:0003270,intestinal obstruction|MP:0003303,peritoneal inflammation|MP:0005388,respiratory system phenotype|MP:0009144,dilated pancreatic duct|MP:0009477,small cecum|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014028,decreased respiratory epithelial chloride transmembrane transport|MP:0014036,meconium ileus|MP:0014182,decreased respiratory epithelial sodium ion transmembrane transport|MP:0014230,dilated crypt of Lieberkuhn|MP:0014231,intestinal mucus accumulation
MGI:3822760	Cftr<tm1Cwr>	MP:0002169,no abnormal phenotype detected
MGI:1857899	Cftr<tm1Eur>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0003449,abnormal intestine goblet cell morphology|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005085,abnormal gallbladder physiology|MP:0010156,abnormal small intestinal crypt cell physiology|MP:0014028,decreased respiratory epithelial chloride transmembrane transport|MP:0014208,decreased intestinal epithelial chloride transmembrane transport
MGI:1856710	Cftr<tm1Hgu>	MP:0000495,abnormal colon morphology|MP:0001175,abnormal lung morphology|MP:0001177,atelectasis|MP:0001861,lung inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0002769,abnormal vas deferens morphology|MP:0003270,intestinal obstruction|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0010831,lethality, incomplete penetrance|MP:0010861,increased respiratory mucosa goblet cell number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013797,abnormal ileal goblet cell morphology|MP:0014028,decreased respiratory epithelial chloride transmembrane transport|MP:0014036,meconium ileus|MP:0014208,decreased intestinal epithelial chloride transmembrane transport
MGI:1857545	Cftr<tm1Hsc>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0003270,intestinal obstruction|MP:0010155,abnormal intestine physiology|MP:0010156,abnormal small intestinal crypt cell physiology|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013792,abnormal small intestine goblet cell morphology|MP:0013795,abnormal colon goblet cell morphology|MP:0014036,meconium ileus|MP:0014183,increased respiratory epithelial sodium ion transmembrane transport
MGI:1857151	Cftr<tm1Kth>	MP:0000242,impaired fertilization|MP:0000477,abnormal intestine morphology|MP:0001127,small ovary|MP:0001135,abnormal uterine cervix morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001663,abnormal digestive system physiology|MP:0001732,postnatal growth retardation|MP:0001765,abnormal ion homeostasis|MP:0001784,abnormal fluid regulation|MP:0001861,lung inflammation|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0001938,delayed sexual maturation|MP:0002637,small uterus|MP:0002680,decreased corpora lutea number|MP:0002693,abnormal pancreas physiology|MP:0003270,intestinal obstruction|MP:0003303,peritoneal inflammation|MP:0003355,decreased ovulation rate|MP:0004002,abnormal jejunum morphology|MP:0004856,decreased ovary weight|MP:0004905,decreased uterus weight|MP:0005376,homeostasis/metabolism phenotype|MP:0009006,prolonged estrous cycle|MP:0009009,absent estrous cycle|MP:0009081,thin uterus|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012519,dilated Brunner's gland|MP:0014028,decreased respiratory epithelial chloride transmembrane transport|MP:0031012,impaired sperm migration in female genital tract
MGI:1856709	Cftr<tm1Unc>	MP:0000242,impaired fertilization|MP:0000477,abnormal intestine morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000495,abnormal colon morphology|MP:0000693,spleen hyperplasia|MP:0001127,small ovary|MP:0001135,abnormal uterine cervix morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0001824,abnormal thymus involution|MP:0001861,lung inflammation|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0001938,delayed sexual maturation|MP:0001944,abnormal pancreas morphology|MP:0002083,premature death|MP:0002163,abnormal gland morphology|MP:0002238,abnormal nasal mucosa morphology|MP:0002240,abnormal paranasal sinus morphology|MP:0002264,abnormal bronchus morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002282,abnormal trachea morphology|MP:0002309,abnormal vital capacity|MP:0002637,small uterus|MP:0002675,asthenozoospermia|MP:0002680,decreased corpora lutea number|MP:0003270,intestinal obstruction|MP:0003303,peritoneal inflammation|MP:0003355,decreased ovulation rate|MP:0003426,pulmonary interstitial fibrosis|MP:0003449,abnormal intestine goblet cell morphology|MP:0003666,impaired sperm capacitation|MP:0003793,abnormal submandibular gland morphology|MP:0004179,transmission ratio distortion|MP:0004247,small pancreas|MP:0004777,abnormal phospholipid level|MP:0004856,decreased ovary weight|MP:0004905,decreased uterus weight|MP:0005084,abnormal gallbladder morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005388,respiratory system phenotype|MP:0009006,prolonged estrous cycle|MP:0009009,absent estrous cycle|MP:0009081,thin uterus|MP:0009161,pancreatic acinar cell zymogen granule accumulation|MP:0009343,dilated gallbladder|MP:0009478,coiled cecum|MP:0009484,ileum hypertrophy|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010861,increased respiratory mucosa goblet cell number|MP:0010895,increased lung compliance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012518,abnormal Brunner's gland morphology|MP:0013494,abnormal trachea gland morphology|MP:0014028,decreased respiratory epithelial chloride transmembrane transport|MP:0014182,decreased respiratory epithelial sodium ion transmembrane transport|MP:0014206,decreased intestinal epithelial sodium ion transmembrane transport|MP:0014208,decreased intestinal epithelial chloride transmembrane transport|MP:0014230,dilated crypt of Lieberkuhn|MP:0014232,dilated pancreatic acinus|MP:0031012,impaired sperm migration in female genital tract
MGI:1857896	Cftr<tm2Cam>	MP:0002083,premature death|MP:0003270,intestinal obstruction|MP:0003303,peritoneal inflammation|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005379,endocrine/exocrine gland phenotype|MP:0005388,respiratory system phenotype|MP:0010155,abnormal intestine physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014028,decreased respiratory epithelial chloride transmembrane transport|MP:0014036,meconium ileus
MGI:2177539	Cftr<tm2Hgu>	MP:0001663,abnormal digestive system physiology|MP:0002133,abnormal respiratory system physiology|MP:0003449,abnormal intestine goblet cell morphology|MP:0005382,craniofacial phenotype|MP:0005389,reproductive system phenotype
MGI:2177535	Cftr<tm2Kth>	MP:0002169,no abnormal phenotype detected
MGI:3688281	Cftr<tm2Mrc>	MP:0000222,decreased neutrophil cell number|MP:0001732,postnatal growth retardation|MP:0001861,lung inflammation|MP:0005381,digestive/alimentary phenotype|MP:0008245,abnormal alveolar macrophage morphology|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0014028,decreased respiratory epithelial chloride transmembrane transport
MGI:1857898	Cftr<tm3Bay>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0001265,decreased body size|MP:0001663,abnormal digestive system physiology|MP:0001926,female infertility|MP:0001944,abnormal pancreas morphology|MP:0002083,premature death|MP:0003270,intestinal obstruction|MP:0005370,liver/biliary system phenotype|MP:0005388,respiratory system phenotype
MGI:2177540	Cftr<tm3Hgu>	MP:0000511,abnormal intestinal mucosa morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000613,abnormal salivary gland morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002928,abnormal bile duct morphology|MP:0003251,gallbladder inflammation|MP:0003270,intestinal obstruction|MP:0003303,peritoneal inflammation|MP:0005379,endocrine/exocrine gland phenotype|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0009342,enlarged gallbladder|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014028,decreased respiratory epithelial chloride transmembrane transport|MP:0014033,abnormal submucosal gland morphology|MP:0014079,decreased small intestinal villus number|MP:0014182,decreased respiratory epithelial sodium ion transmembrane transport|MP:0014206,decreased intestinal epithelial sodium ion transmembrane transport|MP:0014230,dilated crypt of Lieberkuhn|MP:0014233,bile duct epithelium hyperplasia
MGI:3688292	Cftr<tm3Mrc>	MP:0001732,postnatal growth retardation|MP:0001861,lung inflammation|MP:0003270,intestinal obstruction|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0014028,decreased respiratory epithelial chloride transmembrane transport
MGI:1856817	cg	MP:0000436,abnormal head movements|MP:0001394,circling|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003997,tonic-clonic seizures|MP:0005202,lethargy
MGI:6831066	Cgas<em2Nki>	MP:0003240,loss of hippocampal neurons|MP:0012307,impaired spatial learning
MGI:4435548	Cgas<tm1a(EUCOMM)Hmgu>	MP:0001391,abnormal tail movements|MP:0001819,abnormal immune cell physiology|MP:0002376,abnormal dendritic cell physiology|MP:0002451,abnormal macrophage physiology|MP:0004924,abnormal behavior|MP:0008555,abnormal interferon secretion|MP:0008574,decreased circulating interferon-alpha level|MP:0008576,decreased circulating interferon-beta level|MP:0008769,abnormal plasmacytoid dendritic cell physiology|MP:0010053,decreased grip strength|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:5578170	Cgas<tm1d(EUCOMM)Hmgu>	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020928,increased susceptibility to Poxviridae infection|MP:0020934,increased susceptibility to Retroviridae infection|MP:0020943,increased susceptibility to Flaviviridae infection|MP:0031034,increased susceptibility to Poxviridae infection induced morbidity/mortality|MP:0031044,increased susceptibility to Flaviviridae infection induced morbidity/mortality
MGI:1857152	Cga<tm1Sac>	MP:0001121,uterus hypoplasia|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001132,absent mature ovarian follicles|MP:0001144,vagina atresia|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001157,small seminal vesicle|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001928,abnormal ovulation|MP:0002679,abnormal corpus luteum morphology|MP:0002773,decreased circulating luteinizing hormone level|MP:0002780,decreased circulating testosterone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003503,decreased activity of thyroid gland|MP:0004696,abnormal thyroid follicle morphology|MP:0005119,decreased circulating thyroid-stimulating hormone level|MP:0005379,endocrine/exocrine gland phenotype|MP:0008261,arrest of male meiosis|MP:0008329,decreased somatotroph cell number|MP:0008332,decreased lactotroph cell number|MP:0008333,absent lactotrophs|MP:0008337,increased thyrotroph cell number|MP:0008974,proportional dwarf
MGI:1856700	Cgct	MP:0001304,cataract|MP:0002080,prenatal lethality|MP:0003236,abnormal lens capsule morphology|MP:0005545,abnormal lens development|MP:0011697,lens vacuoles|MP:0031345,developmental cataract
MGI:6152430	Cgnl1<em1(IMPC)Mbp>	MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002092,abnormal eye morphology|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0005407,hyperalgesia|MP:0005565,increased blood urea nitrogen level
MGI:8244802	Cgnl1<tm1.1Citi>	MP:0000488,abnormal intestinal epithelium morphology
MGI:5508663	Cgn<tm1.1Citi>	MP:0000512,intestinal ulcer|MP:0005165,increased susceptibility to injury|MP:0005381,digestive/alimentary phenotype
MGI:5521541	Cgn<tm1b(KOMP)Wtsi>	MP:0000783,abnormal forebrain morphology|MP:0001575,cyanosis|MP:0001697,abnormal embryo size|MP:0001914,hemorrhage|MP:0002111,abnormal tail morphology|MP:0003720,abnormal neural tube closure|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:2153936	Cgnz1<NZM2328/J>	MP:0001859,kidney inflammation|MP:0004801,increased susceptibility to systemic lupus erythematosus
MGI:5817761	Cgref1<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0000367,abnormal coat/ hair morphology|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002833,increased heart weight|MP:0002966,decreased circulating alkaline phosphatase level
MGI:5637038	Cgrrf1<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000438,abnormal cranium morphology|MP:0005419,decreased circulating serum albumin level|MP:0008346,increased gamma-delta T cell number|MP:0010124,decreased bone mineral content|MP:0013421,increased CD5-positive gamma-delta T cell number
MGI:5692613	Ch25h<tm1.1(KOMP)Vlcg>	MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis
MGI:4947407	Ch25h<tm1Rus>	MP:0002495,increased IgA level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level
MGI:2159318	Chab1<AKR/J>	MP:0002646,increased intestinal cholesterol absorption
MGI:2159320	Chab2<AKR/J>	MP:0002646,increased intestinal cholesterol absorption
MGI:2159323	Chab3<AKR/J>	MP:0002646,increased intestinal cholesterol absorption
MGI:2159326	Chab4<AKR/J>	MP:0002646,increased intestinal cholesterol absorption
MGI:2159329	Chab5<AKR/J>	MP:0002646,increased intestinal cholesterol absorption
MGI:2159332	Chab6<SJL/J>	MP:0002647,decreased intestinal cholesterol absorption
MGI:2159334	Chab7<SJL/J>	MP:0002647,decreased intestinal cholesterol absorption
MGI:3708453	chac	MP:0001489,decreased startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5529270	Chad<tm1Gast>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003797,abnormal compact bone morphology|MP:0004991,decreased bone strength|MP:0006398,increased long bone epiphyseal plate size|MP:0009347,increased trabecular bone thickness|MP:0010025,decreased total body fat amount
MGI:5905817	Chaer1<em1Holi>	MP:0004486,decreased response of heart to induced stress
MGI:3693625	Chaf1a<tm1Ger>	MP:0001730,embryonic growth arrest|MP:0003111,abnormal cell nucleus morphology|MP:0011104,embryonic lethality before implantation, incomplete penetrance
MGI:6279889	Chaf1b<tm1b(EUCOMM)Hmgu>	MP:0000195,decreased circulating calcium level|MP:0008806,increased circulating amylase level|MP:0011100,preweaning lethality, complete penetrance|MP:0011886,increased circulating lipase level
MGI:6260241	Chaf1b<tm2c(EUCOMM)Hmgu>	MP:0000333,decreased bone marrow cell number|MP:0002083,premature death|MP:0002398,abnormal bone marrow cell morphology/development|MP:0004810,decreased hematopoietic stem cell number|MP:0005152,pancytopenia|MP:0006042,increased apoptosis|MP:0009278,abnormal bone marrow cell physiology|MP:0011091,prenatal lethality, complete penetrance|MP:0011182,decreased hematopoietic cell number
MGI:6336203	Champ1<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002699,abnormal vitreous body morphology|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:7627348	Chapir<em1Kwan>	MP:0004486,decreased response of heart to induced stress|MP:0005385,cardiovascular system phenotype
MGI:3619908	Char11<C57BL/6J>	MP:0005026,decreased susceptibility to parasitic infection
MGI:3697104	Char2a<C3H/HeJ>	MP:0005027,increased susceptibility to parasitic infection
MGI:3697111	Char2b<C3H/HeJ>	MP:0005027,increased susceptibility to parasitic infection
MGI:3033030	Char3<C57BL/6>	MP:0005026,decreased susceptibility to parasitic infection
MGI:2155274	Char4<C57BL/6J>	MP:0002640,reticulocytosis|MP:0005026,decreased susceptibility to parasitic infection
MGI:3714005	Char9<C57BL/6J>	MP:0005026,decreased susceptibility to parasitic infection
MGI:6380711	Chaserr<em1Wei>	MP:0000120,malocclusion|MP:0000160,kyphosis|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0003699,abnormal female reproductive system physiology|MP:0008907,decreased total fat pad weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:6380715	Chaserr<em2Wei>	MP:0000120,malocclusion|MP:0000160,kyphosis|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0003699,abnormal female reproductive system physiology|MP:0008907,decreased total fat pad weight|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4367608	Chat/Slc18a3<tm1.1Vpra>	MP:0000160,kyphosis|MP:0000759,abnormal skeletal muscle morphology|MP:0000940,abnormal motor neuron innervation pattern|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001575,cyanosis|MP:0004144,hypotonia|MP:0004835,abnormal miniature endplate potential|MP:0004836,abnormal synaptic acetylcholine release|MP:0005192,increased motor neuron number|MP:0005386,behavior/neurological phenotype|MP:0009413,skeletal muscle fiber atrophy|MP:0009417,skeletal muscle atrophy|MP:0010768,mortality/aging|MP:0011087,neonatal lethality, complete penetrance|MP:0030676,increased acetylcholine level
MGI:4367609	Chat/Slc18a3<tm1.1Vpra>	MP:0000160,kyphosis|MP:0000759,abnormal skeletal muscle morphology|MP:0000940,abnormal motor neuron innervation pattern|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001575,cyanosis|MP:0004144,hypotonia|MP:0004835,abnormal miniature endplate potential|MP:0004836,abnormal synaptic acetylcholine release|MP:0005192,increased motor neuron number|MP:0005386,behavior/neurological phenotype|MP:0009413,skeletal muscle fiber atrophy|MP:0009417,skeletal muscle atrophy|MP:0010768,mortality/aging|MP:0011087,neonatal lethality, complete penetrance|MP:0030676,increased acetylcholine level
MGI:4999564	Chat/Slc18a3<tm1.2Vpra>	MP:0005386,behavior/neurological phenotype
MGI:4999565	Chat/Slc18a3<tm1.2Vpra>	MP:0005386,behavior/neurological phenotype
MGI:4999561	Chat/Slc18a3<tm1Vpra>	MP:0001399,hyperactivity|MP:0004835,abnormal miniature endplate potential|MP:0005386,behavior/neurological phenotype
MGI:4999563	Chat/Slc18a3<tm1Vpra>	MP:0001399,hyperactivity|MP:0004835,abnormal miniature endplate potential|MP:0005386,behavior/neurological phenotype
MGI:3045900	Chat<tm1.1Jrs>	MP:0000160,kyphosis|MP:0000761,thin diaphragm muscle|MP:0001052,abnormal innervation pattern to muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001078,abnormal phrenic nerve morphology|MP:0001106,abnormal Schwann cell morphology|MP:0002108,abnormal muscle morphology|MP:0003924,diaphragmatic hernia|MP:0005162,carpoptosis|MP:0005192,increased motor neuron number|MP:0011087,neonatal lethality, complete penetrance
MGI:3777637	Chat<tm1(cre/ERT)Nat>	MP:0002169,no abnormal phenotype detected
MGI:3689420	Chat<tm1(cre)Lowl>	MP:0002169,no abnormal phenotype detected
MGI:2450310	Chat<tm1Fhg>	MP:0000160,kyphosis|MP:0001053,abnormal neuromuscular synapse morphology|MP:0002184,abnormal innervation|MP:0002913,abnormal PNS synaptic transmission|MP:0004200,decreased fetal size|MP:0005162,carpoptosis|MP:0005192,increased motor neuron number|MP:0005389,reproductive system phenotype|MP:0011089,perinatal lethality, complete penetrance
MGI:3045899	Chat<tm1Jrs>	MP:0000746,weakness|MP:0001052,abnormal innervation pattern to muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0005404,abnormal axon morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:5583868	Chat<tm1Mlt>	MP:0000160,kyphosis|MP:0000493,rectal prolapse|MP:0000745,tremors|MP:0000747,muscle weakness|MP:0001262,decreased body weight|MP:0001314,cornea opacity|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0002108,abnormal muscle morphology|MP:0002111,abnormal tail morphology|MP:0002269,muscular atrophy|MP:0002757,decreased vertical activity|MP:0003081,abnormal soleus morphology|MP:0003082,abnormal gastrocnemius morphology|MP:0003631,nervous system phenotype|MP:0005507,tail dragging|MP:0009419,skeletal muscle fibrosis|MP:0009420,skeletal muscle endomysial fibrosis|MP:0011620,abnormal habituation to a new environment
MGI:6293853	Chchd10<em1(IMPC)H>	MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level|MP:0010052,increased grip strength
MGI:6149046	Chchd10<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001566,increased circulating phosphate level
MGI:7532644	Chchd10<em2Dpn>	MP:0000266,abnormal heart morphology|MP:0001405,impaired coordination
MGI:7579274	Chchd10<em3Dpn>	MP:0000266,abnormal heart morphology|MP:0000751,myopathy|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0003083,abnormal tibialis anterior morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0009400,decreased skeletal muscle fiber size|MP:0010053,decreased grip strength|MP:0010519,atrioventricular block|MP:0011635,abnormal mitochondrial crista morphology|MP:0011925,abnormal heart echocardiography feature|MP:0012106,impaired exercise endurance|MP:0014390,decreased myocardial fiber mitochondrial DNA content
MGI:6117383	Chchd10<em5Lutzy>	MP:0005294,abnormal heart ventricle morphology|MP:0005384,cellular phenotype|MP:0010955,abnormal respiratory electron transport chain
MGI:6285502	Chchd10<em8Lutzy>	MP:0000160,kyphosis|MP:0000937,abnormal motor neuron morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001263,weight loss|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0001524,impaired limb coordination|MP:0001850,increased susceptibility to otitis media|MP:0002083,premature death|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003243,abnormal dopaminergic neuron morphology|MP:0004090,abnormal sarcomere morphology|MP:0004819,decreased skeletal muscle mass|MP:0005608,cardiac interstitial fibrosis|MP:0006035,abnormal mitochondrial morphology|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010053,decreased grip strength|MP:0011628,increased mitochondrial number|MP:0011635,abnormal mitochondrial crista morphology|MP:0011637,abnormal mitochondrial matrix morphology|MP:0012106,impaired exercise endurance|MP:0014694,anisokaryosis|MP:0020851,abnormal vacuole morphology
MGI:5708199	Chchd1<tm1.1(KOMP)Vlcg>	MP:0001697,abnormal embryo size|MP:0001722,pale yolk sac|MP:0003232,abnormal forebrain development|MP:0003717,pallor|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance
MGI:6449052	Chchd2<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002699,abnormal vitreous body morphology
MGI:6342881	Chchd2<tm1Noha>	MP:0001405,impaired coordination|MP:0001516,abnormal motor coordination/balance|MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0010768,mortality/aging|MP:0011448,decreased dopaminergic neuron number|MP:0011631,decreased mitochondrial size|MP:0011633,abnormal mitochondrial shape|MP:0011636,disorganized mitochondrial cristae|MP:0011637,abnormal mitochondrial matrix morphology|MP:0014065,Lewy bodies|MP:0030940,impaired autophagy
MGI:7519140	Chchd3<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:5287016	Chchd3<TgTn(sb-cHS4,Tyr)2503C-1bOve>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4038368	Chchd4<Gt(IST11943B12)Tigm>	MP:0001730,embryonic growth arrest|MP:0003984,embryonic growth retardation|MP:0005384,cellular phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0010768,mortality/aging|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:5754589	Chchd7<em3(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001175,abnormal lung morphology|MP:0002060,abnormal skin morphology
MGI:3622249	Chcmq1<C57BLKS/J>	MP:0005564,increased hemoglobin content
MGI:3622252	Chcmq2<SM/J>	MP:0005564,increased hemoglobin content
MGI:5548635	Chct1<tm1b(EUCOMM)Wtsi>	MP:0000194,increased circulating calcium level|MP:0002169,no abnormal phenotype detected
MGI:6257542	Chd1l<em1(IMPC)Bay>	MP:0011999,abnormal tail length
MGI:3910467	Chd1l<Gt(E305F08)Wrst>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002052,decreased tumor incidence|MP:0004502,decreased incidence of tumors by chemical induction|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5776692	Chd1<tm1.1Alsr>	MP:0002169,no abnormal phenotype detected
MGI:5637386	Chd1<tm1b(KOMP)Rsan>	MP:0001672,abnormal embryo development|MP:0001680,abnormal mesoderm development|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0002084,abnormal developmental patterning|MP:0002583,absent extraembryonic ectoderm|MP:0003077,abnormal cell cycle|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011092,embryonic lethality, complete penetrance|MP:0011189,small embryonic epiblast|MP:0011191,increased embryonic epiblast cell apoptosis|MP:0012159,absent anterior visceral endoderm
MGI:5513752	Chd1<tm1b(KOMP)Wtsi>	MP:0000455,abnormal maxilla morphology|MP:0001293,anophthalmia|MP:0001697,abnormal embryo size|MP:0002092,abnormal eye morphology|MP:0002100,abnormal tooth morphology|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010052,increased grip strength|MP:0010068,decreased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5637385	Chd1<tm1c(KOMP)Rsan>	MP:0011092,embryonic lethality, complete penetrance
MGI:6380717	Chd2<em1Wei>	MP:0001262,decreased body weight|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3800602	Chd2<Gt(RRBO46)Byg>	MP:0000160,kyphosis|MP:0000162,lordosis|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000274,enlarged heart|MP:0000523,cortical renal glomerulopathies|MP:0000598,abnormal liver morphology|MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001175,abnormal lung morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001293,anophthalmia|MP:0001511,disheveled coat|MP:0001614,abnormal blood vessel morphology|MP:0001654,hepatic necrosis|MP:0001732,postnatal growth retardation|MP:0001783,decreased white adipose tissue amount|MP:0001853,heart inflammation|MP:0001856,myocarditis|MP:0001860,liver inflammation|MP:0001862,interstitial pneumonia|MP:0001914,hemorrhage|MP:0002024,increased T cell derived lymphoma incidence|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0002133,abnormal respiratory system physiology|MP:0002135,abnormal kidney morphology|MP:0002429,abnormal blood cell morphology/development|MP:0002879,increased cellular sensitivity to X-ray irradiation induced cell death|MP:0003077,abnormal cell cycle|MP:0003141,cardiac fibrosis|MP:0003717,pallor|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0004566,myocardial fiber degeneration|MP:0004839,bile duct hyperplasia|MP:0004969,pale kidney|MP:0005016,decreased lymphocyte cell number|MP:0005202,lethargy|MP:0005330,cardiomyopathy|MP:0005426,tachypnea|MP:0008058,abnormal DNA repair|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008254,increased megakaryocyte cell number|MP:0008404,increased cellular sensitivity to methylmethanesulfonate induced cell death|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008476,increased spleen red pulp amount|MP:0008570,lipidosis|MP:0008725,increased heart atrium size|MP:0008770,decreased survivor rate|MP:0008843,absent subcutaneous adipose tissue|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008973,decreased erythroid progenitor cell number|MP:0009082,uterus cyst|MP:0009092,endometrium hyperplasia|MP:0009703,decreased birth body size|MP:0010138,arteritis|MP:0010894,pulmonary alveolar edema|MP:0010909,pulmonary alveolar hemorrhage|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012431,increased lymphoma incidence|MP:0014606,dark spleen|MP:0031253,lordokyphosis
MGI:5605818	Chd2<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0002764,short tibia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0003795,abnormal bone structure|MP:0004122,abnormal sinus arrhythmia|MP:0005343,increased circulating aspartate transaminase level|MP:0008935,decreased mean platelet volume|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content
MGI:5818701	Chd3<em1(IMPC)J>	MP:0000198,decreased circulating phosphate level|MP:0001399,hyperactivity
MGI:6456882	Chd3<tm1.1Cya>	MP:0001614,abnormal blood vessel morphology|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging|MP:0011102,embryonic lethality, incomplete penetrance
MGI:7510181	Chd4<em1Flc>	MP:0000266,abnormal heart morphology|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002953,thick ventricular wall|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003920,abnormal heart right ventricle morphology|MP:0004057,thin myocardium compact layer|MP:0004091,abnormal Z line morphology|MP:0005294,abnormal heart ventricle morphology|MP:0005333,decreased heart rate|MP:0009399,increased skeletal muscle fiber size|MP:0009406,decreased skeletal muscle fiber number|MP:0010402,ventricular septal defect|MP:0010724,thick interventricular septum|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011390,abnormal fetal cardiomyocyte physiology|MP:0011394,increased fetal cardiomyocyte proliferation|MP:0011925,abnormal heart echocardiography feature|MP:0014730,abnormal myocardial fiber myofibril morphology|MP:0031594,increased cardiac jelly amount|MP:0031612,increased fetal cardiomyocyte number|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4329398	Chd4<Gt(RRO120)Byg>	MP:0002663,absent blastocoele|MP:0004264,abnormal extraembryonic tissue physiology|MP:0006042,increased apoptosis|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3641408	Chd4<tm1.1Kge>	MP:0000694,spleen hypoplasia|MP:0001825,arrested T cell differentiation|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002444,abnormal T cell physiology|MP:0005092,decreased double-positive T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008101,lymph node hypoplasia
MGI:5775976	Chd4<tm1.2Bh>	MP:0011092,embryonic lethality, complete penetrance
MGI:3641409	Chd4<tm1.2Kge>	MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0003077,abnormal cell cycle|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:5561559	Chd4<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6430651	Chd5<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0009552,urinary bladder obstruction
MGI:5575642	Chd5<tm1.2Gmbr>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004901,decreased male germ cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006362,abnormal male germ cell morphology|MP:0006380,abnormal spermatid morphology|MP:0008279,arrest of spermiogenesis|MP:0014685,spermiation failure
MGI:6423837	Chd6<em1(IMPC)Mbp>	MP:0002060,abnormal skin morphology|MP:0005278,abnormal cholesterol homeostasis
MGI:4442238	Chd6<tm1.2Fier>	MP:0001405,impaired coordination|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002797,increased thigmotaxis|MP:0005386,behavior/neurological phenotype
MGI:5436059	Chd7<Coa1>	MP:0000780,abnormal corpus callosum morphology|MP:0000787,abnormal telencephalon morphology|MP:0000794,abnormal parietal lobe morphology|MP:0000798,abnormal frontal lobe morphology|MP:0000807,abnormal hippocampus morphology|MP:0000809,absent hippocampus|MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0000913,abnormal brain development|MP:0000934,abnormal telencephalon development|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0002741,small olfactory bulb|MP:0003451,absent olfactory bulb|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0006325,impaired hearing|MP:0008283,small hippocampus|MP:0008547,abnormal neocortex morphology|MP:0009944,abnormal olfactory lobe morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1862039	Chd7<Cycn>	MP:0000037,abnormal lateral semicircular canal morphology|MP:0001265,decreased body size|MP:0001394,circling|MP:0002858,abnormal posterior semicircular canal morphology|MP:0005307,head tossing
MGI:1862009	Chd7<Dz>	MP:0000037,abnormal lateral semicircular canal morphology|MP:0001265,decreased body size|MP:0001394,circling|MP:0002858,abnormal posterior semicircular canal morphology|MP:0005307,head tossing
MGI:1862012	Chd7<Edy>	MP:0000029,abnormal malleus morphology|MP:0000037,abnormal lateral semicircular canal morphology|MP:0001265,decreased body size|MP:0001394,circling|MP:0002858,abnormal posterior semicircular canal morphology|MP:0004417,decreased cochlear nerve compound action potential|MP:0005106,abnormal incus morphology|MP:0005107,abnormal stapes morphology|MP:0005307,head tossing|MP:0030109,abnormal incudomalleolar joint morphology|MP:0030407,abnormal stapes crus morpholgy
MGI:8217193	Chd7<em1Clwa>	MP:0000280,thin ventricular wall|MP:0001302,eyelids open at birth|MP:0001394,circling|MP:0001625,cardiac hypertrophy|MP:0002795,dilated cardiomyopathy|MP:0002953,thick ventricular wall|MP:0005294,abnormal heart ventricle morphology|MP:0006113,abnormal heart septum morphology|MP:0008022,dilated heart ventricle|MP:0010402,ventricular septal defect|MP:0011091,prenatal lethality, complete penetrance|MP:0013908,small lateral ventricles|MP:0030245,round head|MP:0031289,unilateral microphthalmia
MGI:6490625	Chd7<em1Jiao>	MP:0001730,embryonic growth arrest|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7489804	Chd7<em1Kangn>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000547,short limbs|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002116,abnormal craniofacial bone morphology|MP:0003797,abnormal compact bone morphology|MP:0004016,decreased bone mass|MP:0004989,decreased osteoblast cell number|MP:0006396,decreased long bone epiphyseal plate size|MP:0009278,abnormal bone marrow cell physiology|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0013616,decreased volumetric bone mineral density|MP:0013624,decreased femur compact bone thickness|MP:0013630,increased bone trabecular spacing|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization|MP:0030009,increased bone marrow adipose tissue amount
MGI:8217194	Chd7<em2Clwa>	MP:0001625,cardiac hypertrophy|MP:0002795,dilated cardiomyopathy|MP:0002953,thick ventricular wall|MP:0003068,enlarged kidney|MP:0005294,abnormal heart ventricle morphology|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0006113,abnormal heart septum morphology|MP:0008022,dilated heart ventricle|MP:0013908,small lateral ventricles
MGI:3511552	Chd7<Flo>	MP:0000037,abnormal lateral semicircular canal morphology|MP:0001337,dry eyes|MP:0001388,abnormal stationary movement|MP:0001394,circling|MP:0001410,head bobbing|MP:0001516,abnormal motor coordination/balance|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0001526,abnormal placing response|MP:0002082,postnatal lethality|MP:0003126,abnormal external female genitalia morphology|MP:0004290,abnormal stapes footplate morphology|MP:0004401,increased cochlear outer hair cell number|MP:0004480,abnormal round window morphology|MP:0005107,abnormal stapes morphology|MP:0009101,clitoris hypoplasia|MP:0013466,keratoconjunctivitis sicca
MGI:4330734	Chd7<Gt(RRR136)Byg>	MP:0000706,small thymus|MP:0001394,circling|MP:0001823,thymus hypoplasia|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0003007,ectopic thymus|MP:0006126,abnormal cardiac outflow tract development|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0006355,abnormal sixth pharyngeal arch artery morphology|MP:0010526,aortic arch coarctation|MP:0011092,embryonic lethality, complete penetrance|MP:0012729,abnormal common carotid artery morphology
MGI:3707678	Chd7<Gt(S20-7E1)Sor>	MP:0000037,abnormal lateral semicircular canal morphology|MP:0000039,abnormal otic capsule morphology|MP:0000352,decreased cell proliferation|MP:0000556,abnormal hindlimb morphology|MP:0000774,decreased brain size|MP:0000787,abnormal telencephalon morphology|MP:0000952,abnormal CNS glial cell morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001386,abnormal maternal nurturing|MP:0001394,circling|MP:0001395,bidirectional circling|MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0001657,abnormal induced morbidity/mortality|MP:0001923,reduced female fertility|MP:0001927,abnormal estrous cycle|MP:0001938,delayed sexual maturation|MP:0001983,abnormal olfactory system physiology|MP:0002082,postnatal lethality|MP:0002216,abnormal seminiferous tubule morphology|MP:0002428,abnormal semicircular canal morphology|MP:0002636,delayed vaginal opening|MP:0002773,decreased circulating luteinizing hormone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0002858,abnormal posterior semicircular canal morphology|MP:0003161,absent lateral semicircular canal|MP:0003162,decreased lateral semicircular canal size|MP:0003163,absent posterior semicircular canal|MP:0003164,decreased posterior semicircular canal size|MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0003938,abnormal ear development|MP:0004188,delayed embryo turning|MP:0004249,abnormal crista ampullaris morphology|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004290,abnormal stapes footplate morphology|MP:0004310,small otic vesicle|MP:0004401,increased cochlear outer hair cell number|MP:0004409,abnormal crista ampullaris neuroepithelium morphology|MP:0004718,abnormal vestibular nerve morphology|MP:0004737,absent distortion product otoacoustic emissions|MP:0004811,abnormal neuron physiology|MP:0004922,abnormal common crus morphology|MP:0004925,decreased susceptibility to noise-induced hearing loss|MP:0004948,abnormal neuronal precursor proliferation|MP:0004979,abnormal neuronal precursor cell number|MP:0005107,abnormal stapes morphology|MP:0005262,coloboma|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005645,abnormal hypothalamus physiology|MP:0005646,abnormal pituitary gland physiology|MP:0006030,abnormal otic vesicle development|MP:0006043,decreased apoptosis|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0006292,abnormal nasal placode morphology|MP:0006305,abnormal optic eminence morphology|MP:0006306,abnormal nasal pit morphology|MP:0006325,impaired hearing|MP:0006326,conductive hearing impairment|MP:0006329,sensorineural hearing impairment|MP:0008446,decreased retina cone cell number|MP:0008544,impaired olfaction|MP:0008789,abnormal olfactory epithelium morphology|MP:0009008,delayed estrous cycle|MP:0009229,abnormal neurohypophysis median eminence morphology|MP:0009937,abnormal neuron differentiation|MP:0010050,hypermyelination|MP:0010059,olfactory bulb hypoplasia|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011281,abnormal olfactory epithelium cilium morphology|MP:0011677,abnormal olfactory sensory neuron physiology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012020,abnormal olfactory epithelium physiology|MP:0012703,decreased embryonic neuroepithelium thickness|MP:0013350,Rathke's pouch hypoplasia|MP:0014333,short retina cone cell outer segment|MP:0014336,short retina rod cell outer segment|MP:0014490,abnormal inner ear vestibular sensory neuron innervation pattern|MP:0014592,decreased gonadotropin-releasing hormone neuron number|MP:0020348,decreased olfactory sensory neuron number|MP:0030060,absent nasal pit|MP:0030411,decreased round window size|MP:0031491,decreased oval window size
MGI:4127559	Chd7<Gt(XK403)Byg>	MP:0000486,abnormal pulmonary trunk morphology|MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000851,cerebellum hypoplasia|MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0001056,abnormal cranial nerve morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001394,circling|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0002950,abnormal neural crest cell migration|MP:0003387,aorta coarctation|MP:0003395,abnormal subclavian artery morphology|MP:0003631,nervous system phenotype|MP:0004568,fusion of glossopharyngeal and vagus nerve|MP:0005380,embryo phenotype|MP:0006126,abnormal cardiac outflow tract development|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0006355,abnormal sixth pharyngeal arch artery morphology|MP:0009267,abnormal cerebellum fissure morphology|MP:0009957,abnormal cerebellum vermis lobule morphology|MP:0009959,abnormal cerebellar hemisphere morphology|MP:0009963,abnormal cerebellum hemisphere lobule morphology|MP:0009996,abnormal cerebellum vermis lobule VIII morphology|MP:0010005,abnormal lobule simplex morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011659,interrupted aortic arch, type b
MGI:2177299	Chd7<Lda>	MP:0000037,abnormal lateral semicircular canal morphology|MP:0001265,decreased body size|MP:0001394,circling|MP:0002858,abnormal posterior semicircular canal morphology|MP:0005307,head tossing
MGI:5505450	Chd7<Looper>	MP:0000037,abnormal lateral semicircular canal morphology|MP:0001262,decreased body weight|MP:0001394,circling|MP:0001489,decreased startle reflex|MP:0001732,postnatal growth retardation|MP:0001852,conjunctivitis|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002858,abnormal posterior semicircular canal morphology|MP:0003069,abnormal superior semicircular canal morphology|MP:0004290,abnormal stapes footplate morphology|MP:0004479,abnormal oval window morphology|MP:0004897,otosclerosis|MP:0005105,abnormal middle ear ossicle morphology|MP:0005106,abnormal incus morphology|MP:0005107,abnormal stapes morphology|MP:0005251,blepharitis|MP:0005287,narrow eye opening|MP:0006167,eyelid edema|MP:0006325,impaired hearing|MP:0008374,abnormal malleus manubrium morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0030099,facial asymmetry|MP:0030394,abnormal incus short process morphology|MP:0030396,abnormal incus long process morphology|MP:0030831,abnormal glenoid fossa morphology|MP:0031391,increased locomotor activity
MGI:2177297	Chd7<Mt>	MP:0000037,abnormal lateral semicircular canal morphology|MP:0001265,decreased body size|MP:0001394,circling|MP:0002858,abnormal posterior semicircular canal morphology|MP:0005307,head tossing
MGI:1862006	Chd7<Obt>	MP:0000037,abnormal lateral semicircular canal morphology|MP:0001265,decreased body size|MP:0001394,circling|MP:0002858,abnormal posterior semicircular canal morphology|MP:0002859,abnormal inner ear canal fusion|MP:0005307,head tossing
MGI:4999643	Chd7<Ome>	MP:0000446,long snout|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001394,circling|MP:0001522,impaired swimming|MP:0001732,postnatal growth retardation|MP:0001850,increased susceptibility to otitis media|MP:0001922,reduced male fertility|MP:0003330,abnormal auditory tube morphology|MP:0004290,abnormal stapes footplate morphology|MP:0004413,absent cochlear microphonics|MP:0004736,abnormal distortion product otoacoustic emission|MP:0006325,impaired hearing|MP:0010973,increased periosteum thickness|MP:0011861,increased cranium height|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0020900,abnormal middle ear epithelium morphology|MP:0020903,increased middle ear goblet cell number|MP:0030402,abnormal stapes head morphology|MP:0030405,small stapes obturator foramen
MGI:4835266	Chd7<tm1.1Dmm>	MP:0000031,abnormal cochlea morphology|MP:0000954,decreased oligodendrocyte progenitor number|MP:0001286,abnormal eye development|MP:0001306,small lens|MP:0003162,decreased lateral semicircular canal size|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0003938,abnormal ear development|MP:0004269,abnormal optic cup morphology|MP:0004407,increased cochlear hair cell number|MP:0005262,coloboma|MP:0005545,abnormal lens development|MP:0008917,abnormal oligodendrocyte physiology|MP:0009808,decreased oligodendrocyte number|MP:0010205,abnormal oligodendrocyte apoptosis|MP:0011731,decreased myelin sheath thickness|MP:0013438,dysmyelination|MP:0013820,absent optic cup
MGI:4835268	Chd7<tm1.2Dmm>	MP:0001394,circling|MP:0001410,head bobbing|MP:0002428,abnormal semicircular canal morphology
MGI:4433295	Chd7<tm2a(EUCOMM)Wtsi>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000223,decreased monocyte cell number|MP:0000267,abnormal heart development|MP:0000280,thin ventricular wall|MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000780,abnormal corpus callosum morphology|MP:0000807,abnormal hippocampus morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001304,cataract|MP:0001317,abnormal pupil morphology|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0001570,abnormal circulating enzyme level|MP:0001730,embryonic growth arrest|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002184,abnormal innervation|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002652,thin myocardium|MP:0002725,abnormal vein morphology|MP:0002874,decreased hemoglobin content|MP:0002942,decreased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003222,increased cardiomyocyte apoptosis|MP:0003961,decreased lean body mass|MP:0004056,abnormal myocardium compact layer morphology|MP:0004647,decreased lumbar vertebrae number|MP:0004924,abnormal behavior|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005567,decreased circulating total protein level|MP:0006126,abnormal cardiac outflow tract development|MP:0006138,congestive heart failure|MP:0008039,increased NK T cell number|MP:0008821,increased blood uric acid level|MP:0010053,decreased grip strength|MP:0010068,decreased red blood cell distribution width|MP:0010124,decreased bone mineral content|MP:0010165,abnormal response to stress-induced hyperthermia|MP:0010330,abnormal circulating lipoprotein level|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010412,atrioventricular septal defect|MP:0010433,double inlet heart left ventricle|MP:0010453,abnormal coronary vein morphology|MP:0010454,abnormal truncus arteriosus septation|MP:0010455,aortopulmonary window|MP:0010556,thin ventricle myocardium compact layer|MP:0010607,common atrioventricular valve|MP:0011089,perinatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011390,abnormal fetal cardiomyocyte physiology|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0011659,interrupted aortic arch, type b|MP:0012167,abnormal epigenetic regulation of gene expression|MP:0012451,abnormal retrosplenial granular cortex morphology|MP:0012455,increased mammillothalamic tract size|MP:0012462,decreased brain internal capsule size|MP:0012481,increased habenula size|MP:0030992,atrioventricular cushion hypoplasia
MGI:5749385	Chd7<tm2c(EUCOMM)Wtsi>	MP:0000774,decreased brain size|MP:0000849,abnormal cerebellum morphology|MP:0000851,cerebellum hypoplasia|MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0000866,cerebellum vermis hypoplasia|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001523,impaired righting response|MP:0001923,reduced female fertility|MP:0002762,ectopic cerebellar granule cells|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration|MP:0003424,premature neuronal precursor differentiation|MP:0003631,nervous system phenotype|MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004856,decreased ovary weight|MP:0004980,increased neuronal precursor cell number|MP:0004981,decreased neuronal precursor cell number|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0008924,decreased cerebellar granule cell number|MP:0008946,abnormal neuron number|MP:0008947,increased neuron number|MP:0008948,decreased neuron number|MP:0009267,abnormal cerebellum fissure morphology|MP:0009957,abnormal cerebellum vermis lobule morphology|MP:0009959,abnormal cerebellar hemisphere morphology|MP:0009991,abnormal cerebellum vermis lobule IV morphology|MP:0009992,abnormal cerebellum vermis lobule IX morphology|MP:0009993,abnormal cerebellum vermis lobule V morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011121,decreased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012203,abnormal neuronal stem cell morphology|MP:0012206,increased neuronal stem cell self-renewal|MP:0013508,increased granulosa cell apoptosis|MP:0013551,decreased cerebellar granule cell precursor proliferation|MP:0021165,behavioral developmental delay|MP:0031239,increased atretic ovarian follicle number|MP:0031381,decreased secondary ovarian follicle number
MGI:1862003	Chd7<Todo>	MP:0000037,abnormal lateral semicircular canal morphology|MP:0001265,decreased body size|MP:0001394,circling|MP:0002858,abnormal posterior semicircular canal morphology|MP:0005307,head tossing
MGI:7486783	Chd7<Trooper>	MP:0000037,abnormal lateral semicircular canal morphology|MP:0001262,decreased body weight|MP:0001394,circling|MP:0001410,head bobbing|MP:0001852,conjunctivitis|MP:0002428,abnormal semicircular canal morphology|MP:0003164,decreased posterior semicircular canal size|MP:0003166,decreased superior semicircular canal size|MP:0004290,abnormal stapes footplate morphology|MP:0005191,head tilt|MP:0005251,blepharitis|MP:0011400,lethality, complete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0030127,small stapes
MGI:3588650	Chd7<Whi>	MP:0000037,abnormal lateral semicircular canal morphology|MP:0000195,decreased circulating calcium level|MP:0000208,decreased hematocrit|MP:0000223,decreased monocyte cell number|MP:0000780,abnormal corpus callosum morphology|MP:0000807,abnormal hippocampus morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0001120,abnormal uterus morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001337,dry eyes|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0001512,trunk curl|MP:0001785,edema|MP:0001914,hemorrhage|MP:0001940,testis hypoplasia|MP:0001973,increased thermal nociceptive threshold|MP:0002082,postnatal lethality|MP:0002177,abnormal outer ear morphology|MP:0002236,abnormal internal nares morphology|MP:0002622,abnormal cochlear hair cell morphology|MP:0002644,decreased circulating triglyceride level|MP:0002683,delayed fertility|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002730,head shaking|MP:0002741,small olfactory bulb|MP:0002858,abnormal posterior semicircular canal morphology|MP:0003069,abnormal superior semicircular canal morphology|MP:0003126,abnormal external female genitalia morphology|MP:0003161,absent lateral semicircular canal|MP:0003162,decreased lateral semicircular canal size|MP:0003442,decreased circulating glycerol level|MP:0003949,abnormal circulating lipid level|MP:0003961,decreased lean body mass|MP:0004395,increased cochlear inner hair cell number|MP:0004401,increased cochlear outer hair cell number|MP:0004480,abnormal round window morphology|MP:0004852,decreased testis weight|MP:0005107,abnormal stapes morphology|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005291,abnormal glucose tolerance|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0005416,abnormal circulating protein level|MP:0005419,decreased circulating serum albumin level|MP:0005459,decreased percent body fat/body weight|MP:0005565,increased blood urea nitrogen level|MP:0005628,decreased circulating potassium level|MP:0005632,decreased circulating aspartate transaminase level|MP:0006280,abnormal digit development|MP:0006357,abnormal circulating mineral level|MP:0008039,increased NK T cell number|MP:0008536,enlarged third ventricle|MP:0008544,impaired olfaction|MP:0008963,increased carbon dioxide production|MP:0009085,abnormal uterine horn morphology|MP:0009101,clitoris hypoplasia|MP:0009229,abnormal neurohypophysis median eminence morphology|MP:0009655,abnormal secondary palate development|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009890,cleft secondary palate|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010059,olfactory bulb hypoplasia|MP:0010093,decreased circulating magnesium level|MP:0010165,abnormal response to stress-induced hyperthermia|MP:0010330,abnormal circulating lipoprotein level|MP:0010402,ventricular septal defect|MP:0012451,abnormal retrosplenial granular cortex morphology|MP:0013466,keratoconjunctivitis sicca|MP:0013767,decreased palatal rugae number|MP:0014143,decreased body fat mass|MP:0014592,decreased gonadotropin-releasing hormone neuron number|MP:0031391,increased locomotor activity
MGI:6277051	Chd8<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0001402,decreased locomotor activity|MP:0005013,increased lymphocyte cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6390917	Chd8<tm1.1Csbd>	MP:0001402,decreased locomotor activity|MP:0001441,increased grooming behavior|MP:0002152,abnormal brain morphology|MP:0002272,abnormal nervous system electrophysiology|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002797,increased thigmotaxis|MP:0004811,abnormal neuron physiology|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0013140,excessive vocalization|MP:0014382,increased miniature inhibitory postsynaptic current frequency|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude
MGI:3530648	Chd8<tm1Kei>	MP:0000434,megacephaly|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001489,decreased startle reflex|MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001730,embryonic growth arrest|MP:0002176,increased brain weight|MP:0002718,abnormal inner cell mass morphology|MP:0003895,increased ectoderm apoptosis|MP:0004965,inner cell mass degeneration|MP:0006001,abnormal intestinal transit time|MP:0009141,increased prepulse inhibition|MP:0011092,embryonic lethality, complete penetrance|MP:0013916,decreased intestine length
MGI:6144040	Chd8<tm2.1Kei>	MP:0000434,megacephaly|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001489,decreased startle reflex|MP:0002176,increased brain weight|MP:0003861,abnormal nervous system development|MP:0006001,abnormal intestinal transit time|MP:0009141,increased prepulse inhibition|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012315,impaired learning|MP:0013916,decreased intestine length
MGI:6356368	Chd9<em1Ibbr>	MP:0001125,abnormal oocyte morphology|MP:0005389,reproductive system phenotype
MGI:6356369	Chd9<em2Ibbr>	MP:0001125,abnormal oocyte morphology|MP:0005389,reproductive system phenotype
MGI:4820270	Chd9<tm1a(EUCOMM)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005419,decreased circulating serum albumin level|MP:0008805,decreased circulating amylase level|MP:0013412,increased Langerhans cell number
MGI:6403989	Chdh<em1Rmps>	MP:0003360,abnormal depression-related behavior|MP:0005370,liver/biliary system phenotype|MP:0012335,increased circulating homocysteine level|MP:0021134,decreased amino acid betaine level
MGI:5620315	Chdh<tm1b(KOMP)Mbp>	MP:0001925,male infertility|MP:0001926,female infertility|MP:0002942,decreased circulating alanine transaminase level
MGI:4822561	Chdh<tm1Zei>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0010955,abnormal respiratory electron transport chain|MP:0011632,dilated mitochondrion|MP:0011635,abnormal mitochondrial crista morphology
MGI:3046694	Chek1<tm1Jmr>	MP:0000351,increased cell proliferation|MP:0000352,decreased cell proliferation|MP:0001186,pigmentation phenotype|MP:0001648,abnormal apoptosis|MP:0001882,abnormal lactation|MP:0004381,abnormal hair follicle melanocyte morphology|MP:0005171,absent coat pigmentation|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0008057,abnormal DNA replication|MP:0009388,abnormal epidermal melanocyte morphology|MP:0009783,abnormal melanoblast morphology|MP:0012023,decreased melanocyte number
MGI:1928818	Chek1<tm1Mkt>	MP:0003111,abnormal cell nucleus morphology|MP:0004045,abnormal cell cycle checkpoint function|MP:0004966,abnormal inner cell mass proliferation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation|MP:0012743,increased inner cell mass apoptosis|MP:0031678,increased micronucleus incidence
MGI:1926528	Chek1<tm1Sje>	MP:0000352,decreased cell proliferation|MP:0002006,neoplasm|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0004045,abnormal cell cycle checkpoint function|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:4818574	Chek1<tm2.1Sje>	MP:0000627,abnormal mammary gland morphology|MP:0002006,neoplasm|MP:0009506,abnormal mammary gland alveolus morphology
MGI:5521536	Chek2<tm1b(EUCOMM)Hmgu>	MP:0005633,increased circulating sodium level
MGI:2386905	Chek2<tm1Mak>	MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0004045,abnormal cell cycle checkpoint function|MP:0004228,decreased cellular sensitivity to ionizing radiation induced cell death|MP:0004499,increased incidence of tumors by chemical induction
MGI:3038822	Chek2<tm1Nmt>	MP:0003010,decreased mortality induced by ionizing radiation|MP:0004228,decreased cellular sensitivity to ionizing radiation induced cell death
MGI:3812090	Chek2<tm1Pjs>	MP:0003077,abnormal cell cycle|MP:0004025,polyploidy|MP:0005621,abnormal cell physiology
MGI:6151421	Cherp<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0001727,abnormal embryo implantation|MP:0002718,abnormal inner cell mass morphology|MP:0005028,abnormal trophectoderm morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0012058,abnormal morula morphology|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:4364442	Chfr<tm1a(KOMP)Wtsi>	MP:0000280,thin ventricular wall|MP:0000689,abnormal spleen morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002311,abnormal inspiratory capacity|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003917,increased kidney weight|MP:0005333,decreased heart rate|MP:0005343,increased circulating aspartate transaminase level|MP:0010895,increased lung compliance|MP:0011045,decreased lung elastance|MP:0011239,abnormal skin coloration
MGI:3576266	Chfr<tm1Jc>	MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0004028,chromosome breakage|MP:0004046,abnormal mitosis|MP:0004499,increased incidence of tumors by chemical induction|MP:0012431,increased lymphoma incidence
MGI:3653689	Chga<tm1Gnh>	MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0011478,abnormal urine catecholamine level
MGI:3584125	Chga<tm1Skmt>	MP:0000231,hypertension|MP:0001732,postnatal growth retardation|MP:0001739,abnormal adrenal gland secretion|MP:0002625,heart left ventricle hypertrophy|MP:0002753,dilated heart left ventricle|MP:0002909,abnormal adrenal gland physiology|MP:0003963,abnormal corticosterone level|MP:0005662,increased circulating adrenaline level|MP:0005665,increased circulating noradrenaline level|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012574,decreased noradrenaline level|MP:0030762,decreased adrenaline level
MGI:4437075	Chgb<tm1Ribo>	MP:0001739,abnormal adrenal gland secretion|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0008504,abnormal adrenal chromaffin cell morphology|MP:0010147,abnormal endocrine pancreas physiology|MP:0030762,decreased adrenaline level
MGI:3846187	Chi3l1<tm1Eli>	MP:0002376,abnormal dendritic cell physiology|MP:0002446,abnormal macrophage morphology|MP:0002492,decreased IgE level|MP:0005466,abnormal T-helper 2 physiology|MP:0006042,increased apoptosis|MP:0006413,increased T cell apoptosis|MP:0008091,decreased T-helper 2 cell number|MP:0008673,decreased interleukin-13 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008719,impaired neutrophil recruitment|MP:0008723,impaired eosinophil recruitment|MP:0008769,abnormal plasmacytoid dendritic cell physiology|MP:0009335,decreased splenocyte proliferation
MGI:6358337	Chia1<tm1.1Lof>	MP:0000219,increased neutrophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0008673,decreased interleukin-13 secretion
MGI:4363305	Chia1<tm1a(KOMP)Wtsi>	MP:0001262,decreased body weight
MGI:7494199	Chic1<em1(IMPC)Tcp>	MP:0002792,abnormal retina vasculature morphology|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010053,decreased grip strength|MP:0010068,decreased red blood cell distribution width|MP:0010097,abnormal retina blood vessel morphology
MGI:4344880	Chic1<Gt(XQ0221)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5637077	Chic2<tm1b(EUCOMM)Wtsi>	MP:0000274,enlarged heart|MP:0000691,enlarged spleen|MP:0002075,abnormal coat/hair pigmentation|MP:0002941,increased circulating alanine transaminase level|MP:0004222,iris synechia|MP:0004832,enlarged ovary|MP:0008806,increased circulating amylase level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5447948	Chit1<tm1Eli>	MP:0002411,decreased susceptibility to bacterial infection
MGI:3526395	Chka<Gt(XH252)Byg>	MP:0009355,increased liver triglyceride level|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5050150	Chka<tm2a(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:7425585	Chkb<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3847123	Chkb<flp>	MP:0002932,abnormal joint morphology|MP:0004355,short radius|MP:0004359,short ulna
MGI:3578417	Chkb<rmd>	MP:0000550,abnormal forelimb morphology|MP:0000749,muscle degeneration|MP:0000752,dystrophic muscle|MP:0001547,abnormal lipid level|MP:0002106,abnormal muscle physiology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003631,nervous system phenotype|MP:0004087,abnormal muscle fiber morphology|MP:0004121,abnormal sarcolemma morphology|MP:0004361,bowed ulna|MP:0004374,bowed radius|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009434,paraparesis|MP:0010090,increased circulating creatine kinase level
MGI:3797283	Chl1<tm1Msch>	MP:0002063,abnormal learning/memory/conditioning|MP:0003461,abnormal response to novel object|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory
MGI:2429688	Chl1<tm1Mtg>	MP:0001364,decreased anxiety-related response|MP:0001413,abnormal response to new environment|MP:0003631,nervous system phenotype|MP:0003894,abnormal Purkinje cell innervation|MP:0004101,abnormal brain interneuron morphology|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0008535,enlarged lateral ventricles|MP:0008571,abnormal synaptic bouton morphology|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0012014,abnormal olfactory neuron innervation pattern|MP:0014746,abnormal hippocampal mossy fiber innervation pattern
MGI:3720128	Chldq12<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3699393	Chldq1<MRL/MpJ>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3699395	Chldq2<MRL/MpJ>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3699398	Chldq3<MRL/MpJ>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3699402	Chldq4<MRL/MpJ>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3720134	Chldq7<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3720157	Chldq9<RF/J>	MP:0000186,decreased circulating HDL cholesterol level
MGI:3613661	Chlq1<BALB/cJ>	MP:0004702,increased circulating insulin-like growth factor I level
MGI:3613664	Chlq1<DBA/2J>	MP:0005345,abnormal circulating corticosterone level
MGI:3613668	Chlq2<C57BL/6J>	MP:0004702,increased circulating insulin-like growth factor I level
MGI:3613674	Chlq3<C3H/HeJ>	MP:0005669,increased circulating leptin level
MGI:3613675	Chlq4<C3H/HeJ>	MP:0005477,increased circulating thyroxine level
MGI:3613678	Chlq5<C57BL/6J>	MP:0004702,increased circulating insulin-like growth factor I level
MGI:3613681	Chlq6<C3H/HeJ>	MP:0004702,increased circulating insulin-like growth factor I level
MGI:3613683	Chlq7<BALB/cJ>	MP:0005477,increased circulating thyroxine level
MGI:3613685	Chlq8<C3H/HeJ>	MP:0005477,increased circulating thyroxine level
MGI:5700043	Chlsn<tm1b(EUCOMM)Wtsi>	MP:0002608,increased hematocrit
MGI:4124823	Chmp1a<Gt(XC472)Byg>	MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000785,telencephalon hypoplasia|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000820,abnormal choroid plexus morphology|MP:0000851,cerebellum hypoplasia|MP:0000852,small cerebellum|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0002175,decreased brain weight|MP:0002741,small olfactory bulb|MP:0003232,abnormal forebrain development|MP:0004981,decreased neuronal precursor cell number|MP:0006007,abnormal basal ganglion morphology|MP:0006108,abnormal hindbrain development|MP:0006254,thin cerebral cortex|MP:0008441,thin cortical plate|MP:0008469,abnormal protein level|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0009719,reduced cerebellar foliation|MP:0010059,olfactory bulb hypoplasia|MP:0011089,perinatal lethality, complete penetrance|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0012468,decreased striatum size|MP:0013551,decreased cerebellar granule cell precursor proliferation|MP:0020394,decreased neuronal precursor proliferation
MGI:6149048	Chmp2b<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001404,no spontaneous movement|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0005333,decreased heart rate|MP:0009709,hydrometra|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020420,abnormal freezing behavior
MGI:4128363	Chmp2b<Gt(XL952)Byg>	MP:0008263,abnormal hippocampus CA1 region morphology|MP:0009538,abnormal synapse morphology|MP:0009936,abnormal dendritic spine morphology
MGI:7282116	Chmp2b<tm1.1Hiok>	MP:0000316,cellular necrosis|MP:0000788,abnormal cerebral cortex morphology|MP:0000798,abnormal frontal lobe morphology|MP:0001363,increased anxiety-related response|MP:0004045,abnormal cell cycle checkpoint function|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0012307,impaired spatial learning|MP:0012448,abnormal primary motor cortex morphology
MGI:5581416	Chmp3<tm1b(EUCOMM)Hmgu>	MP:0001312,abnormal cornea morphology|MP:0005293,impaired glucose tolerance|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:4126087	Chmp4b<Gt(RRB034)Byg>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4431890	Chmp4c<tm1a(EUCOMM)Wtsi>	MP:0005386,behavior/neurological phenotype|MP:0014373,increased miniature excitatory postsynaptic current amplitude|MP:0014375,increased miniature excitatory postsynaptic current frequency|MP:0021112,impaired social recognition
MGI:5637010	Chmp4c<tm1b(EUCOMM)Wtsi>	MP:0002607,decreased basophil cell number|MP:0002941,increased circulating alanine transaminase level
MGI:3626293	Chmp5<tm1Gho>	MP:0001672,abnormal embryo development|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0001726,abnormal allantois morphology|MP:0002151,abnormal neural tube morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0004187,cardia bifida|MP:0005621,abnormal cell physiology|MP:0005657,abnormal neural plate morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014239,abnormal intracellular organelle morphology
MGI:5637182	Chmp6<tm1b(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5825131	Chmp7<em1(IMPC)J>	MP:0001697,abnormal embryo size|MP:0002075,abnormal coat/hair pigmentation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3617903	Chm<tm1.1Seab>	MP:0001325,abnormal retina morphology|MP:0002169,no abnormal phenotype detected|MP:0004021,abnormal rod electrophysiology|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment
MGI:3617904	Chm<tm1.2Seab>	MP:0001325,abnormal retina morphology|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004021,abnormal rod electrophysiology|MP:0005103,abnormal retina pigmentation|MP:0008587,short photoreceptor outer segment
MGI:3617905	Chm<tm1.3Seab>	MP:0001325,abnormal retina morphology|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0005103,abnormal retina pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer
MGI:3052865	Chm<tm1Jvdh>	MP:0001327,decreased retina photoreceptor cell number|MP:0001716,abnormal placenta labyrinth morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0002584,small ectoplacental cone|MP:0003403,absent placental labyrinth|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004259,small placenta|MP:0005031,abnormal trophoblast layer morphology|MP:0005391,vision/eye phenotype|MP:0005602,decreased angiogenesis|MP:0009657,failure of chorioallantoic fusion|MP:0011091,prenatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011204,abnormal visceral yolk sac blood island morphology|MP:0011523,thin placenta labyrinth
MGI:3617902	Chm<tm1Seab>	MP:0005376,homeostasis/metabolism phenotype
MGI:5644468	Chn1<em1(IMPC)J>	MP:0002968,increased circulating alkaline phosphatase level|MP:0004151,decreased circulating iron level|MP:0005560,decreased circulating glucose level|MP:0005633,increased circulating sodium level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3783264	Chn1<Gt714Lex>	MP:0000940,abnormal motor neuron innervation pattern|MP:0001077,abnormal spinal nerve morphology|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0003631,nervous system phenotype|MP:0004100,abnormal spinal cord interneuron morphology|MP:0004145,abnormal muscle electrophysiology
MGI:3760001	Chn1<mfy>	MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0002272,abnormal nervous system electrophysiology|MP:0002878,abnormal corticospinal tract morphology|MP:0009677,abnormal spinal cord dorsal column morphology
MGI:3768535	Chn1<tm1.1Abet>	MP:0001265,decreased body size|MP:0001396,unidirectional circling|MP:0001406,abnormal gait|MP:0002184,abnormal innervation|MP:0002826,tonic seizures|MP:0003651,abnormal axon extension|MP:0003880,abnormal central pattern generator function|MP:0011380,enlarged brain ventricles
MGI:6406374	Chn1<tm1.1Ece>	MP:0000939,decreased motor neuron number|MP:0001070,abnormal abducens nerve morphology|MP:0002092,abnormal eye morphology|MP:0002184,abnormal innervation|MP:0009450,abnormal axon fasciculation
MGI:3760002	Chn1<tm1.1Ito>	MP:0000955,abnormal spinal cord morphology|MP:0001406,abnormal gait|MP:0002272,abnormal nervous system electrophysiology|MP:0002878,abnormal corticospinal tract morphology|MP:0009677,abnormal spinal cord dorsal column morphology
MGI:5447742	Chn1<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0001523,impaired righting response|MP:0002590,increased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0002702,decreased circulating free fatty acids level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003020,decreased circulating chloride level|MP:0003960,increased lean body mass|MP:0005560,decreased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0005633,increased circulating sodium level|MP:0010025,decreased total body fat amount|MP:0011396,abnormal sleep behavior
MGI:5614296	Chn1<tm1.1Schei>	MP:0002169,no abnormal phenotype detected
MGI:6406376	Chn1<tm1.2Ece>	MP:0001070,abnormal abducens nerve morphology|MP:0002184,abnormal innervation|MP:0005391,vision/eye phenotype
MGI:3768538	Chn1<tm2Abet>	MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0002826,tonic seizures|MP:0003651,abnormal axon extension|MP:0011380,enlarged brain ventricles
MGI:5433303	Chn2<tm1.1Alk>	MP:0000808,abnormal hippocampus development|MP:0008960,abnormal axon pruning
MGI:5433304	Chn2<tm2.1Alk>	MP:0000808,abnormal hippocampus development|MP:0008960,abnormal axon pruning
MGI:5755153	Chodl<em1(IMPC)H>	MP:0001392,abnormal locomotor behavior
MGI:3513436	Chohd2	MP:0005178,increased circulating cholesterol level
MGI:3513437	Chohd3	MP:0005178,increased circulating cholesterol level
MGI:3513438	Chohd4	MP:0005178,increased circulating cholesterol level
MGI:3513440	Chohd5	MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3513441	Chohd6	MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3513442	chohr1	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3513443	chohr2	MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3513445	chohr3	MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0002083,premature death|MP:0002810,microcytic anemia|MP:0002871,albuminuria|MP:0005178,increased circulating cholesterol level|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0009643,abnormal urine homeostasis
MGI:3041089	Chol10<129S1/SvImJ>	MP:0005178,increased circulating cholesterol level
MGI:3041091	Chol11<129S1/SvImJ>	MP:0005178,increased circulating cholesterol level
MGI:2663767	Chol6<CAST/Ei>	MP:0000180,abnormal circulating cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3037953	Chol7<129S1/SvImJ>	MP:0005178,increased circulating cholesterol level
MGI:3037957	Chol8<CAST/Ei>	MP:0005178,increased circulating cholesterol level
MGI:3037960	Chol9<CAST/Ei>	MP:0005178,increased circulating cholesterol level
MGI:6404515	Chordc1<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0005016,decreased lymphocyte cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:4441499	Chordc1<tm1Mbra>	MP:0000218,increased leukocyte cell number|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001263,weight loss|MP:0001505,hunched posture|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0002083,premature death|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002874,decreased hemoglobin content|MP:0004499,increased incidence of tumors by chemical induction|MP:0005156,bradykinesia|MP:0005481,increased chronic myelocytic leukemia incidence|MP:0009395,increased nucleated erythrocyte cell number|MP:0010039,abnormal trophoblast giant cell proliferation|MP:0010380,abnormal inner cell mass apoptosis|MP:0011092,embryonic lethality, complete penetrance|MP:0012114,absent inner cell mass proliferation|MP:0013415,increased myeloid cell number in bone marrow|MP:0013663,increased myeloid cell number|MP:0030943,abnormal centrosome morphology
MGI:6388376	Chp1<em1(IMPC)Tcp>	MP:0000267,abnormal heart development|MP:0000367,abnormal coat/ hair morphology|MP:0000928,incomplete rostral neuropore closure|MP:0001697,abnormal embryo size|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001726,abnormal allantois morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0003984,embryonic growth retardation|MP:0005031,abnormal trophoblast layer morphology|MP:0005562,decreased mean corpuscular hemoglobin|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0012099,decreased spongiotrophoblast size|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014134,abnormal embryo morphology
MGI:5529475	Chp1<vac>	MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0001393,ataxia|MP:0003225,axonal dystrophy|MP:0005405,axon degeneration|MP:0008571,abnormal synaptic bouton morphology|MP:0014329,abnormal Purkinje cell axon morphology
MGI:5565261	Chp2<tm1b(KOMP)Mbp>	MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0010052,increased grip strength|MP:0013278,decreased fasting circulating glucose level
MGI:5463982	Chpf<tm1.1Hwat>	MP:0002169,no abnormal phenotype detected
MGI:5464019	Chpf<tm1.2Hwat>	MP:0002764,short tibia|MP:0003109,short femur|MP:0005390,skeleton phenotype
MGI:5751153	Chpf<tm1b(EUCOMM)Hmgu>	MP:0000559,abnormal femur morphology|MP:0001325,abnormal retina morphology|MP:0002764,short tibia|MP:0011965,decreased total retina thickness
MGI:5007059	Chpf<tm1Lex>	MP:0002169,no abnormal phenotype detected|MP:0005390,skeleton phenotype
MGI:5811624	Chpt1<tm1b(EUCOMM)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5708232	Chrac1<tm1.1(KOMP)Vlcg>	MP:0002599,increased mean platelet volume|MP:0003179,thrombocytopenia
MGI:5749864	Chrdl1<em1(IMPC)H>	MP:0001399,hyperactivity|MP:0010392,prolonged QRS complex duration|MP:0013279,increased fasting circulating glucose level
MGI:6315865	Chrdl1<em1Nja>	MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004859,abnormal synaptic plasticity|MP:0009538,abnormal synapse morphology
MGI:2157350	Chrd<tm1Emdr>	MP:0000018,small ears|MP:0000023,abnormal ear position|MP:0000030,abnormal tympanic ring morphology|MP:0000049,abnormal middle ear morphology|MP:0000087,absent mandible|MP:0000088,short mandible|MP:0000111,cleft palate|MP:0000276,heart right ventricle hypertrophy|MP:0000433,microcephaly|MP:0000458,abnormal mandible morphology|MP:0000680,absent parathyroid glands|MP:0000681,abnormal thyroid gland morphology|MP:0000705,athymia|MP:0000913,abnormal brain development|MP:0000932,absent notochord|MP:0001081,abnormal cranial ganglia morphology|MP:0001083,small geniculate ganglion|MP:0001085,small petrosal ganglion|MP:0001086,absent petrosal ganglion|MP:0001088,small nodose ganglion|MP:0001089,absent nodose ganglion|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001265,decreased body size|MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0001575,cyanosis|MP:0001680,abnormal mesoderm development|MP:0001683,absent mesoderm|MP:0001698,decreased embryo size|MP:0001914,hemorrhage|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002191,abnormal artery morphology|MP:0002192,hydrops fetalis|MP:0002252,abnormal oropharynx morphology|MP:0002256,abnormal laryngeal cartilage morphology|MP:0002633,persistent truncus arteriosus|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0002919,enhanced paired-pulse facilitation|MP:0002925,abnormal cardiovascular development|MP:0002950,abnormal neural crest cell migration|MP:0003008,enhanced long-term potentiation|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003461,abnormal response to novel object|MP:0003499,thyroid gland hypoplasia|MP:0003631,nervous system phenotype|MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0003874,absent pharyngeal arches|MP:0003938,abnormal ear development|MP:0004113,abnormal aortic arch morphology|MP:0004158,right aortic arch|MP:0004160,retroesophageal right subclavian artery|MP:0004310,small otic vesicle|MP:0004422,small temporal bone|MP:0004450,presphenoid bone hypoplasia|MP:0004541,absent auditory tube|MP:0004544,absent esophagus|MP:0004549,small trachea|MP:0004554,small pharynx|MP:0004556,enlarged allantois|MP:0004572,fusion of basioccipital and basisphenoid bone|MP:0004592,small mandible|MP:0004670,small vertebral body|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004899,absent temporal bone squamous part|MP:0004911,absent mandibular condyloid process|MP:0004912,absent mandibular coronoid process|MP:0004913,absent mandibular angle|MP:0005226,abnormal vertebral arch development|MP:0005367,renal/urinary system phenotype|MP:0005389,reproductive system phenotype|MP:0005590,increased vasodilation|MP:0005657,abnormal neural plate morphology|MP:0006020,decreased tympanic ring size|MP:0006031,abnormal pharyngeal pouch morphology|MP:0006285,absent inner ear|MP:0006288,small otic capsule|MP:0006386,absent somites|MP:0008921,increased neurotransmitter release|MP:0009655,abnormal secondary palate development|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0009899,hyoid bone hypoplasia|MP:0010657,absent pulmonary trunk|MP:0010663,abnormal brachiocephalic trunk morphology|MP:0010729,absent arcus anterior|MP:0010768,mortality/aging|MP:0011089,perinatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011238,abnormal inner ear development|MP:0012729,abnormal common carotid artery morphology|MP:0014517,abnormal outer ear development|MP:0030375,short zygomatic arch|MP:0030869,thyroid cartilage hypoplasia|MP:0030874,cricoid cartilage hypoplasia
MGI:5544769	Chrd<tm2.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:2655332	Chrm1<tm1Jwe>	MP:0002272,abnormal nervous system electrophysiology|MP:0003631,nervous system phenotype|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0012124,increased bronchoconstrictive response
MGI:3580391	Chrm1<tm1Kano>	MP:0002945,abnormal inhibitory postsynaptic currents|MP:0005379,endocrine/exocrine gland phenotype|MP:0005381,digestive/alimentary phenotype
MGI:2158709	Chrm1<tm1Nmn>	MP:0004631,abnormal auditory cortex morphology|MP:0004788,abnormal auditory cortex tonotopy|MP:0004996,abnormal CNS synapse formation|MP:0005377,hearing/vestibular/ear phenotype
MGI:2158743	Chrm1<tm1Stl>	MP:0001475,reduced long-term depression|MP:0001906,increased dopamine level|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002920,decreased paired-pulse facilitation|MP:0031391,increased locomotor activity
MGI:4437231	Chrm1<tm2.1Stl>	MP:0001898,abnormal long-term depression|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002920,decreased paired-pulse facilitation|MP:0004753,abnormal miniature excitatory postsynaptic currents
MGI:2155543	Chrm2<tm1Jwe>	MP:0000740,impaired smooth muscle contractility|MP:0001262,decreased body weight|MP:0001529,abnormal vocalization|MP:0001629,abnormal heart rate|MP:0001982,decreased chemically-elicited antinociception|MP:0002206,abnormal CNS synaptic transmission|MP:0002566,abnormal sexual interaction|MP:0005085,abnormal gallbladder physiology|MP:0005385,cardiovascular system phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009747,impaired behavioral response to xenobiotic|MP:0012125,decreased bronchoconstrictive response|MP:0031650,decreased mounting behavior
MGI:3581741	Chrm2<tm1Minm>	MP:0005367,renal/urinary system phenotype|MP:0005369,muscle phenotype|MP:0005391,vision/eye phenotype
MGI:5792039	Chrm3<mpc214H>	MP:0006243,impaired pupillary reflex
MGI:4459925	Chrm3<tm1Abt>	MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior
MGI:2155562	Chrm3<tm1Jwe>	MP:0000740,impaired smooth muscle contractility|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001663,abnormal digestive system physiology|MP:0002078,abnormal glucose homeostasis|MP:0002133,abnormal respiratory system physiology|MP:0002644,decreased circulating triglyceride level|MP:0002696,decreased circulating glucagon level|MP:0002711,decreased glucagon secretion|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0003194,abnormal frequency of paradoxical sleep|MP:0003631,nervous system phenotype|MP:0004994,abnormal brain wave pattern|MP:0005085,abnormal gallbladder physiology|MP:0005292,improved glucose tolerance|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005534,decreased body temperature|MP:0005560,decreased circulating glucose level|MP:0005591,decreased vasodilation|MP:0005668,decreased circulating leptin level|MP:0009283,decreased gonadal fat pad weight|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0010386,abnormal urinary bladder physiology|MP:0011940,decreased food intake|MP:0012125,decreased bronchoconstrictive response
MGI:1888740	Chrm3<tm1Mmt>	MP:0000505,decreased digestive secretion|MP:0000519,hydronephrosis|MP:0000538,abnormal urinary bladder morphology|MP:0000539,distended urinary bladder|MP:0000623,decreased salivation|MP:0000740,impaired smooth muscle contractility|MP:0000741,impaired contractility of urinary bladder detrusor smooth muscle|MP:0000742,impaired contractility of ileal smooth muscle|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002503,abnormal histamine physiology|MP:0002546,mydriasis|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0011941,increased fluid intake|MP:0013300,abnormal submandibular gland physiology
MGI:4438742	Chrm3<tm2.1Jwe>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005560,decreased circulating glucose level
MGI:3770175	Chrm3<tm2Jwe>	MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance
MGI:5645996	Chrm4<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0001488,increased startle reflex
MGI:2155567	Chrm4<tm1Jwe>	MP:0000740,impaired smooth muscle contractility|MP:0001262,decreased body weight|MP:0001529,abnormal vocalization|MP:0001629,abnormal heart rate|MP:0002206,abnormal CNS synaptic transmission|MP:0005085,abnormal gallbladder physiology|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0031391,increased locomotor activity
MGI:3581713	Chrm4<tm1Minm>	MP:0001392,abnormal locomotor behavior|MP:0009745,abnormal behavioral response to xenobiotic
MGI:4442323	Chrm4<tm2.1Jwe>	MP:0001399,hyperactivity|MP:0001906,increased dopamine level|MP:0002822,catalepsy|MP:0004811,abnormal neuron physiology|MP:0009746,enhanced behavioral response to xenobiotic|MP:0009747,impaired behavioral response to xenobiotic|MP:0009749,enhanced behavioral response to addictive substance|MP:0009754,enhanced behavioral response to cocaine
MGI:4830172	Chrm5<tm1Jabe>	MP:0010149,abnormal synaptic dopamine release
MGI:2155599	Chrm5<tm1Jwe>	MP:0001613,abnormal vasodilation|MP:0001905,abnormal dopamine level|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0010149,abnormal synaptic dopamine release
MGI:3613514	Chrm5<tm1Minm>	MP:0000505,decreased digestive secretion|MP:0002503,abnormal histamine physiology|MP:0005379,endocrine/exocrine gland phenotype
MGI:2661114	Chrm5<tm1Yeo>	MP:0000623,decreased salivation|MP:0005111,hyperdipsia|MP:0009750,impaired behavioral response to addictive substance|MP:0020351,decreased vocalization
MGI:3774038	Chrna10<tm1Jbou>	MP:0002622,abnormal cochlear hair cell morphology|MP:0004432,abnormal cochlear hair cell physiology|MP:0004433,abnormal cochlear inner hair cell physiology|MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004632,abnormal cochlear OHC efferent innervation pattern|MP:0004633,abnormal cochlear IHC efferent innervation pattern|MP:0004736,abnormal distortion product otoacoustic emission|MP:0005377,hearing/vestibular/ear phenotype
MGI:5548913	Chrna1<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:4462390	Chrna1<tm1Klee>	MP:0000160,kyphosis|MP:0001052,abnormal innervation pattern to muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0002058,neonatal lethality|MP:0002914,abnormal endplate potential|MP:0004835,abnormal miniature endplate potential|MP:0005162,carpoptosis|MP:0005192,increased motor neuron number
MGI:7425586	Chrna2<em1(IMPC)Mbp>	MP:0001200,thick skin|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0002989,small kidney
MGI:7621414	Chrna2<tm1.1Slot>	MP:0002574,increased vertical activity|MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0031391,increased locomotor activity
MGI:3604548	Chrna2<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3526149	Chrna2<tm1Jbou>	MP:0002207,abnormal long-term potentiation|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009454,impaired contextual conditioning behavior|MP:0031391,increased locomotor activity
MGI:4442209	Chrna3<tm1.1Hwrt>	MP:0000519,hydronephrosis|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002912,abnormal excitatory postsynaptic potential|MP:0005378,growth/size/body region phenotype|MP:0005402,abnormal action potential|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2155602	Chrna3<tm1Bay>	MP:0000522,kidney cortex cyst|MP:0000539,distended urinary bladder|MP:0001262,decreased body weight|MP:0001270,distended abdomen|MP:0001297,microphthalmia|MP:0002083,premature death|MP:0002412,increased susceptibility to bacterial infection|MP:0002546,mydriasis|MP:0003197,nephrocalcinosis|MP:0003280,urinary incontinence|MP:0003484,abnormal channel response|MP:0003619,abnormal urine color|MP:0003631,nervous system phenotype|MP:0005176,eyelids fail to open|MP:0005287,narrow eye opening|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0006243,impaired pupillary reflex|MP:0006276,abnormal autonomic nervous system physiology|MP:0009511,distended stomach|MP:0009646,urinary bladder inflammation|MP:0010386,abnormal urinary bladder physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011625,cystolithiasis|MP:0011766,abnormal urinary bladder mucosa morphology
MGI:5308461	Chrna4<tm1.1Stit>	MP:0005386,behavior/neurological phenotype|MP:0005534,decreased body temperature|MP:0009712,impaired conditioned place preference behavior|MP:0009748,abnormal behavioral response to addictive substance
MGI:5285618	Chrna4<tm1.1Tmcg>	MP:0009712,impaired conditioned place preference behavior|MP:0009752,enhanced behavioral response to nicotine|MP:0009756,impaired behavioral response to nicotine|MP:0010149,abnormal synaptic dopamine release
MGI:5285619	Chrna4<tm1.2Tmcg>	MP:0003990,decreased neurotransmitter release|MP:0009712,impaired conditioned place preference behavior|MP:0009756,impaired behavioral response to nicotine|MP:0010149,abnormal synaptic dopamine release
MGI:1888964	Chrna4<tm1Dra>	MP:0001363,increased anxiety-related response|MP:0001413,abnormal response to new environment|MP:0001442,decreased grooming behavior|MP:0002572,abnormal emotion/affect behavior|MP:0002574,increased vertical activity|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003313,abnormal locomotor activation|MP:0004994,abnormal brain wave pattern|MP:0005386,behavior/neurological phenotype|MP:0009748,abnormal behavioral response to addictive substance
MGI:3700204	Chrna4<tm1Jbou>	MP:0002064,seizures|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003633,abnormal nervous system physiology|MP:0003996,clonic seizures|MP:0004994,abnormal brain wave pattern|MP:0008035,behavioral arrest|MP:0014625,abnormal ictal brain wave pattern
MGI:1926251	Chrna4<tm1Jpc>	MP:0001805,decreased IgG level|MP:0001982,decreased chemically-elicited antinociception|MP:0002152,abnormal brain morphology|MP:0002460,decreased immunoglobulin level|MP:0002493,increased IgG level|MP:0003631,nervous system phenotype|MP:0005387,immune system phenotype|MP:0009475,abnormal nicotine-mediated receptor currents
MGI:2158758	Chrna4<tm1Lst>	MP:0001363,increased anxiety-related response|MP:0001415,increased exploration in new environment|MP:0002804,abnormal motor learning|MP:0005386,behavior/neurological phenotype|MP:0009750,impaired behavioral response to addictive substance|MP:0009752,enhanced behavioral response to nicotine|MP:0011087,neonatal lethality, complete penetrance|MP:0011448,decreased dopaminergic neuron number
MGI:3767042	Chrna4<tm2.1Dra>	MP:0005386,behavior/neurological phenotype|MP:0009748,abnormal behavioral response to addictive substance|MP:0009756,impaired behavioral response to nicotine
MGI:3767041	Chrna4<tm2Dra>	MP:0009748,abnormal behavioral response to addictive substance
MGI:3700205	Chrna4<tm2Jbou>	MP:0002064,seizures|MP:0003633,abnormal nervous system physiology|MP:0003996,clonic seizures|MP:0004994,abnormal brain wave pattern|MP:0008035,behavioral arrest
MGI:3511287	Chrna4<tm2Lst>	MP:0009713,enhanced conditioned place preference behavior|MP:0009752,enhanced behavioral response to nicotine
MGI:6153777	Chrna5<em1(IMPC)H>	MP:0000219,increased neutrophil cell number|MP:0002606,increased basophil cell number|MP:0002875,decreased erythrocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0011239,abnormal skin coloration
MGI:3040917	Chrna5<tm1Mdb>	MP:0002887,decreased susceptibility to pharmacologically induced seizures
MGI:2179133	Chrna6<tm1Nchx>	MP:0002152,abnormal brain morphology
MGI:5620283	Chrna7<tm1.1Ehs>	MP:0002169,no abnormal phenotype detected
MGI:1888407	Chrna7<tm1Bay>	MP:0000222,decreased neutrophil cell number|MP:0000788,abnormal cerebral cortex morphology|MP:0000950,abnormal seizure response to pharmacological agent|MP:0001054,failure of neuromuscular synapse presynaptic differentiation|MP:0001364,decreased anxiety-related response|MP:0001463,abnormal spatial learning|MP:0001805,decreased IgG level|MP:0001921,reduced fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002152,abnormal brain morphology|MP:0002414,abnormal myeloblast morphology/development|MP:0002460,decreased immunoglobulin level|MP:0002675,asthenozoospermia|MP:0003245,abnormal GABAergic neuron morphology|MP:0003631,nervous system phenotype|MP:0004008,abnormal GABA-mediated receptor currents|MP:0004101,abnormal brain interneuron morphology|MP:0004998,decreased CNS synapse formation|MP:0005013,increased lymphocyte cell number|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0008544,impaired olfaction|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0009006,prolonged estrous cycle|MP:0009475,abnormal nicotine-mediated receptor currents|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0011114,abnormal airway basal cell differentiation|MP:0011115,airway basal cell hyperplasia|MP:0011179,decreased erythroblast number|MP:0011987,abnormal GABAergic neuron physiology|MP:0014370,impaired spatial working memory
MGI:5637226	Chrna7<tm1b(EUCOMM)Hmgu>	MP:0001556,increased circulating HDL cholesterol level|MP:0003795,abnormal bone structure|MP:0005178,increased circulating cholesterol level
MGI:2155604	Chrna7<tm2Bay>	MP:0000745,tremors|MP:0000859,abnormal somatosensory cortex morphology|MP:0001402,decreased locomotor activity|MP:0001436,abnormal suckling behavior|MP:0002152,abnormal brain morphology|MP:0003203,increased neuron apoptosis|MP:0009475,abnormal nicotine-mediated receptor currents|MP:0011087,neonatal lethality, complete penetrance
MGI:2158742	Chrna9<tm1Bedv>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0004415,abnormal cochlear nerve compound action potential|MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004632,abnormal cochlear OHC efferent innervation pattern|MP:0004633,abnormal cochlear IHC efferent innervation pattern|MP:0004736,abnormal distortion product otoacoustic emission|MP:0005377,hearing/vestibular/ear phenotype
MGI:3832679	Chrna9<tm1Elgo>	MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004433,abnormal cochlear inner hair cell physiology|MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004925,decreased susceptibility to noise-induced hearing loss|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4432564	Chrna9<tm2a(EUCOMM)Wtsi>	MP:0001262,decreased body weight
MGI:7447408	Chrnb1<em1(IMPC)Bay>	MP:0000111,cleft palate|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003743,abnormal facial morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3768925	Chrnb1<tm1Sjb>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0004835,abnormal miniature endplate potential
MGI:5707003	Chrnb2<tm1.1Cont>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0002062,abnormal associative learning|MP:0002083,premature death|MP:0003858,enhanced coordination|MP:0004924,abnormal behavior|MP:0009436,fragmentation of sleep/wake states|MP:0011620,abnormal habituation to a new environment|MP:0012349,increased susceptibility to induction of seizure by inducing agent|MP:0020160,abnormal behavioral response to nicotine|MP:0031391,increased locomotor activity
MGI:5637195	Chrnb2<tm1b(EUCOMM)Hmgu>	MP:0000274,enlarged heart|MP:0001289,persistence of hyaloid vascular system|MP:0002631,abnormal epididymis morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0010024,increased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1926253	Chrnb2<tm1Jpc>	MP:0000904,abnormal superior colliculus morphology|MP:0001360,abnormal social investigation|MP:0001413,abnormal response to new environment|MP:0001790,abnormal immune system physiology|MP:0001957,apnea|MP:0001982,decreased chemically-elicited antinociception|MP:0002152,abnormal brain morphology|MP:0002272,abnormal nervous system electrophysiology|MP:0002313,abnormal tidal volume|MP:0002338,abnormal pulmonary ventilation|MP:0002460,decreased immunoglobulin level|MP:0002490,abnormal immunoglobulin level|MP:0002493,increased IgG level|MP:0003107,abnormal response to novelty|MP:0004000,impaired passive avoidance behavior|MP:0004165,abnormal lateral geniculate nucleus morphology|MP:0004924,abnormal behavior|MP:0005017,decreased B cell number|MP:0005154,increased B cell proliferation|MP:0005166,decreased susceptibility to injury|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology|MP:0005575,increased pulmonary ventilation|MP:0005585,increased tidal volume|MP:0006149,decreased visual acuity|MP:0009475,abnormal nicotine-mediated receptor currents|MP:0010373,myeloid hyperplasia|MP:0011179,decreased erythroblast number|MP:0012306,enhanced spatial learning
MGI:2158714	Chrnb2<tm1Mdb>	MP:0002169,no abnormal phenotype detected|MP:0004165,abnormal lateral geniculate nucleus morphology|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology
MGI:3032611	Chrnb3<tm1Sfh>	MP:0001399,hyperactivity|MP:0001486,abnormal startle reflex
MGI:6342904	Chrnb4<em1(IMPC)H>	MP:0010052,increased grip strength
MGI:2158716	Chrnb4<tm1Mdb>	MP:0000538,abnormal urinary bladder morphology|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0010386,abnormal urinary bladder physiology
MGI:6856844	Chrnd<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001711,abnormal placenta morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:5607645	Chrne<m1Btlr>	MP:0001262,decreased body weight|MP:0002083,premature death
MGI:2450149	Chrne<tm1Jrs>	MP:0000746,weakness|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001402,decreased locomotor activity|MP:0002083,premature death|MP:0004243,abnormal motor nerve collateral sprouting|MP:0008489,slow postnatal weight gain|MP:0009417,skeletal muscle atrophy
MGI:2158741	Chrne<tm1Vwi>	MP:0000746,weakness|MP:0000759,abnormal skeletal muscle morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002841,impaired skeletal muscle contractility|MP:0002913,abnormal PNS synaptic transmission|MP:0004232,decreased muscle weight|MP:0004835,abnormal miniature endplate potential|MP:0009417,skeletal muscle atrophy|MP:0010053,decreased grip strength
MGI:5314798	Chrne<tm2Vwi>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0001529,abnormal vocalization|MP:0001950,abnormal respiratory sounds|MP:0002841,impaired skeletal muscle contractility|MP:0002913,abnormal PNS synaptic transmission|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004835,abnormal miniature endplate potential|MP:0010053,decreased grip strength
MGI:3615397	Chrng<tm1(Chrne)Mknn>	MP:0001078,abnormal phrenic nerve morphology|MP:0002914,abnormal endplate potential|MP:0005369,muscle phenotype|MP:0005386,behavior/neurological phenotype|MP:0012055,abnormal phrenic nerve innervation pattern to diaphragm
MGI:3586495	Chrng<tm1Mtak>	MP:0000755,hindlimb paralysis|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001429,dehydration|MP:0001436,abnormal suckling behavior|MP:0001575,cyanosis|MP:0001951,abnormal breathing pattern|MP:0002106,abnormal muscle physiology|MP:0002279,abnormal diaphragm morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004835,abnormal miniature endplate potential|MP:0009403,increased variability of skeletal muscle fiber size|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3777606	Chrng<tm1Vwi>	MP:0000937,abnormal motor neuron morphology|MP:0002882,abnormal neuron morphology|MP:0005192,increased motor neuron number|MP:0008143,abnormal dendrite morphology|MP:0008415,abnormal neurite morphology
MGI:4941453	Chrng<tm2(Chrne)Vwi>	MP:0000761,thin diaphragm muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001404,no spontaneous movement|MP:0001512,trunk curl|MP:0001698,decreased embryo size|MP:0002095,abnormal skin pigmentation|MP:0004835,abnormal miniature endplate potential|MP:0011087,neonatal lethality, complete penetrance
MGI:6441122	Chst10<em1(IMPC)Hmgu>	MP:0004952,increased spleen weight|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0011965,decreased total retina thickness
MGI:5485156	Chst10<tm1Mifu>	MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0003370,increased circulating estrogen level|MP:0004904,increased uterus weight|MP:0004906,enlarged uterus|MP:0009092,endometrium hyperplasia
MGI:2388475	Chst10<tm1Msch>	MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0002063,abnormal learning/memory/conditioning|MP:0002206,abnormal CNS synaptic transmission|MP:0002912,abnormal excitatory postsynaptic potential
MGI:3768254	Chst11<Gt(PT-1)1Wran>	MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000137,abnormal vertebrae morphology|MP:0000163,abnormal cartilage morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000440,domed cranium|MP:0000547,short limbs|MP:0001954,respiratory distress|MP:0002427,disproportionate dwarf|MP:0004343,small scapula|MP:0004471,short nasal bone|MP:0004599,abnormal vertebral arch morphology|MP:0004686,decreased length of long bones|MP:0004703,abnormal vertebral column morphology|MP:0005109,abnormal talus morphology|MP:0005306,abnormal phalanx morphology|MP:0006395,abnormal epiphyseal plate morphology|MP:0008151,increased diameter of long bones|MP:0010103,small thoracic cage|MP:0011087,neonatal lethality, complete penetrance|MP:0030384,short facial bone|MP:0030848,short ilium|MP:0030849,wide ilium
MGI:6761403	Chst11<m1Btlr>	MP:0002764,short tibia|MP:0003109,short femur
MGI:4363643	Chst11<tm1a(KOMP)Wtsi>	MP:0000111,cleft palate|MP:0000703,abnormal thymus morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0010484,bicuspid aortic valve|MP:0010530,cerebral arteriovenous malformation|MP:0011100,preweaning lethality, complete penetrance|MP:0011493,double ureter|MP:0012303,umbilical vein stenosis|MP:0013842,ductus venosus stenosis|MP:0013843,hepatic portal vein stenosis|MP:0013844,abnormal perichondrial ossification|MP:0013845,abnormal eye muscle topology|MP:0013859,abnormal vitelline vein connection|MP:0013971,blood in lymph vessels|MP:0013986,abnormal vitelline vein topology|MP:0014001,abnormal vertebral artery topology|MP:0014003,additional anastomosis between intracranial vertebral arteries|MP:0014019,embryo cyst
MGI:6761404	Chst12<m1Btlr>	MP:0002764,short tibia|MP:0004692,small pubis
MGI:5754563	Chst14<em1(IMPC)Tcp>	MP:0001417,decreased exploration in new environment|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5528395	Chst14<tm1.1Msch>	MP:0000116,abnormal tooth development|MP:0000558,abnormal tibia morphology|MP:0000585,kinked tail|MP:0001106,abnormal Schwann cell morphology|MP:0001262,decreased body weight|MP:0002161,abnormal fertility/fecundity|MP:0002834,decreased heart weight|MP:0003089,decreased skin tensile strength|MP:0003402,decreased liver weight|MP:0003631,nervous system phenotype|MP:0003651,abnormal axon extension|MP:0003918,decreased kidney weight|MP:0005164,abnormal response to injury|MP:0008415,abnormal neurite morphology|MP:0009674,decreased birth weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011906,increased Schwann cell proliferation
MGI:5007062	Chst14<tm1Lex>	MP:0001258,decreased body length|MP:0001364,decreased anxiety-related response|MP:0003889,enhanced sensorimotor gating
MGI:4840254	Chst15<tm1Oh>	MP:0000359,abnormal mast cell morphology|MP:0001935,decreased litter size
MGI:4415360	Chst1<tm1(KOMP)Vlcg>	MP:0001353,increased aggression towards mice|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0010768,mortality/aging
MGI:6276839	Chst2<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001297,microphthalmia|MP:0001489,decreased startle reflex|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002989,small kidney|MP:0005343,increased circulating aspartate transaminase level|MP:0009709,hydrometra
MGI:3052713	Chst2<tm1Tmu>	MP:0002442,abnormal leukocyte physiology|MP:0003156,abnormal leukocyte migration
MGI:3604509	Chst3<tm1Dgen>	MP:0001402,decreased locomotor activity|MP:0003063,increased coping response|MP:0009142,decreased prepulse inhibition
MGI:2176247	Chst3<tm1Tmu>	MP:0000222,decreased neutrophil cell number|MP:0001130,abnormal ovarian folliculogenesis|MP:0002397,abnormal bone marrow morphology|MP:0003631,nervous system phenotype|MP:0003863,decreased aggression towards mice|MP:0005018,decreased T cell number|MP:0005348,increased T cell proliferation|MP:0008101,lymph node hypoplasia|MP:0009142,decreased prepulse inhibition
MGI:3664734	Chst4<tm1Mifu>	MP:0003156,abnormal leukocyte migration|MP:0020332,impaired leukocyte tethering or rolling
MGI:2682796	Chst4<tm1Sdr>	MP:0002339,abnormal lymph node morphology|MP:0002345,abnormal lymph node primary follicle morphology|MP:0003156,abnormal leukocyte migration|MP:0003628,abnormal leukocyte adhesion
MGI:5637102	Chst5<tm1b(EUCOMM)Wtsi>	MP:0001417,decreased exploration in new environment|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3664471	Chst5<tm1Knsh>	MP:0001312,abnormal cornea morphology|MP:0003092,decreased cornea stroma thickness|MP:0005300,abnormal cornea stroma morphology|MP:0005543,decreased cornea thickness
MGI:3797060	Chst7<tm1(KOMP)Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:3793437	Chst8<tm1.1Jub>	MP:0001120,abnormal uterus morphology|MP:0001128,ovary hyperplasia|MP:0001385,pup cannibalization|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001919,abnormal reproductive system physiology|MP:0001934,increased litter size|MP:0002160,abnormal reproductive system morphology|MP:0002161,abnormal fertility/fecundity|MP:0002681,increased corpora lutea number|MP:0002781,increased circulating testosterone level|MP:0002808,abnormal barbering behavior|MP:0003378,early sexual maturation|MP:0004851,increased testis weight|MP:0004904,increased uterus weight|MP:0004909,increased seminal vesicle weight|MP:0004928,increased epididymis weight|MP:0009006,prolonged estrous cycle|MP:0014272,increased ovary secretion
MGI:5548572	Chst8<tm1b(KOMP)Mbp>	MP:0001402,decreased locomotor activity|MP:0002092,abnormal eye morphology|MP:0002098,abnormal vibrissa morphology|MP:0002941,increased circulating alanine transaminase level|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:6761406	Chsy1<em1Btlr>	MP:0002764,short tibia|MP:0003109,short femur
MGI:6449020	Chsy1<em1(IMPC)Mbp>	MP:0000063,decreased bone mineral density|MP:0000494,abnormal cecum morphology|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000774,decreased brain size|MP:0001258,decreased body length|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001314,cornea opacity|MP:0001325,abnormal retina morphology|MP:0001891,hydrocephaly|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002152,abnormal brain morphology|MP:0002339,abnormal lymph node morphology|MP:0002590,increased mean corpuscular volume|MP:0002699,abnormal vitreous body morphology|MP:0003795,abnormal bone structure|MP:0004738,abnormal auditory brainstem response|MP:0009476,enlarged cecum|MP:0009552,urinary bladder obstruction|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:6761405	Chsy1<m1Btlr>	MP:0003109,short femur
MGI:1857041	Chsy1<skt>	MP:0000222,decreased neutrophil cell number|MP:0000585,kinked tail|MP:0000811,hippocampal neuron degeneration|MP:0001265,decreased body size|MP:0001505,hunched posture|MP:0001859,kidney inflammation|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003884,decreased macrophage cell number|MP:0004021,abnormal rod electrophysiology|MP:0005114,premature hair loss|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0008586,disorganized photoreceptor outer segment|MP:0008918,microgliosis|MP:0008974,proportional dwarf|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0013258,abnormal extracellular matrix morphology
MGI:5007063	Chsy1<tm1Lex>	MP:0000150,abnormal rib morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000547,short limbs|MP:0000554,abnormal carpal bone morphology|MP:0000746,weakness|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0002114,abnormal axial skeleton morphology|MP:0002115,abnormal limb bone morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002657,chondrodystrophy|MP:0002772,brachypodia|MP:0002993,autoimmune arthritis|MP:0003072,abnormal metatarsal bone morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0003795,abnormal bone structure|MP:0004672,short ribs|MP:0004674,thin ribs|MP:0005306,abnormal phalanx morphology|MP:0005561,increased mean corpuscular hemoglobin|MP:0008918,microgliosis|MP:0009346,decreased trabecular bone thickness|MP:0010068,decreased red blood cell distribution width|MP:0010124,decreased bone mineral content|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0010933,decreased trabecular bone connectivity density|MP:0013616,decreased volumetric bone mineral density|MP:0014106,delayed chondrocyte differentiation|MP:0020010,decreased bone mineral density of femur|MP:0020138,delayed bone mineralization|MP:0021186,decreased bone mineral density of vertebrae
MGI:6761417	Chsy3<em1Btlr>	MP:0002764,short tibia|MP:0003109,short femur
MGI:6152431	Chsy3<em2(IMPC)Mbp>	MP:0000062,increased bone mineral density|MP:0001200,thick skin|MP:0001258,decreased body length|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002599,increased mean platelet volume|MP:0003068,enlarged kidney|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength
MGI:6761411	Chsy3<m1Btlr>	MP:0002764,short tibia|MP:0003109,short femur
MGI:4462054	Chtf18<tm1.1KhK>	MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001922,reduced male fertility|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005169,abnormal male meiosis|MP:0006362,abnormal male germ cell morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0014052,increased male germ cell apoptosis
MGI:5529071	Chtf18<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0001697,abnormal embryo size|MP:0002833,increased heart weight|MP:0003019,increased circulating chloride level|MP:0005344,increased circulating bilirubin level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2675597	chtl	MP:0000371,diluted coat color
MGI:3576635	chtl<2J>	MP:0000371,diluted coat color|MP:0002095,abnormal skin pigmentation|MP:0005172,decreased eye pigmentation|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:4842477	Chtop<tm1a(EUCOMM)Wtsi>	MP:0000138,absent vertebrae|MP:0000141,abnormal vertebral body morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000161,scoliosis|MP:0000284,double outlet right ventricle|MP:0000455,abnormal maxilla morphology|MP:0000492,abnormal rectum morphology|MP:0000497,abnormal small intestine placement|MP:0000613,abnormal salivary gland morphology|MP:0000632,abnormal pineal gland morphology|MP:0000681,abnormal thyroid gland morphology|MP:0000690,absent spleen|MP:0000694,spleen hypoplasia|MP:0000783,abnormal forebrain morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000963,fused dorsal root ganglion|MP:0001015,small superior cervical ganglion|MP:0001088,small nodose ganglion|MP:0001634,internal hemorrhage|MP:0001711,abnormal placenta morphology|MP:0002092,abnormal eye morphology|MP:0002633,persistent truncus arteriosus|MP:0002745,abnormal atrioventricular valve morphology|MP:0002932,abnormal joint morphology|MP:0003130,anal atresia|MP:0003345,decreased rib number|MP:0003451,absent olfactory bulb|MP:0003499,thyroid gland hypoplasia|MP:0003617,urinary bladder hypoplasia|MP:0003686,abnormal eye muscle morphology|MP:0003827,abnormal Wolffian duct morphology|MP:0003924,diaphragmatic hernia|MP:0004158,right aortic arch|MP:0004160,retroesophageal right subclavian artery|MP:0004163,abnormal adenohypophysis morphology|MP:0004164,abnormal neurohypophysis morphology|MP:0004201,fetal growth retardation|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0004603,absent vertebral arch|MP:0004607,abnormal cervical atlas morphology|MP:0004613,fusion of vertebral arches|MP:0004646,decreased cervical vertebrae number|MP:0004648,decreased thoracic vertebrae number|MP:0005157,holoprosencephaly|MP:0005274,abnormal viscerocranium morphology|MP:0006093,arteriovenous malformation|MP:0006107,abnormal fetal atrioventricular canal morphology|MP:0008460,absent dorsal root ganglion|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009804,abnormal brain interventricular foramen morphology|MP:0009917,abnormal hyoid bone body morphology|MP:0010404,ostium primum atrial septal defect|MP:0010406,common atrium|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010440,anomalous pulmonary venous connection|MP:0010484,bicuspid aortic valve|MP:0010668,abnormal hepatic portal vein morphology|MP:0010728,fusion of atlas and occipital bones|MP:0010977,fused right lung lobes|MP:0011100,preweaning lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011361,pelvic kidney|MP:0011797,blind ureter|MP:0011974,intestinal stenosis|MP:0012548,myelocele|MP:0013826,absent hypoglossal canal|MP:0013834,thin hypoglossal nerve|MP:0013835,absent hypoglossal nerve|MP:0013842,ductus venosus stenosis|MP:0013848,subcutaneous edema|MP:0013853,abnormal hepatic portal vein formation|MP:0013855,absent celiac artery|MP:0013857,abnormal abdominal muscle morphology|MP:0013858,abnormal azygos vein topology|MP:0013859,abnormal vitelline vein connection|MP:0013860,anastomosis between common carotid and vertebral artery|MP:0013861,abnormal pancreas topology|MP:0013865,abnormal dorsal pancreas topology|MP:0013873,abnormal ductus venosus morphology|MP:0013876,absent ductus venosus valve|MP:0013878,abnormal ductus venosus valve topology|MP:0013913,absent costovertebral joint|MP:0013915,abnormal brachial plexus formation|MP:0013931,abnormal olfactory bulb position|MP:0013943,abnormal ureter topology|MP:0013952,retroesophageal left subclavian artery|MP:0013969,reduced sympathetic cervical ganglion size|MP:0013978,abnormal carotid artery origin|MP:0013979,abnormal subclavian artery origin|MP:0013986,abnormal vitelline vein topology|MP:0013987,absent intrahepatic inferior vena cava segment|MP:0013999,absent parasellar internal carotid artery|MP:0014001,abnormal vertebral artery topology|MP:0014002,absent extracranial vertebral artery segment|MP:0014019,embryo cyst|MP:0014021,heterochrony
MGI:6385268	Chuk<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001297,microphthalmia|MP:0001672,abnormal embryo development|MP:0002092,abnormal eye morphology|MP:0002100,abnormal tooth morphology|MP:0002109,abnormal limb morphology|MP:0002339,abnormal lymph node morphology|MP:0009709,hydrometra|MP:0011100,preweaning lethality, complete penetrance|MP:0013129,abnormal tooth color
MGI:3714161	Chuk<tm1.1Mpa>	MP:0000098,abnormal vomer bone morphology|MP:0000111,cleft palate|MP:0000159,abnormal xiphoid process morphology|MP:0000432,abnormal head morphology|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001231,abnormal epidermis stratum basale morphology|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0002656,abnormal keratinocyte differentiation|MP:0004448,abnormal presphenoid bone morphology|MP:0005508,abnormal skeleton morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:1857735	Chuk<tm1Aki>	MP:0000435,shortened head|MP:0000445,short snout|MP:0000547,short limbs|MP:0000592,short tail|MP:0001196,shiny skin|MP:0001198,tight skin|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001233,abnormal epidermis suprabasal layer morphology|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0002109,abnormal limb morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0003427,parakeratosis|MP:0003704,abnormal hair follicle development|MP:0005352,small cranium|MP:0005384,cellular phenotype|MP:0005650,abnormal limb bud morphology|MP:0009560,absent epidermis stratum granulosum|MP:0011087,neonatal lethality, complete penetrance
MGI:3528766	Chuk<tm1Lex>	MP:0003799,impaired macrophage chemotaxis|MP:0008719,impaired neutrophil recruitment|MP:0008720,impaired neutrophil chemotaxis|MP:0011706,abnormal fibroblast migration|MP:0011708,decreased fibroblast cell migration|MP:0020416,decreased fibroblast chemotaxis
MGI:1857768	Chuk<tm1Mka>	MP:0000060,delayed bone ossification|MP:0000088,short mandible|MP:0000435,shortened head|MP:0000438,abnormal cranium morphology|MP:0000445,short snout|MP:0000564,syndactyly|MP:0000571,interdigital webbing|MP:0001198,tight skin|MP:0001200,thick skin|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001233,abnormal epidermis suprabasal layer morphology|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001241,absent epidermis stratum corneum|MP:0001302,eyelids open at birth|MP:0001310,abnormal conjunctiva morphology|MP:0001340,abnormal eyelid morphology|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0002060,abnormal skin morphology|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0002459,abnormal B cell physiology|MP:0002544,brachydactyly|MP:0002656,abnormal keratinocyte differentiation|MP:0003050,abnormal sacral vertebrae morphology|MP:0003052,omphalocele|MP:0003142,anotia|MP:0003231,abnormal placenta vasculature|MP:0003276,esophageal atresia|MP:0003935,abnormal craniofacial development|MP:0004321,short sternum|MP:0004379,wide frontal bone|MP:0004384,small interparietal bone|MP:0004418,small parietal bone|MP:0004448,abnormal presphenoid bone morphology|MP:0004620,cervical vertebral fusion|MP:0004622,sacral vertebral fusion|MP:0004657,small sacral vertebrae|MP:0004678,split xiphoid process|MP:0004704,short vertebral column|MP:0004726,abnormal nasal capsule morphology|MP:0005193,abnormal anterior eye segment morphology|MP:0005270,abnormal zygomatic bone morphology|MP:0005300,abnormal cornea stroma morphology|MP:0005306,abnormal phalanx morphology|MP:0005352,small cranium|MP:0005358,abnormal incisor morphology|MP:0005384,cellular phenotype|MP:0005501,abnormal skin physiology|MP:0008525,decreased cranium height|MP:0009560,absent epidermis stratum granulosum|MP:0009703,decreased birth body size|MP:0010103,small thoracic cage|MP:0010234,abnormal vibrissa follicle morphology|MP:0010864,abnormal enamel knot morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0014105,abnormal chondrocyte differentiation|MP:0014321,short forelimb|MP:0020137,decreased bone mineralization|MP:0020859,disorganized cornea epithelium|MP:0030197,small nasal septum|MP:0030266,small vomer bone|MP:0030457,abnormal molar cusp morphology
MGI:3714160	Chuk<tm1Mpa>	MP:0001191,abnormal skin condition|MP:0001196,shiny skin|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001263,weight loss|MP:0002060,abnormal skin morphology|MP:0002656,abnormal keratinocyte differentiation|MP:0002702,decreased circulating free fatty acids level|MP:0002796,impaired skin barrier function|MP:0003982,increased cholesterol level|MP:0005390,skeleton phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:2386272	Chuk<tm1Ver>	MP:0000377,abnormal hair follicle morphology|MP:0000477,abnormal intestine morphology|MP:0000547,short limbs|MP:0000556,abnormal hindlimb morphology|MP:0001196,shiny skin|MP:0001200,thick skin|MP:0001201,translucent skin|MP:0001216,abnormal epidermal layer morphology|MP:0001230,epidermal desquamation|MP:0001233,abnormal epidermis suprabasal layer morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001241,absent epidermis stratum corneum|MP:0001284,absent vibrissae|MP:0002085,abnormal embryonic tissue morphology|MP:0002109,abnormal limb morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002656,abnormal keratinocyte differentiation|MP:0002691,small stomach|MP:0002796,impaired skin barrier function|MP:0003051,curly tail|MP:0003052,omphalocele|MP:0004322,abnormal sternebra morphology|MP:0005306,abnormal phalanx morphology|MP:0005358,abnormal incisor morphology|MP:0005621,abnormal cell physiology|MP:0005650,abnormal limb bud morphology|MP:0008146,asymmetric sternocostal joints|MP:0008277,abnormal sternum ossification|MP:0009343,dilated gallbladder|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0009931,abnormal skin appearance|MP:0011087,neonatal lethality, complete penetrance|MP:0012279,wide sternum|MP:0030079,small incisors
MGI:3817541	Chuk<tm1Yhu>	MP:0000416,sparse hair|MP:0001200,thick skin|MP:0001211,wrinkled skin|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001732,postnatal growth retardation|MP:0002038,increased carcinoma incidence|MP:0002051,increased skin papilloma incidence|MP:0002060,abnormal skin morphology|MP:0002656,abnormal keratinocyte differentiation|MP:0005508,abnormal skeleton morphology|MP:0009583,increased keratinocyte proliferation|MP:0010300,increased skin tumor incidence|MP:0010880,small esophagus|MP:0011085,postnatal lethality, complete penetrance
MGI:3045616	Chuk<tm2Mka>	MP:0001882,abnormal lactation|MP:0002459,abnormal B cell physiology|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009506,abnormal mammary gland alveolus morphology
MGI:5515790	Chuk<tm2Yhu>	MP:0001212,skin lesions|MP:0002083,premature death|MP:0004546,esophagus hyperplasia|MP:0004947,skin inflammation|MP:0008014,increased lung tumor incidence|MP:0009583,increased keratinocyte proliferation|MP:0009704,increased skin squamous cell carcinoma incidence|MP:0010771,integument phenotype
MGI:6477909	Churc1<tm1b(EUCOMM)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002092,abnormal eye morphology|MP:0013772,increased effector memory T-helper cell number
MGI:5317575	Chy10	MP:0001785,edema|MP:0012080,chylous ascites
MGI:5317610	Chy11	MP:0010768,mortality/aging|MP:0012080,chylous ascites
MGI:5317590	Chy12	MP:0001785,edema|MP:0012080,chylous ascites
MGI:5317591	Chy13	MP:0001785,edema|MP:0012080,chylous ascites
MGI:5317572	Chy2	MP:0001785,edema|MP:0011091,prenatal lethality, complete penetrance|MP:0012080,chylous ascites
MGI:5311558	Chy5	MP:0010768,mortality/aging|MP:0012080,chylous ascites
MGI:5311559	Chy6	MP:0000572,abnormal autopod morphology|MP:0000588,thick tail|MP:0001785,edema|MP:0002080,prenatal lethality|MP:0003415,priapism|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012080,chylous ascites
MGI:5311856	Chy7	MP:0011086,postnatal lethality, incomplete penetrance|MP:0012080,chylous ascites
MGI:5317573	Chy8	MP:0001785,edema|MP:0011091,prenatal lethality, complete penetrance|MP:0012080,chylous ascites
MGI:5317574	Chy9	MP:0001265,decreased body size|MP:0001785,edema|MP:0009703,decreased birth body size|MP:0011091,prenatal lethality, complete penetrance|MP:0012080,chylous ascites
MGI:1856696	ci	MP:0000745,tremors|MP:0001411,spinning|MP:0005389,reproductive system phenotype|MP:0005655,increased aggression
MGI:2389260	Cia10<C57BL/10>	MP:0001845,abnormal inflammatory response
MGI:2154512	Cia23<C57BL/10SnSg>	MP:0001845,abnormal inflammatory response
MGI:3528160	Cia27<DBA/1J>	MP:0002493,increased IgG level
MGI:2155050	Cia2<DBA/1J>	MP:0001790,abnormal immune system physiology|MP:0003724,increased susceptibility to induced arthritis
MGI:3713892	Cia34<DBA/1J>	MP:0003436,decreased susceptibility to induced arthritis|MP:0003726,decreased autoantibody level
MGI:3713896	Cia36<DBA/1J>	MP:0003436,decreased susceptibility to induced arthritis|MP:0003726,decreased autoantibody level
MGI:3713900	Cia38<DBA/1J>	MP:0003724,increased susceptibility to induced arthritis|MP:0003725,increased autoantibody level
MGI:3579358	Cia39<C57BL/10Sn>	MP:0003436,decreased susceptibility to induced arthritis
MGI:3579357	Cia39<RIII/WySn>	MP:0002993,autoimmune arthritis
MGI:3640567	Cia40<C57BL/10SnSg>	MP:0003724,increased susceptibility to induced arthritis
MGI:3843961	Cia43<FVB/N>	MP:0003724,increased susceptibility to induced arthritis
MGI:3605629	Cia5b<RIIIS/J>	MP:0003436,decreased susceptibility to induced arthritis
MGI:2155397	Cia5<C57BL/10>	MP:0001845,abnormal inflammatory response
MGI:3605631	Cia5c<RIIIS/J>	MP:0003436,decreased susceptibility to induced arthritis
MGI:2156516	Cia6<C57BL/10SnSg>	MP:0001845,abnormal inflammatory response
MGI:2156517	Cia6<DBA/1J>	MP:0001876,decreased inflammatory response
MGI:2156731	Cia7<DBA/1J>	MP:0001846,increased inflammatory response|MP:0003724,increased susceptibility to induced arthritis
MGI:2157964	Cia8<DBA/1J>	MP:0001846,increased inflammatory response
MGI:2153955	Cia9<NOD/ShiLtJ>	MP:0001790,abnormal immune system physiology
MGI:3716484	Ciaaq1<DBA/1J>	MP:0003725,increased autoantibody level
MGI:4451949	Ciao2a<tm2a(EUCOMM)Wtsi>	MP:0002875,decreased erythrocyte cell number
MGI:6341859	Ciao2b<em1(IMPC)Ccpcz>	MP:0000219,increased neutrophil cell number|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002060,abnormal skin morphology|MP:0004952,increased spleen weight|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5286649	Ciao3<Tg(Tyr)2379G-3bOve>	MP:0006205,embryonic lethality between implantation and somite formation
MGI:4946831	Ciao3<tm1.1Fsl>	MP:0002083,premature death|MP:0002169,no abnormal phenotype detected
MGI:4946833	Ciao3<tm1.2Fsl>	MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3051894	Ciapin1<tm1Yzka>	MP:0000208,decreased hematocrit|MP:0000266,abnormal heart morphology|MP:0000601,small liver|MP:0001698,decreased embryo size|MP:0002447,abnormal erythrocyte morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0011089,perinatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4032237	Ciart<Gt(IST11761C7)Tigm>	MP:0001745,increased circulating corticosterone level|MP:0020469,prolonged circadian behavior period
MGI:4419170	Ciart<tm1a(KOMP)Wtsi>	MP:0020469,prolonged circadian behavior period
MGI:4419228	Ciart<tm1e(KOMP)Wtsi>	MP:0001764,abnormal homeostasis|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging
MGI:7612326	Cib1<em1Xuzg>	MP:0005377,hearing/vestibular/ear phenotype
MGI:5692626	Cib1<tm1b(EUCOMM)Hmgu>	MP:0000222,decreased neutrophil cell number|MP:0001392,abnormal locomotor behavior|MP:0001925,male infertility|MP:0010052,increased grip strength
MGI:3690129	Cib1<tm1Prse>	MP:0000352,decreased cell proliferation|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0004852,decreased testis weight|MP:0005159,azoospermia
MGI:7612327	Cib2<em1Xuzg>	MP:0001525,impaired balance|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004517,decreased vestibular hair cell stereocilia number|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0011061,abnormal inner hair cell kinocilium morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014406,increased or absent distortion product otoacoustic emission threshold
MGI:6192642	Cib2<tm1.1Aela>	MP:0001963,abnormal hearing physiology|MP:0001967,deafness|MP:0002622,abnormal cochlear hair cell morphology|MP:0004362,cochlear hair cell degeneration|MP:0004413,absent cochlear microphonics|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0004737,absent distortion product otoacoustic emissions|MP:0005391,vision/eye phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5548707	Cib2<tm1b(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0001513,limb grasping|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0002102,abnormal ear morphology|MP:0002606,increased basophil cell number|MP:0004738,abnormal auditory brainstem response|MP:0005178,increased circulating cholesterol level|MP:0009142,decreased prepulse inhibition|MP:0010087,increased circulating fructosamine level
MGI:6153778	Cib3<em1(IMPC)H>	MP:0001284,absent vibrissae|MP:0001304,cataract|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001512,trunk curl|MP:0002102,abnormal ear morphology|MP:0008806,increased circulating amylase level
MGI:7612574	Cib3<em1Xuzg>	MP:0001525,impaired balance|MP:0004517,decreased vestibular hair cell stereocilia number|MP:0005377,hearing/vestibular/ear phenotype
MGI:7484788	Cib4<em1(IMPC)Mbp>	MP:0001925,male infertility|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology
MGI:6455014	Cib4<em1Osb>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0009230,abnormal sperm head morphology|MP:0014636,decreased elongated spermatid number
MGI:5637028	Cibar1<tm1b(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0002110,abnormal digit morphology|MP:0002687,oligozoospermia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0003198,calcified tendon|MP:0003442,decreased circulating glycerol level|MP:0003960,increased lean body mass|MP:0004083,polysyndactyly|MP:0004852,decreased testis weight|MP:0005292,improved glucose tolerance|MP:0005296,abnormal humerus morphology|MP:0005389,reproductive system phenotype|MP:0005449,abnormal food intake|MP:0008806,increased circulating amylase level|MP:0008892,abnormal sperm flagellum morphology|MP:0009237,kinked sperm flagellum|MP:0009834,abnormal sperm annulus morphology|MP:0009877,exostosis|MP:0010025,decreased total body fat amount|MP:0010313,increased osteoma incidence|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013304,osteophytes
MGI:4125985	Cic<Gt(XE565)Byg>	MP:0001265,decreased body size|MP:0002270,abnormal pulmonary alveolus morphology|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6455747	Cic<tm1.1Jip>	MP:0000812,abnormal dentate gyrus morphology|MP:0001732,postnatal growth retardation|MP:0002175,decreased brain weight|MP:0006254,thin cerebral cortex|MP:0009956,abnormal cerebellar layer morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5903087	Cic<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity
MGI:5903084	Cic<tm1c(KOMP)Wtsi>	MP:0000788,abnormal cerebral cortex morphology|MP:0001353,increased aggression towards mice|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0003631,nervous system phenotype|MP:0003990,decreased neurotransmitter release|MP:0006254,thin cerebral cortex|MP:0009454,impaired contextual conditioning behavior|MP:0012460,decreased dentate gyrus size|MP:0020337,abnormal pyramidal neuron dendrite morphology|MP:0020395,abnormal response to social novelty|MP:0020594,decreased cerebral cortex cell number|MP:0031391,increased locomotor activity
MGI:6198046	Cidea<tm1b(EUCOMM)Hmgu>	MP:0001258,decreased body length|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0002965,increased circulating serum albumin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003731,abnormal retina outer nuclear layer morphology
MGI:2675505	Cidea<tm1Pli>	MP:0000188,abnormal circulating glucose level|MP:0000371,diluted coat color|MP:0000418,focal hair loss|MP:0000676,abnormal body water content|MP:0001212,skin lesions|MP:0001337,dry eyes|MP:0001510,abnormal coat appearance|MP:0001777,abnormal body temperature homeostasis|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002992,abnormal sebaceous lipid secretion|MP:0005282,decreased fatty acids level|MP:0005376,homeostasis/metabolism phenotype|MP:0008034,enhanced lipolysis|MP:0009133,decreased white fat cell size|MP:0009935,abnormal Meibomian gland acinus morphology|MP:0013116,focal hair loss in head/neck region|MP:0013375,abnormal sebocyte morphology|MP:0014053,dry hair|MP:0014146,decreased white adipose tissue mass|MP:0014169,decreased brown adipose tissue mass|MP:0020523,decreased susceptibility to induced hypothermia
MGI:3762191	Cideb<tm1Pli>	MP:0001262,decreased body weight|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002891,increased insulin sensitivity|MP:0002970,abnormal white adipose tissue morphology|MP:0004953,decreased spleen weight|MP:0005289,increased oxygen consumption|MP:0005334,abnormal fat pad morphology|MP:0005370,liver/biliary system phenotype|MP:0005668,decreased circulating leptin level|MP:0006094,increased fat cell size|MP:0010025,decreased total body fat amount|MP:0011940,decreased food intake|MP:0030969,increased circulating adiponectin level
MGI:5699259	Cidec<tm1.1Gonz>	MP:0002169,no abnormal phenotype detected
MGI:6161259	Cidec<tm1b(EUCOMM)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005178,increased circulating cholesterol level|MP:0008259,abnormal optic disk morphology|MP:0010025,decreased total body fat amount|MP:0013279,increased fasting circulating glucose level
MGI:3815158	Cidec<tm1Maka>	MP:0001783,decreased white adipose tissue amount|MP:0002970,abnormal white adipose tissue morphology|MP:0002971,abnormal brown adipose tissue morphology|MP:0003213,decreased susceptibility to age related obesity|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008034,enhanced lipolysis|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0010378,increased respiratory quotient|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3812467	Cidec<tm1Pli>	MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002891,increased insulin sensitivity|MP:0002971,abnormal brown adipose tissue morphology|MP:0003458,decreased circulating ketone body level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005334,abnormal fat pad morphology|MP:0005335,abnormal gonadal fat pad morphology|MP:0005391,vision/eye phenotype|MP:0005533,increased body temperature|MP:0005668,decreased circulating leptin level|MP:0008034,enhanced lipolysis|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009115,abnormal fat cell morphology|MP:0009283,decreased gonadal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0009642,abnormal blood homeostasis|MP:0010025,decreased total body fat amount|MP:0010771,integument phenotype|MP:0011049,impaired adaptive thermogenesis|MP:0011939,increased food intake
MGI:5313809	Cigs2<tm1.1Anse>	MP:0001793,abnormal susceptibility to infection|MP:0001800,abnormal humoral immune response|MP:0002492,decreased IgE level|MP:0004816,abnormal class switch recombination|MP:0008495,decreased IgG1 level|MP:0008501,increased IgG2b level|MP:0008673,decreased interleukin-13 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0010936,decreased airway resistance
MGI:3769027	Cigs2<tm1.1Kubo>	MP:0002423,abnormal mast cell physiology|MP:0002463,abnormal neutrophil physiology|MP:0008568,abnormal interleukin secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008700,decreased interleukin-4 secretion
MGI:5640772	Ciita<m1Btlr>	MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0020154,impaired humoral immune response
MGI:3664552	Ciita<tm1.1Dim>	MP:0005042,abnormal level of surface class II molecules|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008127,decreased dendritic cell number
MGI:3696056	Ciita<tm1Adm>	MP:0001790,abnormal immune system physiology
MGI:1857456	Ciita<tm1Ccum>	MP:0000188,abnormal circulating glucose level|MP:0001793,abnormal susceptibility to infection|MP:0001845,abnormal inflammatory response|MP:0001869,pancreas inflammation|MP:0002145,abnormal T cell differentiation|MP:0002169,no abnormal phenotype detected|MP:0002352,abnormal popliteal lymph node morphology|MP:0002376,abnormal dendritic cell physiology|MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0003009,abnormal cytokine secretion|MP:0003945,abnormal lymphocyte physiology|MP:0004031,insulitis|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005026,decreased susceptibility to parasitic infection|MP:0005027,increased susceptibility to parasitic infection|MP:0005040,abnormal MHC II cell surface expression on macrophages|MP:0005042,abnormal level of surface class II molecules|MP:0005095,decreased T cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005580,periinsulitis|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:2158705	Ciita<tm1Jpyt>	MP:0001805,decreased IgG level|MP:0002494,increased IgM level|MP:0003944,abnormal T cell subpopulation ratio|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005091,increased double-positive T cell number|MP:0005465,abnormal T-helper 1 physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:2388316	Ciita<tm1Wrth>	MP:0000066,osteoporosis|MP:0000130,abnormal trabecular bone morphology|MP:0003790,absent CD4-positive, alpha-beta T cells|MP:0004984,increased osteoclast cell number|MP:0004992,increased bone resorption|MP:0005387,immune system phenotype|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0013630,increased bone trabecular spacing|MP:0031074,increased circulating type I collagen C-terminal telopeptide level
MGI:3052223	Ciita<tm2Wrth>	MP:0002490,abnormal immunoglobulin level|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:6759477	Cilk1<tm1.1Zfu>	MP:0000137,abnormal vertebrae morphology|MP:0000346,broad head|MP:0000547,short limbs|MP:0000556,abnormal hindlimb morphology|MP:0000562,polydactyly|MP:0001178,pulmonary hypoplasia|MP:0001953,respiratory failure|MP:0003109,short femur|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003723,abnormal long bone morphology|MP:0004134,abnormal chest morphology|MP:0004173,abnormal intervertebral disk morphology|MP:0004600,abnormal vertebral transverse process morphology|MP:0004624,abnormal thoracic cage morphology|MP:0004686,decreased length of long bones|MP:0004703,abnormal vertebral column morphology|MP:0005104,abnormal tarsal bone morphology|MP:0005229,abnormal intervertebral disk development|MP:0006393,absent nucleus pulposus|MP:0008272,abnormal endochondral bone ossification|MP:0009881,increased mouth size|MP:0010744,abnormal cervical flexure morphology|MP:0010825,abnormal lung saccule morphology|MP:0010906,abnormal lung bud morphology|MP:0010995,abnormal lung alveolus development|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011142,abnormal lung-associated mesenchyme development|MP:0011143,thick lung-associated mesenchyme|MP:0011148,decreased mesenchymal cell proliferation involved in lung development|MP:0012719,abnormal neck morphology|MP:0012721,short neck|MP:0013203,abnormal primary cilium morphology|MP:0014105,abnormal chondrocyte differentiation|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization|MP:0030190,small snout|MP:0030941,enhanced autophagy
MGI:4462529	Cilk1<tm1a(KOMP)Mbp>	MP:0000060,delayed bone ossification|MP:0000111,cleft palate|MP:0000527,abnormal kidney development|MP:0000547,short limbs|MP:0000762,abnormal tongue morphology|MP:0001785,edema|MP:0001891,hydrocephaly|MP:0002113,abnormal skeleton development|MP:0002896,abnormal bone mineralization|MP:0003631,nervous system phenotype|MP:0003723,abnormal long bone morphology|MP:0004686,decreased length of long bones|MP:0005108,abnormal ulna morphology|MP:0006280,abnormal digit development|MP:0009743,preaxial polydactyly|MP:0009907,decreased tongue size|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012676,dilated brain ventricle|MP:0013203,abnormal primary cilium morphology
MGI:5548729	Cilk1<tm1b(KOMP)Mbp>	MP:0000219,increased neutrophil cell number|MP:0002606,increased basophil cell number
MGI:5606344	Cilp<tm1b(EUCOMM)Wtsi>	MP:0011239,abnormal skin coloration
MGI:7425885	Cimap1b<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001262,decreased body weight|MP:0002110,abnormal digit morphology
MGI:5548879	Cimap1d<tm1.1(KOMP)Vlcg>	MP:0001284,absent vibrissae|MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0001523,impaired righting response|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0004738,abnormal auditory brainstem response
MGI:5694208	Cimap2<Retro>	MP:0001829,increased activated T cell number|MP:0002436,abnormal CD8-positive, alpha-beta cytotoxic T cell morphology|MP:0005348,increased T cell proliferation|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008566,increased interferon-gamma secretion|MP:0010267,decreased lung tumor incidence|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013281,increased cytotoxic T cell cytolysis|MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality
MGI:4362692	Cimap2<tm1a(KOMP)Wtsi>	MP:0005079,decreased cytotoxic T cell cytolysis|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008762,embryonic lethality
MGI:4819764	Cimap3<tm1.1Heli>	MP:0000284,double outlet right ventricle|MP:0001706,abnormal left-right axis patterning|MP:0001925,male infertility|MP:0004046,abnormal mitosis|MP:0004066,abnormal primitive node morphology|MP:0004131,abnormal motile primary cilium morphology|MP:0005621,abnormal cell physiology|MP:0008933,abnormal motile primary cilium physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013202,abnormal cilium morphology
MGI:6116222	Cimap3<tm2.1Heli>	MP:0005384,cellular phenotype
MGI:6386309	Cimip1<em1(IMPC)Hmgu>	MP:0001392,abnormal locomotor behavior
MGI:4841123	Cimip2b<tm1(KOMP)Wtsi>	MP:0002606,increased basophil cell number|MP:0004738,abnormal auditory brainstem response|MP:0005011,increased eosinophil cell number|MP:0005565,increased blood urea nitrogen level
MGI:4432273	Cimip2c<tm1a(EUCOMM)Wtsi>	MP:0003960,increased lean body mass
MGI:6695986	Cimip4<em1Mngx>	MP:0005389,reproductive system phenotype
MGI:6717361	Cimip4<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5581734	Cimip6<tm1b(KOMP)Wtsi>	MP:0002966,decreased circulating alkaline phosphatase level|MP:0005560,decreased circulating glucose level
MGI:3529487	Cinda1<BALB/c>	MP:0005348,increased T cell proliferation
MGI:3529490	Cinda2<STS/A>	MP:0005348,increased T cell proliferation
MGI:3529474	Cinda3<O20/A>	MP:0005095,decreased T cell proliferation
MGI:3529475	Cinda4<OcB9/Dem>	MP:0005348,increased T cell proliferation
MGI:3529477	Cinda5<OcB9/Dem>	MP:0005348,increased T cell proliferation
MGI:5471942	Cinp<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3864546	Cip2a<Gt(CD0252)Wtsi>	MP:0001156,abnormal spermatogenesis|MP:0002687,oligozoospermia|MP:0004929,decreased epididymis weight|MP:0004930,small epididymis
MGI:6151055	Cipc<tm1.1Nju>	MP:0005386,behavior/neurological phenotype
MGI:2177206	cir	MP:0000026,abnormal inner ear morphology|MP:0000043,organ of Corti degeneration|MP:0001262,decreased body weight|MP:0001385,pup cannibalization|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001442,decreased grooming behavior|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0001967,deafness|MP:0002730,head shaking|MP:0002757,decreased vertical activity|MP:0002857,cochlear ganglion degeneration|MP:0004305,abnormal Rosenthal canal morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004924,abnormal behavior|MP:0006359,absent startle reflex
MGI:5577261	Cir1<tm3a(KOMP)Wtsi>	MP:0000140,absent vertebral pedicles|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000161,scoliosis|MP:0000273,overriding aortic valve|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000489,abnormal large intestine morphology|MP:0000534,abnormal ureter morphology|MP:0000681,abnormal thyroid gland morphology|MP:0000783,abnormal forebrain morphology|MP:0001711,abnormal placenta morphology|MP:0002989,small kidney|MP:0003345,decreased rib number|MP:0003686,abnormal eye muscle morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0003827,abnormal Wolffian duct morphology|MP:0004269,abnormal optic cup morphology|MP:0004442,occipital bone foramen|MP:0004613,fusion of vertebral arches|MP:0004646,decreased cervical vertebrae number|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0010418,perimembraneous ventricular septal defect|MP:0010602,abnormal pulmonary valve cusp morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013836,abnormal hypoglossal nerve topology|MP:0013848,subcutaneous edema|MP:0013913,absent costovertebral joint|MP:0013914,absent intracranial segment of vertebral artery|MP:0013968,multiple persisting craniopharyngeal ducts|MP:0014003,additional anastomosis between intracranial vertebral arteries|MP:0014021,heterochrony|MP:0020500,persistent trigeminal artery
MGI:6822319	Cirbil<em1Cya>	MP:0003037,increased myocardial infarct size|MP:0003222,increased cardiomyocyte apoptosis|MP:0005140,decreased cardiac muscle contractility|MP:0011971,increased circulating lactate dehydrogenase level
MGI:5432527	Cirbp<tm1Jfuji>	MP:0002685,abnormal spermatogonia proliferation|MP:0003077,abnormal cell cycle|MP:0005389,reproductive system phenotype|MP:0011704,decreased fibroblast proliferation|MP:0014617,decreased spermatogonia number
MGI:2661440	Circp1<CBA/J>	MP:0020473,abnormal circadian behavior phase
MGI:2661442	Circp2<CBA/J>	MP:0020473,abnormal circadian behavior phase
MGI:5431499	Ciroz<b2b1167Clo>	MP:0000284,double outlet right ventricle|MP:0000531,right pulmonary isomerism|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0000694,spleen hypoplasia|MP:0002767,situs ambiguus|MP:0004133,heterotaxia|MP:0010412,atrioventricular septal defect|MP:0011250,abdominal situs ambiguus|MP:0011251,bronchial situs inversus|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia
MGI:5635119	Ciroz<tm1b(EUCOMM)Hmgu>	MP:0002767,situs ambiguus|MP:0004133,heterotaxia|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011248,visceral organ asymmetry|MP:0011250,abdominal situs ambiguus|MP:0011251,bronchial situs inversus
MGI:7529393	Cirpil<em1Zpan>	MP:0031217,increased susceptibility to myocardial ischemic injury
MGI:6276862	Cisd1<em1(IMPC)Hmgu>	MP:0002599,increased mean platelet volume|MP:0003019,increased circulating chloride level
MGI:3530226	Cisd1<Gt(OST205742)Lex>	MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport
MGI:3877354	Cisd2<Gt(XS0445)Wtsi>	MP:0000420,ruffled hair|MP:0000745,tremors|MP:0000746,weakness|MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004089,dilated sarcoplasmic reticulum|MP:0004090,abnormal sarcomere morphology|MP:0004231,abnormal calcium ion homeostasis|MP:0005202,lethargy|MP:0005369,muscle phenotype|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0011630,increased mitochondrial size|MP:0011633,abnormal mitochondrial shape|MP:0011635,abnormal mitochondrial crista morphology|MP:0030941,enhanced autophagy
MGI:4434148	Cisd2<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001566,increased circulating phosphate level|MP:0002078,abnormal glucose homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002697,abnormal eye size|MP:0002834,decreased heart weight|MP:0002896,abnormal bone mineralization|MP:0003961,decreased lean body mass|MP:0004924,abnormal behavior|MP:0005343,increased circulating aspartate transaminase level|MP:0008805,decreased circulating amylase level
MGI:3846404	Cisd2<tm1Tfts>	MP:0000021,prominent ears|MP:0000379,decreased hair follicle number|MP:0000749,muscle degeneration|MP:0000921,demyelination|MP:0001219,thick epidermis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001314,cornea opacity|MP:0001330,abnormal optic nerve morphology|MP:0001732,postnatal growth retardation|MP:0002001,blindness|MP:0002075,abnormal coat/hair pigmentation|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0002327,abnormal respiratory function|MP:0002750,exophthalmos|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0003620,oliguria|MP:0003786,premature aging|MP:0003866,abnormal defecation|MP:0004087,abnormal muscle fiber morphology|MP:0004734,small thoracic cavity|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005329,abnormal myocardium layer morphology|MP:0005405,axon degeneration|MP:0005586,decreased tidal volume|MP:0006035,abnormal mitochondrial morphology|MP:0006086,decreased body mass index|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008852,retina neovascularization|MP:0009346,decreased trabecular bone thickness|MP:0010025,decreased total body fat amount|MP:0010955,abnormal respiratory electron transport chain|MP:0011940,decreased food intake|MP:0011942,decreased fluid intake|MP:0020010,decreased bone mineral density of femur|MP:0031253,lordokyphosis
MGI:8273498	Cisd3<em1.1Davis>	MP:0001265,decreased body size|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0004090,abnormal sarcomere morphology|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010053,decreased grip strength|MP:0010954,abnormal cellular respiration|MP:0014344,abnormal skeletal muscle fiber mitochondrial morphology|MP:0014541,increased iron level
MGI:5544426	Cish<tm1.1Cdon>	MP:0005011,increased eosinophil cell number|MP:0005387,immune system phenotype|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008660,increased interleukin-10 secretion|MP:0008672,increased interleukin-13 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion
MGI:5550527	Cish<tm1.1Khk>	MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:5544427	Cish<tm1.2Cdon>	MP:0000685,abnormal immune system morphology|MP:0000693,spleen hyperplasia|MP:0000708,thymus hyperplasia|MP:0001790,abnormal immune system physiology|MP:0001861,lung inflammation|MP:0002281,abnormal respiratory mucosa goblet cell morphology|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0006050,pulmonary fibrosis|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008102,lymph node hyperplasia|MP:0008672,increased interleukin-13 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion|MP:0008711,increased interleukin-9 secretion
MGI:3028946	Cited1<tm1Dunw>	MP:0001711,abnormal placenta morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003123,paternal imprinting|MP:0003231,abnormal placenta vasculature|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009431,decreased fetal weight|MP:0009674,decreased birth weight|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011521,decreased placental labyrinth size|MP:0011527,disorganized placental labyrinth|MP:0012098,increased spongiotrophoblast size
MGI:3623213	Cited1<tm1Fmar>	MP:0000628,abnormal mammary gland development|MP:0000662,abnormal branching of the mammary ductal tree|MP:0005367,renal/urinary system phenotype
MGI:5646605	Cited2<m1H>	MP:0002169,no abnormal phenotype detected
MGI:3696062	Cited2<tm1.1Dunw>	MP:0002169,no abnormal phenotype detected
MGI:3696063	Cited2<tm1.2Dunw>	MP:0000914,exencephaly|MP:0001698,decreased embryo size|MP:0002151,abnormal neural tube morphology|MP:0002192,hydrops fetalis
MGI:2179740	Cited2<tm1Bha>	MP:0000267,abnormal heart development|MP:0000273,overriding aortic valve|MP:0000281,abnormal interventricular septum morphology|MP:0000284,double outlet right ventricle|MP:0000486,abnormal pulmonary trunk morphology|MP:0000527,abnormal kidney development|MP:0000531,right pulmonary isomerism|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0000692,small spleen|MP:0000914,exencephaly|MP:0000963,fused dorsal root ganglion|MP:0000964,small dorsal root ganglion|MP:0001081,abnormal cranial ganglia morphology|MP:0001700,abnormal embryo turning|MP:0001785,edema|MP:0002082,postnatal lethality|MP:0002633,persistent truncus arteriosus|MP:0002766,situs inversus|MP:0003105,abnormal heart atrium morphology|MP:0004113,abnormal aortic arch morphology|MP:0004157,interrupted aortic arch|MP:0004158,right aortic arch|MP:0004252,abnormal direction of heart looping|MP:0005294,abnormal heart ventricle morphology|MP:0005313,absent adrenal gland|MP:0006061,right atrial isomerism|MP:0006063,abnormal inferior vena cava morphology|MP:0006065,abnormal heart position or orientation|MP:0006126,abnormal cardiac outflow tract development|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010404,ostium primum atrial septal defect|MP:0010406,common atrium|MP:0010465,aberrant origin of the right subclavian artery|MP:0010466,vascular ring|MP:0010607,common atrioventricular valve|MP:0011089,perinatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012747,abnormal cardiac neural crest cell morphology|MP:0012749,decreased cardiac neural crest cell number|MP:0012750,absent cardiac neural crest cells|MP:0013176,abnormal tail position or orientation
MGI:3696061	Cited2<tm1Dunw>	MP:0002169,no abnormal phenotype detected
MGI:2176158	Cited2<tm1Jpmb>	MP:0000074,abnormal neurocranium morphology|MP:0000266,abnormal heart morphology|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000301,decreased atrioventricular cushion size|MP:0000508,right-sided isomerism|MP:0000527,abnormal kidney development|MP:0000531,right pulmonary isomerism|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0000963,fused dorsal root ganglion|MP:0001081,abnormal cranial ganglia morphology|MP:0001706,abnormal left-right axis patterning|MP:0001785,edema|MP:0004200,decreased fetal size|MP:0004252,abnormal direction of heart looping|MP:0004837,abnormal neural fold formation|MP:0005376,homeostasis/metabolism phenotype|MP:0006061,right atrial isomerism|MP:0010029,abnormal basicranium morphology|MP:0010402,ventricular septal defect|MP:0010454,abnormal truncus arteriosus septation|MP:0010807,abnormal stomach position or orientation|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012701,increased embryonic neuroepithelium apoptosis
MGI:2385355	Cited2<tm1Ycy>	MP:0000233,abnormal blood flow velocity|MP:0000284,double outlet right ventricle|MP:0000531,right pulmonary isomerism|MP:0000914,exencephaly|MP:0001176,abnormal lung development|MP:0001698,decreased embryo size|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0002274,abnormal type I pneumocyte morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002633,persistent truncus arteriosus|MP:0004780,abnormal surfactant secretion|MP:0006027,impaired lung alveolus development|MP:0006046,atrioventricular valve regurgitation|MP:0009688,abnormal spinal cord central canal morphology|MP:0010402,ventricular septal defect|MP:0010426,abnormal heart and great artery attachment|MP:0010457,pulmonary artery stenosis|MP:0010714,iris coloboma|MP:0010814,absent alveolar lamellar bodies|MP:0010976,small lung lobe|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5472019	Cited2<tm3.1Bha>	MP:0002169,no abnormal phenotype detected
MGI:5472021	Cited2<tm5Bha>	MP:0002169,no abnormal phenotype detected
MGI:5472022	Cited2<tm6Bha>	MP:0002169,no abnormal phenotype detected
MGI:5469080	Cited4<tm1.1(KOMP)Vlcg>	MP:0001417,decreased exploration in new environment|MP:0010052,increased grip strength
MGI:4364407	Cit<tm1a(KOMP)Wtsi>	MP:0005554,decreased circulating creatinine level
MGI:2447844	Cit<tm1Fdc>	MP:0000243,myoclonus|MP:0000745,tremors|MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000830,abnormal diencephalon morphology|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0002175,decreased brain weight|MP:0002685,abnormal spermatogonia proliferation|MP:0002741,small olfactory bulb|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003203,increased neuron apoptosis|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0006099,thin cerebellar granule layer|MP:0008540,abnormal cerebral hemisphere morphology|MP:0009964,abnormal cerebellum lobule morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0012089,decreased midbrain size|MP:0014052,increased male germ cell apoptosis
MGI:5186770	Ciz1<Gt(IST13830B6)Tigm>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0001265,decreased body size|MP:0001353,increased aggression towards mice|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0002757,decreased vertical activity
MGI:6147606	Ciz1<tm1.1Homy>	MP:0000691,enlarged spleen|MP:0000708,thymus hyperplasia|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0008102,lymph node hyperplasia|MP:0008409,increased cellular sensitivity to hydroxyurea induced cell death|MP:0012563,increased tumor incidence following infection
MGI:5561565	Ckap4<tm1b(EUCOMM)Hmgu>	MP:0001304,cataract|MP:0001491,unresponsive to tactile stimuli|MP:0001512,trunk curl|MP:0001697,abnormal embryo size|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5287261	Ckap5<TgTn(sb-cHS4,Tyr)2320F-1Ove>	MP:0000111,cleft palate|MP:0001265,decreased body size
MGI:5570192	Ckap5<tm1.1Eba>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001473,reduced long-term potentiation|MP:0001529,abnormal vocalization|MP:0002152,abnormal brain morphology|MP:0002912,abnormal excitatory postsynaptic potential|MP:0004811,abnormal neuron physiology|MP:0005386,behavior/neurological phenotype|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0009936,abnormal dendritic spine morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0011620,abnormal habituation to a new environment|MP:0013140,excessive vocalization
MGI:5570193	Ckap5<tm1.2Eba>	MP:0011092,embryonic lethality, complete penetrance
MGI:6120753	Ckap5<tm2b(EUCOMM)Hmgu>	MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005534,decreased body temperature|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5692879	Ckb<tm1.1(KOMP)Wtsi>	MP:0001417,decreased exploration in new environment|MP:0002098,abnormal vibrissa morphology|MP:0002175,decreased brain weight|MP:0002590,increased mean corpuscular volume|MP:0003960,increased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005013,increased lymphocyte cell number|MP:0005561,increased mean corpuscular hemoglobin|MP:0008935,decreased mean platelet volume|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010123,increased bone mineral content
MGI:3042843	Ckb<tm1Bew>	MP:0001415,increased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0002887,decreased susceptibility to pharmacologically induced seizures
MGI:3766470	Ckdbp1<129S6/SvEvTac>	MP:0002842,increased systemic arterial blood pressure
MGI:3766472	Ckdbp2<129S6/SvEvTac>	MP:0002842,increased systemic arterial blood pressure|MP:0002871,albuminuria
MGI:3033037	Ckds<FVB/N>	MP:0008528,polycystic kidney
MGI:6849787	Cklf<em1Osb>	MP:0011100,preweaning lethality, complete penetrance
MGI:2180567	Ckmt1<tm2Bew>	MP:0001417,decreased exploration in new environment|MP:0001442,decreased grooming behavior|MP:0001463,abnormal spatial learning|MP:0001489,decreased startle reflex|MP:0001963,abnormal hearing physiology|MP:0002757,decreased vertical activity|MP:0003088,abnormal prepulse inhibition|MP:0003867,increased defecation amount|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010771,integument phenotype
MGI:2180507	Ckmt2<tm1Bew>	MP:0001544,abnormal cardiovascular system physiology|MP:0002127,abnormal cardiovascular system morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002753,dilated heart left ventricle|MP:0005369,muscle phenotype|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0011951,increased cardiac stroke volume
MGI:2179990	Ckm<tm1Bew>	MP:0002106,abnormal muscle physiology|MP:0002714,increased glycogen catabolism rate|MP:0002841,impaired skeletal muscle contractility|MP:0002843,decreased systemic arterial blood pressure|MP:0003915,increased heart left ventricle weight|MP:0005140,decreased cardiac muscle contractility|MP:0010401,increased skeletal muscle glycogen level|MP:0010954,abnormal cellular respiration
MGI:2179994	Ckm<tm2Bew>	MP:0002841,impaired skeletal muscle contractility|MP:0005376,homeostasis/metabolism phenotype
MGI:1856704	ckr	MP:0000781,decreased corpus callosum size|MP:0000825,dilated lateral ventricle|MP:0001394,circling|MP:0001396,unidirectional circling|MP:0001399,hyperactivity|MP:0001442,decreased grooming behavior|MP:0001504,abnormal posture|MP:0002757,decreased vertical activity|MP:0004077,abnormal striatum morphology|MP:0004079,abnormal putamen morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype
MGI:3711167	Cks1b<tm1Sir>	MP:0001262,decreased body weight|MP:0005389,reproductive system phenotype|MP:0008008,early cellular replicative senescence
MGI:5287114	Cks2<TgTn(sb-cHS4,Tyr)2525F-2Ove>	MP:0001926,female infertility
MGI:3586897	Cks2<tm1Sir>	MP:0001925,male infertility|MP:0001926,female infertility|MP:0003205,testicular atrophy|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0008261,arrest of male meiosis|MP:0020550,multinucleated giant male germ cells
MGI:1856703	cl	MP:0000425,loss of eyelid cilia|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000576,clubfoot|MP:0001262,decreased body weight|MP:0001340,abnormal eyelid morphology|MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0003051,curly tail|MP:0004263,abnormal limb posture|MP:0004819,decreased skeletal muscle mass|MP:0008915,fused carpal bones|MP:0008919,fused tarsal bones|MP:0010053,decreased grip strength|MP:0011088,neonatal lethality, incomplete penetrance
MGI:1856592	cla	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001513,limb grasping
MGI:6152432	Clasp1<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001399,hyperactivity|MP:0001404,no spontaneous movement|MP:0002188,small heart|MP:0004931,enlarged epididymis|MP:0009709,hydrometra|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3693618	Clasp2<tm1Gal>	MP:0003091,abnormal cell migration|MP:0005621,abnormal cell physiology
MGI:6152441	Clca1<em2(IMPC)Mbp>	MP:0001102,small superior vagus ganglion|MP:0002098,abnormal vibrissa morphology|MP:0009709,hydrometra
MGI:3759581	Clca1<tm1.1Lex>	MP:0000219,increased neutrophil cell number|MP:0001846,increased inflammatory response|MP:0001861,lung inflammation|MP:0002281,abnormal respiratory mucosa goblet cell morphology|MP:0006382,abnormal lung epithelium morphology|MP:0008721,abnormal chemokine level|MP:0010936,decreased airway resistance
MGI:3722629	Clca1<tm1Dgen>	MP:0001845,abnormal inflammatory response
MGI:3799070	Clca1<tm1Htzm>	MP:0005388,respiratory system phenotype
MGI:6449037	Clca2<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002989,small kidney
MGI:3604504	Clca2<tm1Dgen>	MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0001655,multifocal hepatic necrosis|MP:0002981,increased liver weight
MGI:5007018	Clca4b<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:5618134	Clcc1<m1J>	MP:0000851,cerebellum hypoplasia|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001393,ataxia|MP:0002229,neurodegeneration|MP:0002269,muscular atrophy|MP:0003631,nervous system phenotype|MP:0004098,abnormal cerebellar granule cell morphology|MP:0008025,brain vacuoles|MP:0008924,decreased cerebellar granule cell number|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009413,skeletal muscle fiber atrophy|MP:0009417,skeletal muscle atrophy|MP:0020354,increased endoplasmic reticulum stress
MGI:5635038	Clcc1<tm1b(KOMP)Mbp>	MP:0001325,abnormal retina morphology|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003734,abnormal retina inner plexiform layer morphology|MP:0003984,embryonic growth retardation|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008446,decreased retina cone cell number|MP:0011092,embryonic lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6302789	Clcf1<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:5548715	Clcf1<tm1.1(KOMP)Vlcg>	MP:0000062,increased bone mineral density|MP:0000221,decreased leukocyte cell number|MP:0003233,prolonged QT interval|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:4835025	Clcf1<tm1Zou>	MP:0000909,abnormal facial motor nucleus morphology|MP:0000939,decreased motor neuron number|MP:0001262,decreased body weight|MP:0001435,absent suckling reflex|MP:0003633,abnormal nervous system physiology|MP:0011085,postnatal lethality, complete penetrance
MGI:1856316	Clcn1<adr>	MP:0000759,abnormal skeletal muscle morphology|MP:0001523,impaired righting response|MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002841,impaired skeletal muscle contractility|MP:0003157,impaired muscle relaxation|MP:0004145,abnormal muscle electrophysiology|MP:0004263,abnormal limb posture|MP:0009046,muscle twitch
MGI:1855953	Clcn1<adr-mto>	MP:0000160,kyphosis|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001524,impaired limb coordination|MP:0001921,reduced fertility|MP:0002106,abnormal muscle physiology|MP:0002862,abnormal righting response|MP:0003157,impaired muscle relaxation|MP:0003491,abnormal voluntary movement|MP:0004145,abnormal muscle electrophysiology|MP:0004818,increased skeletal muscle mass|MP:0005369,muscle phenotype|MP:0005405,axon degeneration
MGI:1855954	Clcn1<adr-mto2J>	MP:0001523,impaired righting response|MP:0003157,impaired muscle relaxation|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3573744	Clcn1<adr-mto5J>	MP:0001388,abnormal stationary movement|MP:0009434,paraparesis
MGI:3522441	Clcn1<adr-mto6J>	MP:0000755,hindlimb paralysis|MP:0000756,forelimb paralysis|MP:0001924,infertility
MGI:3583311	Clcn1<adr-mto7J>	MP:0000743,muscle spasm|MP:0001513,limb grasping
MGI:3708172	Clcn1<adr-mto8J>	MP:0000743,muscle spasm|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation
MGI:3789131	Clcn1<adr-mto9J>	MP:0000416,sparse hair|MP:0000755,hindlimb paralysis|MP:0001265,decreased body size|MP:0003157,impaired muscle relaxation|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype
MGI:6725085	Clcn1<em1Btlr>	MP:0001265,decreased body size|MP:0004703,abnormal vertebral column morphology
MGI:7484789	Clcn1<em1(IMPC)Mbp>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000745,tremors|MP:0001258,decreased body length|MP:0001297,microphthalmia|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002092,abnormal eye morphology|MP:0002834,decreased heart weight|MP:0002965,increased circulating serum albumin level|MP:0004738,abnormal auditory brainstem response|MP:0004924,abnormal behavior|MP:0005011,increased eosinophil cell number|MP:0005278,abnormal cholesterol homeostasis|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005560,decreased circulating glucose level|MP:0008935,decreased mean platelet volume|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0020870,decreased thigmotaxis
MGI:5563496	Clcn1<m1Anu>	MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0004143,muscle hypertonia|MP:0009434,paraparesis
MGI:6725084	Clcn1<m1Btlr>	MP:0001265,decreased body size|MP:0004703,abnormal vertebral column morphology
MGI:6849996	Clcn2<em1Uis>	MP:0002006,neoplasm|MP:0002135,abnormal kidney morphology|MP:0002626,increased heart rate|MP:0002666,increased circulating aldosterone level|MP:0002842,increased systemic arterial blood pressure|MP:0002909,abnormal adrenal gland physiology|MP:0003631,nervous system phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0006317,decreased urine sodium level|MP:0011460,decreased urine chloride ion level
MGI:3056299	Clcn2<nmf240>	MP:0001156,abnormal spermatogenesis|MP:0001932,abnormal spermiogenesis|MP:0002229,neurodegeneration|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005159,azoospermia|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005405,axon degeneration|MP:0005551,abnormal eye electrophysiology|MP:0008025,brain vacuoles|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:5912306	Clcn2<nmf289>	MP:0001925,male infertility|MP:0002864,abnormal ocular fundus morphology|MP:0004021,abnormal rod electrophysiology|MP:0005159,azoospermia|MP:0005201,abnormal retina pigment epithelium morphology|MP:0008025,brain vacuoles|MP:0008450,retina photoreceptor degeneration
MGI:2183262	Clcn2<tm1Mlv>	MP:0001146,abnormal testis morphology|MP:0001152,increased Leydig cell number|MP:0001326,retina degeneration|MP:0002784,abnormal Sertoli cell morphology|MP:0005159,azoospermia|MP:0005310,abnormal salivary gland physiology|MP:0006362,abnormal male germ cell morphology|MP:0008450,retina photoreceptor degeneration|MP:0008518,retina outer nuclear layer degeneration
MGI:2183261	Clcn2<tm1Tjj>	MP:0000780,abnormal corpus callosum morphology|MP:0000849,abnormal cerebellum morphology|MP:0000955,abnormal spinal cord morphology|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001154,seminiferous tubule degeneration|MP:0001326,retina degeneration|MP:0001925,male infertility|MP:0002152,abnormal brain morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0002784,abnormal Sertoli cell morphology|MP:0003352,increased circulating renin level|MP:0003631,nervous system phenotype|MP:0003690,abnormal glial cell physiology|MP:0003691,abnormal microglial cell physiology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003830,abnormal testis development|MP:0003871,abnormal myelin sheath morphology|MP:0004109,abnormal Sertoli cell development|MP:0005159,azoospermia|MP:0005253,abnormal eye physiology|MP:0005277,abnormal brainstem morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005386,behavior/neurological phenotype|MP:0005403,abnormal nerve conduction|MP:0006362,abnormal male germ cell morphology|MP:0006379,abnormal spermatocyte morphology|MP:0008025,brain vacuoles|MP:0008128,abnormal brain internal capsule morphology|MP:0008581,disorganized photoreceptor inner segment|MP:0008586,disorganized photoreceptor outer segment|MP:0008917,abnormal oligodendrocyte physiology|MP:0013600,testis degeneration|MP:0031384,impaired blood-brain barrier function
MGI:5618265	Clcn2<tm2.1Tjj>	MP:0003631,nervous system phenotype
MGI:5699055	Clcn3<tm1.1Jrhm>	MP:0000274,enlarged heart|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0004215,abnormal myocardial fiber physiology|MP:0006138,congestive heart failure|MP:0010633,myocardium hypertrophy|MP:0011925,abnormal heart echocardiography feature|MP:0031633,decreased heart left ventricle muscle contractility
MGI:2447864	Clcn3<tm1Lamb>	MP:0000010,abnormal abdominal fat pad morphology|MP:0000160,kyphosis|MP:0000807,abnormal hippocampus morphology|MP:0000811,hippocampal neuron degeneration|MP:0001262,decreased body weight|MP:0001327,decreased retina photoreceptor cell number|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001408,stereotypic behavior|MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0001922,reduced male fertility|MP:0002064,seizures|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002183,gliosis|MP:0002463,abnormal neutrophil physiology|MP:0002467,impaired neutrophil phagocytosis|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003246,loss of GABAergic neurons|MP:0003354,astrocytosis|MP:0003632,abnormal nervous system morphology|MP:0003633,abnormal nervous system physiology|MP:0003997,tonic-clonic seizures|MP:0005044,sepsis|MP:0005560,decreased circulating glucose level|MP:0006300,abnormal entorhinal cortex morphology|MP:0008535,enlarged lateral ventricles|MP:0009745,abnormal behavioral response to xenobiotic|MP:0009746,enhanced behavioral response to xenobiotic|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009971,decreased hippocampus pyramidal cell number|MP:0009974,decreased cerebral cortex pyramidal cell number|MP:0011084,lethality at weaning, incomplete penetrance|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:3530047	Clcn3<tm1Suc>	MP:0000069,kyphoscoliosis|MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0002001,blindness|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology|MP:0002581,abnormal ileum morphology|MP:0006069,abnormal retina neuronal layer morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0009971,decreased hippocampus pyramidal cell number|MP:0030003,hippocampus atrophy
MGI:2183297	Clcn3<tm1Tjj>	MP:0000745,tremors|MP:0000774,decreased brain size|MP:0000807,abnormal hippocampus morphology|MP:0000811,hippocampal neuron degeneration|MP:0001262,decreased body weight|MP:0001327,decreased retina photoreceptor cell number|MP:0001405,impaired coordination|MP:0001408,stereotypic behavior|MP:0001413,abnormal response to new environment|MP:0001504,abnormal posture|MP:0001900,impaired synaptic plasticity|MP:0002001,blindness|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0003632,abnormal nervous system morphology|MP:0003633,abnormal nervous system physiology|MP:0003691,abnormal microglial cell physiology|MP:0004769,abnormal synaptic vesicle morphology|MP:0005253,abnormal eye physiology|MP:0005367,renal/urinary system phenotype|MP:0005551,abnormal eye electrophysiology|MP:0008283,small hippocampus|MP:0008580,photoreceptor inner segment degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0008586,disorganized photoreceptor outer segment|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0031391,increased locomotor activity|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:4834490	Clcn4<tm1Tjj>	MP:0005367,renal/urinary system phenotype
MGI:2181017	Clcn5<tm1Gug>	MP:0000116,abnormal tooth development|MP:0000160,kyphosis|MP:0001759,increased urine glucose level|MP:0001762,polyuria|MP:0002901,increased urine phosphate level|MP:0002962,increased urine protein level|MP:0003197,nephrocalcinosis|MP:0003311,aminoaciduria|MP:0005367,renal/urinary system phenotype|MP:0005441,increased urine calcium level|MP:0011376,abnormal kidney corticomedullary boundary morphology|MP:0011445,abnormal renal protein reabsorption|MP:0020400,cystinuria|MP:0020406,hyperthreoninuria|MP:0030617,hyperglutaminuria|MP:0030682,hydroxyprolinuria
MGI:2181018	Clcn5<tm1Tjj>	MP:0001759,increased urine glucose level|MP:0001762,polyuria|MP:0002901,increased urine phosphate level|MP:0002962,increased urine protein level|MP:0005266,abnormal metabolism|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005441,increased urine calcium level|MP:0005621,abnormal cell physiology|MP:0009350,decreased urine pH|MP:0011417,abnormal renal transport|MP:0011556,increased urine beta2-microglobulin level|MP:0011559,increased urine insulin level
MGI:4457504	Clcn5<tm2.1Tjj>	MP:0001759,increased urine glucose level|MP:0001762,polyuria|MP:0002901,increased urine phosphate level|MP:0002962,increased urine protein level|MP:0005441,increased urine calcium level|MP:0005621,abnormal cell physiology|MP:0009350,decreased urine pH|MP:0011471,decreased urine creatinine level|MP:0011559,increased urine insulin level
MGI:4457505	Clcn5<tm3.1Tjj>	MP:0005384,cellular phenotype
MGI:4834484	Clcn5<tm4.1Tjj>	MP:0002169,no abnormal phenotype detected
MGI:4834485	Clcn5<tm5.1Tjj>	MP:0005367,renal/urinary system phenotype
MGI:7464996	Clcn6<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0001402,decreased locomotor activity|MP:0002092,abnormal eye morphology|MP:0020421,increased freezing behavior
MGI:3687967	Clcn6<tm1Tjj>	MP:0001362,abnormal anxiety-related response|MP:0001364,decreased anxiety-related response|MP:0001973,increased thermal nociceptive threshold|MP:0002757,decreased vertical activity|MP:0002882,abnormal neuron morphology|MP:0005059,lysosomal protein accumulation|MP:0005404,abnormal axon morphology
MGI:6287464	Clcn7<tm1.1Aros>	MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0001258,decreased body length|MP:0008770,decreased survivor rate|MP:0010875,increased bone volume
MGI:5431240	Clcn7<tm1.1Lex>	MP:0000745,tremors|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0001326,retina degeneration|MP:0001504,abnormal posture|MP:0001732,postnatal growth retardation|MP:0001953,respiratory failure|MP:0002229,neurodegeneration|MP:0002826,tonic seizures|MP:0002882,abnormal neuron morphology|MP:0003354,astrocytosis|MP:0005059,lysosomal protein accumulation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005390,skeleton phenotype|MP:0005391,vision/eye phenotype|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008547,abnormal neocortex morphology|MP:0008583,absent photoreceptor inner segment|MP:0008585,absent photoreceptor outer segment|MP:0008918,microgliosis|MP:0010013,cerebral cortex pyramidal cell degeneration
MGI:5882799	Clcn7<tm1.1Mawa>	MP:0000062,increased bone mineral density|MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000135,decreased compact bone thickness|MP:0001265,decreased body size|MP:0002083,premature death|MP:0004984,increased osteoclast cell number|MP:0004991,decreased bone strength|MP:0009347,increased trabecular bone thickness|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0010968,decreased compact bone area|MP:0013631,decreased bone trabecular spacing
MGI:5563124	Clcn7<tm1.1Mjec>	MP:0000062,increased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0013617,increased areal bone mineral density|MP:0013631,decreased bone trabecular spacing
MGI:5563089	Clcn7<tm1.1Teti>	MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000876,Purkinje cell degeneration|MP:0001265,decreased body size|MP:0001541,abnormal osteoclast physiology|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0002397,abnormal bone marrow morphology|MP:0002904,increased circulating parathyroid hormone level|MP:0003631,nervous system phenotype|MP:0004984,increased osteoclast cell number|MP:0004993,decreased bone resorption|MP:0005605,increased bone mass|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0011747,myelofibrosis|MP:0013617,increased areal bone mineral density|MP:0013631,decreased bone trabecular spacing
MGI:2387675	Clcn7<tm1Tjj>	MP:0000065,abnormal bone marrow cavity morphology|MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000432,abnormal head morphology|MP:0000547,short limbs|MP:0001265,decreased body size|MP:0001326,retina degeneration|MP:0001541,abnormal osteoclast physiology|MP:0004982,abnormal osteoclast morphology|MP:0004988,increased osteoblast cell number|MP:0004993,decreased bone resorption|MP:0006219,optic nerve degeneration|MP:0008271,abnormal bone ossification|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5904771	Clcn7<tm2.1Mjec>	MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0009347,increased trabecular bone thickness|MP:0010123,increased bone mineral content|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0013617,increased areal bone mineral density
MGI:2387676	Clcn7<tm2Tjj>	MP:0000065,abnormal bone marrow cavity morphology|MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000432,abnormal head morphology|MP:0000547,short limbs|MP:0001265,decreased body size|MP:0001326,retina degeneration|MP:0001541,abnormal osteoclast physiology|MP:0002075,abnormal coat/hair pigmentation|MP:0003172,abnormal lysosome physiology|MP:0003354,astrocytosis|MP:0004982,abnormal osteoclast morphology|MP:0004988,increased osteoblast cell number|MP:0005060,accumulation of giant lysosomes in kidney/renal tubule cells|MP:0006219,optic nerve degeneration|MP:0008260,abnormal autophagy|MP:0008271,abnormal bone ossification|MP:0008733,abnormal hair shaft melanin granule distribution|MP:0008918,microgliosis|MP:0010878,increased trabecular bone volume|MP:0011086,postnatal lethality, incomplete penetrance|MP:0030941,enhanced autophagy
MGI:4413670	Clcn7<tm3.1Tjj>	MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000811,hippocampal neuron degeneration|MP:0000812,abnormal dentate gyrus morphology|MP:0001513,limb grasping|MP:0002229,neurodegeneration|MP:0003172,abnormal lysosome physiology|MP:0003240,loss of hippocampal neurons|MP:0003241,loss of cortex neurons|MP:0003354,astrocytosis|MP:0005060,accumulation of giant lysosomes in kidney/renal tubule cells|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype|MP:0008535,enlarged lateral ventricles|MP:0008918,microgliosis|MP:0010768,mortality/aging
MGI:4459519	Clcn7<tm4.1Tjj>	MP:0000062,increased bone mineral density|MP:0000067,osteopetrosis|MP:0000130,abnormal trabecular bone morphology|MP:0000811,hippocampal neuron degeneration|MP:0001186,pigmentation phenotype|MP:0001262,decreased body weight|MP:0001326,retina degeneration|MP:0001541,abnormal osteoclast physiology|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0003172,abnormal lysosome physiology|MP:0004982,abnormal osteoclast morphology|MP:0005352,small cranium|MP:0008260,abnormal autophagy|MP:0009347,increased trabecular bone thickness|MP:0014805,impaired tooth eruption
MGI:5695557	Clcn7<tm5.1Tjj>	MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000788,abnormal cerebral cortex morphology|MP:0000811,hippocampal neuron degeneration|MP:0001186,pigmentation phenotype|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002229,neurodegeneration|MP:0003172,abnormal lysosome physiology|MP:0004982,abnormal osteoclast morphology|MP:0005058,abnormal lysosome morphology|MP:0005384,cellular phenotype|MP:0005391,vision/eye phenotype|MP:0009939,abnormal hippocampus neuron morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0010014,hippocampus pyramidal cell degeneration|MP:0010878,increased trabecular bone volume|MP:0012007,abnormal chloride level
MGI:6283545	Clcnka<m1Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:6148223	Clcnka<tm1b(EUCOMM)Hmgu>	MP:0002968,increased circulating alkaline phosphatase level|MP:0003019,increased circulating chloride level|MP:0010025,decreased total body fat amount
MGI:2148676	Clcnka<tm1Suc>	MP:0001762,polyuria|MP:0002988,decreased urine osmolality
MGI:6164702	Clcnkb<em1Haca>	MP:0000530,abnormal kidney vasculature morphology|MP:0001596,hypotension|MP:0001732,postnatal growth retardation|MP:0001762,polyuria|MP:0002988,decreased urine osmolality|MP:0003020,decreased circulating chloride level|MP:0003352,increased circulating renin level|MP:0005377,hearing/vestibular/ear phenotype|MP:0005528,decreased renal glomerular filtration rate|MP:0005619,increased urine potassium level|MP:0005628,decreased circulating potassium level|MP:0006316,increased urine sodium level|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010128,hypovolemia|MP:0011312,abnormal kidney afferent arteriole morphology|MP:0011313,abnormal kidney efferent arteriole morphology|MP:0011459,increased urine chloride ion level|MP:0011563,increased urine prostaglandin level
MGI:6152442	Clcnkb<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000277,abnormal heart shape|MP:0000470,abnormal stomach morphology|MP:0000538,abnormal urinary bladder morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001126,abnormal ovary morphology|MP:0001147,small testis|MP:0001402,decreased locomotor activity|MP:0001944,abnormal pancreas morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002188,small heart|MP:0002339,abnormal lymph node morphology|MP:0002591,decreased mean corpuscular volume|MP:0002606,increased basophil cell number|MP:0002834,decreased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0003795,abnormal bone structure|MP:0003900,shortened QT interval|MP:0003960,increased lean body mass|MP:0005016,decreased lymphocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005292,improved glucose tolerance|MP:0005553,increased circulating creatinine level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010067,increased red blood cell distribution width|MP:0010393,shortened QRS complex duration|MP:0011874,enlarged urinary bladder|MP:0013279,increased fasting circulating glucose level
MGI:6164675	Clcnkb<tm1.1Doel>	MP:0000519,hydronephrosis|MP:0001732,postnatal growth retardation|MP:0001762,polyuria|MP:0002083,premature death|MP:0002829,abnormal juxtaglomerular apparatus morphology|MP:0002988,decreased urine osmolality|MP:0002989,small kidney|MP:0003028,alkalosis|MP:0003029,alkalemia|MP:0004119,hypokalemia|MP:0004757,abnormal distal convoluted tubule morphology|MP:0005367,renal/urinary system phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009051,dilated distal convoluted tubule|MP:0009643,abnormal urine homeostasis|MP:0011301,juxtaglomerular cell hyperplasia|MP:0011344,abnormal loop of Henle ascending limb thick segment morphology|MP:0011417,abnormal renal transport|MP:0011435,increased urine magnesium level|MP:0011442,abnormal renal sodium ion transport|MP:0011563,increased urine prostaglandin level
MGI:5444004	Cldn10<tm1.1Dmu>	MP:0001426,polydipsia|MP:0001566,increased circulating phosphate level|MP:0001762,polyuria|MP:0002136,abnormal kidney physiology|MP:0002986,decreased urine calcium level|MP:0002988,decreased urine osmolality|MP:0003197,nephrocalcinosis|MP:0005565,increased blood urea nitrogen level|MP:0005619,increased urine potassium level|MP:0006357,abnormal circulating mineral level|MP:0009350,decreased urine pH|MP:0009643,abnormal urine homeostasis|MP:0010092,increased circulating magnesium level|MP:0010107,abnormal renal reabsorption|MP:0010111,abnormal renal calcium reabsorption|MP:0011436,decreased urine magnesium level|MP:0011467,decreased urine urea nitrogen level
MGI:6355928	Cldn11<em1(IMPC)H>	MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001488,increased startle reflex|MP:0001925,male infertility|MP:0005565,increased blood urea nitrogen level
MGI:2181029	Cldn11<tm1Ral>	MP:0000745,tremors|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001405,impaired coordination|MP:0001515,abnormal grip strength|MP:0001925,male infertility|MP:0001967,deafness|MP:0002216,abnormal seminiferous tubule morphology|MP:0003631,nervous system phenotype|MP:0003871,abnormal myelin sheath morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004411,decreased endocochlear potential|MP:0004464,absent strial basal cell tight junctions|MP:0004736,abnormal distortion product otoacoustic emission|MP:0005159,azoospermia|MP:0010748,abnormal visual evoked potential|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014740,increased auditory brainstem response wave peak latency|MP:0020355,abnormal Sertoli cell barrier morphology|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:3055494	Cldn11<tm1Sts>	MP:0000048,abnormal stria vascularis morphology|MP:0001925,male infertility|MP:0004411,decreased endocochlear potential|MP:0004464,absent strial basal cell tight junctions|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6368841	Cldn12<tm1.1(KOMP)Vlcg>	MP:0000218,increased leukocyte cell number|MP:0000248,macrocytosis|MP:0000745,tremors|MP:0001258,decreased body length|MP:0001260,increased body weight|MP:0001297,microphthalmia|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0001516,abnormal motor coordination/balance|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002757,decreased vertical activity|MP:0002875,decreased erythrocyte cell number|MP:0002981,increased liver weight|MP:0003631,nervous system phenotype|MP:0004952,increased spleen weight|MP:0005387,immune system phenotype|MP:0005553,increased circulating creatinine level|MP:0005559,increased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005567,decreased circulating total protein level|MP:0005599,increased cardiac muscle contractility|MP:0006086,decreased body mass index|MP:0010124,decreased bone mineral content|MP:0010379,decreased respiratory quotient|MP:0010511,shortened PR interval|MP:0010876,decreased bone volume|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011584,increased alkaline phosphatase activity|MP:0011925,abnormal heart echocardiography feature|MP:0011940,decreased food intake|MP:0011952,decreased cardiac stroke volume|MP:0011954,shortened PQ interval|MP:0011965,decreased total retina thickness|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013278,decreased fasting circulating glucose level|MP:0014142,increased body fat mass|MP:0020151,abnormal circulating non-HDL cholesterol level
MGI:6120761	Cldn12<tm1b(EUCOMM)Wtsi>	MP:0001399,hyperactivity|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0010052,increased grip strength|MP:0011965,decreased total retina thickness
MGI:5697043	Cldn13<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system|MP:0001486,abnormal startle reflex|MP:0002075,abnormal coat/hair pigmentation|MP:0002941,increased circulating alanine transaminase level|MP:0010053,decreased grip strength|MP:0013278,decreased fasting circulating glucose level
MGI:5515777	Cldn13<tm1.1(KOMP)Vlcg>	MP:0002591,decreased mean corpuscular volume|MP:0003131,increased erythrocyte cell number|MP:0005564,increased hemoglobin content|MP:0005566,decreased blood urea nitrogen level|MP:0005627,increased circulating potassium level|MP:0005633,increased circulating sodium level|MP:0013278,decreased fasting circulating glucose level
MGI:2674077	Cldn14<tm1Tbf>	MP:0001967,deafness|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004530,absent outer hair cell stereocilia|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0005386,behavior/neurological phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3794894	Cldn15<tm1Sats>	MP:0000462,abnormal digestive system morphology|MP:0000479,abnormal enterocyte morphology|MP:0000481,abnormal enterocyte cell number|MP:0004002,abnormal jejunum morphology|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0008108,abnormal small intestinal villus morphology|MP:0008883,abnormal enterocyte proliferation|MP:0009483,enlarged ileum|MP:0010155,abnormal intestine physiology|MP:0011882,enlarged duodenum|MP:0013796,abnormal duodenal goblet cell morphology|MP:0013798,abnormal jejunal goblet cell morphology
MGI:4453303	Cldn16<tm1.1Dmu>	MP:0002904,increased circulating parathyroid hormone level|MP:0005441,increased urine calcium level|MP:0009350,decreased urine pH|MP:0010093,decreased circulating magnesium level|MP:0010107,abnormal renal reabsorption|MP:0010111,abnormal renal calcium reabsorption|MP:0011228,abnormal vitamin D level
MGI:7309978	Cldn17<em#Prso>	MP:0001426,polydipsia|MP:0001732,postnatal growth retardation|MP:0002135,abnormal kidney morphology|MP:0002136,abnormal kidney physiology|MP:0002828,abnormal renal glomerular capsule morphology|MP:0003016,increased circulating bicarbonate level|MP:0003019,increased circulating chloride level|MP:0003267,constipation|MP:0003674,oxidative stress|MP:0005370,liver/biliary system phenotype|MP:0005416,abnormal circulating protein level|MP:0005634,decreased circulating sodium level|MP:0009643,abnormal urine homeostasis|MP:0010771,integument phenotype|MP:0011501,increased glomerular capsule space|MP:0011940,decreased food intake|MP:0012311,decreased defecation amount
MGI:5569064	Cldn18<tm1.1(KOMP)Vlcg>	MP:0001120,abnormal uterus morphology|MP:0001175,abnormal lung morphology|MP:0004882,enlarged lung|MP:0005630,increased lung weight|MP:0010067,increased red blood cell distribution width
MGI:3812813	Cldn18<tm1(KOMP)Vlcg>	MP:0006027,impaired lung alveolus development|MP:0010810,increased type II pneumocyte number|MP:0010898,abnormal pulmonary alveolus epithelium morphology|MP:0010899,abnormal pulmonary alveolar system morphology
MGI:5007067	Cldn18<tm1Lex>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0004016,decreased bone mass|MP:0004139,abnormal gastric parietal cell morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0004984,increased osteoclast cell number|MP:0004991,decreased bone strength|MP:0004992,increased bone resorption|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0008396,abnormal osteoclast differentiation|MP:0009346,decreased trabecular bone thickness|MP:0010124,decreased bone mineral content|MP:0010792,abnormal stomach mucosa morphology|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0010933,decreased trabecular bone connectivity density
MGI:5507837	Cldn19<tm1.1(KOMP)Vlcg>	MP:0002702,decreased circulating free fatty acids level|MP:0002833,increased heart weight|MP:0005633,increased circulating sodium level|MP:0010511,shortened PR interval|MP:0010571,shortened ST segment|MP:0011396,abnormal sleep behavior|MP:0011954,shortened PQ interval
MGI:3583804	Cldn19<tm1Sts>	MP:0001106,abnormal Schwann cell morphology|MP:0001405,impaired coordination|MP:0001406,abnormal gait
MGI:5766169	Cldn1<tm1b(NCOM)Mfgc>	MP:0011100,preweaning lethality, complete penetrance
MGI:2183247	Cldn1<tm1Sts>	MP:0001211,wrinkled skin|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001263,weight loss|MP:0001429,dehydration|MP:0002073,abnormal hair growth|MP:0002796,impaired skin barrier function|MP:0011087,neonatal lethality, complete penetrance
MGI:6357940	Cldn23<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0002644,decreased circulating triglyceride level|MP:0005632,decreased circulating aspartate transaminase level
MGI:5007068	Cldn2<tm1Lex>	MP:0004041,increased susceptibility to kidney reperfusion injury|MP:0005039,hypoxia|MP:0005289,increased oxygen consumption|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0006316,increased urine sodium level|MP:0010109,abnormal renal sodium reabsorption|MP:0011442,abnormal renal sodium ion transport|MP:0014781,decreased kidney enzyme/coenzyme level
MGI:4452519	Cldn2<tm1Muto>	MP:0001762,polyuria|MP:0002988,decreased urine osmolality|MP:0005367,renal/urinary system phenotype|MP:0005441,increased urine calcium level|MP:0006316,increased urine sodium level|MP:0010107,abnormal renal reabsorption|MP:0010108,abnormal renal water reabsorption|MP:0010109,abnormal renal sodium reabsorption
MGI:4939725	Cldn34b2<tm1a(KOMP)Wtsi>	MP:0003019,increased circulating chloride level
MGI:6153848	Cldn3<em1(IMPC)H>	MP:0000219,increased neutrophil cell number|MP:0001529,abnormal vocalization|MP:0002968,increased circulating alkaline phosphatase level|MP:0005016,decreased lymphocyte cell number
MGI:5571706	Cldn3<tm1.1Reb>	MP:0005389,reproductive system phenotype
MGI:5609165	Cldn4<tm1.1Jhou>	MP:0001262,decreased body weight|MP:0001762,polyuria|MP:0002608,increased hematocrit|MP:0002666,increased circulating aldosterone level|MP:0003016,increased circulating bicarbonate level|MP:0003020,decreased circulating chloride level|MP:0003028,alkalosis|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005627,increased circulating potassium level|MP:0006316,increased urine sodium level|MP:0010107,abnormal renal reabsorption|MP:0010109,abnormal renal sodium reabsorption|MP:0011459,increased urine chloride ion level
MGI:5485358	Cldn4<tm1.1Yham>	MP:0000195,decreased circulating calcium level|MP:0000516,abnormal renal/urinary system morphology|MP:0000519,hydronephrosis|MP:0000535,ureter urothelium hyperplasia|MP:0002083,premature death|MP:0003589,abnormal ureter physiology|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005441,increased urine calcium level|MP:0010107,abnormal renal reabsorption|MP:0010111,abnormal renal calcium reabsorption|MP:0011336,abnormal kidney pelvis urothelium morphology|MP:0011440,increased kidney cell proliferation|MP:0011459,increased urine chloride ion level
MGI:5609571	Cldn4<tm1.1Zboro>	MP:0002169,no abnormal phenotype detected
MGI:2663040	Cldn5<tm1Sts>	MP:0003631,nervous system phenotype|MP:0011087,neonatal lethality, complete penetrance|MP:0031384,impaired blood-brain barrier function
MGI:3834897	Cldn6<tm1(cre)Dkwu>	MP:0002169,no abnormal phenotype detected
MGI:4414771	Cldn7<tm1Yche>	MP:0001211,wrinkled skin|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001429,dehydration|MP:0001732,postnatal growth retardation|MP:0002135,abnormal kidney morphology|MP:0002608,increased hematocrit|MP:0002666,increased circulating aldosterone level|MP:0005565,increased blood urea nitrogen level|MP:0005619,increased urine potassium level|MP:0006316,increased urine sodium level|MP:0009643,abnormal urine homeostasis|MP:0011085,postnatal lethality, complete penetrance|MP:0011459,increased urine chloride ion level
MGI:5750892	Cldn8<tm1.1Jhou>	MP:0001596,hypotension|MP:0001762,polyuria|MP:0002666,increased circulating aldosterone level|MP:0003016,increased circulating bicarbonate level|MP:0003020,decreased circulating chloride level|MP:0003028,alkalosis|MP:0004119,hypokalemia|MP:0004754,abnormal kidney collecting duct morphology|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005378,growth/size/body region phenotype|MP:0005619,increased urine potassium level|MP:0005628,decreased circulating potassium level|MP:0006316,increased urine sodium level|MP:0011459,increased urine chloride ion level
MGI:6400922	Cldn9<em1(IMPC)H>	MP:0001486,abnormal startle reflex|MP:0002606,increased basophil cell number
MGI:3055084	Cldn9<nmf329>	MP:0000042,abnormal organ of Corti morphology|MP:0001967,deafness|MP:0004402,decreased cochlear outer hair cell number|MP:0004404,cochlear outer hair cell degeneration|MP:0004529,decreased outer hair cell stereocilia number|MP:0004888,abnormal perilymph physiology|MP:0005386,behavior/neurological phenotype|MP:0006359,absent startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6120750	Cldnd2<tm1b(EUCOMM)Hmgu>	MP:0000194,increased circulating calcium level|MP:0002965,increased circulating serum albumin level|MP:0005278,abnormal cholesterol homeostasis|MP:0005568,increased circulating total protein level|MP:0011962,increased cornea thickness|MP:0013279,increased fasting circulating glucose level
MGI:1856593	Cle	MP:0001286,abnormal eye development|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001322,abnormal iris morphology|MP:0002092,abnormal eye morphology
MGI:7624304	Clec10a<m1>	MP:0000219,increased neutrophil cell number|MP:0001194,dermatitis|MP:0005387,immune system phenotype|MP:0010771,integument phenotype
MGI:2183546	Clec10a<tm1Hed>	MP:0000219,increased neutrophil cell number|MP:0001194,dermatitis|MP:0002590,increased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005505,thrombocytosis|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0010771,integument phenotype
MGI:5888865	Clec11a<em1Sjm>	MP:0002398,abnormal bone marrow cell morphology/development|MP:0002999,abnormal bone healing|MP:0003109,short femur|MP:0003419,delayed endochondral bone ossification|MP:0004991,decreased bone strength|MP:0005397,hematopoietic system phenotype|MP:0009115,abnormal fat cell morphology|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0010933,decreased trabecular bone connectivity density|MP:0011711,impaired osteoblast differentiation|MP:0013624,decreased femur compact bone thickness|MP:0013630,increased bone trabecular spacing|MP:0013633,decreased femur maximal load|MP:0013646,decreased energy dissipated prior to femur fracture|MP:0020010,decreased bone mineral density of femur|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization
MGI:5779394	Clec12a<tm1Gdb>	MP:0002412,increased susceptibility to bacterial infection|MP:0008260,abnormal autophagy|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:5617391	Clec12a<tm1Jrld>	MP:0001846,increased inflammatory response|MP:0002463,abnormal neutrophil physiology|MP:0003674,oxidative stress|MP:0005387,immune system phenotype|MP:0008560,increased tumor necrosis factor secretion|MP:0008722,abnormal chemokine secretion|MP:0009278,abnormal bone marrow cell physiology
MGI:5007072	Clec14a<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:5009280	Clec16a<curt>	MP:0000876,Purkinje cell degeneration|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002110,abnormal digit morphology|MP:0005287,narrow eye opening|MP:0006325,impaired hearing|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013179,wavy tail
MGI:6367564	Clec16a<em1(IMPC)J>	MP:0001697,abnormal embryo size|MP:0003385,abnormal body wall morphology|MP:0004738,abnormal auditory brainstem response|MP:0011100,preweaning lethality, complete penetrance
MGI:5648633	Clec16a<tm1.1Hhak>	MP:0001559,hyperglycemia|MP:0002169,no abnormal phenotype detected|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005216,abnormal pancreatic alpha cell morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005379,endocrine/exocrine gland phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0011630,increased mitochondrial size|MP:0011636,disorganized mitochondrial cristae|MP:0014046,abnormal mitophagy
MGI:7380613	Clec1a<tm1Yiw>	MP:0002455,abnormal dendritic cell antigen presentation|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005387,immune system phenotype|MP:0011823,decreased CD8-positive, alpha-beta memory T cell proliferation
MGI:5314117	Clec1b<tm1.1Arte>	MP:0001614,abnormal blood vessel morphology|MP:0001785,edema|MP:0001879,abnormal lymphatic vessel morphology|MP:0001915,intracranial hemorrhage|MP:0002551,abnormal blood coagulation|MP:0005324,ascites|MP:0005388,respiratory system phenotype|MP:0005464,abnormal platelet physiology|MP:0010197,abnormal lymphatic vessel endothelial cell morphology
MGI:4839037	Clec1b<tm1.1Ksi>	MP:0001614,abnormal blood vessel morphology|MP:0001786,skin edema|MP:0001879,abnormal lymphatic vessel morphology|MP:0001914,hemorrhage|MP:0006298,abnormal platelet activation|MP:0009549,decreased platelet aggregation|MP:0010368,abnormal lymphatic system physiology|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5314118	Clec1b<tm1.2Arte>	MP:0001175,abnormal lung morphology|MP:0001785,edema|MP:0001879,abnormal lymphatic vessel morphology|MP:0001915,intracranial hemorrhage|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0004950,abnormal brain vasculature morphology|MP:0005464,abnormal platelet physiology|MP:0006054,spinal hemorrhage|MP:0009549,decreased platelet aggregation|MP:0010198,decreased lymphatic vessel endothelial cell number|MP:0010819,primary atelectasis|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011514,skin hemorrhage|MP:0012080,chylous ascites
MGI:4839036	Clec1b<tm1Ksi>	MP:0000496,abnormal small intestine morphology|MP:0001879,abnormal lymphatic vessel morphology|MP:0003288,intestinal edema
MGI:4462254	Clec1b<tm1Lex>	MP:0000208,decreased hematocrit|MP:0001577,anemia|MP:0001634,internal hemorrhage|MP:0002843,decreased systemic arterial blood pressure|MP:0002874,decreased hemoglobin content|MP:0003179,thrombocytopenia|MP:0004950,abnormal brain vasculature morphology|MP:0008247,abnormal mononuclear cell morphology|MP:0010022,brain vascular congestion|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4820842	Clec1b<tm1Mlkn>	MP:0001879,abnormal lymphatic vessel morphology|MP:0003288,intestinal edema|MP:0006298,abnormal platelet activation
MGI:5552846	Clec1b<tm2Mlkn>	MP:0031051,lymph node hemorrhage
MGI:3826396	Clec2d<tm1.1Mgil>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000194,increased circulating calcium level|MP:0002905,decreased circulating parathyroid hormone level|MP:0003109,short femur|MP:0004148,increased compact bone thickness|MP:0004984,increased osteoclast cell number|MP:0005006,abnormal osteoblast physiology|MP:0005387,immune system phenotype|MP:0006396,decreased long bone epiphyseal plate size|MP:0008396,abnormal osteoclast differentiation|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume
MGI:7262867	Clec2h<tm1.1Apma>	MP:0001859,kidney inflammation|MP:0002703,abnormal renal tubule morphology|MP:0004154,renal tubular necrosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005553,increased circulating creatinine level|MP:0008140,podocyte foot process effacement|MP:0008902,abnormal renal fat pad morphology|MP:0009286,increased abdominal fat pad weight|MP:0009640,abnormal renal tubule epithelium morphology|MP:0011352,proximal convoluted tubule brush border loss|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011430,mesangiolysis|MP:0013284,abnormal renal glomerular filtration|MP:0020411,increased abdominal adipose tissue amount|MP:0020519,renal glomerular immunoglobulin deposits
MGI:6357989	Clec3a<em1(IMPC)J>	MP:0000062,increased bone mineral density|MP:0001284,absent vibrissae|MP:0001399,hyperactivity|MP:0003960,increased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0010025,decreased total body fat amount
MGI:5646134	Clec3b<tm1b(KOMP)Wtsi>	MP:0010053,decreased grip strength
MGI:2178555	Clec3b<tm1Umw>	MP:0000137,abnormal vertebrae morphology|MP:0000160,kyphosis|MP:0004173,abnormal intervertebral disk morphology|MP:0005227,abnormal vertebral body development|MP:0005229,abnormal intervertebral disk development|MP:0005390,skeleton phenotype|MP:0006395,abnormal epiphyseal plate morphology|MP:0031253,lordokyphosis
MGI:5052160	Clec4a2<tm1.1Cfg>	MP:0000702,enlarged lymph nodes|MP:0001154,seminiferous tubule degeneration|MP:0001846,increased inflammatory response|MP:0005154,increased B cell proliferation|MP:0005387,immune system phenotype|MP:0005390,skeleton phenotype|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level
MGI:5620799	Clec4a2<tm1Yiw>	MP:0000685,abnormal immune system morphology|MP:0001790,abnormal immune system physiology|MP:0001846,increased inflammatory response|MP:0001870,salivary gland inflammation|MP:0002493,increased IgG level|MP:0002933,joint inflammation|MP:0003724,increased susceptibility to induced arthritis|MP:0003725,increased autoantibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0006431,abnormal fibrocartilage morphology|MP:0008082,increased single-positive T cell number|MP:0008126,increased dendritic cell number|MP:0008499,increased IgG1 level|MP:0008502,increased IgG3 level|MP:0008588,abnormal circulating interleukin level|MP:0008593,increased circulating interleukin-10 level|MP:0008602,increased circulating interleukin-4 level|MP:0008614,increased circulating interleukin-17 level|MP:0008620,increased circulating interleukin-23 level|MP:0013942,enthesitis|MP:0020039,increased bone ossification
MGI:4460578	Clec4a4<tm1(KOMP)Vlcg>	MP:0001120,abnormal uterus morphology|MP:0009709,hydrometra
MGI:6369851	Clec4b1<em#Tsak>	MP:0002412,increased susceptibility to bacterial infection|MP:0002420,abnormal adaptive immunity|MP:0003009,abnormal cytokine secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008713,abnormal cytokine level
MGI:5052163	Clec4d<tm1.1Cfg>	MP:0000240,extramedullary hematopoiesis|MP:0001861,lung inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0005014,increased B cell number|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008210,increased mature B cell number|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008660,increased interleukin-10 secretion|MP:0008681,increased interleukin-17 secretion|MP:0008705,increased interleukin-6 secretion|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:5528858	Clec4d<tm1.1Shoy>	MP:0000703,abnormal thymus morphology|MP:0001790,abnormal immune system physiology|MP:0001805,decreased IgG level|MP:0001835,abnormal antigen presentation|MP:0001861,lung inflammation|MP:0002500,granulomatous inflammation|MP:0002723,abnormal immune serum protein physiology|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005025,abnormal response to infection|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008127,decreased dendritic cell number|MP:0008559,abnormal interferon-gamma secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008615,decreased circulating interleukin-17 level|MP:0008680,abnormal interleukin-17 secretion|MP:0008722,abnormal chemokine secretion|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:5052164	Clec4e<tm1.1Cfg>	MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000266,abnormal heart morphology|MP:0000285,abnormal heart valve morphology|MP:0002451,abnormal macrophage physiology|MP:0005016,decreased lymphocyte cell number|MP:0005399,increased susceptibility to fungal infection|MP:0008561,decreased tumor necrosis factor secretion
MGI:5013826	Clec4e<tm1Tks>	MP:0000222,decreased neutrophil cell number|MP:0001805,decreased IgG level|MP:0002723,abnormal immune serum protein physiology|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005025,abnormal response to infection|MP:0005398,decreased susceptibility to fungal infection|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008127,decreased dendritic cell number|MP:0008559,abnormal interferon-gamma secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008615,decreased circulating interleukin-17 level|MP:0008661,decreased interleukin-10 secretion|MP:0008680,abnormal interleukin-17 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:5529277	Clec4f<tm1Ymed>	MP:0005387,immune system phenotype|MP:0008567,decreased interferon-gamma secretion|MP:0011072,abnormal macrophage cytokine production
MGI:5052272	Clec4g<tm1.1Cfg>	MP:0000220,increased monocyte cell number|MP:0003131,increased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0005013,increased lymphocyte cell number
MGI:5510586	Clec4g<tm1.1Fhe>	MP:0000716,abnormal immune system cell morphology|MP:0001790,abnormal immune system physiology|MP:0001829,increased activated T cell number|MP:0001860,liver inflammation|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005387,immune system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0020932,decreased susceptibility to Adenoviridae infection
MGI:5582826	Clec4n<tm1.2Mgne>	MP:0001798,impaired macrophage phagocytosis|MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology|MP:0002467,impaired neutrophil phagocytosis|MP:0005399,increased susceptibility to fungal infection|MP:0008555,abnormal interferon secretion|MP:0008556,abnormal tumor necrosis factor secretion|MP:0008560,increased tumor necrosis factor secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion|MP:0008654,increased interleukin-1 alpha secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008681,increased interleukin-17 secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0020183,abnormal susceptibility to fungal infection
MGI:4459637	Clec4n<tm1Yiw>	MP:0000519,hydronephrosis|MP:0004194,abnormal kidney pelvis morphology|MP:0005399,increased susceptibility to fungal infection|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008670,decreased interleukin-12b secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008691,decreased interleukin-23 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0009787,increased susceptibility to infection induced morbidity/mortality
MGI:7425593	Clec5a<em1(IMPC)Mbp>	MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001258,decreased body length|MP:0001289,persistence of hyaloid vascular system|MP:0001314,cornea opacity|MP:0006203,eye hemorrhage
MGI:4441169	Clec5a<tm1Cua>	MP:0003436,decreased susceptibility to induced arthritis
MGI:5529120	Clec7a<tm1.1Bpip>	MP:0001798,impaired macrophage phagocytosis|MP:0002451,abnormal macrophage physiology|MP:0005399,increased susceptibility to fungal infection|MP:0008561,decreased tumor necrosis factor secretion
MGI:3695710	Clec7a<tm1Gdb>	MP:0001663,abnormal digestive system physiology|MP:0001845,abnormal inflammatory response|MP:0001861,lung inflammation|MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology|MP:0003009,abnormal cytokine secretion|MP:0003883,enlarged stomach|MP:0005399,increased susceptibility to fungal infection|MP:0008588,abnormal circulating interleukin level|MP:0008615,decreased circulating interleukin-17 level|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3695711	Clec7a<tm1Yiw>	MP:0002376,abnormal dendritic cell physiology|MP:0002451,abnormal macrophage physiology|MP:0003009,abnormal cytokine secretion|MP:0004880,lung cyst|MP:0005387,immune system phenotype|MP:0005399,increased susceptibility to fungal infection
MGI:5298406	Clec9a<tm1.1Crs>	MP:0002455,abnormal dendritic cell antigen presentation
MGI:5313299	Clec9a<tm1.1Kens>	MP:0001800,abnormal humoral immune response
MGI:5792559	Clec9a<tm1b(KOMP)Wtsi>	MP:0005140,decreased cardiac muscle contractility
MGI:3841125	Clec9a<tm1Crs>	MP:0002455,abnormal dendritic cell antigen presentation
MGI:1856822	clf2	MP:0000111,cleft palate|MP:0005170,cleft upper lip
MGI:2156041	Clgn<tm1Osb>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0005389,reproductive system phenotype|MP:0030978,impaired binding of sperm to zona pellucida
MGI:4440469	Clic1<tm1.1Breit>	MP:0005505,thrombocytosis|MP:0005606,increased bleeding time|MP:0006298,abnormal platelet activation|MP:0009549,decreased platelet aggregation
MGI:5288435	Clic4<tm1.1Aidi>	MP:0001262,decreased body weight|MP:0002412,increased susceptibility to bacterial infection|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008597,decreased circulating interleukin-6 level|MP:0008664,decreased interleukin-12 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:5763611	Clic4<tm1.1Thor>	MP:0005376,homeostasis/metabolism phenotype|MP:0014122,decreased pancreatic islet cell apoptosis
MGI:5426965	Clic4<tm1.1Yus>	MP:0001209,spontaneous skin ulceration|MP:0001798,impaired macrophage phagocytosis|MP:0001935,decreased litter size|MP:0002908,delayed wound healing|MP:0009703,decreased birth body size|MP:0012194,decreased keratinocyte migration|MP:0020861,abnormal cornea wound healing|MP:0030578,decreased keratinocyte adhesion
MGI:3838012	Clic4<tm1Jce>	MP:0000260,abnormal angiogenesis|MP:0001262,decreased body weight|MP:0001923,reduced female fertility|MP:0002792,abnormal retina vasculature morphology|MP:0003710,abnormal physiological neovascularization|MP:0004003,abnormal vascular endothelial cell physiology|MP:0005602,decreased angiogenesis|MP:0006055,abnormal vascular endothelial cell morphology|MP:0008770,decreased survivor rate
MGI:3663254	Clic5<jbg>	MP:0000043,organ of Corti degeneration|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000465,gastrointestinal hemorrhage|MP:0000505,decreased digestive secretion|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001354,increased aggression towards male mice|MP:0001395,bidirectional circling|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0001433,polyphagia|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0002136,abnormal kidney physiology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002712,increased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0002857,cochlear ganglion degeneration|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0004324,vestibular hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0005012,decreased eosinophil cell number|MP:0005165,increased susceptibility to injury|MP:0005202,lethargy|MP:0005325,abnormal renal glomerulus morphology|MP:0005534,decreased body temperature|MP:0005545,abnormal lens development|MP:0005560,decreased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0008006,increased stomach pH|MP:0008059,abnormal podocyte foot process morphology|MP:0008140,podocyte foot process effacement|MP:0010025,decreased total body fat amount|MP:0010180,increased susceptibility to weight loss|MP:0010378,increased respiratory quotient|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011454,abnormal glomerular endothelium fenestra morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:4358575	Clic5<jbg-2J>	MP:0001394,circling|MP:0001410,head bobbing|MP:0001522,impaired swimming|MP:0001967,deafness
MGI:3522004	Clic5<nmf318>	MP:0000043,organ of Corti degeneration|MP:0001394,circling|MP:0001967,deafness|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0005307,head tossing|MP:0006359,absent startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5692701	Clic5<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0001410,head bobbing|MP:0001489,decreased startle reflex|MP:0009142,decreased prepulse inhibition
MGI:7464997	Clic6<em1(IMPC)Mbp>	MP:0001120,abnormal uterus morphology|MP:0001486,abnormal startle reflex
MGI:2157998	Cliff<NZB/BlNJ>	MP:0001961,abnormal reflex
MGI:7484790	Clint1<em1(IMPC)Mbp>	MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:3607146	Clip1<tm1.1Gal>	MP:0006380,abnormal spermatid morphology|MP:0009376,abnormal manchette morphology
MGI:3607145	Clip1<tm1Gal>	MP:0001922,reduced male fertility|MP:0005384,cellular phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009376,abnormal manchette morphology|MP:0009377,ectopic manchette
MGI:7608254	Clip2<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002059,abnormal seminal vesicle morphology|MP:0002397,abnormal bone marrow morphology|MP:0002631,abnormal epididymis morphology|MP:0003795,abnormal bone structure|MP:0010052,increased grip strength|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number
MGI:2387833	Clip2<tm1.1Gal>	MP:0000358,abnormal cell morphology|MP:0000781,decreased corpus callosum size|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001469,abnormal contextual conditioning behavior|MP:0001732,postnatal growth retardation|MP:0001900,impaired synaptic plasticity|MP:0005386,behavior/neurological phenotype|MP:0005508,abnormal skeleton morphology|MP:0012676,dilated brain ventricle
MGI:2387832	Clip2<tm1Gal>	MP:0002169,no abnormal phenotype detected
MGI:5489756	Clip3<tm1.1Ics>	MP:0000738,impaired muscle contractility|MP:0001052,abnormal innervation pattern to muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001078,abnormal phrenic nerve morphology|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002279,abnormal diaphragm morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0012055,abnormal phrenic nerve innervation pattern to diaphragm
MGI:4432186	Clk1<tm1a(EUCOMM)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0000334,decreased granulocyte number|MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0002896,abnormal bone mineralization|MP:0003019,increased circulating chloride level|MP:0005316,abnormal response to tactile stimuli
MGI:6257491	Clk2<em1(IMPC)Bay>	MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0009142,decreased prepulse inhibition
MGI:5751695	Clk2<tm1.1Ppgr>	MP:0009356,decreased liver triglyceride level|MP:0010379,decreased respiratory quotient|MP:0010953,abnormal fatty acid oxidation
MGI:7333070	Clk4<em1Yihc>	MP:0002833,increased heart weight|MP:0004090,abnormal sarcomere morphology|MP:0004093,diffuse Z line|MP:0004564,increased myocardial fiber size|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0005630,increased lung weight|MP:0006138,congestive heart failure|MP:0010579,increased heart left ventricle size|MP:0010633,myocardium hypertrophy
MGI:5513754	Clmn<tm1b(EUCOMM)Wtsi>	MP:0009142,decreased prepulse inhibition
MGI:6187882	Clmp<tm1.1Fgr>	MP:0000462,abnormal digestive system morphology|MP:0000496,abnormal small intestine morphology|MP:0000519,hydronephrosis|MP:0002703,abnormal renal tubule morphology|MP:0003289,abnormal intestinal peristalsis|MP:0003589,abnormal ureter physiology|MP:0004142,abnormal muscle tone|MP:0008489,slow postnatal weight gain|MP:0008770,decreased survivor rate|MP:0008802,abnormal intestinal smooth muscle morphology|MP:0009480,distended cecum|MP:0009854,impaired gastric peristalsis|MP:0010155,abnormal intestine physiology|MP:0011082,abnormal gastrointestinal motility|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011426,abnormal ureter smooth muscle morphology|MP:0011480,impaired ureteric peristalsis|MP:0013862,abnormal cecum position|MP:0013954,increased intestine length|MP:0014022,abnormal duodenum topology|MP:0014023,abnormal intestine placement|MP:0014279,abnormal intestinal rotation|MP:0020989,increased urine lipocalin 2 level
MGI:6187714	Clmp<tm1Fgr>	MP:0000519,hydronephrosis|MP:0002160,abnormal reproductive system morphology|MP:0003289,abnormal intestinal peristalsis|MP:0003589,abnormal ureter physiology|MP:0008489,slow postnatal weight gain|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011426,abnormal ureter smooth muscle morphology|MP:0011480,impaired ureteric peristalsis
MGI:5007002	Clmp<tm1Lex>	MP:0000519,hydronephrosis|MP:0001265,decreased body size|MP:0004924,abnormal behavior|MP:0006144,increased systemic arterial systolic blood pressure|MP:0009642,abnormal blood homeostasis|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6474168	Cln3<em1Dprc>	MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0002182,abnormal astrocyte morphology|MP:0003354,astrocytosis|MP:0005058,abnormal lysosome morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0020448,increased microglial cell activation
MGI:2388888	Cln3<tm1.1Mem>	MP:0000607,abnormal hepatocyte morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0001326,retina degeneration|MP:0001327,decreased retina photoreceptor cell number|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002183,gliosis|MP:0003632,abnormal nervous system morphology|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0005386,behavior/neurological phenotype|MP:0006069,abnormal retina neuronal layer morphology|MP:0008056,abnormal retina ganglion cell morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology
MGI:3759415	Cln3<tm1Blda>	MP:0000745,tremors|MP:0001405,impaired coordination|MP:0001426,polydipsia|MP:0001513,limb grasping|MP:0001762,polyuria|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002988,decreased urine osmolality|MP:0003313,abnormal locomotor activation|MP:0005058,abnormal lysosome morphology|MP:0005367,renal/urinary system phenotype|MP:0005618,decreased urine potassium level|MP:0005627,increased circulating potassium level|MP:0008997,increased blood osmolality
MGI:3623134	Cln3<tm1Mkat>	MP:0000598,abnormal liver morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0002161,abnormal fertility/fecundity|MP:0005058,abnormal lysosome morphology
MGI:1933976	Cln3<tm1Nbm>	MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0001325,abnormal retina morphology|MP:0002152,abnormal brain morphology|MP:0002376,abnormal dendritic cell physiology|MP:0002451,abnormal macrophage physiology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005058,abnormal lysosome morphology|MP:0005241,abnormal retina ganglion layer morphology|MP:0005277,abnormal brainstem morphology|MP:0006007,abnormal basal ganglion morphology|MP:0008195,abnormal professional antigen presenting cell morphology|MP:0011079,decreased macrophage cytokine production|MP:0014695,increased cell adhesion
MGI:3521802	Cln5<tm1Pltn>	MP:0002090,abnormal vision|MP:0002152,abnormal brain morphology|MP:0003246,loss of GABAergic neurons
MGI:2159328	Cln6<nclf>	MP:0000753,paralysis|MP:0000920,abnormal myelination|MP:0002064,seizures|MP:0002083,premature death|MP:0003354,astrocytosis|MP:0003632,abnormal nervous system morphology|MP:0004811,abnormal neuron physiology|MP:0005405,axon degeneration|MP:0031204,hindlimb paresis|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:5513756	Cln6<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0002833,increased heart weight|MP:0005293,impaired glucose tolerance|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount
MGI:6336204	Cln8<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001566,increased circulating phosphate level|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002833,increased heart weight|MP:0002965,increased circulating serum albumin level|MP:0003068,enlarged kidney
MGI:1856959	Cln8<mnd>	MP:0000753,paralysis|MP:0000754,paresis|MP:0000755,hindlimb paralysis|MP:0000920,abnormal myelination|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0001056,abnormal cranial nerve morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001076,abnormal hypoglossal nerve morphology|MP:0001392,abnormal locomotor behavior|MP:0001393,ataxia|MP:0001513,limb grasping|MP:0001935,decreased litter size|MP:0002001,blindness|MP:0002064,seizures|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002183,gliosis|MP:0003632,abnormal nervous system morphology|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005405,axon degeneration|MP:0008455,abnormal retina rod cell inner segment morphology|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0008515,thin retina outer nuclear layer|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:6388365	Clnk<em1(IMPC)Ccpcz>	MP:0000162,lordosis|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002060,abnormal skin morphology|MP:0003604,single kidney|MP:0004819,decreased skeletal muscle mass
MGI:3774508	Clnk<tm1Rygo>	MP:0003080,increased natural killer cell mediated cytotoxicity|MP:0005387,immune system phenotype|MP:0008042,abnormal NK T cell physiology|MP:0008559,abnormal interferon-gamma secretion|MP:0008566,increased interferon-gamma secretion|MP:0008700,decreased interleukin-4 secretion
MGI:3050561	Clnk<tm1Vei>	MP:0002423,abnormal mast cell physiology|MP:0003080,increased natural killer cell mediated cytotoxicity|MP:0005387,immune system phenotype
MGI:1934011	Clns1a<tm1Kwn>	MP:0000313,abnormal cell death|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:7425594	Clock<em1(IMPC)Ccpcz>	MP:0000195,decreased circulating calcium level|MP:0000218,increased leukocyte cell number|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0002060,abnormal skin morphology|MP:0002100,abnormal tooth morphology|MP:0002311,abnormal inspiratory capacity|MP:0002968,increased circulating alkaline phosphatase level|MP:0004953,decreased spleen weight|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005333,decreased heart rate|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0010068,decreased red blood cell distribution width|MP:0010896,decreased lung compliance|MP:0011044,increased lung elastance|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0013763,increased T-helper cell number|MP:0013771,decreased effector memory T-helper cell number
MGI:6197763	Clock<m1Btlr>	MP:0001260,increased body weight
MGI:1861634	Clock<m1Jt>	MP:0000427,abnormal hair cycle|MP:0001260,increased body weight|MP:0001399,hyperactivity|MP:0001413,abnormal response to new environment|MP:0001415,increased exploration in new environment|MP:0001431,abnormal eating behavior|MP:0001463,abnormal spatial learning|MP:0001501,abnormal sleep pattern|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0001666,abnormal intestinal absorption|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002272,abnormal nervous system electrophysiology|MP:0002574,increased vertical activity|MP:0002628,hepatic steatosis|MP:0002665,decreased circulating corticosterone level|MP:0002693,abnormal pancreas physiology|MP:0002773,decreased circulating luteinizing hormone level|MP:0002891,increased insulin sensitivity|MP:0002907,abnormal parturition|MP:0003059,decreased insulin secretion|MP:0003463,abnormal single cell response|MP:0003631,nervous system phenotype|MP:0003969,abnormal luteinizing hormone level|MP:0004080,abnormal nucleus accumbens morphology|MP:0004890,decreased energy expenditure|MP:0004924,abnormal behavior|MP:0005164,abnormal response to injury|MP:0005178,increased circulating cholesterol level|MP:0005181,decreased circulating estradiol level|MP:0005182,increased circulating estradiol level|MP:0005185,decreased circulating progesterone level|MP:0005186,increased circulating progesterone level|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005333,decreased heart rate|MP:0005342,abnormal intestinal lipid absorption|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005416,abnormal circulating protein level|MP:0005449,abnormal food intake|MP:0005458,increased percent body fat/body weight|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0008462,abnormal medium spiny neuron morphology|MP:0008858,abnormal hair cycle anagen phase|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008882,abnormal enterocyte physiology|MP:0008961,abnormal basal metabolism|MP:0009006,prolonged estrous cycle|MP:0009015,short proestrus|MP:0009017,prolonged estrus|MP:0009172,small pancreatic islets|MP:0009661,abnormal pregnancy|MP:0009754,enhanced behavioral response to cocaine|MP:0010080,abnormal hepatocyte physiology|MP:0011020,abnormal circadian temperature homeostasis|MP:0011021,abnormal circadian regulation of heart rate|MP:0011022,abnormal circadian regulation of systemic arterial blood pressure|MP:0013758,increased intestinal glucose absorption|MP:0014121,increased pancreatic islet cell apoptosis|MP:0014639,decreased sleep duration|MP:0020467,abnormal circadian behavior|MP:0020469,prolonged circadian behavior period|MP:0020471,abnormal circadian behavior persistence|MP:0020472,arrhythmic circadian behavior persistence|MP:0020473,abnormal circadian behavior phase|MP:0020477,abnormal locomotor circadian rhythm|MP:0020478,abnormal circadian sleep/wake cycle|MP:0030973,impaired gluconeogenesis
MGI:3652400	Clock<tm1.1Rep>	MP:0020473,abnormal circadian behavior phase|MP:0020474,advanced circadian behavior phase
MGI:4950926	Clock<tm1Jt>	MP:0002169,no abnormal phenotype detected
MGI:6759435	Clp1<em1Slac>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0009980,abnormal cerebellum dentate nucleus morphology|MP:0010053,decreased grip strength
MGI:6759437	Clp1<em2Slac>	MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:5554792	Clp1<tm1.1Pngr>	MP:0000136,abnormal microglial cell morphology|MP:0000162,lordosis|MP:0000433,microcephaly|MP:0000748,progressive muscle weakness|MP:0000753,paralysis|MP:0000774,decreased brain size|MP:0000819,abnormal olfactory bulb morphology|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001080,defasiculated phrenic nerve|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0001525,impaired balance|MP:0001953,respiratory failure|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002651,abnormal sciatic nerve morphology|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0003674,oxidative stress|MP:0003718,maternal effect|MP:0005386,behavior/neurological phenotype|MP:0005388,respiratory system phenotype|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0005498,hyporesponsive to tactile stimuli|MP:0005621,abnormal cell physiology|MP:0006254,thin cerebral cortex|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0008948,decreased neuron number|MP:0009417,skeletal muscle atrophy|MP:0009674,decreased birth weight|MP:0010768,mortality/aging|MP:0011087,neonatal lethality, complete penetrance|MP:0011400,lethality, complete penetrance|MP:0012055,abnormal phrenic nerve innervation pattern to diaphragm
MGI:5554923	Clp1<tm2.2Pngr>	MP:0011092,embryonic lethality, complete penetrance
MGI:3987403	Clpp<Gt(IST11134F10)Tigm>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001194,dermatitis|MP:0001258,decreased body length|MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0001828,abnormal T cell activation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0002083,premature death|MP:0002680,decreased corpora lutea number|MP:0002757,decreased vertical activity|MP:0005159,azoospermia|MP:0008008,early cellular replicative senescence|MP:0008868,abnormal granulosa cell morphology|MP:0010182,decreased susceptibility to weight gain|MP:0010954,abnormal cellular respiration|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011630,increased mitochondrial size|MP:0011636,disorganized mitochondrial cristae|MP:0011704,decreased fibroblast proliferation|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0013508,increased granulosa cell apoptosis|MP:0030937,increased mitochondrial DNA content
MGI:5178248	Clpp<Gt(IST13563G11)Tigm>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001194,dermatitis|MP:0001258,decreased body length|MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0001828,abnormal T cell activation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0002083,premature death|MP:0002680,decreased corpora lutea number|MP:0002757,decreased vertical activity|MP:0005159,azoospermia|MP:0008008,early cellular replicative senescence|MP:0008868,abnormal granulosa cell morphology|MP:0010182,decreased susceptibility to weight gain|MP:0010954,abnormal cellular respiration|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011630,increased mitochondrial size|MP:0011636,disorganized mitochondrial cristae|MP:0011704,decreased fibroblast proliferation|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0013504,increased embryonic tissue cell apoptosis|MP:0030937,increased mitochondrial DNA content
MGI:4820264	Clpp<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000745,tremors|MP:0001258,decreased body length|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002608,increased hematocrit|MP:0002965,increased circulating serum albumin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0003443,increased circulating glycerol level|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0003961,decreased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005014,increased B cell number|MP:0005178,increased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005560,decreased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0008040,decreased NK T cell number|MP:0008210,increased mature B cell number|MP:0008347,decreased gamma-delta T cell number|MP:0008810,increased circulating iron level|MP:0010024,increased total body fat amount|MP:0010025,decreased total body fat amount|MP:0010068,decreased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level|MP:0010124,decreased bone mineral content|MP:0010851,decreased effector memory CD8-positive, alpha-beta T cell number|MP:0012767,increased KLRG1-positive NK cell number|MP:0013022,increased Ly6C high monocyte number|MP:0013025,increased Ly6C low monocyte number|MP:0013513,decreased memory-marker CD4-negative NK T cell number|MP:0013519,decreased CD4-positive NK T cell number|MP:0013522,decreased memory-marker CD4-positive NK T cell number
MGI:7425595	Clpsl2<em1(IMPC)Bay>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0011964,increased total retina thickness
MGI:6361101	Clpsl2<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5696934	Clps<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:2660767	Clps<tm1Lowe>	MP:0000416,sparse hair|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001433,polyphagia|MP:0001510,abnormal coat appearance|MP:0002082,postnatal lethality|MP:0002644,decreased circulating triglyceride level|MP:0002791,steatorrhea|MP:0003743,abnormal facial morphology|MP:0003849,greasy coat|MP:0005178,increased circulating cholesterol level|MP:0005459,decreased percent body fat/body weight|MP:0008489,slow postnatal weight gain|MP:0030531,abnormal facial skin morphology
MGI:4450977	Clps<tm2.1Lowe>	MP:0000186,decreased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005378,growth/size/body region phenotype
MGI:7256882	Clptm1<em1(IMPC)Tcp>	MP:0000208,decreased hematocrit|MP:0000220,increased monocyte cell number|MP:0000702,enlarged lymph nodes|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001728,failure of embryo implantation|MP:0002060,abnormal skin morphology|MP:0002591,decreased mean corpuscular volume|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012058,abnormal morula morphology|MP:0013292,embryonic lethality prior to organogenesis
MGI:5817176	Clptm1l<em1(IMPC)J>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002574,increased vertical activity|MP:0002966,decreased circulating alkaline phosphatase level|MP:0009141,increased prepulse inhibition|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:6281109	Clptm1l<tm1d(EUCOMM)Wtsi>	MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype|MP:0008770,decreased survivor rate|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4419487	Clptm1<tm1a(KOMP)Wtsi>	MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002206,abnormal CNS synaptic transmission|MP:0003631,nervous system phenotype|MP:0004008,abnormal GABA-mediated receptor currents|MP:0005382,craniofacial phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0009939,abnormal hippocampus neuron morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0014384,increased miniature inhibitory postsynaptic current amplitude|MP:0031334,increased inhibitory postsynaptic current amplitude
MGI:7764843	Clptm1<tm1c(KOMP)Wtsi>	MP:0002206,abnormal CNS synaptic transmission|MP:0014384,increased miniature inhibitory postsynaptic current amplitude|MP:0020358,abnormal inhibitory synapse morphology
MGI:3835648	Clptq1<NZB/BlNJ>	MP:0000691,enlarged spleen|MP:0000709,enlarged thymus|MP:0008039,increased NK T cell number|MP:0008167,increased B-1a cell number
MGI:5707301	Clpx<tm1.1(KOMP)Vlcg>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:5582439	Clrn1<tm1.1(KOMP)Vlcg>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0001175,abnormal lung morphology|MP:0001486,abnormal startle reflex|MP:0002060,abnormal skin morphology|MP:0002098,abnormal vibrissa morphology|MP:0002135,abnormal kidney morphology|MP:0004738,abnormal auditory brainstem response
MGI:3850171	Clrn1<tm1.1Kuna>	MP:0000043,organ of Corti degeneration|MP:0001410,head bobbing|MP:0001525,impaired balance|MP:0001967,deafness|MP:0004397,absent cochlear inner hair cells|MP:0004403,absent cochlear outer hair cells|MP:0004414,decreased cochlear microphonics|MP:0004432,abnormal cochlear hair cell physiology|MP:0004438,abnormal vestibular hair cell physiology|MP:0004465,degeneration of organ of Corti supporting cells|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004737,absent distortion product otoacoustic emissions|MP:0004814,reduced linear vestibular evoked potential|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014740,increased auditory brainstem response wave peak latency|MP:0014741,decreased auditory brainstem response wave peak latency
MGI:6099051	Clrn1<tm1.1Ugpa>	MP:0001967,deafness|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004415,abnormal cochlear nerve compound action potential|MP:0004433,abnormal cochlear inner hair cell physiology|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004716,abnormal cochlear nerve morphology|MP:0004740,sensorineural hearing loss|MP:0004746,abnormal cochlear IHC afferent innervation pattern|MP:0006324,abnormal cochlear nerve fiber response|MP:0009538,abnormal synapse morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014406,increased or absent distortion product otoacoustic emission threshold|MP:0020359,abnormal ribbon synapse morphology|MP:0030950,abnormal synaptic vesicle exocytosis
MGI:6099052	Clrn1<tm1.2Ugpa>	MP:0001967,deafness|MP:0002857,cochlear ganglion degeneration|MP:0004433,abnormal cochlear inner hair cell physiology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004716,abnormal cochlear nerve morphology|MP:0004737,absent distortion product otoacoustic emissions|MP:0004746,abnormal cochlear IHC afferent innervation pattern|MP:0006324,abnormal cochlear nerve fiber response|MP:0009538,abnormal synapse morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0020359,abnormal ribbon synapse morphology|MP:0030950,abnormal synaptic vesicle exocytosis
MGI:5432130	Clrn1<tm2.1Kuna>	MP:0001967,deafness|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5912027	Clrn2<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0002574,increased vertical activity|MP:0003961,decreased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5792002	Clrn2<mpc169H>	MP:0000034,abnormal inner ear vestibule morphology|MP:0001967,deafness|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0004433,abnormal cochlear inner hair cell physiology|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004749,nonsyndromic hearing loss|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856823	cls	MP:0000416,sparse hair|MP:0000418,focal hair loss|MP:0001265,decreased body size|MP:0001510,abnormal coat appearance|MP:0002073,abnormal hair growth|MP:0002083,premature death|MP:0003815,hairless|MP:0003849,greasy coat|MP:0005387,immune system phenotype|MP:0009003,abnormal vibrissa number|MP:0011084,lethality at weaning, incomplete penetrance
MGI:6203617	Clspn<tm1.1Hmas>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5085611	Clspn<tm1(KOMP)Vlcg>	MP:0000321,increased bone marrow cell number|MP:0000477,abnormal intestine morphology|MP:0000688,lymphoid hyperplasia|MP:0001672,abnormal embryo development|MP:0001730,embryonic growth arrest|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002109,abnormal limb morphology|MP:0002981,increased liver weight|MP:0003718,maternal effect|MP:0003893,increased hepatocyte proliferation|MP:0004499,increased incidence of tumors by chemical induction|MP:0005014,increased B cell number|MP:0005165,increased susceptibility to injury|MP:0005389,reproductive system phenotype|MP:0005455,increased susceptibility to weight gain|MP:0005516,enhanced liver regeneration|MP:0008058,abnormal DNA repair|MP:0008976,delayed female fertility|MP:0009661,abnormal pregnancy|MP:0010308,decreased tumor latency|MP:0010767,abnormal female meiosis I arrest|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0014443,impaired polar body extrusion|MP:0031269,increased susceptibility to diet-induced hepatic steatosis|MP:0031271,increased susceptibility to age-related hepatic steatosis
MGI:5637427	Clstn1<tm1.1Uge>	MP:0002206,abnormal CNS synaptic transmission|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0002888,abnormal NMDA-mediated synaptic currents|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008143,abnormal dendrite morphology|MP:0009936,abnormal dendritic spine morphology|MP:0011273,prolonged excitatory postsynaptic current decay time|MP:0014379,decreased excitatory postsynaptic current frequency
MGI:5548714	Clstn1<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0002590,increased mean corpuscular volume|MP:0002606,increased basophil cell number|MP:0002608,increased hematocrit|MP:0010124,decreased bone mineral content
MGI:5766210	Clstn2<em1(IMPC)J>	MP:0002574,increased vertical activity
MGI:6093445	Clstn2<tm1Amcr>	MP:0008414,abnormal spatial reference memory|MP:0012307,impaired spatial learning|MP:0020358,abnormal inhibitory synapse morphology|MP:0031391,increased locomotor activity
MGI:5521290	Clstn3<tm1.1Amcr>	MP:0000812,abnormal dentate gyrus morphology|MP:0002912,abnormal excitatory postsynaptic potential|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0011151,abnormal hippocampus stratum radiatum morphology|MP:0014376,decreased miniature excitatory postsynaptic current frequency|MP:0014383,decreased miniature inhibitory postsynaptic current frequency
MGI:5548773	Clstn3<tm1b(EUCOMM)Hmgu>	MP:0000745,tremors|MP:0001175,abnormal lung morphology|MP:0001406,abnormal gait|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0002891,increased insulin sensitivity|MP:0003109,short femur|MP:0003917,increased kidney weight|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005371,limbs/digits/tail phenotype|MP:0005386,behavior/neurological phenotype|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0006086,decreased body mass index|MP:0008963,increased carbon dioxide production|MP:0009133,decreased white fat cell size|MP:0009136,decreased brown fat cell size|MP:0010962,decreased compact bone mass|MP:0014440,increased response to leptin|MP:0031008,decreased bone marrow adipose tissue amount
MGI:6449227	Clstn3<tm1c(EUCOMM)Hmgu>	MP:0005371,limbs/digits/tail phenotype|MP:0005378,growth/size/body region phenotype|MP:0006086,decreased body mass index|MP:0010962,decreased compact bone mass|MP:0031008,decreased bone marrow adipose tissue amount
MGI:7328974	Clta<tm1.2Fmb>	MP:0001405,impaired coordination|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002206,abnormal CNS synaptic transmission|MP:0003631,nervous system phenotype|MP:0003990,decreased neurotransmitter release|MP:0004770,abnormal synaptic vesicle recycling|MP:0004792,abnormal synaptic vesicle number|MP:0004816,abnormal class switch recombination|MP:0008178,decreased germinal center B cell number|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0014711,decreased synaptic vesicle readily releasable pool size
MGI:5312473	Cltb<tm1(KOMP)Vlcg>	MP:0003631,nervous system phenotype|MP:0004770,abnormal synaptic vesicle recycling|MP:0004792,abnormal synaptic vesicle number|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging|MP:0011269,increased excitatory postsynaptic current amplitude|MP:0014710,increased synaptic vesicle readily releasable pool size
MGI:3696995	Cltrn<tm1.1Pngr>	MP:0001762,polyuria|MP:0001764,abnormal homeostasis|MP:0008055,increased urine osmolality|MP:0011417,abnormal renal transport
MGI:3846424	Cltrn<tm1Thu>	MP:0001262,decreased body weight|MP:0001433,polyphagia|MP:0001762,polyuria|MP:0002106,abnormal muscle physiology|MP:0002575,increased circulating ketone body level|MP:0002891,increased insulin sensitivity|MP:0002988,decreased urine osmolality|MP:0003311,aminoaciduria|MP:0003978,decreased circulating carnitine level|MP:0005332,abnormal amino acid level|MP:0005459,decreased percent body fat/body weight|MP:0005633,increased circulating sodium level|MP:0006317,decreased urine sodium level|MP:0009643,abnormal urine homeostasis|MP:0009645,crystalluria|MP:0010958,abnormal tricarboxylic acid cycle|MP:0011467,decreased urine urea nitrogen level|MP:0013723,increased circulating tyrosine level|MP:0030644,increased circulating methionine level
MGI:5523142	Cluap1<tm1.2Hmd>	MP:0000929,open neural tube|MP:0004132,absent embryonic cilia|MP:0004133,heterotaxia|MP:0004188,delayed embryo turning|MP:0004252,abnormal direction of heart looping|MP:0010117,abnormal lateral plate mesoderm morphology|MP:0011068,abnormal ependyma motile cilium physiology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011998,decreased embryonic cilium length|MP:0012270,cardiac edema|MP:0013202,abnormal cilium morphology
MGI:4363468	Cluap1<tm1a(KOMP)Wtsi>	MP:0000291,enlarged pericardium|MP:0001265,decreased body size|MP:0001700,abnormal embryo turning|MP:0003400,kinked neural tube|MP:0004132,absent embryonic cilia|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6147533	Cluh<em1(IMPC)Ccpcz>	MP:0001404,no spontaneous movement|MP:0001510,abnormal coat appearance|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002753,dilated heart left ventricle|MP:0002997,enlarged seminal vesicle|MP:0004599,abnormal vertebral arch morphology|MP:0008259,abnormal optic disk morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013676,increased Ly6C-positive mature NK cell number
MGI:6119580	Cluh<tm1.1Eir>	MP:0000189,hypoglycemia|MP:0000609,abnormal liver physiology|MP:0001764,abnormal homeostasis|MP:0002941,increased circulating alanine transaminase level|MP:0005311,abnormal circulating amino acid level|MP:0005370,liver/biliary system phenotype|MP:0006042,increased apoptosis|MP:0009138,increased brown fat lipid droplet number|MP:0010954,abnormal cellular respiration|MP:0013278,decreased fasting circulating glucose level|MP:0014341,abnormal hepatocyte mitochondrial morphology|MP:0030644,increased circulating methionine level|MP:0030667,increased circulating proline level|MP:0030694,increased circulating serine level|MP:0030703,increased circulating threonine level|MP:0030718,increased circulating lysine level
MGI:6119581	Cluh<tm1.2Eir>	MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0001764,abnormal homeostasis|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0005388,respiratory system phenotype|MP:0009429,decreased embryo weight|MP:0010768,mortality/aging|MP:0010958,abnormal tricarboxylic acid cycle|MP:0011087,neonatal lethality, complete penetrance|MP:0011637,abnormal mitochondrial matrix morphology|MP:0013278,decreased fasting circulating glucose level|MP:0014341,abnormal hepatocyte mitochondrial morphology
MGI:5548920	Clu<tm1b(EUCOMM)Hmgu>	MP:0005655,increased aggression|MP:0013278,decreased fasting circulating glucose level
MGI:2181011	Clu<tm1Jakh>	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0000523,cortical renal glomerulopathies|MP:0001853,heart inflammation|MP:0001856,myocarditis|MP:0003631,nervous system phenotype|MP:0004567,decreased myocardial fiber number|MP:0005140,decreased cardiac muscle contractility|MP:0005161,hematuria|MP:0005294,abnormal heart ventricle morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0011320,abnormal glomerular capillary morphology|MP:0011338,abnormal mesangial matrix morphology|MP:0011339,abnormal glomerular mesangium morphology|MP:0011353,expanded mesangial matrix|MP:0011377,renal glomerulus fibrosis|MP:0011427,increased mesangial cell number|MP:0012270,cardiac edema|MP:0020518,renal glomerular protein deposits|MP:0020519,renal glomerular immunoglobulin deposits
MGI:5554864	Clvs1<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0003019,increased circulating chloride level|MP:0003064,decreased coping response|MP:0013278,decreased fasting circulating glucose level
MGI:6356861	Clxn<tm1.1Osb>	MP:0001625,cardiac hypertrophy|MP:0001706,abnormal left-right axis patterning|MP:0001891,hydrocephaly|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0002766,situs inversus|MP:0004131,abnormal motile primary cilium morphology|MP:0004132,absent embryonic cilia|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0008535,enlarged lateral ventricles|MP:0008933,abnormal motile primary cilium physiology|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011069,abnormal brain ependyma motile cilium physiology|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011380,enlarged brain ventricles|MP:0013197,decreased embryonic cilium number
MGI:5812313	Clybl<tm1b(EUCOMM)Hmgu>	MP:0005419,decreased circulating serum albumin level
MGI:1861106	Cm	MP:0001262,decreased body weight|MP:0001290,delayed eyelid opening|MP:0001292,abnormal lens vesicle development|MP:0001297,microphthalmia|MP:0001299,abnormal eye distance/ position|MP:0001307,fused cornea and lens|MP:0001312,abnormal cornea morphology|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0001473,reduced long-term potentiation|MP:0001504,abnormal posture|MP:0001510,abnormal coat appearance|MP:0001906,increased dopamine level|MP:0001914,hemorrhage|MP:0002092,abnormal eye morphology|MP:0002428,abnormal semicircular canal morphology|MP:0002622,abnormal cochlear hair cell morphology|MP:0002730,head shaking|MP:0002794,lenticonus|MP:0002804,abnormal motor learning|MP:0002922,decreased post-tetanic potentiation|MP:0003237,abnormal lens epithelium morphology|MP:0003631,nervous system phenotype|MP:0004395,increased cochlear inner hair cell number|MP:0004401,increased cochlear outer hair cell number|MP:0004402,decreased cochlear outer hair cell number|MP:0004807,abnormal paired-pulse inhibition|MP:0004994,abnormal brain wave pattern|MP:0005098,abnormal optic choroid morphology|MP:0005176,eyelids fail to open|MP:0005262,coloboma|MP:0005307,head tossing|MP:0005386,behavior/neurological phenotype|MP:0005447,abnormal synaptic norepinephrine release|MP:0008911,induced hyperactivity|MP:0009745,abnormal behavioral response to xenobiotic|MP:0009748,abnormal behavioral response to addictive substance|MP:0010053,decreased grip strength|MP:0010714,iris coloboma|MP:0010718,choroid coloboma|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0031391,increased locomotor activity|MP:0031432,cornea perforation
MGI:3581753	Cma1<tm1Mfg>	MP:0002423,abnormal mast cell physiology
MGI:7519109	Cmah<em1(IMPC)Hmgu>	MP:0002966,decreased circulating alkaline phosphatase level|MP:0005568,increased circulating total protein level
MGI:3711330	Cmah<tm1Ykoz>	MP:0000026,abnormal inner ear morphology|MP:0000042,abnormal organ of Corti morphology|MP:0001405,impaired coordination|MP:0001486,abnormal startle reflex|MP:0001792,impaired wound healing|MP:0001800,abnormal humoral immune response|MP:0002083,premature death|MP:0002428,abnormal semicircular canal morphology|MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0002574,increased vertical activity|MP:0002634,abnormal sensorimotor gating|MP:0004404,cochlear outer hair cell degeneration|MP:0005154,increased B cell proliferation|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0006325,impaired hearing|MP:0008499,increased IgG1 level|MP:0008567,decreased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion
MGI:6361234	Cmas<em1(IMPC)Hmgu>	MP:0001406,abnormal gait|MP:0011100,preweaning lethality, complete penetrance
MGI:6281180	Cmas<tm1.1Bwei>	MP:0001263,weight loss|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002704,tubular nephritis|MP:0002962,increased urine protein level|MP:0003670,dilated renal glomerular capsule|MP:0003985,renal fibrosis|MP:0005264,glomerulosclerosis|MP:0005556,abnormal renal filtration rate|MP:0008060,abnormal podocyte slit diaphragm morphology|MP:0008061,absent podocyte slit diaphragm|MP:0008139,fused podocyte foot processes|MP:0008140,podocyte foot process effacement|MP:0011353,expanded mesangial matrix|MP:0011427,increased mesangial cell number|MP:0011483,renal glomerular synechia|MP:0011509,dilated glomerular capillary|MP:0011868,podocyte microvillus transformation
MGI:3522316	Cmcs<CBA/N>	MP:0001790,abnormal immune system physiology
MGI:3522315	Cmcs<DBA/2>	MP:0001790,abnormal immune system physiology
MGI:6827378	Cmip<tm1.1Ics>	MP:0005367,renal/urinary system phenotype
MGI:5286409	Cmip<tm1a(EUCOMM)Wtsi>	MP:0000489,abnormal large intestine morphology|MP:0000496,abnormal small intestine morphology|MP:0001879,abnormal lymphatic vessel morphology|MP:0002169,no abnormal phenotype detected|MP:0002951,small thyroid gland|MP:0003262,intestinal/bowel diverticulum|MP:0003826,abnormal Mullerian duct morphology|MP:0004160,retroesophageal right subclavian artery|MP:0009820,abnormal liver vasculature morphology|MP:0010420,muscular ventricular septal defect|MP:0011100,preweaning lethality, complete penetrance|MP:0011683,dual inferior vena cava|MP:0013834,thin hypoglossal nerve|MP:0013835,absent hypoglossal nerve|MP:0013840,absent segment of posterior cerebral artery|MP:0013963,jugular vein stenosis|MP:0013968,multiple persisting craniopharyngeal ducts|MP:0013975,abnormal coronary sinus connection|MP:0013986,abnormal vitelline vein topology|MP:0014001,abnormal vertebral artery topology|MP:0014018,embryo tumor|MP:0014019,embryo cyst|MP:0020500,persistent trigeminal artery
MGI:4430512	Cmklr1<tm1Dgen>	MP:0000219,increased neutrophil cell number|MP:0000685,abnormal immune system morphology|MP:0001861,lung inflammation|MP:0002123,abnormal definitive hematopoiesis|MP:0002376,abnormal dendritic cell physiology|MP:0002452,abnormal professional antigen presenting cell physiology|MP:0008245,abnormal alveolar macrophage morphology|MP:0008735,increased susceptibility to endotoxin shock|MP:0010760,abnormal macrophage chemotaxis
MGI:3785491	Cmklr1<tm1Drg>	MP:0003799,impaired macrophage chemotaxis|MP:0008719,impaired neutrophil recruitment
MGI:6360463	Cmklr2<tm1.1Dgen>	MP:0000182,increased circulating LDL cholesterol level|MP:0001260,increased body weight|MP:0005182,increased circulating estradiol level|MP:0009118,increased white fat cell size|MP:0009133,decreased white fat cell size|MP:0009136,decreased brown fat cell size|MP:0010182,decreased susceptibility to weight gain
MGI:5692662	Cmpk1<tm1b(EUCOMM)Wtsi>	MP:0002792,abnormal retina vasculature morphology|MP:0008528,polycystic kidney|MP:0008810,increased circulating iron level|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5692924	Cmpk2<tm1b(KOMP)Wtsi>	MP:0001402,decreased locomotor activity|MP:0002590,increased mean corpuscular volume|MP:0005178,increased circulating cholesterol level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:2155782	Cms1<DBA/2J>	MP:0005398,decreased susceptibility to fungal infection
MGI:2156519	Cms2<DBA/2J>	MP:0002409,decreased susceptibility to infection
MGI:6358810	Cmtm1<em1Osb>	MP:0005389,reproductive system phenotype
MGI:7511808	Cmtm3<em1Wlh>	MP:0000274,enlarged heart|MP:0001625,cardiac hypertrophy|MP:0003953,abnormal hormone level|MP:0004485,increased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005599,increased cardiac muscle contractility|MP:0010633,myocardium hypertrophy|MP:0010724,thick interventricular septum|MP:0011632,dilated mitochondrion|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0021157,increased heart left ventricle wall thickness|MP:0021161,increased heart left ventricle posterior wall thickness|MP:0031131,myocardial fiber disarray
MGI:6457028	Cmtm4<em1Wlh>	MP:0001922,reduced male fertility|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0009230,abnormal sperm head morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0020451,decreased sperm progressive motility
MGI:7442597	Cmtm4<tm1d(EUCOMM)Wtsi>	MP:0001876,decreased inflammatory response|MP:0003453,abnormal keratinocyte physiology|MP:0005014,increased B cell number|MP:0005387,immune system phenotype|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0012573,decreased susceptibility to chemically induced skin inflammation|MP:0020414,abnormal fibroblast physiology
MGI:7330365	Cmtm5<tm1c(KOMP)Wtsi>	MP:0003354,astrocytosis|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0008918,microgliosis|MP:0010748,abnormal visual evoked potential
MGI:7330369	Cmtm5<tm1d(KOMP)Wtsi>	MP:0005404,abnormal axon morphology
MGI:6511038	Cmtm6<tm1c(EUCOMM)Wtsi>	MP:0001406,abnormal gait|MP:0003631,nervous system phenotype|MP:0003998,decreased thermal nociceptive threshold|MP:0005402,abnormal action potential|MP:0005404,abnormal axon morphology|MP:0005572,abnormal pulmonary respiratory rate|MP:0011994,increased nerve conduction velocity
MGI:6407420	Cmtm7<em1(IMPC)J>	MP:0002968,increased circulating alkaline phosphatase level
MGI:5511805	Cmtm7<tm2a(EUCOMM)Hmgu>	MP:0011087,neonatal lethality, complete penetrance
MGI:6258596	Cmtr1<em1(IMPC)J>	MP:0002833,increased heart weight|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5444975	Cmtr1<tm1a(EUCOMM)Hmgu>	MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:6502647	Cmtr1<tm1c(EUCOMM)Hmgu>	MP:0008143,abnormal dendrite morphology|MP:0020069,decreased neocortex size|MP:0020912,abnormal susceptibility to Riboviria infection
MGI:5708242	Cmtr2<tm1.1(KOMP)Vlcg>	MP:0001700,abnormal embryo turning|MP:0002833,increased heart weight|MP:0003960,increased lean body mass|MP:0003984,embryonic growth retardation|MP:0005554,decreased circulating creatinine level|MP:0010025,decreased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:3849165	cmy1	MP:0002795,dilated cardiomyopathy|MP:0003921,abnormal heart left ventricle morphology|MP:0005140,decreased cardiac muscle contractility
MGI:3849169	cmy2	MP:0002795,dilated cardiomyopathy|MP:0003921,abnormal heart left ventricle morphology|MP:0005140,decreased cardiac muscle contractility
MGI:6209671	Cmya5<em1(IMPC)J>	MP:0002626,increased heart rate|MP:0010507,shortened RR interval
MGI:7261228	Cmya5<tm1Cap>	MP:0000849,abnormal cerebellum morphology|MP:0001489,decreased startle reflex|MP:0002797,increased thigmotaxis|MP:0002953,thick ventricular wall|MP:0003081,abnormal soleus morphology|MP:0003082,abnormal gastrocnemius morphology|MP:0003140,dilated heart atrium|MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0004089,dilated sarcoplasmic reticulum|MP:0005386,behavior/neurological phenotype|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006267,abnormal intercalated disk morphology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008725,increased heart atrium size|MP:0008842,lipofuscinosis|MP:0009141,increased prepulse inhibition|MP:0009710,anhedonia|MP:0010069,increased serotonin level|MP:0010630,abnormal cardiac muscle tissue morphology|MP:0011749,perivascular fibrosis|MP:0020396,abnormal social recognition|MP:0020874,abnormal nervous system dopamine level
MGI:5582743	Cnbd2<tm1Dwac>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0002674,abnormal sperm motility|MP:0004850,abnormal testis weight|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0009831,abnormal sperm midpiece morphology|MP:0013209,abnormal motile cilium physiology
MGI:3640662	Cnbp<m1Hrb>	MP:0001293,anophthalmia|MP:0001698,decreased embryo size|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004388,absent prechordal plate|MP:0004592,small mandible|MP:0008533,abnormal anterior visceral endoderm morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011257,abnormal head fold morphology|MP:0011259,abnormal cephalic neural fold morphology|MP:0012138,decreased forebrain size|MP:0012157,rostral body truncation|MP:0012517,absent diencephalon|MP:0012683,absent telencephalon|MP:0012706,decreased embryonic neuroepithelial cell proliferation|MP:0013185,absent anterior definitive endoderm|MP:0013505,decreased embryonic tissue cell apoptosis
MGI:5645124	Cnbp<tm1b(KOMP)Wtsi>	MP:0001697,abnormal embryo size|MP:0003019,increased circulating chloride level|MP:0003984,embryonic growth retardation|MP:0005419,decreased circulating serum albumin level|MP:0005566,decreased blood urea nitrogen level|MP:0005627,increased circulating potassium level|MP:0011100,preweaning lethality, complete penetrance
MGI:6152443	Cndp2<em1(IMPC)Mbp>	MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000702,enlarged lymph nodes|MP:0001146,abnormal testis morphology|MP:0001293,anophthalmia|MP:0001488,increased startle reflex|MP:0001944,abnormal pancreas morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology
MGI:6209668	Cnep1r1<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0002080,prenatal lethality|MP:0003961,decreased lean body mass|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:7512904	Cnga1<em1(IMPC)Bay>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0011965,decreased total retina thickness
MGI:7434652	Cnga1<m1Mhda>	MP:0001326,retina degeneration|MP:0002001,blindness|MP:0002792,abnormal retina vasculature morphology|MP:0002864,abnormal ocular fundus morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0008444,retina cone cell degeneration|MP:0008451,retina rod cell degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0008580,photoreceptor inner segment degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0010097,abnormal retina blood vessel morphology|MP:0012029,abnormal electroretinogram waveform feature|MP:0012144,decreased b-wave amplitude|MP:0014658,absent a-wave
MGI:6725108	Cnga2<tm1.1Kob>	MP:0001764,abnormal homeostasis|MP:0003462,abnormal response to novel odor
MGI:2159208	Cnga2<tm1Gvr>	MP:0000819,abnormal olfactory bulb morphology|MP:0001473,reduced long-term potentiation|MP:0002741,small olfactory bulb|MP:0002922,decreased post-tetanic potentiation|MP:0005236,abnormal olfactory nerve morphology|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2159016	Cnga2<tm1Mom>	MP:0001732,postnatal growth retardation|MP:0001983,abnormal olfactory system physiology|MP:0004811,abnormal neuron physiology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1861912	Cnga2<tm1Ngai>	MP:0001983,abnormal olfactory system physiology|MP:0001984,abnormal olfaction|MP:0004512,anosmia|MP:0011085,postnatal lethality, complete penetrance
MGI:3525590	Cnga2<tm1Reed>	MP:0001983,abnormal olfactory system physiology|MP:0003631,nervous system phenotype|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0010055,abnormal sensory neuron physiology
MGI:3525599	Cnga2<tm2Reed>	MP:0001983,abnormal olfactory system physiology|MP:0003631,nervous system phenotype|MP:0010055,abnormal sensory neuron physiology
MGI:3608770	Cnga3<cpfl5>	MP:0001006,abnormal retina cone cell morphology|MP:0004022,abnormal cone electrophysiology|MP:0006149,decreased visual acuity|MP:0008444,retina cone cell degeneration|MP:0008449,abnormal retina cone cell outer segment morphology|MP:0008584,photoreceptor outer segment degeneration|MP:0011831,abnormal visual contrast sensitivity|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:7861929	Cnga3<em1Eye>	MP:0005391,vision/eye phenotype
MGI:5695897	Cnga3<tm1.1(KOMP)Vlcg>	MP:0000691,enlarged spleen|MP:0001258,decreased body length|MP:0002135,abnormal kidney morphology|MP:0002941,increased circulating alanine transaminase level|MP:0004906,enlarged uterus|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2388388	Cnga3<tm1Biel>	MP:0001327,decreased retina photoreceptor cell number|MP:0001983,abnormal olfactory system physiology|MP:0005253,abnormal eye physiology|MP:0005551,abnormal eye electrophysiology|MP:0008449,abnormal retina cone cell outer segment morphology|MP:0009943,abnormal olfactory bulb periglomerular cell morphology
MGI:7861930	Cnga3<tm1Eye>	MP:0005391,vision/eye phenotype
MGI:2680015	Cnga4<tm1Reed>	MP:0001983,abnormal olfactory system physiology|MP:0005394,taste/olfaction phenotype|MP:0009562,abnormal odor adaptation
MGI:6113885	Cngb1<m1Btlr>	MP:0005201,abnormal retina pigment epithelium morphology|MP:0008515,thin retina outer nuclear layer|MP:0011965,decreased total retina thickness
MGI:3527896	Cngb1<tm1.1Biel>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001327,decreased retina photoreceptor cell number|MP:0002082,postnatal lethality|MP:0004021,abnormal rod electrophysiology|MP:0006068,abnormal retina horizontal cell morphology|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0008450,retina photoreceptor degeneration|MP:0014336,short retina rod cell outer segment
MGI:4878880	Cngb1<tm1.1Glf>	MP:0004021,abnormal rod electrophysiology|MP:0005391,vision/eye phenotype
MGI:3834618	Cngb1<tm1Hazh>	MP:0003463,abnormal single cell response|MP:0004811,abnormal neuron physiology|MP:0005394,taste/olfaction phenotype|MP:0005402,abnormal action potential
MGI:3851598	Cngb1<tm1Sjpi>	MP:0001005,abnormal retina rod cell morphology|MP:0004021,abnormal rod electrophysiology|MP:0005378,growth/size/body region phenotype|MP:0008450,retina photoreceptor degeneration|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0014336,short retina rod cell outer segment
MGI:6274478	Cngb3<cpfl10>	MP:0004022,abnormal cone electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008446,decreased retina cone cell number
MGI:7425596	Cngb3<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002311,abnormal inspiratory capacity|MP:0002339,abnormal lymph node morphology|MP:0002953,thick ventricular wall|MP:0010895,increased lung compliance|MP:0011045,decreased lung elastance
MGI:4367989	Cngb3<tm1Dgen>	MP:0004022,abnormal cone electrophysiology|MP:0005253,abnormal eye physiology|MP:0008444,retina cone cell degeneration|MP:0008446,decreased retina cone cell number|MP:0008449,abnormal retina cone cell outer segment morphology|MP:0008586,disorganized photoreceptor outer segment|MP:0014333,short retina cone cell outer segment|MP:0030005,increased retina apoptosis
MGI:4245251	Cnih1<Gt(OST237199)Lex>	MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0003961,decreased lean body mass
MGI:5513017	Cnih2<tm1.1Ran>	MP:0002169,no abnormal phenotype detected|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0011003,reduced AMPA-mediated synaptic currents
MGI:5635040	Cnih2<tm1b(KOMP)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002574,increased vertical activity|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure
MGI:5513018	Cnih3<tm1.1Ran>	MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype
MGI:5692513	Cnih4<tm1a(EUCOMM)Hmgu>	MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia
MGI:5763463	Cnksr2<em1(IMPC)J>	MP:0001415,increased exploration in new environment|MP:0003795,abnormal bone structure|MP:0005293,impaired glucose tolerance
MGI:2386777	Cnmd<tm1Ref>	MP:0002169,no abnormal phenotype detected
MGI:2448465	Cnmd<tm1Ska>	MP:0000062,increased bone mineral density|MP:0000064,failure of bone resorption|MP:0001533,abnormal skeleton physiology|MP:0001541,abnormal osteoclast physiology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005006,abnormal osteoblast physiology|MP:0008271,abnormal bone ossification|MP:0010878,increased trabecular bone volume|MP:0020011,increased bone mineral density of femur
MGI:5463909	Cnn1<tm1.1Jomm>	MP:0011100,preweaning lethality, complete penetrance
MGI:2181445	Cnn1<tm1Tkhi>	MP:0000164,abnormal cartilage development|MP:0002968,increased circulating alkaline phosphatase level|MP:0002999,abnormal bone healing|MP:0003416,premature bone ossification|MP:0004988,increased osteoblast cell number|MP:0008151,increased diameter of long bones|MP:0008158,increased diameter of femur|MP:0011710,enhanced osteoblast differentiation|MP:0014167,ectopic bone
MGI:3820423	Cnn2<tm1.2Jin>	MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000321,increased bone marrow cell number|MP:0000334,decreased granulocyte number|MP:0000716,abnormal immune system cell morphology|MP:0002451,abnormal macrophage physiology|MP:0002724,enhanced wound healing|MP:0005387,immune system phenotype|MP:0005425,increased macrophage cell number|MP:0010760,abnormal macrophage chemotaxis
MGI:3820421	Cnn2<tm1Jin>	MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0005387,immune system phenotype
MGI:5825453	Cnn3<tm1.1Hjum>	MP:0005387,immune system phenotype
MGI:5825459	Cnn3<tm1.2Hjum>	MP:0000914,exencephaly|MP:0003861,abnormal nervous system development|MP:0011087,neonatal lethality, complete penetrance
MGI:6690510	Cnnm2<tm1.1Hmik>	MP:0001764,abnormal homeostasis|MP:0006263,decreased systemic arterial diastolic blood pressure|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0010093,decreased circulating magnesium level|MP:0010768,mortality/aging|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5692792	Cnnm2<tm1.1(KOMP)Vlcg>	MP:0000062,increased bone mineral density|MP:0000433,microcephaly|MP:0000914,exencephaly|MP:0001297,microphthalmia|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003054,spina bifida|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0011496,abnormal head size
MGI:6690509	Cnnm2<tm1Hmik>	MP:0005378,growth/size/body region phenotype|MP:0006263,decreased systemic arterial diastolic blood pressure|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0010093,decreased circulating magnesium level|MP:0010768,mortality/aging
MGI:4432730	Cnnm4<tm1a(EUCOMM)Wtsi>	MP:0002100,abnormal tooth morphology|MP:0002576,abnormal enamel morphology|MP:0003868,abnormal feces composition|MP:0005391,vision/eye phenotype|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010093,decreased circulating magnesium level|MP:0011436,decreased urine magnesium level|MP:0013129,abnormal tooth color|MP:0030450,abnormal enamel mineralization
MGI:6144058	Cnnm4<tm1b(EUCOMM)Wtsi>	MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0010093,decreased circulating magnesium level
MGI:5907612	Cnot10<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0003984,embryonic growth retardation|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:6151143	Cnot1<tm1Tya>	MP:0003233,prolonged QT interval|MP:0005140,decreased cardiac muscle contractility|MP:0010632,cardiac muscle necrosis|MP:0011085,postnatal lethality, complete penetrance
MGI:6156125	Cnot3<em1(IMPC)Rbrc>	MP:0000063,decreased bone mineral density|MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000598,abnormal liver morphology|MP:0001120,abnormal uterus morphology|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0002135,abnormal kidney morphology|MP:0002797,increased thigmotaxis|MP:0003036,vertebral transformation|MP:0004599,abnormal vertebral arch morphology|MP:0004924,abnormal behavior|MP:0005292,improved glucose tolerance|MP:0009198,abnormal male genitalia morphology|MP:0009204,absent external male genitalia|MP:0009709,hydrometra|MP:0010124,decreased bone mineral content
MGI:6151142	Cnot3<tm1.1Kjkb>	MP:0000274,enlarged heart|MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0003233,prolonged QT interval|MP:0004567,decreased myocardial fiber number|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0005369,muscle phenotype|MP:0006138,congestive heart failure|MP:0010632,cardiac muscle necrosis
MGI:5607530	Cnot3<tm1.1Tya>	MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000601,small liver|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002113,abnormal skeleton development|MP:0002644,decreased circulating triglyceride level|MP:0002891,increased insulin sensitivity|MP:0002896,abnormal bone mineralization|MP:0004984,increased osteoclast cell number|MP:0004992,increased bone resorption|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005459,decreased percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008396,abnormal osteoclast differentiation|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009133,decreased white fat cell size|MP:0009136,decreased brown fat cell size|MP:0009346,decreased trabecular bone thickness|MP:0009703,decreased birth body size|MP:0010869,decreased bone trabecula number|MP:0010873,decreased trabecular bone mass|MP:0011092,embryonic lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level|MP:0014143,decreased body fat mass|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:4881781	Cnot3<tm1Pngr>	MP:0000266,abnormal heart morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002718,abnormal inner cell mass morphology|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003824,decreased left ventricle developed pressure|MP:0005140,decreased cardiac muscle contractility|MP:0010579,increased heart left ventricle size|MP:0011093,embryonic lethality at implantation, complete penetrance|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5636993	Cnot4<tm1b(EUCOMM)Wtsi>	MP:0001258,decreased body length|MP:0001711,abnormal placenta morphology|MP:0002836,abnormal chorion morphology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012768,decreased KLRG1-positive NK cell number|MP:0013406,abnormal epidermal immune compartment
MGI:6725736	Cnot4<tm1d(EUCOMM)Wtsi>	MP:0011092,embryonic lethality, complete penetrance
MGI:6306636	Cnot6l<tm1Tya>	MP:0000188,abnormal circulating glucose level|MP:0001560,abnormal circulating insulin level|MP:0001764,abnormal homeostasis|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0002575,increased circulating ketone body level|MP:0003402,decreased liver weight|MP:0003949,abnormal circulating lipid level|MP:0003960,increased lean body mass|MP:0005289,increased oxygen consumption|MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008965,increased basal metabolism|MP:0009136,decreased brown fat cell size|MP:0010379,decreased respiratory quotient|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:6695889	Cnot6<tm1.2Tya>	MP:0002169,no abnormal phenotype detected
MGI:4451305	Cnot6<tm1a(KOMP)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6156126	Cnot7<em1(IMPC)Rbrc>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001925,male infertility|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003960,increased lean body mass|MP:0004924,abnormal behavior|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010123,increased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:3050544	Cnot7<tm1Jpr>	MP:0001146,abnormal testis morphology|MP:0001152,increased Leydig cell number|MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001925,male infertility|MP:0001929,abnormal gametogenesis|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005250,decreased Sertoli cell number|MP:0006362,abnormal male germ cell morphology
MGI:3044887	Cnot7<tm1Tno>	MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0014052,increased male germ cell apoptosis|MP:0014636,decreased elongated spermatid number|MP:0020550,multinucleated giant male germ cells
MGI:6695887	Cnot8<tm1.2Tya>	MP:0011092,embryonic lethality, complete penetrance
MGI:5296377	Cnot9<m1Tc>	MP:0001785,edema|MP:0002152,abnormal brain morphology|MP:0003632,abnormal nervous system morphology|MP:0004073,caudal body truncation
MGI:5704517	Cnppd1<tm1.1(KOMP)Vlcg>	MP:0000218,increased leukocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin
MGI:6120815	Cnp<tm1b(EUCOMM)Wtsi>	MP:0001402,decreased locomotor activity|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:3051635	Cnp<tm1(cre)Kan>	MP:0000160,kyphosis|MP:0000747,muscle weakness|MP:0000755,hindlimb paralysis|MP:0000947,convulsive seizures|MP:0001263,weight loss|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0002183,gliosis|MP:0005405,axon degeneration|MP:0012674,tomacula|MP:0013438,dysmyelination
MGI:4419843	Cnpy1<tm1(KOMP)Wtsi>	MP:0005419,decreased circulating serum albumin level
MGI:6153309	Cnpy2<em1(IMPC)Wtsi>	MP:0000137,abnormal vertebrae morphology|MP:0000438,abnormal cranium morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001404,no spontaneous movement|MP:0002092,abnormal eye morphology|MP:0002932,abnormal joint morphology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0013772,increased effector memory T-helper cell number
MGI:6355915	Cnpy2<tm1.2Zhli>	MP:0001265,decreased body size|MP:0002310,decreased susceptibility to hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002942,decreased circulating alanine transaminase level|MP:0005370,liver/biliary system phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008944,decreased sensitivity to induced cell death|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis|MP:0031601,decreased endoplasmic reticulum stress
MGI:3767622	Cnpy3<tm1Kmiy>	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002451,abnormal macrophage physiology|MP:0003945,abnormal lymphocyte physiology|MP:0008561,decreased tumor necrosis factor secretion|MP:0008706,decreased interleukin-6 secretion|MP:0011086,postnatal lethality, incomplete penetrance
MGI:7425598	Cnpy4<em1(IMPC)Ccpcz>	MP:0001297,microphthalmia|MP:0001891,hydrocephaly|MP:0002092,abnormal eye morphology|MP:0002152,abnormal brain morphology
MGI:5286685	Cnpy4<Tg(Tyr)2356C-2a1Ove>	MP:0001925,male infertility
MGI:5582419	Cnr1<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001785,edema|MP:0002060,abnormal skin morphology|MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020870,decreased thigmotaxis
MGI:5607776	Cnr1<tm1.1Kpm>	MP:0000788,abnormal cerebral cortex morphology|MP:0001981,increased chemically-elicited antinociception|MP:0004811,abnormal neuron physiology|MP:0004859,abnormal synaptic plasticity|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009775,increased behavioral withdrawal response
MGI:2182924	Cnr1<tm1.1Ltz>	MP:0001417,decreased exploration in new environment|MP:0001899,absent long-term depression|MP:0002063,abnormal learning/memory/conditioning|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002918,abnormal paired-pulse facilitation|MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype|MP:0003632,abnormal nervous system morphology|MP:0003861,abnormal nervous system development|MP:0005386,behavior/neurological phenotype|MP:0009450,abnormal axon fasciculation|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:5435598	Cnr1<tm1.1Pcn>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0011082,abnormal gastrointestinal motility
MGI:3045419	Cnr1<tm1.2Ltz>	MP:0000788,abnormal cerebral cortex morphology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003461,abnormal response to novel object|MP:0003861,abnormal nervous system development|MP:0005386,behavior/neurological phenotype|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0009450,abnormal axon fasciculation|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010698,abnormal impulsive behavior control
MGI:3831701	Cnr1<tm1Dgen>	MP:0001475,reduced long-term depression|MP:0003631,nervous system phenotype|MP:0009747,impaired behavioral response to xenobiotic
MGI:5429061	Cnr1<tm1Lex>	MP:0005459,decreased percent body fat/body weight
MGI:1857736	Cnr1<tm1Map>	MP:0000062,increased bone mineral density|MP:0001353,increased aggression towards mice|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001748,increased circulating adrenocorticotropin level|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002798,abnormal active avoidance behavior|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003008,enhanced long-term potentiation|MP:0003076,increased susceptibility to ischemic brain injury|MP:0003360,abnormal depression-related behavior|MP:0003461,abnormal response to novel object|MP:0003633,abnormal nervous system physiology|MP:0004209,abnormal sweet taste sensitivity|MP:0004948,abnormal neuronal precursor proliferation|MP:0005390,skeleton phenotype|MP:0006060,increased cerebral infarct size|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009710,anhedonia|MP:0009712,impaired conditioned place preference behavior|MP:0009750,impaired behavioral response to addictive substance|MP:0009757,impaired behavioral response to morphine|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010119,abnormal bone mineral density|MP:0031391,increased locomotor activity|MP:0031426,increased sperm motility
MGI:3505551	Cnr1<tm1Ojm>	MP:0001262,decreased body weight|MP:0001899,absent long-term depression|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0002912,abnormal excitatory postsynaptic potential|MP:0005449,abnormal food intake|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0010025,decreased total body fat amount|MP:0014440,increased response to leptin
MGI:1857762	Cnr1<tm1Zim>	MP:0001402,decreased locomotor activity|MP:0001745,increased circulating corticosterone level|MP:0001973,increased thermal nociceptive threshold|MP:0002083,premature death|MP:0002757,decreased vertical activity|MP:0002822,catalepsy|MP:0003043,hypoalgesia|MP:0003718,maternal effect|MP:0005131,increased follicle stimulating hormone level|MP:0005182,increased circulating estradiol level|MP:0005185,decreased circulating progesterone level|MP:0008531,increased chemical nociceptive threshold|MP:0008770,decreased survivor rate|MP:0009750,impaired behavioral response to addictive substance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012009,early parturition
MGI:5523994	Cnr1<tm2.1Ltz>	MP:0002169,no abnormal phenotype detected
MGI:5523992	Cnr1<tm2Ltz>	MP:0001363,increased anxiety-related response|MP:0001454,abnormal cued conditioning behavior|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002917,decreased synaptic depression|MP:0009456,impaired cued conditioning behavior|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:6423856	Cnr2<em1(IMPC)Mbp>	MP:0000494,abnormal cecum morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0009476,enlarged cecum|MP:0010123,increased bone mineral content
MGI:3604531	Cnr2<tm1Dgen>	MP:0000414,alopecia
MGI:2181023	Cnr2<tm1Zim>	MP:0002451,abnormal macrophage physiology|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype
MGI:6152444	Cnrip1<em1(IMPC)Mbp>	MP:0001417,decreased exploration in new environment|MP:0005407,hyperalgesia
MGI:6455146	Cntd1<em1Atot>	MP:0001930,abnormal meiosis
MGI:6152445	Cntd1<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility
MGI:6455147	Cntd1<em2Atot>	MP:0001930,abnormal meiosis
MGI:6161819	Cntd1<tm1e.1(KOMP)Wtsi>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0006379,abnormal spermatocyte morphology|MP:0014633,decreased spermatid number
MGI:5512674	Cntfr<tm1.1Lex>	MP:0000939,decreased motor neuron number|MP:0011089,perinatal lethality, complete penetrance
MGI:4433013	Cntfr<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:2181046	Cntfr<tm1Gdy>	MP:0000910,small facial motor nucleus|MP:0000912,small trigeminal motor nucleus|MP:0000937,abnormal motor neuron morphology|MP:0000939,decreased motor neuron number|MP:0001435,absent suckling reflex|MP:0011087,neonatal lethality, complete penetrance
MGI:3528869	Cntfr<tm1Lex>	MP:0000939,decreased motor neuron number|MP:0003631,nervous system phenotype
MGI:2181048	Cntf<tm1Gdy>	MP:0000937,abnormal motor neuron morphology|MP:0003631,nervous system phenotype
MGI:1857773	Cntf<tm1Mpin>	MP:0000136,abnormal microglial cell morphology|MP:0000747,muscle weakness|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0000954,decreased oligodendrocyte progenitor number|MP:0003631,nervous system phenotype|MP:0003651,abnormal axon extension|MP:0003871,abnormal myelin sheath morphology|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005165,increased susceptibility to injury|MP:0005405,axon degeneration|MP:0008916,abnormal astrocyte physiology|MP:0010053,decreased grip strength|MP:0010205,abnormal oligodendrocyte apoptosis
MGI:5432014	Cntf<tm1Vlcg>	MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0004981,decreased neuronal precursor cell number|MP:0006060,increased cerebral infarct size|MP:0009967,abnormal neuron proliferation
MGI:7287464	Cntln<em1Wli>	MP:0001925,male infertility|MP:0009234,absent sperm head
MGI:5050725	Cntn1<m1J>	MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001516,abnormal motor coordination/balance|MP:0003631,nervous system phenotype|MP:0005369,muscle phenotype|MP:0005391,vision/eye phenotype|MP:0011083,lethality at weaning, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2384082	Cntn1<tm1Brns>	MP:0000746,weakness|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001516,abnormal motor coordination/balance|MP:0001524,impaired limb coordination|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002961,abnormal axon guidance|MP:0004098,abnormal cerebellar granule cell morphology|MP:0005150,cachexia|MP:0005386,behavior/neurological phenotype|MP:0008143,abnormal dendrite morphology|MP:0009450,abnormal axon fasciculation|MP:0009512,abnormal cerebellar Golgi cell morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0014329,abnormal Purkinje cell axon morphology
MGI:5523802	Cntn1<usl>	MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001394,circling|MP:0001516,abnormal motor coordination/balance|MP:0002183,gliosis|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004263,abnormal limb posture|MP:0005391,vision/eye phenotype|MP:0011100,preweaning lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0014085,stomach non-glandular epithelium hyperkeratosis
MGI:2181052	Cntn2<tm1Fuka>	MP:0000951,sporadic seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003631,nervous system phenotype
MGI:2677610	Cntn2<tm1Furl>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0005423,abnormal somatic nervous system physiology|MP:0006282,abnormal spinal cord dorsal horn morphology
MGI:3521785	Cntn2<tm2Furl>	MP:0005423,abnormal somatic nervous system physiology
MGI:3795150	Cntn4<tm1Yyos>	MP:0005236,abnormal olfactory nerve morphology
MGI:6276950	Cntn5<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology|MP:0002941,increased circulating alanine transaminase level
MGI:3051963	Cntn5<tm1Kwat>	MP:0001496,audiogenic seizures
MGI:3613462	Cntn6<tm1Kwat>	MP:0001405,impaired coordination|MP:0003631,nervous system phenotype|MP:0009969,abnormal cerebral cortex pyramidal cell morphology
MGI:6113891	Cntnap1<M1Btlr>	MP:0001262,decreased body weight
MGI:1857037	Cntnap1<shm>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0001522,impaired swimming|MP:0001524,impaired limb coordination|MP:0001921,reduced fertility|MP:0004263,abnormal limb posture|MP:0005403,abnormal nerve conduction|MP:0005404,abnormal axon morphology|MP:0008770,decreased survivor rate|MP:0008814,decreased nerve conduction velocity|MP:0009393,abnormal resting posture|MP:0010732,abnormal node of Ranvier morphology|MP:0010734,abnormal paranode morphology|MP:0010735,abnormal paranodal axoglial junction morphology|MP:0010748,abnormal visual evoked potential|MP:0011083,lethality at weaning, complete penetrance
MGI:1861595	Cntnap1<shm-3J>	MP:0000745,tremors|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0009393,abnormal resting posture
MGI:1861596	Cntnap1<shm-4J>	MP:0000745,tremors|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0009393,abnormal resting posture
MGI:5313551	Cntnap1<shm-5J>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001922,reduced male fertility|MP:0004263,abnormal limb posture
MGI:4818635	Cntnap1<tm1Bhat>	MP:0000160,kyphosis|MP:0000743,muscle spasm|MP:0000745,tremors|MP:0000746,weakness|MP:0000754,paresis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0003631,nervous system phenotype|MP:0003871,abnormal myelin sheath morphology|MP:0005402,abnormal action potential|MP:0005404,abnormal axon morphology|MP:0008814,decreased nerve conduction velocity|MP:0010050,hypermyelination|MP:0011084,lethality at weaning, incomplete penetrance
MGI:3026869	Cntnap1<tm1Pele>	MP:0000745,tremors|MP:0001393,ataxia|MP:0005404,abnormal axon morphology|MP:0008814,decreased nerve conduction velocity
MGI:6153781	Cntnap2<em1(IMPC)H>	MP:0001415,increased exploration in new environment
MGI:2677631	Cntnap2<tm1Pele>	MP:0000780,abnormal corpus callosum morphology|MP:0001265,decreased body size|MP:0001361,social withdrawal|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001447,abnormal nest building behavior|MP:0001516,abnormal motor coordination/balance|MP:0001984,abnormal olfaction|MP:0002064,seizures|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0003998,decreased thermal nociceptive threshold|MP:0004101,abnormal brain interneuron morphology|MP:0004811,abnormal neuron physiology|MP:0005386,behavior/neurological phenotype|MP:0006009,abnormal neuronal migration|MP:0009358,environmentally induced seizures|MP:0014620,abnormal interictal brain wave pattern|MP:0020340,abnormal inhibitory learning|MP:0020351,decreased vocalization|MP:0031391,increased locomotor activity
MGI:5750095	Cntnap2<tm2Pele>	MP:0003462,abnormal response to novel odor|MP:0014115,cognitive inflexibility|MP:0031391,increased locomotor activity
MGI:6196062	Cntnap3<tm1.1Tk>	MP:0002804,abnormal motor learning|MP:0003631,nervous system phenotype
MGI:6415695	Cntnap4<em1Smoc>	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0003224,neuron degeneration|MP:0013219,abnormal substantia nigra pars compacta morphology|MP:0030941,enhanced autophagy
MGI:5585148	Cntnap4<tm1Pele>	MP:0001441,increased grooming behavior|MP:0001488,increased startle reflex|MP:0001906,increased dopamine level|MP:0002064,seizures|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003088,abnormal prepulse inhibition|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0009538,abnormal synapse morphology|MP:0020551,abnormal postsynaptic density morphology
MGI:5823560	Cntnap5a<em1(IMPC)J>	MP:0000208,decreased hematocrit|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount
MGI:6284505	Cntnap5b<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response
MGI:5438058	Cntrl<b2b1468.1Clo>	MP:0000284,double outlet right ventricle|MP:0000519,hydronephrosis|MP:0000536,hydroureter|MP:0001297,microphthalmia|MP:0003675,kidney cyst|MP:0004200,decreased fetal size|MP:0004860,dilated kidney collecting duct|MP:0006124,tricuspid valve stenosis|MP:0008528,polycystic kidney|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010422,heart right ventricle hypoplasia|MP:0010457,pulmonary artery stenosis
MGI:6361235	Cntrob<em1(IMPC)Bay>	MP:0001925,male infertility
MGI:1856826	co	MP:0002894,abnormal otolith morphology|MP:0005191,head tilt
MGI:5513757	Coa5<tm1b(KOMP)Wtsi>	MP:0001120,abnormal uterus morphology|MP:0001402,decreased locomotor activity|MP:0001697,abnormal embryo size|MP:0002768,small adrenal glands|MP:0003717,pallor|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6341938	Coa6<em1(IMPC)Ccpcz>	MP:0002059,abnormal seminal vesicle morphology|MP:0002135,abnormal kidney morphology|MP:0003917,increased kidney weight|MP:0004599,abnormal vertebral arch morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6404491	Coa8<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6355916	Coa8<em1Zev>	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0005369,muscle phenotype|MP:0010955,abnormal respiratory electron transport chain|MP:0012106,impaired exercise endurance
MGI:6382779	Coasy<em1(IMPC)H>	MP:0000219,increased neutrophil cell number|MP:0005627,increased circulating potassium level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6491679	Coasy<tm1.1Vtr>	MP:0001262,decreased body weight|MP:0001391,abnormal tail movements|MP:0001523,impaired righting response|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0003631,nervous system phenotype|MP:0005323,dystonia|MP:0005356,positive geotaxis|MP:0006036,abnormal mitochondrial physiology|MP:0020365,increased brain iron level|MP:0020879,abnormal calcium level|MP:0020883,abnormal magnesium level
MGI:1856827	Cobl<C101>	MP:0002169,no abnormal phenotype detected
MGI:6414524	Cobl<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0013772,increased effector memory T-helper cell number
MGI:7425599	Cobll1<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001529,abnormal vocalization|MP:0002339,abnormal lymph node morphology|MP:0003918,decreased kidney weight|MP:0003960,increased lean body mass|MP:0013129,abnormal tooth color
MGI:7343594	Cobl<tm1.1Bqu>	MP:0001935,decreased litter size|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004736,abnormal distortion product otoacoustic emission|MP:0005380,embryo phenotype|MP:0011062,abnormal outer hair cell kinocilium morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0030944,abnormal pericentriolar material morphology
MGI:1856596	Coc	MP:0001304,cataract
MGI:3624560	Coch<tm1.1Stw>	MP:0002169,no abnormal phenotype detected|MP:0004814,reduced linear vestibular evoked potential|MP:0005377,hearing/vestibular/ear phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3814536	Coch<tm1Mrtn>	MP:0004736,abnormal distortion product otoacoustic emission|MP:0004814,reduced linear vestibular evoked potential|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3624559	Coch<tm1Stw>	MP:0002169,no abnormal phenotype detected
MGI:3040228	Cocia10<C57BL/6J>	MP:0008911,induced hyperactivity|MP:0020871,abnormal locomotor response to cocaine
MGI:3040230	Cocia11<C57BL/6J>	MP:0008911,induced hyperactivity|MP:0020871,abnormal locomotor response to cocaine
MGI:3040232	Cocia12<C57BL/6J>	MP:0008911,induced hyperactivity|MP:0020871,abnormal locomotor response to cocaine
MGI:3040233	Cocia13<A/J>	MP:0008911,induced hyperactivity|MP:0020871,abnormal locomotor response to cocaine
MGI:3040236	Cocia14<C57BL/6J>	MP:0008911,induced hyperactivity|MP:0020871,abnormal locomotor response to cocaine
MGI:3040216	Cocia4<C57BL/6J>	MP:0001392,abnormal locomotor behavior
MGI:3040218	Cocia5<C57BL/6J>	MP:0008911,induced hyperactivity|MP:0020871,abnormal locomotor response to cocaine
MGI:3040219	Cocia6<A/J>	MP:0008911,induced hyperactivity|MP:0020871,abnormal locomotor response to cocaine
MGI:3040222	Cocia7<C57BL/6J>	MP:0008911,induced hyperactivity|MP:0020871,abnormal locomotor response to cocaine
MGI:3040224	Cocia8<C57BL/6J>	MP:0008911,induced hyperactivity|MP:0020871,abnormal locomotor response to cocaine
MGI:3040226	Cocia9<C57BL/6J>	MP:0008911,induced hyperactivity|MP:0020871,abnormal locomotor response to cocaine
MGI:1856828	cod	MP:0000746,weakness|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0001522,impaired swimming|MP:0001524,impaired limb coordination|MP:0001525,impaired balance|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002229,neurodegeneration|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0003632,abnormal nervous system morphology|MP:0004263,abnormal limb posture|MP:0005156,bradykinesia|MP:0005202,lethargy|MP:0005277,abnormal brainstem morphology|MP:0009402,decreased skeletal muscle fiber diameter|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6342908	Cog1<em1(IMPC)Bay>	MP:0001727,abnormal embryo implantation|MP:0002718,abnormal inner cell mass morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:4364810	Cog2<tm1a(KOMP)Wtsi>	MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0002608,increased hematocrit|MP:0002942,decreased circulating alanine transaminase level|MP:0005554,decreased circulating creatinine level|MP:0005571,decreased lactate dehydrogenase level|MP:0005632,decreased circulating aspartate transaminase level|MP:0011100,preweaning lethality, complete penetrance
MGI:5548843	Cog3<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0002079,increased circulating insulin level|MP:0011100,preweaning lethality, complete penetrance
MGI:6257415	Cog4<em1(IMPC)Bay>	MP:0000063,decreased bone mineral density|MP:0001399,hyperactivity|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7425600	Cog5<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002060,abnormal skin morphology|MP:0002110,abnormal digit morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0020422,decreased freezing behavior
MGI:4820323	Cog6<tm1a(EUCOMM)Wtsi>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0001312,abnormal cornea morphology|MP:0001916,intracerebral hemorrhage|MP:0002075,abnormal coat/hair pigmentation|MP:0002169,no abnormal phenotype detected|MP:0002599,increased mean platelet volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0003036,vertebral transformation|MP:0003795,abnormal bone structure|MP:0004613,fusion of vertebral arches|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005011,increased eosinophil cell number|MP:0005018,decreased T cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005568,increased circulating total protein level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0006063,abnormal inferior vena cava morphology|MP:0008040,decreased NK T cell number|MP:0008045,decreased NK cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008097,increased plasma cell number|MP:0008173,increased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008206,increased B-2 B cell number|MP:0008346,increased gamma-delta T cell number|MP:0008806,increased circulating amylase level|MP:0009820,abnormal liver vasculature morphology|MP:0009926,decreased transitional stage T2 B cell number|MP:0010067,increased red blood cell distribution width|MP:0010124,decreased bone mineral content|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010420,muscular ventricular septal defect|MP:0010490,abnormal inferior vena cava valve morphology|MP:0010835,increased CD4-positive, alpha-beta memory T cell number|MP:0010851,decreased effector memory CD8-positive, alpha-beta T cell number|MP:0011683,dual inferior vena cava|MP:0012765,decreased alpha-beta T cell number|MP:0012767,increased KLRG1-positive NK cell number|MP:0013022,increased Ly6C high monocyte number|MP:0013154,increased KLRG1+ CD8 alpha-beta T cell number|MP:0013157,increased KLRG1+ CD4 alpha-beta T cell number|MP:0013417,decreased memory-marker gamma-delta T cell number|MP:0013418,increased memory-marker gamma-delta T cell number|MP:0013421,increased CD5-positive gamma-delta T cell number|MP:0013426,decreased memory-marker NK cell number|MP:0013427,increased memory-marker NK cell number|MP:0013430,increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0013433,increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0013511,increased CD4-negative NK T cell number|MP:0013513,decreased memory-marker CD4-negative NK T cell number|MP:0013519,decreased CD4-positive NK T cell number|MP:0013522,decreased memory-marker CD4-positive NK T cell number|MP:0013669,decreased Ly6C-positive immature NK cell number|MP:0013675,decreased Ly6C-positive mature NK cell number|MP:0013764,decreased T-helper cell number|MP:0013772,increased effector memory T-helper cell number|MP:0013775,increased KLRG1-positive T-helper cell number|MP:0013834,thin hypoglossal nerve|MP:0013859,abnormal vitelline vein connection|MP:0013877,abnormal ductus venosus valve morphology|MP:0013975,abnormal coronary sinus connection|MP:0014001,abnormal vertebral artery topology
MGI:5642366	Cog7<tm1b(EUCOMM)Hmgu>	MP:0004122,abnormal sinus arrhythmia|MP:0005544,cornea deposits|MP:0006243,impaired pupillary reflex|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6361033	Cog8<em1(IMPC)J>	MP:0005635,decreased circulating bilirubin level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2181054	Coil<tm1Agm>	MP:0008770,decreased survivor rate|MP:0008888,abnormal Cajal body morphology|MP:0010768,mortality/aging
MGI:4397569	Col10a1<tm1.1Rpbh>	MP:0000358,abnormal cell morphology|MP:0002427,disproportionate dwarf|MP:0003109,short femur|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004985,decreased osteoclast cell number|MP:0008489,slow postnatal weight gain|MP:0020354,increased endoplasmic reticulum stress
MGI:2152965	Col10a1<tm1Bhr>	MP:0000116,abnormal tooth development|MP:0000130,abnormal trabecular bone morphology|MP:0000160,kyphosis|MP:0000162,lordosis|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001262,decreased body weight|MP:0001823,thymus hypoplasia|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002397,abnormal bone marrow morphology|MP:0002416,abnormal proerythroblast morphology|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004608,abnormal cervical axis morphology|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight|MP:0005017,decreased B cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005150,cachexia|MP:0005202,lethargy|MP:0005390,skeleton phenotype|MP:0008024,absent lymph nodes|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0008477,decreased spleen red pulp amount|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2153000	Col10a1<tm1Ksec>	MP:0000130,abnormal trabecular bone morphology|MP:0000163,abnormal cartilage morphology|MP:0000559,abnormal femur morphology|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0004016,decreased bone mass|MP:0005014,increased B cell number|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008127,decreased dendritic cell number|MP:0008661,decreased interleukin-10 secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0010124,decreased bone mineral content|MP:0013763,increased T-helper cell number|MP:0020010,decreased bone mineral density of femur|MP:0030790,coxa vara
MGI:6259993	Col10a1<tm2.1Rpbh>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002427,disproportionate dwarf|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0004509,abnormal pelvic girdle bone morphology|MP:0008272,abnormal endochondral bone ossification|MP:0014105,abnormal chondrocyte differentiation|MP:0020354,increased endoplasmic reticulum stress
MGI:1856399	Col11a1<cho>	MP:0000031,abnormal cochlea morphology|MP:0000042,abnormal organ of Corti morphology|MP:0000043,organ of Corti degeneration|MP:0000065,abnormal bone marrow cavity morphology|MP:0000088,short mandible|MP:0000111,cleft palate|MP:0000130,abnormal trabecular bone morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000435,shortened head|MP:0000445,short snout|MP:0000556,abnormal hindlimb morphology|MP:0001953,respiratory failure|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0003560,osteoarthritis|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004214,abnormal long bone diaphysis morphology|MP:0004397,absent cochlear inner hair cells|MP:0004403,absent cochlear outer hair cells|MP:0004686,decreased length of long bones|MP:0005377,hearing/vestibular/ear phenotype|MP:0006395,abnormal epiphyseal plate morphology|MP:0006429,abnormal hyaline cartilage morphology|MP:0006432,abnormal costal cartilage morphology|MP:0008069,abnormal joint mobility|MP:0008151,increased diameter of long bones|MP:0008272,abnormal endochondral bone ossification|MP:0008736,micromelia|MP:0009908,protruding tongue|MP:0010768,mortality/aging|MP:0011087,neonatal lethality, complete penetrance|MP:0014740,increased auditory brainstem response wave peak latency|MP:0020137,decreased bone mineralization|MP:0030026,small Meckel's cartilage|MP:0030837,abnormal knee joint morphology|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:6257647	Col11a1<em1(IMPC)Bay>	MP:0000111,cleft palate|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0003743,abnormal facial morphology|MP:0009908,protruding tongue|MP:0010579,increased heart left ventricle size|MP:0011100,preweaning lethality, complete penetrance
MGI:5692880	Col11a2<tm1b(KOMP)Wtsi>	MP:0001488,increased startle reflex|MP:0002591,decreased mean corpuscular volume|MP:0002644,decreased circulating triglyceride level|MP:0003393,decreased cardiac output|MP:0005344,increased circulating bilirubin level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011896,increased circulating unsaturated transferrin level
MGI:2154689	Col11a2<tm1Mne>	MP:0000102,abnormal nasal bone morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000438,abnormal cranium morphology|MP:0000445,short snout|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0003149,abnormal tectorial membrane morphology|MP:0004591,enlarged tectorial membrane|MP:0004740,sensorineural hearing loss|MP:0004749,nonsyndromic hearing loss|MP:0006325,impaired hearing|MP:0006397,disorganized long bone epiphyseal plate|MP:0006433,abnormal articular cartilage morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012546,triangular face|MP:0030049,prominent forehead
MGI:5141135	Col12a1<tm1Debi>	MP:0000069,kyphoscoliosis|MP:0000160,kyphosis|MP:0000164,abnormal cartilage development|MP:0000559,abnormal femur morphology|MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0001513,limb grasping|MP:0001533,abnormal skeleton physiology|MP:0002106,abnormal muscle physiology|MP:0002113,abnormal skeleton development|MP:0003109,short femur|MP:0003795,abnormal bone structure|MP:0003797,abnormal compact bone morphology|MP:0004121,abnormal sarcolemma morphology|MP:0004601,abnormal vertebral spinous process morphology|MP:0004703,abnormal vertebral column morphology|MP:0004986,abnormal osteoblast morphology|MP:0004991,decreased bone strength|MP:0005006,abnormal osteoblast physiology|MP:0005390,skeleton phenotype|MP:0005508,abnormal skeleton morphology|MP:0008152,decreased diameter of femur|MP:0010053,decreased grip strength|MP:0010225,abnormal quadriceps morphology|MP:0010239,decreased skeletal muscle weight|MP:0011090,perinatal lethality, incomplete penetrance|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization|MP:0020849,abnormal actin cytoskeleton morphology
MGI:2386983	Col13a1<tm1Pih>	MP:0000749,muscle degeneration|MP:0000751,myopathy|MP:0000759,abnormal skeletal muscle morphology|MP:0002914,abnormal endplate potential|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004091,abnormal Z line morphology|MP:0004121,abnormal sarcolemma morphology|MP:0004272,abnormal basement membrane morphology|MP:0004510,myositis|MP:0005165,increased susceptibility to injury|MP:0009402,decreased skeletal muscle fiber diameter|MP:0012106,impaired exercise endurance|MP:0014698,decreased fibroblast adhesion
MGI:4838408	Col13a1<tm2Pih>	MP:0002914,abnormal endplate potential
MGI:4838409	Col13a1<tm3.1Pih>	MP:0000745,tremors|MP:0000747,muscle weakness|MP:0000937,abnormal motor neuron morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001732,postnatal growth retardation|MP:0002279,abnormal diaphragm morphology|MP:0002914,abnormal endplate potential|MP:0003081,abnormal soleus morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004769,abnormal synaptic vesicle morphology|MP:0004835,abnormal miniature endplate potential|MP:0004836,abnormal synaptic acetylcholine release|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009413,skeletal muscle fiber atrophy|MP:0009426,decreased soleus weight|MP:0030951,abnormal endocytosis
MGI:6116692	Col13a1<tm4.1Pih>	MP:0000937,abnormal motor neuron morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0002279,abnormal diaphragm morphology|MP:0002914,abnormal endplate potential|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004835,abnormal miniature endplate potential|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0030950,abnormal synaptic vesicle exocytosis|MP:0030951,abnormal endocytosis
MGI:5561558	Col14a1<tm1b(KOMP)Wtsi>	MP:0005293,impaired glucose tolerance
MGI:3846440	Col14a1<tm1Debi>	MP:0002106,abnormal muscle physiology|MP:0003089,decreased skin tensile strength|MP:0003098,decreased tendon stiffness|MP:0005503,abnormal tendon morphology
MGI:2386162	Col15a1<tm1Pih>	MP:0000751,myopathy|MP:0001544,abnormal cardiovascular system physiology|MP:0002108,abnormal muscle morphology|MP:0003658,abnormal capillary morphology|MP:0004087,abnormal muscle fiber morphology|MP:0006055,abnormal vascular endothelial cell morphology|MP:0031318,enhanced skeletal muscle regeneration
MGI:5763667	Col16a1<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0001304,cataract|MP:0005567,decreased circulating total protein level|MP:0010053,decreased grip strength
MGI:5527464	Col17a1<em10Dcr>	MP:0010771,integument phenotype
MGI:5527467	Col17a1<em13Dcr>	MP:0010771,integument phenotype
MGI:5527468	Col17a1<em14Dcr>	MP:0010771,integument phenotype
MGI:7707938	Col17a1<em15Dcr>	MP:0001209,spontaneous skin ulceration
MGI:7707939	Col17a1<em16Dcr>	MP:0010771,integument phenotype
MGI:7707940	Col17a1<em17Dcr>	MP:0010771,integument phenotype
MGI:7707941	Col17a1<em18Dcr>	MP:0010771,integument phenotype
MGI:5504432	Col17a1<em1Dcr>	MP:0010771,integument phenotype
MGI:6276874	Col17a1<em1(IMPC)Mbp>	MP:0000195,decreased circulating calcium level|MP:0002060,abnormal skin morphology|MP:0005419,decreased circulating serum albumin level|MP:0009709,hydrometra|MP:0020421,increased freezing behavior
MGI:5527447	Col17a1<em2Dcr>	MP:0001209,spontaneous skin ulceration
MGI:5527451	Col17a1<em4Dcr>	MP:0005275,abnormal skin tensile strength
MGI:5527454	Col17a1<em5Dcr>	MP:0005275,abnormal skin tensile strength
MGI:5527458	Col17a1<em7Dcr>	MP:0005275,abnormal skin tensile strength
MGI:5527462	Col17a1<em8Dcr>	MP:0001312,abnormal cornea morphology|MP:0002083,premature death|MP:0011160,dermal-epidermal separation|MP:0012402,abnormal nail bed morphology
MGI:5527463	Col17a1<em9Dcr>	MP:0005275,abnormal skin tensile strength
MGI:6195004	Col17a1<tm1.1(COL17A1)Zliu>	MP:0000219,increased neutrophil cell number|MP:0001208,blistering|MP:0001212,skin lesions|MP:0008764,increased mast cell degranulation
MGI:3711776	Col17a1<tm1Shzu>	MP:0000416,sparse hair|MP:0001191,abnormal skin condition|MP:0001208,blistering|MP:0001216,abnormal epidermal layer morphology|MP:0001732,postnatal growth retardation|MP:0002161,abnormal fertility/fecundity|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5621004	Col17a1<tm1Tiin>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000416,sparse hair|MP:0000418,focal hair loss|MP:0001208,blistering|MP:0001212,skin lesions|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001265,decreased body size|MP:0001412,excessive scratching|MP:0001732,postnatal growth retardation|MP:0002060,abnormal skin morphology|MP:0002073,abnormal hair growth|MP:0002075,abnormal coat/hair pigmentation|MP:0002497,increased IgE level|MP:0002606,increased basophil cell number|MP:0003725,increased autoantibody level|MP:0004272,abnormal basement membrane morphology|MP:0004947,skin inflammation|MP:0005011,increased eosinophil cell number|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0008140,podocyte foot process effacement|MP:0010072,increased pruritus|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011159,abnormal epidermal-dermal junction morphology|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011703,increased fibroblast proliferation|MP:0011871,podocyte hypertrophy
MGI:5445917	Col18a1<tm1.1(KOMP)Vlcg>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001303,abnormal lens morphology|MP:0001319,irregularly shaped pupil|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002574,increased vertical activity|MP:0002792,abnormal retina vasculature morphology|MP:0005102,abnormal iris pigmentation|MP:0005560,decreased circulating glucose level|MP:0006241,abnormal placement of pupils|MP:0008259,abnormal optic disk morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0013279,increased fasting circulating glucose level
MGI:2179134	Col18a1<tm1Hms>	MP:0000438,abnormal cranium morphology|MP:0000439,enlarged cranium|MP:0000820,abnormal choroid plexus morphology|MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0000829,dilated fourth ventricle|MP:0001289,persistence of hyaloid vascular system|MP:0001317,abnormal pupil morphology|MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0001552,increased circulating triglyceride level|MP:0001570,abnormal circulating enzyme level|MP:0001891,hydrocephaly|MP:0002006,neoplasm|MP:0002152,abnormal brain morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003975,increased circulating VLDL triglyceride level|MP:0004272,abnormal basement membrane morphology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005099,abnormal ciliary body morphology|MP:0005199,abnormal iris pigment epithelium|MP:0005319,abnormal enzyme/coenzyme level|MP:0005325,abnormal renal glomerulus morphology|MP:0005367,renal/urinary system phenotype|MP:0005541,abnormal iris stromal pigmentation|MP:0005553,increased circulating creatinine level|MP:0006000,abnormal cornea epithelium morphology|MP:0008033,impaired lipolysis|MP:0008140,podocyte foot process effacement|MP:0010622,abnormal tricuspid valve cusp morphology|MP:0011056,abnormal brain ependyma motile cilium morphology|MP:0011338,abnormal mesangial matrix morphology|MP:0011353,expanded mesangial matrix|MP:0011380,enlarged brain ventricles|MP:0031109,subarachnoid hemorrhage
MGI:4948124	Col18a1<tm1Pih>	MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005367,renal/urinary system phenotype
MGI:4948125	Col18a1<tm2Pih>	MP:0005325,abnormal renal glomerulus morphology|MP:0005367,renal/urinary system phenotype|MP:0008140,podocyte foot process effacement
MGI:3053870	Col19a1<tm1Rmz>	MP:0000467,abnormal esophagus morphology|MP:0001263,weight loss|MP:0003158,dysphagia|MP:0003159,abnormal esophageal smooth muscle morphology|MP:0003160,abnormal esophagus development|MP:0004548,dilated esophagus|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3053871	Col19a1<tm2Rmz>	MP:0000418,focal hair loss|MP:0001263,weight loss|MP:0003157,impaired muscle relaxation|MP:0005202,lethargy
MGI:3769585	Col1a1<Aga2>	MP:0000013,abnormal adipose tissue distribution|MP:0000061,fragile skeleton|MP:0000063,decreased bone mineral density|MP:0000069,kyphoscoliosis|MP:0000276,heart right ventricle hypertrophy|MP:0000358,abnormal cell morphology|MP:0000559,abnormal femur morphology|MP:0001243,abnormal dermal layer morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001544,abnormal cardiovascular system physiology|MP:0001614,abnormal blood vessel morphology|MP:0001861,lung inflammation|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0001935,decreased litter size|MP:0002187,abnormal fibula morphology|MP:0002329,abnormal blood gas level|MP:0002904,increased circulating parathyroid hormone level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003109,short femur|MP:0003953,abnormal hormone level|MP:0004506,abnormal pubis morphology|MP:0004507,abnormal ischium morphology|MP:0004675,rib fractures|MP:0004986,abnormal osteoblast morphology|MP:0005006,abnormal osteoblast physiology|MP:0005319,abnormal enzyme/coenzyme level|MP:0005329,abnormal myocardium layer morphology|MP:0005508,abnormal skeleton morphology|MP:0006113,abnormal heart septum morphology|MP:0008152,decreased diameter of femur|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0010124,decreased bone mineral content|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010634,increased QRS amplitude|MP:0010909,pulmonary alveolar hemorrhage|MP:0010970,abnormal compact bone lamellar structure|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011743,abnormal Golgi apparatus morphology|MP:0030279,thin neurocranium|MP:0030441,increased osteoblast apoptosis|MP:0031633,decreased heart left ventricle muscle contractility
MGI:7863770	Col1a1<em1Nju>	MP:0000061,fragile skeleton|MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0001262,decreased body weight|MP:0003795,abnormal bone structure|MP:0004991,decreased bone strength|MP:0004992,increased bone resorption|MP:0008489,slow postnatal weight gain|MP:0009346,decreased trabecular bone thickness|MP:0010124,decreased bone mineral content|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0011091,prenatal lethality, complete penetrance|MP:0011711,impaired osteoblast differentiation|MP:0013630,increased bone trabecular spacing|MP:0013633,decreased femur maximal load|MP:0013638,decreased femur stiffness|MP:0013646,decreased energy dissipated prior to femur fracture|MP:0020040,decreased bone ossification
MGI:3776559	Col1a1<m1Btlr>	MP:0000061,fragile skeleton|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000547,short limbs|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0000572,abnormal autopod morphology|MP:0000755,hindlimb paralysis|MP:0001262,decreased body weight|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0001914,hemorrhage|MP:0004016,decreased bone mass|MP:0004686,decreased length of long bones|MP:0006054,spinal hemorrhage|MP:0011642,abnormal bone collagen fibril morphology|MP:0030679,decreased hydroxyproline level
MGI:5620941	Col1a1<M1Jrt>	MP:0000061,fragile skeleton|MP:0000063,decreased bone mineral density|MP:0000135,decreased compact bone thickness|MP:0000160,kyphosis|MP:0000161,scoliosis|MP:0000559,abnormal femur morphology|MP:0000572,abnormal autopod morphology|MP:0000589,thin tail|MP:0000746,weakness|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001391,abnormal tail movements|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0002161,abnormal fertility/fecundity|MP:0002734,abnormal mechanical nociception|MP:0002757,decreased vertical activity|MP:0002896,abnormal bone mineralization|MP:0002993,autoimmune arthritis|MP:0002999,abnormal bone healing|MP:0003089,decreased skin tensile strength|MP:0003098,decreased tendon stiffness|MP:0003109,short femur|MP:0003560,osteoarthritis|MP:0003797,abnormal compact bone morphology|MP:0003998,decreased thermal nociceptive threshold|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004686,decreased length of long bones|MP:0004703,abnormal vertebral column morphology|MP:0004986,abnormal osteoblast morphology|MP:0004988,increased osteoblast cell number|MP:0004991,decreased bone strength|MP:0004992,increased bone resorption|MP:0005376,homeostasis/metabolism phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005459,decreased percent body fat/body weight|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0009346,decreased trabecular bone thickness|MP:0010124,decreased bone mineral content|MP:0010633,myocardium hypertrophy|MP:0010867,abnormal bone trabecula morphology|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0010879,decreased trabecular bone volume|MP:0011091,prenatal lethality, complete penetrance|MP:0011642,abnormal bone collagen fibril morphology|MP:0011643,abnormal tendon collagen fibril morphology|MP:0013138,thin body|MP:0013258,abnormal extracellular matrix morphology|MP:0013304,osteophytes|MP:0013630,increased bone trabecular spacing|MP:0013631,decreased bone trabecular spacing|MP:0020254,decreased collagen level|MP:0030451,abnormal dentin mineralization|MP:0030854,atlanto-occipital joint dislocation|MP:0030856,abnormal olecranon morphology
MGI:1856671	Col1a1<Mov13>	MP:0000060,delayed bone ossification|MP:0000061,fragile skeleton|MP:0001243,abnormal dermal layer morphology|MP:0001730,embryonic growth arrest|MP:0002075,abnormal coat/hair pigmentation|MP:0003797,abnormal compact bone morphology|MP:0004748,increased susceptibility to age-related hearing loss|MP:0006325,impaired hearing|MP:0010970,abnormal compact bone lamellar structure|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0020040,decreased bone ossification
MGI:2158863	Col1a1<tm1.1Jcm>	MP:0000074,abnormal neurocranium morphology|MP:0000141,abnormal vertebral body morphology|MP:0000150,abnormal rib morphology|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0001182,lung hemorrhage|MP:0001265,decreased body size|MP:0001954,respiratory distress|MP:0002109,abnormal limb morphology|MP:0002244,abnormal turbinate morphology|MP:0002819,abnormal dental pulp cavity morphology|MP:0003723,abnormal long bone morphology|MP:0004134,abnormal chest morphology|MP:0004507,abnormal ischium morphology|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004674,thin ribs|MP:0004675,rib fractures|MP:0004706,short vertebral body|MP:0010099,abnormal thoracic cage shape|MP:0011088,neonatal lethality, incomplete penetrance|MP:0020137,decreased bone mineralization|MP:0030279,thin neurocranium
MGI:6343326	Col1a1<tm11(tetO-Nup88)Jvd>	MP:0002020,increased tumor incidence|MP:0004024,aneuploidy|MP:0004045,abnormal cell cycle checkpoint function|MP:0004046,abnormal mitosis|MP:0008014,increased lung tumor incidence|MP:0008866,chromosomal instability|MP:0009760,abnormal mitotic spindle morphology
MGI:6343327	Col1a1<tm13(tetO-Nup88)Jvd>	MP:0002020,increased tumor incidence|MP:0004024,aneuploidy|MP:0004045,abnormal cell cycle checkpoint function|MP:0004046,abnormal mitosis|MP:0008014,increased lung tumor incidence|MP:0008866,chromosomal instability|MP:0009760,abnormal mitotic spindle morphology
MGI:5755839	Col1a1<tm17(tetO-GFP,-cas9*)Slowe>	MP:0005381,digestive/alimentary phenotype
MGI:5755841	Col1a1<tm18(tetO-GFP,-cas9*)Slowe>	MP:0005381,digestive/alimentary phenotype
MGI:5755842	Col1a1<tm19(tetO-GFP,-cas9*)Slowe>	MP:0005381,digestive/alimentary phenotype
MGI:2179405	Col1a1<tm1Bst>	MP:0001914,hemorrhage|MP:0002083,premature death|MP:0003279,aneurysm|MP:0004044,aortic dissection|MP:0009862,abnormal aorta elastic tissue morphology|MP:0009871,abnormal aorta tunica adventitia morphology
MGI:6256800	Col1a1<tm1(CAG-EGFR*T790M*C797S*L858R)Mje>	MP:0002027,increased lung adenocarcinoma incidence
MGI:5519911	Col1a1<tm1(CAG-Ezh2*)Meln>	MP:0002006,neoplasm|MP:0005387,immune system phenotype|MP:0008177,increased germinal center B cell number|MP:0008481,increased spleen germinal center number|MP:0008483,increased spleen germinal center size
MGI:5527244	Col1a1<tm1(CAG-Mir22)Ppp>	MP:0000221,decreased leukocyte cell number|MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002024,increased T cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002396,abnormal hematopoietic system morphology/development|MP:0004809,increased hematopoietic stem cell number|MP:0008121,increased myeloid dendritic cell number
MGI:5295482	Col1a1<tm1(CAG-Sirt2)Jmi>	MP:0000920,abnormal myelination|MP:0014648,abnormal response to nerve crush injury
MGI:4948122	Col1a1<tm1Dab>	MP:0000598,abnormal liver morphology|MP:0005166,decreased susceptibility to injury
MGI:5529077	Col1a1<tm1(hs1473-PITX1)Smun>	MP:0000550,abnormal forelimb morphology|MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0002110,abnormal digit morphology|MP:0003855,abnormal forelimb zeugopod morphology|MP:0005296,abnormal humerus morphology|MP:0008915,fused carpal bones
MGI:1857154	Col1a1<tm1Jae>	MP:0000064,failure of bone resorption|MP:0000067,osteopetrosis|MP:0000074,abnormal neurocranium morphology|MP:0000418,focal hair loss|MP:0001120,abnormal uterus morphology|MP:0001245,thick dermal layer|MP:0001262,decreased body weight|MP:0001541,abnormal osteoclast physiology|MP:0001935,decreased litter size|MP:0002115,abnormal limb bone morphology|MP:0005258,ocular hypertension|MP:0005390,skeleton phenotype|MP:0005391,vision/eye phenotype|MP:0008256,abnormal myometrium morphology|MP:0008395,abnormal osteoblast differentiation|MP:0008753,abnormal osteocyte morphology|MP:0030278,thick neurocranium|MP:0030441,increased osteoblast apoptosis|MP:0030479,increased osteocyte apoptosis|MP:0030484,abnormal osteocyte lacuna morphology|MP:0030798,joint contracture
MGI:2154695	Col1a1<tm1Jcm>	MP:0000074,abnormal neurocranium morphology|MP:0001954,respiratory distress|MP:0004675,rib fractures|MP:0004706,short vertebral body|MP:0011087,neonatal lethality, complete penetrance
MGI:8219533	Col1a1<tm1(KRT18-ACE2)Irb>	MP:0001862,interstitial pneumonia|MP:0014433,increased cytokine level|MP:0020949,increased susceptibility to Coronaviridae infection
MGI:5781096	Col1a1<tm1(tetO-cas9)Sho>	MP:0002169,no abnormal phenotype detected
MGI:5502558	Col1a1<tm1(tetO-CDKN2A)Ibp>	MP:0000379,decreased hair follicle number|MP:0000414,alopecia|MP:0000427,abnormal hair cycle|MP:0001219,thick epidermis|MP:0003704,abnormal hair follicle development|MP:0005501,abnormal skin physiology|MP:0008008,early cellular replicative senescence
MGI:5527336	Col1a1<tm1(tetO-EML4/ALK)Kkw>	MP:0001263,weight loss|MP:0002083,premature death|MP:0005388,respiratory system phenotype|MP:0008014,increased lung tumor incidence|MP:0008714,increased lung carcinoma incidence|MP:0010639,abnormal tumor pathology
MGI:5555845	Col1a1<tm1(tetO-Fos)Wag>	MP:0000322,increased granulocyte number|MP:0000378,absent hair follicles|MP:0000414,alopecia|MP:0001200,thick skin|MP:0001212,skin lesions|MP:0001214,skin hyperplasia|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001265,decreased body size|MP:0002014,increased papilloma incidence|MP:0002083,premature death|MP:0003427,parakeratosis|MP:0004499,increased incidence of tumors by chemical induction|MP:0004947,skin inflammation|MP:0005387,immune system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0009583,increased keratinocyte proliferation|MP:0010784,abnormal forestomach morphology
MGI:6693286	Col1a1<tm1(tetO-GFP,-RNAi:Eef1a1)Mcg>	MP:0001364,decreased anxiety-related response|MP:0001454,abnormal cued conditioning behavior|MP:0005386,behavior/neurological phenotype|MP:0009456,impaired cued conditioning behavior
MGI:4849370	Col1a1<tm1(tetO-Lin28a)Gqda>	MP:0000017,big ears|MP:0000062,increased bone mineral density|MP:0000351,increased cell proliferation|MP:0000462,abnormal digestive system morphology|MP:0001200,thick skin|MP:0001214,skin hyperplasia|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001264,increased body size|MP:0001934,increased litter size|MP:0001938,delayed sexual maturation|MP:0002083,premature death|MP:0002636,delayed vaginal opening|MP:0002727,decreased circulating insulin level|MP:0002832,coarse hair|MP:0002865,increased growth rate|MP:0002891,increased insulin sensitivity|MP:0003213,decreased susceptibility to age related obesity|MP:0003893,increased hepatocyte proliferation|MP:0003960,increased lean body mass|MP:0005141,liver hyperplasia|MP:0005292,improved glucose tolerance|MP:0005389,reproductive system phenotype|MP:0005508,abnormal skeleton morphology|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008976,delayed female fertility|MP:0009172,small pancreatic islets|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0030069,broad face|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:4868220	Col1a1<tm1(tetO-mCherry)Eggn>	MP:0002169,no abnormal phenotype detected
MGI:5706755	Col1a1<tm1(tetO-URI1)Ndj>	MP:0000598,abnormal liver morphology|MP:0001272,increased metastatic potential|MP:0002083,premature death|MP:0002941,increased circulating alanine transaminase level|MP:0002965,increased circulating serum albumin level|MP:0003324,increased liver adenoma incidence|MP:0003326,liver failure|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003333,liver fibrosis|MP:0004499,increased incidence of tumors by chemical induction|MP:0004789,increased bile salt level|MP:0005560,decreased circulating glucose level|MP:0014783,decreased liver enzyme/coenzyme level
MGI:5704365	Col1a1<tm1(tetO-Vegfc)Mmul>	MP:0002169,no abnormal phenotype detected
MGI:5316453	Col1a1<tm1(tetO-YAP1*)Fcam>	MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0002981,increased liver weight|MP:0003893,increased hepatocyte proliferation|MP:0005141,liver hyperplasia|MP:0008891,decreased hepatocyte apoptosis
MGI:5755843	Col1a1<tm20(tetO-GFP,-cas9*D10A)Slowe>	MP:0005381,digestive/alimentary phenotype
MGI:2178816	Col1a1<tm2.1Bst>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5582206	Col1a1<tm2(CAG-IDH2*R172K)Kkw>	MP:0000255,blood vessel congestion|MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000759,abnormal skeletal muscle morphology|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0002795,dilated cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005202,lethargy|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0008025,brain vacuoles|MP:0009412,skeletal muscle fiber degeneration|MP:0009414,skeletal muscle fiber necrosis|MP:0009420,skeletal muscle endomysial fibrosis|MP:0010401,increased skeletal muscle glycogen level|MP:0011629,decreased mitochondrial number|MP:0011635,abnormal mitochondrial crista morphology|MP:0014071,increased cardiac muscle glycogen level|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014344,abnormal skeletal muscle fiber mitochondrial morphology
MGI:5585642	Col1a1<tm2(tetO-Fosl2,-DsRed)Wag>	MP:0001262,decreased body weight|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0004982,abnormal osteoclast morphology|MP:0004986,abnormal osteoblast morphology|MP:0005006,abnormal osteoblast physiology|MP:0005292,improved glucose tolerance|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005560,decreased circulating glucose level|MP:0009283,decreased gonadal fat pad weight|MP:0009347,increased trabecular bone thickness|MP:0009356,decreased liver triglyceride level|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume|MP:0020039,increased bone ossification|MP:0030968,decreased circulating adiponectin level|MP:0030984,increased circulating osteocalcin level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5582192	Col1a1<tm3(CAG-IDH2*R140Q)Kkw>	MP:0000255,blood vessel congestion|MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000745,tremors|MP:0000759,abnormal skeletal muscle morphology|MP:0001265,decreased body size|MP:0001625,cardiac hypertrophy|MP:0001891,hydrocephaly|MP:0001954,respiratory distress|MP:0002064,seizures|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0002795,dilated cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005202,lethargy|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0008025,brain vacuoles|MP:0010401,increased skeletal muscle glycogen level|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011629,decreased mitochondrial number|MP:0011635,abnormal mitochondrial crista morphology|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014344,abnormal skeletal muscle fiber mitochondrial morphology
MGI:5585716	Col1a1<tm3(tetO-Fosl1,-DsRed)Wag>	MP:0000598,abnormal liver morphology|MP:0001552,increased circulating triglyceride level|MP:0001860,liver inflammation|MP:0002942,decreased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003402,decreased liver weight|MP:0004789,increased bile salt level|MP:0005166,decreased susceptibility to injury|MP:0005178,increased circulating cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005370,liver/biliary system phenotype|MP:0008597,decreased circulating interleukin-6 level|MP:0009356,decreased liver triglyceride level|MP:0010768,mortality/aging|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5294613	Col1a1<tm3(tetO-Mirlet7g/Mir21)Gqda>	MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0012207,decreased neuronal stem cell self-renewal
MGI:5661319	Col1a1<tm4(CAG-FGFR2_iIIIb*K660N)Kkw>	MP:0008014,increased lung tumor incidence
MGI:5586533	Col1a1<tm4(tetO-Jun/Fosl2)Wag>	MP:0009356,decreased liver triglyceride level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5306239	Col1a1<tm8(CAG-BDNF)Jae>	MP:0005376,homeostasis/metabolism phenotype|MP:0005645,abnormal hypothalamus physiology
MGI:4999898	Col1a1<tm8(tetO-GFP/RNAi:Rpa3)Slowe>	MP:0001263,weight loss|MP:0002083,premature death|MP:0003077,abnormal cell cycle
MGI:1856327	Col1a2<oim>	MP:0000061,fragile skeleton|MP:0000063,decreased bone mineral density|MP:0000135,decreased compact bone thickness|MP:0000160,kyphosis|MP:0000161,scoliosis|MP:0000550,abnormal forelimb morphology|MP:0001243,abnormal dermal layer morphology|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001914,hemorrhage|MP:0002060,abnormal skin morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0002896,abnormal bone mineralization|MP:0002932,abnormal joint morphology|MP:0003098,decreased tendon stiffness|MP:0003723,abnormal long bone morphology|MP:0003797,abnormal compact bone morphology|MP:0004991,decreased bone strength|MP:0005384,cellular phenotype|MP:0005503,abnormal tendon morphology|MP:0010869,decreased bone trabecula number|MP:0010970,abnormal compact bone lamellar structure|MP:0011505,camptomelia|MP:0030482,increased osteocyte number|MP:0030837,abnormal knee joint morphology
MGI:3711122	Col1a2<tm1.1Mcbr>	MP:0000062,increased bone mineral density|MP:0000135,decreased compact bone thickness|MP:0001262,decreased body weight|MP:0004991,decreased bone strength|MP:0010124,decreased bone mineral content|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0010968,decreased compact bone area|MP:0011089,perinatal lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013615,increased volumetric bone mineral density
MGI:5575901	Col1a2<tm1b(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000274,enlarged heart|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0000691,enlarged spleen|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0005016,decreased lymphocyte cell number|MP:0005566,decreased blood urea nitrogen level|MP:0008259,abnormal optic disk morphology|MP:0008805,decreased circulating amylase level|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010123,increased bone mineral content|MP:0012362,increased large unstained cell number
MGI:3805459	Col1a2<tm1Mcbr>	MP:0002169,no abnormal phenotype detected
MGI:6194709	Col20a1<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:5637054	Col24a1<tm1b(EUCOMM)Wtsi>	MP:0001258,decreased body length|MP:0010052,increased grip strength
MGI:5781011	Col25a1<tm1.1Tiwa>	MP:0000759,abnormal skeletal muscle morphology|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0001078,abnormal phrenic nerve morphology|MP:0001504,abnormal posture|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0003203,increased neuron apoptosis|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0011087,neonatal lethality, complete penetrance|MP:0012055,abnormal phrenic nerve innervation pattern to diaphragm
MGI:5754564	Col26a1<em3(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0010067,increased red blood cell distribution width|MP:0020421,increased freezing behavior
MGI:6277035	Col27a1<em1(IMPC)Mbp>	MP:0000062,increased bone mineral density|MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0000603,pale liver|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0001325,abnormal retina morphology|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003231,abnormal placenta vasculature|MP:0003743,abnormal facial morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:5315592	Col27a1<tm1.1Rpbh>	MP:0000160,kyphosis|MP:0000440,domed cranium|MP:0000445,short snout|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004686,decreased length of long bones|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0006395,abnormal epiphyseal plate morphology|MP:0010082,sternebra fusion|MP:0010099,abnormal thoracic cage shape
MGI:5315593	Col27a1<tm1.2Rpbh>	MP:0000166,abnormal chondrocyte morphology|MP:0000440,domed cranium|MP:0000547,short limbs|MP:0001175,abnormal lung morphology|MP:0001953,respiratory failure|MP:0002657,chondrodystrophy|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004200,decreased fetal size|MP:0004321,short sternum|MP:0004678,split xiphoid process|MP:0004686,decreased length of long bones|MP:0005508,abnormal skeleton morphology|MP:0006395,abnormal epiphyseal plate morphology|MP:0009780,abnormal chondrocyte physiology|MP:0010082,sternebra fusion|MP:0010146,umbilical hernia|MP:0010902,abnormal pulmonary alveolar sac morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0030273,mandibular retrognathia
MGI:7425601	Col28a1<em1(IMPC)Tcp>	MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:1857275	Col2a1<Dmm>	MP:0000074,abnormal neurocranium morphology|MP:0000088,short mandible|MP:0000111,cleft palate|MP:0000131,abnormal long bone epiphysis morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000435,shortened head|MP:0000547,short limbs|MP:0001178,pulmonary hypoplasia|MP:0001942,abnormal lung volume|MP:0001954,respiratory distress|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002427,disproportionate dwarf|MP:0004672,short ribs|MP:0004686,decreased length of long bones|MP:0004704,short vertebral column|MP:0010103,small thoracic cage|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:7715163	Col2a1<em1(IMPC)Ccpcz>	MP:0000111,cleft palate|MP:0000160,kyphosis|MP:0000220,increased monocyte cell number|MP:0000266,abnormal heart morphology|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0000689,abnormal spleen morphology|MP:0001404,no spontaneous movement|MP:0001672,abnormal embryo development|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0002060,abnormal skin morphology|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0003385,abnormal body wall morphology|MP:0003743,abnormal facial morphology|MP:0004848,abnormal liver size|MP:0005270,abnormal zygomatic bone morphology|MP:0005388,respiratory system phenotype|MP:0009908,protruding tongue|MP:0011495,abnormal head shape|MP:0011496,abnormal head size
MGI:3847803	Col2a1<Lpk>	MP:0000063,decreased bone mineral density|MP:0000111,cleft palate|MP:0000130,abnormal trabecular bone morphology|MP:0000131,abnormal long bone epiphysis morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000163,abnormal cartilage morphology|MP:0000164,abnormal cartilage development|MP:0000166,abnormal chondrocyte morphology|MP:0000445,short snout|MP:0000547,short limbs|MP:0001262,decreased body weight|MP:0001533,abnormal skeleton physiology|MP:0002113,abnormal skeleton development|MP:0002764,short tibia|MP:0003109,short femur|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003795,abnormal bone structure|MP:0004148,increased compact bone thickness|MP:0004200,decreased fetal size|MP:0004351,short humerus|MP:0004359,short ulna|MP:0004686,decreased length of long bones|MP:0004708,short lumbar vertebrae|MP:0005108,abnormal ulna morphology|MP:0005508,abnormal skeleton morphology|MP:0006395,abnormal epiphyseal plate morphology|MP:0006397,disorganized long bone epiphyseal plate|MP:0006399,abnormal long bone epiphyseal ossification zone morphology|MP:0008069,abnormal joint mobility|MP:0008151,increased diameter of long bones|MP:0008271,abnormal bone ossification|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0010879,decreased trabecular bone volume|MP:0011089,perinatal lethality, complete penetrance|MP:0011504,abnormal limb long bone morphology|MP:0013945,abnormal elbow joint morphology
MGI:6760646	Col2a1<m1Btlr>	MP:0002764,short tibia|MP:0003109,short femur
MGI:4999626	Col2a1<M2J>	MP:0000111,cleft palate|MP:0000445,short snout|MP:0001260,increased body weight|MP:0005458,increased percent body fat/body weight|MP:0005459,decreased percent body fat/body weight|MP:0011812,increased cranium length
MGI:5551861	Col2a1<M3J>	MP:0000445,short snout
MGI:5752936	Col2a1<mc13>	MP:0000088,short mandible|MP:0000433,microcephaly|MP:0000547,short limbs|MP:0002109,abnormal limb morphology|MP:0002764,short tibia|MP:0002765,short fibula|MP:0003109,short femur|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004686,decreased length of long bones|MP:0008151,increased diameter of long bones|MP:0008158,increased diameter of femur|MP:0008159,increased diameter of fibula|MP:0008160,increased diameter of humerus|MP:0008161,increased diameter of radius|MP:0008162,increased diameter of tibia|MP:0008163,increased diameter of ulna|MP:0011495,abnormal head shape|MP:0011504,abnormal limb long bone morphology
MGI:3800691	Col2a1<Rgsc413>	MP:0000445,short snout|MP:0000547,short limbs|MP:0001265,decreased body size|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004509,abnormal pelvic girdle bone morphology|MP:0006397,disorganized long bone epiphyseal plate|MP:0011089,perinatal lethality, complete penetrance|MP:0011175,platyspondylia|MP:0014103,increased chondrocyte apoptosis|MP:0014321,short forelimb
MGI:3808759	Col2a1<Rgsc856>	MP:0000137,abnormal vertebrae morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000445,short snout|MP:0000547,short limbs|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0002544,brachydactyly|MP:0003109,short femur|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004200,decreased fetal size|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004667,vertebral body hypoplasia|MP:0005390,skeleton phenotype|MP:0005508,abnormal skeleton morphology|MP:0006395,abnormal epiphyseal plate morphology|MP:0008736,micromelia|MP:0009780,abnormal chondrocyte physiology|MP:0011089,perinatal lethality, complete penetrance|MP:0011175,platyspondylia
MGI:2676325	Col2a1<sedc>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001328,disorganized retina layers|MP:0001410,head bobbing|MP:0001411,spinning|MP:0001663,abnormal digestive system physiology|MP:0002064,seizures|MP:0006325,impaired hearing
MGI:4830258	Col2a1<tm1.1Ksec>	MP:0000088,short mandible|MP:0000103,nasal bone hypoplasia|MP:0000432,abnormal head morphology|MP:0000433,microcephaly|MP:0000443,abnormal snout morphology|MP:0000445,short snout|MP:0000457,maxilla hypoplasia|MP:0000783,abnormal forebrain morphology|MP:0000830,abnormal diencephalon morphology|MP:0000913,abnormal brain development|MP:0001081,abnormal cranial ganglia morphology|MP:0001286,abnormal eye development|MP:0002111,abnormal tail morphology|MP:0002151,abnormal neural tube morphology|MP:0003232,abnormal forebrain development|MP:0003425,abnormal optic vesicle formation|MP:0004282,retrognathia|MP:0004871,premaxilla hypoplasia|MP:0004872,absent nasal septum|MP:0005157,holoprosencephaly|MP:0005163,cyclopia|MP:0006198,enophthalmos|MP:0006290,proboscis|MP:0009266,abnormal mesendoderm development|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012085,midface hypoplasia|MP:0013817,absent nasal cavity
MGI:5425899	Col2a1<tm1.1Mcali>	MP:0002169,no abnormal phenotype detected
MGI:5620959	Col2a1<tm1Dshh>	MP:0000111,cleft palate|MP:0000130,abnormal trabecular bone morphology|MP:0000149,abnormal scapula morphology|MP:0000164,abnormal cartilage development|MP:0000166,abnormal chondrocyte morphology|MP:0000438,abnormal cranium morphology|MP:0000445,short snout|MP:0000547,short limbs|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002113,abnormal skeleton development|MP:0002169,no abnormal phenotype detected|MP:0002657,chondrodystrophy|MP:0003109,short femur|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004134,abnormal chest morphology|MP:0004200,decreased fetal size|MP:0004351,short humerus|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004624,abnormal thoracic cage morphology|MP:0004686,decreased length of long bones|MP:0005225,abnormal vertebrae development|MP:0005306,abnormal phalanx morphology|MP:0006397,disorganized long bone epiphyseal plate|MP:0008151,increased diameter of long bones|MP:0008272,abnormal endochondral bone ossification|MP:0009780,abnormal chondrocyte physiology|MP:0011087,neonatal lethality, complete penetrance|MP:0030384,short facial bone
MGI:2152978	Col2a1<tm1Prc>	MP:0000063,decreased bone mineral density|MP:0000065,abnormal bone marrow cavity morphology|MP:0000088,short mandible|MP:0000111,cleft palate|MP:0000130,abnormal trabecular bone morphology|MP:0000131,abnormal long bone epiphysis morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000141,abnormal vertebral body morphology|MP:0000150,abnormal rib morphology|MP:0000163,abnormal cartilage morphology|MP:0000164,abnormal cartilage development|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000166,abnormal chondrocyte morphology|MP:0000285,abnormal heart valve morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000533,kidney hemorrhage|MP:0000547,short limbs|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001303,abnormal lens morphology|MP:0001698,decreased embryo size|MP:0001954,respiratory distress|MP:0002113,abnormal skeleton development|MP:0002115,abnormal limb bone morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002427,disproportionate dwarf|MP:0002657,chondrodystrophy|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003723,abnormal long bone morphology|MP:0004134,abnormal chest morphology|MP:0004200,decreased fetal size|MP:0004471,short nasal bone|MP:0004599,abnormal vertebral arch morphology|MP:0004669,enlarged vertebral body|MP:0004672,short ribs|MP:0004683,absent intervertebral disk|MP:0004686,decreased length of long bones|MP:0004711,persistence of notochord tissue|MP:0005193,abnormal anterior eye segment morphology|MP:0005195,abnormal posterior eye segment morphology|MP:0005352,small cranium|MP:0005370,liver/biliary system phenotype|MP:0005387,immune system phenotype|MP:0005391,vision/eye phenotype|MP:0005525,increased renal plasma flow rate|MP:0006397,disorganized long bone epiphyseal plate|MP:0006398,increased long bone epiphyseal plate size|MP:0006433,abnormal articular cartilage morphology|MP:0008272,abnormal endochondral bone ossification|MP:0009882,absent palatal shelf|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0014164,abnormal ciliary process morphology|MP:0014291,decreased autopod size|MP:0014430,decreased hyaluronic acid level|MP:0030049,prominent forehead|MP:0030384,short facial bone
MGI:3045169	Col2a1<tm1(SOX9)Crm>	MP:0000137,abnormal vertebrae morphology|MP:0000163,abnormal cartilage morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0001265,decreased body size|MP:0001954,respiratory distress|MP:0002114,abnormal axial skeleton morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003056,abnormal hyoid bone morphology|MP:0004356,radius hypoplasia|MP:0004686,decreased length of long bones|MP:0009890,cleft secondary palate|MP:0010029,abnormal basicranium morphology|MP:0010103,small thoracic cage|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014101,decreased chondrocyte proliferation
MGI:6283535	Col3a1<m1Btlr>	MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008537,increased susceptibility to induced colitis|MP:0012764,increased alpha-beta T cell number
MGI:5306912	Col3a1<m1Lsmi>	MP:0002083,premature death|MP:0003025,increased vasoconstriction|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004044,aortic dissection|MP:0006144,increased systemic arterial systolic blood pressure|MP:0009862,abnormal aorta elastic tissue morphology|MP:0009865,abnormal aorta smooth muscle morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:1857431	Col3a1<tm1Jae>	MP:0000477,abnormal intestine morphology|MP:0000598,abnormal liver morphology|MP:0001175,abnormal lung morphology|MP:0001212,skin lesions|MP:0001265,decreased body size|MP:0001614,abnormal blood vessel morphology|MP:0002083,premature death|MP:0005369,muscle phenotype|MP:0005385,cardiovascular system phenotype|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0009866,abnormal aorta wall morphology|MP:0010546,abnormal subendocardium layer morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1860700	Col3a1<Tsk2>	MP:0001198,tight skin|MP:0001245,thick dermal layer|MP:0002060,abnormal skin morphology|MP:0004947,skin inflammation|MP:0005384,cellular phenotype|MP:0009932,skin fibrosis|MP:0011091,prenatal lethality, complete penetrance|MP:0020386,adipose tissue inflammation
MGI:4822140	Col4a1<Acso>	MP:0000208,decreased hematocrit|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003236,abnormal lens capsule morphology|MP:0003631,nervous system phenotype|MP:0010261,sutural cataract|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:1856689	Col4a1<Bru>	MP:0001265,decreased body size|MP:0001304,cataract|MP:0001322,abnormal iris morphology|MP:0001577,anemia|MP:0001924,infertility|MP:0009274,buphthalmos|MP:0009275,bruising|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011481,anterior iris synechia
MGI:4822198	Col4a1<D456>	MP:0000208,decreased hematocrit|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0002152,abnormal brain morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011697,lens vacuoles
MGI:3579521	Col4a1<deltaex40>	MP:0000746,weakness|MP:0000751,myopathy|MP:0000788,abnormal cerebral cortex morphology|MP:0000791,delaminated cerebral cortex|MP:0000807,abnormal hippocampus morphology|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001575,cyanosis|MP:0001614,abnormal blood vessel morphology|MP:0001916,intracerebral hemorrhage|MP:0001921,reduced fertility|MP:0001954,respiratory distress|MP:0002064,seizures|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002959,increased urine microalbumin level|MP:0003354,astrocytosis|MP:0003954,abnormal Reichert's membrane morphology|MP:0004272,abnormal basement membrane morphology|MP:0006069,abnormal retina neuronal layer morphology|MP:0006221,optic nerve hypoplasia|MP:0008056,abnormal retina ganglion cell morphology|MP:0009026,abnormal brain pia mater morphology|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0010098,abnormal retina blood vessel pattern|MP:0010235,abnormal retina inner limiting membrane morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011187,abnormal parietal endoderm morphology|MP:0011380,enlarged brain ventricles|MP:0021002,brain lesion|MP:0031109,subarachnoid hemorrhage
MGI:4822148	Col4a1<ENU4004>	MP:0000208,decreased hematocrit|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0006203,eye hemorrhage|MP:0010259,anterior polar cataract|MP:0010263,total cataract|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011697,lens vacuoles
MGI:4822157	Col4a1<ENU6005>	MP:0000208,decreased hematocrit|MP:0002152,abnormal brain morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0010259,anterior polar cataract|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011697,lens vacuoles
MGI:4822158	Col4a1<ENU6009>	MP:0000208,decreased hematocrit|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0010259,anterior polar cataract|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4822161	Col4a1<ENU6019>	MP:0000208,decreased hematocrit|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0010259,anterior polar cataract
MGI:4822165	Col4a1<ENU6024>	MP:0000208,decreased hematocrit|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0010259,anterior polar cataract
MGI:4822141	Col4a1<ENU911>	MP:0000208,decreased hematocrit|MP:0001297,microphthalmia|MP:0001314,cornea opacity|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003631,nervous system phenotype|MP:0005542,cornea vascularization|MP:0010259,anterior polar cataract|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011697,lens vacuoles
MGI:4822166	Col4a1<F247>	MP:0000208,decreased hematocrit|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002152,abnormal brain morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003236,abnormal lens capsule morphology
MGI:2178446	Col4a1<Raw>	MP:0001325,abnormal retina morphology|MP:0009275,bruising
MGI:2178448	Col4a1<Svc>	MP:0001265,decreased body size|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001319,irregularly shaped pupil|MP:0001325,abnormal retina morphology|MP:0003381,vitreal fibroplasia|MP:0009274,buphthalmos|MP:0009275,bruising|MP:0010252,anterior subcapsular cataract|MP:0011481,anterior iris synechia
MGI:5896437	Col4a1<tm1.1Ics>	MP:0000528,delayed kidney development|MP:0000752,dystrophic muscle|MP:0001262,decreased body weight|MP:0001762,polyuria|MP:0001859,kidney inflammation|MP:0001915,intracranial hemorrhage|MP:0002136,abnormal kidney physiology|MP:0002828,abnormal renal glomerular capsule morphology|MP:0002871,albuminuria|MP:0002988,decreased urine osmolality|MP:0004193,abnormal kidney papilla morphology|MP:0004754,abnormal kidney collecting duct morphology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004860,dilated kidney collecting duct|MP:0005161,hematuria|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005565,increased blood urea nitrogen level|MP:0008059,abnormal podocyte foot process morphology|MP:0008060,abnormal podocyte slit diaphragm morphology|MP:0008140,podocyte foot process effacement|MP:0009050,dilated proximal convoluted tubule|MP:0010098,abnormal retina blood vessel pattern|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011339,abnormal glomerular mesangium morphology|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011402,renal cast|MP:0011419,erythrocyturia|MP:0011498,abnormal glomerular capsule parietal layer morphology|MP:0011501,increased glomerular capsule space|MP:0011502,parietal capsular epithelium metaplasia|MP:0011509,dilated glomerular capillary|MP:0011682,renal glomerulus cyst|MP:0011843,abnormal kidney collecting duct epithelium morphology|MP:0020153,abnormal urine albumin level|MP:0020254,decreased collagen level
MGI:6140180	Col4a2<em1(IMPC)Wtsi>	MP:0000150,abnormal rib morphology|MP:0000282,abnormal interatrial septum morphology|MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000572,abnormal autopod morphology|MP:0000681,abnormal thyroid gland morphology|MP:0000706,small thymus|MP:0000783,abnormal forebrain morphology|MP:0000841,abnormal hindbrain morphology|MP:0001061,abnormal oculomotor nerve morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001146,abnormal testis morphology|MP:0001303,abnormal lens morphology|MP:0002111,abnormal tail morphology|MP:0002177,abnormal outer ear morphology|MP:0002951,small thyroid gland|MP:0003078,aphakia|MP:0003686,abnormal eye muscle morphology|MP:0004160,retroesophageal right subclavian artery|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0004613,fusion of vertebral arches|MP:0005262,coloboma|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0006063,abnormal inferior vena cava morphology|MP:0006093,arteriovenous malformation|MP:0008922,abnormal cervical rib|MP:0008923,thoracoschisis|MP:0009569,abnormal left lung morphology|MP:0009570,abnormal right lung morphology|MP:0010088,decreased circulating fructosamine level|MP:0010420,muscular ventricular septal defect|MP:0010439,abnormal hepatic vein morphology|MP:0010463,aorta stenosis|MP:0010484,bicuspid aortic valve|MP:0011100,preweaning lethality, complete penetrance|MP:0013162,abnormal thyroid gland isthmus morphology|MP:0013163,absent thyroid gland isthmus|MP:0013848,subcutaneous edema|MP:0013867,abnormal ventral pancreas morphology|MP:0013875,increased trigeminal neuroma incidence|MP:0013876,absent ductus venosus valve|MP:0013877,abnormal ductus venosus valve morphology|MP:0013913,absent costovertebral joint|MP:0013936,abnormal thymus topology|MP:0013971,blood in lymph vessels|MP:0014001,abnormal vertebral artery topology|MP:0014003,additional anastomosis between intracranial vertebral arteries|MP:0014012,abnormal cranial blood vasculature morphology|MP:0014018,embryo tumor|MP:0014019,embryo cyst|MP:0014021,heterochrony|MP:0014023,abnormal intestine placement|MP:0014087,retrolental blood
MGI:4822172	Col4a2<ENU4003>	MP:0000208,decreased hematocrit|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001914,hemorrhage|MP:0002152,abnormal brain morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0009274,buphthalmos|MP:0010259,anterior polar cataract|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4822173	Col4a2<ENU4020>	MP:0000208,decreased hematocrit|MP:0002152,abnormal brain morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003237,abnormal lens epithelium morphology|MP:0010259,anterior polar cataract|MP:0010263,total cataract|MP:0010713,corneal-lenticular stalk|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011697,lens vacuoles
MGI:4822169	Col4a2<ENU415>	MP:0000208,decreased hematocrit|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001914,hemorrhage|MP:0002152,abnormal brain morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005205,abnormal eye anterior chamber morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011962,increased cornea thickness
MGI:4868441	Col4a3<tm1.1Rkl>	MP:0002083,premature death|MP:0002743,glomerulonephritis|MP:0002962,increased urine protein level|MP:0003215,renal interstitial fibrosis|MP:0004970,kidney atrophy|MP:0005325,abnormal renal glomerulus morphology|MP:0005553,increased circulating creatinine level|MP:0008140,podocyte foot process effacement
MGI:5548350	Col4a3<tm1b(EUCOMM)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0001319,irregularly shaped pupil|MP:0002607,decreased basophil cell number|MP:0002874,decreased hemoglobin content|MP:0003917,increased kidney weight|MP:0005016,decreased lymphocyte cell number|MP:0008805,decreased circulating amylase level|MP:0012362,increased large unstained cell number
MGI:1857432	Col4a3<tm1Dec>	MP:0000035,abnormal membranous labyrinth morphology|MP:0000048,abnormal stria vascularis morphology|MP:0001303,abnormal lens morphology|MP:0002083,premature death|MP:0002743,glomerulonephritis|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0002989,small kidney|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0004366,abnormal strial marginal cell morphology|MP:0004368,abnormal stria vascularis vasculature morphology|MP:0004598,abnormal cochlear basement membrane morphology|MP:0004740,sensorineural hearing loss|MP:0004969,pale kidney|MP:0005161,hematuria|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008140,podocyte foot process effacement|MP:0008770,decreased survivor rate|MP:0011320,abnormal glomerular capillary morphology|MP:0011346,renal tubule atrophy|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011349,abnormal renal glomerulus basement membrane thickness|MP:0011353,expanded mesangial matrix|MP:0011377,renal glomerulus fibrosis|MP:0011402,renal cast|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011427,increased mesangial cell number|MP:0011437,glomerulus hemorrhage|MP:0011534,granular kidney|MP:0011868,podocyte microvillus transformation|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1934893	Col4a3<tm1Jhm>	MP:0001262,decreased body weight|MP:0001762,polyuria|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002743,glomerulonephritis|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0002989,small kidney|MP:0003606,kidney failure|MP:0005202,lethargy|MP:0005264,glomerulosclerosis|MP:0005528,decreased renal glomerular filtration rate|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008059,abnormal podocyte foot process morphology|MP:0009644,uremia|MP:0011320,abnormal glomerular capillary morphology|MP:0011346,renal tubule atrophy|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011353,expanded mesangial matrix|MP:0011402,renal cast|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011506,glomerular crescent|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4838011	Col4a4<bwk>	MP:0001265,decreased body size|MP:0001859,kidney inflammation|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0002871,albuminuria|MP:0004969,pale kidney|MP:0005264,glomerulosclerosis|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0008140,podocyte foot process effacement|MP:0011346,renal tubule atrophy|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011402,renal cast|MP:0011405,tubulointerstitial nephritis|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011425,abnormal kidney interstitium morphology|MP:0011483,renal glomerular synechia|MP:0011506,glomerular crescent
MGI:6153784	Col4a4<em1(IMPC)H>	MP:0001304,cataract
MGI:4838032	Col4a4<m1Btlr>	MP:0000521,abnormal kidney cortex morphology|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002705,dilated renal tubule|MP:0002962,increased urine protein level|MP:0002989,small kidney|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0004740,sensorineural hearing loss|MP:0004969,pale kidney|MP:0005161,hematuria|MP:0005264,glomerulosclerosis|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0006325,impaired hearing|MP:0009511,distended stomach|MP:0009644,uremia|MP:0011346,renal tubule atrophy|MP:0011353,expanded mesangial matrix|MP:0011418,leukocyturia|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6501795	Col4a4<m1H>	MP:0000218,increased leukocyte cell number|MP:0001262,decreased body weight|MP:0001762,polyuria|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0002962,increased urine protein level|MP:0003606,kidney failure|MP:0005161,hematuria|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0005558,decreased creatinine clearance|MP:0005565,increased blood urea nitrogen level|MP:0005618,decreased urine potassium level|MP:0006317,decreased urine sodium level|MP:0008059,abnormal podocyte foot process morphology|MP:0008140,podocyte foot process effacement|MP:0011402,renal cast|MP:0011871,podocyte hypertrophy|MP:0011941,increased fluid intake
MGI:6479074	Col4a5<em1Keha>	MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002828,abnormal renal glomerular capsule morphology|MP:0002871,albuminuria|MP:0003215,renal interstitial fibrosis|MP:0005161,hematuria|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0008140,podocyte foot process effacement|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011353,expanded mesangial matrix|MP:0011409,increased renal glomerulus basement membrane thickness
MGI:5548921	Col4a5<tm1b(EUCOMM)Wtsi>	MP:0000194,increased circulating calcium level|MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0001566,increased circulating phosphate level|MP:0002135,abnormal kidney morphology|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004952,increased spleen weight|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005419,decreased circulating serum albumin level|MP:0005505,thrombocytosis|MP:0005553,increased circulating creatinine level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0008806,increased circulating amylase level|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level|MP:0012362,increased large unstained cell number
MGI:3609047	Col4a5<tm1Yseg>	MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002962,increased urine protein level|MP:0003236,abnormal lens capsule morphology|MP:0004969,pale kidney|MP:0005253,abnormal eye physiology|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005565,increased blood urea nitrogen level|MP:0008140,podocyte foot process effacement|MP:0011320,abnormal glomerular capillary morphology|MP:0011346,renal tubule atrophy|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011405,tubulointerstitial nephritis|MP:0011427,increased mesangial cell number|MP:0011483,renal glomerular synechia|MP:0011509,dilated glomerular capillary
MGI:3765459	Col4a6<tm1Jrs>	MP:0002169,no abnormal phenotype detected
MGI:7314199	Col5a1<em1Brle>	MP:0001243,abnormal dermal layer morphology|MP:0001244,thin dermal layer|MP:0003089,decreased skin tensile strength|MP:0008438,abnormal cutaneous collagen fibril morphology
MGI:3664598	Col5a1<tm1Rjw>	MP:0000272,abnormal aorta morphology|MP:0001191,abnormal skin condition|MP:0001243,abnormal dermal layer morphology|MP:0001614,abnormal blood vessel morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0002060,abnormal skin morphology|MP:0003089,decreased skin tensile strength|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5644153	Col5a1<tm2.1Rjw>	MP:0001314,cornea opacity|MP:0002169,no abnormal phenotype detected|MP:0003092,decreased cornea stroma thickness|MP:0003093,abnormal cornea anterior stroma morphology|MP:0003094,abnormal cornea posterior stroma morphology|MP:0003096,increased corneal light-scattering|MP:0005300,abnormal cornea stroma morphology|MP:0005378,growth/size/body region phenotype|MP:0011650,abnormal cornea stroma collagen fibril morphology
MGI:7627383	Col5a2<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001314,cornea opacity|MP:0002060,abnormal skin morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5770420	Col5a2<tm1.1Dgr>	MP:0002169,no abnormal phenotype detected
MGI:5817900	Col5a2<tm1.2Dgr>	MP:0000255,blood vessel congestion|MP:0001544,abnormal cardiovascular system physiology|MP:0003089,decreased skin tensile strength|MP:0003717,pallor|MP:0005501,abnormal skin physiology|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2152946	Col5a2<tm1Rmz>	MP:0001209,spontaneous skin ulceration|MP:0001244,thin dermal layer|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001312,abnormal cornea morphology|MP:0001385,pup cannibalization|MP:0001505,hunched posture|MP:0001954,respiratory distress|MP:0002113,abnormal skeleton development|MP:0003089,decreased skin tensile strength|MP:0003092,decreased cornea stroma thickness|MP:0003705,abnormal hypodermis morphology|MP:0004127,thick hypodermis|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0031253,lordokyphosis
MGI:5000519	Col5a3<tm1Dgr>	MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002693,abnormal pancreas physiology|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005386,behavior/neurological phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009109,decreased pancreas weight|MP:0009114,decreased pancreatic beta cell mass|MP:0014117,increased pancreatic beta cell apoptosis|MP:0014121,increased pancreatic islet cell apoptosis|MP:0030017,decreased adipocyte glucose uptake|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:2153356	Col6a1<tm1Gmb>	MP:0000751,myopathy|MP:0000759,abnormal skeletal muscle morphology|MP:0002108,abnormal muscle morphology|MP:0002279,abnormal diaphragm morphology|MP:0002280,abnormal intercostal muscle morphology|MP:0002841,impaired skeletal muscle contractility|MP:0003852,skeletal muscle necrosis|MP:0005369,muscle phenotype|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:6401814	Col6a1<tm1Sngi>	MP:0000733,abnormal muscle development|MP:0000747,muscle weakness|MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001392,abnormal locomotor behavior|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004819,decreased skeletal muscle mass|MP:0005164,abnormal response to injury|MP:0005293,impaired glucose tolerance|MP:0005390,skeleton phenotype|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009406,decreased skeletal muscle fiber number|MP:0009420,skeletal muscle endomysial fibrosis|MP:0010053,decreased grip strength|MP:0010240,decreased skeletal muscle size
MGI:6114017	Col6a2<m1Btlr>	MP:0001262,decreased body weight
MGI:5548922	Col6a2<tm1.1(KOMP)Vlcg>	MP:0010053,decreased grip strength
MGI:6336114	Col6a3<em1(IMPC)Kmpc>	MP:0000182,increased circulating LDL cholesterol level|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0005542,cornea vascularization|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0010053,decreased grip strength
MGI:6257456	Col6a3<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001258,decreased body length|MP:0003068,enlarged kidney|MP:0003233,prolonged QT interval|MP:0010053,decreased grip strength|MP:0011874,enlarged urinary bladder
MGI:5514357	Col6a3<tm1Chu>	MP:0000731,increased collagen deposition in the muscles|MP:0000751,myopathy|MP:0001262,decreased body weight|MP:0002106,abnormal muscle physiology|MP:0003851,skeletal muscle interstitial fibrosis|MP:0005391,vision/eye phenotype|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010239,decreased skeletal muscle weight|MP:0011643,abnormal tendon collagen fibril morphology|MP:0013237,abnormal skeletal muscle regeneration
MGI:5565209	Col6a3<tm2.1Chu>	MP:0000751,myopathy|MP:0002841,impaired skeletal muscle contractility|MP:0004087,abnormal muscle fiber morphology|MP:0004089,dilated sarcoplasmic reticulum|MP:0005503,abnormal tendon morphology|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0011633,abnormal mitochondrial shape|MP:0011643,abnormal tendon collagen fibril morphology|MP:0030803,abnormal tendon cell morphology
MGI:6367981	Col7a1<em1Kepa>	MP:0000579,abnormal nail morphology|MP:0001208,blistering|MP:0001243,abnormal dermal layer morphology|MP:0002060,abnormal skin morphology|MP:0005378,growth/size/body region phenotype|MP:0010768,mortality/aging
MGI:6367982	Col7a1<em2Kepa>	MP:0000579,abnormal nail morphology|MP:0001208,blistering|MP:0002060,abnormal skin morphology|MP:0005378,growth/size/body region phenotype|MP:0010768,mortality/aging
MGI:6367983	Col7a1<em3Kepa>	MP:0000579,abnormal nail morphology|MP:0001208,blistering|MP:0002060,abnormal skin morphology|MP:0005378,growth/size/body region phenotype|MP:0010768,mortality/aging
MGI:6367984	Col7a1<em4Kepa>	MP:0000579,abnormal nail morphology|MP:0001208,blistering|MP:0002060,abnormal skin morphology|MP:0005378,growth/size/body region phenotype|MP:0010768,mortality/aging
MGI:6367985	Col7a1<em5Kepa>	MP:0000579,abnormal nail morphology|MP:0001208,blistering|MP:0002060,abnormal skin morphology|MP:0005378,growth/size/body region phenotype|MP:0010768,mortality/aging
MGI:6390909	Col7a1<em#Jtol>	MP:0001208,blistering|MP:0008041,absent NK T cells|MP:0008070,absent T cells|MP:0008071,absent B cells
MGI:3796249	Col7a1<tm1.1Lbt>	MP:0002169,no abnormal phenotype detected
MGI:3796248	Col7a1<tm1Lbt>	MP:0000572,abnormal autopod morphology|MP:0000579,abnormal nail morphology|MP:0000762,abnormal tongue morphology|MP:0001208,blistering|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001243,abnormal dermal layer morphology|MP:0002082,postnatal lethality|MP:0002110,abnormal digit morphology|MP:0003723,abnormal long bone morphology|MP:0008489,slow postnatal weight gain|MP:0008770,decreased survivor rate|MP:0010124,decreased bone mineral content|MP:0011160,dermal-epidermal separation
MGI:2154650	Col7a1<tm1Uit>	MP:0001208,blistering|MP:0001243,abnormal dermal layer morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011160,dermal-epidermal separation
MGI:3587610	Col8a1<tm1Bjro>	MP:0003092,decreased cornea stroma thickness|MP:0031177,decreased Descemet membrane thickness|MP:0031213,increased eye anterior chamber depth
MGI:4438451	Col8a2<Aca23>	MP:0002092,abnormal eye morphology|MP:0003092,decreased cornea stroma thickness|MP:0005205,abnormal eye anterior chamber morphology|MP:0005391,vision/eye phenotype|MP:0005543,decreased cornea thickness|MP:0006000,abnormal cornea epithelium morphology|MP:0009829,enlarged eye anterior chamber|MP:0031177,decreased Descemet membrane thickness
MGI:5305275	Col8a2<tm1.1Asj>	MP:0004284,abnormal Descemet membrane morphology|MP:0005301,abnormal cornea endothelium morphology|MP:0006035,abnormal mitochondrial morphology|MP:0006042,increased apoptosis|MP:0008260,abnormal autophagy|MP:0031688,dilated rough endoplasmic reticulum
MGI:3587617	Col8a2<tm1Bjro>	MP:0004284,abnormal Descemet membrane morphology|MP:0031177,decreased Descemet membrane thickness
MGI:5774727	Col8a2<tm2.1Asj>	MP:0004284,abnormal Descemet membrane morphology|MP:0005301,abnormal cornea endothelium morphology|MP:0008260,abnormal autophagy|MP:0009378,abnormal endoplasmic reticulum morphology
MGI:2152964	Col9a1<tm1Jae>	MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0002898,absent cartilage|MP:0002999,abnormal bone healing|MP:0003149,abnormal tectorial membrane morphology|MP:0003560,osteoarthritis|MP:0004591,enlarged tectorial membrane|MP:0005353,abnormal patella morphology|MP:0005391,vision/eye phenotype|MP:0006325,impaired hearing|MP:0006433,abnormal articular cartilage morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014091,abnormal tectorial membrane striated-sheet matrix morphology|MP:0014100,increased chondrocyte proliferation|MP:0030837,abnormal knee joint morphology
MGI:5692882	Col9a2<tm1b(EUCOMM)Wtsi>	MP:0000552,abnormal radius morphology|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0000745,tremors|MP:0001402,decreased locomotor activity|MP:0001552,increased circulating triglyceride level|MP:0002102,abnormal ear morphology|MP:0002764,short tibia|MP:0002932,abnormal joint morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004738,abnormal auditory brainstem response|MP:0005108,abnormal ulna morphology|MP:0005296,abnormal humerus morphology|MP:0009142,decreased prepulse inhibition
MGI:6156598	Col9a3<em1(IMPC)Tcp>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001258,decreased body length|MP:0001552,increased circulating triglyceride level|MP:0002059,abnormal seminal vesicle morphology|MP:0004738,abnormal auditory brainstem response
MGI:5754592	Colec10<em2(IMPC)Tcp>	MP:0000137,abnormal vertebrae morphology|MP:0001120,abnormal uterus morphology|MP:0001258,decreased body length|MP:0001417,decreased exploration in new environment|MP:0001552,increased circulating triglyceride level|MP:0001566,increased circulating phosphate level|MP:0002764,short tibia|MP:0005270,abnormal zygomatic bone morphology|MP:0009142,decreased prepulse inhibition
MGI:5007083	Colec11<tm1Lex>	MP:0002703,abnormal renal tubule morphology|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0005265,abnormal blood urea nitrogen level|MP:0011566,abnormal complement protein level
MGI:6277022	Colec12<em1(IMPC)Mbp>	MP:0000692,small spleen|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0001891,hydrocephaly|MP:0002989,small kidney|MP:0009142,decreased prepulse inhibition
MGI:6194325	Colgalt1<fosse>	MP:0000111,cleft palate|MP:0000554,abnormal carpal bone morphology|MP:0000914,exencephaly|MP:0002092,abnormal eye morphology|MP:0005508,abnormal skeleton morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:6694288	Colgalt1<tm1.1Gpt>	MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001712,abnormal placenta development|MP:0003984,embryonic growth retardation|MP:0004001,decreased hepatocyte proliferation|MP:0005165,increased susceptibility to injury|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0008957,abnormal placenta junctional zone morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011523,thin placenta labyrinth|MP:0011525,abnormal placenta intervillous maternal lacunae morphology|MP:0012703,decreased embryonic neuroepithelium thickness|MP:0013247,placenta necrosis|MP:0014134,abnormal embryo morphology|MP:0030975,placenta hemorrhage
MGI:6763172	Colgalt2<tm1.1Hwei>	MP:0002941,increased circulating alanine transaminase level|MP:0004941,abnormal regulatory T cell morphology|MP:0005165,increased susceptibility to injury|MP:0006413,increased T cell apoptosis|MP:0008596,increased circulating interleukin-6 level|MP:0008602,increased circulating interleukin-4 level|MP:0008629,increased circulating interleukin-9 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0012773,abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell number
MGI:3777571	colm	MP:0003993,abnormal ventral spinal root morphology|MP:0009685,abnormal spinal cord motor column morphology
MGI:1857733	Colq<tm1Jrs>	MP:0000745,tremors|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0008770,decreased survivor rate|MP:0011084,lethality at weaning, incomplete penetrance
MGI:1857734	Colq<tm2Jrs>	MP:0000745,tremors|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0008770,decreased survivor rate|MP:0011084,lethality at weaning, incomplete penetrance
MGI:4842273	Commd10<tm1a(EUCOMM)Wtsi>	MP:0001711,abnormal placenta morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:3714157	Commd1<tm1Bvds>	MP:0000913,abnormal brain development|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001726,abnormal allantois morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0004560,abnormal chorionic plate morphology|MP:0006301,abnormal mesenchyme morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5315712	Commd1<tm2.1Bvds>	MP:0003066,increased liver copper level
MGI:6358284	Commd3<tm1.1Ksuz>	MP:0001806,decreased IgM level|MP:0005387,immune system phenotype|MP:0008174,decreased follicular B cell number|MP:0008191,abnormal follicular B cell physiology|MP:0008211,decreased mature B cell number|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008482,decreased spleen germinal center number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008897,decreased IgG2c level|MP:0013940,abnormal plasmablast number
MGI:6358283	Commd8<tm1.1Ksuz>	MP:0001806,decreased IgM level|MP:0005387,immune system phenotype|MP:0008174,decreased follicular B cell number|MP:0008191,abnormal follicular B cell physiology|MP:0008211,decreased mature B cell number|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008482,decreased spleen germinal center number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008897,decreased IgG2c level|MP:0013940,abnormal plasmablast number
MGI:3864158	Commd9<Gt(AQ0362)Wtsi>	MP:0001544,abnormal cardiovascular system physiology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0001916,intracerebral hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0002725,abnormal vein morphology|MP:0002740,heart hypoplasia|MP:0004787,abnormal dorsal aorta morphology|MP:0004938,dilated vasculature|MP:0005244,hemopericardium|MP:0006085,myocardium necrosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014012,abnormal cranial blood vasculature morphology
MGI:5692742	Commd9<tm1b(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0001322,abnormal iris morphology|MP:0001402,decreased locomotor activity|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0005293,impaired glucose tolerance|MP:0005419,decreased circulating serum albumin level|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level|MP:0011100,preweaning lethality, complete penetrance
MGI:5796331	Commd9<tm1c(KOMP)Wtsi>	MP:0010768,mortality/aging|MP:0011091,prenatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3522304	compas	MP:0001394,circling|MP:0006358,absent pinna reflex
MGI:2180787	Comp<tm1Aol>	MP:0002169,no abnormal phenotype detected|MP:0004883,abnormal vascular wound healing
MGI:3758741	Comp<tm1Mbri>	MP:0000166,abnormal chondrocyte morphology|MP:0000547,short limbs|MP:0000751,myopathy|MP:0001262,decreased body weight|MP:0002427,disproportionate dwarf|MP:0002764,short tibia|MP:0003098,decreased tendon stiffness|MP:0003560,osteoarthritis|MP:0003646,increased muscle fatigability|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004507,abnormal ischium morphology|MP:0004509,abnormal pelvic girdle bone morphology|MP:0005503,abnormal tendon morphology|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010053,decreased grip strength|MP:0014101,decreased chondrocyte proliferation|MP:0014103,increased chondrocyte apoptosis|MP:0030829,abnormal hip joint morphology
MGI:5550566	Comp<tm2.1Mbri>	MP:0000163,abnormal cartilage morphology|MP:0000166,abnormal chondrocyte morphology|MP:0001262,decreased body weight|MP:0002427,disproportionate dwarf|MP:0002764,short tibia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004509,abnormal pelvic girdle bone morphology|MP:0005390,skeleton phenotype|MP:0009780,abnormal chondrocyte physiology|MP:0030829,abnormal hip joint morphology
MGI:4819952	Comt<B2i>	MP:0003461,abnormal response to novel object|MP:0005386,behavior/neurological phenotype
MGI:6274226	Comt<tm1.1Tunb>	MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory|MP:0010698,abnormal impulsive behavior control|MP:0014114,abnormal cognition|MP:0014115,cognitive inflexibility
MGI:5637202	Comt<tm1b(EUCOMM)Wtsi>	MP:0001364,decreased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001566,increased circulating phosphate level|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0004924,abnormal behavior|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0010052,increased grip strength|MP:0010088,decreased circulating fructosamine level|MP:0020870,decreased thigmotaxis
MGI:5661839	Comt<tm1(COMT)Xzho>	MP:0001488,increased startle reflex|MP:0002757,decreased vertical activity|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory|MP:0009141,increased prepulse inhibition|MP:0009142,decreased prepulse inhibition|MP:0009453,enhanced contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior
MGI:2178542	Comt<tm1Kara>	MP:0000231,hypertension|MP:0001354,increased aggression towards male mice|MP:0001363,increased anxiety-related response|MP:0001711,abnormal placenta morphology|MP:0001764,abnormal homeostasis|MP:0001906,increased dopamine level|MP:0002161,abnormal fertility/fecundity|MP:0002294,short gestation period|MP:0002871,albuminuria|MP:0003231,abnormal placenta vasculature|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004256,abnormal maternal decidual layer morphology|MP:0005039,hypoxia|MP:0005325,abnormal renal glomerulus morphology|MP:0008566,increased interferon-gamma secretion|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0009394,increased uterine NK cell number|MP:0009642,abnormal blood homeostasis|MP:0009661,abnormal pregnancy
MGI:4830700	Comt<tm1Mkae>	MP:0008875,abnormal xenobiotic pharmacokinetics
MGI:5661843	Comt<tm2(COMT)Xzho>	MP:0001489,decreased startle reflex|MP:0002574,increased vertical activity|MP:0003106,abnormal fear-related response|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory|MP:0009141,increased prepulse inhibition|MP:0009142,decreased prepulse inhibition|MP:0009454,impaired contextual conditioning behavior|MP:0009455,enhanced cued conditioning behavior
MGI:6198566	conls	MP:0004022,abnormal cone electrophysiology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0008446,decreased retina cone cell number
MGI:4331666	Cop1<Gt(XR0177)Wtsi>	MP:0000267,abnormal heart development|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5301600	Cop1<Gt(XR0653)1.1Wtsi>	MP:0000373,belly spot|MP:0001262,decreased body weight|MP:0002020,increased tumor incidence|MP:0002021,increased incidence of induced tumors|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0004478,increased testicular teratoma incidence|MP:0009222,increased uterus tumor incidence|MP:0009321,increased histiocytic sarcoma incidence
MGI:4344899	Cop1<Gt(XR0653)Wtsi>	MP:0000267,abnormal heart development|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5013594	Cop1<tm2.1Vmd>	MP:0000659,prostate gland hyperplasia|MP:0003607,abnormal prostate gland physiology|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence
MGI:7336745	Copa<tm1.1Shum>	MP:0001175,abnormal lung morphology|MP:0001828,abnormal T cell activation|MP:0001861,lung inflammation|MP:0003828,pulmonary edema|MP:0004939,abnormal B cell morphology|MP:0005092,decreased double-positive T cell number|MP:0006050,pulmonary fibrosis|MP:0008082,increased single-positive T cell number|MP:0010998,pulmonary alveolar proteinosis|MP:0011091,prenatal lethality, complete penetrance|MP:0013772,increased effector memory T-helper cell number|MP:0031054,bronchiolitis|MP:0031238,reactive type II pneumocyte hyperplasia
MGI:6257733	Copb2<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity|MP:0002080,prenatal lethality|MP:0002792,abnormal retina vasculature morphology|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:6107885	Copb2<em1Rstot>	MP:0009850,embryonic lethality between implantation and placentation
MGI:6107886	Copb2<em2Rstot>	MP:0002169,no abnormal phenotype detected
MGI:6107887	Copb2<em3Rstot>	MP:0014257,embryonic lethality prior to tooth bud stage, complete penetrance
MGI:7611910	Copg1<em1Geha>	MP:0002459,abnormal B cell physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0006413,increased T cell apoptosis|MP:0008578,decreased circulating interferon-gamma level|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0020174,abnormal IgG level|MP:0020354,increased endoplasmic reticulum stress
MGI:4432009	Copg1<tm1a(EUCOMM)Wtsi>	MP:0005179,decreased circulating cholesterol level|MP:0005505,thrombocytosis|MP:0005561,increased mean corpuscular hemoglobin
MGI:5646194	Coprs<tm1.1Efab>	MP:0005376,homeostasis/metabolism phenotype|MP:0005670,abnormal white adipose tissue physiology|MP:0009118,increased white fat cell size|MP:0009131,decreased white fat cell number|MP:0009305,decreased retroperitoneal fat pad weight|MP:0011168,abnormal fat cell differentiation
MGI:5646193	Coprs<tm1Efab>	MP:0002169,no abnormal phenotype detected
MGI:2678281	Cops2<tm1Nwe>	MP:0001694,absent egg cylinders|MP:0001695,abnormal gastrulation|MP:0001713,decreased trophoblast giant cell number|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002718,abnormal inner cell mass morphology|MP:0009687,empty decidua capsularis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:2678261	Cops3<tm1Jrl>	MP:0011091,prenatal lethality, complete penetrance
MGI:2678262	Cops3<tm2Jrl>	MP:0011091,prenatal lethality, complete penetrance
MGI:4435445	Cops4<tm1a(EUCOMM)Hmgu>	MP:0001260,increased body weight|MP:0001402,decreased locomotor activity|MP:0004924,abnormal behavior|MP:0005564,increased hemoglobin content|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:4849637	Cops5<tm1Fxc>	MP:0000352,decreased cell proliferation|MP:0001698,decreased embryo size|MP:0003085,abnormal egg cylinder morphology|MP:0003984,embryonic growth retardation|MP:0004029,spontaneous chromosome breakage|MP:0010380,abnormal inner cell mass apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012113,decreased inner cell mass proliferation|MP:0013504,increased embryonic tissue cell apoptosis|MP:0014760,impaired DNA repair
MGI:3511260	Cops5<tm1Jka>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0004965,inner cell mass degeneration|MP:0010039,abnormal trophoblast giant cell proliferation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:3775801	Cops5<tm1Rpar>	MP:0000715,decreased thymocyte number|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002169,no abnormal phenotype detected|MP:0002216,abnormal seminiferous tubule morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004045,abnormal cell cycle checkpoint function|MP:0004852,decreased testis weight|MP:0005092,decreased double-positive T cell number|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0006413,increased T cell apoptosis|MP:0008083,decreased single-positive T cell number|MP:0009232,abnormal sperm nucleus morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0013589,thymus medulla hypoplasia|MP:0014052,increased male germ cell apoptosis|MP:0014636,decreased elongated spermatid number|MP:0020869,immotile sperm|MP:0031354,abnormal acrosome assembly|MP:0031389,abnormal ectoplasmic specialization morphology
MGI:4128701	Cops6<Gt(RRI087)Byg>	MP:0001658,increased mortality induced by gamma-irradiation|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0004503,decreased incidence of tumors by ionizing radiation induction|MP:0008943,increased sensitivity to induced cell death|MP:0009541,increased thymocyte apoptosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance
MGI:5287496	Cops6<Tg(Tyr)2261FOve>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5708189	Cops7a<tm1b(KOMP)Mbp>	MP:0000220,increased monocyte cell number|MP:0000538,abnormal urinary bladder morphology|MP:0001399,hyperactivity|MP:0001925,male infertility|MP:0002092,abnormal eye morphology|MP:0002833,increased heart weight|MP:0004924,abnormal behavior|MP:0005292,improved glucose tolerance|MP:0005566,decreased blood urea nitrogen level|MP:0009142,decreased prepulse inhibition|MP:0020870,decreased thigmotaxis
MGI:6442547	Cops8<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002591,decreased mean corpuscular volume|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3762120	Cops8<tm1.1Nwe>	MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0004966,abnormal inner cell mass proliferation|MP:0011091,prenatal lethality, complete penetrance
MGI:7343892	Cops9<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:5637057	Coq2<tm1b(EUCOMM)Hmgu>	MP:0002834,decreased heart weight|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6114793	Coq3<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001529,abnormal vocalization|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6358727	Coq3<tm1Hek>	MP:0005384,cellular phenotype|MP:0010768,mortality/aging|MP:0011091,prenatal lethality, complete penetrance
MGI:4441729	Coq4<tm1a(EUCOMM)Wtsi>	MP:0001711,abnormal placenta morphology|MP:0002836,abnormal chorion morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:7517092	Coq5<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:7861517	Coq6<em1Shcm>	MP:0002412,increased susceptibility to bacterial infection|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010955,abnormal respiratory electron transport chain|MP:0010959,abnormal oxidative phosphorylation
MGI:4435820	Coq6<tm1a(EUCOMM)Hmgu>	MP:0011092,embryonic lethality, complete penetrance
MGI:5548683	Coq6<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001312,abnormal cornea morphology|MP:0001697,abnormal embryo size|MP:0002699,abnormal vitreous body morphology|MP:0002861,abnormal tail bud morphology|MP:0003232,abnormal forebrain development|MP:0003984,embryonic growth retardation|MP:0005633,increased circulating sodium level|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6451728	Coq6<tm1c(EUCOMM)Hmgu>	MP:0001505,hunched posture|MP:0001511,disheveled coat|MP:0002083,premature death|MP:0002705,dilated renal tubule|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0002989,small kidney|MP:0003215,renal interstitial fibrosis|MP:0004969,pale kidney|MP:0005264,glomerulosclerosis|MP:0005326,abnormal podocyte morphology|MP:0006036,abnormal mitochondrial physiology|MP:0008062,abnormal podocyte slit junction morphology|MP:0008140,podocyte foot process effacement|MP:0011320,abnormal glomerular capillary morphology|MP:0011346,renal tubule atrophy|MP:0011377,renal glomerulus fibrosis|MP:0011402,renal cast|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011628,increased mitochondrial number|MP:0011630,increased mitochondrial size|MP:0011753,decreased podocyte number|MP:0013139,moribund
MGI:6273957	Coq7<em1(IMPC)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:2157003	Coq7<tm1Hek>	MP:0001661,extended life span|MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0006036,abnormal mitochondrial physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2158322	Coq7<tm1Tsh>	MP:0000352,decreased cell proliferation|MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0005058,abnormal lysosome morphology|MP:0006035,abnormal mitochondrial morphology|MP:0010957,abnormal aerobic respiration|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5532528	Coq7<tm2.1Hek>	MP:0011100,preweaning lethality, complete penetrance
MGI:5532527	Coq7<tm2Hek>	MP:0002169,no abnormal phenotype detected|MP:0005384,cellular phenotype|MP:0010955,abnormal respiratory electron transport chain|MP:0012556,increased cell death
MGI:6359448	Coq8a<tm1.1Ics>	MP:0000759,abnormal skeletal muscle morphology|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001548,hyperlipidemia|MP:0002272,abnormal nervous system electrophysiology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0005319,abnormal enzyme/coenzyme level|MP:0008414,abnormal spatial reference memory|MP:0009358,environmentally induced seizures|MP:0009412,skeletal muscle fiber degeneration|MP:0012106,impaired exercise endurance|MP:0014775,decreased skeletal muscle enzyme/coenzyme level|MP:0014781,decreased kidney enzyme/coenzyme level|MP:0014783,decreased liver enzyme/coenzyme level
MGI:5638687	Coq8b<tm1b(EUCOMM)Hmgu>	MP:0001402,decreased locomotor activity|MP:0005293,impaired glucose tolerance|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6455494	Coq8b<tm1c(EUCOMM)Hmgu>	MP:0001505,hunched posture|MP:0001510,abnormal coat appearance|MP:0002083,premature death|MP:0002965,increased circulating serum albumin level|MP:0002989,small kidney|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0004969,pale kidney|MP:0005264,glomerulosclerosis|MP:0005326,abnormal podocyte morphology|MP:0005419,decreased circulating serum albumin level|MP:0005565,increased blood urea nitrogen level|MP:0008062,abnormal podocyte slit junction morphology|MP:0008140,podocyte foot process effacement|MP:0011346,renal tubule atrophy|MP:0011628,increased mitochondrial number|MP:0011630,increased mitochondrial size
MGI:5473628	Coq9<tm1.1Lcl>	MP:0000751,myopathy|MP:0000755,hindlimb paralysis|MP:0000921,demyelination|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0002183,gliosis|MP:0002654,spongiform encephalopathy|MP:0002757,decreased vertical activity|MP:0003141,cardiac fibrosis|MP:0003203,increased neuron apoptosis|MP:0003354,astrocytosis|MP:0003674,oxidative stress|MP:0005114,premature hair loss|MP:0006036,abnormal mitochondrial physiology|MP:0008025,brain vacuoles|MP:0008143,abnormal dendrite morphology|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0014775,decreased skeletal muscle enzyme/coenzyme level|MP:0014777,decreased heart enzyme/coenzyme level|MP:0014779,decreased brain enzyme/coenzyme level|MP:0014781,decreased kidney enzyme/coenzyme level|MP:0014783,decreased liver enzyme/coenzyme level
MGI:3044391	Cora1<BALB/c>	MP:0003009,abnormal cytokine secretion
MGI:3044392	Cora1<STS/A>	MP:0003009,abnormal cytokine secretion
MGI:3772853	Corin<tm1Bamo>	MP:0000371,diluted coat color|MP:0000400,abnormal awl hair morphology|MP:0000402,abnormal zigzag hair morphology
MGI:3574359	Corin<tm1Qwu>	MP:0000231,hypertension|MP:0001260,increased body weight|MP:0001625,cardiac hypertrophy|MP:0002962,increased urine protein level|MP:0004217,salt-sensitive hypertension|MP:0005140,decreased cardiac muscle contractility|MP:0006144,increased systemic arterial systolic blood pressure
MGI:3522302	Cork	MP:0003051,curly tail
MGI:3818509	Coro1a<koy>	MP:0000715,decreased thymocyte number|MP:0002444,abnormal T cell physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:2156815	Coro1a<Lmb3-C57BL/6Scr>	MP:0002217,small lymph nodes|MP:0002743,glomerulonephritis|MP:0003726,decreased autoantibody level|MP:0004802,decreased susceptibility to systemic lupus erythematosus|MP:0004953,decreased spleen weight
MGI:2156814	Coro1a<Lmb3-MRL/MpScr>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004952,increased spleen weight
MGI:3818503	Coro1a<ptcd>	MP:0000714,increased thymocyte number|MP:0001828,abnormal T cell activation|MP:0002435,abnormal effector T cell morphology|MP:0002444,abnormal T cell physiology|MP:0006413,increased T cell apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:5548457	Coro1a<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0003631,nervous system phenotype
MGI:3664599	Coro1a<tm1Achn>	MP:0000715,decreased thymocyte number|MP:0003156,abnormal leukocyte migration|MP:0005018,decreased T cell number|MP:0006413,increased T cell apoptosis|MP:0008050,decreased memory T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008561,decreased tumor necrosis factor secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008764,increased mast cell degranulation
MGI:3778894	Coro1a<tm1Jpie>	MP:0000223,decreased monocyte cell number|MP:0001798,impaired macrophage phagocytosis|MP:0001828,abnormal T cell activation|MP:0002411,decreased susceptibility to bacterial infection|MP:0003850,abnormal thymocyte activation|MP:0005017,decreased B cell number|MP:0005095,decreased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008688,decreased interleukin-2 secretion
MGI:5302401	Coro1b<tm1.1Nfoe>	MP:0005387,immune system phenotype
MGI:4419168	Coro1c<tm1a(KOMP)Wtsi>	MP:0000282,abnormal interatrial septum morphology|MP:0000602,dilated liver sinusoidal space|MP:0000783,abnormal forebrain morphology|MP:0000826,abnormal third ventricle morphology|MP:0000914,exencephaly|MP:0001015,small superior cervical ganglion|MP:0001126,abnormal ovary morphology|MP:0002169,no abnormal phenotype detected|MP:0003131,increased erythrocyte cell number|MP:0003253,dilated bile duct|MP:0003595,epididymal cyst|MP:0003686,abnormal eye muscle morphology|MP:0004463,basisphenoid bone foramen|MP:0005274,abnormal viscerocranium morphology|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008922,abnormal cervical rib|MP:0009493,abnormal cystic duct morphology|MP:0009532,decreased parotid gland size|MP:0010490,abnormal inferior vena cava valve morphology|MP:0013848,subcutaneous edema|MP:0013859,abnormal vitelline vein connection|MP:0013876,absent ductus venosus valve|MP:0013968,multiple persisting craniopharyngeal ducts|MP:0013971,blood in lymph vessels|MP:0013975,abnormal coronary sinus connection|MP:0014001,abnormal vertebral artery topology|MP:0014018,embryo tumor|MP:0014021,heterochrony
MGI:6151182	Coro1c<tm1d(KOMP)Wtsi>	MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0002968,increased circulating alkaline phosphatase level|MP:0004720,abnormal platelet morphology|MP:0005505,thrombocytosis|MP:0011536,decreased urination frequency|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6188963	Coro2b<em1(IMPC)J>	MP:0002075,abnormal coat/hair pigmentation
MGI:6379356	Coro2b<tm1.1Cya>	MP:0002169,no abnormal phenotype detected
MGI:6379355	Coro2b<tm1Cya>	MP:0005166,decreased susceptibility to injury|MP:0005376,homeostasis/metabolism phenotype
MGI:4419137	Coro2b<tm1(KOMP)Wtsi>	MP:0005325,abnormal renal glomerulus morphology|MP:0005367,renal/urinary system phenotype|MP:0005389,reproductive system phenotype|MP:0006315,abnormal urine protein level|MP:0010768,mortality/aging|MP:0014699,increased fibroblast adhesion
MGI:4462636	Coro7<tm1a(EUCOMM)Hmgu>	MP:0002724,enhanced wound healing|MP:0011709,increased fibroblast cell migration|MP:0011743,abnormal Golgi apparatus morphology|MP:0014699,increased fibroblast adhesion|MP:0020849,abnormal actin cytoskeleton morphology
MGI:4431363	Cort<tm1(cre)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:3512113	Cort<tm1Ldl>	MP:0001386,abnormal maternal nurturing|MP:0001748,increased circulating adrenocorticotropin level|MP:0005121,decreased circulating prolactin level|MP:0005123,increased circulating growth hormone level|MP:0005129,increased adrenocorticotropin level|MP:0005138,decreased prolactin level|MP:0005331,insulin resistance|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005559,increased circulating glucose level|MP:0011067,abnormal somatostatin level|MP:0011612,increased circulating ghrelin level
MGI:3665149	cosa	MP:0000042,abnormal organ of Corti morphology|MP:0000048,abnormal stria vascularis morphology|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001522,impaired swimming|MP:0001961,abnormal reflex|MP:0002729,abnormal inner ear canal morphology|MP:0002730,head shaking|MP:0004287,abnormal spiral limbus morphology|MP:0004493,dilated cochlea|MP:0004845,absent vestibuloocular reflex|MP:0006024,collapsed Reissner membrane|MP:0006359,absent startle reflex
MGI:2157139	Cosz1<DBA/2J>	MP:0000950,abnormal seizure response to pharmacological agent
MGI:2389349	Cosz2<DBA/2J>	MP:0000950,abnormal seizure response to pharmacological agent
MGI:2389449	Cosz3<C57BL/6J>	MP:0000950,abnormal seizure response to pharmacological agent
MGI:5613651	Cotl1<tm1b(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0001303,abnormal lens morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0010068,decreased red blood cell distribution width
MGI:7615152	Cox10<em1(IMPC)Bay>	MP:0001410,head bobbing|MP:0001529,abnormal vocalization|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0011100,preweaning lethality, complete penetrance
MGI:3605782	Cox10<tm1Ctm>	MP:0000160,kyphosis|MP:0000751,myopathy|MP:0000759,abnormal skeletal muscle morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000811,hippocampal neuron degeneration|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002229,neurodegeneration|MP:0002757,decreased vertical activity|MP:0003224,neuron degeneration|MP:0003244,loss of dopaminergic neurons|MP:0003313,abnormal locomotor activation|MP:0003646,increased muscle fatigability|MP:0003690,abnormal glial cell physiology|MP:0004167,abnormal cingulate gyrus morphology|MP:0004819,decreased skeletal muscle mass|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005643,decreased dopamine level|MP:0006036,abnormal mitochondrial physiology|MP:0008657,increased interleukin-1 beta secretion|MP:0008722,abnormal chemokine secretion|MP:0008918,microgliosis|MP:0009403,increased variability of skeletal muscle fiber size|MP:0010009,abnormal piriform cortex morphology|MP:0011448,decreased dopaminergic neuron number|MP:0014814,increased brain glucose metabolism|MP:0020448,increased microglial cell activation
MGI:5707593	Cox15<m1Mhda>	MP:0002169,no abnormal phenotype detected
MGI:5695926	Cox15<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0002833,increased heart weight|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0008725,increased heart atrium size|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5292113	Cox15<tm1.1Zev>	MP:0000751,myopathy|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0006038,increased mitochondrial fission|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010954,abnormal cellular respiration|MP:0014342,abnormal muscle fiber mitochondrial morphology
MGI:5292114	Cox15<tm1.2Zev>	MP:0011092,embryonic lethality, complete penetrance
MGI:6276283	Cox16<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2388937	Cox17<tm1Kako>	MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6278517	Cox18<em1(IMPC)J>	MP:0002080,prenatal lethality|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5513759	Cox19<tm1b(EUCOMM)Hmgu>	MP:0000702,enlarged lymph nodes|MP:0001566,increased circulating phosphate level|MP:0005554,decreased circulating creatinine level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5754593	Cox20<em1(IMPC)Tcp>	MP:0000470,abnormal stomach morphology|MP:0001175,abnormal lung morphology|MP:0001488,increased startle reflex|MP:0002989,small kidney|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5548923	Cox4i1<tm1.1(KOMP)Vlcg>	MP:0001415,increased exploration in new environment|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3580677	Cox4i2<tm1Hutt>	MP:0001175,abnormal lung morphology|MP:0001861,lung inflammation|MP:0002133,abnormal respiratory system physiology|MP:0002335,decreased airway responsiveness|MP:0003961,decreased lean body mass|MP:0005292,improved glucose tolerance|MP:0005387,immune system phenotype|MP:0006050,pulmonary fibrosis|MP:0010053,decreased grip strength
MGI:5613669	Cox5b<tm2b(EUCOMM)Hmgu>	MP:0000603,pale liver|MP:0001289,persistence of hyaloid vascular system|MP:0001491,unresponsive to tactile stimuli|MP:0003717,pallor|MP:0004576,abnormal embryonic autopod plate morphology|MP:0004848,abnormal liver size|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:4419915	Cox6a1<tm1(KOMP)Wtsi>	MP:0000609,abnormal liver physiology|MP:0001405,impaired coordination|MP:0001516,abnormal motor coordination/balance|MP:0002108,abnormal muscle morphology|MP:0002269,muscular atrophy|MP:0002651,abnormal sciatic nerve morphology|MP:0005403,abnormal nerve conduction
MGI:2181189	Cox6a2<tm1Djg>	MP:0001544,abnormal cardiovascular system physiology|MP:0004011,decreased diastolic filling velocity|MP:0005385,cardiovascular system phenotype
MGI:6156449	Cox6b1<em1(IMPC)Tcp>	MP:0001297,microphthalmia|MP:0001697,abnormal embryo size|MP:0002060,abnormal skin morphology|MP:0004122,abnormal sinus arrhythmia|MP:0004952,increased spleen weight|MP:0005313,absent adrenal gland|MP:0011100,preweaning lethality, complete penetrance
MGI:7425603	Cox6b2<em1(IMPC)Bay>	MP:0010053,decreased grip strength
MGI:7738839	Cox6b2<em1Osb>	MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0020451,decreased sperm progressive motility
MGI:3580679	Cox7a1<tm1Hutt>	MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0003915,increased heart left ventricle weight|MP:0005385,cardiovascular system phenotype|MP:0005598,decreased heart ventricle muscle contractility|MP:0010954,abnormal cellular respiration
MGI:6385694	Cox7a2l<em1(IMPC)J>	MP:0000194,increased circulating calcium level|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0010506,prolonged RR interval
MGI:4247007	Cox7a2l<Gt(OST241316)Lex>	MP:0003061,decreased aerobic running capacity|MP:0005266,abnormal metabolism|MP:0005290,decreased oxygen consumption|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008964,decreased carbon dioxide production|MP:0010227,decreased quadriceps weight|MP:0010378,increased respiratory quotient|MP:0010954,abnormal cellular respiration|MP:0010959,abnormal oxidative phosphorylation|MP:0011049,impaired adaptive thermogenesis|MP:0020520,whitened brown adipose tissue morphology
MGI:6276120	Cox7a2l<s>	MP:0010955,abnormal respiratory electron transport chain
MGI:6385264	Cox7a2<tm1b(EUCOMM)Hmgu>	MP:0000062,increased bone mineral density|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0010378,increased respiratory quotient|MP:0011939,increased food intake
MGI:6764559	Cox7b2<em1Smtb>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0009230,abnormal sperm head morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology
MGI:4126632	Cox7b<Gt(XH290)Byg>	MP:0009781,abnormal preimplantation embryo development
MGI:5463977	Cox7c<tm1b(KOMP)Mbp>	MP:0001697,abnormal embryo size|MP:0001711,abnormal placenta morphology|MP:0001712,abnormal placenta development|MP:0002080,prenatal lethality|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0005650,abnormal limb bud morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration|MP:0013279,increased fasting circulating glucose level
MGI:7738840	Cox8c<em1Osb>	MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype
MGI:6764558	Cox8c<em1Smtb>	MP:0005389,reproductive system phenotype
MGI:7624377	Coxfa4l3<em1Nyam>	MP:0001859,kidney inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002135,abnormal kidney morphology|MP:0002371,abnormal thymus cortex morphology|MP:0002375,abnormal thymus medulla morphology|MP:0002493,increased IgG level|MP:0005350,increased susceptibility to autoimmune disorder|MP:0006036,abnormal mitochondrial physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0012604,decreased glutathione level|MP:0014245,increased cellular ATP level|MP:0030940,impaired autophagy
MGI:6501733	Cpa1<tm1.1Satom>	MP:0001869,pancreas inflammation|MP:0002693,abnormal pancreas physiology|MP:0004247,small pancreas|MP:0008806,increased circulating amylase level|MP:0009109,decreased pancreas weight|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009149,decreased pancreatic acinar cell number|MP:0013221,pancreatic acinar-to-ductal metaplasia|MP:0013295,pancreas atrophy|MP:0030681,increased circulating hydroxyproline level
MGI:3720733	Cpa1<tm1(cre/ERT2)Dam>	MP:0002169,no abnormal phenotype detected
MGI:6501752	Cpa1<tm1Satom>	MP:0005379,endocrine/exocrine gland phenotype|MP:0008805,decreased circulating amylase level
MGI:5548904	Cpa2<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001926,female infertility|MP:0003020,decreased circulating chloride level
MGI:5605833	Cpa3<tm1.1(KOMP)Vlcg>	MP:0002135,abnormal kidney morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3583651	Cpa3<tm1Hrr>	MP:0000359,abnormal mast cell morphology|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:3760646	Cpa3<tm2Hrr>	MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:3829878	Cpa3<tm3(icre)Hrr>	MP:0001845,abnormal inflammatory response|MP:0002607,decreased basophil cell number|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0011696,absent mast cells
MGI:6376205	Cpa5<em1(IMPC)J>	MP:0005333,decreased heart rate|MP:0005635,decreased circulating bilirubin level|MP:0010506,prolonged RR interval
MGI:7462004	Cpa6<em1(IMPC)Bay>	MP:0001486,abnormal startle reflex|MP:0001926,female infertility
MGI:5428007	Cpap<tm1.1Tkt>	MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:4432238	Cpap<tm1a(EUCOMM)Wtsi>	MP:0000109,abnormal parietal bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000195,decreased circulating calcium level|MP:0000278,abnormal myocardial fiber morphology|MP:0000432,abnormal head morphology|MP:0000438,abnormal cranium morphology|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001293,anophthalmia|MP:0001322,abnormal iris morphology|MP:0001360,abnormal social investigation|MP:0001391,abnormal tail movements|MP:0001402,decreased locomotor activity|MP:0001732,postnatal growth retardation|MP:0001938,delayed sexual maturation|MP:0002111,abnormal tail morphology|MP:0002175,decreased brain weight|MP:0002759,abnormal caudal vertebrae morphology|MP:0002932,abnormal joint morphology|MP:0003631,nervous system phenotype|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003961,decreased lean body mass|MP:0004046,abnormal mitosis|MP:0004083,polysyndactyly|MP:0004200,decreased fetal size|MP:0004221,abnormal iridocorneal angle|MP:0004222,iris synechia|MP:0004284,abnormal Descemet membrane morphology|MP:0004353,abnormal deltoid tuberosity morphology|MP:0004373,bowed humerus|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004609,vertebral fusion|MP:0004619,caudal vertebral fusion|MP:0004624,abnormal thoracic cage morphology|MP:0004657,small sacral vertebrae|MP:0004708,short lumbar vertebrae|MP:0004924,abnormal behavior|MP:0005015,increased T cell number|MP:0005108,abnormal ulna morphology|MP:0005176,eyelids fail to open|MP:0005269,abnormal occipital bone morphology|MP:0005291,abnormal glucose tolerance|MP:0005296,abnormal humerus morphology|MP:0005301,abnormal cornea endothelium morphology|MP:0005352,small cranium|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0005621,abnormal cell physiology|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008148,abnormal sternocostal joint morphology|MP:0008273,abnormal intramembranous bone ossification|MP:0008297,retention of the adrenal gland x-zone|MP:0008866,chromosomal instability|MP:0008948,decreased neuron number|MP:0009199,abnormal external male genitalia morphology|MP:0009431,decreased fetal weight|MP:0009760,abnormal mitotic spindle morphology|MP:0010025,decreased total body fat amount|MP:0010101,increased sacral vertebrae number|MP:0010124,decreased bone mineral content|MP:0010865,prenatal growth retardation|MP:0010948,abnormal double-strand DNA break repair|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011862,decreased cranium length|MP:0013504,increased embryonic tissue cell apoptosis|MP:0014164,abnormal ciliary process morphology|MP:0030048,sloping forehead|MP:0030167,decreased inner canthal distance
MGI:5609805	Cpap<tm1b(EUCOMM)Wtsi>	MP:0001672,abnormal embryo development|MP:0001730,embryonic growth arrest|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5613963	Cpap<tm1d(EUCOMM)Wtsi>	MP:0001700,abnormal embryo turning|MP:0001730,embryonic growth arrest|MP:0004046,abnormal mitosis|MP:0004132,absent embryonic cilia|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis|MP:0030943,abnormal centrosome morphology
MGI:5605652	Cpb1<tm1.1(KOMP)Vlcg>	MP:0005560,decreased circulating glucose level|MP:0005568,increased circulating total protein level
MGI:7433055	Cpb2<em1(IMPC)Ccpcz>	MP:0001284,absent vibrissae|MP:0002833,increased heart weight
MGI:2445419	Cpb2<tm1Efp>	MP:0002551,abnormal blood coagulation
MGI:3608921	Cpb2<tm1Jcmm>	MP:0001792,impaired wound healing|MP:0002006,neoplasm|MP:0002908,delayed wound healing|MP:0003422,abnormal thrombolysis|MP:0005023,abnormal wound healing|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:2159468	Cpb2<tm1Mng>	MP:0002551,abnormal blood coagulation|MP:0005571,decreased lactate dehydrogenase level|MP:0006050,pulmonary fibrosis|MP:0008721,abnormal chemokine level|MP:0008752,abnormal tumor necrosis factor level|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:3510646	Cpb2<tm1Nok>	MP:0001846,increased inflammatory response|MP:0002472,impaired complement alternative pathway|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011502,parietal capsular epithelium metaplasia
MGI:6379278	Cpd<em1(IMPC)J>	MP:0001697,abnormal embryo size|MP:0003717,pallor|MP:0005278,abnormal cholesterol homeostasis|MP:0005293,impaired glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005553,increased circulating creatinine level|MP:0010392,prolonged QRS complex duration|MP:0011100,preweaning lethality, complete penetrance
MGI:3606747	Cpeb1<tm1Rcht>	MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0001929,abnormal gametogenesis|MP:0002160,abnormal reproductive system morphology|MP:0002161,abnormal fertility/fecundity|MP:0002207,abnormal long-term potentiation|MP:0002687,oligozoospermia|MP:0003578,absent ovary|MP:0003582,abnormal ovary development|MP:0004852,decreased testis weight|MP:0005168,abnormal female meiosis|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:5882110	Cpeb2<tm1.1Yshu>	MP:0001951,abnormal breathing pattern|MP:0001952,increased airway responsiveness|MP:0001953,respiratory failure|MP:0001957,apnea|MP:0002337,abnormal whole-body plethysmography|MP:0005574,decreased pulmonary respiratory rate|MP:0012593,increased brain choline acetyltransferase activity|MP:0030676,increased acetylcholine level
MGI:5882111	Cpeb2<tm1.2Yshu>	MP:0001037,abnormal parasympathetic neuron morphology|MP:0001945,bronchoconstriction|MP:0001951,abnormal breathing pattern|MP:0001953,respiratory failure|MP:0001957,apnea|MP:0002337,abnormal whole-body plethysmography|MP:0003631,nervous system phenotype|MP:0005333,decreased heart rate|MP:0005378,growth/size/body region phenotype|MP:0005574,decreased pulmonary respiratory rate|MP:0006277,abnormal parasympathetic nervous system physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012593,increased brain choline acetyltransferase activity|MP:0030676,increased acetylcholine level
MGI:7261344	Cpeb3<em1Gaoxu>	MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002680,decreased corpora lutea number|MP:0004833,ovary atrophy|MP:0004856,decreased ovary weight|MP:0005181,decreased circulating estradiol level|MP:0009093,oocyte degeneration|MP:0011121,decreased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0013508,increased granulosa cell apoptosis|MP:0031018,decreased granulosa cell proliferation|MP:0031020,premature ovarian failure|MP:0031239,increased atretic ovarian follicle number|MP:0031381,decreased secondary ovarian follicle number|MP:0031420,decreased superovulation rate
MGI:5562642	Cpeb3<tm1.2Yshu>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001898,abnormal long-term depression|MP:0001923,reduced female fertility|MP:0003631,nervous system phenotype|MP:0004231,abnormal calcium ion homeostasis|MP:0004811,abnormal neuron physiology|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0008414,abnormal spatial reference memory|MP:0009453,enhanced contextual conditioning behavior|MP:0009936,abnormal dendritic spine morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology
MGI:5587820	Cpeb4<tm1.1Yshu>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0009936,abnormal dendritic spine morphology
MGI:4434181	Cpeb4<tm1a(EUCOMM)Wtsi>	MP:0000245,abnormal erythropoiesis|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001436,abnormal suckling behavior|MP:0001954,respiratory distress|MP:0003631,nervous system phenotype|MP:0003651,abnormal axon extension|MP:0003795,abnormal bone structure|MP:0005369,muscle phenotype|MP:0005621,abnormal cell physiology|MP:0008415,abnormal neurite morphology|MP:0008770,decreased survivor rate|MP:0009546,absent gastric milk in neonates|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0011240,abnormal fetal derived definitive erythrocyte morphology|MP:0011243,decreased fetal derived definitive erythrocyte cell number|MP:0012055,abnormal phrenic nerve innervation pattern to diaphragm
MGI:6120733	Cpeb4<tm1b(EUCOMM)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0002059,abnormal seminal vesicle morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5805966	Cpeb4<tm1d(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:1856395	Cpe<fat>	MP:0000182,increased circulating LDL cholesterol level|MP:0000189,hypoglycemia|MP:0000505,decreased digestive secretion|MP:0001261,obese|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0001559,hyperglycemia|MP:0001752,abnormal hypothalamus secretion|MP:0001924,infertility|MP:0002079,increased circulating insulin level|MP:0002664,decreased circulating adrenocorticotropin level|MP:0003953,abnormal hormone level|MP:0003973,increased pituitary hormone level|MP:0004732,decreased circulating gastrin level|MP:0005117,increased circulating pituitary hormone level|MP:0005123,increased circulating growth hormone level|MP:0005137,increased growth hormone level|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005457,abnormal percent body fat/body weight|MP:0005480,increased circulating triiodothyronine level|MP:0005491,pancreatic islet hyperplasia|MP:0009167,increased pancreatic islet number|MP:0009255,degranulated pancreatic beta cells|MP:0010024,increased total body fat amount|MP:0011049,impaired adaptive thermogenesis
MGI:5548328	Cpe<tm1b(EUCOMM)Hmgu>	MP:0000194,increased circulating calcium level|MP:0000218,increased leukocyte cell number|MP:0001258,decreased body length|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0001925,male infertility|MP:0002590,increased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0002757,decreased vertical activity|MP:0002797,increased thigmotaxis|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003020,decreased circulating chloride level|MP:0004924,abnormal behavior|MP:0005293,impaired glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005559,increased circulating glucose level|MP:0010053,decreased grip strength|MP:0010463,aorta stenosis|MP:0011940,decreased food intake|MP:0013279,increased fasting circulating glucose level
MGI:3527901	Cpe<tm1Yplo>	MP:0000745,tremors|MP:0001257,increased body length|MP:0001261,obese|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001433,polyphagia|MP:0001516,abnormal motor coordination/balance|MP:0001526,abnormal placing response|MP:0001752,abnormal hypothalamus secretion|MP:0001921,reduced fertility|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002106,abnormal muscle physiology|MP:0002757,decreased vertical activity|MP:0004262,abnormal physical strength|MP:0005202,lethargy|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005450,abnormal energy expenditure|MP:0005498,hyporesponsive to tactile stimuli|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010378,increased respiratory quotient
MGI:2153996	Cpfd1<NZB/BlNJ>	MP:0000849,abnormal cerebellum morphology
MGI:2153998	Cpfd2<NZB/BlNJ>	MP:0000849,abnormal cerebellum morphology
MGI:2155992	Cpfd3<NZB/BlNJ>	MP:0000849,abnormal cerebellum morphology
MGI:2157095	Cpfd4<NZB/BlNJ>	MP:0000849,abnormal cerebellum morphology
MGI:2157097	Cpfd5<NZB/BlNJ>	MP:0000849,abnormal cerebellum morphology
MGI:3624359	Cpfl2	MP:0001325,abnormal retina morphology|MP:0004022,abnormal cone electrophysiology|MP:0012671,retina spots
MGI:3624361	Cpfl4	MP:0001325,abnormal retina morphology|MP:0004022,abnormal cone electrophysiology|MP:0012671,retina spots
MGI:4867510	cpfl6	MP:0001326,retina degeneration|MP:0004022,abnormal cone electrophysiology
MGI:3696948	cpfl7	MP:0001326,retina degeneration|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0004022,abnormal cone electrophysiology|MP:0008056,abnormal retina ganglion cell morphology
MGI:6359756	Cpgi5563<tm1.1(NCC)Wcs>	MP:0001260,increased body weight|MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008347,decreased gamma-delta T cell number|MP:0008805,decreased circulating amylase level|MP:0010123,increased bone mineral content|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010845,decreased effector memory CD4-positive, alpha-beta T cell number|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5297398	Cplane1<b2b012Clo>	MP:0000111,cleft palate|MP:0000137,abnormal vertebrae morphology|MP:0000157,abnormal sternum morphology|MP:0000266,abnormal heart morphology|MP:0000284,double outlet right ventricle|MP:0000460,mandible hypoplasia|MP:0000562,polydactyly|MP:0000762,abnormal tongue morphology|MP:0000774,decreased brain size|MP:0000849,abnormal cerebellum morphology|MP:0001178,pulmonary hypoplasia|MP:0001792,impaired wound healing|MP:0002192,hydrops fetalis|MP:0002244,abnormal turbinate morphology|MP:0002633,persistent truncus arteriosus|MP:0002639,micrognathia|MP:0002705,dilated renal tubule|MP:0003675,kidney cyst|MP:0003984,embryonic growth retardation|MP:0004017,duplex kidney|MP:0004158,right aortic arch|MP:0004320,split sternum|MP:0004624,abnormal thoracic cage morphology|MP:0004686,decreased length of long bones|MP:0005170,cleft upper lip|MP:0005377,hearing/vestibular/ear phenotype|MP:0006046,atrioventricular valve regurgitation|MP:0006047,aortic valve regurgitation|MP:0006128,pulmonary valve stenosis|MP:0006130,pulmonary valve atresia|MP:0009703,decreased birth body size|MP:0009743,preaxial polydactyly|MP:0010158,abnormal intestine development|MP:0010402,ventricular septal defect|MP:0010406,common atrium|MP:0010412,atrioventricular septal defect|MP:0010413,complete atrioventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010460,pulmonary artery hypoplasia|MP:0011066,abnormal renal tubule epithelial cell primary cilium morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011884,absent colon|MP:0012285,misaligned sternebrae|MP:0013203,abnormal primary cilium morphology|MP:0013205,abnormal nonmotile primary cilium morphology|MP:0021210,bilateral cleft palate|MP:0031443,abnormal tongue position
MGI:5754571	Cplane1<em1(IMPC)Tcp>	MP:0002092,abnormal eye morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5616147	Cplane2<b2b2804Clo>	MP:0000484,abnormal pulmonary artery morphology|MP:0000562,polydactyly|MP:0000572,abnormal autopod morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002633,persistent truncus arteriosus|MP:0002639,micrognathia|MP:0006063,abnormal inferior vena cava morphology|MP:0009743,preaxial polydactyly|MP:0010406,common atrium|MP:0010412,atrioventricular septal defect
MGI:5560911	Cplane2<b2b2827Clo>	MP:0000562,polydactyly|MP:0000644,dextrocardia|MP:0001178,pulmonary hypoplasia|MP:0001823,thymus hypoplasia|MP:0002633,persistent truncus arteriosus|MP:0002639,micrognathia|MP:0003321,tracheoesophageal fistula|MP:0004133,heterotaxia|MP:0005170,cleft upper lip|MP:0010406,common atrium|MP:0010412,atrioventricular septal defect|MP:0010885,absent trachea|MP:0011254,superior-inferior ventricles
MGI:3588359	Cplaq10<CXB7/ByJ>	MP:0020470,shortened circadian behavior period
MGI:3588362	Cplaq11<CXB7/ByJ>	MP:0020470,shortened circadian behavior period
MGI:3588365	Cplaq12<CXB7/ByJ>	MP:0020470,shortened circadian behavior period
MGI:3053946	Cplaq13<DBA/2J>	MP:0020470,shortened circadian behavior period
MGI:3588354	Cplaq14<CXB7/ByJ>	MP:0020470,shortened circadian behavior period
MGI:3581256	Cplaq8<DBA/2J>	MP:0020469,prolonged circadian behavior period
MGI:3588357	Cplaq9<BXD19/TyJ>	MP:0020470,shortened circadian behavior period
MGI:2679624	Cplx1<tm2Bros>	MP:0000242,impaired fertilization|MP:0000951,sporadic seizures|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001924,infertility|MP:0001925,male infertility|MP:0002083,premature death|MP:0002566,abnormal sexual interaction|MP:0002675,asthenozoospermia|MP:0004542,impaired acrosome reaction|MP:0004807,abnormal paired-pulse inhibition|MP:0004811,abnormal neuron physiology|MP:0005389,reproductive system phenotype|MP:0006335,abnormal hearing electrophysiology|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014376,decreased miniature excitatory postsynaptic current frequency|MP:0014740,increased auditory brainstem response wave peak latency|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:2679626	Cplx2<tm1Bros>	MP:0001362,abnormal anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001417,decreased exploration in new environment|MP:0001440,abnormal grooming behavior|MP:0001442,decreased grooming behavior|MP:0001446,abnormal whisker trimming behavior|MP:0001463,abnormal spatial learning|MP:0001488,increased startle reflex|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0002063,abnormal learning/memory/conditioning|MP:0002065,abnormal fear/anxiety-related behavior|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002757,decreased vertical activity|MP:0002797,increased thigmotaxis|MP:0005357,novel environmental response-related retropulsion|MP:0005386,behavior/neurological phenotype|MP:0005507,tail dragging|MP:0008414,abnormal spatial reference memory|MP:0008911,induced hyperactivity|MP:0020083,decreased hippocampus volume
MGI:2680035	Cplx2<tm1Tyag>	MP:0001473,reduced long-term potentiation
MGI:3796622	Cplx3<tm1Bros>	MP:0003631,nervous system phenotype|MP:0004022,abnormal cone electrophysiology|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology|MP:0010768,mortality/aging
MGI:6403707	Cplx4<em1(IMPC)H>	MP:0002941,increased circulating alanine transaminase level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005568,increased circulating total protein level
MGI:3851151	Cplx4<tm1Bros>	MP:0004021,abnormal rod electrophysiology|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology
MGI:5009698	Cp<m1Btlr>	MP:0004151,decreased circulating iron level|MP:0008807,increased liver iron level
MGI:3714926	Cp<m1Cbea>	MP:0005638,hemochromatosis
MGI:7425604	Cpm<em1(IMPC)Ccpcz>	MP:0001262,decreased body weight|MP:0005387,immune system phenotype|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010067,increased red blood cell distribution width|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013772,increased effector memory T-helper cell number
MGI:5661930	Cpn1<tm1b(KOMP)Wtsi>	MP:0000194,increased circulating calcium level|MP:0010053,decreased grip strength
MGI:3844631	Cpn1<tm1Raw>	MP:0002471,abnormal complement pathway|MP:0005088,increased acute inflammation
MGI:7425605	Cpne1<em1(IMPC)Kmpc>	MP:0005278,abnormal cholesterol homeostasis|MP:0020420,abnormal freezing behavior
MGI:6358726	Cpne5<tm1Mfan>	MP:0001364,decreased anxiety-related response|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype
MGI:5572035	Cpne5<tm2b(EUCOMM)Hmgu>	MP:0000689,abnormal spleen morphology
MGI:5882517	Cpne6<tm1.1Rueg>	MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0009936,abnormal dendritic spine morphology
MGI:6152449	Cpne7<em1(IMPC)Mbp>	MP:0000494,abnormal cecum morphology|MP:0002060,abnormal skin morphology|MP:0010123,increased bone mineral content
MGI:7628719	Cpne7<tm1Parkj>	MP:0002689,abnormal molar morphology|MP:0002818,abnormal dentin morphology|MP:0008008,early cellular replicative senescence|MP:0013250,abnormal dental pulp morphology|MP:0030453,abnormal odontoblast morphology|MP:0030559,abnormal dental pulp canal morphology|MP:0031626,increased dental pulp cell apoptosis
MGI:6306621	Cpox<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:1856966	Cpox<nct>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001309,hydropic eye lens fibers|MP:0002840,abnormal lens fiber morphology
MGI:6117774	Cpox<Rbc16>	MP:0000691,enlarged spleen|MP:0000929,open neural tube|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002810,microcytic anemia|MP:0002884,abnormal pharyngeal arch morphology|MP:0003984,embryonic growth retardation|MP:0005654,porphyria|MP:0008388,hypochromic microcytic anemia|MP:0008476,increased spleen red pulp amount|MP:0010067,increased red blood cell distribution width|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011178,increased erythroblast number|MP:0011890,increased circulating ferritin level|MP:0013165,absent forelimb buds
MGI:3807241	Cpox<Rgsc0129>	MP:0002591,decreased mean corpuscular volume|MP:0002642,anisocytosis|MP:0005562,decreased mean corpuscular hemoglobin
MGI:6313362	Cpq<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0002060,abnormal skin morphology|MP:0005562,decreased mean corpuscular hemoglobin
MGI:6144263	Cps1<em1(IMPC)H>	MP:0000222,decreased neutrophil cell number|MP:0001556,increased circulating HDL cholesterol level|MP:0005013,increased lymphocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0005628,decreased circulating potassium level|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:2386969	Cps1<tm1Mw>	MP:0005309,increased circulating ammonia level|MP:0011085,postnatal lethality, complete penetrance
MGI:6384597	Cpsf1<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:4432649	Cpsf3<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5548494	Cpsf3<tm1b(EUCOMM)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6220914	Cpsf4l<em1(IMPC)J>	MP:0002941,increased circulating alanine transaminase level
MGI:7621294	Cpsf6<em1Bcgen>	MP:0001924,infertility|MP:0005159,azoospermia|MP:0008564,increased interferon-beta secretion|MP:0020914,decreased susceptibility to Riboviria infection
MGI:5911628	Cpsf7<em1(IMPC)J>	MP:0001304,cataract|MP:0010124,decreased bone mineral content
MGI:5749792	Cpt1a<tm1.1Pec>	MP:0001764,abnormal homeostasis|MP:0002792,abnormal retina vasculature morphology|MP:0014508,decreased intestinal crypt stem cell number|MP:0020316,decreased vascular endothelial cell proliferation
MGI:7858930	Cpt1a<tm1.2(IMPC)Wtsi>	MP:0002599,increased mean platelet volume
MGI:3606251	Cpt1a<tm1Pwo>	MP:0001554,increased circulating free fatty acids level|MP:0004179,transmission ratio distortion|MP:0005560,decreased circulating glucose level|MP:0011092,embryonic lethality, complete penetrance
MGI:3617815	Cpt1b<tm1You>	MP:0005376,homeostasis/metabolism phenotype|MP:0011049,impaired adaptive thermogenesis|MP:0011092,embryonic lethality, complete penetrance
MGI:5708252	Cpt1c<tm1b(EUCOMM)Wtsi>	MP:0001120,abnormal uterus morphology|MP:0002175,decreased brain weight|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:3844092	Cpt1c<tm1Dhwu>	MP:0002079,increased circulating insulin level|MP:0005331,insulin resistance|MP:0005378,growth/size/body region phenotype|MP:0005559,increased circulating glucose level|MP:0009355,increased liver triglyceride level|MP:0030974,enhanced gluconeogenesis|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:5432790	Cpt1c<tm1Fghe>	MP:0001463,abnormal spatial learning|MP:0001547,abnormal lipid level|MP:0009936,abnormal dendritic spine morphology
MGI:3639356	Cpt1c<tm1Mdln>	MP:0001262,decreased body weight|MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0002628,hepatic steatosis|MP:0005331,insulin resistance|MP:0005455,increased susceptibility to weight gain|MP:0011940,decreased food intake
MGI:5636913	Cpt2<tm1b(KOMP)Wtsi>	MP:0000137,abnormal vertebrae morphology|MP:0001566,increased circulating phosphate level|MP:0002169,no abnormal phenotype detected|MP:0002282,abnormal trachea morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0005244,hemopericardium|MP:0010439,abnormal hepatic vein morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013852,abnormal Mullerian duct topology|MP:0013971,blood in lymph vessels
MGI:5819280	Cpt2<tm1Mwol>	MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0001552,increased circulating triglyceride level|MP:0002628,hepatic steatosis|MP:0003458,decreased circulating ketone body level|MP:0005178,increased circulating cholesterol level|MP:0009355,increased liver triglyceride level
MGI:5468990	Cp<tm1b(KOMP)Wtsi>	MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002591,decreased mean corpuscular volume|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0003043,hypoalgesia|MP:0004151,decreased circulating iron level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011396,abnormal sleep behavior
MGI:1857981	Cp<tm1Hrs>	MP:0001770,abnormal iron level|MP:0003065,abnormal liver copper level|MP:0005397,hematopoietic system phenotype|MP:0005637,abnormal iron homeostasis|MP:0008807,increased liver iron level|MP:0008809,increased spleen iron level|MP:0011890,increased circulating ferritin level|MP:0012661,decreased circulating ceruloplasmin level
MGI:2384067	Cp<tm1Samd>	MP:0000828,abnormal fourth ventricle morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000921,demyelination|MP:0000939,decreased motor neuron number|MP:0001392,abnormal locomotor behavior|MP:0001405,impaired coordination|MP:0002118,abnormal lipid homeostasis|MP:0002182,abnormal astrocyte morphology|MP:0002882,abnormal neuron morphology|MP:0003224,neuron degeneration|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0004151,decreased circulating iron level|MP:0005164,abnormal response to injury|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0008807,increased liver iron level|MP:0008811,abnormal brain iron level|MP:0008916,abnormal astrocyte physiology|MP:0011896,increased circulating unsaturated transferrin level
MGI:2429641	Cp<tm1Yos>	MP:0000607,abnormal hepatocyte morphology|MP:0001406,abnormal gait|MP:0002118,abnormal lipid homeostasis|MP:0002810,microcytic anemia|MP:0003313,abnormal locomotor activation|MP:0004151,decreased circulating iron level|MP:0008114,abnormal Kupffer cell morphology|MP:0008807,increased liver iron level
MGI:6156486	Cpvl<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001200,thick skin|MP:0002060,abnormal skin morphology|MP:0002833,increased heart weight
MGI:4421558	Cpvl<Tn(mm-DTT)1.1Ddra>	MP:0011091,prenatal lethality, complete penetrance
MGI:6281920	Cpxm1<em1(IMPC)Tcp>	MP:0000220,increased monocyte cell number|MP:0000702,enlarged lymph nodes|MP:0001293,anophthalmia|MP:0002060,abnormal skin morphology
MGI:5007085	Cpxm2<tm1Lex>	MP:0003921,abnormal heart left ventricle morphology|MP:0004486,decreased response of heart to induced stress|MP:0005333,decreased heart rate|MP:0005385,cardiovascular system phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0020204,abnormal heart left ventricle weight
MGI:1856697	cpy	MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0001510,abnormal coat appearance|MP:0002098,abnormal vibrissa morphology
MGI:2153948	Cq1<C57BL/6J>	MP:0005178,increased circulating cholesterol level
MGI:2153949	Cq1<KK>	MP:0005178,increased circulating cholesterol level
MGI:2153951	Cq2<KK>	MP:0005178,increased circulating cholesterol level
MGI:2155364	Cq3<C57BL/6J>	MP:0005178,increased circulating cholesterol level
MGI:3029257	Cq4<KK-A(y)>	MP:0005178,increased circulating cholesterol level
MGI:3029260	Cq5<KK-A(y)>	MP:0005178,increased circulating cholesterol level
MGI:3522042	Cq6<RR>	MP:0005178,increased circulating cholesterol level
MGI:3838179	Cr1l<tm1.1Song>	MP:0005014,increased B cell number|MP:0005016,decreased lymphocyte cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008101,lymph node hypoplasia
MGI:5474762	Cr1l<tm1b(KOMP)Wtsi>	MP:0003984,embryonic growth retardation|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2158683	Cr1l<tm1Hmo>	MP:0000807,abnormal hippocampus morphology|MP:0001846,increased inflammatory response|MP:0004041,increased susceptibility to kidney reperfusion injury|MP:0004256,abnormal maternal decidual layer morphology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005028,abnormal trophectoderm morphology|MP:0005032,abnormal ectoplacental cone morphology|MP:0005565,increased blood urea nitrogen level|MP:0010768,mortality/aging|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:6268702	Cr2<M1Btlr>	MP:0001805,decreased IgG level|MP:0020154,impaired humoral immune response
MGI:4417922	Cr2<tm1.1Jhws>	MP:0001806,decreased IgM level|MP:0005387,immune system phenotype|MP:0008168,decreased B-1a cell number|MP:0008192,abnormal germinal center B cell physiology|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008897,decreased IgG2c level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:1933715	Cr2<tm1Crr>	MP:0000222,decreased neutrophil cell number|MP:0000685,abnormal immune system morphology|MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002359,abnormal spleen germinal center morphology|MP:0002460,decreased immunoglobulin level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004940,abnormal B-1 B cell morphology|MP:0005017,decreased B cell number|MP:0005165,increased susceptibility to injury|MP:0005387,immune system phenotype|MP:0008168,decreased B-1a cell number|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008482,decreased spleen germinal center number|MP:0008484,decreased spleen germinal center size|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008561,decreased tumor necrosis factor secretion|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:1932568	Cr2<tm1Hmo>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002412,increased susceptibility to bacterial infection|MP:0002459,abnormal B cell physiology|MP:0004816,abnormal class switch recombination|MP:0005166,decreased susceptibility to injury|MP:0005367,renal/urinary system phenotype|MP:0008095,abnormal memory B cell differentiation|MP:0008217,abnormal B cell activation
MGI:3531094	Cr2<tm1Tft>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002412,increased susceptibility to bacterial infection|MP:0002420,abnormal adaptive immunity|MP:0008482,decreased spleen germinal center number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:4356009	Cr2<tm2.1(HLA-A)Crr>	MP:0002459,abnormal B cell physiology|MP:0004816,abnormal class switch recombination|MP:0008095,abnormal memory B cell differentiation
MGI:5547397	Cr2<tm2.1Jhws>	MP:0001806,decreased IgM level|MP:0002494,increased IgM level|MP:0005387,immune system phenotype|MP:0008192,abnormal germinal center B cell physiology|MP:0008498,decreased IgG3 level|MP:0010768,mortality/aging
MGI:1857621	Crabp1<tm1Adg>	MP:0002169,no abnormal phenotype detected
MGI:5696935	Crabp1<tm1b(EUCOMM)Wtsi>	MP:0000220,increased monocyte cell number|MP:0001126,abnormal ovary morphology|MP:0001289,persistence of hyaloid vascular system|MP:0004832,enlarged ovary
MGI:2183739	Crabp1<tm1Ipc>	MP:0002169,no abnormal phenotype detected
MGI:6276962	Crabp2<em1(IMPC)Mbp>	MP:0000208,decreased hematocrit|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number
MGI:2183745	Crabp2<tm1Ipc>	MP:0000562,polydactyly
MGI:1857508	Crabp2<tm1Ut>	MP:0009744,postaxial polydactyly
MGI:5910368	Cracd<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001399,hyperactivity|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:5637062	Cracdl<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level
MGI:6343391	Cracr2a<tm1.1Ygwa>	MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008688,decreased interleukin-2 secretion
MGI:3604302	Cradd<tm1Mak>	MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:3574369	Cradd<tm1Shor>	MP:0011091,prenatal lethality, complete penetrance
MGI:6341861	Cramp1<em1(IMPC)Bay>	MP:0000111,cleft palate|MP:0001697,abnormal embryo size|MP:0003795,abnormal bone structure|MP:0004258,abnormal placenta size|MP:0009142,decreased prepulse inhibition|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:5287506	Cramp1<TgTn(sb-rtTA,Tyr)2447AOve>	MP:0000111,cleft palate
MGI:7519110	Crat<em1(IMPC)Bay>	MP:0002217,small lymph nodes
MGI:5427430	Crat<tm1.1Pbrc>	MP:0002078,abnormal glucose homeostasis|MP:0002106,abnormal muscle physiology|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0004215,abnormal myocardial fiber physiology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0010954,abnormal cellular respiration|MP:0010957,abnormal aerobic respiration|MP:0010958,abnormal tricarboxylic acid cycle
MGI:6467931	Crb1<em1Jnk>	MP:0010236,abnormal retina outer limiting membrane morphology
MGI:6259426	Crb1<em2Boc>	MP:0005391,vision/eye phenotype
MGI:6467932	Crb1<em2Jnk>	MP:0010236,abnormal retina outer limiting membrane morphology
MGI:6467933	Crb1<em3Jnk>	MP:0003730,abnormal photoreceptor inner segment morphology|MP:0008450,retina photoreceptor degeneration|MP:0010236,abnormal retina outer limiting membrane morphology
MGI:6467934	Crb1<em4Jnk>	MP:0003730,abnormal photoreceptor inner segment morphology|MP:0008450,retina photoreceptor degeneration|MP:0010236,abnormal retina outer limiting membrane morphology
MGI:2676366	Crb1<rd8>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0001327,decreased retina photoreceptor cell number|MP:0002792,abnormal retina vasculature morphology|MP:0002864,abnormal ocular fundus morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0005103,abnormal retina pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005391,vision/eye phenotype|MP:0005547,abnormal Muller cell morphology|MP:0008515,thin retina outer nuclear layer|MP:0008582,short photoreceptor inner segment|MP:0008584,photoreceptor outer segment degeneration|MP:0008587,short photoreceptor outer segment|MP:0008852,retina neovascularization|MP:0010236,abnormal retina outer limiting membrane morphology|MP:0012671,retina spots
MGI:3052072	Crb1<tm1Wij>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001326,retina degeneration|MP:0001999,photosensitivity|MP:0005547,abnormal Muller cell morphology
MGI:3696955	Crb1<tm2Wij>	MP:0011100,preweaning lethality, complete penetrance
MGI:5466324	Crb2<tm1.1Wij>	MP:0001006,abnormal retina cone cell morphology|MP:0001325,abnormal retina morphology|MP:0001327,decreased retina photoreceptor cell number|MP:0001891,hydrocephaly|MP:0002169,no abnormal phenotype detected|MP:0002864,abnormal ocular fundus morphology|MP:0003727,abnormal retina layer morphology|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005241,abnormal retina ganglion layer morphology|MP:0005391,vision/eye phenotype|MP:0005547,abnormal Muller cell morphology|MP:0005551,abnormal eye electrophysiology|MP:0006069,abnormal retina neuronal layer morphology|MP:0006073,abnormal retina bipolar cell morphology|MP:0008449,abnormal retina cone cell outer segment morphology|MP:0008515,thin retina outer nuclear layer|MP:0008852,retina neovascularization|MP:0010097,abnormal retina blood vessel morphology|MP:0010236,abnormal retina outer limiting membrane morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012676,dilated brain ventricle|MP:0014333,short retina cone cell outer segment|MP:0014336,short retina rod cell outer segment|MP:0021107,retina fold|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:4818586	Crb2<tm1a(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0002098,abnormal vibrissa morphology|MP:0002836,abnormal chorion morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:5296808	Crb2<tm1Vlcg>	MP:0000474,abnormal foregut morphology|MP:0000929,open neural tube|MP:0001680,abnormal mesoderm development|MP:0001685,abnormal endoderm development|MP:0001688,abnormal somite development|MP:0001695,abnormal gastrulation|MP:0001699,increased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0002231,abnormal primitive streak morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0002825,abnormal notochord morphology|MP:0003119,abnormal digestive system development|MP:0003229,abnormal vitelline vasculature morphology|MP:0003886,abnormal embryonic epiblast morphology|MP:0004180,failure of initiation of embryo turning|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004559,small allantois|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011204,abnormal visceral yolk sac blood island morphology|MP:0011257,abnormal head fold morphology|MP:0012081,absent heart tube|MP:0012104,small amniotic cavity|MP:0012739,abnormal anterior primitive streak morphology
MGI:5563834	Crb3<tm1.1Bmar>	MP:0011100,preweaning lethality, complete penetrance
MGI:5749246	Crb3<tm1.1Lprs>	MP:0002169,no abnormal phenotype detected
MGI:5563835	Crb3<tm1.2Bmar>	MP:0000477,abnormal intestine morphology|MP:0001175,abnormal lung morphology|MP:0001954,respiratory distress|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002705,dilated renal tubule|MP:0003675,kidney cyst|MP:0008108,abnormal small intestinal villus morphology|MP:0008109,abnormal small intestinal microvillus morphology|MP:0008141,decreased small intestinal microvillus size|MP:0010809,abnormal club cell morphology|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011350,abnormal proximal convoluted tubule brush border morphology|MP:0014080,fused small intestinal villi|MP:0014473,increased pulmonary alveolus wall thickness
MGI:5749426	Crb3<tm1.2Lprs>	MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002989,small kidney|MP:0003215,renal interstitial fibrosis|MP:0004391,abnormal respiratory conducting tube morphology|MP:0004967,abnormal kidney epithelium morphology|MP:0006382,abnormal lung epithelium morphology|MP:0008108,abnormal small intestinal villus morphology|MP:0008528,polycystic kidney|MP:0010752,impaired mucociliary clearance|MP:0011089,perinatal lethality, complete penetrance|MP:0014080,fused small intestinal villi
MGI:6258757	Crbn<tm1.1Ble>	MP:0000221,decreased leukocyte cell number|MP:0000334,decreased granulocyte number|MP:0001293,anophthalmia|MP:0003179,thrombocytopenia|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008813,decreased common myeloid progenitor cell number|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013660,abnormal bone marrow hematopoietic cell morphology|MP:0013697,decreased granulocyte monocyte progenitor cell number
MGI:5302187	Crbn<tm1.1Jjh>	MP:0005386,behavior/neurological phenotype|MP:0008432,abnormal long-term spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0012307,impaired spatial learning
MGI:5302192	Crbn<tm1.2Jjh>	MP:0001473,reduced long-term potentiation|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008432,abnormal long-term spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0009538,abnormal synapse morphology|MP:0012307,impaired spatial learning
MGI:5558154	Crbn<tm1b(KOMP)Wtsi>	MP:0000494,abnormal cecum morphology|MP:0001333,absent optic nerve|MP:0002092,abnormal eye morphology|MP:0009142,decreased prepulse inhibition
MGI:5568118	Crbn<tm1Csp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001262,decreased body weight|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0005292,improved glucose tolerance|MP:0005386,behavior/neurological phenotype|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0009289,decreased epididymal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:6201600	Crcp<em1(IMPC)J>	MP:0000432,abnormal head morphology|MP:0001513,limb grasping|MP:0002075,abnormal coat/hair pigmentation|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5299333	Creb1<tm1.1Berd>	MP:0005369,muscle phenotype|MP:0030947,increased myoblast proliferation|MP:0030957,abnormal myotube morphology|MP:0031318,enhanced skeletal muscle regeneration
MGI:5618173	Creb1<tm1.1Khk>	MP:0005376,homeostasis/metabolism phenotype
MGI:2153538	Creb1<tm1Gsc>	MP:0001015,small superior cervical ganglion|MP:0001017,abnormal stellate ganglion morphology|MP:0001454,abnormal cued conditioning behavior|MP:0001463,abnormal spatial learning|MP:0001468,abnormal temporal memory|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0002082,postnatal lethality|MP:0002206,abnormal CNS synaptic transmission|MP:0002757,decreased vertical activity|MP:0008770,decreased survivor rate|MP:0009748,abnormal behavioral response to addictive substance|MP:0009776,decreased behavioral withdrawal response
MGI:4460924	Creb1<tm1Nes>	MP:0003463,abnormal single cell response
MGI:4999627	Creb1<tm3.1Gsc>	MP:0001176,abnormal lung development|MP:0003641,small lung|MP:0004007,abnormal lung vasculature morphology|MP:0004200,decreased fetal size|MP:0006027,impaired lung alveolus development|MP:0010887,pale lung|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:2181395	Creb1<tm3Gsc>	MP:0001147,small testis|MP:0002687,oligozoospermia|MP:0002780,decreased circulating testosterone level|MP:0003631,nervous system phenotype|MP:0004852,decreased testis weight|MP:0004910,decreased seminal vesicle weight|MP:0004929,decreased epididymis weight|MP:0010768,mortality/aging
MGI:2183908	Creb1<tm4Gsc>	MP:0020473,abnormal circadian behavior phase
MGI:7608145	Creb3<Gt1Mbac>	MP:0001547,abnormal lipid level|MP:0002727,decreased circulating insulin level|MP:0003961,decreased lean body mass|MP:0004777,abnormal phospholipid level|MP:0004889,increased energy expenditure|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005451,abnormal body composition|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008770,decreased survivor rate|MP:0008965,increased basal metabolism|MP:0009130,increased white fat cell number|MP:0009133,decreased white fat cell size|MP:0009356,decreased liver triglyceride level|MP:0010378,increased respiratory quotient|MP:0013278,decreased fasting circulating glucose level|MP:0014143,decreased body fat mass|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis|MP:0031414,decreased skeletal muscle triglyceride level
MGI:4842311	Creb3l1<tm1e(EUCOMM)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level
MGI:4438907	Creb3l1<tm1Kaim>	MP:0000061,fragile skeleton|MP:0000063,decreased bone mineral density|MP:0000135,decreased compact bone thickness|MP:0001732,postnatal growth retardation|MP:0002398,abnormal bone marrow cell morphology/development|MP:0004986,abnormal osteoblast morphology|MP:0008395,abnormal osteoblast differentiation|MP:0009346,decreased trabecular bone thickness|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization
MGI:7425607	Creb3l2<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:4438923	Creb3l2<tm1Kaim>	MP:0000167,decreased chondrocyte number|MP:0000547,short limbs|MP:0001270,distended abdomen|MP:0002116,abnormal craniofacial bone morphology|MP:0002657,chondrodystrophy|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004686,decreased length of long bones|MP:0004733,abnormal thoracic cavity morphology|MP:0009908,protruding tongue|MP:0011087,neonatal lethality, complete penetrance
MGI:3811836	Creb3l3<tm1.1Sad>	MP:0005087,decreased acute inflammation|MP:0031233,decreased circulating serum amyloid protein level
MGI:5502394	Creb3l3<tm1Ktak>	MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:3811835	Creb3l3<tm1Sad>	MP:0002169,no abnormal phenotype detected
MGI:3589381	Creb3l4<tm1Imad>	MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0020550,multinucleated giant male germ cells
MGI:3718553	Creb3l4<tm1Noj>	MP:0004901,decreased male germ cell number|MP:0006380,abnormal spermatid morphology
MGI:5603360	Creb3<tm1.1(KOMP)Vlcg>	MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4421136	Creb5<tm1Sis>	MP:0011087,neonatal lethality, complete penetrance
MGI:1928775	Crebbp<Gt(U-San)112Imeg>	MP:0000060,delayed bone ossification|MP:0000085,large anterior fontanelle|MP:0000091,short premaxilla|MP:0000097,short maxilla|MP:0000103,nasal bone hypoplasia|MP:0000161,scoliosis|MP:0000259,abnormal vascular development|MP:0000263,absent organized vascular network|MP:0000264,failure of vascular branching|MP:0000266,abnormal heart morphology|MP:0000445,short snout|MP:0000449,broad nasal bridge|MP:0000457,maxilla hypoplasia|MP:0000565,oligodactyly|MP:0000929,open neural tube|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0001614,abnormal blood vessel morphology|MP:0001622,abnormal vasculogenesis|MP:0001698,decreased embryo size|MP:0001719,absent vitelline blood vessels|MP:0001722,pale yolk sac|MP:0001730,embryonic growth arrest|MP:0001783,decreased white adipose tissue amount|MP:0002064,seizures|MP:0002079,increased circulating insulin level|MP:0002082,postnatal lethality|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002088,abnormal embryonic growth/weight/body size|MP:0002702,decreased circulating free fatty acids level|MP:0002757,decreased vertical activity|MP:0002891,increased insulin sensitivity|MP:0003542,abnormal vascular endothelial cell development|MP:0003631,nervous system phenotype|MP:0003717,pallor|MP:0004379,wide frontal bone|MP:0005076,abnormal cell differentiation|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005318,decreased triglyceride level|MP:0005459,decreased percent body fat/body weight|MP:0005602,decreased angiogenesis|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0006057,decreased vascular endothelial cell number|MP:0008752,abnormal tumor necrosis factor level|MP:0009269,decreased fat cell size|MP:0010403,atrial septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014367,impaired long-term object recognition memory|MP:0014440,increased response to leptin|MP:0030969,increased circulating adiponectin level
MGI:3056562	Crebbp<tm1.1Ltz>	MP:0001265,decreased body size|MP:0002080,prenatal lethality|MP:0002083,premature death|MP:0003632,abnormal nervous system morphology
MGI:3056564	Crebbp<tm1.2Ltz>	MP:0003631,nervous system phenotype|MP:0004924,abnormal behavior|MP:0005386,behavior/neurological phenotype|MP:0014367,impaired long-term object recognition memory
MGI:1926888	Crebbp<tm1Dli>	MP:0000238,absent pre-B cells|MP:0000240,extramedullary hematopoiesis|MP:0000321,increased bone marrow cell number|MP:0000322,increased granulocyte number|MP:0000428,abnormal craniofacial morphology|MP:0000691,enlarged spleen|MP:0000929,open neural tube|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002026,increased leukemia incidence|MP:0002123,abnormal definitive hematopoiesis|MP:0002417,abnormal megakaryocyte morphology|MP:0002441,abnormal granulocyte morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008246,abnormal leukocyte morphology|MP:0008254,increased megakaryocyte cell number|MP:0008813,decreased common myeloid progenitor cell number|MP:0009321,increased histiocytic sarcoma incidence|MP:0010296,increased hemolymphoid system tumor incidence|MP:0011092,embryonic lethality, complete penetrance
MGI:3046630	Crebbp<tm1Few>	MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002696,decreased circulating glucagon level|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0010400,increased liver glycogen level
MGI:3618462	Crebbp<tm1Jvd>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0002024,increased T cell derived lymphoma incidence|MP:0002169,no abnormal phenotype detected|MP:0005018,decreased T cell number|MP:0005091,increased double-positive T cell number|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:3056561	Crebbp<tm1Ltz>	MP:0002169,no abnormal phenotype detected
MGI:3578129	Crebbp<tm1Pkb>	MP:0000715,decreased thymocyte number|MP:0001265,decreased body size|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2679376	Crebbp<tm1Reck>	MP:0000267,abnormal heart development|MP:0002082,postnatal lethality|MP:0005369,muscle phenotype|MP:0010556,thin ventricle myocardium compact layer|MP:0011085,postnatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:1928768	Crebbp<tm1Sis>	MP:0000060,delayed bone ossification|MP:0000085,large anterior fontanelle|MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000157,abnormal sternum morphology|MP:0000161,scoliosis|MP:0000783,abnormal forebrain morphology|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0000929,open neural tube|MP:0000955,abnormal spinal cord morphology|MP:0001606,impaired hematopoiesis|MP:0001614,abnormal blood vessel morphology|MP:0001622,abnormal vasculogenesis|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0001732,postnatal growth retardation|MP:0001915,intracranial hemorrhage|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002109,abnormal limb morphology|MP:0002151,abnormal neural tube morphology|MP:0002932,abnormal joint morphology|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004679,xiphoid process foramen|MP:0005385,cardiovascular system phenotype|MP:0005602,decreased angiogenesis|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3612048	Crebbp<tm2Pkb>	MP:0000428,abnormal craniofacial morphology|MP:0000447,flattened snout|MP:0001265,decreased body size|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001447,abnormal nest building behavior|MP:0001732,postnatal growth retardation|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002276,abnormal lung interstitium morphology|MP:0002574,increased vertical activity|MP:0002923,increased post-tetanic potentiation|MP:0003641,small lung|MP:0003862,decreased aggression towards male mice|MP:0004033,supernumerary teeth|MP:0004471,short nasal bone|MP:0004678,split xiphoid process|MP:0005269,abnormal occipital bone morphology|MP:0009890,cleft secondary palate|MP:0010053,decreased grip strength|MP:0010768,mortality/aging|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014367,impaired long-term object recognition memory|MP:0031391,increased locomotor activity
MGI:3878096	Crebrf<Gt(YHD319)Byg>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001386,abnormal maternal nurturing|MP:0001399,hyperactivity|MP:0001513,limb grasping|MP:0002574,increased vertical activity|MP:0002665,decreased circulating corticosterone level|MP:0005121,decreased circulating prolactin level|MP:0005376,homeostasis/metabolism phenotype|MP:0006270,abnormal mammary gland growth during lactation
MGI:5763778	Crebzf<em1(IMPC)J>	MP:0010053,decreased grip strength
MGI:6196852	Creg1<em1Yal>	MP:0001260,increased body weight|MP:0001570,abnormal circulating enzyme level|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0002981,increased liver weight|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005343,increased circulating aspartate transaminase level|MP:0005439,decreased glycogen level|MP:0010027,increased liver cholesterol level|MP:0010359,increased liver free fatty acids level|MP:0013279,increased fasting circulating glucose level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:6164127	Creg1<tm1Yal>	MP:0003037,increased myocardial infarct size|MP:0003222,increased cardiomyocyte apoptosis|MP:0003710,abnormal physiological neovascularization|MP:0004485,increased response of heart to induced stress|MP:0008260,abnormal autophagy|MP:0031633,decreased heart left ventricle muscle contractility
MGI:6376217	Creg2<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0010053,decreased grip strength|MP:0013278,decreased fasting circulating glucose level
MGI:5912278	Creld1<tm1.1Chlm>	MP:0000263,absent organized vascular network|MP:0000428,abnormal craniofacial morphology|MP:0003232,abnormal forebrain development|MP:0003864,abnormal midbrain development|MP:0006108,abnormal hindbrain development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis|MP:0030992,atrioventricular cushion hypoplasia
MGI:7522336	Creld1<tm1c(EUCOMM)Wtsi>	MP:0000267,abnormal heart development|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002169,no abnormal phenotype detected|MP:0003141,cardiac fibrosis|MP:0004067,abnormal trabecula carnea morphology|MP:0006138,congestive heart failure|MP:0008725,increased heart atrium size|MP:0010502,ventricle myocardium hypoplasia|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013258,abnormal extracellular matrix morphology|MP:0031128,cardiovascular shunt
MGI:6836725	Creld2<tm1.1Emass>	MP:0000602,dilated liver sinusoidal space|MP:0000607,abnormal hepatocyte morphology|MP:0001262,decreased body weight|MP:0003402,decreased liver weight|MP:0003887,increased hepatocyte apoptosis|MP:0005331,insulin resistance|MP:0005370,liver/biliary system phenotype|MP:0005378,growth/size/body region phenotype|MP:0008489,slow postnatal weight gain|MP:0020354,increased endoplasmic reticulum stress|MP:0020582,increased ceramide level|MP:0031265,increased susceptibility to hepatic steatosis|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis|MP:0031271,increased susceptibility to age-related hepatic steatosis
MGI:5548672	Creld2<tm1b(EUCOMM)Hmgu>	MP:0001925,male infertility|MP:0002953,thick ventricular wall
MGI:3802585	Crem<tm1.1Endo>	MP:0001363,increased anxiety-related response|MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0001499,abnormal kindling response|MP:0005386,behavior/neurological phenotype
MGI:2181391	Crem<tm1Gsc>	MP:0001147,small testis|MP:0001925,male infertility|MP:0008261,arrest of male meiosis|MP:0031633,decreased heart left ventricle muscle contractility
MGI:2158921	Crem<tm1Saco>	MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005517,impaired liver regeneration|MP:0005578,teratozoospermia|MP:0020467,abnormal circadian behavior|MP:0020550,multinucleated giant male germ cells
MGI:2671821	crf1	MP:0000445,short snout|MP:0001265,decreased body size
MGI:2671825	crf10	MP:0001265,decreased body size|MP:0006411,upturned snout
MGI:2671744	crf12	MP:0006411,upturned snout
MGI:2671827	crf13	MP:0000428,abnormal craniofacial morphology|MP:0001265,decreased body size
MGI:2671828	crf14	MP:0000428,abnormal craniofacial morphology|MP:0000433,microcephaly
MGI:2671829	crf15	MP:0000445,short snout|MP:0030189,broad snout
MGI:2671830	crf16	MP:0000428,abnormal craniofacial morphology|MP:0001265,decreased body size|MP:0002083,premature death|MP:0010179,rough coat
MGI:2671831	crf17	MP:0000428,abnormal craniofacial morphology|MP:0001265,decreased body size
MGI:2671832	crf18	MP:0000428,abnormal craniofacial morphology|MP:0000433,microcephaly|MP:0000445,short snout
MGI:2671833	crf19	MP:0000445,short snout|MP:0001265,decreased body size
MGI:2671740	crf2	MP:0000445,short snout|MP:0001265,decreased body size
MGI:2671834	crf20	MP:0030192,downturned snout
MGI:2671835	crf21	MP:0000445,short snout|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001314,cornea opacity
MGI:2671836	crf22	MP:0000433,microcephaly|MP:0000447,flattened snout|MP:0002100,abnormal tooth morphology
MGI:2671837	crf23	MP:0001265,decreased body size
MGI:2671838	crf25	MP:0000445,short snout|MP:0012722,absent neck
MGI:3046702	crf26	MP:0001265,decreased body size|MP:0001891,hydrocephaly|MP:0002083,premature death
MGI:3033993	crf27	MP:0000445,short snout|MP:0001297,microphthalmia
MGI:3033994	crf29	MP:0000346,broad head|MP:0000445,short snout|MP:0000447,flattened snout
MGI:2671818	crf3	MP:0000023,abnormal ear position|MP:0000445,short snout|MP:0001265,decreased body size|MP:0002177,abnormal outer ear morphology
MGI:3033995	crf30	MP:0000445,short snout|MP:0030069,broad face
MGI:3577416	Crf31	MP:0000445,short snout
MGI:2671819	crf4	MP:0000445,short snout
MGI:2671741	crf5	MP:0000418,focal hair loss|MP:0000428,abnormal craniofacial morphology
MGI:2671742	crf6	MP:0001265,decreased body size|MP:0030066,short face
MGI:2671822	crf7	MP:0000445,short snout|MP:0001265,decreased body size
MGI:2671743	crf8	MP:0000445,short snout
MGI:2671823	crf9	MP:0000137,abnormal vertebrae morphology|MP:0000149,abnormal scapula morphology|MP:0004508,abnormal pectoral girdle bone morphology|MP:0005298,abnormal clavicle morphology|MP:0030192,downturned snout
MGI:3513042	Crhbp<tm1Afs>	MP:0001363,increased anxiety-related response|MP:0001732,postnatal growth retardation|MP:0002797,increased thigmotaxis|MP:0005449,abnormal food intake
MGI:5294437	Crhr1<tm1.1Jde>	MP:0005376,homeostasis/metabolism phenotype
MGI:5294436	Crhr1<tm1Jde>	MP:0003963,abnormal corticosterone level
MGI:2178544	Crhr1<tm1Klee>	MP:0000640,adrenal gland hypoplasia|MP:0001175,abnormal lung morphology|MP:0001362,abnormal anxiety-related response|MP:0001364,decreased anxiety-related response|MP:0001954,respiratory distress|MP:0001958,emphysema|MP:0002063,abnormal learning/memory/conditioning|MP:0002083,premature death|MP:0003953,abnormal hormone level|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005449,abnormal food intake|MP:0010909,pulmonary alveolar hemorrhage|MP:0013366,adrenal gland atrophy|MP:0014287,decreased adrenal gland zona fasciculata size
MGI:2178543	Crhr1<tm1Wrst>	MP:0001364,decreased anxiety-related response|MP:0001987,alcohol preference|MP:0002083,premature death|MP:0002090,abnormal vision|MP:0003631,nervous system phenotype|MP:0003953,abnormal hormone level|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005386,behavior/neurological phenotype|MP:0005551,abnormal eye electrophysiology|MP:0008289,abnormal adrenal medulla morphology|MP:0009776,decreased behavioral withdrawal response
MGI:5440013	Crhr1<tm2.2Jde>	MP:0005376,homeostasis/metabolism phenotype
MGI:5440014	Crhr1<tm2.3Jde>	MP:0002665,decreased circulating corticosterone level
MGI:5440011	Crhr1<tm2Jde>	MP:0002665,decreased circulating corticosterone level
MGI:2678096	Crhr1<tm2Wrst>	MP:0001363,increased anxiety-related response|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001745,increased circulating corticosterone level|MP:0001748,increased circulating adrenocorticotropin level|MP:0002169,no abnormal phenotype detected|MP:0002206,abnormal CNS synaptic transmission|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0010149,abnormal synaptic dopamine release|MP:0031391,increased locomotor activity
MGI:2178616	Crhr2<tm1Jsp>	MP:0001363,increased anxiety-related response|MP:0001619,abnormal vascular permeability|MP:0005376,homeostasis/metabolism phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype
MGI:2178545	Crhr2<tm1Klee>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000231,hypertension|MP:0001363,increased anxiety-related response|MP:0001614,abnormal blood vessel morphology|MP:0002078,abnormal glucose homeostasis|MP:0002573,behavioral despair|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002757,decreased vertical activity|MP:0002891,increased insulin sensitivity|MP:0003953,abnormal hormone level|MP:0005179,decreased circulating cholesterol level|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005449,abnormal food intake|MP:0005601,increased angiogenesis|MP:0005666,abnormal adipose tissue physiology|MP:0009117,abnormal white fat cell morphology|MP:0009136,decreased brown fat cell size|MP:0010025,decreased total body fat amount
MGI:2178619	Crhr2<tm1Mpsp>	MP:0001360,abnormal social investigation|MP:0001431,abnormal eating behavior|MP:0001442,decreased grooming behavior|MP:0002842,increased systemic arterial blood pressure|MP:0003953,abnormal hormone level|MP:0004215,abnormal myocardial fiber physiology|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype
MGI:4452089	Crh<tm1(cre)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:1857392	Crh<tm1Maj>	MP:0000188,abnormal circulating glucose level|MP:0000639,abnormal adrenal gland morphology|MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001179,thick pulmonary interalveolar septum|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001259,abnormal body weight|MP:0001845,abnormal inflammatory response|MP:0001876,decreased inflammatory response|MP:0002133,abnormal respiratory system physiology|MP:0002421,abnormal cell-mediated immunity|MP:0002452,abnormal professional antigen presenting cell physiology|MP:0002665,decreased circulating corticosterone level|MP:0003009,abnormal cytokine secretion|MP:0003631,nervous system phenotype|MP:0003718,maternal effect|MP:0003966,abnormal adrenocorticotropin level|MP:0004781,abnormal surfactant composition|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005095,decreased T cell proliferation|MP:0005345,abnormal circulating corticosterone level|MP:0005418,abnormal circulating hormone level|MP:0005449,abnormal food intake|MP:0005660,abnormal circulating adrenaline level|MP:0005661,decreased circulating adrenaline level|MP:0005663,abnormal circulating noradrenaline level|MP:0005668,decreased circulating leptin level|MP:0008596,increased circulating interleukin-6 level|MP:0009338,increased splenocyte number|MP:0010809,abnormal club cell morphology|MP:0010914,abnormal solitary pulmonary neuroendocrine cell morphology|MP:0011147,increased mesenchymal cell proliferation involved in lung development|MP:0014287,decreased adrenal gland zona fasciculata size
MGI:5819101	Crh<tm2.1Maj>	MP:0001364,decreased anxiety-related response|MP:0001739,abnormal adrenal gland secretion|MP:0002664,decreased circulating adrenocorticotropin level|MP:0002665,decreased circulating corticosterone level|MP:0013308,decreased adrenal gland weight|MP:0013366,adrenal gland atrophy
MGI:5823156	Crh<tm2.2Maj>	MP:0001739,abnormal adrenal gland secretion|MP:0002665,decreased circulating corticosterone level|MP:0003718,maternal effect|MP:0013366,adrenal gland atrophy
MGI:1856833	crhx	MP:0001510,abnormal coat appearance|MP:0002073,abnormal hair growth|MP:0002074,abnormal hair texture|MP:0003413,hair follicle degeneration
MGI:1856834	cri	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000955,abnormal spinal cord morphology|MP:0001393,ataxia|MP:0001423,abnormal liquid preference|MP:0001577,anemia|MP:0001586,abnormal erythrocyte cell number|MP:0001764,abnormal homeostasis|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002668,abnormal circulating potassium level|MP:0002875,decreased erythrocyte cell number|MP:0003632,abnormal nervous system morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003868,abnormal feces composition|MP:0003996,clonic seizures|MP:0004924,abnormal behavior|MP:0005618,decreased urine potassium level|MP:0005628,decreased circulating potassium level|MP:0006317,decreased urine sodium level|MP:0006357,abnormal circulating mineral level|MP:0008027,abnormal spinal cord white matter morphology|MP:0009643,abnormal urine homeostasis|MP:0010768,mortality/aging|MP:0013532,abnormal parotid gland physiology
MGI:6153310	Crim1<em1(IMPC)Wtsi>	MP:0000150,abnormal rib morphology|MP:0000564,syndactyly|MP:0000963,fused dorsal root ganglion|MP:0001067,absent mandibular nerve|MP:0001512,trunk curl|MP:0002092,abnormal eye morphology|MP:0003130,anal atresia|MP:0004175,telangiectasia|MP:0004599,abnormal vertebral arch morphology|MP:0004613,fusion of vertebral arches|MP:0005587,abnormal Meckel's cartilage morphology|MP:0009532,decreased parotid gland size|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010526,aortic arch coarctation|MP:0010528,pulmonary vein hypoplasia|MP:0010912,herniated liver|MP:0011100,preweaning lethality, complete penetrance|MP:0013814,abnormal hepatic portal vein connection|MP:0013836,abnormal hypoglossal nerve topology|MP:0013840,absent segment of posterior cerebral artery|MP:0013848,subcutaneous edema|MP:0013852,abnormal Mullerian duct topology|MP:0013859,abnormal vitelline vein connection|MP:0013876,absent ductus venosus valve|MP:0013877,abnormal ductus venosus valve morphology|MP:0013880,absent ductus venosus|MP:0013932,fragmented Meckel's cartilage|MP:0013970,absent connection between subcutaneous lymph vessels and lymph sac|MP:0013971,blood in lymph vessels|MP:0013986,abnormal vitelline vein topology|MP:0014000,anastomosis between internal carotid artery and basilar artery|MP:0014001,abnormal vertebral artery topology|MP:0014006,absent posterior communicating artery|MP:0014087,retrolental blood|MP:0031428,lens dislocation
MGI:3696690	Crim1<Gt(KST264)Byg>	MP:0000519,hydronephrosis|MP:0000522,kidney cortex cyst|MP:0000523,cortical renal glomerulopathies|MP:0000564,syndactyly|MP:0001306,small lens|MP:0001859,kidney inflammation|MP:0002705,dilated renal tubule|MP:0002871,albuminuria|MP:0002989,small kidney|MP:0003070,increased vascular permeability|MP:0003215,renal interstitial fibrosis|MP:0004154,renal tubular necrosis|MP:0004194,abnormal kidney pelvis morphology|MP:0004269,abnormal optic cup morphology|MP:0004273,abnormal basal lamina morphology|MP:0005264,glomerulosclerosis|MP:0005299,abnormal eye posterior chamber morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005367,renal/urinary system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005528,decreased renal glomerular filtration rate|MP:0005556,abnormal renal filtration rate|MP:0005581,abnormal renin activity|MP:0008059,abnormal podocyte foot process morphology|MP:0008140,podocyte foot process effacement|MP:0008770,decreased survivor rate|MP:0008817,hematoma|MP:0008856,fetal bleb|MP:0011089,perinatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011294,renal glomerulus hypertrophy|MP:0011304,kidney papillary atrophy|MP:0011320,abnormal glomerular capillary morphology|MP:0011321,abnormal peritubular capillary morphology|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011368,increased kidney apoptosis|MP:0011376,abnormal kidney corticomedullary boundary morphology|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011430,mesangiolysis|MP:0011437,glomerulus hemorrhage|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011455,absent glomerular endothelium fenestra|MP:0011480,impaired ureteric peristalsis|MP:0011501,increased glomerular capsule space|MP:0011509,dilated glomerular capillary|MP:0011565,kidney papillary hypoplasia|MP:0011682,renal glomerulus cyst|MP:0011753,decreased podocyte number|MP:0011854,cerebral edema|MP:0011856,abnormal glomerular filtration barrier function|MP:0011857,short kidney papilla|MP:0011859,decreased renal glomerulus basement membrane thickness|MP:0011860,abnormal peritubular capillary endothelium morphology
MGI:5438615	Crim1<tm1.1Dpen>	MP:0000564,syndactyly|MP:0001297,microphthalmia|MP:0001785,edema|MP:0003446,renal hypoplasia|MP:0005325,abnormal renal glomerulus morphology|MP:0008854,bleb|MP:0010831,lethality, incomplete penetrance|MP:0011085,postnatal lethality, complete penetrance
MGI:5438614	Crim1<tm1Dpen>	MP:0002169,no abnormal phenotype detected
MGI:5317218	Crim1<tm1(GFP/cre/ERT2)Pzg>	MP:0002169,no abnormal phenotype detected
MGI:3775195	Crip2<tm1.1Acsc>	MP:0002734,abnormal mechanical nociception|MP:0002736,abnormal nociception after inflammation|MP:0003631,nervous system phenotype
MGI:5696920	Crip3<tm1b(KOMP)Mbp>	MP:0001417,decreased exploration in new environment
MGI:2445952	Crip3<tm1Mjb>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia
MGI:5433707	Cripto<tm1.1Gmin>	MP:0000266,abnormal heart morphology|MP:0001695,abnormal gastrulation|MP:0001700,abnormal embryo turning|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0006386,absent somites|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011256,abnormal neural fold morphology
MGI:1857518	Cripto<tm1Eda>	MP:0000267,abnormal heart development|MP:0001680,abnormal mesoderm development|MP:0001695,abnormal gastrulation|MP:0001719,absent vitelline blood vessels|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002230,abnormal primitive streak formation|MP:0002836,abnormal chorion morphology|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005029,abnormal amnion morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005380,embryo phenotype|MP:0006386,absent somites|MP:0011092,embryonic lethality, complete penetrance|MP:0011204,abnormal visceral yolk sac blood island morphology|MP:0011704,decreased fibroblast proliferation|MP:0012173,short rostral-caudal axis|MP:0014698,decreased fibroblast adhesion
MGI:1934206	Cripto<tm1Mms>	MP:0000267,abnormal heart development|MP:0001674,abnormal germ layer development|MP:0001680,abnormal mesoderm development|MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001695,abnormal gastrulation|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0006386,absent somites|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011186,abnormal visceral endoderm morphology
MGI:5002491	Cripto<tm2.2Mms>	MP:0001728,failure of embryo implantation|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0002169,no abnormal phenotype detected|MP:0003845,abnormal decidualization|MP:0004014,abnormal uterine environment|MP:0009094,abnormal endometrial gland morphology|MP:0009360,endometrium inflammation|MP:0009649,delayed embryo implantation|MP:0009661,abnormal pregnancy|MP:0009663,abnormal uterine-embryonic axis|MP:0009664,abnormal luminal closure|MP:0009666,abnormal embryo attachment
MGI:5523317	Cript<tm1.1(KOMP)Vlcg>	MP:0005562,decreased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5287502	Cript<Tn(sb-rtTA)2427.SB1Ove>	MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:3808726	Crisp1<tm1Pasc>	MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype
MGI:4888856	Crisp2<tm1a(KOMP)Mbp>	MP:0001922,reduced male fertility|MP:0002674,abnormal sperm motility|MP:0002675,asthenozoospermia|MP:0004542,impaired acrosome reaction|MP:0005389,reproductive system phenotype|MP:0020451,decreased sperm progressive motility
MGI:6369005	Crisp2<tm1c(KOMP)Mbp>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0004542,impaired acrosome reaction|MP:0005389,reproductive system phenotype|MP:0020451,decreased sperm progressive motility
MGI:7425608	Crisp3<em1(IMPC)Mhzh>	MP:0001325,abnormal retina morphology
MGI:4950060	Crisp4<tm1.2Mkob>	MP:0004542,impaired acrosome reaction|MP:0005389,reproductive system phenotype
MGI:5431546	Crisp4<tm1(icre)Mpo>	MP:0004852,decreased testis weight
MGI:5548696	Crispld2<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0000266,abnormal heart morphology|MP:0001697,abnormal embryo size|MP:0002644,decreased circulating triglyceride level|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5007091	Crispld2<tm1Lex>	MP:0000685,abnormal immune system morphology|MP:0001790,abnormal immune system physiology|MP:0005292,improved glucose tolerance|MP:0005508,abnormal skeleton morphology
MGI:2181183	Crk<Gt(pU-Hachi)8104Imeg>	MP:0002169,no abnormal phenotype detected
MGI:5510713	Crkl<snoopy>	MP:0000087,absent mandible|MP:0000106,abnormal basisphenoid bone morphology|MP:0000428,abnormal craniofacial morphology|MP:0000457,maxilla hypoplasia|MP:0000458,abnormal mandible morphology|MP:0000460,mandible hypoplasia|MP:0000783,abnormal forebrain morphology|MP:0001286,abnormal eye development|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002234,abnormal pharynx morphology|MP:0004461,basisphenoid bone hypoplasia|MP:0004469,abnormal zygomatic arch morphology|MP:0004871,premaxilla hypoplasia|MP:0005157,holoprosencephaly|MP:0005163,cyclopia|MP:0005249,abnormal palatine bone morphology|MP:0006197,ocular hypotelorism|MP:0006290,proboscis|MP:0009880,decreased mouth size|MP:0009890,cleft secondary palate|MP:0009904,tongue hypoplasia|MP:0009905,absent tongue|MP:0013818,abnormal oral cavity morphology|MP:0021166,delayed palatal shelf elevation|MP:0030160,abnormal auditory bulla morphology|MP:0031460,abnormal palatal shelf morphology|MP:0031463,increased palatal shelf size
MGI:5825167	Crkl<tm1c(EUCOMM)Hmgu>	MP:0000914,exencephaly
MGI:3830004	Crkl<tm1Cur>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0003631,nervous system phenotype
MGI:5904959	Crkl<tm1d(EUCOMM)Hmgu>	MP:0000914,exencephaly|MP:0003051,curly tail|MP:0009929,meningomyelocele
MGI:2446094	Crkl<tm1Hkp>	MP:0000266,abnormal heart morphology|MP:0000585,kinked tail|MP:0000598,abnormal liver morphology|MP:0001262,decreased body weight|MP:0001711,abnormal placenta morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0010402,ventricular septal defect|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance
MGI:1931805	Crkl<tm1Imo>	MP:0000025,otic hypertelorism|MP:0000102,abnormal nasal bone morphology|MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000428,abnormal craniofacial morphology|MP:0000441,increased cranium width|MP:0000704,abnormal thymus development|MP:0001081,abnormal cranial ganglia morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001096,abnormal glossopharyngeal ganglion morphology|MP:0001100,abnormal vagus ganglion morphology|MP:0001262,decreased body weight|MP:0001300,ocular hypertelorism|MP:0003421,abnormal thyroid gland development|MP:0003717,pallor|MP:0003923,abnormal heart left atrium morphology|MP:0004062,dilated heart right atrium|MP:0004113,abnormal aortic arch morphology|MP:0004157,interrupted aortic arch|MP:0004380,short frontal bone|MP:0008525,decreased cranium height|MP:0010402,ventricular septal defect|MP:0010465,aberrant origin of the right subclavian artery|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0013573,abnormal parathyroid gland development
MGI:3665145	Crk<tm1.1Cur>	MP:0000280,thin ventricular wall|MP:0001914,hemorrhage|MP:0002192,hydrops fetalis|MP:0002233,abnormal nose morphology|MP:0002238,abnormal nasal mucosa morphology|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0005294,abnormal heart ventricle morphology|MP:0005590,increased vasodilation|MP:0005592,abnormal vascular smooth muscle morphology|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0011089,perinatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012729,abnormal common carotid artery morphology
MGI:3830007	Crk<tm1Cur>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0003631,nervous system phenotype
MGI:3620771	Crl1<AKR/J>	MP:0002459,abnormal B cell physiology
MGI:3620773	Crl1<A/WySnJ>	MP:0002459,abnormal B cell physiology
MGI:3620772	Crl1<DBA/2J>	MP:0002459,abnormal B cell physiology
MGI:2387956	Crlf1<tm1Wsa>	MP:0000939,decreased motor neuron number|MP:0001436,abnormal suckling behavior|MP:0001606,impaired hematopoiesis|MP:0009546,absent gastric milk in neonates|MP:0011087,neonatal lethality, complete penetrance
MGI:6277006	Crlf2<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001297,microphthalmia|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002339,abnormal lymph node morphology|MP:0002590,increased mean corpuscular volume|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0005344,increased circulating bilirubin level|MP:0020421,increased freezing behavior
MGI:3039288	Crlf2<tm1Jni>	MP:0002405,respiratory system inflammation|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:3623417	Crlf2<tm1Wjl>	MP:0001861,lung inflammation|MP:0002401,abnormal lymphopoiesis|MP:0002460,decreased immunoglobulin level|MP:0002816,colitis|MP:0003009,abnormal cytokine secretion|MP:0005017,decreased B cell number|MP:0005094,abnormal T cell proliferation|MP:0008083,decreased single-positive T cell number|MP:0009335,decreased splenocyte proliferation|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:7608098	Crlf3<em1Gtm>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008143,abnormal dendrite morphology|MP:0021090,abnormal dendrite arborization pattern
MGI:6140181	Crlf3<em1(IMPC)Wtsi>	MP:0003179,thrombocytopenia|MP:0010067,increased red blood cell distribution width
MGI:4363171	Crlf3<tm1a(KOMP)Wtsi>	MP:0001262,decreased body weight|MP:0003179,thrombocytopenia|MP:0003961,decreased lean body mass|MP:0005564,increased hemoglobin content|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:5548496	Crlf3<tm1b(KOMP)Wtsi>	MP:0002591,decreased mean corpuscular volume|MP:0003179,thrombocytopenia
MGI:4432552	Crls1<tm1a(EUCOMM)Wtsi>	MP:0002836,abnormal chorion morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:6356533	Crls1<tm1Geno>	MP:0002971,abnormal brown adipose tissue morphology|MP:0002981,increased liver weight|MP:0005290,decreased oxygen consumption|MP:0005331,insulin resistance|MP:0005370,liver/biliary system phenotype|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009116,abnormal brown fat cell morphology|MP:0009124,increased brown fat cell lipid droplet size|MP:0009289,decreased epididymal fat pad weight|MP:0009295,decreased interscapular fat pad weight|MP:0010379,decreased respiratory quotient|MP:0010955,abnormal respiratory electron transport chain|MP:0011049,impaired adaptive thermogenesis|MP:0011631,decreased mitochondrial size|MP:0011636,disorganized mitochondrial cristae|MP:0011698,abnormal brown adipose tissue physiology|MP:0011699,abnormal brown adipose tissue thermogenesis|MP:0013279,increased fasting circulating glucose level|MP:0014396,decreased fat cell mitochondrial DNA content|MP:0030017,decreased adipocyte glucose uptake
MGI:1856000	Crm	MP:0002075,abnormal coat/hair pigmentation|MP:0002095,abnormal skin pigmentation|MP:0003136,yellow coat color|MP:0005366,variegated coat color
MGI:2668863	Crm<3J>	MP:0003136,yellow coat color|MP:0005366,variegated coat color
MGI:1856001	Crm<J>	MP:0003136,yellow coat color|MP:0005366,variegated coat color
MGI:6430667	Crmp1<em1(IMPC)Mbp>	MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0004402,decreased cochlear outer hair cell number|MP:0004404,cochlear outer hair cell degeneration|MP:0004529,decreased outer hair cell stereocilia number|MP:0004740,sensorineural hearing loss|MP:0005377,hearing/vestibular/ear phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3707322	Crmp1<tm1.1Swl>	MP:0001463,abnormal spatial learning|MP:0002207,abnormal long-term potentiation|MP:0009940,abnormal hippocampus pyramidal cell morphology
MGI:3701338	Crmp1<tm1Pako>	MP:0004948,abnormal neuronal precursor proliferation|MP:0005386,behavior/neurological phenotype|MP:0014551,impaired neuronal migration
MGI:1856835	crn	MP:0000074,abnormal neurocranium morphology|MP:0000075,absent neurocranium|MP:0000107,abnormal frontal bone morphology|MP:0000111,cleft palate|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0001890,anencephaly|MP:0002759,abnormal caudal vertebrae morphology|MP:0003720,abnormal neural tube closure|MP:0006301,abnormal mesenchyme morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:5563544	Crnde<tm1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:3773077	cro	MP:0005369,muscle phenotype
MGI:7425610	Crocc2<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002135,abnormal kidney morphology
MGI:7425609	Crocc<em1(IMPC)Bay>	MP:0001417,decreased exploration in new environment
MGI:3580447	Crocc<tm1Tili>	MP:0001861,lung inflammation|MP:0008450,retina photoreceptor degeneration
MGI:7386925	Crot<em1Akw>	MP:0002169,no abnormal phenotype detected
MGI:6156275	Crot<em1(IMPC)Kmpc>	MP:0002075,abnormal coat/hair pigmentation
MGI:7545590	Crp<em1Wuy>	MP:0000203,abnormal circulating aspartate transaminase level|MP:0000607,abnormal hepatocyte morphology|MP:0002941,increased circulating alanine transaminase level|MP:0005165,increased susceptibility to injury|MP:0020344,abnormal susceptibility to injury induced morbidity/mortality
MGI:6378430	Crppa<em1(IMPC)H>	MP:0000219,increased neutrophil cell number|MP:0002599,increased mean platelet volume
MGI:5776276	Crppa<em2Mbp>	MP:0000752,dystrophic muscle|MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0008489,slow postnatal weight gain|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009414,skeletal muscle fiber necrosis|MP:0009419,skeletal muscle fibrosis|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0010239,decreased skeletal muscle weight
MGI:5470460	Crppa<m1Ddg>	MP:0000778,abnormal nervous system tract morphology|MP:0001953,respiratory failure|MP:0002961,abnormal axon guidance|MP:0004272,abnormal basement membrane morphology|MP:0009450,abnormal axon fasciculation|MP:0009677,abnormal spinal cord dorsal column morphology|MP:0009695,abnormal spinal cord ventral commissure morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011723,ectopic neuron|MP:0020391,radial glial endfoot detachment
MGI:3688856	Crpt<1R>	MP:0000585,kinked tail|MP:0000592,short tail|MP:0011091,prenatal lethality, complete penetrance
MGI:4947397	Crp<tm1Hjf>	MP:0031060,decreased circulating C-reactive protein level
MGI:3588652	Crsl	MP:0001337,dry eyes|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0002082,postnatal lethality|MP:0003069,abnormal superior semicircular canal morphology|MP:0003126,abnormal external female genitalia morphology|MP:0003161,absent lateral semicircular canal|MP:0003162,decreased lateral semicircular canal size|MP:0004395,increased cochlear inner hair cell number|MP:0004401,increased cochlear outer hair cell number|MP:0004480,abnormal round window morphology|MP:0005107,abnormal stapes morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005390,skeleton phenotype|MP:0009101,clitoris hypoplasia|MP:0013466,keratoconjunctivitis sicca|MP:0030411,decreased round window size|MP:0030412,absent round window
MGI:1889324	crsp	MP:0001155,arrest of spermatogenesis|MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0002286,cryptorchism|MP:0002669,abnormal scrotum morphology|MP:0002940,variable body spotting|MP:0003673,abnormal inguinal canal morphology|MP:0005149,abnormal gubernaculum morphology|MP:0005159,azoospermia|MP:0010016,variable depigmentation|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6276953	Crtac1<em1(IMPC)H>	MP:0001392,abnormal locomotor behavior|MP:0002006,neoplasm|MP:0010052,increased grip strength
MGI:5141316	Crtac1<tm1Kota>	MP:0005237,abnormal olfactory tract morphology|MP:0009450,abnormal axon fasciculation
MGI:3834613	Crtam<tm1Achn>	MP:0001828,abnormal T cell activation|MP:0002412,increased susceptibility to bacterial infection|MP:0005348,increased T cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005465,abnormal T-helper 1 physiology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008567,decreased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion|MP:0008682,decreased interleukin-17 secretion
MGI:4361562	Crtam<tm1Tks>	MP:0005025,abnormal response to infection|MP:0005387,immune system phenotype
MGI:3693334	Crtap<tm1Brle>	MP:0000066,osteoporosis|MP:0000069,kyphoscoliosis|MP:0000130,abnormal trabecular bone morphology|MP:0001732,postnatal growth retardation|MP:0002896,abnormal bone mineralization|MP:0003795,abnormal bone structure|MP:0004016,decreased bone mass|MP:0004201,fetal growth retardation|MP:0004686,decreased length of long bones|MP:0005006,abnormal osteoblast physiology|MP:0006397,disorganized long bone epiphyseal plate|MP:0020040,decreased bone ossification
MGI:3829386	Crtc1<Gt(XK522)Byg>	MP:0000008,increased white adipose tissue amount|MP:0001134,absent corpus luteum|MP:0001261,obese|MP:0001354,increased aggression towards male mice|MP:0001356,increased aggression towards female mice|MP:0001360,abnormal social investigation|MP:0001361,social withdrawal|MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001433,polyphagia|MP:0001447,abnormal nest building behavior|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0001764,abnormal homeostasis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002079,increased circulating insulin level|MP:0002566,abnormal sexual interaction|MP:0002573,behavioral despair|MP:0002773,decreased circulating luteinizing hormone level|MP:0004890,decreased energy expenditure|MP:0005293,impaired glucose tolerance|MP:0009081,thin uterus|MP:0009456,impaired cued conditioning behavior|MP:0009710,anhedonia|MP:0010070,decreased serotonin level
MGI:4432872	Crtc1<tm1a(EUCOMM)Wtsi>	MP:0008501,increased IgG2b level
MGI:4355660	Crtc2<tm1.1Khk>	MP:0000609,abnormal liver physiology|MP:0002078,abnormal glucose homeostasis|MP:0002665,decreased circulating corticosterone level|MP:0005439,decreased glycogen level
MGI:4433344	Crtc2<tm1a(EUCOMM)Wtsi>	MP:0030016,increased adipocyte glucose uptake
MGI:5566704	Crtc2<tm1Mmy>	MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0013278,decreased fasting circulating glucose level|MP:0020103,decreased hepatic glucose production|MP:0030973,impaired gluconeogenesis
MGI:5548599	Crtc3<tm1b(KOMP)Wtsi>	MP:0001258,decreased body length|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4879976	Crtc3<tm1Mmy>	MP:0002078,abnormal glucose homeostasis|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005533,increased body temperature|MP:0005621,abnormal cell physiology|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0005670,abnormal white adipose tissue physiology|MP:0009116,abnormal brown fat cell morphology|MP:0009125,decreased brown fat cell lipid droplet size|MP:0009127,increased brown fat cell number|MP:0009133,decreased white fat cell size|MP:0010025,decreased total body fat amount|MP:0030021,increased muscle cell glucose uptake|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3777573	crts	MP:0009685,abnormal spinal cord motor column morphology
MGI:5704085	crup	MP:0001513,limb grasping
MGI:6341903	Crx<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000538,abnormal urinary bladder morphology|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001325,abnormal retina morphology|MP:0001417,decreased exploration in new environment|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0008044,increased NK cell number|MP:0011874,enlarged urinary bladder|MP:0013279,increased fasting circulating glucose level
MGI:7576952	Crx<em1Smgc>	MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005391,vision/eye phenotype|MP:0006071,abnormal retina progenitor cell morphology|MP:0006148,binocular blindness|MP:0008516,disorganized retina outer nuclear layer|MP:0008585,absent photoreceptor outer segment|MP:0010749,absent visual evoked potential|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:7576954	Crx<em2Smgc>	MP:0005391,vision/eye phenotype|MP:0006148,binocular blindness|MP:0008516,disorganized retina outer nuclear layer|MP:0008585,absent photoreceptor outer segment|MP:0010749,absent visual evoked potential
MGI:7640120	Crx<rd23>	MP:0001326,retina degeneration|MP:0005551,abnormal eye electrophysiology|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0010097,abnormal retina blood vessel morphology
MGI:5515375	Crx<Rip>	MP:0001004,abnormal retina photoreceptor morphology|MP:0002001,blindness|MP:0002128,abnormal blood circulation|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005391,vision/eye phenotype|MP:0008582,short photoreceptor inner segment|MP:0008585,absent photoreceptor outer segment|MP:0010097,abnormal retina blood vessel morphology|MP:0012671,retina spots
MGI:5621024	Crx<tm1.1Smgc>	MP:0001006,abnormal retina cone cell morphology|MP:0003727,abnormal retina layer morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005391,vision/eye phenotype|MP:0008446,decreased retina cone cell number|MP:0008518,retina outer nuclear layer degeneration|MP:0008585,absent photoreceptor outer segment|MP:0011997,abnormal retina outer nuclear layer thickness|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0014336,short retina rod cell outer segment
MGI:2181191	Crx<tm1Clc>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001325,abnormal retina morphology|MP:0003727,abnormal retina layer morphology|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology|MP:0006068,abnormal retina horizontal cell morphology|MP:0006073,abnormal retina bipolar cell morphology|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0006075,abnormal retina cone bipolar cell morphology|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008585,absent photoreceptor outer segment|MP:0012029,abnormal electroretinogram waveform feature|MP:0020467,abnormal circadian behavior|MP:0020475,delayed circadian behavior phase
MGI:5699593	Crx<tm1Smgc>	MP:0001006,abnormal retina cone cell morphology|MP:0005391,vision/eye phenotype|MP:0012029,abnormal electroretinogram waveform feature|MP:0014336,short retina rod cell outer segment
MGI:5621025	Crx<tm2.1Smgc>	MP:0001006,abnormal retina cone cell morphology|MP:0003727,abnormal retina layer morphology|MP:0005391,vision/eye phenotype|MP:0008518,retina outer nuclear layer degeneration|MP:0008585,absent photoreceptor outer segment|MP:0012029,abnormal electroretinogram waveform feature|MP:0012144,decreased b-wave amplitude
MGI:4867395	Crx<tvrm65>	MP:0002864,abnormal ocular fundus morphology|MP:0005103,abnormal retina pigmentation|MP:0008450,retina photoreceptor degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0008519,thin retina outer plexiform layer|MP:0008583,absent photoreceptor inner segment|MP:0008585,absent photoreceptor outer segment
MGI:5755154	Cry1<em1(IMPC)H>	MP:0000218,increased leukocyte cell number|MP:0005419,decreased circulating serum albumin level|MP:0013278,decreased fasting circulating glucose level
MGI:7314236	Cry1<em1Liga>	MP:0001156,abnormal spermatogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0004884,abnormal testis physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0014052,increased male germ cell apoptosis
MGI:8240382	Cry1<em1Lijd>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0003461,abnormal response to novel object|MP:0005402,abnormal action potential|MP:0010698,abnormal impulsive behavior control|MP:0012315,impaired learning|MP:0014367,impaired long-term object recognition memory|MP:0014370,impaired spatial working memory|MP:0014413,decreased depression-related behavior
MGI:2181211	Cry1<tm1Asn>	MP:0020470,shortened circadian behavior period
MGI:2181205	Cry1<tm1Jhjh>	MP:0020470,shortened circadian behavior period
MGI:5751243	Cry2<tm1.1Yf>	MP:0020469,prolonged circadian behavior period
MGI:2181212	Cry2<tm1Asn>	MP:0020469,prolonged circadian behavior period|MP:0020471,abnormal circadian behavior persistence
MGI:2181206	Cry2<tm1Jhjh>	MP:0001541,abnormal osteoclast physiology|MP:0010875,increased bone volume|MP:0020469,prolonged circadian behavior period
MGI:3665275	Cryaa<2J>	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001306,small lens|MP:0003236,abnormal lens capsule morphology|MP:0003237,abnormal lens epithelium morphology
MGI:2653028	Cryaa<Aey7>	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract
MGI:3665274	Cryaa<L1N>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001306,small lens|MP:0005391,vision/eye phenotype|MP:0010254,nuclear cataract
MGI:1858023	Cryaa<lop18>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology|MP:0011697,lens vacuoles
MGI:3777403	Cryaa<tm1.1Ady>	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001306,small lens|MP:0008794,increased lens epithelium apoptosis|MP:0008796,increased lens fiber apoptosis|MP:0010254,nuclear cataract
MGI:4437472	Cryaa<tm1Ady>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology|MP:0008841,ruptured lens capsule|MP:0010254,nuclear cataract
MGI:1858025	Cryaa<tm1Wawr>	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001306,small lens|MP:0008794,increased lens epithelium apoptosis
MGI:4437473	Cryaa<tm2Ady>	MP:0005391,vision/eye phenotype
MGI:7571352	Cryab<em1Mtc>	MP:0001625,cardiac hypertrophy|MP:0003141,cardiac fibrosis|MP:0003819,increased left ventricle diastolic pressure|MP:0003921,abnormal heart left ventricle morphology|MP:0005598,decreased heart ventricle muscle contractility|MP:0010633,myocardium hypertrophy
MGI:4999580	Cryab<tm1.1Ady>	MP:0000751,myopathy|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001306,small lens|MP:0001312,abnormal cornea morphology|MP:0002579,disorganized secondary lens fibers|MP:0002840,abnormal lens fiber morphology|MP:0003237,abnormal lens epithelium morphology|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009414,skeletal muscle fiber necrosis|MP:0009419,skeletal muscle fibrosis|MP:0010053,decreased grip strength|MP:0030938,abnormal reticulophagy
MGI:1857969	Cryba1<Po1>	MP:0001297,microphthalmia|MP:0010263,total cataract
MGI:5613243	Cryba1<tm1.1Dbsa>	MP:0002183,gliosis|MP:0003172,abnormal lysosome physiology|MP:0005058,abnormal lysosome morphology|MP:0005059,lysosomal protein accumulation|MP:0005103,abnormal retina pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0030940,impaired autophagy|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:4951042	Cryba1<tm1a(EUCOMM)Hmgu>	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001306,small lens|MP:0002840,abnormal lens fiber morphology|MP:0003172,abnormal lysosome physiology|MP:0003237,abnormal lens epithelium morphology|MP:0004231,abnormal calcium ion homeostasis|MP:0005058,abnormal lysosome morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008260,abnormal autophagy|MP:0010254,nuclear cataract|MP:0011628,increased mitochondrial number|MP:0012538,persistent hyaloid artery|MP:0020378,abnormal cell cytoskeleton morphology|MP:0031345,developmental cataract
MGI:4950379	Cryba2<Aca30>	MP:0001306,small lens|MP:0001312,abnormal cornea morphology|MP:0010251,subcapsular cataract|MP:0010263,total cataract
MGI:7447409	Cryba4<em1(IMPC)Bay>	MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity
MGI:7425612	Crybb1<em1(IMPC)Bay>	MP:0011964,increased total retina thickness
MGI:3796239	Crybb2<0377>	MP:0000879,increased Purkinje cell number|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001306,small lens|MP:0014327,decreased Purkinje cell size
MGI:2137511	Crybb2<Aey2>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology|MP:0010263,total cataract
MGI:5433854	Crybb2<Lop19>	MP:0001304,cataract|MP:0010261,sutural cataract|MP:0010263,total cataract
MGI:1857342	Crybb2<Phil>	MP:0001303,abnormal lens morphology|MP:0010251,subcapsular cataract|MP:0010254,nuclear cataract
MGI:3821715	Crybb2<tm1Itl>	MP:0001129,impaired ovarian folliculogenesis|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001306,small lens|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002682,decreased mature ovarian follicle number|MP:0003077,abnormal cell cycle|MP:0004759,decreased mitotic index|MP:0005182,increased circulating estradiol level|MP:0005185,decreased circulating progesterone level|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0010256,anterior cortical cataract|MP:0010257,posterior cortical cataract|MP:0010263,total cataract|MP:0011121,decreased primordial ovarian follicle number|MP:0013508,increased granulosa cell apoptosis|MP:0031018,decreased granulosa cell proliferation|MP:0031239,increased atretic ovarian follicle number|MP:0031381,decreased secondary ovarian follicle number|MP:0031420,decreased superovulation rate
MGI:5569032	Crybb3<tm1.1(KOMP)Vlcg>	MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis
MGI:5605748	Crybg1<tm1b(KOMP)Wtsi>	MP:0001417,decreased exploration in new environment|MP:0002092,abnormal eye morphology|MP:0005565,increased blood urea nitrogen level|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:1857595	Cryga<1Neu>	MP:0010254,nuclear cataract
MGI:1856493	Cryga<Tol>	MP:0001297,microphthalmia|MP:0002840,abnormal lens fiber morphology|MP:0008841,ruptured lens capsule|MP:0010254,nuclear cataract|MP:0010263,total cataract|MP:0011697,lens vacuoles
MGI:3590646	Crygb<Clapper>	MP:0010262,lamellar cataract
MGI:1857597	Crygb<Nop>	MP:0010254,nuclear cataract
MGI:3777015	Crygb<S11R>	MP:0001303,abnormal lens morphology|MP:0002840,abnormal lens fiber morphology|MP:0010254,nuclear cataract
MGI:2176919	Crygc<Chl3>	MP:0001297,microphthalmia|MP:0001304,cataract
MGI:6356332	Crygc<Lop20>	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0010254,nuclear cataract|MP:0010255,cortical cataract
MGI:4822430	Crygc<M1Sbao>	MP:0001303,abnormal lens morphology|MP:0001306,small lens|MP:0002092,abnormal eye morphology|MP:0003237,abnormal lens epithelium morphology|MP:0005253,abnormal eye physiology|MP:0010254,nuclear cataract|MP:0031345,developmental cataract
MGI:7549103	Crygc<M2J>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology|MP:0010254,nuclear cataract
MGI:3578335	Crygc<MNU8>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology
MGI:5695969	Crygc<tm1.1(KOMP)Vlcg>	MP:0000274,enlarged heart|MP:0001944,abnormal pancreas morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2387106	Crygd<Aey4>	MP:0010254,nuclear cataract
MGI:3578336	Crygd<ENU4011>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology
MGI:3578337	Crygd<ENU910>	MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology
MGI:3578338	Crygd<K10>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001306,small lens|MP:0002840,abnormal lens fiber morphology|MP:0011697,lens vacuoles
MGI:3762620	Crygd<L23>	MP:0001306,small lens|MP:0002840,abnormal lens fiber morphology|MP:0006225,ocular rupture|MP:0010263,total cataract
MGI:1858026	Crygd<Lop12>	MP:0001304,cataract
MGI:3578341	Cryge<ADD15306>	MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology
MGI:1932397	Cryge<Aey1>	MP:0001297,microphthalmia|MP:0001304,cataract
MGI:1857599	Cryge<Elo>	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001306,small lens|MP:0002840,abnormal lens fiber morphology|MP:0005545,abnormal lens development
MGI:3578339	Cryge<ENU418>	MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology
MGI:3578342	Cryge<ENU449>	MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology
MGI:3713105	Cryge<No3>	MP:0001304,cataract|MP:0010254,nuclear cataract
MGI:1855994	Cryge<ns>	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0011697,lens vacuoles
MGI:1855995	Cryge<nz>	MP:0001304,cataract|MP:0005545,abnormal lens development|MP:0010254,nuclear cataract
MGI:1857598	Cryge<t>	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001320,small pupil|MP:0001322,abnormal iris morphology|MP:0003236,abnormal lens capsule morphology|MP:0005545,abnormal lens development|MP:0008841,ruptured lens capsule|MP:0010263,total cataract|MP:0013731,immature cataract
MGI:3578340	Cryge<Z2>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology
MGI:1855996	Crygf<Rop>	MP:0001304,cataract
MGI:6330718	Crygn<em1(IMPC)Hmgu>	MP:0001146,abnormal testis morphology
MGI:4455953	Crygn<tm1a(EUCOMM)Wtsi>	MP:0000848,abnormal pons morphology|MP:0003631,nervous system phenotype|MP:0004738,abnormal auditory brainstem response|MP:0005377,hearing/vestibular/ear phenotype|MP:0008948,decreased neuron number
MGI:1861635	Crygs<Opj>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002579,disorganized secondary lens fibers|MP:0002840,abnormal lens fiber morphology|MP:0010263,total cataract
MGI:2181679	Crygs<rncat>	MP:0001304,cataract
MGI:5635041	Crygs<tm1b(KOMP)Wtsi>	MP:0001556,increased circulating HDL cholesterol level
MGI:3522501	Crygs<tm1Gwis>	MP:0001303,abnormal lens morphology|MP:0002840,abnormal lens fiber morphology
MGI:3703787	Crym<tm1Sasu>	MP:0005377,hearing/vestibular/ear phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005385,cardiovascular system phenotype|MP:0005472,abnormal triiodothyronine level|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level
MGI:7425614	Cryzl1<em1(IMPC)Bay>	MP:0001399,hyperactivity|MP:0011959,abnormal eye posterior chamber depth|MP:0011960,abnormal eye anterior chamber depth
MGI:4331536	Csad<Gt(XP0392)Wtsi>	MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3807581	Cs<ahl4>	MP:0004748,increased susceptibility to age-related hearing loss|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6356756	Csde1<tm1Fda>	MP:0000301,decreased atrioventricular cushion size|MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001712,abnormal placenta development|MP:0001713,decreased trophoblast giant cell number|MP:0002169,no abnormal phenotype detected|MP:0003984,embryonic growth retardation|MP:0004067,abnormal trabecula carnea morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0005380,embryo phenotype|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011521,decreased placental labyrinth size|MP:0012082,delayed heart development|MP:0012099,decreased spongiotrophoblast size|MP:0013272,abnormal translation
MGI:2387437	Cse1l<tm1Ipa>	MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5424913	Csf1<Mhdabap25>	MP:0002966,decreased circulating alkaline phosphatase level
MGI:1856333	Csf1<op>	MP:0000065,abnormal bone marrow cavity morphology|MP:0000066,osteoporosis|MP:0000067,osteopetrosis|MP:0000109,abnormal parietal bone morphology|MP:0000125,absent incisors|MP:0000130,abnormal trabecular bone morphology|MP:0000136,abnormal microglial cell morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000198,decreased circulating phosphate level|MP:0000221,decreased leukocyte cell number|MP:0000223,decreased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000333,decreased bone marrow cell number|MP:0000440,domed cranium|MP:0000547,short limbs|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0000572,abnormal autopod morphology|MP:0000592,short tail|MP:0000628,abnormal mammary gland development|MP:0000662,abnormal branching of the mammary ductal tree|MP:0000711,thymus cortex hypoplasia|MP:0001126,abnormal ovary morphology|MP:0001130,abnormal ovarian folliculogenesis|MP:0001262,decreased body weight|MP:0001380,decreased male mating frequency|MP:0001431,abnormal eating behavior|MP:0001562,abnormal circulating calcium level|MP:0001729,impaired embryo implantation|MP:0001731,abnormal postnatal growth|MP:0001732,postnatal growth retardation|MP:0001882,abnormal lactation|MP:0001921,reduced fertility|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001928,abnormal ovulation|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002356,abnormal spleen red pulp morphology|MP:0002397,abnormal bone marrow morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002673,abnormal sperm number|MP:0002680,decreased corpora lutea number|MP:0002682,decreased mature ovarian follicle number|MP:0002687,oligozoospermia|MP:0002780,decreased circulating testosterone level|MP:0002998,abnormal bone remodeling|MP:0003329,amyloid beta deposits|MP:0003355,decreased ovulation rate|MP:0003357,impaired granulosa cell differentiation|MP:0003795,abnormal bone structure|MP:0003799,impaired macrophage chemotaxis|MP:0003884,decreased macrophage cell number|MP:0004235,abnormal masseter muscle morphology|MP:0004698,abnormal thyroid parafollicular cell morphology|MP:0004738,abnormal auditory brainstem response|MP:0004742,abnormal vestibular system physiology|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004851,increased testis weight|MP:0004884,abnormal testis physiology|MP:0004982,abnormal osteoclast morphology|MP:0004983,abnormal osteoclast cell number|MP:0004985,decreased osteoclast cell number|MP:0005006,abnormal osteoblast physiology|MP:0005341,decreased susceptibility to atherosclerosis|MP:0005362,abnormal Langerhans cell physiology|MP:0005386,behavior/neurological phenotype|MP:0005508,abnormal skeleton morphology|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0006270,abnormal mammary gland growth during lactation|MP:0008114,abnormal Kupffer cell morphology|MP:0008117,abnormal Langerhans cell morphology|MP:0008118,absent Langerhans cell|MP:0008242,abnormal perivascular macrophage morphology|MP:0008396,abnormal osteoclast differentiation|MP:0008415,abnormal neurite morphology|MP:0008489,slow postnatal weight gain|MP:0008826,abnormal splenic cell ratio|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009006,prolonged estrous cycle|MP:0009013,abnormal proestrus|MP:0009090,myometrium hypoplasia|MP:0009091,endometrium hypoplasia|MP:0009325,necrospermia|MP:0009333,abnormal splenocyte physiology|MP:0009505,abnormal mammary gland lobule morphology|MP:0009506,abnormal mammary gland alveolus morphology|MP:0009647,decreased fertilization frequency|MP:0009971,decreased hippocampus pyramidal cell number|MP:0010748,abnormal visual evoked potential|MP:0010868,increased bone trabecula number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011129,decreased tertiary ovarian follicle number|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0013586,thymus medulla atrophy|MP:0014602,decreased female mating frequency|MP:0014740,increased auditory brainstem response wave peak latency|MP:0014742,increased auditory brainstem response wave interpeak latency|MP:0030188,round snout|MP:0030610,absent teeth|MP:0031336,abnormal uterine epithelium development|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:5689434	Csf1r<tm1.1Jwp>	MP:0000062,increased bone mineral density|MP:0000066,osteoporosis|MP:0001265,decreased body size|MP:0002083,premature death|MP:0005508,abnormal skeleton morphology|MP:0030188,round snout|MP:0030610,absent teeth
MGI:2181194	Csf1r<tm1Ers>	MP:0000061,fragile skeleton|MP:0000062,increased bone mineral density|MP:0000064,failure of bone resorption|MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000217,abnormal leukocyte cell number|MP:0000223,decreased monocyte cell number|MP:0000322,increased granulocyte number|MP:0000440,domed cranium|MP:0000547,short limbs|MP:0000585,kinked tail|MP:0000689,abnormal spleen morphology|MP:0000780,abnormal corpus callosum morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000921,demyelination|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001533,abnormal skeleton physiology|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001967,deafness|MP:0002063,abnormal learning/memory/conditioning|MP:0002082,postnatal lethality|MP:0002109,abnormal limb morphology|MP:0002229,neurodegeneration|MP:0002397,abnormal bone marrow morphology|MP:0002429,abnormal blood cell morphology/development|MP:0002566,abnormal sexual interaction|MP:0002687,oligozoospermia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003064,decreased coping response|MP:0003224,neuron degeneration|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003795,abnormal bone structure|MP:0003797,abnormal compact bone morphology|MP:0003884,decreased macrophage cell number|MP:0004686,decreased length of long bones|MP:0004952,increased spleen weight|MP:0004982,abnormal osteoclast morphology|MP:0004986,abnormal osteoblast morphology|MP:0004991,decreased bone strength|MP:0005016,decreased lymphocyte cell number|MP:0005362,abnormal Langerhans cell physiology|MP:0005508,abnormal skeleton morphology|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0008026,abnormal brain white matter morphology|MP:0008113,abnormal macrophage differentiation|MP:0008118,absent Langerhans cell|MP:0008119,decreased Langerhans cell number|MP:0008271,abnormal bone ossification|MP:0008396,abnormal osteoclast differentiation|MP:0008535,enlarged lateral ventricles|MP:0008544,impaired olfaction|MP:0008753,abnormal osteocyte morphology|MP:0008918,microgliosis|MP:0009006,prolonged estrous cycle|MP:0009011,prolonged diestrus|MP:0010047,axonal spheroids|MP:0010050,hypermyelination|MP:0010210,abnormal circulating cytokine level|MP:0010892,increased oligodendrocyte progenitor number|MP:0010970,abnormal compact bone lamellar structure|MP:0011085,postnatal lethality, complete penetrance|MP:0014269,decreased testes secretion|MP:0020137,decreased bone mineralization|MP:0030487,abnormal osteocyte dendritic process morphology
MGI:3653514	Csf1r<tm1Jwp>	MP:0002169,no abnormal phenotype detected
MGI:5305707	Csf1<tm1.2Sabw>	MP:0000061,fragile skeleton|MP:0000065,abnormal bone marrow cavity morphology|MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000223,decreased monocyte cell number|MP:0000322,increased granulocyte number|MP:0000333,decreased bone marrow cell number|MP:0000440,domed cranium|MP:0000692,small spleen|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003795,abnormal bone structure|MP:0003797,abnormal compact bone morphology|MP:0003884,decreased macrophage cell number|MP:0004686,decreased length of long bones|MP:0004953,decreased spleen weight|MP:0004985,decreased osteoclast cell number|MP:0004986,abnormal osteoblast morphology|MP:0004993,decreased bone resorption|MP:0005015,increased T cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005422,osteosclerosis|MP:0005605,increased bone mass|MP:0006398,increased long bone epiphyseal plate size|MP:0008114,abnormal Kupffer cell morphology|MP:0008250,abnormal myeloid leukocyte morphology|MP:0008753,abnormal osteocyte morphology|MP:0009346,decreased trabecular bone thickness|MP:0010868,increased bone trabecula number|MP:0010872,increased trabecular bone mass|MP:0010878,increased trabecular bone volume|MP:0011165,abnormal tooth root development|MP:0011711,impaired osteoblast differentiation|MP:0020137,decreased bone mineralization|MP:0030451,abnormal dentin mineralization|MP:0030479,increased osteocyte apoptosis|MP:0030484,abnormal osteocyte lacuna morphology|MP:0030487,abnormal osteocyte dendritic process morphology|MP:0030506,abnormal dental follicle morphology|MP:0030543,abnormal predentin morphology
MGI:7261176	Csf2ra<em1Szut>	MP:0001798,impaired macrophage phagocytosis|MP:0001861,lung inflammation|MP:0003982,increased cholesterol level|MP:0005013,increased lymphocyte cell number|MP:0008245,abnormal alveolar macrophage morphology
MGI:3652583	Csf2rb2<tm1Cgb>	MP:0002398,abnormal bone marrow cell morphology/development
MGI:2181272	Csf2rb2<tm1Mur>	MP:0002169,no abnormal phenotype detected
MGI:2181245	Csf2rb<tm1Cgb>	MP:0001861,lung inflammation|MP:0002414,abnormal myeloblast morphology/development|MP:0005012,decreased eosinophil cell number|MP:0010998,pulmonary alveolar proteinosis
MGI:2181261	Csf2rb<tm1Mur>	MP:0001861,lung inflammation|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002406,increased susceptibility to infection|MP:0002414,abnormal myeloblast morphology/development|MP:0002465,abnormal eosinophil physiology|MP:0005012,decreased eosinophil cell number
MGI:6324172	Csf2rb<tm2b(EUCOMM)Hmgu>	MP:0001364,decreased anxiety-related response|MP:0004924,abnormal behavior|MP:0005011,increased eosinophil cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0011960,abnormal eye anterior chamber depth|MP:0020870,decreased thigmotaxis
MGI:1930997	Csf2<tm1Ard>	MP:0000688,lymphoid hyperplasia|MP:0001120,abnormal uterus morphology|MP:0001132,absent mature ovarian follicles|MP:0001175,abnormal lung morphology|MP:0001265,decreased body size|MP:0001712,abnormal placenta development|MP:0001715,placental labyrinth hypoplasia|MP:0001732,postnatal growth retardation|MP:0001861,lung inflammation|MP:0001921,reduced fertility|MP:0001928,abnormal ovulation|MP:0001935,decreased litter size|MP:0001958,emphysema|MP:0002161,abnormal fertility/fecundity|MP:0002224,abnormal spleen size|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002442,abnormal leukocyte physiology|MP:0003356,impaired luteinization|MP:0003718,maternal effect|MP:0003799,impaired macrophage chemotaxis|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0004856,decreased ovary weight|MP:0005027,increased susceptibility to parasitic infection|MP:0005040,abnormal MHC II cell surface expression on macrophages|MP:0005185,decreased circulating progesterone level|MP:0005397,hematopoietic system phenotype|MP:0005399,increased susceptibility to fungal infection|MP:0008245,abnormal alveolar macrophage morphology|MP:0009006,prolonged estrous cycle|MP:0009011,prolonged diestrus|MP:0009020,prolonged metestrus|MP:0010998,pulmonary alveolar proteinosis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012098,increased spongiotrophoblast size|MP:0012109,decreased trophoblast glycogen cell number
MGI:1930996	Csf2<tm1Mlg>	MP:0000010,abnormal abdominal fat pad morphology|MP:0000188,abnormal circulating glucose level|MP:0000688,lymphoid hyperplasia|MP:0001175,abnormal lung morphology|MP:0001260,increased body weight|MP:0001547,abnormal lipid level|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002727,decreased circulating insulin level|MP:0003211,abnormal aorta elastic fiber morphology|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004890,decreased energy expenditure|MP:0005215,abnormal pancreatic islet morphology|MP:0005386,behavior/neurological phenotype|MP:0005397,hematopoietic system phenotype|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0008245,abnormal alveolar macrophage morphology|MP:0008903,abnormal mesenteric fat pad morphology|MP:0009285,increased gonadal fat pad weight|MP:0009298,increased mesenteric fat pad weight|MP:0010024,increased total body fat amount|MP:0010768,mortality/aging|MP:0010934,increased subcutaneous adipose tissue amount|MP:0011640,abnormal aorta collagen fibril morphology|MP:0011939,increased food intake|MP:0020411,increased abdominal adipose tissue amount|MP:0030974,enhanced gluconeogenesis
MGI:7425615	Csf3<em1(IMPC)H>	MP:0000222,decreased neutrophil cell number|MP:0002608,increased hematocrit|MP:0002941,increased circulating alanine transaminase level|MP:0005012,decreased eosinophil cell number|MP:0005013,increased lymphocyte cell number
MGI:5582428	Csf3r<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2156882	Csf3r<tm1Eur>	MP:0000222,decreased neutrophil cell number|MP:0000321,increased bone marrow cell number|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002414,abnormal myeloblast morphology/development|MP:0002415,abnormal neutrophil differentiation
MGI:2156982	Csf3r<tm1Link>	MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002620,abnormal monocyte morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0008720,impaired neutrophil chemotaxis
MGI:2655452	Csf3r<tm2Eur>	MP:0000222,decreased neutrophil cell number
MGI:2384410	Csf3r<tm2Link>	MP:0002463,abnormal neutrophil physiology
MGI:2384412	Csf3r<tm3Link>	MP:0000222,decreased neutrophil cell number|MP:0005387,immune system phenotype|MP:0006410,abnormal common myeloid progenitor cell morphology
MGI:2388978	Csf3r<tm4(Epor)Link>	MP:0000222,decreased neutrophil cell number|MP:0000321,increased bone marrow cell number|MP:0000334,decreased granulocyte number|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008720,impaired neutrophil chemotaxis
MGI:1857155	Csf3<tm1Ard>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0001602,impaired myelopoiesis|MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology
MGI:4868209	Csgalnact1<tm1.1Migar>	MP:0000060,delayed bone ossification|MP:0000071,axial skeleton hypoplasia|MP:0000074,abnormal neurocranium morphology|MP:0000111,cleft palate|MP:0000120,malocclusion|MP:0000161,scoliosis|MP:0000163,abnormal cartilage morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000418,focal hair loss|MP:0000428,abnormal craniofacial morphology|MP:0000547,short limbs|MP:0001191,abnormal skin condition|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001293,anophthalmia|MP:0001732,postnatal growth retardation|MP:0001935,decreased litter size|MP:0002092,abnormal eye morphology|MP:0002111,abnormal tail morphology|MP:0002237,abnormal nasal cavity morphology|MP:0003109,short femur|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003420,delayed intramembranous bone ossification|MP:0003755,abnormal palate morphology|MP:0003935,abnormal craniofacial development|MP:0004592,small mandible|MP:0005170,cleft upper lip|MP:0005382,craniofacial phenotype|MP:0005390,skeleton phenotype|MP:0005508,abnormal skeleton morphology|MP:0006396,decreased long bone epiphyseal plate size|MP:0008273,abnormal intramembranous bone ossification|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0008797,facial cleft|MP:0009653,abnormal palate development|MP:0009897,decreased maxillary shelf size|MP:0010029,abnormal basicranium morphology|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011475,abnormal glycosaminoglycan level|MP:0011650,abnormal cornea stroma collagen fibril morphology|MP:0030029,wide cranial sutures|MP:0030066,short face|MP:0030132,periodontium inflammation|MP:0030178,abnormal scalp morphology|MP:0030198,nasal septum hypoplasia|MP:0030245,round head|MP:0030445,abnormal sphenooccipital synchondrosis|MP:0030584,skin atrophy|MP:0030797,joint laxity|MP:0031450,nasal cartilage hypoplasia
MGI:4947395	Csgalnact1<tm1.1Nari>	MP:0000163,abnormal cartilage morphology|MP:0001732,postnatal growth retardation|MP:0002764,short tibia|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004351,short humerus|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype|MP:0006396,decreased long bone epiphyseal plate size|MP:0006397,disorganized long bone epiphyseal plate|MP:0008974,proportional dwarf|MP:0010768,mortality/aging
MGI:5007094	Csgalnact1<tm1Lex>	MP:0001364,decreased anxiety-related response|MP:0005390,skeleton phenotype
MGI:6117386	Csgalnact2<tm1.2Staka>	MP:0002169,no abnormal phenotype detected
MGI:1929683	Csk<tm1Sia>	MP:0000267,abnormal heart development|MP:0000316,cellular necrosis|MP:0000928,incomplete rostral neuropore closure|MP:0001081,abnormal cranial ganglia morphology|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001719,absent vitelline blood vessels|MP:0001721,absent visceral yolk sac blood islands|MP:0001730,embryonic growth arrest|MP:0002151,abnormal neural tube morphology|MP:0002169,no abnormal phenotype detected|MP:0002621,delayed neural tube closure|MP:0003984,embryonic growth retardation|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005384,cellular phenotype|MP:0006030,abnormal otic vesicle development|MP:0006293,absent nasal placodes|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012170,absent optic placodes|MP:0012703,decreased embryonic neuroepithelium thickness|MP:0012707,incomplete caudal neuropore closure|MP:0013241,embryo tissue necrosis
MGI:1861914	Csk<tm1Sor>	MP:0000434,megacephaly|MP:0000928,incomplete rostral neuropore closure|MP:0000929,open neural tube|MP:0000930,wavy neural tube|MP:0000932,absent notochord|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001432,abnormal food preference|MP:0001458,abnormal object recognition memory|MP:0001633,poor circulation|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001726,abnormal allantois morphology|MP:0004073,caudal body truncation|MP:0004556,enlarged allantois|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011259,abnormal cephalic neural fold morphology
MGI:3050293	Csk<tm1Tara>	MP:0000709,enlarged thymus|MP:0000727,absent CD8-positive, alpha-beta T cells|MP:0008076,abnormal CD4-positive T cell differentiation
MGI:5638576	Csk<tm2b(EUCOMM)Hmgu>	MP:0001672,abnormal embryo development|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0002792,abnormal retina vasculature morphology|MP:0003720,abnormal neural tube closure|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003984,embryonic growth retardation|MP:0005632,decreased circulating aspartate transaminase level|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:1930554	Csk<tm2Sia>	MP:0000316,cellular necrosis|MP:0000928,incomplete rostral neuropore closure|MP:0000929,open neural tube|MP:0001081,abnormal cranial ganglia morphology|MP:0001288,abnormal lens induction|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001719,absent vitelline blood vessels|MP:0001721,absent visceral yolk sac blood islands|MP:0001730,embryonic growth arrest|MP:0002151,abnormal neural tube morphology|MP:0003451,absent olfactory bulb|MP:0003984,embryonic growth retardation|MP:0005384,cellular phenotype|MP:0006030,abnormal otic vesicle development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013241,embryo tissue necrosis
MGI:4842999	Csl<tm1(KOMP)Vlcg>	MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0003806,abnormal nucleotide metabolism|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009647,decreased fertilization frequency|MP:0010958,abnormal tricarboxylic acid cycle|MP:0031013,abnormal egg activation
MGI:6140182	Csmd1<em1(IMPC)Wtsi>	MP:0005553,increased circulating creatinine level|MP:0010099,abnormal thoracic cage shape
MGI:3528558	Csmd1<tm1Lex>	MP:0001260,increased body weight|MP:0001363,increased anxiety-related response|MP:0001489,decreased startle reflex|MP:0002572,abnormal emotion/affect behavior|MP:0002573,behavioral despair|MP:0002797,increased thigmotaxis|MP:0003491,abnormal voluntary movement|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0031391,increased locomotor activity
MGI:6152451	Csmd3<em1(IMPC)Mbp>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000367,abnormal coat/ hair morphology|MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0001513,limb grasping|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology|MP:0003960,increased lean body mass|MP:0005344,increased circulating bilirubin level|MP:0006203,eye hemorrhage|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010053,decreased grip strength|MP:0010123,increased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:7260208	Csmd3<em1Yawa>	MP:0000790,abnormal stratification in cerebral cortex|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001441,increased grooming behavior|MP:0001458,abnormal object recognition memory|MP:0001732,postnatal growth retardation|MP:0002175,decreased brain weight|MP:0002797,increased thigmotaxis|MP:0003861,abnormal nervous system development|MP:0004981,decreased neuronal precursor cell number|MP:0005238,increased brain size|MP:0006254,thin cerebral cortex|MP:0008415,abnormal neurite morphology|MP:0009936,abnormal dendritic spine morphology|MP:0020337,abnormal pyramidal neuron dendrite morphology|MP:0020395,abnormal response to social novelty|MP:0020508,decreased dendritic spine density|MP:0020512,abnormal dendritic mushroom spine morphology|MP:0021018,decreased dendritic spine number|MP:0021090,abnormal dendrite arborization pattern
MGI:5285947	Csn1s1<tm1Afk>	MP:0004047,abnormal milk composition|MP:0013716,hypolactation|MP:0020880,abnormal milk calcium level|MP:0020886,abnormal milk phosphate level
MGI:2182074	Csn2<tm1Psim>	MP:0003718,maternal effect|MP:0004047,abnormal milk composition
MGI:3640309	Csn3<tm1Kuma>	MP:0004047,abnormal milk composition|MP:0010249,lactation failure
MGI:5543667	Csnk1a1<tm1.1Ybn>	MP:0001188,hyperpigmentation|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001231,abnormal epidermis stratum basale morphology|MP:0002006,neoplasm|MP:0005501,abnormal skin physiology|MP:0006042,increased apoptosis|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0009387,abnormal epidermal pigmentation|MP:0009388,abnormal epidermal melanocyte morphology|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation|MP:0012015,abnormal eumelanosome eumelanin content|MP:0012022,increased melanocyte number|MP:0013483,abnormal jejunum crypts of Lieberkuhn morphology|MP:0013501,increased fibroblast apoptosis|MP:0030051,increased foot pigmentation
MGI:5543668	Csnk1a1<tm1.2Ybn>	MP:0011092,embryonic lethality, complete penetrance
MGI:5762595	Csnk1a1<tm1c(KOMP)Wtsi>	MP:0000240,extramedullary hematopoiesis|MP:0000333,decreased bone marrow cell number|MP:0000598,abnormal liver morphology|MP:0000609,abnormal liver physiology|MP:0002083,premature death|MP:0002356,abnormal spleen red pulp morphology|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002417,abnormal megakaryocyte morphology|MP:0004120,cardiac ischemia|MP:0004810,decreased hematopoietic stem cell number|MP:0005152,pancytopenia|MP:0005329,abnormal myocardium layer morphology|MP:0008813,decreased common myeloid progenitor cell number|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0013657,abnormal blood cell morphology|MP:0013659,abnormal erythroid lineage cell morphology|MP:0013662,decreased myeloid cell number|MP:0013776,bone marrow failure
MGI:3837651	Csnk1d<Gt(TEA020)Byg>	MP:0001262,decreased body weight|MP:0005386,behavior/neurological phenotype|MP:0009431,decreased fetal weight|MP:0011085,postnatal lethality, complete penetrance
MGI:3849886	Csnk1d<tm1.1Drw>	MP:0009431,decreased fetal weight|MP:0011100,preweaning lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0020469,prolonged circadian behavior period
MGI:3793321	Csnk1e<tm1.1Asil>	MP:0005386,behavior/neurological phenotype|MP:0020469,prolonged circadian behavior period
MGI:3849888	Csnk1e<tm1.1Drw>	MP:0020469,prolonged circadian behavior period
MGI:3793318	Csnk1e<tm1Asil>	MP:0004811,abnormal neuron physiology|MP:0020470,shortened circadian behavior period
MGI:5912107	Csnk1g1<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002590,increased mean corpuscular volume|MP:0005561,increased mean corpuscular hemoglobin|MP:0010052,increased grip strength
MGI:6690844	Csnk1g2<em1Xidw>	MP:0001147,small testis|MP:0001260,increased body weight|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0002216,abnormal seminiferous tubule morphology|MP:0002780,decreased circulating testosterone level|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004852,decreased testis weight|MP:0004909,increased seminal vesicle weight|MP:0005416,abnormal circulating protein level|MP:0008943,increased sensitivity to induced cell death|MP:0008995,early reproductive senescence|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5613652	Csnk1g2<tm1b(EUCOMM)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0001566,increased circulating phosphate level|MP:0002590,increased mean corpuscular volume|MP:0002792,abnormal retina vasculature morphology|MP:0004738,abnormal auditory brainstem response|MP:0005343,increased circulating aspartate transaminase level|MP:0005559,increased circulating glucose level|MP:0005573,increased pulmonary respiratory rate|MP:0005599,increased cardiac muscle contractility|MP:0005627,increased circulating potassium level|MP:0010097,abnormal retina blood vessel morphology|MP:0011965,decreased total retina thickness
MGI:4461713	Csnk1g3<tm1a(EUCOMM)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0000208,decreased hematocrit|MP:0000438,abnormal cranium morphology|MP:0001258,decreased body length|MP:0002875,decreased erythrocyte cell number|MP:0002966,decreased circulating alkaline phosphatase level|MP:0004738,abnormal auditory brainstem response|MP:0005561,increased mean corpuscular hemoglobin|MP:0006358,absent pinna reflex|MP:0010088,decreased circulating fructosamine level|MP:0010124,decreased bone mineral content
MGI:3769802	Csnk2a1<tm1Dcs>	MP:0000270,abnormal heart tube morphology|MP:0000274,enlarged heart|MP:0000295,trabecula carnea hypoplasia|MP:0000453,absent mouth|MP:0000928,incomplete rostral neuropore closure|MP:0000934,abnormal telencephalon development|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001286,abnormal eye development|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0002192,hydrops fetalis|MP:0002884,abnormal pharyngeal arch morphology|MP:0003425,abnormal optic vesicle formation|MP:0003720,abnormal neural tube closure|MP:0004086,absent heartbeat|MP:0004268,abnormal optic stalk morphology|MP:0004838,abnormal neural fold elevation formation|MP:0004937,dilated heart|MP:0005103,abnormal retina pigmentation|MP:0005650,abnormal limb bud morphology|MP:0006030,abnormal otic vesicle development|MP:0006344,small second pharyngeal arch|MP:0008784,craniorachischisis|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011495,abnormal head shape|MP:0012089,decreased midbrain size|MP:0012138,decreased forebrain size|MP:0012263,decreased hindbrain size|MP:0012532,abnormal surface ectoderm morphology|MP:0013180,truncated tail bud|MP:0031587,abnormal pericardium development
MGI:6277015	Csnk2a2<em1(IMPC)Mbp>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001364,decreased anxiety-related response|MP:0001925,male infertility|MP:0002060,abnormal skin morphology|MP:0002574,increased vertical activity|MP:0002590,increased mean corpuscular volume|MP:0002644,decreased circulating triglyceride level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0004924,abnormal behavior|MP:0005344,increased circulating bilirubin level|MP:0005560,decreased circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:2182135	Csnk2a2<tm1Dcs>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002674,abnormal sperm motility|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0006378,abnormal spermatogonia morphology|MP:0006379,abnormal spermatocyte morphology|MP:0006380,abnormal spermatid morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0014052,increased male germ cell apoptosis
MGI:2450157	Csnk2b<tm1.1Bb>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001926,female infertility|MP:0004833,ovary atrophy|MP:0004835,abnormal miniature endplate potential|MP:0004856,decreased ovary weight|MP:0005431,decreased oocyte number|MP:0010053,decreased grip strength|MP:0010948,abnormal double-strand DNA break repair|MP:0011121,decreased primordial ovarian follicle number|MP:0011122,absent primordial ovarian follicles|MP:0011126,absent primary ovarian follicles|MP:0011129,decreased tertiary ovarian follicle number|MP:0011130,absent tertiary ovarian follicles|MP:0013508,increased granulosa cell apoptosis|MP:0031020,premature ovarian failure|MP:0031239,increased atretic ovarian follicle number|MP:0031381,decreased secondary ovarian follicle number|MP:0031382,absent secondary ovarian follicles
MGI:2450158	Csnk2b<tm1.2Bb>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0003984,embryonic growth retardation|MP:0004964,absent inner cell mass|MP:0005033,abnormal trophoblast giant cell morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3576025	csp2	MP:0000137,abnormal vertebrae morphology|MP:0009890,cleft secondary palate
MGI:5566862	Cspg4<tm1.1(cre/ERT2)Fki>	MP:0002169,no abnormal phenotype detected
MGI:4950067	Cspg4<tm1(cre)Akik>	MP:0003631,nervous system phenotype
MGI:2153094	Cspg4<tm1Wbst>	MP:0000182,increased circulating LDL cholesterol level|MP:0000352,decreased cell proliferation|MP:0000812,abnormal dentate gyrus morphology|MP:0001260,increased body weight|MP:0001261,obese|MP:0001556,increased circulating HDL cholesterol level|MP:0002451,abnormal macrophage physiology|MP:0002628,hepatic steatosis|MP:0002971,abnormal brown adipose tissue morphology|MP:0003091,abnormal cell migration|MP:0003212,increased susceptibility to age related obesity|MP:0003631,nervous system phenotype|MP:0005178,increased circulating cholesterol level|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005534,decreased body temperature|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008964,decreased carbon dioxide production|MP:0009131,decreased white fat cell number|MP:0009285,increased gonadal fat pad weight|MP:0009288,increased epididymal fat pad weight|MP:0011049,impaired adaptive thermogenesis|MP:0011167,abnormal adipose tissue development
MGI:5427105	Cspg4<tm1Ychan>	MP:0001262,decreased body weight|MP:0009289,decreased epididymal fat pad weight
MGI:3583953	Cspg5<tm1Fgr>	MP:0001386,abnormal maternal nurturing|MP:0001475,reduced long-term depression|MP:0002206,abnormal CNS synaptic transmission|MP:0002919,enhanced paired-pulse facilitation|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0014379,decreased excitatory postsynaptic current frequency
MGI:6117093	Cspp1<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0005554,decreased circulating creatinine level|MP:0010124,decreased bone mineral content
MGI:5320196	cspr	MP:0001577,anemia|MP:0008762,embryonic lethality
MGI:3575706	Cspt<C57BL/6>	MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:3526868	Csrnp1<Gt(ROSA)80Sor>	MP:0000157,abnormal sternum morphology|MP:0002082,postnatal lethality|MP:0003755,abnormal palate morphology|MP:0005508,abnormal skeleton morphology|MP:0008146,asymmetric sternocostal joints|MP:0009895,decreased palatine bone horizontal plate size|MP:0030383,small presphenoid bone
MGI:3770130	Csrnp1<tm1Jni>	MP:0005380,embryo phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:3770131	Csrnp2<tm1Jni>	MP:0005380,embryo phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:3770132	Csrnp3<tm1Jni>	MP:0005380,embryo phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:5007641	Csrp1<tm1Mbk>	MP:0004883,abnormal vascular wound healing|MP:0005369,muscle phenotype|MP:0005385,cardiovascular system phenotype
MGI:3809532	Csrp2<tm1Rawe>	MP:0004564,increased myocardial fiber size|MP:0006267,abnormal intercalated disk morphology
MGI:3697317	Csrp2<tm1Sfy>	MP:0004883,abnormal vascular wound healing|MP:0005595,abnormal vascular smooth muscle physiology
MGI:7509517	Csrp3<tm1.1Kage>	MP:0002833,increased heart weight|MP:0003915,increased heart left ventricle weight|MP:0004084,abnormal cardiac muscle relaxation|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0010579,increased heart left ventricle size|MP:0010768,mortality/aging|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4947957	Csrp3<tm1.1Rkn>	MP:0000266,abnormal heart morphology|MP:0000751,myopathy|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003141,cardiac fibrosis|MP:0003915,increased heart left ventricle weight|MP:0004486,decreased response of heart to induced stress|MP:0005294,abnormal heart ventricle morphology|MP:0005330,cardiomyopathy|MP:0005599,increased cardiac muscle contractility|MP:0005630,increased lung weight|MP:0006113,abnormal heart septum morphology|MP:0009403,increased variability of skeletal muscle fiber size|MP:0031131,myocardial fiber disarray
MGI:1858015	Csrp3<tm1Crni>	MP:0000274,enlarged heart|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006138,congestive heart failure|MP:0006267,abnormal intercalated disk morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011925,abnormal heart echocardiography feature|MP:0020849,abnormal actin cytoskeleton morphology
MGI:5572024	Cst3<tm1b(EUCOMM)Wtsi>	MP:0001102,small superior vagus ganglion
MGI:5586715	Cst3<tm1(CST3*L68Q)Cnw>	MP:0000604,amyloidosis|MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0006362,abnormal male germ cell morphology|MP:0030978,impaired binding of sperm to zona pellucida
MGI:2182140	Cst3<tm1Karl>	MP:0001272,increased metastatic potential|MP:0003240,loss of hippocampal neurons|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0006060,increased cerebral infarct size
MGI:3629665	Cst5<tm1Hkaw>	MP:0000131,abnormal long bone epiphysis morphology|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0002896,abnormal bone mineralization|MP:0005376,homeostasis/metabolism phenotype|MP:0010879,decreased trabecular bone volume
MGI:7425617	Cst6<em1(IMPC)Ccpcz>	MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0001120,abnormal uterus morphology|MP:0001325,abnormal retina morphology|MP:0001404,no spontaneous movement|MP:0002060,abnormal skin morphology|MP:0002110,abnormal digit morphology|MP:0004357,long tibia|MP:0005419,decreased circulating serum albumin level|MP:0009709,hydrometra|MP:0010090,increased circulating creatine kinase level|MP:0011100,preweaning lethality, complete penetrance
MGI:2447068	Cst6<ichq>	MP:0000377,abnormal hair follicle morphology|MP:0000416,sparse hair|MP:0000647,abnormal sebaceous gland morphology|MP:0001191,abnormal skin condition|MP:0001192,scaly skin|MP:0001200,thick skin|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001246,mixed cellular infiltration to dermis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002060,abnormal skin morphology|MP:0006035,abnormal mitochondrial morphology|MP:0009583,increased keratinocyte proliferation|MP:0009675,orthokeratosis|MP:0011085,postnatal lethality, complete penetrance|MP:0012725,small sebaceous gland
MGI:7859338	Cst7<tm1.2Arte>	MP:0002148,abnormal hypersensitivity reaction|MP:0002465,abnormal eosinophil physiology|MP:0005012,decreased eosinophil cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005061,abnormal eosinophil morphology|MP:0005164,abnormal response to injury|MP:0006042,increased apoptosis
MGI:3770401	Cst7<tm1Ayr>	MP:0002169,no abnormal phenotype detected
MGI:3521755	Cst8<tm1Itl>	MP:0001156,abnormal spermatogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0003666,impaired sperm capacitation|MP:0004542,impaired acrosome reaction|MP:0004852,decreased testis weight|MP:0004929,decreased epididymis weight|MP:0005389,reproductive system phenotype|MP:0009647,decreased fertilization frequency|MP:0020451,decreased sperm progressive motility|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031009,abnormal sperm-egg fusion
MGI:5692621	Cst9<tm1.1(KOMP)Vlcg>	MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis
MGI:3581885	Cst9<tm1Aw>	MP:0002169,no abnormal phenotype detected
MGI:3625305	Cst9<tm1Nnkj>	MP:0002169,no abnormal phenotype detected
MGI:7297511	Csta1<em1Gpt>	MP:0000063,decreased bone mineral density|MP:0001218,thin epidermis|MP:0002655,abnormal keratinocyte morphology|MP:0004989,decreased osteoblast cell number|MP:0009584,decreased keratinocyte proliferation|MP:0010873,decreased trabecular bone mass|MP:0010962,decreased compact bone mass
MGI:5790639	Cstb<tm1b(EUCOMM)Wtsi>	MP:0000220,increased monocyte cell number|MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0001552,increased circulating triglyceride level|MP:0002574,increased vertical activity|MP:0002764,short tibia|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004738,abnormal auditory brainstem response|MP:0005016,decreased lymphocyte cell number|MP:0005554,decreased circulating creatinine level|MP:0011960,abnormal eye anterior chamber depth|MP:0011965,decreased total retina thickness
MGI:1861915	Cstb<tm1Rm>	MP:0000243,myoclonus|MP:0000849,abnormal cerebellum morphology|MP:0000851,cerebellum hypoplasia|MP:0001312,abnormal cornea morphology|MP:0001313,increased incidence of corneal inflammation|MP:0001314,cornea opacity|MP:0001316,cornea scarring|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001648,abnormal apoptosis|MP:0002064,seizures|MP:0003633,abnormal nervous system physiology|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004994,abnormal brain wave pattern|MP:0005253,abnormal eye physiology|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005515,uveitis|MP:0030143,facial muscle spasm
MGI:4868410	Cstb<tm1Yah>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:5754573	Cstdc2<em1(IMPC)Tcp>	MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0003020,decreased circulating chloride level|MP:0009142,decreased prepulse inhibition
MGI:6257447	Cstdc3<em1(IMPC)Tcp>	MP:0002060,abnormal skin morphology|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:6276278	Cstf1<em1(IMPC)J>	MP:0005278,abnormal cholesterol homeostasis|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5145849	Cstf2<Gt(IST10905E6)Tigm>	MP:0001680,abnormal mesoderm development|MP:0001685,abnormal endoderm development|MP:0002399,abnormal pluripotent precursor cell morphology|MP:0002663,absent blastocoele
MGI:3774168	Cstf2t<tm1Ccma>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0014685,spermiation failure
MGI:5613641	Cstf3<tm2b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0010052,increased grip strength|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5614712	Cs<tm1.1(KOMP)Wtsi>	MP:0002110,abnormal digit morphology|MP:0005293,impaired glucose tolerance|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:3580244	Cstza	MP:0000416,sparse hair|MP:0001200,thick skin|MP:0001211,wrinkled skin
MGI:4364134	Ct45a<tm1e(KOMP)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:6370008	Ct55<em1Xdzg>	MP:0002053,decreased incidence of induced tumors|MP:0008539,decreased susceptibility to induced colitis|MP:0010181,decreased susceptibility to weight loss
MGI:7494107	Ct55<em2Xdzg>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002631,abnormal epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0008898,abnormal acrosome morphology|MP:0008995,early reproductive senescence|MP:0009647,decreased fertilization frequency|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0011743,abnormal Golgi apparatus morphology|MP:0014630,abnormal round spermatid morphology|MP:0020451,decreased sperm progressive motility|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0030940,impaired autophagy|MP:0031354,abnormal acrosome assembly|MP:0031372,abnormal sperm individualization
MGI:6477599	Ctag2<em1Utr>	MP:0005389,reproductive system phenotype
MGI:5708266	Ctag2l2<tm1.1(KOMP)Vlcg>	MP:0000274,enlarged heart
MGI:6856672	Ctbp1<em1(IMPC)Bay>	MP:0001258,decreased body length|MP:0011100,preweaning lethality, complete penetrance
MGI:2183644	Ctbp1<tm1Sor>	MP:0001265,decreased body size|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6279895	Ctbp2<em1(IMPC)Bay>	MP:0000266,abnormal heart morphology|MP:0000288,abnormal pericardium morphology|MP:0001417,decreased exploration in new environment|MP:0001691,abnormal somite shape|MP:0001700,abnormal embryo turning|MP:0001785,edema|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:2183646	Ctbp2<Gt(ROSA61)Sor>	MP:0000270,abnormal heart tube morphology|MP:0000292,distended pericardium|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0001719,absent vitelline blood vessels|MP:0003232,abnormal forebrain development|MP:0003864,abnormal midbrain development|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012703,decreased embryonic neuroepithelium thickness
MGI:5804132	Ctbs<em1(IMPC)J>	MP:0005293,impaired glucose tolerance
MGI:5437306	Ctbs<tm1Tbec>	MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005621,abnormal cell physiology|MP:0008114,abnormal Kupffer cell morphology|MP:0009643,abnormal urine homeostasis
MGI:5427642	Ctc1<tm1.1Schg>	MP:0000352,decreased cell proliferation|MP:0000416,sparse hair|MP:0000692,small spleen|MP:0000706,small thymus|MP:0001265,decreased body size|MP:0001606,impaired hematopoiesis|MP:0002083,premature death|MP:0002398,abnormal bone marrow cell morphology/development|MP:0003155,abnormal telomere length|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0008008,early cellular replicative senescence|MP:0008058,abnormal DNA repair|MP:0008866,chromosomal instability|MP:0009335,decreased splenocyte proliferation|MP:0011704,decreased fibroblast proliferation
MGI:5692690	Ctc1<tm1b(KOMP)Wtsi>	MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:7664135	Ctcf<em1Hyao>	MP:0000280,thin ventricular wall|MP:0001177,atelectasis|MP:0002272,abnormal nervous system electrophysiology|MP:0002276,abnormal lung interstitium morphology|MP:0005136,decreased growth hormone level|MP:0005386,behavior/neurological phenotype|MP:0008415,abnormal neurite morphology|MP:0009429,decreased embryo weight|MP:0010499,abnormal ventricle myocardium morphology|MP:0010656,thick myocardium|MP:0010768,mortality/aging|MP:0011087,neonatal lethality, complete penetrance|MP:0012106,impaired exercise endurance|MP:0013138,thin body|MP:0014519,myocardial ventricular hypertrabeculation
MGI:4819542	Ctcfl<tm1.1Vloc>	MP:0001146,abnormal testis morphology|MP:0001156,abnormal spermatogenesis|MP:0005389,reproductive system phenotype
MGI:4819543	Ctcfl<tm1Vloc>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001940,testis hypoplasia|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0008280,abnormal male germ cell apoptosis
MGI:5575496	Ctcf<tm1.1Gfili>	MP:0001730,embryonic growth arrest|MP:0004964,absent inner cell mass|MP:0008527,embryonic lethality at implantation|MP:0012102,absent trophectoderm|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3829010	Ctcf<tm2.1Gal>	MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3663291	Ctcf<tm2Gal>	MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008037,abnormal T cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0008083,decreased single-positive T cell number
MGI:5510826	Ctdnep1<tm1Ryn>	MP:0002085,abnormal embryonic tissue morphology|MP:0003087,absent allantois|MP:0005030,absent amnion|MP:0006323,abnormal extraembryonic mesoderm development|MP:0008391,abnormal primordial germ cell morphology|MP:0008392,decreased primordial germ cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance|MP:0011187,abnormal parietal endoderm morphology|MP:0011200,abnormal extraembryonic coelom morphology|MP:0011257,abnormal head fold morphology
MGI:5510831	Ctdnep1<tm2Ryn>	MP:0002085,abnormal embryonic tissue morphology|MP:0003087,absent allantois|MP:0005030,absent amnion|MP:0006323,abnormal extraembryonic mesoderm development|MP:0008391,abnormal primordial germ cell morphology|MP:0008392,decreased primordial germ cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance|MP:0011187,abnormal parietal endoderm morphology|MP:0011200,abnormal extraembryonic coelom morphology|MP:0011257,abnormal head fold morphology
MGI:5548188	Ctdnep1<tm3Ryn>	MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003881,abnormal nephron morphology|MP:0003918,decreased kidney weight|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005367,renal/urinary system phenotype|MP:0010768,mortality/aging|MP:0011363,renal glomerulus atrophy
MGI:6883639	Ctdp1<em1.1Ntw>	MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0004200,decreased fetal size|MP:0006042,increased apoptosis|MP:0011092,embryonic lethality, complete penetrance
MGI:6156279	Ctdp1<em1(IMPC)Kmpc>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6883660	Ctdp1<em1Ntw>	MP:0011704,decreased fibroblast proliferation|MP:0013501,increased fibroblast apoptosis
MGI:5692843	Ctdsp1<tm1b(EUCOMM)Wtsi>	MP:0000443,abnormal snout morphology|MP:0001399,hyperactivity|MP:0002968,increased circulating alkaline phosphatase level|MP:0010053,decreased grip strength
MGI:5548409	Ctdspl2<tm2b(KOMP)Wtsi>	MP:0001491,unresponsive to tactile stimuli|MP:0003960,increased lean body mass|MP:0004952,increased spleen weight|MP:0010025,decreased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5548581	Ctdspl<tm1.1(KOMP)Mbp>	MP:0005293,impaired glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level
MGI:2675769	Ctf1<tm1Msd>	MP:0000938,motor neuron degeneration|MP:0001261,obese|MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0002702,decreased circulating free fatty acids level|MP:0004890,decreased energy expenditure|MP:0005178,increased circulating cholesterol level|MP:0005290,decreased oxygen consumption|MP:0005331,insulin resistance|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0008034,enhanced lipolysis|MP:0009167,increased pancreatic islet number|MP:0009171,enlarged pancreatic islets|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010378,increased respiratory quotient|MP:0010957,abnormal aerobic respiration|MP:0011940,decreased food intake|MP:0014396,decreased fat cell mitochondrial DNA content
MGI:6376255	Ctf2<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response
MGI:7425618	Cthrc1<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney
MGI:5544610	Cthrc1<tm1.1Suna>	MP:0000066,osteoporosis|MP:0004016,decreased bone mass|MP:0005390,skeleton phenotype|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010924,abnormal osteoid morphology|MP:0013630,increased bone trabecular spacing|MP:0020040,decreased bone ossification
MGI:5544611	Cthrc1<tm1.2Suna>	MP:0000066,osteoporosis|MP:0004016,decreased bone mass|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number
MGI:3830252	Cthrc1<tm1Haak>	MP:0004986,abnormal osteoblast morphology|MP:0004989,decreased osteoblast cell number|MP:0005006,abnormal osteoblast physiology|MP:0005390,skeleton phenotype|MP:0008271,abnormal bone ossification|MP:0010869,decreased bone trabecula number|MP:0010873,decreased trabecular bone mass|MP:0030439,decreased osteoblast proliferation
MGI:3815067	Cthrc1<tm1Hssk>	MP:0002169,no abnormal phenotype detected
MGI:5466394	Cthrc1<tm1Vli>	MP:0000600,liver hypoplasia|MP:0000607,abnormal hepatocyte morphology|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0010400,increased liver glycogen level|MP:0010401,increased skeletal muscle glycogen level|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis
MGI:5614698	Cth<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001417,decreased exploration in new environment|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:4840236	Cth<tm1Iish>	MP:0000598,abnormal liver morphology|MP:0000753,paralysis|MP:0001552,increased circulating triglyceride level|MP:0001732,postnatal growth retardation|MP:0002941,increased circulating alanine transaminase level|MP:0002965,increased circulating serum albumin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0004065,increased susceptibility to induced muscular atrophy|MP:0005311,abnormal circulating amino acid level|MP:0005343,increased circulating aspartate transaminase level|MP:0005385,cardiovascular system phenotype|MP:0005554,decreased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005571,decreased lactate dehydrogenase level|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0008943,increased sensitivity to induced cell death|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0012335,increased circulating homocysteine level|MP:0012604,decreased glutathione level|MP:0030639,decreased circulating taurine level|MP:0030689,cystathioninuria
MGI:3814989	Cth<tm1Liwu>	MP:0000231,hypertension|MP:0005367,renal/urinary system phenotype|MP:0005591,decreased vasodilation|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0012335,increased circulating homocysteine level|MP:0030626,decreased circulating cysteine level
MGI:6208811	Ctif<em1(IMPC)J>	MP:0002075,abnormal coat/hair pigmentation|MP:0002626,increased heart rate|MP:0005292,improved glucose tolerance|MP:0010507,shortened RR interval
MGI:3045165	ctl	MP:0001891,hydrocephaly|MP:0002759,abnormal caudal vertebrae morphology|MP:0002993,autoimmune arthritis|MP:0003051,curly tail|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype
MGI:5766141	Ctla2b<tm1.1(NCOM)Mfgc>	MP:0011100,preweaning lethality, complete penetrance
MGI:6200388	Ctla4<m1Btlr>	MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:2180670	Ctla4<tm1All>	MP:0000703,abnormal thymus morphology|MP:0002083,premature death|MP:0005018,decreased T cell number|MP:0005088,increased acute inflammation|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008101,lymph node hypoplasia|MP:0010016,variable depigmentation
MGI:2180669	Ctla4<tm1Mak>	MP:0002083,premature death|MP:0008566,increased interferon-gamma secretion|MP:0008681,increased interleukin-17 secretion|MP:0008687,increased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion
MGI:3812204	Ctla4<tm1Saka>	MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000693,spleen hyperplasia|MP:0001846,increased inflammatory response|MP:0001856,myocarditis|MP:0001861,lung inflammation|MP:0001870,salivary gland inflammation|MP:0001873,stomach inflammation|MP:0002083,premature death|MP:0002490,abnormal immunoglobulin level|MP:0002493,increased IgG level|MP:0002497,increased IgE level|MP:0003725,increased autoantibody level|MP:0004946,abnormal regulatory T cell physiology|MP:0004973,increased regulatory T cell number|MP:0008102,lymph node hyperplasia|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008826,abnormal splenic cell ratio
MGI:2180668	Ctla4<tm1Shr>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001844,autoimmune response|MP:0001856,myocarditis|MP:0001861,lung inflammation|MP:0001864,vascular inflammation|MP:0001869,pancreas inflammation|MP:0001870,salivary gland inflammation|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0002444,abnormal T cell physiology|MP:0002933,joint inflammation|MP:0003009,abnormal cytokine secretion|MP:0004946,abnormal regulatory T cell physiology|MP:0005015,increased T cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005348,increased T cell proliferation|MP:0008037,abnormal T cell morphology|MP:0008826,abnormal splenic cell ratio|MP:0008828,abnormal lymph node cell ratio
MGI:3720741	Ctla4<tm1Yliu>	MP:0002169,no abnormal phenotype detected
MGI:7466923	Ctnna1<em1Xjz>	MP:0011091,prenatal lethality, complete penetrance
MGI:5696410	Ctnna1<Gt(fVET3A)Hiir>	MP:0002663,absent blastocoele
MGI:2180540	Ctnna1<Gt(pGT1.8geo)4Pgr>	MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002663,absent blastocoele|MP:0004964,absent inner cell mass|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2677796	Ctnna1<tm1Efu>	MP:0000434,megacephaly|MP:0000448,pointed snout|MP:0000789,thickened cerebral cortex|MP:0000823,abnormal lateral ventricle morphology|MP:0000913,abnormal brain development|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001230,epidermal desquamation|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001243,abnormal dermal layer morphology|MP:0001262,decreased body weight|MP:0001284,absent vibrissae|MP:0001732,postnatal growth retardation|MP:0002113,abnormal skeleton development|MP:0002152,abnormal brain morphology|MP:0002176,increased brain weight|MP:0002655,abnormal keratinocyte morphology|MP:0002795,dilated cardiomyopathy|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003420,delayed intramembranous bone ossification|MP:0003566,abnormal cell adhesion|MP:0003704,abnormal hair follicle development|MP:0003718,maternal effect|MP:0004046,abnormal mitosis|MP:0004047,abnormal milk composition|MP:0005501,abnormal skin physiology|MP:0006279,abnormal limb development|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009583,increased keratinocyte proliferation|MP:0009715,thick epidermis stratum basale|MP:0009937,abnormal neuron differentiation|MP:0010172,abnormal mammary gland epithelium physiology|MP:0011085,postnatal lethality, complete penetrance|MP:0014126,increased mammary gland apoptosis
MGI:5689559	Ctnna1<Tvrm5>	MP:0002864,abnormal ocular fundus morphology|MP:0004021,abnormal rod electrophysiology|MP:0005103,abnormal retina pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005551,abnormal eye electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008515,thin retina outer nuclear layer|MP:0010236,abnormal retina outer limiting membrane morphology|MP:0012040,abnormal c-wave shape|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0012671,retina spots
MGI:1856818	Ctnna2<cdf>	MP:0000851,cerebellum hypoplasia|MP:0000852,small cerebellum|MP:0000864,abnormal cerebellum vermis morphology|MP:0000885,ectopic Purkinje cell|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001262,decreased body weight|MP:0001386,abnormal maternal nurturing|MP:0001391,abnormal tail movements|MP:0001393,ataxia|MP:0001454,abnormal cued conditioning behavior|MP:0001488,increased startle reflex|MP:0001513,limb grasping|MP:0001922,reduced male fertility|MP:0003131,increased erythrocyte cell number|MP:0003631,nervous system phenotype|MP:0004812,abnormal linear vestibular evoked potential|MP:0004814,reduced linear vestibular evoked potential|MP:0005377,hearing/vestibular/ear phenotype|MP:0006097,abnormal cerebellar lobule formation|MP:0009142,decreased prepulse inhibition|MP:0009719,reduced cerebellar foliation|MP:0009971,decreased hippocampus pyramidal cell number|MP:0010011,ectopic hippocampus pyramidal cells
MGI:3623589	Ctnna2<tm1Mta>	MP:0000813,abnormal hippocampus layer morphology|MP:0000849,abnormal cerebellum morphology|MP:0002882,abnormal neuron morphology|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5504493	Ctnna3<tm1.1Fvr>	MP:0000278,abnormal myocardial fiber morphology|MP:0001636,irregular heartbeat|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003921,abnormal heart left ventricle morphology|MP:0005140,decreased cardiac muscle contractility|MP:0008772,increased heart ventricle size|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:4129892	Ctnnal1<Gt(RRJ603)Byg>	MP:0000841,abnormal hindbrain morphology|MP:0000913,abnormal brain development|MP:0000929,open neural tube|MP:0003044,impaired basement membrane formation|MP:0003720,abnormal neural tube closure|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012703,decreased embryonic neuroepithelium thickness|MP:0020849,abnormal actin cytoskeleton morphology
MGI:5755098	Ctnnal1<tm1.1Sjm>	MP:0002169,no abnormal phenotype detected
MGI:2656734	Ctnnb1<Bfc>	MP:0000346,broad head|MP:0000432,abnormal head morphology|MP:0000447,flattened snout|MP:0000781,decreased corpus callosum size|MP:0000784,forebrain hypoplasia|MP:0000852,small cerebellum|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001300,ocular hypertelorism|MP:0001304,cataract|MP:0001405,impaired coordination|MP:0001473,reduced long-term potentiation|MP:0001529,abnormal vocalization|MP:0002092,abnormal eye morphology|MP:0002741,small olfactory bulb|MP:0002803,abnormal operant conditioning behavior|MP:0004081,abnormal globus pallidus morphology|MP:0004793,abnormal synaptic vesicle clustering|MP:0005238,increased brain size|MP:0008414,abnormal spatial reference memory|MP:0009142,decreased prepulse inhibition|MP:0009454,impaired contextual conditioning behavior|MP:0009939,abnormal hippocampus neuron morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011496,abnormal head size|MP:0012467,increased striatum size|MP:0020526,enlarged thalamus
MGI:7466919	Ctnnb1<em1V>	MP:0005602,decreased angiogenesis|MP:0009772,abnormal retina development
MGI:7490339	Ctnnb1<tm1.1Smoc>	MP:0004499,increased incidence of tumors by chemical induction
MGI:5430598	Ctnnb1<tm1.2Wvv>	MP:0000432,abnormal head morphology|MP:0000433,microcephaly|MP:0000438,abnormal cranium morphology|MP:0000762,abnormal tongue morphology|MP:0002404,increased intestinal adenoma incidence|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0003935,abnormal craniofacial development|MP:0004539,absent maxilla|MP:0004726,abnormal nasal capsule morphology|MP:0008797,facial cleft|MP:0010279,increased gastrointestinal tumor incidence|MP:0010939,abnormal mandibular prominence morphology|MP:0010940,abnormal maxillary prominence morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0030324,abnormal anterior head development
MGI:5308943	Ctnnb1<tm1Kba>	MP:0001698,decreased embryo size|MP:0003232,abnormal forebrain development|MP:0003935,abnormal craniofacial development|MP:0003984,embryonic growth retardation|MP:0006346,small pharyngeal arch
MGI:1857678	Ctnnb1<tm1Max>	MP:0001674,abnormal germ layer development|MP:0001698,decreased embryo size|MP:0001710,absent amniotic folds|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003087,absent allantois|MP:0003886,abnormal embryonic epiblast morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1858008	Ctnnb1<tm1Mmt>	MP:0000111,cleft palate|MP:0000116,abnormal tooth development|MP:0000130,abnormal trabecular bone morphology|MP:0000164,abnormal cartilage development|MP:0000333,decreased bone marrow cell number|MP:0000414,alopecia|MP:0000428,abnormal craniofacial morphology|MP:0000484,abnormal pulmonary artery morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000496,abnormal small intestine morphology|MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000536,hydroureter|MP:0000538,abnormal urinary bladder morphology|MP:0000540,abnormal urinary bladder urothelium morphology|MP:0000547,short limbs|MP:0000562,polydactyly|MP:0000733,abnormal muscle development|MP:0001154,seminiferous tubule degeneration|MP:0001176,abnormal lung development|MP:0001181,absent lungs|MP:0001284,absent vibrissae|MP:0001297,microphthalmia|MP:0001925,male infertility|MP:0002006,neoplasm|MP:0002058,neonatal lethality|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0002152,abnormal brain morphology|MP:0002169,no abnormal phenotype detected|MP:0002216,abnormal seminiferous tubule morphology|MP:0002404,increased intestinal adenoma incidence|MP:0002705,dilated renal tubule|MP:0002726,abnormal pulmonary vein morphology|MP:0002809,increased spinal cord size|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003126,abnormal external female genitalia morphology|MP:0003205,testicular atrophy|MP:0003237,abnormal lens epithelium morphology|MP:0003321,tracheoesophageal fistula|MP:0003417,premature endochondral bone ossification|MP:0003420,delayed intramembranous bone ossification|MP:0003446,renal hypoplasia|MP:0003604,single kidney|MP:0003632,abnormal nervous system morphology|MP:0003675,kidney cyst|MP:0003743,abnormal facial morphology|MP:0003869,ectopic cartilage|MP:0004007,abnormal lung vasculature morphology|MP:0004163,abnormal adenohypophysis morphology|MP:0004686,decreased length of long bones|MP:0004791,absent lower incisors|MP:0004852,decreased testis weight|MP:0004985,decreased osteoclast cell number|MP:0004993,decreased bone resorption|MP:0005238,increased brain size|MP:0005315,absent pituitary gland|MP:0005385,cardiovascular system phenotype|MP:0005390,skeleton phenotype|MP:0005579,absent outer ear|MP:0005587,abnormal Meckel's cartilage morphology|MP:0005605,increased bone mass|MP:0006262,increased testis tumor incidence|MP:0008000,increased ovary tumor incidence|MP:0008011,intestine polyps|MP:0008271,abnormal bone ossification|MP:0008395,abnormal osteoblast differentiation|MP:0008396,abnormal osteoclast differentiation|MP:0008794,increased lens epithelium apoptosis|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0009550,increased urinary bladder carcinoma incidence|MP:0009903,abnormal medial nasal prominence morphology|MP:0009932,skin fibrosis|MP:0010054,increased hepatoblastoma incidence|MP:0010157,abnormal small intestinal crypt cell proliferation|MP:0010313,increased osteoma incidence|MP:0010320,increased pituitary gland tumor incidence|MP:0010875,increased bone volume|MP:0010939,abnormal mandibular prominence morphology|MP:0010940,abnormal maxillary prominence morphology|MP:0011083,lethality at weaning, complete penetrance|MP:0011085,postnatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011298,ureter hypoplasia|MP:0012163,abnormal dental mesenchyme morphology|MP:0012411,increased granulosa cell tumor incidence|MP:0012570,increased mammary gland tumor incidence in breeding females|MP:0013733,squamous metaplasia of bulbourethral gland|MP:0013734,squamous metaplasia of preputial gland|MP:0013735,squamous metaplasia of urethral gland|MP:0013818,abnormal oral cavity morphology|MP:0014617,decreased spermatogonia number|MP:0020288,ectopic limbs|MP:0030313,abnormal face development
MGI:3039783	Ctnnb1<tm1(Nfkbia)Rsu>	MP:0000128,growth retardation of molars|MP:0000218,increased leukocyte cell number|MP:0000322,increased granulocyte number|MP:0000367,abnormal coat/ hair morphology|MP:0000378,absent hair follicles|MP:0000379,decreased hair follicle number|MP:0000414,alopecia|MP:0000440,domed cranium|MP:0000465,gastrointestinal hemorrhage|MP:0000496,abnormal small intestine morphology|MP:0000574,abnormal foot pad morphology|MP:0000585,kinked tail|MP:0000674,abnormal sweat gland morphology|MP:0000745,tremors|MP:0001265,decreased body size|MP:0001283,sparse vibrissae|MP:0001337,dry eyes|MP:0001505,hunched posture|MP:0001510,abnormal coat appearance|MP:0001525,impaired balance|MP:0001846,increased inflammatory response|MP:0001850,increased susceptibility to otitis media|MP:0001852,conjunctivitis|MP:0001935,decreased litter size|MP:0001967,deafness|MP:0002001,blindness|MP:0002073,abnormal hair growth|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0002351,abnormal cervical lymph node morphology|MP:0002451,abnormal macrophage physiology|MP:0002831,absent Peyer's patches|MP:0003153,early eyelid opening|MP:0003449,abnormal intestine goblet cell morphology|MP:0003704,abnormal hair follicle development|MP:0003887,increased hepatocyte apoptosis|MP:0003888,liver hemorrhage|MP:0003957,abnormal nitric oxide homeostasis|MP:0004830,short incisors|MP:0005027,increased susceptibility to parasitic infection|MP:0005202,lethargy|MP:0005287,narrow eye opening|MP:0005300,abnormal cornea stroma morphology|MP:0005359,growth retardation of incisors|MP:0006000,abnormal cornea epithelium morphology|MP:0006236,absent Meibomian glands|MP:0006402,small molars|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0008463,abnormal peripheral lymph node morphology|MP:0008464,absent peripheral lymph nodes|MP:0009629,small brachial lymph nodes|MP:0009632,small axillary lymph nodes|MP:0009634,absent popliteal lymph nodes|MP:0010234,abnormal vibrissa follicle morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011195,increased hair follicle apoptosis|MP:0013445,Harderian gland atrophy|MP:0013466,keratoconjunctivitis sicca|MP:0013745,abnormal eyelid margin morphology|MP:0030541,misaligned incisors
MGI:2148590	Ctnnb1<tm1Wbm>	MP:0001674,abnormal germ layer development|MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0001683,absent mesoderm|MP:0001695,abnormal gastrulation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001705,abnormal proximal-distal axis patterning|MP:0002084,abnormal developmental patterning|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3056113	Ctnnb1<tm1Yy>	MP:0000440,domed cranium|MP:0000547,short limbs|MP:0003190,fused synovial joints|MP:0003704,abnormal hair follicle development|MP:0005077,abnormal melanogenesis|MP:0005503,abnormal tendon morphology|MP:0005504,abnormal ligament morphology|MP:0006279,abnormal limb development|MP:0011087,neonatal lethality, complete penetrance
MGI:2148569	Ctnnb1<tm2.1Kem>	MP:0001683,absent mesoderm|MP:0002718,abnormal inner cell mass morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5308945	Ctnnb1<tm2Kba>	MP:0001683,absent mesoderm|MP:0001695,abnormal gastrulation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2148567	Ctnnb1<tm2Kem>	MP:0000030,abnormal tympanic ring morphology|MP:0000040,decreased middle ear ossicle number|MP:0000066,osteoporosis|MP:0000067,osteopetrosis|MP:0000074,abnormal neurocranium morphology|MP:0000087,absent mandible|MP:0000128,growth retardation of molars|MP:0000163,abnormal cartilage morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000352,decreased cell proliferation|MP:0000364,abnormal vascular regression|MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000392,accelerated hair follicle regression|MP:0000428,abnormal craniofacial morphology|MP:0000436,abnormal head movements|MP:0000440,domed cranium|MP:0000488,abnormal intestinal epithelium morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000536,hydroureter|MP:0000547,short limbs|MP:0000553,absent radius|MP:0000557,absent hindlimb|MP:0000572,abnormal autopod morphology|MP:0000762,abnormal tongue morphology|MP:0000763,abnormal filiform papillae morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000814,absent dentate gyrus|MP:0000825,dilated lateral ventricle|MP:0000934,abnormal telencephalon development|MP:0000939,decreased motor neuron number|MP:0001176,abnormal lung development|MP:0001181,absent lungs|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001265,decreased body size|MP:0001341,absent eyelids|MP:0001363,increased anxiety-related response|MP:0001382,abnormal nursing|MP:0001408,stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001447,abnormal nest building behavior|MP:0001925,male infertility|MP:0002020,increased tumor incidence|MP:0002058,neonatal lethality|MP:0002064,seizures|MP:0002073,abnormal hair growth|MP:0002080,prenatal lethality|MP:0002116,abnormal craniofacial bone morphology|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0002196,absent corpus callosum|MP:0002216,abnormal seminiferous tubule morphology|MP:0002655,abnormal keratinocyte morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002797,increased thigmotaxis|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002932,abnormal joint morphology|MP:0002989,small kidney|MP:0003413,hair follicle degeneration|MP:0003424,premature neuronal precursor differentiation|MP:0003446,renal hypoplasia|MP:0003605,fused kidneys|MP:0003723,abnormal long bone morphology|MP:0003743,abnormal facial morphology|MP:0003795,abnormal bone structure|MP:0003869,ectopic cartilage|MP:0004016,decreased bone mass|MP:0004163,abnormal adenohypophysis morphology|MP:0004205,absent hyoid bone|MP:0004320,split sternum|MP:0004354,absent deltoid tuberosity|MP:0004359,short ulna|MP:0004382,abnormal hair follicle melanogenesis|MP:0004486,decreased response of heart to induced stress|MP:0004538,abnormal maxillary shelf morphology|MP:0004572,fusion of basioccipital and basisphenoid bone|MP:0004686,decreased length of long bones|MP:0004811,abnormal neuron physiology|MP:0004852,decreased testis weight|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0004984,increased osteoclast cell number|MP:0004985,decreased osteoclast cell number|MP:0004992,increased bone resorption|MP:0004993,decreased bone resorption|MP:0005171,absent coat pigmentation|MP:0005359,growth retardation of incisors|MP:0005386,behavior/neurological phenotype|MP:0005508,abnormal skeleton morphology|MP:0005545,abnormal lens development|MP:0006292,abnormal nasal placode morphology|MP:0006305,abnormal optic eminence morphology|MP:0008154,decreased diameter of humerus|MP:0008223,absent hippocampal commissure|MP:0008264,absent hippocampus CA1 region|MP:0008266,absent hippocampus CA2 region|MP:0008268,absent hippocampus CA3 region|MP:0008274,failure of bone ossification|MP:0008321,small adenohypophysis|MP:0008330,absent somatotrophs|MP:0008333,absent lactotrophs|MP:0008335,decreased gonadotroph cell number|MP:0008339,absent thyrotrophs|MP:0008340,increased corticotroph cell number|MP:0008732,reduced hair shaft melanin granule number|MP:0008858,abnormal hair cycle anagen phase|MP:0009545,abnormal dermis papillary layer morphology|MP:0009612,thick epidermis suprabasal layer|MP:0009686,abnormal spinal cord medial motor column morphology|MP:0009715,thick epidermis stratum basale|MP:0009783,abnormal melanoblast morphology|MP:0009890,cleft secondary palate|MP:0009902,abnormal lateral nasal prominence morphology|MP:0009903,abnormal medial nasal prominence morphology|MP:0009928,abnormal pinna hair pigmentation|MP:0009933,abnormal tail hair pigmentation|MP:0010682,abnormal hair follicle infundibulum morphology|MP:0010771,integument phenotype|MP:0010864,abnormal enamel knot morphology|MP:0010875,increased bone volume|MP:0010879,decreased trabecular bone volume|MP:0010907,absent lung buds|MP:0010939,abnormal mandibular prominence morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011195,increased hair follicle apoptosis|MP:0011290,decreased nephron number|MP:0011386,increased metanephric mesenchyme apoptosis|MP:0011407,absent nephrogenic zone|MP:0011441,decreased kidney cell proliferation|MP:0011712,arrested osteoblast differentiation|MP:0011846,decreased kidney collecting duct number|MP:0012133,absent midbrain-hindbrain boundary|MP:0012306,enhanced spatial learning|MP:0012318,slow extinction of fear memory|MP:0013486,decreased Paneth cell number|MP:0014077,ectopic Paneth cells|MP:0014367,impaired long-term object recognition memory|MP:0014617,decreased spermatogonia number|MP:0020395,abnormal response to social novelty|MP:0030252,narrow frontonasal prominence|MP:0030302,abnormal maxillary zygomatic process morphology|MP:0030313,abnormal face development|MP:0030906,decreased melanoblast proliferation|MP:0031395,cutaneous mastocytosis
MGI:3039784	Ctnnb1<tm2(Nfkbia)Rsu>	MP:0000218,increased leukocyte cell number|MP:0000322,increased granulocyte number|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000440,domed cranium|MP:0000465,gastrointestinal hemorrhage|MP:0000496,abnormal small intestine morphology|MP:0000585,kinked tail|MP:0000696,abnormal Peyer's patch morphology|MP:0000745,tremors|MP:0001265,decreased body size|MP:0001283,sparse vibrissae|MP:0001337,dry eyes|MP:0001340,abnormal eyelid morphology|MP:0001505,hunched posture|MP:0001846,increased inflammatory response|MP:0001850,increased susceptibility to otitis media|MP:0001935,decreased litter size|MP:0001967,deafness|MP:0002001,blindness|MP:0002073,abnormal hair growth|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0002451,abnormal macrophage physiology|MP:0002689,abnormal molar morphology|MP:0003449,abnormal intestine goblet cell morphology|MP:0003704,abnormal hair follicle development|MP:0003887,increased hepatocyte apoptosis|MP:0003888,liver hemorrhage|MP:0004486,decreased response of heart to induced stress|MP:0005202,lethargy|MP:0005358,abnormal incisor morphology|MP:0005390,skeleton phenotype|MP:0006236,absent Meibomian glands|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013445,Harderian gland atrophy|MP:0013466,keratoconjunctivitis sicca
MGI:2148591	Ctnnb1<tm2Wbm>	MP:0001674,abnormal germ layer development|MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0001683,absent mesoderm|MP:0001695,abnormal gastrulation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001705,abnormal proximal-distal axis patterning|MP:0002084,abnormal developmental patterning|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5308947	Ctnnb1<tm3Kba>	MP:0001683,absent mesoderm|MP:0001695,abnormal gastrulation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2148593	Ctnnb1<tm3Wbm>	MP:0001674,abnormal germ layer development|MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0001683,absent mesoderm|MP:0001695,abnormal gastrulation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001705,abnormal proximal-distal axis patterning|MP:0002084,abnormal developmental patterning|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2148594	Ctnnb1<tm4Wbm>	MP:0000219,increased neutrophil cell number|MP:0000378,absent hair follicles|MP:0000414,alopecia|MP:0000418,focal hair loss|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000774,decreased brain size|MP:0000956,decreased spinal cord size|MP:0001219,thick epidermis|MP:0001265,decreased body size|MP:0001280,loss of vibrissae|MP:0001297,microphthalmia|MP:0001306,small lens|MP:0001869,pancreas inflammation|MP:0001944,abnormal pancreas morphology|MP:0002073,abnormal hair growth|MP:0002083,premature death|MP:0002151,abnormal neural tube morphology|MP:0002152,abnormal brain morphology|MP:0002579,disorganized secondary lens fibers|MP:0002693,abnormal pancreas physiology|MP:0003236,abnormal lens capsule morphology|MP:0003237,abnormal lens epithelium morphology|MP:0003334,pancreas fibrosis|MP:0003553,abnormal foreskin morphology|MP:0003632,abnormal nervous system morphology|MP:0005220,abnormal exocrine pancreas morphology|MP:0006279,abnormal limb development|MP:0008347,decreased gamma-delta T cell number|MP:0008841,ruptured lens capsule|MP:0009109,decreased pancreas weight|MP:0009154,pancreatic acinar hypoplasia|MP:0009199,abnormal external male genitalia morphology|MP:0010254,nuclear cataract|MP:0011087,neonatal lethality, complete penetrance
MGI:5548564	Ctnnbip1<tm1b(EUCOMM)Wtsi>	MP:0000274,enlarged heart|MP:0005505,thrombocytosis|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3045424	Ctnnbip1<tm1Taki>	MP:0000432,abnormal head morphology|MP:0000438,abnormal cranium morphology|MP:0000462,abnormal digestive system morphology|MP:0000520,absent kidney|MP:0000528,delayed kidney development|MP:0000914,exencephaly|MP:0000934,abnormal telencephalon development|MP:0001293,anophthalmia|MP:0001648,abnormal apoptosis|MP:0002233,abnormal nose morphology|MP:0003604,single kidney|MP:0003722,absent ureter|MP:0004539,absent maxilla|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005221,abnormal rostral-caudal axis patterning|MP:0009890,cleft secondary palate|MP:0010983,abnormal ureteric bud invasion|MP:0011087,neonatal lethality, complete penetrance|MP:0011364,abnormal metanephros morphology|MP:0011386,increased metanephric mesenchyme apoptosis
MGI:3864239	Ctnnbl1<Gt(AX0016)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5795658	Ctnnbl1<tm1.1Crad>	MP:0004816,abnormal class switch recombination|MP:0005093,decreased B cell proliferation|MP:0005153,abnormal B cell proliferation|MP:0005387,immune system phenotype|MP:0010768,mortality/aging
MGI:5795695	Ctnnbl1<tm1.2Crad>	MP:0011092,embryonic lethality, complete penetrance
MGI:5795692	Ctnnbl1<tm1Crad>	MP:0011092,embryonic lethality, complete penetrance
MGI:3617486	Ctnnd1<tm1Abre>	MP:0000111,cleft palate|MP:0000352,decreased cell proliferation|MP:0000424,retarded hair growth|MP:0001222,epidermal hyperplasia|MP:0001346,abnormal lacrimal gland morphology|MP:0002235,abnormal external nares morphology|MP:0003708,binucleate|MP:0003792,abnormal major salivary gland morphology|MP:0003793,abnormal submandibular gland morphology|MP:0004035,abnormal sublingual gland morphology|MP:0004046,abnormal mitosis|MP:0005170,cleft upper lip|MP:0009760,abnormal mitotic spindle morphology|MP:0009890,cleft secondary palate|MP:0010300,increased skin tumor incidence|MP:0010940,abnormal maxillary prominence morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0013300,abnormal submandibular gland physiology|MP:0013540,increased submandibular gland apoptosis|MP:0021164,oral cleft|MP:0021210,bilateral cleft palate|MP:0021211,unilateral cleft palate|MP:0030099,facial asymmetry|MP:0030115,abnormal nasal tip morphology
MGI:3640772	Ctnnd1<tm1Lfr>	MP:0000522,kidney cortex cyst|MP:0000527,abnormal kidney development|MP:0002989,small kidney|MP:0003446,renal hypoplasia|MP:0004505,decreased renal glomerulus number|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005367,renal/urinary system phenotype|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0009050,dilated proximal convoluted tubule|MP:0009051,dilated distal convoluted tubule|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0011066,abnormal renal tubule epithelial cell primary cilium morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011364,abnormal metanephros morphology|MP:0011368,increased kidney apoptosis|MP:0011440,increased kidney cell proliferation|MP:0014696,decreased cell adhesion
MGI:3056606	Ctnnd2<tm1Lxin>	MP:0001405,impaired coordination|MP:0001454,abnormal cued conditioning behavior|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0002207,abnormal long-term potentiation
MGI:2388945	Ctns<tm1Antc>	MP:0000063,decreased bone mineral density|MP:0000135,decreased compact bone thickness|MP:0000749,muscle degeneration|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002797,increased thigmotaxis|MP:0005103,abnormal retina pigmentation|MP:0005367,renal/urinary system phenotype|MP:0005544,cornea deposits|MP:0005551,abnormal eye electrophysiology|MP:0011632,dilated mitochondrion|MP:0030622,increased cysteine level
MGI:3695473	Ctpr1<BALB/cJ>	MP:0008873,increased physiological sensitivity to xenobiotic
MGI:6356815	Ctps1<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0002060,abnormal skin morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013292,embryonic lethality prior to organogenesis
MGI:7657750	Ctps1<em1Slat>	MP:0002169,no abnormal phenotype detected
MGI:7657751	Ctps1<tm1c(KOMP)Wtsi>	MP:0000333,decreased bone marrow cell number|MP:0000488,abnormal intestinal epithelium morphology|MP:0000689,abnormal spleen morphology|MP:0000706,small thymus|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001806,decreased IgM level|MP:0001823,thymus hypoplasia|MP:0002083,premature death|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003763,abnormal thymus physiology|MP:0004810,decreased hematopoietic stem cell number|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0008045,decreased NK cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008108,abnormal small intestinal villus morphology|MP:0008178,decreased germinal center B cell number|MP:0008941,reticulocytopenia|MP:0010187,decreased T follicular helper cell number|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013436,increased CD8-positive, naive alpha-beta T cell number|MP:0013705,decreased megakaryocyte-erythroid progenitor cell number|MP:0013771,decreased effector memory T-helper cell number|MP:0014082,decreased small intestinal villus height|MP:0020154,impaired humoral immune response
MGI:7657752	Ctps1<tm1d(KOMP)Wtsi>	MP:0001730,embryonic growth arrest|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:4346772	Ctps2<Gt(AS1012)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:7657754	Ctps2<tm1d(EUCOMM)Hmgu>	MP:0002169,no abnormal phenotype detected
MGI:5548390	Ctr9<tm1b(EUCOMM)Wtsi>	MP:0002941,increased circulating alanine transaminase level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6455002	Ctrb1<em1Toth>	MP:0001785,edema|MP:0002693,abnormal pancreas physiology|MP:0003450,enlarged pancreas|MP:0004761,increased susceptibility to induced pancreatitis|MP:0009108,increased pancreas weight
MGI:6446748	Ctrc<m1>	MP:0004761,increased susceptibility to induced pancreatitis
MGI:6120756	Ctrc<tm1b(EUCOMM)Hmgu>	MP:0000559,abnormal femur morphology|MP:0002699,abnormal vitreous body morphology|MP:0009476,enlarged cecum
MGI:3052187	Ctrcts<DBA/2J>	MP:0001304,cataract
MGI:6454999	Ctrl<em1Toth>	MP:0002693,abnormal pancreas physiology|MP:0005379,endocrine/exocrine gland phenotype
MGI:3692648	Ctrq1<C3H/HeJ>	MP:0002412,increased susceptibility to bacterial infection
MGI:3692650	Ctrq2<C3H/HeJ>	MP:0002411,decreased susceptibility to bacterial infection
MGI:3692652	Ctrq3<C3H/HeJ>	MP:0002412,increased susceptibility to bacterial infection
MGI:7425619	Cts3<em1(IMPC)Hmgu>	MP:0002135,abnormal kidney morphology
MGI:5561561	Cts6<tm1b(KOMP)Wtsi>	MP:0000745,tremors
MGI:4365386	Ctsa<tm1.1Avps>	MP:0001183,overexpanded pulmonary alveolus|MP:0001762,polyuria|MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004875,increased mean systemic arterial blood pressure|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0006083,abnormal blood vessel elastic tissue morphology|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008418,abnormal cutaneous elastic fiber morphology|MP:0010768,mortality/aging|MP:0011941,increased fluid intake
MGI:2449708	Ctsa<tm1Adz>	MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000745,tremors|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001511,disheveled coat|MP:0001785,edema|MP:0002083,premature death|MP:0005058,abnormal lysosome morphology|MP:0012175,flat face
MGI:4365387	Ctsa<tm1Avps>	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:6336220	Ctsa<tm2b(EUCOMM)Hmgu>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0000208,decreased hematocrit|MP:0000220,increased monocyte cell number|MP:0000432,abnormal head morphology|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000691,enlarged spleen|MP:0000745,tremors|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0002590,increased mean corpuscular volume|MP:0002644,decreased circulating triglyceride level|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0004952,increased spleen weight|MP:0005179,decreased circulating cholesterol level|MP:0005287,narrow eye opening|MP:0005333,decreased heart rate|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005567,decreased circulating total protein level|MP:0005627,increased circulating potassium level|MP:0008810,increased circulating iron level|MP:0009142,decreased prepulse inhibition|MP:0009456,impaired cued conditioning behavior|MP:0010506,prolonged RR interval|MP:0020420,abnormal freezing behavior|MP:0020421,increased freezing behavior
MGI:2182129	Ctsb<tm1Jde>	MP:0000604,amyloidosis|MP:0000681,abnormal thyroid gland morphology|MP:0001559,hyperglycemia|MP:0001870,salivary gland inflammation|MP:0004031,insulitis|MP:0004155,decreased susceptibility to induced pancreatitis|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005367,renal/urinary system phenotype|MP:0005387,immune system phenotype|MP:0005468,abnormal thyroid hormone level|MP:0006043,decreased apoptosis
MGI:3604533	Ctsc<tm1Dgen>	MP:0001511,disheveled coat|MP:0001973,increased thermal nociceptive threshold|MP:0009142,decreased prepulse inhibition
MGI:2671139	Ctsc<tm1Ley>	MP:0001263,weight loss|MP:0002444,abnormal T cell physiology|MP:0003156,abnormal leukocyte migration|MP:0005025,abnormal response to infection|MP:0005044,sepsis|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008596,increased circulating interleukin-6 level|MP:0008597,decreased circulating interleukin-6 level|MP:0008719,impaired neutrophil recruitment|MP:0008721,abnormal chemokine level
MGI:5752221	Ctsd<m1J>	MP:0000427,abnormal hair cycle|MP:0000511,abnormal intestinal mucosa morphology|MP:0000746,weakness|MP:0000811,hippocampal neuron degeneration|MP:0001262,decreased body weight|MP:0001967,deafness|MP:0002855,abnormal cochlear ganglion morphology|MP:0003224,neuron degeneration|MP:0003225,axonal dystrophy|MP:0003644,thymus atrophy|MP:0005150,cachexia|MP:0010783,abnormal stomach wall morphology|MP:0011083,lethality at weaning, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5702318	Ctsd<tm1.1Thre>	MP:0000703,abnormal thymus morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0002083,premature death|MP:0002183,gliosis|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0003644,thymus atrophy|MP:0005092,decreased double-positive T cell number|MP:0008918,microgliosis|MP:0014078,small intestinal villus atrophy|MP:0014082,decreased small intestinal villus height
MGI:5548925	Ctsd<tm1b(EUCOMM)Wtsi>	MP:0000208,decreased hematocrit|MP:0001314,cornea opacity|MP:0005343,increased circulating aspartate transaminase level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2182078	Ctsd<tm1Cptr>	MP:0000136,abnormal microglial cell morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0001393,ataxia|MP:0001823,thymus hypoplasia|MP:0001835,abnormal antigen presentation|MP:0002001,blindness|MP:0002064,seizures|MP:0002083,premature death|MP:0002357,abnormal spleen white pulp morphology|MP:0002581,abnormal ileum morphology|MP:0002826,tonic seizures|MP:0005016,decreased lymphocyte cell number|MP:0005048,abnormal thrombosis|MP:0005059,lysosomal protein accumulation|MP:0005092,decreased double-positive T cell number|MP:0005156,bradykinesia|MP:0005384,cellular phenotype|MP:0008450,retina photoreceptor degeneration|MP:0008470,abnormal spleen B cell follicle morphology|MP:0011940,decreased food intake|MP:0012504,increased forebrain apoptosis
MGI:5435251	Ctse<C57BL/6JOlaHsd>	MP:0001790,abnormal immune system physiology|MP:0002376,abnormal dendritic cell physiology|MP:0002455,abnormal dendritic cell antigen presentation
MGI:5435933	Ctse<tm1Bchn>	MP:0005389,reproductive system phenotype
MGI:3625688	Ctse<tm1Kjy>	MP:0000414,alopecia|MP:0001190,reddish skin|MP:0001194,dermatitis|MP:0001212,skin lesions|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001246,mixed cellular infiltration to dermis|MP:0002497,increased IgE level|MP:0005011,increased eosinophil cell number|MP:0005091,increased double-positive T cell number|MP:0008635,increased circulating interleukin-18 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion
MGI:3621931	Ctsf<tm1Hap>	MP:0000745,tremors|MP:0000937,abnormal motor neuron morphology|MP:0001263,weight loss|MP:0001392,abnormal locomotor behavior|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0001525,impaired balance|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002183,gliosis|MP:0005150,cachexia|MP:0009434,paraparesis
MGI:2182170	Ctsg<tm1.1Roes>	MP:0009787,increased susceptibility to infection induced morbidity/mortality|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:2182136	Ctsg<tm1Ley>	MP:0002006,neoplasm|MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:3526413	Ctsg<tm2.1(PML/RARA)Ley>	MP:0000218,increased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002398,abnormal bone marrow cell morphology/development|MP:0003179,thrombocytopenia|MP:0004049,increased acute promyelocytic leukemia incidence|MP:0004952,increased spleen weight|MP:0006410,abnormal common myeloid progenitor cell morphology
MGI:3526412	Ctsg<tm2(PML/RARA)Ley>	MP:0002169,no abnormal phenotype detected
MGI:4847629	Ctsg<tm3.1(PML/RARA)Ley>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002083,premature death|MP:0002398,abnormal bone marrow cell morphology/development|MP:0004049,increased acute promyelocytic leukemia incidence|MP:0004952,increased spleen weight|MP:0006410,abnormal common myeloid progenitor cell morphology
MGI:5616353	Ctsh<tm1b(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0010123,increased bone mineral content|MP:0011960,abnormal eye anterior chamber depth|MP:0011965,decreased total retina thickness
MGI:4840055	Ctsh<tm1Thre>	MP:0002092,abnormal eye morphology|MP:0002133,abnormal respiratory system physiology|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0010993,decreased surfactant secretion
MGI:5911511	Ctsj<em1(IMPC)J>	MP:0002075,abnormal coat/hair pigmentation
MGI:5492037	Ctsk<tm1.1Rbar>	MP:0001541,abnormal osteoclast physiology|MP:0004984,increased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0005006,abnormal osteoblast physiology|MP:0005390,skeleton phenotype|MP:0008395,abnormal osteoblast differentiation|MP:0008396,abnormal osteoclast differentiation|MP:0009347,increased trabecular bone thickness|MP:0010868,increased bone trabecula number|MP:0010872,increased trabecular bone mass|MP:0010875,increased bone volume|MP:0010878,increased trabecular bone volume|MP:0010932,increased trabecular bone connectivity density|MP:0010964,increased compact bone volume|MP:0020039,increased bone ossification|MP:0020080,increased bone mineralization
MGI:5605742	Ctsk<tm1b(EUCOMM)Hmgu>	MP:0000062,increased bone mineral density|MP:0001120,abnormal uterus morphology|MP:0002764,short tibia|MP:0009142,decreased prepulse inhibition
MGI:3767171	Ctsk<tm1Mbs>	MP:0000061,fragile skeleton|MP:0000065,abnormal bone marrow cavity morphology|MP:0000067,osteopetrosis|MP:0000130,abnormal trabecular bone morphology|MP:0001541,abnormal osteoclast physiology|MP:0002998,abnormal bone remodeling|MP:0003795,abnormal bone structure|MP:0003797,abnormal compact bone morphology|MP:0004214,abnormal long bone diaphysis morphology|MP:0004984,increased osteoclast cell number|MP:0005006,abnormal osteoblast physiology|MP:0010868,increased bone trabecula number|MP:0010872,increased trabecular bone mass|MP:0010967,increased compact bone area
MGI:2182131	Ctsk<tm1Psa>	MP:0000067,osteopetrosis|MP:0000130,abnormal trabecular bone morphology|MP:0000604,amyloidosis|MP:0001179,thick pulmonary interalveolar septum|MP:0001541,abnormal osteoclast physiology|MP:0003795,abnormal bone structure|MP:0004214,abnormal long bone diaphysis morphology|MP:0006050,pulmonary fibrosis|MP:0006398,increased long bone epiphyseal plate size
MGI:3527195	Ctsk<tm1Vuo>	MP:0000062,increased bone mineral density|MP:0000067,osteopetrosis|MP:0000130,abnormal trabecular bone morphology|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number
MGI:3698312	Ctsk<tm1Ypl>	MP:0000061,fragile skeleton|MP:0000067,osteopetrosis|MP:0000074,abnormal neurocranium morphology|MP:0000116,abnormal tooth development|MP:0000120,malocclusion|MP:0000454,abnormal jaw morphology|MP:0000558,abnormal tibia morphology|MP:0000578,ulcerated autopod|MP:0001255,decreased body height|MP:0001262,decreased body weight|MP:0001533,abnormal skeleton physiology|MP:0001732,postnatal growth retardation|MP:0004189,abnormal alveolar process morphology|MP:0004913,absent mandibular angle|MP:0004945,abnormal bone resorption|MP:0004984,increased osteoclast cell number|MP:0005306,abnormal phalanx morphology|MP:0005378,growth/size/body region phenotype|MP:0005508,abnormal skeleton morphology|MP:0008162,increased diameter of tibia|MP:0010876,decreased bone volume|MP:0010878,increased trabecular bone volume|MP:0030029,wide cranial sutures|MP:0030279,thin neurocranium|MP:0030388,large fontanelles|MP:0031312,spondylolysis
MGI:1856878	Ctsl<fs>	MP:0000414,alopecia|MP:0001156,abnormal spermatogenesis|MP:0001284,absent vibrissae|MP:0002216,abnormal seminiferous tubule morphology|MP:0004852,decreased testis weight|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6286325	Ctsl<m1Btlr>	MP:0000414,alopecia|MP:0002145,abnormal T cell differentiation|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0012764,increased alpha-beta T cell number|MP:0012765,decreased alpha-beta T cell number
MGI:1889860	Ctsl<nkt>	MP:0000217,abnormal leukocyte cell number|MP:0000367,abnormal coat/ hair morphology|MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000422,delayed hair appearance|MP:0000652,enlarged sebaceous gland|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0001194,dermatitis|MP:0001212,skin lesions|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001245,thick dermal layer|MP:0001265,decreased body size|MP:0001314,cornea opacity|MP:0001412,excessive scratching|MP:0001732,postnatal growth retardation|MP:0001846,increased inflammatory response|MP:0001860,liver inflammation|MP:0001874,acanthosis|MP:0002073,abnormal hair growth|MP:0002339,abnormal lymph node morphology|MP:0002343,abnormal lymph node cortex morphology|MP:0002367,abnormal thymus lobule morphology|MP:0002722,abnormal immune system organ morphology|MP:0003644,thymus atrophy|MP:0003704,abnormal hair follicle development|MP:0003809,abnormal hair shaft morphology|MP:0003865,lymph node inflammation|MP:0005150,cachexia|MP:0006033,abnormal external auditory canal morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008102,lymph node hyperplasia|MP:0008859,abnormal hair cycle catagen phase|MP:0009543,abnormal thymus corticomedullary boundary morphology|MP:0009600,hypergranulosis|MP:0009675,orthokeratosis|MP:0010179,rough coat|MP:0010771,integument phenotype|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011223,dilated lymph node medullary sinus|MP:0013251,dental pulp necrosis|MP:0013593,enlarged thymus cortex|MP:0030515,periodontal ligament necrosis|MP:0030571,dilated piliary canal
MGI:5780968	Ctsl<tm1.1Thre>	MP:0000414,alopecia
MGI:5780970	Ctsl<tm1.2Thre>	MP:0000414,alopecia|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0009583,increased keratinocyte proliferation|MP:0010771,integument phenotype
MGI:3583996	Ctsl<tm1Alpk>	MP:0000130,abnormal trabecular bone morphology|MP:0000163,abnormal cartilage morphology|MP:0000367,abnormal coat/ hair morphology|MP:0000376,folliculitis|MP:0000377,abnormal hair follicle morphology|MP:0000383,abnormal hair follicle orientation|MP:0000414,alopecia|MP:0000417,short hair|MP:0000427,abnormal hair cycle|MP:0001194,dermatitis|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001282,short vibrissae|MP:0001283,sparse vibrissae|MP:0001510,abnormal coat appearance|MP:0001541,abnormal osteoclast physiology|MP:0002073,abnormal hair growth|MP:0002500,granulomatous inflammation|MP:0003453,abnormal keratinocyte physiology|MP:0003809,abnormal hair shaft morphology|MP:0003849,greasy coat|MP:0004985,decreased osteoclast cell number|MP:0006396,decreased long bone epiphyseal plate size|MP:0010202,focal dorsal hair loss
MGI:2136432	Ctsl<tm1Cptr>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000382,underdeveloped hair follicles|MP:0000414,alopecia|MP:0000422,delayed hair appearance|MP:0000427,abnormal hair cycle|MP:0000604,amyloidosis|MP:0000681,abnormal thyroid gland morphology|MP:0001192,scaly skin|MP:0001196,shiny skin|MP:0001200,thick skin|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001242,hyperkeratosis|MP:0001245,thick dermal layer|MP:0001284,absent vibrissae|MP:0001544,abnormal cardiovascular system physiology|MP:0001559,hyperglycemia|MP:0001718,abnormal visceral yolk sac morphology|MP:0001870,salivary gland inflammation|MP:0001874,acanthosis|MP:0002625,heart left ventricle hypertrophy|MP:0002626,increased heart rate|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003704,abnormal hair follicle development|MP:0003809,abnormal hair shaft morphology|MP:0004031,insulitis|MP:0004085,abnormal heartbeat|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0004973,increased regulatory T cell number|MP:0005058,abnormal lysosome morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005329,abnormal myocardium layer morphology|MP:0005367,renal/urinary system phenotype|MP:0005468,abnormal thyroid hormone level|MP:0005471,decreased thyroxine level|MP:0005608,cardiac interstitial fibrosis|MP:0006045,mitral valve regurgitation|MP:0006047,aortic valve regurgitation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008726,increased heart left atrium size|MP:0009583,increased keratinocyte proliferation|MP:0010505,abnormal T wave|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010519,atrioventricular block|MP:0010688,hair follicle outer root sheath hyperplasia|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011919,abnormal R wave|MP:0011925,abnormal heart echocardiography feature|MP:0030571,dilated piliary canal|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4431400	Ctsm<tm1(KOMP)Wtsi>	MP:0000220,increased monocyte cell number|MP:0001417,decreased exploration in new environment|MP:0002591,decreased mean corpuscular volume|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0013279,increased fasting circulating glucose level
MGI:5637109	Ctso<tm2b(KOMP)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0002098,abnormal vibrissa morphology|MP:0002599,increased mean platelet volume|MP:0005635,decreased circulating bilirubin level
MGI:6435664	Ctss<em1(IMPC)H>	MP:0002608,increased hematocrit|MP:0004953,decreased spleen weight
MGI:6268420	Ctss<m1Btlr>	MP:0001805,decreased IgG level|MP:0020154,impaired humoral immune response
MGI:2182132	Ctss<tm1Eae>	MP:0001559,hyperglycemia|MP:0001870,salivary gland inflammation|MP:0002453,abnormal B lymphocyte antigen presentation|MP:0003436,decreased susceptibility to induced arthritis|MP:0004031,insulitis|MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:2182133	Ctss<tm1Hap>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002444,abnormal T cell physiology|MP:0002452,abnormal professional antigen presenting cell physiology|MP:0002459,abnormal B cell physiology|MP:0003009,abnormal cytokine secretion|MP:0004003,abnormal vascular endothelial cell physiology|MP:0004824,decreased susceptibility to experimental autoimmune myasthenia gravis|MP:0005602,decreased angiogenesis|MP:0008568,abnormal interleukin secretion
MGI:3046638	Ctsw<tm1Ctnp>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype
MGI:7425622	Ctsz<em1(IMPC)H>	MP:0002599,increased mean platelet volume
MGI:4436876	Ctsz<tm1Thre>	MP:0002169,no abnormal phenotype detected|MP:0005367,renal/urinary system phenotype
MGI:6694204	Cttnbp2<em1Yph>	MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0004792,abnormal synaptic vesicle number|MP:0008414,abnormal spatial reference memory|MP:0008948,decreased neuron number|MP:0009538,abnormal synapse morphology|MP:0009617,decreased brain zinc level|MP:0009936,abnormal dendritic spine morphology|MP:0012315,impaired learning|MP:0020395,abnormal response to social novelty|MP:0020508,decreased dendritic spine density|MP:0020511,decreased dendritic spine length|MP:0020551,abnormal postsynaptic density morphology|MP:0031391,increased locomotor activity
MGI:6694206	Cttnbp2<em2Yph>	MP:0009617,decreased brain zinc level|MP:0009936,abnormal dendritic spine morphology|MP:0020351,decreased vocalization|MP:0020395,abnormal response to social novelty|MP:0020508,decreased dendritic spine density
MGI:6361178	Cttnbp2nl<em1(IMPC)J>	MP:0001488,increased startle reflex|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0010053,decreased grip strength
MGI:5636986	Cttnbp2<tm1b(KOMP)Wtsi>	MP:0008097,increased plasma cell number|MP:0009923,decreased transitional stage T1 B cell number|MP:0010052,increased grip strength|MP:0013430,increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number
MGI:4330257	Cttn<Gt(RRS284)Byg>	MP:0000358,abnormal cell morphology|MP:0003406,failure of zygotic cell division|MP:0004179,transmission ratio distortion|MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012738,abnormal secondary polar body morphology
MGI:4418948	Cttn<tm1.1Okab>	MP:0005384,cellular phenotype
MGI:5296621	Cttn<tm1.2Dvst>	MP:0001614,abnormal blood vessel morphology|MP:0002210,abnormal sex determination|MP:0002463,abnormal neutrophil physiology|MP:0003070,increased vascular permeability|MP:0003156,abnormal leukocyte migration|MP:0003628,abnormal leukocyte adhesion|MP:0004003,abnormal vascular endothelial cell physiology|MP:0005389,reproductive system phenotype|MP:0009858,abnormal cellular extravasation|MP:0010768,mortality/aging|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011131,abnormal lung endothelial cell physiology
MGI:4418949	Cttn<tm1.2Okab>	MP:0005384,cellular phenotype
MGI:5548978	Cttn<tm1b(EUCOMM)Hmgu>	MP:0000745,tremors|MP:0020870,decreased thigmotaxis
MGI:7311988	Ctu1<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response|MP:0005635,decreased circulating bilirubin level|MP:0011100,preweaning lethality, complete penetrance
MGI:4419518	Ctu2<tm1(KOMP)Wtsi>	MP:0002606,increased basophil cell number|MP:0005011,increased eosinophil cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:6830918	Ctxnd2<em1Osb>	MP:0005389,reproductive system phenotype
MGI:1856838	cu	MP:0001262,decreased body weight|MP:0001380,decreased male mating frequency|MP:0001382,abnormal nursing|MP:0001513,limb grasping
MGI:5616362	Cubn<tm1b(EUCOMM)Hmgu>	MP:0001307,fused cornea and lens|MP:0001322,abnormal iris morphology|MP:0004222,iris synechia|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance
MGI:4831004	Cubn<tm1Rkoz>	MP:0002871,albuminuria|MP:0010107,abnormal renal reabsorption|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011227,abnormal vitamin B12 level
MGI:3707335	Cubn<tm1Sarg>	MP:0001685,abnormal endoderm development|MP:0001698,decreased embryo size|MP:0001726,abnormal allantois morphology|MP:0002083,premature death|MP:0002085,abnormal embryonic tissue morphology|MP:0003087,absent allantois|MP:0003229,abnormal vitelline vasculature morphology|MP:0004076,abnormal vitelline vascular remodeling|MP:0004180,failure of initiation of embryo turning|MP:0005030,absent amnion|MP:0006386,absent somites|MP:0009593,absent chorion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011186,abnormal visceral endoderm morphology
MGI:5763461	Cuedc1<em1(IMPC)J>	MP:0000208,decreased hematocrit|MP:0001489,decreased startle reflex|MP:0002591,decreased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number
MGI:5635142	Cuedc2<tm1Qxia>	MP:0002451,abnormal macrophage physiology|MP:0004499,increased incidence of tumors by chemical induction|MP:0008537,increased susceptibility to induced colitis|MP:0011078,increased macrophage cytokine production
MGI:2152042	Cul1<tm1Rsjo>	MP:0001675,abnormal ectoderm development|MP:0001698,decreased embryo size|MP:0005621,abnormal cell physiology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2180659	Cul1<tmTye>	MP:0001675,abnormal ectoderm development|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0005621,abnormal cell physiology|MP:0006042,increased apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6257480	Cul2<em1(IMPC)H>	MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:7491948	Cul3<em1Limi>	MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0000805,abnormal visual cortex morphology|MP:0000839,hypothalamus hyperplasia|MP:0000852,small cerebellum|MP:0000859,abnormal somatosensory cortex morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001399,hyperactivity|MP:0001523,impaired righting response|MP:0001698,decreased embryo size|MP:0002065,abnormal fear/anxiety-related behavior|MP:0002152,abnormal brain morphology|MP:0002272,abnormal nervous system electrophysiology|MP:0002741,small olfactory bulb|MP:0003461,abnormal response to novel object|MP:0005380,embryo phenotype|MP:0005382,craniofacial phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0006254,thin cerebral cortex|MP:0006300,abnormal entorhinal cortex morphology|MP:0008143,abnormal dendrite morphology|MP:0010768,mortality/aging|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012460,decreased dentate gyrus size|MP:0020395,abnormal response to social novelty|MP:0020511,decreased dendritic spine length|MP:0020849,abnormal actin cytoskeleton morphology
MGI:5752857	Cul3<tm1.1Arte>	MP:0000231,hypertension|MP:0000249,abnormal blood vessel physiology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001566,increased circulating phosphate level|MP:0002666,increased circulating aldosterone level|MP:0003019,increased circulating chloride level|MP:0003025,increased vasoconstriction|MP:0004043,abnormal pH regulation|MP:0010092,increased circulating magnesium level|MP:0010996,increased aorta wall thickness|MP:0011091,prenatal lethality, complete penetrance|MP:0012339,hyperkalemia|MP:0012551,metabolic acidosis
MGI:3714267	Cul3<tm1Jdsr>	MP:0000598,abnormal liver morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000807,abnormal hippocampus morphology|MP:0001265,decreased body size|MP:0001363,increased anxiety-related response|MP:0002175,decreased brain weight|MP:0002196,absent corpus callosum|MP:0002206,abnormal CNS synaptic transmission|MP:0002797,increased thigmotaxis|MP:0002920,decreased paired-pulse facilitation|MP:0002981,increased liver weight|MP:0003077,abnormal cell cycle|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005402,abnormal action potential|MP:0006254,thin cerebral cortex|MP:0010768,mortality/aging|MP:0010770,preweaning lethality|MP:0013501,increased fibroblast apoptosis|MP:0014375,increased miniature excitatory postsynaptic current frequency|MP:0014382,increased miniature inhibitory postsynaptic current frequency|MP:0020395,abnormal response to social novelty|MP:0020507,increased dendritic spine density
MGI:2651546	Cul3<tm1Jro>	MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0002582,disorganized extraembryonic tissue|MP:0003077,abnormal cell cycle|MP:0005028,abnormal trophectoderm morphology|MP:0005030,absent amnion|MP:0005033,abnormal trophoblast giant cell morphology|MP:0010736,abnormal extraembryonic ectoderm morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5901731	Cul3<tm1Suc>	MP:0003019,increased circulating chloride level|MP:0005385,cardiovascular system phenotype|MP:0011400,lethality, complete penetrance
MGI:5901732	Cul3<tm2Suc>	MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype
MGI:3805522	Cul4a/Pcid2<tm2Ktc>	MP:0000208,decreased hematocrit|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0000479,abnormal enterocyte morphology|MP:0000689,abnormal spleen morphology|MP:0000694,spleen hypoplasia|MP:0000706,small thymus|MP:0001606,impaired hematopoiesis|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002227,abnormal spleen capsule morphology|MP:0003179,thrombocytopenia|MP:0004810,decreased hematopoietic stem cell number|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0004953,decreased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0008246,abnormal leukocyte morphology|MP:0008477,decreased spleen red pulp amount|MP:0008479,decreased spleen white pulp amount|MP:0008885,increased enterocyte apoptosis|MP:0014078,small intestinal villus atrophy
MGI:3851113	Cul4a/Pcid2<tm2Ktc>	MP:0000208,decreased hematocrit|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0000479,abnormal enterocyte morphology|MP:0000689,abnormal spleen morphology|MP:0000694,spleen hypoplasia|MP:0000706,small thymus|MP:0001606,impaired hematopoiesis|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002227,abnormal spleen capsule morphology|MP:0003179,thrombocytopenia|MP:0004810,decreased hematopoietic stem cell number|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0004953,decreased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0008246,abnormal leukocyte morphology|MP:0008477,decreased spleen red pulp amount|MP:0008479,decreased spleen white pulp amount|MP:0008885,increased enterocyte apoptosis|MP:0014078,small intestinal villus atrophy
MGI:5003269	Cul4a<tm1.1Pra>	MP:0001262,decreased body weight|MP:0004001,decreased hepatocyte proliferation|MP:0004045,abnormal cell cycle checkpoint function|MP:0005165,increased susceptibility to injury|MP:0005389,reproductive system phenotype|MP:0008057,abnormal DNA replication|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008866,chromosomal instability|MP:0011704,decreased fibroblast proliferation|MP:0030943,abnormal centrosome morphology
MGI:3851024	Cul4a<tm1.1Pz>	MP:0004504,decreased incidence of tumors by UV induction
MGI:5003274	Cul4a<tm1.2Pra>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004930,small epididymis|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0006379,abnormal spermatocyte morphology|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0014052,increased male germ cell apoptosis|MP:0014764,impaired double-strand DNA break repair|MP:0020550,multinucleated giant male germ cells
MGI:3851025	Cul4a<tm1.2Pz>	MP:0004045,abnormal cell cycle checkpoint function|MP:0014759,enhanced DNA repair
MGI:5807494	Cul4a<tm1b(EUCOMM)Hmgu>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001325,abnormal retina morphology|MP:0001925,male infertility|MP:0003020,decreased circulating chloride level|MP:0004953,decreased spleen weight|MP:0005627,increased circulating potassium level|MP:0008935,decreased mean platelet volume|MP:0009455,enhanced cued conditioning behavior|MP:0013279,increased fasting circulating glucose level
MGI:3859711	Cul4b<Gt(M119G06)Wrst>	MP:0002084,abnormal developmental patterning
MGI:5502166	Cul4b<tm1.1Pz>	MP:0000352,decreased cell proliferation|MP:0001672,abnormal embryo development|MP:0001675,abnormal ectoderm development|MP:0001693,failure of primitive streak formation|MP:0001698,decreased embryo size|MP:0001717,absent ectoplacental cone|MP:0001730,embryonic growth arrest|MP:0002169,no abnormal phenotype detected|MP:0003229,abnormal vitelline vasculature morphology|MP:0010768,mortality/aging|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5500947	Cul4b<tm1.1Yxg>	MP:0000352,decreased cell proliferation|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001732,postnatal growth retardation|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002582,disorganized extraembryonic tissue|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0004259,small placenta|MP:0004266,pale placenta|MP:0010382,abnormal dosage compensation, by inactivation of X chromosome|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0011527,disorganized placental labyrinth|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5438236	Cul4b<tm1Swl>	MP:0001463,abnormal spatial learning|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0008143,abnormal dendrite morphology|MP:0008948,decreased neuron number|MP:0009936,abnormal dendritic spine morphology|MP:0014370,impaired spatial working memory
MGI:5500946	Cul4b<tm1Yxg>	MP:0002169,no abnormal phenotype detected
MGI:5569059	Cul5<tm1.1(KOMP)Vlcg>	MP:0000288,abnormal pericardium morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001697,abnormal embryo size|MP:0002151,abnormal neural tube morphology|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004952,increased spleen weight|MP:0005166,decreased susceptibility to injury|MP:0008561,decreased tumor necrosis factor secretion|MP:0008655,decreased interleukin-1 alpha secretion|MP:0008706,decreased interleukin-6 secretion|MP:0011092,embryonic lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4434069	Cul7<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001262,decreased body weight|MP:0002896,abnormal bone mineralization
MGI:3039533	Cul7<tm1Jdec>	MP:0000259,abnormal vascular development|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0001713,decreased trophoblast giant cell number|MP:0001914,hemorrhage|MP:0001954,respiratory distress|MP:0011087,neonatal lethality, complete penetrance
MGI:3801047	Cul7<tm1Zqp>	MP:0004201,fetal growth retardation|MP:0008008,early cellular replicative senescence|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:6341880	Cul9<em1(IMPC)Ccpcz>	MP:0000137,abnormal vertebrae morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002135,abnormal kidney morphology|MP:0003036,vertebral transformation|MP:0004599,abnormal vertebral arch morphology|MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level|MP:0010090,increased circulating creatine kinase level|MP:0011971,increased circulating lactate dehydrogenase level
MGI:5007737	Cul9<tm1.2Yxi>	MP:0001262,decreased body weight|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0003364,increased insulinoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0005384,cellular phenotype|MP:0008000,increased ovary tumor incidence|MP:0008014,increased lung tumor incidence|MP:0008019,increased liver tumor incidence|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0010320,increased pituitary gland tumor incidence|MP:0012431,increased lymphoma incidence|MP:0014237,decreased tumor-free survival time
MGI:3581972	Cul9<tm1Jdec>	MP:0002169,no abnormal phenotype detected
MGI:6158509	Cuta<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1861916	Cux1<tm1Ejn>	MP:0000383,abnormal hair follicle orientation|MP:0001274,curly vibrissae|MP:0001278,kinked vibrissae|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0005367,renal/urinary system phenotype|MP:0005409,darkened coat color|MP:0008779,abnormal maternal behavior|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2388352	Cux1<tm1Mbu>	MP:0000367,abnormal coat/ hair morphology|MP:0000377,abnormal hair follicle morphology|MP:0000383,abnormal hair follicle orientation|MP:0000388,absent hair follicle inner root sheath|MP:0000416,sparse hair|MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001274,curly vibrissae|MP:0001282,short vibrissae|MP:0001575,cyanosis|MP:0001732,postnatal growth retardation|MP:0001953,respiratory failure|MP:0002271,abnormal pulmonary alveolar duct morphology|MP:0002324,abnormal alveolocapillary membrane morphology|MP:0003809,abnormal hair shaft morphology|MP:0005389,reproductive system phenotype|MP:0006363,absent auchene hairs|MP:0006364,absent awl hair|MP:0006365,absent guard hair|MP:0006366,absent zigzag hairs|MP:0010768,mortality/aging|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3586992	Cux1<tm1Rhsc>	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000706,small thymus|MP:0000711,thymus cortex hypoplasia|MP:0000715,decreased thymocyte number|MP:0001265,decreased body size|MP:0001279,wavy vibrissae|MP:0001601,abnormal myelopoiesis|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0003795,abnormal bone structure|MP:0005017,decreased B cell number|MP:0005092,decreased double-positive T cell number|MP:0005150,cachexia|MP:0008752,abnormal tumor necrosis factor level|MP:0010025,decreased total body fat amount|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012110,increased hair follicle number
MGI:1861702	Cux1<tm2Ejn>	MP:0000381,enlarged hair follicles|MP:0000414,alopecia|MP:0001732,postnatal growth retardation|MP:0001867,rhinitis|MP:0001922,reduced male fertility|MP:0002082,postnatal lethality|MP:0002412,increased susceptibility to bacterial infection|MP:0002780,decreased circulating testosterone level|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4353153	Cux2<Gt(OST440231)Lex>	MP:0000352,decreased cell proliferation|MP:0002151,abnormal neural tube morphology|MP:0003077,abnormal cell cycle|MP:0003993,abnormal ventral spinal root morphology|MP:0004100,abnormal spinal cord interneuron morphology|MP:0009689,abnormal neural tube ventricular layer morphology|MP:0009691,abnormal neural tube marginal layer morphology|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4429541	Cux2<tm1.1Nieto>	MP:0000788,abnormal cerebral cortex morphology|MP:0000789,thickened cerebral cortex|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0005238,increased brain size|MP:0008547,abnormal neocortex morphology|MP:0008947,increased neuron number
MGI:5906132	Cuzd1<tm1Bag>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0003718,maternal effect|MP:0005376,homeostasis/metabolism phenotype|MP:0006270,abnormal mammary gland growth during lactation|MP:0009506,abnormal mammary gland alveolus morphology|MP:0010174,decreased mammary gland epithelial cell proliferation|MP:0012075,impaired mammary gland growth during pregnancy
MGI:2448160	Cuzd1<tm1Ljm>	MP:0004761,increased susceptibility to induced pancreatitis|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:6152452	Cwc22<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0001914,hemorrhage|MP:0003054,spina bifida|MP:0005343,increased circulating aspartate transaminase level|MP:0009552,urinary bladder obstruction|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011625,cystolithiasis|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6342430	Cwc27<em1Bay>	MP:0003728,abnormal retina photoreceptor layer morphology|MP:0008519,thin retina outer plexiform layer|MP:0011965,decreased total retina thickness|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:5474764	Cwc27<tm1b(KOMP)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5007099	Cwc27<tm1Lex>	MP:0001732,postnatal growth retardation|MP:0001790,abnormal immune system physiology|MP:0004924,abnormal behavior|MP:0009642,abnormal blood homeostasis|MP:0010865,prenatal growth retardation|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6277995	Cwh43<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior
MGI:7437687	Cwh43<em1Mdj>	MP:0000822,abnormal brain ventricle morphology|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001891,hydrocephaly|MP:0010152,abnormal brain ependyma morphology|MP:0012676,dilated brain ventricle|MP:0030966,decreased brain ependyma motile cilium number
MGI:6361162	Cwh43<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6257601	Cx3cl1<em3(IMPC)Ics>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002757,decreased vertical activity|MP:0010378,increased respiratory quotient
MGI:6360180	Cx3cl1<tm1.1Yono>	MP:0001876,decreased inflammatory response|MP:0002376,abnormal dendritic cell physiology
MGI:2388041	Cx3cl1<tm1Lira>	MP:0000223,decreased monocyte cell number|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0011451,increased susceptibility to dopaminergic neuron neurotoxicity
MGI:3526846	Cx3cl1<tm1Sgs>	MP:0006058,decreased cerebral infarct size
MGI:6341929	Cx3cr1<em1(IMPC)Mbp>	MP:0002135,abnormal kidney morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0002989,small kidney|MP:0003068,enlarged kidney
MGI:2450885	Cx3cr1<tm1Ifc>	MP:0003799,impaired macrophage chemotaxis|MP:0005387,immune system phenotype|MP:0005671,abnormal response to transplant|MP:0010766,abnormal NK cell physiology
MGI:2670351	Cx3cr1<tm1Litt>	MP:0000136,abnormal microglial cell morphology|MP:0000223,decreased monocyte cell number|MP:0000753,paralysis|MP:0000754,paresis|MP:0000921,demyelination|MP:0001004,abnormal retina photoreceptor morphology|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0001847,brain inflammation|MP:0001876,decreased inflammatory response|MP:0002376,abnormal dendritic cell physiology|MP:0002442,abnormal leukocyte physiology|MP:0002864,abnormal ocular fundus morphology|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0003691,abnormal microglial cell physiology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003799,impaired macrophage chemotaxis|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004883,abnormal vascular wound healing|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005546,choroidal neovascularization|MP:0006051,brainstem hemorrhage|MP:0008045,decreased NK cell number|MP:0008108,abnormal small intestinal villus morphology|MP:0008126,increased dendritic cell number|MP:0008444,retina cone cell degeneration|MP:0008446,decreased retina cone cell number|MP:0008518,retina outer nuclear layer degeneration|MP:0008587,short photoreceptor outer segment|MP:0008918,microgliosis|MP:0009392,retina gliosis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010766,abnormal NK cell physiology|MP:0011451,increased susceptibility to dopaminergic neuron neurotoxicity|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0014059,abnormal photoreceptor connecting cilium morphology|MP:0031509,decreased vascular smooth muscle cell proliferation
MGI:3608773	Cx3cr1<tm1Zm>	MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0005546,choroidal neovascularization|MP:0006187,retina deposits|MP:0008515,thin retina outer nuclear layer|MP:0009333,abnormal splenocyte physiology
MGI:5569511	Cx3cr1<tm3(Hbegf)Litt>	MP:0002411,decreased susceptibility to bacterial infection
MGI:6277025	Cxadr<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000470,abnormal stomach morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001711,abnormal placenta morphology|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0002989,small kidney|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:5086256	Cxadr<tm1.1Ics>	MP:0000477,abnormal intestine morphology|MP:0000709,enlarged thymus|MP:0000714,increased thymocyte number|MP:0001413,abnormal response to new environment|MP:0001944,abnormal pancreas morphology|MP:0004247,small pancreas|MP:0005220,abnormal exocrine pancreas morphology|MP:0006267,abnormal intercalated disk morphology|MP:0009149,decreased pancreatic acinar cell number|MP:0009164,exocrine pancreas atrophy|MP:0010519,atrioventricular block|MP:0013221,pancreatic acinar-to-ductal metaplasia
MGI:3711226	Cxadr<tm1.1Mds>	MP:0000270,abnormal heart tube morphology|MP:0000275,heart hyperplasia|MP:0000285,abnormal heart valve morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004783,abnormal cardinal vein morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005380,embryo phenotype|MP:0005385,cardiovascular system phenotype|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011394,increased fetal cardiomyocyte proliferation
MGI:3587803	Cxadr<tm1Dvst>	MP:0000278,abnormal myocardial fiber morphology|MP:0000291,enlarged pericardium|MP:0001787,pericardial edema|MP:0003808,increased atrioventricular cushion size|MP:0004068,dilated dorsal aorta|MP:0004090,abnormal sarcomere morphology|MP:0004565,decreased myocardial fiber size|MP:0004783,abnormal cardinal vein morphology|MP:0005294,abnormal heart ventricle morphology|MP:0006035,abnormal mitochondrial morphology|MP:0006107,abnormal fetal atrioventricular canal morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014071,increased cardiac muscle glycogen level
MGI:3815066	Cxadr<tm1Know>	MP:0003141,cardiac fibrosis|MP:0003896,prolonged PR interval|MP:0005140,decreased cardiac muscle contractility|MP:0006267,abnormal intercalated disk morphology|MP:0010507,shortened RR interval|MP:0010510,absent P wave|MP:0010519,atrioventricular block
MGI:3711225	Cxadr<tm1Mds>	MP:0000270,abnormal heart tube morphology|MP:0004783,abnormal cardinal vein morphology|MP:0005294,abnormal heart ventricle morphology|MP:0010768,mortality/aging|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011646,abnormal sinoatrial valve morphology|MP:0011647,absent sinoatrial valve
MGI:3812340	Cxadr<tm1Mgot>	MP:0003896,prolonged PR interval|MP:0003928,increased heart rate variability|MP:0004114,abnormal atrioventricular node morphology|MP:0006141,abnormal atrioventricular node conduction|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3583765	Cxadr<tm1Rwf>	MP:0002652,thin myocardium|MP:0003222,increased cardiomyocyte apoptosis|MP:0005243,hemothorax|MP:0005244,hemopericardium|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3815069	Cxadr<tm2Know>	MP:0004086,absent heartbeat|MP:0005312,pericardial effusion|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2180678	Cxcl10<tm1Adl>	MP:0000921,demyelination|MP:0002444,abnormal T cell physiology|MP:0003009,abnormal cytokine secretion|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0006082,CNS inflammation|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008496,decreased IgG2a level|MP:0008567,decreased interferon-gamma secretion|MP:0008750,abnormal interferon level|MP:0009335,decreased splenocyte proliferation|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020925,increased susceptibility to Hepadnaviridae infection
MGI:7618973	Cxcl11<em1Groj>	MP:0004939,abnormal B cell morphology|MP:0005387,immune system phenotype|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:5575859	Cxcl12<tm1.1Fass>	MP:0003710,abnormal physiological neovascularization
MGI:5708165	Cxcl12<tm1.1(KOMP)Vlcg>	MP:0001120,abnormal uterus morphology|MP:0003179,thrombocytopenia|MP:0004906,enlarged uterus|MP:0009709,hydrometra|MP:0011100,preweaning lethality, complete penetrance
MGI:5486672	Cxcl12<tm1.1Sjm>	MP:0000221,decreased leukocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0002144,abnormal B cell differentiation|MP:0002396,abnormal hematopoietic system morphology/development|MP:0004810,decreased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0005397,hematopoietic system phenotype|MP:0009278,abnormal bone marrow cell physiology
MGI:5488499	Cxcl12<tm1.2Sjm>	MP:0011091,prenatal lethality, complete penetrance
MGI:1934384	Cxcl12<tm1Tng>	MP:0000260,abnormal angiogenesis|MP:0000262,poor arterial differentiation|MP:0000333,decreased bone marrow cell number|MP:0000849,abnormal cerebellum morphology|MP:0000873,thin external granule cell layer|MP:0001602,impaired myelopoiesis|MP:0002982,abnormal primordial germ cell migration|MP:0003631,nervous system phenotype|MP:0005592,abnormal vascular smooth muscle morphology|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0009577,abnormal developmental vascular remodeling|MP:0010418,perimembraneous ventricular septal defect|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0014273,abnormal skin vasculature morphology
MGI:3579534	Cxcl12<tm2Tng>	MP:0002169,no abnormal phenotype detected
MGI:4838646	Cxcl12<tm3.1(HBEGF/EGFP)Tng>	MP:0000333,decreased bone marrow cell number|MP:0001545,abnormal hematopoietic system physiology|MP:0001654,hepatic necrosis|MP:0002083,premature death|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002416,abnormal proerythroblast morphology|MP:0003888,liver hemorrhage|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0008208,decreased pro-B cell number|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008782,increased B cell apoptosis|MP:0008813,decreased common myeloid progenitor cell number|MP:0009278,abnormal bone marrow cell physiology
MGI:6378720	Cxcl13<em2(IMPC)H>	MP:0000218,increased leukocyte cell number|MP:0002606,increased basophil cell number|MP:0005013,increased lymphocyte cell number|MP:0010067,increased red blood cell distribution width
MGI:5640775	Cxcl13<m1Btlr>	MP:0004977,increased B-1 B cell number
MGI:2384500	Cxcl13<tm1Cys>	MP:0000696,abnormal Peyer's patch morphology|MP:0002219,decreased lymph node number|MP:0002362,abnormal spleen marginal zone morphology|MP:0002459,abnormal B cell physiology|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0008201,absent follicular dendritic cells|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008484,decreased spleen germinal center size|MP:0008522,abnormal lymph node germinal center morphology|MP:0009622,absent inguinal lymph nodes|MP:0009628,absent brachial lymph nodes|MP:0009630,absent axillary lymph nodes|MP:0014472,impaired B cell migration
MGI:2673341	Cxcl13<tm1Mmi>	MP:0002459,abnormal B cell physiology|MP:0003156,abnormal leukocyte migration|MP:0003628,abnormal leukocyte adhesion
MGI:7425623	Cxcl14<em1(IMPC)H>	MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level
MGI:5494300	Cxcl14<tm1.1Rih>	MP:0011090,perinatal lethality, incomplete penetrance
MGI:3699311	Cxcl14<tm1Bmsr>	MP:0001262,decreased body weight|MP:0001935,decreased litter size|MP:0005387,immune system phenotype|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3763373	Cxcl14<tm1Tha>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001783,decreased white adipose tissue amount|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0003884,decreased macrophage cell number|MP:0003918,decreased kidney weight|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005293,impaired glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0006094,increased fat cell size|MP:0009356,decreased liver triglyceride level|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011940,decreased food intake
MGI:2385827	Cxcl15<tm1Lira>	MP:0000222,decreased neutrophil cell number|MP:0002412,increased susceptibility to bacterial infection|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:4414661	Cxcl16<tm1Syon>	MP:0002411,decreased susceptibility to bacterial infection|MP:0003721,increased tumor growth/size|MP:0008040,decreased NK T cell number|MP:0008567,decreased interferon-gamma secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0008603,decreased circulating interleukin-4 level|MP:0008700,decreased interleukin-4 secretion|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5582438	Cxcl17<tm1b(EUCOMM)Wtsi>	MP:0001120,abnormal uterus morphology|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002135,abnormal kidney morphology|MP:0002599,increased mean platelet volume|MP:0002941,increased circulating alanine transaminase level|MP:0004906,enlarged uterus
MGI:6277055	Cxcl1<em1(IMPC)Mbp>	MP:0000063,decreased bone mineral density|MP:0000220,increased monocyte cell number|MP:0000702,enlarged lymph nodes|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0010124,decreased bone mineral content
MGI:5788425	Cxcl2<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:6156284	Cxcl5<em1(IMPC)Kmpc>	MP:0001399,hyperactivity|MP:0001489,decreased startle reflex|MP:0002941,increased circulating alanine transaminase level
MGI:5565192	Cxcl5<tm1.1Mkch>	MP:0000222,decreased neutrophil cell number|MP:0002411,decreased susceptibility to bacterial infection|MP:0005387,immune system phenotype|MP:0008561,decreased tumor necrosis factor secretion|MP:0008563,decreased interferon-alpha secretion|MP:0008655,decreased interleukin-1 alpha secretion|MP:0008706,decreased interleukin-6 secretion|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:4819800	Cxcl5<tm1Gscw>	MP:0000322,increased granulocyte number|MP:0002411,decreased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0008597,decreased circulating interleukin-6 level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0010209,abnormal circulating chemokine level
MGI:5636984	Cxcl9<tm1b(EUCOMM)Wtsi>	MP:0000222,decreased neutrophil cell number|MP:0001556,increased circulating HDL cholesterol level|MP:0005013,increased lymphocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0013278,decreased fasting circulating glucose level
MGI:3712351	Cxcl9<tm1Jmf>	MP:0001805,decreased IgG level|MP:0001876,decreased inflammatory response|MP:0002460,decreased immunoglobulin level|MP:0003009,abnormal cytokine secretion|MP:0005387,immune system phenotype|MP:0010768,mortality/aging
MGI:5497392	Cxcr1<tm1a(EUCOMM)Wtsi>	MP:0001258,decreased body length|MP:0002079,increased circulating insulin level|MP:0003179,thrombocytopenia|MP:0010124,decreased bone mineral content|MP:0013279,increased fasting circulating glucose level
MGI:3604601	Cxcr1<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:4842593	Cxcr2<tm1a(EUCOMM)Wtsi>	MP:0000194,increased circulating calcium level|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005011,increased eosinophil cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005292,improved glucose tolerance|MP:0005419,decreased circulating serum albumin level|MP:0005478,decreased circulating thyroxine level|MP:0005505,thrombocytosis|MP:0005553,increased circulating creatinine level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005568,increased circulating total protein level|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008346,increased gamma-delta T cell number|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level|MP:0010092,increased circulating magnesium level|MP:0010835,increased CD4-positive, alpha-beta memory T cell number|MP:0010838,increased CD8-positive, alpha-beta memory T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0011816,decreased pre-pro B cell number|MP:0013022,increased Ly6C high monocyte number|MP:0013025,increased Ly6C low monocyte number|MP:0013154,increased KLRG1+ CD8 alpha-beta T cell number|MP:0013157,increased KLRG1+ CD4 alpha-beta T cell number|MP:0013418,increased memory-marker gamma-delta T cell number|MP:0013427,increased memory-marker NK cell number|MP:0013523,increased memory-marker CD4-positive NK T cell number|MP:0013654,increased CD103-positive CD11b-low dendritic cell number|MP:0013772,increased effector memory T-helper cell number
MGI:3687177	Cxcr2<tm1(IL8RB)Dktr>	MP:0000218,increased leukocyte cell number|MP:0000322,increased granulocyte number|MP:0000601,small liver|MP:0002768,small adrenal glands|MP:0003918,decreased kidney weight|MP:0004953,decreased spleen weight|MP:0005387,immune system phenotype
MGI:1857153	Cxcr2<tm1Mwm>	MP:0000219,increased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000322,increased granulocyte number|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000920,abnormal myelination|MP:0000954,decreased oligodendrocyte progenitor number|MP:0000955,abnormal spinal cord morphology|MP:0001265,decreased body size|MP:0001273,decreased metastatic potential|MP:0001601,abnormal myelopoiesis|MP:0002281,abnormal respiratory mucosa goblet cell morphology|MP:0002334,abnormal airway responsiveness|MP:0002335,decreased airway responsiveness|MP:0002357,abnormal spleen white pulp morphology|MP:0002397,abnormal bone marrow morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002442,abnormal leukocyte physiology|MP:0002444,abnormal T cell physiology|MP:0002463,abnormal neutrophil physiology|MP:0002465,abnormal eosinophil physiology|MP:0002497,increased IgE level|MP:0002908,delayed wound healing|MP:0003009,abnormal cytokine secretion|MP:0003436,decreased susceptibility to induced arthritis|MP:0003447,decreased tumor growth/size|MP:0003448,abnormal tumor morphology|MP:0003917,increased kidney weight|MP:0004909,increased seminal vesicle weight|MP:0004928,increased epididymis weight|MP:0004952,increased spleen weight|MP:0004956,decreased thymus weight|MP:0005014,increased B cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005397,hematopoietic system phenotype|MP:0005398,decreased susceptibility to fungal infection|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0005542,cornea vascularization|MP:0008042,abnormal NK T cell physiology|MP:0008111,abnormal granulocyte differentiation|MP:0008542,enlarged cervical lymph nodes|MP:0008596,increased circulating interleukin-6 level|MP:0008719,impaired neutrophil recruitment|MP:0008720,impaired neutrophil chemotaxis|MP:0008721,abnormal chemokine level|MP:0008751,abnormal interleukin level|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0010373,myeloid hyperplasia|MP:0011225,lymph node medullary cord hyperplasia|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:5532705	Cxcr2<tm1Rmra>	MP:0001263,weight loss|MP:0002463,abnormal neutrophil physiology
MGI:5478545	Cxcr3<tm1Arsa>	MP:0002169,no abnormal phenotype detected
MGI:3604545	Cxcr3<tm1Dgen>	MP:0005559,increased circulating glucose level
MGI:4361116	Cxcr3<tm1Raks>	MP:0001859,kidney inflammation|MP:0002871,albuminuria|MP:0005166,decreased susceptibility to injury|MP:0005554,decreased circulating creatinine level|MP:0005566,decreased blood urea nitrogen level
MGI:2180682	Cxcr3<tm1Wwh>	MP:0001861,lung inflammation|MP:0002020,increased tumor incidence|MP:0003426,pulmonary interstitial fibrosis|MP:0003710,abnormal physiological neovascularization|MP:0003799,impaired macrophage chemotaxis|MP:0004751,increased length of allograft survival|MP:0008750,abnormal interferon level|MP:0009858,abnormal cellular extravasation|MP:0020914,decreased susceptibility to Riboviria infection|MP:0031023,decreased susceptibility to Riboviria infection induced morbidity/mortality
MGI:5297422	Cxcr4<b2b220Clo>	MP:0000519,hydronephrosis|MP:0004017,duplex kidney|MP:0004158,right aortic arch|MP:0004159,double aortic arch|MP:0006115,aortic valve atresia|MP:0008528,polycystic kidney|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010463,aorta stenosis|MP:0010485,aortic arch hypoplasia
MGI:6430655	Cxcr4<em1(IMPC)Mbp>	MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001289,persistence of hyaloid vascular system|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001340,abnormal eyelid morphology|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002060,abnormal skin morphology|MP:0002109,abnormal limb morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0003068,enlarged kidney|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0005013,increased lymphocyte cell number|MP:0005554,decreased circulating creatinine level|MP:0011100,preweaning lethality, complete penetrance
MGI:5301553	Cxcr4<tm1.1Bala>	MP:0000221,decreased leukocyte cell number|MP:0000685,abnormal immune system morphology|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000716,abnormal immune system cell morphology|MP:0001790,abnormal immune system physiology|MP:0002339,abnormal lymph node morphology|MP:0002344,abnormal lymph node B cell domain morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002461,increased immunoglobulin level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002722,abnormal immune system organ morphology|MP:0004953,decreased spleen weight|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005065,abnormal neutrophil morphology|MP:0008044,increased NK cell number|MP:0008045,decreased NK cell number|MP:0008073,abnormal CD4-positive, alpha-beta T cell number|MP:0008210,increased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008783,decreased B cell apoptosis|MP:0010766,abnormal NK cell physiology|MP:0011518,abnormal cell chemotaxis
MGI:1934166	Cxcr4<tm1Qma>	MP:0000333,decreased bone marrow cell number|MP:0000532,kidney vascular congestion|MP:0000533,kidney hemorrhage|MP:0000729,abnormal myogenesis|MP:0000849,abnormal cerebellum morphology|MP:0000853,absent cerebellar foliation|MP:0000873,thin external granule cell layer|MP:0000885,ectopic Purkinje cell|MP:0001177,atelectasis|MP:0001265,decreased body size|MP:0001602,impaired myelopoiesis|MP:0003090,abnormal muscle precursor cell migration|MP:0003633,abnormal nervous system physiology|MP:0008208,decreased pro-B cell number|MP:0011090,perinatal lethality, incomplete penetrance|MP:0020935,decreased susceptibility to Retroviridae infection|MP:0031038,increased susceptibility to Retroviridae infection induced morbidity/mortality
MGI:1934442	Cxcr4<tm1Tng>	MP:0000260,abnormal angiogenesis|MP:0000262,poor arterial differentiation|MP:0000266,abnormal heart morphology|MP:0001603,failure of myelopoiesis|MP:0001622,abnormal vasculogenesis|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002982,abnormal primordial germ cell migration|MP:0003631,nervous system phenotype|MP:0005092,decreased double-positive T cell number|MP:0005380,embryo phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0005592,abnormal vascular smooth muscle morphology|MP:0009577,abnormal developmental vascular remodeling|MP:0010402,ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010428,abnormal heart right ventricle outflow tract morphology|MP:0010617,thick mitral valve cusps|MP:0011087,neonatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0014273,abnormal skin vasculature morphology|MP:0031155,small intestine hemorrhage
MGI:4836915	Cxcr4<tm1Yiw>	MP:0000715,decreased thymocyte number|MP:0003156,abnormal leukocyte migration|MP:0003436,decreased susceptibility to induced arthritis
MGI:1934407	Cxcr4<tm1Yzo>	MP:0000281,abnormal interventricular septum morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0001602,impaired myelopoiesis|MP:0002144,abnormal B cell differentiation|MP:0002192,hydrops fetalis|MP:0002401,abnormal lymphopoiesis|MP:0002459,abnormal B cell physiology|MP:0002982,abnormal primordial germ cell migration|MP:0003631,nervous system phenotype|MP:0004200,decreased fetal size|MP:0005460,abnormal leukopoiesis|MP:0008392,decreased primordial germ cell number|MP:0011089,perinatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3525214	Cxcr4<tm2Yzo>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0002389,abnormal Peyer's patch follicle morphology|MP:0002460,decreased immunoglobulin level|MP:0002833,increased heart weight|MP:0003822,decreased left ventricle systolic pressure|MP:0004978,decreased B-1 B cell number|MP:0005013,increased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005290,decreased oxygen consumption|MP:0005330,cardiomyopathy|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0005658,increased susceptibility to diet-induced obesity|MP:0006138,congestive heart failure|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008098,decreased plasma cell number|MP:0008207,decreased B-2 B cell number|MP:0008211,decreased mature B cell number|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009118,increased white fat cell size|MP:0009119,increased brown fat cell size|MP:0009285,increased gonadal fat pad weight|MP:0009298,increased mesenteric fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0010024,increased total body fat amount|MP:0010934,increased subcutaneous adipose tissue amount|MP:0011049,impaired adaptive thermogenesis|MP:0011749,perivascular fibrosis|MP:0014145,increased white adipose tissue mass|MP:0014170,increased brown adipose tissue mass|MP:0020202,abnormal macrophage cell number|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4878934	Cxcr4<tm3.1Yzo>	MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0001602,impaired myelopoiesis|MP:0001614,abnormal blood vessel morphology|MP:0002459,abnormal B cell physiology|MP:0008208,decreased pro-B cell number|MP:0011089,perinatal lethality, complete penetrance
MGI:5903012	Cxcr5<tm1.1Namt>	MP:0002169,no abnormal phenotype detected|MP:0005363,decreased susceptibility to prion infection|MP:0005387,immune system phenotype|MP:0008200,decreased follicular dendritic cell number|MP:0010740,abnormal dendritic cell chemotaxis
MGI:2158677	Cxcr5<tm1Lipp>	MP:0000696,abnormal Peyer's patch morphology|MP:0002831,absent Peyer's patches|MP:0003156,abnormal leukocyte migration|MP:0005014,increased B cell number|MP:0008024,absent lymph nodes|MP:0008201,absent follicular dendritic cells|MP:0008471,abnormal spleen primary B follicle morphology|MP:0008472,abnormal spleen secondary B follicle morphology|MP:0008474,absent spleen germinal center|MP:0009622,absent inguinal lymph nodes|MP:0009628,absent brachial lymph nodes|MP:0009630,absent axillary lymph nodes|MP:0009633,absent cervical lymph nodes
MGI:3710094	Cxcr6<tm1Lex>	MP:0005389,reproductive system phenotype|MP:0006283,increased medulloblastoma incidence
MGI:3613526	Cxcr6<tm1Litt>	MP:0002169,no abnormal phenotype detected
MGI:3612091	Cxv1<F/St>	MP:0001819,abnormal immune cell physiology
MGI:3612096	Cxv2<DBA/2J>	MP:0001819,abnormal immune cell physiology
MGI:2654854	Cxxc1<tm1Skk>	MP:0001696,failure to gastrulate|MP:0005032,abnormal ectoplacental cone morphology|MP:0009687,empty decidua capsularis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011184,absent embryonic epiblast|MP:0013207,absent endoderm
MGI:5752623	Cxxc1<tm2.1Skk>	MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001940,testis hypoplasia|MP:0002216,abnormal seminiferous tubule morphology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0008898,abnormal acrosome morphology|MP:0009451,abnormal chromosomal synapsis|MP:0012167,abnormal epigenetic regulation of gene expression|MP:0014052,increased male germ cell apoptosis|MP:0014618,increased spermatogonia number
MGI:5776370	Cxxc4<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0005554,decreased circulating creatinine level|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:7606855	Cxxc4<em1Mmda>	MP:0005389,reproductive system phenotype|MP:0008957,abnormal placenta junctional zone morphology|MP:0011519,abnormal placenta labyrinth size
MGI:7606854	Cxxc5<em1Mmda>	MP:0005389,reproductive system phenotype|MP:0008957,abnormal placenta junctional zone morphology|MP:0011519,abnormal placenta labyrinth size
MGI:5703924	Cxxc5<tm1Kych>	MP:0000062,increased bone mineral density|MP:0000149,abnormal scapula morphology|MP:0000150,abnormal rib morphology|MP:0000439,enlarged cranium|MP:0002115,abnormal limb bone morphology|MP:0003072,abnormal metatarsal bone morphology|MP:0004148,increased compact bone thickness|MP:0004348,long femur|MP:0004703,abnormal vertebral column morphology|MP:0005605,increased bone mass|MP:0008159,increased diameter of fibula|MP:0008162,increased diameter of tibia|MP:0010123,increased bone mineral content|MP:0010868,increased bone trabecula number|MP:0011504,abnormal limb long bone morphology|MP:0011710,enhanced osteoblast differentiation|MP:0013149,macrodactyly|MP:0013631,decreased bone trabecular spacing|MP:0020011,increased bone mineral density of femur|MP:0020039,increased bone ossification|MP:0030487,abnormal osteocyte dendritic process morphology
MGI:1856839	cy	MP:0000137,abnormal vertebrae morphology|MP:0000462,abnormal digestive system morphology|MP:0000489,abnormal large intestine morphology|MP:0002111,abnormal tail morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0003051,curly tail|MP:0003119,abnormal digestive system development|MP:0004703,abnormal vertebral column morphology|MP:0005381,digestive/alimentary phenotype|MP:0008787,abnormal tailgut morphology
MGI:5588290	Cyb561a3<tm2b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0013279,increased fasting circulating glucose level
MGI:5692758	Cyb561d2<tm1b(EUCOMM)Wtsi>	MP:0000689,abnormal spleen morphology|MP:0005634,decreased circulating sodium level|MP:0011959,abnormal eye posterior chamber depth
MGI:4432734	Cyb561<tm1a(EUCOMM)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0001413,abnormal response to new environment|MP:0002075,abnormal coat/hair pigmentation|MP:0002608,increased hematocrit|MP:0002896,abnormal bone mineralization|MP:0003131,increased erythrocyte cell number|MP:0003795,abnormal bone structure|MP:0004129,abnormal respiratory quotient|MP:0004924,abnormal behavior|MP:0005419,decreased circulating serum albumin level|MP:0005564,increased hemoglobin content|MP:0005567,decreased circulating total protein level|MP:0006241,abnormal placement of pupils|MP:0008806,increased circulating amylase level|MP:0008810,increased circulating iron level|MP:0010087,increased circulating fructosamine level|MP:0010092,increased circulating magnesium level
MGI:5636891	Cyb561<tm1b(EUCOMM)Wtsi>	MP:0000274,enlarged heart|MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0000455,abnormal maxilla morphology|MP:0000745,tremors|MP:0001322,abnormal iris morphology|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001552,increased circulating triglyceride level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005287,narrow eye opening|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0005567,decreased circulating total protein level|MP:0008806,increased circulating amylase level|MP:0010024,increased total body fat amount|MP:0010097,abnormal retina blood vessel morphology|MP:0010124,decreased bone mineral content|MP:0011496,abnormal head size|MP:0011999,abnormal tail length|MP:0013278,decreased fasting circulating glucose level
MGI:7608255	Cyb5a<em1(IMPC)Bay>	MP:0001529,abnormal vocalization
MGI:3826663	Cyb5a<tm1Wolf>	MP:0005370,liver/biliary system phenotype|MP:0008875,abnormal xenobiotic pharmacokinetics
MGI:6454973	Cyb5b<tm1b(EUCOMM)Hmgu>	MP:0001404,no spontaneous movement|MP:0011100,preweaning lethality, complete penetrance
MGI:5471394	Cyb5d1<tm1.1(KOMP)Vlcg>	MP:0000218,increased leukocyte cell number|MP:0000947,convulsive seizures|MP:0001399,hyperactivity|MP:0001486,abnormal startle reflex|MP:0002100,abnormal tooth morphology|MP:0002702,decreased circulating free fatty acids level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005419,decreased circulating serum albumin level|MP:0005633,increased circulating sodium level|MP:0010025,decreased total body fat amount
MGI:5515784	Cyb5d2<tm1.1(KOMP)Wtsi>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002833,increased heart weight|MP:0005633,increased circulating sodium level|MP:0020870,decreased thigmotaxis
MGI:4420037	Cyb5r1<tm1a(KOMP)Wtsi>	MP:0002080,prenatal lethality
MGI:7596535	Cyb5r1<tm1c(KOMP)Wtsi>	MP:0002080,prenatal lethality
MGI:4455692	Cyb5r2<tm1a(EUCOMM)Hmgu>	MP:0005384,cellular phenotype
MGI:5471295	Cyb5r3<tm1b(KOMP)Wtsi>	MP:0001304,cataract|MP:0011100,preweaning lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:6378817	Cyb5r3<tm1c(KOMP)Wtsi>	MP:0000223,decreased monocyte cell number|MP:0003025,increased vasoconstriction|MP:0004875,increased mean systemic arterial blood pressure|MP:0005333,decreased heart rate|MP:0005590,increased vasodilation|MP:0005591,decreased vasodilation|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0012045,increased susceptibility to hypertension
MGI:3050973	Cyb5r4<tm1Hfb>	MP:0001548,hyperlipidemia|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0010025,decreased total body fat amount|MP:0011939,increased food intake
MGI:3526726	Cyba<nmf333>	MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0001846,increased inflammatory response|MP:0001861,lung inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0002978,absent otoliths|MP:0004813,absent linear vestibular evoked potential|MP:0005044,sepsis|MP:0005191,head tilt|MP:0005377,hearing/vestibular/ear phenotype|MP:0013799,abnormal intestinal goblet cell physiology
MGI:4432216	Cyba<tm1a(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001406,abnormal gait|MP:0001408,stereotypic behavior|MP:0001512,trunk curl|MP:0001523,impaired righting response|MP:0002599,increased mean platelet volume|MP:0003960,increased lean body mass|MP:0005566,decreased blood urea nitrogen level|MP:0008805,decreased circulating amylase level
MGI:5775909	Cyba<tm1Dgh>	MP:0000230,abnormal systemic arterial blood pressure|MP:0001828,abnormal T cell activation|MP:0001876,decreased inflammatory response|MP:0003186,abnormal redox activity|MP:0003633,abnormal nervous system physiology|MP:0003929,decreased heart rate variability|MP:0004183,abnormal sympathetic nervous system physiology|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005333,decreased heart rate|MP:0010697,abnormal systemic arterial blood pressure regulation
MGI:6147802	Cybb<tm1.1Abk>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000691,enlarged spleen|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001454,abnormal cued conditioning behavior|MP:0001556,increased circulating HDL cholesterol level|MP:0002727,decreased circulating insulin level|MP:0003983,decreased cholesterol level|MP:0005238,increased brain size|MP:0005318,decreased triglyceride level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009269,decreased fat cell size|MP:0009288,increased epididymal fat pad weight|MP:0010760,abnormal macrophage chemotaxis|MP:0013278,decreased fasting circulating glucose level
MGI:1857284	Cybb<tm1Din>	MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000278,abnormal myocardial fiber morphology|MP:0000286,abnormal mitral valve morphology|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000352,decreased cell proliferation|MP:0000511,abnormal intestinal mucosa morphology|MP:0001262,decreased body weight|MP:0001273,decreased metastatic potential|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001625,cardiac hypertrophy|MP:0001698,decreased embryo size|MP:0001790,abnormal immune system physiology|MP:0001846,increased inflammatory response|MP:0002128,abnormal blood circulation|MP:0002207,abnormal long-term potentiation|MP:0002406,increased susceptibility to infection|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology|MP:0002500,granulomatous inflammation|MP:0002624,abnormal tricuspid valve morphology|MP:0002745,abnormal atrioventricular valve morphology|MP:0002757,decreased vertical activity|MP:0002843,decreased systemic arterial blood pressure|MP:0002922,decreased post-tetanic potentiation|MP:0003186,abnormal redox activity|MP:0003447,decreased tumor growth/size|MP:0003620,oliguria|MP:0003957,abnormal nitric oxide homeostasis|MP:0003984,embryonic growth retardation|MP:0005088,increased acute inflammation|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005525,increased renal plasma flow rate|MP:0005526,decreased renal plasma flow rate|MP:0005527,increased renal glomerular filtration rate|MP:0005530,decreased renal vascular resistance|MP:0006042,increased apoptosis|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006316,increased urine sodium level|MP:0006317,decreased urine sodium level|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0009674,decreased birth weight|MP:0009873,abnormal aorta tunica media morphology|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010412,atrioventricular septal defect|MP:0010484,bicuspid aortic valve|MP:0010617,thick mitral valve cusps|MP:0010759,decreased right ventricle systolic pressure|MP:0010792,abnormal stomach mucosa morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011470,increased urine creatinine level|MP:0011475,abnormal glycosaminoglycan level|MP:0011741,increased urine nitrite level
MGI:5548926	Cybb<tm2b(KOMP)Wtsi>	MP:0002591,decreased mean corpuscular volume|MP:0004952,increased spleen weight
MGI:4363837	Cybc1<tm1a(KOMP)Wtsi>	MP:0001262,decreased body weight|MP:0005560,decreased circulating glucose level|MP:0005628,decreased circulating potassium level|MP:0005633,increased circulating sodium level|MP:0008805,decreased circulating amylase level|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5637161	Cybrd1<tm1b(EUCOMM)Hmgu>	MP:0001556,increased circulating HDL cholesterol level
MGI:3702743	Cybrd1<tm1Nca>	MP:0002981,increased liver weight|MP:0008743,decreased liver iron level
MGI:7425624	Cyc1<em1(IMPC)Bay>	MP:0001698,decreased embryo size|MP:0003886,abnormal embryonic epiblast morphology|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0003984,embryonic growth retardation|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:3576030	cycsp	MP:0003051,curly tail|MP:0009890,cleft secondary palate
MGI:5581696	Cycs<tm1Arte>	MP:0005384,cellular phenotype|MP:0010768,mortality/aging
MGI:3581449	Cycs<tm1Mak>	MP:0000221,decreased leukocyte cell number|MP:0000238,absent pre-B cells|MP:0000633,abnormal pituitary gland morphology|MP:0000693,spleen hyperplasia|MP:0000746,weakness|MP:0000755,hindlimb paralysis|MP:0000784,forebrain hypoplasia|MP:0000788,abnormal cerebral cortex morphology|MP:0000837,abnormal hypothalamus morphology|MP:0000898,midbrain hyperplasia|MP:0000914,exencephaly|MP:0000919,cranioschisis|MP:0001395,bidirectional circling|MP:0001524,impaired limb coordination|MP:0001823,thymus hypoplasia|MP:0001891,hydrocephaly|MP:0001916,intracerebral hemorrhage|MP:0002083,premature death|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0003644,thymus atrophy|MP:0004952,increased spleen weight|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005150,cachexia|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0020527,small thalamus|MP:0030049,prominent forehead
MGI:2154447	Cycs<tm1Wlm>	MP:0001648,abnormal apoptosis|MP:0001698,decreased embryo size|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003984,embryonic growth retardation|MP:0010954,abnormal cellular respiration|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2183657	Cyct<tm1Jlm>	MP:0000242,impaired fertilization|MP:0001147,small testis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002674,abnormal sperm motility|MP:0002687,oligozoospermia|MP:0003205,testicular atrophy|MP:0010959,abnormal oxidative phosphorylation
MGI:3521835	Cyfip1<Gt(XG769)Byg>	MP:0000929,open neural tube|MP:0003400,kinked neural tube|MP:0003794,delayed somite formation|MP:0003885,abnormal rostral-caudal body axis extension|MP:0009768,impaired somite development|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:3689298	Cyfip1<l7Rl1-2R>	MP:0000929,open neural tube|MP:0003400,kinked neural tube|MP:0003794,delayed somite formation|MP:0003885,abnormal rostral-caudal body axis extension|MP:0009768,impaired somite development|MP:0011091,prenatal lethality, complete penetrance|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:3689299	Cyfip1<l7Rl1-3R>	MP:0000929,open neural tube|MP:0003400,kinked neural tube|MP:0003794,delayed somite formation|MP:0003885,abnormal rostral-caudal body axis extension|MP:0009768,impaired somite development|MP:0011091,prenatal lethality, complete penetrance|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:5751466	Cyfip1<tm1Yhj>	MP:0001362,abnormal anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001898,abnormal long-term depression|MP:0002206,abnormal CNS synaptic transmission|MP:0002919,enhanced paired-pulse facilitation|MP:0009455,enhanced cued conditioning behavior|MP:0011092,embryonic lethality, complete penetrance
MGI:5527294	Cyfip2<M1N>	MP:0009758,impaired behavioral response to cocaine|MP:0009936,abnormal dendritic spine morphology|MP:0014376,decreased miniature excitatory postsynaptic current frequency
MGI:4434196	Cyfip2<tm1a(EUCOMM)Wtsi>	MP:0000841,abnormal hindbrain morphology|MP:0002169,no abnormal phenotype detected|MP:0003584,bifid ureter|MP:0003586,dilated ureter|MP:0004017,duplex kidney|MP:0010484,bicuspid aortic valve|MP:0010490,abnormal inferior vena cava valve morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013848,subcutaneous edema
MGI:5085782	Cyfip2<tm1(KOMP)Vlcg>	MP:0001362,abnormal anxiety-related response|MP:0001399,hyperactivity|MP:0001489,decreased startle reflex|MP:0003631,nervous system phenotype|MP:0009141,increased prepulse inhibition|MP:0009936,abnormal dendritic spine morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:5605810	Cygb<tm1b(EUCOMM)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002135,abnormal kidney morphology|MP:0002833,increased heart weight|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:5140136	Cygb<tm1Nka>	MP:0000609,abnormal liver physiology|MP:0003721,increased tumor growth/size|MP:0004499,increased incidence of tumors by chemical induction|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0014755,increased tumor cell proliferation
MGI:5575764	Cygb<tm1Ppam>	MP:0000352,decreased cell proliferation|MP:0003674,oxidative stress|MP:0006042,increased apoptosis|MP:0009415,skeletal muscle degeneration|MP:0011808,abnormal myoblast differentiation|MP:0012186,abnormal muscle precursor cell physiology|MP:0013160,impaired muscle regeneration
MGI:1856698	Cyl	MP:0002080,prenatal lethality|MP:0002111,abnormal tail morphology|MP:0003051,curly tail
MGI:7628714	Cylc1<em1Chnsr>	MP:0001922,reduced male fertility|MP:0004542,impaired acrosome reaction|MP:0005389,reproductive system phenotype|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009647,decreased fertilization frequency
MGI:7628716	Cylc1<em2Chnsr>	MP:0001922,reduced male fertility|MP:0005389,reproductive system phenotype|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome
MGI:3761624	Cyld<tm1.1Awai>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0002362,abnormal spleen marginal zone morphology|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002459,abnormal B cell physiology|MP:0002495,increased IgA level|MP:0004816,abnormal class switch recombination|MP:0004939,abnormal B cell morphology|MP:0004978,decreased B-1 B cell number|MP:0005014,increased B cell number|MP:0008136,enlarged Peyer's patches|MP:0008173,increased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008186,increased pro-B cell number|MP:0008215,decreased immature B cell number|MP:0008498,decreased IgG3 level|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level
MGI:4819959	Cyld<tm1.1Gmos>	MP:0000585,kinked tail|MP:0000592,short tail|MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001575,cyanosis|MP:0002276,abnormal lung interstitium morphology|MP:0002327,abnormal respiratory function|MP:0003641,small lung|MP:0009703,decreased birth body size|MP:0011087,neonatal lethality, complete penetrance|MP:0011143,thick lung-associated mesenchyme|MP:0011707,impaired fibroblast cell migration
MGI:3761621	Cyld<tm1Awai>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0004978,decreased B-1 B cell number|MP:0005014,increased B cell number|MP:0008136,enlarged Peyer's patches|MP:0008171,abnormal mature B cell morphology|MP:0008215,decreased immature B cell number
MGI:4819961	Cyld<tm1Gmos>	MP:0002169,no abnormal phenotype detected
MGI:3722146	Cyld<tm1Jdgl>	MP:0002411,decreased susceptibility to bacterial infection|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:3528559	Cyld<tm1Lex>	MP:0000199,abnormal circulating serum albumin level|MP:0000488,abnormal intestinal epithelium morphology|MP:0000495,abnormal colon morphology|MP:0000708,thymus hyperplasia|MP:0001263,weight loss|MP:0001505,hunched posture|MP:0001845,abnormal inflammatory response|MP:0002083,premature death|MP:0003282,gastric ulcer|MP:0004499,increased incidence of tumors by chemical induction|MP:0005387,immune system phenotype|MP:0008537,increased susceptibility to induced colitis
MGI:3714113	Cyld<tm1Ref>	MP:0000351,increased cell proliferation|MP:0001222,epidermal hyperplasia|MP:0002051,increased skin papilloma incidence|MP:0005387,immune system phenotype|MP:0009582,abnormal keratinocyte proliferation|MP:0009583,increased keratinocyte proliferation
MGI:3664438	Cyld<tm1Scs>	MP:0002144,abnormal B cell differentiation|MP:0005091,increased double-positive T cell number|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006387,abnormal T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:5464022	Cyp11a1<tm1.1Bcc>	MP:0000639,abnormal adrenal gland morphology|MP:0001748,increased circulating adrenocorticotropin level|MP:0003963,abnormal corticosterone level|MP:0006035,abnormal mitochondrial morphology|MP:0008291,abnormal adrenocortical cell morphology|MP:0008505,absent adrenal chromaffin cells|MP:0011087,neonatal lethality, complete penetrance|MP:0012574,decreased noradrenaline level|MP:0030762,decreased adrenaline level
MGI:2183813	Cyp11a1<tm1Bcc>	MP:0000646,enlarged adrenocortical cells|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001159,absent prostate gland|MP:0001402,decreased locomotor activity|MP:0001547,abnormal lipid level|MP:0001732,postnatal growth retardation|MP:0001748,increased circulating adrenocorticotropin level|MP:0001776,abnormal circulating sodium level|MP:0001939,secondary sex reversal|MP:0002216,abnormal seminiferous tubule morphology|MP:0002269,muscular atrophy|MP:0002631,abnormal epididymis morphology|MP:0002665,decreased circulating corticosterone level|MP:0002667,decreased circulating aldosterone level|MP:0002668,abnormal circulating potassium level|MP:0002670,absent scrotum|MP:0002768,small adrenal glands|MP:0002769,abnormal vas deferens morphology|MP:0002770,absent bulbourethral gland|MP:0002771,absent prostate gland anterior lobe|MP:0004933,abnormal epididymis epithelium morphology|MP:0008288,abnormal adrenal cortex morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011940,decreased food intake
MGI:5692883	Cyp11a1<tm1b(EUCOMM)Hmgu>	MP:0000602,dilated liver sinusoidal space|MP:0003253,dilated bile duct|MP:0004269,abnormal optic cup morphology|MP:0005244,hemopericardium|MP:0011100,preweaning lethality, complete penetrance|MP:0013834,thin hypoglossal nerve|MP:0013840,absent segment of posterior cerebral artery|MP:0014087,retrolental blood
MGI:4442187	Cyp11a1<tm1(GFP/cre)Pzg>	MP:0002169,no abnormal phenotype detected
MGI:3778793	Cyp11a1<tm2Bcc>	MP:0000639,abnormal adrenal gland morphology|MP:0000642,enlarged adrenal glands|MP:0002665,decreased circulating corticosterone level|MP:0002909,abnormal adrenal gland physiology|MP:0005389,reproductive system phenotype|MP:0005418,abnormal circulating hormone level|MP:0006035,abnormal mitochondrial morphology|MP:0006414,decreased T cell apoptosis|MP:0008288,abnormal adrenal cortex morphology|MP:0008293,abnormal adrenal gland zona glomerulosa morphology|MP:0008294,abnormal adrenal gland zona fasciculata morphology|MP:0008770,decreased survivor rate
MGI:3841929	Cyp11b1<tm1Chjk>	MP:0000635,pituitary gland hyperplasia|MP:0000642,enlarged adrenal glands|MP:0001134,absent corpus luteum|MP:0001748,increased circulating adrenocorticotropin level|MP:0001926,female infertility|MP:0002176,increased brain weight|MP:0002665,decreased circulating corticosterone level|MP:0002727,decreased circulating insulin level|MP:0002833,increased heart weight|MP:0002981,increased liver weight|MP:0003353,decreased circulating renin level|MP:0003917,increased kidney weight|MP:0004119,hypokalemia|MP:0004906,enlarged uterus|MP:0004956,decreased thymus weight|MP:0005293,impaired glucose tolerance|MP:0006144,increased systemic arterial systolic blood pressure|MP:0009078,adrenal gland hyperplasia|MP:0009082,uterus cyst|MP:0009092,endometrium hyperplasia|MP:0009221,uterus adenomyosis|MP:0010025,decreased total body fat amount|MP:0011541,decreased urine aldosterone level|MP:0011546,increased urine progesterone level|MP:0011550,decreased urine corticosterone level|MP:0011553,increased urine deoxycorticosterone level|MP:0014286,increased adrenal gland zona fasciculata size
MGI:3582593	Cyp11b2<tm1Hsk>	MP:0001262,decreased body weight|MP:0001596,hypotension|MP:0001745,increased circulating corticosterone level|MP:0002667,decreased circulating aldosterone level|MP:0003020,decreased circulating chloride level|MP:0003352,increased circulating renin level|MP:0005582,increased renin activity|MP:0005627,increased circulating potassium level|MP:0008288,abnormal adrenal cortex morphology|MP:0008291,abnormal adrenocortical cell morphology|MP:0008293,abnormal adrenal gland zona glomerulosa morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031232,increased circulating angiotensin II level
MGI:3842189	Cyp11b2<tm2Hsk>	MP:0001762,polyuria|MP:0002842,increased systemic arterial blood pressure|MP:0002988,decreased urine osmolality|MP:0003141,cardiac fibrosis|MP:0003620,oliguria|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003674,oxidative stress|MP:0004119,hypokalemia|MP:0004564,increased myocardial fiber size|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008055,increased urine osmolality|MP:0011942,decreased fluid intake
MGI:5605834	Cyp17a1<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000198,decreased circulating phosphate level|MP:0001402,decreased locomotor activity|MP:0001529,abnormal vocalization|MP:0001556,increased circulating HDL cholesterol level|MP:0002834,decreased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005178,increased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0009198,abnormal male genitalia morphology|MP:0009204,absent external male genitalia|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0013279,increased fasting circulating glucose level
MGI:3047328	Cyp17a1<tm1Mell>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3722780	Cyp17a1<tm1Vpap>	MP:0001922,reduced male fertility|MP:0002566,abnormal sexual interaction|MP:0002675,asthenozoospermia|MP:0002780,decreased circulating testosterone level|MP:0004179,transmission ratio distortion|MP:0008892,abnormal sperm flagellum morphology|MP:0008995,early reproductive senescence|MP:0011385,abnormal testosterone level
MGI:4418756	Cyp19a1<tm1.1Shah>	MP:0002169,no abnormal phenotype detected
MGI:6163776	Cyp19a1<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0000745,tremors|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0002965,increased circulating serum albumin level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0004151,decreased circulating iron level|MP:0005016,decreased lymphocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005505,thrombocytosis|MP:0005565,increased blood urea nitrogen level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010024,increased total body fat amount|MP:0013279,increased fasting circulating glucose level
MGI:2154536	Cyp19a1<tm1Esi>	MP:0000218,increased leukocyte cell number|MP:0000230,abnormal systemic arterial blood pressure|MP:0000321,increased bone marrow cell number|MP:0000322,increased granulocyte number|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000613,abnormal salivary gland morphology|MP:0000659,prostate gland hyperplasia|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0001121,uterus hypoplasia|MP:0001126,abnormal ovary morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001134,absent corpus luteum|MP:0001145,abnormal male reproductive system morphology|MP:0001152,increased Leydig cell number|MP:0001156,abnormal spermatogenesis|MP:0001260,increased body weight|MP:0001261,obese|MP:0001380,decreased male mating frequency|MP:0001441,increased grooming behavior|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001859,kidney inflammation|MP:0001870,salivary gland inflammation|MP:0001919,abnormal reproductive system physiology|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001932,abnormal spermiogenesis|MP:0002075,abnormal coat/hair pigmentation|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002211,abnormal primary sex determination|MP:0002216,abnormal seminiferous tubule morphology|MP:0002359,abnormal spleen germinal center morphology|MP:0002493,increased IgG level|MP:0002572,abnormal emotion/affect behavior|MP:0002626,increased heart rate|MP:0002628,hepatic steatosis|MP:0002631,abnormal epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002781,increased circulating testosterone level|MP:0002808,abnormal barbering behavior|MP:0002962,increased urine protein level|MP:0003313,abnormal locomotor activation|MP:0003509,increased circulating dihydrotestosterone level|MP:0003511,abnormal labium morphology|MP:0003529,enlarged clitoris|MP:0003572,abnormal uterus development|MP:0003607,abnormal prostate gland physiology|MP:0003725,increased autoantibody level|MP:0003929,decreased heart rate variability|MP:0003961,decreased lean body mass|MP:0004184,abnormal baroreceptor physiology|MP:0004738,abnormal auditory brainstem response|MP:0004834,ovary hemorrhage|MP:0004852,decreased testis weight|MP:0004876,decreased mean systemic arterial blood pressure|MP:0004901,decreased male germ cell number|MP:0004905,decreased uterus weight|MP:0004909,increased seminal vesicle weight|MP:0004958,enlarged prostate gland|MP:0004961,increased prostate gland weight|MP:0005013,increased lymphocyte cell number|MP:0005014,increased B cell number|MP:0005124,increased circulating prolactin level|MP:0005156,bradykinesia|MP:0005178,increased circulating cholesterol level|MP:0005305,prostate gland anterior lobe hyperplasia|MP:0005599,increased cardiac muscle contractility|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0006263,decreased systemic arterial diastolic blood pressure|MP:0006362,abnormal male germ cell morphology|MP:0008210,increased mature B cell number|MP:0008279,arrest of spermiogenesis|MP:0008431,abnormal short-term spatial reference memory|MP:0008466,enlarged mesenteric lymph nodes|MP:0008869,anovulation|MP:0009285,increased gonadal fat pad weight|MP:0009296,increased mammary fat pad weight|MP:0009302,increased renal fat pad weight|MP:0009363,abnormal tertiary ovarian follicle morphology|MP:0009364,abnormal mature ovarian follicle morphology|MP:0009444,ovarian follicular cyst|MP:0009516,enlarged salivary gland|MP:0010024,increased total body fat amount|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0013508,increased granulosa cell apoptosis|MP:0014052,increased male germ cell apoptosis|MP:0014604,hemorrhagic ovary cyst|MP:0014633,decreased spermatid number|MP:0014634,decreased round spermatid number|MP:0014636,decreased elongated spermatid number|MP:0014781,decreased kidney enzyme/coenzyme level|MP:0020519,renal glomerular immunoglobulin deposits|MP:0020550,multinucleated giant male germ cells|MP:0031354,abnormal acrosome assembly|MP:0031361,increased prostate gland anterior lobe weight|MP:0031364,increased prostate gland ventral lobe weight|MP:0031365,prostate gland ventral lobe hyperplasia|MP:0031368,increased prostate gland dorsolateral lobe weight|MP:0031369,prostate gland dorsolateral lobe hyperplasia
MGI:2389548	Cyp19a1<tm1Sih>	MP:0000613,abnormal salivary gland morphology|MP:0001126,abnormal ovary morphology|MP:0001134,absent corpus luteum|MP:0001870,salivary gland inflammation|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002566,abnormal sexual interaction|MP:0002970,abnormal white adipose tissue morphology|MP:0003572,abnormal uterus development|MP:0003725,increased autoantibody level|MP:0003862,decreased aggression towards male mice|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004905,decreased uterus weight|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005425,increased macrophage cell number|MP:0008126,increased dendritic cell number|MP:0008880,lacrimal gland inflammation|MP:0009697,abnormal copulation behavior|MP:0009856,failure of ejaculation|MP:0010024,increased total body fat amount|MP:0013141,sexually aggressive behavior|MP:0020411,increased abdominal adipose tissue amount|MP:0021118,abnormal paternal behavior|MP:0031628,abnormal intromission|MP:0031650,decreased mounting behavior
MGI:2179439	Cyp19a1<tm1Toda>	MP:0000130,abnormal trabecular bone morphology|MP:0000609,abnormal liver physiology|MP:0001126,abnormal ovary morphology|MP:0001134,absent corpus luteum|MP:0001260,increased body weight|MP:0001261,obese|MP:0001552,increased circulating triglyceride level|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0002637,small uterus|MP:0002777,absent ovarian follicles|MP:0002781,increased circulating testosterone level|MP:0003356,impaired luteinization|MP:0003797,abnormal compact bone morphology|MP:0004016,decreased bone mass|MP:0004834,ovary hemorrhage|MP:0004905,decreased uterus weight|MP:0004909,increased seminal vesicle weight|MP:0004984,increased osteoclast cell number|MP:0004992,increased bone resorption|MP:0005178,increased circulating cholesterol level|MP:0005181,decreased circulating estradiol level|MP:0005293,impaired glucose tolerance|MP:0005319,abnormal enzyme/coenzyme level|MP:0005331,insulin resistance|MP:0005455,increased susceptibility to weight gain|MP:0005559,increased circulating glucose level|MP:0005656,decreased aggression|MP:0008257,thin myometrium|MP:0008258,thin endometrium|MP:0008869,anovulation|MP:0008987,abnormal liver lobule morphology|MP:0009285,increased gonadal fat pad weight|MP:0009286,increased abdominal fat pad weight|MP:0009302,increased renal fat pad weight|MP:0010867,abnormal bone trabecula morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0013507,increased ovary apoptosis|MP:0014604,hemorrhagic ovary cyst|MP:0020010,decreased bone mineral density of femur|MP:0031422,failure of superovulation|MP:0031650,decreased mounting behavior
MGI:5632151	Cyp19a1<tm2.1(cre)Shah>	MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype
MGI:2182307	Cyp1a1<tm1.1Dwn>	MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0000599,enlarged liver|MP:0000609,abnormal liver physiology|MP:0000692,small spleen|MP:0000706,small thymus|MP:0002169,no abnormal phenotype detected|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight|MP:0005016,decreased lymphocyte cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005563,abnormal hemoglobin content|MP:0005564,increased hemoglobin content|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss
MGI:6405045	Cyp1a1<tm2025.1(CYP1A1)Arte>	MP:0002169,no abnormal phenotype detected
MGI:4830522	Cyp1a1<tm2.1Dwn>	MP:0005376,homeostasis/metabolism phenotype
MGI:4830523	Cyp1a1<tm3.1Dwn>	MP:0008873,increased physiological sensitivity to xenobiotic
MGI:4830524	Cyp1a1<tm4.1Dwn>	MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight|MP:0005016,decreased lymphocyte cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005563,abnormal hemoglobin content|MP:0005564,increased hemoglobin content|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0010180,increased susceptibility to weight loss
MGI:2182351	Cyp1a2<tm1Dwn>	MP:0000609,abnormal liver physiology|MP:0004502,decreased incidence of tumors by chemical induction|MP:0008872,abnormal physiological response to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0009746,enhanced behavioral response to xenobiotic
MGI:1861917	Cyp1a2<tm1Gonz>	MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002082,postnatal lethality|MP:0002271,abnormal pulmonary alveolar duct morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0004780,abnormal surfactant secretion|MP:0005370,liver/biliary system phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005534,decreased body temperature|MP:0009546,absent gastric milk in neonates|MP:0011088,neonatal lethality, incomplete penetrance
MGI:6405047	Cyp1a2<tm2024.1(CYP1A2)Arte>	MP:0002169,no abnormal phenotype detected
MGI:3840319	Cyp1a<tm1.1Bra>	MP:0005385,cardiovascular system phenotype|MP:0008872,abnormal physiological response to xenobiotic
MGI:6405048	Cyp1a<tm1Arte>	MP:0002169,no abnormal phenotype detected
MGI:3721229	Cyp1a<tm1Dwn>	MP:0000221,decreased leukocyte cell number|MP:0000692,small spleen|MP:0000706,small thymus|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level
MGI:2154690	Cyp1b1<tm1Gonz>	MP:0004221,abnormal iridocorneal angle|MP:0004223,hypoplastic trabecular meshwork|MP:0004226,absent Schlemm's canal|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005203,abnormal trabecular meshwork morphology|MP:0005204,abnormal canal of Schlemm morphology|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0011481,anterior iris synechia
MGI:4842859	Cyp20a1<tm1a(EUCOMM)Wtsi>	MP:0005344,increased circulating bilirubin level
MGI:6156596	Cyp21a1<em1(IMPC)Tcp>	MP:0000691,enlarged spleen|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0003717,pallor|MP:0009453,enhanced contextual conditioning behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2182338	Cyp24a1<tm1Star>	MP:0000194,increased circulating calcium level|MP:0001265,decreased body size|MP:0002082,postnatal lethality|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0005389,reproductive system phenotype|MP:0005441,increased urine calcium level|MP:0008271,abnormal bone ossification|MP:0011228,abnormal vitamin D level
MGI:2183292	Cyp26a1<tm1.1Hmd>	MP:0000266,abnormal heart morphology|MP:0000556,abnormal hindlimb morphology|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001688,abnormal somite development|MP:0001701,incomplete embryo turning|MP:0002151,abnormal neural tube morphology|MP:0003036,vertebral transformation|MP:0003119,abnormal digestive system development|MP:0003445,sirenomelia|MP:0003456,absent tail|MP:0003605,fused kidneys|MP:0003631,nervous system phenotype|MP:0003632,abnormal nervous system morphology|MP:0006108,abnormal hindbrain development|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2183291	Cyp26a1<tm1.1Ptk>	MP:0000137,abnormal vertebrae morphology|MP:0000154,rib fusion|MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0000292,distended pericardium|MP:0000480,increased rib number|MP:0000556,abnormal hindlimb morphology|MP:0000592,short tail|MP:0000757,herniated abdominal wall|MP:0000914,exencephaly|MP:0001065,abnormal trigeminal nerve morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0002135,abnormal kidney morphology|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0003119,abnormal digestive system development|MP:0003445,sirenomelia|MP:0003936,abnormal reproductive system development|MP:0003942,abnormal urinary system development|MP:0004073,caudal body truncation|MP:0004615,cervical vertebral transformation|MP:0008487,abnormal mesonephros morphology|MP:0008786,abnormal hindgut morphology|MP:0009798,abnormal ophthalmic nerve morphology|MP:0009799,abnormal maxillary nerve morphology|MP:0010116,abnormal primitive urogenital sinus morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011361,pelvic kidney|MP:0011772,genital tubercle hypoplasia|MP:0012798,increased rhombomere 4 size|MP:0012818,rhombomere transformation
MGI:2183274	Cyp26a1<tm1Hmd>	MP:0002169,no abnormal phenotype detected
MGI:7314519	Cyp26b1<em1Oncl>	MP:0002746,abnormal semilunar valve morphology|MP:0003958,heart valve hyperplasia|MP:0010402,ventricular septal defect|MP:0010591,enlarged aortic valve|MP:0010593,thick aortic valve cusps|MP:0010595,abnormal aortic valve cusp morphology|MP:0011233,abnormal vitamin A metabolism
MGI:3764694	Cyp26b1<tm1.1Ptk>	MP:0000428,abnormal craniofacial morphology|MP:0001147,small testis|MP:0001954,respiratory distress|MP:0002109,abnormal limb morphology|MP:0004901,decreased male germ cell number|MP:0008280,abnormal male germ cell apoptosis|MP:0011087,neonatal lethality, complete penetrance
MGI:5604888	Cyp26b1<tm1Dcp>	MP:0001672,abnormal embryo development|MP:0002085,abnormal embryonic tissue morphology|MP:0005169,abnormal male meiosis|MP:0011089,perinatal lethality, complete penetrance
MGI:3039046	Cyp26b1<tm1Hmd>	MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000565,oligodactyly|MP:0001216,abnormal epidermal layer morphology|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001302,eyelids open at birth|MP:0001648,abnormal apoptosis|MP:0001705,abnormal proximal-distal axis patterning|MP:0001786,skin edema|MP:0001879,abnormal lymphatic vessel morphology|MP:0001914,hemorrhage|MP:0001954,respiratory distress|MP:0002109,abnormal limb morphology|MP:0002115,abnormal limb bone morphology|MP:0002639,micrognathia|MP:0002796,impaired skin barrier function|MP:0003704,abnormal hair follicle development|MP:0005385,cardiovascular system phenotype|MP:0009594,abnormal corneocyte envelope morphology|MP:0009603,absent keratohyalin granules|MP:0010197,abnormal lymphatic vessel endothelial cell morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0014106,delayed chondrocyte differentiation|MP:0014321,short forelimb|MP:0014322,short hindlimb
MGI:3764691	Cyp26b1<tm1Ptk>	MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0004901,decreased male germ cell number|MP:0005169,abnormal male meiosis
MGI:3706550	Cyp26c1<tm1.1Keya>	MP:0002169,no abnormal phenotype detected
MGI:5708271	Cyp27a1<tm1.1(KOMP)Vlcg>	MP:0000186,decreased circulating HDL cholesterol level|MP:0002644,decreased circulating triglyceride level|MP:0002968,increased circulating alkaline phosphatase level|MP:0002981,increased liver weight|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005333,decreased heart rate|MP:0005419,decreased circulating serum albumin level|MP:0008935,decreased mean platelet volume|MP:0010393,shortened QRS complex duration|MP:0010506,prolonged RR interval
MGI:2181406	Cyp27a1<tm1Elt>	MP:0000180,abnormal circulating cholesterol level|MP:0000198,decreased circulating phosphate level|MP:0000599,enlarged liver|MP:0000642,enlarged adrenal glands|MP:0000646,enlarged adrenocortical cells|MP:0001552,increased circulating triglyceride level|MP:0002175,decreased brain weight|MP:0002647,decreased intestinal cholesterol absorption|MP:0002981,increased liver weight|MP:0003868,abnormal feces composition|MP:0003918,decreased kidney weight|MP:0003975,increased circulating VLDL triglyceride level|MP:0003982,increased cholesterol level|MP:0004773,abnormal bile composition|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005281,increased fatty acids level|MP:0005365,abnormal bile salt homeostasis|MP:0005376,homeostasis/metabolism phenotype|MP:0009355,increased liver triglyceride level|MP:0011228,abnormal vitamin D level|MP:0012226,increased sterol level|MP:0012337,increased vitamin D level|MP:0012338,decreased bile salt level|MP:0013307,increased adrenal gland weight|MP:0014476,abnormal feces lipid level|MP:0014479,decreased feces bile salt level|MP:0031631,decreased lung cholesterol level
MGI:2656261	Cyp27b1<tm1.1Star>	MP:0000559,abnormal femur morphology|MP:0003116,rickets|MP:0020137,decreased bone mineralization
MGI:5588267	Cyp27b1<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000137,abnormal vertebrae morphology|MP:0000149,abnormal scapula morphology|MP:0000150,abnormal rib morphology|MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000221,decreased leukocyte cell number|MP:0000438,abnormal cranium morphology|MP:0000552,abnormal radius morphology|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0001258,decreased body length|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002187,abnormal fibula morphology|MP:0002764,short tibia|MP:0002932,abnormal joint morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0004509,abnormal pelvic girdle bone morphology|MP:0005016,decreased lymphocyte cell number|MP:0005108,abnormal ulna morphology|MP:0005296,abnormal humerus morphology|MP:0005298,abnormal clavicle morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:2182323	Cyp27b1<tm1Dgo>	MP:0000132,thickened long bone epiphysis|MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000702,enlarged lymph nodes|MP:0001127,small ovary|MP:0001130,abnormal ovarian folliculogenesis|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001926,female infertility|MP:0002637,small uterus|MP:0002901,increased urine phosphate level|MP:0002904,increased circulating parathyroid hormone level|MP:0002968,increased circulating alkaline phosphatase level|MP:0004985,decreased osteoclast cell number|MP:0005018,decreased T cell number|MP:0008869,anovulation|MP:0009009,absent estrous cycle|MP:0009091,endometrium hypoplasia|MP:0009642,abnormal blood homeostasis|MP:0010771,integument phenotype|MP:0020137,decreased bone mineralization
MGI:3576226	Cyp27b1<tm1Hfd>	MP:0003116,rickets
MGI:2182334	Cyp27b1<tm1Star>	MP:0000133,abnormal long bone metaphysis morphology|MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0002896,abnormal bone mineralization|MP:0002904,increased circulating parathyroid hormone level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003112,enlarged parathyroid gland|MP:0003116,rickets|MP:0006397,disorganized long bone epiphyseal plate|MP:0006398,increased long bone epiphyseal plate size|MP:0008489,slow postnatal weight gain|MP:0009445,osteomalacia|MP:0009642,abnormal blood homeostasis|MP:0010771,integument phenotype|MP:0020010,decreased bone mineral density of femur|MP:0020137,decreased bone mineralization
MGI:7643808	Cyp2a12<em1Utr>	MP:0002647,decreased intestinal cholesterol absorption|MP:0005365,abnormal bile salt homeostasis|MP:0005584,abnormal enzyme/coenzyme activity
MGI:4837923	Cyp2a5<tm1Ding>	MP:0005376,homeostasis/metabolism phenotype|MP:0008875,abnormal xenobiotic pharmacokinetics
MGI:5572037	Cyp2ab1<tm1b(KOMP)Wtsi>	MP:0000198,decreased circulating phosphate level|MP:0000689,abnormal spleen morphology|MP:0005632,decreased circulating aspartate transaminase level
MGI:4364945	Cyp2b10<tm1a(KOMP)Wtsi>	MP:0001764,abnormal homeostasis|MP:0002941,increased circulating alanine transaminase level|MP:0005376,homeostasis/metabolism phenotype|MP:0005443,abnormal ethanol metabolism|MP:0009642,abnormal blood homeostasis|MP:0010951,abnormal lipid oxidation|MP:0031267,increased susceptibility to alcohol-induced hepatic steatosis
MGI:6304243	Cyp2b9<em1(IMPC)Hmgu>	MP:0002059,abnormal seminal vesicle morphology
MGI:4178127	Cyp2c23<Gt(OST85045)Lex>	MP:0002053,decreased incidence of induced tumors|MP:0002136,abnormal kidney physiology|MP:0002667,decreased circulating aldosterone level|MP:0004217,salt-sensitive hypertension|MP:0005455,increased susceptibility to weight gain|MP:0005633,increased circulating sodium level|MP:0006317,decreased urine sodium level|MP:0011131,abnormal lung endothelial cell physiology|MP:0011140,decreased lung endothelial cell proliferation
MGI:5638557	Cyp2c23<tm1.1Jhc>	MP:0001260,increased body weight|MP:0002136,abnormal kidney physiology|MP:0006144,increased systemic arterial systolic blood pressure|MP:0006317,decreased urine sodium level
MGI:5635042	Cyp2c23<tm1b(EUCOMM)Hmgu>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0005561,increased mean corpuscular hemoglobin
MGI:6856676	Cyp2c38<em1(IMPC)Bay>	MP:0001258,decreased body length|MP:0003795,abnormal bone structure|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:7764503	Cyp2c70<em1Sjka>	MP:0000598,abnormal liver morphology|MP:0001262,decreased body weight|MP:0001860,liver inflammation|MP:0002138,abnormal hepatobiliary system morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0002981,increased liver weight|MP:0003333,liver fibrosis|MP:0004789,increased bile salt level|MP:0004952,increased spleen weight|MP:0005343,increased circulating aspartate transaminase level|MP:0005365,abnormal bile salt homeostasis
MGI:7643809	Cyp2c70<em1Utr>	MP:0000598,abnormal liver morphology|MP:0001654,hepatic necrosis|MP:0001860,liver inflammation|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0002647,decreased intestinal cholesterol absorption|MP:0002928,abnormal bile duct morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0002981,increased liver weight|MP:0005178,increased circulating cholesterol level|MP:0005365,abnormal bile salt homeostasis|MP:0005584,abnormal enzyme/coenzyme activity|MP:0010027,increased liver cholesterol level|MP:0012338,decreased bile salt level|MP:0014479,decreased feces bile salt level
MGI:6404559	Cyp2c<tm1104Arte>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001860,liver inflammation|MP:0005179,decreased circulating cholesterol level
MGI:6404560	Cyp2c<tm1897.1(Alb-CYP2C9)Arte>	MP:0001860,liver inflammation|MP:0011585,decreased alkaline phosphatase activity
MGI:6156425	Cyp2d22<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001402,decreased locomotor activity|MP:0002060,abnormal skin morphology
MGI:6404858	Cyp2d<tm1.1(CYP2D6*)Arte>	MP:0002169,no abnormal phenotype detected
MGI:6404859	Cyp2d<tm1.2Arte>	MP:0002169,no abnormal phenotype detected
MGI:6404900	Cyp2d<tm1836.1(CYP2D6_i2)Arte>	MP:0002169,no abnormal phenotype detected
MGI:6404857	Cyp2d<tm1(CYP2D6*)Arte>	MP:0002169,no abnormal phenotype detected
MGI:6404899	Cyp2d<tm2.1(CYP2D6_i1)Arte>	MP:0002169,no abnormal phenotype detected
MGI:5548927	Cyp2e1<tm1b(KOMP)Wtsi>	MP:0002100,abnormal tooth morphology
MGI:1857483	Cyp2e1<tm1Gonz>	MP:0000607,abnormal hepatocyte morphology|MP:0002628,hepatic steatosis|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004938,dilated vasculature|MP:0008872,abnormal physiological response to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0009642,abnormal blood homeostasis|MP:0009746,enhanced behavioral response to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:6315509	Cyp2f2<em1(IMPC)H>	MP:0000691,enlarged spleen
MGI:5538527	Cyp2f2<tm1Ding>	MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3512181	Cyp2g1<tm1Ding>	MP:0005266,abnormal metabolism|MP:0005394,taste/olfaction phenotype
MGI:3836754	Cyp2j5<tm1Dcz>	MP:0001935,decreased litter size|MP:0003025,increased vasoconstriction|MP:0003371,decreased circulating estrogen level|MP:0003915,increased heart left ventricle weight|MP:0005367,renal/urinary system phenotype|MP:0006144,increased systemic arterial systolic blood pressure|MP:0011417,abnormal renal transport
MGI:3808340	Cyp2r1<tm1(KOMP)Vlcg>	MP:0000198,decreased circulating phosphate level|MP:0005390,skeleton phenotype|MP:0011228,abnormal vitamin D level
MGI:5449902	Cyp2s1<tm1Ding>	MP:0002169,no abnormal phenotype detected
MGI:5635043	Cyp2u1<tm1b(EUCOMM)Wtsi>	MP:0001513,limb grasping|MP:0003795,abnormal bone structure|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6341926	Cyp39a1<em1(IMPC)Ccpcz>	MP:0005568,increased circulating total protein level
MGI:3764486	Cyp3a13<tm1Nki>	MP:0002169,no abnormal phenotype detected
MGI:5605829	Cyp3a41b<tm1b(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:2667348	Cyp46a1<tm1Rus>	MP:0005278,abnormal cholesterol homeostasis
MGI:3640474	Cyp4a10<tm1Jhc>	MP:0000231,hypertension|MP:0000676,abnormal body water content|MP:0003620,oliguria|MP:0004217,salt-sensitive hypertension|MP:0005618,decreased urine potassium level|MP:0006144,increased systemic arterial systolic blood pressure|MP:0010109,abnormal renal sodium reabsorption|MP:0011442,abnormal renal sodium ion transport
MGI:2183240	Cyp4a14<tm1Jhc>	MP:0002118,abnormal lipid homeostasis|MP:0002842,increased systemic arterial blood pressure|MP:0002843,decreased systemic arterial blood pressure|MP:0005529,abnormal renal vascular resistance|MP:0005531,increased renal vascular resistance|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure
MGI:5548340	Cyp4b1<tm1b(KOMP)Wtsi>	MP:0001415,increased exploration in new environment|MP:0002644,decreased circulating triglyceride level|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005566,decreased blood urea nitrogen level|MP:0013279,increased fasting circulating glucose level
MGI:4363698	Cyp4b1<tm1e(KOMP)Wtsi>	MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5613654	Cyp4f14<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:5445372	Cyp4f14<tm1Rspk>	MP:0003868,abnormal feces composition|MP:0005319,abnormal enzyme/coenzyme level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009643,abnormal urine homeostasis
MGI:5692697	Cyp4f16<tm1b(EUCOMM)Hmgu>	MP:0011965,decreased total retina thickness
MGI:5637043	Cyp4f16<tm1b(KOMP)Wtsi>	MP:0001513,limb grasping|MP:0013279,increased fasting circulating glucose level
MGI:5565359	Cyp4f18<tm1.1Pchr>	MP:0005376,homeostasis/metabolism phenotype|MP:0009817,decreased leukotriene level|MP:0010953,abnormal fatty acid oxidation
MGI:5566681	Cyp4f18<tm1.2Pchr>	MP:0002169,no abnormal phenotype detected
MGI:6423306	Cyp4f39<em1Akih>	MP:0001190,reddish skin|MP:0001196,shiny skin|MP:0001211,wrinkled skin|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001263,weight loss|MP:0002796,impaired skin barrier function|MP:0009608,abnormal epidermal lamellar body morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0013530,abnormal periderm morphology|MP:0020583,decreased ceramide level|MP:0030605,abnormal corneocyte morphology
MGI:6201606	Cyp4f39<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:6152453	Cyp4v3<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0001399,hyperactivity|MP:0002092,abnormal eye morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7574754	Cyp4v3<em1Xsu>	MP:0001325,abnormal retina morphology|MP:0002698,abnormal sclera morphology|MP:0003674,oxidative stress|MP:0003690,abnormal glial cell physiology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003734,abnormal retina inner plexiform layer morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005253,abnormal eye physiology|MP:0006187,retina deposits|MP:0008449,abnormal retina cone cell outer segment morphology|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0011965,decreased total retina thickness|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0013245,abnormal lipid metabolism|MP:0014336,short retina rod cell outer segment|MP:0020448,increased microglial cell activation|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:3808361	Cyp4v3<tm1(KOMP)Vlcg>	MP:0001325,abnormal retina morphology|MP:0005098,abnormal optic choroid morphology|MP:0005280,abnormal fatty acids level
MGI:6368621	Cyp4x1<tm1.1Beld>	MP:0001260,increased body weight|MP:0001402,decreased locomotor activity|MP:0005290,decreased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005455,increased susceptibility to weight gain|MP:0005658,increased susceptibility to diet-induced obesity|MP:0009118,increased white fat cell size|MP:0009288,increased epididymal fat pad weight|MP:0010379,decreased respiratory quotient|MP:0020411,increased abdominal adipose tissue amount
MGI:4836362	Cyp51<tm1.1Bfro>	MP:0000111,cleft palate|MP:0000266,abnormal heart morphology|MP:0000279,ventricular hypoplasia|MP:0000413,polyphalangy|MP:0000431,absent palatine bone horizontal plate|MP:0000435,shortened head|MP:0000554,abnormal carpal bone morphology|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000566,synostosis|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001544,abnormal cardiovascular system physiology|MP:0001879,abnormal lymphatic vessel morphology|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0002111,abnormal tail morphology|MP:0002115,abnormal limb bone morphology|MP:0002639,micrognathia|MP:0002740,heart hypoplasia|MP:0003140,dilated heart atrium|MP:0003807,camptodactyly|MP:0004358,bowed tibia|MP:0004374,bowed radius|MP:0005104,abnormal tarsal bone morphology|MP:0005306,abnormal phalanx morphology|MP:0005312,pericardial effusion|MP:0008736,micromelia|MP:0008817,hematoma|MP:0009905,absent tongue|MP:0010196,abnormal lymphatic vessel smooth muscle morphology|MP:0010402,ventricular septal defect|MP:0011091,prenatal lethality, complete penetrance|MP:0020301,short tongue
MGI:5692562	Cyp7a1<tm1b(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0001556,increased circulating HDL cholesterol level|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0004151,decreased circulating iron level|MP:0005178,increased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0005419,decreased circulating serum albumin level|MP:0005566,decreased blood urea nitrogen level|MP:0010097,abnormal retina blood vessel morphology|MP:0011896,increased circulating unsaturated transferrin level
MGI:1857285	Cyp7a1<tm1Rus>	MP:0000598,abnormal liver morphology|MP:0000609,abnormal liver physiology|MP:0001191,abnormal skin condition|MP:0001195,flaky skin|MP:0001197,oily skin|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001238,thin epidermis stratum spinosum|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001242,hyperkeratosis|MP:0001244,thin dermal layer|MP:0001290,delayed eyelid opening|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001732,postnatal growth retardation|MP:0002060,abnormal skin morphology|MP:0002090,abnormal vision|MP:0002118,abnormal lipid homeostasis|MP:0002647,decreased intestinal cholesterol absorption|MP:0002791,steatorrhea|MP:0003849,greasy coat|MP:0003853,dry skin|MP:0004773,abnormal bile composition|MP:0004774,abnormal bile salt level|MP:0005365,abnormal bile salt homeostasis|MP:0005401,abnormal fat-soluble vitamin level|MP:0009674,decreased birth weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5607535	Cyp7b1<tm1b(EUCOMM)Wtsi>	MP:0005293,impaired glucose tolerance|MP:0011965,decreased total retina thickness
MGI:2182328	Cyp7b1<tm1Lth>	MP:0000628,abnormal mammary gland development|MP:0001927,abnormal estrous cycle|MP:0003378,early sexual maturation|MP:0003572,abnormal uterus development|MP:0004894,uterus atrophy|MP:0009009,absent estrous cycle|MP:0031020,premature ovarian failure
MGI:2387030	Cyp7b1<tm1Rus>	MP:0001807,decreased IgA level|MP:0005278,abnormal cholesterol homeostasis|MP:0005376,homeostasis/metabolism phenotype
MGI:3588415	Cyp8b1<tm1Rus>	MP:0000609,abnormal liver physiology|MP:0002118,abnormal lipid homeostasis|MP:0002647,decreased intestinal cholesterol absorption|MP:0002791,steatorrhea|MP:0004772,abnormal bile secretion|MP:0004774,abnormal bile salt level|MP:0005179,decreased circulating cholesterol level|MP:0005365,abnormal bile salt homeostasis
MGI:3044396	Cypr1<STS/A>	MP:0003009,abnormal cytokine secretion
MGI:3044398	Cypr2<BALB/c>	MP:0003009,abnormal cytokine secretion
MGI:3044401	Cypr3<BALB/c>	MP:0003009,abnormal cytokine secretion
MGI:6719563	Cyren<em1Vokh>	MP:0004816,abnormal class switch recombination|MP:0020394,decreased neuronal precursor proliferation
MGI:5569061	Cyren<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0004816,abnormal class switch recombination
MGI:7865345	Cyria<em1Erob>	MP:0002169,no abnormal phenotype detected
MGI:6414515	Cyria<em1(IMPC)Hmgu>	MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0005554,decreased circulating creatinine level|MP:0010097,abnormal retina blood vessel morphology
MGI:7865346	Cyrib<em1Erob>	MP:0000715,decreased thymocyte number|MP:0002145,abnormal T cell differentiation|MP:0002408,abnormal double-positive T cell morphology|MP:0003850,abnormal thymocyte activation|MP:0004918,abnormal negative T cell selection|MP:0004974,decreased regulatory T cell number|MP:0005002,abnormal T cell clonal deletion|MP:0005018,decreased T cell number|MP:0006413,increased T cell apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008351,decreased gamma-delta intraepithelial T cell number|MP:0008827,abnormal thymus cell ratio|MP:0008828,abnormal lymph node cell ratio|MP:0008895,abnormal intraepithelial T cell number|MP:0009541,increased thymocyte apoptosis
MGI:6444806	Cyrib<m1Dmal>	MP:0000219,increased neutrophil cell number|MP:0000494,abnormal cecum morphology|MP:0000689,abnormal spleen morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0003288,intestinal edema|MP:0003332,liver abscess|MP:0008553,increased circulating tumor necrosis factor level|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0013793,abnormal large intestine goblet cell morphology|MP:0031113,pulmonary parenchymal consolidation
MGI:5605796	Cyrib<tm1b(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0001417,decreased exploration in new environment|MP:0001785,edema|MP:0001925,male infertility|MP:0005634,decreased circulating sodium level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1856831	Cys1<cpk>	MP:0000042,abnormal organ of Corti morphology|MP:0000208,decreased hematocrit|MP:0000522,kidney cortex cyst|MP:0000694,spleen hypoplasia|MP:0000745,tremors|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0001436,abnormal suckling behavior|MP:0001823,thymus hypoplasia|MP:0001860,liver inflammation|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002928,abnormal bile duct morphology|MP:0003068,enlarged kidney|MP:0003253,dilated bile duct|MP:0003266,biliary cyst|MP:0003327,liver cyst|MP:0003333,liver fibrosis|MP:0003334,pancreas fibrosis|MP:0003336,pancreas cyst|MP:0003637,cochlear ganglion hypoplasia|MP:0003675,kidney cyst|MP:0003825,abnormal pillar cell morphology|MP:0003917,increased kidney weight|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004403,absent cochlear outer hair cells|MP:0005202,lethargy|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0006021,abnormal Reissner membrane morphology|MP:0008528,polycystic kidney|MP:0009144,dilated pancreatic duct|MP:0009145,abnormal pancreatic acinus morphology|MP:0009157,ectopic pancreatic acinar cells|MP:0009173,absent pancreatic islets|MP:0011085,postnatal lethality, complete penetrance|MP:0011376,abnormal kidney corticomedullary boundary morphology|MP:0011413,colorless urine|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6423836	Cysltr1<em1(IMPC)Mbp>	MP:0002135,abnormal kidney morphology|MP:0002989,small kidney
MGI:2182326	Cysltr1<tm1Ykn>	MP:0002405,respiratory system inflammation|MP:0003071,decreased vascular permeability|MP:0005387,immune system phenotype|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0005621,abnormal cell physiology
MGI:6362811	Cysltr2<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0002135,abnormal kidney morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0002989,small kidney
MGI:3775826	Cysltr2<tm1Sish>	MP:0000343,abnormal response to cardiac infarction
MGI:3521667	Cysltr2<tm1Ykn>	MP:0001844,autoimmune response|MP:0005501,abnormal skin physiology|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0006050,pulmonary fibrosis|MP:0009811,abnormal prostaglandin level
MGI:5548508	Cystm1<tm1b(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0001303,abnormal lens morphology|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0002590,increased mean corpuscular volume|MP:0002757,decreased vertical activity|MP:0002968,increased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0004924,abnormal behavior|MP:0010024,increased total body fat amount|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake|MP:0020870,decreased thigmotaxis
MGI:4458327	Cyth1<Gt(obn)Byg>	MP:0003631,nervous system phenotype
MGI:6149489	Cyth1<tm1Jya>	MP:0005369,muscle phenotype|MP:0011731,decreased myelin sheath thickness|MP:0013438,dysmyelination
MGI:6150927	Cyth2<tm1c(EUCOMM)Wtsi>	MP:0003631,nervous system phenotype|MP:0013438,dysmyelination
MGI:7266327	Cyth2<tm1d(EUCOMM)Wtsi>	MP:0005012,decreased eosinophil cell number|MP:0005597,decreased susceptibility to type I hypersensitivity reaction
MGI:4365249	Cyth3<tm2a(KOMP)Wtsi>	MP:0000609,abnormal liver physiology|MP:0002644,decreased circulating triglyceride level|MP:0003213,decreased susceptibility to age related obesity|MP:0003960,increased lean body mass|MP:0005331,insulin resistance|MP:0005365,abnormal bile salt homeostasis|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005670,abnormal white adipose tissue physiology|MP:0009283,decreased gonadal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0010182,decreased susceptibility to weight gain|MP:0010398,decreased liver glycogen level|MP:0014476,abnormal feces lipid level|MP:0020868,decreased lipogenesis
MGI:7425626	Cyth4<em1(IMPC)Ccpcz>	MP:0001146,abnormal testis morphology|MP:0005573,increased pulmonary respiratory rate|MP:0006415,absent testes|MP:0008810,increased circulating iron level
MGI:3664082	Cytip<tm1Tes>	MP:0000221,decreased leukocyte cell number|MP:0002032,increased sarcoma incidence|MP:0002436,abnormal CD8-positive, alpha-beta cytotoxic T cell morphology|MP:0003156,abnormal leukocyte migration|MP:0005016,decreased lymphocyte cell number|MP:0008101,lymph node hypoplasia|MP:0009858,abnormal cellular extravasation
MGI:3665293	Cytip<tm1Wtw>	MP:0005387,immune system phenotype|MP:0005671,abnormal response to transplant
MGI:5291960	Cytl1<tm1Chun>	MP:0003724,increased susceptibility to induced arthritis|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0005390,skeleton phenotype
MGI:5300700	d-100H	MP:0011400,lethality, complete penetrance
MGI:5696928	D130043K22Rik<tm1b(KOMP)Wtsi>	MP:0001364,decreased anxiety-related response|MP:0002590,increased mean corpuscular volume|MP:0003631,nervous system phenotype|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0009141,increased prepulse inhibition
MGI:5766746	D16Ertd472e<tm1b(EUCOMM)Wtsi>	MP:0001417,decreased exploration in new environment|MP:0002591,decreased mean corpuscular volume|MP:0011965,decreased total retina thickness
MGI:2449784	D17Aus9<df10J>	MP:0000292,distended pericardium|MP:0001730,embryonic growth arrest|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2449786	D17Aus9<df12J>	MP:0000292,distended pericardium|MP:0001730,embryonic growth arrest|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2449787	D17Aus9<df13J>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1857611	D17Aus9<df2J>	MP:0000592,short tail|MP:0001265,decreased body size
MGI:8169118	D1Pas1<em1Dean>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility
MGI:4399403	D1Pas1<tm1(KOMP)Vlcg>	MP:0001147,small testis|MP:0001925,male infertility
MGI:4435522	D430041D05Rik<tm1a(EUCOMM)Hmgu>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002896,abnormal bone mineralization
MGI:5300691	d-58H	MP:0002880,opisthotonus
MGI:6158654	D5Ertd579e<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0003179,thrombocytopenia|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:5637108	D630023F18Rik<tm1b(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5513761	D630045J12Rik<tm1b(KOMP)Wtsi>	MP:0000702,enlarged lymph nodes|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002644,decreased circulating triglyceride level|MP:0005292,improved glucose tolerance|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0013279,increased fasting circulating glucose level
MGI:7505592	D6Ertd527e<em1Psv>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size
MGI:5636910	D6Wsu163e<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0002965,increased circulating serum albumin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003131,increased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0004738,abnormal auditory brainstem response|MP:0005178,increased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005568,increased circulating total protein level|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010087,increased circulating fructosamine level|MP:0011939,increased food intake|MP:0013426,decreased memory-marker NK cell number|MP:0013436,increased CD8-positive, naive alpha-beta T cell number
MGI:4455573	D7Ertd443e<tm2a(KOMP)Wtsi>	MP:0002941,increased circulating alanine transaminase level|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level
MGI:7641809	D930020B18Rik<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5708245	D930020B18Rik<tm1.1(KOMP)Vlcg>	MP:0001926,female infertility
MGI:4432198	D930028M14Rik<tm1a(EUCOMM)Wtsi>	MP:0003686,abnormal eye muscle morphology|MP:0010602,abnormal pulmonary valve cusp morphology|MP:0010912,herniated liver|MP:0011100,preweaning lethality, complete penetrance|MP:0012303,umbilical vein stenosis|MP:0013826,absent hypoglossal canal|MP:0013831,vagus nerve compression|MP:0013835,absent hypoglossal nerve|MP:0013836,abnormal hypoglossal nerve topology|MP:0013847,retropleural edema|MP:0013849,absent abducens nerve|MP:0013915,abnormal brachial plexus formation
MGI:1856840	da	MP:0000372,irregular coat pigmentation|MP:0001265,decreased body size
MGI:4338561	Daam1<Gt(RRT390)Byg>	MP:0000284,double outlet right ventricle|MP:0001265,decreased body size|MP:0001575,cyanosis|MP:0001698,decreased embryo size|MP:0001792,impaired wound healing|MP:0002106,abnormal muscle physiology|MP:0003921,abnormal heart left ventricle morphology|MP:0004090,abnormal sarcomere morphology|MP:0004200,decreased fetal size|MP:0005294,abnormal heart ventricle morphology|MP:0005312,pericardial effusion|MP:0005385,cardiovascular system phenotype|MP:0008770,decreased survivor rate|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0010402,ventricular septal defect|MP:0010768,mortality/aging|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0014698,decreased fibroblast adhesion|MP:0020414,abnormal fibroblast physiology|MP:0031613,fetal cardiomyocyte disarray
MGI:6149780	Daam1<tm1.1Tpy>	MP:0002189,abnormal myocardial trabeculae morphology|MP:0003547,abnormal pulmonary pressure|MP:0003920,abnormal heart right ventricle morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004009,abnormal diastolic filling velocity|MP:0005385,cardiovascular system phenotype|MP:0010556,thin ventricle myocardium compact layer|MP:0010759,decreased right ventricle systolic pressure
MGI:5637022	Daam1<tm1b(EUCOMM)Hmgu>	MP:0005565,increased blood urea nitrogen level|MP:0011100,preweaning lethality, complete penetrance
MGI:4841108	Daam2<tm1a(KOMP)Wtsi>	MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0000455,abnormal maxilla morphology|MP:0001258,decreased body length|MP:0002968,increased circulating alkaline phosphatase level|MP:0013279,increased fasting circulating glucose level
MGI:5637087	Daam2<tm1b(KOMP)Wtsi>	MP:0000443,abnormal snout morphology|MP:0000455,abnormal maxilla morphology|MP:0001566,increased circulating phosphate level|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005564,increased hemoglobin content|MP:0008806,increased circulating amylase level|MP:0012362,increased large unstained cell number
MGI:1856801	Dab1<scm>	MP:0000745,tremors|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0001925,male infertility|MP:0002082,postnatal lethality|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0008770,decreased survivor rate|MP:0009940,abnormal hippocampus pyramidal cell morphology
MGI:2136961	Dab1<scm-2J>	MP:0000745,tremors|MP:0005150,cachexia|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3773692	Dab1<scm-3J>	MP:0000813,abnormal hippocampus layer morphology|MP:0000851,cerebellum hypoplasia|MP:0000853,absent cerebellar foliation|MP:0001265,decreased body size|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4360102	Dab1<scm-4J>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0002152,abnormal brain morphology|MP:0002397,abnormal bone marrow morphology|MP:0003644,thymus atrophy|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5568221	Dab1<scm-5J>	MP:0000746,weakness|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0009956,abnormal cerebellar layer morphology|MP:0011083,lethality at weaning, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013138,thin body
MGI:5573136	Dab1<scm-6J>	MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000807,abnormal hippocampus morphology|MP:0000813,abnormal hippocampus layer morphology|MP:0000851,cerebellum hypoplasia|MP:0000857,abnormal cerebellar foliation|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0011085,postnatal lethality, complete penetrance
MGI:3777253	Dab1<tm1.1Bwh>	MP:0001393,ataxia|MP:0003632,abnormal nervous system morphology
MGI:5141401	Dab1<tm1.1Mull>	MP:0000745,tremors|MP:0000792,abnormal cortical marginal zone morphology|MP:0000934,abnormal telencephalon development|MP:0001393,ataxia|MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0006009,abnormal neuronal migration|MP:0008443,absent subplate|MP:0008547,abnormal neocortex morphology
MGI:3777252	Dab1<tm1Bwh>	MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000885,ectopic Purkinje cell|MP:0002152,abnormal brain morphology|MP:0005386,behavior/neurological phenotype
MGI:1861918	Dab1<tm1Cpr>	MP:0000788,abnormal cerebral cortex morphology|MP:0000792,abnormal cortical marginal zone morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0002083,premature death|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004279,abnormal rostral migratory stream morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0009949,abnormal olfactory bulb granule cell layer morphology|MP:0030956,abnormal neuronal precursor cell migration
MGI:2388292	Dab1<tm2Cpr>	MP:0000788,abnormal cerebral cortex morphology|MP:0000792,abnormal cortical marginal zone morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000852,small cerebellum|MP:0000853,absent cerebellar foliation|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001391,abnormal tail movements|MP:0001393,ataxia|MP:0001525,impaired balance|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004279,abnormal rostral migratory stream morphology|MP:0008265,abnormal hippocampus CA2 region morphology|MP:0008284,abnormal hippocampus pyramidal cell layer
MGI:2388312	Dab1<tm3.1Cpr>	MP:0003631,nervous system phenotype
MGI:3050637	Dab1<tm4Cpr>	MP:0002169,no abnormal phenotype detected
MGI:3833827	Dab1<tm5Cpr>	MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000792,abnormal cortical marginal zone morphology|MP:0000807,abnormal hippocampus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000885,ectopic Purkinje cell|MP:0000934,abnormal telencephalon development|MP:0008440,abnormal subplate morphology
MGI:3833830	Dab1<tm6Cpr>	MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000792,abnormal cortical marginal zone morphology|MP:0000807,abnormal hippocampus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000885,ectopic Purkinje cell|MP:0000934,abnormal telencephalon development|MP:0008440,abnormal subplate morphology
MGI:2654878	Dab1<tm7Cpr>	MP:0002169,no abnormal phenotype detected
MGI:4289309	Dab2ip<Gt(OST348452)Lex>	MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:3796606	Dab2ip<tm1.1Wami>	MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008944,decreased sensitivity to induced cell death
MGI:2387168	Dab2<tm1.1Cpr>	MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003087,absent allantois|MP:0003886,abnormal embryonic epiblast morphology|MP:0005030,absent amnion|MP:0009593,absent chorion|MP:0010380,abnormal inner cell mass apoptosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011201,abnormal visceral yolk sac cavity morphology|MP:0011208,small proamniotic cavity|MP:0012159,absent anterior visceral endoderm
MGI:2429678	Dab2<tm1Xxx>	MP:0001695,abnormal gastrulation|MP:0003085,abnormal egg cylinder morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:5562564	Dab2<tm2.2Xxx>	MP:0002582,disorganized extraembryonic tissue|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011183,abnormal primitive endoderm morphology
MGI:5529614	Dach1<tm1b(KOMP)Wtsi>	MP:0002941,increased circulating alanine transaminase level|MP:0003019,increased circulating chloride level|MP:0011100,preweaning lethality, complete penetrance
MGI:2448366	Dach1<tm1Krs>	MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0003339,decreased pancreatic beta cell number|MP:0003631,nervous system phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0009172,small pancreatic islets|MP:0009177,decreased pancreatic alpha cell number|MP:0009546,absent gastric milk in neonates|MP:0011087,neonatal lethality, complete penetrance|MP:0011820,decreased pancreatic beta cell proliferation
MGI:2182311	Dach1<tm1Mrd>	MP:0001436,abnormal suckling behavior|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0011087,neonatal lethality, complete penetrance
MGI:7425628	Dach2<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000538,abnormal urinary bladder morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0001157,small seminal vesicle|MP:0001293,anophthalmia|MP:0002059,abnormal seminal vesicle morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002217,small lymph nodes|MP:0002339,abnormal lymph node morphology|MP:0005011,increased eosinophil cell number|MP:0011874,enlarged urinary bladder
MGI:3625291	Dach2<tm1.1Mrd>	MP:0002169,no abnormal phenotype detected
MGI:3625290	Dach2<tm1Mrd>	MP:0002169,no abnormal phenotype detected
MGI:4360072	Dact1<tm1.1Bnrc>	MP:0000137,abnormal vertebrae morphology|MP:0000495,abnormal colon morphology|MP:0000519,hydronephrosis|MP:0000520,absent kidney|MP:0000534,abnormal ureter morphology|MP:0000592,short tail|MP:0001539,decreased caudal vertebrae number|MP:0001675,abnormal ectoderm development|MP:0001685,abnormal endoderm development|MP:0001688,abnormal somite development|MP:0002085,abnormal embryonic tissue morphology|MP:0002128,abnormal blood circulation|MP:0002231,abnormal primitive streak morphology|MP:0002731,megacolon|MP:0002861,abnormal tail bud morphology|MP:0003054,spina bifida|MP:0003445,sirenomelia|MP:0003537,hydrometrocolpos|MP:0003591,urethra atresia|MP:0003605,fused kidneys|MP:0004073,caudal body truncation|MP:0004710,small notochord|MP:0008029,abnormal paraxial mesoderm morphology|MP:0008770,decreased survivor rate|MP:0008787,abnormal tailgut morphology|MP:0008999,absent anus|MP:0009204,absent external male genitalia|MP:0009211,absent external female genitalia|MP:0009252,absent urinary bladder|MP:0009538,abnormal synapse morphology|MP:0009768,impaired somite development|MP:0009936,abnormal dendritic spine morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011771,abnormal genital tubercle morphology|MP:0012182,abnormal presomitic mesoderm morphology|MP:0013217,abnormal posterior definitive endoderm morphology|MP:0014376,decreased miniature excitatory postsynaptic current frequency
MGI:4458394	Dact1<tm1Yegc>	MP:0000137,abnormal vertebrae morphology|MP:0000516,abnormal renal/urinary system morphology|MP:0000519,hydronephrosis|MP:0000520,absent kidney|MP:0000592,short tail|MP:0001539,decreased caudal vertebrae number|MP:0001926,female infertility|MP:0002135,abnormal kidney morphology|MP:0002769,abnormal vas deferens morphology|MP:0002825,abnormal notochord morphology|MP:0002990,short ureter|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0003535,absent vagina|MP:0003591,urethra atresia|MP:0003604,single kidney|MP:0003605,fused kidneys|MP:0003675,kidney cyst|MP:0004714,truncated notochord|MP:0005354,abnormal ilium morphology|MP:0008770,decreased survivor rate|MP:0008786,abnormal hindgut morphology|MP:0008999,absent anus|MP:0009084,blind uterus|MP:0009204,absent external male genitalia|MP:0009211,absent external female genitalia|MP:0009252,absent urinary bladder|MP:0009703,decreased birth body size|MP:0009709,hydrometra|MP:0010115,abnormal embryonic cloaca morphology|MP:0010116,abnormal primitive urogenital sinus morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011298,ureter hypoplasia|MP:0011797,blind ureter|MP:0012182,abnormal presomitic mesoderm morphology
MGI:3810282	Dact2<tm1.1Xya>	MP:0002724,enhanced wound healing|MP:0012193,increased keratinocyte migration
MGI:5584408	Dact2<tm1b(EUCOMM)Wtsi>	MP:0000367,abnormal coat/ hair morphology|MP:0000689,abnormal spleen morphology|MP:0002060,abnormal skin morphology|MP:0002590,increased mean corpuscular volume|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration|MP:0011960,abnormal eye anterior chamber depth
MGI:5515616	Dact3<tm1.1Yegc>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002135,abnormal kidney morphology|MP:0003215,renal interstitial fibrosis|MP:0005165,increased susceptibility to injury|MP:0005376,homeostasis/metabolism phenotype|MP:0009640,abnormal renal tubule epithelium morphology
MGI:5637190	Dact3<tm1b(KOMP)Wtsi>	MP:0003960,increased lean body mass|MP:0005292,improved glucose tolerance|MP:0005419,decreased circulating serum albumin level
MGI:2445490	Dad1<tm1Brw>	MP:0002718,abnormal inner cell mass morphology|MP:0010380,abnormal inner cell mass apoptosis|MP:0010768,mortality/aging|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3586491	Dad1<tm1Kni>	MP:0000564,syndactyly|MP:0003984,embryonic growth retardation|MP:0004956,decreased thymus weight|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance
MGI:2183460	Dad1<tm1Wnt>	MP:0001674,abnormal germ layer development|MP:0001680,abnormal mesoderm development|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0005621,abnormal cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011187,abnormal parietal endoderm morphology|MP:0011197,abnormal proamniotic cavity morphology|MP:0011200,abnormal extraembryonic coelom morphology|MP:0012095,increased Reichert's membrane thickness|MP:0012299,hydropic allantois|MP:0013504,increased embryonic tissue cell apoptosis
MGI:7664416	Dag1<tm1.1Sabl>	MP:0000825,dilated lateral ventricle|MP:0001262,decreased body weight|MP:0001698,decreased embryo size|MP:0002106,abnormal muscle physiology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003631,nervous system phenotype|MP:0003954,abnormal Reichert's membrane morphology|MP:0004262,abnormal physical strength|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5438989	Dag1<tm1.1Swin>	MP:0002169,no abnormal phenotype detected
MGI:1934902	Dag1<tm1Kcam>	MP:0001683,absent mesoderm|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002583,absent extraembryonic ectoderm|MP:0003954,abnormal Reichert's membrane morphology|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:2387358	Dag1<tm2Kcam>	MP:0000434,megacephaly|MP:0000752,dystrophic muscle|MP:0000759,abnormal skeletal muscle morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000854,abnormal cerebellum development|MP:0000921,demyelination|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001264,increased body size|MP:0001297,microphthalmia|MP:0001314,cornea opacity|MP:0001473,reduced long-term potentiation|MP:0002001,blindness|MP:0002152,abnormal brain morphology|MP:0002546,mydriasis|MP:0002795,dilated cardiomyopathy|MP:0002972,abnormal cardiac muscle contractility|MP:0003141,cardiac fibrosis|MP:0003354,astrocytosis|MP:0003852,skeletal muscle necrosis|MP:0003871,abnormal myelin sheath morphology|MP:0004021,abnormal rod electrophysiology|MP:0004097,abnormal cerebellar cortex morphology|MP:0004566,myocardial fiber degeneration|MP:0005238,increased brain size|MP:0005385,cardiovascular system phenotype|MP:0005402,abnormal action potential|MP:0005403,abnormal nerve conduction|MP:0006009,abnormal neuronal migration|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008285,abnormal hippocampus granule cell layer|MP:0008814,decreased nerve conduction velocity|MP:0009027,abnormal subarachnoid space morphology|MP:0009274,buphthalmos|MP:0009399,increased skeletal muscle fiber size|MP:0009401,increased skeletal muscle fiber diameter|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010090,increased circulating creatine kinase level|MP:0010238,increased skeletal muscle weight|MP:0011481,anterior iris synechia|MP:0021155,abnormal heart left ventricle wall thickness
MGI:4440458	Dag1<tm3Kcam>	MP:0004021,abnormal rod electrophysiology|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4940531	Dag1<tm4.1Kcam>	MP:0000752,dystrophic muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001513,limb grasping|MP:0005385,cardiovascular system phenotype|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010053,decreased grip strength
MGI:5308743	Dag1<tm5Kcam>	MP:0002169,no abnormal phenotype detected
MGI:4265856	Dagla<Gt(OST288027)Lex>	MP:0002206,abnormal CNS synaptic transmission|MP:0003465,increased single cell response threshold|MP:0003632,abnormal nervous system morphology
MGI:4881474	Dagla<tm1.1Kano>	MP:0001899,absent long-term depression|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003632,abnormal nervous system morphology
MGI:4432581	Dagla<tm1a(EUCOMM)Wtsi>	MP:0000601,small liver|MP:0000692,small spleen|MP:0000706,small thymus|MP:0000774,decreased brain size|MP:0001258,decreased body length|MP:0001488,increased startle reflex|MP:0002188,small heart|MP:0002691,small stomach|MP:0003641,small lung|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:4438719	Dagla<tm1Pado>	MP:0001262,decreased body weight|MP:0001547,abnormal lipid level|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004981,decreased neuronal precursor cell number|MP:0009967,abnormal neuron proliferation
MGI:3529581	Daglb<Gt(OST195261)Lex>	MP:0001547,abnormal lipid level|MP:0003631,nervous system phenotype|MP:0003632,abnormal nervous system morphology|MP:0009967,abnormal neuron proliferation
MGI:4881524	Daglb<tm1.1Kano>	MP:0003631,nervous system phenotype
MGI:3580236	dali	MP:0000445,short snout|MP:0001274,curly vibrissae
MGI:5755383	Dalrd3<em1(IMPC)J>	MP:0020870,decreased thigmotaxis
MGI:7380639	Dancr<em1.1Bcgen>	MP:0000598,abnormal liver morphology|MP:0004502,decreased incidence of tumors by chemical induction
MGI:3056132	Dand5<tm1Belo>	MP:0001706,abnormal left-right axis patterning|MP:0002083,premature death|MP:0002766,situs inversus|MP:0003178,left pulmonary isomerism|MP:0004252,abnormal direction of heart looping|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3528694	Dao<G181R>	MP:0001393,ataxia|MP:0001408,stereotypic behavior|MP:0002204,abnormal synaptic neurotransmitter level|MP:0009747,impaired behavioral response to xenobiotic|MP:0030639,decreased circulating taurine level|MP:0030656,decreased circulating glycine level|MP:0030659,decreased glycine level|MP:0030673,increased circulating alanine level|MP:0030694,increased circulating serine level|MP:0030706,increased glutamine level|MP:0030736,increased glutamic acid level|MP:0030740,decreased circulating glutamic acid level
MGI:5708529	Dao<tm1Ttsu>	MP:0001363,increased anxiety-related response|MP:0030691,increased serine level|MP:0030694,increased circulating serine level
MGI:5911513	Dap3<em1(IMPC)J>	MP:0002968,increased circulating alkaline phosphatase level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3530362	Dap3<Gt(OST147863)Lex>	MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0004180,failure of initiation of embryo turning|MP:0004258,abnormal placenta size|MP:0006035,abnormal mitochondrial morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013502,decreased fibroblast apoptosis
MGI:4111957	Dapk1<Gt(IST12766D5)Tigm>	MP:0001902,reduced NMDA-mediated synaptic currents|MP:0003204,decreased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury
MGI:4440532	Dapk1<tm1Akc>	MP:0002703,abnormal renal tubule morphology|MP:0008944,decreased sensitivity to induced cell death|MP:0011372,decreased renal tubule apoptosis
MGI:5548588	Dapk1<tm1b(EUCOMM)Hmgu>	MP:0001406,abnormal gait
MGI:3052030	Dapk1<tm1Yuk>	MP:0011372,decreased renal tubule apoptosis
MGI:3882715	Dapk3<Gt(YTA407)Byg>	MP:0001672,abnormal embryo development|MP:0002169,no abnormal phenotype detected|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:6727864	Dapk3<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:6336115	Dapl1<em1(IMPC)Kmpc>	MP:0000063,decreased bone mineral density|MP:0001417,decreased exploration in new environment|MP:0002075,abnormal coat/hair pigmentation|MP:0002834,decreased heart weight|MP:0003795,abnormal bone structure|MP:0004924,abnormal behavior|MP:0010124,decreased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:6370165	Dapl1<em1Nju>	MP:0000351,increased cell proliferation|MP:0005549,retina pigment epithelium hyperplasia
MGI:3652582	Dapp1<Gt(OST111213)Lex>	MP:0001800,abnormal humoral immune response|MP:0002412,increased susceptibility to bacterial infection|MP:0005093,decreased B cell proliferation|MP:0008498,decreased IgG3 level
MGI:2680020	Dapp1<tm1Mnz>	MP:0001806,decreased IgM level|MP:0005093,decreased B cell proliferation|MP:0008168,decreased B-1a cell number|MP:0008217,abnormal B cell activation|MP:0008498,decreased IgG3 level
MGI:4455440	Dap<tm1a(KOMP)Mbp>	MP:0001312,abnormal cornea morphology|MP:0001554,increased circulating free fatty acids level|MP:0002833,increased heart weight|MP:0010123,increased bone mineral content
MGI:5906383	Dars1<Gt(Ayu17-9366)Tgjp>	MP:0003984,embryonic growth retardation|MP:0009142,decreased prepulse inhibition|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4362200	Dars2<tm1a(KOMP)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0011100,preweaning lethality, complete penetrance
MGI:2446804	Datd<DBA/2J>	MP:0005416,abnormal circulating protein level
MGI:5311383	Daw1<b2b1116Clo>	MP:0000273,overriding aortic valve|MP:0000644,dextrocardia|MP:0000694,spleen hypoplasia|MP:0003178,left pulmonary isomerism|MP:0004133,heterotaxia|MP:0010402,ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010808,right-sided stomach|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011250,abdominal situs ambiguus|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia|MP:0011683,dual inferior vena cava
MGI:5431501	Daw1<b2b1584Clo>	MP:0000284,double outlet right ventricle|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0000690,absent spleen|MP:0002745,abnormal atrioventricular valve morphology|MP:0003178,left pulmonary isomerism|MP:0004113,abnormal aortic arch morphology|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0006063,abnormal inferior vena cava morphology|MP:0011250,abdominal situs ambiguus|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:6276921	Daxx<em1(IMPC)Mbp>	MP:0000274,enlarged heart|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2179457	Daxx<tm1Led>	MP:0001675,abnormal ectoderm development|MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0003891,increased allantois apoptosis|MP:0005380,embryo phenotype|MP:0006386,absent somites|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012701,increased embryonic neuroepithelium apoptosis|MP:0013181,absent placenta|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3051780	Daxx<tm1Maul>	MP:0003708,binucleate|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3840084	Daxx<tm2Led>	MP:0002169,no abnormal phenotype detected
MGI:7425629	Dazap1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001402,decreased locomotor activity|MP:0001404,no spontaneous movement|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4950678	Dazap1<tm1.1Pyen>	MP:0002169,no abnormal phenotype detected
MGI:4950679	Dazap1<tm1.2Pyen>	MP:0001156,abnormal spermatogenesis|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance
MGI:4950677	Dazap1<tm1Pyen>	MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001265,decreased body size|MP:0001919,abnormal reproductive system physiology|MP:0001925,male infertility|MP:0002083,premature death|MP:0002160,abnormal reproductive system morphology|MP:0002631,abnormal epididymis morphology|MP:0002682,decreased mature ovarian follicle number|MP:0002685,abnormal spermatogonia proliferation|MP:0006379,abnormal spermatocyte morphology|MP:0009661,abnormal pregnancy|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0020550,multinucleated giant male germ cells
MGI:6414488	Dazap2<em1(IMPC)Bay>	MP:0001325,abnormal retina morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology
MGI:3036037	Dazap2<Gt(pGTV1)6-12Sms>	MP:0002169,no abnormal phenotype detected
MGI:2181904	Dazl<tm1Hjc>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0002777,absent ovarian follicles|MP:0006362,abnormal male germ cell morphology
MGI:3841006	Dbacl<C57BL/6Jcl>	MP:0004031,insulitis|MP:0004803,increased susceptibility to autoimmune diabetes
MGI:1857644	Dbf	MP:0000107,abnormal frontal bone morphology|MP:0000108,midline facial cleft|MP:0000149,abnormal scapula morphology|MP:0000428,abnormal craniofacial morphology|MP:0000432,abnormal head morphology|MP:0000441,increased cranium width|MP:0000554,abnormal carpal bone morphology|MP:0000556,abnormal hindlimb morphology|MP:0000558,abnormal tibia morphology|MP:0000562,polydactyly|MP:0000574,abnormal foot pad morphology|MP:0000576,clubfoot|MP:0000585,kinked tail|MP:0000588,thick tail|MP:0000830,abnormal diencephalon morphology|MP:0000919,cranioschisis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001505,hunched posture|MP:0001698,decreased embryo size|MP:0001785,edema|MP:0001891,hydrocephaly|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0002111,abnormal tail morphology|MP:0002187,abnormal fibula morphology|MP:0002636,delayed vaginal opening|MP:0002687,oligozoospermia|MP:0002764,short tibia|MP:0003723,abnormal long bone morphology|MP:0004083,polysyndactyly|MP:0004342,scapular bone foramen|MP:0004358,bowed tibia|MP:0004361,bowed ulna|MP:0004372,bowed fibula|MP:0004374,bowed radius|MP:0004574,broad limb buds|MP:0004650,increased lumbar vertebrae number|MP:0004686,decreased length of long bones|MP:0004852,decreased testis weight|MP:0005104,abnormal tarsal bone morphology|MP:0005371,limbs/digits/tail phenotype|MP:0005382,craniofacial phenotype|MP:0005508,abnormal skeleton morphology|MP:0010099,abnormal thoracic cage shape|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0020242,increased autopod size|MP:0030030,Wormian bones|MP:0030189,broad snout|MP:0030353,wide sagittal suture|MP:0030363,abnormal anterior fontanelle morphology|MP:0030431,wide metopic suture
MGI:5494452	Dbf4<tm1b(KOMP)Wtsi>	MP:0001513,limb grasping|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5495939	Dbh<tm1(flpo)Pjen>	MP:0002169,no abnormal phenotype detected|MP:0006207,embryonic lethality during organogenesis|MP:0011091,prenatal lethality, complete penetrance
MGI:1857556	Dbh<tm1Rpa>	MP:0000266,abnormal heart morphology|MP:0001265,decreased body size|MP:0001344,blepharoptosis|MP:0001732,postnatal growth retardation|MP:0001742,absent circulating adrenaline|MP:0001743,absent circulating noradrenaline|MP:0001745,increased circulating corticosterone level|MP:0001906,increased dopamine level|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002696,decreased circulating glucagon level|MP:0002711,decreased glucagon secretion|MP:0005331,insulin resistance|MP:0005449,abnormal food intake|MP:0005560,decreased circulating glucose level|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:1928960	Dbh<tm2(Th)Rpa>	MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4419106	Dbil5<tm1(KOMP)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005559,increased circulating glucose level|MP:0005568,increased circulating total protein level
MGI:5498509	Dbi<tm1Kier>	MP:0011092,embryonic lethality, complete penetrance
MGI:4939621	Dbi<tm1Smdp>	MP:0000367,abnormal coat/ hair morphology|MP:0000609,abnormal liver physiology|MP:0000746,weakness|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002060,abnormal skin morphology|MP:0005178,increased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005670,abnormal white adipose tissue physiology|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0011083,lethality at weaning, complete penetrance
MGI:2654910	dblr	MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000585,kinked tail|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001648,abnormal apoptosis
MGI:3664319	Dbm2<C57BL/6J>	MP:0002078,abnormal glucose homeostasis|MP:0005559,increased circulating glucose level
MGI:6257430	Dbn1<em1(IMPC)Bay>	MP:0001399,hyperactivity|MP:0001510,abnormal coat appearance|MP:0001566,increased circulating phosphate level
MGI:6158479	Dbn1<em2(IMPC)Mbp>	MP:0001700,abnormal embryo turning|MP:0001726,abnormal allantois morphology|MP:0002824,abnormal chorioallantoic fusion
MGI:5763775	Dbn1<tm1.1Lbc>	MP:0000807,abnormal hippocampus morphology|MP:0001900,impaired synaptic plasticity|MP:0009936,abnormal dendritic spine morphology
MGI:4438710	Dbn1<tm1.1Shira>	MP:0009456,impaired cued conditioning behavior
MGI:4363390	Dbn1<tm1a(KOMP)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0000218,increased leukocyte cell number|MP:0001262,decreased body weight|MP:0002591,decreased mean corpuscular volume|MP:0002942,decreased circulating alanine transaminase level|MP:0003019,increased circulating chloride level|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0005632,decreased circulating aspartate transaminase level|MP:0010025,decreased total body fat amount|MP:0010088,decreased circulating fructosamine level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5501061	Dbn1<tm1b(KOMP)Wtsi>	MP:0000137,abnormal vertebrae morphology|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000602,dilated liver sinusoidal space|MP:0000783,abnormal forebrain morphology|MP:0000787,abnormal telencephalon morphology|MP:0001404,no spontaneous movement|MP:0001415,increased exploration in new environment|MP:0001491,unresponsive to tactile stimuli|MP:0001566,increased circulating phosphate level|MP:0001697,abnormal embryo size|MP:0002702,decreased circulating free fatty acids level|MP:0002757,decreased vertical activity|MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0003019,increased circulating chloride level|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0008026,abnormal brain white matter morphology|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008128,abnormal brain internal capsule morphology|MP:0008922,abnormal cervical rib|MP:0008935,decreased mean platelet volume|MP:0009141,increased prepulse inhibition|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010067,increased red blood cell distribution width|MP:0010092,increased circulating magnesium level|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness|MP:0013279,increased fasting circulating glucose level|MP:0013824,abnormal hypoglossal canal morphology|MP:0013826,absent hypoglossal canal|MP:0013834,thin hypoglossal nerve|MP:0013835,absent hypoglossal nerve|MP:0013915,abnormal brachial plexus formation|MP:0014017,abnormal Wolffian duct connection
MGI:5513763	Dbndd2<tm1b(EUCOMM)Wtsi>	MP:0001147,small testis|MP:0002764,short tibia|MP:0004930,small epididymis|MP:0005505,thrombocytosis|MP:0005554,decreased circulating creatinine level|MP:0009142,decreased prepulse inhibition|MP:0011874,enlarged urinary bladder
MGI:3706950	Dbnl<Gt(betageo)11Byg>	MP:0000745,tremors|MP:0000754,paresis|MP:0001262,decreased body weight|MP:0001806,decreased IgM level|MP:0001828,abnormal T cell activation|MP:0002444,abnormal T cell physiology|MP:0002460,decreased immunoglobulin level|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0008495,decreased IgG1 level|MP:0008688,decreased interleukin-2 secretion|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5812932	Dbnl<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000208,decreased hematocrit|MP:0001289,persistence of hyaloid vascular system|MP:0001402,decreased locomotor activity|MP:0001488,increased startle reflex|MP:0002590,increased mean corpuscular volume|MP:0002644,decreased circulating triglyceride level|MP:0002792,abnormal retina vasculature morphology|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0004738,abnormal auditory brainstem response|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005559,increased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005567,decreased circulating total protein level|MP:0008259,abnormal optic disk morphology|MP:0010052,increased grip strength|MP:0010097,abnormal retina blood vessel morphology|MP:0011941,increased fluid intake|MP:0011965,decreased total retina thickness
MGI:3629216	Dbnl<tm1Jwnd>	MP:0000420,ruffled hair|MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000947,convulsive seizures|MP:0001175,abnormal lung morphology|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001522,impaired swimming|MP:0001544,abnormal cardiovascular system physiology|MP:0001954,respiratory distress|MP:0001958,emphysema|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0004770,abnormal synaptic vesicle recycling|MP:0004952,increased spleen weight|MP:0013807,generalized edema
MGI:2183196	Dbp<tm1Schb>	MP:0001402,decreased locomotor activity|MP:0020470,shortened circadian behavior period|MP:0020477,abnormal locomotor circadian rhythm
MGI:3880498	Dbr1<Gt(YTA280)Byg>	MP:0004816,abnormal class switch recombination|MP:0011091,prenatal lethality, complete penetrance
MGI:5635044	Dbr1<tm1.1(KOMP)Vlcg>	MP:0001303,abnormal lens morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011436,decreased urine magnesium level|MP:0013292,embryonic lethality prior to organogenesis
MGI:2154035	Dbsty1<NZO/HlLt>	MP:0001260,increased body weight|MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level
MGI:2156063	Dbsty2<NZO/HlLt>	MP:0000008,increased white adipose tissue amount
MGI:2448657	Dbsty3<NZO/HlLt>	MP:0001260,increased body weight|MP:0002089,abnormal postnatal growth/weight/body size|MP:0005331,insulin resistance
MGI:2389464	Dbsty4<NZO/HlLt>	MP:0001559,hyperglycemia
MGI:3525662	Dbts1<SM/J>	MP:0005293,impaired glucose tolerance
MGI:3525697	Dbts2<SM/J>	MP:0005293,impaired glucose tolerance
MGI:3704091	Dbt<tm1Geh>	MP:0001954,respiratory distress|MP:0003311,aminoaciduria|MP:0003717,pallor|MP:0005202,lethargy|MP:0005311,abnormal circulating amino acid level|MP:0011085,postnatal lethality, complete penetrance|MP:0030674,decreased circulating alanine level|MP:0030710,decreased circulating glutamine level|MP:0030740,decreased circulating glutamic acid level
MGI:3757953	Dbx1<tm1(DTA)Apie>	MP:0000788,abnormal cerebral cortex morphology|MP:0003631,nervous system phenotype|MP:0005267,abnormal olfactory cortex morphology
MGI:2182329	Dbx1<tm1Tmj>	MP:0000846,abnormal medulla oblongata morphology|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0003245,abnormal GABAergic neuron morphology|MP:0005423,abnormal somatic nervous system physiology|MP:0010745,abnormal pre-Botzinger complex morphology|MP:0010746,abnormal pre-Botzinger complex physiology|MP:0011087,neonatal lethality, complete penetrance|MP:0021102,abnormal ventral interneuron 0 morphology
MGI:5696633	Dbx1<tm2Jcor>	MP:0002169,no abnormal phenotype detected
MGI:7258337	Dbx2<em1Ddu>	MP:0005390,skeleton phenotype|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6341951	Dbx2<em1(IMPC)Bay>	MP:0003795,abnormal bone structure
MGI:5529061	Dcaf10<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0002590,increased mean corpuscular volume|MP:0004924,abnormal behavior|MP:0005561,increased mean corpuscular hemoglobin|MP:0011396,abnormal sleep behavior|MP:0020870,decreased thigmotaxis
MGI:4841129	Dcaf11<tm1a(KOMP)Wtsi>	MP:0002875,decreased erythrocyte cell number
MGI:7703157	Dcaf11<tm1d(KOMP)Wtsi>	MP:0000609,abnormal liver physiology|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002727,decreased circulating insulin level|MP:0004129,abnormal respiratory quotient|MP:0004890,decreased energy expenditure|MP:0005331,insulin resistance|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008432,abnormal long-term spatial reference memory|MP:0010379,decreased respiratory quotient|MP:0012006,abnormal hippocampus physiology|MP:0014367,impaired long-term object recognition memory|MP:0014369,enhanced spatial working memory|MP:0020870,decreased thigmotaxis|MP:0031391,increased locomotor activity
MGI:6341838	Dcaf12<em1(IMPC)Ccpcz>	MP:0001417,decreased exploration in new environment|MP:0005655,increased aggression|MP:0008935,decreased mean platelet volume|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0013772,increased effector memory T-helper cell number
MGI:7333167	Dcaf12l1<em1Marp>	MP:0005389,reproductive system phenotype
MGI:6256448	Dcaf13<em1Hyfn>	MP:0001730,embryonic growth arrest|MP:0002663,absent blastocoele|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012111,failure of morula compaction
MGI:6509579	Dcaf13<em2Hyfn>	MP:0001125,abnormal oocyte morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001131,abnormal ovarian follicle morphology|MP:0001134,absent corpus luteum|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0002777,absent ovarian follicles|MP:0004805,absent oocytes|MP:0005621,abnormal cell physiology|MP:0009648,abnormal superovulation|MP:0011121,decreased primordial ovarian follicle number|MP:0011124,increased primary ovarian follicle number|MP:0013272,abnormal translation|MP:0031020,premature ovarian failure|MP:0031381,decreased secondary ovarian follicle number|MP:0031382,absent secondary ovarian follicles|MP:0031420,decreased superovulation rate|MP:0031422,failure of superovulation
MGI:5002969	Dcaf15<tm1a(EUCOMM)Hmgu>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000455,abnormal maxilla morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001293,anophthalmia|MP:0001307,fused cornea and lens|MP:0001312,abnormal cornea morphology|MP:0001325,abnormal retina morphology|MP:0001926,female infertility|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002188,small heart|MP:0002968,increased circulating alkaline phosphatase level|MP:0003604,single kidney|MP:0004599,abnormal vertebral arch morphology|MP:0004906,enlarged uterus|MP:0004953,decreased spleen weight|MP:0005015,increased T cell number|MP:0008044,increased NK cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0010851,decreased effector memory CD8-positive, alpha-beta T cell number|MP:0010935,increased airway resistance|MP:0011239,abnormal skin coloration|MP:0013436,increased CD8-positive, naive alpha-beta T cell number|MP:0013763,increased T-helper cell number|MP:0013771,decreased effector memory T-helper cell number
MGI:6164306	Dcaf17<tm1.1Assi>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009376,abnormal manchette morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0014052,increased male germ cell apoptosis|MP:0031354,abnormal acrosome assembly|MP:0031373,abnormal manchette perinuclear ring morphology|MP:0031386,elongated manchette
MGI:5287018	Dcaf1<TgTn(sb-cHS4,Tyr)2514D-2Ove>	MP:0006204,embryonic lethality before implantation
MGI:3814063	Dcaf1<tm1.2Yxi>	MP:0011092,embryonic lethality, complete penetrance
MGI:7425630	Dcaf5<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002100,abnormal tooth morphology|MP:0002339,abnormal lymph node morphology|MP:0002764,short tibia|MP:0002966,decreased circulating alkaline phosphatase level|MP:0004952,increased spleen weight|MP:0005419,decreased circulating serum albumin level|MP:0008044,increased NK cell number|MP:0010067,increased red blood cell distribution width|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0011044,increased lung elastance
MGI:6368839	Dcaf6<tm1.1Ntuy>	MP:0001405,impaired coordination|MP:0002106,abnormal muscle physiology|MP:0012106,impaired exercise endurance|MP:0013239,impaired skeletal muscle regeneration|MP:0031328,delayed skeletal muscle regeneration
MGI:5819215	Dcaf7<tm1b(EUCOMM)Wtsi>	MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005568,increased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness
MGI:6341909	Dcaf8<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level|MP:0010895,increased lung compliance|MP:0011045,decreased lung elastance|MP:0020421,increased freezing behavior
MGI:6724058	Dcaf8<em1Rbren>	MP:0001922,reduced male fertility|MP:0009230,abnormal sperm head morphology|MP:0020451,decreased sperm progressive motility|MP:0031436,decreased copulatory plug deposition
MGI:5616357	Dcakd<tm1b(EUCOMM)Hmgu>	MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level
MGI:5569304	Dcbld2<tm1.1Mhms>	MP:0000233,abnormal blood flow velocity|MP:0002792,abnormal retina vasculature morphology|MP:0003719,abnormal pericyte morphology|MP:0005602,decreased angiogenesis|MP:0011134,decreased lung endothelial cell migration|MP:0011140,decreased lung endothelial cell proliferation
MGI:4363322	Dcbld2<tm1a(KOMP)Wtsi>	MP:0001512,trunk curl|MP:0002833,increased heart weight|MP:0004599,abnormal vertebral arch morphology|MP:0004794,increased anti-nuclear antigen antibody level|MP:0010088,decreased circulating fructosamine level
MGI:2446481	Dcc<kanga>	MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0002196,absent corpus callosum|MP:0002878,abnormal corticospinal tract morphology|MP:0002961,abnormal axon guidance|MP:0008223,absent hippocampal commissure|MP:0009681,abnormal pyramidal decussation morphology|MP:0020560,abnormal pontine nuclei morphology
MGI:5444031	Dcc<Tg(H2-Kb-Jak2*V617F)1Shmd>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000321,increased bone marrow cell number|MP:0000322,increased granulocyte number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002123,abnormal definitive hematopoiesis|MP:0002417,abnormal megakaryocyte morphology|MP:0002872,polycythemia|MP:0004952,increased spleen weight|MP:0005065,abnormal neutrophil morphology|MP:0005505,thrombocytosis|MP:0008254,increased megakaryocyte cell number|MP:0008476,increased spleen red pulp amount|MP:0008479,decreased spleen white pulp amount|MP:0008973,decreased erythroid progenitor cell number|MP:0010373,myeloid hyperplasia|MP:0011178,increased erythroblast number|MP:0020399,enhanced megakaryocyte emperipolesis
MGI:5312257	Dcc<tm1.1Mehl>	MP:0002404,increased intestinal adenoma incidence|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0005381,digestive/alimentary phenotype|MP:0013502,decreased fibroblast apoptosis|MP:0014234,decreased enterocyte apoptosis
MGI:5308795	Dcc<tm1.1Nki>	MP:0002152,abnormal brain morphology|MP:0002196,absent corpus callosum|MP:0011087,neonatal lethality, complete penetrance
MGI:5766182	Dcc<tm1b(NCOM)Mfgc>	MP:0000219,increased neutrophil cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:1934924	Dcc<tm1Wbg>	MP:0001330,abnormal optic nerve morphology|MP:0001332,abnormal optic nerve innervation|MP:0001436,abnormal suckling behavior|MP:0001954,respiratory distress|MP:0002006,neoplasm|MP:0002196,absent corpus callosum|MP:0003631,nervous system phenotype|MP:0005103,abnormal retina pigmentation|MP:0008223,absent hippocampal commissure|MP:0009677,abnormal spinal cord dorsal column morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011723,ectopic neuron|MP:0014751,abnormal commissural neuron axon guidance|MP:0020560,abnormal pontine nuclei morphology
MGI:5288002	Dcdc2a<tm1.1Jjlo>	MP:0003631,nervous system phenotype
MGI:5288003	Dcdc2a<tm1.2Jjlo>	MP:0001363,increased anxiety-related response|MP:0001463,abnormal spatial learning|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory|MP:0014365,impaired short-term object recognition memory
MGI:5637175	Dcdc2b<tm1b(KOMP)Wtsi>	MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number
MGI:4458574	Dcdc2c<tm1a(KOMP)Wtsi>	MP:0000137,abnormal vertebrae morphology|MP:0002833,increased heart weight
MGI:4867020	Dchs1<tm1.2Irv>	MP:0000031,abnormal cochlea morphology|MP:0000137,abnormal vertebrae morphology|MP:0000282,abnormal interatrial septum morphology|MP:0000286,abnormal mitral valve morphology|MP:0000477,abnormal intestine morphology|MP:0000527,abnormal kidney development|MP:0001732,postnatal growth retardation|MP:0002151,abnormal neural tube morphology|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002989,small kidney|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003051,curly tail|MP:0003641,small lung|MP:0003675,kidney cyst|MP:0004174,abnormal spine curvature|MP:0004321,short sternum|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0004754,abnormal kidney collecting duct morphology|MP:0004860,dilated kidney collecting duct|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005225,abnormal vertebrae development|MP:0006120,mitral valve prolapse|MP:0008272,abnormal endochondral bone ossification|MP:0008277,abnormal sternum ossification|MP:0010614,abnormal mitral valve cusp morphology|MP:0010617,thick mitral valve cusps|MP:0011085,postnatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0012279,wide sternum
MGI:5806456	Dck<m1Btlr>	MP:0001606,impaired hematopoiesis|MP:0001805,decreased IgG level|MP:0002497,increased IgE level|MP:0005017,decreased B cell number|MP:0005425,increased macrophage cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0020001,decreased response to antigen
MGI:5426400	Dck<memi>	MP:0000691,enlarged spleen|MP:0000706,small thymus|MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0003135,increased erythroid progenitor cell number|MP:0005017,decreased B cell number|MP:0005025,abnormal response to infection|MP:0005348,increased T cell proliferation|MP:0006413,increased T cell apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008250,abnormal myeloid leukocyte morphology|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number
MGI:4440453	Dck<tm1.1Radu>	MP:0000240,extramedullary hematopoiesis|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0002407,abnormal double-negative T cell morphology|MP:0002640,reticulocytosis|MP:0004952,increased spleen weight|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005046,absent spleen white pulp|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008186,increased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008463,abnormal peripheral lymph node morphology
MGI:5449592	Dck<tm1.2Radu>	MP:0002169,no abnormal phenotype detected
MGI:2384319	dcl	MP:0001393,ataxia|MP:0001410,head bobbing|MP:0001524,impaired limb coordination|MP:0002152,abnormal brain morphology|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0003043,hypoalgesia
MGI:5475100	Dclk1<tm1.1(cre/ERT2)Seno>	MP:0005381,digestive/alimentary phenotype
MGI:3617379	Dclk1<tm1.1Jgg>	MP:0000780,abnormal corpus callosum morphology|MP:0002196,absent corpus callosum|MP:0002961,abnormal axon guidance|MP:0008223,absent hippocampal commissure
MGI:5543459	Dclk1<tm1a(EUCOMM)Wtsi>	MP:0001258,decreased body length|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005343,increased circulating aspartate transaminase level|MP:0010052,increased grip strength|MP:0010093,decreased circulating magnesium level
MGI:3626361	Dclk1<tm1Caw>	MP:0002882,abnormal neuron morphology|MP:0005404,abnormal axon morphology
MGI:6272643	Dclk2<em1(IMPC)J>	MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount
MGI:8158768	Dclk3<tm1.1Geno>	MP:0002169,no abnormal phenotype detected|MP:0005386,behavior/neurological phenotype|MP:0008432,abnormal long-term spatial reference memory
MGI:8158770	Dclk3<tm1.2Geno>	MP:0000807,abnormal hippocampus morphology|MP:0001363,increased anxiety-related response|MP:0002797,increased thigmotaxis|MP:0003631,nervous system phenotype|MP:0004077,abnormal striatum morphology|MP:0030635,increased taurine level|MP:0030706,increased glutamine level|MP:0030707,decreased glutamine level|MP:0030737,decreased glutamic acid level|MP:0030753,decreased choline level
MGI:3789591	Dclre1a<tm1Remo>	MP:0003702,abnormal chromosome morphology
MGI:3511952	Dclre1a<tm1Rleg>	MP:0000352,decreased cell proliferation|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002083,premature death|MP:0002412,increased susceptibility to bacterial infection|MP:0005387,immune system phenotype|MP:0009321,increased histiocytic sarcoma incidence|MP:0009442,increased ovarian teratoma incidence|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010308,decreased tumor latency|MP:0010383,increased adenoma incidence|MP:0012431,increased lymphoma incidence
MGI:2180947	Dclre1a<tm1Roka>	MP:0005621,abnormal cell physiology|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:4818788	Dclre1b<tm1Schg>	MP:0001698,decreased embryo size|MP:0002058,neonatal lethality
MGI:5562416	Dclre1c<m1Brck>	MP:0000727,absent CD8-positive, alpha-beta T cells|MP:0003790,absent CD4-positive, alpha-beta T cells|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0008070,absent T cells|MP:0008071,absent B cells|MP:0008209,decreased pre-B cell number|MP:0010130,decreased DN1 thymic pro-T cell number|MP:0010136,decreased DN4 thymocyte number
MGI:5615709	Dclre1c<m1Btlr>	MP:0000219,increased neutrophil cell number|MP:0001806,decreased IgM level|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005425,increased macrophage cell number|MP:0008044,increased NK cell number|MP:0008083,decreased single-positive T cell number|MP:0020001,decreased response to antigen|MP:0020154,impaired humoral immune response
MGI:6199679	Dclre1c<M2Btlr>	MP:0001260,increased body weight|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6199683	Dclre1c<m3Btlr>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0008040,decreased NK T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:2667616	Dclre1c<tm1.1Fwa>	MP:0001802,arrested B cell differentiation|MP:0001825,arrested T cell differentiation
MGI:3802969	Dclre1c<tm1.1Jpdv>	MP:0001825,arrested T cell differentiation|MP:0002144,abnormal B cell differentiation|MP:0008754,abnormal T cell receptor V(D)J recombination
MGI:2667614	Dclre1c<tm1Fwa>	MP:0000694,spleen hypoplasia|MP:0000715,decreased thymocyte number|MP:0001802,arrested B cell differentiation|MP:0001825,arrested T cell differentiation|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0004030,induced chromosome breakage|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0005092,decreased double-positive T cell number|MP:0008071,absent B cells|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008213,absent immature B cells|MP:0008758,abnormal T cell receptor beta chain V(D)J recombination|MP:0008866,chromosomal instability
MGI:3843046	Dclre1c<tm1Jsek>	MP:0000694,spleen hypoplasia|MP:0000715,decreased thymocyte number|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0004030,induced chromosome breakage|MP:0005017,decreased B cell number|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008186,increased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008758,abnormal T cell receptor beta chain V(D)J recombination|MP:0008760,abnormal immunoglobulin heavy chain V(D)J recombination
MGI:4366774	Dclre1c<tm2.2Jpdv>	MP:0000715,decreased thymocyte number|MP:0001802,arrested B cell differentiation|MP:0001825,arrested T cell differentiation|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008211,decreased mature B cell number|MP:0008213,absent immature B cells|MP:0008247,abnormal mononuclear cell morphology|MP:0009339,decreased splenocyte number
MGI:3574021	Dclre1c<tm2Mcow>	MP:0000692,small spleen|MP:0000715,decreased thymocyte number|MP:0001802,arrested B cell differentiation|MP:0001825,arrested T cell differentiation|MP:0002217,small lymph nodes|MP:0002339,abnormal lymph node morphology|MP:0002442,abnormal leukocyte physiology|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0004956,decreased thymus weight|MP:0005016,decreased lymphocyte cell number|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005621,abnormal cell physiology|MP:0008470,abnormal spleen B cell follicle morphology|MP:0010250,absent thymus cortex
MGI:5660397	Dcn<tm1.2Geno>	MP:0002169,no abnormal phenotype detected|MP:0005391,vision/eye phenotype
MGI:2153002	Dcn<tm1Ioz>	MP:0000519,hydronephrosis|MP:0000619,salivary gland epithelial hyperplasia|MP:0001199,thin skin|MP:0001244,thin dermal layer|MP:0001800,abnormal humoral immune response|MP:0001923,reduced female fertility|MP:0002006,neoplasm|MP:0002411,decreased susceptibility to bacterial infection|MP:0002704,tubular nephritis|MP:0002705,dilated renal tubule|MP:0003089,decreased skin tensile strength|MP:0003215,renal interstitial fibrosis|MP:0003668,abnormal periodontal ligament morphology|MP:0003669,periodontal ligament hypercellularity|MP:0003795,abnormal bone structure|MP:0004153,increased renal tubule apoptosis|MP:0004970,kidney atrophy|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005390,skeleton phenotype|MP:0005391,vision/eye phenotype|MP:0005397,hematopoietic system phenotype|MP:0005421,loose skin|MP:0005503,abnormal tendon morphology|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0009640,abnormal renal tubule epithelium morphology|MP:0010792,abnormal stomach mucosa morphology|MP:0011346,renal tubule atrophy|MP:0011501,increased glomerular capsule space
MGI:6711459	Dcp1a<em1Ttsu>	MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7425337	Dcp2<em1Ysa>	MP:0005380,embryo phenotype
MGI:4127248	Dcp2<Gt(RRE061)Byg>	MP:0002169,no abnormal phenotype detected
MGI:6459898	Dcp2<tm1.1Smoc>	MP:0011092,embryonic lethality, complete penetrance
MGI:5618767	Dcp2<tm1b(KOMP)Wtsi>	MP:0002075,abnormal coat/hair pigmentation|MP:0002833,increased heart weight|MP:0011100,preweaning lethality, complete penetrance
MGI:6459897	Dcp2<tm1Smoc>	MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002780,decreased circulating testosterone level|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0014052,increased male germ cell apoptosis
MGI:5505910	Dcps<tm1b(EUCOMM)Hmgu>	MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6696421	Dcst1<em1Nino>	MP:0000242,impaired fertilization|MP:0001925,male infertility
MGI:6696422	Dcst2<em1Nino>	MP:0000242,impaired fertilization|MP:0001925,male infertility
MGI:3589828	Dcstamp<tm1Suda>	MP:0000062,increased bone mineral density|MP:0000067,osteopetrosis|MP:0001541,abnormal osteoclast physiology|MP:0002451,abnormal macrophage physiology|MP:0005605,increased bone mass|MP:0008396,abnormal osteoclast differentiation|MP:0010872,increased trabecular bone mass
MGI:6831164	Dct<em1Jkn>	MP:0000371,diluted coat color
MGI:6831165	Dct<em2Jkn>	MP:0000371,diluted coat color
MGI:6831166	Dct<em3Jkn>	MP:0000371,diluted coat color|MP:0005103,abnormal retina pigmentation|MP:0010192,abnormal retina melanin granule morphology
MGI:3769512	Dctn1<tm1.1Cai>	MP:0001730,embryonic growth arrest|MP:0006042,increased apoptosis|MP:0011092,embryonic lethality, complete penetrance
MGI:4432339	Dctn1<tm1a(EUCOMM)Wtsi>	MP:0005553,increased circulating creatinine level|MP:0011100,preweaning lethality, complete penetrance
MGI:3522484	Dctn1<tm1Cai>	MP:0000938,motor neuron degeneration|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001407,short stride length|MP:0001695,abnormal gastrulation|MP:0001730,embryonic growth arrest|MP:0002151,abnormal neural tube morphology|MP:0006042,increased apoptosis|MP:0006386,absent somites|MP:0011092,embryonic lethality, complete penetrance
MGI:6196333	Dctn1<tm2.1Cai>	MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002757,decreased vertical activity|MP:0003354,astrocytosis|MP:0005059,lysosomal protein accumulation|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0008918,microgliosis|MP:0009417,skeletal muscle atrophy|MP:0009422,decreased gastrocnemius weight
MGI:5606342	Dctn2<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:6153314	Dctn4<em1(IMPC)Wtsi>	MP:0001554,increased circulating free fatty acids level|MP:0011100,preweaning lethality, complete penetrance
MGI:5313698	Dctn5<b2b315Clo>	MP:0000273,overriding aortic valve|MP:0000433,microcephaly|MP:0000452,abnormal mouth morphology|MP:0002092,abnormal eye morphology|MP:0002639,micrognathia|MP:0005157,holoprosencephaly|MP:0008528,polycystic kidney|MP:0009579,acephaly|MP:0010402,ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0011252,situs inversus totalis|MP:0011666,double outlet right ventricle, ventricular defect committed to aorta
MGI:4363526	Dctn5<tm2a(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002608,increased hematocrit|MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance
MGI:5755486	Dctn6<em1(IMPC)J>	MP:0001728,failure of embryo implantation|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0009142,decreased prepulse inhibition|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011184,absent embryonic epiblast|MP:0011185,absent primitive endoderm|MP:0012102,absent trophectoderm|MP:0013292,embryonic lethality prior to organogenesis
MGI:1856379	Dct<slt>	MP:0000371,diluted coat color
MGI:1856380	Dct<slt-2J>	MP:0000371,diluted coat color
MGI:3040516	Dct<Slt-lt3J>	MP:0000371,diluted coat color|MP:0005102,abnormal iris pigmentation
MGI:5548330	Dct<tm1b(KOMP)Mbp>	MP:0001566,increased circulating phosphate level|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0005344,increased circulating bilirubin level
MGI:2387116	Dct<tm1(cre)Bee>	MP:0000371,diluted coat color|MP:0003631,nervous system phenotype|MP:0005391,vision/eye phenotype|MP:0010771,integument phenotype
MGI:4330751	Dcun1d1<Gt(RRR261)Byg>	MP:0000694,spleen hypoplasia|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001265,decreased body size|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002223,lymphoid hypoplasia|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0003205,testicular atrophy|MP:0005578,teratozoospermia|MP:0008770,decreased survivor rate|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0011704,decreased fibroblast proliferation
MGI:6140185	Dcun1d3<em1(IMPC)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005344,increased circulating bilirubin level|MP:0005560,decreased circulating glucose level|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:6356813	Dcun1d5<em1(IMPC)H>	MP:0001392,abnormal locomotor behavior|MP:0002965,increased circulating serum albumin level|MP:0005568,increased circulating total protein level
MGI:5692681	Dcxr<tm1.1(KOMP)Vlcg>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3624537	Dcx<tm1.2Ffr>	MP:0004101,abnormal brain interneuron morphology|MP:0004279,abnormal rostral migratory stream morphology
MGI:4441970	Dcx<tm1a(EUCOMM)Wtsi>	MP:0002079,increased circulating insulin level|MP:0003019,increased circulating chloride level|MP:0005633,increased circulating sodium level
MGI:2387757	Dcx<tm1Caw>	MP:0000807,abnormal hippocampus morphology|MP:0001265,decreased body size|MP:0001462,abnormal avoidance learning behavior|MP:0001463,abnormal spatial learning|MP:0001922,reduced male fertility|MP:0002083,premature death|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004924,abnormal behavior|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0010053,decreased grip strength|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014745,abnormal hippocampal mossy fiber infrapyramidal bundle morphology
MGI:5514501	Dcx<tm1(HBEGF)Pfba>	MP:0003240,loss of hippocampal neurons
MGI:7642254	Dda1<em1(IMPC)Bay>	MP:0001529,abnormal vocalization|MP:0011100,preweaning lethality, complete penetrance
MGI:5792874	Ddah1<tm1.1Geno>	MP:0005311,abnormal circulating amino acid level|MP:0005332,abnormal amino acid level
MGI:5424370	Ddah1<tm1.1Yjch>	MP:0002842,increased systemic arterial blood pressure|MP:0003957,abnormal nitric oxide homeostasis|MP:0005311,abnormal circulating amino acid level|MP:0005332,abnormal amino acid level|MP:0005385,cardiovascular system phenotype|MP:0005584,abnormal enzyme/coenzyme activity
MGI:5792873	Ddah1<tm1Geno>	MP:0003710,abnormal physiological neovascularization|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005602,decreased angiogenesis
MGI:3711768	Ddah1<tm1Pval>	MP:0000484,abnormal pulmonary artery morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001613,abnormal vasodilation|MP:0003025,increased vasoconstriction|MP:0003393,decreased cardiac output|MP:0003957,abnormal nitric oxide homeostasis|MP:0004875,increased mean systemic arterial blood pressure|MP:0005311,abnormal circulating amino acid level|MP:0005333,decreased heart rate|MP:0011091,prenatal lethality, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance
MGI:4887350	Ddah1<tm1Yjch>	MP:0002842,increased systemic arterial blood pressure|MP:0003820,increased left ventricle systolic pressure|MP:0003957,abnormal nitric oxide homeostasis|MP:0004875,increased mean systemic arterial blood pressure|MP:0004878,increased systemic vascular resistance|MP:0005311,abnormal circulating amino acid level|MP:0005332,abnormal amino acid level|MP:0005385,cardiovascular system phenotype|MP:0005595,abnormal vascular smooth muscle physiology|MP:0006144,increased systemic arterial systolic blood pressure
MGI:5527610	Ddah1<tm2a(EUCOMM)Wtsi>	MP:0002875,decreased erythrocyte cell number|MP:0010052,increased grip strength
MGI:5619616	Ddah2<tm1.1(KOMP)Vlcg>	MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4415202	Ddah2<tm1Roab>	MP:0010768,mortality/aging
MGI:6341874	Ddb1<em1(IMPC)Ccpcz>	MP:0000538,abnormal urinary bladder morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001399,hyperactivity|MP:0002060,abnormal skin morphology|MP:0011874,enlarged urinary bladder|MP:0013292,embryonic lethality prior to organogenesis
MGI:3698414	Ddb1<tm1.1Spg>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3698413	Ddb1<tm1Spg>	MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000828,abnormal fourth ventricle morphology|MP:0000852,small cerebellum|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0001147,small testis|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001915,intracranial hemorrhage|MP:0001916,intracerebral hemorrhage|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0003202,abnormal neuron apoptosis|MP:0004938,dilated vasculature|MP:0004950,abnormal brain vasculature morphology|MP:0005250,decreased Sertoli cell number|MP:0005537,abnormal cerebral aqueduct morphology|MP:0006052,cerebellum hemorrhage|MP:0006254,thin cerebral cortex|MP:0006308,enlarged seminiferous tubules|MP:0006418,abnormal testis cord formation|MP:0006428,ectopic Sertoli cells|MP:0008535,enlarged lateral ventricles|MP:0008794,increased lens epithelium apoptosis|MP:0011087,neonatal lethality, complete penetrance
MGI:3036308	Ddb2<tm1Linn>	MP:0001203,increased sensitivity to skin irradiation|MP:0001265,decreased body size|MP:0004228,decreased cellular sensitivity to ionizing radiation induced cell death|MP:0004501,increased incidence of tumors by UV-induction
MGI:3511965	Ddb2<tm1Pra>	MP:0002020,increased tumor incidence|MP:0002083,premature death
MGI:3707217	Ddb2<tm1Vri>	MP:0001203,increased sensitivity to skin irradiation|MP:0004207,increased squamous cell carcinoma incidence
MGI:6273964	Ddc<em1(IMPC)Hmgu>	MP:0002100,abnormal tooth morphology|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance
MGI:3530288	Ddc<Gt(OST129277)Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:5495816	Ddc<tm1.1Nwlh>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001290,delayed eyelid opening|MP:0001344,blepharoptosis|MP:0001363,increased anxiety-related response|MP:0001386,abnormal maternal nurturing|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0001905,abnormal dopamine level|MP:0002204,abnormal synaptic neurotransmitter level|MP:0002574,increased vertical activity|MP:0002690,akinesia|MP:0002797,increased thigmotaxis|MP:0002804,abnormal motor learning|MP:0003313,abnormal locomotor activation|MP:0003964,abnormal noradrenaline level|MP:0005333,decreased heart rate|MP:0005424,jerky movement|MP:0005643,decreased dopamine level|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0008911,induced hyperactivity|MP:0010070,decreased serotonin level|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5296328	Ddc<tm1.1Rhrs>	MP:0002083,premature death|MP:0002136,abnormal kidney physiology|MP:0002667,decreased circulating aldosterone level|MP:0002833,increased heart weight|MP:0002871,albuminuria|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003674,oxidative stress|MP:0003917,increased kidney weight|MP:0004217,salt-sensitive hypertension|MP:0004875,increased mean systemic arterial blood pressure|MP:0005553,increased circulating creatinine level|MP:0005582,increased renin activity|MP:0005583,decreased renin activity|MP:0005643,decreased dopamine level|MP:0006144,increased systemic arterial systolic blood pressure|MP:0011405,tubulointerstitial nephritis
MGI:6151137	Ddc<tm1Umon>	MP:0001386,abnormal maternal nurturing|MP:0001405,impaired coordination|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001923,reduced female fertility|MP:0002085,abnormal embryonic tissue morphology|MP:0005643,decreased dopamine level|MP:0010070,decreased serotonin level|MP:0011049,impaired adaptive thermogenesis|MP:0011092,embryonic lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:4354227	dde	MP:0000564,syndactyly|MP:0001325,abnormal retina morphology|MP:0001386,abnormal maternal nurturing|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001958,emphysema|MP:0002083,premature death|MP:0002427,disproportionate dwarf|MP:0003299,gastric polyps|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0008280,abnormal male germ cell apoptosis|MP:0008730,fused phalanges|MP:0013528,thyroid gland cyst
MGI:5629573	Ddhd1<tm1.1Katn>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005578,teratozoospermia|MP:0009237,kinked sperm flagellum|MP:0009243,hairpin sperm flagellum|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009834,abnormal sperm annulus morphology|MP:0014464,decreased sperm mitochondrial sheath size
MGI:4362938	Ddhd1<tm1a(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0002833,increased heart weight|MP:0003960,increased lean body mass
MGI:5629572	Ddhd1<tm1Katn>	MP:0001922,reduced male fertility
MGI:5662251	Ddhd2<tm1Crv>	MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0001516,abnormal motor coordination/balance|MP:0001525,impaired balance|MP:0001547,abnormal lipid level|MP:0002152,abnormal brain morphology|MP:0002757,decreased vertical activity|MP:0002882,abnormal neuron morphology|MP:0005317,increased triglyceride level|MP:0008432,abnormal long-term spatial reference memory|MP:0012307,impaired spatial learning
MGI:6724340	Ddi1<em1Qsh>	MP:0005389,reproductive system phenotype
MGI:8224165	Ddi2<em1Rase>	MP:0001730,embryonic growth arrest|MP:0002169,no abnormal phenotype detected|MP:0003077,abnormal cell cycle|MP:0003674,oxidative stress|MP:0003984,embryonic growth retardation|MP:0005266,abnormal metabolism|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis|MP:0020354,increased endoplasmic reticulum stress
MGI:5810736	Ddi2<tm1b(EUCOMM)Hmgu>	MP:0000538,abnormal urinary bladder morphology|MP:0002169,no abnormal phenotype detected|MP:0003984,embryonic growth retardation|MP:0004174,abnormal spine curvature|MP:0005293,impaired glucose tolerance|MP:0010935,increased airway resistance|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation|MP:0031661,prenatal lethality prior to heart atrial septation, complete penetrance
MGI:6152456	Ddias<em1(IMPC)Mbp>	MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:6368171	Ddias<tm1Enik>	MP:0000274,enlarged heart|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002396,abnormal hematopoietic system morphology/development|MP:0004901,decreased male germ cell number|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008943,increased sensitivity to induced cell death|MP:0013501,increased fibroblast apoptosis|MP:0014040,increased cellular sensitivity to DNA damaging agent induced cell death|MP:0014634,decreased round spermatid number
MGI:5569942	Ddit3<tm1.1(KOMP)Vlcg>	MP:0005343,increased circulating aspartate transaminase level
MGI:2179046	Ddit3<tm1Aki>	MP:0002176,increased brain weight|MP:0003204,decreased neuron apoptosis|MP:0006043,decreased apoptosis
MGI:2654034	Ddit3<tm1Dron>	MP:0005164,abnormal response to injury|MP:0005379,endocrine/exocrine gland phenotype|MP:0006043,decreased apoptosis|MP:0011075,abnormal macrophage activation involved in immune response|MP:0011081,decreased macrophage apoptosis|MP:0013502,decreased fibroblast apoptosis|MP:0020935,decreased susceptibility to Retroviridae infection
MGI:5441015	Ddit3<tm2.1Dron>	MP:0001402,decreased locomotor activity|MP:0002628,hepatic steatosis|MP:0003982,increased cholesterol level|MP:0004890,decreased energy expenditure|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005658,increased susceptibility to diet-induced obesity|MP:0008037,abnormal T cell morphology|MP:0010024,increased total body fat amount|MP:0031602,white adipose tissue inflammation
MGI:4126302	Ddit4<Gt(XE390)Byg>	MP:0010768,mortality/aging
MGI:8224528	Ddit4l<em1Omunc>	MP:0003058,increased insulin secretion|MP:0005292,improved glucose tolerance|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0009113,increased pancreatic beta cell mass|MP:0009293,decreased inguinal fat pad weight|MP:0014118,decreased pancreatic beta cell apoptosis
MGI:8224527	Ddit4l<em2Omunc>	MP:0005292,improved glucose tolerance|MP:0005378,growth/size/body region phenotype
MGI:5432482	Ddit4<tm1.1Sinc>	MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype
MGI:3497720	Ddit4<tm1Fein>	MP:0002792,abnormal retina vasculature morphology|MP:0010050,hypermyelination|MP:0030006,decreased retina apoptosis
MGI:3583650	Ddit4<tm1Lwe>	MP:0000358,abnormal cell morphology
MGI:5301891	Ddn<tm1Ktry>	MP:0005367,renal/urinary system phenotype
MGI:5548405	Ddost<tm1.1(KOMP)Vlcg>	MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0002768,small adrenal glands|MP:0002874,decreased hemoglobin content|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3628810	Ddo<tm1Rdl>	MP:0030742,increased aspartic acid level
MGI:3625623	Ddo<tm1Snyd>	MP:0001260,increased body weight|MP:0001380,decreased male mating frequency|MP:0001442,decreased grooming behavior|MP:0005646,abnormal pituitary gland physiology|MP:0009856,failure of ejaculation|MP:0030742,increased aspartic acid level
MGI:5791873	Ddr1<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5760026	Ddr1<tm1Lex>	MP:0001364,decreased anxiety-related response|MP:0011640,abnormal aorta collagen fibril morphology|MP:0031391,increased locomotor activity
MGI:2388024	Ddr1<tm1Wfv>	MP:0000438,abnormal cranium morphology|MP:0000628,abnormal mammary gland development|MP:0001728,failure of embryo implantation|MP:0001732,postnatal growth retardation|MP:0001882,abnormal lactation|MP:0002177,abnormal outer ear morphology|MP:0002896,abnormal bone mineralization|MP:0002962,increased urine protein level|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0008060,abnormal podocyte slit diaphragm morphology|MP:0009503,abnormal mammary gland duct morphology|MP:0009640,abnormal renal tubule epithelium morphology|MP:0010173,increased mammary gland epithelial cell proliferation|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011419,erythrocyturia
MGI:5008734	Ddr2<m1Anu>	MP:0001265,decreased body size|MP:0030066,short face
MGI:3640081	Ddr2<slie>	MP:0000445,short snout|MP:0001134,absent corpus luteum|MP:0001142,abnormal vagina orifice morphology|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0002427,disproportionate dwarf|MP:0002750,exophthalmos|MP:0002780,decreased circulating testosterone level|MP:0002784,abnormal Sertoli cell morphology|MP:0003960,increased lean body mass|MP:0005181,decreased circulating estradiol level|MP:0005185,decreased circulating progesterone level|MP:0005361,small pituitary gland|MP:0005459,decreased percent body fat/body weight|MP:0005559,increased circulating glucose level|MP:0005566,decreased blood urea nitrogen level|MP:0006378,abnormal spermatogonia morphology|MP:0008489,slow postnatal weight gain|MP:0008770,decreased survivor rate|MP:0008869,anovulation|MP:0010124,decreased bone mineral content|MP:0013599,Leydig cell atrophy|MP:0014633,decreased spermatid number|MP:0031422,failure of superovulation
MGI:5662369	Ddr2<tm1.1(cre/Esr1*)Rcow>	MP:0000266,abnormal heart morphology|MP:0000438,abnormal cranium morphology|MP:0000447,flattened snout|MP:0000547,short limbs|MP:0001262,decreased body weight|MP:0001921,reduced fertility|MP:0001924,infertility|MP:0002188,small heart|MP:0002764,short tibia|MP:0002834,decreased heart weight|MP:0004084,abnormal cardiac muscle relaxation|MP:0004565,decreased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0008028,pregnancy-related premature death|MP:0010754,abnormal heart left ventricle pressure|MP:0011925,abnormal heart echocardiography feature|MP:0020254,decreased collagen level
MGI:4820346	Ddr2<tm1a(EUCOMM)Wtsi>	MP:0001265,decreased body size|MP:0001924,infertility|MP:0005379,endocrine/exocrine gland phenotype
MGI:5806884	Ddr2<tm1b(EUCOMM)Wtsi>	MP:0001265,decreased body size|MP:0001924,infertility|MP:0005379,endocrine/exocrine gland phenotype
MGI:2388155	Ddr2<tm1Kln>	MP:0000074,abnormal neurocranium morphology|MP:0000102,abnormal nasal bone morphology|MP:0000352,decreased cell proliferation|MP:0000438,abnormal cranium morphology|MP:0000445,short snout|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002427,disproportionate dwarf|MP:0002908,delayed wound healing|MP:0004686,decreased length of long bones|MP:0005352,small cranium|MP:0006395,abnormal epiphyseal plate morphology|MP:0008525,decreased cranium height
MGI:5925352	Ddrgk1<em1Brle>	MP:0000164,abnormal cartilage development|MP:0002875,decreased erythrocyte cell number|MP:0005650,abnormal limb bud morphology|MP:0011261,abnormal limb mesenchyme morphology|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5692746	Ddrgk1<tm1b(EUCOMM)Hmgu>	MP:0000600,liver hypoplasia|MP:0001698,decreased embryo size|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0004229,abnormal embryonic erythropoiesis|MP:0004230,abnormal embryonic erythrocyte morphology|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012556,increased cell death
MGI:5896836	Ddrgk1<tm1c(EUCOMM)Hmgu>	MP:0000223,decreased monocyte cell number|MP:0000334,decreased granulocyte number|MP:0001263,weight loss|MP:0002083,premature death|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004229,abnormal embryonic erythropoiesis|MP:0005016,decreased lymphocyte cell number|MP:0005152,pancytopenia|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:1856597	dds	MP:0001265,decreased body size|MP:0002075,abnormal coat/hair pigmentation
MGI:5645788	Ddt<tm1Lhy>	MP:0003037,increased myocardial infarct size|MP:0005385,cardiovascular system phenotype|MP:0010632,cardiac muscle necrosis|MP:0031217,increased susceptibility to myocardial ischemic injury|MP:0031633,decreased heart left ventricle muscle contractility
MGI:7425631	Ddx10<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0003984,embryonic growth retardation|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012058,abnormal morula morphology
MGI:5526028	Ddx10<m1J>	MP:0000111,cleft palate|MP:0000445,short snout|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0003961,decreased lean body mass|MP:0010124,decreased bone mineral content|MP:0011862,decreased cranium length|MP:0013618,decreased areal bone mineral density
MGI:3578542	Ddx11<cetus>	MP:0000929,open neural tube|MP:0000930,wavy neural tube|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0003400,kinked neural tube|MP:0004251,failure of heart looping|MP:0004559,small allantois|MP:0006386,absent somites|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011199,abnormal amniotic cavity morphology|MP:0012183,decreased paraxial mesoderm size|MP:0013504,increased embryonic tissue cell apoptosis
MGI:4441046	Ddx11<tm1Jiml>	MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001715,placental labyrinth hypoplasia|MP:0001730,embryonic growth arrest|MP:0003077,abnormal cell cycle|MP:0003400,kinked neural tube|MP:0003891,increased allantois apoptosis|MP:0003984,embryonic growth retardation|MP:0004024,aneuploidy|MP:0006386,absent somites|MP:0008932,abnormal embryonic tissue physiology|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012113,decreased inner cell mass proliferation|MP:0012184,absent paraxial mesoderm|MP:0013504,increased embryonic tissue cell apoptosis
MGI:7520045	Ddx17<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0003961,decreased lean body mass|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6693739	Ddx18<em1.1Shx>	MP:0001730,embryonic growth arrest|MP:0002399,abnormal pluripotent precursor cell morphology|MP:0002663,absent blastocoele|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:7425632	Ddx18<em1(IMPC)Bay>	MP:0001293,anophthalmia|MP:0001697,abnormal embryo size|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0003984,embryonic growth retardation|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012111,failure of morula compaction
MGI:6693700	Ddx19a<em1Chaw>	MP:0011091,prenatal lethality, complete penetrance
MGI:6693701	Ddx19b<em1Chaw>	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0008562,increased interferon-alpha secretion|MP:0008564,increased interferon-beta secretion|MP:0010768,mortality/aging|MP:0011091,prenatal lethality, complete penetrance
MGI:6158486	Ddx19b<em1(IMPC)Mbp>	MP:0001925,male infertility|MP:0009198,abnormal male genitalia morphology
MGI:5569068	Ddx1<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3795148	Ddx20<tm1Yosa>	MP:0001131,abnormal ovarian follicle morphology|MP:0001927,abnormal estrous cycle|MP:0002664,decreased circulating adrenocorticotropin level|MP:0003406,failure of zygotic cell division|MP:0004855,increased ovary weight|MP:0009017,prolonged estrus|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:6285598	Ddx21<em1(IMPC)Bay>	MP:0001727,abnormal embryo implantation|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:5563491	Ddx21<m1Anu>	MP:0008762,embryonic lethality
MGI:6153315	Ddx23<em1(IMPC)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:6152457	Ddx24<em1(IMPC)Mbp>	MP:0000639,abnormal adrenal gland morphology|MP:0001126,abnormal ovary morphology|MP:0001415,increased exploration in new environment|MP:0002135,abnormal kidney morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:4130387	Ddx24<Gt(RRK059)Byg>	MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging|MP:0011092,embryonic lethality, complete penetrance|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0014134,abnormal embryo morphology
MGI:3045804	Ddx25<tm1Mld>	MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001648,abnormal apoptosis|MP:0001925,male infertility|MP:0002786,abnormal Leydig cell morphology|MP:0004852,decreased testis weight|MP:0014052,increased male germ cell apoptosis
MGI:4363861	Ddx27<tm1a(KOMP)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6342462	Ddx31<em1(IMPC)J>	MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance
MGI:5692684	Ddx39a<tm1b(KOMP)Wtsi>	MP:0001510,abnormal coat appearance|MP:0001566,increased circulating phosphate level|MP:0001697,abnormal embryo size|MP:0001711,abnormal placenta morphology|MP:0003231,abnormal placenta vasculature|MP:0004258,abnormal placenta size|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration
MGI:6509428	Ddx39b<em1Cya>	MP:0001658,increased mortality induced by gamma-irradiation|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5774968	Ddx3x<tm1.1Lyou>	MP:0000433,microcephaly|MP:0000913,abnormal brain development|MP:0001700,abnormal embryo turning|MP:0001726,abnormal allantois morphology|MP:0002084,abnormal developmental patterning|MP:0002169,no abnormal phenotype detected|MP:0002189,abnormal myocardial trabeculae morphology|MP:0003077,abnormal cell cycle|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0004559,small allantois|MP:0004760,increased mitotic index|MP:0005312,pericardial effusion|MP:0005621,abnormal cell physiology|MP:0009657,failure of chorioallantoic fusion|MP:0011100,preweaning lethality, complete penetrance|MP:0011257,abnormal head fold morphology|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5774969	Ddx3x<tm1.2Lyou>	MP:0001713,decreased trophoblast giant cell number|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0004259,small placenta|MP:0005033,abnormal trophoblast giant cell morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0010402,ventricular septal defect|MP:0010768,mortality/aging|MP:0011100,preweaning lethality, complete penetrance|MP:0011105,embryonic lethality between implantation and placentation, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012099,decreased spongiotrophoblast size|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance|MP:0030989,decreased spongiotrophoblast cell number
MGI:6323445	Ddx3y<em2Osb>	MP:0005389,reproductive system phenotype
MGI:6401407	Ddx41<tm1.1Arte>	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0020934,increased susceptibility to Retroviridae infection
MGI:5548627	Ddx41<tm1b(KOMP)Wtsi>	MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5637061	Ddx42<tm1b(EUCOMM)Wtsi>	MP:0002836,abnormal chorion morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0005477,increased circulating thyroxine level|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:6357907	Ddx46<em1Caox>	MP:0001265,decreased body size|MP:0002419,abnormal innate immunity|MP:0002451,abnormal macrophage physiology|MP:0008560,increased tumor necrosis factor secretion|MP:0008564,increased interferon-beta secretion|MP:0008575,increased circulating interferon-beta level|MP:0008657,increased interleukin-1 beta secretion|MP:0008705,increased interleukin-6 secretion|MP:0010768,mortality/aging|MP:0011078,increased macrophage cytokine production|MP:0011091,prenatal lethality, complete penetrance|MP:0020914,decreased susceptibility to Riboviria infection
MGI:6388358	Ddx46<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001727,abnormal embryo implantation|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7425633	Ddx47<em1(IMPC)Bay>	MP:0001727,abnormal embryo implantation|MP:0011100,preweaning lethality, complete penetrance|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:2182568	Ddx4<tm1Tnc>	MP:0001125,abnormal oocyte morphology|MP:0001153,small seminiferous tubules|MP:0001925,male infertility|MP:0002982,abnormal primordial germ cell migration|MP:0003205,testicular atrophy|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0008392,decreased primordial germ cell number|MP:0014052,increased male germ cell apoptosis|MP:0030934,decreased primordial germ cell proliferation
MGI:4431446	Ddx51<tm1a(KOMP)Wtsi>	MP:0005179,decreased circulating cholesterol level|MP:0010025,decreased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:4434081	Ddx52<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0002896,abnormal bone mineralization|MP:0008045,decreased NK cell number
MGI:5695924	Ddx54<tm1.1(KOMP)Vlcg>	MP:0000274,enlarged heart|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4434030	Ddx55<tm1a(EUCOMM)Wtsi>	MP:0001510,abnormal coat appearance|MP:0010067,increased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance
MGI:5620213	Ddx59<em1(IMPC)J>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002075,abnormal coat/hair pigmentation|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0014586,decreased egg cylinder size
MGI:5463981	Ddx5<tm1.1Arte>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002216,abnormal seminiferous tubule morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0020362,abnormal male germ cell physiology
MGI:5792890	Ddx60<tm1b(EUCOMM)Wtsi>	MP:0008573,increased circulating interferon-alpha level|MP:0008576,decreased circulating interferon-beta level|MP:0020913,increased susceptibility to Riboviria infection|MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality
MGI:5806064	Ddx60<tm1d(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:6720237	Ddx6<em1.1Ysa>	MP:0001126,abnormal ovary morphology|MP:0001131,abnormal ovarian follicle morphology|MP:0001926,female infertility|MP:0004805,absent oocytes|MP:0009361,abnormal primordial ovarian follicle morphology|MP:0011121,decreased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0031381,decreased secondary ovarian follicle number
MGI:7425331	Ddx6<em1.2Ysa>	MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0002230,abnormal primitive streak formation|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0005221,abnormal rostral-caudal axis patterning|MP:0009850,embryonic lethality between implantation and placentation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6152458	Ddx6<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0001489,decreased startle reflex|MP:0001700,abnormal embryo turning|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0002590,increased mean corpuscular volume|MP:0005561,increased mean corpuscular hemoglobin|MP:0005568,increased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5576138	Deaf1<tm1.1Mico>	MP:0003460,decreased fear-related response|MP:0005386,behavior/neurological phenotype|MP:0012306,enhanced spatial learning
MGI:3035918	Deaf1<tm1Sho>	MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0002151,abnormal neural tube morphology|MP:0004620,cervical vertebral fusion|MP:0008148,abnormal sternocostal joint morphology|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4355415	Decr1<tm1Jkh>	MP:0000603,pale liver|MP:0000745,tremors|MP:0001402,decreased locomotor activity|MP:0002981,increased liver weight|MP:0005202,lethargy|MP:0005281,increased fatty acids level|MP:0005560,decreased circulating glucose level|MP:0011049,impaired adaptive thermogenesis|MP:0031116,microvesicular hepatic steatosis
MGI:5548465	Decr2<tm1b(EUCOMM)Wtsi>	MP:0005553,increased circulating creatinine level|MP:0005573,increased pulmonary respiratory rate|MP:0010052,increased grip strength
MGI:3707325	Dedd<tm1Tmiy>	MP:0001262,decreased body weight|MP:0002175,decreased brain weight|MP:0002834,decreased heart weight|MP:0003402,decreased liver weight|MP:0003918,decreased kidney weight|MP:0004852,decreased testis weight|MP:0004953,decreased spleen weight|MP:0005631,decreased lung weight
MGI:3530790	Def6<Gt(OST307148)Lex>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002359,abnormal spleen germinal center morphology|MP:0002461,increased immunoglobulin level|MP:0002493,increased IgG level|MP:0003009,abnormal cytokine secretion|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005015,increased T cell number|MP:0006414,decreased T cell apoptosis|MP:0008049,increased memory T cell number|MP:0008214,increased immature B cell number
MGI:5637165	Defb14<tm1b(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0002599,increased mean platelet volume|MP:0003442,decreased circulating glycerol level|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content
MGI:5312881	Defb14<tm1Wme>	MP:0005387,immune system phenotype
MGI:7427681	Defb19<em1Cya>	MP:0001923,reduced female fertility|MP:0005410,abnormal fertilization
MGI:7377671	Defb1<em1(IMPC)Mbp>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:2180302	Defb1<tm1Hgu>	MP:0005387,immune system phenotype|MP:0010386,abnormal urinary bladder physiology
MGI:2180305	Defb1<tm1Jmw>	MP:0002412,increased susceptibility to bacterial infection|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5645997	Defb20<tm1b(EUCOMM)Hmgu>	MP:0001925,male infertility|MP:0013278,decreased fasting circulating glucose level
MGI:7447410	Defb34<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity
MGI:3528568	Defb3<tm1Lex>	MP:0002412,increased susceptibility to bacterial infection
MGI:5519129	Defb3<tm1Xen>	MP:0000219,increased neutrophil cell number|MP:0001313,increased incidence of corneal inflammation|MP:0005399,increased susceptibility to fungal infection
MGI:5439010	Defb41<tm1(icre)Psip>	MP:0002169,no abnormal phenotype detected
MGI:5692868	Defb43<tm1b(KOMP)Wtsi>	MP:0000280,thin ventricular wall|MP:0004738,abnormal auditory brainstem response
MGI:7484791	Degs1<em1(IMPC)Mbp>	MP:0001614,abnormal blood vessel morphology|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:3529540	Degs1<Gt(OST368559)Lex>	MP:0000063,decreased bone mineral density|MP:0000416,sparse hair|MP:0000745,tremors|MP:0001192,scaly skin|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001764,abnormal homeostasis|MP:0002083,premature death|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002891,increased insulin sensitivity|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003325,decreased liver function|MP:0003961,decreased lean body mass|MP:0005344,increased circulating bilirubin level|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012232,abnormal ceramide level|MP:0030021,increased muscle cell glucose uptake
MGI:7543601	Degs2<tm1Akih>	MP:0010771,integument phenotype|MP:0020583,decreased ceramide level
MGI:3838711	Dek<tm1Siwe>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:5314347	Del(10)77H	MP:0001732,postnatal growth retardation
MGI:5430227	Del(10Grin3b-Tmem259)1Zang	MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0001265,decreased body size|MP:0003354,astrocytosis|MP:0005404,abnormal axon morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0020354,increased endoplasmic reticulum stress
MGI:4126239	Del(10Mcm9-Asf1a)1Byg	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0011092,embryonic lethality, complete penetrance
MGI:4868462	Del(10Prmt2-Col6a1)1Yah	MP:0000208,decreased hematocrit|MP:0001861,lung inflammation|MP:0002133,abnormal respiratory system physiology|MP:0002405,respiratory system inflammation|MP:0002451,abnormal macrophage physiology|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0008713,abnormal cytokine level|MP:0010067,increased red blood cell distribution width
MGI:4868385	Del(10Prmt2-Cstb)4Yah	MP:0005386,behavior/neurological phenotype
MGI:4818358	Del(10Prmt2-Pdxk)4Yey	MP:0001463,abnormal spatial learning|MP:0001516,abnormal motor coordination/balance|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior
MGI:3803339	Del(10Prtn3-Elane)1Deje	MP:0002463,abnormal neutrophil physiology|MP:0005387,immune system phenotype|MP:0008719,impaired neutrophil recruitment
MGI:5517421	Del(10Taar2-Taar9)1Tboz	MP:0001983,abnormal olfactory system physiology|MP:0008544,impaired olfaction
MGI:5517459	Del(10Taar2-Taar9)2Tboz	MP:0001983,abnormal olfactory system physiology|MP:0008544,impaired olfaction
MGI:6342921	Del(11Arf2-Kansl1)8Yah	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002152,abnormal brain morphology|MP:0002912,abnormal excitatory postsynaptic potential|MP:0004471,short nasal bone|MP:0005386,behavior/neurological phenotype|MP:0009456,impaired cued conditioning behavior|MP:0010025,decreased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012319,fast extinction of fear memory|MP:0014253,decreased paired-pulse ratio|MP:0014367,impaired long-term object recognition memory|MP:0020477,abnormal locomotor circadian rhythm|MP:0021110,increased social investigation|MP:0030069,broad face
MGI:3608909	Del(1)1Brk	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000274,enlarged heart|MP:0000321,increased bone marrow cell number|MP:0000416,sparse hair|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001588,abnormal hemoglobin|MP:0001770,abnormal iron level|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0001940,testis hypoplasia|MP:0001943,abnormal respiration|MP:0002357,abnormal spleen white pulp morphology|MP:0002424,abnormal reticulocyte morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002642,anisocytosis|MP:0002810,microcytic anemia|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0003131,increased erythrocyte cell number|MP:0003631,nervous system phenotype|MP:0003717,pallor|MP:0004152,abnormal circulating iron level|MP:0005097,polychromatophilia|MP:0005159,azoospermia|MP:0005377,hearing/vestibular/ear phenotype|MP:0005378,growth/size/body region phenotype|MP:0005391,vision/eye phenotype|MP:0005505,thrombocytosis|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005637,abnormal iron homeostasis|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008476,increased spleen red pulp amount|MP:0008545,absent sperm flagellum|MP:0008738,abnormal liver iron level|MP:0008807,increased liver iron level|MP:0009703,decreased birth body size|MP:0010752,impaired mucociliary clearance|MP:0010768,mortality/aging|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3766574	Del(11Chad-Hoxb1)19Brd	MP:0001926,female infertility
MGI:3521986	Del(11Cops3-Gid4)2Jrl	MP:0000445,short snout|MP:0000447,flattened snout|MP:0001261,obese|MP:0001300,ocular hypertelorism|MP:0001402,decreased locomotor activity|MP:0001413,abnormal response to new environment|MP:0001469,abnormal contextual conditioning behavior|MP:0001488,increased startle reflex|MP:0002574,increased vertical activity|MP:0004471,short nasal bone|MP:0008862,asymmetric snout
MGI:3521985	Del(11Cops3-Rnf112)1Jrl	MP:0000102,abnormal nasal bone morphology|MP:0000438,abnormal cranium morphology|MP:0000445,short snout|MP:0001259,abnormal body weight|MP:0001261,obese|MP:0001402,decreased locomotor activity|MP:0001922,reduced male fertility|MP:0001929,abnormal gametogenesis|MP:0002064,seizures|MP:0002687,oligozoospermia|MP:0002757,decreased vertical activity|MP:0003997,tonic-clonic seizures|MP:0004471,short nasal bone|MP:0004472,broad nasal bone|MP:0004924,abnormal behavior|MP:0004994,abnormal brain wave pattern|MP:0005458,increased percent body fat/body weight|MP:0008525,decreased cranium height|MP:0008892,abnormal sperm flagellum morphology|MP:0009286,increased abdominal fat pad weight|MP:0009674,decreased birth weight|MP:0020470,shortened circadian behavior period|MP:0030189,broad snout
MGI:3720171	Del(11Cxcl16-Zmynd15)1Ifc	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002451,abnormal macrophage physiology|MP:0004850,abnormal testis weight|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0014052,increased male germ cell apoptosis
MGI:7490277	Del(11Hnf1b-Znhit3)11Moro	MP:0000102,abnormal nasal bone morphology|MP:0000432,abnormal head morphology|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000454,abnormal jaw morphology|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0000783,abnormal forebrain morphology|MP:0000787,abnormal telencephalon morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000808,abnormal hippocampus development|MP:0000819,abnormal olfactory bulb morphology|MP:0000825,dilated lateral ventricle|MP:0000830,abnormal diencephalon morphology|MP:0000837,abnormal hypothalamus morphology|MP:0000847,abnormal metencephalon morphology|MP:0000897,abnormal midbrain morphology|MP:0000913,abnormal brain development|MP:0000934,abnormal telencephalon development|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001292,abnormal lens vesicle development|MP:0001293,anophthalmia|MP:0001698,decreased embryo size|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0003208,abnormal neuromere morphology|MP:0003232,abnormal forebrain development|MP:0003425,abnormal optic vesicle formation|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0004096,abnormal midbrain-hindbrain boundary development|MP:0004269,abnormal optic cup morphology|MP:0004471,short nasal bone|MP:0004631,abnormal auditory cortex morphology|MP:0005237,abnormal olfactory tract morphology|MP:0005293,impaired glucose tolerance|MP:0005325,abnormal renal glomerulus morphology|MP:0005379,endocrine/exocrine gland phenotype|MP:0005545,abnormal lens development|MP:0006106,absent tectum|MP:0006108,abnormal hindbrain development|MP:0006254,thin cerebral cortex|MP:0006294,absent optic vesicle|MP:0006306,abnormal nasal pit morphology|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008817,hematoma|MP:0009725,absent lens vesicle|MP:0009946,abnormal olfactory bulb layer morphology|MP:0010002,abnormal ansiform lobule crus I morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0011380,enlarged brain ventricles|MP:0012089,decreased midbrain size|MP:0012132,abnormal midbrain-hindbrain boundary morphology|MP:0012136,absent forebrain|MP:0012138,decreased forebrain size|MP:0012174,flat head|MP:0012176,abnormal head development|MP:0012265,increased hindbrain size|MP:0012517,absent diencephalon|MP:0012682,abnormal septal nucleus morphology|MP:0013906,absent embryonic telencephalon|MP:0020539,increased cerebellum fastigial nucleus size|MP:0030004,hippocampus hypoplasia|MP:0030034,depressed nasal bridge|MP:0030099,facial asymmetry|MP:0030324,abnormal anterior head development|MP:0031289,unilateral microphthalmia
MGI:3762002	Del(11Hoxb3-Hoxb4)1Karl	MP:0000333,decreased bone marrow cell number|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000694,spleen hypoplasia|MP:0001262,decreased body weight|MP:0002123,abnormal definitive hematopoiesis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004953,decreased spleen weight|MP:0005390,skeleton phenotype|MP:0006410,abnormal common myeloid progenitor cell morphology
MGI:3614966	Del(11Irf1-D11Mit23)1Rub	MP:0000274,enlarged heart|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0003975,increased circulating VLDL triglyceride level|MP:0003978,decreased circulating carnitine level|MP:0003982,increased cholesterol level|MP:0008033,impaired lipolysis|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0031418,increased cardiac muscle triglyceride level
MGI:2686850	Del(11Jmjd6-Mettl23)1Flv	MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0001176,abnormal lung development|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0009642,abnormal blood homeostasis|MP:0011089,perinatal lethality, complete penetrance
MGI:3043930	Del(11Jmjd6-Mettl23)1Ysfk	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000600,liver hypoplasia|MP:0000704,abnormal thymus development|MP:0001648,abnormal apoptosis|MP:0001798,impaired macrophage phagocytosis|MP:0001823,thymus hypoplasia|MP:0002874,decreased hemoglobin content|MP:0003799,impaired macrophage chemotaxis|MP:0004200,decreased fetal size|MP:0009395,increased nucleated erythrocyte cell number|MP:0011087,neonatal lethality, complete penetrance
MGI:3766573	Del(11Mpo-Chad)18Brd	MP:0000266,abnormal heart morphology|MP:0000273,overriding aortic valve|MP:0001926,female infertility|MP:0004110,transposition of great arteries|MP:0010418,perimembraneous ventricular septal defect|MP:0010419,inlet ventricular septal defect|MP:0010449,heart right ventricle outflow tract stenosis|MP:0010458,pulmonary trunk hypoplasia|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance
MGI:5472123	Del(11Nlrp1a-Nlrp1c-ps)1Smas	MP:0000222,decreased neutrophil cell number|MP:0001260,increased body weight|MP:0002608,increased hematocrit|MP:0002875,decreased erythrocyte cell number|MP:0020913,increased susceptibility to Riboviria infection
MGI:3838141	Del(11Nme2-Nme1)1Zou	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0002642,anisocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0004151,decreased circulating iron level|MP:0004152,abnormal circulating iron level|MP:0004810,decreased hematopoietic stem cell number|MP:0005397,hematopoietic system phenotype|MP:0005416,abnormal circulating protein level|MP:0009395,increased nucleated erythrocyte cell number|MP:0011087,neonatal lethality, complete penetrance
MGI:7413090	Del(11Rr1367-Rr238931)1Cya	MP:0000088,short mandible|MP:0005381,digestive/alimentary phenotype|MP:0005390,skeleton phenotype|MP:0030258,small mandibular condyloid process|MP:0030283,small mandibular coronoid process
MGI:7398573	Del(11Rr325)1Smun	MP:0011092,embryonic lethality, complete penetrance
MGI:6740196	Del(1)1Smun	MP:0000564,syndactyly|MP:0002109,abnormal limb morphology|MP:0003631,nervous system phenotype|MP:0005390,skeleton phenotype|MP:0008730,fused phalanges
MGI:3055320	Del(11Stat5a-Stat5b)1Mam	MP:0000208,decreased hematocrit|MP:0000692,small spleen|MP:0000706,small thymus|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001802,arrested B cell differentiation|MP:0002052,decreased tumor incidence|MP:0002083,premature death|MP:0002217,small lymph nodes|MP:0005017,decreased B cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008348,absent gamma-delta T cells|MP:0008388,hypochromic microcytic anemia|MP:0010938,decreased total lung capacity|MP:0011087,neonatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3710158	Del(12Bdkrb2-Bdkrb1)1Mki	MP:0002135,abnormal kidney morphology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005566,decreased blood urea nitrogen level|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5766043	Del(12Mir379-Mir410)2Arte	MP:0003631,nervous system phenotype|MP:0010768,mortality/aging
MGI:5524113	Del(13)1Mgld	MP:0001290,delayed eyelid opening
MGI:6514360	Del(13)1N	MP:0012167,abnormal epigenetic regulation of gene expression|MP:0020845,abnormal DNA-templated transcription
MGI:5304931	Del(13)80H	MP:0001265,decreased body size
MGI:4430923	Del(13F2rl1-F2r)1Cgh	MP:0000914,exencephaly|MP:0011102,embryonic lethality, incomplete penetrance
MGI:1856175	Del(1)3H	MP:0000373,belly spot|MP:0000585,kinked tail|MP:0001732,postnatal growth retardation|MP:0002939,head spot|MP:0006204,embryonic lethality before implantation
MGI:6246513	Del(13Naip1-Naip5)1Vnce	MP:0001876,decreased inflammatory response|MP:0005571,decreased lactate dehydrogenase level
MGI:5451135	Del(13Simc1-B4galt7)2Dja	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0003961,decreased lean body mass|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0005367,renal/urinary system phenotype|MP:0005382,craniofacial phenotype|MP:0005390,skeleton phenotype|MP:0009674,decreased birth weight|MP:0011305,dilated kidney calyx|MP:0011622,abnormal habituation to a novel odor
MGI:3714752	Del(14)3Mom	MP:0001003,abnormal olfactory receptor morphology|MP:0005394,taste/olfaction phenotype
MGI:7581999	Del(14Gjb6-Cryl1)1Lmon	MP:0000046,abnormal sulcus ampullaris morphology|MP:0001967,deafness|MP:0003825,abnormal pillar cell morphology|MP:0004591,enlarged tectorial membrane|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013808,abnormal tunnel of Corti morphology
MGI:3775059	Del(14Ltb4r2-Ltb4r1)1Bodd	MP:0003436,decreased susceptibility to induced arthritis|MP:0005387,immune system phenotype|MP:0008720,impaired neutrophil chemotaxis|MP:0014704,decreased pannus formation
MGI:6454679	Del(14Prss51-Prss55)3Osb	MP:0001925,male infertility|MP:0005389,reproductive system phenotype|MP:0009647,decreased fertilization frequency|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031012,impaired sperm migration in female genital tract
MGI:4437040	Del(14Trim13-Dleu2)4Rdf	MP:0002023,increased B cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0005014,increased B cell number|MP:0005153,abnormal B cell proliferation|MP:0008167,increased B-1a cell number|MP:0008478,increased spleen white pulp amount|MP:0008770,decreased survivor rate
MGI:5304666	Del(14Trim13-Rnaseh2b)6Rdf	MP:0002083,premature death|MP:0002401,abnormal lymphopoiesis|MP:0005014,increased B cell number|MP:0009319,increased small lymphocytic lymphoma incidence|MP:0010337,increased chronic lymphocytic leukemia incidence|MP:0011092,embryonic lethality, complete penetrance|MP:0012431,increased lymphoma incidence
MGI:4410584	Del(15Krt7-Krt18)1Tmm	MP:0002085,abnormal embryonic tissue morphology|MP:0003984,embryonic growth retardation|MP:0005266,abnormal metabolism|MP:0005380,embryo phenotype|MP:0005448,abnormal energy homeostasis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:7434630	Del(15Rr21-Rr303293)1Jta	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:7411151	Del(15Rr316124-Rr313939)2Fsp	MP:0000333,decreased bone marrow cell number|MP:0000334,decreased granulocyte number|MP:0005017,decreased B cell number|MP:0005378,growth/size/body region phenotype|MP:0005397,hematopoietic system phenotype|MP:0008254,increased megakaryocyte cell number|MP:0010768,mortality/aging|MP:0013415,increased myeloid cell number in bone marrow
MGI:7434631	Del(15Rr357-Rr303293)2Jta	MP:0004502,decreased incidence of tumors by chemical induction|MP:0005367,renal/urinary system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:6281724	Del(15Rr38-Rr313939)7Fsp	MP:0000111,cleft palate|MP:0000443,abnormal snout morphology|MP:0000445,short snout|MP:0001732,postnatal growth retardation|MP:0005170,cleft upper lip|MP:0005380,embryo phenotype|MP:0009903,abnormal medial nasal prominence morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5431211	Del(16App-Runx1)5Yah	MP:0005385,cardiovascular system phenotype|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3487281	Del(16Cbr1-Fam3b)1Rhr	MP:0000879,increased Purkinje cell number|MP:0001265,decreased body size|MP:0001924,infertility|MP:0005238,increased brain size|MP:0005386,behavior/neurological phenotype|MP:0008914,enlarged cerebellum|MP:0008925,increased cerebellar granule cell number|MP:0020083,decreased hippocampus volume
MGI:3640128	Del(16Cldn5-Hira)5Bld	MP:0002080,prenatal lethality|MP:0003631,nervous system phenotype
MGI:3702630	Del(16Dgcr2-Arvcf)1Ais	MP:0002169,no abnormal phenotype detected|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3702642	Del(16Dgcr2-Hira)1Rak	MP:0000680,absent parathyroid glands|MP:0003139,patent ductus arteriosus|MP:0004113,abnormal aortic arch morphology|MP:0004158,right aortic arch|MP:0004160,retroesophageal right subclavian artery|MP:0005387,immune system phenotype|MP:0010402,ventricular septal defect|MP:0010464,abnormal aortic arch and aortic arch branch attachment|MP:0010465,aberrant origin of the right subclavian artery|MP:0010663,abnormal brachiocephalic trunk morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011659,interrupted aortic arch, type b|MP:0012729,abnormal common carotid artery morphology
MGI:3798964	Del(16Dgcr2-Hira)3Aam	MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0002127,abnormal cardiovascular system morphology|MP:0008143,abnormal dendrite morphology|MP:0008428,abnormal spatial working memory|MP:0009142,decreased prepulse inhibition|MP:0009538,abnormal synapse morphology|MP:0009936,abnormal dendritic spine morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0014376,decreased miniature excitatory postsynaptic current frequency|MP:0014812,abnormal brain physiology
MGI:6845041	Del(16Dppa4-Dppa2)1Reik	MP:0003718,maternal effect|MP:0005389,reproductive system phenotype|MP:0011100,preweaning lethality, complete penetrance
MGI:5689441	Del(16Dyrk1a-Kcnj6)14Yey	MP:0004179,transmission ratio distortion
MGI:3640126	Del(16Es2el-Sept5)3Bld	MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0009142,decreased prepulse inhibition
MGI:3640125	Del(16Es2el-T10)2Bld	MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype
MGI:3623881	Del(16Es2el-Ufd1l)217Bld	MP:0000266,abnormal heart morphology|MP:0000273,overriding aortic valve|MP:0003008,enhanced long-term potentiation|MP:0004101,abnormal brain interneuron morphology|MP:0004160,retroesophageal right subclavian artery|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0006009,abnormal neuronal migration|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0009142,decreased prepulse inhibition|MP:0009967,abnormal neuron proliferation|MP:0010402,ventricular septal defect|MP:0010449,heart right ventricle outflow tract stenosis|MP:0010465,aberrant origin of the right subclavian artery|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011659,interrupted aortic arch, type b|MP:0012460,decreased dentate gyrus size|MP:0030340,absent fourth pharyngeal arch artery|MP:0030341,fourth pharyngeal arch artery hypoplasia
MGI:4399150	Del(16Fam162a-Stfa2l1)1Gusa	MP:0002169,no abnormal phenotype detected
MGI:5519049	Del(16Hspa13-App)3Yah	MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0002106,abnormal muscle physiology|MP:0003858,enhanced coordination|MP:0004819,decreased skeletal muscle mass|MP:0006036,abnormal mitochondrial physiology|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0010053,decreased grip strength|MP:0010954,abnormal cellular respiration|MP:0030937,increased mitochondrial DNA content|MP:0031391,increased locomotor activity
MGI:5689439	Del(16Kcnj15-Mx2)13Yey	MP:0004179,transmission ratio distortion
MGI:5427092	Del(16Lipi-Usp25)1Dja	MP:0001360,abnormal social investigation|MP:0001698,decreased embryo size|MP:0002628,hepatic steatosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005394,taste/olfaction phenotype|MP:0005458,increased percent body fat/body weight|MP:0005658,increased susceptibility to diet-induced obesity|MP:0010024,increased total body fat amount|MP:0010934,increased subcutaneous adipose tissue amount|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012505,increased neural tube apoptosis
MGI:6729278	Del(16Pi4ka-Hira)1Atai	MP:0001402,decreased locomotor activity|MP:0001488,increased startle reflex|MP:0001823,thymus hypoplasia|MP:0002127,abnormal cardiovascular system morphology|MP:0002635,reduced sensorimotor gating|MP:0004157,interrupted aortic arch|MP:0009142,decreased prepulse inhibition|MP:0009456,impaired cued conditioning behavior|MP:0010487,abnormal right subclavian artery morphology|MP:0010748,abnormal visual evoked potential|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012295,enhanced discrimination learning|MP:0020396,abnormal social recognition|MP:0020467,abnormal circadian behavior|MP:0020477,abnormal locomotor circadian rhythm
MGI:5689383	Del(16Setd4-Kcnj6)12Yey	MP:0004179,transmission ratio distortion
MGI:3640127	Del(16T10-Hira)4Bld	MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0009142,decreased prepulse inhibition
MGI:5305766	Del(16Tiam1-Kcnj6)7Yey	MP:0011400,lethality, complete penetrance
MGI:5578624	Del(16Tmprss2-Erg)1Sho	MP:0000659,prostate gland hyperplasia|MP:0002006,neoplasm
MGI:4421830	Del(16Tssk1-Tssk2)1Agr	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia
MGI:3803634	Del(16Tssk1-Tssk2)1Joch	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0014636,decreased elongated spermatid number
MGI:3701447	Del(16Zfp520-Slc25a1)1Awb	MP:0001405,impaired coordination|MP:0003088,abnormal prepulse inhibition|MP:0003631,nervous system phenotype|MP:0004965,inner cell mass degeneration|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5558061	Del(17)5Mom	MP:0001376,abnormal mating receptivity|MP:0003631,nervous system phenotype|MP:0003862,decreased aggression towards male mice|MP:0008779,abnormal maternal behavior|MP:0011678,abnormal vomeronasal sensory neuron physiology|MP:0011679,abnormal vomeronasal sensory neuron morphology
MGI:4367904	Del(17Abcg1-Cbs)2Yah	MP:0001360,abnormal social investigation|MP:0001402,decreased locomotor activity|MP:0003008,enhanced long-term potentiation|MP:0005386,behavior/neurological phenotype|MP:0009453,enhanced contextual conditioning behavior|MP:0012335,increased circulating homocysteine level
MGI:4818361	Del(17Abcg1-Rrp1b)5Yey	MP:0001463,abnormal spatial learning|MP:0001522,impaired swimming|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior
MGI:2447644	Del(17Abcg5-Abcg8)1Hobb	MP:0002599,increased mean platelet volume|MP:0003179,thrombocytopenia|MP:0004773,abnormal bile composition|MP:0005178,increased circulating cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0010026,decreased liver cholesterol level|MP:0010027,increased liver cholesterol level|MP:0010078,increased circulating phytosterol level|MP:0013756,increased intestinal phytosterol absorption
MGI:7482524	Del(17Btnl1-Btnl6)1Ahay	MP:0008359,decreased CD4-positive, gamma-delta intraepithelial T cell number
MGI:5503975	Del(17Fpr1-Fpr2)1Jimw	MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0008883,abnormal enterocyte proliferation
MGI:3028843	Del(17Hspa1b-Hsp1a)1Dix	MP:0000352,decreased cell proliferation|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0003037,increased myocardial infarct size|MP:0003214,neurofibrillary tangles|MP:0004029,spontaneous chromosome breakage|MP:0004030,induced chromosome breakage|MP:0004045,abnormal cell cycle checkpoint function|MP:0004250,tau protein deposits|MP:0004759,decreased mitotic index|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005621,abnormal cell physiology|MP:0006379,abnormal spermatocyte morphology|MP:0008008,early cellular replicative senescence|MP:0009674,decreased birth weight|MP:0014760,impaired DNA repair
MGI:7780142	Del(17Ly6g5c-Ly6g5b)9Osb	MP:0001922,reduced male fertility|MP:0030978,impaired binding of sperm to zona pellucida
MGI:1856187	Del(17)T<hp>	MP:0000292,distended pericardium|MP:0000562,polydactyly|MP:0000585,kinked tail|MP:0000588,thick tail|MP:0000592,short tail|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0000932,absent notochord|MP:0001785,edema|MP:0001935,decreased litter size|MP:0002151,abnormal neural tube morphology|MP:0002825,abnormal notochord morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0003054,spina bifida|MP:0003718,maternal effect|MP:0003720,abnormal neural tube closure|MP:0004607,abnormal cervical atlas morphology|MP:0004608,abnormal cervical axis morphology|MP:0004703,abnormal vertebral column morphology|MP:0004704,short vertebral column|MP:0006281,abnormal tail development|MP:0008489,slow postnatal weight gain|MP:0011091,prenatal lethality, complete penetrance
MGI:1856189	Del(17)T<Orl>	MP:0000592,short tail|MP:0002111,abnormal tail morphology|MP:0002995,primary sex reversal
MGI:5486219	Del(17Trem1-Trem3)1Jkt	MP:0002412,increased susceptibility to bacterial infection|MP:0002941,increased circulating alanine transaminase level|MP:0003009,abnormal cytokine secretion|MP:0005534,decreased body temperature|MP:0008553,increased circulating tumor necrosis factor level|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008638,increased circulating interleukin-1 alpha level|MP:0008654,increased interleukin-1 alpha secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008660,increased interleukin-10 secretion|MP:0008681,increased interleukin-17 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008713,abnormal cytokine level|MP:0008720,impaired neutrophil chemotaxis|MP:0008721,abnormal chemokine level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010209,abnormal circulating chemokine level
MGI:3623611	Del(18Pcdhg)1Xzw	MP:0000745,tremors|MP:0000955,abnormal spinal cord morphology|MP:0000956,decreased spinal cord size|MP:0001436,abnormal suckling behavior|MP:0001505,hunched posture|MP:0001523,impaired righting response|MP:0001951,abnormal breathing pattern|MP:0002229,neurodegeneration|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0004100,abnormal spinal cord interneuron morphology|MP:0004143,muscle hypertonia|MP:0005316,abnormal response to tactile stimuli|MP:0008918,microgliosis|MP:0010146,umbilical hernia|MP:0011087,neonatal lethality, complete penetrance|MP:0013182,increased spinal cord apoptosis
MGI:6473133	Del(19Cyp26a1-Cyp26c1)1Hmd	MP:0000432,abnormal head morphology|MP:0000433,microcephaly|MP:0000784,forebrain hypoplasia|MP:0000929,open neural tube|MP:0000933,abnormal rhombomere morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001082,abnormal geniculate ganglion morphology|MP:0002950,abnormal neural crest cell migration|MP:0003631,nervous system phenotype|MP:0003637,cochlear ganglion hypoplasia|MP:0003743,abnormal facial morphology|MP:0003861,abnormal nervous system development|MP:0006108,abnormal hindbrain development|MP:0006302,abnormal ectomesenchyme morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012090,midbrain hypoplasia|MP:0012265,increased hindbrain size|MP:0013180,truncated tail bud|MP:0013183,absent trigeminal ganglion|MP:0013267,first pharyngeal arch hypoplasia|MP:0013268,second pharyngeal arch hypoplasia
MGI:3487279	Del(19Htr7-Mphosph1)2Hgc	MP:0002169,no abnormal phenotype detected
MGI:6438189	Del(19Oosp2-Oosp3)2Osb	MP:0001935,decreased litter size|MP:0005389,reproductive system phenotype
MGI:2181352	Del(19Poll-Dcpd)1Nmt	MP:0000434,megacephaly|MP:0000440,domed cranium|MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0001156,abnormal spermatogenesis|MP:0001732,postnatal growth retardation|MP:0001872,sinus inflammation|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002083,premature death|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002766,situs inversus|MP:0005384,cellular phenotype|MP:0005537,abnormal cerebral aqueduct morphology|MP:0005578,teratozoospermia|MP:0006254,thin cerebral cortex|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011059,abnormal ependyma motile cilium morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014636,decreased elongated spermatid number
MGI:5789602	Del(1Aim2-Ifi205)1Stsn	MP:0001873,stomach inflammation|MP:0008555,abnormal interferon secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0011081,decreased macrophage apoptosis
MGI:5487815	Del(1Fmo4-Fmo2)1Eshe	MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0008872,abnormal physiological response to xenobiotic|MP:0009779,enhanced behavioral response to anesthetic
MGI:5306360	Del(1Sdccag8-Akt3)CA1C2Ove	MP:0000111,cleft palate|MP:0008528,polycystic kidney|MP:0009743,preaxial polydactyly|MP:0011087,neonatal lethality, complete penetrance
MGI:3840894	Del(2Cd44-Hoxd11)43Ddu	MP:0011091,prenatal lethality, complete penetrance
MGI:4947111	Del(2Cd59b-Cd59a)1Jha	MP:0001585,hemolytic anemia|MP:0001922,reduced male fertility|MP:0002640,reticulocytosis|MP:0002687,oligozoospermia|MP:0002874,decreased hemoglobin content|MP:0010163,hemolysis
MGI:3586512	Del(2Dlx1-Dlx2)1Jlr	MP:0000106,abnormal basisphenoid bone morphology|MP:0000430,absent maxillary shelf|MP:0000431,absent palatine bone horizontal plate|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0001071,abnormal facial nerve morphology|MP:0001270,distended abdomen|MP:0002058,neonatal lethality|MP:0002882,abnormal neuron morphology|MP:0003235,abnormal alisphenoid bone morphology|MP:0003245,abnormal GABAergic neuron morphology|MP:0003869,ectopic cartilage|MP:0004277,abnormal lateral ganglionic eminence morphology|MP:0004456,small pterygoid bone|MP:0004666,absent stapedial artery|MP:0005106,abnormal incus morphology|MP:0005107,abnormal stapes morphology|MP:0005249,abnormal palatine bone morphology|MP:0005270,abnormal zygomatic bone morphology|MP:0005272,abnormal temporal bone morphology|MP:0006400,decreased molar number|MP:0009882,absent palatal shelf|MP:0009890,cleft secondary palate|MP:0014551,impaired neuronal migration|MP:0030108,abnormal incudostapedial joint morphology|MP:0030127,small stapes|MP:0030395,absent incus short process|MP:0030406,absent stapes obturator foramen
MGI:5544489	Del(2Duoxa2-Duoxa1)1Sref	MP:0001262,decreased body weight|MP:0001290,delayed eyelid opening|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0001954,respiratory distress|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002176,increased brain weight|MP:0003419,delayed endochondral bone ossification|MP:0003498,thyroid gland hyperplasia|MP:0003501,iodide oxidation defect|MP:0004953,decreased spleen weight|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005355,enlarged thyroid gland|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level|MP:0008366,enlarged adenohypophysis|MP:0011083,lethality at weaning, complete penetrance|MP:0011504,abnormal limb long bone morphology|MP:0013752,stridor|MP:0020137,decreased bone mineralization|MP:0030001,subglottis stenosis
MGI:2656714	Del(2Gm13672-Hoxd11)68Ddu	MP:0000150,abnormal rib morphology|MP:0000157,abnormal sternum morphology|MP:0001672,abnormal embryo development|MP:0001688,abnormal somite development|MP:0001921,reduced fertility|MP:0003036,vertebral transformation|MP:0003048,abnormal cervical vertebrae morphology|MP:0004322,abnormal sternebra morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004608,abnormal cervical axis morphology|MP:0004615,cervical vertebral transformation|MP:0004648,decreased thoracic vertebrae number|MP:0008148,abnormal sternocostal joint morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012544,abnormal caudal neuropore morphology
MGI:3616194	Del(2Hoxd10)13Ddu	MP:0000755,hindlimb paralysis|MP:0001077,abnormal spinal nerve morphology|MP:0001406,abnormal gait
MGI:3776050	Del(2Hoxd10-Hoxd11)32Ddu	MP:0000521,abnormal kidney cortex morphology|MP:0002989,small kidney|MP:0003014,abnormal kidney medulla morphology|MP:0004936,impaired branching involved in ureteric bud morphogenesis
MGI:3616167	Del(2Hoxd10-Hoxd13)10Ddu	MP:0001077,abnormal spinal nerve morphology
MGI:3776054	Del(2Hoxd10-Hoxd13)38Ddu	MP:0005367,renal/urinary system phenotype
MGI:3616161	Del(2Hoxd10-Hoxd13)7Ddu	MP:0000755,hindlimb paralysis|MP:0002269,muscular atrophy|MP:0003993,abnormal ventral spinal root morphology
MGI:3616203	Del(2Hoxd11-Hoxd13)16Ddu	MP:0001077,abnormal spinal nerve morphology
MGI:1857661	Del(2Hoxd11-Hoxd13)29Ddu	MP:0000562,polydactyly|MP:0000572,abnormal autopod morphology|MP:0002110,abnormal digit morphology|MP:0002544,brachydactyly|MP:0003419,delayed endochondral bone ossification|MP:0004083,polysyndactyly|MP:0005230,ectrodactyly|MP:0006280,abnormal digit development|MP:0009874,abnormal interdigital cell death|MP:0014291,decreased autopod size
MGI:2445999	Del(2Hoxd12-Hoxd13)6Ddu	MP:0011087,neonatal lethality, complete penetrance
MGI:3689842	Del(2Hoxd1-Hoxd10)26Ddu	MP:0000552,abnormal radius morphology|MP:0000554,abnormal carpal bone morphology|MP:0000562,polydactyly|MP:0000572,abnormal autopod morphology|MP:0002058,neonatal lethality|MP:0004575,small limb buds|MP:0005386,behavior/neurological phenotype|MP:0006279,abnormal limb development|MP:0010772,abnormal pollex morphology
MGI:3616192	Del(2Hoxd1-Hoxd13)12Ddu	MP:0000755,hindlimb paralysis|MP:0001077,abnormal spinal nerve morphology|MP:0001406,abnormal gait
MGI:5508523	Del(2Hoxd1-Hoxd9)63Ddu	MP:0000120,malocclusion|MP:0000445,short snout|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002566,abnormal sexual interaction|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011988,increased mating frequency
MGI:3776052	Del(2Hoxd4-Hoxd11)36Ddu	MP:0000521,abnormal kidney cortex morphology|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002989,small kidney|MP:0003014,abnormal kidney medulla morphology|MP:0003446,renal hypoplasia|MP:0004153,increased renal tubule apoptosis|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005325,abnormal renal glomerulus morphology|MP:0008528,polycystic kidney|MP:0011087,neonatal lethality, complete penetrance|MP:0011368,increased kidney apoptosis|MP:0011846,decreased kidney collecting duct number
MGI:3762256	Del(2Hoxd4-Hoxd13)30Ddu	MP:0000471,abnormal stomach epithelium morphology|MP:0000477,abnormal intestine morphology|MP:0000767,abnormal smooth muscle morphology|MP:0001732,postnatal growth retardation|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0004153,increased renal tubule apoptosis|MP:0005367,renal/urinary system phenotype|MP:0008528,polycystic kidney|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011368,increased kidney apoptosis
MGI:3616199	Del(2Hoxd8-Hoxd10)15Ddu	MP:0000755,hindlimb paralysis|MP:0001077,abnormal spinal nerve morphology|MP:0001406,abnormal gait
MGI:3616177	Del(2Hoxd8-Hoxd13)11Ddu	MP:0002544,brachydactyly|MP:0005306,abnormal phalanx morphology|MP:0008730,fused phalanges
MGI:3616165	Del(2Hoxd8-Hoxd13)9Ddu	MP:0000755,hindlimb paralysis|MP:0002269,muscular atrophy|MP:0003993,abnormal ventral spinal root morphology
MGI:3616254	Del(2Hoxd8-Hoxd9)18Ddu	MP:0001077,abnormal spinal nerve morphology
MGI:3574364	Del(2Hoxd8,Hoxd9-Hoxd13)1Cx	MP:0000755,hindlimb paralysis|MP:0002269,muscular atrophy|MP:0003993,abnormal ventral spinal root morphology
MGI:3616210	Del(2Hoxd9)17Ddu	MP:0001077,abnormal spinal nerve morphology
MGI:3616197	Del(2Hoxd9-Hoxd10)14Ddu	MP:0000755,hindlimb paralysis|MP:0001077,abnormal spinal nerve morphology|MP:0001406,abnormal gait
MGI:3616163	Del(2Hoxd9-Hoxd13)8Ddu	MP:0000755,hindlimb paralysis|MP:0002269,muscular atrophy|MP:0003993,abnormal ventral spinal root morphology
MGI:3776055	Del(2Hoxdi-Hoxd9)39Ddu	MP:0003675,kidney cyst
MGI:3840892	Del(2Hoxd-Itga6)42Ddu	MP:0011091,prenatal lethality, complete penetrance
MGI:7780145	Del(2Lcn8-Lcn10)10Osb	MP:0001922,reduced male fertility|MP:0030978,impaired binding of sperm to zona pellucida
MGI:4459474	Del(2Nespas-Gnas)1Hju	MP:0001399,hyperactivity|MP:0001732,postnatal growth retardation|MP:0001786,skin edema|MP:0003122,maternal imprinting|MP:0003787,abnormal imprinting|MP:0003956,abnormal body size|MP:0008877,abnormal DNA methylation|MP:0009674,decreased birth weight|MP:0011085,postnatal lethality, complete penetrance
MGI:3845668	Del(2)Pax6<11Neu>	MP:0000783,abnormal forebrain morphology|MP:0000785,telencephalon hypoplasia|MP:0001186,pigmentation phenotype|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001299,abnormal eye distance/ position|MP:0001307,fused cornea and lens|MP:0002092,abnormal eye morphology|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0005102,abnormal iris pigmentation|MP:0005262,coloboma|MP:0008458,abnormal cortical ventricular zone morphology|MP:0010709,absent eye anterior chamber|MP:0010714,iris coloboma|MP:0011092,embryonic lethality, complete penetrance|MP:0011962,increased cornea thickness
MGI:3845767	Del(2)Pax6<12Neu>	MP:0000783,abnormal forebrain morphology|MP:0000785,telencephalon hypoplasia|MP:0001186,pigmentation phenotype|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001307,fused cornea and lens|MP:0001319,irregularly shaped pupil|MP:0002092,abnormal eye morphology|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0006000,abnormal cornea epithelium morphology|MP:0008458,abnormal cortical ventricular zone morphology|MP:0009859,eye opacity|MP:0010709,absent eye anterior chamber|MP:0011092,embryonic lethality, complete penetrance|MP:0011697,lens vacuoles|MP:0011962,increased cornea thickness
MGI:3845753	Del(2)Pax6<13Neu>	MP:0001186,pigmentation phenotype|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0009859,eye opacity|MP:0011092,embryonic lethality, complete penetrance
MGI:7335223	Del(2Rr263-Rr264)1Maros	MP:0000572,abnormal autopod morphology|MP:0000574,abnormal foot pad morphology|MP:0001392,abnormal locomotor behavior|MP:0002115,abnormal limb bone morphology|MP:0003631,nervous system phenotype|MP:0004694,absent patella|MP:0005109,abnormal talus morphology|MP:0005306,abnormal phalanx morphology|MP:0005367,renal/urinary system phenotype|MP:0005380,embryo phenotype|MP:0005391,vision/eye phenotype|MP:0006279,abnormal limb development|MP:0008494,absence of all nails|MP:0009005,abnormal sesamoid bone of gastrocnemius morphology
MGI:7335222	Del(2Rr263-Rr265)1Kco	MP:0000572,abnormal autopod morphology|MP:0000574,abnormal foot pad morphology|MP:0002115,abnormal limb bone morphology|MP:0005306,abnormal phalanx morphology|MP:0005380,embryo phenotype|MP:0006279,abnormal limb development|MP:0009005,abnormal sesamoid bone of gastrocnemius morphology|MP:0010771,integument phenotype
MGI:6693653	Del(2Spint4-Spint5)1Zuk	MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0005389,reproductive system phenotype
MGI:6448109	Del(2Svs2-Svs5)1Natka	MP:0001922,reduced male fertility|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0030983,failure of copulatory plug deposition
MGI:7424889	Del(3)1Jfm	MP:0008543,atrial fibrillation
MGI:2180470	Del(3Bglap2-Bglap)2Kry	MP:0001147,small testis|MP:0001552,increased circulating triglyceride level|MP:0001751,increased circulating luteinizing hormone level|MP:0002078,abnormal glucose homeostasis|MP:0002113,abnormal skeleton development|MP:0002687,oligozoospermia|MP:0002727,decreased circulating insulin level|MP:0002780,decreased circulating testosterone level|MP:0002998,abnormal bone remodeling|MP:0003059,decreased insulin secretion|MP:0003795,abnormal bone structure|MP:0004148,increased compact bone thickness|MP:0004149,increased bone strength|MP:0004214,abnormal long bone diaphysis morphology|MP:0004852,decreased testis weight|MP:0004890,decreased energy expenditure|MP:0004910,decreased seminal vesicle weight|MP:0004929,decreased epididymis weight|MP:0004984,increased osteoclast cell number|MP:0005182,increased circulating estradiol level|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005389,reproductive system phenotype|MP:0005536,decreased Leydig cell number|MP:0005559,increased circulating glucose level|MP:0005605,increased bone mass|MP:0006379,abnormal spermatocyte morphology|MP:0009114,decreased pancreatic beta cell mass|MP:0009115,abnormal fat cell morphology|MP:0009168,decreased pancreatic islet number|MP:0009172,small pancreatic islets|MP:0009347,increased trabecular bone thickness|MP:0010024,increased total body fat amount|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0011820,decreased pancreatic beta cell proliferation|MP:0014633,decreased spermatid number|MP:0030017,decreased adipocyte glucose uptake
MGI:2181950	Del(3Cd1d2-Cd1d1)1Crw	MP:0001835,abnormal antigen presentation|MP:0008040,decreased NK T cell number|MP:0008042,abnormal NK T cell physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008700,decreased interleukin-4 secretion
MGI:3611776	Del(3Cd1d2-Cd1d1)1Sbp	MP:0002455,abnormal dendritic cell antigen presentation|MP:0005000,abnormal immune tolerance|MP:0008040,decreased NK T cell number
MGI:6696424	Del(3Dcst1-Dcst2)1Nino	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0005389,reproductive system phenotype|MP:0031010,failure of sperm-egg fusion
MGI:5438974	Del(3Gbp2-ps-Gbp5)1Ktak	MP:0005027,increased susceptibility to parasitic infection|MP:0005387,immune system phenotype|MP:0010750,increased susceptibility to parasitic infection induced morbidity/mortality
MGI:3487278	Del(3Lphn2-Prkacb)1Hgc	MP:0002169,no abnormal phenotype detected
MGI:4440552	Del(4C4-C5)1Lap	MP:0000240,extramedullary hematopoiesis|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001120,abnormal uterus morphology|MP:0001260,increased body weight|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002627,increased teratoma incidence|MP:0003667,increased hemangiosarcoma incidence|MP:0003789,increased osteosarcoma incidence|MP:0005376,homeostasis/metabolism phenotype|MP:0005595,abnormal vascular smooth muscle physiology|MP:0008009,delayed cellular replicative senescence|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011703,increased fibroblast proliferation|MP:0031510,increased vascular smooth muscle cell proliferation
MGI:3790457	Del(4Cdkn2a-Cdkn2b)1Brn	MP:0002020,increased tumor incidence|MP:0002026,increased leukemia incidence|MP:0002032,increased sarcoma incidence|MP:0002404,increased intestinal adenoma incidence|MP:0010300,increased skin tumor incidence|MP:0012431,increased lymphoma incidence
MGI:3767464	Del(4Cdkn2a-Cdkn2b)2Brn	MP:0002020,increased tumor incidence|MP:0002026,increased leukemia incidence|MP:0002032,increased sarcoma incidence|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0009828,increased tumor latency|MP:0010275,increased melanoma incidence|MP:0010300,increased skin tumor incidence|MP:0012431,increased lymphoma incidence
MGI:5704342	Del(4Cyp2j13-Cyp2j5)1Brs	MP:0000250,abnormal vasoconstriction|MP:0001574,abnormal oxygen level|MP:0003033,abnormal pulmonary vascular resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype
MGI:3714527	Del(4D4Mit190-D4Mit51)2Aam	MP:0000466,esophageal epithelium hyperplasia|MP:0000516,abnormal renal/urinary system morphology|MP:0000693,spleen hyperplasia|MP:0002080,prenatal lethality|MP:0002676,uterus hyperplasia|MP:0004046,abnormal mitosis|MP:0004207,increased squamous cell carcinoma incidence|MP:0008009,delayed cellular replicative senescence|MP:0011703,increased fibroblast proliferation|MP:0012431,increased lymphoma incidence
MGI:7366921	Del(4Nppb-Nppa)4Vmc	MP:0002833,increased heart weight
MGI:7366912	Del(4Rr604535-Rr604541)1Vmc	MP:0002833,increased heart weight|MP:0004111,abnormal coronary artery morphology
MGI:6400351	Del(4Sdr16c5-Sdr16c6)1Nyk	MP:0000652,enlarged sebaceous gland|MP:0002092,abnormal eye morphology|MP:0003809,abnormal hair shaft morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006167,eyelid edema|MP:0009002,premature hair regrowth|MP:0010137,delayed exit from anagen phase|MP:0010771,integument phenotype|MP:0013386,enlarged Meibomian gland
MGI:3775604	Del(5Cyp3a57-Cyp3a59)2Nki	MP:0002169,no abnormal phenotype detected
MGI:3798083	Del(5D5Mit148-Qdpr)2Jcs	MP:0000018,small ears|MP:0000428,abnormal craniofacial morphology|MP:0000440,domed cranium|MP:0000585,kinked tail|MP:0000788,abnormal cerebral cortex morphology|MP:0000899,abnormal corpora quadrigemina morphology|MP:0001262,decreased body weight|MP:0001300,ocular hypertelorism|MP:0001406,abnormal gait|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0006097,abnormal cerebellar lobule formation|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3798176	Del(5D5Mit348-D5Mit389)6Jcs	MP:0005386,behavior/neurological phenotype
MGI:3798167	Del(5D5Mit388-D5Mit351)4Jcs	MP:0000018,small ears|MP:0000428,abnormal craniofacial morphology|MP:0000440,domed cranium|MP:0000788,abnormal cerebral cortex morphology|MP:0000899,abnormal corpora quadrigemina morphology|MP:0001177,atelectasis|MP:0001300,ocular hypertelorism|MP:0001304,cataract|MP:0001314,cornea opacity|MP:0001650,abnormal seizure response to electrical stimulation|MP:0010714,iris coloboma
MGI:3798174	Del(5D5Mit73-D5Mit351)5Jcs	MP:0000018,small ears|MP:0000120,malocclusion|MP:0000428,abnormal craniofacial morphology|MP:0000440,domed cranium|MP:0000585,kinked tail|MP:0000788,abnormal cerebral cortex morphology|MP:0000899,abnormal corpora quadrigemina morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001300,ocular hypertelorism|MP:0001314,cornea opacity|MP:0001406,abnormal gait|MP:0002064,seizures|MP:0002194,maximal tonic hindlimb extension seizures|MP:0005262,coloboma|MP:0005386,behavior/neurological phenotype|MP:0006097,abnormal cerebellar lobule formation|MP:0008862,asymmetric snout|MP:0008863,craniofacial asymmetry|MP:0008915,fused carpal bones|MP:0009652,abnormal palatal rugae morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0030099,facial asymmetry
MGI:5555958	Del(5Gtf2i-Fkbp6)1Vcam	MP:0000807,abnormal hippocampus morphology|MP:0000818,abnormal amygdala morphology|MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001488,increased startle reflex|MP:0001522,impaired swimming|MP:0001625,cardiac hypertrophy|MP:0002063,abnormal learning/memory/conditioning|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002166,abnormal tumor susceptibility|MP:0002175,decreased brain weight|MP:0002628,hepatic steatosis|MP:0003460,decreased fear-related response|MP:0004262,abnormal physical strength|MP:0004592,small mandible|MP:0004875,increased mean systemic arterial blood pressure|MP:0008143,abnormal dendrite morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0009866,abnormal aorta wall morphology|MP:0009936,abnormal dendritic spine morphology|MP:0010768,mortality/aging|MP:0010996,increased aorta wall thickness|MP:0011617,abnormal habituation|MP:0012446,thin hippocampus stratum oriens|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance|MP:0030981,abnormal dentate gyrus subgranular zone morphology
MGI:5317120	Del(5Gtf2i-Limk1)1Uta	MP:0000774,decreased brain size|MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0001732,postnatal growth retardation|MP:0003863,decreased aggression towards mice|MP:0003998,decreased thermal nociceptive threshold|MP:0005382,craniofacial phenotype|MP:0005385,cardiovascular system phenotype|MP:0008947,increased neuron number|MP:0009142,decreased prepulse inhibition|MP:0011812,increased cranium length|MP:0013908,small lateral ventricles
MGI:5828634	Del(5Kit-Cep135)1Utr	MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011627,decreased skin pigmentation|MP:0012113,decreased inner cell mass proliferation
MGI:5828636	Del(5Kit-Nmu)2Utr	MP:0005380,embryo phenotype|MP:0011627,decreased skin pigmentation
MGI:3798084	Del(5Letm1-D5Mit81)3Jcs	MP:0000018,small ears|MP:0000428,abnormal craniofacial morphology|MP:0000585,kinked tail|MP:0001262,decreased body weight|MP:0001300,ocular hypertelorism|MP:0001650,abnormal seizure response to electrical stimulation|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3798071	Del(5Letm1-Htt)1Jcs	MP:0000788,abnormal cerebral cortex morphology|MP:0000857,abnormal cerebellar foliation|MP:0000899,abnormal corpora quadrigemina morphology|MP:0000947,convulsive seizures|MP:0005391,vision/eye phenotype
MGI:5317121	Del(5Limk1-Trim50)2Uta	MP:0000249,abnormal blood vessel physiology|MP:0000493,rectal prolapse|MP:0000757,herniated abdominal wall|MP:0000774,decreased brain size|MP:0001139,abnormal vagina morphology|MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001417,decreased exploration in new environment|MP:0001486,abnormal startle reflex|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0003631,nervous system phenotype|MP:0005382,craniofacial phenotype|MP:0008526,decreased cranium width|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0010031,abnormal cranium size|MP:0030066,short face
MGI:8242612	Del(5Pilrb1-Pilrb2)1Asw	MP:0003732,abnormal retina outer plexiform layer morphology|MP:0004231,abnormal calcium ion homeostasis|MP:0005253,abnormal eye physiology|MP:0009538,abnormal synapse morphology|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0020359,abnormal ribbon synapse morphology|MP:0020551,abnormal postsynaptic density morphology
MGI:7489863	Del(5Rr426-Rr108735)1Axvi	MP:0005388,respiratory system phenotype
MGI:3691951	Del(6)1Mom	MP:0001375,abnormal mating preference|MP:0004513,avnosmia|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005394,taste/olfaction phenotype|MP:0005656,decreased aggression|MP:0008779,abnormal maternal behavior|MP:0031650,decreased mounting behavior
MGI:2388594	Del(6Dlx6-Dlx5)1Tlu	MP:0000026,abnormal inner ear morphology|MP:0000031,abnormal cochlea morphology|MP:0000036,absent semicircular canals|MP:0000039,abnormal otic capsule morphology|MP:0000041,absent endolymphatic duct|MP:0000049,abnormal middle ear morphology|MP:0000060,delayed bone ossification|MP:0000075,absent neurocranium|MP:0000087,absent mandible|MP:0000102,abnormal nasal bone morphology|MP:0000150,abnormal rib morphology|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000564,syndactyly|MP:0000585,kinked tail|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001286,abnormal eye development|MP:0001297,microphthalmia|MP:0001679,thin apical ectodermal ridge|MP:0002110,abnormal digit morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002115,abnormal limb bone morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002177,abnormal outer ear morphology|MP:0002237,abnormal nasal cavity morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0002898,absent cartilage|MP:0003419,delayed endochondral bone ossification|MP:0004200,decreased fetal size|MP:0004310,small otic vesicle|MP:0004314,absent inner ear vestibule|MP:0004315,absent vestibular saccule|MP:0004369,absent utricle|MP:0004409,abnormal crista ampullaris neuroepithelium morphology|MP:0004439,absent Meckel's cartilage|MP:0004539,absent maxilla|MP:0004726,abnormal nasal capsule morphology|MP:0004989,decreased osteoblast cell number|MP:0005230,ectrodactyly|MP:0006030,abnormal otic vesicle development|MP:0006288,small otic capsule|MP:0010768,mortality/aging|MP:0011089,perinatal lethality, complete penetrance|MP:0030422,abnormal outer ear cartilage morphology|MP:0030467,abnormal cranial cartilage development|MP:0031450,nasal cartilage hypoplasia
MGI:3778644	Del(6Ephb6-Trpv6)1Mhed	MP:0000192,abnormal mineral level|MP:0000414,alopecia|MP:0001194,dermatitis|MP:0001262,decreased body weight|MP:0001384,abnormal pup retrieval|MP:0001562,abnormal circulating calcium level|MP:0001921,reduced fertility|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002904,increased circulating parathyroid hormone level|MP:0002987,abnormal urine osmolality|MP:0003620,oliguria|MP:0004231,abnormal calcium ion homeostasis|MP:0008489,slow postnatal weight gain|MP:0008779,abnormal maternal behavior|MP:0011221,decreased intestinal calcium absorption|MP:0011228,abnormal vitamin D level|MP:0020010,decreased bone mineral density of femur
MGI:5430774	Del(6Ephb6-Trpv6)2Mfre	MP:0000242,impaired fertilization|MP:0001158,abnormal prostate gland morphology|MP:0001168,abnormal prostate gland epithelium morphology|MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0004933,abnormal epididymis epithelium morphology|MP:0005389,reproductive system phenotype|MP:0009325,necrospermia|MP:0009647,decreased fertilization frequency|MP:0009734,abnormal prostate gland duct morphology
MGI:6286400	Del(6Gimap5-Gimap3)1Yout	MP:0002444,abnormal T cell physiology|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005379,endocrine/exocrine gland phenotype|MP:0008045,decreased NK cell number
MGI:4830091	Del(6Slco1b2-Slco1a5)1Nki	MP:0000611,jaundice|MP:0001260,increased body weight|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0002963,decreased urine protein level|MP:0004772,abnormal bile secretion|MP:0004789,increased bile salt level|MP:0005344,increased circulating bilirubin level|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0011464,bilirubinuria
MGI:2154692	Del(6Snca)1Slab	MP:0003243,abnormal dopaminergic neuron morphology|MP:0009538,abnormal synapse morphology
MGI:7310454	Del(6Spam1-Hyal5)1Eki	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002674,abnormal sperm motility|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0009647,decreased fertilization frequency
MGI:3027023	Del(6Vmn1r40-Aldh1l1)1Anl	MP:0001921,reduced fertility
MGI:5908016	Del(7Chrna7-Fan1)1Mima	MP:0001361,social withdrawal|MP:0001364,decreased anxiety-related response|MP:0001441,increased grooming behavior|MP:0002176,increased brain weight|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0004994,abnormal brain wave pattern|MP:0005238,increased brain size|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0008535,enlarged lateral ventricles|MP:0020351,decreased vocalization
MGI:6150456	Del(7Chrna7-Fan1)3Arte	MP:0000950,abnormal seizure response to pharmacological agent|MP:0001260,increased body weight|MP:0001353,increased aggression towards mice|MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0001650,abnormal seizure response to electrical stimulation|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0003631,nervous system phenotype|MP:0004738,abnormal auditory brainstem response|MP:0005386,behavior/neurological phenotype|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012307,impaired spatial learning
MGI:5569506	Del(7Coro1a-Spn)1Dolm	MP:0000010,abnormal abdominal fat pad morphology|MP:0000745,tremors|MP:0000777,increased inferior colliculus size|MP:0000780,abnormal corpus callosum morphology|MP:0000789,thickened cerebral cortex|MP:0000833,thalamus hyperplasia|MP:0000839,hypothalamus hyperplasia|MP:0000905,increased superior colliculus size|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001442,decreased grooming behavior|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002920,decreased paired-pulse facilitation|MP:0003461,abnormal response to novel object|MP:0004080,abnormal nucleus accumbens morphology|MP:0004081,abnormal globus pallidus morphology|MP:0004102,abnormal dorsal striatum morphology|MP:0004103,abnormal ventral striatum morphology|MP:0006007,abnormal basal ganglion morphology|MP:0006254,thin cerebral cortex|MP:0006325,impaired hearing|MP:0006359,absent startle reflex|MP:0008462,abnormal medium spiny neuron morphology|MP:0011621,abnormal habituation to a novel object|MP:0014375,increased miniature excitatory postsynaptic current frequency|MP:0014378,increased excitatory postsynaptic current frequency|MP:0031391,increased locomotor activity
MGI:5449923	Del(7Cyp2s1-Cyp2a5)1Ding	MP:0000609,abnormal liver physiology|MP:0002133,abnormal respiratory system physiology|MP:0003633,abnormal nervous system physiology|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0009779,enhanced behavioral response to anesthetic
MGI:5770474	Del(7Ffar2-Ffar3)1Soff	MP:0002079,increased circulating insulin level|MP:0002702,decreased circulating free fatty acids level|MP:0003564,abnormal insulin secretion|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:4830970	Del(7Gabrb3-Ube3a)1Yhj	MP:0000111,cleft palate|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0001529,abnormal vocalization|MP:0003123,paternal imprinting|MP:0003997,tonic-clonic seizures|MP:0004994,abnormal brain wave pattern|MP:0005449,abnormal food intake|MP:0009454,impaired contextual conditioning behavior|MP:0009703,decreased birth body size|MP:0011083,lethality at weaning, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3662901	Del(7Gm7290-Th)1Lef	MP:0001262,decreased body weight|MP:0002925,abnormal cardiovascular development|MP:0004196,abnormal prenatal growth/weight/body size|MP:0009674,decreased birth weight|MP:0011085,postnatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance
MGI:3769770	Del(7Herc2-Mkrn3)13FRdni	MP:0001402,decreased locomotor activity|MP:0001429,dehydration|MP:0001943,abnormal respiration|MP:0002082,postnatal lethality|MP:0003122,maternal imprinting
MGI:3055500	Del(7Hmx3-Hmx2)2Tlu	MP:0000035,abnormal membranous labyrinth morphology|MP:0000036,absent semicircular canals|MP:0000743,muscle spasm|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0001752,abnormal hypothalamus secretion|MP:0004328,decreased vestibular hair cell number|MP:0004329,vestibular saccular degeneration|MP:0004332,utricular degeneration|MP:0005120,decreased circulating growth hormone level|MP:0005361,small pituitary gland|MP:0006011,abnormal endolymphatic duct morphology|MP:0008321,small adenohypophysis|MP:0011085,postnatal lethality, complete penetrance
MGI:3804041	Del(7Ifitm5-Ifitm6)1Masu	MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0008770,decreased survivor rate|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3772925	Del(7Ins2-Tel)1Lef	MP:0001722,pale yolk sac|MP:0003123,paternal imprinting|MP:0005031,abnormal trophoblast layer morphology|MP:0005312,pericardial effusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012100,absent spongiotrophoblast layer
MGI:4356431	Del(7Ipw-Snord116)1Jbro	MP:0001262,decreased body weight|MP:0001431,abnormal eating behavior|MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality|MP:0003122,maternal imprinting|MP:0004924,abnormal behavior|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging|MP:0011939,increased food intake
MGI:4436885	Del(7Mrgpra1-Mrgprb4)1And	MP:0002736,abnormal nociception after inflammation|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009747,impaired behavioral response to xenobiotic|MP:0010055,abnormal sensory neuron physiology
MGI:7427349	Del(7Mrgpra2a-Mrgpra2b)1Xzd	MP:0002060,abnormal skin morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0008658,decreased interleukin-1 beta secretion
MGI:3810287	Del(7Or2h1-Rr320)1Mkg	MP:0002169,no abnormal phenotype detected
MGI:6694109	Del(7Pira1-Lilra6)1Fgla	MP:0005673,decreased susceptibility to graft versus host disease
MGI:7496047	Del(7Saa1-Saa2)1Itl	MP:0003980,increased circulating phospholipid level|MP:0005178,increased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis
MGI:4462822	Del(7Slx1b-Sept1)4Aam	MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000837,abnormal hypothalamus morphology|MP:0000839,hypothalamus hyperplasia|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001408,stereotypic behavior|MP:0001458,abnormal object recognition memory|MP:0002175,decreased brain weight|MP:0003861,abnormal nervous system development|MP:0004101,abnormal brain interneuron morphology|MP:0004979,abnormal neuronal precursor cell number|MP:0009973,increased cerebral cortex pyramidal cell number|MP:0009974,decreased cerebral cortex pyramidal cell number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020388,decreased radial glial cell number|MP:0020393,increased neuronal precursor proliferation|MP:0031391,increased locomotor activity
MGI:6342834	Del(7Sult1a1-Spn)6Yah	MP:0006254,thin cerebral cortex|MP:0012478,decreased secondary somatosensory cortex size
MGI:1856304	Del(7)Tyr<c-3H>	MP:0000189,hypoglycemia|MP:0000703,abnormal thymus morphology|MP:0001189,absent skin pigmentation|MP:0002095,abnormal skin pigmentation|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0005560,decreased circulating glucose level|MP:0011087,neonatal lethality, complete penetrance
MGI:1856305	Del(7)Tyr<c-6H>	MP:0003085,abnormal egg cylinder morphology|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:3840566	Del(7Tyrobp-Hcst)1Ttk	MP:0005390,skeleton phenotype
MGI:2384048	Del(7Ube3a-Snrpn)1Alb	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001436,abnormal suckling behavior|MP:0001523,impaired righting response|MP:0002082,postnatal lethality|MP:0002169,no abnormal phenotype detected|MP:0004144,hypotonia|MP:0005156,bradykinesia|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4430184	Del(8A4-B3)7H	MP:0001265,decreased body size|MP:0001879,abnormal lymphatic vessel morphology|MP:0003201,extremity edema|MP:0003390,lymphedema|MP:0003599,large penis|MP:0009216,abnormal peritoneum morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0012080,chylous ascites
MGI:7641897	Del(8Adam25-Adam39)1Kzt	MP:0005389,reproductive system phenotype
MGI:2653084	Del(8Atp6v0d1-Agrp)1Rpa	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3041149	Del(8Col4a1-Col4a2)1Epo	MP:0001712,abnormal placenta development|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003044,impaired basement membrane formation|MP:0003954,abnormal Reichert's membrane morphology|MP:0003984,embryonic growth retardation|MP:0004272,abnormal basement membrane morphology|MP:0004938,dilated vasculature|MP:0005244,hemopericardium|MP:0006009,abnormal neuronal migration|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011523,thin placenta labyrinth|MP:0012096,decreased Reichert's membrane thickness
MGI:6693696	Del(8Ddx19a-Ddx19b)1Chaw	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0008562,increased interferon-alpha secretion|MP:0008564,increased interferon-beta secretion|MP:0010768,mortality/aging|MP:0011091,prenatal lethality, complete penetrance|MP:0020938,decreased susceptibility to Picornaviridae infection|MP:0031039,decreased susceptibility to Picornaviridae infection induced morbidity/mortality
MGI:6693697	Del(8Ddx19a-Ddx19b)2Chaw	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0008562,increased interferon-alpha secretion|MP:0008564,increased interferon-beta secretion|MP:0010768,mortality/aging|MP:0011091,prenatal lethality, complete penetrance
MGI:7427351	Del(8Defa1-Def)2Xzd	MP:0002060,abnormal skin morphology|MP:0002412,increased susceptibility to bacterial infection
MGI:5562924	Del(8Defb1-Defb13)1Jrdo	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0004231,abnormal calcium ion homeostasis|MP:0004543,abnormal sperm physiology|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0008893,detached sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0011277,decreased tail pigmentation|MP:0013286,abnormal sperm capacitation|MP:0013287,abnormal acrosome reaction|MP:0013288,premature acrosome reaction|MP:0020451,decreased sperm progressive motility|MP:0030978,impaired binding of sperm to zona pellucida
MGI:3612793	Del(8Nat1-Nat2)1Kss	MP:0008875,abnormal xenobiotic pharmacokinetics
MGI:5694962	Del(8Npy5r-Npy1r)1Snby	MP:0001260,increased body weight|MP:0001399,hyperactivity|MP:0003961,decreased lean body mass|MP:0004889,increased energy expenditure|MP:0004890,decreased energy expenditure|MP:0005455,increased susceptibility to weight gain|MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009298,increased mesenteric fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0010024,increased total body fat amount|MP:0010182,decreased susceptibility to weight gain|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake|MP:0011957,decreased compensatory feeding amount
MGI:2183544	Del(8Pcid2-Cul4a)1Ktc	MP:0011101,prenatal lethality, incomplete penetrance
MGI:3628802	Del(9Apoa1-Apoa4)1Hmez	MP:0000186,decreased circulating HDL cholesterol level|MP:0002644,decreased circulating triglyceride level|MP:0004778,increased macrophage derived foam cell number|MP:0005179,decreased circulating cholesterol level|MP:0005339,increased susceptibility to atherosclerosis
MGI:5449892	Del(9Casp1-Casp4)1Bhk	MP:0002451,abnormal macrophage physiology|MP:0005166,decreased susceptibility to injury|MP:0005571,decreased lactate dehydrogenase level|MP:0008655,decreased interleukin-1 alpha secretion|MP:0008658,decreased interleukin-1 beta secretion
MGI:2180768	Del(9Cd3g-Cd3d)1Cpt	MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0008348,absent gamma-delta T cells|MP:0012765,decreased alpha-beta T cell number
MGI:6361106	Del(9Glb1l2-Gm1110)1Osb	MP:0005389,reproductive system phenotype
MGI:2652177	Del(9Hspb2-Cryab)1Wawr	MP:0000160,kyphosis|MP:0000748,progressive muscle weakness|MP:0000749,muscle degeneration|MP:0000752,dystrophic muscle|MP:0001263,weight loss|MP:0001303,abnormal lens morphology|MP:0001505,hunched posture|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003354,astrocytosis|MP:0003560,osteoarthritis|MP:0003631,nervous system phenotype|MP:0004136,abnormal tongue muscle morphology|MP:0005459,decreased percent body fat/body weight
MGI:7423612	Del(9Rr207838-Rr207840)6Vmc	MP:0003896,prolonged PR interval|MP:0004116,abnormal atrioventricular bundle conduction|MP:0005385,cardiovascular system phenotype|MP:0010392,prolonged QRS complex duration|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6316147	Dele1<em2(IMPC)Ccpcz>	MP:0001126,abnormal ovary morphology|MP:0002098,abnormal vibrissa morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004832,enlarged ovary|MP:0005627,increased circulating potassium level|MP:0009453,enhanced contextual conditioning behavior
MGI:3576678	Del(Lrrc75b-Ggt5)1Bayer	MP:0001304,cataract|MP:0001732,postnatal growth retardation|MP:0002075,abnormal coat/hair pigmentation|MP:0005150,cachexia|MP:0011085,postnatal lethality, complete penetrance
MGI:3776665	Del(MTmt-Tk-mt-Nd5)1Jiha	MP:0000160,kyphosis|MP:0000751,myopathy|MP:0001262,decreased body weight|MP:0001380,decreased male mating frequency|MP:0001577,anemia|MP:0001731,abnormal postnatal growth|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0001967,deafness|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002128,abnormal blood circulation|MP:0002209,decreased germ cell number|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002705,dilated renal tubule|MP:0003058,increased insulin secretion|MP:0003068,enlarged kidney|MP:0003606,kidney failure|MP:0003645,increased pancreatic beta cell number|MP:0004969,pale kidney|MP:0005264,glomerulosclerosis|MP:0005491,pancreatic islet hyperplasia|MP:0005553,increased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0005578,teratozoospermia|MP:0006325,impaired hearing|MP:0008261,arrest of male meiosis|MP:0009050,dilated proximal convoluted tubule|MP:0009051,dilated distal convoluted tubule|MP:0009176,increased pancreatic alpha cell number|MP:0009232,abnormal sperm nucleus morphology|MP:0009234,absent sperm head|MP:0009831,abnormal sperm midpiece morphology|MP:0010559,heart block|MP:0010771,integument phenotype|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0010959,abnormal oxidative phosphorylation|MP:0011632,dilated mitochondrion|MP:0011635,abnormal mitochondrial crista morphology|MP:0012552,lactic acidosis|MP:0013405,increased circulating lactate level
MGI:5584172	Del(XArmcx5-Nxf3)3Jw	MP:0000111,cleft palate|MP:0001732,postnatal growth retardation|MP:0001953,respiratory failure|MP:0009358,environmentally induced seizures|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance
MGI:6473332	Del(XJpx-Ftx)1Ehea	MP:0001923,reduced female fertility
MGI:5898330	Del(XMagea1-Magea6)1Nju	MP:0001153,small seminiferous tubules|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0014040,increased cellular sensitivity to DNA damaging agent induced cell death|MP:0014052,increased male germ cell apoptosis
MGI:7624347	Del(XMagea6-Magea1)1Prp	MP:0001922,reduced male fertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:6477602	Del(XMir465d-Mir465)3Utr	MP:0005389,reproductive system phenotype
MGI:5297602	Del(XNxf2-Nxf3)1Jw	MP:0000951,sporadic seizures|MP:0001176,abnormal lung development|MP:0001178,pulmonary hypoplasia|MP:0001265,decreased body size|MP:0001496,audiogenic seizures|MP:0001732,postnatal growth retardation|MP:0001953,respiratory failure|MP:0008770,decreased survivor rate|MP:0009358,environmentally induced seizures|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011142,abnormal lung-associated mesenchyme development|MP:0021213,complete cleft palate
MGI:5584171	Del(XNxf2-Tmsb15a)2Jw	MP:0002169,no abnormal phenotype detected
MGI:3043691	Del(Y)1H	MP:0002995,primary sex reversal
MGI:3043573	Del(Y)1Psb	MP:0009230,abnormal sperm head morphology
MGI:5446732	Del(Y)2H	MP:0001147,small testis|MP:0001925,male infertility|MP:0002161,abnormal fertility/fecundity|MP:0002213,true hermaphroditism|MP:0005652,sex reversal|MP:0008261,arrest of male meiosis|MP:0009451,abnormal chromosomal synapsis|MP:0011101,prenatal lethality, incomplete penetrance|MP:0031377,ambiguous external genitalia
MGI:5446813	Del(Y)3H	MP:0001147,small testis|MP:0001925,male infertility|MP:0002161,abnormal fertility/fecundity|MP:0002213,true hermaphroditism|MP:0005652,sex reversal|MP:0008261,arrest of male meiosis|MP:0009451,abnormal chromosomal synapsis|MP:0011101,prenatal lethality, incomplete penetrance|MP:0031377,ambiguous external genitalia
MGI:5470161	Del(Y)4H	MP:0005652,sex reversal
MGI:5470548	Del(Y)5H	MP:0002213,true hermaphroditism|MP:0002995,primary sex reversal
MGI:5470550	Del(Y)6H	MP:0002995,primary sex reversal
MGI:4415344	Del(Y<RIII>)2Psb	MP:0002210,abnormal sex determination|MP:0006380,abnormal spermatid morphology|MP:0009230,abnormal sperm head morphology
MGI:6385278	Dennd10<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002110,abnormal digit morphology
MGI:6276860	Dennd1a<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0001700,abnormal embryo turning|MP:0001711,abnormal placenta morphology|MP:0002151,abnormal neural tube morphology|MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6360168	Dennd1a<em1Jgfu>	MP:0000352,decreased cell proliferation|MP:0000596,abnormal liver development|MP:0000601,small liver|MP:0000603,pale liver|MP:0002982,abnormal primordial germ cell migration|MP:0003396,abnormal embryonic hematopoiesis|MP:0004001,decreased hepatocyte proliferation|MP:0004086,absent heartbeat|MP:0005238,increased brain size|MP:0006042,increased apoptosis|MP:0006043,decreased apoptosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0012091,increased midbrain size|MP:0012139,increased forebrain size|MP:0012236,abnormal cholangiocyte morphology|MP:0012265,increased hindbrain size
MGI:6113475	Dennd1b<tm1.1Achn>	MP:0001175,abnormal lung morphology|MP:0004882,enlarged lung|MP:0008102,lymph node hyperplasia
MGI:6113476	Dennd1b<tm1.2Achn>	MP:0001175,abnormal lung morphology|MP:0004882,enlarged lung|MP:0005379,endocrine/exocrine gland phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005466,abnormal T-helper 2 physiology|MP:0006387,abnormal T cell number|MP:0008102,lymph node hyperplasia|MP:0008568,abnormal interleukin secretion
MGI:5708259	Dennd2c<tm1b(KOMP)Wtsi>	MP:0000538,abnormal urinary bladder morphology|MP:0011625,cystolithiasis
MGI:5587052	Dennd2d<tm2b(KOMP)Mbp>	MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5637024	Dennd4c<tm1b(EUCOMM)Wtsi>	MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6402021	Dennd5b<em1(IMPC)Tcp>	MP:0000063,decreased bone mineral density|MP:0000157,abnormal sternum morphology|MP:0000186,decreased circulating HDL cholesterol level|MP:0000218,increased leukocyte cell number|MP:0000689,abnormal spleen morphology|MP:0001417,decreased exploration in new environment|MP:0002059,abnormal seminal vesicle morphology|MP:0002644,decreased circulating triglyceride level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003233,prolonged QT interval|MP:0003795,abnormal bone structure|MP:0003896,prolonged PR interval|MP:0003960,increased lean body mass|MP:0005013,increased lymphocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005333,decreased heart rate|MP:0005560,decreased circulating glucose level|MP:0005567,decreased circulating total protein level|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010068,decreased red blood cell distribution width|MP:0010124,decreased bone mineral content|MP:0010506,prolonged RR interval|MP:0020421,increased freezing behavior
MGI:6317361	Dennd5b<em1Smgo>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000496,abnormal small intestine morphology|MP:0001663,abnormal digestive system physiology|MP:0003271,abnormal duodenum morphology|MP:0003949,abnormal circulating lipid level|MP:0003960,increased lean body mass|MP:0003975,increased circulating VLDL triglyceride level|MP:0005341,decreased susceptibility to atherosclerosis|MP:0009485,distended ileum|MP:0010026,decreased liver cholesterol level|MP:0010155,abnormal intestine physiology|MP:0010182,decreased susceptibility to weight gain|MP:0010360,decreased liver free fatty acids level|MP:0011503,distended jejunum|MP:0011881,distended duodenum|MP:0013957,increased small intestine length|MP:0014143,decreased body fat mass|MP:0020182,abnormal body mass index
MGI:5563480	Dennd5b<m1Anu>	MP:0005387,immune system phenotype
MGI:6209386	Dennd6a<em1(IMPC)J>	MP:0002574,increased vertical activity
MGI:6449025	Dennd6b<em1(IMPC)Hmgu>	MP:0011886,increased circulating lipase level
MGI:6360664	Dennd6b<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0004738,abnormal auditory brainstem response
MGI:5637029	Denr<tm1b(KOMP)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005031,abnormal trophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6284346	Depdc1a<em1(IMPC)J>	MP:0001415,increased exploration in new environment|MP:0004738,abnormal auditory brainstem response
MGI:5637113	Depdc5<tm1b(EUCOMM)Hmgu>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005293,impaired glucose tolerance|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:5752552	Depdc5<tm1c(EUCOMM)Hmgu>	MP:0000434,megacephaly|MP:0001262,decreased body weight|MP:0001513,limb grasping|MP:0002064,seizures|MP:0002083,premature death|MP:0002826,tonic seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003354,astrocytosis|MP:0003997,tonic-clonic seizures|MP:0004148,increased compact bone thickness|MP:0005238,increased brain size|MP:0005386,behavior/neurological phenotype|MP:0005603,neuron hypertrophy|MP:0008143,abnormal dendrite morphology|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:3510110	Depmq1<C57BL/6J>	MP:0009753,enhanced behavioral response to morphine
MGI:3526084	Depp1<tm1(EGFP/cre)Shin>	MP:0002169,no abnormal phenotype detected
MGI:6314233	Deptor<tm1.1Mala>	MP:0002891,increased insulin sensitivity|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0010398,decreased liver glycogen level|MP:0013278,decreased fasting circulating glucose level
MGI:6314236	Deptor<tm1.2Mala>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype
MGI:5571584	Derl1<tm1Kame>	MP:0003984,embryonic growth retardation|MP:0011092,embryonic lethality, complete penetrance
MGI:4947125	Derl2<tm1.1Hpl>	MP:0005370,liver/biliary system phenotype|MP:0005387,immune system phenotype
MGI:4947129	Derl2<tm1.2Hpl>	MP:0000150,abnormal rib morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000189,hypoglycemia|MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0001942,abnormal lung volume|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002114,abnormal axial skeleton morphology|MP:0005150,cachexia|MP:0005621,abnormal cell physiology|MP:0008028,pregnancy-related premature death|MP:0009546,absent gastric milk in neonates|MP:0009780,abnormal chondrocyte physiology|MP:0010082,sternebra fusion|MP:0010099,abnormal thoracic cage shape|MP:0010831,lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5637117	Derl2<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:3759585	Derl3<Gt(IZ)1Zsj>	MP:0002169,no abnormal phenotype detected
MGI:5571585	Derl3<tm1Kame>	MP:0005376,homeostasis/metabolism phenotype
MGI:2157106	Derm1<NC/Nga>	MP:0001194,dermatitis
MGI:2669293	Derms<BALB/cByJ>	MP:0001194,dermatitis
MGI:2669291	Derms<DBA/2J>	MP:0001194,dermatitis
MGI:5319234	Desi2<tm1Mche>	MP:0002169,no abnormal phenotype detected
MGI:2385359	Desp1<C57BL/6>	MP:0002573,behavioral despair
MGI:2385363	Desp2<C3H/He>	MP:0002573,behavioral despair
MGI:5708562	Des<tm1.1Ccrs>	MP:0000748,progressive muscle weakness|MP:0000751,myopathy|MP:0000752,dystrophic muscle|MP:0001636,irregular heartbeat|MP:0002795,dilated cardiomyopathy|MP:0002841,impaired skeletal muscle contractility|MP:0003081,abnormal soleus morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003137,abnormal impulse conducting system conduction|MP:0003141,cardiac fibrosis|MP:0004070,abnormal P wave|MP:0004091,abnormal Z line morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0005369,muscle phenotype|MP:0008543,atrial fibrillation|MP:0008950,ventricular tachycardia|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009412,skeletal muscle fiber degeneration|MP:0009415,skeletal muscle degeneration|MP:0009420,skeletal muscle endomysial fibrosis|MP:0009732,ventricular premature beat|MP:0010053,decreased grip strength|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010519,atrioventricular block|MP:0010520,sinoatrial block|MP:0010553,prolonged HV interval|MP:0011630,increased mitochondrial size|MP:0011952,decreased cardiac stroke volume|MP:0014344,abnormal skeletal muscle fiber mitochondrial morphology
MGI:2178321	Des<tm1Cap>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000749,muscle degeneration|MP:0000759,abnormal skeletal muscle morphology|MP:0000767,abnormal smooth muscle morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002190,disorganized myocardium|MP:0002652,thin myocardium|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0002837,dystrophic cardiac calcinosis|MP:0003141,cardiac fibrosis|MP:0004084,abnormal cardiac muscle relaxation|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0005202,lethargy|MP:0005329,abnormal myocardium layer morphology|MP:0005330,cardiomyopathy|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006138,congestive heart failure|MP:0012106,impaired exercise endurance|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:2159584	Des<tm1Cba>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000761,thin diaphragm muscle|MP:0001914,hemorrhage|MP:0002279,abnormal diaphragm morphology|MP:0002833,increased heart weight|MP:0002837,dystrophic cardiac calcinosis|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003141,cardiac fibrosis|MP:0003211,abnormal aorta elastic fiber morphology|MP:0003819,increased left ventricle diastolic pressure|MP:0003824,decreased left ventricle developed pressure|MP:0003915,increased heart left ventricle weight|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005329,abnormal myocardium layer morphology|MP:0005330,cardiomyopathy|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006085,myocardium necrosis|MP:0009399,increased skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009406,decreased skeletal muscle fiber number|MP:0009413,skeletal muscle fiber atrophy|MP:0009414,skeletal muscle fiber necrosis|MP:0021157,increased heart left ventricle wall thickness
MGI:3764643	Des<tm1Ltho>	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0000281,abnormal interventricular septum morphology|MP:0002837,dystrophic cardiac calcinosis|MP:0003057,abnormal epicardium morphology|MP:0003141,cardiac fibrosis|MP:0003920,abnormal heart right ventricle morphology|MP:0004058,abnormal ventricle papillary muscle morphology|MP:0004566,myocardial fiber degeneration|MP:0004567,decreased myocardial fiber number|MP:0006267,abnormal intercalated disk morphology
MGI:7547399	Det1<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5692826	Deup1<tm1.1(KOMP)Vlcg>	MP:0000195,decreased circulating calcium level|MP:0000208,decreased hematocrit|MP:0001258,decreased body length|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003631,nervous system phenotype|MP:0005384,cellular phenotype|MP:0005388,respiratory system phenotype|MP:0005566,decreased blood urea nitrogen level|MP:0010152,abnormal brain ependyma morphology|MP:0014239,abnormal intracellular organelle morphology|MP:0014241,abnormal intracellular organelle physiology
MGI:6393839	Dexi<em1Kslr>	MP:0005387,immune system phenotype
MGI:3628786	Dfb	MP:0001147,small testis|MP:0001265,decreased body size|MP:0001395,bidirectional circling|MP:0001926,female infertility|MP:0001967,deafness|MP:0002196,absent corpus callosum|MP:0005307,head tossing|MP:0005459,decreased percent body fat/body weight|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2179456	Dffa<tm1Mxu>	MP:0000812,abnormal dentate gyrus morphology|MP:0001463,abnormal spatial learning|MP:0001648,abnormal apoptosis|MP:0008236,decreased susceptibility to neuronal excitotoxicity
MGI:6153316	Dffb<em1(IMPC)Wtsi>	MP:0004794,increased anti-nuclear antigen antibody level
MGI:2449797	Dffb<tm1Osa>	MP:0001648,abnormal apoptosis|MP:0004486,decreased response of heart to induced stress
MGI:1857313	Dfp	MP:0001188,hyperpigmentation|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:1862015	Dfp2	MP:0000575,increased foot pad pigmentation
MGI:3512199	Dfq1<M16i>	MP:0010769,abnormal survival
MGI:5912231	dft	MP:0000585,kinked tail|MP:0000592,short tail|MP:0001935,decreased litter size|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1934012	Dgat1<tm1Far>	MP:0000367,abnormal coat/ hair morphology|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000427,abnormal hair cycle|MP:0000628,abnormal mammary gland development|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001190,reddish skin|MP:0001191,abnormal skin condition|MP:0001192,scaly skin|MP:0001212,skin lesions|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0002891,increased insulin sensitivity|MP:0004047,abnormal milk composition|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005459,decreased percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0006270,abnormal mammary gland growth during lactation|MP:0008858,abnormal hair cycle anagen phase|MP:0008861,abnormal hair shedding|MP:0009297,decreased mammary fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009506,abnormal mammary gland alveolus morphology|MP:0010026,decreased liver cholesterol level|MP:0010174,decreased mammary gland epithelial cell proliferation|MP:0010249,lactation failure|MP:0011232,abnormal vitamin A level|MP:0012075,impaired mammary gland growth during pregnancy|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:4415182	Dgat1<tm1Ryyo>	MP:0001664,abnormal digestion|MP:0002644,decreased circulating triglyceride level
MGI:3842432	Dgat1<tm2Far>	MP:0000414,alopecia
MGI:5569078	Dgat2l6<tm1b(KOMP)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001284,absent vibrissae|MP:0002135,abnormal kidney morphology|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level
MGI:3037903	Dgat2<tm1Far>	MP:0000189,hypoglycemia|MP:0001196,shiny skin|MP:0001198,tight skin|MP:0001216,abnormal epidermal layer morphology|MP:0001218,thin epidermis|MP:0001258,decreased body length|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001429,dehydration|MP:0001436,abnormal suckling behavior|MP:0001547,abnormal lipid level|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002796,impaired skin barrier function|MP:0003853,dry skin|MP:0004777,abnormal phospholipid level|MP:0005282,decreased fatty acids level|MP:0005285,decreased unsaturated fatty acids level|MP:0005318,decreased triglyceride level|MP:0009356,decreased liver triglyceride level|MP:0009431,decreased fetal weight|MP:0009608,abnormal epidermal lamellar body morphology|MP:0009674,decreased birth weight|MP:0009675,orthokeratosis|MP:0010398,decreased liver glycogen level|MP:0011015,decreased body surface temperature|MP:0011087,neonatal lethality, complete penetrance|MP:0013178,tail necrosis
MGI:3604381	Dgat2<tm1Lex>	MP:0001265,decreased body size|MP:0001429,dehydration|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0011085,postnatal lethality, complete penetrance
MGI:5548928	Dgcr2<tm1b(EUCOMM)Wtsi>	MP:0000689,abnormal spleen morphology|MP:0004509,abnormal pelvic girdle bone morphology|MP:0005293,impaired glucose tolerance|MP:0010123,increased bone mineral content
MGI:7425336	Dgcr8<em1Ysa>	MP:0001672,abnormal embryo development|MP:0008762,embryonic lethality
MGI:4125742	Dgcr8<Gt(XG058)Byg>	MP:0001447,abnormal nest building behavior|MP:0002573,behavioral despair|MP:0003631,nervous system phenotype|MP:0004101,abnormal brain interneuron morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0005386,behavior/neurological phenotype|MP:0006009,abnormal neuronal migration|MP:0008428,abnormal spatial working memory|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012307,impaired spatial learning|MP:0012460,decreased dentate gyrus size
MGI:3798965	Dgcr8<Gt(XH157)Byg>	MP:0003008,enhanced long-term potentiation|MP:0005377,hearing/vestibular/ear phenotype|MP:0008143,abnormal dendrite morphology|MP:0008428,abnormal spatial working memory|MP:0009142,decreased prepulse inhibition
MGI:4458072	Dgcr8<tm1.1Blel>	MP:0000274,enlarged heart|MP:0000280,thin ventricular wall|MP:0002083,premature death|MP:0003141,cardiac fibrosis|MP:0003896,prolonged PR interval|MP:0005294,abnormal heart ventricle morphology|MP:0005598,decreased heart ventricle muscle contractility|MP:0010392,prolonged QRS complex duration
MGI:3819698	Dgcr8<tm1.2Blel>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5287251	Dgka<TgTn(sb-cHS4,Tyr)2320A-2Ove>	MP:0001925,male infertility
MGI:3687309	Dgka<tm1Xpz>	MP:0005004,abnormal lymphocyte anergy|MP:0005015,increased T cell number|MP:0008687,increased interleukin-2 secretion
MGI:5903234	Dgkb<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0005333,decreased heart rate|MP:0010052,increased grip strength|MP:0010506,prolonged RR interval
MGI:4836984	Dgkb<Tn(sb-lacZ,GFP)IR3.PV122Jtak>	MP:0001473,reduced long-term potentiation|MP:0001547,abnormal lipid level|MP:0002574,increased vertical activity|MP:0003461,abnormal response to novel object|MP:0008428,abnormal spatial working memory|MP:0008432,abnormal long-term spatial reference memory|MP:0009538,abnormal synapse morphology|MP:0009747,impaired behavioral response to xenobiotic|MP:0009939,abnormal hippocampus neuron morphology|MP:0031391,increased locomotor activity
MGI:6306622	Dgkd<em1(IMPC)H>	MP:0003961,decreased lean body mass|MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:3514143	Dgkd<Gt(RRT600)Byg>	MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002064,seizures
MGI:3692387	Dgkd<tm1Mtop>	MP:0001302,eyelids open at birth|MP:0001954,respiratory distress|MP:0004200,decreased fetal size|MP:0005501,abnormal skin physiology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009674,decreased birth weight|MP:0011087,neonatal lethality, complete penetrance
MGI:6156468	Dgke<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0001146,abnormal testis morphology|MP:0001399,hyperactivity|MP:0005554,decreased circulating creatinine level
MGI:2388044	Dgke<tm1Ngb>	MP:0001473,reduced long-term potentiation|MP:0002826,tonic seizures
MGI:6441172	Dgkg<tm1Yash>	MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0001899,absent long-term depression|MP:0002272,abnormal nervous system electrophysiology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0011269,increased excitatory postsynaptic current amplitude
MGI:5749809	Dgkh<em1(IMPC)J>	MP:0005554,decreased circulating creatinine level|MP:0005566,decreased blood urea nitrogen level
MGI:7294352	Dgkh<em1Mjz>	MP:0005386,behavior/neurological phenotype
MGI:7294346	Dgkh<tm1Skne>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0003063,increased coping response|MP:0008428,abnormal spatial working memory|MP:0012307,impaired spatial learning
MGI:6153317	Dgki<em1(IMPC)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0003443,increased circulating glycerol level|MP:0005458,increased percent body fat/body weight|MP:0010124,decreased bone mineral content|MP:0014142,increased body fat mass
MGI:3584141	Dgki<tm1Mtop>	MP:0001386,abnormal maternal nurturing|MP:0002006,neoplasm|MP:0005386,behavior/neurological phenotype
MGI:6336069	Dgkk<em1(IMPC)Ics>	MP:0001392,abnormal locomotor behavior|MP:0001488,increased startle reflex|MP:0001556,increased circulating HDL cholesterol level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0010053,decreased grip strength
MGI:5569033	Dgkq<tm1b(KOMP)Wtsi>	MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:2674915	Dgkz<tm1Gak>	MP:0001828,abnormal T cell activation|MP:0001845,abnormal inflammatory response|MP:0002444,abnormal T cell physiology|MP:0002451,abnormal macrophage physiology|MP:0003009,abnormal cytokine secretion|MP:0003436,decreased susceptibility to induced arthritis|MP:0005004,abnormal lymphocyte anergy|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005348,increased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008686,abnormal interleukin-2 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008713,abnormal cytokine level|MP:0008750,abnormal interferon level|MP:0011891,decreased circulating ferritin level|MP:0020914,decreased susceptibility to Riboviria infection
MGI:5903047	Dglucy<tm1b(KOMP)Wtsi>	MP:0005385,cardiovascular system phenotype|MP:0030736,increased glutamic acid level
MGI:6111949	Dguok<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001926,female infertility|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content
MGI:6460395	Dguok<tm1.1Anka>	MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003186,abnormal redox activity|MP:0003674,oxidative stress|MP:0003893,increased hepatocyte proliferation|MP:0003917,increased kidney weight|MP:0005178,increased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005386,behavior/neurological phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005516,enhanced liver regeneration|MP:0005560,decreased circulating glucose level|MP:0008843,absent subcutaneous adipose tissue|MP:0010025,decreased total body fat amount|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011632,dilated mitochondrion|MP:0011633,abnormal mitochondrial shape|MP:0011635,abnormal mitochondrial crista morphology|MP:0011639,decreased mitochondrial DNA content|MP:0012017,grizzled coat color|MP:0013245,abnormal lipid metabolism|MP:0014388,decreased hepatocyte mitochondrial DNA content|MP:0014389,decreased skeletal muscle fiber mitochondrial DNA content|MP:0014390,decreased myocardial fiber mitochondrial DNA content|MP:0020427,increased hepatocyte karyomegaly
MGI:1857878	Dh	MP:0000150,abnormal rib morphology|MP:0000157,abnormal sternum morphology|MP:0000322,increased granulocyte number|MP:0000461,decreased presacral vertebrae number|MP:0000462,abnormal digestive system morphology|MP:0000516,abnormal renal/urinary system morphology|MP:0000519,hydronephrosis|MP:0000536,hydroureter|MP:0000556,abnormal hindlimb morphology|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0000566,synostosis|MP:0000690,absent spleen|MP:0000702,enlarged lymph nodes|MP:0001144,vagina atresia|MP:0001262,decreased body weight|MP:0001622,abnormal vasculogenesis|MP:0002082,postnatal lethality|MP:0002110,abnormal digit morphology|MP:0002135,abnormal kidney morphology|MP:0002145,abnormal T cell differentiation|MP:0002460,decreased immunoglobulin level|MP:0002691,small stomach|MP:0002728,absent tibia|MP:0002759,abnormal caudal vertebrae morphology|MP:0002764,short tibia|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003109,short femur|MP:0003130,anal atresia|MP:0003345,decreased rib number|MP:0003531,abnormal vagina development|MP:0003591,urethra atresia|MP:0003617,urinary bladder hypoplasia|MP:0004083,polysyndactyly|MP:0004349,absent femur|MP:0004372,bowed fibula|MP:0004506,abnormal pubis morphology|MP:0004647,decreased lumbar vertebrae number|MP:0004678,split xiphoid process|MP:0004691,absent pubis|MP:0004692,small pubis|MP:0004694,absent patella|MP:0004783,abnormal cardinal vein morphology|MP:0005013,increased lymphocyte cell number|MP:0005104,abnormal tarsal bone morphology|MP:0005353,abnormal patella morphology|MP:0005371,limbs/digits/tail phenotype|MP:0005390,skeleton phenotype|MP:0005505,thrombocytosis|MP:0006062,abnormal vena cava morphology|MP:0008829,triphalangia|MP:0008985,hemimelia|MP:0008999,absent anus|MP:0009000,absent cecum|MP:0009086,blind uterine horn|MP:0009204,absent external male genitalia|MP:0009252,absent urinary bladder|MP:0009743,preaxial polydactyly|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011797,blind ureter|MP:0012179,abnormal splanchnic mesoderm morphology|MP:0012283,decreased sternebra number|MP:0014281,hindlimb oligodactyly|MP:0014322,short hindlimb
MGI:4431942	Dhcr24<tm1a(EUCOMM)Wtsi>	MP:0002644,decreased circulating triglyceride level|MP:0004924,abnormal behavior|MP:0011091,prenatal lethality, complete penetrance
MGI:6715348	Dhcr24<tm1c(EUCOMM)Wtsi>	MP:0000598,abnormal liver morphology|MP:0003868,abnormal feces composition|MP:0004773,abnormal bile composition|MP:0005179,decreased circulating cholesterol level|MP:0010026,decreased liver cholesterol level|MP:0012224,abnormal sterol level
MGI:3027024	Dhcr24<tm1Lex>	MP:0000180,abnormal circulating cholesterol level|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0005179,decreased circulating cholesterol level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008903,abnormal mesenteric fat pad morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013600,testis degeneration
MGI:6276960	Dhcr7<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001297,microphthalmia|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:6515762	Dhcr7<tm1.1Sjf>	MP:0003961,decreased lean body mass|MP:0004773,abnormal bile composition|MP:0004789,increased bile salt level|MP:0005365,abnormal bile salt homeostasis|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0010026,decreased liver cholesterol level|MP:0012224,abnormal sterol level
MGI:6515763	Dhcr7<tm1.2Sbpa>	MP:0011087,neonatal lethality, complete penetrance
MGI:2181641	Dhcr7<tm1Fdp>	MP:0000539,distended urinary bladder|MP:0000746,weakness|MP:0000774,decreased brain size|MP:0000913,abnormal brain development|MP:0001177,atelectasis|MP:0001402,decreased locomotor activity|MP:0001436,abnormal suckling behavior|MP:0001437,no swallowing reflex|MP:0001529,abnormal vocalization|MP:0001575,cyanosis|MP:0002237,abnormal nasal cavity morphology|MP:0002296,aspiration|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0003983,decreased cholesterol level|MP:0004201,fetal growth retardation|MP:0005278,abnormal cholesterol homeostasis|MP:0009546,absent gastric milk in neonates|MP:0009674,decreased birth weight|MP:0009888,palatal shelves fail to meet at midline|MP:0011087,neonatal lethality, complete penetrance
MGI:2387406	Dhcr7<tm1Gst>	MP:0000539,distended urinary bladder|MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001178,pulmonary hypoplasia|MP:0001402,decreased locomotor activity|MP:0001404,no spontaneous movement|MP:0001435,absent suckling reflex|MP:0001547,abnormal lipid level|MP:0001745,increased circulating corticosterone level|MP:0001951,abnormal breathing pattern|MP:0001953,respiratory failure|MP:0001957,apnea|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002274,abnormal type I pneumocyte morphology|MP:0003641,small lung|MP:0004007,abnormal lung vasculature morphology|MP:0004201,fetal growth retardation|MP:0005039,hypoxia|MP:0005278,abnormal cholesterol homeostasis|MP:0005319,abnormal enzyme/coenzyme level|MP:0005574,decreased pulmonary respiratory rate|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005631,decreased lung weight|MP:0006027,impaired lung alveolus development|MP:0006382,abnormal lung epithelium morphology|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0009890,cleft secondary palate|MP:0010026,decreased liver cholesterol level|MP:0010161,decreased brain cholesterol level|MP:0010825,abnormal lung saccule morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0012225,decreased sterol level|MP:0031631,decreased lung cholesterol level
MGI:3621217	Dhcr7<tm2Fdp>	MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0003947,abnormal cholesterol level|MP:0003983,decreased cholesterol level|MP:0012676,dilated brain ventricle
MGI:6513989	Dhdds<em1Sjpi>	MP:0005391,vision/eye phenotype|MP:0009392,retina gliosis
MGI:6693810	Dhdds<tm1.1Sjpi>	MP:0001325,abnormal retina morphology|MP:0001327,decreased retina photoreceptor cell number|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005548,retina pigment epithelium atrophy|MP:0008515,thin retina outer nuclear layer|MP:0009619,abnormal optokinetic reflex|MP:0010452,retina microaneurysm|MP:0011965,decreased total retina thickness|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0031141,increased retina vascular tortuosity
MGI:5613645	Dhdds<tm1b(KOMP)Wtsi>	MP:0000745,tremors|MP:0001303,abnormal lens morphology|MP:0002797,increased thigmotaxis|MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness
MGI:5563476	Dhfr<orana>	MP:0000240,extramedullary hematopoiesis|MP:0000600,liver hypoplasia|MP:0000603,pale liver|MP:0000691,enlarged spleen|MP:0001698,decreased embryo size|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0004200,decreased fetal size|MP:0005376,homeostasis/metabolism phenotype|MP:0005591,decreased vasodilation|MP:0008813,decreased common myeloid progenitor cell number|MP:0008877,abnormal DNA methylation|MP:0008973,decreased erythroid progenitor cell number|MP:0009395,increased nucleated erythrocyte cell number|MP:0011111,lethality during fetal growth through weaning, complete penetrance|MP:0011230,abnormal folic acid level|MP:0013693,abnormal hemopoiesis|MP:0013697,decreased granulocyte monocyte progenitor cell number
MGI:5513765	Dhfr<tm1b(EUCOMM)Wtsi>	MP:0005554,decreased circulating creatinine level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:1934259	Dhh<tm1Amc>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001751,increased circulating luteinizing hormone level|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002286,cryptorchism|MP:0002780,decreased circulating testosterone level|MP:0002784,abnormal Sertoli cell morphology|MP:0002786,abnormal Leydig cell morphology|MP:0002789,male pseudohermaphroditism|MP:0003632,abnormal nervous system morphology|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005189,abnormal anogenital distance|MP:0005536,decreased Leydig cell number|MP:0006362,abnormal male germ cell morphology|MP:0006379,abnormal spermatocyte morphology|MP:0006418,abnormal testis cord formation|MP:0006420,abnormal peritubular myoid cell morphology|MP:0006421,decreased number of peritubular myoid cells|MP:0008279,arrest of spermiogenesis|MP:0014617,decreased spermatogonia number|MP:0014633,decreased spermatid number
MGI:5548703	Dhodh<tm1b(EUCOMM)Wtsi>	MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:4130154	Dhps<Gt(RRM039)Byg>	MP:0000352,decreased cell proliferation|MP:0009781,abnormal preimplantation embryo development|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5780995	Dhps<tm1Itl>	MP:0002169,no abnormal phenotype detected|MP:0011092,embryonic lethality, complete penetrance
MGI:4842333	Dhps<tm2a(EUCOMM)Wtsi>	MP:0005564,increased hemoglobin content|MP:0011100,preweaning lethality, complete penetrance
MGI:5812110	Dhps<tm2c(EUCOMM)Wtsi>	MP:0000333,decreased bone marrow cell number|MP:0000694,spleen hypoplasia|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0005150,cachexia|MP:0008477,decreased spleen red pulp amount|MP:0010375,increased kidney iron level
MGI:5812111	Dhps<tm2d(EUCOMM)Wtsi>	MP:0011091,prenatal lethality, complete penetrance
MGI:7447050	Dhrs1<em1(IMPC)J>	MP:0000745,tremors|MP:0004738,abnormal auditory brainstem response
MGI:4364555	Dhrs2<tm1a(KOMP)Wtsi>	MP:0002941,increased circulating alanine transaminase level
MGI:5007106	Dhrs3<tm1Lex>	MP:0000060,delayed bone ossification|MP:0000266,abnormal heart morphology|MP:0000281,abnormal interventricular septum morphology|MP:0000284,double outlet right ventricle|MP:0000428,abnormal craniofacial morphology|MP:0001302,eyelids open at birth|MP:0001672,abnormal embryo development|MP:0002114,abnormal axial skeleton morphology|MP:0002639,micrognathia|MP:0003889,enhanced sensorimotor gating|MP:0004201,fetal growth retardation|MP:0004609,vertebral fusion|MP:0004620,cervical vertebral fusion|MP:0005444,abnormal retinol metabolism|MP:0009546,absent gastric milk in neonates|MP:0009703,decreased birth body size|MP:0009886,failure of palatal shelf elevation|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0011087,neonatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:4880251	Dhrs3<tm1(NCOM)Mfgc>	MP:0000111,cleft palate|MP:0001297,microphthalmia|MP:0001302,eyelids open at birth|MP:0001785,edema|MP:0005444,abnormal retinol metabolism|MP:0005584,abnormal enzyme/coenzyme activity|MP:0011089,perinatal lethality, complete penetrance|MP:0011234,abnormal retinol level
MGI:5007107	Dhrs4<tm1Lex>	MP:0001800,abnormal humoral immune response|MP:0002573,behavioral despair|MP:0008496,decreased IgG2a level
MGI:7484792	Dhrs7b<em1(IMPC)Mbp>	MP:0001404,no spontaneous movement|MP:0001556,increased circulating HDL cholesterol level|MP:0002941,increased circulating alanine transaminase level|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020420,abnormal freezing behavior
MGI:4253263	Dhrs7b<Gt(OST255410)Lex>	MP:0000749,muscle degeneration|MP:0003644,thymus atrophy|MP:0004545,enlarged esophagus|MP:0010788,stomach hypoplasia|MP:0011085,postnatal lethality, complete penetrance
MGI:7515007	Dhrs7<em1(IMPC)J>	MP:0002834,decreased heart weight
MGI:4399544	Dhrs9<tm1(KOMP)Vlcg>	MP:0005584,abnormal enzyme/coenzyme activity
MGI:6268324	Dhtkd1<em1Hpr>	MP:0005386,behavior/neurological phenotype|MP:0013242,abnormal amino acid metabolism
MGI:5910309	Dhtkd1<em1(IMPC)J>	MP:0001488,increased startle reflex
MGI:6441735	Dhtkd1<tm1Mmgu>	MP:0000920,abnormal myelination|MP:0001973,increased thermal nociceptive threshold|MP:0002644,decreased circulating triglyceride level|MP:0003082,abnormal gastrocnemius morphology|MP:0003442,decreased circulating glycerol level|MP:0003980,increased circulating phospholipid level|MP:0005179,decreased circulating cholesterol level|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0010378,increased respiratory quotient|MP:0011628,increased mitochondrial number|MP:0011630,increased mitochondrial size|MP:0011731,decreased myelin sheath thickness|MP:0012674,tomacula
MGI:6260051	Dhtkd1<tm1Zgwg>	MP:0000748,progressive muscle weakness|MP:0000921,demyelination|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001973,increased thermal nociceptive threshold|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002079,increased circulating insulin level|MP:0002269,muscular atrophy|MP:0002651,abnormal sciatic nerve morphology|MP:0002891,increased insulin sensitivity|MP:0003058,increased insulin secretion|MP:0003632,abnormal nervous system morphology|MP:0003871,abnormal myelin sheath morphology|MP:0004090,abnormal sarcomere morphology|MP:0004702,increased circulating insulin-like growth factor I level|MP:0005215,abnormal pancreatic islet morphology|MP:0005292,improved glucose tolerance|MP:0005405,axon degeneration|MP:0005560,decreased circulating glucose level|MP:0008814,decreased nerve conduction velocity|MP:0010028,aciduria|MP:0010090,increased circulating creatine kinase level|MP:0010400,increased liver glycogen level|MP:0010742,increased Schwann cell number|MP:0011904,abnormal Schwann cell physiology|MP:0011971,increased circulating lactate dehydrogenase level|MP:0012106,impaired exercise endurance
MGI:6442536	Dhx15<em1(IMPC)Tcp>	MP:0000208,decreased hematocrit|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002591,decreased mean corpuscular volume|MP:0003131,increased erythrocyte cell number|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0003900,shortened QT interval|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6393262	Dhx15<tm1c(EUCOMM)Wtsi>	MP:0000694,spleen hypoplasia|MP:0002144,abnormal B cell differentiation|MP:0004953,decreased spleen weight|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008209,decreased pre-B cell number
MGI:5694174	Dhx16<tm1b(EUCOMM)Wtsi>	MP:0001417,decreased exploration in new environment|MP:0002953,thick ventricular wall|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5287023	Dhx29<TgTn(sb-cHS4,Tyr)2354AOve>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5529635	Dhx29<tm1.1(KOMP)Vlcg>	MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0003720,abnormal neural tube closure|MP:0003961,decreased lean body mass|MP:0003984,embryonic growth retardation|MP:0005293,impaired glucose tolerance|MP:0011100,preweaning lethality, complete penetrance|MP:0011435,increased urine magnesium level
MGI:5705780	Dhx30<Gt(IG)1Zsj>	MP:0002151,abnormal neural tube morphology|MP:0003984,embryonic growth retardation|MP:0004180,failure of initiation of embryo turning|MP:0006386,absent somites|MP:0011092,embryonic lethality, complete penetrance
MGI:5474769	Dhx30<tm1.1(KOMP)Vlcg>	MP:0001402,decreased locomotor activity|MP:0001488,increased startle reflex|MP:0001554,increased circulating free fatty acids level|MP:0005560,decreased circulating glucose level|MP:0005633,increased circulating sodium level|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5637153	Dhx33<tm1b(KOMP)Wtsi>	MP:0005477,increased circulating thyroxine level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6404490	Dhx34<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5637055	Dhx35<tm1b(EUCOMM)Wtsi>	MP:0000137,abnormal vertebrae morphology|MP:0000161,scoliosis|MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0000629,absent mammary gland|MP:0001711,abnormal placenta morphology|MP:0002633,persistent truncus arteriosus|MP:0003451,absent olfactory bulb|MP:0004158,right aortic arch|MP:0004163,abnormal adenohypophysis morphology|MP:0004269,abnormal optic cup morphology|MP:0004463,basisphenoid bone foramen|MP:0005031,abnormal trophoblast layer morphology|MP:0005157,holoprosencephaly|MP:0008128,abnormal brain internal capsule morphology|MP:0008923,thoracoschisis|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010589,common truncal valve|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013186,abnormal basilar artery morphology|MP:0013836,abnormal hypoglossal nerve topology|MP:0013952,retroesophageal left subclavian artery|MP:0013970,absent connection between subcutaneous lymph vessels and lymph sac|MP:0013977,symmetric azygos veins|MP:0013981,double lumen aortic arch|MP:0013996,abnormal vertebral artery origin
MGI:5427959	Dhx36<tm1.1Pmt>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5427960	Dhx36<tm1.2Pmt>	MP:0000245,abnormal erythropoiesis|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001585,hemolytic anemia|MP:0001823,thymus hypoplasia|MP:0002416,abnormal proerythroblast morphology|MP:0002590,increased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002812,spherocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003077,abnormal cell cycle|MP:0003656,abnormal erythrocyte physiology|MP:0003717,pallor|MP:0004809,increased hematopoietic stem cell number|MP:0004969,pale kidney|MP:0005460,abnormal leukopoiesis|MP:0008475,intermingled spleen red and white pulp|MP:0011178,increased erythroblast number|MP:0011179,decreased erythroblast number|MP:0013697,decreased granulocyte monocyte progenitor cell number|MP:0013704,increased megakaryocyte-erythroid progenitor cell number
MGI:6258465	Dhx37<em1(IMPC)J>	MP:0002574,increased vertical activity|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0010052,increased grip strength|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012058,abnormal morula morphology|MP:0012129,failure of blastocyst formation|MP:0013292,embryonic lethality prior to organogenesis
MGI:6195283	Dhx38<em1(IMPC)J>	MP:0000208,decreased hematocrit|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002875,decreased erythrocyte cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5548542	Dhx40<tm1b(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0001312,abnormal cornea morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003960,increased lean body mass|MP:0004952,increased spleen weight|MP:0010097,abnormal retina blood vessel morphology|MP:0011960,abnormal eye anterior chamber depth|MP:0011965,decreased total retina thickness
MGI:4839137	Dhx40<tm1(NCOM)Cmhd>	MP:0000063,decreased bone mineral density|MP:0002896,abnormal bone mineralization|MP:0003795,abnormal bone structure|MP:0004924,abnormal behavior|MP:0005179,decreased circulating cholesterol level
MGI:7446978	Dhx57<em1(IMPC)J>	MP:0002834,decreased heart weight|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount
MGI:6194877	Dhx58<em1(IMPC)J>	MP:0009142,decreased prepulse inhibition
MGI:4437255	Dhx58<tm1Aki>	MP:0001144,vagina atresia|MP:0004906,enlarged uterus|MP:0008565,decreased interferon-beta secretion|MP:0008576,decreased circulating interferon-beta level|MP:0008706,decreased interleukin-6 secretion|MP:0011101,prenatal lethality, incomplete penetrance|MP:0020937,increased susceptibility to Picornaviridae infection|MP:0031040,increased susceptibility to Picornaviridae infection induced morbidity/mortality
MGI:3837303	Dhx58<tm1Gnb>	MP:0008555,abnormal interferon secretion|MP:0008562,increased interferon-alpha secretion|MP:0008563,decreased interferon-alpha secretion|MP:0008564,increased interferon-beta secretion|MP:0008565,decreased interferon-beta secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008617,increased circulating interleukin-12 level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0020912,abnormal susceptibility to Riboviria infection|MP:0020914,decreased susceptibility to Riboviria infection|MP:0020937,increased susceptibility to Picornaviridae infection
MGI:5439127	Dhx58<tm1Itl>	MP:0006413,increased T cell apoptosis|MP:0008561,decreased tumor necrosis factor secretion|MP:0008565,decreased interferon-beta secretion|MP:0008567,decreased interferon-gamma secretion|MP:0020943,increased susceptibility to Flaviviridae infection|MP:0031044,increased susceptibility to Flaviviridae infection induced morbidity/mortality
MGI:4437256	Dhx58<tm2.1Aki>	MP:0008565,decreased interferon-beta secretion|MP:0008706,decreased interleukin-6 secretion|MP:0020937,increased susceptibility to Picornaviridae infection|MP:0031040,increased susceptibility to Picornaviridae infection induced morbidity/mortality
MGI:6377202	Dhx8<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000709,enlarged thymus|MP:0001126,abnormal ovary morphology|MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001727,abnormal embryo implantation|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002718,abnormal inner cell mass morphology|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0009142,decreased prepulse inhibition|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6472605	Dhx9<tm1b(EUCOMM)Hmgu>	MP:0005333,decreased heart rate|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake
MGI:3663380	Dhx9<tm1Ehl>	MP:0001672,abnormal embryo development|MP:0001675,abnormal ectoderm development|MP:0001683,absent mesoderm|MP:0001695,abnormal gastrulation|MP:0002230,abnormal primitive streak formation|MP:0003895,increased ectoderm apoptosis|MP:0005030,absent amnion|MP:0005032,abnormal ectoplacental cone morphology|MP:0005380,embryo phenotype|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011187,abnormal parietal endoderm morphology|MP:0012105,delayed gastrulation|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5557965	Dhx9<Tn(pb-Act-RFP)1.071225026-HRAZhu>	MP:0005387,immune system phenotype|MP:0011091,prenatal lethality, complete penetrance
MGI:1856843	di	MP:0003053,delayed tooth eruption|MP:0006369,supernumerary incisors
MGI:2183277	Diablo<tm1Mak>	MP:0002169,no abnormal phenotype detected
MGI:6402885	Diaph1<em1(IMPC)Rbrc>	MP:0000137,abnormal vertebrae morphology|MP:0004599,abnormal vertebral arch morphology
MGI:6113373	Diaph1<M1Btlr>	MP:0002492,decreased IgE level|MP:0008073,abnormal CD4-positive, alpha-beta T cell number|MP:0008077,abnormal CD8-positive, alpha-beta T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010851,decreased effector memory CD8-positive, alpha-beta T cell number|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:6113366	Diaph1<M2Btlr>	MP:0004978,decreased B-1 B cell number|MP:0010839,decreased CD8-positive, alpha-beta memory T cell number
MGI:6113361	Diaph1<m3Btlr>	MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010838,increased CD8-positive, alpha-beta memory T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:3761497	Diaph1<tm1.1Sna>	MP:0001800,abnormal humoral immune response|MP:0003156,abnormal leukocyte migration|MP:0005018,decreased T cell number|MP:0005095,decreased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number
MGI:3722153	Diaph1<tm1Asal>	MP:0000120,malocclusion|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000256,echinocytosis|MP:0000321,increased bone marrow cell number|MP:0000322,increased granulocyte number|MP:0000414,alopecia|MP:0000689,abnormal spleen morphology|MP:0001191,abnormal skin condition|MP:0001194,dermatitis|MP:0001429,dehydration|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0002123,abnormal definitive hematopoiesis|MP:0002339,abnormal lymph node morphology|MP:0002359,abnormal spleen germinal center morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0004952,increased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0005046,absent spleen white pulp
MGI:7450834	Diaph2<em2Kcl>	MP:0005377,hearing/vestibular/ear phenotype
MGI:7450832	Diaph2<em3Kcl>	MP:0005377,hearing/vestibular/ear phenotype
MGI:4459016	Diaph2<Gt(E093H03)Wrst>	MP:0000266,abnormal heart morphology|MP:0001914,hemorrhage|MP:0002152,abnormal brain morphology
MGI:4123435	Diaph2<Gt(W005C03)Wrst>	MP:0002169,no abnormal phenotype detected
MGI:5606179	Diaph2<tm1.2Sna>	MP:0002169,no abnormal phenotype detected
MGI:6120721	Diaph2<tm1b(EUCOMM)Hmgu>	MP:0001566,increased circulating phosphate level
MGI:6456056	Diaph3<tm1.1Pji>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002641,anisopoikilocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005097,polychromatophilia|MP:0010067,increased red blood cell distribution width
MGI:5574347	Diaph3<tm1.1Sna>	MP:0000240,extramedullary hematopoiesis|MP:0001698,decreased embryo size|MP:0003077,abnormal cell cycle|MP:0005385,cardiovascular system phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011179,decreased erythroblast number|MP:0012397,abnormal nucleated erythrocyte cell number
MGI:6456062	Diaph3<tm1.2Pji>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5571349	Diaph3<tm1b(KOMP)Mbp>	MP:0000288,abnormal pericardium morphology|MP:0000428,abnormal craniofacial morphology|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0002546,mydriasis|MP:0002591,decreased mean corpuscular volume|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance
MGI:3688860	Dib1<1R>	MP:0001525,impaired balance
MGI:3688864	Dib2<1R>	MP:0001525,impaired balance
MGI:3843374	Dibg1<129S6/SvEvTac>	MP:0001559,hyperglycemia
MGI:3573900	Dice1b<C57BL/10Sn>	MP:0005026,decreased susceptibility to parasitic infection
MGI:5566696	Dicer1<em1Psv>	MP:0001926,female infertility|MP:0005168,abnormal female meiosis|MP:0005389,reproductive system phenotype|MP:0014445,abnormal spindle assembly in female meiosis
MGI:5566697	Dicer1<em2Psv>	MP:0001926,female infertility|MP:0005168,abnormal female meiosis|MP:0005389,reproductive system phenotype|MP:0014445,abnormal spindle assembly in female meiosis
MGI:5566698	Dicer1<em3Psv>	MP:0001926,female infertility|MP:0005168,abnormal female meiosis|MP:0005389,reproductive system phenotype|MP:0014445,abnormal spindle assembly in female meiosis
MGI:3719397	Dicer1<Gt(RRF266)Byg>	MP:0000260,abnormal angiogenesis|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0020913,increased susceptibility to Riboviria infection|MP:0020914,decreased susceptibility to Riboviria infection|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:6200045	Dicer1<m1Btlr>	MP:0004977,increased B-1 B cell number|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:3589209	Dicer1<tm1.1Bdh>	MP:0001730,embryonic growth arrest|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5707512	Dicer1<tm1.1Doca>	MP:0002169,no abnormal phenotype detected
MGI:3809262	Dicer1<tm1.1Snj>	MP:0001698,decreased embryo size
MGI:5545910	Dicer1<tm1.1Vlcg>	MP:0001672,abnormal embryo development
MGI:3589208	Dicer1<tm1Bdh>	MP:0000106,abnormal basisphenoid bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000160,kyphosis|MP:0000163,abnormal cartilage morphology|MP:0000284,double outlet right ventricle|MP:0000352,decreased cell proliferation|MP:0000428,abnormal craniofacial morphology|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000704,abnormal thymus development|MP:0000705,athymia|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001004,abnormal retina photoreceptor morphology|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001120,abnormal uterus morphology|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001176,abnormal lung development|MP:0001263,weight loss|MP:0001328,disorganized retina layers|MP:0001341,absent eyelids|MP:0001544,abnormal cardiovascular system physiology|MP:0001728,failure of embryo implantation|MP:0001787,pericardial edema|MP:0001800,abnormal humoral immune response|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001863,blood vessel inflammation|MP:0001916,intracerebral hemorrhage|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001932,abnormal spermiogenesis|MP:0002083,premature death|MP:0002116,abnormal craniofacial bone morphology|MP:0002435,abnormal effector T cell morphology|MP:0002460,decreased immunoglobulin level|MP:0002631,abnormal epididymis morphology|MP:0002633,persistent truncus arteriosus|MP:0002637,small uterus|MP:0002639,micrognathia|MP:0002687,oligozoospermia|MP:0002750,exophthalmos|MP:0002784,abnormal Sertoli cell morphology|MP:0003054,spina bifida|MP:0003355,decreased ovulation rate|MP:0003419,delayed endochondral bone ossification|MP:0003574,abnormal oviduct morphology|MP:0003700,abnormal oviduct transport|MP:0003723,abnormal long bone morphology|MP:0003727,abnormal retina layer morphology|MP:0003935,abnormal craniofacial development|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0004449,absent presphenoid bone|MP:0004458,absent alisphenoid bone|MP:0004467,absent zygomatic bone|MP:0004476,absent palatine bone|MP:0004592,small mandible|MP:0004728,abnormal efferent ductules of testis morphology|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0004899,absent temporal bone squamous part|MP:0004901,decreased male germ cell number|MP:0004905,decreased uterus weight|MP:0004924,abnormal behavior|MP:0004930,small epididymis|MP:0004933,abnormal epididymis epithelium morphology|MP:0004941,abnormal regulatory T cell morphology|MP:0004946,abnormal regulatory T cell physiology|MP:0004974,decreased regulatory T cell number|MP:0005159,azoospermia|MP:0005185,decreased circulating progesterone level|MP:0005329,abnormal myocardium layer morphology|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005578,teratozoospermia|MP:0006020,decreased tympanic ring size|MP:0006126,abnormal cardiac outflow tract development|MP:0006208,lethality throughout fetal growth and development|MP:0006213,shallow orbits|MP:0006337,abnormal first pharyngeal arch morphology|MP:0006362,abnormal male germ cell morphology|MP:0006380,abnormal spermatid morphology|MP:0006382,abnormal lung epithelium morphology|MP:0006428,ectopic Sertoli cells|MP:0008094,absent memory B cells|MP:0008100,absent plasma cells|MP:0008178,decreased germinal center B cell number|MP:0008192,abnormal germinal center B cell physiology|MP:0008257,thin myometrium|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008826,abnormal splenic cell ratio|MP:0008828,abnormal lymph node cell ratio|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009071,short oviduct|MP:0009089,short uterine horn|MP:0009096,decreased endometrial gland number|MP:0009140,dilated efferent ductule of testis|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009235,small sperm head|MP:0009236,pinhead sperm|MP:0009237,kinked sperm flagellum|MP:0009242,thin sperm flagellum|MP:0009376,abnormal manchette morphology|MP:0009377,ectopic manchette|MP:0009392,retina gliosis|MP:0009655,abnormal secondary palate development|MP:0009661,abnormal pregnancy|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009833,absent sperm mitochondrial sheath|MP:0009886,failure of palatal shelf elevation|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0010029,abnormal basicranium morphology|MP:0010241,abnormal aortic arch development|MP:0010402,ventricular septal defect|MP:0010556,thin ventricle myocardium compact layer|MP:0010976,small lung lobe|MP:0011089,perinatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011743,abnormal Golgi apparatus morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0012085,midface hypoplasia|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0012173,short rostral-caudal axis|MP:0013239,impaired skeletal muscle regeneration|MP:0013600,testis degeneration|MP:0014052,increased male germ cell apoptosis|MP:0014194,increased epididymal epithelium cell proliferation|MP:0014280,forelimb oligodactyly|MP:0014633,decreased spermatid number|MP:0014634,decreased round spermatid number|MP:0014636,decreased elongated spermatid number|MP:0021217,abnormal palatal shelf bone ossification|MP:0030102,absent orbitosphenoid bone|MP:0030262,frontal bossing|MP:0030266,small vomer bone|MP:0030301,abnormal maxillary frontal process morphology|MP:0030315,small neurocranium|MP:0030591,absent sperm fibrous sheath|MP:0031407,increased Sertoli cell proliferation|MP:0031420,decreased superovulation rate|MP:0031460,abnormal palatal shelf morphology|MP:0031462,decreased palatal shelf size|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:5692797	Dicer1<tm1b(EUCOMM)Wtsi>	MP:0000222,decreased neutrophil cell number|MP:0000690,absent spleen|MP:0001325,abnormal retina morphology|MP:0001556,increased circulating HDL cholesterol level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0004953,decreased spleen weight|MP:0010053,decreased grip strength|MP:0010068,decreased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3589287	Dicer1<tm1Dli>	MP:0005018,decreased T cell number|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0005621,abnormal cell physiology|MP:0006413,increased T cell apoptosis
MGI:2681012	Dicer1<tm1Ghan>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3576927	Dicer1<tm1Gz>	MP:0000260,abnormal angiogenesis|MP:0000601,small liver|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001719,absent vitelline blood vessels|MP:0004076,abnormal vitelline vascular remodeling|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3578093	Dicer1<tm1Mmk>	MP:0000221,decreased leukocyte cell number|MP:0000229,abnormal megakaryocyte differentiation|MP:0000240,extramedullary hematopoiesis|MP:0000321,increased bone marrow cell number|MP:0000691,enlarged spleen|MP:0000715,decreased thymocyte number|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0001732,postnatal growth retardation|MP:0001802,arrested B cell differentiation|MP:0002026,increased leukemia incidence|MP:0002113,abnormal skeleton development|MP:0002127,abnormal cardiovascular system morphology|MP:0002397,abnormal bone marrow morphology|MP:0002417,abnormal megakaryocyte morphology|MP:0003179,thrombocytopenia|MP:0003795,abnormal bone structure|MP:0004880,lung cyst|MP:0004882,enlarged lung|MP:0004989,decreased osteoblast cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005065,abnormal neutrophil morphology|MP:0005397,hematopoietic system phenotype|MP:0006382,abnormal lung epithelium morphology|MP:0008018,increased facial tumor incidence|MP:0008111,abnormal granulocyte differentiation|MP:0008186,increased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008250,abnormal myeloid leukocyte morphology|MP:0008346,increased gamma-delta T cell number|MP:0009439,increased myeloid sarcoma incidence|MP:0010296,increased hemolymphoid system tumor incidence|MP:0010964,increased compact bone volume|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011142,abnormal lung-associated mesenchyme development|MP:0011147,increased mesenchymal cell proliferation involved in lung development|MP:0014237,decreased tumor-free survival time|MP:0030025,giant platelets
MGI:3641051	Dicer1<tm1Smr>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000367,abnormal coat/ hair morphology|MP:0000377,abnormal hair follicle morphology|MP:0000380,small hair follicles|MP:0000383,abnormal hair follicle orientation|MP:0000410,waved hair|MP:0000414,alopecia|MP:0000422,delayed hair appearance|MP:0000522,kidney cortex cyst|MP:0001192,scaly skin|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001732,postnatal growth retardation|MP:0001762,polyuria|MP:0001855,abnormal atrial thrombosis|MP:0002073,abnormal hair growth|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002190,disorganized myocardium|MP:0002705,dilated renal tubule|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002827,abnormal renal corpuscle morphology|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0002988,decreased urine osmolality|MP:0003215,renal interstitial fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0003413,hair follicle degeneration|MP:0003670,dilated renal glomerular capsule|MP:0003704,abnormal hair follicle development|MP:0003809,abnormal hair shaft morphology|MP:0003853,dry skin|MP:0003875,abnormal hair follicle regression|MP:0003918,decreased kidney weight|MP:0004090,abnormal sarcomere morphology|MP:0004969,pale kidney|MP:0005325,abnormal renal glomerulus morphology|MP:0005333,decreased heart rate|MP:0005501,abnormal skin physiology|MP:0005528,decreased renal glomerular filtration rate|MP:0005598,decreased heart ventricle muscle contractility|MP:0006042,increased apoptosis|MP:0006138,congestive heart failure|MP:0008859,abnormal hair cycle catagen phase|MP:0009759,abnormal hair follicle bulge morphology|MP:0010685,abnormal hair follicle inner root sheath morphology|MP:0010771,integument phenotype|MP:0011066,abnormal renal tubule epithelial cell primary cilium morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011368,increased kidney apoptosis|MP:0011440,increased kidney cell proliferation|MP:0011846,decreased kidney collecting duct number|MP:0011925,abnormal heart echocardiography feature|MP:0011941,increased fluid intake|MP:0013305,isosthenuria|MP:0030575,decreased hair follicle cell proliferation|MP:0030920,small hair follicle bulb|MP:0031147,abnormal ventricular thrombosis|MP:0031613,fetal cardiomyocyte disarray
MGI:3809260	Dicer1<tm1Snj>	MP:0000352,decreased cell proliferation|MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000414,alopecia|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001280,loss of vibrissae|MP:0002006,neoplasm|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0003413,hair follicle degeneration|MP:0004046,abnormal mitosis|MP:0005150,cachexia|MP:0005501,abnormal skin physiology|MP:0005621,abnormal cell physiology|MP:0006279,abnormal limb development|MP:0008008,early cellular replicative senescence|MP:0009004,progressive hair loss|MP:0021086,decreased DNA replication
MGI:3622169	Dicer1<tm1Tara>	MP:0000367,abnormal coat/ hair morphology|MP:0000377,abnormal hair follicle morphology|MP:0000703,abnormal thymus morphology|MP:0001265,decreased body size|MP:0001429,dehydration|MP:0001824,abnormal thymus involution|MP:0002006,neoplasm|MP:0002098,abnormal vibrissa morphology|MP:0002371,abnormal thymus cortex morphology|MP:0002375,abnormal thymus medulla morphology|MP:0003414,epidermal cyst|MP:0003704,abnormal hair follicle development|MP:0003724,increased susceptibility to induced arthritis|MP:0003763,abnormal thymus physiology|MP:0004919,abnormal positive T cell selection|MP:0005501,abnormal skin physiology|MP:0006042,increased apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0009544,abnormal thymus epithelium morphology|MP:0009931,abnormal skin appearance|MP:0011085,postnatal lethality, complete penetrance
MGI:5544770	Dicer1<tm2.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:3603539	Dido1<tm1Cmar>	MP:0000220,increased monocyte cell number|MP:0000245,abnormal erythropoiesis|MP:0000322,increased granulocyte number|MP:0000693,spleen hyperplasia|MP:0001577,anemia|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002416,abnormal proerythroblast morphology|MP:0003131,increased erythrocyte cell number|MP:0004952,increased spleen weight|MP:0005384,cellular phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008254,increased megakaryocyte cell number|MP:0008478,increased spleen white pulp amount|MP:0008826,abnormal splenic cell ratio|MP:0009332,abnormal splenocyte morphology
MGI:5318886	Dido1<tm2Cmar>	MP:0001730,embryonic growth arrest|MP:0003886,abnormal embryonic epiblast morphology|MP:0004024,aneuploidy|MP:0005076,abnormal cell differentiation|MP:0008932,abnormal embryonic tissue physiology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011191,increased embryonic epiblast cell apoptosis|MP:0011192,decreased embryonic epiblast cell proliferation|MP:0030943,abnormal centrosome morphology
MGI:3586687	Diht<C3H/HeJArc>	MP:0005534,decreased body temperature
MGI:3586688	Diht<PRI>	MP:0005534,decreased body temperature
MGI:2684155	dill	MP:0000371,diluted coat color
MGI:1934629	Dilp3	MP:0002092,abnormal eye morphology|MP:0002546,mydriasis
MGI:1934630	Dilp4	MP:0002092,abnormal eye morphology|MP:0002546,mydriasis
MGI:7515012	Dimt1<em1(IMPC)J>	MP:0002075,abnormal coat/hair pigmentation|MP:0011100,preweaning lethality, complete penetrance
MGI:7335151	Dino<tm1.1Hyc>	MP:0003010,decreased mortality induced by ionizing radiation|MP:0003207,decreased cellular sensitivity to gamma-irradiation
MGI:7335152	Dino<tm2.1Hyc>	MP:0008009,delayed cellular replicative senescence|MP:0014042,decreased cellular sensitivity to DNA damaging agent induced cell death
MGI:6276908	Dio1<em1(IMPC)Hmgu>	MP:0002135,abnormal kidney morphology
MGI:3613031	Dio1<tm1Vag>	MP:0001260,increased body weight|MP:0002876,abnormal thyroid gland physiology|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003868,abnormal feces composition|MP:0005179,decreased circulating cholesterol level|MP:0005468,abnormal thyroid hormone level|MP:0005470,increased thyroxine level|MP:0005474,increased triiodothyronine level|MP:0005477,increased circulating thyroxine level|MP:0005480,increased circulating triiodothyronine level|MP:0009643,abnormal urine homeostasis
MGI:5513859	Dio2<tm1Acb>	MP:0000063,decreased bone mineral density|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005379,endocrine/exocrine gland phenotype|MP:0005468,abnormal thyroid hormone level|MP:0005477,increased circulating thyroxine level|MP:0010025,decreased total body fat amount
MGI:2182450	Dio2<tm1Vag>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0003868,abnormal feces composition|MP:0003971,abnormal thyroid-stimulating hormone level|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005470,increased thyroxine level|MP:0005477,increased circulating thyroxine level|MP:0009643,abnormal urine homeostasis|MP:0011049,impaired adaptive thermogenesis
MGI:5707059	Dio3<tm1Dmst>	MP:0003893,increased hepatocyte proliferation|MP:0005164,abnormal response to injury|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005477,increased circulating thyroxine level|MP:0005480,increased circulating triiodothyronine level
MGI:2664293	Dio3<tm1Stg>	MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0003122,maternal imprinting|MP:0003965,abnormal pituitary hormone level|MP:0005119,decreased circulating thyroid-stimulating hormone level|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005468,abnormal thyroid hormone level|MP:0005474,increased triiodothyronine level|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4841025	Dip2a<tm2a(KOMP)Wtsi>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0003053,delayed tooth eruption|MP:0005658,increased susceptibility to diet-induced obesity
MGI:5548794	Dip2a<tm2b(KOMP)Wtsi>	MP:0008810,increased circulating iron level
MGI:4431779	Dip2b<tm1a(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0002702,decreased circulating free fatty acids level
MGI:6279900	Dip2c<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000220,increased monocyte cell number|MP:0000642,enlarged adrenal glands|MP:0000702,enlarged lymph nodes|MP:0000706,small thymus|MP:0001120,abnormal uterus morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011874,enlarged urinary bladder
MGI:7548491	Dip2c<em1Ywz>	MP:0001926,female infertility|MP:0003631,nervous system phenotype
MGI:7548499	Dip2c<em2Ywz>	MP:0011400,lethality, complete penetrance
MGI:5548321	Dipk1a<tm1a(EUCOMM)Wtsi>	MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0005633,increased circulating sodium level|MP:0010025,decreased total body fat amount
MGI:6283585	Dipk1c<em1(IMPC)J>	MP:0002574,increased vertical activity
MGI:7493848	Dipk1c<em1Yxy>	MP:0001399,hyperactivity|MP:0002912,abnormal excitatory postsynaptic potential|MP:0005378,growth/size/body region phenotype|MP:0008943,increased sensitivity to induced cell death|MP:0009454,impaired contextual conditioning behavior|MP:0014367,impaired long-term object recognition memory|MP:0020508,decreased dendritic spine density
MGI:6140119	Dipk2b<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology|MP:0003795,abnormal bone structure|MP:0009709,hydrometra|MP:0020421,increased freezing behavior
MGI:7432284	Diras2<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7495776	Dis3l2<em1Dean>	MP:0001125,abnormal oocyte morphology|MP:0001926,female infertility|MP:0005168,abnormal female meiosis|MP:0005389,reproductive system phenotype|MP:0013272,abnormal translation
MGI:6404509	Dis3l2<em1(IMPC)Bay>	MP:0001257,increased body length|MP:0001697,abnormal embryo size|MP:0001914,hemorrhage|MP:0002111,abnormal tail morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:6286049	Dis3l2<em1Jtm>	MP:0000516,abnormal renal/urinary system morphology|MP:0000519,hydronephrosis|MP:0000536,hydroureter|MP:0000539,distended urinary bladder|MP:0001953,respiratory failure|MP:0004174,abnormal spine curvature|MP:0005156,bradykinesia|MP:0005378,growth/size/body region phenotype|MP:0011089,perinatal lethality, complete penetrance
MGI:6286050	Dis3l2<em2Jtm>	MP:0005367,renal/urinary system phenotype
MGI:6286052	Dis3l2<em3Jtm>	MP:0000516,abnormal renal/urinary system morphology|MP:0000519,hydronephrosis|MP:0000536,hydroureter|MP:0000539,distended urinary bladder|MP:0001953,respiratory failure|MP:0004174,abnormal spine curvature|MP:0005156,bradykinesia|MP:0005378,growth/size/body region phenotype|MP:0011089,perinatal lethality, complete penetrance
MGI:8239625	Dis3l<em1Adki>	MP:0002169,no abnormal phenotype detected
MGI:7425637	Dis3l<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002953,thick ventricular wall|MP:0003068,enlarged kidney|MP:0005011,increased eosinophil cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:8239626	Dis3l<em2Adki>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0013272,abnormal translation|MP:0014134,abnormal embryo morphology
MGI:6693492	Dis3<tm1.1Uba>	MP:0004816,abnormal class switch recombination|MP:0004939,abnormal B cell morphology
MGI:5548623	Dis3<tm1e.1(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0001488,increased startle reflex|MP:0002699,abnormal vitreous body morphology|MP:0005293,impaired glucose tolerance|MP:0008259,abnormal optic disk morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:3623217	Disc1<del>	MP:0002063,abnormal learning/memory/conditioning
MGI:6316113	Disc1<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0001304,cataract|MP:0001399,hyperactivity|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0009141,increased prepulse inhibition
MGI:5752777	Disc1<m1H>	MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0002757,decreased vertical activity|MP:0002797,increased thigmotaxis|MP:0004000,impaired passive avoidance behavior|MP:0005386,behavior/neurological phenotype|MP:0031391,increased locomotor activity
MGI:3707421	Disc1<Rgsc1390>	MP:0000774,decreased brain size|MP:0000852,small cerebellum|MP:0001415,increased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0001489,decreased startle reflex|MP:0003088,abnormal prepulse inhibition|MP:0005386,behavior/neurological phenotype|MP:0006254,thin cerebral cortex|MP:0006299,abnormal latent inhibition of conditioning behavior|MP:0006300,abnormal entorhinal cortex morphology|MP:0008428,abnormal spatial working memory|MP:0020527,small thalamus
MGI:3707419	Disc1<Rgsc1393>	MP:0000774,decreased brain size|MP:0000852,small cerebellum|MP:0001423,abnormal liquid preference|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002573,behavioral despair|MP:0003088,abnormal prepulse inhibition|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0006254,thin cerebral cortex|MP:0006299,abnormal latent inhibition of conditioning behavior|MP:0006300,abnormal entorhinal cortex morphology|MP:0008428,abnormal spatial working memory|MP:0020527,small thalamus
MGI:5648808	Disc1<tm1(DISC1/DISC1FP1,DISC1FP1/DISC1,DISC1)Xzho>	MP:0001489,decreased startle reflex|MP:0009745,abnormal behavioral response to xenobiotic
MGI:3623218	Disc1<tm1Kara>	MP:0002063,abnormal learning/memory/conditioning
MGI:5296951	Disc1<tm1Kozo>	MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001473,reduced long-term potentiation|MP:0002207,abnormal long-term potentiation|MP:0002915,abnormal synaptic depression|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008911,induced hyperactivity|MP:0009142,decreased prepulse inhibition|MP:0009453,enhanced contextual conditioning behavior|MP:0010070,decreased serotonin level|MP:0010698,abnormal impulsive behavior control|MP:0031391,increased locomotor activity
MGI:7541191	Discn<em1Zhgp>	MP:0001363,increased anxiety-related response|MP:0001405,impaired coordination|MP:0001441,increased grooming behavior|MP:0002152,abnormal brain morphology|MP:0002797,increased thigmotaxis|MP:0008432,abnormal long-term spatial reference memory|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2448055	Disp1<icb>	MP:0000259,abnormal vascular development|MP:0000267,abnormal heart development|MP:0000550,abnormal forelimb morphology|MP:0000913,abnormal brain development|MP:0000955,abnormal spinal cord morphology|MP:0001688,abnormal somite development|MP:0001706,abnormal left-right axis patterning|MP:0001787,pericardial edema|MP:0002109,abnormal limb morphology|MP:0002151,abnormal neural tube morphology|MP:0003631,nervous system phenotype|MP:0003743,abnormal facial morphology|MP:0004190,abnormal direction of embryo turning|MP:0004251,failure of heart looping|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011495,abnormal head shape
MGI:3052133	Disp1<tm1Amc>	MP:0001954,respiratory distress|MP:0002116,abnormal craniofacial bone morphology|MP:0002243,abnormal vomeronasal organ morphology|MP:0002251,abnormal nasopharynx morphology|MP:0002659,pituitary gland hypoplasia|MP:0002948,abnormal neuron specification|MP:0003743,abnormal facial morphology|MP:0004790,absent upper incisors|MP:0005157,holoprosencephaly|MP:0006197,ocular hypotelorism|MP:0011087,neonatal lethality, complete penetrance|MP:0012258,philtrum hypoplasia|MP:0030314,absent primary palate
MGI:2672101	Disp1<tm1Pab>	MP:0000269,abnormal heart looping|MP:0000292,distended pericardium|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001706,abnormal left-right axis patterning|MP:0002151,abnormal neural tube morphology|MP:0003425,abnormal optic vesicle formation|MP:0004837,abnormal neural fold formation|MP:0005657,abnormal neural plate morphology|MP:0006337,abnormal first pharyngeal arch morphology|MP:0010335,fused first pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2429759	Disp1<tm1Ptch>	MP:0000267,abnormal heart development|MP:0000292,distended pericardium|MP:0000783,abnormal forebrain morphology|MP:0000926,absent floor plate|MP:0001701,incomplete embryo turning|MP:0002151,abnormal neural tube morphology|MP:0004206,abnormal dermomyotome development|MP:0004251,failure of heart looping|MP:0005157,holoprosencephaly|MP:0005163,cyclopia|MP:0005224,abnormal left-right axis symmetry of the somites|MP:0006029,abnormal sclerotome morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3512541	Disp1<tm2Amc>	MP:0002169,no abnormal phenotype detected
MGI:6152459	Disp3<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000538,abnormal urinary bladder morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002135,abnormal kidney morphology|MP:0002188,small heart|MP:0002339,abnormal lymph node morphology|MP:0004832,enlarged ovary|MP:0009709,hydrometra|MP:0010123,increased bone mineral content|MP:0011874,enlarged urinary bladder
MGI:3843377	Diwg1<C57BL/6>	MP:0001559,hyperglycemia|MP:0005455,increased susceptibility to weight gain
MGI:5445766	Dixdc1<tm1.1(KOMP)Vlcg>	MP:0001325,abnormal retina morphology|MP:0001489,decreased startle reflex|MP:0011396,abnormal sleep behavior
MGI:5707820	Dixdc1<tm1Bnrc>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001489,decreased startle reflex|MP:0002757,decreased vertical activity|MP:0003631,nervous system phenotype
MGI:3722306	dj	MP:0000371,diluted coat color|MP:0005408,hypopigmentation|MP:0009379,abnormal foot pigmentation|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:3809481	Dkc1<tm1.1Pjma>	MP:0001262,decreased body weight|MP:0002396,abnormal hematopoietic system morphology/development|MP:0003674,oxidative stress|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005397,hematopoietic system phenotype|MP:0005621,abnormal cell physiology|MP:0008058,abnormal DNA repair|MP:0010771,integument phenotype|MP:0011704,decreased fibroblast proliferation|MP:0011903,decreased hematopoietic stem cell proliferation
MGI:2446497	Dkc1<tm1Bsl>	MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002169,no abnormal phenotype detected|MP:0004179,transmission ratio distortion|MP:0004180,failure of initiation of embryo turning|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012119,increased trophectoderm apoptosis|MP:0012120,trophectoderm cell degeneration
MGI:2449175	Dkc1<tm1Ppp>	MP:0000221,decreased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000333,decreased bone marrow cell number|MP:0000358,abnormal cell morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000716,abnormal immune system cell morphology|MP:0001175,abnormal lung morphology|MP:0001222,epidermal hyperplasia|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001545,abnormal hematopoietic system physiology|MP:0001577,anemia|MP:0001861,lung inflammation|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002018,increased malignant tumor incidence|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002050,increased pheochromocytoma incidence|MP:0002060,abnormal skin morphology|MP:0002123,abnormal definitive hematopoiesis|MP:0002135,abnormal kidney morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002447,abnormal erythrocyte morphology|MP:0002722,abnormal immune system organ morphology|MP:0002874,decreased hemoglobin content|MP:0003179,thrombocytopenia|MP:0003426,pulmonary interstitial fibrosis|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005264,glomerulosclerosis|MP:0005621,abnormal cell physiology|MP:0008209,decreased pre-B cell number|MP:0008477,decreased spleen red pulp amount|MP:0008479,decreased spleen white pulp amount|MP:0008714,increased lung carcinoma incidence|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0009278,abnormal bone marrow cell physiology|MP:0009563,dyskeratosis|MP:0010024,increased total body fat amount|MP:0010363,increased fibrosarcoma incidence|MP:0010384,increased renal carcinoma incidence|MP:0010901,abnormal pulmonary alveolar parenchyma morphology|MP:0011346,renal tubule atrophy|MP:0013501,increased fibroblast apoptosis|MP:0014473,increased pulmonary alveolus wall thickness|MP:0030927,decreased telomere length
MGI:2446500	Dkc1<tm2Bsl>	MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002169,no abnormal phenotype detected|MP:0004179,transmission ratio distortion|MP:0004180,failure of initiation of embryo turning|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012119,increased trophectoderm apoptosis|MP:0012120,trophectoderm cell degeneration
MGI:3849598	Dkc1<tm2Pjma>	MP:0002161,abnormal fertility/fecundity|MP:0005621,abnormal cell physiology
MGI:3849599	Dkc1<tm3Pjma>	MP:0002169,no abnormal phenotype detected
MGI:5311612	Dkf	MP:0000575,increased foot pad pigmentation|MP:0001262,decreased body weight|MP:0002080,prenatal lethality|MP:0009674,decreased birth weight
MGI:2387760	Dkk1<tm1Lmgd>	MP:0000087,absent mandible|MP:0000433,microcephaly|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000568,ectopic digits|MP:0000787,abnormal telencephalon morphology|MP:0001293,anophthalmia|MP:0001678,thick apical ectodermal ridge|MP:0003935,abnormal craniofacial development|MP:0004384,small interparietal bone|MP:0004418,small parietal bone|MP:0004473,absent nasal bone|MP:0004539,absent maxilla|MP:0005650,abnormal limb bud morphology|MP:0006293,absent nasal placodes|MP:0006294,absent optic vesicle|MP:0006337,abnormal first pharyngeal arch morphology|MP:0010939,abnormal mandibular prominence morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0012089,decreased midbrain size|MP:0012138,decreased forebrain size|MP:0012157,rostral body truncation|MP:0012178,absent frontonasal prominence|MP:0012517,absent diencephalon|MP:0030324,abnormal anterior head development
MGI:3777004	Dkk1<tm1Sia>	MP:0004261,abnormal embryonic neuroepithelium morphology
MGI:3590649	Dkk2<tm1Dwu>	MP:0000063,decreased bone mineral density|MP:0002896,abnormal bone mineralization|MP:0004984,increased osteoclast cell number|MP:0005390,skeleton phenotype|MP:0008395,abnormal osteoblast differentiation|MP:0008396,abnormal osteoclast differentiation
MGI:3639316	Dkk2<tm1Lmgd>	MP:0001262,decreased body weight|MP:0001312,abnormal cornea morphology|MP:0006000,abnormal cornea epithelium morphology|MP:0013754,abnormal ocular surface morphology|MP:0020857,cornea epithelium hyperplasia
MGI:3621929	Dkk3<tm1Cni>	MP:0001399,hyperactivity|MP:0002494,increased IgM level|MP:0002590,increased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0002666,increased circulating aldosterone level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0008045,decreased NK cell number
MGI:5572034	Dkk4<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5544771	Dkk4<tm2.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:4438465	Dkkl1<tm1.1Mldp>	MP:0005389,reproductive system phenotype|MP:0005411,delayed fertilization|MP:0009647,decreased fertilization frequency|MP:0030976,impaired sperm penetration of zona pellucida
MGI:3839561	Dkkl1<tm1Ducy>	MP:0004851,increased testis weight|MP:0005390,skeleton phenotype|MP:0008280,abnormal male germ cell apoptosis|MP:0030603,increased sperm number
MGI:5788343	Dlat<em1(IMPC)J>	MP:0001417,decreased exploration in new environment|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:4124985	Dlc1<Gt(XE082)Byg>	MP:0000274,enlarged heart|MP:0000280,thin ventricular wall|MP:0000929,open neural tube|MP:0001716,abnormal placenta labyrinth morphology|MP:0001722,pale yolk sac|MP:0001889,delayed brain development|MP:0002151,abnormal neural tube morphology|MP:0002429,abnormal blood cell morphology/development|MP:0002724,enhanced wound healing|MP:0003105,abnormal heart atrium morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011709,increased fibroblast cell migration|MP:0013241,embryo tissue necrosis
MGI:5468314	Dlc1<tm1.1Lowy>	MP:0002169,no abnormal phenotype detected|MP:0005621,abnormal cell physiology
MGI:3529997	Dlc1<tm1Lec>	MP:0000267,abnormal heart development|MP:0000913,abnormal brain development|MP:0000929,open neural tube|MP:0002169,no abnormal phenotype detected|MP:0002884,abnormal pharyngeal arch morphology|MP:0003232,abnormal forebrain development|MP:0006108,abnormal hindbrain development|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014698,decreased fibroblast adhesion
MGI:2182403	Dld<tm1Ptl>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0003984,embryonic growth retardation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology
MGI:6719366	Dlec1<em1Yogo>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009376,abnormal manchette morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology
MGI:4432388	Dlec1<tm1a(EUCOMM)Wtsi>	MP:0004924,abnormal behavior
MGI:5548818	Dlec1<tm1b(EUCOMM)Wtsi>	MP:0001925,male infertility|MP:0002591,decreased mean corpuscular volume|MP:0002941,increased circulating alanine transaminase level|MP:0004738,abnormal auditory brainstem response
MGI:3777572	dleon	MP:0000940,abnormal motor neuron innervation pattern
MGI:2680670	Dlg1<Gt(gt1.8geo)1Ber>	MP:0000440,domed cranium|MP:0000445,short snout|MP:0000460,mandible hypoplasia|MP:0000527,abnormal kidney development|MP:0000585,kinked tail|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0001575,cyanosis|MP:0003051,curly tail|MP:0003237,abnormal lens epithelium morphology|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0004505,decreased renal glomerulus number|MP:0004871,premaxilla hypoplasia|MP:0009247,meteorism|MP:0009429,decreased embryo weight|MP:0009546,absent gastric milk in neonates|MP:0009885,abnormal palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance|MP:0011290,decreased nephron number|MP:0011365,small metanephros
MGI:4329564	Dlg1<Gt(RRN196)Byg>	MP:0011087,neonatal lethality, complete penetrance
MGI:4354826	Dlg1<tm1.1Agri>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology|MP:0003237,abnormal lens epithelium morphology|MP:0003847,disorganized lens bow|MP:0005391,vision/eye phenotype|MP:0005545,abnormal lens development|MP:0008794,increased lens epithelium apoptosis|MP:0008796,increased lens fiber apoptosis
MGI:4354833	Dlg1<tm1.2Agri>	MP:0000428,abnormal craniofacial morphology|MP:0001303,abnormal lens morphology
MGI:3699270	Dlg1<tm1Jhm>	MP:0000479,abnormal enterocyte morphology|MP:0000519,hydronephrosis|MP:0000534,abnormal ureter morphology|MP:0000536,hydroureter|MP:0000740,impaired smooth muscle contractility|MP:0001954,respiratory distress|MP:0002990,short ureter|MP:0003446,renal hypoplasia|MP:0003604,single kidney|MP:0003672,abnormal ureter development|MP:0004860,dilated kidney collecting duct|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0006032,abnormal ureteric bud morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011290,decreased nephron number|MP:0011426,abnormal ureter smooth muscle morphology|MP:0011480,impaired ureteric peristalsis
MGI:3817231	Dlg1<tm1Rlh>	MP:0000428,abnormal craniofacial morphology|MP:0002058,neonatal lethality|MP:0003009,abnormal cytokine secretion|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0008143,abnormal dendrite morphology|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion|MP:0010050,hypermyelination
MGI:3710242	Dlg1<tm1Taki>	MP:0000111,cleft palate|MP:0000477,abnormal intestine morphology|MP:0000519,hydronephrosis|MP:0000534,abnormal ureter morphology|MP:0001120,abnormal uterus morphology|MP:0001258,decreased body length|MP:0002160,abnormal reproductive system morphology|MP:0002286,cryptorchism|MP:0003446,renal hypoplasia|MP:0003535,absent vagina|MP:0003584,bifid ureter|MP:0003585,large ureter|MP:0003586,dilated ureter|MP:0003642,absent seminal vesicle|MP:0003672,abnormal ureter development|MP:0003826,abnormal Mullerian duct morphology|MP:0003827,abnormal Wolffian duct morphology|MP:0005631,decreased lung weight|MP:0009084,blind uterus|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011298,ureter hypoplasia|MP:0011484,abnormal ureter urothelium morphology|MP:0011727,ectopic ovary
MGI:2388036	Dlg2<tm1Dsb>	MP:0001035,abnormal submandibular ganglion morphology|MP:0001491,unresponsive to tactile stimuli|MP:0001968,abnormal touch/nociception|MP:0002206,abnormal CNS synaptic transmission|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003632,abnormal nervous system morphology|MP:0005386,behavior/neurological phenotype
MGI:4458932	Dlg3<Gt(P038A02)Wrst>	MP:0003232,abnormal forebrain development|MP:0004073,caudal body truncation|MP:0004180,failure of initiation of embryo turning
MGI:4441739	Dlg3<tm1a(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density
MGI:3706312	Dlg3<tm1Grnt>	MP:0000859,abnormal somatosensory cortex morphology|MP:0001463,abnormal spatial learning|MP:0002152,abnormal brain morphology|MP:0002184,abnormal innervation|MP:0002207,abnormal long-term potentiation|MP:0003313,abnormal locomotor activation|MP:0003989,abnormal barrel cortex morphology|MP:0005404,abnormal axon morphology|MP:0009538,abnormal synapse morphology|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0011273,prolonged excitatory postsynaptic current decay time|MP:0020066,abnormal neocortex size
MGI:5495768	Dlg4<tm1.1Tdoi>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001386,abnormal maternal nurturing|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001489,decreased startle reflex|MP:0002063,abnormal learning/memory/conditioning|MP:0002802,abnormal discrimination learning|MP:0002919,enhanced paired-pulse facilitation|MP:0003008,enhanced long-term potentiation|MP:0003635,abnormal synaptic transmission|MP:0003718,maternal effect|MP:0003908,decreased stereotypic behavior|MP:0003990,decreased neurotransmitter release|MP:0004859,abnormal synaptic plasticity|MP:0010052,increased grip strength|MP:0011003,reduced AMPA-mediated synaptic currents|MP:0014370,impaired spatial working memory
MGI:5805884	Dlg4<tm1e(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0003960,increased lean body mass|MP:0005633,increased circulating sodium level|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010123,increased bone mineral content
MGI:2182460	Dlg4<tm1Grnt>	MP:0000647,abnormal sebaceous gland morphology|MP:0000783,abnormal forebrain morphology|MP:0001265,decreased body size|MP:0001463,abnormal spatial learning|MP:0001970,abnormal pain threshold|MP:0002206,abnormal CNS synaptic transmission|MP:0002919,enhanced paired-pulse facilitation|MP:0003008,enhanced long-term potentiation|MP:0003177,allodynia|MP:0004077,abnormal striatum morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3700207	Dlg4<tm1Rlh>	MP:0002184,abnormal innervation|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0002888,abnormal NMDA-mediated synaptic currents|MP:0003008,enhanced long-term potentiation
MGI:3848928	Dlg4<tm2.1Grnt>	MP:0001360,abnormal social investigation|MP:0001362,abnormal anxiety-related response|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001441,increased grooming behavior|MP:0001525,impaired balance|MP:0001745,increased circulating corticosterone level|MP:0002063,abnormal learning/memory/conditioning|MP:0002757,decreased vertical activity|MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype|MP:0009754,enhanced behavioral response to cocaine|MP:0009758,impaired behavioral response to cocaine|MP:0009936,abnormal dendritic spine morphology|MP:0010053,decreased grip strength|MP:0010166,increased response to stress-induced hyperthermia|MP:0020351,decreased vocalization
MGI:4359766	Dlg4<tm3.1Grnt>	MP:0003631,nervous system phenotype
MGI:4888250	Dlg4<tm4.1Grnt>	MP:0002736,abnormal nociception after inflammation|MP:0003631,nervous system phenotype
MGI:5692705	Dlg5<tm1b(EUCOMM)Wtsi>	MP:0000428,abnormal craniofacial morphology|MP:0001297,microphthalmia|MP:0001785,edema|MP:0001891,hydrocephaly|MP:0001914,hemorrhage|MP:0002152,abnormal brain morphology|MP:0003054,spina bifida|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:3757646	Dlg5<tm1Vv>	MP:0000432,abnormal head morphology|MP:0000534,abnormal ureter morphology|MP:0000825,dilated lateral ventricle|MP:0000826,abnormal third ventricle morphology|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology|MP:0002653,abnormal ependyma morphology|MP:0002703,abnormal renal tubule morphology|MP:0003588,ureter stenosis|MP:0003675,kidney cyst|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004754,abnormal kidney collecting duct morphology|MP:0004860,dilated kidney collecting duct|MP:0005238,increased brain size|MP:0005537,abnormal cerebral aqueduct morphology|MP:0005565,increased blood urea nitrogen level|MP:0009937,abnormal neuron differentiation|MP:0011331,abnormal papillary duct morphology
MGI:6156461	Dlgap1<em1(IMPC)Tcp>	MP:0001297,microphthalmia|MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002768,small adrenal glands
MGI:6164155	Dlgap1<tm1Grnt>	MP:0001360,abnormal social investigation|MP:0001441,increased grooming behavior|MP:0002572,abnormal emotion/affect behavior|MP:0005386,behavior/neurological phenotype
MGI:7425639	Dlgap2<em1(IMPC)Mhzh>	MP:0000219,increased neutrophil cell number|MP:0001402,decreased locomotor activity|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0013279,increased fasting circulating glucose level
MGI:6191669	Dlgap2<tm1.1Ssfg>	MP:0001353,increased aggression towards mice|MP:0001360,abnormal social investigation|MP:0001463,abnormal spatial learning|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004811,abnormal neuron physiology|MP:0008911,induced hyperactivity|MP:0009538,abnormal synapse morphology|MP:0020508,decreased dendritic spine density|MP:0020551,abnormal postsynaptic density morphology
MGI:3759300	Dlgap3<tm1Gfng>	MP:0001212,skin lesions|MP:0001363,increased anxiety-related response|MP:0001441,increased grooming behavior|MP:0001501,abnormal sleep pattern|MP:0002797,increased thigmotaxis|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003234,enhanced NMDA-mediated synaptic currents|MP:0004077,abnormal striatum morphology|MP:0009746,enhanced behavioral response to xenobiotic
MGI:4126537	Dlgap4<Gt(XH723)Byg>	MP:0001361,social withdrawal|MP:0001364,decreased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001442,decreased grooming behavior|MP:0001475,reduced long-term depression|MP:0001504,abnormal posture|MP:0001516,abnormal motor coordination/balance|MP:0002063,abnormal learning/memory/conditioning|MP:0002272,abnormal nervous system electrophysiology|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002910,abnormal excitatory postsynaptic currents|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008428,abnormal spatial working memory|MP:0011620,abnormal habituation to a new environment|MP:0012307,impaired spatial learning|MP:0020338,abnormal hippocampal pyramidal neuron dendrite morphology|MP:0020351,decreased vocalization|MP:0020395,abnormal response to social novelty|MP:0020513,abnormal dendritic stubby spine morphology|MP:0020551,abnormal postsynaptic density morphology|MP:0031391,increased locomotor activity
MGI:5796936	Dlgap4<tm1b(KOMP)Wtsi>	MP:0002875,decreased erythrocyte cell number|MP:0003960,increased lean body mass|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0010025,decreased total body fat amount|MP:0013278,decreased fasting circulating glucose level
MGI:3821727	Dlgap5<tm1Tfts>	MP:0001926,female infertility|MP:0003845,abnormal decidualization|MP:0005389,reproductive system phenotype
MGI:6140187	Dlk1<em1(IMPC)Wtsi>	MP:0003961,decreased lean body mass|MP:0005560,decreased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0010024,increased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4879107	Dlk1<tm1.1Jvs>	MP:0000352,decreased cell proliferation|MP:0001262,decreased body weight|MP:0001846,increased inflammatory response|MP:0003122,maternal imprinting|MP:0005076,abnormal cell differentiation|MP:0005378,growth/size/body region phenotype|MP:0009399,increased skeletal muscle fiber size|MP:0009401,increased skeletal muscle fiber diameter|MP:0009406,decreased skeletal muscle fiber number|MP:0009419,skeletal muscle fibrosis|MP:0010768,mortality/aging|MP:0013239,impaired skeletal muscle regeneration|MP:0014169,decreased brown adipose tissue mass
MGI:5471922	Dlk1<tm1.2Jvs>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001715,placental labyrinth hypoplasia|MP:0001716,abnormal placenta labyrinth morphology|MP:0001732,postnatal growth retardation|MP:0002058,neonatal lethality|MP:0002082,postnatal lethality|MP:0003122,maternal imprinting|MP:0005378,growth/size/body region phenotype|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009269,decreased fat cell size|MP:0010768,mortality/aging|MP:0010769,abnormal survival|MP:0012109,decreased trophoblast glycogen cell number
MGI:3640339	Dlk1<tm1Hsul>	MP:0000154,rib fusion|MP:0000155,asymmetric rib joints|MP:0000599,enlarged liver|MP:0001548,hyperlipidemia|MP:0001732,postnatal growth retardation|MP:0001935,decreased litter size|MP:0002628,hepatic steatosis|MP:0003122,maternal imprinting|MP:0004201,fetal growth retardation|MP:0005178,increased circulating cholesterol level|MP:0005287,narrow eye opening|MP:0005334,abnormal fat pad morphology|MP:0006094,increased fat cell size|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3526402	Dlk1<tm1Srba>	MP:0001265,decreased body size|MP:0002362,abnormal spleen marginal zone morphology|MP:0002458,abnormal B cell number|MP:0002461,increased immunoglobulin level|MP:0002494,increased IgM level|MP:0003122,maternal imprinting|MP:0008181,increased marginal zone B cell number|MP:0008189,increased transitional stage B cell number|MP:0008211,decreased mature B cell number|MP:0008214,increased immature B cell number|MP:0008215,decreased immature B cell number|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level|MP:0008896,increased IgG2c level
MGI:6355376	Dlk2<tm1.1Geno>	MP:0001363,increased anxiety-related response|MP:0003633,abnormal nervous system physiology|MP:0005386,behavior/neurological phenotype|MP:0009747,impaired behavioral response to xenobiotic|MP:0014414,increased depression-related behavior
MGI:4821259	Dll1<m1Mhda>	MP:0000063,decreased bone mineral density|MP:0001255,decreased body height|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0002083,premature death|MP:0002644,decreased circulating triglyceride level|MP:0003960,increased lean body mass|MP:0004875,increased mean systemic arterial blood pressure|MP:0005179,decreased circulating cholesterol level|MP:0005333,decreased heart rate|MP:0005387,immune system phenotype|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008821,increased blood uric acid level|MP:0008965,increased basal metabolism|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4849919	Dll1<m594592Hubr>	MP:0000266,abnormal heart morphology|MP:0000592,short tail|MP:0001691,abnormal somite shape|MP:0002151,abnormal neural tube morphology|MP:0002766,situs inversus|MP:0004073,caudal body truncation|MP:0004252,abnormal direction of heart looping
MGI:5473277	Dll1<tm1.1(cre/ERT2)Cle>	MP:0002169,no abnormal phenotype detected
MGI:5426508	Dll1<tm1.1Hri>	MP:0003934,abnormal pancreas development
MGI:5431502	Dll1<tm1.1Mjo>	MP:0000137,abnormal vertebrae morphology
MGI:1861919	Dll1<tm1Gos>	MP:0000062,increased bone mineral density|MP:0000063,decreased bone mineral density|MP:0000913,abnormal brain development|MP:0000963,fused dorsal root ganglion|MP:0001077,abnormal spinal nerve morphology|MP:0001255,decreased body height|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001688,abnormal somite development|MP:0001689,incomplete somite formation|MP:0001691,abnormal somite shape|MP:0001807,decreased IgA level|MP:0001914,hemorrhage|MP:0002644,decreased circulating triglyceride level|MP:0002752,abnormal somatic nervous system morphology|MP:0002825,abnormal notochord morphology|MP:0003866,abnormal defecation|MP:0003934,abnormal pancreas development|MP:0003961,decreased lean body mass|MP:0004066,abnormal primitive node morphology|MP:0004132,absent embryonic cilia|MP:0004190,abnormal direction of embryo turning|MP:0004252,abnormal direction of heart looping|MP:0004647,decreased lumbar vertebrae number|MP:0004875,increased mean systemic arterial blood pressure|MP:0004978,decreased B-1 B cell number|MP:0004981,decreased neuronal precursor cell number|MP:0005014,increased B cell number|MP:0005179,decreased circulating cholesterol level|MP:0005192,increased motor neuron number|MP:0005333,decreased heart rate|MP:0005567,decreased circulating total protein level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008029,abnormal paraxial mesoderm morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008822,decreased blood uric acid level|MP:0008947,increased neuron number|MP:0008965,increased basal metabolism|MP:0009937,abnormal neuron differentiation|MP:0010025,decreased total body fat amount|MP:0010119,abnormal bone mineral density|MP:0010124,decreased bone mineral content|MP:0010180,increased susceptibility to weight loss|MP:0010515,abnormal Q wave|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011940,decreased food intake|MP:0012675,enlarged floor plate|MP:0012728,abnormal somite border morphology|MP:0020234,decreased basal metabolism
MGI:3044907	Dll1<tm1Mjo>	MP:0002622,abnormal cochlear hair cell morphology|MP:0003148,decreased cochlea coiling|MP:0004330,abnormal vestibular saccular macula morphology|MP:0004333,abnormal utricular macula morphology|MP:0004395,increased cochlear inner hair cell number|MP:0004401,increased cochlear outer hair cell number|MP:0005387,immune system phenotype|MP:0006135,artery stenosis|MP:0008183,absent marginal zone B cells|MP:0010463,aorta stenosis|MP:0012024,abnormal nephron morphogenesis|MP:0014273,abnormal skin vasculature morphology|MP:0020327,abnormal capillary branching pattern
MGI:5620942	Dll1<tm3.1Gos>	MP:0003631,nervous system phenotype|MP:0005369,muscle phenotype|MP:0005380,embryo phenotype|MP:0005387,immune system phenotype
MGI:3045636	Dll3<oma>	MP:0000137,abnormal vertebrae morphology|MP:0000154,rib fusion|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001258,decreased body length|MP:0002114,abnormal axial skeleton morphology|MP:0004609,vertebral fusion|MP:0008271,abnormal bone ossification
MGI:1857008	Dll3<pu>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000160,kyphosis|MP:0000162,lordosis|MP:0000438,abnormal cranium morphology|MP:0000589,thin tail|MP:0000592,short tail|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000963,fused dorsal root ganglion|MP:0001077,abnormal spinal nerve morphology|MP:0001258,decreased body length|MP:0001539,decreased caudal vertebrae number|MP:0001688,abnormal somite development|MP:0001691,abnormal somite shape|MP:0002566,abnormal sexual interaction|MP:0003794,delayed somite formation|MP:0004206,abnormal dermomyotome development|MP:0004609,vertebral fusion|MP:0004704,short vertebral column|MP:0005222,abnormal somite size|MP:0005508,abnormal skeleton morphology|MP:0006029,abnormal sclerotome morphology|MP:0008530,abnormal rostral-caudal patterning of the somites|MP:0010082,sternebra fusion|MP:0010152,abnormal brain ependyma morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012182,abnormal presomitic mesoderm morphology|MP:0012728,abnormal somite border morphology|MP:0021138,abnormal multifidus muscle morphology
MGI:5660113	Dll3<pu-2J>	MP:0000547,short limbs|MP:0000585,kinked tail|MP:0001258,decreased body length|MP:0002111,abnormal tail morphology|MP:0003051,curly tail|MP:0005377,hearing/vestibular/ear phenotype
MGI:3036558	Dll3<pu-J>	MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000137,abnormal vertebrae morphology|MP:0000585,kinked tail|MP:0000755,hindlimb paralysis|MP:0001258,decreased body length|MP:0001935,decreased litter size|MP:0002759,abnormal caudal vertebrae morphology|MP:0002907,abnormal parturition|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0004626,vertebral compression|MP:0004673,splayed ribs|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype
MGI:2178443	Dll3<tm1Rbe>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000592,short tail|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000963,fused dorsal root ganglion|MP:0001077,abnormal spinal nerve morphology|MP:0001258,decreased body length|MP:0001539,decreased caudal vertebrae number|MP:0001688,abnormal somite development|MP:0003345,decreased rib number|MP:0003400,kinked neural tube|MP:0003794,delayed somite formation|MP:0004599,abnormal vertebral arch morphology|MP:0004609,vertebral fusion|MP:0004645,decreased vertebrae number|MP:0005225,abnormal vertebrae development|MP:0005390,skeleton phenotype|MP:0005508,abnormal skeleton morphology|MP:0008317,abnormal paravertebral ganglion morphology|MP:0008530,abnormal rostral-caudal patterning of the somites|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012669,abnormal somite segmentation clock|MP:0021138,abnormal multifidus muscle morphology
MGI:3828266	Dll4<tm1Frad>	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000715,decreased thymocyte number|MP:0002145,abnormal T cell differentiation|MP:0002748,abnormal pulmonary valve morphology|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0006126,abnormal cardiac outflow tract development|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008214,increased immature B cell number|MP:0008827,abnormal thymus cell ratio|MP:0010402,ventricular septal defect
MGI:3056460	Dll4<tm1Grid>	MP:0000265,blood vessel atresia|MP:0000364,abnormal vascular regression|MP:0003658,abnormal capillary morphology|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004784,abnormal anterior cardinal vein morphology|MP:0004786,abnormal common cardinal vein morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0005312,pericardial effusion|MP:0006093,arteriovenous malformation|MP:0011100,preweaning lethality, complete penetrance
MGI:3056400	Dll4<tm1Jrt>	MP:0000259,abnormal vascular development|MP:0000295,trabecula carnea hypoplasia|MP:0000364,abnormal vascular regression|MP:0001633,poor circulation|MP:0001787,pericardial edema|MP:0002191,abnormal artery morphology|MP:0002725,abnormal vein morphology|MP:0003105,abnormal heart atrium morphology|MP:0003227,abnormal vascular branching morphogenesis|MP:0003228,abnormal sinus venosus morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003230,abnormal umbilical artery morphology|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004783,abnormal cardinal vein morphology|MP:0004784,abnormal anterior cardinal vein morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0005294,abnormal heart ventricle morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012501,abnormal pericardial cavity morphology
MGI:3828459	Dll4<tm1Kaho>	MP:0000727,absent CD8-positive, alpha-beta T cells|MP:0001823,thymus hypoplasia|MP:0002401,abnormal lymphopoiesis|MP:0003790,absent CD4-positive, alpha-beta T cells|MP:0005092,decreased double-positive T cell number
MGI:3521976	Dll4<tm1Nwg>	MP:0000259,abnormal vascular development|MP:0000364,abnormal vascular regression|MP:0001614,abnormal blood vessel morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0003231,abnormal placenta vasculature|MP:0003410,abnormal artery development|MP:0003411,abnormal vein development|MP:0004783,abnormal cardinal vein morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0005592,abnormal vascular smooth muscle morphology|MP:0009660,abnormal induced retina neovascularization|MP:0010463,aorta stenosis|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012730,abnormal internal carotid artery morphology|MP:0013241,embryo tissue necrosis
MGI:5295263	Dll4<tm1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:5302387	Dll4<tm2.1Vlcg>	MP:0000260,abnormal angiogenesis|MP:0000364,abnormal vascular regression|MP:0001672,abnormal embryo development|MP:0002169,no abnormal phenotype detected|MP:0002792,abnormal retina vasculature morphology|MP:0009660,abnormal induced retina neovascularization
MGI:5545924	Dll4<tm3.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:2680123	Dloc1<C57BL/6J>	MP:0031391,increased locomotor activity
MGI:2680124	Dloc2<129S6/SvEvTac>	MP:0031391,increased locomotor activity
MGI:3688869	Dlp1<1R>	MP:0000371,diluted coat color
MGI:3688872	Dlp2<1R>	MP:0000371,diluted coat color|MP:0000373,belly spot
MGI:3688876	Dlp3<1R>	MP:0000371,diluted coat color
MGI:6277023	Dlst<em1(IMPC)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:5502415	Dlx1as<tm1.1Tlu>	MP:0000438,abnormal cranium morphology|MP:0003631,nervous system phenotype|MP:0004101,abnormal brain interneuron morphology
MGI:1857826	Dlx1<tm1Jlr>	MP:0000111,cleft palate|MP:0001071,abnormal facial nerve morphology|MP:0001265,decreased body size|MP:0002083,premature death|MP:0004666,absent stapedial artery|MP:0004739,conductive hearing loss|MP:0005107,abnormal stapes morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0030127,small stapes|MP:0030406,absent stapes obturator foramen
MGI:3609208	Dlx2<tm1Fsh>	MP:0000111,cleft palate|MP:0001270,distended abdomen|MP:0001436,abnormal suckling behavior|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0003313,abnormal locomotor activation|MP:0011087,neonatal lethality, complete penetrance
MGI:1857828	Dlx2<tm1Jlr>	MP:0000106,abnormal basisphenoid bone morphology|MP:0000430,absent maxillary shelf|MP:0000431,absent palatine bone horizontal plate|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0000759,abnormal skeletal muscle morphology|MP:0001068,abnormal mandibular nerve branching|MP:0001071,abnormal facial nerve morphology|MP:0001436,abnormal suckling behavior|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002058,neonatal lethality|MP:0002739,abnormal olfactory bulb development|MP:0003235,abnormal alisphenoid bone morphology|MP:0003290,intestinal hypoperistalsis|MP:0003313,abnormal locomotor activation|MP:0003869,ectopic cartilage|MP:0004453,abnormal pterygoid bone morphology|MP:0004456,small pterygoid bone|MP:0004666,absent stapedial artery|MP:0005106,abnormal incus morphology|MP:0005107,abnormal stapes morphology|MP:0005249,abnormal palatine bone morphology|MP:0005270,abnormal zygomatic bone morphology|MP:0005272,abnormal temporal bone morphology|MP:0009247,meteorism|MP:0009882,absent palatal shelf|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance|MP:0030108,abnormal incudostapedial joint morphology|MP:0030127,small stapes|MP:0030395,absent incus short process|MP:0030406,absent stapes obturator foramen
MGI:6276901	Dlx3<em1(IMPC)Mbp>	MP:0000194,increased circulating calcium level|MP:0001614,abnormal blood vessel morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002968,increased circulating alkaline phosphatase level|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0020421,increased freezing behavior
MGI:2155443	Dlx3<tm1Mso>	MP:0000288,abnormal pericardium morphology|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001730,embryonic growth arrest|MP:0003403,absent placental labyrinth|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3813130	Dlx3<tm2Mso>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3813133	Dlx3<tm3Mso>	MP:0000414,alopecia|MP:0001222,epidermal hyperplasia|MP:0001263,weight loss|MP:0001731,abnormal postnatal growth
MGI:6460373	Dlx4<em1(IMPC)J>	MP:0005559,increased circulating glucose level
MGI:8240278	Dlx4<tm1.1Mso>	MP:0005390,skeleton phenotype|MP:0010771,integument phenotype
MGI:2447624	Dlx5/Dlx6<tm1Levi>	MP:0000074,abnormal neurocranium morphology|MP:0000077,abnormal interparietal bone morphology|MP:0000102,abnormal nasal bone morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000109,abnormal parietal bone morphology|MP:0000443,abnormal snout morphology|MP:0000452,abnormal mouth morphology|MP:0000454,abnormal jaw morphology|MP:0000455,abnormal maxilla morphology|MP:0000556,abnormal hindlimb morphology|MP:0000564,syndactyly|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001890,anencephaly|MP:0002081,perinatal lethality|MP:0002098,abnormal vibrissa morphology|MP:0002110,abnormal digit morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002260,abnormal thyroid cartilage morphology|MP:0002544,brachydactyly|MP:0002820,abnormal premaxilla morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003056,abnormal hyoid bone morphology|MP:0003072,abnormal metatarsal bone morphology|MP:0003235,abnormal alisphenoid bone morphology|MP:0003755,abnormal palate morphology|MP:0003935,abnormal craniofacial development|MP:0004423,abnormal temporal bone squamous part morphology|MP:0004439,absent Meckel's cartilage|MP:0004452,abnormal pterygoid process morphology|MP:0004594,abnormal mandibular coronoid process morphology|MP:0004595,abnormal mandibular condyloid process morphology|MP:0004596,abnormal mandibular angle morphology|MP:0004726,abnormal nasal capsule morphology|MP:0005105,abnormal middle ear ossicle morphology|MP:0005230,ectrodactyly|MP:0005270,abnormal zygomatic bone morphology|MP:0005274,abnormal viscerocranium morphology|MP:0005306,abnormal phalanx morphology|MP:0006337,abnormal first pharyngeal arch morphology|MP:0009918,abnormal stylohyoid ligament morphology|MP:0010029,abnormal basicranium morphology|MP:0010939,abnormal mandibular prominence morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0020350,fused pharyngeal arches|MP:0030299,lower jaw to upper jaw transformation|MP:0030383,small presphenoid bone
MGI:2447625	Dlx5/Dlx6<tm1Levi>	MP:0000074,abnormal neurocranium morphology|MP:0000077,abnormal interparietal bone morphology|MP:0000102,abnormal nasal bone morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000109,abnormal parietal bone morphology|MP:0000443,abnormal snout morphology|MP:0000452,abnormal mouth morphology|MP:0000454,abnormal jaw morphology|MP:0000455,abnormal maxilla morphology|MP:0000556,abnormal hindlimb morphology|MP:0000564,syndactyly|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001890,anencephaly|MP:0002098,abnormal vibrissa morphology|MP:0002110,abnormal digit morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002260,abnormal thyroid cartilage morphology|MP:0002544,brachydactyly|MP:0002820,abnormal premaxilla morphology|MP:0003056,abnormal hyoid bone morphology|MP:0003072,abnormal metatarsal bone morphology|MP:0003235,abnormal alisphenoid bone morphology|MP:0003755,abnormal palate morphology|MP:0003935,abnormal craniofacial development|MP:0004423,abnormal temporal bone squamous part morphology|MP:0004439,absent Meckel's cartilage|MP:0004452,abnormal pterygoid process morphology|MP:0004594,abnormal mandibular coronoid process morphology|MP:0004595,abnormal mandibular condyloid process morphology|MP:0004596,abnormal mandibular angle morphology|MP:0004726,abnormal nasal capsule morphology|MP:0005105,abnormal middle ear ossicle morphology|MP:0005230,ectrodactyly|MP:0005270,abnormal zygomatic bone morphology|MP:0005274,abnormal viscerocranium morphology|MP:0005306,abnormal phalanx morphology|MP:0006337,abnormal first pharyngeal arch morphology|MP:0009918,abnormal stylohyoid ligament morphology|MP:0010029,abnormal basicranium morphology|MP:0010939,abnormal mandibular prominence morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0030299,lower jaw to upper jaw transformation|MP:0030383,small presphenoid bone
MGI:2180475	Dlx5<tm1.1Levi>	MP:0011085,postnatal lethality, complete penetrance
MGI:4355155	Dlx5<tm1(cre/ERT2)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:1857789	Dlx5<tm1Jlr>	MP:0000029,abnormal malleus morphology|MP:0000031,abnormal cochlea morphology|MP:0000041,absent endolymphatic duct|MP:0000049,abnormal middle ear morphology|MP:0000074,abnormal neurocranium morphology|MP:0000091,short premaxilla|MP:0000098,abnormal vomer bone morphology|MP:0000102,abnormal nasal bone morphology|MP:0000150,abnormal rib morphology|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001093,small trigeminal ganglion|MP:0001265,decreased body size|MP:0002177,abnormal outer ear morphology|MP:0002238,abnormal nasal mucosa morphology|MP:0002249,abnormal larynx morphology|MP:0002566,abnormal sexual interaction|MP:0002639,micrognathia|MP:0002689,abnormal molar morphology|MP:0002741,small olfactory bulb|MP:0002817,abnormal tooth mineralization|MP:0002820,abnormal premaxilla morphology|MP:0003148,decreased cochlea coiling|MP:0003162,decreased lateral semicircular canal size|MP:0003163,absent posterior semicircular canal|MP:0003165,absent superior semicircular canal|MP:0003168,abnormal scala vestibuli morphology|MP:0003235,abnormal alisphenoid bone morphology|MP:0003245,abnormal GABAergic neuron morphology|MP:0003651,abnormal axon extension|MP:0003932,abnormal molar crown morphology|MP:0003935,abnormal craniofacial development|MP:0004136,abnormal tongue muscle morphology|MP:0004237,abnormal pterygoid muscle morphology|MP:0004279,abnormal rostral migratory stream morphology|MP:0004384,small interparietal bone|MP:0004418,small parietal bone|MP:0004423,abnormal temporal bone squamous part morphology|MP:0004444,small supraoccipital bone|MP:0004453,abnormal pterygoid bone morphology|MP:0004470,small nasal bone|MP:0004477,turbinate hypoplasia|MP:0004540,small maxilla|MP:0004594,abnormal mandibular coronoid process morphology|MP:0004595,abnormal mandibular condyloid process morphology|MP:0004596,abnormal mandibular angle morphology|MP:0004665,abnormal stapedial artery morphology|MP:0004726,abnormal nasal capsule morphology|MP:0005236,abnormal olfactory nerve morphology|MP:0005269,abnormal occipital bone morphology|MP:0005271,abnormal lacrimal bone morphology|MP:0005358,abnormal incisor morphology|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006020,decreased tympanic ring size|MP:0006033,abnormal external auditory canal morphology|MP:0006289,otic capsule hypoplasia|MP:0006306,abnormal nasal pit morphology|MP:0008378,small malleus processus brevis|MP:0008789,abnormal olfactory epithelium morphology|MP:0009546,absent gastric milk in neonates|MP:0009890,cleft secondary palate|MP:0009893,cleft primary palate|MP:0009901,abnormal frontonasal prominence morphology|MP:0009902,abnormal lateral nasal prominence morphology|MP:0009942,abnormal olfactory bulb granule cell morphology|MP:0009943,abnormal olfactory bulb periglomerular cell morphology|MP:0009954,abnormal mitral cell morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012014,abnormal olfactory neuron innervation pattern|MP:0013595,absent vomeronasal organ|MP:0013597,small vomeronasal organ|MP:0013933,short Meckel's cartilage|MP:0014155,absent olfactory epithelium|MP:0014166,ectopic cranial bone|MP:0020137,decreased bone mineralization|MP:0030055,small lacrimal bone|MP:0030089,short lower incisors|MP:0030090,short upper incisors|MP:0030148,abnormal mylohyoid muscle morphology|MP:0030187,abnormal epitympanic recess morphology|MP:0030199,deviated nasal septum|MP:0030203,short nasal septum|MP:0030208,abnormal intrinsic tongue muscle morphology|MP:0030250,frontonasal prominence hypoplasia|MP:0030266,small vomer bone|MP:0030321,abnormal tegmen tympani morphology|MP:0030422,abnormal outer ear cartilage morphology|MP:0030870,abnormal superior horn of thyroid cartilage morphology
MGI:2180474	Dlx5<tm1Levi>	MP:0000031,abnormal cochlea morphology|MP:0000034,abnormal inner ear vestibule morphology|MP:0000036,absent semicircular canals|MP:0000039,abnormal otic capsule morphology|MP:0000060,delayed bone ossification|MP:0000074,abnormal neurocranium morphology|MP:0000079,abnormal basioccipital bone morphology|MP:0000085,large anterior fontanelle|MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000350,abnormal cell proliferation|MP:0000431,absent palatine bone horizontal plate|MP:0000438,abnormal cranium morphology|MP:0000445,short snout|MP:0000914,exencephaly|MP:0001270,distended abdomen|MP:0001402,decreased locomotor activity|MP:0001436,abnormal suckling behavior|MP:0001954,respiratory distress|MP:0002169,no abnormal phenotype detected|MP:0002428,abnormal semicircular canal morphology|MP:0003056,abnormal hyoid bone morphology|MP:0003148,decreased cochlea coiling|MP:0003162,decreased lateral semicircular canal size|MP:0003163,absent posterior semicircular canal|MP:0003165,absent superior semicircular canal|MP:0003235,abnormal alisphenoid bone morphology|MP:0003869,ectopic cartilage|MP:0003935,abnormal craniofacial development|MP:0004204,absent stapes|MP:0004249,abnormal crista ampullaris morphology|MP:0004311,otic vesicle hypoplasia|MP:0004330,abnormal vestibular saccular macula morphology|MP:0004333,abnormal utricular macula morphology|MP:0004335,enlarged utricle|MP:0004409,abnormal crista ampullaris neuroepithelium morphology|MP:0004453,abnormal pterygoid bone morphology|MP:0004470,small nasal bone|MP:0004471,short nasal bone|MP:0004912,absent mandibular coronoid process|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006020,decreased tympanic ring size|MP:0006089,abnormal vestibular saccule morphology|MP:0008023,abnormal styloid process morphology|MP:0008065,short endolymphatic duct|MP:0008271,abnormal bone ossification|MP:0008380,abnormal gonial bone morphology|MP:0008395,abnormal osteoblast differentiation|MP:0009247,meteorism|MP:0009546,absent gastric milk in neonates|MP:0009890,cleft secondary palate|MP:0009897,decreased maxillary shelf size|MP:0009913,abnormal hyoid bone greater horn morphology|MP:0009914,abnormal hyoid bone lesser horn morphology|MP:0010743,delayed cranial suture closure|MP:0011087,neonatal lethality, complete penetrance|MP:0012176,abnormal head development|MP:0013933,short Meckel's cartilage|MP:0014166,ectopic cranial bone|MP:0030029,wide cranial sutures|MP:0030030,Wormian bones|MP:0030323,short styloid process|MP:0030870,abnormal superior horn of thyroid cartilage morphology
MGI:4360101	Dlx6os1<tm1.1Jhdk>	MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003246,loss of GABAergic neurons|MP:0014383,decreased miniature inhibitory postsynaptic current frequency
MGI:3809858	Dlx6<tm1Jlr>	MP:0004592,small mandible|MP:0004912,absent mandibular coronoid process|MP:0005382,craniofacial phenotype|MP:0006020,decreased tympanic ring size|MP:0008380,abnormal gonial bone morphology|MP:0010994,aerophagia|MP:0011087,neonatal lethality, complete penetrance|MP:0030259,mandibular condyloid process hypoplasia
MGI:1856844	dm	MP:0000137,abnormal vertebrae morphology|MP:0000154,rib fusion|MP:0000459,abnormal presacral vertebrae morphology|MP:0000464,increased presacral vertebrae number|MP:0000480,increased rib number|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002111,abnormal tail morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002811,macrocytic anemia|MP:0008770,decreased survivor rate|MP:0008813,decreased common myeloid progenitor cell number|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5695120	Dmac2l<tm1b(EUCOMM)Hmgu>	MP:0005287,narrow eye opening
MGI:5443931	Dmap1<tm1.1(KOMP)Vlcg>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5013727	Dmap1<tm1.2Jrc>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3771872	Dmbt1<tm1Janm>	MP:0008537,increased susceptibility to induced colitis
MGI:3514149	Dmbt1<tm1Kumc>	MP:0002006,neoplasm|MP:0005381,digestive/alimentary phenotype
MGI:3497714	Dmbt1<tm1Qaa>	MP:0001694,absent egg cylinders|MP:0002718,abnormal inner cell mass morphology|MP:0004964,absent inner cell mass|MP:0004965,inner cell mass degeneration|MP:0010380,abnormal inner cell mass apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4868734	Dmbt1<tm2Qaa>	MP:0000521,abnormal kidney cortex morphology|MP:0000525,renal tubular acidosis|MP:0003017,decreased circulating bicarbonate level|MP:0005377,hearing/vestibular/ear phenotype|MP:0009349,increased urine pH|MP:0012551,metabolic acidosis
MGI:3641326	Dmbx1<tm1Aoh>	MP:0002082,postnatal lethality
MGI:3055282	Dmbx1<tm1Bhr>	MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0002082,postnatal lethality|MP:0009546,absent gastric milk in neonates
MGI:3759315	Dmbx1<tm1Sse>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001399,hyperactivity|MP:0003631,nervous system phenotype|MP:0005449,abnormal food intake|MP:0005668,decreased circulating leptin level|MP:0009115,abnormal fat cell morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011940,decreased food intake
MGI:3641327	Dmbx1<tm2Aoh>	MP:0002082,postnatal lethality
MGI:3055285	Dmbx1<tm2Bhr>	MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality
MGI:3641328	Dmbx1<tm3(cre)Aoh>	MP:0002082,postnatal lethality
MGI:7294565	Dmc1<em1Jcs>	MP:0005389,reproductive system phenotype
MGI:2177010	Dmc1<Mei11>	MP:0001131,abnormal ovarian follicle morphology|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0004901,decreased male germ cell number|MP:0005168,abnormal female meiosis|MP:0005431,decreased oocyte number|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis
MGI:2176331	Dmc1<tm1Jcs>	MP:0001156,abnormal spermatogenesis|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001929,abnormal gametogenesis|MP:0001931,abnormal oogenesis|MP:0002160,abnormal reproductive system morphology|MP:0002777,absent ovarian follicles|MP:0004805,absent oocytes|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis
MGI:2179026	Dmc1<tm1Tkm>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001924,infertility|MP:0001925,male infertility|MP:0001929,abnormal gametogenesis|MP:0001931,abnormal oogenesis|MP:0002777,absent ovarian follicles|MP:0004805,absent oocytes|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis
MGI:7865766	Dmd<em1Cmusr>	MP:0000130,abnormal trabecular bone morphology|MP:0000266,abnormal heart morphology|MP:0000558,abnormal tibia morphology|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000752,dystrophic muscle|MP:0000759,abnormal skeletal muscle morphology|MP:0001260,increased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0002106,abnormal muscle physiology|MP:0003199,calcified muscle|MP:0003797,abnormal compact bone morphology|MP:0004148,increased compact bone thickness|MP:0004246,abnormal extensor digitorum longus morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0005620,abnormal muscle contractility|MP:0006319,abnormal epididymal fat pad morphology|MP:0009399,increased skeletal muscle fiber size|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009419,skeletal muscle fibrosis|MP:0009461,skeletal muscle hypertrophy|MP:0010238,increased skeletal muscle weight|MP:0014143,decreased body fat mass
MGI:6163634	Dmd<em1Eno>	MP:0000752,dystrophic muscle|MP:0003852,skeletal muscle necrosis|MP:0004510,myositis|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010053,decreased grip strength|MP:0020280,increased creatine kinase level
MGI:6277059	Dmd<em1(IMPC)Hmgu>	MP:0000063,decreased bone mineral density|MP:0002941,increased circulating alanine transaminase level|MP:0002965,increased circulating serum albumin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0005343,increased circulating aspartate transaminase level|MP:0005505,thrombocytosis|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005568,increased circulating total protein level|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010067,increased red blood cell distribution width|MP:0010124,decreased bone mineral content
MGI:8270633	Dmd<em1Rcn>	MP:0000752,dystrophic muscle|MP:0001260,increased body weight|MP:0001625,cardiac hypertrophy|MP:0002626,increased heart rate|MP:0003852,skeletal muscle necrosis|MP:0005599,increased cardiac muscle contractility|MP:0009400,decreased skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009415,skeletal muscle degeneration|MP:0009417,skeletal muscle atrophy|MP:0009419,skeletal muscle fibrosis|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0011925,abnormal heart echocardiography feature|MP:0012735,abnormal response to exercise
MGI:8270634	Dmd<em2Rcn>	MP:0002841,impaired skeletal muscle contractility|MP:0003646,increased muscle fatigability|MP:0005369,muscle phenotype|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0010053,decreased grip strength|MP:0011925,abnormal heart echocardiography feature|MP:0012735,abnormal response to exercise
MGI:6438148	Dmd<em4Eno>	MP:0000747,muscle weakness|MP:0000752,dystrophic muscle|MP:0004510,myositis|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009412,skeletal muscle fiber degeneration|MP:0009419,skeletal muscle fibrosis|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level
MGI:6394017	Dmd<em#Tve>	MP:0000747,muscle weakness|MP:0000752,dystrophic muscle|MP:0001260,increased body weight|MP:0004121,abnormal sarcolemma morphology|MP:0008489,slow postnatal weight gain|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009412,skeletal muscle fiber degeneration|MP:0009414,skeletal muscle fiber necrosis|MP:0009419,skeletal muscle fibrosis|MP:0010090,increased circulating creatine kinase level
MGI:2678393	Dmd<Gt(pT1ATGBetageo)1Ruiz>	MP:0002169,no abnormal phenotype detected
MGI:2148259	Dmd<Gt(ROSABetageo)1Mpd>	MP:0000462,abnormal digestive system morphology|MP:0002106,abnormal muscle physiology|MP:0002108,abnormal muscle morphology|MP:0002127,abnormal cardiovascular system morphology
MGI:1856328	Dmd<mdx>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000733,abnormal muscle development|MP:0000745,tremors|MP:0000747,muscle weakness|MP:0000749,muscle degeneration|MP:0000751,myopathy|MP:0000752,dystrophic muscle|MP:0000759,abnormal skeletal muscle morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001264,increased body size|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001515,abnormal grip strength|MP:0001853,heart inflammation|MP:0001923,reduced female fertility|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002106,abnormal muscle physiology|MP:0002108,abnormal muscle morphology|MP:0002269,muscular atrophy|MP:0002279,abnormal diaphragm morphology|MP:0002280,abnormal intercostal muscle morphology|MP:0002837,dystrophic cardiac calcinosis|MP:0002841,impaired skeletal muscle contractility|MP:0002899,fatigue|MP:0002953,thick ventricular wall|MP:0003061,decreased aerobic running capacity|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003105,abnormal heart atrium morphology|MP:0003157,impaired muscle relaxation|MP:0003199,calcified muscle|MP:0003393,decreased cardiac output|MP:0003631,nervous system phenotype|MP:0003852,skeletal muscle necrosis|MP:0004089,dilated sarcoplasmic reticulum|MP:0004142,abnormal muscle tone|MP:0004145,abnormal muscle electrophysiology|MP:0004510,myositis|MP:0004566,myocardial fiber degeneration|MP:0004597,increased susceptibility to noise-induced hearing loss|MP:0004703,abnormal vertebral column morphology|MP:0004818,increased skeletal muscle mass|MP:0004819,decreased skeletal muscle mass|MP:0005137,increased growth hormone level|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0005369,muscle phenotype|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0005620,abnormal muscle contractility|MP:0006085,myocardium necrosis|MP:0008327,abnormal corticotroph morphology|MP:0008416,increased somatotroph cell size|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008663,increased interleukin-12 secretion|MP:0008687,increased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008837,increased transforming growth factor beta level|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009400,decreased skeletal muscle fiber size|MP:0009401,increased skeletal muscle fiber diameter|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009405,increased skeletal muscle fiber number|MP:0009406,decreased skeletal muscle fiber number|MP:0009410,abnormal skeletal muscle satellite cell proliferation|MP:0009412,skeletal muscle fiber degeneration|MP:0009413,skeletal muscle fiber atrophy|MP:0009414,skeletal muscle fiber necrosis|MP:0009415,skeletal muscle degeneration|MP:0009416,cardiac muscle degeneration|MP:0009417,skeletal muscle atrophy|MP:0009419,skeletal muscle fibrosis|MP:0009420,skeletal muscle endomysial fibrosis|MP:0009461,skeletal muscle hypertrophy|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0010106,abnormal circulating pyruvate kinase level|MP:0010226,increased quadriceps weight|MP:0010227,decreased quadriceps weight|MP:0010238,increased skeletal muscle weight|MP:0010239,decreased skeletal muscle weight|MP:0010252,anterior subcapsular cataract|MP:0010254,nuclear cataract|MP:0010581,abnormal atrium myocardial trabeculae morphology|MP:0011952,decreased cardiac stroke volume|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012106,impaired exercise endurance|MP:0013237,abnormal skeletal muscle regeneration|MP:0013467,diaphragmitis|MP:0014143,decreased body fat mass|MP:0014740,increased auditory brainstem response wave peak latency|MP:0014742,increased auditory brainstem response wave interpeak latency|MP:0020309,increased creatine kinase activity|MP:0030428,abnormal scalene muscle morphology|MP:0030957,abnormal myotube morphology|MP:0031131,myocardial fiber disarray
MGI:1856329	Dmd<mdx-2Cv>	MP:0002279,abnormal diaphragm morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003141,cardiac fibrosis|MP:0003157,impaired muscle relaxation|MP:0005551,abnormal eye electrophysiology|MP:0009412,skeletal muscle fiber degeneration|MP:0009419,skeletal muscle fibrosis
MGI:1856330	Dmd<mdx-3Cv>	MP:0000759,abnormal skeletal muscle morphology|MP:0001515,abnormal grip strength|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002279,abnormal diaphragm morphology|MP:0003141,cardiac fibrosis|MP:0003157,impaired muscle relaxation|MP:0005391,vision/eye phenotype|MP:0005547,abnormal Muller cell morphology|MP:0005551,abnormal eye electrophysiology|MP:0005620,abnormal muscle contractility|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009412,skeletal muscle fiber degeneration|MP:0009419,skeletal muscle fibrosis|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1856331	Dmd<mdx-4Cv>	MP:0000730,increased satellite cell number|MP:0000759,abnormal skeletal muscle morphology|MP:0001515,abnormal grip strength|MP:0002279,abnormal diaphragm morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0005551,abnormal eye electrophysiology|MP:0005620,abnormal muscle contractility|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009414,skeletal muscle fiber necrosis|MP:0009419,skeletal muscle fibrosis
MGI:1856332	Dmd<mdx-5Cv>	MP:0000730,increased satellite cell number|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0002279,abnormal diaphragm morphology|MP:0002841,impaired skeletal muscle contractility|MP:0002899,fatigue|MP:0003646,increased muscle fatigability|MP:0004071,prolonged P wave|MP:0004215,abnormal myocardial fiber physiology|MP:0005369,muscle phenotype|MP:0005385,cardiovascular system phenotype|MP:0005620,abnormal muscle contractility|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009419,skeletal muscle fibrosis|MP:0010053,decreased grip strength|MP:0010392,prolonged QRS complex duration|MP:0010509,decreased P wave amplitude|MP:0014143,decreased body fat mass
MGI:3531484	Dmd<tm1.1Khan>	MP:0001925,male infertility|MP:0009399,increased skeletal muscle fiber size|MP:0009412,skeletal muscle fiber degeneration|MP:0009414,skeletal muscle fiber necrosis
MGI:5569634	Dmd<tm1.1Know>	MP:0001856,myocarditis|MP:0004121,abnormal sarcolemma morphology|MP:0020938,decreased susceptibility to Picornaviridae infection
MGI:3531483	Dmd<tm1Khan>	MP:0002169,no abnormal phenotype detected
MGI:5781149	Dmd<tm1Kmf>	MP:0000749,muscle degeneration|MP:0000752,dystrophic muscle|MP:0001260,increased body weight|MP:0004510,myositis|MP:0009414,skeletal muscle fiber necrosis|MP:0009419,skeletal muscle fibrosis|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level
MGI:2429942	Dmd<tm1Mok>	MP:0000749,muscle degeneration|MP:0002279,abnormal diaphragm morphology|MP:0003950,abnormal plasma membrane morphology
MGI:2148260	Dmd<tm1Ndl>	MP:0006190,retina ischemia
MGI:4451237	Dmgdh<tm1a(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0002875,decreased erythrocyte cell number|MP:0010052,increased grip strength
MGI:6342886	Dmkn<tm1Jonca>	MP:0001192,scaly skin|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0009605,decreased keratohyalin granule number|MP:0009607,decreased keratohyalin granule size|MP:0010771,integument phenotype
MGI:5708272	Dmp1<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0000198,decreased circulating phosphate level|MP:0001258,decreased body length|MP:0002135,abnormal kidney morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003068,enlarged kidney|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0005333,decreased heart rate|MP:0005566,decreased blood urea nitrogen level|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0010506,prolonged RR interval
MGI:3795591	Dmp1<tm1.1Mis>	MP:0000060,delayed bone ossification|MP:0000133,abnormal long bone metaphysis morphology|MP:0003109,short femur|MP:0003797,abnormal compact bone morphology
MGI:3040629	Dmp1<tm1Mis>	MP:0000060,delayed bone ossification|MP:0000128,growth retardation of molars|MP:0000133,abnormal long bone metaphysis morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000168,abnormal bone marrow development|MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000259,abnormal vascular development|MP:0002113,abnormal skeleton development|MP:0002136,abnormal kidney physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002577,reduced enamel thickness|MP:0002817,abnormal tooth mineralization|MP:0002818,abnormal dentin morphology|MP:0002819,abnormal dental pulp cavity morphology|MP:0002904,increased circulating parathyroid hormone level|MP:0002998,abnormal bone remodeling|MP:0003109,short femur|MP:0003116,rickets|MP:0003668,abnormal periodontal ligament morphology|MP:0003797,abnormal compact bone morphology|MP:0004189,abnormal alveolar process morphology|MP:0004985,decreased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0005390,skeleton phenotype|MP:0005416,abnormal circulating protein level|MP:0006400,decreased molar number|MP:0008151,increased diameter of long bones|MP:0008753,abnormal osteocyte morphology|MP:0009445,osteomalacia|MP:0010868,increased bone trabecula number|MP:0010926,increased osteoid volume|MP:0011584,increased alkaline phosphatase activity|MP:0011712,arrested osteoblast differentiation|MP:0011721,abnormal bone mineralization involved in bone maturation|MP:0020137,decreased bone mineralization|MP:0030131,abnormal periodontium morphology|MP:0030451,abnormal dentin mineralization|MP:0030452,abnormal cementum mineralization|MP:0030466,alveolar process atrophy|MP:0030484,abnormal osteocyte lacuna morphology|MP:0030485,abnormal osteocyte lacunocanalicular system morphology|MP:0030486,abnormal osteocyte canaliculus morphology|MP:0030540,misaligned teeth|MP:0030542,abnormal dentin development|MP:0030543,abnormal predentin morphology|MP:0030545,abnormal acellular cementum morphology|MP:0030546,abnormal cellular cementum morphology|MP:0030549,abnormal cementocyte lacunocanalicular system morphology|MP:0030550,abnormal cementoblast morphology|MP:0030552,decreased cementoblast number|MP:0030555,abnormal cementocyte lacuna morphology|MP:0030556,abnormal cementocyte canaliculus morphology|MP:0030557,abnormal cementocyte dendritic process morphology|MP:0030884,rachitic rosary
MGI:6507410	Dmpk<em1Sws>	MP:0005369,muscle phenotype
MGI:6507411	Dmpk<em2Sws>	MP:0005369,muscle phenotype
MGI:3054407	Dmpk<tm1Bew>	MP:0002106,abnormal muscle physiology
MGI:2182402	Dmpk<tm1Rdd>	MP:0000748,progressive muscle weakness|MP:0000751,myopathy|MP:0002841,impaired skeletal muscle contractility|MP:0003896,prolonged PR interval|MP:0004089,dilated sarcoplasmic reticulum|MP:0004090,abnormal sarcomere morphology|MP:0004092,absent Z line|MP:0004215,abnormal myocardial fiber physiology|MP:0004231,abnormal calcium ion homeostasis|MP:0006141,abnormal atrioventricular node conduction|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009403,increased variability of skeletal muscle fiber size|MP:0010519,atrioventricular block|MP:0010559,heart block|MP:0031318,enhanced skeletal muscle regeneration
MGI:3665271	Dmpk<tm2Bew>	MP:0002169,no abnormal phenotype detected
MGI:3578534	dmpl	MP:0001730,embryonic growth arrest|MP:0002231,abnormal primitive streak morphology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:1856599	dmpy	MP:0000428,abnormal craniofacial morphology|MP:0000432,abnormal head morphology|MP:0000443,abnormal snout morphology|MP:0000445,short snout|MP:0000572,abnormal autopod morphology|MP:0001265,decreased body size|MP:0002110,abnormal digit morphology|MP:0003072,abnormal metatarsal bone morphology|MP:0003743,abnormal facial morphology|MP:0003956,abnormal body size|MP:0004635,short metatarsal bones|MP:0005508,abnormal skeleton morphology
MGI:3795566	Dmq1<FVB/NJ>	MP:0010299,increased mammary gland tumor incidence
MGI:3795568	Dmq2<FVB/NJ>	MP:0010299,increased mammary gland tumor incidence
MGI:3795571	Dmq3<M16i>	MP:0001272,increased metastatic potential
MGI:3795572	Dmq4<FVB/NJ>	MP:0001272,increased metastatic potential
MGI:2385912	Dmrt1<tm1.1Zark>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002784,abnormal Sertoli cell morphology|MP:0003830,abnormal testis development|MP:0004901,decreased male germ cell number|MP:0005169,abnormal male meiosis|MP:0031407,increased Sertoli cell proliferation
MGI:3512139	Dmrt2<tm1Rjo>	MP:0000137,abnormal vertebrae morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000157,abnormal sternum morphology|MP:0000585,kinked tail|MP:0000737,abnormal myotome development|MP:0001177,atelectasis|MP:0001688,abnormal somite development|MP:0001954,respiratory distress|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0003939,abnormal myotome morphology|MP:0004206,abnormal dermomyotome development|MP:0004320,split sternum|MP:0004444,small supraoccipital bone|MP:0004619,caudal vertebral fusion|MP:0004621,lumbar vertebral fusion|MP:0004623,thoracic vertebral fusion|MP:0004677,truncated ribs|MP:0005389,reproductive system phenotype|MP:0006029,abnormal sclerotome morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:4420993	Dmrt3<tm1Hgc>	MP:0000120,malocclusion|MP:0001406,abnormal gait|MP:0001522,impaired swimming|MP:0001524,impaired limb coordination|MP:0002083,premature death|MP:0003880,abnormal central pattern generator function|MP:0003936,abnormal reproductive system development|MP:0004100,abnormal spinal cord interneuron morphology|MP:0005386,behavior/neurological phenotype|MP:0005424,jerky movement|MP:0010540,long stride length
MGI:3812826	Dmrt3<tm1(KOMP)Vlcg>	MP:0003631,nervous system phenotype|MP:0008547,abnormal neocortex morphology
MGI:3699123	Dmrta1<tm1.1Zark>	MP:0001375,abnormal mating preference|MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype|MP:0005394,taste/olfaction phenotype|MP:0009433,polyovular ovarian follicle|MP:0031629,abnormal mounting behavior
MGI:5527460	Dmrta2<tm1.1Fuma>	MP:0000785,telencephalon hypoplasia|MP:0003631,nervous system phenotype
MGI:5527461	Dmrta2<tm1.2Fuma>	MP:0000785,telencephalon hypoplasia|MP:0000788,abnormal cerebral cortex morphology|MP:0000809,absent hippocampus|MP:0002741,small olfactory bulb|MP:0003631,nervous system phenotype|MP:0004948,abnormal neuronal precursor proliferation|MP:0004981,decreased neuronal precursor cell number|MP:0008948,decreased neuron number
MGI:5613136	Dmrta2<tm1Ejbd>	MP:0000778,abnormal nervous system tract morphology|MP:0000787,abnormal telencephalon morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000789,thickened cerebral cortex|MP:0000807,abnormal hippocampus morphology|MP:0000809,absent hippocampus|MP:0000814,absent dentate gyrus|MP:0001265,decreased body size|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0002199,abnormal brain commissure morphology|MP:0002741,small olfactory bulb|MP:0003631,nervous system phenotype|MP:0004948,abnormal neuronal precursor proliferation|MP:0006254,thin cerebral cortex|MP:0008031,decreased Cajal-Retzius cell number|MP:0008440,abnormal subplate morphology|MP:0008458,abnormal cortical ventricular zone morphology|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008547,abnormal neocortex morphology|MP:0008934,absent choroid plexus|MP:0009546,absent gastric milk in neonates|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5705340	Dmrtb1<tm1.1Zark>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002631,abnormal epididymis morphology|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0008280,abnormal male germ cell apoptosis|MP:0009452,abnormal synaptonemal complex
MGI:3711103	Dmrtc2<tm1.1Zark>	MP:0001147,small testis|MP:0005389,reproductive system phenotype
MGI:3711104	Dmrtc2<tm1.2Zark>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002784,abnormal Sertoli cell morphology|MP:0003830,abnormal testis development|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0006362,abnormal male germ cell morphology|MP:0006378,abnormal spermatogonia morphology|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis|MP:0014633,decreased spermatid number
MGI:3697743	Dmrtc2<tm1(cre)Knis>	MP:0001147,small testis|MP:0001929,abnormal gametogenesis|MP:0001940,testis hypoplasia|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0014633,decreased spermatid number
MGI:3043043	Dms	MP:0001145,abnormal male reproductive system morphology|MP:0001146,abnormal testis morphology|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0005159,azoospermia|MP:0005386,behavior/neurological phenotype|MP:0008261,arrest of male meiosis
MGI:2182441	Dmtf1<tm1Cjs>	MP:0000516,abnormal renal/urinary system morphology|MP:0000539,distended urinary bladder|MP:0000715,decreased thymocyte number|MP:0001145,abnormal male reproductive system morphology|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0002020,increased tumor incidence|MP:0002021,increased incidence of induced tumors|MP:0002064,seizures|MP:0002444,abnormal T cell physiology|MP:0009546,absent gastric milk in neonates|MP:0009703,decreased birth body size|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013320,dilated seminal vesicle
MGI:2447353	Dmtn<tm1Ahc>	MP:0000208,decreased hematocrit|MP:0001577,anemia|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002812,spherocytosis|MP:0002813,microcytosis|MP:0031085,increased erythrocyte osmotic fragility
MGI:6849816	Dmwd<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0013279,increased fasting circulating glucose level
MGI:6257485	Dmxl1<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:4432280	Dmxl2<tm1a(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected|MP:0003961,decreased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011091,prenatal lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011513,abnormal vertebral artery morphology|MP:0013877,abnormal ductus venosus valve morphology|MP:0013968,multiple persisting craniopharyngeal ducts|MP:0013971,blood in lymph vessels|MP:0014018,embryo tumor
MGI:5705577	Dmxl2<tm1c(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0001415,increased exploration in new environment|MP:0001751,increased circulating luteinizing hormone level|MP:0001752,abnormal hypothalamus secretion|MP:0001921,reduced fertility|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001927,abnormal estrous cycle|MP:0001938,delayed sexual maturation|MP:0002636,delayed vaginal opening|MP:0002680,decreased corpora lutea number|MP:0002780,decreased circulating testosterone level|MP:0003355,decreased ovulation rate|MP:0003550,short perineum|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0005376,homeostasis/metabolism phenotype|MP:0009008,delayed estrous cycle|MP:0009015,short proestrus|MP:0014592,decreased gonadotropin-releasing hormone neuron number
MGI:3051268	Dmyaq1<C3H/HeJ>	MP:0005409,darkened coat color
MGI:3051270	Dmyaq2<C3H/HeJ>	MP:0005409,darkened coat color
MGI:3051272	Dmyaq3<C3H/HeJ>	MP:0005409,darkened coat color
MGI:5515895	Dna2<tm1.1Lzhg>	MP:0002027,increased lung adenocarcinoma incidence|MP:0003702,abnormal chromosome morphology|MP:0004024,aneuploidy|MP:0004046,abnormal mitosis|MP:0008866,chromosomal instability|MP:0010207,abnormal telomere morphology|MP:0010264,increased hepatoma incidence|MP:0011092,embryonic lethality, complete penetrance|MP:0012431,increased lymphoma incidence|MP:0030927,decreased telomere length
MGI:6147713	Dnaaf11<tm1.1Hmd>	MP:0020869,immotile sperm
MGI:6147714	Dnaaf11<tm1.2Hmd>	MP:0000440,domed cranium|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0001706,abnormal left-right axis patterning|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0004158,right aortic arch|MP:0006062,abnormal vena cava morphology|MP:0008933,abnormal motile primary cilium physiology|MP:0010808,right-sided stomach|MP:0010975,abnormal lung lobe morphology|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011069,abnormal brain ependyma motile cilium physiology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011649,immotile respiratory cilia|MP:0013858,abnormal azygos vein topology
MGI:6295123	Dnaaf1<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0010511,shortened PR interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5532530	Dnaaf2<tm1.1(KOMP)Vlcg>	MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001706,abnormal left-right axis patterning|MP:0001719,absent vitelline blood vessels|MP:0001730,embryonic growth arrest|MP:0001787,pericardial edema|MP:0002861,abnormal tail bud morphology|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0004066,abnormal primitive node morphology|MP:0004073,caudal body truncation|MP:0004180,failure of initiation of embryo turning|MP:0004252,abnormal direction of heart looping|MP:0005568,increased circulating total protein level|MP:0005633,increased circulating sodium level|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011396,abnormal sleep behavior|MP:0012277,increased tail bud apoptosis|MP:0012505,increased neural tube apoptosis|MP:0013197,decreased embryonic cilium number|MP:0013292,embryonic lethality prior to organogenesis|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5526981	Dnaaf2<tm1.1Mkis>	MP:0000644,dextrocardia|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0004133,heterotaxia|MP:0006254,thin cerebral cortex|MP:0008535,enlarged lateral ventricles|MP:0010808,right-sided stomach|MP:0011056,abnormal brain ependyma motile cilium morphology|MP:0011069,abnormal brain ependyma motile cilium physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011249,abdominal situs inversus|MP:0011252,situs inversus totalis|MP:0011380,enlarged brain ventricles|MP:0011649,immotile respiratory cilia|MP:0030963,abnormal brain ependyma motile cilium location or orientation
MGI:5442117	Dnaaf3<b2b1739Clo>	MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0002725,abnormal vein morphology|MP:0003178,left pulmonary isomerism|MP:0004113,abnormal aortic arch morphology|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0004703,abnormal vertebral column morphology|MP:0006063,abnormal inferior vena cava morphology|MP:0011249,abdominal situs inversus|MP:0011250,abdominal situs ambiguus|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia|MP:0011683,dual inferior vena cava
MGI:6393544	Dnaaf3<em1(IMPC)J>	MP:0003385,abnormal body wall morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5311375	Dnaaf4<b2b811.1Clo>	MP:0000157,abnormal sternum morphology|MP:0000273,overriding aortic valve|MP:0000644,dextrocardia|MP:0000689,abnormal spleen morphology|MP:0001625,cardiac hypertrophy|MP:0001944,abnormal pancreas morphology|MP:0004110,transposition of great arteries|MP:0004133,heterotaxia|MP:0006061,right atrial isomerism|MP:0006063,abnormal inferior vena cava morphology|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010476,coronary fistula|MP:0010808,right-sided stomach|MP:0010854,lung situs inversus|MP:0011069,abnormal brain ependyma motile cilium physiology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011250,abdominal situs ambiguus|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia|MP:0011665,d-loop transposition of the great arteries|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5547589	Dnaaf4<tm1.2Jjlo>	MP:0000440,domed cranium|MP:0000644,dextrocardia|MP:0000689,abnormal spleen morphology|MP:0001891,hydrocephaly|MP:0002767,situs ambiguus|MP:0010808,right-sided stomach|MP:0010854,lung situs inversus|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011069,abnormal brain ependyma motile cilium physiology|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011252,situs inversus totalis
MGI:5635054	Dnaaf4<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0001512,trunk curl|MP:0006243,impaired pupillary reflex|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6257519	Dnaaf5<em1(IMPC)Bay>	MP:0003961,decreased lean body mass|MP:0011100,preweaning lethality, complete penetrance
MGI:7569243	Dnaaf5<em1Slb>	MP:0000434,megacephaly|MP:0001872,sinus inflammation|MP:0001893,non-obstructive hydrocephaly|MP:0001925,male infertility|MP:0002083,premature death|MP:0002766,situs inversus|MP:0004133,heterotaxia|MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011056,abnormal brain ependyma motile cilium morphology|MP:0011069,abnormal brain ependyma motile cilium physiology|MP:0011380,enlarged brain ventricles|MP:0011649,immotile respiratory cilia|MP:0020869,immotile sperm|MP:0031253,lordokyphosis
MGI:7569249	Dnaaf5<em2Slb>	MP:0011100,preweaning lethality, complete penetrance
MGI:7569317	Dnaaf5<em3Slb>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:5609302	Dnaaf6rt<tm1.1Hmd>	MP:0002169,no abnormal phenotype detected
MGI:5609303	Dnaaf6rt<tm1.2Hmd>	MP:0001925,male infertility|MP:0002160,abnormal reproductive system morphology|MP:0002675,asthenozoospermia|MP:0003698,abnormal male reproductive system physiology|MP:0005367,renal/urinary system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009239,short sperm flagellum|MP:0009242,thin sperm flagellum|MP:0009838,abnormal sperm axoneme morphology
MGI:5605794	Dnaaf9<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0009142,decreased prepulse inhibition
MGI:6257726	Dnah10<em1(IMPC)Bay>	MP:0001925,male infertility
MGI:6780038	Dnah10<em1Yxc>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0014468,disorganized sperm mitochondrial sheath|MP:0020869,immotile sperm
MGI:6780039	Dnah10<em2Yxc>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0014468,disorganized sperm mitochondrial sheath|MP:0020869,immotile sperm
MGI:4821828	Dnah11<avc4>	MP:0002081,perinatal lethality|MP:0003649,decreased heart right ventricle size|MP:0004157,interrupted aortic arch|MP:0006128,pulmonary valve stenosis|MP:0010404,ostium primum atrial septal defect|MP:0010412,atrioventricular septal defect|MP:0010413,complete atrioventricular septal defect|MP:0010460,pulmonary artery hypoplasia
MGI:5311388	Dnah11<b2b1203Clo>	MP:0000644,dextrocardia|MP:0002135,abnormal kidney morphology|MP:0003675,kidney cyst|MP:0004017,duplex kidney|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0004391,abnormal respiratory conducting tube morphology|MP:0011250,abdominal situs ambiguus|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia|MP:0011683,dual inferior vena cava
MGI:5311393	Dnah11<b2b1279Clo>	MP:0000284,double outlet right ventricle|MP:0000286,abnormal mitral valve morphology|MP:0000644,dextrocardia|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002639,micrognathia|MP:0003178,left pulmonary isomerism|MP:0004133,heterotaxia|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011250,abdominal situs ambiguus|MP:0011252,situs inversus totalis|MP:0011665,d-loop transposition of the great arteries
MGI:5437083	Dnah11<b2b1289Clo>	MP:0000276,heart right ventricle hypertrophy|MP:0000519,hydronephrosis|MP:0000542,left-sided isomerism|MP:0000598,abnormal liver morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002625,heart left ventricle hypertrophy|MP:0003178,left pulmonary isomerism|MP:0003342,accessory spleen|MP:0004017,duplex kidney|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0008528,polycystic kidney|MP:0010420,muscular ventricular septal defect|MP:0010466,vascular ring|MP:0011250,abdominal situs ambiguus|MP:0011253,situs inversus with levocardia|MP:0011745,isolation of the left subclavian artery
MGI:5696351	Dnah11<b2b1468.2Clo>	MP:0000644,dextrocardia|MP:0002766,situs inversus|MP:0011649,immotile respiratory cilia
MGI:5437727	Dnah11<b2b1727Clo>	MP:0000519,hydronephrosis|MP:0000694,spleen hypoplasia|MP:0001943,abnormal respiration|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0010412,atrioventricular septal defect|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011649,immotile respiratory cilia|MP:0011666,double outlet right ventricle, ventricular defect committed to aorta
MGI:5446158	Dnah11<b2b1775Clo>	MP:0000284,double outlet right ventricle|MP:0000477,abnormal intestine morphology|MP:0000644,dextrocardia|MP:0000694,spleen hypoplasia|MP:0004133,heterotaxia|MP:0004703,abnormal vertebral column morphology|MP:0005083,abnormal biliary tract morphology|MP:0006063,abnormal inferior vena cava morphology|MP:0010402,ventricular septal defect|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011249,abdominal situs inversus|MP:0011250,abdominal situs ambiguus|MP:0011252,situs inversus totalis|MP:0011683,dual inferior vena cava
MGI:5491272	Dnah11<b2b2349Clo>	MP:0000284,double outlet right ventricle|MP:0000519,hydronephrosis|MP:0000531,right pulmonary isomerism|MP:0000644,dextrocardia|MP:0004133,heterotaxia|MP:0004733,abnormal thoracic cavity morphology|MP:0010412,atrioventricular septal defect|MP:0010607,common atrioventricular valve|MP:0010975,abnormal lung lobe morphology|MP:0011250,abdominal situs ambiguus|MP:0011252,situs inversus totalis|MP:0011254,superior-inferior ventricles|MP:0011510,biventricular, discordant atrioventricular connection|MP:0011511,biventricular, ambiguous atrioventricular connection|MP:0011665,d-loop transposition of the great arteries
MGI:5311372	Dnah11<b2b598Clo>	MP:0000519,hydronephrosis|MP:0000644,dextrocardia|MP:0002135,abnormal kidney morphology|MP:0003178,left pulmonary isomerism|MP:0004133,heterotaxia|MP:0008528,polycystic kidney|MP:0010402,ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011250,abdominal situs ambiguus|MP:0011252,situs inversus totalis
MGI:1856917	Dnah11<iv>	MP:0000531,right pulmonary isomerism|MP:0000572,abnormal autopod morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0001727,abnormal embryo implantation|MP:0001921,reduced fertility|MP:0002127,abnormal cardiovascular system morphology|MP:0002766,situs inversus|MP:0003105,abnormal heart atrium morphology|MP:0003178,left pulmonary isomerism|MP:0004131,abnormal motile primary cilium morphology|MP:0004133,heterotaxia|MP:0006061,right atrial isomerism|MP:0006063,abnormal inferior vena cava morphology|MP:0008461,left atrial isomerism|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0010489,abnormal heart atrium auricular region morphology|MP:0010668,abnormal hepatic portal vein morphology|MP:0012093,absent nodal flow
MGI:3640793	Dnah11<lrm3>	MP:0000644,dextrocardia|MP:0001785,edema|MP:0002766,situs inversus|MP:0003178,left pulmonary isomerism|MP:0010807,abnormal stomach position or orientation
MGI:3640798	Dnah11<lrm5>	MP:0000650,mesocardia|MP:0001785,edema|MP:0002766,situs inversus|MP:0010808,right-sided stomach
MGI:3623683	Dnah11<tm1.1Bknr>	MP:0002169,no abnormal phenotype detected
MGI:3623682	Dnah11<tm1Bknr>	MP:0000266,abnormal heart morphology|MP:0001935,decreased litter size|MP:0002766,situs inversus|MP:0004066,abnormal primitive node morphology|MP:0008933,abnormal motile primary cilium physiology
MGI:2152963	Dnah11<tm1Ssp>	MP:0001706,abnormal left-right axis patterning|MP:0002766,situs inversus|MP:0003178,left pulmonary isomerism|MP:0004066,abnormal primitive node morphology|MP:0008933,abnormal motile primary cilium physiology|MP:0010808,right-sided stomach|MP:0012093,absent nodal flow
MGI:6694906	Dnah17<em1Qsh>	MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0009838,abnormal sperm axoneme morphology
MGI:6694909	Dnah17<em2Qsh>	MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0009838,abnormal sperm axoneme morphology
MGI:4940768	Dnah17<tm1e(KOMP)Wtsi>	MP:0001925,male infertility|MP:0002073,abnormal hair growth
MGI:3512923	Dnah1<ferf1>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0009647,decreased fertilization frequency|MP:0013287,abnormal acrosome reaction|MP:0020451,decreased sperm progressive motility|MP:0030976,impaired sperm penetration of zona pellucida
MGI:5614692	Dnah1<tm1b(EUCOMM)Hmgu>	MP:0000195,decreased circulating calcium level|MP:0001510,abnormal coat appearance|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0011239,abnormal skin coloration
MGI:2151944	Dnah1<tm1Ihgg>	MP:0001925,male infertility|MP:0002133,abnormal respiratory system physiology|MP:0002675,asthenozoospermia
MGI:6257800	Dnah2<em1(IMPC)Tcp>	MP:0001399,hyperactivity|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002059,abnormal seminal vesicle morphology|MP:0002339,abnormal lymph node morphology|MP:0002687,oligozoospermia|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009830,abnormal sperm connecting piece morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009833,absent sperm mitochondrial sheath|MP:0009834,abnormal sperm annulus morphology|MP:0009836,abnormal sperm principal piece morphology|MP:0009837,abnormal sperm end piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0020869,immotile sperm|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0030591,absent sperm fibrous sheath|MP:0031351,abnormal sperm flagellum thickness|MP:0031356,abnormal outer dense fiber morphology
MGI:5294340	Dnah5<b2b002Clo>	MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000644,dextrocardia|MP:0004133,heterotaxia|MP:0010435,abnormal heart atrium and ventricle connection|MP:0010607,common atrioventricular valve|MP:0011249,abdominal situs inversus|MP:0011252,situs inversus totalis|MP:0011253,situs inversus with levocardia|MP:0011254,superior-inferior ventricles|MP:0011510,biventricular, discordant atrioventricular connection|MP:0011511,biventricular, ambiguous atrioventricular connection
MGI:5285078	Dnah5<b2b016Clo>	MP:0000284,double outlet right ventricle|MP:0000519,hydronephrosis|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0004017,duplex kidney|MP:0006063,abnormal inferior vena cava morphology|MP:0010808,right-sided stomach|MP:0010854,lung situs inversus|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011252,situs inversus totalis
MGI:5297426	Dnah5<b2b1003Clo>	MP:0002135,abnormal kidney morphology|MP:0003446,renal hypoplasia|MP:0003675,kidney cyst|MP:0004017,duplex kidney|MP:0011250,abdominal situs ambiguus|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia
MGI:5311385	Dnah5<b2b1134Clo>	MP:0001544,abnormal cardiovascular system physiology|MP:0004133,heterotaxia|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia
MGI:5311386	Dnah5<b2b1154Clo>	MP:0000284,double outlet right ventricle|MP:0000644,dextrocardia|MP:0001544,abnormal cardiovascular system physiology|MP:0003178,left pulmonary isomerism|MP:0004133,heterotaxia|MP:0010412,atrioventricular septal defect|MP:0011250,abdominal situs ambiguus|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5433326	Dnah5<b2b1537Clo>	MP:0000644,dextrocardia|MP:0004133,heterotaxia|MP:0006063,abnormal inferior vena cava morphology|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia|MP:0011683,dual inferior vena cava
MGI:5430344	Dnah5<b2b1565Clo>	MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia
MGI:5552945	Dnah5<b2b2395Clo>	MP:0000276,heart right ventricle hypertrophy|MP:0000445,short snout|MP:0000644,dextrocardia|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia|MP:0003178,left pulmonary isomerism|MP:0004017,duplex kidney|MP:0004133,heterotaxia|MP:0006061,right atrial isomerism|MP:0010412,atrioventricular septal defect|MP:0010440,anomalous pulmonary venous connection|MP:0010460,pulmonary artery hypoplasia|MP:0010808,right-sided stomach|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia|MP:0011683,dual inferior vena cava
MGI:5645238	Dnah5<b2b2451Clo>	MP:0000689,abnormal spleen morphology|MP:0001944,abnormal pancreas morphology|MP:0004133,heterotaxia|MP:0006063,abnormal inferior vena cava morphology|MP:0009705,abnormal midgut morphology|MP:0011250,abdominal situs ambiguus
MGI:5614979	Dnah5<b2b2570Clo>	MP:0000644,dextrocardia|MP:0010466,vascular ring|MP:0011249,abdominal situs inversus|MP:0011252,situs inversus totalis
MGI:5618818	Dnah5<b2b2925Clo>	MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0000690,absent spleen|MP:0003178,left pulmonary isomerism|MP:0004133,heterotaxia|MP:0010406,common atrium|MP:0010422,heart right ventricle hypoplasia|MP:0010441,total anomalous pulmonary venous connection|MP:0010487,abnormal right subclavian artery morphology|MP:0011249,abdominal situs inversus|MP:0011252,situs inversus totalis|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5648248	Dnah5<b2b3491Clo>	MP:0000644,dextrocardia|MP:0004133,heterotaxia|MP:0011250,abdominal situs ambiguus
MGI:5311153	Dnah5<b2b601Clo>	MP:0000284,double outlet right ventricle|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0010412,atrioventricular septal defect|MP:0010413,complete atrioventricular septal defect|MP:0011250,abdominal situs ambiguus|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:3722326	Dnah5<hlb612>	MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000284,double outlet right ventricle|MP:0000432,abnormal head morphology|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0000689,abnormal spleen morphology|MP:0000690,absent spleen|MP:0001891,hydrocephaly|MP:0002766,situs inversus|MP:0003178,left pulmonary isomerism|MP:0003283,abnormal digestive organ placement|MP:0004110,transposition of great arteries|MP:0004113,abnormal aortic arch morphology|MP:0004133,heterotaxia|MP:0004157,interrupted aortic arch|MP:0006061,right atrial isomerism|MP:0006063,abnormal inferior vena cava morphology|MP:0008461,left atrial isomerism|MP:0010402,ventricular septal defect|MP:0010405,ostium secundum atrial septal defect|MP:0010406,common atrium|MP:0010412,atrioventricular septal defect|MP:0010607,common atrioventricular valve|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011083,lethality at weaning, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011254,superior-inferior ventricles
MGI:2180081	Dnah5<Tg1Htz>	MP:0000439,enlarged cranium|MP:0000440,domed cranium|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0001850,increased susceptibility to otitis media|MP:0001872,sinus inflammation|MP:0001891,hydrocephaly|MP:0001954,respiratory distress|MP:0001963,abnormal hearing physiology|MP:0002082,postnatal lethality|MP:0002766,situs inversus|MP:0006254,thin cerebral cortex|MP:0008535,enlarged lateral ventricles|MP:0011649,immotile respiratory cilia|MP:0014185,cerebellum atrophy
MGI:5708173	Dnah5<tm1b(KOMP)Wtsi>	MP:0000194,increased circulating calcium level|MP:0005565,increased blood urea nitrogen level|MP:0005568,increased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6276840	Dnah6<em1(IMPC)Mbp>	MP:0001120,abnormal uterus morphology|MP:0002135,abnormal kidney morphology|MP:0009709,hydrometra
MGI:6473983	Dnah8<em1Osb>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0014468,disorganized sperm mitochondrial sheath|MP:0020869,immotile sperm|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0031356,abnormal outer dense fiber morphology
MGI:6720876	Dnah9<em1Hmd>	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011059,abnormal ependyma motile cilium morphology
MGI:5317589	Dnai1<b2b1526Clo>	MP:0000445,short snout|MP:0000644,dextrocardia|MP:0000694,spleen hypoplasia|MP:0002639,micrognathia|MP:0003178,left pulmonary isomerism|MP:0004133,heterotaxia|MP:0010463,aorta stenosis|MP:0011249,abdominal situs inversus|MP:0011250,abdominal situs ambiguus|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia|MP:0011683,dual inferior vena cava
MGI:5285080	Dnai1<b2b284Clo>	MP:0000284,double outlet right ventricle|MP:0000644,dextrocardia|MP:0001891,hydrocephaly|MP:0002082,postnatal lethality|MP:0002127,abnormal cardiovascular system morphology|MP:0004113,abnormal aortic arch morphology|MP:0004133,heterotaxia|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011250,abdominal situs ambiguus|MP:0011251,bronchial situs inversus|MP:0011252,situs inversus totalis|MP:0013206,abnormal motile cilium morphology|MP:0013209,abnormal motile cilium physiology
MGI:6343354	Dnai1<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:4415595	Dnai1<tm1.1Leo>	MP:0001947,abnormal mucociliary clearance|MP:0001950,abnormal respiratory sounds|MP:0002133,abnormal respiratory system physiology|MP:0003631,nervous system phenotype|MP:0030118,rhinosinusitis|MP:0031088,coughing|MP:0031089,sneezing
MGI:4415703	Dnai1<tm1.2Leo>	MP:0001891,hydrocephaly|MP:0003354,astrocytosis|MP:0012676,dilated brain ventricle
MGI:5619080	Dnai2<b2b3405Clo>	MP:0002766,situs inversus|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia
MGI:7444920	Dnai2<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0002591,decreased mean corpuscular volume|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011874,enlarged urinary bladder
MGI:6343372	Dnai3<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6314811	Dnai4<em1(IMPC)J>	MP:0001925,male infertility|MP:0002590,increased mean corpuscular volume
MGI:7467315	Dnai7<em1(IMPC)Tcp>	MP:0001289,persistence of hyaloid vascular system|MP:0001925,male infertility|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:3664581	Dnai7<Gt(VICTR21)709Lex>	MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0004499,increased incidence of tumors by chemical induction
MGI:5445777	Dnaja1<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0005633,increased circulating sodium level|MP:0010052,increased grip strength|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3573790	Dnaja1<tm1Kate>	MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001157,small seminal vesicle|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0006379,abnormal spermatocyte morphology|MP:0014636,decreased elongated spermatid number
MGI:6152466	Dnaja2<em1(IMPC)Mbp>	MP:0001404,no spontaneous movement|MP:0001926,female infertility|MP:0002699,abnormal vitreous body morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3040717	Dnaja3<tm1.1Jdl>	MP:0000274,enlarged heart|MP:0000295,trabecula carnea hypoplasia|MP:0001402,decreased locomotor activity|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0003222,increased cardiomyocyte apoptosis|MP:0003984,embryonic growth retardation|MP:0004090,abnormal sarcomere morphology|MP:0005312,pericardial effusion|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006138,congestive heart failure|MP:0010955,abnormal respiratory electron transport chain|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011632,dilated mitochondrion|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014390,decreased myocardial fiber mitochondrial DNA content|MP:0031131,myocardial fiber disarray
MGI:3040718	Dnaja3<tm1.2Jdl>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3040716	Dnaja3<tm1Jdl>	MP:0002169,no abnormal phenotype detected
MGI:5521538	Dnaja4<tm1b(KOMP)Wtsi>	MP:0002591,decreased mean corpuscular volume|MP:0005560,decreased circulating glucose level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011396,abnormal sleep behavior
MGI:5614700	Dnajb11<tm1b(EUCOMM)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0001488,increased startle reflex|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0010097,abnormal retina blood vessel morphology|MP:0010574,dilated aorta|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5471844	Dnajb12<tm1.1(KOMP)Vlcg>	MP:0000955,abnormal spinal cord morphology|MP:0002110,abnormal digit morphology|MP:0005633,increased circulating sodium level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011396,abnormal sleep behavior
MGI:6388373	Dnajb14<em1(IMPC)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:6314206	Dnajb14<em1(IMPC)J>	MP:0001566,increased circulating phosphate level|MP:0002590,increased mean corpuscular volume|MP:0003385,abnormal body wall morphology|MP:0003795,abnormal bone structure|MP:0004738,abnormal auditory brainstem response|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:3700841	Dnajb1<tm1Kate>	MP:0002169,no abnormal phenotype detected
MGI:5807189	Dnajb2<em1(IMPC)J>	MP:0001363,increased anxiety-related response|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation
MGI:5468983	Dnajb3<tm1.1(KOMP)Vlcg>	MP:0001417,decreased exploration in new environment|MP:0004924,abnormal behavior|MP:0005560,decreased circulating glucose level|MP:0013279,increased fasting circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:6241427	Dnajb4<em1(IMPC)J>	MP:0001529,abnormal vocalization
MGI:7444110	Dnajb4<em1Sngi>	MP:0000747,muscle weakness|MP:0000759,abnormal skeletal muscle morphology|MP:0002279,abnormal diaphragm morphology|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004090,abnormal sarcomere morphology|MP:0009400,decreased skeletal muscle fiber size|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009417,skeletal muscle atrophy|MP:0009419,skeletal muscle fibrosis
MGI:7444112	Dnajb4<em2Sngi>	MP:0000747,muscle weakness|MP:0002279,abnormal diaphragm morphology|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004090,abnormal sarcomere morphology|MP:0004819,decreased skeletal muscle mass|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009419,skeletal muscle fibrosis|MP:0010053,decreased grip strength
MGI:6887933	Dnajb4<tm1Suky>	MP:0000008,increased white adipose tissue amount|MP:0001260,increased body weight|MP:0002833,increased heart weight|MP:0005397,hematopoietic system phenotype
MGI:6117091	Dnajb5<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:2151092	Dnajb6<Gt(ROSABetageo)6AD1Jcc>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003403,absent placental labyrinth|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5445758	Dnajb7<tm1.1(KOMP)Vlcg>	MP:0002060,abnormal skin morphology|MP:0013279,increased fasting circulating glucose level
MGI:6724291	Dnajb8<em1Sbai>	MP:0005389,reproductive system phenotype
MGI:4124484	Dnajb9<Gt(KST256)Byg>	MP:0000188,abnormal circulating glucose level|MP:0000189,hypoglycemia|MP:0001394,circling|MP:0001399,hyperactivity|MP:0002712,increased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0003339,decreased pancreatic beta cell number|MP:0003402,decreased liver weight|MP:0005191,head tilt|MP:0005216,abnormal pancreatic alpha cell morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009160,abnormal pancreatic acinar cell zymogen granule morphology|MP:0009176,increased pancreatic alpha cell number|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0010398,decreased liver glycogen level|MP:0011090,perinatal lethality, incomplete penetrance|MP:0012556,increased cell death|MP:0014117,increased pancreatic beta cell apoptosis
MGI:4436651	Dnajc10<tm1a(EUCOMM)Hmgu>	MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:5007111	Dnajc10<tm1Lex>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0003961,decreased lean body mass|MP:0012322,decreased total tissue mass
MGI:4453462	Dnajc10<tm1Tiw>	MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype
MGI:5707591	Dnajc11<spc>	MP:0000221,decreased leukocyte cell number|MP:0000694,spleen hypoplasia|MP:0000745,tremors|MP:0000748,progressive muscle weakness|MP:0000937,abnormal motor neuron morphology|MP:0001392,abnormal locomotor behavior|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0002083,premature death|MP:0002875,decreased erythrocyte cell number|MP:0004263,abnormal limb posture|MP:0004956,decreased thymus weight|MP:0005017,decreased B cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005150,cachexia|MP:0005397,hematopoietic system phenotype|MP:0008025,brain vacuoles|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010129,increased DN1 thymic pro-T cell number|MP:0011636,disorganized mitochondrial cristae|MP:0012051,spasticity|MP:0013585,thymus cortex atrophy|MP:0013590,enlarged thymus medulla
MGI:8277166	Dnajc12<em1.1Mjfa>	MP:0001402,decreased locomotor activity|MP:0002272,abnormal nervous system electrophysiology|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology|MP:0010070,decreased serotonin level|MP:0020875,decreased nervous system dopamine level|MP:0030671,decreased circulating phenylalanine level
MGI:6279911	Dnajc12<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6157328	Dnajc13<em1(IMPC)J>	MP:0005344,increased circulating bilirubin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:6405716	Dnajc13<tm1.1Mjfa>	MP:0002169,no abnormal phenotype detected
MGI:5471951	Dnajc14<tm1.1(KOMP)Vlcg>	MP:0003019,increased circulating chloride level|MP:0003960,increased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005419,decreased circulating serum albumin level|MP:0005633,increased circulating sodium level|MP:0011396,abnormal sleep behavior
MGI:4329547	Dnajc15<Gt(RRN226)Byg>	MP:0001783,decreased white adipose tissue amount|MP:0002118,abnormal lipid homeostasis|MP:0002310,decreased susceptibility to hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002981,increased liver weight|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005387,immune system phenotype|MP:0005438,abnormal glycogen homeostasis|MP:0005440,increased glycogen level|MP:0010026,decreased liver cholesterol level|MP:0010400,increased liver glycogen level|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0031003,increased kidney glycogen level
MGI:5548512	Dnajc15<tm1b(KOMP)Wtsi>	MP:0000689,abnormal spleen morphology|MP:0004509,abnormal pelvic girdle bone morphology|MP:0005559,increased circulating glucose level
MGI:5463938	Dnajc16<tm1.1(KOMP)Vlcg>	MP:0004738,abnormal auditory brainstem response|MP:0005650,abnormal limb bud morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4128855	Dnajc17<Gt(RRH136)Byg>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4434811	Dnajc17<tm1a(EUCOMM)Hmgu>	MP:0002968,increased circulating alkaline phosphatase level
MGI:5548585	Dnajc17<tm1b(EUCOMM)Hmgu>	MP:0004738,abnormal auditory brainstem response|MP:0010087,increased circulating fructosamine level|MP:0011100,preweaning lethality, complete penetrance
MGI:6150874	Dnajc18<tm1b(EUCOMM)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:4435205	Dnajc19<tm1a(EUCOMM)Hmgu>	MP:0001262,decreased body weight|MP:0003961,decreased lean body mass|MP:0005559,increased circulating glucose level
MGI:5766144	Dnajc21<tm1.1(NCOM)Mfgc>	MP:0002764,short tibia|MP:0004122,abnormal sinus arrhythmia|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3809863	Dnajc24<m1Jkn>	MP:0000562,polydactyly|MP:0001698,decreased embryo size|MP:0011092,embryonic lethality, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:4298298	Dnajc27<Gt(OST374030)Lex>	MP:0003447,decreased tumor growth/size|MP:0004502,decreased incidence of tumors by chemical induction|MP:0008883,abnormal enterocyte proliferation
MGI:5614706	Dnajc27<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0010052,increased grip strength|MP:0010097,abnormal retina blood vessel morphology|MP:0011965,decreased total retina thickness
MGI:5463945	Dnajc28<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0002574,increased vertical activity
MGI:6467409	Dnajc2<em1Adu>	MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:6316603	Dnajc2<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0000218,increased leukocyte cell number|MP:0001552,increased circulating triglyceride level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6467410	Dnajc2<em2Adu>	MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:5749449	Dnajc30<tm1.1(KOMP)Vlcg>	MP:0000194,increased circulating calcium level|MP:0005292,improved glucose tolerance|MP:0005568,increased circulating total protein level|MP:0013279,increased fasting circulating glucose level
MGI:5085552	Dnajc30<tm1(KOMP)Vlcg>	MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001363,increased anxiety-related response|MP:0002175,decreased brain weight|MP:0002797,increased thigmotaxis|MP:0004811,abnormal neuron physiology|MP:0004889,increased energy expenditure|MP:0005290,decreased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006038,increased mitochondrial fission|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0011628,increased mitochondrial number|MP:0011633,abnormal mitochondrial shape|MP:0011942,decreased fluid intake|MP:0020337,abnormal pyramidal neuron dendrite morphology|MP:0020395,abnormal response to social novelty|MP:0020508,decreased dendritic spine density
MGI:6200312	Dnajc3<m1Btlr>	MP:0001262,decreased body weight|MP:0005015,increased T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0008537,increased susceptibility to induced colitis|MP:0010838,increased CD8-positive, alpha-beta memory T cell number
MGI:3578105	Dnajc3<tm8663Wcl>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0003339,decreased pancreatic beta cell number|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005449,abnormal food intake|MP:0005459,decreased percent body fat/body weight|MP:0009114,decreased pancreatic beta cell mass
MGI:5548519	Dnajc5b<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment|MP:0003900,shortened QT interval|MP:0010571,shortened ST segment
MGI:5445923	Dnajc5g<tm1.1(KOMP)Vlcg>	MP:0001297,microphthalmia|MP:0002079,increased circulating insulin level|MP:0010053,decreased grip strength|MP:0013279,increased fasting circulating glucose level
MGI:3050763	Dnajc5<tm1Sud>	MP:0000748,progressive muscle weakness|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001392,abnormal locomotor behavior|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001489,decreased startle reflex|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0001515,abnormal grip strength|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0001732,postnatal growth retardation|MP:0002001,blindness|MP:0002083,premature death|MP:0002090,abnormal vision|MP:0002183,gliosis|MP:0002913,abnormal PNS synaptic transmission|MP:0002914,abnormal endplate potential|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0004819,decreased skeletal muscle mass|MP:0005202,lethargy|MP:0005377,hearing/vestibular/ear phenotype|MP:0005551,abnormal eye electrophysiology|MP:0006325,impaired hearing|MP:0006326,conductive hearing impairment|MP:0006336,abnormal otoacoustic response|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0010053,decreased grip strength|MP:0031287,bilateral cryptorchism
MGI:4440489	Dnajc6<tm1Legr>	MP:0001262,decreased body weight|MP:0004770,abnormal synaptic vesicle recycling|MP:0004792,abnormal synaptic vesicle number|MP:0008976,delayed female fertility|MP:0009674,decreased birth weight|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5752955	Dnajc7<tm1.2Neg>	MP:0002628,hepatic steatosis|MP:0005178,increased circulating cholesterol level
MGI:5476999	Dnajc7<tm1b(KOMP)Wtsi>	MP:0001402,decreased locomotor activity|MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin
MGI:5637033	Dnajc8<tm1b(KOMP)Wtsi>	MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0005561,increased mean corpuscular hemoglobin|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5474770	Dnajc9<tm1.1(KOMP)Vlcg>	MP:0001554,increased circulating free fatty acids level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5708222	Dnal1<tm1.1(KOMP)Vlcg>	MP:0001175,abnormal lung morphology|MP:0001785,edema|MP:0002581,abnormal ileum morphology|MP:0005012,decreased eosinophil cell number|MP:0008528,polycystic kidney|MP:0010378,increased respiratory quotient|MP:0011100,preweaning lethality, complete penetrance
MGI:5548493	Dnal4<tm1b(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0001417,decreased exploration in new environment|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7541056	Dnali1<em1Yxc>	MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0030590,abnormal sperm fibrous sheath morphology
MGI:4430191	Dnase1l1<tm1Dkfz>	MP:0001405,impaired coordination
MGI:6257487	Dnase1l2<em1(IMPC)Bay>	MP:0000063,decreased bone mineral density|MP:0000689,abnormal spleen morphology
MGI:5638888	Dnase1l2<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001399,hyperactivity|MP:0001486,abnormal startle reflex|MP:0002075,abnormal coat/hair pigmentation|MP:0005566,decreased blood urea nitrogen level|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:5501065	Dnase1l2<tm1.1(KOMP)Wtsi>	MP:0000194,increased circulating calcium level|MP:0000432,abnormal head morphology|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0000470,abnormal stomach morphology|MP:0000558,abnormal tibia morphology|MP:0000572,abnormal autopod morphology|MP:0000579,abnormal nail morphology|MP:0000689,abnormal spleen morphology|MP:0001258,decreased body length|MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001402,decreased locomotor activity|MP:0001529,abnormal vocalization|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002092,abnormal eye morphology|MP:0002110,abnormal digit morphology|MP:0002111,abnormal tail morphology|MP:0002544,brachydactyly|MP:0002764,short tibia|MP:0002833,increased heart weight|MP:0002932,abnormal joint morphology|MP:0003795,abnormal bone structure|MP:0003921,abnormal heart left ventricle morphology|MP:0003961,decreased lean body mass|MP:0004174,abnormal spine curvature|MP:0004609,vertebral fusion|MP:0004613,fusion of vertebral arches|MP:0005343,increased circulating aspartate transaminase level|MP:0005565,increased blood urea nitrogen level|MP:0006203,eye hemorrhage|MP:0008259,abnormal optic disk morphology|MP:0010024,increased total body fat amount|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0011952,decreased cardiac stroke volume|MP:0013279,increased fasting circulating glucose level
MGI:5308556	Dnase1l2<tm1Eckh>	MP:0000579,abnormal nail morphology|MP:0003111,abnormal cell nucleus morphology|MP:0003809,abnormal hair shaft morphology
MGI:4362265	Dnase1l2<tm1(KOMP)Wtsi>	MP:0000572,abnormal autopod morphology|MP:0001258,decreased body length|MP:0002110,abnormal digit morphology|MP:0002111,abnormal tail morphology|MP:0002544,brachydactyly|MP:0002764,short tibia|MP:0002833,increased heart weight|MP:0003189,fused joints|MP:0003795,abnormal bone structure|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0011999,abnormal tail length
MGI:6449033	Dnase1l3<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001146,abnormal testis morphology|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002699,abnormal vitreous body morphology|MP:0004952,increased spleen weight|MP:0010067,increased red blood cell distribution width
MGI:5581508	Dnase1l3<tm1Dkit>	MP:0000313,abnormal cell death
MGI:5620311	Dnase1<tm1.1(KOMP)Vlcg>	MP:0000538,abnormal urinary bladder morphology|MP:0004738,abnormal auditory brainstem response
MGI:2387029	Dnase1<tm1Tmo>	MP:0000691,enlarged spleen|MP:0001859,kidney inflammation|MP:0002083,premature death|MP:0002743,glomerulonephritis|MP:0003606,kidney failure|MP:0004154,renal tubular necrosis|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004802,decreased susceptibility to systemic lupus erythematosus|MP:0005554,decreased circulating creatinine level|MP:0005566,decreased blood urea nitrogen level|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0011371,decreased kidney apoptosis
MGI:6400348	Dnase1<tm2092.1Arte>	MP:0002135,abnormal kidney morphology|MP:0002743,glomerulonephritis|MP:0003725,increased autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004796,increased anti-histone antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0005553,increased circulating creatinine level
MGI:3040926	Dnase2a<tm1Aea>	MP:0000761,thin diaphragm muscle|MP:0001577,anemia|MP:0001648,abnormal apoptosis|MP:0002123,abnormal definitive hematopoiesis|MP:0003924,diaphragmatic hernia|MP:0011089,perinatal lethality, complete penetrance
MGI:2449811	Dnase2a<tm1Osa>	MP:0000245,abnormal erythropoiesis|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0001577,anemia|MP:0001823,thymus hypoplasia|MP:0002875,decreased erythrocyte cell number|MP:0009395,increased nucleated erythrocyte cell number|MP:0011111,lethality during fetal growth through weaning, complete penetrance
MGI:4435602	Dnase2b<tm1a(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0001556,increased circulating HDL cholesterol level
MGI:2675502	Dnase2b<tm1Osa>	MP:0001304,cataract|MP:0002090,abnormal vision|MP:0005551,abnormal eye electrophysiology
MGI:6257565	Dnd1<em1(IMPC)Bay>	MP:0000063,decreased bone mineral density|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002792,abnormal retina vasculature morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0010579,increased heart left ventricle size
MGI:2158668	Dnd1<Ter>	MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001147,small testis|MP:0001925,male infertility|MP:0002209,decreased germ cell number|MP:0004478,increased testicular teratoma incidence|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0004901,decreased male germ cell number|MP:0005431,decreased oocyte number|MP:0006262,increased testis tumor incidence
MGI:5644313	Dnd1<tm1Na>	MP:0002006,neoplasm|MP:0005389,reproductive system phenotype|MP:0010831,lethality, incomplete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:3621906	Dner<tm1Hta>	MP:0000854,abnormal cerebellum development|MP:0000857,abnormal cerebellar foliation|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000952,abnormal CNS glial cell morphology|MP:0001405,impaired coordination|MP:0002763,ectopic Bergmann glia cells|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003894,abnormal Purkinje cell innervation|MP:0011270,decreased excitatory postsynaptic current amplitude
MGI:5637119	Dner<tm3b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0005343,increased circulating aspartate transaminase level
MGI:6885589	Dnhd1<em1Glin>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009243,hairpin sperm flagellum|MP:0020451,decreased sperm progressive motility
MGI:3033341	Dnm1<Ftfl>	MP:0000947,convulsive seizures|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001499,abnormal kindling response|MP:0001524,impaired limb coordination|MP:0001650,abnormal seizure response to electrical stimulation|MP:0002064,seizures|MP:0002826,tonic seizures|MP:0003997,tonic-clonic seizures|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014740,increased auditory brainstem response wave peak latency|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:6448439	Dnm1l<em1Hise>	MP:0003889,enhanced sensorimotor gating|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0008415,abnormal neurite morphology|MP:0009141,increased prepulse inhibition|MP:0009538,abnormal synapse morphology|MP:0009936,abnormal dendritic spine morphology
MGI:4818906	Dnm1l<Py>	MP:0000266,abnormal heart morphology|MP:0001264,increased body size|MP:0001492,abnormal pilomotor reflex|MP:0001544,abnormal cardiovascular system physiology|MP:0001786,skin edema|MP:0002652,thin myocardium|MP:0002837,dystrophic cardiac calcinosis|MP:0002941,increased circulating alanine transaminase level|MP:0003819,increased left ventricle diastolic pressure|MP:0003822,decreased left ventricle systolic pressure|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0004084,abnormal cardiac muscle relaxation|MP:0004564,increased myocardial fiber size|MP:0004876,decreased mean systemic arterial blood pressure|MP:0004937,dilated heart|MP:0005266,abnormal metabolism|MP:0005324,ascites|MP:0005343,increased circulating aspartate transaminase level|MP:0005426,tachypnea|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0005621,abnormal cell physiology|MP:0006035,abnormal mitochondrial morphology|MP:0006138,congestive heart failure|MP:0008775,abnormal heart ventricle pressure|MP:0010017,visceral vascular congestion|MP:0010018,pulmonary vascular congestion|MP:0010019,liver vascular congestion|MP:0010334,pleural effusion|MP:0010954,abnormal cellular respiration|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011091,prenatal lethality, complete penetrance|MP:0011705,absent fibroblast proliferation|MP:0014010,abnormal peroxisome morphology|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014698,decreased fibroblast adhesion
MGI:4366510	Dnm1l<tm1.1Hise>	MP:0000852,small cerebellum|MP:0000854,abnormal cerebellum development|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000880,decreased Purkinje cell number|MP:0009546,absent gastric milk in neonates|MP:0009719,reduced cerebellar foliation|MP:0011085,postnatal lethality, complete penetrance|MP:0014331,abnormal Purkinje cell mitochondrial morphology
MGI:4438630	Dnm1l<tm1.1Miha>	MP:0000784,forebrain hypoplasia|MP:0000852,small cerebellum|MP:0002152,abnormal brain morphology|MP:0003203,increased neuron apoptosis|MP:0004998,decreased CNS synapse formation|MP:0005277,abnormal brainstem morphology|MP:0006035,abnormal mitochondrial morphology|MP:0008026,abnormal brain white matter morphology|MP:0008415,abnormal neurite morphology|MP:0009027,abnormal subarachnoid space morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0030309,abnormal posterior cranial fossa morphology
MGI:4366511	Dnm1l<tm1.2Hise>	MP:0001634,internal hemorrhage|MP:0001698,decreased embryo size|MP:0001714,absent trophoblast giant cells|MP:0004215,abnormal myocardial fiber physiology|MP:0006035,abnormal mitochondrial morphology|MP:0006043,decreased apoptosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:4438631	Dnm1l<tm1.2Miha>	MP:0000267,abnormal heart development|MP:0000597,delayed hepatic development|MP:0001698,decreased embryo size|MP:0006035,abnormal mitochondrial morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011630,increased mitochondrial size|MP:0011704,decreased fibroblast proliferation|MP:0012703,decreased embryonic neuroepithelium thickness|MP:0014010,abnormal peroxisome morphology|MP:0014178,increased brain apoptosis
MGI:5602830	Dnm1l<tm1b(KOMP)Wtsi>	MP:0000367,abnormal coat/ hair morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001312,abnormal cornea morphology|MP:0002699,abnormal vitreous body morphology|MP:0008259,abnormal optic disk morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5708172	Dnm1<tm1.1(KOMP)Vlcg>	MP:0001914,hemorrhage|MP:0003054,spina bifida|MP:0011100,preweaning lethality, complete penetrance
MGI:5800540	Dnm1<tm1.2Frk>	MP:0003631,nervous system phenotype
MGI:8257049	Dnm1<tm1Frk>	MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002083,premature death|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003635,abnormal synaptic transmission|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0009358,environmentally induced seizures|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014254,increased paired-pulse ratio
MGI:3709883	Dnm1<tm1Pdc>	MP:0001436,abnormal suckling behavior|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002206,abnormal CNS synaptic transmission|MP:0002882,abnormal neuron morphology|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004769,abnormal synaptic vesicle morphology|MP:0004770,abnormal synaptic vesicle recycling|MP:0004792,abnormal synaptic vesicle number|MP:0011085,postnatal lethality, complete penetrance
MGI:4457321	Dnm1<tm2.1Pdc>	MP:0002169,no abnormal phenotype detected
MGI:5800541	Dnm1<tm2.2Frk>	MP:0003631,nervous system phenotype
MGI:5491244	Dnm2<b2b2159Clo>	MP:0000111,cleft palate|MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000519,hydronephrosis|MP:0001297,microphthalmia|MP:0001891,hydrocephaly|MP:0008528,polycystic kidney|MP:0010402,ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010466,vascular ring|MP:0010541,aorta hypoplasia|MP:0012260,encephalomeningocele
MGI:7378850	Dnm2<Rbc12>	MP:0000208,decreased hematocrit|MP:0002416,abnormal proerythroblast morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002810,microcytic anemia|MP:0002874,decreased hemoglobin content|MP:0005376,homeostasis/metabolism phenotype|MP:0005562,decreased mean corpuscular hemoglobin|MP:0009278,abnormal bone marrow cell physiology|MP:0013292,embryonic lethality prior to organogenesis
MGI:4848043	Dnm2<tm1.1Ics>	MP:0000747,muscle weakness|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0002269,muscular atrophy|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004231,abnormal calcium ion homeostasis|MP:0004818,increased skeletal muscle mass|MP:0004819,decreased skeletal muscle mass|MP:0005620,abnormal muscle contractility|MP:0005621,abnormal cell physiology|MP:0009399,increased skeletal muscle fiber size|MP:0009400,decreased skeletal muscle fiber size|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009674,decreased birth weight|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5708178	Dnm2<tm1.1(KOMP)Vlcg>	MP:0001102,small superior vagus ganglion|MP:0002968,increased circulating alkaline phosphatase level|MP:0004906,enlarged uterus|MP:0005562,decreased mean corpuscular hemoglobin|MP:0009709,hydrometra|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4457365	Dnm2<tm1.1Pdc>	MP:0002169,no abnormal phenotype detected
MGI:4457366	Dnm2<tm1.2Pdc>	MP:0005397,hematopoietic system phenotype|MP:0011092,embryonic lethality, complete penetrance
MGI:6506378	Dnm2<tm2.1Ics>	MP:0000751,myopathy|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004145,abnormal muscle electrophysiology|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005402,abnormal action potential|MP:0005425,increased macrophage cell number|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0010239,decreased skeletal muscle weight|MP:0011730,increased myelin sheath thickness|MP:0012322,decreased total tissue mass
MGI:7464883	Dnm2<tm4.1Ics>	MP:0001262,decreased body weight|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0009400,decreased skeletal muscle fiber size|MP:0010053,decreased grip strength|MP:0011089,perinatal lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011630,increased mitochondrial size|MP:0011633,abnormal mitochondrial shape|MP:0011635,abnormal mitochondrial crista morphology|MP:0011940,decreased food intake
MGI:3826836	Dnm3os<tm1Tkk>	MP:0000063,decreased bone mineral density|MP:0000074,abnormal neurocranium morphology|MP:0000120,malocclusion|MP:0000137,abnormal vertebrae morphology|MP:0000438,abnormal cranium morphology|MP:0000754,paresis|MP:0001255,decreased body height|MP:0001258,decreased body length|MP:0001406,abnormal gait|MP:0002108,abnormal muscle morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0004613,fusion of vertebral arches|MP:0006319,abnormal epididymal fat pad morphology|MP:0008271,abnormal bone ossification|MP:0008489,slow postnatal weight gain|MP:0008770,decreased survivor rate|MP:0009431,decreased fetal weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0021186,decreased bone mineral density of vertebrae
MGI:5285526	Dnm3<tm1.2Pdc>	MP:0002169,no abnormal phenotype detected
MGI:6152467	Dnmbp<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001489,decreased startle reflex|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002574,increased vertical activity|MP:0002989,small kidney|MP:0004738,abnormal auditory brainstem response|MP:0009141,increased prepulse inhibition
MGI:7506564	Dnmt1<em1Jiemw>	MP:0011091,prenatal lethality, complete penetrance
MGI:7506781	Dnmt1<em2Jiemw>	MP:0003203,increased neuron apoptosis|MP:0003461,abnormal response to novel object|MP:0008414,abnormal spatial reference memory|MP:0008428,abnormal spatial working memory|MP:0008948,decreased neuron number|MP:0012207,decreased neuronal stem cell self-renewal|MP:0012307,impaired spatial learning|MP:0014257,embryonic lethality prior to tooth bud stage, complete penetrance
MGI:3586549	Dnmt1<MommeD2>	MP:0011100,preweaning lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1857601	Dnmt1<tm1Enl>	MP:0001730,embryonic growth arrest|MP:0002151,abnormal neural tube morphology|MP:0006386,absent somites|MP:0008877,abnormal DNA methylation|MP:0011092,embryonic lethality, complete penetrance
MGI:1857157	Dnmt1<tm1Jae>	MP:0000352,decreased cell proliferation|MP:0001722,pale yolk sac|MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0003787,abnormal imprinting|MP:0008877,abnormal DNA methylation|MP:0011092,embryonic lethality, complete penetrance|MP:0012131,small visceral yolk sac|MP:0013504,increased embryonic tissue cell apoptosis
MGI:2387992	Dnmt1<tm1Jrc>	MP:0001926,female infertility|MP:0003787,abnormal imprinting
MGI:1930971	Dnmt1<tm2Enl>	MP:0000352,decreased cell proliferation|MP:0000929,open neural tube|MP:0001690,failure of somite differentiation|MP:0001730,embryonic growth arrest|MP:0002151,abnormal neural tube morphology|MP:0004180,failure of initiation of embryo turning|MP:0008877,abnormal DNA methylation|MP:0009768,impaired somite development|MP:0011092,embryonic lethality, complete penetrance
MGI:2156895	Dnmt1<tm2Jae>	MP:0002144,abnormal B cell differentiation|MP:0008208,decreased pro-B cell number
MGI:3763529	Dnmt1<tm2Jrc>	MP:0002169,no abnormal phenotype detected
MGI:2657151	Dnmt1<tm3Jae>	MP:0002169,no abnormal phenotype detected
MGI:7646874	Dnmt3a<em1Hsas>	MP:0002907,abnormal parturition|MP:0003787,abnormal imprinting|MP:0008878,abnormal DNA methylation during gametogenesis|MP:0009661,abnormal pregnancy|MP:0011101,prenatal lethality, incomplete penetrance
MGI:8175483	Dnmt3a<em1Hwg>	MP:0000438,abnormal cranium morphology|MP:0000774,decreased brain size|MP:0001261,obese|MP:0001533,abnormal skeleton physiology|MP:0002152,abnormal brain morphology|MP:0003461,abnormal response to novel object|MP:0004357,long tibia|MP:0004695,increased length of long bones|MP:0005386,behavior/neurological phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0006254,thin cerebral cortex|MP:0006398,increased long bone epiphyseal plate size|MP:0008026,abnormal brain white matter morphology|MP:0013624,decreased femur compact bone thickness|MP:0013626,decreased femur yield load|MP:0013633,decreased femur maximal load|MP:0013639,decreased bone stiffness|MP:0014142,increased body fat mass|MP:0020351,decreased vocalization
MGI:3711711	Dnmt3a<tm1.1Jae>	MP:0001265,decreased body size|MP:0011085,postnatal lethality, complete penetrance
MGI:8175499	Dnmt3a<tm1.1Rlvn>	MP:0000065,abnormal bone marrow cavity morphology|MP:0000438,abnormal cranium morphology|MP:0000558,abnormal tibia morphology|MP:0000774,decreased brain size|MP:0000822,abnormal brain ventricle morphology|MP:0001254,increased body height|MP:0001260,increased body weight|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001264,increased body size|MP:0001409,increased stereotypic behavior|MP:0002026,increased leukemia incidence|MP:0002062,abnormal associative learning|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002152,abnormal brain morphology|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002757,decreased vertical activity|MP:0003461,abnormal response to novel object|MP:0003961,decreased lean body mass|MP:0004348,long femur|MP:0004357,long tibia|MP:0004514,dystocia|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0006254,thin cerebral cortex|MP:0006398,increased long bone epiphyseal plate size|MP:0009453,enhanced contextual conditioning behavior|MP:0009455,enhanced cued conditioning behavior|MP:0009703,decreased birth body size|MP:0010024,increased total body fat amount|MP:0010273,increased classified tumor incidence|MP:0010379,decreased respiratory quotient|MP:0011085,postnatal lethality, complete penetrance|MP:0011940,decreased food intake|MP:0013624,decreased femur compact bone thickness|MP:0020351,decreased vocalization|MP:0020838,increased acute myeloid leukemia incidence|MP:0030007,abnormal bone marrow adipose tissue morphology|MP:0030050,large mandible|MP:0031392,hypoactivity
MGI:4364077	Dnmt3a<tm1a(KOMP)Wtsi>	MP:0010052,increased grip strength
MGI:5446396	Dnmt3a<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000947,convulsive seizures|MP:0001417,decreased exploration in new environment|MP:0001697,abnormal embryo size|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0010024,increased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2182408	Dnmt3a<tm1Enl>	MP:0001732,postnatal growth retardation|MP:0002083,premature death
MGI:3711072	Dnmt3a<tm1Jae>	MP:0000939,decreased motor neuron number|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0002083,premature death|MP:0003631,nervous system phenotype|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0010053,decreased grip strength
MGI:6188116	Dnmt3a<tm1Trow>	MP:0002400,abnormal multipotent stem cell morphology|MP:0004809,increased hematopoietic stem cell number|MP:0013660,abnormal bone marrow hematopoietic cell morphology|MP:0013891,increased common myeloid progenitor cell number
MGI:3047824	Dnmt3a<tm3.2Enl>	MP:0001732,postnatal growth retardation|MP:0002083,premature death
MGI:6158518	Dnmt3b<em1(IMPC)Mbp>	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0000433,microcephaly|MP:0001297,microphthalmia|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003231,abnormal placenta vasculature|MP:0003743,abnormal facial morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape
MGI:5515362	Dnmt3b<MommeD14>	MP:0011110,preweaning lethality, incomplete penetrance|MP:0012167,abnormal epigenetic regulation of gene expression
MGI:2182409	Dnmt3b<tm1Enl>	MP:0000281,abnormal interventricular septum morphology|MP:0000601,small liver|MP:0000928,incomplete rostral neuropore closure|MP:0001914,hemorrhage|MP:0003984,embryonic growth retardation|MP:0011091,prenatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3047834	Dnmt3b<tm5.2Enl>	MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0011091,prenatal lethality, complete penetrance
MGI:3628446	Dnmt3b<tm6Enl>	MP:0000085,large anterior fontanelle|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001300,ocular hypertelorism|MP:0004379,wide frontal bone|MP:0004471,short nasal bone|MP:0009541,increased thymocyte apoptosis|MP:0009674,decreased birth weight|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3628447	Dnmt3b<tm7Enl>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0009541,increased thymocyte apoptosis|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:6156103	Dnmt3c<em2Sky>	MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype
MGI:6156107	Dnmt3c<em5Sky>	MP:0005389,reproductive system phenotype
MGI:6156101	Dnmt3c<rahu>	MP:0001147,small testis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0008878,abnormal DNA methylation during gametogenesis|MP:0014052,increased male germ cell apoptosis
MGI:7646871	Dnmt3l<em1Hsas>	MP:0003787,abnormal imprinting|MP:0005389,reproductive system phenotype|MP:0008878,abnormal DNA methylation during gametogenesis
MGI:6257768	Dnmt3l<em1(IMPC)Bay>	MP:0001925,male infertility|MP:0001926,female infertility
MGI:2155766	Dnmt3l<tm1Bes>	MP:0000914,exencephaly|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001787,pericardial edema|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0002836,abnormal chorion morphology|MP:0004901,decreased male germ cell number|MP:0005031,abnormal trophoblast layer morphology|MP:0005032,abnormal ectoplacental cone morphology|MP:0005159,azoospermia|MP:0009397,increased trophoblast giant cell number|MP:0009657,failure of chorioallantoic fusion|MP:0011091,prenatal lethality, complete penetrance|MP:0020515,abnormal visceral yolk sac endoderm morphology
MGI:6120722	Dnmt3l<tm1b(EUCOMM)Hmgu>	MP:0000062,increased bone mineral density|MP:0001147,small testis|MP:0001289,persistence of hyaloid vascular system|MP:0005561,increased mean corpuscular hemoglobin
MGI:2447127	Dnmt3l<tm1Enl>	MP:0000929,open neural tube|MP:0001147,small testis|MP:0001924,infertility|MP:0001931,abnormal oogenesis|MP:0001932,abnormal spermiogenesis|MP:0002836,abnormal chorion morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:3574947	Dnmt3l<tm1Scot>	MP:0001116,small gonad|MP:0001924,infertility|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0011750,abnormal seminiferous tubule epithelium morphology
MGI:3720376	Dnmt3l<tm2Bes>	MP:0002169,no abnormal phenotype detected
MGI:6120903	Dnpep<em1Dlp>	MP:0002169,no abnormal phenotype detected
MGI:6117753	Dnpep<tm1e(EUCOMM)Wtsi>	MP:0002599,increased mean platelet volume|MP:0005553,increased circulating creatinine level
MGI:3040355	Dntcs1<C3H/HeJ>	MP:0030101,carious teeth
MGI:3040358	Dntcs2<C57BL/6J>	MP:0030101,carious teeth
MGI:3613755	dntm	MP:0001501,abnormal sleep pattern
MGI:6479050	Dnttip1<em1Shmc>	MP:0000215,absent erythrocytes|MP:0000277,abnormal heart shape|MP:0000291,enlarged pericardium|MP:0002740,heart hypoplasia|MP:0004046,abnormal mitosis|MP:0004201,fetal growth retardation|MP:0005370,liver/biliary system phenotype|MP:0005387,immune system phenotype|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5635045	Dnttip1<tm1b(KOMP)Wtsi>	MP:0005505,thrombocytosis|MP:0011100,preweaning lethality, complete penetrance
MGI:3715912	Dntt<tm1Fwa>	MP:0000685,abnormal immune system morphology
MGI:2177306	Dntt<tm1Gfn>	MP:0002169,no abnormal phenotype detected
MGI:3613594	Dntt<tm1Tok>	MP:0000717,abnormal lymphocyte cell number|MP:0008037,abnormal T cell morphology|MP:0008347,decreased gamma-delta T cell number
MGI:5505648	Dntt<tm2b(KOMP)Wtsi>	MP:0001556,increased circulating HDL cholesterol level|MP:0003063,increased coping response|MP:0005178,increased circulating cholesterol level|MP:0005633,increased circulating sodium level
MGI:6200765	dny	MP:0000416,sparse hair|MP:0000417,short hair|MP:0009351,thin hair shaft
MGI:1856598	Do	MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001408,stereotypic behavior|MP:0001525,impaired balance|MP:0011085,postnatal lethality, complete penetrance
MGI:2155966	Dob1<AKR/J>	MP:0000008,increased white adipose tissue amount
MGI:2157552	Dob2<SWR/J>	MP:0000008,increased white adipose tissue amount
MGI:2157553	Dob3<AKR/J>	MP:0000008,increased white adipose tissue amount
MGI:2446881	Dob7<SWR/J>	MP:0000008,increased white adipose tissue amount|MP:0001260,increased body weight
MGI:3042481	Doc2a<tm1Ytk>	MP:0001473,reduced long-term potentiation|MP:0002799,abnormal passive avoidance behavior|MP:0012443,increased corpus callosum size|MP:0012449,increased primary motor cortex size|MP:0012473,increased cingulate cortex size|MP:0012477,increased secondary somatosensory cortex size
MGI:4440451	Doc2b<tm1Aljg>	MP:0002206,abnormal CNS synaptic transmission|MP:0002945,abnormal inhibitory postsynaptic currents
MGI:6856664	Doc2g<tm1.2Aljg>	MP:0003631,nervous system phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:4436497	Dock10<tm1a(EUCOMM)Hmgu>	MP:0001802,arrested B cell differentiation|MP:0002362,abnormal spleen marginal zone morphology|MP:0002459,abnormal B cell physiology|MP:0002608,increased hematocrit|MP:0002874,decreased hemoglobin content|MP:0004924,abnormal behavior|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005378,growth/size/body region phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005564,increased hemoglobin content|MP:0008082,increased single-positive T cell number|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008191,abnormal follicular B cell physiology|MP:0008827,abnormal thymus cell ratio|MP:0010768,mortality/aging
MGI:7330190	Dock10<tm1Thar>	MP:0003631,nervous system phenotype|MP:0003799,impaired macrophage chemotaxis|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005017,decreased B cell number|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0008916,abnormal astrocyte physiology|MP:0010761,abnormal microglial cell chemotaxis
MGI:6690850	Dock11<tm1.1Mmar>	MP:0002362,abnormal spleen marginal zone morphology|MP:0005378,growth/size/body region phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0008182,decreased marginal zone B cell number|MP:0008241,abnormal metallophilic macrophage morphology|MP:0008827,abnormal thymus cell ratio|MP:0010768,mortality/aging
MGI:7330191	Dock11<tm1Thar>	MP:0003631,nervous system phenotype|MP:0003799,impaired macrophage chemotaxis|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005391,vision/eye phenotype
MGI:5548661	Dock11<tm2b(KOMP)Wtsi>	MP:0002092,abnormal eye morphology|MP:0003917,increased kidney weight
MGI:5618859	Dock1<b2b3190Clo>	MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0000519,hydronephrosis|MP:0001823,thymus hypoplasia|MP:0002192,hydrops fetalis|MP:0002633,persistent truncus arteriosus|MP:0002639,micrognathia|MP:0006130,pulmonary valve atresia|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect
MGI:5301316	Dock1<tm1.1Ysfk>	MP:0000266,abnormal heart morphology|MP:0000729,abnormal myogenesis|MP:0001622,abnormal vasculogenesis|MP:0001785,edema|MP:0003544,abnormal vascular endothelial cell migration|MP:0010402,ventricular septal defect|MP:0010428,abnormal heart right ventricle outflow tract morphology|MP:0010617,thick mitral valve cusps|MP:0011091,prenatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3828065	Dock1<tm1Jfco>	MP:0000729,abnormal myogenesis|MP:0000733,abnormal muscle development|MP:0000761,thin diaphragm muscle|MP:0001177,atelectasis|MP:0001575,cyanosis|MP:0001785,edema|MP:0002106,abnormal muscle physiology|MP:0002279,abnormal diaphragm morphology|MP:0002280,abnormal intercostal muscle morphology|MP:0004819,decreased skeletal muscle mass|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009703,decreased birth body size|MP:0010402,ventricular septal defect|MP:0010428,abnormal heart right ventricle outflow tract morphology|MP:0010617,thick mitral valve cusps|MP:0011083,lethality at weaning, complete penetrance
MGI:5515752	Dock1<tm2.1Jfco>	MP:0005379,endocrine/exocrine gland phenotype
MGI:6284832	Dock2<m10Btlr>	MP:0008044,increased NK cell number|MP:0008170,decreased B-1b cell number
MGI:6284840	Dock2<m11Btlr>	MP:0002144,abnormal B cell differentiation|MP:0002436,abnormal CD8-positive, alpha-beta cytotoxic T cell morphology|MP:0004977,increased B-1 B cell number|MP:0005017,decreased B cell number|MP:0008045,decreased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6284854	Dock2<M12Btlr>	MP:0008168,decreased B-1a cell number
MGI:6285149	Dock2<m13Btlr>	MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0012764,increased alpha-beta T cell number
MGI:6285155	Dock2<M14Btlr>	MP:0002619,abnormal lymphocyte morphology|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:6305375	Dock2<m15Btlr>	MP:0004977,increased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008044,increased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6305853	Dock2<M16Btlr>	MP:0008077,abnormal CD8-positive, alpha-beta T cell number
MGI:5563487	Dock2<m1Anu>	MP:0005017,decreased B cell number|MP:0005018,decreased T cell number
MGI:5014755	Dock2<m1Btlr>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0002144,abnormal B cell differentiation|MP:0004816,abnormal class switch recombination|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005387,immune system phenotype
MGI:5563490	Dock2<m2Anu>	MP:0005018,decreased T cell number|MP:0008037,abnormal T cell morphology|MP:0008211,decreased mature B cell number
MGI:5049870	Dock2<m2Btlr>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0002144,abnormal B cell differentiation|MP:0004816,abnormal class switch recombination|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:5563488	Dock2<m3Anu>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:5461202	Dock2<m3Btlr>	MP:0001790,abnormal immune system physiology|MP:0001800,abnormal humoral immune response|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation
MGI:5640757	Dock2<m4Btlr>	MP:0002144,abnormal B cell differentiation|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation
MGI:5695264	Dock2<m5Btlr>	MP:0001606,impaired hematopoiesis|MP:0002144,abnormal B cell differentiation|MP:0005014,increased B cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008082,increased single-positive T cell number|MP:0008083,decreased single-positive T cell number
MGI:5806434	Dock2<m6Btlr>	MP:0002492,decreased IgE level|MP:0020001,decreased response to antigen
MGI:6114020	Dock2<m7Btlr>	MP:0000219,increased neutrophil cell number|MP:0002497,increased IgE level|MP:0005017,decreased B cell number|MP:0005425,increased macrophage cell number|MP:0008044,increased NK cell number
MGI:6284818	Dock2<m8Btlr>	MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:6284824	Dock2<M9Btlr>	MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:5637116	Dock2<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0004952,increased spleen weight|MP:0005566,decreased blood urea nitrogen level|MP:0005627,increased circulating potassium level
MGI:2152031	Dock2<tm1Tsas>	MP:0000685,abnormal immune system morphology|MP:0000689,abnormal spleen morphology|MP:0000694,spleen hypoplasia|MP:0000696,abnormal Peyer's patch morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002396,abnormal hematopoietic system morphology/development|MP:0003091,abnormal cell migration|MP:0003156,abnormal leukocyte migration|MP:0005016,decreased lymphocyte cell number|MP:0005018,decreased T cell number|MP:0008101,lymph node hypoplasia|MP:0008182,decreased marginal zone B cell number|MP:0008211,decreased mature B cell number|MP:0008720,impaired neutrophil chemotaxis|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:3831156	Dock3<tm1Dasc>	MP:0000746,weakness|MP:0000788,abnormal cerebral cortex morphology|MP:0000852,small cerebellum|MP:0000955,abnormal spinal cord morphology|MP:0001023,L5 dorsal root ganglion hypertrophy|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001522,impaired swimming|MP:0002269,muscular atrophy|MP:0002804,abnormal motor learning|MP:0003225,axonal dystrophy|MP:0003631,nervous system phenotype|MP:0003691,abnormal microglial cell physiology|MP:0003993,abnormal ventral spinal root morphology|MP:0004768,abnormal axonal transport|MP:0010047,axonal spheroids
MGI:6449030	Dock4<em1(IMPC)Hmgu>	MP:0001486,abnormal startle reflex|MP:0004906,enlarged uterus|MP:0010052,increased grip strength
MGI:4880372	Dock4<tm1(NCOM)Mfgc>	MP:0010144,abnormal tumor vascularization|MP:0011092,embryonic lethality, complete penetrance|MP:0020373,abnormal blood vessel lumen formation
MGI:3828069	Dock5<Gt(AN0268)Wtsi>	MP:0005369,muscle phenotype|MP:0010768,mortality/aging
MGI:1861664	Dock5<rlc>	MP:0001304,cataract
MGI:5639331	Dock6<em1(IMPC)J>	MP:0003131,increased erythrocyte cell number|MP:0005344,increased circulating bilirubin level|MP:0005564,increased hemoglobin content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1856946	Dock7<m>	MP:0000371,diluted coat color|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001783,decreased white adipose tissue amount|MP:0002940,variable body spotting|MP:0005386,behavior/neurological phenotype|MP:0005606,increased bleeding time|MP:0009557,decreased platelet ADP level|MP:0014168,abnormal brown adipose tissue mass
MGI:3795855	Dock7<mnlt>	MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0001360,abnormal social investigation|MP:0002095,abnormal skin pigmentation|MP:0005175,non-pigmented tail tip|MP:0005376,homeostasis/metabolism phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005391,vision/eye phenotype|MP:0008779,abnormal maternal behavior|MP:0030930,decreased digit pigmentation
MGI:3835422	Dock8<cpm>	MP:0001800,abnormal humoral immune response|MP:0005018,decreased T cell number|MP:0008182,decreased marginal zone B cell number|MP:0008484,decreased spleen germinal center size
MGI:5563486	Dock8<m1Anu>	MP:0001806,decreased IgM level|MP:0001830,decreased activated T cell number|MP:0005018,decreased T cell number
MGI:5789558	Dock8<m1Btlr>	MP:0001805,decreased IgG level|MP:0020154,impaired humoral immune response
MGI:5563483	Dock8<m2Anu>	MP:0001806,decreased IgM level|MP:0001830,decreased activated T cell number|MP:0005018,decreased T cell number|MP:0008183,absent marginal zone B cells
MGI:6285537	Dock8<M2Btlr>	MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:6285541	Dock8<M3Btlr>	MP:0001805,decreased IgG level|MP:0020154,impaired humoral immune response
MGI:6305076	Dock8<m4Btlr>	MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0004978,decreased B-1 B cell number|MP:0005018,decreased T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:3835421	Dock8<pri>	MP:0000920,abnormal myelination|MP:0001800,abnormal humoral immune response|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004978,decreased B-1 B cell number|MP:0005018,decreased T cell number|MP:0008178,decreased germinal center B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008484,decreased spleen germinal center size|MP:0009858,abnormal cellular extravasation
MGI:5437274	Dock8<tm1Ysfk>	MP:0001805,decreased IgG level|MP:0002376,abnormal dendritic cell physiology|MP:0005095,decreased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008182,decreased marginal zone B cell number|MP:0008200,decreased follicular dendritic cell number
MGI:5804021	Dock9<em1(IMPC)J>	MP:0000062,increased bone mineral density|MP:0002590,increased mean corpuscular volume|MP:0003960,increased lean body mass|MP:0005278,abnormal cholesterol homeostasis|MP:0005344,increased circulating bilirubin level|MP:0005561,increased mean corpuscular hemoglobin|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:7330189	Dock9<tm1Thar>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005391,vision/eye phenotype
MGI:5646512	Dohh<tm1.1Sbal>	MP:0001262,decreased body weight|MP:0001654,hepatic necrosis|MP:0001656,focal hepatic necrosis|MP:0002083,premature death|MP:0004154,renal tubular necrosis|MP:0005150,cachexia|MP:0005397,hematopoietic system phenotype|MP:0010375,increased kidney iron level
MGI:5646515	Dohh<tm1.2Sbal>	MP:0000689,abnormal spleen morphology|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:3527270	Dok1<tm1Ppp>	MP:0002027,increased lung adenocarcinoma incidence|MP:0002398,abnormal bone marrow cell morphology/development|MP:0005094,abnormal T cell proliferation|MP:0011703,increased fibroblast proliferation
MGI:3527415	Dok1<tm1Yyam>	MP:0001262,decreased body weight|MP:0001806,decreased IgM level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005154,increased B cell proliferation|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005459,decreased percent body fat/body weight|MP:0005668,decreased circulating leptin level|MP:0009269,decreased fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0010182,decreased susceptibility to weight gain|MP:0014169,decreased brown adipose tissue mass|MP:0030969,increased circulating adiponectin level
MGI:3527246	Dok2<tm1Ppp>	MP:0002027,increased lung adenocarcinoma incidence|MP:0002462,abnormal granulocyte physiology|MP:0008014,increased lung tumor incidence
MGI:4829861	Dok3<tm1Brs>	MP:0005425,increased macrophage cell number
MGI:6376621	Dok3<tm1Kplm>	MP:0002459,abnormal B cell physiology|MP:0002494,increased IgM level|MP:0005154,increased B cell proliferation|MP:0008502,increased IgG3 level|MP:0014469,abnormal B cell calcium ion homeostasis|MP:0020155,enhanced humoral immune response
MGI:4443003	Dok3<tm1Ppp>	MP:0002027,increased lung adenocarcinoma incidence
MGI:6278523	Dok4<em1(IMPC)J>	MP:0010052,increased grip strength
MGI:6294072	Dok6<em1(IMPC)J>	MP:0001284,absent vibrissae
MGI:5582445	Dok7<tm1.1(KOMP)Vlcg>	MP:0000219,increased neutrophil cell number|MP:0001258,decreased body length|MP:0004738,abnormal auditory brainstem response|MP:0005016,decreased lymphocyte cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:3702943	Dok7<tm1Yyam>	MP:0001052,abnormal innervation pattern to muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002690,akinesia|MP:0011087,neonatal lethality, complete penetrance
MGI:5636724	Dok7<tm2Yyam>	MP:0000747,muscle weakness|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0002082,postnatal lethality
MGI:5605979	Dolk<em1(IMPC)J>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:5007112	Dolk<tm1Lex>	MP:0003107,abnormal response to novelty|MP:0003360,abnormal depression-related behavior|MP:0005407,hyperalgesia|MP:0011100,preweaning lethality, complete penetrance
MGI:7565622	Donson<em1Anpj>	MP:0000433,microcephaly|MP:0000547,short limbs|MP:0001265,decreased body size|MP:0008057,abnormal DNA replication
MGI:4433969	Donson<tm1a(EUCOMM)Wtsi>	MP:0009850,embryonic lethality between implantation and placentation
MGI:6402020	Dop1a<em1(IMPC)Tcp>	MP:0000627,abnormal mammary gland morphology|MP:0002060,abnormal skin morphology|MP:0002637,small uterus|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010124,decreased bone mineral content
MGI:4452820	Dop1b<tm1a(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0001510,abnormal coat appearance|MP:0002702,decreased circulating free fatty acids level|MP:0003442,decreased circulating glycerol level|MP:0003960,increased lean body mass|MP:0005565,increased blood urea nitrogen level|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content
MGI:3784999	Dot1l<Gt(RRR032)Byg>	MP:0011091,prenatal lethality, complete penetrance
MGI:5468988	Dot1l<tm1.1Saam>	MP:0000222,decreased neutrophil cell number|MP:0000333,decreased bone marrow cell number|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0002123,abnormal definitive hematopoiesis|MP:0002169,no abnormal phenotype detected|MP:0002398,abnormal bone marrow cell morphology/development|MP:0003447,decreased tumor growth/size|MP:0004810,decreased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0005460,abnormal leukopoiesis|MP:0008813,decreased common myeloid progenitor cell number|MP:0009278,abnormal bone marrow cell physiology
MGI:4459468	Dot1l<tm1.1Tche>	MP:0000274,enlarged heart|MP:0000352,decreased cell proliferation|MP:0000592,short tail|MP:0001698,decreased embryo size|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004024,aneuploidy|MP:0005621,abnormal cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis|MP:0030928,increased telomere length
MGI:5471952	Dot1l<tm1.1Wezh>	MP:0002169,no abnormal phenotype detected
MGI:5471957	Dot1l<tm1.2Wezh>	MP:0011100,preweaning lethality, complete penetrance
MGI:4362351	Dot1l<tm1a(KOMP)Wtsi>	MP:0004924,abnormal behavior
MGI:5925348	Dot1l<tm1c(KOMP)Wtsi>	MP:0001732,postnatal growth retardation|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0006433,abnormal articular cartilage morphology
MGI:5471956	Dot1l<tm1Wezh>	MP:0002169,no abnormal phenotype detected
MGI:1856846	dp	MP:0000371,diluted coat color
MGI:4461400	Dp(10Prmt2-Pdxk)2Yey	MP:0010768,mortality/aging
MGI:7398591	Dp(11)2Smun	MP:0011092,embryonic lethality, complete penetrance
MGI:6342922	Dp(11Arf2-Kansl1)9Yah	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002152,abnormal brain morphology|MP:0005386,behavior/neurological phenotype|MP:0009453,enhanced contextual conditioning behavior|MP:0009455,enhanced cued conditioning behavior|MP:0010025,decreased total body fat amount|MP:0012318,slow extinction of fear memory
MGI:3577256	Dp(11Cops3-Rnf112)1Jrl	MP:0001262,decreased body weight|MP:0001362,abnormal anxiety-related response|MP:0001399,hyperactivity|MP:0001469,abnormal contextual conditioning behavior|MP:0001489,decreased startle reflex|MP:0003631,nervous system phenotype|MP:0004924,abnormal behavior|MP:0004953,decreased spleen weight|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0005459,decreased percent body fat/body weight|MP:0009287,decreased abdominal fat pad weight|MP:0031391,increased locomotor activity
MGI:7398594	Dp(11Kcnj16-Rr325)4Smun	MP:0005306,abnormal phalanx morphology|MP:0008494,absence of all nails|MP:0012199,abnormal interphalangeal joint morphology
MGI:7398595	Dp(11Kcnj2-Rr325)5Smun	MP:0005306,abnormal phalanx morphology|MP:0008494,absence of all nails|MP:0012199,abnormal interphalangeal joint morphology
MGI:3766572	Dp(11Mpo-Chad)18Brd	MP:0001265,decreased body size|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6448073	Dp(11Pigs-Nlk)1Kkgg	MP:0011091,prenatal lethality, complete penetrance
MGI:5466681	Dp(1)21H	MP:0001262,decreased body weight|MP:0009674,decreased birth weight
MGI:5466695	Dp(1)22H	MP:0001732,postnatal growth retardation|MP:0006204,embryonic lethality before implantation|MP:0010865,prenatal growth retardation
MGI:3487283	Dp(16Cbr1-Fam3b)1Rhr	MP:0000439,enlarged cranium|MP:0000774,decreased brain size|MP:0000789,thickened cerebral cortex|MP:0000825,dilated lateral ventricle|MP:0000852,small cerebellum|MP:0001260,increased body weight|MP:0001264,increased body size|MP:0001458,abnormal object recognition memory|MP:0001473,reduced long-term potentiation|MP:0002006,neoplasm|MP:0002152,abnormal brain morphology|MP:0002176,increased brain weight|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002757,decreased vertical activity|MP:0002797,increased thigmotaxis|MP:0002875,decreased erythrocyte cell number|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0004348,long femur|MP:0004809,increased hematopoietic stem cell number|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005505,thrombocytosis|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008143,abnormal dendrite morphology|MP:0008254,increased megakaryocyte cell number|MP:0008282,enlarged hippocampus|MP:0008428,abnormal spatial working memory|MP:0011069,abnormal brain ependyma motile cilium physiology|MP:0020082,increased hippocampus volume|MP:0030050,large mandible
MGI:3702631	Dp(16Dgcr2-Arvcf)1Ais	MP:0002169,no abnormal phenotype detected
MGI:5703806	Dp(16Dyrk1a-B3galt5)5TybEmcf	MP:0005385,cardiovascular system phenotype
MGI:5519056	Dp(16Hspa13-App)2Yah	MP:0000759,abnormal skeletal muscle morphology|MP:0001405,impaired coordination|MP:0004818,increased skeletal muscle mass|MP:0005377,hearing/vestibular/ear phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0010052,increased grip strength|MP:0010954,abnormal cellular respiration|MP:0012106,impaired exercise endurance|MP:0014386,decreased muscle fiber mitochondrial DNA content
MGI:5561090	Dp(16Ifnar1-Kcnj6)10Yey	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0004157,interrupted aortic arch|MP:0006126,abnormal cardiac outflow tract development|MP:0010403,atrial septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010419,inlet ventricular septal defect|MP:0010448,heart left ventricle outflow tract stenosis|MP:0010457,pulmonary artery stenosis|MP:0010607,common atrioventricular valve
MGI:5703808	Dp(16Igsf5-Zbtb21)6TybEmcf	MP:0005385,cardiovascular system phenotype
MGI:5703812	Dp(16Lipi-Hunk)9TybEmcf	MP:0005385,cardiovascular system phenotype
MGI:5703798	Dp(16Lipi-Zbtb21)1TybEmcf	MP:0000267,abnormal heart development|MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0001891,hydrocephaly|MP:0006126,abnormal cardiac outflow tract development|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3714529	Dp(16Lipi-Zbtb21)1Yey	MP:0000266,abnormal heart morphology|MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000286,abnormal mitral valve morphology|MP:0000477,abnormal intestine morphology|MP:0001417,decreased exploration in new environment|MP:0001473,reduced long-term potentiation|MP:0001891,hydrocephaly|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002206,abnormal CNS synaptic transmission|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003387,aorta coarctation|MP:0004179,transmission ratio distortion|MP:0006261,annular pancreas|MP:0008414,abnormal spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0010403,atrial septal defect|MP:0010417,subarterial ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010449,heart right ventricle outflow tract stenosis|MP:0011092,embryonic lethality, complete penetrance|MP:0012307,impaired spatial learning|MP:0014379,decreased excitatory postsynaptic current frequency|MP:0020508,decreased dendritic spine density|MP:0020551,abnormal postsynaptic density morphology
MGI:5703804	Dp(16Mir802-Vps26c)4TybEmcf	MP:0005385,cardiovascular system phenotype
MGI:5703802	Dp(16Mir802-Zbtb21)3TybEmcf	MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5703800	Dp(16Mis18a-Runx1)2TybEmcf	MP:0005385,cardiovascular system phenotype
MGI:5561088	Dp(16Tiam1-Il10rb)8Yey	MP:0005385,cardiovascular system phenotype
MGI:5305765	Dp(16Tiam1-Kcnj6)6Yey	MP:0000266,abnormal heart morphology
MGI:4367905	Dp(17Abcg1-Cbs)1Yah	MP:0001463,abnormal spatial learning|MP:0002574,increased vertical activity|MP:0002800,abnormal short-term object recognition memory|MP:0003008,enhanced long-term potentiation|MP:0005386,behavior/neurological phenotype|MP:0008431,abnormal short-term spatial reference memory|MP:0012334,decreased circulating homocysteine level|MP:0014365,impaired short-term object recognition memory
MGI:4461399	Dp(17Abcg1-Rrp1b)3Yey	MP:0010768,mortality/aging
MGI:5451036	Dp(17Nfkbil1-Or2h1)1Cogr	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0011092,embryonic lethality, complete penetrance
MGI:3714526	Dp(4D4Mit190-D4Mit51)1Aam	MP:0000352,decreased cell proliferation|MP:0000914,exencephaly|MP:0001297,microphthalmia|MP:0002081,perinatal lethality|MP:0003051,curly tail|MP:0004046,abnormal mitosis|MP:0006281,abnormal tail development|MP:0008008,early cellular replicative senescence|MP:0012505,increased neural tube apoptosis
MGI:5490970	Dp(5Gtf2i-Gtf2ird1)1Lro	MP:0001529,abnormal vocalization
MGI:4366954	Dp(7Gm7290-Th)1Lef	MP:0002169,no abnormal phenotype detected
MGI:4359729	Dp(7Herc2-Mkrn3)1Taku	MP:0001363,increased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001454,abnormal cued conditioning behavior|MP:0001488,increased startle reflex|MP:0001898,abnormal long-term depression|MP:0001906,increased dopamine level|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002807,abnormal eye blink conditioning behavior|MP:0003121,genetic imprinting|MP:0003212,increased susceptibility to age related obesity|MP:0003459,increased fear-related response|MP:0003631,nervous system phenotype|MP:0003858,enhanced coordination|MP:0003894,abnormal Purkinje cell innervation|MP:0010070,decreased serotonin level|MP:0010540,long stride length|MP:0012575,increased noradrenaline level|MP:0020351,decreased vocalization|MP:0030761,increased adrenaline level
MGI:4462823	Dp(7Slx1b-Sept1)5Aam	MP:0000837,abnormal hypothalamus morphology|MP:0001402,decreased locomotor activity
MGI:3604472	Dpagt1<Gt(OST281303)Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:3620022	Dpagt1<tm1Jxm>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3620023	Dpagt1<tm2Jxm>	MP:0002169,no abnormal phenotype detected
MGI:4262238	Dpcd/Poll<Gt(OST280355)Lex>	MP:0000440,domed cranium|MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001850,increased susceptibility to otitis media|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002236,abnormal internal nares morphology|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002766,situs inversus|MP:0005578,teratozoospermia|MP:0009239,short sperm flagellum|MP:0010752,impaired mucociliary clearance|MP:0010769,abnormal survival
MGI:2389068	Dpep1<tm1Mwl>	MP:0002169,no abnormal phenotype detected
MGI:6488126	Dpep3<em1Qsh>	MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype
MGI:5614559	Dpf1<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0003960,increased lean body mass|MP:0010053,decreased grip strength
MGI:5435603	Dpf2<tm1.2Grc>	MP:0002169,no abnormal phenotype detected
MGI:5609343	Dpf2<tm1b(EUCOMM)Hmgu>	MP:0000266,abnormal heart morphology|MP:0000428,abnormal craniofacial morphology|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0002059,abnormal seminal vesicle morphology|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0002135,abnormal kidney morphology|MP:0003717,pallor|MP:0011100,preweaning lethality, complete penetrance
MGI:6362057	Dpf3<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0001402,decreased locomotor activity|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:5440860	Dpf3<tm1.1Grc>	MP:0002169,no abnormal phenotype detected
MGI:5648733	Dph1<tm1.1Cmch>	MP:0000088,short mandible|MP:0000111,cleft palate|MP:0000460,mandible hypoplasia|MP:0001785,edema|MP:0003717,pallor|MP:0004201,fetal growth retardation|MP:0004471,short nasal bone|MP:0004476,absent palatine bone|MP:0005352,small cranium|MP:0005382,craniofacial phenotype|MP:0009888,palatal shelves fail to meet at midline|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011862,decreased cranium length|MP:0013933,short Meckel's cartilage|MP:0030072,round face|MP:0031443,abnormal tongue position
MGI:3033421	Dph1<tm1Bhr>	MP:0000111,cleft palate|MP:0001176,abnormal lung development|MP:0001953,respiratory failure|MP:0002020,increased tumor incidence|MP:0002113,abnormal skeleton development|MP:0002116,abnormal craniofacial bone morphology|MP:0002151,abnormal neural tube morphology|MP:0002192,hydrops fetalis|MP:0003077,abnormal cell cycle|MP:0003984,embryonic growth retardation|MP:0005621,abnormal cell physiology|MP:0008944,decreased sensitivity to induced cell death|MP:0009395,increased nucleated erythrocyte cell number|MP:0009431,decreased fetal weight|MP:0009743,preaxial polydactyly|MP:0010819,primary atelectasis|MP:0011087,neonatal lethality, complete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011143,thick lung-associated mesenchyme|MP:0011704,decreased fibroblast proliferation
MGI:3033425	Dph1<tm2Bhr>	MP:0000111,cleft palate|MP:0001176,abnormal lung development|MP:0001265,decreased body size|MP:0001324,abnormal eye pigmentation|MP:0001688,abnormal somite development|MP:0001700,abnormal embryo turning|MP:0001953,respiratory failure|MP:0002020,increased tumor incidence|MP:0002092,abnormal eye morphology|MP:0002113,abnormal skeleton development|MP:0002116,abnormal craniofacial bone morphology|MP:0002151,abnormal neural tube morphology|MP:0002192,hydrops fetalis|MP:0002639,micrognathia|MP:0003077,abnormal cell cycle|MP:0003103,liver degeneration|MP:0003984,embryonic growth retardation|MP:0004476,absent palatine bone|MP:0005352,small cranium|MP:0009395,increased nucleated erythrocyte cell number|MP:0009431,decreased fetal weight|MP:0009743,preaxial polydactyly|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0010819,primary atelectasis|MP:0011083,lethality at weaning, complete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011143,thick lung-associated mesenchyme|MP:0012240,abnormal hepatoblast morphology|MP:0013933,short Meckel's cartilage|MP:0031443,abnormal tongue position|MP:0031462,decreased palatal shelf size
MGI:4840638	Dph2<tm2(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:3629060	Dph3<tm1Lepp>	MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0002151,abnormal neural tube morphology|MP:0003984,embryonic growth retardation|MP:0004188,delayed embryo turning|MP:0004259,small placenta|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012505,increased neural tube apoptosis|MP:0012509,neural tube degeneration
MGI:4880925	Dph6<tm1a(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0001258,decreased body length|MP:0002075,abnormal coat/hair pigmentation|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003036,vertebral transformation|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008040,decreased NK T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008097,increased plasma cell number|MP:0008126,increased dendritic cell number|MP:0008181,increased marginal zone B cell number|MP:0008211,decreased mature B cell number|MP:0008346,increased gamma-delta T cell number|MP:0008524,increased plasmacytoid dendritic cell number|MP:0010067,increased red blood cell distribution width|MP:0010092,increased circulating magnesium level|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010835,increased CD4-positive, alpha-beta memory T cell number|MP:0010851,decreased effector memory CD8-positive, alpha-beta T cell number|MP:0013418,increased memory-marker gamma-delta T cell number|MP:0013421,increased CD5-positive gamma-delta T cell number|MP:0013430,increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0013433,increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0013514,increased memory-marker CD4-negative NK T cell number|MP:0013651,increased CD11b-low dendritic cell number|MP:0013675,decreased Ly6C-positive mature NK cell number|MP:0013764,decreased T-helper cell number|MP:0013772,increased effector memory T-helper cell number|MP:0013775,increased KLRG1-positive T-helper cell number
MGI:5466675	Dp(In4)20H	MP:0000438,abnormal cranium morphology|MP:0005409,darkened coat color|MP:0008489,slow postnatal weight gain|MP:0008527,embryonic lethality at implantation|MP:0009674,decreased birth weight|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011568,decreased foot pigmentation
MGI:5636953	Dpm1<tm1b(KOMP)Wtsi>	MP:0001711,abnormal placenta morphology|MP:0002836,abnormal chorion morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0009397,increased trophoblast giant cell number|MP:0010052,increased grip strength|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5692609	Dpm2<tm1b(EUCOMM)Hmgu>	MP:0000274,enlarged heart|MP:0005293,impaired glucose tolerance|MP:0005568,increased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance
MGI:5548565	Dpm3<tm1.1(KOMP)Vlcg>	MP:0001325,abnormal retina morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2681146	Dpml<BALB/cJ>	MP:0001905,abnormal dopamine level
MGI:5697177	Dpmy	MP:0000745,tremors|MP:0000921,demyelination|MP:0001505,hunched posture|MP:0001921,reduced fertility|MP:0002269,muscular atrophy|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6470392	Dpp3<tm1b(EUCOMM)Hmgu>	MP:0008259,abnormal optic disk morphology
MGI:6469644	Dpp3<tm1d(EUCOMM)Hmgu>	MP:0000321,increased bone marrow cell number|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0004686,decreased length of long bones|MP:0004984,increased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0004992,increased bone resorption|MP:0005389,reproductive system phenotype|MP:0006043,decreased apoptosis|MP:0008559,abnormal interferon-gamma secretion|MP:0008560,increased tumor necrosis factor secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008660,increased interleukin-10 secretion|MP:0008705,increased interleukin-6 secretion|MP:0009346,decreased trabecular bone thickness|MP:0010768,mortality/aging|MP:0010876,decreased bone volume|MP:0010926,increased osteoid volume|MP:0010929,increased osteoid thickness|MP:0013630,increased bone trabecular spacing|MP:0020040,decreased bone ossification
MGI:6400423	Dpp4<em1Rba>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0001182,lung hemorrhage|MP:0001861,lung inflammation|MP:0001954,respiratory distress|MP:0005016,decreased lymphocyte cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0010180,increased susceptibility to weight loss|MP:0010894,pulmonary alveolar edema|MP:0012041,increased susceptibility to pulmonary hyaline membrane formation|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031047,decreased susceptibility to Coronaviridae infection induced morbidity/mortality|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:7298193	Dpp4<em3Gpt>	MP:0005387,immune system phenotype
MGI:6400999	Dpp4<tm1.1(DPP4)Pbmj>	MP:0001861,lung inflammation|MP:0003070,increased vascular permeability|MP:0003828,pulmonary edema|MP:0011018,pulmonary hyaline membrane formation|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:5694187	Dpp4<tm1b(EUCOMM)Wtsi>	MP:0004738,abnormal auditory brainstem response|MP:0005016,decreased lymphocyte cell number|MP:0005292,improved glucose tolerance
MGI:5788094	Dpp4<tm1(DPP4)Vlcg>	MP:0000219,increased neutrophil cell number|MP:0001179,thick pulmonary interalveolar septum|MP:0001861,lung inflammation|MP:0001862,interstitial pneumonia|MP:0003828,pulmonary edema|MP:0005425,increased macrophage cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010858,pulmonary epithelial necrosis|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031053,pleuritis
MGI:5487468	Dpp4<tm1Lex>	MP:0005292,improved glucose tolerance
MGI:2150161	Dpp4<tm1Nwa>	MP:0001262,decreased body weight|MP:0002079,increased circulating insulin level|MP:0002712,increased circulating glucagon level|MP:0003058,increased insulin secretion|MP:0005292,improved glucose tolerance
MGI:5302080	Dpp6<tm1.1Dahn>	MP:0002207,abnormal long-term potentiation|MP:0003412,abnormal afterhyperpolarization|MP:0003484,abnormal channel response|MP:0003635,abnormal synaptic transmission
MGI:6284363	Dpp8<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0002590,increased mean corpuscular volume|MP:0002757,decreased vertical activity|MP:0002797,increased thigmotaxis|MP:0002834,decreased heart weight|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005293,impaired glucose tolerance|MP:0005333,decreased heart rate|MP:0005561,increased mean corpuscular hemoglobin|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010506,prolonged RR interval
MGI:7431364	Dpp9<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000745,tremors|MP:0001404,no spontaneous movement|MP:0003961,decreased lean body mass
MGI:5574450	Dpp9<tm1.1Mdg>	MP:0005376,homeostasis/metabolism phenotype|MP:0010768,mortality/aging|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:6157525	Dpp9<tm1.1Npa>	MP:0001262,decreased body weight|MP:0001436,abnormal suckling behavior|MP:0004136,abnormal tongue muscle morphology|MP:0005382,craniofacial phenotype|MP:0009546,absent gastric milk in neonates|MP:0009907,decreased tongue size|MP:0011087,neonatal lethality, complete penetrance
MGI:4435737	Dpp9<tm1a(EUCOMM)Hmgu>	MP:0000198,decreased circulating phosphate level|MP:0002644,decreased circulating triglyceride level|MP:0002968,increased circulating alkaline phosphatase level
MGI:5548821	Dpp9<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001363,increased anxiety-related response|MP:0002797,increased thigmotaxis|MP:0004924,abnormal behavior|MP:0008810,increased circulating iron level|MP:0011100,preweaning lethality, complete penetrance
MGI:4362687	Dppa1<tm1a(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0003960,increased lean body mass|MP:0010378,increased respiratory quotient|MP:0011939,increased food intake
MGI:5574608	Dppa1<tm1b(KOMP)Wtsi>	MP:0000288,abnormal pericardium morphology|MP:0000689,abnormal spleen morphology|MP:0001700,abnormal embryo turning|MP:0002590,increased mean corpuscular volume|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration|MP:0013292,embryonic lethality prior to organogenesis
MGI:6842976	Dppa2<tm1.1Reik>	MP:0003718,maternal effect
MGI:6845043	Dppa2<tm1.2Reik>	MP:0011100,preweaning lethality, complete penetrance
MGI:3057184	Dppa3<tm1Dcp>	MP:0001923,reduced female fertility
MGI:2683709	Dppa3<tm1Masu>	MP:0001926,female infertility|MP:0003718,maternal effect|MP:0005389,reproductive system phenotype
MGI:5448272	Dppa3<tm1(rtTA)Nkn>	MP:0003406,failure of zygotic cell division|MP:0008877,abnormal DNA methylation
MGI:3848331	Dppa4<tm1.1Hjf>	MP:0000150,abnormal rib morphology|MP:0001175,abnormal lung morphology|MP:0001177,atelectasis|MP:0001923,reduced female fertility|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003718,maternal effect|MP:0004200,decreased fetal size|MP:0004678,split xiphoid process|MP:0008146,asymmetric sternocostal joints|MP:0008277,abnormal sternum ossification|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:6842978	Dppa4<tm1.1Reik>	MP:0003718,maternal effect
MGI:6845044	Dppa4<tm1.2Reik>	MP:0003718,maternal effect|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3625479	Dppa5a<tm1Yam>	MP:0002169,no abnormal phenotype detected
MGI:2387341	Dpt<tm1Hsh>	MP:0001191,abnormal skin condition|MP:0001244,thin dermal layer|MP:0003092,decreased cornea stroma thickness|MP:0003094,abnormal cornea posterior stroma morphology|MP:0005275,abnormal skin tensile strength|MP:0005300,abnormal cornea stroma morphology|MP:0005391,vision/eye phenotype|MP:0005421,loose skin|MP:0005543,decreased cornea thickness|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0010024,increased total body fat amount
MGI:3852180	Dp(XTceal3-Plp1)1Gmh	MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001961,abnormal reflex|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0005405,axon degeneration|MP:0008025,brain vacuoles|MP:0008503,abnormal spinal cord grey matter morphology|MP:0009679,abnormal spinal cord ventral column morphology|MP:0011731,decreased myelin sheath thickness
MGI:6152469	Dpy19l1<em1(IMPC)Mbp>	MP:0001157,small seminal vesicle|MP:0001404,no spontaneous movement|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002059,abnormal seminal vesicle morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5007114	Dpy19l2<tm1Lex>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002686,globozoospermia|MP:0004543,abnormal sperm physiology|MP:0004852,decreased testis weight|MP:0006362,abnormal male germ cell morphology|MP:0008898,abnormal acrosome morphology|MP:0009231,detached acrosome|MP:0009238,coiled sperm flagellum|MP:0009376,abnormal manchette morphology|MP:0009377,ectopic manchette|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009833,absent sperm mitochondrial sheath|MP:0009836,abnormal sperm principal piece morphology|MP:0009839,multiflagellated sperm|MP:0031372,abnormal sperm individualization|MP:0031386,elongated manchette
MGI:4433660	Dpy19l3<tm1a(EUCOMM)Wtsi>	MP:0000208,decreased hematocrit|MP:0002702,decreased circulating free fatty acids level|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number
MGI:7466927	Dpy19l4<em1(IMPC)J>	MP:0000218,increased leukocyte cell number
MGI:4887610	Dpy30<tm1a(KOMP)Wtsi>	MP:0001693,failure of primitive streak formation|MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0003886,abnormal embryonic epiblast morphology|MP:0003984,embryonic growth retardation|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005633,increased circulating sodium level|MP:0009266,abnormal mesendoderm development|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:5513767	Dpyd<tm1b(KOMP)Wtsi>	MP:0000470,abnormal stomach morphology|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0002631,abnormal epididymis morphology
MGI:5312892	Dpysl2<tm1.1Gosh>	MP:0003631,nervous system phenotype|MP:0008143,abnormal dendrite morphology
MGI:5255169	Dpysl3<Gt(IST14728H3)Tigm>	MP:0003631,nervous system phenotype|MP:0003651,abnormal axon extension|MP:0004768,abnormal axonal transport|MP:0009937,abnormal neuron differentiation
MGI:5751828	Dpysl3<tm1Gosh>	MP:0008143,abnormal dendrite morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0009970,increased hippocampus pyramidal cell number|MP:0012458,decreased hippocampus pyramidal cell length
MGI:3790672	Dpysl4<tm1Ttq>	MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0009940,abnormal hippocampus pyramidal cell morphology
MGI:4941238	Dpysl5<tm1Gosh>	MP:0001513,limb grasping|MP:0001899,absent long-term depression|MP:0004811,abnormal neuron physiology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0014327,decreased Purkinje cell size
MGI:7580968	Dqx1<em1(IMPC)Tcp>	MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011874,enlarged urinary bladder
MGI:5692708	Dram1<tm1.1(KOMP)Vlcg>	MP:0000598,abnormal liver morphology|MP:0001175,abnormal lung morphology|MP:0010052,increased grip strength
MGI:7564405	Dram2<em1Jean>	MP:0005165,increased susceptibility to injury|MP:0005253,abnormal eye physiology|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0011965,decreased total retina thickness
MGI:5708205	Dram2<tm1b(EUCOMM)Wtsi>	MP:0002075,abnormal coat/hair pigmentation
MGI:2667159	Drap1<tm1Mms>	MP:0001680,abnormal mesoderm development|MP:0001695,abnormal gastrulation|MP:0002174,abnormal gastrulation movements|MP:0002230,abnormal primitive streak formation|MP:0009266,abnormal mesendoderm development|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012184,absent paraxial mesoderm|MP:0012274,increased axial mesoderm size
MGI:3833678	Draxin<tm1Htnk>	MP:0000781,decreased corpus callosum size|MP:0002196,absent corpus callosum|MP:0004100,abnormal spinal cord interneuron morphology|MP:0008222,decreased hippocampal commissure size|MP:0008223,absent hippocampal commissure|MP:0008226,decreased anterior commissure size|MP:0008227,absent anterior commissure
MGI:5006993	Draxin<tm1Lex>	MP:0002727,decreased circulating insulin level
MGI:5438062	Drc1<b2b1654Clo>	MP:0000644,dextrocardia|MP:0000690,absent spleen|MP:0002639,micrognathia|MP:0003178,left pulmonary isomerism|MP:0004113,abnormal aortic arch morphology|MP:0004133,heterotaxia|MP:0004157,interrupted aortic arch|MP:0006063,abnormal inferior vena cava morphology|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010439,abnormal hepatic vein morphology|MP:0011249,abdominal situs inversus|MP:0011250,abdominal situs ambiguus|MP:0011252,situs inversus totalis|MP:0011253,situs inversus with levocardia|MP:0011569,abnormal azygos vein morphology|MP:0011659,interrupted aortic arch, type b|MP:0011683,dual inferior vena cava|MP:0031515,l-loop transposition of the great arteries
MGI:5552738	Drc1<b2b2237Clo>	MP:0000644,dextrocardia|MP:0011249,abdominal situs inversus|MP:0011252,situs inversus totalis
MGI:6361227	Drc1<em1(IMPC)Bay>	MP:0001925,male infertility
MGI:7294418	Drc1<em1Mngx>	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0002687,oligozoospermia|MP:0005378,growth/size/body region phenotype|MP:0008545,absent sperm flagellum|MP:0008770,decreased survivor rate|MP:0009239,short sperm flagellum|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance
MGI:7294419	Drc1<em2Mngx>	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0005378,growth/size/body region phenotype|MP:0008545,absent sperm flagellum|MP:0008770,decreased survivor rate|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009241,thick sperm flagellum|MP:0009376,abnormal manchette morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020869,immotile sperm|MP:0031438,abnormal sperm radial spoke morphology
MGI:7294420	Drc1<em3Mngx>	MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0005378,growth/size/body region phenotype|MP:0008545,absent sperm flagellum|MP:0008770,decreased survivor rate|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009241,thick sperm flagellum|MP:0009376,abnormal manchette morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020869,immotile sperm|MP:0031438,abnormal sperm radial spoke morphology
MGI:5784926	Drc7<em1(IMPC)J>	MP:0001925,male infertility|MP:0002075,abnormal coat/hair pigmentation|MP:0002968,increased circulating alkaline phosphatase level|MP:0004122,abnormal sinus arrhythmia|MP:0010053,decreased grip strength
MGI:6488166	Drc7<tm1.1Osb>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005384,cellular phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009239,short sperm flagellum|MP:0009376,abnormal manchette morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0014636,decreased elongated spermatid number|MP:0020869,immotile sperm
MGI:5427817	Drd1<tm1.1(IL2RA/Venus)Koba>	MP:0002803,abnormal operant conditioning behavior|MP:0002882,abnormal neuron morphology|MP:0005386,behavior/neurological phenotype
MGI:5617500	Drd1<tm1.1Mmsh>	MP:0005386,behavior/neurological phenotype|MP:0009456,impaired cued conditioning behavior
MGI:3527153	Drd1<tm1(cre)Rpa>	MP:0001265,decreased body size|MP:0004924,abnormal behavior
MGI:1857158	Drd1<tm1Jcd>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001488,increased startle reflex|MP:0001505,hunched posture|MP:0001511,disheveled coat|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002090,abnormal vision|MP:0002573,behavioral despair|MP:0002757,decreased vertical activity|MP:0002797,increased thigmotaxis|MP:0002799,abnormal passive avoidance behavior|MP:0003246,loss of GABAergic neurons|MP:0005551,abnormal eye electrophysiology|MP:0006009,abnormal neuronal migration|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0010167,decreased response to stress-induced hyperthermia|MP:0020340,abnormal inhibitory learning
MGI:2159306	Drd1<tm1Stl>	MP:0000774,decreased brain size|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009747,impaired behavioral response to xenobiotic|MP:0009758,impaired behavioral response to cocaine|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012468,decreased striatum size
MGI:3829942	Drd1<tm1Tono>	MP:0004859,abnormal synaptic plasticity
MGI:5603761	Drd1<tm2.1Stl>	MP:0002169,no abnormal phenotype detected|MP:0003460,decreased fear-related response|MP:0009454,impaired contextual conditioning behavior
MGI:5603922	Drd1<tm2.2Stl>	MP:0011100,preweaning lethality, complete penetrance
MGI:3707260	Drd1<tm2Jcd>	MP:0000243,myoclonus|MP:0000774,decreased brain size|MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0001262,decreased body weight|MP:0001504,abnormal posture|MP:0001512,trunk curl|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0002064,seizures|MP:0002169,no abnormal phenotype detected|MP:0002175,decreased brain weight|MP:0002183,gliosis|MP:0002574,increased vertical activity|MP:0003354,astrocytosis|MP:0003632,abnormal nervous system morphology|MP:0003633,abnormal nervous system physiology|MP:0003691,abnormal microglial cell physiology|MP:0004077,abnormal striatum morphology|MP:0005156,bradykinesia|MP:0005323,dystonia|MP:0005574,decreased pulmonary respiratory rate|MP:0008535,enlarged lateral ventricles|MP:0011085,postnatal lethality, complete penetrance|MP:0012138,decreased forebrain size|MP:0012468,decreased striatum size|MP:0012559,decreased forebrain volume|MP:0014620,abnormal interictal brain wave pattern|MP:0020083,decreased hippocampus volume|MP:0030986,striatum atrophy|MP:0031391,increased locomotor activity
MGI:3527157	Drd1<tm2Rpa>	MP:0009712,impaired conditioned place preference behavior|MP:0009758,impaired behavioral response to cocaine
MGI:5570458	Drd2<m1Anu>	MP:0002169,no abnormal phenotype detected
MGI:5617501	Drd2<tm1.1Mmsh>	MP:0005386,behavior/neurological phenotype
MGI:5292350	Drd2<tm1.1Mrub>	MP:0001399,hyperactivity|MP:0001732,postnatal growth retardation|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002803,abnormal operant conditioning behavior|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003463,abnormal single cell response|MP:0003953,abnormal hormone level|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005124,increased circulating prolactin level|MP:0005136,decreased growth hormone level|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0008329,decreased somatotroph cell number|MP:0008489,slow postnatal weight gain|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008911,induced hyperactivity|MP:0009754,enhanced behavioral response to cocaine|MP:0010149,abnormal synaptic dopamine release|MP:0011532,decreased urine major urinary protein level
MGI:2387895	Drd2<tm1Ebo>	MP:0000635,pituitary gland hyperplasia|MP:0000636,enlarged pituitary gland|MP:0000646,enlarged adrenocortical cells|MP:0001127,small ovary|MP:0001147,small testis|MP:0001188,hyperpigmentation|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001506,limp posture|MP:0001744,hypersecretion of corticosterone|MP:0001745,increased circulating corticosterone level|MP:0001748,increased circulating adrenocorticotropin level|MP:0001921,reduced fertility|MP:0001923,reduced female fertility|MP:0001927,abnormal estrous cycle|MP:0002041,increased pituitary adenoma incidence|MP:0002690,akinesia|MP:0002757,decreased vertical activity|MP:0002822,catalepsy|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003371,decreased circulating estrogen level|MP:0004811,abnormal neuron physiology|MP:0004924,abnormal behavior|MP:0005117,increased circulating pituitary hormone level|MP:0005120,decreased circulating growth hormone level|MP:0005124,increased circulating prolactin level|MP:0005156,bradykinesia|MP:0005386,behavior/neurological phenotype|MP:0005534,decreased body temperature|MP:0005646,abnormal pituitary gland physiology|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0008294,abnormal adrenal gland zona fasciculata morphology|MP:0008295,abnormal adrenal gland zona reticularis morphology|MP:0008299,adrenal cortical hyperplasia|MP:0008324,abnormal melanotroph morphology|MP:0008329,decreased somatotroph cell number|MP:0008331,increased lactotroph cell number|MP:0008337,increased thyrotroph cell number|MP:0008371,pituitary intermediate lobe hyperplasia|MP:0008423,decreased lactotroph cell size|MP:0009011,prolonged diestrus|MP:0009016,abnormal estrus|MP:0009712,impaired conditioned place preference behavior|MP:0011940,decreased food intake|MP:0011942,decreased fluid intake|MP:0013348,adenohypophysis hyperplasia
MGI:2679435	Drd2<tm1(IL2RA)Koba>	MP:0001396,unidirectional circling|MP:0003313,abnormal locomotor activation|MP:0011448,decreased dopaminergic neuron number
MGI:1857875	Drd2<tm1Low>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000633,abnormal pituitary gland morphology|MP:0000636,enlarged pituitary gland|MP:0000913,abnormal brain development|MP:0001258,decreased body length|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001392,abnormal locomotor behavior|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001489,decreased startle reflex|MP:0001529,abnormal vocalization|MP:0001732,postnatal growth retardation|MP:0001762,polyuria|MP:0001899,absent long-term depression|MP:0002206,abnormal CNS synaptic transmission|MP:0002570,alcohol aversion|MP:0002626,increased heart rate|MP:0002676,uterus hyperplasia|MP:0002757,decreased vertical activity|MP:0002803,abnormal operant conditioning behavior|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003088,abnormal prepulse inhibition|MP:0003109,short femur|MP:0003245,abnormal GABAergic neuron morphology|MP:0003313,abnormal locomotor activation|MP:0003354,astrocytosis|MP:0003402,decreased liver weight|MP:0003462,abnormal response to novel odor|MP:0003546,decreased alcohol consumption|MP:0003631,nervous system phenotype|MP:0004163,abnormal adenohypophysis morphology|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004875,increased mean systemic arterial blood pressure|MP:0004953,decreased spleen weight|MP:0005120,decreased circulating growth hormone level|MP:0005124,increased circulating prolactin level|MP:0005137,increased growth hormone level|MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype|MP:0005573,increased pulmonary respiratory rate|MP:0005575,increased pulmonary ventilation|MP:0005576,decreased pulmonary ventilation|MP:0005585,increased tidal volume|MP:0006009,abnormal neuronal migration|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0006299,abnormal latent inhibition of conditioning behavior|MP:0006316,increased urine sodium level|MP:0008331,increased lactotroph cell number|MP:0008335,decreased gonadotroph cell number|MP:0008657,increased interleukin-1 beta secretion|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008916,abnormal astrocyte physiology|MP:0008918,microgliosis|MP:0008939,increased pituitary gland weight|MP:0009082,uterus cyst|MP:0009089,short uterine horn|MP:0009221,uterus adenomyosis|MP:0009293,decreased inguinal fat pad weight|MP:0009750,impaired behavioral response to addictive substance|MP:0009755,impaired behavioral response to alcohol|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0010167,decreased response to stress-induced hyperthermia|MP:0011451,increased susceptibility to dopaminergic neuron neurotoxicity|MP:0011939,increased food intake|MP:0013334,adenohypophysis peliosis|MP:0013348,adenohypophysis hyperplasia|MP:0013355,adenohypophysis hypertrophy
MGI:3576789	Drd2<tm1Mok>	MP:0003463,abnormal single cell response|MP:0003973,increased pituitary hormone level|MP:0005409,darkened coat color|MP:0005418,abnormal circulating hormone level|MP:0008370,enlarged pituitary intermediate lobe
MGI:2388386	Drd2<tm1Schm>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001392,abnormal locomotor behavior|MP:0001505,hunched posture|MP:0001666,abnormal intestinal absorption|MP:0001905,abnormal dopamine level|MP:0002083,premature death|MP:0003867,increased defecation amount|MP:0005156,bradykinesia|MP:0006001,abnormal intestinal transit time|MP:0006003,abnormal large intestinal transit time|MP:0011939,increased food intake|MP:0011941,increased fluid intake
MGI:5499882	Drd2<tm1Smoc>	MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0008916,abnormal astrocyte physiology
MGI:2656648	Drd2<tm1Yyw>	MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002757,decreased vertical activity|MP:0003862,decreased aggression towards male mice|MP:0005156,bradykinesia|MP:0009745,abnormal behavioral response to xenobiotic|MP:0009747,impaired behavioral response to xenobiotic
MGI:2675755	Drd2<tm2Ebo>	MP:0005386,behavior/neurological phenotype|MP:0009746,enhanced behavioral response to xenobiotic|MP:0009747,impaired behavioral response to xenobiotic
MGI:5431831	Drd2<tm3.1Ebo>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001905,abnormal dopamine level|MP:0001906,increased dopamine level|MP:0002272,abnormal nervous system electrophysiology|MP:0002574,increased vertical activity|MP:0003631,nervous system phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008911,induced hyperactivity|MP:0009746,enhanced behavioral response to xenobiotic|MP:0009754,enhanced behavioral response to cocaine|MP:0009758,impaired behavioral response to cocaine|MP:0009778,impaired behavioral response to anesthetic|MP:0009779,enhanced behavioral response to anesthetic
MGI:6293855	Drd3<em1(IMPC)Mbp>	MP:0000692,small spleen
MGI:1857159	Drd3<tm1Dac>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001410,head bobbing|MP:0001415,increased exploration in new environment|MP:0001442,decreased grooming behavior|MP:0001489,decreased startle reflex|MP:0001516,abnormal motor coordination/balance|MP:0001961,abnormal reflex|MP:0002574,increased vertical activity|MP:0003313,abnormal locomotor activation|MP:0003546,decreased alcohol consumption|MP:0005582,increased renin activity|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006317,decreased urine sodium level|MP:0008872,abnormal physiological response to xenobiotic|MP:0009712,impaired conditioned place preference behavior|MP:0009748,abnormal behavioral response to addictive substance|MP:0009751,enhanced behavioral response to alcohol|MP:0009757,impaired behavioral response to morphine|MP:0009775,increased behavioral withdrawal response|MP:0011432,decreased urine flow rate|MP:0031391,increased locomotor activity
MGI:3698033	Drd3<tm1Rmw>	MP:0001409,increased stereotypic behavior|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005643,decreased dopamine level
MGI:3044114	Drd3<tm1Stl>	MP:0000676,abnormal body water content|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001454,abnormal cued conditioning behavior|MP:0005449,abnormal food intake|MP:0005455,increased susceptibility to weight gain|MP:0005458,increased percent body fat/body weight|MP:0005669,increased circulating leptin level|MP:0010024,increased total body fat amount
MGI:2178631	Drd4<tm1Dkg>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001906,increased dopamine level|MP:0002090,abnormal vision|MP:0002629,hyperactivity elicited by ethanol administration|MP:0002757,decreased vertical activity|MP:0003631,nervous system phenotype|MP:0003858,enhanced coordination|MP:0005386,behavior/neurological phenotype|MP:0005551,abnormal eye electrophysiology|MP:0009750,impaired behavioral response to addictive substance|MP:0009754,enhanced behavioral response to cocaine
MGI:3575692	Drd4<tm1(IL2RA)Tao>	MP:0003463,abnormal single cell response
MGI:5603762	Drd5<tm1.1Stl>	MP:0002169,no abnormal phenotype detected|MP:0005386,behavior/neurological phenotype
MGI:5603923	Drd5<tm1.2Stl>	MP:0011100,preweaning lethality, complete penetrance
MGI:3604549	Drd5<tm1Dgen>	MP:0002169,no abnormal phenotype detected|MP:0005391,vision/eye phenotype
MGI:5569103	Drd5<tm1Shay>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0031303,enhanced behavioral response to methamphetamine
MGI:3528074	Drd5<tm1Sib>	MP:0000231,hypertension|MP:0002136,abnormal kidney physiology|MP:0002833,increased heart weight|MP:0002842,increased systemic arterial blood pressure|MP:0002909,abnormal adrenal gland physiology|MP:0004183,abnormal sympathetic nervous system physiology|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure
MGI:7256883	Drg1<em1(IMPC)Tcp>	MP:0000613,abnormal salivary gland morphology|MP:0002060,abnormal skin morphology|MP:0010067,increased red blood cell distribution width|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4432942	Drg2<tm1a(EUCOMM)Wtsi>	MP:0000198,decreased circulating phosphate level|MP:0001262,decreased body weight|MP:0003313,abnormal locomotor activation|MP:0004357,long tibia
MGI:6444651	Drg2<tm1Jgwp>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001363,increased anxiety-related response|MP:0001405,impaired coordination|MP:0001516,abnormal motor coordination/balance|MP:0004686,decreased length of long bones|MP:0005386,behavior/neurological phenotype|MP:0008770,decreased survivor rate|MP:0010149,abnormal synaptic dopamine release|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization
MGI:6276984	Drgx<em1(IMPC)Mbp>	MP:0000538,abnormal urinary bladder morphology|MP:0000598,abnormal liver morphology|MP:0000639,abnormal adrenal gland morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001711,abnormal placenta morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0005292,improved glucose tolerance|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2182636	Drgx<tm1And>	MP:0000965,abnormal sensory neuron morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001262,decreased body weight|MP:0001441,increased grooming behavior|MP:0001973,increased thermal nociceptive threshold|MP:0002083,premature death|MP:0002085,abnormal embryonic tissue morphology|MP:0005386,behavior/neurological phenotype|MP:0005498,hyporesponsive to tactile stimuli|MP:0008531,increased chemical nociceptive threshold|MP:0011085,postnatal lethality, complete penetrance
MGI:3837198	Drinkcacl21<PWK/PhJ>	MP:0001423,abnormal liquid preference
MGI:3838583	Drinkcacl22<PWK/PhJ>	MP:0001423,abnormal liquid preference
MGI:3838593	Drinkcacl23<PWK/PhJ>	MP:0001423,abnormal liquid preference
MGI:3837188	Drinkcacl24<PWK/PhJ>	MP:0001423,abnormal liquid preference|MP:0011941,increased fluid intake
MGI:3838576	Drinkcacl25<C57BL/6J>	MP:0001423,abnormal liquid preference
MGI:3837200	Drinkcala1<PWK/PhJ>	MP:0001423,abnormal liquid preference
MGI:3838585	Drinkcala2<PWK/PhJ>	MP:0001423,abnormal liquid preference
MGI:3837191	Drinkcala3<C57BL/6J>	MP:0001423,abnormal liquid preference|MP:0011941,increased fluid intake
MGI:3837321	Drinkkcl1<C57BL/6J>	MP:0011941,increased fluid intake
MGI:3838555	Drinkkcl2<C57BL/6J>	MP:0011941,increased fluid intake
MGI:3837331	Drinkkcl3<C57BL/6J>	MP:0001423,abnormal liquid preference
MGI:3837195	Drinkkcl4<C57BL/6J>	MP:0011941,increased fluid intake
MGI:3838580	Drinkkcl5<C57BL/6J>	MP:0001423,abnormal liquid preference
MGI:3837312	Drinkmgcl21<PWK/PhJ>	MP:0001423,abnormal liquid preference|MP:0011941,increased fluid intake
MGI:3838587	Drinkmgcl22<PWK/PhJ>	MP:0001423,abnormal liquid preference
MGI:3837193	Drinkmgcl23<C57BL/6J>	MP:0011941,increased fluid intake
MGI:3837189	Drinkmgcl24<PWK/PhJ>	MP:0001423,abnormal liquid preference
MGI:3838595	Drinkmgcl25<PWK/PhJ>	MP:0001423,abnormal liquid preference
MGI:3838574	Drinknacl1<C57BL/6J>	MP:0001423,abnormal liquid preference
MGI:3837336	Drinknacl2<C57BL/6J>	MP:0001423,abnormal liquid preference|MP:0011941,increased fluid intake
MGI:3837325	Drinknh4cl1<C57BL/6J>	MP:0011941,increased fluid intake
MGI:3838572	Drinknh4cl2<C57BL/6J>	MP:0001423,abnormal liquid preference
MGI:3837318	Drinkqhcl1<C57BL/6J>	MP:0011941,increased fluid intake
MGI:3838588	Drinkqhcl2<C57BL/6J>	MP:0001423,abnormal liquid preference
MGI:3837313	Drinksac1<C57BL/6J>	MP:0001423,abnormal liquid preference|MP:0011941,increased fluid intake
MGI:3838591	Drinksac2<PWK/PhJ>	MP:0001423,abnormal liquid preference
MGI:3837333	Drinksac3<C57BL/6J>	MP:0011941,increased fluid intake
MGI:3838579	Drinksac4<PWK/PhJ>	MP:0001423,abnormal liquid preference
MGI:3837185	Drinksac5<C57BL/6J>	MP:0011941,increased fluid intake
MGI:3837316	Drinkwater1<C57BL/6J>	MP:0011941,increased fluid intake
MGI:5544789	Drosha<tm1.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:5431545	Drosha<tm1Ghan>	MP:0001265,decreased body size|MP:0009759,abnormal hair follicle bulge morphology
MGI:3801076	Drosha<tm1Litt>	MP:0000367,abnormal coat/ hair morphology|MP:0000377,abnormal hair follicle morphology|MP:0000380,small hair follicles|MP:0000410,waved hair|MP:0000414,alopecia|MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0001192,scaly skin|MP:0001222,epidermal hyperplasia|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002006,neoplasm|MP:0002073,abnormal hair growth|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0002962,increased urine protein level|MP:0003413,hair follicle degeneration|MP:0003446,renal hypoplasia|MP:0003809,abnormal hair shaft morphology|MP:0003828,pulmonary edema|MP:0003853,dry skin|MP:0003875,abnormal hair follicle regression|MP:0004505,decreased renal glomerulus number|MP:0005325,abnormal renal glomerulus morphology|MP:0005367,renal/urinary system phenotype|MP:0005501,abnormal skin physiology|MP:0006042,increased apoptosis|MP:0006138,congestive heart failure|MP:0008528,polycystic kidney|MP:0008859,abnormal hair cycle catagen phase|MP:0010685,abnormal hair follicle inner root sheath morphology|MP:0010768,mortality/aging|MP:0010771,integument phenotype|MP:0011089,perinatal lethality, complete penetrance|MP:0011334,abnormal nephrogenic zone morphology|MP:0011368,increased kidney apoptosis|MP:0011940,decreased food intake
MGI:5544790	Drosha<tm2.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:5546234	Drosha<tm3Vlcg>	MP:0011092,embryonic lethality, complete penetrance
MGI:5431939	Drp2<tm1.1Brp>	MP:0001106,abnormal Schwann cell morphology|MP:0003631,nervous system phenotype|MP:0003871,abnormal myelin sheath morphology|MP:0010050,hypermyelination|MP:0010742,increased Schwann cell number
MGI:3579883	Drsi<C3H/HeNCrl>	MP:0002837,dystrophic cardiac calcinosis|MP:0005568,increased circulating total protein level
MGI:1861455	Ds	MP:0000161,scoliosis|MP:0000562,polydactyly|MP:0000919,cranioschisis|MP:0001672,abnormal embryo development|MP:0002085,abnormal embryonic tissue morphology|MP:0008770,decreased survivor rate|MP:0009469,increased skin hamartoma incidence|MP:0009470,mirror image duplication|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:2156926	Dsc1<tm1Dga>	MP:0000414,alopecia|MP:0001194,dermatitis|MP:0001195,flaky skin|MP:0001212,skin lesions|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001247,dermal cyst|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001302,eyelids open at birth|MP:0001314,cornea opacity|MP:0001511,disheveled coat|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0003413,hair follicle degeneration|MP:0003427,parakeratosis|MP:0004241,acantholysis|MP:0005386,behavior/neurological phenotype|MP:0009264,failure of eyelid fusion|MP:0010700,hair follicle comedo|MP:0030533,abnormal snout skin morphology
MGI:3028701	Dsc1<tm1Pko>	MP:0002169,no abnormal phenotype detected|MP:0010771,integument phenotype
MGI:6509038	Dsc2<tm1.1Leu>	MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype
MGI:6509042	Dsc2<tm1.2Leu>	MP:0001625,cardiac hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0003141,cardiac fibrosis|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0006042,increased apoptosis|MP:0010768,mortality/aging|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4455602	Dsc2<tm1e(KOMP)Wtsi>	MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0005287,narrow eye opening|MP:0005542,cornea vascularization
MGI:6120697	Dsc3<tm1b(EUCOMM)Wtsi>	MP:0001333,absent optic nerve|MP:0001399,hyperactivity|MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:3615340	Dsc3<tm1Pko>	MP:0002169,no abnormal phenotype detected|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3812225	Dsc3<tm2Pko>	MP:0000416,sparse hair|MP:0001208,blistering|MP:0001212,skin lesions|MP:0001217,absent epidermis|MP:0001222,epidermal hyperplasia|MP:0002169,no abnormal phenotype detected|MP:0003414,epidermal cyst|MP:0004241,acantholysis|MP:0008770,decreased survivor rate|MP:0010771,integument phenotype|MP:0011088,neonatal lethality, incomplete penetrance|MP:0030578,decreased keratinocyte adhesion
MGI:4830358	Dscam<2J>	MP:0000160,kyphosis|MP:0000440,domed cranium|MP:0001325,abnormal retina morphology|MP:0001504,abnormal posture|MP:0001512,trunk curl|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005240,abnormal amacrine cell morphology|MP:0005241,abnormal retina ganglion layer morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0006069,abnormal retina neuronal layer morphology|MP:0006075,abnormal retina cone bipolar cell morphology|MP:0008509,disorganized retina ganglion layer|MP:0008512,disorganized retina inner nuclear layer|MP:0009393,abnormal resting posture|MP:0009450,abnormal axon fasciculation
MGI:5488751	Dscam<3J>	MP:0000160,kyphosis|MP:0000440,domed cranium|MP:0001329,retina hyperplasia|MP:0001891,hydrocephaly|MP:0003243,abnormal dopaminergic neuron morphology|MP:0004143,muscle hypertonia|MP:0005240,abnormal amacrine cell morphology|MP:0008056,abnormal retina ganglion cell morphology|MP:0008415,abnormal neurite morphology|MP:0008508,thick retina ganglion layer|MP:0008535,enlarged lateral ventricles|MP:0011380,enlarged brain ventricles|MP:0011996,abnormal retina inner nuclear layer thickness|MP:0014265,thick retina inner plexiform layer
MGI:3761008	Dscam<del17>	MP:0000018,small ears|MP:0000160,kyphosis|MP:0000440,domed cranium|MP:0000780,abnormal corpus callosum morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000822,abnormal brain ventricle morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000827,dilated third ventricle|MP:0000857,abnormal cerebellar foliation|MP:0001290,delayed eyelid opening|MP:0001325,abnormal retina morphology|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0002064,seizures|MP:0002152,abnormal brain morphology|MP:0002199,abnormal brain commissure morphology|MP:0002741,small olfactory bulb|MP:0002804,abnormal motor learning|MP:0002983,increased retina ganglion cell number|MP:0003734,abnormal retina inner plexiform layer morphology|MP:0005240,abnormal amacrine cell morphology|MP:0005241,abnormal retina ganglion layer morphology|MP:0005551,abnormal eye electrophysiology|MP:0006073,abnormal retina bipolar cell morphology|MP:0006254,thin cerebral cortex|MP:0008128,abnormal brain internal capsule morphology|MP:0008509,disorganized retina ganglion layer|MP:0008535,enlarged lateral ventricles|MP:0008779,abnormal maternal behavior|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012468,decreased striatum size|MP:0012676,dilated brain ventricle|MP:0030076,abnormal cranial cavity morphology|MP:0031442,enlarged cerebral aqueduct
MGI:7425642	Dscaml1<em1(IMPC)Bay>	MP:0001325,abnormal retina morphology|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0011959,abnormal eye posterior chamber depth|MP:0011960,abnormal eye anterior chamber depth|MP:0011964,increased total retina thickness
MGI:3864487	Dscaml1<Gt(CC0772)Wtsi>	MP:0001325,abnormal retina morphology|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005240,abnormal amacrine cell morphology|MP:0005241,abnormal retina ganglion layer morphology|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0008056,abnormal retina ganglion cell morphology|MP:0008105,increased amacrine cell number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014265,thick retina inner plexiform layer
MGI:3840666	Dscam<tm1.1Kzy>	MP:0001943,abnormal respiration|MP:0001951,abnormal breathing pattern|MP:0001954,respiratory distress|MP:0001957,apnea|MP:0003880,abnormal central pattern generator function|MP:0005423,abnormal somatic nervous system physiology|MP:0005574,decreased pulmonary respiratory rate|MP:0008947,increased neuron number|MP:0010768,mortality/aging|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012008,delayed parturition
MGI:5305025	Dscam<tm1.1Pfu>	MP:0005240,abnormal amacrine cell morphology|MP:0009450,abnormal axon fasciculation
MGI:5305022	Dscam<tm1Pfu>	MP:0005240,abnormal amacrine cell morphology|MP:0008056,abnormal retina ganglion cell morphology|MP:0008105,increased amacrine cell number|MP:0009450,abnormal axon fasciculation
MGI:4362627	Dscc1<tm1a(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0000150,abnormal rib morphology|MP:0000480,increased rib number|MP:0003960,increased lean body mass|MP:0004609,vertebral fusion|MP:0004647,decreased lumbar vertebrae number|MP:0004651,increased thoracic vertebrae number|MP:0004924,abnormal behavior|MP:0005565,increased blood urea nitrogen level|MP:0010101,increased sacral vertebrae number|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5583872	Dsel<tm1Mmac>	MP:0000192,abnormal mineral level|MP:0003631,nervous system phenotype|MP:0005584,abnormal enzyme/coenzyme activity
MGI:6314263	Dse<tm1b(EUCOMM)Hmgu>	MP:0002590,increased mean corpuscular volume|MP:0005343,increased circulating aspartate transaminase level|MP:0011100,preweaning lethality, complete penetrance
MGI:4366965	Dse<tm1Mmac>	MP:0000585,kinked tail|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001935,decreased litter size|MP:0003089,decreased skin tensile strength|MP:0003705,abnormal hypodermis morphology|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0009703,decreased birth body size
MGI:4364614	Dsg1b<tm1a(KOMP)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001312,abnormal cornea morphology|MP:0001322,abnormal iris morphology|MP:0001340,abnormal eyelid morphology|MP:0001510,abnormal coat appearance|MP:0003179,thrombocytopenia|MP:0010123,increased bone mineral content
MGI:6152470	Dsg1c<em1(IMPC)Mbp>	MP:0000194,increased circulating calcium level|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001556,increased circulating HDL cholesterol level|MP:0002965,increased circulating serum albumin level|MP:0004924,abnormal behavior|MP:0005178,increased circulating cholesterol level|MP:0005553,increased circulating creatinine level|MP:0005568,increased circulating total protein level|MP:0020870,decreased thigmotaxis
MGI:7570178	Dsg2<em1Spin>	MP:0001625,cardiac hypertrophy|MP:0001636,irregular heartbeat|MP:0002925,abnormal cardiovascular development|MP:0003141,cardiac fibrosis|MP:0003566,abnormal cell adhesion|MP:0003822,decreased left ventricle systolic pressure|MP:0003898,abnormal QRS complex|MP:0005244,hemopericardium|MP:0005294,abnormal heart ventricle morphology|MP:0005598,decreased heart ventricle muscle contractility|MP:0006267,abnormal intercalated disk morphology|MP:0009732,ventricular premature beat|MP:0010394,decreased QRS amplitude|MP:0010759,decreased right ventricle systolic pressure|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0030578,decreased keratinocyte adhesion|MP:0031533,abnormal heart left ventricle wall morphology|MP:0031534,abnormal heart right ventricle wall morphology
MGI:6283557	Dsg2<m1Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:6283577	Dsg2<m2Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:6283582	Dsg2<m3Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:4432319	Dsg2<tm1a(EUCOMM)Wtsi>	MP:0005330,cardiomyopathy
MGI:5792555	Dsg2<tm1b(EUCOMM)Wtsi>	MP:0001510,abnormal coat appearance|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005140,decreased cardiac muscle contractility|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0005567,decreased circulating total protein level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6501716	Dsg2<tm1d(EUCOMM)Wtsi>	MP:0001853,heart inflammation|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0005385,cardiovascular system phenotype|MP:0009732,ventricular premature beat|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010392,prolonged QRS complex duration|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010509,decreased P wave amplitude|MP:0010631,increased Q wave amplitude|MP:0011920,abnormal S wave|MP:0011925,abnormal heart echocardiography feature
MGI:3609221	Dsg2<tm1Leu>	MP:0000313,abnormal cell death|MP:0011093,embryonic lethality at implantation, complete penetrance|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:6508032	Dsg2<tm3.1Leu>	MP:0000488,abnormal intestinal epithelium morphology|MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0013298,increased susceptibility to colitis induced morbidity/mortality
MGI:1856692	Dsg3<bal>	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0001208,blistering|MP:0001265,decreased body size|MP:0002073,abnormal hair growth|MP:0002497,increased IgE level|MP:0031395,cutaneous mastocytosis
MGI:1857386	Dsg3<bal-Pas>	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0001208,blistering|MP:0003809,abnormal hair shaft morphology|MP:0005114,premature hair loss|MP:0009598,thin epidermis stratum granulosum|MP:0030520,oral mucosa blisters
MGI:5708345	Dsg3<sqk>	MP:0000219,increased neutrophil cell number|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000418,focal hair loss|MP:0000762,abnormal tongue morphology|MP:0001219,thick epidermis|MP:0001234,absent suprabasal layer|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001852,conjunctivitis|MP:0001926,female infertility|MP:0001954,respiratory distress|MP:0002073,abnormal hair growth|MP:0002132,abnormal respiratory system morphology|MP:0002249,abnormal larynx morphology|MP:0002256,abnormal laryngeal cartilage morphology|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0002406,increased susceptibility to infection|MP:0003453,abnormal keratinocyte physiology|MP:0003747,mouth mucosal ulcer|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005092,decreased double-positive T cell number|MP:0005150,cachexia|MP:0005668,decreased circulating leptin level|MP:0008083,decreased single-positive T cell number|MP:0008190,decreased transitional stage B cell number|MP:0008209,decreased pre-B cell number|MP:0008215,decreased immature B cell number|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009247,meteorism|MP:0009474,thick epidermis stratum spinosum|MP:0010025,decreased total body fat amount|MP:0010099,abnormal thoracic cage shape|MP:0010371,abnormal epiglottis morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012491,larynx stenosis|MP:0013752,stridor|MP:0030000,abnormal subglottis morphology|MP:0030001,subglottis stenosis|MP:0030533,abnormal snout skin morphology|MP:0030894,epiglottis hyperplasia
MGI:1857388	Dsg3<tm1Stan>	MP:0000414,alopecia|MP:0000427,abnormal hair cycle|MP:0001208,blistering|MP:0001212,skin lesions|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001852,conjunctivitis|MP:0003747,mouth mucosal ulcer|MP:0003809,abnormal hair shaft morphology|MP:0004241,acantholysis|MP:0010025,decreased total body fat amount|MP:0011084,lethality at weaning, incomplete penetrance|MP:0030578,decreased keratinocyte adhesion
MGI:3846150	Dsg4<arm>	MP:0000381,enlarged hair follicles|MP:0001190,reddish skin|MP:0001265,decreased body size|MP:0001284,absent vibrissae|MP:0001786,skin edema|MP:0003809,abnormal hair shaft morphology|MP:0003848,brittle hair|MP:0006365,absent guard hair|MP:0010685,abnormal hair follicle inner root sheath morphology
MGI:1856929	Dsg4<lah>	MP:0000384,distorted hair follicle pattern|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000417,short hair|MP:0001192,scaly skin|MP:0001194,dermatitis|MP:0001200,thick skin|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001279,wavy vibrissae|MP:0001282,short vibrissae|MP:0001510,abnormal coat appearance|MP:0001874,acanthosis|MP:0002073,abnormal hair growth|MP:0002074,abnormal hair texture|MP:0003413,hair follicle degeneration|MP:0003809,abnormal hair shaft morphology|MP:0003811,abnormal hair cortex morphology|MP:0008858,abnormal hair cycle anagen phase|MP:0008859,abnormal hair cycle catagen phase|MP:0010179,rough coat|MP:0010688,hair follicle outer root sheath hyperplasia|MP:0014659,increased skin stiffness
MGI:2661039	Dsg4<lah-J>	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000417,short hair|MP:0000580,deformed nails|MP:0000583,long toenails|MP:0000647,abnormal sebaceous gland morphology|MP:0001191,abnormal skin condition|MP:0001192,scaly skin|MP:0001194,dermatitis|MP:0001200,thick skin|MP:0001211,wrinkled skin|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001245,thick dermal layer|MP:0001246,mixed cellular infiltration to dermis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001284,absent vibrissae|MP:0001874,acanthosis|MP:0002073,abnormal hair growth|MP:0002074,abnormal hair texture|MP:0002095,abnormal skin pigmentation|MP:0002497,increased IgE level|MP:0003089,decreased skin tensile strength|MP:0003427,parakeratosis|MP:0008463,abnormal peripheral lymph node morphology|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008853,decreased abdominal adipose tissue amount|MP:0009703,decreased birth body size|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6114027	Dsg4<m1Btlr>	MP:0013115,focal hair loss in abdominal region|MP:0013116,focal hair loss in head/neck region
MGI:5007752	Dsg4<tbird>	MP:0000416,sparse hair|MP:0001510,abnormal coat appearance|MP:0003849,greasy coat
MGI:4437597	Dsht	MP:0000373,belly spot|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001262,decreased body weight|MP:0001539,decreased caudal vertebrae number|MP:0002111,abnormal tail morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0003051,curly tail|MP:0004653,absent caudal vertebrae|MP:0004703,abnormal vertebral column morphology|MP:0005225,abnormal vertebrae development|MP:0005262,coloboma|MP:0005371,limbs/digits/tail phenotype|MP:0006281,abnormal tail development|MP:0010714,iris coloboma
MGI:3052992	Dspd	MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0009230,abnormal sperm head morphology
MGI:6276974	Dsp<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000702,enlarged lymph nodes|MP:0001700,abnormal embryo turning|MP:0001711,abnormal placenta morphology|MP:0002151,abnormal neural tube morphology|MP:0002339,abnormal lymph node morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:7464254	Dsp<em1Melr>	MP:0004485,increased response of heart to induced stress|MP:0005385,cardiovascular system phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5695883	Dspp<tm1.1(KOMP)Vlcg>	MP:0002135,abnormal kidney morphology|MP:0005292,improved glucose tolerance|MP:0008528,polycystic kidney|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2653208	Dspp<tm1Kul>	MP:0000126,brittle teeth|MP:0000527,abnormal kidney development|MP:0001176,abnormal lung development|MP:0002100,abnormal tooth morphology|MP:0002818,abnormal dentin morphology|MP:0002819,abnormal dental pulp cavity morphology|MP:0003668,abnormal periodontal ligament morphology|MP:0003933,abnormal cementum morphology|MP:0004189,abnormal alveolar process morphology|MP:0011035,abnormal branching involved in alveolar duct morphogenesis|MP:0011365,small metanephros|MP:0011368,increased kidney apoptosis|MP:0011457,abnormal metanephric ureteric bud development|MP:0012024,abnormal nephron morphogenesis|MP:0012026,abnormal S-shaped body morphology|MP:0030131,abnormal periodontium morphology|MP:0030132,periodontium inflammation|MP:0030451,abnormal dentin mineralization|MP:0030466,alveolar process atrophy|MP:0030484,abnormal osteocyte lacuna morphology|MP:0030486,abnormal osteocyte canaliculus morphology|MP:0030490,periodontal pocket|MP:0030516,abnormal junctional epithelium morphology|MP:0030517,detached junctional epithelium|MP:0030543,abnormal predentin morphology
MGI:3511272	Dsp<rul>	MP:0000416,sparse hair|MP:0000420,ruffled hair|MP:0001511,disheveled coat|MP:0001874,acanthosis|MP:0002074,abnormal hair texture|MP:0003141,cardiac fibrosis|MP:0003809,abnormal hair shaft morphology|MP:0003812,abnormal hair medulla|MP:0003921,abnormal heart left ventricle morphology|MP:0005333,decreased heart rate|MP:0008767,abnormal hair medullary septa cells|MP:0010234,abnormal vibrissa follicle morphology|MP:0010392,prolonged QRS complex duration|MP:0010505,abnormal T wave|MP:0010506,prolonged RR interval|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0011160,dermal-epidermal separation|MP:0011919,abnormal R wave|MP:0011925,abnormal heart echocardiography feature|MP:0012515,abnormal heart apex morphology|MP:0030520,oral mucosa blisters
MGI:2156542	Dsp<tm1Efu>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0001216,abnormal epidermal layer morphology|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0002578,impaired ability to fire action potentials|MP:0002651,abnormal sciatic nerve morphology|MP:0002946,delayed axon extension|MP:0002952,ventricular cardiomyopathy|MP:0003137,abnormal impulse conducting system conduction|MP:0003141,cardiac fibrosis|MP:0004091,abnormal Z line morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005598,decreased heart ventricle muscle contractility|MP:0006042,increased apoptosis|MP:0006267,abnormal intercalated disk morphology|MP:0008022,dilated heart ventricle|MP:0008725,increased heart atrium size|MP:0008814,decreased nerve conduction velocity|MP:0009594,abnormal corneocyte envelope morphology|MP:0009732,ventricular premature beat|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010392,prolonged QRS complex duration|MP:0010546,abnormal subendocardium layer morphology|MP:0010636,bundle branch block|MP:0014696,decreased cell adhesion|MP:0031330,delayed peripheral nervous system regeneration
MGI:2182575	Dsp<tm2Efu>	MP:0001675,abnormal ectoderm development|MP:0001685,abnormal endoderm development|MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0014586,decreased egg cylinder size
MGI:3721790	Dss1<SEG/Pas>	MP:0002673,abnormal sperm number
MGI:2156163	Dssc1<C57BL/6J>	MP:0002816,colitis
MGI:2155047	Dssc2<C3H/HeJ>	MP:0002816,colitis
MGI:1856019	Dst<dt>	MP:0000754,paresis|MP:0000921,demyelination|MP:0001513,limb grasping|MP:0001524,impaired limb coordination|MP:0002083,premature death|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0003225,axonal dystrophy|MP:0003632,abnormal nervous system morphology|MP:0005323,dystonia
MGI:1856672	Dst<dt-23J>	MP:0003225,axonal dystrophy
MGI:6119708	Dst<dt-23Rbrc>	MP:0000955,abnormal spinal cord morphology|MP:0000965,abnormal sensory neuron morphology|MP:0001077,abnormal spinal nerve morphology|MP:0001402,decreased locomotor activity|MP:0001504,abnormal posture|MP:0001523,impaired righting response|MP:0001524,impaired limb coordination|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002229,neurodegeneration|MP:0002269,muscular atrophy|MP:0002882,abnormal neuron morphology|MP:0003313,abnormal locomotor activation|MP:0005277,abnormal brainstem morphology|MP:0005323,dystonia|MP:0008489,slow postnatal weight gain|MP:0010047,axonal spheroids|MP:0011731,decreased myelin sheath thickness
MGI:1856673	Dst<dt-24J>	MP:0003225,axonal dystrophy
MGI:1858037	Dst<dt-27J>	MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0000958,peripheral nervous system degeneration|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000965,abnormal sensory neuron morphology|MP:0001106,abnormal Schwann cell morphology|MP:0002651,abnormal sciatic nerve morphology|MP:0002752,abnormal somatic nervous system morphology|MP:0003633,abnormal nervous system physiology|MP:0003871,abnormal myelin sheath morphology|MP:0003994,abnormal dorsal spinal root morphology|MP:0004768,abnormal axonal transport|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration
MGI:1857524	Dst<dt-30J>	MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0005323,dystonia
MGI:1857525	Dst<dt-31J>	MP:0002083,premature death|MP:0005323,dystonia
MGI:1857841	Dst<dt-32J>	MP:0001513,limb grasping|MP:0002082,postnatal lethality|MP:0002752,abnormal somatic nervous system morphology|MP:0003280,urinary incontinence|MP:0003281,fecal incontinence
MGI:1889074	Dst<dt-33J>	MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0002064,seizures|MP:0011085,postnatal lethality, complete penetrance
MGI:3051681	Dst<dt-35J>	MP:0002066,abnormal motor capabilities/coordination/movement
MGI:2681971	Dst<dt-36J>	MP:0001504,abnormal posture
MGI:3580065	Dst<dt-37J>	MP:0000333,decreased bone marrow cell number|MP:0000921,demyelination|MP:0001265,decreased body size|MP:0001523,impaired righting response|MP:0002883,chromatolysis|MP:0003225,axonal dystrophy|MP:0005323,dystonia|MP:0009400,decreased skeletal muscle fiber size
MGI:3589419	Dst<dt-38J>	MP:0000743,muscle spasm|MP:0000746,weakness|MP:0001265,decreased body size|MP:0001504,abnormal posture|MP:0005389,reproductive system phenotype
MGI:4354157	Dst<dt-39J>	MP:0001516,abnormal motor coordination/balance|MP:0005150,cachexia|MP:0005323,dystonia
MGI:1859982	Dst<dt-alb>	MP:0002882,abnormal neuron morphology|MP:0003632,abnormal nervous system morphology|MP:0005323,dystonia
MGI:1856021	Dst<dt-J>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001299,abnormal eye distance/ position|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001489,decreased startle reflex|MP:0001504,abnormal posture|MP:0001516,abnormal motor coordination/balance|MP:0001525,impaired balance|MP:0001527,athetotic walking movements|MP:0002095,abnormal skin pigmentation|MP:0002980,abnormal postural reflex|MP:0005316,abnormal response to tactile stimuli|MP:0005356,positive geotaxis|MP:0005656,decreased aggression|MP:0006198,enophthalmos|MP:0011085,postnatal lethality, complete penetrance
MGI:7711525	Dst<em1Dcr>	MP:0010771,integument phenotype
MGI:7712932	Dst<em3Dcr>	MP:0010771,integument phenotype
MGI:7712933	Dst<em4Dcr>	MP:0010771,integument phenotype
MGI:7712934	Dst<em5Dcr>	MP:0010771,integument phenotype
MGI:3917429	Dst<Gt(E182H05)Wrst>	MP:0000774,decreased brain size|MP:0000911,abnormal trigeminal motor nucleus morphology|MP:0000921,demyelination|MP:0000955,abnormal spinal cord morphology|MP:0000964,small dorsal root ganglion|MP:0001504,abnormal posture|MP:0001524,impaired limb coordination|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0002882,abnormal neuron morphology|MP:0004145,abnormal muscle electrophysiology|MP:0004811,abnormal neuron physiology|MP:0005277,abnormal brainstem morphology|MP:0005323,dystonia|MP:0005405,axon degeneration|MP:0010047,axonal spheroids|MP:0011731,decreased myelin sheath thickness
MGI:5619125	Dst<m1Btlr>	MP:0001262,decreased body weight|MP:0001393,ataxia
MGI:5619126	Dst<m2Btlr>	MP:0001408,stereotypic behavior|MP:0005191,head tilt|MP:0005386,behavior/neurological phenotype
MGI:5619133	Dst<m3Btlr>	MP:0001393,ataxia|MP:0001524,impaired limb coordination
MGI:1889311	Dstn<corn1>	MP:0000351,increased cell proliferation|MP:0001304,cataract|MP:0001312,abnormal cornea morphology|MP:0005387,immune system phenotype|MP:0005542,cornea vascularization|MP:0005601,increased angiogenesis|MP:0006000,abnormal cornea epithelium morphology|MP:0008778,abnormal lymphangiogenesis|MP:0020854,increased cornea epithelium thickness|MP:0020857,cornea epithelium hyperplasia
MGI:2388156	Dstn<corn1-2J>	MP:0005391,vision/eye phenotype|MP:0006000,abnormal cornea epithelium morphology
MGI:4943283	Dstn<tm1.1Wit>	MP:0001312,abnormal cornea morphology|MP:0003631,nervous system phenotype
MGI:5707436	Dstn<tm1b(KOMP)Wtsi>	MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:1856421	Dst<Tg4>	MP:0000747,muscle weakness|MP:0000920,abnormal myelination|MP:0000958,peripheral nervous system degeneration|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000964,small dorsal root ganglion|MP:0000965,abnormal sensory neuron morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001096,abnormal glossopharyngeal ganglion morphology|MP:0001106,abnormal Schwann cell morphology|MP:0001344,blepharoptosis|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001524,impaired limb coordination|MP:0001852,conjunctivitis|MP:0002082,postnatal lethality|MP:0002106,abnormal muscle physiology|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003224,neuron degeneration|MP:0003633,abnormal nervous system physiology|MP:0003871,abnormal myelin sheath morphology|MP:0003994,abnormal dorsal spinal root morphology|MP:0004069,abnormal muscle spindle morphology|MP:0004091,abnormal Z line morphology|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0006258,abnormal circumvallate papillae morphology|MP:0006260,abnormal gustatory papilla taste bud morphology|MP:0008489,slow postnatal weight gain|MP:0014344,abnormal skeletal muscle fiber mitochondrial morphology
MGI:5636893	Dst<tm1b(EUCOMM)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0001491,unresponsive to tactile stimuli|MP:0001697,abnormal embryo size|MP:0002966,decreased circulating alkaline phosphatase level|MP:0010097,abnormal retina blood vessel morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2429314	Dst<tm1Efu>	MP:0000414,alopecia|MP:0000585,kinked tail|MP:0001208,blistering|MP:0001523,impaired righting response|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0002908,delayed wound healing|MP:0003871,abnormal myelin sheath morphology|MP:0005323,dystonia|MP:0005405,axon degeneration
MGI:6121070	Dstyk<tm1.2Zlh>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0012307,impaired spatial learning
MGI:5692745	Dtl<tm1b(EUCOMM)Wtsi>	MP:0010053,decreased grip strength
MGI:3699089	Dtl<tm1Hch>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2148537	Dtna<tm1Jrs>	MP:0000752,dystrophic muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001405,impaired coordination|MP:0003141,cardiac fibrosis|MP:0004566,myocardial fiber degeneration|MP:0005330,cardiomyopathy|MP:0010053,decreased grip strength
MGI:3621006	Dtnb<Gt(OST109050)Lex>	MP:0002169,no abnormal phenotype detected
MGI:1856628	Dtnbp1<sdy>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0001364,decreased anxiety-related response|MP:0002136,abnormal kidney physiology|MP:0002803,abnormal operant conditioning behavior|MP:0003043,hypoalgesia|MP:0003179,thrombocytopenia|MP:0004725,decreased platelet serotonin level|MP:0005098,abnormal optic choroid morphology|MP:0005172,decreased eye pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0009142,decreased prepulse inhibition|MP:0009455,enhanced cued conditioning behavior|MP:0009549,decreased platelet aggregation|MP:0010193,abnormal choroid melanin granule morphology|MP:0011620,abnormal habituation to a new environment|MP:0013894,abnormal behavioral response to amphetamine|MP:0014365,impaired short-term object recognition memory|MP:0020432,decreased platelet dense granule number|MP:0020467,abnormal circadian behavior|MP:0031391,increased locomotor activity
MGI:3774127	Dtnbp1<sdy-Btlr>	MP:0000371,diluted coat color|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:5513769	Dtnbp1<tm1b(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0001120,abnormal uterus morphology|MP:0001325,abnormal retina morphology|MP:0001566,increased circulating phosphate level|MP:0002075,abnormal coat/hair pigmentation|MP:0005013,increased lymphocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0005102,abnormal iris pigmentation|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:2179747	Dtnb<tm1Ked>	MP:0002169,no abnormal phenotype detected
MGI:6153785	Dtx1<em1(IMPC)H>	MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0005178,increased circulating cholesterol level|MP:0005559,increased circulating glucose level|MP:0009142,decreased prepulse inhibition
MGI:4355028	Dtx1<tm1.1Mzl>	MP:0003725,increased autoantibody level|MP:0003850,abnormal thymocyte activation|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004796,increased anti-histone antibody level|MP:0005348,increased T cell proliferation|MP:0008687,increased interleukin-2 secretion
MGI:4355029	Dtx1<tm1.2Mzl>	MP:0000693,spleen hyperplasia|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002619,abnormal lymphocyte morphology|MP:0002743,glomerulonephritis|MP:0003850,abnormal thymocyte activation|MP:0003945,abnormal lymphocyte physiology|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004796,increased anti-histone antibody level|MP:0004946,abnormal regulatory T cell physiology|MP:0005154,increased B cell proliferation|MP:0005348,increased T cell proliferation|MP:0008182,decreased marginal zone B cell number|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008747,abnormal T cell anergy|MP:0008838,decreased transforming growth factor beta level|MP:0009542,decreased thymocyte apoptosis|MP:0020519,renal glomerular immunoglobulin deposits
MGI:3530026	Dtx1<tm1Crey>	MP:0002169,no abnormal phenotype detected
MGI:3690124	Dtx1<tm1Mjb>	MP:0005387,immune system phenotype
MGI:3690125	Dtx2<tm1Mjb>	MP:0005387,immune system phenotype
MGI:6094231	Dtx3<em1(IMPC)J>	MP:0005562,decreased mean corpuscular hemoglobin
MGI:6322954	Dtx3l<em1(IMPC)H>	MP:0001399,hyperactivity|MP:0002590,increased mean corpuscular volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0005419,decreased circulating serum albumin level|MP:0005561,increased mean corpuscular hemoglobin
MGI:6341925	Dtx4<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001404,no spontaneous movement|MP:0002968,increased circulating alkaline phosphatase level|MP:0005293,impaired glucose tolerance|MP:0010935,increased airway resistance|MP:0011100,preweaning lethality, complete penetrance
MGI:4867962	Dtymk<tm1(KOMP)Mbp>	MP:0003631,nervous system phenotype|MP:0005319,abnormal enzyme/coenzyme level|MP:0014257,embryonic lethality prior to tooth bud stage, complete penetrance
MGI:3589163	Ducm1<129X1/SvJ>	MP:0002452,abnormal professional antigen presenting cell physiology
MGI:6760628	Duox1<m1Btlr>	MP:0005390,skeleton phenotype
MGI:6760629	Duox1<m2Btlr>	MP:0005390,skeleton phenotype
MGI:6761324	Duox2<em1Btlr>	MP:0001265,decreased body size|MP:0002764,short tibia|MP:0003109,short femur|MP:0004692,small pubis
MGI:6277071	Duox2<em1(IMPC)Mbp>	MP:0000194,increased circulating calcium level|MP:0000219,increased neutrophil cell number|MP:0000266,abnormal heart morphology|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0001417,decreased exploration in new environment|MP:0001556,increased circulating HDL cholesterol level|MP:0001926,female infertility|MP:0002135,abnormal kidney morphology|MP:0002188,small heart|MP:0002339,abnormal lymph node morphology|MP:0002590,increased mean corpuscular volume|MP:0002834,decreased heart weight|MP:0002965,increased circulating serum albumin level|MP:0002989,small kidney|MP:0005016,decreased lymphocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0005553,increased circulating creatinine level|MP:0005568,increased circulating total protein level|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0013279,increased fasting circulating glucose level|MP:0020421,increased freezing behavior
MGI:6760623	Duox2<m1Btlr>	MP:0001265,decreased body size|MP:0002764,short tibia|MP:0003109,short femur|MP:0004692,small pubis
MGI:3712359	Duox2<thyd>	MP:0000063,decreased bone mineral density|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001924,infertility|MP:0003149,abnormal tectorial membrane morphology|MP:0003498,thyroid gland hyperplasia|MP:0003503,decreased activity of thyroid gland|MP:0004163,abnormal adenohypophysis morphology|MP:0004664,delayed inner ear development|MP:0004696,abnormal thyroid follicle morphology|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005390,skeleton phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005478,decreased circulating thyroxine level|MP:0011721,abnormal bone mineralization involved in bone maturation|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013618,decreased areal bone mineral density
MGI:5637016	Duoxa2<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000137,abnormal vertebrae morphology|MP:0000182,increased circulating LDL cholesterol level|MP:0000194,increased circulating calcium level|MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0000432,abnormal head morphology|MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0000552,abnormal radius morphology|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0001258,decreased body length|MP:0001322,abnormal iris morphology|MP:0001340,abnormal eyelid morphology|MP:0001556,increased circulating HDL cholesterol level|MP:0002073,abnormal hair growth|MP:0002169,no abnormal phenotype detected|MP:0002834,decreased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002932,abnormal joint morphology|MP:0002965,increased circulating serum albumin level|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0003961,decreased lean body mass|MP:0004599,abnormal vertebral arch morphology|MP:0004738,abnormal auditory brainstem response|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005108,abnormal ulna morphology|MP:0005178,increased circulating cholesterol level|MP:0005270,abnormal zygomatic bone morphology|MP:0005292,improved glucose tolerance|MP:0005296,abnormal humerus morphology|MP:0005298,abnormal clavicle morphology|MP:0005478,decreased circulating thyroxine level|MP:0005553,increased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0005568,increased circulating total protein level|MP:0005633,increased circulating sodium level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0006358,absent pinna reflex|MP:0008045,decreased NK cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008174,decreased follicular B cell number|MP:0008207,decreased B-2 B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008524,increased plasmacytoid dendritic cell number|MP:0008805,decreased circulating amylase level|MP:0008810,increased circulating iron level|MP:0008935,decreased mean platelet volume|MP:0009923,decreased transitional stage T1 B cell number|MP:0010024,increased total body fat amount|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010068,decreased red blood cell distribution width|MP:0010087,increased circulating fructosamine level|MP:0010099,abnormal thoracic cage shape|MP:0010124,decreased bone mineral content|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0012764,increased alpha-beta T cell number|MP:0012768,decreased KLRG1-positive NK cell number|MP:0013026,decreased Ly6C low monocyte number|MP:0013279,increased fasting circulating glucose level|MP:0013417,decreased memory-marker gamma-delta T cell number|MP:0013429,decreased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0013436,increased CD8-positive, naive alpha-beta T cell number|MP:0013649,decreased CD11b-high dendritic cell number|MP:0013763,increased T-helper cell number|MP:0013771,decreased effector memory T-helper cell number
MGI:1856848	dup	MP:0000160,kyphosis|MP:0000161,scoliosis|MP:0000162,lordosis|MP:0001256,abnormal body length|MP:0001258,decreased body length|MP:0001259,abnormal body weight|MP:0001262,decreased body weight|MP:0001270,distended abdomen|MP:0002111,abnormal tail morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002706,abnormal kidney size|MP:0003956,abnormal body size|MP:0004174,abnormal spine curvature|MP:0004624,abnormal thoracic cage morphology|MP:0004703,abnormal vertebral column morphology|MP:0005508,abnormal skeleton morphology
MGI:7428761	Dus1l<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0001489,decreased startle reflex|MP:0003961,decreased lean body mass|MP:0009141,increased prepulse inhibition|MP:0010024,increased total body fat amount
MGI:6120729	Dus2<tm1b(EUCOMM)Wtsi>	MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width
MGI:3052343	Dusp10<tm1Flv>	MP:0001829,increased activated T cell number|MP:0002420,abnormal adaptive immunity|MP:0003009,abnormal cytokine secretion|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005095,decreased T cell proliferation|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion
MGI:3870220	Dusp11<Gt(BB0198)Wtsi>	MP:0005387,immune system phenotype|MP:0008553,increased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008735,increased susceptibility to endotoxin shock|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011075,abnormal macrophage activation involved in immune response|MP:0011078,increased macrophage cytokine production
MGI:5548616	Dusp11<tm1b(EUCOMM)Wtsi>	MP:0001312,abnormal cornea morphology|MP:0001392,abnormal locomotor behavior|MP:0005343,increased circulating aspartate transaminase level|MP:0010392,prolonged QRS complex duration|MP:0011965,decreased total retina thickness
MGI:6152471	Dusp12<em1(IMPC)Mbp>	MP:0000639,abnormal adrenal gland morphology|MP:0002606,increased basophil cell number|MP:0009141,increased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:7607984	Dusp12<em1Zhzy>	MP:0003141,cardiac fibrosis|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0005331,insulin resistance|MP:0008022,dilated heart ventricle|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0010633,myocardium hypertrophy
MGI:5548474	Dusp13b<tm1b(KOMP)Wtsi>	MP:0005576,decreased pulmonary ventilation
MGI:6196886	Dusp14<em1Lyg>	MP:0000274,enlarged heart|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0004485,increased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005630,increased lung weight|MP:0010633,myocardium hypertrophy
MGI:4233674	Dusp14<Gt(OST210117)Lex>	MP:0001800,abnormal humoral immune response|MP:0001828,abnormal T cell activation|MP:0003009,abnormal cytokine secretion|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005348,increased T cell proliferation|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005380,embryo phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008086,increased T-helper 1 cell number|MP:0010219,increased T-helper 17 cell number
MGI:5897441	Dusp15<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0010053,decreased grip strength
MGI:6156484	Dusp16<em1(IMPC)Tcp>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000208,decreased hematocrit|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001258,decreased body length|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003795,abnormal bone structure|MP:0004952,increased spleen weight|MP:0005344,increased circulating bilirubin level|MP:0005561,increased mean corpuscular hemoglobin|MP:0009142,decreased prepulse inhibition
MGI:3856395	Dusp16<Gt(AE0704)Wtsi>	MP:0001545,abnormal hematopoietic system physiology|MP:0009674,decreased birth weight|MP:0011087,neonatal lethality, complete penetrance
MGI:5823442	Dusp18<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002110,abnormal digit morphology|MP:0002833,increased heart weight|MP:0002965,increased circulating serum albumin level
MGI:2667529	Dusp1<tm1Brv>	MP:0000322,increased granulocyte number|MP:0000601,small liver|MP:0000733,abnormal muscle development|MP:0000750,abnormal muscle regeneration|MP:0001011,abnormal superior cervical ganglion morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001364,decreased anxiety-related response|MP:0001431,abnormal eating behavior|MP:0001573,abnormal circulating alanine transaminase level|MP:0001596,hypotension|MP:0001861,lung inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0003009,abnormal cytokine secretion|MP:0003203,increased neuron apoptosis|MP:0003213,decreased susceptibility to age related obesity|MP:0003313,abnormal locomotor activation|MP:0003360,abnormal depression-related behavior|MP:0003402,decreased liver weight|MP:0003828,pulmonary edema|MP:0003957,abnormal nitric oxide homeostasis|MP:0004889,increased energy expenditure|MP:0005179,decreased circulating cholesterol level|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005534,decreased body temperature|MP:0005565,increased blood urea nitrogen level|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0008143,abnormal dendrite morphology|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008657,increased interleukin-1 beta secretion|MP:0008705,increased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0008764,increased mast cell degranulation|MP:0009269,decreased fat cell size|MP:0009287,decreased abdominal fat pad weight|MP:0009289,decreased epididymal fat pad weight|MP:0009400,decreased skeletal muscle fiber size|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010025,decreased total body fat amount|MP:0010378,increased respiratory quotient|MP:0010954,abnormal cellular respiration|MP:0011808,abnormal myoblast differentiation|MP:0020102,increased hepatic glucose production|MP:0030948,decreased myoblast proliferation|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis|MP:0031270,decreased susceptibility to age-related hepatic steatosis
MGI:4364283	Dusp1<tm1(KOMP)Wtsi>	MP:0001262,decreased body weight|MP:0002942,decreased circulating alanine transaminase level|MP:0010025,decreased total body fat amount
MGI:3762529	Dusp1<tm1Lex>	MP:0002419,abnormal innate immunity|MP:0003724,increased susceptibility to induced arthritis|MP:0008553,increased circulating tumor necrosis factor level|MP:0008577,increased circulating interferon-gamma level|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008721,abnormal chemokine level|MP:0008735,increased susceptibility to endotoxin shock|MP:0008751,abnormal interleukin level|MP:0009814,increased prostaglandin level
MGI:6368881	Dusp22<tm1Tht>	MP:0000691,enlarged spleen|MP:0001806,decreased IgM level|MP:0001828,abnormal T cell activation|MP:0001846,increased inflammatory response|MP:0001859,kidney inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002460,decreased immunoglobulin level|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005093,decreased B cell proliferation|MP:0005325,abnormal renal glomerulus morphology|MP:0005348,increased T cell proliferation|MP:0005350,increased susceptibility to autoimmune disorder|MP:0008217,abnormal B cell activation|MP:0008478,increased spleen white pulp amount|MP:0008498,decreased IgG3 level|MP:0008553,increased circulating tumor necrosis factor level|MP:0008566,increased interferon-gamma secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008596,increased circulating interleukin-6 level|MP:0008614,increased circulating interleukin-17 level|MP:0008681,increased interleukin-17 secretion|MP:0008687,increased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008713,abnormal cytokine level|MP:0011339,abnormal glomerular mesangium morphology|MP:0011567,increased renal glomerulus lobularity
MGI:6361751	Dusp26<em1Jhxia>	MP:0000598,abnormal liver morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003333,liver fibrosis|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005343,increased circulating aspartate transaminase level|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0010359,increased liver free fatty acids level|MP:0010398,decreased liver glycogen level|MP:0013279,increased fasting circulating glucose level
MGI:4363735	Dusp26<tm1a(KOMP)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0001262,decreased body weight|MP:0003960,increased lean body mass|MP:0003961,decreased lean body mass|MP:0005567,decreased circulating total protein level|MP:0010093,decreased circulating magnesium level
MGI:6278287	Dusp29<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:3664737	Dusp2<tm1Cmac>	MP:0002423,abnormal mast cell physiology|MP:0003009,abnormal cytokine secretion|MP:0003436,decreased susceptibility to induced arthritis|MP:0011075,abnormal macrophage activation involved in immune response
MGI:4820135	Dusp3<tm1a(KOMP)Wtsi>	MP:0003961,decreased lean body mass|MP:0005296,abnormal humerus morphology|MP:0005554,decreased circulating creatinine level
MGI:5548619	Dusp3<tm1b(KOMP)Wtsi>	MP:0002079,increased circulating insulin level|MP:0003443,increased circulating glycerol level|MP:0010053,decreased grip strength|MP:0010068,decreased red blood cell distribution width|MP:0010124,decreased bone mineral content
MGI:5792725	Dusp3<tm1Srah>	MP:0002874,decreased hemoglobin content|MP:0005602,decreased angiogenesis
MGI:4127030	Dusp4<Gt(XG164)Byg>	MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008660,increased interleukin-10 secretion
MGI:4431999	Dusp4<tm1a(EUCOMM)Wtsi>	MP:0001539,decreased caudal vertebrae number|MP:0003345,decreased rib number|MP:0004647,decreased lumbar vertebrae number|MP:0004648,decreased thoracic vertebrae number|MP:0005560,decreased circulating glucose level|MP:0005628,decreased circulating potassium level|MP:0005633,increased circulating sodium level|MP:0005634,decreased circulating sodium level|MP:0010101,increased sacral vertebrae number
MGI:4456264	Dusp4<tm1Jmol>	MP:0008783,decreased B cell apoptosis
MGI:4947517	Dusp4<tm1Plev>	MP:0002451,abnormal macrophage physiology|MP:0005027,increased susceptibility to parasitic infection|MP:0008496,decreased IgG2a level|MP:0008499,increased IgG1 level|MP:0008560,increased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008663,increased interleukin-12 secretion|MP:0008672,increased interleukin-13 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008705,increased interleukin-6 secretion
MGI:5706941	Dusp5<tm1.1Achn>	MP:0000714,increased thymocyte number|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0020184,abnormal susceptibility to parasitic infection
MGI:5706846	Dusp5<tm1.1Skey>	MP:0004499,increased incidence of tumors by chemical induction
MGI:4456654	Dusp5<tm1a(KOMP)Wtsi>	MP:0002398,abnormal bone marrow cell morphology/development|MP:0002444,abnormal T cell physiology|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005348,increased T cell proliferation|MP:0006413,increased T cell apoptosis|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number
MGI:5888995	Dusp5<tm1d(KOMP)Wtsi>	MP:0006413,increased T cell apoptosis
MGI:3827011	Dusp6<tm1Jmol>	MP:0000267,abnormal heart development|MP:0000275,heart hyperplasia|MP:0000730,increased satellite cell number|MP:0002106,abnormal muscle physiology|MP:0002833,increased heart weight|MP:0003038,decreased myocardial infarct size|MP:0004486,decreased response of heart to induced stress|MP:0004952,increased spleen weight|MP:0005369,muscle phenotype|MP:0005385,cardiovascular system phenotype|MP:0008944,decreased sensitivity to induced cell death
MGI:3526178	Dusp6<tm1Sms>	MP:0000039,abnormal otic capsule morphology|MP:0000060,delayed bone ossification|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000438,abnormal cranium morphology|MP:0001262,decreased body weight|MP:0002082,postnatal lethality|MP:0004738,abnormal auditory brainstem response|MP:0005105,abnormal middle ear ossicle morphology|MP:0006399,abnormal long bone epiphyseal ossification zone morphology|MP:0030350,premature coronal suture closure
MGI:7450804	Dusp7<em2Smoc>	MP:0011091,prenatal lethality, complete penetrance
MGI:4419457	Dusp7<tm1(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001488,increased startle reflex|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002075,abnormal coat/hair pigmentation|MP:0002753,dilated heart left ventricle|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis
MGI:6423842	Dusp8<em1(IMPC)Mbp>	MP:0000774,decreased brain size|MP:0001258,decreased body length|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002175,decreased brain weight|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002989,small kidney|MP:0010053,decreased grip strength
MGI:5788467	Dusp8<tm1Jmol>	MP:0000278,abnormal myocardial fiber morphology|MP:0004084,abnormal cardiac muscle relaxation|MP:0004486,decreased response of heart to induced stress|MP:0005599,increased cardiac muscle contractility|MP:0010580,decreased heart left ventricle size|MP:0010724,thick interventricular septum
MGI:3604672	Dusp9<tm1Skey>	MP:0001716,abnormal placenta labyrinth morphology|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6443640	Dut<em1Bgv>	MP:0002718,abnormal inner cell mass morphology|MP:0005028,abnormal trophectoderm morphology|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:6392158	Dux<em1Ditr>	MP:0001385,pup cannibalization|MP:0001728,failure of embryo implantation|MP:0001935,decreased litter size|MP:0009781,abnormal preimplantation embryo development|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012008,delayed parturition|MP:0012128,abnormal blastocyst formation
MGI:1856849	dv	MP:0001394,circling
MGI:2137230	Dvl1<tm1Awb>	MP:0001446,abnormal whisker trimming behavior|MP:0001447,abnormal nest building behavior|MP:0001489,decreased startle reflex|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002635,reduced sensorimotor gating|MP:0003631,nervous system phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0009142,decreased prepulse inhibition|MP:0021117,abnormal huddling behavior
MGI:7531373	Dvl2<tm1.2Wds>	MP:0000267,abnormal heart development
MGI:2429760	Dvl2<tm1Awb>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000159,abnormal xiphoid process morphology|MP:0000161,scoliosis|MP:0000284,double outlet right ventricle|MP:0000585,kinked tail|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001575,cyanosis|MP:0001688,abnormal somite development|MP:0002632,vestigial tail|MP:0002633,persistent truncus arteriosus|MP:0003047,abnormal thoracic vertebrae morphology|MP:0004110,transposition of great arteries|MP:0005377,hearing/vestibular/ear phenotype|MP:0010402,ventricular septal defect|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5618437	Dvl3<b2b2866Clo>	MP:0000445,short snout|MP:0000519,hydronephrosis|MP:0001823,thymus hypoplasia|MP:0002639,micrognathia|MP:0006198,enophthalmos|MP:0011666,double outlet right ventricle, ventricular defect committed to aorta
MGI:3831892	Dvl3<tm1Awb>	MP:0000284,double outlet right ventricle|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002633,persistent truncus arteriosus|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0004678,split xiphoid process|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3716113	Dwh	MP:0000372,irregular coat pigmentation|MP:0002940,variable body spotting|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype
MGI:3027098	dwt	MP:0001265,decreased body size|MP:0008329,decreased somatotroph cell number|MP:0008417,decreased somatotroph cell size
MGI:3608996	Dxcp1<C57BL/10SnJ>	MP:0000111,cleft palate
MGI:3609000	Dxcp2<C57BL/10SnJ>	MP:0000111,cleft palate
MGI:6416506	Dxz4<em1Rinn>	MP:0002169,no abnormal phenotype detected
MGI:6257483	Dym<em1(IMPC)Tcp>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001258,decreased body length|MP:0001488,increased startle reflex|MP:0002059,abnormal seminal vesicle morphology|MP:0002590,increased mean corpuscular volume|MP:0002644,decreased circulating triglyceride level|MP:0002764,short tibia|MP:0002932,abnormal joint morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0005179,decreased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content|MP:0011874,enlarged urinary bladder
MGI:3817312	Dym<Gt(GTR1.3)1Rul>	MP:0000120,malocclusion|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000166,abnormal chondrocyte morphology|MP:0000519,hydronephrosis|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002114,abnormal axial skeleton morphology|MP:0002115,abnormal limb bone morphology|MP:0002764,short tibia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003587,ureter obstruction|MP:0004174,abnormal spine curvature|MP:0004351,short humerus|MP:0004610,small vertebrae|MP:0004672,short ribs|MP:0005352,small cranium|MP:0005386,behavior/neurological phenotype|MP:0006397,disorganized long bone epiphyseal plate|MP:0006399,abnormal long bone epiphyseal ossification zone morphology|MP:0008526,decreased cranium width|MP:0008546,abnormal vesicle-mediated transport|MP:0009703,decreased birth body size|MP:0011862,decreased cranium length|MP:0014239,abnormal intracellular organelle morphology
MGI:2661085	Dync1h1<Cra1>	MP:0000743,muscle spasm|MP:0000753,paralysis|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0001405,impaired coordination|MP:0001438,aphagia|MP:0004191,neuronal intranuclear inclusions|MP:0005113,decreased spinal cord ventral horn cell number|MP:0010053,decreased grip strength|MP:0011087,neonatal lethality, complete penetrance
MGI:2447991	Dync1h1<Loa>	MP:0000743,muscle spasm|MP:0000753,paralysis|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0000940,abnormal motor neuron innervation pattern|MP:0001405,impaired coordination|MP:0001435,absent suckling reflex|MP:0001438,aphagia|MP:0001515,abnormal grip strength|MP:0004191,neuronal intranuclear inclusions|MP:0004768,abnormal axonal transport|MP:0005113,decreased spinal cord ventral horn cell number|MP:0011087,neonatal lethality, complete penetrance
MGI:1861136	Dync1h1<Swl>	MP:0001524,impaired limb coordination|MP:0001731,abnormal postnatal growth|MP:0001925,male infertility|MP:0005424,jerky movement|MP:0009393,abnormal resting posture
MGI:5287503	Dync1h1<TgTn(sb-rtTA,Tyr)2489AOve>	MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:7616510	Dync1h1<tm1.1Ics>	MP:0000350,abnormal cell proliferation|MP:0000745,tremors|MP:0000774,decreased brain size|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0002200,abnormal brain ventricular system morphology|MP:0003203,increased neuron apoptosis|MP:0003648,abnormal radial glial cell morphology|MP:0004046,abnormal mitosis|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0006009,abnormal neuronal migration|MP:0006254,thin cerebral cortex|MP:0008458,abnormal cortical ventricular zone morphology|MP:0008489,slow postnatal weight gain|MP:0011091,prenatal lethality, complete penetrance
MGI:6198574	Dync1h1<tm1.1Sjki>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0005369,muscle phenotype|MP:0005455,increased susceptibility to weight gain|MP:0010053,decreased grip strength
MGI:6324189	Dync1h1<tm1dIcs>	MP:0001402,decreased locomotor activity|MP:0001529,abnormal vocalization|MP:0005293,impaired glucose tolerance
MGI:7641512	Dync1h1<tm1Ics>	MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging
MGI:2661091	Dync1h1<tm1Noh>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5440332	Dync1i2<m1H>	MP:0001392,abnormal locomotor behavior
MGI:4441864	Dync1i2<tm1a(EUCOMM)Wtsi>	MP:0005179,decreased circulating cholesterol level|MP:0005634,decreased circulating sodium level|MP:0010025,decreased total body fat amount
MGI:5754595	Dync1li1<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000598,abnormal liver morphology|MP:0000702,enlarged lymph nodes|MP:0001146,abnormal testis morphology|MP:0001175,abnormal lung morphology|MP:0001297,microphthalmia|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002188,small heart|MP:0002546,mydriasis|MP:0002989,small kidney|MP:0004958,enlarged prostate gland|MP:0010067,increased red blood cell distribution width|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4950685	Dync1li1<m1Emcf>	MP:0001363,increased anxiety-related response|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0003172,abnormal lysosome physiology|MP:0003631,nervous system phenotype|MP:0003867,increased defecation amount|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential|MP:0006009,abnormal neuronal migration|MP:0008143,abnormal dendrite morphology|MP:0010052,increased grip strength
MGI:6208819	Dync1li2<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001399,hyperactivity|MP:0001529,abnormal vocalization|MP:0001925,male infertility|MP:0002075,abnormal coat/hair pigmentation
MGI:5311370	Dync2h1<b2b414Clo>	MP:0000428,abnormal craniofacial morphology|MP:0000452,abnormal mouth morphology|MP:0000520,absent kidney|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000572,abnormal autopod morphology|MP:0002092,abnormal eye morphology|MP:0002132,abnormal respiratory system morphology|MP:0002639,micrognathia|MP:0003321,tracheoesophageal fistula|MP:0004017,duplex kidney|MP:0005157,holoprosencephaly|MP:0006063,abnormal inferior vena cava morphology|MP:0006197,ocular hypotelorism|MP:0010406,common atrium|MP:0010413,complete atrioventricular septal defect|MP:0010476,coronary fistula|MP:0010551,abnormal coronary vessel morphology|MP:0010635,aorta pulmonary collateral arteries|MP:0010975,abnormal lung lobe morphology|MP:0011671,balanced complete atrioventricular canal|MP:0011672,unbalanced complete atrioventricular canal, left dominant
MGI:6156128	Dync2h1<em1(IMPC)Rbrc>	MP:0011100,preweaning lethality, complete penetrance
MGI:3623884	Dync2h1<Gt(RRM278)Byg>	MP:0002152,abnormal brain morphology|MP:0004252,abnormal direction of heart looping|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3578144	Dync2h1<lln>	MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0000955,abnormal spinal cord morphology|MP:0001706,abnormal left-right axis patterning|MP:0004252,abnormal direction of heart looping|MP:0005380,embryo phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3799301	Dync2h1<m152Asp>	MP:0000788,abnormal cerebral cortex morphology
MGI:3799308	Dync2h1<m407Asp>	MP:0003232,abnormal forebrain development
MGI:4355983	Dync2h1<mmi>	MP:0000937,abnormal motor neuron morphology
MGI:6756365	Dync2h1<pol>	MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0004131,abnormal motile primary cilium morphology|MP:0004252,abnormal direction of heart looping|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5287275	Dync2h1<Tg(Tyr)2307AOve>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4359237	Dync2h1<ttn>	MP:0013202,abnormal cilium morphology
MGI:6156579	Dync2i1<em1(IMPC)Tcp>	MP:0000266,abnormal heart morphology|MP:0000470,abnormal stomach morphology|MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:7580876	Dync2i1<Tn(pb-Act-RFP)1.1Zhu>	MP:0000562,polydactyly|MP:0000787,abnormal telencephalon morphology|MP:0001785,edema|MP:0003051,curly tail|MP:0004592,small mandible|MP:0005157,holoprosencephaly|MP:0010940,abnormal maxillary prominence morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012089,decreased midbrain size|MP:0012270,cardiac edema|MP:0013202,abnormal cilium morphology
MGI:6116689	Dync2i2<tm1Blnw>	MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001297,microphthalmia|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0002151,abnormal neural tube morphology|MP:0003054,spina bifida|MP:0003984,embryonic growth retardation|MP:0005650,abnormal limb bud morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011261,abnormal limb mesenchyme morphology|MP:0011685,abnormal limb paddle morphology|MP:0013203,abnormal primary cilium morphology|MP:0013213,abnormal embryonic neuroepithelium primary cilium morphology|MP:0020850,abnormal microtubule cytoskeleton morphology
MGI:7580877	Dync2i2<Tn(pb-Act-RFP)1.1Zhu>	MP:0000269,abnormal heart looping|MP:0000787,abnormal telencephalon morphology|MP:0000929,open neural tube|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012089,decreased midbrain size|MP:0013202,abnormal cilium morphology
MGI:3505858	Dync2li1<tm1Aar>	MP:0000925,abnormal floor plate morphology|MP:0000929,open neural tube|MP:0001701,incomplete embryo turning|MP:0001706,abnormal left-right axis patterning|MP:0001787,pericardial edema|MP:0002084,abnormal developmental patterning|MP:0002151,abnormal neural tube morphology|MP:0002825,abnormal notochord morphology|MP:0004131,abnormal motile primary cilium morphology|MP:0004132,absent embryonic cilia|MP:0004180,failure of initiation of embryo turning|MP:0004252,abnormal direction of heart looping|MP:0006108,abnormal hindbrain development|MP:0006281,abnormal tail development|MP:0008926,abnormal anterior definitive endoderm morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011260,abnormal head mesenchyme morphology|MP:0011998,decreased embryonic cilium length|MP:0012138,decreased forebrain size|MP:0030538,abnormal notochordal plate morphology
MGI:4368846	Dynll1<Gt(EUCE0287d04)Hmgu>	MP:0000644,dextrocardia|MP:0000914,exencephaly|MP:0001181,absent lungs|MP:0001297,microphthalmia|MP:0001785,edema|MP:0003178,left pulmonary isomerism|MP:0003641,small lung|MP:0004157,interrupted aortic arch|MP:0005262,coloboma|MP:0006126,abnormal cardiac outflow tract development|MP:0010808,right-sided stomach|MP:0011998,decreased embryonic cilium length|MP:0013203,abnormal primary cilium morphology|MP:0013213,abnormal embryonic neuroepithelium primary cilium morphology
MGI:5755433	Dynll1<tm1.1Jhh>	MP:0002169,no abnormal phenotype detected|MP:0004939,abnormal B cell morphology|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number
MGI:4419330	Dynll1<tm1(KOMP)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005344,increased circulating bilirubin level|MP:0005560,decreased circulating glucose level|MP:0010088,decreased circulating fructosamine level|MP:0011100,preweaning lethality, complete penetrance
MGI:7520901	Dynll2<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex
MGI:4432163	Dynlrb1<tm1a(EUCOMM)Wtsi>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0003651,abnormal axon extension|MP:0003795,abnormal bone structure|MP:0011092,embryonic lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:6466548	Dynlrb1<tm1c(EUCOMM)Wtsi>	MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0001525,impaired balance|MP:0003631,nervous system phenotype|MP:0004297,abnormal proprioceptive neuron morphology|MP:0004768,abnormal axonal transport
MGI:5052400	Dynlrb2<tm1a(KOMP)Wtsi>	MP:0001566,increased circulating phosphate level|MP:0001925,male infertility|MP:0002599,increased mean platelet volume|MP:0002833,increased heart weight|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010092,increased circulating magnesium level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:4820829	Dynlt2a1<tm1June>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0008280,abnormal male germ cell apoptosis|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009839,multiflagellated sperm
MGI:7859519	Dynlt2b<em1Ktmr>	MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005384,cellular phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009238,coiled sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0014636,decreased elongated spermatid number|MP:0020869,immotile sperm|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0031356,abnormal outer dense fiber morphology
MGI:7859520	Dynlt2b<em2Ktmr>	MP:0002169,no abnormal phenotype detected
MGI:4431764	Dynlt2b<tm1e(EUCOMM)Wtsi>	MP:0001925,male infertility|MP:0011940,decreased food intake
MGI:5708198	Dynlt2b<tm2b(EUCOMM)Wtsi>	MP:0001925,male infertility
MGI:4457572	Dynlt4<tm1e(EUCOMM)Wtsi>	MP:0000208,decreased hematocrit|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number
MGI:6149776	Dyrk1a<em1Kzy>	MP:0001262,decreased body weight|MP:0001529,abnormal vocalization|MP:0002175,decreased brain weight|MP:0002757,decreased vertical activity|MP:0003863,decreased aggression towards mice|MP:0008432,abnormal long-term spatial reference memory|MP:0008540,abnormal cerebral hemisphere morphology|MP:0009358,environmentally induced seizures|MP:0012088,abnormal midbrain size|MP:0012307,impaired spatial learning|MP:0014115,cognitive inflexibility|MP:0020351,decreased vocalization|MP:0021111,decreased social investigation
MGI:4338238	Dyrk1a<Gt(XQ0369)Wtsi>	MP:0004179,transmission ratio distortion|MP:0011092,embryonic lethality, complete penetrance
MGI:5648391	Dyrk1a<tm1Jdc>	MP:0000715,decreased thymocyte number|MP:0003077,abnormal cell cycle|MP:0005017,decreased B cell number|MP:0005092,decreased double-positive T cell number|MP:0006413,increased T cell apoptosis|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number
MGI:2386937	Dyrk1a<tm1Mla>	MP:0000433,microcephaly|MP:0000771,abnormal brain size|MP:0000774,decreased brain size|MP:0000812,abnormal dentate gyrus morphology|MP:0000832,abnormal thalamus morphology|MP:0000859,abnormal somatosensory cortex morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0002175,decreased brain weight|MP:0002834,decreased heart weight|MP:0002892,decreased superior colliculus size|MP:0003402,decreased liver weight|MP:0003861,abnormal nervous system development|MP:0003984,embryonic growth retardation|MP:0006105,small tectum|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012089,decreased midbrain size|MP:0012263,decreased hindbrain size|MP:0020083,decreased hippocampus volume|MP:0020568,abnormal premotor cortex morphology
MGI:7642198	Dyrk1b<em1Yax>	MP:0004486,decreased response of heart to induced stress|MP:0010768,mortality/aging
MGI:5548430	Dyrk1b<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0004738,abnormal auditory brainstem response|MP:0005016,decreased lymphocyte cell number|MP:0005566,decreased blood urea nitrogen level|MP:0005568,increased circulating total protein level|MP:0009141,increased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness|MP:0012361,decreased large unstained cell number
MGI:6336070	Dyrk2<em1(IMPC)Ics>	MP:0012361,decreased large unstained cell number
MGI:6711272	Dyrk2<tm1.1Kyos>	MP:0000111,cleft palate|MP:0000445,short snout|MP:0000547,short limbs|MP:0004449,absent presphenoid bone|MP:0004609,vertebral fusion|MP:0008385,absent basisphenoid bone|MP:0009609,absent basioccipital bone|MP:0009904,tongue hypoplasia|MP:0010082,sternebra fusion|MP:0011089,perinatal lethality, complete penetrance|MP:0013203,abnormal primary cilium morphology|MP:0020137,decreased bone mineralization
MGI:3831552	Dyrk3<tm1Dowo>	MP:0005397,hematopoietic system phenotype|MP:0008973,decreased erythroid progenitor cell number|MP:0031276,abnormal stress erythropoiesis
MGI:3713116	Dyrk4<tm1Dgen>	MP:0005389,reproductive system phenotype
MGI:2155603	Dyscalc2<C3H/HeJ>	MP:0002839,increased susceptibility to dystrophic cardiac calcinosis
MGI:2155601	Dyscalc2<C57BL/6J>	MP:0002838,decreased susceptibility to dystrophic cardiac calcinosis
MGI:2389353	Dyscalc3<C3H/HeJ>	MP:0002838,decreased susceptibility to dystrophic cardiac calcinosis
MGI:2389352	Dyscalc3<C57BL/6J>	MP:0002839,increased susceptibility to dystrophic cardiac calcinosis
MGI:2389351	Dyscalc4<C3H/HeJ>	MP:0002838,decreased susceptibility to dystrophic cardiac calcinosis
MGI:2389350	Dyscalc4<C57BL/6J>	MP:0002839,increased susceptibility to dystrophic cardiac calcinosis
MGI:1857883	Dysf<im>	MP:0000748,progressive muscle weakness|MP:0000752,dystrophic muscle
MGI:3055150	Dysf<prmd>	MP:0000759,abnormal skeletal muscle morphology|MP:0001513,limb grasping|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004262,abnormal physical strength|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009412,skeletal muscle fiber degeneration|MP:0009414,skeletal muscle fiber necrosis|MP:0009420,skeletal muscle endomysial fibrosis|MP:0013239,impaired skeletal muscle regeneration
MGI:6690810	Dysf<tm1.1Mdcb>	MP:0000604,amyloidosis|MP:0000752,dystrophic muscle|MP:0002106,abnormal muscle physiology|MP:0002908,delayed wound healing|MP:0009414,skeletal muscle fiber necrosis|MP:0009419,skeletal muscle fibrosis
MGI:2661116	Dysf<tm1Kcam>	MP:0000752,dystrophic muscle|MP:0003852,skeletal muscle necrosis|MP:0004121,abnormal sarcolemma morphology|MP:0004510,myositis|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009412,skeletal muscle fiber degeneration|MP:0009414,skeletal muscle fiber necrosis|MP:0009419,skeletal muscle fibrosis|MP:0010090,increased circulating creatine kinase level|MP:0013239,impaired skeletal muscle regeneration
MGI:3055139	Dysf<tm1Meho>	MP:0000759,abnormal skeletal muscle morphology|MP:0001513,limb grasping|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004262,abnormal physical strength|MP:0009399,increased skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009414,skeletal muscle fiber necrosis|MP:0009420,skeletal muscle endomysial fibrosis
MGI:6402623	Dytn<em1(IMPC)J>	MP:0000198,decreased circulating phosphate level|MP:0000218,increased leukocyte cell number|MP:0001415,increased exploration in new environment|MP:0002834,decreased heart weight|MP:0005333,decreased heart rate|MP:0010124,decreased bone mineral content
MGI:4841203	Dzank1<tm1a(KOMP)Wtsi>	MP:0010768,mortality/aging
MGI:5548739	Dzank1<tm1b(KOMP)Wtsi>	MP:0002574,increased vertical activity|MP:0006203,eye hemorrhage
MGI:6718494	Dzip1<em1Sasl>	MP:0000286,abnormal mitral valve morphology|MP:0006120,mitral valve prolapse|MP:0011951,increased cardiac stroke volume|MP:0013206,abnormal motile cilium morphology
MGI:7435644	Dzip1<em1Yxc>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0008545,absent sperm flagellum
MGI:6357885	Dzip1l<em1(IMPC)J>	MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002574,increased vertical activity|MP:0004738,abnormal auditory brainstem response|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape
MGI:5563494	Dzip1l<warpy>	MP:0000111,cleft palate|MP:0000522,kidney cortex cyst|MP:0000562,polydactyly|MP:0001299,abnormal eye distance/ position|MP:0002092,abnormal eye morphology|MP:0003255,bile duct proliferation|MP:0003675,kidney cyst|MP:0003917,increased kidney weight|MP:0004860,dilated kidney collecting duct|MP:0009050,dilated proximal convoluted tubule|MP:0010831,lethality, incomplete penetrance|MP:0011307,kidney medulla cyst|MP:0013294,prenatal lethality prior to heart atrial septation|MP:0031448,bilateral cleft upper lip
MGI:5557987	Dzip1<tm1.1Blnw>	MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0002151,abnormal neural tube morphology|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0013203,abnormal primary cilium morphology
MGI:6718491	Dzip1<tm1Sasl>	MP:0000286,abnormal mitral valve morphology|MP:0006120,mitral valve prolapse|MP:0010614,abnormal mitral valve cusp morphology
MGI:5563492	Dzip3<m1Anu>	MP:0008762,embryonic lethality
MGI:6266929	E130114P18Rik<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity
MGI:6281341	E130308A19Rik<em1(IMPC)J>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:5689821	E130311K13Rik<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0002941,increased circulating alanine transaminase level
MGI:5637520	E2f1<tm1.1Dgj>	MP:0004501,increased incidence of tumors by UV-induction|MP:0005379,endocrine/exocrine gland phenotype|MP:0005384,cellular phenotype|MP:0014762,impaired base-excision repair|MP:0014764,impaired double-strand DNA break repair
MGI:1857424	E2f1<tm1Meg>	MP:0000313,abnormal cell death|MP:0000623,decreased salivation|MP:0000709,enlarged thymus|MP:0000714,increased thymocyte number|MP:0001262,decreased body weight|MP:0001870,salivary gland inflammation|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0002408,abnormal double-positive T cell morphology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0003077,abnormal cell cycle|MP:0003205,testicular atrophy|MP:0004022,abnormal cone electrophysiology|MP:0004031,insulitis|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0004955,increased thymus weight|MP:0004974,decreased regulatory T cell number|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005015,increased T cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0005215,abnormal pancreatic islet morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0006043,decreased apoptosis|MP:0006071,abnormal retina progenitor cell morphology|MP:0006073,abnormal retina bipolar cell morphology|MP:0006309,decreased retina ganglion cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008515,thin retina outer nuclear layer|MP:0008566,increased interferon-gamma secretion|MP:0008699,increased interleukin-4 secretion
MGI:1857944	E2f1<tm1Njd>	MP:0000613,abnormal salivary gland morphology|MP:0001152,increased Leydig cell number|MP:0001154,seminiferous tubule degeneration|MP:0001203,increased sensitivity to skin irradiation|MP:0001262,decreased body weight|MP:0001272,increased metastatic potential|MP:0001560,abnormal circulating insulin level|MP:0001944,abnormal pancreas morphology|MP:0002020,increased tumor incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002163,abnormal gland morphology|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0003205,testicular atrophy|MP:0003452,abnormal parotid gland morphology|MP:0003793,abnormal submandibular gland morphology|MP:0004852,decreased testis weight|MP:0005215,abnormal pancreatic islet morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005220,abnormal exocrine pancreas morphology|MP:0005293,impaired glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0008716,increased lung non-small cell carcinoma incidence|MP:0009109,decreased pancreas weight|MP:0009168,decreased pancreatic islet number|MP:0009172,small pancreatic islets|MP:0009321,increased histiocytic sarcoma incidence|MP:0010025,decreased total body fat amount|MP:0010287,increased reproductive system tumor incidence|MP:0011168,abnormal fat cell differentiation|MP:0012431,increased lymphoma incidence|MP:0013440,abnormal exorbital lacrimal gland morphology|MP:0030016,increased adipocyte glucose uptake
MGI:2179111	E2f2<tm1Zubi>	MP:0000313,abnormal cell death|MP:0000685,abnormal immune system morphology|MP:0000691,enlarged spleen|MP:0001190,reddish skin|MP:0001790,abnormal immune system physiology|MP:0001846,increased inflammatory response|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002060,abnormal skin morphology|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0002357,abnormal spleen white pulp morphology|MP:0002743,glomerulonephritis|MP:0003944,abnormal T cell subpopulation ratio|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004952,increased spleen weight|MP:0005348,increased T cell proliferation|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005621,abnormal cell physiology|MP:0008049,increased memory T cell number|MP:0009004,progressive hair loss|MP:0011294,renal glomerulus hypertrophy|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0020519,renal glomerular immunoglobulin deposits
MGI:2177317	E2f3<tm1.1Gle>	MP:0010768,mortality/aging|MP:0011092,embryonic lethality, complete penetrance
MGI:2177428	E2f3<tm1.2Gle>	MP:0005621,abnormal cell physiology|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6160166	E2f3<tm1b(KOMP)Wtsi>	MP:0000432,abnormal head morphology|MP:0000443,abnormal snout morphology|MP:0001404,no spontaneous movement|MP:0001488,increased startle reflex|MP:0001697,abnormal embryo size|MP:0003960,increased lean body mass|MP:0004002,abnormal jejunum morphology|MP:0005293,impaired glucose tolerance|MP:0011100,preweaning lethality, complete penetrance
MGI:2177435	E2f3<tm1Lees>	MP:0000352,decreased cell proliferation|MP:0000420,ruffled hair|MP:0001855,abnormal atrial thrombosis|MP:0001861,lung inflammation|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0003077,abnormal cell cycle|MP:0003828,pulmonary edema|MP:0005621,abnormal cell physiology|MP:0006138,congestive heart failure|MP:0008489,slow postnatal weight gain|MP:0009431,decreased fetal weight|MP:0010334,pleural effusion|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0020409,abnormal cardiac thrombosis
MGI:3806814	E2f3<tm2.1Gle>	MP:0001783,decreased white adipose tissue amount|MP:0010768,mortality/aging
MGI:3840180	E2f3<tm2Lees>	MP:0003077,abnormal cell cycle|MP:0005621,abnormal cell physiology
MGI:3806817	E2f3<tm3.1Gle>	MP:0010768,mortality/aging
MGI:3840181	E2f3<tm3Lees>	MP:0002169,no abnormal phenotype detected
MGI:1888951	E2f4<tm1Jrn>	MP:0000208,decreased hematocrit|MP:0000248,macrocytosis|MP:0000334,decreased granulocyte number|MP:0000346,broad head|MP:0000445,short snout|MP:0000488,abnormal intestinal epithelium morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000496,abnormal small intestine morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000715,decreased thymocyte number|MP:0001209,spontaneous skin ulceration|MP:0001265,decreased body size|MP:0001400,hyperresponsive|MP:0001529,abnormal vocalization|MP:0001577,anemia|MP:0001823,thymus hypoplasia|MP:0001914,hemorrhage|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002424,abnormal reticulocyte morphology|MP:0002441,abnormal granulocyte morphology|MP:0004200,decreased fetal size|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008044,increased NK cell number|MP:0008108,abnormal small intestinal villus morphology|MP:0008142,decreased small intestinal villus size|MP:0010178,increased number of Howell-Jolly bodies|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013792,abnormal small intestine goblet cell morphology|MP:0013795,abnormal colon goblet cell morphology
MGI:1888952	E2f4<tm1Lees>	MP:0000049,abnormal middle ear morphology|MP:0000208,decreased hematocrit|MP:0000248,macrocytosis|MP:0000445,short snout|MP:0000477,abnormal intestine morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001429,dehydration|MP:0001529,abnormal vocalization|MP:0001577,anemia|MP:0001850,increased susceptibility to otitis media|MP:0001867,rhinitis|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002237,abnormal nasal cavity morphology|MP:0002244,abnormal turbinate morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002416,abnormal proerythroblast morphology|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0005449,abnormal food intake|MP:0008789,abnormal olfactory epithelium morphology|MP:0009395,increased nucleated erythrocyte cell number|MP:0010178,increased number of Howell-Jolly bodies|MP:0011086,postnatal lethality, incomplete penetrance|MP:0030189,broad snout|MP:0031276,abnormal stress erythropoiesis
MGI:5706731	E2f4<tm2.1Lees>	MP:0002169,no abnormal phenotype detected|MP:0011050,abnormal respiratory motile cilium morphology
MGI:1926192	E2f5<tm1Dli>	MP:0000074,abnormal neurocranium morphology|MP:0000420,ruffled hair|MP:0000788,abnormal cerebral cortex morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0001393,ataxia|MP:0001429,dehydration|MP:0001893,non-obstructive hydrocephaly|MP:0001916,intracerebral hemorrhage|MP:0001917,intraventricular hemorrhage|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0003632,abnormal nervous system morphology|MP:0006423,dilated rete testis|MP:0009257,dilated seminiferous tubule|MP:0010152,abnormal brain ependyma morphology|MP:0030316,enlarged neurocranium
MGI:7431365	E2f6<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000538,abnormal urinary bladder morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0001157,small seminal vesicle|MP:0001529,abnormal vocalization|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002100,abnormal tooth morphology|MP:0011874,enlarged urinary bladder|MP:0013129,abnormal tooth color
MGI:3582265	E2f6<tm1Hgmr>	MP:0002169,no abnormal phenotype detected
MGI:3790807	E2f6<tm1Lees>	MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0005384,cellular phenotype|MP:0005397,hematopoietic system phenotype
MGI:3617817	E2f6<tm1Sgau>	MP:0001152,increased Leydig cell number|MP:0002687,oligozoospermia|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0005384,cellular phenotype
MGI:3773722	E2f7<tm1.1Gle>	MP:0002169,no abnormal phenotype detected
MGI:3773724	E2f8<tm1.1Gle>	MP:0002169,no abnormal phenotype detected
MGI:5907607	E330023G01Rik<Tn(pb-Act-RFP)1.1Zhu>	MP:0000097,short maxilla|MP:0000120,malocclusion|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0001121,uterus hypoplasia|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001340,abnormal eyelid morphology|MP:0001923,reduced female fertility|MP:0002083,premature death|MP:0004537,abnormal palatine bone horizontal plate morphology|MP:0005287,narrow eye opening|MP:0011129,decreased tertiary ovarian follicle number|MP:0011130,absent tertiary ovarian follicles|MP:0012085,midface hypoplasia|MP:0014051,abnormal maxillary-premaxillary suture morphology|MP:0030082,long lower incisors
MGI:3050154	E4f1<tm1Pisc>	MP:0001648,abnormal apoptosis|MP:0001674,abnormal germ layer development|MP:0001698,decreased embryo size|MP:0004046,abnormal mitosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3578552	e9.58a	MP:0000592,short tail|MP:0001730,embryonic growth arrest|MP:0003051,curly tail|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3578547	e9.5a19c	MP:0000266,abnormal heart morphology|MP:0001730,embryonic growth arrest|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3711808	Eac1<C57BL/6ByJ>	MP:0003545,increased alcohol consumption
MGI:3711811	Eac2<BALB/cJ>	MP:0003546,decreased alcohol consumption
MGI:3711810	Eac2<C57BL/6ByJ>	MP:0003545,increased alcohol consumption
MGI:3711812	Eac3<C57BL/6ByJ>	MP:0003545,increased alcohol consumption
MGI:3711814	Eac4<C57BL/6ByJ>	MP:0003545,increased alcohol consumption
MGI:3711817	Eac5<C57BL/6ByJ>	MP:0003545,increased alcohol consumption
MGI:3711819	Eac6<C57BL/6ByJ>	MP:0003545,increased alcohol consumption
MGI:2155435	Eae10<SJL/J>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:2429572	Eae11<SJL/J>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:2156761	Eae12<SJL/J>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:2389273	Eae13<SJL/J>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:2157005	Eae14<C57BL/10>	MP:0000921,demyelination|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:2157872	Eae15<SJL/J>	MP:0021002,brain lesion
MGI:2157874	Eae16<SJL/J>	MP:0001846,increased inflammatory response|MP:0021002,brain lesion
MGI:2157861	Eae17<SJL/J>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:2157550	Eae18<NOD>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis
MGI:2157876	Eae19<SJL/J>	MP:0000921,demyelination
MGI:3586840	Eae1<A/J>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:3586841	Eae1<PL/J>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:2155282	Eae20<SJL/J>	MP:0000921,demyelination
MGI:2154824	Eae21<SJL/J>	MP:0001846,increased inflammatory response|MP:0021002,brain lesion
MGI:2157878	Eae22<SJL/J>	MP:0001846,increased inflammatory response|MP:0021002,brain lesion
MGI:2157880	Eae23<SJL/J>	MP:0001846,increased inflammatory response|MP:0021002,brain lesion
MGI:2445556	Eae25<SJL/J>	MP:0001846,increased inflammatory response|MP:0003632,abnormal nervous system morphology
MGI:2384624	Eae26<B10.RIII>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:3530265	Eae27<RIIIS/J>	MP:0006082,CNS inflammation
MGI:3530268	Eae2b<C57BL/10SnSg>	MP:0006082,CNS inflammation
MGI:2389477	Eae2<RIIIS/J>	MP:0003436,decreased susceptibility to induced arthritis
MGI:3586462	Eae30<SJL/J>	MP:0005403,abnormal nerve conduction
MGI:3586464	Eae31<SJL/J>	MP:0005403,abnormal nerve conduction
MGI:3586465	Eae32<C57BL/10SnSg>	MP:0005403,abnormal nerve conduction
MGI:3586467	Eae33<C57BL/10SnSg>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:3586469	Eae34<C57BL/10SnSg>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:3586471	Eae35<C57BL/10SnSg>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:3586474	Eae36<SJL/J>	MP:0005350,increased susceptibility to autoimmune disorder
MGI:3586475	Eae37<C57BL/10SnSg>	MP:0005350,increased susceptibility to autoimmune disorder
MGI:3586477	Eae38<C57BL/10SnSg>	MP:0005350,increased susceptibility to autoimmune disorder
MGI:3530267	Eae39<RIIIS/J>	MP:0006082,CNS inflammation
MGI:3530273	Eae41<C57BL/10SnSg>	MP:0006082,CNS inflammation
MGI:2155481	Eae42<C57BL/10SnSg>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis
MGI:2155482	Eae42<SJL/J>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:2156762	Eae43<B10.S/DvTe>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:2157441	Eae44a<B10.S/DvTe>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:2157442	Eae44a<SJL/J>	MP:0001847,brain inflammation
MGI:2157445	Eae44b<SJL/J>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis
MGI:2156869	Eae4<ABH>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:2157449	Eae5<SJL/J>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:2157446	Eae7<B10.S/DvTe>	MP:0001847,brain inflammation|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:2157447	Eae7<SJL/J>	MP:0001847,brain inflammation|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis
MGI:6690858	Eaf1<tm1.1Zhow>	MP:0003607,abnormal prostate gland physiology|MP:0003608,prostate gland inflammation|MP:0005389,reproductive system phenotype|MP:0009219,increased prostate intraepithelial neoplasia incidence
MGI:5548645	Eaf1<tm1b(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3834174	Eaf2<tm1Zhow>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001158,abnormal prostate gland morphology|MP:0001168,abnormal prostate gland epithelium morphology|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002083,premature death|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003607,abnormal prostate gland physiology|MP:0003608,prostate gland inflammation|MP:0004961,increased prostate gland weight|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0010300,increased skin tumor incidence|MP:0012431,increased lymphoma incidence
MGI:3608866	Eam<BALB/cBy>	MP:0001402,decreased locomotor activity
MGI:3608865	Eam<C57BL/6By>	MP:0001402,decreased locomotor activity
MGI:3836283	Eamcd1<A/WySn>	MP:0001856,myocarditis|MP:0008944,decreased sensitivity to induced cell death
MGI:3574856	Eamcd2<A/WySn>	MP:0001856,myocarditis
MGI:7868001	Ear2<em1(IMPC)Bay>	MP:0001258,decreased body length|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7425646	Ear6<em1(IMPC)Bay>	MP:0001486,abnormal startle reflex|MP:0010025,decreased total body fat amount
MGI:3609608	Earheal1<129X1/SvJ>	MP:0002724,enhanced wound healing
MGI:3609611	Earheal3<DBA/1J>	MP:0002724,enhanced wound healing
MGI:3609613	Earheal4<DBA/1J>	MP:0002724,enhanced wound healing
MGI:4359722	Ebag9<tm1Rehm>	MP:0002411,decreased susceptibility to bacterial infection|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005078,abnormal cytotoxic T cell physiology|MP:0008051,abnormal memory T cell physiology
MGI:6293851	Ebf1<em1(IMPC)Mbp>	MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0001404,no spontaneous movement|MP:0001711,abnormal placenta morphology|MP:0002060,abnormal skin morphology|MP:0002965,increased circulating serum albumin level|MP:0003068,enlarged kidney|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6199986	Ebf1<m1Btlr>	MP:0002491,decreased IgD level|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number
MGI:6199990	Ebf1<m2Btlr>	MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0002491,decreased IgD level|MP:0002494,increased IgM level|MP:0004978,decreased B-1 B cell number|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0008167,increased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0008207,decreased B-2 B cell number|MP:0008560,increased tumor necrosis factor secretion
MGI:6199994	Ebf1<M3Btlr>	MP:0004978,decreased B-1 B cell number|MP:0005015,increased T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number
MGI:6268783	Ebf1<M4Btlr>	MP:0005017,decreased B cell number|MP:0008045,decreased NK cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0012764,increased alpha-beta T cell number
MGI:6286040	Ebf1<M5Btlr>	MP:0002619,abnormal lymphocyte morphology|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number
MGI:6286045	Ebf1<m6Btlr>	MP:0002491,decreased IgD level|MP:0002619,abnormal lymphocyte morphology|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010845,decreased effector memory CD4-positive, alpha-beta T cell number|MP:0012764,increased alpha-beta T cell number
MGI:5007783	Ebf1<Serv>	MP:0005017,decreased B cell number
MGI:5316286	Ebf1<tm1.1Rug>	MP:0001802,arrested B cell differentiation|MP:0004978,decreased B-1 B cell number|MP:0005014,increased B cell number|MP:0005093,decreased B cell proliferation|MP:0005387,immune system phenotype|MP:0008178,decreased germinal center B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008192,abnormal germinal center B cell physiology|MP:0008209,decreased pre-B cell number|MP:0008215,decreased immature B cell number|MP:0008482,decreased spleen germinal center number|MP:0008495,decreased IgG1 level|MP:0008498,decreased IgG3 level|MP:0008782,increased B cell apoptosis
MGI:1928729	Ebf1<tm1Rug>	MP:0000130,abnormal trabecular bone morphology|MP:0000333,decreased bone marrow cell number|MP:0000847,abnormal metencephalon morphology|MP:0001265,decreased body size|MP:0001802,arrested B cell differentiation|MP:0001806,decreased IgM level|MP:0002083,premature death|MP:0002397,abnormal bone marrow morphology|MP:0002628,hepatic steatosis|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003795,abnormal bone structure|MP:0004077,abnormal striatum morphology|MP:0004103,abnormal ventral striatum morphology|MP:0004277,abnormal lateral ganglionic eminence morphology|MP:0004939,abnormal B cell morphology|MP:0004984,increased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0005397,hematopoietic system phenotype|MP:0008128,abnormal brain internal capsule morphology|MP:0008202,absent B-1 B cells|MP:0008208,decreased pro-B cell number|MP:0008212,absent mature B cells|MP:0008271,abnormal bone ossification|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009347,increased trabecular bone thickness|MP:0010860,abnormal anterior commissure pars posterior morphology|MP:0012468,decreased striatum size|MP:0020137,decreased bone mineralization|MP:0020138,delayed bone mineralization
MGI:6279917	Ebf2<em1(IMPC)Mbp>	MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0001325,abnormal retina morphology|MP:0001404,no spontaneous movement|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001926,female infertility|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002637,small uterus|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0002997,enlarged seminal vesicle|MP:0003068,enlarged kidney|MP:0003231,abnormal placenta vasculature|MP:0003743,abnormal facial morphology|MP:0003900,shortened QT interval|MP:0005293,impaired glucose tolerance|MP:0010571,shortened ST segment|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011495,abnormal head shape
MGI:2446576	Ebf2<tm1.1Ggc>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000867,abnormal cerebellum anterior vermis morphology|MP:0000880,decreased Purkinje cell number|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002764,short tibia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0004991,decreased bone strength|MP:0009115,abnormal fat cell morphology|MP:0013624,decreased femur compact bone thickness|MP:0020010,decreased bone mineral density of femur
MGI:5052069	Ebf2<tm1Ddr>	MP:0005279,narcolepsy|MP:0008415,abnormal neurite morphology|MP:0008948,decreased neuron number
MGI:2446575	Ebf2<tm1Ggc>	MP:0000837,abnormal hypothalamus morphology|MP:0000849,abnormal cerebellum morphology|MP:0001146,abnormal testis morphology|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001505,hunched posture|MP:0001732,postnatal growth retardation|MP:0001752,abnormal hypothalamus secretion|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001940,testis hypoplasia|MP:0002160,abnormal reproductive system morphology|MP:0002161,abnormal fertility/fecundity|MP:0002216,abnormal seminiferous tubule morphology|MP:0002631,abnormal epididymis morphology|MP:0002651,abnormal sciatic nerve morphology|MP:0004853,abnormal ovary size|MP:0008814,decreased nerve conduction velocity
MGI:3037977	Ebf2<tm1Reed>	MP:0000819,abnormal olfactory bulb morphology|MP:0002566,abnormal sexual interaction|MP:0002741,small olfactory bulb|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012014,abnormal olfactory neuron innervation pattern
MGI:3714342	Ebf2<tm2.1(Zfp423)Reed>	MP:0000819,abnormal olfactory bulb morphology|MP:0001265,decreased body size|MP:0005236,abnormal olfactory nerve morphology|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0008789,abnormal olfactory epithelium morphology|MP:0011827,impaired neuron differentiation
MGI:3714341	Ebf2<tm2(Zfp423)Reed>	MP:0002169,no abnormal phenotype detected|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0008789,abnormal olfactory epithelium morphology|MP:0011827,impaired neuron differentiation
MGI:5461560	Ebf2<tm3.1(Zfp423*)Reed>	MP:0003631,nervous system phenotype
MGI:5461559	Ebf2<tm3(Zfp423*)Reed>	MP:0003631,nervous system phenotype
MGI:3037961	Ebf3<tm1Reed>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0002741,small olfactory bulb|MP:0011087,neonatal lethality, complete penetrance
MGI:6384599	Ebf4<em1(IMPC)Bay>	MP:0001257,increased body length
MGI:3793965	Ebi3<Gt716Lex>	MP:0001828,abnormal T cell activation|MP:0001847,brain inflammation|MP:0003354,astrocytosis|MP:0005425,increased macrophage cell number|MP:0008073,abnormal CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008566,increased interferon-gamma secretion|MP:0008661,decreased interleukin-10 secretion|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:2448308	Ebi3<tm1Rsb>	MP:0000685,abnormal immune system morphology|MP:0001790,abnormal immune system physiology|MP:0002433,abnormal T-helper 1 cell morphology|MP:0002434,abnormal T-helper 2 cell morphology|MP:0005027,increased susceptibility to parasitic infection|MP:0008045,decreased NK cell number|MP:0008091,decreased T-helper 2 cell number|MP:0008539,decreased susceptibility to induced colitis|MP:0008566,increased interferon-gamma secretion|MP:0008700,decreased interleukin-4 secretion
MGI:6856862	Ebna1bp2<em1(IMPC)Tcp>	MP:0000691,enlarged spleen|MP:0001120,abnormal uterus morphology|MP:0001417,decreased exploration in new environment|MP:0003068,enlarged kidney|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012111,failure of morula compaction|MP:0013292,embryonic lethality prior to organogenesis
MGI:1857832	Ebp<Td>	MP:0000414,alopecia|MP:0001195,flaky skin|MP:0001212,skin lesions|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1857338	Ebp<Td-ho>	MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0003396,abnormal embryonic hematopoiesis|MP:0004229,abnormal embryonic erythropoiesis|MP:0004230,abnormal embryonic erythrocyte morphology|MP:0008770,decreased survivor rate|MP:0011091,prenatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1856853	ec	MP:0001296,macrophthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001305,enlarged lens|MP:0001306,small lens|MP:0001994,increased blinking frequency|MP:0003236,abnormal lens capsule morphology|MP:0008841,ruptured lens capsule|MP:0011697,lens vacuoles|MP:0031428,lens dislocation
MGI:3032538	Eccp<1Jrt>	MP:0001303,abnormal lens morphology|MP:0001314,cornea opacity|MP:0001319,irregularly shaped pupil|MP:0001326,retina degeneration|MP:0002638,abnormal pupillary reflex|MP:0005391,vision/eye phenotype
MGI:4415329	Ecd<tm1.1Viba>	MP:0011100,preweaning lethality, complete penetrance
MGI:2158947	Ece1<tm1Reh>	MP:0000040,decreased middle ear ossicle number|MP:0000273,overriding aortic valve|MP:0000274,enlarged heart|MP:0000284,double outlet right ventricle|MP:0001048,absent enteric neurons|MP:0001613,abnormal vasodilation|MP:0002191,abnormal artery morphology|MP:0002192,hydrops fetalis|MP:0002633,persistent truncus arteriosus|MP:0003138,absent tympanic ring|MP:0003494,parathyroid hypoplasia|MP:0003499,thyroid gland hypoplasia|MP:0003798,abnormal Harderian gland pigmentation|MP:0004157,interrupted aortic arch|MP:0004159,double aortic arch|MP:0004204,absent stapes|MP:0004318,absent incus|MP:0004319,absent malleus|MP:0004423,abnormal temporal bone squamous part morphology|MP:0004439,absent Meckel's cartilage|MP:0004460,alisphenoid bone hypoplasia|MP:0004475,palatine bone hypoplasia|MP:0004592,small mandible|MP:0005312,pericardial effusion|MP:0005508,abnormal skeleton morphology|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0006355,abnormal sixth pharyngeal arch artery morphology|MP:0006356,abnormal third pharyngeal arch artery morphology|MP:0008023,abnormal styloid process morphology|MP:0009388,abnormal epidermal melanocyte morphology|MP:0009525,abnormal submandibular duct morphology|MP:0009707,absent external auditory canal|MP:0009867,abnormal ascending aorta morphology|MP:0009905,absent tongue|MP:0010191,abnormal choroid melanocyte morphology|MP:0010402,ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010426,abnormal heart and great artery attachment|MP:0010465,aberrant origin of the right subclavian artery|MP:0010486,absent right subclavian artery|MP:0010572,persistent right dorsal aorta|MP:0010720,absent sublingual duct|MP:0010722,persistent cervical thymus|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012310,persistent ductus caroticus|MP:0013917,persistent right 6th pharyngeal arch artery|MP:0030122,temporal bone squamous part hypoplasia|MP:0030992,atrioventricular cushion hypoplasia
MGI:2181668	Ece2<tm1Ywa>	MP:0003631,nervous system phenotype
MGI:6160000	Ecel1<em1Hiki>	MP:0000940,abnormal motor neuron innervation pattern|MP:0001070,abnormal abducens nerve morphology|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002961,abnormal axon guidance|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0012055,abnormal phrenic nerve innervation pattern to diaphragm
MGI:6160056	Ecel1<em2Hiki>	MP:0000940,abnormal motor neuron innervation pattern|MP:0001052,abnormal innervation pattern to muscle|MP:0001070,abnormal abducens nerve morphology|MP:0001953,respiratory failure|MP:0002961,abnormal axon guidance|MP:0011089,perinatal lethality, complete penetrance|MP:0012055,abnormal phrenic nerve innervation pattern to diaphragm
MGI:4462383	Ecel1<tm1Hiki>	MP:0000761,thin diaphragm muscle|MP:0000940,abnormal motor neuron innervation pattern|MP:0001052,abnormal innervation pattern to muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001078,abnormal phrenic nerve morphology|MP:0001953,respiratory failure|MP:0003631,nervous system phenotype|MP:0011087,neonatal lethality, complete penetrance|MP:0012055,abnormal phrenic nerve innervation pattern to diaphragm
MGI:3629091	Ecel1<tm1Jroh>	MP:0001177,atelectasis|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002316,anoxia|MP:0003631,nervous system phenotype|MP:0005385,cardiovascular system phenotype|MP:0005390,skeleton phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:5692640	Ech1<tm1b(EUCOMM)Wtsi>	MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount
MGI:6376198	Echdc1<em1(IMPC)J>	MP:0000182,increased circulating LDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0003975,increased circulating VLDL triglyceride level|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:6361232	Echs1<em1(IMPC)Hmgu>	MP:0002764,short tibia
MGI:6458749	Echs1<em1Jynz>	MP:0001547,abnormal lipid level|MP:0010358,abnormal free fatty acids level|MP:0011092,embryonic lethality, complete penetrance
MGI:2180887	Eci1<tm1Wst>	MP:0001547,abnormal lipid level|MP:0005283,increased unsaturated fatty acids level|MP:0005317,increased triglyceride level|MP:0009643,abnormal urine homeostasis
MGI:5548579	Eci3<tm1b(EUCOMM)Wtsi>	MP:0002941,increased circulating alanine transaminase level
MGI:5692542	Ecm1<tm1b(EUCOMM)Hmgu>	MP:0000222,decreased neutrophil cell number|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4940879	Ecm1<tm1Bsun>	MP:0002083,premature death|MP:0002492,decreased IgE level|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005387,immune system phenotype|MP:0005466,abnormal T-helper 2 physiology|MP:0005597,decreased susceptibility to type I hypersensitivity reaction
MGI:6147390	Ecpas<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001529,abnormal vocalization|MP:0001566,increased circulating phosphate level|MP:0002075,abnormal coat/hair pigmentation|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:6386762	Ecpas<em1Plch>	MP:0002882,abnormal neuron morphology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0004008,abnormal GABA-mediated receptor currents|MP:0010733,abnormal axon initial segment morphology|MP:0011987,abnormal GABAergic neuron physiology
MGI:6355397	Ecrg4<tm1.1Toko>	MP:0008414,abnormal spatial reference memory|MP:0012206,increased neuronal stem cell self-renewal|MP:0012306,enhanced spatial learning
MGI:5766758	Ecrg4<tm1b(EUCOMM)Hmgu>	MP:0001257,increased body length|MP:0002764,short tibia|MP:0005178,increased circulating cholesterol level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010393,shortened QRS complex duration|MP:0011960,abnormal eye anterior chamber depth|MP:0012361,decreased large unstained cell number
MGI:5006988	Ecrg4<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:5583063	Ecscr<tm1.1(KOMP)Vlcg>	MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0000955,abnormal spinal cord morphology|MP:0001157,small seminal vesicle|MP:0002059,abnormal seminal vesicle morphology|MP:0002135,abnormal kidney morphology|MP:0002631,abnormal epididymis morphology|MP:0003068,enlarged kidney|MP:0004931,enlarged epididymis
MGI:4364516	Ecscr<tm1a(KOMP)Wtsi>	MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0003443,increased circulating glycerol level|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005670,abnormal white adipose tissue physiology|MP:0008034,enhanced lipolysis
MGI:5140166	Ecscr<tm1Iked>	MP:0001914,hemorrhage|MP:0003544,abnormal vascular endothelial cell migration|MP:0003711,pathological neovascularization|MP:0020322,decreased vascular endothelial cell apoptosis
MGI:5503987	Ecsit<mpc178H>	MP:0005330,cardiomyopathy
MGI:2683025	Ecsit<tm1Gho>	MP:0000352,decreased cell proliferation|MP:0001680,abnormal mesoderm development|MP:0001683,absent mesoderm|MP:0001698,decreased embryo size|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011190,thick embryonic epiblast
MGI:2678389	Ect2<Gt(pT1ATGBetageo)1Ruiz>	MP:0011091,prenatal lethality, complete penetrance
MGI:5433509	Ect2<tm1.2Cjd>	MP:0002718,abnormal inner cell mass morphology|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5548931	Ect2<tm1b(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0004738,abnormal auditory brainstem response|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:1861195	Ed	MP:0002110,abnormal digit morphology
MGI:3039665	Eda2r<tm1Vmd>	MP:0002169,no abnormal phenotype detected
MGI:6286370	Eda<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000274,enlarged heart|MP:0001944,abnormal pancreas morphology|MP:0002060,abnormal skin morphology
MGI:8209579	Eda<em1Ywu>	MP:0000675,abnormal eccrine sweat gland morphology|MP:0010771,integument phenotype|MP:0013371,hypohidrosis|MP:0030457,abnormal molar cusp morphology
MGI:8209580	Eda<em2Ywu>	MP:0000379,decreased hair follicle number|MP:0000416,sparse hair|MP:0000675,abnormal eccrine sweat gland morphology|MP:0006402,small molars|MP:0009651,abnormal eyelid development|MP:0013371,hypohidrosis|MP:0014139,abnormal ectoderm morphology|MP:0030457,abnormal molar cusp morphology|MP:0030496,taurodontia
MGI:8209581	Eda<em3Ywu>	MP:0000675,abnormal eccrine sweat gland morphology|MP:0010771,integument phenotype|MP:0013371,hypohidrosis|MP:0030457,abnormal molar cusp morphology
MGI:8209582	Eda<em4Ywu>	MP:0000379,decreased hair follicle number|MP:0000416,sparse hair|MP:0000577,absent eccrine glands|MP:0000585,kinked tail|MP:0005382,craniofacial phenotype|MP:0006400,decreased molar number|MP:0006402,small molars|MP:0009651,abnormal eyelid development|MP:0010233,hairless tail|MP:0013371,hypohidrosis|MP:0014139,abnormal ectoderm morphology|MP:0030457,abnormal molar cusp morphology|MP:0030496,taurodontia
MGI:1856832	Edaradd<cr>	MP:0000367,abnormal coat/ hair morphology|MP:0000379,decreased hair follicle number|MP:0000382,underdeveloped hair follicles|MP:0000416,sparse hair|MP:0000417,short hair|MP:0000418,focal hair loss|MP:0000422,delayed hair appearance|MP:0000585,kinked tail|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000876,Purkinje cell degeneration|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001199,thin skin|MP:0001216,abnormal epidermal layer morphology|MP:0001244,thin dermal layer|MP:0001262,decreased body weight|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001340,abnormal eyelid morphology|MP:0001386,abnormal maternal nurturing|MP:0001547,abnormal lipid level|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0001943,abnormal respiration|MP:0002060,abnormal skin morphology|MP:0002073,abnormal hair growth|MP:0002074,abnormal hair texture|MP:0002075,abnormal coat/hair pigmentation|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002095,abnormal skin pigmentation|MP:0002100,abnormal tooth morphology|MP:0002152,abnormal brain morphology|MP:0002177,abnormal outer ear morphology|MP:0002277,abnormal respiratory mucosa morphology|MP:0002576,abnormal enamel morphology|MP:0003312,abnormal locomotor coordination|MP:0003704,abnormal hair follicle development|MP:0003717,pallor|MP:0005287,narrow eye opening|MP:0005358,abnormal incisor morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0006236,absent Meibomian glands|MP:0006365,absent guard hair|MP:0006366,absent zigzag hairs|MP:0006400,decreased molar number|MP:0006402,small molars|MP:0009267,abnormal cerebellum fissure morphology|MP:0009825,cornea ulcer|MP:0009956,abnormal cerebellar layer morphology|MP:0012078,abnormal tail ring morphology|MP:0013897,decreased eyelid cilium number|MP:0030457,abnormal molar cusp morphology
MGI:3778293	Edaradd<cr-2Btlr>	MP:0000017,big ears|MP:0000418,focal hair loss|MP:0001265,decreased body size|MP:0001510,abnormal coat appearance|MP:0001943,abnormal respiration
MGI:3027636	Edaradd<cr-2J>	MP:0000585,kinked tail
MGI:3027289	Edaradd<cr-3J>	MP:0000416,sparse hair|MP:0001921,reduced fertility|MP:0001950,abnormal respiratory sounds|MP:0002111,abnormal tail morphology
MGI:3778290	Edaradd<cr-Btlr>	MP:0000418,focal hair loss|MP:0000585,kinked tail|MP:0002100,abnormal tooth morphology|MP:0013176,abnormal tail position or orientation
MGI:6467489	Edaradd<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:1856016	Edar<dl>	MP:0000125,absent incisors|MP:0000367,abnormal coat/ hair morphology|MP:0000400,abnormal awl hair morphology|MP:0000408,absent duvet hair|MP:0000411,shiny fur|MP:0000416,sparse hair|MP:0000418,focal hair loss|MP:0000427,abnormal hair cycle|MP:0000585,kinked tail|MP:0001510,abnormal coat appearance|MP:0002073,abnormal hair growth|MP:0002074,abnormal hair texture|MP:0002100,abnormal tooth morphology|MP:0002689,abnormal molar morphology|MP:0003704,abnormal hair follicle development|MP:0004033,supernumerary teeth|MP:0005358,abnormal incisor morphology|MP:0006042,increased apoptosis|MP:0006363,absent auchene hairs|MP:0006365,absent guard hair|MP:0006366,absent zigzag hairs|MP:0006400,decreased molar number|MP:0006402,small molars|MP:0009003,abnormal vibrissa number|MP:0010233,hairless tail|MP:0011100,preweaning lethality, complete penetrance|MP:0030079,small incisors
MGI:6200340	Edar<dl-2Btlr>	MP:0000372,irregular coat pigmentation|MP:0000418,focal hair loss
MGI:3778288	Edar<dl-Btlr>	MP:0000418,focal hair loss|MP:0000585,kinked tail|MP:0002100,abnormal tooth morphology|MP:0013176,abnormal tail position or orientation
MGI:1856018	Edar<dl-J>	MP:0000367,abnormal coat/ hair morphology|MP:0000378,absent hair follicles|MP:0000400,abnormal awl hair morphology|MP:0000408,absent duvet hair|MP:0001510,abnormal coat appearance|MP:0002075,abnormal coat/hair pigmentation|MP:0003791,abnormal minor salivary gland morphology|MP:0005409,darkened coat color|MP:0006236,absent Meibomian glands|MP:0006258,abnormal circumvallate papillae morphology|MP:0006363,absent auchene hairs|MP:0006365,absent guard hair|MP:0006367,absent sweat gland|MP:0009533,absent palatine gland|MP:0009534,absent anterior lingual gland|MP:0010864,abnormal enamel knot morphology|MP:0013458,decreased eccrine gland number
MGI:1856017	Edar<Dl-slk>	MP:0000125,absent incisors|MP:0001510,abnormal coat appearance|MP:0002100,abnormal tooth morphology|MP:0003931,absent molars|MP:0005358,abnormal incisor morphology|MP:0006400,decreased molar number|MP:0006402,small molars|MP:0009003,abnormal vibrissa number|MP:0030079,small incisors|MP:0030457,abnormal molar cusp morphology|MP:0030494,abnormal molar root morphology
MGI:5314348	Edar<Dl-slk2H>	MP:0003849,greasy coat|MP:0005409,darkened coat color|MP:0010233,hairless tail
MGI:1858018	Edar<Tg(OVE1A)Ove>	MP:0001304,cataract
MGI:1857813	Edar<Tg(OVE1B)Ove>	MP:0000377,abnormal hair follicle morphology|MP:0000416,sparse hair|MP:0000418,focal hair loss|MP:0000585,kinked tail|MP:0001304,cataract|MP:0003849,greasy coat|MP:0006236,absent Meibomian glands|MP:0006365,absent guard hair
MGI:5484581	Edar<tm1.1Bamo>	MP:0000400,abnormal awl hair morphology|MP:0000405,abnormal auchene hair morphology|MP:0000662,abnormal branching of the mammary ductal tree|MP:0005379,endocrine/exocrine gland phenotype|MP:0008904,abnormal mammary fat pad morphology|MP:0013457,increased eccrine gland number
MGI:5548453	Edar<tm1b(KOMP)Wtsi>	MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1856197	Eda<Ta>	MP:0000125,absent incisors|MP:0000367,abnormal coat/ hair morphology|MP:0000372,irregular coat pigmentation|MP:0000397,abnormal guard hair morphology|MP:0000418,focal hair loss|MP:0000572,abnormal autopod morphology|MP:0000577,absent eccrine glands|MP:0000585,kinked tail|MP:0001199,thin skin|MP:0001218,thin epidermis|MP:0001284,absent vibrissae|MP:0001340,abnormal eyelid morphology|MP:0001510,abnormal coat appearance|MP:0002073,abnormal hair growth|MP:0002074,abnormal hair texture|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0002095,abnormal skin pigmentation|MP:0002132,abnormal respiratory system morphology|MP:0002233,abnormal nose morphology|MP:0002237,abnormal nasal cavity morphology|MP:0002277,abnormal respiratory mucosa morphology|MP:0002576,abnormal enamel morphology|MP:0002689,abnormal molar morphology|MP:0003704,abnormal hair follicle development|MP:0004381,abnormal hair follicle melanocyte morphology|MP:0004830,short incisors|MP:0005287,narrow eye opening|MP:0005358,abnormal incisor morphology|MP:0005508,abnormal skeleton morphology|MP:0006236,absent Meibomian glands|MP:0006365,absent guard hair|MP:0006366,absent zigzag hairs|MP:0006370,abnormal hair follicle pheomelanosome pheomelanin content|MP:0006371,absent hair follicle pheomelanosome pheomelanin|MP:0006400,decreased molar number|MP:0006402,small molars|MP:0008538,decreased zigzag hair amount|MP:0009003,abnormal vibrissa number|MP:0009652,abnormal palatal rugae morphology|MP:0009659,striated fur|MP:0010231,transverse fur striping|MP:0010233,hairless tail|MP:0012078,abnormal tail ring morphology|MP:0013177,abnormal tail tip morphology|MP:0013370,anhidrosis|MP:0013580,abnormal nasal gland morphology|MP:0013582,abnormal lateral nasal gland morphology|MP:0030457,abnormal molar cusp morphology|MP:0030494,abnormal molar root morphology
MGI:1858152	Eda<Ta-10J>	MP:0000367,abnormal coat/ hair morphology|MP:0000372,irregular coat pigmentation|MP:0000585,kinked tail|MP:0002073,abnormal hair growth|MP:0002075,abnormal coat/hair pigmentation|MP:0002111,abnormal tail morphology|MP:0005287,narrow eye opening|MP:0009659,striated fur|MP:0010231,transverse fur striping|MP:0010233,hairless tail
MGI:1858153	Eda<Ta-23H>	MP:0000367,abnormal coat/ hair morphology|MP:0000372,irregular coat pigmentation|MP:0000585,kinked tail|MP:0002073,abnormal hair growth|MP:0002075,abnormal coat/hair pigmentation|MP:0006366,absent zigzag hairs|MP:0009659,striated fur|MP:0010231,transverse fur striping|MP:0010233,hairless tail|MP:0012078,abnormal tail ring morphology
MGI:1858154	Eda<Ta-26H>	MP:0002073,abnormal hair growth|MP:0002074,abnormal hair texture|MP:0002075,abnormal coat/hair pigmentation|MP:0002832,coarse hair|MP:0005371,limbs/digits/tail phenotype|MP:0005382,craniofacial phenotype|MP:0010231,transverse fur striping
MGI:5304933	Eda<Ta-27H>	MP:0010233,hairless tail
MGI:5304934	Eda<Ta-28H>	MP:0001302,eyelids open at birth|MP:0010233,hairless tail
MGI:1858155	Eda<Ta-29H>	MP:0000119,abnormal tooth eruption|MP:0000367,abnormal coat/ hair morphology|MP:0000585,kinked tail|MP:0002073,abnormal hair growth|MP:0002074,abnormal hair texture|MP:0002075,abnormal coat/hair pigmentation|MP:0005287,narrow eye opening|MP:0006365,absent guard hair|MP:0006366,absent zigzag hairs|MP:0009003,abnormal vibrissa number|MP:0009659,striated fur|MP:0010231,transverse fur striping|MP:0010233,hairless tail|MP:0012078,abnormal tail ring morphology
MGI:1858156	Eda<Ta-30H>	MP:0000119,abnormal tooth eruption|MP:0000367,abnormal coat/ hair morphology|MP:0000585,kinked tail|MP:0002073,abnormal hair growth|MP:0002074,abnormal hair texture|MP:0002075,abnormal coat/hair pigmentation|MP:0005287,narrow eye opening|MP:0006365,absent guard hair|MP:0006366,absent zigzag hairs|MP:0009003,abnormal vibrissa number|MP:0009659,striated fur|MP:0010231,transverse fur striping|MP:0010233,hairless tail|MP:0012078,abnormal tail ring morphology
MGI:1858157	Eda<Ta-32H>	MP:0000119,abnormal tooth eruption|MP:0000367,abnormal coat/ hair morphology|MP:0000585,kinked tail|MP:0002073,abnormal hair growth|MP:0002074,abnormal hair texture|MP:0002075,abnormal coat/hair pigmentation|MP:0002111,abnormal tail morphology|MP:0005287,narrow eye opening|MP:0006365,absent guard hair|MP:0006366,absent zigzag hairs|MP:0009003,abnormal vibrissa number|MP:0009659,striated fur|MP:0010231,transverse fur striping|MP:0010233,hairless tail
MGI:1858158	Eda<Ta-33H>	MP:0002073,abnormal hair growth|MP:0002074,abnormal hair texture|MP:0002075,abnormal coat/hair pigmentation|MP:0002832,coarse hair|MP:0005371,limbs/digits/tail phenotype|MP:0005382,craniofacial phenotype|MP:0010231,transverse fur striping
MGI:5304937	Eda<Ta-35H>	MP:0003815,hairless|MP:0010233,hairless tail
MGI:5450862	Eda<Ta-36H>	MP:0002111,abnormal tail morphology
MGI:5304938	Eda<Ta-37H>	MP:0003815,hairless|MP:0010233,hairless tail
MGI:5304939	Eda<Ta-38H>	MP:0000116,abnormal tooth development|MP:0005176,eyelids fail to open|MP:0010233,hairless tail
MGI:1862031	Eda<Ta-40H>	MP:0002075,abnormal coat/hair pigmentation
MGI:5509473	Eda<Ta-43H>	MP:0001926,female infertility|MP:0002100,abnormal tooth morphology|MP:0005287,narrow eye opening|MP:0009003,abnormal vibrissa number|MP:0009659,striated fur|MP:0013558,abnormal exocrine gland morphology
MGI:1856552	Eda<Ta-4J>	MP:0010231,transverse fur striping
MGI:1856201	Eda<Ta-5J>	MP:0009652,abnormal palatal rugae morphology
MGI:1856202	Eda<Ta-6J>	MP:0000367,abnormal coat/ hair morphology|MP:0000417,short hair|MP:0000418,focal hair loss|MP:0000577,absent eccrine glands|MP:0001262,decreased body weight|MP:0001312,abnormal cornea morphology|MP:0001313,increased incidence of corneal inflammation|MP:0001314,cornea opacity|MP:0001851,eye inflammation|MP:0001852,conjunctivitis|MP:0002001,blindness|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0003136,yellow coat color|MP:0005251,blepharitis|MP:0005287,narrow eye opening|MP:0005542,cornea vascularization|MP:0006000,abnormal cornea epithelium morphology|MP:0006236,absent Meibomian glands|MP:0006365,absent guard hair|MP:0006366,absent zigzag hairs|MP:0006400,decreased molar number|MP:0006401,absent male preputial gland|MP:0009652,abnormal palatal rugae morphology|MP:0013478,corneal limbitis|MP:0013745,abnormal eyelid margin morphology
MGI:1858159	Eda<Ta-9J>	MP:0000367,abnormal coat/ hair morphology|MP:0000372,irregular coat pigmentation|MP:0000585,kinked tail|MP:0002073,abnormal hair growth|MP:0002075,abnormal coat/hair pigmentation|MP:0002111,abnormal tail morphology|MP:0005287,narrow eye opening|MP:0009659,striated fur|MP:0010231,transverse fur striping|MP:0010233,hairless tail
MGI:1856200	Eda<Ta-By>	MP:0000585,kinked tail|MP:0001510,abnormal coat appearance|MP:0002073,abnormal hair growth|MP:0002074,abnormal hair texture|MP:0002111,abnormal tail morphology|MP:0005287,narrow eye opening|MP:0006365,absent guard hair|MP:0010233,hairless tail
MGI:1856199	Eda<Ta-J>	MP:0000396,increased curvature of hairs|MP:0000416,sparse hair|MP:0000418,focal hair loss
MGI:6156550	Edc3<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001146,abnormal testis morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002599,increased mean platelet volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0003068,enlarged kidney|MP:0003604,single kidney|MP:0011874,enlarged urinary bladder
MGI:4433903	Edc4<tm1a(EUCOMM)Wtsi>	MP:0002875,decreased erythrocyte cell number|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:6361108	Eddm13<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6459754	Eddm3b<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5700046	Eddm3b<tm1b(KOMP)Wtsi>	MP:0002606,increased basophil cell number|MP:0002753,dilated heart left ventricle|MP:0005011,increased eosinophil cell number|MP:0005102,abnormal iris pigmentation
MGI:6336117	Edem1<em1(IMPC)Kmpc>	MP:0000194,increased circulating calcium level|MP:0001556,increased circulating HDL cholesterol level|MP:0002599,increased mean platelet volume|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content
MGI:6162234	Edem3<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0001404,no spontaneous movement|MP:0001491,unresponsive to tactile stimuli|MP:0002075,abnormal coat/hair pigmentation|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:6780026	Edil3<em1Gha>	MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:6117667	Edil3<Tg(lacZ)1Tq>	MP:0003724,increased susceptibility to induced arthritis|MP:0005390,skeleton phenotype|MP:0006433,abnormal articular cartilage morphology|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0014103,increased chondrocyte apoptosis|MP:0020290,floppy ears|MP:0030423,abnormal pinna cartilage morphology
MGI:3817261	Edil3<tm1Tq>	MP:0002463,abnormal neutrophil physiology|MP:0003628,abnormal leukocyte adhesion|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009858,abnormal cellular extravasation|MP:0020333,enhanced leukocyte tethering or rolling
MGI:3573945	Edn1<tm1.1Ywa>	MP:0000428,abnormal craniofacial morphology|MP:0002127,abnormal cardiovascular system morphology|MP:0005385,cardiovascular system phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:1857637	Edn1<tm1Utj>	MP:0000049,abnormal middle ear morphology|MP:0000111,cleft palate|MP:0000114,cleft chin|MP:0000272,abnormal aorta morphology|MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000460,mandible hypoplasia|MP:0000762,abnormal tongue morphology|MP:0002127,abnormal cardiovascular system morphology|MP:0002318,hypercapnia|MP:0002329,abnormal blood gas level|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0002754,dilated heart right ventricle|MP:0002842,increased systemic arterial blood pressure|MP:0003056,abnormal hyoid bone morphology|MP:0004136,abnormal tongue muscle morphology|MP:0004181,abnormal carotid artery morphology|MP:0004183,abnormal sympathetic nervous system physiology|MP:0004205,absent hyoid bone|MP:0004875,increased mean systemic arterial blood pressure|MP:0005039,hypoxia|MP:0005579,absent outer ear|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006337,abnormal first pharyngeal arch morphology|MP:0006344,small second pharyngeal arch|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0009524,absent submandibular gland|MP:0010402,ventricular septal defect|MP:0010486,absent right subclavian artery|MP:0010543,aorta tubular hypoplasia|MP:0010544,interrupted aorta|MP:0011089,perinatal lethality, complete penetrance|MP:0030427,abnormal neck muscle morphology
MGI:3044563	Edn1<tm1Ywa>	MP:0000231,hypertension|MP:0002136,abnormal kidney physiology|MP:0002169,no abnormal phenotype detected|MP:0003620,oliguria|MP:0004217,salt-sensitive hypertension|MP:0004486,decreased response of heart to induced stress|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005367,renal/urinary system phenotype|MP:0005380,embryo phenotype|MP:0005385,cardiovascular system phenotype|MP:0005611,decreased circulating antidiuretic hormone level|MP:0005634,decreased circulating sodium level|MP:0006144,increased systemic arterial systolic blood pressure|MP:0006263,decreased systemic arterial diastolic blood pressure|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006317,decreased urine sodium level|MP:0008055,increased urine osmolality|MP:0009643,abnormal urine homeostasis
MGI:4438396	Edn2<tm1.1Nat>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002318,hypercapnia|MP:0003016,increased circulating bicarbonate level|MP:0003030,acidemia|MP:0003031,acidosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005534,decreased body temperature|MP:0005560,decreased circulating glucose level|MP:0010025,decreased total body fat amount|MP:0010768,mortality/aging|MP:0010902,abnormal pulmonary alveolar sac morphology|MP:0011049,impaired adaptive thermogenesis|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5544096	Edn2<tm1.2Nat>	MP:0001265,decreased body size|MP:0005391,vision/eye phenotype|MP:0011085,postnatal lethality, complete penetrance
MGI:5603356	Edn2<tm1b(KOMP)Mbp>	MP:0011100,preweaning lethality, complete penetrance
MGI:5519239	Edn2<tm1Ywa>	MP:0000255,blood vessel congestion|MP:0000746,weakness|MP:0001127,small ovary|MP:0001133,impaired luteal cell differentiation|MP:0001134,absent corpus luteum|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002318,hypercapnia|MP:0002575,increased circulating ketone body level|MP:0002608,increased hematocrit|MP:0002637,small uterus|MP:0002971,abnormal brown adipose tissue morphology|MP:0003016,increased circulating bicarbonate level|MP:0003030,acidemia|MP:0003031,acidosis|MP:0003948,abnormal gas homeostasis|MP:0005039,hypoxia|MP:0005185,decreased circulating progesterone level|MP:0005376,homeostasis/metabolism phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005479,decreased circulating triiodothyronine level|MP:0005534,decreased body temperature|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0008032,abnormal lipolysis|MP:0008770,decreased survivor rate|MP:0008821,increased blood uric acid level|MP:0009642,abnormal blood homeostasis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010902,abnormal pulmonary alveolar sac morphology|MP:0010937,increased total lung capacity|MP:0011049,impaired adaptive thermogenesis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011285,increased circulating erythropoietin level|MP:0013609,abnormal ovarian medulla morphology|MP:0031420,decreased superovulation rate
MGI:1856392	Edn3<ls>	MP:0001045,abnormal enteric ganglia morphology|MP:0002731,megacolon|MP:0002940,variable body spotting|MP:0005075,abnormal melanosome morphology|MP:0009783,abnormal melanoblast morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:1857160	Edn3<tm1Ywa>	MP:0000495,abnormal colon morphology|MP:0001048,absent enteric neurons|MP:0002083,premature death|MP:0002926,aganglionic megacolon|MP:0002940,variable body spotting|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3589247	Edn3<tmgc48>	MP:0002557,abnormal social/conspecific interaction behavior|MP:0002940,variable body spotting|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5618847	Ednra<m1Mhda>	MP:0000022,abnormal ear shape|MP:0000024,lowered ear position|MP:0000029,abnormal malleus morphology|MP:0000088,short mandible|MP:0000120,malocclusion|MP:0000435,shortened head|MP:0000438,abnormal cranium morphology|MP:0000445,short snout|MP:0000454,abnormal jaw morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001296,macrophthalmia|MP:0001489,decreased startle reflex|MP:0001943,abnormal respiration|MP:0002309,abnormal vital capacity|MP:0002311,abnormal inspiratory capacity|MP:0002639,micrognathia|MP:0004469,abnormal zygomatic arch morphology|MP:0004595,abnormal mandibular condyloid process morphology|MP:0004739,conductive hearing loss|MP:0005270,abnormal zygomatic bone morphology|MP:0006325,impaired hearing|MP:0009142,decreased prepulse inhibition|MP:0010030,abnormal orbit morphology|MP:0010771,integument phenotype|MP:0010896,decreased lung compliance|MP:0010938,decreased total lung capacity|MP:0011210,abnormal temporomandibular joint morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0030072,round face|MP:0030092,abnormal outer ear helix morphology|MP:0030104,round orbits|MP:0030109,abnormal incudomalleolar joint morphology|MP:0030247,prominent cheeks|MP:0030261,abnormal temporal bone zygomatic process morphology|MP:0030319,abnormal temporal bone petrous part morphology|MP:0030351,wide coronal suture|MP:0030353,wide sagittal suture|MP:0030357,wide lambdoid suture|MP:0030395,absent incus short process|MP:0030416,absent temporal bone zygomatic process
MGI:5644807	Ednra<tm1b(EUCOMM)Hmgu>	MP:0000428,abnormal craniofacial morphology|MP:0001304,cataract|MP:0003743,abnormal facial morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:3773699	Ednra<tm1Hku>	MP:0000029,abnormal malleus morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0003056,abnormal hyoid bone morphology|MP:0003138,absent tympanic ring|MP:0003235,abnormal alisphenoid bone morphology|MP:0004189,abnormal alveolar process morphology|MP:0004452,abnormal pterygoid process morphology|MP:0005107,abnormal stapes morphology|MP:0005249,abnormal palatine bone morphology|MP:0005270,abnormal zygomatic bone morphology|MP:0008381,absent gonial bone|MP:0011089,perinatal lethality, complete penetrance|MP:0030261,abnormal temporal bone zygomatic process morphology|MP:0030299,lower jaw to upper jaw transformation|MP:0030323,short styloid process|MP:0030416,absent temporal bone zygomatic process
MGI:1857473	Ednra<tm1Ywa>	MP:0000114,cleft chin|MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000452,abnormal mouth morphology|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0000460,mandible hypoplasia|MP:0000614,absent salivary gland|MP:0001065,abnormal trigeminal nerve morphology|MP:0001068,abnormal mandibular nerve branching|MP:0001071,abnormal facial nerve morphology|MP:0001823,thymus hypoplasia|MP:0002108,abnormal muscle morphology|MP:0002127,abnormal cardiovascular system morphology|MP:0002177,abnormal outer ear morphology|MP:0002191,abnormal artery morphology|MP:0002338,abnormal pulmonary ventilation|MP:0002633,persistent truncus arteriosus|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0003007,ectopic thymus|MP:0003138,absent tympanic ring|MP:0003139,patent ductus arteriosus|MP:0003235,abnormal alisphenoid bone morphology|MP:0003755,abnormal palate morphology|MP:0004159,double aortic arch|MP:0004181,abnormal carotid artery morphology|MP:0004204,absent stapes|MP:0004318,absent incus|MP:0004319,absent malleus|MP:0004439,absent Meckel's cartilage|MP:0004468,small zygomatic bone|MP:0004787,abnormal dorsal aorta morphology|MP:0005105,abnormal middle ear ossicle morphology|MP:0005249,abnormal palatine bone morphology|MP:0005508,abnormal skeleton morphology|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006019,absent tympanic membrane|MP:0006337,abnormal first pharyngeal arch morphology|MP:0006344,small second pharyngeal arch|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0006355,abnormal sixth pharyngeal arch artery morphology|MP:0006356,abnormal third pharyngeal arch artery morphology|MP:0008023,abnormal styloid process morphology|MP:0008381,absent gonial bone|MP:0009524,absent submandibular gland|MP:0009867,abnormal ascending aorta morphology|MP:0009904,tongue hypoplasia|MP:0010418,perimembraneous ventricular septal defect|MP:0010465,aberrant origin of the right subclavian artery|MP:0010486,absent right subclavian artery|MP:0010543,aorta tubular hypoplasia|MP:0010544,interrupted aorta|MP:0010572,persistent right dorsal aorta|MP:0011089,perinatal lethality, complete penetrance|MP:0011665,d-loop transposition of the great arteries|MP:0013262,abnormal mouth floor morphology|MP:0013917,persistent right 6th pharyngeal arch artery|MP:0030228,absent tubotympanic recess|MP:0030299,lower jaw to upper jaw transformation
MGI:3773698	Ednra<tm2.1Hku>	MP:0004439,absent Meckel's cartilage|MP:0005272,abnormal temporal bone morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:3836966	Ednra<tm2Hku>	MP:0011089,perinatal lethality, complete penetrance
MGI:2687362	Ednra<tm2Ywa>	MP:0000029,abnormal malleus morphology|MP:0000088,short mandible|MP:0000428,abnormal craniofacial morphology|MP:0000458,abnormal mandible morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002169,no abnormal phenotype detected|MP:0002987,abnormal urine osmolality|MP:0004318,absent incus|MP:0004319,absent malleus|MP:0004439,absent Meckel's cartilage|MP:0005106,abnormal incus morphology|MP:0005107,abnormal stapes morphology|MP:0005358,abnormal incisor morphology|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005382,craniofacial phenotype|MP:0005385,cardiovascular system phenotype|MP:0005610,increased circulating antidiuretic hormone level|MP:0008797,facial cleft|MP:0009904,tongue hypoplasia|MP:0013262,abnormal mouth floor morphology
MGI:3773700	Ednra<tm3(Ednrb)Hku>	MP:0000458,abnormal mandible morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0003056,abnormal hyoid bone morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:5693851	Ednra<tm6(Edn1)Hku>	MP:0000104,abnormal sphenoid bone morphology|MP:0000454,abnormal jaw morphology|MP:0000458,abnormal mandible morphology|MP:0001284,absent vibrissae|MP:0001302,eyelids open at birth|MP:0003716,anteriorly rotated ears|MP:0004235,abnormal masseter muscle morphology|MP:0004423,abnormal temporal bone squamous part morphology|MP:0005105,abnormal middle ear ossicle morphology|MP:0005107,abnormal stapes morphology|MP:0005249,abnormal palatine bone morphology|MP:0005587,abnormal Meckel's cartilage morphology|MP:0008380,abnormal gonial bone morphology|MP:0009800,abnormal mandibular nerve morphology|MP:0010150,abnormal mandibular ramus morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0030110,incudomalleolar fusion|MP:0030258,small mandibular condyloid process|MP:0030284,short mandibular coronoid process|MP:0030300,upper jaw to lower jaw transformation
MGI:5693853	Ednra<tm7(Hand2)Hku>	MP:0004423,abnormal temporal bone squamous part morphology|MP:0004899,absent temporal bone squamous part|MP:0005587,abnormal Meckel's cartilage morphology|MP:0008380,abnormal gonial bone morphology|MP:0008381,absent gonial bone|MP:0011089,perinatal lethality, complete penetrance|MP:0030300,upper jaw to lower jaw transformation
MGI:1856148	Ednrb<s>	MP:0002731,megacolon|MP:0002938,white spotting|MP:0002940,variable body spotting|MP:0005174,abnormal tail pigmentation|MP:0009379,abnormal foot pigmentation|MP:0010016,variable depigmentation
MGI:3850186	Ednrb<s-12MNURn>	MP:0002938,white spotting|MP:0011085,postnatal lethality, complete penetrance
MGI:5308101	Ednrb<s-136H>	MP:0000373,belly spot|MP:0002938,white spotting|MP:0002939,head spot
MGI:2155794	Ednrb<s-13Pub>	MP:0001265,decreased body size|MP:0011091,prenatal lethality, complete penetrance
MGI:1857328	Ednrb<s-15DttMb>	MP:0001078,abnormal phrenic nerve morphology|MP:0001265,decreased body size|MP:0002152,abnormal brain morphology|MP:0002279,abnormal diaphragm morphology|MP:0003632,abnormal nervous system morphology|MP:0005508,abnormal skeleton morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:5311840	Ednrb<s-160H>	MP:0002938,white spotting
MGI:5311841	Ednrb<s-161H>	MP:0002938,white spotting
MGI:5308102	Ednrb<s-162H>	MP:0001265,decreased body size|MP:0002938,white spotting
MGI:2155795	Ednrb<s-17FrS>	MP:0002731,megacolon|MP:0002938,white spotting|MP:0011085,postnatal lethality, complete penetrance
MGI:1857330	Ednrb<s-17Pub>	MP:0001265,decreased body size|MP:0011100,preweaning lethality, complete penetrance
MGI:1857325	Ednrb<s-1Acrg>	MP:0001265,decreased body size|MP:0011091,prenatal lethality, complete penetrance
MGI:1857326	Ednrb<s-1Chlc>	MP:0002731,megacolon|MP:0002938,white spotting|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2155796	Ednrb<s-1MLPf>	MP:0001265,decreased body size|MP:0011091,prenatal lethality, complete penetrance
MGI:2155797	Ednrb<s-1Pu>	MP:0001265,decreased body size|MP:0011091,prenatal lethality, complete penetrance
MGI:2155802	Ednrb<s-1XMLP>	MP:0001265,decreased body size|MP:0011091,prenatal lethality, complete penetrance
MGI:2155803	Ednrb<s-1XMLPc>	MP:0001265,decreased body size|MP:0011091,prenatal lethality, complete penetrance
MGI:1857331	Ednrb<s-24Pub>	MP:0001265,decreased body size|MP:0011100,preweaning lethality, complete penetrance
MGI:2155810	Ednrb<s-27Pu>	MP:0001265,decreased body size|MP:0011091,prenatal lethality, complete penetrance
MGI:1857332	Ednrb<s-27Pub>	MP:0002731,megacolon|MP:0002938,white spotting|MP:0011085,postnatal lethality, complete penetrance
MGI:2155811	Ednrb<s-29Pub>	MP:0001265,decreased body size|MP:0011091,prenatal lethality, complete penetrance
MGI:5607170	Ednrb<s-2Btlr>	MP:0002940,variable body spotting|MP:0008569,lethality at weaning
MGI:2155812	Ednrb<s-2CHLd>	MP:0001265,decreased body size|MP:0011100,preweaning lethality, complete penetrance
MGI:2155814	Ednrb<s-2Etopc>	MP:0001265,decreased body size|MP:0011091,prenatal lethality, complete penetrance
MGI:2155815	Ednrb<s-2MLPl>	MP:0001265,decreased body size|MP:0011091,prenatal lethality, complete penetrance
MGI:2155838	Ednrb<s-31Pub>	MP:0001265,decreased body size|MP:0011091,prenatal lethality, complete penetrance
MGI:1857333	Ednrb<s-36Pub>	MP:0000163,abnormal cartilage morphology|MP:0000351,increased cell proliferation|MP:0000431,absent palatine bone horizontal plate|MP:0001265,decreased body size|MP:0003154,abnormal soft palate morphology|MP:0003632,abnormal nervous system morphology|MP:0004760,increased mitotic index|MP:0005170,cleft upper lip|MP:0005508,abnormal skeleton morphology|MP:0008271,abnormal bone ossification|MP:0009652,abnormal palatal rugae morphology|MP:0009655,abnormal secondary palate development|MP:0009886,failure of palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0009898,maxillary shelf hypoplasia|MP:0011087,neonatal lethality, complete penetrance
MGI:6198508	Ednrb<s-3Btlr>	MP:0000373,belly spot
MGI:2155839	Ednrb<s-3CHLo>	MP:0002731,megacolon|MP:0002938,white spotting|MP:0011085,postnatal lethality, complete penetrance
MGI:2155840	Ednrb<s-3Etopf>	MP:0001265,decreased body size|MP:0011091,prenatal lethality, complete penetrance
MGI:2155841	Ednrb<s-48UThc>	MP:0001265,decreased body size|MP:0011091,prenatal lethality, complete penetrance
MGI:2155849	Ednrb<s-4Blec>	MP:0001265,decreased body size|MP:0011091,prenatal lethality, complete penetrance
MGI:1857327	Ednrb<s-4Chlc>	MP:0001265,decreased body size|MP:0011100,preweaning lethality, complete penetrance
MGI:1857329	Ednrb<s-4Pub>	MP:0001265,decreased body size|MP:0011100,preweaning lethality, complete penetrance
MGI:2155852	Ednrb<s-52Pub>	MP:0001265,decreased body size|MP:0011091,prenatal lethality, complete penetrance
MGI:2155855	Ednrb<s-9ThW>	MP:0001265,decreased body size|MP:0011091,prenatal lethality, complete penetrance
MGI:5516429	Ednrb<s-Btlr>	MP:0002940,variable body spotting|MP:0011083,lethality at weaning, complete penetrance
MGI:1856149	Ednrb<s-l>	MP:0000026,abnormal inner ear morphology|MP:0000048,abnormal stria vascularis morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0001048,absent enteric neurons|MP:0002075,abnormal coat/hair pigmentation|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002622,abnormal cochlear hair cell morphology|MP:0002731,megacolon|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0004302,abnormal Deiters cell morphology|MP:0008786,abnormal hindgut morphology|MP:0010741,abnormal melanocyte proliferation|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011494,abnormal pigmentation pattern
MGI:5501500	Ednrb<s+Ms>	MP:0001186,pigmentation phenotype
MGI:5804183	Ednrb<tm1.1Nrd>	MP:0001265,decreased body size|MP:0001574,abnormal oxygen level|MP:0002075,abnormal coat/hair pigmentation|MP:0002731,megacolon|MP:0002938,white spotting|MP:0003027,abnormal blood pH regulation|MP:0003032,hypocapnia|MP:0003394,increased cardiac output|MP:0004486,decreased response of heart to induced stress|MP:0004875,increased mean systemic arterial blood pressure|MP:0005150,cachexia|MP:0005600,increased heart ventricle muscle contractility|MP:0011083,lethality at weaning, complete penetrance|MP:0013404,decreased circulating lactate level
MGI:3795226	Ednrb<tm1.1Yko>	MP:0002938,white spotting|MP:0003270,intestinal obstruction|MP:0005591,decreased vasodilation|MP:0011085,postnatal lethality, complete penetrance
MGI:3640402	Ednrb<tm1Myks>	MP:0002083,premature death|MP:0002731,megacolon|MP:0003091,abnormal cell migration|MP:0005171,absent coat pigmentation
MGI:3813973	Ednrb<tm1Nrd>	MP:0009388,abnormal epidermal melanocyte morphology|MP:0012023,decreased melanocyte number
MGI:3693642	Ednrb<tm1Yko>	MP:0002842,increased systemic arterial blood pressure|MP:0003620,oliguria|MP:0003957,abnormal nitric oxide homeostasis|MP:0005385,cardiovascular system phenotype|MP:0005583,decreased renin activity|MP:0005591,decreased vasodilation|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0006274,abnormal urine sodium level|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis
MGI:1857161	Ednrb<tm1Ywa>	MP:0000495,abnormal colon morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0001732,postnatal growth retardation|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0002926,aganglionic megacolon|MP:0002938,white spotting|MP:0003043,hypoalgesia|MP:0003270,intestinal obstruction|MP:0004381,abnormal hair follicle melanocyte morphology|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005087,decreased acute inflammation|MP:0005100,abnormal choroid pigmentation|MP:0005150,cachexia|MP:0010016,variable depigmentation|MP:0010155,abnormal intestine physiology|MP:0013795,abnormal colon goblet cell morphology|MP:0014484,decreased feces water content
MGI:2674291	Ednrb<WS4>	MP:0000031,abnormal cochlea morphology|MP:0000043,organ of Corti degeneration|MP:0000048,abnormal stria vascularis morphology|MP:0001963,abnormal hearing physiology|MP:0001967,deafness|MP:0002083,premature death|MP:0002731,megacolon|MP:0002940,variable body spotting|MP:0004362,cochlear hair cell degeneration|MP:0004364,thin stria vascularis|MP:0006010,absent strial intermediate cells
MGI:6120786	Eea1<tm1b(EUCOMM)Hmgu>	MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3611895	Eed<lusk>	MP:0000371,diluted coat color|MP:0002427,disproportionate dwarf
MGI:5524154	Eef1a1<tm1(FBXW7*)Iaai>	MP:0002006,neoplasm|MP:0010308,decreased tumor latency
MGI:6693287	Eef1a1<tm1Klan>	MP:0001454,abnormal cued conditioning behavior|MP:0009456,impaired cued conditioning behavior
MGI:3837679	Eef1a1<tm1(Kras*)Arge>	MP:0001883,increased mammary adenocarcinoma incidence|MP:0008762,embryonic lethality|MP:0010299,increased mammary gland tumor incidence|MP:0014237,decreased tumor-free survival time
MGI:5692071	Eef1a1<tm1Tcrl>	MP:0000929,open neural tube|MP:0003054,spina bifida|MP:0005157,holoprosencephaly|MP:0011085,postnatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011400,lethality, complete penetrance
MGI:5491024	Eef1a1<tm2Arge>	MP:0002408,abnormal double-positive T cell morphology|MP:0009278,abnormal bone marrow cell physiology|MP:0010336,increased acute lymphoblastic leukemia incidence
MGI:7277681	Eef1a2<em1Abb>	MP:0000951,sporadic seizures|MP:0000955,abnormal spinal cord morphology|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002183,gliosis|MP:0002229,neurodegeneration
MGI:7277680	Eef1a2<em#Abb>	MP:0000955,abnormal spinal cord morphology|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0004819,decreased skeletal muscle mass|MP:0004924,abnormal behavior|MP:0010053,decreased grip strength
MGI:1857093	Eef1a2<wst>	MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0000921,demyelination|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0001052,abnormal innervation pattern to muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001263,weight loss|MP:0001405,impaired coordination|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002083,premature death|MP:0002108,abnormal muscle morphology|MP:0002183,gliosis|MP:0002217,small lymph nodes|MP:0002223,lymphoid hypoplasia|MP:0002914,abnormal endplate potential|MP:0003444,abnormal neurotransmitter uptake|MP:0003644,thymus atrophy|MP:0003990,decreased neurotransmitter release|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008098,decreased plasma cell number|MP:0008489,slow postnatal weight gain|MP:0008866,chromosomal instability|MP:0009434,paraparesis
MGI:5660733	Eef1akmt2<tm1b(EUCOMM)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0006243,impaired pupillary reflex
MGI:5823412	Eef1b2<em1(IMPC)J>	MP:0000062,increased bone mineral density|MP:0000063,decreased bone mineral density|MP:0001284,absent vibrissae|MP:0001399,hyperactivity|MP:0001489,decreased startle reflex|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0010053,decreased grip strength|MP:0010123,increased bone mineral content|MP:0010124,decreased bone mineral content
MGI:7425647	Eef1d<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001314,cornea opacity|MP:0001325,abnormal retina morphology|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0004738,abnormal auditory brainstem response|MP:0006203,eye hemorrhage|MP:0011100,preweaning lethality, complete penetrance
MGI:6467473	Eef1d<tm1.2Mkma>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001454,abnormal cued conditioning behavior|MP:0001496,audiogenic seizures|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0003061,decreased aerobic running capacity|MP:0003997,tonic-clonic seizures|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0006254,thin cerebral cortex|MP:0012507,midbrain atrophy|MP:0013272,abnormal translation|MP:0020354,increased endoplasmic reticulum stress|MP:0030003,hippocampus atrophy
MGI:3574590	Eef1e1<Gt(OST377244)Lex>	MP:0000351,increased cell proliferation|MP:0002018,increased malignant tumor incidence|MP:0003077,abnormal cell cycle|MP:0009336,increased splenocyte proliferation|MP:0009341,decreased splenocyte apoptosis|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance
MGI:5766155	Eef2kmt<tm1b(EUCOMM)Wtsi>	MP:0005293,impaired glucose tolerance|MP:0005573,increased pulmonary respiratory rate
MGI:5759976	Eef2k<tm1.1Cgpd>	MP:0004811,abnormal neuron physiology|MP:0008944,decreased sensitivity to induced cell death
MGI:4819586	Eef2k<tm1Agry>	MP:0001125,abnormal oocyte morphology|MP:0001130,abnormal ovarian folliculogenesis|MP:0003107,abnormal response to novelty|MP:0003699,abnormal female reproductive system physiology|MP:0006043,decreased apoptosis|MP:0008871,abnormal ovarian follicle number|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009006,prolonged estrous cycle|MP:0009017,prolonged estrus|MP:0009083,uterus hypertrophy|MP:0011120,increased primordial ovarian follicle number|MP:0011124,increased primary ovarian follicle number|MP:0011128,increased tertiary ovarian follicle number|MP:0013475,delayed reproductive senescence|MP:0031383,increased secondary ovarian follicle number|MP:0031421,increased superovulation rate
MGI:5441712	Eef2<tm1.1Lepp>	MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0005384,cellular phenotype|MP:0005621,abnormal cell physiology|MP:0008932,abnormal embryonic tissue physiology|MP:0008944,decreased sensitivity to induced cell death|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0011088,neonatal lethality, incomplete penetrance
MGI:7425648	Eefsec<em1(IMPC)Hmgu>	MP:0001523,impaired righting response|MP:0011100,preweaning lethality, complete penetrance
MGI:6513232	Eeig1<tm1Soyle>	MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010768,mortality/aging
MGI:6342819	Eepd1<em1(IMPC)J>	MP:0001566,increased circulating phosphate level
MGI:8190679	Eepd1<em1Lju>	MP:0000008,increased white adipose tissue amount|MP:0002079,increased circulating insulin level|MP:0002971,abnormal brown adipose tissue morphology|MP:0003212,increased susceptibility to age related obesity|MP:0004890,decreased energy expenditure|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005658,increased susceptibility to diet-induced obesity|MP:0009118,increased white fat cell size|MP:0010024,increased total body fat amount|MP:0011049,impaired adaptive thermogenesis|MP:0014142,increased body fat mass
MGI:8190723	Eepd1<em2Lju>	MP:0002079,increased circulating insulin level|MP:0004890,decreased energy expenditure|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0006094,increased fat cell size|MP:0009118,increased white fat cell size|MP:0009119,increased brown fat cell size|MP:0010024,increased total body fat amount|MP:0011049,impaired adaptive thermogenesis|MP:0014142,increased body fat mass
MGI:6120787	Efcab14<tm1b(KOMP)Wtsi>	MP:0002753,dilated heart left ventricle|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005333,decreased heart rate|MP:0010123,increased bone mineral content|MP:0011965,decreased total retina thickness
MGI:6120736	Efcab2<tm1b(EUCOMM)Wtsi>	MP:0003733,abnormal retina inner nuclear layer morphology
MGI:6153325	Efcab3<em1(IMPC)Wtsi>	MP:0005238,increased brain size|MP:0008535,enlarged lateral ventricles|MP:0008914,enlarged cerebellum|MP:0020563,increased pontine nuclei size
MGI:6195014	Efcab3<tm1.1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6423824	Efcab5<em1(IMPC)Mbp>	MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0004832,enlarged ovary
MGI:5707302	Efcab6<tm1.1(KOMP)Vlcg>	MP:0010053,decreased grip strength
MGI:5912016	Efcab7<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response|MP:0005567,decreased circulating total protein level
MGI:6356320	Efcab9<em1Chng>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0002674,abnormal sperm motility|MP:0004543,abnormal sperm physiology|MP:0008892,abnormal sperm flagellum morphology
MGI:6356321	Efcab9<em2Chng>	MP:0001922,reduced male fertility
MGI:6367978	Efcc1<em1(IMPC)Tcp>	MP:0002060,abnormal skin morphology|MP:0005562,decreased mean corpuscular hemoglobin
MGI:5695896	Efemp1<tm1.1(KOMP)Vlcg>	MP:0000494,abnormal cecum morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3774265	Efemp1<tm1Eap>	MP:0002092,abnormal eye morphology|MP:0005201,abnormal retina pigment epithelium morphology
MGI:3604387	Efemp1<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:3770755	Efemp1<tm1Lmar>	MP:0003099,retina detachment|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology|MP:0005548,retina pigment epithelium atrophy|MP:0006238,abnormal choriocapillaris morphology
MGI:3776015	Efemp1<tm2Lmar>	MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000159,abnormal xiphoid process morphology|MP:0000160,kyphosis|MP:0000493,rectal prolapse|MP:0000689,abnormal spleen morphology|MP:0000757,herniated abdominal wall|MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001265,decreased body size|MP:0001510,abnormal coat appearance|MP:0001921,reduced fertility|MP:0001924,infertility|MP:0001935,decreased litter size|MP:0002073,abnormal hair growth|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0002160,abnormal reproductive system morphology|MP:0002832,coarse hair|MP:0003103,liver degeneration|MP:0003385,abnormal body wall morphology|MP:0003402,decreased liver weight|MP:0003786,premature aging|MP:0003918,decreased kidney weight|MP:0004953,decreased spleen weight|MP:0004970,kidney atrophy|MP:0005114,premature hair loss|MP:0005155,herniated intestine|MP:0005376,homeostasis/metabolism phenotype|MP:0005391,vision/eye phenotype|MP:0005421,loose skin|MP:0006077,inguinal hernia|MP:0008418,abnormal cutaneous elastic fiber morphology|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0010025,decreased total body fat amount|MP:0010239,decreased skeletal muscle weight
MGI:5660409	Efemp2<tm1.1Chu>	MP:0000274,enlarged heart|MP:0000414,alopecia|MP:0000550,abnormal forelimb morphology|MP:0001183,overexpanded pulmonary alveolus|MP:0001244,thin dermal layer|MP:0001344,blepharoptosis|MP:0001954,respiratory distress|MP:0005421,loose skin|MP:0008418,abnormal cutaneous elastic fiber morphology|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0009862,abnormal aorta elastic tissue morphology|MP:0009865,abnormal aorta smooth muscle morphology|MP:0009867,abnormal ascending aorta morphology|MP:0009869,abnormal descending aorta morphology|MP:0010202,focal dorsal hair loss|MP:0010661,ascending aorta aneurysm|MP:0010996,increased aorta wall thickness|MP:0011157,abnormal hypodermis muscle layer morphology|MP:0011575,dilated aorta bulb|MP:0011643,abnormal tendon collagen fibril morphology|MP:0031086,wheezing|MP:0031132,increased artery tortuosity|MP:0031134,increased carotid artery tortuosity
MGI:4410301	Efemp2<tm1.1Tynk>	MP:0000249,abnormal blood vessel physiology|MP:0009862,abnormal aorta elastic tissue morphology
MGI:4947939	Efemp2<tm1.2Hiya>	MP:0003211,abnormal aorta elastic fiber morphology|MP:0005489,vascular smooth muscle hyperplasia|MP:0005592,abnormal vascular smooth muscle morphology|MP:0005595,abnormal vascular smooth muscle physiology|MP:0009873,abnormal aorta tunica media morphology|MP:0010661,ascending aorta aneurysm|MP:0011089,perinatal lethality, complete penetrance|MP:0020161,increased vascular endothelial cell proliferation|MP:0020321,increased vascular endothelial cell apoptosis|MP:0031510,increased vascular smooth muscle cell proliferation
MGI:4410302	Efemp2<tm1.2Tynk>	MP:0000272,abnormal aorta morphology|MP:0003924,diaphragmatic hernia|MP:0009862,abnormal aorta elastic tissue morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3604551	Efemp2<tm1Dgen>	MP:0000272,abnormal aorta morphology|MP:0001914,hemorrhage|MP:0001958,emphysema|MP:0002169,no abnormal phenotype detected|MP:0002191,abnormal artery morphology|MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0003279,aneurysm|MP:0003705,abnormal hypodermis morphology|MP:0006135,artery stenosis|MP:0009862,abnormal aorta elastic tissue morphology|MP:0009865,abnormal aorta smooth muscle morphology|MP:0009866,abnormal aorta wall morphology|MP:0009873,abnormal aorta tunica media morphology|MP:0010641,descending aorta stenosis|MP:0010996,increased aorta wall thickness|MP:0011089,perinatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6316340	Efhb<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response|MP:0010506,prolonged RR interval
MGI:3774032	Efhc1<tm1Kzy>	MP:0000243,myoclonus|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0008283,small hippocampus|MP:0011069,abnormal brain ependyma motile cilium physiology|MP:0011380,enlarged brain ventricles
MGI:6711681	Efhd1<em1Wei>	MP:0003203,increased neuron apoptosis|MP:0003651,abnormal axon extension|MP:0005404,abnormal axon morphology|MP:0008948,decreased neuron number|MP:0010055,abnormal sensory neuron physiology
MGI:3800038	Efhd2<tm1(KOMP)Vlcg>	MP:0002494,increased IgM level|MP:0002497,increased IgE level|MP:0003631,nervous system phenotype|MP:0004768,abnormal axonal transport|MP:0005025,abnormal response to infection|MP:0005387,immune system phenotype|MP:0008097,increased plasma cell number|MP:0008177,increased germinal center B cell number|MP:0008483,increased spleen germinal center size|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level
MGI:6257755	Efl1<em1(IMPC)Bay>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0002582,disorganized extraembryonic tissue|MP:0003984,embryonic growth retardation|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0014586,decreased egg cylinder size
MGI:5792012	Efl1<mpc102H>	MP:0001406,abnormal gait
MGI:4433482	Efna1<tm1a(EUCOMM)Wtsi>	MP:0001529,abnormal vocalization|MP:0003036,vertebral transformation|MP:0004647,decreased lumbar vertebrae number|MP:0010101,increased sacral vertebrae number|MP:0010344,increased hibernoma incidence
MGI:4849544	Efna1<tm1Jinc>	MP:0001636,irregular heartbeat|MP:0003921,abnormal heart left ventricle morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0006126,abnormal cardiac outflow tract development|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0010593,thick aortic valve cusps|MP:0010594,thick aortic valve|MP:0010617,thick mitral valve cusps|MP:0010620,thick mitral valve|MP:0010725,thin interventricular septum
MGI:5695873	Efna2<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity
MGI:2182943	Efna2<tm1Jgf>	MP:0000819,abnormal olfactory bulb morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0002152,abnormal brain morphology|MP:0009937,abnormal neuron differentiation
MGI:4398688	Efna3<tm1.1Ebp>	MP:0001473,reduced long-term potentiation|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0002912,abnormal excitatory postsynaptic potential
MGI:3852474	Efna3<tm1Ebp>	MP:0003461,abnormal response to novel object|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0009940,abnormal hippocampus pyramidal cell morphology
MGI:3605006	Efna3<tm1Rax>	MP:0002169,no abnormal phenotype detected
MGI:5608692	Efna4<tm1.1(KOMP)Vlcg>	MP:0001312,abnormal cornea morphology|MP:0005560,decreased circulating glucose level|MP:0006243,impaired pupillary reflex|MP:0011396,abnormal sleep behavior|MP:0011471,decreased urine creatinine level
MGI:5548373	Efna5<tm1b(EUCOMM)Wtsi>	MP:0000642,enlarged adrenal glands|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001319,irregularly shaped pupil|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001925,male infertility|MP:0002797,increased thigmotaxis|MP:0003068,enlarged kidney|MP:0004906,enlarged uterus|MP:0004924,abnormal behavior|MP:0008528,polycystic kidney|MP:0009709,hydrometra|MP:0010053,decreased grip strength|MP:0013279,increased fasting circulating glucose level
MGI:2182573	Efna5<tm1Ddmo>	MP:0000111,cleft palate|MP:0000771,abnormal brain size|MP:0000928,incomplete rostral neuropore closure|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001262,decreased body weight|MP:0001890,anencephaly|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002082,postnatal lethality|MP:0002679,abnormal corpus luteum morphology|MP:0003507,abnormal ovary physiology|MP:0003720,abnormal neural tube closure|MP:0004834,ovary hemorrhage|MP:0005389,reproductive system phenotype|MP:0009433,polyovular ovarian follicle|MP:0009648,abnormal superovulation|MP:0011259,abnormal cephalic neural fold morphology|MP:0011700,increased cumulus expansion|MP:0031420,decreased superovulation rate
MGI:2429768	Efna5<tm1Wrst>	MP:0006009,abnormal neuronal migration
MGI:5302529	Efnb1<tm1.1Jwu>	MP:0005387,immune system phenotype
MGI:3653700	Efnb1<tm1.1Rha>	MP:0000111,cleft palate|MP:0001785,edema|MP:0003052,omphalocele|MP:0008525,decreased cranium height|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3039290	Efnb1<tm1.1Sor>	MP:0000030,abnormal tympanic ring morphology|MP:0000107,abnormal frontal bone morphology|MP:0000150,abnormal rib morphology|MP:0000562,polydactyly|MP:0000780,abnormal corpus callosum morphology|MP:0001061,abnormal oculomotor nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0002098,abnormal vibrissa morphology|MP:0002196,absent corpus callosum|MP:0003631,nervous system phenotype|MP:0004378,frontal bone foramen|MP:0005404,abnormal axon morphology|MP:0009882,absent palatal shelf|MP:0009890,cleft secondary palate|MP:0012752,abnormal cardiac neural crest cell migration|MP:0012757,abnormal cranial neural crest cell migration
MGI:3653699	Efnb1<tm1Rha>	MP:0000111,cleft palate|MP:0000155,asymmetric rib joints|MP:0000164,abnormal cartilage development|MP:0000554,abnormal carpal bone morphology|MP:0000562,polydactyly|MP:0000572,abnormal autopod morphology|MP:0001785,edema|MP:0002114,abnormal axial skeleton morphology|MP:0003052,omphalocele|MP:0004083,polysyndactyly|MP:0004321,short sternum|MP:0004322,abnormal sternebra morphology|MP:0005389,reproductive system phenotype|MP:0008146,asymmetric sternocostal joints|MP:0008271,abnormal bone ossification|MP:0008525,decreased cranium height|MP:0008915,fused carpal bones|MP:0009743,preaxial polydactyly|MP:0010082,sternebra fusion|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3039289	Efnb1<tm1Sor>	MP:0000030,abnormal tympanic ring morphology|MP:0000111,cleft palate|MP:0000562,polydactyly|MP:0006322,abnormal perichondrium morphology|MP:0009886,failure of palatal shelf elevation|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3850114	Efnb1<tm2.2Sor>	MP:0003631,nervous system phenotype|MP:0005390,skeleton phenotype
MGI:3850116	Efnb1<tm3.2Sor>	MP:0000780,abnormal corpus callosum morphology|MP:0002196,absent corpus callosum|MP:0003631,nervous system phenotype|MP:0005390,skeleton phenotype
MGI:3850119	Efnb1<tm4.2Sor>	MP:0002196,absent corpus callosum|MP:0003631,nervous system phenotype|MP:0005390,skeleton phenotype
MGI:3051215	Efnb2<tm1.1Henk>	MP:0000260,abnormal angiogenesis|MP:0000266,abnormal heart morphology|MP:0000291,enlarged pericardium|MP:0001394,circling|MP:0001410,head bobbing|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0002925,abnormal cardiovascular development|MP:0003164,decreased posterior semicircular canal size|MP:0003166,decreased superior semicircular canal size|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004885,abnormal endolymph physiology|MP:0005389,reproductive system phenotype|MP:0008066,small endolymphatic duct|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5302530	Efnb2<tm1.1Jwu>	MP:0005387,immune system phenotype
MGI:2176476	Efnb2<tm1And>	MP:0000260,abnormal angiogenesis|MP:0000269,abnormal heart looping|MP:0000274,enlarged heart|MP:0000293,absent myocardial trabeculae|MP:0001698,decreased embryo size|MP:0003229,abnormal vitelline vasculature morphology|MP:0003974,abnormal endocardium morphology|MP:0003984,embryonic growth retardation|MP:0004783,abnormal cardinal vein morphology|MP:0004784,abnormal anterior cardinal vein morphology|MP:0005294,abnormal heart ventricle morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005385,cardiovascular system phenotype|MP:0009577,abnormal developmental vascular remodeling|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012253,abnormal intersomitic vessel morphology
MGI:3051214	Efnb2<tm1Henk>	MP:0000111,cleft palate|MP:0000285,abnormal heart valve morphology|MP:0000537,abnormal urethra morphology|MP:0001394,circling|MP:0001410,head bobbing|MP:0001925,male infertility|MP:0002428,abnormal semicircular canal morphology|MP:0003124,hypospadia|MP:0003125,abnormal septation of the cloaca|MP:0003128,splayed clitoris|MP:0003129,persistent cloaca|MP:0003130,anal atresia|MP:0003164,decreased posterior semicircular canal size|MP:0003166,decreased superior semicircular canal size|MP:0003321,tracheoesophageal fistula|MP:0003631,nervous system phenotype|MP:0004885,abnormal endolymph physiology|MP:0004887,decreased endolymph production|MP:0004922,abnormal common crus morphology|MP:0005187,abnormal penis morphology|MP:0005189,abnormal anogenital distance|MP:0005385,cardiovascular system phenotype|MP:0005404,abnormal axon morphology|MP:0006012,dilated endolymphatic duct|MP:0006014,dilated endolymphatic sac|MP:0006389,abnormal vestibular endolymph physiology|MP:0006391,abnormal vestibular endolymph ionic homeostasis|MP:0008066,small endolymphatic duct|MP:0010591,enlarged aortic valve|MP:0010594,thick aortic valve|MP:0010600,enlarged pulmonary valve|MP:0010601,thick pulmonary valve|MP:0010617,thick mitral valve cusps|MP:0010860,abnormal anterior commissure pars posterior morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011105,embryonic lethality between implantation and placentation, incomplete penetrance|MP:0014751,abnormal commissural neuron axon guidance|MP:0031529,pulmonary valve hyperplasia|MP:0031568,aortic valve hyperplasia
MGI:2182626	Efnb2<tm1Kln>	MP:0000260,abnormal angiogenesis|MP:0002950,abnormal neural crest cell migration|MP:0003984,embryonic growth retardation|MP:0004783,abnormal cardinal vein morphology|MP:0005380,embryo phenotype|MP:0006338,abnormal second pharyngeal arch morphology|MP:0006344,small second pharyngeal arch|MP:0006345,absent second pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012253,abnormal intersomitic vessel morphology|MP:0012493,absent pharyngeal arch arteries
MGI:3526816	Efnb2<tm1Sor>	MP:0002169,no abnormal phenotype detected
MGI:5085263	Efnb2<tm2.1Henk>	MP:0002083,premature death|MP:0005381,digestive/alimentary phenotype
MGI:2182630	Efnb2<tm2.1Kln>	MP:0002169,no abnormal phenotype detected
MGI:2176538	Efnb2<tm2And>	MP:0000260,abnormal angiogenesis|MP:0000380,small hair follicles|MP:0000424,retarded hair growth|MP:0001195,flaky skin|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001732,postnatal growth retardation|MP:0004126,thin hypodermis|MP:0005501,abnormal skin physiology|MP:0010771,integument phenotype|MP:0011085,postnatal lethality, complete penetrance
MGI:3526818	Efnb2<tm2Sor>	MP:0001093,small trigeminal ganglion|MP:0001688,abnormal somite development|MP:0005223,abnormal dorsal-ventral polarity of the somites|MP:0006341,small first pharyngeal arch|MP:0008530,abnormal rostral-caudal patterning of the somites|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012755,decreased cranial neural crest cell number|MP:0012757,abnormal cranial neural crest cell migration|MP:0012761,increased cranial neural crest cell apoptosis|MP:0013012,abnormal trunk neural crest cell migration
MGI:5085271	Efnb2<tm3.1Henk>	MP:0002083,premature death|MP:0005381,digestive/alimentary phenotype|MP:0005404,abnormal axon morphology
MGI:2182632	Efnb2<tm3.1Kln>	MP:0000292,distended pericardium|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004784,abnormal anterior cardinal vein morphology|MP:0005380,embryo phenotype|MP:0006346,small pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012253,abnormal intersomitic vessel morphology
MGI:3026687	Efnb2<tm4Kln>	MP:0001473,reduced long-term potentiation|MP:0001898,abnormal long-term depression|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:3573787	Efnb2<tm5.1Kln>	MP:0001879,abnormal lymphatic vessel morphology|MP:0002083,premature death|MP:0002349,abnormal afferent lymphatic vessel morphology|MP:0003659,abnormal lymph circulation|MP:0003660,chylothorax|MP:0011085,postnatal lethality, complete penetrance
MGI:3573785	Efnb2<tm5Kln>	MP:0003660,chylothorax|MP:0011085,postnatal lethality, complete penetrance
MGI:3573786	Efnb2<tm6Kln>	MP:0001879,abnormal lymphatic vessel morphology|MP:0003659,abnormal lymph circulation
MGI:5578532	Efnb3<lltw>	MP:0001393,ataxia|MP:0001523,impaired righting response|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0010768,mortality/aging|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5474282	Efnb3<m1Btlr>	MP:0001524,impaired limb coordination|MP:0002862,abnormal righting response
MGI:3026702	Efnb3<tm1.1Henk>	MP:0002169,no abnormal phenotype detected|MP:0005404,abnormal axon morphology|MP:0008960,abnormal axon pruning
MGI:3026703	Efnb3<tm1.2Henk>	MP:0002169,no abnormal phenotype detected
MGI:3026700	Efnb3<tm1Henk>	MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0002184,abnormal innervation|MP:0002878,abnormal corticospinal tract morphology|MP:0005404,abnormal axon morphology|MP:0008960,abnormal axon pruning
MGI:2388046	Efnb3<tm1Nwg>	MP:0000940,abnormal motor neuron innervation pattern|MP:0001406,abnormal gait|MP:0001473,reduced long-term potentiation|MP:0001898,abnormal long-term depression|MP:0002878,abnormal corticospinal tract morphology|MP:0003631,nervous system phenotype|MP:0003880,abnormal central pattern generator function
MGI:3851474	Efnb3<tm2.1Henk>	MP:0005404,abnormal axon morphology|MP:0008960,abnormal axon pruning
MGI:3851475	Efnb3<tm2Henk>	MP:0001406,abnormal gait
MGI:3851478	Efnb3<tm3.1Henk>	MP:0005404,abnormal axon morphology|MP:0008960,abnormal axon pruning
MGI:3851477	Efnb3<tm3Henk>	MP:0001406,abnormal gait
MGI:6358560	Efr3a<tm1Bgsn>	MP:0003204,decreased neuron apoptosis|MP:0003424,premature neuronal precursor differentiation|MP:0003631,nervous system phenotype
MGI:6276872	Efr3b<em1(IMPC)Mbp>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001926,female infertility|MP:0002797,increased thigmotaxis|MP:0003960,increased lean body mass|MP:0004924,abnormal behavior|MP:0005293,impaired glucose tolerance|MP:0005554,decreased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content
MGI:7594220	Efr3b<tm1Gpt>	MP:0002272,abnormal nervous system electrophysiology|MP:0002578,impaired ability to fire action potentials|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0020395,abnormal response to social novelty
MGI:3611072	Efs<tm1Kale>	MP:0001846,increased inflammatory response|MP:0001859,kidney inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002444,abnormal T cell physiology|MP:0002461,increased immunoglobulin level|MP:0002493,increased IgG level|MP:0002495,increased IgA level|MP:0003306,small intestinal inflammation|MP:0008566,increased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion
MGI:6358537	Eftud2<em1Lajm>	MP:0011088,neonatal lethality, incomplete penetrance|MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:6358539	Eftud2<em2Lajm>	MP:0003984,embryonic growth retardation|MP:0005389,reproductive system phenotype|MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:5695118	Eftud2<tm1b(KOMP)Wtsi>	MP:0000194,increased circulating calcium level|MP:0000221,decreased leukocyte cell number|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0001489,decreased startle reflex|MP:0001556,increased circulating HDL cholesterol level|MP:0002953,thick ventricular wall|MP:0002965,increased circulating serum albumin level|MP:0003921,abnormal heart left ventricle morphology|MP:0005016,decreased lymphocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0005505,thrombocytosis|MP:0005568,increased circulating total protein level|MP:0005599,increased cardiac muscle contractility|MP:0010053,decreased grip strength|MP:0010579,increased heart left ventricle size|MP:0010580,decreased heart left ventricle size|MP:0011100,preweaning lethality, complete penetrance
MGI:3527008	Egaq1<M16i>	MP:0002865,increased growth rate
MGI:3527725	Egaq2<M16i>	MP:0002865,increased growth rate
MGI:3527729	Egaq3<M16i>	MP:0002865,increased growth rate
MGI:3527701	Egaq4<M16i>	MP:0002865,increased growth rate
MGI:5662543	Egfem1<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001486,abnormal startle reflex|MP:0002591,decreased mean corpuscular volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0005293,impaired glucose tolerance|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0013278,decreased fasting circulating glucose level
MGI:6438196	Egfl6<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:5427906	Egfl6<tm1Ksek>	MP:0002169,no abnormal phenotype detected
MGI:4353265	Egfl7<Gt(1-13)Stmn>	MP:0002169,no abnormal phenotype detected
MGI:3721958	Egfl7<Gt(OST80956)Lex>	MP:0000259,abnormal vascular development|MP:0001614,abnormal blood vessel morphology|MP:0001785,edema|MP:0002792,abnormal retina vasculature morphology|MP:0004086,absent heartbeat|MP:0005039,hypoxia|MP:0005602,decreased angiogenesis|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3826822	Egfl7<tm1.1Cjku>	MP:0002169,no abnormal phenotype detected
MGI:3721404	Egfl7<tm1Wye>	MP:0000259,abnormal vascular development|MP:0001614,abnormal blood vessel morphology|MP:0002792,abnormal retina vasculature morphology|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5695940	Egfl8<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis
MGI:5007118	Egfl8<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:3808156	Egflam<tm1Tfir>	MP:0001005,abnormal retina rod cell morphology|MP:0001006,abnormal retina cone cell morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005253,abnormal eye physiology
MGI:5775041	Egfr<m2Btlr>	MP:0001200,thick skin|MP:0001511,disheveled coat|MP:0010179,rough coat
MGI:2682255	Egfr<Mhdadsk5>	MP:0000410,waved hair|MP:0000575,increased foot pad pigmentation|MP:0000579,abnormal nail morphology|MP:0000583,long toenails|MP:0001219,thick epidermis|MP:0002095,abnormal skin pigmentation|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:3834077	Egfr<tm1.1Dwt>	MP:0000377,abnormal hair follicle morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000968,abnormal sensory neuron innervation pattern
MGI:5320891	Egfr<tm1.1Tyj>	MP:0011092,embryonic lethality, complete penetrance
MGI:4433235	Egfr<tm1a(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number
MGI:3513096	Egfr<tm1Dwt>	MP:0000377,abnormal hair follicle morphology|MP:0000410,waved hair|MP:0001194,dermatitis|MP:0001216,abnormal epidermal layer morphology|MP:0001698,decreased embryo size|MP:0001715,placental labyrinth hypoplasia|MP:0001716,abnormal placenta labyrinth morphology|MP:0002060,abnormal skin morphology|MP:0002497,increased IgE level|MP:0002796,impaired skin barrier function|MP:0003631,nervous system phenotype|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0008086,increased T-helper 1 cell number|MP:0008090,increased T-helper 2 cell number|MP:0010219,increased T-helper 17 cell number
MGI:1856402	Egfr<tm1Mag>	MP:0000383,abnormal hair follicle orientation|MP:0000384,distorted hair follicle pattern|MP:0000422,delayed hair appearance|MP:0000468,abnormal esophageal epithelium morphology|MP:0000495,abnormal colon morphology|MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000762,abnormal tongue morphology|MP:0000763,abnormal filiform papillae morphology|MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000852,small cerebellum|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000880,decreased Purkinje cell number|MP:0001176,abnormal lung development|MP:0001274,curly vibrissae|MP:0001279,wavy vibrissae|MP:0001302,eyelids open at birth|MP:0001341,absent eyelids|MP:0001510,abnormal coat appearance|MP:0001713,decreased trophoblast giant cell number|MP:0001716,abnormal placenta labyrinth morphology|MP:0001732,postnatal growth retardation|MP:0002718,abnormal inner cell mass morphology|MP:0003704,abnormal hair follicle development|MP:0003809,abnormal hair shaft morphology|MP:0004259,small placenta|MP:0004860,dilated kidney collecting duct|MP:0005150,cachexia|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0006254,thin cerebral cortex|MP:0006257,abnormal fungiform papillae morphology|MP:0010685,abnormal hair follicle inner root sheath morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011093,embryonic lethality at implantation, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0012099,decreased spongiotrophoblast size
MGI:3763534	Egfr<tm1Msi>	MP:0008489,slow postnatal weight gain|MP:0008553,increased circulating tumor necrosis factor level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0031324,delayed liver regeneration
MGI:1935113	Egfr<tm1Rdk>	MP:0000088,short mandible|MP:0000111,cleft palate|MP:0000448,pointed snout|MP:0000477,abnormal intestine morphology|MP:0000764,abnormal tongue epithelium morphology|MP:0001177,atelectasis|MP:0001179,thick pulmonary interalveolar septum|MP:0001195,flaky skin|MP:0001218,thin epidermis|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001274,curly vibrissae|MP:0001302,eyelids open at birth|MP:0001307,fused cornea and lens|MP:0001575,cyanosis|MP:0001666,abnormal intestinal absorption|MP:0001698,decreased embryo size|MP:0001944,abnormal pancreas morphology|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002073,abnormal hair growth|MP:0002177,abnormal outer ear morphology|MP:0002264,abnormal bronchus morphology|MP:0002268,abnormal terminal bronchiole morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002276,abnormal lung interstitium morphology|MP:0002626,increased heart rate|MP:0003704,abnormal hair follicle development|MP:0003853,dry skin|MP:0004200,decreased fetal size|MP:0004247,small pancreas|MP:0004259,small placenta|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005220,abnormal exocrine pancreas morphology|MP:0006026,dilated terminal bronchiole tube|MP:0006027,impaired lung alveolus development|MP:0008816,petechiae|MP:0008817,hematoma|MP:0009254,disorganized pancreatic islets|MP:0009931,abnormal skin appearance|MP:0010856,dilated respiratory conducting tube|MP:0010890,decreased alveolar lamellar body number|MP:0010900,abnormal pulmonary interalveolar septum morphology|MP:0010911,abnormal pulmonary acinus morphology|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011085,postnatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0013542,abnormal submandibular gland branching morphogenesis|MP:0030026,small Meckel's cartilage
MGI:1935108	Egfr<tm1Wag>	MP:0000377,abnormal hair follicle morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001216,abnormal epidermal layer morphology|MP:0001218,thin epidermis|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001262,decreased body weight|MP:0001284,absent vibrissae|MP:0001302,eyelids open at birth|MP:0001429,dehydration|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0002098,abnormal vibrissa morphology|MP:0004256,abnormal maternal decidual layer morphology|MP:0004259,small placenta|MP:0005150,cachexia|MP:0005543,decreased cornea thickness|MP:0009429,decreased embryo weight|MP:0010897,abnormal bronchiole epithelium morphology|MP:0010898,abnormal pulmonary alveolus epithelium morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012099,decreased spongiotrophoblast size
MGI:2673586	Egfr<tm2(EGFR)Wag>	MP:0000379,decreased hair follicle number|MP:0000383,abnormal hair follicle orientation|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000417,short hair|MP:0000422,delayed hair appearance|MP:0000427,abnormal hair cycle|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001274,curly vibrissae|MP:0001625,cardiac hypertrophy|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002625,heart left ventricle hypertrophy|MP:0002746,abnormal semilunar valve morphology|MP:0003631,nervous system phenotype|MP:0011091,prenatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011710,enhanced osteoblast differentiation|MP:0014107,premature chondrocyte differentiation
MGI:3037902	Egfr<Vel>	MP:0000383,abnormal hair follicle orientation|MP:0000410,waved hair|MP:0001263,weight loss|MP:0001274,curly vibrissae|MP:0001297,microphthalmia|MP:0001302,eyelids open at birth|MP:0001314,cornea opacity|MP:0001340,abnormal eyelid morphology|MP:0001715,placental labyrinth hypoplasia|MP:0005031,abnormal trophoblast layer morphology|MP:0008899,plush coat|MP:0009264,failure of eyelid fusion|MP:0009651,abnormal eyelid development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011708,decreased fibroblast cell migration
MGI:1856397	Egfr<wa2>	MP:0000272,abnormal aorta morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0000396,increased curvature of hairs|MP:0000399,increased curvature of guard hairs|MP:0000410,waved hair|MP:0000417,short hair|MP:0000627,abnormal mammary gland morphology|MP:0001265,decreased body size|MP:0001274,curly vibrissae|MP:0001282,short vibrissae|MP:0001304,cataract|MP:0001882,abnormal lactation|MP:0002074,abnormal hair texture|MP:0002092,abnormal eye morphology|MP:0002098,abnormal vibrissa morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002747,abnormal aortic valve morphology|MP:0003141,cardiac fibrosis|MP:0003812,abnormal hair medulla|MP:0003820,increased left ventricle systolic pressure|MP:0003896,prolonged PR interval|MP:0003921,abnormal heart left ventricle morphology|MP:0005598,decreased heart ventricle muscle contractility|MP:0006047,aortic valve regurgitation|MP:0006116,calcified aortic valve|MP:0006117,aortic valve stenosis|MP:0006265,increased pulse pressure|MP:0009801,abnormal hair cortex keratinization|MP:0010506,prolonged RR interval|MP:0010579,increased heart left ventricle size|MP:0010591,enlarged aortic valve|MP:0010594,thick aortic valve|MP:0011926,abnormal heart valve physiology|MP:0011951,increased cardiac stroke volume|MP:0031580,enlarged semilunar valve|MP:0031633,decreased heart left ventricle muscle contractility|MP:0031634,decreased heart right ventricle muscle contractility
MGI:1856499	Egfr<wa2-4J>	MP:0000410,waved hair
MGI:2178387	Egfr<Wa5>	MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0001302,eyelids open at birth|MP:0001316,cornea scarring|MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0002074,abnormal hair texture|MP:0002092,abnormal eye morphology|MP:0002098,abnormal vibrissa morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012099,decreased spongiotrophoblast size
MGI:2176530	Egf<tm1Dle>	MP:0002169,no abnormal phenotype detected
MGI:7786416	egl2	MP:0001891,hydrocephaly|MP:0004269,abnormal optic cup morphology|MP:0008067,retina ganglion cell degeneration
MGI:4128927	Egln1<Gt(RRG405)Byg>	MP:0000266,abnormal heart morphology|MP:0001262,decreased body weight|MP:0004484,abnormal response of heart to induced stress|MP:0005385,cardiovascular system phenotype|MP:0005397,hematopoietic system phenotype
MGI:4948909	Egln1<tm1.1Brei>	MP:0000343,abnormal response to cardiac infarction|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000717,abnormal lymphocyte cell number|MP:0001190,reddish skin|MP:0001598,abnormal blood viscosity|MP:0001732,postnatal growth retardation|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002608,increased hematocrit|MP:0002872,polycythemia|MP:0003038,decreased myocardial infarct size|MP:0003179,thrombocytopenia|MP:0003223,decreased cardiomyocyte apoptosis|MP:0004952,increased spleen weight|MP:0005385,cardiovascular system phenotype|MP:0005397,hematopoietic system phenotype|MP:0010127,hypervolemia|MP:0010551,abnormal coronary vessel morphology|MP:0010768,mortality/aging|MP:0011178,increased erythroblast number|MP:0012397,abnormal nucleated erythrocyte cell number
MGI:5521374	Egln1<tm1.1Fsl>	MP:0002608,increased hematocrit|MP:0002872,polycythemia|MP:0004952,increased spleen weight|MP:0005564,increased hemoglobin content|MP:0005575,increased pulmonary ventilation|MP:0005585,increased tidal volume|MP:0011091,prenatal lethality, complete penetrance
MGI:3793288	Egln1<tm1.1Kael>	MP:0011111,lethality during fetal growth through weaning, complete penetrance
MGI:4948912	Egln1<tm1.2Brei>	MP:0011100,preweaning lethality, complete penetrance
MGI:3690045	Egln1<tm1Fong>	MP:0000266,abnormal heart morphology|MP:0000281,abnormal interventricular septum morphology|MP:0001711,abnormal placenta morphology|MP:0001713,decreased trophoblast giant cell number|MP:0001716,abnormal placenta labyrinth morphology|MP:0001722,pale yolk sac|MP:0002450,abnormal lymph organ development|MP:0004067,abnormal trabecula carnea morphology|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0005294,abnormal heart ventricle morphology|MP:0005369,muscle phenotype|MP:0006138,congestive heart failure|MP:0008725,increased heart atrium size|MP:0010556,thin ventricle myocardium compact layer|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012082,delayed heart development
MGI:3777476	Egln1<tm1Kael>	MP:0000255,blood vessel congestion|MP:0000274,enlarged heart|MP:0001190,reddish skin|MP:0001265,decreased body size|MP:0001914,hemorrhage|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0002872,polycythemia|MP:0003921,abnormal heart left ventricle morphology|MP:0004120,cardiac ischemia|MP:0004485,increased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0004566,myocardial fiber degeneration|MP:0005329,abnormal myocardium layer morphology|MP:0005598,decreased heart ventricle muscle contractility|MP:0005601,increased angiogenesis|MP:0005608,cardiac interstitial fibrosis|MP:0010018,pulmonary vascular congestion|MP:0010019,liver vascular congestion|MP:0011285,increased circulating erythropoietin level|MP:0011629,decreased mitochondrial number
MGI:3847435	Egln1<tm1Pec>	MP:0011091,prenatal lethality, complete penetrance
MGI:5521468	Egln1<tm2.1Fsl>	MP:0000240,extramedullary hematopoiesis|MP:0002083,premature death|MP:0002608,increased hematocrit|MP:0002833,increased heart weight|MP:0002872,polycythemia|MP:0002981,increased liver weight|MP:0003135,increased erythroid progenitor cell number|MP:0004952,increased spleen weight|MP:0005564,increased hemoglobin content|MP:0009820,abnormal liver vasculature morphology|MP:0011287,increased erythropoietin level
MGI:5521471	Egln1<tm2.2Fsl>	MP:0002608,increased hematocrit|MP:0002872,polycythemia|MP:0004952,increased spleen weight|MP:0005564,increased hemoglobin content|MP:0005575,increased pulmonary ventilation|MP:0011091,prenatal lethality, complete penetrance
MGI:3778917	Egln1<tm2Fong>	MP:0000218,increased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000530,abnormal kidney vasculature morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000602,dilated liver sinusoidal space|MP:0000691,enlarged spleen|MP:0001190,reddish skin|MP:0001614,abnormal blood vessel morphology|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002608,increased hematocrit|MP:0002872,polycythemia|MP:0003658,abnormal capillary morphology|MP:0004007,abnormal lung vasculature morphology|MP:0004938,dilated vasculature|MP:0005325,abnormal renal glomerulus morphology|MP:0005564,increased hemoglobin content|MP:0005601,increased angiogenesis|MP:0008770,decreased survivor rate|MP:0008826,abnormal splenic cell ratio|MP:0011285,increased circulating erythropoietin level|MP:0020327,abnormal capillary branching pattern
MGI:3690046	Egln2<tm1Fong>	MP:0005380,embryo phenotype|MP:0005385,cardiovascular system phenotype|MP:0005397,hematopoietic system phenotype
MGI:3776872	Egln2<tm1Pec>	MP:0002106,abnormal muscle physiology|MP:0003852,skeletal muscle necrosis|MP:0005290,decreased oxygen consumption|MP:0006036,abnormal mitochondrial physiology
MGI:5609356	Egln3<tm1b(EUCOMM)Wtsi>	MP:0004122,abnormal sinus arrhythmia|MP:0008259,abnormal optic disk morphology
MGI:3690047	Egln3<tm1Fong>	MP:0005369,muscle phenotype|MP:0005380,embryo phenotype|MP:0005385,cardiovascular system phenotype|MP:0005397,hematopoietic system phenotype
MGI:5583030	Egln3<tm1Jomy>	MP:0002169,no abnormal phenotype detected
MGI:3795244	Egln3<tm1Pjr>	MP:0001013,enlarged superior cervical ganglion|MP:0001317,abnormal pupil morphology|MP:0001739,abnormal adrenal gland secretion|MP:0002184,abnormal innervation|MP:0002843,decreased systemic arterial blood pressure|MP:0002882,abnormal neuron morphology|MP:0003204,decreased neuron apoptosis|MP:0003437,abnormal carotid body morphology|MP:0003861,abnormal nervous system development|MP:0004811,abnormal neuron physiology|MP:0005404,abnormal axon morphology|MP:0005661,decreased circulating adrenaline level|MP:0005664,decreased circulating noradrenaline level|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0008289,abnormal adrenal medulla morphology|MP:0008504,abnormal adrenal chromaffin cell morphology|MP:0008770,decreased survivor rate|MP:0008872,abnormal physiological response to xenobiotic
MGI:3527699	Egq10<M16i>	MP:0002865,increased growth rate
MGI:3527039	Egq11<M16i>	MP:0002865,increased growth rate
MGI:3527054	Egq12<M16i>	MP:0002865,increased growth rate
MGI:3526976	Egq1<M16i>	MP:0002865,increased growth rate
MGI:3526988	Egq2<M16i>	MP:0002865,increased growth rate
MGI:3527006	Egq3<M16i>	MP:0002865,increased growth rate
MGI:3527693	Egq4<M16i>	MP:0002865,increased growth rate
MGI:3527723	Egq5<M16i>	MP:0002865,increased growth rate
MGI:3527789	Egq6<M16i>	MP:0002865,increased growth rate
MGI:3527667	Egq7<M16i>	MP:0002865,increased growth rate
MGI:3527028	Egq8<M16i>	MP:0002865,increased growth rate
MGI:3527679	Egq9<M16i>	MP:0002865,increased growth rate
MGI:5766183	Egr1<tm1b(NCOM)Mfgc>	MP:0001258,decreased body length|MP:0001697,abnormal embryo size|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002637,small uterus|MP:0002764,short tibia|MP:0003232,abnormal forebrain development|MP:0003642,absent seminal vesicle|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0005013,increased lymphocyte cell number|MP:0006108,abnormal hindbrain development|MP:0008259,abnormal optic disk morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2384433	Egr1<tm1Jmi>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000217,abnormal leukocyte cell number|MP:0000245,abnormal erythropoiesis|MP:0000321,increased bone marrow cell number|MP:0000609,abnormal liver physiology|MP:0001126,abnormal ovary morphology|MP:0001134,absent corpus luteum|MP:0001245,thick dermal layer|MP:0001573,abnormal circulating alanine transaminase level|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0001764,abnormal homeostasis|MP:0001860,liver inflammation|MP:0001876,decreased inflammatory response|MP:0001919,abnormal reproductive system physiology|MP:0001926,female infertility|MP:0001928,abnormal ovulation|MP:0002006,neoplasm|MP:0002024,increased T cell derived lymphoma incidence|MP:0002051,increased skin papilloma incidence|MP:0002090,abnormal vision|MP:0002092,abnormal eye morphology|MP:0002697,abnormal eye size|MP:0002908,delayed wound healing|MP:0003141,cardiac fibrosis|MP:0003179,thrombocytopenia|MP:0003426,pulmonary interstitial fibrosis|MP:0003691,abnormal microglial cell physiology|MP:0004046,abnormal mitosis|MP:0004499,increased incidence of tumors by chemical induction|MP:0004759,decreased mitotic index|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004848,abnormal liver size|MP:0004883,abnormal vascular wound healing|MP:0004905,decreased uterus weight|MP:0004952,increased spleen weight|MP:0004984,increased osteoclast cell number|MP:0005013,increased lymphocyte cell number|MP:0005065,abnormal neutrophil morphology|MP:0005132,decreased luteinizing hormone level|MP:0005164,abnormal response to injury|MP:0005184,abnormal circulating progesterone level|MP:0005370,liver/biliary system phenotype|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0005517,impaired liver regeneration|MP:0006050,pulmonary fibrosis|MP:0006058,decreased cerebral infarct size|MP:0008246,abnormal leukocyte morphology|MP:0008552,abnormal circulating tumor necrosis factor level|MP:0008752,abnormal tumor necrosis factor level|MP:0008872,abnormal physiological response to xenobiotic|MP:0009009,absent estrous cycle|MP:0009355,increased liver triglyceride level|MP:0010308,decreased tumor latency|MP:0013599,Leydig cell atrophy|MP:0014655,abnormal cornea curvature|MP:0031213,increased eye anterior chamber depth
MGI:2683282	Egr1<tm1Lch>	MP:0002801,abnormal long-term object recognition memory
MGI:2181755	Egr1<tm1Pch>	MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001153,small seminiferous tubules|MP:0001157,small seminal vesicle|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001746,abnormal pituitary secretion|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002566,abnormal sexual interaction|MP:0002637,small uterus|MP:0002687,oligozoospermia|MP:0002774,small prostate gland|MP:0002780,decreased circulating testosterone level|MP:0004852,decreased testis weight|MP:0004896,abnormal endometrium morphology|MP:0005136,decreased growth hormone level|MP:0005536,decreased Leydig cell number|MP:0005656,decreased aggression|MP:0008329,decreased somatotroph cell number|MP:0008365,adenohypophysis hypoplasia|MP:0008869,anovulation
MGI:2177610	Egr1<tm1The>	MP:0001926,female infertility|MP:0003631,nervous system phenotype
MGI:2651550	Egr2<tm1.1Jchn>	MP:0012795,absent rhombomere 3|MP:0012803,absent rhombomere 5
MGI:1931057	Egr2<tm1Grid>	MP:0001056,abnormal cranial nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001265,decreased body size|MP:0002855,abnormal cochlear ganglion morphology|MP:0004568,fusion of glossopharyngeal and vagus nerve|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012795,absent rhombomere 3|MP:0012803,absent rhombomere 5
MGI:3574072	Egr2<tm1Jmi>	MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0001106,abnormal Schwann cell morphology|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0002651,abnormal sciatic nerve morphology|MP:0006108,abnormal hindbrain development|MP:0011085,postnatal lethality, complete penetrance|MP:0011906,increased Schwann cell proliferation
MGI:1857507	Egr2<tm1Pch>	MP:0000458,abnormal mandible morphology|MP:0000745,tremors|MP:0000933,abnormal rhombomere morphology|MP:0001056,abnormal cranial nerve morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0001070,abnormal abducens nerve morphology|MP:0001071,abnormal facial nerve morphology|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001106,abnormal Schwann cell morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001290,delayed eyelid opening|MP:0001402,decreased locomotor activity|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002113,abnormal skeleton development|MP:0002151,abnormal neural tube morphology|MP:0002651,abnormal sciatic nerve morphology|MP:0002747,abnormal aortic valve morphology|MP:0002752,abnormal somatic nervous system morphology|MP:0002764,short tibia|MP:0002896,abnormal bone mineralization|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0004355,short radius|MP:0004686,decreased length of long bones|MP:0008150,decreased diameter of long bones|MP:0008152,decreased diameter of femur|MP:0008155,decreased diameter of radius|MP:0008156,decreased diameter of tibia|MP:0010591,enlarged aortic valve|MP:0010593,thick aortic valve cusps|MP:0010605,thick pulmonary valve cusps|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012793,decreased rhombomere 3 size|MP:0012795,absent rhombomere 3|MP:0012801,decreased rhombomere 5 size|MP:0012803,absent rhombomere 5|MP:0012805,decreased rhombomere 6 size
MGI:3836632	Egr2<tm2Jmi>	MP:0000745,tremors|MP:0000746,weakness|MP:0000755,hindlimb paralysis|MP:0000920,abnormal myelination|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001106,abnormal Schwann cell morphology|MP:0001263,weight loss|MP:0001406,abnormal gait|MP:0001954,respiratory distress|MP:0002651,abnormal sciatic nerve morphology|MP:0004568,fusion of glossopharyngeal and vagus nerve|MP:0008814,decreased nerve conduction velocity|MP:0010771,integument phenotype|MP:0011085,postnatal lethality, complete penetrance
MGI:2183227	Egr2<tm3Pch>	MP:0001544,abnormal cardiovascular system physiology|MP:0002625,heart left ventricle hypertrophy|MP:0003921,abnormal heart left ventricle morphology|MP:0006047,aortic valve regurgitation|MP:0010463,aorta stenosis|MP:0010593,thick aortic valve cusps|MP:0010595,abnormal aortic valve cusp morphology|MP:0010605,thick pulmonary valve cusps
MGI:3798483	Egr2<tm4Pch>	MP:0000745,tremors|MP:0000753,paralysis|MP:0000920,abnormal myelination|MP:0001082,abnormal geniculate ganglion morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001096,abnormal glossopharyngeal ganglion morphology|MP:0001100,abnormal vagus ganglion morphology|MP:0001265,decreased body size|MP:0001524,impaired limb coordination|MP:0002855,abnormal cochlear ganglion morphology|MP:0005573,increased pulmonary respiratory rate|MP:0011083,lethality at weaning, complete penetrance|MP:0011906,increased Schwann cell proliferation
MGI:5548115	Egr3<tm1.1Kfuji>	MP:0008838,decreased transforming growth factor beta level
MGI:2180063	Egr3<tm1Jmi>	MP:0000161,scoliosis|MP:0000745,tremors|MP:0000939,decreased motor neuron number|MP:0000959,abnormal somatic sensory system morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001025,abnormal sympathetic neuron morphology|MP:0001038,abnormal cholinergic neuron morphology|MP:0001344,blepharoptosis|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003633,abnormal nervous system physiology|MP:0004069,abnormal muscle spindle morphology|MP:0004263,abnormal limb posture|MP:0004297,abnormal proprioceptive neuron morphology|MP:0005423,abnormal somatic nervous system physiology|MP:0008468,absent muscle spindles|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2450146	Egr4<tm1Jmi>	MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005169,abnormal male meiosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0008893,detached sperm flagellum|MP:0009230,abnormal sperm head morphology|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014052,increased male germ cell apoptosis
MGI:1861150	Eh	MP:0000018,small ears|MP:0000030,abnormal tympanic ring morphology|MP:0000412,excessive hair|MP:0000426,ectopic hair growth|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0006020,decreased tympanic ring size|MP:0009247,meteorism|MP:0009546,absent gastric milk in neonates|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance|MP:0030075,hairy ears
MGI:6342439	Ehbp1<em1(IMPC)J>	MP:0000277,abnormal heart shape|MP:0000783,abnormal forebrain morphology|MP:0000897,abnormal midbrain morphology|MP:0000928,incomplete rostral neuropore closure|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001701,incomplete embryo turning|MP:0001712,abnormal placenta development|MP:0001722,pale yolk sac|MP:0002884,abnormal pharyngeal arch morphology|MP:0003400,kinked neural tube|MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0013176,abnormal tail position or orientation|MP:0013177,abnormal tail tip morphology|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014134,abnormal embryo morphology
MGI:6156963	Ehbp1l1<em1Aha>	MP:0001577,anemia|MP:0008109,abnormal small intestinal microvillus morphology|MP:0008141,decreased small intestinal microvillus size|MP:0011087,neonatal lethality, complete penetrance
MGI:4432707	Ehbp1l1<tm1a(EUCOMM)Wtsi>	MP:0000602,dilated liver sinusoidal space|MP:0001303,abnormal lens morphology|MP:0002237,abnormal nasal cavity morphology|MP:0002239,abnormal nasal septum morphology|MP:0002652,thin myocardium|MP:0002928,abnormal bile duct morphology|MP:0003078,aphakia|MP:0003686,abnormal eye muscle morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0005262,coloboma|MP:0009493,abnormal cystic duct morphology|MP:0009770,abnormal optic chiasm morphology|MP:0009907,decreased tongue size|MP:0010418,perimembraneous ventricular septal defect|MP:0010595,abnormal aortic valve cusp morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011683,dual inferior vena cava|MP:0013833,absent olfactory nerve|MP:0013848,subcutaneous edema|MP:0013852,abnormal Mullerian duct topology|MP:0013855,absent celiac artery|MP:0013875,increased trigeminal neuroma incidence|MP:0013876,absent ductus venosus valve|MP:0013877,abnormal ductus venosus valve morphology|MP:0013971,blood in lymph vessels|MP:0014003,additional anastomosis between intracranial vertebral arteries|MP:0014018,embryo tumor|MP:0014087,retrolental blood|MP:0030474,fused incisors
MGI:4458097	Ehd1<tm1.1Haba>	MP:0002169,no abnormal phenotype detected
MGI:4458098	Ehd1<tm1.2Haba>	MP:0000120,malocclusion|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001925,male infertility|MP:0002208,abnormal germ cell morphology|MP:0003671,abnormal eyelid aperture|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0006378,abnormal spermatogonia morphology|MP:0006379,abnormal spermatocyte morphology|MP:0006380,abnormal spermatid morphology|MP:0008279,arrest of spermiogenesis|MP:0008898,abnormal acrosome morphology|MP:0009851,abnormal Sertoli cell phagocytosis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0014052,increased male germ cell apoptosis|MP:0014685,spermiation failure|MP:0031345,developmental cataract
MGI:4432418	Ehd1<tm1a(EUCOMM)Wtsi>	MP:0003019,increased circulating chloride level|MP:0003671,abnormal eyelid aperture|MP:0005561,increased mean corpuscular hemoglobin
MGI:3712350	Ehd1<tm1Mhor>	MP:0003091,abnormal cell migration|MP:0005384,cellular phenotype|MP:0005621,abnormal cell physiology|MP:0011708,decreased fibroblast cell migration
MGI:6394087	Ehd2<tm1.1Cbm>	MP:0002702,decreased circulating free fatty acids level|MP:0005376,homeostasis/metabolism phenotype|MP:0005666,abnormal adipose tissue physiology|MP:0009117,abnormal white fat cell morphology|MP:0009118,increased white fat cell size|MP:0009121,increased white fat cell lipid droplet size|MP:0009124,increased brown fat cell lipid droplet size|MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0020325,abnormal beige fat cell morphology|MP:0020414,abnormal fibroblast physiology|MP:0030016,increased adipocyte glucose uptake
MGI:6394084	Ehd2<tm1Cbm>	MP:0009121,increased white fat cell lipid droplet size
MGI:4950928	Ehd3<tm1.2Haba>	MP:0002169,no abnormal phenotype detected
MGI:4360181	Ehd4<tm1.1Haba>	MP:0000351,increased cell proliferation|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005215,abnormal pancreatic islet morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0006307,abnormal seminiferous tubule size|MP:0006308,enlarged seminiferous tubules|MP:0006380,abnormal spermatid morphology|MP:0014052,increased male germ cell apoptosis
MGI:7425649	Ehf<em1(IMPC)Kmpc>	MP:0000208,decreased hematocrit|MP:0000452,abnormal mouth morphology|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001340,abnormal eyelid morphology|MP:0001402,decreased locomotor activity|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0003960,increased lean body mass|MP:0005287,narrow eye opening|MP:0005292,improved glucose tolerance|MP:0005542,cornea vascularization|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content|MP:0013278,decreased fasting circulating glucose level
MGI:6364857	Ehf<em1Zfa>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0003119,abnormal digestive system development|MP:0008108,abnormal small intestinal villus morphology
MGI:6450139	Ehhadh<tm1b(KOMP)Wtsi>	MP:0005566,decreased blood urea nitrogen level|MP:0005627,increased circulating potassium level|MP:0010506,prolonged RR interval
MGI:1857810	Ehhadh<tm1Jkr>	MP:0002118,abnormal lipid homeostasis|MP:0020847,abnormal peroxisome physiology
MGI:5287449	Ehmt1<Tg(Tyr)2265COve>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4418563	Ehmt1<tm1.1Tara>	MP:0000598,abnormal liver morphology|MP:0001260,increased body weight|MP:0001261,obese|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001423,abnormal liquid preference|MP:0001516,abnormal motor coordination/balance|MP:0001554,increased circulating free fatty acids level|MP:0002079,increased circulating insulin level|MP:0002757,decreased vertical activity|MP:0003631,nervous system phenotype|MP:0005288,abnormal oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005534,decreased body temperature|MP:0005559,increased circulating glucose level|MP:0009121,increased white fat cell lipid droplet size|MP:0009124,increased brown fat cell lipid droplet size|MP:0009136,decreased brown fat cell size|MP:0009137,decreased brown fat lipid droplet number|MP:0009288,increased epididymal fat pad weight|MP:0009294,increased interscapular fat pad weight|MP:0009295,decreased interscapular fat pad weight|MP:0009355,increased liver triglyceride level|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0009747,impaired behavioral response to xenobiotic|MP:0011049,impaired adaptive thermogenesis|MP:0011698,abnormal brown adipose tissue physiology|MP:0014172,decreased fatty acid oxidation
MGI:4418565	Ehmt1<tm1.2Tara>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002757,decreased vertical activity
MGI:5605800	Ehmt1<tm1b(EUCOMM)Hmgu>	MP:0000182,increased circulating LDL cholesterol level|MP:0000219,increased neutrophil cell number|MP:0001314,cornea opacity|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002599,increased mean platelet volume|MP:0002797,increased thigmotaxis|MP:0003960,increased lean body mass|MP:0004924,abnormal behavior|MP:0005178,increased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005554,decreased circulating creatinine level|MP:0005566,decreased blood urea nitrogen level|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:5708543	Ehmt1<tm1Bzhu>	MP:0000102,abnormal nasal bone morphology|MP:0000120,malocclusion|MP:0001436,abnormal suckling behavior|MP:0001732,postnatal growth retardation|MP:0003420,delayed intramembranous bone ossification|MP:0003842,abnormal metopic suture morphology|MP:0008770,decreased survivor rate|MP:0009429,decreased embryo weight|MP:0009431,decreased fetal weight|MP:0009546,absent gastric milk in neonates|MP:0009703,decreased birth body size|MP:0010865,prenatal growth retardation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012167,abnormal epigenetic regulation of gene expression
MGI:3575505	Ehmt1<tm1Yshk>	MP:0000929,open neural tube|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001458,abnormal object recognition memory|MP:0001488,increased startle reflex|MP:0001689,incomplete somite formation|MP:0001900,impaired synaptic plasticity|MP:0002062,abnormal associative learning|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002757,decreased vertical activity|MP:0002919,enhanced paired-pulse facilitation|MP:0003461,abnormal response to novel object|MP:0003984,embryonic growth retardation|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008143,abnormal dendrite morphology|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0009936,abnormal dendritic spine morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5543772	Ehmt1<tm2Yshk>	MP:0000301,decreased atrioventricular cushion size|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0010412,atrioventricular septal defect|MP:0010614,abnormal mitral valve cusp morphology|MP:0010625,absent tricuspid valve cusps|MP:0011088,neonatal lethality, incomplete penetrance
MGI:8266917	Ehmt2<em1Jchw>	MP:0002079,increased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype
MGI:3772197	Ehmt2<Gt(ES62)Feil>	MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0001713,decreased trophoblast giant cell number|MP:0003787,abnormal imprinting|MP:0004259,small placenta|MP:0011091,prenatal lethality, complete penetrance
MGI:4459641	Ehmt2<tm1.1Cza>	MP:0003449,abnormal intestine goblet cell morphology|MP:0005027,increased susceptibility to parasitic infection|MP:0008495,decreased IgG1 level|MP:0008500,increased IgG2a level|MP:0008566,increased interferon-gamma secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008681,increased interleukin-17 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion
MGI:5471303	Ehmt2<tm1.1(KOMP)Mbp>	MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4418499	Ehmt2<tm1.1Tara>	MP:0001261,obese|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001423,abnormal liquid preference|MP:0002757,decreased vertical activity|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology|MP:0008911,induced hyperactivity|MP:0009746,enhanced behavioral response to xenobiotic|MP:0009747,impaired behavioral response to xenobiotic
MGI:5708540	Ehmt2<tm1Bzhu>	MP:0002169,no abnormal phenotype detected
MGI:2183571	Ehmt2<tm1Yshk>	MP:0001648,abnormal apoptosis|MP:0001730,embryonic growth arrest|MP:0005621,abnormal cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5475024	Ei24<tm1.1Hzha>	MP:0011091,prenatal lethality, complete penetrance
MGI:5475023	Ei24<tm1Hzha>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0000745,tremors|MP:0000788,abnormal cerebral cortex morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000890,thin cerebellar molecular layer|MP:0000953,abnormal oligodendrocyte morphology|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0003203,increased neuron apoptosis|MP:0003225,axonal dystrophy|MP:0003354,astrocytosis|MP:0003492,abnormal involuntary movement|MP:0003631,nervous system phenotype|MP:0003632,abnormal nervous system morphology|MP:0004924,abnormal behavior|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0006254,thin cerebral cortex|MP:0008025,brain vacuoles|MP:0008026,abnormal brain white matter morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008535,enlarged lateral ventricles|MP:0008948,decreased neuron number|MP:0008987,abnormal liver lobule morphology|MP:0009267,abnormal cerebellum fissure morphology|MP:0009719,reduced cerebellar foliation|MP:0009971,decreased hippocampus pyramidal cell number|MP:0009974,decreased cerebral cortex pyramidal cell number|MP:0010047,axonal spheroids|MP:0011731,decreased myelin sheath thickness|MP:0011975,neuronal cytoplasmic inclusions|MP:0014341,abnormal hepatocyte mitochondrial morphology|MP:0030940,impaired autophagy
MGI:6695793	Eid1<em1Gpt>	MP:0000787,abnormal telencephalon morphology|MP:0001361,social withdrawal|MP:0001441,increased grooming behavior|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012207,decreased neuronal stem cell self-renewal|MP:0012307,impaired spatial learning
MGI:6402774	Eid2b<em1(IMPC)J>	MP:0000062,increased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0000218,increased leukocyte cell number|MP:0002591,decreased mean corpuscular volume|MP:0005559,increased circulating glucose level|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5909135	Eid2<em1(IMPC)J>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0002574,increased vertical activity
MGI:7518987	Eid3<em1(IMPC)J>	MP:0002834,decreased heart weight
MGI:5617790	Eif1ad<tm1b(EUCOMM)Hmgu>	MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0012362,increased large unstained cell number|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5617256	Eif1b<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0004738,abnormal auditory brainstem response
MGI:6152472	Eif2a<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001415,increased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002599,increased mean platelet volume|MP:0009142,decreased prepulse inhibition
MGI:5170065	Eif2a<Gt(IST13504C3)Tigm>	MP:0002169,no abnormal phenotype detected
MGI:6257436	Eif2ak1<em1(IMPC)Bay>	MP:0004952,increased spleen weight|MP:0010025,decreased total body fat amount
MGI:2679454	Eif2ak1<tm1Jjch>	MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000274,enlarged heart|MP:0001589,abnormal mean corpuscular hemoglobin|MP:0002447,abnormal erythrocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002811,macrocytic anemia|MP:0003656,abnormal erythrocyte physiology|MP:0005637,abnormal iron homeostasis|MP:0011171,increased number of Heinz bodies|MP:0031085,increased erythrocyte osmotic fragility
MGI:7790457	Eif2ak2<em1Btlr>	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:6276868	Eif2ak2<em1(IMPC)Mbp>	MP:0000194,increased circulating calcium level|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0002965,increased circulating serum albumin level|MP:0005553,increased circulating creatinine level
MGI:5438001	Eif2ak2<tm1Ajs>	MP:0005621,abnormal cell physiology
MGI:2182566	Eif2ak2<tm1Cwe>	MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008699,increased interleukin-4 secretion|MP:0020937,increased susceptibility to Picornaviridae infection
MGI:2182590	Eif2ak2<tm1Jcbe>	MP:0002006,neoplasm|MP:0005384,cellular phenotype|MP:0005387,immune system phenotype|MP:0008943,increased sensitivity to induced cell death|MP:0008944,decreased sensitivity to induced cell death|MP:0008973,decreased erythroid progenitor cell number|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0020913,increased susceptibility to Riboviria infection|MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:3774276	Eif2ak3<tm1.1Drc>	MP:0003340,acute pancreas inflammation|MP:0004247,small pancreas|MP:0005220,abnormal exocrine pancreas morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0008806,increased circulating amylase level|MP:0009145,abnormal pancreatic acinus morphology|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009164,exocrine pancreas atrophy
MGI:2183829	Eif2ak3<tm1Drc>	MP:0000066,osteoporosis|MP:0000135,decreased compact bone thickness|MP:0000141,abnormal vertebral body morphology|MP:0000556,abnormal hindlimb morphology|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001505,hunched posture|MP:0001559,hyperglycemia|MP:0001732,postnatal growth retardation|MP:0002114,abnormal axial skeleton morphology|MP:0002727,decreased circulating insulin level|MP:0003335,exocrine pancreatic insufficiency|MP:0003339,decreased pancreatic beta cell number|MP:0003564,abnormal insulin secretion|MP:0003797,abnormal compact bone morphology|MP:0004986,abnormal osteoblast morphology|MP:0005006,abnormal osteoblast physiology|MP:0005216,abnormal pancreatic alpha cell morphology|MP:0005220,abnormal exocrine pancreas morphology|MP:0005225,abnormal vertebrae development|MP:0005293,impaired glucose tolerance|MP:0005508,abnormal skeleton morphology|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009172,small pancreatic islets|MP:0009174,absent pancreatic beta cells|MP:0009178,absent pancreatic alpha cells|MP:0010400,increased liver glycogen level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0020137,decreased bone mineralization|MP:0030441,increased osteoblast apoptosis
MGI:2177666	Eif2ak3<tm1Dron>	MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality|MP:0002693,abnormal pancreas physiology|MP:0002727,decreased circulating insulin level|MP:0002791,steatorrhea|MP:0003335,exocrine pancreatic insufficiency|MP:0003339,decreased pancreatic beta cell number|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005215,abnormal pancreatic islet morphology|MP:0005220,abnormal exocrine pancreas morphology|MP:0005293,impaired glucose tolerance|MP:0005621,abnormal cell physiology|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009176,increased pancreatic alpha cell number|MP:0011085,postnatal lethality, complete penetrance
MGI:5049871	Eif2ak4<m1Btlr>	MP:0002451,abnormal macrophage physiology|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020931,increased susceptibility to Adenoviridae infection
MGI:3774318	Eif2ak4<tm1.1Dron>	MP:0001432,abnormal food preference
MGI:3582154	Eif2ak4<tm1.2Dron>	MP:0001432,abnormal food preference|MP:0001469,abnormal contextual conditioning behavior|MP:0002207,abnormal long-term potentiation|MP:0002376,abnormal dendritic cell physiology|MP:0003009,abnormal cytokine secretion|MP:0008414,abnormal spatial reference memory
MGI:2387965	Eif2ak4<tm1Drc>	MP:0001431,abnormal eating behavior|MP:0001732,postnatal growth retardation|MP:0001934,increased litter size|MP:0001935,decreased litter size|MP:0002865,increased growth rate|MP:0003402,decreased liver weight|MP:0003718,maternal effect|MP:0004819,decreased skeletal muscle mass|MP:0005311,abnormal circulating amino acid level|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4364625	Eif2b2<tm2a(KOMP)Wtsi>	MP:0005561,increased mean corpuscular hemoglobin
MGI:5636947	Eif2b3<tm1b(EUCOMM)Hmgu>	MP:0002874,decreased hemoglobin content|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6117465	Eif2b4<tm1.1Vdk>	MP:0000951,sporadic seizures|MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0001393,ataxia|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology|MP:0009978,abnormal cerebellum white matter morphology
MGI:6416103	Eif2b5<tm1.1Sidr>	MP:0000921,demyelination|MP:0001405,impaired coordination|MP:0002183,gliosis|MP:0003633,abnormal nervous system physiology|MP:0008489,slow postnatal weight gain|MP:0010053,decreased grip strength
MGI:6117472	Eif2b5<tm1.1Vdk>	MP:0000783,abnormal forebrain morphology|MP:0000920,abnormal myelination|MP:0000951,sporadic seizures|MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology|MP:0002763,ectopic Bergmann glia cells|MP:0003313,abnormal locomotor activation|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005404,abnormal axon morphology|MP:0008025,brain vacuoles|MP:0008513,thin retina inner plexiform layer|MP:0009808,decreased oligodendrocyte number|MP:0009978,abnormal cerebellum white matter morphology|MP:0010053,decreased grip strength|MP:0014429,increased hyaluronic acid level
MGI:4432328	Eif2b5<tm1a(EUCOMM)Wtsi>	MP:0002591,decreased mean corpuscular volume|MP:0002834,decreased heart weight|MP:0005560,decreased circulating glucose level|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:5306369	Eif2b5<tm1Oels>	MP:0000921,demyelination|MP:0001405,impaired coordination|MP:0002182,abnormal astrocyte morphology|MP:0003691,abnormal microglial cell physiology|MP:0005404,abnormal axon morphology|MP:0005459,decreased percent body fat/body weight|MP:0008026,abnormal brain white matter morphology|MP:0008128,abnormal brain internal capsule morphology|MP:0008872,abnormal physiological response to xenobiotic|MP:0008916,abnormal astrocyte physiology|MP:0010160,increased oligodendrocyte number
MGI:6416109	Eif2b5<tm2.1Sidr>	MP:0003633,abnormal nervous system physiology|MP:0010768,mortality/aging
MGI:6276847	Eif2d<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001417,decreased exploration in new environment|MP:0002339,abnormal lymph node morphology
MGI:6293838	Eif2s1<em1(IMPC)Mbp>	MP:0001489,decreased startle reflex|MP:0001728,failure of embryo implantation|MP:0002060,abnormal skin morphology|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0009142,decreased prepulse inhibition|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:2388264	Eif2s1<tm1Rjk>	MP:0000189,hypoglycemia|MP:0001436,abnormal suckling behavior|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0011087,neonatal lethality, complete penetrance
MGI:6257461	Eif2s2<em3(IMPC)Bay>	MP:0000689,abnormal spleen morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001399,hyperactivity|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3838881	Eif2s2<Gt(XH413)Byg>	MP:0001935,decreased litter size|MP:0002053,decreased incidence of induced tumors|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0030934,decreased primordial germ cell proliferation
MGI:6117845	Eif2s3y<em1Asah>	MP:0005389,reproductive system phenotype
MGI:6117853	Eif2s3y<em2Asah>	MP:0001925,male infertility|MP:0001940,testis hypoplasia|MP:0002685,abnormal spermatogonia proliferation|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0006379,abnormal spermatocyte morphology|MP:0014633,decreased spermatid number
MGI:6117849	Eif2s3y<em#Asah>	MP:0001925,male infertility|MP:0001940,testis hypoplasia|MP:0002685,abnormal spermatogonia proliferation|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype
MGI:5636799	Eif3b<Gt(GT529)Skmz>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:1856583	Eif3c<Xs>	MP:0000373,belly spot|MP:0000562,polydactyly|MP:0002109,abnormal limb morphology|MP:0002177,abnormal outer ear morphology|MP:0002938,white spotting|MP:0002939,head spot|MP:0008770,decreased survivor rate|MP:0009049,abnormal hallux morphology
MGI:1856274	Eif3c<Xs-J>	MP:0000373,belly spot|MP:0000562,polydactyly|MP:0002938,white spotting
MGI:3617494	Eif3c<Xsl>	MP:0000373,belly spot|MP:0000562,polydactyly|MP:0001732,postnatal growth retardation
MGI:7425650	Eif3e<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:6295473	Eif3e<tm1Fshb>	MP:0000601,small liver|MP:0001262,decreased body weight|MP:0001698,decreased embryo size|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003984,embryonic growth retardation|MP:0005384,cellular phenotype|MP:0011091,prenatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0013272,abnormal translation
MGI:6384603	Eif3f<em1(IMPC)Hmgu>	MP:0002075,abnormal coat/hair pigmentation|MP:0011100,preweaning lethality, complete penetrance
MGI:3847510	Eif3f<tm1(KOMP)Vlcg>	MP:0002106,abnormal muscle physiology|MP:0003961,decreased lean body mass|MP:0004065,increased susceptibility to induced muscular atrophy|MP:0004819,decreased skeletal muscle mass|MP:0009400,decreased skeletal muscle fiber size|MP:0009687,empty decidua capsularis|MP:0011092,embryonic lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013272,abnormal translation
MGI:5514383	Eif3h<MommeD12>	MP:0009687,empty decidua capsularis|MP:0011092,embryonic lethality, complete penetrance|MP:0012167,abnormal epigenetic regulation of gene expression
MGI:5514384	Eif3h<MommeD38>	MP:0009687,empty decidua capsularis|MP:0011092,embryonic lethality, complete penetrance|MP:0012167,abnormal epigenetic regulation of gene expression
MGI:5008832	Eif3h<tm1a(EUCOMM)Hmgu>	MP:0005031,abnormal trophoblast layer morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:6399916	Eif3k<em1(IMPC)Hmgu>	MP:0002100,abnormal tooth morphology|MP:0005568,increased circulating total protein level|MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance
MGI:5553070	Eif3m<tm1.1Nju>	MP:0001262,decreased body weight|MP:0003402,decreased liver weight|MP:0003918,decreased kidney weight|MP:0005370,liver/biliary system phenotype|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0008907,decreased total fat pad weight|MP:0011092,embryonic lethality, complete penetrance
MGI:5553067	Eif3m<tm1Nju>	MP:0000598,abnormal liver morphology|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0003984,embryonic growth retardation|MP:0011092,embryonic lethality, complete penetrance
MGI:7646942	Eif4a1<tm1.1Bea>	MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0005397,hematopoietic system phenotype|MP:0008178,decreased germinal center B cell number|MP:0008208,decreased pro-B cell number|MP:0008495,decreased IgG1 level
MGI:7461814	Eif4a2<em1(IMPC)J>	MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001415,increased exploration in new environment|MP:0001512,trunk curl|MP:0002797,increased thigmotaxis|MP:0004924,abnormal behavior
MGI:6155638	Eif4a3<tm1.1Dlsi>	MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000934,abnormal telencephalon development|MP:0008547,abnormal neocortex morphology|MP:0012138,decreased forebrain size|MP:0012203,abnormal neuronal stem cell morphology|MP:0012683,absent telencephalon|MP:0020069,decreased neocortex size
MGI:6306475	Eif4b<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003984,embryonic growth retardation|MP:0004738,abnormal auditory brainstem response|MP:0010052,increased grip strength|MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance
MGI:6790235	Eif4b<tm1.1Smoc>	MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0000692,small spleen|MP:0000706,small thymus|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001861,lung inflammation|MP:0002083,premature death|MP:0003846,matted coat|MP:0005016,decreased lymphocyte cell number|MP:0005425,increased macrophage cell number|MP:0008045,decreased NK cell number|MP:0008537,increased susceptibility to induced colitis|MP:0011940,decreased food intake|MP:0020913,increased susceptibility to Riboviria infection|MP:0020946,increased susceptibility to Orthomyxoviridae infection|MP:0031046,increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:6790236	Eif4b<tm1.2Smoc>	MP:0000601,small liver|MP:0003717,pallor|MP:0004200,decreased fetal size|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0014134,abnormal embryo morphology
MGI:7539704	Eif4e1b<em1Dean>	MP:0001926,female infertility|MP:0003718,maternal effect
MGI:7543289	Eif4e1b<em1Glin>	MP:0001926,female infertility|MP:0003718,maternal effect|MP:0004832,enlarged ovary|MP:0005389,reproductive system phenotype|MP:0011124,increased primary ovarian follicle number|MP:0011128,increased tertiary ovarian follicle number|MP:0031383,increased secondary ovarian follicle number
MGI:7539705	Eif4e1b<em2Dean>	MP:0001926,female infertility|MP:0003718,maternal effect
MGI:7539706	Eif4e1b<em3Dean>	MP:0001926,female infertility|MP:0003718,maternal effect
MGI:5444035	Eif4e2<tm1.1Nso>	MP:0000774,decreased brain size|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0009674,decreased birth weight|MP:0011087,neonatal lethality, complete penetrance
MGI:4364967	Eif4e3<tm1a(KOMP)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0001406,abnormal gait|MP:0002942,decreased circulating alanine transaminase level|MP:0005179,decreased circulating cholesterol level|MP:0005571,decreased lactate dehydrogenase level|MP:0005632,decreased circulating aspartate transaminase level|MP:0010869,decreased bone trabecula number
MGI:2177923	Eif4ebp1<tm1Nso>	MP:0000189,hypoglycemia|MP:0001262,decreased body weight|MP:0001783,decreased white adipose tissue amount|MP:0004215,abnormal myocardial fiber physiology|MP:0005289,increased oxygen consumption|MP:0005599,increased cardiac muscle contractility|MP:0005621,abnormal cell physiology|MP:0005668,decreased circulating leptin level|MP:0005670,abnormal white adipose tissue physiology|MP:0009283,decreased gonadal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0010025,decreased total body fat amount
MGI:3700567	Eif4ebp1<tm1Pjb>	MP:0001262,decreased body weight|MP:0005376,homeostasis/metabolism phenotype
MGI:3607258	Eif4ebp2<tm1Klan>	MP:0001360,abnormal social investigation|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001463,abnormal spatial learning|MP:0001529,abnormal vocalization|MP:0002062,abnormal associative learning|MP:0002206,abnormal CNS synaptic transmission|MP:0002207,abnormal long-term potentiation|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0011269,increased excitatory postsynaptic current amplitude|MP:0014373,increased miniature excitatory postsynaptic current amplitude|MP:0014375,increased miniature excitatory postsynaptic current frequency|MP:0014384,increased miniature inhibitory postsynaptic current amplitude
MGI:5695888	Eif4ebp3<tm1.1(KOMP)Vlcg>	MP:0002574,increased vertical activity|MP:0006203,eye hemorrhage
MGI:5754596	Eif4enif1<em1(IMPC)Tcp>	MP:0000538,abnormal urinary bladder morphology|MP:0001147,small testis|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0003020,decreased circulating chloride level|MP:0003717,pallor|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration
MGI:7425335	Eif4enif1<em1Ysa>	MP:0005380,embryo phenotype
MGI:4830310	Eif4e<tm1.1Lfur>	MP:0005621,abnormal cell physiology
MGI:5605837	Eif4e<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:7490226	Eif4e<Tn(pb-Act-RFP)1Xwu>	MP:0001262,decreased body weight|MP:0001727,abnormal embryo implantation|MP:0003886,abnormal embryonic epiblast morphology|MP:0005380,embryo phenotype|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance|MP:0013272,abnormal translation
MGI:6696153	Eif4g1<em1Bjbl>	MP:0001360,abnormal social investigation|MP:0003008,enhanced long-term potentiation|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0014384,increased miniature inhibitory postsynaptic current amplitude|MP:0020395,abnormal response to social novelty
MGI:6414502	Eif4g1<em1(IMPC)Hmgu>	MP:0000063,decreased bone mineral density|MP:0001529,abnormal vocalization|MP:0002792,abnormal retina vasculature morphology|MP:0002941,increased circulating alanine transaminase level|MP:0003961,decreased lean body mass|MP:0004953,decreased spleen weight|MP:0005343,increased circulating aspartate transaminase level|MP:0010024,increased total body fat amount|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011964,increased total retina thickness|MP:0013279,increased fasting circulating glucose level
MGI:5466854	Eif4g1<tm1.1Mjff>	MP:0002169,no abnormal phenotype detected
MGI:5498138	Eif4g2<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001303,abnormal lens morphology|MP:0001399,hyperactivity|MP:0002968,increased circulating alkaline phosphatase level|MP:0003020,decreased circulating chloride level|MP:0003795,abnormal bone structure|MP:0005293,impaired glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level|MP:0013292,embryonic lethality prior to organogenesis
MGI:2182646	Eif4g2<tm1Yam>	MP:0001674,abnormal germ layer development|MP:0001683,absent mesoderm|MP:0001696,failure to gastrulate|MP:0003984,embryonic growth retardation|MP:0005076,abnormal cell differentiation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6696154	Eif4g3<em1Bjbl>	MP:0002169,no abnormal phenotype detected
MGI:4125062	Eif4g3<Gt(XC431)Byg>	MP:0001147,small testis
MGI:3512906	Eif4g3<repro8>	MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:4123901	Eif4h<Gt(Ex279)Byg>	MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0000852,small cerebellum|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002108,abnormal muscle morphology|MP:0003646,increased muscle fatigability|MP:0003718,maternal effect|MP:0005277,abnormal brainstem morphology|MP:0005386,behavior/neurological phenotype|MP:0005508,abnormal skeleton morphology|MP:0008143,abnormal dendrite morphology|MP:0008428,abnormal spatial working memory|MP:0008526,decreased cranium width|MP:0008535,enlarged lateral ventricles|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008911,induced hyperactivity|MP:0008948,decreased neuron number|MP:0009293,decreased inguinal fat pad weight|MP:0009456,impaired cued conditioning behavior|MP:0009936,abnormal dendritic spine morphology|MP:0010025,decreased total body fat amount|MP:0010031,abnormal cranium size
MGI:5607536	Eif4h<tm1b(EUCOMM)Wtsi>	MP:0000280,thin ventricular wall|MP:0001697,abnormal embryo size|MP:0001914,hemorrhage|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness
MGI:5812102	Eif5a2<tm1d(EUCOMM)Hmgu>	MP:0002169,no abnormal phenotype detected
MGI:4127188	Eif5a<Gt(RRE174)Byg>	MP:0000352,decreased cell proliferation|MP:0009781,abnormal preimplantation embryo development|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6324040	Eif5b<em1(IMPC)J>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0003984,embryonic growth retardation|MP:0010053,decreased grip strength|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012129,failure of blastocyst formation
MGI:3817934	Eif6<tm1Sbif>	MP:0000600,liver hypoplasia|MP:0001262,decreased body weight|MP:0003402,decreased liver weight|MP:0004046,abnormal mitosis|MP:0005621,abnormal cell physiology|MP:0009115,abnormal fat cell morphology|MP:0010025,decreased total body fat amount|MP:0010080,abnormal hepatocyte physiology|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2680935	Eila1<C57BL/6J>	MP:0002629,hyperactivity elicited by ethanol administration
MGI:2680938	Eila2<C57BL/6J>	MP:0002629,hyperactivity elicited by ethanol administration
MGI:2680942	Eila3<C3H/HeJ>	MP:0002629,hyperactivity elicited by ethanol administration
MGI:5755665	Eipr1<em1(IMPC)J>	MP:0000208,decreased hematocrit|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0002875,decreased erythrocyte cell number|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:2157558	El1<EL>	MP:0002064,seizures
MGI:2155257	El2<EL>	MP:0002064,seizures
MGI:2157531	El3<EL/SuzSeyFrkJ>	MP:0002064,seizures
MGI:2157528	El4<EL/SuzSeyFrkJ>	MP:0002064,seizures
MGI:2157538	El5<EL/SuzSeyFrkJ>	MP:0002064,seizures
MGI:2157541	El6<DDY/Jcl>	MP:0002064,seizures
MGI:5300460	Elac1<Tn(sb-Tyr)1799B.CA18Ove>	MP:0002169,no abnormal phenotype detected
MGI:7545038	Elac2<em1Afi>	MP:0000659,prostate gland hyperplasia|MP:0001163,abnormal prostate gland anterior lobe morphology|MP:0003608,prostate gland inflammation|MP:0005305,prostate gland anterior lobe hyperplasia|MP:0005389,reproductive system phenotype|MP:0009381,abnormal prostate gland dorsolateral lobe morphology|MP:0010768,mortality/aging|MP:0031369,prostate gland dorsolateral lobe hyperplasia
MGI:5637003	Elac2<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6357902	Elac2<tm1c(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0005140,decreased cardiac muscle contractility|MP:0005384,cellular phenotype|MP:0005621,abnormal cell physiology|MP:0006036,abnormal mitochondrial physiology|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0010959,abnormal oxidative phosphorylation|MP:0011925,abnormal heart echocardiography feature|MP:0013272,abnormal translation
MGI:6357904	Elac2<tm1d(EUCOMM)Wtsi>	MP:0011092,embryonic lethality, complete penetrance
MGI:5619132	Elane<M1Btlr>	MP:0008561,decreased tumor necrosis factor secretion
MGI:2182177	Elane<tm1(cre)Roes>	MP:0008719,impaired neutrophil recruitment|MP:0009787,increased susceptibility to infection induced morbidity/mortality|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:3785264	Elane<tm1Link>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:2182771	Elane<tm1Sds>	MP:0001845,abnormal inflammatory response|MP:0001970,abnormal pain threshold|MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0005164,abnormal response to injury|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:5548671	Elapor1<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment|MP:0002699,abnormal vitreous body morphology|MP:0002764,short tibia|MP:0002792,abnormal retina vasculature morphology|MP:0005016,decreased lymphocyte cell number|MP:0005559,increased circulating glucose level|MP:0010097,abnormal retina blood vessel morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011941,increased fluid intake
MGI:5006999	Elapor1<tm1Lex>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia
MGI:5563910	Elavl1<tm1.1Atas>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005095,decreased T cell proliferation|MP:0010220,decreased T-helper 17 cell number
MGI:5316082	Elavl1<tm1.1Bndr>	MP:0000316,cellular necrosis|MP:0002128,abnormal blood circulation|MP:0003658,abnormal capillary morphology|MP:0003710,abnormal physiological neovascularization
MGI:4437584	Elavl1<tm1.1Dkon>	MP:0000220,increased monocyte cell number|MP:0002044,increased colon adenoma incidence|MP:0003060,increased aerobic running capacity|MP:0003721,increased tumor growth/size|MP:0004064,decreased susceptibility to induced muscular atrophy|MP:0004499,increased incidence of tumors by chemical induction|MP:0005289,increased oxygen consumption|MP:0005387,immune system phenotype|MP:0005425,increased macrophage cell number|MP:0005620,abnormal muscle contractility|MP:0008537,increased susceptibility to induced colitis|MP:0008553,increased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level|MP:0008617,increased circulating interleukin-12 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008735,increased susceptibility to endotoxin shock|MP:0008963,increased carbon dioxide production|MP:0009314,increased colon adenocarcinoma incidence|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010378,increased respiratory quotient|MP:0010760,abnormal macrophage chemotaxis|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0012107,enhanced exercise endurance
MGI:4414854	Elavl1<tm1.1Thla>	MP:0000333,decreased bone marrow cell number|MP:0000694,spleen hypoplasia|MP:0001823,thymus hypoplasia|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0011100,preweaning lethality, complete penetrance
MGI:3847912	Elavl1<tm1.2Dkon>	MP:0001713,decreased trophoblast giant cell number|MP:0001715,placental labyrinth hypoplasia|MP:0001722,pale yolk sac|MP:0003984,embryonic growth retardation|MP:0004256,abnormal maternal decidual layer morphology|MP:0004259,small placenta|MP:0004560,abnormal chorionic plate morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0008959,abnormal spongiotrophoblast cell morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012099,decreased spongiotrophoblast size
MGI:5635064	Elavl1<tm1b(EUCOMM)Hmgu>	MP:0001293,anophthalmia|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0002109,abnormal limb morphology|MP:0002941,increased circulating alanine transaminase level|MP:0003984,embryonic growth retardation|MP:0005562,decreased mean corpuscular hemoglobin|MP:0006243,impaired pupillary reflex|MP:0011100,preweaning lethality, complete penetrance
MGI:3847911	Elavl1<tm1Dkon>	MP:0000108,midline facial cleft|MP:0000547,short limbs|MP:0000564,syndactyly|MP:0000566,synostosis|MP:0000690,absent spleen|MP:0001176,abnormal lung development|MP:0002116,abnormal craniofacial bone morphology|MP:0002169,no abnormal phenotype detected|MP:0002444,abnormal T cell physiology|MP:0003419,delayed endochondral bone ossification|MP:0003850,abnormal thymocyte activation|MP:0004575,small limb buds|MP:0004678,split xiphoid process|MP:0004919,abnormal positive T cell selection|MP:0005090,increased double-negative T cell number|MP:0005091,increased double-positive T cell number|MP:0005225,abnormal vertebrae development|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0009323,abnormal spleen development|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5543892	Elavl1<tm1Lix>	MP:0001861,lung inflammation|MP:0001876,decreased inflammatory response
MGI:4414853	Elavl1<tm1Thla>	MP:0000221,decreased leukocyte cell number|MP:0000322,increased granulocyte number|MP:0000333,decreased bone marrow cell number|MP:0000334,decreased granulocyte number|MP:0000352,decreased cell proliferation|MP:0000488,abnormal intestinal epithelium morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000495,abnormal colon morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000694,spleen hypoplasia|MP:0001823,thymus hypoplasia|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002459,abnormal B cell physiology|MP:0003270,intestinal obstruction|MP:0003449,abnormal intestine goblet cell morphology|MP:0005092,decreased double-positive T cell number|MP:0005150,cachexia|MP:0006413,increased T cell apoptosis|MP:0008101,lymph node hypoplasia|MP:0008250,abnormal myeloid leukocyte morphology|MP:0008783,decreased B cell apoptosis|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0009511,distended stomach|MP:0014078,small intestinal villus atrophy
MGI:6794069	Elavl2<em1(IMPC)J>	MP:0000579,abnormal nail morphology|MP:0001319,irregularly shaped pupil|MP:0011100,preweaning lethality, complete penetrance
MGI:6720236	Elavl2<tm1.2Ysa>	MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001732,postnatal growth retardation|MP:0001926,female infertility|MP:0004805,absent oocytes|MP:0005389,reproductive system phenotype|MP:0008770,decreased survivor rate|MP:0009093,oocyte degeneration|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011122,absent primordial ovarian follicles
MGI:5440933	Elavl3<tm1.1Rbd>	MP:0000948,nonconvulsive seizures|MP:0001405,impaired coordination|MP:0004994,abnormal brain wave pattern|MP:0005386,behavior/neurological phenotype|MP:0008840,abnormal spike wave discharge|MP:0010768,mortality/aging|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3664094	Elavl4<tm1Okn>	MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002161,abnormal fertility/fecundity|MP:0003203,increased neuron apoptosis|MP:0003861,abnormal nervous system development|MP:0009937,abnormal neuron differentiation
MGI:3689519	Elda3<LS>	MP:0002629,hyperactivity elicited by ethanol administration
MGI:3689521	Elda4<LS>	MP:0003313,abnormal locomotor activation
MGI:3689522	Elda4<SS>	MP:0002629,hyperactivity elicited by ethanol administration
MGI:5563532	Eldr<tm1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:3590647	Elf1<tm1Jml>	MP:0002144,abnormal B cell differentiation|MP:0002459,abnormal B cell physiology
MGI:5548404	Elf3<tm1b(KOMP)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:2662485	Elf3<tm1Pjh>	MP:0000479,abnormal enterocyte morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0001265,decreased body size|MP:0003449,abnormal intestine goblet cell morphology|MP:0005036,diarrhea|MP:0005150,cachexia|MP:0005202,lethargy|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:7408147	Elf4<em1Hdu>	MP:0002418,increased susceptibility to viral infection|MP:0002451,abnormal macrophage physiology|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008750,abnormal interferon level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level
MGI:2388892	Elf4<tm1Nim>	MP:0001845,abnormal inflammatory response|MP:0002123,abnormal definitive hematopoiesis|MP:0002145,abnormal T cell differentiation|MP:0002220,large lymphoid organs|MP:0002619,abnormal lymphocyte morphology|MP:0003945,abnormal lymphocyte physiology|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004809,increased hematopoietic stem cell number|MP:0005014,increased B cell number|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005154,increased B cell proliferation|MP:0005348,increased T cell proliferation|MP:0008040,decreased NK T cell number|MP:0008045,decreased NK cell number|MP:0010766,abnormal NK cell physiology
MGI:3573855	Elf5<tm1Mapr>	MP:0000628,abnormal mammary gland development|MP:0001882,abnormal lactation|MP:0010249,lactation failure|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3578666	Elf5<tm1Plp>	MP:0001675,abnormal ectoderm development|MP:0001683,absent mesoderm|MP:0001698,decreased embryo size|MP:0002583,absent extraembryonic ectoderm|MP:0003984,embryonic growth retardation|MP:0005033,abnormal trophoblast giant cell morphology|MP:0006301,abnormal mesenchyme morphology|MP:0009593,absent chorion|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3844569	Elf5<tm1Sin>	MP:0000628,abnormal mammary gland development|MP:0001882,abnormal lactation|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0008770,decreased survivor rate|MP:0010249,lactation failure|MP:0010768,mortality/aging|MP:0010771,integument phenotype
MGI:4948126	Elf5<tm2Sin>	MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0011092,embryonic lethality, complete penetrance
MGI:5697443	Elfn1<tm1.1Jaru>	MP:0001399,hyperactivity|MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002757,decreased vertical activity|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002916,increased synaptic depression|MP:0003107,abnormal response to novelty|MP:0004994,abnormal brain wave pattern|MP:0009358,environmentally induced seizures|MP:0009936,abnormal dendritic spine morphology|MP:0010698,abnormal impulsive behavior control|MP:0031391,increased locomotor activity
MGI:5692822	Elfn1<tm1.1(KOMP)Vlcg>	MP:0000955,abnormal spinal cord morphology|MP:0001399,hyperactivity|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:3812600	Elfn1<tm1(KOMP)Vlcg>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0002064,seizures|MP:0003631,nervous system phenotype|MP:0010053,decreased grip strength
MGI:5548902	Elfn2<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001529,abnormal vocalization|MP:0002135,abnormal kidney morphology|MP:0002574,increased vertical activity|MP:0004924,abnormal behavior|MP:0005011,increased eosinophil cell number|MP:0020870,decreased thigmotaxis
MGI:4460634	Elfn2<tm1(KOMP)Vlcg>	MP:0001361,social withdrawal|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001496,audiogenic seizures|MP:0002206,abnormal CNS synaptic transmission|MP:0002797,increased thigmotaxis|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002912,abnormal excitatory postsynaptic potential
MGI:5585644	Elk1<tm1.1(KOMP)Vlcg>	MP:0002079,increased circulating insulin level|MP:0002833,increased heart weight
MGI:3028871	Elk1<tm1Nor>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0003631,nervous system phenotype|MP:0005387,immune system phenotype
MGI:3043408	Elk1<tm2Nor>	MP:0005389,reproductive system phenotype
MGI:6336071	Elk3<em1(IMPC)Ics>	MP:0001556,increased circulating HDL cholesterol level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level
MGI:5781314	Elk3<tm1.2Ics>	MP:0002792,abnormal retina vasculature morphology|MP:0003660,chylothorax|MP:0005385,cardiovascular system phenotype|MP:0005391,vision/eye phenotype|MP:0005602,decreased angiogenesis|MP:0006055,abnormal vascular endothelial cell morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2182950	Elk3<tm1Wlyk>	MP:0000249,abnormal blood vessel physiology|MP:0001402,decreased locomotor activity|MP:0001544,abnormal cardiovascular system physiology|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0003660,chylothorax|MP:0004038,lymphangiectasis|MP:0010820,abnormal pleura morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4432021	Elk4<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000186,decreased circulating HDL cholesterol level|MP:0000208,decreased hematocrit|MP:0001262,decreased body weight|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001325,abnormal retina morphology|MP:0001391,abnormal tail movements|MP:0002644,decreased circulating triglyceride level|MP:0002875,decreased erythrocyte cell number|MP:0002896,abnormal bone mineralization|MP:0002944,increased lactate dehydrogenase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003020,decreased circulating chloride level|MP:0003442,decreased circulating glycerol level|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005018,decreased T cell number|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0005634,decreased circulating sodium level|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008211,decreased mature B cell number|MP:0010088,decreased circulating fructosamine level
MGI:3036598	Elk4<tm1Rtr>	MP:0000715,decreased thymocyte number|MP:0004917,abnormal T cell selection|MP:0004919,abnormal positive T cell selection|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number
MGI:5790670	Ell2<tm1.1Cmil>	MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002460,decreased immunoglobulin level|MP:0003132,increased pre-B cell number|MP:0008098,decreased plasma cell number|MP:0008173,increased follicular B cell number|MP:0008186,increased pro-B cell number|MP:0008211,decreased mature B cell number|MP:0008214,increased immature B cell number|MP:0008495,decreased IgG1 level|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009923,decreased transitional stage T1 B cell number|MP:0009926,decreased transitional stage T2 B cell number|MP:0010228,decreased transitional stage T3 B cell number|MP:0020154,impaired humoral immune response
MGI:4441868	Ell2<tm1a(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002968,increased circulating alkaline phosphatase level|MP:0005419,decreased circulating serum albumin level|MP:0010052,increased grip strength
MGI:5548782	Ell2<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002968,increased circulating alkaline phosphatase level
MGI:5792877	Ell2<tm2.1Cmil>	MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002460,decreased immunoglobulin level|MP:0008211,decreased mature B cell number|MP:0008495,decreased IgG1 level
MGI:1933265	Ell<tm1Hhi>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2155993	Elmaz1<A/J>	MP:0001415,increased exploration in new environment
MGI:2155996	Elmaz2<CBA/J>	MP:0001415,increased exploration in new environment
MGI:6200276	Elmo1<M1Btlr>	MP:0001806,decreased IgM level|MP:0004977,increased B-1 B cell number|MP:0005017,decreased B cell number|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010838,increased CD8-positive, alpha-beta memory T cell number|MP:0020154,impaired humoral immune response
MGI:6200281	Elmo1<m2Btlr>	MP:0005017,decreased B cell number
MGI:6283440	Elmo1<m3Btlr>	MP:0008045,decreased NK cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010848,decreased central memory CD8 positive, alpha-beta T cell number
MGI:6283500	Elmo1<M4Btlr>	MP:0004939,abnormal B cell morphology|MP:0004977,increased B-1 B cell number|MP:0008037,abnormal T cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:4838426	Elmo1<tm1.1Ravi>	MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0014052,increased male germ cell apoptosis
MGI:4838428	Elmo1<tm1.2Ravi>	MP:0001146,abnormal testis morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0002784,abnormal Sertoli cell morphology|MP:0008280,abnormal male germ cell apoptosis|MP:0009853,decreased Sertoli cell phagocytosis|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0020550,multinucleated giant male germ cells
MGI:4939780	Elmo1<tm1a(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0003960,increased lean body mass|MP:0005561,increased mean corpuscular hemoglobin|MP:0010052,increased grip strength|MP:0010067,increased red blood cell distribution width|MP:0013278,decreased fasting circulating glucose level
MGI:7544996	Elmo2<tm1.1Jfco>	MP:0002169,no abnormal phenotype detected
MGI:4451842	Elmo2<tm1a(EUCOMM)Hmgu>	MP:0011102,embryonic lethality, incomplete penetrance|MP:0011111,lethality during fetal growth through weaning, complete penetrance
MGI:7544981	Elmo2<tm1c(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7544997	Elmo2<tm2.1Jfco>	MP:0009399,increased skeletal muscle fiber size|MP:0031318,enhanced skeletal muscle regeneration
MGI:5548855	Elmo3<tm1.1(KOMP)Vlcg>	MP:0001314,cornea opacity|MP:0004738,abnormal auditory brainstem response
MGI:5437446	Elmod1<rda-2J>	MP:0000043,organ of Corti degeneration|MP:0001394,circling|MP:0001967,deafness|MP:0002857,cochlear ganglion degeneration|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0006359,absent startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4435771	Elmod1<tm1a(EUCOMM)Hmgu>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000221,decreased leukocyte cell number|MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001486,abnormal startle reflex|MP:0002874,decreased hemoglobin content|MP:0002968,increased circulating alkaline phosphatase level|MP:0003019,increased circulating chloride level|MP:0003062,abnormal coping response|MP:0003179,thrombocytopenia|MP:0003313,abnormal locomotor activation|MP:0004924,abnormal behavior|MP:0005017,decreased B cell number|MP:0005179,decreased circulating cholesterol level|MP:0005316,abnormal response to tactile stimuli|MP:0005560,decreased circulating glucose level|MP:0005564,increased hemoglobin content|MP:0005565,increased blood urea nitrogen level|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength
MGI:5548895	Elmod1<tm1b(EUCOMM)Hmgu>	MP:0000221,decreased leukocyte cell number|MP:0000223,decreased monocyte cell number|MP:0000745,tremors|MP:0001322,abnormal iris morphology|MP:0001364,decreased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0001512,trunk curl|MP:0001566,increased circulating phosphate level|MP:0002102,abnormal ear morphology|MP:0002590,increased mean corpuscular volume|MP:0002833,increased heart weight|MP:0003917,increased kidney weight|MP:0003928,increased heart rate variability|MP:0003960,increased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0004924,abnormal behavior|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005385,cardiovascular system phenotype|MP:0005561,increased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010067,increased red blood cell distribution width|MP:0010511,shortened PR interval|MP:0011954,shortened PQ interval|MP:0012361,decreased large unstained cell number|MP:0020870,decreased thigmotaxis
MGI:5692836	Elmod2<tm1b(EUCOMM)Hmgu>	MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001556,increased circulating HDL cholesterol level|MP:0003961,decreased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0005564,increased hemoglobin content|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5901857	Elmod3<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:6455516	Elmod3<em1Jili>	MP:0001262,decreased body weight|MP:0004398,cochlear inner hair cell degeneration|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004533,fused inner hair cell stereocilia|MP:0004536,short inner hair cell stereocilia|MP:0004736,abnormal distortion product otoacoustic emission|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0020849,abnormal actin cytoskeleton morphology
MGI:2153007	Eln<tm1Dyl>	MP:0000231,hypertension|MP:0000249,abnormal blood vessel physiology|MP:0000484,abnormal pulmonary artery morphology|MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001183,overexpanded pulmonary alveolus|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0001958,emphysema|MP:0002191,abnormal artery morphology|MP:0002747,abnormal aortic valve morphology|MP:0003352,increased circulating renin level|MP:0003394,increased cardiac output|MP:0003395,abnormal subclavian artery morphology|MP:0003410,abnormal artery development|MP:0003907,decreased aorta elastin content|MP:0004875,increased mean systemic arterial blood pressure|MP:0004883,abnormal vascular wound healing|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006027,impaired lung alveolus development|MP:0006083,abnormal blood vessel elastic tissue morphology|MP:0006135,artery stenosis|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0009862,abnormal aorta elastic tissue morphology|MP:0009866,abnormal aorta wall morphology|MP:0010598,abnormal aortic valve annulus morphology|MP:0010996,increased aorta wall thickness|MP:0010997,decreased aorta wall thickness|MP:0011085,postnatal lethality, complete penetrance|MP:0011951,increased cardiac stroke volume
MGI:3688738	Elnv<EL/SuzSeyFrkJ>	MP:0002064,seizures
MGI:6277021	Eloa<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001293,anophthalmia|MP:0001700,abnormal embryo turning|MP:0002092,abnormal eye morphology|MP:0002699,abnormal vitreous body morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:3701319	Eloa<tm1Aso>	MP:0000280,thin ventricular wall|MP:0000352,decreased cell proliferation|MP:0000597,delayed hepatic development|MP:0001698,decreased embryo size|MP:0001889,delayed brain development|MP:0002740,heart hypoplasia|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0008008,early cellular replicative senescence|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012703,decreased embryonic neuroepithelium thickness|MP:0013501,increased fibroblast apoptosis|MP:0013504,increased embryonic tissue cell apoptosis
MGI:7641810	Elobl<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5569949	Elof1<tm1.1(KOMP)Vlcg>	MP:0001672,abnormal embryo development|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002833,increased heart weight|MP:0003064,decreased coping response|MP:0003087,absent allantois|MP:0003886,abnormal embryonic epiblast morphology|MP:0003984,embryonic growth retardation|MP:0005419,decreased circulating serum albumin level|MP:0005633,increased circulating sodium level|MP:0006386,absent somites|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011192,decreased embryonic epiblast cell proliferation|MP:0011388,absent heart|MP:0012724,absent head fold|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:5532707	Elovl1<tm1.1Akih>	MP:0001190,reddish skin|MP:0001196,shiny skin|MP:0002796,impaired skin barrier function|MP:0004777,abnormal phospholipid level|MP:0009431,decreased fetal weight|MP:0009608,abnormal epidermal lamellar body morphology|MP:0009674,decreased birth weight|MP:0009823,abnormal sphingomyelin level|MP:0009931,abnormal skin appearance|MP:0011087,neonatal lethality, complete penetrance|MP:0012232,abnormal ceramide level
MGI:6782853	Elovl2<em1Haml>	MP:0001325,abnormal retina morphology|MP:0003727,abnormal retina layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0005283,increased unsaturated fatty acids level|MP:0005285,decreased unsaturated fatty acids level|MP:0005389,reproductive system phenotype|MP:0006149,decreased visual acuity
MGI:4939584	Elovl2<tm1Jaco>	MP:0001155,arrest of spermatogenesis|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005282,decreased fatty acids level|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0009230,abnormal sperm head morphology
MGI:5556073	Elovl3<burf>	MP:0000372,irregular coat pigmentation|MP:0000420,ruffled hair|MP:0001290,delayed eyelid opening|MP:0001510,abnormal coat appearance|MP:0001511,disheveled coat|MP:0002075,abnormal coat/hair pigmentation|MP:0003136,yellow coat color|MP:0013146,eye lesions
MGI:3036781	Elovl3<tm1Jaco>	MP:0000367,abnormal coat/ hair morphology|MP:0000377,abnormal hair follicle morphology|MP:0000416,sparse hair|MP:0000652,enlarged sebaceous gland|MP:0001194,dermatitis|MP:0001219,thick epidermis|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0002796,impaired skin barrier function|MP:0002991,abnormal sebaceous gland physiology|MP:0002992,abnormal sebaceous lipid secretion|MP:0005072,abnormal hair follicle melanin granule morphology|MP:0005379,endocrine/exocrine gland phenotype|MP:0011019,abnormal adaptive thermogenesis
MGI:3722127	Elovl4<tm1Kzh>	MP:0001191,abnormal skin condition|MP:0001196,shiny skin|MP:0001199,thin skin|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001263,weight loss|MP:0002081,perinatal lethality|MP:0002447,abnormal erythrocyte morphology|MP:0002796,impaired skin barrier function|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0004200,decreased fetal size|MP:0009431,decreased fetal weight|MP:0009931,abnormal skin appearance|MP:0014321,short forelimb
MGI:3692750	Elovl4<tm1Rayy>	MP:0001325,abnormal retina morphology|MP:0002092,abnormal eye morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0004022,abnormal cone electrophysiology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005280,abnormal fatty acids level|MP:0005551,abnormal eye electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008515,thin retina outer nuclear layer|MP:0014336,short retina rod cell outer segment
MGI:3664793	Elovl4<tm1Sie>	MP:0001325,abnormal retina morphology|MP:0002161,abnormal fertility/fecundity|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0014336,short retina rod cell outer segment
MGI:3711216	Elovl4<tm1Wked>	MP:0001190,reddish skin|MP:0001216,abnormal epidermal layer morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0002090,abnormal vision|MP:0002796,impaired skin barrier function|MP:0004021,abnormal rod electrophysiology|MP:0004792,abnormal synaptic vesicle number|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005202,lethargy|MP:0011087,neonatal lethality, complete penetrance|MP:0030950,abnormal synaptic vesicle exocytosis
MGI:6480262	Elovl4<tm2b(EUCOMM)Hmgu>	MP:0000428,abnormal craniofacial morphology|MP:0001417,decreased exploration in new environment|MP:0013292,embryonic lethality prior to organogenesis
MGI:4462372	Elovl4<tm2Kzh>	MP:0001191,abnormal skin condition|MP:0001196,shiny skin|MP:0001199,thin skin|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001263,weight loss|MP:0002081,perinatal lethality|MP:0002796,impaired skin barrier function|MP:0009931,abnormal skin appearance
MGI:5492043	Elovl4<tm3Kzh>	MP:0001005,abnormal retina rod cell morphology|MP:0005285,decreased unsaturated fatty acids level|MP:0005376,homeostasis/metabolism phenotype|MP:0005391,vision/eye phenotype
MGI:7435542	Elovl5<em1(IMPC)Tcp>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001322,abnormal iris morphology|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001556,increased circulating HDL cholesterol level|MP:0002599,increased mean platelet volume|MP:0002757,decreased vertical activity|MP:0002764,short tibia|MP:0002792,abnormal retina vasculature morphology|MP:0002834,decreased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0003900,shortened QT interval|MP:0003961,decreased lean body mass|MP:0005278,abnormal cholesterol homeostasis|MP:0006243,impaired pupillary reflex|MP:0010024,increased total body fat amount|MP:0010068,decreased red blood cell distribution width|MP:0010097,abnormal retina blood vessel morphology|MP:0010124,decreased bone mineral content|MP:0010393,shortened QRS complex duration|MP:0010511,shortened PR interval|MP:0013279,increased fasting circulating glucose level
MGI:3847980	Elovl5<Gt(DTM098)Byg>	MP:0000609,abnormal liver physiology|MP:0001926,female infertility|MP:0002628,hepatic steatosis
MGI:3530353	Elovl6<Gt(OST222498)Lex>	MP:0000598,abnormal liver morphology|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003858,enhanced coordination|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005215,abnormal pancreatic islet morphology|MP:0005280,abnormal fatty acids level|MP:0005292,improved glucose tolerance|MP:0005378,growth/size/body region phenotype|MP:0005668,decreased circulating leptin level|MP:0010080,abnormal hepatocyte physiology|MP:0011102,embryonic lethality, incomplete penetrance|MP:0014172,decreased fatty acid oxidation
MGI:5637121	Elovl6<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0001552,increased circulating triglyceride level|MP:0002968,increased circulating alkaline phosphatase level|MP:0008806,increased circulating amylase level|MP:0010067,increased red blood cell distribution width|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3835595	Elp1<Gt(BGB184)Byg>	MP:0000259,abnormal vascular development|MP:0000913,abnormal brain development|MP:0000928,incomplete rostral neuropore closure|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001721,absent visceral yolk sac blood islands|MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003874,absent pharyngeal arches|MP:0004229,abnormal embryonic erythropoiesis|MP:0004259,small placenta|MP:0004573,absent limb buds|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5512768	Elp1<tm1.1Gilas>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0000964,small dorsal root ganglion|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0001973,increased thermal nociceptive threshold|MP:0002175,decreased brain weight|MP:0002980,abnormal postural reflex|MP:0003289,abnormal intestinal peristalsis|MP:0008415,abnormal neurite morphology|MP:0008492,dorsal root ganglion degeneration
MGI:5297555	Elp1<tm1.1Id>	MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0000292,distended pericardium|MP:0000298,absent atrioventricular cushions|MP:0000913,abnormal brain development|MP:0000934,abnormal telencephalon development|MP:0001698,decreased embryo size|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004086,absent heartbeat|MP:0004783,abnormal cardinal vein morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0005312,pericardial effusion|MP:0006126,abnormal cardiac outflow tract development|MP:0006294,absent optic vesicle|MP:0006345,absent second pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012541,absent lamina terminalis
MGI:7714931	Elp1<tm1.2Id>	MP:0000069,kyphoscoliosis|MP:0000160,kyphosis|MP:0000519,hydronephrosis|MP:0000539,distended urinary bladder|MP:0000960,abnormal sensory ganglion morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001011,abnormal superior cervical ganglion morphology|MP:0001017,abnormal stellate ganglion morphology|MP:0001052,abnormal innervation pattern to muscle|MP:0001059,optic nerve atrophy|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001332,abnormal optic nerve innervation|MP:0001344,blepharoptosis|MP:0001393,ataxia|MP:0001412,excessive scratching|MP:0001436,abnormal suckling behavior|MP:0001441,increased grooming behavior|MP:0001496,audiogenic seizures|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0001712,abnormal placenta development|MP:0001732,postnatal growth retardation|MP:0001852,conjunctivitis|MP:0001973,increased thermal nociceptive threshold|MP:0004069,abnormal muscle spindle morphology|MP:0004201,fetal growth retardation|MP:0005302,neurogenic bladder|MP:0005508,abnormal skeleton morphology|MP:0006222,optic neuropathy|MP:0006257,abnormal fungiform papillae morphology|MP:0006276,abnormal autonomic nervous system physiology|MP:0006404,abnormal lumbar dorsal root ganglion morphology|MP:0008259,abnormal optic disk morphology|MP:0008489,slow postnatal weight gain|MP:0008507,thin retina ganglion layer|MP:0008770,decreased survivor rate|MP:0009358,environmentally induced seizures|MP:0009703,decreased birth body size|MP:0010025,decreased total body fat amount|MP:0010155,abnormal intestine physiology|MP:0011090,perinatal lethality, incomplete penetrance
MGI:4362242	Elp1<tm1a(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5558022	Elp1<tm1c(KOMP)Wtsi>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0000966,decreased sensory neuron number|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001011,abnormal superior cervical ganglion morphology|MP:0001147,small testis|MP:0001925,male infertility|MP:0003203,increased neuron apoptosis|MP:0003743,abnormal facial morphology|MP:0003793,abnormal submandibular gland morphology|MP:0004200,decreased fetal size|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0008947,increased neuron number|MP:0008948,decreased neuron number|MP:0009451,abnormal chromosomal synapsis|MP:0009937,abnormal neuron differentiation|MP:0010382,abnormal dosage compensation, by inactivation of X chromosome|MP:0010948,abnormal double-strand DNA break repair|MP:0011087,neonatal lethality, complete penetrance|MP:0011751,abnormal X-Y chromosome synapsis during male meiosis|MP:0030273,mandibular retrognathia
MGI:5297554	Elp1<tm1Id>	MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0000292,distended pericardium|MP:0000298,absent atrioventricular cushions|MP:0000913,abnormal brain development|MP:0000934,abnormal telencephalon development|MP:0001698,decreased embryo size|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004086,absent heartbeat|MP:0004783,abnormal cardinal vein morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0005312,pericardial effusion|MP:0006126,abnormal cardiac outflow tract development|MP:0006294,absent optic vesicle|MP:0006345,absent second pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012541,absent lamina terminalis
MGI:6715576	Elp2<em2Bjw>	MP:0000433,microcephaly|MP:0000745,tremors|MP:0000783,abnormal forebrain morphology|MP:0000837,abnormal hypothalamus morphology|MP:0000859,abnormal somatosensory cortex morphology|MP:0000876,Purkinje cell degeneration|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001441,increased grooming behavior|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002199,abnormal brain commissure morphology|MP:0004101,abnormal brain interneuron morphology|MP:0004144,hypotonia|MP:0004981,decreased neuronal precursor cell number|MP:0006254,thin cerebral cortex|MP:0008026,abnormal brain white matter morphology|MP:0008128,abnormal brain internal capsule morphology|MP:0008143,abnormal dendrite morphology|MP:0008225,abnormal anterior commissure morphology|MP:0008439,abnormal cortical plate morphology|MP:0009937,abnormal neuron differentiation|MP:0010053,decreased grip strength|MP:0011083,lethality at weaning, complete penetrance|MP:0014185,cerebellum atrophy|MP:0020070,decreased neocortex volume|MP:0020351,decreased vocalization|MP:0020508,decreased dendritic spine density
MGI:6715581	Elp2<em3Bjw>	MP:0001698,decreased embryo size|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4345664	Elp3<Gt(AQ0461)Wtsi>	MP:0003984,embryonic growth retardation|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5704311	Elp3<tm1.1Tac>	MP:0000488,abnormal intestinal epithelium morphology|MP:0005381,digestive/alimentary phenotype|MP:0014353,abnormal gastrointestinal brush cell morphology|MP:0031319,impaired intestine regeneration
MGI:7462006	Elp4<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0011960,abnormal eye anterior chamber depth
MGI:7464998	Elp4<em1(IMPC)Tcp>	MP:0001289,persistence of hyaloid vascular system|MP:0002574,increased vertical activity|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:8275247	Elp6<em1Bjw>	MP:0000745,tremors|MP:0000747,muscle weakness|MP:0001393,ataxia|MP:0001513,limb grasping|MP:0001524,impaired limb coordination|MP:0001525,impaired balance|MP:0002083,premature death|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0008489,slow postnatal weight gain|MP:0020338,abnormal hippocampal pyramidal neuron dendrite morphology|MP:0031391,increased locomotor activity
MGI:6361007	Elp6<em1(IMPC)J>	MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5563405	Elp6<m1Anu>	MP:0001405,impaired coordination
MGI:3521883	Elpfm<C3H/HeJ>	MP:0005319,abnormal enzyme/coenzyme level
MGI:3843370	Elpt2<C57BL/6>	MP:0005669,increased circulating leptin level
MGI:3843371	Elpt3<129S6/SvEvTac>	MP:0005669,increased circulating leptin level
MGI:2663488	Elpt<C57BL/6J>	MP:0005669,increased circulating leptin level
MGI:3040469	Elsgp1<NZB/BlNJ>	MP:0002723,abnormal immune serum protein physiology
MGI:3040471	Elsgp2<NZB/BlNJ>	MP:0002723,abnormal immune serum protein physiology
MGI:3040473	Elsgp3<NZB/BlNJ>	MP:0002723,abnormal immune serum protein physiology
MGI:3040486	Elsgp4<NZB/BlNJ>	MP:0002723,abnormal immune serum protein physiology
MGI:3040488	Elsgp4<NZW/LacJ>	MP:0002723,abnormal immune serum protein physiology
MGI:1861119	Em	MP:0001304,cataract
MGI:5558162	Emb<tm1b(KOMP)Wtsi>	MP:0000598,abnormal liver morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7611846	Emb<tm1Heij>	MP:0001176,abnormal lung development|MP:0003641,small lung|MP:0005380,embryo phenotype|MP:0009431,decreased fetal weight|MP:0010811,decreased type II pneumocyte number|MP:0010813,abnormal alveolar lamellar body morphology|MP:0010816,decreased type I pneumocyte number|MP:0010865,prenatal growth retardation|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011585,decreased alkaline phosphatase activity|MP:0012172,abnormal amniotic fluid composition
MGI:5085894	Emc10<Gt(OST181617)Lex>	MP:0001363,increased anxiety-related response|MP:0001922,reduced male fertility|MP:0005292,improved glucose tolerance
MGI:7310069	Emc10<tm1.2Smoc>	MP:0000242,impaired fertilization|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0003666,impaired sperm capacitation|MP:0004542,impaired acrosome reaction|MP:0004852,decreased testis weight|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009237,kinked sperm flagellum|MP:0009243,hairpin sperm flagellum|MP:0011977,abnormal sodium ion homeostasis|MP:0031393,abnormal bicarbonate homeostasis
MGI:5548589	Emc10<tm1b(EUCOMM)Wtsi>	MP:0000280,thin ventricular wall|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0001529,abnormal vocalization|MP:0013278,decreased fasting circulating glucose level
MGI:7611969	Emc1<em1Xjz>	MP:0001006,abnormal retina cone cell morphology|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008446,decreased retina cone cell number|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008584,photoreceptor outer segment degeneration|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0030005,increased retina apoptosis
MGI:6376213	Emc3<em1Xjz>	MP:0001326,retina degeneration|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0008515,thin retina outer nuclear layer
MGI:5629314	Emc3<tm1b(EUCOMM)Wtsi>	MP:0002757,decreased vertical activity|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:5299564	Emc4<tm1(KOMP)Wtsi>	MP:0002075,abnormal coat/hair pigmentation|MP:0002606,increased basophil cell number|MP:0005011,increased eosinophil cell number|MP:0010580,decreased heart left ventricle size|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:5583060	Emc6<tm1.1(KOMP)Vlcg>	MP:0002608,increased hematocrit|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5807495	Emc7<tm1b(KOMP)Mbp>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5006995	Emc7<tm1Lex>	MP:0010166,increased response to stress-induced hyperthermia|MP:0010770,preweaning lethality
MGI:5692625	Emc8<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0000274,enlarged heart|MP:0002546,mydriasis|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:6153329	Emcn<em1(IMPC)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000208,decreased hematocrit|MP:0002599,increased mean platelet volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0008806,increased circulating amylase level
MGI:8278585	Emcn<tm1.2Pdmr>	MP:0002871,albuminuria|MP:0005325,abnormal renal glomerulus morphology|MP:0005385,cardiovascular system phenotype|MP:0008059,abnormal podocyte foot process morphology|MP:0008139,fused podocyte foot processes|MP:0008140,podocyte foot process effacement|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011454,abnormal glomerular endothelium fenestra morphology|MP:0011499,abnormal glomerular capsule space morphology|MP:0011855,abnormal glomerular filtration barrier morphology|MP:0011856,abnormal glomerular filtration barrier function
MGI:6156285	Emd<em1(IMPC)Kmpc>	MP:0001566,increased circulating phosphate level|MP:0002059,abnormal seminal vesicle morphology|MP:0009455,enhanced cued conditioning behavior
MGI:3621266	Emd<tm1.1Stw>	MP:0000278,abnormal myocardial fiber morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0002833,increased heart weight|MP:0003082,abnormal gastrocnemius morphology|MP:0004485,increased response of heart to induced stress|MP:0004565,decreased myocardial fiber size|MP:0005369,muscle phenotype|MP:0005384,cellular phenotype|MP:0005598,decreased heart ventricle muscle contractility|MP:0006321,increased myocardial fiber number|MP:0011925,abnormal heart echocardiography feature|MP:0031633,decreased heart left ventricle muscle contractility|MP:0031634,decreased heart right ventricle muscle contractility
MGI:3621049	Emd<tm1Ykh>	MP:0000278,abnormal myocardial fiber morphology|MP:0001405,impaired coordination|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003896,prolonged PR interval
MGI:5569963	Eme1<tm1.1(KOMP)Wtsi>	MP:0000689,abnormal spleen morphology|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number
MGI:5787927	Emg1<tm1.1Btr>	MP:0000352,decreased cell proliferation|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0000929,open neural tube|MP:0000930,wavy neural tube|MP:0000934,abnormal telencephalon development|MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0002875,decreased erythrocyte cell number|MP:0003984,embryonic growth retardation|MP:0006042,increased apoptosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5616355	Emg1<tm1.1(KOMP)Wtsi>	MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005632,decreased circulating aspartate transaminase level|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness|MP:0013292,embryonic lethality prior to organogenesis
MGI:4839753	Emg1<tm1Hdin>	MP:0001730,embryonic growth arrest|MP:0002663,absent blastocoele|MP:0004964,absent inner cell mass|MP:0008830,abnormal nucleolus morphology|MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4433468	Emid1<tm1a(EUCOMM)Wtsi>	MP:0002702,decreased circulating free fatty acids level
MGI:3028845	Emilin1<tm1Gmb>	MP:0001243,abnormal dermal layer morphology|MP:0009549,decreased platelet aggregation|MP:0009862,abnormal aorta elastic tissue morphology|MP:0009866,abnormal aorta wall morphology|MP:0012356,increased prothrombin time
MGI:6151442	Emilin2<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0010053,decreased grip strength
MGI:5755385	Emilin2<tm1.2Jhp>	MP:0002551,abnormal blood coagulation|MP:0005164,abnormal response to injury|MP:0009549,decreased platelet aggregation
MGI:5635065	Emilin3<tm1.1(KOMP)Vlcg>	MP:0001289,persistence of hyaloid vascular system|MP:0001399,hyperactivity|MP:0002833,increased heart weight|MP:0009142,decreased prepulse inhibition
MGI:6153330	Eml1<em1(IMPC)Wtsi>	MP:0002875,decreased erythrocyte cell number|MP:0005561,increased mean corpuscular hemoglobin|MP:0006358,absent pinna reflex|MP:0013278,decreased fasting circulating glucose level
MGI:5560734	Eml1<heco>	MP:0000243,myoclonus|MP:0000422,delayed hair appearance|MP:0000438,abnormal cranium morphology|MP:0000789,thickened cerebral cortex|MP:0000913,abnormal brain development|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001290,delayed eyelid opening|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0002064,seizures|MP:0002862,abnormal righting response|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003203,increased neuron apoptosis|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0003648,abnormal radial glial cell morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0005156,bradykinesia|MP:0008457,abnormal cortical intermediate zone morphology|MP:0009760,abnormal mitotic spindle morphology|MP:0011380,enlarged brain ventricles|MP:0011723,ectopic neuron|MP:0011724,ectopic cortical neuron|MP:0012307,impaired spatial learning|MP:0012506,brain atrophy
MGI:6286305	Eml1<m1Btlr>	MP:0030245,round head
MGI:6473556	Eml1<tm1.2Ics>	MP:0000788,abnormal cerebral cortex morphology|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002196,absent corpus callosum|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0006254,thin cerebral cortex|MP:0008226,decreased anterior commissure size|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008439,abnormal cortical plate morphology|MP:0008457,abnormal cortical intermediate zone morphology|MP:0008458,abnormal cortical ventricular zone morphology|MP:0008535,enlarged lateral ventricles|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011723,ectopic neuron|MP:0012474,decreased cingulate cortex size|MP:0013908,small lateral ventricles|MP:0020762,abnormal dorsal subiculum morphology
MGI:6690860	Eml1<tvrm360>	MP:0000825,dilated lateral ventricle|MP:0000917,obstructive hydrocephaly|MP:0001325,abnormal retina morphology|MP:0002083,premature death|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005547,abnormal Muller cell morphology|MP:0006068,abnormal retina horizontal cell morphology|MP:0006069,abnormal retina neuronal layer morphology|MP:0006071,abnormal retina progenitor cell morphology|MP:0009772,abnormal retina development|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011723,ectopic neuron|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0020813,abnormal photoreceptor outer segment disc membrane morphology
MGI:5609351	Eml2<tm1b(EUCOMM)Wtsi>	MP:0002092,abnormal eye morphology|MP:0002874,decreased hemoglobin content|MP:0003731,abnormal retina outer nuclear layer morphology
MGI:7386926	Eml3<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0000194,increased circulating calcium level|MP:0000221,decreased leukocyte cell number|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6151437	Eml4<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0003896,prolonged PR interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2154048	Emo1<BALB/cJ>	MP:0002065,abnormal fear/anxiety-related behavior
MGI:2154050	Emo1<C57BL/6J>	MP:0002065,abnormal fear/anxiety-related behavior
MGI:2389480	Emo2<BALB/cJ>	MP:0002065,abnormal fear/anxiety-related behavior
MGI:2389481	Emo2<C57BL/6J>	MP:0002065,abnormal fear/anxiety-related behavior
MGI:2154415	Emo3<A/J>	MP:0002065,abnormal fear/anxiety-related behavior
MGI:2154416	Emo3<C3H/HeJ>	MP:0002065,abnormal fear/anxiety-related behavior
MGI:2154418	Emo3<DBA/2J>	MP:0002065,abnormal fear/anxiety-related behavior
MGI:2154417	Emo3<I/LnJ>	MP:0002065,abnormal fear/anxiety-related behavior
MGI:2154419	Emo3<RIIIS/J>	MP:0002065,abnormal fear/anxiety-related behavior
MGI:5007120	Emp1<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:5925410	Emp2<tm1.1Tac>	MP:0000218,increased leukocyte cell number|MP:0001711,abnormal placenta morphology|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0003231,abnormal placenta vasculature|MP:0009394,increased uterine NK cell number|MP:0012529,abnormal decidua basalis morphology
MGI:6341933	Emsy<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0000274,enlarged heart|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001157,small seminal vesicle|MP:0001672,abnormal embryo development|MP:0001691,abnormal somite shape|MP:0001697,abnormal embryo size|MP:0002059,abnormal seminal vesicle morphology|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0002631,abnormal epididymis morphology|MP:0002764,short tibia|MP:0002861,abnormal tail bud morphology|MP:0002874,decreased hemoglobin content|MP:0002884,abnormal pharyngeal arch morphology|MP:0003036,vertebral transformation|MP:0003232,abnormal forebrain development|MP:0003425,abnormal optic vesicle formation|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0004931,enlarged epididymis|MP:0005293,impaired glucose tolerance|MP:0005650,abnormal limb bud morphology|MP:0006108,abnormal hindbrain development|MP:0008044,increased NK cell number|MP:0009806,abnormal otic vesicle morphology|MP:0010067,increased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5474622	Emv72<a>	MP:0003721,increased tumor growth/size|MP:0005078,abnormal cytotoxic T cell physiology
MGI:5474624	Emv72<b>	MP:0003447,decreased tumor growth/size|MP:0005078,abnormal cytotoxic T cell physiology|MP:0008037,abnormal T cell morphology
MGI:3762664	Emx1<tm1.1(cre)Ito>	MP:0002169,no abnormal phenotype detected
MGI:5695972	Emx1<tm1.1(KOMP)Vlcg>	MP:0001926,female infertility|MP:0002175,decreased brain weight|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1928281	Emx1<tm1(cre)Ito>	MP:0002169,no abnormal phenotype detected
MGI:2684610	Emx1<tm1(cre)Krj>	MP:0002169,no abnormal phenotype detected
MGI:2176219	Emx1<tm1(cre)Yql>	MP:0002196,absent corpus callosum
MGI:1857433	Emx1<tm1Jlr>	MP:0000780,abnormal corpus callosum morphology|MP:0002196,absent corpus callosum|MP:0005389,reproductive system phenotype
MGI:3038078	Emx2<Pdo>	MP:0000029,abnormal malleus morphology|MP:0000031,abnormal cochlea morphology|MP:0001967,deafness|MP:0002989,small kidney|MP:0004318,absent incus|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004395,increased cochlear inner hair cell number|MP:0004401,increased cochlear outer hair cell number|MP:0004417,decreased cochlear nerve compound action potential|MP:0004739,conductive hearing loss|MP:0004740,sensorineural hearing loss|MP:0004750,syndromic hearing loss|MP:0004767,increased cochlear nerve compound action potential|MP:0005105,abnormal middle ear ossicle morphology|MP:0005106,abnormal incus morphology|MP:0005107,abnormal stapes morphology|MP:0005385,cardiovascular system phenotype|MP:0006325,impaired hearing|MP:0006358,absent pinna reflex|MP:0011087,neonatal lethality, complete penetrance|MP:0030108,abnormal incudostapedial joint morphology|MP:0030109,abnormal incudomalleolar joint morphology|MP:0030396,abnormal incus long process morphology|MP:0030398,absent incus lenticular process|MP:0030402,abnormal stapes head morphology
MGI:2148858	Emx2<tm1Pgr>	MP:0000029,abnormal malleus morphology|MP:0000520,absent kidney|MP:0000781,decreased corpus callosum size|MP:0000788,abnormal cerebral cortex morphology|MP:0000814,absent dentate gyrus|MP:0000815,abnormal Ammon gyrus morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000827,dilated third ventricle|MP:0002741,small olfactory bulb|MP:0003005,abnormal hippocampal fimbria morphology|MP:0004318,absent incus|MP:0004395,increased cochlear inner hair cell number|MP:0004401,increased cochlear outer hair cell number|MP:0005107,abnormal stapes morphology|MP:0008226,decreased anterior commissure size|MP:0008540,abnormal cerebral hemisphere morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0020545,decreased hippocampal fornix size|MP:0030109,abnormal incudomalleolar joint morphology
MGI:2136350	Emx2<tm1Sia>	MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000814,absent dentate gyrus|MP:0002211,abnormal primary sex determination|MP:0003557,absent vas deferens|MP:0003558,absent uterus|MP:0003575,absent oviduct|MP:0003578,absent ovary|MP:0003642,absent seminal vesicle|MP:0003722,absent ureter|MP:0004171,abnormal pallium development|MP:0004727,absent epididymis|MP:0004729,absent efferent ductules of testis|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005644,agonadal|MP:0006415,absent testes|MP:0006425,absent Mullerian ducts|MP:0009072,absent cranial vagina|MP:0009074,Wolffian duct degeneration|MP:0009206,absent internal male genitalia|MP:0009210,absent internal female genitalia|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011386,increased metanephric mesenchyme apoptosis|MP:0011412,gonadal ridge hypoplasia|MP:0011457,abnormal metanephric ureteric bud development|MP:0011760,abnormal ureteric bud tip morphology
MGI:3579416	Emx2<tm2(cre)Sia>	MP:0002623,abnormal vestibular hair cell morphology
MGI:4888743	Emx2<wndr>	MP:0000788,abnormal cerebral cortex morphology|MP:0002741,small olfactory bulb|MP:0003446,renal hypoplasia|MP:0003651,abnormal axon extension|MP:0011087,neonatal lethality, complete penetrance
MGI:6740432	En1<em1Smun>	MP:0000150,abnormal rib morphology|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0004321,short sternum|MP:0012281,decreased sternebra size
MGI:3046940	En1<tm1.1(Wnt1)Wrst>	MP:0000777,increased inferior colliculus size|MP:0011087,neonatal lethality, complete penetrance
MGI:1857163	En1<tm1Alj>	MP:0000060,delayed bone ossification|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000567,truncated digits|MP:0000568,ectopic digits|MP:0000572,abnormal autopod morphology|MP:0000574,abnormal foot pad morphology|MP:0000579,abnormal nail morphology|MP:0000580,deformed nails|MP:0000675,abnormal eccrine sweat gland morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000850,absent cerebellum|MP:0000913,abnormal brain development|MP:0001056,abnormal cranial nerve morphology|MP:0001062,absent oculomotor nerve|MP:0001064,absent trochlear nerve|MP:0001211,wrinkled skin|MP:0001265,decreased body size|MP:0001436,abnormal suckling behavior|MP:0001438,aphagia|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0001679,thin apical ectodermal ridge|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002152,abnormal brain morphology|MP:0003345,decreased rib number|MP:0003704,abnormal hair follicle development|MP:0003813,abnormal hair follicle dermal papilla morphology|MP:0003864,abnormal midbrain development|MP:0004321,short sternum|MP:0006097,abnormal cerebellar lobule formation|MP:0009038,decreased inferior colliculus size|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance
MGI:2137030	En1<tm1Gld>	MP:0002109,abnormal limb morphology|MP:0002184,abnormal innervation|MP:0002206,abnormal CNS synaptic transmission|MP:0002961,abnormal axon guidance|MP:0009937,abnormal neuron differentiation|MP:0011089,perinatal lethality, complete penetrance|MP:0011448,decreased dopaminergic neuron number|MP:0012089,decreased midbrain size
MGI:1889804	En1<tm1(Otx2)Wrst>	MP:0000777,increased inferior colliculus size|MP:0000849,abnormal cerebellum morphology|MP:0000864,abnormal cerebellum vermis morphology|MP:0000868,decreased anterior vermis size|MP:0000899,abnormal corpora quadrigemina morphology|MP:0000905,increased superior colliculus size|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001906,increased dopamine level|MP:0002152,abnormal brain morphology|MP:0002199,abnormal brain commissure morphology|MP:0002882,abnormal neuron morphology|MP:0003312,abnormal locomotor coordination|MP:0003877,abnormal serotonergic neuron morphology|MP:0006097,abnormal cerebellar lobule formation|MP:0006098,absent cerebellar lobules|MP:0010070,decreased serotonin level|MP:0011450,ectopic dopaminergic neuron|MP:0031391,increased locomotor activity
MGI:3047856	En1<tm1(PDGFB)Nist>	MP:0000854,abnormal cerebellum development|MP:0003091,abnormal cell migration|MP:0004950,abnormal brain vasculature morphology|MP:0005386,behavior/neurological phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:4947582	En1<tm1(Tnf)Fpit>	MP:0000220,increased monocyte cell number|MP:0003224,neuron degeneration|MP:0003243,abnormal dopaminergic neuron morphology|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008918,microgliosis|MP:0008948,decreased neuron number
MGI:3046939	En1<tm1(Wnt1)Wrst>	MP:0000351,increased cell proliferation|MP:0000777,increased inferior colliculus size|MP:0000841,abnormal hindbrain morphology|MP:0000849,abnormal cerebellum morphology|MP:0003077,abnormal cell cycle|MP:0011087,neonatal lethality, complete penetrance
MGI:1857749	En1<tm2Alj>	MP:0000849,abnormal cerebellum morphology|MP:0000869,abnormal cerebellum posterior vermis morphology|MP:0002229,neurodegeneration|MP:0002892,decreased superior colliculus size|MP:0003225,axonal dystrophy|MP:0003631,nervous system phenotype|MP:0005405,axon degeneration|MP:0005643,decreased dopamine level|MP:0008260,abnormal autophagy|MP:0009039,absent inferior colliculus|MP:0010047,axonal spheroids|MP:0010149,abnormal synaptic dopamine release|MP:0011448,decreased dopaminergic neuron number|MP:0012089,decreased midbrain size|MP:0012785,decreased rhombomere 1 size
MGI:3029756	En1<tm2(cre)Gld>	MP:0009538,abnormal synapse morphology|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3718978	En1<tm3.1(En2)Alj>	MP:0000569,abnormal digit pigmentation|MP:0000580,deformed nails
MGI:1930621	En1<tm3(En2)Alj>	MP:0000574,abnormal foot pad morphology|MP:0000579,abnormal nail morphology|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0002109,abnormal limb morphology|MP:0003631,nervous system phenotype
MGI:1930647	En1<tm4(en)Alj>	MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000569,abnormal digit pigmentation|MP:0000580,deformed nails|MP:0000854,abnormal cerebellum development|MP:0001925,male infertility|MP:0002083,premature death|MP:0002110,abnormal digit morphology|MP:0002152,abnormal brain morphology|MP:0002161,abnormal fertility/fecundity|MP:0004322,abnormal sternebra morphology|MP:0008146,asymmetric sternocostal joints|MP:0008277,abnormal sternum ossification|MP:0009038,decreased inferior colliculus size
MGI:1930664	En1<tm5(en)Alj>	MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000569,abnormal digit pigmentation|MP:0000574,abnormal foot pad morphology|MP:0000579,abnormal nail morphology|MP:0000580,deformed nails|MP:0000675,abnormal eccrine sweat gland morphology|MP:0002083,premature death|MP:0002110,abnormal digit morphology|MP:0002115,abnormal limb bone morphology|MP:0002152,abnormal brain morphology|MP:0003631,nervous system phenotype|MP:0003704,abnormal hair follicle development|MP:0005390,skeleton phenotype|MP:0006097,abnormal cerebellar lobule formation|MP:0008730,fused phalanges|MP:0010768,mortality/aging|MP:0012089,decreased midbrain size
MGI:3789091	En1<tm8.1Alj>	MP:0000776,abnormal inferior colliculus morphology|MP:0000867,abnormal cerebellum anterior vermis morphology|MP:0000868,decreased anterior vermis size
MGI:1857164	En2<tm1Alj>	MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000854,abnormal cerebellum development|MP:0000857,abnormal cerebellar foliation|MP:0000864,abnormal cerebellum vermis morphology|MP:0000869,abnormal cerebellum posterior vermis morphology|MP:0000873,thin external granule cell layer|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000900,decreased colliculi size|MP:0001360,abnormal social investigation|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001440,abnormal grooming behavior|MP:0001441,increased grooming behavior|MP:0001442,decreased grooming behavior|MP:0001463,abnormal spatial learning|MP:0001515,abnormal grip strength|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002557,abnormal social/conspecific interaction behavior|MP:0003313,abnormal locomotor activation|MP:0003863,decreased aggression towards mice|MP:0003867,increased defecation amount|MP:0004924,abnormal behavior|MP:0010069,increased serotonin level
MGI:1930810	En2<tm2Alj>	MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000854,abnormal cerebellum development|MP:0000857,abnormal cerebellar foliation|MP:0000864,abnormal cerebellum vermis morphology|MP:0000869,abnormal cerebellum posterior vermis morphology|MP:0009038,decreased inferior colliculus size
MGI:1930812	En2<tm3.1Alj>	MP:0003631,nervous system phenotype
MGI:1930811	En2<tm3Alj>	MP:0003631,nervous system phenotype
MGI:3789089	En2<tm5.1Alj>	MP:0000857,abnormal cerebellar foliation|MP:0001921,reduced fertility|MP:0003631,nervous system phenotype|MP:0009957,abnormal cerebellum vermis lobule morphology|MP:0009963,abnormal cerebellum hemisphere lobule morphology
MGI:3056050	Enah<tm1Fbg>	MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0002196,absent corpus callosum|MP:0002199,abnormal brain commissure morphology|MP:0002961,abnormal axon guidance|MP:0008221,abnormal hippocampal commissure morphology
MGI:3512772	Enam<abte>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000208,decreased hematocrit|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001664,abnormal digestion|MP:0002577,reduced enamel thickness|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0003404,absent enamel|MP:0003797,abnormal compact bone morphology|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006086,decreased body mass index|MP:0008851,decreased hemoglobin concentration distribution width|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010968,decreased compact bone area|MP:0011584,increased alkaline phosphatase activity|MP:0011894,decreased circulating transferrin level|MP:0030139,abnormal upper incisor color
MGI:5694082	Enam<Abte2>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002644,decreased circulating triglyceride level|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005397,hematopoietic system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006086,decreased body mass index|MP:0010025,decreased total body fat amount|MP:0010096,abnormal incisor color|MP:0010124,decreased bone mineral content|MP:0011584,increased alkaline phosphatase activity|MP:0011894,decreased circulating transferrin level
MGI:3055582	Enam<Rgsc395>	MP:0002100,abnormal tooth morphology|MP:0002576,abnormal enamel morphology
MGI:3055586	Enam<Rgsc514>	MP:0002100,abnormal tooth morphology|MP:0002576,abnormal enamel morphology
MGI:3055587	Enam<Rgsc521>	MP:0002100,abnormal tooth morphology|MP:0002576,abnormal enamel morphology|MP:0003404,absent enamel|MP:0005358,abnormal incisor morphology
MGI:3796583	Enam<tm1.1Jcch>	MP:0000122,premature tooth eruption|MP:0000452,abnormal mouth morphology|MP:0002100,abnormal tooth morphology|MP:0002576,abnormal enamel morphology|MP:0002577,reduced enamel thickness|MP:0002649,abnormal enamel rod pattern|MP:0002650,abnormal ameloblast morphology|MP:0002689,abnormal molar morphology|MP:0002817,abnormal tooth mineralization|MP:0003053,delayed tooth eruption|MP:0003404,absent enamel|MP:0003932,abnormal molar crown morphology|MP:0005358,abnormal incisor morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0010096,abnormal incisor color|MP:0010747,abnormal enamel organ morphology|MP:0030136,abnormal lower incisor morphology|MP:0030137,abnormal upper incisor morphology|MP:0030138,abnormal lower incisor color|MP:0030139,abnormal upper incisor color|MP:0030220,mandibular cyst|MP:0030221,maxillary cyst|MP:0030450,abnormal enamel mineralization|MP:0030457,abnormal molar cusp morphology|MP:0030458,abnormal tooth wear|MP:0030459,abnormal tooth attrition|MP:0030514,absent Tomes' process
MGI:1861180	Enc	MP:0001304,cataract|MP:0010254,nuclear cataract|MP:0010261,sutural cataract|MP:0011091,prenatal lethality, complete penetrance
MGI:5051006	Enc1<tm1a(EUCOMM)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005179,decreased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0005560,decreased circulating glucose level|MP:0005566,decreased blood urea nitrogen level
MGI:7481964	Endod1<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0009142,decreased prepulse inhibition
MGI:3034030	Endog/D2Wsu81e<tm1Mxu>	MP:0008280,abnormal male germ cell apoptosis|MP:0008944,decreased sensitivity to induced cell death|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5548410	Endog<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation
MGI:3514015	Endog<tm1Mili>	MP:0002169,no abnormal phenotype detected
MGI:3761639	Endog<tm1Vdaw>	MP:0002169,no abnormal phenotype detected
MGI:4842897	Endou<tm1(KOMP)Vlcg>	MP:0001325,abnormal retina morphology
MGI:5582894	Endou<tm1Tft>	MP:0005387,immune system phenotype
MGI:7490161	Endov<em1(IMPC)Mbp>	MP:0002060,abnormal skin morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0005419,decreased circulating serum albumin level
MGI:6452240	Endov<tm1Ial>	MP:0004502,decreased incidence of tumors by chemical induction|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype
MGI:6341858	Eng<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000266,abnormal heart morphology|MP:0001691,abnormal somite shape|MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0002989,small kidney|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:3052745	Eng<Gt(Betageo)1Jrt>	MP:0002169,no abnormal phenotype detected
MGI:2177823	Eng<tm1Dyl>	MP:0000259,abnormal vascular development|MP:0000265,blood vessel atresia|MP:0001689,incomplete somite formation|MP:0001698,decreased embryo size|MP:0003229,abnormal vitelline vasculature morphology|MP:0004181,abnormal carotid artery morphology|MP:0004251,failure of heart looping|MP:0004787,abnormal dorsal aorta morphology|MP:0005312,pericardial effusion|MP:0005592,abnormal vascular smooth muscle morphology|MP:0005602,decreased angiogenesis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012253,abnormal intersomitic vessel morphology|MP:0012732,abnormal perineural vascular plexus morphology
MGI:2177822	Eng<tm1Hma>	MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0001577,anemia|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0002652,thin myocardium|MP:0003229,abnormal vitelline vasculature morphology|MP:0003396,abnormal embryonic hematopoiesis|MP:0003658,abnormal capillary morphology|MP:0003984,embryonic growth retardation|MP:0004787,abnormal dorsal aorta morphology|MP:0005312,pericardial effusion|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0008772,increased heart ventricle size|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2177824	Eng<tm1Mle>	MP:0000267,abnormal heart development|MP:0000274,enlarged heart|MP:0000420,ruffled hair|MP:0000433,microcephaly|MP:0001263,weight loss|MP:0001614,abnormal blood vessel morphology|MP:0001634,internal hemorrhage|MP:0001719,absent vitelline blood vessels|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002884,abnormal pharyngeal arch morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003935,abnormal craniofacial development|MP:0003974,abnormal endocardium morphology|MP:0003984,embryonic growth retardation|MP:0004086,absent heartbeat|MP:0004176,ear telangiectasia|MP:0004177,tail telangiectasia|MP:0004178,neck telangiectasia|MP:0005385,cardiovascular system phenotype|MP:0005435,hemoperitoneum|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011204,abnormal visceral yolk sac blood island morphology|MP:0013241,embryo tissue necrosis
MGI:3712802	Eng<tm2.1Hma>	MP:0001402,decreased locomotor activity|MP:0001429,dehydration|MP:0001614,abnormal blood vessel morphology|MP:0001914,hemorrhage|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0004883,abnormal vascular wound healing|MP:0005036,diarrhea|MP:0005385,cardiovascular system phenotype|MP:0006093,arteriovenous malformation|MP:0010530,cerebral arteriovenous malformation|MP:0010531,gastrointestinal arteriovenous malformation|MP:0013139,moribund
MGI:3712803	Eng<tm2.2Hma>	MP:0001672,abnormal embryo development|MP:0003229,abnormal vitelline vasculature morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:5781010	Enho<tm1.1Butl>	MP:0001260,increased body weight|MP:0001402,decreased locomotor activity|MP:0001552,increased circulating triglyceride level|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005378,growth/size/body region phenotype|MP:0005458,increased percent body fat/body weight|MP:0009355,increased liver triglyceride level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013245,abnormal lipid metabolism|MP:0013279,increased fasting circulating glucose level|MP:0014142,increased body fat mass|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:5569049	Enho<tm1.1(KOMP)Vlcg>	MP:0001402,decreased locomotor activity
MGI:5688642	Enho<tm1Cmwo>	MP:0000877,abnormal Purkinje cell morphology|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0003313,abnormal locomotor activation|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0011940,decreased food intake
MGI:7328569	Enkd1<em1Jzho>	MP:0002090,abnormal vision|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0008545,absent sperm flagellum|MP:0010393,shortened QRS complex duration|MP:0010748,abnormal visual evoked potential|MP:0011065,abnormal kidney epithelial cell primary cilium morphology|MP:0011919,abnormal R wave|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0013202,abnormal cilium morphology|MP:0014059,abnormal photoreceptor connecting cilium morphology
MGI:6158488	Enkur<em1(IMPC)Mbp>	MP:0001404,no spontaneous movement|MP:0001914,hemorrhage|MP:0001925,male infertility|MP:0002060,abnormal skin morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003743,abnormal facial morphology|MP:0011495,abnormal head shape
MGI:6156078	Enkur<tm1Hmf>	MP:0000596,abnormal liver development|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0000689,abnormal spleen morphology|MP:0000690,absent spleen|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002674,abnormal sperm motility|MP:0002767,situs ambiguus|MP:0004543,abnormal sperm physiology|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0009647,decreased fertilization frequency|MP:0010808,right-sided stomach|MP:0011252,situs inversus totalis|MP:0020451,decreased sperm progressive motility|MP:0031012,impaired sperm migration in female genital tract
MGI:3050549	Eno1<Gt(ROSABetageo)1Ev>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6279897	Eno2<em1(IMPC)H>	MP:0010392,prolonged QRS complex duration
MGI:3765961	Eno2<tm1(DTA)Hsak>	MP:0000812,abnormal dentate gyrus morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000897,abnormal midbrain morphology|MP:0001003,abnormal olfactory receptor morphology|MP:0001038,abnormal cholinergic neuron morphology|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001454,abnormal cued conditioning behavior|MP:0001460,abnormal olfactory discrimination memory|MP:0001469,abnormal contextual conditioning behavior|MP:0001984,abnormal olfaction|MP:0002063,abnormal learning/memory/conditioning|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002804,abnormal motor learning|MP:0003203,increased neuron apoptosis|MP:0004082,abnormal habenula morphology|MP:0005386,behavior/neurological phenotype|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0008428,abnormal spatial working memory|MP:0008432,abnormal long-term spatial reference memory|MP:0008462,abnormal medium spiny neuron morphology|MP:0008924,decreased cerebellar granule cell number|MP:0008948,decreased neuron number|MP:0009142,decreased prepulse inhibition|MP:0009456,impaired cued conditioning behavior|MP:0009756,impaired behavioral response to nicotine|MP:0010698,abnormal impulsive behavior control|MP:0011620,abnormal habituation to a new environment|MP:0012307,impaired spatial learning
MGI:7425652	Eno3<em1(IMPC)Bay>	MP:0001513,limb grasping|MP:0005293,impaired glucose tolerance
MGI:4127723	Eno4<Gt(RRF299)Byg>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004929,decreased epididymis weight|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009237,kinked sperm flagellum|MP:0009831,abnormal sperm midpiece morphology|MP:0009834,abnormal sperm annulus morphology|MP:0009835,absent sperm annulus|MP:0009836,abnormal sperm principal piece morphology|MP:0009837,abnormal sperm end piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0030590,abnormal sperm fibrous sheath morphology
MGI:7543408	Enoph1<em1Zhgy>	MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury
MGI:5634704	Enox1<tm1.1(KOMP)Vlcg>	MP:0000208,decreased hematocrit|MP:0010024,increased total body fat amount|MP:0011954,shortened PQ interval
MGI:4130009	Enox2<Gt(RRJ357)Byg>	MP:0002169,no abnormal phenotype detected
MGI:5692565	Enpep<tm1b(KOMP)Wtsi>	MP:0001488,increased startle reflex
MGI:2182774	Enpep<tm1Mdc>	MP:0005387,immune system phenotype
MGI:3785162	Enpp1<asj>	MP:0000049,abnormal middle ear morphology|MP:0000192,abnormal mineral level|MP:0000198,decreased circulating phosphate level|MP:0000272,abnormal aorta morphology|MP:0001325,abnormal retina morphology|MP:0001406,abnormal gait|MP:0001850,increased susceptibility to otitis media|MP:0002135,abnormal kidney morphology|MP:0002933,joint inflammation|MP:0003195,calcinosis|MP:0003196,calcified skin|MP:0003330,abnormal auditory tube morphology|MP:0003560,osteoarthritis|MP:0004111,abnormal coronary artery morphology|MP:0004181,abnormal carotid artery morphology|MP:0004480,abnormal round window morphology|MP:0004665,abnormal stapedial artery morphology|MP:0004739,conductive hearing loss|MP:0005190,osteomyelitis|MP:0006018,abnormal tympanic membrane morphology|MP:0006133,calcified artery|MP:0006188,calcified retina|MP:0006325,impaired hearing|MP:0009393,abnormal resting posture|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009820,abnormal liver vasculature morphology|MP:0010234,abnormal vibrissa follicle morphology|MP:0010522,calcified aorta|MP:0010678,abnormal skin adnexa morphology|MP:0011315,abnormal kidney arcuate artery morphology|MP:0011317,abnormal renal artery morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013945,abnormal elbow joint morphology|MP:0020903,increased middle ear goblet cell number|MP:0030110,incudomalleolar fusion|MP:0030226,middle ear polyps|MP:0030410,middle ear effusion|MP:0030413,tympanic membrane retraction|MP:0030533,abnormal snout skin morphology|MP:0030837,abnormal knee joint morphology|MP:0030863,decreased joint mobility
MGI:5607149	Enpp1<asj-2J>	MP:0000161,scoliosis|MP:0000198,decreased circulating phosphate level|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001505,hunched posture|MP:0001562,abnormal circulating calcium level|MP:0001565,abnormal circulating phosphate level|MP:0002932,abnormal joint morphology|MP:0003195,calcinosis|MP:0003196,calcified skin|MP:0003197,nephrocalcinosis|MP:0003200,calcified joint|MP:0004231,abnormal calcium ion homeostasis|MP:0006357,abnormal circulating mineral level|MP:0010234,abnormal vibrissa follicle morphology|MP:0010522,calcified aorta|MP:0030863,decreased joint mobility
MGI:7425653	Enpp1<em1(IMPC)Ccpcz>	MP:0000137,abnormal vertebrae morphology|MP:0000149,abnormal scapula morphology|MP:0000150,abnormal rib morphology|MP:0000162,lordosis|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000438,abnormal cranium morphology|MP:0000627,abnormal mammary gland morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001486,abnormal startle reflex|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002932,abnormal joint morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0004122,abnormal sinus arrhythmia|MP:0004174,abnormal spine curvature|MP:0004357,long tibia|MP:0004609,vertebral fusion|MP:0005333,decreased heart rate|MP:0005385,cardiovascular system phenotype|MP:0010099,abnormal thoracic cage shape|MP:0010506,prolonged RR interval|MP:0010935,increased airway resistance|MP:0011239,abnormal skin coloration|MP:0013279,increased fasting circulating glucose level|MP:0020421,increased freezing behavior
MGI:4939484	Enpp1<m1Amgn>	MP:0000063,decreased bone mineral density|MP:0000955,abnormal spinal cord morphology|MP:0001406,abnormal gait|MP:0002932,abnormal joint morphology|MP:0003198,calcified tendon|MP:0003200,calcified joint|MP:0004016,decreased bone mass|MP:0006133,calcified artery|MP:0009877,exostosis|MP:0010124,decreased bone mineral content|MP:0010522,calcified aorta|MP:0030776,calcified calcaneal tendon|MP:0030837,abnormal knee joint morphology|MP:0030863,decreased joint mobility
MGI:2385534	Enpp1<tm1Gdg>	MP:0000003,abnormal adipose tissue morphology|MP:0000130,abnormal trabecular bone morphology|MP:0000164,abnormal cartilage development|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003189,fused joints|MP:0003653,decreased skin turgor|MP:0004685,calcified intervertebral disk|MP:0005006,abnormal osteoblast physiology|MP:0005592,abnormal vascular smooth muscle morphology|MP:0010522,calcified aorta|MP:0020039,increased bone ossification|MP:0030776,calcified calcaneal tendon
MGI:1857079	Enpp1<ttw>	MP:0000066,osteoporosis|MP:0000137,abnormal vertebrae morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000198,decreased circulating phosphate level|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001515,abnormal grip strength|MP:0001533,abnormal skeleton physiology|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002114,abnormal axial skeleton morphology|MP:0002896,abnormal bone mineralization|MP:0002932,abnormal joint morphology|MP:0003195,calcinosis|MP:0003200,calcified joint|MP:0003560,osteoarthritis|MP:0004173,abnormal intervertebral disk morphology|MP:0004685,calcified intervertebral disk|MP:0005376,homeostasis/metabolism phenotype|MP:0005504,abnormal ligament morphology|MP:0010522,calcified aorta|MP:0011584,increased alkaline phosphatase activity|MP:0013941,abnormal enthesis morphology|MP:0014099,abnormal chondrocyte proliferation|MP:0030776,calcified calcaneal tendon|MP:0030783,abnormal posterior longitudinal ligament morphology
MGI:6402836	Enpp1<ttw-Ham>	MP:0000377,abnormal hair follicle morphology|MP:0000955,abnormal spinal cord morphology|MP:0001263,weight loss|MP:0002083,premature death|MP:0002098,abnormal vibrissa morphology|MP:0002932,abnormal joint morphology|MP:0003189,fused joints|MP:0004609,vertebral fusion|MP:0004612,fusion of vertebral bodies|MP:0005504,abnormal ligament morphology|MP:0006392,abnormal nucleus pulposus morphology|MP:0008853,decreased abdominal adipose tissue amount|MP:0008915,fused carpal bones|MP:0009133,decreased white fat cell size|MP:0011940,decreased food intake|MP:0030422,abnormal outer ear cartilage morphology|MP:0030783,abnormal posterior longitudinal ligament morphology|MP:0030807,abnormal forelimb joint morphology|MP:0030811,abnormal hand joint morphology
MGI:3720192	Enpp2<tm1.1Bout>	MP:0011091,prenatal lethality, complete penetrance
MGI:3790757	Enpp2<tm1.1Vart>	MP:0000352,decreased cell proliferation|MP:0000929,open neural tube|MP:0001614,abnormal blood vessel morphology|MP:0001622,abnormal vasculogenesis|MP:0001636,irregular heartbeat|MP:0001688,abnormal somite development|MP:0001726,abnormal allantois morphology|MP:0002128,abnormal blood circulation|MP:0002151,abnormal neural tube morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003651,abnormal axon extension|MP:0003984,embryonic growth retardation|MP:0004180,failure of initiation of embryo turning|MP:0004560,abnormal chorionic plate morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012505,increased neural tube apoptosis
MGI:3640942	Enpp2<tm1.1Whm>	MP:0000929,open neural tube|MP:0000930,wavy neural tube|MP:0001614,abnormal blood vessel morphology|MP:0001719,absent vitelline blood vessels|MP:0001785,edema|MP:0003232,abnormal forebrain development|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0004180,failure of initiation of embryo turning|MP:0004557,dilated allantois|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3529186	Enpp2<tm1Lex>	MP:0008554,decreased circulating tumor necrosis factor level|MP:0008597,decreased circulating interleukin-6 level|MP:0008721,abnormal chemokine level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0011100,preweaning lethality, complete penetrance
MGI:4418729	Enpp2<tm1Mmas>	MP:0001698,decreased embryo size|MP:0003229,abnormal vitelline vasculature morphology|MP:0004180,failure of initiation of embryo turning|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0020515,abnormal visceral yolk sac endoderm morphology
MGI:3785736	Enpp2<tm1Vart>	MP:0002169,no abnormal phenotype detected|MP:0005380,embryo phenotype|MP:0008762,embryonic lethality|MP:0010768,mortality/aging
MGI:3640941	Enpp2<tm1Whm>	MP:0002169,no abnormal phenotype detected
MGI:5755608	Enpp3<tm1Ktak>	MP:0000324,increased mast cell number|MP:0001858,intestinal inflammation|MP:0001861,lung inflammation|MP:0002423,abnormal mast cell physiology|MP:0002464,abnormal basophil physiology|MP:0002497,increased IgE level|MP:0002606,increased basophil cell number|MP:0005387,immune system phenotype|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008699,increased interleukin-4 secretion|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0013956,decreased colon length
MGI:6336073	Enpp4<em1(IMPC)Ics>	MP:0000063,decreased bone mineral density|MP:0001566,increased circulating phosphate level
MGI:5635066	Enpp5<tm1b(KOMP)Mbp>	MP:0005560,decreased circulating glucose level|MP:0006243,impaired pupillary reflex
MGI:8226230	Enpp6<tm1Aoki>	MP:0000920,abnormal myelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0002628,hepatic steatosis|MP:0003871,abnormal myelin sheath morphology|MP:0005266,abnormal metabolism|MP:0009643,abnormal urine homeostasis|MP:0013438,dysmyelination|MP:0021131,increased glycerophosphocholine level|MP:0031269,increased susceptibility to diet-induced hepatic steatosis
MGI:4947121	Enpp7<tm1Rudd>	MP:0000488,abnormal intestinal epithelium morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0002006,neoplasm|MP:0003868,abnormal feces composition|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0008142,decreased small intestinal villus size|MP:0011585,decreased alkaline phosphatase activity
MGI:6392061	Ensa<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0003960,increased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis
MGI:5511855	Ensa<tm1a(EUCOMM)Hmgu>	MP:0005380,embryo phenotype|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4433342	Entpd1<tm1a(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0002078,abnormal glucose homeostasis|MP:0002092,abnormal eye morphology|MP:0003062,abnormal coping response|MP:0003442,decreased circulating glycerol level|MP:0005015,increased T cell number
MGI:5548332	Entpd1<tm1b(EUCOMM)Wtsi>	MP:0003019,increased circulating chloride level|MP:0005633,increased circulating sodium level
MGI:2673318	Entpd1<tm1Djp>	MP:0000740,impaired smooth muscle contractility|MP:0003076,increased susceptibility to ischemic brain injury|MP:0004145,abnormal muscle electrophysiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0005445,abnormal neurotransmitter secretion|MP:0005447,abnormal synaptic norepinephrine release|MP:0005464,abnormal platelet physiology|MP:0006060,increased cerebral infarct size|MP:0008921,increased neurotransmitter release|MP:0009549,decreased platelet aggregation
MGI:2182811	Entpd1<tm1Rdr>	MP:0000233,abnormal blood flow velocity|MP:0002152,abnormal brain morphology|MP:0002463,abnormal neutrophil physiology|MP:0003141,cardiac fibrosis|MP:0003179,thrombocytopenia|MP:0003333,liver fibrosis|MP:0003985,renal fibrosis|MP:0004003,abnormal vascular endothelial cell physiology|MP:0005606,increased bleeding time|MP:0006050,pulmonary fibrosis|MP:0009549,decreased platelet aggregation|MP:0011746,spleen fibrosis
MGI:5545886	Entpd2<tm1Srob>	MP:0001985,abnormal gustatory system physiology|MP:0001986,abnormal taste sensitivity|MP:0003477,abnormal nerve fiber response|MP:0006260,abnormal gustatory papilla taste bud morphology
MGI:5616091	Entpd3<tm1.1Mjz>	MP:0000966,decreased sensory neuron number|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0010073,decreased pruritus
MGI:5806325	Entpd5<m1Btlr>	MP:0001262,decreased body weight
MGI:4830114	Entpd5<tm1Rre>	MP:0000189,hypoglycemia|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0001262,decreased body weight|MP:0001860,liver inflammation|MP:0001925,male infertility|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003887,increased hepatocyte apoptosis|MP:0003893,increased hepatocyte proliferation|MP:0003983,decreased cholesterol level|MP:0005318,decreased triglyceride level|MP:0005344,increased circulating bilirubin level|MP:0005419,decreased circulating serum albumin level|MP:0008114,abnormal Kupffer cell morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0010040,abnormal oval cell morphology|MP:0010042,abnormal oval cell physiology
MGI:4363445	Entpd6<tm1a(KOMP)Wtsi>	MP:0002111,abnormal tail morphology|MP:0002941,increased circulating alanine transaminase level|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010124,decreased bone mineral content
MGI:5469828	Entpd7<tm1Ktak>	MP:0002411,decreased susceptibility to bacterial infection|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0008073,abnormal CD4-positive, alpha-beta T cell number|MP:0010155,abnormal intestine physiology|MP:0010219,increased T-helper 17 cell number
MGI:6771668	Entpd8<tm1Ktak>	MP:0003868,abnormal feces composition|MP:0005381,digestive/alimentary phenotype|MP:0006043,decreased apoptosis|MP:0008537,increased susceptibility to induced colitis|MP:0010155,abnormal intestine physiology
MGI:6336205	Entr1<em1(IMPC)Mbp>	MP:0000194,increased circulating calcium level|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000538,abnormal urinary bladder morphology|MP:0000598,abnormal liver morphology|MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0001556,increased circulating HDL cholesterol level|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0004832,enlarged ovary|MP:0005178,increased circulating cholesterol level|MP:0005568,increased circulating total protein level|MP:0011874,enlarged urinary bladder
MGI:6414562	Eny2<em1(IMPC)Bay>	MP:0001714,absent trophoblast giant cells|MP:0001727,abnormal embryo implantation|MP:0004964,absent inner cell mass|MP:0011100,preweaning lethality, complete penetrance|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:1861117	Eo	MP:0001297,microphthalmia|MP:0001302,eyelids open at birth|MP:0009859,eye opacity
MGI:1856858	eob	MP:0001297,microphthalmia|MP:0001302,eyelids open at birth|MP:0001304,cataract|MP:0001382,abnormal nursing|MP:0001386,abnormal maternal nurturing|MP:0001935,decreased litter size|MP:0002082,postnatal lethality|MP:0002697,abnormal eye size|MP:0008770,decreased survivor rate
MGI:5554599	eob5	MP:0001302,eyelids open at birth
MGI:5578313	Eogt<em1(IMPC)J>	MP:0001523,impaired righting response|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7607995	Eogt<tm1.1Okaj>	MP:0002792,abnormal retina vasculature morphology|MP:0003070,increased vascular permeability
MGI:7608000	Eogt<tm1.2Okaj>	MP:0000260,abnormal angiogenesis|MP:0002792,abnormal retina vasculature morphology|MP:0003070,increased vascular permeability
MGI:4830338	Eomes<tm1.1Bflu>	MP:0002020,increased tumor incidence|MP:0003156,abnormal leukocyte migration|MP:0008050,decreased memory T cell number
MGI:5499762	Eomes<tm1.1(cre/ERT2)Sjar>	MP:0002169,no abnormal phenotype detected|MP:0009850,embryonic lethality between implantation and placentation
MGI:3774028	Eomes<tm1.1Rob>	MP:0005031,abnormal trophoblast layer morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3774148	Eomes<tm1.1Whk>	MP:0001330,abnormal optic nerve morphology|MP:0006309,decreased retina ganglion cell number|MP:0008056,abnormal retina ganglion cell morphology|MP:0008507,thin retina ganglion layer|MP:0030005,increased retina apoptosis
MGI:2182814	Eomes<tm1Apr>	MP:0001683,absent mesoderm|MP:0001730,embryonic growth arrest|MP:0003085,abnormal egg cylinder morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0008045,decreased NK cell number|MP:0008050,decreased memory T cell number|MP:0009331,absent primitive node|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012685,abnormal primitive streak elongation|MP:0012739,abnormal anterior primitive streak morphology
MGI:5636935	Eomes<tm1b(EUCOMM)Wtsi>	MP:0003961,decreased lean body mass|MP:0005554,decreased circulating creatinine level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3579497	Eomes<tm1Jrt>	MP:0001714,absent trophoblast giant cells|MP:0001728,failure of embryo implantation|MP:0001730,embryonic growth arrest|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012102,absent trophectoderm
MGI:3774027	Eomes<tm1Rob>	MP:0000774,decreased brain size|MP:0000812,abnormal dentate gyrus morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0001353,increased aggression towards mice|MP:0001357,increased aggression towards humans|MP:0001415,increased exploration in new environment|MP:0002169,no abnormal phenotype detected|MP:0002741,small olfactory bulb|MP:0003202,abnormal neuron apoptosis|MP:0004948,abnormal neuronal precursor proliferation|MP:0006254,thin cerebral cortex|MP:0008227,absent anterior commissure|MP:0010053,decreased grip strength|MP:0014751,abnormal commissural neuron axon guidance
MGI:3802572	Eomes<tm1Srnr>	MP:0005387,immune system phenotype|MP:0008050,decreased memory T cell number
MGI:3774146	Eomes<tm1Whk>	MP:0002169,no abnormal phenotype detected
MGI:4399131	Eomes<tm2.1Rob>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:3813243	Ep300<Plt6>	MP:0000221,decreased leukocyte cell number|MP:0002082,postnatal lethality|MP:0005012,decreased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005505,thrombocytosis
MGI:5606036	Ep300<tm1.1Wtp>	MP:0002169,no abnormal phenotype detected
MGI:1858020	Ep300<tm1Dli>	MP:0000274,enlarged heart|MP:0000296,absent trabeculae carneae|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001297,microphthalmia|MP:0001689,incomplete somite formation|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001730,embryonic growth arrest|MP:0002006,neoplasm|MP:0003229,abnormal vitelline vasculature morphology|MP:0003400,kinked neural tube|MP:0003743,abnormal facial morphology|MP:0003984,embryonic growth retardation|MP:0005140,decreased cardiac muscle contractility|MP:0005312,pericardial effusion|MP:0005397,hematopoietic system phenotype|MP:0005621,abnormal cell physiology|MP:0008008,early cellular replicative senescence|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:3578128	Ep300<tm1Pkb>	MP:0000715,decreased thymocyte number|MP:0001265,decreased body size|MP:0001577,anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002642,anisocytosis|MP:0005505,thrombocytosis|MP:0008254,increased megakaryocyte cell number|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2679374	Ep300<tm1Reck>	MP:0000267,abnormal heart development|MP:0000280,thin ventricular wall|MP:0000285,abnormal heart valve morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000496,abnormal small intestine morphology|MP:0000729,abnormal myogenesis|MP:0001176,abnormal lung development|MP:0001265,decreased body size|MP:0001575,cyanosis|MP:0001622,abnormal vasculogenesis|MP:0001634,internal hemorrhage|MP:0001785,edema|MP:0001914,hemorrhage|MP:0001953,respiratory failure|MP:0002108,abnormal muscle morphology|MP:0002652,thin myocardium|MP:0004087,abnormal muscle fiber morphology|MP:0008108,abnormal small intestinal villus morphology|MP:0009400,decreased skeletal muscle fiber size|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010500,myocardium hypoplasia|MP:0010556,thin ventricle myocardium compact layer|MP:0010592,abnormal atrioventricular septum morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012082,delayed heart development|MP:0031590,abnormal epicardium development
MGI:3526150	Ep300<tm2Pkb>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0002006,neoplasm|MP:0005091,increased double-positive T cell number|MP:0008083,decreased single-positive T cell number
MGI:3843052	Ep300<tm2Reck>	MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001800,abnormal humoral immune response|MP:0001829,increased activated T cell number|MP:0001859,kidney inflammation|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0002420,abnormal adaptive immunity|MP:0002461,increased immunoglobulin level|MP:0002743,glomerulonephritis|MP:0003985,renal fibrosis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004952,increased spleen weight|MP:0005014,increased B cell number|MP:0005093,decreased B cell proliferation|MP:0005325,abnormal renal glomerulus morphology|MP:0008182,decreased marginal zone B cell number|MP:0008188,abnormal transitional stage B cell morphology|MP:0008240,abnormal spleen marginal zone macrophage morphology|MP:0008254,increased megakaryocyte cell number|MP:0008475,intermingled spleen red and white pulp|MP:0008501,increased IgG2b level|MP:0008782,increased B cell apoptosis|MP:0010138,arteritis|MP:0020518,renal glomerular protein deposits
MGI:3612049	Ep300<tm3Pkb>	MP:0011086,postnatal lethality, incomplete penetrance
MGI:6314262	Ep400<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:3764913	Ep400<tm1Fuku>	MP:0000215,absent erythrocytes|MP:0000930,wavy neural tube|MP:0001577,anemia|MP:0001730,embryonic growth arrest|MP:0002151,abnormal neural tube morphology|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4845875	Ep400<tm3.1Fuku>	MP:0011091,prenatal lethality, complete penetrance
MGI:6257575	Epas1<em1(IMPC)Wtsi>	MP:0010024,increased total body fat amount
MGI:5518445	Epas1<tm1.1Fsl>	MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0002608,increased hematocrit|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0003131,increased erythrocyte cell number|MP:0004952,increased spleen weight|MP:0005013,increased lymphocyte cell number|MP:0005564,increased hemoglobin content|MP:0005573,increased pulmonary respiratory rate|MP:0010460,pulmonary artery hypoplasia|MP:0010755,abnormal heart right ventricle pressure|MP:0010831,lethality, incomplete penetrance|MP:0011285,increased circulating erythropoietin level
MGI:3710344	Epas1<tm1.1Mcs>	MP:0011091,prenatal lethality, complete penetrance|MP:0020843,abnormal type I cell of carotid body physiology|MP:0031252,abnormal physiological response to hypoxia
MGI:5548386	Epas1<tm1b(EUCOMM)Hmgu>	MP:0000266,abnormal heart morphology|MP:0002874,decreased hemoglobin content|MP:0011100,preweaning lethality, complete penetrance
MGI:2386334	Epas1<tm1Fong>	MP:0000260,abnormal angiogenesis|MP:0001914,hemorrhage|MP:0003229,abnormal vitelline vasculature morphology|MP:0009703,decreased birth body size|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3526731	Epas1<tm1Mcs>	MP:0008973,decreased erythroid progenitor cell number|MP:0010768,mortality/aging
MGI:2663583	Epas1<tm1Pec>	MP:0000260,abnormal angiogenesis|MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001179,thick pulmonary interalveolar septum|MP:0001544,abnormal cardiovascular system physiology|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0004007,abnormal lung vasculature morphology|MP:0004780,abnormal surfactant secretion|MP:0005166,decreased susceptibility to injury|MP:0010811,decreased type II pneumocyte number|MP:0010813,abnormal alveolar lamellar body morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:1861921	Epas1<tm1Rus>	MP:0005333,decreased heart rate|MP:0005664,decreased circulating noradrenaline level|MP:0006138,congestive heart failure|MP:0010017,visceral vascular congestion|MP:0010019,liver vascular congestion|MP:0010021,heart vascular congestion|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:2653011	Epas1<tm1Yfk>	MP:0003710,abnormal physiological neovascularization|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005551,abnormal eye electrophysiology
MGI:5446029	Epas1<tm1Yms>	MP:0000208,decreased hematocrit|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004151,decreased circulating iron level
MGI:3838872	Epb41l1<tm1.1Aliv>	MP:0002169,no abnormal phenotype detected
MGI:5661983	Epb41l1<tm1b(EUCOMM)Wtsi>	MP:0001340,abnormal eyelid morphology|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001488,increased startle reflex|MP:0002833,increased heart weight|MP:0003960,increased lean body mass|MP:0005102,abnormal iris pigmentation|MP:0005292,improved glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010123,increased bone mineral content|MP:0012121,sclerocornea|MP:0013279,increased fasting circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:4345511	Epb41l2<Gt(AL0682)Wtsi>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype|MP:0011750,abnormal seminiferous tubule epithelium morphology
MGI:3838853	Epb41l2<tm1.1Aliv>	MP:0002169,no abnormal phenotype detected
MGI:4820843	Epb41l2<tm1Note>	MP:0005389,reproductive system phenotype
MGI:5297225	Epb41l3<tm1.1Jglt>	MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002272,abnormal nervous system electrophysiology|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0010050,hypermyelination|MP:0010738,abnormal internode morphology
MGI:5140703	Epb41l3<tm1Bhat>	MP:0002169,no abnormal phenotype detected
MGI:3609004	Epb41l3<tm1Jkis>	MP:0002006,neoplasm|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0010735,abnormal paranodal axoglial junction morphology
MGI:3846735	Epb41l3<tm1Sohn>	MP:0002006,neoplasm|MP:0005379,endocrine/exocrine gland phenotype
MGI:5468966	Epb41l4a<tm1b(KOMP)Mbp>	MP:0002135,abnormal kidney morphology|MP:0002833,increased heart weight|MP:0005560,decreased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0010053,decreased grip strength
MGI:5577266	Epb41l4b<tm1b(EUCOMM)Hmgu>	MP:0001258,decreased body length
MGI:3715119	Epb41l5<Gt(AE0088)Wtsi>	MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002231,abnormal primitive streak morphology|MP:0003885,abnormal rostral-caudal body axis extension|MP:0006206,embryonic lethality between somite formation and embryo turning
MGI:3714922	Epb41l5<Gt(XC282)Byg>	MP:0011091,prenatal lethality, complete penetrance
MGI:3578147	Epb41l5<lulu>	MP:0000267,abnormal heart development|MP:0001680,abnormal mesoderm development|MP:0001685,abnormal endoderm development|MP:0001730,embryonic growth arrest|MP:0002151,abnormal neural tube morphology|MP:0002231,abnormal primitive streak morphology|MP:0003111,abnormal cell nucleus morphology|MP:0003885,abnormal rostral-caudal body axis extension|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005657,abnormal neural plate morphology|MP:0006206,embryonic lethality between somite formation and embryo turning|MP:0006386,absent somites|MP:0009657,failure of chorioallantoic fusion|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011205,excessive folding of visceral yolk sac|MP:0012183,decreased paraxial mesoderm size|MP:0012272,decreased axial mesoderm size
MGI:4436105	Epb41l5<tm1a(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0002590,increased mean corpuscular volume|MP:0002833,increased heart weight|MP:0003442,decreased circulating glycerol level|MP:0003960,increased lean body mass
MGI:3822451	Epb41l5<tm1Sia>	MP:0000474,abnormal foregut morphology|MP:0001674,abnormal germ layer development|MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0001685,abnormal endoderm development|MP:0001698,decreased embryo size|MP:0002084,abnormal developmental patterning|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005657,abnormal neural plate morphology|MP:0006386,absent somites
MGI:5474773	Epb41<tm1b(KOMP)Mbp>	MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2183903	Epb41<tm1Cnby>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0001585,hemolytic anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002812,spherocytosis|MP:0005343,increased circulating aspartate transaminase level|MP:0005561,increased mean corpuscular hemoglobin|MP:0008476,increased spleen red pulp amount|MP:0008807,increased liver iron level|MP:0008808,decreased spleen iron level|MP:0008956,decreased cellular hemoglobin content|MP:0010090,increased circulating creatine kinase level|MP:0010375,increased kidney iron level
MGI:2182816	Epb42<tm1Llp>	MP:0000208,decreased hematocrit|MP:0001429,dehydration|MP:0001577,anemia|MP:0001765,abnormal ion homeostasis|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002812,spherocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004952,increased spleen weight|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008809,increased spleen iron level
MGI:4125320	Epc1<Gt(XB645)Byg>	MP:0000733,abnormal muscle development|MP:0011085,postnatal lethality, complete penetrance
MGI:4842670	Epc1<tm1a(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0001262,decreased body weight|MP:0002590,increased mean corpuscular volume|MP:0002896,abnormal bone mineralization|MP:0002944,increased lactate dehydrogenase level|MP:0003062,abnormal coping response|MP:0004924,abnormal behavior|MP:0010090,increased circulating creatine kinase level
MGI:4431957	Epc2<tm1a(EUCOMM)Wtsi>	MP:0004599,abnormal vertebral arch morphology|MP:0005571,decreased lactate dehydrogenase level
MGI:5692601	Epc2<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0002797,increased thigmotaxis|MP:0004924,abnormal behavior|MP:0005573,increased pulmonary respiratory rate|MP:0010097,abnormal retina blood vessel morphology|MP:0010378,increased respiratory quotient|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness
MGI:4127340	Epcam<Gt(RST412)Byg>	MP:0000477,abnormal intestine morphology|MP:0000479,abnormal enterocyte morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000495,abnormal colon morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0001634,internal hemorrhage|MP:0001732,postnatal growth retardation|MP:0008489,slow postnatal weight gain|MP:0010155,abnormal intestine physiology|MP:0011085,postnatal lethality, complete penetrance
MGI:4127613	Epcam<Gt(RST556)Byg>	MP:0001698,decreased embryo size|MP:0001713,decreased trophoblast giant cell number|MP:0001716,abnormal placenta labyrinth morphology|MP:0001730,embryonic growth arrest|MP:0002621,delayed neural tube closure|MP:0003720,abnormal neural tube closure|MP:0004259,small placenta|MP:0005048,abnormal thrombosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5318399	Epcam<tm1.1Mcu>	MP:0003091,abnormal cell migration|MP:0005362,abnormal Langerhans cell physiology|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008117,abnormal Langerhans cell morphology
MGI:5449522	Epcam<tm1.2Hmd>	MP:0010155,abnormal intestine physiology|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance
MGI:5582762	Epcam<tm1.2Msiv>	MP:0000477,abnormal intestine morphology|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002581,abnormal ileum morphology|MP:0003271,abnormal duodenum morphology|MP:0003288,intestinal edema|MP:0003306,small intestinal inflammation|MP:0004002,abnormal jejunum morphology|MP:0005202,lethargy|MP:0005386,behavior/neurological phenotype|MP:0008882,abnormal enterocyte physiology|MP:0008883,abnormal enterocyte proliferation|MP:0010155,abnormal intestine physiology|MP:0011085,postnatal lethality, complete penetrance|MP:0014083,blunted small intestinal villi
MGI:5449520	Epcam<tm1Hmd>	MP:0000511,abnormal intestinal mucosa morphology|MP:0001732,postnatal growth retardation|MP:0005036,diarrhea|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0031154,intestinal hemorrhage
MGI:4433980	Epcip<tm1a(EUCOMM)Wtsi>	MP:0004599,abnormal vertebral arch morphology
MGI:3576032	epdm	MP:0001208,blistering
MGI:5766175	Epdr1<tm1b(NCOM)Mfgc>	MP:0000219,increased neutrophil cell number|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002764,short tibia|MP:0005016,decreased lymphocyte cell number
MGI:1856859	epf	MP:0001935,decreased litter size|MP:0002064,seizures|MP:0002083,premature death|MP:0008770,decreased survivor rate|MP:0009354,emprosthotonos
MGI:3043134	Epfpq1<L6>	MP:0005334,abnormal fat pad morphology
MGI:3042946	Epfpq2<L6>	MP:0005334,abnormal fat pad morphology
MGI:3043143	Epfpq3<L6>	MP:0005334,abnormal fat pad morphology
MGI:3043138	Epfpq4<L6>	MP:0005334,abnormal fat pad morphology
MGI:3042958	Epfq1<L6>	MP:0008844,decreased subcutaneous adipose tissue amount
MGI:3042960	Epfq2<L6>	MP:0008844,decreased subcutaneous adipose tissue amount
MGI:3043153	Epfq3<L6>	MP:0005334,abnormal fat pad morphology
MGI:3043112	Epfq4<L6>	MP:0005334,abnormal fat pad morphology
MGI:3042983	Epfq5<L6>	MP:0005334,abnormal fat pad morphology
MGI:6358076	Epg5<em1(IMPC)H>	MP:0000062,increased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000745,tremors|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001489,decreased startle reflex|MP:0002606,increased basophil cell number|MP:0002626,increased heart rate|MP:0002764,short tibia|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0004952,increased spleen weight|MP:0005013,increased lymphocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0008806,increased circulating amylase level|MP:0008810,increased circulating iron level|MP:0009142,decreased prepulse inhibition|MP:0010067,increased red blood cell distribution width|MP:0012362,increased large unstained cell number
MGI:6283983	Epg5<M1Btlr>	MP:0000745,tremors|MP:0001394,circling
MGI:5505596	Epg5<tm1Ygz>	MP:0000160,kyphosis|MP:0000755,hindlimb paralysis|MP:0000807,abnormal hippocampus morphology|MP:0000937,abnormal motor neuron morphology|MP:0000939,decreased motor neuron number|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001443,poor grooming|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0001783,decreased white adipose tissue amount|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002184,abnormal innervation|MP:0002269,muscular atrophy|MP:0003354,astrocytosis|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0004087,abnormal muscle fiber morphology|MP:0004091,abnormal Z line morphology|MP:0005370,liver/biliary system phenotype|MP:0008260,abnormal autophagy|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008446,decreased retina cone cell number|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008918,microgliosis|MP:0009122,decreased white fat cell lipid droplet size|MP:0009133,decreased white fat cell size|MP:0009400,decreased skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009412,skeletal muscle fiber degeneration|MP:0009971,decreased hippocampus pyramidal cell number|MP:0009974,decreased cerebral cortex pyramidal cell number|MP:0010047,axonal spheroids|MP:0010179,rough coat|MP:0011630,increased mitochondrial size|MP:0011975,neuronal cytoplasmic inclusions|MP:0012029,abnormal electroretinogram waveform feature|MP:0012144,decreased b-wave amplitude|MP:0020811,abnormal photoreceptor outer segment size|MP:0030005,increased retina apoptosis|MP:0030940,impaired autophagy
MGI:5475149	Epgn<tm1.1Msdr>	MP:0004952,increased spleen weight|MP:0009108,increased pancreas weight|MP:0010771,integument phenotype
MGI:5577269	Epgn<tm1b(KOMP)Wtsi>	MP:0001523,impaired righting response
MGI:5576040	Epha10<tm1.1(KOMP)Vlcg>	MP:0001523,impaired righting response
MGI:3822370	Epha1<tm1Sld>	MP:0000585,kinked tail|MP:0001144,vagina atresia|MP:0001270,distended abdomen|MP:0001926,female infertility|MP:0003537,hydrometrocolpos|MP:0003541,vaginal inflammation|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004904,increased uterus weight|MP:0004906,enlarged uterus|MP:0005390,skeleton phenotype|MP:0009087,dilated uterine horn|MP:0009360,endometrium inflammation
MGI:6277036	Epha2<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology
MGI:3688255	Epha2<Gt(KST085)Byg>	MP:0001272,increased metastatic potential|MP:0004499,increased incidence of tumors by chemical induction|MP:0010255,cortical cataract
MGI:2448472	Epha2<Gt(ROSABetageo)CN3Yiw>	MP:0000259,abnormal vascular development|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001304,cataract|MP:0001684,abnormal axial mesoderm morphology|MP:0002111,abnormal tail morphology|MP:0002151,abnormal neural tube morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0004713,split notochord|MP:0006029,abnormal sclerotome morphology
MGI:2668054	Epha2<Gt(U3Betageo)J3A3Rul>	MP:0002169,no abnormal phenotype detected
MGI:3040415	Epha2<tm1Jrui>	MP:0000260,abnormal angiogenesis
MGI:6362808	Epha3<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001258,decreased body length|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:2681606	Epha3<tm1Abn>	MP:0000267,abnormal heart development|MP:0000297,abnormal atrioventricular cushion morphology|MP:0001175,abnormal lung morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001575,cyanosis|MP:0003140,dilated heart atrium|MP:0003828,pulmonary edema|MP:0003896,prolonged PR interval|MP:0005202,lethargy|MP:0005333,decreased heart rate|MP:0006046,atrioventricular valve regurgitation|MP:0006137,venoocclusion|MP:0006138,congestive heart failure|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0010018,pulmonary vascular congestion|MP:0010019,liver vascular congestion|MP:0010404,ostium primum atrial septal defect|MP:0010519,atrioventricular block|MP:0010592,abnormal atrioventricular septum morphology|MP:0010909,pulmonary alveolar hemorrhage|MP:0011090,perinatal lethality, incomplete penetrance|MP:0030992,atrioventricular cushion hypoplasia
MGI:2156201	Epha4<Gt(PST038)Byg>	MP:0001052,abnormal innervation pattern to muscle|MP:0001406,abnormal gait|MP:0002878,abnormal corticospinal tract morphology|MP:0002961,abnormal axon guidance|MP:0008225,abnormal anterior commissure morphology
MGI:4422099	Epha4<m1Btlr>	MP:0001524,impaired limb coordination
MGI:1857307	Epha4<rb>	MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001922,reduced male fertility|MP:0002286,cryptorchism|MP:0010053,decreased grip strength
MGI:2687029	Epha4<rb-2J>	MP:0001386,abnormal maternal nurturing|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002286,cryptorchism|MP:0003312,abnormal locomotor coordination|MP:0010053,decreased grip strength
MGI:4430285	Epha4<tm1.1Bzh>	MP:0001070,abnormal abducens nerve morphology|MP:0002169,no abnormal phenotype detected|MP:0002184,abnormal innervation
MGI:4430286	Epha4<tm1.2Bzh>	MP:0000939,decreased motor neuron number|MP:0000955,abnormal spinal cord morphology|MP:0001070,abnormal abducens nerve morphology|MP:0001406,abnormal gait|MP:0002184,abnormal innervation|MP:0009450,abnormal axon fasciculation|MP:0009677,abnormal spinal cord dorsal column morphology
MGI:2156472	Epha4<tm1Byd>	MP:0000860,abnormal primary somatosensory cortex morphology|MP:0001406,abnormal gait|MP:0001473,reduced long-term potentiation|MP:0001524,impaired limb coordination|MP:0001526,abnormal placing response|MP:0002184,abnormal innervation|MP:0002878,abnormal corticospinal tract morphology|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0003989,abnormal barrel cortex morphology|MP:0008225,abnormal anterior commissure morphology|MP:0008227,absent anterior commissure|MP:0009677,abnormal spinal cord dorsal column morphology|MP:0010859,abnormal anterior commissure pars anterior morphology|MP:0010860,abnormal anterior commissure pars posterior morphology
MGI:4430283	Epha4<tm1Bzh>	MP:0001406,abnormal gait
MGI:2654411	Epha4<tm1Kldr>	MP:0000940,abnormal motor neuron innervation pattern|MP:0001406,abnormal gait|MP:0002878,abnormal corticospinal tract morphology|MP:0003880,abnormal central pattern generator function|MP:0008225,abnormal anterior commissure morphology|MP:0009677,abnormal spinal cord dorsal column morphology|MP:0010859,abnormal anterior commissure pars anterior morphology|MP:0010860,abnormal anterior commissure pars posterior morphology|MP:0020529,ectopic thalamus
MGI:2156478	Epha4<tm1Kln>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:2149729	Epha4<tm1Pch>	MP:0005404,abnormal axon morphology
MGI:3693889	Epha4<tm1Pvan>	MP:0003631,nervous system phenotype
MGI:4398687	Epha4<tm2.1Kldr>	MP:0004753,abnormal miniature excitatory postsynaptic currents
MGI:4398683	Epha4<tm2Kldr>	MP:0001406,abnormal gait|MP:0008225,abnormal anterior commissure morphology|MP:0009677,abnormal spinal cord dorsal column morphology
MGI:2156479	Epha4<tm2Kln>	MP:0000860,abnormal primary somatosensory cortex morphology|MP:0001406,abnormal gait|MP:0002184,abnormal innervation|MP:0003989,abnormal barrel cortex morphology|MP:0009677,abnormal spinal cord dorsal column morphology
MGI:2156481	Epha4<tm3Kln>	MP:0001406,abnormal gait|MP:0002878,abnormal corticospinal tract morphology
MGI:2156482	Epha4<tm4Kln>	MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype
MGI:3026688	Epha4<tm5Kln>	MP:0000860,abnormal primary somatosensory cortex morphology|MP:0001406,abnormal gait|MP:0002184,abnormal innervation|MP:0002878,abnormal corticospinal tract morphology|MP:0003631,nervous system phenotype|MP:0003989,abnormal barrel cortex morphology|MP:0020529,ectopic thalamus
MGI:3603431	Epha4<tm6Kln>	MP:0000860,abnormal primary somatosensory cortex morphology|MP:0002184,abnormal innervation|MP:0003880,abnormal central pattern generator function|MP:0003989,abnormal barrel cortex morphology|MP:0020529,ectopic thalamus
MGI:5766186	Epha5<tm1b(NCOM)Mfgc>	MP:0009142,decreased prepulse inhibition|MP:0013279,increased fasting circulating glucose level
MGI:3043641	Epha5<tm1Jgf>	MP:0000968,abnormal sensory neuron innervation pattern
MGI:5605744	Epha6<tm1b(KOMP)Wtsi>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis
MGI:3797071	Epha6<tm1Lex>	MP:0001454,abnormal cued conditioning behavior|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0020340,abnormal inhibitory learning
MGI:3575006	Epha7<tm1Jf>	MP:0001890,anencephaly|MP:0002152,abnormal brain morphology
MGI:3583808	Epha7<tm1Ud>	MP:0005404,abnormal axon morphology
MGI:2182746	Epha8<tm1Bbd>	MP:0000778,abnormal nervous system tract morphology|MP:0002961,abnormal axon guidance|MP:0003631,nervous system phenotype
MGI:6277042	Ephb1<em1(IMPC)Mbp>	MP:0000538,abnormal urinary bladder morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0001415,increased exploration in new environment|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney
MGI:5306414	Ephb1<tm1.1Henk>	MP:0005404,abnormal axon morphology
MGI:2677305	Ephb1<tm1Cmn>	MP:0004267,abnormal optic tract morphology|MP:0005391,vision/eye phenotype|MP:0005404,abnormal axon morphology|MP:0008960,abnormal axon pruning|MP:0014746,abnormal hippocampal mossy fiber innervation pattern
MGI:5659739	Ephb1<tm1Dgen>	MP:0000859,abnormal somatosensory cortex morphology|MP:0002961,abnormal axon guidance|MP:0008128,abnormal brain internal capsule morphology|MP:0008228,increased anterior commissure size|MP:0009450,abnormal axon fasciculation|MP:0012462,decreased brain internal capsule size|MP:0020140,increased brain external capsule size
MGI:2677312	Ephb1<tm2Cmn>	MP:0003631,nervous system phenotype
MGI:6276938	Ephb2<em1(IMPC)Mbp>	MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0001325,abnormal retina morphology|MP:0001415,increased exploration in new environment
MGI:3692752	Ephb2<tm1Jf>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0001663,abnormal digestive system physiology|MP:0005404,abnormal axon morphology
MGI:2149765	Ephb2<tm1Paw>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0002092,abnormal eye morphology|MP:0002946,delayed axon extension|MP:0002961,abnormal axon guidance|MP:0004267,abnormal optic tract morphology|MP:0004742,abnormal vestibular system physiology|MP:0005404,abnormal axon morphology|MP:0008960,abnormal axon pruning|MP:0010860,abnormal anterior commissure pars posterior morphology|MP:0014746,abnormal hippocampal mossy fiber innervation pattern
MGI:2149670	Ephb2<tm2Paw>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0002946,delayed axon extension|MP:0002961,abnormal axon guidance|MP:0003124,hypospadia|MP:0003631,nervous system phenotype|MP:0005189,abnormal anogenital distance|MP:0005404,abnormal axon morphology|MP:0014746,abnormal hippocampal mossy fiber innervation pattern
MGI:4431255	Ephb2<tm3.1Jf>	MP:0005404,abnormal axon morphology|MP:0014746,abnormal hippocampal mossy fiber innervation pattern
MGI:2149669	Ephb3<tm1Kln>	MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0008960,abnormal axon pruning
MGI:5614904	Ephb4<b2b2412Clo>	MP:0000273,overriding aortic valve|MP:0000484,abnormal pulmonary artery morphology|MP:0000519,hydronephrosis|MP:0003675,kidney cyst|MP:0004113,abnormal aortic arch morphology|MP:0008528,polycystic kidney|MP:0010418,perimembraneous ventricular septal defect|MP:0010466,vascular ring
MGI:7594044	Ephb4<em1(IMPC)Bay>	MP:0001529,abnormal vocalization|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration|MP:0013278,decreased fasting circulating glucose level
MGI:5575404	Ephb4<tm1.1Jwu>	MP:0005387,immune system phenotype
MGI:2183162	Ephb4<tm1And>	MP:0000260,abnormal angiogenesis|MP:0000264,failure of vascular branching|MP:0000266,abnormal heart morphology|MP:0000293,absent myocardial trabeculae|MP:0002188,small heart|MP:0003411,abnormal vein development|MP:0003974,abnormal endocardium morphology|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004251,failure of heart looping|MP:0004784,abnormal anterior cardinal vein morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3522020	Ephb6<tm1Jwu>	MP:0003009,abnormal cytokine secretion|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005095,decreased T cell proliferation|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction
MGI:2389310	Ephb6<tm1Tom>	MP:0002006,neoplasm|MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:2389311	Ephb6<tm2Tom>	MP:0002006,neoplasm|MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:5430762	Ephb6/Trpv6<tm1.1Mfre>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0004933,abnormal epididymis epithelium morphology|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0009325,necrospermia|MP:0009647,decreased fertilization frequency
MGI:5430771	Ephb6/Trpv6<tm1.1Mfre>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0004933,abnormal epididymis epithelium morphology|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0009325,necrospermia|MP:0009647,decreased fertilization frequency
MGI:2137236	Ephx1<tm1Gonz>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:5609316	Ephx2<tm1.1Arte>	MP:0002792,abnormal retina vasculature morphology|MP:0003227,abnormal vascular branching morphogenesis
MGI:2149064	Ephx2<tm1Gonz>	MP:0001547,abnormal lipid level|MP:0002792,abnormal retina vasculature morphology|MP:0003227,abnormal vascular branching morphogenesis|MP:0005266,abnormal metabolism|MP:0006264,decreased systemic arterial systolic blood pressure
MGI:6108326	Ephx3<tm1.2Dcz>	MP:0002169,no abnormal phenotype detected
MGI:1856860	epi	MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002791,steatorrhea|MP:0003868,abnormal feces composition|MP:0005016,decreased lymphocyte cell number|MP:0005220,abnormal exocrine pancreas morphology|MP:0005492,exocrine pancreas hypoplasia|MP:0005560,decreased circulating glucose level|MP:0008260,abnormal autophagy|MP:0009154,pancreatic acinar hypoplasia|MP:0011090,perinatal lethality, incomplete penetrance|MP:0014476,abnormal feces lipid level
MGI:3857785	Epm2aip1<Gt(BA0314)Wtsi>	MP:0001363,increased anxiety-related response|MP:0002078,abnormal glucose homeostasis|MP:0002628,hepatic steatosis|MP:0003213,decreased susceptibility to age related obesity|MP:0003383,abnormal gluconeogenesis|MP:0005292,improved glucose tolerance|MP:0005369,muscle phenotype|MP:0005386,behavior/neurological phenotype|MP:0005438,abnormal glycogen homeostasis|MP:0005560,decreased circulating glucose level|MP:0010398,decreased liver glycogen level
MGI:3764832	Epm2a<Tg(TcraK,TcrbK)TG-BFlv>	MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008877,abnormal DNA methylation
MGI:2182627	Epm2a<tm1Kzy>	MP:0000189,hypoglycemia|MP:0000243,myoclonus|MP:0000266,abnormal heart morphology|MP:0000747,muscle weakness|MP:0000811,hippocampal neuron degeneration|MP:0000876,Purkinje cell degeneration|MP:0001260,increased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001433,polyphagia|MP:0001488,increased startle reflex|MP:0001525,impaired balance|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002575,increased circulating ketone body level|MP:0002628,hepatic steatosis|MP:0002799,abnormal passive avoidance behavior|MP:0002891,increased insulin sensitivity|MP:0003203,increased neuron apoptosis|MP:0004889,increased energy expenditure|MP:0004994,abnormal brain wave pattern|MP:0005178,increased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005319,abnormal enzyme/coenzyme level|MP:0005405,axon degeneration|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0010053,decreased grip strength|MP:0010378,increased respiratory quotient|MP:0011941,increased fluid intake|MP:0014063,Lafora bodies|MP:0014071,increased cardiac muscle glycogen level|MP:0014142,increased body fat mass|MP:0030018,increased cardiac muscle cell glucose uptake
MGI:4356015	Epn1<tm1Ocr>	MP:0002169,no abnormal phenotype detected
MGI:4356016	Epn2<tm1Ocr>	MP:0002169,no abnormal phenotype detected
MGI:4838863	Epn3<tm1.1Pdc>	MP:0002169,no abnormal phenotype detected
MGI:5548611	Epn3<tm1b(KOMP)Wtsi>	MP:0004738,abnormal auditory brainstem response|MP:0005561,increased mean corpuscular hemoglobin
MGI:3052727	Epor<tm1.1(EGFP/icre)Uk>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2386088	Epor<tm1.1(EPOR)Jtp>	MP:0011100,preweaning lethality, complete penetrance
MGI:2386092	Epor<tm1.2(EPOR)Jtp>	MP:0000208,decreased hematocrit|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0004953,decreased spleen weight|MP:0005391,vision/eye phenotype|MP:0008105,increased amacrine cell number|MP:0008106,decreased amacrine cell number|MP:0008453,decreased retina rod cell number|MP:0008513,thin retina inner plexiform layer|MP:0008519,thin retina outer plexiform layer|MP:0011965,decreased total retina thickness|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:2386096	Epor<tm1.3(EPOR*)Jtp>	MP:0002169,no abnormal phenotype detected|MP:0011100,preweaning lethality, complete penetrance
MGI:2386099	Epor<tm1.4(EPOR*)Jtp>	MP:0002416,abnormal proerythroblast morphology|MP:0002608,increased hematocrit|MP:0002642,anisocytosis|MP:0002813,microcytosis|MP:0002872,polycythemia|MP:0005564,increased hemoglobin content
MGI:1857575	Epor<tm1Cos>	MP:0000245,abnormal erythropoiesis|MP:0000601,small liver|MP:0000603,pale liver|MP:0001577,anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002875,decreased erythrocyte cell number|MP:0004230,abnormal embryonic erythrocyte morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:3613398	Epor<tm1Hwu>	MP:0004275,abnormal postnatal subventricular zone morphology
MGI:1857770	Epor<tm1Jae>	MP:0000245,abnormal erythropoiesis|MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000279,ventricular hypoplasia|MP:0000281,abnormal interventricular septum morphology|MP:0000601,small liver|MP:0000603,pale liver|MP:0001577,anemia|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0001787,pericardial edema|MP:0002953,thick ventricular wall|MP:0003135,increased erythroid progenitor cell number|MP:0003887,increased hepatocyte apoptosis|MP:0004032,abnormal interventricular groove morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0005602,decreased angiogenesis|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0031589,detached epicardium
MGI:2388345	Epor<tm1Jni>	MP:0000245,abnormal erythropoiesis|MP:0002608,increased hematocrit
MGI:1861922	Epor<tm1Lizon>	MP:0000216,absent erythroid progenitor cell|MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0000603,pale liver|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0001722,pale yolk sac|MP:0002875,decreased erythrocyte cell number|MP:0003631,nervous system phenotype|MP:0003887,increased hepatocyte apoptosis|MP:0005397,hematopoietic system phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2388346	Epor<tm2Jni>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis
MGI:3767166	Epo<Tg(TAg/Epo)134.3LCPjr>	MP:0001577,anemia|MP:0002319,hyperoxia|MP:0002320,hyperventilation|MP:0002833,increased heart weight|MP:0003913,increased heart right ventricle weight|MP:0003915,increased heart left ventricle weight|MP:0004564,increased myocardial fiber size|MP:0004952,increased spleen weight|MP:0005039,hypoxia|MP:0005290,decreased oxygen consumption|MP:0005575,increased pulmonary ventilation|MP:0005639,hemosiderosis
MGI:1858038	Epo<tm1Jae>	MP:0000245,abnormal erythropoiesis|MP:0000267,abnormal heart development|MP:0000279,ventricular hypoplasia|MP:0000281,abnormal interventricular septum morphology|MP:0000601,small liver|MP:0000603,pale liver|MP:0001577,anemia|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0001787,pericardial edema|MP:0002953,thick ventricular wall|MP:0003135,increased erythroid progenitor cell number|MP:0003887,increased hepatocyte apoptosis|MP:0004032,abnormal interventricular groove morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0005602,decreased angiogenesis|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0031589,detached epicardium
MGI:4839526	Epo<tm1Knni>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6293847	Eppin<em1(IMPC)Mbp>	MP:0000494,abnormal cecum morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0005553,increased circulating creatinine level|MP:0009476,enlarged cecum|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3612496	Eppiq2<A/J>	MP:0003088,abnormal prepulse inhibition
MGI:3805682	Eppk1<tm1Gwi>	MP:0002169,no abnormal phenotype detected|MP:0003453,abnormal keratinocyte physiology
MGI:3830327	Eppk1<tm1Safu>	MP:0002724,enhanced wound healing|MP:0012193,increased keratinocyte migration
MGI:6156792	Eprs1<tm1.1Xen>	MP:0001262,decreased body weight|MP:0001661,extended life span|MP:0001780,decreased brown adipose tissue amount|MP:0002891,increased insulin sensitivity|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005666,abnormal adipose tissue physiology|MP:0008034,enhanced lipolysis|MP:0008853,decreased abdominal adipose tissue amount|MP:0008963,increased carbon dioxide production|MP:0009133,decreased white fat cell size|MP:0014173,increased fatty acid beta-oxidation
MGI:5513771	Eprs1<tm1b(EUCOMM)Hmgu>	MP:0001175,abnormal lung morphology|MP:0001697,abnormal embryo size|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6156802	Eprs1<tm2.1Xen>	MP:0002169,no abnormal phenotype detected
MGI:6153979	Eps15l1<em1(IMPC)J>	MP:0001319,irregularly shaped pupil|MP:0001399,hyperactivity|MP:0001529,abnormal vocalization|MP:0002590,increased mean corpuscular volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0005561,increased mean corpuscular hemoglobin|MP:0010025,decreased total body fat amount
MGI:6505484	Eps15l1<tm1.1Noff>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001438,aphagia|MP:0001732,postnatal growth retardation|MP:0001951,abnormal breathing pattern|MP:0002083,premature death|MP:0004792,abnormal synaptic vesicle number|MP:0004793,abnormal synaptic vesicle clustering|MP:0004924,abnormal behavior|MP:0005498,hyporesponsive to tactile stimuli|MP:0009546,absent gastric milk in neonates|MP:0011086,postnatal lethality, incomplete penetrance|MP:0030951,abnormal endocytosis
MGI:4362352	Eps15<tm1a(KOMP)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0000221,decreased leukocyte cell number|MP:0001194,dermatitis|MP:0001260,increased body weight|MP:0001556,increased circulating HDL cholesterol level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:5485036	Eps15<tm1Noff>	MP:0000221,decreased leukocyte cell number|MP:0002357,abnormal spleen white pulp morphology|MP:0002362,abnormal spleen marginal zone morphology|MP:0003631,nervous system phenotype|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0008180,abnormal marginal zone B cell morphology|MP:0008181,increased marginal zone B cell number|MP:0008470,abnormal spleen B cell follicle morphology|MP:0009922,increased transitional stage T1 B cell number
MGI:5548540	Eps8l1<tm2b(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0005576,decreased pulmonary ventilation|MP:0010067,increased red blood cell distribution width
MGI:6120769	Eps8l2<tm1b(EUCOMM)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0000220,increased monocyte cell number|MP:0000443,abnormal snout morphology|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0002102,abnormal ear morphology|MP:0002606,increased basophil cell number|MP:0002875,decreased erythrocyte cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0005179,decreased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0005561,increased mean corpuscular hemoglobin|MP:0009142,decreased prepulse inhibition|MP:0009456,impaired cued conditioning behavior|MP:0010088,decreased circulating fructosamine level|MP:0012362,increased large unstained cell number
MGI:5544327	Eps8l2<tm1Wma>	MP:0002622,abnormal cochlear hair cell morphology|MP:0004417,decreased cochlear nerve compound action potential|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004524,short cochlear hair cell stereocilia|MP:0004534,decreased inner hair cell stereocilia number|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004738,abnormal auditory brainstem response|MP:0004742,abnormal vestibular system physiology|MP:0006325,impaired hearing|MP:0006335,abnormal hearing electrophysiology|MP:0006388,abnormal auditory summating potential|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5605809	Eps8l3<tm1b(KOMP)Mbp>	MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology
MGI:3693626	Eps8<tm1Ppdf>	MP:0001987,alcohol preference|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002169,no abnormal phenotype detected|MP:0002863,improved righting response|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003234,enhanced NMDA-mediated synaptic currents|MP:0003545,increased alcohol consumption|MP:0004524,short cochlear hair cell stereocilia|MP:0005621,abnormal cell physiology
MGI:6362648	Epsti1<em1Mjnh>	MP:0003884,decreased macrophage cell number|MP:0008113,abnormal macrophage differentiation
MGI:3055805	Ept	MP:0001394,circling|MP:0001522,impaired swimming|MP:0005377,hearing/vestibular/ear phenotype
MGI:5498555	Epx<tm1.1(cre)Jlee>	MP:0005387,immune system phenotype
MGI:5812914	Epx<tm1b(EUCOMM)Wtsi>	MP:0000220,increased monocyte cell number|MP:0001552,increased circulating triglyceride level|MP:0010024,increased total body fat amount
MGI:2182952	Epx<tm1Nal>	MP:0005061,abnormal eosinophil morphology|MP:0005387,immune system phenotype
MGI:6304421	Epyc<em1Yuna>	MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5762921	Epyc<tm1Mhok>	MP:0003109,short femur|MP:0003560,osteoarthritis
MGI:5704086	eqlb	MP:0001405,impaired coordination|MP:0001516,abnormal motor coordination/balance|MP:0005191,head tilt
MGI:3723138	Eqtn<tm1Gar>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002687,oligozoospermia|MP:0004542,impaired acrosome reaction|MP:0009647,decreased fertilization frequency
MGI:3778037	Era1<CAST/EiJ>	MP:0020474,advanced circadian behavior phase
MGI:6257585	Eral1<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3830089	Erap1<tm1.1Gnie>	MP:0001835,abnormal antigen presentation|MP:0001841,decreased level of surface class I molecules|MP:0005025,abnormal response to infection|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005095,decreased T cell proliferation|MP:0008567,decreased interferon-gamma secretion
MGI:3604456	Erap1<tm1Dgen>	MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0000708,thymus hyperplasia|MP:0003068,enlarged kidney
MGI:3653695	Erap1<tm1Iay>	MP:0001841,decreased level of surface class I molecules|MP:0005078,abnormal cytotoxic T cell physiology
MGI:3714520	Erap1<tm1Luc>	MP:0001835,abnormal antigen presentation|MP:0001840,increased level of surface class I molecules|MP:0001841,decreased level of surface class I molecules|MP:0003945,abnormal lymphocyte physiology|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005387,immune system phenotype
MGI:3664437	Erap1<tm1Nsha>	MP:0001836,abnormal antigen presentation via MHC class I|MP:0001841,decreased level of surface class I molecules|MP:0003009,abnormal cytokine secretion|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology
MGI:6241474	Erap1<tm2b(EUCOMM)Wtsi>	MP:0000598,abnormal liver morphology|MP:0001399,hyperactivity|MP:0002833,increased heart weight|MP:0003960,increased lean body mass|MP:0005419,decreased circulating serum albumin level|MP:0005505,thrombocytosis|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content
MGI:3577040	Erars1<DBA/2J>	MP:0002461,increased immunoglobulin level|MP:0004794,increased anti-nuclear antigen antibody level
MGI:3577041	Erars2<C57BL/6J>	MP:0001800,abnormal humoral immune response|MP:0002461,increased immunoglobulin level
MGI:2671879	Erbb2<l11Jus8>	MP:0001719,absent vitelline blood vessels|MP:0001914,hemorrhage|MP:0002128,abnormal blood circulation|MP:0003105,abnormal heart atrium morphology|MP:0003140,dilated heart atrium|MP:0003229,abnormal vitelline vasculature morphology|MP:0003400,kinked neural tube|MP:0005385,cardiovascular system phenotype|MP:0010493,abnormal atrium myocardium morphology|MP:0010519,atrioventricular block|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6279893	Erbb2<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:1929071	Erbb2<tm1Cbm>	MP:0000296,absent trabeculae carneae|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0002950,abnormal neural crest cell migration|MP:0003631,nervous system phenotype|MP:0004075,decreased Schwann cell precursor number|MP:0004981,decreased neuronal precursor cell number|MP:0011092,embryonic lethality, complete penetrance
MGI:1928827	Erbb2<tm1Gne>	MP:0000274,enlarged heart|MP:0000280,thin ventricular wall|MP:0000293,absent myocardial trabeculae|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001076,abnormal hypoglossal nerve morphology|MP:0001082,abnormal geniculate ganglion morphology|MP:0001084,abnormal petrosal ganglion morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001102,small superior vagus ganglion|MP:0001633,poor circulation|MP:0001636,irregular heartbeat|MP:0002855,abnormal cochlear ganglion morphology|MP:0003993,abnormal ventral spinal root morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1929070	Erbb2<tm1Haus>	MP:0000293,absent myocardial trabeculae|MP:0000301,decreased atrioventricular cushion size|MP:0000940,abnormal motor neuron innervation pattern|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001056,abnormal cranial nerve morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001082,abnormal geniculate ganglion morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:2387154	Erbb2<tm1Klee>	MP:0000278,abnormal myocardial fiber morphology|MP:0000495,abnormal colon morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002795,dilated cardiomyopathy|MP:0004084,abnormal cardiac muscle relaxation|MP:0005294,abnormal heart ventricle morphology|MP:0005598,decreased heart ventricle muscle contractility|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0014316,decreased heart left ventricle posterior wall thickness|MP:0014317,decreased heart left ventricle septal wall thickness|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0031633,decreased heart left ventricle muscle contractility
MGI:2179176	Erbb2<tm1Mul>	MP:0000274,enlarged heart|MP:0000296,absent trabeculae carneae|MP:0001636,irregular heartbeat|MP:0002128,abnormal blood circulation|MP:0008317,abnormal paravertebral ganglion morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2651799	Erbb2<tm1Vrtn>	MP:0000953,abnormal oligodendrocyte morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2177255	Erbb2<tm2Cbm>	MP:0000921,demyelination|MP:0005386,behavior/neurological phenotype
MGI:2179519	Erbb2<tm2Mul>	MP:0005385,cardiovascular system phenotype|MP:0008317,abnormal paravertebral ganglion morphology
MGI:2449788	Erbb2<tm3(Erbb2)Mul>	MP:0000120,malocclusion|MP:0000992,absent primary muscle spindle|MP:0000995,absent secondary muscle spindle|MP:0000996,partial loss of secondary muscle spindle|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001524,impaired limb coordination|MP:0002083,premature death|MP:0004263,abnormal limb posture|MP:0005150,cachexia|MP:0013239,impaired skeletal muscle regeneration|MP:0030972,increased myoblast apoptosis
MGI:3521857	Erbb2<tm4(Erbb2)Mul>	MP:0002169,no abnormal phenotype detected
MGI:3521858	Erbb2<tm5(Erbb2)Mul>	MP:0002169,no abnormal phenotype detected
MGI:3521859	Erbb2<tm6(Erbb2)Mul>	MP:0002169,no abnormal phenotype detected
MGI:3521860	Erbb2<tm7(Erbb2)Mul>	MP:0000965,abnormal sensory neuron morphology
MGI:3793285	Erbb2<tm8.1(Erbb2)Mul>	MP:0002189,abnormal myocardial trabeculae morphology|MP:0003631,nervous system phenotype|MP:0005389,reproductive system phenotype|MP:0008317,abnormal paravertebral ganglion morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3525444	Erbb2<tm8(Erbb2)Mul>	MP:0000628,abnormal mammary gland development|MP:0002080,prenatal lethality|MP:0009505,abnormal mammary gland lobule morphology|MP:0010299,increased mammary gland tumor incidence
MGI:4455202	Erbb3<m3329Ddg>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0001077,abnormal spinal nerve morphology|MP:0003632,abnormal nervous system morphology|MP:0009450,abnormal axon fasciculation|MP:0009798,abnormal ophthalmic nerve morphology|MP:0009800,abnormal mandibular nerve morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3513098	Erbb3<tm1.1Dwt>	MP:0011085,postnatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5446930	Erbb3<tm1.1(ERBB3)Mul>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0006270,abnormal mammary gland growth during lactation|MP:0006271,abnormal involution of the mammary gland|MP:0009503,abnormal mammary gland duct morphology|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009506,abnormal mammary gland alveolus morphology|MP:0009674,decreased birth weight|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013716,hypolactation|MP:0014126,increased mammary gland apoptosis
MGI:3690340	Erbb3<tm1.1Squ>	MP:0002169,no abnormal phenotype detected
MGI:1929072	Erbb3<tm1Cbm>	MP:0000938,motor neuron degeneration|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000964,small dorsal root ganglion|MP:0001056,abnormal cranial nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001105,abnormal PNS glial cell morphology|MP:0001109,absent Schwann cell precursors|MP:0001262,decreased body weight|MP:0001404,no spontaneous movement|MP:0001491,unresponsive to tactile stimuli|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration|MP:0011089,perinatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:1928828	Erbb3<tm1Gne>	MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000300,thin atrioventricular cushion|MP:0000471,abnormal stomach epithelium morphology|MP:0000645,absent adrenergic chromaffin cells|MP:0000783,abnormal forebrain morphology|MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0000820,abnormal choroid plexus morphology|MP:0000841,abnormal hindbrain morphology|MP:0000844,abnormal pontine flexure morphology|MP:0000851,cerebellum hypoplasia|MP:0000856,abnormal cerebellar plate morphology|MP:0000865,absent cerebellum vermis|MP:0000880,decreased Purkinje cell number|MP:0000897,abnormal midbrain morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001085,small petrosal ganglion|MP:0001088,small nodose ganglion|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001107,decreased Schwann cell number|MP:0001633,poor circulation|MP:0001944,abnormal pancreas morphology|MP:0002152,abnormal brain morphology|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002200,abnormal brain ventricular system morphology|MP:0003634,abnormal glial cell morphology|MP:0003993,abnormal ventral spinal root morphology|MP:0004203,abnormal cranial flexure morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005537,abnormal cerebral aqueduct morphology|MP:0006046,atrioventricular valve regurgitation|MP:0008547,abnormal neocortex morphology|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014551,impaired neuronal migration|MP:0031550,abnormal atrioventricular valve development
MGI:3690339	Erbb3<tm1Squ>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001108,absent Schwann cells|MP:0002745,abnormal atrioventricular valve morphology|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:1929598	Erbb3<tm2Cbm>	MP:0000639,abnormal adrenal gland morphology|MP:0000645,absent adrenergic chromaffin cells|MP:0000938,motor neuron degeneration|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000964,small dorsal root ganglion|MP:0001007,abnormal sympathetic system morphology|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001011,abnormal superior cervical ganglion morphology|MP:0001015,small superior cervical ganglion|MP:0001056,abnormal cranial nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001105,abnormal PNS glial cell morphology|MP:0001109,absent Schwann cell precursors|MP:0001262,decreased body weight|MP:0001404,no spontaneous movement|MP:0001491,unresponsive to tactile stimuli|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002950,abnormal neural crest cell migration|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration|MP:0008316,abnormal prevertebral ganglion morphology|MP:0008317,abnormal paravertebral ganglion morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012574,decreased noradrenaline level
MGI:3835516	Erbb3<tm3Cbm>	MP:0001108,absent Schwann cells
MGI:4421788	Erbb4<tm1.1(cre/ERT2)Aibs>	MP:0002169,no abnormal phenotype detected
MGI:2680217	Erbb4<tm1Fej>	MP:0000628,abnormal mammary gland development|MP:0001882,abnormal lactation|MP:0003008,enhanced long-term potentiation|MP:0005386,behavior/neurological phenotype|MP:0006270,abnormal mammary gland growth during lactation|MP:0009142,decreased prepulse inhibition|MP:0031391,increased locomotor activity
MGI:1929607	Erbb4<tm1Grl>	MP:0000233,abnormal blood flow velocity|MP:0000296,absent trabeculae carneae|MP:0000301,decreased atrioventricular cushion size|MP:0000940,abnormal motor neuron innervation pattern|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001056,abnormal cranial nerve morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0001071,abnormal facial nerve morphology|MP:0001072,abnormal vestibulocochlear nerve morphology|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001082,abnormal geniculate ganglion morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001399,hyperactivity|MP:0003088,abnormal prepulse inhibition|MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3603749	Erbb4<tm1Htig>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000280,thin ventricular wall|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0003137,abnormal impulse conducting system conduction|MP:0003233,prolonged QT interval|MP:0004564,increased myocardial fiber size|MP:0004567,decreased myocardial fiber number|MP:0006267,abnormal intercalated disk morphology|MP:0008950,ventricular tachycardia|MP:0010392,prolonged QRS complex duration|MP:0014721,increased polyploid cardiomyocyte number|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3849991	Erbin<Gt(BGA258)Byg>	MP:0000920,abnormal myelination|MP:0003871,abnormal myelin sheath morphology|MP:0005404,abnormal axon morphology|MP:0005498,hyporesponsive to tactile stimuli|MP:0008814,decreased nerve conduction velocity
MGI:3849990	Erbin<tm1Line>	MP:0000920,abnormal myelination|MP:0003871,abnormal myelin sheath morphology|MP:0005404,abnormal axon morphology|MP:0005498,hyporesponsive to tactile stimuli|MP:0008814,decreased nerve conduction velocity
MGI:4127703	Erc1<Gt(RRF343)Byg>	MP:0003992,increased mortality induced by ionizing radiation|MP:0008762,embryonic lethality
MGI:5692791	Erc1<tm1b(EUCOMM)Hmgu>	MP:0001566,increased circulating phosphate level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance|MP:0011960,abnormal eye anterior chamber depth|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3763189	Erc1<tm1Sud>	MP:0002169,no abnormal phenotype detected|MP:0011092,embryonic lethality, complete penetrance
MGI:3783990	Erc2<tm1.1Sud>	MP:0001415,increased exploration in new environment|MP:0002204,abnormal synaptic neurotransmitter level|MP:0002206,abnormal CNS synaptic transmission|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004792,abnormal synaptic vesicle number|MP:0009538,abnormal synapse morphology|MP:0014710,increased synaptic vesicle readily releasable pool size
MGI:4940481	Erc2<tm1.2Sud>	MP:0002945,abnormal inhibitory postsynaptic currents
MGI:5440304	Erc2<tm1Toh>	MP:0001005,abnormal retina rod cell morphology|MP:0001325,abnormal retina morphology|MP:0002090,abnormal vision|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0006068,abnormal retina horizontal cell morphology|MP:0006073,abnormal retina bipolar cell morphology|MP:0008519,thin retina outer plexiform layer
MGI:2158940	Ercc1<tm1Dwm>	MP:0000609,abnormal liver physiology|MP:0003103,liver degeneration|MP:0003325,decreased liver function|MP:0004024,aneuploidy|MP:0004025,polyploidy|MP:0009703,decreased birth body size|MP:0011085,postnatal lethality, complete penetrance|MP:0014694,anisokaryosis
MGI:2183944	Ercc1<tm1Jhjh>	MP:0000063,decreased bone mineral density|MP:0000160,kyphosis|MP:0000352,decreased cell proliferation|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0000694,spleen hypoplasia|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001731,abnormal postnatal growth|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002136,abnormal kidney physiology|MP:0002628,hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0002962,increased urine protein level|MP:0003031,acidosis|MP:0003786,premature aging|MP:0003887,increased hepatocyte apoptosis|MP:0003984,embryonic growth retardation|MP:0004001,decreased hepatocyte proliferation|MP:0004201,fetal growth retardation|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004810,decreased hematopoietic stem cell number|MP:0004816,abnormal class switch recombination|MP:0004819,decreased skeletal muscle mass|MP:0005093,decreased B cell proliferation|MP:0005323,dystonia|MP:0005560,decreased circulating glucose level|MP:0008008,early cellular replicative senescence|MP:0008058,abnormal DNA repair|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0009355,increased liver triglyceride level|MP:0011083,lethality at weaning, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0013697,decreased granulocyte monocyte progenitor cell number|MP:0013705,decreased megakaryocyte-erythroid progenitor cell number
MGI:2183945	Ercc1<tm2Jhjh>	MP:0000352,decreased cell proliferation|MP:0000607,abnormal hepatocyte morphology|MP:0000689,abnormal spleen morphology|MP:0001199,thin skin|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001924,infertility|MP:0002083,premature death|MP:0002705,dilated renal tubule|MP:0004810,decreased hematopoietic stem cell number|MP:0008813,decreased common myeloid progenitor cell number|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008973,decreased erythroid progenitor cell number|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0013697,decreased granulocyte monocyte progenitor cell number|MP:0013705,decreased megakaryocyte-erythroid progenitor cell number
MGI:5621284	Ercc2<Mhdarco15>	MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001306,small lens|MP:0001926,female infertility|MP:0005389,reproductive system phenotype|MP:0010179,rough coat|MP:0010254,nuclear cataract|MP:0011697,lens vacuoles|MP:0012734,abnormal response to radiation|MP:0031345,developmental cataract
MGI:2183947	Ercc2<tm1Jhjh>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3693615	Ercc2<tm1Jmch>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2183949	Ercc2<tm2(ERCC2)Jhjh>	MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000160,kyphosis|MP:0000208,decreased hematocrit|MP:0000367,abnormal coat/ hair morphology|MP:0000377,abnormal hair follicle morphology|MP:0000381,enlarged hair follicles|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000647,abnormal sebaceous gland morphology|MP:0000652,enlarged sebaceous gland|MP:0000691,enlarged spleen|MP:0000745,tremors|MP:0001192,scaly skin|MP:0001200,thick skin|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001242,hyperkeratosis|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0001874,acanthosis|MP:0001923,reduced female fertility|MP:0001928,abnormal ovulation|MP:0002006,neoplasm|MP:0002021,increased incidence of induced tumors|MP:0002083,premature death|MP:0002427,disproportionate dwarf|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002938,white spotting|MP:0003786,premature aging|MP:0003848,brittle hair|MP:0003849,greasy coat|MP:0005150,cachexia|MP:0005311,abnormal circulating amino acid level|MP:0005387,immune system phenotype|MP:0005508,abnormal skeleton morphology|MP:0005621,abnormal cell physiology|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0009115,abnormal fat cell morphology
MGI:3696121	Ercc2<tm2Jmch>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3664604	Ercc2<tm3Jhjh>	MP:0001146,abnormal testis morphology|MP:0001190,reddish skin|MP:0001202,skin photosensitivity|MP:0001314,cornea opacity|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0001874,acanthosis|MP:0002083,premature death|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0004501,increased incidence of tumors by UV-induction|MP:0005150,cachexia|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008058,abnormal DNA repair|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008918,microgliosis|MP:0010308,decreased tumor latency|MP:0010771,integument phenotype
MGI:4410296	Ercc3<tm1.1Gima>	MP:0002006,neoplasm|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:5766184	Ercc3<tm1b(NCOM)Mfgc>	MP:0005562,decreased mean corpuscular hemoglobin|MP:0005627,increased circulating potassium level|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3836421	Ercc3<tm1Jhjh>	MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:3836429	Ercc3<tm2Jhjh>	MP:0001222,epidermal hyperplasia|MP:0001874,acanthosis|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0010768,mortality/aging
MGI:6314793	Ercc4<em1(IMPC)J>	MP:0001293,anophthalmia|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:3028660	Ercc4<tm1Fwa>	MP:0000598,abnormal liver morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0005384,cellular phenotype|MP:0008402,increased cellular sensitivity to alkylating agent induced cell death|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0011083,lethality at weaning, complete penetrance|MP:0014760,impaired DNA repair|MP:0020427,increased hepatocyte karyomegaly
MGI:2182793	Ercc5<tm1Shm>	MP:0000477,abnormal intestine morphology|MP:0000478,delayed intestine development|MP:0000496,abnormal small intestine morphology|MP:0000601,small liver|MP:0000607,abnormal hepatocyte morphology|MP:0001664,abnormal digestion|MP:0001732,postnatal growth retardation|MP:0002691,small stomach|MP:0004953,decreased spleen weight|MP:0005653,phototoxicity|MP:0011085,postnatal lethality, complete penetrance
MGI:5636892	Ercc5<tm2b(EUCOMM)Hmgu>	MP:0000208,decreased hematocrit|MP:0002875,decreased erythrocyte cell number|MP:0005505,thrombocytosis|MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:3043588	Ercc5<tm2Shm>	MP:0005378,growth/size/body region phenotype|MP:0005653,phototoxicity|MP:0010768,mortality/aging
MGI:3043589	Ercc5<tm3Shm>	MP:0000496,abnormal small intestine morphology|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0005653,phototoxicity
MGI:3043590	Ercc5<tm4Shm>	MP:0005378,growth/size/body region phenotype|MP:0005653,phototoxicity|MP:0010768,mortality/aging
MGI:6791389	Ercc6l2<em1Mengf>	MP:0001805,decreased IgG level|MP:0001807,decreased IgA level|MP:0004816,abnormal class switch recombination|MP:0005018,decreased T cell number|MP:0005387,immune system phenotype|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0010768,mortality/aging
MGI:6792078	Ercc6l2<em2Mengf>	MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype
MGI:6280029	Ercc6l<tm1.1Ajlc>	MP:0002169,no abnormal phenotype detected
MGI:6280030	Ercc6l<tm1.2Ajlc>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0003111,abnormal cell nucleus morphology|MP:0004025,polyploidy|MP:0004045,abnormal cell cycle checkpoint function|MP:0005621,abnormal cell physiology|MP:0008008,early cellular replicative senescence|MP:0008057,abnormal DNA replication|MP:0008866,chromosomal instability|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0013504,increased embryonic tissue cell apoptosis|MP:0014178,increased brain apoptosis|MP:0031678,increased micronucleus incidence
MGI:1932102	Ercc6<tm1Gvh>	MP:0001202,skin photosensitivity|MP:0001262,decreased body weight|MP:0001326,retina degeneration|MP:0001392,abnormal locomotor behavior|MP:0001394,circling|MP:0001405,impaired coordination|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0001999,photosensitivity|MP:0002021,increased incidence of induced tumors|MP:0003354,astrocytosis|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004465,degeneration of organ of Corti supporting cells|MP:0004586,pillar cell degeneration|MP:0004628,Deiters cell degeneration|MP:0005621,abnormal cell physiology|MP:0006325,impaired hearing|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008918,microgliosis|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013787,photophobia|MP:0014409,decreased distortion product otoacoustic emission amplitude
MGI:6377199	Ercc8<em1(IMPC)H>	MP:0001392,abnormal locomotor behavior|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:2449180	Ercc8<tm1Jhjh>	MP:0001202,skin photosensitivity|MP:0001203,increased sensitivity to skin irradiation|MP:0003354,astrocytosis|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004501,increased incidence of tumors by UV-induction|MP:0006325,impaired hearing|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008450,retina photoreceptor degeneration|MP:0008918,microgliosis|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013787,photophobia|MP:0014409,decreased distortion product otoacoustic emission amplitude|MP:0014760,impaired DNA repair
MGI:3057313	Ereg<tm1Dwt>	MP:0001263,weight loss|MP:0008537,increased susceptibility to induced colitis|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:3054792	Ereg<tm1Sawa>	MP:0001194,dermatitis
MGI:5007127	Erfe<tm1Lex>	MP:0000208,decreased hematocrit|MP:0000609,abnormal liver physiology|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0004151,decreased circulating iron level|MP:0005165,increased susceptibility to injury|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:5708181	Erf<tm1.1(KOMP)Mbp>	MP:0000443,abnormal snout morphology|MP:0001697,abnormal embryo size|MP:0002100,abnormal tooth morphology|MP:0003984,embryonic growth retardation|MP:0009552,urinary bladder obstruction|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3719472	Erf<tm1Gmav>	MP:0000784,forebrain hypoplasia|MP:0000929,open neural tube|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001722,pale yolk sac|MP:0001726,abnormal allantois morphology|MP:0001785,edema|MP:0002836,abnormal chorion morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003403,absent placental labyrinth|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0005032,abnormal ectoplacental cone morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0006042,increased apoptosis|MP:0009429,decreased embryo weight|MP:0009657,failure of chorioallantoic fusion|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012090,midbrain hypoplasia|MP:0012099,decreased spongiotrophoblast size|MP:0012134,absent umbilical cord|MP:0012264,hindbrain hypoplasia
MGI:5499177	Erf<tm2Gmav>	MP:0002169,no abnormal phenotype detected
MGI:6257827	Erg<em1(IMPC)Bay>	MP:0000221,decreased leukocyte cell number|MP:0000689,abnormal spleen morphology|MP:0001510,abnormal coat appearance|MP:0002953,thick ventricular wall|MP:0010579,increased heart left ventricle size|MP:0011100,preweaning lethality, complete penetrance|MP:0011959,abnormal eye posterior chamber depth|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6294102	Ergic1<em1(IMPC)J>	MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:6314735	Ergic2<em1(IMPC)Hmgu>	MP:0002059,abnormal seminal vesicle morphology|MP:0002833,increased heart weight|MP:0004357,long tibia|MP:0008810,increased circulating iron level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7582033	Ergic2<tm1.1Bcgen>	MP:0000274,enlarged heart|MP:0005140,decreased cardiac muscle contractility|MP:0005378,growth/size/body region phenotype|MP:0005598,decreased heart ventricle muscle contractility|MP:0008772,increased heart ventricle size|MP:0010499,abnormal ventricle myocardium morphology|MP:0010579,increased heart left ventricle size
MGI:7582035	Ergic3<tm1.1Bcgen>	MP:0000274,enlarged heart|MP:0005140,decreased cardiac muscle contractility|MP:0005378,growth/size/body region phenotype|MP:0005598,decreased heart ventricle muscle contractility|MP:0008772,increased heart ventricle size|MP:0010499,abnormal ventricle myocardium morphology|MP:0010579,increased heart left ventricle size
MGI:3803955	Erg<mld2>	MP:0003179,thrombocytopenia|MP:0003984,embryonic growth retardation|MP:0004229,abnormal embryonic erythropoiesis|MP:0004810,decreased hematopoietic stem cell number|MP:0005397,hematopoietic system phenotype|MP:0008190,decreased transitional stage B cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5910506	Erg<tm1.1Iwamo>	MP:0003560,osteoarthritis|MP:0003724,increased susceptibility to induced arthritis|MP:0006433,abnormal articular cartilage morphology
MGI:5775397	Erg<tm1.1Path>	MP:0000276,heart right ventricle hypertrophy|MP:0001182,lung hemorrhage|MP:0002725,abnormal vein morphology|MP:0003548,pulmonary hypertension|MP:0003828,pulmonary edema|MP:0004125,abnormal venule morphology|MP:0005152,pancytopenia|MP:0006137,venoocclusion|MP:0010758,increased right ventricle systolic pressure|MP:0011400,lethality, complete penetrance|MP:0020161,increased vascular endothelial cell proliferation
MGI:5910545	Erg<tm1.2Iwamo>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5443836	Erg<tm1Poet>	MP:0002169,no abnormal phenotype detected
MGI:5443838	Erg<tm2Poet>	MP:0000259,abnormal vascular development|MP:0000267,abnormal heart development|MP:0001634,internal hemorrhage|MP:0001698,decreased embryo size|MP:0001915,intracranial hemorrhage|MP:0005312,pericardial effusion|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009577,abnormal developmental vascular remodeling|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3838637	Eri1<tm1.2Anse>	MP:0000352,decreased cell proliferation|MP:0001265,decreased body size|MP:0002082,postnatal lethality|MP:0004200,decreased fetal size|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6285594	Eri2<em1(IMPC)Bay>	MP:0010511,shortened PR interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6717351	Erich2<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6152473	Erich3<em1(IMPC)Mbp>	MP:0002092,abnormal eye morphology|MP:0002574,increased vertical activity
MGI:6152474	Erlec1<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology|MP:0004738,abnormal auditory brainstem response|MP:0009141,increased prepulse inhibition|MP:0010025,decreased total body fat amount
MGI:6156564	Erlin1<em1(IMPC)Tcp>	MP:0000063,decreased bone mineral density|MP:0000470,abnormal stomach morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0001126,abnormal ovary morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002768,small adrenal glands|MP:0002941,increased circulating alanine transaminase level|MP:0003961,decreased lean body mass|MP:0011874,enlarged urinary bladder
MGI:4820210	Erlin2<tm1a(EUCOMM)Wtsi>	MP:0008806,increased circulating amylase level
MGI:5692688	Erln<tm1b(KOMP)Wtsi>	MP:0008935,decreased mean platelet volume
MGI:6153851	Ermn<em1(IMPC)H>	MP:0001552,increased circulating triglyceride level|MP:0005505,thrombocytosis|MP:0005565,increased blood urea nitrogen level
MGI:6860511	Ermn<tm1Bcgen>	MP:0000921,demyelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0001405,impaired coordination|MP:0008814,decreased nerve conduction velocity
MGI:5615223	Ermp1<b2b2633Clo>	MP:0000111,cleft palate|MP:0001293,anophthalmia|MP:0002135,abnormal kidney morphology|MP:0004158,right aortic arch|MP:0005170,cleft upper lip|MP:0010466,vascular ring|MP:0010488,abnormal left subclavian artery morphology|MP:0011659,interrupted aortic arch, type b|MP:0011670,double outlet right ventricle, noncommitted ventricular septal defect
MGI:7865790	Ermp1<em1Gjom>	MP:0001859,kidney inflammation|MP:0002135,abnormal kidney morphology|MP:0002962,increased urine protein level|MP:0003985,renal fibrosis|MP:0005264,glomerulosclerosis|MP:0005527,increased renal glomerular filtration rate|MP:0011092,embryonic lethality, complete penetrance
MGI:5505907	Ermp1<tm1.1(KOMP)Vlcg>	MP:0000195,decreased circulating calcium level|MP:0003019,increased circulating chloride level|MP:0005633,increased circulating sodium level|MP:0009142,decreased prepulse inhibition|MP:0011954,shortened PQ interval
MGI:3778372	Ern1<tm1Dron>	MP:0002078,abnormal glucose homeostasis|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3622330	Ern1<tm1Rjk>	MP:0000600,liver hypoplasia|MP:0001698,decreased embryo size|MP:0002123,abnormal definitive hematopoiesis|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0005432,abnormal pro-B cell morphology|MP:0005621,abnormal cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4365396	Ern1<tm1Tiw>	MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0004259,small placenta|MP:0004264,abnormal extraembryonic tissue physiology|MP:0004265,abnormal placental transport|MP:0005031,abnormal trophoblast layer morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4949317	Ern1<tm2.1Rjk>	MP:0002169,no abnormal phenotype detected
MGI:5607643	Ern2<m1Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:5789538	Ern2<M2Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:5806430	Ern2<m3Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:2677494	Ern2<tm1Dron>	MP:0008537,increased susceptibility to induced colitis
MGI:4125474	Ero1a<Gt(XST171)Byg>	MP:0002451,abnormal macrophage physiology|MP:0008944,decreased sensitivity to induced cell death|MP:0011081,decreased macrophage apoptosis
MGI:3864866	Ero1b<Gt(P077G11)Wrst>	MP:0002078,abnormal glucose homeostasis|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0009254,disorganized pancreatic islets
MGI:6342880	Erp29<tm1Dfer>	MP:0001935,decreased litter size|MP:0008407,decreased cellular sensitivity to hydrogen peroxide|MP:0008944,decreased sensitivity to induced cell death
MGI:5563471	Erp44<m1Anu>	MP:0001192,scaly skin|MP:0001255,decreased body height|MP:0002075,abnormal coat/hair pigmentation
MGI:5052408	Erp44<tm1a(KOMP)Wtsi>	MP:0003960,increased lean body mass|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3769411	Errfi1<tm1.1Jwj>	MP:0001120,abnormal uterus morphology|MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001183,overexpanded pulmonary alveolus|MP:0001200,thick skin|MP:0001222,epidermal hyperplasia|MP:0001402,decreased locomotor activity|MP:0001431,abnormal eating behavior|MP:0001575,cyanosis|MP:0002051,increased skin papilloma incidence|MP:0002083,premature death|MP:0002276,abnormal lung interstitium morphology|MP:0002932,abnormal joint morphology|MP:0003641,small lung|MP:0004007,abnormal lung vasculature morphology|MP:0004904,increased uterus weight|MP:0005488,bronchial epithelial hyperplasia|MP:0006027,impaired lung alveolus development|MP:0009092,endometrium hyperplasia|MP:0009546,absent gastric milk in neonates|MP:0009674,decreased birth weight|MP:0010810,increased type II pneumocyte number|MP:0010887,pale lung|MP:0010910,bronchiolar epithelial hyperplasia|MP:0010942,abnormal respiratory epithelium morphology|MP:0010945,lung epithelium hyperplasia|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3603195	Errfi1<tm1Gvw>	MP:0000709,enlarged thymus|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0003560,osteoarthritis|MP:0003711,pathological neovascularization|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0030332,accelerated temporomandibular joint osteoarthritis
MGI:3769404	Errfi1<tm1Jwj>	MP:0001120,abnormal uterus morphology|MP:0001926,female infertility|MP:0002051,increased skin papilloma incidence|MP:0002169,no abnormal phenotype detected|MP:0002676,uterus hyperplasia|MP:0004868,increased endometrial carcinoma incidence|MP:0004904,increased uterus weight|MP:0005388,respiratory system phenotype|MP:0009092,endometrium hyperplasia|MP:0013401,increased endometrial gland number
MGI:3639295	Errfi1<tm1Kln>	MP:0000163,abnormal cartilage morphology|MP:0000493,rectal prolapse|MP:0000574,abnormal foot pad morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001195,flaky skin|MP:0001209,spontaneous skin ulceration|MP:0001222,epidermal hyperplasia|MP:0001290,delayed eyelid opening|MP:0002038,increased carcinoma incidence|MP:0002051,increased skin papilloma incidence|MP:0002083,premature death|MP:0003795,abnormal bone structure|MP:0004499,increased incidence of tumors by chemical induction|MP:0010383,increased adenoma incidence
MGI:5575860	Errfi1<tm3.1Gvw>	MP:0000559,abnormal femur morphology|MP:0002083,premature death|MP:0002932,abnormal joint morphology|MP:0002936,joint swelling|MP:0003560,osteoarthritis|MP:0006433,abnormal articular cartilage morphology|MP:0008272,abnormal endochondral bone ossification|MP:0011692,increased chondrocyte number
MGI:1856031	Es3<c-nH>	MP:0002080,prenatal lethality|MP:0005584,abnormal enzyme/coenzyme activity
MGI:3722082	Esam<tm1Dvst>	MP:0001262,decreased body weight|MP:0003071,decreased vascular permeability|MP:0003156,abnormal leukocyte migration|MP:0009858,abnormal cellular extravasation
MGI:2675994	Esam<tm1Tq>	MP:0001262,decreased body weight|MP:0002052,decreased tumor incidence|MP:0005602,decreased angiogenesis
MGI:6828774	Esco1<tm1.1Ge>	MP:0004046,abnormal mitosis
MGI:4419798	Esco1<tm1(KOMP)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0001262,decreased body weight|MP:0002942,decreased circulating alanine transaminase level|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0010025,decreased total body fat amount
MGI:5308062	Esco2<tm1.1Ge>	MP:0000352,decreased cell proliferation|MP:0000433,microcephaly|MP:0000808,abnormal hippocampus development|MP:0000809,absent hippocampus|MP:0003111,abnormal cell nucleus morphology|MP:0003203,increased neuron apoptosis|MP:0003702,abnormal chromosome morphology|MP:0004046,abnormal mitosis|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004760,increased mitotic index|MP:0004948,abnormal neuronal precursor proliferation|MP:0008547,abnormal neocortex morphology|MP:0031678,increased micronucleus incidence
MGI:5308063	Esco2<tm1.2Ge>	MP:0004046,abnormal mitosis|MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5897850	Esd<em1(IMPC)J>	MP:0000208,decreased hematocrit|MP:0001488,increased startle reflex|MP:0002874,decreased hemoglobin content
MGI:3609119	Esl1<SL/Kh>	MP:0002023,increased B cell derived lymphoma incidence
MGI:7490359	Esm1<tm1.1Rha>	MP:0002792,abnormal retina vasculature morphology|MP:0003071,decreased vascular permeability|MP:0004003,abnormal vascular endothelial cell physiology|MP:0005602,decreased angiogenesis|MP:0006055,abnormal vascular endothelial cell morphology|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0009858,abnormal cellular extravasation|MP:0010144,abnormal tumor vascularization
MGI:2387170	Esmr<DBA/2NCrj>	MP:0005026,decreased susceptibility to parasitic infection
MGI:3587957	Espl1<Gt(XL058)Byg>	MP:0002052,decreased tumor incidence|MP:0006205,embryonic lethality between implantation and somite formation
MGI:3624200	Espl1<tm1.1Kna>	MP:0000333,decreased bone marrow cell number|MP:0000607,abnormal hepatocyte morphology|MP:0002658,abnormal liver regeneration
MGI:3624002	Espl1<tm1.1Tno>	MP:0003702,abnormal chromosome morphology
MGI:3624201	Espl1<tm1.2Kna>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3624003	Espl1<tm1.2Tno>	MP:0004957,abnormal blastocyst morphology|MP:0004966,abnormal inner cell mass proliferation|MP:0011092,embryonic lethality, complete penetrance|MP:0014693,abnormal cell nucleus size
MGI:3775062	Espl1<tm2Pzg>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0004024,aneuploidy|MP:0004046,abnormal mitosis|MP:0004760,increased mitotic index|MP:0006207,embryonic lethality during organogenesis|MP:0006362,abnormal male germ cell morphology|MP:0006379,abnormal spermatocyte morphology|MP:0008393,absent primordial germ cells|MP:0011411,abnormal gonadal ridge morphology|MP:0014619,absent spermatogonia|MP:0014633,decreased spermatid number|MP:0030934,decreased primordial germ cell proliferation|MP:0030943,abnormal centrosome morphology
MGI:1856573	Espn<je>	MP:0000026,abnormal inner ear morphology|MP:0000034,abnormal inner ear vestibule morphology|MP:0000042,abnormal organ of Corti morphology|MP:0000043,organ of Corti degeneration|MP:0000048,abnormal stria vascularis morphology|MP:0000745,tremors|MP:0001382,abnormal nursing|MP:0001388,abnormal stationary movement|MP:0001392,abnormal locomotor behavior|MP:0001394,circling|MP:0001395,bidirectional circling|MP:0001406,abnormal gait|MP:0001442,decreased grooming behavior|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0001961,abnormal reflex|MP:0001967,deafness|MP:0002622,abnormal cochlear hair cell morphology|MP:0002630,abnormal endocochlear potential|MP:0002730,head shaking|MP:0002757,decreased vertical activity|MP:0002855,abnormal cochlear ganglion morphology|MP:0002857,cochlear ganglion degeneration|MP:0002895,abnormal otolithic membrane morphology|MP:0003107,abnormal response to novelty|MP:0003149,abnormal tectorial membrane morphology|MP:0003150,detached tectorial membrane|MP:0003866,abnormal defecation|MP:0003878,abnormal ear physiology|MP:0004324,vestibular hair cell degeneration|MP:0004331,vestibular saccular macula degeneration|MP:0004333,abnormal utricular macula morphology|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004409,abnormal crista ampullaris neuroepithelium morphology|MP:0004413,absent cochlear microphonics|MP:0004416,absent cochlear nerve compound action potential|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004523,decreased cochlear hair cell stereocilia number|MP:0004524,short cochlear hair cell stereocilia|MP:0004525,thin cochlear hair cell stereocilia|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004586,pillar cell degeneration|MP:0004742,abnormal vestibular system physiology|MP:0004813,absent linear vestibular evoked potential|MP:0004814,reduced linear vestibular evoked potential|MP:0006335,abnormal hearing electrophysiology|MP:0010323,retropulsion|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:7581062	Espnl<em1Pgg>	MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0005377,hearing/vestibular/ear phenotype|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:7581066	Espnl<em2Pgg>	MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5554914	Espnl<tm1b(KOMP)Wtsi>	MP:0004738,abnormal auditory brainstem response|MP:0005633,increased circulating sodium level|MP:0010052,increased grip strength
MGI:4431731	Espn<tm1a(EUCOMM)Wtsi>	MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0006358,absent pinna reflex
MGI:7581076	Espn<tm1Pgg>	MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004519,thin vestibular hair cell stereocilia|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0005377,hearing/vestibular/ear phenotype
MGI:3512201	Espq1<M16i>	MP:0010769,abnormal survival
MGI:3512207	Espq2<M16i>	MP:0010769,abnormal survival
MGI:3512237	Espq3<M16i>	MP:0010769,abnormal survival
MGI:3512211	Espq4<M16i>	MP:0010769,abnormal survival
MGI:5559339	Esr1<tm1.1(cre)And>	MP:0001353,increased aggression towards mice|MP:0001360,abnormal social investigation|MP:0003863,decreased aggression towards mice
MGI:5433576	Esr1<tm1.1Gust>	MP:0000628,abnormal mammary gland development|MP:0001121,uterus hypoplasia|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001260,increased body weight|MP:0001261,obese|MP:0001925,male infertility|MP:0001926,female infertility|MP:0004834,ovary hemorrhage|MP:0005559,increased circulating glucose level|MP:0014604,hemorrhagic ovary cyst
MGI:5574591	Esr1<tm1.1Ics>	MP:0001126,abnormal ovary morphology|MP:0001134,absent corpus luteum|MP:0001613,abnormal vasodilation|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001926,female infertility|MP:0003091,abnormal cell migration|MP:0004003,abnormal vascular endothelial cell physiology|MP:0004834,ovary hemorrhage|MP:0005185,decreased circulating progesterone level|MP:0005389,reproductive system phenotype|MP:0009363,abnormal tertiary ovarian follicle morphology|MP:0009444,ovarian follicular cyst|MP:0011121,decreased primordial ovarian follicle number
MGI:2388616	Esr1<tm1.1Lja>	MP:0000135,decreased compact bone thickness|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001126,abnormal ovary morphology|MP:0001134,absent corpus luteum|MP:0001926,female infertility|MP:0003109,short femur|MP:0003355,decreased ovulation rate|MP:0003795,abnormal bone structure|MP:0004016,decreased bone mass|MP:0004904,increased uterus weight|MP:0004906,enlarged uterus|MP:0005185,decreased circulating progesterone level|MP:0009082,uterus cyst|MP:0009092,endometrium hyperplasia|MP:0009251,enlarged endometrial glands|MP:0009363,abnormal tertiary ovarian follicle morphology|MP:0009671,abnormal uterus physiology|MP:0010968,decreased compact bone area|MP:0013615,increased volumetric bone mineral density|MP:0013616,decreased volumetric bone mineral density|MP:0013618,decreased areal bone mineral density
MGI:2386760	Esr1<tm1.1Mma>	MP:0001121,uterus hypoplasia|MP:0001126,abnormal ovary morphology|MP:0001130,abnormal ovarian folliculogenesis|MP:0001134,absent corpus luteum|MP:0001261,obese|MP:0001533,abnormal skeleton physiology|MP:0001613,abnormal vasodilation|MP:0001751,increased circulating luteinizing hormone level|MP:0001926,female infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002490,abnormal immunoglobulin level|MP:0002757,decreased vertical activity|MP:0002781,increased circulating testosterone level|MP:0002896,abnormal bone mineralization|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003763,abnormal thymus physiology|MP:0004901,decreased male germ cell number|MP:0004905,decreased uterus weight|MP:0005182,increased circulating estradiol level|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0006416,abnormal rete testis morphology|MP:0008984,vagina hypoplasia|MP:0009009,absent estrous cycle|MP:0009278,abnormal bone marrow cell physiology|MP:0009444,ovarian follicular cyst|MP:0013615,increased volumetric bone mineral density|MP:0013616,decreased volumetric bone mineral density|MP:0031239,increased atretic ovarian follicle number
MGI:4950046	Esr1<tm1.1Ohl>	MP:0001533,abnormal skeleton physiology|MP:0001751,increased circulating luteinizing hormone level|MP:0002490,abnormal immunoglobulin level|MP:0002781,increased circulating testosterone level|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003763,abnormal thymus physiology|MP:0005182,increased circulating estradiol level|MP:0005385,cardiovascular system phenotype|MP:0009278,abnormal bone marrow cell physiology
MGI:4829939	Esr1<tm1.1Pws>	MP:0002160,abnormal reproductive system morphology|MP:0004883,abnormal vascular wound healing
MGI:4430564	Esr1<tm1.1Scma>	MP:0000130,abnormal trabecular bone morphology|MP:0001541,abnormal osteoclast physiology|MP:0002113,abnormal skeleton development|MP:0004984,increased osteoclast cell number|MP:0010962,decreased compact bone mass
MGI:3842664	Esr1<tm1.2Awo>	MP:0001131,abnormal ovarian follicle morphology|MP:0001134,absent corpus luteum|MP:0001751,increased circulating luteinizing hormone level|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0001935,decreased litter size|MP:0002016,ovary cyst|MP:0002680,decreased corpora lutea number|MP:0002773,decreased circulating luteinizing hormone level|MP:0003969,abnormal luteinizing hormone level|MP:0005182,increased circulating estradiol level|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0008335,decreased gonadotroph cell number|MP:0008994,early vaginal opening|MP:0009011,prolonged diestrus|MP:0009444,ovarian follicular cyst
MGI:3775510	Esr1<tm1.2Mma>	MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0002680,decreased corpora lutea number|MP:0002773,decreased circulating luteinizing hormone level|MP:0002781,increased circulating testosterone level|MP:0004834,ovary hemorrhage|MP:0004902,abnormal uterus size|MP:0008334,increased gonadotroph cell number|MP:0008871,abnormal ovarian follicle number|MP:0008995,early reproductive senescence|MP:0009011,prolonged diestrus|MP:0009093,oocyte degeneration|MP:0009365,abnormal theca cell layer morphology|MP:0009371,increased theca cell number|MP:0009444,ovarian follicular cyst|MP:0009662,abnormal uterine receptivity|MP:0014604,hemorrhagic ovary cyst|MP:0031420,decreased superovulation rate
MGI:3833893	Esr1<tm1Arnal>	MP:0001533,abnormal skeleton physiology|MP:0001751,increased circulating luteinizing hormone level|MP:0001924,infertility|MP:0002490,abnormal immunoglobulin level|MP:0002781,increased circulating testosterone level|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004984,increased osteoclast cell number|MP:0005182,increased circulating estradiol level
MGI:3795228	Esr1<tm1Geog>	MP:0000628,abnormal mammary gland development|MP:0001120,abnormal uterus morphology|MP:0001121,uterus hypoplasia|MP:0001134,absent corpus luteum|MP:0001139,abnormal vagina morphology|MP:0001260,increased body weight|MP:0001264,increased body size|MP:0001751,increased circulating luteinizing hormone level|MP:0001926,female infertility|MP:0002637,small uterus|MP:0002781,increased circulating testosterone level|MP:0003357,impaired granulosa cell differentiation|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005182,increased circulating estradiol level|MP:0008869,anovulation|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008984,vagina hypoplasia|MP:0009285,increased gonadal fat pad weight|MP:0009296,increased mammary fat pad weight|MP:0009371,increased theca cell number|MP:0009444,ovarian follicular cyst|MP:0011128,increased tertiary ovarian follicle number
MGI:3696669	Esr1<tm1Gsc>	MP:0001123,dilated uterus|MP:0001126,abnormal ovary morphology|MP:0001134,absent corpus luteum|MP:0001926,female infertility|MP:0003631,nervous system phenotype|MP:0003969,abnormal luteinizing hormone level|MP:0004896,abnormal endometrium morphology|MP:0009097,absent endometrial glands|MP:0009359,endometrium atrophy|MP:0009365,abnormal theca cell layer morphology|MP:0011128,increased tertiary ovarian follicle number
MGI:2150897	Esr1<tm1Ksk>	MP:0000008,increased white adipose tissue amount|MP:0000137,abnormal vertebrae morphology|MP:0000172,abnormal bone marrow cell number|MP:0000242,impaired fertilization|MP:0000523,cortical renal glomerulopathies|MP:0000628,abnormal mammary gland development|MP:0000715,decreased thymocyte number|MP:0000837,abnormal hypothalamus morphology|MP:0001120,abnormal uterus morphology|MP:0001121,uterus hypoplasia|MP:0001126,abnormal ovary morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001134,absent corpus luteum|MP:0001140,abnormal vagina epithelium morphology|MP:0001146,abnormal testis morphology|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001258,decreased body length|MP:0001260,increased body weight|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001356,increased aggression towards female mice|MP:0001376,abnormal mating receptivity|MP:0001380,decreased male mating frequency|MP:0001384,abnormal pup retrieval|MP:0001385,pup cannibalization|MP:0001386,abnormal maternal nurturing|MP:0001399,hyperactivity|MP:0001556,increased circulating HDL cholesterol level|MP:0001728,failure of embryo implantation|MP:0001823,thymus hypoplasia|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002113,abnormal skeleton development|MP:0002123,abnormal definitive hematopoiesis|MP:0002136,abnormal kidney physiology|MP:0002144,abnormal B cell differentiation|MP:0002184,abnormal innervation|MP:0002216,abnormal seminiferous tubule morphology|MP:0002458,abnormal B cell number|MP:0002490,abnormal immunoglobulin level|MP:0002574,increased vertical activity|MP:0002631,abnormal epididymis morphology|MP:0002637,small uterus|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002736,abnormal nociception after inflammation|MP:0002743,glomerulonephritis|MP:0002764,short tibia|MP:0002780,decreased circulating testosterone level|MP:0002781,increased circulating testosterone level|MP:0002834,decreased heart weight|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003698,abnormal male reproductive system physiology|MP:0003699,abnormal female reproductive system physiology|MP:0003763,abnormal thymus physiology|MP:0003862,decreased aggression towards male mice|MP:0004000,impaired passive avoidance behavior|MP:0004359,short ulna|MP:0004484,abnormal response of heart to induced stress|MP:0004686,decreased length of long bones|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004728,abnormal efferent ductules of testis morphology|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004816,abnormal class switch recombination|MP:0004834,ovary hemorrhage|MP:0004850,abnormal testis weight|MP:0004852,decreased testis weight|MP:0004890,decreased energy expenditure|MP:0004896,abnormal endometrium morphology|MP:0004905,decreased uterus weight|MP:0004933,abnormal epididymis epithelium morphology|MP:0004956,decreased thymus weight|MP:0004989,decreased osteoblast cell number|MP:0004991,decreased bone strength|MP:0005017,decreased B cell number|MP:0005091,increased double-positive T cell number|MP:0005121,decreased circulating prolactin level|MP:0005178,increased circulating cholesterol level|MP:0005181,decreased circulating estradiol level|MP:0005182,increased circulating estradiol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005375,adipose tissue phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype|MP:0005397,hematopoietic system phenotype|MP:0005498,hyporesponsive to tactile stimuli|MP:0005559,increased circulating glucose level|MP:0005578,teratozoospermia|MP:0005631,decreased lung weight|MP:0005646,abnormal pituitary gland physiology|MP:0005656,decreased aggression|MP:0005669,increased circulating leptin level|MP:0006396,decreased long bone epiphyseal plate size|MP:0006423,dilated rete testis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008097,increased plasma cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008332,decreased lactotroph cell number|MP:0008481,increased spleen germinal center number|MP:0008487,abnormal mesonephros morphology|MP:0008502,increased IgG3 level|MP:0008737,abnormal spleen physiology|MP:0008828,abnormal lymph node cell ratio|MP:0008869,anovulation|MP:0008872,abnormal physiological response to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008893,detached sperm flagellum|MP:0009118,increased white fat cell size|MP:0009130,increased white fat cell number|MP:0009140,dilated efferent ductule of testis|MP:0009205,abnormal internal male genitalia morphology|MP:0009257,dilated seminiferous tubule|MP:0009285,increased gonadal fat pad weight|MP:0009288,increased epididymal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009300,increased parametrial fat pad weight|MP:0009302,increased renal fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0009444,ovarian follicular cyst|MP:0009674,decreased birth weight|MP:0009780,abnormal chondrocyte physiology|MP:0009824,spermatic granuloma|MP:0009856,failure of ejaculation|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010967,increased compact bone area|MP:0010968,decreased compact bone area|MP:0011294,renal glomerulus hypertrophy|MP:0011353,expanded mesangial matrix|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0011833,abnormal cremaster muscle morphology|MP:0013618,decreased areal bone mineral density|MP:0020010,decreased bone mineral density of femur|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization|MP:0020519,renal glomerular immunoglobulin deposits|MP:0021182,decreased femoral compact bone area|MP:0030985,decreased circulating osteocalcin level|MP:0031422,failure of superovulation|MP:0031436,decreased copulatory plug deposition|MP:0031628,abnormal intromission
MGI:2386759	Esr1<tm1Mma>	MP:0000066,osteoporosis|MP:0001541,abnormal osteoclast physiology|MP:0004984,increased osteoclast cell number|MP:0004992,increased bone resorption|MP:0020010,decreased bone mineral density of femur|MP:0020039,increased bone ossification|MP:0020080,increased bone mineralization
MGI:4459300	Esr1<tm1Sakh>	MP:0000627,abnormal mammary gland morphology|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001882,abnormal lactation|MP:0009506,abnormal mammary gland alveolus morphology
MGI:3839670	Esr1<tm1Syeh>	MP:0001119,abnormal female reproductive system morphology|MP:0001121,uterus hypoplasia|MP:0001126,abnormal ovary morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001134,absent corpus luteum|MP:0001145,abnormal male reproductive system morphology|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001261,obese|MP:0001919,abnormal reproductive system physiology|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002687,oligozoospermia|MP:0002781,increased circulating testosterone level|MP:0003607,abnormal prostate gland physiology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0008256,abnormal myometrium morphology|MP:0008868,abnormal granulosa cell morphology|MP:0008984,vagina hypoplasia|MP:0009736,abnormal prostate gland branching morphogenesis|MP:0010024,increased total body fat amount|MP:0011121,decreased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number|MP:0014604,hemorrhagic ovary cyst|MP:0031239,increased atretic ovarian follicle number
MGI:5605085	Esr1<tm2.1(cre)And>	MP:0002169,no abnormal phenotype detected
MGI:4361324	Esr1<tm2.1Gsc>	MP:0000628,abnormal mammary gland development|MP:0001926,female infertility|MP:0002637,small uterus|MP:0004834,ovary hemorrhage
MGI:2385778	Esr1<tm2Ksk>	MP:0001751,increased circulating luteinizing hormone level
MGI:5301452	Esr1<tm3.1Ksk>	MP:0000628,abnormal mammary gland development|MP:0001121,uterus hypoplasia|MP:0001131,abnormal ovarian follicle morphology|MP:0001134,absent corpus luteum|MP:0002637,small uterus|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005133,increased luteinizing hormone level|MP:0005182,increased circulating estradiol level|MP:0009009,absent estrous cycle|MP:0009082,uterus cyst|MP:0009096,decreased endometrial gland number|MP:0011121,decreased primordial ovarian follicle number
MGI:5465426	Esr1<tm4.2Ksk>	MP:0000062,increased bone mineral density|MP:0000628,abnormal mammary gland development|MP:0001260,increased body weight|MP:0001751,increased circulating luteinizing hormone level|MP:0002781,increased circulating testosterone level|MP:0002865,increased growth rate|MP:0003572,abnormal uterus development|MP:0005378,growth/size/body region phenotype|MP:0010024,increased total body fat amount
MGI:6192684	Esr1<tm5.1Ksk>	MP:0001120,abnormal uterus morphology|MP:0001121,uterus hypoplasia|MP:0001134,absent corpus luteum|MP:0001924,infertility|MP:0003205,testicular atrophy
MGI:5751115	Esr2<tm1.1Gust>	MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001926,female infertility|MP:0005389,reproductive system phenotype|MP:0008869,anovulation|MP:0009363,abnormal tertiary ovarian follicle morphology|MP:0031239,increased atretic ovarian follicle number|MP:0031383,increased secondary ovarian follicle number
MGI:5604770	Esr2<tm1.1Ksk>	MP:0001923,reduced female fertility|MP:0003355,decreased ovulation rate|MP:0031422,failure of superovulation
MGI:3775924	Esr2<tm1.1Pcn>	MP:0002908,delayed wound healing
MGI:3775925	Esr2<tm1.2Pcn>	MP:0001925,male infertility|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0002680,decreased corpora lutea number|MP:0003631,nervous system phenotype|MP:0005367,renal/urinary system phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0031239,increased atretic ovarian follicle number|MP:0031422,failure of superovulation
MGI:5427668	Esr2<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:2386761	Esr2<tm1Mma>	MP:0000219,increased neutrophil cell number|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001923,reduced female fertility|MP:0002208,abnormal germ cell morphology|MP:0002680,decreased corpora lutea number|MP:0002757,decreased vertical activity|MP:0002797,increased thigmotaxis|MP:0002908,delayed wound healing|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004149,increased bone strength|MP:0004359,short ulna|MP:0004859,abnormal synaptic plasticity|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype|MP:0008271,abnormal bone ossification|MP:0008532,decreased chemical nociceptive threshold|MP:0010024,increased total body fat amount|MP:0013616,decreased volumetric bone mineral density
MGI:2152217	Esr2<tm1Unc>	MP:0000172,abnormal bone marrow cell number|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000321,increased bone marrow cell number|MP:0000322,increased granulocyte number|MP:0000343,abnormal response to cardiac infarction|MP:0000392,accelerated hair follicle regression|MP:0000479,abnormal enterocyte morphology|MP:0000538,abnormal urinary bladder morphology|MP:0000540,abnormal urinary bladder urothelium morphology|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000694,spleen hypoplasia|MP:0000702,enlarged lymph nodes|MP:0000774,decreased brain size|MP:0000836,abnormal substantia nigra morphology|MP:0000859,abnormal somatosensory cortex morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001167,prostate gland epithelial hyperplasia|MP:0001175,abnormal lung morphology|MP:0001218,thin epidermis|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001354,increased aggression towards male mice|MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001577,anemia|MP:0001625,cardiac hypertrophy|MP:0001751,increased circulating luteinizing hormone level|MP:0001884,mammary gland alveolar hyperplasia|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002182,abnormal astrocyte morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002401,abnormal lymphopoiesis|MP:0002458,abnormal B cell number|MP:0002566,abnormal sexual interaction|MP:0002680,decreased corpora lutea number|MP:0002736,abnormal nociception after inflammation|MP:0002816,colitis|MP:0002833,increased heart weight|MP:0002842,increased systemic arterial blood pressure|MP:0002891,increased insulin sensitivity|MP:0002896,abnormal bone mineralization|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003025,increased vasoconstriction|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003059,decreased insulin secretion|MP:0003131,increased erythrocyte cell number|MP:0003132,increased pre-B cell number|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004145,abnormal muscle electrophysiology|MP:0004348,long femur|MP:0004484,abnormal response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0004702,increased circulating insulin-like growth factor I level|MP:0004738,abnormal auditory brainstem response|MP:0004746,abnormal cochlear IHC afferent innervation pattern|MP:0004782,abnormal surfactant physiology|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0004924,abnormal behavior|MP:0004988,increased osteoblast cell number|MP:0005324,ascites|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype|MP:0005460,abnormal leukopoiesis|MP:0005481,increased chronic myelocytic leukemia incidence|MP:0005498,hyporesponsive to tactile stimuli|MP:0005559,increased circulating glucose level|MP:0005560,decreased circulating glucose level|MP:0005590,increased vasodilation|MP:0005592,abnormal vascular smooth muscle morphology|MP:0005595,abnormal vascular smooth muscle physiology|MP:0005620,abnormal muscle contractility|MP:0005643,decreased dopamine level|MP:0006267,abnormal intercalated disk morphology|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0006270,abnormal mammary gland growth during lactation|MP:0008022,dilated heart ventricle|MP:0008186,increased pro-B cell number|MP:0008254,increased megakaryocyte cell number|MP:0008547,abnormal neocortex morphology|MP:0008859,abnormal hair cycle catagen phase|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008882,abnormal enterocyte physiology|MP:0008883,abnormal enterocyte proliferation|MP:0008948,decreased neuron number|MP:0009171,enlarged pancreatic islets|MP:0009372,abnormal cumulus oophorus morphology|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009580,increased keratinocyte apoptosis|MP:0009646,urinary bladder inflammation|MP:0009648,abnormal superovulation|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010070,decreased serotonin level|MP:0010386,abnormal urinary bladder physiology|MP:0010967,increased compact bone area|MP:0011473,increased urine glycosaminoglycan level|MP:0011747,myelofibrosis|MP:0014234,decreased enterocyte apoptosis|MP:0014730,abnormal myocardial fiber myofibril morphology|MP:0031239,increased atretic ovarian follicle number|MP:0031420,decreased superovulation rate|MP:0031422,failure of superovulation|MP:0031650,decreased mounting behavior
MGI:6276892	Esrp1<em1(IMPC)Mbp>	MP:0000063,decreased bone mineral density|MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0001126,abnormal ovary morphology|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002109,abnormal limb morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0008797,facial cleft|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:4450974	Esrp1<m1Btlr>	MP:0001394,circling|MP:0001399,hyperactivity|MP:0005377,hearing/vestibular/ear phenotype
MGI:5707241	Esrp1<tm1.1Rpc>	MP:0003755,abnormal palate morphology|MP:0004475,palatine bone hypoplasia|MP:0004870,small premaxilla|MP:0009890,cleft secondary palate|MP:0009893,cleft primary palate|MP:0009898,maxillary shelf hypoplasia|MP:0021210,bilateral cleft palate|MP:0031448,bilateral cleft upper lip
MGI:5707244	Esrp1<tm1.2Rpc>	MP:0000111,cleft palate|MP:0005170,cleft upper lip|MP:0005371,limbs/digits/tail phenotype|MP:0006306,abnormal nasal pit morphology|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009888,palatal shelves fail to meet at midline|MP:0009893,cleft primary palate|MP:0009898,maxillary shelf hypoplasia|MP:0009902,abnormal lateral nasal prominence morphology|MP:0009903,abnormal medial nasal prominence morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0013545,cleft hard palate|MP:0013546,cleft soft palate|MP:0021210,bilateral cleft palate|MP:0031448,bilateral cleft upper lip|MP:0031462,decreased palatal shelf size
MGI:6156498	Esrp2<em1(IMPC)Tcp>	MP:0000274,enlarged heart|MP:0000702,enlarged lymph nodes
MGI:4399676	Esrp2<tm1(KOMP)Vlcg>	MP:0000596,abnormal liver development|MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0003893,increased hepatocyte proliferation|MP:0005376,homeostasis/metabolism phenotype|MP:0005419,decreased circulating serum albumin level|MP:0008469,abnormal protein level
MGI:5496789	Esrra<tm1.1Ics>	MP:0000130,abnormal trabecular bone morphology|MP:0001533,abnormal skeleton physiology
MGI:5620908	Esrra<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0002757,decreased vertical activity|MP:0002941,increased circulating alanine transaminase level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010052,increased grip strength|MP:0011954,shortened PQ interval
MGI:3604552	Esrra<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:2682818	Esrra<tm1Vgi>	MP:0000067,osteopetrosis|MP:0000130,abnormal trabecular bone morphology|MP:0000240,extramedullary hematopoiesis|MP:0000333,decreased bone marrow cell number|MP:0000679,increased percent water in carcass|MP:0001262,decreased body weight|MP:0002118,abnormal lipid homeostasis|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0004985,decreased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0004993,decreased bone resorption|MP:0005317,increased triglyceride level|MP:0005376,homeostasis/metabolism phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005666,abnormal adipose tissue physiology|MP:0008396,abnormal osteoclast differentiation|MP:0009124,increased brown fat cell lipid droplet size|MP:0009133,decreased white fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0009338,increased splenocyte number|MP:0010878,increased trabecular bone volume|MP:0010954,abnormal cellular respiration|MP:0011049,impaired adaptive thermogenesis|MP:0011629,decreased mitochondrial number|MP:0014396,decreased fat cell mitochondrial DNA content
MGI:3720481	Esrrb<tm1.1Nat>	MP:0000274,enlarged heart|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0004090,abnormal sarcomere morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005598,decreased heart ventricle muscle contractility|MP:0006138,congestive heart failure|MP:0012557,decreased calcium uptake by cardiac muscle|MP:0012558,increased calcium uptake by cardiac muscle
MGI:3720482	Esrrb<tm1.2Nat>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857422	Esrrb<tm1Vgi>	MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001713,decreased trophoblast giant cell number|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002836,abnormal chorion morphology|MP:0003403,absent placental labyrinth|MP:0003984,embryonic growth retardation|MP:0003988,disorganized embryonic tissue|MP:0005031,abnormal trophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0009593,absent chorion|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012100,absent spongiotrophoblast layer
MGI:3604501	Esrrg<tm1Dgen>	MP:0005604,hyperekplexia|MP:0011085,postnatal lethality, complete penetrance
MGI:3771320	Esrrg<tm1Rev>	MP:0003014,abnormal kidney medulla morphology|MP:0003137,abnormal impulse conducting system conduction|MP:0003233,prolonged QT interval|MP:0004193,abnormal kidney papilla morphology|MP:0004194,abnormal kidney pelvis morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0005325,abnormal renal glomerulus morphology|MP:0009546,absent gastric milk in neonates|MP:0009674,decreased birth weight|MP:0010392,prolonged QRS complex duration|MP:0010570,prolonged ST segment|MP:0010636,bundle branch block|MP:0010955,abnormal respiratory electron transport chain|MP:0011085,postnatal lethality, complete penetrance|MP:0011303,absent kidney papilla|MP:0011628,increased mitochondrial number|MP:0013405,increased circulating lactate level
MGI:5620890	Esrrg<tm1Sjda>	MP:0006325,impaired hearing|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:6376226	Ess2<tm1.1Nbioc>	MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008039,increased NK T cell number|MP:0008050,decreased memory T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008346,increased gamma-delta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:7523171	Ess2<tm1Nbioc>	MP:0011092,embryonic lethality, complete penetrance
MGI:3578544	essa1a	MP:0000266,abnormal heart morphology|MP:0001701,incomplete embryo turning|MP:0001730,embryonic growth arrest|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:3578540	essa99j1	MP:0001701,incomplete embryo turning|MP:0001730,embryonic growth arrest|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:3578546	essam2	MP:0001701,incomplete embryo turning|MP:0001730,embryonic growth arrest|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:3512203	Estoq1<M16i>	MP:0010769,abnormal survival
MGI:3512209	Estoq2<M16i>	MP:0010769,abnormal survival
MGI:3512241	Estoq3<M16i>	MP:0010769,abnormal survival
MGI:3512193	Estoq4<M16i>	MP:0010769,abnormal survival
MGI:2153820	Esx1<tm1Bhr>	MP:0001265,decreased body size|MP:0001712,abnormal placenta development|MP:0003231,abnormal placenta vasculature|MP:0004201,fetal growth retardation|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004920,increased placenta weight|MP:0005031,abnormal trophoblast layer morphology|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0011531,abnormal syncytiotrophoblast morphology|MP:0012108,increased trophoblast glycogen cell number
MGI:7425656	Esyt1<em1(IMPC)Hmgu>	MP:0001406,abnormal gait|MP:0002100,abnormal tooth morphology|MP:0012121,sclerocornea|MP:0012122,abnormal iris transillumination
MGI:3856884	Esyt2<Gt(AN0678)Wtsi>	MP:0005389,reproductive system phenotype|MP:0011805,decreased cell migration
MGI:5605752	Esyt2<tm2b(KOMP)Wtsi>	MP:0000691,enlarged spleen|MP:0011965,decreased total retina thickness
MGI:5548398	Esyt3<tm1b(EUCOMM)Wtsi>	MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level
MGI:5792823	Esyt3<tm1d(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5443915	Et(cre)TFC.09Lois	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype
MGI:7336303	Etfa<em1(IMPC)J>	MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:7425657	Etfb<em1(IMPC)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002833,increased heart weight|MP:0004952,increased spleen weight|MP:0008259,abnormal optic disk morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:6188078	Etfbkmt<em1Yshk>	MP:0005289,increased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0008965,increased basal metabolism|MP:0014173,increased fatty acid beta-oxidation|MP:0020523,decreased susceptibility to induced hypothermia
MGI:5701718	Etfdh<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:7612287	Etfdh<tm1c(EUCOMM)Hmgu>	MP:0000751,myopathy|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001405,impaired coordination|MP:0002106,abnormal muscle physiology|MP:0010959,abnormal oxidative phosphorylation|MP:0011636,disorganized mitochondrial cristae|MP:0014344,abnormal skeletal muscle fiber mitochondrial morphology|MP:0014652,increased skeletal muscle fiber mitochondrial size
MGI:3838184	Ethe1<tm1.1Zev>	MP:0000192,abnormal mineral level|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0005266,abnormal metabolism|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0013405,increased circulating lactate level
MGI:5692653	Ethe1<tm1b(EUCOMM)Wtsi>	MP:0008935,decreased mean platelet volume|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3044656	Ethm1<DBA/2J>	MP:0001777,abnormal body temperature homeostasis
MGI:3044659	Ethm2<C57BL/6J>	MP:0001777,abnormal body temperature homeostasis
MGI:3044661	Ethm3<C57BL/6J>	MP:0001777,abnormal body temperature homeostasis
MGI:3044663	Ethm4<C57BL/6J>	MP:0001777,abnormal body temperature homeostasis
MGI:6404508	Etl4<em1(IMPC)Bay>	MP:0001257,increased body length
MGI:3624626	Etl4<Gt(6LSN)6029Gos>	MP:0000585,kinked tail|MP:0002169,no abnormal phenotype detected|MP:0002759,abnormal caudal vertebrae morphology|MP:0002825,abnormal notochord morphology|MP:0005390,skeleton phenotype
MGI:3624627	Etl4<Gt(pU8)80211Imeg>	MP:0000141,abnormal vertebral body morphology|MP:0000585,kinked tail|MP:0002169,no abnormal phenotype detected|MP:0002759,abnormal caudal vertebrae morphology|MP:0004173,abnormal intervertebral disk morphology|MP:0004683,absent intervertebral disk|MP:0005229,abnormal intervertebral disk development|MP:0006392,abnormal nucleus pulposus morphology
MGI:1857746	Etn2<Sd>	MP:0000071,axial skeleton hypoplasia|MP:0000137,abnormal vertebrae morphology|MP:0000138,absent vertebrae|MP:0000141,abnormal vertebral body morphology|MP:0000161,scoliosis|MP:0000162,lordosis|MP:0000516,abnormal renal/urinary system morphology|MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000592,short tail|MP:0001258,decreased body length|MP:0001539,decreased caudal vertebrae number|MP:0001951,abnormal breathing pattern|MP:0002135,abnormal kidney morphology|MP:0002160,abnormal reproductive system morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0002989,small kidney|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0003054,spina bifida|MP:0003129,persistent cloaca|MP:0003130,anal atresia|MP:0003446,renal hypoplasia|MP:0003456,absent tail|MP:0003604,single kidney|MP:0004173,abnormal intervertebral disk morphology|MP:0004174,abnormal spine curvature|MP:0004608,abnormal cervical axis morphology|MP:0004643,abnormal vertebrae number|MP:0004653,absent caudal vertebrae|MP:0004656,absent sacral vertebrae|MP:0004659,abnormal odontoid process morphology|MP:0004681,intervertebral disk hypoplasia|MP:0004704,short vertebral column|MP:0006392,abnormal nucleus pulposus morphology|MP:0008817,hematoma|MP:0009052,anal stenosis|MP:0009252,absent urinary bladder|MP:0009879,abnormal arcus anterior morphology|MP:0010113,abnormal sacrum morphology|MP:0010730,absent odontoid process|MP:0010819,primary atelectasis|MP:0011087,neonatal lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011788,absent urethra
MGI:5502897	Etn2<tm1Kymm>	MP:0002169,no abnormal phenotype detected
MGI:5502903	Etn2<tm2.1Kymm>	MP:0000585,kinked tail|MP:0000592,short tail|MP:0003130,anal atresia|MP:0003446,renal hypoplasia|MP:0006392,abnormal nucleus pulposus morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:3665247	Etn3<Ppd>	MP:0000428,abnormal craniofacial morphology|MP:0000550,abnormal forelimb morphology|MP:0000572,abnormal autopod morphology|MP:0000585,kinked tail|MP:0001297,microphthalmia|MP:0002051,increased skin papilloma incidence|MP:0002110,abnormal digit morphology|MP:0002113,abnormal skeleton development|MP:0002135,abnormal kidney morphology|MP:0002160,abnormal reproductive system morphology|MP:0003051,curly tail|MP:0005389,reproductive system phenotype|MP:0006279,abnormal limb development|MP:0010768,mortality/aging
MGI:5584119	Etn3<tm1.1Jwi>	MP:0002113,abnormal skeleton development|MP:0006279,abnormal limb development
MGI:5584118	Etn3<tm1Jwi>	MP:0002169,no abnormal phenotype detected
MGI:5584134	Etn3<tm2.1Jwi>	MP:0002113,abnormal skeleton development|MP:0006279,abnormal limb development
MGI:5584131	Etn3<tm2Jwi>	MP:0002169,no abnormal phenotype detected
MGI:5574604	Etnk1<tm1b(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0000689,abnormal spleen morphology
MGI:3526407	Etnk2<tm1Mkar>	MP:0001935,decreased litter size|MP:0003631,nervous system phenotype|MP:0003718,maternal effect|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype
MGI:3823016	Etnk2<tm1Sinc>	MP:0002169,no abnormal phenotype detected
MGI:7425658	Etnppl<em1(IMPC)Hmgu>	MP:0000745,tremors|MP:0002100,abnormal tooth morphology
MGI:6431555	Etnppl<tm1.2Mrl>	MP:0004777,abnormal phospholipid level
MGI:2155059	Etohc1<C57BL/6J>	MP:0001425,abnormal alcohol consumption
MGI:2155061	Etohc2<C57BL/6J>	MP:0001425,abnormal alcohol consumption
MGI:2157399	Etohc3<C57BL/6J>	MP:0001425,abnormal alcohol consumption
MGI:2155093	Etohr<C57BL/6J>	MP:0009755,impaired behavioral response to alcohol
MGI:2155094	Etohr<DBA/2J>	MP:0002629,hyperactivity elicited by ethanol administration
MGI:5563474	Ets1<m1Anu>	MP:0005387,immune system phenotype
MGI:3711457	Ets1<tm1.1Dds>	MP:0000221,decreased leukocyte cell number|MP:0000351,increased cell proliferation|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002356,abnormal spleen red pulp morphology|MP:0002369,abnormal thymus subcapsular epithelium morphology|MP:0002371,abnormal thymus cortex morphology|MP:0002401,abnormal lymphopoiesis|MP:0004953,decreased spleen weight|MP:0004955,increased thymus weight|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005017,decreased B cell number|MP:0005091,increased double-positive T cell number|MP:0008050,decreased memory T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0009322,increased splenocyte apoptosis|MP:0009542,decreased thymocyte apoptosis|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2182735	Ets1<tm1Fwa>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002144,abnormal B cell differentiation|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0005387,immune system phenotype|MP:0008186,increased pro-B cell number|MP:0008203,absent B-1a cells|MP:0008208,decreased pro-B cell number|MP:0008211,decreased mature B cell number|MP:0008782,increased B cell apoptosis|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2182789	Ets1<tm1Jml>	MP:0001823,thymus hypoplasia|MP:0005090,increased double-negative T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation
MGI:7460359	Ets1<tm1Most>	MP:0000284,double outlet right ventricle
MGI:2182780	Ets1<tm2Jml>	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000373,belly spot|MP:0000715,decreased thymocyte number|MP:0001828,abnormal T cell activation|MP:0002442,abnormal leukocyte physiology|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005018,decreased T cell number|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005095,decreased T cell proliferation|MP:0005397,hematopoietic system phenotype|MP:0006126,abnormal cardiac outflow tract development|MP:0008045,decreased NK cell number|MP:0008097,increased plasma cell number|MP:0010428,abnormal heart right ventricle outflow tract morphology|MP:0010484,bicuspid aortic valve|MP:0010766,abnormal NK cell physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0012749,decreased cardiac neural crest cell number
MGI:1856643	Ets1<vs>	MP:0000370,head blaze|MP:0000373,belly spot|MP:0002938,white spotting
MGI:5702953	Ets2<m1Mhda>	MP:0002169,no abnormal phenotype detected
MGI:1891557	Ets2<tm1Rgo>	MP:0000383,abnormal hair follicle orientation|MP:0000399,increased curvature of guard hairs|MP:0000401,increased curvature of awl hairs|MP:0000403,increased curvature of zigzag hairs|MP:0000406,increased curvature of auchene hairs|MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0001698,decreased embryo size|MP:0002086,abnormal extraembryonic tissue morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0005032,abnormal ectoplacental cone morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:2682649	Ets2<tm2Rgo>	MP:0003447,decreased tumor growth/size
MGI:3769393	Ets2<tm3Rgo>	MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0002169,no abnormal phenotype detected|MP:0005031,abnormal trophoblast layer morphology|MP:0010299,increased mammary gland tumor incidence|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:4353393	Ets2<tm5.1Rgo>	MP:0000410,waved hair|MP:0010768,mortality/aging
MGI:4353394	Ets2<tm5.2Rgo>	MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:4838417	Etv1<tm1.1(cre/ERT2)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:2384493	Etv1<tm1Tmj>	MP:0000959,abnormal somatic sensory system morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0000988,abnormal pacinian corpuscle morphology|MP:0000999,abnormal golgi tendon organ morphology|MP:0001000,absent golgi tendon organ|MP:0001052,abnormal innervation pattern to muscle|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001524,impaired limb coordination|MP:0002083,premature death|MP:0002578,impaired ability to fire action potentials|MP:0003993,abnormal ventral spinal root morphology|MP:0004069,abnormal muscle spindle morphology|MP:0005403,abnormal nerve conduction|MP:0008485,increased muscle spindle number|MP:0030996,decreased pacinian corpuscle number|MP:0030998,small pacinian corpuscles
MGI:2663693	Etv1<tm1Wds>	MP:0000966,decreased sensory neuron number
MGI:2384496	Etv1<tm2Tmj>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0000966,decreased sensory neuron number|MP:0000968,abnormal sensory neuron innervation pattern|MP:0000988,abnormal pacinian corpuscle morphology|MP:0000999,abnormal golgi tendon organ morphology|MP:0001000,absent golgi tendon organ|MP:0001052,abnormal innervation pattern to muscle|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001524,impaired limb coordination|MP:0002083,premature death|MP:0002961,abnormal axon guidance|MP:0003993,abnormal ventral spinal root morphology|MP:0004069,abnormal muscle spindle morphology|MP:0008485,increased muscle spindle number|MP:0030996,decreased pacinian corpuscle number
MGI:3830713	Etv2<Gt(141.1H7)Cmhd>	MP:0000259,abnormal vascular development|MP:0000267,abnormal heart development|MP:0002085,abnormal embryonic tissue morphology|MP:0003984,embryonic growth retardation|MP:0004086,absent heartbeat|MP:0004787,abnormal dorsal aorta morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4415819	Etv2<tm1Dlim>	MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001719,absent vitelline blood vessels|MP:0001721,absent visceral yolk sac blood islands|MP:0001722,pale yolk sac|MP:0003984,embryonic growth retardation|MP:0004229,abnormal embryonic erythropoiesis|MP:0004810,decreased hematopoietic stem cell number|MP:0005385,cardiovascular system phenotype|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5474866	Etv2<tm1Vkou>	MP:0000215,absent erythrocytes|MP:0000216,absent erythroid progenitor cell|MP:0002169,no abnormal phenotype detected|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5009241	Etv2<tm2.1Dlim>	MP:0002169,no abnormal phenotype detected
MGI:5475251	Etv2<tm2.1Nshk>	MP:0000260,abnormal angiogenesis|MP:0003229,abnormal vitelline vasculature morphology|MP:0006057,decreased vascular endothelial cell number|MP:0011182,decreased hematopoietic cell number
MGI:6336119	Etv4<em1(IMPC)Kmpc>	MP:0000063,decreased bone mineral density|MP:0001399,hyperactivity|MP:0002059,abnormal seminal vesicle morphology|MP:0002599,increased mean platelet volume|MP:0010124,decreased bone mineral content
MGI:2387770	Etv4<tm1Arbr>	MP:0000520,absent kidney|MP:0000937,abnormal motor neuron morphology|MP:0000939,decreased motor neuron number|MP:0000940,abnormal motor neuron innervation pattern|MP:0000959,abnormal somatic sensory system morphology|MP:0001052,abnormal innervation pattern to muscle|MP:0001524,impaired limb coordination|MP:0003446,renal hypoplasia|MP:0030996,decreased pacinian corpuscle number|MP:0030998,small pacinian corpuscles
MGI:2445834	Etv4<tm1Hass>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0001378,abnormal ejaculation|MP:0001925,male infertility|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype
MGI:5563470	Etv5<sco>	MP:0000562,polydactyly|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002135,abnormal kidney morphology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3849049	Etv5<tm1.2Xsun>	MP:0000562,polydactyly
MGI:4415294	Etv5<tm1Hass>	MP:0011092,embryonic lethality, complete penetrance
MGI:3589421	Etv5<tm1Kmm>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0002243,abnormal vomeronasal organ morphology|MP:0002566,abnormal sexual interaction|MP:0002675,asthenozoospermia|MP:0002685,abnormal spermatogonia proliferation|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0006379,abnormal spermatocyte morphology|MP:0014052,increased male germ cell apoptosis|MP:0014617,decreased spermatogonia number|MP:0014619,absent spermatogonia|MP:0014684,impaired spermiation
MGI:6257614	Etv6<em1(IMPC)Rbrc>	MP:0000063,decreased bone mineral density|MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000277,abnormal heart shape|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0003917,increased kidney weight|MP:0004857,abnormal heart weight|MP:0004952,increased spleen weight|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0008725,increased heart atrium size|MP:0008821,increased blood uric acid level|MP:0011100,preweaning lethality, complete penetrance|MP:0012362,increased large unstained cell number
MGI:7568839	Etv6<em3Knic>	MP:0002458,abnormal B cell number|MP:0003405,abnormal platelet shape|MP:0005397,hematopoietic system phenotype|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0013693,abnormal hemopoiesis|MP:0013707,abnormal hematopoietic precursor cell morphology|MP:0020215,impaired blood coagulation
MGI:5284820	Etv6<tm1.1(RUNX1,hsb5)Lvdw>	MP:0002026,increased leukemia incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4355899	Etv6<tm1(RUNX1)Haho>	MP:0000222,decreased neutrophil cell number|MP:0001732,postnatal growth retardation|MP:0001802,arrested B cell differentiation|MP:0002006,neoplasm|MP:0002026,increased leukemia incidence|MP:0002082,postnatal lethality|MP:0002123,abnormal definitive hematopoiesis|MP:0002144,abnormal B cell differentiation|MP:0002401,abnormal lymphopoiesis|MP:0002414,abnormal myeloblast morphology/development|MP:0003179,thrombocytopenia|MP:0003288,intestinal edema|MP:0004499,increased incidence of tumors by chemical induction|MP:0004809,increased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005380,embryo phenotype|MP:0005387,immune system phenotype|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008973,decreased erythroid progenitor cell number|MP:0009278,abnormal bone marrow cell physiology|MP:0010373,myeloid hyperplasia|MP:0011091,prenatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:2177950	Etv6<tm1Sho>	MP:0000291,enlarged pericardium|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0003984,embryonic growth retardation|MP:0005380,embryo phenotype|MP:0005385,cardiovascular system phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3056143	Etv6<tm2.1Sho>	MP:0000245,abnormal erythropoiesis|MP:0001719,absent vitelline blood vessels|MP:0011091,prenatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3056142	Etv6<tm2Sho>	MP:0000222,decreased neutrophil cell number|MP:0000229,abnormal megakaryocyte differentiation|MP:0002169,no abnormal phenotype detected|MP:0003179,thrombocytopenia
MGI:3772780	Etv6<tm3(NTRK3)Sho>	MP:0001884,mammary gland alveolar hyperplasia|MP:0002083,premature death|MP:0005481,increased chronic myelocytic leukemia incidence|MP:0010299,increased mammary gland tumor incidence
MGI:6377661	Eva1a<em1(IMPC)J>	MP:0010392,prolonged QRS complex duration
MGI:6514805	Eva1a<tm1Nju>	MP:0008415,abnormal neurite morphology|MP:0012204,abnormal neuronal stem cell physiology|MP:0012207,decreased neuronal stem cell self-renewal|MP:0030940,impaired autophagy
MGI:5006998	Eva1c<tm1Lex>	MP:0002638,abnormal pupillary reflex
MGI:6276864	Evc2<em1(IMPC)Mbp>	MP:0000443,abnormal snout morphology|MP:0000494,abnormal cecum morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001120,abnormal uterus morphology|MP:0001258,decreased body length|MP:0001325,abnormal retina morphology|MP:0002060,abnormal skin morphology|MP:0005084,abnormal gallbladder morphology|MP:0005566,decreased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0006203,eye hemorrhage|MP:0009142,decreased prepulse inhibition|MP:0009709,hydrometra|MP:0010053,decreased grip strength|MP:0030610,absent teeth
MGI:5697353	Evc2<tm1.1Mis>	MP:0000433,microcephaly|MP:0000547,short limbs|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002427,disproportionate dwarf|MP:0002764,short tibia|MP:0002765,short fibula|MP:0003109,short femur|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0005352,small cranium|MP:0008489,slow postnatal weight gain|MP:0010124,decreased bone mineral content|MP:0010879,decreased trabecular bone volume|MP:0011110,preweaning lethality, incomplete penetrance|MP:0030081,small upper incisors
MGI:5439465	Evc2<tm1.1Vlrp>	MP:0000547,short limbs|MP:0002764,short tibia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004355,short radius|MP:0004672,short ribs|MP:0009780,abnormal chondrocyte physiology|MP:0010029,abnormal basicranium morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011711,impaired osteoblast differentiation
MGI:5697358	Evc2<tm2.1Mis>	MP:0000116,abnormal tooth development|MP:0002427,disproportionate dwarf|MP:0002650,abnormal ameloblast morphology|MP:0002764,short tibia|MP:0002765,short fibula|MP:0003109,short femur|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype|MP:0010768,mortality/aging|MP:0030089,short lower incisors|MP:0030090,short upper incisors
MGI:5697356	Evc2<tm2Mis>	MP:0002169,no abnormal phenotype detected
MGI:3721399	Evc<tm1Jago>	MP:0000060,delayed bone ossification|MP:0000079,abnormal basioccipital bone morphology|MP:0000547,short limbs|MP:0000558,abnormal tibia morphology|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001438,aphagia|MP:0001924,infertility|MP:0002100,abnormal tooth morphology|MP:0002689,abnormal molar morphology|MP:0002764,short tibia|MP:0003109,short femur|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004604,abnormal vertebral pedicle morphology|MP:0004672,short ribs|MP:0004686,decreased length of long bones|MP:0005358,abnormal incisor morphology|MP:0010099,abnormal thoracic cage shape|MP:0010103,small thoracic cage|MP:0011085,postnatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0014107,premature chondrocyte differentiation|MP:0030876,abnormal costochondral joint morphology
MGI:5695907	Evi2b<tm1.1(KOMP)Vlcg>	MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney
MGI:4458636	Evi5<tm1a(KOMP)Wtsi>	MP:0013278,decreased fasting circulating glucose level
MGI:5560907	Evl<b2b2600Clo>	MP:0000284,double outlet right ventricle|MP:0004056,abnormal myocardium compact layer morphology|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5548406	Evl<tm1b(KOMP)Wtsi>	MP:0005505,thrombocytosis|MP:0013279,increased fasting circulating glucose level
MGI:3764986	Evl<tm1Fbg>	MP:0002169,no abnormal phenotype detected
MGI:3521919	Evl<tm1Lfr>	MP:0003156,abnormal leukocyte migration
MGI:2387422	Evpl<tm1Fmw>	MP:0009594,abnormal corneocyte envelope morphology
MGI:3851189	Evta	MP:0002938,white spotting
MGI:7424832	Evx1os<em1Shx>	MP:0002169,no abnormal phenotype detected
MGI:2182858	Evx1<tm1.1Gld>	MP:0003631,nervous system phenotype|MP:0021102,abnormal ventral interneuron 0 morphology
MGI:2177782	Evx1<tm1Mrc>	MP:0002085,abnormal embryonic tissue morphology|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012102,absent trophectoderm
MGI:4850026	Evx2/Hoxd13<tm5.1(Hoxd11/lacZ)Ddu>	MP:0000550,abnormal forelimb morphology|MP:0000554,abnormal carpal bone morphology|MP:0002544,brachydactyly|MP:0004355,short radius|MP:0004359,short ulna|MP:0004361,bowed ulna|MP:0004374,bowed radius
MGI:4850027	Evx2/Hoxd13<tm5.1(Hoxd11/lacZ)Ddu>	MP:0000550,abnormal forelimb morphology|MP:0000554,abnormal carpal bone morphology|MP:0002544,brachydactyly|MP:0004355,short radius|MP:0004359,short ulna|MP:0004361,bowed ulna|MP:0004374,bowed radius
MGI:4850021	Evx2/Hoxd13<tm5(Hoxd11/lacZ)Ddu>	MP:0002543,brachyphalangia|MP:0002544,brachydactyly
MGI:4850024	Evx2/Hoxd13<tm5(Hoxd11/lacZ)Ddu>	MP:0002543,brachyphalangia|MP:0002544,brachydactyly
MGI:2445967	Evx2<tm1Ddu>	MP:0000547,short limbs|MP:0000554,abnormal carpal bone morphology|MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0002110,abnormal digit morphology|MP:0002543,brachyphalangia|MP:0003073,abnormal metacarpal bone morphology|MP:0004634,short metacarpal bones|MP:0005306,abnormal phalanx morphology
MGI:5513772	Ewsr1<tm1b(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0001399,hyperactivity|MP:0001785,edema|MP:0002764,short tibia|MP:0002968,increased circulating alkaline phosphatase level|MP:0005013,increased lymphocyte cell number|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:3584017	Ewsr1<tm1(ERG)Thr>	MP:0002024,increased T cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0005013,increased lymphocyte cell number
MGI:3713772	Ewsr1<tm1Sblee>	MP:0000063,decreased bone mineral density|MP:0000160,kyphosis|MP:0000221,decreased leukocyte cell number|MP:0000694,spleen hypoplasia|MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001658,increased mortality induced by gamma-irradiation|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002169,no abnormal phenotype detected|MP:0002269,muscular atrophy|MP:0005092,decreased double-positive T cell number|MP:0005169,abnormal male meiosis|MP:0006379,abnormal spermatocyte morphology|MP:0006380,abnormal spermatid morphology|MP:0008008,early cellular replicative senescence|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008843,absent subcutaneous adipose tissue|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014633,decreased spermatid number|MP:0014693,abnormal cell nucleus size
MGI:4429147	Ewsr1<tm2(FLI1*)Sblee>	MP:0002083,premature death|MP:0004153,increased renal tubule apoptosis|MP:0013501,increased fibroblast apoptosis
MGI:3615635	Exa<BALB/cBy>	MP:0001417,decreased exploration in new environment
MGI:3576028	excph	MP:0000914,exencephaly
MGI:6120806	Exd1<tm1b(EUCOMM)Hmgu>	MP:0002833,increased heart weight|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:5781095	Exd1<tm1Embrp>	MP:0010768,mortality/aging|MP:0020362,abnormal male germ cell physiology
MGI:7738844	Exd2<em1Embrp>	MP:0005389,reproductive system phenotype
MGI:2389275	Exen1<SELH/Bc>	MP:0000914,exencephaly
MGI:1856601	exf	MP:0000367,abnormal coat/ hair morphology|MP:0000417,short hair|MP:0000418,focal hair loss|MP:0001192,scaly skin|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001412,excessive scratching|MP:0001852,conjunctivitis|MP:0001874,acanthosis|MP:0002073,abnormal hair growth|MP:0002074,abnormal hair texture|MP:0002082,postnatal lethality|MP:0002412,increased susceptibility to bacterial infection|MP:0003427,parakeratosis|MP:0003815,hairless|MP:0003846,matted coat|MP:0005114,premature hair loss|MP:0006167,eyelid edema|MP:0008489,slow postnatal weight gain|MP:0008770,decreased survivor rate|MP:0009473,abnormal skin exfoliation|MP:0009474,thick epidermis stratum spinosum|MP:0009597,impaired stratum corneum desquamation|MP:0009599,thick epidermis stratum granulosum|MP:0010179,rough coat|MP:0010771,integument phenotype
MGI:2180503	exma	MP:0000372,irregular coat pigmentation|MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0000783,abnormal forebrain morphology|MP:0000914,exencephaly|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001394,circling|MP:0001698,decreased embryo size|MP:0011087,neonatal lethality, complete penetrance
MGI:2653925	Exo1<tm1Wed>	MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005169,abnormal male meiosis|MP:0005431,decreased oocyte number|MP:0008866,chromosomal instability|MP:0008966,abnormal chiasmata formation|MP:0008967,absent chiasmata formation|MP:0009564,abnormal meiotic configurations|MP:0009761,abnormal meiotic spindle morphology|MP:0012431,increased lymphoma incidence|MP:0014052,increased male germ cell apoptosis|MP:0014766,impaired mismatch repair
MGI:5523452	Exo1<tm2Wed>	MP:0001147,small testis|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002687,oligozoospermia|MP:0004815,abnormal somatic hypermutation frequency|MP:0004816,abnormal class switch recombination|MP:0004852,decreased testis weight|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0008280,abnormal male germ cell apoptosis|MP:0009797,abnormal mismatch repair|MP:0010383,increased adenoma incidence|MP:0012431,increased lymphoma incidence|MP:0014764,impaired double-strand DNA break repair
MGI:5523450	Exo1<tm3.1Wed>	MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0010383,increased adenoma incidence|MP:0012431,increased lymphoma incidence|MP:0014764,impaired double-strand DNA break repair
MGI:6723809	Exo5<em1Qsh>	MP:0002687,oligozoospermia
MGI:6158495	Exoc1<em1(IMPC)Mbp>	MP:0001415,increased exploration in new environment|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:4888885	Exoc1<tm1a(EUCOMM)Hmgu>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5909206	Exoc2<em1(IMPC)J>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6278537	Exoc3l2<em1(IMPC)J>	MP:0001697,abnormal embryo size|MP:0002834,decreased heart weight|MP:0002965,increased circulating serum albumin level|MP:0005293,impaired glucose tolerance|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:4363569	Exoc3l2<tm1a(KOMP)Wtsi>	MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0002100,abnormal tooth morphology|MP:0005358,abnormal incisor morphology
MGI:5548646	Exoc3l2<tm1b(KOMP)Wtsi>	MP:0000602,dilated liver sinusoidal space|MP:0001711,abnormal placenta morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0008810,increased circulating iron level|MP:0010912,herniated liver|MP:0011100,preweaning lethality, complete penetrance|MP:0013878,abnormal ductus venosus valve topology
MGI:6294137	Exoc3l4<em1(IMPC)J>	MP:0000266,abnormal heart morphology|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001787,pericardial edema|MP:0003984,embryonic growth retardation|MP:0005031,abnormal trophoblast layer morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012270,cardiac edema
MGI:6406426	Exoc3l<em1(IMPC)J>	MP:0001488,increased startle reflex|MP:0010124,decreased bone mineral content
MGI:7612042	Exoc3l<em1Mema>	MP:0002169,no abnormal phenotype detected
MGI:7612043	Exoc3l<em2Mema>	MP:0002169,no abnormal phenotype detected
MGI:5823225	Exoc3<tm2b(EUCOMM)Hmgu>	MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0013278,decreased fasting circulating glucose level
MGI:6509449	Exoc3<tm2c(EUCOMM)Hmgu>	MP:0002599,increased mean platelet volume|MP:0005048,abnormal thrombosis|MP:0005464,abnormal platelet physiology|MP:0005607,decreased bleeding time|MP:0009549,decreased platelet aggregation|MP:0020965,increased platelet dense granule secretion|MP:0020966,decreased platelet dense granule secretion|MP:0031121,increased susceptibility to induced thrombosis
MGI:5571596	Exoc4<em1(IMPC)J>	MP:0005633,increased circulating sodium level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4975171	Exoc4<Gt(SABetageo4)Sor>	MP:0001680,abnormal mesoderm development|MP:0001698,decreased embryo size|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012105,delayed gastrulation|MP:0012131,small visceral yolk sac|MP:0012142,absent amniotic cavity|MP:0012183,decreased paraxial mesoderm size
MGI:5774863	Exoc5<tm1c(KOMP)Mbp>	MP:0000266,abnormal heart morphology|MP:0000519,hydronephrosis|MP:0000534,abnormal ureter morphology|MP:0001914,hemorrhage|MP:0002705,dilated renal tubule|MP:0003587,ureter obstruction|MP:0003589,abnormal ureter physiology|MP:0003624,anuria|MP:0005367,renal/urinary system phenotype|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011426,abnormal ureter smooth muscle morphology|MP:0011484,abnormal ureter urothelium morphology|MP:0011491,ureteropelvic junction obstruction
MGI:6414561	Exoc6b<em1(IMPC)Hmgu>	MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance
MGI:1856894	Exoc6<hbd>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000248,macrocytosis|MP:0000691,enlarged spleen|MP:0002416,abnormal proerythroblast morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002810,microcytic anemia|MP:0002813,microcytosis|MP:0002814,hyperchromasia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005097,polychromatophilia|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005637,abnormal iron homeostasis|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008387,hypochromic anemia|MP:0008808,decreased spleen iron level|MP:0008810,increased circulating iron level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011188,increased erythrocyte protoporphyrin level|MP:0031084,decreased erythrocyte osmotic fragility
MGI:5692632	Exoc6<tm1b(EUCOMM)Wtsi>	MP:0001399,hyperactivity|MP:0001491,unresponsive to tactile stimuli|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003717,pallor|MP:0005560,decreased circulating glucose level|MP:0009931,abnormal skin appearance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7539664	Exoc7<em1(IMPC)Bay>	MP:0001392,abnormal locomotor behavior|MP:0011100,preweaning lethality, complete penetrance
MGI:7639919	Exoc7<em1Utr>	MP:0005159,azoospermia|MP:0006379,abnormal spermatocyte morphology
MGI:5548744	Exoc8<tm1.1(KOMP)Vlcg>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6455039	Exosc10<em1Dean>	MP:0001125,abnormal oocyte morphology|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0005431,decreased oocyte number|MP:0012128,abnormal blastocyst formation
MGI:5544774	Exosc10<tm1.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:6316601	Exosc1<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0003886,abnormal embryonic epiblast morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011191,increased embryonic epiblast cell apoptosis|MP:0011207,absent ectoplacental cavity|MP:0011209,absent extraembryonic coelom|MP:0012028,abnormal visceral endoderm physiology|MP:0012142,absent amniotic cavity|MP:0014134,abnormal embryo morphology|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance|MP:0014586,decreased egg cylinder size
MGI:6324232	Exosc2<em1(IMPC)J>	MP:0001714,absent trophoblast giant cells|MP:0001728,failure of embryo implantation|MP:0002718,abnormal inner cell mass morphology|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0005028,abnormal trophectoderm morphology|MP:0005266,abnormal metabolism|MP:0009781,abnormal preimplantation embryo development|MP:0011100,preweaning lethality, complete penetrance|MP:0011183,abnormal primitive endoderm morphology|MP:0011189,small embryonic epiblast|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:5695911	Exosc3<tm1.1(KOMP)Vlcg>	MP:0002135,abnormal kidney morphology|MP:0008528,polycystic kidney|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013279,increased fasting circulating glucose level|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5544772	Exosc3<tm2.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:6437048	Exosc7<em1(IMPC)Bay>	MP:0001727,abnormal embryo implantation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:5445928	Exosc8<tm1.1(KOMP)Vlcg>	MP:0002079,increased circulating insulin level|MP:0005561,increased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6120790	Exph5<tm1b(EUCOMM)Wtsi>	MP:0000198,decreased circulating phosphate level|MP:0001364,decreased anxiety-related response|MP:0004924,abnormal behavior|MP:0005554,decreased circulating creatinine level|MP:0005628,decreased circulating potassium level|MP:0020870,decreased thigmotaxis
MGI:6802112	Exph5<tm1Tiz>	MP:0001952,increased airway responsiveness|MP:0002944,increased lactate dehydrogenase level|MP:0003674,oxidative stress|MP:0005466,abnormal T-helper 2 physiology|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008568,abnormal interleukin secretion|MP:0008672,increased interleukin-13 secretion|MP:0008702,increased interleukin-5 secretion
MGI:2157967	Exq1<A/J>	MP:0001417,decreased exploration in new environment|MP:0002906,increased susceptibility to pharmacologically induced seizures
MGI:2157968	Exq1<C57BL/6J>	MP:0000950,abnormal seizure response to pharmacological agent|MP:0001415,increased exploration in new environment
MGI:2156190	Ext1<Gt(LST064)Byg>	MP:0002092,abnormal eye morphology|MP:0002109,abnormal limb morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:4437240	Ext1<tm1.1Vcs>	MP:0002006,neoplasm|MP:0010029,abnormal basicranium morphology|MP:0010079,increased osteochondroma incidence|MP:0030443,abnormal cranial synchondrosis
MGI:4818621	Ext1<tm1.1Yama>	MP:0010079,increased osteochondroma incidence
MGI:4437237	Ext1<tm1.2Vcs>	MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0008762,embryonic lethality|MP:0010768,mortality/aging
MGI:1888710	Ext1<tm1Dews>	MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001698,decreased embryo size|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003988,disorganized embryonic tissue|MP:0005508,abnormal skeleton morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3528880	Ext1<tm1Lex>	MP:0002083,premature death
MGI:3834913	Ext1<tm1Vcs>	MP:0002006,neoplasm|MP:0002169,no abnormal phenotype detected|MP:0010079,increased osteochondroma incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2682061	Ext1<tm1Yama>	MP:0000161,scoliosis|MP:0000163,abnormal cartilage morphology|MP:0000164,abnormal cartilage development|MP:0000428,abnormal craniofacial morphology|MP:0000550,abnormal forelimb morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000850,absent cerebellum|MP:0000913,abnormal brain development|MP:0001255,decreased body height|MP:0001341,absent eyelids|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001409,increased stereotypic behavior|MP:0001447,abnormal nest building behavior|MP:0002092,abnormal eye morphology|MP:0002102,abnormal ear morphology|MP:0002196,absent corpus callosum|MP:0002199,abnormal brain commissure morphology|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002961,abnormal axon guidance|MP:0003451,absent olfactory bulb|MP:0003460,decreased fear-related response|MP:0003635,abnormal synaptic transmission|MP:0003998,decreased thermal nociceptive threshold|MP:0004221,abnormal iridocorneal angle|MP:0004374,bowed radius|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005300,abnormal cornea stroma morphology|MP:0005508,abnormal skeleton morphology|MP:0005543,decreased cornea thickness|MP:0006254,thin cerebral cortex|MP:0006395,abnormal epiphyseal plate morphology|MP:0008161,increased diameter of radius|MP:0008163,increased diameter of ulna|MP:0008223,absent hippocampal commissure|MP:0008227,absent anterior commissure|MP:0009039,absent inferior colliculus|MP:0009877,exostosis|MP:0009890,cleft secondary palate|MP:0009894,absent hard palate|MP:0010079,increased osteochondroma incidence|MP:0010714,iris coloboma|MP:0010719,ciliary body coloboma|MP:0011003,reduced AMPA-mediated synaptic currents|MP:0011087,neonatal lethality, complete penetrance|MP:0012760,decreased cranial neural crest cell proliferation|MP:0020351,decreased vocalization|MP:0030883,dislocated radius head|MP:0031212,decreased eye anterior chamber depth|MP:0031391,increased locomotor activity
MGI:3608690	Ext2<tm1Werb>	MP:0000163,abnormal cartilage morphology|MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002113,abnormal skeleton development|MP:0005390,skeleton phenotype|MP:0005508,abnormal skeleton morphology|MP:0008271,abnormal bone ossification|MP:0009877,exostosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0014586,decreased egg cylinder size
MGI:7641465	Extl1<em1Caox>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001262,decreased body weight|MP:0002135,abnormal kidney morphology|MP:0002376,abnormal dendritic cell physiology|MP:0002461,increased immunoglobulin level|MP:0002493,increased IgG level|MP:0002499,chronic inflammation|MP:0004941,abnormal regulatory T cell morphology|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005087,decreased acute inflammation|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005387,immune system phenotype|MP:0008087,decreased T helper 1 cell number|MP:0008127,decreased dendritic cell number|MP:0008553,increased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level|MP:0008614,increased circulating interleukin-17 level|MP:0008705,increased interleukin-6 secretion|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010219,increased T-helper 17 cell number|MP:0010740,abnormal dendritic cell chemotaxis|MP:0013022,increased Ly6C high monocyte number|MP:0020349,abnormal dendritic cell migration
MGI:5502231	Extl2<tm1Hkit>	MP:0000358,abnormal cell morphology
MGI:6277069	Extl3<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001158,abnormal prostate gland morphology|MP:0001297,microphthalmia|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3844734	Extl3<tm1.1Okam>	MP:0011092,embryonic lethality, complete penetrance
MGI:3621949	Exz1<BALB/c>	MP:0008303,early degeneration of the adrenal gland x-zone
MGI:3621951	Exz2<BALB/c>	MP:0008303,early degeneration of the adrenal gland x-zone
MGI:1856863	ey2	MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology
MGI:2679343	Ey3	MP:0001286,abnormal eye development|MP:0001293,anophthalmia|MP:0001314,cornea opacity|MP:0004222,iris synechia|MP:0011091,prenatal lethality, complete penetrance
MGI:5013381	ey4	MP:0001293,anophthalmia|MP:0001303,abnormal lens morphology|MP:0001312,abnormal cornea morphology
MGI:1857803	Eya1<bor>	MP:0000031,abnormal cochlea morphology|MP:0000044,absent organ of Corti|MP:0001394,circling|MP:0001410,head bobbing|MP:0001926,female infertility|MP:0001967,deafness|MP:0002428,abnormal semicircular canal morphology|MP:0002855,abnormal cochlear ganglion morphology|MP:0003148,decreased cochlea coiling|MP:0003162,decreased lateral semicircular canal size|MP:0003164,decreased posterior semicircular canal size|MP:0003166,decreased superior semicircular canal size|MP:0003446,renal hypoplasia|MP:0003604,single kidney|MP:0004328,decreased vestibular hair cell number|MP:0004395,increased cochlear inner hair cell number|MP:0004401,increased cochlear outer hair cell number|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0004529,decreased outer hair cell stereocilia number|MP:0004922,abnormal common crus morphology|MP:0005565,increased blood urea nitrogen level|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology|MP:0008065,short endolymphatic duct|MP:0008488,abnormal semicircular canal ampulla morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5805682	Eya1<tm1b(EUCOMM)Hmgu>	MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3812010	Eya1<tm1Px>	MP:0002169,no abnormal phenotype detected
MGI:2150426	Eya1<tm1Rilm>	MP:0000026,abnormal inner ear morphology|MP:0000031,abnormal cochlea morphology|MP:0000037,abnormal lateral semicircular canal morphology|MP:0000041,absent endolymphatic duct|MP:0000090,absent premaxilla|MP:0000106,abnormal basisphenoid bone morphology|MP:0000154,rib fusion|MP:0000433,microcephaly|MP:0000438,abnormal cranium morphology|MP:0000454,abnormal jaw morphology|MP:0000460,mandible hypoplasia|MP:0000520,absent kidney|MP:0000680,absent parathyroid glands|MP:0000705,athymia|MP:0000759,abnormal skeletal muscle morphology|MP:0001071,abnormal facial nerve morphology|MP:0001072,abnormal vestibulocochlear nerve morphology|MP:0001082,abnormal geniculate ganglion morphology|MP:0001086,absent petrosal ganglion|MP:0001302,eyelids open at birth|MP:0002260,abnormal thyroid cartilage morphology|MP:0002428,abnormal semicircular canal morphology|MP:0002857,cochlear ganglion degeneration|MP:0002858,abnormal posterior semicircular canal morphology|MP:0002925,abnormal cardiovascular development|MP:0003056,abnormal hyoid bone morphology|MP:0003110,absent malleus processus brevis|MP:0003142,anotia|MP:0003147,absent cochlea|MP:0003148,decreased cochlea coiling|MP:0003164,decreased posterior semicircular canal size|MP:0003166,decreased superior semicircular canal size|MP:0003446,renal hypoplasia|MP:0003499,thyroid gland hypoplasia|MP:0003604,single kidney|MP:0003722,absent ureter|MP:0003740,fusion of middle ear ossicles|MP:0003935,abnormal craniofacial development|MP:0004113,abnormal aortic arch morphology|MP:0004160,retroesophageal right subclavian artery|MP:0004204,absent stapes|MP:0004299,absent vestibular ganglion|MP:0004310,small otic vesicle|MP:0004314,absent inner ear vestibule|MP:0004328,decreased vestibular hair cell number|MP:0004395,increased cochlear inner hair cell number|MP:0004427,abnormal vestibular labyrinth morphology|MP:0004452,abnormal pterygoid process morphology|MP:0004506,abnormal pubis morphology|MP:0004507,abnormal ischium morphology|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0004529,decreased outer hair cell stereocilia number|MP:0004539,absent maxilla|MP:0004620,cervical vertebral fusion|MP:0004739,conductive hearing loss|MP:0005105,abnormal middle ear ossicle morphology|MP:0005106,abnormal incus morphology|MP:0005107,abnormal stapes morphology|MP:0005270,abnormal zygomatic bone morphology|MP:0005272,abnormal temporal bone morphology|MP:0005352,small cranium|MP:0005579,absent outer ear|MP:0006011,abnormal endolymphatic duct morphology|MP:0006018,abnormal tympanic membrane morphology|MP:0006020,decreased tympanic ring size|MP:0006030,abnormal otic vesicle development|MP:0006033,abnormal external auditory canal morphology|MP:0006089,abnormal vestibular saccule morphology|MP:0006285,absent inner ear|MP:0008063,increased otic epithelial cell apoptosis|MP:0008064,decreased otic epithelial cell proliferation|MP:0008065,short endolymphatic duct|MP:0008148,abnormal sternocostal joint morphology|MP:0008488,abnormal semicircular canal ampulla morphology|MP:0009653,abnormal palate development|MP:0009707,absent external auditory canal|MP:0009890,cleft secondary palate|MP:0009895,decreased palatine bone horizontal plate size|MP:0009897,decreased maxillary shelf size|MP:0009914,abnormal hyoid bone lesser horn morphology|MP:0010466,vascular ring|MP:0010978,absent ureteric bud|MP:0011087,neonatal lethality, complete penetrance|MP:0011386,increased metanephric mesenchyme apoptosis|MP:0011659,interrupted aortic arch, type b|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013163,absent thyroid gland isthmus|MP:0013222,abnormal first pharyngeal pouch morphology|MP:0013290,persistent ultimobranchial bodies|MP:0030097,preauricular pit|MP:0030155,absent tympanic cavity|MP:0030161,absent auditory bulla|MP:0030204,large nasal septum
MGI:5316865	Eya1<tm2Px>	MP:0002622,abnormal cochlear hair cell morphology|MP:0004396,decreased cochlear inner hair cell number|MP:0004402,decreased cochlear outer hair cell number
MGI:6276852	Eya2<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology
MGI:7260239	Eya2<tm1Px>	MP:0001485,abnormal pinna reflex|MP:0005377,hearing/vestibular/ear phenotype|MP:0006325,impaired hearing
MGI:7260240	Eya2<tm2Px>	MP:0000706,small thymus|MP:0001485,abnormal pinna reflex|MP:0005377,hearing/vestibular/ear phenotype|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3834107	Eya3<Gt(W096D02)Wrst>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001415,increased exploration in new environment|MP:0003896,prolonged PR interval|MP:0005367,renal/urinary system phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0005586,decreased tidal volume|MP:0010053,decreased grip strength|MP:0010394,decreased QRS amplitude|MP:0010508,abnormal heart electrocardiography waveform feature
MGI:5311638	Eya4<TgTn(Prm1-sb10,sb-Tyr)1739AOve>	MP:0000111,cleft palate|MP:0011087,neonatal lethality, complete penetrance
MGI:5548437	Eya4<tm1b(KOMP)Wtsi>	MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0002768,small adrenal glands|MP:0011100,preweaning lethality, complete penetrance
MGI:3775095	Eya4<tm1Jse>	MP:0001262,decreased body weight|MP:0001850,increased susceptibility to otitis media|MP:0001925,male infertility|MP:0003330,abnormal auditory tube morphology|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004738,abnormal auditory brainstem response|MP:0006018,abnormal tympanic membrane morphology|MP:0009891,abnormal palate bone morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0020900,abnormal middle ear epithelium morphology|MP:0020903,increased middle ear goblet cell number|MP:0030154,abnormal tympanic cavity morphology|MP:0030226,middle ear polyps|MP:0030410,middle ear effusion|MP:0030413,tympanic membrane retraction
MGI:2156116	Eye1<DBA/2J>	MP:0005391,vision/eye phenotype
MGI:2429729	Eye2<DBA/2J>	MP:0002092,abnormal eye morphology
MGI:3038746	eyes1	MP:0001297,microphthalmia
MGI:5002726	eyl2	MP:0001286,abnormal eye development|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001314,cornea opacity|MP:0005193,abnormal anterior eye segment morphology|MP:0031432,cornea perforation
MGI:6359900	eyl5	MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001314,cornea opacity
MGI:7640011	eyl7	MP:0001297,microphthalmia
MGI:5692587	Ezh1<tm1b(EUCOMM)Wtsi>	MP:0000208,decreased hematocrit|MP:0001925,male infertility|MP:0002875,decreased erythrocyte cell number|MP:0005559,increased circulating glucose level|MP:0009142,decreased prepulse inhibition|MP:0010068,decreased red blood cell distribution width
MGI:4941012	Ezh1<tm1Jnw>	MP:0002169,no abnormal phenotype detected
MGI:5474772	Ezh1<tm1Sgon>	MP:0000333,decreased bone marrow cell number|MP:0000692,small spleen|MP:0002223,lymphoid hypoplasia|MP:0004810,decreased hematopoietic stem cell number|MP:0005017,decreased B cell number|MP:0005397,hematopoietic system phenotype|MP:0008008,early cellular replicative senescence|MP:0008208,decreased pro-B cell number|MP:0008215,decreased immature B cell number|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008250,abnormal myeloid leukocyte morphology|MP:0008474,absent spleen germinal center|MP:0008477,decreased spleen red pulp amount|MP:0008479,decreased spleen white pulp amount|MP:0009278,abnormal bone marrow cell physiology|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:6259828	Ezh2<em1Jbn>	MP:0001260,increased body weight|MP:0001698,decreased embryo size|MP:0002833,increased heart weight|MP:0002865,increased growth rate|MP:0003917,increased kidney weight|MP:0004952,increased spleen weight|MP:0010819,primary atelectasis|MP:0011089,perinatal lethality, complete penetrance
MGI:7610894	Ezh2<em1Jiaf>	MP:0001260,increased body weight|MP:0005006,abnormal osteoblast physiology|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype|MP:0010768,mortality/aging|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0013620,increased internal diameter of femur|MP:0013623,increased femur compact bone thickness
MGI:6393578	Ezh2<tm1.1Nesh>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002023,increased B cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002357,abnormal spleen white pulp morphology
MGI:3805309	Ezh2<tm1.1Sho>	MP:0001696,failure to gastrulate|MP:0001730,embryonic growth arrest|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2661099	Ezh2<tm1.1Tara>	MP:0011091,prenatal lethality, complete penetrance
MGI:4432638	Ezh2<tm1a(EUCOMM)Wtsi>	MP:0001552,increased circulating triglyceride level|MP:0005561,increased mean corpuscular hemoglobin|MP:0010101,increased sacral vertebrae number
MGI:2182844	Ezh2<tm1Jnw>	MP:0001696,failure to gastrulate|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003984,embryonic growth retardation|MP:0011092,embryonic lethality, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:2661097	Ezh2<tm1Tara>	MP:0002144,abnormal B cell differentiation|MP:0002169,no abnormal phenotype detected|MP:0005093,decreased B cell proliferation|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005432,abnormal pro-B cell morphology|MP:0008178,decreased germinal center B cell number|MP:0008209,decreased pre-B cell number|MP:0008215,decreased immature B cell number|MP:0008482,decreased spleen germinal center number|MP:0008484,decreased spleen germinal center size|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008755,abnormal immunoglobulin V(D)J recombination
MGI:4412411	Ezh2<tm1Yugo>	MP:0009937,abnormal neuron differentiation
MGI:3823218	Ezh2<tm2.1Sho>	MP:0003984,embryonic growth retardation|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:3823217	Ezh2<tm2Sho>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000715,decreased thymocyte number|MP:0000953,abnormal oligodendrocyte morphology|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002026,increased leukemia incidence|MP:0002907,abnormal parturition|MP:0004057,thin myocardium compact layer|MP:0004514,dystocia|MP:0004896,abnormal endometrium morphology|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008876,decreased uterine NK cell number|MP:0009092,endometrium hyperplasia|MP:0009094,abnormal endometrial gland morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011873,enlarged uterine horn|MP:0013401,increased endometrial gland number|MP:0013438,dysmyelination|MP:0014519,myocardial ventricular hypertrabeculation|MP:0031336,abnormal uterine epithelium development
MGI:6404408	Ezhip<em1Marg>	MP:0001127,small ovary|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0004856,decreased ovary weight|MP:0005389,reproductive system phenotype|MP:0008995,early reproductive senescence|MP:0011121,decreased primordial ovarian follicle number
MGI:3052158	Ezr<tm1Aim>	MP:0000488,abnormal intestinal epithelium morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:5508539	Ezr<tm1Sats>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0004139,abnormal gastric parietal cell morphology|MP:0005381,digestive/alimentary phenotype|MP:0008003,achlorhydria|MP:0008109,abnormal small intestinal microvillus morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4431855	Ezr<tm2a(EUCOMM)Wtsi>	MP:0001325,abnormal retina morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:3052159	Ezr<tm2Aim>	MP:0008688,decreased interleukin-2 secretion
MGI:1856864	f	MP:0000137,abnormal vertebrae morphology|MP:0000208,decreased hematocrit|MP:0000373,belly spot|MP:0000432,abnormal head morphology|MP:0000585,kinked tail|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0002123,abnormal definitive hematopoiesis|MP:0002151,abnormal neural tube morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002825,abnormal notochord morphology|MP:0002875,decreased erythrocyte cell number|MP:0002938,white spotting|MP:0003717,pallor|MP:0004609,vertebral fusion|MP:0004619,caudal vertebral fusion|MP:0005176,eyelids fail to open|MP:0005229,abnormal intervertebral disk development|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005637,abnormal iron homeostasis|MP:0008387,hypochromic anemia|MP:0008388,hypochromic microcytic anemia|MP:0010696,increased siderocyte number|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3578149	F10ex	MP:0000914,exencephaly|MP:0011089,perinatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5548338	F10<tm1b(EUCOMM)Hmgu>	MP:0003917,increased kidney weight|MP:0005554,decreased circulating creatinine level|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:3759686	F10<tm1Ccmt>	MP:0001634,internal hemorrhage|MP:0002058,neonatal lethality|MP:0005606,increased bleeding time|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3613747	F10<tm1Edr>	MP:0001634,internal hemorrhage|MP:0005385,cardiovascular system phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3760000	F10<tm2Ccmt>	MP:0003141,cardiac fibrosis|MP:0010768,mortality/aging|MP:0020367,increased heart iron level
MGI:3578522	f11ex	MP:0000428,abnormal craniofacial morphology|MP:0000914,exencephaly|MP:0001265,decreased body size|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3583782	F11r<Gt(KST235)Byg>	MP:0005385,cardiovascular system phenotype|MP:0005602,decreased angiogenesis|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3054821	F11r<tm1.1Dej>	MP:0002376,abnormal dendritic cell physiology|MP:0005617,increased susceptibility to type IV hypersensitivity reaction
MGI:2384015	F11<tm1Gjb>	MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0009549,decreased platelet aggregation|MP:0012359,increased partial thromboplastin time
MGI:5824302	F12<tm1Fjc>	MP:0005389,reproductive system phenotype|MP:0009812,abnormal bradykinin level|MP:0012359,increased partial thromboplastin time
MGI:3720935	F12<tm1Pbfd>	MP:0002169,no abnormal phenotype detected|MP:0003075,abnormal response to CNS ischemic injury|MP:0006058,decreased cerebral infarct size
MGI:5645817	F13a1<tm1Akic>	MP:0004898,uterine hemorrhage|MP:0005606,increased bleeding time|MP:0008028,pregnancy-related premature death
MGI:2684302	F13a1<tm1Gdi>	MP:0000343,abnormal response to cardiac infarction|MP:0001914,hemorrhage|MP:0001923,reduced female fertility|MP:0002083,premature death|MP:0002551,abnormal blood coagulation|MP:0004898,uterine hemorrhage|MP:0005243,hemothorax|MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0005435,hemoperitoneum|MP:0005606,increased bleeding time|MP:0008028,pregnancy-related premature death|MP:0009661,abnormal pregnancy|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0031152,subcutaneous hemorrhage
MGI:5645820	F13b<tm1Akic>	MP:0005606,increased bleeding time
MGI:5548326	F2rl1<tm1b(EUCOMM)Wtsi>	MP:0001488,increased startle reflex
MGI:3530061	F2rl1<tm1Bpd>	MP:0000230,abnormal systemic arterial blood pressure|MP:0001846,increased inflammatory response|MP:0001876,decreased inflammatory response|MP:0001970,abnormal pain threshold|MP:0002733,abnormal thermal nociception|MP:0004761,increased susceptibility to induced pancreatitis|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0008734,decreased susceptibility to endotoxin shock|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:2179844	F2rl1<tm1Cgh>	MP:0002078,abnormal glucose homeostasis|MP:0002743,glomerulonephritis|MP:0005085,abnormal gallbladder physiology|MP:0005166,decreased susceptibility to injury|MP:0005292,improved glucose tolerance|MP:0005387,immune system phenotype|MP:0005501,abnormal skin physiology|MP:0008127,decreased dendritic cell number|MP:0020332,impaired leukocyte tethering or rolling
MGI:3620551	F2rl1<tm1Jkaw>	MP:0005616,decreased susceptibility to type IV hypersensitivity reaction
MGI:2389587	F2rl1<tm1Mslb>	MP:0001876,decreased inflammatory response|MP:0002492,decreased IgE level
MGI:2448473	F2rl1<tm1Wrf>	MP:0001860,liver inflammation|MP:0003436,decreased susceptibility to induced arthritis|MP:0006060,increased cerebral infarct size|MP:0008636,decreased circulating interleukin-18 level|MP:0008872,abnormal physiological response to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:2445957	F2rl2<tm1Cgh>	MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0031120,decreased susceptibility to induced thrombosis
MGI:2182919	F2rl3<tm1.1Cgh>	MP:0005606,increased bleeding time|MP:0031120,decreased susceptibility to induced thrombosis
MGI:2182916	F2rl3<tm1Cgh>	MP:0005387,immune system phenotype
MGI:1857306	F2r<tm1Ajc>	MP:0000062,increased bone mineral density|MP:0000135,decreased compact bone thickness|MP:0000292,distended pericardium|MP:0001260,increased body weight|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0001719,absent vitelline blood vessels|MP:0001762,polyuria|MP:0001914,hemorrhage|MP:0002006,neoplasm|MP:0003051,curly tail|MP:0003202,abnormal neuron apoptosis|MP:0003228,abnormal sinus venosus morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004086,absent heartbeat|MP:0004348,long femur|MP:0005085,abnormal gallbladder physiology|MP:0005244,hemopericardium|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005390,skeleton phenotype|MP:0005397,hematopoietic system phenotype|MP:0005416,abnormal circulating protein level|MP:0005621,abnormal cell physiology|MP:0006315,abnormal urine protein level|MP:0006316,increased urine sodium level|MP:0009349,increased urine pH|MP:0010868,increased bone trabecula number|MP:0010874,abnormal bone volume|MP:0010878,increased trabecular bone volume|MP:0010964,increased compact bone volume|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0013631,decreased bone trabecular spacing|MP:0021030,decreased tumor necrosis factor (ligand) superfamily member 11 level|MP:0021032,increased tumor necrosis factor receptor superfamily member 11b level
MGI:3038377	F2r<tm1Pago>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000343,abnormal response to cardiac infarction|MP:0001876,decreased inflammatory response|MP:0002161,abnormal fertility/fecundity|MP:0002339,abnormal lymph node morphology|MP:0003071,decreased vascular permeability|MP:0003921,abnormal heart left ventricle morphology|MP:0004181,abnormal carotid artery morphology|MP:0004883,abnormal vascular wound healing|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0008466,enlarged mesenteric lymph nodes|MP:0008713,abnormal cytokine level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010155,abnormal intestine physiology|MP:0010695,abnormal blood pressure regulation|MP:0010697,abnormal systemic arterial blood pressure regulation|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4430880	F2r<tm2Cgh>	MP:0000914,exencephaly|MP:0001544,abnormal cardiovascular system physiology|MP:0001785,edema|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0008770,decreased survivor rate|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5637201	F2<tm1b(EUCOMM)Hmgu>	MP:0000745,tremors|MP:0001417,decreased exploration in new environment|MP:0002591,decreased mean corpuscular volume|MP:0002965,increased circulating serum albumin level|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010087,increased circulating fructosamine level|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2177949	F2<tm1Jes>	MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0003229,abnormal vitelline vasculature morphology|MP:0003717,pallor|MP:0010831,lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3831686	F2<tm1Jld>	MP:0002169,no abnormal phenotype detected|MP:0002412,increased susceptibility to bacterial infection
MGI:2177948	F2<tm1Sjd>	MP:0000292,distended pericardium|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0001722,pale yolk sac|MP:0001730,embryonic growth arrest|MP:0001914,hemorrhage|MP:0005244,hemopericardium|MP:0005376,homeostasis/metabolism phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011515,purpura|MP:0013241,embryo tissue necrosis|MP:0020215,impaired blood coagulation|MP:0031154,intestinal hemorrhage
MGI:5140722	F2<tm2Jld>	MP:0001634,internal hemorrhage|MP:0003436,decreased susceptibility to induced arthritis|MP:0005416,abnormal circulating protein level|MP:0005606,increased bleeding time|MP:0008734,decreased susceptibility to endotoxin shock|MP:0011085,postnatal lethality, complete penetrance|MP:0014706,decreased synovial pannus formation|MP:0031120,decreased susceptibility to induced thrombosis|MP:0031152,subcutaneous hemorrhage
MGI:2178048	F3<tm1.1Dwr>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0002551,abnormal blood coagulation|MP:0003628,abnormal leukocyte adhesion|MP:0004883,abnormal vascular wound healing|MP:0005017,decreased B cell number|MP:0005397,hematopoietic system phenotype|MP:0005595,abnormal vascular smooth muscle physiology|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008597,decreased circulating interleukin-6 level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009660,abnormal induced retina neovascularization|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0009858,abnormal cellular extravasation|MP:0020332,impaired leukocyte tethering or rolling|MP:0031510,increased vascular smooth muscle cell proliferation
MGI:2178434	F3<tm1Dco>	MP:0000291,enlarged pericardium|MP:0001672,abnormal embryo development|MP:0001719,absent vitelline blood vessels|MP:0001722,pale yolk sac|MP:0001723,disorganized yolk sac vascular plexus|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003717,pallor|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013241,embryo tissue necrosis
MGI:2178047	F3<tm1Dwr>	MP:0001855,abnormal atrial thrombosis|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002551,abnormal blood coagulation|MP:0005048,abnormal thrombosis|MP:0008028,pregnancy-related premature death|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012329,increased circulating factor VIII level|MP:0012358,decreased partial thromboplastin time|MP:0012616,increased circulating factor IX level|MP:0020409,abnormal cardiac thrombosis|MP:0020985,increased circulating factor XI level|MP:0031147,abnormal ventricular thrombosis
MGI:3795857	F3<tm1(F3)Lasn>	MP:0002048,increased lung adenoma incidence|MP:0005376,homeostasis/metabolism phenotype|MP:0008714,increased lung carcinoma incidence
MGI:5647876	F3<tm1Fct>	MP:0002551,abnormal blood coagulation|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004230,abnormal embryonic erythrocyte morphology|MP:0006323,abnormal extraembryonic mesoderm development|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1861745	F3<tm1Gjb>	MP:0000266,abnormal heart morphology|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001634,internal hemorrhage|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0001914,hemorrhage|MP:0001916,intracerebral hemorrhage|MP:0002001,blindness|MP:0002451,abnormal macrophage physiology|MP:0003232,abnormal forebrain development|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0005387,immune system phenotype|MP:0008706,decreased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0011085,postnatal lethality, complete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:2158778	F3<tm1Jld>	MP:0000249,abnormal blood vessel physiology|MP:0000274,enlarged heart|MP:0000292,distended pericardium|MP:0001722,pale yolk sac|MP:0001914,hemorrhage|MP:0002551,abnormal blood coagulation|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004230,abnormal embryonic erythrocyte morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013241,embryo tissue necrosis
MGI:3803978	F3<tm1Nmk>	MP:0003141,cardiac fibrosis
MGI:8250822	F5<em1Alir>	MP:0005416,abnormal circulating protein level|MP:0005606,increased bleeding time|MP:0010768,mortality/aging|MP:0012356,increased prothrombin time|MP:0012359,increased partial thromboplastin time
MGI:1931525	F5<tm1Dgi>	MP:0001634,internal hemorrhage|MP:0001688,abnormal somite development|MP:0001718,abnormal visceral yolk sac morphology|MP:0001721,absent visceral yolk sac blood islands|MP:0001914,hemorrhage|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011514,skin hemorrhage
MGI:1931528	F5<tm2Dgi>	MP:0002551,abnormal blood coagulation|MP:0003333,liver fibrosis|MP:0003717,pallor|MP:0005048,abnormal thrombosis|MP:0005202,lethargy|MP:0010768,mortality/aging|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5636916	F7<tm1b(EUCOMM)Hmgu>	MP:0000443,abnormal snout morphology|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2182766	F7<tm1Pec>	MP:0001634,internal hemorrhage|MP:0002169,no abnormal phenotype detected|MP:0005385,cardiovascular system phenotype|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3831192	F7<tm1(tTA,tetO-F7)Edr>	MP:0002551,abnormal blood coagulation|MP:0003141,cardiac fibrosis|MP:0005416,abnormal circulating protein level|MP:0009698,heart hemorrhage|MP:0010768,mortality/aging|MP:0012356,increased prothrombin time|MP:0012359,increased partial thromboplastin time
MGI:3578532	f8ga	MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:8213039	F8<tm1.1Len>	MP:0005000,abnormal immune tolerance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020215,impaired blood coagulation
MGI:5582808	F8<tm1.1Rmnt>	MP:0012328,decreased circulating factor VIII level
MGI:2179981	F8<tm1Kaz>	MP:0005000,abnormal immune tolerance|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0020215,impaired blood coagulation
MGI:2179968	F8<tm2Kaz>	MP:0002551,abnormal blood coagulation
MGI:6196100	F9<em1Dlli>	MP:0012359,increased partial thromboplastin time|MP:0020344,abnormal susceptibility to injury induced morbidity/mortality
MGI:6196102	F9<em2Dlli>	MP:0005376,homeostasis/metabolism phenotype
MGI:6196103	F9<em3Dlli>	MP:0002551,abnormal blood coagulation|MP:0012359,increased partial thromboplastin time|MP:0020344,abnormal susceptibility to injury induced morbidity/mortality
MGI:1932297	F9<tm1Dws>	MP:0000208,decreased hematocrit|MP:0000691,enlarged spleen|MP:0001634,internal hemorrhage|MP:0001914,hemorrhage|MP:0002083,premature death|MP:0002551,abnormal blood coagulation|MP:0005385,cardiovascular system phenotype|MP:0005606,increased bleeding time|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:1932244	F9<tm1Emg>	MP:0001914,hemorrhage|MP:0002551,abnormal blood coagulation|MP:0005370,liver/biliary system phenotype|MP:0005606,increased bleeding time|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012305,umbilical cord hemorrhage
MGI:1932265	F9<tm1Ver>	MP:0002551,abnormal blood coagulation|MP:0005023,abnormal wound healing|MP:0005376,homeostasis/metabolism phenotype|MP:0005606,increased bleeding time
MGI:3055509	F9<tm2(F9)Dws>	MP:0005606,increased bleeding time
MGI:4847605	F9<tm3Dws>	MP:0000208,decreased hematocrit|MP:0002551,abnormal blood coagulation|MP:0005606,increased bleeding time
MGI:1856865	fa	MP:0001406,abnormal gait|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003312,abnormal locomotor coordination|MP:0011083,lethality at weaning, complete penetrance
MGI:6449054	Fa2h<em1(IMPC)Mbp>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000367,abnormal coat/ hair morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0003068,enlarged kidney|MP:0005179,decreased circulating cholesterol level|MP:0010053,decreased grip strength|MP:0020421,increased freezing behavior
MGI:6268374	Fa2h<m1Btlr>	MP:0000414,alopecia
MGI:4430585	Fa2h<tm1.1Hama>	MP:0000849,abnormal cerebellum morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0000921,demyelination|MP:0001330,abnormal optic nerve morphology|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001547,abnormal lipid level|MP:0002063,abnormal learning/memory/conditioning|MP:0002182,abnormal astrocyte morphology|MP:0002757,decreased vertical activity|MP:0002804,abnormal motor learning|MP:0003631,nervous system phenotype|MP:0003871,abnormal myelin sheath morphology|MP:0003983,decreased cholesterol level|MP:0005404,abnormal axon morphology|MP:0014327,decreased Purkinje cell size|MP:0020380,abnormal galactolipid level
MGI:4430576	Fa2h<tm1Hama>	MP:0000849,abnormal cerebellum morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001547,abnormal lipid level|MP:0002757,decreased vertical activity|MP:0005386,behavior/neurological phenotype|MP:0014327,decreased Purkinje cell size|MP:0020380,abnormal galactolipid level
MGI:3829000	Fa2h<tm1Meck>	MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000418,focal hair loss|MP:0000422,delayed hair appearance|MP:0000423,delayed hair regrowth|MP:0000652,enlarged sebaceous gland|MP:0000755,hindlimb paralysis|MP:0001195,flaky skin|MP:0001216,abnormal epidermal layer morphology|MP:0001510,abnormal coat appearance|MP:0002757,decreased vertical activity|MP:0002991,abnormal sebaceous gland physiology|MP:0002992,abnormal sebaceous lipid secretion|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0003809,abnormal hair shaft morphology|MP:0003871,abnormal myelin sheath morphology|MP:0005404,abnormal axon morphology|MP:0009794,sebaceous gland hyperplasia|MP:0010137,delayed exit from anagen phase|MP:0013378,increased sebocyte number|MP:0030571,dilated piliary canal|MP:0030923,abnormal hair follicle ostium morphology
MGI:6399917	Faah<em1(IMPC)H>	MP:0002599,increased mean platelet volume|MP:0005560,decreased circulating glucose level|MP:0008810,increased circulating iron level|MP:0013279,increased fasting circulating glucose level
MGI:5644434	Faah<tm1.1Flee>	MP:0000818,abnormal amygdala morphology|MP:0001364,decreased anxiety-related response|MP:0004166,abnormal limbic system morphology|MP:0012319,fast extinction of fear memory|MP:0030764,increased anandamide level
MGI:2182901	Faah<tm1Crv>	MP:0001402,decreased locomotor activity|MP:0001973,increased thermal nociceptive threshold|MP:0001981,increased chemically-elicited antinociception|MP:0001987,alcohol preference|MP:0002822,catalepsy|MP:0002863,improved righting response|MP:0003545,increased alcohol consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005534,decreased body temperature|MP:0008531,increased chemical nociceptive threshold
MGI:3529190	Faah<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:7548790	Faap100<em1Jzc>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001750,increased circulating follicle stimulating hormone level|MP:0002777,absent ovarian follicles|MP:0004833,ovary atrophy|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0005159,azoospermia|MP:0008392,decreased primordial germ cell number|MP:0008871,abnormal ovarian follicle number|MP:0009009,absent estrous cycle|MP:0030934,decreased primordial germ cell proliferation|MP:0030935,increased primordial germ cell apoptosis
MGI:4456552	Faap20<tm1(KOMP)Mbp>	MP:0001127,small ovary|MP:0001131,abnormal ovarian follicle morphology|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001545,abnormal hematopoietic system physiology|MP:0001935,decreased litter size|MP:0003077,abnormal cell cycle|MP:0004901,decreased male germ cell number|MP:0005152,pancytopenia|MP:0005621,abnormal cell physiology
MGI:4433784	Fabp12<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight
MGI:5548934	Fabp1<tm1b(EUCOMM)Hmgu>	MP:0000221,decreased leukocyte cell number|MP:0000223,decreased monocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0005344,increased circulating bilirubin level|MP:0012361,decreased large unstained cell number
MGI:2664854	Fabp1<tm1Bin>	MP:0002078,abnormal glucose homeostasis|MP:0002139,abnormal hepatobiliary system physiology
MGI:2687013	Fabp1<tm1Ddsn>	MP:0001547,abnormal lipid level|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002727,decreased circulating insulin level|MP:0009356,decreased liver triglyceride level
MGI:6336213	Fabp2<em1(IMPC)Hmgu>	MP:0000702,enlarged lymph nodes|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level
MGI:3046293	Fabp2<tm1Mto>	MP:0002079,increased circulating insulin level|MP:0002981,increased liver weight|MP:0003402,decreased liver weight|MP:0003443,increased circulating glycerol level|MP:0003917,increased kidney weight|MP:0003949,abnormal circulating lipid level|MP:0005179,decreased circulating cholesterol level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0009288,increased epididymal fat pad weight|MP:0009307,decreased uterine fat pad weight
MGI:4126159	Fabp3<Gt(XE705)Byg>	MP:0000187,abnormal triglyceride level|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001780,decreased brown adipose tissue amount|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002971,abnormal brown adipose tissue morphology|MP:0005281,increased fatty acids level|MP:0005282,decreased fatty acids level|MP:0005289,increased oxygen consumption|MP:0005317,increased triglyceride level|MP:0005318,decreased triglyceride level|MP:0005560,decreased circulating glucose level|MP:0010358,abnormal free fatty acids level|MP:0010378,increased respiratory quotient|MP:0010398,decreased liver glycogen level|MP:0011049,impaired adaptive thermogenesis|MP:0011698,abnormal brown adipose tissue physiology
MGI:4431873	Fabp3<tm1a(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract
MGI:2677970	Fabp3<tm1Bin>	MP:0000189,hypoglycemia|MP:0001554,increased circulating free fatty acids level|MP:0001625,cardiac hypertrophy|MP:0002118,abnormal lipid homeostasis|MP:0002833,increased heart weight|MP:0002899,fatigue|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0030018,increased cardiac muscle cell glucose uptake
MGI:3609428	Fabp3<tm1Jshr>	MP:0002891,increased insulin sensitivity|MP:0005560,decreased circulating glucose level
MGI:2148887	Fabp4<tm1Brsp>	MP:0000189,hypoglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0005281,increased fatty acids level|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0008033,impaired lipolysis
MGI:2450172	Fabp5<tm1Hota>	MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0030016,increased adipocyte glucose uptake
MGI:2182961	Fabp5<tm1Kdo>	MP:0002796,impaired skin barrier function|MP:0005387,immune system phenotype
MGI:5495685	Fabp6<tm1Lbal>	MP:0002644,decreased circulating triglyceride level|MP:0003402,decreased liver weight|MP:0004789,increased bile salt level|MP:0005179,decreased circulating cholesterol level|MP:0005365,abnormal bile salt homeostasis|MP:0010026,decreased liver cholesterol level
MGI:6153790	Fabp7<em1(IMPC)H>	MP:0002875,decreased erythrocyte cell number|MP:0005561,increased mean corpuscular hemoglobin
MGI:3665437	Fabp7<tm1Owad>	MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0001363,increased anxiety-related response|MP:0001902,reduced NMDA-mediated synaptic currents|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005282,decreased fatty acids level|MP:0008911,induced hyperactivity|MP:0009142,decreased prepulse inhibition|MP:0009453,enhanced contextual conditioning behavior
MGI:4867465	Fabp9<tm1Vise>	MP:0005389,reproductive system phenotype|MP:0009230,abnormal sperm head morphology
MGI:4880717	Fadd<tm1.1Mpa>	MP:0008762,embryonic lethality
MGI:5573271	Fadd<tm1e.1(KOMP)Wtsi>	MP:0001120,abnormal uterus morphology|MP:0001697,abnormal embryo size|MP:0003720,abnormal neural tube closure|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:2159360	Fadd<tm1Mak>	MP:0000295,trabecula carnea hypoplasia|MP:0001634,internal hemorrhage|MP:0001698,decreased embryo size|MP:0002652,thin myocardium|MP:0003984,embryonic growth retardation|MP:0005329,abnormal myocardium layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013502,decreased fibroblast apoptosis
MGI:3700154	Fadd<tm1Mpa>	MP:0000491,crypts of Lieberkuhn abscesses|MP:0000494,abnormal cecum morphology|MP:0000495,abnormal colon morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000512,intestinal ulcer|MP:0001262,decreased body weight|MP:0002816,colitis|MP:0003631,nervous system phenotype|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005036,diarrhea|MP:0005387,immune system phenotype|MP:0008882,abnormal enterocyte physiology|MP:0008883,abnormal enterocyte proliferation|MP:0008885,increased enterocyte apoptosis|MP:0009481,cecum inflammation|MP:0010205,abnormal oligodendrocyte apoptosis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013486,decreased Paneth cell number
MGI:2159365	Fadd<tm1Wnt>	MP:0008944,decreased sensitivity to induced cell death|MP:0011092,embryonic lethality, complete penetrance
MGI:4837702	Fadd<tm2.1Wnt>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001586,abnormal erythrocyte cell number|MP:0003944,abnormal T cell subpopulation ratio|MP:0005014,increased B cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005094,abnormal T cell proliferation|MP:0009258,abnormal thymocyte apoptosis
MGI:5147023	Fads1<Gt(IST11525H2)Tigm>	MP:0001547,abnormal lipid level|MP:0002083,premature death|MP:0003949,abnormal circulating lipid level|MP:0004974,decreased regulatory T cell number|MP:0008247,abnormal mononuclear cell morphology|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008883,abnormal enterocyte proliferation|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0009814,increased prostaglandin level|MP:0009815,decreased prostaglandin level
MGI:5695931	Fads1<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001566,increased circulating phosphate level|MP:0002176,increased brain weight|MP:0002644,decreased circulating triglyceride level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003917,increased kidney weight|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4365366	Fads2<tm1Mtna>	MP:0000512,intestinal ulcer|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000706,small thymus|MP:0001129,impaired ovarian folliculogenesis|MP:0001156,abnormal spermatogenesis|MP:0001194,dermatitis|MP:0001209,spontaneous skin ulceration|MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0002223,lymphoid hypoplasia|MP:0002357,abnormal spleen white pulp morphology|MP:0002371,abnormal thymus cortex morphology|MP:0002682,decreased mature ovarian follicle number|MP:0002686,globozoospermia|MP:0002981,increased liver weight|MP:0003068,enlarged kidney|MP:0003356,impaired luteinization|MP:0005159,azoospermia|MP:0006380,abnormal spermatid morphology|MP:0008279,arrest of spermiogenesis|MP:0008476,increased spleen red pulp amount|MP:0008839,absent acrosome|MP:0009355,increased liver triglyceride level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0011743,abnormal Golgi apparatus morphology|MP:0011940,decreased food intake|MP:0030980,abnormal acroplaxome morphology|MP:0031354,abnormal acrosome assembly|MP:0031355,abnormal proacrosomal vesicle fusion
MGI:3814170	Fads2<tm1Wst>	MP:0001125,abnormal oocyte morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001131,abnormal ovarian follicle morphology|MP:0001132,absent mature ovarian follicles|MP:0001146,abnormal testis morphology|MP:0001919,abnormal reproductive system physiology|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001929,abnormal gametogenesis|MP:0002451,abnormal macrophage physiology|MP:0002784,abnormal Sertoli cell morphology|MP:0003696,abnormal zona pellucida morphology|MP:0003697,absent zona pellucida|MP:0004852,decreased testis weight|MP:0004884,abnormal testis physiology|MP:0005159,azoospermia|MP:0005285,decreased unsaturated fatty acids level|MP:0005376,homeostasis/metabolism phenotype|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0008279,arrest of spermiogenesis|MP:0008868,abnormal granulosa cell morphology|MP:0009368,absent theca folliculi|MP:0009549,decreased platelet aggregation|MP:0009815,decreased prostaglandin level|MP:0020111,decreased thromboxane level|MP:0031120,decreased susceptibility to induced thrombosis
MGI:4364316	Fads3<tm1a(KOMP)Wtsi>	MP:0005281,increased fatty acids level|MP:0005282,decreased fatty acids level|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010359,increased liver free fatty acids level|MP:0010360,decreased liver free fatty acids level|MP:0010768,mortality/aging
MGI:5692754	Fads3<tm1b(EUCOMM)Hmgu>	MP:0000198,decreased circulating phosphate level|MP:0004738,abnormal auditory brainstem response|MP:0006358,absent pinna reflex
MGI:6194112	Fads6<tm1b(EUCOMM)Wtsi>	MP:0000194,increased circulating calcium level|MP:0000494,abnormal cecum morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0002060,abnormal skin morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003271,abnormal duodenum morphology|MP:0004906,enlarged uterus|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level|MP:0010097,abnormal retina blood vessel morphology
MGI:6153791	Faf1<em1(IMPC)H>	MP:0000745,tremors|MP:0001406,abnormal gait|MP:0001925,male infertility|MP:0002941,increased circulating alanine transaminase level|MP:0003961,decreased lean body mass|MP:0005560,decreased circulating glucose level|MP:0008810,increased circulating iron level|MP:0010024,increased total body fat amount|MP:0020421,increased freezing behavior
MGI:3795251	Faf1<Gt(2C98)Wen>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4332074	Faf1<Gt(RRT033)Byg>	MP:0011092,embryonic lethality, complete penetrance
MGI:4127400	Faf1<Gt(XK588)Byg>	MP:0001405,impaired coordination|MP:0008944,decreased sensitivity to induced cell death|MP:0011452,decreased susceptibility to dopaminergic neuron neurotoxicity
MGI:6152475	Faf2<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0001297,microphthalmia|MP:0001404,no spontaneous movement|MP:0001614,abnormal blood vessel morphology|MP:0001700,abnormal embryo turning|MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001726,abnormal allantois morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0003232,abnormal forebrain development|MP:0003425,abnormal optic vesicle formation|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance
MGI:5805286	Faf2<tm1Tfji>	MP:0001262,decreased body weight|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003976,decreased circulating VLDL triglyceride level|MP:0003980,increased circulating phospholipid level|MP:0003981,decreased circulating phospholipid level|MP:0005343,increased circulating aspartate transaminase level|MP:0005376,homeostasis/metabolism phenotype|MP:0010331,abnormal apolipoprotein level|MP:0031115,macrovesicular hepatic steatosis
MGI:2155424	Fah<1R>	MP:0009643,abnormal urine homeostasis|MP:0011087,neonatal lethality, complete penetrance
MGI:2155425	Fah<2R>	MP:0009643,abnormal urine homeostasis|MP:0011085,postnatal lethality, complete penetrance
MGI:6358775	Fahd1<tm1.1Pjdr>	MP:0005266,abnormal metabolism
MGI:4431777	Fahd2a<tm1a(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0001257,increased body length|MP:0003960,increased lean body mass
MGI:6423839	Fah<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:3613754	Fah<swst>	MP:0001501,abnormal sleep pattern
MGI:2429529	Fah<tm1Mgo>	MP:0000189,hypoglycemia|MP:0000203,abnormal circulating aspartate transaminase level|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0000611,jaundice|MP:0001263,weight loss|MP:0001859,kidney inflammation|MP:0001860,liver inflammation|MP:0002658,abnormal liver regeneration|MP:0002705,dilated renal tubule|MP:0003068,enlarged kidney|MP:0003311,aminoaciduria|MP:0003324,increased liver adenoma incidence|MP:0003326,liver failure|MP:0003331,increased hepatocellular carcinoma incidence|MP:0004001,decreased hepatocyte proliferation|MP:0004969,pale kidney|MP:0005165,increased susceptibility to injury|MP:0005311,abnormal circulating amino acid level|MP:0005332,abnormal amino acid level|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005370,liver/biliary system phenotype|MP:0005517,impaired liver regeneration|MP:0005553,increased circulating creatinine level|MP:0008019,increased liver tumor incidence|MP:0008891,decreased hepatocyte apoptosis|MP:0008987,abnormal liver lobule morphology|MP:0009110,pancreas hyperplasia|MP:0009176,increased pancreatic alpha cell number|MP:0009641,kidney degeneration|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010080,abnormal hepatocyte physiology|MP:0010264,increased hepatoma incidence|MP:0011087,neonatal lethality, complete penetrance|MP:0012602,increased alpha-fetoprotein level|MP:0013723,increased circulating tyrosine level|MP:0014341,abnormal hepatocyte mitochondrial morphology
MGI:7425663	Faim2<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001304,cataract|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003917,increased kidney weight
MGI:4888719	Faim2<tm1.1Jbsc>	MP:0006060,increased cerebral infarct size
MGI:3604553	Faim2<tm1Dgen>	MP:0000519,hydronephrosis|MP:0002135,abnormal kidney morphology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003068,enlarged kidney|MP:0003917,increased kidney weight
MGI:6764557	Faiml<em1Smtb>	MP:0001147,small testis|MP:0005389,reproductive system phenotype
MGI:4831133	Faim<tm1Kplm>	MP:0001860,liver inflammation|MP:0002941,increased circulating alanine transaminase level|MP:0003326,liver failure|MP:0003887,increased hepatocyte apoptosis|MP:0003888,liver hemorrhage|MP:0008782,increased B cell apoptosis|MP:0009541,increased thymocyte apoptosis|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:4362853	Fam107b<tm1a(KOMP)Wtsi>	MP:0000367,abnormal coat/ hair morphology|MP:0000452,abnormal mouth morphology|MP:0001262,decreased body weight|MP:0003131,increased erythrocyte cell number|MP:0006325,impaired hearing
MGI:4433953	Fam110b<tm1a(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0003131,increased erythrocyte cell number|MP:0005316,abnormal response to tactile stimuli|MP:0005566,decreased blood urea nitrogen level|MP:0008211,decreased mature B cell number
MGI:5312485	Fam111a<tm1(KOMP)Vlcg>	MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype
MGI:5788340	Fam114a1<em1(IMPC)J>	MP:0005344,increased circulating bilirubin level|MP:0010053,decreased grip strength
MGI:7310255	Fam114a2<em1Qsh>	MP:0005389,reproductive system phenotype
MGI:6384602	Fam117a<em1(IMPC)Bay>	MP:0009142,decreased prepulse inhibition
MGI:4432848	Fam117b<tm1a(EUCOMM)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001325,abnormal retina morphology|MP:0002644,decreased circulating triglyceride level|MP:0002896,abnormal bone mineralization|MP:0005179,decreased circulating cholesterol level|MP:0005566,decreased blood urea nitrogen level
MGI:7330324	Fam118a<em1(IMPC)J>	MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval
MGI:5781315	Fam120a<em1(IMPC)J>	MP:0000062,increased bone mineral density|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:6863921	Fam120b<em1Qqlg>	MP:0002834,decreased heart weight|MP:0004564,increased myocardial fiber size|MP:0005598,decreased heart ventricle muscle contractility|MP:0008058,abnormal DNA repair|MP:0010580,decreased heart left ventricle size|MP:0010725,thin interventricular septum|MP:0010768,mortality/aging|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0011952,decreased cardiac stroke volume|MP:0031131,myocardial fiber disarray|MP:0031609,increased fetal cardiomyocyte size
MGI:5635075	Fam120b<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system
MGI:6341919	Fam120c<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000627,abnormal mammary gland morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001399,hyperactivity|MP:0002311,abnormal inspiratory capacity|MP:0003020,decreased circulating chloride level|MP:0003917,increased kidney weight|MP:0005634,decreased circulating sodium level|MP:0008045,decreased NK cell number|MP:0010895,increased lung compliance|MP:0011048,decreased lung tissue damping
MGI:4345880	Fam120c<Gt(AP0628)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:6341892	Fam124a<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002060,abnormal skin morphology
MGI:6257570	Fam131a<em1(IMPC)Bay>	MP:0005293,impaired glucose tolerance
MGI:7256884	Fam135a<em1(IMPC)Tcp>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002591,decreased mean corpuscular volume|MP:0002792,abnormal retina vasculature morphology|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010097,abnormal retina blood vessel morphology|MP:0020421,increased freezing behavior
MGI:6148317	Fam135b<em1(IMPC)Rbrc>	MP:0009142,decreased prepulse inhibition
MGI:4944370	Fam136a<tm1a(KOMP)Wtsi>	MP:0004748,increased susceptibility to age-related hearing loss
MGI:4364167	Fam13a<tm1e(KOMP)Wtsi>	MP:0001554,increased circulating free fatty acids level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005375,adipose tissue phenotype|MP:0005378,growth/size/body region phenotype|MP:0005670,abnormal white adipose tissue physiology|MP:0008034,enhanced lipolysis|MP:0009133,decreased white fat cell size|MP:0031602,white adipose tissue inflammation
MGI:4420095	Fam13a<tm2a(KOMP)Wtsi>	MP:0005166,decreased susceptibility to injury
MGI:4842400	Fam13b<tm1a(EUCOMM)Wtsi>	MP:0003233,prolonged QT interval|MP:0004071,prolonged P wave|MP:0004485,increased response of heart to induced stress|MP:0005385,cardiovascular system phenotype|MP:0010392,prolonged QRS complex duration
MGI:5548837	Fam13b<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001491,unresponsive to tactile stimuli|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6342897	Fam149b<em1(IMPC)Bay>	MP:0001925,male infertility
MGI:6442001	Fam151a<em1Jkn>	MP:0005385,cardiovascular system phenotype|MP:0005391,vision/eye phenotype
MGI:5548636	Fam151b<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0001325,abnormal retina morphology|MP:0005103,abnormal retina pigmentation|MP:0005391,vision/eye phenotype|MP:0008444,retina cone cell degeneration|MP:0008451,retina rod cell degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0008587,short photoreceptor outer segment|MP:0012143,decreased a-wave amplitude|MP:0020816,decreased photoreceptor outer segment number
MGI:4955130	Fam161a<Gt(462E7)Cmhd>	MP:0001004,abnormal retina photoreceptor morphology|MP:0002090,abnormal vision|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008586,disorganized photoreceptor outer segment|MP:0008918,microgliosis|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0012147,increased a-wave implicit time|MP:0012150,increased b-wave implicit time|MP:0014059,abnormal photoreceptor connecting cilium morphology|MP:0030005,increased retina apoptosis|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:5472171	Fam161a<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0002626,increased heart rate|MP:0002792,abnormal retina vasculature morphology|MP:0002833,increased heart weight|MP:0003064,decreased coping response|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005633,increased circulating sodium level|MP:0008259,abnormal optic disk morphology|MP:0010052,increased grip strength|MP:0010097,abnormal retina blood vessel morphology|MP:0010507,shortened RR interval
MGI:6341852	Fam161b<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0000759,abnormal skeletal muscle morphology|MP:0002339,abnormal lymph node morphology
MGI:5613649	Fam162a<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0009142,decreased prepulse inhibition|MP:0010097,abnormal retina blood vessel morphology
MGI:5637187	Fam163a<tm2b(KOMP)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0001258,decreased body length|MP:0001322,abnormal iris morphology|MP:0002546,mydriasis|MP:0002608,increased hematocrit|MP:0002968,increased circulating alkaline phosphatase level|MP:0003131,increased erythrocyte cell number|MP:0003960,increased lean body mass|MP:0005292,improved glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005564,increased hemoglobin content|MP:0005568,increased circulating total protein level|MP:0010025,decreased total body fat amount
MGI:7425666	Fam167a<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000367,abnormal coat/ hair morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001510,abnormal coat appearance|MP:0010935,increased airway resistance|MP:0011047,increased lung tissue damping
MGI:6304254	Fam168a<em1(IMPC)J>	MP:0001325,abnormal retina morphology|MP:0001566,increased circulating phosphate level|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:5754599	Fam170a<em1(IMPC)Tcp>	MP:0001925,male infertility
MGI:6453859	Fam170a<em1Osb>	MP:0001260,increased body weight|MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009234,absent sperm head|MP:0009282,decreased hyperactivated sperm motility|MP:0009831,abnormal sperm midpiece morphology|MP:0020451,decreased sperm progressive motility
MGI:6453868	Fam170b<em2Osb>	MP:0005389,reproductive system phenotype
MGI:6363558	Fam171a1<em1(IMPC)J>	MP:0005565,increased blood urea nitrogen level
MGI:8187544	Fam171a2<em1Smoc>	MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0014812,abnormal brain physiology
MGI:8187547	Fam171a2<em1Yjt>	MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010769,abnormal survival|MP:0014812,abnormal brain physiology
MGI:7284069	Fam181a<em1Qsh>	MP:0005389,reproductive system phenotype
MGI:5780054	Fam181b<tm1.2Lswr>	MP:0002169,no abnormal phenotype detected
MGI:3663687	Fam184b<tm1Mnkm>	MP:0002169,no abnormal phenotype detected
MGI:5620317	Fam184b<tm2b(EUCOMM)Wtsi>	MP:0000194,increased circulating calcium level|MP:0005559,increased circulating glucose level
MGI:6341875	Fam185a<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0002060,abnormal skin morphology|MP:0005554,decreased circulating creatinine level|MP:0005633,increased circulating sodium level|MP:0009709,hydrometra|MP:0011047,increased lung tissue damping
MGI:5554938	Fam186b<tm1b(KOMP)Mbp>	MP:0001556,increased circulating HDL cholesterol level|MP:0005633,increased circulating sodium level|MP:0013279,increased fasting circulating glucose level
MGI:6314220	Fam193a<em1(IMPC)J>	MP:0002590,increased mean corpuscular volume
MGI:6158490	Fam199x<em1(IMPC)Mbp>	MP:0002941,increased circulating alanine transaminase level|MP:0004906,enlarged uterus|MP:0005343,increased circulating aspartate transaminase level
MGI:7330328	Fam204a<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:6866934	Fam209<em1Osb>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0005389,reproductive system phenotype|MP:0008898,abnormal acrosome morphology
MGI:6866939	Fam209<em2Osb>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0005389,reproductive system phenotype|MP:0008898,abnormal acrosome morphology
MGI:5572032	Fam209<tm1b(KOMP)Wtsi>	MP:0000689,abnormal spleen morphology
MGI:5548797	Fam20a<tm1b(KOMP)Wtsi>	MP:0001314,cornea opacity|MP:0002100,abnormal tooth morphology|MP:0002135,abnormal kidney morphology|MP:0002764,short tibia|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:5432376	Fam20a<tm1Lex>	MP:0002135,abnormal kidney morphology|MP:0002576,abnormal enamel morphology|MP:0002649,abnormal enamel rod pattern|MP:0002650,abnormal ameloblast morphology|MP:0002689,abnormal molar morphology|MP:0002705,dilated renal tubule|MP:0003404,absent enamel|MP:0005358,abnormal incisor morphology|MP:0005378,growth/size/body region phenotype|MP:0006133,calcified artery|MP:0006402,small molars|MP:0010768,mortality/aging|MP:0010923,calcified pulmonary alveolus|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011309,abnormal kidney arterial blood vessel morphology|MP:0030138,abnormal lower incisor color|MP:0030139,abnormal upper incisor color|MP:0030457,abnormal molar cusp morphology|MP:0030458,abnormal tooth wear|MP:0030460,enamel pits|MP:0030500,conical molar
MGI:5432371	Fam20b<Gt(GST_4283_D8)Lex>	MP:0000597,delayed hepatic development|MP:0001176,abnormal lung development|MP:0001286,abnormal eye development|MP:0001698,decreased embryo size|MP:0002113,abnormal skeleton development|MP:0003119,abnormal digestive system development|MP:0011092,embryonic lethality, complete penetrance
MGI:6761288	Fam20b<m1Btlr>	MP:0002764,short tibia|MP:0003109,short femur
MGI:5428020	Fam20c<tm1.1Cqi>	MP:0000060,delayed bone ossification|MP:0000061,fragile skeleton|MP:0000063,decreased bone mineral density|MP:0000135,decreased compact bone thickness|MP:0000198,decreased circulating phosphate level|MP:0000445,short snout|MP:0001255,decreased body height|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002904,increased circulating parathyroid hormone level|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003116,rickets|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003668,abnormal periodontal ligament morphology|MP:0003933,abnormal cementum morphology|MP:0004214,abnormal long bone diaphysis morphology|MP:0004703,abnormal vertebral column morphology|MP:0005352,small cranium|MP:0005416,abnormal circulating protein level|MP:0005508,abnormal skeleton morphology|MP:0008753,abnormal osteocyte morphology|MP:0009445,osteomalacia|MP:0010743,delayed cranial suture closure|MP:0010876,decreased bone volume|MP:0011228,abnormal vitamin D level|MP:0011504,abnormal limb long bone morphology|MP:0011711,impaired osteoblast differentiation|MP:0012175,flat face|MP:0014101,decreased chondrocyte proliferation|MP:0014104,decreased chondrocyte apoptosis|MP:0014105,abnormal chondrocyte differentiation|MP:0020137,decreased bone mineralization|MP:0020254,decreased collagen level|MP:0030132,periodontium inflammation|MP:0030153,dental pulp inflammation|MP:0030462,tooth abscess|MP:0030466,alveolar process atrophy|MP:0030484,abnormal osteocyte lacuna morphology|MP:0030485,abnormal osteocyte lacunocanalicular system morphology|MP:0030486,abnormal osteocyte canaliculus morphology|MP:0030487,abnormal osteocyte dendritic process morphology|MP:0030490,periodontal pocket|MP:0030515,periodontal ligament necrosis|MP:0030517,detached junctional epithelium
MGI:5432377	Fam20c<tm1Lex>	MP:0000061,fragile skeleton|MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000137,abnormal vertebrae morphology|MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000240,extramedullary hematopoiesis|MP:0000454,abnormal jaw morphology|MP:0000455,abnormal maxilla morphology|MP:0000559,abnormal femur morphology|MP:0000613,abnormal salivary gland morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001270,distended abdomen|MP:0001348,abnormal lacrimal gland physiology|MP:0001402,decreased locomotor activity|MP:0001454,abnormal cued conditioning behavior|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002100,abnormal tooth morphology|MP:0002818,abnormal dentin morphology|MP:0002819,abnormal dental pulp cavity morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003088,abnormal prepulse inhibition|MP:0003404,absent enamel|MP:0003795,abnormal bone structure|MP:0003930,abnormal tooth hard tissue morphology|MP:0005422,osteosclerosis|MP:0005508,abnormal skeleton morphology|MP:0005536,decreased Leydig cell number|MP:0006325,impaired hearing|MP:0006395,abnormal epiphyseal plate morphology|MP:0006402,small molars|MP:0009346,decreased trabecular bone thickness|MP:0010124,decreased bone mineral content|MP:0010870,absent bone trabeculae|MP:0010879,decreased trabecular bone volume|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011498,abnormal glomerular capsule parietal layer morphology|MP:0013251,dental pulp necrosis|MP:0030223,mandibular hyperostosis|MP:0030463,apical tooth abscess|MP:0030493,abnormal tooth root morphology|MP:0030500,conical molar|MP:0030542,abnormal dentin development
MGI:5605775	Fam210a<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000135,decreased compact bone thickness|MP:0001552,increased circulating triglyceride level|MP:0002590,increased mean corpuscular volume|MP:0003797,abnormal compact bone morphology|MP:0004984,increased osteoclast cell number|MP:0004991,decreased bone strength|MP:0010965,decreased compact bone volume|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0020040,decreased bone ossification
MGI:6159130	Fam210a<tm1c(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000135,decreased compact bone thickness|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002109,abnormal limb morphology|MP:0004984,increased osteoclast cell number|MP:0004991,decreased bone strength|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0010965,decreased compact bone volume|MP:0013630,increased bone trabecular spacing|MP:0020040,decreased bone ossification
MGI:7703659	Fam210b<em1Cya>	MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0001209,spontaneous skin ulceration|MP:0001212,skin lesions|MP:0002493,increased IgG level|MP:0002743,glomerulonephritis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0009333,abnormal splenocyte physiology|MP:0009338,increased splenocyte number
MGI:5548530	Fam210b<tm1b(KOMP)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005419,decreased circulating serum albumin level
MGI:5548573	Fam216a<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract
MGI:6194710	Fam217a<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6194711	Fam217a<em2Osb>	MP:0002169,no abnormal phenotype detected
MGI:5614560	Fam217b<tm1.1(KOMP)Vlcg>	MP:0001303,abnormal lens morphology|MP:0004151,decreased circulating iron level|MP:0005560,decreased circulating glucose level|MP:0011436,decreased urine magnesium level
MGI:6341824	Fam219a<em1(IMPC)Ccpcz>	MP:0000598,abnormal liver morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001262,decreased body weight|MP:0002100,abnormal tooth morphology|MP:0010935,increased airway resistance
MGI:6341850	Fam221a<em1(IMPC)Ccpcz>	MP:0000160,kyphosis|MP:0000219,increased neutrophil cell number|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000702,enlarged lymph nodes|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0004174,abnormal spine curvature|MP:0005559,increased circulating glucose level|MP:0005564,increased hemoglobin content|MP:0005568,increased circulating total protein level|MP:0010935,increased airway resistance|MP:0013436,increased CD8-positive, naive alpha-beta T cell number
MGI:6259165	Fam222a<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0001284,absent vibrissae|MP:0010053,decreased grip strength
MGI:6358067	Fam227b<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000495,abnormal colon morphology|MP:0000627,abnormal mammary gland morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0000759,abnormal skeletal muscle morphology|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002060,abnormal skin morphology|MP:0002100,abnormal tooth morphology|MP:0002339,abnormal lymph node morphology|MP:0002581,abnormal ileum morphology|MP:0002631,abnormal epididymis morphology|MP:0003271,abnormal duodenum morphology|MP:0004002,abnormal jejunum morphology|MP:0004931,enlarged epididymis|MP:0010052,increased grip strength
MGI:7490163	Fam229b<em1(IMPC)Mbp>	MP:0002092,abnormal eye morphology|MP:0002606,increased basophil cell number
MGI:6459758	Fam229b<em1Osb>	MP:0005389,reproductive system phenotype
MGI:4432729	Fam234b<tm1a(EUCOMM)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000194,increased circulating calcium level|MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0005571,decreased lactate dehydrogenase level|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:7610511	Fam246a<em1Amj>	MP:0002169,no abnormal phenotype detected
MGI:6149736	Fam24b<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002591,decreased mean corpuscular volume
MGI:6152487	Fam32a<em1(IMPC)Mbp>	MP:0000639,abnormal adrenal gland morphology|MP:0001293,anophthalmia|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0003068,enlarged kidney|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6477316	Fam3a<em1Cya>	MP:0002941,increased circulating alanine transaminase level|MP:0003957,abnormal nitric oxide homeostasis|MP:0005015,increased T cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005376,homeostasis/metabolism phenotype|MP:0005425,increased macrophage cell number|MP:0008039,increased NK T cell number|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011009,increased circulating glutamate dehydrogenase level|MP:0012659,decreased superoxide dismutase level
MGI:5756071	Fam3b<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment
MGI:4882127	Fam3b<tm1Bkht>	MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003839,abnormal insulin clearance|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:4324675	Fam3c<Gt(OST459445)Lex>	MP:0005390,skeleton phenotype
MGI:5467558	Fam3c<tm1.1Lex>	MP:0005390,skeleton phenotype
MGI:5467559	Fam3c<tm2(FAM3C)Lex>	MP:0005390,skeleton phenotype
MGI:6695714	Fam3d<em1Wko>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000222,decreased neutrophil cell number|MP:0000488,abnormal intestinal epithelium morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000495,abnormal colon morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000691,enlarged spleen|MP:0002463,abnormal neutrophil physiology|MP:0002816,colitis|MP:0003884,decreased macrophage cell number|MP:0004499,increased incidence of tumors by chemical induction|MP:0005166,decreased susceptibility to injury|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0008713,abnormal cytokine level|MP:0010377,abnormal gut flora balance|MP:0013023,decreased Ly6C high monocyte number|MP:0013298,increased susceptibility to colitis induced morbidity/mortality|MP:0013795,abnormal colon goblet cell morphology|MP:0013799,abnormal intestinal goblet cell physiology|MP:0013956,decreased colon length|MP:0014201,abnormal intestinal epithelium physiology|MP:0014219,decreased intestinal mucosa thickness
MGI:5007269	Fam3d<tm1Lex>	MP:0001364,decreased anxiety-related response|MP:0014413,decreased depression-related behavior
MGI:6324370	Fam43a<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0001488,increased startle reflex
MGI:7783439	Fam50a<em1Zfhu>	MP:0001147,small testis|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis
MGI:7783440	Fam50b<em1Zfhu>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009833,absent sperm mitochondrial sheath|MP:0009838,abnormal sperm axoneme morphology|MP:0031356,abnormal outer dense fiber morphology
MGI:6341876	Fam53a<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001297,microphthalmia|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002997,enlarged seminal vesicle|MP:0004174,abnormal spine curvature|MP:0005568,increased circulating total protein level|MP:0009141,increased prepulse inhibition
MGI:5548690	Fam53b<tm1b(EUCOMM)Hmgu>	MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0004738,abnormal auditory brainstem response|MP:0005561,increased mean corpuscular hemoglobin|MP:0005633,increased circulating sodium level|MP:0009142,decreased prepulse inhibition|MP:0010068,decreased red blood cell distribution width|MP:0010087,increased circulating fructosamine level|MP:0011951,increased cardiac stroke volume
MGI:6241421	Fam53c<em1(IMPC)J>	MP:0001417,decreased exploration in new environment
MGI:5708215	Fam72a<tm1.1(KOMP)Vlcg>	MP:0002135,abnormal kidney morphology|MP:0004815,abnormal somatic hypermutation frequency|MP:0004816,abnormal class switch recombination|MP:0005565,increased blood urea nitrogen level|MP:0008177,increased germinal center B cell number|MP:0008528,polycystic kidney|MP:0008782,increased B cell apoptosis
MGI:5203950	Fam76b<Gt(IST14004H1)Tigm>	MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001846,increased inflammatory response|MP:0002357,abnormal spleen white pulp morphology|MP:0002359,abnormal spleen germinal center morphology|MP:0002451,abnormal macrophage physiology|MP:0004952,increased spleen weight|MP:0005017,decreased B cell number|MP:0008560,increased tumor necrosis factor secretion|MP:0008705,increased interleukin-6 secretion|MP:0008826,abnormal splenic cell ratio|MP:0008918,microgliosis|MP:0013663,increased myeloid cell number|MP:0014523,increased response to brain injury|MP:0020448,increased microglial cell activation
MGI:6341939	Fam81a<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001489,decreased startle reflex|MP:0002060,abnormal skin morphology
MGI:6390575	Fam81b<em1(IMPC)J>	MP:0001556,increased circulating HDL cholesterol level|MP:0003961,decreased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0010024,increased total body fat amount
MGI:6195295	Fam83a<em1(IMPC)J>	MP:0005293,impaired glucose tolerance
MGI:6430645	Fam83b<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001304,cataract|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney
MGI:7425672	Fam83c<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity
MGI:6341891	Fam83d<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001293,anophthalmia|MP:0001489,decreased startle reflex|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0009142,decreased prepulse inhibition|MP:0013279,increased fasting circulating glucose level
MGI:4431981	Fam83g<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0002608,increased hematocrit|MP:0002644,decreased circulating triglyceride level|MP:0003131,increased erythrocyte cell number
MGI:2668878	Fam83g<wly>	MP:0000410,waved hair
MGI:6341855	Fam83h<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000367,abnormal coat/ hair morphology|MP:0000627,abnormal mammary gland morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001402,decreased locomotor activity|MP:0001404,no spontaneous movement|MP:0001417,decreased exploration in new environment|MP:0001510,abnormal coat appearance|MP:0002059,abnormal seminal vesicle morphology|MP:0002135,abnormal kidney morphology|MP:0002188,small heart|MP:0004924,abnormal behavior|MP:0005084,abnormal gallbladder morphology|MP:0005627,increased circulating potassium level|MP:0008935,decreased mean platelet volume|MP:0010053,decreased grip strength|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020421,increased freezing behavior
MGI:7431366	Fam83h<em2(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0002060,abnormal skin morphology|MP:0005559,increased circulating glucose level|MP:0020421,increased freezing behavior
MGI:6143820	Fam83h<tm1.1Jpsi>	MP:0000416,sparse hair|MP:0000746,weakness|MP:0001192,scaly skin|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001511,disheveled coat|MP:0002083,premature death|MP:0003053,delayed tooth eruption|MP:0005382,craniofacial phenotype|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013818,abnormal oral cavity morphology|MP:0030490,periodontal pocket
MGI:7425673	Fam8a1<em1(IMPC)Bay>	MP:0001513,limb grasping|MP:0002574,increased vertical activity
MGI:7425674	Fam91a1<em1(IMPC)Bay>	MP:0000443,abnormal snout morphology|MP:0000556,abnormal hindlimb morphology|MP:0000572,abnormal autopod morphology|MP:0001392,abnormal locomotor behavior|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5287269	Fam91a1<Tg(Tyr)2261COve>	MP:0001925,male infertility
MGI:6489290	Fan1<em1Mem>	MP:0008402,increased cellular sensitivity to alkylating agent induced cell death|MP:0014693,abnormal cell nucleus size
MGI:6489296	Fan1<em2Mem>	MP:0008402,increased cellular sensitivity to alkylating agent induced cell death|MP:0014693,abnormal cell nucleus size
MGI:5897147	Fan1<tm1.1Jrou>	MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0004025,polyploidy|MP:0005367,renal/urinary system phenotype|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009640,abnormal renal tubule epithelium morphology|MP:0011346,renal tubule atrophy|MP:0014760,impaired DNA repair
MGI:4940765	Fan1<tm1a(KOMP)Wtsi>	MP:0001429,dehydration|MP:0003215,renal interstitial fibrosis|MP:0005150,cachexia|MP:0005367,renal/urinary system phenotype|MP:0005565,increased blood urea nitrogen level|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008943,increased sensitivity to induced cell death|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011405,tubulointerstitial nephritis|MP:0011440,increased kidney cell proliferation
MGI:5796264	Fan1<tm1d(KOMP)Wtsi>	MP:0002703,abnormal renal tubule morphology|MP:0003111,abnormal cell nucleus morphology|MP:0003325,decreased liver function|MP:0004025,polyploidy|MP:0005367,renal/urinary system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0020427,increased hepatocyte karyomegaly
MGI:2674095	Fanca<tm1.1Wong>	MP:0000438,abnormal cranium morphology|MP:0001154,seminiferous tubule degeneration|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001923,reduced female fertility|MP:0002209,decreased germ cell number|MP:0003984,embryonic growth retardation|MP:0004852,decreased testis weight|MP:0005391,vision/eye phenotype|MP:0005621,abnormal cell physiology
MGI:4434431	Fanca<tm1a(EUCOMM)Wtsi>	MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008943,increased sensitivity to induced cell death
MGI:2183470	Fanca<tm1Faw>	MP:0001116,small gonad|MP:0001126,abnormal ovary morphology|MP:0001132,absent mature ovarian follicles|MP:0001152,increased Leydig cell number|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002590,increased mean corpuscular volume|MP:0003179,thrombocytopenia|MP:0003702,abnormal chromosome morphology|MP:0004029,spontaneous chromosome breakage|MP:0004030,induced chromosome breakage|MP:0005390,skeleton phenotype
MGI:2674094	Fanca<tm1Wong>	MP:0000438,abnormal cranium morphology|MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0002006,neoplasm|MP:0002016,ovary cyst|MP:0002209,decreased germ cell number|MP:0002682,decreased mature ovarian follicle number|MP:0004834,ovary hemorrhage|MP:0005158,ovary hypoplasia|MP:0005169,abnormal male meiosis|MP:0008995,early reproductive senescence|MP:0014052,increased male germ cell apoptosis
MGI:3609190	Fanca<tm1Zqw>	MP:0004028,chromosome breakage
MGI:5688399	Fancb<em1Shnk>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0002776,increased Sertoli cell number|MP:0004901,decreased male germ cell number|MP:0006378,abnormal spermatogonia morphology|MP:0006380,abnormal spermatid morphology|MP:0008392,decreased primordial germ cell number|MP:0014052,increased male germ cell apoptosis|MP:0014764,impaired double-strand DNA break repair
MGI:1858040	Fancc<tm1Mab>	MP:0001126,abnormal ovary morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001134,absent corpus luteum|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001545,abnormal hematopoietic system physiology|MP:0001921,reduced fertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0002160,abnormal reproductive system morphology|MP:0002161,abnormal fertility/fecundity|MP:0003179,thrombocytopenia|MP:0003205,testicular atrophy|MP:0005397,hematopoietic system phenotype|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008404,increased cellular sensitivity to methylmethanesulfonate induced cell death|MP:0008813,decreased common myeloid progenitor cell number|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0030927,decreased telomere length
MGI:1858041	Fancc<tm1Mgo>	MP:0000239,absent common myeloid progenitor cells|MP:0001121,uterus hypoplasia|MP:0001127,small ovary|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002209,decreased germ cell number|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0002777,absent ovarian follicles|MP:0004029,spontaneous chromosome breakage|MP:0004030,induced chromosome breakage|MP:0004045,abnormal cell cycle checkpoint function|MP:0004852,decreased testis weight|MP:0005158,ovary hypoplasia|MP:0005431,decreased oocyte number
MGI:6302758	Fancd2<em1(IMPC)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0002989,small kidney|MP:0008810,increased circulating iron level|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:6392092	Fancd2<em1Tzh>	MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0000746,weakness|MP:0001127,small ovary|MP:0001131,abnormal ovarian follicle morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003078,aphakia|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0004810,decreased hematopoietic stem cell number|MP:0005159,azoospermia|MP:0005545,abnormal lens development|MP:0009772,abnormal retina development|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011178,increased erythroblast number|MP:0011179,decreased erythroblast number
MGI:3530554	Fancd2<Gt(OST57859)Lex>	MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001732,postnatal growth retardation|MP:0002038,increased carcinoma incidence|MP:0002216,abnormal seminiferous tubule morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002682,decreased mature ovarian follicle number|MP:0002687,oligozoospermia|MP:0003179,thrombocytopenia|MP:0004201,fetal growth retardation|MP:0004810,decreased hematopoietic stem cell number|MP:0005169,abnormal male meiosis|MP:0006379,abnormal spermatocyte morphology|MP:0010383,increased adenoma incidence|MP:0011090,perinatal lethality, incomplete penetrance|MP:0014040,increased cellular sensitivity to DNA damaging agent induced cell death
MGI:2673422	Fancd2<tm1Hou>	MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001732,postnatal growth retardation|MP:0001924,infertility|MP:0002038,increased carcinoma incidence|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0004201,fetal growth retardation|MP:0004810,decreased hematopoietic stem cell number|MP:0005169,abnormal male meiosis|MP:0006379,abnormal spermatocyte morphology|MP:0008871,abnormal ovarian follicle number|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008943,increased sensitivity to induced cell death|MP:0010383,increased adenoma incidence|MP:0010768,mortality/aging|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5467996	Fance<Tg(Tyr)2364E-2a2Ove>	MP:0001922,reduced male fertility|MP:0001940,testis hypoplasia|MP:0002216,abnormal seminiferous tubule morphology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0008489,slow postnatal weight gain
MGI:6388628	Fancf<em1(IMPC)J>	MP:0001314,cornea opacity|MP:0002590,increased mean corpuscular volume|MP:0005542,cornea vascularization|MP:0005561,increased mean corpuscular hemoglobin|MP:0012121,sclerocornea
MGI:4398963	Fancf<tm1Nki>	MP:0001127,small ovary|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001927,abnormal estrous cycle|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0004025,polyploidy|MP:0005159,azoospermia|MP:0005378,growth/size/body region phenotype|MP:0008000,increased ovary tumor incidence|MP:0008058,abnormal DNA repair|MP:0008871,abnormal ovarian follicle number|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0010383,increased adenoma incidence|MP:0011121,decreased primordial ovarian follicle number|MP:0012411,increased granulosa cell tumor incidence
MGI:2183264	Fancg<tm1Ada>	MP:0001126,abnormal ovary morphology|MP:0001130,abnormal ovarian folliculogenesis|MP:0001146,abnormal testis morphology|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001924,infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0004028,chromosome breakage|MP:0004029,spontaneous chromosome breakage|MP:0004852,decreased testis weight
MGI:2183473	Fancg<tm1Faw>	MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001130,abnormal ovarian folliculogenesis|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001932,abnormal spermiogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0004028,chromosome breakage|MP:0004029,spontaneous chromosome breakage|MP:0004030,induced chromosome breakage
MGI:6827418	Fanci<em1Szh>	MP:0002169,no abnormal phenotype detected
MGI:6827419	Fanci<em2Szh>	MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0008878,abnormal DNA methylation during gametogenesis|MP:0014052,increased male germ cell apoptosis
MGI:6394228	Fanci<tm1.1Itl>	MP:0000120,malocclusion|MP:0000428,abnormal craniofacial morphology|MP:0001116,small gonad|MP:0001117,absent gametes|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001925,male infertility|MP:0001926,female infertility|MP:0003179,thrombocytopenia|MP:0004029,spontaneous chromosome breakage|MP:0004030,induced chromosome breakage|MP:0004810,decreased hematopoietic stem cell number|MP:0005159,azoospermia|MP:0005545,abnormal lens development|MP:0008008,early cellular replicative senescence|MP:0008730,fused phalanges|MP:0009703,decreased birth body size|MP:0009772,abnormal retina development|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0010772,abnormal pollex morphology|MP:0011102,embryonic lethality, incomplete penetrance|MP:0013697,decreased granulocyte monocyte progenitor cell number|MP:0013707,abnormal hematopoietic precursor cell morphology|MP:0014040,increased cellular sensitivity to DNA damaging agent induced cell death|MP:0020414,abnormal fibroblast physiology
MGI:4456047	Fanci<tm1a(EUCOMM)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:1861640	Fancl<gcd>	MP:0001119,abnormal female reproductive system morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001147,small testis|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0002216,abnormal seminiferous tubule morphology|MP:0002637,small uterus|MP:0002680,decreased corpora lutea number|MP:0002687,oligozoospermia|MP:0004930,small epididymis|MP:0008257,thin myometrium|MP:0008392,decreased primordial germ cell number|MP:0009009,absent estrous cycle|MP:0009094,abnormal endometrial gland morphology|MP:0009226,small uterine cervix|MP:0009429,decreased embryo weight|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014604,hemorrhagic ovary cyst|MP:0030934,decreased primordial germ cell proliferation|MP:0031420,decreased superovulation rate|MP:0031422,failure of superovulation
MGI:5605778	Fancl<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0002075,abnormal coat/hair pigmentation|MP:0002606,increased basophil cell number|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005011,increased eosinophil cell number|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:2451263	Fancl<tm1Ceb>	MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002637,small uterus|MP:0004901,decreased male germ cell number|MP:0011091,prenatal lethality, complete penetrance
MGI:6508081	Fancm<em1Qsh>	MP:0001154,seminiferous tubule degeneration|MP:0001925,male infertility|MP:0002006,neoplasm|MP:0002216,abnormal seminiferous tubule morphology|MP:0005397,hematopoietic system phenotype|MP:0006380,abnormal spermatid morphology|MP:0014040,increased cellular sensitivity to DNA damaging agent induced cell death|MP:0014052,increased male germ cell apoptosis
MGI:4355560	Fancm<tm1.1Htr>	MP:0001126,abnormal ovary morphology|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0002216,abnormal seminiferous tubule morphology|MP:0002682,decreased mature ovarian follicle number|MP:0003701,elevated level of mitotic sister chromatid exchange|MP:0004179,transmission ratio distortion|MP:0005159,azoospermia|MP:0005397,hematopoietic system phenotype|MP:0010264,increased hepatoma incidence|MP:0014619,absent spermatogonia
MGI:6360213	Fank1<em1Mngx>	MP:0002169,no abnormal phenotype detected
MGI:2386791	Fap<tm1Schn>	MP:0002169,no abnormal phenotype detected
MGI:2656736	Fap<tm2Schn>	MP:0002169,no abnormal phenotype detected
MGI:1861221	Far	MP:0000106,abnormal basisphenoid bone morphology|MP:0000120,malocclusion|MP:0000163,abnormal cartilage morphology|MP:0000448,pointed snout|MP:0000455,abnormal maxilla morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0001302,eyelids open at birth|MP:0002098,abnormal vibrissa morphology|MP:0002820,abnormal premaxilla morphology|MP:0003235,abnormal alisphenoid bone morphology|MP:0003631,nervous system phenotype|MP:0004452,abnormal pterygoid process morphology|MP:0004537,abnormal palatine bone horizontal plate morphology|MP:0004831,long incisors|MP:0004899,absent temporal bone squamous part|MP:0004912,absent mandibular coronoid process|MP:0005270,abnormal zygomatic bone morphology|MP:0008377,absent malleus manubrium|MP:0009653,abnormal palate development|MP:0009799,abnormal maxillary nerve morphology|MP:0009890,cleft secondary palate|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014051,abnormal maxillary-premaxillary suture morphology|MP:0030376,thick zygomatic arch|MP:0031460,abnormal palatal shelf morphology
MGI:6153339	Far1<em1(IMPC)Wtsi>	MP:0000062,increased bone mineral density|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0006379,abnormal spermatocyte morphology|MP:0008770,decreased survivor rate|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012220,abnormal ether lipid level|MP:0014052,increased male germ cell apoptosis|MP:0020550,multinucleated giant male germ cells
MGI:7354967	Far2<em1Akih>	MP:0001312,abnormal cornea morphology|MP:0001337,dry eyes|MP:0001994,increased blinking frequency|MP:0005252,abnormal Meibomian gland morphology|MP:0005253,abnormal eye physiology|MP:0005389,reproductive system phenotype|MP:0013391,abnormal Meibomian gland physiology|MP:0014131,abnormal tear film morphology|MP:0014132,abnormal tear film physiology|MP:0020219,increased tear production
MGI:5494450	Far2<tm2b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000418,focal hair loss|MP:0001303,abnormal lens morphology|MP:0001510,abnormal coat appearance|MP:0001547,abnormal lipid level|MP:0002060,abnormal skin morphology|MP:0002833,increased heart weight|MP:0005179,decreased circulating cholesterol level|MP:0009535,abnormal skin sebaceous gland morphology|MP:0012725,small sebaceous gland|MP:0013279,increased fasting circulating glucose level|MP:0013376,abnormal sebocyte differentiation|MP:0030572,abnormal pilosebaceous unit morphology
MGI:5588287	Farp1<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0001488,increased startle reflex|MP:0002699,abnormal vitreous body morphology|MP:0013279,increased fasting circulating glucose level
MGI:4363551	Farp2<tm1a(KOMP)Wtsi>	MP:0000427,abnormal hair cycle|MP:0002644,decreased circulating triglyceride level|MP:0008861,abnormal hair shedding
MGI:4847666	Farp2<tm1Akum>	MP:0001541,abnormal osteoclast physiology|MP:0004984,increased osteoclast cell number|MP:0004985,decreased osteoclast cell number|MP:0004993,decreased bone resorption|MP:0010867,abnormal bone trabecula morphology|MP:0010868,increased bone trabecula number|MP:0010877,abnormal trabecular bone volume
MGI:7621486	Fars2<em1Chenk>	MP:0001675,abnormal ectoderm development|MP:0001730,embryonic growth arrest|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5817223	Fars2<em1(IMPC)J>	MP:0005343,increased circulating aspartate transaminase level|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:7621487	Fars2<em2Chenk>	MP:0001675,abnormal ectoderm development|MP:0001730,embryonic growth arrest|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:7621488	Fars2<em3Chenk>	MP:0000358,abnormal cell morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0002175,decreased brain weight|MP:0003241,loss of cortex neurons|MP:0006036,abnormal mitochondrial physiology|MP:0006042,increased apoptosis|MP:0006254,thin cerebral cortex|MP:0010959,abnormal oxidative phosphorylation|MP:0011087,neonatal lethality, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0011635,abnormal mitochondrial crista morphology|MP:0014246,decreased cellular ATP level
MGI:4441679	Farsa<tm2a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000221,decreased leukocyte cell number|MP:0002079,increased circulating insulin level|MP:0003020,decreased circulating chloride level|MP:0005293,impaired glucose tolerance|MP:0005634,decreased circulating sodium level|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:3803664	Fasl<del1Hong>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0001272,increased metastatic potential|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0008827,abnormal thymus cell ratio|MP:0012431,increased lymphoma incidence
MGI:1856384	Fasl<gld>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000334,decreased granulocyte number|MP:0000607,abnormal hepatocyte morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000921,demyelination|MP:0001194,dermatitis|MP:0001541,abnormal osteoclast physiology|MP:0001577,anemia|MP:0001656,focal hepatic necrosis|MP:0001786,skin edema|MP:0001798,impaired macrophage phagocytosis|MP:0001847,brain inflammation|MP:0001851,eye inflammation|MP:0001860,liver inflammation|MP:0001862,interstitial pneumonia|MP:0002006,neoplasm|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0002339,abnormal lymph node morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002444,abnormal T cell physiology|MP:0002461,increased immunoglobulin level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0002942,decreased circulating alanine transaminase level|MP:0003204,decreased neuron apoptosis|MP:0003725,increased autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004952,increased spleen weight|MP:0005013,increased lymphocyte cell number|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005094,abnormal T cell proliferation|MP:0005166,decreased susceptibility to injury|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005551,abnormal eye electrophysiology|MP:0006042,increased apoptosis|MP:0006082,CNS inflammation|MP:0008037,abnormal T cell morphology|MP:0008280,abnormal male germ cell apoptosis|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008553,increased circulating tumor necrosis factor level|MP:0008751,abnormal interleukin level|MP:0008891,decreased hepatocyte apoptosis|MP:0009321,increased histiocytic sarcoma incidence|MP:0010766,abnormal NK cell physiology|MP:0010768,mortality/aging|MP:0020937,increased susceptibility to Picornaviridae infection|MP:0030603,increased sperm number
MGI:5578030	Fasl<m1Btlr>	MP:0001800,abnormal humoral immune response
MGI:5688496	Fasl<m2Btlr>	MP:0001805,decreased IgG level|MP:0020154,impaired humoral immune response
MGI:1856334	Fas<lpr>	MP:0000048,abnormal stria vascularis morphology|MP:0000219,increased neutrophil cell number|MP:0000420,ruffled hair|MP:0000523,cortical renal glomerulopathies|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0000681,abnormal thyroid gland morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0000921,demyelination|MP:0001191,abnormal skin condition|MP:0001212,skin lesions|MP:0001220,epidermal necrosis|MP:0001260,increased body weight|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001544,abnormal cardiovascular system physiology|MP:0001656,focal hepatic necrosis|MP:0001790,abnormal immune system physiology|MP:0001805,decreased IgG level|MP:0001830,decreased activated T cell number|MP:0001844,autoimmune response|MP:0001847,brain inflammation|MP:0001852,conjunctivitis|MP:0001859,kidney inflammation|MP:0001863,blood vessel inflammation|MP:0001864,vascular inflammation|MP:0001870,salivary gland inflammation|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002136,abnormal kidney physiology|MP:0002163,abnormal gland morphology|MP:0002334,abnormal airway responsiveness|MP:0002339,abnormal lymph node morphology|MP:0002375,abnormal thymus medulla morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002444,abnormal T cell physiology|MP:0002461,increased immunoglobulin level|MP:0002490,abnormal immunoglobulin level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002533,abnormal type III hypersensitivity reaction|MP:0002722,abnormal immune system organ morphology|MP:0002743,glomerulonephritis|MP:0002871,albuminuria|MP:0002936,joint swelling|MP:0002962,increased urine protein level|MP:0002965,increased circulating serum albumin level|MP:0003204,decreased neuron apoptosis|MP:0003504,thyroid gland inflammation|MP:0003606,kidney failure|MP:0003628,abnormal leukocyte adhesion|MP:0003644,thymus atrophy|MP:0003670,dilated renal glomerular capsule|MP:0003725,increased autoantibody level|MP:0003793,abnormal submandibular gland morphology|MP:0004111,abnormal coronary artery morphology|MP:0004367,abnormal strial intermediate cell morphology|MP:0004368,abnormal stria vascularis vasculature morphology|MP:0004481,abnormal conjunctival epithelium morphology|MP:0004696,abnormal thyroid follicle morphology|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004796,increased anti-histone antibody level|MP:0004797,increased anti-erythrocyte antigen antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0004939,abnormal B cell morphology|MP:0004952,increased spleen weight|MP:0004955,increased thymus weight|MP:0005012,decreased eosinophil cell number|MP:0005017,decreased B cell number|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005090,increased double-negative T cell number|MP:0005094,abnormal T cell proliferation|MP:0005325,abnormal renal glomerulus morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005379,endocrine/exocrine gland phenotype|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005391,vision/eye phenotype|MP:0005416,abnormal circulating protein level|MP:0005466,abnormal T-helper 2 physiology|MP:0005565,increased blood urea nitrogen level|MP:0005568,increased circulating total protein level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005615,increased susceptibility to type III hypersensitivity reaction|MP:0006042,increased apoptosis|MP:0006043,decreased apoptosis|MP:0006082,CNS inflammation|MP:0008037,abnormal T cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008097,increased plasma cell number|MP:0008102,lymph node hyperplasia|MP:0008136,enlarged Peyer's patches|MP:0008140,podocyte foot process effacement|MP:0008173,increased follicular B cell number|MP:0008180,abnormal marginal zone B cell morphology|MP:0008181,increased marginal zone B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008189,increased transitional stage B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008211,decreased mature B cell number|MP:0008214,increased immature B cell number|MP:0008215,decreased immature B cell number|MP:0008217,abnormal B cell activation|MP:0008246,abnormal leukocyte morphology|MP:0008346,increased gamma-delta T cell number|MP:0008482,decreased spleen germinal center number|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level|MP:0008688,decreased interleukin-2 secretion|MP:0008751,abnormal interleukin level|MP:0008766,abnormal B cell receptor editing|MP:0008783,decreased B cell apoptosis|MP:0008826,abnormal splenic cell ratio|MP:0008828,abnormal lymph node cell ratio|MP:0008879,submandibular gland inflammation|MP:0008880,lacrimal gland inflammation|MP:0008891,decreased hepatocyte apoptosis|MP:0008978,abnormal vagina weight|MP:0009338,increased splenocyte number|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010766,abnormal NK cell physiology|MP:0010768,mortality/aging|MP:0011081,decreased macrophage apoptosis|MP:0011294,renal glomerulus hypertrophy|MP:0011320,abnormal glomerular capillary morphology|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011353,expanded mesangial matrix|MP:0011369,increased renal glomerulus apoptosis|MP:0011402,renal cast|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011427,increased mesangial cell number|MP:0011440,increased kidney cell proliferation|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011506,glomerular crescent|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013455,lacrimal gland atrophy|MP:0013585,thymus cortex atrophy|MP:0014708,increased synovial pannus formation|MP:0020332,impaired leukocyte tethering or rolling|MP:0020518,renal glomerular protein deposits|MP:0020519,renal glomerular immunoglobulin deposits|MP:0020937,increased susceptibility to Picornaviridae infection|MP:0031051,lymph node hemorrhage|MP:0031052,lymph node necrosis
MGI:1856335	Fas<lpr-cg>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001844,autoimmune response|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0002148,abnormal hypersensitivity reaction|MP:0002221,abnormal lymph organ size|MP:0002461,increased immunoglobulin level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0003725,increased autoantibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004952,increased spleen weight
MGI:4366050	Fasl<tm1.1Ast>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001194,dermatitis|MP:0002083,premature death|MP:0002461,increased immunoglobulin level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0002743,glomerulonephritis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005387,immune system phenotype|MP:0008019,increased liver tumor incidence|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008553,increased circulating tumor necrosis factor level|MP:0009321,increased histiocytic sarcoma incidence|MP:0011402,renal cast|MP:0011506,glomerular crescent
MGI:5006689	Fasl<tm1.1Bksa>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0004952,increased spleen weight|MP:0008056,abnormal retina ganglion cell morphology
MGI:4888490	Fasl<tm1.1Cgm>	MP:0002494,increased IgM level|MP:0005154,increased B cell proliferation|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0008097,increased plasma cell number|MP:0008177,increased germinal center B cell number
MGI:3032864	Fasl<tm1.1Lest>	MP:0000599,enlarged liver|MP:0000613,abnormal salivary gland morphology|MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001844,autoimmune response|MP:0002083,premature death|MP:0002339,abnormal lymph node morphology|MP:0002407,abnormal double-negative T cell morphology|MP:0002493,increased IgG level|MP:0002743,glomerulonephritis|MP:0002962,increased urine protein level
MGI:3032852	Fasl<tm1Lest>	MP:0002169,no abnormal phenotype detected
MGI:4366051	Fasl<tm2.1Ast>	MP:0005078,abnormal cytotoxic T cell physiology|MP:0010768,mortality/aging
MGI:5006688	Fasl<tm2.1Bksa>	MP:0005391,vision/eye phenotype|MP:0006303,abnormal retina nerve fiber layer morphology|MP:0006309,decreased retina ganglion cell number|MP:0008067,retina ganglion cell degeneration|MP:0030005,increased retina apoptosis
MGI:5607750	Fas<m1Btlr>	MP:0000219,increased neutrophil cell number|MP:0008044,increased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:6283435	Fas<m2Btlr>	MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number
MGI:3765071	Fasn<tm1.1Sem>	MP:0011091,prenatal lethality, complete penetrance
MGI:2664027	Fasn<tm1Schi>	MP:0006204,embryonic lethality before implantation|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3765070	Fasn<tm1Sem>	MP:0001262,decreased body weight|MP:0001431,abnormal eating behavior|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002702,decreased circulating free fatty acids level|MP:0002712,increased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0002981,increased liver weight|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005179,decreased circulating cholesterol level|MP:0005280,abnormal fatty acids level|MP:0005286,decreased saturated fatty acids level|MP:0005289,increased oxygen consumption|MP:0005317,increased triglyceride level|MP:0005559,increased circulating glucose level|MP:0005560,decreased circulating glucose level|MP:0005645,abnormal hypothalamus physiology|MP:0008907,decreased total fat pad weight|MP:0009642,abnormal blood homeostasis|MP:0010025,decreased total body fat amount|MP:0010026,decreased liver cholesterol level|MP:0011957,decreased compensatory feeding amount|MP:0031391,increased locomotor activity
MGI:4455060	Fas<theo>	MP:0000702,enlarged lymph nodes|MP:0004794,increased anti-nuclear antigen antibody level
MGI:5637084	Fastkd2<tm1b(EUCOMM)Wtsi>	MP:0001510,abnormal coat appearance|MP:0004953,decreased spleen weight|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:7543098	Fastkd3<em1(IMPC)J>	MP:0002834,decreased heart weight|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount
MGI:5607864	Fastkd5<em1(IMPC)J>	MP:0001523,impaired righting response|MP:0005560,decreased circulating glucose level|MP:0010393,shortened QRS complex duration|MP:0011396,abnormal sleep behavior
MGI:5646000	Fastkd5<tm1.1(KOMP)Vlcg>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014586,decreased egg cylinder size
MGI:4461026	Fastk<tm1.1Andp>	MP:0000222,decreased neutrophil cell number|MP:0002463,abnormal neutrophil physiology|MP:0008561,decreased tumor necrosis factor secretion|MP:0008691,decreased interleukin-23 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5548524	Fastk<tm1.1(KOMP)Vlcg>	MP:0002833,increased heart weight|MP:0005292,improved glucose tolerance
MGI:5607749	Fas<tm1.1(ALPP)Chnd>	MP:0002169,no abnormal phenotype detected
MGI:3690544	Fas<tm1.1Cgn>	MP:0000685,abnormal immune system morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes
MGI:3589104	Fas<tm1Ach>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002358,abnormal spleen periarteriolar lymphoid sheath morphology|MP:0002461,increased immunoglobulin level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005013,increased lymphocyte cell number|MP:0005091,increased double-positive T cell number|MP:0006043,decreased apoptosis|MP:0008126,increased dendritic cell number
MGI:3690464	Fas<tm1Cgn>	MP:0000685,abnormal immune system morphology|MP:0000691,enlarged spleen|MP:0000694,spleen hypoplasia|MP:0000702,enlarged lymph nodes|MP:0000716,abnormal immune system cell morphology|MP:0001263,weight loss|MP:0001824,abnormal thymus involution|MP:0001829,increased activated T cell number|MP:0001846,increased inflammatory response|MP:0001859,kidney inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002083,premature death|MP:0002722,abnormal immune system organ morphology|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005090,increased double-negative T cell number|MP:0005387,immune system phenotype|MP:0006050,pulmonary fibrosis|MP:0006413,increased T cell apoptosis|MP:0008049,increased memory T cell number|MP:0008101,lymph node hypoplasia|MP:0010922,alveolitis
MGI:3045400	Fas<tm1Dlo>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001648,abnormal apoptosis|MP:0001824,abnormal thymus involution|MP:0002461,increased immunoglobulin level
MGI:1861923	Fas<tm1Osa>	MP:0000218,increased leukocyte cell number|MP:0000607,abnormal hepatocyte morphology|MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002083,premature death|MP:0002148,abnormal hypersensitivity reaction|MP:0002221,abnormal lymph organ size|MP:0002493,increased IgG level|MP:0003725,increased autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0005002,abnormal T cell clonal deletion|MP:0005013,increased lymphocyte cell number|MP:0005014,increased B cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005141,liver hyperplasia|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level
MGI:2156198	Fat1<Gt(GST070)Byg>	MP:0011087,neonatal lethality, complete penetrance
MGI:4124012	Fat1<Gt(KST249)Byg>	MP:0000160,kyphosis|MP:0000733,abnormal muscle development|MP:0000759,abnormal skeletal muscle morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001263,weight loss|MP:0001297,microphthalmia|MP:0001405,impaired coordination|MP:0001504,abnormal posture|MP:0002083,premature death|MP:0002792,abnormal retina vasculature morphology|MP:0003099,retina detachment|MP:0003675,kidney cyst|MP:0004038,lymphangiectasis|MP:0004510,myositis|MP:0004819,decreased skeletal muscle mass|MP:0005261,aniridia|MP:0005390,skeleton phenotype|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009414,skeletal muscle fiber necrosis|MP:0009417,skeletal muscle atrophy|MP:0010056,ectopic skeletal muscle|MP:0010452,retina microaneurysm
MGI:6153609	Fat1<tm1.1Nsib>	MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0005264,glomerulosclerosis|MP:0005326,abnormal podocyte morphology|MP:0008060,abnormal podocyte slit diaphragm morphology|MP:0008140,podocyte foot process effacement|MP:0011339,abnormal glomerular mesangium morphology|MP:0011868,podocyte microvillus transformation
MGI:5524121	Fat1<tm1.2Fhel>	MP:0000733,abnormal muscle development|MP:0000759,abnormal skeletal muscle morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0004510,myositis|MP:0004924,abnormal behavior|MP:0008065,short endolymphatic duct|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009414,skeletal muscle fiber necrosis|MP:0010056,ectopic skeletal muscle|MP:0011088,neonatal lethality, incomplete penetrance|MP:0030039,abnormal facial muscle morphology
MGI:2662293	Fat1<tm1Cfc>	MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0003078,aphakia|MP:0005157,holoprosencephaly|MP:0005163,cyclopia|MP:0005548,retina pigment epithelium atrophy|MP:0006069,abnormal retina neuronal layer morphology|MP:0006290,proboscis|MP:0008062,abnormal podocyte slit junction morphology|MP:0008139,fused podocyte foot processes|MP:0010771,integument phenotype|MP:0011085,postnatal lethality, complete penetrance
MGI:5524119	Fat1<tm1Fhel>	MP:0000733,abnormal muscle development|MP:0000759,abnormal skeletal muscle morphology|MP:0010056,ectopic skeletal muscle
MGI:4421682	Fat2<tm1Anjm>	MP:0002169,no abnormal phenotype detected
MGI:7425675	Fat3<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0000759,abnormal skeletal muscle morphology|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology|MP:0002953,thick ventricular wall|MP:0004832,enlarged ovary|MP:0004906,enlarged uterus|MP:0010895,increased lung compliance|MP:0011045,decreased lung elastance
MGI:5295415	Fat3<tm1.2Good>	MP:0001325,abnormal retina morphology|MP:0005240,abnormal amacrine cell morphology|MP:0005391,vision/eye phenotype|MP:0006069,abnormal retina neuronal layer morphology|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0008508,thick retina ganglion layer
MGI:3846573	Fat4<tm1.1Hmc>	MP:0000031,abnormal cochlea morphology|MP:0000137,abnormal vertebrae morphology|MP:0000160,kyphosis|MP:0000282,abnormal interatrial septum morphology|MP:0000477,abnormal intestine morphology|MP:0000527,abnormal kidney development|MP:0002151,abnormal neural tube morphology|MP:0002703,abnormal renal tubule morphology|MP:0002989,small kidney|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003051,curly tail|MP:0003641,small lung|MP:0003675,kidney cyst|MP:0004321,short sternum|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0004754,abnormal kidney collecting duct morphology|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005225,abnormal vertebrae development|MP:0008272,abnormal endochondral bone ossification|MP:0008277,abnormal sternum ossification|MP:0009703,decreased birth body size|MP:0011087,neonatal lethality, complete penetrance|MP:0011368,increased kidney apoptosis|MP:0011441,decreased kidney cell proliferation|MP:0012279,wide sternum
MGI:3846574	Fat4<tm2Hmc>	MP:0003051,curly tail|MP:0003675,kidney cyst|MP:0009703,decreased birth body size|MP:0011087,neonatal lethality, complete penetrance
MGI:7645868	Fate1<em1(IMPC)Mbp>	MP:0002590,increased mean corpuscular volume|MP:0010067,increased red blood cell distribution width
MGI:3698783	Fatmq1<CAST/EiJ>	MP:0010025,decreased total body fat amount
MGI:3698785	Fatmq2<CAST/EiJ>	MP:0010025,decreased total body fat amount
MGI:3629159	Fatpad3<CAST/EiJ>	MP:0005334,abnormal fat pad morphology|MP:0009285,increased gonadal fat pad weight
MGI:2154089	Fatq1<MH>	MP:0000008,increased white adipose tissue amount
MGI:6452962	Fau<tm1.1Smoc>	MP:0001935,decreased litter size|MP:0003718,maternal effect|MP:0004896,abnormal endometrium morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:6258582	Faxc<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0011100,preweaning lethality, complete penetrance
MGI:4432655	Fbf1<tm1a(EUCOMM)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000218,increased leukocyte cell number|MP:0002079,increased circulating insulin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005296,abnormal humerus morphology|MP:0005419,decreased circulating serum albumin level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0013279,increased fasting circulating glucose level
MGI:3038488	Fbgl1<KK/Ta>	MP:0001559,hyperglycemia
MGI:3038490	Fbgl2<KK/Ta>	MP:0001559,hyperglycemia
MGI:3043754	Fbl<Gt(pGT1-3)1Jca>	MP:0001730,embryonic growth arrest|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6257420	Fblim1<em5(IMPC)Tcp>	MP:0002764,short tibia|MP:0003450,enlarged pancreas
MGI:5432800	Fblim1<tm1.1Chen>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000352,decreased cell proliferation|MP:0001541,abnormal osteoclast physiology|MP:0004984,increased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0006042,increased apoptosis|MP:0008395,abnormal osteoblast differentiation|MP:0008396,abnormal osteoclast differentiation|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume
MGI:5317180	Fblim1<tm1.2Ref>	MP:0002169,no abnormal phenotype detected
MGI:3802971	Fbln1<Gt(XST011)Byg>	MP:0000030,abnormal tympanic ring morphology|MP:0000102,abnormal nasal bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000109,abnormal parietal bone morphology|MP:0000266,abnormal heart morphology|MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000438,abnormal cranium morphology|MP:0000933,abnormal rhombomere morphology|MP:0001056,abnormal cranial nerve morphology|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001614,abnormal blood vessel morphology|MP:0001634,internal hemorrhage|MP:0001823,thymus hypoplasia|MP:0001914,hemorrhage|MP:0001916,intracerebral hemorrhage|MP:0001954,respiratory distress|MP:0002127,abnormal cardiovascular system morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002639,micrognathia|MP:0002820,abnormal premaxilla morphology|MP:0003499,thyroid gland hypoplasia|MP:0003641,small lung|MP:0004160,retroesophageal right subclavian artery|MP:0004568,fusion of glossopharyngeal and vagus nerve|MP:0006030,abnormal otic vesicle development|MP:0006054,spinal hemorrhage|MP:0006203,eye hemorrhage|MP:0008816,petechiae|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010404,ostium primum atrial septal defect|MP:0010405,ostium secundum atrial septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010454,abnormal truncus arteriosus septation|MP:0010465,aberrant origin of the right subclavian artery|MP:0010502,ventricle myocardium hypoplasia|MP:0011087,neonatal lethality, complete penetrance|MP:0012261,increased hindbrain apoptosis|MP:0012729,abnormal common carotid artery morphology|MP:0030867,small thyroid cartilage
MGI:2384028	Fbln1<tm1Tmpl>	MP:0000208,decreased hematocrit|MP:0000284,double outlet right ventricle|MP:0001176,abnormal lung development|MP:0001183,overexpanded pulmonary alveolus|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001823,thymus hypoplasia|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0001951,abnormal breathing pattern|MP:0002276,abnormal lung interstitium morphology|MP:0003658,abnormal capillary morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0006027,impaired lung alveolus development|MP:0008059,abnormal podocyte foot process morphology|MP:0008816,petechiae|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011359,decreased glomerular capillary number|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011509,dilated glomerular capillary
MGI:3774118	Fbln2<tm1Chu>	MP:0005385,cardiovascular system phenotype
MGI:4442490	Fbln5<tm1.1Hiya>	MP:0003447,decreased tumor growth/size|MP:0005602,decreased angiogenesis
MGI:2681517	Fbln5<tm1Eno>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000249,abnormal blood vessel physiology|MP:0000272,abnormal aorta morphology|MP:0001175,abnormal lung morphology|MP:0001273,decreased metastatic potential|MP:0001958,emphysema|MP:0002268,abnormal terminal bronchiole morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002295,abnormal pulmonary circulation|MP:0003211,abnormal aorta elastic fiber morphology|MP:0003447,decreased tumor growth/size|MP:0003674,oxidative stress|MP:0004883,abnormal vascular wound healing|MP:0005421,loose skin|MP:0005595,abnormal vascular smooth muscle physiology|MP:0005602,decreased angiogenesis|MP:0006083,abnormal blood vessel elastic tissue morphology|MP:0009867,abnormal ascending aorta morphology|MP:0010179,rough coat|MP:0010464,abnormal aortic arch and aortic arch branch attachment|MP:0031121,increased susceptibility to induced thrombosis
MGI:2681527	Fbln5<tm1Krc>	MP:0000272,abnormal aorta morphology|MP:0000428,abnormal craniofacial morphology|MP:0000445,short snout|MP:0001175,abnormal lung morphology|MP:0001958,emphysema|MP:0002268,abnormal terminal bronchiole morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002295,abnormal pulmonary circulation|MP:0002754,dilated heart right ventricle|MP:0005421,loose skin
MGI:6360596	Fbln7<tm1.1Hiya>	MP:0003197,nephrocalcinosis|MP:0003215,renal interstitial fibrosis|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005388,respiratory system phenotype|MP:0005554,decreased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005621,abnormal cell physiology|MP:0010771,integument phenotype
MGI:6303799	Fbn1<em1Chop>	MP:0001262,decreased body weight|MP:0002089,abnormal postnatal growth/weight/body size|MP:0003961,decreased lean body mass|MP:0004811,abnormal neuron physiology|MP:0004890,decreased energy expenditure|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0011940,decreased food intake|MP:0014143,decreased body fat mass
MGI:6750862	Fbn1<em1(IMPC)H>	MP:0000219,increased neutrophil cell number|MP:0002599,increased mean platelet volume|MP:0004952,increased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0011110,preweaning lethality, incomplete penetrance
MGI:8245561	Fbn1<em1Kkim>	MP:0000160,kyphosis|MP:0000272,abnormal aorta morphology|MP:0001198,tight skin|MP:0001262,decreased body weight|MP:0001634,internal hemorrhage|MP:0002083,premature death|MP:0004011,decreased diastolic filling velocity|MP:0004044,aortic dissection|MP:0009862,abnormal aorta elastic tissue morphology|MP:0009864,abnormal aorta endothelium morphology|MP:0009865,abnormal aorta smooth muscle morphology|MP:0009871,abnormal aorta tunica adventitia morphology|MP:0009873,abnormal aorta tunica media morphology|MP:0010139,aortitis|MP:0010470,dilated ascending aorta|MP:0011572,abnormal aorta bulb morphology|MP:0031133,increased aorta tortuosity
MGI:4839045	Fbn1<tm1.2Lysa>	MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003211,abnormal aorta elastic fiber morphology|MP:0005503,abnormal tendon morphology|MP:0008419,abnormal cutaneous microfibril morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:3690325	Fbn1<tm1Hcd>	MP:0000150,abnormal rib morphology|MP:0000160,kyphosis|MP:0001183,overexpanded pulmonary alveolus|MP:0001614,abnormal blood vessel morphology|MP:0003211,abnormal aorta elastic fiber morphology|MP:0004044,aortic dissection|MP:0005508,abnormal skeleton morphology|MP:0006045,mitral valve regurgitation|MP:0006120,mitral valve prolapse|MP:0008726,increased heart left atrium size|MP:0009866,abnormal aorta wall morphology|MP:0010579,increased heart left ventricle size|MP:0010614,abnormal mitral valve cusp morphology|MP:0010996,increased aorta wall thickness|MP:0011085,postnatal lethality, complete penetrance
MGI:5439624	Fbn1<tm1Itl>	MP:0002127,abnormal cardiovascular system morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:4880665	Fbn1<tm1Lper>	MP:0000160,kyphosis|MP:0001175,abnormal lung morphology|MP:0001861,lung inflammation|MP:0001958,emphysema|MP:0002083,premature death|MP:0003211,abnormal aorta elastic fiber morphology|MP:0004389,abnormal respiratory bronchiole morphology|MP:0005243,hemothorax|MP:0005508,abnormal skeleton morphology|MP:0009873,abnormal aorta tunica media morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:1934905	Fbn1<tm1Rmz>	MP:0000272,abnormal aorta morphology|MP:0001176,abnormal lung development|MP:0001182,lung hemorrhage|MP:0001183,overexpanded pulmonary alveolus|MP:0001958,emphysema|MP:0002270,abnormal pulmonary alveolus morphology|MP:0004007,abnormal lung vasculature morphology|MP:0004044,aortic dissection|MP:0005243,hemothorax|MP:0005244,hemopericardium|MP:0006027,impaired lung alveolus development|MP:0010483,aortic sinus aneurysm|MP:0010900,abnormal pulmonary interalveolar septum morphology|MP:0010915,increased solitary pulmonary neuroendocrine cell number|MP:0010918,abnormal pulmonary neuroendocrine body morphology|MP:0010919,increased number of pulmonary neuroendocrine bodies|MP:0011085,postnatal lethality, complete penetrance|MP:0031157,abnormal arterial thrombosis
MGI:5558867	Fbn1<tm2.1Hcd>	MP:0001243,abnormal dermal layer morphology|MP:0002433,abnormal T-helper 1 cell morphology|MP:0003725,increased autoantibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005014,increased B cell number|MP:0008097,increased plasma cell number|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0008568,abnormal interleukin secretion|MP:0008672,increased interleukin-13 secretion|MP:0008711,increased interleukin-9 secretion|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0011092,embryonic lethality, complete penetrance|MP:0014659,increased skin stiffness
MGI:4839071	Fbn1<tm2.1Lysa>	MP:0005385,cardiovascular system phenotype|MP:0010768,mortality/aging|MP:0010771,integument phenotype
MGI:1934906	Fbn1<tm2Rmz>	MP:0000063,decreased bone mineral density|MP:0000150,abnormal rib morphology|MP:0000160,kyphosis|MP:0000272,abnormal aorta morphology|MP:0001183,overexpanded pulmonary alveolus|MP:0001267,enlarged chest|MP:0001614,abnormal blood vessel morphology|MP:0001861,lung inflammation|MP:0001914,hemorrhage|MP:0001954,respiratory distress|MP:0001958,emphysema|MP:0002083,premature death|MP:0002964,aortic elastic tissue lesions|MP:0003924,diaphragmatic hernia|MP:0004695,increased length of long bones|MP:0005243,hemothorax|MP:0005244,hemopericardium|MP:0006027,impaired lung alveolus development|MP:0006278,aortic aneurysm|MP:0009871,abnormal aorta tunica adventitia morphology|MP:0009872,abnormal aorta tunica intima morphology|MP:0009873,abnormal aorta tunica media morphology|MP:0010139,aortitis|MP:0010522,calcified aorta|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume
MGI:5558868	Fbn1<tm3.1Hcd>	MP:0001243,abnormal dermal layer morphology|MP:0002433,abnormal T-helper 1 cell morphology|MP:0003725,increased autoantibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005014,increased B cell number|MP:0008097,increased plasma cell number|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0008568,abnormal interleukin secretion|MP:0008672,increased interleukin-13 secretion|MP:0008711,increased interleukin-9 secretion|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009932,skin fibrosis|MP:0014659,increased skin stiffness
MGI:5313375	Fbn1<tm3.2Lysa>	MP:0001200,thick skin|MP:0001243,abnormal dermal layer morphology|MP:0001245,thick dermal layer|MP:0002060,abnormal skin morphology|MP:0002543,brachyphalangia|MP:0002764,short tibia|MP:0004355,short radius|MP:0004359,short ulna|MP:0004634,short metacarpal bones|MP:0004686,decreased length of long bones|MP:0005385,cardiovascular system phenotype|MP:0008844,decreased subcutaneous adipose tissue amount
MGI:3641232	Fbn1<tm3Rmz>	MP:0000150,abnormal rib morphology|MP:0001183,overexpanded pulmonary alveolus|MP:0002279,abnormal diaphragm morphology|MP:0002280,abnormal intercostal muscle morphology|MP:0002998,abnormal bone remodeling|MP:0003211,abnormal aorta elastic fiber morphology|MP:0003924,diaphragmatic hernia|MP:0004671,long ribs|MP:0005243,hemothorax|MP:0005244,hemopericardium|MP:0005275,abnormal skin tensile strength|MP:0009862,abnormal aorta elastic tissue morphology|MP:0010661,ascending aorta aneurysm|MP:0011085,postnatal lethality, complete penetrance|MP:0014274,decreased respiration
MGI:1857348	Fbn1<Tsk>	MP:0000163,abnormal cartilage morphology|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000276,heart right ventricle hypertrophy|MP:0000324,increased mast cell number|MP:0000439,enlarged cranium|MP:0000538,abnormal urinary bladder morphology|MP:0001175,abnormal lung morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001183,overexpanded pulmonary alveolus|MP:0001191,abnormal skin condition|MP:0001198,tight skin|MP:0001200,thick skin|MP:0001243,abnormal dermal layer morphology|MP:0001245,thick dermal layer|MP:0001505,hunched posture|MP:0001625,cardiac hypertrophy|MP:0001762,polyuria|MP:0001861,lung inflammation|MP:0001958,emphysema|MP:0002060,abnormal skin morphology|MP:0002267,abnormal bronchiole morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002754,dilated heart right ventricle|MP:0003120,abnormal tracheal cartilage morphology|MP:0003140,dilated heart atrium|MP:0003141,cardiac fibrosis|MP:0003705,abnormal hypodermis morphology|MP:0003725,increased autoantibody level|MP:0003905,abnormal aorta elastin content|MP:0003920,abnormal heart right ventricle morphology|MP:0004127,thick hypodermis|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004593,long mandible|MP:0004671,long ribs|MP:0004695,increased length of long bones|MP:0004707,enlarged lumbar vertebrae|MP:0004735,enlarged thoracic cavity|MP:0005081,abnormal dermis reticular layer morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005501,abnormal skin physiology|MP:0005503,abnormal tendon morphology|MP:0005508,abnormal skeleton morphology|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0006432,abnormal costal cartilage morphology|MP:0008054,abnormal uterine NK cell morphology|MP:0008419,abnormal cutaneous microfibril morphology|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0009545,abnormal dermis papillary layer morphology|MP:0009826,abnormal dermis reticular layer collagen network|MP:0009871,abnormal aorta tunica adventitia morphology|MP:0009932,skin fibrosis|MP:0010386,abnormal urinary bladder physiology|MP:0010895,increased lung compliance|MP:0010900,abnormal pulmonary interalveolar septum morphology|MP:0010904,abnormal alveolar pore morphology|MP:0010908,dilated pulmonary alveolar duct|MP:0010922,alveolitis|MP:0010937,increased total lung capacity|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0014474,decreased pulmonary alveolus wall thickness|MP:0030799,abnormal tendon sheath morphology
MGI:6257481	Fbn2<em1(IMPC)Rbrc>	MP:0000150,abnormal rib morphology|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000438,abnormal cranium morphology|MP:0000458,abnormal mandible morphology|MP:0000552,abnormal radius morphology|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0000564,syndactyly|MP:0000572,abnormal autopod morphology|MP:0000579,abnormal nail morphology|MP:0000598,abnormal liver morphology|MP:0001258,decreased body length|MP:0001314,cornea opacity|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002110,abnormal digit morphology|MP:0002111,abnormal tail morphology|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002187,abnormal fibula morphology|MP:0002932,abnormal joint morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0003795,abnormal bone structure|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004609,vertebral fusion|MP:0004857,abnormal heart weight|MP:0005108,abnormal ulna morphology|MP:0005270,abnormal zygomatic bone morphology|MP:0005296,abnormal humerus morphology|MP:0005298,abnormal clavicle morphology|MP:0005542,cornea vascularization|MP:0008259,abnormal optic disk morphology|MP:0008805,decreased circulating amylase level|MP:0010053,decreased grip strength|MP:0010123,increased bone mineral content|MP:0010570,prolonged ST segment
MGI:1935123	Fbn2<fp>	MP:0000564,syndactyly|MP:0000747,muscle weakness|MP:0001513,limb grasping|MP:0010053,decreased grip strength
MGI:1935122	Fbn2<fp-2J>	MP:0000564,syndactyly
MGI:2157491	Fbn2<fp-3J>	MP:0000564,syndactyly
MGI:5547954	Fbn2<fp-4J>	MP:0000564,syndactyly|MP:0005391,vision/eye phenotype|MP:0008730,fused phalanges
MGI:4438056	Fbn2<mz>	MP:0000564,syndactyly|MP:0000747,muscle weakness|MP:0001265,decreased body size|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0004145,abnormal muscle electrophysiology|MP:0004818,increased skeletal muscle mass|MP:0008730,fused phalanges|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010053,decreased grip strength
MGI:6194346	Fbn2<timon>	MP:0000554,abnormal carpal bone morphology|MP:0000564,syndactyly|MP:0001785,edema|MP:0001921,reduced fertility|MP:0002092,abnormal eye morphology|MP:0002102,abnormal ear morphology|MP:0002639,micrognathia|MP:0005508,abnormal skeleton morphology
MGI:2445938	Fbn2<tm1Rmz>	MP:0000564,syndactyly|MP:0000572,abnormal autopod morphology|MP:0002113,abnormal skeleton development|MP:0002932,abnormal joint morphology|MP:0002998,abnormal bone remodeling|MP:0004016,decreased bone mass|MP:0005388,respiratory system phenotype|MP:0009874,abnormal interdigital cell death
MGI:6269410	Fbp1<m1Btlr>	MP:0000189,hypoglycemia
MGI:5637205	Fbp2<tm2b(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0001303,abnormal lens morphology|MP:0001529,abnormal vocalization|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6764589	Fbrs<em1(IMPC)J>	MP:0001304,cataract|MP:0002942,decreased circulating alanine transaminase level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005278,abnormal cholesterol homeostasis|MP:0005344,increased circulating bilirubin level|MP:0005632,decreased circulating aspartate transaminase level|MP:0005635,decreased circulating bilirubin level|MP:0011100,preweaning lethality, complete penetrance
MGI:6281945	Fbrsl1<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0000706,small thymus|MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0001325,abnormal retina morphology|MP:0002111,abnormal tail morphology|MP:0004609,vertebral fusion|MP:0004930,small epididymis|MP:0010052,increased grip strength|MP:0010067,increased red blood cell distribution width|MP:0010392,prolonged QRS complex duration
MGI:3834642	Fbrwt1<C57BL/6J>	MP:0000783,abnormal forebrain morphology
MGI:3834644	Fbrwt2<C57BL/6J>	MP:0000783,abnormal forebrain morphology
MGI:3701638	Fbtq2<C3H/HeJ>	MP:0003795,abnormal bone structure|MP:0004149,increased bone strength|MP:0013615,increased volumetric bone mineral density|MP:0013637,increased femur stiffness
MGI:3701639	Fbtq3<C57BL/6J>	MP:0001533,abnormal skeleton physiology|MP:0003795,abnormal bone structure|MP:0004149,increased bone strength
MGI:3701642	Fbtq4<C3H/HeJ>	MP:0004149,increased bone strength
MGI:3701644	Fbtq5<C3H/HeJ>	MP:0004149,increased bone strength|MP:0013615,increased volumetric bone mineral density
MGI:3701646	Fbtq6<C3H/HeJ>	MP:0001533,abnormal skeleton physiology|MP:0003795,abnormal bone structure|MP:0004149,increased bone strength
MGI:3701648	Fbtq7<C3H/HeJ>	MP:0013615,increased volumetric bone mineral density
MGI:3701650	Fbtq8<C3H/HeJ>	MP:0004149,increased bone strength|MP:0013615,increased volumetric bone mineral density|MP:0013637,increased femur stiffness
MGI:5788017	Fbxl12<tm1Kei>	MP:0001732,postnatal growth retardation|MP:0003984,embryonic growth retardation|MP:0004201,fetal growth retardation|MP:0004259,small placenta|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0008957,abnormal placenta junctional zone morphology|MP:0009546,absent gastric milk in neonates|MP:0009703,decreased birth body size|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6488167	Fbxl13<em1Osb>	MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype
MGI:5548838	Fbxl16<tm1b(KOMP)Wtsi>	MP:0001491,unresponsive to tactile stimuli|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5605815	Fbxl18<tm1b(EUCOMM)Hmgu>	MP:0001312,abnormal cornea morphology|MP:0002606,increased basophil cell number|MP:0005011,increased eosinophil cell number
MGI:6838372	Fbxl19<tm1.2Hko>	MP:0001258,decreased body length|MP:0003984,embryonic growth retardation|MP:0004575,small limb buds|MP:0006337,abnormal first pharyngeal arch morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011260,abnormal head mesenchyme morphology|MP:0011264,abnormal cardiac mesenchyme morphology|MP:0012177,delayed head development
MGI:5692857	Fbxl19<tm1b(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0002599,increased mean platelet volume|MP:0002606,increased basophil cell number|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005560,decreased circulating glucose level|MP:0005567,decreased circulating total protein level
MGI:5812919	Fbxl20<tm1b(KOMP)Wtsi>	MP:0002590,increased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3765911	Fbxl20<tm1Seto>	MP:0001265,decreased body size|MP:0002083,premature death|MP:0002920,decreased paired-pulse facilitation|MP:0004247,small pancreas|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3522308	Fbxl21<Psttm>	MP:0005645,abnormal hypothalamus physiology|MP:0020414,abnormal fibroblast physiology|MP:0020470,shortened circadian behavior period
MGI:5503967	Fbxl21<tm1Kei>	MP:0020467,abnormal circadian behavior
MGI:5637143	Fbxl21<tm2b(EUCOMM)Wtsi>	MP:0001513,limb grasping
MGI:5548639	Fbxl22<tm1.1(KOMP)Vlcg>	MP:0002764,short tibia
MGI:3687377	Fbxl3<Afh>	MP:0005645,abnormal hypothalamus physiology|MP:0020469,prolonged circadian behavior period
MGI:6450148	Fbxl3<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000759,abnormal skeletal muscle morphology|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001325,abnormal retina morphology|MP:0001891,hydrocephaly|MP:0002060,abnormal skin morphology|MP:0002152,abnormal brain morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003019,increased circulating chloride level|MP:0003271,abnormal duodenum morphology|MP:0003402,decreased liver weight|MP:0003961,decreased lean body mass|MP:0004953,decreased spleen weight|MP:0005567,decreased circulating total protein level|MP:0013771,decreased effector memory T-helper cell number
MGI:5906265	Fbxl3<m1Btlr>	MP:0020467,abnormal circadian behavior|MP:0020475,delayed circadian behavior phase
MGI:5752834	Fbxl3<M1Jt>	MP:0020469,prolonged circadian behavior period
MGI:5805979	Fbxl3<Mgbe>	MP:0020469,prolonged circadian behavior period
MGI:2449078	Fbxl3<Ovtm>	MP:0020469,prolonged circadian behavior period
MGI:5494565	Fbxl3<tm1.1Ljp>	MP:0020469,prolonged circadian behavior period
MGI:5503966	Fbxl3<tm1Kei>	MP:0020469,prolonged circadian behavior period|MP:0020476,abnormal circardian behavior entrainment
MGI:6514034	Fbxl4<tm1.2Lrsn>	MP:0000160,kyphosis|MP:0001262,decreased body weight|MP:0001860,liver inflammation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003103,liver degeneration|MP:0005367,renal/urinary system phenotype|MP:0005385,cardiovascular system phenotype|MP:0010959,abnormal oxidative phosphorylation|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011629,decreased mitochondrial number|MP:0011639,decreased mitochondrial DNA content
MGI:4302129	Fbxl5<Gt(OST386421)Lex>	MP:0002447,abnormal erythrocyte morphology|MP:0003984,embryonic growth retardation|MP:0005637,abnormal iron homeostasis|MP:0008743,decreased liver iron level|MP:0008809,increased spleen iron level|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0020369,increased intestine iron level
MGI:4458019	Fbxl5<L5Jcs32>	MP:0000929,open neural tube|MP:0001787,pericardial edema|MP:0011092,embryonic lethality, complete penetrance
MGI:5295288	Fbxl5<tm1Kei>	MP:0001634,internal hemorrhage|MP:0001672,abnormal embryo development|MP:0001770,abnormal iron level|MP:0001914,hemorrhage|MP:0003674,oxidative stress|MP:0003984,embryonic growth retardation|MP:0004264,abnormal extraembryonic tissue physiology|MP:0005032,abnormal ectoplacental cone morphology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5295289	Fbxl5<tm2.1Kei>	MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0001570,abnormal circulating enzyme level|MP:0001770,abnormal iron level|MP:0001860,liver inflammation|MP:0002551,abnormal blood coagulation|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0003326,liver failure|MP:0003674,oxidative stress|MP:0003888,liver hemorrhage|MP:0005343,increased circulating aspartate transaminase level|MP:0006036,abnormal mitochondrial physiology|MP:0008807,increased liver iron level|MP:0008810,increased circulating iron level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011897,decreased circulating unsaturated transferrin level|MP:0011971,increased circulating lactate dehydrogenase level|MP:0012356,increased prothrombin time|MP:0012359,increased partial thromboplastin time|MP:0014341,abnormal hepatocyte mitochondrial morphology
MGI:7425800	Fbxl9<em1(IMPC)Bay>	MP:0005293,impaired glucose tolerance
MGI:6721013	Fbxo10<em1Ccg>	MP:0002169,no abnormal phenotype detected
MGI:5827555	Fbxo10<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001523,impaired righting response|MP:0002075,abnormal coat/hair pigmentation
MGI:6721015	Fbxo10<em2Ccg>	MP:0002169,no abnormal phenotype detected
MGI:5806267	Fbxo10<tm1b(KOMP)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000208,decreased hematocrit|MP:0000222,decreased neutrophil cell number|MP:0002591,decreased mean corpuscular volume|MP:0002644,decreased circulating triglyceride level|MP:0005140,decreased cardiac muscle contractility|MP:0005560,decreased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005566,decreased blood urea nitrogen level
MGI:1862017	Fbxo11<Jf>	MP:0000108,midline facial cleft|MP:0000111,cleft palate|MP:0000445,short snout|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001302,eyelids open at birth|MP:0001485,abnormal pinna reflex|MP:0001850,increased susceptibility to otitis media|MP:0001967,deafness|MP:0003009,abnormal cytokine secretion|MP:0003330,abnormal auditory tube morphology|MP:0004411,decreased endocochlear potential|MP:0005105,abnormal middle ear ossicle morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0006325,impaired hearing|MP:0006358,absent pinna reflex|MP:0011087,neonatal lethality, complete penetrance|MP:0030154,abnormal tympanic cavity morphology|MP:0030226,middle ear polyps|MP:0030410,middle ear effusion|MP:0030413,tympanic membrane retraction|MP:0030419,excessive cerumen
MGI:3690632	Fbxo11<Mutt>	MP:0000108,midline facial cleft|MP:0000111,cleft palate|MP:0001489,decreased startle reflex|MP:0006325,impaired hearing|MP:0011090,perinatal lethality, incomplete penetrance|MP:0030066,short face
MGI:4434283	Fbxo11<tm2a(EUCOMM)Wtsi>	MP:0000379,decreased hair follicle number|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0008469,abnormal protein level|MP:0009603,absent keratohyalin granules|MP:0011087,neonatal lethality, complete penetrance
MGI:5637115	Fbxo11<tm2b(EUCOMM)Wtsi>	MP:0000208,decreased hematocrit|MP:0001399,hyperactivity|MP:0002764,short tibia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004151,decreased circulating iron level|MP:0005287,narrow eye opening|MP:0005567,decreased circulating total protein level|MP:0010067,increased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:2655776	Fbxo15<tm1Yam>	MP:0002169,no abnormal phenotype detected
MGI:6159262	Fbxo21<em1(IMPC)J>	MP:0001312,abnormal cornea morphology|MP:0001529,abnormal vocalization
MGI:7444787	Fbxo21<em1Smbk>	MP:0004953,decreased spleen weight|MP:0005015,increased T cell number|MP:0009278,abnormal bone marrow cell physiology|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0013696,increased granulocyte monocyte progenitor cell number|MP:0031276,abnormal stress erythropoiesis
MGI:7518950	Fbxo22<em1Mkt>	MP:0005621,abnormal cell physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:5605802	Fbxo22<tm1b(EUCOMM)Wtsi>	MP:0000280,thin ventricular wall|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002111,abnormal tail morphology|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0010580,decreased heart left ventricle size
MGI:7628680	Fbxo24<em1Syu>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0011635,abnormal mitochondrial crista morphology|MP:0014052,increased male germ cell apoptosis|MP:0014468,disorganized sperm mitochondrial sheath|MP:0014636,decreased elongated spermatid number|MP:0020362,abnormal male germ cell physiology|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0031620,abnormal chromatoid body morphology
MGI:6341913	Fbxo25<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000538,abnormal urinary bladder morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001402,decreased locomotor activity|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004924,abnormal behavior|MP:0008935,decreased mean platelet volume|MP:0011874,enlarged urinary bladder|MP:0020870,decreased thigmotaxis
MGI:7425677	Fbxo28<em1(IMPC)Mhzh>	MP:0002606,increased basophil cell number|MP:0004924,abnormal behavior|MP:0005011,increased eosinophil cell number|MP:0010052,increased grip strength|MP:0020870,decreased thigmotaxis
MGI:5694184	Fbxo2<tm1b(EUCOMM)Wtsi>	MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0005559,increased circulating glucose level|MP:0013278,decreased fasting circulating glucose level
MGI:3711101	Fbxo2<tm1Hlp>	MP:0000032,cochlear degeneration|MP:0001967,deafness|MP:0002622,abnormal cochlear hair cell morphology|MP:0002857,cochlear ganglion degeneration|MP:0003631,nervous system phenotype|MP:0004300,abnormal organ of Corti supporting cell morphology|MP:0004362,cochlear hair cell degeneration|MP:0004430,abnormal Claudius cell morphology|MP:0004465,degeneration of organ of Corti supporting cells|MP:0004748,increased susceptibility to age-related hearing loss|MP:0005386,behavior/neurological phenotype|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5632527	Fbxo30<tm1b(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0001289,persistence of hyaloid vascular system|MP:0001399,hyperactivity|MP:0001489,decreased startle reflex|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0009141,increased prepulse inhibition|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2676047	Fbxo32<tm1Glas>	MP:0004064,decreased susceptibility to induced muscular atrophy
MGI:5548601	Fbxo33<tm1b(EUCOMM)Wtsi>	MP:0002941,increased circulating alanine transaminase level|MP:0004738,abnormal auditory brainstem response|MP:0006358,absent pinna reflex
MGI:5605754	Fbxo36<tm1b(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0002591,decreased mean corpuscular volume|MP:0002606,increased basophil cell number|MP:0002953,thick ventricular wall|MP:0003179,thrombocytopenia|MP:0003921,abnormal heart left ventricle morphology|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008935,decreased mean platelet volume|MP:0010053,decreased grip strength|MP:0010067,increased red blood cell distribution width
MGI:7311994	Fbxo38<em1Crmk>	MP:0001156,abnormal spermatogenesis|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001922,reduced male fertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0003402,decreased liver weight|MP:0004109,abnormal Sertoli cell development|MP:0004852,decreased testis weight|MP:0005169,abnormal male meiosis|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011750,abnormal seminiferous tubule epithelium morphology
MGI:6794059	Fbxo3<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:5548413	Fbxo41<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0002833,increased heart weight|MP:0003917,increased kidney weight|MP:0004738,abnormal auditory brainstem response|MP:0005179,decreased circulating cholesterol level|MP:0006203,eye hemorrhage|MP:0010053,decreased grip strength
MGI:4881288	Fbxo41<tm1(KOMP)Vlcg>	MP:0000745,tremors|MP:0000852,small cerebellum|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0003631,nervous system phenotype|MP:0006009,abnormal neuronal migration|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6836768	Fbxo42<em1(IMPC)J>	MP:0000194,increased circulating calcium level|MP:0002942,decreased circulating alanine transaminase level|MP:0004738,abnormal auditory brainstem response|MP:0005505,thrombocytosis|MP:0005632,decreased circulating aspartate transaminase level|MP:0005635,decreased circulating bilirubin level|MP:0010392,prolonged QRS complex duration|MP:0011100,preweaning lethality, complete penetrance
MGI:6201341	Fbxo43<tm1.1Kald>	MP:0001925,male infertility|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:6201342	Fbxo43<tm1.2Kald>	MP:0001125,abnormal oocyte morphology|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002006,neoplasm|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0008261,arrest of male meiosis|MP:0009443,parthenogenesis|MP:0014052,increased male germ cell apoptosis
MGI:5569043	Fbxo44<tm1b(KOMP)Wtsi>	MP:0010053,decreased grip strength
MGI:3849742	Fbxo45<tm1Kei>	MP:0000160,kyphosis|MP:0000774,decreased brain size|MP:0000778,abnormal nervous system tract morphology|MP:0000934,abnormal telencephalon development|MP:0000937,abnormal motor neuron morphology|MP:0000940,abnormal motor neuron innervation pattern|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001404,no spontaneous movement|MP:0001512,trunk curl|MP:0001953,respiratory failure|MP:0003631,nervous system phenotype|MP:0003717,pallor|MP:0006009,abnormal neuronal migration|MP:0008129,absent brain internal capsule|MP:0008227,absent anterior commissure|MP:0008439,abnormal cortical plate morphology|MP:0008503,abnormal spinal cord grey matter morphology|MP:0009450,abnormal axon fasciculation|MP:0011087,neonatal lethality, complete penetrance
MGI:7261293	Fbxo47<em1Keish>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0009452,abnormal synaptonemal complex|MP:0011752,abnormal X-Y chromosome synaptonemal complex assembly during male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:4431644	Fbxo47<tm1a(EUCOMM)Wtsi>	MP:0001925,male infertility|MP:0010052,increased grip strength
MGI:7356592	Fbxo48<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response|MP:0005632,decreased circulating aspartate transaminase level|MP:0005635,decreased circulating bilirubin level
MGI:5301830	Fbxo4<tm1.1Jadi>	MP:0000240,extramedullary hematopoiesis|MP:0002020,increased tumor incidence|MP:0002047,increased hepatic hemangioma incidence|MP:0002083,premature death|MP:0002947,increased hemangioma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0009222,increased uterus tumor incidence|MP:0009321,increased histiocytic sarcoma incidence|MP:0009439,increased myeloid sarcoma incidence|MP:0010299,increased mammary gland tumor incidence|MP:0010373,myeloid hyperplasia|MP:0011703,increased fibroblast proliferation|MP:0012431,increased lymphoma incidence
MGI:5319202	Fbxo4<tm1Kei>	MP:0002169,no abnormal phenotype detected|MP:0005384,cellular phenotype
MGI:7425678	Fbxo5<em1(IMPC)Mbp>	MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002591,decreased mean corpuscular volume|MP:0002699,abnormal vitreous body morphology|MP:0003068,enlarged kidney|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0020421,increased freezing behavior
MGI:3640940	Fbxo5<tm1Dlim>	MP:0001672,abnormal embryo development|MP:0002663,absent blastocoele|MP:0002718,abnormal inner cell mass morphology|MP:0004046,abnormal mitosis|MP:0005031,abnormal trophoblast layer morphology|MP:0009760,abnormal mitotic spindle morphology|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4434927	Fbxo7<tm1a(EUCOMM)Hmgu>	MP:0002416,abnormal proerythroblast morphology|MP:0003135,increased erythroid progenitor cell number|MP:0008186,increased pro-B cell number|MP:0011179,decreased erythroblast number
MGI:4842259	Fbxo7<tm1a(EUCOMM)Wtsi>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0001156,abnormal spermatogenesis|MP:0001577,anemia|MP:0001823,thymus hypoplasia|MP:0001829,increased activated T cell number|MP:0001925,male infertility|MP:0002145,abnormal T cell differentiation|MP:0002412,increased susceptibility to bacterial infection|MP:0002590,increased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002687,oligozoospermia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003644,thymus atrophy|MP:0004151,decreased circulating iron level|MP:0004852,decreased testis weight|MP:0004952,increased spleen weight|MP:0005018,decreased T cell number|MP:0005090,increased double-negative T cell number|MP:0005344,increased circulating bilirubin level|MP:0005386,behavior/neurological phenotype|MP:0005505,thrombocytosis|MP:0005561,increased mean corpuscular hemoglobin|MP:0005578,teratozoospermia|MP:0005633,increased circulating sodium level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008049,increased memory T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008279,arrest of spermiogenesis|MP:0008945,hyperchromic macrocytic anemia|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010035,increased erythrocyte clearance|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level|MP:0010768,mortality/aging|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0011178,increased erythroblast number|MP:0011913,abnormal reticulocyte cell number|MP:0013762,abnormal effector T cell number|MP:0020869,immotile sperm
MGI:6120740	Fbxo7<tm1b(EUCOMM)Wtsi>	MP:0011085,postnatal lethality, complete penetrance
MGI:6117789	Fbxo7<tm1c(EUCOMM)Wtsi>	MP:0005018,decreased T cell number|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:5513776	Fbxo9<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment|MP:0001556,increased circulating HDL cholesterol level|MP:0002606,increased basophil cell number|MP:0002768,small adrenal glands|MP:0005011,increased eosinophil cell number|MP:0005178,increased circulating cholesterol level
MGI:6274925	Fbxw10<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0010025,decreased total body fat amount|MP:0011874,enlarged urinary bladder
MGI:6343251	Fbxw11<tm1Nakay>	MP:0001730,embryonic growth arrest|MP:0003984,embryonic growth retardation|MP:0004264,abnormal extraembryonic tissue physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6341864	Fbxw15<em1(IMPC)Ccpcz>	MP:0001175,abnormal lung morphology|MP:0001566,increased circulating phosphate level|MP:0003604,single kidney|MP:0005270,abnormal zygomatic bone morphology
MGI:7641811	Fbxw15<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6341868	Fbxw16<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0002100,abnormal tooth morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013436,increased CD8-positive, naive alpha-beta T cell number
MGI:6160169	Fbxw17<tm1b(KOMP)Wtsi>	MP:0010097,abnormal retina blood vessel morphology
MGI:6341894	Fbxw18<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0001891,hydrocephaly|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002100,abnormal tooth morphology|MP:0002152,abnormal brain morphology|MP:0003019,increased circulating chloride level|MP:0005633,increased circulating sodium level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6341923	Fbxw20<em1(IMPC)Ccpcz>	MP:0000470,abnormal stomach morphology|MP:0000627,abnormal mammary gland morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002060,abnormal skin morphology|MP:0002100,abnormal tooth morphology|MP:0002339,abnormal lymph node morphology|MP:0003883,enlarged stomach
MGI:6358064	Fbxw25<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002110,abnormal digit morphology
MGI:5548906	Fbxw26<tm1b(KOMP)Wtsi>	MP:0008044,increased NK cell number|MP:0012767,increased KLRG1-positive NK cell number|MP:0013426,decreased memory-marker NK cell number
MGI:5692636	Fbxw2<tm1b(EUCOMM)Hmgu>	MP:0002606,increased basophil cell number
MGI:1857833	Fbxw4<Dac>	MP:0000565,oligodactyly
MGI:1857834	Fbxw4<Dac-2J>	MP:0000565,oligodactyly
MGI:7641837	Fbxw5<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6488664	Fbxw5<em1Syli>	MP:0001625,cardiac hypertrophy|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0005140,decreased cardiac muscle contractility|MP:0005385,cardiovascular system phenotype|MP:0005608,cardiac interstitial fibrosis|MP:0005630,increased lung weight|MP:0031217,increased susceptibility to myocardial ischemic injury
MGI:3623969	Fbxw7as1<tm1Opaz>	MP:0000267,abnormal heart development|MP:0000298,absent atrioventricular cushions|MP:0001262,decreased body weight|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0002843,decreased systemic arterial blood pressure|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0003447,decreased tumor growth/size|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011204,abnormal visceral yolk sac blood island morphology
MGI:4867641	Fbxw7<tm1.1Axbe>	MP:0000788,abnormal cerebral cortex morphology|MP:0000852,small cerebellum|MP:0000854,abnormal cerebellum development|MP:0000857,abnormal cerebellar foliation|MP:0000866,cerebellum vermis hypoplasia|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000913,abnormal brain development|MP:0002081,perinatal lethality|MP:0003631,nervous system phenotype|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004981,decreased neuronal precursor cell number|MP:0006104,abnormal tectum morphology|MP:0008439,abnormal cortical plate morphology|MP:0008457,abnormal cortical intermediate zone morphology|MP:0009267,abnormal cerebellum fissure morphology|MP:0009937,abnormal neuron differentiation|MP:0014327,decreased Purkinje cell size|MP:0020528,thalamus hypoplasia
MGI:6157076	Fbxw7<tm1.1Iken>	MP:0000111,cleft palate|MP:0001179,thick pulmonary interalveolar septum|MP:0001302,eyelids open at birth|MP:0001953,respiratory failure|MP:0002133,abnormal respiratory system physiology|MP:0011089,perinatal lethality, complete penetrance
MGI:3767578	Fbxw7<tm1.1Kei>	MP:0000259,abnormal vascular development|MP:0011091,prenatal lethality, complete penetrance
MGI:5293735	Fbxw7<tm1.2Axbe>	MP:0011092,embryonic lethality, complete penetrance
MGI:3798866	Fbxw7<tm1Iaai>	MP:0000333,decreased bone marrow cell number|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001823,thymus hypoplasia|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002024,increased T cell derived lymphoma incidence|MP:0002145,abnormal T cell differentiation|MP:0002631,abnormal epididymis morphology|MP:0002687,oligozoospermia|MP:0002780,decreased circulating testosterone level|MP:0002784,abnormal Sertoli cell morphology|MP:0003205,testicular atrophy|MP:0003830,abnormal testis development|MP:0004810,decreased hematopoietic stem cell number|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0004929,decreased epididymis weight|MP:0004930,small epididymis|MP:0005089,decreased double-negative T cell number|MP:0005250,decreased Sertoli cell number|MP:0005387,immune system phenotype|MP:0006428,ectopic Sertoli cells|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0013600,testis degeneration|MP:0014052,increased male germ cell apoptosis|MP:0020355,abnormal Sertoli cell barrier morphology|MP:0020362,abnormal male germ cell physiology
MGI:6157075	Fbxw7<tm1Iken>	MP:0003253,dilated bile duct|MP:0004839,bile duct hyperplasia
MGI:5007620	Fbxw7<tm1Itom>	MP:0000111,cleft palate|MP:0001179,thick pulmonary interalveolar septum|MP:0001302,eyelids open at birth|MP:0006027,impaired lung alveolus development|MP:0011087,neonatal lethality, complete penetrance
MGI:3767577	Fbxw7<tm1Kei>	MP:0000709,enlarged thymus|MP:0001825,arrested T cell differentiation|MP:0001828,abnormal T cell activation|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0005091,increased double-positive T cell number|MP:0006413,increased T cell apoptosis|MP:0008083,decreased single-positive T cell number|MP:0012431,increased lymphoma incidence
MGI:3036571	Fbxw7<tm1Kin>	MP:0000259,abnormal vascular development|MP:0001622,abnormal vasculogenesis|MP:0001688,abnormal somite development|MP:0001787,pericardial edema|MP:0001915,intracranial hemorrhage|MP:0003717,pallor|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004950,abnormal brain vasculature morphology|MP:0005602,decreased angiogenesis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012728,abnormal somite border morphology
MGI:3038749	Fbxw7<tm1Sje>	MP:0000267,abnormal heart development|MP:0000913,abnormal brain development|MP:0000929,open neural tube|MP:0001586,abnormal erythrocyte cell number|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0001723,disorganized yolk sac vascular plexus|MP:0002006,neoplasm|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5524152	Fbxw7<tm2Iaai>	MP:0002006,neoplasm|MP:0005380,embryo phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0010308,decreased tumor latency|MP:0011400,lethality, complete penetrance
MGI:3526146	Fbxw8<Gt(RRT057)Byg>	MP:0000771,abnormal brain size|MP:0001177,atelectasis|MP:0001262,decreased body weight|MP:0001575,cyanosis|MP:0001698,decreased embryo size|MP:0001954,respiratory distress|MP:0004200,decreased fetal size|MP:0004921,decreased placenta weight|MP:0005390,skeleton phenotype|MP:0008489,slow postnatal weight gain|MP:0008770,decreased survivor rate|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5692737	Fbxw8<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0002606,increased basophil cell number|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3665136	Fbxw8<tm1Kei>	MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0003984,embryonic growth retardation|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0005384,cellular phenotype|MP:0005388,respiratory system phenotype|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:4441814	Fbxw9<tm1a(EUCOMM)Wtsi>	MP:0000681,abnormal thyroid gland morphology|MP:0000690,absent spleen|MP:0001293,anophthalmia|MP:0002282,abnormal trachea morphology|MP:0008024,absent lymph nodes|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5548567	Fbxw9<tm1b(EUCOMM)Wtsi>	MP:0000689,abnormal spleen morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0010052,increased grip strength|MP:0011965,decreased total retina thickness
MGI:1856866	fc	MP:0002940,variable body spotting
MGI:3852359	Fcamr<tm1Shib>	MP:0002359,abnormal spleen germinal center morphology|MP:0004815,abnormal somatic hypermutation frequency|MP:0008095,abnormal memory B cell differentiation|MP:0008193,abnormal marginal zone B cell physiology|MP:0008198,abnormal follicular dendritic cell antigen presentation|MP:0008481,increased spleen germinal center number|MP:0008483,increased spleen germinal center size
MGI:3852360	Fcamr<tm2Shib>	MP:0008193,abnormal marginal zone B cell physiology|MP:0008198,abnormal follicular dendritic cell antigen presentation|MP:0008481,increased spleen germinal center number|MP:0008483,increased spleen germinal center size
MGI:3712201	Fcer1a<tm1Ftl>	MP:0001800,abnormal humoral immune response|MP:0002423,abnormal mast cell physiology|MP:0005012,decreased eosinophil cell number|MP:0008603,decreased circulating interleukin-4 level
MGI:2383982	Fcer1a<tm1Knt>	MP:0002423,abnormal mast cell physiology|MP:0003423,reduced thrombolysis|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0005597,decreased susceptibility to type I hypersensitivity reaction
MGI:5583085	Fcer1g<tm1b(KOMP)Wtsi>	MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1857165	Fcer1g<tm1Rav>	MP:0001588,abnormal hemoglobin|MP:0001798,impaired macrophage phagocytosis|MP:0001819,abnormal immune cell physiology|MP:0002423,abnormal mast cell physiology|MP:0002455,abnormal dendritic cell antigen presentation|MP:0002490,abnormal immunoglobulin level|MP:0002497,increased IgE level|MP:0003038,decreased myocardial infarct size|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004867,decreased platelet calcium level|MP:0005027,increased susceptibility to parasitic infection|MP:0005387,immune system phenotype|MP:0005390,skeleton phenotype|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0006298,abnormal platelet activation|MP:0008561,decreased tumor necrosis factor secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008670,decreased interleukin-12b secretion|MP:0008691,decreased interleukin-23 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008817,hematoma|MP:0009549,decreased platelet aggregation|MP:0010766,abnormal NK cell physiology
MGI:2384004	Fcer1g<tm1Tks>	MP:0001798,impaired macrophage phagocytosis|MP:0001805,decreased IgG level|MP:0001835,abnormal antigen presentation|MP:0001876,decreased inflammatory response|MP:0002451,abnormal macrophage physiology|MP:0004828,decreased susceptibility to autoimmune hemolytic anemia|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005095,decreased T cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008042,abnormal NK T cell physiology|MP:0008127,decreased dendritic cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008559,abnormal interferon-gamma secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008680,abnormal interleukin-17 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008713,abnormal cytokine level|MP:0008722,abnormal chemokine secretion|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0010766,abnormal NK cell physiology
MGI:3511262	Fcer2a<Hie>	MP:0002497,increased IgE level
MGI:3583003	Fcer2a<tm1Kik>	MP:0001790,abnormal immune system physiology|MP:0001800,abnormal humoral immune response|MP:0002461,increased immunoglobulin level|MP:0003009,abnormal cytokine secretion
MGI:1934672	Fcer2a<tm1Max>	MP:0001666,abnormal intestinal absorption|MP:0002494,increased IgM level|MP:0002497,increased IgE level|MP:0005534,decreased body temperature|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008723,impaired eosinophil recruitment|MP:0010760,abnormal macrophage chemotaxis
MGI:1934933	Fcer2a<tm1Putt>	MP:0002497,increased IgE level|MP:0005153,abnormal B cell proliferation
MGI:5548824	Fcgbp<tm1b(EUCOMM)Wtsi>	MP:0002059,abnormal seminal vesicle morphology|MP:0002092,abnormal eye morphology|MP:0002968,increased circulating alkaline phosphatase level
MGI:2679238	Fcgr1<tm1Hoga>	MP:0001798,impaired macrophage phagocytosis|MP:0001876,decreased inflammatory response|MP:0002421,abnormal cell-mediated immunity|MP:0002454,abnormal macrophage antigen presentation|MP:0002493,increased IgG level
MGI:3664782	Fcgr1<tm1Jgjw>	MP:0002455,abnormal dendritic cell antigen presentation|MP:0008115,abnormal dendritic cell differentiation
MGI:2664927	Fcgr1<tm1Jsv>	MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002455,abnormal dendritic cell antigen presentation|MP:0002531,abnormal type I hypersensitivity reaction|MP:0003436,decreased susceptibility to induced arthritis|MP:0004828,decreased susceptibility to autoimmune hemolytic anemia
MGI:4399748	Fcgr2b<tm1.1Jsv>	MP:0002169,no abnormal phenotype detected
MGI:5432537	Fcgr2b<tm1.2Rav>	MP:0005390,skeleton phenotype
MGI:5468717	Fcgr2b<tm1Kgcs>	MP:0002494,increased IgM level|MP:0003724,increased susceptibility to induced arthritis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004829,increased anti-chromatin antibody level|MP:0008177,increased germinal center B cell number|MP:0008499,increased IgG1 level|MP:0008502,increased IgG3 level|MP:0008783,decreased B cell apoptosis|MP:0020518,renal glomerular protein deposits
MGI:1857166	Fcgr2b<tm1Ttk>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001262,decreased body weight|MP:0001429,dehydration|MP:0001505,hunched posture|MP:0001577,anemia|MP:0001650,abnormal seizure response to electrical stimulation|MP:0001785,edema|MP:0001846,increased inflammatory response|MP:0001859,kidney inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001864,vascular inflammation|MP:0001869,pancreas inflammation|MP:0001870,salivary gland inflammation|MP:0002083,premature death|MP:0002148,abnormal hypersensitivity reaction|MP:0002194,maximal tonic hindlimb extension seizures|MP:0002423,abnormal mast cell physiology|MP:0002461,increased immunoglobulin level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002743,glomerulonephritis|MP:0002962,increased urine protein level|MP:0003724,increased susceptibility to induced arthritis|MP:0003997,tonic-clonic seizures|MP:0005026,decreased susceptibility to parasitic infection|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level|MP:0010768,mortality/aging
MGI:5812933	Fcgr3<tm1b(EUCOMM)Hmgu>	MP:0000745,tremors|MP:0001363,increased anxiety-related response|MP:0001406,abnormal gait|MP:0002626,increased heart rate|MP:0003233,prolonged QT interval|MP:0010091,decreased circulating creatine kinase level
MGI:1861924	Fcgr3<tm1Jsv>	MP:0000217,abnormal leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0001798,impaired macrophage phagocytosis|MP:0002455,abnormal dendritic cell antigen presentation|MP:0002463,abnormal neutrophil physiology|MP:0002531,abnormal type I hypersensitivity reaction|MP:0003436,decreased susceptibility to induced arthritis|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004828,decreased susceptibility to autoimmune hemolytic anemia|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005612,decreased susceptibility to type II hypersensitivity reaction|MP:0008719,impaired neutrophil recruitment|MP:0008765,decreased mast cell degranulation
MGI:3620982	Fcgr3<tm1Ttk>	MP:0005597,decreased susceptibility to type I hypersensitivity reaction
MGI:5428684	Fcgr4<tm1.1Rav>	MP:0003436,decreased susceptibility to induced arthritis|MP:0005166,decreased susceptibility to injury|MP:0005387,immune system phenotype
MGI:5521465	Fcgr4<tm1Rav>	MP:0002993,autoimmune arthritis|MP:0004985,decreased osteoclast cell number|MP:0004993,decreased bone resorption|MP:0005390,skeleton phenotype|MP:0005416,abnormal circulating protein level
MGI:3511510	Fcgrt<tm1Dcr>	MP:0001805,decreased IgG level|MP:0005419,decreased circulating serum albumin level
MGI:3838491	Fcgrt<tm1Esw>	MP:0001800,abnormal humoral immune response|MP:0005419,decreased circulating serum albumin level|MP:0008495,decreased IgG1 level
MGI:7481205	Fcho1<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:5775007	Fcho2<tm1b(EUCOMM)Hmgu>	MP:0005419,decreased circulating serum albumin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level|MP:0011100,preweaning lethality, complete penetrance
MGI:5142529	Fcmr<tm1.2Khl>	MP:0002462,abnormal granulocyte physiology|MP:0002942,decreased circulating alanine transaminase level|MP:0005017,decreased B cell number|MP:0005166,decreased susceptibility to injury|MP:0005387,immune system phenotype|MP:0006413,increased T cell apoptosis|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:5513774	Fcmr<tm1b(KOMP)Wtsi>	MP:0000642,enlarged adrenal glands
MGI:5496253	Fcmr<tm1Mak>	MP:0002412,increased susceptibility to bacterial infection|MP:0002462,abnormal granulocyte physiology|MP:0003009,abnormal cytokine secretion|MP:0005074,impaired granulocyte bactericidal activity|MP:0005397,hematopoietic system phenotype|MP:0008561,decreased tumor necrosis factor secretion|MP:0008706,decreased interleukin-6 secretion|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:5450845	Fcmr<tm1Ohno>	MP:0001806,decreased IgM level|MP:0002490,abnormal immunoglobulin level|MP:0002494,increased IgM level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004829,increased anti-chromatin antibody level|MP:0004939,abnormal B cell morphology|MP:0004977,increased B-1 B cell number|MP:0005015,increased T cell number|MP:0005025,abnormal response to infection|MP:0008182,decreased marginal zone B cell number|MP:0008495,decreased IgG1 level|MP:0008502,increased IgG3 level
MGI:5297089	Fcna<tm1Tefu>	MP:0002412,increased susceptibility to bacterial infection|MP:0005387,immune system phenotype|MP:0009062,impaired lectin complement pathway|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:5468800	Fcnb<tm1Tefu>	MP:0002412,increased susceptibility to bacterial infection|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:5427592	Fcor<tm1Jnak>	MP:0001262,decreased body weight|MP:0005289,increased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0009118,increased white fat cell size|MP:0010379,decreased respiratory quotient
MGI:6441119	Fcrl2<em1(IMPC)H>	MP:0001566,increased circulating phosphate level|MP:0005343,increased circulating aspartate transaminase level|MP:0010090,increased circulating creatine kinase level
MGI:5007138	Fcrl2<tm1Lex>	MP:0001260,increased body weight|MP:0001264,increased body size|MP:0003960,increased lean body mass|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010024,increased total body fat amount|MP:0012323,increased total tissue mass
MGI:5637186	Fcrl6<tm1b(KOMP)Wtsi>	MP:0002953,thick ventricular wall
MGI:4822412	Fcrla<tm1.1Cln>	MP:0001800,abnormal humoral immune response|MP:0005387,immune system phenotype|MP:0008499,increased IgG1 level
MGI:5583069	Fcrla<tm1b(KOMP)Wtsi>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001120,abnormal uterus morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002135,abnormal kidney morphology|MP:0004906,enlarged uterus|MP:0009709,hydrometra|MP:0010067,increased red blood cell distribution width
MGI:4838081	Fcrlb<tm1Pdb>	MP:0004794,increased anti-nuclear antigen antibody level|MP:0008499,increased IgG1 level
MGI:3691674	Fcs1<Pohnpei>	MP:0000351,increased cell proliferation
MGI:3691676	Fcs2<Pohnpei>	MP:0000352,decreased cell proliferation
MGI:2668942	Fcsa1<C57BL/6>	MP:0008158,increased diameter of femur
MGI:2668944	Fcsa2<C57BL/6>	MP:0008158,increased diameter of femur
MGI:2668946	Fcsa3<C57BL/6>	MP:0008158,increased diameter of femur
MGI:2668948	Fcsa4<C57BL/6>	MP:0008158,increased diameter of femur
MGI:2668950	Fcsa5<C57BL/6>	MP:0008158,increased diameter of femur
MGI:2668952	Fcsa6<C57BL/6>	MP:0008158,increased diameter of femur
MGI:2668954	Fcsa7<C57BL/6>	MP:0008158,increased diameter of femur
MGI:1856867	fd	MP:0000367,abnormal coat/ hair morphology|MP:0000402,abnormal zigzag hair morphology|MP:0000416,sparse hair|MP:0001510,abnormal coat appearance|MP:0008538,decreased zigzag hair amount
MGI:1860664	fd<2J>	MP:0000367,abnormal coat/ hair morphology|MP:0000402,abnormal zigzag hair morphology|MP:0000416,sparse hair|MP:0001510,abnormal coat appearance|MP:0008538,decreased zigzag hair amount
MGI:5007032	Fdcsp<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:4451370	Fdft1<tm1a(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:3579504	Fdft1<tm1Kan>	MP:0000745,tremors|MP:0000921,demyelination|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001524,impaired limb coordination|MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0003631,nervous system phenotype
MGI:2383989	Fdft1<tm1Yma>	MP:0000928,incomplete rostral neuropore closure|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6857767	Fdps<tm1Jiy>	MP:0000274,enlarged heart|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0008260,abnormal autophagy|MP:0011925,abnormal heart echocardiography feature|MP:0011951,increased cardiac stroke volume
MGI:5588266	Fdx1<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:7855429	Fdx1<tm1Xch>	MP:0000358,abnormal cell morphology|MP:0001698,decreased embryo size|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0009308,increased adenocarcinoma incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014134,abnormal embryo morphology
MGI:6156129	Fdx2<em1(IMPC)Rbrc>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003212,increased susceptibility to age related obesity|MP:0003271,abnormal duodenum morphology|MP:0003917,increased kidney weight|MP:0004002,abnormal jejunum morphology|MP:0004857,abnormal heart weight|MP:0004952,increased spleen weight|MP:0012362,increased large unstained cell number
MGI:5568483	Fdxacb1<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0001399,hyperactivity|MP:0001512,trunk curl|MP:0005633,increased circulating sodium level
MGI:6414485	Fdxr<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:6115883	Fdxr<tm1Xch>	MP:0001672,abnormal embryo development|MP:0001770,abnormal iron level|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002628,hepatic steatosis|MP:0002947,increased hemangioma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003667,increased hemangiosarcoma incidence|MP:0003886,abnormal embryonic epiblast morphology|MP:0005637,abnormal iron homeostasis|MP:0006035,abnormal mitochondrial morphology|MP:0008019,increased liver tumor incidence|MP:0008469,abnormal protein level|MP:0008714,increased lung carcinoma incidence|MP:0008807,increased liver iron level|MP:0009439,increased myeloid sarcoma incidence|MP:0010286,increased plasmacytoma incidence|MP:0010736,abnormal extraembryonic ectoderm morphology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011703,increased fibroblast proliferation|MP:0012431,increased lymphoma incidence|MP:0012555,decreased cell death|MP:0012602,increased alpha-fetoprotein level|MP:0014136,abnormal extraembryonic endoderm morphology|MP:0014141,abnormal mesoderm morphology|MP:0031301,chronic liver inflammation
MGI:1856868	fe	MP:0000371,diluted coat color|MP:0001191,abnormal skin condition|MP:0001212,skin lesions|MP:0002075,abnormal coat/hair pigmentation
MGI:1858114	Fech<m1Pas>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000611,jaundice|MP:0001202,skin photosensitivity|MP:0001270,distended abdomen|MP:0001402,decreased locomotor activity|MP:0001570,abnormal circulating enzyme level|MP:0001921,reduced fertility|MP:0002447,abnormal erythrocyte morphology|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0002981,increased liver weight|MP:0004147,increased porphyrin level|MP:0004952,increased spleen weight|MP:0005097,polychromatophilia|MP:0005344,increased circulating bilirubin level|MP:0008387,hypochromic anemia|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010175,leptocytosis|MP:0011188,increased erythrocyte protoporphyrin level|MP:0031084,decreased erythrocyte osmotic fragility
MGI:6188968	Fech<tm1.1(FECH*)Emi>	MP:0001698,decreased embryo size|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2384729	Fech<tm1Dab>	MP:0001202,skin photosensitivity|MP:0011092,embryonic lethality, complete penetrance
MGI:2155169	Fecq1<QSo>	MP:0001934,increased litter size
MGI:2155910	Fecq2<QSo>	MP:0001934,increased litter size
MGI:3640555	Fecq3<C57BL/10SnSg>	MP:0001934,increased litter size
MGI:6150325	Fem1a<tm1Seno>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000495,abnormal colon morphology|MP:0001262,decreased body weight|MP:0003269,colon polyps|MP:0005389,reproductive system phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0010768,mortality/aging|MP:0012436,increased colon tumor incidence|MP:0013298,increased susceptibility to colitis induced morbidity/mortality|MP:0013956,decreased colon length
MGI:3586916	Fem1b<tm1Jfma>	MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005293,impaired glucose tolerance
MGI:3811024	Fem1b<tm1Mms>	MP:0000666,decreased prostate gland duct number|MP:0005389,reproductive system phenotype
MGI:3043637	Fem1c<Gt(ROSABetageo)3Sor>	MP:0003631,nervous system phenotype|MP:0005389,reproductive system phenotype
MGI:2389354	Fembm1<C57BL/6J>	MP:0030823,increased femur size
MGI:2389358	Fembm3<C57BL/6J>	MP:0030823,increased femur size
MGI:2389360	Fembm4<DBA/2J>	MP:0030823,increased femur size
MGI:2389362	Fembm5<DBA/2J>	MP:0030823,increased femur size
MGI:2386580	Fembrs1<MRL/MpJ>	MP:0004149,increased bone strength
MGI:2386584	Fembrs2<SJL/J>	MP:0004149,increased bone strength
MGI:2386586	Fembrs3<MRL/MpJ>	MP:0004149,increased bone strength
MGI:2389081	Fembrs4<MRL/MpJ>	MP:0004149,increased bone strength
MGI:2389085	Fembrs5<MRL/MpJ>	MP:0004149,increased bone strength
MGI:2389087	Fembrs6<MRL/MpJ>	MP:0004149,increased bone strength
MGI:2154532	Feml1<C57BL/6J>	MP:0004348,long femur
MGI:2157112	Feml2<C57BL/6J>	MP:0004348,long femur
MGI:2157113	Feml2<CAST/EiJ>	MP:0001258,decreased body length
MGI:2429718	Feml3<C57BL/6J>	MP:0004348,long femur
MGI:2429719	Feml3<CAST/EiJ>	MP:0001258,decreased body length|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0003109,short femur
MGI:3698811	Feml4<CAST/EiJ>	MP:0003109,short femur
MGI:3665273	Fen1<tm1Bew>	MP:0011091,prenatal lethality, complete penetrance
MGI:3711354	Fen1<tm1Bhsh>	MP:0000352,decreased cell proliferation|MP:0000603,pale liver|MP:0001176,abnormal lung development|MP:0001178,pulmonary hypoplasia|MP:0002169,no abnormal phenotype detected|MP:0003396,abnormal embryonic hematopoiesis|MP:0003984,embryonic growth retardation|MP:0004229,abnormal embryonic erythropoiesis|MP:0005631,decreased lung weight|MP:0009246,pale spleen|MP:0011087,neonatal lethality, complete penetrance|MP:0011143,thick lung-associated mesenchyme|MP:0020414,abnormal fibroblast physiology
MGI:2670036	Fen1<tm1Klng>	MP:0001713,decreased trophoblast giant cell number|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002169,no abnormal phenotype detected|MP:0004957,abnormal blastocyst morphology|MP:0004964,absent inner cell mass|MP:0004965,inner cell mass degeneration|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0014760,impaired DNA repair|MP:0021086,decreased DNA replication
MGI:2385597	Fen1<tm1Rak>	MP:0002023,increased B cell derived lymphoma incidence|MP:0003644,thymus atrophy|MP:0004843,abnormal Paneth cell morphology|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5629667	Fen1<tm2.1Bhsh>	MP:0002020,increased tumor incidence|MP:0004024,aneuploidy|MP:0004029,spontaneous chromosome breakage|MP:0005621,abnormal cell physiology|MP:0008014,increased lung tumor incidence|MP:0008019,increased liver tumor incidence|MP:0008866,chromosomal instability|MP:0010207,abnormal telomere morphology|MP:0010365,increased thymus tumor incidence|MP:0010948,abnormal double-strand DNA break repair|MP:0011704,decreased fibroblast proliferation
MGI:3808779	Fen1<tm2Klng>	MP:0000008,increased white adipose tissue amount|MP:0000352,decreased cell proliferation|MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0001261,obese|MP:0002023,increased B cell derived lymphoma incidence|MP:0002032,increased sarcoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002362,abnormal spleen marginal zone morphology|MP:0005387,immune system phenotype|MP:0006094,increased fat cell size|MP:0008470,abnormal spleen B cell follicle morphology|MP:0014262,increased spleen B cell follicle number|MP:0014347,increased spleen B cell follicle size
MGI:5767323	Fen1<tm3.1Bhsh>	MP:0000240,extramedullary hematopoiesis|MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0001861,lung inflammation|MP:0001862,interstitial pneumonia|MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002083,premature death|MP:0002499,chronic inflammation|MP:0002743,glomerulonephritis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005621,abnormal cell physiology|MP:0008019,increased liver tumor incidence|MP:0008097,increased plasma cell number|MP:0008404,increased cellular sensitivity to methylmethanesulfonate induced cell death|MP:0008866,chromosomal instability|MP:0008943,increased sensitivity to induced cell death|MP:0009590,increased gonad tumor incidence|MP:0011368,increased kidney apoptosis|MP:0020519,renal glomerular immunoglobulin deposits|MP:0030002,increased lung apoptosis
MGI:3808783	Fen1<tm3Klng>	MP:0000929,open neural tube|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0005621,abnormal cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5563522	Fendrr<tm1Vlcg>	MP:0000467,abnormal esophagus morphology|MP:0001176,abnormal lung development|MP:0001178,pulmonary hypoplasia|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003159,abnormal esophageal smooth muscle morphology|MP:0003641,small lung|MP:0004007,abnormal lung vasculature morphology|MP:0010402,ventricular septal defect|MP:0010975,abnormal lung lobe morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:5804646	Fer1l4<tm1b(EUCOMM)Hmgu>	MP:0001284,absent vibrissae
MGI:7439933	Fer1l4<tm1Osb>	MP:0005389,reproductive system phenotype
MGI:7439947	Fer1l5<tm1Osb>	MP:0001922,reduced male fertility|MP:0004542,impaired acrosome reaction|MP:0005389,reproductive system phenotype|MP:0030976,impaired sperm penetration of zona pellucida|MP:0031010,failure of sperm-egg fusion
MGI:7440012	Fer1l6<tm1Osb>	MP:0005389,reproductive system phenotype
MGI:4460989	Ferd3l<tm1Yono>	MP:0000925,abnormal floor plate morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0009937,abnormal neuron differentiation|MP:0011448,decreased dopaminergic neuron number
MGI:6156446	Fer<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000443,abnormal snout morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001325,abnormal retina morphology|MP:0001417,decreased exploration in new environment|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002599,increased mean platelet volume|MP:0002989,small kidney|MP:0004738,abnormal auditory brainstem response|MP:0004952,increased spleen weight|MP:0010067,increased red blood cell distribution width|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3828498	Fermt1<tm1Ref>	MP:0000477,abnormal intestine morphology|MP:0000495,abnormal colon morphology|MP:0001218,thin epidermis|MP:0001429,dehydration|MP:0001732,postnatal growth retardation|MP:0002581,abnormal ileum morphology|MP:0002962,increased urine protein level|MP:0003304,large intestinal inflammation|MP:0005367,renal/urinary system phenotype|MP:0008055,increased urine osmolality|MP:0009482,ileum inflammation|MP:0009485,distended ileum|MP:0009511,distended stomach|MP:0009584,decreased keratinocyte proliferation|MP:0011085,postnatal lethality, complete penetrance|MP:0030578,decreased keratinocyte adhesion|MP:0030584,skin atrophy
MGI:3845885	Fermt2<Gt(AM0293)Wtsi>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5788419	Fermt2<tm1.1Gxo>	MP:0000063,decreased bone mineral density|MP:0000075,absent neurocranium|MP:0000149,abnormal scapula morphology|MP:0000157,abnormal sternum morphology|MP:0000160,kyphosis|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000166,abnormal chondrocyte morphology|MP:0000167,decreased chondrocyte number|MP:0000547,short limbs|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002543,brachyphalangia|MP:0002544,brachydactyly|MP:0002657,chondrodystrophy|MP:0002764,short tibia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003419,delayed endochondral bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004321,short sternum|MP:0004337,clavicle hypoplasia|MP:0004338,small clavicle|MP:0004340,short scapula|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004610,small vertebrae|MP:0004626,vertebral compression|MP:0004686,decreased length of long bones|MP:0005390,skeleton phenotype|MP:0005508,abnormal skeleton morphology|MP:0006279,abnormal limb development|MP:0006397,disorganized long bone epiphyseal plate|MP:0008273,abnormal intramembranous bone ossification|MP:0008817,hematoma|MP:0010082,sternebra fusion|MP:0010103,small thoracic cage|MP:0010879,decreased trabecular bone volume|MP:0011087,neonatal lethality, complete penetrance|MP:0012279,wide sternum|MP:0013624,decreased femur compact bone thickness|MP:0014101,decreased chondrocyte proliferation|MP:0014103,increased chondrocyte apoptosis
MGI:4433009	Fermt2<tm1a(EUCOMM)Wtsi>	MP:0005379,endocrine/exocrine gland phenotype
MGI:3790102	Fermt2<tm1Ref>	MP:0001674,abnormal germ layer development|MP:0003886,abnormal embryonic epiblast morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0014696,decreased cell adhesion
MGI:5705846	Fermt3<tm1.1Efp>	MP:0000218,increased leukocyte cell number|MP:0002875,decreased erythrocyte cell number|MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0006298,abnormal platelet activation|MP:0009549,decreased platelet aggregation|MP:0010177,acanthocytosis|MP:0010768,mortality/aging|MP:0031120,decreased susceptibility to induced thrombosis
MGI:5588285	Fermt3<tm1b(KOMP)Wtsi>	MP:0001785,edema|MP:0001914,hemorrhage|MP:0011100,preweaning lethality, complete penetrance
MGI:3785479	Fermt3<tm1Ref>	MP:0000067,osteopetrosis|MP:0000465,gastrointestinal hemorrhage|MP:0001577,anemia|MP:0001634,internal hemorrhage|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0002447,abnormal erythrocyte morphology|MP:0002641,anisopoikilocytosis|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0005048,abnormal thrombosis|MP:0005606,increased bleeding time|MP:0006298,abnormal platelet activation|MP:0008816,petechiae|MP:0009395,increased nucleated erythrocyte cell number|MP:0009549,decreased platelet aggregation|MP:0011085,postnatal lethality, complete penetrance
MGI:5551978	Fermt3<tm2.1Ref>	MP:0002435,abnormal effector T cell morphology|MP:0002444,abnormal T cell physiology
MGI:5551979	Fermt3<tm2.2Ref>	MP:0001544,abnormal cardiovascular system physiology|MP:0002082,postnatal lethality|MP:0002396,abnormal hematopoietic system morphology/development
MGI:1862018	Fers	MP:0001394,circling
MGI:2180299	Fer<tm1Pag>	MP:0002169,no abnormal phenotype detected
MGI:2180300	Fer<tm2Pag>	MP:0002169,no abnormal phenotype detected
MGI:2182586	Fes<tm1Mcs>	MP:0000217,abnormal leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0000333,decreased bone marrow cell number|MP:0001212,skin lesions|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0001852,conjunctivitis|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002412,increased susceptibility to bacterial infection|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002451,abnormal macrophage physiology|MP:0005017,decreased B cell number|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:2670783	Fes<tm1Pag>	MP:0002169,no abnormal phenotype detected|MP:0005397,hematopoietic system phenotype
MGI:2182589	Fes<tm2Mcs>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000465,gastrointestinal hemorrhage|MP:0000798,abnormal frontal lobe morphology|MP:0001270,distended abdomen|MP:0001622,abnormal vasculogenesis|MP:0001914,hemorrhage|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002192,hydrops fetalis|MP:0003749,down-turned corners of mouth|MP:0003888,liver hemorrhage|MP:0004057,thin myocardium compact layer|MP:0008022,dilated heart ventricle|MP:0008535,enlarged lateral ventricles|MP:0009432,increased fetal weight|MP:0010402,ventricular septal defect|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0030192,downturned snout
MGI:3578748	Fes<tm2Pag>	MP:0001601,abnormal myelopoiesis|MP:0001934,increased litter size|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0003132,increased pre-B cell number|MP:0005017,decreased B cell number|MP:0005564,increased hemoglobin content|MP:0008186,increased pro-B cell number|MP:0008735,increased susceptibility to endotoxin shock
MGI:5514274	Fetub<tm1Wja>	MP:0000242,impaired fertilization|MP:0001926,female infertility|MP:0003696,abnormal zona pellucida morphology|MP:0005389,reproductive system phenotype
MGI:2449922	Fev<tm1Esd>	MP:0001353,increased aggression towards mice|MP:0001363,increased anxiety-related response|MP:0001405,impaired coordination|MP:0003877,abnormal serotonergic neuron morphology|MP:0008948,decreased neuron number|MP:0009937,abnormal neuron differentiation|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3811164	Fez1<tm1Kei>	MP:0001262,decreased body weight|MP:0001409,increased stereotypic behavior|MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0001906,increased dopamine level|MP:0002062,abnormal associative learning|MP:0002574,increased vertical activity|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0031391,increased locomotor activity
MGI:5140793	Fezf1<tm1.1Bche>	MP:0006092,abnormal olfactory sensory neuron morphology
MGI:5603434	Fezf1<tm1.1(cre/folA)Hze>	MP:0002169,no abnormal phenotype detected
MGI:3626294	Fezf1<tm1Hibi>	MP:0002739,abnormal olfactory bulb development|MP:0002741,small olfactory bulb|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004279,abnormal rostral migratory stream morphology|MP:0006009,abnormal neuronal migration|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5140810	Fezf1<tm1Taku>	MP:0001270,distended abdomen|MP:0001961,abnormal reflex|MP:0002741,small olfactory bulb|MP:0003651,abnormal axon extension|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:6273951	Fezf2<em1(IMPC)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0004738,abnormal auditory brainstem response|MP:0008259,abnormal optic disk morphology|MP:0010053,decreased grip strength|MP:0011965,decreased total retina thickness|MP:0013279,increased fasting circulating glucose level
MGI:5433045	Fezf2<tm1.1Nses>	MP:0002878,abnormal corticospinal tract morphology
MGI:3046867	Fezf2<tm1Hibi>	MP:0000832,abnormal thalamus morphology|MP:0000934,abnormal telencephalon development|MP:0001388,abnormal stationary movement|MP:0001399,hyperactivity|MP:0001432,abnormal food preference|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002961,abnormal axon guidance|MP:0008228,increased anterior commissure size
MGI:3525887	Fezf2<tm1Skm>	MP:0000788,abnormal cerebral cortex morphology|MP:0002196,absent corpus callosum|MP:0002243,abnormal vomeronasal organ morphology|MP:0002961,abnormal axon guidance|MP:0005404,abnormal axon morphology|MP:0011679,abnormal vomeronasal sensory neuron morphology|MP:0013597,small vomeronasal organ
MGI:3037018	Ffal1<C57BL/6J>	MP:0001554,increased circulating free fatty acids level
MGI:3812531	Ffaq2<NZW/LacJ>	MP:0001554,increased circulating free fatty acids level
MGI:5695958	Ffar1<tm1.1(KOMP)Vlcg>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3821733	Ffar1<tm1Dgen>	MP:0000187,abnormal triglyceride level|MP:0001560,abnormal circulating insulin level|MP:0001985,abnormal gustatory system physiology|MP:0001986,abnormal taste sensitivity|MP:0002644,decreased circulating triglyceride level|MP:0002696,decreased circulating glucagon level|MP:0005376,homeostasis/metabolism phenotype|MP:0005418,abnormal circulating hormone level|MP:0009355,increased liver triglyceride level|MP:0010055,abnormal sensory neuron physiology|MP:0011939,increased food intake|MP:0014125,decreased amylin secretion
MGI:3774293	Ffar1<tm1Heed>	MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0003383,abnormal gluconeogenesis|MP:0005292,improved glucose tolerance|MP:0011969,abnormal circulating triglyceride level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3713759	Ffar1<tm1Lex>	MP:0003059,decreased insulin secretion|MP:0003565,abnormal glucagon secretion|MP:0005559,increased circulating glucose level
MGI:5635083	Ffar2<tm1b(EUCOMM)Hmgu>	MP:0001488,increased startle reflex|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level
MGI:4367910	Ffar2<tm1Dgen>	MP:0001861,lung inflammation|MP:0002462,abnormal granulocyte physiology|MP:0002463,abnormal neutrophil physiology|MP:0002467,impaired neutrophil phagocytosis|MP:0003724,increased susceptibility to induced arthritis|MP:0005015,increased T cell number|MP:0008537,increased susceptibility to induced colitis|MP:0008720,impaired neutrophil chemotaxis|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:5462347	Ffar2<tm1Fmgb>	MP:0002727,decreased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0010155,abnormal intestine physiology
MGI:5013800	Ffar2<tm1Gzt>	MP:0005385,cardiovascular system phenotype
MGI:3808703	Ffar2<tm1Lex>	MP:0001553,abnormal circulating free fatty acids level
MGI:5770445	Ffar2<tm1Soff>	MP:0002079,increased circulating insulin level|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:4436772	Ffar2<tm2Lex>	MP:0000495,abnormal colon morphology|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001845,abnormal inflammatory response|MP:0003293,rectal hemorrhage|MP:0003304,large intestinal inflammation|MP:0003866,abnormal defecation|MP:0005044,sepsis|MP:0005065,abnormal neutrophil morphology|MP:0008539,decreased susceptibility to induced colitis|MP:0008553,increased circulating tumor necrosis factor level|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008713,abnormal cytokine level|MP:0008720,impaired neutrophil chemotaxis|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:6449046	Ffar3<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney
MGI:4459441	Ffar3<tm1Dgen>	MP:0005666,abnormal adipose tissue physiology
MGI:5462348	Ffar3<tm1Fmgb>	MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0010155,abnormal intestine physiology
MGI:5013799	Ffar3<tm1Gzt>	MP:0001015,small superior cervical ganglion|MP:0001629,abnormal heart rate|MP:0002575,increased circulating ketone body level|MP:0003964,abnormal noradrenaline level|MP:0005288,abnormal oxygen consumption|MP:0005290,decreased oxygen consumption|MP:0005333,decreased heart rate|MP:0005534,decreased body temperature|MP:0005664,decreased circulating noradrenaline level|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009253,abnormal sympathetic neuron physiology|MP:0009284,abnormal sympathetic neuron innervation pattern
MGI:3829251	Ffar3<tm1Reh>	MP:0001262,decreased body weight|MP:0001664,abnormal digestion|MP:0003868,abnormal feces composition|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005448,abnormal energy homeostasis|MP:0005668,decreased circulating leptin level|MP:0006001,abnormal intestinal transit time|MP:0009289,decreased epididymal fat pad weight|MP:0009356,decreased liver triglyceride level
MGI:5770446	Ffar3<tm1Soff>	MP:0002079,increased circulating insulin level|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:5635615	Ffar4<tm1.1Mbj>	MP:0003564,abnormal insulin secretion|MP:0008953,abnormal pancreatic somatostatin secretion
MGI:5316909	Ffar4<tm1Gdds>	MP:0000008,increased white adipose tissue amount|MP:0000182,increased circulating LDL cholesterol level|MP:0001547,abnormal lipid level|MP:0001556,increased circulating HDL cholesterol level|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0004890,decreased energy expenditure|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0009118,increased white fat cell size|MP:0009171,enlarged pancreatic islets|MP:0009355,increased liver triglyceride level|MP:0010024,increased total body fat amount|MP:0010379,decreased respiratory quotient
MGI:4881214	Ffar4<tm1(KOMP)Vlcg>	MP:0002970,abnormal white adipose tissue morphology|MP:0005290,decreased oxygen consumption|MP:0005670,abnormal white adipose tissue physiology|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0011049,impaired adaptive thermogenesis|MP:0011169,abnormal white fat cell differentation|MP:0011170,abnormal brown fat cell differentiation|MP:0011698,abnormal brown adipose tissue physiology|MP:0020426,abnormal beige fat cell physiology
MGI:3529053	Ffar4<tm1Lex>	MP:0005376,homeostasis/metabolism phenotype
MGI:4818767	Ffar4<tm1Sdmk>	MP:0001985,abnormal gustatory system physiology|MP:0001986,abnormal taste sensitivity|MP:0010055,abnormal sensory neuron physiology
MGI:2152976	Fga<tm1Jld>	MP:0000920,abnormal myelination|MP:0001656,focal hepatic necrosis|MP:0001926,female infertility|MP:0002083,premature death|MP:0002551,abnormal blood coagulation|MP:0003336,pancreas cyst|MP:0003888,liver hemorrhage|MP:0004014,abnormal uterine environment|MP:0004898,uterine hemorrhage|MP:0005023,abnormal wound healing|MP:0005245,hemarthrosis|MP:0005435,hemoperitoneum|MP:0009549,decreased platelet aggregation|MP:0010768,mortality/aging|MP:0011514,skin hemorrhage|MP:0012330,decreased circulating fibrinogen level|MP:0020215,impaired blood coagulation|MP:0031137,vaginal hemorrhage|MP:0031152,subcutaneous hemorrhage|MP:0031153,stomach hemorrhage
MGI:5707443	Fgb<tm1.1(KOMP)Vlcg>	MP:0000198,decreased circulating phosphate level|MP:0000274,enlarged heart|MP:0001785,edema|MP:0005293,impaired glucose tolerance|MP:0010067,increased red blood cell distribution width|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6156442	Fgd1<em1(IMPC)Tcp>	MP:0000428,abnormal craniofacial morphology|MP:0000709,enlarged thymus|MP:0001297,microphthalmia|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0003984,embryonic growth retardation
MGI:6341930	Fgd3<em1(IMPC)Ccpcz>	MP:0000221,decreased leukocyte cell number|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001417,decreased exploration in new environment|MP:0002059,abnormal seminal vesicle morphology|MP:0005016,decreased lymphocyte cell number|MP:0005554,decreased circulating creatinine level
MGI:5460858	Fgd4<tm1.1Ics>	MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0002272,abnormal nervous system electrophysiology|MP:0003871,abnormal myelin sheath morphology|MP:0005402,abnormal action potential|MP:0008814,decreased nerve conduction velocity|MP:0010053,decreased grip strength
MGI:4849414	Fgd4<tm1a(EUCOMM)Wtsi>	MP:0000182,increased circulating LDL cholesterol level
MGI:5460855	Fgd4<tm1Ics>	MP:0000920,abnormal myelination|MP:0003631,nervous system phenotype|MP:0003871,abnormal myelin sheath morphology
MGI:6449031	Fgd5<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001289,persistence of hyaloid vascular system|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001711,abnormal placenta morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002833,increased heart weight|MP:0003068,enlarged kidney|MP:0003231,abnormal placenta vasculature|MP:0003402,decreased liver weight|MP:0004924,abnormal behavior|MP:0005179,decreased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0009142,decreased prepulse inhibition|MP:0010067,increased red blood cell distribution width|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation|MP:0020870,decreased thigmotaxis
MGI:5642321	Fgd5<tm1Djr>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5642323	Fgd5<tm2Djr>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5642327	Fgd5<tm3(cre/ERT2)Djr>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4398706	Fgf10<Mhdaaey17>	MP:0000549,decreased limb number|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0002840,abnormal lens fiber morphology|MP:0003237,abnormal lens epithelium morphology|MP:0005287,narrow eye opening|MP:0005391,vision/eye phenotype|MP:0006072,abnormal retina apoptosis|MP:0011091,prenatal lethality, complete penetrance|MP:0013445,Harderian gland atrophy
MGI:4849925	Fgf10<ptls>	MP:0000549,decreased limb number|MP:0001181,absent lungs|MP:0004573,absent limb buds
MGI:5438701	Fgf10<tm1.1(cre/ERT2)Sbel>	MP:0000549,decreased limb number|MP:0009510,cecal atresia|MP:0010907,absent lung buds|MP:0031343,colon atresia
MGI:3526181	Fgf10<tm1.1Sms>	MP:0001176,abnormal lung development|MP:0001181,absent lungs|MP:0001672,abnormal embryo development|MP:0002102,abnormal ear morphology|MP:0002132,abnormal respiratory system morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:4456398	Fgf10<tm1.2Sms>	MP:0002169,no abnormal phenotype detected
MGI:5548400	Fgf10<tm1b(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0000428,abnormal craniofacial morphology|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001402,decreased locomotor activity|MP:0001556,increased circulating HDL cholesterol level|MP:0003961,decreased lean body mass|MP:0004924,abnormal behavior|MP:0005178,increased circulating cholesterol level|MP:0005287,narrow eye opening|MP:0006243,impaired pupillary reflex|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0020870,decreased thigmotaxis
MGI:1859647	Fgf10<tm1Ska>	MP:0000003,abnormal adipose tissue morphology|MP:0000026,abnormal inner ear morphology|MP:0000149,abnormal scapula morphology|MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000486,abnormal pulmonary trunk morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000495,abnormal colon morphology|MP:0000537,abnormal urethra morphology|MP:0000549,decreased limb number|MP:0000551,absent forelimb|MP:0000553,absent radius|MP:0000557,absent hindlimb|MP:0000614,absent salivary gland|MP:0000644,dextrocardia|MP:0000662,abnormal branching of the mammary ductal tree|MP:0000706,small thymus|MP:0001176,abnormal lung development|MP:0001181,absent lungs|MP:0001199,thin skin|MP:0001201,translucent skin|MP:0001262,decreased body weight|MP:0001302,eyelids open at birth|MP:0002085,abnormal embryonic tissue morphology|MP:0002100,abnormal tooth morphology|MP:0002295,abnormal pulmonary circulation|MP:0002297,abnormal forced expiratory flow rates|MP:0002691,small stomach|MP:0002989,small kidney|MP:0003014,abnormal kidney medulla morphology|MP:0003334,pancreas fibrosis|MP:0003339,decreased pancreatic beta cell number|MP:0003809,abnormal hair shaft morphology|MP:0003924,diaphragmatic hernia|MP:0004140,abnormal gastric chief cell morphology|MP:0004247,small pancreas|MP:0004352,absent humerus|MP:0004360,absent ulna|MP:0004830,short incisors|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005314,absent thyroid gland|MP:0005315,absent pituitary gland|MP:0005358,abnormal incisor morphology|MP:0005369,muscle phenotype|MP:0005650,abnormal limb bud morphology|MP:0006065,abnormal heart position or orientation|MP:0006279,abnormal limb development|MP:0006288,small otic capsule|MP:0006402,small molars|MP:0008320,absent adenohypophysis|MP:0008786,abnormal hindgut morphology|MP:0008904,abnormal mammary fat pad morphology|MP:0009479,abnormal cecum development|MP:0009509,absent rectum|MP:0009510,cecal atresia|MP:0009522,submandibular gland hypoplasia|MP:0009524,absent submandibular gland|MP:0009525,abnormal submandibular duct morphology|MP:0010489,abnormal heart atrium auricular region morphology|MP:0010521,absent pulmonary artery|MP:0010646,absent pulmonary vein|MP:0010794,abnormal stomach submucosa morphology|MP:0010907,absent lung buds|MP:0011089,perinatal lethality, complete penetrance|MP:0011195,increased hair follicle apoptosis|MP:0011305,dilated kidney calyx|MP:0011332,abnormal kidney outer medulla morphology|MP:0011333,abnormal kidney inner medulla morphology|MP:0011457,abnormal metanephric ureteric bud development|MP:0011759,absent Rathke's pouch|MP:0011884,absent colon|MP:0013338,abnormal neurohypophysis development|MP:0013352,abnormal Rathke's pouch apoptosis|MP:0013495,decreased trachea gland number|MP:0013531,abnormal periderm development|MP:0013721,abnormal mammary placode morphology|MP:0013956,decreased colon length|MP:0021206,abnormal limb muscle morphology|MP:0030920,small hair follicle bulb|MP:0031300,perineal hypospadia
MGI:1927833	Fgf10<tm1Wss>	MP:0000018,small ears|MP:0000031,abnormal cochlea morphology|MP:0000034,abnormal inner ear vestibule morphology|MP:0000549,decreased limb number|MP:0000551,absent forelimb|MP:0000557,absent hindlimb|MP:0000618,small salivary gland|MP:0000623,decreased salivation|MP:0000624,xerostomia|MP:0000762,abnormal tongue morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001145,abnormal male reproductive system morphology|MP:0001158,abnormal prostate gland morphology|MP:0001159,absent prostate gland|MP:0001176,abnormal lung development|MP:0001181,absent lungs|MP:0001216,abnormal epidermal layer morphology|MP:0001218,thin epidermis|MP:0001347,absent lacrimal glands|MP:0001426,polydipsia|MP:0002577,reduced enamel thickness|MP:0002729,abnormal inner ear canal morphology|MP:0002770,absent bulbourethral gland|MP:0003124,hypospadia|MP:0003162,decreased lateral semicircular canal size|MP:0003163,absent posterior semicircular canal|MP:0003165,absent superior semicircular canal|MP:0003595,epididymal cyst|MP:0003642,absent seminal vesicle|MP:0003755,abnormal palate morphology|MP:0003760,decreased palatal length|MP:0003827,abnormal Wolffian duct morphology|MP:0004035,abnormal sublingual gland morphology|MP:0004200,decreased fetal size|MP:0004249,abnormal crista ampullaris morphology|MP:0004317,small vestibular saccule|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004573,absent limb buds|MP:0006027,impaired lung alveolus development|MP:0006090,abnormal utricle morphology|MP:0008881,absent Harderian gland|MP:0009479,abnormal cecum development|MP:0009520,decreased submandibular gland size|MP:0009522,submandibular gland hypoplasia|MP:0009655,abnormal secondary palate development|MP:0009884,palatal shelf fusion with tongue or mandible|MP:0009890,cleft secondary palate|MP:0010116,abnormal primitive urogenital sinus morphology|MP:0011025,abnormal branching involved in trachea morphogenesis|MP:0011028,impaired branching involved in bronchus morphogenesis|MP:0011030,impaired branching involved in preterminal bronchiole morphogenesis|MP:0011064,abnormal vestibular hair cell kinocilium morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0013264,tongue ankylosis|MP:0013541,abnormal submandibular gland development|MP:0013580,abnormal nasal gland morphology|MP:0013582,abnormal lateral nasal gland morphology|MP:0013766,absent palatal rugae|MP:0021215,abnormal palatal mesenchymal cell proliferation
MGI:4432799	Fgf11<tm1a(EUCOMM)Wtsi>	MP:0001486,abnormal startle reflex|MP:0002590,increased mean corpuscular volume|MP:0005316,abnormal response to tactile stimuli
MGI:5636914	Fgf12<tm1b(KOMP)Wtsi>	MP:0001510,abnormal coat appearance|MP:0020870,decreased thigmotaxis
MGI:3768545	Fgf12<tm1Gol>	MP:0005386,behavior/neurological phenotype
MGI:6728807	Fgf13<em1Xuzh>	MP:0000790,abnormal stratification in cerebral cortex|MP:0002184,abnormal innervation|MP:0003063,increased coping response|MP:0003651,abnormal axon extension|MP:0006009,abnormal neuronal migration|MP:0008414,abnormal spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0009937,abnormal neuron differentiation|MP:0012307,impaired spatial learning|MP:0020508,decreased dendritic spine density
MGI:5704313	Fgf13<tm1Jom>	MP:0001499,abnormal kindling response|MP:0002064,seizures|MP:0002206,abnormal CNS synaptic transmission|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0009358,environmentally induced seizures|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014378,increased excitatory postsynaptic current frequency|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude
MGI:5433221	Fgf13<tm1Xuzh>	MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001458,abnormal object recognition memory|MP:0001463,abnormal spatial learning|MP:0002573,behavioral despair|MP:0002882,abnormal neuron morphology|MP:0003360,abnormal depression-related behavior|MP:0004098,abnormal cerebellar granule cell morphology|MP:0005404,abnormal axon morphology|MP:0006009,abnormal neuronal migration|MP:0008428,abnormal spatial working memory|MP:0008947,increased neuron number|MP:0008948,decreased neuron number|MP:0009456,impaired cued conditioning behavior|MP:0009969,abnormal cerebral cortex pyramidal cell morphology
MGI:6341935	Fgf14<em1(IMPC)Ccpcz>	MP:0000160,kyphosis|MP:0000681,abnormal thyroid gland morphology|MP:0000689,abnormal spleen morphology|MP:0001262,decreased body weight|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0004174,abnormal spine curvature|MP:0005355,enlarged thyroid gland|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4819866	Fgf14<Tg(tetO-MAPT*P301L)4510Kha>	MP:0000811,hippocampal neuron degeneration|MP:0000812,abnormal dentate gyrus morphology|MP:0000955,abnormal spinal cord morphology|MP:0001263,weight loss|MP:0001362,abnormal anxiety-related response|MP:0001363,increased anxiety-related response|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001415,increased exploration in new environment|MP:0001417,decreased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0001522,impaired swimming|MP:0002175,decreased brain weight|MP:0002878,abnormal corticospinal tract morphology|MP:0002882,abnormal neuron morphology|MP:0003214,neurofibrillary tangles|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0004250,tau protein deposits|MP:0005323,dystonia|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008414,abnormal spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0009971,decreased hippocampus pyramidal cell number|MP:0012508,forebrain atrophy|MP:0031391,increased locomotor activity
MGI:2183403	Fgf14<tm1Dor>	MP:0000746,weakness|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001473,reduced long-term potentiation|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0001525,impaired balance|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002206,abnormal CNS synaptic transmission|MP:0002272,abnormal nervous system electrophysiology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003313,abnormal locomotor activation|MP:0003633,abnormal nervous system physiology|MP:0008489,slow postnatal weight gain|MP:0010053,decreased grip strength|MP:0012307,impaired spatial learning|MP:0031391,increased locomotor activity
MGI:5692586	Fgf15<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology|MP:0004258,abnormal placenta size|MP:0011100,preweaning lethality, complete penetrance
MGI:3044957	Fgf15<tm1Sms>	MP:0000272,abnormal aorta morphology|MP:0000273,overriding aortic valve|MP:0000281,abnormal interventricular septum morphology|MP:0000284,double outlet right ventricle|MP:0002082,postnatal lethality|MP:0005377,hearing/vestibular/ear phenotype|MP:0006126,abnormal cardiac outflow tract development|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010465,aberrant origin of the right subclavian artery|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3790778	Fgf16<tm1(cre)Sms>	MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:3811646	Fgf16<tm1Nit>	MP:0002740,heart hypoplasia|MP:0002834,decreased heart weight|MP:0003921,abnormal heart left ventricle morphology|MP:0011395,decreased fetal cardiomyocyte proliferation
MGI:3804709	Fgf16<tm1Paca>	MP:0000266,abnormal heart morphology|MP:0000280,thin ventricular wall|MP:0000295,trabecula carnea hypoplasia|MP:0001634,internal hemorrhage|MP:0003140,dilated heart atrium|MP:0003984,embryonic growth retardation|MP:0005294,abnormal heart ventricle morphology|MP:0005385,cardiovascular system phenotype|MP:0006337,abnormal first pharyngeal arch morphology|MP:0008022,dilated heart ventricle|MP:0011091,prenatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7425685	Fgf17<em1(IMPC)H>	MP:0010052,increased grip strength
MGI:2385594	Fgf17<tm1Dor>	MP:0000864,abnormal cerebellum vermis morphology|MP:0000867,abnormal cerebellum anterior vermis morphology|MP:0000868,decreased anterior vermis size|MP:0000877,abnormal Purkinje cell morphology|MP:0009038,decreased inferior colliculus size
MGI:2178751	Fgf18<tm1Dor>	MP:0000060,delayed bone ossification|MP:0000074,abnormal neurocranium morphology|MP:0000150,abnormal rib morphology|MP:0000457,maxilla hypoplasia|MP:0001575,cyanosis|MP:0002109,abnormal limb morphology|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0002115,abnormal limb bone morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002187,abnormal fibula morphology|MP:0002314,abnormal respiratory mechanics|MP:0002835,abnormal cranial suture morphology|MP:0003072,abnormal metatarsal bone morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003420,delayed intramembranous bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004358,bowed tibia|MP:0004374,bowed radius|MP:0004734,small thoracic cavity|MP:0006398,increased long bone epiphyseal plate size|MP:0008395,abnormal osteoblast differentiation|MP:0009703,decreased birth body size|MP:0009886,failure of palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance|MP:0030315,small neurocranium
MGI:2179607	Fgf18<tm1Sjt>	MP:0000060,delayed bone ossification|MP:0000150,abnormal rib morphology|MP:0000160,kyphosis|MP:0001176,abnormal lung development|MP:0002187,abnormal fibula morphology|MP:0002764,short tibia|MP:0003641,small lung|MP:0004007,abnormal lung vasculature morphology|MP:0004355,short radius|MP:0004359,short ulna|MP:0004734,small thoracic cavity|MP:0010743,delayed cranial suture closure|MP:0010825,abnormal lung saccule morphology|MP:0010976,small lung lobe|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011143,thick lung-associated mesenchyme
MGI:5425911	Fgf18<tm1Tri>	MP:0000427,abnormal hair cycle|MP:0001510,abnormal coat appearance|MP:0008858,abnormal hair cycle anagen phase|MP:0008860,abnormal hair cycle telogen phase|MP:0010771,integument phenotype
MGI:2383991	Fgf1<tm1Bas>	MP:0002169,no abnormal phenotype detected
MGI:6341920	Fgf20<em1(IMPC)Ccpcz>	MP:0000137,abnormal vertebrae morphology|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000470,abnormal stomach morphology|MP:0000556,abnormal hindlimb morphology|MP:0000572,abnormal autopod morphology|MP:0000579,abnormal nail morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001314,cornea opacity|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0001556,increased circulating HDL cholesterol level|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002100,abnormal tooth morphology|MP:0002110,abnormal digit morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002989,small kidney|MP:0003795,abnormal bone structure|MP:0003883,enlarged stomach|MP:0003918,decreased kidney weight|MP:0004599,abnormal vertebral arch morphology|MP:0004609,vertebral fusion|MP:0004613,fusion of vertebral arches|MP:0005178,increased circulating cholesterol level|MP:0005565,increased blood urea nitrogen level|MP:0005568,increased circulating total protein level|MP:0009142,decreased prepulse inhibition|MP:0010099,abnormal thoracic cage shape
MGI:5425761	Fgf20<tm1.1Dor>	MP:0000042,abnormal organ of Corti morphology|MP:0000400,abnormal awl hair morphology|MP:0000402,abnormal zigzag hair morphology|MP:0000405,abnormal auchene hair morphology|MP:0001967,deafness|MP:0002622,abnormal cochlear hair cell morphology|MP:0003704,abnormal hair follicle development|MP:0003825,abnormal pillar cell morphology|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004402,decreased cochlear outer hair cell number|MP:0004408,decreased cochlear hair cell number|MP:0004497,decreased organ of Corti supporting cell number|MP:0004589,abnormal cochlear hair cell development|MP:0005377,hearing/vestibular/ear phenotype|MP:0006365,absent guard hair|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4354163	Fgf21<tm1.1Djm>	MP:0000189,hypoglycemia|MP:0003383,abnormal gluconeogenesis|MP:0003458,decreased circulating ketone body level|MP:0005290,decreased oxygen consumption|MP:0005560,decreased circulating glucose level|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5486224	Fgf21<tm1.2Djm>	MP:0002169,no abnormal phenotype detected
MGI:4436716	Fgf21<tm1Emf>	MP:0000003,abnormal adipose tissue morphology|MP:0000005,increased brown adipose tissue amount|MP:0000609,abnormal liver physiology|MP:0001259,abnormal body weight|MP:0001260,increased body weight|MP:0001402,decreased locomotor activity|MP:0001547,abnormal lipid level|MP:0001552,increased circulating triglyceride level|MP:0001752,abnormal hypothalamus secretion|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0003960,increased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0005282,decreased fatty acids level|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005449,abnormal food intake|MP:0005534,decreased body temperature|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0008033,impaired lipolysis|MP:0009116,abnormal brown fat cell morphology|MP:0009118,increased white fat cell size|MP:0009285,increased gonadal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0009642,abnormal blood homeostasis|MP:0010024,increased total body fat amount|MP:0010400,increased liver glycogen level|MP:0011049,impaired adaptive thermogenesis|MP:0020309,increased creatine kinase activity
MGI:5427438	Fgf21<tm1Fdl>	MP:0001257,increased body length|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0004357,long tibia|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005120,decreased circulating growth hormone level|MP:0005123,increased circulating growth hormone level|MP:0006398,increased long bone epiphyseal plate size
MGI:5007140	Fgf21<tm1Lex>	MP:0005670,abnormal white adipose tissue physiology|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0011698,abnormal brown adipose tissue physiology|MP:0011699,abnormal brown adipose tissue thermogenesis
MGI:4436721	Fgf21<tm1Nit>	MP:0000008,increased white adipose tissue amount|MP:0001260,increased body weight|MP:0001553,abnormal circulating free fatty acids level|MP:0001554,increased circulating free fatty acids level|MP:0001783,decreased white adipose tissue amount|MP:0002575,increased circulating ketone body level|MP:0002702,decreased circulating free fatty acids level|MP:0002981,increased liver weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0008033,impaired lipolysis|MP:0008034,enhanced lipolysis|MP:0009118,increased white fat cell size|MP:0009132,abnormal white fat cell size|MP:0009133,decreased white fat cell size
MGI:5548535	Fgf22<tm1b(EUCOMM)Hmgu>	MP:0001406,abnormal gait|MP:0008806,increased circulating amylase level
MGI:4818348	Fgf22<tm1Dgen>	MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0002916,increased synaptic depression|MP:0002919,enhanced paired-pulse facilitation|MP:0004769,abnormal synaptic vesicle morphology|MP:0004792,abnormal synaptic vesicle number|MP:0004793,abnormal synaptic vesicle clustering|MP:0014376,decreased miniature excitatory postsynaptic current frequency
MGI:5438777	Fgf22<tm1Rpgr>	MP:0004502,decreased incidence of tumors by chemical induction|MP:0010771,integument phenotype
MGI:7425686	Fgf23<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0001362,abnormal anxiety-related response|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0002792,abnormal retina vasculature morphology|MP:0003020,decreased circulating chloride level|MP:0004151,decreased circulating iron level|MP:0005565,increased blood urea nitrogen level|MP:0011044,increased lung elastance|MP:0020421,increased freezing behavior
MGI:5305729	Fgf23<tm1.1Kew>	MP:0000198,decreased circulating phosphate level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003797,abnormal compact bone morphology|MP:0009445,osteomalacia|MP:0010924,abnormal osteoid morphology|MP:0010929,increased osteoid thickness|MP:0011228,abnormal vitamin D level
MGI:3512143	Fgf23<tm1Blan>	MP:0000061,fragile skeleton|MP:0000063,decreased bone mineral density|MP:0000132,thickened long bone epiphysis|MP:0000135,decreased compact bone thickness|MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000167,decreased chondrocyte number|MP:0000189,hypoglycemia|MP:0000194,increased circulating calcium level|MP:0000559,abnormal femur morphology|MP:0000692,small spleen|MP:0001199,thin skin|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001566,increased circulating phosphate level|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002114,abnormal axial skeleton morphology|MP:0002264,abnormal bronchus morphology|MP:0002727,decreased circulating insulin level|MP:0002896,abnormal bone mineralization|MP:0002968,increased circulating alkaline phosphatase level|MP:0005292,improved glucose tolerance|MP:0005419,decreased circulating serum albumin level|MP:0005565,increased blood urea nitrogen level|MP:0005636,abnormal mineral homeostasis|MP:0006396,decreased long bone epiphyseal plate size|MP:0010123,increased bone mineral content|MP:0013616,decreased volumetric bone mineral density
MGI:3652903	Fgf23<tm1Sliu>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001562,abnormal circulating calcium level|MP:0001565,abnormal circulating phosphate level|MP:0002083,premature death|MP:0002896,abnormal bone mineralization|MP:0002905,decreased circulating parathyroid hormone level|MP:0003109,short femur|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0011228,abnormal vitamin D level
MGI:3033408	Fgf23<tm1Tyam>	MP:0000063,decreased bone mineral density|MP:0000167,decreased chondrocyte number|MP:0000189,hypoglycemia|MP:0000194,increased circulating calcium level|MP:0000694,spleen hypoplasia|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001566,increased circulating phosphate level|MP:0001732,postnatal growth retardation|MP:0001924,infertility|MP:0002083,premature death|MP:0002113,abnormal skeleton development|MP:0002135,abnormal kidney morphology|MP:0002160,abnormal reproductive system morphology|MP:0002644,decreased circulating triglyceride level|MP:0002905,decreased circulating parathyroid hormone level|MP:0003109,short femur|MP:0003644,thymus atrophy|MP:0005016,decreased lymphocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0005265,abnormal blood urea nitrogen level|MP:0005325,abnormal renal glomerulus morphology|MP:0010110,abnormal renal phosphate reabsorption|MP:0011228,abnormal vitamin D level
MGI:2384001	Fgf2<tm1Bas>	MP:0000789,thickened cerebral cortex|MP:0000790,abnormal stratification in cerebral cortex|MP:0000798,abnormal frontal lobe morphology|MP:0002414,abnormal myeloblast morphology/development|MP:0002908,delayed wound healing|MP:0003248,loss of glutamate neurons|MP:0005377,hearing/vestibular/ear phenotype
MGI:2180834	Fgf2<tm1Bee>	MP:0005391,vision/eye phenotype
MGI:5637206	Fgf2<tm1b(EUCOMM)Wtsi>	MP:0001325,abnormal retina morphology|MP:0001513,limb grasping|MP:0002965,increased circulating serum albumin level|MP:0005568,increased circulating total protein level
MGI:1857458	Fgf2<tm1Doe>	MP:0000343,abnormal response to cardiac infarction|MP:0002882,abnormal neuron morphology|MP:0003026,decreased vasoconstriction|MP:0003037,increased myocardial infarct size|MP:0003222,increased cardiomyocyte apoptosis|MP:0003248,loss of glutamate neurons|MP:0003544,abnormal vascular endothelial cell migration|MP:0003822,decreased left ventricle systolic pressure|MP:0003824,decreased left ventricle developed pressure|MP:0004084,abnormal cardiac muscle relaxation|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005140,decreased cardiac muscle contractility|MP:0005505,thrombocytosis|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0009937,abnormal neuron differentiation|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0009974,decreased cerebral cortex pyramidal cell number|MP:0014638,increased sleep duration
MGI:2384003	Fgf2<tm1Zllr>	MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0001596,hypotension|MP:0003241,loss of cortex neurons|MP:0004184,abnormal baroreceptor physiology|MP:0005369,muscle phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0006009,abnormal neuronal migration|MP:0006254,thin cerebral cortex|MP:0008221,abnormal hippocampal commissure morphology|MP:0008503,abnormal spinal cord grey matter morphology|MP:0009974,decreased cerebral cortex pyramidal cell number
MGI:3512180	Fgf2<tm2Doe>	MP:0002397,abnormal bone marrow morphology|MP:0003222,increased cardiomyocyte apoptosis|MP:0003822,decreased left ventricle systolic pressure|MP:0004084,abnormal cardiac muscle relaxation|MP:0005140,decreased cardiac muscle contractility|MP:0010124,decreased bone mineral content|MP:0021186,decreased bone mineral density of vertebrae
MGI:3831082	Fgf2<tm3Doe>	MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:6268746	Fgf3<M1Btlr>	MP:0000585,kinked tail|MP:0001262,decreased body weight|MP:0003051,curly tail
MGI:3767558	Fgf3<tm1.1Sms>	MP:0000035,abnormal membranous labyrinth morphology|MP:0000592,short tail|MP:0001394,circling|MP:0001672,abnormal embryo development|MP:0002082,postnatal lethality|MP:0002102,abnormal ear morphology|MP:0003051,curly tail|MP:0003148,decreased cochlea coiling|MP:0003163,absent posterior semicircular canal|MP:0003165,absent superior semicircular canal|MP:0003168,abnormal scala vestibuli morphology|MP:0004493,dilated cochlea|MP:0004923,absent common crus|MP:0005191,head tilt|MP:0006013,absent endolymphatic sac|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology|MP:0008065,short endolymphatic duct|MP:0008309,dilated scala media|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4456396	Fgf3<tm1.2Sms>	MP:0002169,no abnormal phenotype detected
MGI:1931059	Fgf3<tm1Mrc>	MP:0000026,abnormal inner ear morphology|MP:0000031,abnormal cochlea morphology|MP:0000034,abnormal inner ear vestibule morphology|MP:0000035,abnormal membranous labyrinth morphology|MP:0000041,absent endolymphatic duct|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001489,decreased startle reflex|MP:0001523,impaired righting response|MP:0001539,decreased caudal vertebrae number|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0002151,abnormal neural tube morphology|MP:0002428,abnormal semicircular canal morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0003051,curly tail|MP:0003148,decreased cochlea coiling|MP:0003163,absent posterior semicircular canal|MP:0003165,absent superior semicircular canal|MP:0003169,abnormal scala media morphology|MP:0003637,cochlear ganglion hypoplasia|MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0003984,embryonic growth retardation|MP:0004619,caudal vertebral fusion|MP:0004923,absent common crus|MP:0005191,head tilt|MP:0006013,absent endolymphatic sac|MP:0006030,abnormal otic vesicle development|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology|MP:0006358,absent pinna reflex|MP:0008065,short endolymphatic duct|MP:0008309,dilated scala media|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3027990	Fgf3<tm1Sng>	MP:0000588,thick tail|MP:0000592,short tail|MP:0002111,abnormal tail morphology|MP:0004310,small otic vesicle|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:4456397	Fgf3<tm2.1Sms>	MP:0000585,kinked tail
MGI:1931060	Fgf3<tm2Mrc>	MP:0000026,abnormal inner ear morphology|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001081,abnormal cranial ganglia morphology|MP:0001698,decreased embryo size|MP:0002082,postnatal lethality|MP:0002759,abnormal caudal vertebrae morphology|MP:0003051,curly tail
MGI:5605838	Fgf3<tm4b(EUCOMM)Hmgu>	MP:0000702,enlarged lymph nodes|MP:0001404,no spontaneous movement|MP:0001491,unresponsive to tactile stimuli|MP:0001697,abnormal embryo size|MP:0002111,abnormal tail morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:6316123	Fgf4<em1(IMPC)H>	MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:1931061	Fgf4<tm1.1Mrt>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:1931062	Fgf4<tm1.2Mrt>	MP:0005388,respiratory system phenotype
MGI:1931072	Fgf4<tm1Gol>	MP:0001672,abnormal embryo development|MP:0001724,abnormal extraembryonic endoderm formation|MP:0001730,embryonic growth arrest|MP:0009687,empty decidua capsularis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012113,decreased inner cell mass proliferation|MP:0014586,decreased egg cylinder size
MGI:1858005	Fgf4<tm1Mrc>	MP:0002169,no abnormal phenotype detected
MGI:1858006	Fgf4<tm2Mrc>	MP:0002080,prenatal lethality
MGI:1856336	Fgf5<go>	MP:0000367,abnormal coat/ hair morphology|MP:0000402,abnormal zigzag hair morphology|MP:0000405,abnormal auchene hair morphology|MP:0000427,abnormal hair cycle|MP:0001281,increased vibrissae length|MP:0002073,abnormal hair growth|MP:0002881,long hair|MP:0009271,increased guard hair length
MGI:1856478	Fgf5<go-Y>	MP:0000367,abnormal coat/ hair morphology|MP:0000397,abnormal guard hair morphology|MP:0002073,abnormal hair growth|MP:0002881,long hair|MP:0008858,abnormal hair cycle anagen phase
MGI:3777563	Fgf5<m1Btlr>	MP:0002881,long hair
MGI:5478737	Fgf5<m2Btlr>	MP:0002881,long hair
MGI:1857847	Fgf5<tm1Mrt>	MP:0002073,abnormal hair growth|MP:0002881,long hair
MGI:2680821	Fgf5<tm1Tzi>	MP:0002881,long hair
MGI:1857573	Fgf6<tm1Ffi>	MP:0002169,no abnormal phenotype detected
MGI:1927559	Fgf6<tm1Thbr>	MP:0000445,short snout|MP:0000730,increased satellite cell number|MP:0003091,abnormal cell migration|MP:0005382,craniofacial phenotype|MP:0013239,impaired skeletal muscle regeneration
MGI:6324182	Fgf7<tm1e.1(EUCOMM)Hmgu>	MP:0001319,irregularly shaped pupil|MP:0001322,abnormal iris morphology|MP:0001486,abnormal startle reflex|MP:0001523,impaired righting response|MP:0002546,mydriasis|MP:0006241,abnormal placement of pupils|MP:0006243,impaired pupillary reflex|MP:0011999,abnormal tail length
MGI:1891569	Fgf7<tm1Efu>	MP:0000527,abnormal kidney development|MP:0000694,spleen hypoplasia|MP:0001510,abnormal coat appearance|MP:0001511,disheveled coat|MP:0001790,abnormal immune system physiology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002989,small kidney|MP:0003846,matted coat|MP:0003849,greasy coat|MP:0004769,abnormal synaptic vesicle morphology|MP:0004792,abnormal synaptic vesicle number|MP:0004793,abnormal synaptic vesicle clustering|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005671,abnormal response to transplant|MP:0010771,integument phenotype|MP:0011290,decreased nephron number|MP:0011331,abnormal papillary duct morphology|MP:0011333,abnormal kidney inner medulla morphology|MP:0011360,kidney cortex hypoplasia|MP:0011565,kidney papillary hypoplasia|MP:0011843,abnormal kidney collecting duct epithelium morphology|MP:0014383,decreased miniature inhibitory postsynaptic current frequency
MGI:4430251	Fgf8<tm1.1Jyhl>	MP:0000270,abnormal heart tube morphology|MP:0000929,open neural tube|MP:0001680,abnormal mesoderm development|MP:0001698,decreased embryo size|MP:0002084,abnormal developmental patterning|MP:0002231,abnormal primitive streak morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0005029,abnormal amnion morphology|MP:0009331,absent primitive node
MGI:1857843	Fgf8<tm1.1Mrt>	MP:0000850,absent cerebellum|MP:0003451,absent olfactory bulb|MP:0009039,absent inferior colliculus|MP:0011087,neonatal lethality, complete penetrance
MGI:2150346	Fgf8<tm1.2Mrt>	MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0001698,decreased embryo size|MP:0001726,abnormal allantois morphology|MP:0002836,abnormal chorion morphology|MP:0003886,abnormal embryonic epiblast morphology|MP:0005029,abnormal amnion morphology|MP:0006386,absent somites|MP:0009331,absent primitive node|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011388,absent heart|MP:0012685,abnormal primitive streak elongation
MGI:2150347	Fgf8<tm1.3Mrt>	MP:0002169,no abnormal phenotype detected|MP:0004113,abnormal aortic arch morphology|MP:0004157,interrupted aortic arch|MP:0004161,cervical aortic arch|MP:0006126,abnormal cardiac outflow tract development
MGI:2150348	Fgf8<tm1.4Mrt>	MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0001726,abnormal allantois morphology|MP:0002836,abnormal chorion morphology|MP:0003886,abnormal embryonic epiblast morphology|MP:0004113,abnormal aortic arch morphology|MP:0005029,abnormal amnion morphology|MP:0006386,absent somites|MP:0009331,absent primitive node|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011388,absent heart|MP:0012685,abnormal primitive streak elongation
MGI:5637224	Fgf8<tm1b(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4839641	Fgf8<tm1(cre)Itl>	MP:0002169,no abnormal phenotype detected
MGI:4430252	Fgf8<tm1Jyhl>	MP:0001680,abnormal mesoderm development|MP:0001683,absent mesoderm|MP:0001688,abnormal somite development|MP:0002231,abnormal primitive streak morphology|MP:0004837,abnormal neural fold formation|MP:0012278,abnormal cardiogenic mesoderm morphology
MGI:2686864	Fgf8<tm1Moon>	MP:0000284,double outlet right ventricle|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0002925,abnormal cardiovascular development|MP:0003649,decreased heart right ventricle size|MP:0004158,right aortic arch|MP:0006126,abnormal cardiac outflow tract development|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0006355,abnormal sixth pharyngeal arch artery morphology|MP:0006356,abnormal third pharyngeal arch artery morphology|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0010402,ventricular septal defect|MP:0010465,aberrant origin of the right subclavian artery|MP:0012729,abnormal common carotid artery morphology|MP:0012752,abnormal cardiac neural crest cell migration
MGI:2150350	Fgf8<tm1Mrc>	MP:0002080,prenatal lethality
MGI:4437219	Fgf8<tm2.1Jyhl>	MP:0001262,decreased body weight|MP:0002082,postnatal lethality|MP:0003631,nervous system phenotype|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2150351	Fgf8<tm2Mrc>	MP:0002169,no abnormal phenotype detected
MGI:3612999	Fgf8<tm2Mrt>	MP:0003631,nervous system phenotype
MGI:5293829	Fgf9<Aca12>	MP:0001304,cataract|MP:0001306,small lens|MP:0002090,abnormal vision|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype|MP:0005391,vision/eye phenotype|MP:0005545,abnormal lens development|MP:0010768,mortality/aging|MP:0031213,increased eye anterior chamber depth
MGI:2182127	Fgf9<Eks>	MP:0000091,short premaxilla|MP:0000157,abnormal sternum morphology|MP:0000547,short limbs|MP:0000552,abnormal radius morphology|MP:0000566,synostosis|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001175,abnormal lung morphology|MP:0001300,ocular hypertelorism|MP:0001575,cyanosis|MP:0001732,postnatal growth retardation|MP:0001956,hypopnea|MP:0002750,exophthalmos|MP:0002764,short tibia|MP:0002765,short fibula|MP:0002932,abnormal joint morphology|MP:0003109,short femur|MP:0003189,fused joints|MP:0003491,abnormal voluntary movement|MP:0003641,small lung|MP:0003723,abnormal long bone morphology|MP:0004321,short sternum|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004471,short nasal bone|MP:0004599,abnormal vertebral arch morphology|MP:0004613,fusion of vertebral arches|MP:0004676,wide ribs|MP:0005272,abnormal temporal bone morphology|MP:0005296,abnormal humerus morphology|MP:0008158,increased diameter of femur|MP:0008159,increased diameter of fibula|MP:0008160,increased diameter of humerus|MP:0008161,increased diameter of radius|MP:0008162,increased diameter of tibia|MP:0008163,increased diameter of ulna|MP:0009890,cleft secondary palate|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0012085,midface hypoplasia|MP:0014299,increased cochlea size|MP:0014562,increased tympanic ring size|MP:0030032,high forehead|MP:0030350,premature coronal suture closure|MP:0030354,premature sagittal suture closure|MP:0030372,enlarged Meckel's cartilage
MGI:3621452	Fgf9<tm1.1Fwan>	MP:0002169,no abnormal phenotype detected
MGI:3621453	Fgf9<tm1.2Fwan>	MP:0001178,pulmonary hypoplasia|MP:0001954,respiratory distress|MP:0003641,small lung|MP:0003717,pallor|MP:0011089,perinatal lethality, complete penetrance
MGI:6726116	Fgf9<tm1.2Zqch>	MP:0000088,short mandible|MP:0002820,abnormal premaxilla morphology|MP:0003416,premature bone ossification|MP:0003742,narrow head|MP:0003758,narrow palate|MP:0004592,small mandible|MP:0005269,abnormal occipital bone morphology|MP:0009655,abnormal secondary palate development|MP:0009880,decreased mouth size|MP:0009890,cleft secondary palate|MP:0009891,abnormal palate bone morphology|MP:0009906,increased tongue size|MP:0011087,neonatal lethality, complete penetrance|MP:0013550,abnormal secondary palate morphology|MP:0014430,decreased hyaluronic acid level|MP:0021166,delayed palatal shelf elevation|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0031306,abnormal cartilage physiology|MP:0031443,abnormal tongue position|MP:0031462,decreased palatal shelf size
MGI:5523233	Fgf9<tm1b(KOMP)Wtsi>	MP:0000111,cleft palate|MP:0000274,enlarged heart|MP:0001304,cataract|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0001697,abnormal embryo size|MP:0002792,abnormal retina vasculature morphology|MP:0002833,increased heart weight|MP:0003385,abnormal body wall morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:2135961	Fgf9<tm1Dor>	MP:0000111,cleft palate|MP:0000267,abnormal heart development|MP:0000494,abnormal cecum morphology|MP:0000496,abnormal small intestine morphology|MP:0000566,synostosis|MP:0001146,abnormal testis morphology|MP:0001178,pulmonary hypoplasia|MP:0001575,cyanosis|MP:0001663,abnormal digestive system physiology|MP:0001940,testis hypoplasia|MP:0001953,respiratory failure|MP:0002211,abnormal primary sex determination|MP:0002740,heart hypoplasia|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002995,primary sex reversal|MP:0002996,ovotestis|MP:0003140,dilated heart atrium|MP:0004109,abnormal Sertoli cell development|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0004932,epididymis hypoplasia|MP:0005039,hypoxia|MP:0005379,endocrine/exocrine gland phenotype|MP:0005631,decreased lung weight|MP:0006418,abnormal testis cord formation|MP:0006419,disorganized testis cords|MP:0006421,decreased number of peritubular myoid cells|MP:0008022,dilated heart ventricle|MP:0008725,increased heart atrium size|MP:0009431,decreased fetal weight|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011142,abnormal lung-associated mesenchyme development|MP:0011146,abnormal mesenchymal cell proliferation involved in lung development|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0013602,abnormal Leydig cell differentiation
MGI:3621451	Fgf9<tm1Fwan>	MP:0011086,postnatal lethality, incomplete penetrance
MGI:5910441	Fgf9<tm1Zgwg>	MP:0000060,delayed bone ossification|MP:0000116,abnormal tooth development|MP:0000164,abnormal cartilage development|MP:0000566,synostosis|MP:0001146,abnormal testis morphology|MP:0001436,abnormal suckling behavior|MP:0002082,postnatal lethality|MP:0002932,abnormal joint morphology|MP:0003051,curly tail|MP:0003189,fused joints|MP:0003200,calcified joint|MP:0003491,abnormal voluntary movement|MP:0004173,abnormal intervertebral disk morphology|MP:0004609,vertebral fusion|MP:0004619,caudal vertebral fusion|MP:0005358,abnormal incisor morphology|MP:0005367,renal/urinary system phenotype|MP:0005388,respiratory system phenotype|MP:0006279,abnormal limb development|MP:0010114,abnormal coccyx morphology|MP:0011692,increased chondrocyte number|MP:0020039,increased bone ossification|MP:0030541,misaligned incisors|MP:0030837,abnormal knee joint morphology
MGI:5888855	Fgfbp1<tm1Gvdz>	MP:0001053,abnormal neuromuscular synapse morphology
MGI:5573274	Fgfbp3<tm1.1(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number
MGI:4949899	Fgfbp3<tm1Tohe>	MP:0001363,increased anxiety-related response
MGI:3836281	Fgfr1<Eask>	MP:0000022,abnormal ear shape|MP:0000023,abnormal ear position|MP:0000024,lowered ear position|MP:0002177,abnormal outer ear morphology|MP:0005391,vision/eye phenotype|MP:0011091,prenatal lethality, complete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3574787	Fgfr1<Hspy>	MP:0000018,small ears|MP:0000022,abnormal ear shape|MP:0000024,lowered ear position|MP:0000026,abnormal inner ear morphology|MP:0000049,abnormal middle ear morphology|MP:0000088,short mandible|MP:0000443,abnormal snout morphology|MP:0000445,short snout|MP:0001485,abnormal pinna reflex|MP:0001850,increased susceptibility to otitis media|MP:0002177,abnormal outer ear morphology|MP:0003878,abnormal ear physiology|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0003984,embryonic growth retardation|MP:0004402,decreased cochlear outer hair cell number|MP:0004411,decreased endocochlear potential|MP:0004415,abnormal cochlear nerve compound action potential|MP:0004471,short nasal bone|MP:0005106,abnormal incus morphology|MP:0005107,abnormal stapes morphology|MP:0005352,small cranium|MP:0005377,hearing/vestibular/ear phenotype|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0030108,abnormal incudostapedial joint morphology|MP:0030160,abnormal auditory bulla morphology|MP:0030394,abnormal incus short process morphology|MP:0030396,abnormal incus long process morphology|MP:0030398,absent incus lenticular process|MP:0030399,abnormal incus body morphology|MP:0030403,absent stapes head|MP:0030408,abnormal stapes posterior crus morphology|MP:0030411,decreased round window size|MP:0030412,absent round window|MP:0030419,excessive cerumen
MGI:6423849	Fgfr1op2<em1(IMPC)Mbp>	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002060,abnormal skin morphology|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0002699,abnormal vitreous body morphology|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0011100,preweaning lethality, complete penetrance
MGI:5828624	Fgfr1<tm10.1Sor>	MP:0001672,abnormal embryo development|MP:0001688,abnormal somite development|MP:0001730,embryonic growth arrest|MP:0002950,abnormal neural crest cell migration|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0006345,absent second pharyngeal arch|MP:0008854,bleb|MP:0011092,embryonic lethality, complete penetrance|MP:0011732,decreased somite size
MGI:2657013	Fgfr1<tm1.1Jpa>	MP:0001695,abnormal gastrulation|MP:0011092,embryonic lethality, complete penetrance
MGI:5583086	Fgfr1<tm1.1(KOMP)Vlcg>	MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0010378,increased respiratory quotient|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3529270	Fgfr1<tm1.1Upir>	MP:0000267,abnormal heart development|MP:0000428,abnormal craniofacial morphology|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002088,abnormal embryonic growth/weight/body size|MP:0002151,abnormal neural tube morphology|MP:0002152,abnormal brain morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:2153353	Fgfr1<tm1Cxd>	MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002151,abnormal neural tube morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:2448986	Fgfr1<tm1Jpa>	MP:0000111,cleft palate|MP:0000116,abnormal tooth development|MP:0000849,abnormal cerebellum morphology|MP:0000854,abnormal cerebellum development|MP:0000864,abnormal cerebellum vermis morphology|MP:0000865,absent cerebellum vermis|MP:0000897,abnormal midbrain morphology|MP:0001063,abnormal trochlear nerve morphology|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0002058,neonatal lethality|MP:0002639,micrognathia|MP:0003661,abnormal locus ceruleus morphology|MP:0005170,cleft upper lip|MP:0005382,craniofacial phenotype|MP:0009039,absent inferior colliculus|MP:0009652,abnormal palatal rugae morphology|MP:0009655,abnormal secondary palate development|MP:0009886,failure of palatal shelf elevation|MP:0009888,palatal shelves fail to meet at midline|MP:0009889,persistence of medial edge epithelium during palatal shelf fusion|MP:0009890,cleft secondary palate|MP:0009893,cleft primary palate|MP:0009903,abnormal medial nasal prominence morphology|MP:0009914,abnormal hyoid bone lesser horn morphology|MP:0021213,complete cleft palate|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0031443,abnormal tongue position|MP:0031462,decreased palatal shelf size
MGI:2153342	Fgfr1<tm1Jrt>	MP:0000270,abnormal heart tube morphology|MP:0000897,abnormal midbrain morphology|MP:0001680,abnormal mesoderm development|MP:0001693,failure of primitive streak formation|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0001721,absent visceral yolk sac blood islands|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002174,abnormal gastrulation movements|MP:0002231,abnormal primitive streak morphology|MP:0002836,abnormal chorion morphology|MP:0003400,kinked neural tube|MP:0003885,abnormal rostral-caudal body axis extension|MP:0003984,embryonic growth retardation|MP:0004556,enlarged allantois|MP:0005657,abnormal neural plate morphology|MP:0006386,absent somites|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011205,excessive folding of visceral yolk sac|MP:0011256,abnormal neural fold morphology|MP:0011257,abnormal head fold morphology|MP:0011260,abnormal head mesenchyme morphology|MP:0012183,decreased paraxial mesoderm size|MP:0012274,increased axial mesoderm size|MP:0012740,abnormal posterior primitive streak morphology|MP:0014586,decreased egg cylinder size|MP:0020515,abnormal visceral yolk sac endoderm morphology|MP:0020516,abnormal visceral yolk sac mesenchyme morphology|MP:0030537,abnormal notochordal process morphology
MGI:2150650	Fgfr1<tm1Led>	MP:0001680,abnormal mesoderm development|MP:0001698,decreased embryo size|MP:0002084,abnormal developmental patterning|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002151,abnormal neural tube morphology|MP:0002231,abnormal primitive streak morphology|MP:0003085,abnormal egg cylinder morphology|MP:0003885,abnormal rostral-caudal body axis extension|MP:0003984,embryonic growth retardation|MP:0004573,absent limb buds|MP:0005221,abnormal rostral-caudal axis patterning|MP:0006386,absent somites|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0011205,excessive folding of visceral yolk sac|MP:0011208,small proamniotic cavity|MP:0012131,small visceral yolk sac|MP:0014586,decreased egg cylinder size
MGI:3606056	Fgfr1<tm1Swnr>	MP:0010771,integument phenotype
MGI:3528437	Fgfr1<tm1Upir>	MP:0000042,abnormal organ of Corti morphology|MP:0000780,abnormal corpus callosum morphology|MP:0000798,abnormal frontal lobe morphology|MP:0000937,abnormal motor neuron morphology|MP:0002169,no abnormal phenotype detected|MP:0002182,abnormal astrocyte morphology|MP:0002199,abnormal brain commissure morphology|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0006009,abnormal neuronal migration|MP:0008219,abnormal dorsal telencephalic commissure morphology|MP:0008221,abnormal hippocampal commissure morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0014747,abnormal motor neuron axon guidance
MGI:2153355	Fgfr1<tm2.1Cxd>	MP:0000081,premature cranial suture closure|MP:0000106,abnormal basisphenoid bone morphology|MP:0000592,short tail|MP:0001265,decreased body size|MP:0001300,ocular hypertelorism|MP:0002116,abnormal craniofacial bone morphology|MP:0004831,long incisors|MP:0004988,increased osteoblast cell number|MP:0005249,abnormal palatine bone morphology|MP:0005274,abnormal viscerocranium morphology|MP:0008863,craniofacial asymmetry|MP:0012085,midface hypoplasia|MP:0014051,abnormal maxillary-premaxillary suture morphology|MP:0030099,facial asymmetry|MP:0030350,premature coronal suture closure|MP:0030354,premature sagittal suture closure|MP:0030367,premature metopic suture closure|MP:0030434,premature maxillary-premaxillary suture closure|MP:0030438,increased osteoblast proliferation
MGI:2153344	Fgfr1<tm2.1Jrt>	MP:0002169,no abnormal phenotype detected
MGI:2153343	Fgfr1<tm2Jrt>	MP:0000018,small ears|MP:0000029,abnormal malleus morphology|MP:0000040,decreased middle ear ossicle number|MP:0000042,abnormal organ of Corti morphology|MP:0000111,cleft palate|MP:0000154,rib fusion|MP:0000480,increased rib number|MP:0000554,abnormal carpal bone morphology|MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0000864,abnormal cerebellum vermis morphology|MP:0001539,decreased caudal vertebrae number|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002950,abnormal neural crest cell migration|MP:0003036,vertebral transformation|MP:0003138,absent tympanic ring|MP:0003235,abnormal alisphenoid bone morphology|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0004073,caudal body truncation|MP:0004402,decreased cochlear outer hair cell number|MP:0004423,abnormal temporal bone squamous part morphology|MP:0004453,abnormal pterygoid bone morphology|MP:0004608,abnormal cervical axis morphology|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004617,sacral vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0005104,abnormal tarsal bone morphology|MP:0005105,abnormal middle ear ossicle morphology|MP:0005106,abnormal incus morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005306,abnormal phalanx morphology|MP:0005382,craniofacial phenotype|MP:0006020,decreased tympanic ring size|MP:0006281,abnormal tail development|MP:0006338,abnormal second pharyngeal arch morphology|MP:0006344,small second pharyngeal arch|MP:0008023,abnormal styloid process morphology|MP:0008148,abnormal sternocostal joint morphology|MP:0008381,absent gonial bone|MP:0009038,decreased inferior colliculus size|MP:0009655,abnormal secondary palate development|MP:0009845,abnormal neural crest cell morphology|MP:0009886,failure of palatal shelf elevation|MP:0009914,abnormal hyoid bone lesser horn morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0030119,abnormal retrotympanic process morphology|MP:0030125,small gonial bone|MP:0031443,abnormal tongue position
MGI:2181473	Fgfr1<tm3.1Cxd>	MP:0011092,embryonic lethality, complete penetrance
MGI:2153346	Fgfr1<tm3.1Jrt>	MP:0001688,abnormal somite development|MP:0001695,abnormal gastrulation|MP:0006386,absent somites|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012183,decreased paraxial mesoderm size
MGI:3620057	Fgfr1<tm3.1Sor>	MP:0003054,spina bifida|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2181474	Fgfr1<tm3.2Cxd>	MP:0000164,abnormal cartilage development|MP:0000556,abnormal hindlimb morphology|MP:0000565,oligodactyly|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0002114,abnormal axial skeleton morphology|MP:0003854,abnormal forelimb stylopod morphology|MP:0003855,abnormal forelimb zeugopod morphology|MP:0004576,abnormal embryonic autopod plate morphology|MP:0005222,abnormal somite size|MP:0005657,abnormal neural plate morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0013164,abnormal forelimb bud morphology|MP:0014280,forelimb oligodactyly
MGI:2181471	Fgfr1<tm3Cxd>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2153345	Fgfr1<tm3Jrt>	MP:0001688,abnormal somite development|MP:0001695,abnormal gastrulation|MP:0006386,absent somites|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012183,decreased paraxial mesoderm size
MGI:3619011	Fgfr1<tm3Sor>	MP:0011092,embryonic lethality, complete penetrance
MGI:2153348	Fgfr1<tm4.1Jrt>	MP:0002169,no abnormal phenotype detected|MP:0005377,hearing/vestibular/ear phenotype
MGI:3620059	Fgfr1<tm4.1Sor>	MP:0001698,decreased embryo size|MP:0002110,abnormal digit morphology|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:2153347	Fgfr1<tm4Jrt>	MP:0000164,abnormal cartilage development|MP:0000550,abnormal forelimb morphology|MP:0000554,abnormal carpal bone morphology|MP:0001539,decreased caudal vertebrae number|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0003036,vertebral transformation|MP:0004608,abnormal cervical axis morphology|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004617,sacral vertebral transformation|MP:0005104,abnormal tarsal bone morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005306,abnormal phalanx morphology|MP:0006344,small second pharyngeal arch|MP:0008148,abnormal sternocostal joint morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3619012	Fgfr1<tm4Sor>	MP:0011092,embryonic lethality, complete penetrance
MGI:2153350	Fgfr1<tm5.1Jrt>	MP:0002169,no abnormal phenotype detected
MGI:3620060	Fgfr1<tm5.1Sor>	MP:0000108,midline facial cleft
MGI:3620061	Fgfr1<tm5.2Sor>	MP:0000274,enlarged heart|MP:0001680,abnormal mesoderm development|MP:0001690,failure of somite differentiation|MP:0002084,abnormal developmental patterning|MP:0002174,abnormal gastrulation movements|MP:0003886,abnormal embryonic epiblast morphology|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0004251,failure of heart looping|MP:0004957,abnormal blastocyst morphology|MP:0008784,craniorachischisis|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011183,abnormal primitive endoderm morphology|MP:0012183,decreased paraxial mesoderm size|MP:0012274,increased axial mesoderm size
MGI:2153349	Fgfr1<tm5Jrt>	MP:0000154,rib fusion|MP:0001539,decreased caudal vertebrae number|MP:0001688,abnormal somite development|MP:0002058,neonatal lethality|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0004073,caudal body truncation|MP:0004574,broad limb buds|MP:0004615,cervical vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0006344,small second pharyngeal arch|MP:0008148,abnormal sternocostal joint morphology|MP:0010117,abnormal lateral plate mesoderm morphology|MP:0010728,fusion of atlas and occipital bones|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011256,abnormal neural fold morphology
MGI:2153352	Fgfr1<tm6.1Jrt>	MP:0000137,abnormal vertebrae morphology|MP:0000154,rib fusion|MP:0002114,abnormal axial skeleton morphology|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004617,sacral vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0008148,abnormal sternocostal joint morphology
MGI:2153351	Fgfr1<tm6Jrt>	MP:0000154,rib fusion|MP:0000864,abnormal cerebellum vermis morphology|MP:0001539,decreased caudal vertebrae number|MP:0001688,abnormal somite development|MP:0002109,abnormal limb morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002622,abnormal cochlear hair cell morphology|MP:0003036,vertebral transformation|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0004073,caudal body truncation|MP:0004301,absent organ of Corti supporting cells|MP:0004395,increased cochlear inner hair cell number|MP:0004403,absent cochlear outer hair cells|MP:0004492,abnormal orientation of inner hair cell stereociliary bundles|MP:0004574,broad limb buds|MP:0004589,abnormal cochlear hair cell development|MP:0004615,cervical vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004837,abnormal neural fold formation|MP:0006344,small second pharyngeal arch|MP:0008148,abnormal sternocostal joint morphology|MP:0009038,decreased inferior colliculus size|MP:0010117,abnormal lateral plate mesoderm morphology|MP:0010728,fusion of atlas and occipital bones|MP:0011087,neonatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011732,decreased somite size
MGI:5828620	Fgfr1<tm7.1Sor>	MP:0002169,no abnormal phenotype detected
MGI:5828622	Fgfr1<tm8.1Sor>	MP:0000150,abnormal rib morphology|MP:0000153,rib bifurcation|MP:0002114,abnormal axial skeleton morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0004624,abnormal thoracic cage morphology|MP:0004647,decreased lumbar vertebrae number|MP:0004648,decreased thoracic vertebrae number|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype
MGI:5828623	Fgfr1<tm9.1Sor>	MP:0000111,cleft palate|MP:0004616,lumbar vertebral transformation|MP:0004651,increased thoracic vertebrae number|MP:0009744,postaxial polydactyly|MP:0010326,malleus hypoplasia|MP:0011085,postnatal lethality, complete penetrance|MP:0013268,second pharyngeal arch hypoplasia|MP:0030084,tympanic ring hypoplasia|MP:0030107,incus hypoplasia|MP:0030124,middle ear ossicle hypoplasia|MP:0030128,stapes hypoplasia|MP:0030322,styloid process hypoplasia
MGI:4835423	Fgfr2<hob>	MP:0000549,decreased limb number|MP:0001178,pulmonary hypoplasia|MP:0002995,primary sex reversal|MP:0006208,lethality throughout fetal growth and development
MGI:4461798	Fgfr2<m1Sgg>	MP:0000106,abnormal basisphenoid bone morphology|MP:0000118,arrest of tooth development|MP:0000120,malocclusion|MP:0000137,abnormal vertebrae morphology|MP:0000157,abnormal sternum morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000462,abnormal digestive system morphology|MP:0000549,decreased limb number|MP:0000762,abnormal tongue morphology|MP:0000774,decreased brain size|MP:0001347,absent lacrimal glands|MP:0001677,absent apical ectodermal ridge|MP:0001698,decreased embryo size|MP:0001954,respiratory distress|MP:0002058,neonatal lethality|MP:0002750,exophthalmos|MP:0002989,small kidney|MP:0003641,small lung|MP:0003938,abnormal ear development|MP:0004247,small pancreas|MP:0004320,split sternum|MP:0004377,small frontal bone|MP:0004418,small parietal bone|MP:0004449,absent presphenoid bone|MP:0004469,abnormal zygomatic arch morphology|MP:0004537,abnormal palatine bone horizontal plate morphology|MP:0004609,vertebral fusion|MP:0004620,cervical vertebral fusion|MP:0004726,abnormal nasal capsule morphology|MP:0004831,long incisors|MP:0004989,decreased osteoblast cell number|MP:0005378,growth/size/body region phenotype|MP:0006213,shallow orbits|MP:0006279,abnormal limb development|MP:0008272,abnormal endochondral bone ossification|MP:0008525,decreased cranium height|MP:0008785,abnormal sternum manubrium morphology|MP:0009524,absent submandibular gland|MP:0009653,abnormal palate development|MP:0009703,decreased birth body size|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009890,cleft secondary palate|MP:0010743,delayed cranial suture closure|MP:0011011,impaired lung lobe morphogenesis|MP:0030029,wide cranial sutures|MP:0030200,abnormal nasal septum cartilage morphology|MP:0030205,thick nasal septum|MP:0030350,premature coronal suture closure|MP:0030464,abnormal cranial cartilage morphology
MGI:1856633	Fgfr2<svs>	MP:0000666,decreased prostate gland duct number|MP:0002059,abnormal seminal vesicle morphology|MP:0004961,increased prostate gland weight|MP:0009736,abnormal prostate gland branching morphogenesis|MP:0013317,abnormal seminal vesicle development|MP:0013904,abnormal seminal vesicle muscle layer morphology
MGI:3044427	Fgfr2<tm1.1Dor>	MP:0001712,abnormal placenta development|MP:0004573,absent limb buds|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2153811	Fgfr2<tm1.1Dsn>	MP:0000031,abnormal cochlea morphology|MP:0000035,abnormal membranous labyrinth morphology|MP:0000039,abnormal otic capsule morphology|MP:0000111,cleft palate|MP:0000118,arrest of tooth development|MP:0000440,domed cranium|MP:0000470,abnormal stomach morphology|MP:0000492,abnormal rectum morphology|MP:0000551,absent forelimb|MP:0000557,absent hindlimb|MP:0000613,abnormal salivary gland morphology|MP:0000629,absent mammary gland|MP:0000762,abnormal tongue morphology|MP:0001176,abnormal lung development|MP:0001181,absent lungs|MP:0001199,thin skin|MP:0001201,translucent skin|MP:0001218,thin epidermis|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001244,thin dermal layer|MP:0001265,decreased body size|MP:0001341,absent eyelids|MP:0002428,abnormal semicircular canal morphology|MP:0002691,small stomach|MP:0003051,curly tail|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0003315,abnormal perineum morphology|MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0003755,abnormal palate morphology|MP:0003760,decreased palatal length|MP:0003816,abnormal pituitary gland development|MP:0003934,abnormal pancreas development|MP:0004247,small pancreas|MP:0004310,small otic vesicle|MP:0004343,small scapula|MP:0004346,absent acromion|MP:0004507,abnormal ischium morphology|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004619,caudal vertebral fusion|MP:0004691,absent pubis|MP:0005298,abnormal clavicle morphology|MP:0005354,abnormal ilium morphology|MP:0005382,craniofacial phenotype|MP:0006011,abnormal endolymphatic duct morphology|MP:0006279,abnormal limb development|MP:0006287,inner ear cyst|MP:0006288,small otic capsule|MP:0008320,absent adenohypophysis|MP:0009479,abnormal cecum development|MP:0009509,absent rectum|MP:0009510,cecal atresia|MP:0009522,submandibular gland hypoplasia|MP:0009524,absent submandibular gland|MP:0009525,abnormal submandibular duct morphology|MP:0009655,abnormal secondary palate development|MP:0009884,palatal shelf fusion with tongue or mandible|MP:0009890,cleft secondary palate|MP:0011026,impaired branching involved in trachea morphogenesis|MP:0011089,perinatal lethality, complete penetrance|MP:0011158,absent hypodermis muscle layer|MP:0011627,decreased skin pigmentation|MP:0011759,absent Rathke's pouch|MP:0013264,tongue ankylosis|MP:0013351,abnormal Rathke's pouch development|MP:0013352,abnormal Rathke's pouch apoptosis|MP:0013580,abnormal nasal gland morphology|MP:0013582,abnormal lateral nasal gland morphology|MP:0013721,abnormal mammary placode morphology|MP:0013766,absent palatal rugae|MP:0013785,abnormal mammary gland bud morphology|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0030358,premature squamoparietal suture closure|MP:0031300,perineal hypospadia
MGI:3700782	Fgfr2<tm1.1Wrst>	MP:0001672,abnormal embryo development|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2153790	Fgfr2<tm1Cxd>	MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001712,abnormal placenta development|MP:0002169,no abnormal phenotype detected|MP:0003231,abnormal placenta vasculature|MP:0003403,absent placental labyrinth|MP:0003984,embryonic growth retardation|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004310,small otic vesicle|MP:0004556,enlarged allantois|MP:0004573,absent limb buds|MP:0005031,abnormal trophoblast layer morphology|MP:0009397,increased trophoblast giant cell number|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3044679	Fgfr2<tm1Dor>	MP:0000367,abnormal coat/ hair morphology|MP:0000745,tremors|MP:0001176,abnormal lung development|MP:0001265,decreased body size|MP:0001347,absent lacrimal glands|MP:0001698,decreased embryo size|MP:0002152,abnormal brain morphology|MP:0002182,abnormal astrocyte morphology|MP:0004793,abnormal synaptic vesicle clustering|MP:0005391,vision/eye phenotype|MP:0009004,progressive hair loss|MP:0011028,impaired branching involved in bronchus morphogenesis|MP:0013192,decreased sebaceous gland number|MP:0013331,abnormal lacrimal gland development|MP:0013470,absent lacrimal gland bud
MGI:2153810	Fgfr2<tm1Dsn>	MP:0000377,abnormal hair follicle morphology|MP:0000383,abnormal hair follicle orientation|MP:0000402,abnormal zigzag hair morphology|MP:0000427,abnormal hair cycle|MP:0000579,abnormal nail morphology|MP:0000649,sebaceous gland atrophy|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0002051,increased skin papilloma incidence|MP:0003414,epidermal cyst|MP:0003427,parakeratosis|MP:0004499,increased incidence of tumors by chemical induction|MP:0004947,skin inflammation|MP:0008346,increased gamma-delta T cell number|MP:0009583,increased keratinocyte proliferation|MP:0020386,adipose tissue inflammation
MGI:3603464	Fgfr2<tm1Ewj>	MP:0000077,abnormal interparietal bone morphology|MP:0000081,premature cranial suture closure|MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000102,abnormal nasal bone morphology|MP:0000163,abnormal cartilage morphology|MP:0000164,abnormal cartilage development|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000435,shortened head|MP:0000458,abnormal mandible morphology|MP:0000703,abnormal thymus morphology|MP:0000780,abnormal corpus callosum morphology|MP:0001177,atelectasis|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001613,abnormal vasodilation|MP:0001891,hydrocephaly|MP:0001953,respiratory failure|MP:0002116,abnormal craniofacial bone morphology|MP:0002152,abnormal brain morphology|MP:0002835,abnormal cranial suture morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0003140,dilated heart atrium|MP:0003755,abnormal palate morphology|MP:0003760,decreased palatal length|MP:0003840,abnormal coronal suture morphology|MP:0003843,abnormal sagittal suture morphology|MP:0004469,abnormal zygomatic arch morphology|MP:0004471,short nasal bone|MP:0004592,small mandible|MP:0004596,abnormal mandibular angle morphology|MP:0004985,decreased osteoclast cell number|MP:0005238,increased brain size|MP:0005352,small cranium|MP:0008395,abnormal osteoblast differentiation|MP:0008525,decreased cranium height|MP:0008534,enlarged fourth ventricle|MP:0008540,abnormal cerebral hemisphere morphology|MP:0009247,meteorism|MP:0009674,decreased birth weight|MP:0009887,abnormal palatal shelf fusion at midline|MP:0010029,abnormal basicranium morphology|MP:0010994,aerophagia|MP:0010998,pulmonary alveolar proteinosis|MP:0011013,bronchiolectasis|MP:0011087,neonatal lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0011710,enhanced osteoblast differentiation|MP:0011861,increased cranium height|MP:0011862,decreased cranium length|MP:0014051,abnormal maxillary-premaxillary suture morphology|MP:0030064,small face|MP:0030167,decreased inner canthal distance|MP:0030194,abnormal intermaxillary suture morphology|MP:0030265,parietal bossing|MP:0030301,abnormal maxillary frontal process morphology|MP:0030302,abnormal maxillary zygomatic process morphology|MP:0030315,small neurocranium|MP:0030350,premature coronal suture closure|MP:0030356,premature lambdoid suture closure|MP:0030391,premature zygomaticomaxillary suture closure|MP:0030431,wide metopic suture|MP:0030438,increased osteoblast proliferation
MGI:2153799	Fgfr2<tm1Lni>	MP:0001685,abnormal endoderm development|MP:0002084,abnormal developmental patterning|MP:0002663,absent blastocoele|MP:0003085,abnormal egg cylinder morphology|MP:0003845,abnormal decidualization|MP:0004965,inner cell mass degeneration|MP:0005380,embryo phenotype|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011185,absent primitive endoderm
MGI:3699313	Fgfr2<tm1Schl>	MP:0000081,premature cranial suture closure|MP:0000111,cleft palate|MP:0000438,abnormal cranium morphology|MP:0001943,abnormal respiration|MP:0002750,exophthalmos|MP:0003120,abnormal tracheal cartilage morphology|MP:0003189,fused joints|MP:0009888,palatal shelves fail to meet at midline|MP:0011087,neonatal lethality, complete penetrance|MP:0030066,short face|MP:0030350,premature coronal suture closure
MGI:3700773	Fgfr2<tm1Wrst>	MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype
MGI:2183527	Fgfr2<tm2.1Lni>	MP:0000549,decreased limb number|MP:0001181,absent lungs|MP:0004792,abnormal synaptic vesicle number|MP:0004793,abnormal synaptic vesicle clustering|MP:0009524,absent submandibular gland|MP:0011087,neonatal lethality, complete penetrance
MGI:2153815	Fgfr2<tm2.2Dsn>	MP:0002169,no abnormal phenotype detected
MGI:2153817	Fgfr2<tm2.3Dsn>	MP:0000074,abnormal neurocranium morphology|MP:0000097,short maxilla|MP:0000189,hypoglycemia|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000521,abnormal kidney cortex morphology|MP:0000596,abnormal liver development|MP:0001175,abnormal lung morphology|MP:0001265,decreased body size|MP:0001669,abnormal intestinal glucose absorption|MP:0001732,postnatal growth retardation|MP:0002267,abnormal bronchiole morphology|MP:0002750,exophthalmos|MP:0002989,small kidney|MP:0003641,small lung|MP:0004322,abnormal sternebra morphology|MP:0004469,abnormal zygomatic arch morphology|MP:0004505,decreased renal glomerulus number|MP:0004678,split xiphoid process|MP:0005379,endocrine/exocrine gland phenotype|MP:0005381,digestive/alimentary phenotype|MP:0006027,impaired lung alveolus development|MP:0006213,shallow orbits|MP:0008277,abnormal sternum ossification|MP:0009050,dilated proximal convoluted tubule|MP:0009051,dilated distal convoluted tubule|MP:0009570,abnormal right lung morphology|MP:0010911,abnormal pulmonary acinus morphology|MP:0011011,impaired lung lobe morphogenesis|MP:0011085,postnatal lethality, complete penetrance|MP:0011290,decreased nephron number|MP:0012667,split sternal manubrium|MP:0014152,absent exorbital lacrimal gland|MP:0030350,premature coronal suture closure
MGI:3604072	Fgfr2<tm2Cxd>	MP:0000074,abnormal neurocranium morphology|MP:0000081,premature cranial suture closure|MP:0000120,malocclusion|MP:0000130,abnormal trabecular bone morphology|MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0001300,ocular hypertelorism|MP:0001698,decreased embryo size|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0002835,abnormal cranial suture morphology|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003843,abnormal sagittal suture morphology|MP:0004448,abnormal presphenoid bone morphology|MP:0004451,short presphenoid bone|MP:0004469,abnormal zygomatic arch morphology|MP:0004471,short nasal bone|MP:0005249,abnormal palatine bone morphology|MP:0008525,decreased cranium height|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012085,midface hypoplasia|MP:0030275,thin frontal bone|MP:0030281,thin parietal bone|MP:0030350,premature coronal suture closure|MP:0030390,premature facial suture closure|MP:0030424,premature palatomaxillary suture closure|MP:0030425,wide intermaxillary suture|MP:0030434,premature maxillary-premaxillary suture closure|MP:0030436,premature frontonasal suture closure
MGI:2153813	Fgfr2<tm2Dsn>	MP:0002169,no abnormal phenotype detected|MP:0009522,submandibular gland hypoplasia
MGI:4430185	Fgfr2<tm2Ewj>	MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000157,abnormal sternum morphology|MP:0000440,domed cranium|MP:0000566,synostosis|MP:0000780,abnormal corpus callosum morphology|MP:0001262,decreased body weight|MP:0001533,abnormal skeleton physiology|MP:0001732,postnatal growth retardation|MP:0002113,abnormal skeleton development|MP:0002152,abnormal brain morphology|MP:0002764,short tibia|MP:0002835,abnormal cranial suture morphology|MP:0003109,short femur|MP:0003760,decreased palatal length|MP:0003841,abnormal lambdoid suture morphology|MP:0003843,abnormal sagittal suture morphology|MP:0004351,short humerus|MP:0004355,short radius|MP:0004471,short nasal bone|MP:0005270,abnormal zygomatic bone morphology|MP:0005352,small cranium|MP:0008534,enlarged fourth ventricle|MP:0008535,enlarged lateral ventricles|MP:0008540,abnormal cerebral hemisphere morphology|MP:0009887,abnormal palatal shelf fusion at midline|MP:0011085,postnatal lethality, complete penetrance|MP:0011710,enhanced osteoblast differentiation|MP:0011861,increased cranium height|MP:0030167,decreased inner canthal distance|MP:0030302,abnormal maxillary zygomatic process morphology|MP:0030350,premature coronal suture closure|MP:0030420,short basicranium|MP:0030438,increased osteoblast proliferation
MGI:3699314	Fgfr2<tm2Schl>	MP:0000111,cleft palate|MP:0002169,no abnormal phenotype detected|MP:0003120,abnormal tracheal cartilage morphology|MP:0009888,palatal shelves fail to meet at midline
MGI:6406986	Fgfr2<tm3.1Cxd>	MP:0000120,malocclusion|MP:0000130,abnormal trabecular bone morphology|MP:0000131,abnormal long bone epiphysis morphology|MP:0000428,abnormal craniofacial morphology|MP:0000435,shortened head|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000441,increased cranium width|MP:0000564,syndactyly|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001300,ocular hypertelorism|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003418,premature intramembranous bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004053,abnormal synchondrosis|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0006399,abnormal long bone epiphyseal ossification zone morphology|MP:0008272,abnormal endochondral bone ossification|MP:0010743,delayed cranial suture closure|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011710,enhanced osteoblast differentiation|MP:0011861,increased cranium height|MP:0011862,decreased cranium length|MP:0012085,midface hypoplasia|MP:0012173,short rostral-caudal axis|MP:0030095,abnormal midface morphology|MP:0030350,premature coronal suture closure|MP:0030420,short basicranium|MP:0030443,abnormal cranial synchondrosis|MP:0030467,abnormal cranial cartilage development
MGI:2183529	Fgfr2<tm3.1Lni>	MP:0000060,delayed bone ossification|MP:0000081,premature cranial suture closure|MP:0000104,abnormal sphenoid bone morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0000432,abnormal head morphology|MP:0000440,domed cranium|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002750,exophthalmos|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003743,abnormal facial morphology|MP:0003840,abnormal coronal suture morphology|MP:0004448,abnormal presphenoid bone morphology|MP:0005367,renal/urinary system phenotype|MP:0008489,slow postnatal weight gain|MP:0008525,decreased cranium height|MP:0010029,abnormal basicranium morphology|MP:0030196,abnormal nasomaxillary suture morphology|MP:0030350,premature coronal suture closure|MP:0030437,abnormal osteoblast proliferation
MGI:6406985	Fgfr2<tm3Cxd>	MP:0000074,abnormal neurocranium morphology|MP:0000079,abnormal basioccipital bone morphology|MP:0000091,short premaxilla|MP:0000097,short maxilla|MP:0000102,abnormal nasal bone morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000438,abnormal cranium morphology|MP:0000771,abnormal brain size|MP:0001300,ocular hypertelorism|MP:0003108,short zygomatic bone|MP:0004380,short frontal bone|MP:0004471,short nasal bone|MP:0006213,shallow orbits|MP:0010029,abnormal basicranium morphology|MP:0010876,decreased bone volume|MP:0011862,decreased cranium length|MP:0030076,abnormal cranial cavity morphology|MP:0030095,abnormal midface morphology|MP:0030301,abnormal maxillary frontal process morphology|MP:0030350,premature coronal suture closure|MP:0030353,wide sagittal suture|MP:0030375,short zygomatic arch|MP:0030431,wide metopic suture|MP:0030445,abnormal sphenooccipital synchondrosis|MP:0030446,premature sphenooccipital synchondrosis closure|MP:0030448,premature presphenoid synchondrosis closure
MGI:2153818	Fgfr2<tm3Dsn>	MP:0000111,cleft palate|MP:0000149,abnormal scapula morphology|MP:0000267,abnormal heart development|MP:0000273,overriding aortic valve|MP:0000280,thin ventricular wall|MP:0000284,double outlet right ventricle|MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000527,abnormal kidney development|MP:0000537,abnormal urethra morphology|MP:0000549,decreased limb number|MP:0000613,abnormal salivary gland morphology|MP:0000704,abnormal thymus development|MP:0001181,absent lungs|MP:0001199,thin skin|MP:0001216,abnormal epidermal layer morphology|MP:0001218,thin epidermis|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001341,absent eyelids|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0002060,abnormal skin morphology|MP:0002295,abnormal pulmonary circulation|MP:0002655,abnormal keratinocyte morphology|MP:0002989,small kidney|MP:0003051,curly tail|MP:0003124,hypospadia|MP:0003420,delayed intramembranous bone ossification|MP:0003704,abnormal hair follicle development|MP:0003934,abnormal pancreas development|MP:0004032,abnormal interventricular groove morphology|MP:0004067,abnormal trabecula carnea morphology|MP:0004200,decreased fetal size|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004619,caudal vertebral fusion|MP:0005294,abnormal heart ventricle morphology|MP:0005314,absent thyroid gland|MP:0006030,abnormal otic vesicle development|MP:0006288,small otic capsule|MP:0008320,absent adenohypophysis|MP:0009003,abnormal vibrissa number|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010422,heart right ventricle hypoplasia|MP:0010454,abnormal truncus arteriosus septation|MP:0010521,absent pulmonary artery|MP:0010585,abnormal conotruncal ridge morphology|MP:0010587,conotruncal ridge hypoplasia|MP:0010646,absent pulmonary vein|MP:0010647,heart left atrium hypoplasia|MP:0011089,perinatal lethality, complete penetrance|MP:0011290,decreased nephron number|MP:0013310,abnormal adrenal gland development|MP:0013578,abnormal stomach glandular region morphology|MP:0030610,absent teeth|MP:0031525,thin left ventricle myocardium compact layer
MGI:5450938	Fgfr2<tm3Ewj>	MP:0000081,premature cranial suture closure|MP:0000157,abnormal sternum morphology|MP:0000435,shortened head|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001725,abnormal umbilical cord morphology|MP:0001732,postnatal growth retardation|MP:0001874,acanthosis|MP:0002060,abnormal skin morphology|MP:0009545,abnormal dermis papillary layer morphology|MP:0009601,epidermis stratum granulosum hyperplasia|MP:0009611,epidermis stratum spinosum hyperplasia|MP:0011085,postnatal lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0012085,midface hypoplasia|MP:0030350,premature coronal suture closure|MP:0030358,premature squamoparietal suture closure|MP:0030391,premature zygomaticomaxillary suture closure
MGI:2183528	Fgfr2<tm3Lni>	MP:0000537,abnormal urethra morphology|MP:0000549,decreased limb number
MGI:3053095	Fgfr2<tm4Lni>	MP:0000081,premature cranial suture closure|MP:0000097,short maxilla|MP:0000102,abnormal nasal bone morphology|MP:0000104,abnormal sphenoid bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000120,malocclusion|MP:0000440,domed cranium|MP:0001175,abnormal lung morphology|MP:0001300,ocular hypertelorism|MP:0001302,eyelids open at birth|MP:0001953,respiratory failure|MP:0002114,abnormal axial skeleton morphology|MP:0002750,exophthalmos|MP:0004322,abnormal sternebra morphology|MP:0004552,fused tracheal cartilage rings|MP:0004609,vertebral fusion|MP:0004988,increased osteoblast cell number|MP:0005006,abnormal osteoblast physiology|MP:0005249,abnormal palatine bone morphology|MP:0006400,decreased molar number|MP:0008271,abnormal bone ossification|MP:0009250,abnormal appendicular skeleton morphology|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009890,cleft secondary palate|MP:0010029,abnormal basicranium morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0030066,short face|MP:0030350,premature coronal suture closure|MP:0030420,short basicranium
MGI:4847622	Fgfr3<m1J>	MP:0000069,kyphoscoliosis|MP:0000160,kyphosis|MP:0000161,scoliosis|MP:0001925,male infertility|MP:0002111,abnormal tail morphology|MP:0013176,abnormal tail position or orientation
MGI:3831364	Fgfr3<tm1.1Aomw>	MP:0000042,abnormal organ of Corti morphology|MP:0000060,delayed bone ossification|MP:0000074,abnormal neurocranium morphology|MP:0000120,malocclusion|MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000441,increased cranium width|MP:0000443,abnormal snout morphology|MP:0000445,short snout|MP:0000566,synostosis|MP:0001265,decreased body size|MP:0001300,ocular hypertelorism|MP:0002820,abnormal premaxilla morphology|MP:0002835,abnormal cranial suture morphology|MP:0003825,abnormal pillar cell morphology|MP:0003840,abnormal coronal suture morphology|MP:0003841,abnormal lambdoid suture morphology|MP:0003843,abnormal sagittal suture morphology|MP:0004302,abnormal Deiters cell morphology|MP:0004384,small interparietal bone|MP:0004386,enlarged interparietal bone|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004441,small occipital bone|MP:0004471,short nasal bone|MP:0004537,abnormal palatine bone horizontal plate morphology|MP:0005269,abnormal occipital bone morphology|MP:0005270,abnormal zygomatic bone morphology|MP:0005382,craniofacial phenotype|MP:0006325,impaired hearing|MP:0006331,abnormal patterning of the organ of Corti|MP:0008304,abnormal organ of Corti supporting cell differentiation|MP:0008525,decreased cranium height|MP:0010941,abnormal foramen magnum morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013624,decreased femur compact bone thickness|MP:0020010,decreased bone mineral density of femur|MP:0030274,maxillary retrognathia|MP:0030275,thin frontal bone|MP:0030281,thin parietal bone|MP:0030302,abnormal maxillary zygomatic process morphology
MGI:6416441	Fgfr3<tm1.1(FGFR3*)Ytc>	MP:0000060,delayed bone ossification|MP:0000063,decreased bone mineral density|MP:0000074,abnormal neurocranium morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000160,kyphosis|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002427,disproportionate dwarf|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004214,abnormal long bone diaphysis morphology|MP:0004371,bowed femur|MP:0004624,abnormal thoracic cage morphology|MP:0004703,abnormal vertebral column morphology|MP:0004985,decreased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0006396,decreased long bone epiphyseal plate size|MP:0008158,increased diameter of femur|MP:0008271,abnormal bone ossification|MP:0008770,decreased survivor rate|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0010879,decreased trabecular bone volume|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012085,midface hypoplasia|MP:0013630,increased bone trabecular spacing|MP:0014101,decreased chondrocyte proliferation|MP:0014288,rhizomelic limb|MP:0030245,round head|MP:0030367,premature metopic suture closure|MP:0030370,absent jugum limitans|MP:0030435,premature craniofacial suture closure|MP:0030541,misaligned incisors
MGI:2388062	Fgfr3<tm1.1Iwa>	MP:0000060,delayed bone ossification|MP:0000120,malocclusion|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000166,abnormal chondrocyte morphology|MP:0000547,short limbs|MP:0002083,premature death|MP:0002427,disproportionate dwarf|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004174,abnormal spine curvature|MP:0004686,decreased length of long bones|MP:0006395,abnormal epiphyseal plate morphology|MP:0006429,abnormal hyaline cartilage morphology|MP:0006432,abnormal costal cartilage morphology|MP:0008277,abnormal sternum ossification|MP:0009911,increased hyoid bone size|MP:0010103,small thoracic cage|MP:0011091,prenatal lethality, complete penetrance|MP:0014099,abnormal chondrocyte proliferation|MP:0014105,abnormal chondrocyte differentiation|MP:0030245,round head
MGI:3831363	Fgfr3<tm1Aomw>	MP:0000428,abnormal craniofacial morphology|MP:0002169,no abnormal phenotype detected
MGI:2135666	Fgfr3<tm1Cxd>	MP:0000166,abnormal chondrocyte morphology|MP:0000434,megacephaly|MP:0000592,short tail|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002427,disproportionate dwarf|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004351,short humerus|MP:0004704,short vertebral column|MP:0004706,short vertebral body|MP:0005508,abnormal skeleton morphology|MP:0006398,increased long bone epiphyseal plate size
MGI:1931521	Fgfr3<tm1Dor>	MP:0000031,abnormal cochlea morphology|MP:0000042,abnormal organ of Corti morphology|MP:0000063,decreased bone mineral density|MP:0000069,kyphoscoliosis|MP:0000130,abnormal trabecular bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000160,kyphosis|MP:0000161,scoliosis|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000559,abnormal femur morphology|MP:0000585,kinked tail|MP:0001262,decreased body weight|MP:0001967,deafness|MP:0002083,premature death|MP:0002114,abnormal axial skeleton morphology|MP:0002622,abnormal cochlear hair cell morphology|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003151,absent tunnel of Corti|MP:0003152,abnormal pillar cell differentiation|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003631,nervous system phenotype|MP:0003723,abnormal long bone morphology|MP:0004173,abnormal intervertebral disk morphology|MP:0004312,absent pillar cells|MP:0004348,long femur|MP:0004350,long humerus|MP:0004370,long ulna|MP:0004371,bowed femur|MP:0004373,bowed humerus|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004401,increased cochlear outer hair cell number|MP:0004632,abnormal cochlear OHC efferent innervation pattern|MP:0004669,enlarged vertebral body|MP:0004734,small thoracic cavity|MP:0004740,sensorineural hearing loss|MP:0004840,increased Deiters cell number|MP:0005296,abnormal humerus morphology|MP:0006398,increased long bone epiphyseal plate size|MP:0008951,long radius|MP:0009546,absent gastric milk in neonates|MP:0010876,decreased bone volume|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2388058	Fgfr3<tm1Iwa>	MP:0002006,neoplasm
MGI:2135634	Fgfr3<tm1Led>	MP:0000069,kyphoscoliosis|MP:0000137,abnormal vertebrae morphology|MP:0000160,kyphosis|MP:0000161,scoliosis|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001954,respiratory distress|MP:0002111,abnormal tail morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002187,abnormal fibula morphology|MP:0002758,long tail|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003723,abnormal long bone morphology|MP:0004174,abnormal spine curvature|MP:0004348,long femur|MP:0004350,long humerus|MP:0004371,bowed femur|MP:0004705,elongated vertebral body|MP:0004984,increased osteoclast cell number|MP:0006394,abnormal vertebral epiphyseal plate morphology|MP:0006395,abnormal epiphyseal plate morphology|MP:0006398,increased long bone epiphyseal plate size|MP:0008158,increased diameter of femur|MP:0011084,lethality at weaning, incomplete penetrance|MP:0013179,wavy tail|MP:0020039,increased bone ossification|MP:0030792,large femur head
MGI:3840003	Fgfr3<tm1Llm>	MP:0000029,abnormal malleus morphology|MP:0000031,abnormal cochlea morphology|MP:0000042,abnormal organ of Corti morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000167,decreased chondrocyte number|MP:0000434,megacephaly|MP:0000440,domed cranium|MP:0000592,short tail|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001967,deafness|MP:0002083,premature death|MP:0002427,disproportionate dwarf|MP:0002764,short tibia|MP:0003048,abnormal cervical vertebrae morphology|MP:0003109,short femur|MP:0004302,abnormal Deiters cell morphology|MP:0004358,bowed tibia|MP:0004361,bowed ulna|MP:0004372,bowed fibula|MP:0004374,bowed radius|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004626,vertebral compression|MP:0004652,small caudal vertebrae|MP:0004672,short ribs|MP:0004686,decreased length of long bones|MP:0004708,short lumbar vertebrae|MP:0005105,abnormal middle ear ossicle morphology|MP:0005106,abnormal incus morphology|MP:0005107,abnormal stapes morphology|MP:0005272,abnormal temporal bone morphology|MP:0005508,abnormal skeleton morphology|MP:0006395,abnormal epiphyseal plate morphology|MP:0008272,abnormal endochondral bone ossification|MP:0008273,abnormal intramembranous bone ossification|MP:0008525,decreased cranium height|MP:0010208,prognathia|MP:0010941,abnormal foramen magnum morphology|MP:0011496,abnormal head size|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012085,midface hypoplasia|MP:0030094,foramen magnum stenosis|MP:0030190,small snout|MP:0030420,short basicranium
MGI:3823022	Fgfr3<tm1Schl>	MP:0005390,skeleton phenotype
MGI:2135635	Fgfr3<tm1Wei>	MP:0000160,kyphosis|MP:0000585,kinked tail|MP:0002758,long tail|MP:0003723,abnormal long bone morphology|MP:0004348,long femur|MP:0004371,bowed femur|MP:0006398,increased long bone epiphyseal plate size
MGI:2135667	Fgfr3<tm2Cxd>	MP:0002169,no abnormal phenotype detected
MGI:5426422	Fgfr3<tm2Llm>	MP:0000060,delayed bone ossification|MP:0000130,abnormal trabecular bone morphology|MP:0000131,abnormal long bone epiphysis morphology|MP:0000440,domed cranium|MP:0001265,decreased body size|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002896,abnormal bone mineralization|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0004624,abnormal thoracic cage morphology|MP:0004672,short ribs|MP:0004686,decreased length of long bones|MP:0004984,increased osteoclast cell number|MP:0005390,skeleton phenotype|MP:0006399,abnormal long bone epiphyseal ossification zone morphology
MGI:3823026	Fgfr3<tm2Schl>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000160,kyphosis|MP:0000548,long limbs|MP:0000585,kinked tail|MP:0002111,abnormal tail morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002758,long tail|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0004348,long femur|MP:0004350,long humerus|MP:0004357,long tibia|MP:0004370,long ulna
MGI:2135636	Fgfr3<tm2Wei>	MP:0000109,abnormal parietal bone morphology|MP:0000120,malocclusion|MP:0000160,kyphosis|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0002427,disproportionate dwarf|MP:0002764,short tibia|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004380,short frontal bone|MP:0004471,short nasal bone|MP:0004831,long incisors|MP:0006396,decreased long bone epiphyseal plate size|MP:0006397,disorganized long bone epiphyseal plate|MP:0010941,abnormal foramen magnum morphology|MP:0030245,round head|MP:0030541,misaligned incisors
MGI:2135673	Fgfr3<tm3.1Cxd>	MP:0000060,delayed bone ossification|MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000434,megacephaly|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000441,increased cranium width|MP:0000592,short tail|MP:0001541,abnormal osteoclast physiology|MP:0002427,disproportionate dwarf|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003723,abnormal long bone morphology|MP:0004053,abnormal synchondrosis|MP:0004351,short humerus|MP:0004610,small vertebrae|MP:0006397,disorganized long bone epiphyseal plate|MP:0008271,abnormal bone ossification|MP:0008525,decreased cranium height|MP:0011710,enhanced osteoblast differentiation|MP:0014101,decreased chondrocyte proliferation|MP:0030383,small presphenoid bone|MP:0030420,short basicranium|MP:0030444,premature cranial synchondrosis closure
MGI:7516790	Fgfr3<tm3.1Llm>	MP:0000061,fragile skeleton|MP:0000130,abnormal trabecular bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000141,abnormal vertebral body morphology|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000441,increased cranium width|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002764,short tibia|MP:0003109,short femur|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003797,abnormal compact bone morphology|MP:0004148,increased compact bone thickness|MP:0004686,decreased length of long bones|MP:0004706,short vertebral body|MP:0004991,decreased bone strength|MP:0005508,abnormal skeleton morphology|MP:0006397,disorganized long bone epiphyseal plate|MP:0006399,abnormal long bone epiphyseal ossification zone morphology|MP:0008272,abnormal endochondral bone ossification|MP:0009346,decreased trabecular bone thickness|MP:0010208,prognathia|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0010941,abnormal foramen magnum morphology|MP:0010964,increased compact bone volume|MP:0010970,abnormal compact bone lamellar structure|MP:0011862,decreased cranium length|MP:0013626,decreased femur yield load|MP:0013630,increased bone trabecular spacing|MP:0013633,decreased femur maximal load|MP:0013639,decreased bone stiffness|MP:0013642,decreased vertebra stiffness|MP:0013643,decreased vertebra maximal load|MP:0013646,decreased energy dissipated prior to femur fracture|MP:0014105,abnormal chondrocyte differentiation|MP:0021135,abnormal annulus fibrosus morphology|MP:0021186,decreased bone mineral density of vertebrae|MP:0030420,short basicranium|MP:0030444,premature cranial synchondrosis closure|MP:0030446,premature sphenooccipital synchondrosis closure
MGI:2135670	Fgfr3<tm3Cxd>	MP:0001951,abnormal breathing pattern|MP:0002089,abnormal postnatal growth/weight/body size|MP:0004924,abnormal behavior|MP:0005508,abnormal skeleton morphology|MP:0011083,lethality at weaning, complete penetrance
MGI:2135676	Fgfr3<tm4.1Cxd>	MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000547,short limbs|MP:0002764,short tibia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003723,abnormal long bone morphology|MP:0004174,abnormal spine curvature|MP:0004214,abnormal long bone diaphysis morphology|MP:0004351,short humerus|MP:0004358,bowed tibia|MP:0004359,short ulna|MP:0004361,bowed ulna|MP:0004686,decreased length of long bones|MP:0005006,abnormal osteoblast physiology|MP:0005108,abnormal ulna morphology|MP:0006027,impaired lung alveolus development|MP:0006432,abnormal costal cartilage morphology|MP:0008151,increased diameter of long bones|MP:0008271,abnormal bone ossification|MP:0008278,failure of sternum ossification|MP:0010099,abnormal thoracic cage shape|MP:0010103,small thoracic cage|MP:0010768,mortality/aging|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011703,increased fibroblast proliferation|MP:0012279,wide sternum|MP:0014100,increased chondrocyte proliferation|MP:0014105,abnormal chondrocyte differentiation|MP:0030245,round head
MGI:2135675	Fgfr3<tm4Cxd>	MP:0002006,neoplasm|MP:0005508,abnormal skeleton morphology|MP:0006027,impaired lung alveolus development|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2135677	Fgfr3<tm5.1Cxd>	MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000166,abnormal chondrocyte morphology|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000441,increased cranium width|MP:0000592,short tail|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002083,premature death|MP:0002427,disproportionate dwarf|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003417,premature endochondral bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004358,bowed tibia|MP:0004372,bowed fibula|MP:0004686,decreased length of long bones|MP:0004831,long incisors|MP:0006396,decreased long bone epiphyseal plate size|MP:0006397,disorganized long bone epiphyseal plate|MP:0008525,decreased cranium height|MP:0014105,abnormal chondrocyte differentiation|MP:0030420,short basicranium|MP:0030444,premature cranial synchondrosis closure
MGI:2148505	Fgfr3<tm5Cxd>	MP:0001951,abnormal breathing pattern|MP:0002089,abnormal postnatal growth/weight/body size|MP:0004924,abnormal behavior|MP:0005508,abnormal skeleton morphology|MP:0011083,lethality at weaning, complete penetrance
MGI:4459835	Fgfr3<tm6.2Cxd>	MP:0000063,decreased bone mineral density|MP:0004348,long femur
MGI:4459830	Fgfr3<tm6Cxd>	MP:0000585,kinked tail|MP:0009780,abnormal chondrocyte physiology
MGI:6199491	Fgfr4<M1Btlr>	MP:0001262,decreased body weight|MP:0008168,decreased B-1a cell number
MGI:4429449	Fgfr4<tm1Axul>	MP:0005384,cellular phenotype|MP:0005621,abnormal cell physiology
MGI:5548936	Fgfr4<tm1b(EUCOMM)Wtsi>	MP:0001257,increased body length
MGI:2135678	Fgfr4<tm1Cxd>	MP:0001262,decreased body weight
MGI:3849002	Fgfrl1<tm1.1Ptew>	MP:0000071,axial skeleton hypoplasia|MP:0000074,abnormal neurocranium morphology|MP:0000104,abnormal sphenoid bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000208,decreased hematocrit|MP:0000259,abnormal vascular development|MP:0000440,domed cranium|MP:0000460,mandible hypoplasia|MP:0000955,abnormal spinal cord morphology|MP:0001255,decreased body height|MP:0001577,anemia|MP:0001954,respiratory distress|MP:0002152,abnormal brain morphology|MP:0002652,thin myocardium|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003048,abnormal cervical vertebrae morphology|MP:0003056,abnormal hyoid bone morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0004201,fetal growth retardation|MP:0004266,pale placenta|MP:0004321,short sternum|MP:0004447,small basioccipital bone|MP:0004462,small basisphenoid bone|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004572,fusion of basioccipital and basisphenoid bone|MP:0004607,abnormal cervical atlas morphology|MP:0004734,small thoracic cavity|MP:0005269,abnormal occipital bone morphology|MP:0005508,abnormal skeleton morphology|MP:0006128,pulmonary valve stenosis|MP:0006396,decreased long bone epiphyseal plate size|MP:0008277,abnormal sternum ossification|MP:0009250,abnormal appendicular skeleton morphology|MP:0009384,cardiac valve regurgitation|MP:0009703,decreased birth body size|MP:0009912,decreased hyoid bone size|MP:0010103,small thoracic cage|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010743,delayed cranial suture closure|MP:0010941,abnormal foramen magnum morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011177,abnormal erythroblast number|MP:0011380,enlarged brain ventricles|MP:0011527,disorganized placental labyrinth|MP:0012085,midface hypoplasia|MP:0012251,abnormal diaphragm development|MP:0012514,pectus excavatum|MP:0030279,thin neurocranium|MP:0030867,small thyroid cartilage|MP:0030872,small cricoid cartilage|MP:0031574,thick atrioventricular valve|MP:0031584,thick semilunar valve
MGI:3849001	Fgfrl1<tm1Ptew>	MP:0002169,no abnormal phenotype detected
MGI:3771861	Fgfrl1<tm1True>	MP:0000074,abnormal neurocranium morphology|MP:0000440,domed cranium|MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000734,muscle hypoplasia|MP:0000761,thin diaphragm muscle|MP:0001404,no spontaneous movement|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0003924,diaphragmatic hernia|MP:0004505,decreased renal glomerulus number|MP:0004686,decreased length of long bones|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005352,small cranium|MP:0005376,homeostasis/metabolism phenotype|MP:0005388,respiratory system phenotype|MP:0005390,skeleton phenotype|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0010987,abnormal nephrogenic mesenchyme morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011292,absent nephron|MP:0011364,abnormal metanephros morphology|MP:0011366,absent metanephros|MP:0011368,increased kidney apoptosis|MP:0011441,decreased kidney cell proliferation|MP:0012251,abnormal diaphragm development
MGI:5707709	Fgfrl1<tm2.1True>	MP:0004505,decreased renal glomerulus number|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0010768,mortality/aging
MGI:2384029	Fgg<tm1Fjc>	MP:0001634,internal hemorrhage|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001914,hemorrhage|MP:0002551,abnormal blood coagulation|MP:0004259,small placenta|MP:0004898,uterine hemorrhage|MP:0005388,respiratory system phenotype|MP:0031137,vaginal hemorrhage|MP:0031434,increased miscarriage rate
MGI:2384081	Fgg<tm1Jld>	MP:0005435,hemoperitoneum|MP:0005606,increased bleeding time|MP:0009549,decreased platelet aggregation
MGI:3771182	Fgg<tm1Lord>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0001926,female infertility|MP:0002551,abnormal blood coagulation|MP:0002591,decreased mean corpuscular volume|MP:0003422,abnormal thrombolysis|MP:0004898,uterine hemorrhage|MP:0005048,abnormal thrombosis|MP:0005435,hemoperitoneum|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012330,decreased circulating fibrinogen level
MGI:3046446	Fgg<tm2Jld>	MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0005397,hematopoietic system phenotype
MGI:4451404	Fggy<tm1a(KOMP)Wtsi>	MP:0004609,vertebral fusion
MGI:4436664	Fgl1<tm1a(EUCOMM)Hmgu>	MP:0002896,abnormal bone mineralization|MP:0003795,abnormal bone structure
MGI:6276619	Fgl1<tm1b(EUCOMM)Hmgu>	MP:0001194,dermatitis|MP:0003447,decreased tumor growth/size|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005017,decreased B cell number|MP:0005378,growth/size/body region phenotype|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number
MGI:5510996	Fgl1<tm1Cuko>	MP:0000008,increased white adipose tissue amount|MP:0000186,decreased circulating HDL cholesterol level|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001559,hyperglycemia|MP:0002702,decreased circulating free fatty acids level|MP:0003383,abnormal gluconeogenesis|MP:0004847,abnormal liver weight|MP:0005179,decreased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0009116,abnormal brown fat cell morphology|MP:0009118,increased white fat cell size|MP:0009124,increased brown fat cell lipid droplet size|MP:0009131,decreased white fat cell number|MP:0009355,increased liver triglyceride level|MP:0010379,decreased respiratory quotient|MP:0031115,macrovesicular hepatic steatosis
MGI:3582343	Fgl2<tm1Pam>	MP:0000533,kidney hemorrhage|MP:0000691,enlarged spleen|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001914,hemorrhage|MP:0002376,abnormal dendritic cell physiology|MP:0002389,abnormal Peyer's patch follicle morphology|MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002551,abnormal blood coagulation|MP:0002743,glomerulonephritis|MP:0002989,small kidney|MP:0003918,decreased kidney weight|MP:0004751,increased length of allograft survival|MP:0004946,abnormal regulatory T cell physiology|MP:0004973,increased regulatory T cell number|MP:0005161,hematuria|MP:0005325,abnormal renal glomerulus morphology|MP:0005348,increased T cell proliferation|MP:0005553,increased circulating creatinine level|MP:0008126,increased dendritic cell number|MP:0008133,decreased Peyer's patch number|MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance|MP:0011339,abnormal glomerular mesangium morphology|MP:0011377,renal glomerulus fibrosis|MP:0013260,decreased dendritic cell apoptosis|MP:0020153,abnormal urine albumin level|MP:0020950,decreased susceptibility to Coronaviridae infection|MP:0031047,decreased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:3038987	Fgl2<tm1Stsm>	MP:0005387,immune system phenotype
MGI:2660578	Fglu2<KK>	MP:0001559,hyperglycemia
MGI:2156633	Fglu<KK/TaJcl>	MP:0001559,hyperglycemia
MGI:3665439	Fgr<Mhdaali18>	MP:0000063,decreased bone mineral density|MP:0000065,abnormal bone marrow cavity morphology|MP:0000574,abnormal foot pad morphology|MP:0001194,dermatitis|MP:0001846,increased inflammatory response|MP:0002110,abnormal digit morphology|MP:0002111,abnormal tail morphology|MP:0002932,abnormal joint morphology|MP:0002993,autoimmune arthritis|MP:0003072,abnormal metatarsal bone morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0005306,abnormal phalanx morphology|MP:0005371,limbs/digits/tail phenotype|MP:0010124,decreased bone mineral content|MP:0010968,decreased compact bone area|MP:0011514,skin hemorrhage
MGI:2384040	Fgr<tm1Hev>	MP:0001845,abnormal inflammatory response|MP:0008559,abnormal interferon-gamma secretion
MGI:2384041	Fgr<tm2Hev>	MP:0002169,no abnormal phenotype detected
MGI:1856602	fh	MP:0000060,delayed bone ossification|MP:0000564,syndactyly|MP:0001297,microphthalmia|MP:0001302,eyelids open at birth|MP:0001314,cornea opacity|MP:0001325,abnormal retina morphology|MP:0001785,edema|MP:0002110,abnormal digit morphology|MP:0003419,delayed endochondral bone ossification|MP:0008271,abnormal bone ossification|MP:0008817,hematoma|MP:0008856,fetal bleb
MGI:3711129	Fh1<tm1.1Pjp>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3710112	Fh1<tm1Pjp>	MP:0000519,hydronephrosis|MP:0001762,polyuria|MP:0003068,enlarged kidney|MP:0003606,kidney failure|MP:0003675,kidney cyst|MP:0005264,glomerulosclerosis|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009640,abnormal renal tubule epithelium morphology|MP:0009643,abnormal urine homeostasis|MP:0010958,abnormal tricarboxylic acid cycle|MP:0011308,kidney corticomedullary cyst|MP:0020414,abnormal fibroblast physiology
MGI:5638570	Fhip1a<tm1b(EUCOMM)Wtsi>	MP:0001711,abnormal placenta morphology|MP:0002875,decreased erythrocyte cell number|MP:0005031,abnormal trophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0005561,increased mean corpuscular hemoglobin|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:6156492	Fhip1b<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000219,increased neutrophil cell number|MP:0000274,enlarged heart|MP:0000470,abnormal stomach morphology|MP:0001126,abnormal ovary morphology|MP:0001258,decreased body length|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001944,abnormal pancreas morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002092,abnormal eye morphology|MP:0002100,abnormal tooth morphology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005016,decreased lymphocyte cell number|MP:0011874,enlarged urinary bladder|MP:0013278,decreased fasting circulating glucose level
MGI:6305103	Fhip2a<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system|MP:0001392,abnormal locomotor behavior|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0005293,impaired glucose tolerance|MP:0008259,abnormal optic disk morphology
MGI:6341922	Fhip2b<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus
MGI:6693525	Fhip2b<em1Wwan>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000218,increased leukocyte cell number|MP:0000691,enlarged spleen|MP:0001860,liver inflammation|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0004499,increased incidence of tumors by chemical induction|MP:0005179,decreased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0008537,increased susceptibility to induced colitis|MP:0008713,abnormal cytokine level|MP:0009288,increased epididymal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0010377,abnormal gut flora balance
MGI:2176611	Fhit<tm1Hbn>	MP:0000334,decreased granulocyte number|MP:0000414,alopecia|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0002406,increased susceptibility to infection|MP:0004499,increased incidence of tumors by chemical induction
MGI:3057316	Fhit<tm1Tko>	MP:0000496,abnormal small intestine morphology|MP:0002014,increased papilloma incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0012431,increased lymphoma incidence
MGI:5705759	Fhl1<tm1.1Mihi>	MP:0000751,myopathy|MP:0001262,decreased body weight|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010053,decreased grip strength|MP:0012106,impaired exercise endurance
MGI:4433852	Fhl1<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0005179,decreased circulating cholesterol level
MGI:3698169	Fhl1<tm1Chen>	MP:0001544,abnormal cardiovascular system physiology|MP:0003631,nervous system phenotype|MP:0004486,decreased response of heart to induced stress|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype
MGI:8249201	Fhl2<em1Huag>	MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0008868,abnormal granulosa cell morphology|MP:0008871,abnormal ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0013508,increased granulosa cell apoptosis|MP:0031018,decreased granulosa cell proliferation|MP:0031239,increased atretic ovarian follicle number|MP:0031381,decreased secondary ovarian follicle number
MGI:3029431	Fhl2<tm1Chen>	MP:0001625,cardiac hypertrophy|MP:0002169,no abnormal phenotype detected|MP:0003141,cardiac fibrosis
MGI:3603305	Fhl2<tm2Wlm>	MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0001625,cardiac hypertrophy|MP:0004016,decreased bone mass
MGI:3050807	Fhl5<tm1Saco>	MP:0001145,abnormal male reproductive system morphology|MP:0001147,small testis|MP:0001929,abnormal gametogenesis|MP:0002662,abnormal cauda epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0008898,abnormal acrosome morphology|MP:0008975,delayed male fertility|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009243,hairpin sperm flagellum
MGI:6381400	Fhod1<em1(IMPC)J>	MP:0002626,increased heart rate|MP:0002833,increased heart weight|MP:0010507,shortened RR interval
MGI:6455142	Fhod1<tm1.1Ryut>	MP:0002169,no abnormal phenotype detected
MGI:6158459	Fhod3<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0001417,decreased exploration in new environment|MP:0001711,abnormal placenta morphology|MP:0002151,abnormal neural tube morphology|MP:0003231,abnormal placenta vasculature|MP:0003232,abnormal forebrain development|MP:0003425,abnormal optic vesicle formation|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation|MP:0020421,increased freezing behavior
MGI:5440613	Fhod3<tm1Hsum>	MP:0000267,abnormal heart development|MP:0001698,decreased embryo size|MP:0002189,abnormal myocardial trabeculae morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004085,abnormal heartbeat|MP:0004086,absent heartbeat|MP:0005312,pericardial effusion|MP:0005598,decreased heart ventricle muscle contractility|MP:0009328,delayed heart looping|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7567874	Fibcd1<tm1Spte>	MP:0005016,decreased lymphocyte cell number|MP:0005164,abnormal response to injury|MP:0005398,decreased susceptibility to fungal infection|MP:0008555,abnormal interferon secretion|MP:0008752,abnormal tumor necrosis factor level|MP:0009786,decreased susceptibility to infection induced morbidity/mortality|MP:0014433,increased cytokine level|MP:0014434,decreased cytokine level
MGI:4820356	Fibp<tm1e(EUCOMM)Wtsi>	MP:0002875,decreased erythrocyte cell number|MP:0005561,increased mean corpuscular hemoglobin
MGI:6120693	Ficd<tm1b(EUCOMM)Hmgu>	MP:0000452,abnormal mouth morphology|MP:0001284,absent vibrissae|MP:0001488,increased startle reflex|MP:0005565,increased blood urea nitrogen level
MGI:3716838	Fig4<plt1>	MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000371,diluted coat color|MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000428,abnormal craniofacial morphology|MP:0000694,spleen hypoplasia|MP:0000745,tremors|MP:0000747,muscle weakness|MP:0000921,demyelination|MP:0000937,abnormal motor neuron morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002229,neurodegeneration|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002651,abnormal sciatic nerve morphology|MP:0002654,spongiform encephalopathy|MP:0003105,abnormal heart atrium morphology|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0003632,abnormal nervous system morphology|MP:0003795,abnormal bone structure|MP:0003797,abnormal compact bone morphology|MP:0003871,abnormal myelin sheath morphology|MP:0004263,abnormal limb posture|MP:0004338,small clavicle|MP:0004686,decreased length of long bones|MP:0004831,long incisors|MP:0004986,abnormal osteoblast morphology|MP:0005075,abnormal melanosome morphology|MP:0005371,limbs/digits/tail phenotype|MP:0005402,abnormal action potential|MP:0005403,abnormal nerve conduction|MP:0005408,hypopigmentation|MP:0005508,abnormal skeleton morphology|MP:0008271,abnormal bone ossification|MP:0008814,decreased nerve conduction velocity|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0010879,decreased trabecular bone volume|MP:0010933,decreased trabecular bone connectivity density
MGI:5431009	Fig4<tm1.1Mm>	MP:0001262,decreased body weight|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002654,spongiform encephalopathy|MP:0003354,astrocytosis|MP:0010771,integument phenotype
MGI:2158347	Figla<tm1Dean>	MP:0001127,small ovary|MP:0001130,abnormal ovarian folliculogenesis|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0005168,abnormal female meiosis|MP:0005389,reproductive system phenotype|MP:0005431,decreased oocyte number|MP:0010767,abnormal female meiosis I arrest|MP:0011122,absent primordial ovarian follicles|MP:0013507,increased ovary apoptosis|MP:0014764,impaired double-strand DNA break repair|MP:0031474,increased female germ cell apoptosis
MGI:1856870	Fign<fi>	MP:0000035,abnormal membranous labyrinth morphology|MP:0000036,absent semicircular canals|MP:0000039,abnormal otic capsule morphology|MP:0000458,abnormal mandible morphology|MP:0000562,polydactyly|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001306,small lens|MP:0001314,cornea opacity|MP:0001347,absent lacrimal glands|MP:0001386,abnormal maternal nurturing|MP:0001395,bidirectional circling|MP:0001405,impaired coordination|MP:0001488,increased startle reflex|MP:0001732,postnatal growth retardation|MP:0001851,eye inflammation|MP:0001852,conjunctivitis|MP:0001921,reduced fertility|MP:0001967,deafness|MP:0002116,abnormal craniofacial bone morphology|MP:0002730,head shaking|MP:0003077,abnormal cell cycle|MP:0003161,absent lateral semicircular canal|MP:0003312,abnormal locomotor coordination|MP:0004452,abnormal pterygoid process morphology|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004748,increased susceptibility to age-related hearing loss|MP:0005377,hearing/vestibular/ear phenotype|MP:0005542,cornea vascularization|MP:0006071,abnormal retina progenitor cell morphology|MP:0006097,abnormal cerebellar lobule formation|MP:0008919,fused tarsal bones|MP:0009772,abnormal retina development|MP:0009890,cleft secondary palate|MP:0013387,Meibomian gland hypertrophy|MP:0013447,Harderian gland hypertrophy|MP:0030233,absent mandibular canal|MP:0030235,absent mandibular foramen|MP:0030237,absent mental foramen|MP:0030796,hip dislocation|MP:0030838,abnormal acetabular fossa morphology|MP:0030842,absent subarcuate fossa|MP:0031432,cornea perforation
MGI:6140190	Fignl1<em1(IMPC)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:7546940	Fignl1<tm1.1Osb>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6758815	Fignl2<tm1.1Geno>	MP:0003651,abnormal axon extension|MP:0004811,abnormal neuron physiology|MP:0005404,abnormal axon morphology|MP:0008415,abnormal neurite morphology
MGI:1926595	Fign<tm1Frk>	MP:0001297,microphthalmia|MP:0002730,head shaking|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:7578805	Filip1l<em1Slib>	MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0008883,abnormal enterocyte proliferation|MP:0013799,abnormal intestinal goblet cell physiology|MP:0014221,increased colon goblet cell number
MGI:6153511	Filip1<tm1Msat>	MP:0000780,abnormal corpus callosum morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0004811,abnormal neuron physiology|MP:0014812,abnormal brain physiology|MP:0020511,decreased dendritic spine length
MGI:6416507	Firre<em1.1Rinn>	MP:0002169,no abnormal phenotype detected
MGI:7639967	Firrm<em1.1Gpt>	MP:0001730,embryonic growth arrest|MP:0011092,embryonic lethality, complete penetrance
MGI:7295831	Firrm<em1Gpt>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0004805,absent oocytes|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0005431,decreased oocyte number|MP:0008261,arrest of male meiosis|MP:0009451,abnormal chromosomal synapsis|MP:0009452,abnormal synaptonemal complex|MP:0013236,ovary degeneration|MP:0014052,increased male germ cell apoptosis|MP:0031020,premature ovarian failure
MGI:4434838	Firrm<tm1a(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0001556,increased circulating HDL cholesterol level|MP:0002590,increased mean corpuscular volume|MP:0002896,abnormal bone mineralization|MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level
MGI:5548899	Firrm<tm1b(EUCOMM)Hmgu>	MP:0004509,abnormal pelvic girdle bone morphology|MP:0008806,increased circulating amylase level|MP:0011100,preweaning lethality, complete penetrance
MGI:6444618	Fis1<tm1.1Itl>	MP:0000759,abnormal skeletal muscle morphology|MP:0004091,abnormal Z line morphology|MP:0005533,increased body temperature|MP:0006036,abnormal mitochondrial physiology|MP:0008575,increased circulating interferon-beta level|MP:0008596,increased circulating interleukin-6 level|MP:0008608,increased circulating interleukin-13 level|MP:0008647,increased circulating interleukin-12b level|MP:0011630,increased mitochondrial size|MP:0011635,abnormal mitochondrial crista morphology|MP:0012106,impaired exercise endurance
MGI:5692658	Fis1<tm1b(EUCOMM)Hmgu>	MP:0005344,increased circulating bilirubin level|MP:0011100,preweaning lethality, complete penetrance
MGI:2449573	fit2<1R>	MP:0001265,decreased body size
MGI:3689107	fit4<1R>	MP:0001265,decreased body size|MP:0011085,postnatal lethality, complete penetrance
MGI:3689108	fit5<1R>	MP:0001265,decreased body size|MP:0001925,male infertility|MP:0001926,female infertility|MP:0003936,abnormal reproductive system development|MP:0004852,decreased testis weight
MGI:6690472	Fitm1<tm1Nani>	MP:0003915,increased heart left ventricle weight|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010768,mortality/aging
MGI:5621176	Fitm2<tm1.1Dls>	MP:0000603,pale liver|MP:0001260,increased body weight|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002970,abnormal white adipose tissue morphology|MP:0002981,increased liver weight|MP:0005280,abnormal fatty acids level|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005670,abnormal white adipose tissue physiology|MP:0008553,increased circulating tumor necrosis factor level|MP:0009116,abnormal brown fat cell morphology|MP:0009117,abnormal white fat cell morphology|MP:0009124,increased brown fat cell lipid droplet size|MP:0009137,decreased brown fat lipid droplet number
MGI:5634705	Fitm2<tm1.1(KOMP)Vlcg>	MP:0000288,abnormal pericardium morphology|MP:0003984,embryonic growth retardation|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6690473	Fitm2<tm1Nani>	MP:0003914,decreased heart right ventricle weight|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010580,decreased heart left ventricle size|MP:0010768,mortality/aging|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5692624	Fjx1<tm1.1(KOMP)Vlcg>	MP:0001258,decreased body length
MGI:3771953	Fjx1<tm1Awp>	MP:0002169,no abnormal phenotype detected|MP:0008143,abnormal dendrite morphology
MGI:1857314	Fk	MP:0000373,belly spot|MP:0001921,reduced fertility|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002075,abnormal coat/hair pigmentation|MP:0002161,abnormal fertility/fecundity|MP:0002938,white spotting|MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:5432211	Fkbp10<tm2a(EUCOMM)Wtsi>	MP:0000358,abnormal cell morphology|MP:0000428,abnormal craniofacial morphology|MP:0000550,abnormal forelimb morphology|MP:0002085,abnormal embryonic tissue morphology|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0005564,increased hemoglobin content|MP:0008805,decreased circulating amylase level|MP:0009142,decreased prepulse inhibition|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0010865,prenatal growth retardation|MP:0010997,decreased aorta wall thickness|MP:0011087,neonatal lethality, complete penetrance|MP:0011642,abnormal bone collagen fibril morphology|MP:0013258,abnormal extracellular matrix morphology
MGI:6276877	Fkbp11<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0002092,abnormal eye morphology|MP:0002152,abnormal brain morphology|MP:0002339,abnormal lymph node morphology
MGI:3529240	Fkbp11<Gt(OST298786)Lex>	MP:0000062,increased bone mineral density|MP:0001846,increased inflammatory response|MP:0002461,increased immunoglobulin level|MP:0010123,increased bone mineral content
MGI:5319193	Fkbp1a<tm1.1Shou>	MP:0004215,abnormal myocardial fiber physiology|MP:0010508,abnormal heart electrocardiography waveform feature
MGI:5444178	Fkbp1a<tm1Grc>	MP:0002169,no abnormal phenotype detected
MGI:3514012	Fkbp1a<tm1Slh>	MP:0000759,abnormal skeletal muscle morphology|MP:0002106,abnormal muscle physiology|MP:0003674,oxidative stress|MP:0005620,abnormal muscle contractility|MP:0012106,impaired exercise endurance
MGI:2158807	Fkbp1a<tm1Zuk>	MP:0000274,enlarged heart|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001654,hepatic necrosis|MP:0001785,edema|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003140,dilated heart atrium|MP:0003717,pallor|MP:0003888,liver hemorrhage|MP:0004067,abnormal trabecula carnea morphology|MP:0004937,dilated heart|MP:0005329,abnormal myocardium layer morphology|MP:0005598,decreased heart ventricle muscle contractility|MP:0006138,congestive heart failure|MP:0010402,ventricular septal defect|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0021158,decreased heart left ventricle wall thickness
MGI:3796254	Fkbp1b<tm1.1Okam>	MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype
MGI:3623214	Fkbp1b<tm1Amks>	MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0008543,atrial fibrillation|MP:0008950,ventricular tachycardia
MGI:5692614	Fkbp1b<tm1b(EUCOMM)Hmgu>	MP:0001488,increased startle reflex|MP:0010097,abnormal retina blood vessel morphology
MGI:2182644	Fkbp1b<tm1Syf>	MP:0000231,hypertension|MP:0000281,abnormal interventricular septum morphology|MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0003915,increased heart left ventricle weight|MP:0004215,abnormal myocardial fiber physiology|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0010724,thick interventricular septum|MP:0021161,increased heart left ventricle posterior wall thickness
MGI:6313351	Fkbp4<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0001304,cataract|MP:0001404,no spontaneous movement|MP:0001711,abnormal placenta morphology|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology|MP:0002591,decreased mean corpuscular volume|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0003385,abnormal body wall morphology|MP:0004930,small epididymis|MP:0004931,enlarged epididymis|MP:0005278,abnormal cholesterol homeostasis|MP:0005333,decreased heart rate|MP:0006415,absent testes|MP:0009198,abnormal male genitalia morphology|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3579432	Fkbp4<tm1Dvds>	MP:0000242,impaired fertilization|MP:0000664,small prostate gland anterior lobe|MP:0001146,abnormal testis morphology|MP:0001157,small seminal vesicle|MP:0001158,abnormal prostate gland morphology|MP:0001728,failure of embryo implantation|MP:0001919,abnormal reproductive system physiology|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002059,abnormal seminal vesicle morphology|MP:0002212,abnormal secondary sex determination|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002771,absent prostate gland anterior lobe|MP:0002789,male pseudohermaphroditism|MP:0003124,hypospadia|MP:0009243,hairpin sperm flagellum|MP:0009662,abnormal uterine receptivity|MP:0009664,abnormal luminal closure|MP:0011101,prenatal lethality, incomplete penetrance|MP:0031286,unilateral cryptorchism|MP:0031378,ambiguous external male genitalia
MGI:3690438	Fkbp4<tm1Shou>	MP:0000628,abnormal mammary gland development|MP:0001145,abnormal male reproductive system morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001919,abnormal reproductive system physiology|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0002160,abnormal reproductive system morphology|MP:0002674,abnormal sperm motility|MP:0002781,increased circulating testosterone level|MP:0003553,abnormal foreskin morphology|MP:0003845,abnormal decidualization|MP:0004910,decreased seminal vesicle weight|MP:0005187,abnormal penis morphology|MP:0005188,small penis|MP:0005189,abnormal anogenital distance|MP:0009735,abnormal prostate gland development|MP:0031294,penile hypospadia|MP:0031420,decreased superovulation rate
MGI:3710108	Fkbp5<Gt(RRC236)Byg>	MP:0002169,no abnormal phenotype detected
MGI:5548348	Fkbp5<tm1b(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0001314,cornea opacity|MP:0002606,increased basophil cell number|MP:0003917,increased kidney weight|MP:0003960,increased lean body mass|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5296970	Fkbp5<tm1Dvds>	MP:0001363,increased anxiety-related response|MP:0002665,decreased circulating corticosterone level|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0014413,decreased depression-related behavior
MGI:5635086	Fkbp6<tm1b(KOMP)Wtsi>	MP:0001513,limb grasping|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:2663987	Fkbp6<tm1Pngr>	MP:0001147,small testis|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis
MGI:3775614	Fkbp8<Gt(OST287985)Lex>	MP:0000755,hindlimb paralysis|MP:0000955,abnormal spinal cord morphology|MP:0000962,disorganized dorsal root ganglion|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0002151,abnormal neural tube morphology|MP:0002809,increased spinal cord size|MP:0003054,spina bifida|MP:0004609,vertebral fusion|MP:0004704,short vertebral column|MP:0005226,abnormal vertebral arch development|MP:0008489,slow postnatal weight gain|MP:0012505,increased neural tube apoptosis
MGI:3777160	Fkbp8<tm1Kei>	MP:0000150,abnormal rib morphology|MP:0000161,scoliosis|MP:0000576,clubfoot|MP:0000832,abnormal thalamus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000914,exencephaly|MP:0000955,abnormal spinal cord morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001265,decreased body size|MP:0001429,dehydration|MP:0001436,abnormal suckling behavior|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002109,abnormal limb morphology|MP:0002151,abnormal neural tube morphology|MP:0002152,abnormal brain morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004599,abnormal vertebral arch morphology|MP:0005621,abnormal cell physiology|MP:0008540,abnormal cerebral hemisphere morphology|MP:0009937,abnormal neuron differentiation|MP:0011087,neonatal lethality, complete penetrance
MGI:3042750	Fkbp8<tm1Tili>	MP:0000964,small dorsal root ganglion|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0002151,abnormal neural tube morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4435917	Fkbp9<tm1a(EUCOMM)Hmgu>	MP:0002942,decreased circulating alanine transaminase level|MP:0005567,decreased circulating total protein level|MP:0005632,decreased circulating aspartate transaminase level|MP:0005634,decreased circulating sodium level
MGI:5558157	Fkbpl<tm1.1(KOMP)Wtsi>	MP:0003227,abnormal vascular branching morphogenesis|MP:0003721,increased tumor growth/size|MP:0005601,increased angiogenesis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010144,abnormal tumor vascularization|MP:0011092,embryonic lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4431442	Fkbpl<tm1(KOMP)Wtsi>	MP:0000249,abnormal blood vessel physiology|MP:0003227,abnormal vascular branching morphogenesis|MP:0003721,increased tumor growth/size|MP:0005601,increased angiogenesis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010144,abnormal tumor vascularization|MP:0011092,embryonic lethality, complete penetrance|MP:0012253,abnormal intersomitic vessel morphology
MGI:6404009	Fkrp<tm1.1Pg>	MP:0000751,myopathy|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005385,cardiovascular system phenotype|MP:0009399,increased skeletal muscle fiber size|MP:0009401,increased skeletal muscle fiber diameter|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009419,skeletal muscle fibrosis
MGI:4835412	Fkrp<tm1.1Scbr>	MP:0002169,no abnormal phenotype detected
MGI:6404019	Fkrp<tm1.2Pg>	MP:0014257,embryonic lethality prior to tooth bud stage, complete penetrance
MGI:4834518	Fkrp<tm1Itl>	MP:0000440,domed cranium|MP:0000747,muscle weakness|MP:0000752,dystrophic muscle|MP:0000790,abnormal stratification in cerebral cortex|MP:0000812,abnormal dentate gyrus morphology|MP:0000825,dilated lateral ventricle|MP:0000857,abnormal cerebellar foliation|MP:0001262,decreased body weight|MP:0001314,cornea opacity|MP:0001513,limb grasping|MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology|MP:0002697,abnormal eye size|MP:0002941,increased circulating alanine transaminase level|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0005241,abnormal retina ganglion layer morphology|MP:0005277,abnormal brainstem morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0006009,abnormal neuronal migration|MP:0006221,optic nerve hypoplasia|MP:0008259,abnormal optic disk morphology|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009412,skeletal muscle fiber degeneration|MP:0009414,skeletal muscle fiber necrosis|MP:0009419,skeletal muscle fibrosis|MP:0009703,decreased birth body size|MP:0010090,increased circulating creatine kinase level|MP:0010235,abnormal retina inner limiting membrane morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0030265,parietal bossing
MGI:4834519	Fkrp<tm1Qll>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4835411	Fkrp<tm1Scbr>	MP:0000749,muscle degeneration|MP:0000752,dystrophic muscle|MP:0000776,abnormal inferior colliculus morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000792,abnormal cortical marginal zone morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000825,dilated lateral ventricle|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000904,abnormal superior colliculus morphology|MP:0001262,decreased body weight|MP:0001785,edema|MP:0001891,hydrocephaly|MP:0002699,abnormal vitreous body morphology|MP:0003083,abnormal tibialis anterior morphology|MP:0003648,abnormal radial glial cell morphology|MP:0004246,abnormal extensor digitorum longus morphology|MP:0004510,myositis|MP:0005623,abnormal meninges morphology|MP:0006104,abnormal tectum morphology|MP:0008030,abnormal Cajal-Retzius cell morphology|MP:0008439,abnormal cortical plate morphology|MP:0008547,abnormal neocortex morphology|MP:0009026,abnormal brain pia mater morphology|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009406,decreased skeletal muscle fiber number|MP:0009959,abnormal cerebellar hemisphere morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011723,ectopic neuron
MGI:5810875	Fkrp<tvrm53>	MP:0000752,dystrophic muscle|MP:0002792,abnormal retina vasculature morphology|MP:0003381,vitreal fibroplasia|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0004022,abnormal cone electrophysiology|MP:0005547,abnormal Muller cell morphology|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0012031,abnormal b-wave amplitude|MP:0012145,increased a-wave amplitude
MGI:5435589	Fktn<tm1.2Kcam>	MP:0011092,embryonic lethality, complete penetrance
MGI:5435571	Fktn<tm1Kcam>	MP:0000746,weakness|MP:0000752,dystrophic muscle|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0011102,embryonic lethality, incomplete penetrance
MGI:3577652	Fktn<tm1Ttd>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0003044,impaired basement membrane formation|MP:0003085,abnormal egg cylinder morphology|MP:0003954,abnormal Reichert's membrane morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011105,embryonic lethality between implantation and placentation, incomplete penetrance|MP:0011116,absent Reichert's membrane|MP:0011191,increased embryonic epiblast cell apoptosis|MP:0011201,abnormal visceral yolk sac cavity morphology|MP:0012094,abnormal Reichert's membrane thickness
MGI:3690337	Fktn<tm2(FCMD)Ttd>	MP:0005369,muscle phenotype|MP:0005584,abnormal enzyme/coenzyme activity
MGI:5514346	Fktn<tm3.1Ttd>	MP:0000731,increased collagen deposition in the muscles|MP:0000752,dystrophic muscle|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003833,decreased satellite cell number|MP:0003852,skeletal muscle necrosis|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009417,skeletal muscle atrophy|MP:0009419,skeletal muscle fibrosis|MP:0010090,increased circulating creatine kinase level|MP:0010239,decreased skeletal muscle weight|MP:0012185,abnormal muscle precursor cell morphology|MP:0012186,abnormal muscle precursor cell physiology|MP:0013239,impaired skeletal muscle regeneration
MGI:3832562	Fktn<tm3(FKTN)Ttd>	MP:0005376,homeostasis/metabolism phenotype
MGI:1856872	fl	MP:0000552,abnormal radius morphology|MP:0001265,decreased body size|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0005108,abnormal ulna morphology|MP:0008770,decreased survivor rate|MP:0009703,decreased birth body size
MGI:3723476	Fl1sa<A/J>	MP:0001547,abnormal lipid level|MP:0002981,increased liver weight|MP:0009355,increased liver triglyceride level
MGI:3723475	Fl1sa<SM/JNshm>	MP:0003402,decreased liver weight|MP:0009356,decreased liver triglyceride level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3723479	Fl2sa<A/JNshm>	MP:0001547,abnormal lipid level|MP:0002981,increased liver weight
MGI:7490164	Flacc1<em1(IMPC)Mbp>	MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney
MGI:6489264	Flacc1<em1Jw>	MP:0005389,reproductive system phenotype
MGI:5049958	flanka	MP:0000266,abnormal heart morphology|MP:0000432,abnormal head morphology|MP:0002151,abnormal neural tube morphology
MGI:3842151	Flcn<Gt(RRX115)Byg>	MP:0001685,abnormal endoderm development|MP:0003085,abnormal egg cylinder morphology|MP:0003675,kidney cyst|MP:0004499,increased incidence of tumors by chemical induction|MP:0010294,increased kidney tumor incidence|MP:0011091,prenatal lethality, complete penetrance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012431,increased lymphoma incidence
MGI:3829644	Flcn<tm1.1Btt>	MP:0011092,embryonic lethality, complete penetrance
MGI:3774416	Flcn<tm1.1Lss>	MP:0011091,prenatal lethality, complete penetrance
MGI:3829641	Flcn<tm1Btt>	MP:0000533,kidney hemorrhage|MP:0003606,kidney failure|MP:0003917,increased kidney weight|MP:0004860,dilated kidney collecting duct|MP:0005565,increased blood urea nitrogen level|MP:0008528,polycystic kidney|MP:0009050,dilated proximal convoluted tubule|MP:0009640,abnormal renal tubule epithelium morphology|MP:0010384,increased renal carcinoma incidence|MP:0011085,postnatal lethality, complete penetrance|MP:0011363,renal glomerulus atrophy
MGI:1856880	Flg<ft>	MP:0000018,small ears|MP:0000019,thick ears|MP:0001192,scaly skin|MP:0001194,dermatitis|MP:0001195,flaky skin|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001242,hyperkeratosis|MP:0001265,decreased body size|MP:0001874,acanthosis|MP:0002060,abnormal skin morphology|MP:0002082,postnatal lethality|MP:0002493,increased IgG level|MP:0002497,increased IgE level|MP:0002796,impaired skin barrier function|MP:0003810,abnormal hair cuticle|MP:0003853,dry skin|MP:0004947,skin inflammation|MP:0005387,immune system phenotype|MP:0005501,abnormal skin physiology|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008566,increased interferon-gamma secretion|MP:0008660,increased interleukin-10 secretion|MP:0008672,increased interleukin-13 secretion|MP:0008681,increased interleukin-17 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion|MP:0008713,abnormal cytokine level|MP:0009336,increased splenocyte proliferation|MP:0009598,thin epidermis stratum granulosum|MP:0009675,orthokeratosis|MP:0009795,epidermal spongiosis|MP:0009931,abnormal skin appearance|MP:0010771,integument phenotype|MP:0012078,abnormal tail ring morphology|MP:0013178,tail necrosis|MP:0020084,short ears
MGI:5496587	Flg<tm1Amag>	MP:0001192,scaly skin|MP:0001194,dermatitis|MP:0001196,shiny skin|MP:0001212,skin lesions|MP:0001230,epidermal desquamation|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001547,abnormal lipid level|MP:0001800,abnormal humoral immune response|MP:0001846,increased inflammatory response|MP:0002060,abnormal skin morphology|MP:0002497,increased IgE level|MP:0003853,dry skin|MP:0003982,increased cholesterol level|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008499,increased IgG1 level|MP:0009605,decreased keratohyalin granule number|MP:0010771,integument phenotype
MGI:3803949	Fli1<tm1.1Dkw>	MP:0000693,spleen hyperplasia|MP:0001800,abnormal humoral immune response|MP:0002144,abnormal B cell differentiation|MP:0004816,abnormal class switch recombination|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008189,increased transitional stage B cell number|MP:0008495,decreased IgG1 level|MP:0008498,decreased IgG3 level|MP:0008826,abnormal splenic cell ratio
MGI:1888942	Fli1<tm1Adh>	MP:0000259,abnormal vascular development|MP:0001915,intracranial hemorrhage|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002417,abnormal megakaryocyte morphology|MP:0009022,abnormal brain meninges morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3652588	Fli1<tm1Ber>	MP:0000208,decreased hematocrit|MP:0000691,enlarged spleen|MP:0000715,decreased thymocyte number|MP:0001577,anemia|MP:0002026,increased leukemia incidence
MGI:2386167	Fli1<tm1Dkw>	MP:0000601,small liver|MP:0000603,pale liver|MP:0001606,impaired hematopoiesis|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0001917,intraventricular hemorrhage|MP:0002416,abnormal proerythroblast morphology|MP:0006054,spinal hemorrhage|MP:0008255,decreased megakaryocyte cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4441373	Fli1<tm1Matr>	MP:0001262,decreased body weight|MP:0001614,abnormal blood vessel morphology|MP:0001914,hemorrhage|MP:0003070,increased vascular permeability|MP:0003279,aneurysm|MP:0003719,abnormal pericyte morphology|MP:0004112,abnormal arteriole morphology|MP:0004125,abnormal venule morphology|MP:0005412,vascular stenosis|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006056,increased vascular endothelial cell number|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0020326,dilated capillary
MGI:4878921	Fli1<tm1Morl>	MP:0000220,increased monocyte cell number|MP:0000228,abnormal thrombopoiesis|MP:0000229,abnormal megakaryocyte differentiation|MP:0000245,abnormal erythropoiesis|MP:0000334,decreased granulocyte number|MP:0003131,increased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0003179,thrombocytopenia|MP:0005397,hematopoietic system phenotype|MP:0008044,increased NK cell number|MP:0008246,abnormal leukocyte morphology
MGI:1888943	Fli1<tm2Adh>	MP:0001915,intracranial hemorrhage
MGI:5908596	Flicr<em1Doi>	MP:0004031,insulitis|MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:5548451	Flii<tm1b(KOMP)Mbp>	MP:0001697,abnormal embryo size|MP:0002135,abnormal kidney morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2179825	Flii<tm1Hdc>	MP:0001730,embryonic growth arrest|MP:0002724,enhanced wound healing|MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:5613381	flim	MP:0001406,abnormal gait|MP:0001524,impaired limb coordination
MGI:1934627	Flna<Dilp2>	MP:0000157,abnormal sternum morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000284,double outlet right ventricle|MP:0001319,irregularly shaped pupil|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0002546,mydriasis|MP:0002633,persistent truncus arteriosus|MP:0003052,omphalocele|MP:0003649,decreased heart right ventricle size|MP:0006126,abnormal cardiac outflow tract development|MP:0009886,failure of palatal shelf elevation|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009890,cleft secondary palate|MP:0010402,ventricular septal defect|MP:0010404,ostium primum atrial septal defect|MP:0010620,thick mitral valve|MP:0011091,prenatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4123079	Flna<Gt(F015B06)Wrst>	MP:0002169,no abnormal phenotype detected
MGI:3699305	Flna<tm1.1Caw>	MP:0000297,abnormal atrioventricular cushion morphology|MP:0000771,abnormal brain size|MP:0001575,cyanosis|MP:0001614,abnormal blood vessel morphology|MP:0002633,persistent truncus arteriosus|MP:0004003,abnormal vascular endothelial cell physiology|MP:0004157,interrupted aortic arch|MP:0005386,behavior/neurological phenotype|MP:0006055,abnormal vascular endothelial cell morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0011087,neonatal lethality, complete penetrance
MGI:3699306	Flna<tm1.2Caw>	MP:0000218,increased leukocyte cell number|MP:0000260,abnormal angiogenesis|MP:0000266,abnormal heart morphology|MP:0000364,abnormal vascular regression|MP:0001614,abnormal blood vessel morphology|MP:0001654,hepatic necrosis|MP:0001785,edema|MP:0001914,hemorrhage|MP:0001923,reduced female fertility|MP:0001958,emphysema|MP:0002083,premature death|MP:0002633,persistent truncus arteriosus|MP:0004157,interrupted aortic arch|MP:0004937,dilated heart|MP:0005048,abnormal thrombosis|MP:0006126,abnormal cardiac outflow tract development|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010432,common ventricle|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012253,abnormal intersomitic vessel morphology
MGI:3704947	Flnb<Gt(BGB085)Byg>	MP:0000063,decreased bone mineral density|MP:0000069,kyphoscoliosis|MP:0000135,decreased compact bone thickness|MP:0000260,abnormal angiogenesis|MP:0001262,decreased body weight|MP:0001504,abnormal posture|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002764,short tibia|MP:0003410,abnormal artery development|MP:0004609,vertebral fusion|MP:0004683,absent intervertebral disk|MP:0004703,abnormal vertebral column morphology|MP:0004950,abnormal brain vasculature morphology|MP:0005621,abnormal cell physiology|MP:0006429,abnormal hyaline cartilage morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011708,decreased fibroblast cell migration|MP:0020487,abnormal middle cerebral artery morphology
MGI:3775521	Flnb<Gt(RRF239)Byg>	MP:0000157,abnormal sternum morphology|MP:0000161,scoliosis|MP:0000552,abnormal radius morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0004609,vertebral fusion|MP:0005108,abnormal ulna morphology|MP:0008915,fused carpal bones|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3784954	Flnb<Gt(XD076)Byg>	MP:0000160,kyphosis|MP:0000166,abnormal chondrocyte morphology|MP:0001265,decreased body size|MP:0001504,abnormal posture|MP:0002896,abnormal bone mineralization|MP:0004322,abnormal sternebra morphology|MP:0004620,cervical vertebral fusion|MP:0008271,abnormal bone ossification|MP:0008770,decreased survivor rate|MP:0008915,fused carpal bones|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5620888	Flnb<skm2>	MP:0000157,abnormal sternum morphology|MP:0000161,scoliosis|MP:0000162,lordosis|MP:0001255,decreased body height|MP:0001406,abnormal gait|MP:0001429,dehydration|MP:0003345,decreased rib number|MP:0004623,thoracic vertebral fusion|MP:0004624,abnormal thoracic cage morphology|MP:0005426,tachypnea|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5637156	Flnb<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000222,decreased neutrophil cell number|MP:0002965,increased circulating serum albumin level|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010068,decreased red blood cell distribution width|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:5620800	Flnb<tm1Vshn>	MP:0000060,delayed bone ossification|MP:0000063,decreased bone mineral density|MP:0000074,abnormal neurocranium morphology|MP:0000109,abnormal parietal bone morphology|MP:0000154,rib fusion|MP:0000160,kyphosis|MP:0000161,scoliosis|MP:0000162,lordosis|MP:0000166,abnormal chondrocyte morphology|MP:0000552,abnormal radius morphology|MP:0001732,postnatal growth retardation|MP:0002113,abnormal skeleton development|MP:0002115,abnormal limb bone morphology|MP:0002543,brachyphalangia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003420,delayed intramembranous bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004355,short radius|MP:0004609,vertebral fusion|MP:0004620,cervical vertebral fusion|MP:0004624,abnormal thoracic cage morphology|MP:0004674,thin ribs|MP:0004686,decreased length of long bones|MP:0005108,abnormal ulna morphology|MP:0005269,abnormal occipital bone morphology|MP:0005274,abnormal viscerocranium morphology|MP:0005353,abnormal patella morphology|MP:0006322,abnormal perichondrium morphology|MP:0006396,decreased long bone epiphyseal plate size|MP:0008155,decreased diameter of radius|MP:0008157,decreased diameter of ulna|MP:0008489,slow postnatal weight gain|MP:0009780,abnormal chondrocyte physiology|MP:0010103,small thoracic cage|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013258,abnormal extracellular matrix morphology|MP:0014289,decreased distal limb length|MP:0014696,decreased cell adhesion|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization|MP:0021186,decreased bone mineral density of vertebrae|MP:0030797,joint laxity
MGI:6257599	Flnc<em1(IMPC)Bay>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0001399,hyperactivity|MP:0001691,abnormal somite shape|MP:0003229,abnormal vitelline vasculature morphology|MP:0005534,decreased body temperature|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5907163	Flnc<tm1.1Rsdf>	MP:0001402,decreased locomotor activity|MP:0002757,decreased vertical activity|MP:0004087,abnormal muscle fiber morphology|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0005369,muscle phenotype|MP:0009412,skeletal muscle fiber degeneration|MP:0010053,decreased grip strength|MP:0010379,decreased respiratory quotient|MP:0010768,mortality/aging|MP:0011940,decreased food intake
MGI:3526406	Flnc<tm1Lmk>	MP:0000729,abnormal myogenesis|MP:0000759,abnormal skeletal muscle morphology|MP:0001953,respiratory failure|MP:0002279,abnormal diaphragm morphology|MP:0002280,abnormal intercostal muscle morphology|MP:0003081,abnormal soleus morphology|MP:0003083,abnormal tibialis anterior morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004200,decreased fetal size|MP:0004246,abnormal extensor digitorum longus morphology|MP:0004819,decreased skeletal muscle mass|MP:0005385,cardiovascular system phenotype|MP:0005498,hyporesponsive to tactile stimuli|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009406,decreased skeletal muscle fiber number|MP:0011087,neonatal lethality, complete penetrance
MGI:4868388	Flot1<tm1.1Arte>	MP:0002442,abnormal leukocyte physiology|MP:0003329,amyloid beta deposits|MP:0008719,impaired neutrophil recruitment|MP:0008720,impaired neutrophil chemotaxis
MGI:5527543	Flot2<tm1Mak>	MP:0000358,abnormal cell morphology
MGI:5007145	Flrt1<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:5495469	Flrt2<tm1.1Kln>	MP:0003631,nervous system phenotype|MP:0006009,abnormal neuronal migration
MGI:4950410	Flrt2<tm1Rob>	MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0003974,abnormal endocardium morphology|MP:0005380,embryo phenotype|MP:0010556,thin ventricle myocardium compact layer|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0031590,abnormal epicardium development
MGI:3821876	Flrt3<tm1Kln>	MP:0011086,postnatal lethality, incomplete penetrance
MGI:3797077	Flrt3<tm1Rob>	MP:0000267,abnormal heart development|MP:0000928,incomplete rostral neuropore closure|MP:0001685,abnormal endoderm development|MP:0002085,abnormal embryonic tissue morphology|MP:0003044,impaired basement membrane formation|MP:0003720,abnormal neural tube closure|MP:0004187,cardia bifida|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012157,rostral body truncation|MP:0013283,failure of ventral body wall closure
MGI:3821877	Flrt3<tm2Kln>	MP:0000928,incomplete rostral neuropore closure|MP:0001672,abnormal embryo development|MP:0002151,abnormal neural tube morphology|MP:0003984,embryonic growth retardation|MP:0003988,disorganized embryonic tissue|MP:0004180,failure of initiation of embryo turning|MP:0004187,cardia bifida|MP:0004272,abnormal basement membrane morphology|MP:0008533,abnormal anterior visceral endoderm morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0013283,failure of ventral body wall closure
MGI:5523702	Flt1<tm1.1Fong>	MP:0001265,decreased body size|MP:0003038,decreased myocardial infarct size|MP:0003070,increased vascular permeability|MP:0005425,increased macrophage cell number|MP:0005601,increased angiogenesis|MP:0012200,increased endothelial cell proliferation
MGI:5544799	Flt1<tm1.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:3840946	Flt1<tm1Eze>	MP:0005385,cardiovascular system phenotype
MGI:3693075	Flt1<tm1Gne>	MP:0005542,cornea vascularization
MGI:1857717	Flt1<tm1Jrt>	MP:0000259,abnormal vascular development|MP:0000267,abnormal heart development|MP:0001614,abnormal blood vessel morphology|MP:0001672,abnormal embryo development|MP:0001723,disorganized yolk sac vascular plexus|MP:0001730,embryonic growth arrest|MP:0002128,abnormal blood circulation|MP:0003229,abnormal vitelline vasculature morphology|MP:0003710,abnormal physiological neovascularization|MP:0004230,abnormal embryonic erythrocyte morphology|MP:0004485,increased response of heart to induced stress|MP:0004787,abnormal dorsal aorta morphology|MP:0005601,increased angiogenesis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011204,abnormal visceral yolk sac blood island morphology|MP:0012717,increased hemangioblast number
MGI:1934260	Flt1<tm1Msh>	MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0003224,neuron degeneration|MP:0003799,impaired macrophage chemotaxis|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0005542,cornea vascularization
MGI:3527129	Flt1<tm2Msh>	MP:0000259,abnormal vascular development|MP:0001672,abnormal embryo development|MP:0001700,abnormal embryo turning|MP:0001730,embryonic growth arrest|MP:0002169,no abnormal phenotype detected|MP:0004787,abnormal dorsal aorta morphology|MP:0006055,abnormal vascular endothelial cell morphology|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:6442533	Flt3<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000759,abnormal skeletal muscle morphology|MP:0001120,abnormal uterus morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002110,abnormal digit morphology|MP:0002135,abnormal kidney morphology|MP:0003961,decreased lean body mass|MP:0008045,decreased NK cell number|MP:0009709,hydrometra|MP:0013771,decreased effector memory T-helper cell number
MGI:2158499	Flt3l<tm1Imx>	MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0000223,decreased monocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0000694,spleen hypoplasia|MP:0000716,abnormal immune system cell morphology|MP:0001602,impaired myelopoiesis|MP:0002455,abnormal dendritic cell antigen presentation|MP:0002494,increased IgM level|MP:0002722,abnormal immune system organ morphology|MP:0003884,decreased macrophage cell number|MP:0004751,increased length of allograft survival|MP:0004810,decreased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005022,abnormal immature B cell morphology|MP:0005027,increased susceptibility to parasitic infection|MP:0005089,decreased double-negative T cell number|MP:0005461,abnormal dendritic cell morphology|MP:0005465,abnormal T-helper 1 physiology|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008045,decreased NK cell number|MP:0008051,abnormal memory T cell physiology|MP:0008101,lymph node hypoplasia|MP:0008122,decreased myeloid dendritic cell number|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0008127,decreased dendritic cell number|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008246,abnormal leukocyte morphology|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0010740,abnormal dendritic cell chemotaxis|MP:0013649,decreased CD11b-high dendritic cell number|MP:0013655,decreased CD103-positive CD11b-low dendritic cell number
MGI:3628823	Flt3<m1Btlr>	MP:0001262,decreased body weight|MP:0002217,small lymph nodes|MP:0002376,abnormal dendritic cell physiology|MP:0002451,abnormal macrophage physiology|MP:0002455,abnormal dendritic cell antigen presentation|MP:0008045,decreased NK cell number|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0008127,decreased dendritic cell number|MP:0008553,increased circulating tumor necrosis factor level|MP:0008563,decreased interferon-alpha secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008574,decreased circulating interferon-alpha level|MP:0008578,decreased circulating interferon-gamma level|MP:0008596,increased circulating interleukin-6 level|MP:0008618,decreased circulating interleukin-12 level|MP:0008664,decreased interleukin-12 secretion|MP:0009339,decreased splenocyte number|MP:0010766,abnormal NK cell physiology|MP:0020913,increased susceptibility to Riboviria infection|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:5565508	Flt3<tm1.1Dosm>	MP:0000172,abnormal bone marrow cell number|MP:0000321,increased bone marrow cell number|MP:0000333,decreased bone marrow cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001802,arrested B cell differentiation|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002397,abnormal bone marrow morphology|MP:0008478,increased spleen white pulp amount|MP:0009278,abnormal bone marrow cell physiology
MGI:3763385	Flt3<tm1Dgg>	MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0000691,enlarged spleen|MP:0002123,abnormal definitive hematopoiesis|MP:0002144,abnormal B cell differentiation|MP:0002396,abnormal hematopoietic system morphology/development|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008211,decreased mature B cell number|MP:0008476,increased spleen red pulp amount|MP:0008478,increased spleen white pulp amount
MGI:3783339	Flt3<tm1Dosm>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000321,increased bone marrow cell number|MP:0000322,increased granulocyte number|MP:0000691,enlarged spleen|MP:0001802,arrested B cell differentiation|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002357,abnormal spleen white pulp morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004809,increased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0008009,delayed cellular replicative senescence|MP:0008126,increased dendritic cell number|MP:0008186,increased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008255,decreased megakaryocyte cell number|MP:0008475,intermingled spleen red and white pulp
MGI:2384051	Flt3<tm1Irl>	MP:0002144,abnormal B cell differentiation|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number
MGI:5565506	Flt3<tm2.1Dosm>	MP:0000218,increased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000321,increased bone marrow cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001601,abnormal myelopoiesis|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002397,abnormal bone marrow morphology|MP:0003667,increased hemangiosarcoma incidence|MP:0004939,abnormal B cell morphology|MP:0005505,thrombocytosis|MP:0008186,increased pro-B cell number|MP:0008254,increased megakaryocyte cell number|MP:0008475,intermingled spleen red and white pulp|MP:0008478,increased spleen white pulp amount|MP:0009278,abnormal bone marrow cell physiology|MP:0009321,increased histiocytic sarcoma incidence|MP:0010373,myeloid hyperplasia|MP:0011815,increased pre-pro B cell number
MGI:1856694	Flt4<Chy>	MP:0000013,abnormal adipose tissue distribution|MP:0000477,abnormal intestine morphology|MP:0000598,abnormal liver morphology|MP:0001245,thick dermal layer|MP:0001785,edema|MP:0001879,abnormal lymphatic vessel morphology|MP:0002082,postnatal lethality|MP:0003201,extremity edema|MP:0003390,lymphedema|MP:0003659,abnormal lymph circulation|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0008778,abnormal lymphangiogenesis|MP:0010194,absent lymphatic vessels|MP:0012080,chylous ascites
MGI:4441407	Flt4<tm1.1Ichi>	MP:0012080,chylous ascites
MGI:5295072	Flt4<tm1.2Yhe>	MP:0001785,edema|MP:0005385,cardiovascular system phenotype|MP:0008778,abnormal lymphangiogenesis|MP:0010194,absent lymphatic vessels
MGI:2181789	Flt4<tm1Ali>	MP:0000259,abnormal vascular development|MP:0001722,pale yolk sac|MP:0001787,pericardial edema|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004784,abnormal anterior cardinal vein morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0005244,hemopericardium|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012732,abnormal perineural vascular plexus morphology
MGI:3805195	Flt4<tm2.1Ali>	MP:0002169,no abnormal phenotype detected
MGI:3804462	Flt4<tm2Ali>	MP:0001879,abnormal lymphatic vessel morphology|MP:0002192,hydrops fetalis|MP:0003659,abnormal lymph circulation|MP:0010194,absent lymphatic vessels|MP:0011087,neonatal lethality, complete penetrance|MP:0012080,chylous ascites
MGI:3776022	Flvcr1<tm1.1Jlab>	MP:0000245,abnormal erythropoiesis|MP:0000274,enlarged heart|MP:0000428,abnormal craniofacial morphology|MP:0000572,abnormal autopod morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001265,decreased body size|MP:0001577,anemia|MP:0002169,no abnormal phenotype detected|MP:0006279,abnormal limb development|MP:0008941,reticulocytopenia|MP:0008945,hyperchromic macrocytic anemia|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5474636	Flvcr1<tm1Etol>	MP:0000087,absent mandible|MP:0000163,abnormal cartilage morphology|MP:0000259,abnormal vascular development|MP:0001786,skin edema|MP:0001914,hemorrhage|MP:0005397,hematopoietic system phenotype|MP:0005508,abnormal skeleton morphology|MP:0006280,abnormal digit development|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0030026,small Meckel's cartilage
MGI:3776021	Flvcr1<tm1Jlab>	MP:0000428,abnormal craniofacial morphology|MP:0000572,abnormal autopod morphology|MP:0005367,renal/urinary system phenotype|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0006279,abnormal limb development|MP:0006280,abnormal digit development|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:6415546	Flvcr2<tm1.1Tda>	MP:0000259,abnormal vascular development|MP:0005385,cardiovascular system phenotype|MP:0006055,abnormal vascular endothelial cell morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0012201,decreased endothelial cell proliferation
MGI:6415560	Flvcr2<tm1.2Tda>	MP:0000259,abnormal vascular development|MP:0001575,cyanosis|MP:0001847,brain inflammation|MP:0003719,abnormal pericyte morphology|MP:0004950,abnormal brain vasculature morphology|MP:0005039,hypoxia|MP:0005156,bradykinesia|MP:0005385,cardiovascular system phenotype|MP:0005602,decreased angiogenesis|MP:0006080,brain ischemia|MP:0010022,brain vascular congestion|MP:0011087,neonatal lethality, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0012201,decreased endothelial cell proliferation
MGI:4435324	Flvcr2<tm1a(EUCOMM)Hmgu>	MP:0000182,increased circulating LDL cholesterol level|MP:0001175,abnormal lung morphology|MP:0001556,increased circulating HDL cholesterol level|MP:0002725,abnormal vein morphology|MP:0002947,increased hemangioma incidence|MP:0003827,abnormal Wolffian duct morphology|MP:0005178,increased circulating cholesterol level|MP:0006063,abnormal inferior vena cava morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011683,dual inferior vena cava|MP:0013834,thin hypoglossal nerve|MP:0013836,abnormal hypoglossal nerve topology|MP:0013840,absent segment of posterior cerebral artery|MP:0013843,hepatic portal vein stenosis|MP:0013852,abnormal Mullerian duct topology|MP:0013876,absent ductus venosus valve|MP:0013877,abnormal ductus venosus valve morphology|MP:0013971,blood in lymph vessels|MP:0014018,embryo tumor
MGI:5613663	Flywch1<tm1b(EUCOMM)Hmgu>	MP:0001697,abnormal embryo size|MP:0002966,decreased circulating alkaline phosphatase level|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration
MGI:5616360	Flywch2<tm4b(EUCOMM)Hmgu>	MP:0005293,impaired glucose tolerance|MP:0010097,abnormal retina blood vessel morphology|MP:0010570,prolonged ST segment
MGI:1856873	fm	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000696,abnormal Peyer's patch morphology|MP:0000703,abnormal thymus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0002083,premature death|MP:0002339,abnormal lymph node morphology|MP:0002882,abnormal neuron morphology|MP:0003631,nervous system phenotype|MP:0003947,abnormal cholesterol level|MP:0004097,abnormal cerebellar cortex morphology|MP:0005150,cachexia|MP:0008540,abnormal cerebral hemisphere morphology|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009589,sphingomyelinosis|MP:0009823,abnormal sphingomyelin level|MP:0009841,foam cell reticulosis|MP:0011975,neuronal cytoplasmic inclusions
MGI:6392175	Fmc1<em1Aitn>	MP:0008236,decreased susceptibility to neuronal excitotoxicity|MP:0009747,impaired behavioral response to xenobiotic|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5548510	Fmc1<tm1b(EUCOMM)Wtsi>	MP:0001399,hyperactivity|MP:0001491,unresponsive to tactile stimuli|MP:0002100,abnormal tooth morphology|MP:0002152,abnormal brain morphology|MP:0002792,abnormal retina vasculature morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3513016	Fmgty10<BALB/cJ>	MP:0000559,abnormal femur morphology
MGI:3513015	Fmgty10<C57BL/6J>	MP:0000559,abnormal femur morphology
MGI:3513017	Fmgty11<C3H/HeJ>	MP:0000559,abnormal femur morphology
MGI:3513018	Fmgty11<DBA/2J>	MP:0000559,abnormal femur morphology
MGI:3513019	Fmgty12<C3H/HeJ>	MP:0000559,abnormal femur morphology|MP:0001542,abnormal bone strength
MGI:3513021	Fmgty13<BALB/cJ>	MP:0000559,abnormal femur morphology|MP:0001542,abnormal bone strength
MGI:3513023	Fmgty14<C57BL/6J>	MP:0000559,abnormal femur morphology|MP:0001542,abnormal bone strength
MGI:3512976	Fmgty1<BALB/cJ>	MP:0000559,abnormal femur morphology
MGI:3512974	Fmgty1<C3H/HeJ>	MP:0000559,abnormal femur morphology|MP:0004148,increased compact bone thickness
MGI:3512977	Fmgty1<C57BL/6J>	MP:0000559,abnormal femur morphology
MGI:3512975	Fmgty1<DBA/2J>	MP:0000559,abnormal femur morphology
MGI:3512978	Fmgty2<C3H/HeJ>	MP:0000559,abnormal femur morphology
MGI:3512980	Fmgty3<C3H/HeJ>	MP:0000559,abnormal femur morphology
MGI:3512982	Fmgty4<C57BL/6J>	MP:0000559,abnormal femur morphology
MGI:3512989	Fmgty5<BALB/cJ>	MP:0000559,abnormal femur morphology|MP:0001542,abnormal bone strength
MGI:3512991	Fmgty6<C57BL/6J>	MP:0000559,abnormal femur morphology
MGI:3512993	Fmgty7<DBA/2J>	MP:0000559,abnormal femur morphology|MP:0001542,abnormal bone strength
MGI:3512996	Fmgty8<C3H/HeJ>	MP:0000559,abnormal femur morphology
MGI:3513000	Fmgty9<C3H/HeJ>	MP:0004148,increased compact bone thickness
MGI:3512998	Fmgty9<C57BL/6J>	MP:0000559,abnormal femur morphology|MP:0001542,abnormal bone strength
MGI:7346402	Fmn1<em1Zllr>	MP:0000564,syndactyly
MGI:7346403	Fmn1<em2Zllr>	MP:0005371,limbs/digits/tail phenotype
MGI:7346396	Fmn1<em3Zllr>	MP:0005371,limbs/digits/tail phenotype
MGI:2654744	Fmn1<ld-3J>	MP:0000547,short limbs|MP:0000554,abnormal carpal bone morphology|MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0001925,male infertility|MP:0002187,abnormal fibula morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0003604,single kidney|MP:0005108,abnormal ulna morphology|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3718051	Fmn1<ld-Lsk>	MP:0000552,abnormal radius morphology|MP:0000572,abnormal autopod morphology|MP:0002109,abnormal limb morphology|MP:0002764,short tibia|MP:0005108,abnormal ulna morphology|MP:0005430,absent fibula|MP:0009728,abnormal calcaneum morphology|MP:0014320,abnormal autopod rotation
MGI:1856291	Fmn1<ld-TgHD>	MP:0000520,absent kidney|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000558,abnormal tibia morphology|MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0002135,abnormal kidney morphology|MP:0002187,abnormal fibula morphology|MP:0003604,single kidney|MP:0004639,fused metacarpal bones|MP:0004642,fused metatarsal bones|MP:0005390,skeleton phenotype|MP:0008730,fused phalanges|MP:0008915,fused carpal bones|MP:0008919,fused tarsal bones|MP:0011530,fused radius and ulna
MGI:3046837	Fmn1<tm1.1Zllr>	MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology
MGI:3800994	Fmn1<tm1Awb>	MP:0000520,absent kidney|MP:0003604,single kidney|MP:0003722,absent ureter|MP:0005371,limbs/digits/tail phenotype|MP:0005621,abnormal cell physiology|MP:0011797,blind ureter
MGI:2386598	Fmn1<tm1Led>	MP:0000520,absent kidney|MP:0003604,single kidney|MP:0005371,limbs/digits/tail phenotype
MGI:3046836	Fmn1<tm1Zllr>	MP:0002169,no abnormal phenotype detected
MGI:2386599	Fmn1<tm2Led>	MP:0003604,single kidney|MP:0005371,limbs/digits/tail phenotype
MGI:3848983	Fmn1<tm2Made>	MP:0000565,oligodactyly|MP:0000572,abnormal autopod morphology|MP:0003604,single kidney|MP:0004642,fused metatarsal bones|MP:0005430,absent fibula
MGI:2448909	Fmn2<tm1Led>	MP:0001125,abnormal oocyte morphology|MP:0001382,abnormal nursing|MP:0001923,reduced female fertility|MP:0009661,abnormal pregnancy|MP:0012737,abnormal primary polar body morphology|MP:0014443,impaired polar body extrusion
MGI:6119534	Fmnl1<tm1.1Sdb>	MP:0011092,embryonic lethality, complete penetrance
MGI:6119535	Fmnl1<tm1.2Sdb>	MP:0002446,abnormal macrophage morphology|MP:0002451,abnormal macrophage physiology|MP:0003799,impaired macrophage chemotaxis|MP:0003884,decreased macrophage cell number|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008114,abnormal Kupffer cell morphology|MP:0010768,mortality/aging
MGI:5754566	Fmnl2<em2(IMPC)Tcp>	MP:0002764,short tibia|MP:0005278,abnormal cholesterol homeostasis|MP:0009142,decreased prepulse inhibition
MGI:5561555	Fmnl3<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001289,persistence of hyaloid vascular system|MP:0001491,unresponsive to tactile stimuli|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration
MGI:7641906	Fmo13<em1Osb>	MP:0005389,reproductive system phenotype
MGI:7628220	Fmo1<em1Anz>	MP:0004811,abnormal neuron physiology|MP:0005386,behavior/neurological phenotype|MP:0011448,decreased dopaminergic neuron number|MP:0014433,increased cytokine level
MGI:7430777	Fmo1<em1(IMPC)J>	MP:0002590,increased mean corpuscular volume|MP:0005561,increased mean corpuscular hemoglobin
MGI:6152488	Fmo3<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001126,abnormal ovary morphology|MP:0001293,anophthalmia|MP:0001399,hyperactivity|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0004832,enlarged ovary
MGI:6458889	Fmo3<em1Jmbn>	MP:0010025,decreased total body fat amount
MGI:6430647	Fmo5<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000774,decreased brain size|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0003068,enlarged kidney
MGI:5707817	Fmo5<tm1Eshe>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001262,decreased body weight|MP:0002078,abnormal glucose homeostasis|MP:0004889,increased energy expenditure|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005318,decreased triglyceride level|MP:0005334,abnormal fat pad morphology|MP:0005336,abnormal inguinal fat pad morphology|MP:0005560,decreased circulating glucose level|MP:0008489,slow postnatal weight gain|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008853,decreased abdominal adipose tissue amount|MP:0009133,decreased white fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0010378,increased respiratory quotient|MP:0011939,increased food intake|MP:0013243,abnormal carbohydrate metabolism|MP:0013245,abnormal lipid metabolism|MP:0013278,decreased fasting circulating glucose level|MP:0014171,increased fatty acid oxidation|MP:0014172,decreased fatty acid oxidation
MGI:2154550	Fmod<tm1Aol>	MP:0001314,cornea opacity|MP:0002697,abnormal eye size|MP:0002698,abnormal sclera morphology|MP:0003098,decreased tendon stiffness|MP:0003102,sclera thinning|MP:0003560,osteoarthritis|MP:0005378,growth/size/body region phenotype|MP:0005503,abnormal tendon morphology|MP:0006433,abnormal articular cartilage morphology
MGI:6194712	Fmr1nb<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:3603442	Fmr1<tm1.1Cidz>	MP:0000877,abnormal Purkinje cell morphology|MP:0001898,abnormal long-term depression|MP:0002807,abnormal eye blink conditioning behavior
MGI:6715338	Fmr1<tm1.1Ics>	MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0003461,abnormal response to novel object|MP:0004792,abnormal synaptic vesicle number|MP:0014373,increased miniature excitatory postsynaptic current amplitude|MP:0020351,decreased vocalization|MP:0020357,abnormal excitatory synapse morphology|MP:0020395,abnormal response to social novelty|MP:0020507,increased dendritic spine density|MP:0020551,abnormal postsynaptic density morphology
MGI:3808885	Fmr1<tm1.2Cidz>	MP:0001148,enlarged testis|MP:0002206,abnormal CNS synaptic transmission|MP:0003008,enhanced long-term potentiation|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0009940,abnormal hippocampus pyramidal cell morphology
MGI:1857169	Fmr1<tm1Cgr>	MP:0000812,abnormal dentate gyrus morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0000947,convulsive seizures|MP:0001148,enlarged testis|MP:0001260,increased body weight|MP:0001325,abnormal retina morphology|MP:0001353,increased aggression towards mice|MP:0001360,abnormal social investigation|MP:0001361,social withdrawal|MP:0001362,abnormal anxiety-related response|MP:0001363,increased anxiety-related response|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001409,increased stereotypic behavior|MP:0001415,increased exploration in new environment|MP:0001441,increased grooming behavior|MP:0001458,abnormal object recognition memory|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001486,abnormal startle reflex|MP:0001488,increased startle reflex|MP:0001489,decreased startle reflex|MP:0001496,audiogenic seizures|MP:0001529,abnormal vocalization|MP:0001898,abnormal long-term depression|MP:0001973,increased thermal nociceptive threshold|MP:0002062,abnormal associative learning|MP:0002063,abnormal learning/memory/conditioning|MP:0002152,abnormal brain morphology|MP:0002574,increased vertical activity|MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0002807,abnormal eye blink conditioning behavior|MP:0003107,abnormal response to novelty|MP:0003313,abnormal locomotor activation|MP:0003477,abnormal nerve fiber response|MP:0003863,decreased aggression towards mice|MP:0003997,tonic-clonic seizures|MP:0004000,impaired passive avoidance behavior|MP:0004851,increased testis weight|MP:0004948,abnormal neuronal precursor proliferation|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0008143,abnormal dendrite morphology|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0009141,increased prepulse inhibition|MP:0009456,impaired cued conditioning behavior|MP:0009712,impaired conditioned place preference behavior|MP:0009936,abnormal dendritic spine morphology|MP:0009937,abnormal neuron differentiation|MP:0011737,hypodipsia|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0020467,abnormal circadian behavior|MP:0021111,decreased social investigation|MP:0031391,increased locomotor activity
MGI:3840615	Fmr1<tm1Rbd>	MP:0001364,decreased anxiety-related response|MP:0001409,increased stereotypic behavior|MP:0001415,increased exploration in new environment|MP:0001489,decreased startle reflex|MP:0001496,audiogenic seizures|MP:0001898,abnormal long-term depression|MP:0001973,increased thermal nociceptive threshold|MP:0004851,increased testis weight|MP:0031391,increased locomotor activity
MGI:3711215	Fmr1<tm1Usdn>	MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0002016,ovary cyst|MP:0002152,abnormal brain morphology|MP:0002680,decreased corpora lutea number|MP:0003702,abnormal chromosome morphology|MP:0004000,impaired passive avoidance behavior|MP:0004833,ovary atrophy|MP:0004851,increased testis weight|MP:0005168,abnormal female meiosis|MP:0006361,abnormal female germ cell morphology|MP:0008143,abnormal dendrite morphology|MP:0008868,abnormal granulosa cell morphology|MP:0008871,abnormal ovarian follicle number|MP:0009363,abnormal tertiary ovarian follicle morphology|MP:0009372,abnormal cumulus oophorus morphology|MP:0009936,abnormal dendritic spine morphology|MP:0031239,increased atretic ovarian follicle number|MP:0031391,increased locomotor activity
MGI:2451086	Fmr1<tm2Cgr>	MP:0001405,impaired coordination|MP:0002063,abnormal learning/memory/conditioning|MP:0004191,neuronal intranuclear inclusions|MP:0004924,abnormal behavior|MP:0010053,decreased grip strength
MGI:1856874	fmt	MP:0000745,tremors|MP:0003492,abnormal involuntary movement|MP:0004924,abnormal behavior|MP:0005386,behavior/neurological phenotype
MGI:3710812	Fmtq3<NZB/BlNJ>	MP:0004991,decreased bone strength
MGI:2156189	Fn1<Gt(Ex180)Byg>	MP:0001695,abnormal gastrulation|MP:0011092,embryonic lethality, complete penetrance
MGI:5604386	Fn1<tm1.1Sakai>	MP:0000609,abnormal liver physiology|MP:0005164,abnormal response to injury
MGI:2668886	Fn1<tm1Bwg>	MP:0002006,neoplasm|MP:0002169,no abnormal phenotype detected|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype
MGI:2655527	Fn1<tm1Feb>	MP:0002083,premature death|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0008469,abnormal protein level
MGI:1857170	Fn1<tm1Hyn>	MP:0000267,abnormal heart development|MP:0000932,absent notochord|MP:0001622,abnormal vasculogenesis|MP:0001680,abnormal mesoderm development|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0001721,absent visceral yolk sac blood islands|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002151,abnormal neural tube morphology|MP:0003400,kinked neural tube|MP:0003974,abnormal endocardium morphology|MP:0003984,embryonic growth retardation|MP:0004180,failure of initiation of embryo turning|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0005029,abnormal amnion morphology|MP:0006386,absent somites|MP:0009657,failure of chorioallantoic fusion|MP:0010117,abnormal lateral plate mesoderm morphology|MP:0010656,thick myocardium|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012173,short rostral-caudal axis|MP:0031593,decreased cardiac jelly amount
MGI:3056581	Fn1<tm1Ksek>	MP:0002006,neoplasm|MP:0005385,cardiovascular system phenotype|MP:0011704,decreased fibroblast proliferation|MP:0013258,abnormal extracellular matrix morphology
MGI:2387457	Fn1<tm1Ref>	MP:0002169,no abnormal phenotype detected|MP:0003076,increased susceptibility to ischemic brain injury|MP:0003203,increased neuron apoptosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0006060,increased cerebral infarct size|MP:0031120,decreased susceptibility to induced thrombosis
MGI:5296500	Fn1<tm2.1Ref>	MP:0000585,kinked tail|MP:0001689,incomplete somite formation|MP:0001701,incomplete embryo turning|MP:0002085,abnormal embryonic tissue morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003400,kinked neural tube|MP:0004573,absent limb buds|MP:0005382,craniofacial phenotype|MP:0005385,cardiovascular system phenotype|MP:0008530,abnormal rostral-caudal patterning of the somites|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012173,short rostral-caudal axis|MP:0012277,increased tail bud apoptosis
MGI:3046766	Fn1<tm2Bwg>	MP:0002169,no abnormal phenotype detected
MGI:2655542	Fn1<tm2Feb>	MP:0001209,spontaneous skin ulceration|MP:0001212,skin lesions|MP:0001792,impaired wound healing|MP:0002083,premature death
MGI:2177825	Fn1<tm2Hyn>	MP:0000266,abnormal heart morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0002825,abnormal notochord morphology|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0005029,abnormal amnion morphology|MP:0006386,absent somites|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012173,short rostral-caudal axis|MP:0013200,head mesenchyme hypoplasia
MGI:2177826	Fn1<tm3Hyn>	MP:0000266,abnormal heart morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0002825,abnormal notochord morphology|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0005029,abnormal amnion morphology|MP:0006386,absent somites|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012173,short rostral-caudal axis|MP:0013200,head mesenchyme hypoplasia
MGI:3764511	Fn1<tm4Hyn>	MP:0000259,abnormal vascular development|MP:0000292,distended pericardium|MP:0000297,abnormal atrioventricular cushion morphology|MP:0001577,anemia|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0001723,disorganized yolk sac vascular plexus|MP:0001914,hemorrhage|MP:0003231,abnormal placenta vasculature|MP:0003400,kinked neural tube|MP:0004076,abnormal vitelline vascular remodeling|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0011091,prenatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3693634	Fn3k<tm1Mvdc>	MP:0005621,abnormal cell physiology|MP:0009643,abnormal urine homeostasis
MGI:5909220	Fnbp1<em1(IMPC)J>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005655,increased aggression
MGI:5548692	Fnbp1l<tm1.1(KOMP)Vlcg>	MP:0003960,increased lean body mass|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6194704	Fndc11<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6367979	Fndc3a<em1(IMPC)Tcp>	MP:0000218,increased leukocyte cell number|MP:0001258,decreased body length|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001925,male infertility|MP:0002764,short tibia|MP:0002792,abnormal retina vasculature morphology|MP:0002834,decreased heart weight|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005013,increased lymphocyte cell number|MP:0005419,decreased circulating serum albumin level|MP:0010024,increased total body fat amount|MP:0010097,abnormal retina blood vessel morphology|MP:0010124,decreased bone mineral content|MP:0020421,increased freezing behavior
MGI:1857062	Fndc3a<sys>	MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002784,abnormal Sertoli cell morphology|MP:0004852,decreased testis weight|MP:0020550,multinucleated giant male germ cells
MGI:5696910	Fndc3b<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0002631,abnormal epididymis morphology|MP:0002833,increased heart weight|MP:0004931,enlarged epididymis|MP:0009552,urinary bladder obstruction|MP:0011100,preweaning lethality, complete penetrance
MGI:4822558	Fndc3b<tm1Maim>	MP:0005076,abnormal cell differentiation|MP:0005376,homeostasis/metabolism phenotype|MP:0011087,neonatal lethality, complete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0011708,decreased fibroblast cell migration|MP:0014698,decreased fibroblast adhesion|MP:0020039,increased bone ossification
MGI:5616359	Fndc4<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001513,limb grasping|MP:0002574,increased vertical activity|MP:0013279,increased fasting circulating glucose level
MGI:6103906	Fndc4<tm1.1Mabo>	MP:0001263,weight loss|MP:0008537,increased susceptibility to induced colitis|MP:0013956,decreased colon length
MGI:6693646	Fndc5<em21Gpt>	MP:0001570,abnormal circulating enzyme level|MP:0003949,abnormal circulating lipid level|MP:0004924,abnormal behavior|MP:0005378,growth/size/body region phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010953,abnormal fatty acid oxidation|MP:0030940,impaired autophagy|MP:0031265,increased susceptibility to hepatic steatosis|MP:0031269,increased susceptibility to diet-induced hepatic steatosis
MGI:6307130	Fndc5<tm1.1Brsp>	MP:0004993,decreased bone resorption|MP:0005390,skeleton phenotype|MP:0008753,abnormal osteocyte morphology|MP:0010872,increased trabecular bone mass|MP:0010932,increased trabecular bone connectivity density|MP:0012072,decreased susceptibility to osteoporosis|MP:0030484,abnormal osteocyte lacuna morphology
MGI:5692832	Fndc7<tm1.1(KOMP)Vlcg>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005568,increased circulating total protein level
MGI:6361164	Fndc8<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5708249	Fndc9<tm1.1(KOMP)Vlcg>	MP:0000219,increased neutrophil cell number|MP:0001399,hyperactivity|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002599,increased mean platelet volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0005016,decreased lymphocyte cell number|MP:0005344,increased circulating bilirubin level|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:7425688	Fnip1<em1(IMPC)Ccpcz>	MP:0000219,increased neutrophil cell number|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000494,abnormal cecum morphology|MP:0000627,abnormal mammary gland morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0000709,enlarged thymus|MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0001944,abnormal pancreas morphology|MP:0002311,abnormal inspiratory capacity|MP:0002753,dilated heart left ventricle|MP:0002797,increased thigmotaxis|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0002981,increased liver weight|MP:0003233,prolonged QT interval|MP:0003961,decreased lean body mass|MP:0004174,abnormal spine curvature|MP:0004953,decreased spleen weight|MP:0005015,increased T cell number|MP:0005016,decreased lymphocyte cell number|MP:0005292,improved glucose tolerance|MP:0005333,decreased heart rate|MP:0005599,increased cardiac muscle contractility|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008810,increased circulating iron level|MP:0009476,enlarged cecum|MP:0010053,decreased grip strength|MP:0010068,decreased red blood cell distribution width|MP:0010379,decreased respiratory quotient|MP:0010392,prolonged QRS complex duration|MP:0010506,prolonged RR interval|MP:0010570,prolonged ST segment|MP:0010574,dilated aorta|MP:0010579,increased heart left ventricle size|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0010851,decreased effector memory CD8-positive, alpha-beta T cell number|MP:0010895,increased lung compliance|MP:0010936,decreased airway resistance|MP:0011045,decreased lung elastance|MP:0011048,decreased lung tissue damping|MP:0011951,increased cardiac stroke volume|MP:0013279,increased fasting circulating glucose level|MP:0013519,decreased CD4-positive NK T cell number|MP:0013522,decreased memory-marker CD4-positive NK T cell number|MP:0013763,increased T-helper cell number|MP:0013771,decreased effector memory T-helper cell number|MP:0020421,increased freezing behavior
MGI:4130078	Fnip1<Gt(RRM154)Byg>	MP:0000692,small spleen|MP:0001802,arrested B cell differentiation|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005367,renal/urinary system phenotype|MP:0008071,absent B cells|MP:0008186,increased pro-B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008205,absent B-2 B cells|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008782,increased B cell apoptosis
MGI:5437714	Fnip1<LPAB.1>	MP:0000759,abnormal skeletal muscle morphology|MP:0001802,arrested B cell differentiation|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002459,abnormal B cell physiology|MP:0002492,decreased IgE level|MP:0004978,decreased B-1 B cell number|MP:0005330,cardiomyopathy|MP:0008071,absent B cells|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008782,increased B cell apoptosis|MP:0010400,increased liver glycogen level
MGI:5806459	Fnip1<m1Btlr>	MP:0000172,abnormal bone marrow cell number|MP:0000274,enlarged heart|MP:0000759,abnormal skeletal muscle morphology|MP:0001606,impaired hematopoiesis|MP:0001625,cardiac hypertrophy|MP:0001806,decreased IgM level|MP:0005385,cardiovascular system phenotype|MP:0008071,absent B cells|MP:0008182,decreased marginal zone B cell number|MP:0009332,abnormal splenocyte morphology|MP:0010392,prolonged QRS complex duration|MP:0010511,shortened PR interval|MP:0014071,increased cardiac muscle glycogen level|MP:0030941,enhanced autophagy
MGI:6199692	Fnip1<m2Btlr>	MP:0004977,increased B-1 B cell number|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number
MGI:6285877	Fnip1<M3Btlr>	MP:0002144,abnormal B cell differentiation
MGI:5445115	Fnip1<tm1.1Baba>	MP:0001625,cardiac hypertrophy|MP:0002106,abnormal muscle physiology|MP:0002108,abnormal muscle morphology|MP:0003675,kidney cyst|MP:0006036,abnormal mitochondrial physiology
MGI:5445116	Fnip1<tm1.2Baba>	MP:0000692,small spleen|MP:0001802,arrested B cell differentiation|MP:0002083,premature death|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005367,renal/urinary system phenotype|MP:0008071,absent B cells|MP:0008186,increased pro-B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008205,absent B-2 B cells|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008782,increased B cell apoptosis
MGI:5749952	Fnip2<tm1.1Lss>	MP:0005367,renal/urinary system phenotype
MGI:5749954	Fnip2<tm1.2Lss>	MP:0002169,no abnormal phenotype detected
MGI:5303094	Fnip2<tm1a(KOMP)Wtsi>	MP:0008810,increased circulating iron level
MGI:1889331	Fnld	MP:0000367,abnormal coat/ hair morphology|MP:0001259,abnormal body weight|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6241419	Fnos2	MP:0001394,circling|MP:0001410,head bobbing
MGI:5578487	Fnta<tm1b(KOMP)Wtsi>	MP:0002075,abnormal coat/hair pigmentation|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3581448	Fntb<tm1.1Bbd>	MP:0001675,abnormal ectoderm development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012113,decreased inner cell mass proliferation
MGI:4441481	Fntb<tm1.1Mbrg>	MP:0000358,abnormal cell morphology|MP:0000379,decreased hair follicle number|MP:0000382,underdeveloped hair follicles|MP:0000383,abnormal hair follicle orientation|MP:0000414,alopecia|MP:0001265,decreased body size|MP:0002655,abnormal keratinocyte morphology|MP:0003077,abnormal cell cycle|MP:0003809,abnormal hair shaft morphology|MP:0009584,decreased keratinocyte proliferation|MP:0011195,increased hair follicle apoptosis|MP:0011704,decreased fibroblast proliferation
MGI:3581447	Fntb<tm1Bbd>	MP:0000352,decreased cell proliferation|MP:0000692,small spleen|MP:0001545,abnormal hematopoietic system physiology|MP:0002908,delayed wound healing|MP:0004502,decreased incidence of tumors by chemical induction
MGI:5605771	Fntb<tm1b(EUCOMM)Hmgu>	MP:0003179,thrombocytopenia|MP:0011100,preweaning lethality, complete penetrance
MGI:2154958	Fob1<F line>	MP:0000008,increased white adipose tissue amount
MGI:2446884	Fob2<F line>	MP:0000008,increased white adipose tissue amount
MGI:3045989	Fob3a<L line>	MP:0001262,decreased body weight|MP:0010025,decreased total body fat amount
MGI:3045991	Fob3b<L line>	MP:0001262,decreased body weight|MP:0010025,decreased total body fat amount
MGI:2389486	Fob3<F line>	MP:0000008,increased white adipose tissue amount
MGI:2446882	Fob4<F line>	MP:0000008,increased white adipose tissue amount
MGI:3609129	Foc1<NFS/N>	MP:0002023,increased B cell derived lymphoma incidence
MGI:6257727	Focad<em1(IMPC)Bay>	MP:0000111,cleft palate|MP:0001293,anophthalmia|MP:0001415,increased exploration in new environment|MP:0003743,abnormal facial morphology|MP:0004258,abnormal placenta size|MP:0004953,decreased spleen weight|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7289725	Folh1<em2Smoc>	MP:0005166,decreased susceptibility to injury|MP:0012306,enhanced spatial learning|MP:0030737,decreased glutamic acid level
MGI:5630065	Folh1<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity
MGI:2388359	Folh1<tm1Nle>	MP:0000260,abnormal angiogenesis|MP:0001363,increased anxiety-related response|MP:0002651,abnormal sciatic nerve morphology|MP:0002842,increased systemic arterial blood pressure|MP:0004220,abnormal peripheral nervous system regeneration|MP:0005386,behavior/neurological phenotype|MP:0005602,decreased angiogenesis|MP:0006055,abnormal vascular endothelial cell morphology|MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0011939,increased food intake
MGI:5766053	Folh1<tm2Nle>	MP:0000811,hippocampal neuron degeneration|MP:0003858,enhanced coordination|MP:0005166,decreased susceptibility to injury|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging|MP:0012066,decreased astrocyte number|MP:0012306,enhanced spatial learning
MGI:5695973	Folr1<tm1.1(KOMP)Vlcg>	MP:0000274,enlarged heart|MP:0001147,small testis|MP:0002135,abnormal kidney morphology|MP:0002941,increased circulating alanine transaminase level|MP:0003984,embryonic growth retardation|MP:0005278,abnormal cholesterol homeostasis|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2383986	Folr1<tm1Fnn>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0000928,incomplete rostral neuropore closure|MP:0001689,incomplete somite formation|MP:0001701,incomplete embryo turning|MP:0002950,abnormal neural crest cell migration|MP:0003984,embryonic growth retardation|MP:0004499,increased incidence of tumors by chemical induction|MP:0006294,absent optic vesicle|MP:0006342,absent first pharyngeal arch|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011172,abnormal otic pit morphology|MP:0011230,abnormal folic acid level|MP:0012136,absent forebrain|MP:0012335,increased circulating homocysteine level|MP:0012703,decreased embryonic neuroepithelium thickness|MP:0012708,delayed rostral neuropore closure|MP:0013183,absent trigeminal ganglion
MGI:2383987	Folr2<tm1Fnn>	MP:0002169,no abnormal phenotype detected
MGI:5634956	Fosb<tm1.1Yun>	MP:0001364,decreased anxiety-related response|MP:0001415,increased exploration in new environment|MP:0003313,abnormal locomotor activation|MP:0031391,increased locomotor activity
MGI:5603357	Fosb<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002591,decreased mean corpuscular volume|MP:0003068,enlarged kidney
MGI:2385943	Fosb<tm1Brv>	MP:0003997,tonic-clonic seizures
MGI:1857395	Fosb<tm1Meg>	MP:0001265,decreased body size|MP:0001382,abnormal nursing|MP:0001384,abnormal pup retrieval|MP:0001386,abnormal maternal nurturing|MP:0001650,abnormal seizure response to electrical stimulation|MP:0001902,reduced NMDA-mediated synaptic currents|MP:0002068,abnormal parental behavior|MP:0003194,abnormal frequency of paradoxical sleep
MGI:5634957	Fosb<tm2.1Yun>	MP:0001363,increased anxiety-related response|MP:0001415,increased exploration in new environment|MP:0002063,abnormal learning/memory/conditioning|MP:0002572,abnormal emotion/affect behavior|MP:0003313,abnormal locomotor activation|MP:0003360,abnormal depression-related behavior|MP:0012307,impaired spatial learning|MP:0031391,increased locomotor activity
MGI:6276903	Fos<em1(IMPC)Mbp>	MP:0001404,no spontaneous movement|MP:0001417,decreased exploration in new environment|MP:0001914,hemorrhage|MP:0003743,abnormal facial morphology|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2385824	Fosl1<tm1Wag>	MP:0000291,enlarged pericardium|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0004230,abnormal embryonic erythrocyte morphology|MP:0004560,abnormal chorionic plate morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011203,abnormal parietal yolk sac morphology|MP:0020515,abnormal visceral yolk sac endoderm morphology
MGI:3055993	Fosl1<tm2.1Wag>	MP:0011091,prenatal lethality, complete penetrance
MGI:3055991	Fosl1<tm2Wag>	MP:0000066,osteoporosis|MP:0002169,no abnormal phenotype detected|MP:0004016,decreased bone mass|MP:0005006,abnormal osteoblast physiology|MP:0005370,liver/biliary system phenotype|MP:0005385,cardiovascular system phenotype
MGI:3521815	Fosl2<tm1Wag>	MP:0000131,abnormal long bone epiphysis morphology|MP:0000137,abnormal vertebrae morphology|MP:0000163,abnormal cartilage morphology|MP:0001732,postnatal growth retardation|MP:0002113,abnormal skeleton development|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0004599,abnormal vertebral arch morphology|MP:0005225,abnormal vertebrae development|MP:0011085,postnatal lethality, complete penetrance|MP:0014105,abnormal chondrocyte differentiation
MGI:3757560	Fosl2<tm2.1Wag>	MP:0000063,decreased bone mineral density|MP:0001265,decreased body size|MP:0001541,abnormal osteoclast physiology|MP:0001732,postnatal growth retardation|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0004992,increased bone resorption|MP:0005039,hypoxia|MP:0008396,abnormal osteoclast differentiation|MP:0011085,postnatal lethality, complete penetrance
MGI:3521818	Fosl2<tm2Wag>	MP:0000160,kyphosis|MP:0000166,abnormal chondrocyte morphology|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0004982,abnormal osteoclast morphology|MP:0004986,abnormal osteoblast morphology|MP:0005006,abnormal osteoblast physiology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005375,adipose tissue phenotype|MP:0005390,skeleton phenotype|MP:0005560,decreased circulating glucose level|MP:0008396,abnormal osteoclast differentiation|MP:0009285,increased gonadal fat pad weight|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0011085,postnatal lethality, complete penetrance|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization|MP:0030985,decreased circulating osteocalcin level
MGI:5488905	Fos<tm1.1(cre/ERT2)Luo>	MP:0002169,no abnormal phenotype detected
MGI:5660357	Fos<tm1.1Fawa>	MP:0002169,no abnormal phenotype detected
MGI:2387304	Fos<tm1Mxu>	MP:0002063,abnormal learning/memory/conditioning|MP:0002272,abnormal nervous system electrophysiology|MP:0003313,abnormal locomotor activation|MP:0004924,abnormal behavior|MP:0008143,abnormal dendrite morphology|MP:0008946,abnormal neuron number|MP:0009712,impaired conditioned place preference behavior
MGI:1857171	Fos<tm1Pa>	MP:0000121,failure of tooth eruption|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000585,kinked tail|MP:0001129,impaired ovarian folliculogenesis|MP:0001156,abnormal spermatogenesis|MP:0001265,decreased body size|MP:0001273,decreased metastatic potential|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001463,abnormal spatial learning|MP:0001501,abnormal sleep pattern|MP:0002083,premature death|MP:0002216,abnormal seminiferous tubule morphology|MP:0002401,abnormal lymphopoiesis|MP:0002673,abnormal sperm number|MP:0003194,abnormal frequency of paradoxical sleep|MP:0003448,abnormal tumor morphology|MP:0003723,abnormal long bone morphology|MP:0004214,abnormal long bone diaphysis morphology|MP:0004686,decreased length of long bones|MP:0004921,decreased placenta weight|MP:0005551,abnormal eye electrophysiology|MP:0006325,impaired hearing|MP:0006359,absent startle reflex|MP:0006397,disorganized long bone epiphyseal plate|MP:0008453,decreased retina rod cell number|MP:0008489,slow postnatal weight gain|MP:0008515,thin retina outer nuclear layer|MP:0009431,decreased fetal weight|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014639,decreased sleep duration|MP:0030610,absent teeth|MP:0031239,increased atretic ovarian follicle number|MP:0031650,decreased mounting behavior
MGI:2181817	Fos<tm1Wag>	MP:0000065,abnormal bone marrow cavity morphology|MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000131,abnormal long bone epiphysis morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000134,abnormal compact bone thickness|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000445,short snout|MP:0000547,short limbs|MP:0000689,abnormal spleen morphology|MP:0000715,decreased thymocyte number|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002357,abnormal spleen white pulp morphology|MP:0002364,abnormal thymus size|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0003009,abnormal cytokine secretion|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003797,abnormal compact bone morphology|MP:0004179,transmission ratio distortion|MP:0004200,decreased fetal size|MP:0004985,decreased osteoclast cell number|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005092,decreased double-positive T cell number|MP:0005382,craniofacial phenotype|MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype|MP:0009339,decreased splenocyte number|MP:0010868,increased bone trabecula number|MP:0011078,increased macrophage cytokine production|MP:0011080,increased macrophage apoptosis|MP:0011090,perinatal lethality, incomplete penetrance|MP:0030006,decreased retina apoptosis|MP:0030505,tooth impaction|MP:0030610,absent teeth
MGI:2384074	Fos<tm2(Fosl1)Wag>	MP:0001463,abnormal spatial learning|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype|MP:0030005,increased retina apoptosis
MGI:5142238	Fos<tm3.1Wag>	MP:0008560,increased tumor necrosis factor secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008735,increased susceptibility to endotoxin shock
MGI:5142239	Fos<tm4.1Wag>	MP:0008560,increased tumor necrosis factor secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock
MGI:5142240	Fos<tm5.1Wag>	MP:0004985,decreased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0008396,abnormal osteoclast differentiation|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume
MGI:5142241	Fos<tm6.1Wag>	MP:0008396,abnormal osteoclast differentiation|MP:0008553,increased circulating tumor necrosis factor level|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008735,increased susceptibility to endotoxin shock
MGI:2679338	Fos<tm7Wag>	MP:0000352,decreased cell proliferation|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0002062,abnormal associative learning|MP:0002169,no abnormal phenotype detected|MP:0003447,decreased tumor growth/size|MP:0006042,increased apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008661,decreased interleukin-10 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:2653543	Foxa1<tm1Gsc>	MP:0000189,hypoglycemia|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001560,abnormal circulating insulin level|MP:0001732,postnatal growth retardation|MP:0001739,abnormal adrenal gland secretion|MP:0002696,decreased circulating glucagon level|MP:0011085,postnatal lethality, complete penetrance|MP:0014126,increased mammary gland apoptosis
MGI:2384404	Foxa1<tm1Stf>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000189,hypoglycemia|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002078,abnormal glucose homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002696,decreased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005123,increased circulating growth hormone level|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0014161,increased circulating cortisol level
MGI:6393315	Foxa2<tm1.1Khk>	MP:0002281,abnormal respiratory mucosa goblet cell morphology|MP:0002405,respiratory system inflammation|MP:0005165,increased susceptibility to injury
MGI:4417942	Foxa2<tm1.1Stf>	MP:0001399,hyperactivity|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003960,increased lean body mass|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0008963,increased carbon dioxide production|MP:0008965,increased basal metabolism|MP:0010025,decreased total body fat amount|MP:0011939,increased food intake|MP:0011941,increased fluid intake
MGI:5490029	Foxa2<tm1(cre/ERT2)Hssk>	MP:0002169,no abnormal phenotype detected
MGI:3822329	Foxa2<tm1(cre)Heli>	MP:0010768,mortality/aging
MGI:2158924	Foxa2<tm1Dnl>	MP:0000120,malocclusion|MP:0000313,abnormal cell death|MP:0000926,absent floor plate|MP:0000932,absent notochord|MP:0001286,abnormal eye development|MP:0001406,abnormal gait|MP:0001523,impaired righting response|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001685,abnormal endoderm development|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001923,reduced female fertility|MP:0002078,abnormal glucose homeostasis|MP:0002085,abnormal embryonic tissue morphology|MP:0002151,abnormal neural tube morphology|MP:0003861,abnormal nervous system development|MP:0005266,abnormal metabolism|MP:0008029,abnormal paraxial mesoderm morphology|MP:0009009,absent estrous cycle|MP:0009021,absent estrus|MP:0009331,absent primitive node|MP:0009355,increased liver triglyceride level|MP:0009937,abnormal neuron differentiation|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012271,abnormal chordamesoderm morphology|MP:0031434,increased miscarriage rate
MGI:1857725	Foxa2<tm1Jrt>	MP:0000120,malocclusion|MP:0000474,abnormal foregut morphology|MP:0000926,absent floor plate|MP:0000932,absent notochord|MP:0001265,decreased body size|MP:0001394,circling|MP:0001505,hunched posture|MP:0001683,absent mesoderm|MP:0001691,abnormal somite shape|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002151,abnormal neural tube morphology|MP:0002230,abnormal primitive streak formation|MP:0003400,kinked neural tube|MP:0004831,long incisors|MP:0005221,abnormal rostral-caudal axis patterning|MP:0009331,absent primitive node|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011183,abnormal primitive endoderm morphology|MP:0011732,decreased somite size|MP:0011733,fused somites|MP:0012135,embryonic-extraembryonic boundary constriction|MP:0012157,rostral body truncation|MP:0012685,abnormal primitive streak elongation|MP:0013504,increased embryonic tissue cell apoptosis
MGI:2177337	Foxa2<tm1Khk>	MP:0000189,hypoglycemia|MP:0000219,increased neutrophil cell number|MP:0001177,atelectasis|MP:0001265,decreased body size|MP:0001385,pup cannibalization|MP:0001575,cyanosis|MP:0001729,impaired embryo implantation|MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0001954,respiratory distress|MP:0002064,seizures|MP:0002079,increased circulating insulin level|MP:0002169,no abnormal phenotype detected|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002314,abnormal respiratory mechanics|MP:0002696,decreased circulating glucagon level|MP:0003564,abnormal insulin secretion|MP:0003653,decreased skin turgor|MP:0003845,abnormal decidualization|MP:0004780,abnormal surfactant secretion|MP:0004781,abnormal surfactant composition|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005387,immune system phenotype|MP:0005425,increased macrophage cell number|MP:0005440,increased glycogen level|MP:0006027,impaired lung alveolus development|MP:0009096,decreased endometrial gland number|MP:0009177,decreased pancreatic alpha cell number|MP:0009254,disorganized pancreatic islets|MP:0009667,abnormal embryo invasion|MP:0009671,abnormal uterus physiology|MP:0010018,pulmonary vascular congestion|MP:0010814,absent alveolar lamellar bodies|MP:0010817,absent type I pneumocytes|MP:0010825,abnormal lung saccule morphology|MP:0010856,dilated respiratory conducting tube|MP:0010861,increased respiratory mucosa goblet cell number|MP:0010896,decreased lung compliance|MP:0010935,increased airway resistance|MP:0010993,decreased surfactant secretion|MP:0011018,pulmonary hyaline membrane formation|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0013400,abnormal endometrial gland development|MP:0014473,increased pulmonary alveolus wall thickness
MGI:5532711	Foxa2<tm2.1Heli>	MP:0002169,no abnormal phenotype detected
MGI:3774419	Foxa2<tm2(cre/Esr1*)Moon>	MP:0003935,abnormal craniofacial development|MP:0011092,embryonic lethality, complete penetrance|MP:0012082,delayed heart development
MGI:2178218	Foxa3<tm1Khk>	MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001661,extended life span|MP:0001922,reduced male fertility|MP:0002118,abnormal lipid homeostasis|MP:0002169,no abnormal phenotype detected|MP:0002784,abnormal Sertoli cell morphology|MP:0002891,increased insulin sensitivity|MP:0004852,decreased testis weight|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005668,decreased circulating leptin level|MP:0008390,abnormal primordial germ cell proliferation|MP:0009133,decreased white fat cell size|MP:0009136,decreased brown fat cell size|MP:0010182,decreased susceptibility to weight gain|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0013278,decreased fasting circulating glucose level|MP:0014052,increased male germ cell apoptosis|MP:0014143,decreased body fat mass|MP:0020103,decreased hepatic glucose production|MP:0020325,abnormal beige fat cell morphology|MP:0030016,increased adipocyte glucose uptake
MGI:2183919	Foxb1<tm1Blh>	MP:0000929,open neural tube|MP:0001265,decreased body size|MP:0001513,limb grasping|MP:0001698,decreased embryo size|MP:0004073,caudal body truncation|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0013718,galactostasis
MGI:2384415	Foxb1<tm1Lby>	MP:0000627,abnormal mammary gland morphology|MP:0003631,nervous system phenotype|MP:0004162,abnormal mammillary body morphology|MP:0005386,behavior/neurological phenotype|MP:0009038,decreased inferior colliculus size|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009505,abnormal mammary gland lobule morphology|MP:0009506,abnormal mammary gland alveolus morphology|MP:0013718,galactostasis
MGI:2384086	Foxb1<tm1Pgr>	MP:0000837,abnormal hypothalamus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000867,abnormal cerebellum anterior vermis morphology|MP:0000897,abnormal midbrain morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001382,abnormal nursing|MP:0001386,abnormal maternal nurturing|MP:0001463,abnormal spatial learning|MP:0001732,postnatal growth retardation|MP:0002566,abnormal sexual interaction|MP:0003718,maternal effect|MP:0004162,abnormal mammillary body morphology|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory|MP:0009038,decreased inferior colliculus size|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2384416	Foxb1<tm1Sli>	MP:0001265,decreased body size|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0005386,behavior/neurological phenotype|MP:0010053,decreased grip strength|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2384129	Foxb1<tm2Pgr>	MP:0002152,abnormal brain morphology
MGI:6357983	Foxb2<em1(IMPC)J>	MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:1856705	Foxc1<ch>	MP:0000060,delayed bone ossification|MP:0000074,abnormal neurocranium morphology|MP:0000088,short mandible|MP:0000104,abnormal sphenoid bone morphology|MP:0000149,abnormal scapula morphology|MP:0000150,abnormal rib morphology|MP:0000157,abnormal sternum morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000163,abnormal cartilage morphology|MP:0000164,abnormal cartilage development|MP:0000445,short snout|MP:0000516,abnormal renal/urinary system morphology|MP:0000519,hydronephrosis|MP:0000527,abnormal kidney development|MP:0000530,abnormal kidney vasculature morphology|MP:0000536,hydroureter|MP:0000547,short limbs|MP:0000554,abnormal carpal bone morphology|MP:0000556,abnormal hindlimb morphology|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000825,dilated lateral ventricle|MP:0000826,abnormal third ventricle morphology|MP:0000828,abnormal fourth ventricle morphology|MP:0000854,abnormal cerebellum development|MP:0000913,abnormal brain development|MP:0000923,abnormal roof plate morphology|MP:0000955,abnormal spinal cord morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001302,eyelids open at birth|MP:0001304,cataract|MP:0001893,non-obstructive hydrocephaly|MP:0001915,intracranial hemorrhage|MP:0001953,respiratory failure|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0002115,abnormal limb bone morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002135,abnormal kidney morphology|MP:0002160,abnormal reproductive system morphology|MP:0002187,abnormal fibula morphology|MP:0002200,abnormal brain ventricular system morphology|MP:0002256,abnormal laryngeal cartilage morphology|MP:0002257,abnormal arytenoid cartilage morphology|MP:0002258,abnormal cricoid cartilage morphology|MP:0002260,abnormal thyroid cartilage morphology|MP:0002546,mydriasis|MP:0002823,abnormal rib development|MP:0002825,abnormal notochord morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003056,abnormal hyoid bone morphology|MP:0003068,enlarged kidney|MP:0003072,abnormal metatarsal bone morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0003232,abnormal forebrain development|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003584,bifid ureter|MP:0003631,nervous system phenotype|MP:0003672,abnormal ureter development|MP:0003816,abnormal pituitary gland development|MP:0003817,abnormal pituitary diverticulum morphology|MP:0003827,abnormal Wolffian duct morphology|MP:0003861,abnormal nervous system development|MP:0003935,abnormal craniofacial development|MP:0004017,duplex kidney|MP:0004077,abnormal striatum morphology|MP:0004200,decreased fetal size|MP:0004221,abnormal iridocorneal angle|MP:0004226,absent Schlemm's canal|MP:0004322,abnormal sternebra morphology|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004376,absent frontal bone|MP:0004599,abnormal vertebral arch morphology|MP:0004600,abnormal vertebral transverse process morphology|MP:0004607,abnormal cervical atlas morphology|MP:0004726,abnormal nasal capsule morphology|MP:0004915,abnormal Reichert's cartilage morphology|MP:0005104,abnormal tarsal bone morphology|MP:0005193,abnormal anterior eye segment morphology|MP:0005203,abnormal trabecular meshwork morphology|MP:0005204,abnormal canal of Schlemm morphology|MP:0005225,abnormal vertebrae development|MP:0005269,abnormal occipital bone morphology|MP:0005306,abnormal phalanx morphology|MP:0005353,abnormal patella morphology|MP:0005391,vision/eye phenotype|MP:0005537,abnormal cerebral aqueduct morphology|MP:0005542,cornea vascularization|MP:0008148,abnormal sternocostal joint morphology|MP:0008275,failure of endochondral bone ossification|MP:0008276,failure of intramembranous bone ossification|MP:0008277,abnormal sternum ossification|MP:0008278,failure of sternum ossification|MP:0008487,abnormal mesonephros morphology|MP:0008915,fused carpal bones|MP:0008919,fused tarsal bones|MP:0009003,abnormal vibrissa number|MP:0010941,abnormal foramen magnum morphology|MP:0010980,ectopic ureteric bud|MP:0011087,neonatal lethality, complete penetrance|MP:0011309,abnormal kidney arterial blood vessel morphology|MP:0011311,abnormal kidney venous blood vessel morphology|MP:0011318,abnormal right renal artery morphology|MP:0011364,abnormal metanephros morphology|MP:0011410,ectopic testis|MP:0011481,anterior iris synechia|MP:0011486,ectopic ureter|MP:0011727,ectopic ovary|MP:0011797,blind ureter|MP:0011835,abnormal urogenital fold morphology|MP:0012513,absent sternum body|MP:0013261,absent epiglottis|MP:0013743,ciliary body hypoplasia|MP:0014164,abnormal ciliary process morphology|MP:0030026,small Meckel's cartilage|MP:0030318,enlarged maxillary zygomatic process|MP:0030420,short basicranium|MP:0030859,absent sesamoid bone of gastrocnemius|MP:0030861,abnormal triquetrum morphology
MGI:3797008	Foxc1<hith>	MP:0000107,abnormal frontal bone morphology|MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000792,abnormal cortical marginal zone morphology|MP:0000807,abnormal hippocampus morphology|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001322,abnormal iris morphology|MP:0001891,hydrocephaly|MP:0002092,abnormal eye morphology|MP:0002196,absent corpus callosum|MP:0003648,abnormal radial glial cell morphology|MP:0004272,abnormal basement membrane morphology|MP:0005623,abnormal meninges morphology|MP:0008547,abnormal neocortex morphology|MP:0009022,abnormal brain meninges morphology|MP:0009937,abnormal neuron differentiation|MP:0009967,abnormal neuron proliferation|MP:0010709,absent eye anterior chamber|MP:0011723,ectopic neuron|MP:0011962,increased cornea thickness|MP:0020391,radial glial endfoot detachment
MGI:5443919	Foxc1<tm1.1Tsku>	MP:0001891,hydrocephaly|MP:0002092,abnormal eye morphology|MP:0010709,absent eye anterior chamber|MP:0011962,increased cornea thickness
MGI:1857869	Foxc1<tm1Blh>	MP:0000075,absent neurocranium|MP:0000158,absent sternum|MP:0000159,abnormal xiphoid process morphology|MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0001116,small gonad|MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001131,abnormal ovarian follicle morphology|MP:0001147,small testis|MP:0001302,eyelids open at birth|MP:0001304,cataract|MP:0001306,small lens|MP:0001312,abnormal cornea morphology|MP:0001319,irregularly shaped pupil|MP:0001322,abnormal iris morphology|MP:0001346,abnormal lacrimal gland morphology|MP:0001348,abnormal lacrimal gland physiology|MP:0001891,hydrocephaly|MP:0001915,intracranial hemorrhage|MP:0002016,ovary cyst|MP:0002116,abnormal craniofacial bone morphology|MP:0002192,hydrops fetalis|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0002746,abnormal semilunar valve morphology|MP:0002747,abnormal aortic valve morphology|MP:0002748,abnormal pulmonary valve morphology|MP:0002982,abnormal primordial germ cell migration|MP:0003139,patent ductus arteriosus|MP:0003574,abnormal oviduct morphology|MP:0003584,bifid ureter|MP:0004017,duplex kidney|MP:0004157,interrupted aortic arch|MP:0004221,abnormal iridocorneal angle|MP:0004223,hypoplastic trabecular meshwork|MP:0004353,abnormal deltoid tuberosity morphology|MP:0004462,small basisphenoid bone|MP:0004599,abnormal vertebral arch morphology|MP:0004670,small vertebral body|MP:0004674,thin ribs|MP:0005104,abnormal tarsal bone morphology|MP:0005193,abnormal anterior eye segment morphology|MP:0005198,abnormal aqueous drainage system morphology|MP:0005199,abnormal iris pigment epithelium|MP:0005203,abnormal trabecular meshwork morphology|MP:0005204,abnormal canal of Schlemm morphology|MP:0005296,abnormal humerus morphology|MP:0005301,abnormal cornea endothelium morphology|MP:0005380,embryo phenotype|MP:0005391,vision/eye phenotype|MP:0005431,decreased oocyte number|MP:0005508,abnormal skeleton morphology|MP:0006000,abnormal cornea epithelium morphology|MP:0006226,iris hypoplasia|MP:0006230,iris stroma hypoplasia|MP:0006241,abnormal placement of pupils|MP:0006250,abnormal line of Schwalbe morphology|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0006419,disorganized testis cords|MP:0008271,abnormal bone ossification|MP:0008277,abnormal sternum ossification|MP:0008487,abnormal mesonephros morphology|MP:0008969,abnormal nasolacrimal duct morphology|MP:0009022,abnormal brain meninges morphology|MP:0009071,short oviduct|MP:0009093,oocyte degeneration|MP:0009433,polyovular ovarian follicle|MP:0009937,abnormal neuron differentiation|MP:0009967,abnormal neuron proliferation|MP:0010402,ventricular septal defect|MP:0010526,aortic arch coarctation|MP:0010593,thick aortic valve cusps|MP:0010595,abnormal aortic valve cusp morphology|MP:0010602,abnormal pulmonary valve cusp morphology|MP:0010605,thick pulmonary valve cusps|MP:0011087,neonatal lethality, complete penetrance|MP:0011481,anterior iris synechia|MP:0013440,abnormal exorbital lacrimal gland morphology|MP:0013474,abnormal lacrimal gland branching morphogenesis|MP:0013605,abnormal ovarian bursa morphology|MP:0013608,abnormal ovarian cortex morphology|MP:0013609,abnormal ovarian medulla morphology|MP:0013738,abnormal testis tunica albuginea morphology|MP:0014153,absent intraorbital lacrimal gland|MP:0014604,hemorrhagic ovary cyst|MP:0020854,increased cornea epithelium thickness|MP:0030302,abnormal maxillary zygomatic process morphology|MP:0030318,enlarged maxillary zygomatic process
MGI:3773756	Foxc1<tm1Tsku>	MP:0002169,no abnormal phenotype detected
MGI:5882729	Foxc2<tm1.1Miu>	MP:0001879,abnormal lymphatic vessel morphology|MP:0003390,lymphedema|MP:0005312,pericardial effusion|MP:0005382,craniofacial phenotype|MP:0005385,cardiovascular system phenotype|MP:0005390,skeleton phenotype|MP:0010418,perimembraneous ventricular septal defect|MP:0011087,neonatal lethality, complete penetrance|MP:0011659,interrupted aortic arch, type b
MGI:5443920	Foxc2<tm1.1Tsku>	MP:0002169,no abnormal phenotype detected
MGI:5443921	Foxc2<tm1.2Tsku>	MP:0002652,thin myocardium|MP:0010402,ventricular septal defect
MGI:1857865	Foxc2<tm1Blh>	MP:0000029,abnormal malleus morphology|MP:0000111,cleft palate|MP:0000141,abnormal vertebral body morphology|MP:0000154,rib fusion|MP:0000163,abnormal cartilage morphology|MP:0000431,absent palatine bone horizontal plate|MP:0001322,abnormal iris morphology|MP:0001614,abnormal blood vessel morphology|MP:0001691,abnormal somite shape|MP:0001915,intracranial hemorrhage|MP:0002400,abnormal multipotent stem cell morphology|MP:0002989,small kidney|MP:0003345,decreased rib number|MP:0003400,kinked neural tube|MP:0004204,absent stapes|MP:0004221,abnormal iridocorneal angle|MP:0004318,absent incus|MP:0004384,small interparietal bone|MP:0004443,absent supraoccipital bone|MP:0004445,small exoccipital bone|MP:0004447,small basioccipital bone|MP:0004449,absent presphenoid bone|MP:0004456,small pterygoid bone|MP:0004476,absent palatine bone|MP:0004592,small mandible|MP:0004599,abnormal vertebral arch morphology|MP:0005105,abnormal middle ear ossicle morphology|MP:0005199,abnormal iris pigment epithelium|MP:0005203,abnormal trabecular meshwork morphology|MP:0005204,abnormal canal of Schlemm morphology|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006020,decreased tympanic ring size|MP:0006054,spinal hemorrhage|MP:0006230,iris stroma hypoplasia|MP:0008380,abnormal gonial bone morphology|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0030026,small Meckel's cartilage|MP:0030121,small temporal bone squamous part
MGI:1857740	Foxc2<tm1Miu>	MP:0000005,increased brown adipose tissue amount|MP:0000029,abnormal malleus morphology|MP:0000078,abnormal supraoccipital bone morphology|MP:0000104,abnormal sphenoid bone morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0000141,abnormal vertebral body morphology|MP:0000154,rib fusion|MP:0000702,enlarged lymph nodes|MP:0001177,atelectasis|MP:0001304,cataract|MP:0001344,blepharoptosis|MP:0001788,periorbital edema|MP:0002092,abnormal eye morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002218,increased lymph node number|MP:0002898,absent cartilage|MP:0002989,small kidney|MP:0003201,extremity edema|MP:0003235,abnormal alisphenoid bone morphology|MP:0003390,lymphedema|MP:0003659,abnormal lymph circulation|MP:0004038,lymphangiectasis|MP:0004095,ocular distichiasis|MP:0004105,cornea abrasion|MP:0004106,lymphatic vessel hyperplasia|MP:0004107,abnormal thoracic duct morphology|MP:0004113,abnormal aortic arch morphology|MP:0004448,abnormal presphenoid bone morphology|MP:0004452,abnormal pterygoid process morphology|MP:0004505,decreased renal glomerulus number|MP:0004537,abnormal palatine bone horizontal plate morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004670,small vertebral body|MP:0004706,short vertebral body|MP:0005105,abnormal middle ear ossicle morphology|MP:0005297,spina bifida occulta|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005327,abnormal mesangial cell morphology|MP:0006030,abnormal otic vesicle development|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0006356,abnormal third pharyngeal arch artery morphology|MP:0008061,absent podocyte slit diaphragm|MP:0008138,absent podocyte foot process|MP:0008271,abnormal bone ossification|MP:0008382,gonial bone hypoplasia|MP:0009859,eye opacity|MP:0009890,cleft secondary palate|MP:0010030,abnormal orbit morphology|MP:0010326,malleus hypoplasia|MP:0010402,ventricular septal defect|MP:0010526,aortic arch coarctation|MP:0011089,perinatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011339,abnormal glomerular mesangium morphology|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011359,decreased glomerular capillary number|MP:0011437,glomerulus hemorrhage|MP:0011455,absent glomerular endothelium fenestra|MP:0011509,dilated glomerular capillary|MP:0011659,interrupted aortic arch, type b|MP:0030290,absent soft palate
MGI:2180362	Foxd1<tm1Lai>	MP:0000527,abnormal kidney development|MP:0000528,delayed kidney development|MP:0000534,abnormal ureter morphology|MP:0000639,abnormal adrenal gland morphology|MP:0000783,abnormal forebrain morphology|MP:0001325,abnormal retina morphology|MP:0001438,aphagia|MP:0002768,small adrenal glands|MP:0002989,small kidney|MP:0002990,short ureter|MP:0003605,fused kidneys|MP:0003881,abnormal nephron morphology|MP:0004505,decreased renal glomerulus number|MP:0004860,dilated kidney collecting duct|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005367,renal/urinary system phenotype|MP:0005426,tachypnea|MP:0009247,meteorism|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0010987,abnormal nephrogenic mesenchyme morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011334,abnormal nephrogenic zone morphology|MP:0011361,pelvic kidney
MGI:6273962	Foxd2<em1(IMPC)Hmgu>	MP:0001325,abnormal retina morphology|MP:0002764,short tibia|MP:0002941,increased circulating alanine transaminase level|MP:0005627,increased circulating potassium level|MP:0008259,abnormal optic disk morphology|MP:0011886,increased circulating lipase level
MGI:2183921	Foxd2<tm1Blh>	MP:0000519,hydronephrosis|MP:0000536,hydroureter|MP:0002989,small kidney|MP:0002990,short ureter
MGI:7424844	Foxd3os<em1Shx>	MP:0002169,no abnormal phenotype detected
MGI:2388720	Foxd3<tm1.1Lby>	MP:0000350,abnormal cell proliferation|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001705,abnormal proximal-distal axis patterning|MP:0001724,abnormal extraembryonic endoderm formation|MP:0002084,abnormal developmental patterning|MP:0003886,abnormal embryonic epiblast morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:2388719	Foxd3<tm1Lby>	MP:0000350,abnormal cell proliferation|MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001705,abnormal proximal-distal axis patterning|MP:0001716,abnormal placenta labyrinth morphology|MP:0001724,abnormal extraembryonic endoderm formation|MP:0002084,abnormal developmental patterning|MP:0003886,abnormal embryonic epiblast morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011189,small embryonic epiblast|MP:0011192,decreased embryonic epiblast cell proliferation|MP:0011255,abnormal anterior visceral endoderm cell migration|MP:0012100,absent spongiotrophoblast layer
MGI:2388721	Foxd3<tm2Lby>	MP:0000350,abnormal cell proliferation|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001705,abnormal proximal-distal axis patterning|MP:0001716,abnormal placenta labyrinth morphology|MP:0001724,abnormal extraembryonic endoderm formation|MP:0002084,abnormal developmental patterning|MP:0003886,abnormal embryonic epiblast morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0012100,absent spongiotrophoblast layer
MGI:6158507	Foxd4<em1(IMPC)Mbp>	MP:0001293,anophthalmia|MP:0002092,abnormal eye morphology
MGI:2181780	Foxe1<tm1Rdl>	MP:0000111,cleft palate|MP:0000383,abnormal hair follicle orientation|MP:0000396,increased curvature of hairs|MP:0000410,waved hair|MP:0000416,sparse hair|MP:0001510,abnormal coat appearance|MP:0003351,decreased circulating levels of thyroid hormone|MP:0003421,abnormal thyroid gland development|MP:0003809,abnormal hair shaft morphology|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005314,absent thyroid gland|MP:0009888,palatal shelves fail to meet at midline|MP:0011085,postnatal lethality, complete penetrance
MGI:1856851	Foxe3<dyl>	MP:0001292,abnormal lens vesicle development|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001306,small lens|MP:0001307,fused cornea and lens|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001320,small pupil|MP:0001322,abnormal iris morphology|MP:0002638,abnormal pupillary reflex|MP:0002840,abnormal lens fiber morphology|MP:0003237,abnormal lens epithelium morphology|MP:0004221,abnormal iridocorneal angle|MP:0004224,absent trabecular meshwork|MP:0005099,abnormal ciliary body morphology|MP:0005193,abnormal anterior eye segment morphology|MP:0005204,abnormal canal of Schlemm morphology|MP:0005300,abnormal cornea stroma morphology|MP:0005301,abnormal cornea endothelium morphology|MP:0005542,cornea vascularization|MP:0005545,abnormal lens development|MP:0006000,abnormal cornea epithelium morphology|MP:0006226,iris hypoplasia|MP:0010713,corneal-lenticular stalk|MP:0011481,anterior iris synechia|MP:0014655,abnormal cornea curvature|MP:0031345,developmental cataract
MGI:6276996	Foxe3<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001314,cornea opacity|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology
MGI:2387330	Foxe3<rct>	MP:0001303,abnormal lens morphology|MP:0002579,disorganized secondary lens fibers|MP:0002840,abnormal lens fiber morphology|MP:0003237,abnormal lens epithelium morphology|MP:0005545,abnormal lens development|MP:0010255,cortical cataract|MP:0010259,anterior polar cataract
MGI:3604211	Foxe3<tm1Mjam>	MP:0000272,abnormal aorta morphology|MP:0001288,abnormal lens induction|MP:0001297,microphthalmia|MP:0001312,abnormal cornea morphology|MP:0001320,small pupil|MP:0002840,abnormal lens fiber morphology|MP:0003237,abnormal lens epithelium morphology|MP:0003631,nervous system phenotype|MP:0004113,abnormal aortic arch morphology|MP:0004283,absent cornea endothelium|MP:0004484,abnormal response of heart to induced stress|MP:0005176,eyelids fail to open|MP:0005205,abnormal eye anterior chamber morphology|MP:0005300,abnormal cornea stroma morphology|MP:0005545,abnormal lens development|MP:0005595,abnormal vascular smooth muscle physiology|MP:0008817,hematoma|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009867,abnormal ascending aorta morphology|MP:0010470,dilated ascending aorta|MP:0011697,lens vacuoles|MP:0020855,decreased cornea epithelium thickness|MP:0021107,retina fold
MGI:3707205	Foxe3<tm1Pca>	MP:0001304,cataract|MP:0001306,small lens|MP:0001307,fused cornea and lens|MP:0001312,abnormal cornea morphology|MP:0001322,abnormal iris morphology|MP:0004221,abnormal iridocorneal angle|MP:0004224,absent trabecular meshwork|MP:0005099,abnormal ciliary body morphology|MP:0005193,abnormal anterior eye segment morphology|MP:0005204,abnormal canal of Schlemm morphology|MP:0005300,abnormal cornea stroma morphology|MP:0005301,abnormal cornea endothelium morphology|MP:0005542,cornea vascularization|MP:0006226,iris hypoplasia|MP:0011481,anterior iris synechia
MGI:6469362	Foxf1<em1Vvk>	MP:0000484,abnormal pulmonary artery morphology|MP:0001178,pulmonary hypoplasia|MP:0001182,lung hemorrhage|MP:0001263,weight loss|MP:0001861,lung inflammation|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002726,abnormal pulmonary vein morphology|MP:0003250,absent gallbladder|MP:0003641,small lung|MP:0004007,abnormal lung vasculature morphology|MP:0005084,abnormal gallbladder morphology|MP:0005602,decreased angiogenesis|MP:0010977,fused right lung lobes|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011140,decreased lung endothelial cell proliferation
MGI:5902536	Foxf1<tm1.1Vvk>	MP:0003227,abnormal vascular branching morphogenesis|MP:0005602,decreased angiogenesis|MP:0006057,decreased vascular endothelial cell number
MGI:1929432	Foxf1<tm1Pca>	MP:0001688,abnormal somite development|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0001726,abnormal allantois morphology|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003794,delayed somite formation|MP:0004180,failure of initiation of embryo turning|MP:0004559,small allantois|MP:0005029,abnormal amnion morphology|MP:0006323,abnormal extraembryonic mesoderm development|MP:0008786,abnormal hindgut morphology|MP:0009657,failure of chorioallantoic fusion|MP:0009706,absent midgut|MP:0010117,abnormal lateral plate mesoderm morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012740,abnormal posterior primitive streak morphology|MP:0020516,abnormal visceral yolk sac mesenchyme morphology
MGI:2179135	Foxf1<tm1Rhc>	MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001182,lung hemorrhage|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0004007,abnormal lung vasculature morphology|MP:0004780,abnormal surfactant secretion|MP:0006027,impaired lung alveolus development|MP:0010825,abnormal lung saccule morphology|MP:0010906,abnormal lung bud morphology|MP:0010977,fused right lung lobes|MP:0011087,neonatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5550485	Foxf1<tm2Rhc>	MP:0003159,abnormal esophageal smooth muscle morphology|MP:0004005,impaired contractility of intestinal smooth muscle|MP:0004548,dilated esophagus|MP:0008802,abnormal intestinal smooth muscle morphology|MP:0010831,lethality, incomplete penetrance|MP:0011089,perinatal lethality, complete penetrance
MGI:2667134	Foxf2<tm1Miu>	MP:0000431,absent palatine bone horizontal plate|MP:0001436,abnormal suckling behavior|MP:0004448,abnormal presphenoid bone morphology|MP:0004453,abnormal pterygoid bone morphology|MP:0004537,abnormal palatine bone horizontal plate morphology|MP:0004538,abnormal maxillary shelf morphology|MP:0005381,digestive/alimentary phenotype|MP:0005388,respiratory system phenotype|MP:0009247,meteorism|MP:0009546,absent gastric milk in neonates|MP:0009886,failure of palatal shelf elevation|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0010704,abnormal optic canal morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0030290,absent soft palate|MP:0031443,abnormal tongue position
MGI:3056482	Foxf2<W174R>	MP:0001265,decreased body size|MP:0001286,abnormal eye development|MP:0001732,postnatal growth retardation|MP:0002092,abnormal eye morphology|MP:0002750,exophthalmos|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004221,abnormal iridocorneal angle|MP:0004223,hypoplastic trabecular meshwork|MP:0004226,absent Schlemm's canal|MP:0005193,abnormal anterior eye segment morphology|MP:0005204,abnormal canal of Schlemm morphology|MP:0005208,abnormal iris stroma morphology|MP:0005382,craniofacial phenotype|MP:0006223,optic nerve swelling|MP:0011085,postnatal lethality, complete penetrance|MP:0011481,anterior iris synechia|MP:0013742,absent ciliary body|MP:0013743,ciliary body hypoplasia|MP:0014163,abnormal ciliary muscle morphology|MP:0014164,abnormal ciliary process morphology
MGI:8220248	Foxg1<em1Skyl>	MP:0000428,abnormal craniofacial morphology|MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0000783,abnormal forebrain morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000920,abnormal myelination|MP:0001286,abnormal eye development|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001408,stereotypic behavior|MP:0001441,increased grooming behavior|MP:0002175,decreased brain weight|MP:0002184,abnormal innervation|MP:0002196,absent corpus callosum|MP:0002797,increased thigmotaxis|MP:0004101,abnormal brain interneuron morphology|MP:0006254,thin cerebral cortex|MP:0008035,behavioral arrest|MP:0008283,small hippocampus|MP:0008458,abnormal cortical ventricular zone morphology|MP:0009901,abnormal frontonasal prominence morphology|MP:0009937,abnormal neuron differentiation|MP:0010892,increased oligodendrocyte progenitor number|MP:0011087,neonatal lethality, complete penetrance|MP:0014318,abnormal oligodendrocyte differentiation|MP:0020389,increased radial glial cell number
MGI:5427355	Foxg1<tm1Chzh>	MP:0000812,abnormal dentate gyrus morphology|MP:0003648,abnormal radial glial cell morphology|MP:0004948,abnormal neuronal precursor proliferation
MGI:1932522	Foxg1<tm1(cre)Skm>	MP:0000787,abnormal telencephalon morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000805,abnormal visual cortex morphology|MP:0002152,abnormal brain morphology|MP:0002169,no abnormal phenotype detected|MP:0006149,decreased visual acuity|MP:0006254,thin cerebral cortex|MP:0008540,abnormal cerebral hemisphere morphology|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0009974,decreased cerebral cortex pyramidal cell number|MP:0010748,abnormal visual evoked potential|MP:0011089,perinatal lethality, complete penetrance|MP:0012468,decreased striatum size|MP:0012559,decreased forebrain volume|MP:0020083,decreased hippocampus volume|MP:0020527,small thalamus
MGI:1857771	Foxg1<tm1M>	MP:0000438,abnormal cranium morphology|MP:0000787,abnormal telencephalon morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000934,abnormal telencephalon development|MP:0000936,small embryonic telencephalon|MP:0001325,abnormal retina morphology|MP:0001404,no spontaneous movement|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002092,abnormal eye morphology|MP:0002152,abnormal brain morphology|MP:0002741,small olfactory bulb|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0006069,abnormal retina neuronal layer morphology|MP:0006292,abnormal nasal placode morphology|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008547,abnormal neocortex morphology|MP:0008789,abnormal olfactory epithelium morphology|MP:0009690,abnormal neural tube mantle layer morphology|MP:0009937,abnormal neuron differentiation|MP:0011087,neonatal lethality, complete penetrance
MGI:5615244	Foxh1<b2b2662Clo>	MP:0000024,lowered ear position|MP:0000087,absent mandible|MP:0000157,abnormal sternum morphology|MP:0000433,microcephaly|MP:0000438,abnormal cranium morphology|MP:0000477,abnormal intestine morphology|MP:0000531,right pulmonary isomerism|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0000690,absent spleen|MP:0001293,anophthalmia|MP:0001823,thymus hypoplasia|MP:0001890,anencephaly|MP:0003104,acrania|MP:0003388,absent pericardium|MP:0003924,diaphragmatic hernia|MP:0004113,abnormal aortic arch morphology|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0004733,abnormal thoracic cavity morphology|MP:0005163,cyclopia|MP:0006063,abnormal inferior vena cava morphology|MP:0006290,proboscis|MP:0009880,decreased mouth size|MP:0010406,common atrium|MP:0010432,common ventricle|MP:0010446,heart left ventricle hypoplasia|MP:0010466,vascular ring|MP:0010487,abnormal right subclavian artery morphology|MP:0010808,right-sided stomach|MP:0011250,abdominal situs ambiguus|MP:0011253,situs inversus with levocardia|MP:0011667,double outlet right ventricle with atrioventricular septal defect|MP:0011668,double outlet right ventricle, Taussig bing type
MGI:2179442	Foxh1<tm1Jlw>	MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0000295,trabecula carnea hypoplasia|MP:0000932,absent notochord|MP:0001698,decreased embryo size|MP:0001787,pericardial edema|MP:0002190,disorganized myocardium|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0003872,absent heart right ventricle|MP:0003921,abnormal heart left ventricle morphology|MP:0003984,embryonic growth retardation|MP:0004251,failure of heart looping|MP:0005157,holoprosencephaly|MP:0005294,abnormal heart ventricle morphology|MP:0005657,abnormal neural plate morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0009266,abnormal mesendoderm development|MP:0009331,absent primitive node|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011733,fused somites|MP:0012135,embryonic-extraembryonic boundary constriction|MP:0012165,absent neural folds|MP:0012276,absent prechordal mesoderm|MP:0012501,abnormal pericardial cavity morphology|MP:0012739,abnormal anterior primitive streak morphology|MP:0030324,abnormal anterior head development
MGI:5705372	Foxh1<tm2.1(Foxh1)Cvw>	MP:0002169,no abnormal phenotype detected
MGI:5705374	Foxh1<tm3.1(Foxh1*)Cvw>	MP:0002169,no abnormal phenotype detected
MGI:2448634	Foxi1<tm1Sven>	MP:0000026,abnormal inner ear morphology|MP:0000031,abnormal cochlea morphology|MP:0000035,abnormal membranous labyrinth morphology|MP:0000525,renal tubular acidosis|MP:0000849,abnormal cerebellum morphology|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001522,impaired swimming|MP:0001925,male infertility|MP:0001967,deafness|MP:0002631,abnormal epididymis morphology|MP:0002978,absent otoliths|MP:0003147,absent cochlea|MP:0003226,absent cochlear modiolus|MP:0003631,nervous system phenotype|MP:0004314,absent inner ear vestibule|MP:0004316,enlarged vestibular saccule|MP:0004335,enlarged utricle|MP:0004410,absent endocochlear potential|MP:0004543,abnormal sperm physiology|MP:0004922,abnormal common crus morphology|MP:0004928,increased epididymis weight|MP:0004931,enlarged epididymis|MP:0005191,head tilt|MP:0005272,abnormal temporal bone morphology|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0006012,dilated endolymphatic duct|MP:0006014,dilated endolymphatic sac|MP:0006015,dilated lateral semicircular canal|MP:0006016,dilated posterior semicircular canal|MP:0006042,increased apoptosis|MP:0006287,inner ear cyst|MP:0006325,impaired hearing|MP:0006358,absent pinna reflex|MP:0009237,kinked sperm flagellum|MP:0009349,increased urine pH|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011843,abnormal kidney collecting duct epithelium morphology|MP:0031012,impaired sperm migration in female genital tract
MGI:6113414	Foxi2<tm1.1Akg>	MP:0002169,no abnormal phenotype detected
MGI:5569961	Foxi2<tm1.1(KOMP)Vlcg>	MP:0005560,decreased circulating glucose level
MGI:7493416	Foxi3<em1Ybz>	MP:0000018,small ears|MP:0000074,abnormal neurocranium morphology|MP:0000111,cleft palate|MP:0000438,abnormal cranium morphology|MP:0000458,abnormal mandible morphology|MP:0003138,absent tympanic ring|MP:0004318,absent incus|MP:0004319,absent malleus|MP:0004455,pterygoid bone hypoplasia|MP:0005107,abnormal stapes morphology|MP:0005270,abnormal zygomatic bone morphology|MP:0005272,abnormal temporal bone morphology|MP:0005579,absent outer ear|MP:0008863,craniofacial asymmetry|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0009880,decreased mouth size|MP:0011087,neonatal lethality, complete penetrance|MP:0030085,syngnathia|MP:0030119,abnormal retrotympanic process morphology
MGI:7493423	Foxi3<em2Ybz>	MP:0002169,no abnormal phenotype detected
MGI:7493424	Foxi3<em3Akg>	MP:0002169,no abnormal phenotype detected
MGI:5559053	Foxi3<tm1.1Akg>	MP:0002169,no abnormal phenotype detected
MGI:5559167	Foxi3<tm1.2Akg>	MP:0000049,abnormal middle ear morphology|MP:0000453,absent mouth|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0000919,cranioschisis|MP:0001082,abnormal geniculate ganglion morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001284,absent vibrissae|MP:0003138,absent tympanic ring|MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0003743,abnormal facial morphology|MP:0003861,abnormal nervous system development|MP:0003874,absent pharyngeal arches|MP:0004204,absent stapes|MP:0004318,absent incus|MP:0004319,absent malleus|MP:0004423,abnormal temporal bone squamous part morphology|MP:0004467,absent zygomatic bone|MP:0005249,abnormal palatine bone morphology|MP:0005579,absent outer ear|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006031,abnormal pharyngeal pouch morphology|MP:0006285,absent inner ear|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011173,abnormal otic placode morphology|MP:0012761,increased cranial neural crest cell apoptosis|MP:0013504,increased embryonic tissue cell apoptosis|MP:0030064,small face|MP:0030085,syngnathia
MGI:5297425	Foxj1<b2b774Clo>	MP:0000276,heart right ventricle hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0004133,heterotaxia|MP:0011252,situs inversus totalis
MGI:5585638	Foxj1<tm1.1(cre/ERT2/GFP)Htg>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0000284,double outlet right ventricle|MP:0000644,dextrocardia|MP:0001891,hydrocephaly|MP:0002766,situs inversus|MP:0006065,abnormal heart position or orientation|MP:0006126,abnormal cardiac outflow tract development|MP:0008725,increased heart atrium size|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010425,abnormal heart and great vessel attachment|MP:0010433,double inlet heart left ventricle
MGI:2181746	Foxj1<tm1Bph>	MP:0000531,right pulmonary isomerism|MP:0000644,dextrocardia|MP:0000820,abnormal choroid plexus morphology|MP:0001402,decreased locomotor activity|MP:0001706,abnormal left-right axis patterning|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0001924,infertility|MP:0004133,heterotaxia|MP:0004201,fetal growth retardation|MP:0005150,cachexia|MP:0005385,cardiovascular system phenotype|MP:0008489,slow postnatal weight gain|MP:0008545,absent sperm flagellum|MP:0009431,decreased fetal weight|MP:0009703,decreased birth body size|MP:0010541,aorta hypoplasia|MP:0010807,abnormal stomach position or orientation|MP:0010808,right-sided stomach|MP:0010854,lung situs inversus|MP:0011054,absent respiratory motile cilia|MP:0011057,absent brain ependyma motile cilia|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011252,situs inversus totalis|MP:0011645,absent oviduct epithelium motile cilium
MGI:2158221	Foxj1<tm1Slb>	MP:0000644,dextrocardia|MP:0000822,abnormal brain ventricle morphology|MP:0000825,dilated lateral ventricle|MP:0000913,abnormal brain development|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0002739,abnormal olfactory bulb development|MP:0002741,small olfactory bulb|MP:0002766,situs inversus|MP:0003354,astrocytosis|MP:0004066,abnormal primitive node morphology|MP:0004110,transposition of great arteries|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0010152,abnormal brain ependyma morphology|MP:0011054,absent respiratory motile cilia|MP:0011057,absent brain ependyma motile cilia|MP:0011085,postnatal lethality, complete penetrance|MP:0011645,absent oviduct epithelium motile cilium|MP:0011998,decreased embryonic cilium length|MP:0012027,abnormal embryonic cilium location or orientation|MP:0012093,absent nodal flow
MGI:6693625	Foxj2<tm1.1Mxc>	MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0009451,abnormal chromosomal synapsis
MGI:4128374	Foxj3<Gt(XL913)Byg>	MP:0002106,abnormal muscle physiology|MP:0002841,impaired skeletal muscle contractility|MP:0003081,abnormal soleus morphology|MP:0003852,skeletal muscle necrosis|MP:0004246,abnormal extensor digitorum longus morphology|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009410,abnormal skeletal muscle satellite cell proliferation|MP:0013239,impaired skeletal muscle regeneration
MGI:4452760	Foxj3<tm1a(EUCOMM)Wtsi>	MP:0000194,increased circulating calcium level|MP:0002968,increased circulating alkaline phosphatase level|MP:0004122,abnormal sinus arrhythmia
MGI:5613664	Foxj3<tm1b(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0000367,abnormal coat/ hair morphology|MP:0001491,unresponsive to tactile stimuli|MP:0001510,abnormal coat appearance|MP:0002092,abnormal eye morphology|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration
MGI:2450307	Foxk1<tm1Djg>	MP:0000729,abnormal myogenesis|MP:0001265,decreased body size|MP:0003077,abnormal cell cycle|MP:0012185,abnormal muscle precursor cell morphology|MP:0013239,impaired skeletal muscle regeneration
MGI:5788415	Foxk2<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0003795,abnormal bone structure|MP:0010053,decreased grip strength|MP:0010097,abnormal retina blood vessel morphology|MP:0010124,decreased bone mineral content
MGI:6356327	Foxk2<tm1.1Sven>	MP:0030017,decreased adipocyte glucose uptake
MGI:6356328	Foxk2<tm1.2Sven>	MP:0001262,decreased body weight|MP:0002079,increased circulating insulin level|MP:0003926,decreased cellular glucose uptake|MP:0005293,impaired glucose tolerance|MP:0013404,decreased circulating lactate level|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:2180191	Foxl1<tm1Hfk>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000501,abnormal digestive secretion|MP:0001265,decreased body size|MP:0003892,abnormal gastric gland morphology|MP:0004139,abnormal gastric parietal cell morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0005211,increased stomach mucosa thickness|MP:0010797,abnormal pyloric gastric gland morphology|MP:0014077,ectopic Paneth cells
MGI:2178230	Foxl1<tm1Khk>	MP:0000470,abnormal stomach morphology|MP:0000473,abnormal stomach glandular epithelium morphology|MP:0000478,delayed intestine development|MP:0000488,abnormal intestinal epithelium morphology|MP:0001732,postnatal growth retardation|MP:0002006,neoplasm|MP:0003449,abnormal intestine goblet cell morphology|MP:0004002,abnormal jejunum morphology|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0008108,abnormal small intestinal villus morphology|MP:0008142,decreased small intestinal villus size|MP:0010792,abnormal stomach mucosa morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:8250561	Foxl2<tm1.1Rthi>	MP:0002016,ovary cyst|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012411,increased granulosa cell tumor incidence
MGI:4940388	Foxl2<tm1(GFP/cre/ERT2)Pzg>	MP:0002169,no abnormal phenotype detected
MGI:3044226	Foxl2<tm1Gpil>	MP:0001126,abnormal ovary morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001262,decreased body weight|MP:0001302,eyelids open at birth|MP:0001926,female infertility|MP:0002092,abnormal eye morphology|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013395,eyelid hypoplasia
MGI:3029503	Foxl2<tm1Tre>	MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001132,absent mature ovarian follicles|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0003357,impaired granulosa cell differentiation|MP:0005389,reproductive system phenotype|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011122,absent primordial ovarian follicles|MP:0031018,decreased granulosa cell proliferation|MP:0031239,increased atretic ovarian follicle number|MP:0031382,absent secondary ovarian follicles
MGI:4430192	Foxl2<tm2.1Tre>	MP:0001126,abnormal ovary morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001131,abnormal ovarian follicle morphology|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001751,increased circulating luteinizing hormone level|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002636,delayed vaginal opening|MP:0002675,asthenozoospermia|MP:0002680,decreased corpora lutea number|MP:0002687,oligozoospermia|MP:0002773,decreased circulating luteinizing hormone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0002995,primary sex reversal|MP:0003355,decreased ovulation rate|MP:0003507,abnormal ovary physiology|MP:0004852,decreased testis weight|MP:0004853,abnormal ovary size|MP:0004856,decreased ovary weight|MP:0004884,abnormal testis physiology|MP:0005130,decreased follicle stimulating hormone level|MP:0005250,decreased Sertoli cell number|MP:0005378,growth/size/body region phenotype|MP:0005382,craniofacial phenotype|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0009017,prolonged estrus|MP:0020869,immotile sperm
MGI:4430196	Foxl2<tm3Tre>	MP:0005389,reproductive system phenotype
MGI:4430207	Foxl2<tm4(cre)Tre>	MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001131,abnormal ovarian follicle morphology|MP:0001132,absent mature ovarian follicles|MP:0001926,female infertility|MP:0002082,postnatal lethality|MP:0005389,reproductive system phenotype
MGI:3522201	Foxm1<tm1.1Rhc>	MP:0000279,ventricular hypoplasia|MP:0000484,abnormal pulmonary artery morphology|MP:0001176,abnormal lung development|MP:0001914,hemorrhage|MP:0002188,small heart|MP:0002192,hydrops fetalis|MP:0002844,aortic hypertrophy|MP:0002975,vascular smooth muscle hypertrophy|MP:0003077,abnormal cell cycle|MP:0003658,abnormal capillary morphology|MP:0004007,abnormal lung vasculature morphology|MP:0004181,abnormal carotid artery morphology|MP:0004564,increased myocardial fiber size|MP:0008022,dilated heart ventricle|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0008989,abnormal liver sinusoid morphology|MP:0009497,abnormal intrahepatic bile duct morphology|MP:0010439,abnormal hepatic vein morphology|MP:0010499,abnormal ventricle myocardium morphology|MP:0010580,decreased heart left ventricle size|MP:0010617,thick mitral valve cusps|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011148,decreased mesenchymal cell proliferation involved in lung development|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0011648,thick heart valve cusps|MP:0012240,abnormal hepatoblast morphology|MP:0012243,decreased hepatoblast number|MP:0012246,abnormal hepatic cord morphology|MP:0031609,increased fetal cardiomyocyte size|MP:0031611,decreased fetal cardiomyocyte number
MGI:3527889	Foxm1<tm1Cle>	MP:0000607,abnormal hepatocyte morphology|MP:0001953,respiratory failure|MP:0002081,perinatal lethality|MP:0002652,thin myocardium|MP:0014719,abnormal polyploid cardiomyocyte morphology|MP:0014725,decreased binucleate cardiomyocyte number|MP:0031131,myocardial fiber disarray
MGI:2448247	Foxm1<tm1Rhc>	MP:0000607,abnormal hepatocyte morphology|MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001861,lung inflammation|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002048,increased lung adenoma incidence|MP:0002078,abnormal glucose homeostasis|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002658,abnormal liver regeneration|MP:0003077,abnormal cell cycle|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003336,pancreas cyst|MP:0003339,decreased pancreatic beta cell number|MP:0003564,abnormal insulin secretion|MP:0004007,abnormal lung vasculature morphology|MP:0004391,abnormal respiratory conducting tube morphology|MP:0004499,increased incidence of tumors by chemical induction|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005215,abnormal pancreatic islet morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005220,abnormal exocrine pancreas morphology|MP:0005293,impaired glucose tolerance|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0008989,abnormal liver sinusoid morphology|MP:0009109,decreased pancreas weight|MP:0009114,decreased pancreatic beta cell mass|MP:0009148,pancreas necrosis|MP:0009172,small pancreatic islets|MP:0009176,increased pancreatic alpha cell number|MP:0009497,abnormal intrahepatic bile duct morphology|MP:0010018,pulmonary vascular congestion|MP:0010266,decreased liver tumor incidence|MP:0010439,abnormal hepatic vein morphology|MP:0010816,decreased type I pneumocyte number|MP:0010825,abnormal lung saccule morphology|MP:0010827,small lung saccule|MP:0010889,small alveolar lamellar bodies|MP:0010993,decreased surfactant secretion|MP:0011018,pulmonary hyaline membrane formation|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0011143,thick lung-associated mesenchyme|MP:0011820,decreased pancreatic beta cell proliferation|MP:0012240,abnormal hepatoblast morphology|MP:0012243,decreased hepatoblast number|MP:0012246,abnormal hepatic cord morphology
MGI:1856108	Foxn1<nu>	MP:0000062,increased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000221,decreased leukocyte cell number|MP:0000367,abnormal coat/ hair morphology|MP:0000377,abnormal hair follicle morphology|MP:0000579,abnormal nail morphology|MP:0000580,deformed nails|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000704,abnormal thymus development|MP:0000705,athymia|MP:0000706,small thymus|MP:0001127,small ovary|MP:0001199,thin skin|MP:0001216,abnormal epidermal layer morphology|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001279,wavy vibrissae|MP:0001282,short vibrissae|MP:0001284,absent vibrissae|MP:0001313,increased incidence of corneal inflammation|MP:0001732,postnatal growth retardation|MP:0001828,abnormal T cell activation|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0002083,premature death|MP:0002085,abnormal embryonic tissue morphology|MP:0002108,abnormal muscle morphology|MP:0002339,abnormal lymph node morphology|MP:0002347,abnormal lymph node T cell domain morphology|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002411,decreased susceptibility to bacterial infection|MP:0002675,asthenozoospermia|MP:0002773,decreased circulating luteinizing hormone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0002942,decreased circulating alanine transaminase level|MP:0003361,abnormal circulating gonadotropin level|MP:0003797,abnormal compact bone morphology|MP:0003809,abnormal hair shaft morphology|MP:0003810,abnormal hair cuticle|MP:0003811,abnormal hair cortex morphology|MP:0003815,hairless|MP:0004125,abnormal venule morphology|MP:0004751,increased length of allograft survival|MP:0004819,decreased skeletal muscle mass|MP:0005016,decreased lymphocyte cell number|MP:0005018,decreased T cell number|MP:0005026,decreased susceptibility to parasitic infection|MP:0005251,blepharitis|MP:0005324,ascites|MP:0005379,endocrine/exocrine gland phenotype|MP:0005542,cornea vascularization|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008567,decreased interferon-gamma secretion|MP:0008597,decreased circulating interleukin-6 level|MP:0008600,decreased circulating interleukin-2 level|MP:0008732,reduced hair shaft melanin granule number|MP:0008737,abnormal spleen physiology|MP:0008826,abnormal splenic cell ratio|MP:0008866,chromosomal instability|MP:0009238,coiled sperm flagellum|MP:0009400,decreased skeletal muscle fiber size|MP:0009801,abnormal hair cortex keratinization|MP:0010210,abnormal circulating cytokine level|MP:0010286,increased plasmacytoma incidence|MP:0010685,abnormal hair follicle inner root sheath morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012307,impaired spatial learning|MP:0012399,short nails|MP:0012400,nail dystrophy|MP:0012403,abnormal nail plate morphology|MP:0012405,abnormal nail matrix morphology|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0030605,abnormal corneocyte morphology|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:5464997	Foxn1<nu-2J>	MP:0000382,underdeveloped hair follicles|MP:0000705,athymia|MP:0001211,wrinkled skin|MP:0001265,decreased body size|MP:0001274,curly vibrissae|MP:0001282,short vibrissae|MP:0001283,sparse vibrissae|MP:0001284,absent vibrissae|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002098,abnormal vibrissa morphology|MP:0003815,hairless|MP:0003848,brittle hair|MP:0010681,abnormal hair follicle bulb morphology|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856110	Foxn1<nu-Bc>	MP:0002073,abnormal hair growth|MP:0003815,hairless
MGI:1929717	Foxn1<nu-StL>	MP:0000705,athymia|MP:0003815,hairless|MP:0008070,absent T cells
MGI:1856109	Foxn1<nu-str>	MP:0000219,increased neutrophil cell number|MP:0000322,increased granulocyte number|MP:0000685,abnormal immune system morphology|MP:0000694,spleen hypoplasia|MP:0000696,abnormal Peyer's patch morphology|MP:0000705,athymia|MP:0000716,abnormal immune system cell morphology|MP:0001790,abnormal immune system physiology|MP:0001800,abnormal humoral immune response|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002460,decreased immunoglobulin level|MP:0002722,abnormal immune system organ morphology|MP:0003815,hairless|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004751,increased length of allograft survival|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005018,decreased T cell number|MP:0005150,cachexia|MP:0008101,lymph node hypoplasia|MP:0010268,decreased lymphoma incidence
MGI:1856502	Foxn1<nu-Y>	MP:0000704,abnormal thymus development|MP:0000705,athymia|MP:0001262,decreased body weight|MP:0003815,hairless|MP:0008070,absent T cells|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5704081	Foxn1<sepe>	MP:0000705,athymia|MP:0003815,hairless
MGI:5297717	Foxn1<tm1.1Cbln>	MP:0000708,thymus hyperplasia|MP:0000717,abnormal lymphocyte cell number|MP:0001823,thymus hypoplasia|MP:0005091,increased double-positive T cell number|MP:0005387,immune system phenotype|MP:0008083,decreased single-positive T cell number|MP:0010129,increased DN1 thymic pro-T cell number
MGI:4454641	Foxn1<tm1.1Dmsu>	MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0002169,no abnormal phenotype detected|MP:0002375,abnormal thymus medulla morphology|MP:0003644,thymus atrophy|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0009543,abnormal thymus corticomedullary boundary morphology
MGI:5696875	Foxn1<tm1.1(KOMP)Vlcg>	MP:0000703,abnormal thymus morphology|MP:0000705,athymia|MP:0002060,abnormal skin morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4454640	Foxn1<tm1Dmsu>	MP:0000705,athymia|MP:0003815,hairless
MGI:2680674	Foxn1<tm1Nrm>	MP:0000704,abnormal thymus development|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0002145,abnormal T cell differentiation|MP:0002169,no abnormal phenotype detected|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0009544,abnormal thymus epithelium morphology|MP:0010250,absent thymus cortex|MP:0010771,integument phenotype|MP:0013587,absent thymus medulla|MP:0014130,thymus cyst
MGI:1926361	Foxn1<tm1Tbo>	MP:0000217,abnormal leukocyte cell number|MP:0000703,abnormal thymus morphology|MP:0000704,abnormal thymus development|MP:0000705,athymia|MP:0003704,abnormal hair follicle development|MP:0003815,hairless|MP:0005014,increased B cell number|MP:0008070,absent T cells|MP:0009544,abnormal thymus epithelium morphology
MGI:3760773	Foxn1<tm2Nrm>	MP:0005387,immune system phenotype
MGI:3653425	Foxn1<tm2Tbo>	MP:0003815,hairless|MP:0005015,increased T cell number
MGI:3760775	Foxn1<tm3(cre)Nrm>	MP:0005387,immune system phenotype
MGI:2674905	Foxn1<tw>	MP:0000382,underdeveloped hair follicles|MP:0002095,abnormal skin pigmentation|MP:0003815,hairless
MGI:7490165	Foxn2<em1(IMPC)Tcp>	MP:0001289,persistence of hyaloid vascular system|MP:0002792,abnormal retina vasculature morphology|MP:0003131,increased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010097,abnormal retina blood vessel morphology
MGI:6257754	Foxn3<em1(IMPC)Bay>	MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:4126144	Foxn3<Gt(XE749)Byg>	MP:0000074,abnormal neurocranium morphology|MP:0000079,abnormal basioccipital bone morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000109,abnormal parietal bone morphology|MP:0000120,malocclusion|MP:0000161,scoliosis|MP:0000433,microcephaly|MP:0000460,mandible hypoplasia|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001732,postnatal growth retardation|MP:0002116,abnormal craniofacial bone morphology|MP:0002152,abnormal brain morphology|MP:0005269,abnormal occipital bone morphology|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009891,abnormal palate bone morphology|MP:0010743,delayed cranial suture closure|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0030082,long lower incisors|MP:0030083,long upper incisors|MP:0030279,thin neurocranium|MP:0030320,abnormal temporal bone tympanic part morphology
MGI:7431369	Foxn4<em1(IMPC)Ccpcz>	MP:0000438,abnormal cranium morphology|MP:0000689,abnormal spleen morphology|MP:0001404,no spontaneous movement|MP:0002060,abnormal skin morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003961,decreased lean body mass|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013129,abnormal tooth color
MGI:3054789	Foxn4<tm1Xia>	MP:0002984,retina hypoplasia|MP:0006069,abnormal retina neuronal layer morphology|MP:0006070,increased retina photoreceptor cell number|MP:0008056,abnormal retina ganglion cell morphology|MP:0008106,decreased amacrine cell number|MP:0008107,absent retina horizontal cells|MP:0011086,postnatal lethality, incomplete penetrance|MP:0030005,increased retina apoptosis
MGI:5305498	Foxo1<tm1.1Dac>	MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000291,enlarged pericardium|MP:0001614,abnormal blood vessel morphology|MP:0001672,abnormal embryo development|MP:0001688,abnormal somite development|MP:0001691,abnormal somite shape|MP:0002189,abnormal myocardial trabeculae morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004086,absent heartbeat|MP:0004787,abnormal dorsal aorta morphology|MP:0006341,small first pharyngeal arch|MP:0006344,small second pharyngeal arch|MP:0006345,absent second pharyngeal arch|MP:0011100,preweaning lethality, complete penetrance|MP:0011732,decreased somite size
MGI:3844655	Foxo1<tm1.1Mrc>	MP:0011092,embryonic lethality, complete penetrance
MGI:3698868	Foxo1<tm1.1Rdp>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4367752	Foxo1<tm1.1Stlp>	MP:0000687,small lymphoid organs|MP:0000692,small spleen|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008081,abnormal single-positive T cell number|MP:0009542,decreased thymocyte apoptosis
MGI:5630066	Foxo1<tm1b(EUCOMM)Wtsi>	MP:0001399,hyperactivity|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0005344,increased circulating bilirubin level|MP:0005655,increased aggression|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3840910	Foxo1<tm1Flv>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000753,paralysis|MP:0001505,hunched posture|MP:0001828,abnormal T cell activation|MP:0001845,abnormal inflammatory response|MP:0002083,premature death|MP:0002111,abnormal tail morphology|MP:0002444,abnormal T cell physiology|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004946,abnormal regulatory T cell physiology|MP:0004973,increased regulatory T cell number|MP:0005015,increased T cell number|MP:0005348,increased T cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0008537,increased susceptibility to induced colitis|MP:0008566,increased interferon-gamma secretion|MP:0009931,abnormal skin appearance
MGI:3487370	Foxo1<tm1Mrc>	MP:0002169,no abnormal phenotype detected
MGI:3698867	Foxo1<tm1Rdp>	MP:0002083,premature death|MP:0002947,increased hemangioma incidence|MP:0005292,improved glucose tolerance
MGI:3052743	Foxo1<tm1Tf>	MP:0000263,absent organized vascular network|MP:0001718,abnormal visceral yolk sac morphology|MP:0003873,pharyngeal arch hypoplasia|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004787,abnormal dorsal aorta morphology|MP:0005312,pericardial effusion|MP:0006341,small first pharyngeal arch|MP:0006345,absent second pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012492,pharyngeal arch artery hypoplasia
MGI:2447732	Foxo1<tm1Whb>	MP:0000292,distended pericardium|MP:0001719,absent vitelline blood vessels|MP:0009328,delayed heart looping|MP:0010398,decreased liver glycogen level|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012253,abnormal intersomitic vessel morphology|MP:0012730,abnormal internal carotid artery morphology
MGI:5305499	Foxo1<tm2.1Dac>	MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0003383,abnormal gluconeogenesis|MP:0003976,decreased circulating VLDL triglyceride level|MP:0004890,decreased energy expenditure|MP:0005179,decreased circulating cholesterol level|MP:0005331,insulin resistance|MP:0005458,increased percent body fat/body weight|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005666,abnormal adipose tissue physiology|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008964,decreased carbon dioxide production|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level|MP:0010379,decreased respiratory quotient
MGI:3038979	Foxo3<Gt(VICTR20)1Kca>	MP:0001129,impaired ovarian folliculogenesis|MP:0002682,decreased mature ovarian follicle number|MP:0008995,early reproductive senescence|MP:0009093,oocyte degeneration
MGI:3510105	Foxo3<Gt(XAO26)Byg>	MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0001130,abnormal ovarian folliculogenesis|MP:0001828,abnormal T cell activation|MP:0001846,increased inflammatory response|MP:0001859,kidney inflammation|MP:0001861,lung inflammation|MP:0001870,salivary gland inflammation|MP:0002444,abnormal T cell physiology|MP:0002722,abnormal immune system organ morphology|MP:0005348,increased T cell proliferation|MP:0008995,early reproductive senescence
MGI:4949204	Foxo3<mommeR1>	MP:0001125,abnormal oocyte morphology|MP:0001131,abnormal ovarian follicle morphology|MP:0001134,absent corpus luteum|MP:0001931,abnormal oogenesis|MP:0002006,neoplasm|MP:0002681,increased corpora lutea number|MP:0002777,absent ovarian follicles|MP:0003507,abnormal ovary physiology|MP:0004832,enlarged ovary|MP:0008871,abnormal ovarian follicle number|MP:0008995,early reproductive senescence|MP:0009361,abnormal primordial ovarian follicle morphology|MP:0009442,increased ovarian teratoma incidence|MP:0009648,abnormal superovulation|MP:0011121,decreased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number|MP:0012736,abnormal polar body morphology|MP:0031383,increased secondary ovarian follicle number
MGI:5471395	Foxo3<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0002590,increased mean corpuscular volume|MP:0002833,increased heart weight|MP:0002875,decreased erythrocyte cell number|MP:0003020,decreased circulating chloride level|MP:0003179,thrombocytopenia|MP:0005293,impaired glucose tolerance|MP:0005561,increased mean corpuscular hemoglobin|MP:0009142,decreased prepulse inhibition|MP:0010392,prolonged QRS complex duration|MP:0011396,abnormal sleep behavior|MP:0012121,sclerocornea
MGI:2668328	Foxo3<tm1.1Rdp>	MP:0001125,abnormal oocyte morphology|MP:0001130,abnormal ovarian folliculogenesis|MP:0001194,dermatitis|MP:0001577,anemia|MP:0001585,hemolytic anemia|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001923,reduced female fertility|MP:0001927,abnormal estrous cycle|MP:0002083,premature death|MP:0002640,reticulocytosis|MP:0003505,increased prolactinoma incidence|MP:0003667,increased hemangiosarcoma incidence|MP:0004832,enlarged ovary|MP:0005293,impaired glucose tolerance|MP:0008000,increased ovary tumor incidence|MP:0008995,early reproductive senescence|MP:0009009,absent estrous cycle|MP:0010308,decreased tumor latency|MP:0031239,increased atretic ovarian follicle number
MGI:3719789	Foxo3<tm1Nmt>	MP:0001926,female infertility|MP:0002590,increased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002875,decreased erythrocyte cell number|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0005068,abnormal NK cell morphology|MP:0005397,hematopoietic system phenotype|MP:0005561,increased mean corpuscular hemoglobin|MP:0006043,decreased apoptosis|MP:0008044,increased NK cell number|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:2668317	Foxo3<tm1Rdp>	MP:0003507,abnormal ovary physiology|MP:0004832,enlarged ovary|MP:0009361,abnormal primordial ovarian follicle morphology
MGI:5708197	Foxo4<tm1.1(KOMP)Vlcg>	MP:0000538,abnormal urinary bladder morphology|MP:0001925,male infertility
MGI:3038982	Foxo4<tm1Kca>	MP:0002169,no abnormal phenotype detected
MGI:5473578	Foxo6<tm1Abru>	MP:0001402,decreased locomotor activity|MP:0001441,increased grooming behavior|MP:0001468,abnormal temporal memory|MP:0004994,abnormal brain wave pattern|MP:0005386,behavior/neurological phenotype|MP:0014367,impaired long-term object recognition memory|MP:0020508,decreased dendritic spine density|MP:0020510,increased dendritic spine length|MP:0021018,decreased dendritic spine number
MGI:5292882	Foxo6<tm1(KOMP)Vlcg>	MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003383,abnormal gluconeogenesis|MP:0003799,impaired macrophage chemotaxis|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008114,abnormal Kupffer cell morphology|MP:0009133,decreased white fat cell size|MP:0009356,decreased liver triglyceride level|MP:0010182,decreased susceptibility to weight gain|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake|MP:0013278,decreased fasting circulating glucose level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:4421653	Foxp1<tm1.1Pwt>	MP:0001828,abnormal T cell activation|MP:0005387,immune system phenotype|MP:0006413,increased T cell apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:5615648	Foxp1<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0003960,increased lean body mass|MP:0011100,preweaning lethality, complete penetrance
MGI:3056542	Foxp1<tm1Eem>	MP:0000267,abnormal heart development|MP:0000284,double outlet right ventricle|MP:0001636,irregular heartbeat|MP:0001914,hemorrhage|MP:0002190,disorganized myocardium|MP:0002192,hydrops fetalis|MP:0002633,persistent truncus arteriosus|MP:0003808,increased atrioventricular cushion size|MP:0005333,decreased heart rate|MP:0010402,ventricular septal defect|MP:0010556,thin ventricle myocardium compact layer|MP:0010588,conotruncal ridge hyperplasia|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3711150	Foxp1<tm1Rao>	MP:0001802,arrested B cell differentiation|MP:0002144,abnormal B cell differentiation|MP:0002459,abnormal B cell physiology|MP:0008211,decreased mature B cell number|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4829787	Foxp1<tm2.1Eem>	MP:0000267,abnormal heart development|MP:0000280,thin ventricular wall|MP:0000284,double outlet right ventricle|MP:0002953,thick ventricular wall|MP:0003808,increased atrioventricular cushion size|MP:0004090,abnormal sarcomere morphology|MP:0005385,cardiovascular system phenotype|MP:0006126,abnormal cardiac outflow tract development|MP:0010402,ventricular septal defect|MP:0010724,thick interventricular septum|MP:0011087,neonatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011394,increased fetal cardiomyocyte proliferation|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0014726,abnormal cardiomyocyte maturation
MGI:3793745	Foxp2<N549K>	MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0002083,premature death|MP:0002862,abnormal righting response|MP:0008489,slow postnatal weight gain
MGI:3793742	Foxp2<R552H>	MP:0000852,small cerebellum|MP:0001475,reduced long-term depression|MP:0001529,abnormal vocalization|MP:0002083,premature death|MP:0002804,abnormal motor learning|MP:0002862,abnormal righting response|MP:0002919,enhanced paired-pulse facilitation|MP:0008489,slow postnatal weight gain|MP:0009719,reduced cerebellar foliation
MGI:3793751	Foxp2<S321X>	MP:0000852,small cerebellum|MP:0002083,premature death|MP:0002862,abnormal righting response|MP:0008489,slow postnatal weight gain|MP:0009719,reduced cerebellar foliation
MGI:3584266	Foxp2<tm1Bux>	MP:0000054,delayed ear emergence|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000890,thin cerebellar molecular layer|MP:0001183,overexpanded pulmonary alveolus|MP:0001290,delayed eyelid opening|MP:0001402,decreased locomotor activity|MP:0001523,impaired righting response|MP:0001732,postnatal growth retardation|MP:0001961,abnormal reflex|MP:0003648,abnormal radial glial cell morphology|MP:0004391,abnormal respiratory conducting tube morphology|MP:0005356,positive geotaxis|MP:0006027,impaired lung alveolus development|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0020351,decreased vocalization
MGI:3778383	Foxp2<tm1Momo>	MP:0000774,decreased brain size|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001523,impaired righting response|MP:0001529,abnormal vocalization|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0005156,bradykinesia|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0020351,decreased vocalization
MGI:3851106	Foxp2<tm1Woen>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0010394,decreased QRS amplitude|MP:0020351,decreased vocalization
MGI:3851122	Foxp2<tm2.1Woen>	MP:0001417,decreased exploration in new environment|MP:0001898,abnormal long-term depression|MP:0004859,abnormal synaptic plasticity|MP:0005385,cardiovascular system phenotype|MP:0005643,decreased dopamine level|MP:0008143,abnormal dendrite morphology|MP:0008415,abnormal neurite morphology|MP:0020351,decreased vocalization
MGI:3851108	Foxp2<tm2.2Woen>	MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0001431,abnormal eating behavior|MP:0001489,decreased startle reflex|MP:0001544,abnormal cardiovascular system physiology|MP:0001906,increased dopamine level|MP:0003461,abnormal response to novel object|MP:0003961,decreased lean body mass|MP:0005448,abnormal energy homeostasis|MP:0005573,increased pulmonary respiratory rate|MP:0006357,abnormal circulating mineral level|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008907,decreased total fat pad weight|MP:0010069,increased serotonin level|MP:0011890,increased circulating ferritin level
MGI:3817855	Foxp3<m1Btlr>	MP:0000414,alopecia|MP:0001192,scaly skin|MP:0001212,skin lesions|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0003853,dry skin|MP:0003936,abnormal reproductive system development|MP:0005159,azoospermia|MP:0010768,mortality/aging
MGI:1857034	Foxp3<sf>	MP:0000018,small ears|MP:0000019,thick ears|MP:0000020,scaly ears|MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000274,enlarged heart|MP:0000465,gastrointestinal hemorrhage|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000602,dilated liver sinusoidal space|MP:0000603,pale liver|MP:0000611,jaundice|MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0001116,small gonad|MP:0001145,abnormal male reproductive system morphology|MP:0001147,small testis|MP:0001192,scaly skin|MP:0001194,dermatitis|MP:0001198,tight skin|MP:0001212,skin lesions|MP:0001216,abnormal epidermal layer morphology|MP:0001222,epidermal hyperplasia|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0001290,delayed eyelid opening|MP:0001505,hunched posture|MP:0001577,anemia|MP:0001655,multifocal hepatic necrosis|MP:0001732,postnatal growth retardation|MP:0001764,abnormal homeostasis|MP:0001846,increased inflammatory response|MP:0001852,conjunctivitis|MP:0001855,abnormal atrial thrombosis|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001870,salivary gland inflammation|MP:0001925,male infertility|MP:0001951,abnormal breathing pattern|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002286,cryptorchism|MP:0002339,abnormal lymph node morphology|MP:0002344,abnormal lymph node B cell domain morphology|MP:0002347,abnormal lymph node T cell domain morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002371,abnormal thymus cortex morphology|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002424,abnormal reticulocyte morphology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002435,abnormal effector T cell morphology|MP:0002446,abnormal macrophage morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002459,abnormal B cell physiology|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002590,increased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002619,abnormal lymphocyte morphology|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002670,absent scrotum|MP:0002771,absent prostate gland anterior lobe|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0003292,melena|MP:0003427,parakeratosis|MP:0003550,short perineum|MP:0003642,absent seminal vesicle|MP:0004947,skin inflammation|MP:0004952,increased spleen weight|MP:0004969,pale kidney|MP:0005036,diarrhea|MP:0005097,polychromatophilia|MP:0005150,cachexia|MP:0005202,lethargy|MP:0005251,blepharitis|MP:0005287,narrow eye opening|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005639,hemosiderosis|MP:0008234,absent spleen marginal zone|MP:0008255,decreased megakaryocyte cell number|MP:0008475,intermingled spleen red and white pulp|MP:0008476,increased spleen red pulp amount|MP:0008478,increased spleen white pulp amount|MP:0009675,orthokeratosis|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010334,pleural effusion|MP:0011083,lethality at weaning, complete penetrance|MP:0011224,abnormal lymph node medullary cord morphology|MP:0012078,abnormal tail ring morphology|MP:0012246,abnormal hepatic cord morphology|MP:0014263,decreased spleen B cell follicle number|MP:0014678,increased erythrophagocytosis
MGI:2654936	Foxp3<tm1.1Ayr>	MP:0000020,scaly ears|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001192,scaly skin|MP:0001194,dermatitis|MP:0001265,decreased body size|MP:0001823,thymus hypoplasia|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002145,abnormal T cell differentiation|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0003865,lymph node inflammation|MP:0004947,skin inflammation|MP:0005092,decreased double-positive T cell number|MP:0005350,increased susceptibility to autoimmune disorder|MP:0008397,abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology
MGI:2654935	Foxp3<tm1Ayr>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001194,dermatitis|MP:0001265,decreased body size|MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0002169,no abnormal phenotype detected|MP:0005092,decreased double-positive T cell number|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005387,immune system phenotype
MGI:4950682	Foxp3<tm1(CD2/CD52)Shori>	MP:0004974,decreased regulatory T cell number|MP:0005617,increased susceptibility to type IV hypersensitivity reaction
MGI:3812203	Foxp3<tm1(cre)Saka>	MP:0001873,stomach inflammation|MP:0003725,increased autoantibody level
MGI:3576270	Foxp3<tm1Flv>	MP:0002169,no abnormal phenotype detected
MGI:3696705	Foxp3<tm1Tch>	MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000491,crypts of Lieberkuhn abscesses|MP:0000691,enlarged spleen|MP:0001194,dermatitis|MP:0001577,anemia|MP:0001829,increased activated T cell number|MP:0001845,abnormal inflammatory response|MP:0002169,no abnormal phenotype detected|MP:0002281,abnormal respiratory mucosa goblet cell morphology|MP:0002405,respiratory system inflammation|MP:0002497,increased IgE level|MP:0003009,abnormal cytokine secretion|MP:0003179,thrombocytopenia|MP:0003945,abnormal lymphocyte physiology|MP:0004975,absent regulatory T cells|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008499,increased IgG1 level|MP:0008553,increased circulating tumor necrosis factor level|MP:0008577,increased circulating interferon-gamma level|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008602,increased circulating interleukin-4 level|MP:0008626,increased circulating interleukin-5 level|MP:0008721,abnormal chemokine level|MP:0011085,postnatal lethality, complete penetrance
MGI:5609975	Foxp3<tm2.1(EGFP/cre)Shori>	MP:0004974,decreased regulatory T cell number
MGI:3574964	Foxp3<tm2Ayr>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype
MGI:3700150	Foxp3<tm2Flv>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001192,scaly skin|MP:0001265,decreased body size|MP:0001790,abnormal immune system physiology|MP:0001925,male infertility|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0003725,increased autoantibody level|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005251,blepharitis|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology
MGI:3699400	Foxp3<tm2Tch>	MP:0005387,immune system phenotype
MGI:3698131	Foxp3<tm3(HBEGF/GFP)Ayr>	MP:0000691,enlarged spleen|MP:0001194,dermatitis|MP:0001263,weight loss|MP:0001852,conjunctivitis|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002376,abnormal dendritic cell physiology|MP:0003865,lymph node inflammation|MP:0005018,decreased T cell number|MP:0005150,cachexia|MP:0005156,bradykinesia|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008126,increased dendritic cell number|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3707723	Foxp3<tm3Tch>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002722,abnormal immune system organ morphology|MP:0002816,colitis|MP:0003009,abnormal cytokine secretion|MP:0003944,abnormal T cell subpopulation ratio|MP:0003945,abnormal lymphocyte physiology|MP:0004946,abnormal regulatory T cell physiology|MP:0005018,decreased T cell number|MP:0005348,increased T cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0006413,increased T cell apoptosis|MP:0010768,mortality/aging|MP:0011085,postnatal lethality, complete penetrance
MGI:4430232	Foxp3<tm5.2Ayr>	MP:0000696,abnormal Peyer's patch morphology|MP:0002145,abnormal T cell differentiation|MP:0002378,abnormal gut-associated lymphoid tissue morphology|MP:0004974,decreased regulatory T cell number|MP:0005015,increased T cell number|MP:0005232,abnormal mesenteric lymph node morphology|MP:0008894,abnormal intraepithelial T cell morphology
MGI:4430233	Foxp3<tm6.2Ayr>	MP:0004974,decreased regulatory T cell number
MGI:4430234	Foxp3<tm7.2Ayr>	MP:0004941,abnormal regulatory T cell morphology|MP:0004974,decreased regulatory T cell number
MGI:4436759	Foxp3<tm8Ayr>	MP:0001844,autoimmune response|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected
MGI:4127879	Foxp4<Gt(RRF116)Byg>	MP:0000914,exencephaly|MP:0000925,abnormal floor plate morphology|MP:0002151,abnormal neural tube morphology|MP:0002825,abnormal notochord morphology|MP:0003054,spina bifida|MP:0005157,holoprosencephaly|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3055161	Foxp4<tm1Eem>	MP:0000266,abnormal heart morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0002151,abnormal neural tube morphology|MP:0003119,abnormal digestive system development|MP:0003321,tracheoesophageal fistula|MP:0004187,cardia bifida|MP:0006065,abnormal heart position or orientation|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5433099	Foxp4<tm2.1Eem>	MP:0010768,mortality/aging
MGI:1857026	Foxq1<sa>	MP:0000411,shiny fur|MP:0001510,abnormal coat appearance|MP:0002073,abnormal hair growth|MP:0003809,abnormal hair shaft morphology|MP:0005070,impaired natural killer cell mediated cytotoxicity
MGI:2176727	Foxq1<sa-e1>	MP:0000411,shiny fur|MP:0000717,abnormal lymphocyte cell number|MP:0001510,abnormal coat appearance|MP:0002073,abnormal hair growth|MP:0002074,abnormal hair texture|MP:0003809,abnormal hair shaft morphology|MP:0003811,abnormal hair cortex morphology|MP:0003812,abnormal hair medulla
MGI:1934612	Foxq1<sa-J>	MP:0000411,shiny fur
MGI:3805482	Foxq1<tm1Wen>	MP:0000411,shiny fur|MP:0000432,abnormal head morphology|MP:0000505,decreased digestive secretion|MP:0000913,abnormal brain development|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:6156427	Foxr1<em1(IMPC)Tcp>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0001127,small ovary|MP:0002059,abnormal seminal vesicle morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011874,enlarged urinary bladder
MGI:6257446	Foxred1<em1(IMPC)Bay>	MP:0004952,increased spleen weight|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5635089	Foxred2<tm1.1(KOMP)Vlcg>	MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping
MGI:3807067	Foxs1<tm1Kmor>	MP:0005389,reproductive system phenotype|MP:0009489,abnormal blood vessel endothelium morphology|MP:0031138,testicular hemorrhage
MGI:3606198	Foxs1<tm1Sven>	MP:0003858,enhanced coordination|MP:0005659,decreased susceptibility to diet-induced obesity
MGI:4435288	Fpgs<tm1a(EUCOMM)Hmgu>	MP:0001262,decreased body weight
MGI:2660579	Fpli<C57BL/6J>	MP:0002079,increased circulating insulin level
MGI:2663726	Fpr1<tm1Gao>	MP:0002412,increased susceptibility to bacterial infection|MP:0002419,abnormal innate immunity|MP:0008720,impaired neutrophil chemotaxis|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:4459724	Fpr2<tm1.1Jimw>	MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0008539,decreased susceptibility to induced colitis
MGI:4459725	Fpr2<tm1.2Jimw>	MP:0000495,abnormal colon morphology|MP:0000512,intestinal ulcer|MP:0001876,decreased inflammatory response|MP:0002044,increased colon adenoma incidence|MP:0002217,small lymph nodes|MP:0002376,abnormal dendritic cell physiology|MP:0002419,abnormal innate immunity|MP:0002460,decreased immunoglobulin level|MP:0002492,decreased IgE level|MP:0002816,colitis|MP:0003009,abnormal cytokine secretion|MP:0003799,impaired macrophage chemotaxis|MP:0004499,increased incidence of tumors by chemical induction|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005087,decreased acute inflammation|MP:0008127,decreased dendritic cell number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008567,decreased interferon-gamma secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0008720,impaired neutrophil chemotaxis|MP:0008883,abnormal enterocyte proliferation|MP:0009278,abnormal bone marrow cell physiology|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010740,abnormal dendritic cell chemotaxis|MP:0010862,decreased respiratory mucosa goblet cell number
MGI:4456271	Fpr2<tm1Rjf>	MP:0002463,abnormal neutrophil physiology|MP:0003724,increased susceptibility to induced arthritis|MP:0003799,impaired macrophage chemotaxis|MP:0005088,increased acute inflammation|MP:0005164,abnormal response to injury
MGI:5800460	Fpr3<del>	MP:0011678,abnormal vomeronasal sensory neuron physiology
MGI:5584405	Fpr3<tm1b(EUCOMM)Hmgu>	MP:0000495,abnormal colon morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001417,decreased exploration in new environment|MP:0002581,abnormal ileum morphology|MP:0002608,increased hematocrit|MP:0002699,abnormal vitreous body morphology|MP:0004924,abnormal behavior|MP:0005178,increased circulating cholesterol level|MP:0005564,increased hemoglobin content|MP:0011678,abnormal vomeronasal sensory neuron physiology
MGI:4358376	fpw	MP:0000351,increased cell proliferation|MP:0000352,decreased cell proliferation|MP:0001533,abnormal skeleton physiology|MP:0001732,postnatal growth retardation|MP:0001935,decreased litter size|MP:0002685,abnormal spermatogonia proliferation|MP:0004001,decreased hepatocyte proliferation|MP:0005668,decreased circulating leptin level|MP:0008489,slow postnatal weight gain|MP:0008553,increased circulating tumor necrosis factor level|MP:0008578,decreased circulating interferon-gamma level|MP:0008593,increased circulating interleukin-10 level|MP:0008597,decreased circulating interleukin-6 level|MP:0008639,decreased circulating interleukin-1 alpha level
MGI:5648214	Fras1<b2b3323Clo>	MP:0000520,absent kidney|MP:0002092,abnormal eye morphology|MP:0002110,abnormal digit morphology|MP:0002639,micrognathia|MP:0010418,perimembraneous ventricular septal defect
MGI:5463442	Fras1<bfb>	MP:0000150,abnormal rib morphology|MP:0000157,abnormal sternum morphology|MP:0000520,absent kidney|MP:0001208,blistering|MP:0001302,eyelids open at birth|MP:0002989,small kidney|MP:0004322,abnormal sternebra morphology|MP:0005287,narrow eye opening|MP:0005382,craniofacial phenotype|MP:0008854,bleb|MP:0009743,preaxial polydactyly|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009890,cleft secondary palate|MP:0021213,complete cleft palate|MP:0031152,subcutaneous hemorrhage|MP:0031460,abnormal palatal shelf morphology
MGI:1856691	Fras1<bl>	MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000528,delayed kidney development|MP:0000564,syndactyly|MP:0000576,clubfoot|MP:0001297,microphthalmia|MP:0002073,abnormal hair growth|MP:0002989,small kidney|MP:0003604,single kidney|MP:0003675,kidney cyst|MP:0004272,abnormal basement membrane morphology|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005242,cryptophthalmos|MP:0006032,abnormal ureteric bud morphology|MP:0008854,bleb|MP:0008856,fetal bleb|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011364,abnormal metanephros morphology|MP:0011386,increased metanephric mesenchyme apoptosis
MGI:7425689	Fras1<em1(IMPC)Ccpcz>	MP:0000137,abnormal vertebrae morphology|MP:0000689,abnormal spleen morphology|MP:0010935,increased airway resistance|MP:0011047,increased lung tissue damping|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020421,increased freezing behavior
MGI:5822820	Fras1<rdf>	MP:0000111,cleft palate|MP:0000520,absent kidney|MP:0000556,abnormal hindlimb morphology|MP:0000564,syndactyly|MP:0000592,short tail|MP:0001195,flaky skin|MP:0001208,blistering|MP:0001265,decreased body size|MP:0001302,eyelids open at birth|MP:0001732,postnatal growth retardation|MP:0002092,abnormal eye morphology|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0003604,single kidney|MP:0009743,preaxial polydactyly|MP:0009874,abnormal interdigital cell death|MP:0011085,postnatal lethality, complete penetrance|MP:0013177,abnormal tail tip morphology
MGI:5449389	Fras1<tm1.2Pjsc>	MP:0000520,absent kidney|MP:0001208,blistering|MP:0001914,hemorrhage
MGI:2667194	Fras1<tm1Chpk>	MP:0000520,absent kidney|MP:0000564,syndactyly|MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001208,blistering|MP:0004007,abnormal lung vasculature morphology|MP:0004272,abnormal basement membrane morphology|MP:0005242,cryptophthalmos|MP:0006382,abnormal lung epithelium morphology|MP:0010977,fused right lung lobes|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:2384128	Frat1<tm1Brn>	MP:0002169,no abnormal phenotype detected
MGI:3530460	Frat2<tm1Brn>	MP:0002169,no abnormal phenotype detected
MGI:3526691	Frem1<bat>	MP:0000102,abnormal nasal bone morphology|MP:0000428,abnormal craniofacial morphology|MP:0000445,short snout|MP:0000493,rectal prolapse|MP:0000564,syndactyly|MP:0001286,abnormal eye development|MP:0001310,abnormal conjunctiva morphology|MP:0001312,abnormal cornea morphology|MP:0001341,absent eyelids|MP:0002135,abnormal kidney morphology|MP:0002835,abnormal cranial suture morphology|MP:0003604,single kidney|MP:0003842,abnormal metopic suture morphology|MP:0004472,broad nasal bone|MP:0005242,cryptophthalmos|MP:0005262,coloboma|MP:0005543,decreased cornea thickness|MP:0008854,bleb|MP:0008862,asymmetric snout|MP:0012085,midface hypoplasia|MP:0014051,abnormal maxillary-premaxillary suture morphology|MP:0020856,absent cornea epithelium|MP:0030095,abnormal midface morphology|MP:0030166,increased inner canthal distance|MP:0030193,short philtrum|MP:0030195,abnormal internasal suture morphology|MP:0030367,premature metopic suture closure|MP:0030368,trigonocephaly
MGI:3526693	Frem1<bfd>	MP:0002092,abnormal eye morphology|MP:0002110,abnormal digit morphology|MP:0002135,abnormal kidney morphology
MGI:2671826	Frem1<crf11>	MP:0000428,abnormal craniofacial morphology|MP:0000493,rectal prolapse|MP:0001297,microphthalmia|MP:0003604,single kidney|MP:0005242,cryptophthalmos|MP:0010977,fused right lung lobes
MGI:3038748	Frem1<eyes2>	MP:0000493,rectal prolapse|MP:0001297,microphthalmia|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002092,abnormal eye morphology|MP:0003604,single kidney|MP:0003924,diaphragmatic hernia|MP:0005084,abnormal gallbladder morphology|MP:0005176,eyelids fail to open|MP:0005189,abnormal anogenital distance|MP:0005242,cryptophthalmos|MP:0010977,fused right lung lobes|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012251,abnormal diaphragm development
MGI:1856897	Frem1<heb>	MP:0000562,polydactyly|MP:0001208,blistering|MP:0001216,abnormal epidermal layer morphology|MP:0001293,anophthalmia|MP:0001302,eyelids open at birth|MP:0002152,abnormal brain morphology|MP:0003153,early eyelid opening|MP:0008854,bleb|MP:0011101,prenatal lethality, incomplete penetrance|MP:0021107,retina fold
MGI:3665235	Frem1<tm1Ksek>	MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000564,syndactyly|MP:0001208,blistering|MP:0002835,abnormal cranial suture morphology|MP:0005242,cryptophthalmos|MP:0030367,premature metopic suture closure
MGI:5427907	Frem1<tm2.1Ksek>	MP:0002169,no abnormal phenotype detected
MGI:5429852	Frem2<b2b1562Clo>	MP:0000520,absent kidney|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0005242,cryptophthalmos
MGI:5618918	Frem2<b2b3270Clo>	MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0003924,diaphragmatic hernia|MP:0004158,right aortic arch
MGI:6389578	Frem2<em2Hali>	MP:0003604,single kidney|MP:0005242,cryptophthalmos|MP:0005371,limbs/digits/tail phenotype
MGI:1856964	Frem2<my>	MP:0000445,short snout|MP:0000520,absent kidney|MP:0000564,syndactyly|MP:0000576,clubfoot|MP:0001286,abnormal eye development|MP:0001672,abnormal embryo development|MP:0001891,hydrocephaly|MP:0002060,abnormal skin morphology|MP:0002109,abnormal limb morphology|MP:0002778,meroanencephaly|MP:0003044,impaired basement membrane formation|MP:0003104,acrania|MP:0003743,abnormal facial morphology|MP:0003935,abnormal craniofacial development|MP:0004272,abnormal basement membrane morphology|MP:0005242,cryptophthalmos|MP:0008854,bleb|MP:0008855,eye bleb|MP:0009743,preaxial polydactyly|MP:0011090,perinatal lethality, incomplete penetrance|MP:0013258,abnormal extracellular matrix morphology|MP:0030066,short face
MGI:3603530	Frem2<my-F11>	MP:0000018,small ears|MP:0000285,abnormal heart valve morphology|MP:0000416,sparse hair|MP:0000432,abnormal head morphology|MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0000929,open neural tube|MP:0001175,abnormal lung morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001914,hemorrhage|MP:0002075,abnormal coat/hair pigmentation|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0002940,variable body spotting|MP:0005579,absent outer ear|MP:0009674,decreased birth weight|MP:0010403,atrial septal defect|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3578641	Frem2<my-Ucl>	MP:0000564,syndactyly|MP:0005242,cryptophthalmos|MP:0008856,fetal bleb|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3794302	Frem2<ne>	MP:0000022,abnormal ear shape|MP:0000372,irregular coat pigmentation|MP:0000564,syndactyly|MP:0001297,microphthalmia|MP:0001340,abnormal eyelid morphology|MP:0001935,decreased litter size|MP:0005242,cryptophthalmos|MP:0005367,renal/urinary system phenotype|MP:0005385,cardiovascular system phenotype|MP:0008730,fused phalanges
MGI:6455416	Frem3<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:7495885	Frey1<em1Osb>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0004543,abnormal sperm physiology|MP:0004884,abnormal testis physiology|MP:0005389,reproductive system phenotype|MP:0031010,failure of sperm-egg fusion
MGI:7495886	Frey1<em2Osb>	MP:0001925,male infertility|MP:0005389,reproductive system phenotype
MGI:5569048	Frey1<tm1.1(KOMP)Vlcg>	MP:0000198,decreased circulating phosphate level|MP:0001925,male infertility|MP:0002060,abnormal skin morphology|MP:0005389,reproductive system phenotype|MP:0005554,decreased circulating creatinine level|MP:0009647,decreased fertilization frequency|MP:0031010,failure of sperm-egg fusion
MGI:3767190	frg	MP:0000097,short maxilla|MP:0000445,short snout|MP:0001265,decreased body size|MP:0001300,ocular hypertelorism|MP:0001935,decreased litter size|MP:0008525,decreased cranium height|MP:0010119,abnormal bone mineral density|MP:0030066,short face
MGI:2183538	Frk<tm1Liu>	MP:0002006,neoplasm|MP:0005479,decreased circulating triiodothyronine level
MGI:1856032	Frl<a>	MP:0000416,sparse hair|MP:0000418,focal hair loss|MP:0001211,wrinkled skin|MP:0001262,decreased body weight|MP:0008861,abnormal hair shedding|MP:0009004,progressive hair loss|MP:0009659,striated fur|MP:0009703,decreased birth body size|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1856033	Frl<b>	MP:0000416,sparse hair|MP:0000418,focal hair loss|MP:0001211,wrinkled skin|MP:0001262,decreased body weight|MP:0001510,abnormal coat appearance|MP:0002073,abnormal hair growth|MP:0008770,decreased survivor rate|MP:0008861,abnormal hair shedding|MP:0009004,progressive hair loss|MP:0009659,striated fur|MP:0009703,decreased birth body size|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1856034	Frl<c>	MP:0000416,sparse hair|MP:0000418,focal hair loss|MP:0001211,wrinkled skin|MP:0001262,decreased body weight|MP:0001510,abnormal coat appearance|MP:0002073,abnormal hair growth|MP:0008861,abnormal hair shedding|MP:0009004,progressive hair loss|MP:0009659,striated fur|MP:0009703,decreased birth body size
MGI:6316341	Frmd3<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0001312,abnormal cornea morphology|MP:0001415,increased exploration in new environment|MP:0002574,increased vertical activity|MP:0004738,abnormal auditory brainstem response
MGI:7664563	Frmd3<em1Zhaj>	MP:0000627,abnormal mammary gland morphology|MP:0000628,abnormal mammary gland development|MP:0000662,abnormal branching of the mammary ductal tree|MP:0009508,increased mammary gland ductal carcinoma incidence|MP:0010299,increased mammary gland tumor incidence|MP:0012075,impaired mammary gland growth during pregnancy|MP:0013778,abnormal mammary gland myoepithelium morphology|MP:0013781,abnormal mammary gland luminal epithelium morphology
MGI:6158930	Frmd4a<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5617791	Frmd4b<tm1b(EUCOMM)Wtsi>	MP:0002574,increased vertical activity|MP:0005102,abnormal iris pigmentation|MP:0011239,abnormal skin coloration|MP:0011962,increased cornea thickness
MGI:7611626	Frmd5<em#Yuw>	MP:0001441,increased grooming behavior|MP:0001926,female infertility|MP:0002272,abnormal nervous system electrophysiology|MP:0002572,abnormal emotion/affect behavior|MP:0002574,increased vertical activity|MP:0003461,abnormal response to novel object|MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype|MP:0008414,abnormal spatial reference memory|MP:0014379,decreased excitatory postsynaptic current frequency|MP:0020511,decreased dendritic spine length|MP:0020512,abnormal dendritic mushroom spine morphology|MP:0020513,abnormal dendritic stubby spine morphology|MP:0020514,abnormal dendritic thin spine morphology|MP:0021090,abnormal dendrite arborization pattern|MP:0021111,decreased social investigation|MP:0021112,impaired social recognition
MGI:4435944	Frmd5<tm1a(EUCOMM)Hmgu>	MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength
MGI:5548809	Frmd5<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001399,hyperactivity|MP:0001926,female infertility
MGI:6149190	Frmd6<em1(IMPC)H>	MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001529,abnormal vocalization|MP:0002833,increased heart weight|MP:0005287,narrow eye opening|MP:0005655,increased aggression|MP:0010392,prolonged QRS complex duration
MGI:6489960	Frmd7<tm1b(KOMP)Wtsi>	MP:0005391,vision/eye phenotype|MP:0014647,decreased horizontal optokinetic reflex
MGI:7549274	Frmd8<em2Smoc>	MP:0004499,increased incidence of tumors by chemical induction|MP:0004952,increased spleen weight|MP:0008537,increased susceptibility to induced colitis|MP:0010180,increased susceptibility to weight loss|MP:0013298,increased susceptibility to colitis induced morbidity/mortality|MP:0013955,increased colon length
MGI:6203645	Frmd8<tm1.1(KOMP)Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:7425691	Frmpd1<em1(IMPC)Bay>	MP:0000063,decreased bone mineral density
MGI:5766262	Frmpd1<em1(IMPC)J>	MP:0000556,abnormal hindlimb morphology|MP:0000572,abnormal autopod morphology|MP:0010053,decreased grip strength
MGI:5461737	Frmpd4<tm1.1Pfw>	MP:0002736,abnormal nociception after inflammation|MP:0002882,abnormal neuron morphology|MP:0003998,decreased thermal nociceptive threshold
MGI:2155698	Frp1<C57BL/6J>	MP:0020470,shortened circadian behavior period
MGI:2156000	Frp2<C57BL/6J>	MP:0020470,shortened circadian behavior period
MGI:2680071	Frp3<BALB/cJ>	MP:0020470,shortened circadian behavior period
MGI:5704087	frqz	MP:0001405,impaired coordination|MP:0002083,premature death
MGI:8158797	Frrs1l<tm1.1(FRRS1L)Jchoi>	MP:0021113,enhanced social recognition
MGI:4941526	Frrs1l<tm1a(EUCOMM)Hmgu>	MP:0005386,behavior/neurological phenotype|MP:0014416,decreased social novelty preference
MGI:5637141	Frrs1l<tm1b(EUCOMM)Hmgu>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001284,absent vibrissae|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001409,increased stereotypic behavior|MP:0001512,trunk curl|MP:0001513,limb grasping|MP:0001524,impaired limb coordination|MP:0001951,abnormal breathing pattern|MP:0002064,seizures|MP:0002152,abnormal brain morphology|MP:0004994,abnormal brain wave pattern|MP:0005376,homeostasis/metabolism phenotype|MP:0009142,decreased prepulse inhibition|MP:0009436,fragmentation of sleep/wake states|MP:0009456,impaired cued conditioning behavior|MP:0010053,decreased grip strength|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014370,impaired spatial working memory|MP:0014639,decreased sleep duration
MGI:4842283	Frrs1<tm1a(EUCOMM)Wtsi>	MP:0001554,increased circulating free fatty acids level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011940,decreased food intake
MGI:3768913	Frs2<tm1.1Fwan>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5548401	Frs2<tm1b(EUCOMM)Wtsi>	MP:0004738,abnormal auditory brainstem response|MP:0011100,preweaning lethality, complete penetrance
MGI:3768912	Frs2<tm1Fwan>	MP:0000281,abnormal interventricular septum morphology
MGI:3521833	Frs2<tm1Schl>	MP:0000266,abnormal heart morphology|MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000854,abnormal cerebellum development|MP:0000856,abnormal cerebellar plate morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002109,abnormal limb morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0005391,vision/eye phenotype|MP:0006254,thin cerebral cortex|MP:0011091,prenatal lethality, complete penetrance
MGI:3521971	Frs2<tm2Schl>	MP:0003631,nervous system phenotype|MP:0004200,decreased fetal size|MP:0005382,craniofacial phenotype|MP:0005391,vision/eye phenotype
MGI:3580390	Frs2<tm3Scl>	MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0005033,abnormal trophoblast giant cell morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0012685,abnormal primitive streak elongation
MGI:6116679	Frs3<tm1Jheb>	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype
MGI:3923669	Fryl<Gt(Ayu21-T312)Imeg>	MP:0000519,hydronephrosis|MP:0000522,kidney cortex cyst|MP:0000527,abnormal kidney development|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001859,kidney inflammation|MP:0002083,premature death|MP:0002703,abnormal renal tubule morphology|MP:0003068,enlarged kidney|MP:0003215,renal interstitial fibrosis|MP:0003675,kidney cyst|MP:0004754,abnormal kidney collecting duct morphology|MP:0004860,dilated kidney collecting duct|MP:0004969,pale kidney|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011307,kidney medulla cyst|MP:0011368,increased kidney apoptosis
MGI:4454126	Fryl<tm1a(KOMP)Wtsi>	MP:0002095,abnormal skin pigmentation
MGI:5692715	Fryl<tm1b(KOMP)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0001711,abnormal placenta morphology|MP:0004259,small placenta|MP:0005561,increased mean corpuscular hemoglobin|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0013247,placenta necrosis|MP:0030975,placenta hemorrhage
MGI:5320664	Frzb<tm1.1Fplu>	MP:0000062,increased bone mineral density|MP:0000208,decreased hematocrit|MP:0000559,abnormal femur morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001533,abnormal skeleton physiology|MP:0002998,abnormal bone remodeling|MP:0003795,abnormal bone structure|MP:0004148,increased compact bone thickness|MP:0004149,increased bone strength|MP:0006282,abnormal spinal cord dorsal horn morphology|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0010123,increased bone mineral content
MGI:3604496	Frzb<tm1Dgen>	MP:0001405,impaired coordination|MP:0001973,increased thermal nociceptive threshold|MP:0014413,decreased depression-related behavior
MGI:3803336	Frzb<tm1Nat>	MP:0002169,no abnormal phenotype detected
MGI:3700160	frzl	MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0005377,hearing/vestibular/ear phenotype
MGI:6376285	Fsbp<em1(IMPC)J>	MP:0003179,thrombocytopenia|MP:0005553,increased circulating creatinine level
MGI:7425692	Fscb<em1(IMPC)Bay>	MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0011965,decreased total retina thickness
MGI:3529245	Fscn1<Gt(OST124903)Lex>	MP:0000373,belly spot|MP:0001265,decreased body size|MP:0001951,abnormal breathing pattern|MP:0002376,abnormal dendritic cell physiology|MP:0003077,abnormal cell cycle|MP:0005362,abnormal Langerhans cell physiology|MP:0005404,abnormal axon morphology|MP:0008415,abnormal neurite morphology|MP:0008535,enlarged lateral ventricles|MP:0008912,nervous|MP:0009546,absent gastric milk in neonates|MP:0009783,abnormal melanoblast morphology|MP:0009784,abnormal melanoblast migration|MP:0010740,abnormal dendritic cell chemotaxis|MP:0010768,mortality/aging|MP:0010860,abnormal anterior commissure pars posterior morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011277,decreased tail pigmentation|MP:0012023,decreased melanocyte number|MP:0020414,abnormal fibroblast physiology|MP:0030930,decreased digit pigmentation
MGI:5605764	Fscn1<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020870,decreased thigmotaxis
MGI:3807774	Fscn2<ahl8>	MP:0004529,decreased outer hair cell stereocilia number|MP:0004534,decreased inner hair cell stereocilia number|MP:0004738,abnormal auditory brainstem response|MP:0004748,increased susceptibility to age-related hearing loss|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6386115	Fscn2<em1Fhan>	MP:0001326,retina degeneration|MP:0002090,abnormal vision|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004524,short cochlear hair cell stereocilia|MP:0006325,impaired hearing|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008580,photoreceptor inner segment degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0011965,decreased total retina thickness|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0014409,decreased distortion product otoacoustic emission amplitude|MP:0020811,abnormal photoreceptor outer segment size
MGI:3612337	Fscn2<tm1Sykk>	MP:0001325,abnormal retina morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:3612338	Fscn2<tm2Sykk>	MP:0001325,abnormal retina morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:7431460	Fscn3<em1(IMPC)J>	MP:0010052,increased grip strength
MGI:7594032	Fscn3<em1Qsh>	MP:0002169,no abnormal phenotype detected|MP:0005389,reproductive system phenotype
MGI:6257803	Fsd1l<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:6158496	Fsd2<em1(IMPC)Mbp>	MP:0000198,decreased circulating phosphate level|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001297,microphthalmia|MP:0001314,cornea opacity|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002626,increased heart rate|MP:0002833,increased heart weight|MP:0002989,small kidney|MP:0003900,shortened QT interval|MP:0004832,enlarged ovary|MP:0009709,hydrometra|MP:0010052,increased grip strength|MP:0010507,shortened RR interval|MP:0010571,shortened ST segment
MGI:1857434	Fshb<tm1Zuk>	MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001751,increased circulating luteinizing hormone level|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0002637,small uterus|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005130,decreased follicle stimulating hormone level|MP:0005185,decreased circulating progesterone level|MP:0005250,decreased Sertoli cell number|MP:0009009,absent estrous cycle|MP:0014617,decreased spermatogonia number|MP:0014634,decreased round spermatid number
MGI:4456197	Fshr<tm1Hht>	MP:0004834,ovary hemorrhage
MGI:4415446	Fshr<tm1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0001486,abnormal startle reflex|MP:0003961,decreased lean body mass|MP:0005102,abnormal iris pigmentation|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0013279,increased fasting circulating glucose level
MGI:2384130	Fshr<tm1Mha>	MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001144,vagina atresia|MP:0001153,small seminiferous tubules|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001926,female infertility|MP:0002782,abnormal testes secretion|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0004894,uterus atrophy|MP:0004905,decreased uterus weight|MP:0005131,increased follicle stimulating hormone level|MP:0009009,absent estrous cycle|MP:0014270,decreased ovary secretion
MGI:2384087	Fshr<tm1Saco>	MP:0000010,abnormal abdominal fat pad morphology|MP:0000160,kyphosis|MP:0000691,enlarged spleen|MP:0000811,hippocampal neuron degeneration|MP:0000812,abnormal dentate gyrus morphology|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001130,abnormal ovarian folliculogenesis|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001140,abnormal vagina epithelium morphology|MP:0001142,abnormal vagina orifice morphology|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001157,small seminal vesicle|MP:0001260,increased body weight|MP:0001261,obese|MP:0001263,weight loss|MP:0001363,increased anxiety-related response|MP:0001505,hunched posture|MP:0001577,anemia|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0001938,delayed sexual maturation|MP:0002016,ovary cyst|MP:0002216,abnormal seminiferous tubule morphology|MP:0002229,neurodegeneration|MP:0002293,long gestation period|MP:0002631,abnormal epididymis morphology|MP:0002637,small uterus|MP:0002660,abnormal caput epididymis morphology|MP:0002661,abnormal corpus epididymis morphology|MP:0002675,asthenozoospermia|MP:0002678,increased follicle recruitment|MP:0002685,abnormal spermatogonia proliferation|MP:0002687,oligozoospermia|MP:0002777,absent ovarian follicles|MP:0002780,decreased circulating testosterone level|MP:0002781,increased circulating testosterone level|MP:0002797,increased thigmotaxis|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003132,increased pre-B cell number|MP:0003195,calcinosis|MP:0003354,astrocytosis|MP:0003507,abnormal ovary physiology|MP:0003529,enlarged clitoris|MP:0003579,increased ovarian carcinoma incidence|MP:0003717,pallor|MP:0003786,premature aging|MP:0003830,abnormal testis development|MP:0004014,abnormal uterine environment|MP:0004543,abnormal sperm physiology|MP:0004805,absent oocytes|MP:0004833,ovary atrophy|MP:0004849,abnormal testis size|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0004894,uterus atrophy|MP:0004895,vagina atrophy|MP:0004898,uterine hemorrhage|MP:0004904,increased uterus weight|MP:0004905,decreased uterus weight|MP:0004906,enlarged uterus|MP:0004910,decreased seminal vesicle weight|MP:0004929,decreased epididymis weight|MP:0004930,small epididymis|MP:0004933,abnormal epididymis epithelium morphology|MP:0005048,abnormal thrombosis|MP:0005131,increased follicle stimulating hormone level|MP:0005133,increased luteinizing hormone level|MP:0005150,cachexia|MP:0005181,decreased circulating estradiol level|MP:0005185,decreased circulating progesterone level|MP:0005250,decreased Sertoli cell number|MP:0005578,teratozoospermia|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006042,increased apoptosis|MP:0006361,abnormal female germ cell morphology|MP:0006362,abnormal male germ cell morphology|MP:0006378,abnormal spermatogonia morphology|MP:0006380,abnormal spermatid morphology|MP:0008000,increased ovary tumor incidence|MP:0008334,increased gonadotroph cell number|MP:0008337,increased thyrotroph cell number|MP:0008868,abnormal granulosa cell morphology|MP:0008869,anovulation|MP:0008871,abnormal ovarian follicle number|MP:0008892,abnormal sperm flagellum morphology|MP:0008908,increased total fat pad weight|MP:0008975,delayed male fertility|MP:0008976,delayed female fertility|MP:0008980,decreased vagina weight|MP:0008994,early vaginal opening|MP:0008995,early reproductive senescence|MP:0009006,prolonged estrous cycle|MP:0009009,absent estrous cycle|MP:0009011,prolonged diestrus|MP:0009016,abnormal estrus|MP:0009081,thin uterus|MP:0009082,uterus cyst|MP:0009090,myometrium hypoplasia|MP:0009093,oocyte degeneration|MP:0009094,abnormal endometrial gland morphology|MP:0009221,uterus adenomyosis|MP:0009222,increased uterus tumor incidence|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009233,enlarged sperm head|MP:0009237,kinked sperm flagellum|MP:0009248,small caput epididymis|MP:0009251,enlarged endometrial glands|MP:0009433,polyovular ovarian follicle|MP:0009838,abnormal sperm axoneme morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011125,decreased primary ovarian follicle number|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0013348,adenohypophysis hyperplasia|MP:0014633,decreased spermatid number|MP:0014634,decreased round spermatid number|MP:0014636,decreased elongated spermatid number|MP:0020010,decreased bone mineral density of femur|MP:0030826,decreased femur weight
MGI:6257799	Fsip1<em1(IMPC)Bay>	MP:0001925,male infertility
MGI:7647189	Fsip1<em1Nali>	MP:0001932,abnormal spermiogenesis|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0014633,decreased spermatid number|MP:0020451,decreased sperm progressive motility
MGI:6724283	Fsip2<em1Nali>	MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009239,short sperm flagellum|MP:0009280,decreased activated sperm motility|MP:0030591,absent sperm fibrous sheath
MGI:3772851	fsq	MP:0001406,abnormal gait|MP:0001523,impaired righting response|MP:0001891,hydrocephaly|MP:0001924,infertility|MP:0002980,abnormal postural reflex|MP:0004143,muscle hypertonia|MP:0005369,muscle phenotype|MP:0010261,sutural cataract
MGI:6333014	Fst<em1(IMPC)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001289,persistence of hyaloid vascular system|MP:0002699,abnormal vitreous body morphology|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:3865165	Fstl1<Gt(P086B03)Wrst>	MP:0002169,no abnormal phenotype detected
MGI:5297548	Fstl1<tm1.1Mvdh>	MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003915,increased heart left ventricle weight|MP:0004485,increased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0005602,decreased angiogenesis|MP:0006113,abnormal heart septum morphology|MP:0010018,pulmonary vascular congestion|MP:0010551,abnormal coronary vessel morphology|MP:0010579,increased heart left ventricle size|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4950852	Fstl1<tm1.1Ning>	MP:0000536,hydroureter|MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001575,cyanosis|MP:0001951,abnormal breathing pattern|MP:0002151,abnormal neural tube morphology|MP:0002249,abnormal larynx morphology|MP:0002267,abnormal bronchiole morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002282,abnormal trachea morphology|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0004202,pulmonary hyperplasia|MP:0004551,decreased tracheal cartilage ring number|MP:0005440,increased glycogen level|MP:0005508,abnormal skeleton morphology|MP:0006382,abnormal lung epithelium morphology|MP:0010810,increased type II pneumocyte number|MP:0010816,decreased type I pneumocyte number|MP:0010819,primary atelectasis|MP:0010883,trachea stenosis|MP:0010890,decreased alveolar lamellar body number|MP:0010902,abnormal pulmonary alveolar sac morphology|MP:0010993,decreased surfactant secretion|MP:0011087,neonatal lethality, complete penetrance
MGI:5440894	Fstl1<tm1.1Nju>	MP:0000519,hydronephrosis|MP:0000534,abnormal ureter morphology|MP:0000536,hydroureter|MP:0002989,small kidney|MP:0003586,dilated ureter|MP:0003588,ureter stenosis|MP:0003672,abnormal ureter development|MP:0004194,abnormal kidney pelvis morphology|MP:0011304,kidney papillary atrophy|MP:0011484,abnormal ureter urothelium morphology
MGI:5293374	Fstl1<tm1.2Mvdh>	MP:0000150,abnormal rib morphology|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002110,abnormal digit morphology|MP:0002267,abnormal bronchiole morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0003856,abnormal hindlimb stylopod morphology|MP:0003857,abnormal hindlimb zeugopod morphology|MP:0004174,abnormal spine curvature|MP:0004372,bowed fibula|MP:0004607,abnormal cervical atlas morphology|MP:0004608,abnormal cervical axis morphology|MP:0004694,absent patella|MP:0006432,abnormal costal cartilage morphology|MP:0008146,asymmetric sternocostal joints|MP:0008730,fused phalanges|MP:0010819,primary atelectasis|MP:0010975,abnormal lung lobe morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011505,camptomelia|MP:0020040,decreased bone ossification|MP:0030859,absent sesamoid bone of gastrocnemius|MP:0031253,lordokyphosis
MGI:6858119	Fstl1<tm1Ajn>	MP:0001942,abnormal lung volume|MP:0001958,emphysema|MP:0002133,abnormal respiratory system physiology|MP:0010895,increased lung compliance|MP:0010950,abnormal lung hysteresivity|MP:0011045,decreased lung elastance|MP:0030002,increased lung apoptosis
MGI:5636888	Fstl1<tm1b(EUCOMM)Hmgu>	MP:0000222,decreased neutrophil cell number|MP:0001556,increased circulating HDL cholesterol level|MP:0005013,increased lymphocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0013278,decreased fasting circulating glucose level
MGI:5440890	Fstl1<tm1Nju>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0002738,hyperresponsive to tactile stimuli|MP:0003998,decreased thermal nociceptive threshold|MP:0005402,abnormal action potential|MP:0008532,decreased chemical nociceptive threshold|MP:0014378,increased excitatory postsynaptic current frequency
MGI:5293378	Fstl1<tm2.1(cre/ERT2)Mvdh>	MP:0000150,abnormal rib morphology|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002267,abnormal bronchiole morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0006432,abnormal costal cartilage morphology|MP:0008146,asymmetric sternocostal joints|MP:0008730,fused phalanges|MP:0010819,primary atelectasis|MP:0010975,abnormal lung lobe morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011505,camptomelia
MGI:5692647	Fstl3<tm1.1(KOMP)Vlcg>	MP:0000598,abnormal liver morphology|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis
MGI:3526450	Fstl3<tm1Alsc>	MP:0000010,abnormal abdominal fat pad morphology|MP:0000013,abnormal adipose tissue distribution|MP:0000231,hypertension|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002833,increased heart weight|MP:0002891,increased insulin sensitivity|MP:0003645,increased pancreatic beta cell number|MP:0003820,increased left ventricle systolic pressure|MP:0005215,abnormal pancreatic islet morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005292,improved glucose tolerance|MP:0005370,liver/biliary system phenotype|MP:0006144,increased systemic arterial systolic blood pressure|MP:0009171,enlarged pancreatic islets|MP:0010398,decreased liver glycogen level|MP:0014782,increased liver enzyme/coenzyme level|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis
MGI:3775825	Fstl4<tm1Mno>	MP:0002169,no abnormal phenotype detected
MGI:4889199	Fst<tm1Alsc>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0008995,early reproductive senescence|MP:0009361,abnormal primordial ovarian follicle morphology|MP:0011124,increased primary ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0031239,increased atretic ovarian follicle number|MP:0031383,increased secondary ovarian follicle number
MGI:1857467	Fst<tm1Zuk>	MP:0001196,shiny skin|MP:0001198,tight skin|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002098,abnormal vibrissa morphology|MP:0002106,abnormal muscle physiology|MP:0002823,abnormal rib development|MP:0003082,abnormal gastrocnemius morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003345,decreased rib number|MP:0003346,abnormal pectoral muscle morphology|MP:0003717,pallor|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0004246,abnormal extensor digitorum longus morphology|MP:0004647,decreased lumbar vertebrae number|MP:0004791,absent lower incisors|MP:0004819,decreased skeletal muscle mass|MP:0004981,decreased neuronal precursor cell number|MP:0005359,growth retardation of incisors|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0008148,abnormal sternocostal joint morphology|MP:0008507,thin retina ganglion layer|MP:0008789,abnormal olfactory epithelium morphology|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009422,decreased gastrocnemius weight|MP:0009431,decreased fetal weight|MP:0009890,cleft secondary palate|MP:0009894,absent hard palate|MP:0009937,abnormal neuron differentiation|MP:0010227,decreased quadriceps weight|MP:0010239,decreased skeletal muscle weight|MP:0011087,neonatal lethality, complete penetrance
MGI:5708274	Fth1<tm1.1(KOMP)Vlcg>	MP:0002092,abnormal eye morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4847958	Fth1<tm1.1Lck>	MP:0001860,liver inflammation|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003888,liver hemorrhage|MP:0005343,increased circulating aspartate transaminase level|MP:0005370,liver/biliary system phenotype|MP:0005637,abnormal iron homeostasis|MP:0008738,abnormal liver iron level|MP:0008808,decreased spleen iron level|MP:0008810,increased circulating iron level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0031115,macrovesicular hepatic steatosis
MGI:6115889	Fth1<tm1.1Ruvi>	MP:0011091,prenatal lethality, complete penetrance
MGI:4847967	Fth1<tm1.2Lck>	MP:0011091,prenatal lethality, complete penetrance
MGI:2386942	Fth1<tm1Cbea>	MP:0005637,abnormal iron homeostasis|MP:0011092,embryonic lethality, complete penetrance|MP:0011890,increased circulating ferritin level
MGI:3526872	Fth1<tm1Kjt>	MP:0003674,oxidative stress|MP:0004811,abnormal neuron physiology|MP:0011091,prenatal lethality, complete penetrance
MGI:4847957	Fth1<tm1Lck>	MP:0005621,abnormal cell physiology|MP:0006036,abnormal mitochondrial physiology|MP:0008943,increased sensitivity to induced cell death
MGI:6156131	Ftl1<em1(IMPC)Rbrc>	MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0002100,abnormal tooth morphology|MP:0002764,short tibia|MP:0004152,abnormal circulating iron level|MP:0004924,abnormal behavior|MP:0005505,thrombocytosis|MP:0010067,increased red blood cell distribution width
MGI:6115891	Ftl1<tm1.1Ruvi>	MP:0001396,unidirectional circling|MP:0003631,nervous system phenotype|MP:0005191,head tilt|MP:0008248,abnormal mononuclear phagocyte morphology|MP:0008743,decreased liver iron level|MP:0008810,increased circulating iron level|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:6156132	Ftl2-ps<em1(IMPC)Rbrc>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart
MGI:3699426	Ftms1<SJL/J>	MP:0010024,increased total body fat amount
MGI:4829589	Ftmt<tm1Mdf>	MP:0002169,no abnormal phenotype detected
MGI:3853459	Fto<Gt(RRZ624)Byg>	MP:0005378,growth/size/body region phenotype
MGI:4356560	Fto<I367F>	MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0002712,increased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0003960,increased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0005266,abnormal metabolism|MP:0005289,increased oxygen consumption|MP:0005459,decreased percent body fat/body weight|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0008963,increased carbon dioxide production|MP:0008964,decreased carbon dioxide production|MP:0010025,decreased total body fat amount|MP:0010378,increased respiratory quotient|MP:0011478,abnormal urine catecholamine level
MGI:4868738	Fto<tm1.1Pzg>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0001431,abnormal eating behavior|MP:0001732,postnatal growth retardation|MP:0003961,decreased lean body mass|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005288,abnormal oxygen consumption|MP:0008962,abnormal carbon dioxide production
MGI:5494489	Fto<tm1.1Rdc>	MP:0001262,decreased body weight|MP:0002083,premature death|MP:0003961,decreased lean body mass|MP:0005376,homeostasis/metabolism phenotype|MP:0008964,decreased carbon dioxide production|MP:0010024,increased total body fat amount|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake
MGI:4868744	Fto<tm1.2Pzg>	MP:0000063,decreased bone mineral density|MP:0001194,dermatitis|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001431,abnormal eating behavior|MP:0001732,postnatal growth retardation|MP:0003961,decreased lean body mass|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005150,cachexia|MP:0005288,abnormal oxygen consumption|MP:0005658,increased susceptibility to diet-induced obesity|MP:0008962,abnormal carbon dioxide production|MP:0010024,increased total body fat amount|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5494490	Fto<tm1.2Rdc>	MP:0001262,decreased body weight|MP:0003961,decreased lean body mass|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0010379,decreased respiratory quotient|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011939,increased food intake
MGI:4868745	Fto<tm1.3Pzg>	MP:0000063,decreased bone mineral density|MP:0001194,dermatitis|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001431,abnormal eating behavior|MP:0001732,postnatal growth retardation|MP:0003961,decreased lean body mass|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005150,cachexia|MP:0005288,abnormal oxygen consumption|MP:0005658,increased susceptibility to diet-induced obesity|MP:0008962,abnormal carbon dioxide production|MP:0010024,increased total body fat amount|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4432397	Fto<tm1a(EUCOMM)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0002942,decreased circulating alanine transaminase level|MP:0004151,decreased circulating iron level|MP:0005571,decreased lactate dehydrogenase level|MP:0005632,decreased circulating aspartate transaminase level
MGI:3841156	Fto<tm1Urt>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001433,polyphagia|MP:0001732,postnatal growth retardation|MP:0003961,decreased lean body mass|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005418,abnormal circulating hormone level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005662,increased circulating adrenaline level|MP:0005668,decreased circulating leptin level|MP:0008963,increased carbon dioxide production|MP:0008965,increased basal metabolism|MP:0009133,decreased white fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0010025,decreased total body fat amount|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1860759	Fts	MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000572,abnormal autopod morphology|MP:0000708,thymus hyperplasia|MP:0000714,increased thymocyte number|MP:0000934,abnormal telencephalon development|MP:0000937,abnormal motor neuron morphology|MP:0001126,abnormal ovary morphology|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0001701,incomplete embryo turning|MP:0001706,abnormal left-right axis patterning|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002084,abnormal developmental patterning|MP:0002110,abnormal digit morphology|MP:0002209,decreased germ cell number|MP:0002444,abnormal T cell physiology|MP:0002825,abnormal notochord morphology|MP:0003855,abnormal forelimb zeugopod morphology|MP:0003857,abnormal hindlimb zeugopod morphology|MP:0004252,abnormal direction of heart looping|MP:0005650,abnormal limb bud morphology|MP:0006279,abnormal limb development|MP:0006280,abnormal digit development|MP:0008037,abnormal T cell morphology|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0009875,absent interdigital cell death|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012087,absent midbrain|MP:0013176,abnormal tail position or orientation|MP:0014281,hindlimb oligodactyly|MP:0030934,decreased primordial germ cell proliferation
MGI:4126824	Ftsj1<Gt(RRD143)Byg>	MP:0002169,no abnormal phenotype detected
MGI:5548495	Ftsj1<tm1b(EUCOMM)Wtsi>	MP:0000198,decreased circulating phosphate level|MP:0001399,hyperactivity|MP:0002792,abnormal retina vasculature morphology|MP:0002942,decreased circulating alanine transaminase level|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005632,decreased circulating aspartate transaminase level|MP:0011965,decreased total retina thickness
MGI:7341380	Ftsj1<tm1Tomik>	MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001473,reduced long-term potentiation|MP:0001475,reduced long-term depression|MP:0001900,impaired synaptic plasticity|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0009936,abnormal dendritic spine morphology|MP:0012307,impaired spatial learning|MP:0020508,decreased dendritic spine density|MP:0020512,abnormal dendritic mushroom spine morphology|MP:0020514,abnormal dendritic thin spine morphology|MP:0020551,abnormal postsynaptic density morphology
MGI:6160397	Ftx<tm1.1Oka>	MP:0001297,microphthalmia|MP:0001322,abnormal iris morphology|MP:0002169,no abnormal phenotype detected|MP:0003078,aphakia|MP:0005193,abnormal anterior eye segment morphology|MP:0005391,vision/eye phenotype|MP:0010382,abnormal dosage compensation, by inactivation of X chromosome
MGI:2385340	Fubi1<DDY/Stm>	MP:0000527,abnormal kidney development
MGI:6152489	Fubp1<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001404,no spontaneous movement|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology|MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0020870,decreased thigmotaxis
MGI:5789037	Fubp1<tm1.1Dlev>	MP:0000333,decreased bone marrow cell number|MP:0000601,small liver|MP:0000603,pale liver|MP:0000694,spleen hypoplasia|MP:0000790,abnormal stratification in cerebral cortex|MP:0001178,pulmonary hypoplasia|MP:0001577,anemia|MP:0001625,cardiac hypertrophy|MP:0001711,abnormal placenta morphology|MP:0001823,thymus hypoplasia|MP:0001914,hemorrhage|MP:0002123,abnormal definitive hematopoiesis|MP:0002128,abnormal blood circulation|MP:0002152,abnormal brain morphology|MP:0002223,lymphoid hypoplasia|MP:0003641,small lung|MP:0003717,pallor|MP:0004200,decreased fetal size|MP:0005017,decreased B cell number|MP:0006098,absent cerebellar lobules|MP:0008255,decreased megakaryocyte cell number|MP:0008540,abnormal cerebral hemisphere morphology|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0010865,prenatal growth retardation|MP:0010866,abnormal prenatal body size|MP:0010902,abnormal pulmonary alveolar sac morphology|MP:0011038,impaired branching involved in alveolar sac morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011523,thin placenta labyrinth|MP:0011525,abnormal placenta intervillous maternal lacunae morphology|MP:0014399,decreased hematopoietic precursor cell number
MGI:5803874	Fuca1<em1(IMPC)J>	MP:0001417,decreased exploration in new environment|MP:0004738,abnormal auditory brainstem response
MGI:6118143	Fuca1<tm1Tlub>	MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0003354,astrocytosis|MP:0005058,abnormal lysosome morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008025,brain vacuoles|MP:0008842,lipofuscinosis|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0009643,abnormal urine homeostasis|MP:0010047,axonal spheroids|MP:0010053,decreased grip strength|MP:0010162,increased brain cholesterol level|MP:0011874,enlarged urinary bladder
MGI:5007150	Fuca2<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:4888746	fuddle	MP:0000111,cleft palate|MP:0000787,abnormal telencephalon morphology|MP:0003651,abnormal axon extension|MP:0008283,small hippocampus|MP:0008535,enlarged lateral ventricles|MP:0010714,iris coloboma|MP:0011085,postnatal lethality, complete penetrance
MGI:4363327	Fundc1<tm1a(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5790641	Fundc1<tm1c(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0002834,decreased heart weight
MGI:6509183	Fundc2<tm1Qim>	MP:0003179,thrombocytopenia|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0006042,increased apoptosis|MP:0031120,decreased susceptibility to induced thrombosis
MGI:7512905	Fuom<em1(IMPC)Hmgu>	MP:0005561,increased mean corpuscular hemoglobin
MGI:5427618	Fuom<tm1Ckp>	MP:0001262,decreased body weight|MP:0001376,abnormal mating receptivity|MP:0002566,abnormal sexual interaction|MP:0004174,abnormal spine curvature|MP:0004924,abnormal behavior
MGI:3700009	Furin<tm1.1Jwmc>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1857604	Furin<tm1Ajmr>	MP:0000267,abnormal heart development|MP:0000270,abnormal heart tube morphology|MP:0000914,exencephaly|MP:0001691,abnormal somite shape|MP:0001698,decreased embryo size|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0001719,absent vitelline blood vessels|MP:0001726,abnormal allantois morphology|MP:0002084,abnormal developmental patterning|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003384,abnormal ventral body wall morphology|MP:0003400,kinked neural tube|MP:0004180,failure of initiation of embryo turning|MP:0004187,cardia bifida|MP:0004251,failure of heart looping|MP:0004783,abnormal cardinal vein morphology|MP:0005657,abnormal neural plate morphology|MP:0009657,failure of chorioallantoic fusion|MP:0009706,absent midgut|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011204,abnormal visceral yolk sac blood island morphology|MP:0011205,excessive folding of visceral yolk sac|MP:0011732,decreased somite size|MP:0012173,short rostral-caudal axis
MGI:5548958	Furin<tm1b(EUCOMM)Wtsi>	MP:0002098,abnormal vibrissa morphology|MP:0002544,brachydactyly|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3700008	Furin<tm1Jwmc>	MP:0001125,abnormal oocyte morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001926,female infertility|MP:0002169,no abnormal phenotype detected|MP:0002682,decreased mature ovarian follicle number|MP:0004946,abnormal regulatory T cell physiology|MP:0008869,anovulation|MP:0009761,abnormal meiotic spindle morphology|MP:0011129,decreased tertiary ovarian follicle number|MP:0012737,abnormal primary polar body morphology|MP:0013508,increased granulosa cell apoptosis|MP:0031018,decreased granulosa cell proliferation|MP:0031239,increased atretic ovarian follicle number|MP:0031380,abnormal secondary ovarian follicle number|MP:0031383,increased secondary ovarian follicle number|MP:0031420,decreased superovulation rate|MP:0031422,failure of superovulation
MGI:2177561	Fus<Gt(U3NeoSV1)HO14Ggh>	MP:0000706,small thymus|MP:0001436,abnormal suckling behavior|MP:0002223,lymphoid hypoplasia|MP:0002490,abnormal immunoglobulin level|MP:0003702,abnormal chromosome morphology|MP:0004024,aneuploidy|MP:0004028,chromosome breakage|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:6100933	Fus<tm1.1Emcf>	MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001406,abnormal gait|MP:0001524,impaired limb coordination|MP:0002083,premature death
MGI:5548484	Fus<tm1.1(KOMP)Vlcg>	MP:0001697,abnormal embryo size|MP:0009141,increased prepulse inhibition|MP:0010378,increased respiratory quotient|MP:0011100,preweaning lethality, complete penetrance
MGI:5776262	Fus<tm1c(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:2177655	Fus<tm1(DDIT3)Dron>	MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001658,increased mortality induced by gamma-irradiation|MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0005169,abnormal male meiosis|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5776263	Fus<tm1d(EUCOMM)Wtsi>	MP:0011087,neonatal lethality, complete penetrance
MGI:6120691	Fut1<tm1b(KOMP)Wtsi>	MP:0002059,abnormal seminal vesicle morphology|MP:0002691,small stomach
MGI:2183219	Fut1<tm1Sdo>	MP:0002693,abnormal pancreas physiology|MP:0003698,abnormal male reproductive system physiology
MGI:2183220	Fut2<tm1Sdo>	MP:0001663,abnormal digestive system physiology|MP:0003699,abnormal female reproductive system physiology|MP:0004014,abnormal uterine environment|MP:0005399,increased susceptibility to fungal infection
MGI:6336074	Fut4<em1(IMPC)Ics>	MP:0002135,abnormal kidney morphology|MP:0003961,decreased lean body mass|MP:0005554,decreased circulating creatinine level|MP:0010024,increased total body fat amount|MP:0010123,increased bone mineral content|MP:0020420,abnormal freezing behavior
MGI:2387994	Fut4<tm1Jbl>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0005011,increased eosinophil cell number|MP:0020332,impaired leukocyte tethering or rolling
MGI:1888982	Fut7<tm1Brs>	MP:0000511,abnormal intestinal mucosa morphology|MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype|MP:0010792,abnormal stomach mucosa morphology
MGI:2387664	Fut7<tm1Jbl>	MP:0001273,decreased metastatic potential|MP:0001790,abnormal immune system physiology|MP:0002345,abnormal lymph node primary follicle morphology|MP:0002442,abnormal leukocyte physiology|MP:0002462,abnormal granulocyte physiology|MP:0003156,abnormal leukocyte migration|MP:0003627,abnormal leukocyte tethering or rolling|MP:0003628,abnormal leukocyte adhesion|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008255,decreased megakaryocyte cell number|MP:0008719,impaired neutrophil recruitment
MGI:6153343	Fut8<em1(IMPC)Wtsi>	MP:0000150,abnormal rib morphology|MP:0000602,dilated liver sinusoidal space|MP:0003827,abnormal Wolffian duct morphology|MP:0004613,fusion of vertebral arches|MP:0006054,spinal hemorrhage|MP:0006093,arteriovenous malformation|MP:0010668,abnormal hepatic portal vein morphology|MP:0013834,thin hypoglossal nerve|MP:0013836,abnormal hypoglossal nerve topology|MP:0013877,abnormal ductus venosus valve morphology|MP:0013971,blood in lymph vessels|MP:0014018,embryo tumor|MP:0014023,abnormal intestine placement
MGI:3608699	Fut8<tm1Nta>	MP:0001183,overexpanded pulmonary alveolus|MP:0001732,postnatal growth retardation|MP:0001943,abnormal respiration|MP:0001958,emphysema|MP:0002338,abnormal pulmonary ventilation|MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0008770,decreased survivor rate|MP:0010856,dilated respiratory conducting tube|MP:0010895,increased lung compliance|MP:0010903,abnormal pulmonary alveolus wall morphology|MP:0010908,dilated pulmonary alveolar duct|MP:0010937,increased total lung capacity|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3044951	Fut9<tm1Nari>	MP:0010768,mortality/aging|MP:0012203,abnormal neuronal stem cell morphology|MP:0012206,increased neuronal stem cell self-renewal
MGI:5311392	Fuz<b2b1273Clo>	MP:0000562,polydactyly|MP:0000598,abnormal liver morphology|MP:0001178,pulmonary hypoplasia|MP:0001293,anophthalmia|MP:0003321,tracheoesophageal fistula|MP:0003924,diaphragmatic hernia|MP:0004158,right aortic arch|MP:0006130,pulmonary valve atresia|MP:0010412,atrioventricular septal defect|MP:0011674,multiple major aortopulmonary collateral arteries|MP:0011683,dual inferior vena cava
MGI:6276997	Fuz<em1(IMPC)Mbp>	MP:0000111,cleft palate|MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0001293,anophthalmia|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0002151,abnormal neural tube morphology|MP:0003231,abnormal placenta vasculature|MP:0003425,abnormal optic vesicle formation|MP:0003720,abnormal neural tube closure|MP:0003743,abnormal facial morphology|MP:0008797,facial cleft|MP:0011100,preweaning lethality, complete penetrance
MGI:4346364	Fuz<Gt(AN0439)Wtsi>	MP:0000562,polydactyly|MP:0000897,abnormal midbrain morphology|MP:0000927,small floor plate|MP:0000937,abnormal motor neuron morphology|MP:0000955,abnormal spinal cord morphology|MP:0001297,microphthalmia|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0001785,edema|MP:0001787,pericardial edema|MP:0002084,abnormal developmental patterning|MP:0003720,abnormal neural tube closure|MP:0008480,absent eye pigmentation|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0013203,abnormal primary cilium morphology|MP:0021105,abnormal ventral interneuron 3 morphology
MGI:3531090	Fuz<Gt(OSTGST001398)Lex>	MP:0000031,abnormal cochlea morphology|MP:0000060,delayed bone ossification|MP:0000081,premature cranial suture closure|MP:0000116,abnormal tooth development|MP:0000125,absent incisors|MP:0000150,abnormal rib morphology|MP:0000157,abnormal sternum morphology|MP:0000428,abnormal craniofacial morphology|MP:0000455,abnormal maxilla morphology|MP:0000457,maxilla hypoplasia|MP:0000458,abnormal mandible morphology|MP:0000460,mandible hypoplasia|MP:0000562,polydactyly|MP:0000762,abnormal tongue morphology|MP:0000830,abnormal diencephalon morphology|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0001178,pulmonary hypoplasia|MP:0001293,anophthalmia|MP:0002092,abnormal eye morphology|MP:0002132,abnormal respiratory system morphology|MP:0002633,persistent truncus arteriosus|MP:0003420,delayed intramembranous bone ossification|MP:0003723,abnormal long bone morphology|MP:0003761,arched palate|MP:0003817,abnormal pituitary diverticulum morphology|MP:0004077,abnormal striatum morphology|MP:0004620,cervical vertebral fusion|MP:0005249,abnormal palatine bone morphology|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0008934,absent choroid plexus|MP:0009653,abnormal palate development|MP:0009845,abnormal neural crest cell morphology|MP:0009890,cleft secondary palate|MP:0010454,abnormal truncus arteriosus septation|MP:0011087,neonatal lethality, complete penetrance|MP:0011260,abnormal head mesenchyme morphology|MP:0012260,encephalomeningocele|MP:0012676,dilated brain ventricle|MP:0012757,abnormal cranial neural crest cell migration|MP:0013264,tongue ankylosis|MP:0013550,abnormal secondary palate morphology|MP:0013818,abnormal oral cavity morphology|MP:0021166,delayed palatal shelf elevation|MP:0030345,enlarged maxillary prominence|MP:0030373,Meckel's cartilage hyperplasia
MGI:3505588	Fv4<r>	MP:0020935,decreased susceptibility to Retroviridae infection
MGI:1857315	Fw	MP:0000371,diluted coat color
MGI:3771339	Fwth1<C57BL/6J>	MP:0030069,broad face
MGI:3771342	Fwth2<DBA/2J>	MP:0030069,broad face
MGI:5571595	Fxn<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7616951	Fxn<em8Lutzy>	MP:0003077,abnormal cell cycle|MP:0006036,abnormal mitochondrial physiology|MP:0008008,early cellular replicative senescence|MP:0009429,decreased embryo weight|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011628,increased mitochondrial number|MP:0011631,decreased mitochondrial size|MP:0011638,abnormal mitochondrial chromosome morphology|MP:0011704,decreased fibroblast proliferation
MGI:2177162	Fxn<tm1Mkn>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002086,abnormal extraembryonic tissue morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0013241,embryo tissue necrosis|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3046849	Fxr1<tm1.2Dln>	MP:0000278,abnormal myocardial fiber morphology|MP:0000733,abnormal muscle development|MP:0011087,neonatal lethality, complete penetrance|MP:0014273,abnormal skin vasculature morphology
MGI:3046846	Fxr1<tm1Dln>	MP:0000692,small spleen|MP:0000733,abnormal muscle development|MP:0001147,small testis|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002188,small heart|MP:0002190,disorganized myocardium|MP:0003641,small lung|MP:0010053,decreased grip strength
MGI:5559216	Fxr1<tm1Drad>	MP:0011087,neonatal lethality, complete penetrance
MGI:2388128	Fxr2<tm1Cgr>	MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001973,increased thermal nociceptive threshold|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003460,decreased fear-related response|MP:0005389,reproductive system phenotype|MP:0009142,decreased prepulse inhibition|MP:0031391,increased locomotor activity
MGI:5577265	Fxr2<tm2b(EUCOMM)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3576231	Fxyd1<tm1Atck>	MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0005599,increased cardiac muscle contractility
MGI:3586329	Fxyd2<tm1Kdr>	MP:0002169,no abnormal phenotype detected
MGI:2387972	Fxyd4<tm1Grt>	MP:0001265,decreased body size|MP:0001762,polyuria|MP:0001765,abnormal ion homeostasis|MP:0002847,abnormal renal glomerular filtration rate|MP:0005376,homeostasis/metabolism phenotype|MP:0005627,increased circulating potassium level|MP:0011939,increased food intake|MP:0011941,increased fluid intake
MGI:7310029	Fxyd5<em1Namje>	MP:0002006,neoplasm|MP:0004502,decreased incidence of tumors by chemical induction
MGI:4244813	Fxyd6<Gt(OST236306)Lex>	MP:0009456,impaired cued conditioning behavior
MGI:5708194	Fxyd7<tm1b(KOMP)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5548460	Fyb1<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0003179,thrombocytopenia|MP:0004738,abnormal auditory brainstem response|MP:0010378,increased respiratory quotient
MGI:3663737	Fyb1<tm1Gak>	MP:0000715,decreased thymocyte number|MP:0002444,abnormal T cell physiology|MP:0003179,thrombocytopenia|MP:0003628,abnormal leukocyte adhesion|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008688,decreased interleukin-2 secretion
MGI:6117089	Fyco1<em1(IMPC)J>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0020870,decreased thigmotaxis
MGI:7451138	Fyco1<tm1.1Arte>	MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology|MP:0003237,abnormal lens epithelium morphology|MP:0004777,abnormal phospholipid level|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0011743,abnormal Golgi apparatus morphology|MP:0013732,mature cataract|MP:0030940,impaired autophagy
MGI:6718512	Fyco1<tm1.1Tbph>	MP:0005389,reproductive system phenotype
MGI:7451139	Fyco1<tm1.2Arte>	MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology|MP:0003237,abnormal lens epithelium morphology|MP:0004777,abnormal phospholipid level|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0011743,abnormal Golgi apparatus morphology|MP:0013732,mature cataract|MP:0030940,impaired autophagy
MGI:4842482	Fyn<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:3639430	Fyn<tm1Fam>	MP:0000920,abnormal myelination
MGI:2179145	Fyn<tm1Rmp>	MP:0001828,abnormal T cell activation|MP:0002465,abnormal eosinophil physiology|MP:0002492,decreased IgE level|MP:0003850,abnormal thymocyte activation|MP:0005018,decreased T cell number|MP:0005095,decreased T cell proliferation|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008347,decreased gamma-delta T cell number|MP:0008688,decreased interleukin-2 secretion|MP:0008698,abnormal interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion
MGI:1857172	Fyn<tm1Sor>	MP:0000781,decreased corpus callosum size|MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000920,abnormal myelination|MP:0001156,abnormal spermatogenesis|MP:0001330,abnormal optic nerve morphology|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001819,abnormal immune cell physiology|MP:0001932,abnormal spermiogenesis|MP:0002444,abnormal T cell physiology|MP:0002451,abnormal macrophage physiology|MP:0002492,decreased IgE level|MP:0002494,increased IgM level|MP:0002674,abnormal sperm motility|MP:0002687,oligozoospermia|MP:0003850,abnormal thymocyte activation|MP:0004542,impaired acrosome reaction|MP:0004929,decreased epididymis weight|MP:0005002,abnormal T cell clonal deletion|MP:0005094,abnormal T cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005389,reproductive system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005578,teratozoospermia|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008500,increased IgG2a level|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008721,abnormal chemokine level|MP:0009230,abnormal sperm head morphology|MP:0009647,decreased fertilization frequency|MP:0009830,abnormal sperm connecting piece morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0009970,increased hippocampus pyramidal cell number|MP:0010011,ectopic hippocampus pyramidal cells|MP:0010766,abnormal NK cell physiology|MP:0013286,abnormal sperm capacitation|MP:0030976,impaired sperm penetration of zona pellucida
MGI:1930480	Fyn<tm1Yik>	MP:0000790,abnormal stratification in cerebral cortex|MP:0000813,abnormal hippocampus layer morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000837,abnormal hypothalamus morphology|MP:0000859,abnormal somatosensory cortex morphology|MP:0000920,abnormal myelination|MP:0001153,small seminiferous tubules|MP:0001384,abnormal pup retrieval|MP:0001386,abnormal maternal nurturing|MP:0001436,abnormal suckling behavior|MP:0001486,abnormal startle reflex|MP:0001496,audiogenic seizures|MP:0001906,increased dopamine level|MP:0001984,abnormal olfaction|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003009,abnormal cytokine secretion|MP:0003459,increased fear-related response|MP:0003999,enhanced passive avoidance behavior|MP:0004821,increased susceptibility to experimental autoimmune uveoretinitis|MP:0004852,decreased testis weight|MP:0008560,increased tumor necrosis factor secretion|MP:0008568,abnormal interleukin secretion|MP:0009751,enhanced behavioral response to alcohol|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010069,increased serotonin level|MP:0020469,prolonged circadian behavior period|MP:0020477,abnormal locomotor circadian rhythm|MP:0031389,abnormal ectoplasmic specialization morphology
MGI:6324036	Fyttd1<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0005553,increased circulating creatinine level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010024,increased total body fat amount
MGI:3604499	Fzd10<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:6276875	Fzd1<em1(IMPC)Mbp>	MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0004924,abnormal behavior|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0020420,abnormal freezing behavior|MP:0020421,increased freezing behavior|MP:0020870,decreased thigmotaxis
MGI:5465303	Fzd1<tm1.1Boer>	MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001132,absent mature ovarian follicles|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0009094,abnormal endometrial gland morphology|MP:0009096,decreased endometrial gland number
MGI:4442608	Fzd1<tm1.1Nat>	MP:0005382,craniofacial phenotype|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype
MGI:3604554	Fzd1<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:5558153	Fzd2<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4442611	Fzd2<tm1.1Nat>	MP:0000111,cleft palate|MP:0001265,decreased body size|MP:0001983,abnormal olfactory system physiology|MP:0002272,abnormal nervous system electrophysiology|MP:0003631,nervous system phenotype|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5692578	Fzd3<tm1b(EUCOMM)Hmgu>	MP:0005293,impaired glucose tolerance|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5429212	Fzd3<tm1(FZD3)Lex>	MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0002635,reduced sensorimotor gating|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0009142,decreased prepulse inhibition|MP:0009456,impaired cued conditioning behavior|MP:0014413,decreased depression-related behavior
MGI:2388632	Fzd3<tm1Nat>	MP:0000556,abnormal hindlimb morphology|MP:0000778,abnormal nervous system tract morphology|MP:0000781,decreased corpus callosum size|MP:0000787,abnormal telencephalon morphology|MP:0000928,incomplete rostral neuropore closure|MP:0000955,abnormal spinal cord morphology|MP:0001175,abnormal lung morphology|MP:0001529,abnormal vocalization|MP:0001575,cyanosis|MP:0001951,abnormal breathing pattern|MP:0003051,curly tail|MP:0004077,abnormal striatum morphology|MP:0006254,thin cerebral cortex|MP:0008129,absent brain internal capsule|MP:0008227,absent anterior commissure|MP:0008535,enlarged lateral ventricles|MP:0011087,neonatal lethality, complete penetrance|MP:0012468,decreased striatum size
MGI:5510964	Fzd3<tm2.1Nat>	MP:0002169,no abnormal phenotype detected
MGI:5582423	Fzd4<tm1.1(KOMP)Vlcg>	MP:0001785,edema
MGI:5312687	Fzd4<tm1.1Lex>	MP:0005385,cardiovascular system phenotype|MP:0005602,decreased angiogenesis
MGI:2387667	Fzd4<tm1Nat>	MP:0000042,abnormal organ of Corti morphology|MP:0000048,abnormal stria vascularis morphology|MP:0000259,abnormal vascular development|MP:0000371,diluted coat color|MP:0000467,abnormal esophagus morphology|MP:0000469,abnormal esophageal squamous epithelium morphology|MP:0000849,abnormal cerebellum morphology|MP:0000851,cerebellum hypoplasia|MP:0000880,decreased Purkinje cell number|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001133,impaired luteal cell differentiation|MP:0001134,absent corpus luteum|MP:0001263,weight loss|MP:0001289,persistence of hyaloid vascular system|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001489,decreased startle reflex|MP:0001504,abnormal posture|MP:0001505,hunched posture|MP:0001664,abnormal digestion|MP:0001728,failure of embryo implantation|MP:0001914,hemorrhage|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002083,premature death|MP:0002679,abnormal corpus luteum morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002989,small kidney|MP:0003356,impaired luteinization|MP:0004362,cochlear hair cell degeneration|MP:0004363,stria vascularis degeneration|MP:0004368,abnormal stria vascularis vasculature morphology|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004545,enlarged esophagus|MP:0004950,abnormal brain vasculature morphology|MP:0005185,decreased circulating progesterone level|MP:0005389,reproductive system phenotype|MP:0005551,abnormal eye electrophysiology|MP:0005602,decreased angiogenesis|MP:0006185,retina hemorrhage|MP:0006243,impaired pupillary reflex|MP:0006325,impaired hearing|MP:0006359,absent startle reflex|MP:0008916,abnormal astrocyte physiology|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009619,abnormal optokinetic reflex|MP:0009772,abnormal retina development|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4412057	Fzd4<tm2.1Nat>	MP:0002169,no abnormal phenotype detected
MGI:5708175	Fzd5<tm1.1(KOMP)Vlcg>	MP:0011100,preweaning lethality, complete penetrance
MGI:3583769	Fzd5<tm1Cle>	MP:0005391,vision/eye phenotype|MP:0014077,ectopic Paneth cells
MGI:2177951	Fzd5<tm1Mmt>	MP:0001718,abnormal visceral yolk sac morphology|MP:0001722,pale yolk sac|MP:0001723,disorganized yolk sac vascular plexus|MP:0001914,hemorrhage|MP:0003425,abnormal optic vesicle formation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004269,abnormal optic cup morphology|MP:0005253,abnormal eye physiology|MP:0005545,abnormal lens development|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0030005,increased retina apoptosis
MGI:3796576	Fzd5<tm1Nat>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857024	Fzd6<rst>	MP:0000383,abnormal hair follicle orientation|MP:0001510,abnormal coat appearance
MGI:3604497	Fzd6<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3050103	Fzd6<tm1Nat>	MP:0000383,abnormal hair follicle orientation
MGI:4442616	Fzd7<tm1.1Nat>	MP:0000266,abnormal heart morphology|MP:0000585,kinked tail|MP:0000592,short tail
MGI:6257749	Fzd8<em1(IMPC)Bay>	MP:0002953,thick ventricular wall|MP:0005599,increased cardiac muscle contractility|MP:0005635,decreased circulating bilirubin level|MP:0010579,increased heart left ventricle size|MP:0011960,abnormal eye anterior chamber depth
MGI:3604555	Fzd8<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:4442631	Fzd8<tm1Nat>	MP:0002169,no abnormal phenotype detected
MGI:3528585	Fzd9<tm1Lex>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0003795,abnormal bone structure
MGI:3586504	Fzd9<tm1Sjp>	MP:0000812,abnormal dentate gyrus morphology|MP:0001463,abnormal spatial learning|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003232,abnormal forebrain development
MGI:3526665	Fzd9<tm1Uta>	MP:0000063,decreased bone mineral density|MP:0000135,decreased compact bone thickness|MP:0000141,abnormal vertebral body morphology|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001533,abnormal skeleton physiology|MP:0002083,premature death|MP:0002113,abnormal skeleton development|MP:0002339,abnormal lymph node morphology|MP:0002356,abnormal spleen red pulp morphology|MP:0002362,abnormal spleen marginal zone morphology|MP:0003644,thymus atrophy|MP:0004989,decreased osteoblast cell number|MP:0004991,decreased bone strength|MP:0005011,increased eosinophil cell number|MP:0005017,decreased B cell number|MP:0005386,behavior/neurological phenotype|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008271,abnormal bone ossification|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0010879,decreased trabecular bone volume|MP:0011224,abnormal lymph node medullary cord morphology|MP:0011711,impaired osteoblast differentiation|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization|MP:0030439,decreased osteoblast proliferation
MGI:4820747	Fzr1<Gt(3003)Tgen>	MP:0001714,absent trophoblast giant cells|MP:0001716,abnormal placenta labyrinth morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011708,decreased fibroblast cell migration
MGI:3805590	Fzr1<Gt(RRJ067)Byg>	MP:0000352,decreased cell proliferation|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001714,absent trophoblast giant cells|MP:0003708,binucleate|MP:0003984,embryonic growth retardation|MP:0004046,abnormal mitosis|MP:0004259,small placenta|MP:0005386,behavior/neurological phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5707435	Fzr1<tm1.1(KOMP)Vlcg>	MP:0001697,abnormal embryo size|MP:0004258,abnormal placenta size|MP:0011100,preweaning lethality, complete penetrance
MGI:3800719	Fzr1<tm1.1Mama>	MP:0000352,decreased cell proliferation|MP:0001458,abnormal object recognition memory|MP:0001516,abnormal motor coordination/balance|MP:0001715,placental labyrinth hypoplasia|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0003447,decreased tumor growth/size|MP:0003984,embryonic growth retardation|MP:0004266,pale placenta|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005033,abnormal trophoblast giant cell morphology|MP:0006262,increased testis tumor incidence|MP:0008014,increased lung tumor incidence|MP:0008019,increased liver tumor incidence|MP:0008973,decreased erythroid progenitor cell number|MP:0010299,increased mammary gland tumor incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4410513	Fzr1<tm1.2Stge>	MP:0008762,embryonic lethality
MGI:4820748	Fzr1<tm1(Fzr1)Shku>	MP:0010768,mortality/aging
MGI:3800718	Fzr1<tm1Mama>	MP:0005380,embryo phenotype|MP:0010768,mortality/aging
MGI:5708739	G0s2<tm1Jgte>	MP:0001262,decreased body weight|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0003960,increased lean body mass|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005670,abnormal white adipose tissue physiology|MP:0008034,enhanced lipolysis|MP:0008853,decreased abdominal adipose tissue amount|MP:0008907,decreased total fat pad weight|MP:0009133,decreased white fat cell size|MP:0009356,decreased liver triglyceride level|MP:0010379,decreased respiratory quotient|MP:0011581,increased triglyceride lipase activity|MP:0011699,abnormal brown adipose tissue thermogenesis|MP:0014143,decreased body fat mass|MP:0014146,decreased white adipose tissue mass|MP:0020523,decreased susceptibility to induced hypothermia|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3808572	G0s2<tm1(KOMP)Vlcg>	MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001554,increased circulating free fatty acids level|MP:0001780,decreased brown adipose tissue amount|MP:0001882,abnormal lactation|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0002942,decreased circulating alanine transaminase level|MP:0003402,decreased liver weight|MP:0003443,increased circulating glycerol level|MP:0003718,maternal effect|MP:0003918,decreased kidney weight|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005370,liver/biliary system phenotype|MP:0005632,decreased circulating aspartate transaminase level|MP:0005670,abnormal white adipose tissue physiology|MP:0008034,enhanced lipolysis|MP:0008489,slow postnatal weight gain|MP:0009133,decreased white fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009303,decreased renal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0009546,absent gastric milk in neonates|MP:0010025,decreased total body fat amount|MP:0010046,decreased omental fat pad weight|MP:0011168,abnormal fat cell differentiation|MP:0014605,dark liver|MP:0020523,decreased susceptibility to induced hypothermia|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3578157	g2e	MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0011089,perinatal lethality, complete penetrance
MGI:6156577	G2e3<em1(IMPC)Tcp>	MP:0000063,decreased bone mineral density|MP:0000627,abnormal mammary gland morphology|MP:0000689,abnormal spleen morphology|MP:0001258,decreased body length|MP:0001944,abnormal pancreas morphology|MP:0002060,abnormal skin morphology|MP:0002188,small heart|MP:0002637,small uterus|MP:0002764,short tibia|MP:0002989,small kidney|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005343,increased circulating aspartate transaminase level|MP:0009456,impaired cued conditioning behavior|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:3808723	G2e3<Gt(RRM192)Byg>	MP:0006042,increased apoptosis|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5550593	G3bp1<tm1b(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0001510,abnormal coat appearance|MP:0002966,decreased circulating alkaline phosphatase level|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration|MP:0011965,decreased total retina thickness
MGI:3604716	G3bp1<tm1Tazi>	MP:0000352,decreased cell proliferation|MP:0000428,abnormal craniofacial morphology|MP:0000592,short tail|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0001915,intracranial hemorrhage|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003203,increased neuron apoptosis|MP:0003718,maternal effect|MP:0003984,embryonic growth retardation|MP:0011089,perinatal lethality, complete penetrance
MGI:4461696	G3bp2<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:7506302	G6pc1<em1Jyc>	MP:0000189,hypoglycemia|MP:0000599,enlarged liver|MP:0001265,decreased body size|MP:0001552,increased circulating triglyceride level|MP:0001764,abnormal homeostasis|MP:0002628,hepatic steatosis|MP:0003068,enlarged kidney|MP:0005178,increased circulating cholesterol level|MP:0005325,abnormal renal glomerulus morphology|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0008489,slow postnatal weight gain|MP:0008821,increased blood uric acid level|MP:0008989,abnormal liver sinusoid morphology|MP:0009355,increased liver triglyceride level|MP:0009640,abnormal renal tubule epithelium morphology|MP:0010400,increased liver glycogen level
MGI:5478554	G6pc1<tm1.1Ics>	MP:0000521,abnormal kidney cortex morphology|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0001552,increased circulating triglyceride level|MP:0002135,abnormal kidney morphology|MP:0002628,hepatic steatosis|MP:0002703,abnormal renal tubule morphology|MP:0002901,increased urine phosphate level|MP:0002959,increased urine microalbumin level|MP:0002981,increased liver weight|MP:0003068,enlarged kidney|MP:0003324,increased liver adenoma incidence|MP:0003917,increased kidney weight|MP:0005178,increased circulating cholesterol level|MP:0005326,abnormal podocyte morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0008821,increased blood uric acid level|MP:0009350,decreased urine pH|MP:0009355,increased liver triglyceride level|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0009810,increased urine uric acid level|MP:0010400,increased liver glycogen level|MP:0011435,increased urine magnesium level|MP:0031003,increased kidney glycogen level
MGI:2387343	G6pc1<tm1Jyc>	MP:0000164,abnormal cartilage development|MP:0000599,enlarged liver|MP:0001552,increased circulating triglyceride level|MP:0001654,hepatic necrosis|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0002705,dilated renal tubule|MP:0002932,abnormal joint morphology|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003068,enlarged kidney|MP:0005178,increased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0008821,increased blood uric acid level|MP:0009640,abnormal renal tubule epithelium morphology|MP:0010400,increased liver glycogen level|MP:0011346,renal tubule atrophy|MP:0011363,renal glomerulus atrophy|MP:0031003,increased kidney glycogen level
MGI:4418685	G6pc1<tm2.2Jyc>	MP:0000189,hypoglycemia|MP:0001552,increased circulating triglyceride level|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002981,increased liver weight|MP:0003917,increased kidney weight|MP:0005178,increased circulating cholesterol level|MP:0008821,increased blood uric acid level|MP:0009642,abnormal blood homeostasis|MP:0010400,increased liver glycogen level|MP:0031003,increased kidney glycogen level
MGI:4461063	G6pc2<tm1.1Pesa>	MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008567,decreased interferon-gamma secretion
MGI:3819785	G6pc2<tm1Lex>	MP:0002644,decreased circulating triglyceride level|MP:0005379,endocrine/exocrine gland phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005560,decreased circulating glucose level
MGI:3710232	G6pc3<tm1Jyc>	MP:0000222,decreased neutrophil cell number|MP:0000322,increased granulocyte number|MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0005074,impaired granulocyte bactericidal activity|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3697438	G6pc3<tm1Rmob>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002712,increased circulating glucagon level|MP:0005179,decreased circulating cholesterol level|MP:0009176,increased pancreatic alpha cell number
MGI:5754601	G6pd2<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes
MGI:2182739	G6pdx<a-m1Neu>	MP:0000343,abnormal response to cardiac infarction|MP:0001577,anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002875,decreased erythrocyte cell number|MP:0003186,abnormal redox activity|MP:0003656,abnormal erythrocyte physiology|MP:0005397,hematopoietic system phenotype|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005563,abnormal hemoglobin content|MP:0005602,decreased angiogenesis
MGI:2183760	G6pdx<a-m2Neu>	MP:0003631,nervous system phenotype
MGI:2387672	G6pdx<tm1Luz>	MP:0000266,abnormal heart morphology|MP:0000432,abnormal head morphology|MP:0001614,abnormal blood vessel morphology|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001716,abnormal placenta labyrinth morphology|MP:0001730,embryonic growth arrest|MP:0001914,hemorrhage|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002836,abnormal chorion morphology|MP:0003123,paternal imprinting|MP:0003891,increased allantois apoptosis|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004259,small placenta|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004937,dilated heart|MP:0004938,dilated vasculature|MP:0008029,abnormal paraxial mesoderm morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012703,decreased embryonic neuroepithelium thickness|MP:0013241,embryo tissue necrosis|MP:0013504,increased embryonic tissue cell apoptosis
MGI:1857316	Ga	MP:0002075,abnormal coat/hair pigmentation
MGI:2179955	Gaa<tm1.1Rabn>	MP:0000160,kyphosis|MP:0000748,progressive muscle weakness|MP:0000751,myopathy|MP:0001406,abnormal gait|MP:0010401,increased skeletal muscle glycogen level|MP:0014071,increased cardiac muscle glycogen level|MP:0014074,increased brain glycogen level
MGI:2148550	Gaa<tm1Rabn>	MP:0000160,kyphosis|MP:0000747,muscle weakness|MP:0000748,progressive muscle weakness|MP:0000751,myopathy|MP:0000755,hindlimb paralysis|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0002757,decreased vertical activity|MP:0004087,abnormal muscle fiber morphology|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0005058,abnormal lysosome morphology|MP:0005330,cardiomyopathy|MP:0010053,decreased grip strength|MP:0010400,increased liver glycogen level|MP:0010401,increased skeletal muscle glycogen level|MP:0014071,increased cardiac muscle glycogen level|MP:0014074,increased brain glycogen level
MGI:2179961	Gaa<tm1Vdp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000276,heart right ventricle hypertrophy|MP:0000278,abnormal myocardial fiber morphology|MP:0000748,progressive muscle weakness|MP:0002106,abnormal muscle physiology|MP:0002269,muscular atrophy|MP:0002625,heart left ventricle hypertrophy|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003137,abnormal impulse conducting system conduction|MP:0003898,abnormal QRS complex|MP:0004819,decreased skeletal muscle mass|MP:0005330,cardiomyopathy|MP:0005438,abnormal glycogen homeostasis|MP:0006087,increased body mass index|MP:0031511,globular heart
MGI:2179960	Gaa<tm2Rabn>	MP:0000160,kyphosis|MP:0000748,progressive muscle weakness|MP:0000751,myopathy|MP:0000755,hindlimb paralysis|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0005330,cardiomyopathy|MP:0010401,increased skeletal muscle glycogen level|MP:0014071,increased cardiac muscle glycogen level|MP:0014074,increased brain glycogen level
MGI:2667211	Gab1<tm1Ajw>	MP:0002086,abnormal extraembryonic tissue morphology|MP:0002127,abnormal cardiovascular system morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3578648	Gab1<tm1Gsf>	MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005439,decreased glycogen level|MP:0005560,decreased circulating glucose level
MGI:1926435	Gab1<tm1Thir>	MP:0000279,ventricular hypoplasia|MP:0000280,thin ventricular wall|MP:0001218,thin epidermis|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001341,absent eyelids|MP:0001698,decreased embryo size|MP:0001713,decreased trophoblast giant cell number|MP:0001715,placental labyrinth hypoplasia|MP:0001914,hemorrhage|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0003153,early eyelid opening|MP:0003704,abnormal hair follicle development|MP:0004259,small placenta|MP:0005244,hemopericardium|MP:0008816,petechiae|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:1934204	Gab1<tm1Wbm>	MP:0000759,abnormal skeletal muscle morphology|MP:0001218,thin epidermis|MP:0001713,decreased trophoblast giant cell number|MP:0001716,abnormal placenta labyrinth morphology|MP:0003090,abnormal muscle precursor cell migration|MP:0003231,abnormal placenta vasculature|MP:0003359,hypaxial muscle hypoplasia|MP:0003402,decreased liver weight|MP:0003453,abnormal keratinocyte physiology|MP:0003704,abnormal hair follicle development|MP:0004201,fetal growth retardation|MP:0004819,decreased skeletal muscle mass|MP:0004924,abnormal behavior|MP:0009890,cleft secondary palate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011523,thin placenta labyrinth|MP:0011527,disorganized placental labyrinth|MP:0012251,abnormal diaphragm development|MP:0030208,abnormal intrinsic tongue muscle morphology
MGI:3759861	Gab1<tm2Wbm>	MP:0001716,abnormal placenta labyrinth morphology|MP:0003402,decreased liver weight|MP:0005369,muscle phenotype|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3759864	Gab1<tm3Wbm>	MP:0003402,decreased liver weight|MP:0005369,muscle phenotype|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011523,thin placenta labyrinth|MP:0011527,disorganized placental labyrinth
MGI:3759866	Gab1<tm4Wbm>	MP:0001302,eyelids open at birth|MP:0001792,impaired wound healing
MGI:3759868	Gab1<tm5Wbm>	MP:0000729,abnormal myogenesis|MP:0003091,abnormal cell migration|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011523,thin placenta labyrinth|MP:0011527,disorganized placental labyrinth|MP:0012185,abnormal muscle precursor cell morphology
MGI:6257457	Gab2<em1(IMPC)Bay>	MP:0002764,short tibia
MGI:3714456	Gab2<tm1Gsf>	MP:0005025,abnormal response to infection|MP:0020935,decreased susceptibility to Retroviridae infection
MGI:2182762	Gab2<tm1Hhg>	MP:0000336,decreased mast cell number|MP:0005387,immune system phenotype|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0008765,decreased mast cell degranulation
MGI:3576606	Gab2<tm1Pngr>	MP:0000067,osteopetrosis|MP:0000333,decreased bone marrow cell number|MP:0004982,abnormal osteoclast morphology|MP:0004985,decreased osteoclast cell number|MP:0004993,decreased bone resorption|MP:0005605,increased bone mass|MP:0008396,abnormal osteoclast differentiation|MP:0010872,increased trabecular bone mass|MP:0010961,increased compact bone mass
MGI:2660754	Gab2<tm1Thir>	MP:0000336,decreased mast cell number|MP:0002423,abnormal mast cell physiology|MP:0005397,hematopoietic system phenotype|MP:0005462,abnormal mast cell differentiation
MGI:5297346	Gab2<tm2.1Thir>	MP:0005387,immune system phenotype
MGI:5297247	Gab2<tm3.1Thir>	MP:0000336,decreased mast cell number|MP:0005387,immune system phenotype|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0008765,decreased mast cell degranulation
MGI:5297248	Gab2<tm4.1Thir>	MP:0000336,decreased mast cell number|MP:0005387,immune system phenotype|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0008765,decreased mast cell degranulation
MGI:6446855	Gab3<em1Khoe>	MP:0004514,dystocia|MP:0005387,immune system phenotype|MP:0008045,decreased NK cell number|MP:0008054,abnormal uterine NK cell morphology|MP:0009397,increased trophoblast giant cell number|MP:0010766,abnormal NK cell physiology|MP:0010768,mortality/aging|MP:0013700,abnormal mature NK cell morphology
MGI:6446861	Gab3<m1Khoe>	MP:0004514,dystocia|MP:0005387,immune system phenotype|MP:0008045,decreased NK cell number|MP:0008054,abnormal uterine NK cell morphology|MP:0009397,increased trophoblast giant cell number|MP:0010766,abnormal NK cell physiology|MP:0010768,mortality/aging|MP:0013700,abnormal mature NK cell morphology
MGI:2654214	Gab3<tm1Lrr>	MP:0002169,no abnormal phenotype detected
MGI:3530477	Gabarap<Gt(OST28330)Lex>	MP:0002169,no abnormal phenotype detected
MGI:3530887	Gabarap<Gt(OST31915)Lex>	MP:0002169,no abnormal phenotype detected
MGI:5637004	Gabarapl2<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0003917,increased kidney weight|MP:0005016,decreased lymphocyte cell number|MP:0005419,decreased circulating serum albumin level|MP:0011100,preweaning lethality, complete penetrance
MGI:2156199	Gabbr1<Gt(KST229)Byg>	MP:0011087,neonatal lethality, complete penetrance
MGI:2159352	Gabbr1<tm1Bet>	MP:0000920,abnormal myelination|MP:0001363,increased anxiety-related response|MP:0001406,abnormal gait|MP:0001473,reduced long-term potentiation|MP:0001496,audiogenic seizures|MP:0001751,increased circulating luteinizing hormone level|MP:0001923,reduced female fertility|MP:0001927,abnormal estrous cycle|MP:0002064,seizures|MP:0002272,abnormal nervous system electrophysiology|MP:0002572,abnormal emotion/affect behavior|MP:0002651,abnormal sciatic nerve morphology|MP:0002738,hyperresponsive to tactile stimuli|MP:0002752,abnormal somatic nervous system morphology|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003216,absence seizures|MP:0003635,abnormal synaptic transmission|MP:0003871,abnormal myelin sheath morphology|MP:0003996,clonic seizures|MP:0003997,tonic-clonic seizures|MP:0003998,decreased thermal nociceptive threshold|MP:0004000,impaired passive avoidance behavior|MP:0005124,increased circulating prolactin level|MP:0005378,growth/size/body region phenotype|MP:0005404,abnormal axon morphology|MP:0005498,hyporesponsive to tactile stimuli|MP:0006404,abnormal lumbar dorsal root ganglion morphology|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009015,short proestrus|MP:0009017,prolonged estrus|MP:0009747,impaired behavioral response to xenobiotic|MP:0014413,decreased depression-related behavior|MP:0031391,increased locomotor activity
MGI:3604487	Gabbr1<tm1Dgen>	MP:0000746,weakness|MP:0001402,decreased locomotor activity|MP:0001429,dehydration|MP:0001504,abnormal posture|MP:0002083,premature death|MP:0008843,absent subcutaneous adipose tissue
MGI:2159354	Gabbr1<tm1Pngl>	MP:0000951,sporadic seizures|MP:0001262,decreased body weight|MP:0002272,abnormal nervous system electrophysiology|MP:0002911,abnormal inhibitory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0003997,tonic-clonic seizures|MP:0005402,abnormal action potential|MP:0009141,increased prepulse inhibition|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3512743	Gabbr1<tm2.1Bet>	MP:0001777,abnormal body temperature homeostasis|MP:0031391,increased locomotor activity
MGI:3512742	Gabbr1<tm2Bet>	MP:0001501,abnormal sleep pattern|MP:0002206,abnormal CNS synaptic transmission|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology|MP:0005386,behavior/neurological phenotype|MP:0011620,abnormal habituation to a new environment
MGI:3665432	Gabbr1<tm3Bet>	MP:0001458,abnormal object recognition memory|MP:0001473,reduced long-term potentiation|MP:0002805,abnormal conditioned taste aversion behavior|MP:0002910,abnormal excitatory postsynaptic currents
MGI:3665433	Gabbr1<tm4Bet>	MP:0002805,abnormal conditioned taste aversion behavior|MP:0002945,abnormal inhibitory postsynaptic currents
MGI:5568072	Gabbr2<tm1.1Stmo>	MP:0002910,abnormal excitatory postsynaptic currents|MP:0004859,abnormal synaptic plasticity|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008432,abnormal long-term spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0009538,abnormal synapse morphology|MP:0012006,abnormal hippocampus physiology
MGI:3839235	Gabbr2<tm1Arca>	MP:0001262,decreased body weight|MP:0002064,seizures|MP:0002083,premature death|MP:0002911,abnormal inhibitory postsynaptic potential|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003997,tonic-clonic seizures
MGI:3610995	Gabbr2<tm1Bet>	MP:0001363,increased anxiety-related response|MP:0001968,abnormal touch/nociception|MP:0002272,abnormal nervous system electrophysiology|MP:0002572,abnormal emotion/affect behavior|MP:0002738,hyperresponsive to tactile stimuli|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003635,abnormal synaptic transmission|MP:0003996,clonic seizures|MP:0003998,decreased thermal nociceptive threshold|MP:0004000,impaired passive avoidance behavior|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009747,impaired behavioral response to xenobiotic|MP:0014413,decreased depression-related behavior|MP:0014624,abnormal brain delta wave pattern|MP:0031391,increased locomotor activity
MGI:3054951	Gabpa<Gt(XH074)Byg>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0004200,decreased fetal size|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3665313	Gabpa<tm1.1Sjb>	MP:0011092,embryonic lethality, complete penetrance
MGI:3763374	Gabpa<tm1Agro>	MP:0003903,increased cell mass|MP:0004045,abnormal cell cycle checkpoint function|MP:0005380,embryo phenotype|MP:0011704,decreased fibroblast proliferation|MP:0021086,decreased DNA replication
MGI:3711315	Gabpa<tm1Pjh>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0002913,abnormal PNS synaptic transmission|MP:0003484,abnormal channel response|MP:0003990,decreased neurotransmitter release|MP:0004836,abnormal synaptic acetylcholine release|MP:0005369,muscle phenotype
MGI:3050761	Gabpa<tm1Rist>	MP:0011091,prenatal lethality, complete penetrance
MGI:3799311	Gabpb1<tm1Hhx>	MP:0003631,nervous system phenotype|MP:0005369,muscle phenotype|MP:0005387,immune system phenotype|MP:0009434,paraparesis
MGI:3801692	Gabpb1<tm2Hhx>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7512906	Gabpb2<em1(IMPC)Tcp>	MP:0000470,abnormal stomach morphology|MP:0002792,abnormal retina vasculature morphology|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010097,abnormal retina blood vessel morphology
MGI:3821584	Gabpb2<Gt(RRJ488)Byg>	MP:0002494,increased IgM level|MP:0005154,increased B cell proliferation|MP:0008481,increased spleen germinal center number|MP:0008499,increased IgG1 level
MGI:2137421	Gabra1<tm1.1Geh>	MP:0000243,myoclonus|MP:0001263,weight loss|MP:0002064,seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003216,absence seizures|MP:0003997,tonic-clonic seizures|MP:0005377,hearing/vestibular/ear phenotype|MP:0008840,abnormal spike wave discharge|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0009538,abnormal synapse morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude
MGI:5705517	Gabra1<tm1.1Mjga>	MP:0000243,myoclonus|MP:0002064,seizures|MP:0002082,postnatal lethality|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003216,absence seizures|MP:0003997,tonic-clonic seizures|MP:0008840,abnormal spike wave discharge|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude
MGI:2183155	Gabra1<tm1.1Uru>	MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0008414,abnormal spatial reference memory|MP:0008872,abnormal physiological response to xenobiotic|MP:0009747,impaired behavioral response to xenobiotic
MGI:2137418	Gabra1<tm1Geh>	MP:0002169,no abnormal phenotype detected
MGI:2177611	Gabra1<tm1Rmck>	MP:0009745,abnormal behavioral response to xenobiotic
MGI:2177612	Gabra1<tm1Twr>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001443,poor grooming|MP:0001935,decreased litter size|MP:0004008,abnormal GABA-mediated receptor currents|MP:0005386,behavior/neurological phenotype|MP:0008872,abnormal physiological response to xenobiotic|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3617385	Gabra1<tm2.1Geh>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001386,abnormal maternal nurturing|MP:0001392,abnormal locomotor behavior|MP:0001400,hyperresponsive|MP:0001405,impaired coordination|MP:0001505,hunched posture|MP:0002083,premature death|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003313,abnormal locomotor activation|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3617384	Gabra1<tm2Geh>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001392,abnormal locomotor behavior|MP:0001400,hyperresponsive|MP:0001405,impaired coordination|MP:0001488,increased startle reflex|MP:0001505,hunched posture|MP:0002083,premature death|MP:0003313,abnormal locomotor activation
MGI:3654126	Gabra1<tm3.1Geh>	MP:0004000,impaired passive avoidance behavior
MGI:3654125	Gabra1<tm3Geh>	MP:0002169,no abnormal phenotype detected
MGI:4361392	Gabra1<tm4Geh>	MP:0001415,increased exploration in new environment|MP:0005386,behavior/neurological phenotype
MGI:6149191	Gabra2<em1(IMPC)H>	MP:0001314,cornea opacity|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001512,trunk curl|MP:0001513,limb grasping|MP:0002797,increased thigmotaxis|MP:0003960,increased lean body mass|MP:0004924,abnormal behavior|MP:0005333,decreased heart rate|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010506,prolonged RR interval|MP:0013278,decreased fasting circulating glucose level
MGI:3628505	Gabra2<tm1.1Dias>	MP:0005376,homeostasis/metabolism phenotype|MP:0009747,impaired behavioral response to xenobiotic
MGI:5000434	Gabra2<tm1.1Geh>	MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0009453,enhanced contextual conditioning behavior|MP:0009455,enhanced cued conditioning behavior|MP:0009779,enhanced behavioral response to anesthetic|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2183163	Gabra2<tm1.1Uru>	MP:0004008,abnormal GABA-mediated receptor currents|MP:0009747,impaired behavioral response to xenobiotic
MGI:3812421	Gabra2<tm1Dns>	MP:0002082,postnatal lethality|MP:0002806,abnormal conditioned emotional response|MP:0008770,decreased survivor rate
MGI:2183161	Gabra2<tm1Uru>	MP:0001982,decreased chemically-elicited antinociception|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5140553	Gabra2<tm2.1Uru>	MP:0001982,decreased chemically-elicited antinociception|MP:0002206,abnormal CNS synaptic transmission|MP:0004008,abnormal GABA-mediated receptor currents|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:2183168	Gabra3<tm1.1Uru>	MP:0005376,homeostasis/metabolism phenotype
MGI:3604586	Gabra3<tm1Dgen>	MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0009142,decreased prepulse inhibition|MP:0031391,increased locomotor activity
MGI:3611843	Gabra3<tm2Uru>	MP:0004008,abnormal GABA-mediated receptor currents|MP:0009142,decreased prepulse inhibition|MP:0031391,increased locomotor activity
MGI:3691194	Gabra4<tm1.1Geh>	MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003998,decreased thermal nociceptive threshold|MP:0004008,abnormal GABA-mediated receptor currents|MP:0009747,impaired behavioral response to xenobiotic
MGI:3604588	Gabra4<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:6399879	Gabra5<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis
MGI:2183170	Gabra5<tm1.1Uru>	MP:0008263,abnormal hippocampus CA1 region morphology|MP:0009142,decreased prepulse inhibition|MP:0009455,enhanced cued conditioning behavior|MP:0009745,abnormal behavioral response to xenobiotic|MP:0011942,decreased fluid intake|MP:0031391,increased locomotor activity
MGI:3623342	Gabra5<tm1Twr>	MP:0000031,abnormal cochlea morphology|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0002207,abnormal long-term potentiation|MP:0002857,cochlear ganglion degeneration|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004008,abnormal GABA-mediated receptor currents|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004490,type IV spiral ligament fibrocyte degeneration|MP:0004632,abnormal cochlear OHC efferent innervation pattern|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004740,sensorineural hearing loss|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:1857173	Gabra6<tm1Geh>	MP:0003631,nervous system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0008875,abnormal xenobiotic pharmacokinetics
MGI:2179278	Gabra6<tm1Wwis>	MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype
MGI:3047798	Gabra6<tm2(cre)Wwis>	MP:0002169,no abnormal phenotype detected
MGI:5704358	Gabrb1<m1Qnma>	MP:0001265,decreased body size|MP:0001926,female infertility|MP:0001987,alcohol preference|MP:0002679,abnormal corpus luteum morphology|MP:0002803,abnormal operant conditioning behavior|MP:0003463,abnormal single cell response|MP:0005130,decreased follicle stimulating hormone level|MP:0005132,decreased luteinizing hormone level|MP:0005134,decreased thyroid-stimulating hormone level|MP:0005136,decreased growth hormone level|MP:0005138,decreased prolactin level|MP:0005386,behavior/neurological phenotype|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0009751,enhanced behavioral response to alcohol|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0014384,increased miniature inhibitory postsynaptic current amplitude
MGI:5704359	Gabrb1<m2Qnma>	MP:0001265,decreased body size|MP:0001926,female infertility|MP:0001987,alcohol preference|MP:0002679,abnormal corpus luteum morphology|MP:0003463,abnormal single cell response|MP:0005136,decreased growth hormone level|MP:0005138,decreased prolactin level|MP:0009435,abnormal miniature inhibitory postsynaptic currents
MGI:5698075	Gabrb1<tm1b(KOMP)Wtsi>	MP:0000062,increased bone mineral density
MGI:2677669	Gabrb2<tm1.1Kwa>	MP:0009745,abnormal behavioral response to xenobiotic
MGI:2177615	Gabrb2<tm1.1Twr>	MP:0000031,abnormal cochlea morphology|MP:0002857,cochlear ganglion degeneration|MP:0004287,abnormal spiral limbus morphology|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004490,type IV spiral ligament fibrocyte degeneration|MP:0004632,abnormal cochlear OHC efferent innervation pattern|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004740,sensorineural hearing loss|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:2177613	Gabrb2<tm1Twr>	MP:0001415,increased exploration in new environment|MP:0004008,abnormal GABA-mediated receptor currents|MP:0005376,homeostasis/metabolism phenotype
MGI:6449209	Gabrb3<tm1.1Rmac>	MP:0000243,myoclonus|MP:0001363,increased anxiety-related response|MP:0001386,abnormal maternal nurturing|MP:0001399,hyperactivity|MP:0001922,reduced male fertility|MP:0002064,seizures|MP:0002206,abnormal CNS synaptic transmission|MP:0002797,increased thigmotaxis|MP:0002826,tonic seizures|MP:0002862,abnormal righting response|MP:0003216,absence seizures|MP:0003631,nervous system phenotype|MP:0003862,decreased aggression towards male mice|MP:0003997,tonic-clonic seizures|MP:0008414,abnormal spatial reference memory|MP:0008489,slow postnatal weight gain|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0010232,delayed skin pigmentation appearance|MP:0011087,neonatal lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012307,impaired spatial learning|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude|MP:0014416,decreased social novelty preference|MP:0014486,prolonged miniature inhibitory postsynaptic current decay phase|MP:0014625,abnormal ictal brain wave pattern|MP:0021111,decreased social investigation
MGI:1857174	Gabrb3<tm1Geh>	MP:0000031,abnormal cochlea morphology|MP:0000111,cleft palate|MP:0001265,decreased body size|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001400,hyperresponsive|MP:0001405,impaired coordination|MP:0001447,abnormal nest building behavior|MP:0001513,limb grasping|MP:0001522,impaired swimming|MP:0002064,seizures|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002068,abnormal parental behavior|MP:0002083,premature death|MP:0002206,abnormal CNS synaptic transmission|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002757,decreased vertical activity|MP:0002857,cochlear ganglion degeneration|MP:0003461,abnormal response to novel object|MP:0003637,cochlear ganglion hypoplasia|MP:0003986,small cochlear ganglion|MP:0003987,small vestibular ganglion|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004490,type IV spiral ligament fibrocyte degeneration|MP:0004632,abnormal cochlear OHC efferent innervation pattern|MP:0004716,abnormal cochlear nerve morphology|MP:0004740,sensorineural hearing loss|MP:0004746,abnormal cochlear IHC afferent innervation pattern|MP:0004924,abnormal behavior|MP:0006409,vestibular ganglion hypoplasia|MP:0009957,abnormal cerebellum vermis lobule morphology|MP:0009989,abnormal cerebellum vermis lobule II morphology|MP:0009990,abnormal cerebellum vermis lobule III morphology|MP:0009991,abnormal cerebellum vermis lobule IV morphology|MP:0009993,abnormal cerebellum vermis lobule V morphology|MP:0009994,abnormal cerebellum vermis lobule VI morphology|MP:0009995,abnormal cerebellum vermis lobule VII morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014406,increased or absent distortion product otoacoustic emission threshold|MP:0031391,increased locomotor activity|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:2449764	Gabrb3<tm1Uru>	MP:0000745,tremors|MP:0001961,abnormal reflex|MP:0002206,abnormal CNS synaptic transmission|MP:0002862,abnormal righting response|MP:0004008,abnormal GABA-mediated receptor currents|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential|MP:0009747,impaired behavioral response to xenobiotic
MGI:3767248	Gabrb3<tm2.1Geh>	MP:0001261,obese|MP:0001380,decreased male mating frequency|MP:0001386,abnormal maternal nurturing|MP:0001399,hyperactivity|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002169,no abnormal phenotype detected|MP:0003216,absence seizures|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004924,abnormal behavior|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008397,abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology|MP:0009747,impaired behavioral response to xenobiotic|MP:0010221,abnormal T-helper 17 cell differentiation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011939,increased food intake
MGI:5908395	Gabrb3<tm2.1Uru>	MP:0001409,increased stereotypic behavior|MP:0002206,abnormal CNS synaptic transmission|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002911,abnormal inhibitory postsynaptic potential|MP:0005386,behavior/neurological phenotype|MP:0009453,enhanced contextual conditioning behavior|MP:0009939,abnormal hippocampus neuron morphology|MP:0011269,increased excitatory postsynaptic current amplitude|MP:0011273,prolonged excitatory postsynaptic current decay time|MP:0020335,abnormal dentate gyrus neuron dendrite morphology|MP:0020395,abnormal response to social novelty
MGI:3767251	Gabrb3<tm2.2Geh>	MP:0000111,cleft palate|MP:0011083,lethality at weaning, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5526859	Gabrd<tm1.1Jmag>	MP:0002206,abnormal CNS synaptic transmission|MP:0002578,impaired ability to fire action potentials|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0011269,increased excitatory postsynaptic current amplitude|MP:0011987,abnormal GABAergic neuron physiology
MGI:1861926	Gabrd<tm1Geh>	MP:0001363,increased anxiety-related response|MP:0001364,decreased anxiety-related response|MP:0001384,abnormal pup retrieval|MP:0001385,pup cannibalization|MP:0001386,abnormal maternal nurturing|MP:0001447,abnormal nest building behavior|MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0001935,decreased litter size|MP:0002082,postnatal lethality|MP:0002272,abnormal nervous system electrophysiology|MP:0002573,behavioral despair|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003216,absence seizures|MP:0003360,abnormal depression-related behavior|MP:0005377,hearing/vestibular/ear phenotype|MP:0009778,impaired behavioral response to anesthetic
MGI:6149197	Gabre<em1(IMPC)H>	MP:0010506,prolonged RR interval
MGI:6364588	Gabre<tm1Cya>	MP:0001921,reduced fertility|MP:0009778,impaired behavioral response to anesthetic
MGI:7425699	Gabrg1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000438,abnormal cranium morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001120,abnormal uterus morphology|MP:0001303,abnormal lens morphology|MP:0001312,abnormal cornea morphology|MP:0002092,abnormal eye morphology|MP:0002111,abnormal tail morphology|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0013129,abnormal tooth color|MP:0020421,increased freezing behavior
MGI:6506870	Gabrg1<em1Ktka>	MP:0020374,abnormal nocifensive behavior|MP:0020954,decreased mechanical nociceptive threshold
MGI:6382411	Gabrg2<em1(IMPC)Mbp>	MP:0000063,decreased bone mineral density|MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0002060,abnormal skin morphology|MP:0002834,decreased heart weight|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:5504520	Gabrg2<tm1.1(Gabrg2)Wwis>	MP:0001399,hyperactivity|MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001732,postnatal growth retardation|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0011083,lethality at weaning, complete penetrance
MGI:4415057	Gabrg2<tm1.1Stmo>	MP:0005386,behavior/neurological phenotype|MP:0008414,abnormal spatial reference memory|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0009538,abnormal synapse morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0014382,increased miniature inhibitory postsynaptic current frequency|MP:0014384,increased miniature inhibitory postsynaptic current amplitude
MGI:6718838	Gabrg2<tm1.2Rmac>	MP:0000243,myoclonus|MP:0002064,seizures|MP:0002272,abnormal nervous system electrophysiology|MP:0002574,increased vertical activity|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003216,absence seizures|MP:0003997,tonic-clonic seizures|MP:0012011,febrile seizures|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude|MP:0031185,sudden unexpected death in epilepsy|MP:0031391,increased locomotor activity
MGI:3574929	Gabrg2<tm1Dc>	MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009747,impaired behavioral response to xenobiotic
MGI:1861927	Gabrg2<tm1Geh>	MP:0001922,reduced male fertility|MP:0004008,abnormal GABA-mediated receptor currents|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0009746,enhanced behavioral response to xenobiotic
MGI:2177608	Gabrg2<tm1Lusc>	MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0003631,nervous system phenotype|MP:0011085,postnatal lethality, complete penetrance
MGI:3764923	Gabrg2<tm1Spet>	MP:0000745,tremors|MP:0001406,abnormal gait|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003216,absence seizures|MP:0004994,abnormal brain wave pattern|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3721943	Gabrg2<tm1Wul>	MP:0001405,impaired coordination|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004008,abnormal GABA-mediated receptor currents|MP:0004811,abnormal neuron physiology|MP:0005386,behavior/neurological phenotype|MP:0009747,impaired behavioral response to xenobiotic
MGI:3582967	Gabrg2<tm2.1Geh>	MP:0011085,postnatal lethality, complete penetrance
MGI:3579440	Gabrg2<tm2Geh>	MP:0001363,increased anxiety-related response
MGI:2680624	Gabrg2<tm2Lusc>	MP:0001402,decreased locomotor activity|MP:0002064,seizures|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected
MGI:5474655	Gabrg2<tm2Spet>	MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures
MGI:5911525	Gabrg3<em1(IMPC)J>	MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:7411378	Gabrp<em1(IMPC)J>	MP:0000745,tremors
MGI:3604585	Gabrp<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3604492	Gabrq<tm1Dgen>	MP:0009142,decreased prepulse inhibition
MGI:2683490	Gabrr1<tm1Llu>	MP:0001984,abnormal olfaction|MP:0002272,abnormal nervous system electrophysiology|MP:0002734,abnormal mechanical nociception|MP:0002738,hyperresponsive to tactile stimuli
MGI:2446461	Gabrr1<tm1Nsp>	MP:0004021,abnormal rod electrophysiology
MGI:5548937	Gabrr2<tm1b(KOMP)Wtsi>	MP:0001146,abnormal testis morphology|MP:0001147,small testis
MGI:4442416	Gad1<tm1.1Bgc>	MP:0009886,failure of palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0010146,umbilical hernia
MGI:3762150	Gad1<tm1.1Rpa>	MP:0004101,abnormal brain interneuron morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:3590301	Gad1<tm1.1Tama>	MP:0003631,nervous system phenotype
MGI:3785546	Gad1<tm1(Gria2)Mony>	MP:0002912,abnormal excitatory postsynaptic potential|MP:0004994,abnormal brain wave pattern
MGI:2177566	Gad1<tm1Mrc>	MP:0001429,dehydration|MP:0001436,abnormal suckling behavior|MP:0001575,cyanosis|MP:0005039,hypoxia|MP:0009247,meteorism|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance|MP:0030248,narrow maxilla
MGI:2177565	Gad1<tm1Oba>	MP:0000111,cleft palate|MP:0001177,atelectasis|MP:0001270,distended abdomen|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0005386,behavior/neurological phenotype|MP:0009546,absent gastric milk in neonates|MP:0011087,neonatal lethality, complete penetrance|MP:0012595,decreased glutamate decarboxylase activity|MP:0030733,decreased gamma-aminobutyric acid level
MGI:3527168	Gad1<tm1Rpa>	MP:0000805,abnormal visual cortex morphology|MP:0002169,no abnormal phenotype detected|MP:0004101,abnormal brain interneuron morphology
MGI:3590300	Gad1<tm1Tama>	MP:0002272,abnormal nervous system electrophysiology|MP:0003492,abnormal involuntary movement
MGI:5805403	Gad1<tm1Zjh>	MP:0011400,lethality, complete penetrance
MGI:3793303	Gad1<tm2Oba>	MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003632,abnormal nervous system morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005382,craniofacial phenotype
MGI:5512722	Gad2<tm1.1Ksvo>	MP:0002169,no abnormal phenotype detected
MGI:1861928	Gad2<tm1Bae>	MP:0002064,seizures|MP:0002083,premature death|MP:0003631,nervous system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0030733,decreased gamma-aminobutyric acid level
MGI:5548938	Gad2<tm1b(EUCOMM)Wtsi>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002574,increased vertical activity|MP:0002797,increased thigmotaxis|MP:0002968,increased circulating alkaline phosphatase level|MP:0003019,increased circulating chloride level|MP:0004924,abnormal behavior|MP:0005293,impaired glucose tolerance|MP:0005633,increased circulating sodium level|MP:0009142,decreased prepulse inhibition|MP:0010379,decreased respiratory quotient|MP:0013279,increased fasting circulating glucose level
MGI:4355159	Gad2<tm1(cre/ERT2)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:3038621	Gad2<tm1Miya>	MP:0001262,decreased body weight|MP:0001869,pancreas inflammation|MP:0002064,seizures|MP:0002083,premature death|MP:0005559,increased circulating glucose level
MGI:2177567	Gad2<tm1Oba>	MP:0000243,myoclonus|MP:0001363,increased anxiety-related response|MP:0002064,seizures|MP:0002083,premature death|MP:0003063,increased coping response|MP:0003631,nervous system phenotype|MP:0003862,decreased aggression towards male mice|MP:0003997,tonic-clonic seizures|MP:0030733,decreased gamma-aminobutyric acid level
MGI:4418713	Gad2<tm2(cre)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:2182720	Gadd45a<tm1Ajf>	MP:0000221,decreased leukocyte cell number|MP:0000714,increased thymocyte number|MP:0000914,exencephaly|MP:0001203,increased sensitivity to skin irradiation|MP:0001204,decreased sensitivity to skin irradiation|MP:0001846,increased inflammatory response|MP:0002083,premature death|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002401,abnormal lymphopoiesis|MP:0002494,increased IgM level|MP:0002607,decreased basophil cell number|MP:0002743,glomerulonephritis|MP:0002962,increased urine protein level|MP:0003111,abnormal cell nucleus morphology|MP:0003702,abnormal chromosome morphology|MP:0003725,increased autoantibody level|MP:0004023,abnormal chromosome number|MP:0004024,aneuploidy|MP:0004046,abnormal mitosis|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0004501,increased incidence of tumors by UV-induction|MP:0004759,decreased mitotic index|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004796,increased anti-histone antibody level|MP:0004955,increased thymus weight|MP:0005012,decreased eosinophil cell number|MP:0005015,increased T cell number|MP:0005016,decreased lymphocyte cell number|MP:0005348,increased T cell proliferation|MP:0005621,abnormal cell physiology|MP:0008499,increased IgG1 level|MP:0009050,dilated proximal convoluted tubule|MP:0011427,increased mesangial cell number|MP:0011440,increased kidney cell proliferation|MP:0011512,mesangial cell interposition|MP:0011703,increased fibroblast proliferation|MP:0012010,parturition failure|MP:0014762,impaired base-excision repair|MP:0030943,abnormal centrosome morphology
MGI:3608798	Gadd45b<tm1Daa>	MP:0002398,abnormal bone marrow cell morphology/development
MGI:2687355	Gadd45b<tm1Flv>	MP:0000693,spleen hyperplasia|MP:0002376,abnormal dendritic cell physiology|MP:0002743,glomerulonephritis|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005348,increased T cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008566,increased interferon-gamma secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0020519,renal glomerular immunoglobulin deposits
MGI:4420969	Gadd45gip1<tm1Kong>	MP:0000352,decreased cell proliferation|MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011198,absent proamniotic cavity|MP:0012114,absent inner cell mass proliferation|MP:0013504,increased embryonic tissue cell apoptosis
MGI:4420970	Gadd45gip1<tm2Kong>	MP:0000479,abnormal enterocyte morphology|MP:0003059,decreased insulin secretion|MP:0003119,abnormal digestive system development|MP:0003339,decreased pancreatic beta cell number|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005215,abnormal pancreatic islet morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005381,digestive/alimentary phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0008108,abnormal small intestinal villus morphology|MP:0008109,abnormal small intestinal microvillus morphology|MP:0009114,decreased pancreatic beta cell mass|MP:0010157,abnormal small intestinal crypt cell proliferation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011628,increased mitochondrial number|MP:0011635,abnormal mitochondrial crista morphology|MP:0011637,abnormal mitochondrial matrix morphology|MP:0011820,decreased pancreatic beta cell proliferation|MP:0014079,decreased small intestinal villus number|MP:0014082,decreased small intestinal villus height
MGI:2182738	Gadd45g<tm1Flv>	MP:0002534,abnormal type IV hypersensitivity reaction|MP:0005465,abnormal T-helper 1 physiology|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008567,decreased interferon-gamma secretion|MP:0010766,abnormal NK cell physiology|MP:0011014,decreased core body temperature|MP:0011049,impaired adaptive thermogenesis|MP:0011698,abnormal brown adipose tissue physiology
MGI:2182734	Gadd45g<tm1Jni>	MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001924,infertility|MP:0001939,secondary sex reversal|MP:0002016,ovary cyst|MP:0002995,primary sex reversal|MP:0003830,abnormal testis development|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008871,abnormal ovarian follicle number
MGI:3653832	Gadd45g<tm1Mhol>	MP:0001924,infertility|MP:0001939,secondary sex reversal|MP:0002995,primary sex reversal|MP:0003830,abnormal testis development|MP:0005621,abnormal cell physiology|MP:0006424,absent testis cords
MGI:7425701	Gak<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000627,abnormal mammary gland morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001404,no spontaneous movement|MP:0002135,abnormal kidney morphology|MP:0002591,decreased mean corpuscular volume|MP:0003068,enlarged kidney|MP:0003917,increased kidney weight|MP:0010067,increased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance
MGI:5305732	Gak<tm1Legr>	MP:0011092,embryonic lethality, complete penetrance
MGI:5305045	Gak<tm1Noj>	MP:0004782,abnormal surfactant physiology|MP:0005384,cellular phenotype|MP:0010900,abnormal pulmonary interalveolar septum morphology|MP:0010902,abnormal pulmonary alveolar sac morphology|MP:0010995,abnormal lung alveolus development|MP:0011087,neonatal lethality, complete penetrance
MGI:5305733	Gak<tm2Legr>	MP:0000598,abnormal liver morphology|MP:0000611,jaundice|MP:0000812,abnormal dentate gyrus morphology|MP:0000815,abnormal Ammon gyrus morphology|MP:0001211,wrinkled skin|MP:0001216,abnormal epidermal layer morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001260,increased body weight|MP:0001265,decreased body size|MP:0001429,dehydration|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002796,impaired skin barrier function|MP:0002928,abnormal bile duct morphology|MP:0003950,abnormal plasma membrane morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0004981,decreased neuronal precursor cell number|MP:0005202,lethargy|MP:0008458,abnormal cortical ventricular zone morphology|MP:0009937,abnormal neuron differentiation|MP:0010398,decreased liver glycogen level|MP:0011085,postnatal lethality, complete penetrance|MP:0012242,abnormal hepatoblast differentiation
MGI:7425702	Gal3st1<em1(IMPC)Rbrc>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000745,tremors|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0002152,abnormal brain morphology|MP:0002631,abnormal epididymis morphology|MP:0002797,increased thigmotaxis|MP:0003795,abnormal bone structure|MP:0004599,abnormal vertebral arch morphology|MP:0004924,abnormal behavior|MP:0004930,small epididymis|MP:0005292,improved glucose tolerance|MP:0009142,decreased prepulse inhibition
MGI:5520956	Gal3st1<tm1.1Hjg>	MP:0001762,polyuria|MP:0005367,renal/urinary system phenotype|MP:0005619,increased urine potassium level|MP:0009350,decreased urine pH|MP:0009643,abnormal urine homeostasis|MP:0010768,mortality/aging|MP:0011736,decreased urine ammonia level|MP:0012551,metabolic acidosis
MGI:2386400	Gal3st1<tm1Kho>	MP:0000745,tremors|MP:0000746,weakness|MP:0000920,abnormal myelination|MP:0001146,abnormal testis morphology|MP:0001155,arrest of spermatogenesis|MP:0001393,ataxia|MP:0001506,limp posture|MP:0001524,impaired limb coordination|MP:0001925,male infertility|MP:0002152,abnormal brain morphology|MP:0003492,abnormal involuntary movement|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005404,abnormal axon morphology|MP:0008261,arrest of male meiosis|MP:0010734,abnormal paranode morphology|MP:0014052,increased male germ cell apoptosis|MP:0020550,multinucleated giant male germ cells
MGI:6114064	Galc<M1Btlr>	MP:0001262,decreased body weight
MGI:6268378	Galc<m2Btlr>	MP:0001265,decreased body size|MP:0001393,ataxia|MP:0004875,increased mean systemic arterial blood pressure|MP:0005333,decreased heart rate|MP:0006143,increased systemic arterial diastolic blood pressure
MGI:6304952	Galc<m3Btlr>	MP:0000755,hindlimb paralysis|MP:0001393,ataxia
MGI:6725088	Galc<m4Btlr>	MP:0000160,kyphosis|MP:0001265,decreased body size|MP:0004703,abnormal vertebral column morphology
MGI:2385783	Galc<tm1Wngr>	MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000921,demyelination|MP:0001790,abnormal immune system physiology|MP:0002083,premature death|MP:0005150,cachexia|MP:0005584,abnormal enzyme/coenzyme activity
MGI:1856218	Galc<twi>	MP:0000063,decreased bone mineral density|MP:0000133,abnormal long bone metaphysis morphology|MP:0000135,decreased compact bone thickness|MP:0000136,abnormal microglial cell morphology|MP:0000527,abnormal kidney development|MP:0000745,tremors|MP:0000748,progressive muscle weakness|MP:0000754,paresis|MP:0000755,hindlimb paralysis|MP:0000783,abnormal forebrain morphology|MP:0000841,abnormal hindbrain morphology|MP:0000846,abnormal medulla oblongata morphology|MP:0000848,abnormal pons morphology|MP:0000921,demyelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0000958,peripheral nervous system degeneration|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001523,impaired righting response|MP:0001524,impaired limb coordination|MP:0001541,abnormal osteoclast physiology|MP:0001547,abnormal lipid level|MP:0001785,edema|MP:0002083,premature death|MP:0002113,abnormal skeleton development|MP:0002135,abnormal kidney morphology|MP:0002136,abnormal kidney physiology|MP:0002152,abnormal brain morphology|MP:0002182,abnormal astrocyte morphology|MP:0002183,gliosis|MP:0002446,abnormal macrophage morphology|MP:0002651,abnormal sciatic nerve morphology|MP:0002998,abnormal bone remodeling|MP:0003354,astrocytosis|MP:0003633,abnormal nervous system physiology|MP:0003871,abnormal myelin sheath morphology|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004967,abnormal kidney epithelium morphology|MP:0005150,cachexia|MP:0005167,abnormal blood-brain barrier function|MP:0005367,renal/urinary system phenotype|MP:0005405,axon degeneration|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006082,CNS inflammation|MP:0008026,abnormal brain white matter morphology|MP:0008027,abnormal spinal cord white matter morphology|MP:0008469,abnormal protein level|MP:0008752,abnormal tumor necrosis factor level|MP:0009046,muscle twitch|MP:0009434,paraparesis|MP:0009808,decreased oligodendrocyte number|MP:0009823,abnormal sphingomyelin level|MP:0009978,abnormal cerebellum white matter morphology|MP:0010047,axonal spheroids|MP:0010170,abnormal glial cell apoptosis|MP:0010869,decreased bone trabecula number|MP:0010892,increased oligodendrocyte progenitor number|MP:0030825,decreased femur size|MP:0030826,decreased femur weight
MGI:1856219	Galc<twi-2J>	MP:0000745,tremors|MP:0001406,abnormal gait
MGI:3800611	Galc<twi-4J>	MP:0000745,tremors|MP:0001393,ataxia
MGI:3800471	Galc<twi-5J>	MP:0000745,tremors|MP:0000746,weakness|MP:0000780,abnormal corpus callosum morphology|MP:0000921,demyelination|MP:0000955,abnormal spinal cord morphology|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002183,gliosis|MP:0003354,astrocytosis|MP:0005150,cachexia|MP:0005391,vision/eye phenotype|MP:0005404,abnormal axon morphology|MP:0008246,abnormal leukocyte morphology|MP:0008489,slow postnatal weight gain|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2148688	Galk1<tm1Stb>	MP:0001764,abnormal homeostasis|MP:0005391,vision/eye phenotype
MGI:5613648	Galk2<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002110,abnormal digit morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0005344,increased circulating bilirubin level|MP:0010052,increased grip strength|MP:0010097,abnormal retina blood vessel morphology
MGI:2686931	Galns<tm1Toma>	MP:0001312,abnormal cornea morphology|MP:0003172,abnormal lysosome physiology|MP:0011473,increased urine glycosaminoglycan level
MGI:3612971	Galns<tm2(GALNS)Toma>	MP:0000163,abnormal cartilage morphology|MP:0001312,abnormal cornea morphology|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0005059,lysosomal protein accumulation
MGI:3715442	Galns<tm3Toma>	MP:0005059,lysosomal protein accumulation
MGI:3529233	Galnt10<Gt(OST354785)Lex>	MP:0002169,no abnormal phenotype detected
MGI:6472727	Galnt11<tm1Kgth>	MP:0000182,increased circulating LDL cholesterol level|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005565,increased blood urea nitrogen level
MGI:5662540	Galnt12<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0002833,increased heart weight
MGI:6276859	Galnt13<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney
MGI:3699607	Galnt13<tm1Jxm>	MP:0002169,no abnormal phenotype detected
MGI:5007152	Galnt14<tm1Lex>	MP:0003858,enhanced coordination
MGI:5695943	Galnt17<tm1.1(KOMP)Vlcg>	MP:0010053,decreased grip strength
MGI:5637158	Galnt18<tm1b(KOMP)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0008044,increased NK cell number|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level
MGI:3769258	Galnt1<tm1.1Jxm>	MP:0000221,decreased leukocyte cell number|MP:0000267,abnormal heart development|MP:0000274,enlarged heart|MP:0000351,increased cell proliferation|MP:0001790,abnormal immune system physiology|MP:0001805,decreased IgG level|MP:0002607,decreased basophil cell number|MP:0003958,heart valve hyperplasia|MP:0005012,decreased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005419,decreased circulating serum albumin level|MP:0005606,increased bleeding time|MP:0006047,aortic valve regurgitation|MP:0006117,aortic valve stenosis|MP:0006128,pulmonary valve stenosis|MP:0008028,pregnancy-related premature death|MP:0008098,decreased plasma cell number|MP:0008101,lymph node hypoplasia|MP:0008178,decreased germinal center B cell number|MP:0008482,decreased spleen germinal center number|MP:0010470,dilated ascending aorta|MP:0010594,thick aortic valve|MP:0010601,thick pulmonary valve|MP:0010620,thick mitral valve|MP:0010629,thick tricuspid valve|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011925,abnormal heart echocardiography feature|MP:0011929,abnormal aortic valve flow|MP:0011931,abnormal pulmonary valve flow|MP:0020332,impaired leukocyte tethering or rolling|MP:0031633,decreased heart left ventricle muscle contractility
MGI:1931149	Galnt1<tm1Jxm>	MP:0002169,no abnormal phenotype detected
MGI:6414556	Galnt2<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6368825	Galnt2<tm1.2Mrl>	MP:0000186,decreased circulating HDL cholesterol level|MP:0005317,increased triglyceride level|MP:0011582,decreased triglyceride lipase activity
MGI:7431371	Galnt3<em1(IMPC)Ccpcz>	MP:0005011,increased eosinophil cell number
MGI:5435287	Galnt3<tcal>	MP:0000062,increased bone mineral density|MP:0000762,abnormal tongue morphology|MP:0001566,increased circulating phosphate level|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0002837,dystrophic cardiac calcinosis|MP:0003195,calcinosis|MP:0003196,calcified skin|MP:0003197,nephrocalcinosis|MP:0003199,calcified muscle|MP:0005250,decreased Sertoli cell number|MP:0005416,abnormal circulating protein level|MP:0010522,calcified aorta|MP:0010868,increased bone trabecula number|MP:0010964,increased compact bone volume|MP:0011368,increased kidney apoptosis|MP:0011585,decreased alkaline phosphatase activity|MP:0012337,increased vitamin D level|MP:0013601,increased testis apoptosis|MP:0031197,calcified testicular artery
MGI:5052340	Galnt3<tm1.1Cfg>	MP:0000223,decreased monocyte cell number|MP:0003179,thrombocytopenia|MP:0005344,increased circulating bilirubin level
MGI:4355571	Galnt3<tm1Mjec>	MP:0000062,increased bone mineral density|MP:0000194,increased circulating calcium level|MP:0000559,abnormal femur morphology|MP:0001153,small seminiferous tubules|MP:0001566,increased circulating phosphate level|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0002905,decreased circulating parathyroid hormone level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005578,teratozoospermia|MP:0011228,abnormal vitamin D level
MGI:6690609	Galnt3<tm1Tok>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0014052,increased male germ cell apoptosis|MP:0020869,immotile sperm|MP:0031354,abnormal acrosome assembly|MP:0031355,abnormal proacrosomal vesicle fusion
MGI:3775952	Galnt4<tm1Tabk>	MP:0002169,no abnormal phenotype detected
MGI:6342892	Galnt9<em1(IMPC)H>	MP:0001314,cornea opacity
MGI:5577268	Galntl5<tm1b(KOMP)Wtsi>	MP:0011959,abnormal eye posterior chamber depth
MGI:5574442	Galntl5<tm1Nari>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008898,abnormal acrosome morphology
MGI:6377462	Galntl6<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:3817530	Galp<tm1Stei>	MP:0004856,decreased ovary weight|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0011957,decreased compensatory feeding amount
MGI:6355930	Galr1<em1(IMPC)H>	MP:0000691,enlarged spleen|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number
MGI:3604584	Galr1<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:2446477	Galr1<tm1Tpi>	MP:0002912,abnormal excitatory postsynaptic potential|MP:0005386,behavior/neurological phenotype|MP:0009712,impaired conditioned place preference behavior
MGI:6741055	Galr2<em1(IMPC)H>	MP:0005419,decreased circulating serum albumin level
MGI:3050672	Galr2<Gt1Stei>	MP:0005386,behavior/neurological phenotype
MGI:3530476	Galr2<Gt(OST105469)Lex>	MP:0002757,decreased vertical activity|MP:0002912,abnormal excitatory postsynaptic potential|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0009712,impaired conditioned place preference behavior
MGI:3622325	Galr2<tm1Dgen>	MP:0001022,abnormal L5 dorsal root ganglion morphology|MP:0001973,increased thermal nociceptive threshold
MGI:3528737	Galr3<tm1Lex>	MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0003631,nervous system phenotype|MP:0003982,increased cholesterol level|MP:0005317,increased triglyceride level|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005386,behavior/neurological phenotype|MP:0005397,hematopoietic system phenotype
MGI:3910613	Galt<Gt(E285B04)Wrst>	MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0001732,postnatal growth retardation|MP:0001847,brain inflammation|MP:0001860,liver inflammation|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002679,abnormal corpus luteum morphology|MP:0003674,oxidative stress|MP:0004018,abnormal galactose homeostasis|MP:0008871,abnormal ovarian follicle number|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011854,cerebral edema|MP:0014327,decreased Purkinje cell size
MGI:6361662	Gal<tm1.1Pjen>	MP:0003063,increased coping response|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0011620,abnormal habituation to a new environment
MGI:2183172	Gal<tm1Wyn>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0000807,abnormal hippocampus morphology|MP:0000966,decreased sensory neuron number|MP:0001021,small L4 dorsal root ganglion|MP:0001024,small L5 dorsal root ganglion|MP:0001458,abnormal object recognition memory|MP:0001560,abnormal circulating insulin level|MP:0001746,abnormal pituitary secretion|MP:0001882,abnormal lactation|MP:0002064,seizures|MP:0002163,abnormal gland morphology|MP:0002164,abnormal gland physiology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002997,enlarged seminal vesicle|MP:0003008,enhanced long-term potentiation|MP:0003059,decreased insulin secretion|MP:0003368,decreased circulating glucocorticoid level|MP:0004852,decreased testis weight|MP:0004858,abnormal nervous system regeneration|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0008332,decreased lactotroph cell number|MP:0010249,lactation failure|MP:0014269,decreased testes secretion|MP:0014440,increased response to leptin
MGI:2180188	Galt<tm1Sgl>	MP:0004018,abnormal galactose homeostasis
MGI:6268363	Gamt<m1Btlr>	MP:0001262,decreased body weight
MGI:3044282	Gamt<tm1Isb>	MP:0000679,increased percent water in carcass|MP:0001262,decreased body weight|MP:0001506,limp posture|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0002082,postnatal lethality|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0005332,abnormal amino acid level|MP:0005554,decreased circulating creatinine level|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010062,decreased creatine level|MP:0010065,decreased circulating creatine level|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011468,abnormal urine amino acid level|MP:0011471,decreased urine creatinine level|MP:0020550,multinucleated giant male germ cells|MP:0030633,decreased urine creatine level
MGI:6695176	Ganab<em#Xche>	MP:0002169,no abnormal phenotype detected|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3522303	gand	MP:0000371,diluted coat color|MP:0001393,ataxia|MP:0001523,impaired righting response|MP:0011085,postnatal lethality, complete penetrance
MGI:3812434	Gan<tm1Jpj>	MP:0000940,abnormal motor neuron innervation pattern|MP:0002269,muscular atrophy|MP:0003632,abnormal nervous system morphology|MP:0003993,abnormal ventral spinal root morphology
MGI:3611911	Gan<tm1Yany>	MP:0000358,abnormal cell morphology|MP:0000743,muscle spasm|MP:0000746,weakness|MP:0000748,progressive muscle weakness|MP:0001263,weight loss|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0002064,seizures|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0003313,abnormal locomotor activation|MP:0003871,abnormal myelin sheath morphology|MP:0004768,abnormal axonal transport|MP:0005404,abnormal axon morphology
MGI:4431861	Gap43<tm1a(EUCOMM)Wtsi>	MP:0001260,increased body weight|MP:0001262,decreased body weight
MGI:2180341	Gap43<tm1Kmr>	MP:0000788,abnormal cerebral cortex morphology|MP:0000861,disorganized barrel cortex|MP:0002961,abnormal axon guidance|MP:0003651,abnormal axon extension|MP:0004948,abnormal neuronal precursor proliferation|MP:0008770,decreased survivor rate|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2448337	Gap43<tm1Mcf>	MP:0001262,decreased body weight|MP:0001332,abnormal optic nerve innervation|MP:0001334,absent optic tract|MP:0002083,premature death|MP:0005404,abnormal axon morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020549,increased optic chiasm size
MGI:6423823	Gapdh<em1(IMPC)Mbp>	MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001614,abnormal blood vessel morphology|MP:0002699,abnormal vitreous body morphology|MP:0003984,embryonic growth retardation|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2183515	Gapdh<m1Neu>	MP:0005584,abnormal enzyme/coenzyme activity|MP:0011100,preweaning lethality, complete penetrance|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0011609,decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity
MGI:2183516	Gapdh<m2Neu>	MP:0005584,abnormal enzyme/coenzyme activity|MP:0011100,preweaning lethality, complete penetrance|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0011609,decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity
MGI:2183517	Gapdh<m3Neu>	MP:0005584,abnormal enzyme/coenzyme activity|MP:0008770,decreased survivor rate|MP:0011100,preweaning lethality, complete penetrance|MP:0011609,decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity
MGI:2183518	Gapdh<m4Neu>	MP:0005584,abnormal enzyme/coenzyme activity|MP:0011100,preweaning lethality, complete penetrance|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011609,decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity
MGI:3701514	Gapdh<M5Neu>	MP:0011100,preweaning lethality, complete penetrance|MP:0011609,decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity
MGI:3701515	Gapdh<M6Neu>	MP:0002596,abnormal hematocrit|MP:0002874,decreased hemoglobin content|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005397,hematopoietic system phenotype|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011609,decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity
MGI:3701517	Gapdh<M7Neu>	MP:0011100,preweaning lethality, complete penetrance|MP:0011609,decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity
MGI:3701520	Gapdh<M8Neu>	MP:0011100,preweaning lethality, complete penetrance|MP:0011609,decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity
MGI:3701521	Gapdh<M9Neu>	MP:0011100,preweaning lethality, complete penetrance|MP:0011609,decreased glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity
MGI:3522094	Gapdhs<tm1Dao>	MP:0001925,male infertility|MP:0002675,asthenozoospermia
MGI:3809581	Gapt<tm1.1Wz>	MP:0002494,increased IgM level|MP:0005154,increased B cell proliferation|MP:0005387,immune system phenotype|MP:0008181,increased marginal zone B cell number|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level
MGI:6158489	Gapvd1<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002188,small heart|MP:0002339,abnormal lymph node morphology|MP:0003068,enlarged kidney|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:4432700	Gar1<tm1a(EUCOMM)Wtsi>	MP:0003019,increased circulating chloride level|MP:0003020,decreased circulating chloride level|MP:0005633,increased circulating sodium level|MP:0005634,decreased circulating sodium level
MGI:7427461	Garem1<em1.1Hkon>	MP:0001262,decreased body weight|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:6423851	Garem1<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002574,increased vertical activity|MP:0002989,small kidney
MGI:6456657	Garem2<tm1.2Hkon>	MP:0001364,decreased anxiety-related response|MP:0001415,increased exploration in new environment|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002574,increased vertical activity|MP:0003063,increased coping response|MP:0008415,abnormal neurite morphology
MGI:6358081	Garin1a<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001157,small seminal vesicle|MP:0001262,decreased body weight|MP:0001489,decreased startle reflex|MP:0002059,abnormal seminal vesicle morphology|MP:0002135,abnormal kidney morphology|MP:0009709,hydrometra
MGI:6825733	Garin1a<em1Osb>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology
MGI:6341899	Garin1b<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002135,abnormal kidney morphology|MP:0003604,single kidney|MP:0005627,increased circulating potassium level
MGI:6825731	Garin1b<em1Osb>	MP:0001925,male infertility|MP:0004542,impaired acrosome reaction|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009280,decreased activated sperm motility|MP:0030976,impaired sperm penetration of zona pellucida
MGI:6341834	Garin2<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis
MGI:7620297	Garin2<em1Maq>	MP:0002169,no abnormal phenotype detected
MGI:7666151	Garin2<em1Osb>	MP:0002675,asthenozoospermia|MP:0009230,abnormal sperm head morphology|MP:0030976,impaired sperm penetration of zona pellucida
MGI:7666152	Garin3<em1Osb>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0030976,impaired sperm penetration of zona pellucida|MP:0030978,impaired binding of sperm to zona pellucida
MGI:7666153	Garin4<em1Osb>	MP:0009230,abnormal sperm head morphology|MP:0030976,impaired sperm penetration of zona pellucida
MGI:7666154	Garin5a<em1Osb>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0009230,abnormal sperm head morphology|MP:0030976,impaired sperm penetration of zona pellucida
MGI:7666155	Garin5b<em1Osb>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0009230,abnormal sperm head morphology|MP:0030976,impaired sperm penetration of zona pellucida
MGI:7425705	Garnl3<em1(IMPC)Bay>	MP:0001293,anophthalmia
MGI:5803794	Garre1<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:3760297	Gars1<C201R>	MP:0000747,muscle weakness|MP:0000965,abnormal sensory neuron morphology|MP:0001052,abnormal innervation pattern to muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001524,impaired limb coordination|MP:0002651,abnormal sciatic nerve morphology|MP:0002913,abnormal PNS synaptic transmission|MP:0003083,abnormal tibialis anterior morphology|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0003635,abnormal synaptic transmission|MP:0008814,decreased nerve conduction velocity|MP:0009406,decreased skeletal muscle fiber number|MP:0009428,decreased tibialis anterior weight|MP:0010053,decreased grip strength|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0014587,impaired fine motor coordination
MGI:6156586	Gars1<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000274,enlarged heart|MP:0000470,abnormal stomach morphology|MP:0000692,small spleen|MP:0001417,decreased exploration in new environment|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:3655818	Gars1<Gt(XM256)6Byg>	MP:0002169,no abnormal phenotype detected|MP:0011091,prenatal lethality, complete penetrance
MGI:3513831	Gars1<Nmf249>	MP:0000921,demyelination|MP:0001052,abnormal innervation pattern to muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0002913,abnormal PNS synaptic transmission|MP:0002914,abnormal endplate potential|MP:0003631,nervous system phenotype|MP:0003632,abnormal nervous system morphology|MP:0003635,abnormal synaptic transmission|MP:0004232,decreased muscle weight|MP:0005403,abnormal nerve conduction|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0008814,decreased nerve conduction velocity|MP:0010053,decreased grip strength|MP:0011091,prenatal lethality, complete penetrance|MP:0014603,neuromuscular synapse degeneration
MGI:5513780	Gart<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2388397	Gas1<tm1Fan>	MP:0000029,abnormal malleus morphology|MP:0000030,abnormal tympanic ring morphology|MP:0000039,abnormal otic capsule morphology|MP:0000074,abnormal neurocranium morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0000564,syndactyly|MP:0000566,synostosis|MP:0000852,small cerebellum|MP:0000854,abnormal cerebellum development|MP:0000857,abnormal cerebellar foliation|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000877,abnormal Purkinje cell morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001286,abnormal eye development|MP:0001297,microphthalmia|MP:0001306,small lens|MP:0001312,abnormal cornea morphology|MP:0001322,abnormal iris morphology|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0001679,thin apical ectodermal ridge|MP:0002092,abnormal eye morphology|MP:0002115,abnormal limb bone morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002543,brachyphalangia|MP:0002544,brachydactyly|MP:0002699,abnormal vitreous body morphology|MP:0002820,abnormal premaxilla morphology|MP:0004053,abnormal synchondrosis|MP:0004423,abnormal temporal bone squamous part morphology|MP:0004459,small alisphenoid bone|MP:0004634,short metacarpal bones|MP:0004635,short metatarsal bones|MP:0004726,abnormal nasal capsule morphology|MP:0004871,premaxilla hypoplasia|MP:0005099,abnormal ciliary body morphology|MP:0005107,abnormal stapes morphology|MP:0005157,holoprosencephaly|MP:0005172,decreased eye pigmentation|MP:0005193,abnormal anterior eye segment morphology|MP:0005195,abnormal posterior eye segment morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005241,abnormal retina ganglion layer morphology|MP:0005262,coloboma|MP:0005287,narrow eye opening|MP:0005306,abnormal phalanx morphology|MP:0005358,abnormal incisor morphology|MP:0005650,abnormal limb bud morphology|MP:0006033,abnormal external auditory canal morphology|MP:0006069,abnormal retina neuronal layer morphology|MP:0006099,thin cerebellar granule layer|MP:0006280,abnormal digit development|MP:0008023,abnormal styloid process morphology|MP:0008374,abnormal malleus manubrium morphology|MP:0008381,absent gonial bone|MP:0008382,gonial bone hypoplasia|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0009655,abnormal secondary palate development|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0010029,abnormal basicranium morphology|MP:0010324,abnormal malleus processus brevis morphology|MP:0010327,abnormal malleus neck morphology|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011261,abnormal limb mesenchyme morphology|MP:0011962,increased cornea thickness|MP:0012085,midface hypoplasia|MP:0013595,absent vomeronasal organ|MP:0013826,absent hypoglossal canal|MP:0014291,decreased autopod size|MP:0014327,decreased Purkinje cell size|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0030321,abnormal tegmen tympani morphology|MP:0030322,styloid process hypoplasia|MP:0031499,decreased cornea size
MGI:3711070	Gas1<tm2Fan>	MP:0000030,abnormal tympanic ring morphology|MP:0000097,short maxilla|MP:0000141,abnormal vertebral body morphology|MP:0000547,short limbs|MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0000925,abnormal floor plate morphology|MP:0002110,abnormal digit morphology|MP:0004418,small parietal bone|MP:0004981,decreased neuronal precursor cell number|MP:0009903,abnormal medial nasal prominence morphology|MP:0014281,hindlimb oligodactyly
MGI:5569062	Gas2l1<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001925,male infertility|MP:0002060,abnormal skin morphology|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis
MGI:4841109	Gas2l2<tm1a(KOMP)Wtsi>	MP:0000106,abnormal basisphenoid bone morphology|MP:0000141,abnormal vertebral body morphology|MP:0000443,abnormal snout morphology|MP:0000602,dilated liver sinusoidal space|MP:0000614,absent salivary gland|MP:0000644,dextrocardia|MP:0000783,abnormal forebrain morphology|MP:0000897,abnormal midbrain morphology|MP:0000928,incomplete rostral neuropore closure|MP:0000963,fused dorsal root ganglion|MP:0001293,anophthalmia|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002169,no abnormal phenotype detected|MP:0002237,abnormal nasal cavity morphology|MP:0002240,abnormal paranasal sinus morphology|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0002767,situs ambiguus|MP:0003078,aphakia|MP:0003266,biliary cyst|MP:0003330,abnormal auditory tube morphology|MP:0003586,dilated ureter|MP:0003686,abnormal eye muscle morphology|MP:0004268,abnormal optic stalk morphology|MP:0004603,absent vertebral arch|MP:0004613,fusion of vertebral arches|MP:0004666,absent stapedial artery|MP:0004738,abnormal auditory brainstem response|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006358,absent pinna reflex|MP:0009576,oral atresia|MP:0009905,absent tongue|MP:0010025,decreased total body fat amount|MP:0010418,perimembraneous ventricular septal defect|MP:0010752,impaired mucociliary clearance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0013820,absent optic cup|MP:0013823,absent segment of anterior cerebral artery|MP:0013852,abnormal Mullerian duct topology|MP:0013875,increased trigeminal neuroma incidence|MP:0013877,abnormal ductus venosus valve morphology|MP:0013936,abnormal thymus topology|MP:0013976,abnormal left vena cava superior connection|MP:0013995,abnormal external carotid artery origin|MP:0014001,abnormal vertebral artery topology|MP:0014018,embryo tumor|MP:0020488,abnormal middle cerebral artery origin|MP:0020490,abnormal ophthalmic artery origin
MGI:6336196	Gas2l2<tm1c(KOMP)Wtsi>	MP:0001891,hydrocephaly|MP:0002237,abnormal nasal cavity morphology|MP:0002240,abnormal paranasal sinus morphology|MP:0010752,impaired mucociliary clearance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5925364	Gas2l3<tm1c(EUCOMM)Hmgu>	MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003567,abnormal fetal cardiomyocyte proliferation|MP:0004937,dilated heart|MP:0005385,cardiovascular system phenotype|MP:0005608,cardiac interstitial fibrosis|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0013289,abnormal mitotic cytokinesis
MGI:5925365	Gas2l3<tm1d(EUCOMM)Hmgu>	MP:0000278,abnormal myocardial fiber morphology|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0004564,increased myocardial fiber size|MP:0004567,decreased myocardial fiber number|MP:0005140,decreased cardiac muscle contractility|MP:0005370,liver/biliary system phenotype|MP:0005608,cardiac interstitial fibrosis|MP:0008022,dilated heart ventricle|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0020409,abnormal cardiac thrombosis|MP:0031609,increased fetal cardiomyocyte size|MP:0031611,decreased fetal cardiomyocyte number
MGI:4841616	Gas2<tm1a(EUCOMM)Hmgu>	MP:0001963,abnormal hearing physiology|MP:0003825,abnormal pillar cell morphology|MP:0004300,abnormal organ of Corti supporting cell morphology|MP:0004302,abnormal Deiters cell morphology|MP:0004402,decreased cochlear outer hair cell number|MP:0004736,abnormal distortion product otoacoustic emission|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6725132	Gas2<tm1c(EUCOMM)Hmgu>	MP:0003825,abnormal pillar cell morphology|MP:0004736,abnormal distortion product otoacoustic emission|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6187669	Gas2<tm1(GFP/cre/ERT2)Pzg>	MP:0001126,abnormal ovary morphology|MP:0001130,abnormal ovarian folliculogenesis|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002680,decreased corpora lutea number|MP:0003355,decreased ovulation rate|MP:0003582,abnormal ovary development|MP:0004273,abnormal basal lamina morphology|MP:0008868,abnormal granulosa cell morphology|MP:0009433,polyovular ovarian follicle|MP:0011129,decreased tertiary ovarian follicle number
MGI:6489537	Gas5<em1Gpt>	MP:0000066,osteoporosis|MP:0000130,abnormal trabecular bone morphology|MP:0002080,prenatal lethality|MP:0002999,abnormal bone healing|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0011711,impaired osteoblast differentiation|MP:0013630,increased bone trabecular spacing
MGI:5766764	Gas6<tm1.1(KOMP)Vlcg>	MP:0000274,enlarged heart|MP:0002092,abnormal eye morphology|MP:0002968,increased circulating alkaline phosphatase level
MGI:3664768	Gas6<tm1Hiar>	MP:0000199,abnormal circulating serum albumin level|MP:0002871,albuminuria|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005387,immune system phenotype|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0011441,decreased kidney cell proliferation|MP:0011506,glomerular crescent
MGI:2675495	Gas6<tm1Pec>	MP:0003070,increased vascular permeability|MP:0005391,vision/eye phenotype|MP:0009446,abnormal platelet dense granule physiology|MP:0009549,decreased platelet aggregation|MP:0031120,decreased susceptibility to induced thrombosis
MGI:5789880	Gas7<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0002590,increased mean corpuscular volume|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:5702632	Gas7<tm1Slch>	MP:0000748,progressive muscle weakness|MP:0000939,decreased motor neuron number|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001405,impaired coordination|MP:0003081,abnormal soleus morphology|MP:0003631,nervous system phenotype|MP:0004243,abnormal motor nerve collateral sprouting|MP:0005378,growth/size/body region phenotype|MP:0009401,increased skeletal muscle fiber diameter|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0010053,decreased grip strength
MGI:7519112	Gas8<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:3870680	Gas8<Gt(CH0760)Wtsi>	MP:0001891,hydrocephaly|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0010808,right-sided stomach|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011069,abnormal brain ependyma motile cilium physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011253,situs inversus with levocardia
MGI:2155784	Gasa1<BALB/cCrSlc>	MP:0001873,stomach inflammation
MGI:2155786	Gasa2<BALB/cCrSlc>	MP:0001873,stomach inflammation
MGI:3582613	Gast<tm1(INS)Ez>	MP:0002079,increased circulating insulin level|MP:0003564,abnormal insulin secretion|MP:0005292,improved glucose tolerance
MGI:2182563	Gast<tm1Lcs>	MP:0000501,abnormal digestive secretion|MP:0001663,abnormal digestive system physiology|MP:0001873,stomach inflammation|MP:0003892,abnormal gastric gland morphology|MP:0004139,abnormal gastric parietal cell morphology|MP:0004151,decreased circulating iron level|MP:0005637,abnormal iron homeostasis|MP:0010301,increased stomach tumor incidence|MP:0010792,abnormal stomach mucosa morphology|MP:0011896,increased circulating unsaturated transferrin level
MGI:2384400	Gast<tm1Psi>	MP:0000495,abnormal colon morphology|MP:0004499,increased incidence of tumors by chemical induction|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:2182565	Gast<tm1Tcw>	MP:0000495,abnormal colon morphology|MP:0004138,abnormal mucous neck cell morphology|MP:0004139,abnormal gastric parietal cell morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0008006,increased stomach pH|MP:0010792,abnormal stomach mucosa morphology
MGI:3687875	Gata1<Plt13>	MP:0000228,abnormal thrombopoiesis|MP:0000240,extramedullary hematopoiesis|MP:0000601,small liver|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0001698,decreased embryo size|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002417,abnormal megakaryocyte morphology|MP:0003179,thrombocytopenia|MP:0004025,polyploidy|MP:0004952,increased spleen weight|MP:0008254,increased megakaryocyte cell number|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0013241,embryo tissue necrosis
MGI:3778536	Gata1<tm10Sho>	MP:0005397,hematopoietic system phenotype|MP:0008973,decreased erythroid progenitor cell number
MGI:5521597	Gata1<tm1.1Yen>	MP:0000245,abnormal erythropoiesis|MP:0005397,hematopoietic system phenotype|MP:0008973,decreased erythroid progenitor cell number
MGI:3038080	Gata1<tm1Mym>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000603,pale liver|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0001719,absent vitelline blood vessels|MP:0001722,pale yolk sac|MP:0001770,abnormal iron level|MP:0002083,premature death|MP:0002416,abnormal proerythroblast morphology|MP:0002417,abnormal megakaryocyte morphology|MP:0003179,thrombocytopenia|MP:0004229,abnormal embryonic erythropoiesis|MP:0008477,decreased spleen red pulp amount|MP:0008479,decreased spleen white pulp amount|MP:0008770,decreased survivor rate|MP:0008973,decreased erythroid progenitor cell number|MP:0009246,pale spleen|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2677342	Gata1<tm1Phi>	MP:0000245,abnormal erythropoiesis|MP:0001577,anemia|MP:0002169,no abnormal phenotype detected
MGI:1857600	Gata1<tm1Sho>	MP:0000245,abnormal erythropoiesis|MP:0001577,anemia|MP:0005012,decreased eosinophil cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2177587	Gata1<tm2.1Sho>	MP:0000229,abnormal megakaryocyte differentiation|MP:0001545,abnormal hematopoietic system physiology|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002417,abnormal megakaryocyte morphology|MP:0002599,increased mean platelet volume|MP:0003179,thrombocytopenia|MP:0005397,hematopoietic system phenotype|MP:0008254,increased megakaryocyte cell number
MGI:5521598	Gata1<tm2.1Yen>	MP:0005397,hematopoietic system phenotype
MGI:2177586	Gata1<tm2Sho>	MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0000229,abnormal megakaryocyte differentiation|MP:0000240,extramedullary hematopoiesis|MP:0000333,decreased bone marrow cell number|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002356,abnormal spleen red pulp morphology|MP:0002397,abnormal bone marrow morphology|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002417,abnormal megakaryocyte morphology|MP:0002596,abnormal hematocrit|MP:0002599,increased mean platelet volume|MP:0002643,poikilocytosis|MP:0002875,decreased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0003179,thrombocytopenia|MP:0003405,abnormal platelet shape|MP:0004984,increased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0005016,decreased lymphocyte cell number|MP:0005097,polychromatophilia|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008254,increased megakaryocyte cell number|MP:0008770,decreased survivor rate|MP:0008801,abnormal erythroid progenitor cell morphology|MP:0008872,abnormal physiological response to xenobiotic|MP:0008973,decreased erythroid progenitor cell number|MP:0009338,increased splenocyte number|MP:0010178,increased number of Howell-Jolly bodies|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0010964,increased compact bone volume|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011747,myelofibrosis|MP:0020039,increased bone ossification
MGI:2183389	Gata1<tm4Sho>	MP:0000229,abnormal megakaryocyte differentiation|MP:0000245,abnormal erythropoiesis|MP:0001577,anemia|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:2429992	Gata1<tm5(GATA3)Sho>	MP:0000245,abnormal erythropoiesis|MP:0000291,enlarged pericardium|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0002123,abnormal definitive hematopoiesis|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0008770,decreased survivor rate|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3037864	Gata1<tm6Sho>	MP:0000208,decreased hematocrit|MP:0000217,abnormal leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000691,enlarged spleen|MP:0001844,autoimmune response|MP:0002133,abnormal respiratory system physiology|MP:0002267,abnormal bronchiole morphology|MP:0002875,decreased erythrocyte cell number|MP:0005012,decreased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005388,respiratory system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005501,abnormal skin physiology|MP:0008603,decreased circulating interleukin-4 level|MP:0008609,decreased circulating interleukin-13 level|MP:0009676,abnormal hemostasis
MGI:3582677	Gata1<tm7Sho>	MP:0000245,abnormal erythropoiesis|MP:0000600,liver hypoplasia|MP:0000603,pale liver|MP:0002413,abnormal megakaryocyte progenitor cell morphology
MGI:3582685	Gata1<tm8.1Sho>	MP:0002417,abnormal megakaryocyte morphology
MGI:3582683	Gata1<tm8.2Sho>	MP:0000245,abnormal erythropoiesis|MP:0000600,liver hypoplasia|MP:0000603,pale liver|MP:0002417,abnormal megakaryocyte morphology
MGI:3588564	Gata1<tm9Sho>	MP:0001606,impaired hematopoiesis|MP:0005397,hematopoietic system phenotype
MGI:3628640	Gata2<tm1.1Sac>	MP:0001577,anemia|MP:0011092,embryonic lethality, complete penetrance
MGI:5605839	Gata2<tm1b(KOMP)Wtsi>	MP:0001126,abnormal ovary morphology|MP:0001697,abnormal embryo size|MP:0002135,abnormal kidney morphology|MP:0002631,abnormal epididymis morphology|MP:0003984,embryonic growth retardation|MP:0004727,absent epididymis|MP:0004738,abnormal auditory brainstem response|MP:0004931,enlarged epididymis|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3620070	Gata2<tm1Jeng>	MP:0002169,no abnormal phenotype detected
MGI:4818492	Gata2<tm1Msal>	MP:0003245,abnormal GABAergic neuron morphology|MP:0003631,nervous system phenotype|MP:0003877,abnormal serotonergic neuron morphology|MP:0009937,abnormal neuron differentiation
MGI:2673268	Gata2<tm1Mym>	MP:0002123,abnormal definitive hematopoiesis|MP:0002429,abnormal blood cell morphology/development|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3628639	Gata2<tm1Sac>	MP:0001728,failure of embryo implantation|MP:0001732,postnatal growth retardation|MP:0001746,abnormal pituitary secretion|MP:0001926,female infertility|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003816,abnormal pituitary gland development|MP:0003845,abnormal decidualization|MP:0004896,abnormal endometrium morphology|MP:0004910,decreased seminal vesicle weight|MP:0005119,decreased circulating thyroid-stimulating hormone level|MP:0009671,abnormal uterus physiology
MGI:1857743	Gata2<tm1Sho>	MP:0000291,enlarged pericardium|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0001719,absent vitelline blood vessels|MP:0001722,pale yolk sac|MP:0003396,abnormal embryonic hematopoiesis|MP:0005377,hearing/vestibular/ear phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3805382	Gata2<tm2(Gata2)Jeng>	MP:0000516,abnormal renal/urinary system morphology|MP:0000519,hydronephrosis|MP:0000534,abnormal ureter morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0003446,renal hypoplasia|MP:0003585,large ureter|MP:0003672,abnormal ureter development|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:2183390	Gata2<tm2Sho>	MP:0005397,hematopoietic system phenotype|MP:0010768,mortality/aging
MGI:4837902	Gata2<tm3.1Sho>	MP:0001577,anemia|MP:0003135,increased erythroid progenitor cell number|MP:0005397,hematopoietic system phenotype|MP:0008973,decreased erythroid progenitor cell number|MP:0031276,abnormal stress erythropoiesis
MGI:5014788	Gata2<tm4.1Sho>	MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0005397,hematopoietic system phenotype|MP:0008813,decreased common myeloid progenitor cell number
MGI:3027100	Gata3<jal>	MP:0000377,abnormal hair follicle morphology|MP:0000410,waved hair|MP:0000414,alopecia|MP:0000427,abnormal hair cycle|MP:0001265,decreased body size|MP:0001274,curly vibrissae|MP:0001282,short vibrissae|MP:0002074,abnormal hair texture|MP:0002098,abnormal vibrissa morphology|MP:0003809,abnormal hair shaft morphology|MP:0003810,abnormal hair cuticle|MP:0008733,abnormal hair shaft melanin granule distribution|MP:0010202,focal dorsal hair loss
MGI:5518949	Gata3<tm1.1Gan>	MP:0000031,abnormal cochlea morphology|MP:0000042,abnormal organ of Corti morphology|MP:0001262,decreased body weight|MP:0002622,abnormal cochlear hair cell morphology|MP:0002855,abnormal cochlear ganglion morphology|MP:0002856,abnormal vestibular ganglion morphology|MP:0002857,cochlear ganglion degeneration|MP:0003148,decreased cochlea coiling|MP:0004249,abnormal crista ampullaris morphology|MP:0004405,absent cochlear hair cells|MP:0004408,decreased cochlear hair cell number|MP:0004497,decreased organ of Corti supporting cell number|MP:0006042,increased apoptosis|MP:0006286,inner ear hypoplasia|MP:0011087,neonatal lethality, complete penetrance|MP:0011238,abnormal inner ear development
MGI:3719568	Gata3<tm1.1Mbu>	MP:0001800,abnormal humoral immune response|MP:0008566,increased interferon-gamma secretion|MP:0008700,decreased interleukin-4 secretion
MGI:3720332	Gata3<tm1.2Mbu>	MP:0003827,abnormal Wolffian duct morphology|MP:0008487,abnormal mesonephros morphology|MP:0009073,absent Wolffian ducts|MP:0010978,absent ureteric bud|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2181200	Gata3<tm1Gsv>	MP:0000026,abnormal inner ear morphology|MP:0000029,abnormal malleus morphology|MP:0000030,abnormal tympanic ring morphology|MP:0000036,absent semicircular canals|MP:0000043,organ of Corti degeneration|MP:0000111,cleft palate|MP:0000266,abnormal heart morphology|MP:0000270,abnormal heart tube morphology|MP:0000284,double outlet right ventricle|MP:0000454,abnormal jaw morphology|MP:0000457,maxilla hypoplasia|MP:0000458,abnormal mandible morphology|MP:0000460,mandible hypoplasia|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001071,abnormal facial nerve morphology|MP:0001093,small trigeminal ganglion|MP:0001914,hemorrhage|MP:0002234,abnormal pharynx morphology|MP:0002633,persistent truncus arteriosus|MP:0002639,micrognathia|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0002689,abnormal molar morphology|MP:0002950,abnormal neural crest cell migration|MP:0002961,abnormal axon guidance|MP:0003148,decreased cochlea coiling|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0003743,abnormal facial morphology|MP:0003873,pharyngeal arch hypoplasia|MP:0004113,abnormal aortic arch morphology|MP:0004157,interrupted aortic arch|MP:0004161,cervical aortic arch|MP:0004310,small otic vesicle|MP:0004315,absent vestibular saccule|MP:0004362,cochlear hair cell degeneration|MP:0004369,absent utricle|MP:0004398,cochlear inner hair cell degeneration|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004465,degeneration of organ of Corti supporting cells|MP:0004468,small zygomatic bone|MP:0004540,small maxilla|MP:0004586,pillar cell degeneration|MP:0004592,small mandible|MP:0004664,delayed inner ear development|MP:0004737,absent distortion product otoacoustic emissions|MP:0004740,sensorineural hearing loss|MP:0004923,absent common crus|MP:0005105,abnormal middle ear ossicle morphology|MP:0005106,abnormal incus morphology|MP:0005107,abnormal stapes morphology|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006011,abnormal endolymphatic duct morphology|MP:0006030,abnormal otic vesicle development|MP:0006126,abnormal cardiac outflow tract development|MP:0006287,inner ear cyst|MP:0006337,abnormal first pharyngeal arch morphology|MP:0008380,abnormal gonial bone morphology|MP:0009655,abnormal secondary palate development|MP:0009861,abnormal pyloric sphincter morphology|MP:0009880,decreased mouth size|MP:0009904,tongue hypoplasia|MP:0010355,abnormal first pharyngeal arch artery morphology|MP:0010356,abnormal second pharyngeal arch artery morphology|MP:0010402,ventricular septal defect|MP:0010585,abnormal conotruncal ridge morphology|MP:0010650,abnormal aorticopulmonary septum morphology|MP:0010780,abnormal stomach smooth muscle circular layer morphology|MP:0010805,abnormal stomach smooth muscle outer longitudinal layer morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013818,abnormal oral cavity morphology|MP:0030080,small lower incisors|MP:0030086,bony syngnathia|MP:0030100,hemifacial hypoplasia|MP:0030111,absent temporomandibular joint
MGI:2683927	Gata3<tm1Iho>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001825,arrested T cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0003944,abnormal T cell subpopulation ratio|MP:0005012,decreased eosinophil cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005092,decreased double-positive T cell number|MP:0006413,increased T cell apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008077,abnormal CD8-positive, alpha-beta T cell number|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2153826	Gata3<tm1Jeng>	MP:0001544,abnormal cardiovascular system physiology|MP:0002080,prenatal lethality|MP:0002088,abnormal embryonic growth/weight/body size|MP:0002116,abnormal craniofacial bone morphology|MP:0002123,abnormal definitive hematopoiesis|MP:0002151,abnormal neural tube morphology|MP:0002152,abnormal brain morphology|MP:0002169,no abnormal phenotype detected|MP:0002447,abnormal erythrocyte morphology|MP:0002551,abnormal blood coagulation|MP:0002722,abnormal immune system organ morphology
MGI:3487291	Gata3<tm1Jfz>	MP:0002145,abnormal T cell differentiation|MP:0002169,no abnormal phenotype detected|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002492,decreased IgE level|MP:0002855,abnormal cochlear ganglion morphology|MP:0004861,abnormal Raphe nucleus morphology|MP:0005027,increased susceptibility to parasitic infection|MP:0006270,abnormal mammary gland growth during lactation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008086,increased T-helper 1 cell number|MP:0008091,decreased T-helper 2 cell number|MP:0008673,decreased interleukin-13 secretion|MP:0010070,decreased serotonin level|MP:0010249,lactation failure
MGI:2153825	Gata3<tm1Jml>	MP:0000716,abnormal immune system cell morphology
MGI:2181201	Gata3<tm2Gsv>	MP:0000026,abnormal inner ear morphology|MP:0000036,absent semicircular canals|MP:0000968,abnormal sensory neuron innervation pattern|MP:0002961,abnormal axon guidance|MP:0003148,decreased cochlea coiling|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0004310,small otic vesicle|MP:0004315,absent vestibular saccule|MP:0004369,absent utricle|MP:0004664,delayed inner ear development|MP:0004923,absent common crus|MP:0006011,abnormal endolymphatic duct morphology|MP:0006030,abnormal otic vesicle development|MP:0006287,inner ear cyst|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4418042	Gata3<tm2Jeng>	MP:0000715,decreased thymocyte number|MP:0002081,perinatal lethality|MP:0002145,abnormal T cell differentiation|MP:0002408,abnormal double-positive T cell morphology|MP:0005089,decreased double-negative T cell number|MP:0006387,abnormal T cell number|MP:0008347,decreased gamma-delta T cell number
MGI:3696958	Gata3<tm3Gsv>	MP:0000377,abnormal hair follicle morphology|MP:0000383,abnormal hair follicle orientation|MP:0000416,sparse hair|MP:0000417,short hair|MP:0000422,delayed hair appearance|MP:0000427,abnormal hair cycle|MP:0000652,enlarged sebaceous gland|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001015,small superior cervical ganglion|MP:0001191,abnormal skin condition|MP:0001192,scaly skin|MP:0001211,wrinkled skin|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001242,hyperkeratosis|MP:0001244,thin dermal layer|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001282,short vibrissae|MP:0001344,blepharoptosis|MP:0001672,abnormal embryo development|MP:0001732,postnatal growth retardation|MP:0002060,abnormal skin morphology|MP:0002073,abnormal hair growth|MP:0002074,abnormal hair texture|MP:0002796,impaired skin barrier function|MP:0003861,abnormal nervous system development|MP:0005018,decreased T cell number|MP:0005072,abnormal hair follicle melanin granule morphology|MP:0005287,narrow eye opening|MP:0005379,endocrine/exocrine gland phenotype|MP:0008843,absent subcutaneous adipose tissue|MP:0009004,progressive hair loss|MP:0009284,abnormal sympathetic neuron innervation pattern|MP:0009733,absent nipple|MP:0010684,abnormal hair follicle outer root sheath morphology|MP:0010685,abnormal hair follicle inner root sheath morphology|MP:0010690,thick hair follicle outer root sheath
MGI:7424847	Gata3un<em1Shx>	MP:0002169,no abnormal phenotype detected
MGI:7280955	Gata4<em1Vigr>	MP:0005389,reproductive system phenotype
MGI:5287452	Gata4<Tg(Tyr)2265AOve>	MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:5141274	Gata4<tm1.1Jmol>	MP:0002780,decreased circulating testosterone level|MP:0004484,abnormal response of heart to induced stress|MP:0004486,decreased response of heart to induced stress|MP:0004910,decreased seminal vesicle weight|MP:0005294,abnormal heart ventricle morphology
MGI:3778685	Gata4<tm1.1Sad>	MP:0000278,abnormal myocardial fiber morphology|MP:0000280,thin ventricular wall|MP:0001127,small ovary|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001625,cardiac hypertrophy|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0002016,ovary cyst|MP:0002083,premature death|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002753,dilated heart left ventricle|MP:0002784,abnormal Sertoli cell morphology|MP:0003205,testicular atrophy|MP:0003222,increased cardiomyocyte apoptosis|MP:0003507,abnormal ovary physiology|MP:0003828,pulmonary edema|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0004937,dilated heart|MP:0005140,decreased cardiac muscle contractility|MP:0005294,abnormal heart ventricle morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0009444,ovarian follicular cyst|MP:0011091,prenatal lethality, complete penetrance|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014052,increased male germ cell apoptosis|MP:0014515,decreased circulating anti-Mullerian hormone level|MP:0014636,decreased elongated spermatid number|MP:0020356,abnormal Sertoli cell barrier function|MP:0020451,decreased sperm progressive motility|MP:0020550,multinucleated giant male germ cells|MP:0031420,decreased superovulation rate|MP:0031422,failure of superovulation|MP:0031645,increased myocardial fiber apoptosis
MGI:2386766	Gata4<tm1.1Sho>	MP:0002127,abnormal cardiovascular system morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3526854	Gata4<tm1.1Wtp>	MP:0000284,double outlet right ventricle|MP:0002740,heart hypoplasia|MP:0003984,embryonic growth retardation|MP:0005312,pericardial effusion|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0010422,heart right ventricle hypoplasia|MP:0010432,common ventricle|MP:0010587,conotruncal ridge hypoplasia|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0030992,atrioventricular cushion hypoplasia
MGI:3526856	Gata4<tm1.2Wtp>	MP:0000266,abnormal heart morphology|MP:0001127,small ovary|MP:0001175,abnormal lung morphology|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0001938,delayed sexual maturation|MP:0003507,abnormal ovary physiology|MP:0003924,diaphragmatic hernia|MP:0004007,abnormal lung vasculature morphology|MP:0004856,decreased ovary weight|MP:0004896,abnormal endometrium morphology|MP:0004905,decreased uterus weight|MP:0005181,decreased circulating estradiol level|MP:0005389,reproductive system phenotype|MP:0006042,increased apoptosis|MP:0009008,delayed estrous cycle|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010825,abnormal lung saccule morphology|MP:0010856,dilated respiratory conducting tube|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012061,abnormal diaphragm central tendon morphology|MP:0031420,decreased superovulation rate
MGI:2179443	Gata4<tm1Eno>	MP:0000267,abnormal heart development|MP:0000270,abnormal heart tube morphology|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0002151,abnormal neural tube morphology|MP:0003924,diaphragmatic hernia|MP:0003984,embryonic growth retardation|MP:0004187,cardia bifida|MP:0011092,embryonic lethality, complete penetrance|MP:0011200,abnormal extraembryonic coelom morphology|MP:0012083,absent foregut
MGI:5427934	Gata4<tm1Grg>	MP:0000280,thin ventricular wall|MP:0002652,thin myocardium|MP:0003105,abnormal heart atrium morphology|MP:0003984,embryonic growth retardation|MP:0004225,patent cardiac foramen ovale|MP:0006128,pulmonary valve stenosis|MP:0009328,delayed heart looping|MP:0010403,atrial septal defect|MP:0010463,aorta stenosis|MP:0010556,thin ventricle myocardium compact layer|MP:0010593,thick aortic valve cusps|MP:0010605,thick pulmonary valve cusps|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation
MGI:2386265	Gata4<tm1Jml>	MP:0000267,abnormal heart development|MP:0000474,abnormal foregut morphology|MP:0001698,decreased embryo size|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0001718,abnormal visceral yolk sac morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0012081,absent heart tube
MGI:2386764	Gata4<tm1Sho>	MP:0000267,abnormal heart development|MP:0000284,double outlet right ventricle|MP:0001176,abnormal lung development|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002211,abnormal primary sex determination|MP:0002213,true hermaphroditism|MP:0002652,thin myocardium|MP:0002784,abnormal Sertoli cell morphology|MP:0002995,primary sex reversal|MP:0003140,dilated heart atrium|MP:0003717,pallor|MP:0005294,abnormal heart ventricle morphology|MP:0005385,cardiovascular system phenotype|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010432,common ventricle|MP:0010454,abnormal truncus arteriosus septation|MP:0010561,absent coronary vessels|MP:0010585,abnormal conotruncal ridge morphology|MP:0010607,common atrioventricular valve|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013603,abnormal fetal Leydig cell differentiation
MGI:3526853	Gata4<tm1Wtp>	MP:0000267,abnormal heart development|MP:0000281,abnormal interventricular septum morphology|MP:0000284,double outlet right ventricle|MP:0002192,hydrops fetalis|MP:0004056,abnormal myocardium compact layer morphology|MP:0004062,dilated heart right atrium|MP:0006046,atrioventricular valve regurgitation|MP:0010413,complete atrioventricular septal defect|MP:0010503,myocardial trabeculae hypoplasia|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation
MGI:5296251	Gata5<tm1.1Nemr>	MP:0005385,cardiovascular system phenotype|MP:0010484,bicuspid aortic valve|MP:0010595,abnormal aortic valve cusp morphology
MGI:5296243	Gata5<tm1.2Nemr>	MP:0000231,hypertension|MP:0000267,abnormal heart development|MP:0000274,enlarged heart|MP:0000280,thin ventricular wall|MP:0001613,abnormal vasodilation|MP:0001859,kidney inflammation|MP:0002128,abnormal blood circulation|MP:0002135,abnormal kidney morphology|MP:0002962,increased urine protein level|MP:0003915,increased heart left ventricle weight|MP:0003920,abnormal heart right ventricle morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004217,salt-sensitive hypertension|MP:0004564,increased myocardial fiber size|MP:0004567,decreased myocardial fiber number|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005386,behavior/neurological phenotype|MP:0005528,decreased renal glomerular filtration rate|MP:0005583,decreased renin activity|MP:0005600,increased heart ventricle muscle contractility|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008727,increased heart right atrium size|MP:0010463,aorta stenosis|MP:0010484,bicuspid aortic valve|MP:0010503,myocardial trabeculae hypoplasia|MP:0010595,abnormal aortic valve cusp morphology|MP:0010724,thick interventricular septum|MP:0011572,abnormal aorta bulb morphology|MP:0011749,perivascular fibrosis|MP:0031611,decreased fetal cardiomyocyte number
MGI:4417873	Gata5<tm1Eem>	MP:0000516,abnormal renal/urinary system morphology|MP:0001119,abnormal female reproductive system morphology|MP:0003550,short perineum
MGI:2386318	Gata5<tm1Eno>	MP:0001119,abnormal female reproductive system morphology|MP:0001139,abnormal vagina morphology|MP:0001140,abnormal vagina epithelium morphology|MP:0001142,abnormal vagina orifice morphology|MP:0001923,reduced female fertility|MP:0003315,abnormal perineum morphology|MP:0003316,perineal fistula|MP:0003529,enlarged clitoris|MP:0003541,vaginal inflammation|MP:0003550,short perineum|MP:0011485,abnormal urethra urothelium morphology|MP:0011763,urethritis|MP:0011780,abnormal female urethra morphology|MP:0011850,absent clitoral bone|MP:0013313,female preputial gland hypoplasia
MGI:7424848	Gata6os<em1Shx>	MP:0002169,no abnormal phenotype detected
MGI:6364852	Gata6os<em1Zfa>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0003119,abnormal digestive system development|MP:0004502,decreased incidence of tumors by chemical induction|MP:0008108,abnormal small intestinal villus morphology|MP:0008882,abnormal enterocyte physiology|MP:0012734,abnormal response to radiation
MGI:7424849	Gata6os<em2Shx>	MP:0002169,no abnormal phenotype detected
MGI:6364853	Gata6os<em2Zfa>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0003119,abnormal digestive system development|MP:0008108,abnormal small intestinal villus morphology
MGI:6364855	Gata6os<em4Zfa>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0003119,abnormal digestive system development|MP:0008108,abnormal small intestinal villus morphology
MGI:3663288	Gata6<tm1Eno>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology
MGI:2177784	Gata6<tm1Gsv>	MP:0001685,abnormal endoderm development|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012113,decreased inner cell mass proliferation
MGI:5700508	Gata6<tm1Hadj>	MP:0001921,reduced fertility|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3785386	Gata6<tm1Kgac>	MP:0005388,respiratory system phenotype
MGI:2177785	Gata6<tm1Msp>	MP:0001685,abnormal endoderm development|MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011189,small embryonic epiblast|MP:0011191,increased embryonic epiblast cell apoptosis|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3576383	Gata6<tm1Sad>	MP:0001698,decreased embryo size|MP:0005385,cardiovascular system phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012235,abnormal liver bud morphology
MGI:3654150	Gata6<tm2.1Sad>	MP:0002169,no abnormal phenotype detected|MP:0009743,preaxial polydactyly|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3656027	Gata6<tm2.2Sad>	MP:0011092,embryonic lethality, complete penetrance|MP:0011183,abnormal primitive endoderm morphology|MP:0011185,absent primitive endoderm
MGI:3623678	Gata6<tm2Msp>	MP:0000284,double outlet right ventricle|MP:0001575,cyanosis|MP:0002127,abnormal cardiovascular system morphology|MP:0002633,persistent truncus arteriosus|MP:0004157,interrupted aortic arch|MP:0004160,retroesophageal right subclavian artery|MP:0010418,perimembraneous ventricular septal defect|MP:0010485,aortic arch hypoplasia|MP:0010565,absent fetal ductus arteriosus|MP:0011089,perinatal lethality, complete penetrance
MGI:3662652	Gata6<tm2Sad>	MP:0011092,embryonic lethality, complete penetrance
MGI:3762633	Gatad2a<tm1Rnu>	MP:0000928,incomplete rostral neuropore closure|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001730,embryonic growth arrest|MP:0003229,abnormal vitelline vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011256,abnormal neural fold morphology
MGI:4434913	Gatad2b<tm1a(EUCOMM)Hmgu>	MP:0000780,abnormal corpus callosum morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0001386,abnormal maternal nurturing|MP:0001415,increased exploration in new environment|MP:0002797,increased thigmotaxis|MP:0003743,abnormal facial morphology|MP:0004101,abnormal brain interneuron morphology|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0005386,behavior/neurological phenotype|MP:0006254,thin cerebral cortex|MP:0008414,abnormal spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0010768,mortality/aging|MP:0011089,perinatal lethality, complete penetrance|MP:0012066,decreased astrocyte number|MP:0012167,abnormal epigenetic regulation of gene expression|MP:0020389,increased radial glial cell number|MP:0030189,broad snout
MGI:5692829	Gatad2b<tm1b(EUCOMM)Hmgu>	MP:0000220,increased monocyte cell number|MP:0001402,decreased locomotor activity|MP:0002590,increased mean corpuscular volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0011100,preweaning lethality, complete penetrance
MGI:6358623	Gatb<em1(IMPC)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:6113823	Gatm<em1Btlr>	MP:0005387,immune system phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008883,abnormal enterocyte proliferation|MP:0008885,increased enterocyte apoptosis|MP:0010062,decreased creatine level|MP:0013956,decreased colon length
MGI:6113820	Gatm<m1Btlr>	MP:0005036,diarrhea|MP:0008537,increased susceptibility to induced colitis|MP:0008885,increased enterocyte apoptosis|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010062,decreased creatine level|MP:0010180,increased susceptibility to weight loss|MP:0013482,abnormal duodenum crypts of Lieberkuhn morphology|MP:0013956,decreased colon length
MGI:5465452	Gatm<tm1.1Isb>	MP:0000161,scoliosis|MP:0001146,abnormal testis morphology|MP:0001156,abnormal spermatogenesis|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001431,abnormal eating behavior|MP:0001783,decreased white adipose tissue amount|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002078,abnormal glucose homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0003383,abnormal gluconeogenesis|MP:0004144,hypotonia|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0006086,decreased body mass index|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009356,decreased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0011468,abnormal urine amino acid level|MP:0011471,decreased urine creatinine level|MP:0030016,increased adipocyte glucose uptake|MP:0030021,increased muscle cell glucose uptake|MP:0030633,decreased urine creatine level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5548533	Gatm<tm1b(KOMP)Wtsi>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0005179,decreased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005627,increased circulating potassium level|MP:0008806,increased circulating amylase level|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0010068,decreased red blood cell distribution width|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake
MGI:2660582	Gauc<KK>	MP:0005293,impaired glucose tolerance
MGI:6284267	Gba1<em1(IMPC)H>	MP:0000428,abnormal craniofacial morphology|MP:0004174,abnormal spine curvature|MP:0008806,increased circulating amylase level|MP:0010392,prolonged QRS complex duration|MP:0011100,preweaning lethality, complete penetrance
MGI:3698019	Gba1<tm1.1Clk>	MP:0001190,reddish skin|MP:0001211,wrinkled skin|MP:0001438,aphagia|MP:0011087,neonatal lethality, complete penetrance
MGI:5587841	Gba1<tm1.1Eginn>	MP:0003354,astrocytosis|MP:0004077,abnormal striatum morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008493,alpha-synuclein inclusion body
MGI:3687966	Gba1<tm1.1Karl>	MP:0005584,abnormal enzyme/coenzyme activity|MP:0011087,neonatal lethality, complete penetrance
MGI:5461046	Gba1<tm1.1Mjff>	MP:0002169,no abnormal phenotype detected
MGI:4867659	Gba1<tm1.1Pmis>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000160,kyphosis|MP:0000186,decreased circulating HDL cholesterol level|MP:0000240,extramedullary hematopoiesis|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000703,abnormal thymus morphology|MP:0001265,decreased body size|MP:0001533,abnormal skeleton physiology|MP:0002145,abnormal T cell differentiation|MP:0002874,decreased hemoglobin content|MP:0002981,increased liver weight|MP:0003717,pallor|MP:0005092,decreased double-positive T cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0008395,abnormal osteoblast differentiation|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008577,increased circulating interferon-gamma level|MP:0008593,increased circulating interleukin-10 level|MP:0008597,decreased circulating interleukin-6 level|MP:0008599,increased circulating interleukin-2 level|MP:0008608,increased circulating interleukin-13 level|MP:0008623,increased circulating interleukin-3 level|MP:0008629,increased circulating interleukin-9 level|MP:0008639,decreased circulating interleukin-1 alpha level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0010209,abnormal circulating chemokine level|MP:0010210,abnormal circulating cytokine level|MP:0020040,decreased bone ossification
MGI:7484418	Gba1<tm1.1Smoc>	MP:0001190,reddish skin|MP:0001211,wrinkled skin|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001265,decreased body size|MP:0003652,abnormal skin turgor|MP:0011085,postnatal lethality, complete penetrance
MGI:2680317	Gba1<tm1Ggb>	MP:0001191,abnormal skin condition|MP:0001211,wrinkled skin|MP:0003853,dry skin|MP:0011089,perinatal lethality, complete penetrance
MGI:3687965	Gba1<tm1Karl>	MP:0000136,abnormal microglial cell morphology|MP:0000753,paralysis|MP:0001406,abnormal gait|MP:0002064,seizures|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002152,abnormal brain morphology|MP:0003224,neuron degeneration|MP:0003354,astrocytosis
MGI:1857175	Gba1<tm1Nsb>	MP:0001575,cyanosis|MP:0001943,abnormal respiration|MP:0002081,perinatal lethality|MP:0002446,abnormal macrophage morphology|MP:0002690,akinesia|MP:0005449,abnormal food intake|MP:0009674,decreased birth weight
MGI:2180202	Gba1<tm1Rlp>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000599,enlarged liver|MP:0001190,reddish skin|MP:0001211,wrinkled skin|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0001845,abnormal inflammatory response|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002339,abnormal lymph node morphology|MP:0002446,abnormal macrophage morphology|MP:0002493,increased IgG level|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003865,lymph node inflammation|MP:0003887,increased hepatocyte apoptosis|MP:0004947,skin inflammation|MP:0004952,increased spleen weight|MP:0005179,decreased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005390,skeleton phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008114,abnormal Kupffer cell morphology|MP:0008737,abnormal spleen physiology|MP:0008770,decreased survivor rate|MP:0008842,lipofuscinosis|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5587918	Gba1<tm2.1Eginn>	MP:0003354,astrocytosis|MP:0004077,abnormal striatum morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008493,alpha-synuclein inclusion body
MGI:2680322	Gba1<tm2Ggb>	MP:0000609,abnormal liver physiology|MP:0000689,abnormal spleen morphology|MP:0002295,abnormal pulmonary circulation
MGI:3764510	Gba1<tm2Karl>	MP:0000753,paralysis|MP:0000774,decreased brain size|MP:0000811,hippocampal neuron degeneration|MP:0000880,decreased Purkinje cell number|MP:0001191,abnormal skin condition|MP:0001406,abnormal gait|MP:0002064,seizures|MP:0002082,postnatal lethality|MP:0002118,abnormal lipid homeostasis|MP:0002152,abnormal brain morphology|MP:0002446,abnormal macrophage morphology|MP:0002882,abnormal neuron morphology|MP:0009974,decreased cerebral cortex pyramidal cell number|MP:0011087,neonatal lethality, complete penetrance
MGI:2180204	Gba1<tm2Rlp>	MP:0001190,reddish skin|MP:0001211,wrinkled skin|MP:0001242,hyperkeratosis|MP:0001429,dehydration|MP:0003653,decreased skin turgor|MP:0009546,absent gastric milk in neonates|MP:0009703,decreased birth body size|MP:0011085,postnatal lethality, complete penetrance
MGI:2680324	Gba1<tm3Ggb>	MP:0000609,abnormal liver physiology|MP:0000689,abnormal spleen morphology|MP:0002152,abnormal brain morphology|MP:0002295,abnormal pulmonary circulation
MGI:2680328	Gba1<tm4Ggb>	MP:0000609,abnormal liver physiology|MP:0000689,abnormal spleen morphology|MP:0002295,abnormal pulmonary circulation
MGI:4433071	Gba2<tm1a(EUCOMM)Wtsi>	MP:0005554,decreased circulating creatinine level
MGI:3691302	Gba2<tm1Rus>	MP:0001147,small testis|MP:0001547,abnormal lipid level|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006042,increased apoptosis|MP:0006362,abnormal male germ cell morphology|MP:0009257,dilated seminiferous tubule|MP:0030978,impaired binding of sperm to zona pellucida
MGI:4868492	Gbe1<m1Yty>	MP:0000255,blood vessel congestion|MP:0001785,edema|MP:0002652,thin myocardium|MP:0005294,abnormal heart ventricle morphology|MP:0005333,decreased heart rate|MP:0010018,pulmonary vascular congestion|MP:0010019,liver vascular congestion|MP:0010402,ventricular septal defect|MP:0010580,decreased heart left ventricle size|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011394,increased fetal cardiomyocyte proliferation|MP:0014072,decreased cardiac muscle glycogen level
MGI:5293612	Gbe1<tm1.1Hoa>	MP:0000266,abnormal heart morphology|MP:0002078,abnormal glucose homeostasis|MP:0002106,abnormal muscle physiology|MP:0010398,decreased liver glycogen level|MP:0010399,decreased skeletal muscle glycogen level|MP:0011089,perinatal lethality, complete penetrance
MGI:5293611	Gbe1<tm1Hoa>	MP:0000266,abnormal heart morphology|MP:0000598,abnormal liver morphology|MP:0000759,abnormal skeletal muscle morphology|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002715,decreased glycogen catabolism rate|MP:0005291,abnormal glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0010400,increased liver glycogen level|MP:0010401,increased skeletal muscle glycogen level
MGI:5767122	Gbe1<tm2.1Hoa>	MP:0000746,weakness|MP:0000755,hindlimb paralysis|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0003333,liver fibrosis|MP:0005440,increased glycogen level|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0010400,increased liver glycogen level|MP:0012051,spasticity|MP:0013278,decreased fasting circulating glucose level|MP:0014068,abnormal muscle glycogen level|MP:0014074,increased brain glycogen level
MGI:5767121	Gbe1<tm2Hoa>	MP:0002083,premature death|MP:0005440,increased glycogen level|MP:0010400,increased liver glycogen level|MP:0014068,abnormal muscle glycogen level|MP:0014074,increased brain glycogen level
MGI:8161094	Gbf1<em1Xzha>	MP:0001304,cataract|MP:0002579,disorganized secondary lens fibers|MP:0003237,abnormal lens epithelium morphology|MP:0010263,total cataract|MP:0011091,prenatal lethality, complete penetrance|MP:0020354,increased endoplasmic reticulum stress|MP:0030939,abnormal autophagosome formation|MP:0030941,enhanced autophagy
MGI:4419544	Gbf1<tm1a(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5569959	Gbgt1<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0010052,increased grip strength
MGI:5013366	Gbp2b<tm1Tigm>	MP:0001263,weight loss|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0005036,diarrhea|MP:0005387,immune system phenotype|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:5438973	Gbp2-ps<tm1.1Ktak>	MP:0005387,immune system phenotype
MGI:5475104	Gbp2<tm1.1Kpf>	MP:0005027,increased susceptibility to parasitic infection|MP:0005387,immune system phenotype|MP:0010750,increased susceptibility to parasitic infection induced morbidity/mortality
MGI:5548331	Gbp2<tm1b(KOMP)Wtsi>	MP:0013279,increased fasting circulating glucose level
MGI:5426809	Gbp5<tm1Tigm>	MP:0002412,increased susceptibility to bacterial infection|MP:0008636,decreased circulating interleukin-18 level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008658,decreased interleukin-1 beta secretion|MP:0008685,decreased interleukin-18 secretion|MP:0008719,impaired neutrophil recruitment
MGI:6284359	Gbp7<em1(IMPC)J>	MP:0002968,increased circulating alkaline phosphatase level
MGI:6829662	Gbp7<tm1Ddgd>	MP:0002412,increased susceptibility to bacterial infection|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:3047357	Gbrln<C57BL/6J>	MP:0000807,abnormal hippocampus morphology
MGI:2675452	Gbvq1<CAST/EiJ>	MP:0020132,increased gallbladder volume
MGI:5502431	Gbx1<tm1.1Stwt>	MP:0000939,decreased motor neuron number|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0003631,nervous system phenotype|MP:0004297,abnormal proprioceptive neuron morphology
MGI:5548939	Gbx1<tm1b(KOMP)Wtsi>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0002797,increased thigmotaxis|MP:0002968,increased circulating alkaline phosphatase level|MP:0004924,abnormal behavior|MP:0011874,enlarged urinary bladder
MGI:5544724	Gbx1<tm1Mrh>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001973,increased thermal nociceptive threshold|MP:0003245,abnormal GABAergic neuron morphology|MP:0003313,abnormal locomotor activation|MP:0011994,increased nerve conduction velocity
MGI:5502433	Gbx1<tm1Stwt>	MP:0002169,no abnormal phenotype detected
MGI:2388610	Gbx2<tm1.1Alj>	MP:0002169,no abnormal phenotype detected
MGI:1857634	Gbx2<tm1.1Mrt>	MP:0000026,abnormal inner ear morphology|MP:0000033,absent scala media|MP:0000035,abnormal membranous labyrinth morphology|MP:0000041,absent endolymphatic duct|MP:0000042,abnormal organ of Corti morphology|MP:0000111,cleft palate|MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000776,abnormal inferior colliculus morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000841,abnormal hindbrain morphology|MP:0000847,abnormal metencephalon morphology|MP:0000848,abnormal pons morphology|MP:0000849,abnormal cerebellum morphology|MP:0000850,absent cerebellum|MP:0000854,abnormal cerebellum development|MP:0000897,abnormal midbrain morphology|MP:0000937,abnormal motor neuron morphology|MP:0001066,absent trigeminal nerve|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001575,cyanosis|MP:0002127,abnormal cardiovascular system morphology|MP:0002184,abnormal innervation|MP:0002855,abnormal cochlear ganglion morphology|MP:0002950,abnormal neural crest cell migration|MP:0003146,absent cochlear ganglion|MP:0003148,decreased cochlea coiling|MP:0003161,absent lateral semicircular canal|MP:0003163,absent posterior semicircular canal|MP:0003165,absent superior semicircular canal|MP:0003232,abnormal forebrain development|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0003543,abnormal vascular endothelial cell differentiation|MP:0003661,abnormal locus ceruleus morphology|MP:0003740,fusion of middle ear ossicles|MP:0003864,abnormal midbrain development|MP:0004096,abnormal midbrain-hindbrain boundary development|MP:0004113,abnormal aortic arch morphology|MP:0004158,right aortic arch|MP:0004160,retroesophageal right subclavian artery|MP:0004249,abnormal crista ampullaris morphology|MP:0004310,small otic vesicle|MP:0004315,absent vestibular saccule|MP:0004330,abnormal vestibular saccular macula morphology|MP:0004443,absent supraoccipital bone|MP:0004568,fusion of glossopharyngeal and vagus nerve|MP:0004923,absent common crus|MP:0006108,abnormal hindbrain development|MP:0006287,inner ear cyst|MP:0006289,otic capsule hypoplasia|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0008023,abnormal styloid process morphology|MP:0009843,decreased neural crest cell number|MP:0009845,abnormal neural crest cell morphology|MP:0010418,perimembraneous ventricular septal defect|MP:0011087,neonatal lethality, complete penetrance|MP:0011659,interrupted aortic arch, type b|MP:0012132,abnormal midbrain-hindbrain boundary morphology|MP:0012800,abnormal rhombomere 5 morphology|MP:0030124,middle ear ossicle hypoplasia|MP:0030322,styloid process hypoplasia
MGI:3665450	Gbx2<tm1Mrt>	MP:0002169,no abnormal phenotype detected
MGI:6150910	Gcat<em1Jiha>	MP:0002169,no abnormal phenotype detected
MGI:2450787	Gca<tm1Roes>	MP:0008734,decreased susceptibility to endotoxin shock
MGI:7620191	Gcc2<em1Cya>	MP:0003725,increased autoantibody level
MGI:2182942	Gcdh<tm1Dmk>	MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001523,impaired righting response|MP:0002229,neurodegeneration|MP:0002931,glutaricadicuria|MP:0003068,enlarged kidney|MP:0005202,lethargy|MP:0013242,abnormal amino acid metabolism
MGI:5692549	Gcdh<tm2b(EUCOMM)Hmgu>	MP:0001510,abnormal coat appearance|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005560,decreased circulating glucose level|MP:0005567,decreased circulating total protein level|MP:0005632,decreased circulating aspartate transaminase level|MP:0010579,increased heart left ventricle size|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration
MGI:6423074	Gcg<em1(IMPC)H>	MP:0001402,decreased locomotor activity|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6361025	Gcgr<em1Tshu>	MP:0013278,decreased fasting circulating glucose level
MGI:6690504	Gcgr<em2Smoc>	MP:0000609,abnormal liver physiology|MP:0002712,increased circulating glucagon level|MP:0002981,increased liver weight|MP:0005216,abnormal pancreatic alpha cell morphology|MP:0005292,improved glucose tolerance|MP:0009108,increased pancreas weight|MP:0013278,decreased fasting circulating glucose level|MP:0014109,increased pancreatic alpha cell proliferation|MP:0014143,decreased body fat mass
MGI:5569085	Gcgr<tm1.1(KOMP)Vlcg>	MP:0000194,increased circulating calcium level|MP:0001488,increased startle reflex|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002135,abnormal kidney morphology|MP:0002590,increased mean corpuscular volume|MP:0002727,decreased circulating insulin level|MP:0002981,increased liver weight|MP:0003068,enlarged kidney|MP:0003795,abnormal bone structure|MP:0003917,increased kidney weight|MP:0003960,increased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005565,increased blood urea nitrogen level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0013278,decreased fasting circulating glucose level
MGI:3623116	Gcgr<tm1(GCGR)Kasu>	MP:0002169,no abnormal phenotype detected
MGI:2179458	Gcgr<tm1Jcp>	MP:0001262,decreased body weight|MP:0002712,increased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0003365,increased glucagonoma incidence|MP:0003402,decreased liver weight|MP:0003450,enlarged pancreas|MP:0005215,abnormal pancreatic islet morphology|MP:0005216,abnormal pancreatic alpha cell morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0005560,decreased circulating glucose level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008853,decreased abdominal adipose tissue amount|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009153,increased pancreas tumor incidence|MP:0009171,enlarged pancreatic islets|MP:0009179,abnormal pancreatic alpha cell differentiation|MP:0010182,decreased susceptibility to weight gain|MP:0011819,increased pancreatic beta cell proliferation|MP:0013558,abnormal exocrine gland morphology|MP:0031270,decreased susceptibility to age-related hepatic steatosis
MGI:3505881	Gcgr<tm1Mjch>	MP:0000182,increased circulating LDL cholesterol level|MP:0000189,hypoglycemia|MP:0001402,decreased locomotor activity|MP:0001780,decreased brown adipose tissue amount|MP:0001935,decreased litter size|MP:0002710,increased glucagon secretion|MP:0002712,increased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0004789,increased bile salt level|MP:0005216,abnormal pancreatic alpha cell morphology|MP:0005290,decreased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005311,abnormal circulating amino acid level|MP:0005318,decreased triglyceride level|MP:0005379,endocrine/exocrine gland phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0006087,increased body mass index|MP:0008964,decreased carbon dioxide production|MP:0009108,increased pancreas weight|MP:0009113,increased pancreatic beta cell mass|MP:0009176,increased pancreatic alpha cell number|MP:0009283,decreased gonadal fat pad weight|MP:0009295,decreased interscapular fat pad weight|MP:0010025,decreased total body fat amount|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011940,decreased food intake|MP:0014109,increased pancreatic alpha cell proliferation|MP:0020090,decreased susceptibility to diet-induced non-insulin dependent diabetes|MP:0030589,increased pancreatic alpha cell mass
MGI:5566811	Gcgr<tm2.1Mjch>	MP:0000189,hypoglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002712,increased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0004789,increased bile salt level|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0009108,increased pancreas weight|MP:0009113,increased pancreatic beta cell mass|MP:0009176,increased pancreatic alpha cell number|MP:0014109,increased pancreatic alpha cell proliferation
MGI:4399066	Gcg<tm1Yhys>	MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001732,postnatal growth retardation|MP:0001762,polyuria|MP:0002083,premature death|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005216,abnormal pancreatic alpha cell morphology|MP:0005292,improved glucose tolerance|MP:0005381,digestive/alimentary phenotype|MP:0005559,increased circulating glucose level|MP:0009108,increased pancreas weight|MP:0009167,increased pancreatic islet number
MGI:6257690	Gch1<em1(IMPC)H>	MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6474002	Gch1<em1Ypt>	MP:0000598,abnormal liver morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002152,abnormal brain morphology|MP:0008489,slow postnatal weight gain|MP:0010070,decreased serotonin level|MP:0011085,postnatal lethality, complete penetrance|MP:0012574,decreased noradrenaline level|MP:0013294,prenatal lethality prior to heart atrial septation|MP:0020078,decreased brain tyrosine 3-monooxygenase activity|MP:0020351,decreased vocalization|MP:0020875,decreased nervous system dopamine level|MP:0030697,increased phenylalanine level
MGI:5708509	Gch1<tm1.2Drg>	MP:0005333,decreased heart rate|MP:0005643,decreased dopamine level|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6149199	Gck<em1(IMPC)H>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0010087,increased circulating fructosamine level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:3044558	Gck<Gena348>	MP:0001260,increased body weight|MP:0001559,hyperglycemia|MP:0005293,impaired glucose tolerance
MGI:4357928	Gck<Gls006>	MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005215,abnormal pancreatic islet morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005559,increased circulating glucose level|MP:0009114,decreased pancreatic beta cell mass|MP:0009172,small pancreatic islets|MP:0010768,mortality/aging|MP:0011606,decreased glucokinase activity
MGI:2679373	Gck<Hlb62>	MP:0001559,hyperglycemia|MP:0005293,impaired glucose tolerance
MGI:5640861	Gck<M1Btlr>	MP:0005293,impaired glucose tolerance
MGI:4820836	Gck<m1Rge>	MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0001732,postnatal growth retardation|MP:0001759,increased urine glucose level|MP:0002079,increased circulating insulin level|MP:0002082,postnatal lethality|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0009114,decreased pancreatic beta cell mass|MP:0009172,small pancreatic islets
MGI:6197913	Gck<m2Btlr>	MP:0005293,impaired glucose tolerance
MGI:6149158	Gckr<em1(IMPC)H>	MP:0005293,impaired glucose tolerance|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level
MGI:3033228	Gck<Rgsc149>	MP:0001559,hyperglycemia|MP:0006353,increased glycosylated hemoglobin level
MGI:3033222	Gck<Rgsc210>	MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level|MP:0002082,postnatal lethality|MP:0002628,hepatic steatosis|MP:0005293,impaired glucose tolerance|MP:0006353,increased glycosylated hemoglobin level|MP:0010398,decreased liver glycogen level
MGI:3033229	Gck<Rgsc236>	MP:0001559,hyperglycemia|MP:0006353,increased glycosylated hemoglobin level
MGI:3033223	Gck<Rgsc272>	MP:0001559,hyperglycemia|MP:0002727,decreased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0006353,increased glycosylated hemoglobin level
MGI:3033224	Gck<Rgsc341>	MP:0001559,hyperglycemia|MP:0005293,impaired glucose tolerance|MP:0006353,increased glycosylated hemoglobin level
MGI:3033225	Gck<Rgsc392>	MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0002628,hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0006353,increased glycosylated hemoglobin level|MP:0010398,decreased liver glycogen level
MGI:3033226	Gck<Rgsc475>	MP:0001559,hyperglycemia|MP:0002727,decreased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0006353,increased glycosylated hemoglobin level
MGI:3033230	Gck<Rgsc552>	MP:0001559,hyperglycemia|MP:0006353,increased glycosylated hemoglobin level
MGI:3033231	Gck<Rgsc553>	MP:0001559,hyperglycemia|MP:0006353,increased glycosylated hemoglobin level
MGI:3033227	Gck<Rgsc702>	MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level|MP:0002082,postnatal lethality|MP:0002628,hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0006353,increased glycosylated hemoglobin level|MP:0010398,decreased liver glycogen level
MGI:3033232	Gck<Rgsc735>	MP:0001559,hyperglycemia|MP:0006353,increased glycosylated hemoglobin level
MGI:3811737	Gck<Rgsc960>	MP:0001559,hyperglycemia
MGI:2384075	Gckr<tm1Bms>	MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005319,abnormal enzyme/coenzyme level|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005559,increased circulating glucose level|MP:0010398,decreased liver glycogen level|MP:0011606,decreased glucokinase activity
MGI:2386670	Gckr<tm1Jfg>	MP:0002727,decreased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0011606,decreased glucokinase activity|MP:0014783,decreased liver enzyme/coenzyme level
MGI:3618626	Gck<Sgrd>	MP:0001559,hyperglycemia|MP:0002727,decreased circulating insulin level
MGI:3618627	Gck<Sgrd-2Nwu>	MP:0001559,hyperglycemia|MP:0002727,decreased circulating insulin level
MGI:2177709	Gck<tm1.1Mgn>	MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005439,decreased glycogen level|MP:0005559,increased circulating glucose level|MP:0010398,decreased liver glycogen level|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2177710	Gck<tm1.2Mgn>	MP:0001554,increased circulating free fatty acids level|MP:0001559,hyperglycemia|MP:0002628,hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0010398,decreased liver glycogen level|MP:0011085,postnatal lethality, complete penetrance
MGI:1861929	Gck<tm1Efr>	MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0005293,impaired glucose tolerance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3615946	Gck<tm1Hrt>	MP:0003141,cardiac fibrosis|MP:0003562,abnormal pancreatic beta cell physiology|MP:0003896,prolonged PR interval|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0010392,prolonged QRS complex duration|MP:0011628,increased mitochondrial number|MP:0011635,abnormal mitochondrial crista morphology|MP:0011925,abnormal heart echocardiography feature|MP:0013279,increased fasting circulating glucose level
MGI:2177708	Gck<tm1Mgn>	MP:0005559,increased circulating glucose level
MGI:2177703	Gck<tm1Tka>	MP:0001559,hyperglycemia|MP:0001732,postnatal growth retardation|MP:0001759,increased urine glucose level|MP:0002628,hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005293,impaired glucose tolerance|MP:0005379,endocrine/exocrine gland phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0030970,ketosis
MGI:1857469	Gck<tm1Ts>	MP:0000180,abnormal circulating cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0005293,impaired glucose tolerance|MP:0010398,decreased liver glycogen level|MP:0011085,postnatal lethality, complete penetrance|MP:0031116,microvesicular hepatic steatosis
MGI:6690662	Gck<tm1Ydor>	MP:0000189,hypoglycemia|MP:0002079,increased circulating insulin level|MP:0003058,increased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005293,impaired glucose tolerance|MP:0009113,increased pancreatic beta cell mass|MP:0009114,decreased pancreatic beta cell mass|MP:0010147,abnormal endocrine pancreas physiology|MP:0011819,increased pancreatic beta cell proliferation|MP:0013278,decreased fasting circulating glucose level
MGI:3701697	Gck<tm2Mgn>	MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0003564,abnormal insulin secretion|MP:0005293,impaired glucose tolerance|MP:0005379,endocrine/exocrine gland phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0011606,decreased glucokinase activity
MGI:3701764	Gck<tm3Mgn>	MP:0000189,hypoglycemia|MP:0001560,abnormal circulating insulin level|MP:0002078,abnormal glucose homeostasis|MP:0003564,abnormal insulin secretion|MP:0005379,endocrine/exocrine gland phenotype|MP:0005560,decreased circulating glucose level|MP:0011606,decreased glucokinase activity
MGI:5475270	Gclc<tm1c(EUCOMM)Wtsi>	MP:0001304,cataract|MP:0003674,oxidative stress|MP:0010254,nuclear cataract
MGI:2429419	Gclc<tm1Dwn>	MP:0000609,abnormal liver physiology|MP:0011092,embryonic lethality, complete penetrance
MGI:2387010	Gclc<tm1Mwl>	MP:0000352,decreased cell proliferation|MP:0001672,abnormal embryo development|MP:0001683,absent mesoderm|MP:0001696,failure to gastrulate|MP:0001730,embryonic growth arrest|MP:0002169,no abnormal phenotype detected|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0003984,embryonic growth retardation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5518957	Gclc<tm1Tdal>	MP:0000598,abnormal liver morphology|MP:0001732,postnatal growth retardation|MP:0001764,abnormal homeostasis|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0004167,abnormal cingulate gyrus morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0011629,decreased mitochondrial number
MGI:2447852	Gclm<tm1Tdal>	MP:0002272,abnormal nervous system electrophysiology|MP:0003674,oxidative stress|MP:0004167,abnormal cingulate gyrus morphology|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0030623,decreased cysteine level|MP:0030626,decreased circulating cysteine level
MGI:3723647	Gclm<tm1Tjka>	MP:0001130,abnormal ovarian folliculogenesis|MP:0002678,increased follicle recruitment|MP:0002941,increased circulating alanine transaminase level|MP:0003507,abnormal ovary physiology|MP:0003674,oxidative stress|MP:0005376,homeostasis/metabolism phenotype|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0008871,abnormal ovarian follicle number|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009006,prolonged estrous cycle|MP:0009009,absent estrous cycle|MP:0009017,prolonged estrus|MP:0009361,abnormal primordial ovarian follicle morphology|MP:0009362,abnormal primary ovarian follicle morphology|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011121,decreased primordial ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0012604,decreased glutathione level|MP:0013508,increased granulosa cell apoptosis|MP:0021106,abnormal secondary ovarian follicle morphology|MP:0031019,increased granulosa cell proliferation|MP:0031020,premature ovarian failure
MGI:3653426	Gcm1<tm1Hoso>	MP:0009937,abnormal neuron differentiation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2183479	Gcm1<tm1Jcc>	MP:0000351,increased cell proliferation|MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0003403,absent placental labyrinth|MP:0004560,abnormal chorionic plate morphology|MP:0004875,increased mean systemic arterial blood pressure|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011524,thick placenta labyrinth|MP:0011526,abnormal placenta fetal blood space morphology|MP:0011529,increased placenta intervillous maternal lacunae size|MP:0011531,abnormal syncytiotrophoblast morphology|MP:0013241,embryo tissue necrosis
MGI:2675754	Gcm1<tm1Ral>	MP:0002169,no abnormal phenotype detected
MGI:2153827	Gcm1<tm1Weg>	MP:0002080,prenatal lethality|MP:0002086,abnormal extraembryonic tissue morphology
MGI:5584165	Gcm2<tm1.1Malx>	MP:0002169,no abnormal phenotype detected
MGI:5584282	Gcm2<tm1.2Malx>	MP:0000195,decreased circulating calcium level|MP:0001566,increased circulating phosphate level|MP:0002905,decreased circulating parathyroid hormone level|MP:0003494,parathyroid hypoplasia|MP:0010831,lethality, incomplete penetrance
MGI:5292469	Gcm2<tm1Hoso>	MP:0000774,decreased brain size|MP:0000928,incomplete rostral neuropore closure|MP:0008877,abnormal DNA methylation|MP:0009937,abnormal neuron differentiation|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:1889069	Gcm2<tm1Kry>	MP:0000130,abnormal trabecular bone morphology|MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000680,absent parathyroid glands|MP:0003433,decreased activity of parathyroid|MP:0005441,increased urine calcium level|MP:0005605,increased bone mass|MP:0006339,abnormal third pharyngeal arch morphology|MP:0008271,abnormal bone ossification|MP:0011090,perinatal lethality, incomplete penetrance|MP:0013573,abnormal parathyroid gland development
MGI:6477990	Gcn1<em1(IMPC)J>	MP:0000266,abnormal heart morphology|MP:0000928,incomplete rostral neuropore closure|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001701,incomplete embryo turning|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004180,failure of initiation of embryo turning|MP:0005031,abnormal trophoblast layer morphology|MP:0005559,increased circulating glucose level|MP:0005635,decreased circulating bilirubin level|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0014134,abnormal embryo morphology
MGI:6436699	Gcn1<em1Itohk>	MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0011092,embryonic lethality, complete penetrance
MGI:6436701	Gcn1<em2Itohk>	MP:0000358,abnormal cell morphology|MP:0000432,abnormal head morphology|MP:0000460,mandible hypoplasia|MP:0001177,atelectasis|MP:0001698,decreased embryo size|MP:0001890,anencephaly|MP:0001953,respiratory failure|MP:0002750,exophthalmos|MP:0003984,embryonic growth retardation|MP:0004045,abnormal cell cycle checkpoint function|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0004760,increased mitotic index|MP:0009431,decreased fetal weight|MP:0011089,perinatal lethality, complete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0012531,delayed limb development|MP:0013395,eyelid hypoplasia|MP:0020414,abnormal fibroblast physiology
MGI:5910931	Gcna<tm1.1Dcp>	MP:0001146,abnormal testis morphology|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0002169,no abnormal phenotype detected|MP:0002216,abnormal seminiferous tubule morphology|MP:0002685,abnormal spermatogonia proliferation|MP:0002687,oligozoospermia|MP:0003077,abnormal cell cycle|MP:0003205,testicular atrophy|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005169,abnormal male meiosis|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0008058,abnormal DNA repair|MP:0008866,chromosomal instability|MP:0008967,absent chiasmata formation|MP:0009230,abnormal sperm head morphology|MP:0009451,abnormal chromosomal synapsis|MP:0010768,mortality/aging|MP:0014617,decreased spermatogonia number
MGI:7425706	Gcnt1<em1(IMPC)Ccpcz>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0001489,decreased startle reflex|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology|MP:0002599,increased mean platelet volume|MP:0003961,decreased lean body mass|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0008810,increased circulating iron level
MGI:2681554	Gcnt1<tm1Jxm>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000716,abnormal immune system cell morphology|MP:0001790,abnormal immune system physiology|MP:0001845,abnormal inflammatory response|MP:0002144,abnormal B cell differentiation|MP:0002498,abnormal acute inflammation|MP:0003156,abnormal leukocyte migration|MP:0005386,behavior/neurological phenotype|MP:0020332,impaired leukocyte tethering or rolling
MGI:2681555	Gcnt1<tm2Jxm>	MP:0002169,no abnormal phenotype detected
MGI:3589370	Gcnt2<tm1Tmu>	MP:0001402,decreased locomotor activity|MP:0002015,epithelioid cyst|MP:0005017,decreased B cell number|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0009640,abnormal renal tubule epithelium morphology
MGI:3849681	Gcnt3<tm1.1Jxm>	MP:0000511,abnormal intestinal mucosa morphology|MP:0001666,abnormal intestinal absorption|MP:0001807,decreased IgA level|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008537,increased susceptibility to induced colitis
MGI:3699606	Gcnt3<tm1Jxm>	MP:0002169,no abnormal phenotype detected
MGI:3849682	Gcnt4<tm1.1Jxm>	MP:0000219,increased neutrophil cell number|MP:0000511,abnormal intestinal mucosa morphology|MP:0001354,increased aggression towards male mice|MP:0005478,decreased circulating thyroxine level
MGI:3849680	Gcnt4<tm1Jxm>	MP:0002169,no abnormal phenotype detected
MGI:3763735	Gcsam<tm1.1Rsky>	MP:0005387,immune system phenotype|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches
MGI:3046816	Gcsfis<C57BL/6J>	MP:0000691,enlarged spleen
MGI:6153793	Gcsh<em1(IMPC)H>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0002590,increased mean corpuscular volume|MP:0002606,increased basophil cell number|MP:0005561,increased mean corpuscular hemoglobin|MP:0006386,absent somites|MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance|MP:0011105,embryonic lethality between implantation and placentation, incomplete penetrance|MP:0012165,absent neural folds|MP:0013292,embryonic lethality prior to organogenesis
MGI:2446889	Gct1<SWR/Bm>	MP:0012411,increased granulosa cell tumor incidence
MGI:3574519	Gct4<CAST/Ei>	MP:0002052,decreased tumor incidence
MGI:2446888	Gct4<SJL/Bm>	MP:0012411,increased granulosa cell tumor incidence
MGI:3574504	Gct5<SWXJ9/BmJ>	MP:0012411,increased granulosa cell tumor incidence
MGI:3574506	Gct7<SWXJ9/BmJ>	MP:0012411,increased granulosa cell tumor incidence
MGI:3574508	Gct8<SWXJ9/BmJ>	MP:0012411,increased granulosa cell tumor incidence
MGI:3574510	Gct9<SWXJ9/BmJ>	MP:0012411,increased granulosa cell tumor incidence
MGI:5577272	Gc<tm1.1(KOMP)Vlcg>	MP:0000186,decreased circulating HDL cholesterol level|MP:0002644,decreased circulating triglyceride level|MP:0002941,increased circulating alanine transaminase level|MP:0005179,decreased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0005567,decreased circulating total protein level
MGI:2176841	Gc<tm1Nec>	MP:0002896,abnormal bone mineralization|MP:0002998,abnormal bone remodeling|MP:0003432,increased activity of parathyroid|MP:0005006,abnormal osteoblast physiology|MP:0011228,abnormal vitamin D level
MGI:5704443	Gdap1<tm1.1Ics>	MP:0003674,oxidative stress|MP:0004768,abnormal axonal transport|MP:0005402,abnormal action potential|MP:0008814,decreased nerve conduction velocity|MP:0011630,increased mitochondrial size|MP:0013438,dysmyelination|MP:0030937,increased mitochondrial DNA content
MGI:5690110	Gdap1<tm1.2Geno>	MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0002883,chromatolysis|MP:0003651,abnormal axon extension|MP:0004231,abnormal calcium ion homeostasis|MP:0004768,abnormal axonal transport|MP:0005402,abnormal action potential|MP:0008415,abnormal neurite morphology|MP:0008814,decreased nerve conduction velocity|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0011630,increased mitochondrial size|MP:0014320,abnormal autopod rotation
MGI:5704441	Gdap1<tm1Ics>	MP:0003631,nervous system phenotype|MP:0005384,cellular phenotype|MP:0008814,decreased nerve conduction velocity|MP:0013438,dysmyelination
MGI:5569041	Gdap1<tm2b(KOMP)Wtsi>	MP:0000639,abnormal adrenal gland morphology|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0001120,abnormal uterus morphology|MP:0002060,abnormal skin morphology|MP:0002631,abnormal epididymis morphology|MP:0002768,small adrenal glands|MP:0004931,enlarged epididymis
MGI:6140193	Gdap2<em1(IMPC)Wtsi>	MP:0000062,increased bone mineral density|MP:0003960,increased lean body mass|MP:0005419,decreased circulating serum albumin level|MP:0005478,decreased circulating thyroxine level|MP:0005505,thrombocytosis|MP:0006358,absent pinna reflex|MP:0008805,decreased circulating amylase level|MP:0010025,decreased total body fat amount|MP:0010088,decreased circulating fructosamine level
MGI:5000323	Gda<tm1a(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0000186,decreased circulating HDL cholesterol level|MP:0000208,decreased hematocrit|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level|MP:0010123,increased bone mineral content|MP:0013764,decreased T-helper cell number|MP:0013772,increased effector memory T-helper cell number
MGI:3615639	Gdcr1<BALB/cJ>	MP:0014778,increased brain enzyme/coenzyme level
MGI:5548506	Gde1<tm1b(EUCOMM)Hmgu>	MP:0001406,abnormal gait|MP:0001489,decreased startle reflex|MP:0002574,increased vertical activity|MP:0002591,decreased mean corpuscular volume|MP:0002757,decreased vertical activity|MP:0002968,increased circulating alkaline phosphatase level|MP:0004924,abnormal behavior|MP:0005178,increased circulating cholesterol level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5583864	Gde1<tm1Crv>	MP:0005584,abnormal enzyme/coenzyme activity
MGI:2445719	Gdf10<tm1Sjl>	MP:0002169,no abnormal phenotype detected
MGI:5569964	Gdf10<tm2b(KOMP)Wtsi>	MP:0001402,decreased locomotor activity|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0005344,increased circulating bilirubin level
MGI:5544775	Gdf11<tm1.1Vlcg>	MP:0000111,cleft palate|MP:0000480,increased rib number|MP:0000592,short tail|MP:0005371,limbs/digits/tail phenotype
MGI:2449673	Gdf11<tm1Clf>	MP:0000527,abnormal kidney development|MP:0001327,decreased retina photoreceptor cell number|MP:0001330,abnormal optic nerve morphology|MP:0001539,decreased caudal vertebrae number|MP:0002983,increased retina ganglion cell number|MP:0003036,vertebral transformation|MP:0003456,absent tail|MP:0004656,absent sacral vertebrae|MP:0004980,increased neuronal precursor cell number|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0006095,absent amacrine cells|MP:0008514,absent retina inner plexiform layer|MP:0008789,abnormal olfactory epithelium morphology|MP:0009937,abnormal neuron differentiation|MP:0011087,neonatal lethality, complete penetrance|MP:0012536,delayed optic fissure closure|MP:0013167,abnormal hindlimb bud morphology
MGI:2449672	Gdf11<tm1Sjl>	MP:0000111,cleft palate|MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000155,asymmetric rib joints|MP:0000464,increased presacral vertebrae number|MP:0000470,abnormal stomach morphology|MP:0000471,abnormal stomach epithelium morphology|MP:0000480,increased rib number|MP:0000492,abnormal rectum morphology|MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000556,abnormal hindlimb morphology|MP:0000592,short tail|MP:0000689,abnormal spleen morphology|MP:0000955,abnormal spinal cord morphology|MP:0001539,decreased caudal vertebrae number|MP:0001944,abnormal pancreas morphology|MP:0002058,neonatal lethality|MP:0002111,abnormal tail morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0002809,increased spinal cord size|MP:0002989,small kidney|MP:0003036,vertebral transformation|MP:0003048,abnormal cervical vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0003052,omphalocele|MP:0003456,absent tail|MP:0003604,single kidney|MP:0003722,absent ureter|MP:0003755,abnormal palate morphology|MP:0003886,abnormal embryonic epiblast morphology|MP:0004073,caudal body truncation|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004650,increased lumbar vertebrae number|MP:0004651,increased thoracic vertebrae number|MP:0004703,abnormal vertebral column morphology|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005034,abnormal anus morphology|MP:0005220,abnormal exocrine pancreas morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005371,limbs/digits/tail phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0006042,increased apoptosis|MP:0008148,abnormal sternocostal joint morphology|MP:0008787,abnormal tailgut morphology|MP:0009114,decreased pancreatic beta cell mass|MP:0009149,decreased pancreatic acinar cell number|MP:0009167,increased pancreatic islet number|MP:0009172,small pancreatic islets|MP:0009175,abnormal pancreatic beta cell differentiation|MP:0010978,absent ureteric bud|MP:0011087,neonatal lethality, complete penetrance|MP:0011290,decreased nephron number|MP:0011364,abnormal metanephros morphology|MP:0013175,bifurcated tail|MP:0030589,increased pancreatic alpha cell mass
MGI:4438484	Gdf11<tm2.2Sjl>	MP:0004651,increased thoracic vertebrae number
MGI:5636965	Gdf11<tm2b(EUCOMM)Hmgu>	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0001325,abnormal retina morphology|MP:0002111,abnormal tail morphology|MP:0003743,abnormal facial morphology|MP:0005564,increased hemoglobin content|MP:0005568,increased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance|MP:0011951,increased cardiac stroke volume
MGI:5496693	Gdf15<tm1Breit>	MP:0000008,increased white adipose tissue amount|MP:0001260,increased body weight|MP:0001402,decreased locomotor activity|MP:0003961,decreased lean body mass|MP:0004890,decreased energy expenditure|MP:0005376,homeostasis/metabolism phenotype|MP:0008961,abnormal basal metabolism|MP:0009292,increased inguinal fat pad weight|MP:0009298,increased mesenteric fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0010024,increased total body fat amount|MP:0011939,increased food intake
MGI:4399064	Gdf15<tm1Kuns>	MP:0000939,decreased motor neuron number|MP:0000966,decreased sensory neuron number|MP:0001019,abnormal L4 dorsal root ganglion morphology|MP:0001022,abnormal L5 dorsal root ganglion morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0001071,abnormal facial nerve morphology|MP:0001260,increased body weight|MP:0001405,impaired coordination|MP:0002752,abnormal somatic nervous system morphology|MP:0008948,decreased neuron number
MGI:2386300	Gdf15<tm1Sjl>	MP:0001262,decreased body weight|MP:0001759,increased urine glucose level|MP:0001762,polyuria|MP:0002135,abnormal kidney morphology|MP:0003037,increased myocardial infarct size|MP:0003917,increased kidney weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005607,decreased bleeding time|MP:0009586,increased platelet aggregation|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011939,increased food intake|MP:0011941,increased fluid intake|MP:0031121,increased susceptibility to induced thrombosis
MGI:3806583	Gdf1<tm1.1Dmus>	MP:0000462,abnormal digestive system morphology|MP:0004133,heterotaxia|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3806582	Gdf1<tm1Dmus>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:2181719	Gdf1<tm1Sjl>	MP:0000531,right pulmonary isomerism|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0000689,abnormal spleen morphology|MP:0001706,abnormal left-right axis patterning|MP:0002135,abnormal kidney morphology|MP:0002766,situs inversus|MP:0004110,transposition of great arteries|MP:0006062,abnormal vena cava morphology|MP:0006261,annular pancreas|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010413,complete atrioventricular septal defect|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5692607	Gdf2<tm1.1(KOMP)Vlcg>	MP:0002590,increased mean corpuscular volume
MGI:5703975	Gdf2<tm1Lex>	MP:0001614,abnormal blood vessel morphology|MP:0001879,abnormal lymphatic vessel morphology|MP:0002792,abnormal retina vasculature morphology|MP:0004038,lymphangiectasis|MP:0005385,cardiovascular system phenotype|MP:0010097,abnormal retina blood vessel morphology|MP:0010098,abnormal retina blood vessel pattern
MGI:5444242	Gdf2<tm1Sjl>	MP:0002792,abnormal retina vasculature morphology|MP:0005508,abnormal skeleton morphology|MP:0006093,arteriovenous malformation
MGI:3764814	Gdf3<Gt(AD0857)Wtsi>	MP:0001683,absent mesoderm|MP:0002230,abnormal primitive streak formation|MP:0008770,decreased survivor rate|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0011255,abnormal anterior visceral endoderm cell migration|MP:0012157,rostral body truncation|MP:0012159,absent anterior visceral endoderm|MP:0012685,abnormal primitive streak elongation
MGI:3612535	Gdf3<tm1Mms>	MP:0001680,abnormal mesoderm development|MP:0001685,abnormal endoderm development|MP:0001687,thin endoderm|MP:0002084,abnormal developmental patterning|MP:0002230,abnormal primitive streak formation|MP:0004713,split notochord|MP:0005221,abnormal rostral-caudal axis patterning|MP:0008533,abnormal anterior visceral endoderm morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011255,abnormal anterior visceral endoderm cell migration|MP:0012135,embryonic-extraembryonic boundary constriction|MP:0012156,rostral-caudal axis duplication|MP:0013207,absent endoderm
MGI:2673981	Gdf3<tm1Zuk>	MP:0001783,decreased white adipose tissue amount|MP:0005292,improved glucose tolerance|MP:0005378,growth/size/body region phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008770,decreased survivor rate|MP:0008965,increased basal metabolism|MP:0009115,abnormal fat cell morphology|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1855972	Gdf5<bp>	MP:0002115,abnormal limb bone morphology|MP:0002427,disproportionate dwarf|MP:0002543,brachyphalangia|MP:0002764,short tibia|MP:0002772,brachypodia|MP:0003072,abnormal metatarsal bone morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0003109,short femur|MP:0003723,abnormal long bone morphology|MP:0004351,short humerus|MP:0004359,short ulna|MP:0004686,decreased length of long bones|MP:0005306,abnormal phalanx morphology
MGI:1856340	Gdf5<bp-3J>	MP:0000554,abnormal carpal bone morphology|MP:0002110,abnormal digit morphology|MP:0002772,brachypodia|MP:0003072,abnormal metatarsal bone morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0004634,short metacarpal bones|MP:0004635,short metatarsal bones|MP:0004686,decreased length of long bones|MP:0005104,abnormal tarsal bone morphology|MP:0005306,abnormal phalanx morphology|MP:0005353,abnormal patella morphology|MP:0006280,abnormal digit development|MP:0008730,fused phalanges|MP:0008915,fused carpal bones|MP:0011261,abnormal limb mesenchyme morphology
MGI:4847635	Gdf5<bp-4J>	MP:0001922,reduced male fertility|MP:0002115,abnormal limb bone morphology|MP:0002427,disproportionate dwarf|MP:0002543,brachyphalangia|MP:0004634,short metacarpal bones|MP:0004635,short metatarsal bones|MP:0005306,abnormal phalanx morphology|MP:0006279,abnormal limb development|MP:0006280,abnormal digit development|MP:0008730,fused phalanges|MP:0011504,abnormal limb long bone morphology
MGI:5502183	Gdf5<Bp-5J>	MP:0002109,abnormal limb morphology|MP:0002427,disproportionate dwarf|MP:0002544,brachydactyly|MP:0002772,brachypodia|MP:0008736,micromelia
MGI:5695012	Gdf5<bp-6J>	MP:0002544,brachydactyly|MP:0002772,brachypodia|MP:0008736,micromelia
MGI:1855973	Gdf5<bp-H>	MP:0000164,abnormal cartilage development|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0002109,abnormal limb morphology|MP:0002187,abnormal fibula morphology|MP:0002764,short tibia|MP:0002765,short fibula|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003419,delayed endochondral bone ossification|MP:0008272,abnormal endochondral bone ossification
MGI:1855974	Gdf5<bp-J>	MP:0000060,delayed bone ossification|MP:0000554,abnormal carpal bone morphology|MP:0002110,abnormal digit morphology|MP:0002115,abnormal limb bone morphology|MP:0002543,brachyphalangia|MP:0002772,brachypodia|MP:0004634,short metacarpal bones|MP:0004635,short metatarsal bones|MP:0004686,decreased length of long bones|MP:0005104,abnormal tarsal bone morphology|MP:0005306,abnormal phalanx morphology|MP:0006279,abnormal limb development|MP:0006280,abnormal digit development|MP:0008730,fused phalanges|MP:0011261,abnormal limb mesenchyme morphology|MP:0030795,joint dislocation
MGI:1856810	Gdf5<brp>	MP:0000547,short limbs|MP:0000572,abnormal autopod morphology|MP:0001262,decreased body weight|MP:0001935,decreased litter size|MP:0002543,brachyphalangia|MP:0002764,short tibia|MP:0002765,short fibula|MP:0002772,brachypodia|MP:0003109,short femur|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004686,decreased length of long bones|MP:0005306,abnormal phalanx morphology|MP:0006279,abnormal limb development|MP:0009674,decreased birth weight
MGI:7425707	Gdf5<em1(IMPC)Bay>	MP:0003795,abnormal bone structure|MP:0010053,decreased grip strength
MGI:6414491	Gdf5<em1(IMPC)H>	MP:0000062,increased bone mineral density|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000572,abnormal autopod morphology|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0002110,abnormal digit morphology|MP:0002757,decreased vertical activity|MP:0003795,abnormal bone structure|MP:0005016,decreased lymphocyte cell number
MGI:3847115	Gdf5<png>	MP:0004686,decreased length of long bones
MGI:3699319	Gdf5<Rgsc451>	MP:0000131,abnormal long bone epiphysis morphology|MP:0000163,abnormal cartilage morphology|MP:0000167,decreased chondrocyte number|MP:0002772,brachypodia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003189,fused joints|MP:0004686,decreased length of long bones|MP:0005306,abnormal phalanx morphology|MP:0006433,abnormal articular cartilage morphology
MGI:7425708	Gdf6<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001325,abnormal retina morphology|MP:0001404,no spontaneous movement|MP:0001891,hydrocephaly|MP:0002110,abnormal digit morphology|MP:0002152,abnormal brain morphology|MP:0008259,abnormal optic disk morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011047,increased lung tissue damping|MP:0011100,preweaning lethality, complete penetrance
MGI:2661063	Gdf6<tm1Kng>	MP:0000029,abnormal malleus morphology|MP:0000554,abnormal carpal bone morphology|MP:0003189,fused joints|MP:0005104,abnormal tarsal bone morphology|MP:0005105,abnormal middle ear ossicle morphology|MP:0005106,abnormal incus morphology|MP:0005107,abnormal stapes morphology|MP:0006433,abnormal articular cartilage morphology|MP:0008372,small malleus|MP:0008915,fused carpal bones|MP:0008919,fused tarsal bones|MP:0011086,postnatal lethality, incomplete penetrance|MP:0030106,small incus|MP:0030108,abnormal incudostapedial joint morphology|MP:0030109,abnormal incudomalleolar joint morphology|MP:0030123,small middle ear ossicles|MP:0030127,small stapes|MP:0030349,absent coronal suture|MP:0030400,abnormal stapes annular ligament morphology|MP:0030401,absent stapes annular ligament
MGI:3604391	Gdf6<tm1Lex>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001963,abnormal hearing physiology|MP:0002082,postnatal lethality|MP:0005508,abnormal skeleton morphology|MP:0008259,abnormal optic disk morphology
MGI:2387817	Gdf7<tm1Kng>	MP:0001157,small seminal vesicle|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002059,abnormal seminal vesicle morphology|MP:0002083,premature death|MP:0013318,abnormal branching involved in seminal vesicle morphogenesis|MP:0013899,abnormal seminal vesicle epithelium morphology
MGI:2653921	Gdf7<tm1Tmj>	MP:0000788,abnormal cerebral cortex morphology|MP:0000825,dilated lateral ventricle|MP:0000829,dilated fourth ventricle|MP:0001891,hydrocephaly|MP:0021092,abnormal dorsal interneuron 1 morphology
MGI:2386906	Gdf7<tm2Tmj>	MP:0000783,abnormal forebrain morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000924,absent roof plate|MP:0000929,open neural tube|MP:0002151,abnormal neural tube morphology|MP:0008934,absent choroid plexus|MP:0012089,decreased midbrain size|MP:0012138,decreased forebrain size|MP:0021091,abnormal dorsal interneuron morphology
MGI:1930111	Gdf9<tm1Zuk>	MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001130,abnormal ovarian folliculogenesis|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0002016,ovary cyst
MGI:2388605	Gdi1<tm1Toni>	MP:0001454,abnormal cued conditioning behavior|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002919,enhanced paired-pulse facilitation|MP:0003863,decreased aggression towards mice|MP:0004494,abnormal synaptic glutamate release|MP:0004495,decreased synaptic glutamate release|MP:0004792,abnormal synaptic vesicle number|MP:0005376,homeostasis/metabolism phenotype|MP:0005394,taste/olfaction phenotype|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0008428,abnormal spatial working memory|MP:0014744,abnormal hippocampal mossy fiber suprapyramidal bundle morphology
MGI:2386302	Gdi1<tm1Ytk>	MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002919,enhanced paired-pulse facilitation
MGI:4974973	Gdi2<Gt(S1-11F1)Sor>	MP:0003984,embryonic growth retardation|MP:0005387,immune system phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5588293	Gdi2<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0005293,impaired glucose tolerance|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:1856883	gdn	MP:0000015,abnormal ear pigmentation|MP:0000367,abnormal coat/ hair morphology|MP:0002877,abnormal melanocyte morphology|MP:0003136,yellow coat color|MP:0004381,abnormal hair follicle melanocyte morphology|MP:0005072,abnormal hair follicle melanin granule morphology|MP:0005174,abnormal tail pigmentation|MP:0009379,abnormal foot pigmentation
MGI:4456155	Gdnf<tm1.1Neas>	MP:0000939,decreased motor neuron number|MP:0001038,abnormal cholinergic neuron morphology|MP:0005369,muscle phenotype
MGI:2136844	Gdnf<tm1Bbd>	MP:0000520,absent kidney|MP:0000939,decreased motor neuron number|MP:0001011,abnormal superior cervical ganglion morphology|MP:0001048,absent enteric neurons|MP:0002989,small kidney|MP:0003307,pyloric stenosis|MP:0003604,single kidney|MP:0010978,absent ureteric bud|MP:0010983,abnormal ureteric bud invasion|MP:0011087,neonatal lethality, complete penetrance|MP:0011881,distended duodenum
MGI:5553062	Gdnf<tm1(cre/ERT2)Cos>	MP:0005367,renal/urinary system phenotype
MGI:2136846	Gdnf<tm1Lmgd>	MP:0000520,absent kidney|MP:0000522,kidney cortex cyst|MP:0000527,abnormal kidney development|MP:0001045,abnormal enteric ganglia morphology|MP:0001047,abnormal enteric cholinergic neuron morphology|MP:0001048,absent enteric neurons|MP:0002135,abnormal kidney morphology|MP:0002703,abnormal renal tubule morphology|MP:0002731,megacolon|MP:0002827,abnormal renal corpuscle morphology|MP:0002955,increased compensatory renal growth|MP:0002989,small kidney|MP:0003215,renal interstitial fibrosis|MP:0003268,chronic constipation|MP:0003290,intestinal hypoperistalsis|MP:0003604,single kidney|MP:0003917,increased kidney weight|MP:0003918,decreased kidney weight|MP:0004505,decreased renal glomerulus number|MP:0004875,increased mean systemic arterial blood pressure|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005326,abnormal podocyte morphology|MP:0005367,renal/urinary system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0006032,abnormal ureteric bud morphology|MP:0008139,fused podocyte foot processes|MP:0009511,distended stomach|MP:0010800,abnormal submucous nerve plexus morphology|MP:0010801,abnormal myenteric nerve plexus morphology|MP:0010978,absent ureteric bud|MP:0011087,neonatal lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011290,decreased nephron number|MP:0011294,renal glomerulus hypertrophy|MP:0011359,decreased glomerular capillary number|MP:0011405,tubulointerstitial nephritis|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011427,increased mesangial cell number|MP:0011440,increased kidney cell proliferation|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011753,decreased podocyte number
MGI:2136843	Gdnf<tm1Rosl>	MP:0000477,abnormal intestine morphology|MP:0000520,absent kidney|MP:0000939,decreased motor neuron number|MP:0000940,abnormal motor neuron innervation pattern|MP:0000964,small dorsal root ganglion|MP:0001044,abnormal enteric nervous system morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001048,absent enteric neurons|MP:0001052,abnormal innervation pattern to muscle|MP:0001077,abnormal spinal nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0002356,abnormal spleen red pulp morphology|MP:0003290,intestinal hypoperistalsis|MP:0003446,renal hypoplasia|MP:0003604,single kidney|MP:0003722,absent ureter|MP:0004069,abnormal muscle spindle morphology|MP:0005445,abnormal neurotransmitter secretion|MP:0009684,abnormal spinal cord lateral motor column morphology|MP:0010978,absent ureteric bud|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0020491,abnormal ovary topology
MGI:2136845	Gdnf<tm2Bbd>	MP:0000520,absent kidney|MP:0000939,decreased motor neuron number|MP:0001011,abnormal superior cervical ganglion morphology|MP:0001048,absent enteric neurons|MP:0003307,pyloric stenosis|MP:0003604,single kidney|MP:0010978,absent ureteric bud|MP:0010983,abnormal ureteric bud invasion|MP:0011087,neonatal lethality, complete penetrance|MP:0011881,distended duodenum
MGI:6487892	Gdpd2<tm1.1Soc>	MP:0000955,abnormal spinal cord morphology|MP:0003077,abnormal cell cycle|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0020393,increased neuronal precursor proliferation
MGI:4880967	Gdpd2<tm1a(KOMP)Wtsi>	MP:0013279,increased fasting circulating glucose level
MGI:7425709	Gdpd3<em1(IMPC)Ics>	MP:0008535,enlarged lateral ventricles|MP:0012443,increased corpus callosum size|MP:0012450,decreased primary motor cortex size
MGI:6280493	Gdpd3<em1Tsr>	MP:0002169,no abnormal phenotype detected
MGI:5563465	Gdpd3<m1Anu>	MP:0005387,immune system phenotype
MGI:5302017	Gdpd5<tm1.1Itl>	MP:0000937,abnormal motor neuron morphology|MP:0000939,decreased motor neuron number|MP:0004948,abnormal neuronal precursor proliferation|MP:0009937,abnormal neuron differentiation
MGI:5607539	Gdpd5<tm1b(EUCOMM)Hmgu>	MP:0000689,abnormal spleen morphology|MP:0001914,hemorrhage|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration
MGI:1856604	ge	MP:0000371,diluted coat color|MP:0000372,irregular coat pigmentation|MP:0001189,absent skin pigmentation|MP:0001324,abnormal eye pigmentation|MP:0002075,abnormal coat/hair pigmentation
MGI:5752803	Gem184	MP:0000373,belly spot|MP:0000585,kinked tail|MP:0001890,anencephaly|MP:0002081,perinatal lethality
MGI:5762644	gem224	MP:0000428,abnormal craniofacial morphology|MP:0002082,postnatal lethality|MP:0009743,preaxial polydactyly
MGI:5762650	gem225	MP:0002082,postnatal lethality|MP:0003856,abnormal hindlimb stylopod morphology
MGI:2451054	Gemin2<tm1Msd>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6324166	Gemin4<em1(IMPC)Ics>	MP:0001556,increased circulating HDL cholesterol level|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0005568,increased circulating total protein level|MP:0010024,increased total body fat amount
MGI:4182717	Gemin4<Gt(OST99065)Lex>	MP:0009850,embryonic lethality between implantation and placentation
MGI:6153794	Gemin5<em1(IMPC)H>	MP:0002599,increased mean platelet volume|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6279925	Gemin6<em1(IMPC)Bay>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:5439008	Gem<tm1.1Jgun>	MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0004179,transmission ratio distortion|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:6303587	Gen1<Tn(pb-Act-RFP)1.1Zhu>	MP:0000519,hydronephrosis|MP:0000585,kinked tail|MP:0001948,vesicoureteral reflux|MP:0002621,delayed neural tube closure|MP:0003604,single kidney|MP:0004017,duplex kidney|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005376,homeostasis/metabolism phenotype|MP:0005384,cellular phenotype|MP:0006032,abnormal ureteric bud morphology|MP:0010980,ectopic ureteric bud
MGI:5490097	Gena100	MP:0000575,increased foot pad pigmentation|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation
MGI:5490343	Gena111	MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0009703,decreased birth body size|MP:0010179,rough coat
MGI:5488925	Gena115	MP:0001265,decreased body size|MP:0009703,decreased birth body size
MGI:5488926	Gena119	MP:0000454,abnormal jaw morphology|MP:0000585,kinked tail|MP:0001512,trunk curl|MP:0001513,limb grasping
MGI:5488927	Gena127	MP:0000371,diluted coat color|MP:0002080,prenatal lethality
MGI:5490099	Gena135	MP:0001391,abnormal tail movements|MP:0001401,jumpy|MP:0001406,abnormal gait|MP:0002626,increased heart rate|MP:0005655,increased aggression|MP:0012001,abnormal touch escape response
MGI:5490344	Gena140	MP:0000435,shortened head|MP:0001265,decreased body size
MGI:5490346	Gena143	MP:0001406,abnormal gait
MGI:5490347	Gena144	MP:0002572,abnormal emotion/affect behavior
MGI:5488924	Gena15	MP:0001265,decreased body size|MP:0009703,decreased birth body size
MGI:5490349	Gena151	MP:0001386,abnormal maternal nurturing|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001413,abnormal response to new environment|MP:0001488,increased startle reflex|MP:0012001,abnormal touch escape response
MGI:5490350	Gena155	MP:0001265,decreased body size|MP:0012000,abnormal limb position
MGI:5490100	Gena160	MP:0000373,belly spot|MP:0002730,head shaking|MP:0006358,absent pinna reflex|MP:0030930,decreased digit pigmentation
MGI:5660117	Gena165	MP:0001297,microphthalmia
MGI:5490351	Gena172	MP:0000373,belly spot|MP:0009379,abnormal foot pigmentation
MGI:5660118	Gena176	MP:0000575,increased foot pad pigmentation
MGI:5490352	Gena185	MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0010052,increased grip strength
MGI:5490353	Gena187	MP:0001399,hyperactivity
MGI:5490101	Gena200	MP:0005498,hyporesponsive to tactile stimuli|MP:0010053,decreased grip strength
MGI:5490354	Gena214	MP:0001394,circling|MP:0001399,hyperactivity|MP:0001491,unresponsive to tactile stimuli|MP:0001513,limb grasping
MGI:5490355	Gena217	MP:0009142,decreased prepulse inhibition
MGI:5142488	Gena221	MP:0001265,decreased body size
MGI:5490356	Gena26	MP:0000373,belly spot|MP:0000585,kinked tail|MP:0000592,short tail|MP:0004142,abnormal muscle tone|MP:0009379,abnormal foot pigmentation
MGI:5490379	Gena287	MP:0001265,decreased body size|MP:0009659,striated fur|MP:0009703,decreased birth body size
MGI:5490380	Gena31	MP:0009659,striated fur|MP:0011091,prenatal lethality, complete penetrance
MGI:5490358	Gena313	MP:0001265,decreased body size|MP:0001523,impaired righting response
MGI:5490359	Gena316	MP:0001405,impaired coordination
MGI:5490361	Gena318	MP:0000585,kinked tail|MP:0002572,abnormal emotion/affect behavior|MP:0031391,increased locomotor activity
MGI:5490104	Gena321	MP:0001488,increased startle reflex
MGI:5490362	Gena323	MP:0001264,increased body size|MP:0004142,abnormal muscle tone
MGI:5490236	Gena327	MP:0001552,increased circulating triglyceride level
MGI:5490105	Gena339	MP:0000346,broad head
MGI:4830781	Gena341	MP:0000198,decreased circulating phosphate level|MP:0002966,decreased circulating alkaline phosphatase level
MGI:5490381	Gena342	MP:0001394,circling|MP:0001410,head bobbing
MGI:5490363	Gena344	MP:0009250,abnormal appendicular skeleton morphology
MGI:5490366	Gena346	MP:0001559,hyperglycemia|MP:0008736,micromelia
MGI:5490382	Gena350	MP:0001406,abnormal gait|MP:0012001,abnormal touch escape response
MGI:5490367	Gena353	MP:0012002,impaired touch escape response
MGI:5490368	Gena357	MP:0000745,tremors
MGI:5490369	Gena359	MP:0000428,abnormal craniofacial morphology|MP:0002233,abnormal nose morphology|MP:0030253,vertical orbital dystopia
MGI:5490106	Gena360	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:5490370	Gena371	MP:0003456,absent tail
MGI:5490371	Gena377	MP:0001405,impaired coordination
MGI:5490372	Gena381	MP:0001265,decreased body size|MP:0002968,increased circulating alkaline phosphatase level|MP:0003983,decreased cholesterol level|MP:0005409,darkened coat color
MGI:5490373	Gena382	MP:0002942,decreased circulating alanine transaminase level|MP:0005632,decreased circulating aspartate transaminase level
MGI:4830603	Gena383	MP:0003019,increased circulating chloride level|MP:0005633,increased circulating sodium level
MGI:5490107	Gena391	MP:0000188,abnormal circulating glucose level|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level
MGI:5490374	Gena394	MP:0005293,impaired glucose tolerance
MGI:5490375	Gena396	MP:0001559,hyperglycemia
MGI:5490378	Gena397	MP:0000189,hypoglycemia
MGI:5490111	Gena40	MP:0005409,darkened coat color
MGI:2158382	Gena401	MP:0001394,circling|MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0001967,deafness
MGI:5490112	Gena91	MP:0000745,tremors
MGI:2157985	Geot<C57BL/6By>	MP:0001961,abnormal reflex
MGI:5692769	Get1<tm1.1(KOMP)Vlcg>	MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3640791	Get3<tm1Hbha>	MP:0011092,embryonic lethality, complete penetrance
MGI:6257709	Get4<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2183216	Gfap<tm1Ito>	MP:0001475,reduced long-term depression|MP:0002807,abnormal eye blink conditioning behavior|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:2183213	Gfap<tm1Ldtk>	MP:0000781,decreased corpus callosum size|MP:0000920,abnormal myelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0001614,abnormal blood vessel morphology|MP:0001893,non-obstructive hydrocephaly|MP:0002182,abnormal astrocyte morphology|MP:0005167,abnormal blood-brain barrier function|MP:0008026,abnormal brain white matter morphology|MP:0008917,abnormal oligodendrocyte physiology
MGI:1857176	Gfap<tm1Mes>	MP:0002182,abnormal astrocyte morphology|MP:0003008,enhanced long-term potentiation|MP:0005165,increased susceptibility to injury
MGI:2183221	Gfap<tm1Pkny>	MP:0002182,abnormal astrocyte morphology|MP:0003631,nervous system phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype
MGI:2384719	Gfap<tm2Ito>	MP:0003631,nervous system phenotype
MGI:3692741	Gfap<tm2Mes>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002182,abnormal astrocyte morphology|MP:0002183,gliosis|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0008811,abnormal brain iron level
MGI:2384720	Gfap<tm3Ito>	MP:0002182,abnormal astrocyte morphology
MGI:3690430	Gfap<tm3Mes>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002182,abnormal astrocyte morphology|MP:0002183,gliosis
MGI:2384721	Gfap<tm4Ito>	MP:0000952,abnormal CNS glial cell morphology|MP:0002182,abnormal astrocyte morphology
MGI:3586492	Gfap<tm5Ito>	MP:0002169,no abnormal phenotype detected
MGI:5762603	Gfer<tm1.1Crg>	MP:0000598,abnormal liver morphology|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0001654,hepatic necrosis|MP:0001656,focal hepatic necrosis|MP:0001860,liver inflammation|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003333,liver fibrosis|MP:0003674,oxidative stress|MP:0003887,increased hepatocyte apoptosis|MP:0003893,increased hepatocyte proliferation|MP:0009355,increased liver triglyceride level|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0010026,decreased liver cholesterol level|MP:0010027,increased liver cholesterol level|MP:0010042,abnormal oval cell physiology|MP:0010954,abnormal cellular respiration|MP:0011629,decreased mitochondrial number|MP:0011632,dilated mitochondrion|MP:0011633,abnormal mitochondrial shape|MP:0011635,abnormal mitochondrial crista morphology|MP:0011638,abnormal mitochondrial chromosome morphology|MP:0014341,abnormal hepatocyte mitochondrial morphology|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis
MGI:5762605	Gfer<tm1.2Crg>	MP:0011092,embryonic lethality, complete penetrance
MGI:4456605	Gfer<tm1(KOMP)Mbp>	MP:0003674,oxidative stress|MP:0004001,decreased hepatocyte proliferation|MP:0005165,increased susceptibility to injury|MP:0005517,impaired liver regeneration|MP:0006036,abnormal mitochondrial physiology|MP:0010080,abnormal hepatocyte physiology|MP:0010951,abnormal lipid oxidation|MP:0011092,embryonic lethality, complete penetrance|MP:0011629,decreased mitochondrial number|MP:0011632,dilated mitochondrion|MP:0011635,abnormal mitochondrial crista morphology|MP:0014341,abnormal hepatocyte mitochondrial morphology|MP:0014388,decreased hepatocyte mitochondrial DNA content
MGI:7431372	Gfi1b<em1(IMPC)Ccpcz>	MP:0000438,abnormal cranium morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001417,decreased exploration in new environment|MP:0001944,abnormal pancreas morphology|MP:0002060,abnormal skin morphology|MP:0002311,abnormal inspiratory capacity|MP:0003795,abnormal bone structure|MP:0010896,decreased lung compliance|MP:0011044,increased lung elastance|MP:0011100,preweaning lethality, complete penetrance
MGI:5558052	Gfi1b<tm1.1Haho>	MP:0000216,absent erythroid progenitor cell|MP:0000229,abnormal megakaryocyte differentiation|MP:0001577,anemia|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002874,decreased hemoglobin content|MP:0003179,thrombocytopenia|MP:0003714,absent platelets|MP:0011085,postnatal lethality, complete penetrance
MGI:5636937	Gfi1b<tm1b(EUCOMM)Hmgu>	MP:0000222,decreased neutrophil cell number|MP:0002080,prenatal lethality|MP:0002965,increased circulating serum albumin level|MP:0005013,increased lymphocyte cell number|MP:0005344,increased circulating bilirubin level|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:2388162	Gfi1b<tm1Sho>	MP:0000215,absent erythrocytes|MP:0000229,abnormal megakaryocyte differentiation|MP:0000245,abnormal erythropoiesis|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003717,pallor|MP:0004229,abnormal embryonic erythropoiesis|MP:0004230,abnormal embryonic erythrocyte morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3821577	Gfi1b<tm1Tmo>	MP:0000245,abnormal erythropoiesis|MP:0001634,internal hemorrhage|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4868580	Gfi1b<tm2Tmo>	MP:0002429,abnormal blood cell morphology/development|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0004809,increased hematopoietic stem cell number|MP:0005397,hematopoietic system phenotype|MP:0009338,increased splenocyte number|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:4881336	Gfi1<Gen>	MP:0001601,abnormal myelopoiesis|MP:0005387,immune system phenotype|MP:0008053,abnormal NK cell differentiation|MP:0008791,decreased NK cell degranulation|MP:0010766,abnormal NK cell physiology|MP:0011689,absent neutrophils
MGI:3696050	Gfi1<tm1.1Wep>	MP:0000706,small thymus|MP:0001265,decreased body size|MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0005017,decreased B cell number
MGI:2449921	Gfi1<tm1Sho>	MP:0000043,organ of Corti degeneration|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001732,postnatal growth retardation|MP:0001967,deafness|MP:0002083,premature death|MP:0002622,abnormal cochlear hair cell morphology|MP:0002623,abnormal vestibular hair cell morphology|MP:0002857,cochlear ganglion degeneration|MP:0004327,increased vestibular hair cell number|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004402,decreased cochlear outer hair cell number|MP:0004404,cochlear outer hair cell degeneration|MP:0004465,degeneration of organ of Corti supporting cells|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004589,abnormal cochlear hair cell development|MP:0004632,abnormal cochlear OHC efferent innervation pattern|MP:0005191,head tilt|MP:0006359,absent startle reflex
MGI:2660761	Gfi1<tm1Tmo>	MP:0000220,increased monocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000334,decreased granulocyte number|MP:0000715,decreased thymocyte number|MP:0001262,decreased body weight|MP:0001601,abnormal myelopoiesis|MP:0001967,deafness|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0003009,abnormal cytokine secretion|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004536,short inner hair cell stereocilia|MP:0004742,abnormal vestibular system physiology|MP:0004809,increased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008111,abnormal granulocyte differentiation|MP:0008112,abnormal monocyte differentiation|MP:0008560,increased tumor necrosis factor secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008660,increased interleukin-10 secretion|MP:0008735,increased susceptibility to endotoxin shock
MGI:3696049	Gfi1<tm1Wep>	MP:0001265,decreased body size|MP:0002123,abnormal definitive hematopoiesis|MP:0003944,abnormal T cell subpopulation ratio|MP:0005094,abnormal T cell proliferation|MP:0005466,abnormal T-helper 2 physiology
MGI:6477635	Gfi1<tm2.1(GFP/cre/ERT2)Gan>	MP:0002169,no abnormal phenotype detected|MP:0005377,hearing/vestibular/ear phenotype
MGI:3057195	Gfi1<tm2Tmo>	MP:0000222,decreased neutrophil cell number|MP:0000715,decreased thymocyte number|MP:0002145,abnormal T cell differentiation
MGI:3695403	Gfi1<tm3(Gfib1)Tmo>	MP:0000334,decreased granulocyte number|MP:0001410,head bobbing|MP:0001967,deafness|MP:0002620,abnormal monocyte morphology|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004530,absent outer hair cell stereocilia|MP:0005397,hematopoietic system phenotype|MP:0006358,absent pinna reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3695404	Gfi1<tm4Tmo>	MP:0000222,decreased neutrophil cell number|MP:0000715,decreased thymocyte number|MP:0001967,deafness|MP:0002145,abnormal T cell differentiation|MP:0002401,abnormal lymphopoiesis|MP:0002620,abnormal monocyte morphology|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004530,absent outer hair cell stereocilia|MP:0004742,abnormal vestibular system physiology|MP:0005016,decreased lymphocyte cell number|MP:0005065,abnormal neutrophil morphology|MP:0005089,decreased double-negative T cell number|MP:0006358,absent pinna reflex
MGI:5468263	Gfi1<tm5.1(GFI1*)Tmo>	MP:0000220,increased monocyte cell number|MP:0002123,abnormal definitive hematopoiesis|MP:0004046,abnormal mitosis|MP:0005397,hematopoietic system phenotype
MGI:5468264	Gfi1<tm6.1(GFI1)Tmo>	MP:0005397,hematopoietic system phenotype
MGI:4432285	Gfm1<tm1a(EUCOMM)Wtsi>	MP:0001554,increased circulating free fatty acids level
MGI:6508027	Gfm1<tm1c(EUCOMM)Wtsi>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0010221,abnormal T-helper 17 cell differentiation
MGI:6152490	Gfm2<em1(IMPC)Mbp>	MP:0000639,abnormal adrenal gland morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5635093	Gfod1<tm1b(KOMP)Mbp>	MP:0001392,abnormal locomotor behavior
MGI:3698817	Gfpq1<CAST/EiJ>	MP:0009285,increased gonadal fat pad weight
MGI:5637207	Gfpt1<tm1b(EUCOMM)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5692888	Gfpt1<tm1c(EUCOMM)Wtsi>	MP:0000747,muscle weakness|MP:0000751,myopathy|MP:0001053,abnormal neuromuscular synapse morphology|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003646,increased muscle fatigability|MP:0003871,abnormal myelin sheath morphology|MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0004121,abnormal sarcolemma morphology|MP:0004145,abnormal muscle electrophysiology|MP:0005369,muscle phenotype|MP:0005378,growth/size/body region phenotype|MP:0009399,increased skeletal muscle fiber size|MP:0009400,decreased skeletal muscle fiber size|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009413,skeletal muscle fiber atrophy|MP:0009414,skeletal muscle fiber necrosis|MP:0010053,decreased grip strength|MP:0011731,decreased myelin sheath thickness
MGI:5636966	Gfpt2<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001529,abnormal vocalization|MP:0002100,abnormal tooth morphology|MP:0002792,abnormal retina vasculature morphology|MP:0005419,decreased circulating serum albumin level|MP:0010067,increased red blood cell distribution width|MP:0010097,abnormal retina blood vessel morphology|MP:0013279,increased fasting circulating glucose level
MGI:3045109	Gfra1<tm1Bjh>	MP:0000462,abnormal digestive system morphology|MP:0000477,abnormal intestine morphology|MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000534,abnormal ureter morphology|MP:0001033,abnormal parasympathetic system morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0001664,abnormal digestion|MP:0003722,absent ureter|MP:0008314,abnormal pterygopalatine ganglion morphology|MP:0008315,abnormal otic ganglion morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:5514386	Gfra1<tm1(cre/ERT2)Sjn>	MP:0000520,absent kidney
MGI:1926439	Gfra1<tm1Jmi>	MP:0000392,accelerated hair follicle regression|MP:0000520,absent kidney|MP:0000538,abnormal urinary bladder morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001199,thin skin|MP:0002135,abnormal kidney morphology|MP:0003290,intestinal hypoperistalsis|MP:0005445,abnormal neurotransmitter secretion|MP:0006032,abnormal ureteric bud morphology|MP:0010983,abnormal ureteric bud invasion|MP:0011087,neonatal lethality, complete penetrance
MGI:1934205	Gfra1<tm1Rosl>	MP:0000939,decreased motor neuron number|MP:0001046,abnormal enteric neuron morphology|MP:0001048,absent enteric neurons|MP:0001052,abnormal innervation pattern to muscle|MP:0001065,abnormal trigeminal nerve morphology|MP:0001077,abnormal spinal nerve morphology|MP:0001085,small petrosal ganglion|MP:0001087,abnormal nodose ganglion morphology|MP:0002135,abnormal kidney morphology|MP:0002752,abnormal somatic nervous system morphology|MP:0003244,loss of dopaminergic neurons|MP:0003722,absent ureter|MP:0003827,abnormal Wolffian duct morphology|MP:0005386,behavior/neurological phenotype|MP:0008133,decreased Peyer's patch number|MP:0009684,abnormal spinal cord lateral motor column morphology|MP:0010978,absent ureteric bud|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011292,absent nephron
MGI:3715157	Gfra1<tm2.1Jmi>	MP:0000520,absent kidney|MP:0001044,abnormal enteric nervous system morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3715156	Gfra1<tm2Jmi>	MP:0000939,decreased motor neuron number|MP:0002989,small kidney|MP:0006032,abnormal ureteric bud morphology|MP:0010981,abnormal branching involved in ureteric bud morphogenesis|MP:0011760,abnormal ureteric bud tip morphology
MGI:3774317	Gfra1<tm3Jmi>	MP:0000520,absent kidney|MP:0000937,abnormal motor neuron morphology|MP:0000939,decreased motor neuron number|MP:0000940,abnormal motor neuron innervation pattern|MP:0001048,absent enteric neurons|MP:0003632,abnormal nervous system morphology|MP:0004069,abnormal muscle spindle morphology|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0011089,perinatal lethality, complete penetrance
MGI:3759280	Gfra2<tm1Jmi>	MP:0001037,abnormal parasympathetic neuron morphology|MP:0001262,decreased body weight|MP:0004141,abnormal enteroendocrine cell morphology|MP:0006001,abnormal intestinal transit time
MGI:1926440	Gfra2<tm1Msa>	MP:0000392,accelerated hair follicle regression|MP:0001036,small submandibular ganglion|MP:0001199,thin skin|MP:0001262,decreased body weight|MP:0001337,dry eyes|MP:0001344,blepharoptosis|MP:0001500,decreased kindling response|MP:0003290,intestinal hypoperistalsis|MP:0008313,abnormal parasympathetic postganglionic fiber morphology|MP:0008965,increased basal metabolism|MP:0009283,decreased gonadal fat pad weight|MP:0011939,increased food intake|MP:0011941,increased fluid intake
MGI:2651728	Gfra3<tm1Adav>	MP:0001011,abnormal superior cervical ganglion morphology|MP:0001015,small superior cervical ganglion|MP:0004948,abnormal neuronal precursor proliferation
MGI:2136781	Gfra3<tm1Hmd>	MP:0001011,abnormal superior cervical ganglion morphology|MP:0001014,absent superior cervical ganglion|MP:0001015,small superior cervical ganglion|MP:0001344,blepharoptosis|MP:0003203,increased neuron apoptosis|MP:0006009,abnormal neuronal migration|MP:0009284,abnormal sympathetic neuron innervation pattern|MP:0009561,superior cervical ganglion degeneration
MGI:2183558	Gfra3<tm1Jmi>	MP:0001007,abnormal sympathetic system morphology|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001011,abnormal superior cervical ganglion morphology|MP:0001015,small superior cervical ganglion|MP:0001025,abnormal sympathetic neuron morphology|MP:0001344,blepharoptosis
MGI:3045508	Gfra3<tm1Wss>	MP:0001344,blepharoptosis
MGI:3625130	Gfra4<tm1Msa>	MP:0002876,abnormal thyroid gland physiology|MP:0005379,endocrine/exocrine gland phenotype|MP:0020039,increased bone ossification|MP:0020080,increased bone mineralization
MGI:5007153	Gfral<tm1Lex>	MP:0001259,abnormal body weight|MP:0001433,polyphagia|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005449,abnormal food intake|MP:0005658,increased susceptibility to diet-induced obesity|MP:0010358,abnormal free fatty acids level|MP:0011969,abnormal circulating triglyceride level
MGI:2651890	Gfus<tm1Jbl>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000491,crypts of Lieberkuhn abscesses|MP:0000495,abnormal colon morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0001265,decreased body size|MP:0001429,dehydration|MP:0001924,infertility|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0003304,large intestinal inflammation|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005036,diarrhea|MP:0005202,lethargy|MP:0005553,increased circulating creatinine level|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5529101	Gfy<tm1Yyos>	MP:0008544,impaired olfaction|MP:0008789,abnormal olfactory epithelium morphology|MP:0011281,abnormal olfactory epithelium cilium morphology|MP:0012020,abnormal olfactory epithelium physiology
MGI:3856874	Gga1<Gt(AN0619)Wtsi>	MP:0000189,hypoglycemia|MP:0001570,abnormal circulating enzyme level|MP:0008489,slow postnatal weight gain|MP:0009674,decreased birth weight|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5695948	Gga1<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001925,male infertility|MP:0004738,abnormal auditory brainstem response
MGI:3960314	Gga2<Gt(IST10483E10)Tigm>	MP:0000189,hypoglycemia|MP:0009674,decreased birth weight|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3880898	Gga2<Gt(SYA176)Byg>	MP:0011092,embryonic lethality, complete penetrance
MGI:3587929	Gga3<Gt(RRC067)Byg>	MP:0000189,hypoglycemia|MP:0001570,abnormal circulating enzyme level|MP:0008489,slow postnatal weight gain|MP:0009674,decreased birth weight|MP:0011088,neonatal lethality, incomplete penetrance
MGI:7261305	Ggct<em1.2Smoc>	MP:0000208,decreased hematocrit|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002640,reticulocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0003674,oxidative stress|MP:0008008,early cellular replicative senescence|MP:0008476,increased spleen red pulp amount|MP:0011704,decreased fibroblast proliferation
MGI:6198558	Ggcx<tm1.1Kry>	MP:0000189,hypoglycemia|MP:0002891,increased insulin sensitivity|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008963,increased carbon dioxide production|MP:0009289,decreased epididymal fat pad weight|MP:0011922,abnormal circulating osteocalcin level|MP:0013138,thin body|MP:0030985,decreased circulating osteocalcin level
MGI:3708899	Ggcx<tm1Dgi>	MP:0001634,internal hemorrhage|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5621178	Ggcx<tm1Sinos>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001577,anemia|MP:0001925,male infertility|MP:0002083,premature death|MP:0002216,abnormal seminiferous tubule morphology|MP:0002674,abnormal sperm motility|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0003205,testicular atrophy|MP:0004852,decreased testis weight|MP:0004898,uterine hemorrhage|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0005606,increased bleeding time|MP:0006380,abnormal spermatid morphology|MP:0008028,pregnancy-related premature death|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009238,coiled sperm flagellum|MP:0009282,decreased hyperactivated sperm motility|MP:0009831,abnormal sperm midpiece morphology|MP:0010768,mortality/aging|MP:0013601,increased testis apoptosis|MP:0014052,increased male germ cell apoptosis|MP:0020215,impaired blood coagulation|MP:0031137,vaginal hemorrhage|MP:0031152,subcutaneous hemorrhage
MGI:6286375	Ggh<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0002637,small uterus|MP:0011874,enlarged urinary bladder
MGI:1856884	ggld	MP:0008495,decreased IgG1 level
MGI:6695979	Ggnbp1<em1Lchao>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0005165,increased susceptibility to injury|MP:0005578,teratozoospermia|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009237,kinked sperm flagellum|MP:0011750,abnormal seminiferous tubule epithelium morphology
MGI:4072637	Ggnbp2<Gt(IST12476F10)Tigm>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001716,abnormal placenta labyrinth morphology|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002631,abnormal epididymis morphology|MP:0003717,pallor|MP:0004266,pale placenta|MP:0004852,decreased testis weight|MP:0004884,abnormal testis physiology|MP:0004901,decreased male germ cell number|MP:0004930,small epididymis|MP:0005159,azoospermia|MP:0005376,homeostasis/metabolism phenotype|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0008279,arrest of spermiogenesis|MP:0008770,decreased survivor rate|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0008898,abnormal acrosome morphology|MP:0008957,abnormal placenta junctional zone morphology|MP:0009231,detached acrosome|MP:0009377,ectopic manchette|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014633,decreased spermatid number|MP:0031354,abnormal acrosome assembly|MP:0031374,abnormal manchette assembly
MGI:6355945	Ggnbp2<tm1Bbs>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0005159,azoospermia|MP:0005250,decreased Sertoli cell number|MP:0008770,decreased survivor rate|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0013601,increased testis apoptosis
MGI:5513782	Ggnbp2<tm1b(KOMP)Wtsi>	MP:0001293,anophthalmia|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0005567,decreased circulating total protein level|MP:0010393,shortened QRS complex duration|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5503309	Ggn<tm1Dpj>	MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0014764,impaired double-strand DNA break repair
MGI:5548447	Ggps1<tm1b(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0000367,abnormal coat/ hair morphology|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001556,increased circulating HDL cholesterol level|MP:0002699,abnormal vitreous body morphology|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:1856850	Ggt1<dwg>	MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000371,diluted coat color|MP:0001265,decreased body size|MP:0001304,cataract|MP:0001924,infertility|MP:0002113,abnormal skeleton development|MP:0002427,disproportionate dwarf|MP:0002764,short tibia|MP:0003109,short femur|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004016,decreased bone mass|MP:0004610,small vertebrae|MP:0004984,increased osteoclast cell number|MP:0005471,decreased thyroxine level|MP:0006396,decreased long bone epiphyseal plate size|MP:0008477,decreased spleen red pulp amount
MGI:1857767	Ggt1<enu1>	MP:0000160,kyphosis|MP:0000755,hindlimb paralysis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001304,cataract|MP:0001402,decreased locomotor activity|MP:0001510,abnormal coat appearance|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002083,premature death|MP:0003415,priapism|MP:0008912,nervous|MP:0012604,decreased glutathione level|MP:0013730,glutathionuria|MP:0030653,increased circulating glutathione level
MGI:1857766	Ggt1<tm1Zuk>	MP:0000371,diluted coat color|MP:0001121,uterus hypoplasia|MP:0001129,impaired ovarian folliculogenesis|MP:0001134,absent corpus luteum|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001262,decreased body weight|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002075,abnormal coat/hair pigmentation|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002427,disproportionate dwarf|MP:0002687,oligozoospermia|MP:0002780,decreased circulating testosterone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003936,abnormal reproductive system development|MP:0004016,decreased bone mass|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004852,decreased testis weight|MP:0004932,epididymis hypoplasia|MP:0005123,increased circulating growth hormone level|MP:0005148,seminal vesicle hypoplasia|MP:0005158,ovary hypoplasia|MP:0005181,decreased circulating estradiol level|MP:0009009,absent estrous cycle|MP:0009093,oocyte degeneration|MP:0010254,nuclear cataract|MP:0011130,absent tertiary ovarian follicles|MP:0020869,immotile sperm|MP:0030623,decreased cysteine level|MP:0030626,decreased circulating cysteine level|MP:0030983,failure of copulatory plug deposition|MP:0031422,failure of superovulation
MGI:2182354	Ggt5<tm1Mwl>	MP:0005087,decreased acute inflammation|MP:0010768,mortality/aging
MGI:6719253	Ggta1<tm1Ajfda>	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0010255,cortical cataract
MGI:1857435	Ggta1<tm1Jbl>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0002169,no abnormal phenotype detected|MP:0002490,abnormal immunoglobulin level|MP:0002494,increased IgM level|MP:0005671,abnormal response to transplant|MP:0010267,decreased lung tumor incidence
MGI:7442770	Ghitm<em1Ltk>	MP:0003084,abnormal skeletal muscle fiber morphology|MP:0005385,cardiovascular system phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0010053,decreased grip strength|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0014341,abnormal hepatocyte mitochondrial morphology
MGI:6303931	Gh<m1Btlr>	MP:0001262,decreased body weight
MGI:1856425	Ghrhr<lit>	MP:0000062,increased bone mineral density|MP:0000063,decreased bone mineral density|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001501,abnormal sleep pattern|MP:0001731,abnormal postnatal growth|MP:0001732,postnatal growth retardation|MP:0001882,abnormal lactation|MP:0001922,reduced male fertility|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002113,abnormal skeleton development|MP:0003109,short femur|MP:0003194,abnormal frequency of paradoxical sleep|MP:0003212,increased susceptibility to age related obesity|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0004016,decreased bone mass|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005120,decreased circulating growth hormone level|MP:0005136,decreased growth hormone level|MP:0005138,decreased prolactin level|MP:0005266,abnormal metabolism|MP:0005361,small pituitary gland|MP:0005386,behavior/neurological phenotype|MP:0005560,decreased circulating glucose level|MP:0008322,abnormal somatotroph morphology|MP:0008329,decreased somatotroph cell number|MP:0008417,decreased somatotroph cell size|MP:0008436,decreased somatotroph secretory granule number|MP:0008437,absent somatotroph secretory granules|MP:0008489,slow postnatal weight gain|MP:0008831,abnormal insulin-like growth factor I level|MP:0008974,proportional dwarf|MP:0010024,increased total body fat amount|MP:0010119,abnormal bone mineral density|MP:0013616,decreased volumetric bone mineral density|MP:0020010,decreased bone mineral density of femur
MGI:5445807	Ghrhr<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0001552,increased circulating triglyceride level|MP:0002757,decreased vertical activity|MP:0002834,decreased heart weight|MP:0002941,increased circulating alanine transaminase level|MP:0003179,thrombocytopenia|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005343,increased circulating aspartate transaminase level|MP:0005560,decreased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010024,increased total body fat amount|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content|MP:0011396,abnormal sleep behavior
MGI:5620318	Ghrh<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0002834,decreased heart weight|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0013278,decreased fasting circulating glucose level
MGI:3051561	Ghrh<tm1Salv>	MP:0000609,abnormal liver physiology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001935,decreased litter size|MP:0002659,pituitary gland hypoplasia|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005136,decreased growth hormone level
MGI:3763213	Ghrl<tm1Lex>	MP:0005266,abnormal metabolism|MP:0005381,digestive/alimentary phenotype|MP:0005449,abnormal food intake|MP:0010379,decreased respiratory quotient
MGI:3709886	Ghrl<tm1Mko>	MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0003058,increased insulin secretion|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005560,decreased circulating glucose level
MGI:3045041	Ghrl<tm1Mws>	MP:0005452,abnormal adipose tissue amount|MP:0010379,decreased respiratory quotient
MGI:2681803	Ghrl<tm1Rgs>	MP:0002169,no abnormal phenotype detected|MP:0005534,decreased body temperature|MP:0011049,impaired adaptive thermogenesis|MP:0011396,abnormal sleep behavior|MP:0012289,abnormal non-rapid eye movement sleep pattern
MGI:5485215	Ghrl<tm2.1(cre/EGFP)Suss>	MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:5640787	Ghr<m1Btlr>	MP:0001262,decreased body weight|MP:0001265,decreased body size
MGI:5056123	Ghr<tm1.1Dlr>	MP:0003059,decreased insulin secretion|MP:0005559,increased circulating glucose level|MP:0009114,decreased pancreatic beta cell mass|MP:0010070,decreased serotonin level|MP:0011820,decreased pancreatic beta cell proliferation
MGI:4414833	Ghr<tm1.1Jero>	MP:0001262,decreased body weight|MP:0002176,increased brain weight|MP:0003402,decreased liver weight|MP:0004686,decreased length of long bones|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005123,increased circulating growth hormone level|MP:0005458,increased percent body fat/body weight|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight
MGI:4359891	Ghr<tm1.1Masp>	MP:0000063,decreased bone mineral density|MP:0001554,increased circulating free fatty acids level|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002981,increased liver weight|MP:0003918,decreased kidney weight|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005123,increased circulating growth hormone level|MP:0005293,impaired glucose tolerance|MP:0009356,decreased liver triglyceride level
MGI:4359895	Ghr<tm1.2Masp>	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation
MGI:2681515	Ghr<tm1Arge>	MP:0000130,abnormal trabecular bone morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000166,abnormal chondrocyte morphology|MP:0000692,small spleen|MP:0001732,postnatal growth retardation|MP:0001935,decreased litter size|MP:0001938,delayed sexual maturation|MP:0002989,small kidney|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005123,increased circulating growth hormone level|MP:0008974,proportional dwarf
MGI:5472175	Ghr<tm1b(KOMP)Wtsi>	MP:0001303,abnormal lens morphology|MP:0005633,increased circulating sodium level
MGI:5550361	Ghr<tm1c(KOMP)Wtsi>	MP:0000005,increased brown adipose tissue amount|MP:0001260,increased body weight|MP:0001784,abnormal fluid regulation|MP:0003917,increased kidney weight|MP:0003960,increased lean body mass|MP:0004702,increased circulating insulin-like growth factor I level|MP:0004953,decreased spleen weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005669,increased circulating leptin level|MP:0008596,increased circulating interleukin-6 level|MP:0009118,increased white fat cell size|MP:0009285,increased gonadal fat pad weight|MP:0009298,increased mesenteric fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0009425,increased soleus weight|MP:0010024,increased total body fat amount|MP:0010934,increased subcutaneous adipose tissue amount|MP:0030968,decreased circulating adiponectin level
MGI:2388126	Ghr<tm1Jjk>	MP:0000008,increased white adipose tissue amount|MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000189,hypoglycemia|MP:0001129,impaired ovarian folliculogenesis|MP:0001156,abnormal spermatogenesis|MP:0001258,decreased body length|MP:0001259,abnormal body weight|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001462,abnormal avoidance learning behavior|MP:0001661,extended life span|MP:0001729,impaired embryo implantation|MP:0001732,postnatal growth retardation|MP:0001745,increased circulating corticosterone level|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0001938,delayed sexual maturation|MP:0002063,abnormal learning/memory/conditioning|MP:0002113,abnormal skeleton development|MP:0002175,decreased brain weight|MP:0002176,increased brain weight|MP:0002191,abnormal artery morphology|MP:0002293,long gestation period|MP:0002636,delayed vaginal opening|MP:0002644,decreased circulating triglyceride level|MP:0002680,decreased corpora lutea number|MP:0002682,decreased mature ovarian follicle number|MP:0002696,decreased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0002764,short tibia|MP:0002773,decreased circulating luteinizing hormone level|MP:0002780,decreased circulating testosterone level|MP:0002782,abnormal testes secretion|MP:0002834,decreased heart weight|MP:0002891,increased insulin sensitivity|MP:0002965,increased circulating serum albumin level|MP:0002989,small kidney|MP:0003019,increased circulating chloride level|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003355,decreased ovulation rate|MP:0003356,impaired luteinization|MP:0003402,decreased liver weight|MP:0003503,decreased activity of thyroid gland|MP:0003507,abnormal ovary physiology|MP:0003797,abnormal compact bone morphology|MP:0003918,decreased kidney weight|MP:0003949,abnormal circulating lipid level|MP:0003961,decreased lean body mass|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0004686,decreased length of long bones|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0004852,decreased testis weight|MP:0004904,increased uterus weight|MP:0004908,abnormal seminal vesicle weight|MP:0004910,decreased seminal vesicle weight|MP:0004920,increased placenta weight|MP:0004927,abnormal epididymis weight|MP:0004929,decreased epididymis weight|MP:0004953,decreased spleen weight|MP:0005123,increased circulating growth hormone level|MP:0005124,increased circulating prolactin level|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005181,decreased circulating estradiol level|MP:0005449,abnormal food intake|MP:0005458,increased percent body fat/body weight|MP:0005473,decreased triiodothyronine level|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level|MP:0005534,decreased body temperature|MP:0005560,decreased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0008271,abnormal bone ossification|MP:0008938,decreased pituitary gland weight|MP:0008940,delayed balanopreputial separation|MP:0008974,proportional dwarf|MP:0008975,delayed male fertility|MP:0008976,delayed female fertility|MP:0009006,prolonged estrous cycle|MP:0009011,prolonged diestrus|MP:0009019,abnormal metestrus|MP:0009114,decreased pancreatic beta cell mass|MP:0009172,small pancreatic islets|MP:0009286,increased abdominal fat pad weight|MP:0009289,decreased epididymal fat pad weight|MP:0009294,increased interscapular fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0009431,decreased fetal weight|MP:0009642,abnormal blood homeostasis|MP:0009674,decreased birth weight|MP:0010090,increased circulating creatine kinase level|MP:0010124,decreased bone mineral content|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011939,increased food intake|MP:0013278,decreased fasting circulating glucose level|MP:0013618,decreased areal bone mineral density|MP:0014269,decreased testes secretion|MP:0014636,decreased elongated spermatid number|MP:0014810,increased circulating urea level|MP:0030969,increased circulating adiponectin level|MP:0031362,decreased prostate gland ventral lobe weight
MGI:3526104	Ghr<tm1Mwat>	MP:0001559,hyperglycemia|MP:0001732,postnatal growth retardation|MP:0002176,increased brain weight|MP:0004701,decreased circulating insulin-like growth factor I level
MGI:3526105	Ghr<tm2Mwat>	MP:0000692,small spleen|MP:0001559,hyperglycemia|MP:0001732,postnatal growth retardation|MP:0002176,increased brain weight|MP:0002989,small kidney|MP:0003402,decreased liver weight|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0010024,increased total body fat amount
MGI:3042267	Gh<Sma1>	MP:0000005,increased brown adipose tissue amount|MP:0000008,increased white adipose tissue amount|MP:0000601,small liver|MP:0001921,reduced fertility|MP:0001923,reduced female fertility|MP:0001938,delayed sexual maturation|MP:0002427,disproportionate dwarf|MP:0002636,delayed vaginal opening|MP:0004163,abnormal adenohypophysis morphology|MP:0005361,small pituitary gland|MP:0008321,small adenohypophysis|MP:0008330,absent somatotrophs|MP:0008333,absent lactotrophs|MP:0008938,decreased pituitary gland weight|MP:0011612,increased circulating ghrelin level
MGI:3821589	Ghsr<tm1.1Lex>	MP:0001663,abnormal digestive system physiology|MP:0008872,abnormal physiological response to xenobiotic
MGI:3613057	Ghsr<tm1Lowl>	MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005450,abnormal energy expenditure|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0010025,decreased total body fat amount|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake
MGI:4356103	Ghsr<tm1Mws>	MP:0002803,abnormal operant conditioning behavior
MGI:3040440	Ghsr<tm1Rgs>	MP:0001262,decreased body weight|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003968,abnormal growth hormone level|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0005449,abnormal food intake
MGI:5569080	Gh<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0000266,abnormal heart morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001258,decreased body length|MP:0001402,decreased locomotor activity|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002135,abnormal kidney morphology|MP:0002188,small heart|MP:0002834,decreased heart weight|MP:0002989,small kidney|MP:0003179,thrombocytopenia|MP:0003795,abnormal bone structure|MP:0003918,decreased kidney weight|MP:0003961,decreased lean body mass|MP:0004953,decreased spleen weight|MP:0005293,impaired glucose tolerance|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:6414761	Gid8<em1(IMPC)J>	MP:0001404,no spontaneous movement|MP:0011100,preweaning lethality, complete penetrance
MGI:7779907	Gigyf1<em1.1Xio>	MP:0001402,decreased locomotor activity|MP:0001441,increased grooming behavior|MP:0002882,abnormal neuron morphology|MP:0003247,abnormal glutaminergic neuron morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0014416,decreased social novelty preference|MP:0021112,impaired social recognition
MGI:6437041	Gigyf1<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7779906	Gigyf1<em1Xio>	MP:0001441,increased grooming behavior|MP:0001442,decreased grooming behavior|MP:0001458,abnormal object recognition memory|MP:0002797,increased thigmotaxis|MP:0008431,abnormal short-term spatial reference memory|MP:0014416,decreased social novelty preference|MP:0021112,impaired social recognition
MGI:4126459	Gigyf2<Gt(XH076)Byg>	MP:0000938,motor neuron degeneration|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002229,neurodegeneration|MP:0003077,abnormal cell cycle|MP:0005449,abnormal food intake|MP:0008493,alpha-synuclein inclusion body|MP:0008946,abnormal neuron number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5805684	Gigyf2<tm1b(EUCOMM)Wtsi>	MP:0000208,decreased hematocrit|MP:0000745,tremors|MP:0001147,small testis|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001566,increased circulating phosphate level|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004952,increased spleen weight|MP:0005012,decreased eosinophil cell number|MP:0010067,increased red blood cell distribution width|MP:0013279,increased fasting circulating glucose level
MGI:6268754	Gimap1<m1Btlr>	MP:0002491,decreased IgD level|MP:0002494,increased IgM level|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:4459837	Gimap1<tm1.1Gwb>	MP:0000715,decreased thymocyte number|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008168,decreased B-1a cell number|MP:0008170,decreased B-1b cell number|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008207,decreased B-2 B cell number|MP:0009926,decreased transitional stage T2 B cell number
MGI:5883410	Gimap3<em1(IMPC)J>	MP:0001312,abnormal cornea morphology
MGI:6280701	Gimap3<tm1.1Yout>	MP:0000715,decreased thymocyte number|MP:0005018,decreased T cell number|MP:0005379,endocrine/exocrine gland phenotype|MP:0005397,hematopoietic system phenotype
MGI:3795278	Gimap4<tm1Jcbs>	MP:0002444,abnormal T cell physiology
MGI:4456885	Gimap5<m1Btlr>	MP:0000219,increased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000322,increased granulocyte number|MP:0000488,abnormal intestinal epithelium morphology|MP:0000598,abnormal liver morphology|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001858,intestinal inflammation|MP:0002083,premature death|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002459,abnormal B cell physiology|MP:0002816,colitis|MP:0002874,decreased hemoglobin content|MP:0003179,thrombocytopenia|MP:0003644,thymus atrophy|MP:0004809,increased hematopoietic stem cell number|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0004978,decreased B-1 B cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005036,diarrhea|MP:0005093,decreased B cell proliferation|MP:0005150,cachexia|MP:0005153,abnormal B cell proliferation|MP:0005370,liver/biliary system phenotype|MP:0005671,abnormal response to transplant|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008040,decreased NK T cell number|MP:0008042,abnormal NK T cell physiology|MP:0008045,decreased NK cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008211,decreased mature B cell number|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0008603,decreased circulating interleukin-4 level|MP:0008700,decreased interleukin-4 secretion|MP:0010067,increased red blood cell distribution width|MP:0013795,abnormal colon goblet cell morphology|MP:0014263,decreased spleen B cell follicle number|MP:0014348,decreased spleen B cell follicle size
MGI:3828512	Gimap5<tm1Wlr>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000322,increased granulocyte number|MP:0000596,abnormal liver development|MP:0000603,pale liver|MP:0000689,abnormal spleen morphology|MP:0000694,spleen hypoplasia|MP:0000717,abnormal lymphocyte cell number|MP:0001586,abnormal erythrocyte cell number|MP:0001654,hepatic necrosis|MP:0002083,premature death|MP:0002217,small lymph nodes|MP:0002447,abnormal erythrocyte morphology|MP:0002642,anisocytosis|MP:0003103,liver degeneration|MP:0003179,thrombocytopenia|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005370,liver/biliary system phenotype|MP:0005563,abnormal hemoglobin content|MP:0005671,abnormal response to transplant|MP:0008040,decreased NK T cell number|MP:0008045,decreased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008246,abnormal leukocyte morphology|MP:0008770,decreased survivor rate|MP:0008986,abnormal liver parenchyma morphology
MGI:6280692	Gimap5<tm1Yout>	MP:0005018,decreased T cell number|MP:0005379,endocrine/exocrine gland phenotype|MP:0005397,hematopoietic system phenotype
MGI:6160453	Gimap6<tm1.1Gwb>	MP:0002444,abnormal T cell physiology|MP:0005014,increased B cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0006035,abnormal mitochondrial morphology|MP:0006413,increased T cell apoptosis|MP:0008246,abnormal leukocyte morphology|MP:0008260,abnormal autophagy|MP:0014046,abnormal mitophagy
MGI:4364125	Gimap6<tm1a(KOMP)Wtsi>	MP:0000220,increased monocyte cell number|MP:0003019,increased circulating chloride level|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0008805,decreased circulating amylase level|MP:0010024,increased total body fat amount|MP:0013510,decreased CD4-negative NK T cell number|MP:0013513,decreased memory-marker CD4-negative NK T cell number|MP:0013514,increased memory-marker CD4-negative NK T cell number
MGI:5515619	Gimap6<tm1b(KOMP)Wtsi>	MP:0000194,increased circulating calcium level|MP:0001556,increased circulating HDL cholesterol level|MP:0002591,decreased mean corpuscular volume|MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0004151,decreased circulating iron level|MP:0005178,increased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0005633,increased circulating sodium level|MP:0011396,abnormal sleep behavior|MP:0013279,increased fasting circulating glucose level
MGI:7464999	Gimap7<em1(IMPC)Tcp>	MP:0002092,abnormal eye morphology|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5608694	Gimap8<tm1.1(KOMP)Vlcg>	MP:0002833,increased heart weight|MP:0002875,decreased erythrocyte cell number
MGI:6152491	Gin1<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000277,abnormal heart shape|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus
MGI:5692806	Ginm1<tm1b(EUCOMM)Wtsi>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0008259,abnormal optic disk morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:3706309	Gins1<tm1Ntak>	MP:0001730,embryonic growth arrest|MP:0002582,disorganized extraembryonic tissue|MP:0003988,disorganized embryonic tissue|MP:0010380,abnormal inner cell mass apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:6470391	Gins2<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0011886,increased circulating lipase level
MGI:6257451	Gins3<em1(IMPC)Tcp>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7464047	Gins3<em1Pcamp>	MP:0004201,fetal growth retardation|MP:0005380,embryo phenotype|MP:0008008,early cellular replicative senescence|MP:0009429,decreased embryo weight|MP:0010768,mortality/aging|MP:0011111,lethality during fetal growth through weaning, complete penetrance|MP:0021086,decreased DNA replication
MGI:5692744	Gins4<tm1b(EUCOMM)Hmgu>	MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001488,increased startle reflex|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness|MP:0013292,embryonic lethality prior to organogenesis
MGI:5575557	Gins4<tm1Ntak>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012113,decreased inner cell mass proliferation|MP:0012743,increased inner cell mass apoptosis
MGI:3531081	Gipc1<Gt(OST93079)Lex>	MP:0000351,increased cell proliferation|MP:0000352,decreased cell proliferation|MP:0001262,decreased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0001614,abnormal blood vessel morphology|MP:0001792,impaired wound healing|MP:0002834,decreased heart weight|MP:0003227,abnormal vascular branching morphogenesis|MP:0003394,increased cardiac output|MP:0005598,decreased heart ventricle muscle contractility|MP:0011952,decreased cardiac stroke volume
MGI:5644333	Gipc1<tm1.1Mhsi>	MP:0002128,abnormal blood circulation|MP:0005385,cardiovascular system phenotype|MP:0010477,coronary artery aneurysm|MP:0011655,abnormal systemic artery morphology
MGI:3663921	Gipc1<tm1Mvc>	MP:0002962,increased urine protein level
MGI:6278289	Gipc2<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology
MGI:3622811	Gipc3<ahl5-Black Swiss>	MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5446012	Gipc3<tm1b(KOMP)Wtsi>	MP:0000955,abnormal spinal cord morphology|MP:0001297,microphthalmia|MP:0001489,decreased startle reflex|MP:0002590,increased mean corpuscular volume|MP:0002631,abnormal epididymis morphology|MP:0003020,decreased circulating chloride level|MP:0003179,thrombocytopenia|MP:0004738,abnormal auditory brainstem response|MP:0005561,increased mean corpuscular hemoglobin|MP:0010511,shortened PR interval
MGI:6266823	Gipr<em1(IMPC)Bay>	MP:0001406,abnormal gait|MP:0001523,impaired righting response|MP:0001529,abnormal vocalization|MP:0004924,abnormal behavior|MP:0005655,increased aggression
MGI:3036704	Gipr<tm1Thor>	MP:0002694,abnormal pancreas secretion|MP:0002727,decreased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level
MGI:2149964	Gipr<tm1Yse>	MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level
MGI:5559592	Gip<tm1.1Gmost>	MP:0002169,no abnormal phenotype detected
MGI:5478539	Gip<tm1Nina>	MP:0000598,abnormal liver morphology|MP:0001262,decreased body weight|MP:0002727,decreased circulating insulin level|MP:0004889,increased energy expenditure|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005452,abnormal adipose tissue amount|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0010025,decreased total body fat amount
MGI:2660576	Giq1<KK>	MP:0005293,impaired glucose tolerance
MGI:3762634	Git1<Gt(FHCRC-GT-S10-12C1)Sor>	MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001458,abnormal object recognition memory|MP:0001463,abnormal spatial learning|MP:0001522,impaired swimming|MP:0002169,no abnormal phenotype detected|MP:0002206,abnormal CNS synaptic transmission|MP:0008948,decreased neuron number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0014623,abnormal brain theta wave pattern
MGI:3850987	Git1<tm1.2Rtp>	MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0003460,decreased fear-related response|MP:0008770,decreased survivor rate|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior
MGI:4440887	Git1<tm1Bcb>	MP:0001176,abnormal lung development|MP:0001182,lung hemorrhage|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002803,abnormal operant conditioning behavior|MP:0003631,nervous system phenotype|MP:0004007,abnormal lung vasculature morphology|MP:0005385,cardiovascular system phenotype|MP:0006057,decreased vascular endothelial cell number|MP:0008143,abnormal dendrite morphology|MP:0008770,decreased survivor rate|MP:0010856,dilated respiratory conducting tube|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0020316,decreased vascular endothelial cell proliferation|MP:0020508,decreased dendritic spine density
MGI:3762635	Git2<Gt(XG510)Byg>	MP:0001973,increased thermal nociceptive threshold|MP:0002169,no abnormal phenotype detected|MP:0008182,decreased marginal zone B cell number
MGI:3664625	Git2<tm1Hsb>	MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0001861,lung inflammation|MP:0002333,abnormal lung compliance|MP:0002415,abnormal neutrophil differentiation|MP:0002463,abnormal neutrophil physiology|MP:0005399,increased susceptibility to fungal infection|MP:0008720,impaired neutrophil chemotaxis
MGI:3043946	Gja10<tm1Kwi>	MP:0005551,abnormal eye electrophysiology|MP:0006068,abnormal retina horizontal cell morphology
MGI:5433359	Gja10<tm2(Hbegf/EGFP)Kwi>	MP:0001005,abnormal retina rod cell morphology|MP:0001006,abnormal retina cone cell morphology|MP:0001325,abnormal retina morphology|MP:0002090,abnormal vision|MP:0005551,abnormal eye electrophysiology|MP:0008451,retina rod cell degeneration|MP:0008519,thin retina outer plexiform layer|MP:0008520,disorganized retina outer plexiform layer
MGI:7619077	Gja1<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0001404,no spontaneous movement|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0002060,abnormal skin morphology|MP:0003743,abnormal facial morphology|MP:0003795,abnormal bone structure|MP:0011495,abnormal head shape|MP:0011496,abnormal head size
MGI:3762750	Gja1<Gt(ROSANBetageo)15C3Masn>	MP:0000267,abnormal heart development|MP:0011089,perinatal lethality, complete penetrance
MGI:2682016	Gja1<M1Jrt>	MP:0000060,delayed bone ossification|MP:0000063,decreased bone mineral density|MP:0000126,brittle teeth|MP:0000333,decreased bone marrow cell number|MP:0000438,abnormal cranium morphology|MP:0000564,syndactyly|MP:0001126,abnormal ovary morphology|MP:0001265,decreased body size|MP:0001314,cornea opacity|MP:0001319,irregularly shaped pupil|MP:0001322,abnormal iris morphology|MP:0001636,irregular heartbeat|MP:0001853,heart inflammation|MP:0001882,abnormal lactation|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002100,abnormal tooth morphology|MP:0002110,abnormal digit morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002416,abnormal proerythroblast morphology|MP:0002577,reduced enamel thickness|MP:0002682,decreased mature ovarian follicle number|MP:0002972,abnormal cardiac muscle contractility|MP:0003137,abnormal impulse conducting system conduction|MP:0003141,cardiac fibrosis|MP:0003896,prolonged PR interval|MP:0004071,prolonged P wave|MP:0004225,patent cardiac foramen ovale|MP:0004991,decreased bone strength|MP:0005306,abnormal phalanx morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005333,decreased heart rate|MP:0005358,abnormal incisor morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0008868,abnormal granulosa cell morphology|MP:0009732,ventricular premature beat|MP:0010124,decreased bone mineral content|MP:0010392,prolonged QRS complex duration|MP:0013508,increased granulosa cell apoptosis|MP:0031018,decreased granulosa cell proliferation|MP:0031420,decreased superovulation rate|MP:0031633,decreased heart left ventricle muscle contractility|MP:0031634,decreased heart right ventricle muscle contractility
MGI:5476936	Gja1<tm10Kwi>	MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0002189,abnormal myocardial trabeculae morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0005385,cardiovascular system phenotype|MP:0006110,ventricular fibrillation|MP:0006126,abnormal cardiac outflow tract development|MP:0008950,ventricular tachycardia|MP:0010392,prolonged QRS complex duration|MP:0010519,atrioventricular block|MP:0011087,neonatal lethality, complete penetrance
MGI:3652926	Gja1<tm1.1Gfi>	MP:0002081,perinatal lethality|MP:0003861,abnormal nervous system development|MP:0004067,abnormal trabecula carnea morphology|MP:0004111,abnormal coronary artery morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0010428,abnormal heart right ventricle outflow tract morphology|MP:0021160,decreased heart right ventricle wall thickness
MGI:2445472	Gja1<tm1.1Kwi>	MP:0002463,abnormal neutrophil physiology|MP:0011087,neonatal lethality, complete penetrance
MGI:6119694	Gja1<tm1Clo>	MP:0002169,no abnormal phenotype detected
MGI:2159007	Gja1<tm1Dlg>	MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000873,thin external granule cell layer|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000884,delaminated Purkinje cell layer|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000887,delaminated cerebellar granule layer|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001443,poor grooming|MP:0001544,abnormal cardiovascular system physiology|MP:0001596,hypotension|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002169,no abnormal phenotype detected|MP:0002762,ectopic cerebellar granule cells|MP:0003648,abnormal radial glial cell morphology|MP:0004097,abnormal cerebellar cortex morphology|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004924,abnormal behavior|MP:0005333,decreased heart rate|MP:0005418,abnormal circulating hormone level|MP:0006097,abnormal cerebellar lobule formation|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0008283,small hippocampus|MP:0008458,abnormal cortical ventricular zone morphology|MP:0008535,enlarged lateral ventricles|MP:0009642,abnormal blood homeostasis|MP:0011380,enlarged brain ventricles
MGI:3051881	Gja1<tm1Gfi>	MP:0002083,premature death|MP:0002626,increased heart rate|MP:0010472,abnormal ascending aorta and coronary artery attachment
MGI:1857177	Gja1<tm1Kdr>	MP:0000060,delayed bone ossification|MP:0000074,abnormal neurocranium morphology|MP:0000109,abnormal parietal bone morphology|MP:0000116,abnormal tooth development|MP:0000150,abnormal rib morphology|MP:0000438,abnormal cranium morphology|MP:0000448,pointed snout|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001147,small testis|MP:0001436,abnormal suckling behavior|MP:0001544,abnormal cardiovascular system physiology|MP:0001575,cyanosis|MP:0001785,edema|MP:0001951,abnormal breathing pattern|MP:0002209,decreased germ cell number|MP:0002336,abnormal pulmonary gas exchange|MP:0002748,abnormal pulmonary valve morphology|MP:0003108,short zygomatic bone|MP:0003137,abnormal impulse conducting system conduction|MP:0003235,abnormal alisphenoid bone morphology|MP:0003419,delayed endochondral bone ossification|MP:0003420,delayed intramembranous bone ossification|MP:0004067,abnormal trabecula carnea morphology|MP:0004111,abnormal coronary artery morphology|MP:0004377,small frontal bone|MP:0004385,interparietal bone hypoplasia|MP:0004469,abnormal zygomatic arch morphology|MP:0004470,small nasal bone|MP:0004540,small maxilla|MP:0004592,small mandible|MP:0004624,abnormal thoracic cage morphology|MP:0004901,decreased male germ cell number|MP:0005006,abnormal osteoblast physiology|MP:0005269,abnormal occipital bone morphology|MP:0005352,small cranium|MP:0005595,abnormal vascular smooth muscle physiology|MP:0006020,decreased tympanic ring size|MP:0006126,abnormal cardiac outflow tract development|MP:0008395,abnormal osteoblast differentiation|MP:0010392,prolonged QRS complex duration|MP:0010428,abnormal heart right ventricle outflow tract morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0030080,small lower incisors|MP:0030190,small snout|MP:0030281,thin parietal bone|MP:0030315,small neurocranium
MGI:2445468	Gja1<tm1Kwi>	MP:0000750,abnormal muscle regeneration|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001636,irregular heartbeat|MP:0001879,abnormal lymphatic vessel morphology|MP:0001925,male infertility|MP:0002169,no abnormal phenotype detected|MP:0002463,abnormal neutrophil physiology|MP:0002626,increased heart rate|MP:0002776,increased Sertoli cell number|MP:0002784,abnormal Sertoli cell morphology|MP:0002796,impaired skin barrier function|MP:0003137,abnormal impulse conducting system conduction|MP:0003390,lymphedema|MP:0003631,nervous system phenotype|MP:0003690,abnormal glial cell physiology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010194,absent lymphatic vessels|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0014617,decreased spermatogonia number|MP:0014633,decreased spermatid number
MGI:6119696	Gja1<tm2Clo>	MP:0002169,no abnormal phenotype detected
MGI:2386240	Gja1<tm2(Gjb1)Kwi>	MP:0000280,thin ventricular wall|MP:0001131,abnormal ovarian follicle morphology|MP:0001262,decreased body weight|MP:0001304,cataract|MP:0001636,irregular heartbeat|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0003355,decreased ovulation rate|MP:0003718,maternal effect|MP:0003838,abnormal milk ejection|MP:0003920,abnormal heart right ventricle morphology|MP:0004067,abnormal trabecula carnea morphology|MP:0004852,decreased testis weight|MP:0005294,abnormal heart ventricle morphology|MP:0008950,ventricular tachycardia|MP:0009506,abnormal mammary gland alveolus morphology|MP:0009732,ventricular premature beat|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013781,abnormal mammary gland luminal epithelium morphology
MGI:5584311	Gja1<tm3.1Clo>	MP:0004883,abnormal vascular wound healing|MP:0031508,abnormal vascular smooth muscle cell proliferation
MGI:3774163	Gja1<tm3Gfi>	MP:0000564,syndactyly|MP:0003137,abnormal impulse conducting system conduction|MP:0004215,abnormal myocardial fiber physiology|MP:0005385,cardiovascular system phenotype|MP:0008950,ventricular tachycardia|MP:0010394,decreased QRS amplitude|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2386241	Gja1<tm3(Gja5)Kwi>	MP:0001131,abnormal ovarian follicle morphology|MP:0001262,decreased body weight|MP:0001625,cardiac hypertrophy|MP:0001636,irregular heartbeat|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0003355,decreased ovulation rate|MP:0004852,decreased testis weight|MP:0005391,vision/eye phenotype|MP:0009732,ventricular premature beat|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5430315	Gja1<tm4Gfi>	MP:0001629,abnormal heart rate|MP:0003137,abnormal impulse conducting system conduction
MGI:3525196	Gja1<tm4Kwi>	MP:0000277,abnormal heart shape|MP:0001131,abnormal ovarian follicle morphology|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001191,abnormal skin condition|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001926,female infertility|MP:0002188,small heart|MP:0002753,dilated heart left ventricle|MP:0002796,impaired skin barrier function|MP:0003233,prolonged QT interval|MP:0003356,impaired luteinization|MP:0005333,decreased heart rate|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5430316	Gja1<tm5Gfi>	MP:0002972,abnormal cardiac muscle contractility|MP:0005385,cardiovascular system phenotype
MGI:3620584	Gja1<tm6.1(Gjb3)Kwi>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0004071,prolonged P wave|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0005380,embryo phenotype|MP:0010392,prolonged QRS complex duration|MP:0010394,decreased QRS amplitude|MP:0010428,abnormal heart right ventricle outflow tract morphology|MP:0010449,heart right ventricle outflow tract stenosis|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3620583	Gja1<tm6(Gjb3)Kwi>	MP:0002169,no abnormal phenotype detected
MGI:3763136	Gja1<tm7(Gja2)Kwi>	MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001134,absent corpus luteum|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002016,ovary cyst|MP:0002188,small heart|MP:0003900,shortened QT interval|MP:0004116,abnormal atrioventricular bundle conduction|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005333,decreased heart rate|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0006379,abnormal spermatocyte morphology|MP:0008871,abnormal ovarian follicle number|MP:0010392,prolonged QRS complex duration|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3776014	Gja1<tm8.1Kwi>	MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3776013	Gja1<tm8Kwi>	MP:0000063,decreased bone mineral density|MP:0000102,abnormal nasal bone morphology|MP:0000130,abnormal trabecular bone morphology|MP:0000416,sparse hair|MP:0000428,abnormal craniofacial morphology|MP:0000433,microcephaly|MP:0000564,syndactyly|MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0002577,reduced enamel thickness|MP:0003930,abnormal tooth hard tissue morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004469,abnormal zygomatic arch morphology|MP:0004592,small mandible|MP:0005385,cardiovascular system phenotype|MP:0005508,abnormal skeleton morphology|MP:0005621,abnormal cell physiology|MP:0008950,ventricular tachycardia|MP:0010392,prolonged QRS complex duration|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010768,mortality/aging|MP:0010873,decreased trabecular bone mass|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011919,abnormal R wave|MP:0030034,depressed nasal bridge|MP:0030064,small face
MGI:3522220	Gja1<W45X>	MP:0000266,abnormal heart morphology|MP:0000281,abnormal interventricular septum morphology|MP:0004057,thin myocardium compact layer|MP:0004111,abnormal coronary artery morphology|MP:0006049,semilunar valve regurgitation|MP:0010453,abnormal coronary vein morphology|MP:0010476,coronary fistula|MP:0010477,coronary artery aneurysm|MP:0010551,abnormal coronary vessel morphology|MP:0010594,thick aortic valve|MP:0010601,thick pulmonary valve|MP:0031526,thin right ventricle myocardium compact layer|MP:0031584,thick semilunar valve
MGI:5762597	Gja3<tm1.1Vmb>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0010254,nuclear cataract
MGI:2181813	Gja4<tm1Paul>	MP:0001926,female infertility|MP:0002679,abnormal corpus luteum morphology|MP:0005168,abnormal female meiosis|MP:0008869,anovulation
MGI:3051866	Gja5<tm1(Gja7)Hvr>	MP:0003137,abnormal impulse conducting system conduction|MP:0004071,prolonged P wave|MP:0010392,prolonged QRS complex duration|MP:0010508,abnormal heart electrocardiography waveform feature
MGI:2445238	Gja5<tm1Kwi>	MP:0001636,irregular heartbeat|MP:0002626,increased heart rate|MP:0003137,abnormal impulse conducting system conduction|MP:0003233,prolonged QT interval|MP:0004071,prolonged P wave|MP:0010392,prolonged QRS complex duration|MP:0011953,prolonged PQ interval
MGI:4818408	Gja5<tm1Mchn>	MP:0002169,no abnormal phenotype detected|MP:0005165,increased susceptibility to injury
MGI:2445466	Gja5<tm1Paul>	MP:0000266,abnormal heart morphology|MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0002795,dilated cardiomyopathy|MP:0003137,abnormal impulse conducting system conduction|MP:0003233,prolonged QT interval|MP:0003896,prolonged PR interval|MP:0003898,abnormal QRS complex|MP:0004071,prolonged P wave|MP:0004072,abnormal frontal plane axis|MP:0004253,bifid atrial appendage|MP:0005165,increased susceptibility to injury|MP:0006122,mitral valve stenosis|MP:0010392,prolonged QRS complex duration|MP:0010402,ventricular septal defect|MP:0010404,ostium primum atrial septal defect|MP:0010460,pulmonary artery hypoplasia|MP:0010464,abnormal aortic arch and aortic arch branch attachment|MP:0010514,fragmented QRS complex|MP:0010607,common atrioventricular valve|MP:0010636,bundle branch block|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5544269	Gja5<tm2.1Kwi>	MP:0003352,increased circulating renin level|MP:0004876,decreased mean systemic arterial blood pressure
MGI:2429652	Gja8<Aey5>	MP:0001304,cataract|MP:0001306,small lens|MP:0002840,abnormal lens fiber morphology
MGI:3052418	Gja8<dcm>	MP:0001260,increased body weight|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001312,abnormal cornea morphology|MP:0001317,abnormal pupil morphology|MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0002840,abnormal lens fiber morphology|MP:0004268,abnormal optic stalk morphology
MGI:3774321	Gja8<L1>	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology|MP:0008841,ruptured lens capsule|MP:0011697,lens vacuoles
MGI:1861479	Gja8<Lop10>	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology|MP:0005545,abnormal lens development|MP:0008841,ruptured lens capsule|MP:0010254,nuclear cataract
MGI:1857499	Gja8<No2>	MP:0010254,nuclear cataract
MGI:5489751	Gja8<R205G>	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001306,small lens|MP:0002840,abnormal lens fiber morphology|MP:0010254,nuclear cataract|MP:0011697,lens vacuoles
MGI:5548980	Gja8<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0003917,increased kidney weight|MP:0008806,increased circulating amylase level
MGI:2656266	Gja8<tm1(Gja3)Tww>	MP:0001286,abnormal eye development|MP:0001297,microphthalmia|MP:0001306,small lens|MP:0005545,abnormal lens development
MGI:2137411	Gja8<tm1Paul>	MP:0001286,abnormal eye development|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001306,small lens|MP:0002092,abnormal eye morphology|MP:0002840,abnormal lens fiber morphology|MP:0005545,abnormal lens development
MGI:3620557	Gja8<tm1Rtm>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0005253,abnormal eye physiology|MP:0005551,abnormal eye electrophysiology
MGI:8175626	Gjb1<em1Ckab>	MP:0000921,demyelination|MP:0001405,impaired coordination|MP:0003632,abnormal nervous system morphology|MP:0005403,abnormal nerve conduction|MP:0008814,decreased nerve conduction velocity|MP:0010053,decreased grip strength
MGI:8175627	Gjb1<em2Ckab>	MP:0000921,demyelination|MP:0001405,impaired coordination|MP:0003632,abnormal nervous system morphology|MP:0005403,abnormal nerve conduction|MP:0008814,decreased nerve conduction velocity|MP:0010053,decreased grip strength
MGI:8224458	Gjb1<em2Rwb>	MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0005405,axon degeneration|MP:0008814,decreased nerve conduction velocity|MP:0011904,abnormal Schwann cell physiology
MGI:8226617	Gjb1<em4Rwb>	MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0005405,axon degeneration|MP:0008814,decreased nerve conduction velocity|MP:0011904,abnormal Schwann cell physiology
MGI:1857927	Gjb1<tm1Kwi>	MP:0000598,abnormal liver morphology|MP:0000609,abnormal liver physiology|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001106,abnormal Schwann cell morphology|MP:0001262,decreased body weight|MP:0003631,nervous system phenotype|MP:0003632,abnormal nervous system morphology|MP:0003871,abnormal myelin sheath morphology|MP:0005386,behavior/neurological phenotype|MP:0005403,abnormal nerve conduction|MP:0005404,abnormal axon morphology|MP:0008814,decreased nerve conduction velocity|MP:0010053,decreased grip strength|MP:0010400,increased liver glycogen level
MGI:5615096	Gjb2<tm1Kkam>	MP:0000031,abnormal cochlea morphology|MP:0003878,abnormal ear physiology|MP:0003950,abnormal plasma membrane morphology|MP:0004740,sensorineural hearing loss|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2155739	Gjb2<tm1Kwi>	MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0004265,abnormal placental transport|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011521,decreased placental labyrinth size
MGI:3043744	Gjb2<tm1Mony>	MP:0003984,embryonic growth retardation|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0011091,prenatal lethality, complete penetrance
MGI:2183509	Gjb2<tm1Ugds>	MP:0000032,cochlear degeneration|MP:0000043,organ of Corti degeneration|MP:0001967,deafness|MP:0002857,cochlear ganglion degeneration|MP:0003879,abnormal hair cell physiology|MP:0004362,cochlear hair cell degeneration|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004411,decreased endocochlear potential|MP:0004465,degeneration of organ of Corti supporting cells|MP:0004482,abnormal interdental cell morphology|MP:0004562,abnormal inner hair cell synaptic ribbon morphology|MP:0004740,sensorineural hearing loss|MP:0006403,abnormal cochlear endolymph ionic homeostasis|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4867482	Gjb2<tm2.2Kwi>	MP:0000579,abnormal nail morphology|MP:0000592,short tail|MP:0001192,scaly skin|MP:0001196,shiny skin|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001265,decreased body size|MP:0001926,female infertility|MP:0002060,abnormal skin morphology|MP:0002111,abnormal tail morphology|MP:0002796,impaired skin barrier function|MP:0004411,decreased endocochlear potential|MP:0005391,vision/eye phenotype|MP:0006325,impaired hearing|MP:0009583,increased keratinocyte proliferation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5441202	Gjb2<tm3.1(Gjb1)Kwi>	MP:0000087,absent mandible|MP:0001879,abnormal lymphatic vessel morphology|MP:0002169,no abnormal phenotype detected|MP:0003390,lymphedema|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5441203	Gjb2<tm3.2(Gjb1)Kwi>	MP:0000087,absent mandible|MP:0001879,abnormal lymphatic vessel morphology|MP:0003390,lymphedema|MP:0005385,cardiovascular system phenotype|MP:0006301,abnormal mesenchyme morphology|MP:0010194,absent lymphatic vessels|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5441204	Gjb2<tm3.3(Gjb1)Kwi>	MP:0003390,lymphedema|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5441201	Gjb2<tm3(Gjb1)Kwi>	MP:0002169,no abnormal phenotype detected
MGI:5692890	Gjb3<tm1.1(KOMP)Vlcg>	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0000603,pale liver|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0002590,increased mean corpuscular volume|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004738,abnormal auditory brainstem response|MP:0009931,abnormal skin appearance|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration
MGI:2155738	Gjb3<tm1Kwi>	MP:0001711,abnormal placenta morphology|MP:0001726,abnormal allantois morphology|MP:0004259,small placenta|MP:0004560,abnormal chorionic plate morphology|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011521,decreased placental labyrinth size|MP:0011525,abnormal placenta intervillous maternal lacunae morphology|MP:0012099,decreased spongiotrophoblast size
MGI:3711982	Gjb3<tm2.1Kwi>	MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0002724,enhanced wound healing|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5572041	Gjb4<tm1.1(KOMP)Vlcg>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001120,abnormal uterus morphology|MP:0004906,enlarged uterus|MP:0009709,hydrometra
MGI:3811558	Gjb4<tm1Kwi>	MP:0008544,impaired olfaction
MGI:3769388	Gjb5<tm1Kwi>	MP:0001712,abnormal placenta development|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004921,decreased placenta weight|MP:0009431,decreased fetal weight|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:4848154	Gjb6<tm1.1Fama>	MP:0005377,hearing/vestibular/ear phenotype|MP:0006332,abnormal cochlear potential|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5486677	Gjb6<tm1.1Mcsa>	MP:0005377,hearing/vestibular/ear phenotype
MGI:2447863	Gjb6<tm1Kwi>	MP:0000043,organ of Corti degeneration|MP:0000048,abnormal stria vascularis morphology|MP:0001363,increased anxiety-related response|MP:0001967,deafness|MP:0002757,decreased vertical activity|MP:0003631,nervous system phenotype|MP:0003633,abnormal nervous system physiology|MP:0003879,abnormal hair cell physiology|MP:0004362,cochlear hair cell degeneration|MP:0004368,abnormal stria vascularis vasculature morphology|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004410,absent endocochlear potential|MP:0004411,decreased endocochlear potential|MP:0004740,sensorineural hearing loss|MP:0004999,abnormal blood-inner ear barrier function|MP:0005332,abnormal amino acid level|MP:0005387,immune system phenotype|MP:0005643,decreased dopamine level|MP:0006358,absent pinna reflex|MP:0006403,abnormal cochlear endolymph ionic homeostasis|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5607781	Gjb6<tm2.2Kwi>	MP:0000647,abnormal sebaceous gland morphology|MP:0000652,enlarged sebaceous gland|MP:0001216,abnormal epidermal layer morphology|MP:0001242,hyperkeratosis|MP:0003849,greasy coat|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0011968,decreased threshold for auditory brainstem response|MP:0013378,increased sebocyte number
MGI:5317162	Gjc1<tm1.1(Gjd2)Kwi>	MP:0000274,enlarged heart|MP:0000297,abnormal atrioventricular cushion morphology|MP:0001698,decreased embryo size|MP:0003137,abnormal impulse conducting system conduction|MP:0003631,nervous system phenotype|MP:0003984,embryonic growth retardation|MP:0004937,dilated heart|MP:0005140,decreased cardiac muscle contractility|MP:0005312,pericardial effusion|MP:0005333,decreased heart rate|MP:0005391,vision/eye phenotype|MP:0006138,congestive heart failure|MP:0010519,atrioventricular block|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1861741	Gjc1<tm1.1Kni>	MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0000274,enlarged heart|MP:0000296,absent trabeculae carneae|MP:0000298,absent atrioventricular cushions|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0004259,small placenta|MP:0005140,decreased cardiac muscle contractility|MP:0006042,increased apoptosis|MP:0010559,heart block|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5692889	Gjc1<tm1.1(KOMP)Vlcg>	MP:0000288,abnormal pericardium morphology|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5317163	Gjc1<tm1.2(Gjd2)Kwi>	MP:0000274,enlarged heart|MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0005140,decreased cardiac muscle contractility|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1861740	Gjc1<tm1Kni>	MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0000274,enlarged heart|MP:0000296,absent trabeculae carneae|MP:0000298,absent atrioventricular cushions|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0004259,small placenta|MP:0005140,decreased cardiac muscle contractility|MP:0006042,increased apoptosis|MP:0010559,heart block|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2386124	Gjc1<tm1Kwi>	MP:0005385,cardiovascular system phenotype|MP:0006142,abnormal sinoatrial node conduction|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011953,prolonged PQ interval
MGI:3530292	Gjc1<tm1Weil>	MP:0005253,abnormal eye physiology|MP:0005551,abnormal eye electrophysiology
MGI:3608792	Gjc1<tm2.1Kni>	MP:0001606,impaired hematopoiesis|MP:0002652,thin myocardium|MP:0003393,decreased cardiac output|MP:0012701,increased embryonic neuroepithelium apoptosis
MGI:3608701	Gjc1<tm2Kni>	MP:0001606,impaired hematopoiesis|MP:0002652,thin myocardium|MP:0003137,abnormal impulse conducting system conduction|MP:0003231,abnormal placenta vasculature|MP:0003393,decreased cardiac output|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012701,increased embryonic neuroepithelium apoptosis
MGI:2664941	Gjc2<tm1(EGFP)Kwi>	MP:0000849,abnormal cerebellum morphology|MP:0000920,abnormal myelination|MP:0002152,abnormal brain morphology|MP:0002229,neurodegeneration|MP:0003354,astrocytosis|MP:0008917,abnormal oligodendrocyte physiology|MP:0008918,microgliosis|MP:0009978,abnormal cerebellum white matter morphology
MGI:2668351	Gjc2<tm1Paul>	MP:0002169,no abnormal phenotype detected
MGI:5140116	Gjc2<tm2.1Kwi>	MP:0000849,abnormal cerebellum morphology|MP:0000876,Purkinje cell degeneration|MP:0000920,abnormal myelination|MP:0001402,decreased locomotor activity|MP:0002757,decreased vertical activity|MP:0002804,abnormal motor learning|MP:0003354,astrocytosis|MP:0008026,abnormal brain white matter morphology|MP:0008917,abnormal oligodendrocyte physiology|MP:0008918,microgliosis|MP:0009978,abnormal cerebellum white matter morphology|MP:0010160,increased oligodendrocyte number
MGI:6257715	Gjc3<em1(IMPC)Bay>	MP:0010097,abnormal retina blood vessel morphology
MGI:4420945	Gjc3<tm1.1Kwi>	MP:0003631,nervous system phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype
MGI:3619604	Gjc3<tm1Paul>	MP:0000921,demyelination|MP:0004597,increased susceptibility to noise-induced hearing loss|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2388389	Gjd2<tm1Kwi>	MP:0001454,abnormal cued conditioning behavior|MP:0002272,abnormal nervous system electrophysiology|MP:0003059,decreased insulin secretion|MP:0003463,abnormal single cell response|MP:0003477,abnormal nerve fiber response|MP:0003562,abnormal pancreatic beta cell physiology|MP:0003564,abnormal insulin secretion|MP:0005241,abnormal retina ganglion layer morphology|MP:0005381,digestive/alimentary phenotype|MP:0005386,behavior/neurological phenotype
MGI:2388290	Gjd2<tm1Mony>	MP:0002206,abnormal CNS synaptic transmission|MP:0002911,abnormal inhibitory postsynaptic potential|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0004994,abnormal brain wave pattern|MP:0005402,abnormal action potential
MGI:2388383	Gjd2<tm1Paul>	MP:0002206,abnormal CNS synaptic transmission|MP:0003631,nervous system phenotype
MGI:3835284	Gjd2<tm4Kwi>	MP:0003058,increased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005291,abnormal glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005391,vision/eye phenotype
MGI:3624629	Gjd3<tm1.2Kwi>	MP:0003137,abnormal impulse conducting system conduction|MP:0003631,nervous system phenotype|MP:0006141,abnormal atrioventricular node conduction|MP:0011954,shortened PQ interval
MGI:5544288	Gjd3<tm2.1Kwi>	MP:0005385,cardiovascular system phenotype|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010511,shortened PR interval|MP:0010768,mortality/aging
MGI:5574610	Gjd4<tm1.1(KOMP)Vlcg>	MP:0005633,increased circulating sodium level|MP:0010053,decreased grip strength
MGI:5009133	Gjd4<tm1.1Malt>	MP:0000730,increased satellite cell number|MP:0003884,decreased macrophage cell number|MP:0005369,muscle phenotype|MP:0031318,enhanced skeletal muscle regeneration
MGI:6355933	Gje1<em1(IMPC)H>	MP:0005419,decreased circulating serum albumin level
MGI:3529958	Gje1<Mhdaaey12>	MP:0001292,abnormal lens vesicle development|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001306,small lens|MP:0001314,cornea opacity|MP:0001325,abnormal retina morphology|MP:0002840,abnormal lens fiber morphology|MP:0005545,abnormal lens development|MP:0010258,polar cataract|MP:0011962,increased cornea thickness|MP:0021107,retina fold
MGI:5776523	Gje1<tm1b(EUCOMM)Hmgu>	MP:0002169,no abnormal phenotype detected
MGI:6111538	Gk2<em1Btlr>	MP:0010771,integument phenotype
MGI:6200351	Gk2<em1(IMPC)J>	MP:0001925,male infertility
MGI:6359868	Gk2<em1Osb>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0005389,reproductive system phenotype|MP:0009237,kinked sperm flagellum|MP:0009832,abnormal sperm mitochondrial sheath morphology
MGI:6111537	Gk2<em2Btlr>	MP:0010771,integument phenotype
MGI:6359789	Gk2<em#Juhu>	MP:0001925,male infertility|MP:0002674,abnormal sperm motility|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0009237,kinked sperm flagellum|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0014464,decreased sperm mitochondrial sheath size
MGI:6111536	Gk5<em1Btlr>	MP:0000414,alopecia
MGI:5568575	Gk5<m1Btlr>	MP:0000383,abnormal hair follicle orientation|MP:0000414,alopecia|MP:0000427,abnormal hair cycle|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001547,abnormal lipid level|MP:0002992,abnormal sebaceous lipid secretion|MP:0003413,hair follicle degeneration|MP:0003982,increased cholesterol level|MP:0005317,increased triglyceride level|MP:0005376,homeostasis/metabolism phenotype|MP:0008858,abnormal hair cycle anagen phase|MP:0008859,abnormal hair cycle catagen phase|MP:0008860,abnormal hair cycle telogen phase|MP:0009131,decreased white fat cell number|MP:0010771,integument phenotype|MP:0012232,abnormal ceramide level
MGI:6111758	Gk5<m2Btlr>	MP:0000414,alopecia|MP:0003413,hair follicle degeneration
MGI:6111759	Gk5<m3Btlr>	MP:0000414,alopecia|MP:0003413,hair follicle degeneration
MGI:6199058	Gk5<m4Btlr>	MP:0009004,progressive hair loss
MGI:6199607	Gk5<m5Btlr>	MP:0000414,alopecia|MP:0010838,increased CD8-positive, alpha-beta memory T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0012764,increased alpha-beta T cell number
MGI:6470626	Gkap1<em1Feis>	MP:0001146,abnormal testis morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0004851,increased testis weight|MP:0004928,increased epididymis weight|MP:0004931,enlarged epididymis|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0006379,abnormal spermatocyte morphology|MP:0009256,enlarged corpus epididymis|MP:0030603,increased sperm number
MGI:5614699	Gkap1<tm2b(EUCOMM)Hmgu>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0011965,decreased total retina thickness
MGI:5696902	Gkn1<tm1.1(KOMP)Vlcg>	MP:0000438,abnormal cranium morphology|MP:0000458,abnormal mandible morphology|MP:0001926,female infertility|MP:0002135,abnormal kidney morphology
MGI:5548517	Gkn2<tm1.1(KOMP)Vlcg>	MP:0000274,enlarged heart|MP:0001663,abnormal digestive system physiology|MP:0001873,stomach inflammation|MP:0002175,decreased brain weight|MP:0002412,increased susceptibility to bacterial infection|MP:0002419,abnormal innate immunity|MP:0002544,brachydactyly|MP:0002591,decreased mean corpuscular volume|MP:0003960,increased lean body mass|MP:0005076,abnormal cell differentiation|MP:0005465,abnormal T-helper 1 physiology|MP:0008713,abnormal cytokine level|MP:0008721,abnormal chemokine level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0010025,decreased total body fat amount|MP:0010792,abnormal stomach mucosa morphology|MP:0013278,decreased fasting circulating glucose level|MP:0013567,gastric gland atrophy|MP:0013662,decreased myeloid cell number|MP:0020186,abnormal susceptibility to bacterial infection
MGI:2429928	Gk<tm1Wjc>	MP:0000189,hypoglycemia|MP:0001402,decreased locomotor activity|MP:0001436,abnormal suckling behavior|MP:0001732,postnatal growth retardation|MP:0001746,abnormal pituitary secretion|MP:0002628,hepatic steatosis|MP:0003443,increased circulating glycerol level|MP:0005281,increased fatty acids level|MP:0005282,decreased fatty acids level|MP:0005560,decreased circulating glucose level|MP:0011085,postnatal lethality, complete penetrance|MP:0030780,increased urine glycerol level
MGI:1861794	Gla<tm1Kul>	MP:0000358,abnormal cell morphology|MP:0000598,abnormal liver morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001636,irregular heartbeat|MP:0002135,abnormal kidney morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002833,increased heart weight|MP:0005330,cardiomyopathy|MP:0005333,decreased heart rate|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0010506,prolonged RR interval|MP:0010574,dilated aorta
MGI:5007155	Glb1l2<tm1Lex>	MP:0000221,decreased leukocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0005293,impaired glucose tolerance|MP:0008045,decreased NK cell number
MGI:6414538	Glb1l3<em1(IMPC)Bay>	MP:0001258,decreased body length|MP:0003795,abnormal bone structure
MGI:3579514	Glb1<tm1Adz>	MP:0000745,tremors|MP:0000849,abnormal cerebellum morphology|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0002152,abnormal brain morphology|MP:0002882,abnormal neuron morphology|MP:0005277,abnormal brainstem morphology
MGI:2429923	Glb1<tm1Jmat>	MP:0000601,small liver|MP:0000607,abnormal hepatocyte morphology|MP:0000692,small spleen|MP:0000745,tremors|MP:0000753,paralysis|MP:0000876,Purkinje cell degeneration|MP:0001385,pup cannibalization|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001431,abnormal eating behavior|MP:0001513,limb grasping|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002183,gliosis|MP:0002401,abnormal lymphopoiesis|MP:0002757,decreased vertical activity|MP:0002882,abnormal neuron morphology|MP:0003313,abnormal locomotor activation|MP:0005150,cachexia|MP:0005325,abnormal renal glomerulus morphology|MP:0005390,skeleton phenotype|MP:0010760,abnormal macrophage chemotaxis
MGI:2670565	Glce<tm1Jpli>	MP:0000111,cleft palate|MP:0000157,abnormal sternum morphology|MP:0000520,absent kidney|MP:0000562,polydactyly|MP:0001175,abnormal lung morphology|MP:0001258,decreased body length|MP:0001953,respiratory failure|MP:0002113,abnormal skeleton development|MP:0002896,abnormal bone mineralization|MP:0003051,curly tail|MP:0004624,abnormal thoracic cage morphology|MP:0005306,abnormal phalanx morphology|MP:0009729,absent tarsus bones|MP:0010714,iris coloboma|MP:0011087,neonatal lethality, complete penetrance|MP:0014473,increased pulmonary alveolus wall thickness
MGI:5560908	Gldc<b2b2679Clo>	MP:0000087,absent mandible|MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0000519,hydronephrosis|MP:0001293,anophthalmia|MP:0003052,omphalocele|MP:0003675,kidney cyst|MP:0005170,cleft upper lip|MP:0010402,ventricular septal defect
MGI:4380899	Gldc<Gt(EUCG0001d02)Hmgu>	MP:0000439,enlarged cranium|MP:0000440,domed cranium|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0000929,open neural tube|MP:0001891,hydrocephaly|MP:0001915,intracranial hemorrhage|MP:0002083,premature death|MP:0002151,abnormal neural tube morphology|MP:0003984,embryonic growth retardation|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011230,abnormal folic acid level|MP:0011380,enlarged brain ventricles|MP:0030616,hyperglycinuria|MP:0030655,increased circulating glycine level
MGI:4820272	Gldc<tm1a(EUCOMM)Wtsi>	MP:0004599,abnormal vertebral arch morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:4840020	Gldn<tm1Pele>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology
MGI:4431602	Gle1<tm1a(EUCOMM)Wtsi>	MP:0002833,increased heart weight|MP:0011100,preweaning lethality, complete penetrance
MGI:4123950	Glg1<Gt(KST005)Byg>	MP:0000111,cleft palate|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002111,abnormal tail morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0004173,abnormal intervertebral disk morphology|MP:0004200,decreased fetal size|MP:0004538,abnormal maxillary shelf morphology|MP:0008770,decreased survivor rate|MP:0009247,meteorism|MP:0009431,decreased fetal weight|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4125299	Glg1<Gt(RST092)Byg>	MP:0003628,abnormal leukocyte adhesion|MP:0005385,cardiovascular system phenotype|MP:0009858,abnormal cellular extravasation|MP:0011092,embryonic lethality, complete penetrance|MP:0020333,enhanced leukocyte tethering or rolling
MGI:4364575	Glg1<tm1a(KOMP)Wtsi>	MP:0001552,increased circulating triglyceride level|MP:0003443,increased circulating glycerol level|MP:0004599,abnormal vertebral arch morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4829764	Glg1<tm1Brle>	MP:0001265,decreased body size|MP:0001533,abnormal skeleton physiology|MP:0003795,abnormal bone structure|MP:0004200,decreased fetal size|MP:0006396,decreased long bone epiphyseal plate size|MP:0009703,decreased birth body size|MP:0009780,abnormal chondrocyte physiology|MP:0010103,small thoracic cage
MGI:1857797	Gli1<tm1Alj>	MP:0002169,no abnormal phenotype detected
MGI:2449767	Gli1<tm2Alj>	MP:0005389,reproductive system phenotype
MGI:1857509	Gli2<tm1Alj>	MP:0000060,delayed bone ossification|MP:0000079,abnormal basioccipital bone morphology|MP:0000097,short maxilla|MP:0000106,abnormal basisphenoid bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000109,abnormal parietal bone morphology|MP:0000141,abnormal vertebral body morphology|MP:0000167,decreased chondrocyte number|MP:0000430,absent maxillary shelf|MP:0000431,absent palatine bone horizontal plate|MP:0000433,microcephaly|MP:0000474,abnormal foregut morphology|MP:0000480,increased rib number|MP:0000547,short limbs|MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0000873,thin external granule cell layer|MP:0001176,abnormal lung development|MP:0001178,pulmonary hypoplasia|MP:0001698,decreased embryo size|MP:0001785,edema|MP:0002151,abnormal neural tube morphology|MP:0002764,short tibia|MP:0002765,short fibula|MP:0003109,short femur|MP:0003120,abnormal tracheal cartilage morphology|MP:0003138,absent tympanic ring|MP:0003159,abnormal esophageal smooth muscle morphology|MP:0003160,abnormal esophagus development|MP:0003641,small lung|MP:0003723,abnormal long bone morphology|MP:0004174,abnormal spine curvature|MP:0004321,short sternum|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004374,bowed radius|MP:0004449,absent presphenoid bone|MP:0004592,small mandible|MP:0004683,absent intervertebral disk|MP:0004790,absent upper incisors|MP:0004791,absent lower incisors|MP:0005631,decreased lung weight|MP:0006395,abnormal epiphyseal plate morphology|MP:0009570,abnormal right lung morphology|MP:0009719,reduced cerebellar foliation|MP:0009885,abnormal palatal shelf elevation|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009890,cleft secondary palate|MP:0009937,abnormal neuron differentiation|MP:0010810,increased type II pneumocyte number|MP:0010827,small lung saccule|MP:0010881,esophagus hypoplasia|MP:0010882,trachea hypoplasia|MP:0010883,trachea stenosis|MP:0010884,esophagus stenosis|MP:0011089,perinatal lethality, complete penetrance|MP:0011143,thick lung-associated mesenchyme|MP:0011148,decreased mesenchymal cell proliferation involved in lung development|MP:0011495,abnormal head shape|MP:0030258,small mandibular condyloid process|MP:0030331,absent temporomandibular joint disk
MGI:3834146	Gli2<tm1Blnw>	MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0002151,abnormal neural tube morphology|MP:0003720,abnormal neural tube closure|MP:0011091,prenatal lethality, complete penetrance|MP:0030255,abnormal maxillary dental arch morphology|MP:0030301,abnormal maxillary frontal process morphology
MGI:2158472	Gli2<tm2.1Alj>	MP:0000925,abnormal floor plate morphology|MP:0000926,absent floor plate|MP:0000937,abnormal motor neuron morphology|MP:0000955,abnormal spinal cord morphology|MP:0002081,perinatal lethality|MP:0002825,abnormal notochord morphology|MP:0003641,small lung|MP:0004711,persistence of notochord tissue|MP:0005389,reproductive system phenotype|MP:0010824,absent right lung accessory lobe|MP:0021105,abnormal ventral interneuron 3 morphology
MGI:4941341	Gli2<tm2.1(Gli3)Blnw>	MP:0001265,decreased body size
MGI:2158720	Gli2<tm3.1(Gli1)Alj>	MP:0003631,nervous system phenotype|MP:0009004,progressive hair loss|MP:0011100,preweaning lethality, complete penetrance
MGI:2158719	Gli2<tm3(Gli1)Alj>	MP:0001265,decreased body size|MP:0001524,impaired limb coordination|MP:0002083,premature death|MP:0005156,bradykinesia|MP:0005389,reproductive system phenotype|MP:0009004,progressive hair loss|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2158722	Gli2<tm4.1(Gli2)Alj>	MP:0002169,no abnormal phenotype detected
MGI:3032719	Gli2<tm5.1(GLI3)Alj>	MP:0002948,abnormal neuron specification|MP:0011085,postnatal lethality, complete penetrance
MGI:3032718	Gli2<tm5(GLI3)Alj>	MP:0000925,abnormal floor plate morphology|MP:0002948,abnormal neuron specification|MP:0021105,abnormal ventral interneuron 3 morphology
MGI:3664542	Gli2<tm6.1Alj>	MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0000873,thin external granule cell layer|MP:0001891,hydrocephaly|MP:0002084,abnormal developmental patterning|MP:0005221,abnormal rostral-caudal axis patterning|MP:0009719,reduced cerebellar foliation|MP:0011089,perinatal lethality, complete penetrance
MGI:1856280	Gli3<add>	MP:0006280,abnormal digit development
MGI:3720956	Gli3<Mos1>	MP:0000373,belly spot|MP:0000934,abnormal telencephalon development|MP:0005408,hypopigmentation|MP:0008762,embryonic lethality|MP:0009783,abnormal melanoblast morphology
MGI:1856282	Gli3<Pdn>	MP:0000111,cleft palate|MP:0000562,polydactyly|MP:0000566,synostosis|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000808,abnormal hippocampus development|MP:0000832,abnormal thalamus morphology|MP:0000837,abnormal hypothalamus morphology|MP:0000914,exencephaly|MP:0001302,eyelids open at birth|MP:0001891,hydrocephaly|MP:0002082,postnatal lethality|MP:0002110,abnormal digit morphology|MP:0002196,absent corpus callosum|MP:0002654,spongiform encephalopathy|MP:0002764,short tibia|MP:0002765,short fibula|MP:0003006,abnormal hippocampal fornix morphology|MP:0003451,absent olfactory bulb|MP:0003648,abnormal radial glial cell morphology|MP:0005236,abnormal olfactory nerve morphology|MP:0006009,abnormal neuronal migration|MP:0006254,thin cerebral cortex|MP:0008223,absent hippocampal commissure|MP:0008227,absent anterior commissure|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008540,abnormal cerebral hemisphere morphology|MP:0012260,encephalomeningocele|MP:0012667,split sternal manubrium|MP:0013362,absent pineal gland
MGI:2183948	Gli3<TgBR>	MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0000757,herniated abdominal wall|MP:0000914,exencephaly|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001333,absent optic nerve|MP:0001891,hydrocephaly|MP:0001954,respiratory distress|MP:0002081,perinatal lethality|MP:0002109,abnormal limb morphology|MP:0005508,abnormal skeleton morphology|MP:0009743,preaxial polydactyly
MGI:3798850	Gli3<tm1.1Alj>	MP:0000776,abnormal inferior colliculus morphology|MP:0000841,abnormal hindbrain morphology|MP:0000849,abnormal cerebellum morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000897,abnormal midbrain morphology|MP:0000904,abnormal superior colliculus morphology|MP:0009048,enlarged tectum|MP:0009719,reduced cerebellar foliation|MP:0012132,abnormal midbrain-hindbrain boundary morphology|MP:0031442,enlarged cerebral aqueduct
MGI:5425256	Gli3<tm1.2Zllr>	MP:0000562,polydactyly|MP:0002728,absent tibia|MP:0008272,abnormal endochondral bone ossification|MP:0008985,hemimelia
MGI:3798847	Gli3<tm1Alj>	MP:0000841,abnormal hindbrain morphology|MP:0000857,abnormal cerebellar foliation|MP:0000933,abnormal rhombomere morphology|MP:0003631,nervous system phenotype|MP:0005381,digestive/alimentary phenotype|MP:0006104,abnormal tectum morphology|MP:0009048,enlarged tectum|MP:0010768,mortality/aging|MP:0012132,abnormal midbrain-hindbrain boundary morphology|MP:0031442,enlarged cerebral aqueduct
MGI:3700159	Gli3<tm1Blnw>	MP:0000562,polydactyly
MGI:2182576	Gli3<tm1Urt>	MP:0000106,abnormal basisphenoid bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000439,enlarged cranium|MP:0000477,abnormal intestine morphology|MP:0000495,abnormal colon morphology|MP:0000547,short limbs|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000571,interdigital webbing|MP:0000579,abnormal nail morphology|MP:0001186,pigmentation phenotype|MP:0002109,abnormal limb morphology|MP:0002135,abnormal kidney morphology|MP:0002256,abnormal laryngeal cartilage morphology|MP:0002764,short tibia|MP:0002896,abnormal bone mineralization|MP:0003130,anal atresia|MP:0003604,single kidney|MP:0003984,embryonic growth retardation|MP:0004083,polysyndactyly|MP:0004174,abnormal spine curvature|MP:0004358,bowed tibia|MP:0004361,bowed ulna|MP:0004374,bowed radius|MP:0004462,small basisphenoid bone|MP:0004463,basisphenoid bone foramen|MP:0004537,abnormal palatine bone horizontal plate morphology|MP:0004609,vertebral fusion|MP:0005313,absent adrenal gland|MP:0008275,failure of endochondral bone ossification|MP:0011087,neonatal lethality, complete penetrance|MP:0011505,camptomelia|MP:0013261,absent epiglottis
MGI:3711052	Gli3<tm2Blnw>	MP:0000562,polydactyly|MP:0000566,synostosis|MP:0002110,abnormal digit morphology|MP:0002728,absent tibia|MP:0002764,short tibia|MP:0005306,abnormal phalanx morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:5780889	Gli3<tm3.1Blnw>	MP:0000547,short limbs|MP:0000553,absent radius|MP:0000556,abnormal hindlimb morphology|MP:0000561,adactyly|MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0000572,abnormal autopod morphology|MP:0002109,abnormal limb morphology|MP:0002169,no abnormal phenotype detected|MP:0002544,brachydactyly|MP:0002764,short tibia|MP:0002765,short fibula|MP:0003109,short femur|MP:0003855,abnormal forelimb zeugopod morphology|MP:0004340,short scapula|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004360,absent ulna|MP:0004361,bowed ulna|MP:0004374,bowed radius|MP:0008275,failure of endochondral bone ossification|MP:0011090,perinatal lethality, incomplete penetrance|MP:0014291,decreased autopod size|MP:0014321,short forelimb|MP:0014322,short hindlimb
MGI:1856275	Gli3<Xt>	MP:0000039,abnormal otic capsule morphology|MP:0000074,abnormal neurocranium morphology|MP:0000157,abnormal sternum morphology|MP:0000288,abnormal pericardium morphology|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0000553,absent radius|MP:0000556,abnormal hindlimb morphology|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000776,abnormal inferior colliculus morphology|MP:0000783,abnormal forebrain morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000841,abnormal hindbrain morphology|MP:0000846,abnormal medulla oblongata morphology|MP:0000849,abnormal cerebellum morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000897,abnormal midbrain morphology|MP:0000904,abnormal superior colliculus morphology|MP:0000928,incomplete rostral neuropore closure|MP:0000930,wavy neural tube|MP:0000933,abnormal rhombomere morphology|MP:0000934,abnormal telencephalon development|MP:0000935,abnormal folding of telencephalic vesicles|MP:0001081,abnormal cranial ganglia morphology|MP:0001216,abnormal epidermal layer morphology|MP:0001286,abnormal eye development|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001678,thick apical ectodermal ridge|MP:0001786,skin edema|MP:0001914,hemorrhage|MP:0002110,abnormal digit morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002115,abnormal limb bone morphology|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0002152,abnormal brain morphology|MP:0002233,abnormal nose morphology|MP:0002237,abnormal nasal cavity morphology|MP:0002239,abnormal nasal septum morphology|MP:0002621,delayed neural tube closure|MP:0002728,absent tibia|MP:0002884,abnormal pharyngeal arch morphology|MP:0003052,omphalocele|MP:0003069,abnormal superior semicircular canal morphology|MP:0003072,abnormal metatarsal bone morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0003109,short femur|MP:0003161,absent lateral semicircular canal|MP:0003425,abnormal optic vesicle formation|MP:0003451,absent olfactory bulb|MP:0003631,nervous system phenotype|MP:0003723,abnormal long bone morphology|MP:0004174,abnormal spine curvature|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0004372,bowed fibula|MP:0004457,abnormal orbitosphenoid bone morphology|MP:0004506,abnormal pubis morphology|MP:0004613,fusion of vertebral arches|MP:0004622,sacral vertebral fusion|MP:0004784,abnormal anterior cardinal vein morphology|MP:0005176,eyelids fail to open|MP:0005236,abnormal olfactory nerve morphology|MP:0005237,abnormal olfactory tract morphology|MP:0005306,abnormal phalanx morphology|MP:0005650,abnormal limb bud morphology|MP:0006030,abnormal otic vesicle development|MP:0006292,abnormal nasal placode morphology|MP:0006343,enlarged first pharyngeal arch|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008789,abnormal olfactory epithelium morphology|MP:0008818,abnormal interfrontal bone morphology|MP:0008915,fused carpal bones|MP:0008919,fused tarsal bones|MP:0009048,enlarged tectum|MP:0009719,reduced cerebellar foliation|MP:0009770,abnormal optic chiasm morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011238,abnormal inner ear development|MP:0011362,ectopic adrenal gland|MP:0011727,ectopic ovary|MP:0011964,increased total retina thickness|MP:0012101,acoria|MP:0013362,absent pineal gland|MP:0013443,Harderian gland hyperplasia|MP:0013529,decreased nipple number|MP:0021107,retina fold|MP:0030031,abnormal forehead morphology|MP:0030203,short nasal septum|MP:0030205,thick nasal septum|MP:0031442,enlarged cerebral aqueduct|MP:0031449,abnormal nasal cartilage morphology
MGI:1856283	Gli3<Xt-2H>	MP:0000562,polydactyly|MP:0002110,abnormal digit morphology|MP:0005306,abnormal phalanx morphology
MGI:1856284	Gli3<Xt-3H>	MP:0000157,abnormal sternum morphology|MP:0000373,belly spot|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000914,exencephaly|MP:0001785,edema|MP:0002080,prenatal lethality|MP:0002110,abnormal digit morphology|MP:0002543,brachyphalangia|MP:0003743,abnormal facial morphology|MP:0004083,polysyndactyly|MP:0004321,short sternum|MP:0008818,abnormal interfrontal bone morphology|MP:0008854,bleb|MP:0009049,abnormal hallux morphology|MP:0010082,sternebra fusion|MP:0031447,unilateral cleft upper lip|MP:0031448,bilateral cleft upper lip
MGI:1856285	Gli3<Xt-4H>	MP:0002110,abnormal digit morphology|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:1856286	Gli3<Xt-5H>	MP:0000562,polydactyly|MP:0002110,abnormal digit morphology|MP:0005306,abnormal phalanx morphology
MGI:1856287	Gli3<Xt-6H>	MP:0000562,polydactyly|MP:0002110,abnormal digit morphology|MP:0005306,abnormal phalanx morphology
MGI:1856288	Gli3<Xt-7H>	MP:0002110,abnormal digit morphology
MGI:1856276	Gli3<Xt-J>	MP:0000023,abnormal ear position|MP:0000074,abnormal neurocranium morphology|MP:0000075,absent neurocranium|MP:0000111,cleft palate|MP:0000116,abnormal tooth development|MP:0000157,abnormal sternum morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000413,polyphalangy|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001286,abnormal eye development|MP:0001699,increased embryo size|MP:0001785,edema|MP:0002085,abnormal embryonic tissue morphology|MP:0002098,abnormal vibrissa morphology|MP:0002110,abnormal digit morphology|MP:0002152,abnormal brain morphology|MP:0002728,absent tibia|MP:0002764,short tibia|MP:0003641,small lung|MP:0003723,abnormal long bone morphology|MP:0003841,abnormal lambdoid suture morphology|MP:0003935,abnormal craniofacial development|MP:0004135,abnormal mammary gland embryonic development|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004576,abnormal embryonic autopod plate morphology|MP:0004599,abnormal vertebral arch morphology|MP:0005306,abnormal phalanx morphology|MP:0005631,decreased lung weight|MP:0008160,increased diameter of humerus|MP:0008161,increased diameter of radius|MP:0008163,increased diameter of ulna|MP:0009003,abnormal vibrissa number|MP:0009569,abnormal left lung morphology|MP:0009571,abnormal right lung accessory lobe morphology|MP:0009573,abnormal right lung middle lobe morphology|MP:0009574,abnormal right lung caudal lobe morphology|MP:0010768,mortality/aging|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012139,increased forebrain size|MP:0013720,abnormal mammary line morphology|MP:0013721,abnormal mammary placode morphology|MP:0013785,abnormal mammary gland bud morphology|MP:0030353,wide sagittal suture|MP:0030356,premature lambdoid suture closure|MP:0030431,wide metopic suture
MGI:7425713	Glipr1<em1(IMPC)Hmgu>	MP:0002699,abnormal vitreous body morphology
MGI:7541080	Glipr1l1<em1Mkob>	MP:0004542,impaired acrosome reaction|MP:0031009,abnormal sperm-egg fusion
MGI:3773696	Glipr1<tm1Tt>	MP:0002020,increased tumor incidence|MP:0008403,decreased cellular sensitivity to alkylating agent induced cell death
MGI:2445222	Glis1<tm1Mnks>	MP:0002169,no abnormal phenotype detected
MGI:3785519	Glis2<tm1Amj>	MP:0001426,polydipsia|MP:0001762,polyuria|MP:0002083,premature death|MP:0002705,dilated renal tubule|MP:0002743,glomerulonephritis|MP:0002828,abnormal renal glomerular capsule morphology|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0003918,decreased kidney weight|MP:0004153,increased renal tubule apoptosis|MP:0004969,pale kidney|MP:0004970,kidney atrophy|MP:0005264,glomerulosclerosis|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0009641,kidney degeneration|MP:0011346,renal tubule atrophy|MP:0011363,renal glomerulus atrophy|MP:0011402,renal cast|MP:0011501,increased glomerular capsule space
MGI:3719836	Glis2<tm1Tre>	MP:0000522,kidney cortex cyst|MP:0002135,abnormal kidney morphology|MP:0003215,renal interstitial fibrosis|MP:0003918,decreased kidney weight|MP:0004153,increased renal tubule apoptosis|MP:0011346,renal tubule atrophy|MP:0011422,kidney medulla atrophy|MP:0011423,kidney cortex atrophy
MGI:5296613	Glis3<tm1.2Chan>	MP:0001265,decreased body size|MP:0001429,dehydration|MP:0001559,hyperglycemia|MP:0001732,postnatal growth retardation|MP:0002575,increased circulating ketone body level|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0005379,endocrine/exocrine gland phenotype|MP:0005559,increased circulating glucose level|MP:0009172,small pancreatic islets|MP:0009174,absent pancreatic beta cells|MP:0009177,decreased pancreatic alpha cell number|MP:0009178,absent pancreatic alpha cells|MP:0009181,decreased pancreatic delta cell number|MP:0009191,decreased pancreatic epsilon cell number|MP:0009254,disorganized pancreatic islets|MP:0011085,postnatal lethality, complete penetrance
MGI:3848053	Glis3<tm1Amj>	MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0002705,dilated renal tubule|MP:0008528,polycystic kidney|MP:0009674,decreased birth weight|MP:0011066,abnormal renal tubule epithelial cell primary cilium morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011501,increased glomerular capsule space
MGI:3849863	Glis3<tm1Hiha>	MP:0000522,kidney cortex cyst|MP:0001732,postnatal growth retardation|MP:0002693,abnormal pancreas physiology|MP:0003339,decreased pancreatic beta cell number|MP:0003503,decreased activity of thyroid gland|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0008528,polycystic kidney|MP:0009172,small pancreatic islets|MP:0009177,decreased pancreatic alpha cell number|MP:0009181,decreased pancreatic delta cell number|MP:0011085,postnatal lethality, complete penetrance
MGI:6306615	Glmn<em1(IMPC)Bay>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0001672,abnormal embryo development|MP:0001691,abnormal somite shape|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001718,abnormal visceral yolk sac morphology|MP:0001722,pale yolk sac|MP:0001914,hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0002861,abnormal tail bud morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0003717,pallor|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0006108,abnormal hindbrain development|MP:0008854,bleb|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3817643	Glmn<Gt(OST109778)Lex>	MP:0001701,incomplete embryo turning|MP:0001723,disorganized yolk sac vascular plexus|MP:0001914,hemorrhage|MP:0002621,delayed neural tube closure|MP:0003984,embryonic growth retardation|MP:0005312,pericardial effusion|MP:0006042,increased apoptosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011260,abnormal head mesenchyme morphology
MGI:6760605	Glmn<m1Btlr>	MP:0000062,increased bone mineral density
MGI:3865377	Glmp<Gt(P084H04)Wrst>	MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0001860,liver inflammation|MP:0002941,increased circulating alanine transaminase level|MP:0003333,liver fibrosis|MP:0003674,oxidative stress|MP:0003887,increased hepatocyte apoptosis|MP:0004952,increased spleen weight|MP:0005058,abnormal lysosome morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0005389,reproductive system phenotype|MP:0008114,abnormal Kupffer cell morphology|MP:0008807,increased liver iron level|MP:0008842,lipofuscinosis|MP:0009820,abnormal liver vasculature morphology|MP:0010080,abnormal hepatocyte physiology|MP:0010768,mortality/aging|MP:0031148,abnormal liver sinusoidal endothelial cell morphology
MGI:5006986	Glmp<tm1Lex>	MP:0000601,small liver|MP:0001577,anemia|MP:0001790,abnormal immune system physiology|MP:0001860,liver inflammation|MP:0002968,increased circulating alkaline phosphatase level|MP:0005560,decreased circulating glucose level
MGI:5760037	Glo1<Gt(VICTR48)1493Lex>	MP:0001559,hyperglycemia|MP:0002727,decreased circulating insulin level
MGI:5285709	Glo1<tm1a(KOMP)Mbp>	MP:0001364,decreased anxiety-related response|MP:0005266,abnormal metabolism|MP:0014414,increased depression-related behavior
MGI:4958093	Glod5<Gt(111.1G4)Cmhd>	MP:0002169,no abnormal phenotype detected
MGI:5551409	Glp1r<tm1.1Stof>	MP:0002078,abnormal glucose homeostasis|MP:0005378,growth/size/body region phenotype|MP:0005449,abnormal food intake
MGI:5551480	Glp1r<tm1.2Stof>	MP:0001560,abnormal circulating insulin level|MP:0005291,abnormal glucose tolerance|MP:0005293,impaired glucose tolerance
MGI:5637223	Glp1r<tm1b(KOMP)Mbp>	MP:0005293,impaired glucose tolerance|MP:0013279,increased fasting circulating glucose level
MGI:2150310	Glp1r<tm1Ddr>	MP:0001262,decreased body weight|MP:0002694,abnormal pancreas secretion|MP:0002727,decreased circulating insulin level|MP:0003961,decreased lean body mass|MP:0005164,abnormal response to injury|MP:0005293,impaired glucose tolerance|MP:0005449,abnormal food intake|MP:0005559,increased circulating glucose level|MP:0010025,decreased total body fat amount|MP:0011940,decreased food intake
MGI:5446802	Glp2r<tm1.1Xfg>	MP:0001261,obese|MP:0002574,increased vertical activity|MP:0003961,decreased lean body mass|MP:0005266,abnormal metabolism|MP:0005289,increased oxygen consumption|MP:0005458,increased percent body fat/body weight|MP:0011082,abnormal gastrointestinal motility|MP:0011939,increased food intake|MP:0011945,increased eating frequency
MGI:3827107	Glp2r<tm1Ddr>	MP:0001663,abnormal digestive system physiology|MP:0003868,abnormal feces composition|MP:0005381,digestive/alimentary phenotype|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010155,abnormal intestine physiology|MP:0013487,abnormal Paneth cell physiology
MGI:3802579	Glra1<cincinnati>	MP:0000745,tremors|MP:0001523,impaired righting response|MP:0004924,abnormal behavior|MP:0011085,postnatal lethality, complete penetrance
MGI:6471171	Glra1<m1Cpai>	MP:0000743,muscle spasm|MP:0000745,tremors|MP:0001265,decreased body size|MP:0001391,abnormal tail movements|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002206,abnormal CNS synaptic transmission|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude
MGI:2429918	Glra1<nmf11>	MP:0000692,small spleen|MP:0000745,tremors|MP:0001406,abnormal gait|MP:0001783,decreased white adipose tissue amount|MP:0002064,seizures|MP:0002083,premature death|MP:0003644,thymus atrophy|MP:0005551,abnormal eye electrophysiology
MGI:1856362	Glra1<spd>	MP:0000242,impaired fertilization|MP:0000745,tremors|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001486,abnormal startle reflex|MP:0001488,increased startle reflex|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001925,male infertility|MP:0004143,muscle hypertonia|MP:0004542,impaired acrosome reaction|MP:0005604,hyperekplexia
MGI:1856177	Glra1<spd-ot>	MP:0000743,muscle spasm|MP:0000745,tremors|MP:0002082,postnatal lethality|MP:0002272,abnormal nervous system electrophysiology|MP:0003631,nervous system phenotype|MP:0005572,abnormal pulmonary respiratory rate|MP:0008948,decreased neuron number|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5790694	Glra1<spd-ot9J>	MP:0001265,decreased body size|MP:0003997,tonic-clonic seizures|MP:0011100,preweaning lethality, complete penetrance
MGI:5293666	Glra1<tm1.1Geh>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001488,increased startle reflex|MP:0002862,abnormal righting response|MP:0002906,increased susceptibility to pharmacologically induced seizures
MGI:3696673	Glra1<tm1Betz>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001488,increased startle reflex|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003463,abnormal single cell response|MP:0004022,abnormal cone electrophysiology|MP:0004143,muscle hypertonia|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging|MP:0012146,increased b-wave amplitude
MGI:2676917	Glra1<tm1Rah>	MP:0001488,increased startle reflex|MP:0001513,limb grasping|MP:0002064,seizures|MP:0003484,abnormal channel response|MP:0005386,behavior/neurological phenotype|MP:0011085,postnatal lethality, complete penetrance
MGI:5293667	Glra1<tm2.1Geh>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001488,increased startle reflex|MP:0002862,abnormal righting response|MP:0002906,increased susceptibility to pharmacologically induced seizures
MGI:5548940	Glra2<tm1b(KOMP)Wtsi>	MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0002591,decreased mean corpuscular volume|MP:0005013,increased lymphocyte cell number|MP:0008806,increased circulating amylase level|MP:0010068,decreased red blood cell distribution width|MP:0010087,increased circulating fructosamine level
MGI:3662671	Glra2<tm1Clc>	MP:0003463,abnormal single cell response|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype
MGI:3777271	Glra2<tm1Lex>	MP:0002945,abnormal inhibitory postsynaptic currents|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:3043776	Glra3<tm1.1Umu>	MP:0002736,abnormal nociception after inflammation|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0005253,abnormal eye physiology
MGI:3604595	Glra3<tm1Dgen>	MP:0002906,increased susceptibility to pharmacologically induced seizures
MGI:5775008	Glra4<tm1b(KOMP)Wtsi>	MP:0000182,increased circulating LDL cholesterol level
MGI:6156599	Glrb<em1(IMPC)Tcp>	MP:0000219,increased neutrophil cell number|MP:0002833,increased heart weight|MP:0002941,increased circulating alanine transaminase level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0004952,increased spleen weight|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0011100,preweaning lethality, complete penetrance|MP:0020422,decreased freezing behavior
MGI:1856363	Glrb<spa>	MP:0000061,fragile skeleton|MP:0000242,impaired fertilization|MP:0000642,enlarged adrenal glands|MP:0000743,muscle spasm|MP:0000745,tremors|MP:0000877,abnormal Purkinje cell morphology|MP:0000955,abnormal spinal cord morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001077,abnormal spinal nerve morphology|MP:0001265,decreased body size|MP:0001386,abnormal maternal nurturing|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001488,increased startle reflex|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0001785,edema|MP:0001914,hemorrhage|MP:0001922,reduced male fertility|MP:0004143,muscle hypertonia|MP:0004173,abnormal intervertebral disk morphology|MP:0004542,impaired acrosome reaction|MP:0004703,abnormal vertebral column morphology|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005604,hyperekplexia|MP:0008288,abnormal adrenal cortex morphology|MP:0009025,abnormal brain dura mater morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1856176	Glrb<spa-Alb>	MP:0000745,tremors|MP:0001406,abnormal gait|MP:0001523,impaired righting response|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0004143,muscle hypertonia|MP:0011100,preweaning lethality, complete penetrance
MGI:5301815	Glrx2<tm1Ysh>	MP:0005253,abnormal eye physiology|MP:0005584,abnormal enzyme/coenzyme activity
MGI:3829374	Glrx3<Gt(RRF094)Byg>	MP:0000313,abnormal cell death|MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0001915,intracranial hemorrhage|MP:0003077,abnormal cell cycle|MP:0003708,binucleate|MP:0004084,abnormal cardiac muscle relaxation|MP:0004215,abnormal myocardial fiber physiology|MP:0004485,increased response of heart to induced stress|MP:0005140,decreased cardiac muscle contractility|MP:0005312,pericardial effusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:5705872	Glrx3<tm1.1(KOMP)Vlcg>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002968,increased circulating alkaline phosphatase level|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014586,decreased egg cylinder size
MGI:3526399	Glrx<tm1Ysh>	MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0008944,decreased sensitivity to induced cell death
MGI:3820704	Glrx<tm3Ysh>	MP:0000352,decreased cell proliferation|MP:0003091,abnormal cell migration|MP:0003237,abnormal lens epithelium morphology|MP:0003950,abnormal plasma membrane morphology|MP:0005621,abnormal cell physiology
MGI:4357927	Gls001	MP:0001559,hyperglycemia
MGI:4357929	Gls007	MP:0001559,hyperglycemia
MGI:6156429	Gls2<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000367,abnormal coat/ hair morphology|MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0002060,abnormal skin morphology|MP:0005505,thrombocytosis|MP:0011874,enlarged urinary bladder
MGI:6695948	Gls2<em1Xen>	MP:0002712,increased circulating glucagon level|MP:0009176,increased pancreatic alpha cell number|MP:0013278,decreased fasting circulating glucose level|MP:0020103,decreased hepatic glucose production|MP:0030709,increased circulating glutamine level
MGI:6257528	Gls<em1(IMPC)H>	MP:0011100,preweaning lethality, complete penetrance
MGI:4843620	Gls<tm1a(KOMP)Mbp>	MP:0002182,abnormal astrocyte morphology|MP:0005384,cellular phenotype
MGI:3514104	Gls<tm1Sray>	MP:0002327,abnormal respiratory function|MP:0004924,abnormal behavior|MP:0011087,neonatal lethality, complete penetrance
MGI:5430235	Gls<tm2.1Sray>	MP:0002169,no abnormal phenotype detected|MP:0003313,abnormal locomotor activation|MP:0030586,impaired behavioral response to amphetamine
MGI:6717349	Glt6d1<em2Osb>	MP:0005389,reproductive system phenotype
MGI:3529969	Glt8d1<Gt(OST464546)Lex>	MP:0002169,no abnormal phenotype detected
MGI:5007157	Glt8d1<tm1Lex>	MP:0002635,reduced sensorimotor gating
MGI:4364018	Glt8d2<tm1a(KOMP)Wtsi>	MP:0002079,increased circulating insulin level|MP:0008806,increased circulating amylase level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5007158	Glt8d2<tm1Lex>	MP:0002420,abnormal adaptive immunity|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2671842	glu5	MP:0001559,hyperglycemia|MP:0005293,impaired glucose tolerance
MGI:3626006	Gluchos1<C57BL/6J>	MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance
MGI:3626010	Gluchos3<C57BL/6J>	MP:0002727,decreased circulating insulin level
MGI:3835667	Glud1<tm1.1Pma>	MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009254,disorganized pancreatic islets
MGI:5750936	Glul<tm1.1Geno>	MP:0001399,hyperactivity|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0003106,abnormal fear-related response|MP:0003674,oxidative stress|MP:0005309,increased circulating ammonia level|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype
MGI:6285753	Glul<tm1.1Ncd>	MP:0000249,abnormal blood vessel physiology|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002064,seizures|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0002757,decreased vertical activity|MP:0003313,abnormal locomotor activation|MP:0003354,astrocytosis|MP:0004950,abnormal brain vasculature morphology|MP:0010014,hippocampus pyramidal cell degeneration|MP:0030707,decreased glutamine level|MP:0030733,decreased gamma-aminobutyric acid level|MP:0030737,decreased glutamic acid level|MP:0030743,decreased aspartic acid level|MP:0031391,increased locomotor activity
MGI:3715484	Glul<tm1Whla>	MP:0011092,embryonic lethality, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance
MGI:4462791	Glul<tm3Whla>	MP:0001731,abnormal postnatal growth|MP:0001765,abnormal ion homeostasis|MP:0002152,abnormal brain morphology|MP:0005332,abnormal amino acid level|MP:0005449,abnormal food intake|MP:0005560,decreased circulating glucose level|MP:0011085,postnatal lethality, complete penetrance|MP:0030604,abnormal ammonia homeostasis|MP:0030658,increased glycine level|MP:0030707,decreased glutamine level|MP:0031639,decreased alanine level
MGI:6682154	Glyat<tm1b(EUCOMM)Hmgu>	MP:0020421,increased freezing behavior
MGI:5501049	Glycam1<tm1.1(KOMP)Vlcg>	MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0011396,abnormal sleep behavior
MGI:5817225	Glyctk<em1(IMPC)J>	MP:0001312,abnormal cornea morphology|MP:0002968,increased circulating alkaline phosphatase level
MGI:7279292	Glyr1<em1Dsr>	MP:0005380,embryo phenotype|MP:0010402,ventricular septal defect|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6388369	Glyr1<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001322,abnormal iris morphology|MP:0002060,abnormal skin morphology|MP:0002764,short tibia|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0006243,impaired pupillary reflex|MP:0008528,polycystic kidney
MGI:6281929	Gm1043<em1(IMPC)Wtsi>	MP:0005343,increased circulating aspartate transaminase level
MGI:6399918	Gm10851<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology|MP:0005084,abnormal gallbladder morphology|MP:0009342,enlarged gallbladder
MGI:6477603	Gm1140<em1Utr>	MP:0005389,reproductive system phenotype
MGI:5548909	Gm12258<tm1b(EUCOMM)Hmgu>	MP:0001488,increased startle reflex|MP:0004738,abnormal auditory brainstem response
MGI:7785517	Gm12610<em1Rwan>	MP:0005166,decreased susceptibility to injury|MP:0005554,decreased circulating creatinine level|MP:0006264,decreased systemic arterial systolic blood pressure
MGI:6101194	Gm12695<em1(IMPC)J>	MP:0001529,abnormal vocalization
MGI:5085888	Gm128<Gt(OST18039)Lex>	MP:0002169,no abnormal phenotype detected
MGI:5429747	Gm128<tm1Osb>	MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0009647,decreased fertilization frequency
MGI:6392255	Gm13030<em1Ploen>	MP:0003699,abnormal female reproductive system physiology
MGI:4419244	Gm13547<tm1a(KOMP)Wtsi>	MP:0004609,vertebral fusion
MGI:7641910	Gm13570<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6152492	Gm14496<em2(IMPC)Mbp>	MP:0000494,abnormal cecum morphology|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis
MGI:6477604	Gm14692<em1Utr>	MP:0005389,reproductive system phenotype
MGI:6510264	Gm15441<em1Gonz>	MP:0001764,abnormal homeostasis|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005381,digestive/alimentary phenotype|MP:0011578,increased lipoprotein lipase activity
MGI:6399883	Gm15551<em1(IMPC)Ccpcz>	MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001392,abnormal locomotor behavior|MP:0001417,decreased exploration in new environment|MP:0002059,abnormal seminal vesicle morphology|MP:0002169,no abnormal phenotype detected|MP:0002997,enlarged seminal vesicle
MGI:8215376	Gm15915<em1Bcgen>	MP:0000245,abnormal erythropoiesis|MP:0000333,decreased bone marrow cell number|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004810,decreased hematopoietic stem cell number|MP:0008813,decreased common myeloid progenitor cell number|MP:0009278,abnormal bone marrow cell physiology|MP:0011903,decreased hematopoietic stem cell proliferation|MP:0013705,decreased megakaryocyte-erythroid progenitor cell number|MP:0031276,abnormal stress erythropoiesis
MGI:8215381	Gm15915<em2Bcgen>	MP:0000245,abnormal erythropoiesis
MGI:7386870	Gm16364<tm1Zhaoy>	MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0004889,increased energy expenditure|MP:0005292,improved glucose tolerance|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009269,decreased fat cell size|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:7386871	Gm16364<tm2Zhaoy>	MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0014146,decreased white adipose tissue mass|MP:0020868,decreased lipogenesis|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:6690649	Gm16685<em1Osb>	MP:0005397,hematopoietic system phenotype|MP:0013299,decreased susceptibility to colitis induced morbidity/mortality
MGI:7641856	Gm17266<em1Osb>	MP:0001147,small testis
MGI:8205456	Gm2044<em1Meli>	MP:0003507,abnormal ovary physiology|MP:0005181,decreased circulating estradiol level|MP:0005389,reproductive system phenotype
MGI:6153352	Gm20646<em1(IMPC)Wtsi>	MP:0000182,increased circulating LDL cholesterol level
MGI:7543240	Gm26330<em1Liuq>	MP:0001261,obese|MP:0001552,increased circulating triglyceride level|MP:0001762,polyuria|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005458,increased percent body fat/body weight|MP:0005534,decreased body temperature|MP:0008045,decreased NK cell number|MP:0008964,decreased carbon dioxide production|MP:0009171,enlarged pancreatic islets|MP:0010024,increased total body fat amount|MP:0011939,increased food intake|MP:0011941,increased fluid intake
MGI:6343542	Gm26878<em1Psta>	MP:0005388,respiratory system phenotype|MP:0011088,neonatal lethality, incomplete penetrance
MGI:6740205	Gm29348<em1Smun>	MP:0002109,abnormal limb morphology
MGI:6740206	Gm29348<em2Smun>	MP:0002109,abnormal limb morphology
MGI:6740207	Gm29348<em3Smun>	MP:0002169,no abnormal phenotype detected
MGI:6740379	Gm29348<em4Smun>	MP:0002109,abnormal limb morphology
MGI:7425715	Gm2a<em1(IMPC)H>	MP:0000194,increased circulating calcium level|MP:0005565,increased blood urea nitrogen level
MGI:1861930	Gm2a<tm1Rlp>	MP:0000818,abnormal amygdala morphology|MP:0000837,abnormal hypothalamus morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001405,impaired coordination|MP:0002152,abnormal brain morphology|MP:0004000,impaired passive avoidance behavior|MP:0004097,abnormal cerebellar cortex morphology|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004166,abnormal limbic system morphology|MP:0005267,abnormal olfactory cortex morphology|MP:0006300,abnormal entorhinal cortex morphology|MP:0009969,abnormal cerebral cortex pyramidal cell morphology
MGI:7334829	Gm34583<tm1.1Bcgen>	MP:0003043,hypoalgesia|MP:0005166,decreased susceptibility to injury
MGI:6150424	Gm36723<em1Flv>	MP:0002401,abnormal lymphopoiesis|MP:0002411,decreased susceptibility to bacterial infection|MP:0005016,decreased lymphocyte cell number|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005387,immune system phenotype|MP:0008045,decreased NK cell number|MP:0008567,decreased interferon-gamma secretion|MP:0010766,abnormal NK cell physiology|MP:0013667,increased immature NK cell number|MP:0013672,decreased mature NK cell number
MGI:6150426	Gm36723<em2Flv>	MP:0005387,immune system phenotype
MGI:6150427	Gm36723<em3Flv>	MP:0013672,decreased mature NK cell number
MGI:8263065	Gm38257<em1Svpu>	MP:0005386,behavior/neurological phenotype|MP:0020513,abnormal dendritic stubby spine morphology|MP:0020514,abnormal dendritic thin spine morphology|MP:0021018,decreased dendritic spine number|MP:0021090,abnormal dendrite arborization pattern
MGI:8263066	Gm38257<em2Svpu>	MP:0001364,decreased anxiety-related response|MP:0005386,behavior/neurological phenotype|MP:0020514,abnormal dendritic thin spine morphology|MP:0021018,decreased dendritic spine number|MP:0021090,abnormal dendrite arborization pattern
MGI:7625636	Gm38999<em1Doca>	MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0003205,testicular atrophy|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0006378,abnormal spermatogonia morphology|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0008878,abnormal DNA methylation during gametogenesis|MP:0010948,abnormal double-strand DNA break repair|MP:0014052,increased male germ cell apoptosis
MGI:6794076	Gm40600<em1Cya>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002492,decreased IgE level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0005014,increased B cell number|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0008097,increased plasma cell number|MP:0008098,decreased plasma cell number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008499,increased IgG1 level|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level|MP:0008896,increased IgG2c level|MP:0008897,decreased IgG2c level|MP:0013940,abnormal plasmablast number
MGI:7624349	Gm41261<em1Geh>	MP:0003546,decreased alcohol consumption|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0009745,abnormal behavioral response to xenobiotic|MP:0009755,impaired behavioral response to alcohol|MP:0014382,increased miniature inhibitory postsynaptic current frequency|MP:0020157,abnormal behavioral response to alcohol
MGI:6693618	Gm41610<em1Scrp>	MP:0005387,immune system phenotype|MP:0008608,increased circulating interleukin-13 level|MP:0008626,increased circulating interleukin-5 level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0012358,decreased partial thromboplastin time
MGI:5754602	Gm4922<em1(IMPC)Tcp>	MP:0000062,increased bone mineral density|MP:0000702,enlarged lymph nodes|MP:0002590,increased mean corpuscular volume|MP:0009142,decreased prepulse inhibition
MGI:7641908	Gm4984<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6382549	Gm5127<em1(IMPC)J>	MP:0001552,increased circulating triglyceride level|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005553,increased circulating creatinine level|MP:0010506,prolonged RR interval
MGI:4435240	Gm5134<tm1a(EUCOMM)Hmgu>	MP:0001413,abnormal response to new environment|MP:0002644,decreased circulating triglyceride level|MP:0005266,abnormal metabolism
MGI:7425717	Gm5148<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001404,no spontaneous movement|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010574,dilated aorta
MGI:6360721	Gm5447<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0004738,abnormal auditory brainstem response
MGI:4364386	Gm5544<tm1a(KOMP)Wtsi>	MP:0000106,abnormal basisphenoid bone morphology|MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0002989,small kidney|MP:0003686,abnormal eye muscle morphology|MP:0004442,occipital bone foramen|MP:0004463,basisphenoid bone foramen|MP:0004613,fusion of vertebral arches|MP:0008182,decreased marginal zone B cell number|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012501,abnormal pericardial cavity morphology|MP:0013830,abnormal intrathoracic topology of vagus nerve|MP:0013836,abnormal hypoglossal nerve topology|MP:0013840,absent segment of posterior cerebral artery|MP:0013848,subcutaneous edema|MP:0013971,blood in lymph vessels|MP:0013985,abnormal umbilical vein topology|MP:0014018,embryo tumor
MGI:6202381	Gm5547<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:6194713	Gm5617<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6194714	Gm5617<em2Osb>	MP:0002169,no abnormal phenotype detected
MGI:6257563	Gm614<em1(IMPC)Bay>	MP:0002574,increased vertical activity
MGI:6727377	Gm614<tm1.1Cya>	MP:0004802,decreased susceptibility to systemic lupus erythematosus|MP:0005387,immune system phenotype|MP:0008782,increased B cell apoptosis
MGI:4455593	Gm6578<tm1a(KOMP)Wtsi>	MP:0001258,decreased body length
MGI:6477606	Gm6812<em1Utr>	MP:0005389,reproductive system phenotype
MGI:6415700	Gm7694<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0010052,increased grip strength
MGI:6764560	Gm773<em1Smtb>	MP:0001922,reduced male fertility|MP:0005389,reproductive system phenotype|MP:0030976,impaired sperm penetration of zona pellucida
MGI:5693246	Gm94<tm1b(KOMP)Wtsi>	MP:0002574,increased vertical activity|MP:0003961,decreased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0010024,increased total body fat amount
MGI:2662409	Gmcl1<Gt(OST6847)Lex>	MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0003111,abnormal cell nucleus morphology|MP:0004182,abnormal spermiation|MP:0005578,teratozoospermia|MP:0006379,abnormal spermatocyte morphology|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009839,multiflagellated sperm|MP:0020550,multinucleated giant male germ cells|MP:0031408,multi-headed sperm
MGI:2450853	Gmcl1<tm1Nkn>	MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0003111,abnormal cell nucleus morphology|MP:0004182,abnormal spermiation|MP:0005578,teratozoospermia|MP:0006379,abnormal spermatocyte morphology|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009839,multiflagellated sperm|MP:0020550,multinucleated giant male germ cells|MP:0031408,multi-headed sperm
MGI:4363597	Gmds<tm1a(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0001258,decreased body length|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003795,abnormal bone structure|MP:0003884,decreased macrophage cell number|MP:0003961,decreased lean body mass|MP:0004974,decreased regulatory T cell number|MP:0008039,increased NK T cell number|MP:0008045,decreased NK cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0008127,decreased dendritic cell number|MP:0008346,increased gamma-delta T cell number|MP:0008810,increased circulating iron level|MP:0009926,decreased transitional stage T2 B cell number|MP:0010024,increased total body fat amount|MP:0010052,increased grip strength|MP:0010093,decreased circulating magnesium level|MP:0010124,decreased bone mineral content|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010851,decreased effector memory CD8-positive, alpha-beta T cell number|MP:0012765,decreased alpha-beta T cell number|MP:0012768,decreased KLRG1-positive NK cell number|MP:0013155,decreased KLRG1+ CD8 alpha-beta T cell number|MP:0013427,increased memory-marker NK cell number|MP:0013429,decreased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0013430,increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0013511,increased CD4-negative NK T cell number|MP:0013513,decreased memory-marker CD4-negative NK T cell number|MP:0013519,decreased CD4-positive NK T cell number|MP:0013522,decreased memory-marker CD4-positive NK T cell number|MP:0013667,increased immature NK cell number|MP:0013672,decreased mature NK cell number|MP:0013675,decreased Ly6C-positive mature NK cell number|MP:0013679,increased Ly6C-positive NK T cell number|MP:0013764,decreased T-helper cell number
MGI:6766467	Gmeb2<em1(IMPC)J>	MP:0000266,abnormal heart morphology|MP:0001488,increased startle reflex|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001722,pale yolk sac|MP:0002111,abnormal tail morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0003229,abnormal vitelline vasculature morphology|MP:0003400,kinked neural tube|MP:0003960,increased lean body mass|MP:0003984,embryonic growth retardation|MP:0005031,abnormal trophoblast layer morphology|MP:0005632,decreased circulating aspartate transaminase level|MP:0005635,decreased circulating bilirubin level|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0012099,decreased spongiotrophoblast size
MGI:3056591	Gmfb<tm1Lim>	MP:0000847,abnormal metencephalon morphology|MP:0001525,impaired balance|MP:0002807,abnormal eye blink conditioning behavior
MGI:7736707	Gmfg<tm1Jyw>	MP:0002494,increased IgM level|MP:0008193,abnormal marginal zone B cell physiology|MP:0014472,impaired B cell migration|MP:0031207,decreased lymphocyte chemotaxis
MGI:6195688	Gmip<tm1b(KOMP)Wtsi>	MP:0010088,decreased circulating fructosamine level
MGI:6343381	Gmnc<tm1.1Strc>	MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0001127,small ovary|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002152,abnormal brain morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0002262,abnormal nasal mucosa goblet cell morphology|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0005159,azoospermia|MP:0008770,decreased survivor rate|MP:0009070,small oviduct|MP:0009363,abnormal tertiary ovarian follicle morphology|MP:0010861,increased respiratory mucosa goblet cell number|MP:0010942,abnormal respiratory epithelium morphology|MP:0011054,absent respiratory motile cilia|MP:0011057,absent brain ependyma motile cilia|MP:0011121,decreased primordial ovarian follicle number|MP:0011645,absent oviduct epithelium motile cilium|MP:0012556,increased cell death|MP:0012676,dilated brain ventricle|MP:0013206,abnormal motile cilium morphology|MP:0013236,ovary degeneration|MP:0014636,decreased elongated spermatid number|MP:0030003,hippocampus atrophy|MP:0031381,decreased secondary ovarian follicle number
MGI:4841069	Gmnc<tm1a(KOMP)Wtsi>	MP:0001732,postnatal growth retardation|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0008489,slow postnatal weight gain|MP:0010861,increased respiratory mucosa goblet cell number|MP:0011054,absent respiratory motile cilia|MP:0011085,postnatal lethality, complete penetrance
MGI:5637172	Gmnc<tm1b(KOMP)Wtsi>	MP:0005633,increased circulating sodium level|MP:0010052,increased grip strength
MGI:3664114	Gmnn<Gt(XT0615)Wtsi>	MP:0001730,embryonic growth arrest|MP:0003111,abnormal cell nucleus morphology|MP:0004046,abnormal mitosis|MP:0004964,absent inner cell mass|MP:0005028,abnormal trophectoderm morphology|MP:0005076,abnormal cell differentiation|MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4456373	Gmnn<tm1.2Kio>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4363191	Gmnn<tm1a(KOMP)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract
MGI:3718544	Gmnn<tm1Nyma>	MP:0000352,decreased cell proliferation|MP:0002718,abnormal inner cell mass morphology|MP:0003111,abnormal cell nucleus morphology|MP:0003566,abnormal cell adhesion|MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012102,absent trophectoderm
MGI:4999617	Gmnn<tm1Tjm>	MP:0000216,absent erythroid progenitor cell|MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000333,decreased bone marrow cell number|MP:0000334,decreased granulocyte number|MP:0001577,anemia|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002356,abnormal spleen red pulp morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002416,abnormal proerythroblast morphology|MP:0002875,decreased erythrocyte cell number|MP:0003631,nervous system phenotype|MP:0004809,increased hematopoietic stem cell number|MP:0005386,behavior/neurological phenotype|MP:0005505,thrombocytosis|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008254,increased megakaryocyte cell number|MP:0008941,reticulocytopenia|MP:0008973,decreased erythroid progenitor cell number|MP:0009278,abnormal bone marrow cell physiology|MP:0010768,mortality/aging|MP:0011285,increased circulating erythropoietin level|MP:0011903,decreased hematopoietic stem cell proliferation
MGI:6257412	Gmppa<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001314,cornea opacity|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0005565,increased blood urea nitrogen level|MP:0009142,decreased prepulse inhibition|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior
MGI:6711468	Gmppa<tm1d(EUCOMM)Wtsi>	MP:0000748,progressive muscle weakness|MP:0000751,myopathy|MP:0000759,abnormal skeletal muscle morphology|MP:0000876,Purkinje cell degeneration|MP:0001262,decreased body weight|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004091,abnormal Z line morphology|MP:0004819,decreased skeletal muscle mass|MP:0008547,abnormal neocortex morphology|MP:0008814,decreased nerve conduction velocity|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0009642,abnormal blood homeostasis|MP:0010014,hippocampus pyramidal cell degeneration|MP:0020240,increased skeletal muscle cell apoptosis
MGI:7610557	Gmppb<em1Frap>	MP:0005380,embryo phenotype|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:6257525	Gmpr<em1(IMPC)Bay>	MP:0005270,abnormal zygomatic bone morphology
MGI:7425718	Gmps<em1(IMPC)Tcp>	MP:0000218,increased leukocyte cell number|MP:0001289,persistence of hyaloid vascular system|MP:0001392,abnormal locomotor behavior|MP:0001697,abnormal embryo size|MP:0002792,abnormal retina vasculature morphology|MP:0003961,decreased lean body mass|MP:0005013,increased lymphocyte cell number|MP:0010024,increased total body fat amount|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3043037	Gn	MP:0000373,belly spot|MP:0002075,abnormal coat/hair pigmentation|MP:0002939,head spot|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6376284	Gna11<em1Mman>	MP:0000063,decreased bone mineral density|MP:0000135,decreased compact bone thickness|MP:0000195,decreased circulating calcium level|MP:0001566,increased circulating phosphate level|MP:0002905,decreased circulating parathyroid hormone level|MP:0010869,decreased bone trabecula number|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation|MP:0013630,increased bone trabecular spacing
MGI:2682213	Gna11<Mhdadsk7>	MP:0000575,increased foot pad pigmentation|MP:0001188,hyperpigmentation|MP:0005409,darkened coat color|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation
MGI:4432307	Gna11<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000194,increased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0001262,decreased body weight|MP:0002644,decreased circulating triglyceride level|MP:0002874,decreased hemoglobin content|MP:0002896,abnormal bone mineralization|MP:0004924,abnormal behavior|MP:0005567,decreased circulating total protein level|MP:0008805,decreased circulating amylase level
MGI:5697314	Gna11<tm1b(EUCOMM)Wtsi>	MP:0000208,decreased hematocrit|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0004609,vertebral fusion|MP:0010067,increased red blood cell distribution width
MGI:2151589	Gna11<tm1Soff>	MP:0001552,increased circulating triglyceride level|MP:0002628,hepatic steatosis|MP:0003631,nervous system phenotype|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0009355,increased liver triglyceride level
MGI:2183606	Gna12<tm1Citb>	MP:0002169,no abnormal phenotype detected
MGI:5609362	Gna13<tm1b(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0001697,abnormal embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2151775	Gna13<tm1Soff>	MP:0000260,abnormal angiogenesis|MP:0000291,enlarged pericardium|MP:0001614,abnormal blood vessel morphology|MP:0001719,absent vitelline blood vessels|MP:0001722,pale yolk sac|MP:0001914,hemorrhage|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011205,excessive folding of visceral yolk sac
MGI:3583877	Gna13<tm2.1Cgh>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3697690	Gna13<tm2.1Soff>	MP:0002551,abnormal blood coagulation|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time
MGI:3697691	Gna13<tm2.2Soff>	MP:0002551,abnormal blood coagulation|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time
MGI:3583876	Gna13<tm2Cgh>	MP:0003631,nervous system phenotype|MP:0010768,mortality/aging
MGI:6336120	Gna14<em1(IMPC)Kmpc>	MP:0003960,increased lean body mass|MP:0005278,abnormal cholesterol homeostasis|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:6316114	Gna15<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001148,enlarged testis|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002699,abnormal vitreous body morphology|MP:0004832,enlarged ovary|MP:0004906,enlarged uterus
MGI:2152420	Gna15<tm1Tmw>	MP:0002169,no abnormal phenotype detected
MGI:5606346	Gnai1<tm1b(EUCOMM)Wtsi>	MP:0000689,abnormal spleen morphology
MGI:3028010	Gnai1<tm1Drs>	MP:0001469,abnormal contextual conditioning behavior|MP:0002062,abnormal associative learning|MP:0002063,abnormal learning/memory/conditioning|MP:0002207,abnormal long-term potentiation|MP:0002799,abnormal passive avoidance behavior|MP:0002801,abnormal long-term object recognition memory
MGI:3711989	Gnai2<tm1.1Rneu>	MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002626,increased heart rate|MP:0003631,nervous system phenotype|MP:0005333,decreased heart rate|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:2152603	Gnai2<tm1Lbi>	MP:0000217,abnormal leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0000489,abnormal large intestine morphology|MP:0000493,rectal prolapse|MP:0000495,abnormal colon morphology|MP:0000512,intestinal ulcer|MP:0000685,abnormal immune system morphology|MP:0000714,increased thymocyte number|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001663,abnormal digestive system physiology|MP:0001665,chronic diarrhea|MP:0001732,postnatal growth retardation|MP:0001790,abnormal immune system physiology|MP:0001846,increased inflammatory response|MP:0002083,premature death|MP:0002444,abnormal T cell physiology|MP:0002461,increased immunoglobulin level|MP:0002463,abnormal neutrophil physiology|MP:0002465,abnormal eosinophil physiology|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002731,megacolon|MP:0002816,colitis|MP:0002899,fatigue|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0003009,abnormal cytokine secretion|MP:0003303,peritoneal inflammation|MP:0003304,large intestinal inflammation|MP:0003628,abnormal leukocyte adhesion|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005011,increased eosinophil cell number|MP:0005012,decreased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005015,increased T cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0008082,increased single-positive T cell number|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008602,increased circulating interleukin-4 level|MP:0008626,increased circulating interleukin-5 level|MP:0008657,increased interleukin-1 beta secretion|MP:0008687,increased interleukin-2 secretion|MP:0008713,abnormal cytokine level|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009858,abnormal cellular extravasation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011111,lethality during fetal growth through weaning, complete penetrance
MGI:2152617	Gnai2<tm1Rmm>	MP:0005385,cardiovascular system phenotype
MGI:5471645	Gnai2<tm2.1Lbi>	MP:0004499,increased incidence of tumors by chemical induction|MP:0008537,increased susceptibility to induced colitis|MP:0010220,decreased T-helper 17 cell number
MGI:5614236	Gnai2<tm2.1Rneu>	MP:0000343,abnormal response to cardiac infarction|MP:0002169,no abnormal phenotype detected|MP:0003038,decreased myocardial infarct size
MGI:3652743	Gnai3<tm1Lbi>	MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0002444,abnormal T cell physiology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0004621,lumbar vertebral fusion|MP:0005387,immune system phenotype|MP:0008148,abnormal sternocostal joint morphology
MGI:2152618	Gnai3<tm1Rmm>	MP:0005385,cardiovascular system phenotype
MGI:2151207	Gnal<tm1Rax>	MP:0001265,decreased body size|MP:0001384,abnormal pup retrieval|MP:0001386,abnormal maternal nurturing|MP:0001436,abnormal suckling behavior|MP:0001984,abnormal olfaction|MP:0003462,abnormal response to novel odor|MP:0009326,absent maternal crouching|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031391,increased locomotor activity
MGI:6295353	Gnao1<em1Rneu>	MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0010053,decreased grip strength|MP:0011087,neonatal lethality, complete penetrance|MP:0020424,increased kindling response
MGI:6513138	Gnao1<em2Rneu>	MP:0001399,hyperactivity|MP:0001407,short stride length|MP:0001413,abnormal response to new environment|MP:0002797,increased thigmotaxis|MP:0005386,behavior/neurological phenotype|MP:0012106,impaired exercise endurance
MGI:3759767	Gnao1<tm1Adhi>	MP:0004022,abnormal cone electrophysiology|MP:0005551,abnormal eye electrophysiology
MGI:5548941	Gnao1<tm1b(EUCOMM)Hmgu>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001523,impaired righting response|MP:0001552,increased circulating triglyceride level|MP:0002875,decreased erythrocyte cell number|MP:0003795,abnormal bone structure|MP:0004151,decreased circulating iron level|MP:0005012,decreased eosinophil cell number|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0008806,increased circulating amylase level|MP:0010068,decreased red blood cell distribution width|MP:0010124,decreased bone mineral content|MP:0010379,decreased respiratory quotient|MP:0011100,preweaning lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:2152683	Gnao1<tm1Ejne>	MP:0000745,tremors|MP:0000951,sporadic seizures|MP:0002083,premature death|MP:0003484,abnormal channel response|MP:0004215,abnormal myocardial fiber physiology|MP:0005386,behavior/neurological phenotype|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2152685	Gnao1<tm1Lbi>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001360,abnormal social investigation|MP:0001396,unidirectional circling|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001924,infertility|MP:0002083,premature death|MP:0003484,abnormal channel response|MP:0003998,decreased thermal nociceptive threshold|MP:0005407,hyperalgesia|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5620501	Gnao1<tm2.1Rneu>	MP:0001499,abnormal kindling response|MP:0002083,premature death|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging|MP:0010831,lethality, incomplete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014620,abnormal interictal brain wave pattern
MGI:3759769	Gnao1<tm2Adhi>	MP:0005391,vision/eye phenotype
MGI:4889046	Gnao1<tm2Lbi>	MP:0000745,tremors|MP:0001392,abnormal locomotor behavior|MP:0005376,homeostasis/metabolism phenotype|MP:0005551,abnormal eye electrophysiology|MP:0010769,abnormal survival
MGI:5508226	Gnao1<tm2Rneu>	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001417,decreased exploration in new environment|MP:0008840,abnormal spike wave discharge|MP:0010053,decreased grip strength|MP:0011400,lethality, complete penetrance
MGI:4889047	Gnao1<tm3Lbi>	MP:0002079,increased circulating insulin level|MP:0003058,increased insulin secretion|MP:0003953,abnormal hormone level|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level
MGI:4941848	Gnao1<tm4.1Lbi>	MP:0001919,abnormal reproductive system physiology|MP:0003956,abnormal body size|MP:0004924,abnormal behavior|MP:0010769,abnormal survival
MGI:4941847	Gnao1<tm4Lbi>	MP:0001944,abnormal pancreas morphology|MP:0002079,increased circulating insulin level|MP:0003058,increased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0004924,abnormal behavior|MP:0005291,abnormal glucose tolerance|MP:0009114,decreased pancreatic beta cell mass|MP:0011678,abnormal vomeronasal sensory neuron physiology
MGI:5516345	Gnaq<M1J>	MP:0000575,increased foot pad pigmentation|MP:0005409,darkened coat color|MP:0009385,abnormal dermal pigmentation|MP:0009387,abnormal epidermal pigmentation|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation
MGI:2681766	Gnaq<Mhdadsk1>	MP:0000575,increased foot pad pigmentation|MP:0002095,abnormal skin pigmentation|MP:0005409,darkened coat color|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation
MGI:2681784	Gnaq<Mhdadsk10>	MP:0000575,increased foot pad pigmentation|MP:0001188,hyperpigmentation|MP:0005409,darkened coat color|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation
MGI:2151661	Gnaq<tm1Soff>	MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001899,absent long-term depression|MP:0002184,abnormal innervation|MP:0002272,abnormal nervous system electrophysiology|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0003412,abnormal afterhyperpolarization|MP:0003631,nervous system phenotype|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0009549,decreased platelet aggregation|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2446363	Gnaq<tm2.1Soff>	MP:0001516,abnormal motor coordination/balance|MP:0002551,abnormal blood coagulation|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4459475	Gnasas1<tm1.1Hju>	MP:0001399,hyperactivity|MP:0001732,postnatal growth retardation|MP:0001786,skin edema|MP:0003122,maternal imprinting|MP:0003787,abnormal imprinting|MP:0003956,abnormal body size|MP:0008877,abnormal DNA methylation|MP:0009674,decreased birth weight|MP:0011085,postnatal lethality, complete penetrance
MGI:4950057	Gnasas1<tm1.1Jop>	MP:0008877,abnormal DNA methylation
MGI:3621477	Gnasas1<tm1Jop>	MP:0001265,decreased body size|MP:0001436,abnormal suckling behavior|MP:0003122,maternal imprinting|MP:0005202,lethargy|MP:0011085,postnatal lethality, complete penetrance
MGI:4950064	Gnasas1<tm2.1Jop>	MP:0008877,abnormal DNA methylation
MGI:4950063	Gnas/Nespas<tm1.1Jop>	MP:0008877,abnormal DNA methylation
MGI:4950066	Gnas/Nespas<tm2.1Jop>	MP:0008877,abnormal DNA methylation
MGI:2183318	Gnas<Oedsml>	MP:0000005,increased brown adipose tissue amount|MP:0000195,decreased circulating calcium level|MP:0001262,decreased body weight|MP:0001510,abnormal coat appearance|MP:0001566,increased circulating phosphate level|MP:0001732,postnatal growth retardation|MP:0001785,edema|MP:0001845,abnormal inflammatory response|MP:0001954,respiratory distress|MP:0002188,small heart|MP:0002192,hydrops fetalis|MP:0002834,decreased heart weight|MP:0002904,increased circulating parathyroid hormone level|MP:0003787,abnormal imprinting|MP:0009703,decreased birth body size|MP:0011085,postnatal lethality, complete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5320896	Gnas<tm1.1Plag>	MP:0011088,neonatal lethality, incomplete penetrance
MGI:5320901	Gnas<tm1.2Plag>	MP:0011088,neonatal lethality, incomplete penetrance
MGI:2152744	Gnas<tm1Gwa>	MP:0001212,skin lesions|MP:0001261,obese|MP:0001523,impaired righting response|MP:0003546,decreased alcohol consumption|MP:0003705,abnormal hypodermis morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0014167,ectopic bone
MGI:3050794	Gnas<tm1Jop>	MP:0002169,no abnormal phenotype detected
MGI:3050783	Gnas<tm1Kel>	MP:0000746,weakness|MP:0001402,decreased locomotor activity|MP:0001436,abnormal suckling behavior|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0002082,postnatal lethality|MP:0002696,decreased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0003787,abnormal imprinting|MP:0005560,decreased circulating glucose level|MP:0008489,slow postnatal weight gain|MP:0009295,decreased interscapular fat pad weight|MP:0011085,postnatal lethality, complete penetrance|MP:0011612,increased circulating ghrelin level
MGI:2152743	Gnas<tm1Lsw>	MP:0000005,increased brown adipose tissue amount|MP:0000008,increased white adipose tissue amount|MP:0000195,decreased circulating calcium level|MP:0000528,delayed kidney development|MP:0000745,tremors|MP:0001258,decreased body length|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001404,no spontaneous movement|MP:0001504,abnormal posture|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0001786,skin edema|MP:0002060,abnormal skin morphology|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002078,abnormal glucose homeostasis|MP:0002177,abnormal outer ear morphology|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0002904,increased circulating parathyroid hormone level|MP:0002971,abnormal brown adipose tissue morphology|MP:0002988,decreased urine osmolality|MP:0003121,genetic imprinting|MP:0003497,insensitivity to parathyroid hormone|MP:0003948,abnormal gas homeostasis|MP:0003956,abnormal body size|MP:0003960,increased lean body mass|MP:0004097,abnormal cerebellar cortex morphology|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005290,decreased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005560,decreased circulating glucose level|MP:0006086,decreased body mass index|MP:0006087,increased body mass index|MP:0008770,decreased survivor rate|MP:0009124,increased brown fat cell lipid droplet size|MP:0009289,decreased epididymal fat pad weight|MP:0009294,increased interscapular fat pad weight|MP:0009295,decreased interscapular fat pad weight|MP:0009546,absent gastric milk in neonates|MP:0009642,abnormal blood homeostasis|MP:0009673,increased birth weight|MP:0009674,decreased birth weight|MP:0009702,increased birth body size|MP:0009703,decreased birth body size|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0013585,thymus cortex atrophy|MP:0030021,increased muscle cell glucose uptake|MP:0030768,increased urine dopamine level|MP:0030772,increased urine noradrenaline level|MP:0030773,decreased urine noradrenaline level|MP:0031391,increased locomotor activity
MGI:3043369	Gnas<tm2.1Lsw>	MP:0000198,decreased circulating phosphate level|MP:0002905,decreased circulating parathyroid hormone level|MP:0003122,maternal imprinting|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005384,cellular phenotype
MGI:4887402	Gnas<tm2Jop>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0003109,short femur|MP:0003948,abnormal gas homeostasis|MP:0003961,decreased lean body mass|MP:0005289,increased oxygen consumption|MP:0005386,behavior/neurological phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005668,decreased circulating leptin level|MP:0008489,slow postnatal weight gain|MP:0008963,increased carbon dioxide production|MP:0008965,increased basal metabolism|MP:0009674,decreased birth weight|MP:0010025,decreased total body fat amount|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011939,increased food intake
MGI:3579575	Gnas<tm2Kel>	MP:0001399,hyperactivity|MP:0001413,abnormal response to new environment|MP:0003123,paternal imprinting|MP:0003631,nervous system phenotype
MGI:4887403	Gnas<tm3Jop>	MP:0001431,abnormal eating behavior|MP:0003961,decreased lean body mass|MP:0005386,behavior/neurological phenotype|MP:0008489,slow postnatal weight gain|MP:0009674,decreased birth weight|MP:0010025,decreased total body fat amount|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3830998	Gnas<tm3Kel>	MP:0001259,abnormal body weight|MP:0003123,paternal imprinting|MP:0003787,abnormal imprinting|MP:0005334,abnormal fat pad morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3043361	Gnas<tm3Lsw>	MP:0000131,abnormal long bone epiphysis morphology|MP:0000164,abnormal cartilage development|MP:0000440,domed cranium|MP:0000547,short limbs|MP:0000558,abnormal tibia morphology|MP:0001575,cyanosis|MP:0002136,abnormal kidney physiology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002667,decreased circulating aldosterone level|MP:0002988,decreased urine osmolality|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003353,decreased circulating renin level|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005379,endocrine/exocrine gland phenotype|MP:0005528,decreased renal glomerular filtration rate|MP:0005581,abnormal renin activity|MP:0011087,neonatal lethality, complete penetrance|MP:0011563,increased urine prostaglandin level
MGI:3582306	Gnas<tm4Lsw>	MP:0000003,abnormal adipose tissue morphology|MP:0000005,increased brown adipose tissue amount|MP:0000008,increased white adipose tissue amount|MP:0001261,obese|MP:0001552,increased circulating triglyceride level|MP:0001785,edema|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002080,prenatal lethality|MP:0002135,abnormal kidney morphology|MP:0003123,paternal imprinting|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0009294,increased interscapular fat pad weight|MP:0009642,abnormal blood homeostasis|MP:0010024,increased total body fat amount|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3609165	Gnas<tm5.1Lsw>	MP:0000030,abnormal tympanic ring morphology|MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000189,hypoglycemia|MP:0000195,decreased circulating calcium level|MP:0000428,abnormal craniofacial morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000455,abnormal maxilla morphology|MP:0000457,maxilla hypoplasia|MP:0000458,abnormal mandible morphology|MP:0000460,mandible hypoplasia|MP:0000762,abnormal tongue morphology|MP:0000964,small dorsal root ganglion|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001300,ocular hypertelorism|MP:0001402,decreased locomotor activity|MP:0001436,abnormal suckling behavior|MP:0001552,increased circulating triglyceride level|MP:0001575,cyanosis|MP:0001745,increased circulating corticosterone level|MP:0001783,decreased white adipose tissue amount|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002116,abnormal craniofacial bone morphology|MP:0002260,abnormal thyroid cartilage morphology|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002712,increased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0002820,abnormal premaxilla morphology|MP:0002891,increased insulin sensitivity|MP:0002904,increased circulating parathyroid hormone level|MP:0002981,increased liver weight|MP:0003056,abnormal hyoid bone morphology|MP:0003416,premature bone ossification|MP:0003631,nervous system phenotype|MP:0003960,increased lean body mass|MP:0004889,increased energy expenditure|MP:0004911,absent mandibular condyloid process|MP:0004912,absent mandibular coronoid process|MP:0004913,absent mandibular angle|MP:0005292,improved glucose tolerance|MP:0005358,abnormal incisor morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005380,embryo phenotype|MP:0005382,craniofacial phenotype|MP:0005385,cardiovascular system phenotype|MP:0005394,taste/olfaction phenotype|MP:0005450,abnormal energy expenditure|MP:0005491,pancreatic islet hyperplasia|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0005670,abnormal white adipose tissue physiology|MP:0008271,abnormal bone ossification|MP:0008384,absent nasal capsule|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009108,increased pancreas weight|MP:0009133,decreased white fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0009303,decreased renal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0009888,palatal shelves fail to meet at midline|MP:0009892,palate bone hypoplasia|MP:0009908,protruding tongue|MP:0009917,abnormal hyoid bone body morphology|MP:0010025,decreased total body fat amount|MP:0010400,increased liver glycogen level|MP:0011049,impaired adaptive thermogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011167,abnormal adipose tissue development|MP:0011478,abnormal urine catecholamine level|MP:0012336,decreased vitamin D level|MP:0014143,decreased body fat mass|MP:0014171,increased fatty acid oxidation|MP:0021213,complete cleft palate|MP:0030072,round face|MP:0030200,abnormal nasal septum cartilage morphology|MP:0030367,premature metopic suture closure|MP:0031414,decreased skeletal muscle triglyceride level
MGI:3707708	Gnat1<irdr>	MP:0004022,abnormal cone electrophysiology
MGI:2152779	Gnat1<tm1Clma>	MP:0004021,abnormal rod electrophysiology|MP:0005253,abnormal eye physiology|MP:0005394,taste/olfaction phenotype|MP:0005551,abnormal eye electrophysiology|MP:0006069,abnormal retina neuronal layer morphology|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0014336,short retina rod cell outer segment|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:3588845	Gnat2<cpfl3>	MP:0001006,abnormal retina cone cell morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004022,abnormal cone electrophysiology
MGI:6798111	Gnat2<cpfl3-2J>	MP:0004022,abnormal cone electrophysiology|MP:0005391,vision/eye phenotype
MGI:6163746	Gnat2<m1Erica>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001325,abnormal retina morphology|MP:0002183,gliosis|MP:0005547,abnormal Muller cell morphology|MP:0006068,abnormal retina horizontal cell morphology|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0006075,abnormal retina cone bipolar cell morphology|MP:0008444,retina cone cell degeneration|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:2152966	Gnat3<tm1Rfm>	MP:0001986,abnormal taste sensitivity|MP:0004209,abnormal sweet taste sensitivity|MP:0004210,abnormal bitter taste sensitivity|MP:0004213,abnormal umami taste sensitivity
MGI:5708275	Gnaz<tm1.1(KOMP)Vlcg>	MP:0001258,decreased body length|MP:0002060,abnormal skin morphology|MP:0010024,increased total body fat amount
MGI:3575007	Gnaz<tm1Iah>	MP:0001262,decreased body weight|MP:0001921,reduced fertility|MP:0001980,abnormal chemically-elicited antinociception|MP:0001982,decreased chemically-elicited antinociception|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:2447341	Gnaz<tm1Lfb>	MP:0001982,decreased chemically-elicited antinociception|MP:0009549,decreased platelet aggregation|MP:0009750,impaired behavioral response to addictive substance|MP:0009754,enhanced behavioral response to cocaine|MP:0031120,decreased susceptibility to induced thrombosis
MGI:7620469	Gnb1<em1Dgold>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001523,impaired righting response|MP:0002193,minimal clonic seizures|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0008432,abnormal long-term spatial reference memory|MP:0008779,abnormal maternal behavior|MP:0008840,abnormal spike wave discharge|MP:0011091,prenatal lethality, complete penetrance|MP:0012307,impaired spatial learning|MP:0020351,decreased vocalization
MGI:6257631	Gnb1<em1(IMPC)Bay>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0008797,facial cleft|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness
MGI:7620476	Gnb1<em2Dgold>	MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging|MP:0011091,prenatal lethality, complete penetrance
MGI:4438390	Gnb1<Gt(prvSStrap)4B8Yiw>	MP:0000352,decreased cell proliferation|MP:0000774,decreased brain size|MP:0000914,exencephaly|MP:0001436,abnormal suckling behavior|MP:0001953,respiratory failure|MP:0002152,abnormal brain morphology|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0005657,abnormal neural plate morphology|MP:0006254,thin cerebral cortex|MP:0008458,abnormal cortical ventricular zone morphology|MP:0009937,abnormal neuron differentiation|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:7425719	Gnb1l<em1(IMPC)Tcp>	MP:0000195,decreased circulating calcium level|MP:0000219,increased neutrophil cell number|MP:0001417,decreased exploration in new environment|MP:0001697,abnormal embryo size|MP:0002151,abnormal neural tube morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003232,abnormal forebrain development|MP:0003864,abnormal midbrain development|MP:0006108,abnormal hindbrain development|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:3530640	Gnb1l<Gt(OST35527)Lex>	MP:0002743,glomerulonephritis|MP:0005344,increased circulating bilirubin level|MP:0008470,abnormal spleen B cell follicle morphology|MP:0009142,decreased prepulse inhibition|MP:0011091,prenatal lethality, complete penetrance
MGI:5817218	Gnb2<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0002626,increased heart rate|MP:0005278,abnormal cholesterol homeostasis|MP:0005419,decreased circulating serum albumin level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005566,decreased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0010053,decreased grip strength|MP:0010507,shortened RR interval|MP:0010571,shortened ST segment|MP:0020870,decreased thigmotaxis
MGI:3812642	Gnb3<tm1(KOMP)Vlcg>	MP:0001005,abnormal retina rod cell morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5755155	Gnb4<em1(IMPC)H>	MP:0000274,enlarged heart|MP:0000691,enlarged spleen|MP:0001325,abnormal retina morphology|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0002968,increased circulating alkaline phosphatase level|MP:0004924,abnormal behavior|MP:0010052,increased grip strength|MP:0020870,decreased thigmotaxis
MGI:5516195	Gnb5<tm1.1(KOMP)Vlcg>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:2664296	Gnb5<tm1Ck>	MP:0001265,decreased body size|MP:0003631,nervous system phenotype|MP:0005391,vision/eye phenotype|MP:0006142,abnormal sinoatrial node conduction|MP:0008489,slow postnatal weight gain|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1856605	gnd	MP:0000755,hindlimb paralysis|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001505,hunched posture|MP:0001510,abnormal coat appearance|MP:0001516,abnormal motor coordination/balance|MP:0002566,abnormal sexual interaction|MP:0003225,axonal dystrophy
MGI:6363412	Gne<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002151,abnormal neural tube morphology|MP:0002699,abnormal vitreous body morphology|MP:0003984,embryonic growth retardation|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:7611836	Gne<em1Lx>	MP:0001915,intracranial hemorrhage|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0006054,spinal hemorrhage|MP:0010768,mortality/aging|MP:0012732,abnormal perineural vascular plexus morphology|MP:0014257,embryonic lethality prior to tooth bud stage, complete penetrance
MGI:5320944	Gne<tm1.1Masn>	MP:0001859,kidney inflammation|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0002871,albuminuria|MP:0003606,kidney failure|MP:0004969,pale kidney|MP:0005264,glomerulosclerosis|MP:0008140,podocyte foot process effacement|MP:0011290,decreased nephron number|MP:0011294,renal glomerulus hypertrophy|MP:0011353,expanded mesangial matrix|MP:0011501,increased glomerular capsule space
MGI:3713799	Gne<tm1Dar>	MP:0000519,hydronephrosis|MP:0000523,cortical renal glomerulopathies|MP:0000533,kidney hemorrhage|MP:0001262,decreased body weight|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002828,abnormal renal glomerular capsule morphology|MP:0002962,increased urine protein level|MP:0005326,abnormal podocyte morphology|MP:0005369,muscle phenotype|MP:0005565,increased blood urea nitrogen level|MP:0008062,abnormal podocyte slit junction morphology|MP:0008139,fused podocyte foot processes|MP:0008140,podocyte foot process effacement|MP:0009546,absent gastric milk in neonates|MP:0011085,postnatal lethality, complete penetrance|MP:0011348,abnormal renal glomerulus basement membrane morphology
MGI:2182685	Gne<tm1Rhk>	MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3582472	Gnf1<C57BL/6J>	MP:0000063,decreased bone mineral density|MP:0001262,decreased body weight|MP:0002089,abnormal postnatal growth/weight/body size|MP:0010025,decreased total body fat amount
MGI:3582474	Gnf2<C57BL/6J>	MP:0010025,decreased total body fat amount
MGI:3582476	Gnf3<C57BL/6J>	MP:0010025,decreased total body fat amount
MGI:3582478	Gnf4<C57BL/6J>	MP:0003402,decreased liver weight
MGI:7327089	Gng12<em1(IMPC)J>	MP:0000194,increased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0001488,increased startle reflex
MGI:7512907	Gng12<em1(IMPC)Tcp>	MP:0000194,increased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0001293,anophthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:5548691	Gng13<tm1.1(KOMP)Vlcg>	MP:0001120,abnormal uterus morphology|MP:0002989,small kidney|MP:0005559,increased circulating glucose level|MP:0010024,increased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4460590	Gng13<tm1(KOMP)Vlcg>	MP:0001265,decreased body size|MP:0001924,infertility|MP:0004021,abnormal rod electrophysiology|MP:0005391,vision/eye phenotype
MGI:5517361	Gng13<tm1Liqh>	MP:0001983,abnormal olfactory system physiology|MP:0005499,abnormal olfactory system morphology|MP:0008544,impaired olfaction|MP:0008770,decreased survivor rate|MP:0011677,abnormal olfactory sensory neuron physiology
MGI:3055576	Gng3<tm1.1Rbs>	MP:0000947,convulsive seizures|MP:0001496,audiogenic seizures|MP:0002083,premature death|MP:0005668,decreased circulating leptin level|MP:0008489,slow postnatal weight gain|MP:0009293,decreased inguinal fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight
MGI:5629569	Gng5<tm1.1Rbs>	MP:0000267,abnormal heart development|MP:0000270,abnormal heart tube morphology|MP:0003872,absent heart right ventricle|MP:0003873,pharyngeal arch hypoplasia|MP:0004251,failure of heart looping|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011257,abnormal head fold morphology|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0012278,abnormal cardiogenic mesoderm morphology|MP:0012511,dilated aortic sac|MP:0013267,first pharyngeal arch hypoplasia|MP:0013504,increased embryonic tissue cell apoptosis|MP:0014044,absent cardiac outflow tract
MGI:3604392	Gng7<tm1Lex>	MP:0001488,increased startle reflex|MP:0002079,increased circulating insulin level|MP:0003633,abnormal nervous system physiology
MGI:5584308	Gng8<tm1(tTA)Rtir>	MP:0001360,abnormal social investigation|MP:0002757,decreased vertical activity|MP:0003491,abnormal voluntary movement|MP:0003862,decreased aggression towards male mice|MP:0005394,taste/olfaction phenotype|MP:0008779,abnormal maternal behavior|MP:0009945,abnormal accessory olfactory bulb morphology|MP:0011679,abnormal vomeronasal sensory neuron morphology|MP:0031391,increased locomotor activity
MGI:3783323	Gngt1<tm1Dgen>	MP:0004021,abnormal rod electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008587,short photoreceptor outer segment
MGI:5140545	Gngt1<tm1Ogk>	MP:0001326,retina degeneration|MP:0004021,abnormal rod electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0008518,retina outer nuclear layer degeneration
MGI:3603438	Gngt1<tm1Yf>	MP:0001999,photosensitivity|MP:0005391,vision/eye phenotype
MGI:6257706	Gngt2<em1(IMPC)Bay>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003960,increased lean body mass|MP:0004952,increased spleen weight|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010579,increased heart left ventricle size|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness|MP:0013279,increased fasting circulating glucose level
MGI:6257571	Gnl1<em1(IMPC)Tcp>	MP:0000438,abnormal cranium morphology|MP:0001258,decreased body length|MP:0001402,decreased locomotor activity|MP:0001513,limb grasping|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002574,increased vertical activity|MP:0002599,increased mean platelet volume|MP:0002764,short tibia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010024,increased total body fat amount|MP:0010052,increased grip strength|MP:0010511,shortened PR interval
MGI:7425720	Gnl2<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology|MP:0010025,decreased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:4974804	Gnl3<Gt(S4-4B1)Sor>	MP:0000352,decreased cell proliferation|MP:0002663,absent blastocoele|MP:0003984,embryonic growth retardation|MP:0004964,absent inner cell mass|MP:0006042,increased apoptosis|MP:0011092,embryonic lethality, complete penetrance|MP:0012102,absent trophectoderm
MGI:3701318	Gnl3<Gt(W223E05)Wrst>	MP:0000352,decreased cell proliferation|MP:0001730,embryonic growth arrest|MP:0003077,abnormal cell cycle|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0004957,abnormal blastocyst morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance
MGI:3699142	Gnl3<tm1Rylt>	MP:0003077,abnormal cell cycle|MP:0008008,early cellular replicative senescence|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0013501,increased fibroblast apoptosis
MGI:5523416	Gnl3<tm2.1Rylt>	MP:0000787,abnormal telencephalon morphology|MP:0000830,abnormal diencephalon morphology|MP:0000854,abnormal cerebellum development|MP:0000956,decreased spinal cord size|MP:0001953,respiratory failure|MP:0002152,abnormal brain morphology|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0005621,abnormal cell physiology|MP:0006102,decreased tegmentum size|MP:0006104,abnormal tectum morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0012203,abnormal neuronal stem cell morphology
MGI:5523418	Gnl3<tm2.2Rylt>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3640328	Gnmt<tm1Cwa>	MP:0005332,abnormal amino acid level
MGI:3842652	Gnmt<tm1Ymac>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000602,dilated liver sinusoidal space|MP:0001654,hepatic necrosis|MP:0002047,increased hepatic hemangioma incidence|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003103,liver degeneration|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003402,decreased liver weight|MP:0005178,increased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0010019,liver vascular congestion|MP:0010400,increased liver glycogen level|MP:0030644,increased circulating methionine level
MGI:2670461	Gnpat<tm1Just>	MP:0000547,short limbs|MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0000877,abnormal Purkinje cell morphology|MP:0000920,abnormal myelination|MP:0001127,small ovary|MP:0001262,decreased body weight|MP:0001289,persistence of hyaloid vascular system|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002175,decreased brain weight|MP:0002216,abnormal seminiferous tubule morphology|MP:0002427,disproportionate dwarf|MP:0002794,lenticonus|MP:0003063,increased coping response|MP:0003908,decreased stereotypic behavior|MP:0005159,azoospermia|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005205,abnormal eye anterior chamber morphology|MP:0005394,taste/olfaction phenotype|MP:0006221,optic nerve hypoplasia|MP:0008261,arrest of male meiosis|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008814,decreased nerve conduction velocity|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0009977,abnormal cerebellar granule cell migration|MP:0010734,abnormal paranode morphology|MP:0010735,abnormal paranodal axoglial junction morphology|MP:0020422,decreased freezing behavior
MGI:5513784	Gnpda1<tm1b(KOMP)Mbp>	MP:0000219,increased neutrophil cell number|MP:0001120,abnormal uterus morphology|MP:0001697,abnormal embryo size|MP:0002989,small kidney|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5696907	Gnpda2<tm1.1(KOMP)Vlcg>	MP:0002590,increased mean corpuscular volume
MGI:3662646	Gnpnat1<tm1Mak>	MP:0000352,decreased cell proliferation|MP:0001683,absent mesoderm|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002584,small ectoplacental cone|MP:0003087,absent allantois|MP:0003984,embryonic growth retardation|MP:0005030,absent amnion|MP:0009593,absent chorion|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6336212	Gnptab<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000470,abnormal stomach morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001304,cataract|MP:0001404,no spontaneous movement|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002691,small stomach|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0003231,abnormal placenta vasculature|MP:0004258,abnormal placenta size|MP:0004832,enlarged ovary|MP:0009552,urinary bladder obstruction|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3757945	Gnptab<Gt(OST97730)Lex>	MP:0000166,abnormal chondrocyte morphology|MP:0001169,abnormal bulbourethral gland morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001326,retina degeneration|MP:0001570,abnormal circulating enzyme level|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003793,abnormal submandibular gland morphology|MP:0003961,decreased lean body mass|MP:0005220,abnormal exocrine pancreas morphology|MP:0005551,abnormal eye electrophysiology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008450,retina photoreceptor degeneration|MP:0009160,abnormal pancreatic acinar cell zymogen granule morphology|MP:0013558,abnormal exocrine gland morphology|MP:0013582,abnormal lateral nasal gland morphology|MP:0013594,abnormal parotid gland acinus morphology
MGI:5616922	Gnptab<nym>	MP:0000160,kyphosis|MP:0000166,abnormal chondrocyte morphology|MP:0000447,flattened snout|MP:0000748,progressive muscle weakness|MP:0000774,decreased brain size|MP:0000876,Purkinje cell degeneration|MP:0000889,abnormal cerebellar molecular layer|MP:0000921,demyelination|MP:0001200,thick skin|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0001847,brain inflammation|MP:0001944,abnormal pancreas morphology|MP:0002083,premature death|MP:0002161,abnormal fertility/fecundity|MP:0002169,no abnormal phenotype detected|MP:0003354,astrocytosis|MP:0003743,abnormal facial morphology|MP:0004097,abnormal cerebellar cortex morphology|MP:0004174,abnormal spine curvature|MP:0005059,lysosomal protein accumulation|MP:0005508,abnormal skeleton morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006162,thick eyelids|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0008770,decreased survivor rate|MP:0009105,penis prolapse|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009978,abnormal cerebellum white matter morphology|MP:0010047,axonal spheroids|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012506,brain atrophy|MP:0013159,Purkinje cell axonal dystrophy|MP:0014114,abnormal cognition|MP:0014185,cerebellum atrophy|MP:0014659,increased skin stiffness|MP:0030035,small nasal bridge
MGI:5811451	Gnptab<tm1Dkji>	MP:0000063,decreased bone mineral density|MP:0000160,kyphosis|MP:0000166,abnormal chondrocyte morphology|MP:0000358,abnormal cell morphology|MP:0000613,abnormal salivary gland morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0003174,increased lysosomal enzyme secretion|MP:0004016,decreased bone mass|MP:0005058,abnormal lysosome morphology|MP:0008705,increased interleukin-6 secretion|MP:0010124,decreased bone mineral content|MP:0030074,coarse facial features
MGI:4818381	Gnptab<tm1Kkol>	MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000166,abnormal chondrocyte morphology|MP:0001265,decreased body size|MP:0001541,abnormal osteoclast physiology|MP:0002113,abnormal skeleton development|MP:0003172,abnormal lysosome physiology|MP:0003797,abnormal compact bone morphology|MP:0004016,decreased bone mass|MP:0004214,abnormal long bone diaphysis morphology|MP:0004704,short vertebral column|MP:0004984,increased osteoclast cell number|MP:0004986,abnormal osteoblast morphology|MP:0004989,decreased osteoblast cell number|MP:0004992,increased bone resorption|MP:0005508,abnormal skeleton morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006395,abnormal epiphyseal plate morphology|MP:0008753,abnormal osteocyte morphology|MP:0010879,decreased trabecular bone volume|MP:0011711,impaired osteoblast differentiation|MP:0031074,increased circulating type I collagen C-terminal telopeptide level
MGI:6423833	Gnptg<em1(IMPC)Mbp>	MP:0001304,cataract|MP:0001488,increased startle reflex|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002699,abnormal vitreous body morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0002989,small kidney|MP:0005238,increased brain size|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010067,increased red blood cell distribution width
MGI:3757947	Gnptg<tm1Lex>	MP:0005584,abnormal enzyme/coenzyme activity
MGI:7621903	Gnrh1<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002834,decreased heart weight|MP:0010053,decreased grip strength
MGI:1856393	Gnrh1<hpg>	MP:0000321,increased bone marrow cell number|MP:0000653,abnormal sex gland morphology|MP:0001119,abnormal female reproductive system morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001142,abnormal vagina orifice morphology|MP:0001145,abnormal male reproductive system morphology|MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0001199,thin skin|MP:0001262,decreased body weight|MP:0001929,abnormal gametogenesis|MP:0002286,cryptorchism|MP:0002637,small uterus|MP:0002669,abnormal scrotum morphology|MP:0002785,absent Leydig cells|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003631,nervous system phenotype|MP:0005014,increased B cell number|MP:0005128,decreased adrenocorticotropin level|MP:0005130,decreased follicle stimulating hormone level|MP:0005132,decreased luteinizing hormone level|MP:0005138,decreased prolactin level|MP:0005188,small penis|MP:0005189,abnormal anogenital distance|MP:0005390,skeleton phenotype|MP:0005646,abnormal pituitary gland physiology|MP:0008210,increased mature B cell number|MP:0008214,increased immature B cell number|MP:0008261,arrest of male meiosis|MP:0008826,abnormal splenic cell ratio
MGI:5792105	Gnrh1<mpc294H>	MP:0001261,obese
MGI:4949468	Gnrh1<tm1.1Hjn>	MP:0001751,increased circulating luteinizing hormone level|MP:0002636,delayed vaginal opening|MP:0003507,abnormal ovary physiology|MP:0003631,nervous system phenotype|MP:0003699,abnormal female reproductive system physiology|MP:0003953,abnormal hormone level|MP:0005182,increased circulating estradiol level|MP:0005186,increased circulating progesterone level|MP:0008976,delayed female fertility|MP:0009007,short estrous cycle|MP:0009012,short diestrus|MP:0009015,short proestrus|MP:0009047,short metestrus
MGI:3855285	Gnrhr<Gt(181A6)Cmhd>	MP:0001126,abnormal ovary morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001134,absent corpus luteum|MP:0001143,constricted vagina orifice|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001157,small seminal vesicle|MP:0001260,increased body weight|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002636,delayed vaginal opening|MP:0002716,small male preputial gland|MP:0002773,decreased circulating luteinizing hormone level|MP:0002780,decreased circulating testosterone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003699,abnormal female reproductive system physiology|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0004930,small epididymis|MP:0005181,decreased circulating estradiol level|MP:0005185,decreased circulating progesterone level|MP:0005188,small penis|MP:0006379,abnormal spermatocyte morphology|MP:0009009,absent estrous cycle|MP:0009081,thin uterus|MP:0009199,abnormal external male genitalia morphology|MP:0009205,abnormal internal male genitalia morphology|MP:0009209,abnormal internal female genitalia morphology|MP:0031239,increased atretic ovarian follicle number
MGI:3574585	Gnrhr<hh>	MP:0001116,small gonad|MP:0001119,abnormal female reproductive system morphology|MP:0001121,uterus hypoplasia|MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001134,absent corpus luteum|MP:0001145,abnormal male reproductive system morphology|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001157,small seminal vesicle|MP:0001919,abnormal reproductive system physiology|MP:0001925,male infertility|MP:0002160,abnormal reproductive system morphology|MP:0002286,cryptorchism|MP:0002636,delayed vaginal opening|MP:0002773,decreased circulating luteinizing hormone level|MP:0002780,decreased circulating testosterone level|MP:0002786,abnormal Leydig cell morphology|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003363,decreased circulating gonadotropin level|MP:0003510,decreased circulating dihydrotestosterone level|MP:0004852,decreased testis weight|MP:0004930,small epididymis|MP:0005130,decreased follicle stimulating hormone level|MP:0005132,decreased luteinizing hormone level|MP:0005185,decreased circulating progesterone level|MP:0005188,small penis|MP:0005189,abnormal anogenital distance|MP:0005418,abnormal circulating hormone level|MP:0008261,arrest of male meiosis|MP:0009009,absent estrous cycle|MP:0011130,absent tertiary ovarian follicles
MGI:5576332	Gnrhr<tm1.1Bhr>	MP:0001126,abnormal ovary morphology|MP:0001145,abnormal male reproductive system morphology|MP:0001147,small testis|MP:0002680,decreased corpora lutea number|MP:0002773,decreased circulating luteinizing hormone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003363,decreased circulating gonadotropin level|MP:0005389,reproductive system phenotype|MP:0009017,prolonged estrus|MP:0011128,increased tertiary ovarian follicle number
MGI:3795249	Gnrhr<tm1.1(cre)Uboe>	MP:0002169,no abnormal phenotype detected
MGI:5576329	Gnrhr<tm1Bhr>	MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001929,abnormal gametogenesis|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009234,absent sperm head
MGI:5517591	Gnrhr<tm1(GNRHR1)Xen>	MP:0001923,reduced female fertility|MP:0001927,abnormal estrous cycle|MP:0002773,decreased circulating luteinizing hormone level|MP:0002780,decreased circulating testosterone level|MP:0003969,abnormal luteinizing hormone level|MP:0005164,abnormal response to injury|MP:0005182,increased circulating estradiol level|MP:0005389,reproductive system phenotype|MP:0009006,prolonged estrous cycle|MP:0009020,prolonged metestrus
MGI:5908153	Gnrhr<tm2.1(GNRHR)Djb>	MP:0001116,small gonad|MP:0001129,impaired ovarian folliculogenesis|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0001928,abnormal ovulation|MP:0001935,decreased litter size|MP:0002680,decreased corpora lutea number|MP:0002682,decreased mature ovarian follicle number|MP:0002773,decreased circulating luteinizing hormone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0004901,decreased male germ cell number|MP:0005130,decreased follicle stimulating hormone level|MP:0005132,decreased luteinizing hormone level|MP:0005133,increased luteinizing hormone level|MP:0005646,abnormal pituitary gland physiology|MP:0009017,prolonged estrus|MP:0011129,decreased tertiary ovarian follicle number
MGI:4881048	Gns<tm1e(EUCOMM)Hmgu>	MP:0001402,decreased locomotor activity|MP:0002083,premature death|MP:0003172,abnormal lysosome physiology|MP:0003354,astrocytosis|MP:0008918,microgliosis
MGI:3510600	Golga1<awag>	MP:0000745,tremors|MP:0001304,cataract|MP:0001312,abnormal cornea morphology|MP:0001513,limb grasping|MP:0001891,hydrocephaly|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6358612	Golga2<tm1.1Baos>	MP:0000852,small cerebellum|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000890,thin cerebellar molecular layer|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0003203,increased neuron apoptosis|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0010768,mortality/aging|MP:0011743,abnormal Golgi apparatus morphology|MP:0030949,abnormal Golgi vesicle transport|MP:0030953,abnormal Golgi cisterna morphology
MGI:6358613	Golga2<tm1.2Baos>	MP:0000880,decreased Purkinje cell number|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002083,premature death|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0006380,abnormal spermatid morphology|MP:0008489,slow postnatal weight gain|MP:0008839,absent acrosome|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009833,absent sperm mitochondrial sheath|MP:0011743,abnormal Golgi apparatus morphology|MP:0020378,abnormal cell cytoskeleton morphology|MP:0020451,decreased sperm progressive motility|MP:0020849,abnormal actin cytoskeleton morphology|MP:0020850,abnormal microtubule cytoskeleton morphology|MP:0020869,immotile sperm|MP:0030949,abnormal Golgi vesicle transport|MP:0031354,abnormal acrosome assembly|MP:0031355,abnormal proacrosomal vesicle fusion
MGI:5008102	Golga2<tm1(KOMP)Vlcg>	MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0001175,abnormal lung morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002275,abnormal type II pneumocyte morphology|MP:0003333,liver fibrosis|MP:0004782,abnormal surfactant physiology|MP:0006050,pulmonary fibrosis|MP:0011101,prenatal lethality, incomplete penetrance|MP:0014228,increased alveolar macrophage number
MGI:3512949	Golga3<repro27>	MP:0000242,impaired fertilization|MP:0001146,abnormal testis morphology|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008280,abnormal male germ cell apoptosis|MP:0008545,absent sperm flagellum|MP:0008893,detached sperm flagellum|MP:0009230,abnormal sperm head morphology|MP:0009647,decreased fertilization frequency
MGI:1857972	Golga3<Tg(06MGMT)T604Kccri>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0009230,abnormal sperm head morphology
MGI:5692901	Golga3<tm1b(EUCOMM)Hmgu>	MP:0001925,male infertility|MP:0002874,decreased hemoglobin content|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005293,impaired glucose tolerance|MP:0005343,increased circulating aspartate transaminase level
MGI:6414492	Golga4<em1(IMPC)Bay>	MP:0002626,increased heart rate|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6514717	Golga4<em1Syu>	MP:0005389,reproductive system phenotype
MGI:6149914	Golga5<em1Lanyu>	MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005382,craniofacial phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype|MP:0010768,mortality/aging
MGI:6149915	Golga5<em2Lanyu>	MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005382,craniofacial phenotype|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype|MP:0010768,mortality/aging
MGI:6149916	Golga5<em3Lanyu>	MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005382,craniofacial phenotype|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype|MP:0010768,mortality/aging
MGI:5635144	Golga5<tm1b(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0001488,increased startle reflex|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005344,increased circulating bilirubin level|MP:0010053,decreased grip strength
MGI:5692760	Golga7<tm1b(KOMP)Wtsi>	MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:6149904	Golgb1<em33Lanyu>	MP:0000111,cleft palate|MP:0005382,craniofacial phenotype|MP:0009653,abnormal palate development|MP:0009886,failure of palatal shelf elevation|MP:0009888,palatal shelves fail to meet at midline|MP:0014430,decreased hyaluronic acid level|MP:0031443,abnormal tongue position|MP:0031462,decreased palatal shelf size
MGI:6149910	Golgb1<em8Lanyu>	MP:0000111,cleft palate|MP:0005382,craniofacial phenotype|MP:0009653,abnormal palate development|MP:0009886,failure of palatal shelf elevation|MP:0009888,palatal shelves fail to meet at midline|MP:0014430,decreased hyaluronic acid level|MP:0031443,abnormal tongue position|MP:0031462,decreased palatal shelf size
MGI:6149903	Golgb1<m1Lanyu>	MP:0000111,cleft palate|MP:0005380,embryo phenotype|MP:0005382,craniofacial phenotype|MP:0005384,cellular phenotype|MP:0009653,abnormal palate development|MP:0009886,failure of palatal shelf elevation|MP:0009888,palatal shelves fail to meet at midline|MP:0014430,decreased hyaluronic acid level|MP:0031443,abnormal tongue position|MP:0031462,decreased palatal shelf size
MGI:4124004	Golm1<Gt(KST273)Byg>	MP:0000607,abnormal hepatocyte morphology|MP:0001263,weight loss|MP:0001859,kidney inflammation|MP:0001860,liver inflammation|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002628,hepatic steatosis|MP:0002828,abnormal renal glomerular capsule morphology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004969,pale kidney|MP:0004970,kidney atrophy|MP:0005202,lethargy|MP:0005264,glomerulosclerosis|MP:0010179,rough coat|MP:0011294,renal glomerulus hypertrophy|MP:0011402,renal cast|MP:0011508,abnormal glomerular capillary thrombosis
MGI:6156473	Golph3<em1(IMPC)Tcp>	MP:0000438,abnormal cranium morphology|MP:0000550,abnormal forelimb morphology|MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0001157,small seminal vesicle|MP:0002060,abnormal skin morphology|MP:0002599,increased mean platelet volume|MP:0002764,short tibia|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0004738,abnormal auditory brainstem response|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5816876	Golt1a<tm1b(KOMP)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0005344,increased circulating bilirubin level|MP:0005560,decreased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin
MGI:6120732	Golt1b<tm1b(EUCOMM)Wtsi>	MP:0000627,abnormal mammary gland morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0001406,abnormal gait|MP:0003393,decreased cardiac output|MP:0010052,increased grip strength|MP:0010506,prolonged RR interval|MP:0011874,enlarged urinary bladder
MGI:4829629	Gon4l<justy>	MP:0000621,increased salivary adenocarcinoma incidence|MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0001800,abnormal humoral immune response|MP:0001802,arrested B cell differentiation|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002460,decreased immunoglobulin level|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008071,absent B cells|MP:0008208,decreased pro-B cell number|MP:0008215,decreased immature B cell number|MP:0008479,decreased spleen white pulp amount
MGI:2386794	Gopc<tm1.1Tno>	MP:0000242,impaired fertilization|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0008839,absent acrosome|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009238,coiled sperm flagellum|MP:0009832,abnormal sperm mitochondrial sheath morphology
MGI:5051001	Gopc<tm1a(EUCOMM)Wtsi>	MP:0005621,abnormal cell physiology|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5766157	Gopc<tm1e.1(EUCOMM)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0000494,abnormal cecum morphology|MP:0001566,increased circulating phosphate level|MP:0009476,enlarged cecum|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4125788	Gorab<Gt(XG183)Byg>	MP:0000379,decreased hair follicle number|MP:0000382,underdeveloped hair follicles|MP:0000428,abnormal craniofacial morphology|MP:0001243,abnormal dermal layer morphology|MP:0001505,hunched posture|MP:0001786,skin edema|MP:0001954,respiratory distress|MP:0009545,abnormal dermis papillary layer morphology|MP:0010771,integument phenotype|MP:0011087,neonatal lethality, complete penetrance|MP:0013205,abnormal nonmotile primary cilium morphology
MGI:5618686	Gorasp1<tm1a(KOMP)Catr>	MP:0005384,cellular phenotype|MP:0013243,abnormal carbohydrate metabolism|MP:0030954,abnormal Golgi cis cisterna morphology
MGI:5766756	Gorasp1<tm1b(KOMP)Wtsi>	MP:0005554,decreased circulating creatinine level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5904163	Gorasp2<tm1.1Maal>	MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0006379,abnormal spermatocyte morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0011743,abnormal Golgi apparatus morphology
MGI:5548699	Gosr2<tm1b(EUCOMM)Hmgu>	MP:0001406,abnormal gait|MP:0008806,increased circulating amylase level|MP:0010087,increased circulating fructosamine level|MP:0011100,preweaning lethality, complete penetrance
MGI:6514807	Got1l1<tm1.1Himo>	MP:0005376,homeostasis/metabolism phenotype|MP:0030707,decreased glutamine level|MP:0030737,decreased glutamic acid level
MGI:5812935	Got1<tm1b(EUCOMM)Hmgu>	MP:0000221,decreased leukocyte cell number|MP:0002607,decreased basophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005560,decreased circulating glucose level|MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6276937	Got2<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0000274,enlarged heart|MP:0000277,abnormal heart shape|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000928,incomplete rostral neuropore closure|MP:0001304,cataract|MP:0001614,abnormal blood vessel morphology|MP:0001700,abnormal embryo turning|MP:0001701,incomplete embryo turning|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001726,abnormal allantois morphology|MP:0001914,hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0002699,abnormal vitreous body morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0002884,abnormal pharyngeal arch morphology|MP:0002989,small kidney|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0005031,abnormal trophoblast layer morphology|MP:0006108,abnormal hindbrain development|MP:0009476,enlarged cecum|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0012099,decreased spongiotrophoblast size|MP:0012708,delayed rostral neuropore closure|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:7464269	Got2<em1Pcamp>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7464270	Got2<em2Pcamp>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7464273	Got2<em3Pcamp>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1856887	gp	MP:0001302,eyelids open at birth|MP:0001305,enlarged lens|MP:0001314,cornea opacity|MP:0001341,absent eyelids|MP:0002001,blindness
MGI:5436067	Gp1ba<Plt17>	MP:0003179,thrombocytopenia
MGI:2181691	Gp1ba<tm1Ware>	MP:0000229,abnormal megakaryocyte differentiation|MP:0003179,thrombocytopenia|MP:0005606,increased bleeding time|MP:0030025,giant platelets
MGI:5692575	Gp1bb<tm1.1(KOMP)Vlcg>	MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002590,increased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0003179,thrombocytopenia|MP:0009709,hydrometra
MGI:3793296	Gp1bb<tm1Frla>	MP:0003179,thrombocytopenia|MP:0004720,abnormal platelet morphology|MP:0005606,increased bleeding time|MP:0031120,decreased susceptibility to induced thrombosis
MGI:3510459	Gp1bb<tm1Ware>	MP:0002599,increased mean platelet volume|MP:0003179,thrombocytopenia|MP:0005606,increased bleeding time
MGI:3793297	Gp1bb<tm2Frla>	MP:0003179,thrombocytopenia|MP:0004720,abnormal platelet morphology|MP:0005606,increased bleeding time|MP:0031120,decreased susceptibility to induced thrombosis
MGI:6152493	Gp2<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000598,abnormal liver morphology|MP:0000639,abnormal adrenal gland morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002188,small heart|MP:0002339,abnormal lymph node morphology|MP:0002989,small kidney|MP:0003179,thrombocytopenia
MGI:3525203	Gp2<tm1Awl>	MP:0002169,no abnormal phenotype detected|MP:0005379,endocrine/exocrine gland phenotype
MGI:3623935	Gp5<tm1Cgh>	MP:0002169,no abnormal phenotype detected
MGI:2652408	Gp5<tm1Drp>	MP:0005607,decreased bleeding time
MGI:5502382	Gp6<tm1.1(GP6)Ics>	MP:0005397,hematopoietic system phenotype
MGI:5620877	Gp6<tm1Beni>	MP:0002551,abnormal blood coagulation|MP:0005606,increased bleeding time
MGI:2675830	Gp6<tm1Ware>	MP:0002123,abnormal definitive hematopoiesis|MP:0002551,abnormal blood coagulation|MP:0006298,abnormal platelet activation|MP:0009549,decreased platelet aggregation
MGI:5697310	Gp6<tm2b(EUCOMM)Hmgu>	MP:0002098,abnormal vibrissa morphology|MP:0004357,long tibia|MP:0004738,abnormal auditory brainstem response|MP:0005013,increased lymphocyte cell number|MP:0011960,abnormal eye anterior chamber depth
MGI:5548499	Gp9<tm1.1(KOMP)Vlcg>	MP:0002599,increased mean platelet volume|MP:0002606,increased basophil cell number
MGI:4889205	Gpa33<tm1(GNAS)Wtsi>	MP:0005381,digestive/alimentary phenotype
MGI:5774782	Gpa33<tm1Jkhh>	MP:0000477,abnormal intestine morphology|MP:0000512,intestinal ulcer|MP:0001792,impaired wound healing|MP:0004499,increased incidence of tumors by chemical induction|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005000,abnormal immune tolerance|MP:0005036,diarrhea|MP:0005381,digestive/alimentary phenotype|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008126,increased dendritic cell number|MP:0008537,increased susceptibility to induced colitis|MP:0010180,increased susceptibility to weight loss|MP:0013298,increased susceptibility to colitis induced morbidity/mortality|MP:0014201,abnormal intestinal epithelium physiology|MP:0014219,decreased intestinal mucosa thickness|MP:0014222,decreased colon goblet cell number
MGI:5696901	Gpa33<tm2b(KOMP)Wtsi>	MP:0001120,abnormal uterus morphology|MP:0001293,anophthalmia|MP:0008528,polycystic kidney|MP:0010052,increased grip strength
MGI:6257784	Gpaa1<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0002792,abnormal retina vasculature morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6433996	Gpalpp1<em1(IMPC)Hmgu>	MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0005564,increased hemoglobin content|MP:0010511,shortened PR interval
MGI:3785384	Gpam<tm1.1Dali>	MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0002575,increased circulating ketone body level|MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0005331,insulin resistance|MP:0005459,decreased percent body fat/body weight|MP:0008489,slow postnatal weight gain|MP:0009283,decreased gonadal fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0009356,decreased liver triglyceride level
MGI:3528590	Gpam<tm1Lex>	MP:0005459,decreased percent body fat/body weight
MGI:2669956	Gpam<tm1Rcol>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001262,decreased body weight|MP:0002118,abnormal lipid homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0003976,decreased circulating VLDL triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0005280,abnormal fatty acids level|MP:0005459,decreased percent body fat/body weight|MP:0008489,slow postnatal weight gain|MP:0009283,decreased gonadal fat pad weight|MP:0009356,decreased liver triglyceride level
MGI:5574607	Gpank1<tm1.1(KOMP)Vlcg>	MP:0005575,increased pulmonary ventilation|MP:0005576,decreased pulmonary ventilation|MP:0005585,increased tidal volume
MGI:6368203	Gpat2<tm1.1Nkn>	MP:0001147,small testis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0006362,abnormal male germ cell morphology|MP:0006379,abnormal spermatocyte morphology|MP:0008878,abnormal DNA methylation during gametogenesis|MP:0014052,increased male germ cell apoptosis
MGI:5638667	Gpat3<tm1Reg>	MP:0001399,hyperactivity|MP:0001780,decreased brown adipose tissue amount|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0004889,increased energy expenditure|MP:0005178,increased circulating cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008907,decreased total fat pad weight|MP:0008963,increased carbon dioxide production|MP:0010025,decreased total body fat amount|MP:0010027,increased liver cholesterol level
MGI:3624276	Gpat4<Gt(DTM030)Byg>	MP:0000627,abnormal mammary gland morphology|MP:0004047,abnormal milk composition|MP:0009503,abnormal mammary gland duct morphology|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009506,abnormal mammary gland alveolus morphology|MP:0013716,hypolactation
MGI:4184661	Gpat4<Gt(OST103559)Lex>	MP:0010769,abnormal survival
MGI:6153355	Gpatch1<em1(IMPC)Wtsi>	MP:0001711,abnormal placenta morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:7514926	Gpatch2<em1Boui>	MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype
MGI:6276982	Gpatch3<em1(IMPC)Mbp>	MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0002092,abnormal eye morphology|MP:0009709,hydrometra
MGI:7425721	Gpatch4<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001157,small seminal vesicle|MP:0001402,decreased locomotor activity|MP:0002059,abnormal seminal vesicle morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002591,decreased mean corpuscular volume|MP:0003961,decreased lean body mass|MP:0005387,immune system phenotype|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0013279,increased fasting circulating glucose level|MP:0020421,increased freezing behavior
MGI:7299757	Gpbar1<em1Gpt>	MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5548845	Gpbar1<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002941,increased circulating alanine transaminase level
MGI:4359279	Gpbar1<tm1.2Auw>	MP:0002079,increased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3692767	Gpbar1<tm1Gvas>	MP:0002830,gallstones|MP:0002929,abnormal bile duct development|MP:0004773,abnormal bile composition|MP:0005084,abnormal gallbladder morphology|MP:0005278,abnormal cholesterol homeostasis|MP:0005370,liver/biliary system phenotype
MGI:3691111	Gpbar1<tm1Ktan>	MP:0005178,increased circulating cholesterol level|MP:0005365,abnormal bile salt homeostasis|MP:0005452,abnormal adipose tissue amount|MP:0005455,increased susceptibility to weight gain
MGI:5692726	Gpbp1<tm1b(EUCOMM)Wtsi>	MP:0001406,abnormal gait|MP:0002059,abnormal seminal vesicle morphology|MP:0005292,improved glucose tolerance|MP:0005344,increased circulating bilirubin level|MP:0011100,preweaning lethality, complete penetrance
MGI:6430666	Gpc1<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000702,enlarged lymph nodes|MP:0000774,decreased brain size|MP:0002092,abnormal eye morphology|MP:0002152,abnormal brain morphology|MP:0002175,decreased brain weight|MP:0002339,abnormal lymph node morphology|MP:0002574,increased vertical activity|MP:0010067,increased red blood cell distribution width
MGI:4124092	Gpc1<Gt(GST062)Byg>	MP:0002175,decreased brain weight|MP:0005397,hematopoietic system phenotype
MGI:5548614	Gpc2<tm1.1(KOMP)Vlcg>	MP:0002768,small adrenal glands|MP:0002989,small kidney|MP:0004122,abnormal sinus arrhythmia|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5478626	Gpc2<tm1Alan>	MP:0002169,no abnormal phenotype detected
MGI:4399525	Gpc2<tm1(KOMP)Vlcg>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:2156194	Gpc3<Gt(Ex136)Byg>	MP:0001264,increased body size|MP:0001699,increased embryo size|MP:0003014,abnormal kidney medulla morphology|MP:0003384,abnormal ventral body wall morphology|MP:0003675,kidney cyst|MP:0004678,split xiphoid process|MP:0011087,neonatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011307,kidney medulla cyst
MGI:2657134	Gpc3<tm1Arge>	MP:0000087,absent mandible|MP:0000189,hypoglycemia|MP:0000373,belly spot|MP:0000477,abnormal intestine morphology|MP:0000519,hydronephrosis|MP:0000522,kidney cortex cyst|MP:0000562,polydactyly|MP:0000692,small spleen|MP:0001260,increased body weight|MP:0001270,distended abdomen|MP:0001732,postnatal growth retardation|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0002938,white spotting|MP:0003014,abnormal kidney medulla morphology|MP:0003675,kidney cyst|MP:0004920,increased placenta weight|MP:0004953,decreased spleen weight|MP:0005388,respiratory system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008146,asymmetric sternocostal joints|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011307,kidney medulla cyst|MP:0011308,kidney corticomedullary cyst|MP:0011423,kidney cortex atrophy|MP:0011520,increased placental labyrinth size|MP:0014347,increased spleen B cell follicle size
MGI:2159356	Gpc3<tm1Fil>	MP:0000460,mandible hypoplasia|MP:0000521,abnormal kidney cortex morphology|MP:0000527,abnormal kidney development|MP:0001123,dilated uterus|MP:0001144,vagina atresia|MP:0001260,increased body weight|MP:0001861,lung inflammation|MP:0001867,rhinitis|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002412,increased susceptibility to bacterial infection|MP:0002707,abnormal kidney weight|MP:0003014,abnormal kidney medulla morphology|MP:0003068,enlarged kidney|MP:0003315,abnormal perineum morphology|MP:0003675,kidney cyst|MP:0004754,abnormal kidney collecting duct morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005376,homeostasis/metabolism phenotype|MP:0005630,increased lung weight|MP:0006032,abnormal ureteric bud morphology|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0010981,abnormal branching involved in ureteric bud morphogenesis|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2159355	Gpc3<tm1Snd>	MP:0000284,double outlet right ventricle|MP:0001264,increased body size|MP:0003014,abnormal kidney medulla morphology|MP:0003139,patent ductus arteriosus|MP:0003384,abnormal ventral body wall morphology|MP:0003675,kidney cyst|MP:0004678,split xiphoid process|MP:0008272,abnormal endochondral bone ossification|MP:0008396,abnormal osteoclast differentiation|MP:0010146,umbilical hernia|MP:0010402,ventricular septal defect|MP:0010413,complete atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010419,inlet ventricular septal defect|MP:0010476,coronary fistula|MP:0010551,abnormal coronary vessel morphology|MP:0010607,common atrioventricular valve|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5007161	Gpc4<tm1Lex>	MP:0001577,anemia
MGI:5635154	Gpc4<tm2b(EUCOMM)Wtsi>	MP:0000443,abnormal snout morphology|MP:0001314,cornea opacity|MP:0005278,abnormal cholesterol homeostasis|MP:0005344,increased circulating bilirubin level|MP:0005554,decreased circulating creatinine level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005566,decreased blood urea nitrogen level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:8164254	Gpc5<tm1c(KOMP)Wtsi>	MP:0002924,delayed CNS synapse formation|MP:0004792,abnormal synaptic vesicle number|MP:0004859,abnormal synaptic plasticity|MP:0004996,abnormal CNS synapse formation|MP:0008571,abnormal synaptic bouton morphology|MP:0009936,abnormal dendritic spine morphology|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0020357,abnormal excitatory synapse morphology|MP:0020512,abnormal dendritic mushroom spine morphology|MP:0020514,abnormal dendritic thin spine morphology|MP:0020551,abnormal postsynaptic density morphology
MGI:5007162	Gpc6<tm1Lex>	MP:0000111,cleft palate|MP:0002764,short tibia|MP:0002765,short fibula|MP:0003109,short femur|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004214,abnormal long bone diaphysis morphology|MP:0004686,decreased length of long bones|MP:0004872,absent nasal septum|MP:0005352,small cranium|MP:0009431,decreased fetal weight|MP:0011087,neonatal lethality, complete penetrance|MP:0014101,decreased chondrocyte proliferation|MP:0030190,small snout
MGI:6098731	Gpc6<tm2c(EUCOMM)Wtsi>	MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003743,abnormal facial morphology|MP:0004686,decreased length of long bones
MGI:6156444	Gpcpd1<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000195,decreased circulating calcium level|MP:0000702,enlarged lymph nodes|MP:0002060,abnormal skin morphology|MP:0005278,abnormal cholesterol homeostasis|MP:0005419,decreased circulating serum albumin level|MP:0005554,decreased circulating creatinine level|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:7610680	Gpcpd1<tm1c(EUCOMM)Hmgu>	MP:0001559,hyperglycemia|MP:0003058,increased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0014068,abnormal muscle glycogen level|MP:0021131,increased glycerophosphocholine level|MP:0030018,increased cardiac muscle cell glucose uptake|MP:0030021,increased muscle cell glucose uptake
MGI:3692960	Gpd1<d>	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0005584,abnormal enzyme/coenzyme activity
MGI:6441117	Gpd1<em1(IMPC)Hmgu>	MP:0000194,increased circulating calcium level|MP:0001406,abnormal gait|MP:0001566,increased circulating phosphate level|MP:0005553,increased circulating creatinine level|MP:0005627,increased circulating potassium level
MGI:6382408	Gpd1<em1(IMPC)Mbp>	MP:0002060,abnormal skin morphology
MGI:5823414	Gpd1l<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:2387347	Gpd2<tm1Lbr>	MP:0001262,decreased body weight|MP:0001783,decreased white adipose tissue amount|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0005376,homeostasis/metabolism phenotype|MP:0006086,decreased body mass index|MP:0009289,decreased epididymal fat pad weight|MP:0009301,decreased parametrial fat pad weight|MP:0010182,decreased susceptibility to weight gain|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2181289	Gpd2<tm1Tka>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001431,abnormal eating behavior|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005178,increased circulating cholesterol level|MP:0005290,decreased oxygen consumption|MP:0005472,abnormal triiodothyronine level|MP:0005477,increased circulating thyroxine level|MP:0005480,increased circulating triiodothyronine level|MP:0005533,increased body temperature|MP:0009125,decreased brown fat cell lipid droplet size|MP:0011049,impaired adaptive thermogenesis|MP:0014169,decreased brown adipose tissue mass
MGI:3573766	Gpdc1<C3H/HeN>	MP:0002816,colitis
MGI:3573768	Gpdc2<C3H/HeN>	MP:0002816,colitis
MGI:3573770	Gpdc3<C3H/HeN>	MP:0002816,colitis
MGI:7425722	Gper1<em1(IMPC)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0005333,decreased heart rate|MP:0005628,decreased circulating potassium level|MP:0009476,enlarged cecum
MGI:3839350	Gper1<tm1135.2Arte>	MP:0003402,decreased liver weight|MP:0005389,reproductive system phenotype
MGI:3837567	Gper1<tm1.1Lmlf>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002696,decreased circulating glucagon level|MP:0002711,decreased glucagon secretion|MP:0003059,decreased insulin secretion|MP:0003109,short femur|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004875,increased mean systemic arterial blood pressure|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0006135,artery stenosis
MGI:3773753	Gper1<tm1Cwan>	MP:0003638,abnormal response/metabolism to endogenous compounds
MGI:4355679	Gper1<tm1Dgen>	MP:0005018,decreased T cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3640769	gpg1	MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0000914,exencephaly|MP:0001181,absent lungs|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0002639,micrognathia|MP:0003178,left pulmonary isomerism|MP:0003641,small lung|MP:0004131,abnormal motile primary cilium morphology|MP:0004251,failure of heart looping|MP:0010454,abnormal truncus arteriosus septation|MP:0010808,right-sided stomach
MGI:3640771	gpg2	MP:0000428,abnormal craniofacial morphology|MP:0000531,right pulmonary isomerism|MP:0000562,polydactyly|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0000914,exencephaly|MP:0001181,absent lungs|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0002639,micrognathia|MP:0002766,situs inversus|MP:0003054,spina bifida|MP:0003641,small lung|MP:0004113,abnormal aortic arch morphology|MP:0004251,failure of heart looping|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005262,coloboma|MP:0010454,abnormal truncus arteriosus septation|MP:0010807,abnormal stomach position or orientation
MGI:3640774	gpg3	MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0000762,abnormal tongue morphology|MP:0000914,exencephaly|MP:0001181,absent lungs|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0002639,micrognathia|MP:0003119,abnormal digestive system development|MP:0004131,abnormal motile primary cilium morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005262,coloboma|MP:0010402,ventricular septal defect|MP:0010454,abnormal truncus arteriosus septation|MP:0010807,abnormal stomach position or orientation
MGI:3640777	gpg4	MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0000644,dextrocardia|MP:0000914,exencephaly|MP:0001181,absent lungs|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0002639,micrognathia|MP:0002766,situs inversus|MP:0003178,left pulmonary isomerism|MP:0003641,small lung|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005262,coloboma|MP:0010454,abnormal truncus arteriosus septation|MP:0010808,right-sided stomach
MGI:3640780	gpg5	MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0000914,exencephaly|MP:0001181,absent lungs|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0002639,micrognathia|MP:0004251,failure of heart looping|MP:0010454,abnormal truncus arteriosus septation|MP:0010807,abnormal stomach position or orientation
MGI:3615364	Gphb5<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:3573779	Gphb5<tm1Lmac>	MP:0002169,no abnormal phenotype detected
MGI:2182559	Gphn<tm1Jrs>	MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001400,hyperresponsive|MP:0001436,abnormal suckling behavior|MP:0001504,abnormal posture|MP:0001529,abnormal vocalization|MP:0001957,apnea|MP:0002272,abnormal nervous system electrophysiology|MP:0003651,abnormal axon extension|MP:0003734,abnormal retina inner plexiform layer morphology|MP:0005192,increased motor neuron number|MP:0011087,neonatal lethality, complete penetrance
MGI:4888559	Gphn<tm1Trill>	MP:0002169,no abnormal phenotype detected
MGI:3694479	Gpi1<a-m1Ehs>	MP:0011100,preweaning lethality, complete penetrance
MGI:2177275	Gpi1<a-m1H>	MP:0002085,abnormal embryonic tissue morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:2177276	Gpi1<b-m1H>	MP:0011092,embryonic lethality, complete penetrance
MGI:1857497	Gpi1<b-m1Neu>	MP:0000208,decreased hematocrit|MP:0001262,decreased body weight|MP:0002447,abnormal erythrocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002833,increased heart weight|MP:0002875,decreased erythrocyte cell number|MP:0002981,increased liver weight|MP:0003656,abnormal erythrocyte physiology|MP:0004952,increased spleen weight|MP:0005344,increased circulating bilirubin level|MP:0005559,increased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010831,lethality, incomplete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031084,decreased erythrocyte osmotic fragility
MGI:2177277	Gpi1<b-m2H>	MP:0011092,embryonic lethality, complete penetrance
MGI:1857274	Gpi1<b-m2Neu>	MP:0000208,decreased hematocrit|MP:0001262,decreased body weight|MP:0002447,abnormal erythrocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002833,increased heart weight|MP:0002875,decreased erythrocyte cell number|MP:0002981,increased liver weight|MP:0003656,abnormal erythrocyte physiology|MP:0004952,increased spleen weight|MP:0005344,increased circulating bilirubin level|MP:0005559,increased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005630,increased lung weight|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010831,lethality, incomplete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031084,decreased erythrocyte osmotic fragility
MGI:2177278	Gpi1<b-m3H>	MP:0011091,prenatal lethality, complete penetrance
MGI:1932543	Gpi1<b-m3Neu>	MP:0002080,prenatal lethality
MGI:5311827	Gpi1<b-M5H>	MP:0002080,prenatal lethality
MGI:3771171	Gpihbp1<tm1Sgy>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:5695879	Gpld1<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002135,abnormal kidney morphology|MP:0002176,increased brain weight|MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0003068,enlarged kidney|MP:0003917,increased kidney weight|MP:0003960,increased lean body mass|MP:0004952,increased spleen weight|MP:0005179,decreased circulating cholesterol level|MP:0010025,decreased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5427086	Gpm6a<tm1.1Tahi>	MP:0003631,nervous system phenotype|MP:0003651,abnormal axon extension|MP:0005389,reproductive system phenotype
MGI:3529252	Gpm6a<tm1Lex>	MP:0005458,increased percent body fat/body weight
MGI:5487806	Gpm6b<tm1Kan>	MP:0003871,abnormal myelin sheath morphology|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology
MGI:7356629	Gpn1<em1(IMPC)J>	MP:0002591,decreased mean corpuscular volume|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0005559,increased circulating glucose level|MP:0005632,decreased circulating aspartate transaminase level|MP:0005635,decreased circulating bilirubin level|MP:0011100,preweaning lethality, complete penetrance|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:2177814	Gpnmb<R150X>	MP:0001322,abnormal iris morphology|MP:0005102,abnormal iris pigmentation|MP:0006228,iris atrophy
MGI:5443925	Gpnmb<tm1.1(KOMP)Vlcg>	MP:0005564,increased hemoglobin content|MP:0013279,increased fasting circulating glucose level
MGI:5608675	Gpnmb<tm1Ari>	MP:0002376,abnormal dendritic cell physiology|MP:0003447,decreased tumor growth/size
MGI:7790560	Gpr101<em7036Tac>	MP:0000136,abnormal microglial cell morphology|MP:0000220,increased monocyte cell number|MP:0001846,increased inflammatory response|MP:0002079,increased circulating insulin level|MP:0002981,increased liver weight|MP:0005293,impaired glucose tolerance|MP:0005658,increased susceptibility to diet-induced obesity|MP:0008553,increased circulating tumor necrosis factor level|MP:0010762,abnormal microglial cell activation|MP:0011940,decreased food intake|MP:0014142,increased body fat mass|MP:0020873,abnormal arcuate nucleus of hypothalamus morphology
MGI:5699603	Gpr101<tm1b(KOMP)Mbp>	MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0004924,abnormal behavior|MP:0011960,abnormal eye anterior chamber depth|MP:0020870,decreased thigmotaxis
MGI:4362797	Gpr107<tm1a(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5645975	Gpr107<tm1Brs>	MP:0001698,decreased embryo size|MP:0008546,abnormal vesicle-mediated transport|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6267426	Gpr108<tm1.1Brs>	MP:0008560,increased tumor necrosis factor secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:5766757	Gpr108<tm1b(EUCOMM)Hmgu>	MP:0002764,short tibia|MP:0004738,abnormal auditory brainstem response|MP:0011960,abnormal eye anterior chamber depth
MGI:5051634	Gpr119<tm1Jleo>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:6157471	Gpr119<tm1Tjkw>	MP:0001262,decreased body weight|MP:0002727,decreased circulating insulin level|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype
MGI:3663376	Gpr12<tm1Dgen>	MP:0000182,increased circulating LDL cholesterol level|MP:0001260,increased body weight|MP:0001261,obese|MP:0001556,increased circulating HDL cholesterol level|MP:0002981,increased liver weight|MP:0005178,increased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005386,behavior/neurological phenotype|MP:0005450,abnormal energy expenditure|MP:0005458,increased percent body fat/body weight|MP:0005559,increased circulating glucose level|MP:0009285,increased gonadal fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0010379,decreased respiratory quotient
MGI:2388138	Gpr132<tm1Witt>	MP:0000691,enlarged spleen|MP:0001846,increased inflammatory response|MP:0001859,kidney inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002339,abnormal lymph node morphology|MP:0002461,increased immunoglobulin level|MP:0002495,increased IgA level|MP:0002722,abnormal immune system organ morphology|MP:0003799,impaired macrophage chemotaxis|MP:0003945,abnormal lymphocyte physiology|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005150,cachexia|MP:0005154,increased B cell proliferation|MP:0005348,increased T cell proliferation|MP:0008499,increased IgG1 level|MP:0009623,enlarged inguinal lymph nodes
MGI:5912036	Gpr135<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:5692651	Gpr137b<tm1b(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number
MGI:6093478	Gpr137<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:5605824	Gpr139<tm1.1(KOMP)Vlcg>	MP:0001981,increased chemically-elicited antinociception|MP:0002272,abnormal nervous system electrophysiology|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0009713,enhanced conditioned place preference behavior|MP:0009776,decreased behavioral withdrawal response|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5754575	Gpr141b<em1(IMPC)Tcp>	MP:0001417,decreased exploration in new environment
MGI:5603570	Gpr142<tm1.1(KOMP)Vlcg>	MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content
MGI:3529039	Gpr142<tm1Lex>	MP:0000188,abnormal circulating glucose level|MP:0001560,abnormal circulating insulin level|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005381,digestive/alimentary phenotype|MP:0005418,abnormal circulating hormone level|MP:0013279,increased fasting circulating glucose level|MP:0020151,abnormal circulating non-HDL cholesterol level
MGI:1931862	Gpr143<tm1Inc>	MP:0001332,abnormal optic nerve innervation|MP:0002864,abnormal ocular fundus morphology|MP:0005075,abnormal melanosome morphology|MP:0005101,abnormal ciliary body pigmentation|MP:0005103,abnormal retina pigmentation|MP:0005199,abnormal iris pigment epithelium|MP:0005201,abnormal retina pigment epithelium morphology
MGI:6368525	Gpr146<em1Bdu>	MP:0005387,immune system phenotype
MGI:6153856	Gpr146<em1(IMPC)H>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000745,tremors|MP:0002591,decreased mean corpuscular volume|MP:0002644,decreased circulating triglyceride level|MP:0002874,decreased hemoglobin content|MP:0002941,increased circulating alanine transaminase level|MP:0004151,decreased circulating iron level|MP:0004952,increased spleen weight|MP:0005179,decreased circulating cholesterol level|MP:0005505,thrombocytosis|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010067,increased red blood cell distribution width
MGI:4442841	Gpr149<tm1.1Zuk>	MP:0001130,abnormal ovarian folliculogenesis|MP:0001927,abnormal estrous cycle|MP:0001934,increased litter size|MP:0005376,homeostasis/metabolism phenotype|MP:0005410,abnormal fertilization|MP:0009017,prolonged estrus|MP:0011128,increased tertiary ovarian follicle number|MP:0031383,increased secondary ovarian follicle number|MP:0031411,increased ovulation rate|MP:0031421,increased superovulation rate|MP:0031424,enhanced female fertility
MGI:5473295	Gpr149<tm1Yab>	MP:0001968,abnormal touch/nociception
MGI:6094272	Gpr150<em1(IMPC)J>	MP:0001510,abnormal coat appearance|MP:0002098,abnormal vibrissa morphology|MP:0010511,shortened PR interval
MGI:3604578	Gpr151<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:5548871	Gpr152<tm1b(EUCOMM)Wtsi>	MP:0004738,abnormal auditory brainstem response|MP:0006358,absent pinna reflex|MP:0010053,decreased grip strength
MGI:5927713	Gpr153<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0010053,decreased grip strength
MGI:6152494	Gpr155<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001157,small seminal vesicle|MP:0002059,abnormal seminal vesicle morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0003068,enlarged kidney
MGI:5608696	Gpr156<tm1.1(KOMP)Vlcg>	MP:0001363,increased anxiety-related response|MP:0001406,abnormal gait|MP:0001488,increased startle reflex|MP:0002272,abnormal nervous system electrophysiology|MP:0002573,behavioral despair|MP:0002797,increased thigmotaxis|MP:0003064,decreased coping response|MP:0004924,abnormal behavior|MP:0005402,abnormal action potential
MGI:8255455	Gpr156<tm3.1(GPR156*E533D)Vlcg>	MP:0001363,increased anxiety-related response|MP:0001488,increased startle reflex|MP:0002272,abnormal nervous system electrophysiology|MP:0002573,behavioral despair|MP:0002797,increased thigmotaxis|MP:0003064,decreased coping response|MP:0005402,abnormal action potential
MGI:3808194	Gpr158<tm1(KOMP)Vlcg>	MP:0001364,decreased anxiety-related response|MP:0002882,abnormal neuron morphology|MP:0003247,abnormal glutaminergic neuron morphology|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0010167,decreased response to stress-induced hyperthermia|MP:0011002,enhanced AMPA-mediated synaptic currents|MP:0014378,increased excitatory postsynaptic current frequency|MP:0014413,decreased depression-related behavior|MP:0020507,increased dendritic spine density
MGI:5697047	Gpr15<em1(IMPC)J>	MP:0001486,abnormal startle reflex|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:8276514	Gpr15lg<em1Darl>	MP:0005018,decreased T cell number|MP:0005387,immune system phenotype|MP:0008539,decreased susceptibility to induced colitis|MP:0020212,impaired leukocyte migration
MGI:5006994	Gpr15lg<tm1Lex>	MP:0008500,increased IgG2a level
MGI:3815547	Gpr15<tm1.1Litt>	MP:0002412,increased susceptibility to bacterial infection|MP:0004946,abnormal regulatory T cell physiology|MP:0004974,decreased regulatory T cell number|MP:0005089,decreased double-negative T cell number|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008537,increased susceptibility to induced colitis|MP:0008566,increased interferon-gamma secretion|MP:0008681,increased interleukin-17 secretion|MP:0009278,abnormal bone marrow cell physiology|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0010768,mortality/aging
MGI:6152495	Gpr160<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0020421,increased freezing behavior
MGI:6357710	Gpr161<tm1.2Smuk>	MP:0000018,small ears|MP:0000097,short maxilla|MP:0000428,abnormal craniofacial morphology|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0000460,mandible hypoplasia|MP:0000562,polydactyly|MP:0000897,abnormal midbrain morphology|MP:0000955,abnormal spinal cord morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002116,abnormal craniofacial bone morphology|MP:0003142,anotia|MP:0003864,abnormal midbrain development|MP:0003935,abnormal craniofacial development|MP:0004376,absent frontal bone|MP:0004377,small frontal bone|MP:0004418,small parietal bone|MP:0004474,enlarged nasal bone|MP:0004540,small maxilla|MP:0004592,small mandible|MP:0004870,small premaxilla|MP:0008273,abnormal intramembranous bone ossification|MP:0008534,enlarged fourth ventricle|MP:0009048,enlarged tectum|MP:0009888,palatal shelves fail to meet at midline|MP:0011089,perinatal lethality, complete penetrance|MP:0012091,increased midbrain size|MP:0012260,encephalomeningocele|MP:0013545,cleft hard palate|MP:0020393,increased neuronal precursor proliferation|MP:0030198,nasal septum hypoplasia|MP:0031442,enlarged cerebral aqueduct
MGI:5475126	Gpr161<tm1Lex>	MP:0000428,abnormal craniofacial morphology|MP:0000914,exencephaly|MP:0001677,absent apical ectodermal ridge|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0002151,abnormal neural tube morphology|MP:0003054,spina bifida|MP:0005380,embryo phenotype|MP:0006279,abnormal limb development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012675,enlarged floor plate
MGI:1857087	Gpr161<vl>	MP:0000373,belly spot|MP:0000755,hindlimb paralysis|MP:0001304,cataract|MP:0003054,spina bifida|MP:0004837,abnormal neural fold formation|MP:0005397,hematopoietic system phenotype|MP:0011697,lens vacuoles
MGI:6257781	Gpr173<em1(IMPC)Bay>	MP:0001399,hyperactivity|MP:0001510,abnormal coat appearance|MP:0011239,abnormal skin coloration
MGI:5644336	Gpr174<tm1Cys>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004946,abnormal regulatory T cell physiology|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0008082,increased single-positive T cell number|MP:0008088,abnormal T-helper 1 cell differentiation
MGI:5812931	Gpr176<tm1b(EUCOMM)Hmgu>	MP:0000432,abnormal head morphology|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level
MGI:6459292	Gpr176<tm1Hokh>	MP:0020470,shortened circadian behavior period
MGI:5431477	Gpr179<nob5>	MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005391,vision/eye phenotype
MGI:5548896	Gpr17<tm1b(KOMP)Mbp>	MP:0000219,increased neutrophil cell number|MP:0002599,increased mean platelet volume
MGI:4819569	Gpr17<tm1Dgen>	MP:0003070,increased vascular permeability
MGI:4415438	Gpr17<tm1(KOMP)Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:4399154	Gpr17<tm1Qrlu>	MP:0000920,abnormal myelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0005386,behavior/neurological phenotype
MGI:3623918	Gpr180<tm1Ynak>	MP:0002191,abnormal artery morphology|MP:0005166,decreased susceptibility to injury
MGI:5569038	Gpr182<tm2b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001399,hyperactivity|MP:0002590,increased mean corpuscular volume|MP:0004952,increased spleen weight|MP:0005561,increased mean corpuscular hemoglobin
MGI:6712271	Gpr182<tm2c(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0002396,abnormal hematopoietic system morphology/development|MP:0004810,decreased hematopoietic stem cell number|MP:0010209,abnormal circulating chemokine level|MP:0031220,increased circulating CXCL10 level
MGI:4399081	Gpr183<tm1.1Cys>	MP:0008191,abnormal follicular B cell physiology
MGI:5617257	Gpr183<tm1.1(KOMP)Vlcg>	MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number
MGI:4355834	Gpr183<tm1.2Rbr>	MP:0002459,abnormal B cell physiology|MP:0008098,decreased plasma cell number
MGI:5007167	Gpr183<tm1Lex>	MP:0008122,decreased myeloid dendritic cell number|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0008550,abnormal circulating interferon-beta level|MP:0008573,increased circulating interferon-alpha level|MP:0008577,increased circulating interferon-gamma level
MGI:5708707	Gpr18<tm1.1Cys>	MP:0005387,immune system phenotype|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008363,decreased CD8-positive, gamma-delta intraepithelial T cell number
MGI:5788557	Gpr18<tm1Lex>	MP:0002412,increased susceptibility to bacterial infection|MP:0005165,increased susceptibility to injury
MGI:3604494	Gpr19<tm1Dgen>	MP:0001363,increased anxiety-related response|MP:0005386,behavior/neurological phenotype
MGI:5314799	Gpr21<tm1Dgen>	MP:0001399,hyperactivity|MP:0002891,increased insulin sensitivity|MP:0003960,increased lean body mass|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0010209,abnormal circulating chemokine level|MP:0031233,decreased circulating serum amyloid protein level
MGI:3805680	Gpr22<tm1.1Jwad>	MP:0004485,increased response of heart to induced stress
MGI:5548628	Gpr22<tm1b(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001566,increased circulating phosphate level|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0003960,increased lean body mass|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0005627,increased circulating potassium level|MP:0010025,decreased total body fat amount
MGI:3805679	Gpr22<tm1Jwad>	MP:0002169,no abnormal phenotype detected
MGI:6257624	Gpr25<em1(IMPC)Bay>	MP:0010097,abnormal retina blood vessel morphology|MP:0011239,abnormal skin coloration
MGI:5446723	Gpr26<tm1Yugs>	MP:0001552,increased circulating triglyceride level|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0004890,decreased energy expenditure|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005418,abnormal circulating hormone level|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0010024,increased total body fat amount|MP:0011613,decreased circulating ghrelin level|MP:0011939,increased food intake
MGI:5317543	Gpr26<tm1Zgwg>	MP:0001363,increased anxiety-related response|MP:0001987,alcohol preference|MP:0002573,behavioral despair|MP:0002797,increased thigmotaxis|MP:0005386,behavior/neurological phenotype
MGI:6423080	Gpr27<tm1Tac>	MP:0001262,decreased body weight|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0010147,abnormal endocrine pancreas physiology
MGI:6360179	Gpr31b<tm1Ktak>	MP:0001876,decreased inflammatory response|MP:0002376,abnormal dendritic cell physiology|MP:0002412,increased susceptibility to bacterial infection
MGI:5548418	Gpr33<tm1b(EUCOMM)Hmgu>	MP:0001406,abnormal gait
MGI:5696894	Gpr34<tm1.1(KOMP)Vlcg>	MP:0001284,absent vibrissae
MGI:4887271	Gpr34<tm1.1Shbg>	MP:0000952,abnormal CNS glial cell morphology|MP:0003009,abnormal cytokine secretion|MP:0003156,abnormal leukocyte migration|MP:0005399,increased susceptibility to fungal infection|MP:0005547,abnormal Muller cell morphology|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008660,increased interleukin-10 secretion|MP:0008663,increased interleukin-12 secretion|MP:0008687,increased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion|MP:0008722,abnormal chemokine secretion
MGI:6436880	Gpr35<em1Niess>	MP:0005387,immune system phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0010180,increased susceptibility to weight loss|MP:0013956,decreased colon length
MGI:6436881	Gpr35<em2Niess>	MP:0003963,abnormal corticosterone level|MP:0008537,increased susceptibility to induced colitis|MP:0010180,increased susceptibility to weight loss|MP:0013956,decreased colon length
MGI:4881257	Gpr35<tm1(KOMP)Vlcg>	MP:0008539,decreased susceptibility to induced colitis|MP:0008721,abnormal chemokine level|MP:0008751,abnormal interleukin level|MP:0013299,decreased susceptibility to colitis induced morbidity/mortality
MGI:5439168	Gpr37l1<tm1.1Gtva>	MP:0002169,no abnormal phenotype detected
MGI:5439169	Gpr37l1<tm1.2Gtva>	MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000873,thin external granule cell layer|MP:0000889,abnormal cerebellar molecular layer|MP:0002804,abnormal motor learning|MP:0003153,early eyelid opening|MP:0003313,abnormal locomotor activation|MP:0003858,enhanced coordination|MP:0004948,abnormal neuronal precursor proliferation|MP:0008579,abnormal Purkinje cell differentiation|MP:0009956,abnormal cerebellar layer morphology|MP:0010388,abnormal Bergmann glial cell differentiation
MGI:6150820	Gpr37l1<tm1d(EUCOMM)Wtsi>	MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004875,increased mean systemic arterial blood pressure|MP:0005385,cardiovascular system phenotype|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0006265,increased pulse pressure
MGI:3528734	Gpr37l1<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:3768566	Gpr37<tm1.1Ryot>	MP:0001402,decreased locomotor activity|MP:0002206,abnormal CNS synaptic transmission|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003224,neuron degeneration|MP:0004811,abnormal neuron physiology|MP:0005643,decreased dopamine level|MP:0011452,decreased susceptibility to dopaminergic neuron neurotoxicity
MGI:3604579	Gpr37<tm1Dgen>	MP:0005458,increased percent body fat/body weight
MGI:3027992	Gpr37<tm1Gtva>	MP:0002169,no abnormal phenotype detected
MGI:3027995	Gpr37<tm2Gtva>	MP:0000836,abnormal substantia nigra morphology|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0005643,decreased dopamine level
MGI:6257772	Gpr39<em1(IMPC)Bay>	MP:0000063,decreased bone mineral density
MGI:6158475	Gpr39<em1(IMPC)Mbp>	MP:0002135,abnormal kidney morphology|MP:0008528,polycystic kidney
MGI:3701833	Gpr39<tm1Dgen>	MP:0002727,decreased circulating insulin level|MP:0005215,abnormal pancreatic islet morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005559,increased circulating glucose level
MGI:3723512	Gpr39<tm1Lex>	MP:0000503,excessive digestive secretion|MP:0001260,increased body weight|MP:0001664,abnormal digestion|MP:0003883,enlarged stomach|MP:0003961,decreased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0005458,increased percent body fat/body weight|MP:0006003,abnormal large intestinal transit time|MP:0011082,abnormal gastrointestinal motility|MP:0011957,decreased compensatory feeding amount
MGI:3615760	Gpr3<tm1Cled>	MP:0001125,abnormal oocyte morphology|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001923,reduced female fertility|MP:0001931,abnormal oogenesis|MP:0001935,decreased litter size|MP:0003699,abnormal female reproductive system physiology|MP:0003718,maternal effect|MP:0005168,abnormal female meiosis|MP:0009007,short estrous cycle
MGI:3604483	Gpr3<tm1Dgen>	MP:0001973,increased thermal nociceptive threshold
MGI:8215534	Gpr45<em1Zz>	MP:0000005,increased brown adipose tissue amount|MP:0000008,increased white adipose tissue amount|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0001261,obese|MP:0001433,polyphagia|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005452,abnormal adipose tissue amount|MP:0006094,increased fat cell size|MP:0009355,increased liver triglyceride level|MP:0010378,increased respiratory quotient|MP:0013279,increased fasting circulating glucose level
MGI:8215535	Gpr45<em2Zz>	MP:0001260,increased body weight|MP:0005378,growth/size/body region phenotype|MP:0005658,increased susceptibility to diet-induced obesity
MGI:8215531	Gpr45<m1Btlr>	MP:0001260,increased body weight
MGI:8215532	Gpr45<m2Btlr>	MP:0001260,increased body weight
MGI:8213372	Gpr45<Tn(pb-Act-RFP)1.1Zhu>	MP:0001260,increased body weight|MP:0001261,obese|MP:0001402,decreased locomotor activity|MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002272,abnormal nervous system electrophysiology|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0003961,decreased lean body mass|MP:0004890,decreased energy expenditure|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005386,behavior/neurological phenotype|MP:0005534,decreased body temperature|MP:0005669,increased circulating leptin level|MP:0009285,increased gonadal fat pad weight|MP:0009294,increased interscapular fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0010024,increased total body fat amount|MP:0011049,impaired adaptive thermogenesis|MP:0014638,increased sleep duration
MGI:8213387	Gpr45<Tn(pb-Act-RFP)1.2Zhu>	MP:0001260,increased body weight|MP:0005293,impaired glucose tolerance|MP:0010024,increased total body fat amount
MGI:5776512	Gpr4<tm1Mglg>	MP:0000525,renal tubular acidosis|MP:0001957,apnea|MP:0002318,hypercapnia|MP:0002901,increased urine phosphate level|MP:0002986,decreased urine calcium level|MP:0003031,acidosis|MP:0003447,decreased tumor growth/size|MP:0003477,abnormal nerve fiber response|MP:0003620,oliguria|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005576,decreased pulmonary ventilation|MP:0005602,decreased angiogenesis|MP:0008055,increased urine osmolality|MP:0010144,abnormal tumor vascularization|MP:0011470,increased urine creatinine level|MP:0011735,increased urine ammonia level
MGI:3700206	Gpr4<tm1Witt>	MP:0000260,abnormal angiogenesis|MP:0000533,kidney hemorrhage|MP:0001182,lung hemorrhage|MP:0001575,cyanosis|MP:0001914,hemorrhage|MP:0001954,respiratory distress|MP:0005325,abnormal renal glomerulus morphology|MP:0005435,hemoperitoneum|MP:0005488,bronchial epithelial hyperplasia|MP:0005592,abnormal vascular smooth muscle morphology|MP:0008816,petechiae|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011428,decreased mesangial cell number|MP:0011437,glomerulus hemorrhage|MP:0014273,abnormal skin vasculature morphology
MGI:3775916	Gpr50<tm1Dgen>	MP:0001399,hyperactivity|MP:0002089,abnormal postnatal growth/weight/body size|MP:0005289,increased oxygen consumption|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008489,slow postnatal weight gain|MP:0008963,increased carbon dioxide production|MP:0011939,increased food intake
MGI:5618129	Gpr52<tm1Kohi>	MP:0001364,decreased anxiety-related response|MP:0001488,increased startle reflex|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0009746,enhanced behavioral response to xenobiotic
MGI:7377673	Gpr55<em1(IMPC)Mbp>	MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount
MGI:4365395	Gpr55<tm1.1Mijr>	MP:0000130,abnormal trabecular bone morphology|MP:0001541,abnormal osteoclast physiology|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0004985,decreased osteoclast cell number|MP:0008396,abnormal osteoclast differentiation|MP:0008872,abnormal physiological response to xenobiotic|MP:0010875,increased bone volume
MGI:5751199	Gpr55<tm1Gsk>	MP:0005385,cardiovascular system phenotype
MGI:3528724	Gpr55<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:5000016	Gpr55<tm1Tigm>	MP:0003631,nervous system phenotype
MGI:6257526	Gpr61<em1(IMPC)Bay>	MP:0000063,decreased bone mineral density|MP:0001399,hyperactivity
MGI:6508026	Gpr61<tm1Dgen>	MP:0001260,increased body weight|MP:0001261,obese|MP:0001433,polyphagia|MP:0001489,decreased startle reflex|MP:0001552,increased circulating triglyceride level|MP:0002079,increased circulating insulin level|MP:0002981,increased liver weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005645,abnormal hypothalamus physiology|MP:0005669,increased circulating leptin level|MP:0009286,increased abdominal fat pad weight|MP:0009288,increased epididymal fat pad weight|MP:0009298,increased mesenteric fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0011939,increased food intake|MP:0014142,increased body fat mass|MP:0020867,increased lipogenesis
MGI:6356366	Gpr62<em1Fjw>	MP:0002169,no abnormal phenotype detected
MGI:5569065	Gpr63<tm1.1(KOMP)Vlcg>	MP:0000195,decreased circulating calcium level|MP:0002941,increased circulating alanine transaminase level
MGI:5582421	Gpr65<tm1b(KOMP)Wtsi>	MP:0002060,abnormal skin morphology|MP:0002631,abnormal epididymis morphology|MP:0003960,increased lean body mass|MP:0004931,enlarged epididymis|MP:0010025,decreased total body fat amount
MGI:5776515	Gpr65<tm1Dgen>	MP:0005388,respiratory system phenotype
MGI:3530470	Gpr65<tm1Witt>	MP:0001819,abnormal immune cell physiology|MP:0002442,abnormal leukocyte physiology
MGI:3837432	Gpr65<Tn(sb-lacZ,GFP)T1.88Jtak>	MP:0002451,abnormal macrophage physiology|MP:0004993,decreased bone resorption|MP:0008561,decreased tumor necrosis factor secretion|MP:0008656,abnormal interleukin-1 beta secretion|MP:0010124,decreased bone mineral content|MP:0010879,decreased trabecular bone volume
MGI:6257550	Gpr68<em1(IMPC)Bay>	MP:0000221,decreased leukocyte cell number
MGI:5445001	Gpr68<tm1.1Aha>	MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005379,endocrine/exocrine gland phenotype
MGI:3849457	Gpr68<tm1.1Yaxu>	MP:0000005,increased brown adipose tissue amount|MP:0000220,increased monocyte cell number|MP:0001541,abnormal osteoclast physiology|MP:0002451,abnormal macrophage physiology|MP:0002971,abnormal brown adipose tissue morphology|MP:0003447,decreased tumor growth/size|MP:0003884,decreased macrophage cell number|MP:0005375,adipose tissue phenotype|MP:0005387,immune system phenotype|MP:0005390,skeleton phenotype|MP:0008396,abnormal osteoclast differentiation
MGI:3837434	Gpr68<tm1Aha>	MP:0002696,decreased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005387,immune system phenotype|MP:0005560,decreased circulating glucose level
MGI:5776516	Gpr68<tm1Dgen>	MP:0002136,abnormal kidney physiology|MP:0005367,renal/urinary system phenotype|MP:0005388,respiratory system phenotype
MGI:3849456	Gpr68<tm1Yaxu>	MP:0000223,decreased monocyte cell number|MP:0001541,abnormal osteoclast physiology|MP:0001780,decreased brown adipose tissue amount|MP:0002451,abnormal macrophage physiology|MP:0002971,abnormal brown adipose tissue morphology|MP:0003721,increased tumor growth/size|MP:0008396,abnormal osteoclast differentiation
MGI:3604582	Gpr6<tm1Dgen>	MP:0002062,abnormal associative learning|MP:0002169,no abnormal phenotype detected|MP:0004077,abnormal striatum morphology
MGI:7711515	Gpr75<em1Tes>	MP:0001363,increased anxiety-related response|MP:0003213,decreased susceptibility to age related obesity|MP:0009454,impaired contextual conditioning behavior
MGI:3808413	Gpr75<tm1(KOMP)Vlcg>	MP:0003674,oxidative stress|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0012144,decreased b-wave amplitude|MP:0030005,increased retina apoptosis
MGI:3604388	Gpr82<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:6510825	Gpr82<tm1Shbg>	MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001973,increased thermal nociceptive threshold|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003960,increased lean body mass|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005292,improved glucose tolerance|MP:0005318,decreased triglyceride level|MP:0005452,abnormal adipose tissue amount|MP:0005533,increased body temperature|MP:0005560,decreased circulating glucose level|MP:0009269,decreased fat cell size|MP:0010025,decreased total body fat amount|MP:0010182,decreased susceptibility to weight gain|MP:0011940,decreased food intake|MP:0013278,decreased fasting circulating glucose level|MP:0020477,abnormal locomotor circadian rhythm
MGI:7425723	Gpr83<em1(IMPC)Ccpcz>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001262,decreased body weight|MP:0002152,abnormal brain morphology|MP:0005293,impaired glucose tolerance|MP:0008040,decreased NK T cell number|MP:0013519,decreased CD4-positive NK T cell number|MP:0013522,decreased memory-marker CD4-positive NK T cell number
MGI:3768257	Gpr83<tm1.1Ayr>	MP:0002169,no abnormal phenotype detected
MGI:3831302	Gpr83<tm1.1Fpow>	MP:0000693,spleen hyperplasia|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:5554947	Gpr83<tm1.2Lex>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0011976,sweet preference|MP:0012307,impaired spatial learning
MGI:5695942	Gpr84<tm1.1(KOMP)Vlcg>	MP:0002941,increased circulating alanine transaminase level
MGI:3528887	Gpr84<tm1Lex>	MP:0005387,immune system phenotype|MP:0005466,abnormal T-helper 2 physiology|MP:0008672,increased interleukin-13 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion
MGI:3789983	Gpr85<tm1Mima>	MP:0001262,decreased body weight|MP:0002176,increased brain weight|MP:0005238,increased brain size|MP:0009453,enhanced contextual conditioning behavior
MGI:5614561	Gpr87<tm1.1(KOMP)Vlcg>	MP:0002968,increased circulating alkaline phosphatase level
MGI:5428728	Gpr87<tm1Lex>	MP:0000559,abnormal femur morphology|MP:0004610,small vertebrae
MGI:4947986	Gpr88<tm1.1(cre/GFP)Rpa>	MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001415,increased exploration in new environment|MP:0002062,abnormal associative learning|MP:0002272,abnormal nervous system electrophysiology|MP:0002804,abnormal motor learning|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004008,abnormal GABA-mediated receptor currents|MP:0004811,abnormal neuron physiology|MP:0009456,impaired cued conditioning behavior|MP:0009745,abnormal behavioral response to xenobiotic|MP:0010053,decreased grip strength|MP:0011269,increased excitatory postsynaptic current amplitude|MP:0012293,impaired active avoidance behavior|MP:0030585,enhanced behavioral response to amphetamine
MGI:5818030	Gpr88<tm1.2Ics>	MP:0001364,decreased anxiety-related response|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001409,increased stereotypic behavior|MP:0001415,increased exploration in new environment|MP:0001442,decreased grooming behavior|MP:0001447,abnormal nest building behavior|MP:0002757,decreased vertical activity|MP:0002804,abnormal motor learning|MP:0004924,abnormal behavior|MP:0008428,abnormal spatial working memory|MP:0010069,increased serotonin level|MP:0011620,abnormal habituation to a new environment|MP:0012306,enhanced spatial learning|MP:0014812,abnormal brain physiology|MP:0020508,decreased dendritic spine density|MP:0020875,decreased nervous system dopamine level|MP:0020876,increased nervous system dopamine level
MGI:7434700	Gpr89<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:6441474	Gpr89<ex>	MP:0006387,abnormal T cell number|MP:0008037,abnormal T cell morphology|MP:0009703,decreased birth body size
MGI:5446388	Gpr89<tm1.1Ymae>	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000652,enlarged sebaceous gland|MP:0001192,scaly skin|MP:0001194,dermatitis|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002655,abnormal keratinocyte morphology|MP:0002796,impaired skin barrier function|MP:0003677,abnormal ear lobe morphology|MP:0003936,abnormal reproductive system development|MP:0003941,abnormal skin development|MP:0005408,hypopigmentation
MGI:4820816	Gprasp1<tm1.1Jlw>	MP:0009758,impaired behavioral response to cocaine
MGI:4365990	Gprasp1<tm1Ics>	MP:0002757,decreased vertical activity|MP:0005386,behavior/neurological phenotype|MP:0009758,impaired behavioral response to cocaine
MGI:6385181	Gprasp2<em1(IMPC)J>	MP:0002968,increased circulating alkaline phosphatase level|MP:0010124,decreased bone mineral content
MGI:6287842	Gprasp2<tm1.1Jpe>	MP:0001260,increased body weight|MP:0001354,increased aggression towards male mice|MP:0001360,abnormal social investigation|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001447,abnormal nest building behavior|MP:0001898,abnormal long-term depression|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003461,abnormal response to novel object|MP:0008428,abnormal spatial working memory|MP:0009936,abnormal dendritic spine morphology|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0012307,impaired spatial learning|MP:0020338,abnormal hippocampal pyramidal neuron dendrite morphology|MP:0020551,abnormal postsynaptic density morphology|MP:0031391,increased locomotor activity
MGI:6452643	Gprc5a<em1Jaap>	MP:0002871,albuminuria|MP:0005264,glomerulosclerosis|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0008140,podocyte foot process effacement|MP:0010768,mortality/aging|MP:0011353,expanded mesangial matrix|MP:0011409,increased renal glomerulus basement membrane thickness
MGI:3619232	Gprc5a<tm1Jsx>	MP:0002169,no abnormal phenotype detected
MGI:3765976	Gprc5a<tm1Rlo>	MP:0001861,lung inflammation|MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0008014,increased lung tumor incidence
MGI:5766162	Gprc5b<tm1b(EUCOMM)Wtsi>	MP:0000598,abnormal liver morphology|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis
MGI:5293387	Gprc5b<tm1Yhir>	MP:0001402,decreased locomotor activity|MP:0004924,abnormal behavior|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5293388	Gprc5c<tm1Yhir>	MP:0002590,increased mean corpuscular volume|MP:0002606,increased basophil cell number|MP:0002640,reticulocytosis|MP:0002968,increased circulating alkaline phosphatase level|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011971,increased circulating lactate dehydrogenase level
MGI:5707439	Gprc6a<tm1.1(KOMP)Vlcg>	MP:0004955,increased thymus weight|MP:0005564,increased hemoglobin content
MGI:4949090	Gprc6a<tm1.1Kry>	MP:0001147,small testis|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004910,decreased seminal vesicle weight|MP:0004929,decreased epididymis weight|MP:0014052,increased male germ cell apoptosis
MGI:3831176	Gprc6a<tm1Ldq>	MP:0000008,increased white adipose tissue amount|MP:0000063,decreased bone mineral density|MP:0000628,abnormal mammary gland development|MP:0001147,small testis|MP:0001565,abnormal circulating phosphate level|MP:0001935,decreased litter size|MP:0002078,abnormal glucose homeostasis|MP:0002628,hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0002780,decreased circulating testosterone level|MP:0002891,increased insulin sensitivity|MP:0002896,abnormal bone mineralization|MP:0002901,increased urine phosphate level|MP:0003961,decreased lean body mass|MP:0004852,decreased testis weight|MP:0004910,decreased seminal vesicle weight|MP:0005182,increased circulating estradiol level|MP:0005291,abnormal glucose tolerance|MP:0005418,abnormal circulating hormone level|MP:0005441,increased urine calcium level|MP:0005559,increased circulating glucose level|MP:0009199,abnormal external male genitalia morphology|MP:0009205,abnormal internal male genitalia morphology|MP:0009355,increased liver triglyceride level|MP:0009643,abnormal urine homeostasis|MP:0011556,increased urine beta2-microglobulin level
MGI:6153795	Gprin1<em1(IMPC)H>	MP:0008810,increased circulating iron level
MGI:6363182	Gprin3<em1Sns>	MP:0002272,abnormal nervous system electrophysiology|MP:0002803,abnormal operant conditioning behavior|MP:0008143,abnormal dendrite morphology|MP:0008462,abnormal medium spiny neuron morphology|MP:0009758,impaired behavioral response to cocaine
MGI:5605814	Gps1<tm1b(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5708370	Gps2<tm1Jsz>	MP:0006207,embryonic lethality during organogenesis
MGI:3807518	Gpsm1<tm1.1Lajb>	MP:0001262,decreased body weight|MP:0001431,abnormal eating behavior|MP:0001783,decreased white adipose tissue amount|MP:0003631,nervous system phenotype|MP:0004184,abnormal baroreceptor physiology|MP:0004876,decreased mean systemic arterial blood pressure|MP:0004889,increased energy expenditure|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005590,increased vasodilation
MGI:5558155	Gpsm1<tm2b(KOMP)Wtsi>	MP:0001258,decreased body length|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0005576,decreased pulmonary ventilation|MP:0012125,decreased bronchoconstrictive response
MGI:3850860	Gpsm2<tm1.2Fuma>	MP:0001967,deafness|MP:0002948,abnormal neuron specification|MP:0003631,nervous system phenotype|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004536,short inner hair cell stereocilia|MP:0005076,abnormal cell differentiation|MP:0006358,absent pinna reflex|MP:0006359,absent startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4441912	Gpsm2<tm1a(EUCOMM)Wtsi>	MP:0001967,deafness|MP:0002622,abnormal cochlear hair cell morphology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0011060,abnormal kinocilium morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0020378,abnormal cell cytoskeleton morphology
MGI:5548664	Gpsm2<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002599,increased mean platelet volume|MP:0002699,abnormal vitreous body morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4075252	Gpsm3<Gt(IST12408A1)Tigm>	MP:0000223,decreased monocyte cell number|MP:0002442,abnormal leukocyte physiology|MP:0003156,abnormal leukocyte migration|MP:0003436,decreased susceptibility to induced arthritis
MGI:5569069	Gpsm3<tm1.1(KOMP)Wtsi>	MP:0000062,increased bone mineral density
MGI:4363039	Gpt2<tm1a(KOMP)Wtsi>	MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000913,abnormal brain development|MP:0001402,decreased locomotor activity|MP:0002083,premature death|MP:0005266,abnormal metabolism|MP:0005332,abnormal amino acid level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008540,abnormal cerebral hemisphere morphology|MP:0009538,abnormal synapse morphology|MP:0009939,abnormal hippocampus neuron morphology|MP:0010958,abnormal tricarboxylic acid cycle|MP:0013242,abnormal amino acid metabolism
MGI:5548355	Gpx1<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001258,decreased body length|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis
MGI:2388705	Gpx1<tm1Kola>	MP:0000316,cellular necrosis|MP:0000352,decreased cell proliferation|MP:0000358,abnormal cell morphology|MP:0001846,increased inflammatory response|MP:0003076,increased susceptibility to ischemic brain injury|MP:0003077,abnormal cell cycle|MP:0003203,increased neuron apoptosis|MP:0003674,oxidative stress|MP:0005164,abnormal response to injury|MP:0005387,immune system phenotype|MP:0006060,increased cerebral infarct size|MP:0006080,brain ischemia|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0010768,mortality/aging
MGI:3589261	Gpx1<tm1Mgr>	MP:0001262,decreased body weight|MP:0001547,abnormal lipid level|MP:0006036,abnormal mitochondrial physiology
MGI:2158814	Gpx1<tm1Ysh>	MP:0001304,cataract|MP:0002857,cochlear ganglion degeneration|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004597,increased susceptibility to noise-induced hearing loss|MP:0005464,abnormal platelet physiology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0011592,abnormal catalase activity|MP:0011603,decreased glutathione peroxidase activity|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013481,abnormal ileum crypts of Lieberkuhn morphology|MP:0013483,abnormal jejunum crypts of Lieberkuhn morphology
MGI:1888703	Gpx2<tm1Coh>	MP:0005381,digestive/alimentary phenotype
MGI:2651587	Gpx2<tm2Coh>	MP:0005381,digestive/alimentary phenotype
MGI:5692559	Gpx3<tm1b(KOMP)Wtsi>	MP:0005293,impaired glucose tolerance|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:4456189	Gpx3<tm1Hjco>	MP:0001775,abnormal selenium level|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0011603,decreased glutathione peroxidase activity
MGI:5320577	Gpx3<tm1Jlos>	MP:0000249,abnormal blood vessel physiology|MP:0005607,decreased bleeding time|MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0009586,increased platelet aggregation|MP:0009642,abnormal blood homeostasis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0031121,increased susceptibility to induced thrombosis
MGI:5708166	Gpx4<tm1.1(KOMP)Vlcg>	MP:0009709,hydrometra|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5425616	Gpx4<tm1.1Qra>	MP:0002229,neurodegeneration|MP:0003354,astrocytosis|MP:0003887,increased hepatocyte apoptosis|MP:0005150,cachexia|MP:0005202,lethargy|MP:0010954,abnormal cellular respiration|MP:0011400,lethality, complete penetrance
MGI:3589378	Gpx4<tm1Marc>	MP:0005389,reproductive system phenotype
MGI:2651590	Gpx4<tm1Prol>	MP:0001658,increased mortality induced by gamma-irradiation|MP:0001674,abnormal germ layer development|MP:0001696,failure to gastrulate|MP:0002169,no abnormal phenotype detected|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3785543	Gpx4<tm1Ssd>	MP:0003674,oxidative stress|MP:0006036,abnormal mitochondrial physiology|MP:0011092,embryonic lethality, complete penetrance
MGI:2663628	Gpx4<tm1Yana>	MP:0001648,abnormal apoptosis|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:3810784	Gpx4<tm2.1Marc>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3810783	Gpx4<tm2Marc>	MP:0000859,abnormal somatosensory cortex morphology|MP:0000947,convulsive seizures|MP:0001263,weight loss|MP:0001393,ataxia|MP:0002082,postnatal lethality|MP:0002557,abnormal social/conspecific interaction behavior|MP:0003203,increased neuron apoptosis|MP:0003354,astrocytosis|MP:0008267,abnormal hippocampus CA3 region morphology
MGI:5433757	Gpx4<tm3Marc>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0009230,abnormal sperm head morphology|MP:0009237,kinked sperm flagellum|MP:0009647,decreased fertilization frequency|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009836,abnormal sperm principal piece morphology|MP:0014467,increased sperm mitochondrial size
MGI:5769979	Gpx4<tm4Marc>	MP:0000242,impaired fertilization|MP:0001674,abnormal germ layer development|MP:0001696,failure to gastrulate|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002674,abnormal sperm motility|MP:0004543,abnormal sperm physiology|MP:0009230,abnormal sperm head morphology|MP:0009237,kinked sperm flagellum|MP:0009647,decreased fertilization frequency|MP:0009687,empty decidua capsularis|MP:0009831,abnormal sperm midpiece morphology|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0014467,increased sperm mitochondrial size
MGI:4359923	Gpx5<tm1115.2Arte>	MP:0001922,reduced male fertility|MP:0009232,abnormal sperm nucleus morphology
MGI:5817343	Gpx6<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:5692672	Gpx7<tm1.1(KOMP)Vlcg>	MP:0001333,absent optic nerve|MP:0002092,abnormal eye morphology|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5473571	Gpx7<tm1Whle>	MP:0000274,enlarged heart|MP:0000691,enlarged spleen|MP:0001800,abnormal humoral immune response|MP:0001864,vascular inflammation|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002020,increased tumor incidence|MP:0002026,increased leukemia incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0002743,glomerulonephritis|MP:0003674,oxidative stress|MP:0004794,increased anti-nuclear antigen antibody level|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0010318,increased salivary gland tumor incidence|MP:0010799,stomach mucosa hyperplasia|MP:0012431,increased lymphoma incidence|MP:0013501,increased fibroblast apoptosis
MGI:5007170	Gpx8<tm1Lex>	MP:0001194,dermatitis|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis
MGI:5910393	Gramd1b<em1(IMPC)J>	MP:0000914,exencephaly|MP:0001491,unresponsive to tactile stimuli|MP:0002111,abnormal tail morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011495,abnormal head shape
MGI:6356548	Gramd1b<em1Pton>	MP:0000639,abnormal adrenal gland morphology|MP:0002665,decreased circulating corticosterone level|MP:0005278,abnormal cholesterol homeostasis|MP:0005376,homeostasis/metabolism phenotype|MP:0008288,abnormal adrenal cortex morphology|MP:0008294,abnormal adrenal gland zona fasciculata morphology
MGI:4451563	Gramd1c<tm1a(KOMP)Wtsi>	MP:0000609,abnormal liver physiology|MP:0002665,decreased circulating corticosterone level|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0012338,decreased bile salt level|MP:0013275,abnormal xenobiotic metabolism|MP:0014161,increased circulating cortisol level
MGI:5661974	Gramd1c<tm1b(KOMP)Wtsi>	MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0001513,limb grasping|MP:0001552,increased circulating triglyceride level|MP:0002959,increased urine microalbumin level|MP:0005343,increased circulating aspartate transaminase level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0013278,decreased fasting circulating glucose level
MGI:6156594	Gramd2a<em1(IMPC)Tcp>	MP:0000598,abnormal liver morphology|MP:0000702,enlarged lymph nodes|MP:0001944,abnormal pancreas morphology|MP:0002637,small uterus|MP:0004609,vertebral fusion|MP:0011874,enlarged urinary bladder
MGI:5825313	Gramd2b<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001303,abnormal lens morphology|MP:0001399,hyperactivity|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002075,abnormal coat/hair pigmentation|MP:0002590,increased mean corpuscular volume|MP:0005293,impaired glucose tolerance|MP:0005561,increased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:2180009	Grap2<tm1Amch>	MP:0000715,decreased thymocyte number|MP:0001825,arrested T cell differentiation|MP:0005090,increased double-negative T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3051853	Grap2<tm1Eac>	MP:0000715,decreased thymocyte number|MP:0001829,increased activated T cell number|MP:0002407,abnormal double-negative T cell morphology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0005018,decreased T cell number|MP:0008049,increased memory T cell number
MGI:2179974	Grap<tm1Gsf>	MP:0005348,increased T cell proliferation|MP:0008074,increased CD4-positive, alpha-beta T cell number
MGI:3789155	Grass1<C57BL/6J>	MP:0002411,decreased susceptibility to bacterial infection|MP:0005044,sepsis|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:3789154	Grass1<DBA/2J>	MP:0002412,increased susceptibility to bacterial infection|MP:0005044,sepsis
MGI:2668436	Grb10<Gt(Betageo)1Ward>	MP:0000599,enlarged liver|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002282,abnormal trachea morphology|MP:0003123,paternal imprinting|MP:0004199,increased fetal size|MP:0004260,enlarged placenta|MP:0009702,increased birth body size|MP:0010400,increased liver glycogen level|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3759253	Grb10<Gt(XC302)Byg>	MP:0001260,increased body weight|MP:0002891,increased insulin sensitivity|MP:0003397,increased muscle weight|MP:0003960,increased lean body mass|MP:0005630,increased lung weight|MP:0009108,increased pancreas weight|MP:0011100,preweaning lethality, complete penetrance
MGI:5568580	Grb10<tm1.1Fliu>	MP:0001260,increased body weight|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0003058,increased insulin secretion|MP:0003212,increased susceptibility to age related obesity|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005290,decreased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005560,decreased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005666,abnormal adipose tissue physiology|MP:0006319,abnormal epididymal fat pad morphology|MP:0006320,abnormal interscapular fat pad morphology|MP:0009108,increased pancreas weight|MP:0009113,increased pancreatic beta cell mass|MP:0009118,increased white fat cell size|MP:0009119,increased brown fat cell size|MP:0010181,decreased susceptibility to weight loss|MP:0011014,decreased core body temperature|MP:0011049,impaired adaptive thermogenesis|MP:0011698,abnormal brown adipose tissue physiology|MP:0011819,increased pancreatic beta cell proliferation|MP:0014142,increased body fat mass|MP:0014172,decreased fatty acid oxidation|MP:0020520,whitened brown adipose tissue morphology
MGI:3839230	Grb10<tm1.1Fuis>	MP:0001262,decreased body weight|MP:0003984,embryonic growth retardation|MP:0004200,decreased fetal size|MP:0004259,small placenta|MP:0004921,decreased placenta weight
MGI:3839150	Grb10<tm1Fuis>	MP:0005378,growth/size/body region phenotype
MGI:3029164	Grb14<tm1Daly>	MP:0001262,decreased body weight|MP:0002833,increased heart weight|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0004953,decreased spleen weight|MP:0005292,improved glucose tolerance
MGI:4462852	Grb2<tm1.1Hua>	MP:0000715,decreased thymocyte number|MP:0002145,abnormal T cell differentiation|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:4432956	Grb2<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:4949889	Grb2<tm1Lnit>	MP:0001805,decreased IgG level|MP:0002144,abnormal B cell differentiation|MP:0002459,abnormal B cell physiology|MP:0002494,increased IgM level|MP:0005017,decreased B cell number|MP:0005154,increased B cell proliferation|MP:0008097,increased plasma cell number|MP:0008174,decreased follicular B cell number|MP:0008194,abnormal memory B cell physiology|MP:0008211,decreased mature B cell number|MP:0008482,decreased spleen germinal center number|MP:0008484,decreased spleen germinal center size|MP:0008498,decreased IgG3 level|MP:0008782,increased B cell apoptosis|MP:0009923,decreased transitional stage T1 B cell number|MP:0009926,decreased transitional stage T2 B cell number
MGI:2152451	Grb2<tm1Paw>	MP:0001685,abnormal endoderm development|MP:0002169,no abnormal phenotype detected|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation|MP:0020935,decreased susceptibility to Retroviridae infection
MGI:2677457	Grb2<tm2Paw>	MP:0000458,abnormal mandible morphology|MP:0001258,decreased body length|MP:0001785,edema|MP:0001914,hemorrhage|MP:0009546,absent gastric milk in neonates|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance|MP:0011521,decreased placental labyrinth size
MGI:5484776	Grb2<tm3.1Paw>	MP:0005367,renal/urinary system phenotype
MGI:5636886	Grb7<tm1b(EUCOMM)Wtsi>	MP:0001312,abnormal cornea morphology
MGI:7572892	Grb7<tm1d(EUCOMM)Wtsi>	MP:0003718,maternal effect|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0008779,abnormal maternal behavior|MP:0010768,mortality/aging
MGI:5635156	Grcc10<tm1.1(KOMP)Vlcg>	MP:0001575,cyanosis|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7618841	Greb1<em1Rkom>	MP:0001729,impaired embryo implantation|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0003845,abnormal decidualization|MP:0005671,abnormal response to transplant|MP:0009662,abnormal uterine receptivity|MP:0009663,abnormal uterine-embryonic axis|MP:0009664,abnormal luminal closure|MP:0009703,decreased birth body size
MGI:6117871	Greb1l<em1Cjea>	MP:0000267,abnormal heart development|MP:0000477,abnormal intestine morphology|MP:0000520,absent kidney|MP:0000600,liver hypoplasia|MP:0000914,exencephaly|MP:0001147,small testis|MP:0001178,pulmonary hypoplasia|MP:0001698,decreased embryo size|MP:0003830,abnormal testis development|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005294,abnormal heart ventricle morphology|MP:0006032,abnormal ureteric bud morphology|MP:0006425,absent Mullerian ducts|MP:0009073,absent Wolffian ducts|MP:0010788,stomach hypoplasia|MP:0011092,embryonic lethality, complete penetrance|MP:0011493,double ureter|MP:0011760,abnormal ureteric bud tip morphology
MGI:5812878	Greb1l<em1(IMPC)J>	MP:0001304,cataract|MP:0001700,abnormal embryo turning|MP:0003720,abnormal neural tube closure|MP:0003961,decreased lean body mass|MP:0003984,embryonic growth retardation|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:5548756	Greb1<tm1b(KOMP)Wtsi>	MP:0001258,decreased body length|MP:0010053,decreased grip strength
MGI:1856289	Grem1<ld>	MP:0000520,absent kidney|MP:0000558,abnormal tibia morphology|MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0002135,abnormal kidney morphology|MP:0002187,abnormal fibula morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003446,renal hypoplasia|MP:0003604,single kidney|MP:0003722,absent ureter|MP:0003723,abnormal long bone morphology|MP:0005650,abnormal limb bud morphology|MP:0010982,abnormal ureteric bud elongation|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0011530,fused radius and ulna
MGI:1856290	Grem1<ld-J>	MP:0000520,absent kidney|MP:0003604,single kidney|MP:0010982,abnormal ureteric bud elongation
MGI:3046937	Grem1<tm1Azun>	MP:0000520,absent kidney|MP:0000538,abnormal urinary bladder morphology|MP:0000565,oligodactyly|MP:0001575,cyanosis|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0001954,respiratory distress|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003604,single kidney|MP:0003722,absent ureter|MP:0004639,fused metacarpal bones|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0006042,increased apoptosis|MP:0006279,abnormal limb development|MP:0006382,abnormal lung epithelium morphology|MP:0010982,abnormal ureteric bud elongation|MP:0010983,abnormal ureteric bud invasion|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011261,abnormal limb mesenchyme morphology|MP:0011366,absent metanephros|MP:0011386,increased metanephric mesenchyme apoptosis|MP:0011504,abnormal limb long bone morphology
MGI:3054923	Grem1<tm1Rmh>	MP:0000520,absent kidney|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0005367,renal/urinary system phenotype|MP:0005389,reproductive system phenotype|MP:0011085,postnatal lethality, complete penetrance
MGI:6257621	Grem2<em1(IMPC)Bay>	MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011951,increased cardiac stroke volume|MP:0013279,increased fasting circulating glucose level
MGI:6871050	Grem2<em1Stpg>	MP:0001868,ovary inflammation|MP:0001923,reduced female fertility|MP:0001927,abnormal estrous cycle|MP:0001935,decreased litter size|MP:0002680,decreased corpora lutea number|MP:0003507,abnormal ovary physiology|MP:0003953,abnormal hormone level|MP:0005376,homeostasis/metabolism phenotype|MP:0005418,abnormal circulating hormone level|MP:0009010,abnormal diestrus|MP:0009011,prolonged diestrus|MP:0009018,short estrus|MP:0009020,prolonged metestrus|MP:0011124,increased primary ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0021106,abnormal secondary ovarian follicle morphology|MP:0030089,short lower incisors|MP:0030090,short upper incisors
MGI:6343527	Grem2<tm1Akh>	MP:0000218,increased leukocyte cell number|MP:0001846,increased inflammatory response|MP:0002626,increased heart rate|MP:0005385,cardiovascular system phenotype|MP:0008660,increased interleukin-10 secretion|MP:0008721,abnormal chemokine level|MP:0008837,increased transforming growth factor beta level|MP:0031215,abnormal response to myocardial ischemic injury|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5702891	Grem2<tm1Lex>	MP:0000062,increased bone mineral density|MP:0000126,brittle teeth|MP:0002577,reduced enamel thickness|MP:0002818,abnormal dentin morphology|MP:0004592,small mandible|MP:0005358,abnormal incisor morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005391,vision/eye phenotype|MP:0020011,increased bone mineral density of femur|MP:0030080,small lower incisors|MP:0030081,small upper incisors|MP:0030457,abnormal molar cusp morphology|MP:0030458,abnormal tooth wear
MGI:4437209	Grhl1<m1Btlr>	MP:0000418,focal hair loss|MP:0001265,decreased body size|MP:0005376,homeostasis/metabolism phenotype
MGI:4938813	Grhl1<m1J>	MP:0000416,sparse hair|MP:0001265,decreased body size
MGI:3778923	Grhl1<tm1Jane>	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000422,delayed hair appearance|MP:0001216,abnormal epidermal layer morphology|MP:0001242,hyperkeratosis|MP:0001732,postnatal growth retardation|MP:0005385,cardiovascular system phenotype
MGI:5056365	Grhl2<clft3>	MP:0000108,midline facial cleft|MP:0000774,decreased brain size|MP:0012260,encephalomeningocele
MGI:6277030	Grhl2<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000288,abnormal pericardium morphology|MP:0000428,abnormal craniofacial morphology|MP:0000564,syndactyly|MP:0000914,exencephaly|MP:0001488,increased startle reflex|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0002109,abnormal limb morphology|MP:0002151,abnormal neural tube morphology|MP:0003232,abnormal forebrain development|MP:0003257,abnormal abdominal wall morphology|MP:0003425,abnormal optic vesicle formation|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0020421,increased freezing behavior
MGI:4331210	Grhl2<Gt(AC0205)Wtsi>	MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0003054,spina bifida|MP:0003720,abnormal neural tube closure|MP:0008797,facial cleft|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3896011	Grhl2<Gt(E115B04)Wrst>	MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0003984,embryonic growth retardation|MP:0004838,abnormal neural fold elevation formation|MP:0008797,facial cleft|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012686,everted embryonic neuroepithelium|MP:0012707,incomplete caudal neuropore closure
MGI:4340678	Grhl2<Gt(RRU622)Byg>	MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0003984,embryonic growth retardation|MP:0004838,abnormal neural fold elevation formation|MP:0008797,facial cleft|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012686,everted embryonic neuroepithelium|MP:0012707,incomplete caudal neuropore closure
MGI:4942413	Grhl2<m1Nisw>	MP:0000266,abnormal heart morphology|MP:0000280,thin ventricular wall|MP:0000438,abnormal cranium morphology|MP:0000564,syndactyly|MP:0000571,interdigital webbing|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0001935,decreased litter size|MP:0003385,abnormal body wall morphology|MP:0003984,embryonic growth retardation|MP:0004320,split sternum|MP:0004391,abnormal respiratory conducting tube morphology|MP:0005262,coloboma|MP:0005294,abnormal heart ventricle morphology|MP:0008797,facial cleft|MP:0010831,lethality, incomplete penetrance|MP:0010976,small lung lobe|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0030095,abnormal midface morphology|MP:0030579,thoracoabdominoschisis
MGI:4836381	Grhl2<tm1.1Jane>	MP:0000919,cranioschisis|MP:0004838,abnormal neural fold elevation formation|MP:0008797,facial cleft|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012707,incomplete caudal neuropore closure
MGI:1856837	Grhl3<ct>	MP:0000914,exencephaly|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0001890,anencephaly|MP:0002621,delayed neural tube closure|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0003720,abnormal neural tube closure|MP:0004201,fetal growth retardation|MP:0012547,spina bifida cystica
MGI:3047567	Grhl3<ct-2J>	MP:0002151,abnormal neural tube morphology|MP:0003051,curly tail
MGI:1860481	Grhl3<ct-J>	MP:0000929,open neural tube|MP:0003051,curly tail
MGI:4433681	Grhl3<tm1a(EUCOMM)Wtsi>	MP:0000194,increased circulating calcium level|MP:0001325,abnormal retina morphology|MP:0002092,abnormal eye morphology|MP:0002492,decreased IgE level|MP:0002644,decreased circulating triglyceride level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003313,abnormal locomotor activation|MP:0005559,increased circulating glucose level|MP:0005566,decreased blood urea nitrogen level
MGI:3690001	Grhl3<tm1Bogi>	MP:0000111,cleft palate|MP:0000471,abnormal stomach epithelium morphology|MP:0000477,abnormal intestine morphology|MP:0000914,exencephaly|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001302,eyelids open at birth|MP:0001547,abnormal lipid level|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0003720,abnormal neural tube closure|MP:0003935,abnormal craniofacial development|MP:0009474,thick epidermis stratum spinosum|MP:0009583,increased keratinocyte proliferation|MP:0009653,abnormal palate development|MP:0011089,perinatal lethality, complete penetrance|MP:0013531,abnormal periderm development|MP:0030605,abnormal corneocyte morphology|MP:0031154,intestinal hemorrhage
MGI:4430902	Grhl3<tm1(cre)Cgh>	MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0002151,abnormal neural tube morphology|MP:0003054,spina bifida
MGI:2684328	Grhl3<tm1Jane>	MP:0000137,abnormal vertebrae morphology|MP:0000160,kyphosis|MP:0000585,kinked tail|MP:0000914,exencephaly|MP:0001219,thick epidermis|MP:0001698,decreased embryo size|MP:0002006,neoplasm|MP:0003054,spina bifida|MP:0004601,abnormal vertebral spinous process morphology|MP:0004603,absent vertebral arch|MP:0004604,abnormal vertebral pedicle morphology|MP:0009583,increased keratinocyte proliferation|MP:0009594,abnormal corneocyte envelope morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5444857	Grhl3<tm2.1(F2rl1)Cgh>	MP:0001192,scaly skin|MP:0001212,skin lesions|MP:0001222,epidermal hyperplasia|MP:0001412,excessive scratching|MP:0003054,spina bifida|MP:0011089,perinatal lethality, complete penetrance
MGI:4836382	Grhl3<tm2.1Jane>	MP:0003054,spina bifida|MP:0011111,lethality during fetal growth through weaning, complete penetrance
MGI:5306651	Grhl3<tm3.1Jane>	MP:0002169,no abnormal phenotype detected
MGI:4301247	Grhpr<Gt(OST383093)Lex>	MP:0002708,nephrolithiasis|MP:0003197,nephrocalcinosis|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0005360,urolithiasis|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0009646,urinary bladder inflammation|MP:0011346,renal tubule atrophy|MP:0011517,hyperoxaluria
MGI:1856890	gri	MP:0000371,diluted coat color|MP:0001259,abnormal body weight|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001922,reduced male fertility|MP:0002089,abnormal postnatal growth/weight/body size|MP:0003956,abnormal body size|MP:0005376,homeostasis/metabolism phenotype
MGI:6153796	Gria1<em1(IMPC)H>	MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0002965,increased circulating serum albumin level|MP:0003043,hypoalgesia|MP:0005565,increased blood urea nitrogen level|MP:0008810,increased circulating iron level|MP:0009142,decreased prepulse inhibition|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0020420,abnormal freezing behavior|MP:0020422,decreased freezing behavior|MP:0020955,increased mechanical nociceptive threshold
MGI:6257717	Gria1<em1(IMPC)Hmgu>	MP:0001399,hyperactivity|MP:0001489,decreased startle reflex|MP:0002757,decreased vertical activity|MP:0002968,increased circulating alkaline phosphatase level|MP:0008806,increased circulating amylase level|MP:0009142,decreased prepulse inhibition|MP:0010124,decreased bone mineral content
MGI:2178080	Gria1<tm1Erk>	MP:0001360,abnormal social investigation|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001413,abnormal response to new environment|MP:0002566,abnormal sexual interaction|MP:0002574,increased vertical activity|MP:0003862,decreased aggression towards male mice|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype
MGI:5760004	Gria1<tm1Lex>	MP:0005565,increased blood urea nitrogen level|MP:0006352,decreased glycosylated hemoglobin level|MP:0031391,increased locomotor activity
MGI:2653986	Gria1<tm1Rlh>	MP:0001473,reduced long-term potentiation|MP:0001899,absent long-term depression|MP:0002062,abnormal associative learning|MP:0008432,abnormal long-term spatial reference memory
MGI:2178057	Gria1<tm1Rsp>	MP:0000955,abnormal spinal cord morphology|MP:0001265,decreased body size|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001364,decreased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001413,abnormal response to new environment|MP:0001415,increased exploration in new environment|MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002566,abnormal sexual interaction|MP:0002572,abnormal emotion/affect behavior|MP:0002574,increased vertical activity|MP:0002736,abnormal nociception after inflammation|MP:0003631,nervous system phenotype|MP:0003862,decreased aggression towards male mice|MP:0005322,abnormal serotonin level|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0008532,decreased chemical nociceptive threshold|MP:0008911,induced hyperactivity|MP:0009745,abnormal behavioral response to xenobiotic|MP:0009776,decreased behavioral withdrawal response|MP:0011003,reduced AMPA-mediated synaptic currents
MGI:3605220	Gria1<tm2Rlh>	MP:0003631,nervous system phenotype|MP:0008143,abnormal dendrite morphology
MGI:3798452	Gria1<tm2Rsp>	MP:0002272,abnormal nervous system electrophysiology|MP:0002578,impaired ability to fire action potentials|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0002912,abnormal excitatory postsynaptic potential|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory|MP:0009713,enhanced conditioned place preference behavior|MP:0011003,reduced AMPA-mediated synaptic currents
MGI:3762912	Gria1<tm4Rlh>	MP:0001899,absent long-term depression
MGI:3793349	Gria1<tm5Rlh>	MP:0002062,abnormal associative learning
MGI:3793350	Gria1<tm6Rlh>	MP:0002169,no abnormal phenotype detected
MGI:5562310	Gria1<tm7Rlh>	MP:0002207,abnormal long-term potentiation|MP:0003631,nervous system phenotype
MGI:6276861	Gria2<em1(IMPC)H>	MP:0002941,increased circulating alanine transaminase level|MP:0010053,decreased grip strength|MP:0010392,prolonged QRS complex duration|MP:0011100,preweaning lethality, complete penetrance
MGI:5693873	Gria2<tm1.1Bvis>	MP:0002063,abnormal learning/memory/conditioning|MP:0003008,enhanced long-term potentiation|MP:0008432,abnormal long-term spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0012307,impaired spatial learning
MGI:2178125	Gria2<tm1.1Phs>	MP:0003631,nervous system phenotype
MGI:5760009	Gria2<tm1Lex>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0010053,decreased grip strength|MP:0020478,abnormal circadian sleep/wake cycle
MGI:2178124	Gria2<tm1Phs>	MP:0002272,abnormal nervous system electrophysiology|MP:0003631,nervous system phenotype
MGI:3584143	Gria2<tm1Rlh>	MP:0001900,impaired synaptic plasticity
MGI:1857436	Gria2<tm1Rod>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0001442,decreased grooming behavior|MP:0001961,abnormal reflex|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0003008,enhanced long-term potentiation|MP:0003461,abnormal response to novel object|MP:0004263,abnormal limb posture|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0010053,decreased grip strength|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2178120	Gria2<tm1Rsp>	MP:0000811,hippocampal neuron degeneration|MP:0001401,jumpy|MP:0001440,abnormal grooming behavior|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002572,abnormal emotion/affect behavior|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0003997,tonic-clonic seizures|MP:0005621,abnormal cell physiology|MP:0009434,paraparesis|MP:0011085,postnatal lethality, complete penetrance|MP:0031391,increased locomotor activity
MGI:2680703	Gria2<tm1Sans>	MP:0005377,hearing/vestibular/ear phenotype
MGI:2178122	Gria2<tm2.1Rsp>	MP:0001262,decreased body weight|MP:0002064,seizures|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:3623451	Gria2<tm2Rlh>	MP:0001899,absent long-term depression
MGI:2178121	Gria2<tm2Rsp>	MP:0000952,abnormal CNS glial cell morphology|MP:0001262,decreased body weight|MP:0001460,abnormal olfactory discrimination memory|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002083,premature death|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003240,loss of hippocampal neurons|MP:0004101,abnormal brain interneuron morphology|MP:0005202,lethargy|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0009937,abnormal neuron differentiation|MP:0011085,postnatal lethality, complete penetrance
MGI:3665137	Gria2<tm3.1Rsp>	MP:0000955,abnormal spinal cord morphology|MP:0001900,impaired synaptic plasticity|MP:0001968,abnormal touch/nociception|MP:0002736,abnormal nociception after inflammation|MP:0005407,hyperalgesia|MP:0008532,decreased chemical nociceptive threshold|MP:0011002,enhanced AMPA-mediated synaptic currents
MGI:3611335	Gria2<tm3Rsp>	MP:0001363,increased anxiety-related response|MP:0001380,decreased male mating frequency|MP:0001384,abnormal pup retrieval|MP:0001405,impaired coordination|MP:0001415,increased exploration in new environment|MP:0001460,abnormal olfactory discrimination memory|MP:0001463,abnormal spatial learning|MP:0002063,abnormal learning/memory/conditioning|MP:0002566,abnormal sexual interaction|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002918,abnormal paired-pulse facilitation|MP:0003240,loss of hippocampal neurons|MP:0003862,decreased aggression towards male mice|MP:0004101,abnormal brain interneuron morphology|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0008414,abnormal spatial reference memory|MP:0008428,abnormal spatial working memory|MP:0009937,abnormal neuron differentiation|MP:0031650,decreased mounting behavior
MGI:5898442	Gria3<em1Wthg>	MP:0001501,abnormal sleep pattern|MP:0004753,abnormal miniature excitatory postsynaptic currents
MGI:3611329	Gria3<tm1.1Rsp>	MP:0001405,impaired coordination|MP:0003313,abnormal locomotor activation|MP:0003546,decreased alcohol consumption
MGI:3604486	Gria3<tm1Dgen>	MP:0001262,decreased body weight|MP:0001489,decreased startle reflex|MP:0001973,increased thermal nociceptive threshold|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0005386,behavior/neurological phenotype
MGI:3584156	Gria3<tm1Rlh>	MP:0003631,nervous system phenotype
MGI:2668336	Gria3<tm1Zpj>	MP:0001922,reduced male fertility|MP:0002161,abnormal fertility/fecundity|MP:0002207,abnormal long-term potentiation
MGI:3584157	Gria3<tm2Rlh>	MP:0003631,nervous system phenotype
MGI:3580141	Gria4<spkw1>	MP:0003216,absence seizures|MP:0008840,abnormal spike wave discharge
MGI:3798456	Gria4<tm1.1Mony>	MP:0001417,decreased exploration in new environment|MP:0001458,abnormal object recognition memory|MP:0002272,abnormal nervous system electrophysiology|MP:0002578,impaired ability to fire action potentials|MP:0002757,decreased vertical activity|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0002911,abnormal inhibitory postsynaptic potential|MP:0002912,abnormal excitatory postsynaptic potential|MP:0004811,abnormal neuron physiology|MP:0005402,abnormal action potential|MP:0008428,abnormal spatial working memory
MGI:3604485	Gria4<tm1Dgen>	MP:0000950,abnormal seizure response to pharmacological agent|MP:0001973,increased thermal nociceptive threshold|MP:0003216,absence seizures|MP:0031391,increased locomotor activity
MGI:3798453	Gria4<tm1Mony>	MP:0002886,abnormal glutamate-mediated receptor currents|MP:0005253,abnormal eye physiology
MGI:3584158	Gria4<tm1Rlh>	MP:0003631,nervous system phenotype
MGI:5298021	Gria4<tm1Yfkk>	MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001489,decreased startle reflex|MP:0002574,increased vertical activity|MP:0002757,decreased vertical activity|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008414,abnormal spatial reference memory|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008911,induced hyperactivity|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0014369,enhanced spatial working memory
MGI:7411380	Grid1<em1(IMPC)J>	MP:0009141,increased prepulse inhibition|MP:0010052,increased grip strength
MGI:3712980	Grid1<tm1Jnz>	MP:0001262,decreased body weight|MP:0004404,cochlear outer hair cell degeneration|MP:0004411,decreased endocochlear potential|MP:0004490,type IV spiral ligament fibrocyte degeneration|MP:0004597,increased susceptibility to noise-induced hearing loss|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004737,absent distortion product otoacoustic emissions|MP:0004738,abnormal auditory brainstem response|MP:0005386,behavior/neurological phenotype|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856048	Grid2<ho>	MP:0001406,abnormal gait|MP:0001408,stereotypic behavior|MP:0001516,abnormal motor coordination/balance|MP:0001925,male infertility|MP:0002204,abnormal synaptic neurotransmitter level|MP:0003312,abnormal locomotor coordination|MP:0003313,abnormal locomotor activation
MGI:1857527	Grid2<ho-11J>	MP:0001406,abnormal gait
MGI:1857526	Grid2<ho-13J>	MP:0001406,abnormal gait
MGI:3505770	Grid2<ho-15J>	MP:0000436,abnormal head movements|MP:0001389,abnormal eye movement|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0002566,abnormal sexual interaction
MGI:3606110	Grid2<ho-16J>	MP:0000743,muscle spasm|MP:0000745,tremors|MP:0001406,abnormal gait
MGI:3606123	Grid2<ho-17J>	MP:0000745,tremors|MP:0001393,ataxia|MP:0001406,abnormal gait
MGI:5578544	Grid2<ho-18J>	MP:0001393,ataxia|MP:0001925,male infertility|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5578546	Grid2<ho-19J>	MP:0001265,decreased body size|MP:0001393,ataxia
MGI:5582465	Grid2<ho-20J>	MP:0000745,tremors|MP:0001406,abnormal gait|MP:0005389,reproductive system phenotype
MGI:5582467	Grid2<ho-21J>	MP:0001406,abnormal gait|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype
MGI:5691954	Grid2<ho-2Btlr>	MP:0001406,abnormal gait
MGI:1856050	Grid2<ho-4J>	MP:0000886,abnormal cerebellar granule layer morphology|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001525,impaired balance|MP:0002804,abnormal motor learning|MP:0003312,abnormal locomotor coordination|MP:0003894,abnormal Purkinje cell innervation|MP:0004097,abnormal cerebellar cortex morphology|MP:0004814,reduced linear vestibular evoked potential|MP:0004996,abnormal CNS synapse formation|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0014331,abnormal Purkinje cell mitochondrial morphology
MGI:1856051	Grid2<ho-5J>	MP:0001408,stereotypic behavior|MP:0001925,male infertility
MGI:1856504	Grid2<ho-8J>	MP:0000743,muscle spasm|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0003312,abnormal locomotor coordination|MP:0003313,abnormal locomotor activation
MGI:3847268	Grid2<ho-Btlr>	MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0001925,male infertility|MP:0005202,lethargy|MP:0008913,weaving
MGI:1856049	Grid2<ho-cpr>	MP:0000920,abnormal myelination|MP:0001393,ataxia|MP:0001527,athetotic walking movements|MP:0001925,male infertility|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002082,postnatal lethality|MP:0008770,decreased survivor rate|MP:0009393,abnormal resting posture
MGI:1856052	Grid2<ho-Jic>	MP:0001406,abnormal gait
MGI:1856053	Grid2<ho-Jwg>	MP:0000242,impaired fertilization|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002674,abnormal sperm motility|MP:0003631,nervous system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0030976,impaired sperm penetration of zona pellucida
MGI:2655335	Grid2<ho-Nancy>	MP:0000852,small cerebellum|MP:0000877,abnormal Purkinje cell morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0001525,impaired balance|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0003312,abnormal locomotor coordination|MP:0003894,abnormal Purkinje cell innervation|MP:0004996,abnormal CNS synapse formation|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0010323,retropulsion|MP:0014185,cerebellum atrophy
MGI:3796575	Grid2ip<tm1.1Mmsh>	MP:0001898,abnormal long-term depression|MP:0001961,abnormal reflex|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:1857337	Grid2<Lc>	MP:0000841,abnormal hindbrain morphology|MP:0000854,abnormal cerebellum development|MP:0000876,Purkinje cell degeneration|MP:0000880,decreased Purkinje cell number|MP:0000897,abnormal midbrain morphology|MP:0000911,abnormal trigeminal motor nucleus morphology|MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0001436,abnormal suckling behavior|MP:0001440,abnormal grooming behavior|MP:0001463,abnormal spatial learning|MP:0001516,abnormal motor coordination/balance|MP:0001745,increased circulating corticosterone level|MP:0001748,increased circulating adrenocorticotropin level|MP:0002802,abnormal discrimination learning|MP:0004814,reduced linear vestibular evoked potential|MP:0004844,abnormal vestibuloocular reflex|MP:0009546,absent gastric milk in neonates|MP:0009619,abnormal optokinetic reflex|MP:0009674,decreased birth weight|MP:0011087,neonatal lethality, complete penetrance|MP:0012490,abnormal cochlear VIII nucleus morphology
MGI:1857346	Grid2<Lc-J>	MP:0000857,abnormal cerebellar foliation|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000876,Purkinje cell degeneration|MP:0000880,decreased Purkinje cell number|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0005039,hypoxia|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008913,weaving|MP:0009514,titubation|MP:0009719,reduced cerebellar foliation|MP:0011083,lethality at weaning, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014185,cerebellum atrophy
MGI:4949272	Grid2<tm1(cre)Mwa>	MP:0001389,abnormal eye movement|MP:0003631,nervous system phenotype
MGI:3577356	Grid2<tm1(cre/PGR*)Ksak>	MP:0001393,ataxia|MP:0001405,impaired coordination
MGI:2178052	Grid2<tm1Mim>	MP:0000849,abnormal cerebellum morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0000890,thin cerebellar molecular layer|MP:0001389,abnormal eye movement|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0001899,absent long-term depression|MP:0001961,abnormal reflex|MP:0002206,abnormal CNS synaptic transmission|MP:0002757,decreased vertical activity|MP:0002807,abnormal eye blink conditioning behavior|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003313,abnormal locomotor activation|MP:0003894,abnormal Purkinje cell innervation|MP:0004008,abnormal GABA-mediated receptor currents|MP:0004844,abnormal vestibuloocular reflex|MP:0004996,abnormal CNS synapse formation|MP:0005164,abnormal response to injury|MP:0005191,head tilt|MP:0005402,abnormal action potential|MP:0009141,increased prepulse inhibition|MP:0009619,abnormal optokinetic reflex|MP:0014384,increased miniature inhibitory postsynaptic current amplitude
MGI:3765001	Grid2<tm1Mmsh>	MP:0000877,abnormal Purkinje cell morphology|MP:0001475,reduced long-term depression|MP:0002206,abnormal CNS synaptic transmission|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0011271,prolonged excitatory postsynaptic current rise time|MP:0011273,prolonged excitatory postsynaptic current decay time
MGI:3576122	Grid2<tm2Mim>	MP:0000877,abnormal Purkinje cell morphology
MGI:3851243	Grid2<tm2Msmh>	MP:0005386,behavior/neurological phenotype|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0009538,abnormal synapse morphology
MGI:2151353	Grid2<tpr>	MP:0001393,ataxia|MP:0001406,abnormal gait
MGI:5751064	Grid2<ts3>	MP:0000755,hindlimb paralysis|MP:0000852,small cerebellum|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000889,abnormal cerebellar molecular layer|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0001524,impaired limb coordination|MP:0002161,abnormal fertility/fecundity|MP:0004996,abnormal CNS synapse formation|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008924,decreased cerebellar granule cell number|MP:0009964,abnormal cerebellum lobule morphology|MP:0014185,cerebellum atrophy
MGI:6163777	Grik1<tm1b(KOMP)Mbp>	MP:0001399,hyperactivity|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount
MGI:2176347	Grik1<tm1Sfh>	MP:0002272,abnormal nervous system electrophysiology|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003008,enhanced long-term potentiation|MP:0008531,increased chemical nociceptive threshold
MGI:3623113	Grik1<tm2Sfh>	MP:0001262,decreased body weight|MP:0002886,abnormal glutamate-mediated receptor currents
MGI:3623114	Grik1<tm3Sfh>	MP:0002169,no abnormal phenotype detected
MGI:3623590	Grik2<tm1Bvis>	MP:0002206,abnormal CNS synaptic transmission|MP:0002207,abnormal long-term potentiation|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003463,abnormal single cell response
MGI:1857979	Grik2<tm1Sfh>	MP:0001262,decreased body weight|MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0002206,abnormal CNS synaptic transmission|MP:0002207,abnormal long-term potentiation|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0002920,decreased paired-pulse facilitation|MP:0003460,decreased fear-related response
MGI:6316117	Grik3<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0001258,decreased body length|MP:0001304,cataract|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0004924,abnormal behavior|MP:0013279,increased fasting circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:3844281	Grik3<tm1Cmul>	MP:0001473,reduced long-term potentiation|MP:0002206,abnormal CNS synaptic transmission|MP:0002920,decreased paired-pulse facilitation|MP:0002922,decreased post-tetanic potentiation
MGI:6276880	Grik4<em1(IMPC)Mbp>	MP:0002092,abnormal eye morphology|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount
MGI:4413475	Grik4<tm1.1Sfh>	MP:0002910,abnormal excitatory postsynaptic currents|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:4360478	Grik4<tm1(cre)Ksak>	MP:0002169,no abnormal phenotype detected
MGI:6367943	Grik5<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000774,decreased brain size|MP:0001258,decreased body length|MP:0001293,anophthalmia|MP:0001304,cataract|MP:0002092,abnormal eye morphology|MP:0002152,abnormal brain morphology|MP:0002699,abnormal vitreous body morphology|MP:0010052,increased grip strength
MGI:2668206	Grik5<tm1Cont>	MP:0002206,abnormal CNS synaptic transmission|MP:0002910,abnormal excitatory postsynaptic currents|MP:0011274,short excitatory postsynaptic current decay time
MGI:3604589	Grik5<tm1Dgen>	MP:0001488,increased startle reflex|MP:0001973,increased thermal nociceptive threshold|MP:0002906,increased susceptibility to pharmacologically induced seizures
MGI:3798977	Grin1<Rgsc174>	MP:0001360,abnormal social investigation|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0004000,impaired passive avoidance behavior|MP:0004811,abnormal neuron physiology|MP:0005386,behavior/neurological phenotype|MP:0008872,abnormal physiological response to xenobiotic|MP:0009745,abnormal behavioral response to xenobiotic|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:4361333	Grin1<tm1.1Ese>	MP:0001360,abnormal social investigation|MP:0001473,reduced long-term potentiation|MP:0002757,decreased vertical activity|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0009142,decreased prepulse inhibition|MP:0011003,reduced AMPA-mediated synaptic currents
MGI:2178082	Grin1<tm1.1Phs>	MP:0001384,abnormal pup retrieval|MP:0001385,pup cannibalization|MP:0001386,abnormal maternal nurturing|MP:0001399,hyperactivity|MP:0001438,aphagia|MP:0001447,abnormal nest building behavior|MP:0001575,cyanosis|MP:0001951,abnormal breathing pattern|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002272,abnormal nervous system electrophysiology|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002888,abnormal NMDA-mediated synaptic currents|MP:0003631,nervous system phenotype|MP:0009326,absent maternal crouching|MP:0009327,abnormal maternal grooming|MP:0009546,absent gastric milk in neonates|MP:0011087,neonatal lethality, complete penetrance
MGI:2655232	Grin1<tm1.1Slab>	MP:0001399,hyperactivity|MP:0001954,respiratory distress|MP:0011087,neonatal lethality, complete penetrance
MGI:4432313	Grin1<tm1a(EUCOMM)Wtsi>	MP:0003179,thrombocytopenia
MGI:1928280	Grin1<tm1Bhk>	MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001361,social withdrawal|MP:0001380,decreased male mating frequency|MP:0001408,stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001488,increased startle reflex|MP:0001513,limb grasping|MP:0001922,reduced male fertility|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002557,abnormal social/conspecific interaction behavior|MP:0003863,decreased aggression towards mice|MP:0004738,abnormal auditory brainstem response|MP:0006335,abnormal hearing electrophysiology|MP:0008428,abnormal spatial working memory|MP:0009142,decreased prepulse inhibition|MP:0020351,decreased vocalization|MP:0021117,abnormal huddling behavior|MP:0031391,increased locomotor activity
MGI:1928283	Grin1<tm1Blt>	MP:0001392,abnormal locomotor behavior|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001488,increased startle reflex|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0003633,abnormal nervous system physiology
MGI:5431094	Grin1<tm1c(EUCOMM)Wtsi>	MP:0001902,reduced NMDA-mediated synaptic currents|MP:0002888,abnormal NMDA-mediated synaptic currents|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0011270,decreased excitatory postsynaptic current amplitude
MGI:1928327	Grin1<tm1Cur>	MP:0001177,atelectasis|MP:0001182,lung hemorrhage|MP:0001183,overexpanded pulmonary alveolus|MP:0001575,cyanosis|MP:0001901,absence of NMDA-mediated synaptic currents|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0003631,nervous system phenotype|MP:0005385,cardiovascular system phenotype|MP:0009546,absent gastric milk in neonates|MP:0011089,perinatal lethality, complete penetrance
MGI:5574216	Grin1<tm1Jjwd>	MP:0001362,abnormal anxiety-related response|MP:0002805,abnormal conditioned taste aversion behavior|MP:0002888,abnormal NMDA-mediated synaptic currents|MP:0003545,increased alcohol consumption|MP:0003546,decreased alcohol consumption|MP:0005394,taste/olfaction phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0020157,abnormal behavioral response to alcohol
MGI:3833550	Grin1<tm1Mim>	MP:0002272,abnormal nervous system electrophysiology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002980,abnormal postural reflex|MP:0003631,nervous system phenotype|MP:0003997,tonic-clonic seizures|MP:0004994,abnormal brain wave pattern
MGI:3760845	Grin1<tm1Nak>	MP:0001436,abnormal suckling behavior|MP:0001575,cyanosis|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0008236,decreased susceptibility to neuronal excitotoxicity|MP:0009546,absent gastric milk in neonates|MP:0011087,neonatal lethality, complete penetrance
MGI:3611337	Grin1<tm1Rsp>	MP:0001901,absence of NMDA-mediated synaptic currents|MP:0002207,abnormal long-term potentiation|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0002888,abnormal NMDA-mediated synaptic currents|MP:0005389,reproductive system phenotype|MP:0008428,abnormal spatial working memory|MP:0009758,impaired behavioral response to cocaine
MGI:2655224	Grin1<tm1Slab>	MP:0011087,neonatal lethality, complete penetrance
MGI:1928270	Grin1<tm1Stl>	MP:0001393,ataxia|MP:0001436,abnormal suckling behavior|MP:0001575,cyanosis|MP:0001901,absence of NMDA-mediated synaptic currents|MP:0001957,apnea|MP:0005277,abnormal brainstem morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3692441	Grin1<tm1Yql>	MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001423,abnormal liquid preference|MP:0001447,abnormal nest building behavior|MP:0001473,reduced long-term potentiation|MP:0001899,absent long-term depression|MP:0002272,abnormal nervous system electrophysiology|MP:0002566,abnormal sexual interaction|MP:0002797,increased thigmotaxis|MP:0002804,abnormal motor learning|MP:0002888,abnormal NMDA-mediated synaptic currents|MP:0002910,abnormal excitatory postsynaptic currents|MP:0005376,homeostasis/metabolism phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0008428,abnormal spatial working memory|MP:0008462,abnormal medium spiny neuron morphology|MP:0009142,decreased prepulse inhibition|MP:0031391,increased locomotor activity
MGI:2178084	Grin1<tm2.1Phs>	MP:0001402,decreased locomotor activity|MP:0001523,impaired righting response|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0005449,abnormal food intake|MP:0011085,postnatal lethality, complete penetrance
MGI:1928284	Grin1<tm2Blt>	MP:0001262,decreased body weight|MP:0001435,absent suckling reflex|MP:0001732,postnatal growth retardation|MP:0003633,abnormal nervous system physiology|MP:0011085,postnatal lethality, complete penetrance
MGI:2178083	Grin1<tm2Phs>	MP:0001438,aphagia|MP:0011087,neonatal lethality, complete penetrance|MP:0014274,decreased respiration
MGI:1928279	Grin1<tm2Stl>	MP:0001458,abnormal object recognition memory|MP:0001460,abnormal olfactory discrimination memory|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0001901,absence of NMDA-mediated synaptic currents|MP:0002802,abnormal discrimination learning|MP:0002888,abnormal NMDA-mediated synaptic currents|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002969,impaired social transmission of food preference|MP:0003463,abnormal single cell response|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:5811328	Grin2a<tm1.1Jpleo>	MP:0001364,decreased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0003631,nervous system phenotype|MP:0008428,abnormal spatial working memory
MGI:5505778	Grin2a<tm1.1Nhk>	MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0003631,nervous system phenotype|MP:0009454,impaired contextual conditioning behavior
MGI:5292331	Grin2a<tm1.1Ppao>	MP:0001982,decreased chemically-elicited antinociception|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003177,allodynia|MP:0003998,decreased thermal nociceptive threshold|MP:0005386,behavior/neurological phenotype|MP:0008532,decreased chemical nociceptive threshold
MGI:4414793	Grin2a<tm1.1Tnkw>	MP:0001902,reduced NMDA-mediated synaptic currents|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003360,abnormal depression-related behavior|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:1928285	Grin2a<tm1Mim>	MP:0001401,jumpy|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001488,increased startle reflex|MP:0001902,reduced NMDA-mediated synaptic currents
MGI:1928506	Grin2a<tm1Nak>	MP:0002757,decreased vertical activity|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005386,behavior/neurological phenotype
MGI:1928287	Grin2a<tm1Rsp>	MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001473,reduced long-term potentiation|MP:0001500,decreased kindling response|MP:0003631,nervous system phenotype|MP:0009454,impaired contextual conditioning behavior
MGI:7449028	Grin2b<em1Weya>	MP:0002888,abnormal NMDA-mediated synaptic currents|MP:0003063,increased coping response|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0020507,increased dendritic spine density
MGI:5307054	Grin2b<tm1.1(Grin2a)Bjha>	MP:0001265,decreased body size|MP:0001360,abnormal social investigation|MP:0001361,social withdrawal|MP:0001436,abnormal suckling behavior|MP:0002081,perinatal lethality|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0002888,abnormal NMDA-mediated synaptic currents|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0031391,increased locomotor activity
MGI:4443321	Grin2b<tm1.1Jlbr>	MP:0001361,social withdrawal|MP:0001436,abnormal suckling behavior|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001475,reduced long-term depression|MP:0001522,impaired swimming|MP:0001899,absent long-term depression|MP:0002062,abnormal associative learning|MP:0002063,abnormal learning/memory/conditioning|MP:0002797,increased thigmotaxis|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002912,abnormal excitatory postsynaptic potential|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0011274,short excitatory postsynaptic current decay time|MP:0020508,decreased dendritic spine density|MP:0031391,increased locomotor activity
MGI:5314923	Grin2b<tm1.1Jwhe>	MP:0001468,abnormal temporal memory|MP:0001473,reduced long-term potentiation|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:5505780	Grin2b<tm1.1Nhk>	MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001473,reduced long-term potentiation|MP:0002803,abnormal operant conditioning behavior|MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype
MGI:5605840	Grin2b<tm1e.1(KOMP)Wtsi>	MP:0000274,enlarged heart|MP:0001402,decreased locomotor activity|MP:0001488,increased startle reflex|MP:0002599,increased mean platelet volume|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3699608	Grin2b<tm1(GRIN2A/GRIN2B)Twr>	MP:0002888,abnormal NMDA-mediated synaptic currents|MP:0005386,behavior/neurological phenotype
MGI:4360480	Grin2b<tm1Ksak>	MP:0001473,reduced long-term potentiation|MP:0001901,absence of NMDA-mediated synaptic currents|MP:0003631,nervous system phenotype|MP:0008143,abnormal dendrite morphology|MP:0009538,abnormal synapse morphology
MGI:1928295	Grin2b<tm1Mim>	MP:0000861,disorganized barrel cortex|MP:0001435,absent suckling reflex|MP:0001488,increased startle reflex|MP:0001899,absent long-term depression|MP:0001901,absence of NMDA-mediated synaptic currents|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0009141,increased prepulse inhibition|MP:0009546,absent gastric milk in neonates|MP:0011087,neonatal lethality, complete penetrance
MGI:5432023	Grin2b<tm1Mony>	MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001458,abnormal object recognition memory|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001516,abnormal motor coordination/balance|MP:0002063,abnormal learning/memory/conditioning|MP:0002802,abnormal discrimination learning|MP:0002888,abnormal NMDA-mediated synaptic currents|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008414,abnormal spatial reference memory|MP:0008428,abnormal spatial working memory|MP:0011089,perinatal lethality, complete penetrance
MGI:1928293	Grin2b<tm1Rsp>	MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001473,reduced long-term potentiation|MP:0002888,abnormal NMDA-mediated synaptic currents|MP:0011087,neonatal lethality, complete penetrance
MGI:3701351	Grin2b<tm1Tya>	MP:0001454,abnormal cued conditioning behavior|MP:0001900,impaired synaptic plasticity|MP:0003631,nervous system phenotype|MP:0014812,abnormal brain physiology
MGI:2179059	Grin2b<tm2Mim>	MP:0001898,abnormal long-term depression|MP:0002206,abnormal CNS synaptic transmission|MP:0002912,abnormal excitatory postsynaptic potential|MP:0011085,postnatal lethality, complete penetrance
MGI:3718038	Grin2c<tm1Bnno>	MP:0002169,no abnormal phenotype detected
MGI:3513208	Grin2c<tm1(Grin2b)Ulme>	MP:0000889,abnormal cerebellar molecular layer|MP:0000890,thin cerebellar molecular layer|MP:0001405,impaired coordination|MP:0006099,thin cerebellar granule layer
MGI:3054830	Grin2c<tm1Mwa>	MP:0002169,no abnormal phenotype detected
MGI:1928510	Grin2c<tm1Nak>	MP:0002757,decreased vertical activity|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005386,behavior/neurological phenotype
MGI:1928301	Grin2c<tm1Nts>	MP:0002206,abnormal CNS synaptic transmission|MP:0002888,abnormal NMDA-mediated synaptic currents
MGI:1928514	Grin2c<tm1Rsp>	MP:0001525,impaired balance
MGI:3850683	Grin2c<tm2Rsp>	MP:0001525,impaired balance
MGI:8245572	Grin2d<em10Frk>	MP:0000851,cerebellum hypoplasia|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002169,no abnormal phenotype detected|MP:0002207,abnormal long-term potentiation|MP:0002272,abnormal nervous system electrophysiology|MP:0003008,enhanced long-term potentiation|MP:0003216,absence seizures|MP:0008571,abnormal synaptic bouton morphology|MP:0008770,decreased survivor rate|MP:0008840,abnormal spike wave discharge|MP:0011273,prolonged excitatory postsynaptic current decay time|MP:0012307,impaired spatial learning|MP:0012468,decreased striatum size|MP:0013140,excessive vocalization|MP:0014629,hypothalamus hypoplasia|MP:0020528,thalamus hypoplasia|MP:0020551,abnormal postsynaptic density morphology|MP:0031185,sudden unexpected death in epilepsy
MGI:4432794	Grin2d<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0002644,decreased circulating triglyceride level|MP:0002834,decreased heart weight|MP:0002896,abnormal bone mineralization|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005634,decreased circulating sodium level
MGI:1928298	Grin2d<tm1Mim>	MP:0001402,decreased locomotor activity|MP:0001488,increased startle reflex|MP:0002757,decreased vertical activity|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:5692762	Grin3a<tm1b(EUCOMM)Hmgu>	MP:0002631,abnormal epididymis morphology
MGI:3604389	Grin3a<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:2387963	Grin3a<tm1Nnk>	MP:0003088,abnormal prepulse inhibition|MP:0003463,abnormal single cell response|MP:0005386,behavior/neurological phenotype|MP:0005551,abnormal eye electrophysiology|MP:0008143,abnormal dendrite morphology
MGI:6120779	Grin3b<tm1b(KOMP)Wtsi>	MP:0001406,abnormal gait|MP:0002644,decreased circulating triglyceride level|MP:0005344,increased circulating bilirubin level|MP:0005627,increased circulating potassium level|MP:0010067,increased red blood cell distribution width
MGI:3512173	Grin3b<tm1Yaha>	MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002557,abnormal social/conspecific interaction behavior|MP:0008489,slow postnatal weight gain
MGI:4943769	Grina<tm1.1Ldh>	MP:0002169,no abnormal phenotype detected
MGI:1856852	Grip1<eb>	MP:0000520,absent kidney|MP:0000549,decreased limb number|MP:0000564,syndactyly|MP:0000571,interdigital webbing|MP:0000576,clubfoot|MP:0000929,open neural tube|MP:0001265,decreased body size|MP:0001286,abnormal eye development|MP:0001292,abnormal lens vesicle development|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001302,eyelids open at birth|MP:0001304,cataract|MP:0001314,cornea opacity|MP:0001322,abnormal iris morphology|MP:0001340,abnormal eyelid morphology|MP:0001614,abnormal blood vessel morphology|MP:0001914,hemorrhage|MP:0002092,abnormal eye morphology|MP:0002109,abnormal limb morphology|MP:0002151,abnormal neural tube morphology|MP:0002152,abnormal brain morphology|MP:0002551,abnormal blood coagulation|MP:0002989,small kidney|MP:0003078,aphakia|MP:0003604,single kidney|MP:0003675,kidney cyst|MP:0005300,abnormal cornea stroma morphology|MP:0005545,abnormal lens development|MP:0006000,abnormal cornea epithelium morphology|MP:0006203,eye hemorrhage|MP:0008528,polycystic kidney|MP:0008854,bleb|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011961,abnormal cornea thickness|MP:0021107,retina fold
MGI:2449094	Grip1<tm1Paw>	MP:0001208,blistering|MP:0001915,intracranial hemorrhage|MP:0011091,prenatal lethality, complete penetrance
MGI:3035931	Grip1<tm1Rha>	MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0001208,blistering|MP:0010768,mortality/aging|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3798437	Grip1<tm1Rlh>	MP:0003631,nervous system phenotype
MGI:3035933	Grip2<tm1Rha>	MP:0003631,nervous system phenotype
MGI:6117099	Gripap1<tm1Rlh>	MP:0001473,reduced long-term potentiation|MP:0003247,abnormal glutaminergic neuron morphology|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008414,abnormal spatial reference memory|MP:0012293,impaired active avoidance behavior|MP:0012307,impaired spatial learning
MGI:2668595	Grk1<tm1Citb>	MP:0001005,abnormal retina rod cell morphology|MP:0004021,abnormal rod electrophysiology|MP:0006072,abnormal retina apoptosis|MP:0008450,retina photoreceptor degeneration|MP:0014336,short retina rod cell outer segment
MGI:5902745	Grk1<tvrm207>	MP:0008450,retina photoreceptor degeneration|MP:0011965,decreased total retina thickness|MP:0012029,abnormal electroretinogram waveform feature|MP:0012671,retina spots
MGI:3763201	Grk2<tm1.1Gwd>	MP:0000270,abnormal heart tube morphology|MP:0001730,embryonic growth arrest|MP:0001787,pericardial edema|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3763199	Grk2<tm1Gwd>	MP:0002169,no abnormal phenotype detected|MP:0002459,abnormal B cell physiology|MP:0005014,increased B cell number|MP:0005017,decreased B cell number|MP:0005385,cardiovascular system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008173,increased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010768,mortality/aging
MGI:2180127	Grk2<tm1Mca>	MP:0000279,ventricular hypoplasia|MP:0000280,thin ventricular wall|MP:0000281,abnormal interventricular septum morphology|MP:0000295,trabecula carnea hypoplasia|MP:0001698,decreased embryo size|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002190,disorganized myocardium|MP:0002652,thin myocardium|MP:0002740,heart hypoplasia|MP:0003717,pallor|MP:0004055,heart atrium hypoplasia|MP:0004057,thin myocardium compact layer|MP:0004062,dilated heart right atrium|MP:0004201,fetal growth retardation|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0031633,decreased heart left ventricle muscle contractility
MGI:7377674	Grk3<em1(IMPC)Mbp>	MP:0020421,increased freezing behavior
MGI:2429934	Grk3<tm1Rjl>	MP:0001983,abnormal olfactory system physiology
MGI:4359726	Grk4<tm1Rjl>	MP:0002169,no abnormal phenotype detected
MGI:5582424	Grk5<tm1b(KOMP)Mbp>	MP:0001258,decreased body length|MP:0002135,abnormal kidney morphology
MGI:3604583	Grk5<tm1Dgen>	MP:0001973,increased thermal nociceptive threshold
MGI:2383968	Grk5<tm1Rjl>	MP:0000622,increased salivation|MP:0000745,tremors|MP:0001402,decreased locomotor activity|MP:0001625,cardiac hypertrophy|MP:0001952,increased airway responsiveness|MP:0002206,abnormal CNS synaptic transmission|MP:0003998,decreased thermal nociceptive threshold|MP:0004486,decreased response of heart to induced stress|MP:0005534,decreased body temperature|MP:0005620,abnormal muscle contractility|MP:0011014,decreased core body temperature
MGI:4359730	Grk5<tm2Rjl>	MP:0001625,cardiac hypertrophy|MP:0002169,no abnormal phenotype detected|MP:0004486,decreased response of heart to induced stress
MGI:2661089	Grk6<tm1.1Mca>	MP:0000691,enlarged spleen|MP:0001798,impaired macrophage phagocytosis|MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0002493,increased IgG level|MP:0002743,glomerulonephritis|MP:0003944,abnormal T cell subpopulation ratio|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004952,increased spleen weight|MP:0008049,increased memory T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008478,increased spleen white pulp amount|MP:0008809,increased spleen iron level|MP:0009338,increased splenocyte number|MP:0009749,enhanced behavioral response to addictive substance|MP:0009754,enhanced behavioral response to cocaine|MP:0011339,abnormal glomerular mesangium morphology|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0031391,increased locomotor activity
MGI:3664783	Grm1<crv4>	MP:0000005,increased brown adipose tissue amount|MP:0000069,kyphoscoliosis|MP:0000743,muscle spasm|MP:0000745,tremors|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002871,albuminuria|MP:0003631,nervous system phenotype|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005165,increased susceptibility to injury|MP:0005264,glomerulosclerosis|MP:0005287,narrow eye opening|MP:0005326,abnormal podocyte morphology|MP:0008140,podocyte foot process effacement|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011402,renal cast|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011856,abnormal glomerular filtration barrier function
MGI:5688490	Grm1<m1Btlr>	MP:0000160,kyphosis|MP:0001393,ataxia|MP:0002083,premature death
MGI:3588968	Grm1<nmf373>	MP:0000745,tremors|MP:0001393,ataxia|MP:0001513,limb grasping
MGI:2652658	Grm1<rcw>	MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001525,impaired balance
MGI:3057287	Grm1<rcw-2J>	MP:0001265,decreased body size|MP:0001386,abnormal maternal nurturing|MP:0001393,ataxia|MP:0002566,abnormal sexual interaction
MGI:3579803	Grm1<rcw-3J>	MP:0001265,decreased body size|MP:0001393,ataxia|MP:0003631,nervous system phenotype
MGI:3611054	Grm1<rcw-4J>	MP:0001265,decreased body size|MP:0001386,abnormal maternal nurturing|MP:0001393,ataxia|MP:0002272,abnormal nervous system electrophysiology|MP:0002566,abnormal sexual interaction
MGI:5432227	Grm1<Tg(p18A4.B)1352Szc>	MP:0001188,hyperpigmentation|MP:0010322,increased cutaneous melanoma incidence|MP:0010741,abnormal melanocyte proliferation
MGI:1857986	Grm1<tm1Crpl>	MP:0000745,tremors|MP:0001393,ataxia|MP:0001417,decreased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001475,reduced long-term depression|MP:0001523,impaired righting response
MGI:3604591	Grm1<tm1Dgen>	MP:0000063,decreased bone mineral density|MP:0000746,weakness|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001505,hunched posture|MP:0001524,impaired limb coordination|MP:0002083,premature death|MP:0010124,decreased bone mineral content
MGI:3604007	Grm1<tm1Kyo>	MP:0002272,abnormal nervous system electrophysiology|MP:0005386,behavior/neurological phenotype
MGI:1857987	Grm1<tm1Stl>	MP:0000745,tremors|MP:0001393,ataxia|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0001921,reduced fertility|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0011274,short excitatory postsynaptic current decay time
MGI:4867882	Grm1<tvrm84>	MP:0001393,ataxia|MP:0012029,abnormal electroretinogram waveform feature
MGI:3614809	Grm1<wobl>	MP:0001393,ataxia|MP:0002161,abnormal fertility/fecundity
MGI:3665323	Grm2<tm1Ddsc>	MP:0001362,abnormal anxiety-related response
MGI:1857988	Grm2<tm1Nak>	MP:0001405,impaired coordination|MP:0001475,reduced long-term depression|MP:0001906,increased dopamine level|MP:0001988,cocaine preference|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0008236,decreased susceptibility to neuronal excitotoxicity|MP:0011987,abnormal GABAergic neuron physiology|MP:0031391,increased locomotor activity
MGI:5636981	Grm3<tm1b(KOMP)Wtsi>	MP:0001297,microphthalmia|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:3665324	Grm3<tm1Ddsc>	MP:0001362,abnormal anxiety-related response
MGI:3604593	Grm3<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:5558949	Grm3<tm1Vbn>	MP:0004811,abnormal neuron physiology|MP:0008916,abnormal astrocyte physiology
MGI:5427673	Grm4<tm1Dgen>	MP:0009141,increased prepulse inhibition
MGI:1857980	Grm4<tm1Hpn>	MP:0002804,abnormal motor learning|MP:0002920,decreased paired-pulse facilitation|MP:0002922,decreased post-tetanic potentiation
MGI:3840366	Grm5<tm1.1Jixu>	MP:0005386,behavior/neurological phenotype
MGI:4353518	Grm5<tm1.1Kksz>	MP:0002736,abnormal nociception after inflammation|MP:0003546,decreased alcohol consumption
MGI:3840382	Grm5<tm1.2Jixu>	MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0006299,abnormal latent inhibition of conditioning behavior|MP:0020340,abnormal inhibitory learning
MGI:5427674	Grm5<tm1Dgen>	MP:0001262,decreased body weight|MP:0001516,abnormal motor coordination/balance|MP:0001973,increased thermal nociceptive threshold|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0010025,decreased total body fat amount
MGI:3575086	Grm5<tm1Fcq>	MP:0001473,reduced long-term potentiation|MP:0002556,abnormal cocaine consumption|MP:0009758,impaired behavioral response to cocaine
MGI:1857437	Grm5<tm1Rod>	MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0002062,abnormal associative learning|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003313,abnormal locomotor activation|MP:0003477,abnormal nerve fiber response|MP:0012296,impaired discrimination learning|MP:0012315,impaired learning|MP:0014115,cognitive inflexibility
MGI:8272179	Grm6<em#Mrho>	MP:0005551,abnormal eye electrophysiology|MP:0006149,decreased visual acuity|MP:0008144,nyctalopia|MP:0011269,increased excitatory postsynaptic current amplitude|MP:0011831,abnormal visual contrast sensitivity|MP:0012144,decreased b-wave amplitude|MP:0020357,abnormal excitatory synapse morphology|MP:0020425,abnormal retinal bipolar cell electrophysiology
MGI:3605835	Grm6<nob3>	MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005253,abnormal eye physiology|MP:0005391,vision/eye phenotype
MGI:7703919	Grm6<nob3-2J>	MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005253,abnormal eye physiology
MGI:7703959	Grm6<nob3-3J>	MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005253,abnormal eye physiology
MGI:3580353	Grm6<nob4>	MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005253,abnormal eye physiology|MP:0005551,abnormal eye electrophysiology
MGI:5754842	Grm6<nob7>	MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0012144,decreased b-wave amplitude
MGI:5754533	Grm6<nob8>	MP:0012144,decreased b-wave amplitude
MGI:5548472	Grm6<tm1b(EUCOMM)Wtsi>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0002092,abnormal eye morphology|MP:0002546,mydriasis|MP:0002833,increased heart weight|MP:0003917,increased kidney weight|MP:0006243,impaired pupillary reflex
MGI:1857985	Grm6<tm1Nak>	MP:0003635,abnormal synaptic transmission|MP:0005386,behavior/neurological phenotype|MP:0005551,abnormal eye electrophysiology
MGI:6149200	Grm7<em1(IMPC)H>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002599,increased mean platelet volume|MP:0010052,increased grip strength
MGI:5688492	Grm7<m1Btlr>	MP:0000947,convulsive seizures|MP:0002738,hyperresponsive to tactile stimuli
MGI:3809761	Grm7<tm1Betz>	MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0008428,abnormal spatial working memory|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:3604484	Grm7<tm1Dgen>	MP:0001405,impaired coordination|MP:0002906,increased susceptibility to pharmacologically induced seizures
MGI:1857984	Grm7<tm1Nak>	MP:0001378,abnormal ejaculation|MP:0001469,abnormal contextual conditioning behavior|MP:0001922,reduced male fertility|MP:0002064,seizures|MP:0002566,abnormal sexual interaction|MP:0002805,abnormal conditioned taste aversion behavior|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0009856,failure of ejaculation|MP:0031628,abnormal intromission
MGI:5427675	Grm8<tm1Dgen>	MP:0001392,abnormal locomotor behavior|MP:0009142,decreased prepulse inhibition
MGI:3603321	Grm8<tm1Duv>	MP:0001260,increased body weight|MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001522,impaired swimming|MP:0005331,insulin resistance|MP:0005458,increased percent body fat/body weight
MGI:3574927	Grm8<tm1En>	MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:4841284	Grm8<tm2a(KOMP)Wtsi>	MP:0001325,abnormal retina morphology
MGI:6750883	Grn<em1(IMPC)H>	MP:0002599,increased mean platelet volume
MGI:4421705	Grn<tm1.1Aidi>	MP:0000837,abnormal hypothalamus morphology|MP:0001259,abnormal body weight|MP:0001426,polydipsia|MP:0001752,abnormal hypothalamus secretion|MP:0001762,polyuria|MP:0001859,kidney inflammation|MP:0002136,abnormal kidney physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002705,dilated renal tubule|MP:0002981,increased liver weight|MP:0002988,decreased urine osmolality|MP:0003068,enlarged kidney|MP:0003354,astrocytosis|MP:0003691,abnormal microglial cell physiology|MP:0003917,increased kidney weight|MP:0004860,dilated kidney collecting duct|MP:0005165,increased susceptibility to injury|MP:0005376,homeostasis/metabolism phenotype|MP:0005418,abnormal circulating hormone level|MP:0005610,increased circulating antidiuretic hormone level|MP:0005618,decreased urine potassium level|MP:0008560,increased tumor necrosis factor secretion|MP:0008663,increased interleukin-12 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0008845,abnormal paraventricular hypothalamic nucleus morphology|MP:0008846,abnormal supraoptic nucleus morphology|MP:0008918,microgliosis|MP:0009615,abnormal zinc homeostasis|MP:0011436,decreased urine magnesium level|MP:0011444,abnormal renal water homeostasis|MP:0011471,decreased urine creatinine level|MP:0011612,increased circulating ghrelin level|MP:0011939,increased food intake|MP:0011941,increased fluid intake
MGI:4949110	Grn<tm1.1Far>	MP:0002229,neurodegeneration|MP:0002451,abnormal macrophage physiology|MP:0003244,loss of dopaminergic neurons|MP:0004022,abnormal cone electrophysiology|MP:0004811,abnormal neuron physiology|MP:0006303,abnormal retina nerve fiber layer morphology|MP:0008056,abnormal retina ganglion cell morphology|MP:0008067,retina ganglion cell degeneration|MP:0008560,increased tumor necrosis factor secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008660,increased interleukin-10 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008918,microgliosis|MP:0010369,abnormal thalamus neuron morphology|MP:0011451,increased susceptibility to dopaminergic neuron neurotoxicity|MP:0011975,neuronal cytoplasmic inclusions|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:5443906	Grn<tm1.1Geno>	MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0001442,decreased grooming behavior|MP:0001463,abnormal spatial learning|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0003354,astrocytosis|MP:0003633,abnormal nervous system physiology|MP:0008918,microgliosis|MP:0008986,abnormal liver parenchyma morphology|MP:0010080,abnormal hepatocyte physiology|MP:0020427,increased hepatocyte karyomegaly
MGI:6150889	Grn<tm1.1Hiok>	MP:0000316,cellular necrosis|MP:0000788,abnormal cerebral cortex morphology|MP:0000798,abnormal frontal lobe morphology|MP:0000807,abnormal hippocampus morphology|MP:0000832,abnormal thalamus morphology|MP:0000897,abnormal midbrain morphology|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001405,impaired coordination|MP:0002175,decreased brain weight|MP:0004045,abnormal cell cycle checkpoint function|MP:0004250,tau protein deposits|MP:0008432,abnormal long-term spatial reference memory|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009454,impaired contextual conditioning behavior|MP:0011975,neuronal cytoplasmic inclusions|MP:0012307,impaired spatial learning|MP:0012448,abnormal primary motor cortex morphology|MP:0012489,abnormal retrosplenial region morphology|MP:0014062,nervous system inclusion bodies|MP:0020508,decreased dendritic spine density
MGI:4867226	Grn<tm1Blrl>	MP:0001360,abnormal social investigation|MP:0001405,impaired coordination|MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002797,increased thigmotaxis|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003354,astrocytosis|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0003862,decreased aggression towards male mice|MP:0005386,behavior/neurological phenotype|MP:0008143,abnormal dendrite morphology|MP:0008415,abnormal neurite morphology|MP:0008842,lipofuscinosis|MP:0008918,microgliosis|MP:0020508,decreased dendritic spine density
MGI:4949109	Grn<tm1Far>	MP:0003244,loss of dopaminergic neurons|MP:0004811,abnormal neuron physiology|MP:0008918,microgliosis|MP:0011451,increased susceptibility to dopaminergic neuron neurotoxicity
MGI:3762618	Grn<tm1Mni>	MP:0001354,increased aggression towards male mice|MP:0001363,increased anxiety-related response|MP:0001378,abnormal ejaculation
MGI:5811645	Grn<tm2.1Far>	MP:0001212,skin lesions|MP:0001441,increased grooming behavior|MP:0002083,premature death|MP:0002451,abnormal macrophage physiology|MP:0008770,decreased survivor rate|MP:0008842,lipofuscinosis|MP:0008918,microgliosis|MP:0009538,abnormal synapse morphology|MP:0010369,abnormal thalamus neuron morphology|MP:0011975,neuronal cytoplasmic inclusions
MGI:2671718	gro	MP:0001262,decreased body weight|MP:0001265,decreased body size
MGI:2671752	gro10	MP:0001265,decreased body size
MGI:2671753	gro14	MP:0001262,decreased body weight|MP:0001265,decreased body size
MGI:2671754	gro17	MP:0001262,decreased body weight|MP:0001265,decreased body size
MGI:2671748	gro2	MP:0001265,decreased body size
MGI:2671755	gro20	MP:0000274,enlarged heart|MP:0001265,decreased body size|MP:0002872,polycythemia
MGI:2671756	gro21	MP:0001265,decreased body size
MGI:2671720	gro22	MP:0001265,decreased body size|MP:0005179,decreased circulating cholesterol level
MGI:2671757	gro24	MP:0001262,decreased body weight|MP:0001265,decreased body size
MGI:2671758	gro25	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0005159,azoospermia
MGI:2671759	gro26	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0005159,azoospermia
MGI:2671760	gro27	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0008911,induced hyperactivity
MGI:2671761	gro28	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002083,premature death|MP:0010179,rough coat
MGI:2671762	gro29	MP:0001262,decreased body weight|MP:0001265,decreased body size
MGI:2671763	gro30	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002083,premature death
MGI:2671764	gro31	MP:0001262,decreased body weight|MP:0001265,decreased body size
MGI:2671765	gro32	MP:0001262,decreased body weight|MP:0001265,decreased body size
MGI:2671766	gro33	MP:0001265,decreased body size
MGI:2671767	gro34	MP:0001262,decreased body weight|MP:0001265,decreased body size
MGI:2671768	gro35	MP:0001262,decreased body weight|MP:0001265,decreased body size
MGI:2671769	gro36	MP:0001262,decreased body weight|MP:0001265,decreased body size
MGI:2671770	gro37	MP:0001265,decreased body size
MGI:2671771	gro38	MP:0001262,decreased body weight|MP:0001265,decreased body size
MGI:2671772	gro39	MP:0001265,decreased body size
MGI:2671749	gro4	MP:0001262,decreased body weight|MP:0001265,decreased body size
MGI:2671721	gro40	MP:0001265,decreased body size
MGI:2671722	gro41	MP:0001265,decreased body size
MGI:2671723	gro42	MP:0001265,decreased body size
MGI:2671773	gro43	MP:0001265,decreased body size
MGI:2671774	gro44	MP:0001265,decreased body size
MGI:2671776	gro45	MP:0001264,increased body size
MGI:2671777	gro46	MP:0001265,decreased body size|MP:0008911,induced hyperactivity
MGI:2671778	gro47	MP:0001265,decreased body size|MP:0008911,induced hyperactivity
MGI:2671779	gro48	MP:0001265,decreased body size|MP:0001399,hyperactivity
MGI:2671780	gro49	MP:0001265,decreased body size
MGI:2671781	gro50	MP:0001265,decreased body size|MP:0001399,hyperactivity
MGI:3033996	gro52	MP:0001265,decreased body size
MGI:3033997	gro53	MP:0001265,decreased body size
MGI:3033998	gro54	MP:0001265,decreased body size
MGI:3033999	gro55	MP:0001265,decreased body size
MGI:3034000	gro56	MP:0001265,decreased body size
MGI:3034001	gro57	MP:0001265,decreased body size
MGI:3034002	gro58	MP:0001265,decreased body size
MGI:3034003	gro59	MP:0001265,decreased body size
MGI:2671750	gro6	MP:0001265,decreased body size
MGI:3034004	gro60	MP:0001265,decreased body size
MGI:3034005	gro61	MP:0001265,decreased body size
MGI:3034006	gro62	MP:0001265,decreased body size
MGI:3034008	gro63	MP:0001265,decreased body size
MGI:3038751	gro64	MP:0001265,decreased body size
MGI:3038753	gro65	MP:0001265,decreased body size
MGI:3038756	gro66	MP:0001265,decreased body size
MGI:3041816	gro67	MP:0001265,decreased body size
MGI:3041817	gro68	MP:0001265,decreased body size
MGI:3041818	gro69	MP:0001265,decreased body size|MP:0002083,premature death
MGI:2671751	gro7	MP:0001265,decreased body size
MGI:3041819	gro70	MP:0001265,decreased body size
MGI:3043658	gro71	MP:0001265,decreased body size
MGI:3043659	gro72	MP:0001265,decreased body size
MGI:3043660	gro73	MP:0001265,decreased body size
MGI:3043661	gro74	MP:0001265,decreased body size
MGI:3043662	gro75	MP:0001265,decreased body size
MGI:3046705	gro76	MP:0001265,decreased body size
MGI:3046708	gro77	MP:0001265,decreased body size
MGI:3046711	gro78	MP:0001265,decreased body size
MGI:3046714	gro79	MP:0001265,decreased body size
MGI:3046717	gro80	MP:0001265,decreased body size
MGI:3046720	gro81	MP:0001265,decreased body size
MGI:3046723	gro82	MP:0001265,decreased body size
MGI:3046726	gro83	MP:0001265,decreased body size
MGI:3046729	gro84	MP:0001265,decreased body size
MGI:3046732	gro85	MP:0001265,decreased body size
MGI:3577439	gro86	MP:0001265,decreased body size|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3577441	gro87	MP:0001265,decreased body size
MGI:3577442	gro88	MP:0001265,decreased body size
MGI:3577443	gro89	MP:0001265,decreased body size
MGI:3577444	gro90	MP:0001265,decreased body size
MGI:3577445	gro91	MP:0001265,decreased body size
MGI:3577446	gro92	MP:0001265,decreased body size
MGI:3577447	gro93	MP:0001265,decreased body size
MGI:3577448	gro94	MP:0001265,decreased body size
MGI:4432720	Grpel1<tm1a(EUCOMM)Wtsi>	MP:0011092,embryonic lethality, complete penetrance
MGI:7410924	Grpel1<tm1c(EUCOMM)Wtsi>	MP:0000759,abnormal skeletal muscle morphology|MP:0001263,weight loss|MP:0002106,abnormal muscle physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005560,decreased circulating glucose level|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009417,skeletal muscle atrophy|MP:0009419,skeletal muscle fibrosis|MP:0010053,decreased grip strength
MGI:5749869	Grp<em1(IMPC)H>	MP:0000223,decreased monocyte cell number|MP:0000274,enlarged heart|MP:0002599,increased mean platelet volume|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:1857462	Grpr<tm1Jfb>	MP:0002169,no abnormal phenotype detected|MP:0005449,abnormal food intake
MGI:2388628	Grpr<tm1Wada>	MP:0001360,abnormal social investigation|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0031391,increased locomotor activity
MGI:5565455	Grp<tm1Jfb>	MP:0001440,abnormal grooming behavior
MGI:5636902	Grsf1<tm1b(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number
MGI:5513788	Grtp1<tm1b(EUCOMM)Hmgu>	MP:0001157,small seminal vesicle|MP:0001297,microphthalmia|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level
MGI:6342498	Grxcr1<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0002102,abnormal ear morphology|MP:0004738,abnormal auditory brainstem response|MP:0005178,increased circulating cholesterol level|MP:0009142,decreased prepulse inhibition
MGI:5792093	Grxcr1<mpc265H>	MP:0000034,abnormal inner ear vestibule morphology|MP:0001967,deafness
MGI:1856991	Grxcr1<pi>	MP:0000043,organ of Corti degeneration|MP:0001395,bidirectional circling|MP:0001409,increased stereotypic behavior|MP:0001410,head bobbing|MP:0001522,impaired swimming|MP:0001961,abnormal reflex|MP:0001967,deafness|MP:0002856,abnormal vestibular ganglion morphology|MP:0002857,cochlear ganglion degeneration|MP:0003149,abnormal tectorial membrane morphology|MP:0004249,abnormal crista ampullaris morphology|MP:0004331,vestibular saccular macula degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004363,stria vascularis degeneration|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004428,abnormal type I vestibular cell|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004534,decreased inner hair cell stereocilia number|MP:0004536,short inner hair cell stereocilia|MP:0004578,abnormal cochlear hair bundle tip links morphology|MP:0004742,abnormal vestibular system physiology|MP:0011063,absent inner hair cell kinocilia|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3027304	Grxcr1<pi-2J>	MP:0001395,bidirectional circling|MP:0001410,head bobbing|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0004742,abnormal vestibular system physiology|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3029627	Grxcr1<pi-3J>	MP:0001395,bidirectional circling|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0004536,short inner hair cell stereocilia|MP:0004742,abnormal vestibular system physiology|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4422102	Grxcr1<pi-4J>	MP:0001395,bidirectional circling|MP:0001410,head bobbing|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2681910	Grxcr1<pi-tde>	MP:0001394,circling|MP:0004324,vestibular hair cell degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004417,decreased cochlear nerve compound action potential|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004519,thin vestibular hair cell stereocilia|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004525,thin cochlear hair cell stereocilia|MP:0005307,head tossing
MGI:3513407	Grxcr1<pi-Tg(Eno2-Gabrb3)0370Brll>	MP:0001395,bidirectional circling|MP:0001410,head bobbing|MP:0001967,deafness|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004428,abnormal type I vestibular cell|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0006359,absent startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0031674,long inner hair cell stereocilia
MGI:5636505	Grxcr2<tm1.1Dck>	MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004814,reduced linear vestibular evoked potential|MP:0006325,impaired hearing|MP:0011062,abnormal outer hair cell kinocilium morphology|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6450519	Grxcr2<tm1Dck>	MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856892	gs	MP:0000400,abnormal awl hair morphology|MP:0000405,abnormal auchene hair morphology|MP:0000416,sparse hair|MP:0000420,ruffled hair|MP:0000422,delayed hair appearance|MP:0001192,scaly skin|MP:0001278,kinked vibrissae|MP:0006365,absent guard hair|MP:0006366,absent zigzag hairs|MP:0009703,decreased birth body size|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1861191	Gs	MP:0000402,abnormal zigzag hair morphology|MP:0000411,shiny fur|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0001510,abnormal coat appearance|MP:0002074,abnormal hair texture|MP:0003849,greasy coat|MP:0005409,darkened coat color|MP:0010179,rough coat
MGI:3630279	Gsc2<tm1Ais>	MP:0002169,no abnormal phenotype detected
MGI:3630276	Gsc2<tm1Bhr>	MP:0002169,no abnormal phenotype detected
MGI:1857726	Gsc<tm1Bhr>	MP:0000029,abnormal malleus morphology|MP:0000049,abnormal middle ear morphology|MP:0000088,short mandible|MP:0000107,abnormal frontal bone morphology|MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000428,abnormal craniofacial morphology|MP:0000454,abnormal jaw morphology|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0001436,abnormal suckling behavior|MP:0001951,abnormal breathing pattern|MP:0002233,abnormal nose morphology|MP:0002237,abnormal nasal cavity morphology|MP:0002238,abnormal nasal mucosa morphology|MP:0002239,abnormal nasal septum morphology|MP:0003138,absent tympanic ring|MP:0003235,abnormal alisphenoid bone morphology|MP:0003717,pallor|MP:0004452,abnormal pterygoid process morphology|MP:0004873,absent turbinates|MP:0005249,abnormal palatine bone morphology|MP:0005371,limbs/digits/tail phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006019,absent tympanic membrane|MP:0006033,abnormal external auditory canal morphology|MP:0008148,abnormal sternocostal joint morphology|MP:0008376,small malleus manubrium|MP:0008378,small malleus processus brevis|MP:0010029,abnormal basicranium morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0030209,abnormal extrinsic tongue muscle morphology|MP:0030210,abnormal genioglossus muscle morphology
MGI:1857496	Gsc<tm1Pgr>	MP:0000098,abnormal vomer bone morphology|MP:0000100,abnormal ethmoid bone morphology|MP:0000154,rib fusion|MP:0000458,abnormal mandible morphology|MP:0000460,mandible hypoplasia|MP:0000480,increased rib number|MP:0002237,abnormal nasal cavity morphology|MP:0002239,abnormal nasal septum morphology|MP:0002932,abnormal joint morphology|MP:0003110,absent malleus processus brevis|MP:0003138,absent tympanic ring|MP:0004234,abnormal masticatory muscle morphology|MP:0004448,abnormal presphenoid bone morphology|MP:0004450,presphenoid bone hypoplasia|MP:0004456,small pterygoid bone|MP:0004459,small alisphenoid bone|MP:0004475,palatine bone hypoplasia|MP:0004596,abnormal mandibular angle morphology|MP:0004615,cervical vertebral transformation|MP:0004627,abnormal trochanter morphology|MP:0004689,small ischium|MP:0004726,abnormal nasal capsule morphology|MP:0005249,abnormal palatine bone morphology|MP:0005296,abnormal humerus morphology|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006018,abnormal tympanic membrane morphology|MP:0006019,absent tympanic membrane|MP:0006020,decreased tympanic ring size|MP:0008148,abnormal sternocostal joint morphology|MP:0008376,small malleus manubrium|MP:0009546,absent gastric milk in neonates|MP:0009575,abnormal pubic symphysis morphology|MP:0009703,decreased birth body size|MP:0009707,absent external auditory canal|MP:0010029,abnormal basicranium morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0012069,abnormal horizontal basal cell of olfactory epithelium morphology|MP:0030059,absent ethmoturbinates|MP:0030187,abnormal epitympanic recess morphology|MP:0030208,abnormal intrinsic tongue muscle morphology|MP:0030266,small vomer bone|MP:0030283,small mandibular coronoid process|MP:0030305,small cribriform plate|MP:0030788,abnormal femur head morphology|MP:0030816,abnormal shoulder joint morphology|MP:0030828,abnormal obturator foramen morphology|MP:0030829,abnormal hip joint morphology|MP:0030830,abnormal acetabulum morphology|MP:0030831,abnormal glenoid fossa morphology|MP:0030832,abnormal scapular coracoid process morphology
MGI:4849547	Gsdma3<Ae>	MP:0000423,delayed hair regrowth|MP:0000427,abnormal hair cycle|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0001211,wrinkled skin|MP:0001222,epidermal hyperplasia|MP:0001314,cornea opacity|MP:0001510,abnormal coat appearance|MP:0002060,abnormal skin morphology|MP:0003810,abnormal hair cuticle|MP:0004947,skin inflammation|MP:0005501,abnormal skin physiology|MP:0008859,abnormal hair cycle catagen phase|MP:0009004,progressive hair loss|MP:0009351,thin hair shaft|MP:0009759,abnormal hair follicle bulge morphology|MP:0010678,abnormal skin adnexa morphology
MGI:1856680	Gsdma3<Bsk>	MP:0000414,alopecia|MP:0000416,sparse hair|MP:0001200,thick skin|MP:0001211,wrinkled skin|MP:0001314,cornea opacity|MP:0005389,reproductive system phenotype
MGI:2385837	Gsdma3<Dfl>	MP:0000397,abnormal guard hair morphology|MP:0000414,alopecia|MP:0001200,thick skin|MP:0001211,wrinkled skin|MP:0001314,cornea opacity
MGI:2661437	Gsdma3<Fgn>	MP:0000414,alopecia|MP:0000427,abnormal hair cycle
MGI:3838513	Gsdma3<M1Btlr>	MP:0000017,big ears|MP:0001211,wrinkled skin|MP:0001297,microphthalmia|MP:0001314,cornea opacity|MP:0002832,coarse hair|MP:0002881,long hair|MP:0009004,progressive hair loss
MGI:5566687	Gsdma3<M2Btlr>	MP:0001194,dermatitis|MP:0001212,skin lesions|MP:0003853,dry skin|MP:0009004,progressive hair loss|MP:0009859,eye opacity
MGI:5694663	Gsdma3<Mhdaclp1>	MP:0000414,alopecia|MP:0000648,absent sebaceous gland|MP:0011585,decreased alkaline phosphatase activity
MGI:3526126	Gsdma3<Rco2>	MP:0001191,abnormal skin condition|MP:0001510,abnormal coat appearance|MP:0002073,abnormal hair growth|MP:0003704,abnormal hair follicle development|MP:0010771,integument phenotype
MGI:1856139	Gsdma3<Re-Den>	MP:0001510,abnormal coat appearance
MGI:1861663	Gsdma3<Rim3>	MP:0000379,decreased hair follicle number|MP:0000416,sparse hair|MP:0000427,abnormal hair cycle|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001314,cornea opacity|MP:0001874,acanthosis|MP:0002073,abnormal hair growth|MP:0003095,abnormal cornea stroma development|MP:0006000,abnormal cornea epithelium morphology|MP:0008858,abnormal hair cycle anagen phase|MP:0009600,hypergranulosis|MP:0009742,increased cornea stroma thickness|MP:0020859,disorganized cornea epithelium
MGI:5085494	Gsdma3<tm1(KOMP)Vlcg>	MP:0000208,decreased hematocrit|MP:0002875,decreased erythrocyte cell number|MP:0005013,increased lymphocyte cell number|MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:7312160	Gsdma<em1Cya>	MP:0002412,increased susceptibility to bacterial infection|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:6860353	Gsdmc<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000220,increased monocyte cell number|MP:0000702,enlarged lymph nodes
MGI:5910442	Gsdmd<em1Flv>	MP:0005036,diarrhea|MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality
MGI:5776362	Gsdmd<em3Fcw>	MP:0008658,decreased interleukin-1 beta secretion|MP:0011073,abnormal macrophage apoptosis
MGI:6196334	Gsdmd<em4Fcw>	MP:0011073,abnormal macrophage apoptosis|MP:0020186,abnormal susceptibility to bacterial infection
MGI:6268770	Gsdmd<m1Btlr>	MP:0008658,decreased interleukin-1 beta secretion
MGI:3814179	Gsdmd<tm1.1Tshir>	MP:0002169,no abnormal phenotype detected
MGI:6196337	Gsdme<em1Fsha>	MP:0005166,decreased susceptibility to injury|MP:0005377,hearing/vestibular/ear phenotype
MGI:3583715	Gsdme<tm1Ant>	MP:0004401,increased cochlear outer hair cell number|MP:0004402,decreased cochlear outer hair cell number|MP:0005377,hearing/vestibular/ear phenotype
MGI:5692646	Gsdme<tm1b(KOMP)Wtsi>	MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010087,increased circulating fructosamine level
MGI:4455973	Gse1<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001262,decreased body weight|MP:0002875,decreased erythrocyte cell number|MP:0002896,abnormal bone mineralization|MP:0002968,increased circulating alkaline phosphatase level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0005568,increased circulating total protein level
MGI:2682762	Gsfrco010	MP:0000416,sparse hair
MGI:2682774	Gsfwnw	MP:0000372,irregular coat pigmentation|MP:0002098,abnormal vibrissa morphology
MGI:2682778	Gsfwt	MP:0011277,decreased tail pigmentation
MGI:6361165	Gsg1<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5817921	Gsg1l<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:6152496	Gsg1l<em1(IMPC)Mbp>	MP:0000063,decreased bone mineral density|MP:0002092,abnormal eye morphology|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:6505615	Gsg1l<tm1.2Tern>	MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003461,abnormal response to novel object|MP:0003635,abnormal synaptic transmission|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004924,abnormal behavior|MP:0005402,abnormal action potential|MP:0011269,increased excitatory postsynaptic current amplitude|MP:0011274,short excitatory postsynaptic current decay time
MGI:3589623	Gsi1<FGS/Kist>	MP:0005264,glomerulosclerosis
MGI:3589625	Gsi2<FGS/Kist>	MP:0005264,glomerulosclerosis
MGI:3771223	Gsk3a<tm1.1Jrw>	MP:0002891,increased insulin sensitivity|MP:0003960,increased lean body mass|MP:0005292,improved glucose tolerance|MP:0005459,decreased percent body fat/body weight|MP:0010400,increased liver glycogen level
MGI:5752934	Gsk3a<tm1.2Svij>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0009230,abnormal sperm head morphology|MP:0009831,abnormal sperm midpiece morphology
MGI:4436696	Gsk3a<tm1a(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0001406,abnormal gait
MGI:4434136	Gsk3a<tm1a(EUCOMM)Wtsi>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0003442,decreased circulating glycerol level|MP:0004647,decreased lumbar vertebrae number|MP:0005382,craniofacial phenotype|MP:0005560,decreased circulating glucose level|MP:0010025,decreased total body fat amount|MP:0010101,increased sacral vertebrae number|MP:0030431,wide metopic suture
MGI:5695125	Gsk3a<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0008935,decreased mean platelet volume
MGI:3578225	Gsk3a<tm1Dral>	MP:0002169,no abnormal phenotype detected|MP:0005376,homeostasis/metabolism phenotype
MGI:3830814	Gsk3b<tm1.1Atak>	MP:0001469,abnormal contextual conditioning behavior|MP:0002063,abnormal learning/memory/conditioning|MP:0002113,abnormal skeleton development|MP:0002999,abnormal bone healing|MP:0005386,behavior/neurological phenotype|MP:0008414,abnormal spatial reference memory|MP:0010878,increased trabecular bone volume|MP:0010964,increased compact bone volume
MGI:4867288	Gsk3b<tm1.1Ypc>	MP:0005382,craniofacial phenotype|MP:0009886,failure of palatal shelf elevation|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0010768,mortality/aging
MGI:4867289	Gsk3b<tm1.2Ypc>	MP:0009653,abnormal palate development|MP:0009886,failure of palatal shelf elevation|MP:0009888,palatal shelves fail to meet at midline|MP:0011087,neonatal lethality, complete penetrance|MP:0021213,complete cleft palate
MGI:3604596	Gsk3b<tm1Dgen>	MP:0002169,no abnormal phenotype detected|MP:0011100,preweaning lethality, complete penetrance
MGI:3578226	Gsk3b<tm1Dral>	MP:0003037,increased myocardial infarct size|MP:0003038,decreased myocardial infarct size|MP:0003896,prolonged PR interval|MP:0005376,homeostasis/metabolism phenotype|MP:0005438,abnormal glycogen homeostasis|MP:0010509,decreased P wave amplitude
MGI:3701999	Gsk3b<tm1Grc>	MP:0000060,delayed bone ossification|MP:0003037,increased myocardial infarct size|MP:0003038,decreased myocardial infarct size|MP:0004320,split sternum|MP:0004679,xiphoid process foramen|MP:0008277,abnormal sternum ossification|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance
MGI:1888887	Gsk3b<tm1Jrw>	MP:0000060,delayed bone ossification|MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0001417,decreased exploration in new environment|MP:0001533,abnormal skeleton physiology|MP:0002078,abnormal glucose homeostasis|MP:0002573,behavioral despair|MP:0002727,decreased circulating insulin level|MP:0004148,increased compact bone thickness|MP:0004320,split sternum|MP:0004679,xiphoid process foramen|MP:0004992,increased bone resorption|MP:0005006,abnormal osteoblast physiology|MP:0005560,decreased circulating glucose level|MP:0005605,increased bone mass|MP:0008277,abnormal sternum ossification|MP:0009142,decreased prepulse inhibition|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0010872,increased trabecular bone mass|MP:0010878,increased trabecular bone volume|MP:0010961,increased compact bone mass|MP:0011087,neonatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011710,enhanced osteoblast differentiation|MP:0020039,increased bone ossification
MGI:5440976	Gsk3b<tm2138.1Arte>	MP:0010653,abnormal Wallerian degeneration
MGI:3794785	Gsk3b<tm2Jrw>	MP:0002703,abnormal renal tubule morphology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005367,renal/urinary system phenotype|MP:0005440,increased glycogen level
MGI:5784741	Gskip<tm1.2Ekn>	MP:0000060,delayed bone ossification|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0003717,pallor|MP:0003756,abnormal hard palate morphology|MP:0005388,respiratory system phenotype|MP:0005390,skeleton phenotype|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0010819,primary atelectasis|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0020351,decreased vocalization|MP:0031460,abnormal palatal shelf morphology
MGI:2179509	Gsn<tm1Djk>	MP:0000067,osteopetrosis|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001533,abnormal skeleton physiology|MP:0001541,abnormal osteoclast physiology|MP:0001790,abnormal immune system physiology|MP:0001876,decreased inflammatory response|MP:0002083,premature death|MP:0002272,abnormal nervous system electrophysiology|MP:0002295,abnormal pulmonary circulation|MP:0002998,abnormal bone remodeling|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003070,increased vascular permeability|MP:0003076,increased susceptibility to ischemic brain injury|MP:0004148,increased compact bone thickness|MP:0004214,abnormal long bone diaphysis morphology|MP:0005023,abnormal wound healing|MP:0005508,abnormal skeleton morphology|MP:0005606,increased bleeding time|MP:0006060,increased cerebral infarct size|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0006298,abnormal platelet activation|MP:0008396,abnormal osteoclast differentiation|MP:0008719,impaired neutrophil recruitment|MP:0008720,impaired neutrophil chemotaxis|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0013782,abnormal mammary duct terminal end bud morphology
MGI:6414468	Gspt1<em1(IMPC)Bay>	MP:0001727,abnormal embryo implantation|MP:0002574,increased vertical activity|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:5635159	Gspt2<tm1.1(KOMP)Vlcg>	MP:0003795,abnormal bone structure|MP:0006243,impaired pupillary reflex
MGI:1857772	Gsr<a1Neu>	MP:0002169,no abnormal phenotype detected
MGI:6423838	Gsr<em1(IMPC)Mbp>	MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney
MGI:3530486	Gsr<Gt(OST124402)Lex>	MP:0002792,abnormal retina vasculature morphology
MGI:5287683	Gss<tm1Wink>	MP:0011092,embryonic lethality, complete penetrance
MGI:4430389	Gsta3<tm1Sell>	MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:3530889	Gsta4<Gt(OST203280)Lex>	MP:0005293,impaired glucose tolerance
MGI:5629310	Gsta4<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0002075,abnormal coat/hair pigmentation|MP:0002699,abnormal vitreous body morphology|MP:0010067,increased red blood cell distribution width
MGI:3032766	Gsta4<tm1Pzim>	MP:0000168,abnormal bone marrow development|MP:0001935,decreased litter size|MP:0002412,increased susceptibility to bacterial infection|MP:0002941,increased circulating alanine transaminase level|MP:0003674,oxidative stress|MP:0005266,abnormal metabolism|MP:0005343,increased circulating aspartate transaminase level
MGI:5605781	Gstcd<tm1b(EUCOMM)Wtsi>	MP:0000691,enlarged spleen|MP:0002335,decreased airway responsiveness|MP:0005566,decreased blood urea nitrogen level|MP:0005628,decreased circulating potassium level|MP:0008560,increased tumor necrosis factor secretion
MGI:5294676	Gstk1<tm1Pgb>	MP:0000539,distended urinary bladder|MP:0002083,premature death|MP:0002644,decreased circulating triglyceride level|MP:0002743,glomerulonephritis|MP:0002959,increased urine microalbumin level|MP:0003917,increased kidney weight|MP:0004851,increased testis weight|MP:0004893,decreased adiponectin level|MP:0004953,decreased spleen weight|MP:0005325,abnormal renal glomerulus morphology|MP:0005367,renal/urinary system phenotype|MP:0005384,cellular phenotype|MP:0008140,podocyte foot process effacement|MP:0008477,decreased spleen red pulp amount|MP:0009552,urinary bladder obstruction|MP:0009646,urinary bladder inflammation|MP:0010769,abnormal survival|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011763,urethritis
MGI:4456470	Gstm1<tm1Gcw>	MP:0001402,decreased locomotor activity|MP:0001906,increased dopamine level|MP:0002557,abnormal social/conspecific interaction behavior|MP:0003203,increased neuron apoptosis|MP:0008872,abnormal physiological response to xenobiotic|MP:0009745,abnormal behavioral response to xenobiotic|MP:0010069,increased serotonin level|MP:0031391,increased locomotor activity
MGI:3828070	Gstm1<tm1Kfuj>	MP:0008875,abnormal xenobiotic pharmacokinetics
MGI:5603358	Gstm4<tm2b(EUCOMM)Hmgu>	MP:0000689,abnormal spleen morphology|MP:0011239,abnormal skin coloration
MGI:6276837	Gstm5<em1(IMPC)Mbp>	MP:0001417,decreased exploration in new environment|MP:0002965,increased circulating serum albumin level|MP:0002968,increased circulating alkaline phosphatase level
MGI:6148222	Gstm6<tm1b(EUCOMM)Hmgu>	MP:0001566,increased circulating phosphate level|MP:0005560,decreased circulating glucose level|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount
MGI:3574914	Gstml<C57BL/6J>	MP:0010769,abnormal survival
MGI:3774328	Gsto1<del1Gab>	MP:0005376,homeostasis/metabolism phenotype
MGI:5827741	Gsto1<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001392,abnormal locomotor behavior|MP:0001488,increased startle reflex|MP:0001510,abnormal coat appearance|MP:0002075,abnormal coat/hair pigmentation|MP:0003961,decreased lean body mass|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:4840928	Gsto2<tm2a(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0002098,abnormal vibrissa morphology|MP:0002833,increased heart weight|MP:0010123,increased bone mineral content
MGI:3046099	Gstp1/Gstp2<tm1Wolf>	MP:0001260,increased body weight|MP:0002051,increased skin papilloma incidence
MGI:3046101	Gstp1/Gstp2<tm1Wolf>	MP:0001260,increased body weight|MP:0002051,increased skin papilloma incidence
MGI:4435247	Gstt1<tm1a(EUCOMM)Hmgu>	MP:0001402,decreased locomotor activity|MP:0005559,increased circulating glucose level
MGI:3828088	Gstt1<tm1Kfuj>	MP:0008875,abnormal xenobiotic pharmacokinetics
MGI:7783749	Gstt2<em1Rmah>	MP:0001846,increased inflammatory response|MP:0008560,increased tumor necrosis factor secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008660,increased interleukin-10 secretion|MP:0008663,increased interleukin-12 secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008872,abnormal physiological response to xenobiotic
MGI:3529566	Gstt2<Gt(OST236003)Lex>	MP:0002169,no abnormal phenotype detected
MGI:2183286	Gstz1<tm1Jmfc>	MP:0000598,abnormal liver morphology|MP:0002135,abnormal kidney morphology|MP:0002628,hepatic steatosis|MP:0002893,ketoaciduria|MP:0003674,oxidative stress|MP:0003946,renal necrosis|MP:0009640,abnormal renal tubule epithelium morphology|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011368,increased kidney apoptosis|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis
MGI:3050206	Gstz1<tm1Pgb>	MP:0000221,decreased leukocyte cell number|MP:0000316,cellular necrosis|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001654,hepatic necrosis|MP:0001860,liver inflammation|MP:0002083,premature death|MP:0002499,chronic inflammation|MP:0002837,dystrophic cardiac calcinosis|MP:0002981,increased liver weight|MP:0003917,increased kidney weight|MP:0004953,decreased spleen weight|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0014341,abnormal hepatocyte mitochondrial morphology|MP:0031115,macrovesicular hepatic steatosis
MGI:6324150	Gstz1<tm3b(EUCOMM)Hmgu>	MP:0001566,increased circulating phosphate level|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005627,increased circulating potassium level|MP:0011965,decreased total retina thickness
MGI:2154448	Gsx1<tm1Ssp>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000435,shortened head|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001290,delayed eyelid opening|MP:0001746,abnormal pituitary secretion|MP:0001752,abnormal hypothalamus secretion|MP:0001924,infertility|MP:0002083,premature death|MP:0002163,abnormal gland morphology|MP:0002164,abnormal gland physiology|MP:0003663,abnormal thermosensation|MP:0005016,decreased lymphocyte cell number|MP:0005361,small pituitary gland|MP:0006399,abnormal long bone epiphyseal ossification zone morphology|MP:0008321,small adenohypophysis|MP:0008329,decreased somatotroph cell number|MP:0008332,decreased lactotroph cell number|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014269,decreased testes secretion|MP:0014270,decreased ovary secretion
MGI:4412063	Gsx2<tm1.1Kc>	MP:0000913,abnormal brain development
MGI:2150162	Gsx2<tm1Ssp>	MP:0000828,abnormal fourth ventricle morphology|MP:0001575,cyanosis|MP:0001957,apnea|MP:0003232,abnormal forebrain development|MP:0004101,abnormal brain interneuron morphology|MP:0004103,abnormal ventral striatum morphology|MP:0004186,abnormal area postrema morphology|MP:0004277,abnormal lateral ganglionic eminence morphology|MP:0005039,hypoxia|MP:0005379,endocrine/exocrine gland phenotype|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0006108,abnormal hindbrain development|MP:0009546,absent gastric milk in neonates|MP:0011087,neonatal lethality, complete penetrance|MP:0012468,decreased striatum size
MGI:4412065	Gsx2<tm2.1Kc>	MP:0000819,abnormal olfactory bulb morphology|MP:0002169,no abnormal phenotype detected|MP:0004277,abnormal lateral ganglionic eminence morphology|MP:0009937,abnormal neuron differentiation
MGI:4412067	Gsx2<tm2.2Kc>	MP:0000787,abnormal telencephalon morphology|MP:0000934,abnormal telencephalon development|MP:0009937,abnormal neuron differentiation|MP:0012468,decreased striatum size
MGI:5503017	Gt(Ayu21-B137)Imeg	MP:0002169,no abnormal phenotype detected
MGI:5503018	Gt(Ayu21-B137)Imeg<tm1(CAG-Ptf1aos)Kymm>	MP:0002169,no abnormal phenotype detected
MGI:5503019	Gt(Ayu21-B137)Imeg<tm2(CAG-Ptf1aos*/Etn2*)Kymm>	MP:0002169,no abnormal phenotype detected
MGI:7431467	Gtf2a1l<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0002965,increased circulating serum albumin level|MP:0005568,increased circulating total protein level
MGI:5565081	Gtf2a1<tm1.1Jjdh>	MP:0001146,abnormal testis morphology|MP:0001153,small seminiferous tubules|MP:0001436,abnormal suckling behavior|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0008279,arrest of spermiogenesis|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014052,increased male germ cell apoptosis|MP:0014636,decreased elongated spermatid number
MGI:4363802	Gtf2a1<tm1a(KOMP)Wtsi>	MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:5513790	Gtf2b<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5752549	Gtf2e2<tm1b(EUCOMM)Wtsi>	MP:0002599,increased mean platelet volume|MP:0005553,increased circulating creatinine level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4432932	Gtf2h2<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6382787	Gtf2h3<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response|MP:0010392,prolonged QRS complex duration|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5514340	Gtf2h5<tm1.1Wive>	MP:0011085,postnatal lethality, complete penetrance
MGI:3831534	Gtf2i<Gt(RRI105)Byg>	MP:0011092,embryonic lethality, complete penetrance
MGI:3831531	Gtf2i<Gt(XC455)Byg>	MP:0011092,embryonic lethality, complete penetrance
MGI:3831527	Gtf2i<Gt(XE029)Byg>	MP:0000108,midline facial cleft|MP:0000292,distended pericardium|MP:0000428,abnormal craniofacial morphology|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0001265,decreased body size|MP:0001634,internal hemorrhage|MP:0001698,decreased embryo size|MP:0003742,narrow head|MP:0003873,pharyngeal arch hypoplasia|MP:0003984,embryonic growth retardation|MP:0004251,failure of heart looping|MP:0004557,dilated allantois|MP:0009657,failure of chorioallantoic fusion|MP:0011092,embryonic lethality, complete penetrance
MGI:3880452	Gtf2i<Gt(YTA365)Byg>	MP:0011092,embryonic lethality, complete penetrance
MGI:7610744	Gtf2ird1<em1(IMPC)Ccpcz>	MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0002092,abnormal eye morphology|MP:0002100,abnormal tooth morphology|MP:0002311,abnormal inspiratory capacity|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0008259,abnormal optic disk morphology|MP:0008935,decreased mean platelet volume|MP:0009142,decreased prepulse inhibition|MP:0010097,abnormal retina blood vessel morphology|MP:0010099,abnormal thoracic cage shape|MP:0010896,decreased lung compliance|MP:0010935,increased airway resistance|MP:0011044,increased lung elastance|MP:0011047,increased lung tissue damping
MGI:3831526	Gtf2ird1<Gt(XE465)Byg>	MP:0000108,midline facial cleft|MP:0000160,kyphosis|MP:0000292,distended pericardium|MP:0000373,belly spot|MP:0000428,abnormal craniofacial morphology|MP:0000440,domed cranium|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0001265,decreased body size|MP:0001634,internal hemorrhage|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0003229,abnormal vitelline vasculature morphology|MP:0003717,pallor|MP:0003742,narrow head|MP:0003873,pharyngeal arch hypoplasia|MP:0003984,embryonic growth retardation|MP:0004251,failure of heart looping|MP:0004376,absent frontal bone|MP:0004383,absent interparietal bone|MP:0004419,absent parietal bone|MP:0004443,absent supraoccipital bone|MP:0004557,dilated allantois|MP:0005352,small cranium|MP:0009657,failure of chorioallantoic fusion|MP:0010043,abnormal frontonasal suture morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2182322	Gtf2ird1<Tg(Alb1-Myc)166.8Sst>	MP:0000120,malocclusion|MP:0000445,short snout|MP:0000454,abnormal jaw morphology|MP:0000607,abnormal hepatocyte morphology|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001413,abnormal response to new environment|MP:0001431,abnormal eating behavior|MP:0001441,increased grooming behavior|MP:0001447,abnormal nest building behavior|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0001745,increased circulating corticosterone level|MP:0002065,abnormal fear/anxiety-related behavior|MP:0002757,decreased vertical activity|MP:0002981,increased liver weight|MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0008019,increased liver tumor incidence|MP:0008489,slow postnatal weight gain|MP:0008819,abnormal mastication|MP:0008862,asymmetric snout|MP:0010053,decreased grip strength|MP:0010166,increased response to stress-induced hyperthermia|MP:0020467,abnormal circadian behavior|MP:0030098,periorbital fullness
MGI:4454555	Gtf2ird1<tm1Hrd>	MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001262,decreased body weight|MP:0001282,short vibrissae|MP:0001283,sparse vibrissae|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001529,abnormal vocalization|MP:0001745,increased circulating corticosterone level|MP:0002263,abnormal laryngeal muscle morphology|MP:0003633,abnormal nervous system physiology|MP:0003743,abnormal facial morphology|MP:0004811,abnormal neuron physiology|MP:0005534,decreased body temperature|MP:0010025,decreased total body fat amount
MGI:3835413	Gtf2ird1<tm1Lro>	MP:0001265,decreased body size|MP:0001364,decreased anxiety-related response|MP:0001454,abnormal cued conditioning behavior|MP:0003460,decreased fear-related response|MP:0003863,decreased aggression towards mice|MP:0005322,abnormal serotonin level
MGI:3698407	Gtf2ird1<tm2Hrd>	MP:0004924,abnormal behavior|MP:0005382,craniofacial phenotype
MGI:5810123	Gtf2i<tm1.1Bdash>	MP:0002169,no abnormal phenotype detected
MGI:5810273	Gtf2i<tm1.2Bdash>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5532204	Gtf2i<tm1Vcam>	MP:0000428,abnormal craniofacial morphology|MP:0000445,short snout|MP:0000449,broad nasal bridge|MP:0001147,small testis|MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001672,abnormal embryo development|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002757,decreased vertical activity|MP:0003205,testicular atrophy|MP:0003631,nervous system phenotype|MP:0004924,abnormal behavior|MP:0005386,behavior/neurological phenotype|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011184,absent embryonic epiblast|MP:0011192,decreased embryonic epiblast cell proliferation
MGI:6257463	Gtf3c1<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:5287017	Gtf3c1<TgTn(sb-cHS4,Tyr)2344E-3Ove>	MP:0006204,embryonic lethality before implantation
MGI:4834341	Gt(MS-2.111)Pgr	MP:0002082,postnatal lethality
MGI:4834338	Gt(MS-2.44)Pgr	MP:0002169,no abnormal phenotype detected
MGI:3521912	Gt(OST75692)Lex	MP:0002080,prenatal lethality
MGI:5614568	Gtpbp10<tm1b(KOMP)Mbp>	MP:0001303,abnormal lens morphology|MP:0001312,abnormal cornea morphology|MP:0002098,abnormal vibrissa morphology|MP:0002591,decreased mean corpuscular volume|MP:0002626,increased heart rate|MP:0005553,increased circulating creatinine level|MP:0005564,increased hemoglobin content|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content|MP:0013278,decreased fasting circulating glucose level
MGI:2385801	Gtpbp1<tm1Ynim>	MP:0002169,no abnormal phenotype detected
MGI:5548500	Gtpbp2<tm1b(KOMP)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002792,abnormal retina vasculature morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4364401	Gtpbp3<tm1a(KOMP)Wtsi>	MP:0001711,abnormal placenta morphology|MP:0002836,abnormal chorion morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6362818	Gtpbp4<em1(IMPC)Tcp>	MP:0002075,abnormal coat/hair pigmentation|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6257770	Gtpbp6<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:1890203	Gt(ROSA)26Sor	MP:0002169,no abnormal phenotype detected
MGI:5705809	Gt(ROSA)26Sor<em1(CAG-cas9*,-EGFP)Rsky>	MP:0002169,no abnormal phenotype detected
MGI:8254642	Gt(ROSA)26Sor<em1(CAG-SNCA,-ZsGreen)Yfa>	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002229,neurodegeneration|MP:0002961,abnormal axon guidance|MP:0003244,loss of dopaminergic neurons|MP:0005156,bradykinesia|MP:0008143,abnormal dendrite morphology|MP:0009538,abnormal synapse morphology|MP:0020508,decreased dendritic spine density|MP:0020511,decreased dendritic spine length|MP:0021018,decreased dendritic spine number
MGI:6121115	Gt(ROSA)26Sor<em1(CAG-TMEM14B,-EGFP)Xqw>	MP:0000789,thickened cerebral cortex|MP:0002152,abnormal brain morphology|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0005238,increased brain size|MP:0008439,abnormal cortical plate morphology|MP:0008457,abnormal cortical intermediate zone morphology|MP:0008547,abnormal neocortex morphology|MP:0020067,increased neocortex size
MGI:7705191	Gt(ROSA)26Sor<em1(CAG-Zbtb21,-GFP)Jhan>	MP:0001473,reduced long-term potentiation|MP:0002206,abnormal CNS synaptic transmission|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008414,abnormal spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0012307,impaired spatial learning|MP:0020508,decreased dendritic spine density|MP:0020551,abnormal postsynaptic density morphology
MGI:6470593	Gt(ROSA)26Sor<em1(CAG-Zfas1)Cya>	MP:0002753,dilated heart left ventricle|MP:0003222,increased cardiomyocyte apoptosis|MP:0004231,abnormal calcium ion homeostasis|MP:0005140,decreased cardiac muscle contractility
MGI:6403442	Gt(ROSA)26Sor<em1(DPP4)Yowa>	MP:0002183,gliosis|MP:0020949,increased susceptibility to Coronaviridae infection
MGI:6163665	Gt(ROSA)26Sor<em1(ptxA)Btar>	MP:0001967,deafness|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004536,short inner hair cell stereocilia|MP:0011087,neonatal lethality, complete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:7626321	Gt(ROSA)26Sor<em1(Tbc1d15)Jren>	MP:0003038,decreased myocardial infarct size|MP:0006036,abnormal mitochondrial physiology|MP:0031216,decreased susceptibility to myocardial ischemic injury
MGI:6710954	Gt(ROSA)26Sor<em1(Tor1b)Wtd>	MP:0001262,decreased body weight|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging
MGI:7621224	Gt(ROSA)26Sor<em1(Ube2s)Chaw>	MP:0014436,decreased interferon level|MP:0031040,increased susceptibility to Picornaviridae infection induced morbidity/mortality
MGI:7748772	Gt(ROSA)26Sor<em5(CAG-KANK4,-tdTomato)Bcgen>	MP:0000259,abnormal vascular development|MP:0002128,abnormal blood circulation|MP:0002191,abnormal artery morphology|MP:0020329,decreased capillary density
MGI:7331585	Gt(ROSA)26Sor<em#(CAG-Fstl5)Jrio>	MP:0002764,short tibia|MP:0003109,short femur|MP:0010119,abnormal bone mineral density|MP:0020010,decreased bone mineral density of femur
MGI:5308583	Gt(ROSA)26Sor<tm10.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:5470254	Gt(ROSA)26Sor<tm10(Gata2)Jhai>	MP:0008762,embryonic lethality
MGI:5314029	Gt(ROSA)26Sor<tm10(Lmp1)Rsky>	MP:0000691,enlarged spleen|MP:0001790,abnormal immune system physiology|MP:0002144,abnormal B cell differentiation|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004939,abnormal B cell morphology|MP:0005014,increased B cell number|MP:0005017,decreased B cell number|MP:0005154,increased B cell proliferation|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008186,increased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5308582	Gt(ROSA)26Sor<tm10Sia>	MP:0002169,no abnormal phenotype detected
MGI:5308585	Gt(ROSA)26Sor<tm11.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:5496785	Gt(ROSA)26Sor<tm1.1(Aco1*)Mwh>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0002590,increased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005561,increased mean corpuscular hemoglobin|MP:0008807,increased liver iron level|MP:0008809,increased spleen iron level|MP:0010768,mortality/aging|MP:0020369,increased intestine iron level
MGI:6506458	Gt(ROSA)26Sor<tm1.1(Alb-PCSK9)Mby>	MP:0000182,increased circulating LDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005378,growth/size/body region phenotype
MGI:7449316	Gt(ROSA)26Sor<tm1.1(CAG-ATP1A3*D591V,-EGFP)Bcgen>	MP:0005253,abnormal eye physiology|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:5503124	Gt(ROSA)26Sor<tm11(CAG-Braf*/ERT2)Rkuhn>	MP:0002169,no abnormal phenotype detected
MGI:5583838	Gt(ROSA)26Sor<tm1.1(CAG-cas9*,-EGFP)Fezh>	MP:0002169,no abnormal phenotype detected
MGI:5318241	Gt(ROSA)26Sor<tm1.1(CAG-COX8A/Dendra2)Dcc>	MP:0002169,no abnormal phenotype detected
MGI:5484612	Gt(ROSA)26Sor<tm1.1(CAG-EGFP/Rpl10a,-birA)Wtp>	MP:0002169,no abnormal phenotype detected
MGI:4879001	Gt(ROSA)26Sor<tm1.1(CAG-Fto)Rdc>	MP:0000183,decreased circulating LDL cholesterol level|MP:0001260,increased body weight|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001556,increased circulating HDL cholesterol level|MP:0002079,increased circulating insulin level|MP:0003949,abnormal circulating lipid level|MP:0003953,abnormal hormone level|MP:0003960,increased lean body mass|MP:0004889,increased energy expenditure|MP:0004893,decreased adiponectin level|MP:0005293,impaired glucose tolerance|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0005669,increased circulating leptin level|MP:0009286,increased abdominal fat pad weight|MP:0010024,increased total body fat amount|MP:0011939,increased food intake
MGI:5304352	Gt(ROSA)26Sor<tm1.1(CAG-Insc/GFP)Jakn>	MP:0004980,increased neuronal precursor cell number
MGI:5792834	Gt(ROSA)26Sor<tm1.1(CAG-Mirc20)Eem>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000343,abnormal response to cardiac infarction|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0003223,decreased cardiomyocyte apoptosis|MP:0004215,abnormal myocardial fiber physiology|MP:0004565,decreased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0006321,increased myocardial fiber number|MP:0011394,increased fetal cardiomyocyte proliferation|MP:0014722,decreased polyploid cardiomyocyte number|MP:0014724,increased binucleate cardiomyocyte number|MP:0031645,increased myocardial fiber apoptosis
MGI:5496142	Gt(ROSA)26Sor<tm1.1(CAG-PSTPIP1)Dtg>	MP:0005387,immune system phenotype
MGI:6343570	Gt(ROSA)26Sor<tm1.1(CAG-SPAST*C448Y)Baas>	MP:0000745,tremors|MP:0000955,abnormal spinal cord morphology|MP:0001263,weight loss|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002878,abnormal corticospinal tract morphology|MP:0004768,abnormal axonal transport|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration
MGI:5617961	Gt(ROSA)26Sor<tm1.1(CAG-tdTomato,-EGFP)Pjen>	MP:0002169,no abnormal phenotype detected
MGI:4443071	Gt(ROSA)26Sor<tm1.1(CAG-Trp53*,-EGFP)Medz>	MP:0009542,decreased thymocyte apoptosis
MGI:5494989	Gt(ROSA)26Sor<tm1.1(CAG-Upp1,-GFP)Gp>	MP:0014174,decreased fatty acid beta-oxidation|MP:0031116,microvesicular hepatic steatosis
MGI:5698913	Gt(ROSA)26Sor<tm1.1(CAG-Venus,-Sdk2)Jrs>	MP:0005551,abnormal eye electrophysiology
MGI:6887963	Gt(ROSA)26Sor<tm1.1(CAG-YFP/DROSHA*E1147K)Gess>	MP:0000520,absent kidney|MP:0001732,postnatal growth retardation|MP:0002006,neoplasm|MP:0002703,abnormal renal tubule morphology|MP:0002962,increased urine protein level|MP:0003446,renal hypoplasia|MP:0005264,glomerulosclerosis|MP:0010768,mortality/aging|MP:0011334,abnormal nephrogenic zone morphology|MP:0011368,increased kidney apoptosis
MGI:4437208	Gt(ROSA)26Sor<tm1.1(CMV-luc,-ALPP)Cklr>	MP:0002169,no abnormal phenotype detected
MGI:5437345	Gt(ROSA)26Sor<tm1.1(Ctnna3)Jvh>	MP:0001713,decreased trophoblast giant cell number|MP:0009397,increased trophoblast giant cell number|MP:0010038,abnormal placenta physiology|MP:0010768,mortality/aging
MGI:5707276	Gt(ROSA)26Sor<tm1.1(DUX4*)Plj>	MP:0000160,kyphosis|MP:0000414,alopecia|MP:0000424,retarded hair growth|MP:0000493,rectal prolapse|MP:0000702,enlarged lymph nodes|MP:0000745,tremors|MP:0000751,myopathy|MP:0000752,dystrophic muscle|MP:0000955,abnormal spinal cord morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001393,ataxia|MP:0001523,impaired righting response|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002081,perinatal lethality|MP:0002109,abnormal limb morphology|MP:0003852,skeletal muscle necrosis|MP:0003866,abnormal defecation|MP:0004200,decreased fetal size|MP:0005088,increased acute inflammation|MP:0005369,muscle phenotype|MP:0009400,decreased skeletal muscle fiber size|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009419,skeletal muscle fibrosis|MP:0009635,enlarged popliteal lymph nodes|MP:0010053,decreased grip strength|MP:0010103,small thoracic cage|MP:0011092,embryonic lethality, complete penetrance|MP:0013905,preputial gland inflammation
MGI:3689411	Gt(ROSA)26Sor<tm1.1Fia>	MP:0002169,no abnormal phenotype detected
MGI:4939371	Gt(ROSA)26Sor<tm1.1(FLII)Hdc>	MP:0001792,impaired wound healing
MGI:5470256	Gt(ROSA)26Sor<tm11(Gata3)Jhai>	MP:0010768,mortality/aging
MGI:3696101	Gt(ROSA)26Sor<tm1.1Hjf>	MP:0002169,no abnormal phenotype detected
MGI:5512720	Gt(ROSA)26Sor<tm1.1Ksvo>	MP:0002169,no abnormal phenotype detected
MGI:5314030	Gt(ROSA)26Sor<tm11(Lmp1)Rsky>	MP:0000691,enlarged spleen|MP:0001790,abnormal immune system physiology|MP:0001829,increased activated T cell number|MP:0002144,abnormal B cell differentiation|MP:0002444,abnormal T cell physiology|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004939,abnormal B cell morphology|MP:0005014,increased B cell number|MP:0005017,decreased B cell number|MP:0005154,increased B cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008186,increased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5750303	Gt(ROSA)26Sor<tm1.1(Loxl2)Acan>	MP:0001846,increased inflammatory response|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002631,abnormal epididymis morphology|MP:0002656,abnormal keratinocyte differentiation|MP:0003596,epididymis inflammation|MP:0004499,increased incidence of tumors by chemical induction|MP:0004933,abnormal epididymis epithelium morphology|MP:0010308,decreased tumor latency|MP:0010639,abnormal tumor pathology|MP:0013600,testis degeneration|MP:0014186,epididymis hypertrophy|MP:0014187,spermatocele|MP:0014188,epididymis fibrosis|MP:0014192,increased epididymal cell proliferation|MP:0014194,increased epididymal epithelium cell proliferation
MGI:5292497	Gt(ROSA)26Sor<tm1.1Lrsn>	MP:0002169,no abnormal phenotype detected
MGI:4949242	Gt(ROSA)26Sor<tm1.1(Lyn/Celsr1/EGFP)Rodr>	MP:0011255,abnormal anterior visceral endoderm cell migration
MGI:5426507	Gt(ROSA)26Sor<tm1.1(Maml1/EGFP)Hri>	MP:0003934,abnormal pancreas development|MP:0009175,abnormal pancreatic beta cell differentiation
MGI:5559204	Gt(ROSA)26Sor<tm1.1(Mir26a-1)Coh>	MP:0009167,increased pancreatic islet number|MP:0011932,abnormal endocrine pancreas development
MGI:3821931	Gt(ROSA)26Sor<tm1.1(MYC/ERT2)Gev>	MP:0000351,increased cell proliferation|MP:0006042,increased apoptosis
MGI:4887449	Gt(ROSA)26Sor<tm1.1(Otx2)Daac>	MP:0011448,decreased dopaminergic neuron number|MP:0011452,decreased susceptibility to dopaminergic neuron neurotoxicity
MGI:3806367	Gt(ROSA)26Sor<tm1.1(PDGFB)Cbet>	MP:0003396,abnormal embryonic hematopoiesis|MP:0004076,abnormal vitelline vascular remodeling
MGI:5559321	Gt(ROSA)26Sor<tm1.1(Phc2*)Hko>	MP:0000480,increased rib number|MP:0003036,vertebral transformation|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004620,cervical vertebral fusion
MGI:3584145	Gt(ROSA)26Sor<tm1.1(rtTA2S*M2)Whsu>	MP:0002169,no abnormal phenotype detected
MGI:4443293	Gt(ROSA)26Sor<tm1.1(rtTA,tetO-cre)Bkmn>	MP:0002169,no abnormal phenotype detected
MGI:4462841	Gt(ROSA)26Sor<tm1.1(Sall1)Ryn>	MP:0001262,decreased body weight
MGI:5308584	Gt(ROSA)26Sor<tm11Sia>	MP:0002169,no abnormal phenotype detected
MGI:5052152	Gt(ROSA)26Sor<tm1.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:5524282	Gt(ROSA)26Sor<tm1.1(Sstr3/GFP)Bky>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0005389,reproductive system phenotype|MP:0009243,hairpin sperm flagellum
MGI:5574305	Gt(ROSA)26Sor<tm1.1(Ubc-BCL3)Sbn>	MP:0005093,decreased B cell proliferation|MP:0008173,increased follicular B cell number|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number
MGI:5316078	Gt(ROSA)26Sor<tm1.1(Ubc-ROCK1*)Dnsh>	MP:0002871,albuminuria|MP:0008059,abnormal podocyte foot process morphology|MP:0008140,podocyte foot process effacement|MP:0011353,expanded mesangial matrix
MGI:5547722	Gt(ROSA)26Sor<tm1.1(Wls/YFP)Mbtr>	MP:0000222,decreased neutrophil cell number
MGI:5308587	Gt(ROSA)26Sor<tm12.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:6267028	Gt(ROSA)26Sor<tm1.2(CAG-PLS3,-GFP)Bwir>	MP:0004148,increased compact bone thickness|MP:0004149,increased bone strength|MP:0004985,decreased osteoclast cell number|MP:0004993,decreased bone resorption|MP:0010869,decreased bone trabecula number|MP:0013630,increased bone trabecular spacing|MP:0013640,increased bone stiffness
MGI:5617963	Gt(ROSA)26Sor<tm1.2(CAG-tdTomato,-EGFP)Pjen>	MP:0002169,no abnormal phenotype detected
MGI:5308586	Gt(ROSA)26Sor<tm12Sia>	MP:0002169,no abnormal phenotype detected
MGI:5308589	Gt(ROSA)26Sor<tm13.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:5317935	Gt(ROSA)26Sor<tm1.3(CAG-mTFP1)Imayo>	MP:0002169,no abnormal phenotype detected
MGI:5617964	Gt(ROSA)26Sor<tm1.3(CAG-tdTomato,-EGFP)Pjen>	MP:0002169,no abnormal phenotype detected
MGI:5308588	Gt(ROSA)26Sor<tm13Sia>	MP:0002169,no abnormal phenotype detected
MGI:5308591	Gt(ROSA)26Sor<tm14.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:3809524	Gt(ROSA)26Sor<tm14(CAG-tdTomato)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5470260	Gt(ROSA)26Sor<tm14Jhai>	MP:0010768,mortality/aging
MGI:5308590	Gt(ROSA)26Sor<tm14Sia>	MP:0002169,no abnormal phenotype detected
MGI:5308594	Gt(ROSA)26Sor<tm15.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:5308592	Gt(ROSA)26Sor<tm15Sia>	MP:0002169,no abnormal phenotype detected
MGI:5308596	Gt(ROSA)26Sor<tm16.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:5502191	Gt(ROSA)26Sor<tm16Jhai>	MP:0005384,cellular phenotype
MGI:5308595	Gt(ROSA)26Sor<tm16Sia>	MP:0002169,no abnormal phenotype detected
MGI:5308598	Gt(ROSA)26Sor<tm17.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:5308597	Gt(ROSA)26Sor<tm17Sia>	MP:0002169,no abnormal phenotype detected
MGI:5491539	Gt(ROSA)26Sor<tm18.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:6195702	Gt(ROSA)26Sor<tm18(Zeb2)Jhai>	MP:0002083,premature death|MP:0010365,increased thymus tumor incidence|MP:0014049,increased T cell acute lymphoblastic leukemia incidence
MGI:5491541	Gt(ROSA)26Sor<tm19.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:5605718	Gt(ROSA)26Sor<tm1(ACTB-Map2k5*/EGFP)Zxi>	MP:0000812,abnormal dentate gyrus morphology|MP:0004811,abnormal neuron physiology|MP:0008414,abnormal spatial reference memory|MP:0008432,abnormal long-term spatial reference memory|MP:0012306,enhanced spatial learning|MP:0014368,enhanced long-term object recognition memory
MGI:5052130	Gt(ROSA)26Sor<tm1(Actb-Met)Fmai>	MP:0005391,vision/eye phenotype
MGI:5543261	Gt(ROSA)26Sor<tm1(Actb-T,-GFP)Dalco>	MP:0002169,no abnormal phenotype detected
MGI:7438178	Gt(ROSA)26Sor<tm1(ADGRG6)Jlp>	MP:0002169,no abnormal phenotype detected
MGI:4367459	Gt(ROSA)26Sor<tm1Afst>	MP:0002169,no abnormal phenotype detected
MGI:3512295	Gt(ROSA)26Sor<tm1(Akt1/EGFP)Glas>	MP:0003397,increased muscle weight|MP:0003398,increased skeletal muscle size|MP:0009399,increased skeletal muscle fiber size|MP:0010025,decreased total body fat amount
MGI:5582802	Gt(ROSA)26Sor<tm1(B4galt1)Clib>	MP:0001764,abnormal homeostasis|MP:0004843,abnormal Paneth cell morphology|MP:0005087,decreased acute inflammation|MP:0005381,digestive/alimentary phenotype|MP:0005397,hematopoietic system phenotype|MP:0008539,decreased susceptibility to induced colitis|MP:0008597,decreased circulating interleukin-6 level|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010377,abnormal gut flora balance
MGI:5925311	Gt(ROSA)26Sor<tm1(Bcor*A)Vjba>	MP:0000088,short mandible|MP:0000352,decreased cell proliferation|MP:0000445,short snout|MP:0000550,abnormal forelimb morphology|MP:0000841,abnormal hindbrain morphology|MP:0002092,abnormal eye morphology|MP:0009278,abnormal bone marrow cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5496634	Gt(ROSA)26Sor<tm1(Bmi1)Aiwa>	MP:0004809,increased hematopoietic stem cell number|MP:0005397,hematopoietic system phenotype|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011902,increased hematopoietic stem cell proliferation
MGI:5508369	Gt(ROSA)26Sor<tm1(Cacna1c*)Red>	MP:0002882,abnormal neuron morphology|MP:0003233,prolonged QT interval|MP:0004593,long mandible|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype
MGI:5804675	Gt(ROSA)26Sor<tm1(CAG-AR)Zsu>	MP:0002018,increased malignant tumor incidence|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence
MGI:5574111	Gt(ROSA)26Sor<tm1(CAG-Bcl3,-EGFP)Hoev>	MP:0000691,enlarged spleen|MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0004816,abnormal class switch recombination|MP:0004978,decreased B-1 B cell number|MP:0005013,increased lymphocyte cell number|MP:0005093,decreased B cell proliferation|MP:0008166,abnormal B-2 B cell morphology|MP:0008168,decreased B-1a cell number|MP:0008172,abnormal follicular B cell morphology|MP:0008182,decreased marginal zone B cell number|MP:0008183,absent marginal zone B cells|MP:0008215,decreased immature B cell number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008783,decreased B cell apoptosis|MP:0009921,abnormal transitional stage T3 B cell morphology|MP:0009923,decreased transitional stage T1 B cell number
MGI:5304351	Gt(ROSA)26Sor<tm1(CAG-Bgeo,-Insc/GFP)Jakn>	MP:0000788,abnormal cerebral cortex morphology|MP:0000789,thickened cerebral cortex|MP:0000790,abnormal stratification in cerebral cortex|MP:0000913,abnormal brain development|MP:0002064,seizures|MP:0002882,abnormal neuron morphology|MP:0003648,abnormal radial glial cell morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0008439,abnormal cortical plate morphology|MP:0008457,abnormal cortical intermediate zone morphology|MP:0008947,increased neuron number
MGI:4398910	Gt(ROSA)26Sor<tm1(CAG-Bmi1,-EGFP)Nki>	MP:0000659,prostate gland hyperplasia|MP:0002006,neoplasm|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0010299,increased mammary gland tumor incidence|MP:0010320,increased pituitary gland tumor incidence
MGI:5305709	Gt(ROSA)26Sor<tm1(CAG-Bmpr1a)Que>	MP:0000468,abnormal esophageal epithelium morphology|MP:0010784,abnormal forestomach morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5927425	Gt(ROSA)26Sor<tm1(CAG-CAMK2G*T287D,-EGFP)Whua>	MP:0004499,increased incidence of tumors by chemical induction|MP:0005381,digestive/alimentary phenotype|MP:0008539,decreased susceptibility to induced colitis
MGI:5583839	Gt(ROSA)26Sor<tm1(CAG-cas9*,-EGFP)Fezh>	MP:0002169,no abnormal phenotype detected|MP:0006068,abnormal retina horizontal cell morphology
MGI:5614050	Gt(ROSA)26Sor<tm1(CAG-CHRM4*,-mCitrine)Ute>	MP:0002169,no abnormal phenotype detected
MGI:5301821	Gt(ROSA)26Sor<tm1(CAG-COP4*E123T*H134R,-tdTomato)Gfng>	MP:0002169,no abnormal phenotype detected
MGI:5573198	Gt(ROSA)26Sor<tm1(CAG-ECFP/EYFP*)Phep>	MP:0002169,no abnormal phenotype detected
MGI:3850169	Gt(ROSA)26Sor<tm1(CAG-EGFP)Blh>	MP:0002169,no abnormal phenotype detected
MGI:3623345	Gt(ROSA)26Sor<tm1(CAG-EGFP)Luo>	MP:0002169,no abnormal phenotype detected
MGI:5484611	Gt(ROSA)26Sor<tm1(CAG-EGFP/Rpl10a,-birA)Wtp>	MP:0002169,no abnormal phenotype detected
MGI:5564783	Gt(ROSA)26Sor<tm1(CAG-EGFP/Vamp2)Ggc>	MP:0002169,no abnormal phenotype detected
MGI:5707028	Gt(ROSA)26Sor<tm1(CAG-Errfi1)Jwj>	MP:0002169,no abnormal phenotype detected
MGI:5527402	Gt(ROSA)26Sor<tm1(CAG-Etv2,-GFP)Hkata>	MP:0001577,anemia|MP:0001914,hemorrhage|MP:0002123,abnormal definitive hematopoiesis|MP:0002169,no abnormal phenotype detected|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002398,abnormal bone marrow cell morphology/development|MP:0003229,abnormal vitelline vasculature morphology|MP:0005380,embryo phenotype|MP:0005385,cardiovascular system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0010768,mortality/aging|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5613106	Gt(ROSA)26Sor<tm1(CAG-Foxn1/ERT2,-GFP)Cbln>	MP:0001824,abnormal thymus involution|MP:0005015,increased T cell number|MP:0005379,endocrine/exocrine gland phenotype
MGI:5447989	Gt(ROSA)26Sor<tm1(CAG-FOXO1,GFP)Moli>	MP:0005387,immune system phenotype
MGI:5301865	Gt(ROSA)26Sor<tm1(CAG-GFP/Eif2c2)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:3838361	Gt(ROSA)26Sor<tm1(CAG-Kcnj11*,-GFP)Nich>	MP:0000188,abnormal circulating glucose level|MP:0001559,hyperglycemia|MP:0001944,abnormal pancreas morphology|MP:0002695,abnormal circulating glucagon level|MP:0002696,decreased circulating glucagon level|MP:0002712,increased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005215,abnormal pancreatic islet morphology|MP:0005216,abnormal pancreatic alpha cell morphology|MP:0008489,slow postnatal weight gain|MP:0009109,decreased pancreas weight|MP:0009168,decreased pancreatic islet number|MP:0009172,small pancreatic islets|MP:0009177,decreased pancreatic alpha cell number
MGI:3840211	Gt(ROSA)26Sor<tm1(CAG-lacZ,-EGFP)Glh>	MP:0000267,abnormal heart development|MP:0011087,neonatal lethality, complete penetrance
MGI:6407423	Gt(ROSA)26Sor<tm1(CAG-LMNA*)Cyh>	MP:0000160,kyphosis|MP:0000752,dystrophic muscle|MP:0000759,abnormal skeletal muscle morphology|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0002083,premature death|MP:0002970,abnormal white adipose tissue morphology|MP:0003111,abnormal cell nucleus morphology|MP:0003233,prolonged QT interval|MP:0004819,decreased skeletal muscle mass|MP:0005290,decreased oxygen consumption|MP:0005333,decreased heart rate|MP:0005424,jerky movement|MP:0005534,decreased body temperature|MP:0008964,decreased carbon dioxide production|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0010378,increased respiratory quotient|MP:0011635,abnormal mitochondrial crista morphology|MP:0014143,decreased body fat mass|MP:0020234,decreased basal metabolism|MP:0020354,increased endoplasmic reticulum stress
MGI:4441172	Gt(ROSA)26Sor<tm1(CAG-Lmx1b,ALPP)Rjo>	MP:0000574,abnormal foot pad morphology|MP:0004819,decreased skeletal muscle mass|MP:0005503,abnormal tendon morphology|MP:0005508,abnormal skeleton morphology|MP:0030835,abnormal ankle joint morphology
MGI:5581667	Gt(ROSA)26Sor<tm1(CAG-Mafb,-tdTomato)Good>	MP:0002855,abnormal cochlear ganglion morphology|MP:0003631,nervous system phenotype|MP:0004562,abnormal inner hair cell synaptic ribbon morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5494696	Gt(ROSA)26Sor<tm1(CAG-MAP2K7*/MAPK8,-EGFP)Ftw>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype
MGI:5629288	Gt(ROSA)26Sor<tm1(CAG-MFN2*T105M)Dple>	MP:0000377,abnormal hair follicle morphology|MP:0000920,abnormal myelination|MP:0001407,short stride length|MP:0001954,respiratory distress|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0003081,abnormal soleus morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003631,nervous system phenotype|MP:0005324,ascites|MP:0006035,abnormal mitochondrial morphology|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009413,skeletal muscle fiber atrophy|MP:0011629,decreased mitochondrial number
MGI:5702434	Gt(ROSA)26Sor<tm1(CAG-Mir182)Dgk>	MP:0002169,no abnormal phenotype detected
MGI:5474351	Gt(ROSA)26Sor<tm1(CAG-Mir21)Jake>	MP:0002182,abnormal astrocyte morphology|MP:0005164,abnormal response to injury|MP:0005165,increased susceptibility to injury|MP:0008916,abnormal astrocyte physiology
MGI:5907349	Gt(ROSA)26Sor<tm1(CAG-Mlip)Dzw>	MP:0004486,decreased response of heart to induced stress|MP:0005385,cardiovascular system phenotype
MGI:6196127	Gt(ROSA)26Sor<tm1(CAG-MYCN,-luc)Jhsc>	MP:0002039,increased neuroblastoma incidence|MP:0008301,adrenal medulla hyperplasia
MGI:5502770	Gt(ROSA)26Sor<tm1(CAG-NPM1*)Geno>	MP:0000229,abnormal megakaryocyte differentiation|MP:0000691,enlarged spleen|MP:0003179,thrombocytopenia|MP:0004720,abnormal platelet morphology|MP:0008254,increased megakaryocyte cell number|MP:0010373,myeloid hyperplasia
MGI:5750673	Gt(ROSA)26Sor<tm1(CAG-Nr2f2)Tsa>	MP:0000274,enlarged heart|MP:0001544,abnormal cardiovascular system physiology|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0005140,decreased cardiac muscle contractility|MP:0005290,decreased oxygen consumption|MP:0005621,abnormal cell physiology|MP:0006036,abnormal mitochondrial physiology|MP:0010955,abnormal respiratory electron transport chain|MP:0010959,abnormal oxidative phosphorylation|MP:0011633,abnormal mitochondrial shape|MP:0011634,abnormal mitochondrial inner membrane morphology|MP:0014172,decreased fatty acid oxidation
MGI:5052133	Gt(ROSA)26Sor<tm1(CAG-PIK3CA*H1047R,-EGFP)Balj>	MP:0001883,increased mammary adenocarcinoma incidence|MP:0002083,premature death|MP:0006271,abnormal involution of the mammary gland|MP:0010299,increased mammary gland tumor incidence
MGI:5484551	Gt(ROSA)26Sor<tm1(CAG-PLS3,-GFP)Bwir>	MP:0003631,nervous system phenotype|MP:0005369,muscle phenotype
MGI:5496233	Gt(ROSA)26Sor<tm1(CAG-PSTPIP1)Dtg>	MP:0002169,no abnormal phenotype detected
MGI:6378624	Gt(ROSA)26Sor<tm1(CAG-PTPN1,-EGFP)Mtr>	MP:0005305,prostate gland anterior lobe hyperplasia|MP:0009219,increased prostate intraepithelial neoplasia incidence
MGI:5550559	Gt(ROSA)26Sor<tm1(CAG-RABVgp4,-TVA)Arenk>	MP:0002169,no abnormal phenotype detected
MGI:4939476	Gt(ROSA)26Sor<tm1(CAG-Rheb*)Pfw>	MP:0000788,abnormal cerebral cortex morphology|MP:0000789,thickened cerebral cortex|MP:0002176,increased brain weight|MP:0005238,increased brain size|MP:0005603,neuron hypertrophy|MP:0010050,hypermyelination|MP:0010160,increased oligodendrocyte number
MGI:5052360	Gt(ROSA)26Sor<tm1(CAG-Rhoj,-EGFP)Auem>	MP:0000259,abnormal vascular development|MP:0002792,abnormal retina vasculature morphology|MP:0003984,embryonic growth retardation|MP:0009660,abnormal induced retina neovascularization|MP:0011091,prenatal lethality, complete penetrance
MGI:8207504	Gt(ROSA)26Sor<tm1(CAG-SETBP1*G870S,-EGFP)Ase>	MP:0000172,abnormal bone marrow cell number|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000433,microcephaly|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000822,abnormal brain ventricle morphology|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002417,abnormal megakaryocyte morphology|MP:0003179,thrombocytopenia|MP:0003648,abnormal radial glial cell morphology|MP:0003984,embryonic growth retardation|MP:0004230,abnormal embryonic erythrocyte morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0005202,lethargy|MP:0009937,abnormal neuron differentiation|MP:0010373,myeloid hyperplasia|MP:0011747,myelofibrosis|MP:0013663,increased myeloid cell number|MP:0013891,increased common myeloid progenitor cell number|MP:0014257,embryonic lethality prior to tooth bud stage, complete penetrance|MP:0020389,increased radial glial cell number|MP:0020838,increased acute myeloid leukemia incidence|MP:0031058,hepatosplenomegaly
MGI:6159129	Gt(ROSA)26Sor<tm1(CAG-Slc39a14*L438R)Wvh>	MP:0000061,fragile skeleton|MP:0000558,abnormal tibia morphology|MP:0003797,abnormal compact bone morphology|MP:0004984,increased osteoclast cell number|MP:0005006,abnormal osteoblast physiology|MP:0005382,craniofacial phenotype|MP:0008152,decreased diameter of femur|MP:0008156,decreased diameter of tibia|MP:0009347,increased trabecular bone thickness|MP:0010868,increased bone trabecula number|MP:0010869,decreased bone trabecula number|MP:0010873,decreased trabecular bone mass|MP:0010878,increased trabecular bone volume|MP:0010879,decreased trabecular bone volume|MP:0010933,decreased trabecular bone connectivity density|MP:0013623,increased femur compact bone thickness|MP:0013630,increased bone trabecular spacing|MP:0013631,decreased bone trabecular spacing|MP:0013638,decreased femur stiffness|MP:0020039,increased bone ossification|MP:0020040,decreased bone ossification|MP:0020080,increased bone mineralization|MP:0020137,decreased bone mineralization
MGI:6473659	Gt(ROSA)26Sor<tm1(CAG-SNCA)Tanj>	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0002882,abnormal neuron morphology|MP:0003631,nervous system phenotype|MP:0003634,abnormal glial cell morphology|MP:0008493,alpha-synuclein inclusion body
MGI:4820800	Gt(ROSA)26Sor<tm1(CAG-Sox2,-EGFP)Blh>	MP:0001175,abnormal lung morphology|MP:0001954,respiratory distress|MP:0002006,neoplasm|MP:0002027,increased lung adenocarcinoma incidence|MP:0002083,premature death|MP:0005488,bronchial epithelial hyperplasia|MP:0010910,bronchiolar epithelial hyperplasia|MP:0010945,lung epithelium hyperplasia
MGI:8259352	Gt(ROSA)26Sor<tm1(CAG-STAT5B*N642H,-EGFP)Biat>	MP:0000321,increased bone marrow cell number|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001263,weight loss|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002398,abnormal bone marrow cell morphology/development|MP:0004809,increased hematopoietic stem cell number|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005068,abnormal NK cell morphology|MP:0008044,increased NK cell number|MP:0008045,decreased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0010766,abnormal NK cell physiology|MP:0011181,increased hematopoietic cell number|MP:0013673,increased mature NK cell number
MGI:5504463	Gt(ROSA)26Sor<tm1(CAG-tdTomato*,-EGFP*)Ees>	MP:0002169,no abnormal phenotype detected
MGI:4443069	Gt(ROSA)26Sor<tm1(CAG-Trp53*,-EGFP)Medz>	MP:0001545,abnormal hematopoietic system physiology|MP:0005397,hematopoietic system phenotype
MGI:5787602	Gt(ROSA)26Sor<tm1(CAG-Wnt5a,-AcGFP)Skde>	MP:0001120,abnormal uterus morphology|MP:0001672,abnormal embryo development|MP:0001711,abnormal placenta morphology|MP:0001729,impaired embryo implantation|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0004256,abnormal maternal decidual layer morphology|MP:0005389,reproductive system phenotype|MP:0009352,impaired spacing of implantation sites|MP:0009353,twin decidual capsule|MP:0009663,abnormal uterine-embryonic axis|MP:0009666,abnormal embryo attachment|MP:0010039,abnormal trophoblast giant cell proliferation|MP:0011521,decreased placental labyrinth size
MGI:3774555	Gt(ROSA)26Sor<tm1(Cdkn1b)Dor>	MP:0000280,thin ventricular wall|MP:0002740,heart hypoplasia
MGI:5492378	Gt(ROSA)26Sor<tm1(Cdkn1c)Jfpa>	MP:0003022,increased coronary flow rate|MP:0003038,decreased myocardial infarct size|MP:0010754,abnormal heart left ventricle pressure
MGI:2669525	Gt(ROSA)26Sor<tm1(cre/ERT)Nat>	MP:0002169,no abnormal phenotype detected
MGI:3815322	Gt(ROSA)26Sor<tm1(Crh)Jde>	MP:0000950,abnormal seizure response to pharmacological agent|MP:0001363,increased anxiety-related response|MP:0008236,decreased susceptibility to neuronal excitotoxicity
MGI:3664628	Gt(ROSA)26Sor<tm1(CTNNB1)Nerl>	MP:0000172,abnormal bone marrow cell number|MP:0000221,decreased leukocyte cell number|MP:0000334,decreased granulocyte number|MP:0001577,anemia|MP:0001602,impaired myelopoiesis|MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0002083,premature death|MP:0002416,abnormal proerythroblast morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0005089,decreased double-negative T cell number|MP:0005387,immune system phenotype
MGI:3834604	Gt(ROSA)26Sor<tm1(Dkk1)Flng>	MP:0000557,absent hindlimb|MP:0014321,short forelimb
MGI:3610389	Gt(ROSA)26Sor<tm1(DTA)Jpmb>	MP:0000298,absent atrioventricular cushions|MP:0000471,abnormal stomach epithelium morphology|MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000921,demyelination|MP:0000929,open neural tube|MP:0000966,decreased sensory neuron number|MP:0001263,weight loss|MP:0001393,ataxia|MP:0001516,abnormal motor coordination/balance|MP:0001614,abnormal blood vessel morphology|MP:0001636,irregular heartbeat|MP:0001698,decreased embryo size|MP:0001777,abnormal body temperature homeostasis|MP:0001829,increased activated T cell number|MP:0001844,autoimmune response|MP:0001876,decreased inflammatory response|MP:0001914,hemorrhage|MP:0001973,increased thermal nociceptive threshold|MP:0002064,seizures|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002188,small heart|MP:0002735,abnormal chemical nociception|MP:0002989,small kidney|MP:0003141,cardiac fibrosis|MP:0003229,abnormal vitelline vasculature morphology|MP:0003289,abnormal intestinal peristalsis|MP:0003631,nervous system phenotype|MP:0003632,abnormal nervous system morphology|MP:0003635,abnormal synaptic transmission|MP:0003865,lymph node inflammation|MP:0003873,pharyngeal arch hypoplasia|MP:0003896,prolonged PR interval|MP:0003928,increased heart rate variability|MP:0004021,abnormal rod electrophysiology|MP:0004115,abnormal sinoatrial node morphology|MP:0004505,decreased renal glomerulus number|MP:0004787,abnormal dorsal aorta morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005333,decreased heart rate|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0005405,axon degeneration|MP:0005548,retina pigment epithelium atrophy|MP:0006001,abnormal intestinal transit time|MP:0006082,CNS inflammation|MP:0008026,abnormal brain white matter morphology|MP:0009808,decreased oligodendrocyte number|MP:0009854,impaired gastric peristalsis|MP:0010073,decreased pruritus|MP:0010519,atrioventricular block|MP:0010809,abnormal club cell morphology|MP:0010918,abnormal pulmonary neuroendocrine body morphology|MP:0011082,abnormal gastrointestinal motility|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011388,absent heart|MP:0011731,decreased myelin sheath thickness|MP:0012089,decreased midbrain size|MP:0012133,absent midbrain-hindbrain boundary|MP:0021107,retina fold|MP:0030992,atrioventricular cushion hypoplasia
MGI:5528898	Gt(ROSA)26Sor<tm1(DTA)Kio>	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0009164,exocrine pancreas atrophy
MGI:3829362	Gt(ROSA)26Sor<tm1(DTA)Lky>	MP:0000313,abnormal cell death|MP:0000689,abnormal spleen morphology|MP:0000955,abnormal spinal cord morphology|MP:0001265,decreased body size|MP:0001925,male infertility|MP:0002347,abnormal lymph node T cell domain morphology|MP:0003154,abnormal soft palate morphology|MP:0004163,abnormal adenohypophysis morphology|MP:0004974,decreased regulatory T cell number|MP:0005012,decreased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005092,decreased double-positive T cell number|MP:0005379,endocrine/exocrine gland phenotype|MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008040,decreased NK T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008335,decreased gonadotroph cell number|MP:0008495,decreased IgG1 level|MP:0008673,decreased interleukin-13 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0008754,abnormal T cell receptor V(D)J recombination|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0021202,abnormal palatopharyngeus muscle morphology|MP:0021204,abnormal superior pharyngeal constrictor muscle morphology|MP:0030224,abnormal soft palate muscle morphology|MP:0030292,abnormal tensor veli palatini muscle morphology|MP:0030294,abnormal levator veli palatini muscle morphology|MP:0031462,decreased palatal shelf size
MGI:3618991	Gt(ROSA)26Sor<tm1(DTA)Mrc>	MP:0000088,short mandible|MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000428,abnormal craniofacial morphology|MP:0000599,enlarged liver|MP:0000729,abnormal myogenesis|MP:0000746,weakness|MP:0000750,abnormal muscle regeneration|MP:0000939,decreased motor neuron number|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001265,decreased body size|MP:0001325,abnormal retina morphology|MP:0001505,hunched posture|MP:0001577,anemia|MP:0002083,premature death|MP:0002108,abnormal muscle morphology|MP:0002111,abnormal tail morphology|MP:0002115,abnormal limb bone morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003052,omphalocele|MP:0003054,spina bifida|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003257,abnormal abdominal wall morphology|MP:0003450,enlarged pancreas|MP:0003647,absent oligodendrocytes|MP:0003833,decreased satellite cell number|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005369,muscle phenotype|MP:0005380,embryo phenotype|MP:0005547,abnormal Muller cell morphology|MP:0005551,abnormal eye electrophysiology|MP:0006408,dorsal root ganglion hypoplasia|MP:0008146,asymmetric sternocostal joints|MP:0008449,abnormal retina cone cell outer segment morphology|MP:0008489,slow postnatal weight gain|MP:0008586,disorganized photoreceptor outer segment|MP:0008852,retina neovascularization|MP:0009419,skeletal muscle fibrosis|MP:0009516,enlarged salivary gland|MP:0010097,abnormal retina blood vessel morphology|MP:0010235,abnormal retina inner limiting membrane morphology|MP:0010236,abnormal retina outer limiting membrane morphology|MP:0010768,mortality/aging|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012174,flat head|MP:0012709,delayed caudal neuropore closure|MP:0013239,impaired skeletal muscle regeneration|MP:0013482,abnormal duodenum crypts of Lieberkuhn morphology|MP:0013483,abnormal jejunum crypts of Lieberkuhn morphology|MP:0014179,abnormal blood-retina barrier function|MP:0030091,macrodontia
MGI:3055489	Gt(ROSA)26Sor<tm1(DTA)Riet>	MP:0000745,tremors|MP:0000788,abnormal cerebral cortex morphology|MP:0000921,demyelination|MP:0001127,small ovary|MP:0001260,increased body weight|MP:0001263,weight loss|MP:0002083,premature death|MP:0002206,abnormal CNS synaptic transmission|MP:0002632,vestigial tail|MP:0002941,increased circulating alanine transaminase level|MP:0003103,liver degeneration|MP:0003531,abnormal vagina development|MP:0003647,absent oligodendrocytes|MP:0004856,decreased ovary weight|MP:0004905,decreased uterus weight|MP:0005017,decreased B cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005389,reproductive system phenotype|MP:0005405,axon degeneration|MP:0005508,abnormal skeleton morphology|MP:0008031,decreased Cajal-Retzius cell number|MP:0008948,decreased neuron number|MP:0009434,paraparesis|MP:0010768,mortality/aging|MP:0011085,postnatal lethality, complete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0020411,increased abdominal adipose tissue amount|MP:0021103,abnormal ventral interneuron 1 morphology|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:5514362	Gt(ROSA)26Sor<tm1(DTA)Vlcg>	MP:0001402,decreased locomotor activity|MP:0001547,abnormal lipid level|MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002169,no abnormal phenotype detected|MP:0002727,decreased circulating insulin level|MP:0002780,decreased circulating testosterone level|MP:0003059,decreased insulin secretion|MP:0003961,decreased lean body mass|MP:0004016,decreased bone mass|MP:0004889,increased energy expenditure|MP:0004893,decreased adiponectin level|MP:0004989,decreased osteoblast cell number|MP:0004992,increased bone resorption|MP:0005289,increased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0006042,increased apoptosis|MP:0008963,increased carbon dioxide production|MP:0009114,decreased pancreatic beta cell mass|MP:0009131,decreased white fat cell number|MP:0009283,decreased gonadal fat pad weight|MP:0010876,decreased bone volume|MP:0011820,decreased pancreatic beta cell proliferation|MP:0011939,increased food intake|MP:0014573,increased circulating resistin level|MP:0020040,decreased bone ossification|MP:0030985,decreased circulating osteocalcin level
MGI:6273758	Gt(ROSA)26Sor<tm1(DUX4)Sqh>	MP:0000747,muscle weakness|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0002080,prenatal lethality|MP:0002498,abnormal acute inflammation|MP:0002757,decreased vertical activity|MP:0004819,decreased skeletal muscle mass|MP:0008770,decreased survivor rate|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009412,skeletal muscle fiber degeneration
MGI:5468098	Gt(ROSA)26Sor<tm1(Eif1a-tTA,tetO-mCherry/HTR4*D100A)Conk>	MP:0000062,increased bone mineral density|MP:0008271,abnormal bone ossification|MP:0010768,mortality/aging
MGI:5774458	Gt(ROSA)26Sor<tm1(en/Cdx1,-EGFP)Npln>	MP:0000137,abnormal vertebrae morphology|MP:0000154,rib fusion|MP:0000373,belly spot|MP:0000519,hydronephrosis|MP:0000585,kinked tail|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0002075,abnormal coat/hair pigmentation|MP:0003036,vertebral transformation|MP:0003048,abnormal cervical vertebrae morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004609,vertebral fusion|MP:0004615,cervical vertebral transformation|MP:0004647,decreased lumbar vertebrae number|MP:0004648,decreased thoracic vertebrae number|MP:0009546,absent gastric milk in neonates|MP:0009933,abnormal tail hair pigmentation|MP:0009934,abnormal hind foot hair pigmentation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5568502	Gt(ROSA)26Sor<tm1(ETV6/SYK)Hjum>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002494,increased IgM level|MP:0005014,increased B cell number|MP:0005154,increased B cell proliferation|MP:0008099,abnormal plasma cell differentiation|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008660,increased interleukin-10 secretion|MP:0008713,abnormal cytokine level|MP:0008782,increased B cell apoptosis|MP:0010209,abnormal circulating chemokine level
MGI:3769110	Gt(ROSA)26Sor<tm1(EWSR1/FLI1)Sbk>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002344,abnormal lymph node B cell domain morphology|MP:0002429,abnormal blood cell morphology/development|MP:0002875,decreased erythrocyte cell number|MP:0005505,thrombocytosis|MP:0008476,increased spleen red pulp amount
MGI:2449038	Gt(ROSA)26Sor<tm1(EYFP)Cos>	MP:0000218,increased leukocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000596,abnormal liver development|MP:0000600,liver hypoplasia|MP:0001614,abnormal blood vessel morphology|MP:0002169,no abnormal phenotype detected|MP:0003402,decreased liver weight|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008778,abnormal lymphangiogenesis|MP:0010180,increased susceptibility to weight loss|MP:0020186,abnormal susceptibility to bacterial infection
MGI:5498471	Gt(ROSA)26Sor<tm1Fan>	MP:0000585,kinked tail|MP:0000955,abnormal spinal cord morphology|MP:0000963,fused dorsal root ganglion|MP:0001504,abnormal posture|MP:0002114,abnormal axial skeleton morphology|MP:0004173,abnormal intervertebral disk morphology|MP:0004609,vertebral fusion|MP:0004620,cervical vertebral fusion|MP:0009768,impaired somite development|MP:0011087,neonatal lethality, complete penetrance|MP:0011732,decreased somite size
MGI:5694148	Gt(ROSA)26Sor<tm1(Fgf8)Lma>	MP:0000562,polydactyly|MP:0001919,abnormal reproductive system physiology|MP:0002113,abnormal skeleton development|MP:0006279,abnormal limb development|MP:0009728,abnormal calcaneum morphology|MP:0011771,abnormal genital tubercle morphology
MGI:5009041	Gt(ROSA)26Sor<tm1(Flt1)Dlam>	MP:0002067,abnormal sensory capabilities/reflexes/nociception
MGI:5581726	Gt(ROSA)26Sor<tm1(Gck)Ydor>	MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0002727,decreased circulating insulin level|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005289,increased oxygen consumption|MP:0009114,decreased pancreatic beta cell mass|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011820,decreased pancreatic beta cell proliferation|MP:0013278,decreased fasting circulating glucose level
MGI:5518625	Gt(ROSA)26Sor<tm1(Gli2)Jmao>	MP:0005381,digestive/alimentary phenotype
MGI:5702870	Gt(ROSA)26Sor<tm1(GNAQ*)Cvrk>	MP:0000019,thick ears|MP:0000575,increased foot pad pigmentation|MP:0000702,enlarged lymph nodes|MP:0001186,pigmentation phenotype|MP:0001188,hyperpigmentation|MP:0001262,decreased body weight|MP:0001272,increased metastatic potential|MP:0001324,abnormal eye pigmentation|MP:0001516,abnormal motor coordination/balance|MP:0002006,neoplasm|MP:0002075,abnormal coat/hair pigmentation|MP:0002095,abnormal skin pigmentation|MP:0002750,exophthalmos|MP:0002877,abnormal melanocyte morphology|MP:0003798,abnormal Harderian gland pigmentation|MP:0005075,abnormal melanosome morphology|MP:0005100,abnormal choroid pigmentation|MP:0005191,head tilt|MP:0005193,abnormal anterior eye segment morphology|MP:0005197,abnormal uvea morphology|MP:0005307,head tossing|MP:0005386,behavior/neurological phenotype|MP:0006359,absent startle reflex|MP:0009023,abnormal spinal cord meninges morphology|MP:0009385,abnormal dermal pigmentation|MP:0009387,abnormal epidermal pigmentation|MP:0009389,abnormal extracutaneous pigmentation|MP:0009390,abnormal otic pigmentation|MP:0009391,abnormal leptomeninges pigmentation|MP:0010037,ectopic melanocytes|MP:0010276,increased intraocular melanoma incidence|MP:0010741,abnormal melanocyte proliferation|MP:0011160,dermal-epidermal separation|MP:0011276,increased tail pigmentation|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012021,abnormal melanocyte number
MGI:5004724	Gt(ROSA)26Sor<tm1(gp80)Eces>	MP:0000691,enlarged spleen|MP:0001807,decreased IgA level|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002497,increased IgE level|MP:0004816,abnormal class switch recombination|MP:0004952,increased spleen weight|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005425,increased macrophage cell number|MP:0008098,decreased plasma cell number|MP:0008174,decreased follicular B cell number|MP:0008178,decreased germinal center B cell number|MP:0008181,increased marginal zone B cell number|MP:0008474,absent spleen germinal center|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008783,decreased B cell apoptosis|MP:0009321,increased histiocytic sarcoma incidence|MP:0014237,decreased tumor-free survival time
MGI:3573780	Gt(ROSA)26Sor<tm1(Gphb5)Lmac>	MP:0000445,short snout|MP:0001262,decreased body weight|MP:0002727,decreased circulating insulin level|MP:0004380,short frontal bone|MP:0004471,short nasal bone|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005318,decreased triglyceride level|MP:0005385,cardiovascular system phenotype|MP:0005477,increased circulating thyroxine level|MP:0005480,increased circulating triiodothyronine level|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity
MGI:5561086	Gt(ROSA)26Sor<tm1(Grem1)Svok>	MP:0000351,increased cell proliferation|MP:0000413,polyphalangy|MP:0000551,absent forelimb|MP:0000556,abnormal hindlimb morphology|MP:0000557,absent hindlimb|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0002110,abnormal digit morphology|MP:0002544,brachydactyly|MP:0002765,short fibula|MP:0004358,bowed tibia|MP:0004371,bowed femur|MP:0005430,absent fibula|MP:0006043,decreased apoptosis|MP:0008829,triphalangia|MP:0009049,abnormal hallux morphology|MP:0009743,preaxial polydactyly|MP:0009744,postaxial polydactyly|MP:0013164,abnormal forelimb bud morphology|MP:0014280,forelimb oligodactyly
MGI:6220715	Gt(ROSA)26Sor<tm1(H1/tetO-RNAi:Fxn)Dhg>	MP:0000278,abnormal myocardial fiber morphology|MP:0001263,weight loss|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0002083,premature death|MP:0003141,cardiac fibrosis|MP:0003233,prolonged QT interval|MP:0004090,abnormal sarcomere morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005330,cardiomyopathy|MP:0005404,abnormal axon morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008450,retina photoreceptor degeneration|MP:0008492,dorsal root ganglion degeneration|MP:0008770,decreased survivor rate|MP:0010053,decreased grip strength|MP:0010510,absent P wave|MP:0011630,increased mitochondrial size|MP:0011636,disorganized mitochondrial cristae|MP:0011731,decreased myelin sheath thickness|MP:0020367,increased heart iron level
MGI:5007772	Gt(ROSA)26Sor<tm1(H1/tetO-RNAi:Pdpk1)Mrl>	MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level
MGI:3803958	Gt(ROSA)26Sor<tm1(HA)Libl>	MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype
MGI:3772576	Gt(ROSA)26Sor<tm1(HBEGF)Awai>	MP:0000172,abnormal bone marrow cell number|MP:0000351,increased cell proliferation|MP:0000468,abnormal esophageal epithelium morphology|MP:0000717,abnormal lymphocyte cell number|MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000921,demyelination|MP:0000966,decreased sensory neuron number|MP:0001126,abnormal ovary morphology|MP:0001131,abnormal ovarian follicle morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001399,hyperactivity|MP:0001790,abnormal immune system physiology|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0002078,abnormal glucose homeostasis|MP:0002619,abnormal lymphocyte morphology|MP:0002727,decreased circulating insulin level|MP:0002882,abnormal neuron morphology|MP:0002891,increased insulin sensitivity|MP:0003203,increased neuron apoptosis|MP:0003354,astrocytosis|MP:0003402,decreased liver weight|MP:0003631,nervous system phenotype|MP:0003948,abnormal gas homeostasis|MP:0003961,decreased lean body mass|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004890,decreased energy expenditure|MP:0004939,abnormal B cell morphology|MP:0005120,decreased circulating growth hormone level|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005418,abnormal circulating hormone level|MP:0005450,abnormal energy expenditure|MP:0005560,decreased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0006007,abnormal basal ganglion morphology|MP:0006243,impaired pupillary reflex|MP:0006309,decreased retina ganglion cell number|MP:0008083,decreased single-positive T cell number|MP:0008212,absent mature B cells|MP:0008213,absent immature B cells|MP:0008321,small adenohypophysis|MP:0008329,decreased somatotroph cell number|MP:0008826,abnormal splenic cell ratio|MP:0008828,abnormal lymph node cell ratio|MP:0008847,abnormal suprachiasmatic nucleus morphology|MP:0008948,decreased neuron number|MP:0009011,prolonged diestrus|MP:0009017,prolonged estrus|MP:0009304,increased retroperitoneal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0009713,enhanced conditioned place preference behavior|MP:0010024,increased total body fat amount|MP:0010073,decreased pruritus|MP:0010378,increased respiratory quotient|MP:0010934,increased subcutaneous adipose tissue amount|MP:0011942,decreased fluid intake|MP:0020476,abnormal circardian behavior entrainment|MP:0031015,abnormal granulosa cell apoptosis|MP:0031472,abnormal female germ cell apoptosis
MGI:3583991	Gt(ROSA)26Sor<tm1(HD*103Q)Xwy>	MP:0001402,decreased locomotor activity|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0010013,cerebral cortex pyramidal cell degeneration
MGI:3822482	Gt(ROSA)26Sor<tm1(Hesx1)Jpmb>	MP:0000914,exencephaly|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3696099	Gt(ROSA)26Sor<tm1Hjf>	MP:0002169,no abnormal phenotype detected
MGI:5470285	Gt(ROSA)26Sor<tm1(Hoxa2)Fmr>	MP:0000913,abnormal brain development|MP:0000954,decreased oligodendrocyte progenitor number
MGI:5496396	Gt(ROSA)26Sor<tm1Iaai>	MP:0009278,abnormal bone marrow cell physiology
MGI:5616234	Gt(ROSA)26Sor<tm1(Irx3*)Hui>	MP:0001262,decreased body weight|MP:0004889,increased energy expenditure|MP:0005292,improved glucose tolerance|MP:0005386,behavior/neurological phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005670,abnormal white adipose tissue physiology|MP:0009269,decreased fat cell size
MGI:4460818	Gt(ROSA)26Sor<tm1(ITK/SYK)Jrld>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001270,distended abdomen|MP:0001505,hunched posture|MP:0001828,abnormal T cell activation|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0005150,cachexia|MP:0005202,lethargy|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0008083,decreased single-positive T cell number
MGI:5824048	Gt(ROSA)26Sor<tm1(JAG1)Xin>	MP:0005379,endocrine/exocrine gland phenotype
MGI:3801312	Gt(ROSA)26Sor<tm1Joe>	MP:0002169,no abnormal phenotype detected
MGI:5502574	Gt(ROSA)26Sor<tm1Jus>	MP:0000218,increased leukocyte cell number|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0001270,distended abdomen|MP:0001577,anemia|MP:0001802,arrested B cell differentiation|MP:0001846,increased inflammatory response|MP:0001858,intestinal inflammation|MP:0001859,kidney inflammation|MP:0001860,liver inflammation|MP:0001873,stomach inflammation|MP:0001954,respiratory distress|MP:0002006,neoplasm|MP:0002083,premature death|MP:0003068,enlarged kidney|MP:0003179,thrombocytopenia|MP:0003763,abnormal thymus physiology|MP:0005017,decreased B cell number|MP:0005092,decreased double-positive T cell number|MP:0005202,lethargy|MP:0005387,immune system phenotype|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008246,abnormal leukocyte morphology|MP:0008475,intermingled spleen red and white pulp|MP:0010336,increased acute lymphoblastic leukemia incidence|MP:0012362,increased large unstained cell number|MP:0031110,meningitis
MGI:3832575	Gt(ROSA)26Sor<tm1(Kcnj11*V59M)Fmas>	MP:0000747,muscle weakness|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001525,impaired balance|MP:0001559,hyperglycemia|MP:0001762,polyuria|MP:0002272,abnormal nervous system electrophysiology|MP:0002712,increased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0003484,abnormal channel response|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005215,abnormal pancreatic islet morphology|MP:0005216,abnormal pancreatic alpha cell morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005402,abnormal action potential|MP:0005559,increased circulating glucose level|MP:0009176,increased pancreatic alpha cell number|MP:0010053,decreased grip strength|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5438799	Gt(ROSA)26Sor<tm1(LDLR/avidin)Svo>	MP:0002169,no abnormal phenotype detected
MGI:5527542	Gt(ROSA)26Sor<tm1(LRRK2*R1441C)Djmo>	MP:0002169,no abnormal phenotype detected|MP:0003243,abnormal dopaminergic neuron morphology|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype
MGI:3052356	Gt(ROSA)26Sor<tm1(Luc)Kael>	MP:0002169,no abnormal phenotype detected
MGI:3665249	Gt(ROSA)26Sor<tm1(MAML1)Wsp>	MP:0000414,alopecia|MP:0001243,abnormal dermal layer morphology|MP:0001247,dermal cyst|MP:0001265,decreased body size|MP:0001852,conjunctivitis|MP:0002073,abnormal hair growth|MP:0002092,abnormal eye morphology|MP:0002111,abnormal tail morphology|MP:0002151,abnormal neural tube morphology|MP:0002490,abnormal immunoglobulin level|MP:0002655,abnormal keratinocyte morphology|MP:0003248,loss of glutamate neurons|MP:0004207,increased squamous cell carcinoma incidence|MP:0004481,abnormal conjunctival epithelium morphology|MP:0004981,decreased neuronal precursor cell number|MP:0005026,decreased susceptibility to parasitic infection|MP:0005027,increased susceptibility to parasitic infection|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0005542,cornea vascularization|MP:0006000,abnormal cornea epithelium morphology|MP:0009825,cornea ulcer|MP:0013464,decreased conjunctiva goblet cell number|MP:0013465,abnormal conjunctiva goblet cell differentiation|MP:0013744,abnormal conjunctival sac morphology
MGI:5056520	Gt(ROSA)26Sor<tm1Maoh>	MP:0002169,no abnormal phenotype detected
MGI:7543648	Gt(ROSA)26Sor<tm1(Mib1*V943F)Jlp>	MP:0005294,abnormal heart ventricle morphology|MP:0010556,thin ventricle myocardium compact layer
MGI:5438292	Gt(ROSA)26Sor<tm1(Mir7-1,-EGFP)Horn>	MP:0002711,decreased glucagon secretion|MP:0003059,decreased insulin secretion
MGI:3709879	Gt(ROSA)26Sor<tm1(Mirn155)Rsky>	MP:0001800,abnormal humoral immune response|MP:0005389,reproductive system phenotype|MP:0008177,increased germinal center B cell number
MGI:3821930	Gt(ROSA)26Sor<tm1(MYC/ERT2)Gev>	MP:0002009,preneoplasia
MGI:4941056	Gt(ROSA)26Sor<tm1(Myc)Rcse>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0002006,neoplasm|MP:0004023,abnormal chromosome number|MP:0008866,chromosomal instability|MP:0010172,abnormal mammary gland epithelium physiology|MP:0014126,increased mammary gland apoptosis
MGI:5604877	Gt(ROSA)26Sor<tm1(Neurog3*S183A*S187A)Axbe>	MP:0003645,increased pancreatic beta cell number
MGI:3844634	Gt(ROSA)26Sor<tm1(Nfatc2*)Rao>	MP:0001828,abnormal T cell activation|MP:0002396,abnormal hematopoietic system morphology/development|MP:0008750,abnormal interferon level|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2684314	Gt(ROSA)26Sor<tm1(Notch1)Dam>	MP:0000065,abnormal bone marrow cavity morphology|MP:0000130,abnormal trabecular bone morphology|MP:0000218,increased leukocyte cell number|MP:0000585,kinked tail|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0001732,postnatal growth retardation|MP:0001944,abnormal pancreas morphology|MP:0002026,increased leukemia incidence|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002628,hepatic steatosis|MP:0002703,abnormal renal tubule morphology|MP:0002981,increased liver weight|MP:0003057,abnormal epicardium morphology|MP:0003339,decreased pancreatic beta cell number|MP:0003934,abnormal pancreas development|MP:0004057,thin myocardium compact layer|MP:0005017,decreased B cell number|MP:0005215,abnormal pancreatic islet morphology|MP:0005220,abnormal exocrine pancreas morphology|MP:0005244,hemopericardium|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005391,vision/eye phenotype|MP:0005422,osteosclerosis|MP:0005508,abnormal skeleton morphology|MP:0005605,increased bone mass|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0006208,lethality throughout fetal growth and development|MP:0008901,absent epididymal fat pad|MP:0009143,abnormal pancreatic duct morphology|MP:0009165,abnormal endocrine pancreas morphology|MP:0009173,absent pancreatic islets|MP:0009177,decreased pancreatic alpha cell number|MP:0009178,absent pancreatic alpha cells|MP:0009347,increased trabecular bone thickness|MP:0010315,increased cholangiocarcinoma incidence|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0011085,postnatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011169,abnormal white fat cell differentation|MP:0011174,lipodystrophy|MP:0013631,decreased bone trabecular spacing|MP:0020410,increased liposarcoma incidence|MP:0030278,thick neurocranium
MGI:5430379	Gt(ROSA)26Sor<tm1(NOTCH1/GFP)Xhsu>	MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death
MGI:4830990	Gt(ROSA)26Sor<tm1(NOTCH3)Sat>	MP:0002169,no abnormal phenotype detected
MGI:4820644	Gt(ROSA)26Sor<tm1(Ntn4)Dyl>	MP:0000377,abnormal hair follicle morphology|MP:0001190,reddish skin|MP:0001265,decreased body size|MP:0001272,increased metastatic potential|MP:0001510,abnormal coat appearance|MP:0001544,abnormal cardiovascular system physiology|MP:0001614,abnormal blood vessel morphology|MP:0001879,abnormal lymphatic vessel morphology|MP:0004106,lymphatic vessel hyperplasia|MP:0008778,abnormal lymphangiogenesis|MP:0010144,abnormal tumor vascularization|MP:0014273,abnormal skin vasculature morphology
MGI:6196853	Gt(ROSA)26Sor<tm1(OVAL/fla,GFP)Vnce>	MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001846,increased inflammatory response|MP:0002743,glomerulonephritis|MP:0002933,joint inflammation|MP:0002936,joint swelling|MP:0003306,small intestinal inflammation|MP:0005015,increased T cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005325,abnormal renal glomerulus morphology|MP:0005390,skeleton phenotype|MP:0008635,increased circulating interleukin-18 level|MP:0010210,abnormal circulating cytokine level
MGI:3814559	Gt(ROSA)26Sor<tm1(PDGFRA*)Hsc>	MP:0000445,short snout|MP:0003418,premature intramembranous bone ossification|MP:0008273,abnormal intramembranous bone ossification|MP:0008818,abnormal interfrontal bone morphology|MP:0030350,premature coronal suture closure|MP:0030367,premature metopic suture closure
MGI:5559320	Gt(ROSA)26Sor<tm1(Phc2*)Hko>	MP:0005390,skeleton phenotype
MGI:5604517	Gt(ROSA)26Sor<tm1Phep>	MP:0002169,no abnormal phenotype detected
MGI:5000472	Gt(ROSA)26Sor<tm1(Pik3ca*H1047R)Egan>	MP:0001126,abnormal ovary morphology|MP:0001614,abnormal blood vessel morphology|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002006,neoplasm|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0010299,increased mammary gland tumor incidence
MGI:4940857	Gt(ROSA)26Sor<tm1(Pim1-E2F1)Rebr>	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0005508,abnormal skeleton morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5516595	Gt(ROSA)26Sor<tm1(Ptpn22*)Draw>	MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0002743,glomerulonephritis|MP:0003725,increased autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005014,increased B cell number|MP:0008177,increased germinal center B cell number|MP:0011353,expanded mesangial matrix
MGI:3776029	Gt(ROSA)26Sor<tm1(ptxA)Cgh>	MP:0000189,hypoglycemia|MP:0000914,exencephaly|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002169,no abnormal phenotype detected|MP:0003720,abnormal neural tube closure|MP:0005292,improved glucose tolerance|MP:0005379,endocrine/exocrine gland phenotype
MGI:5447471	Gt(ROSA)26Sor<tm1(Pyy)Paba>	MP:0002896,abnormal bone mineralization|MP:0003109,short femur|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0004610,small vertebrae|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0004991,decreased bone strength|MP:0010879,decreased trabecular bone volume|MP:0010968,decreased compact bone area|MP:0020010,decreased bone mineral density of femur
MGI:5307896	Gt(ROSA)26Sor<tm1(RAC1*)Jkis>	MP:0002006,neoplasm
MGI:4431227	Gt(ROSA)26Sor<tm1(RARA*)Clmd>	MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0003446,renal hypoplasia|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0010979,small ureteric bud
MGI:3793772	Gt(ROSA)26Sor<tm1(RARA*)Soc>	MP:0000785,telencephalon hypoplasia|MP:0000939,decreased motor neuron number|MP:0004276,abnormal medial ganglionic eminence morphology
MGI:5471977	Gt(ROSA)26Sor<tm1(RICTOR)Jger>	MP:0002083,premature death|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0010144,abnormal tumor vascularization|MP:0010278,increased glioma incidence|MP:0010312,increased oligodendroglioma incidence
MGI:3835030	Gt(ROSA)26Sor<tm1(RNAi:Bmpr2)Dliu>	MP:0000240,extramedullary hematopoiesis|MP:0000465,gastrointestinal hemorrhage|MP:0000484,abnormal pulmonary artery morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001614,abnormal blood vessel morphology|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002357,abnormal spleen white pulp morphology|MP:0002640,reticulocytosis|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0003814,vascular smooth muscle hypoplasia|MP:0005150,cachexia|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0005602,decreased angiogenesis|MP:0008011,intestine polyps|MP:0031154,intestinal hemorrhage
MGI:5295281	Gt(ROSA)26Sor<tm1(RNU6-RNAi:Rad18)Wbaa>	MP:0001262,decreased body weight|MP:0001935,decreased litter size|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004929,decreased epididymis weight|MP:0006380,abnormal spermatid morphology|MP:0009452,abnormal synaptonemal complex|MP:0011100,preweaning lethality, complete penetrance|MP:0014764,impaired double-strand DNA break repair
MGI:4418115	Gt(ROSA)26Sor<tm1(RNU6-RNAi:Trpv1)Thch>	MP:0001970,abnormal pain threshold|MP:0001973,increased thermal nociceptive threshold|MP:0002735,abnormal chemical nociception|MP:0005535,abnormal body temperature|MP:0008872,abnormal physiological response to xenobiotic
MGI:3584142	Gt(ROSA)26Sor<tm1(rtTA2S*M2)Whsu>	MP:0002169,no abnormal phenotype detected
MGI:3805312	Gt(ROSA)26Sor<tm1(Rybp/EGFP)Cve>	MP:0001304,cataract|MP:0002699,abnormal vitreous body morphology|MP:0002840,abnormal lens fiber morphology|MP:0005262,coloboma|MP:0005542,cornea vascularization|MP:0010709,absent eye anterior chamber|MP:0021107,retina fold
MGI:4462840	Gt(ROSA)26Sor<tm1(Sall1)Ryn>	MP:0001262,decreased body weight|MP:0002169,no abnormal phenotype detected
MGI:5052151	Gt(ROSA)26Sor<tm1Sia>	MP:0002169,no abnormal phenotype detected
MGI:5586718	Gt(ROSA)26Sor<tm1(Sirt1)Ktm>	MP:0001260,increased body weight|MP:0001402,decreased locomotor activity|MP:0003213,decreased susceptibility to age related obesity|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005478,decreased circulating thyroxine level|MP:0009289,decreased epididymal fat pad weight|MP:0010025,decreased total body fat amount|MP:0011939,increased food intake|MP:0011940,decreased food intake|MP:0014440,increased response to leptin|MP:0020523,decreased susceptibility to induced hypothermia|MP:0021023,increased adipose tissue noradrenaline turnover
MGI:3576373	Gt(ROSA)26Sor<tm1(Smo/EYFP)Amc>	MP:0000832,abnormal thalamus morphology|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0001183,overexpanded pulmonary alveolus|MP:0001944,abnormal pancreas morphology|MP:0001958,emphysema|MP:0002006,neoplasm|MP:0002036,increased rhabdomyosarcoma incidence|MP:0002083,premature death|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002633,persistent truncus arteriosus|MP:0003299,gastric polyps|MP:0003631,nervous system phenotype|MP:0004165,abnormal lateral geniculate nucleus morphology|MP:0004208,increased basal cell carcinoma incidence|MP:0005238,increased brain size|MP:0005379,endocrine/exocrine gland phenotype|MP:0005388,respiratory system phenotype|MP:0006126,abnormal cardiac outflow tract development|MP:0006283,increased medulloblastoma incidence|MP:0008011,intestine polyps|MP:0010158,abnormal intestine development|MP:0010811,decreased type II pneumocyte number|MP:0010828,abnormal bronchioalveolar stem cell morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012176,abnormal head development|MP:0012748,increased cardiac neural crest cell number|MP:0030313,abnormal face development
MGI:3840598	Gt(ROSA)26Sor<tm1(SNCA*A53T)Djmo>	MP:0002169,no abnormal phenotype detected
MGI:1861932	Gt(ROSA)26Sor<tm1Sor>	MP:0001081,abnormal cranial ganglia morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001093,small trigeminal ganglion|MP:0002169,no abnormal phenotype detected|MP:0002962,increased urine protein level|MP:0002983,increased retina ganglion cell number|MP:0003119,abnormal digestive system development|MP:0003727,abnormal retina layer morphology|MP:0003934,abnormal pancreas development|MP:0004024,aneuploidy|MP:0004505,decreased renal glomerulus number|MP:0004880,lung cyst|MP:0005264,glomerulosclerosis|MP:0005367,renal/urinary system phenotype|MP:0005389,reproductive system phenotype|MP:0006069,abnormal retina neuronal layer morphology|MP:0006095,absent amacrine cells|MP:0008140,podocyte foot process effacement|MP:0008514,absent retina inner plexiform layer|MP:0008770,decreased survivor rate|MP:0009156,absent pancreatic acini|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011087,neonatal lethality, complete penetrance|MP:0011753,decreased podocyte number|MP:0014765,enhanced mismatch repair
MGI:5882069	Gt(ROSA)26Sor<tm1(SPOP*F133V)Mrbn>	MP:0001158,abnormal prostate gland morphology
MGI:4838411	Gt(ROSA)26Sor<tm1(SRF/VP16)Antu>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001262,decreased body weight|MP:0001326,retina degeneration|MP:0001328,disorganized retina layers|MP:0001330,abnormal optic nerve morphology|MP:0002864,abnormal ocular fundus morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005551,abnormal eye electrophysiology|MP:0008450,retina photoreceptor degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0008842,lipofuscinosis|MP:0010097,abnormal retina blood vessel morphology
MGI:3778925	Gt(ROSA)26Sor<tm1(Stat3*A661C*N663C)Sbkv>	MP:0001433,polyphagia|MP:0001861,lung inflammation|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002727,decreased circulating insulin level|MP:0004973,increased regulatory T cell number|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005661,decreased circulating adrenaline level|MP:0005664,decreased circulating noradrenaline level|MP:0008086,increased T-helper 1 cell number|MP:0008489,slow postnatal weight gain|MP:0008614,increased circulating interleukin-17 level|MP:0008681,increased interleukin-17 secretion|MP:0009283,decreased gonadal fat pad weight|MP:0010219,increased T-helper 17 cell number|MP:0010221,abnormal T-helper 17 cell differentiation|MP:0010896,decreased lung compliance|MP:0010935,increased airway resistance|MP:0011044,increased lung elastance|MP:0031391,increased locomotor activity
MGI:5551717	Gt(ROSA)26Sor<tm1(Tbx1/GFP)Bem>	MP:0000031,abnormal cochlea morphology|MP:0000284,double outlet right ventricle|MP:0000705,athymia|MP:0000783,abnormal forebrain morphology|MP:0001082,abnormal geniculate ganglion morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001096,abnormal glossopharyngeal ganglion morphology|MP:0001100,abnormal vagus ganglion morphology|MP:0002428,abnormal semicircular canal morphology|MP:0002633,persistent truncus arteriosus|MP:0002857,cochlear ganglion degeneration|MP:0003161,absent lateral semicircular canal|MP:0003425,abnormal optic vesicle formation|MP:0004298,vestibular ganglion degeneration|MP:0004315,absent vestibular saccule|MP:0004369,absent utricle|MP:0004922,abnormal common crus morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005385,cardiovascular system phenotype|MP:0006011,abnormal endolymphatic duct morphology|MP:0006292,abnormal nasal placode morphology|MP:0009901,abnormal frontonasal prominence morphology|MP:0010402,ventricular septal defect|MP:0011085,postnatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance
MGI:5604017	Gt(ROSA)26Sor<tm1(Tbx1)Rche>	MP:0000704,abnormal thymus development|MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0009544,abnormal thymus epithelium morphology|MP:0013225,abnormal third pharyngeal pouch morphology
MGI:3833549	Gt(ROSA)26Sor<tm1(Tcfe2a/Tal1)Xhsu>	MP:0001601,abnormal myelopoiesis|MP:0002401,abnormal lymphopoiesis
MGI:5550462	Gt(ROSA)26Sor<tm1(tetO-RNAi:Hivep3)Glm>	MP:0004148,increased compact bone thickness|MP:0004988,increased osteoblast cell number|MP:0005605,increased bone mass|MP:0010875,increased bone volume
MGI:5557984	Gt(ROSA)26Sor<tm1(tetO-Sox9)Msan>	MP:0005076,abnormal cell differentiation|MP:0010898,abnormal pulmonary alveolus epithelium morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:3778905	Gt(ROSA)26Sor<tm1(Tfrc*)Nca>	MP:0008807,increased liver iron level|MP:0008810,increased circulating iron level|MP:0020367,increased heart iron level
MGI:3785744	Gt(ROSA)26Sor<tm1(Tgfbr1*)Crm>	MP:0000249,abnormal blood vessel physiology|MP:0000416,sparse hair|MP:0001191,abnormal skin condition|MP:0001200,thick skin|MP:0001218,thin epidermis|MP:0001243,abnormal dermal layer morphology|MP:0001245,thick dermal layer|MP:0001262,decreased body weight|MP:0001614,abnormal blood vessel morphology|MP:0002191,abnormal artery morphology|MP:0002975,vascular smooth muscle hypertrophy|MP:0003215,renal interstitial fibrosis|MP:0004007,abnormal lung vasculature morphology|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0011309,abnormal kidney arterial blood vessel morphology
MGI:5524275	Gt(ROSA)26Sor<tm1(TMPRSS2/ERG)Key>	MP:0031365,prostate gland ventral lobe hyperplasia
MGI:3796847	Gt(ROSA)26Sor<tm1(Trpv1,ECFP)Mde>	MP:0001394,circling|MP:0003463,abnormal single cell response|MP:0005386,behavior/neurological phenotype|MP:0008235,increased susceptibility to neuronal excitotoxicity
MGI:5292522	Gt(ROSA)26Sor<tm1(tTA,CMV*1-Rheb,-EGFP)Gtm>	MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0008916,abnormal astrocyte physiology
MGI:5431136	Gt(ROSA)26Sor<tm1(tTA,tetO-Mir155)Fjsl>	MP:0000599,enlarged liver|MP:0000685,abnormal immune system morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000708,thymus hyperplasia|MP:0001393,ataxia|MP:0001505,hunched posture|MP:0001510,abnormal coat appearance|MP:0001954,respiratory distress|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0003631,nervous system phenotype|MP:0004952,increased spleen weight|MP:0006042,increased apoptosis|MP:0008478,increased spleen white pulp amount|MP:0010537,tumor regression|MP:0031204,hindlimb paresis
MGI:4830734	Gt(ROSA)26Sor<tm1(tTA,tetO-Mir21)Fjsl>	MP:0000221,decreased leukocyte cell number|MP:0000420,ruffled hair|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001505,hunched posture|MP:0001577,anemia|MP:0001954,respiratory distress|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0002397,abnormal bone marrow morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003448,abnormal tumor morphology|MP:0008475,intermingled spleen red and white pulp|MP:0009543,abnormal thymus corticomedullary boundary morphology|MP:0012431,increased lymphoma incidence|MP:0031204,hindlimb paresis
MGI:3814188	Gt(ROSA)26Sor<tm1(Tva)Dsa>	MP:0002021,increased incidence of induced tumors|MP:0009151,increased pancreatic ductal adenocarcinoma incidence|MP:0009152,increased pancreatic intraepithelial neoplasia incidence
MGI:5304689	Gt(ROSA)26Sor<tm1Uga>	MP:0001473,reduced long-term potentiation|MP:0002882,abnormal neuron morphology|MP:0003635,abnormal synaptic transmission
MGI:5573190	Gt(ROSA)26Sor<tm1(uprt)Tnr>	MP:0002169,no abnormal phenotype detected
MGI:3776037	Gt(ROSA)26Sor<tm1Uzs>	MP:0005387,immune system phenotype
MGI:4421844	Gt(ROSA)26Sor<tm1(Vegfa*)Jhai>	MP:0000065,abnormal bone marrow cavity morphology|MP:0000150,abnormal rib morphology|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0004214,abnormal long bone diaphysis morphology|MP:0008271,abnormal bone ossification|MP:0011089,perinatal lethality, complete penetrance
MGI:3769474	Gt(ROSA)26Sor<tm1(Wnt4)Bhr>	MP:0000071,axial skeleton hypoplasia|MP:0000160,kyphosis|MP:0000163,abnormal cartilage morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000440,domed cranium|MP:0000547,short limbs|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0002116,abnormal craniofacial bone morphology|MP:0002397,abnormal bone marrow morphology|MP:0002427,disproportionate dwarf|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0004377,small frontal bone|MP:0004441,small occipital bone|MP:0004471,short nasal bone|MP:0004506,abnormal pubis morphology|MP:0004708,short lumbar vertebrae|MP:0004831,long incisors|MP:0006397,disorganized long bone epiphyseal plate|MP:0014101,decreased chondrocyte proliferation
MGI:5702438	Gt(ROSA)26Sor<tm2.1(CAG-EGFP,-DTA*G128D)Pjen>	MP:0001925,male infertility
MGI:5085260	Gt(ROSA)26Sor<tm2.1(CAG-EGFP)Maoh>	MP:0002169,no abnormal phenotype detected
MGI:5496225	Gt(ROSA)26Sor<tm2.1(CAG-PSTPIP1*)Dtg>	MP:0001262,decreased body weight|MP:0001394,circling|MP:0001732,postnatal growth retardation|MP:0003631,nervous system phenotype|MP:0005390,skeleton phenotype|MP:0008553,increased circulating tumor necrosis factor level|MP:0008638,increased circulating interleukin-1 alpha level|MP:0008641,increased circulating interleukin-1 beta level|MP:0009703,decreased birth body size|MP:0010771,integument phenotype|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3814860	Gt(ROSA)26Sor<tm2.1(Cd74/MOG)Awai>	MP:0001800,abnormal humoral immune response|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis
MGI:5605717	Gt(ROSA)26Sor<tm2.1Ksvo>	MP:0002169,no abnormal phenotype detected
MGI:3763537	Gt(ROSA)26Sor<tm2.1(Mirn150)Rsky>	MP:0001802,arrested B cell differentiation|MP:0001825,arrested T cell differentiation|MP:0004978,decreased B-1 B cell number|MP:0005016,decreased lymphocyte cell number|MP:0008207,decreased B-2 B cell number|MP:0008211,decreased mature B cell number|MP:0008782,increased B cell apoptosis
MGI:5000148	Gt(ROSA)26Sor<tm2.1(MYC/ERT)Hsc>	MP:0000351,increased cell proliferation
MGI:5308557	Gt(ROSA)26Sor<tm2.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:5605725	Gt(ROSA)26Sor<tm2.2Ksvo>	MP:0002169,no abnormal phenotype detected
MGI:5812282	Gt(ROSA)26Sor<tm2(ATF4)Myz>	MP:0003222,increased cardiomyocyte apoptosis|MP:0005376,homeostasis/metabolism phenotype|MP:0010522,calcified aorta
MGI:5085997	Gt(ROSA)26Sor<tm2Bet>	MP:0000598,abnormal liver morphology|MP:0000606,decreased hepatocyte number|MP:0002169,no abnormal phenotype detected|MP:0002928,abnormal bile duct morphology|MP:0002929,abnormal bile duct development|MP:0002981,increased liver weight|MP:0003893,increased hepatocyte proliferation|MP:0009497,abnormal intrahepatic bile duct morphology
MGI:3623346	Gt(ROSA)26Sor<tm2(CAG-Dsred2/EGFP)Luo>	MP:0001923,reduced female fertility
MGI:5423998	Gt(ROSA)26Sor<tm2(CAG-EGFP)Npa>	MP:0002169,no abnormal phenotype detected
MGI:3809503	Gt(ROSA)26Sor<tm2(CAG-EYFP)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5700497	Gt(ROSA)26Sor<tm2(CAG-HIST1H2BB/EGFP)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:5646274	Gt(ROSA)26Sor<tm2(CAG-Lancl1)Pfw>	MP:0001156,abnormal spermatogenesis|MP:0003186,abnormal redox activity|MP:0008236,decreased susceptibility to neuronal excitotoxicity|MP:0008280,abnormal male germ cell apoptosis|MP:0008413,decreased cellular sensitivity to oxidative stress|MP:0020450,abnormal sperm progressive motility|MP:0030603,increased sperm number|MP:0031426,increased sperm motility
MGI:6196138	Gt(ROSA)26Sor<tm2(CAG-Lin28b,-luc)Jhsc>	MP:0002039,increased neuroblastoma incidence
MGI:5563798	Gt(ROSA)26Sor<tm2(CAG-Mir128-2)Ans>	MP:0001402,decreased locomotor activity
MGI:5301613	Gt(ROSA)26Sor<tm2(CAG-Notch2*)Uzs>	MP:0000321,increased bone marrow cell number|MP:0001802,arrested B cell differentiation|MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0002362,abnormal spleen marginal zone morphology|MP:0004952,increased spleen weight|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005154,increased B cell proliferation|MP:0008168,decreased B-1a cell number|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008193,abnormal marginal zone B cell physiology|MP:0008207,decreased B-2 B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008482,decreased spleen germinal center number|MP:0008495,decreased IgG1 level|MP:0008498,decreased IgG3 level|MP:0009339,decreased splenocyte number|MP:0009922,increased transitional stage T1 B cell number|MP:0009926,decreased transitional stage T2 B cell number|MP:0014348,decreased spleen B cell follicle size
MGI:6275547	Gt(ROSA)26Sor<tm2(CAG-Nr5a1)Fjd>	MP:0001120,abnormal uterus morphology|MP:0001926,female infertility|MP:0003845,abnormal decidualization|MP:0004896,abnormal endometrium morphology|MP:0009080,uterus inflammation|MP:0009082,uterus cyst|MP:0009094,abnormal endometrial gland morphology|MP:0009251,enlarged endometrial glands|MP:0011873,enlarged uterine horn|MP:0013400,abnormal endometrial gland development
MGI:5496232	Gt(ROSA)26Sor<tm2(CAG-PSTPIP1*)Dtg>	MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype
MGI:5908402	Gt(ROSA)26Sor<tm2(CARD11*L225LI)Jrld>	MP:0000172,abnormal bone marrow cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0002023,increased B cell derived lymphoma incidence|MP:0005014,increased B cell number|MP:0005154,increased B cell proliferation|MP:0008097,increased plasma cell number|MP:0008217,abnormal B cell activation|MP:0011085,postnatal lethality, complete penetrance|MP:0013940,abnormal plasmablast number
MGI:6459917	Gt(ROSA)26Sor<tm2(CARD14*)Irc>	MP:0000219,increased neutrophil cell number|MP:0001193,psoriasis|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001874,acanthosis|MP:0002083,premature death|MP:0003427,parakeratosis|MP:0004947,skin inflammation|MP:0005560,decreased circulating glucose level|MP:0008126,increased dendritic cell number|MP:0009583,increased keratinocyte proliferation|MP:0010771,integument phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:3814853	Gt(ROSA)26Sor<tm2(Cd74/MOG)Awai>	MP:0002459,abnormal B cell physiology|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis
MGI:3653504	Gt(ROSA)26Sor<tm2(DTA)Riet>	MP:0000745,tremors|MP:0000921,demyelination|MP:0001034,abnormal parasympathetic ganglion morphology|MP:0001071,abnormal facial nerve morphology|MP:0001263,weight loss|MP:0002169,no abnormal phenotype detected|MP:0003647,absent oligodendrocytes|MP:0004805,absent oocytes|MP:0005405,axon degeneration|MP:0009434,paraparesis|MP:0010768,mortality/aging|MP:0011085,postnatal lethality, complete penetrance
MGI:3839913	Gt(ROSA)26Sor<tm2(GFP/tetX)Gld>	MP:0002206,abnormal CNS synaptic transmission
MGI:4414671	Gt(ROSA)26Sor<tm2(Gli2*)Flng>	MP:0000164,abnormal cartilage development|MP:0001265,decreased body size|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004686,decreased length of long bones
MGI:5468804	Gt(ROSA)26Sor<tm2(H1/tetO-RNAi:Kdm1a)Arte>	MP:0000218,increased leukocyte cell number|MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002416,abnormal proerythroblast morphology|MP:0002417,abnormal megakaryocyte morphology|MP:0002599,increased mean platelet volume|MP:0003135,increased erythroid progenitor cell number|MP:0004720,abnormal platelet morphology|MP:0004809,increased hematopoietic stem cell number|MP:0005397,hematopoietic system phenotype|MP:0008111,abnormal granulocyte differentiation|MP:0008112,abnormal monocyte differentiation|MP:0008254,increased megakaryocyte cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0011285,increased circulating erythropoietin level|MP:0011902,increased hematopoietic stem cell proliferation
MGI:5290086	Gt(ROSA)26Sor<tm2(H1/tetO-RNAi:lacZ)Jcbr>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype
MGI:3699420	Gt(ROSA)26Sor<tm2(HIF1A/luc)Kael>	MP:0002169,no abnormal phenotype detected
MGI:5662519	Gt(ROSA)26Sor<tm2(HOXC9)Odk>	MP:0005382,craniofacial phenotype
MGI:5496402	Gt(ROSA)26Sor<tm2Iaai>	MP:0009278,abnormal bone marrow cell physiology
MGI:5586728	Gt(ROSA)26Sor<tm2(ITK/Syk)Hjum>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001829,increased activated T cell number|MP:0001846,increased inflammatory response|MP:0002490,abnormal immunoglobulin level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0003009,abnormal cytokine secretion|MP:0005387,immune system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008097,increased plasma cell number|MP:0008210,increased mature B cell number|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008599,increased circulating interleukin-2 level|MP:0008602,increased circulating interleukin-4 level|MP:0008660,increased interleukin-10 secretion|MP:0008687,increased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008705,increased interleukin-6 secretion|MP:0010210,abnormal circulating cytokine level
MGI:5474352	Gt(ROSA)26Sor<tm2Jake>	MP:0002182,abnormal astrocyte morphology|MP:0005164,abnormal response to injury|MP:0008916,abnormal astrocyte physiology
MGI:5567929	Gt(ROSA)26Sor<tm2(Lmp1/CD40)Uzs>	MP:0000599,enlarged liver|MP:0000685,abnormal immune system morphology|MP:0000691,enlarged spleen|MP:0001790,abnormal immune system physiology|MP:0001800,abnormal humoral immune response|MP:0001828,abnormal T cell activation|MP:0002023,increased B cell derived lymphoma incidence|MP:0002459,abnormal B cell physiology|MP:0004816,abnormal class switch recombination|MP:0004952,increased spleen weight|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005154,increased B cell proliferation|MP:0008173,increased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008217,abnormal B cell activation|MP:0009623,enlarged inguinal lymph nodes|MP:0014347,increased spleen B cell follicle size
MGI:7543652	Gt(ROSA)26Sor<tm2(Mib1)Jlp>	MP:0005385,cardiovascular system phenotype
MGI:3763536	Gt(ROSA)26Sor<tm2(Mirn150)Rsky>	MP:0004978,decreased B-1 B cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008207,decreased B-2 B cell number|MP:0008211,decreased mature B cell number|MP:0008782,increased B cell apoptosis
MGI:4941057	Gt(ROSA)26Sor<tm2(myc*T58A)Rcse>	MP:0000630,mammary gland hyperplasia|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001884,mammary gland alveolar hyperplasia|MP:0004024,aneuploidy|MP:0004025,polyploidy|MP:0006271,abnormal involution of the mammary gland|MP:0008866,chromosomal instability|MP:0009277,increased brain tumor incidence|MP:0009506,abnormal mammary gland alveolus morphology|MP:0010172,abnormal mammary gland epithelium physiology|MP:0010320,increased pituitary gland tumor incidence|MP:0014237,decreased tumor-free survival time
MGI:3834904	Gt(ROSA)26Sor<tm2Nat>	MP:0002169,no abnormal phenotype detected
MGI:3844635	Gt(ROSA)26Sor<tm2(Nfatc2*)Rao>	MP:0001828,abnormal T cell activation|MP:0002396,abnormal hematopoietic system morphology/development|MP:0008750,abnormal interferon level|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5430391	Gt(ROSA)26Sor<tm2(Notch2)Ryn>	MP:0000527,abnormal kidney development|MP:0002705,dilated renal tubule|MP:0002989,small kidney|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0009050,dilated proximal convoluted tubule|MP:0011087,neonatal lethality, complete penetrance|MP:0011334,abnormal nephrogenic zone morphology|MP:0011387,absent metanephric mesenchyme|MP:0011457,abnormal metanephric ureteric bud development|MP:0011682,renal glomerulus cyst
MGI:5056498	Gt(ROSA)26Sor<tm2(OVA/EGFP)Dwir>	MP:0010080,abnormal hepatocyte physiology
MGI:3803568	Gt(ROSA)26Sor<tm2(Pax3)Joe>	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0000550,abnormal forelimb morphology|MP:0001340,abnormal eyelid morphology|MP:0001341,absent eyelids|MP:0002082,postnatal lethality|MP:0002116,abnormal craniofacial bone morphology|MP:0002169,no abnormal phenotype detected|MP:0002896,abnormal bone mineralization|MP:0003359,hypaxial muscle hypoplasia|MP:0003631,nervous system phenotype|MP:0003755,abnormal palate morphology|MP:0003760,decreased palatal length|MP:0004452,abnormal pterygoid process morphology|MP:0004454,absent pterygoid process|MP:0004458,absent alisphenoid bone|MP:0004460,alisphenoid bone hypoplasia|MP:0005369,muscle phenotype|MP:0005371,limbs/digits/tail phenotype|MP:0006020,decreased tympanic ring size|MP:0008271,abnormal bone ossification|MP:0008395,abnormal osteoblast differentiation|MP:0009264,failure of eyelid fusion|MP:0009651,abnormal eyelid development|MP:0009655,abnormal secondary palate development|MP:0009886,failure of palatal shelf elevation
MGI:5510667	Gt(ROSA)26Sor<tm2(Pik3ca*)Dsa>	MP:0002038,increased carcinoma incidence|MP:0003450,enlarged pancreas|MP:0009108,increased pancreas weight|MP:0009151,increased pancreatic ductal adenocarcinoma incidence|MP:0009152,increased pancreatic intraepithelial neoplasia incidence|MP:0013221,pancreatic acinar-to-ductal metaplasia
MGI:5000473	Gt(ROSA)26Sor<tm2(Pik3ca)Egan>	MP:0002169,no abnormal phenotype detected
MGI:2136519	Gt(ROSA)26Sor<tm2Sho>	MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype
MGI:5308555	Gt(ROSA)26Sor<tm2Sia>	MP:0002169,no abnormal phenotype detected
MGI:5586719	Gt(ROSA)26Sor<tm2(Sirt1)Ktm>	MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype
MGI:3840596	Gt(ROSA)26Sor<tm2(SNCA*119)Djmo>	MP:0002169,no abnormal phenotype detected|MP:0005643,decreased dopamine level|MP:0005665,increased circulating noradrenaline level|MP:0010069,increased serotonin level|MP:0012575,increased noradrenaline level
MGI:5694150	Gt(ROSA)26Sor<tm2(Sp8)Lma>	MP:0005371,limbs/digits/tail phenotype
MGI:3710095	Gt(ROSA)26Sor<tm2(SS18)Mrc>	MP:0000751,myopathy|MP:0000759,abnormal skeletal muscle morphology|MP:0001265,decreased body size|MP:0002006,neoplasm|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5543802	Gt(ROSA)26Sor<tm2(tTA,CMV*1-KIAA1549/BRAF,-EGFP)Gtm>	MP:0000462,abnormal digestive system morphology|MP:0001663,abnormal digestive system physiology|MP:0002083,premature death|MP:0003631,nervous system phenotype|MP:0003883,enlarged stomach|MP:0008786,abnormal hindgut morphology|MP:0012065,increased astrocyte number|MP:0012204,abnormal neuronal stem cell physiology|MP:0012206,increased neuronal stem cell self-renewal
MGI:5618146	Gt(ROSA)26Sor<tm2(Ubc-GPR52)Kohi>	MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0031304,impaired behavioral response to methamphetamine
MGI:5009043	Gt(ROSA)26Sor<tm2(VEGFB*)Dlam>	MP:0003631,nervous system phenotype|MP:0009577,abnormal developmental vascular remodeling
MGI:5295852	Gt(ROSA)26Sor<tm2Wbaa>	MP:0002169,no abnormal phenotype detected
MGI:4439155	Gt(ROSA)26Sor<tm3.1(CAG-EYFP)Hze>	MP:0002169,no abnormal phenotype detected
MGI:3832630	Gt(ROSA)26Sor<tm3.1(CAG-Il17a)Awai>	MP:0000208,decreased hematocrit|MP:0000322,increased granulocyte number|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0004947,skin inflammation|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008681,increased interleukin-17 secretion
MGI:5056535	Gt(ROSA)26Sor<tm3.1(CAG-mCFP)Maoh>	MP:0002169,no abnormal phenotype detected
MGI:5586989	Gt(ROSA)26Sor<tm3.1(CAG-SORL1)Tew>	MP:0003632,abnormal nervous system morphology|MP:0008770,decreased survivor rate|MP:0011090,perinatal lethality, incomplete penetrance
MGI:4355015	Gt(ROSA)26Sor<tm31(H1/tetO-RNAi:Insr)Arte>	MP:0001559,hyperglycemia|MP:0005331,insulin resistance
MGI:5308559	Gt(ROSA)26Sor<tm3.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:5008454	Gt(ROSA)26Sor<tm35.1(CAG-aop3/GFP)Hze>	MP:0002169,no abnormal phenotype detected
MGI:4887237	Gt(ROSA)26Sor<tm37(H1/tetO-RNAi:Tafazzin)Arte>	MP:0000278,abnormal myocardial fiber morphology|MP:0001262,decreased body weight|MP:0002753,dilated heart left ventricle|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004090,abnormal sarcomere morphology|MP:0005140,decreased cardiac muscle contractility|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006038,increased mitochondrial fission|MP:0011628,increased mitochondrial number|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4950879	Gt(ROSA)26Sor<tm38.1(CAG-GCaMP3)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5008455	Gt(ROSA)26Sor<tm39.1(CAG-hop/EYFP)Hze>	MP:0002169,no abnormal phenotype detected|MP:0003633,abnormal nervous system physiology
MGI:5614054	Gt(ROSA)26Sor<tm3(CAG-Chrm3*,-mCitrine)Ute>	MP:0002169,no abnormal phenotype detected
MGI:3623347	Gt(ROSA)26Sor<tm3(CAG-EGFP/Dsred2)Luo>	MP:0001921,reduced fertility|MP:0002083,premature death
MGI:3809521	Gt(ROSA)26Sor<tm3(CAG-EYFP)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5432216	Gt(ROSA)26Sor<tm3(CAG-flpo/ERT2)Alj>	MP:0002169,no abnormal phenotype detected
MGI:3832627	Gt(ROSA)26Sor<tm3(CAG-Il17a)Awai>	MP:0000322,increased granulocyte number|MP:0001790,abnormal immune system physiology|MP:0002463,abnormal neutrophil physiology|MP:0008614,increased circulating interleukin-17 level|MP:0008681,increased interleukin-17 secretion
MGI:3778920	Gt(ROSA)26Sor<tm3(CAG-MIR17-92,-EGFP)Rsky>	MP:0000240,extramedullary hematopoiesis|MP:0000685,abnormal immune system morphology|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0001790,abnormal immune system physiology|MP:0001828,abnormal T cell activation|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0002362,abnormal spleen marginal zone morphology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002490,abnormal immunoglobulin level|MP:0002494,increased IgM level|MP:0002962,increased urine protein level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004939,abnormal B cell morphology|MP:0004952,increased spleen weight|MP:0004969,pale kidney|MP:0005013,increased lymphocyte cell number|MP:0005014,increased B cell number|MP:0005154,increased B cell proliferation|MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008102,lymph node hyperplasia|MP:0008167,increased B-1a cell number|MP:0008177,increased germinal center B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008217,abnormal B cell activation|MP:0008475,intermingled spleen red and white pulp|MP:0008477,decreased spleen red pulp amount|MP:0008478,increased spleen white pulp amount|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level|MP:0011294,renal glomerulus hypertrophy|MP:0011339,abnormal glomerular mesangium morphology|MP:0011353,expanded mesangial matrix|MP:0011427,increased mesangial cell number
MGI:5700416	Gt(ROSA)26Sor<tm3(CAG-tdTomato,-EGFP*)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:5423999	Gt(ROSA)26Sor<tm3(CMV-EGFP)Npa>	MP:0002169,no abnormal phenotype detected
MGI:3774184	Gt(ROSA)26Sor<tm3Dym>	MP:0010768,mortality/aging
MGI:3828280	Gt(ROSA)26Sor<tm3(Gli3)Amc>	MP:0000063,decreased bone mineral density|MP:0000547,short limbs|MP:0000562,polydactyly
MGI:5290071	Gt(ROSA)26Sor<tm3(H1/tetO-RNAi:Mir143)Jcbr>	MP:0002079,increased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:3832385	Gt(ROSA)26Sor<tm3(HIF1A*)Kael>	MP:0000607,abnormal hepatocyte morphology|MP:0010768,mortality/aging|MP:0010771,integument phenotype|MP:0031116,microvesicular hepatic steatosis
MGI:6112016	Gt(ROSA)26Sor<tm3(Irf4)Evdr>	MP:0001262,decreased body weight|MP:0002891,increased insulin sensitivity|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005386,behavior/neurological phenotype|MP:0008963,increased carbon dioxide production|MP:0009132,abnormal white fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0010954,abnormal cellular respiration|MP:0011167,abnormal adipose tissue development|MP:0014143,decreased body fat mass|MP:0020521,browned white adipose tissue morphology
MGI:4941058	Gt(ROSA)26Sor<tm3(myc*S62A)Rcse>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0004024,aneuploidy|MP:0004025,polyploidy|MP:0008866,chromosomal instability|MP:0009277,increased brain tumor incidence|MP:0009506,abnormal mammary gland alveolus morphology
MGI:5007799	Gt(ROSA)26Sor<tm3(NOTCH3*R1031C)Sat>	MP:0000272,abnormal aorta morphology|MP:0004950,abnormal brain vasculature morphology|MP:0005592,abnormal vascular smooth muscle morphology
MGI:3766932	Gt(ROSA)26Sor<tm3(phiC31*)Sor>	MP:0002169,no abnormal phenotype detected
MGI:5295755	Gt(ROSA)26Sor<tm3(RNAi:Fabp4)Mrl>	MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001431,abnormal eating behavior|MP:0005376,homeostasis/metabolism phenotype|MP:0010024,increased total body fat amount
MGI:3849063	Gt(ROSA)26Sor<tm3(rtTA,tetO-cre/ERT)Nat>	MP:0002169,no abnormal phenotype detected
MGI:5311032	Gt(ROSA)26Sor<tm3(Runx2)Flng>	MP:0002169,no abnormal phenotype detected
MGI:5308558	Gt(ROSA)26Sor<tm3Sia>	MP:0002169,no abnormal phenotype detected
MGI:5470246	Gt(ROSA)26Sor<tm3(Snai2)Jhai>	MP:0001914,hemorrhage|MP:0003717,pallor|MP:0008762,embryonic lethality
MGI:3840600	Gt(ROSA)26Sor<tm3(SNCA*E46K)Djmo>	MP:0002169,no abnormal phenotype detected
MGI:3710098	Gt(ROSA)26Sor<tm3(SS18/EGFP)Mrc>	MP:0000313,abnormal cell death|MP:0000733,abnormal muscle development|MP:0000751,myopathy|MP:0001265,decreased body size|MP:0002006,neoplasm|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002085,abnormal embryonic tissue morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5297100	Gt(ROSA)26Sor<tm3(tetO-EGFP,-RNAi:T)Bgh>	MP:0004714,truncated notochord|MP:0006281,abnormal tail development
MGI:5512655	Gt(ROSA)26Sor<tm3(tetO-Mir193)Arte>	MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002703,abnormal renal tubule morphology|MP:0002871,albuminuria|MP:0003675,kidney cyst|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0008060,abnormal podocyte slit diaphragm morphology|MP:0008140,podocyte foot process effacement|MP:0011346,renal tubule atrophy
MGI:5461316	Gt(ROSA)26Sor<tm40.1(CAG-aop3/EGFP)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5562445	Gt(ROSA)26Sor<tm407(H1/tetO-RNAi:Large)Arte>	MP:0000752,dystrophic muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001513,limb grasping|MP:0003852,skeletal muscle necrosis|MP:0004272,abnormal basement membrane morphology|MP:0005165,increased susceptibility to injury|MP:0005369,muscle phenotype|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009420,skeletal muscle endomysial fibrosis|MP:0031318,enhanced skeletal muscle regeneration
MGI:5056536	Gt(ROSA)26Sor<tm4.1(CAG-mCitrine)Maoh>	MP:0002169,no abnormal phenotype detected
MGI:5308561	Gt(ROSA)26Sor<tm4.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:5426927	Gt(ROSA)26Sor<tm47(HTT)Arte>	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0002757,decreased vertical activity|MP:0014062,nervous system inclusion bodies
MGI:5426928	Gt(ROSA)26Sor<tm48(HTT)Arte>	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0002757,decreased vertical activity|MP:0008462,abnormal medium spiny neuron morphology|MP:0014062,nervous system inclusion bodies
MGI:5426929	Gt(ROSA)26Sor<tm49(HTT)Arte>	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0002757,decreased vertical activity
MGI:3716464	Gt(ROSA)26Sor<tm4(ACTB-tdTomato,-EGFP)Luo>	MP:0000267,abnormal heart development|MP:0002169,no abnormal phenotype detected|MP:0011087,neonatal lethality, complete penetrance
MGI:3766933	Gt(ROSA)26Sor<tm4(attB/attP)Sor>	MP:0002169,no abnormal phenotype detected
MGI:5449932	Gt(ROSA)26Sor<tm4(CAG-EGFP*)Nat>	MP:0002169,no abnormal phenotype detected
MGI:3777625	Gt(ROSA)26Sor<tm4(CAG-lacZ,-EGFP)Dym>	MP:0001218,thin epidermis|MP:0002060,abnormal skin morphology
MGI:5424000	Gt(ROSA)26Sor<tm4(EEF1A1-EGFP)Npa>	MP:0002169,no abnormal phenotype detected
MGI:5495288	Gt(ROSA)26Sor<tm4(EWSR1/ATF1)Mrc>	MP:0000428,abnormal craniofacial morphology|MP:0000751,myopathy|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001935,decreased litter size|MP:0002006,neoplasm|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002109,abnormal limb morphology|MP:0003448,abnormal tumor morphology|MP:0003721,increased tumor growth/size|MP:0004499,increased incidence of tumors by chemical induction|MP:0009828,increased tumor latency|MP:0010307,abnormal tumor latency|MP:0011092,embryonic lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5521554	Gt(ROSA)26Sor<tm4(H1/tetO-RNAi:Ezh2)Arte>	MP:0000628,abnormal mammary gland development|MP:0001265,decreased body size|MP:0002217,small lymph nodes|MP:0009503,abnormal mammary gland duct morphology|MP:0010174,decreased mammary gland epithelial cell proliferation|MP:0011091,prenatal lethality, complete penetrance|MP:0012075,impaired mammary gland growth during pregnancy
MGI:5290084	Gt(ROSA)26Sor<tm4(H1/tetO-RNAi:Mir145)Jcbr>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype
MGI:3832386	Gt(ROSA)26Sor<tm4(HIF2A*)Kael>	MP:0000414,alopecia|MP:0000598,abnormal liver morphology|MP:0001190,reddish skin|MP:0001222,epidermal hyperplasia|MP:0001265,decreased body size|MP:0001614,abnormal blood vessel morphology|MP:0002083,premature death|MP:0002608,increased hematocrit|MP:0002628,hepatic steatosis|MP:0002640,reticulocytosis|MP:0002795,dilated cardiomyopathy|MP:0002981,increased liver weight|MP:0003070,increased vascular permeability|MP:0003141,cardiac fibrosis|MP:0003893,increased hepatocyte proliferation|MP:0003921,abnormal heart left ventricle morphology|MP:0004938,dilated vasculature|MP:0005378,growth/size/body region phenotype|MP:0005598,decreased heart ventricle muscle contractility|MP:0005601,increased angiogenesis|MP:0009583,increased keratinocyte proliferation|MP:0010018,pulmonary vascular congestion|MP:0010019,liver vascular congestion|MP:0010768,mortality/aging|MP:0013298,increased susceptibility to colitis induced morbidity/mortality
MGI:3687199	Gt(ROSA)26Sor<tm4(Ikbkb)Rsky>	MP:0000351,increased cell proliferation|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002459,abnormal B cell physiology|MP:0002494,increased IgM level|MP:0005014,increased B cell number|MP:0008097,increased plasma cell number|MP:0008178,decreased germinal center B cell number|MP:0008499,increased IgG1 level|MP:0008783,decreased B cell apoptosis|MP:0008826,abnormal splenic cell ratio
MGI:3785819	Gt(ROSA)26Sor<tm4(RNAi:Gsk3a,Gsk3b)Rkuhn>	MP:0001262,decreased body weight|MP:0004179,transmission ratio distortion
MGI:5308560	Gt(ROSA)26Sor<tm4Sia>	MP:0002169,no abnormal phenotype detected
MGI:5470243	Gt(ROSA)26Sor<tm4(Snai1)Jhai>	MP:0001672,abnormal embryo development|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5297159	Gt(ROSA)26Sor<tm4(tetO-RNAi:T)Bgh>	MP:0000932,absent notochord|MP:0002151,abnormal neural tube morphology|MP:0003087,absent allantois|MP:0004073,caudal body truncation|MP:0009768,impaired somite development|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3831175	Gt(ROSA)26Sor<tm4(Wnt7a)Amc>	MP:0006055,abnormal vascular endothelial cell morphology
MGI:5613577	Gt(ROSA)26Sor<tm4(Wnt7b)Flng>	MP:0000062,increased bone mineral density|MP:0000065,abnormal bone marrow cavity morphology|MP:0000558,abnormal tibia morphology|MP:0000691,enlarged spleen|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0004686,decreased length of long bones|MP:0004952,increased spleen weight|MP:0004985,decreased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0004992,increased bone resorption|MP:0005605,increased bone mass|MP:0010872,increased trabecular bone mass|MP:0010878,increased trabecular bone volume|MP:0010879,decreased trabecular bone volume|MP:0014106,delayed chondrocyte differentiation|MP:0020039,increased bone ossification|MP:0030984,increased circulating osteocalcin level|MP:0031074,increased circulating type I collagen C-terminal telopeptide level
MGI:5426930	Gt(ROSA)26Sor<tm50(HTT)Arte>	MP:0001405,impaired coordination|MP:0002083,premature death|MP:0002757,decreased vertical activity
MGI:5056537	Gt(ROSA)26Sor<tm5.1(CAG-mOrange)Maoh>	MP:0002169,no abnormal phenotype detected
MGI:5426931	Gt(ROSA)26Sor<tm51(HTT)Arte>	MP:0002083,premature death
MGI:5308565	Gt(ROSA)26Sor<tm5.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:5649273	Gt(ROSA)26Sor<tm5(ASPSCR1/TFE3)Mrc>	MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0010274,increased organ/body region tumor incidence|MP:0030287,enlarged occipital bone
MGI:3795199	Gt(ROSA)26Sor<tm5(CAG-EGFP,-lacZ)Dym>	MP:0002169,no abnormal phenotype detected
MGI:5700398	Gt(ROSA)26Sor<tm5(CAG-flpo)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:5470248	Gt(ROSA)26Sor<tm5(CAG-Mdm4,-EGFP)Jhai>	MP:0002169,no abnormal phenotype detected
MGI:5443817	Gt(ROSA)26Sor<tm5(CAG-Sun1/sfGFP)Nat>	MP:0002169,no abnormal phenotype detected
MGI:3848910	Gt(ROSA)26Sor<tm5(Etv4/en,-GFP)Amc>	MP:0000413,polyphalangy|MP:0000562,polydactyly|MP:0002109,abnormal limb morphology
MGI:5521555	Gt(ROSA)26Sor<tm5(H1/tetO-RNAi:Ezh2)Arte>	MP:0000628,abnormal mammary gland development|MP:0001265,decreased body size|MP:0002217,small lymph nodes|MP:0009503,abnormal mammary gland duct morphology|MP:0010174,decreased mammary gland epithelial cell proliferation|MP:0011091,prenatal lethality, complete penetrance|MP:0012075,impaired mammary gland growth during pregnancy
MGI:3809722	Gt(ROSA)26Sor<tm5(Map3k14)Rsky>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0008181,increased marginal zone B cell number|MP:0008210,increased mature B cell number
MGI:5788276	Gt(ROSA)26Sor<tm5Mom>	MP:0005394,taste/olfaction phenotype|MP:0011677,abnormal olfactory sensory neuron physiology
MGI:5308564	Gt(ROSA)26Sor<tm5Sia>	MP:0002169,no abnormal phenotype detected
MGI:5297162	Gt(ROSA)26Sor<tm5(tetO-RNAi:T)Bgh>	MP:0000932,absent notochord|MP:0001680,abnormal mesoderm development|MP:0002151,abnormal neural tube morphology|MP:0003087,absent allantois|MP:0004073,caudal body truncation|MP:0004714,truncated notochord|MP:0009768,impaired somite development|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5613578	Gt(ROSA)26Sor<tm5(Wnt5a)Flng>	MP:0000428,abnormal craniofacial morphology|MP:0005390,skeleton phenotype|MP:0008762,embryonic lethality
MGI:5056526	Gt(ROSA)26Sor<tm6.1(CAG-tdTomato)Maoh>	MP:0002169,no abnormal phenotype detected
MGI:5308567	Gt(ROSA)26Sor<tm6.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:5478743	Gt(ROSA)26Sor<tm65.1(CAG-tdTomato)Hze>	MP:0002169,no abnormal phenotype detected
MGI:3809505	Gt(ROSA)26Sor<tm66.1(CAG-tdTomato)Hze>	MP:0002169,no abnormal phenotype detected
MGI:3809522	Gt(ROSA)26Sor<tm6(CAG-ZsGreen1)Hze>	MP:0002169,no abnormal phenotype detected
MGI:3809723	Gt(ROSA)26Sor<tm6(Map3k14*)Rsky>	MP:0000691,enlarged spleen|MP:0000696,abnormal Peyer's patch morphology|MP:0000702,enlarged lymph nodes|MP:0004978,decreased B-1 B cell number|MP:0008210,increased mature B cell number|MP:0008470,abnormal spleen B cell follicle morphology
MGI:5308566	Gt(ROSA)26Sor<tm6Sia>	MP:0002169,no abnormal phenotype detected
MGI:5438577	Gt(ROSA)26Sor<tm6(tetO-dTomato,-Ctnnb1*)Bgh>	MP:0005621,abnormal cell physiology
MGI:5470250	Gt(ROSA)26Sor<tm6(Vegfa*)Jhai>	MP:0008762,embryonic lethality
MGI:5056538	Gt(ROSA)26Sor<tm7.1(CAG-EGFP/RNAi:Tyr)Maoh>	MP:0000015,abnormal ear pigmentation|MP:0002075,abnormal coat/hair pigmentation|MP:0005546,choroidal neovascularization
MGI:5308569	Gt(ROSA)26Sor<tm7.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:5603432	Gt(ROSA)26Sor<tm75.1(CAG-tdTomato*)Hze>	MP:0002169,no abnormal phenotype detected
MGI:4412286	Gt(ROSA)26Sor<tm7(CAG-mCherry,-EGFP/tetX)Dym>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001415,increased exploration in new environment|MP:0001525,impaired balance|MP:0001951,abnormal breathing pattern|MP:0001956,hypopnea|MP:0002081,perinatal lethality|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003878,abnormal ear physiology|MP:0004770,abnormal synaptic vesicle recycling|MP:0005288,abnormal oxygen consumption|MP:0005333,decreased heart rate|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0005575,increased pulmonary ventilation|MP:0005585,increased tidal volume|MP:0009141,increased prepulse inhibition|MP:0009453,enhanced contextual conditioning behavior|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:4430527	Gt(ROSA)26Sor<tm7(Pik3ca*,-EGFP)Rsky>	MP:0000161,scoliosis|MP:0000351,increased cell proliferation|MP:0000689,abnormal spleen morphology|MP:0000920,abnormal myelination|MP:0001614,abnormal blood vessel morphology|MP:0001634,internal hemorrhage|MP:0002083,premature death|MP:0002109,abnormal limb morphology|MP:0002628,hepatic steatosis|MP:0002725,abnormal vein morphology|MP:0003675,kidney cyst|MP:0003888,liver hemorrhage|MP:0003985,renal fibrosis|MP:0004938,dilated vasculature|MP:0009461,skeletal muscle hypertrophy|MP:0010200,enlarged lymphatic vessel|MP:0010273,increased classified tumor incidence|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0013328,visceromegaly
MGI:5308568	Gt(ROSA)26Sor<tm7Sia>	MP:0002169,no abnormal phenotype detected
MGI:4839792	Gt(ROSA)26Sor<tm7(SMO*/YFP)Amc>	MP:0000913,abnormal brain development|MP:0009901,abnormal frontonasal prominence morphology
MGI:5607578	Gt(ROSA)26Sor<tm80.1(CAG-COP4*L132C/EYFP)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5308579	Gt(ROSA)26Sor<tm8.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:5470252	Gt(ROSA)26Sor<tm8(Aifm1)Jhai>	MP:0010768,mortality/aging
MGI:4430550	Gt(ROSA)26Sor<tm8(Map2k1*,-EGFP)Rsky>	MP:0002651,abnormal sciatic nerve morphology|MP:0003631,nervous system phenotype|MP:0003871,abnormal myelin sheath morphology|MP:0005403,abnormal nerve conduction|MP:0010050,hypermyelination|MP:0011730,increased myelin sheath thickness|MP:0011994,increased nerve conduction velocity|MP:0012674,tomacula
MGI:4353628	Gt(ROSA)26Sor<tm8(RNAi:Crhr1)Rkuhn>	MP:0001364,decreased anxiety-related response|MP:0002665,decreased circulating corticosterone level
MGI:5308572	Gt(ROSA)26Sor<tm8Sia>	MP:0002169,no abnormal phenotype detected
MGI:5308581	Gt(ROSA)26Sor<tm9.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:5558090	Gt(ROSA)26Sor<tm95.1(CAG-GCaMP6f)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5558094	Gt(ROSA)26Sor<tm96(CAG-GCaMP6s)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5470253	Gt(ROSA)26Sor<tm9(Aifm1*)Jhai>	MP:0010768,mortality/aging
MGI:3809523	Gt(ROSA)26Sor<tm9(CAG-tdTomato)Hze>	MP:0002169,no abnormal phenotype detected|MP:0012734,abnormal response to radiation|MP:0031319,impaired intestine regeneration
MGI:5548082	Gt(ROSA)26Sor<tm9(EGFP/Rpl10a)Amc>	MP:0002169,no abnormal phenotype detected
MGI:4430551	Gt(ROSA)26Sor<tm9(Rac1*,-EGFP)Rsky>	MP:0002006,neoplasm|MP:0005379,endocrine/exocrine gland phenotype
MGI:5308580	Gt(ROSA)26Sor<tm9Sia>	MP:0002169,no abnormal phenotype detected
MGI:6385644	Gtsf1l<em1(IMPC)J>	MP:0000218,increased leukocyte cell number
MGI:6121438	Gtsf1l<em1Miya>	MP:0005389,reproductive system phenotype
MGI:4397586	Gtsf1<tm1Miya>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:6121439	Gtsf2<tm1.1Miya>	MP:0005389,reproductive system phenotype
MGI:2664159	Guca1a/Guca1b<tm1Jnc>	MP:0004021,abnormal rod electrophysiology|MP:0005551,abnormal eye electrophysiology
MGI:2664160	Guca1a/Guca1b<tm1Jnc>	MP:0004021,abnormal rod electrophysiology|MP:0005551,abnormal eye electrophysiology
MGI:4999776	Guca1a<tm1.1Hunt>	MP:0001327,decreased retina photoreceptor cell number|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0008446,decreased retina cone cell number|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment
MGI:5473300	Guca1a<tm1Itl>	MP:0001325,abnormal retina morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology
MGI:3822772	Guca1b<tm1Amd>	MP:0004021,abnormal rod electrophysiology|MP:0005391,vision/eye phenotype
MGI:6276988	Guca2a<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology
MGI:2447173	Guca2a<tm1.1Mcoh>	MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0008883,abnormal enterocyte proliferation
MGI:2679505	Guca2b<tm1Lorz>	MP:0002136,abnormal kidney physiology|MP:0004216,salt-resistant hypertension|MP:0005556,abnormal renal filtration rate|MP:0005618,decreased urine potassium level|MP:0005633,increased circulating sodium level|MP:0006317,decreased urine sodium level|MP:0008864,abnormal intestinal secretion|MP:0009643,abnormal urine homeostasis
MGI:4354143	Gucy1a1<tm1.1Brou>	MP:0000276,heart right ventricle hypertrophy|MP:0001330,abnormal optic nerve morphology|MP:0002842,increased systemic arterial blood pressure|MP:0004007,abnormal lung vasculature morphology|MP:0005206,abnormal aqueous humor|MP:0005253,abnormal eye physiology|MP:0005258,ocular hypertension|MP:0006303,abnormal retina nerve fiber layer morphology|MP:0006309,decreased retina ganglion cell number|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010755,abnormal heart right ventricle pressure
MGI:3640804	Gucy1a1<tm1.1Dko>	MP:0001613,abnormal vasodilation|MP:0006144,increased systemic arterial systolic blood pressure|MP:0009548,abnormal platelet aggregation
MGI:3640797	Gucy1a2<tm1.1Dko>	MP:0005385,cardiovascular system phenotype|MP:0005397,hematopoietic system phenotype
MGI:3710142	Gucy1b1<tm1.1Frb>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000477,abnormal intestine morphology|MP:0000494,abnormal cecum morphology|MP:0001262,decreased body weight|MP:0001613,abnormal vasodilation|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0003290,intestinal hypoperistalsis|MP:0003303,peritoneal inflammation|MP:0003631,nervous system phenotype|MP:0003883,enlarged stomach|MP:0004548,dilated esophagus|MP:0006001,abnormal intestinal transit time|MP:0006144,increased systemic arterial systolic blood pressure|MP:0006298,abnormal platelet activation|MP:0009343,dilated gallbladder|MP:0009476,enlarged cecum|MP:0009480,distended cecum|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5432118	Gucy1b1<tm1.2Frb>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000231,hypertension|MP:0005591,decreased vasodilation|MP:0006144,increased systemic arterial systolic blood pressure
MGI:5296786	Gucy1b1<tm1Zhen>	MP:0002169,no abnormal phenotype detected|MP:0005385,cardiovascular system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0009549,decreased platelet aggregation|MP:0031120,decreased susceptibility to induced thrombosis
MGI:5444154	Gucy1b2<tm2Mom>	MP:0003631,nervous system phenotype
MGI:2665316	Gucy2c<tm1Gar>	MP:0001260,increased body weight|MP:0001433,polyphagia|MP:0001625,cardiac hypertrophy|MP:0002079,increased circulating insulin level|MP:0002411,decreased susceptibility to bacterial infection|MP:0002628,hepatic steatosis|MP:0002833,increased heart weight|MP:0005036,diarrhea|MP:0005293,impaired glucose tolerance|MP:0005669,increased circulating leptin level|MP:0009355,increased liver triglyceride level|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0010024,increased total body fat amount|MP:0010934,increased subcutaneous adipose tissue amount|MP:0011958,increased compensatory feeding amount
MGI:2678361	Gucy2c<tm1Gian>	MP:0002409,decreased susceptibility to infection
MGI:3521821	Gucy2d<tm1Sdm>	MP:0001983,abnormal olfactory system physiology|MP:0009943,abnormal olfactory bulb periglomerular cell morphology
MGI:6274710	Gucy2e<cpfl9>	MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008444,retina cone cell degeneration|MP:0012671,retina spots
MGI:2183212	Gucy2e<tm1Gar>	MP:0001006,abnormal retina cone cell morphology|MP:0001326,retina degeneration|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005253,abnormal eye physiology|MP:0005551,abnormal eye electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008446,decreased retina cone cell number|MP:0008448,abnormal retina cone cell inner segment morphology|MP:0008449,abnormal retina cone cell outer segment morphology
MGI:3709985	Gucy2f<tm1Wbae>	MP:0004021,abnormal rod electrophysiology
MGI:3850214	Gucy2g<tm1Rbya>	MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0005367,renal/urinary system phenotype
MGI:7439318	Guf1<tm1.1Nju>	MP:0001153,small seminiferous tubules|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002781,increased circulating testosterone level|MP:0004852,decreased testis weight|MP:0005130,decreased follicle stimulating hormone level|MP:0005132,decreased luteinizing hormone level|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0014052,increased male germ cell apoptosis
MGI:7439317	Guf1<tm1Nju>	MP:0001153,small seminiferous tubules|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight
MGI:7385089	Guk1<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:7425728	Gulo<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001293,anophthalmia|MP:0001399,hyperactivity|MP:0001556,increased circulating HDL cholesterol level|MP:0002092,abnormal eye morphology|MP:0003961,decreased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0008259,abnormal optic disk morphology
MGI:2157331	Gulo<sfx>	MP:0000061,fragile skeleton|MP:0000135,decreased compact bone thickness|MP:0000141,abnormal vertebral body morphology|MP:0000167,decreased chondrocyte number|MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000208,decreased hematocrit|MP:0000692,small spleen|MP:0000706,small thymus|MP:0001402,decreased locomotor activity|MP:0001511,disheveled coat|MP:0001533,abnormal skeleton physiology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003068,enlarged kidney|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005238,increased brain size|MP:0005370,liver/biliary system phenotype|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0008396,abnormal osteoclast differentiation|MP:0008489,slow postnatal weight gain|MP:0020010,decreased bone mineral density of femur
MGI:3510598	Gulo<sfx-2J>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000755,hindlimb paralysis|MP:0001265,decreased body size|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0002896,abnormal bone mineralization|MP:0003116,rickets|MP:0030827,femur fracture
MGI:2158350	Gulo<tm1Mae>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000208,decreased hematocrit|MP:0000465,gastrointestinal hemorrhage|MP:0001263,weight loss|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0001914,hemorrhage|MP:0002083,premature death|MP:0002875,decreased erythrocyte cell number|MP:0003070,increased vascular permeability|MP:0005178,increased circulating cholesterol level|MP:0005245,hemarthrosis|MP:0005562,decreased mean corpuscular hemoglobin|MP:0009862,abnormal aorta elastic tissue morphology|MP:0009864,abnormal aorta endothelium morphology|MP:0009865,abnormal aorta smooth muscle morphology|MP:0011229,abnormal vitamin C level|MP:0030884,rachitic rosary
MGI:6280023	Gulp1<em1(IMPC)J>	MP:0003795,abnormal bone structure|MP:0010025,decreased total body fat amount
MGI:7865670	Gulp1<tm1.2Kimj>	MP:0001533,abnormal skeleton physiology|MP:0001541,abnormal osteoclast physiology|MP:0003797,abnormal compact bone morphology|MP:0004148,increased compact bone thickness|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0005390,skeleton phenotype|MP:0005605,increased bone mass|MP:0008396,abnormal osteoclast differentiation|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume|MP:0013631,decreased bone trabecular spacing|MP:0014454,increased hormone level|MP:0031073,decreased circulating type I collagen C-terminal telopeptide level
MGI:7425729	Gusb<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:1856041	Gusb<mps>	MP:0000358,abnormal cell morphology|MP:0000445,short snout|MP:0000547,short limbs|MP:0000588,thick tail|MP:0000592,short tail|MP:0001258,decreased body length|MP:0001783,decreased white adipose tissue amount|MP:0001882,abnormal lactation|MP:0001925,male infertility|MP:0002083,premature death|MP:0002427,disproportionate dwarf|MP:0004470,small nasal bone|MP:0005058,abnormal lysosome morphology|MP:0005179,decreased circulating cholesterol level|MP:0005319,abnormal enzyme/coenzyme level|MP:0005325,abnormal renal glomerulus morphology|MP:0005508,abnormal skeleton morphology|MP:0011473,increased urine glycosaminoglycan level
MGI:2152564	Gusb<mps-2J>	MP:0000435,shortened head|MP:0000547,short limbs|MP:0000588,thick tail|MP:0000592,short tail|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0005058,abnormal lysosome morphology
MGI:3722138	Gusb<mps-3J>	MP:0000435,shortened head|MP:0000445,short snout|MP:0001265,decreased body size|MP:0002566,abnormal sexual interaction
MGI:2451059	Gusb<tm1Sly>	MP:0000547,short limbs|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality|MP:0002115,abnormal limb bone morphology|MP:0004686,decreased length of long bones|MP:0005058,abnormal lysosome morphology|MP:0005060,accumulation of giant lysosomes in kidney/renal tubule cells|MP:0006395,abnormal epiphyseal plate morphology|MP:0006433,abnormal articular cartilage morphology|MP:0008151,increased diameter of long bones|MP:0011473,increased urine glycosaminoglycan level|MP:0030066,short face
MGI:2451060	Gusb<tm2Sly>	MP:0003723,abnormal long bone morphology|MP:0003743,abnormal facial morphology|MP:0004686,decreased length of long bones|MP:0005058,abnormal lysosome morphology|MP:0006433,abnormal articular cartilage morphology|MP:0008151,increased diameter of long bones|MP:0011473,increased urine glycosaminoglycan level
MGI:2451061	Gusb<tm3Sly>	MP:0003723,abnormal long bone morphology|MP:0003743,abnormal facial morphology|MP:0004686,decreased length of long bones|MP:0005058,abnormal lysosome morphology|MP:0006433,abnormal articular cartilage morphology|MP:0008151,increased diameter of long bones|MP:0011473,increased urine glycosaminoglycan level
MGI:2661042	Gusb<tm4Sly>	MP:0000074,abnormal neurocranium morphology|MP:0000435,shortened head|MP:0000547,short limbs|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001967,deafness|MP:0002114,abnormal axial skeleton morphology|MP:0005422,osteosclerosis|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2154093	Gvhd1<C57BL/10J>	MP:0005672,increased susceptibility to graft versus host disease
MGI:2155826	Gvhd2<C57BL/10J>	MP:0005672,increased susceptibility to graft versus host disease
MGI:2154975	Gvhd3<C57BL/10Sn>	MP:0001263,weight loss
MGI:2386611	Gvhd4<DBA/2J>	MP:0002135,abnormal kidney morphology|MP:0004771,increased anti-single stranded DNA antibody level
MGI:2386613	Gvhd5<DBA/2J>	MP:0004771,increased anti-single stranded DNA antibody level
MGI:6257824	Gxylt1<em1(IMPC)Bay>	MP:0001718,abnormal visceral yolk sac morphology|MP:0001722,pale yolk sac|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6257694	Gxylt2<em1(IMPC)Bay>	MP:0010025,decreased total body fat amount|MP:0010097,abnormal retina blood vessel morphology
MGI:2180359	Gy	MP:0000042,abnormal organ of Corti morphology|MP:0000063,decreased bone mineral density|MP:0000088,short mandible|MP:0000091,short premaxilla|MP:0000150,abnormal rib morphology|MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000432,abnormal head morphology|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000592,short tail|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001340,abnormal eyelid morphology|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001523,impaired righting response|MP:0001925,male infertility|MP:0001967,deafness|MP:0002083,premature death|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002100,abnormal tooth morphology|MP:0002102,abnormal ear morphology|MP:0002115,abnormal limb bone morphology|MP:0002187,abnormal fibula morphology|MP:0002428,abnormal semicircular canal morphology|MP:0002687,oligozoospermia|MP:0002730,head shaking|MP:0002764,short tibia|MP:0002765,short fibula|MP:0002835,abnormal cranial suture morphology|MP:0002901,increased urine phosphate level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003109,short femur|MP:0003150,detached tectorial membrane|MP:0003723,abnormal long bone morphology|MP:0004231,abnormal calcium ion homeostasis|MP:0004329,vestibular saccular degeneration|MP:0004332,utricular degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004380,short frontal bone|MP:0004471,short nasal bone|MP:0004673,splayed ribs|MP:0004686,decreased length of long bones|MP:0004716,abnormal cochlear nerve morphology|MP:0004852,decreased testis weight|MP:0005251,blepharitis|MP:0005353,abnormal patella morphology|MP:0005628,decreased circulating potassium level|MP:0006358,absent pinna reflex|MP:0006397,disorganized long bone epiphyseal plate|MP:0008151,increased diameter of long bones|MP:0008525,decreased cranium height|MP:0009445,osteomalacia|MP:0010025,decreased total body fat amount|MP:0010924,abnormal osteoid morphology|MP:0011221,decreased intestinal calcium absorption|MP:0011476,abnormal urine nucleotide level|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014322,short hindlimb
MGI:4364071	Gyg1<tm1a(KOMP)Wtsi>	MP:0001175,abnormal lung morphology|MP:0001177,atelectasis|MP:0001179,thick pulmonary interalveolar septum|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002078,abnormal glucose homeostasis|MP:0002275,abnormal type II pneumocyte morphology|MP:0003061,decreased aerobic running capacity|MP:0004145,abnormal muscle electrophysiology|MP:0004890,decreased energy expenditure|MP:0005290,decreased oxygen consumption|MP:0005438,abnormal glycogen homeostasis|MP:0006138,congestive heart failure|MP:0008964,decreased carbon dioxide production|MP:0010401,increased skeletal muscle glycogen level|MP:0010889,small alveolar lamellar bodies|MP:0010951,abnormal lipid oxidation|MP:0010954,abnormal cellular respiration|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012106,impaired exercise endurance|MP:0012735,abnormal response to exercise|MP:0014071,increased cardiac muscle glycogen level|MP:0031007,decreased lung glycogen level
MGI:5548475	Gyg1<tm1b(KOMP)Wtsi>	MP:0001491,unresponsive to tactile stimuli|MP:0004609,vertebral fusion|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:6359801	Gykl1<em#Juhu>	MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0002674,abnormal sperm motility|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009237,kinked sperm flagellum|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0014464,decreased sperm mitochondrial sheath size
MGI:3039642	Gypa<tm1Skmz>	MP:0002447,abnormal erythrocyte morphology
MGI:6156134	Gypc<em1(IMPC)Rbrc>	MP:0006352,decreased glycosylated hemoglobin level
MGI:6358063	Gys1<em1(IMPC)Bay>	MP:0001258,decreased body length|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration
MGI:3052742	Gys1<Gt(OST33395)Lex>	MP:0000255,blood vessel congestion|MP:0000280,thin ventricular wall|MP:0000281,abnormal interventricular septum morphology|MP:0000295,trabecula carnea hypoplasia|MP:0002128,abnormal blood circulation|MP:0002833,increased heart weight|MP:0003140,dilated heart atrium|MP:0003141,cardiac fibrosis|MP:0003888,liver hemorrhage|MP:0005294,abnormal heart ventricle morphology|MP:0005439,decreased glycogen level|MP:0010018,pulmonary vascular congestion|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0012501,abnormal pericardial cavity morphology
MGI:4882117	Gys1<tm1.1Arte>	MP:0002714,increased glycogen catabolism rate|MP:0004130,abnormal muscle cell glucose uptake|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005438,abnormal glycogen homeostasis|MP:0010399,decreased skeletal muscle glycogen level
MGI:4432767	Gys1<tm1a(EUCOMM)Wtsi>	MP:0001175,abnormal lung morphology|MP:0003631,nervous system phenotype|MP:0011090,perinatal lethality, incomplete penetrance|MP:0031007,decreased lung glycogen level
MGI:5619172	Gys1<tm1c(EUCOMM)Wtsi>	MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002803,abnormal operant conditioning behavior|MP:0002919,enhanced paired-pulse facilitation|MP:0003631,nervous system phenotype|MP:0014075,decreased brain glycogen level
MGI:6200356	Gys2<m1Btlr>	MP:0013278,decreased fasting circulating glucose level
MGI:6200360	Gys2<m2Btlr>	MP:0013278,decreased fasting circulating glucose level
MGI:6200366	Gys2<m3Btlr>	MP:0005293,impaired glucose tolerance
MGI:5568615	Gys2<tm1.1Arte>	MP:0002078,abnormal glucose homeostasis|MP:0002715,decreased glycogen catabolism rate|MP:0002727,decreased circulating insulin level|MP:0003383,abnormal gluconeogenesis|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005560,decreased circulating glucose level|MP:0009355,increased liver triglyceride level|MP:0010080,abnormal hepatocyte physiology|MP:0010398,decreased liver glycogen level
MGI:4462836	Gys2<tm1.1Pro>	MP:0000187,abnormal triglyceride level|MP:0002078,abnormal glucose homeostasis|MP:0002715,decreased glycogen catabolism rate|MP:0002727,decreased circulating insulin level|MP:0002834,decreased heart weight|MP:0003383,abnormal gluconeogenesis|MP:0003402,decreased liver weight|MP:0003457,abnormal circulating ketone body level|MP:0005293,impaired glucose tolerance|MP:0005439,decreased glycogen level|MP:0005560,decreased circulating glucose level|MP:0006263,decreased systemic arterial diastolic blood pressure|MP:0009355,increased liver triglyceride level|MP:0012106,impaired exercise endurance|MP:0030020,decreased cardiac muscle cell glucose uptake
MGI:4364592	Gys2<tm1a(KOMP)Wtsi>	MP:0000194,increased circulating calcium level|MP:0001262,decreased body weight|MP:0002098,abnormal vibrissa morphology|MP:0003019,increased circulating chloride level|MP:0003442,decreased circulating glycerol level|MP:0005370,liver/biliary system phenotype|MP:0005560,decreased circulating glucose level|MP:0005568,increased circulating total protein level|MP:0005633,increased circulating sodium level|MP:0010398,decreased liver glycogen level
MGI:7256894	Gzf1<em1(IMPC)Tcp>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002591,decreased mean corpuscular volume|MP:0002764,short tibia|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0004085,abnormal heartbeat|MP:0004738,abnormal auditory brainstem response|MP:0005567,decreased circulating total protein level|MP:0010024,increased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3526655	Gzma<tm1Ley>	MP:0003721,increased tumor growth/size|MP:0005079,decreased cytotoxic T cell cytolysis
MGI:2449926	Gzma<tm1Simn>	MP:0002006,neoplasm|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:7484793	Gzmb<em1(IMPC)Ccpcz>	MP:0004924,abnormal behavior|MP:0013129,abnormal tooth color
MGI:5532521	Gzmb<tm1Asmv>	MP:0005387,immune system phenotype
MGI:1857156	Gzmb<tm1Ley>	MP:0003447,decreased tumor growth/size|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006414,decreased T cell apoptosis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010766,abnormal NK cell physiology
MGI:3574017	Gzmb<tm2.1Ley>	MP:0005079,decreased cytotoxic T cell cytolysis
MGI:3577761	Gzmb<tm2Ley>	MP:0001790,abnormal immune system physiology|MP:0005079,decreased cytotoxic T cell cytolysis
MGI:5636646	Gzmk<tm1.1Pib>	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:3665444	Gzmm<tm1(cre)Mjs>	MP:0020916,increased susceptibility to Herpesvirales infection
MGI:5637209	H13<tm1b(KOMP)Wtsi>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000151,absent ribs|MP:0000282,abnormal interatrial septum morphology|MP:0000284,double outlet right ventricle|MP:0000443,abnormal snout morphology|MP:0000520,absent kidney|MP:0000602,dilated liver sinusoidal space|MP:0000783,abnormal forebrain morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000841,abnormal hindbrain morphology|MP:0000914,exencephaly|MP:0000963,fused dorsal root ganglion|MP:0001014,absent superior cervical ganglion|MP:0001015,small superior cervical ganglion|MP:0001711,abnormal placenta morphology|MP:0002111,abnormal tail morphology|MP:0002152,abnormal brain morphology|MP:0002177,abnormal outer ear morphology|MP:0002766,situs inversus|MP:0002836,abnormal chorion morphology|MP:0002858,abnormal posterior semicircular canal morphology|MP:0002951,small thyroid gland|MP:0002989,small kidney|MP:0003178,left pulmonary isomerism|MP:0003232,abnormal forebrain development|MP:0003632,abnormal nervous system morphology|MP:0003686,abnormal eye muscle morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0003827,abnormal Wolffian duct morphology|MP:0004110,transposition of great arteries|MP:0004160,retroesophageal right subclavian artery|MP:0004259,small placenta|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004607,abnormal cervical atlas morphology|MP:0004665,abnormal stapedial artery morphology|MP:0004666,absent stapedial artery|MP:0004686,decreased length of long bones|MP:0005031,abnormal trophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0006425,absent Mullerian ducts|MP:0008023,abnormal styloid process morphology|MP:0008128,abnormal brain internal capsule morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0008923,thoracoschisis|MP:0009770,abnormal optic chiasm morphology|MP:0009820,abnormal liver vasculature morphology|MP:0010123,increased bone mineral content|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010439,abnormal hepatic vein morphology|MP:0010490,abnormal inferior vena cava valve morphology|MP:0010602,abnormal pulmonary valve cusp morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level|MP:0013824,abnormal hypoglossal canal morphology|MP:0013826,absent hypoglossal canal|MP:0013834,thin hypoglossal nerve|MP:0013835,absent hypoglossal nerve|MP:0013836,abnormal hypoglossal nerve topology|MP:0013840,absent segment of posterior cerebral artery|MP:0013848,subcutaneous edema|MP:0013855,absent celiac artery|MP:0013858,abnormal azygos vein topology|MP:0013859,abnormal vitelline vein connection|MP:0013861,abnormal pancreas topology|MP:0013864,enlarged paraumbilical vein|MP:0013871,abnormal stapedial artery topology|MP:0013876,absent ductus venosus valve|MP:0013877,abnormal ductus venosus valve morphology|MP:0013915,abnormal brachial plexus formation|MP:0013936,abnormal thymus topology|MP:0013966,abnormal infrahyoid muscle morphology|MP:0013967,abnormal infrahyoid muscle connection|MP:0013968,multiple persisting craniopharyngeal ducts|MP:0013969,reduced sympathetic cervical ganglion size|MP:0013971,blood in lymph vessels|MP:0013977,symmetric azygos veins|MP:0013985,abnormal umbilical vein topology|MP:0013986,abnormal vitelline vein topology|MP:0013992,persistent dorsal ophthalmic artery|MP:0013996,abnormal vertebral artery origin|MP:0014006,absent posterior communicating artery|MP:0014018,embryo tumor|MP:0014021,heterochrony|MP:0014023,abnormal intestine placement|MP:0020493,absent inferior vena cava
MGI:2655221	H19<tm1.1Sriv>	MP:0005384,cellular phenotype
MGI:3612987	H19<tm1Jvs>	MP:0002169,no abnormal phenotype detected
MGI:1860792	H19<tm1Lda>	MP:0001260,increased body weight|MP:0003721,increased tumor growth/size
MGI:1930620	H19<tm1Tilg>	MP:0001260,increased body weight|MP:0003123,paternal imprinting|MP:0004920,increased placenta weight
MGI:3623136	H19<tm6Tilg>	MP:0003121,genetic imprinting
MGI:3701075	H19<tm7Msb>	MP:0005384,cellular phenotype
MGI:3663884	H19<tm7Tilg>	MP:0003121,genetic imprinting
MGI:6276980	H1f0<em1(IMPC)Mbp>	MP:0001120,abnormal uterus morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0009709,hydrometra|MP:0020421,increased freezing behavior
MGI:2182779	H1f0<tm1Ais>	MP:0002169,no abnormal phenotype detected
MGI:5445805	H1f10<tm1.1(KOMP)Vlcg>	MP:0000955,abnormal spinal cord morphology|MP:0001399,hyperactivity|MP:0001554,increased circulating free fatty acids level|MP:0002152,abnormal brain morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005633,increased circulating sodium level|MP:0013279,increased fasting circulating glucose level
MGI:7550834	H1f1<em1Ibbr>	MP:0003718,maternal effect
MGI:2386881	H1f1<tm1Drab>	MP:0002169,no abnormal phenotype detected
MGI:2182775	H1f2<tm1Ais>	MP:0004587,decreased cellular sensitivity to X-ray irradiation
MGI:2182776	H1f3<tm1Ais>	MP:0002169,no abnormal phenotype detected
MGI:2386170	H1f3<tm1Mkk>	MP:0002169,no abnormal phenotype detected
MGI:6361222	H1f4<em1(IMPC)Bay>	MP:0010123,increased bone mineral content
MGI:2182777	H1f4<tm1Ais>	MP:0002169,no abnormal phenotype detected
MGI:7425730	H1f5<em1(IMPC)Bay>	MP:0000063,decreased bone mineral density|MP:0010124,decreased bone mineral content
MGI:4421548	H1f6<tm1.1(mm)Ddra>	MP:0002169,no abnormal phenotype detected
MGI:2386872	H1f6<tm1Ais>	MP:0002169,no abnormal phenotype detected
MGI:3578782	H1f6<tm1Drab>	MP:0002169,no abnormal phenotype detected
MGI:3579810	H1f7<tm1Idvd>	MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology
MGI:3704974	H1f7<tm1Yoni>	MP:0000242,impaired fertilization|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0004543,abnormal sperm physiology|MP:0005578,teratozoospermia
MGI:5548770	H1f8<tm1b(KOMP)Wtsi>	MP:0002941,increased circulating alanine transaminase level|MP:0005292,improved glucose tolerance|MP:0005343,increased circulating aspartate transaminase level
MGI:3603609	H1f8<tm1Eya>	MP:0002169,no abnormal phenotype detected
MGI:2157977	H2-Aa<b-tm1Blt>	MP:0000702,enlarged lymph nodes|MP:0000708,thymus hyperplasia|MP:0000709,enlarged thymus|MP:0005040,abnormal MHC II cell surface expression on macrophages|MP:0008037,abnormal T cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0009333,abnormal splenocyte physiology
MGI:3586447	H2-Ab1<bm12>	MP:0001585,hemolytic anemia|MP:0001844,autoimmune response|MP:0002083,premature death|MP:0002444,abnormal T cell physiology|MP:0002490,abnormal immunoglobulin level|MP:0002962,increased urine protein level|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004797,increased anti-erythrocyte antigen antibody level|MP:0004824,decreased susceptibility to experimental autoimmune myasthenia gravis|MP:0005014,increased B cell number|MP:0005026,decreased susceptibility to parasitic infection|MP:0005042,abnormal level of surface class II molecules|MP:0005090,increased double-negative T cell number|MP:0005351,decreased susceptibility to autoimmune disorder|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:5521551	H2-Ab1<b-tm1.1Jssh>	MP:0002145,abnormal T cell differentiation|MP:0002455,abnormal dendritic cell antigen presentation|MP:0004974,decreased regulatory T cell number
MGI:5285594	H2-Ab1<b-tm1.1Koni>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:4436864	H2-Ab1<b-tm1.1Sish>	MP:0002376,abnormal dendritic cell physiology|MP:0008561,decreased tumor necrosis factor secretion|MP:0008664,decreased interleukin-12 secretion
MGI:1927483	H2-Ab1<b-tm1Doi>	MP:0000685,abnormal immune system morphology|MP:0000689,abnormal spleen morphology|MP:0000716,abnormal immune system cell morphology|MP:0001732,postnatal growth retardation|MP:0001790,abnormal immune system physiology|MP:0001921,reduced fertility|MP:0002358,abnormal spleen periarteriolar lymphoid sheath morphology|MP:0002362,abnormal spleen marginal zone morphology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0002722,abnormal immune system organ morphology|MP:0003009,abnormal cytokine secretion|MP:0004031,insulitis|MP:0005026,decreased susceptibility to parasitic infection|MP:0005027,increased susceptibility to parasitic infection|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008474,absent spleen germinal center|MP:0008495,decreased IgG1 level|MP:0008828,abnormal lymph node cell ratio|MP:0009967,abnormal neuron proliferation
MGI:2158420	H2-Ab1<b-tm1Gru>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002459,abnormal B cell physiology|MP:0002494,increased IgM level|MP:0003410,abnormal artery development|MP:0003945,abnormal lymphocyte physiology|MP:0005042,abnormal level of surface class II molecules|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005671,abnormal response to transplant|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0008495,decreased IgG1 level
MGI:2387946	H2-Ab1<b-tm1Hpl>	MP:0002169,no abnormal phenotype detected
MGI:2384629	H2-Ab1<b-tm1Koni>	MP:0002169,no abnormal phenotype detected
MGI:5543894	H2-Ab1<b-tm1Wug>	MP:0002376,abnormal dendritic cell physiology|MP:0002459,abnormal B cell physiology|MP:0003790,absent CD4-positive, alpha-beta T cells|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005387,immune system phenotype
MGI:5618308	H2-Ab1<g7-em1Ygch>	MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:6140198	H2ab3<em1(IMPC)Wtsi>	MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level
MGI:7567987	H2aj<em1Cmnn>	MP:0002169,no abnormal phenotype detected
MGI:6153359	H2al2a<em1(IMPC)Wtsi>	MP:0001925,male infertility|MP:0002111,abnormal tail morphology
MGI:2670743	H2ax<tm1Fwa>	MP:0001265,decreased body size|MP:0002024,increased T cell derived lymphoma incidence|MP:0004816,abnormal class switch recombination|MP:0005016,decreased lymphocyte cell number|MP:0008866,chromosomal instability
MGI:2156048	H2ax<tm1Nus>	MP:0000352,decreased cell proliferation|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001658,increased mortality induced by gamma-irradiation|MP:0001732,postnatal growth retardation|MP:0001805,decreased IgG level|MP:0003447,decreased tumor growth/size|MP:0003710,abnormal physiological neovascularization|MP:0004816,abnormal class switch recombination|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008261,arrest of male meiosis|MP:0008852,retina neovascularization|MP:0010144,abnormal tumor vascularization|MP:0020316,decreased vascular endothelial cell proliferation|MP:0020321,increased vascular endothelial cell apoptosis
MGI:6403860	H2az1<em1(IMPC)J>	MP:0001488,increased startle reflex|MP:0005567,decreased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2387764	H2az1<tm1Ily>	MP:0002718,abnormal inner cell mass morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3579319	H2<b>	MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005580,periinsulitis|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:6266818	H2bc21<em1(IMPC)Bay>	MP:0003795,abnormal bone structure|MP:0010123,increased bone mineral content
MGI:5495670	H2bc21<tm1Dlc>	MP:0003204,decreased neuron apoptosis|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0008544,impaired olfaction
MGI:6156478	H2bc4<em1(IMPC)Tcp>	MP:0000691,enlarged spleen|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0011874,enlarged urinary bladder
MGI:5637040	H2bl1<tm1b(EUCOMM)Wtsi>	MP:0001925,male infertility
MGI:3579320	H2<d>	MP:0000208,decreased hematocrit|MP:0000609,abnormal liver physiology|MP:0002145,abnormal T cell differentiation|MP:0003009,abnormal cytokine secretion|MP:0003725,increased autoantibody level|MP:0005026,decreased susceptibility to parasitic infection
MGI:6118941	H2-D1<b-em1Dvs>	MP:0001790,abnormal immune system physiology|MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:6118958	H2-D1<b-em2Dvs>	MP:0001790,abnormal immune system physiology|MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:6118961	H2-D1<b-em3Dvs>	MP:0001790,abnormal immune system physiology|MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:6118903	H2-D1<b-em4Dvs>	MP:0001790,abnormal immune system physiology|MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:3577203	H2-D1<bm14>	MP:0000921,demyelination|MP:0001828,abnormal T cell activation|MP:0030987,spinal cord inflammation
MGI:2658725	H2<dlAb1-Ea>	MP:0002412,increased susceptibility to bacterial infection|MP:0002490,abnormal immunoglobulin level|MP:0002494,increased IgM level|MP:0005387,immune system phenotype|MP:0006387,abnormal T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:2384509	H2-DMa<tm1Doi>	MP:0002452,abnormal professional antigen presenting cell physiology|MP:0005387,immune system phenotype
MGI:3688433	H2-DMa<tm1Liz>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002452,abnormal professional antigen presenting cell physiology|MP:0005041,abnormal antigen presentation via MHC class II|MP:0005043,defective assembly of class II molecules
MGI:2652160	H2-DMa<tm1Lkrl>	MP:0001835,abnormal antigen presentation|MP:0002452,abnormal professional antigen presenting cell physiology|MP:0004919,abnormal positive T cell selection|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:1861933	H2-DMa<tm1Luc>	MP:0001265,decreased body size|MP:0001835,abnormal antigen presentation|MP:0002083,premature death|MP:0002412,increased susceptibility to bacterial infection|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004919,abnormal positive T cell selection|MP:0005041,abnormal antigen presentation via MHC class II|MP:0005042,abnormal level of surface class II molecules|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005465,abnormal T-helper 1 physiology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008567,decreased interferon-gamma secretion
MGI:3688434	H2-DMa<tm2Liz>	MP:0002452,abnormal professional antigen presenting cell physiology|MP:0005041,abnormal antigen presentation via MHC class II|MP:0005095,decreased T cell proliferation
MGI:5297122	H2-Eb1<b-tm1a(KOMP)Wtsi>	MP:0004174,abnormal spine curvature
MGI:3628768	H2<h2>	MP:0004031,insulitis|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005580,periinsulitis|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3628615	H2<h4>	MP:0003009,abnormal cytokine secretion|MP:0003504,thyroid gland inflammation|MP:0004031,insulitis|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005580,periinsulitis|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3628763	H2<i5>	MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005580,periinsulitis|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3628766	H2<i7>	MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005580,periinsulitis|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3579322	H2<k>	MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005580,periinsulitis|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:1931444	H2-K1<b-tm1Bpe>	MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:6118907	H2-K1<d-em4Dvs>	MP:0001790,abnormal immune system physiology|MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:6118979	H2-K1<d-em5Dvs>	MP:0001790,abnormal immune system physiology|MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:6118982	H2-K1<d-em7Dvs>	MP:0001790,abnormal immune system physiology|MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:3618114	H2-K<bm1>	MP:0001363,increased anxiety-related response|MP:0001388,abnormal stationary movement|MP:0001441,increased grooming behavior|MP:0001489,decreased startle reflex|MP:0001529,abnormal vocalization|MP:0003153,early eyelid opening
MGI:3618267	H2-K<dm4>	MP:0005387,immune system phenotype
MGI:3618268	H2-K<dm5>	MP:0005387,immune system phenotype
MGI:3701255	H2-M3<tm1Crw>	MP:0001830,decreased activated T cell number|MP:0002412,increased susceptibility to bacterial infection|MP:0002419,abnormal innate immunity|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005078,abnormal cytotoxic T cell physiology|MP:0008567,decreased interferon-gamma secretion|MP:0011077,decreased macrophage nitric oxide production
MGI:4420089	H2-M5<tm1(KOMP)Wtsi>	MP:0002833,increased heart weight|MP:0003960,increased lean body mass|MP:0005561,increased mean corpuscular hemoglobin
MGI:5467632	H2-Oa/Brd2<Tg(otx2-lacZ)F5pImat>	MP:0000428,abnormal craniofacial morphology|MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0002151,abnormal neural tube morphology|MP:0003077,abnormal cell cycle|MP:0003984,embryonic growth retardation|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012701,increased embryonic neuroepithelium apoptosis|MP:0012702,increased embryonic neuroepithelium thickness
MGI:5467633	H2-Oa/Brd2<Tg(otx2-lacZ)F5pImat>	MP:0000428,abnormal craniofacial morphology|MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0002151,abnormal neural tube morphology|MP:0003077,abnormal cell cycle|MP:0003984,embryonic growth retardation|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012701,increased embryonic neuroepithelium apoptosis|MP:0012702,increased embryonic neuroepithelium thickness
MGI:2386294	H2-Oa<tm1Dma>	MP:0005041,abnormal antigen presentation via MHC class II|MP:0008074,increased CD4-positive, alpha-beta T cell number
MGI:2675254	H2-Oa<tm1Lkar>	MP:0005041,abnormal antigen presentation via MHC class II|MP:0005387,immune system phenotype|MP:0008499,increased IgG1 level
MGI:6189528	H2-Ob<em1Tvg>	MP:0005043,defective assembly of class II molecules|MP:0005387,immune system phenotype|MP:0020935,decreased susceptibility to Retroviridae infection
MGI:3573873	H2-Ob<vic1>	MP:0002053,decreased incidence of induced tumors|MP:0002410,decreased susceptibility to viral infection|MP:0020935,decreased susceptibility to Retroviridae infection
MGI:5707442	H2-Q10<tm1.1(KOMP)Mbp>	MP:0000538,abnormal urinary bladder morphology|MP:0008044,increased NK cell number|MP:0008045,decreased NK cell number|MP:0008347,decreased gamma-delta T cell number|MP:0011625,cystolithiasis|MP:0013666,decreased immature NK cell number|MP:0013672,decreased mature NK cell number
MGI:3044027	H2-T23<tm1Cant>	MP:0002412,increased susceptibility to bacterial infection|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008051,abnormal memory T cell physiology|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:3719723	H2-T23<tm2Cant>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology
MGI:3821721	H2-T23<tm3Cant>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:6153358	H2-T24<em1(IMPC)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0005344,increased circulating bilirubin level|MP:0005567,decreased circulating total protein level
MGI:5056519	H2-T3<tm1Maoh>	MP:0002169,no abnormal phenotype detected
MGI:5056530	H2-T3<tm2.1(CAG-EGFP)Maoh>	MP:0002169,no abnormal phenotype detected
MGI:6414914	H3c2<tm1Mak>	MP:0003690,abnormal glial cell physiology|MP:0010768,mortality/aging
MGI:2682911	H3f3a<Gt(ROSABetageo)14E7Ev>	MP:0001515,abnormal grip strength|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5474375	H3f3a<tm1.1Mnn>	MP:0002169,no abnormal phenotype detected
MGI:5474377	H3f3a<tm1.2Mnn>	MP:0001265,decreased body size|MP:0001922,reduced male fertility
MGI:5614694	H3f3b<tm1.1(KOMP)Mbp>	MP:0001488,increased startle reflex|MP:0002135,abnormal kidney morphology|MP:0005178,increased circulating cholesterol level|MP:0008528,polycystic kidney
MGI:5474376	H3f3b<tm1.1Mnn>	MP:0002169,no abnormal phenotype detected
MGI:5474462	H3f3b<tm1.1Psk>	MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0003077,abnormal cell cycle|MP:0003111,abnormal cell nucleus morphology|MP:0003702,abnormal chromosome morphology|MP:0003984,embryonic growth retardation|MP:0004025,polyploidy|MP:0010831,lethality, incomplete penetrance
MGI:5474378	H3f3b<tm1.2Mnn>	MP:0001265,decreased body size|MP:0001925,male infertility|MP:0008279,arrest of spermiogenesis
MGI:5474383	H3f3b<tm1Psk>	MP:0002169,no abnormal phenotype detected
MGI:7852264	H3f4<em1Aha>	MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0002776,increased Sertoli cell number|MP:0003205,testicular atrophy|MP:0003674,oxidative stress|MP:0003953,abnormal hormone level|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0006420,abnormal peritubular myoid cell morphology|MP:0008008,early cellular replicative senescence|MP:0010948,abnormal double-strand DNA break repair|MP:0011384,abnormal progesterone level|MP:0011385,abnormal testosterone level|MP:0011416,abnormal testis interstitial tissue morphology|MP:0014271,increased testes secretion
MGI:6323659	H3f4<em1Osb>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002662,abnormal cauda epididymis morphology|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0006378,abnormal spermatogonia morphology|MP:0006379,abnormal spermatocyte morphology|MP:0014052,increased male germ cell apoptosis|MP:0014636,decreased elongated spermatid number
MGI:6277028	H4c16<em1(IMPC)Mbp>	MP:0000709,enlarged thymus|MP:0001293,anophthalmia|MP:0001944,abnormal pancreas morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0005562,decreased mean corpuscular hemoglobin
MGI:7573117	H4c1<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0001303,abnormal lens morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002792,abnormal retina vasculature morphology|MP:0020421,increased freezing behavior
MGI:7574680	H4c2<em1(IMPC)Bay>	MP:0005632,decreased circulating aspartate transaminase level
MGI:4432827	H6pd<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight
MGI:6449815	H6pd<tm1c(EUCOMM)Wtsi>	MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003963,abnormal corticosterone level|MP:0005292,improved glucose tolerance|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008033,impaired lipolysis|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009269,decreased fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0013278,decreased fasting circulating glucose level|MP:0020868,decreased lipogenesis
MGI:3624665	H6pd<tm1Pmst>	MP:0000642,enlarged adrenal glands|MP:0001262,decreased body weight|MP:0002665,decreased circulating corticosterone level|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003961,decreased lean body mass|MP:0005560,decreased circulating glucose level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009417,skeletal muscle atrophy|MP:0009428,decreased tibialis anterior weight|MP:0010227,decreased quadriceps weight|MP:0010401,increased skeletal muscle glycogen level
MGI:6285800	Haao<em1Dunw>	MP:0000111,cleft palate|MP:0000137,abnormal vertebrae morphology|MP:0000266,abnormal heart morphology|MP:0000564,syndactyly|MP:0000576,clubfoot|MP:0001672,abnormal embryo development|MP:0002989,small kidney|MP:0003718,maternal effect|MP:0013242,abnormal amino acid metabolism
MGI:5432202	Haao<tm1a(KOMP)Wtsi>	MP:0001415,increased exploration in new environment|MP:0003360,abnormal depression-related behavior|MP:0005386,behavior/neurological phenotype|MP:0013242,abnormal amino acid metabolism
MGI:5766263	Haao<tm2b(KOMP)Mbp>	MP:0005559,increased circulating glucose level|MP:0010123,increased bone mineral content
MGI:5560205	Habp2<tm1Lex>	MP:0001860,liver inflammation|MP:0003333,liver fibrosis|MP:0005164,abnormal response to injury|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:6763956	Habp4<em1Jkob>	MP:0004499,increased incidence of tumors by chemical induction|MP:0014201,abnormal intestinal epithelium physiology
MGI:7425734	Hacd1<em1(IMPC)Mbp>	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002060,abnormal skin morphology|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0011100,preweaning lethality, complete penetrance
MGI:6118922	Hacd1<tm1Akih>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0005376,homeostasis/metabolism phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009422,decreased gastrocnemius weight
MGI:4841604	Hacd2<tm1a(EUCOMM)Hmgu>	MP:0000189,hypoglycemia|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0005150,cachexia|MP:0005202,lethargy|MP:0005376,homeostasis/metabolism phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0010959,abnormal oxidative phosphorylation|MP:0011085,postnatal lethality, complete penetrance|MP:0011699,abnormal brown adipose tissue thermogenesis|MP:0012552,lactic acidosis|MP:0013405,increased circulating lactate level
MGI:7444802	Hacd2<tm1b(EUCOMM)Hmgu>	MP:0000259,abnormal vascular development|MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001719,absent vitelline blood vessels|MP:0001722,pale yolk sac|MP:0001730,embryonic growth arrest|MP:0001787,pericardial edema|MP:0002652,thin myocardium|MP:0002884,abnormal pharyngeal arch morphology|MP:0002925,abnormal cardiovascular development|MP:0003227,abnormal vascular branching morphogenesis|MP:0003229,abnormal vitelline vasculature morphology|MP:0003794,delayed somite formation|MP:0003984,embryonic growth retardation|MP:0004573,absent limb buds|MP:0004777,abnormal phospholipid level|MP:0004785,abnormal posterior cardinal vein morphology|MP:0005244,hemopericardium|MP:0006035,abnormal mitochondrial morphology|MP:0006281,abnormal tail development|MP:0006294,absent optic vesicle|MP:0010951,abnormal lipid oxidation|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0010959,abnormal oxidative phosphorylation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011632,dilated mitochondrion|MP:0011635,abnormal mitochondrial crista morphology|MP:0012177,delayed head development|MP:0012708,delayed rostral neuropore closure|MP:0013906,absent embryonic telencephalon|MP:0014012,abnormal cranial blood vasculature morphology|MP:0014134,abnormal embryo morphology
MGI:7444806	Hacd2<tm1d(EUCOMM)Hmgu>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6316126	Hacd3<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000601,small liver|MP:0001120,abnormal uterus morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001489,decreased startle reflex|MP:0002092,abnormal eye morphology|MP:0002699,abnormal vitreous body morphology|MP:0006203,eye hemorrhage|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5548835	Hace1<tm1b(KOMP)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3759063	Hace1<tm1Pngr>	MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0008014,increased lung tumor incidence
MGI:8161181	Hacl1<tm1.1Pvv>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0002968,increased circulating alkaline phosphatase level|MP:0002981,increased liver weight|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0005281,increased fatty acids level|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005458,increased percent body fat/body weight|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008853,decreased abdominal adipose tissue amount|MP:0009356,decreased liver triglyceride level|MP:0009643,abnormal urine homeostasis|MP:0010180,increased susceptibility to weight loss|MP:0010398,decreased liver glycogen level|MP:0010953,abnormal fatty acid oxidation|MP:0031269,increased susceptibility to diet-induced hepatic steatosis
MGI:5548710	Hacl1<tm1b(KOMP)Wtsi>	MP:0000274,enlarged heart|MP:0002092,abnormal eye morphology
MGI:7266257	Hadha<em1Mbg>	MP:0001405,impaired coordination|MP:0001625,cardiac hypertrophy|MP:0002090,abnormal vision|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003393,decreased cardiac output|MP:0003458,decreased circulating ketone body level|MP:0005140,decreased cardiac muscle contractility|MP:0005201,abnormal retina pigment epithelium morphology|MP:0009642,abnormal blood homeostasis|MP:0010378,increased respiratory quotient|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011925,abnormal heart echocardiography feature|MP:0011952,decreased cardiac stroke volume|MP:0012106,impaired exercise endurance|MP:0012144,decreased b-wave amplitude|MP:0013278,decreased fasting circulating glucose level|MP:0014172,decreased fatty acid oxidation|MP:0020963,decreased c-wave amplitude
MGI:2137697	Hadha<tm1Jib>	MP:0000189,hypoglycemia|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0001554,increased circulating free fatty acids level|MP:0002079,increased circulating insulin level|MP:0002279,abnormal diaphragm morphology|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0003978,decreased circulating carnitine level|MP:0003979,increased circulating carnitine level|MP:0003984,embryonic growth retardation|MP:0005329,abnormal myocardium layer morphology|MP:0005331,insulin resistance|MP:0005344,increased circulating bilirubin level|MP:0005565,increased blood urea nitrogen level|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0011087,neonatal lethality, complete penetrance|MP:0014341,abnormal hepatocyte mitochondrial morphology|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis
MGI:6285597	Hadhb<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:3698125	Hadhb<m1Ytc>	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0000759,abnormal skeletal muscle morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0002971,abnormal brown adipose tissue morphology|MP:0003137,abnormal impulse conducting system conduction|MP:0003141,cardiac fibrosis|MP:0003896,prolonged PR interval|MP:0005330,cardiomyopathy|MP:0005560,decreased circulating glucose level|MP:0008489,slow postnatal weight gain
MGI:7444796	Hadh<em1Jgao>	MP:0001147,small testis|MP:0001922,reduced male fertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005169,abnormal male meiosis|MP:0005578,teratozoospermia|MP:0008898,abnormal acrosome morphology|MP:0009234,absent sperm head|MP:0009238,coiled sperm flagellum|MP:0009243,hairpin sperm flagellum|MP:0013288,premature acrosome reaction|MP:0014052,increased male germ cell apoptosis|MP:0020451,decreased sperm progressive motility|MP:0020550,multinucleated giant male germ cells
MGI:4329502	Hadh<Gt(RRM279)Byg>	MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001777,abnormal body temperature homeostasis|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0003058,increased insulin secretion|MP:0003458,decreased circulating ketone body level|MP:0005533,increased body temperature|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009643,abnormal urine homeostasis|MP:0010025,decreased total body fat amount|MP:0010379,decreased respiratory quotient|MP:0010953,abnormal fatty acid oxidation
MGI:4867189	Hadh<tm1Csta>	MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0005216,abnormal pancreatic alpha cell morphology|MP:0005280,abnormal fatty acids level|MP:0005281,increased fatty acids level|MP:0005560,decreased circulating glucose level|MP:0010028,aciduria
MGI:5774454	hael	MP:0001399,hyperactivity|MP:0002826,tonic seizures|MP:0011085,postnatal lethality, complete penetrance
MGI:2429754	Hag	MP:0000402,abnormal zigzag hair morphology|MP:0000410,waved hair|MP:0000418,focal hair loss|MP:0003809,abnormal hair shaft morphology
MGI:6432325	Hagh<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002591,decreased mean corpuscular volume|MP:0010067,increased red blood cell distribution width
MGI:5565170	Haglr<tm1Vlcg>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0011086,postnatal lethality, incomplete penetrance
MGI:7580969	Hal<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0010053,decreased grip strength
MGI:1856300	Hal<his>	MP:0011654,histidinuria
MGI:7424869	Halr1<em1Shx>	MP:0002169,no abnormal phenotype detected
MGI:5563533	Halr1<tm1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:5529331	Hamp/Hamp2<tm1.1(HAMP)Bjs>	MP:0005397,hematopoietic system phenotype|MP:0008810,increased circulating iron level
MGI:5529332	Hamp/Hamp2<tm1.1(HAMP)Bjs>	MP:0005397,hematopoietic system phenotype|MP:0008810,increased circulating iron level
MGI:5529330	Hamp<tm1.1(HAMP)Bjs>	MP:0005397,hematopoietic system phenotype|MP:0008810,increased circulating iron level
MGI:3701082	Hamp<tm1Svl>	MP:0001263,weight loss|MP:0002447,abnormal erythrocyte morphology|MP:0004152,abnormal circulating iron level|MP:0005639,hemosiderosis|MP:0008808,decreased spleen iron level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0011890,increased circulating ferritin level
MGI:5582417	Hamp<tm2.1Svl>	MP:0001770,abnormal iron level|MP:0008807,increased liver iron level|MP:0008810,increased circulating iron level
MGI:4838016	Hand1<tm1.1(EGFP/cre)Abfi>	MP:0002169,no abnormal phenotype detected|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3042297	Hand1<tm1Cse>	MP:0001724,abnormal extraembryonic endoderm formation|MP:0004076,abnormal vitelline vascular remodeling|MP:0011092,embryonic lethality, complete penetrance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2153824	Hand1<tm1Eno>	MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0001700,abnormal embryo turning|MP:0001719,absent vitelline blood vessels|MP:0002151,abnormal neural tube morphology|MP:0002169,no abnormal phenotype detected|MP:0002824,abnormal chorioallantoic fusion|MP:0002836,abnormal chorion morphology|MP:0003984,embryonic growth retardation|MP:0005029,abnormal amnion morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011205,excessive folding of visceral yolk sac
MGI:2153823	Hand1<tm1Jcc>	MP:0001713,decreased trophoblast giant cell number|MP:0001718,abnormal visceral yolk sac morphology|MP:0001727,abnormal embryo implantation|MP:0001730,embryonic growth arrest|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0002584,small ectoplacental cone|MP:0004251,failure of heart looping|MP:0005033,abnormal trophoblast giant cell morphology|MP:0008959,abnormal spongiotrophoblast cell morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011203,abnormal parietal yolk sac morphology
MGI:4843975	Hand1<tm2.1(Hand1)Abfi>	MP:0000280,thin ventricular wall|MP:0000281,abnormal interventricular septum morphology|MP:0000352,decreased cell proliferation|MP:0000428,abnormal craniofacial morphology|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0002127,abnormal cardiovascular system morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005244,hemopericardium|MP:0005650,abnormal limb bud morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5544632	Hand1<tm2.1Jcc>	MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000279,ventricular hypoplasia|MP:0000280,thin ventricular wall|MP:0000428,abnormal craniofacial morphology|MP:0000847,abnormal metencephalon morphology|MP:0000934,abnormal telencephalon development|MP:0001258,decreased body length|MP:0001688,abnormal somite development|MP:0001711,abnormal placenta morphology|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001722,pale yolk sac|MP:0001727,abnormal embryo implantation|MP:0010395,abnormal pharyngeal arch development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0030989,decreased spongiotrophoblast cell number
MGI:3514024	Hand1<tm2Eno>	MP:0002169,no abnormal phenotype detected
MGI:4843970	Hand1<tm2(Hand1)Abfi>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000352,decreased cell proliferation|MP:0001680,abnormal mesoderm development|MP:0001718,abnormal visceral yolk sac morphology|MP:0002151,abnormal neural tube morphology|MP:0002189,abnormal myocardial trabeculae morphology|MP:0004556,enlarged allantois|MP:0004937,dilated heart|MP:0006113,abnormal heart septum morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0006372,impaired placental function|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5604130	Hand1<tm3Abfi>	MP:0000091,short premaxilla|MP:0000108,midline facial cleft|MP:0000455,abnormal maxilla morphology|MP:0000460,mandible hypoplasia|MP:0002058,neonatal lethality|MP:0002884,abnormal pharyngeal arch morphology|MP:0003235,abnormal alisphenoid bone morphology|MP:0003843,abnormal sagittal suture morphology|MP:0004377,small frontal bone|MP:0004385,interparietal bone hypoplasia|MP:0004455,pterygoid bone hypoplasia|MP:0004461,basisphenoid bone hypoplasia|MP:0004470,small nasal bone|MP:0004473,absent nasal bone|MP:0004726,abnormal nasal capsule morphology|MP:0004869,frontal bone hypoplasia|MP:0004872,absent nasal septum|MP:0004899,absent temporal bone squamous part|MP:0004915,abnormal Reichert's cartilage morphology|MP:0009653,abnormal palate development|MP:0009655,abnormal secondary palate development|MP:0009887,abnormal palatal shelf fusion at midline|MP:0010029,abnormal basicranium morphology|MP:0013933,short Meckel's cartilage|MP:0030112,zygomatic bone hypoplasia|MP:0031443,abnormal tongue position
MGI:5604131	Hand1<tm4Abfi>	MP:0000103,nasal bone hypoplasia|MP:0000108,midline facial cleft|MP:0002058,neonatal lethality|MP:0002884,abnormal pharyngeal arch morphology|MP:0003235,abnormal alisphenoid bone morphology|MP:0004592,small mandible|MP:0004726,abnormal nasal capsule morphology|MP:0004871,premaxilla hypoplasia|MP:0004872,absent nasal septum|MP:0009887,abnormal palatal shelf fusion at midline|MP:0030122,temporal bone squamous part hypoplasia|MP:0031443,abnormal tongue position
MGI:6766586	Hand1<tm5Abfi>	MP:0000281,abnormal interventricular septum morphology|MP:0001625,cardiac hypertrophy|MP:0001914,hemorrhage|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002652,thin myocardium|MP:0003649,decreased heart right ventricle size|MP:0006126,abnormal cardiac outflow tract development|MP:0010402,ventricular septal defect|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0012270,cardiac edema|MP:0012515,abnormal heart apex morphology|MP:0012556,increased cell death|MP:0031525,thin left ventricle myocardium compact layer
MGI:6437756	Hand2<em1(IMPC)Rbrc>	MP:0000137,abnormal vertebrae morphology|MP:0004599,abnormal vertebral arch morphology
MGI:5906350	Hand2os1<em1Eno>	MP:0003872,absent heart right ventricle|MP:0003984,embryonic growth retardation|MP:0005312,pericardial effusion|MP:0005385,cardiovascular system phenotype|MP:0010432,common ventricle|MP:0011092,embryonic lethality, complete penetrance|MP:0012167,abnormal epigenetic regulation of gene expression
MGI:7424833	Hand2os1<em1Shx>	MP:0002169,no abnormal phenotype detected
MGI:5906352	Hand2os1<em2Eno>	MP:0002169,no abnormal phenotype detected
MGI:7424834	Hand2os1<em2Shx>	MP:0002740,heart hypoplasia|MP:0011089,perinatal lethality, complete penetrance
MGI:7424835	Hand2os1<em3Shx>	MP:0002169,no abnormal phenotype detected
MGI:3803647	Hand2<tm1.1Majh>	MP:0000088,short mandible|MP:0000267,abnormal heart development|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001698,decreased embryo size|MP:0002116,abnormal craniofacial bone morphology|MP:0003631,nervous system phenotype|MP:0009937,abnormal neuron differentiation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4453961	Hand2<tm1.2Zllr>	MP:0000292,distended pericardium|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0003984,embryonic growth retardation|MP:0012511,dilated aortic sac|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3715149	Hand2<tm1Cse>	MP:0000276,heart right ventricle hypertrophy|MP:0000460,mandible hypoplasia|MP:0000704,abnormal thymus development|MP:0002189,abnormal myocardial trabeculae morphology|MP:0003077,abnormal cell cycle|MP:0003649,decreased heart right ventricle size|MP:0004157,interrupted aortic arch|MP:0004160,retroesophageal right subclavian artery|MP:0005294,abnormal heart ventricle morphology|MP:0005380,embryo phenotype|MP:0005382,craniofacial phenotype|MP:0005385,cardiovascular system phenotype|MP:0006126,abnormal cardiac outflow tract development|MP:0006279,abnormal limb development|MP:0009886,failure of palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0010017,visceral vascular congestion|MP:0010019,liver vascular congestion|MP:0010418,perimembraneous ventricular septal defect|MP:0010457,pulmonary artery stenosis|MP:0010465,aberrant origin of the right subclavian artery|MP:0010768,mortality/aging|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011394,increased fetal cardiomyocyte proliferation
MGI:1857639	Hand2<tm1Dsr>	MP:0000269,abnormal heart looping|MP:0000293,absent myocardial trabeculae|MP:0000296,absent trabeculae carneae|MP:0000550,abnormal forelimb morphology|MP:0001633,poor circulation|MP:0001689,incomplete somite formation|MP:0001698,decreased embryo size|MP:0001785,edema|MP:0002652,thin myocardium|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0003872,absent heart right ventricle|MP:0003873,pharyngeal arch hypoplasia|MP:0003874,absent pharyngeal arches|MP:0003984,embryonic growth retardation|MP:0005140,decreased cardiac muscle contractility|MP:0005294,abnormal heart ventricle morphology|MP:0005312,pericardial effusion|MP:0006042,increased apoptosis|MP:0006126,abnormal cardiac outflow tract development|MP:0006138,congestive heart failure|MP:0010355,abnormal first pharyngeal arch artery morphology|MP:0010422,heart right ventricle hypoplasia|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011732,decreased somite size|MP:0012511,dilated aortic sac|MP:0013164,abnormal forelimb bud morphology|MP:0013166,small forelimb buds|MP:0030339,absent second pharyngeal arch artery
MGI:3804207	Hand2<tm1Majh>	MP:0000088,short mandible|MP:0000267,abnormal heart development|MP:0001436,abnormal suckling behavior|MP:0001698,decreased embryo size|MP:0002116,abnormal craniofacial bone morphology|MP:0003631,nervous system phenotype|MP:0009890,cleft secondary palate|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4940061	Hand2<tm2.1Dsr>	MP:0002169,no abnormal phenotype detected
MGI:3838372	Hand2<tm2Eno>	MP:0000281,abnormal interventricular septum morphology|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000454,abnormal jaw morphology|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0002753,dilated heart left ventricle|MP:0003649,decreased heart right ventricle size|MP:0003743,abnormal facial morphology|MP:0003808,increased atrioventricular cushion size|MP:0003920,abnormal heart right ventricle morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0005650,abnormal limb bud morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0006337,abnormal first pharyngeal arch morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5646001	Hap1<tm1b(KOMP)Wtsi>	MP:0005565,increased blood urea nitrogen level|MP:0011100,preweaning lethality, complete penetrance
MGI:2179728	Hap1<tm1Hay>	MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001429,dehydration|MP:0001431,abnormal eating behavior|MP:0002175,decreased brain weight|MP:0003717,pallor|MP:0003853,dry skin|MP:0005421,loose skin|MP:0005668,decreased circulating leptin level|MP:0006254,thin cerebral cortex|MP:0008489,slow postnatal weight gain|MP:0009546,absent gastric milk in neonates|MP:0011085,postnatal lethality, complete penetrance
MGI:3521576	Hap1<tm1Id>	MP:0001436,abnormal suckling behavior|MP:0001732,postnatal growth retardation|MP:0009546,absent gastric milk in neonates|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2670598	Hap1<tm1Xjl>	MP:0000837,abnormal hypothalamus morphology|MP:0002229,neurodegeneration|MP:0005386,behavior/neurological phenotype|MP:0008489,slow postnatal weight gain|MP:0008546,abnormal vesicle-mediated transport|MP:0008845,abnormal paraventricular hypothalamic nucleus morphology|MP:0009546,absent gastric milk in neonates|MP:0011085,postnatal lethality, complete penetrance|MP:0020556,abnormal ventromedial hypothalamic nucleus morphology
MGI:3521577	Hap1<tm2Id>	MP:0001436,abnormal suckling behavior|MP:0001732,postnatal growth retardation|MP:0011085,postnatal lethality, complete penetrance
MGI:4830316	Hap1<tm2Xjl>	MP:0000837,abnormal hypothalamus morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001516,abnormal motor coordination/balance|MP:0003064,decreased coping response|MP:0008415,abnormal neurite morphology|MP:0009710,anhedonia|MP:0009967,abnormal neuron proliferation|MP:0011827,impaired neuron differentiation|MP:0011940,decreased food intake
MGI:5515316	Hapln1<tm1.1(KOMP)Mbp>	MP:0001523,impaired righting response|MP:0011100,preweaning lethality, complete penetrance
MGI:1857729	Hapln1<tm1Nid>	MP:0000131,abnormal long bone epiphysis morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000162,lordosis|MP:0000164,abnormal cartilage development|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000445,short snout|MP:0002115,abnormal limb bone morphology|MP:0002427,disproportionate dwarf|MP:0004340,short scapula|MP:0004592,small mandible|MP:0004686,decreased length of long bones|MP:0005508,abnormal skeleton morphology|MP:0005587,abnormal Meckel's cartilage morphology|MP:0010029,abnormal basicranium morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011175,platyspondylia|MP:0012175,flat face|MP:0030124,middle ear ossicle hypoplasia|MP:0030420,short basicranium
MGI:4437572	Hapln2<tm1Ooh>	MP:0005404,abnormal axon morphology|MP:0010748,abnormal visual evoked potential|MP:0014812,abnormal brain physiology
MGI:7425735	Hapln3<em1(IMPC)Hmgu>	MP:0005011,increased eosinophil cell number
MGI:6192343	Hapln4<tm1Ooh>	MP:0002882,abnormal neuron morphology|MP:0004998,decreased CNS synapse formation
MGI:7645937	Hapstr1<tm1.1Menm>	MP:0001263,weight loss|MP:0002073,abnormal hair growth|MP:0003304,large intestinal inflammation|MP:0009480,distended cecum
MGI:5792078	Hars1<mpc231H>	MP:0001967,deafness
MGI:6302803	Hars2<em1(IMPC)J>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0004738,abnormal auditory brainstem response|MP:0009331,absent primitive node|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:5636903	Has1<tm1b(KOMP)Wtsi>	MP:0002606,increased basophil cell number|MP:0005012,decreased eosinophil cell number
MGI:4835713	Has1<tm1Nita>	MP:0002169,no abnormal phenotype detected
MGI:5489753	Has2<tm1.1Chg>	MP:0000088,short mandible|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0002639,micrognathia|MP:0005587,abnormal Meckel's cartilage morphology|MP:0009653,abnormal palate development|MP:0009886,failure of palatal shelf elevation|MP:0009906,increased tongue size|MP:0009908,protruding tongue|MP:0011087,neonatal lethality, complete penetrance|MP:0013818,abnormal oral cavity morphology|MP:0013933,short Meckel's cartilage|MP:0021213,complete cleft palate|MP:0031462,decreased palatal shelf size
MGI:4835686	Has2<tm1.1Nita>	MP:0002169,no abnormal phenotype detected
MGI:4360705	Has2<tm1.1Yama>	MP:0000163,abnormal cartilage morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000167,decreased chondrocyte number|MP:0000547,short limbs|MP:0001406,abnormal gait|MP:0002932,abnormal joint morphology|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0005306,abnormal phalanx morphology|MP:0006279,abnormal limb development|MP:0006280,abnormal digit development|MP:0006397,disorganized long bone epiphyseal plate|MP:0006399,abnormal long bone epiphyseal ossification zone morphology
MGI:2386077	Has2<tm1Jam>	MP:0000266,abnormal heart morphology|MP:0000296,absent trabeculae carneae|MP:0000298,absent atrioventricular cushions|MP:0001614,abnormal blood vessel morphology|MP:0001636,irregular heartbeat|MP:0001691,abnormal somite shape|MP:0001701,incomplete embryo turning|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0001724,abnormal extraembryonic endoderm formation|MP:0001787,pericardial edema|MP:0002085,abnormal embryonic tissue morphology|MP:0003649,decreased heart right ventricle size|MP:0003984,embryonic growth retardation|MP:0004055,heart atrium hypoplasia|MP:0006126,abnormal cardiac outflow tract development|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0010655,absent cardiac jelly|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011260,abnormal head mesenchyme morphology
MGI:5636921	Has3<tm1b(EUCOMM)Wtsi>	MP:0001510,abnormal coat appearance|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003960,increased lean body mass
MGI:3689925	Has3<tm1Daq>	MP:0002133,abnormal respiratory system physiology
MGI:6203625	Haspin<tm1Htan>	MP:0006362,abnormal male germ cell morphology
MGI:5523519	Hat1<tm1.1Mrpa>	MP:0000062,increased bone mineral density|MP:0000087,absent mandible|MP:0000137,abnormal vertebrae morphology|MP:0000281,abnormal interventricular septum morphology|MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0000458,abnormal mandible morphology|MP:0000749,muscle degeneration|MP:0000755,hindlimb paralysis|MP:0001176,abnormal lung development|MP:0001179,thick pulmonary interalveolar septum|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001953,respiratory failure|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0002133,abnormal respiratory system physiology|MP:0002233,abnormal nose morphology|MP:0002269,muscular atrophy|MP:0002276,abnormal lung interstitium morphology|MP:0003674,oxidative stress|MP:0003786,premature aging|MP:0004046,abnormal mitosis|MP:0004819,decreased skeletal muscle mass|MP:0005649,increased spleen neoplasm incidence|MP:0006036,abnormal mitochondrial physiology|MP:0008008,early cellular replicative senescence|MP:0008019,increased liver tumor incidence|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008853,decreased abdominal adipose tissue amount|MP:0009269,decreased fat cell size|MP:0009321,increased histiocytic sarcoma incidence|MP:0009415,skeletal muscle degeneration|MP:0009417,skeletal muscle atrophy|MP:0009703,decreased birth body size|MP:0010025,decreased total body fat amount|MP:0010294,increased kidney tumor incidence|MP:0010819,primary atelectasis|MP:0010948,abnormal double-strand DNA break repair|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011143,thick lung-associated mesenchyme|MP:0011630,increased mitochondrial size|MP:0011636,disorganized mitochondrial cristae|MP:0011704,decreased fibroblast proliferation|MP:0031253,lordokyphosis
MGI:5529369	Hat1<tm1Mrpa>	MP:0002169,no abnormal phenotype detected
MGI:4943912	Haus3<L5Jcs31>	MP:0008762,embryonic lethality
MGI:6259158	Haus4<em1(IMPC)J>	MP:0001727,abnormal embryo implantation|MP:0003984,embryonic growth retardation|MP:0004738,abnormal auditory brainstem response|MP:0004964,absent inner cell mass|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6117369	Haus6<tm1.2Sdwb>	MP:0001672,abnormal embryo development|MP:0009760,abnormal mitotic spindle morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:5437711	Havcr1<tm1Kuch>	MP:0000691,enlarged spleen|MP:0001829,increased activated T cell number|MP:0001844,autoimmune response|MP:0002145,abnormal T cell differentiation|MP:0002376,abnormal dendritic cell physiology|MP:0002459,abnormal B cell physiology|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005015,increased T cell number|MP:0005090,increased double-negative T cell number|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:4845870	Havcr1<tm1Shw>	MP:0005387,immune system phenotype
MGI:5438833	Havcr1<tm1Vlcg>	MP:0002405,respiratory system inflammation|MP:0003009,abnormal cytokine secretion|MP:0005387,immune system phenotype|MP:0008660,increased interleukin-10 secretion|MP:0008672,increased interleukin-13 secretion|MP:0008681,increased interleukin-17 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion
MGI:5692796	Havcr2<tm1b(KOMP)Wtsi>	MP:0002135,abnormal kidney morphology|MP:0004952,increased spleen weight
MGI:5447924	Havcr2<tm1Bmed>	MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005095,decreased T cell proliferation|MP:0008567,decreased interferon-gamma secretion|MP:0010181,decreased susceptibility to weight loss|MP:0010677,decreased activation-induced cell death of T cells|MP:0020947,decreased susceptibility to Orthomyxoviridae infection|MP:0031045,decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:2680763	Havcr2<tm1Tbs>	MP:0005387,immune system phenotype
MGI:5617473	Havcr2<tm1Vlcg>	MP:0005018,decreased T cell number|MP:0008567,decreased interferon-gamma secretion
MGI:5056144	Hax1<tm1.1Gach>	MP:0000061,fragile skeleton|MP:0000333,decreased bone marrow cell number|MP:0000694,spleen hypoplasia|MP:0000715,decreased thymocyte number|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0002083,premature death|MP:0002458,abnormal B cell number|MP:0002619,abnormal lymphocyte morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0005017,decreased B cell number|MP:0005092,decreased double-positive T cell number|MP:0006387,abnormal T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008168,decreased B-1a cell number|MP:0008173,increased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008496,decreased IgG2a level|MP:0009923,decreased transitional stage T1 B cell number|MP:0009926,decreased transitional stage T2 B cell number
MGI:3777018	Hax1<tm1Jni>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000333,decreased bone marrow cell number|MP:0001405,impaired coordination|MP:0001428,adipsia|MP:0001438,aphagia|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0003203,increased neuron apoptosis|MP:0003313,abnormal locomotor activation|MP:0003354,astrocytosis|MP:0005016,decreased lymphocyte cell number|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0008083,decreased single-positive T cell number|MP:0008215,decreased immature B cell number
MGI:2447989	hb	MP:0000034,abnormal inner ear vestibule morphology|MP:0000036,absent semicircular canals|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0001967,deafness|MP:0004413,absent cochlear microphonics|MP:0004416,absent cochlear nerve compound action potential|MP:0006024,collapsed Reissner membrane|MP:0006358,absent pinna reflex
MGI:2677498	Hba-a1<tm1Led>	MP:0000226,abnormal mean corpuscular volume|MP:0001588,abnormal hemoglobin|MP:0001589,abnormal mean corpuscular hemoglobin|MP:0002447,abnormal erythrocyte morphology|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0005097,polychromatophilia|MP:0005505,thrombocytosis
MGI:2451238	Hba-a1<tm1Shs>	MP:0001577,anemia|MP:0001588,abnormal hemoglobin|MP:0002319,hyperoxia|MP:0003060,increased aerobic running capacity|MP:0005289,increased oxygen consumption|MP:0008963,increased carbon dioxide production|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0010957,abnormal aerobic respiration
MGI:2677594	Hba-a1<tm1Ywk>	MP:0001577,anemia|MP:0001585,hemolytic anemia|MP:0001588,abnormal hemoglobin|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002874,decreased hemoglobin content|MP:0005562,decreased mean corpuscular hemoglobin
MGI:5311830	Hba-a2<c-m1H>	MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:2677682	Hba<b2(th)>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0001588,abnormal hemoglobin|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0003131,increased erythrocyte cell number|MP:0003984,embryonic growth retardation|MP:0005378,growth/size/body region phenotype|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008388,hypochromic microcytic anemia|MP:0010035,increased erythrocyte clearance|MP:0010175,leptocytosis|MP:0010176,dacryocytosis|MP:0010177,acanthocytosis|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0011240,abnormal fetal derived definitive erythrocyte morphology|MP:0012120,trophectoderm cell degeneration
MGI:2677681	Hba<b3(th)>	MP:0000208,decreased hematocrit|MP:0001262,decreased body weight|MP:0001588,abnormal hemoglobin|MP:0002082,postnatal lethality|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0003131,increased erythrocyte cell number|MP:0003984,embryonic growth retardation|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008388,hypochromic microcytic anemia|MP:0009703,decreased birth body size|MP:0010175,leptocytosis|MP:0010176,dacryocytosis|MP:0010177,acanthocytosis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0011240,abnormal fetal derived definitive erythrocyte morphology|MP:0012120,trophectoderm cell degeneration
MGI:5427393	Hba<c2>	MP:0002169,no abnormal phenotype detected
MGI:1858116	Hba<g2>	MP:0002169,no abnormal phenotype detected
MGI:1858115	Hba<th-J>	MP:0001262,decreased body weight|MP:0002082,postnatal lethality|MP:0002718,abnormal inner cell mass morphology|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0003131,increased erythrocyte cell number|MP:0003718,maternal effect|MP:0004957,abnormal blastocyst morphology|MP:0005028,abnormal trophectoderm morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2683568	Hba<tm1.1Ney>	MP:0002169,no abnormal phenotype detected
MGI:2683492	Hba<tm1Ney>	MP:0000314,schistocytosis|MP:0001577,anemia|MP:0002192,hydrops fetalis|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002874,decreased hemoglobin content|MP:0003131,increased erythrocyte cell number|MP:0003717,pallor|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010175,leptocytosis|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2450531	Hba<tm1Paz>	MP:0002192,hydrops fetalis|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002874,decreased hemoglobin content|MP:0004200,decreased fetal size|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2677497	Hba-x<tm1Led>	MP:0000226,abnormal mean corpuscular volume|MP:0001577,anemia|MP:0001588,abnormal hemoglobin|MP:0001589,abnormal mean corpuscular hemoglobin|MP:0001732,postnatal growth retardation|MP:0001935,decreased litter size|MP:0002447,abnormal erythrocyte morphology|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0005097,polychromatophilia|MP:0005505,thrombocytosis|MP:0011091,prenatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3821597	Hbb-b1<MommeD7>	MP:0000240,extramedullary hematopoiesis|MP:0000314,schistocytosis|MP:0000598,abnormal liver morphology|MP:0000600,liver hypoplasia|MP:0000691,enlarged spleen|MP:0002082,postnatal lethality|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002810,microcytic anemia|MP:0002812,spherocytosis|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0005097,polychromatophilia|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008388,hypochromic microcytic anemia|MP:0008476,increased spleen red pulp amount|MP:0009395,increased nucleated erythrocyte cell number|MP:0010035,increased erythrocyte clearance|MP:0010067,increased red blood cell distribution width|MP:0010175,leptocytosis|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0014713,abnormal erythrocyte basophilic stippling
MGI:5460881	Hbb-b1<Rbc13>	MP:0000240,extramedullary hematopoiesis|MP:0000314,schistocytosis|MP:0000598,abnormal liver morphology|MP:0000600,liver hypoplasia|MP:0000691,enlarged spleen|MP:0002591,decreased mean corpuscular volume|MP:0002641,anisopoikilocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002810,microcytic anemia|MP:0002812,spherocytosis|MP:0003717,pallor|MP:0005097,polychromatophilia|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008388,hypochromic microcytic anemia|MP:0008476,increased spleen red pulp amount|MP:0009395,increased nucleated erythrocyte cell number|MP:0010035,increased erythrocyte clearance|MP:0010067,increased red blood cell distribution width|MP:0010175,leptocytosis|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0014713,abnormal erythrocyte basophilic stippling
MGI:3526656	Hbb-b1<tm1Ley>	MP:0005397,hematopoietic system phenotype
MGI:2384424	Hbb-b1<tm1Shs>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001585,hemolytic anemia|MP:0001588,abnormal hemoglobin|MP:0002319,hyperoxia|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003031,acidosis|MP:0003060,increased aerobic running capacity|MP:0003135,increased erythroid progenitor cell number|MP:0003656,abnormal erythrocyte physiology|MP:0005289,increased oxygen consumption|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005576,decreased pulmonary ventilation|MP:0008387,hypochromic anemia|MP:0008809,increased spleen iron level|MP:0008963,increased carbon dioxide production|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0010957,abnormal aerobic respiration|MP:0011171,increased number of Heinz bodies
MGI:5692892	Hbb-bh2<tm1b(EUCOMM)Hmgu>	MP:0005562,decreased mean corpuscular hemoglobin|MP:0010067,increased red blood cell distribution width
MGI:1856047	Hbb<d3th>	MP:0000208,decreased hematocrit|MP:0001588,abnormal hemoglobin|MP:0001935,decreased litter size|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002594,low mean erythrocyte cell number|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002813,microcytosis|MP:0002814,hyperchromasia|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005563,abnormal hemoglobin content|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1856044	Hbb<d4>	MP:0000691,enlarged spleen|MP:0001190,reddish skin|MP:0001588,abnormal hemoglobin|MP:0001625,cardiac hypertrophy|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0002446,abnormal macrophage morphology|MP:0002608,increased hematocrit|MP:0002872,polycythemia|MP:0003131,increased erythrocyte cell number|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008476,increased spleen red pulp amount|MP:0009278,abnormal bone marrow cell physiology|MP:0009931,abnormal skin appearance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011236,increased blood oxygen capacity
MGI:5427385	Hbb<d5>	MP:0002169,no abnormal phenotype detected
MGI:5427387	Hbb<d6>	MP:0002169,no abnormal phenotype detected
MGI:5427390	Hbb<d7>	MP:0002169,no abnormal phenotype detected
MGI:2677684	Hbb<s>	MP:0002169,no abnormal phenotype detected
MGI:3843171	Hbb<tm1.1(HBG1,HBB*)Ryan>	MP:0000065,abnormal bone marrow cavity morphology|MP:0000240,extramedullary hematopoiesis|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001770,abnormal iron level|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002810,microcytic anemia|MP:0002875,decreased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008475,intermingled spleen red and white pulp|MP:0008476,increased spleen red pulp amount|MP:0008807,increased liver iron level|MP:0008809,increased spleen iron level|MP:0008850,increased hemoglobin concentration distribution width|MP:0011089,perinatal lethality, complete penetrance
MGI:2664239	Hbb<tm1Tow>	MP:0000321,increased bone marrow cell number|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002874,decreased hemoglobin content|MP:0004952,increased spleen weight|MP:0011091,prenatal lethality, complete penetrance
MGI:1857179	Hbb<tm1Unc>	MP:0000208,decreased hematocrit|MP:0001577,anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002640,reticulocytosis|MP:0002643,poikilocytosis|MP:0003717,pallor|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011089,perinatal lethality, complete penetrance
MGI:1888408	Hbb<tm2Unc>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008807,increased liver iron level|MP:0008809,increased spleen iron level|MP:0008850,increased hemoglobin concentration distribution width|MP:0009703,decreased birth body size|MP:0010375,increased kidney iron level|MP:0011085,postnatal lethality, complete penetrance
MGI:2655703	Hbegf<tm1.1Mek>	MP:0000274,enlarged heart|MP:0001544,abnormal cardiovascular system physiology|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002745,abnormal atrioventricular valve morphology|MP:0002746,abnormal semilunar valve morphology|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0004564,increased myocardial fiber size|MP:0005598,decreased heart ventricle muscle contractility|MP:0008022,dilated heart ventricle|MP:0010224,abnormal heart ventricle outflow tract morphology|MP:0010591,enlarged aortic valve|MP:0010594,thick aortic valve|MP:0010600,enlarged pulmonary valve|MP:0010601,thick pulmonary valve|MP:0010618,enlarged mitral valve|MP:0010620,thick mitral valve|MP:0010627,enlarged tricuspid valve|MP:0010629,thick tricuspid valve|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031570,enlarged atrioventricular valve|MP:0031580,enlarged semilunar valve
MGI:2665039	Hbegf<tm1Dcl>	MP:0000274,enlarged heart|MP:0001178,pulmonary hypoplasia|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002833,increased heart weight|MP:0003869,ectopic cartilage|MP:0005598,decreased heart ventricle muscle contractility|MP:0006027,impaired lung alveolus development|MP:0006117,aortic valve stenosis|MP:0006128,pulmonary valve stenosis|MP:0010574,dilated aorta|MP:0010591,enlarged aortic valve|MP:0010600,enlarged pulmonary valve|MP:0031550,abnormal atrioventricular valve development|MP:0031555,abnormal pulmonary valve development|MP:0031570,enlarged atrioventricular valve|MP:0031575,atrioventricular valve stenosis|MP:0031580,enlarged semilunar valve|MP:0031585,semilunar valve stenosis
MGI:4398735	Hbegf<tm1Hhar>	MP:0001360,abnormal social investigation|MP:0001399,hyperactivity|MP:0008414,abnormal spatial reference memory|MP:0009142,decreased prepulse inhibition|MP:0009745,abnormal behavioral response to xenobiotic|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0031391,increased locomotor activity
MGI:2655700	Hbegf<tm1Mek>	MP:0002169,no abnormal phenotype detected
MGI:2682958	Hbegf<tm2Mek>	MP:0000274,enlarged heart|MP:0000285,abnormal heart valve morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0002083,premature death|MP:0002127,abnormal cardiovascular system morphology|MP:0002652,thin myocardium|MP:0002745,abnormal atrioventricular valve morphology|MP:0002795,dilated cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0005140,decreased cardiac muscle contractility|MP:0005406,abnormal heart size|MP:0010224,abnormal heart ventricle outflow tract morphology|MP:0031570,enlarged atrioventricular valve|MP:0031580,enlarged semilunar valve|MP:0031633,decreased heart left ventricle muscle contractility
MGI:2682961	Hbegf<tm3Mek>	MP:0000278,abnormal myocardial fiber morphology|MP:0001219,thick epidermis|MP:0001265,decreased body size|MP:0001625,cardiac hypertrophy|MP:0011090,perinatal lethality, incomplete penetrance
MGI:4818437	Hbegf<tm4Mek>	MP:0001544,abnormal cardiovascular system physiology|MP:0002745,abnormal atrioventricular valve morphology|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0010224,abnormal heart ventricle outflow tract morphology
MGI:2681991	Hbmd	MP:0005422,osteosclerosis
MGI:2660604	Hbnr1<SWR>	MP:0005026,decreased susceptibility to parasitic infection
MGI:2660606	Hbnr2<SWR>	MP:0002492,decreased IgE level|MP:0002500,granulomatous inflammation|MP:0005026,decreased susceptibility to parasitic infection
MGI:2660608	Hbnr3<SWR>	MP:0005027,increased susceptibility to parasitic infection
MGI:2687249	Hbnr4<SWR>	MP:0002723,abnormal immune serum protein physiology
MGI:2687251	Hbnr5<SWR>	MP:0005026,decreased susceptibility to parasitic infection
MGI:2687253	Hbnr6<SWR>	MP:0002497,increased IgE level
MGI:2687255	Hbnr7<SWR>	MP:0008497,decreased IgG2b level
MGI:2687257	Hbnr8<SWR>	MP:0005026,decreased susceptibility to parasitic infection
MGI:6361942	Hbp1<tm1.1Ohts>	MP:0000781,decreased corpus callosum size|MP:0000787,abnormal telencephalon morphology|MP:0000809,absent hippocampus|MP:0000934,abnormal telencephalon development|MP:0002196,absent corpus callosum|MP:0003077,abnormal cell cycle|MP:0003203,increased neuron apoptosis|MP:0008458,abnormal cortical ventricular zone morphology|MP:0008948,decreased neuron number|MP:0012203,abnormal neuronal stem cell morphology|MP:0012206,increased neuronal stem cell self-renewal|MP:0014558,decreased cortical ventricular zone thickness|MP:0030004,hippocampus hypoplasia
MGI:5766254	Hbq1a<tm1.1(KOMP)Vlcg>	MP:0003131,increased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin
MGI:4126253	Hbs1l<Gt(XE494)Byg>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4887599	Hbs1l<tm1a(KOMP)Wtsi>	MP:0000102,abnormal nasal bone morphology|MP:0000120,malocclusion|MP:0000137,abnormal vertebrae morphology|MP:0000218,increased leukocyte cell number|MP:0000223,decreased monocyte cell number|MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0000445,short snout|MP:0001262,decreased body weight|MP:0001314,cornea opacity|MP:0001325,abnormal retina morphology|MP:0001554,increased circulating free fatty acids level|MP:0001556,increased circulating HDL cholesterol level|MP:0001925,male infertility|MP:0002100,abnormal tooth morphology|MP:0002111,abnormal tail morphology|MP:0002599,increased mean platelet volume|MP:0002687,oligozoospermia|MP:0002968,increased circulating alkaline phosphatase level|MP:0003036,vertebral transformation|MP:0003743,abnormal facial morphology|MP:0003795,abnormal bone structure|MP:0004471,short nasal bone|MP:0004973,increased regulatory T cell number|MP:0005103,abnormal retina pigmentation|MP:0005178,increased circulating cholesterol level|MP:0005270,abnormal zygomatic bone morphology|MP:0005292,improved glucose tolerance|MP:0005505,thrombocytosis|MP:0005561,increased mean corpuscular hemoglobin|MP:0005568,increased circulating total protein level|MP:0008119,decreased Langerhans cell number|MP:0008211,decreased mature B cell number|MP:0008810,increased circulating iron level|MP:0008862,asymmetric snout|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010835,increased CD4-positive, alpha-beta memory T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0010851,decreased effector memory CD8-positive, alpha-beta T cell number|MP:0013421,increased CD5-positive gamma-delta T cell number|MP:0013430,increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0013513,decreased memory-marker CD4-negative NK T cell number|MP:0013764,decreased T-helper cell number
MGI:6718578	Hbs1l<tm1c(KOMP)Wtsi>	MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0000880,decreased Purkinje cell number|MP:0003245,abnormal GABAergic neuron morphology|MP:0003631,nervous system phenotype|MP:0004981,decreased neuronal precursor cell number|MP:0020393,increased neuronal precursor proliferation
MGI:6718579	Hbs1l<tm1d(KOMP)Wtsi>	MP:0001730,embryonic growth arrest|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3707212	Hbtq<C57BL/6J>	MP:0001417,decreased exploration in new environment
MGI:3027637	Hc<0>	MP:0001952,increased airway responsiveness|MP:0002412,increased susceptibility to bacterial infection|MP:0003333,liver fibrosis|MP:0005166,decreased susceptibility to injury|MP:0005376,homeostasis/metabolism phenotype
MGI:3044820	Hc<1>	MP:0002169,no abnormal phenotype detected
MGI:6316148	Hcar1<em1(IMPC)Ccpcz>	MP:0000558,abnormal tibia morphology|MP:0001399,hyperactivity|MP:0002135,abnormal kidney morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003036,vertebral transformation|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004599,abnormal vertebral arch morphology|MP:0005553,increased circulating creatinine level|MP:0013771,decreased effector memory T-helper cell number
MGI:3832418	Hcar1<tm1Dgen>	MP:0008033,impaired lipolysis
MGI:7612088	Hcar1<tm1Lex>	MP:0002792,abnormal retina vasculature morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0004165,abnormal lateral geniculate nucleus morphology|MP:0005253,abnormal eye physiology|MP:0008056,abnormal retina ganglion cell morphology|MP:0009671,abnormal uterus physiology|MP:0012144,decreased b-wave amplitude|MP:0030005,increased retina apoptosis
MGI:6316149	Hcar2<em1(IMPC)Ccpcz>	MP:0000538,abnormal urinary bladder morphology
MGI:2653103	Hcar2<tm1Soff>	MP:0002118,abnormal lipid homeostasis
MGI:3826866	Hccs<tm1Tcc>	MP:0000274,enlarged heart|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0002953,thick ventricular wall|MP:0003140,dilated heart atrium|MP:0003567,abnormal fetal cardiomyocyte proliferation|MP:0004215,abnormal myocardial fiber physiology|MP:0005329,abnormal myocardium layer morphology|MP:0005608,cardiac interstitial fibrosis|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0010519,atrioventricular block|MP:0010520,sinoatrial block|MP:0010636,bundle branch block|MP:0010955,abnormal respiratory electron transport chain|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0014072,decreased cardiac muscle glycogen level|MP:0031607,abnormal fetal cardiomyocyte mitochondrial morphology|MP:0031608,decreased fetal cardiomyocyte size
MGI:6860324	Hcfc1<em1Poche>	MP:0000102,abnormal nasal bone morphology|MP:0000208,decreased hematocrit|MP:0000373,belly spot|MP:0000438,abnormal cranium morphology|MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004377,small frontal bone|MP:0004418,small parietal bone|MP:0004470,small nasal bone|MP:0005332,abnormal amino acid level|MP:0005352,small cranium|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006254,thin cerebral cortex|MP:0006411,upturned snout|MP:0010499,abnormal ventricle myocardium morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011277,decreased tail pigmentation|MP:0012085,midface hypoplasia|MP:0012335,increased circulating homocysteine level|MP:0030066,short face|MP:0030630,increased circulating methylmalonic acid level|MP:0030930,decreased digit pigmentation
MGI:5787629	Hcfc1<tm1Lwh>	MP:0000352,decreased cell proliferation|MP:0001258,decreased body length|MP:0001698,decreased embryo size|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003961,decreased lean body mass|MP:0005517,impaired liver regeneration|MP:0006042,increased apoptosis|MP:0011092,embryonic lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014134,abnormal embryo morphology
MGI:6108107	Hcfc2<em1Btlr>	MP:0008561,decreased tumor necrosis factor secretion
MGI:5445585	Hcfc2<fkls>	MP:0002419,abnormal innate immunity|MP:0008561,decreased tumor necrosis factor secretion|MP:0008565,decreased interferon-beta secretion|MP:0008574,decreased circulating interferon-alpha level|MP:0008576,decreased circulating interferon-beta level|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality|MP:0031046,increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:3046690	Hcif1<C57BR/cdJ>	MP:0002021,increased incidence of induced tumors|MP:0010264,increased hepatoma incidence
MGI:3663799	Hck<tm1Ern>	MP:0001177,atelectasis|MP:0001179,thick pulmonary interalveolar septum|MP:0001183,overexpanded pulmonary alveolus|MP:0001790,abnormal immune system physiology|MP:0001861,lung inflammation|MP:0001954,respiratory distress|MP:0001958,emphysema|MP:0002027,increased lung adenocarcinoma incidence|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002451,abnormal macrophage physiology|MP:0004202,pulmonary hyperplasia|MP:0005011,increased eosinophil cell number|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006050,pulmonary fibrosis|MP:0008245,abnormal alveolar macrophage morphology|MP:0008553,increased circulating tumor necrosis factor level|MP:0008702,increased interleukin-5 secretion|MP:0010942,abnormal respiratory epithelium morphology|MP:0010944,respiratory epithelium hypertrophy|MP:0011045,decreased lung elastance
MGI:2384049	Hck<tm1Hev>	MP:0001798,impaired macrophage phagocytosis|MP:0001845,abnormal inflammatory response|MP:0002463,abnormal neutrophil physiology
MGI:7425737	Hcls1<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001333,absent optic nerve|MP:0002092,abnormal eye morphology|MP:0003917,increased kidney weight
MGI:3623117	Hcls1<tm1Wtn>	MP:0001800,abnormal humoral immune response|MP:0002459,abnormal B cell physiology|MP:0005017,decreased B cell number|MP:0005095,decreased T cell proliferation
MGI:3623118	Hcls1<tm2Wtn>	MP:0001800,abnormal humoral immune response|MP:0002459,abnormal B cell physiology|MP:0005017,decreased B cell number|MP:0005095,decreased T cell proliferation
MGI:6153798	Hcn1<em1(IMPC)H>	MP:0000745,tremors|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0002833,increased heart weight|MP:0004738,abnormal auditory brainstem response|MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval
MGI:6268766	Hcn1<M1Btlr>	MP:0005333,decreased heart rate
MGI:5293229	Hcn1<tm1.1Lex>	MP:0001970,abnormal pain threshold|MP:0002272,abnormal nervous system electrophysiology
MGI:2686950	Hcn1<tm1Kndl>	MP:0002169,no abnormal phenotype detected|MP:0005386,behavior/neurological phenotype
MGI:2686951	Hcn1<tm2Kndl>	MP:0001463,abnormal spatial learning|MP:0002063,abnormal learning/memory/conditioning|MP:0002797,increased thigmotaxis|MP:0002804,abnormal motor learning|MP:0002807,abnormal eye blink conditioning behavior|MP:0003360,abnormal depression-related behavior|MP:0003393,decreased cardiac output|MP:0003928,increased heart rate variability|MP:0004085,abnormal heartbeat|MP:0004215,abnormal myocardial fiber physiology|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential|MP:0006142,abnormal sinoatrial node conduction|MP:0010504,abnormal RR interval|MP:0010520,sinoatrial block|MP:0010637,sinus bradycardia
MGI:3838227	Hcn2<ap>	MP:0000745,tremors|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001409,increased stereotypic behavior|MP:0001504,abnormal posture|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0001924,infertility|MP:0002083,premature death|MP:0002572,abnormal emotion/affect behavior|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003216,absence seizures|MP:0003312,abnormal locomotor coordination|MP:0003360,abnormal depression-related behavior|MP:0003997,tonic-clonic seizures|MP:0008840,abnormal spike wave discharge|MP:0011940,decreased food intake
MGI:6114037	Hcn2<m1Btlr>	MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:6269370	Hcn2<m2Btlr>	MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001525,impaired balance
MGI:6285968	Hcn2<m3Btlr>	MP:0001262,decreased body weight
MGI:6305115	Hcn2<m4Btlr>	MP:0001262,decreased body weight
MGI:5295434	Hcn2<tm1.1Lex>	MP:0001968,abnormal touch/nociception|MP:0001973,increased thermal nociceptive threshold|MP:0002736,abnormal nociception after inflammation|MP:0008531,increased chemical nociceptive threshold
MGI:5295435	Hcn2<tm1.2Lex>	MP:0001393,ataxia|MP:0002083,premature death|MP:0004811,abnormal neuron physiology|MP:0005402,abnormal action potential
MGI:2449917	Hcn2<tm1Ldw>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001636,irregular heartbeat|MP:0002272,abnormal nervous system electrophysiology|MP:0003216,absence seizures|MP:0003412,abnormal afterhyperpolarization|MP:0003470,abnormal summary potential|MP:0003488,decreased channel response intensity|MP:0006142,abnormal sinoatrial node conduction
MGI:3582957	Hcn2<trls>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0003631,nervous system phenotype|MP:0005159,azoospermia|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3810301	Hcn2<trls-2J>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5443894	Hcn3<tm1.1Biel>	MP:0003233,prolonged QT interval|MP:0004215,abnormal myocardial fiber physiology|MP:0005402,abnormal action potential|MP:0010505,abnormal T wave
MGI:4888968	Hcn4<tm1.1Ggc>	MP:0002083,premature death|MP:0003137,abnormal impulse conducting system conduction|MP:0005333,decreased heart rate|MP:0006142,abnormal sinoatrial node conduction|MP:0010519,atrioventricular block|MP:0011953,prolonged PQ interval
MGI:2684538	Hcn4<tm1.1Jsr>	MP:0001629,abnormal heart rate|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3809312	Hcn4<tm1(cre/ERT2)Anlu>	MP:0002169,no abnormal phenotype detected|MP:0005385,cardiovascular system phenotype
MGI:2684537	Hcn4<tm1Jsr>	MP:0003137,abnormal impulse conducting system conduction|MP:0005333,decreased heart rate|MP:0010520,sinoatrial block|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5560747	Hcn4<tm1Nnka>	MP:0002272,abnormal nervous system electrophysiology|MP:0002741,small olfactory bulb|MP:0009948,abnormal olfactory bulb glomerular layer morphology
MGI:3775108	Hcn4<tm1Rsei>	MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4418969	Hcn4<tm1Sev>	MP:0002169,no abnormal phenotype detected
MGI:5529675	Hcn4<tm2.1(cre/ERT2)Sev>	MP:0011092,embryonic lethality, complete penetrance
MGI:5529677	Hcn4<tm3Sev>	MP:0011092,embryonic lethality, complete penetrance
MGI:1856895	hcp	MP:0000164,abnormal cartilage development|MP:0001265,decreased body size|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002427,disproportionate dwarf|MP:0003723,abnormal long bone morphology|MP:0004686,decreased length of long bones|MP:0030876,abnormal costochondral joint morphology
MGI:3604598	Hcrtr1<tm1Dgen>	MP:0002556,abnormal cocaine consumption|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0012341,low preference for an addictive substance
MGI:5000034	Hcrtr1<tm1Mmsc>	MP:0003360,abnormal depression-related behavior|MP:0005386,behavior/neurological phenotype
MGI:4949132	Hcrtr2<tm1Tesc>	MP:0003360,abnormal depression-related behavior|MP:0004142,abnormal muscle tone|MP:0004811,abnormal neuron physiology|MP:0005279,narcolepsy|MP:0005386,behavior/neurological phenotype|MP:0009436,fragmentation of sleep/wake states
MGI:2664995	Hcrtr2<tm1Ywa>	MP:0001501,abnormal sleep pattern|MP:0005279,narcolepsy|MP:0012288,abnormal paradoxical sleep pattern|MP:0012289,abnormal non-rapid eye movement sleep pattern
MGI:5582427	Hcrt<tm1.1(KOMP)Vlcg>	MP:0001402,decreased locomotor activity|MP:0005013,increased lymphocyte cell number|MP:0005333,decreased heart rate|MP:0010053,decreased grip strength|MP:0010506,prolonged RR interval
MGI:2151182	Hcrt<tm1Ywa>	MP:0000230,abnormal systemic arterial blood pressure|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001501,abnormal sleep pattern|MP:0001504,abnormal posture|MP:0002272,abnormal nervous system electrophysiology|MP:0002574,increased vertical activity|MP:0002626,increased heart rate|MP:0003212,increased susceptibility to age related obesity|MP:0003313,abnormal locomotor activation|MP:0004142,abnormal muscle tone|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005279,narcolepsy|MP:0005573,increased pulmonary respiratory rate|MP:0008035,behavioral arrest|MP:0009436,fragmentation of sleep/wake states|MP:0011020,abnormal circadian temperature homeostasis|MP:0012287,increased frequency of paradoxical sleep|MP:0012288,abnormal paradoxical sleep pattern|MP:0012289,abnormal non-rapid eye movement sleep pattern
MGI:2156892	Hcs1<C3H/He>	MP:0010264,increased hepatoma incidence
MGI:2157085	Hcs2<C3H/He>	MP:0010264,increased hepatoma incidence
MGI:2157086	Hcs3<A/J>	MP:0010264,increased hepatoma incidence
MGI:2155988	Hcs5<C3H/He>	MP:0010264,increased hepatoma incidence
MGI:2446816	Hcs6<M. spretus>	MP:0010264,increased hepatoma incidence
MGI:2154096	Hcs7<C3H/HeJ>	MP:0002021,increased incidence of induced tumors|MP:0010264,increased hepatoma incidence
MGI:2154095	Hcs7<C57BL/6J>	MP:0010266,decreased liver tumor incidence
MGI:3046654	Hcs8<CBA/J>	MP:0002021,increased incidence of induced tumors|MP:0010264,increased hepatoma incidence
MGI:3046659	Hcs9<C57BR/cdJ>	MP:0002021,increased incidence of induced tumors|MP:0010264,increased hepatoma incidence
MGI:2446491	Hcst<tm1.1Cln>	MP:0000067,osteopetrosis|MP:0000130,abnormal trabecular bone morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0001541,abnormal osteoclast physiology|MP:0001921,reduced fertility|MP:0004256,abnormal maternal decidual layer morphology|MP:0004260,enlarged placenta|MP:0004985,decreased osteoclast cell number|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005387,immune system phenotype|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008396,abnormal osteoclast differentiation|MP:0008567,decreased interferon-gamma secretion|MP:0008876,decreased uterine NK cell number|MP:0010875,increased bone volume|MP:0012529,abnormal decidua basalis morphology
MGI:3843505	Hcst<tm1.1Dnax>	MP:0001273,decreased metastatic potential|MP:0003447,decreased tumor growth/size|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004952,increased spleen weight|MP:0005025,abnormal response to infection|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005324,ascites|MP:0005387,immune system phenotype|MP:0008042,abnormal NK T cell physiology|MP:0008566,increased interferon-gamma secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008699,increased interleukin-4 secretion|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5620313	Hcst<tm1b(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0010123,increased bone mineral content
MGI:5605841	Hc<tm1b(EUCOMM)Wtsi>	MP:0010053,decreased grip strength|MP:0013278,decreased fasting circulating glucose level
MGI:3622240	Hctq1<NZW/LacJ>	MP:0002608,increased hematocrit
MGI:5463976	Hdac10<tm1.1(KOMP)Mbp>	MP:0002968,increased circulating alkaline phosphatase level
MGI:6156292	Hdac11<em1(IMPC)Kmpc>	MP:0002941,increased circulating alanine transaminase level
MGI:5707970	Hdac11<tm1.2Mrl>	MP:0003721,increased tumor growth/size|MP:0008567,decreased interferon-gamma secretion|MP:0008660,increased interleukin-10 secretion
MGI:3586552	Hdac1<MommeD5>	MP:0001730,embryonic growth arrest|MP:0003984,embryonic growth retardation|MP:0011091,prenatal lethality, complete penetrance
MGI:3717923	Hdac1<tm1.1Eno>	MP:0000377,abnormal hair follicle morphology|MP:0000383,abnormal hair follicle orientation|MP:0000384,distorted hair follicle pattern|MP:0000402,abnormal zigzag hair morphology|MP:0000414,alopecia|MP:0000417,short hair|MP:0000575,increased foot pad pigmentation|MP:0000579,abnormal nail morphology|MP:0000647,abnormal sebaceous gland morphology|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001242,hyperkeratosis|MP:0001265,decreased body size|MP:0001282,short vibrissae|MP:0001340,abnormal eyelid morphology|MP:0001510,abnormal coat appearance|MP:0002015,epithelioid cyst|MP:0002098,abnormal vibrissa morphology|MP:0002111,abnormal tail morphology|MP:0002169,no abnormal phenotype detected|MP:0002655,abnormal keratinocyte morphology|MP:0002656,abnormal keratinocyte differentiation|MP:0003704,abnormal hair follicle development|MP:0003809,abnormal hair shaft morphology|MP:0003812,abnormal hair medulla|MP:0005287,narrow eye opening|MP:0009598,thin epidermis stratum granulosum|MP:0010037,ectopic melanocytes|MP:0010683,dilated hair follicle infundibulum|MP:0011276,increased tail pigmentation|MP:0012404,abnormal nail color|MP:0012405,abnormal nail matrix morphology|MP:0013740,Meibomian gland hyperplasia|MP:0030038,abnormal periorbital region morphology
MGI:5494616	Hdac1<tm1.1Mrl>	MP:0005370,liver/biliary system phenotype|MP:0005397,hematopoietic system phenotype
MGI:4440556	Hdac1<tm1.1Pmt>	MP:0000352,decreased cell proliferation
MGI:5485390	Hdac1<tm1.1Shmc>	MP:0005387,immune system phenotype
MGI:3717925	Hdac1<tm1.2Eno>	MP:0011092,embryonic lethality, complete penetrance
MGI:4440558	Hdac1<tm1.2Pmt>	MP:0003077,abnormal cell cycle|MP:0011092,embryonic lethality, complete penetrance
MGI:5548383	Hdac1<tm1b(EUCOMM)Wtsi>	MP:0001417,decreased exploration in new environment|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance
MGI:2183177	Hdac1<tm1Sei>	MP:0001726,abnormal allantois morphology|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012176,abnormal head development
MGI:7425738	Hdac2<em1(IMPC)Kmpc>	MP:0001404,no spontaneous movement|MP:0001491,unresponsive to tactile stimuli|MP:0011100,preweaning lethality, complete penetrance
MGI:3712002	Hdac2<Gt(W035F03)Joe>	MP:0000274,enlarged heart|MP:0000511,abnormal intestinal mucosa morphology|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001544,abnormal cardiovascular system physiology|MP:0002127,abnormal cardiovascular system morphology|MP:0002175,decreased brain weight|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002953,thick ventricular wall|MP:0003429,insensitivity to growth hormone|MP:0004093,diffuse Z line|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004610,small vertebrae|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005202,lethargy|MP:0005329,abnormal myocardium layer morphology|MP:0005385,cardiovascular system phenotype|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011394,increased fetal cardiomyocyte proliferation|MP:0013916,decreased intestine length|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014730,abnormal myocardial fiber myofibril morphology|MP:0030564,thick myocardium compact layer
MGI:3717927	Hdac2<tm1.1Eno>	MP:0002169,no abnormal phenotype detected
MGI:5485392	Hdac2<tm1.1Shmc>	MP:0005387,immune system phenotype
MGI:3717930	Hdac2<tm1.2Eno>	MP:0001575,cyanosis|MP:0003920,abnormal heart right ventricle morphology|MP:0005333,decreased heart rate|MP:0010724,thick interventricular septum|MP:0011087,neonatal lethality, complete penetrance|MP:0011392,increased fetal cardiomyocyte apoptosis|MP:0011394,increased fetal cardiomyocyte proliferation
MGI:4440562	Hdac2<tm1.2Pmt>	MP:0009703,decreased birth body size|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3844984	Hdac2<tm1.2Rdp>	MP:0000812,abnormal dentate gyrus morphology|MP:0001265,decreased body size|MP:0001921,reduced fertility|MP:0003008,enhanced long-term potentiation|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0009453,enhanced contextual conditioning behavior|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5613704	Hdac2<tm1Lex>	MP:0000266,abnormal heart morphology|MP:0005551,abnormal eye electrophysiology|MP:0011087,neonatal lethality, complete penetrance|MP:0011963,abnormal total retina thickness|MP:0012050,decreased susceptilbility to retina ischemic injury
MGI:3831693	Hdac3<tm1.1Eno>	MP:0000266,abnormal heart morphology|MP:0001547,abnormal lipid level|MP:0001625,cardiac hypertrophy|MP:0001728,failure of embryo implantation|MP:0001926,female infertility|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0003845,abnormal decidualization|MP:0004896,abnormal endometrium morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0005406,abnormal heart size|MP:0005608,cardiac interstitial fibrosis|MP:0009662,abnormal uterine receptivity|MP:0009666,abnormal embryo attachment|MP:0009671,abnormal uterus physiology|MP:0010954,abnormal cellular respiration|MP:0011635,abnormal mitochondrial crista morphology|MP:0013399,endometrium fibrosis|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0020253,increased collagen level|MP:0031418,increased cardiac muscle triglyceride level|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4889069	Hdac3<tm1.1Laz>	MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002628,hepatic steatosis|MP:0005150,cachexia|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014368,enhanced long-term object recognition memory
MGI:3793479	Hdac3<tm1.1Swh>	MP:0011092,embryonic lethality, complete penetrance
MGI:3831694	Hdac3<tm1.2Eno>	MP:0001695,abnormal gastrulation|MP:0011092,embryonic lethality, complete penetrance
MGI:4433408	Hdac3<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6441050	Hdac4<em1Hcu>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001431,abnormal eating behavior|MP:0001432,abnormal food preference|MP:0001441,increased grooming behavior|MP:0002757,decreased vertical activity|MP:0002803,abnormal operant conditioning behavior|MP:0003063,increased coping response|MP:0003863,decreased aggression towards mice|MP:0005455,increased susceptibility to weight gain|MP:0010182,decreased susceptibility to weight gain|MP:0011939,increased food intake|MP:0011940,decreased food intake
MGI:6341845	Hdac4<em1(IMPC)Ccpcz>	MP:0001404,no spontaneous movement|MP:0002968,increased circulating alkaline phosphatase level|MP:0008044,increased NK cell number
MGI:4294162	Hdac4<Gt(OST361114)Lex>	MP:0000947,convulsive seizures|MP:0001262,decreased body weight|MP:0001973,increased thermal nociceptive threshold|MP:0001994,increased blinking frequency|MP:0002826,tonic seizures|MP:0003492,abnormal involuntary movement|MP:0003631,nervous system phenotype|MP:0005390,skeleton phenotype|MP:0008840,abnormal spike wave discharge|MP:0009358,environmentally induced seizures|MP:0031391,increased locomotor activity
MGI:3525071	Hdac4<tm1Eno>	MP:0000137,abnormal vertebrae morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000440,domed cranium|MP:0000914,exencephaly|MP:0001265,decreased body size|MP:0003417,premature endochondral bone ossification|MP:0005369,muscle phenotype|MP:0006432,abnormal costal cartilage morphology|MP:0008271,abnormal bone ossification|MP:0011085,postnatal lethality, complete penetrance|MP:0030356,premature lambdoid suture closure
MGI:4418117	Hdac4<tm2.1Eno>	MP:0004243,abnormal motor nerve collateral sprouting|MP:0005369,muscle phenotype
MGI:3056065	Hdac5<tm1Eno>	MP:0001625,cardiac hypertrophy|MP:0005369,muscle phenotype
MGI:3776868	Hdac6<tm1.1Pmt>	MP:0000062,increased bone mineral density|MP:0001260,increased body weight|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0003631,nervous system phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0008594,decreased circulating interleukin-10 level|MP:0008661,decreased interleukin-10 secretion|MP:0010123,increased bone mineral content
MGI:5693117	Hdac6<tm1.1Tyao>	MP:0003091,abnormal cell migration
MGI:5792141	Hdac6<tm1Anfi>	MP:0003631,nervous system phenotype|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0008414,abnormal spatial reference memory
MGI:3759271	Hdac6<tm1Pmt>	MP:0002169,no abnormal phenotype detected
MGI:6509076	Hdac7<tm1b(EUCOMM)Hmgu>	MP:0002075,abnormal coat/hair pigmentation|MP:0002968,increased circulating alkaline phosphatase level|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3693627	Hdac7<tm1Eno>	MP:0000280,thin ventricular wall|MP:0001622,abnormal vasculogenesis|MP:0001634,internal hemorrhage|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0003140,dilated heart atrium|MP:0004783,abnormal cardinal vein morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0005312,pericardial effusion|MP:0006055,abnormal vascular endothelial cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3851814	Hdac8<tm1.1Eno>	MP:0001915,intracranial hemorrhage|MP:0002169,no abnormal phenotype detected|MP:0004378,frontal bone foramen|MP:0005389,reproductive system phenotype|MP:0008276,failure of intramembranous bone ossification|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3851815	Hdac8<tm1.2Eno>	MP:0000914,exencephaly|MP:0001915,intracranial hemorrhage|MP:0003121,genetic imprinting|MP:0004023,abnormal chromosome number|MP:0004378,frontal bone foramen|MP:0004920,increased placenta weight|MP:0008276,failure of intramembranous bone ossification|MP:0008957,abnormal placenta junctional zone morphology|MP:0008959,abnormal spongiotrophoblast cell morphology|MP:0009429,decreased embryo weight|MP:0010038,abnormal placenta physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014321,short forelimb|MP:0014760,impaired DNA repair
MGI:4432268	Hdac8<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0010124,decreased bone mineral content
MGI:2387834	Hdac9<tm1Eno>	MP:0001625,cardiac hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0005369,muscle phenotype
MGI:2182618	Hdc<tm1Nagy>	MP:0000005,increased brown adipose tissue amount|MP:0000008,increased white adipose tissue amount|MP:0000336,decreased mast cell number|MP:0000359,abnormal mast cell morphology|MP:0000361,decreased mast cell protease storage|MP:0000362,decreased mast cell histamine storage|MP:0000836,abnormal substantia nigra morphology|MP:0001261,obese|MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0001906,increased dopamine level|MP:0001973,increased thermal nociceptive threshold|MP:0002063,abnormal learning/memory/conditioning|MP:0002079,increased circulating insulin level|MP:0002152,abnormal brain morphology|MP:0002734,abnormal mechanical nociception|MP:0002799,abnormal passive avoidance behavior|MP:0004077,abnormal striatum morphology|MP:0005293,impaired glucose tolerance|MP:0005386,behavior/neurological phenotype|MP:0005450,abnormal energy expenditure|MP:0005455,increased susceptibility to weight gain|MP:0005669,increased circulating leptin level|MP:0008531,increased chemical nociceptive threshold|MP:0009118,increased white fat cell size|MP:0009142,decreased prepulse inhibition|MP:0009288,increased epididymal fat pad weight|MP:0009294,increased interscapular fat pad weight|MP:0013894,abnormal behavioral response to amphetamine
MGI:6153799	Hddc2<em1(IMPC)H>	MP:0000219,increased neutrophil cell number|MP:0001399,hyperactivity|MP:0001566,increased circulating phosphate level|MP:0002606,increased basophil cell number|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0010088,decreased circulating fructosamine level
MGI:5695919	Hddc3<tm1.1(KOMP)Vlcg>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001925,male infertility|MP:0001944,abnormal pancreas morphology|MP:0002135,abnormal kidney morphology|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level
MGI:6156453	Hdgfl1<em1(IMPC)Tcp>	MP:0001147,small testis|MP:0002833,increased heart weight|MP:0005419,decreased circulating serum albumin level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6459764	Hdgfl1<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5605750	Hdgfl2<tm1b(KOMP)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5007175	Hdgfl2<tm1Lex>	MP:0002968,increased circulating alkaline phosphatase level|MP:0011704,decreased fibroblast proliferation
MGI:6156464	Hdgfl3<em1(IMPC)Tcp>	MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0011874,enlarged urinary bladder
MGI:3798476	Hdgf<tm1Sefr>	MP:0002757,decreased vertical activity
MGI:5300462	Hdhd2<Tn(sb-Tyr)1799B.CA8Ove>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:2680127	Hdis<C57BL/6J>	MP:0001392,abnormal locomotor behavior
MGI:2154922	Hdl1<C57BL/6J>	MP:0001556,increased circulating HDL cholesterol level
MGI:2156039	Hdl2<CAST/EiJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3521765	Hdl34<C3H/HeJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3586848	Hdl35<C57BL/6J>	MP:0000186,decreased circulating HDL cholesterol level
MGI:3586849	Hdl36<C3H/HeJ>	MP:0000186,decreased circulating HDL cholesterol level
MGI:3521767	Hdl37<C3H/HeJ>	MP:0002830,gallstones
MGI:3521769	Hdl39<C3H/HeJ>	MP:0002830,gallstones
MGI:2429579	Hdl3<C57BL/6J>	MP:0001556,increased circulating HDL cholesterol level
MGI:3586978	Hdl40<C57BL/6J>	MP:0000186,decreased circulating HDL cholesterol level
MGI:2429738	Hdl4<CAST/EiJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3037014	Hdl5<C57BL/6J>	MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level
MGI:3037017	Hdl6<DBA/2J>	MP:0001556,increased circulating HDL cholesterol level
MGI:2663743	Hdl7<DBA/2J>	MP:0001556,increased circulating HDL cholesterol level
MGI:6367972	Hdlbp<em1(IMPC)H>	MP:0011100,preweaning lethality, complete penetrance
MGI:3528046	Hdlcl1<C57BL/6J>	MP:0001556,increased circulating HDL cholesterol level
MGI:4367718	Hdlk	MP:0000565,oligodactyly|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0008730,fused phalanges|MP:0014281,hindlimb oligodactyly
MGI:3840004	Hdlq102<129S1/SvImJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:2663756	Hdlq10<CAST/Ei>	MP:0001556,increased circulating HDL cholesterol level
MGI:2663762	Hdlq11<DBA/2J>	MP:0001556,increased circulating HDL cholesterol level
MGI:2663764	Hdlq12<DBA/2J>	MP:0001556,increased circulating HDL cholesterol level
MGI:3037951	Hdlq13<129S1/SvImJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3038657	Hdlq14<129S1/SvImJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3038659	Hdlq15<129S1/SvImJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3038661	Hdlq16<129S1/SvImJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3038655	Hdlq17<129S1/SvImJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3038663	Hdlq18<129S1/SvImJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3041307	Hdlq20<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3041309	Hdlq21<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3041414	Hdlq22<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3041416	Hdlq23<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3041418	Hdlq24<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3041421	Hdlq25<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3041423	Hdlq26<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3041426	Hdlq27<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3041428	Hdlq28<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3041430	Hdlq29<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:2387159	Hdlq2<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3041432	Hdlq30<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3041436	Hdlq31<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3041438	Hdlq32<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3664895	Hdlq33<PERA/EiJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3664899	Hdlq34<PERA/EiJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3664904	Hdlq35<PERA/EiJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3664909	Hdlq37<PERA/EiJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:2387164	Hdlq3<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3688198	Hdlq42<A/J>	MP:0001556,increased circulating HDL cholesterol level
MGI:3688214	Hdlq43<C57BL/6J>	MP:0001556,increased circulating HDL cholesterol level
MGI:3688203	Hdlq44<C57BL/6J>	MP:0001556,increased circulating HDL cholesterol level
MGI:3688226	Hdlq45<C57BL/6J>	MP:0001556,increased circulating HDL cholesterol level
MGI:3688230	Hdlq46<C57BL/6J>	MP:0001556,increased circulating HDL cholesterol level
MGI:3688233	Hdlq47<C57BL/6J>	MP:0001556,increased circulating HDL cholesterol level
MGI:3688236	Hdlq48<C57BL/6J>	MP:0001556,increased circulating HDL cholesterol level
MGI:3688208	Hdlq49<C57BL/6J>	MP:0001556,increased circulating HDL cholesterol level
MGI:3688218	Hdlq50<C57BL/6J>	MP:0001556,increased circulating HDL cholesterol level
MGI:3688222	Hdlq51<C57BL/6J>	MP:0001556,increased circulating HDL cholesterol level
MGI:3839830	Hdlq52<129S1/SvImJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3839974	Hdlq53<129S1/SvImJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3839983	Hdlq54<129S1/SvImJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3839989	Hdlq55<129S1/SvImJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3839993	Hdlq56<C57BL/6J>	MP:0001556,increased circulating HDL cholesterol level
MGI:3839996	Hdlq57<129S1/SvImJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3038132	Hdlq5<C57BL/6J>	MP:0000186,decreased circulating HDL cholesterol level
MGI:3038134	Hdlq5<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3037952	Hdlq67<129S1/SvImJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3038136	Hdlq6<C57BL/6J>	MP:0000186,decreased circulating HDL cholesterol level
MGI:3038137	Hdlq6<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3038138	Hdlq7<C57BL/6J>	MP:0000186,decreased circulating HDL cholesterol level
MGI:3038139	Hdlq7<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3664897	Hdlq83<PERA/EiJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3041095	Hdlq89<RIIIS/J>	MP:0001556,increased circulating HDL cholesterol level
MGI:3041096	Hdlq90<RIIIS/J>	MP:0001556,increased circulating HDL cholesterol level
MGI:3839758	Hdlq92<C57BL/6J>	MP:0001556,increased circulating HDL cholesterol level
MGI:3041093	Hdlq99<129S1/SvImJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:6400426	Hdnr<em1Bbr>	MP:0003916,decreased heart left ventricle weight|MP:0005599,increased cardiac muscle contractility|MP:0005629,abnormal lung weight
MGI:3037031	Hdp1<Jrt>	MP:0000233,abnormal blood flow velocity|MP:0002747,abnormal aortic valve morphology|MP:0002844,aortic hypertrophy|MP:0005385,cardiovascular system phenotype|MP:0008022,dilated heart ventricle|MP:0008772,increased heart ventricle size
MGI:3870446	Hdx<Gt(CD0231)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:3757589	He	MP:0000022,abnormal ear shape|MP:0000063,decreased bone mineral density|MP:0000088,short mandible|MP:0001265,decreased body size|MP:0003713,abnormal ear rotation|MP:0005377,hearing/vestibular/ear phenotype|MP:0008525,decreased cranium height|MP:0010124,decreased bone mineral content
MGI:2669649	Heal10<MRL/MpJ>	MP:0002724,enhanced wound healing
MGI:2669652	Heal11<C57BL/6J>	MP:0002724,enhanced wound healing
MGI:3051556	Heal12<CAST/EiJ>	MP:0002724,enhanced wound healing
MGI:3051558	Heal13<CAST/EiJ>	MP:0002724,enhanced wound healing
MGI:2669653	Heal14<C57BL/6J>	MP:0002724,enhanced wound healing
MGI:2669654	Heal17<C57BL/6J>	MP:0002724,enhanced wound healing
MGI:2669655	Heal18<C57BL/6J>	MP:0002724,enhanced wound healing
MGI:2157054	Heal1<C57BL/6NTac>	MP:0002724,enhanced wound healing
MGI:2669658	Heal21<C57BL/6J>	MP:0002724,enhanced wound healing
MGI:2389287	Heal2<MRL/MpJ>	MP:0002724,enhanced wound healing
MGI:2389291	Heal3<MRL/MpJ>	MP:0002724,enhanced wound healing
MGI:2669643	Heal4<MRL/MpJ>	MP:0002724,enhanced wound healing
MGI:2669645	Heal5<MRL/MpJ>	MP:0002724,enhanced wound healing
MGI:2156806	Heal6<MRL/MpJ>	MP:0002724,enhanced wound healing
MGI:2389293	Heal7<MRL/MpJ>	MP:0002724,enhanced wound healing
MGI:2389295	Heal8<MRL/MpJ>	MP:0002724,enhanced wound healing
MGI:4435825	Heatr3<tm1a(EUCOMM)Hmgu>	MP:0003443,increased circulating glycerol level
MGI:7484555	Heatr4<em1(IMPC)J>	MP:0002834,decreased heart weight
MGI:7541217	Heatr5b<em1Jgg>	MP:0014257,embryonic lethality prior to tooth bud stage, complete penetrance
MGI:6324674	Heca<em1(IMPC)J>	MP:0001556,increased circulating HDL cholesterol level|MP:0003961,decreased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0010024,increased total body fat amount
MGI:5313700	Hectd1<b2b327Clo>	MP:0000272,abnormal aorta morphology|MP:0000273,overriding aortic valve|MP:0002746,abnormal semilunar valve morphology|MP:0002748,abnormal pulmonary valve morphology|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010469,ascending aorta hypoplasia|MP:0010476,coronary fistula|MP:0010541,aorta hypoplasia
MGI:3706565	Hectd1<Gt(XC266)Byg>	MP:0000074,abnormal neurocranium morphology|MP:0000107,abnormal frontal bone morphology|MP:0000109,abnormal parietal bone morphology|MP:0000914,exencephaly|MP:0001297,microphthalmia|MP:0001299,abnormal eye distance/ position|MP:0002085,abnormal embryonic tissue morphology|MP:0002092,abnormal eye morphology|MP:0003935,abnormal craniofacial development|MP:0004383,absent interparietal bone|MP:0004838,abnormal neural fold elevation formation|MP:0030028,absent exoccipital bone|MP:0030329,absent temporal bone petrous part
MGI:2137552	Hectd1<opm>	MP:0000074,abnormal neurocranium morphology|MP:0000107,abnormal frontal bone morphology|MP:0000109,abnormal parietal bone morphology|MP:0000914,exencephaly|MP:0001297,microphthalmia|MP:0001299,abnormal eye distance/ position|MP:0002092,abnormal eye morphology|MP:0003631,nervous system phenotype|MP:0003935,abnormal craniofacial development|MP:0004383,absent interparietal bone|MP:0004838,abnormal neural fold elevation formation|MP:0006301,abnormal mesenchyme morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011260,abnormal head mesenchyme morphology|MP:0030028,absent exoccipital bone|MP:0030329,absent temporal bone petrous part
MGI:5605813	Hectd1<tm1b(EUCOMM)Hmgu>	MP:0000194,increased circulating calcium level|MP:0002075,abnormal coat/hair pigmentation|MP:0002606,increased basophil cell number|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005011,increased eosinophil cell number
MGI:5548812	Hectd2<tm1b(KOMP)Wtsi>	MP:0000149,abnormal scapula morphology|MP:0002631,abnormal epididymis morphology|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content
MGI:6256423	Hectd3<tm1Lex>	MP:0002411,decreased susceptibility to bacterial infection|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008576,decreased circulating interferon-beta level|MP:0008597,decreased circulating interleukin-6 level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:4880080	Hectd3<tm1(NCOM)Cmhd>	MP:0000063,decreased bone mineral density|MP:0000601,small liver|MP:0000692,small spleen|MP:0000706,small thymus|MP:0000774,decreased brain size|MP:0001258,decreased body length|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002188,small heart|MP:0002691,small stomach|MP:0003641,small lung|MP:0003795,abnormal bone structure|MP:0005599,increased cardiac muscle contractility|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:6120795	Hecw1<tm2b(EUCOMM)Hmgu>	MP:0000745,tremors|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001566,increased circulating phosphate level|MP:0013278,decreased fasting circulating glucose level
MGI:6720293	Hecw2<tm1.1Fhe>	MP:0000477,abnormal intestine morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0009854,impaired gastric peristalsis|MP:0010801,abnormal myenteric nerve plexus morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0013958,decreased small intestine length|MP:0020394,decreased neuronal precursor proliferation
MGI:4441860	Hecw2<tm1a(EUCOMM)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5635160	Heg1<tm1.1(KOMP)Vlcg>	MP:0005561,increased mean corpuscular hemoglobin|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3838392	Heg1<tm1Mlkn>	MP:0000267,abnormal heart development|MP:0001182,lung hemorrhage|MP:0003105,abnormal heart atrium morphology|MP:0003659,abnormal lymph circulation|MP:0004038,lymphangiectasis|MP:0005244,hemopericardium|MP:0010195,abnormal lymphatic vessel endothelium morphology|MP:0010402,ventricular septal defect|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012080,chylous ascites
MGI:4881306	Helb<tm1(KOMP)Vlcg>	MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0010948,abnormal double-strand DNA break repair
MGI:4431905	Hells<tm1a(EUCOMM)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000334,decreased granulocyte number|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0008495,decreased IgG1 level
MGI:5548365	Hells<tm1b(EUCOMM)Wtsi>	MP:0002753,dilated heart left ventricle|MP:0005333,decreased heart rate|MP:0011100,preweaning lethality, complete penetrance|MP:0011951,increased cardiac stroke volume
MGI:2178586	Hells<tm1Kmu>	MP:0000692,small spleen|MP:0000706,small thymus|MP:0001262,decreased body weight|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0003123,paternal imprinting|MP:0003702,abnormal chromosome morphology|MP:0004153,increased renal tubule apoptosis|MP:0004154,renal tubular necrosis|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005017,decreased B cell number|MP:0005090,increased double-negative T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0011087,neonatal lethality, complete penetrance
MGI:3622321	Hells<tm1Rarc>	MP:0000060,delayed bone ossification|MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000131,abnormal long bone epiphysis morphology|MP:0000160,kyphosis|MP:0000189,hypoglycemia|MP:0000352,decreased cell proliferation|MP:0000414,alopecia|MP:0000558,abnormal tibia morphology|MP:0000706,small thymus|MP:0001177,atelectasis|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001823,thymus hypoplasia|MP:0001953,respiratory failure|MP:0002075,abnormal coat/hair pigmentation|MP:0002114,abnormal axial skeleton morphology|MP:0002135,abnormal kidney morphology|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002764,short tibia|MP:0002989,small kidney|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003109,short femur|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0003419,delayed endochondral bone ossification|MP:0003723,abnormal long bone morphology|MP:0003786,premature aging|MP:0004023,abnormal chromosome number|MP:0005150,cachexia|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009429,decreased embryo weight|MP:0009431,decreased fetal weight|MP:0009674,decreased birth weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:7645530	Helq<em1Eljt>	MP:0005389,reproductive system phenotype
MGI:6362816	Helq<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0002989,small kidney|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:4127882	Helq<Gt(RRF112)Byg>	MP:0001126,abnormal ovary morphology|MP:0001132,absent mature ovarian follicles|MP:0001147,small testis|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002016,ovary cyst|MP:0002041,increased pituitary adenoma incidence|MP:0002404,increased intestinal adenoma incidence|MP:0002682,decreased mature ovarian follicle number|MP:0003205,testicular atrophy|MP:0004833,ovary atrophy|MP:0006378,abnormal spermatogonia morphology|MP:0008000,increased ovary tumor incidence|MP:0010288,increased gland tumor incidence|MP:0010299,increased mammary gland tumor incidence|MP:0012411,increased granulosa cell tumor incidence|MP:0012437,increased Harderian gland tumor incidence
MGI:3703237	Helt<tm1Wrst>	MP:0001262,decreased body weight|MP:0001436,abnormal suckling behavior|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002083,premature death|MP:0003246,loss of GABAergic neurons|MP:0003631,nervous system phenotype|MP:0003997,tonic-clonic seizures|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3721409	Helt<tm1Yono>	MP:0003246,loss of GABAergic neurons|MP:0003247,abnormal glutaminergic neuron morphology
MGI:5707023	Helz2<tm1Tesa>	MP:0001547,abnormal lipid level|MP:0002078,abnormal glucose homeostasis|MP:0002628,hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0003948,abnormal gas homeostasis|MP:0004848,abnormal liver size|MP:0005289,increased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005669,increased circulating leptin level|MP:0008489,slow postnatal weight gain|MP:0009356,decreased liver triglyceride level|MP:0010379,decreased respiratory quotient|MP:0013278,decreased fasting circulating glucose level
MGI:6266831	Helz<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3623109	Helz<Gt1Whk>	MP:0002169,no abnormal phenotype detected
MGI:2671712	hem1	MP:0000221,decreased leukocyte cell number
MGI:2671713	hem2	MP:0000221,decreased leukocyte cell number
MGI:2671715	hem3	MP:0000208,decreased hematocrit|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number
MGI:2671716	hem4	MP:0000208,decreased hematocrit|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number
MGI:2671717	hem5	MP:0000208,decreased hematocrit|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number
MGI:3034014	hem6	MP:0001545,abnormal hematopoietic system physiology|MP:0001586,abnormal erythrocyte cell number|MP:0001764,abnormal homeostasis|MP:0001925,male infertility|MP:0002424,abnormal reticulocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002593,high mean erythrocyte cell number|MP:0002675,asthenozoospermia|MP:0002810,microcytic anemia|MP:0002874,decreased hemoglobin content|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005578,teratozoospermia|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008388,hypochromic microcytic anemia
MGI:7314490	Hemgn<em1Xguo>	MP:0001698,decreased embryo size|MP:0003402,decreased liver weight|MP:0004200,decreased fetal size|MP:0011179,decreased erythroblast number
MGI:5576041	Hemgn<tm1.1(KOMP)Vlcg>	MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin
MGI:4822324	Hemk2<tm1Gxu>	MP:0001672,abnormal embryo development|MP:0001693,failure of primitive streak formation|MP:0001698,decreased embryo size|MP:0004965,inner cell mass degeneration|MP:0005032,abnormal ectoplacental cone morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:3652966	Hemq1<DBA/2J>	MP:0002608,increased hematocrit
MGI:3652967	Hemq2<C57BL/6J>	MP:0002608,increased hematocrit
MGI:3652969	Hemq3<C57BL/6J>	MP:0002608,increased hematocrit
MGI:3652970	Hemq3<DBA/2J>	MP:0002608,increased hematocrit
MGI:3652973	Hemq4<DBA/2J>	MP:0002608,increased hematocrit
MGI:3652979	Hemq5<C57BL/6J>	MP:0002608,increased hematocrit
MGI:3652980	Hemq5<DBA/2J>	MP:0002608,increased hematocrit
MGI:3652983	Hemq6<C57BL/6J>	MP:0002608,increased hematocrit
MGI:7311761	Henmt1<em2Pdz>	MP:0001925,male infertility|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis
MGI:5910969	Henmt1<pin>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype|MP:0009232,abnormal sperm nucleus morphology|MP:0009236,pinhead sperm|MP:0009239,short sperm flagellum|MP:0009376,abnormal manchette morphology|MP:0009833,absent sperm mitochondrial sheath|MP:0014685,spermiation failure
MGI:5618261	Hepacam<tm1.1Tjj>	MP:0003690,abnormal glial cell physiology|MP:0003871,abnormal myelin sheath morphology|MP:0008025,brain vacuoles|MP:0008917,abnormal oligodendrocyte physiology
MGI:5618262	Hepacam<tm1.2Tjj>	MP:0003690,abnormal glial cell physiology|MP:0003871,abnormal myelin sheath morphology|MP:0008025,brain vacuoles|MP:0008917,abnormal oligodendrocyte physiology
MGI:4420297	Hepacam<tm1Vlcg>	MP:0002182,abnormal astrocyte morphology|MP:0005238,increased brain size|MP:0008025,brain vacuoles|MP:0011854,cerebral edema
MGI:7425739	Heph<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000702,enlarged lymph nodes|MP:0001566,increased circulating phosphate level|MP:0002339,abnormal lymph node morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0008810,increased circulating iron level
MGI:1856476	Hephl1<cw>	MP:0000367,abnormal coat/ hair morphology|MP:0000685,abnormal immune system morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000709,enlarged thymus|MP:0001274,curly vibrissae|MP:0002023,increased B cell derived lymphoma incidence|MP:0002074,abnormal hair texture|MP:0002083,premature death|MP:0002098,abnormal vibrissa morphology|MP:0002339,abnormal lymph node morphology|MP:0005409,darkened coat color|MP:0012431,increased lymphoma incidence
MGI:6314748	Hephl1<cw-2J>	MP:0001274,curly vibrissae
MGI:1856003	Hephl1<cw-thd>	MP:0000418,focal hair loss|MP:0001279,wavy vibrissae|MP:0001283,sparse vibrissae|MP:0001800,abnormal humoral immune response|MP:0002098,abnormal vibrissa morphology
MGI:1857042	Heph<sla>	MP:0000208,decreased hematocrit|MP:0000248,macrocytosis|MP:0001577,anemia|MP:0001770,abnormal iron level|MP:0002123,abnormal definitive hematopoiesis|MP:0002169,no abnormal phenotype detected|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002641,anisopoikilocytosis|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004265,abnormal placental transport|MP:0005097,polychromatophilia|MP:0005397,hematopoietic system phenotype|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005637,abnormal iron homeostasis|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008387,hypochromic anemia|MP:0011188,increased erythrocyte protoporphyrin level|MP:0020369,increased intestine iron level
MGI:1862022	Heph<Sla>	MP:0001577,anemia
MGI:5490635	Heph<tm1.1Jdun>	MP:0005376,homeostasis/metabolism phenotype
MGI:5490638	Heph<tm1.2Jdun>	MP:0000367,abnormal coat/ hair morphology
MGI:6153767	Herc1<em2(IMPC)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract
MGI:6153732	Herc1<em3(IMPC)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0001325,abnormal retina morphology|MP:0001925,male infertility|MP:0002079,increased circulating insulin level|MP:0002599,increased mean platelet volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0003019,increased circulating chloride level|MP:0003961,decreased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005011,increased eosinophil cell number|MP:0005293,impaired glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005633,increased circulating sodium level|MP:0008806,increased circulating amylase level|MP:0010024,increased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010124,decreased bone mineral content|MP:0013022,increased Ly6C high monocyte number|MP:0013025,increased Ly6C low monocyte number|MP:0013279,increased fasting circulating glucose level
MGI:3613033	Herc1<tbl>	MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0001255,decreased body height|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0008770,decreased survivor rate
MGI:4346577	Herc2<Gt(AR0530)Wtsi>	MP:0000876,Purkinje cell degeneration|MP:0001405,impaired coordination|MP:0003631,nervous system phenotype|MP:0005058,abnormal lysosome morphology|MP:0008260,abnormal autophagy|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0013159,Purkinje cell axonal dystrophy
MGI:1857895	Herc2<J>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002680,decreased corpora lutea number|MP:0002687,oligozoospermia|MP:0004901,decreased male germ cell number|MP:0006380,abnormal spermatid morphology
MGI:3717746	Herc2<jdf2-10R>	MP:0001265,decreased body size|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1857686	Herc2<jdf2-1R>	MP:0001265,decreased body size|MP:0001925,male infertility|MP:0001926,female infertility|MP:0004924,abnormal behavior
MGI:1857900	Herc2<jdf2-2R>	MP:0001265,decreased body size|MP:0001925,male infertility|MP:0001926,female infertility|MP:0004924,abnormal behavior
MGI:1856616	Herc2<jdf2-3R>	MP:0001265,decreased body size|MP:0001925,male infertility|MP:0001926,female infertility|MP:0004924,abnormal behavior
MGI:1857901	Herc2<jdf2-4R>	MP:0011091,prenatal lethality, complete penetrance
MGI:3717743	Herc2<jdf2-5R>	MP:0011091,prenatal lethality, complete penetrance
MGI:3717744	Herc2<jdf2-6R>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857902	Herc2<jdf2-7R>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857687	Herc2<jdf2-8R>	MP:0001265,decreased body size|MP:0001925,male infertility|MP:0001926,female infertility|MP:0004924,abnormal behavior
MGI:3717745	Herc2<jdf2-9R>	MP:0001265,decreased body size|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5792014	Herc2<mpc178H>	MP:0003961,decreased lean body mass|MP:0014143,decreased body fat mass
MGI:4434045	Herc3<tm1a(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0001391,abnormal tail movements|MP:0001512,trunk curl|MP:0004924,abnormal behavior|MP:0009141,increased prepulse inhibition|MP:0009759,abnormal hair follicle bulge morphology
MGI:3768764	Herc4<Gt(RRH224)Byg>	MP:0001155,arrest of spermatogenesis|MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0009237,kinked sperm flagellum
MGI:5605780	Herc4<tm1b(KOMP)Wtsi>	MP:0002606,increased basophil cell number|MP:0005011,increased eosinophil cell number
MGI:5692668	Herc6<tm1b(EUCOMM)Hmgu>	MP:0002606,increased basophil cell number|MP:0003179,thrombocytopenia|MP:0005011,increased eosinophil cell number
MGI:7380421	Herc6<tm1Kshim>	MP:0002997,enlarged seminal vesicle|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0013899,abnormal seminal vesicle epithelium morphology
MGI:5571583	Herpud1<tm1Kame>	MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0006058,decreased cerebral infarct size
MGI:5708210	Herpud2<tm1.1(KOMP)Vlcg>	MP:0001488,increased startle reflex
MGI:4868726	Hes1<tm1.1Frad>	MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008214,increased immature B cell number|MP:0008347,decreased gamma-delta T cell number|MP:0010129,increased DN1 thymic pro-T cell number|MP:0010130,decreased DN1 thymic pro-T cell number|MP:0010132,decreased DN2 thymocyte number|MP:0010134,decreased DN3 thymocyte number|MP:0010136,decreased DN4 thymocyte number
MGI:4412375	Hes1<tm1(cre/ERT2)Lcm>	MP:0002169,no abnormal phenotype detected|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2149672	Hes1<tm1Fgu>	MP:0000034,abnormal inner ear vestibule morphology|MP:0000433,microcephaly|MP:0000470,abnormal stomach morphology|MP:0000477,abnormal intestine morphology|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0001258,decreased body length|MP:0001328,disorganized retina layers|MP:0001698,decreased embryo size|MP:0001890,anencephaly|MP:0001944,abnormal pancreas morphology|MP:0002151,abnormal neural tube morphology|MP:0002622,abnormal cochlear hair cell morphology|MP:0002659,pituitary gland hypoplasia|MP:0002691,small stomach|MP:0002928,abnormal bile duct morphology|MP:0002929,abnormal bile duct development|MP:0003250,absent gallbladder|MP:0003400,kinked neural tube|MP:0003641,small lung|MP:0003816,abnormal pituitary gland development|MP:0003934,abnormal pancreas development|MP:0004327,increased vestibular hair cell number|MP:0004395,increased cochlear inner hair cell number|MP:0004401,increased cochlear outer hair cell number|MP:0005076,abnormal cell differentiation|MP:0005220,abnormal exocrine pancreas morphology|MP:0006069,abnormal retina neuronal layer morphology|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology|MP:0006292,abnormal nasal placode morphology|MP:0009493,abnormal cystic duct morphology|MP:0009495,abnormal common bile duct morphology|MP:0009498,abnormal extrahepatic bile duct morphology|MP:0009937,abnormal neuron differentiation|MP:0010915,increased solitary pulmonary neuroendocrine cell number|MP:0010919,increased number of pulmonary neuroendocrine bodies|MP:0010949,decreased club cell number|MP:0011089,perinatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012686,everted embryonic neuroepithelium
MGI:3808031	Hes1<tm1Kag>	MP:0002006,neoplasm|MP:0003631,nervous system phenotype|MP:0003934,abnormal pancreas development|MP:0009175,abnormal pancreatic beta cell differentiation
MGI:5562879	Hes1<tm2.1Kag>	MP:0003631,nervous system phenotype
MGI:3521989	Hes3<tm1Kag>	MP:0002169,no abnormal phenotype detected
MGI:2149674	Hes5<tm1Fgu>	MP:0000034,abnormal inner ear vestibule morphology|MP:0002882,abnormal neuron morphology|MP:0004327,increased vestibular hair cell number|MP:0004395,increased cochlear inner hair cell number|MP:0004401,increased cochlear outer hair cell number|MP:0005547,abnormal Muller cell morphology|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology
MGI:6725087	Hes7<M1Btlr>	MP:0000069,kyphoscoliosis|MP:0000585,kinked tail|MP:0004703,abnormal vertebral column morphology
MGI:4420236	Hes7<tm1.1Dihz>	MP:0000592,short tail|MP:0003345,decreased rib number|MP:0004609,vertebral fusion|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6113385	Hes7<tm1.1Ybes>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000592,short tail|MP:0001258,decreased body length|MP:0002823,abnormal rib development|MP:0003345,decreased rib number|MP:0004645,decreased vertebrae number|MP:0005225,abnormal vertebrae development
MGI:2652222	Hes7<tm1Kag>	MP:0000137,abnormal vertebrae morphology|MP:0000141,abnormal vertebral body morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001258,decreased body length|MP:0001688,abnormal somite development|MP:0001689,incomplete somite formation|MP:0001691,abnormal somite shape|MP:0003050,abnormal sacral vertebrae morphology|MP:0003345,decreased rib number|MP:0004599,abnormal vertebral arch morphology|MP:0004612,fusion of vertebral bodies|MP:0004613,fusion of vertebral arches|MP:0005222,abnormal somite size|MP:0005223,abnormal dorsal-ventral polarity of the somites|MP:0005224,abnormal left-right axis symmetry of the somites|MP:0005227,abnormal vertebral body development|MP:0005229,abnormal intervertebral disk development|MP:0011087,neonatal lethality, complete penetrance|MP:0011733,fused somites
MGI:5426214	Hes7<tm2.1Dihz>	MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000585,kinked tail|MP:0000592,short tail|MP:0004703,abnormal vertebral column morphology|MP:0005508,abnormal skeleton morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:6113393	Hes7<tm2.1Ybes>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000592,short tail|MP:0001258,decreased body length|MP:0001688,abnormal somite development|MP:0002823,abnormal rib development|MP:0003345,decreased rib number|MP:0004645,decreased vertebrae number|MP:0005225,abnormal vertebrae development|MP:0012669,abnormal somite segmentation clock|MP:0012728,abnormal somite border morphology
MGI:3046536	Hes7<tm2Kag>	MP:0000585,kinked tail|MP:0001689,incomplete somite formation
MGI:5426215	Hes7<tm3.1Dihz>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001688,abnormal somite development|MP:0003050,abnormal sacral vertebrae morphology|MP:0004609,vertebral fusion|MP:0005508,abnormal skeleton morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:6113394	Hes7<tm3.1Ybes>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000592,short tail|MP:0001258,decreased body length|MP:0002823,abnormal rib development|MP:0003345,decreased rib number|MP:0004645,decreased vertebrae number|MP:0005225,abnormal vertebrae development
MGI:6274391	Hesx1<em1(IMPC)J>	MP:0000111,cleft palate|MP:0001293,anophthalmia|MP:0003743,abnormal facial morphology|MP:0008797,facial cleft|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape
MGI:3822473	Hesx1<tm1(cre)Jpmb>	MP:0000934,abnormal telencephalon development|MP:0000936,small embryonic telencephalon|MP:0001286,abnormal eye development|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0005193,abnormal anterior eye segment morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:1931124	Hesx1<tm1Icar>	MP:0000428,abnormal craniofacial morphology|MP:0000433,microcephaly|MP:0000445,short snout|MP:0000783,abnormal forebrain morphology|MP:0000787,abnormal telencephalon morphology|MP:0000837,abnormal hypothalamus morphology|MP:0000934,abnormal telencephalon development|MP:0000936,small embryonic telencephalon|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0002196,absent corpus callosum|MP:0002233,abnormal nose morphology|MP:0002237,abnormal nasal cavity morphology|MP:0003232,abnormal forebrain development|MP:0003425,abnormal optic vesicle formation|MP:0004096,abnormal midbrain-hindbrain boundary development|MP:0004269,abnormal optic cup morphology|MP:0004309,absent otic vesicle|MP:0006198,enophthalmos|MP:0006292,abnormal nasal placode morphology|MP:0006306,abnormal nasal pit morphology|MP:0008223,absent hippocampal commissure|MP:0008227,absent anterior commissure|MP:0008321,small adenohypophysis|MP:0008789,abnormal olfactory epithelium morphology|MP:0009901,abnormal frontonasal prominence morphology|MP:0010059,olfactory bulb hypoplasia|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011759,absent Rathke's pouch|MP:0012004,abnormal septum pellucidum morphology|MP:0012138,decreased forebrain size|MP:0012703,decreased embryonic neuroepithelium thickness|MP:0013342,bifurcated Rathke's pouch|MP:0013597,small vomeronasal organ|MP:0014198,absent pituitary infundibular stalk
MGI:3822474	Hesx1<tm2Jpmb>	MP:0000428,abnormal craniofacial morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0004163,abnormal adenohypophysis morphology|MP:0013356,ectopic pituitary gland
MGI:3822475	Hesx1<tm3Jpmb>	MP:0000633,abnormal pituitary gland morphology|MP:0000780,abnormal corpus callosum morphology|MP:0000783,abnormal forebrain morphology|MP:0000787,abnormal telencephalon morphology|MP:0000936,small embryonic telencephalon|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0004163,abnormal adenohypophysis morphology|MP:0008219,abnormal dorsal telencephalic commissure morphology|MP:0008225,abnormal anterior commissure morphology|MP:0008227,absent anterior commissure|MP:0009901,abnormal frontonasal prominence morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012138,decreased forebrain size|MP:0012178,absent frontonasal prominence|MP:0013351,abnormal Rathke's pouch development|MP:0013356,ectopic pituitary gland|MP:0013357,ectopic adenohypophysis
MGI:5314527	Hesx1<tm4.1Jpmb>	MP:0000936,small embryonic telencephalon|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0003232,abnormal forebrain development
MGI:3581540	Hexa<tm1Cota>	MP:0000607,abnormal hepatocyte morphology|MP:0002882,abnormal neuron morphology
MGI:2429698	Hexa<tm1Grv>	MP:0000947,convulsive seizures|MP:0001263,weight loss|MP:0001406,abnormal gait|MP:0001526,abnormal placing response|MP:0001935,decreased litter size|MP:0002090,abnormal vision|MP:0002631,abnormal epididymis morphology|MP:0002757,decreased vertical activity|MP:0002882,abnormal neuron morphology|MP:0003633,abnormal nervous system physiology
MGI:1857181	Hexa<tm1Rlp>	MP:0002152,abnormal brain morphology|MP:0002882,abnormal neuron morphology
MGI:5690250	Hexb<lysd>	MP:0000745,tremors|MP:0002118,abnormal lipid homeostasis|MP:0002229,neurodegeneration|MP:0005058,abnormal lysosome morphology|MP:0020851,abnormal vacuole morphology
MGI:5792023	Hexb<mpc191H>	MP:0000745,tremors
MGI:6120816	Hexb<tm1b(EUCOMM)Hmgu>	MP:0000220,increased monocyte cell number|MP:0000745,tremors|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0002968,increased circulating alkaline phosphatase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005505,thrombocytosis|MP:0008810,increased circulating iron level|MP:0010088,decreased circulating fructosamine level
MGI:2429701	Hexb<tm1Grv>	MP:0000242,impaired fertilization|MP:0000745,tremors|MP:0000747,muscle weakness|MP:0000755,hindlimb paralysis|MP:0000955,abnormal spinal cord morphology|MP:0001393,ataxia|MP:0001650,abnormal seizure response to electrical stimulation|MP:0002083,premature death|MP:0002161,abnormal fertility/fecundity|MP:0002566,abnormal sexual interaction|MP:0002631,abnormal epididymis morphology|MP:0003633,abnormal nervous system physiology|MP:0004728,abnormal efferent ductules of testis morphology|MP:0004928,increased epididymis weight|MP:0005202,lethargy|MP:0009249,enlarged caput epididymis|MP:0009256,enlarged corpus epididymis
MGI:1857438	Hexb<tm1Rlp>	MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0002461,increased immunoglobulin level|MP:0002882,abnormal neuron morphology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005156,bradykinesia|MP:0006082,CNS inflammation|MP:0008602,increased circulating interleukin-4 level|MP:0010025,decreased total body fat amount|MP:0012504,increased forebrain apoptosis
MGI:3819173	Hexim1<Gt(XB322)Byg>	MP:0000280,thin ventricular wall|MP:0000281,abnormal interventricular septum morphology|MP:0002795,dilated cardiomyopathy|MP:0004057,thin myocardium compact layer|MP:0004111,abnormal coronary artery morphology|MP:0008772,increased heart ventricle size|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3052225	Hexim1<tm1Maqs>	MP:0000277,abnormal heart shape|MP:0003921,abnormal heart left ventricle morphology|MP:0004055,heart atrium hypoplasia|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0010724,thick interventricular septum|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011392,increased fetal cardiomyocyte apoptosis|MP:0031607,abnormal fetal cardiomyocyte mitochondrial morphology|MP:0031611,decreased fetal cardiomyocyte number
MGI:3043217	Hey1<tm1Gess>	MP:0002169,no abnormal phenotype detected
MGI:3574059	Hey1<tm1Kkb>	MP:0005369,muscle phenotype
MGI:3604208	Hey1<tm2Gess>	MP:0002169,no abnormal phenotype detected
MGI:2387937	Hey2<tm1Gess>	MP:0000276,heart right ventricle hypertrophy|MP:0000277,abnormal heart shape|MP:0001732,postnatal growth retardation|MP:0002127,abnormal cardiovascular system morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0004225,patent cardiac foramen ovale|MP:0006123,tricuspid valve atresia|MP:0006124,tricuspid valve stenosis|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031131,myocardial fiber disarray
MGI:3574394	Hey2<tm1Kkb>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000286,abnormal mitral valve morphology|MP:0001732,postnatal growth retardation|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002624,abnormal tricuspid valve morphology|MP:0002745,abnormal atrioventricular valve morphology|MP:0002746,abnormal semilunar valve morphology|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002833,increased heart weight|MP:0003140,dilated heart atrium|MP:0003141,cardiac fibrosis|MP:0003828,pulmonary edema|MP:0003974,abnormal endocardium morphology|MP:0004091,abnormal Z line morphology|MP:0004566,myocardial fiber degeneration|MP:0005329,abnormal myocardium layer morphology|MP:0005333,decreased heart rate|MP:0005630,increased lung weight|MP:0006044,tricuspid valve regurgitation|MP:0006045,mitral valve regurgitation|MP:0006046,atrioventricular valve regurgitation|MP:0006047,aortic valve regurgitation|MP:0006117,aortic valve stenosis|MP:0006124,tricuspid valve stenosis|MP:0006138,congestive heart failure|MP:0010018,pulmonary vascular congestion|MP:0010019,liver vascular congestion|MP:0010405,ostium secundum atrial septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010499,abnormal ventricle myocardium morphology|MP:0010594,thick aortic valve|MP:0010595,abnormal aortic valve cusp morphology|MP:0010601,thick pulmonary valve|MP:0010602,abnormal pulmonary valve cusp morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014731,disorganized myocardial fiber myofibrils|MP:0031584,thick semilunar valve|MP:0031633,decreased heart left ventricle muscle contractility
MGI:2447620	Hey2<tm1Mtc>	MP:0000280,thin ventricular wall|MP:0000286,abnormal mitral valve morphology|MP:0000484,abnormal pulmonary artery morphology|MP:0001265,decreased body size|MP:0001614,abnormal blood vessel morphology|MP:0001732,postnatal growth retardation|MP:0002624,abnormal tricuspid valve morphology|MP:0002745,abnormal atrioventricular valve morphology|MP:0002753,dilated heart left ventricle|MP:0005140,decreased cardiac muscle contractility|MP:0005294,abnormal heart ventricle morphology|MP:0005330,cardiomyopathy|MP:0005385,cardiovascular system phenotype|MP:0005608,cardiac interstitial fibrosis|MP:0006113,abnormal heart septum morphology|MP:0006123,tricuspid valve atresia|MP:0006124,tricuspid valve stenosis|MP:0008824,absent interventricular septum membranous part|MP:0010017,visceral vascular congestion|MP:0010018,pulmonary vascular congestion|MP:0010019,liver vascular congestion|MP:0010402,ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010617,thick mitral valve cusps|MP:0010997,decreased aorta wall thickness|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2387940	Hey2<tm1Uts>	MP:0000267,abnormal heart development|MP:0000273,overriding aortic valve|MP:0000274,enlarged heart|MP:0000276,heart right ventricle hypertrophy|MP:0000277,abnormal heart shape|MP:0002625,heart left ventricle hypertrophy|MP:0006123,tricuspid valve atresia|MP:0006128,pulmonary valve stenosis|MP:0010403,atrial septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010457,pulmonary artery stenosis|MP:0010602,abnormal pulmonary valve cusp morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5433499	Hey2<tm2.1Mtc>	MP:0001625,cardiac hypertrophy|MP:0003141,cardiac fibrosis|MP:0004215,abnormal myocardial fiber physiology|MP:0004485,increased response of heart to induced stress|MP:0005140,decreased cardiac muscle contractility|MP:0006138,congestive heart failure
MGI:3711159	Hey2<tm2Eno>	MP:0010402,ventricular septal defect|MP:0011087,neonatal lethality, complete penetrance
MGI:4365754	Heyl<tm1.2Abmu>	MP:0000966,decreased sensory neuron number
MGI:5571348	Heyl<tm1b(KOMP)Wtsi>	MP:0011396,abnormal sleep behavior
MGI:3785385	Heyl<tm1Gess>	MP:0002169,no abnormal phenotype detected
MGI:5302514	Heyl<tm1Kkb>	MP:0005369,muscle phenotype
MGI:1856607	hf	MP:0000596,abnormal liver development|MP:0002138,abnormal hepatobiliary system morphology|MP:0005370,liver/biliary system phenotype
MGI:4821356	Hfe<tm1.1Gfn>	MP:0000592,short tail|MP:0001258,decreased body length|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001492,abnormal pilomotor reflex|MP:0002980,abnormal postural reflex|MP:0008911,induced hyperactivity
MGI:5516426	Hfe<tm1.1Jrco>	MP:0001260,increased body weight|MP:0003354,astrocytosis|MP:0003674,oxidative stress|MP:0008807,increased liver iron level|MP:0008811,abnormal brain iron level
MGI:2385350	Hfe<tm1.1Nca>	MP:0001770,abnormal iron level|MP:0008807,increased liver iron level
MGI:3775648	Hfe<tm1.1Wsr>	MP:0005637,abnormal iron homeostasis|MP:0005638,hemochromatosis|MP:0008807,increased liver iron level|MP:0008808,decreased spleen iron level|MP:0008810,increased circulating iron level
MGI:1934013	Hfe<tm1Gfn>	MP:0000066,osteoporosis|MP:0000130,abnormal trabecular bone morphology|MP:0001260,increased body weight|MP:0001770,abnormal iron level|MP:0004984,increased osteoclast cell number|MP:0005637,abnormal iron homeostasis|MP:0008807,increased liver iron level|MP:0008809,increased spleen iron level|MP:0008810,increased circulating iron level|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume
MGI:2181388	Hfe<tm1Sly>	MP:0008807,increased liver iron level
MGI:3775647	Hfe<tm1Wsr>	MP:0002169,no abnormal phenotype detected|MP:0005376,homeostasis/metabolism phenotype|MP:0005638,hemochromatosis|MP:0008807,increased liver iron level|MP:0008808,decreased spleen iron level|MP:0008810,increased circulating iron level
MGI:2385353	Hfe<tm2Nca>	MP:0001770,abnormal iron level|MP:0008807,increased liver iron level|MP:0008808,decreased spleen iron level|MP:0008810,increased circulating iron level
MGI:3033459	Hfe<tm2Sly>	MP:0000771,abnormal brain size|MP:0000781,decreased corpus callosum size|MP:0001458,abnormal object recognition memory|MP:0002175,decreased brain weight|MP:0003224,neuron degeneration|MP:0003461,abnormal response to novel object|MP:0008414,abnormal spatial reference memory|MP:0008428,abnormal spatial working memory|MP:0008807,increased liver iron level|MP:0008811,abnormal brain iron level|MP:0010161,decreased brain cholesterol level|MP:0011380,enlarged brain ventricles|MP:0012307,impaired spatial learning
MGI:3033462	Hfe<tm3Sly>	MP:0008807,increased liver iron level
MGI:3722331	Hfgi1<C57BL/6Ola>	MP:0001873,stomach inflammation|MP:0002401,abnormal lymphopoiesis
MGI:3722333	Hfgi2<C57BL/6Ola>	MP:0001873,stomach inflammation|MP:0002401,abnormal lymphopoiesis
MGI:2661489	Hfib1<BALB/cJ>	MP:0000598,abnormal liver morphology
MGI:1861103	Hfm	MP:0000018,small ears|MP:0000024,lowered ear position|MP:0000120,malocclusion|MP:0002884,abnormal pharyngeal arch morphology|MP:0003873,pharyngeal arch hypoplasia|MP:0011091,prenatal lethality, complete penetrance
MGI:4288793	Hfm1<Gt(OST347241)Lex>	MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001929,abnormal gametogenesis|MP:0001930,abnormal meiosis|MP:0001931,abnormal oogenesis|MP:0001940,testis hypoplasia|MP:0002160,abnormal reproductive system morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0002680,decreased corpora lutea number|MP:0008261,arrest of male meiosis|MP:0008871,abnormal ovarian follicle number|MP:0008966,abnormal chiasmata formation|MP:0009451,abnormal chromosomal synapsis|MP:0009452,abnormal synaptonemal complex|MP:0009564,abnormal meiotic configurations|MP:0011751,abnormal X-Y chromosome synapsis during male meiosis
MGI:3622237	Hgbq1<SM/J>	MP:0005564,increased hemoglobin content
MGI:1856664	Hgd<aku>	MP:0003619,abnormal urine color|MP:0005390,skeleton phenotype|MP:0030619,homogentisic aciduria
MGI:4841281	Hgd<tm1a(KOMP)Wtsi>	MP:0006433,abnormal articular cartilage morphology|MP:0009642,abnormal blood homeostasis|MP:0030619,homogentisic aciduria
MGI:6416342	Hgd<tm1c(KOMP)Wtsi>	MP:0006433,abnormal articular cartilage morphology|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis
MGI:3497731	Hgfac<tm1Hk>	MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0031319,impaired intestine regeneration
MGI:6294039	Hgf<tm1.1Tbf>	MP:0004364,thin stria vascularis|MP:0004367,abnormal strial intermediate cell morphology|MP:0004411,decreased endocochlear potential|MP:0006325,impaired hearing
MGI:1857656	Hgf<tm1Cbm>	MP:0000598,abnormal liver morphology|MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0000602,dilated liver sinusoidal space|MP:0000607,abnormal hepatocyte morphology|MP:0000608,dissociated hepatocytes|MP:0001634,internal hemorrhage|MP:0001636,irregular heartbeat|MP:0001711,abnormal placenta morphology|MP:0001713,decreased trophoblast giant cell number|MP:0002875,decreased erythrocyte cell number|MP:0009431,decreased fetal weight|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011527,disorganized placental labyrinth
MGI:3574633	Hgf<tm1Jmw>	MP:0004001,decreased hepatocyte proliferation|MP:0004367,abnormal strial intermediate cell morphology|MP:0005517,impaired liver regeneration
MGI:1929776	Hgf<tm1Kita>	MP:0000601,small liver|MP:0001698,decreased embryo size|MP:0001713,decreased trophoblast giant cell number|MP:0004259,small placenta|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:6294041	Hgf<tm1Tbf>	MP:0000043,organ of Corti degeneration|MP:0000048,abnormal stria vascularis morphology|MP:0004300,abnormal organ of Corti supporting cell morphology|MP:0004364,thin stria vascularis|MP:0004367,abnormal strial intermediate cell morphology|MP:0004402,decreased cochlear outer hair cell number|MP:0004404,cochlear outer hair cell degeneration|MP:0004411,decreased endocochlear potential|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004864,spiral ligament degeneration|MP:0005386,behavior/neurological phenotype|MP:0006325,impaired hearing
MGI:5754568	Hgsnat<em4(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001175,abnormal lung morphology|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0001566,increased circulating phosphate level|MP:0002764,short tibia|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0005278,abnormal cholesterol homeostasis|MP:0005419,decreased circulating serum albumin level|MP:0005627,increased circulating potassium level|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0011874,enlarged urinary bladder
MGI:4441956	Hgsnat<tm1a(EUCOMM)Wtsi>	MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0000691,enlarged spleen|MP:0000788,abnormal cerebral cortex morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0000952,abnormal CNS glial cell morphology|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002083,premature death|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003354,astrocytosis|MP:0003632,abnormal nervous system morphology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004952,increased spleen weight|MP:0005058,abnormal lysosome morphology|MP:0005565,increased blood urea nitrogen level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008114,abnormal Kupffer cell morphology|MP:0008918,microgliosis|MP:0010499,abnormal ventricle myocardium morphology|MP:0010943,abnormal bronchus epithelium morphology|MP:0011475,abnormal glycosaminoglycan level|MP:0011635,abnormal mitochondrial crista morphology|MP:0014331,abnormal Purkinje cell mitochondrial morphology
MGI:5286648	Hgs<Tg(Tyr)2400A-1Ove>	MP:0006205,embryonic lethality between implantation and somite formation
MGI:4431739	Hgs<tm1a(EUCOMM)Wtsi>	MP:0003062,abnormal coping response
MGI:6163774	Hgs<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:1861937	Hgs<tm1Sor>	MP:0000929,open neural tube|MP:0000930,wavy neural tube|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0004180,failure of initiation of embryo turning|MP:0004187,cardia bifida|MP:0004557,dilated allantois|MP:0005221,abnormal rostral-caudal axis patterning|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012083,absent foregut
MGI:2684533	Hgs<tm1Sug>	MP:0001698,decreased embryo size|MP:0004180,failure of initiation of embryo turning|MP:0011092,embryonic lethality, complete penetrance
MGI:3576931	Hgs<tm1Tkh>	MP:0005621,abnormal cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3818694	Hgs<tm2Tkh>	MP:0001732,postnatal growth retardation|MP:0001924,infertility|MP:0002573,behavioral despair|MP:0002757,decreased vertical activity|MP:0003203,increased neuron apoptosis|MP:0004000,impaired passive avoidance behavior|MP:0008489,slow postnatal weight gain|MP:0009940,abnormal hippocampus pyramidal cell morphology
MGI:1857076	Hgs<tn>	MP:0000753,paralysis|MP:0000846,abnormal medulla oblongata morphology|MP:0000852,small cerebellum|MP:0000876,Purkinje cell degeneration|MP:0000913,abnormal brain development|MP:0000952,abnormal CNS glial cell morphology|MP:0000956,decreased spinal cord size|MP:0001077,abnormal spinal nerve morphology|MP:0001255,decreased body height|MP:0001265,decreased body size|MP:0001388,abnormal stationary movement|MP:0001409,increased stereotypic behavior|MP:0001504,abnormal posture|MP:0001516,abnormal motor coordination/balance|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0002880,opisthotonus|MP:0003225,axonal dystrophy|MP:0003871,abnormal myelin sheath morphology|MP:0004097,abnormal cerebellar cortex morphology|MP:0004601,abnormal vertebral spinous process morphology|MP:0004703,abnormal vertebral column morphology|MP:0004706,short vertebral body|MP:0005150,cachexia|MP:0005156,bradykinesia|MP:0005377,hearing/vestibular/ear phenotype|MP:0005404,abnormal axon morphology|MP:0005424,jerky movement|MP:0006099,thin cerebellar granule layer|MP:0008027,abnormal spinal cord white matter morphology|MP:0008503,abnormal spinal cord grey matter morphology|MP:0008948,decreased neuron number|MP:0009346,decreased trabecular bone thickness|MP:0009393,abnormal resting posture|MP:0012089,decreased midbrain size|MP:0012263,decreased hindbrain size|MP:0012484,decreased corticospinal tract size|MP:0020533,decreased pons size
MGI:7425740	Hhat<em1(IMPC)Ccpcz>	MP:0000428,abnormal craniofacial morphology|MP:0000564,syndactyly|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001293,anophthalmia|MP:0001672,abnormal embryo development|MP:0001785,edema|MP:0002102,abnormal ear morphology|MP:0002111,abnormal tail morphology|MP:0002177,abnormal outer ear morphology|MP:0003743,abnormal facial morphology|MP:0005157,holoprosencephaly|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0011496,abnormal head size|MP:0013523,increased memory-marker CD4-positive NK T cell number
MGI:6152499	Hhatl<em1(IMPC)Mbp>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0001402,decreased locomotor activity|MP:0001404,no spontaneous movement|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001486,abnormal startle reflex|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020421,increased freezing behavior
MGI:3038358	Hhat<Tg(TFAP2A-cre)1Will>	MP:0000117,absent tooth placode|MP:0000118,arrest of tooth development|MP:0000164,abnormal cartilage development|MP:0000438,abnormal cranium morphology|MP:0000458,abnormal mandible morphology|MP:0000565,oligodactyly|MP:0000783,abnormal forebrain morphology|MP:0000897,abnormal midbrain morphology|MP:0000936,small embryonic telencephalon|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001286,abnormal eye development|MP:0001297,microphthalmia|MP:0001698,decreased embryo size|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002237,abnormal nasal cavity morphology|MP:0003104,acrania|MP:0003425,abnormal optic vesicle formation|MP:0003830,abnormal testis development|MP:0004383,absent interparietal bone|MP:0004419,absent parietal bone|MP:0004443,absent supraoccipital bone|MP:0004445,small exoccipital bone|MP:0004447,small basioccipital bone|MP:0004703,abnormal vertebral column morphology|MP:0004872,absent nasal septum|MP:0004911,absent mandibular condyloid process|MP:0004912,absent mandibular coronoid process|MP:0004913,absent mandibular angle|MP:0006418,abnormal testis cord formation|MP:0008274,failure of bone ossification|MP:0009653,abnormal palate development|MP:0009845,abnormal neural crest cell morphology|MP:0009846,abnormal neural crest morphology|MP:0009885,abnormal palatal shelf elevation|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009904,tongue hypoplasia|MP:0010939,abnormal mandibular prominence morphology|MP:0010940,abnormal maxillary prominence morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0012092,diencephalon hypoplasia|MP:0012247,absent cornea|MP:0013603,abnormal fetal Leydig cell differentiation|MP:0013818,abnormal oral cavity morphology|MP:0030249,small frontonasal prominence|MP:0030268,agnathia|MP:0031449,abnormal nasal cartilage morphology|MP:0031450,nasal cartilage hypoplasia
MGI:3051900	Hhat<tm1Ptch>	MP:0000565,oligodactyly|MP:0000926,absent floor plate|MP:0000939,decreased motor neuron number|MP:0001698,decreased embryo size|MP:0002427,disproportionate dwarf|MP:0002657,chondrodystrophy|MP:0005157,holoprosencephaly|MP:0011087,neonatal lethality, complete penetrance|MP:0021104,abnormal ventral interneuron 2 morphology|MP:0021105,abnormal ventral interneuron 3 morphology
MGI:3051901	Hhat<tm2Ptch>	MP:0000565,oligodactyly|MP:0000926,absent floor plate|MP:0000939,decreased motor neuron number|MP:0001698,decreased embryo size|MP:0002427,disproportionate dwarf|MP:0002657,chondrodystrophy|MP:0005157,holoprosencephaly|MP:0011087,neonatal lethality, complete penetrance|MP:0021104,abnormal ventral interneuron 2 morphology|MP:0021105,abnormal ventral interneuron 3 morphology
MGI:4999724	Hhex<tm1.1Tmj>	MP:0000783,abnormal forebrain morphology|MP:0002231,abnormal primitive streak morphology|MP:0003085,abnormal egg cylinder morphology|MP:0003984,embryonic growth retardation|MP:0008533,abnormal anterior visceral endoderm morphology|MP:0010769,abnormal survival|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014586,decreased egg cylinder size
MGI:2449914	Hhex<tm1Cwb>	MP:0000280,thin ventricular wall|MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000596,abnormal liver development|MP:0001614,abnormal blood vessel morphology|MP:0001622,abnormal vasculogenesis|MP:0001785,edema|MP:0001787,pericardial edema|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002745,abnormal atrioventricular valve morphology|MP:0003232,abnormal forebrain development|MP:0003421,abnormal thyroid gland development|MP:0003649,decreased heart right ventricle size|MP:0003808,increased atrioventricular cushion size|MP:0003814,vascular smooth muscle hypoplasia|MP:0004057,thin myocardium compact layer|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0010402,ventricular septal defect|MP:0010449,heart right ventricle outflow tract stenosis|MP:0010585,abnormal conotruncal ridge morphology|MP:0010588,conotruncal ridge hyperplasia|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011877,absent liver|MP:0012138,decreased forebrain size
MGI:3849291	Hhex<tm1Jomb>	MP:0001672,abnormal embryo development|MP:0011091,prenatal lethality, complete penetrance
MGI:2448661	Hhex<tm1Ngu>	MP:0000596,abnormal liver development|MP:0000607,abnormal hepatocyte morphology|MP:0001606,impaired hematopoiesis|MP:0008112,abnormal monocyte differentiation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012235,abnormal liver bud morphology
MGI:2177762	Hhex<tm1Rbe>	MP:0000681,abnormal thyroid gland morphology|MP:0000934,abnormal telencephalon development|MP:0000936,small embryonic telencephalon|MP:0001293,anophthalmia|MP:0003232,abnormal forebrain development|MP:0003421,abnormal thyroid gland development|MP:0003425,abnormal optic vesicle formation|MP:0003984,embryonic growth retardation|MP:0004268,abnormal optic stalk morphology|MP:0004276,abnormal medial ganglionic eminence morphology|MP:0006292,abnormal nasal placode morphology|MP:0006293,absent nasal placodes|MP:0006337,abnormal first pharyngeal arch morphology|MP:0008926,abnormal anterior definitive endoderm morphology|MP:0010335,fused first pharyngeal arch|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011759,absent Rathke's pouch|MP:0011877,absent liver|MP:0012136,absent forebrain|MP:0012138,decreased forebrain size|MP:0012157,rostral body truncation|MP:0012234,abnormal hepatic diverticulum morphology|MP:0012245,abnormal hepatoblast migration|MP:0012501,abnormal pericardial cavity morphology|MP:0013906,absent embryonic telencephalon
MGI:3721426	Hhex<tm2Cwb>	MP:0003327,liver cyst
MGI:4451243	Hhipl1<tm1a(KOMP)Wtsi>	MP:0005378,growth/size/body region phenotype|MP:0005595,abnormal vascular smooth muscle physiology|MP:0010768,mortality/aging|MP:0011805,decreased cell migration|MP:0031509,decreased vascular smooth muscle cell proliferation
MGI:5637060	Hhipl1<tm1b(KOMP)Wtsi>	MP:0002989,small kidney|MP:0004357,long tibia|MP:0010052,increased grip strength
MGI:2450891	Hhip<tm1Amc>	MP:0000473,abnormal stomach glandular epithelium morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001175,abnormal lung morphology|MP:0001953,respiratory failure|MP:0002151,abnormal neural tube morphology|MP:0002271,abnormal pulmonary alveolar duct morphology|MP:0003178,left pulmonary isomerism|MP:0003641,small lung|MP:0003934,abnormal pancreas development|MP:0005215,abnormal pancreatic islet morphology|MP:0009172,small pancreatic islets|MP:0009254,disorganized pancreatic islets|MP:0010819,primary atelectasis|MP:0011087,neonatal lethality, complete penetrance|MP:0011820,decreased pancreatic beta cell proliferation|MP:0013291,ectopic pancreas
MGI:1861590	Hi	MP:0000588,thick tail|MP:0000592,short tail|MP:0001539,decreased caudal vertebrae number|MP:0001926,female infertility|MP:0002111,abnormal tail morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0005508,abnormal skeleton morphology
MGI:5637002	Hibadh<tm1b(EUCOMM)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0011239,abnormal skin coloration|MP:0011960,abnormal eye anterior chamber depth|MP:0011965,decreased total retina thickness|MP:0013278,decreased fasting circulating glucose level
MGI:6257527	Hibch<em1(IMPC)Tcp>	MP:0001697,abnormal embryo size|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4946618	Hic1<tm1.1Kori>	MP:0002169,no abnormal phenotype detected
MGI:4946619	Hic1<tm1.2Kori>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2386879	Hic1<tm1Sbb>	MP:0000018,small ears|MP:0000024,lowered ear position|MP:0000445,short snout|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0001194,dermatitis|MP:0001272,increased metastatic potential|MP:0001698,decreased embryo size|MP:0002018,increased malignant tumor incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0002038,increased carcinoma incidence|MP:0003104,acrania|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003384,abnormal ventral body wall morphology|MP:0003755,abnormal palate morphology|MP:0003935,abnormal craniofacial development|MP:0004200,decreased fetal size|MP:0004207,increased squamous cell carcinoma incidence|MP:0005157,holoprosencephaly|MP:0009025,abnormal brain dura mater morphology|MP:0010348,increased pancreatic islet cell carcinoma incidence|MP:0011089,perinatal lethality, complete penetrance|MP:0012431,increased lymphoma incidence
MGI:4946620	Hic1<tm2.1Kori>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5703657	Hic2<Gt(E225A08)1.1Wrst>	MP:0000273,overriding aortic valve|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002652,thin myocardium|MP:0003984,embryonic growth retardation|MP:0005380,embryo phenotype|MP:0005385,cardiovascular system phenotype|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010768,mortality/aging|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance
MGI:5703658	Hic2<Gt(E225A08)1.2Wrst>	MP:0011102,embryonic lethality, incomplete penetrance
MGI:3919233	Hic2<Gt(E225A08)Wrst>	MP:0011092,embryonic lethality, complete penetrance
MGI:4329590	Hic2<Gt(RRN127)Byg>	MP:0000273,overriding aortic valve|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002652,thin myocardium|MP:0003984,embryonic growth retardation|MP:0005329,abnormal myocardium layer morphology|MP:0005385,cardiovascular system phenotype|MP:0010402,ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010770,preweaning lethality|MP:0011092,embryonic lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6276981	Hif1an<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003795,abnormal bone structure|MP:0009142,decreased prepulse inhibition|MP:0010392,prolonged QRS complex duration|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4459908	Hif1an<tm1.1Rsjo>	MP:0002169,no abnormal phenotype detected|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0010182,decreased susceptibility to weight gain
MGI:4459899	Hif1an<tm1.2Rsjo>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001574,abnormal oxygen level|MP:0001942,abnormal lung volume|MP:0002626,increased heart rate|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003028,alkalosis|MP:0003032,hypocapnia|MP:0003402,decreased liver weight|MP:0003976,decreased circulating VLDL triglyceride level|MP:0005178,increased circulating cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005418,abnormal circulating hormone level|MP:0005560,decreased circulating glucose level|MP:0005573,increased pulmonary respiratory rate|MP:0005585,increased tidal volume|MP:0005621,abnormal cell physiology|MP:0008963,increased carbon dioxide production|MP:0008965,increased basal metabolism|MP:0009133,decreased white fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0010182,decreased susceptibility to weight gain|MP:0010227,decreased quadriceps weight|MP:0011939,increased food intake|MP:0011941,increased fluid intake|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3613538	Hif1a<tm1.1Mcs>	MP:0001672,abnormal embryo development|MP:0001730,embryonic growth arrest|MP:0001914,hemorrhage|MP:0002084,abnormal developmental patterning|MP:0003886,abnormal embryonic epiblast morphology|MP:0005312,pericardial effusion|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance
MGI:2677899	Hif1a<tm1.1Stom>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857719	Hif1a<tm1Jhu>	MP:0000259,abnormal vascular development|MP:0000270,abnormal heart tube morphology|MP:0000288,abnormal pericardium morphology|MP:0000929,open neural tube|MP:0001614,abnormal blood vessel morphology|MP:0001689,incomplete somite formation|MP:0001730,embryonic growth arrest|MP:0002190,disorganized myocardium|MP:0004068,dilated dorsal aorta|MP:0004787,abnormal dorsal aorta morphology|MP:0005294,abnormal heart ventricle morphology|MP:0005312,pericardial effusion|MP:0005329,abnormal myocardium layer morphology|MP:0006042,increased apoptosis|MP:0006126,abnormal cardiac outflow tract development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011260,abnormal head mesenchyme morphology|MP:0012253,abnormal intersomitic vessel morphology|MP:0012265,increased hindbrain size|MP:0012492,pharyngeal arch artery hypoplasia|MP:0012493,absent pharyngeal arch arteries|MP:0012501,abnormal pericardial cavity morphology
MGI:3641209	Hif1a<tm1Kats>	MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion|MP:0008713,abnormal cytokine level
MGI:3613537	Hif1a<tm1Mcs>	MP:0002169,no abnormal phenotype detected
MGI:2179429	Hif1a<tm1Pec>	MP:0000260,abnormal angiogenesis|MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0000293,absent myocardial trabeculae|MP:0000364,abnormal vascular regression|MP:0000929,open neural tube|MP:0001730,embryonic growth arrest|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0002950,abnormal neural crest cell migration|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004187,cardia bifida|MP:0004787,abnormal dorsal aorta morphology|MP:0005266,abnormal metabolism|MP:0005294,abnormal heart ventricle morphology|MP:0006344,small second pharyngeal arch|MP:0006345,absent second pharyngeal arch|MP:0010642,absent third pharyngeal arch|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:2385358	Hif1a<tm1Rsjo>	MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001723,disorganized yolk sac vascular plexus|MP:0003204,decreased neuron apoptosis|MP:0004787,abnormal dorsal aorta morphology|MP:0004837,abnormal neural fold formation|MP:0005039,hypoxia|MP:0005602,decreased angiogenesis|MP:0013504,increased embryonic tissue cell apoptosis
MGI:2677892	Hif1a<tm1Stom>	MP:0001544,abnormal cardiovascular system physiology|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0004789,increased bile salt level|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005406,abnormal heart size|MP:0005602,decreased angiogenesis|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0010377,abnormal gut flora balance|MP:0010378,increased respiratory quotient|MP:0014143,decreased body fat mass|MP:0020523,decreased susceptibility to induced hypothermia
MGI:3619142	Hif1a<tm2Mcs>	MP:0002169,no abnormal phenotype detected
MGI:2385361	Hif1a<tm2Rsjo>	MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001723,disorganized yolk sac vascular plexus|MP:0004787,abnormal dorsal aorta morphology|MP:0004837,abnormal neural fold formation|MP:0005039,hypoxia|MP:0005602,decreased angiogenesis|MP:0013504,increased embryonic tissue cell apoptosis
MGI:2386679	Hif1a<tm3Rsjo>	MP:0000157,abnormal sternum morphology|MP:0000164,abnormal cartilage development|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000230,abnormal systemic arterial blood pressure|MP:0000260,abnormal angiogenesis|MP:0000352,decreased cell proliferation|MP:0000547,short limbs|MP:0000627,abnormal mammary gland morphology|MP:0001052,abnormal innervation pattern to muscle|MP:0001177,atelectasis|MP:0001179,thick pulmonary interalveolar septum|MP:0001303,abnormal lens morphology|MP:0001306,small lens|MP:0001575,cyanosis|MP:0001625,cardiac hypertrophy|MP:0001663,abnormal digestive system physiology|MP:0001698,decreased embryo size|MP:0001876,decreased inflammatory response|MP:0001882,abnormal lactation|MP:0001891,hydrocephaly|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002078,abnormal glucose homeostasis|MP:0002106,abnormal muscle physiology|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0002332,abnormal exercise endurance|MP:0002442,abnormal leukocyte physiology|MP:0002451,abnormal macrophage physiology|MP:0002840,abnormal lens fiber morphology|MP:0002908,delayed wound healing|MP:0003076,increased susceptibility to ischemic brain injury|MP:0003120,abnormal tracheal cartilage morphology|MP:0003156,abnormal leukocyte migration|MP:0003383,abnormal gluconeogenesis|MP:0003436,decreased susceptibility to induced arthritis|MP:0003447,decreased tumor growth/size|MP:0003544,abnormal vascular endothelial cell migration|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003723,abnormal long bone morphology|MP:0003799,impaired macrophage chemotaxis|MP:0003915,increased heart left ventricle weight|MP:0003921,abnormal heart left ventricle morphology|MP:0004001,decreased hepatocyte proliferation|MP:0004047,abnormal milk composition|MP:0004084,abnormal cardiac muscle relaxation|MP:0004215,abnormal myocardial fiber physiology|MP:0004686,decreased length of long bones|MP:0004780,abnormal surfactant secretion|MP:0004809,increased hematopoietic stem cell number|MP:0004924,abnormal behavior|MP:0004950,abnormal brain vasculature morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005165,increased susceptibility to injury|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005391,vision/eye phenotype|MP:0005535,abnormal body temperature|MP:0005560,decreased circulating glucose level|MP:0005602,decreased angiogenesis|MP:0005621,abnormal cell physiology|MP:0005630,increased lung weight|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0006060,increased cerebral infarct size|MP:0006397,disorganized long bone epiphyseal plate|MP:0006398,increased long bone epiphyseal plate size|MP:0008008,early cellular replicative senescence|MP:0008125,abnormal dendritic cell number|MP:0008148,abnormal sternocostal joint morphology|MP:0008537,increased susceptibility to induced colitis|MP:0008556,abnormal tumor necrosis factor secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008655,decreased interleukin-1 alpha secretion|MP:0008656,abnormal interleukin-1 beta secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008796,increased lens fiber apoptosis|MP:0008813,decreased common myeloid progenitor cell number|MP:0008872,abnormal physiological response to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009506,abnormal mammary gland alveolus morphology|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0010090,increased circulating creatine kinase level|MP:0010099,abnormal thoracic cage shape|MP:0010398,decreased liver glycogen level|MP:0010551,abnormal coronary vessel morphology|MP:0010724,thick interventricular septum|MP:0010754,abnormal heart left ventricle pressure|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0010768,mortality/aging|MP:0011087,neonatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0020316,decreased vascular endothelial cell proliferation|MP:0020890,abnormal milk sodium level|MP:0021157,increased heart left ventricle wall thickness|MP:0031324,delayed liver regeneration
MGI:3776878	Hif3a<tm1Mym>	MP:0000484,abnormal pulmonary artery morphology|MP:0001176,abnormal lung development|MP:0002270,abnormal pulmonary alveolus morphology|MP:0004566,myocardial fiber degeneration|MP:0005329,abnormal myocardium layer morphology|MP:0008727,increased heart right atrium size|MP:0010563,increased heart right ventricle size|MP:0010755,abnormal heart right ventricle pressure|MP:0010995,abnormal lung alveolus development|MP:0011144,thin lung-associated mesenchyme
MGI:7587820	Higd1c<em1Chaa>	MP:0005385,cardiovascular system phenotype|MP:0005576,decreased pulmonary ventilation|MP:0031252,abnormal physiological response to hypoxia
MGI:7587821	Higd1c<em2Chaa>	MP:0003438,abnormal carotid body physiology|MP:0005385,cardiovascular system phenotype|MP:0005576,decreased pulmonary ventilation|MP:0020843,abnormal type I cell of carotid body physiology|MP:0031252,abnormal physiological response to hypoxia
MGI:7587822	Higd1c<em3Chaa>	MP:0005385,cardiovascular system phenotype|MP:0005576,decreased pulmonary ventilation|MP:0031252,abnormal physiological response to hypoxia
MGI:5708204	Higd2a<tm1.1(KOMP)Vlcg>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:2449650	Hikeshi<1R>	MP:0001176,abnormal lung development|MP:0001575,cyanosis|MP:0001958,emphysema|MP:0005376,homeostasis/metabolism phenotype|MP:0005388,respiratory system phenotype|MP:0010809,abnormal club cell morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6156137	Hikeshi<em1(IMPC)Rbrc>	MP:0000598,abnormal liver morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:7425741	Hilpda<em1(IMPC)Mhzh>	MP:0000280,thin ventricular wall|MP:0005140,decreased cardiac muscle contractility|MP:0010580,decreased heart left ventricle size
MGI:6724249	Hilpda<tm1Xen>	MP:0001402,decreased locomotor activity|MP:0001556,increased circulating HDL cholesterol level|MP:0002757,decreased vertical activity|MP:0004890,decreased energy expenditure|MP:0005290,decreased oxygen consumption|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005534,decreased body temperature|MP:0011049,impaired adaptive thermogenesis|MP:0011939,increased food intake|MP:0011940,decreased food intake
MGI:3852353	Hinfp<tm1Gss>	MP:0001672,abnormal embryo development|MP:0003695,delayed blastocyst hatching from the zona pellucida|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2663678	Hint1<tm1.1Tpm>	MP:0002169,no abnormal phenotype detected
MGI:4433692	Hint1<tm1a(EUCOMM)Wtsi>	MP:0002875,decreased erythrocyte cell number|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:6782387	Hint1<tm1b(EUCOMM)Wtsi>	MP:0004486,decreased response of heart to induced stress
MGI:2674018	Hint1<tm1Ibw>	MP:0001262,decreased body weight|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0004499,increased incidence of tumors by chemical induction|MP:0011703,increased fibroblast proliferation
MGI:2663677	Hint1<tm1Tpm>	MP:0002169,no abnormal phenotype detected
MGI:5812015	Hint2<tm1.1Geno>	MP:0000598,abnormal liver morphology|MP:0001260,increased body weight|MP:0001745,increased circulating corticosterone level|MP:0001777,abnormal body temperature homeostasis|MP:0002079,increased circulating insulin level|MP:0002644,decreased circulating triglyceride level|MP:0002696,decreased circulating glucagon level|MP:0002891,increased insulin sensitivity|MP:0002941,increased circulating alanine transaminase level|MP:0002965,increased circulating serum albumin level|MP:0002981,increased liver weight|MP:0003059,decreased insulin secretion|MP:0003674,oxidative stress|MP:0004892,increased adiponectin level|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005337,abnormal retroperitoneal fat pad morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005669,increased circulating leptin level|MP:0006036,abnormal mitochondrial physiology|MP:0009355,increased liver triglyceride level|MP:0010080,abnormal hepatocyte physiology|MP:0010955,abnormal respiratory electron transport chain|MP:0012574,decreased noradrenaline level|MP:0014341,abnormal hepatocyte mitochondrial morphology|MP:0031115,macrovesicular hepatic steatosis
MGI:6305724	Hip1<em1(IMPC)Hmgu>	MP:0000137,abnormal vertebrae morphology|MP:0001258,decreased body length|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001489,decreased startle reflex|MP:0002757,decreased vertical activity|MP:0005554,decreased circulating creatinine level|MP:0010123,increased bone mineral content
MGI:3045594	Hip1r<tm1Tsr>	MP:0002169,no abnormal phenotype detected
MGI:5574597	Hip1r<tm2b(KOMP)Wtsi>	MP:0001303,abnormal lens morphology|MP:0009142,decreased prepulse inhibition
MGI:2668380	Hip1<tm1Hay>	MP:0000160,kyphosis|MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002108,abnormal muscle morphology
MGI:2182862	Hip1<tm1Tsr>	MP:0000239,absent common myeloid progenitor cells|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0003205,testicular atrophy|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0005397,hematopoietic system phenotype|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014052,increased male germ cell apoptosis|MP:0020550,multinucleated giant male germ cells
MGI:3044188	Hip1<tm2.1Tsr>	MP:0000160,kyphosis|MP:0001925,male infertility|MP:0005390,skeleton phenotype|MP:0005391,vision/eye phenotype|MP:0005397,hematopoietic system phenotype
MGI:3044186	Hip1<tm2Tsr>	MP:0002169,no abnormal phenotype detected
MGI:3044458	Hip1<tm3Tsr>	MP:0000239,absent common myeloid progenitor cells|MP:0001263,weight loss|MP:0001297,microphthalmia|MP:0001306,small lens|MP:0001922,reduced male fertility|MP:0003631,nervous system phenotype|MP:0005390,skeleton phenotype|MP:0005397,hematopoietic system phenotype|MP:0006380,abnormal spermatid morphology|MP:0010254,nuclear cataract|MP:0011090,perinatal lethality, incomplete penetrance|MP:0013600,testis degeneration|MP:0031253,lordokyphosis
MGI:4356264	Hip1<tm4Tsr>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001601,abnormal myelopoiesis|MP:0002019,abnormal tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0004810,decreased hematopoietic stem cell number|MP:0005397,hematopoietic system phenotype|MP:0008019,increased liver tumor incidence|MP:0008476,increased spleen red pulp amount|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:6280488	Hip1<tm5.1(HIP1)Tsr>	MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0004019,abnormal vitamin homeostasis|MP:0004703,abnormal vertebral column morphology|MP:0005266,abnormal metabolism|MP:0005319,abnormal enzyme/coenzyme level|MP:0005332,abnormal amino acid level|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype|MP:0021012,decreased acetylcholine level|MP:0021127,decreased phosphocholine level|MP:0030685,decreased cystathionine level|MP:0031253,lordokyphosis
MGI:6280492	Hip1<tm5.2(HIP1)Tsr>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype
MGI:3624126	Hipk1<tm1Hko>	MP:0002151,abnormal neural tube morphology|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death
MGI:3584135	Hipk1<tm1Mak>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:4429497	Hipk2<tm1Afus>	MP:0000352,decreased cell proliferation|MP:0001262,decreased body weight|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003077,abnormal cell cycle|MP:0009674,decreased birth weight
MGI:3487301	Hipk2<tm1Ejh>	MP:0001095,enlarged trigeminal ganglion|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0003107,abnormal response to novelty|MP:0003204,decreased neuron apoptosis|MP:0003491,abnormal voluntary movement|MP:0005323,dystonia|MP:0005643,decreased dopamine level|MP:0006102,decreased tegmentum size|MP:0009750,impaired behavioral response to addictive substance|MP:0011448,decreased dopaminergic neuron number|MP:0020543,decreased substantia nigra size
MGI:3624127	Hipk2<tm1Hko>	MP:0002151,abnormal neural tube morphology|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death
MGI:5548422	Hipk2<tm2b(EUCOMM)Hmgu>	MP:0000443,abnormal snout morphology|MP:0000455,abnormal maxilla morphology|MP:0001303,abnormal lens morphology|MP:0002100,abnormal tooth morphology|MP:0002833,increased heart weight|MP:0003917,increased kidney weight|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4161864	Hipk3<Gt(OST51087)Lex>	MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0009172,small pancreatic islets|MP:0011820,decreased pancreatic beta cell proliferation
MGI:5588270	Hipk3<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0002599,increased mean platelet volume|MP:0002941,increased circulating alanine transaminase level|MP:0004738,abnormal auditory brainstem response|MP:0005505,thrombocytosis|MP:0009142,decreased prepulse inhibition|MP:0011965,decreased total retina thickness|MP:0013279,increased fasting circulating glucose level
MGI:5632532	Hipk4<tm1b(KOMP)Mbp>	MP:0000242,impaired fertilization|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002965,increased circulating serum albumin level|MP:0005389,reproductive system phenotype|MP:0005566,decreased blood urea nitrogen level|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009233,enlarged sperm head|MP:0009235,small sperm head|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0014052,increased male germ cell apoptosis|MP:0020451,decreased sperm progressive motility|MP:0030980,abnormal acroplaxome morphology
MGI:2154097	Hipp1<C57BL/6J>	MP:0008282,enlarged hippocampus
MGI:2156001	Hipp2<C57BL/6J>	MP:0008282,enlarged hippocampus
MGI:3770306	Hipq1<C57BL/6Wehi>	MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance
MGI:3770307	Hipq1<DBA/2Wehi>	MP:0003058,increased insulin secretion
MGI:5498673	hipr	MP:0001745,increased circulating corticosterone level|MP:0002629,hyperactivity elicited by ethanol administration|MP:0005386,behavior/neurological phenotype|MP:0008911,induced hyperactivity|MP:0009454,impaired contextual conditioning behavior|MP:0009713,enhanced conditioned place preference behavior|MP:0009754,enhanced behavioral response to cocaine
MGI:4431679	Hira<tm1a(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0003345,decreased rib number
MGI:2178130	Hira<tm1Pjs>	MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000270,abnormal heart tube morphology|MP:0000432,abnormal head morphology|MP:0000783,abnormal forebrain morphology|MP:0000913,abnormal brain development|MP:0000929,open neural tube|MP:0001614,abnormal blood vessel morphology|MP:0001636,irregular heartbeat|MP:0001672,abnormal embryo development|MP:0001684,abnormal axial mesoderm morphology|MP:0001689,incomplete somite formation|MP:0001691,abnormal somite shape|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001706,abnormal left-right axis patterning|MP:0001726,abnormal allantois morphology|MP:0001730,embryonic growth arrest|MP:0001787,pericardial edema|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002151,abnormal neural tube morphology|MP:0002231,abnormal primitive streak morphology|MP:0002825,abnormal notochord morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0004096,abnormal midbrain-hindbrain boundary development|MP:0004251,failure of heart looping|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004387,abnormal prechordal plate morphology|MP:0004556,enlarged allantois|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005380,embryo phenotype|MP:0005657,abnormal neural plate morphology|MP:0006108,abnormal hindbrain development|MP:0008029,abnormal paraxial mesoderm morphology|MP:0009266,abnormal mesendoderm development|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011260,abnormal head mesenchyme morphology|MP:0011732,decreased somite size|MP:0012135,embryonic-extraembryonic boundary constriction
MGI:3037947	Hira<tm2Pjs>	MP:0001672,abnormal embryo development|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4421559	Hira<Tn(mm-DTT-3XSstop)L.1Ddra>	MP:0001672,abnormal embryo development|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5548743	Hirip3<tm1.1(KOMP)Mbp>	MP:0000219,increased neutrophil cell number|MP:0001120,abnormal uterus morphology|MP:0001399,hyperactivity|MP:0002176,increased brain weight|MP:0002606,increased basophil cell number|MP:0002833,increased heart weight|MP:0004738,abnormal auditory brainstem response|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:4453981	Hirip3<tm1(KOMP)Mbp>	MP:0008226,decreased anterior commissure size
MGI:5617502	Hist1<tm1Sis>	MP:0001935,decreased litter size|MP:0005389,reproductive system phenotype|MP:0012128,abnormal blastocyst formation
MGI:3037878	Hivan1<CAST/EiJ>	MP:0002135,abnormal kidney morphology
MGI:4867979	Hivep1<tm1(KOMP)Mbp>	MP:0002833,increased heart weight|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2182914	Hivep2<tm1Sis>	MP:0000716,abnormal immune system cell morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000805,abnormal visual cortex morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001447,abnormal nest building behavior|MP:0001973,increased thermal nociceptive threshold|MP:0002367,abnormal thymus lobule morphology|MP:0002371,abnormal thymus cortex morphology|MP:0002375,abnormal thymus medulla morphology|MP:0002434,abnormal T-helper 2 cell morphology|MP:0003635,abnormal synaptic transmission|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004994,abnormal brain wave pattern|MP:0006082,CNS inflammation|MP:0006254,thin cerebral cortex|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0008428,abnormal spatial working memory|MP:0008916,abnormal astrocyte physiology|MP:0008948,decreased neuron number|MP:0009142,decreased prepulse inhibition|MP:0009710,anhedonia|MP:0009808,decreased oligodendrocyte number|MP:0009936,abnormal dendritic spine morphology|MP:0009938,abnormal hippocampus granule cell morphology|MP:0013593,enlarged thymus cortex|MP:0020335,abnormal dentate gyrus neuron dendrite morphology|MP:0020395,abnormal response to social novelty|MP:0020510,increased dendritic spine length|MP:0031391,increased locomotor activity
MGI:3586993	Hivep3<tm1Glm>	MP:0000065,abnormal bone marrow cavity morphology|MP:0000130,abnormal trabecular bone morphology|MP:0001541,abnormal osteoclast physiology|MP:0004148,increased compact bone thickness|MP:0004985,decreased osteoclast cell number|MP:0004993,decreased bone resorption|MP:0005006,abnormal osteoblast physiology|MP:0005422,osteosclerosis|MP:0005605,increased bone mass|MP:0008396,abnormal osteoclast differentiation|MP:0008688,decreased interleukin-2 secretion|MP:0009347,increased trabecular bone thickness|MP:0010867,abnormal bone trabecula morphology|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume|MP:0012072,decreased susceptibility to osteoporosis|MP:0020039,increased bone ossification
MGI:2667235	Hivep3<tm1Lcw>	MP:0000519,hydronephrosis|MP:0000562,polydactyly|MP:0002627,increased teratoma incidence|MP:0005092,decreased double-positive T cell number
MGI:5550461	Hivep3<tm2Glm>	MP:0004148,increased compact bone thickness|MP:0004988,increased osteoblast cell number|MP:0005006,abnormal osteoblast physiology|MP:0005390,skeleton phenotype|MP:0005605,increased bone mass|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume
MGI:5550463	Hivep3<tm3Glm>	MP:0001533,abnormal skeleton physiology|MP:0005605,increased bone mass
MGI:3587747	Hjv<tm1Arbr>	MP:0001925,male infertility|MP:0005376,homeostasis/metabolism phenotype|MP:0005637,abnormal iron homeostasis|MP:0005638,hemochromatosis|MP:0008807,increased liver iron level|MP:0008808,decreased spleen iron level|MP:0010768,mortality/aging|MP:0013302,increased pancreas iron level|MP:0020367,increased heart iron level
MGI:5554937	Hjv<tm1b(KOMP)Wtsi>	MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0008810,increased circulating iron level|MP:0009141,increased prepulse inhibition|MP:0020870,decreased thigmotaxis
MGI:5792151	Hjv<tm1Kpan>	MP:0002169,no abnormal phenotype detected|MP:0002446,abnormal macrophage morphology|MP:0005637,abnormal iron homeostasis|MP:0005638,hemochromatosis|MP:0008807,increased liver iron level|MP:0008808,decreased spleen iron level|MP:0008810,increased circulating iron level|MP:0011890,increased circulating ferritin level|MP:0011897,decreased circulating unsaturated transferrin level
MGI:3587746	Hjv<tm1Nca>	MP:0000607,abnormal hepatocyte morphology|MP:0001770,abnormal iron level|MP:0002446,abnormal macrophage morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005637,abnormal iron homeostasis|MP:0005638,hemochromatosis|MP:0008807,increased liver iron level|MP:0008808,decreased spleen iron level|MP:0008810,increased circulating iron level|MP:0010375,increased kidney iron level|MP:0010768,mortality/aging
MGI:5141508	Hjv<tm2Nca>	MP:0005376,homeostasis/metabolism phenotype
MGI:1861098	Hk	MP:0000585,kinked tail|MP:0000592,short tail|MP:0002759,abnormal caudal vertebrae morphology|MP:0005034,abnormal anus morphology
MGI:2151848	Hk1<dea>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000689,abnormal spleen morphology|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001585,hemolytic anemia|MP:0001926,female infertility|MP:0002447,abnormal erythrocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002814,hyperchromasia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0004952,increased spleen weight|MP:0005097,polychromatophilia|MP:0005344,increased circulating bilirubin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008476,increased spleen red pulp amount|MP:0008807,increased liver iron level|MP:0010375,increased kidney iron level
MGI:5320615	Hk2<tm1.1Uku>	MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000874,irregular external granule cell layer thickness|MP:0002169,no abnormal phenotype detected|MP:0004948,abnormal neuronal precursor proliferation|MP:0009977,abnormal cerebellar granule cell migration
MGI:3624862	Hk2<tm1Laak>	MP:0001262,decreased body weight|MP:0003984,embryonic growth retardation|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:6257703	Hk3<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0002060,abnormal skin morphology|MP:0002768,small adrenal glands
MGI:7425742	Hkdc1<em1(IMPC)Bay>	MP:0000063,decreased bone mineral density|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:6379689	Hkdc1<em1Xjz>	MP:0003728,abnormal retina photoreceptor layer morphology|MP:0005391,vision/eye phenotype|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:6379690	Hkdc1<em2Xjz>	MP:0003728,abnormal retina photoreceptor layer morphology|MP:0005391,vision/eye phenotype|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:4887590	Hkdc1<tm1a(KOMP)Wtsi>	MP:0003926,decreased cellular glucose uptake|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0009356,decreased liver triglyceride level|MP:0011100,preweaning lethality, complete penetrance
MGI:3708383	hkp	MP:0001489,decreased startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856901	hl	MP:0000061,fragile skeleton|MP:0000377,abnormal hair follicle morphology|MP:0001533,abnormal skeleton physiology|MP:0001542,abnormal bone strength|MP:0002073,abnormal hair growth|MP:0002083,premature death|MP:0003413,hair follicle degeneration|MP:0003704,abnormal hair follicle development|MP:0003718,maternal effect|MP:0005114,premature hair loss|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2183058	Hlb10	MP:0002842,increased systemic arterial blood pressure
MGI:2683075	Hlb102	MP:0001952,increased airway responsiveness
MGI:2183055	Hlb12	MP:0002842,increased systemic arterial blood pressure
MGI:2656275	hlb124	MP:0001260,increased body weight|MP:0001261,obese|MP:0005458,increased percent body fat/body weight
MGI:2656177	Hlb125	MP:0001260,increased body weight|MP:0001261,obese|MP:0005458,increased percent body fat/body weight
MGI:2183059	Hlb13	MP:0002842,increased systemic arterial blood pressure
MGI:2679511	Hlb130	MP:0000445,short snout|MP:0009436,fragmentation of sleep/wake states
MGI:2683083	Hlb131	MP:0001260,increased body weight|MP:0001261,obese|MP:0005458,increased percent body fat/body weight
MGI:2656171	Hlb132	MP:0001260,increased body weight|MP:0001261,obese|MP:0005458,increased percent body fat/body weight
MGI:2679515	Hlb141	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number
MGI:3794293	hlb145	MP:0000221,decreased leukocyte cell number
MGI:3575173	Hlb147	MP:0001260,increased body weight|MP:0001261,obese|MP:0005458,increased percent body fat/body weight
MGI:2183060	hlb15	MP:0002842,increased systemic arterial blood pressure
MGI:2679518	hlb156	MP:0000222,decreased neutrophil cell number
MGI:3575176	Hlb163	MP:0001260,increased body weight|MP:0001261,obese|MP:0005458,increased percent body fat/body weight
MGI:2679528	Hlb171	MP:0001952,increased airway responsiveness
MGI:2679533	Hlb173	MP:0001952,increased airway responsiveness
MGI:2656327	Hlb18	MP:0000218,increased leukocyte cell number
MGI:3575179	Hlb181	MP:0001260,increased body weight|MP:0001261,obese|MP:0005458,increased percent body fat/body weight
MGI:3575182	Hlb197	MP:0001260,increased body weight|MP:0001261,obese|MP:0005458,increased percent body fat/body weight
MGI:3575185	Hlb199	MP:0001260,increased body weight|MP:0001261,obese|MP:0005458,increased percent body fat/body weight
MGI:2680492	Hlb206	MP:0000186,decreased circulating HDL cholesterol level
MGI:2680496	Hlb211	MP:0001556,increased circulating HDL cholesterol level
MGI:2680499	Hlb212	MP:0001556,increased circulating HDL cholesterol level
MGI:2680448	Hlb216	MP:0000186,decreased circulating HDL cholesterol level
MGI:2680501	Hlb228	MP:0001260,increased body weight|MP:0001261,obese|MP:0005458,increased percent body fat/body weight
MGI:3575188	Hlb230	MP:0001260,increased body weight|MP:0001261,obese|MP:0005458,increased percent body fat/body weight
MGI:3795177	hlb233	MP:0004122,abnormal sinus arrhythmia
MGI:2680477	Hlb237	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:2680508	Hlb239	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:2683094	Hlb240	MP:0001556,increased circulating HDL cholesterol level
MGI:3575146	hlb241	MP:0000186,decreased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3575161	hlb242	MP:0005178,increased circulating cholesterol level
MGI:3767002	hlb243	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3575143	Hlb245	MP:0005178,increased circulating cholesterol level
MGI:2680511	Hlb250	MP:0001556,increased circulating HDL cholesterol level
MGI:2680514	Hlb252	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:3575167	hlb258	MP:0002551,abnormal blood coagulation|MP:0012330,decreased circulating fibrinogen level
MGI:2183062	Hlb27	MP:0002842,increased systemic arterial blood pressure
MGI:3575164	Hlb280	MP:0001556,increased circulating HDL cholesterol level
MGI:3575170	Hlb289	MP:0001559,hyperglycemia
MGI:3578745	Hlb290	MP:0001559,hyperglycemia
MGI:2680479	Hlb295	MP:0000186,decreased circulating HDL cholesterol level
MGI:2683085	Hlb299	MP:0005178,increased circulating cholesterol level
MGI:2680482	Hlb300	MP:0005178,increased circulating cholesterol level
MGI:3575135	Hlb304	MP:0000208,decreased hematocrit|MP:0002811,macrocytic anemia|MP:0002874,decreased hemoglobin content
MGI:3575192	hlb324B	MP:0000063,decreased bone mineral density|MP:0010124,decreased bone mineral content
MGI:3575247	Hlb328	MP:0000063,decreased bone mineral density|MP:0010124,decreased bone mineral content
MGI:3575250	Hlb330	MP:0000063,decreased bone mineral density|MP:0010124,decreased bone mineral content
MGI:3578518	Hlb336	MP:0010123,increased bone mineral content
MGI:3718207	hlb349A	MP:0001261,obese|MP:0005458,increased percent body fat/body weight|MP:0005658,increased susceptibility to diet-induced obesity
MGI:3575131	hlb385	MP:0000221,decreased leukocyte cell number
MGI:3763723	hlb388	MP:0001556,increased circulating HDL cholesterol level
MGI:2183061	Hlb39	MP:0002842,increased systemic arterial blood pressure
MGI:3575152	Hlb395	MP:0001552,increased circulating triglyceride level
MGI:3575155	Hlb396	MP:0001556,increased circulating HDL cholesterol level
MGI:3578732	Hlb397	MP:0001556,increased circulating HDL cholesterol level
MGI:2183064	Hlb40	MP:0002842,increased systemic arterial blood pressure
MGI:3578432	Hlb413	MP:0002334,abnormal airway responsiveness
MGI:3784206	hlb414	MP:0001952,increased airway responsiveness
MGI:3797727	Hlb426	MP:0006144,increased systemic arterial systolic blood pressure
MGI:4359837	hlb431	MP:0003233,prolonged QT interval
MGI:4359846	hlb437	MP:0001559,hyperglycemia
MGI:2683062	Hlb44	MP:0001260,increased body weight|MP:0001261,obese|MP:0005376,homeostasis/metabolism phenotype|MP:0005458,increased percent body fat/body weight
MGI:3794340	Hlb446	MP:0001556,increased circulating HDL cholesterol level
MGI:3784207	hlb454	MP:0001952,increased airway responsiveness
MGI:3794319	hlb459	MP:0002626,increased heart rate
MGI:3709364	Hlb468	MP:0002626,increased heart rate
MGI:3795172	Hlb476	MP:0001556,increased circulating HDL cholesterol level
MGI:3794333	Hlb477	MP:0001556,increased circulating HDL cholesterol level
MGI:3795182	hlb495	MP:0003057,abnormal epicardium morphology|MP:0003916,decreased heart left ventricle weight
MGI:3795163	hlb497	MP:0001552,increased circulating triglyceride level
MGI:4359848	hlb505	MP:0001552,increased circulating triglyceride level
MGI:4359850	hlb516	MP:0003233,prolonged QT interval
MGI:2683068	hlb52	MP:0001260,increased body weight|MP:0001261,obese|MP:0005376,homeostasis/metabolism phenotype|MP:0005458,increased percent body fat/body weight|MP:0005658,increased susceptibility to diet-induced obesity
MGI:3795194	hlb520	MP:0002753,dilated heart left ventricle|MP:0003057,abnormal epicardium morphology|MP:0003916,decreased heart left ventricle weight
MGI:3795198	hlb521	MP:0002753,dilated heart left ventricle|MP:0003057,abnormal epicardium morphology|MP:0003916,decreased heart left ventricle weight
MGI:3794337	Hlb529	MP:0001556,increased circulating HDL cholesterol level
MGI:2656311	hlb54	MP:0002842,increased systemic arterial blood pressure
MGI:4359851	hlb541	MP:0005458,increased percent body fat/body weight
MGI:4831127	hlb549	MP:0002633,persistent truncus arteriosus|MP:0005157,holoprosencephaly
MGI:4831129	hlb550	MP:0000266,abnormal heart morphology|MP:0003052,omphalocele
MGI:4359853	hlb560	MP:0001552,increased circulating triglyceride level
MGI:3794335	Hlb561	MP:0001556,increased circulating HDL cholesterol level
MGI:4359854	hlb566	MP:0003233,prolonged QT interval
MGI:3794321	hlb575	MP:0005458,increased percent body fat/body weight
MGI:4359855	hlb579	MP:0005458,increased percent body fat/body weight
MGI:4359858	hlb583	MP:0005458,increased percent body fat/body weight
MGI:3794331	Hlb586	MP:0001556,increased circulating HDL cholesterol level
MGI:3794323	Hlb589	MP:0001556,increased circulating HDL cholesterol level
MGI:2656319	Hlb59	MP:0002842,increased systemic arterial blood pressure
MGI:3794325	Hlb592	MP:0001556,increased circulating HDL cholesterol level
MGI:3795167	Hlb594	MP:0001556,increased circulating HDL cholesterol level
MGI:2183067	Hlb60	MP:0002842,increased systemic arterial blood pressure
MGI:2183068	Hlb66	MP:0002842,increased systemic arterial blood pressure
MGI:2183069	Hlb68	MP:0002842,increased systemic arterial blood pressure
MGI:2183071	hlb72	MP:0002842,increased systemic arterial blood pressure
MGI:2183072	Hlb73	MP:0002842,increased systemic arterial blood pressure
MGI:2183074	Hlb75	MP:0002842,increased systemic arterial blood pressure
MGI:2679379	Hlb76	MP:0002842,increased systemic arterial blood pressure
MGI:2656286	Hlb80	MP:0001260,increased body weight|MP:0001261,obese|MP:0005458,increased percent body fat/body weight
MGI:2656280	Hlb81	MP:0001260,increased body weight|MP:0001261,obese|MP:0005458,increased percent body fat/body weight
MGI:2656277	Hlb93	MP:0001260,increased body weight|MP:0001261,obese|MP:0005458,increased percent body fat/body weight
MGI:2656330	Hlb95	MP:0000218,increased leukocyte cell number
MGI:3521779	Hlbsb1<SPRET/Pt>	MP:0011581,increased triglyceride lipase activity
MGI:5817955	Hlcs<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0001392,abnormal locomotor behavior|MP:0001417,decreased exploration in new environment|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002075,abnormal coat/hair pigmentation|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:2447987	Hld	MP:0000807,abnormal hippocampus morphology|MP:0000813,abnormal hippocampus layer morphology|MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0006009,abnormal neuronal migration|MP:0008143,abnormal dendrite morphology|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0010011,ectopic hippocampus pyramidal cells|MP:0014746,abnormal hippocampal mossy fiber innervation pattern
MGI:3848924	hle	MP:0000767,abnormal smooth muscle morphology|MP:0000914,exencephaly|MP:0001176,abnormal lung development|MP:0001178,pulmonary hypoplasia|MP:0001182,lung hemorrhage|MP:0005262,coloboma|MP:0011089,perinatal lethality, complete penetrance
MGI:3045480	Hlf<tm1Schb>	MP:0002169,no abnormal phenotype detected
MGI:3521891	Hlpx<C3H/HeJ>	MP:0005319,abnormal enzyme/coenzyme level
MGI:2154099	Hlq1<MH>	MP:0001777,abnormal body temperature homeostasis
MGI:2154977	Hlq2<MH>	MP:0001777,abnormal body temperature homeostasis
MGI:2155351	Hlq3<MH>	MP:0001777,abnormal body temperature homeostasis
MGI:2155353	Hlq4<MH>	MP:0001777,abnormal body temperature homeostasis
MGI:2156747	Hlq5<MH>	MP:0001777,abnormal body temperature homeostasis
MGI:6467481	Hltf<em1(IMPC)Bay>	MP:0001257,increased body length|MP:0010097,abnormal retina blood vessel morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5484565	Hltf<tm1.1Arte>	MP:0004811,abnormal neuron physiology|MP:0004948,abnormal neuronal precursor proliferation|MP:0009747,impaired behavioral response to xenobiotic
MGI:5532313	Hltf<tm1.2Geno>	MP:0000189,hypoglycemia|MP:0002654,spongiform encephalopathy|MP:0005386,behavior/neurological phenotype|MP:0008025,brain vacuoles|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014178,increased brain apoptosis
MGI:2182089	Hlx<tm1Rph>	MP:0000245,abnormal erythropoiesis|MP:0000477,abnormal intestine morphology|MP:0000596,abnormal liver development|MP:0000600,liver hypoplasia|MP:0001046,abnormal enteric neuron morphology|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0002192,hydrops fetalis|MP:0002279,abnormal diaphragm morphology|MP:0003250,absent gallbladder|MP:0003717,pallor|MP:0003924,diaphragmatic hernia|MP:0004200,decreased fetal size|MP:0004247,small pancreas|MP:0004882,enlarged lung|MP:0005419,decreased circulating serum albumin level|MP:0011089,perinatal lethality, complete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0012235,abnormal liver bud morphology
MGI:1861096	Hm	MP:0000571,interdigital webbing|MP:0005306,abnormal phalanx morphology
MGI:7256895	Hmbox1<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000702,enlarged lymph nodes|MP:0000745,tremors|MP:0001200,thick skin|MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0003020,decreased circulating chloride level|MP:0003068,enlarged kidney|MP:0005016,decreased lymphocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0009454,impaired contextual conditioning behavior
MGI:3923525	Hmbox1<Gt(Ayu21-T346)Imeg>	MP:0000358,abnormal cell morphology
MGI:6393997	Hmbs<tm1.1Rjde>	MP:0000598,abnormal liver morphology|MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001290,delayed eyelid opening|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0005424,jerky movement|MP:0005654,porphyria|MP:0009643,abnormal urine homeostasis|MP:0011188,increased erythrocyte protoporphyrin level|MP:0020284,decreased hydroxymethylbilane synthase level|MP:0020456,decreased myelin sheath amount|MP:0031496,motor developmental delay
MGI:5642364	Hmbs<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0002699,abnormal vitreous body morphology|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2182340	Hmbs<tm1Uam>	MP:0011091,prenatal lethality, complete penetrance
MGI:6393999	Hmbs<tm2.1Rjde>	MP:0011091,prenatal lethality, complete penetrance
MGI:2182346	Hmbs<tm2Uam>	MP:0002169,no abnormal phenotype detected
MGI:2182347	Hmbs<tm3Uam>	MP:0011091,prenatal lethality, complete penetrance
MGI:6154268	Hmces<em1Dfel>	MP:0001935,decreased litter size|MP:0008489,slow postnatal weight gain|MP:0008877,abnormal DNA methylation|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance|MP:0012167,abnormal epigenetic regulation of gene expression
MGI:6154269	Hmces<em2Dfel>	MP:0001935,decreased litter size|MP:0008489,slow postnatal weight gain|MP:0008877,abnormal DNA methylation|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance|MP:0012167,abnormal epigenetic regulation of gene expression
MGI:5823446	Hmcn1<em1(IMPC)J>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0008259,abnormal optic disk morphology|MP:0010053,decreased grip strength
MGI:6693467	Hmcn1<em1Jhm>	MP:0002169,no abnormal phenotype detected
MGI:6693469	Hmcn1<em3Jhm>	MP:0002169,no abnormal phenotype detected
MGI:6715212	Hmcn1<tm1Vog>	MP:0003406,failure of zygotic cell division|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:6693470	Hmcn2<em1Jhm>	MP:0002169,no abnormal phenotype detected
MGI:6693473	Hmcn2<em3Jhm>	MP:0002169,no abnormal phenotype detected
MGI:5692846	Hmcn2<tm1b(EUCOMM)Wtsi>	MP:0002608,increased hematocrit|MP:0003921,abnormal heart left ventricle morphology|MP:0005564,increased hemoglobin content
MGI:3521881	Hmdc<C3H/HeJ>	MP:0005319,abnormal enzyme/coenzyme level
MGI:5901855	Hmg20a<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001697,abnormal embryo size|MP:0001914,hemorrhage|MP:0011100,preweaning lethality, complete penetrance
MGI:3621126	Hmga1<tm1Afus>	MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001625,cardiac hypertrophy|MP:0002023,increased B cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002625,heart left ventricle hypertrophy|MP:0005329,abnormal myocardium layer morphology|MP:0010373,myeloid hyperplasia
MGI:3583805	Hmga1<tm1Brun>	MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0009172,small pancreatic islets
MGI:2673322	Hmga1<tm1Cha>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002784,abnormal Sertoli cell morphology|MP:0004901,decreased male germ cell number|MP:0004930,small epididymis|MP:0005159,azoospermia|MP:0011750,abnormal seminiferous tubule epithelium morphology
MGI:5561566	Hmga1<tm2b(EUCOMM)Hmgu>	MP:0001491,unresponsive to tactile stimuli|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:7294377	Hmga2<em1Sson>	MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001441,increased grooming behavior|MP:0001447,abnormal nest building behavior|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002176,increased brain weight|MP:0002572,abnormal emotion/affect behavior|MP:0002687,oligozoospermia|MP:0002757,decreased vertical activity|MP:0003550,short perineum|MP:0004852,decreased testis weight|MP:0004910,decreased seminal vesicle weight|MP:0004929,decreased epididymis weight|MP:0005238,increased brain size|MP:0005352,small cranium|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008525,decreased cranium height|MP:0008526,decreased cranium width|MP:0008892,abnormal sperm flagellum morphology|MP:0009105,penis prolapse|MP:0009230,abnormal sperm head morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011862,decreased cranium length|MP:0014052,increased male germ cell apoptosis
MGI:1856426	Hmga2<pg>	MP:0000018,small ears|MP:0001127,small ovary|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002286,cryptorchism|MP:0002566,abnormal sexual interaction|MP:0002637,small uterus|MP:0002758,long tail|MP:0002772,brachypodia|MP:0002881,long hair|MP:0003415,priapism|MP:0005448,abnormal energy homeostasis|MP:0008489,slow postnatal weight gain|MP:0008974,proportional dwarf
MGI:1858044	Hmga2<pg-Tg40ACha>	MP:0000771,abnormal brain size|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002768,small adrenal glands|MP:0008974,proportional dwarf
MGI:1858043	Hmga2<pg-Tg40BCha>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0005459,decreased percent body fat/body weight|MP:0008974,proportional dwarf
MGI:2386412	Hmga2<tm1Cha>	MP:0000435,shortened head|MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0006378,abnormal spermatogonia morphology|MP:0009674,decreased birth weight
MGI:5704391	Hmgb1<tm1.1Dltg>	MP:0004761,increased susceptibility to induced pancreatitis|MP:0005379,endocrine/exocrine gland phenotype|MP:0008553,increased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level|MP:0008806,increased circulating amylase level|MP:0009148,pancreas necrosis|MP:0011971,increased circulating lactate dehydrogenase level
MGI:5563518	Hmgb1<tm1.1Ttg>	MP:0001798,impaired macrophage phagocytosis|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0003884,decreased macrophage cell number|MP:0005397,hematopoietic system phenotype|MP:0008635,increased circulating interleukin-18 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008657,increased interleukin-1 beta secretion|MP:0008684,increased interleukin-18 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0008943,increased sensitivity to induced cell death|MP:0011080,increased macrophage apoptosis
MGI:3530901	Hmgb1<tm1Meb>	MP:0000189,hypoglycemia|MP:0001177,atelectasis|MP:0001302,eyelids open at birth|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002715,decreased glycogen catabolism rate|MP:0004028,chromosome breakage|MP:0005150,cachexia|MP:0005202,lethargy|MP:0011087,neonatal lethality, complete penetrance
MGI:2387671	Hmgb2<tm1Meb>	MP:0001146,abnormal testis morphology|MP:0001922,reduced male fertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002286,cryptorchism|MP:0002675,asthenozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0005578,teratozoospermia|MP:0020550,multinucleated giant male germ cells
MGI:3574779	Hmgb3<tm1Dmb>	MP:0000245,abnormal erythropoiesis|MP:0002123,abnormal definitive hematopoiesis|MP:0002591,decreased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0005460,abnormal leukopoiesis|MP:0005564,increased hemoglobin content|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008249,abnormal common lymphocyte progenitor cell morphology
MGI:3575663	Hmgb3<tm2Dmb>	MP:0002169,no abnormal phenotype detected
MGI:6361167	Hmgb4<em1Osb>	MP:0005389,reproductive system phenotype
MGI:3640351	Hmgcl<tm1Gam>	MP:0000266,abnormal heart morphology|MP:0000607,abnormal hepatocyte morphology|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0014341,abnormal hepatocyte mitochondrial morphology
MGI:5538619	Hmgcl<tm2Gam>	MP:0000189,hypoglycemia|MP:0002083,premature death|MP:0003383,abnormal gluconeogenesis|MP:0003979,increased circulating carnitine level|MP:0005202,lethargy|MP:0005309,increased circulating ammonia level|MP:0005376,homeostasis/metabolism phenotype|MP:0010080,abnormal hepatocyte physiology|MP:0014341,abnormal hepatocyte mitochondrial morphology
MGI:6515596	Hmgcr<em1Bcgen>	MP:0001552,increased circulating triglyceride level|MP:0005376,homeostasis/metabolism phenotype
MGI:2682329	Hmgcr<tm1Ishi>	MP:0002169,no abnormal phenotype detected|MP:0011092,embryonic lethality, complete penetrance
MGI:5662445	Hmgcr<tm2Ishi>	MP:0000182,increased circulating LDL cholesterol level|MP:0000183,decreased circulating LDL cholesterol level|MP:0000189,hypoglycemia|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000609,abnormal liver physiology|MP:0000611,jaundice|MP:0001263,weight loss|MP:0001554,increased circulating free fatty acids level|MP:0001654,hepatic necrosis|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002644,decreased circulating triglyceride level|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003326,liver failure|MP:0003980,increased circulating phospholipid level|MP:0005178,increased circulating cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005281,increased fatty acids level|MP:0005283,increased unsaturated fatty acids level|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0008986,abnormal liver parenchyma morphology|MP:0009355,increased liver triglyceride level|MP:0010026,decreased liver cholesterol level|MP:0010330,abnormal circulating lipoprotein level|MP:0010332,abnormal circulating apolipoprotein level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020253,increased collagen level|MP:0031116,microvesicular hepatic steatosis
MGI:6280025	Hmgcs1<em1(IMPC)J>	MP:0002941,increased circulating alanine transaminase level|MP:0004738,abnormal auditory brainstem response|MP:0011100,preweaning lethality, complete penetrance
MGI:6324174	Hmgcs2<em1(IMPC)Tcp>	MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0001262,decreased body weight|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0003457,abnormal circulating ketone body level|MP:0003458,decreased circulating ketone body level|MP:0003961,decreased lean body mass|MP:0005202,lethargy|MP:0005455,increased susceptibility to weight gain|MP:0008489,slow postnatal weight gain|MP:0009355,increased liver triglyceride level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014142,increased body fat mass|MP:0031116,microvesicular hepatic steatosis
MGI:6416128	Hmgcs2<em1Wilh>	MP:0005389,reproductive system phenotype
MGI:6416129	Hmgcs2<em2Wilh>	MP:0005389,reproductive system phenotype
MGI:6457108	Hmgcs2<tm1.1Yil>	MP:0001262,decreased body weight|MP:0001764,abnormal homeostasis|MP:0002083,premature death|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0008770,decreased survivor rate|MP:0013483,abnormal jejunum crypts of Lieberkuhn morphology|MP:0013485,increased Paneth cell number|MP:0013798,abnormal jejunal goblet cell morphology|MP:0014508,decreased intestinal crypt stem cell number|MP:0014509,abnormal intestinal crypt stem cell physiology|MP:0031320,enhanced intestine regeneration
MGI:6457280	Hmgcs2<tm1Yil>	MP:0002169,no abnormal phenotype detected
MGI:6336076	Hmgn1<em1(IMPC)Ics>	MP:0003961,decreased lean body mass|MP:0005554,decreased circulating creatinine level|MP:0010024,increased total body fat amount|MP:0011940,decreased food intake
MGI:3590648	Hmgn1<tm1Mbus>	MP:0001203,increased sensitivity to skin irradiation|MP:0001272,increased metastatic potential|MP:0001489,decreased startle reflex|MP:0001658,increased mortality induced by gamma-irradiation|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002018,increased malignant tumor incidence|MP:0002020,increased tumor incidence|MP:0002050,increased pheochromocytoma incidence|MP:0002665,decreased circulating corticosterone level|MP:0002757,decreased vertical activity|MP:0002947,increased hemangioma incidence|MP:0004045,abnormal cell cycle checkpoint function|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0005621,abnormal cell physiology|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0009142,decreased prepulse inhibition|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011703,increased fibroblast proliferation
MGI:5317455	Hmgn2<tm1.1Mbus>	MP:0010768,mortality/aging
MGI:5572042	Hmgn2<tm1b(KOMP)Wtsi>	MP:0001697,abnormal embryo size|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4366465	Hmgn3<tm1.2Mbus>	MP:0001973,increased thermal nociceptive threshold|MP:0002665,decreased circulating corticosterone level|MP:0002727,decreased circulating insulin level|MP:0002781,increased circulating testosterone level|MP:0005291,abnormal glucose tolerance|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005559,increased circulating glucose level|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0010180,increased susceptibility to weight loss
MGI:5317454	Hmgn5<tm1.1Mbus>	MP:0002169,no abnormal phenotype detected
MGI:5588022	Hmgn5<tm1.2Mbus>	MP:0000334,decreased granulocyte number|MP:0001586,abnormal erythrocyte cell number|MP:0001943,abnormal respiration|MP:0001958,emphysema|MP:0002297,abnormal forced expiratory flow rates|MP:0002304,abnormal total lung capacity|MP:0002311,abnormal inspiratory capacity|MP:0002314,abnormal respiratory mechanics|MP:0002492,decreased IgE level|MP:0002495,increased IgA level|MP:0005291,abnormal glucose tolerance|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0009142,decreased prepulse inhibition
MGI:4460446	Hmgxb3<tm1a(EUCOMM)Wtsi>	MP:0000026,abnormal inner ear morphology|MP:0000914,exencephaly|MP:0002947,increased hemangioma incidence|MP:0003686,abnormal eye muscle morphology|MP:0004269,abnormal optic cup morphology|MP:0004463,basisphenoid bone foramen|MP:0006063,abnormal inferior vena cava morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013834,thin hypoglossal nerve|MP:0013835,absent hypoglossal nerve|MP:0013836,abnormal hypoglossal nerve topology|MP:0013848,subcutaneous edema|MP:0013876,absent ductus venosus valve|MP:0013877,abnormal ductus venosus valve morphology|MP:0013971,blood in lymph vessels
MGI:7526309	Hmgxb4<em1(IMPC)J>	MP:0001258,decreased body length|MP:0001402,decreased locomotor activity|MP:0001488,increased startle reflex|MP:0002834,decreased heart weight|MP:0003961,decreased lean body mass|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount
MGI:7643694	Hmgxb4<tm1.2Zhji>	MP:0003071,decreased vascular permeability|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0011077,decreased macrophage nitric oxide production
MGI:7643689	Hmgxb4<tm1Zhji>	MP:0002169,no abnormal phenotype detected
MGI:3576616	hml	MP:0000026,abnormal inner ear morphology|MP:0000035,abnormal membranous labyrinth morphology|MP:0000048,abnormal stria vascularis morphology|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001967,deafness|MP:0002083,premature death|MP:0003149,abnormal tectorial membrane morphology|MP:0003168,abnormal scala vestibuli morphology|MP:0004308,abnormal basilar membrane morphology|MP:0004862,small scala tympani|MP:0005377,hearing/vestibular/ear phenotype|MP:0006021,abnormal Reissner membrane morphology|MP:0006325,impaired hearing|MP:0008308,small scala media|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2682898	Hmmr<tm1Baa>	MP:0001921,reduced fertility
MGI:6120687	Hmmr<tm1b(EUCOMM)Hmgu>	MP:0000062,increased bone mineral density|MP:0001289,persistence of hyaloid vascular system|MP:0002764,short tibia|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:5696779	Hmmr<tm1Plou>	MP:0001129,impaired ovarian folliculogenesis|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002682,decreased mature ovarian follicle number|MP:0005389,reproductive system phenotype|MP:0005431,decreased oocyte number|MP:0008868,abnormal granulosa cell morphology|MP:0009761,abnormal meiotic spindle morphology|MP:0011125,decreased primary ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0031381,decreased secondary ovarian follicle number
MGI:6276956	Hmox1<em1(IMPC)Mbp>	MP:0000428,abnormal craniofacial morphology|MP:0001297,microphthalmia|MP:0001404,no spontaneous movement|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0003231,abnormal placenta vasculature|MP:0003743,abnormal facial morphology|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011495,abnormal head shape
MGI:3526228	Hmox1<tm1.1Gkl>	MP:0000322,increased granulocyte number|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005014,increased B cell number|MP:0005425,increased macrophage cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008553,increased circulating tumor necrosis factor level|MP:0008565,decreased interferon-beta secretion|MP:0008566,increased interferon-gamma secretion|MP:0009336,increased splenocyte proliferation|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0020953,decreased susceptibility to Paramyxoviridae infection
MGI:5649369	Hmox1<tm1.1Hes>	MP:0001876,decreased inflammatory response|MP:0002702,decreased circulating free fatty acids level|MP:0002891,increased insulin sensitivity|MP:0002942,decreased circulating alanine transaminase level|MP:0003186,abnormal redox activity|MP:0004889,increased energy expenditure|MP:0005266,abnormal metabolism|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005632,decreased circulating aspartate transaminase level|MP:0006036,abnormal mitochondrial physiology|MP:0008561,decreased tumor necrosis factor secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008706,decreased interleukin-6 secretion|MP:0009269,decreased fat cell size|MP:0010182,decreased susceptibility to weight gain|MP:0010954,abnormal cellular respiration|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3846093	Hmox1<tm1.2Gkl>	MP:0000691,enlarged spleen|MP:0001846,increased inflammatory response|MP:0001860,liver inflammation|MP:0002083,premature death|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2429784	Hmox1<tm1Mlee>	MP:0000343,abnormal response to cardiac infarction|MP:0002191,abnormal artery morphology|MP:0002754,dilated heart right ventricle|MP:0002941,increased circulating alanine transaminase level|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0003326,liver failure|MP:0003674,oxidative stress|MP:0003913,increased heart right ventricle weight|MP:0005027,increased susceptibility to parasitic infection|MP:0005048,abnormal thrombosis|MP:0005595,abnormal vascular smooth muscle physiology|MP:0006085,myocardium necrosis|MP:0010750,increased susceptibility to parasitic infection induced morbidity/mortality|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011854,cerebral edema|MP:0031510,increased vascular smooth muscle cell proliferation
MGI:2388322	Hmox1<tm1Poss>	MP:0000208,decreased hematocrit|MP:0000217,abnormal leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0001147,small testis|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001443,poor grooming|MP:0001577,anemia|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001924,infertility|MP:0002083,premature death|MP:0002499,chronic inflammation|MP:0002591,decreased mean corpuscular volume|MP:0002642,anisocytosis|MP:0002743,glomerulonephritis|MP:0002810,microcytic anemia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003333,liver fibrosis|MP:0003606,kidney failure|MP:0003674,oxidative stress|MP:0003884,decreased macrophage cell number|MP:0004151,decreased circulating iron level|MP:0004153,increased renal tubule apoptosis|MP:0004154,renal tubular necrosis|MP:0005150,cachexia|MP:0005264,glomerulosclerosis|MP:0005565,increased blood urea nitrogen level|MP:0005637,abnormal iron homeostasis|MP:0008826,abnormal splenic cell ratio|MP:0008828,abnormal lymph node cell ratio|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011352,proximal convoluted tubule brush border loss|MP:0011402,renal cast|MP:0011506,glomerular crescent|MP:0011890,increased circulating ferritin level
MGI:3526703	Hmox1<tm1Ysh>	MP:0001544,abnormal cardiovascular system physiology|MP:0002972,abnormal cardiac muscle contractility|MP:0003037,increased myocardial infarct size|MP:0006085,myocardium necrosis|MP:0011091,prenatal lethality, complete penetrance
MGI:5692581	Hmox2<tm1b(EUCOMM)Hmgu>	MP:0000223,decreased monocyte cell number|MP:0000274,enlarged heart|MP:0001406,abnormal gait|MP:0004952,increased spleen weight|MP:0010067,increased red blood cell distribution width
MGI:2388325	Hmox2<tm1Poss>	MP:0001770,abnormal iron level|MP:0001943,abnormal respiration|MP:0002106,abnormal muscle physiology|MP:0002133,abnormal respiratory system physiology|MP:0002309,abnormal vital capacity|MP:0002726,abnormal pulmonary vein morphology|MP:0002736,abnormal nociception after inflammation|MP:0003477,abnormal nerve fiber response|MP:0003631,nervous system phenotype|MP:0004036,abnormal muscle relaxation|MP:0005039,hypoxia|MP:0005416,abnormal circulating protein level|MP:0005574,decreased pulmonary respiratory rate|MP:0006001,abnormal intestinal transit time|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3688286	Hmtb1<A/J>	MP:0005048,abnormal thrombosis|MP:0005607,decreased bleeding time
MGI:3688289	Hmtb2<A/J>	MP:0002551,abnormal blood coagulation
MGI:3688294	Hmtb3<A/J>	MP:0002551,abnormal blood coagulation|MP:0005607,decreased bleeding time
MGI:3815106	Hmtb4<C57BL/6J>	MP:0005048,abnormal thrombosis
MGI:3815109	Hmtb5<C57BL/6J>	MP:0005606,increased bleeding time
MGI:3815118	Hmtb8<C57BL/6J>	MP:0005048,abnormal thrombosis
MGI:3815121	Hmtb9<C57BL/6J>	MP:0005048,abnormal thrombosis
MGI:3807705	Hmx1<dmbo>	MP:0000023,abnormal ear position|MP:0000024,lowered ear position|MP:0000914,exencephaly|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0005377,hearing/vestibular/ear phenotype|MP:0005382,craniofacial phenotype|MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype|MP:0008383,enlarged gonial bone|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0030119,abnormal retrotympanic process morphology|MP:0030213,gonial bone hyperplasia
MGI:3807082	Hmx1<mpe>	MP:0000023,abnormal ear position|MP:0000024,lowered ear position|MP:0001265,decreased body size|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5515732	Hmx1<tm1.1Arte>	MP:0002184,abnormal innervation|MP:0009937,abnormal neuron differentiation
MGI:5708171	Hmx2<tm1.1(KOMP)Vlcg>	MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003917,increased kidney weight|MP:0004738,abnormal auditory brainstem response|MP:0008528,polycystic kidney|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2154542	Hmx2<tm1Tlu>	MP:0000026,abnormal inner ear morphology|MP:0000034,abnormal inner ear vestibule morphology|MP:0000036,absent semicircular canals|MP:0001394,circling|MP:0001399,hyperactivity|MP:0002859,abnormal inner ear canal fusion|MP:0003631,nervous system phenotype|MP:0003938,abnormal ear development|MP:0004249,abnormal crista ampullaris morphology|MP:0005191,head tilt
MGI:1857493	Hmx3<tm1Ebo>	MP:0000026,abnormal inner ear morphology|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001732,postnatal growth retardation|MP:0002169,no abnormal phenotype detected|MP:0002428,abnormal semicircular canal morphology|MP:0002858,abnormal posterior semicircular canal morphology|MP:0003161,absent lateral semicircular canal|MP:0003163,absent posterior semicircular canal|MP:0003164,decreased posterior semicircular canal size|MP:0003166,decreased superior semicircular canal size|MP:0004314,absent inner ear vestibule
MGI:1857577	Hmx3<tm1Tlu>	MP:0000037,abnormal lateral semicircular canal morphology|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001728,failure of embryo implantation|MP:0001923,reduced female fertility|MP:0003845,abnormal decidualization|MP:0004249,abnormal crista ampullaris morphology|MP:0004331,vestibular saccular macula degeneration|MP:0004334,utricular macular degeneration|MP:0004425,abnormal otolith organ morphology|MP:0004427,abnormal vestibular labyrinth morphology|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1857541	Hmx3<tm2Tlu>	MP:0000037,abnormal lateral semicircular canal morphology|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001728,failure of embryo implantation|MP:0001923,reduced female fertility|MP:0003845,abnormal decidualization|MP:0004249,abnormal crista ampullaris morphology|MP:0004331,vestibular saccular macula degeneration|MP:0004334,utricular macular degeneration|MP:0004425,abnormal otolith organ morphology|MP:0004427,abnormal vestibular labyrinth morphology|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2384429	Hnf1a<tm1.1Ylee>	MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0001156,abnormal spermatogenesis|MP:0001265,decreased body size|MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level|MP:0001762,polyuria|MP:0001924,infertility|MP:0002160,abnormal reproductive system morphology|MP:0002566,abnormal sexual interaction|MP:0002727,decreased circulating insulin level|MP:0003339,decreased pancreatic beta cell number|MP:0003982,increased cholesterol level|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005123,increased circulating growth hormone level|MP:0005215,abnormal pancreatic islet morphology|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2154359	Hnf1a<tm1Mya>	MP:0000063,decreased bone mineral density|MP:0000473,abnormal stomach glandular epithelium morphology|MP:0000599,enlarged liver|MP:0000611,jaundice|MP:0001262,decreased body weight|MP:0001433,polyphagia|MP:0001732,postnatal growth retardation|MP:0001759,increased urine glucose level|MP:0001762,polyuria|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0002628,hepatic steatosis|MP:0002901,increased urine phosphate level|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0002985,abnormal urine calcium level|MP:0003059,decreased insulin secretion|MP:0003311,aminoaciduria|MP:0003325,decreased liver function|MP:0003893,increased hepatocyte proliferation|MP:0005150,cachexia|MP:0005178,increased circulating cholesterol level|MP:0005309,increased circulating ammonia level|MP:0005311,abnormal circulating amino acid level|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005448,abnormal energy homeostasis|MP:0005528,decreased renal glomerular filtration rate|MP:0005558,decreased creatinine clearance|MP:0005559,increased circulating glucose level|MP:0008822,decreased blood uric acid level|MP:0008843,absent subcutaneous adipose tissue|MP:0009109,decreased pancreas weight|MP:0009114,decreased pancreatic beta cell mass|MP:0009172,small pancreatic islets|MP:0009643,abnormal urine homeostasis|MP:0009810,increased urine uric acid level|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011447,abnormal renal glucose reabsorption|MP:0011765,oroticaciduria|MP:0020401,argininuria|MP:0030662,decreased circulating arginine level|MP:0030670,increased circulating phenylalanine level|MP:0030681,increased circulating hydroxyproline level|MP:0030682,hydroxyprolinuria|MP:0030719,decreased circulating lysine level
MGI:2384426	Hnf1a<tm2Mya>	MP:0000063,decreased bone mineral density|MP:0000473,abnormal stomach glandular epithelium morphology|MP:0000599,enlarged liver|MP:0000611,jaundice|MP:0001262,decreased body weight|MP:0001433,polyphagia|MP:0001732,postnatal growth retardation|MP:0001759,increased urine glucose level|MP:0001762,polyuria|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0002628,hepatic steatosis|MP:0002901,increased urine phosphate level|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0002985,abnormal urine calcium level|MP:0003311,aminoaciduria|MP:0003325,decreased liver function|MP:0003893,increased hepatocyte proliferation|MP:0005150,cachexia|MP:0005178,increased circulating cholesterol level|MP:0005309,increased circulating ammonia level|MP:0005311,abnormal circulating amino acid level|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005448,abnormal energy homeostasis|MP:0005528,decreased renal glomerular filtration rate|MP:0005558,decreased creatinine clearance|MP:0008822,decreased blood uric acid level|MP:0008843,absent subcutaneous adipose tissue|MP:0009643,abnormal urine homeostasis|MP:0009810,increased urine uric acid level|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011447,abnormal renal glucose reabsorption|MP:0011765,oroticaciduria|MP:0020401,argininuria|MP:0030662,decreased circulating arginine level|MP:0030670,increased circulating phenylalanine level|MP:0030681,increased circulating hydroxyproline level|MP:0030682,hydroxyprolinuria|MP:0030719,decreased circulating lysine level
MGI:2450154	Hnf1a<tm2Ylee>	MP:0001924,infertility
MGI:5471835	Hnf1b<tm1Ics>	MP:0002703,abnormal renal tubule morphology|MP:0011682,renal glomerulus cyst
MGI:1857866	Hnf1b<tm1Mya>	MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002582,disorganized extraembryonic tissue|MP:0002663,absent blastocoele|MP:0003988,disorganized embryonic tissue|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology
MGI:1857856	Hnf1b<tm1Sce>	MP:0001675,abnormal ectoderm development|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002718,abnormal inner cell mass morphology|MP:0003886,abnormal embryonic epiblast morphology|MP:0003984,embryonic growth retardation|MP:0005367,renal/urinary system phenotype|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011183,abnormal primitive endoderm morphology|MP:0011198,absent proamniotic cavity|MP:0011207,absent ectoplacental cavity|MP:0012158,absent visceral endoderm|MP:0012162,absent parietal endoderm
MGI:6716050	Hnf1b<tm2Ics>	MP:0001559,hyperglycemia|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003334,pancreas fibrosis|MP:0003338,pancreas lipomatosis|MP:0003341,chronic pancreas inflammation|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0009143,abnormal pancreatic duct morphology|MP:0009149,decreased pancreatic acinar cell number|MP:0009154,pancreatic acinar hypoplasia|MP:0009168,decreased pancreatic islet number|MP:0009172,small pancreatic islets|MP:0013221,pancreatic acinar-to-ductal metaplasia|MP:0013279,increased fasting circulating glucose level
MGI:2181390	Hnf1b<tm2Mya>	MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001724,abnormal extraembryonic endoderm formation|MP:0001730,embryonic growth arrest|MP:0002582,disorganized extraembryonic tissue|MP:0002663,absent blastocoele|MP:0003988,disorganized embryonic tissue|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2183520	Hnf4a<tm1.1Gonz>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0001263,weight loss|MP:0002083,premature death|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0003484,abnormal channel response|MP:0005179,decreased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0014341,abnormal hepatocyte mitochondrial morphology
MGI:3622273	Hnf4a<tm1.1Mwei>	MP:0005293,impaired glucose tolerance
MGI:2183525	Hnf4a<tm1.2Gonz>	MP:0011100,preweaning lethality, complete penetrance
MGI:5613635	Hnf4a<tm1b(EUCOMM)Hmgu>	MP:0000194,increased circulating calcium level|MP:0001262,decreased body weight|MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001556,increased circulating HDL cholesterol level|MP:0002792,abnormal retina vasculature morphology|MP:0005178,increased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0005355,enlarged thyroid gland|MP:0005554,decreased circulating creatinine level|MP:0010097,abnormal retina blood vessel morphology|MP:0011964,increased total retina thickness
MGI:3052820	Hnf4a<tm1(cre)Sdv>	MP:0002169,no abnormal phenotype detected
MGI:2158682	Hnf4a<tm1Dnl>	MP:0001672,abnormal embryo development|MP:0001675,abnormal ectoderm development|MP:0001683,absent mesoderm|MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002230,abnormal primitive streak formation|MP:0003087,absent allantois|MP:0003895,increased ectoderm apoptosis|MP:0003984,embryonic growth retardation|MP:0005030,absent amnion|MP:0009593,absent chorion|MP:0011092,embryonic lethality, complete penetrance|MP:0012105,delayed gastrulation|MP:0012131,small visceral yolk sac|MP:0013504,increased embryonic tissue cell apoptosis
MGI:2183519	Hnf4a<tm1Gonz>	MP:0011100,preweaning lethality, complete penetrance
MGI:3625863	Hnf4a<tm1Mwei>	MP:0002169,no abnormal phenotype detected
MGI:2385463	Hnf4a<tm1Sad>	MP:0000527,abnormal kidney development|MP:0000596,abnormal liver development|MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000608,dissociated hepatocytes|MP:0001426,polydipsia|MP:0001759,increased urine glucose level|MP:0001762,polyuria|MP:0002135,abnormal kidney morphology|MP:0002169,no abnormal phenotype detected|MP:0002901,increased urine phosphate level|MP:0002989,small kidney|MP:0003197,nephrocalcinosis|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0010398,decreased liver glycogen level
MGI:3622274	Hnf4a<tm2.1Mwei>	MP:0002118,abnormal lipid homeostasis|MP:0002575,increased circulating ketone body level|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0004119,hypokalemia|MP:0004151,decreased circulating iron level|MP:0005179,decreased circulating cholesterol level|MP:0005344,increased circulating bilirubin level
MGI:3625865	Hnf4a<tm2Mwei>	MP:0011092,embryonic lethality, complete penetrance
MGI:6276900	Hnf4g<em1(IMPC)Mbp>	MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0004738,abnormal auditory brainstem response
MGI:3664775	Hnf4g<tm1Dgen>	MP:0001260,increased body weight|MP:0001447,abnormal nest building behavior|MP:0001943,abnormal respiration|MP:0003064,decreased coping response|MP:0003313,abnormal locomotor activation|MP:0005376,homeostasis/metabolism phenotype|MP:0005450,abnormal energy expenditure|MP:0011940,decreased food intake|MP:0011942,decreased fluid intake
MGI:3615293	Hnl<BALB/cBy>	MP:0012575,increased noradrenaline level
MGI:4364774	Hnmt<tm1a(KOMP)Wtsi>	MP:0001353,increased aggression towards mice|MP:0001354,increased aggression towards male mice|MP:0001402,decreased locomotor activity|MP:0001501,abnormal sleep pattern|MP:0005386,behavior/neurological phenotype|MP:0012289,abnormal non-rapid eye movement sleep pattern|MP:0030755,increased histamine level
MGI:5818661	Hnrnpa1<tm1.1Cyf>	MP:0000538,abnormal urinary bladder morphology|MP:0001258,decreased body length|MP:0002280,abnormal intercostal muscle morphology|MP:0002626,increased heart rate|MP:0002795,dilated cardiomyopathy|MP:0004070,abnormal P wave|MP:0004136,abnormal tongue muscle morphology|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008022,dilated heart ventricle|MP:0010511,shortened PR interval|MP:0011087,neonatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0030421,tongue muscle hypoplasia
MGI:6471775	Hnrnpa2b1<tm1.1Caox>	MP:0005387,immune system phenotype|MP:0008565,decreased interferon-beta secretion|MP:0008576,decreased circulating interferon-beta level|MP:0008750,abnormal interferon level|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:5812384	Hnrnpa3<em1Ionsz>	MP:0000790,abnormal stratification in cerebral cortex|MP:0001176,abnormal lung development|MP:0003077,abnormal cell cycle|MP:0003641,small lung|MP:0004046,abnormal mitosis|MP:0004760,increased mitotic index|MP:0005039,hypoxia|MP:0006254,thin cerebral cortex|MP:0008058,abnormal DNA repair|MP:0008458,abnormal cortical ventricular zone morphology|MP:0008547,abnormal neocortex morphology|MP:0009567,mitotic nondisjunction|MP:0009937,abnormal neuron differentiation|MP:0010898,abnormal pulmonary alveolus epithelium morphology|MP:0010900,abnormal pulmonary interalveolar septum morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3853060	Hnrnpab<Gt(AV0462)Wtsi>	MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0008415,abnormal neurite morphology|MP:0009937,abnormal neuron differentiation
MGI:5692610	Hnrnpab<tm2b(EUCOMM)Hmgu>	MP:0000195,decreased circulating calcium level|MP:0001697,abnormal embryo size|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2678411	Hnrnpc<Gt(U3Betageo)1Ruiz>	MP:0011091,prenatal lethality, complete penetrance
MGI:3029723	Hnrnpc<Gt(U3His)4A4Rul>	MP:0001696,failure to gastrulate|MP:0001730,embryonic growth arrest|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5635221	Hnrnpc<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001415,increased exploration in new environment|MP:0005292,improved glucose tolerance|MP:0005419,decreased circulating serum albumin level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5605733	Hnrnpd<tm1b(KOMP)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002606,increased basophil cell number|MP:0002797,increased thigmotaxis|MP:0004924,abnormal behavior|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number
MGI:3693617	Hnrnpd<tm1Rjsc>	MP:0000533,kidney hemorrhage|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0004201,fetal growth retardation|MP:0005343,increased circulating aspartate transaminase level|MP:0005565,increased blood urea nitrogen level|MP:0008553,increased circulating tumor necrosis factor level|MP:0008735,increased susceptibility to endotoxin shock|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size
MGI:6391198	Hnrnpf<tm1Jsdc>	MP:0000231,hypertension|MP:0001759,increased urine glucose level|MP:0001762,polyuria|MP:0002703,abnormal renal tubule morphology|MP:0002871,albuminuria|MP:0003215,renal interstitial fibrosis|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0006144,increased systemic arterial systolic blood pressure|MP:0009643,abnormal urine homeostasis|MP:0031229,increased angiotensin II level
MGI:6358741	Hnrnph1<em1Lagbu>	MP:0031304,impaired behavioral response to methamphetamine
MGI:7768008	Hnrnph1<tm1.1Nju>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002631,abnormal epididymis morphology|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0004852,decreased testis weight|MP:0005169,abnormal male meiosis|MP:0006379,abnormal spermatocyte morphology|MP:0014052,increased male germ cell apoptosis|MP:0014633,decreased spermatid number|MP:0020355,abnormal Sertoli cell barrier morphology|MP:0020356,abnormal Sertoli cell barrier function|MP:0031389,abnormal ectoplasmic specialization morphology
MGI:5707432	Hnrnph1<tm1b(KOMP)Wtsi>	MP:0000222,decreased neutrophil cell number|MP:0002590,increased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0005013,increased lymphocyte cell number|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance
MGI:6147827	Hnrnph2<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0000428,abnormal craniofacial morphology|MP:0001284,absent vibrissae|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation
MGI:7539577	Hnrnph2<em1Jpat>	MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000428,abnormal craniofacial morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001300,ocular hypertelorism|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0001496,audiogenic seizures|MP:0001525,impaired balance|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0004994,abnormal brain wave pattern|MP:0005537,abnormal cerebral aqueduct morphology|MP:0008525,decreased cranium height|MP:0010053,decreased grip strength|MP:0011101,prenatal lethality, incomplete penetrance|MP:0014624,abnormal brain delta wave pattern|MP:0021090,abnormal dendrite arborization pattern
MGI:7539576	Hnrnph2<em2Jpat>	MP:0000097,short maxilla|MP:0000428,abnormal craniofacial morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001300,ocular hypertelorism|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001496,audiogenic seizures|MP:0001525,impaired balance|MP:0001891,hydrocephaly|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002572,abnormal emotion/affect behavior|MP:0002797,increased thigmotaxis|MP:0003908,decreased stereotypic behavior|MP:0005537,abnormal cerebral aqueduct morphology|MP:0008414,abnormal spatial reference memory|MP:0008525,decreased cranium height|MP:0010053,decreased grip strength|MP:0011620,abnormal habituation to a new environment|MP:0012307,impaired spatial learning|MP:0014114,abnormal cognition|MP:0021112,impaired social recognition
MGI:7539578	Hnrnph2<em3Jpat>	MP:0000428,abnormal craniofacial morphology|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0006276,abnormal autonomic nervous system physiology|MP:0010769,abnormal survival
MGI:7287681	Hnrnpk<tm1.1Cya>	MP:0001147,small testis|MP:0001265,decreased body size|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0008261,arrest of male meiosis|MP:0009248,small caput epididymis|MP:0014052,increased male germ cell apoptosis|MP:0031210,small cauda epididymis
MGI:3707008	Hnrnpll<thdr>	MP:0002145,abnormal T cell differentiation|MP:0008051,abnormal memory T cell physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0010833,abnormal memory T cell morphology
MGI:5442362	Hnrnpl<tm1.1Tmo>	MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0005018,decreased T cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005348,increased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:5442363	Hnrnpl<tm1.2Tmo>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4820294	Hnrnpr<tm1a(EUCOMM)Wtsi>	MP:0003631,nervous system phenotype|MP:0004030,induced chromosome breakage|MP:0005378,growth/size/body region phenotype|MP:0010768,mortality/aging|MP:0014764,impaired double-strand DNA break repair
MGI:7550686	Hnrnpu<em1Frk>	MP:0001523,impaired righting response|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002194,maximal tonic hindlimb extension seizures|MP:0003631,nervous system phenotype|MP:0004994,abnormal brain wave pattern|MP:0005356,positive geotaxis|MP:0009674,decreased birth weight|MP:0011091,prenatal lethality, complete penetrance|MP:0020351,decreased vocalization|MP:0021165,behavioral developmental delay
MGI:3580289	Hnrnpu<Gt(U3Neo)1Rul>	MP:0001675,abnormal ectoderm development|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003984,embryonic growth retardation|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5648110	Hnrnpu<tm1.1Tman>	MP:0000278,abnormal myocardial fiber morphology|MP:0000280,thin ventricular wall|MP:0002169,no abnormal phenotype detected|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003222,increased cardiomyocyte apoptosis|MP:0004090,abnormal sarcomere morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0004567,decreased myocardial fiber number|MP:0005598,decreased heart ventricle muscle contractility|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0010725,thin interventricular septum|MP:0011085,postnatal lethality, complete penetrance|MP:0011629,decreased mitochondrial number|MP:0011925,abnormal heart echocardiography feature|MP:0020419,decreased cardiac muscle relaxation|MP:0030567,abnormal I band morphology
MGI:6416172	Hoatz<em1Seta>	MP:0001147,small testis|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006362,abnormal male germ cell morphology|MP:0008028,pregnancy-related premature death|MP:0008535,enlarged lateral ventricles|MP:0008892,abnormal sperm flagellum morphology|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011059,abnormal ependyma motile cilium morphology|MP:0011069,abnormal brain ependyma motile cilium physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011380,enlarged brain ventricles|MP:0030964,decreased brain ependyma motile cilium length
MGI:7425743	Hoga1<em1(IMPC)Bay>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:4419886	Hoga1<tm2a(KOMP)Wtsi>	MP:0000609,abnormal liver physiology|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis
MGI:3614833	Hom1<AKR>	MP:0004851,increased testis weight|MP:0004910,decreased seminal vesicle weight
MGI:3614829	Hom1<A/Ph>	MP:0002781,increased circulating testosterone level|MP:0004851,increased testis weight|MP:0004910,decreased seminal vesicle weight
MGI:5496433	Homer1<tm1Kino>	MP:0001968,abnormal touch/nociception|MP:0005386,behavior/neurological phenotype|MP:0008143,abnormal dendrite morphology|MP:0008432,abnormal long-term spatial reference memory|MP:0009454,impaired contextual conditioning behavior
MGI:3526529	Homer1<tm1Mhd>	MP:0002693,abnormal pancreas physiology|MP:0009713,enhanced conditioned place preference behavior|MP:0009754,enhanced behavioral response to cocaine|MP:0014812,abnormal brain physiology
MGI:5086112	Homer1<tm2Mhd>	MP:0002736,abnormal nociception after inflammation|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:6342431	Homer2<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response|MP:0010392,prolonged QRS complex duration
MGI:3526530	Homer2<tm1Mhd>	MP:0002062,abnormal associative learning|MP:0002556,abnormal cocaine consumption|MP:0002693,abnormal pancreas physiology|MP:0005386,behavior/neurological phenotype|MP:0009713,enhanced conditioned place preference behavior|MP:0009754,enhanced behavioral response to cocaine|MP:0014812,abnormal brain physiology
MGI:3526157	Homer3<tm1Mhd>	MP:0005386,behavior/neurological phenotype
MGI:1856652	Hook1<azh>	MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008545,absent sperm flagellum|MP:0008893,detached sperm flagellum|MP:0008898,abnormal acrosome morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009376,abnormal manchette morphology|MP:0009377,ectopic manchette
MGI:6156501	Hook1<em1(IMPC)Tcp>	MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0001925,male infertility|MP:0002060,abnormal skin morphology
MGI:6358628	Hook2<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001157,small seminal vesicle|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010067,increased red blood cell distribution width
MGI:5766178	Hook3<tm1b(NCOM)Mfgc>	MP:0000063,decreased bone mineral density|MP:0001175,abnormal lung morphology|MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0002606,increased basophil cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0005343,increased circulating aspartate transaminase level|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content
MGI:2389244	Hopx<tm1.1Joe>	MP:0001176,abnormal lung development|MP:0001182,lung hemorrhage|MP:0002275,abnormal type II pneumocyte morphology|MP:0002652,thin myocardium|MP:0003233,prolonged QT interval|MP:0004057,thin myocardium compact layer|MP:0004071,prolonged P wave|MP:0004072,abnormal frontal plane axis|MP:0005312,pericardial effusion|MP:0005329,abnormal myocardium layer morphology|MP:0005586,decreased tidal volume|MP:0006027,impaired lung alveolus development|MP:0006321,increased myocardial fiber number|MP:0010392,prolonged QRS complex duration|MP:0010553,prolonged HV interval|MP:0010560,intraventricular block|MP:0010992,increased surfactant secretion|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011142,abnormal lung-associated mesenchyme development|MP:0011143,thick lung-associated mesenchyme
MGI:2389233	Hopx<tm1Eno>	MP:0000274,enlarged heart|MP:0000275,heart hyperplasia|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0001730,embryonic growth arrest|MP:0002106,abnormal muscle physiology|MP:0002652,thin myocardium|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0003141,cardiac fibrosis|MP:0003567,abnormal fetal cardiomyocyte proliferation|MP:0005140,decreased cardiac muscle contractility|MP:0005244,hemopericardium|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5300731	Hopx<tm2.1(cre/ERT2)Joe>	MP:0005381,digestive/alimentary phenotype
MGI:5013480	Hormad1<tm1.1Atot>	MP:0005389,reproductive system phenotype
MGI:5013481	Hormad1<tm1.2Atot>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0008280,abnormal male germ cell apoptosis|MP:0008966,abnormal chiasmata formation|MP:0009452,abnormal synaptonemal complex|MP:0010948,abnormal double-strand DNA break repair|MP:0014443,impaired polar body extrusion|MP:0014445,abnormal spindle assembly in female meiosis
MGI:5013479	Hormad1<tm1Atot>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0008280,abnormal male germ cell apoptosis|MP:0008966,abnormal chiasmata formation|MP:0009452,abnormal synaptonemal complex|MP:0010948,abnormal double-strand DNA break repair|MP:0014443,impaired polar body extrusion|MP:0014445,abnormal spindle assembly in female meiosis
MGI:5587823	Hormad1<tm1Kura>	MP:0001925,male infertility|MP:0003718,maternal effect|MP:0004024,aneuploidy|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0008280,abnormal male germ cell apoptosis|MP:0009451,abnormal chromosomal synapsis|MP:0014764,impaired double-strand DNA break repair
MGI:4887242	Hormad1<tm1Rajk>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001728,failure of embryo implantation|MP:0001730,embryonic growth arrest|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001930,abnormal meiosis|MP:0004024,aneuploidy|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0008966,abnormal chiasmata formation|MP:0009451,abnormal chromosomal synapsis|MP:0009781,abnormal preimplantation embryo development|MP:0010767,abnormal female meiosis I arrest|MP:0014052,increased male germ cell apoptosis|MP:0014445,abnormal spindle assembly in female meiosis
MGI:7425744	Hormad2<em1(IMPC)Ccpcz>	MP:0000208,decreased hematocrit|MP:0000627,abnormal mammary gland morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001417,decreased exploration in new environment|MP:0001925,male infertility|MP:0002311,abnormal inspiratory capacity|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0011045,decreased lung elastance
MGI:5427605	Hormad2<tm1.2Atot>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0008280,abnormal male germ cell apoptosis|MP:0008966,abnormal chiasmata formation
MGI:5427603	Hormad2<tm1Atot>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0008280,abnormal male germ cell apoptosis
MGI:5466566	Hormad2<tm1Kura>	MP:0001147,small testis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0008280,abnormal male germ cell apoptosis
MGI:5789897	Hotair<tm1.1Hyc>	MP:0000553,absent radius|MP:0000554,abnormal carpal bone morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0004614,caudal vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004639,fused metacarpal bones|MP:0004647,decreased lumbar vertebrae number|MP:0008915,fused carpal bones
MGI:5790422	Hotair<tm1Vlcg>	MP:0000556,abnormal hindlimb morphology|MP:0002111,abnormal tail morphology|MP:0004614,caudal vertebral transformation
MGI:5790439	Hotair<tm2Vlcg>	MP:0004614,caudal vertebral transformation
MGI:5563534	Hottip<tm1Vlcg>	MP:0000747,muscle weakness|MP:0001513,limb grasping|MP:0002169,no abnormal phenotype detected|MP:0003082,abnormal gastrocnemius morphology|MP:0009406,decreased skeletal muscle fiber number|MP:0009422,decreased gastrocnemius weight|MP:0009728,abnormal calcaneum morphology|MP:0010053,decreased grip strength
MGI:5708276	Hoxa10<tm1.1(KOMP)Vlcg>	MP:0010123,increased bone mineral content
MGI:2150505	Hoxa10<tm1Ipc>	MP:0000480,increased rib number|MP:0001077,abnormal spinal nerve morphology|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002114,abnormal axial skeleton morphology|MP:0002286,cryptorchism|MP:0002670,absent scrotum|MP:0002784,abnormal Sertoli cell morphology|MP:0003550,short perineum|MP:0004616,lumbar vertebral transformation|MP:0004617,sacral vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004672,short ribs|MP:0004680,small xiphoid process|MP:0005149,abnormal gubernaculum morphology|MP:0005159,azoospermia|MP:0008146,asymmetric sternocostal joints|MP:0009082,uterus cyst|MP:0009213,absent male inguinal canal|MP:0009218,absent peritoneal vaginal process|MP:0012283,decreased sternebra number|MP:0031286,unilateral cryptorchism|MP:0031287,bilateral cryptorchism
MGI:2150430	Hoxa10<tm1Rilm>	MP:0000480,increased rib number|MP:0000664,small prostate gland anterior lobe|MP:0000665,decreased ductal branching in the coagulating gland|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001163,abnormal prostate gland anterior lobe morphology|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002769,abnormal vas deferens morphology|MP:0004651,increased thoracic vertebrae number|MP:0005149,abnormal gubernaculum morphology|MP:0005159,azoospermia|MP:0013317,abnormal seminal vesicle development|MP:0031287,bilateral cryptorchism
MGI:7738733	Hoxa11os<em1Kaf>	MP:0001858,intestinal inflammation|MP:0003009,abnormal cytokine secretion|MP:0003292,melena|MP:0003674,oxidative stress|MP:0005036,diarrhea|MP:0005290,decreased oxygen consumption|MP:0005381,digestive/alimentary phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0008537,increased susceptibility to induced colitis|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0010959,abnormal oxidative phosphorylation|MP:0011631,decreased mitochondrial size|MP:0011632,dilated mitochondrion|MP:0011635,abnormal mitochondrial crista morphology|MP:0011637,abnormal mitochondrial matrix morphology|MP:0011639,decreased mitochondrial DNA content
MGI:3814861	Hoxa11<tm1Dmwe>	MP:0001925,male infertility|MP:0001926,female infertility
MGI:2389126	Hoxa11<tm1Mrc>	MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0004355,short radius|MP:0004650,increased lumbar vertebrae number|MP:0005390,skeleton phenotype|MP:0008161,increased diameter of radius|MP:0008163,increased diameter of ulna
MGI:2135973	Hoxa11<tm1Ssp>	MP:0000150,abnormal rib morphology|MP:0000552,abnormal radius morphology|MP:0000554,abnormal carpal bone morphology|MP:0000558,abnormal tibia morphology|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0002187,abnormal fibula morphology|MP:0002286,cryptorchism|MP:0002769,abnormal vas deferens morphology|MP:0003345,decreased rib number|MP:0003857,abnormal hindlimb zeugopod morphology|MP:0004014,abnormal uterine environment|MP:0004355,short radius|MP:0004359,short ulna|MP:0004617,sacral vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004650,increased lumbar vertebrae number|MP:0005108,abnormal ulna morphology|MP:0005159,azoospermia|MP:0008258,thin endometrium|MP:0008915,fused carpal bones|MP:0009096,decreased endometrial gland number|MP:0009214,vas deferens hypoplasia|MP:0014052,increased male germ cell apoptosis
MGI:2388357	Hoxa11<tm2.1(Hoxa13)Ssp>	MP:0000554,abnormal carpal bone morphology|MP:0001926,female infertility|MP:0003855,abnormal forelimb zeugopod morphology|MP:0003857,abnormal hindlimb zeugopod morphology|MP:0004355,short radius|MP:0004359,short ulna|MP:0004896,abnormal endometrium morphology|MP:0005109,abnormal talus morphology|MP:0005367,renal/urinary system phenotype|MP:0005371,limbs/digits/tail phenotype|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype|MP:0009097,absent endometrial glands|MP:0009728,abnormal calcaneum morphology
MGI:1857336	Hoxa13<Hd>	MP:0000516,abnormal renal/urinary system morphology|MP:0000519,hydronephrosis|MP:0000554,abnormal carpal bone morphology|MP:0000564,syndactyly|MP:0000661,small prostate gland ventral lobe|MP:0000666,decreased prostate gland duct number|MP:0001135,abnormal uterine cervix morphology|MP:0001157,small seminal vesicle|MP:0001163,abnormal prostate gland anterior lobe morphology|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002059,abnormal seminal vesicle morphology|MP:0002110,abnormal digit morphology|MP:0002115,abnormal limb bone morphology|MP:0002544,brachydactyly|MP:0003072,abnormal metatarsal bone morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0003270,intestinal obstruction|MP:0003446,renal hypoplasia|MP:0003550,short perineum|MP:0003617,urinary bladder hypoplasia|MP:0003675,kidney cyst|MP:0003800,monodactyly|MP:0005104,abnormal tarsal bone morphology|MP:0005230,ectrodactyly|MP:0008983,small vagina|MP:0009001,absent hallux|MP:0009087,dilated uterine horn|MP:0009103,abnormal penile bone morphology|MP:0009104,small penile bone|MP:0009227,uterine cervix hypoplasia|MP:0009252,absent urinary bladder|MP:0009740,small prostate gland dorsolateral lobe|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011780,abnormal female urethra morphology|MP:0011828,urinary bladder cyst|MP:0011829,vesicovaginal fistula|MP:0013318,abnormal branching involved in seminal vesicle morphogenesis|MP:0013323,abnormal ampullary gland morphology|MP:0014281,hindlimb oligodactyly
MGI:2152356	Hoxa13<tm1.1Mrc>	MP:0000280,thin ventricular wall|MP:0000492,abnormal rectum morphology|MP:0000564,syndactyly|MP:0000572,abnormal autopod morphology|MP:0001219,thick epidermis|MP:0001715,placental labyrinth hypoplasia|MP:0001785,edema|MP:0002109,abnormal limb morphology|MP:0003124,hypospadia|MP:0003230,abnormal umbilical artery morphology|MP:0003942,abnormal urinary system development|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012302,umbilical artery stenosis
MGI:2150506	Hoxa13<tm1Ipc>	MP:0000554,abnormal carpal bone morphology|MP:0000565,oligodactyly|MP:0000571,interdigital webbing|MP:0002110,abnormal digit morphology|MP:0002187,abnormal fibula morphology|MP:0002544,brachydactyly|MP:0004576,abnormal embryonic autopod plate morphology|MP:0005104,abnormal tarsal bone morphology|MP:0005306,abnormal phalanx morphology|MP:0006253,clinodactyly|MP:0006279,abnormal limb development|MP:0006280,abnormal digit development|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3521726	Hoxa13<tm1Jwi>	MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0002544,brachydactyly|MP:0011091,prenatal lethality, complete penetrance
MGI:2152348	Hoxa13<tm1Mrc>	MP:0002109,abnormal limb morphology|MP:0003230,abnormal umbilical artery morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:2150507	Hoxa13<tm2Ipc>	MP:0000554,abnormal carpal bone morphology|MP:0000565,oligodactyly|MP:0000571,interdigital webbing|MP:0002110,abnormal digit morphology|MP:0002187,abnormal fibula morphology|MP:0002544,brachydactyly|MP:0004576,abnormal embryonic autopod plate morphology|MP:0005104,abnormal tarsal bone morphology|MP:0005306,abnormal phalanx morphology|MP:0006253,clinodactyly|MP:0006279,abnormal limb development|MP:0006280,abnormal digit development|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:1857504	Hoxa1<tm1Ipc>	MP:0000026,abnormal inner ear morphology|MP:0000030,abnormal tympanic ring morphology|MP:0000031,abnormal cochlea morphology|MP:0000033,absent scala media|MP:0000034,abnormal inner ear vestibule morphology|MP:0000035,abnormal membranous labyrinth morphology|MP:0000036,absent semicircular canals|MP:0000039,abnormal otic capsule morphology|MP:0000041,absent endolymphatic duct|MP:0000077,abnormal interparietal bone morphology|MP:0000079,abnormal basioccipital bone morphology|MP:0000080,abnormal exoccipital bone morphology|MP:0000743,muscle spasm|MP:0000841,abnormal hindbrain morphology|MP:0000843,absent facial nuclei|MP:0000933,abnormal rhombomere morphology|MP:0001056,abnormal cranial nerve morphology|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001101,abnormal superior vagus ganglion morphology|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002316,anoxia|MP:0002621,delayed neural tube closure|MP:0003146,absent cochlear ganglion|MP:0003147,absent cochlea|MP:0003163,absent posterior semicircular canal|MP:0003165,absent superior semicircular canal|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0003987,small vestibular ganglion|MP:0004249,abnormal crista ampullaris morphology|MP:0004310,small otic vesicle|MP:0004315,absent vestibular saccule|MP:0004330,abnormal vestibular saccular macula morphology|MP:0004333,abnormal utricular macula morphology|MP:0004369,absent utricle|MP:0004561,absent facial nerve|MP:0004715,absent vestibulocochlear nerve|MP:0004923,absent common crus|MP:0006013,absent endolymphatic sac|MP:0009806,abnormal otic vesicle morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0012797,decreased rhombomere 4 size|MP:0012801,decreased rhombomere 5 size|MP:0012816,abnormal rhombomere boundary morphology
MGI:1857840	Hoxa1<tm1Mrc>	MP:0000026,abnormal inner ear morphology|MP:0000031,abnormal cochlea morphology|MP:0000034,abnormal inner ear vestibule morphology|MP:0000040,decreased middle ear ossicle number|MP:0000041,absent endolymphatic duct|MP:0000049,abnormal middle ear morphology|MP:0000432,abnormal head morphology|MP:0000841,abnormal hindbrain morphology|MP:0000842,absent superior olivary complex nucleus|MP:0000843,absent facial nuclei|MP:0000848,abnormal pons morphology|MP:0000910,small facial motor nucleus|MP:0000933,abnormal rhombomere morphology|MP:0001056,abnormal cranial nerve morphology|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001082,abnormal geniculate ganglion morphology|MP:0001083,small geniculate ganglion|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001098,small superior glossopharyngeal ganglion|MP:0001102,small superior vagus ganglion|MP:0002169,no abnormal phenotype detected|MP:0002177,abnormal outer ear morphology|MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0004310,small otic vesicle|MP:0004715,absent vestibulocochlear nerve|MP:0004717,absent cochlear nerve|MP:0004719,absent vestibular nerve|MP:0006030,abnormal otic vesicle development|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3056069	Hoxa1<tm1Rez>	MP:0000030,abnormal tympanic ring morphology|MP:0000031,abnormal cochlea morphology|MP:0000079,abnormal basioccipital bone morphology|MP:0001056,abnormal cranial nerve morphology|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0002428,abnormal semicircular canal morphology|MP:0004204,absent stapes|MP:0004568,fusion of glossopharyngeal and vagus nerve|MP:0008372,small malleus|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012757,abnormal cranial neural crest cell migration|MP:0012794,increased rhombomere 3 size|MP:0012817,rhombomere fusion
MGI:1931847	Hoxa1<tm2Ipc>	MP:0002169,no abnormal phenotype detected
MGI:2151686	Hoxa1<tm3.1Mrc>	MP:0000273,overriding aortic valve|MP:0000276,heart right ventricle hypertrophy|MP:0000680,absent parathyroid glands|MP:0001823,thymus hypoplasia|MP:0002127,abnormal cardiovascular system morphology|MP:0002163,abnormal gland morphology|MP:0003494,parathyroid hypoplasia|MP:0004113,abnormal aortic arch morphology|MP:0004158,right aortic arch|MP:0004160,retroesophageal right subclavian artery|MP:0006126,abnormal cardiac outflow tract development|MP:0006344,small second pharyngeal arch|MP:0010402,ventricular septal defect|MP:0010484,bicuspid aortic valve|MP:0011089,perinatal lethality, complete penetrance|MP:0011659,interrupted aortic arch, type b|MP:0012261,increased hindbrain apoptosis|MP:0012730,abnormal internal carotid artery morphology|MP:0012731,abnormal external carotid artery morphology
MGI:4818445	Hoxa1<tm7.1(cre)Mrc>	MP:0002169,no abnormal phenotype detected
MGI:5287662	Hoxa1<tm8.2Mrc>	MP:0006030,abnormal otic vesicle development|MP:0011087,neonatal lethality, complete penetrance
MGI:2385690	Hoxa2<tm1.1Fmr>	MP:0000029,abnormal malleus morphology|MP:0000049,abnormal middle ear morphology|MP:0000913,abnormal brain development|MP:0002116,abnormal craniofacial bone morphology|MP:0002169,no abnormal phenotype detected|MP:0003056,abnormal hyoid bone morphology|MP:0004204,absent stapes|MP:0005106,abnormal incus morphology|MP:0005107,abnormal stapes morphology|MP:0005579,absent outer ear|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006208,lethality throughout fetal growth and development|MP:0008023,abnormal styloid process morphology|MP:0008380,abnormal gonial bone morphology|MP:0008386,absent styloid process|MP:0009915,absent hyoid bone lesser horns|MP:0010892,increased oligodendrocyte progenitor number|MP:0011089,perinatal lethality, complete penetrance|MP:0012490,abnormal cochlear VIII nucleus morphology|MP:0014563,duplicated tympanic ring
MGI:2385691	Hoxa2<tm1.2Fmr>	MP:0000428,abnormal craniofacial morphology|MP:0002102,abnormal ear morphology|MP:0003632,abnormal nervous system morphology|MP:0004924,abnormal behavior|MP:0005508,abnormal skeleton morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:5613670	Hoxa2<tm1b(EUCOMM)Wtsi>	MP:0000443,abnormal snout morphology|MP:0001406,abnormal gait|MP:0004738,abnormal auditory brainstem response|MP:0005554,decreased circulating creatinine level|MP:0009142,decreased prepulse inhibition|MP:0010379,decreased respiratory quotient|MP:0011100,preweaning lethality, complete penetrance
MGI:2385689	Hoxa2<tm1Fmr>	MP:0001732,postnatal growth retardation|MP:0002169,no abnormal phenotype detected|MP:0005107,abnormal stapes morphology|MP:0008023,abnormal styloid process morphology|MP:0009914,abnormal hyoid bone lesser horn morphology|MP:0011083,lethality at weaning, complete penetrance|MP:0012788,abnormal rhombomere 2 morphology
MGI:1857530	Hoxa2<tm1Grid>	MP:0000029,abnormal malleus morphology|MP:0000030,abnormal tympanic ring morphology|MP:0000039,abnormal otic capsule morphology|MP:0000079,abnormal basioccipital bone morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0001071,abnormal facial nerve morphology|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001438,aphagia|MP:0002177,abnormal outer ear morphology|MP:0003056,abnormal hyoid bone morphology|MP:0003631,nervous system phenotype|MP:0004204,absent stapes|MP:0004423,abnormal temporal bone squamous part morphology|MP:0004665,abnormal stapedial artery morphology|MP:0005105,abnormal middle ear ossicle morphology|MP:0005106,abnormal incus morphology|MP:0005272,abnormal temporal bone morphology|MP:0005579,absent outer ear|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006033,abnormal external auditory canal morphology|MP:0008023,abnormal styloid process morphology|MP:0008380,abnormal gonial bone morphology|MP:0009247,meteorism|MP:0009655,abnormal secondary palate development|MP:0009886,failure of palatal shelf elevation|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009888,palatal shelves fail to meet at midline|MP:0009889,persistence of medial edge epithelium during palatal shelf fusion|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance|MP:0012793,decreased rhombomere 3 size|MP:0012816,abnormal rhombomere boundary morphology|MP:0014563,duplicated tympanic ring|MP:0030119,abnormal retrotympanic process morphology|MP:0030227,abnormal tubotympanic recess morphology
MGI:1857626	Hoxa2<tm1Ipc>	MP:0000029,abnormal malleus morphology|MP:0000039,abnormal otic capsule morphology|MP:0000079,abnormal basioccipital bone morphology|MP:0000164,abnormal cartilage development|MP:0000909,abnormal facial motor nucleus morphology|MP:0001071,abnormal facial nerve morphology|MP:0001436,abnormal suckling behavior|MP:0002113,abnormal skeleton development|MP:0002116,abnormal craniofacial bone morphology|MP:0003110,absent malleus processus brevis|MP:0003168,abnormal scala vestibuli morphology|MP:0004204,absent stapes|MP:0004423,abnormal temporal bone squamous part morphology|MP:0005106,abnormal incus morphology|MP:0005107,abnormal stapes morphology|MP:0005272,abnormal temporal bone morphology|MP:0005579,absent outer ear|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006018,abnormal tympanic membrane morphology|MP:0008380,abnormal gonial bone morphology|MP:0008383,enlarged gonial bone|MP:0008386,absent styloid process|MP:0009890,cleft secondary palate|MP:0009909,bifid tongue|MP:0009915,absent hyoid bone lesser horns|MP:0009937,abnormal neuron differentiation|MP:0011087,neonatal lethality, complete penetrance|MP:0012786,increased rhombomere 1 size|MP:0012788,abnormal rhombomere 2 morphology|MP:0012792,abnormal rhombomere 3 morphology|MP:0014563,duplicated tympanic ring|MP:0030119,abnormal retrotympanic process morphology|MP:0030150,absent stylohyoid muscle|MP:0030154,abnormal tympanic cavity morphology|MP:0030158,absent stapedius muscle|MP:0030159,abnormal tensor tympani muscle morphology|MP:0030320,abnormal temporal bone tympanic part morphology
MGI:1858003	Hoxa2<tm1Mrc>	MP:0000079,abnormal basioccipital bone morphology|MP:0000438,abnormal cranium morphology|MP:0001436,abnormal suckling behavior|MP:0004136,abnormal tongue muscle morphology|MP:0005105,abnormal middle ear ossicle morphology|MP:0005579,absent outer ear|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance|MP:0030211,abnormal styloglossus muscle morphology
MGI:2385709	Hoxa2<tm1(tetO)Mllo>	MP:0000933,abnormal rhombomere morphology|MP:0003631,nervous system phenotype|MP:0004136,abnormal tongue muscle morphology|MP:0004423,abnormal temporal bone squamous part morphology|MP:0004666,absent stapedial artery|MP:0005105,abnormal middle ear ossicle morphology|MP:0005107,abnormal stapes morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0008023,abnormal styloid process morphology|MP:0008378,small malleus processus brevis|MP:0009909,bifid tongue|MP:0009914,abnormal hyoid bone lesser horn morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0012788,abnormal rhombomere 2 morphology|MP:0012792,abnormal rhombomere 3 morphology|MP:0030108,abnormal incudostapedial joint morphology
MGI:2385712	Hoxa2<tm2.1Fmr>	MP:0000428,abnormal craniofacial morphology|MP:0000913,abnormal brain development|MP:0002102,abnormal ear morphology|MP:0003631,nervous system phenotype|MP:0003632,abnormal nervous system morphology|MP:0004924,abnormal behavior|MP:0005508,abnormal skeleton morphology|MP:0010892,increased oligodendrocyte progenitor number|MP:0011087,neonatal lethality, complete penetrance
MGI:3038600	Hoxa2<tm2(cre)Mrc>	MP:0000966,decreased sensory neuron number
MGI:2385711	Hoxa2<tm2Fmr>	MP:0000428,abnormal craniofacial morphology|MP:0002102,abnormal ear morphology|MP:0003632,abnormal nervous system morphology|MP:0004924,abnormal behavior|MP:0005508,abnormal skeleton morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:2388564	Hoxa3<tm1Kth>	MP:0000705,athymia|MP:0002081,perinatal lethality|MP:0003056,abnormal hyoid bone morphology
MGI:1857992	Hoxa3<tm1Mrc>	MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000680,absent parathyroid glands|MP:0000681,abnormal thyroid gland morphology|MP:0000705,athymia|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0001270,distended abdomen|MP:0002108,abnormal muscle morphology|MP:0002127,abnormal cardiovascular system morphology|MP:0002132,abnormal respiratory system morphology|MP:0002249,abnormal larynx morphology|MP:0002258,abnormal cricoid cartilage morphology|MP:0002260,abnormal thyroid cartilage morphology|MP:0002282,abnormal trachea morphology|MP:0002633,persistent truncus arteriosus|MP:0002725,abnormal vein morphology|MP:0002753,dilated heart left ventricle|MP:0002884,abnormal pharyngeal arch morphology|MP:0002951,small thyroid gland|MP:0003048,abnormal cervical vertebrae morphology|MP:0003743,abnormal facial morphology|MP:0003955,abnormal ultimobranchial body morphology|MP:0004136,abnormal tongue muscle morphology|MP:0004549,small trachea|MP:0004568,fusion of glossopharyngeal and vagus nerve|MP:0005298,abnormal clavicle morphology|MP:0005406,abnormal heart size|MP:0005508,abnormal skeleton morphology|MP:0006117,aortic valve stenosis|MP:0006340,abnormal fourth pharyngeal arch morphology|MP:0009913,abnormal hyoid bone greater horn morphology|MP:0009914,abnormal hyoid bone lesser horn morphology|MP:0009915,absent hyoid bone lesser horns|MP:0010371,abnormal epiglottis morphology|MP:0010527,bicuspid pulmonary valve|MP:0010541,aorta hypoplasia|MP:0011089,perinatal lethality, complete penetrance|MP:0012491,larynx stenosis|MP:0013162,abnormal thyroid gland isthmus morphology|MP:0013163,absent thyroid gland isthmus|MP:0030291,short soft palate
MGI:4461254	Hoxa3<tm1Nrm>	MP:0000680,absent parathyroid glands|MP:0000705,athymia|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0002058,neonatal lethality|MP:0004568,fusion of glossopharyngeal and vagus nerve|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005382,craniofacial phenotype|MP:0005388,respiratory system phenotype|MP:0009913,abnormal hyoid bone greater horn morphology|MP:0009914,abnormal hyoid bone lesser horn morphology
MGI:2388565	Hoxa3<tm2(Hoxd3)Mrc>	MP:0005382,craniofacial phenotype|MP:0005387,immune system phenotype
MGI:4461300	Hoxa3<tm2Nrm>	MP:0000680,absent parathyroid glands|MP:0000705,athymia|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0002058,neonatal lethality|MP:0004568,fusion of glossopharyngeal and vagus nerve|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005382,craniofacial phenotype|MP:0005388,respiratory system phenotype|MP:0009913,abnormal hyoid bone greater horn morphology|MP:0009914,abnormal hyoid bone lesser horn morphology
MGI:2680649	Hoxa3<tm3Mrc>	MP:0001051,abnormal somatic motor system morphology
MGI:6423848	Hoxa4<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001120,abnormal uterus morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney
MGI:1857628	Hoxa4<tm1Bhr>	MP:0000155,asymmetric rib joints|MP:0000480,increased rib number|MP:0003048,abnormal cervical vertebrae morphology|MP:0004615,cervical vertebral transformation|MP:0008277,abnormal sternum ossification|MP:0010082,sternebra fusion
MGI:2150391	Hoxa4<tm1Mrc>	MP:0001505,hunched posture|MP:0003048,abnormal cervical vertebrae morphology|MP:0003631,nervous system phenotype|MP:0004508,abnormal pectoral girdle bone morphology
MGI:3723622	Hoxa5<tm1.1Ljea>	MP:0000159,abnormal xiphoid process morphology|MP:0000480,increased rib number|MP:0001176,abnormal lung development|MP:0001954,respiratory distress|MP:0002169,no abnormal phenotype detected|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002282,abnormal trachea morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0004880,lung cyst|MP:0005388,respiratory system phenotype|MP:0010768,mortality/aging|MP:0010902,abnormal pulmonary alveolar sac morphology|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3723624	Hoxa5<tm1.2Ljea>	MP:0001177,atelectasis|MP:0001958,emphysema|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0009438,cricoid and tracheal cartilage fusion|MP:0010861,increased respiratory mucosa goblet cell number|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3723623	Hoxa5<tm1Ljea>	MP:0001177,atelectasis|MP:0003048,abnormal cervical vertebrae morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0009438,cricoid and tracheal cartilage fusion|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2150397	Hoxa5<tm1Rob>	MP:0000054,delayed ear emergence|MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000480,increased rib number|MP:0000501,abnormal digestive secretion|MP:0001177,atelectasis|MP:0001179,thick pulmonary interalveolar septum|MP:0001183,overexpanded pulmonary alveolus|MP:0001290,delayed eyelid opening|MP:0001575,cyanosis|MP:0001732,postnatal growth retardation|MP:0001861,lung inflammation|MP:0001927,abnormal estrous cycle|MP:0001954,respiratory distress|MP:0001958,emphysema|MP:0002016,ovary cyst|MP:0002249,abnormal larynx morphology|MP:0002258,abnormal cricoid cartilage morphology|MP:0002267,abnormal bronchiole morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002281,abnormal respiratory mucosa goblet cell morphology|MP:0002282,abnormal trachea morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0003378,early sexual maturation|MP:0003421,abnormal thyroid gland development|MP:0004551,decreased tracheal cartilage ring number|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004780,abnormal surfactant secretion|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005182,increased circulating estradiol level|MP:0005629,abnormal lung weight|MP:0006027,impaired lung alveolus development|MP:0008146,asymmetric sternocostal joints|MP:0008245,abnormal alveolar macrophage morphology|MP:0009006,prolonged estrous cycle|MP:0009011,prolonged diestrus|MP:0009018,short estrus|MP:0009020,prolonged metestrus|MP:0009247,meteorism|MP:0009438,cricoid and tracheal cartilage fusion|MP:0010082,sternebra fusion|MP:0010810,increased type II pneumocyte number|MP:0010825,abnormal lung saccule morphology|MP:0010861,increased respiratory mucosa goblet cell number|MP:0010883,trachea stenosis|MP:0010897,abnormal bronchiole epithelium morphology|MP:0010900,abnormal pulmonary interalveolar septum morphology|MP:0010901,abnormal pulmonary alveolar parenchyma morphology|MP:0010911,abnormal pulmonary acinus morphology|MP:0010943,abnormal bronchus epithelium morphology|MP:0010993,decreased surfactant secretion|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011028,impaired branching involved in bronchus morphogenesis|MP:0011034,impaired branching involved in respiratory bronchiole morphogenesis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012284,increased sternebra number|MP:0013497,trachea occlusion
MGI:2150392	Hoxa6<tm1Mrc>	MP:0000155,asymmetric rib joints|MP:0000480,increased rib number|MP:0003048,abnormal cervical vertebrae morphology|MP:0004618,thoracic vertebral transformation
MGI:2150400	Hoxa7<tm1Mrc>	MP:0002169,no abnormal phenotype detected
MGI:2150411	Hoxa9<tm1Ipc>	MP:0000480,increased rib number|MP:0004616,lumbar vertebral transformation
MGI:2150427	Hoxa9<tm1Mrc>	MP:0000333,decreased bone marrow cell number|MP:0000694,spleen hypoplasia|MP:0001262,decreased body weight|MP:0004809,increased hematopoietic stem cell number|MP:0004953,decreased spleen weight|MP:0006410,abnormal common myeloid progenitor cell morphology
MGI:5522944	Hoxa<tm1.1Ssp>	MP:0001119,abnormal female reproductive system morphology|MP:0001120,abnormal uterus morphology|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002662,abnormal cauda epididymis morphology|MP:0002769,abnormal vas deferens morphology|MP:0004930,small epididymis|MP:0008257,thin myometrium|MP:0009081,thin uterus|MP:0009094,abnormal endometrial gland morphology|MP:0009205,abnormal internal male genitalia morphology|MP:0009209,abnormal internal female genitalia morphology|MP:0031287,bilateral cryptorchism
MGI:5810732	Hoxb13<tm1b(KOMP)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:2655241	Hoxb13<tm1Mrc>	MP:0000588,thick tail|MP:0000778,abnormal nervous system tract morphology|MP:0000955,abnormal spinal cord morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0002111,abnormal tail morphology|MP:0002151,abnormal neural tube morphology|MP:0002184,abnormal innervation|MP:0002758,long tail|MP:0002759,abnormal caudal vertebrae morphology|MP:0002809,increased spinal cord size|MP:0003607,abnormal prostate gland physiology|MP:0004703,abnormal vertebral column morphology|MP:0005498,hyporesponsive to tactile stimuli|MP:0009380,abnormal prostate gland ventral lobe morphology|MP:0009937,abnormal neuron differentiation
MGI:2655242	Hoxb13<tm2Mrc>	MP:0000588,thick tail|MP:0000778,abnormal nervous system tract morphology|MP:0000955,abnormal spinal cord morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0002111,abnormal tail morphology|MP:0002151,abnormal neural tube morphology|MP:0002184,abnormal innervation|MP:0002758,long tail|MP:0002759,abnormal caudal vertebrae morphology|MP:0002809,increased spinal cord size|MP:0004703,abnormal vertebral column morphology|MP:0005498,hyporesponsive to tactile stimuli|MP:0009380,abnormal prostate gland ventral lobe morphology|MP:0009937,abnormal neuron differentiation
MGI:2656726	Hoxb13<tm3Mrc>	MP:0000588,thick tail|MP:0000778,abnormal nervous system tract morphology|MP:0000955,abnormal spinal cord morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0002111,abnormal tail morphology|MP:0002151,abnormal neural tube morphology|MP:0002184,abnormal innervation|MP:0002758,long tail|MP:0002759,abnormal caudal vertebrae morphology|MP:0002809,increased spinal cord size|MP:0004703,abnormal vertebral column morphology|MP:0005498,hyporesponsive to tactile stimuli|MP:0009937,abnormal neuron differentiation
MGI:2656729	Hoxb13<tm4Mrc>	MP:0000588,thick tail|MP:0000778,abnormal nervous system tract morphology|MP:0000955,abnormal spinal cord morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0002111,abnormal tail morphology|MP:0002151,abnormal neural tube morphology|MP:0002184,abnormal innervation|MP:0002758,long tail|MP:0002759,abnormal caudal vertebrae morphology|MP:0002809,increased spinal cord size|MP:0004703,abnormal vertebral column morphology|MP:0005498,hyporesponsive to tactile stimuli|MP:0009937,abnormal neuron differentiation
MGI:5287678	Hoxb1<tm1.1Mist>	MP:0000909,abnormal facial motor nucleus morphology|MP:0012490,abnormal cochlear VIII nucleus morphology
MGI:2151762	Hoxb1<tm1Brd>	MP:0001071,abnormal facial nerve morphology|MP:0009937,abnormal neuron differentiation|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012796,abnormal rhombomere 4 morphology|MP:0014747,abnormal motor neuron axon guidance
MGI:3773272	Hoxb1<tm1(cre)Og>	MP:0000428,abnormal craniofacial morphology|MP:0003632,abnormal nervous system morphology|MP:0005386,behavior/neurological phenotype
MGI:1857824	Hoxb1<tm1Mrc>	MP:0000843,absent facial nuclei|MP:0000910,small facial motor nucleus|MP:0001071,abnormal facial nerve morphology|MP:0001265,decreased body size|MP:0002100,abnormal tooth morphology|MP:0003631,nervous system phenotype|MP:0004235,abnormal masseter muscle morphology|MP:0004239,abnormal temporalis muscle morphology|MP:0009937,abnormal neuron differentiation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012524,abnormal lower lip morphology|MP:0030040,absent facial muscle|MP:0030067,narrow face|MP:0030141,facial paralysis|MP:0030142,facial muscle degeneration|MP:0030146,abnormal digastric posterior belly morphology|MP:0030151,abnormal buccinator muscle morphology|MP:0030152,abnormal depressor anguli oris muscle morphology|MP:0030184,abnormal zygomaticus muscle morphology|MP:0030430,absent levator nasolabialis muscle
MGI:2151770	Hoxb1<tm2Brd>	MP:0001071,abnormal facial nerve morphology|MP:0009937,abnormal neuron differentiation|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012796,abnormal rhombomere 4 morphology|MP:0014747,abnormal motor neuron axon guidance
MGI:1857857	Hoxb1<tm2Mrc>	MP:0000843,absent facial nuclei|MP:0000910,small facial motor nucleus|MP:0001071,abnormal facial nerve morphology|MP:0001265,decreased body size|MP:0002100,abnormal tooth morphology|MP:0003631,nervous system phenotype|MP:0004235,abnormal masseter muscle morphology|MP:0004239,abnormal temporalis muscle morphology|MP:0009937,abnormal neuron differentiation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012524,abnormal lower lip morphology|MP:0030040,absent facial muscle|MP:0030067,narrow face|MP:0030141,facial paralysis|MP:0030142,facial muscle degeneration|MP:0030146,abnormal digastric posterior belly morphology|MP:0030151,abnormal buccinator muscle morphology|MP:0030152,abnormal depressor anguli oris muscle morphology|MP:0030184,abnormal zygomaticus muscle morphology|MP:0030430,absent levator nasolabialis muscle
MGI:1857859	Hoxb1<tm3Mrc>	MP:0000428,abnormal craniofacial morphology|MP:0003632,abnormal nervous system morphology
MGI:1928090	Hoxb1<tm5Mrc>	MP:0000843,absent facial nuclei|MP:0000966,decreased sensory neuron number|MP:0004561,absent facial nerve
MGI:2668513	Hoxb1<tm6(cre)Mrc>	MP:0002169,no abnormal phenotype detected
MGI:3046794	Hoxb1<tm7Mrc>	MP:0002169,no abnormal phenotype detected
MGI:3702595	Hoxb1<tm8(Hoxa1)Mrc>	MP:0011086,postnatal lethality, incomplete penetrance
MGI:2151774	Hoxb2<tm1Fmr>	MP:0000843,absent facial nuclei|MP:0001386,abnormal maternal nurturing|MP:0002083,premature death|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012796,abnormal rhombomere 4 morphology|MP:0012818,rhombomere transformation
MGI:2151772	Hoxb2<tm1Mrc>	MP:0000157,abnormal sternum morphology|MP:0000843,absent facial nuclei|MP:0001071,abnormal facial nerve morphology|MP:0001083,small geniculate ganglion|MP:0001265,decreased body size|MP:0001386,abnormal maternal nurturing|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0003385,abnormal body wall morphology|MP:0004320,split sternum|MP:0004561,absent facial nerve|MP:0004599,abnormal vertebral arch morphology|MP:0004615,cervical vertebral transformation|MP:0005253,abnormal eye physiology|MP:0009879,abnormal arcus anterior morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012285,misaligned sternebrae|MP:0012524,abnormal lower lip morphology|MP:0030067,narrow face|MP:0030140,facial muscle atrophy|MP:0030141,facial paralysis|MP:0030430,absent levator nasolabialis muscle
MGI:5470286	Hoxb2<tm2.1Fmr>	MP:0002169,no abnormal phenotype detected
MGI:5470287	Hoxb2<tm2.2Fmr>	MP:0000913,abnormal brain development|MP:0000954,decreased oligodendrocyte progenitor number
MGI:5490993	Hoxb2<tm3.1Fmr>	MP:0002169,no abnormal phenotype detected
MGI:5490994	Hoxb2<tm3.2Fmr>	MP:0000042,abnormal organ of Corti morphology|MP:0000848,abnormal pons morphology|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0005277,abnormal brainstem morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012490,abnormal cochlear VIII nucleus morphology
MGI:7612311	Hoxb3os<em1Kabo>	MP:0005367,renal/urinary system phenotype|MP:0010768,mortality/aging|MP:0011440,increased kidney cell proliferation
MGI:2151773	Hoxb3<tm1Mrc>	MP:0004568,fusion of glossopharyngeal and vagus nerve|MP:0010701,fusion of atlas and odontoid process|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3045971	Hoxb4<tm1.1Karl>	MP:0000333,decreased bone marrow cell number|MP:0000694,spleen hypoplasia|MP:0002123,abnormal definitive hematopoiesis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number
MGI:4949668	Hoxb4<tm1.1Mev>	MP:0002169,no abnormal phenotype detected
MGI:1857390	Hoxb4<tm1Bay>	MP:0001265,decreased body size|MP:0003924,diaphragmatic hernia|MP:0004134,abnormal chest morphology|MP:0004320,split sternum|MP:0004322,abnormal sternebra morphology|MP:0004608,abnormal cervical axis morphology|MP:0004615,cervical vertebral transformation|MP:0008770,decreased survivor rate|MP:0011087,neonatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3045970	Hoxb4<tm1Karl>	MP:0002169,no abnormal phenotype detected
MGI:2388364	Hoxb4<tm1Nrm>	MP:0000157,abnormal sternum morphology|MP:0000266,abnormal heart morphology|MP:0000280,thin ventricular wall|MP:0001265,decreased body size|MP:0001785,edema|MP:0001954,respiratory distress|MP:0003048,abnormal cervical vertebrae morphology|MP:0003257,abnormal abdominal wall morphology|MP:0003384,abnormal ventral body wall morphology|MP:0003385,abnormal body wall morphology|MP:0003388,absent pericardium|MP:0003717,pallor|MP:0003924,diaphragmatic hernia|MP:0004320,split sternum|MP:0006065,abnormal heart position or orientation|MP:0008022,dilated heart ventricle|MP:0010725,thin interventricular septum|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2388369	Hoxb4<tm2.1Nrm>	MP:0003048,abnormal cervical vertebrae morphology
MGI:2151429	Hoxb4<tm2Bay>	MP:0004608,abnormal cervical axis morphology|MP:0004615,cervical vertebral transformation|MP:0005369,muscle phenotype|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype|MP:0010768,mortality/aging
MGI:2388367	Hoxb4<tm2Nrm>	MP:0003048,abnormal cervical vertebrae morphology|MP:0003384,abnormal ventral body wall morphology|MP:0004320,split sternum
MGI:2151484	Hoxb5<tm1Mrc>	MP:0000137,abnormal vertebrae morphology|MP:0000149,abnormal scapula morphology|MP:0002752,abnormal somatic nervous system morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0004508,abnormal pectoral girdle bone morphology|MP:0004615,cervical vertebral transformation|MP:0004618,thoracic vertebral transformation
MGI:3514269	Hoxb6<tm1Cka>	MP:0000245,abnormal erythropoiesis|MP:0002123,abnormal definitive hematopoiesis|MP:0003036,vertebral transformation|MP:0003345,decreased rib number|MP:0005387,immune system phenotype
MGI:2151485	Hoxb6<tm1Mrc>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000152,absent proximal rib|MP:0000153,rib bifurcation|MP:0002752,abnormal somatic nervous system morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003345,decreased rib number|MP:0004615,cervical vertebral transformation|MP:0004618,thoracic vertebral transformation
MGI:2150401	Hoxb7<tm1Mrc>	MP:0000154,rib fusion|MP:0003345,decreased rib number|MP:0012283,decreased sternebra number
MGI:1934178	Hoxb8<tm1.1Jdes>	MP:0000150,abnormal rib morphology|MP:0000155,asymmetric rib joints|MP:0000157,abnormal sternum morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001077,abnormal spinal nerve morphology|MP:0001212,skin lesions|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0004615,cervical vertebral transformation|MP:0008148,abnormal sternocostal joint morphology
MGI:2159735	Hoxb8<tm1.1Mrc>	MP:0000136,abnormal microglial cell morphology|MP:0000418,focal hair loss|MP:0001191,abnormal skin condition|MP:0001212,skin lesions|MP:0001440,abnormal grooming behavior|MP:0001441,increased grooming behavior|MP:0001501,abnormal sleep pattern|MP:0001510,abnormal coat appearance|MP:0001973,increased thermal nociceptive threshold|MP:0003631,nervous system phenotype|MP:0005390,skeleton phenotype|MP:0006282,abnormal spinal cord dorsal horn morphology
MGI:1934177	Hoxb8<tm1Jdes>	MP:0000150,abnormal rib morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001212,skin lesions|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0004703,abnormal vertebral column morphology
MGI:2159734	Hoxb8<tm1Mrc>	MP:0001191,abnormal skin condition|MP:0001441,increased grooming behavior|MP:0001510,abnormal coat appearance|MP:0002823,abnormal rib development
MGI:2683089	Hoxb8<tm1Omm>	MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0002083,premature death|MP:0002100,abnormal tooth morphology|MP:0004618,thoracic vertebral transformation|MP:0008148,abnormal sternocostal joint morphology|MP:0012283,decreased sternebra number
MGI:1934179	Hoxb8<tm2Jdes>	MP:0001513,limb grasping
MGI:4818439	Hoxb8<tm3.1(IRES-rtTA2*M2)Mrc>	MP:0000418,focal hair loss|MP:0001441,increased grooming behavior|MP:0001973,increased thermal nociceptive threshold|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0006282,abnormal spinal cord dorsal horn morphology
MGI:4818431	Hoxb8<tm4.1(cre/Esr1*)Mrc>	MP:0001212,skin lesions
MGI:2150429	Hoxb9<tm1Mrc>	MP:0000154,rib fusion|MP:0000480,increased rib number|MP:0000706,small thymus|MP:0003036,vertebral transformation|MP:0004322,abnormal sternebra morphology|MP:0004624,abnormal thoracic cage morphology|MP:0008148,abnormal sternocostal joint morphology
MGI:1860874	Hoxb<tm1Brd>	MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000157,abnormal sternum morphology|MP:0000274,enlarged heart|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001634,internal hemorrhage|MP:0001785,edema|MP:0003048,abnormal cervical vertebrae morphology|MP:0003257,abnormal abdominal wall morphology|MP:0004174,abnormal spine curvature|MP:0004320,split sternum|MP:0004568,fusion of glossopharyngeal and vagus nerve|MP:0004570,absent glossopharyngeal nerve|MP:0004607,abnormal cervical atlas morphology|MP:0004608,abnormal cervical axis morphology|MP:0004615,cervical vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0006065,abnormal heart position or orientation|MP:0009703,decreased birth body size|MP:0010103,small thoracic cage|MP:0011087,neonatal lethality, complete penetrance|MP:0012281,decreased sternebra size|MP:0012283,decreased sternebra number
MGI:4462853	Hoxc10<tm1Emca>	MP:0000559,abnormal femur morphology|MP:0000939,decreased motor neuron number|MP:0001261,obese|MP:0001405,impaired coordination|MP:0002896,abnormal bone mineralization|MP:0003036,vertebral transformation|MP:0003109,short femur|MP:0003345,decreased rib number|MP:0003604,single kidney|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004614,caudal vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004627,abnormal trochanter morphology|MP:0004672,short ribs|MP:0006429,abnormal hyaline cartilage morphology|MP:0009417,skeletal muscle atrophy|MP:0010239,decreased skeletal muscle weight|MP:0010240,decreased skeletal muscle size|MP:0030774,abnormal ischiofemoral ligament morphology|MP:0030784,abnormal iliofemoral ligament morphology|MP:0030830,abnormal acetabulum morphology
MGI:5614571	Hoxc12<tm1.1(KOMP)Vlcg>	MP:0000745,tremors|MP:0011999,abnormal tail length|MP:0013278,decreased fasting circulating glucose level
MGI:1861361	Hoxc13<N>	MP:0000427,abnormal hair cycle|MP:0000582,toenail hyperkeratosis|MP:0000749,muscle degeneration|MP:0001216,abnormal epidermal layer morphology|MP:0001265,decreased body size|MP:0001284,absent vibrissae|MP:0001510,abnormal coat appearance|MP:0002074,abnormal hair texture|MP:0002082,postnatal lethality|MP:0003809,abnormal hair shaft morphology|MP:0003810,abnormal hair cuticle|MP:0003815,hairless|MP:0003848,brittle hair|MP:0008770,decreased survivor rate
MGI:1926422	Hoxc13<tm1Mrc>	MP:0000414,alopecia|MP:0000425,loss of eyelid cilia|MP:0000580,deformed nails|MP:0000746,weakness|MP:0000763,abnormal filiform papillae morphology|MP:0000764,abnormal tongue epithelium morphology|MP:0001263,weight loss|MP:0001284,absent vibrissae|MP:0002073,abnormal hair growth|MP:0002114,abnormal axial skeleton morphology|MP:0003848,brittle hair|MP:0004614,caudal vertebral transformation|MP:0010233,hairless tail|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1926425	Hoxc13<tm2Mrc>	MP:0000414,alopecia|MP:0000425,loss of eyelid cilia|MP:0000580,deformed nails|MP:0000746,weakness|MP:0000763,abnormal filiform papillae morphology|MP:0000764,abnormal tongue epithelium morphology|MP:0001263,weight loss|MP:0001284,absent vibrissae|MP:0002073,abnormal hair growth|MP:0002114,abnormal axial skeleton morphology|MP:0003848,brittle hair|MP:0004614,caudal vertebral transformation|MP:0010233,hairless tail|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2151697	Hoxc13<tm3.1Mrc>	MP:0000416,sparse hair|MP:0000418,focal hair loss|MP:0000580,deformed nails|MP:0000763,abnormal filiform papillae morphology|MP:0002073,abnormal hair growth
MGI:2151694	Hoxc13<tm3Mrc>	MP:0000416,sparse hair|MP:0000418,focal hair loss|MP:0000580,deformed nails|MP:0000763,abnormal filiform papillae morphology|MP:0002073,abnormal hair growth
MGI:1857570	Hoxc4<tm1Hsu>	MP:0000480,increased rib number|MP:0002823,abnormal rib development|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003631,nervous system phenotype|MP:0004679,xiphoid process foramen|MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype|MP:0008148,abnormal sternocostal joint morphology|MP:0012284,increased sternebra number
MGI:2150683	Hoxc4<tm1Mrc>	MP:0002083,premature death|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003159,abnormal esophageal smooth muscle morphology|MP:0004323,sternum hypoplasia|MP:0004618,thoracic vertebral transformation|MP:0004672,short ribs|MP:0008148,abnormal sternocostal joint morphology|MP:0009546,absent gastric milk in neonates|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3844593	Hoxc4<tm2.1Mrc>	MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002492,decreased IgE level|MP:0004815,abnormal somatic hypermutation frequency|MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0010768,mortality/aging
MGI:2150689	Hoxc6<tm1Dds>	MP:0000628,abnormal mammary gland development|MP:0001881,abnormal mammary gland physiology|MP:0001882,abnormal lactation|MP:0004618,thoracic vertebral transformation|MP:0013711,abnormal inguinal mammary gland morphology|MP:0013712,abnormal thoracic mammary gland morphology
MGI:4365795	Hoxc8<tm1Jepl>	MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype
MGI:2149030	Hoxc8<tm1Phb>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000157,abnormal sternum morphology|MP:0000480,increased rib number|MP:0000743,muscle spasm|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001961,abnormal reflex|MP:0002114,abnormal axial skeleton morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003807,camptodactyly|MP:0004353,abnormal deltoid tuberosity morphology|MP:0004617,sacral vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004678,split xiphoid process|MP:0005296,abnormal humerus morphology|MP:0008148,abnormal sternocostal joint morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012284,increased sternebra number
MGI:4365797	Hoxc8<tm2Jepl>	MP:0000480,increased rib number|MP:0004615,cervical vertebral transformation|MP:0005386,behavior/neurological phenotype|MP:0008148,abnormal sternocostal joint morphology
MGI:4365796	Hoxc8<tm3(Hoxc9)Jepl>	MP:0005386,behavior/neurological phenotype|MP:0008148,abnormal sternocostal joint morphology
MGI:4365798	Hoxc8<tm4(Hoxc9)Jepl>	MP:0000480,increased rib number|MP:0004615,cervical vertebral transformation|MP:0005386,behavior/neurological phenotype|MP:0008148,abnormal sternocostal joint morphology
MGI:2150685	Hoxc9<tm1Hsu>	MP:0000157,abnormal sternum morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000160,kyphosis|MP:0000480,increased rib number|MP:0001732,postnatal growth retardation|MP:0003047,abnormal thoracic vertebrae morphology|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0005390,skeleton phenotype|MP:0008146,asymmetric sternocostal joints|MP:0008148,abnormal sternocostal joint morphology
MGI:3640654	Hoxc<tm1Nogu>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0001284,absent vibrissae|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0004614,caudal vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004617,sacral vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0011087,neonatal lethality, complete penetrance
MGI:1857962	Hoxd10<tm1Mrc>	MP:0001077,abnormal spinal nerve morphology|MP:0001388,abnormal stationary movement|MP:0001406,abnormal gait|MP:0002932,abnormal joint morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0003698,abnormal male reproductive system physiology|MP:0004600,abnormal vertebral transverse process morphology|MP:0004622,sacral vertebral fusion|MP:0005353,abnormal patella morphology
MGI:2151798	Hoxd11<tm1Ipc>	MP:0000464,increased presacral vertebrae number|MP:0000552,abnormal radius morphology|MP:0000554,abnormal carpal bone morphology|MP:0001925,male infertility|MP:0003050,abnormal sacral vertebrae morphology|MP:0004617,sacral vertebral transformation|MP:0004634,short metacarpal bones|MP:0004650,increased lumbar vertebrae number|MP:0005108,abnormal ulna morphology|MP:0005306,abnormal phalanx morphology|MP:0005354,abnormal ilium morphology|MP:0008915,fused carpal bones
MGI:1857963	Hoxd11<tm1Mrc>	MP:0004617,sacral vertebral transformation|MP:0004650,increased lumbar vertebrae number|MP:0008915,fused carpal bones
MGI:3051383	Hoxd11<tm2.1Ddu>	MP:0003049,abnormal lumbar vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0004617,sacral vertebral transformation|MP:0004650,increased lumbar vertebrae number
MGI:2389127	Hoxd11<tm2.1(Hoxd11)Mrc>	MP:0004638,elongated metacarpal bones|MP:0004647,decreased lumbar vertebrae number|MP:0005306,abnormal phalanx morphology
MGI:3051381	Hoxd11<tm2Ddu>	MP:0000554,abnormal carpal bone morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0004650,increased lumbar vertebrae number
MGI:5523688	Hoxd12<m1Hsj>	MP:0000547,short limbs|MP:0000550,abnormal forelimb morphology|MP:0000552,abnormal radius morphology|MP:0000556,abnormal hindlimb morphology|MP:0000558,abnormal tibia morphology|MP:0000565,oligodactyly|MP:0002110,abnormal digit morphology|MP:0002187,abnormal fibula morphology|MP:0002543,brachyphalangia|MP:0002544,brachydactyly|MP:0002932,abnormal joint morphology|MP:0004635,short metatarsal bones|MP:0005108,abnormal ulna morphology|MP:0005306,abnormal phalanx morphology|MP:0006253,clinodactyly|MP:0014322,short hindlimb
MGI:1857964	Hoxd12<tm1Mrc>	MP:0000550,abnormal forelimb morphology|MP:0000554,abnormal carpal bone morphology|MP:0002110,abnormal digit morphology|MP:0002543,brachyphalangia|MP:0004634,short metacarpal bones
MGI:2177960	Hoxd12<tm2Ddu>	MP:0000767,abnormal smooth muscle morphology|MP:0002544,brachydactyly|MP:0005306,abnormal phalanx morphology|MP:0009055,abnormal internal anal sphincter morphology
MGI:4361275	Hoxd13<Dyc>	MP:0000554,abnormal carpal bone morphology|MP:0000564,syndactyly|MP:0000572,abnormal autopod morphology|MP:0001925,male infertility|MP:0002544,brachydactyly|MP:0003072,abnormal metatarsal bone morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0004083,polysyndactyly|MP:0005104,abnormal tarsal bone morphology|MP:0006279,abnormal limb development|MP:0006280,abnormal digit development|MP:0006401,absent male preputial gland|MP:0008271,abnormal bone ossification|MP:0009049,abnormal hallux morphology|MP:0009744,postaxial polydactyly
MGI:1857397	Hoxd13<spdh>	MP:0000554,abnormal carpal bone morphology|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0001925,male infertility|MP:0002059,abnormal seminal vesicle morphology|MP:0002110,abnormal digit morphology|MP:0002544,brachydactyly|MP:0003072,abnormal metatarsal bone morphology|MP:0003419,delayed endochondral bone ossification|MP:0004634,short metacarpal bones|MP:0004635,short metatarsal bones|MP:0004636,decreased metacarpal bone number|MP:0004640,decreased metatarsal bone number|MP:0005104,abnormal tarsal bone morphology|MP:0005230,ectrodactyly|MP:0005371,limbs/digits/tail phenotype|MP:0006280,abnormal digit development|MP:0006401,absent male preputial gland|MP:0008271,abnormal bone ossification|MP:0013901,absent female preputial gland
MGI:1857871	Hoxd13<tm1Ddu>	MP:0000060,delayed bone ossification|MP:0000493,rectal prolapse|MP:0000554,abnormal carpal bone morphology|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000767,abnormal smooth muscle morphology|MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0002085,abnormal embryonic tissue morphology|MP:0002110,abnormal digit morphology|MP:0002543,brachyphalangia|MP:0002544,brachydactyly|MP:0003072,abnormal metatarsal bone morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0004622,sacral vertebral fusion|MP:0004634,short metacarpal bones|MP:0004635,short metatarsal bones|MP:0005034,abnormal anus morphology|MP:0005230,ectrodactyly|MP:0005306,abnormal phalanx morphology|MP:0009055,abnormal internal anal sphincter morphology
MGI:2151805	Hoxd13<tm1Mrc>	MP:0000554,abnormal carpal bone morphology|MP:0000555,absent carpal bone|MP:0000562,polydactyly|MP:0000571,interdigital webbing|MP:0002110,abnormal digit morphology|MP:0002543,brachyphalangia|MP:0004634,short metacarpal bones|MP:0005379,endocrine/exocrine gland phenotype
MGI:3616015	Hoxd1<tm1Ddu>	MP:0003048,abnormal cervical vertebrae morphology|MP:0004607,abnormal cervical atlas morphology|MP:0004620,cervical vertebral fusion|MP:0010728,fusion of atlas and occipital bones|MP:0010729,absent arcus anterior|MP:0010730,absent odontoid process
MGI:3526155	Hoxd1<tm1Mrc>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0001973,increased thermal nociceptive threshold|MP:0002736,abnormal nociception after inflammation|MP:0014488,abnormal skin sensory neuron innervation pattern
MGI:1857959	Hoxd3<tm1Mrc>	MP:0001077,abnormal spinal nerve morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0004607,abnormal cervical atlas morphology|MP:0004608,abnormal cervical axis morphology|MP:0008146,asymmetric sternocostal joints|MP:0010728,fusion of atlas and occipital bones|MP:0010730,absent odontoid process|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011513,abnormal vertebral artery morphology
MGI:2388512	Hoxd3<tm2Mrc>	MP:0010729,absent arcus anterior|MP:0010730,absent odontoid process
MGI:2388516	Hoxd3<tm3(Hoxa3)Mrc>	MP:0005390,skeleton phenotype
MGI:2151488	Hoxd4<tm1Bhr>	MP:0000079,abnormal basioccipital bone morphology|MP:0000480,increased rib number|MP:0003048,abnormal cervical vertebrae morphology|MP:0004607,abnormal cervical atlas morphology|MP:0004608,abnormal cervical axis morphology|MP:0004615,cervical vertebral transformation|MP:0004659,abnormal odontoid process morphology
MGI:2151815	Hoxd8<tm1Jdes>	MP:0000480,increased rib number|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0008146,asymmetric sternocostal joints
MGI:2150414	Hoxd9<tm1Ipc>	MP:0003050,abnormal sacral vertebrae morphology|MP:0004351,short humerus|MP:0004353,abnormal deltoid tuberosity morphology|MP:0004614,caudal vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004617,sacral vertebral transformation|MP:0004622,sacral vertebral fusion
MGI:2446027	Hoxd<tm11.1Ddu>	MP:0000562,polydactyly|MP:0002110,abnormal digit morphology
MGI:2446018	Hoxd<tm11Ddu>	MP:0002110,abnormal digit morphology|MP:0005230,ectrodactyly
MGI:5522949	Hoxd<tm1.1Ssp>	MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002769,abnormal vas deferens morphology|MP:0005389,reproductive system phenotype|MP:0030983,failure of copulatory plug deposition
MGI:3051374	Hoxd<tm12Ddu>	MP:0002080,prenatal lethality|MP:0005221,abnormal rostral-caudal axis patterning
MGI:3840830	Hoxd<tm17Ddu>	MP:0000492,abnormal rectum morphology|MP:0002543,brachyphalangia
MGI:3616018	Hoxd<tm21(Hoxd11)Ddu>	MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0003049,abnormal lumbar vertebrae morphology|MP:0004620,cervical vertebral fusion|MP:0005367,renal/urinary system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008528,polycystic kidney|MP:0011088,neonatal lethality, incomplete penetrance
MGI:1857854	Hoxd<tm3Ddu>	MP:0002169,no abnormal phenotype detected
MGI:2651622	Hoxd<tm4Ddu>	MP:0002169,no abnormal phenotype detected
MGI:2445979	Hoxd<tm5Ddu>	MP:0004647,decreased lumbar vertebrae number
MGI:4432659	Hp1bp3<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0005376,homeostasis/metabolism phenotype|MP:0005384,cellular phenotype|MP:0009674,decreased birth weight|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1856902	hpc	MP:0000852,small cerebellum|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0001377,abnormal mating frequency|MP:0001406,abnormal gait|MP:0001523,impaired righting response|MP:0001524,impaired limb coordination|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002082,postnatal lethality|MP:0003684,abnormal inferior olivary complex morphology|MP:0003996,clonic seizures|MP:0004924,abnormal behavior|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0011084,lethality at weaning, incomplete penetrance
MGI:6257540	Hpca<em1(IMPC)H>	MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0002968,increased circulating alkaline phosphatase level|MP:0005293,impaired glucose tolerance|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content
MGI:7407147	Hpcal1<em1Ylzg>	MP:0002981,increased liver weight|MP:0003448,abnormal tumor morphology|MP:0004499,increased incidence of tumors by chemical induction|MP:0005343,increased circulating aspartate transaminase level|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0030673,increased circulating alanine level
MGI:5548765	Hpcal4<tm1.1(KOMP)Vlcg>	MP:0000062,increased bone mineral density|MP:0005631,decreased lung weight
MGI:3800240	Hpcal4<tm1(KOMP)Vlcg>	MP:0001973,increased thermal nociceptive threshold|MP:0005386,behavior/neurological phenotype
MGI:3055313	Hpca<tm1Toho>	MP:0000811,hippocampal neuron degeneration|MP:0003224,neuron degeneration|MP:0008235,increased susceptibility to neuronal excitotoxicity
MGI:3046740	Hpcr1<DBA/2J>	MP:0004502,decreased incidence of tumors by chemical induction|MP:0010265,decreased hepatoma incidence
MGI:3046742	Hpcr2<DBA/2J>	MP:0004502,decreased incidence of tumors by chemical induction|MP:0010265,decreased hepatoma incidence
MGI:7619080	Hpd<em1(IMPC)Bay>	MP:0001410,head bobbing
MGI:1856056	Hpd<hty>	MP:0009643,abnormal urine homeostasis|MP:0013724,decreased circulating tyrosine level
MGI:6423071	Hpdl<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001257,increased body length|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001364,decreased anxiety-related response|MP:0001404,no spontaneous movement|MP:0001711,abnormal placenta morphology|MP:0002060,abnormal skin morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0004924,abnormal behavior|MP:0009142,decreased prepulse inhibition|MP:0010097,abnormal retina blood vessel morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020870,decreased thigmotaxis
MGI:7447439	Hpdl<em1Jgg>	MP:0001262,decreased body weight|MP:0002064,seizures|MP:0002229,neurodegeneration|MP:0003203,increased neuron apoptosis|MP:0005202,lethargy|MP:0011085,postnatal lethality, complete penetrance
MGI:3043732	Hpdty<129S1>	MP:0000562,polydactyly
MGI:6153365	Hpf1<em1(IMPC)Wtsi>	MP:0000572,abnormal autopod morphology|MP:0010067,increased red blood cell distribution width
MGI:3623744	Hpgds<tm1Urad>	MP:0001246,mixed cellular infiltration to dermis|MP:0001785,edema|MP:0001846,increased inflammatory response|MP:0002339,abnormal lymph node morphology|MP:0003009,abnormal cytokine secretion|MP:0005088,increased acute inflammation|MP:0005596,increased susceptibility to type I hypersensitivity reaction
MGI:6391344	Hpgd<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:2657242	Hpgd<tm1Bhk>	MP:0000364,abnormal vascular regression|MP:0003139,patent ductus arteriosus|MP:0006138,congestive heart failure|MP:0009811,abnormal prostaglandin level|MP:0009814,increased prostaglandin level|MP:0011087,neonatal lethality, complete penetrance
MGI:3771208	Hpgd<tm1Ljm>	MP:0002679,abnormal corpus luteum morphology|MP:0005186,increased circulating progesterone level|MP:0009814,increased prostaglandin level|MP:0012009,early parturition
MGI:1856903	hph1	MP:0000767,abnormal smooth muscle morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0002191,abnormal artery morphology|MP:0002691,small stomach|MP:0003913,increased heart right ventricle weight|MP:0003957,abnormal nitric oxide homeostasis|MP:0004007,abnormal lung vasculature morphology|MP:0030670,increased circulating phenylalanine level
MGI:2389297	Hpi1<C57BL/6J>	MP:0001845,abnormal inflammatory response
MGI:2156005	Hpi2<C57BL/6J>	MP:0001845,abnormal inflammatory response
MGI:2154104	Hpic2<DBA/2J>	MP:0002822,catalepsy
MGI:2389366	Hpic3<LP/J>	MP:0002822,catalepsy|MP:0009747,impaired behavioral response to xenobiotic
MGI:2389368	Hpic4<LP/J>	MP:0002822,catalepsy|MP:0009747,impaired behavioral response to xenobiotic
MGI:3576026	hpld	MP:0001178,pulmonary hypoplasia|MP:0002279,abnormal diaphragm morphology
MGI:3576027	hpmd	MP:0000111,cleft palate|MP:0000460,mandible hypoplasia|MP:0004678,split xiphoid process|MP:0006337,abnormal first pharyngeal arch morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3575149	Hpn<Hlb320>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001265,decreased body size|MP:0002644,decreased circulating triglyceride level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0006325,impaired hearing
MGI:3639336	Hpn<tm1Qwu>	MP:0000920,abnormal myelination|MP:0002855,abnormal cochlear ganglion morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003149,abnormal tectorial membrane morphology|MP:0003503,decreased activity of thyroid gland|MP:0004433,abnormal cochlear inner hair cell physiology|MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004591,enlarged tectorial membrane|MP:0005471,decreased thyroxine level|MP:0006325,impaired hearing|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014091,abnormal tectorial membrane striated-sheet matrix morphology
MGI:1857297	Hprt1<b-m1>	MP:0001516,abnormal motor coordination/balance|MP:0002757,decreased vertical activity|MP:0005386,behavior/neurological phenotype|MP:0005643,decreased dopamine level
MGI:1857298	Hprt1<b-m2>	MP:0001516,abnormal motor coordination/balance|MP:0003313,abnormal locomotor activation|MP:0005386,behavior/neurological phenotype|MP:0005643,decreased dopamine level
MGI:1857299	Hprt1<b-m3>	MP:0001441,increased grooming behavior|MP:0001501,abnormal sleep pattern|MP:0003243,abnormal dopaminergic neuron morphology|MP:0005643,decreased dopamine level|MP:0012592,decreased brain choline acetyltransferase activity|MP:0020078,decreased brain tyrosine 3-monooxygenase activity
MGI:3835521	Hprt1<tm10(Ple162-EGFP/cre)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5569238	Hprt1<tm1.1(CAG-DLL1*,-Venus)Gos>	MP:0002169,no abnormal phenotype detected
MGI:5523896	Hprt1<tm1.1(CAG-Smpd1)Jhkh>	MP:0003360,abnormal depression-related behavior|MP:0008872,abnormal physiological response to xenobiotic|MP:0009937,abnormal neuron differentiation|MP:0012232,abnormal ceramide level
MGI:3835522	Hprt1<tm11(Ple176-EGFP/cre)Ems>	MP:0002169,no abnormal phenotype detected
MGI:3582526	Hprt1<tm1.1Pobe>	MP:0002169,no abnormal phenotype detected
MGI:3835523	Hprt1<tm12(Ple177-EGFP/cre)Ems>	MP:0002169,no abnormal phenotype detected
MGI:3835524	Hprt1<tm13(Ple54-EGFP)Ems>	MP:0002169,no abnormal phenotype detected
MGI:3835525	Hprt1<tm14(Ple103-EGFP/cre)Ems>	MP:0002169,no abnormal phenotype detected
MGI:3835527	Hprt1<tm15(Ple111-EGFP)Ems>	MP:0002169,no abnormal phenotype detected
MGI:3835530	Hprt1<tm16(Ple167-EGFP/cre)Ems>	MP:0002169,no abnormal phenotype detected
MGI:3835532	Hprt1<tm17(Ple48-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:3835531	Hprt1<tm18(Ple90-EGFP)Ems>	MP:0002169,no abnormal phenotype detected
MGI:3835533	Hprt1<tm19(Ple88-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:2450106	Hprt1<tm1(ACTB-Epor)Unc>	MP:0002123,abnormal definitive hematopoiesis|MP:0005397,hematopoietic system phenotype
MGI:5605470	Hprt1<tm1(ACTB-Opa1)Lsc>	MP:0005166,decreased susceptibility to injury|MP:0005378,growth/size/body region phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0011635,abnormal mitochondrial crista morphology
MGI:4435169	Hprt1<tm1a(EUCOMM)Hmgu>	MP:0001406,abnormal gait|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number
MGI:3839278	Hprt1<tm1(APOA5)Lap>	MP:0005376,homeostasis/metabolism phenotype
MGI:5608589	Hprt1<tm1(CAG-Glra3*)Jcme>	MP:0001363,increased anxiety-related response|MP:0001458,abnormal object recognition memory|MP:0001899,absent long-term depression|MP:0002206,abnormal CNS synaptic transmission|MP:0002272,abnormal nervous system electrophysiology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003631,nervous system phenotype|MP:0004494,abnormal synaptic glutamate release|MP:0005386,behavior/neurological phenotype|MP:0008414,abnormal spatial reference memory|MP:0008428,abnormal spatial working memory
MGI:5618914	Hprt1<tm1(CAG-Gys1*)Jjg>	MP:0003061,decreased aerobic running capacity|MP:0010401,increased skeletal muscle glycogen level|MP:0010954,abnormal cellular respiration|MP:0012106,impaired exercise endurance|MP:0012735,abnormal response to exercise|MP:0014074,increased brain glycogen level|MP:0030940,impaired autophagy
MGI:5574440	Hprt1<tm1(CAG-NRIP1)Vcls>	MP:0000496,abnormal small intestine morphology|MP:0004843,abnormal Paneth cell morphology|MP:0008883,abnormal enterocyte proliferation|MP:0014234,decreased enterocyte apoptosis
MGI:4849516	Hprt1<tm1(CAG-Sox9,-EGFP)Akis>	MP:0000534,abnormal ureter morphology|MP:0011426,abnormal ureter smooth muscle morphology
MGI:3846738	Hprt1<tm1(CAG-Tgfbr1*)Lba>	MP:0001828,abnormal T cell activation
MGI:5449926	Hprt1<tm1(CMV-GFP)Nat>	MP:0002169,no abnormal phenotype detected
MGI:3687214	Hprt1<tm1(CUX1)Anep>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000598,abnormal liver morphology|MP:0000662,abnormal branching of the mammary ductal tree|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0001175,abnormal lung morphology|MP:0001545,abnormal hematopoietic system physiology|MP:0001577,anemia|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002357,abnormal spleen white pulp morphology|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002875,decreased erythrocyte cell number|MP:0005017,decreased B cell number|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008826,abnormal splenic cell ratio|MP:0010299,increased mammary gland tumor incidence|MP:0010373,myeloid hyperplasia
MGI:1861939	Hprt1<tm1Detl>	MP:0000745,tremors|MP:0000947,convulsive seizures|MP:0001260,increased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0002064,seizures|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002628,hepatic steatosis|MP:0002757,decreased vertical activity|MP:0003205,testicular atrophy|MP:0004191,neuronal intranuclear inclusions|MP:0005424,jerky movement
MGI:3050087	Hprt1<tm1Dhm>	MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0004084,abnormal cardiac muscle relaxation|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005598,decreased heart ventricle muscle contractility
MGI:4462242	Hprt1<tm1Dwm>	MP:0003171,phenotypic reversion
MGI:3051543	Hprt1<tm1(Ggt1-Agtr1)Cof>	MP:0002169,no abnormal phenotype detected
MGI:5487445	Hprt1<tm1(H1-RNAi:Tmsb4x)Prri>	MP:0001614,abnormal blood vessel morphology|MP:0001634,internal hemorrhage|MP:0001915,intracranial hemorrhage|MP:0005244,hemopericardium|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5567081	Hprt1<tm1(Ins2-HBEGF)Herr>	MP:0001263,weight loss|MP:0001426,polydipsia|MP:0001559,hyperglycemia|MP:0001762,polyuria|MP:0002083,premature death|MP:0003058,increased insulin secretion|MP:0003059,decreased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005215,abnormal pancreatic islet morphology|MP:0009113,increased pancreatic beta cell mass|MP:0009114,decreased pancreatic beta cell mass|MP:0030971,ketoacidosis
MGI:3697440	Hprt1<tm1Isrd>	MP:0002169,no abnormal phenotype detected
MGI:6192354	Hprt1<tm1(MAPT)Dph>	MP:0000160,kyphosis|MP:0000754,paresis|MP:0000807,abnormal hippocampus morphology|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002083,premature death|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0008260,abnormal autophagy|MP:0009412,skeletal muscle fiber degeneration|MP:0010053,decreased grip strength|MP:0012006,abnormal hippocampus physiology|MP:0012307,impaired spatial learning
MGI:3815189	Hprt1<tm1(Nfkb1-EGFP)Cjo>	MP:0002169,no abnormal phenotype detected
MGI:5428689	Hprt1<tm1(Nphs1-CMIP)Dsah>	MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0005264,glomerulosclerosis|MP:0005326,abnormal podocyte morphology|MP:0008060,abnormal podocyte slit diaphragm morphology|MP:0008061,absent podocyte slit diaphragm|MP:0008140,podocyte foot process effacement|MP:0011353,expanded mesangial matrix|MP:0011427,increased mesangial cell number
MGI:3850734	Hprt1<tm1(Rcan1)Zyga>	MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0003447,decreased tumor growth/size|MP:0005505,thrombocytosis|MP:0008254,increased megakaryocyte cell number|MP:0020316,decreased vascular endothelial cell proliferation
MGI:5559077	Hprt1<tm1(tetO-EGFP/Rac1*)Shaw>	MP:0002962,increased urine protein level|MP:0005367,renal/urinary system phenotype|MP:0008140,podocyte foot process effacement
MGI:5576753	Hprt1<tm1(TG-cre)1Sasr>	MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:3835534	Hprt1<tm20(Ple53-EGFP)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5569240	Hprt1<tm2.1(CAG-DLL1*,-Venus)Gos>	MP:0002169,no abnormal phenotype detected
MGI:2449453	Hprt1<tm2(AGT)Sig>	MP:0002842,increased systemic arterial blood pressure
MGI:3839279	Hprt1<tm2(APOA5)Lap>	MP:0005376,homeostasis/metabolism phenotype
MGI:5438010	Hprt1<tm2(CAG-Myof)Isrd>	MP:0005369,muscle phenotype
MGI:5618922	Hprt1<tm2(CAG-Ppp1r3c)Jjg>	MP:0014074,increased brain glycogen level|MP:0030940,impaired autophagy
MGI:5314539	Hprt1<tm2(CAG-TBX2,-EGFP)Akis>	MP:0000267,abnormal heart development
MGI:5449929	Hprt1<tm2(CMV-tdTomato)Nat>	MP:0002169,no abnormal phenotype detected
MGI:4360515	Hprt1<tm2(CUX1)Anep>	MP:0001883,increased mammary adenocarcinoma incidence|MP:0005379,endocrine/exocrine gland phenotype|MP:0005387,immune system phenotype|MP:0010299,increased mammary gland tumor incidence
MGI:2668517	Hprt1<tm2Detl>	MP:0001402,decreased locomotor activity|MP:0002064,seizures|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0004191,neuronal intranuclear inclusions
MGI:3582838	Hprt1<tm2(Pgk1-Pac/TK)Brd>	MP:0000266,abnormal heart morphology|MP:0000273,overriding aortic valve|MP:0000274,enlarged heart|MP:0000284,double outlet right ventricle|MP:0000285,abnormal heart valve morphology|MP:0000286,abnormal mitral valve morphology|MP:0000428,abnormal craniofacial morphology|MP:0001698,decreased embryo size|MP:0001785,edema|MP:0002169,no abnormal phenotype detected|MP:0002633,persistent truncus arteriosus|MP:0002747,abnormal aortic valve morphology|MP:0002925,abnormal cardiovascular development|MP:0003920,abnormal heart right ventricle morphology|MP:0004110,transposition of great arteries|MP:0004113,abnormal aortic arch morphology|MP:0004157,interrupted aortic arch|MP:0004158,right aortic arch|MP:0004160,retroesophageal right subclavian artery|MP:0005312,pericardial effusion|MP:0005389,reproductive system phenotype|MP:0006126,abnormal cardiac outflow tract development|MP:0006128,pulmonary valve stenosis|MP:0006138,congestive heart failure|MP:0009845,abnormal neural crest cell morphology|MP:0010402,ventricular septal defect|MP:0010449,heart right ventricle outflow tract stenosis|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011262,abnormal pharyngeal arch mesenchyme morphology|MP:0011659,interrupted aortic arch, type b|MP:0031517,interrupted aortic arch, type c
MGI:5569239	Hprt1<tm3.1(CAG-DLL1*,-Venus)Gos>	MP:0002169,no abnormal phenotype detected
MGI:4834648	Hprt1<tm31(Ple67-EGFP)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834653	Hprt1<tm32(Ple112-EGFP)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5529935	Hprt1<tm331a(Ple275-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532374	Hprt1<tm332(Ple272-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532376	Hprt1<tm333(Ple281-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532380	Hprt1<tm334a(Ple279-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532381	Hprt1<tm335(Ple277-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532382	Hprt1<tm336a(Ple134-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532383	Hprt1<tm337a(Ple285-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532384	Hprt1<tm338a(Ple284-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532385	Hprt1<tm339a(Ple280-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834776	Hprt1<tm33(Ple183-EGFP)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532387	Hprt1<tm340(Ple252-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532389	Hprt1<tm341a(Ple273-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532390	Hprt1<tm342a(Ple282-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532392	Hprt1<tm343(Ple270-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532492	Hprt1<tm344a(Ple5-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532493	Hprt1<tm345a(icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532496	Hprt1<tm346a(Ple264-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532499	Hprt1<tm347a(Ple155-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532501	Hprt1<tm348a(Ple265-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532502	Hprt1<tm349a(hs671-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834787	Hprt1<tm34(Ple186-EGFP)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532518	Hprt1<tm350a(Ple232-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532519	Hprt1<tm351a(Ple198-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5532520	Hprt1<tm352a(Hspa1a-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5568222	Hprt1<tm353(Ple274-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5568225	Hprt1<tm354(Ple283-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5568226	Hprt1<tm355(Ple286-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5568227	Hprt1<tm356a(Ple271-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5568229	Hprt1<tm357(Ple278-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5568239	Hprt1<tm358(Ple287-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5568240	Hprt1<tm359a(Ple94-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5568241	Hprt1<tm360a(Ple253-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5568242	Hprt1<tm361a(Ple267-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5568381	Hprt1<tm362a(Ple304-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5568243	Hprt1<tm363a(hs1218-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5568383	Hprt1<tm364a(CAG-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5568246	Hprt1<tm365a(Ple266-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5568249	Hprt1<tm366a(Ple67-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5568250	Hprt1<tm367a(Ple251-icre/ERT2)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834777	Hprt1<tm37(lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834846	Hprt1<tm38(Ple17-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834848	Hprt1<tm39(Ple24-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:3839280	Hprt1<tm3(APOA5)Lap>	MP:0005376,homeostasis/metabolism phenotype
MGI:5576942	Hprt1<tm3(CAG-Tbx18,-Venus)Akis>	MP:0005385,cardiovascular system phenotype|MP:0011085,postnatal lethality, complete penetrance
MGI:2668518	Hprt1<tm3Detl>	MP:0005386,behavior/neurological phenotype
MGI:4834850	Hprt1<tm40(Ple34-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834790	Hprt1<tm41(Ple160-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834828	Hprt1<tm42(Ple131-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834856	Hprt1<tm43(Ple140-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834779	Hprt1<tm44(Ple49-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834831	Hprt1<tm45(Ple67-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5576943	Hprt1<tm4(CAG-Tbx18/VP64,-Venus)Akis>	MP:0000288,abnormal pericardium morphology|MP:0002740,heart hypoplasia|MP:0003228,abnormal sinus venosus morphology|MP:0005385,cardiovascular system phenotype|MP:0010556,thin ventricle myocardium compact layer|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation
MGI:2668519	Hprt1<tm4Detl>	MP:0001402,decreased locomotor activity|MP:0001961,abnormal reflex|MP:0002064,seizures|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0004191,neuronal intranuclear inclusions
MGI:3830628	Hprt1<tm4(Ple88-EGFP)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5568544	Hprt1<tm4(Tek-IGF1R)Geno>	MP:0003025,increased vasoconstriction|MP:0003544,abnormal vascular endothelial cell migration|MP:0003957,abnormal nitric oxide homeostasis|MP:0004003,abnormal vascular endothelial cell physiology|MP:0004883,abnormal vascular wound healing|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype
MGI:4834832	Hprt1<tm50(Ple55-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4835013	Hprt1<tm53(CAG-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834789	Hprt1<tm54(Ple233-EGFP)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834861	Hprt1<tm56(Ple25-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4836990	Hprt1<tm57(Ple26-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834869	Hprt1<tm58(Ple119-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834875	Hprt1<tm59(Ple123-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5607312	Hprt1<tm5(Camk2a-BACE1)Geno>	MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001407,short stride length|MP:0001516,abnormal motor coordination/balance|MP:0002229,neurodegeneration|MP:0002969,impaired social transmission of food preference|MP:0003354,astrocytosis|MP:0003632,abnormal nervous system morphology|MP:0004191,neuronal intranuclear inclusions|MP:0005394,taste/olfaction phenotype|MP:0008414,abnormal spatial reference memory|MP:0011620,abnormal habituation to a new environment|MP:0014370,impaired spatial working memory
MGI:2668520	Hprt1<tm5Detl>	MP:0005386,behavior/neurological phenotype
MGI:4943867	Hprt1<tm5(Myh7-GFP,Myh6-CFP)Unc>	MP:0002169,no abnormal phenotype detected
MGI:4834877	Hprt1<tm62(Ple153-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834836	Hprt1<tm63(Ple12-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834840	Hprt1<tm64(Ple170-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834842	Hprt1<tm65(Ple53-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834844	Hprt1<tm66(Ple5-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834879	Hprt1<tm67(Ple238-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834880	Hprt1<tm68(Ple127-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834883	Hprt1<tm69(Ple134-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5629842	Hprt1<tm6(CAG-fat-1)Geno>	MP:0005280,abnormal fatty acids level
MGI:2668521	Hprt1<tm6Detl>	MP:0001402,decreased locomotor activity|MP:0002064,seizures|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0004191,neuronal intranuclear inclusions
MGI:4834886	Hprt1<tm70(Ple240-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834887	Hprt1<tm71(Ple155-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4834888	Hprt1<tm72(Ple158-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4835011	Hprt1<tm73(Ple142-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:4835014	Hprt1<tm74(Ple232-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5050094	Hprt1<tm75(Ple143-lacZ)Ems>	MP:0002169,no abnormal phenotype detected
MGI:2668522	Hprt1<tm7Detl>	MP:0005386,behavior/neurological phenotype
MGI:3830629	Hprt1<tm7(Ple185-EGFP)Ems>	MP:0002169,no abnormal phenotype detected
MGI:5319310	Hprt1<tm86(NR2E1,bEMS223)Ems>	MP:0003631,nervous system phenotype|MP:0004948,abnormal neuronal precursor proliferation|MP:0005385,cardiovascular system phenotype|MP:0005391,vision/eye phenotype
MGI:3830630	Hprt1<tm8(Ple151-EGFP)Ems>	MP:0002169,no abnormal phenotype detected
MGI:3835520	Hprt1<tm9(Ple178-EGFP/cre)Ems>	MP:0002169,no abnormal phenotype detected
MGI:1856712	Hps1<ep>	MP:0000371,diluted coat color|MP:0001183,overexpanded pulmonary alveolus|MP:0001325,abnormal retina morphology|MP:0001570,abnormal circulating enzyme level|MP:0002136,abnormal kidney physiology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002451,abnormal macrophage physiology|MP:0003068,enlarged kidney|MP:0003172,abnormal lysosome physiology|MP:0003174,increased lysosomal enzyme secretion|MP:0004725,decreased platelet serotonin level|MP:0005075,abnormal melanosome morphology|MP:0005100,abnormal choroid pigmentation|MP:0005101,abnormal ciliary body pigmentation|MP:0005102,abnormal iris pigmentation|MP:0005172,decreased eye pigmentation|MP:0005339,increased susceptibility to atherosclerosis|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0009448,decreased platelet ATP level|MP:0009557,decreased platelet ADP level|MP:0009643,abnormal urine homeostasis|MP:0010766,abnormal NK cell physiology|MP:0010815,enlarged alveolar lamellar bodies|MP:0010922,alveolitis|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation|MP:0020432,decreased platelet dense granule number
MGI:5500910	Hps1<ep-7J>	MP:0000371,diluted coat color|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:1856707	Hps3<coa>	MP:0000371,diluted coat color|MP:0004725,decreased platelet serotonin level|MP:0005075,abnormal melanosome morphology|MP:0005100,abnormal choroid pigmentation|MP:0005102,abnormal iris pigmentation|MP:0005103,abnormal retina pigmentation|MP:0005606,increased bleeding time|MP:0008480,absent eye pigmentation|MP:0009446,abnormal platelet dense granule physiology|MP:0009448,decreased platelet ATP level|MP:0009549,decreased platelet aggregation|MP:0020432,decreased platelet dense granule number
MGI:5515379	Hps3<coa-2Btlr>	MP:0000371,diluted coat color
MGI:5515383	Hps3<coa-3Btlr>	MP:0000371,diluted coat color
MGI:1861609	Hps3<coa-6J>	MP:0000371,diluted coat color|MP:0002551,abnormal blood coagulation|MP:0005606,increased bleeding time
MGI:3698876	Hps3<coa-7J>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation
MGI:3722183	Hps3<coa-8J>	MP:0000371,diluted coat color
MGI:3799709	Hps3<coa-Btlr>	MP:0000371,diluted coat color|MP:0005387,immune system phenotype
MGI:1856931	Hps4<le>	MP:0000015,abnormal ear pigmentation|MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0002095,abnormal skin pigmentation|MP:0002963,decreased urine protein level|MP:0003173,decreased lysosomal enzyme secretion|MP:0003174,increased lysosomal enzyme secretion|MP:0004721,abnormal platelet dense granule morphology|MP:0004725,decreased platelet serotonin level|MP:0005075,abnormal melanosome morphology|MP:0005100,abnormal choroid pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005341,decreased susceptibility to atherosclerosis|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time
MGI:6314202	Hps5<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0002075,abnormal coat/hair pigmentation|MP:0004924,abnormal behavior|MP:0005102,abnormal iris pigmentation|MP:0012122,abnormal iris transillumination
MGI:1856144	Hps5<ru2>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0005100,abnormal choroid pigmentation|MP:0005201,abnormal retina pigment epithelium morphology
MGI:3794862	Hps5<ru2-2Btlr>	MP:0000371,diluted coat color|MP:0005387,immune system phenotype
MGI:5607739	Hps5<ru2-3Btlr>	MP:0000371,diluted coat color|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation|MP:0011568,decreased foot pigmentation
MGI:6114045	Hps5<ru2-4Btlr>	MP:0000371,diluted coat color|MP:0005408,hypopigmentation
MGI:1856547	Hps5<ru2-8J>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0002075,abnormal coat/hair pigmentation|MP:0005172,decreased eye pigmentation
MGI:3778297	Hps5<ru2-Btlr>	MP:0000371,diluted coat color|MP:0002412,increased susceptibility to bacterial infection|MP:0005172,decreased eye pigmentation|MP:0009379,abnormal foot pigmentation|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:1856145	Hps5<ru2-hz>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation
MGI:1856147	Hps5<ru2-J>	MP:0009643,abnormal urine homeostasis
MGI:1856146	Hps5<ru2-mr>	MP:0000371,diluted coat color|MP:0002136,abnormal kidney physiology|MP:0004725,decreased platelet serotonin level|MP:0005172,decreased eye pigmentation|MP:0005341,decreased susceptibility to atherosclerosis|MP:0005606,increased bleeding time|MP:0009448,decreased platelet ATP level|MP:0009557,decreased platelet ADP level|MP:0020432,decreased platelet dense granule number
MGI:1889780	Hps5<ru2-r>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation
MGI:6257719	Hps6<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000692,small spleen|MP:0000706,small thymus|MP:0001258,decreased body length|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0002546,mydriasis|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:3584178	Hps6<ru-2J>	MP:0005387,immune system phenotype
MGI:1856545	Hps6<ru-3J>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0002075,abnormal coat/hair pigmentation|MP:0005172,decreased eye pigmentation
MGI:1856546	Hps6<ru-4J>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0002075,abnormal coat/hair pigmentation|MP:0005172,decreased eye pigmentation
MGI:1856410	Hps6<ru-6J>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation
MGI:3770622	Hps6<ru-7J>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation|MP:0005377,hearing/vestibular/ear phenotype|MP:0011279,decreased ear pigmentation
MGI:3836435	Hps6<ru-8J>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation
MGI:3799748	Hps6<ru-Btlr>	MP:0000371,diluted coat color|MP:0005387,immune system phenotype
MGI:5749801	Hpse2<em1(IMPC)J>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0006243,impaired pupillary reflex|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4308701	Hpse2<Gt(OST411605)Lex>	MP:0000477,abnormal intestine morphology|MP:0000539,distended urinary bladder|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001761,abnormal urination pattern|MP:0002083,premature death|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0002968,increased circulating alkaline phosphatase level|MP:0002989,small kidney|MP:0003280,urinary incontinence|MP:0005367,renal/urinary system phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0008489,slow postnatal weight gain|MP:0010386,abnormal urinary bladder physiology|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011535,increased urination frequency|MP:0011769,urinary bladder fibrosis
MGI:5615466	Hpse<tm1.2Mdh>	MP:0000221,decreased leukocyte cell number|MP:0005011,increased eosinophil cell number|MP:0005087,decreased acute inflammation|MP:0006382,abnormal lung epithelium morphology|MP:0008117,abnormal Langerhans cell morphology|MP:0008723,impaired eosinophil recruitment|MP:0010740,abnormal dendritic cell chemotaxis
MGI:3844469	Hpse<tm1Jpli>	MP:0000628,abnormal mammary gland development|MP:0003711,pathological neovascularization|MP:0005564,increased hemoglobin content|MP:0005601,increased angiogenesis
MGI:3769352	Hp<tm1Alev>	MP:0003193,decreased cholesterol efflux|MP:0003917,increased kidney weight|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0005558,decreased creatinine clearance
MGI:2181293	Hp<tm1Skl>	MP:0000332,hemoglobinemia|MP:0002136,abnormal kidney physiology|MP:0002703,abnormal renal tubule morphology|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010375,increased kidney iron level|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3721787	Hpw1<SEG/Pas>	MP:0004961,increased prostate gland weight
MGI:2447193	Hpx<tm1Altr>	MP:0000315,hemoglobinuria|MP:0002136,abnormal kidney physiology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005397,hematopoietic system phenotype|MP:0010375,increased kidney iron level|MP:0012666,increased circulating haptoglobin level
MGI:2385945	Hras<tm1Esn>	MP:0002169,no abnormal phenotype detected
MGI:3580632	Hras<tm1Grnt>	MP:0003631,nervous system phenotype
MGI:3845022	Hras<tm1Jaf>	MP:0000116,abnormal tooth development|MP:0000120,malocclusion|MP:0000440,domed cranium|MP:0001436,abnormal suckling behavior|MP:0001732,postnatal growth retardation|MP:0002006,neoplasm|MP:0002014,increased papilloma incidence|MP:0002051,increased skin papilloma incidence|MP:0002083,premature death|MP:0002576,abnormal enamel morphology|MP:0002649,abnormal enamel rod pattern|MP:0002650,abnormal ameloblast morphology|MP:0003141,cardiac fibrosis|MP:0003404,absent enamel|MP:0003667,increased hemangiosarcoma incidence|MP:0005379,endocrine/exocrine gland phenotype|MP:0010301,increased stomach tumor incidence|MP:0011086,postnatal lethality, incomplete penetrance|MP:0030199,deviated nasal septum|MP:0030219,jaw cyst|MP:0030450,abnormal enamel mineralization|MP:0030471,abnormal ameloblast differentiation|MP:0030521,abnormal cervical loop morphology|MP:0030522,abnormal stellate reticulum morphology|MP:0030523,abnormal stratum intermedium morphology
MGI:2386128	Hras<tm1Mok>	MP:0004502,decreased incidence of tumors by chemical induction|MP:0012080,chylous ascites
MGI:5608504	Hras<tm1Rak>	MP:0002169,no abnormal phenotype detected
MGI:3803581	Hras<tm1Xbr>	MP:0002169,no abnormal phenotype detected
MGI:3803587	Hras<tm2Xbr>	MP:0000091,short premaxilla|MP:0000097,short maxilla|MP:0000107,abnormal frontal bone morphology|MP:0000231,hypertension|MP:0000266,abnormal heart morphology|MP:0000276,heart right ventricle hypertrophy|MP:0000438,abnormal cranium morphology|MP:0000628,abnormal mammary gland development|MP:0000630,mammary gland hyperplasia|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001614,abnormal blood vessel morphology|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002006,neoplasm|MP:0002625,heart left ventricle hypertrophy|MP:0002842,increased systemic arterial blood pressure|MP:0003108,short zygomatic bone|MP:0003743,abnormal facial morphology|MP:0003769,abnormal lip morphology|MP:0003985,renal fibrosis|MP:0005367,renal/urinary system phenotype|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008725,increased heart atrium size|MP:0008772,increased heart ventricle size|MP:0009873,abnormal aorta tunica media morphology|MP:0010234,abnormal vibrissa follicle morphology|MP:0010591,enlarged aortic valve|MP:0011471,decreased urine creatinine level|MP:0030034,depressed nasal bridge|MP:0030036,short nasal bridge|MP:0030062,choanal stenosis|MP:0031232,increased circulating angiotensin II level
MGI:1856058	Hr<ba>	MP:0000416,sparse hair|MP:0000629,absent mammary gland|MP:0001191,abnormal skin condition|MP:0001200,thick skin|MP:0001201,translucent skin|MP:0001211,wrinkled skin|MP:0001262,decreased body weight|MP:0001280,loss of vibrissae|MP:0001510,abnormal coat appearance|MP:0003815,hairless|MP:0009722,abnormal nipple development|MP:0013529,decreased nipple number
MGI:2661912	Hr<bldy>	MP:0000414,alopecia|MP:0001211,wrinkled skin
MGI:5911421	Hrc<tm1.1Desa>	MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0004215,abnormal myocardial fiber physiology|MP:0004485,increased response of heart to induced stress|MP:0005140,decreased cardiac muscle contractility|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0010754,abnormal heart left ventricle pressure|MP:0011925,abnormal heart echocardiography feature|MP:0020345,abnormal myocardial fiber currents|MP:0020419,decreased cardiac muscle relaxation
MGI:3697445	Hrc<tm1Blk>	MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0004485,increased response of heart to induced stress|MP:0004819,decreased skeletal muscle mass|MP:0005334,abnormal fat pad morphology|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype
MGI:3714797	Hrdg1<A/J>	MP:0003455,decreased susceptibility to induced retina damage
MGI:3714798	Hrdg1<C57BL/6J>	MP:0001326,retina degeneration
MGI:2387298	Hrec<C57BL/6J>	MP:0002123,abnormal definitive hematopoiesis
MGI:2387299	Hrec<DBA/2J>	MP:0002123,abnormal definitive hematopoiesis
MGI:6404510	Hr<em1(IMPC)H>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000219,increased neutrophil cell number|MP:0000367,abnormal coat/ hair morphology|MP:0001284,absent vibrissae|MP:0002098,abnormal vibrissa morphology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005016,decreased lymphocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0008805,decreased circulating amylase level
MGI:3789962	Hrg<tm1Wja>	MP:0000220,increased monocyte cell number|MP:0003422,abnormal thrombolysis|MP:0005376,homeostasis/metabolism phenotype|MP:0005607,decreased bleeding time|MP:0012331,increased circulating fibrinogen level|MP:0012355,decreased prothrombin time
MGI:2182954	Hrh1<Bphs-r>	MP:0005387,immune system phenotype
MGI:2182953	Hrh1<Bphs-s>	MP:0002412,increased susceptibility to bacterial infection|MP:0005025,abnormal response to infection|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:6156138	Hrh1<em1(IMPC)Rbrc>	MP:0002135,abnormal kidney morphology
MGI:2182945	Hrh1<tm1Wtn>	MP:0000005,increased brown adipose tissue amount|MP:0000008,increased white adipose tissue amount|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001417,decreased exploration in new environment|MP:0001554,increased circulating free fatty acids level|MP:0001806,decreased IgM level|MP:0001876,decreased inflammatory response|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002727,decreased circulating insulin level|MP:0002757,decreased vertical activity|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004924,abnormal behavior|MP:0005018,decreased T cell number|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0008498,decreased IgG3 level|MP:0008567,decreased interferon-gamma secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0009355,increased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0011939,increased food intake|MP:0011940,decreased food intake|MP:0011943,abnormal circadian feeding behavior|MP:0020477,abnormal locomotor circadian rhythm|MP:0031415,increased skeletal muscle triglyceride level
MGI:2182949	Hrh2<tm1Wtn>	MP:0000505,decreased digestive secretion|MP:0004139,abnormal gastric parietal cell morphology|MP:0004731,increased circulating gastrin level|MP:0005211,increased stomach mucosa thickness|MP:0008004,abnormal stomach pH|MP:0010792,abnormal stomach mucosa morphology
MGI:3607154	Hrh2<tm1Yfks>	MP:0000505,decreased digestive secretion|MP:0001650,abnormal seizure response to electrical stimulation|MP:0002574,increased vertical activity|MP:0003883,enlarged stomach|MP:0003892,abnormal gastric gland morphology|MP:0004138,abnormal mucous neck cell morphology|MP:0004139,abnormal gastric parietal cell morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0004731,increased circulating gastrin level|MP:0008006,increased stomach pH|MP:0010799,stomach mucosa hyperplasia|MP:0013569,gastric gland hyperplasia
MGI:2155218	Hrh3<Eae8-r>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis
MGI:2155128	Hrh3<Eae8-s>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:5052375	Hrh3<tm1.1Jhwa>	MP:0002078,abnormal glucose homeostasis|MP:0005559,increased circulating glucose level|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3050799	Hrh3<tm1Kot>	MP:0001402,decreased locomotor activity|MP:0001433,polyphagia|MP:0002079,increased circulating insulin level|MP:0005290,decreased oxygen consumption|MP:0005331,insulin resistance|MP:0005450,abnormal energy expenditure|MP:0005455,increased susceptibility to weight gain|MP:0005669,increased circulating leptin level|MP:0010024,increased total body fat amount|MP:0011014,decreased core body temperature|MP:0014441,decreased response to leptin
MGI:2387415	Hrh3<tm1Twl>	MP:0001362,abnormal anxiety-related response|MP:0001363,increased anxiety-related response|MP:0001364,decreased anxiety-related response|MP:0001463,abnormal spatial learning|MP:0001544,abnormal cardiovascular system physiology|MP:0003313,abnormal locomotor activation|MP:0003633,abnormal nervous system physiology|MP:0003953,abnormal hormone level|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005387,immune system phenotype|MP:0005447,abnormal synaptic norepinephrine release|MP:0011020,abnormal circadian temperature homeostasis|MP:0031384,impaired blood-brain barrier function
MGI:5812925	Hrh4<tm1b(EUCOMM)Hmgu>	MP:0002834,decreased heart weight|MP:0011962,increased cornea thickness|MP:0011965,decreased total retina thickness
MGI:3528886	Hrh4<tm1Lex>	MP:0001876,decreased inflammatory response|MP:0002376,abnormal dendritic cell physiology|MP:0002423,abnormal mast cell physiology|MP:0002492,decreased IgE level|MP:0008495,decreased IgG1 level|MP:0008721,abnormal chemokine level|MP:0008751,abnormal interleukin level
MGI:3851914	Hr<Hp>	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000417,short hair|MP:0000427,abnormal hair cycle|MP:0001199,thin skin|MP:0001211,wrinkled skin|MP:0001216,abnormal epidermal layer morphology|MP:0001274,curly vibrissae|MP:0001279,wavy vibrissae|MP:0002098,abnormal vibrissa morphology|MP:0003414,epidermal cyst|MP:0003809,abnormal hair shaft morphology|MP:0003813,abnormal hair follicle dermal papilla morphology|MP:0009003,abnormal vibrissa number|MP:0010234,abnormal vibrissa follicle morphology|MP:0010685,abnormal hair follicle inner root sheath morphology
MGI:3851709	Hr<hr+>	MP:0010771,integument phenotype
MGI:1856057	Hr<hr>	MP:0000580,deformed nails|MP:0000627,abnormal mammary gland morphology|MP:0000649,sebaceous gland atrophy|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001247,dermal cyst|MP:0001382,abnormal nursing|MP:0002026,increased leukemia incidence|MP:0002060,abnormal skin morphology|MP:0003815,hairless|MP:0004813,absent linear vestibular evoked potential|MP:0005018,decreased T cell number|MP:0005081,abnormal dermis reticular layer morphology|MP:0005095,decreased T cell proliferation|MP:0005425,increased macrophage cell number
MGI:5289957	Hr<hr-2Pas>	MP:0002073,abnormal hair growth|MP:0003815,hairless
MGI:3720713	Hrk<tm1Ast>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0003204,decreased neuron apoptosis
MGI:3574591	Hrk<tm1Nnz>	MP:0001011,abnormal superior cervical ganglion morphology|MP:0001076,abnormal hypoglossal nerve morphology|MP:0003204,decreased neuron apoptosis
MGI:2682426	Hrl<C57BL/6J>	MP:0020917,decreased susceptibility to Herpesvirales infection
MGI:3805975	Hr<m1Btlr>	MP:0000583,long toenails|MP:0001211,wrinkled skin|MP:0003815,hairless|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005421,loose skin
MGI:3624265	Hr<m1Enu>	MP:0000414,alopecia|MP:0000580,deformed nails|MP:0001216,abnormal epidermal layer morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001247,dermal cyst|MP:0001280,loss of vibrissae|MP:0001874,acanthosis|MP:0002500,granulomatous inflammation|MP:0005421,loose skin
MGI:3834982	Hr<m2Btlr>	MP:0001200,thick skin|MP:0001211,wrinkled skin|MP:0003815,hairless
MGI:5304503	Hr<M3Btlr>	MP:0000414,alopecia|MP:0009004,progressive hair loss
MGI:5465443	Hr<m4Btlr>	MP:0000414,alopecia|MP:0010680,abnormal skin adnexa physiology
MGI:5619134	Hr<m5Btlr>	MP:0000414,alopecia|MP:0001211,wrinkled skin
MGI:6198336	Hr<m6Btlr>	MP:0000414,alopecia
MGI:1856060	Hr<N>	MP:0000416,sparse hair|MP:0001196,shiny skin|MP:0001199,thin skin|MP:0001211,wrinkled skin|MP:0001274,curly vibrissae|MP:0001282,short vibrissae|MP:0001510,abnormal coat appearance|MP:0001882,abnormal lactation|MP:0002073,abnormal hair growth|MP:0002098,abnormal vibrissa morphology|MP:0003815,hairless
MGI:6140199	Hrnr<em1(IMPC)Wtsi>	MP:0005419,decreased circulating serum albumin level
MGI:2662872	Hrq1<CBA/CaJ>	MP:0002626,increased heart rate
MGI:2662876	Hrq2<CBA/CaJ>	MP:0002626,increased heart rate
MGI:1856059	Hr<rh>	MP:0000425,loss of eyelid cilia|MP:0000495,abnormal colon morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000580,deformed nails|MP:0000583,long toenails|MP:0000647,abnormal sebaceous gland morphology|MP:0001200,thick skin|MP:0001210,skin ridges|MP:0001211,wrinkled skin|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001260,increased body weight|MP:0001340,abnormal eyelid morphology|MP:0001345,Meibomian gland atrophy|MP:0001783,decreased white adipose tissue amount|MP:0001851,eye inflammation|MP:0001882,abnormal lactation|MP:0003414,epidermal cyst|MP:0003637,cochlear ganglion hypoplasia|MP:0003644,thymus atrophy|MP:0003815,hairless|MP:0004396,decreased cochlear inner hair cell number|MP:0004402,decreased cochlear outer hair cell number|MP:0004526,absent cochlear hair cell stereocilia|MP:0005252,abnormal Meibomian gland morphology|MP:0006162,thick eyelids|MP:0008507,thin retina ganglion layer|MP:0008513,thin retina inner plexiform layer|MP:0009004,progressive hair loss|MP:0009935,abnormal Meibomian gland acinus morphology|MP:0010699,dilated hair follicle|MP:0013390,Meibomian gland cyst|MP:0013745,abnormal eyelid margin morphology|MP:0014082,decreased small intestinal villus height|MP:0030031,abnormal forehead morphology|MP:0030570,abnormal piliary canal morphology
MGI:5552015	Hr<rh-10J>	MP:0000377,abnormal hair follicle morphology|MP:0000583,long toenails|MP:0001200,thick skin|MP:0001211,wrinkled skin|MP:0001265,decreased body size|MP:0003815,hairless|MP:0010699,dilated hair follicle|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1856506	Hr<rh-8J>	MP:0000414,alopecia|MP:0000427,abnormal hair cycle|MP:0001247,dermal cyst|MP:0009931,abnormal skin appearance|MP:0010683,dilated hair follicle infundibulum|MP:0010687,absent hair follicle dermal papilla
MGI:3039558	Hr<rh-bmh>	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0001247,dermal cyst|MP:0005387,immune system phenotype|MP:0010683,dilated hair follicle infundibulum|MP:0010684,abnormal hair follicle outer root sheath morphology|MP:0010685,abnormal hair follicle inner root sheath morphology|MP:0030571,dilated piliary canal
MGI:3630275	Hr<rh-Chr>	MP:0000647,abnormal sebaceous gland morphology|MP:0001247,dermal cyst|MP:0003815,hairless|MP:0012725,small sebaceous gland|MP:0013379,decreased sebocyte cell number
MGI:3580645	Hr<rh-R>	MP:0000377,abnormal hair follicle morphology|MP:0000583,long toenails|MP:0001211,wrinkled skin|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001247,dermal cyst|MP:0001382,abnormal nursing|MP:0004956,decreased thymus weight|MP:0009003,abnormal vibrissa number|MP:0009004,progressive hair loss|MP:0009600,hypergranulosis|MP:0009601,epidermis stratum granulosum hyperplasia|MP:0010682,abnormal hair follicle infundibulum morphology|MP:0010683,dilated hair follicle infundibulum
MGI:2678250	Hr<rhsl>	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000583,long toenails|MP:0001195,flaky skin|MP:0001200,thick skin|MP:0001211,wrinkled skin|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0001247,dermal cyst|MP:0001382,abnormal nursing|MP:0002060,abnormal skin morphology|MP:0002083,premature death|MP:0002098,abnormal vibrissa morphology|MP:0002656,abnormal keratinocyte differentiation|MP:0003644,thymus atrophy|MP:0005421,loose skin
MGI:3630274	Hr<rh-Y>	MP:0001247,dermal cyst|MP:0001926,female infertility|MP:0002060,abnormal skin morphology|MP:0003355,decreased ovulation rate|MP:0003413,hair follicle degeneration|MP:0003815,hairless
MGI:2389062	Hrtfm1<C57BL/6J>	MP:0001544,abnormal cardiovascular system physiology|MP:0002083,premature death
MGI:2389064	Hrtfm2<C57BL/6J>	MP:0001544,abnormal cardiovascular system physiology|MP:0002083,premature death
MGI:2389063	Hrtfm2<DBA/2J>	MP:0002082,postnatal lethality|MP:0002795,dilated cardiomyopathy
MGI:1858045	Hr<Tg5053Mm>	MP:0001191,abnormal skin condition|MP:0001200,thick skin|MP:0001211,wrinkled skin|MP:0001212,skin lesions|MP:0003413,hair follicle degeneration|MP:0003414,epidermal cyst|MP:0009004,progressive hair loss
MGI:3052135	Hr<tm1Cct>	MP:0000414,alopecia|MP:0001211,wrinkled skin|MP:0001214,skin hyperplasia|MP:0001247,dermal cyst|MP:0002060,abnormal skin morphology|MP:0030571,dilated piliary canal
MGI:3042966	Hrtpq1<L6>	MP:0002833,increased heart weight
MGI:3043472	Hrtq1<L6>	MP:0002834,decreased heart weight
MGI:3042954	Hrtq2<L6>	MP:0002834,decreased heart weight
MGI:3043103	Hrtq3<L6>	MP:0002834,decreased heart weight
MGI:3814836	Hrtr1<A/J>	MP:0002626,increased heart rate
MGI:3606124	Hr<USP>	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000583,long toenails|MP:0000607,abnormal hepatocyte morphology|MP:0001191,abnormal skin condition|MP:0001200,thick skin|MP:0001211,wrinkled skin|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0001245,thick dermal layer|MP:0001247,dermal cyst|MP:0001806,decreased IgM level|MP:0001824,abnormal thymus involution|MP:0002060,abnormal skin morphology|MP:0002346,abnormal lymph node secondary follicle morphology|MP:0002490,abnormal immunoglobulin level|MP:0002493,increased IgG level|MP:0002743,glomerulonephritis|MP:0003413,hair follicle degeneration|MP:0003865,lymph node inflammation|MP:0004126,thin hypodermis|MP:0005350,increased susceptibility to autoimmune disorder|MP:0009623,enlarged inguinal lymph nodes|MP:0009635,enlarged popliteal lymph nodes|MP:0010699,dilated hair follicle|MP:0011225,lymph node medullary cord hyperplasia|MP:0013585,thymus cortex atrophy
MGI:3814848	Hrvhf1<C57BL/6J>	MP:0003928,increased heart rate variability
MGI:3778076	Hrwq<129S1/SvImJ>	MP:0002834,decreased heart weight
MGI:1856609	hs	MP:0002939,head spot
MGI:7408175	Hs1bp3<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0002098,abnormal vibrissa morphology
MGI:1934916	Hs2st1<Gt(pGT1.8TM)ST125Nimr>	MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000562,polydactyly|MP:0001286,abnormal eye development|MP:0001304,cataract|MP:0002896,abnormal bone mineralization|MP:0004620,cervical vertebral fusion|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005201,abnormal retina pigment epithelium morphology|MP:0006032,abnormal ureteric bud morphology|MP:0008056,abnormal retina ganglion cell morphology|MP:0008277,abnormal sternum ossification|MP:0009890,cleft secondary palate|MP:0010714,iris coloboma|MP:0011089,perinatal lethality, complete penetrance
MGI:4439161	Hs2st1<tm1.1Je>	MP:0001552,increased circulating triglyceride level|MP:0002118,abnormal lipid homeostasis|MP:0010080,abnormal hepatocyte physiology
MGI:4439258	Hs2st1<tm1.2Je>	MP:0000520,absent kidney|MP:0011087,neonatal lethality, complete penetrance
MGI:2655749	Hs3st1<tm1Nws>	MP:0005376,homeostasis/metabolism phenotype|MP:0009429,decreased embryo weight|MP:0010768,mortality/aging|MP:0011085,postnatal lethality, complete penetrance
MGI:5566804	Hs3st2<tm1.1Fawa>	MP:0002169,no abnormal phenotype detected
MGI:5312610	Hs3st3a1<tm1(KOMP)Vlcg>	MP:0002599,increased mean platelet volume|MP:0002833,increased heart weight|MP:0002941,increased circulating alanine transaminase level|MP:0003179,thrombocytopenia|MP:0005266,abnormal metabolism|MP:0005310,abnormal salivary gland physiology|MP:0005343,increased circulating aspartate transaminase level|MP:0005568,increased circulating total protein level|MP:0009525,abnormal submandibular duct morphology|MP:0010025,decreased total body fat amount|MP:0010506,prolonged RR interval|MP:0011949,increased drinking frequency|MP:0013542,abnormal submandibular gland branching morphogenesis
MGI:6152497	Hs3st3b1<em2(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0020420,abnormal freezing behavior|MP:0020421,increased freezing behavior
MGI:4399627	Hs3st3b1<tm1(KOMP)Vlcg>	MP:0005310,abnormal salivary gland physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0011949,increased drinking frequency|MP:0013541,abnormal submandibular gland development|MP:0013542,abnormal submandibular gland branching morphogenesis
MGI:6152500	Hs3st5<em1(IMPC)Mbp>	MP:0001399,hyperactivity|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney
MGI:3663624	Hs6st1<Gt(betageo)1Tprt>	MP:0005241,abnormal retina ganglion layer morphology
MGI:3793787	Hs6st1<tm1.1Wvc>	MP:0001183,overexpanded pulmonary alveolus|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3715259	Hs6st1<tm1Kkm>	MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0001732,postnatal growth retardation|MP:0002092,abnormal eye morphology|MP:0002113,abnormal skeleton development|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003231,abnormal placenta vasculature|MP:0005104,abnormal tarsal bone morphology|MP:0005306,abnormal phalanx morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3793786	Hs6st1<tm1Wvc>	MP:0005376,homeostasis/metabolism phenotype
MGI:3528762	Hs6st2<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:5750173	Hsbp1l1<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system|MP:0006243,impaired pupillary reflex
MGI:5588201	Hsbp1<tm1Miv>	MP:0001685,abnormal endoderm development|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2665083	Hscfr<AKR/J>	MP:0002123,abnormal definitive hematopoiesis
MGI:5566777	Hsd11b1<tm1.1Awhi>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0011939,increased food intake
MGI:3817966	Hsd11b1<tm1.1Ggla>	MP:0000642,enlarged adrenal glands|MP:0002665,decreased circulating corticosterone level|MP:0005369,muscle phenotype|MP:0005584,abnormal enzyme/coenzyme activity
MGI:5566778	Hsd11b1<tm1.2Awhi>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005449,abnormal food intake
MGI:5532495	Hsd11b1<tm1.2Tuck>	MP:0001560,abnormal circulating insulin level|MP:0005376,homeostasis/metabolism phenotype|MP:0006319,abnormal epididymal fat pad morphology|MP:0010182,decreased susceptibility to weight gain
MGI:4362580	Hsd11b1<tm1a(KOMP)Wtsi>	MP:0001745,increased circulating corticosterone level|MP:0003963,abnormal corticosterone level|MP:0010934,increased subcutaneous adipose tissue amount|MP:0011702,abnormal fibroblast proliferation|MP:0011703,increased fibroblast proliferation|MP:0020254,decreased collagen level
MGI:5444438	Hsd11b1<tm1Ggla>	MP:0000642,enlarged adrenal glands|MP:0001431,abnormal eating behavior|MP:0001556,increased circulating HDL cholesterol level|MP:0002665,decreased circulating corticosterone level|MP:0002727,decreased circulating insulin level|MP:0005291,abnormal glucose tolerance|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype
MGI:2385796	Hsd11b1<tm1Yko>	MP:0000010,abnormal abdominal fat pad morphology|MP:0000180,abnormal circulating cholesterol level|MP:0000183,decreased circulating LDL cholesterol level|MP:0000642,enlarged adrenal glands|MP:0000807,abnormal hippocampus morphology|MP:0001176,abnormal lung development|MP:0001463,abnormal spatial learning|MP:0001556,increased circulating HDL cholesterol level|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0003963,abnormal corticosterone level|MP:0005178,increased circulating cholesterol level|MP:0005277,abnormal brainstem morphology|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0006319,abnormal epididymal fat pad morphology|MP:0010400,increased liver glycogen level|MP:0010814,absent alveolar lamellar bodies|MP:0010889,small alveolar lamellar bodies|MP:0010890,decreased alveolar lamellar body number|MP:0010993,decreased surfactant secretion|MP:0012172,abnormal amniotic fluid composition
MGI:2386169	Hsd11b2<tm1Yko>	MP:0000231,hypertension|MP:0000477,abnormal intestine morphology|MP:0000746,weakness|MP:0001436,abnormal suckling behavior|MP:0001762,polyuria|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002667,decreased circulating aldosterone level|MP:0002833,increased heart weight|MP:0003020,decreased circulating chloride level|MP:0003068,enlarged kidney|MP:0004564,increased myocardial fiber size|MP:0005618,decreased urine potassium level|MP:0005628,decreased circulating potassium level|MP:0006317,decreased urine sodium level|MP:0009051,dilated distal convoluted tubule|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011471,decreased urine creatinine level
MGI:4245470	Hsd17b11<Gt(OST237628)Lex>	MP:0008214,increased immature B cell number|MP:0008500,increased IgG2a level
MGI:5581418	Hsd17b11<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0002833,increased heart weight|MP:0002960,decreased urine microalbumin level|MP:0011471,decreased urine creatinine level
MGI:4122956	Hsd17b12<Gt(A030E06)Wrst>	MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002399,abnormal pluripotent precursor cell morphology|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0003984,embryonic growth retardation|MP:0004556,enlarged allantois|MP:0005621,abnormal cell physiology|MP:0006386,absent somites|MP:0009593,absent chorion|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0012113,decreased inner cell mass proliferation
MGI:5007180	Hsd17b13<tm1Lex>	MP:0001860,liver inflammation|MP:0002169,no abnormal phenotype detected|MP:0002628,hepatic steatosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0009355,increased liver triglyceride level|MP:0014174,decreased fatty acid beta-oxidation|MP:0020867,increased lipogenesis|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis
MGI:5007181	Hsd17b14<tm1Lex>	MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0008500,increased IgG2a level|MP:0010166,increased response to stress-induced hyperthermia|MP:0013600,testis degeneration
MGI:5576042	Hsd17b1<tm1.1(KOMP)Vlcg>	MP:0000208,decreased hematocrit|MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0002591,decreased mean corpuscular volume|MP:0002757,decreased vertical activity|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0003020,decreased circulating chloride level|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0005627,increased circulating potassium level|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0011396,abnormal sleep behavior
MGI:3799948	Hsd17b1<tm1(KOMP)Vlcg>	MP:0001126,abnormal ovary morphology|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002636,delayed vaginal opening|MP:0002679,abnormal corpus luteum morphology|MP:0002680,decreased corpora lutea number|MP:0004855,increased ovary weight|MP:0004903,abnormal uterus weight|MP:0005133,increased luteinizing hormone level|MP:0005389,reproductive system phenotype|MP:0011384,abnormal progesterone level
MGI:3773836	Hsd17b2<tm1Mpo>	MP:0000434,megacephaly|MP:0000788,abnormal cerebral cortex morphology|MP:0000914,exencephaly|MP:0001405,impaired coordination|MP:0001501,abnormal sleep pattern|MP:0001525,impaired balance|MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002175,decreased brain weight|MP:0003014,abnormal kidney medulla morphology|MP:0003918,decreased kidney weight|MP:0003984,embryonic growth retardation|MP:0004201,fetal growth retardation|MP:0004259,small placenta|MP:0004969,pale kidney|MP:0008535,enlarged lateral ventricles|MP:0009641,kidney degeneration|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011408,renal tubule hypertrophy|MP:0011527,disorganized placental labyrinth|MP:0011843,abnormal kidney collecting duct epithelium morphology|MP:0012098,increased spongiotrophoblast size|MP:0020526,enlarged thalamus
MGI:6508689	Hsd17b3<tm1.2Mpo>	MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001260,increased body weight|MP:0001751,increased circulating luteinizing hormone level|MP:0001922,reduced male fertility|MP:0002108,abnormal muscle morphology|MP:0002781,increased circulating testosterone level|MP:0002784,abnormal Sertoli cell morphology|MP:0003509,increased circulating dihydrotestosterone level|MP:0003918,decreased kidney weight|MP:0003953,abnormal hormone level|MP:0004852,decreased testis weight|MP:0004910,decreased seminal vesicle weight|MP:0004929,decreased epididymis weight|MP:0004952,increased spleen weight|MP:0005186,increased circulating progesterone level|MP:0005189,abnormal anogenital distance|MP:0005389,reproductive system phenotype|MP:0008938,decreased pituitary gland weight|MP:0008940,delayed balanopreputial separation|MP:0009819,abnormal circulating androgen level|MP:0011384,abnormal progesterone level|MP:0011385,abnormal testosterone level|MP:0013602,abnormal Leydig cell differentiation|MP:0014142,increased body fat mass|MP:0031362,decreased prostate gland ventral lobe weight
MGI:6156445	Hsd17b4<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000274,enlarged heart|MP:0000642,enlarged adrenal glands|MP:0000689,abnormal spleen morphology|MP:0001304,cataract|MP:0001319,irregularly shaped pupil|MP:0001322,abnormal iris morphology|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001697,abnormal embryo size|MP:0002059,abnormal seminal vesicle morphology|MP:0002092,abnormal eye morphology|MP:0002100,abnormal tooth morphology|MP:0002637,small uterus|MP:0004738,abnormal auditory brainstem response|MP:0005632,decreased circulating aspartate transaminase level|MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011874,enlarged urinary bladder
MGI:2385822	Hsd17b4<tm1Baes>	MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0001145,abnormal male reproductive system morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001304,cataract|MP:0001363,increased anxiety-related response|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001547,abnormal lipid level|MP:0001666,abnormal intestinal absorption|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001929,abnormal gametogenesis|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002631,abnormal epididymis morphology|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0004774,abnormal bile salt level|MP:0005202,lethargy|MP:0005281,increased fatty acids level|MP:0005405,axon degeneration|MP:0006362,abnormal male germ cell morphology|MP:0006380,abnormal spermatid morphology|MP:0008918,microgliosis|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5523923	Hsd17b4<tm2Baes>	MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0000921,demyelination|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0003224,neuron degeneration|MP:0003631,nervous system phenotype|MP:0005281,increased fatty acids level|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005405,axon degeneration|MP:0008918,microgliosis|MP:0014185,cerebellum atrophy
MGI:5056371	Hsd17b7<rud>	MP:0000788,abnormal cerebral cortex morphology|MP:0004686,decreased length of long bones
MGI:3811923	Hsd17b7<tm1Gibo>	MP:0000266,abnormal heart morphology|MP:0000913,abnormal brain development|MP:0000936,small embryonic telencephalon|MP:0001622,abnormal vasculogenesis|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0004096,abnormal midbrain-hindbrain boundary development|MP:0005312,pericardial effusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012089,decreased midbrain size|MP:0012090,midbrain hypoplasia|MP:0012263,decreased hindbrain size|MP:0012264,hindbrain hypoplasia
MGI:4456868	Hsd17b7<tm1Mpo>	MP:0000282,abnormal interatrial septum morphology|MP:0000288,abnormal pericardium morphology|MP:0000784,forebrain hypoplasia|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001719,absent vitelline blood vessels|MP:0002118,abnormal lipid homeostasis|MP:0002884,abnormal pharyngeal arch morphology|MP:0003658,abnormal capillary morphology|MP:0004567,decreased myocardial fiber number|MP:0004937,dilated heart|MP:0005312,pericardial effusion|MP:0010656,thick myocardium|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012505,increased neural tube apoptosis
MGI:5755139	Hsd17b8<em1(IMPC)J>	MP:0013279,increased fasting circulating glucose level
MGI:7621193	Hsd3b6<tm1.1Hokh>	MP:0013388,small Meibomian gland
MGI:7621194	Hsd3b6<tm1.2Hokh>	MP:0001337,dry eyes|MP:0001345,Meibomian gland atrophy|MP:0011385,abnormal testosterone level|MP:0013391,abnormal Meibomian gland physiology|MP:0020219,increased tear production
MGI:3716711	Hsd3b7<tm1Rus>	MP:0001192,scaly skin|MP:0001197,oily skin|MP:0001732,postnatal growth retardation|MP:0002644,decreased circulating triglyceride level|MP:0002647,decreased intestinal cholesterol absorption|MP:0005278,abnormal cholesterol homeostasis|MP:0005281,increased fatty acids level|MP:0005365,abnormal bile salt homeostasis|MP:0009355,increased liver triglyceride level|MP:0011085,postnatal lethality, complete penetrance
MGI:6257572	Hsdl2<em1(IMPC)Bay>	MP:0001925,male infertility
MGI:5285187	Hsf1<tm1.1Echr>	MP:0005168,abnormal female meiosis|MP:0009769,abnormal meiotic spindle assembly checkpoint
MGI:5445761	Hsf1<tm1.1(KOMP)Vlcg>	MP:0001325,abnormal retina morphology|MP:0001697,abnormal embryo size|MP:0005560,decreased circulating glucose level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011396,abnormal sleep behavior
MGI:3044161	Hsf1<tm1Anak>	MP:0001156,abnormal spermatogenesis|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype
MGI:2155444	Hsf1<tm1Ijb>	MP:0000780,abnormal corpus callosum morphology|MP:0000822,abnormal brain ventricle morphology|MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0001262,decreased body weight|MP:0001716,abnormal placenta labyrinth morphology|MP:0001732,postnatal growth retardation|MP:0001926,female infertility|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002152,abnormal brain morphology|MP:0002182,abnormal astrocyte morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0003406,failure of zygotic cell division|MP:0004077,abnormal striatum morphology|MP:0004079,abnormal putamen morphology|MP:0005168,abnormal female meiosis|MP:0008026,abnormal brain white matter morphology|MP:0008560,increased tumor necrosis factor secretion|MP:0009451,abnormal chromosomal synapsis|MP:0009452,abnormal synaptonemal complex|MP:0009769,abnormal meiotic spindle assembly checkpoint|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012099,decreased spongiotrophoblast size
MGI:3033933	Hsf1<tm1Miv>	MP:0000313,abnormal cell death|MP:0001926,female infertility|MP:0008944,decreased sensitivity to induced cell death
MGI:7281837	Hsf2bp<em1Amp>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0006379,abnormal spermatocyte morphology|MP:0008871,abnormal ovarian follicle number|MP:0009451,abnormal chromosomal synapsis|MP:0011121,decreased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0014760,impaired DNA repair|MP:0031381,decreased secondary ovarian follicle number
MGI:6467326	Hsf2bp<em1Roka>	MP:0001147,small testis|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0006379,abnormal spermatocyte morphology|MP:0009451,abnormal chromosomal synapsis|MP:0011101,prenatal lethality, incomplete penetrance
MGI:7281840	Hsf2bp<em2Amp>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001923,reduced female fertility|MP:0001930,abnormal meiosis|MP:0001935,decreased litter size|MP:0002687,oligozoospermia|MP:0005169,abnormal male meiosis|MP:0014760,impaired DNA repair
MGI:4435082	Hsf2bp<tm1a(EUCOMM)Hmgu>	MP:0000562,polydactyly|MP:0001260,increased body weight|MP:0001556,increased circulating HDL cholesterol level|MP:0001756,abnormal urination|MP:0003179,thrombocytopenia|MP:0005559,increased circulating glucose level|MP:0005560,decreased circulating glucose level|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:5548644	Hsf2bp<tm1b(EUCOMM)Hmgu>	MP:0000702,enlarged lymph nodes|MP:0001147,small testis|MP:0001925,male infertility|MP:0010948,abnormal double-strand DNA break repair
MGI:5471287	Hsf2<tm1b(KOMP)Wtsi>	MP:0003870,decreased urine glucose level|MP:0005560,decreased circulating glucose level|MP:0005633,increased circulating sodium level
MGI:2429646	Hsf2<tm1Ijb>	MP:0002169,no abnormal phenotype detected
MGI:2664486	Hsf2<tm1Miv>	MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001916,intracerebral hemorrhage|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012681,collapsed brain ventricles
MGI:2182620	Hsf2<tm1Mmr>	MP:0001131,abnormal ovarian follicle morphology|MP:0001134,absent corpus luteum|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002682,decreased mature ovarian follicle number|MP:0002687,oligozoospermia|MP:0003718,maternal effect|MP:0004834,ovary hemorrhage|MP:0004852,decreased testis weight|MP:0004929,decreased epididymis weight|MP:0005169,abnormal male meiosis|MP:0005431,decreased oocyte number|MP:0006361,abnormal female germ cell morphology|MP:0008280,abnormal male germ cell apoptosis|MP:0008283,small hippocampus|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0009444,ovarian follicular cyst|MP:0009452,abnormal synaptonemal complex
MGI:3056560	Hsf4<ldis1>	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001306,small lens|MP:0002840,abnormal lens fiber morphology|MP:0003237,abnormal lens epithelium morphology|MP:0031428,lens dislocation
MGI:3057199	Hsf4<tm1Anak>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001309,hydropic eye lens fibers|MP:0003236,abnormal lens capsule morphology|MP:0003237,abnormal lens epithelium morphology|MP:0008841,ruptured lens capsule
MGI:5468954	Hsf4<tm1b(KOMP)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001312,abnormal cornea morphology|MP:0001319,irregularly shaped pupil|MP:0002833,increased heart weight|MP:0002941,increased circulating alanine transaminase level|MP:0005102,abnormal iris pigmentation
MGI:3527211	Hsf4<tm1Miv>	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology
MGI:3848361	Hsf4<tm1Xyk>	MP:0001303,abnormal lens morphology|MP:0002840,abnormal lens fiber morphology
MGI:7709565	Hsf5<em1Asla>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:6293914	Hsf5<em1(IMPC)J>	MP:0001925,male infertility|MP:0003961,decreased lean body mass|MP:0005333,decreased heart rate|MP:0010024,increased total body fat amount|MP:0013279,increased fasting circulating glucose level
MGI:6357916	Hsfy2<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0001925,male infertility|MP:0004738,abnormal auditory brainstem response
MGI:3662663	Hsh2d<tm1Viss>	MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004952,increased spleen weight|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008687,increased interleukin-2 secretion
MGI:2389121	Hsl1<C57BL/6J>	MP:0002319,hyperoxia
MGI:3041832	Hsm1<CAST/EiJ>	MP:0002591,decreased mean corpuscular volume
MGI:4329776	Hsp90aa1<Gt(S17-2G1)Sor>	MP:0001925,male infertility
MGI:4126277	Hsp90aa1<Gt(XE444)Byg>	MP:0001147,small testis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0008280,abnormal male germ cell apoptosis
MGI:5286686	Hsp90aa1<Tg(Tyr)2396BOve>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001147,small testis|MP:0001326,retina degeneration|MP:0001925,male infertility|MP:0002001,blindness|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008580,photoreceptor inner segment degeneration|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0014059,abnormal photoreceptor connecting cilium morphology|MP:0020813,abnormal photoreceptor outer segment disc membrane morphology|MP:0030005,increased retina apoptosis
MGI:5294812	Hsp90aa1<tm1.1Udon>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002376,abnormal dendritic cell physiology|MP:0002455,abnormal dendritic cell antigen presentation|MP:0003609,small scrotum|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0008567,decreased interferon-gamma secretion|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014052,increased male germ cell apoptosis
MGI:5441560	Hsp90aa1<tm1.2Udon>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0003205,testicular atrophy|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0008280,abnormal male germ cell apoptosis
MGI:4364475	Hsp90aa1<tm1(KOMP)Wtsi>	MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0001925,male infertility|MP:0002968,increased circulating alkaline phosphatase level|MP:0005358,abnormal incisor morphology|MP:0010052,increased grip strength
MGI:1857893	Hsp90ab1<Gt(pGT1.8geo)1Pgr>	MP:0001716,abnormal placenta labyrinth morphology|MP:0003231,abnormal placenta vasculature|MP:0004086,absent heartbeat|MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013241,embryo tissue necrosis
MGI:4460991	Hsp90b1<tm1.2Alee>	MP:0001698,decreased embryo size|MP:0003988,disorganized embryonic tissue|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:3837939	Hsp90b1<tm1Yarg>	MP:0001674,abnormal germ layer development|MP:0001685,abnormal endoderm development|MP:0001693,failure of primitive streak formation|MP:0001698,decreased embryo size|MP:0001706,abnormal left-right axis patterning|MP:0001724,abnormal extraembryonic endoderm formation|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0005030,absent amnion|MP:0005076,abnormal cell differentiation|MP:0009593,absent chorion|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011198,absent proamniotic cavity
MGI:3700023	Hsp90b1<tm1Zhli>	MP:0000371,diluted coat color|MP:0004382,abnormal hair follicle melanogenesis|MP:0008732,reduced hair shaft melanin granule number
MGI:6306701	Hspa12a<tm1.1Zdi>	MP:0002446,abnormal macrophage morphology|MP:0002891,increased insulin sensitivity|MP:0003076,increased susceptibility to ischemic brain injury|MP:0003631,nervous system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0006060,increased cerebral infarct size|MP:0008735,increased susceptibility to endotoxin shock|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010182,decreased susceptibility to weight gain|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:6694146	Hspa13<tm1.1Smoc>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002492,decreased IgE level|MP:0002962,increased urine protein level|MP:0003726,decreased autoantibody level|MP:0004815,abnormal somatic hypermutation frequency|MP:0004816,abnormal class switch recombination|MP:0005166,decreased susceptibility to injury|MP:0008098,decreased plasma cell number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008897,decreased IgG2c level|MP:0013940,abnormal plasmablast number
MGI:2183896	Hspa1a<tm1.1Msk>	MP:0005621,abnormal cell physiology
MGI:2183895	Hspa1a<tm1Msk>	MP:0005621,abnormal cell physiology|MP:0008943,increased sensitivity to induced cell death
MGI:2183894	Hspa1b<tm1.1Msk>	MP:0005621,abnormal cell physiology
MGI:3611984	Hspa1b<tm1Bwy>	MP:0003076,increased susceptibility to ischemic brain injury|MP:0006060,increased cerebral infarct size
MGI:2180762	Hspa1b<tm1Clib>	MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003957,abnormal nitric oxide homeostasis|MP:0005534,decreased body temperature|MP:0008705,increased interleukin-6 secretion|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3575001	Hspa1b<tm1Jss>	MP:0008412,increased cellular sensitivity to oxidative stress|MP:0011368,increased kidney apoptosis
MGI:2183891	Hspa1b<tm1Msk>	MP:0005621,abnormal cell physiology|MP:0008943,increased sensitivity to induced cell death
MGI:6724293	Hspa1l<em1Nju>	MP:0005389,reproductive system phenotype
MGI:2447605	Hspa2<tm1Dix>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005169,abnormal male meiosis
MGI:3690321	Hspa4l<tm1Imad>	MP:0000194,increased circulating calcium level|MP:0000519,hydronephrosis|MP:0000521,abnormal kidney cortex morphology|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0002135,abnormal kidney morphology|MP:0002136,abnormal kidney physiology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004970,kidney atrophy|MP:0005367,renal/urinary system phenotype|MP:0005565,increased blood urea nitrogen level|MP:0005633,increased circulating sodium level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0014686,premature spermiation
MGI:4836945	Hspa4<tm1.1Miv>	MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003214,neurofibrillary tangles|MP:0004250,tau protein deposits|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior
MGI:5308719	Hspa4<tm1Imad>	MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0006379,abnormal spermatocyte morphology|MP:0006380,abnormal spermatid morphology|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis|MP:0014634,decreased round spermatid number|MP:0014636,decreased elongated spermatid number
MGI:4888745	Hspa5<baffled>	MP:0000111,cleft palate|MP:0000780,abnormal corpus callosum morphology|MP:0000784,forebrain hypoplasia|MP:0000787,abnormal telencephalon morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000807,abnormal hippocampus morphology|MP:0000849,abnormal cerebellum morphology|MP:0001265,decreased body size|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002741,small olfactory bulb|MP:0002989,small kidney|MP:0003631,nervous system phenotype|MP:0003651,abnormal axon extension|MP:0005404,abnormal axon morphology|MP:0008026,abnormal brain white matter morphology|MP:0008128,abnormal brain internal capsule morphology|MP:0008457,abnormal cortical intermediate zone morphology|MP:0008817,hematoma|MP:0009450,abnormal axon fasciculation|MP:0009937,abnormal neuron differentiation|MP:0009967,abnormal neuron proliferation|MP:0010993,decreased surfactant secretion|MP:0011087,neonatal lethality, complete penetrance
MGI:3664111	Hspa5<tm1.1Alee>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0004957,abnormal blastocyst morphology|MP:0009687,empty decidua capsularis|MP:0010380,abnormal inner cell mass apoptosis|MP:0011093,embryonic lethality at implantation, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:5445740	Hspa5<tm1.1(KOMP)Vlcg>	MP:0001556,increased circulating HDL cholesterol level|MP:0002833,increased heart weight|MP:0003020,decreased circulating chloride level|MP:0005178,increased circulating cholesterol level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3814698	Hspa5<tm1Alee>	MP:0002169,no abnormal phenotype detected|MP:0005389,reproductive system phenotype
MGI:3773635	Hspa5<tm1Aoe>	MP:0001177,atelectasis|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0003215,renal interstitial fibrosis|MP:0003717,pallor|MP:0004200,decreased fetal size|MP:0004780,abnormal surfactant secretion|MP:0005165,increased susceptibility to injury|MP:0010813,abnormal alveolar lamellar body morphology|MP:0010909,pulmonary alveolar hemorrhage|MP:0011087,neonatal lethality, complete penetrance|MP:0011346,renal tubule atrophy
MGI:5265211	Hspa9<Gt(IST14901H6)Tigm>	MP:0005397,hematopoietic system phenotype|MP:0008209,decreased pre-B cell number|MP:0011092,embryonic lethality, complete penetrance
MGI:5568935	Hspb1<tm1.1Jdn>	MP:0001792,impaired wound healing|MP:0001846,increased inflammatory response|MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology|MP:0002908,delayed wound healing|MP:0003077,abnormal cell cycle|MP:0005023,abnormal wound healing|MP:0008705,increased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0011704,decreased fibroblast proliferation
MGI:5488491	Hspb1<tm1.1(KOMP)Vlcg>	MP:0000195,decreased circulating calcium level|MP:0002833,increased heart weight|MP:0005561,increased mean corpuscular hemoglobin
MGI:3760083	Hspb1<tm1Msk>	MP:0002169,no abnormal phenotype detected
MGI:5447475	Hspb2<tm1.1Ijb>	MP:0005385,cardiovascular system phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0010954,abnormal cellular respiration
MGI:5445926	Hspb2<tm1.1(KOMP)Vlcg>	MP:0002804,abnormal motor learning|MP:0002833,increased heart weight|MP:0009198,abnormal male genitalia morphology
MGI:5445925	Hspb3<tm1.1(KOMP)Vlcg>	MP:0002702,decreased circulating free fatty acids level|MP:0013279,increased fasting circulating glucose level
MGI:7584374	Hspb6<em1Cya>	MP:0000272,abnormal aorta morphology|MP:0006042,increased apoptosis|MP:0031274,increased susceptibility to induced aneurysm formation|MP:0031281,increased susceptibility to aneurysm induced morbidity/mortality
MGI:6116705	Hspb7<tm1.1Chen>	MP:0000266,abnormal heart morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6116704	Hspb7<tm1.1Yty>	MP:0000751,myopathy|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002279,abnormal diaphragm morphology|MP:0002297,abnormal forced expiratory flow rates|MP:0002327,abnormal respiratory function|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009419,skeletal muscle fibrosis|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6116706	Hspb7<tm1.2Chen>	MP:0002188,small heart|MP:0004067,abnormal trabecula carnea morphology|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0004783,abnormal cardinal vein morphology|MP:0006138,congestive heart failure|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0010580,decreased heart left ventricle size|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0021160,decreased heart right ventricle wall thickness|MP:0031511,globular heart
MGI:6314208	Hspb8<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0000367,abnormal coat/ hair morphology|MP:0001399,hyperactivity|MP:0001566,increased circulating phosphate level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5433119	Hspb8<tm1.1Depr>	MP:0000266,abnormal heart morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0003819,increased left ventricle diastolic pressure|MP:0005329,abnormal myocardium layer morphology|MP:0005598,decreased heart ventricle muscle contractility|MP:0005630,increased lung weight|MP:0008597,decreased circulating interleukin-6 level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010579,increased heart left ventricle size|MP:0010724,thick interventricular septum|MP:0010954,abnormal cellular respiration
MGI:6392625	Hspb8<tm1.1Vti>	MP:0000759,abnormal skeletal muscle morphology|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:6392623	Hspb8<tm1Vti>	MP:0000751,myopathy|MP:0001405,impaired coordination|MP:0002269,muscular atrophy|MP:0002651,abnormal sciatic nerve morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004087,abnormal muscle fiber morphology|MP:0004091,abnormal Z line morphology|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential|MP:0005405,axon degeneration|MP:0009412,skeletal muscle fiber degeneration|MP:0010053,decreased grip strength|MP:0030940,impaired autophagy
MGI:5925402	Hspb9<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation
MGI:5637015	Hspbap1<tm1b(EUCOMM)Hmgu>	MP:0003960,increased lean body mass|MP:0004952,increased spleen weight|MP:0010025,decreased total body fat amount
MGI:5661504	Hspbp1<tm1Jhoh>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis|MP:0014633,decreased spermatid number|MP:0014634,decreased round spermatid number|MP:0014636,decreased elongated spermatid number
MGI:6188980	Hspd1<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:4214000	Hspd1<Gt(OST171441)Lex>	MP:0000937,abnormal motor neuron morphology|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001698,decreased embryo size|MP:0002878,abnormal corticospinal tract morphology|MP:0003491,abnormal voluntary movement|MP:0003984,embryonic growth retardation|MP:0004179,transmission ratio distortion|MP:0006035,abnormal mitochondrial morphology|MP:0009400,decreased skeletal muscle fiber size|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011105,embryonic lethality between implantation and placentation, incomplete penetrance|MP:0011636,disorganized mitochondrial cristae|MP:0012051,spasticity
MGI:6385857	Hspd1<tm1c(EUCOMM)Hmgu>	MP:0000274,enlarged heart|MP:0000280,thin ventricular wall|MP:0001544,abnormal cardiovascular system physiology|MP:0001577,anemia|MP:0001614,abnormal blood vessel morphology|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002875,decreased erythrocyte cell number|MP:0003141,cardiac fibrosis|MP:0003656,abnormal erythrocyte physiology|MP:0003674,oxidative stress|MP:0003984,embryonic growth retardation|MP:0005630,increased lung weight|MP:0006036,abnormal mitochondrial physiology|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011925,abnormal heart echocardiography feature|MP:0012688,abnormal heart ventricles weight|MP:0013657,abnormal blood cell morphology|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3712964	Hspg2<tm1.1Rdgr>	MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0005390,skeleton phenotype
MGI:3811188	Hspg2<tm1.1Soni>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001290,delayed eyelid opening|MP:0002083,premature death|MP:0002657,chondrodystrophy|MP:0002914,abnormal endplate potential|MP:0002932,abnormal joint morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004145,abnormal muscle electrophysiology|MP:0004835,abnormal miniature endplate potential|MP:0004924,abnormal behavior|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009409,abnormal skeletal muscle fiber type ratio
MGI:1934891	Hspg2<tm1Nid>	MP:0000060,delayed bone ossification|MP:0000088,short mandible|MP:0000141,abnormal vertebral body morphology|MP:0000163,abnormal cartilage morphology|MP:0000164,abnormal cartilage development|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000547,short limbs|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000914,exencephaly|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001953,respiratory failure|MP:0002427,disproportionate dwarf|MP:0005508,abnormal skeleton morphology|MP:0006397,disorganized long bone epiphyseal plate|MP:0008271,abnormal bone ossification|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0014101,decreased chondrocyte proliferation|MP:0030029,wide cranial sutures
MGI:3712962	Hspg2<tm1Rdgr>	MP:0000060,delayed bone ossification|MP:0000130,abnormal trabecular bone morphology|MP:0000131,abnormal long bone epiphysis morphology|MP:0000157,abnormal sternum morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001406,abnormal gait|MP:0002108,abnormal muscle morphology|MP:0002397,abnormal bone marrow morphology|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003312,abnormal locomotor coordination|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003560,osteoarthritis|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0004373,bowed humerus|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004686,decreased length of long bones|MP:0004703,abnormal vertebral column morphology|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0005296,abnormal humerus morphology|MP:0005508,abnormal skeleton morphology|MP:0005621,abnormal cell physiology|MP:0008151,increased diameter of long bones|MP:0008160,increased diameter of humerus|MP:0008271,abnormal bone ossification|MP:0008525,decreased cranium height|MP:0009459,skeletal muscle hyperplasia|MP:0012175,flat face|MP:0030788,abnormal femur head morphology|MP:0030789,abnormal femur neck morphology|MP:0030793,short femur neck
MGI:1934892	Hspg2<tm1Ref>	MP:0000065,abnormal bone marrow cavity morphology|MP:0000075,absent neurocranium|MP:0000088,short mandible|MP:0000100,abnormal ethmoid bone morphology|MP:0000104,abnormal sphenoid bone morphology|MP:0000111,cleft palate|MP:0000133,abnormal long bone metaphysis morphology|MP:0000150,abnormal rib morphology|MP:0000163,abnormal cartilage morphology|MP:0000164,abnormal cartilage development|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000166,abnormal chondrocyte morphology|MP:0000288,abnormal pericardium morphology|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000547,short limbs|MP:0000602,dilated liver sinusoidal space|MP:0000787,abnormal telencephalon morphology|MP:0000914,exencephaly|MP:0001182,lung hemorrhage|MP:0001258,decreased body length|MP:0001636,irregular heartbeat|MP:0001698,decreased embryo size|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0002152,abnormal brain morphology|MP:0002427,disproportionate dwarf|MP:0002657,chondrodystrophy|MP:0002746,abnormal semilunar valve morphology|MP:0002747,abnormal aortic valve morphology|MP:0002748,abnormal pulmonary valve morphology|MP:0003044,impaired basement membrane formation|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003279,aneurysm|MP:0003632,abnormal nervous system morphology|MP:0003723,abnormal long bone morphology|MP:0004056,abnormal myocardium compact layer morphology|MP:0004110,transposition of great arteries|MP:0004134,abnormal chest morphology|MP:0004148,increased compact bone thickness|MP:0004174,abnormal spine curvature|MP:0004272,abnormal basement membrane morphology|MP:0004376,absent frontal bone|MP:0004419,absent parietal bone|MP:0004471,short nasal bone|MP:0004669,enlarged vertebral body|MP:0004686,decreased length of long bones|MP:0004783,abnormal cardinal vein morphology|MP:0005229,abnormal intervertebral disk development|MP:0005244,hemopericardium|MP:0005269,abnormal occipital bone morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005508,abnormal skeleton morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0006397,disorganized long bone epiphyseal plate|MP:0008272,abnormal endochondral bone ossification|MP:0010426,abnormal heart and great artery attachment|MP:0010472,abnormal ascending aorta and coronary artery attachment|MP:0010584,abnormal conotruncus septation|MP:0010586,absent conotruncal ridges|MP:0010588,conotruncal ridge hyperplasia|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011238,abnormal inner ear development|MP:0011514,skin hemorrhage|MP:0014516,abnormal middle ear development|MP:0020137,decreased bone mineralization|MP:0020390,abnormal radial glial cell endfoot morphology
MGI:2449915	Hspg2<tm1Soin>	MP:0005376,homeostasis/metabolism phenotype
MGI:3811187	Hspg2<tm1Soni>	MP:0000921,demyelination|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001290,delayed eyelid opening|MP:0003871,abnormal myelin sheath morphology|MP:0004924,abnormal behavior|MP:0005402,abnormal action potential|MP:0005404,abnormal axon morphology|MP:0010732,abnormal node of Ranvier morphology|MP:0010734,abnormal paranode morphology|MP:0010738,abnormal internode morphology|MP:0010742,increased Schwann cell number|MP:0010768,mortality/aging
MGI:5617737	Hsph1<tm1Kzn>	MP:0005621,abnormal cell physiology|MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury
MGI:3511517	Hstx1<PWD/Ph>	MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia
MGI:3587086	Htas2<C57BL/6J>	MP:0005443,abnormal ethanol metabolism|MP:0005534,decreased body temperature
MGI:3587089	Htas3<DBA/2J>	MP:0005443,abnormal ethanol metabolism|MP:0005534,decreased body temperature
MGI:3587090	Htas4<C57BL/6J>	MP:0005443,abnormal ethanol metabolism|MP:0005534,decreased body temperature
MGI:3026855	Htatip2<tm1Hx>	MP:0000627,abnormal mammary gland morphology|MP:0001272,increased metastatic potential|MP:0002018,increased malignant tumor incidence|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002038,increased carcinoma incidence|MP:0002039,increased neuroblastoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003570,increased uterus leiomyoma incidence|MP:0003667,increased hemangiosarcoma incidence|MP:0005621,abnormal cell physiology|MP:0008000,increased ovary tumor incidence|MP:0009311,increased duodenum adenocarcinoma incidence|MP:0009551,increased urinary bladder transitional cell carcinoma incidence|MP:0011703,increased fibroblast proliferation|MP:0014127,increased thymoma incidence
MGI:6362658	Htatsf1<tm1Jakn>	MP:0002399,abnormal pluripotent precursor cell morphology
MGI:1856907	htd	MP:0001191,abnormal skin condition|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001510,abnormal coat appearance|MP:0001745,increased circulating corticosterone level|MP:0001921,reduced fertility|MP:0002073,abnormal hair growth|MP:0003793,abnormal submandibular gland morphology|MP:0003815,hairless|MP:0004697,abnormal thyroid follicular cell morphology|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level|MP:0010831,lethality, incomplete penetrance
MGI:1856908	htr	MP:0001330,abnormal optic nerve morphology|MP:0001406,abnormal gait|MP:0003312,abnormal locomotor coordination
MGI:2387407	Htr1a<tm1Rhn>	MP:0001363,increased anxiety-related response|MP:0001906,increased dopamine level|MP:0002573,behavioral despair|MP:0003631,nervous system phenotype|MP:0005322,abnormal serotonin level|MP:0012575,increased noradrenaline level|MP:0014812,abnormal brain physiology
MGI:2387410	Htr1a<tm1Tct>	MP:0001363,increased anxiety-related response|MP:0002573,behavioral despair|MP:0002797,increased thigmotaxis|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:2387408	Htr1a<tm1Toth>	MP:0001363,increased anxiety-related response|MP:0001463,abnormal spatial learning|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002920,decreased paired-pulse facilitation|MP:0031391,increased locomotor activity
MGI:2387416	Htr1a<tm2Rhn>	MP:0002757,decreased vertical activity
MGI:5439287	Htr1a<tm3.1Rhn>	MP:0001501,abnormal sleep pattern|MP:0009436,fragmentation of sleep/wake states|MP:0012287,increased frequency of paradoxical sleep|MP:0012291,increased slow-wave sleep duration|MP:0014638,increased sleep duration
MGI:5463939	Htr1b<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0002833,increased heart weight|MP:0003960,increased lean body mass|MP:0005379,endocrine/exocrine gland phenotype|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2653030	Htr1b<tm1Rhn>	MP:0001147,small testis|MP:0001260,increased body weight|MP:0001354,increased aggression towards male mice|MP:0001364,decreased anxiety-related response|MP:0001463,abnormal spatial learning|MP:0001489,decreased startle reflex|MP:0002803,abnormal operant conditioning behavior|MP:0003313,abnormal locomotor activation|MP:0004988,increased osteoblast cell number|MP:0005605,increased bone mass|MP:0011941,increased fluid intake|MP:0020039,increased bone ossification|MP:0030438,increased osteoblast proliferation
MGI:5529062	Htr1d<tm1.1(KOMP)Vlcg>	MP:0005379,endocrine/exocrine gland phenotype|MP:0010053,decreased grip strength
MGI:3528763	Htr1d<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:5520176	Htr1f<tm1.1(KOMP)Vlcg>	MP:0002590,increased mean corpuscular volume|MP:0005633,increased circulating sodium level|MP:0011999,abnormal tail length
MGI:3604523	Htr1f<tm1Dgen>	MP:0001973,increased thermal nociceptive threshold|MP:0009141,increased prepulse inhibition
MGI:3653429	Htr2a<tm1Grch>	MP:0001362,abnormal anxiety-related response|MP:0001364,decreased anxiety-related response|MP:0002574,increased vertical activity|MP:0005390,skeleton phenotype
MGI:3624812	Htr2a<tm1Rhn>	MP:0000479,abnormal enterocyte morphology|MP:0008802,abnormal intestinal smooth muscle morphology|MP:0013486,decreased Paneth cell number
MGI:5550591	Htr2b<tm1b(EUCOMM)Wtsi>	MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount
MGI:3604521	Htr2b<tm1Dgen>	MP:0002169,no abnormal phenotype detected|MP:0011092,embryonic lethality, complete penetrance
MGI:3837400	Htr2b<tm1Kry>	MP:0002727,decreased circulating insulin level|MP:0005390,skeleton phenotype|MP:0009114,decreased pancreatic beta cell mass|MP:0011820,decreased pancreatic beta cell proliferation
MGI:1888735	Htr2b<tm1Lum>	MP:0000267,abnormal heart development|MP:0000296,absent trabeculae carneae|MP:0001262,decreased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0001698,decreased embryo size|MP:0001921,reduced fertility|MP:0002127,abnormal cardiovascular system morphology|MP:0002190,disorganized myocardium|MP:0002834,decreased heart weight|MP:0003140,dilated heart atrium|MP:0003984,embryonic growth retardation|MP:0005294,abnormal heart ventricle morphology|MP:0005385,cardiovascular system phenotype|MP:0010759,decreased right ventricle systolic pressure|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation
MGI:8278435	Htr2c<em1Yonxu>	MP:0001473,reduced long-term potentiation|MP:0005386,behavior/neurological phenotype|MP:0008431,abnormal short-term spatial reference memory|MP:0009456,impaired cued conditioning behavior
MGI:4830457	Htr2c<tm1.1Eme>	MP:0000421,mottled coat|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001429,dehydration|MP:0001492,abnormal pilomotor reflex|MP:0001505,hunched posture|MP:0001732,postnatal growth retardation|MP:0004144,hypotonia|MP:0004889,increased energy expenditure|MP:0010053,decreased grip strength|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011939,increased food intake|MP:0011940,decreased food intake
MGI:5751109	Htr2c<tm1Arte>	MP:0001745,increased circulating corticosterone level|MP:0003063,increased coping response|MP:0004000,impaired passive avoidance behavior|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype
MGI:3841486	Htr2c<tm1Jke>	MP:0000008,increased white adipose tissue amount|MP:0001399,hyperactivity|MP:0001433,polyphagia|MP:0002083,premature death|MP:0003961,decreased lean body mass|MP:0003997,tonic-clonic seizures|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005458,increased percent body fat/body weight|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0009747,impaired behavioral response to xenobiotic
MGI:1857439	Htr2c<tm1Jul>	MP:0000008,increased white adipose tissue amount|MP:0000951,sporadic seizures|MP:0001260,increased body weight|MP:0001413,abnormal response to new environment|MP:0001433,polyphagia|MP:0001441,increased grooming behavior|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002826,tonic seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003212,increased susceptibility to age related obesity|MP:0003631,nervous system phenotype|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003997,tonic-clonic seizures|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005386,behavior/neurological phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0008752,abnormal tumor necrosis factor level|MP:0009288,increased epididymal fat pad weight|MP:0009302,increased renal fat pad weight|MP:0009747,impaired behavioral response to xenobiotic
MGI:3823041	Htr2c<tm1Knk>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001433,polyphagia|MP:0001732,postnatal growth retardation|MP:0001783,decreased white adipose tissue amount|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005123,increased circulating growth hormone level|MP:0005179,decreased circulating cholesterol level|MP:0005266,abnormal metabolism|MP:0005376,homeostasis/metabolism phenotype|MP:0005535,abnormal body temperature|MP:0005560,decreased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0006086,decreased body mass index|MP:0008489,slow postnatal weight gain|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008965,increased basal metabolism|MP:0009746,enhanced behavioral response to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011612,increased circulating ghrelin level|MP:0014143,decreased body fat mass|MP:0014169,decreased brown adipose tissue mass
MGI:5569357	Htr2c<tm2Jke>	MP:0001260,increased body weight|MP:0001399,hyperactivity|MP:0001559,hyperglycemia|MP:0002064,seizures|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002712,increased circulating glucagon level|MP:0004129,abnormal respiratory quotient|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005290,decreased oxygen consumption|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0010768,mortality/aging|MP:0011939,increased food intake
MGI:3823042	Htr2c<tm2Knk>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype
MGI:5429022	Htr2c<tm2Lex>	MP:0005375,adipose tissue phenotype
MGI:6147798	Htr3a<em1.1(IMPC)J>	MP:0003043,hypoalgesia
MGI:3045973	Htr3a<tm1Ckn>	MP:0000321,increased bone marrow cell number|MP:0000519,hydronephrosis|MP:0000538,abnormal urinary bladder morphology|MP:0000539,distended urinary bladder|MP:0000540,abnormal urinary bladder urothelium morphology|MP:0001761,abnormal urination pattern|MP:0001859,kidney inflammation|MP:0002083,premature death|MP:0002962,increased urine protein level|MP:0003280,urinary incontinence|MP:0003608,prostate gland inflammation|MP:0005016,decreased lymphocyte cell number|MP:0005150,cachexia|MP:0005302,neurogenic bladder|MP:0005565,increased blood urea nitrogen level|MP:0009552,urinary bladder obstruction|MP:0010386,abnormal urinary bladder physiology|MP:0011403,pyelonephritis|MP:0011405,tubulointerstitial nephritis|MP:0011774,abnormal urinary bladder detrusor smooth muscle morphology|MP:0011777,abnormal male prostatic urethra morphology|MP:0011784,abnormal urinary bladder neck morphology|MP:0011799,increased urinary bladder weight|MP:0011801,urethra obstruction|MP:0011802,seminal vesiculitis
MGI:3055155	Htr3a<tm1Jul>	MP:0008531,increased chemical nociceptive threshold
MGI:5445922	Htr3b<tm1.1(KOMP)Vlcg>	MP:0003795,abnormal bone structure|MP:0010053,decreased grip strength
MGI:3027491	Htr4<tm1Comp>	MP:0001259,abnormal body weight|MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001783,decreased white adipose tissue amount|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005388,respiratory system phenotype|MP:0005449,abnormal food intake|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3604474	Htr4<tm1Dgen>	MP:0005565,increased blood urea nitrogen level
MGI:3604475	Htr5a<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3513844	Htr5a<tm1Rhn>	MP:0001415,increased exploration in new environment|MP:0003107,abnormal response to novelty
MGI:3528439	Htr5b<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:3839298	Htr6<tm1Arte>	MP:0001262,decreased body weight|MP:0010025,decreased total body fat amount|MP:0011940,decreased food intake|MP:0020234,decreased basal metabolism
MGI:3529298	Htr6<tm1Lex>	MP:0001258,decreased body length|MP:0001262,decreased body weight
MGI:3844587	Htr6<tm1Tct>	MP:0002629,hyperactivity elicited by ethanol administration|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0009755,impaired behavioral response to alcohol
MGI:5498765	Htr7<tm1b(KOMP)Wtsi>	MP:0003019,increased circulating chloride level|MP:0005633,increased circulating sodium level|MP:0013278,decreased fasting circulating glucose level
MGI:3604477	Htr7<tm1Dgen>	MP:0001973,increased thermal nociceptive threshold|MP:0003858,enhanced coordination
MGI:3575513	Htr7<tm1Mrg>	MP:0001777,abnormal body temperature homeostasis
MGI:2450732	Htr7<tm1Sut>	MP:0001777,abnormal body temperature homeostasis
MGI:3722446	Htr7<tm1Wtkn>	MP:0001650,abnormal seizure response to electrical stimulation|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:5558036	Htra1<tm1.1Pfi>	MP:0005378,growth/size/body region phenotype|MP:0009347,increased trabecular bone thickness|MP:0010875,increased bone volume
MGI:5285550	Htra1<tm1Ybf>	MP:0005391,vision/eye phenotype
MGI:1856960	Htra2<mnd2>	MP:0000685,abnormal immune system morphology|MP:0000703,abnormal thymus morphology|MP:0000743,muscle spasm|MP:0000752,dystrophic muscle|MP:0000938,motor neuron degeneration|MP:0000955,abnormal spinal cord morphology|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001409,increased stereotypic behavior|MP:0001505,hunched posture|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002182,abnormal astrocyte morphology|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0002269,muscular atrophy|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002690,akinesia|MP:0003632,abnormal nervous system morphology|MP:0003643,spleen atrophy|MP:0004924,abnormal behavior|MP:0005092,decreased double-positive T cell number|MP:0005156,bradykinesia|MP:0005323,dystonia|MP:0005402,abnormal action potential|MP:0008083,decreased single-positive T cell number|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0010025,decreased total body fat amount
MGI:5752861	Htra2<tm1.1Hohj>	MP:0000745,tremors|MP:0000747,muscle weakness|MP:0000753,paralysis|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001404,no spontaneous movement|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0003631,nervous system phenotype|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0005202,lethargy|MP:0006035,abnormal mitochondrial morphology|MP:0010053,decreased grip strength|MP:0010955,abnormal respiratory electron transport chain|MP:0014178,increased brain apoptosis
MGI:5695938	Htra2<tm1.1(KOMP)Vlcg>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5752863	Htra2<tm1.2Hohj>	MP:0000745,tremors|MP:0000747,muscle weakness|MP:0000753,paralysis|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001404,no spontaneous movement|MP:0001405,impaired coordination|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0004098,abnormal cerebellar granule cell morphology|MP:0005016,decreased lymphocyte cell number|MP:0005202,lethargy|MP:0006035,abnormal mitochondrial morphology|MP:0010053,decreased grip strength|MP:0010955,abnormal respiratory electron transport chain|MP:0011632,dilated mitochondrion|MP:0011634,abnormal mitochondrial inner membrane morphology|MP:0011635,abnormal mitochondrial crista morphology|MP:0014178,increased brain apoptosis
MGI:3512633	Htra2<tm1Jdo>	MP:0000416,sparse hair|MP:0000692,small spleen|MP:0000706,small thymus|MP:0000745,tremors|MP:0000774,decreased brain size|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001388,abnormal stationary movement|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002188,small heart|MP:0002690,akinesia|MP:0003242,loss of basal ganglia neurons|MP:0006007,abnormal basal ganglion morphology|MP:0006035,abnormal mitochondrial morphology|MP:0006042,increased apoptosis|MP:0008235,increased susceptibility to neuronal excitotoxicity
MGI:6266863	Htra4<tm1.2Hohj>	MP:0002169,no abnormal phenotype detected
MGI:6437757	Htt<em1(IMPC)H>	MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2177751	Htt<tm1.1Pfs>	MP:0000774,decreased brain size|MP:0001353,increased aggression towards mice
MGI:2388035	Htt<tm1.1Tna>	MP:0003354,astrocytosis
MGI:2177756	Htt<tm1Detl>	MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001524,impaired limb coordination|MP:0003224,neuron degeneration|MP:0003631,nervous system phenotype|MP:0003997,tonic-clonic seizures|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype
MGI:2177743	Htt<tm1Hay>	MP:0000835,abnormal subthalamic nucleus morphology|MP:0001399,hyperactivity|MP:0001400,hyperresponsive|MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002063,abnormal learning/memory/conditioning|MP:0002086,abnormal extraembryonic tissue morphology|MP:0004081,abnormal globus pallidus morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011105,embryonic lethality between implantation and placentation, incomplete penetrance
MGI:1857180	Htt<tm1Mem>	MP:0001675,abnormal ectoderm development|MP:0001698,decreased embryo size|MP:0001724,abnormal extraembryonic endoderm formation|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0003895,increased ectoderm apoptosis|MP:0006323,abnormal extraembryonic mesoderm development|MP:0009331,absent primitive node|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0012135,embryonic-extraembryonic boundary constriction
MGI:2675580	Htt<tm1Mfc>	MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001441,increased grooming behavior|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002152,abnormal brain morphology|MP:0002574,increased vertical activity|MP:0002757,decreased vertical activity|MP:0003313,abnormal locomotor activation|MP:0005499,abnormal olfactory system morphology|MP:0031391,increased locomotor activity
MGI:2388030	Htt<tm1Msl>	MP:0003631,nervous system phenotype
MGI:1857722	Htt<tm1Szi>	MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002582,disorganized extraembryonic tissue|MP:0003085,abnormal egg cylinder morphology|MP:0003954,abnormal Reichert's membrane morphology|MP:0003988,disorganized embryonic tissue|MP:0011092,embryonic lethality, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011191,increased embryonic epiblast cell apoptosis|MP:0011199,abnormal amniotic cavity morphology|MP:0012095,increased Reichert's membrane thickness|MP:0012104,small amniotic cavity|MP:0013504,increased embryonic tissue cell apoptosis|MP:0014586,decreased egg cylinder size
MGI:2177753	Htt<tm2.1Pfs>	MP:0000774,decreased brain size|MP:0001353,increased aggression towards mice
MGI:2177757	Htt<tm2Detl>	MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0001524,impaired limb coordination|MP:0001525,impaired balance|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002183,gliosis|MP:0002882,abnormal neuron morphology|MP:0003224,neuron degeneration|MP:0003631,nervous system phenotype|MP:0003858,enhanced coordination|MP:0003997,tonic-clonic seizures|MP:0004077,abnormal striatum morphology|MP:0004102,abnormal dorsal striatum morphology|MP:0004103,abnormal ventral striatum morphology|MP:0004191,neuronal intranuclear inclusions|MP:0004924,abnormal behavior|MP:0005376,homeostasis/metabolism phenotype|MP:0008917,abnormal oligodendrocyte physiology|MP:0008918,microgliosis|MP:0009808,decreased oligodendrocyte number|MP:0011731,decreased myelin sheath thickness|MP:0012506,brain atrophy|MP:0013438,dysmyelination|MP:0020070,decreased neocortex volume|MP:0030635,increased taurine level
MGI:1861703	Htt<tm2Mem>	MP:0003631,nervous system phenotype
MGI:2388032	Htt<tm2Msl>	MP:0001402,decreased locomotor activity|MP:0002574,increased vertical activity|MP:0004077,abnormal striatum morphology|MP:0004811,abnormal neuron physiology
MGI:1861699	Htt<tm3Mem>	MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype
MGI:3603606	Htt<tm3Szi>	MP:0000350,abnormal cell proliferation|MP:0000352,decreased cell proliferation|MP:0001415,increased exploration in new environment|MP:0003111,abnormal cell nucleus morphology|MP:0003858,enhanced coordination|MP:0005621,abnormal cell physiology|MP:0010768,mortality/aging
MGI:1861934	Htt<tm4Mem>	MP:0000788,abnormal cerebral cortex morphology|MP:0001513,limb grasping|MP:0004077,abnormal striatum morphology|MP:0004191,neuronal intranuclear inclusions|MP:0008462,abnormal medium spiny neuron morphology|MP:0014812,abnormal brain physiology
MGI:3663763	Htt<tm4Szi>	MP:0002085,abnormal embryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0003984,embryonic growth retardation|MP:0006386,absent somites|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:6400708	Htt<tm5Detl>	MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001505,hunched posture|MP:0002797,increased thigmotaxis|MP:0002804,abnormal motor learning|MP:0004077,abnormal striatum morphology|MP:0005386,behavior/neurological phenotype|MP:0010053,decreased grip strength|MP:0010540,long stride length|MP:0011091,prenatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1861935	Htt<tm5Mem>	MP:0000745,tremors|MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0003631,nervous system phenotype|MP:0004077,abnormal striatum morphology|MP:0004191,neuronal intranuclear inclusions|MP:0004924,abnormal behavior|MP:0005386,behavior/neurological phenotype|MP:0008462,abnormal medium spiny neuron morphology|MP:0014812,abnormal brain physiology
MGI:3697905	Htt<tm6Mem>	MP:0001265,decreased body size|MP:0002066,abnormal motor capabilities/coordination/movement
MGI:3697906	Htt<tm7Mem>	MP:0000022,abnormal ear shape|MP:0000024,lowered ear position|MP:0000438,abnormal cranium morphology|MP:0000778,abnormal nervous system tract morphology|MP:0000783,abnormal forebrain morphology|MP:0000787,abnormal telencephalon morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000825,dilated lateral ventricle|MP:0000832,abnormal thalamus morphology|MP:0000897,abnormal midbrain morphology|MP:0001200,thick skin|MP:0004077,abnormal striatum morphology|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0005537,abnormal cerebral aqueduct morphology|MP:0008225,abnormal anterior commissure morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0031442,enlarged cerebral aqueduct
MGI:3697907	Htt<tm8Mem>	MP:0011100,preweaning lethality, complete penetrance
MGI:1861101	hubb	MP:0000611,jaundice|MP:0001147,small testis|MP:0001150,enlarged scrotum|MP:0001156,abnormal spermatogenesis|MP:0001385,pup cannibalization|MP:0001386,abnormal maternal nurturing|MP:0001569,abnormal circulating bilirubin level|MP:0001925,male infertility|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002608,increased hematocrit|MP:0002981,increased liver weight|MP:0003136,yellow coat color|MP:0004952,increased spleen weight|MP:0005159,azoospermia|MP:0005344,increased circulating bilirubin level|MP:0006077,inguinal hernia|MP:0008779,abnormal maternal behavior|MP:0009327,abnormal maternal grooming
MGI:1856910	hug	MP:0001325,abnormal retina morphology|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001921,reduced fertility|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003734,abnormal retina inner plexiform layer morphology|MP:0006069,abnormal retina neuronal layer morphology|MP:0008450,retina photoreceptor degeneration|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0011965,decreased total retina thickness
MGI:5613639	Hunk<tm1b(EUCOMM)Wtsi>	MP:0002110,abnormal digit morphology|MP:0005559,increased circulating glucose level|MP:0009142,decreased prepulse inhibition
MGI:4361146	Hunk<tm1Lach>	MP:0002169,no abnormal phenotype detected
MGI:3583576	Hus1<tm1.1Rsw>	MP:0000928,incomplete rostral neuropore closure|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0002151,abnormal neural tube morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:1927769	Hus1<tm1Led>	MP:0000928,incomplete rostral neuropore closure|MP:0001688,abnormal somite development|MP:0001691,abnormal somite shape|MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001726,abnormal allantois morphology|MP:0002084,abnormal developmental patterning|MP:0002151,abnormal neural tube morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003396,abnormal embryonic hematopoiesis|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0004028,chromosome breakage|MP:0004180,failure of initiation of embryo turning|MP:0004573,absent limb buds|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011204,abnormal visceral yolk sac blood island morphology|MP:0011705,absent fibroblast proliferation|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3869880	Huwe1<Gt(DC0732)Wtsi>	MP:0000433,microcephaly|MP:0001701,incomplete embryo turning|MP:0002188,small heart|MP:0003984,embryonic growth retardation|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4350712	Huwe1<Gt(P036B01)Wrst>	MP:0001685,abnormal endoderm development
MGI:3897892	Huwe1<Gt(P125E01)Wrst>	MP:0001695,abnormal gastrulation|MP:0002084,abnormal developmental patterning
MGI:5314816	Huwe1<tm1.1Mak>	MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002144,abnormal B cell differentiation|MP:0004816,abnormal class switch recombination|MP:0005093,decreased B cell proliferation|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008203,absent B-1a cells|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008498,decreased IgG3 level|MP:0008782,increased B cell apoptosis|MP:0020913,increased susceptibility to Riboviria infection
MGI:5314817	Huwe1<tm1.2Mak>	MP:0000274,enlarged heart|MP:0001698,decreased embryo size|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011732,decreased somite size
MGI:4439480	Huwe1<tm1Alas>	MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000812,abnormal dentate gyrus morphology|MP:0000852,small cerebellum|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002058,neonatal lethality|MP:0002152,abnormal brain morphology|MP:0002660,abnormal caput epididymis morphology|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0004948,abnormal neuronal precursor proliferation|MP:0004980,increased neuronal precursor cell number|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0006254,thin cerebral cortex|MP:0006378,abnormal spermatogonia morphology|MP:0006379,abnormal spermatocyte morphology|MP:0013601,increased testis apoptosis|MP:0014052,increased male germ cell apoptosis|MP:0020362,abnormal male germ cell physiology
MGI:5315772	Huwe1<tm1Wgu>	MP:0000538,abnormal urinary bladder morphology|MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0001762,polyuria|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002727,decreased circulating insulin level|MP:0003339,decreased pancreatic beta cell number|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0009254,disorganized pancreatic islets
MGI:3843777	Hvcn1<Gt(RRN293)Byg>	MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology
MGI:6355949	Hvf	MP:0000063,decreased bone mineral density|MP:0000069,kyphoscoliosis|MP:0000141,abnormal vertebral body morphology|MP:0000160,kyphosis|MP:0000161,scoliosis|MP:0001262,decreased body weight|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003961,decreased lean body mass|MP:0004173,abnormal intervertebral disk morphology|MP:0004600,abnormal vertebral transverse process morphology|MP:0004601,abnormal vertebral spinous process morphology|MP:0004621,lumbar vertebral fusion|MP:0004682,small intervertebral disk|MP:0005376,homeostasis/metabolism phenotype|MP:0014143,decreased body fat mass
MGI:3628942	hvlk	MP:0020916,increased susceptibility to Herpesvirales infection
MGI:5311636	Hw	MP:0001265,decreased body size|MP:0001394,circling|MP:0002080,prenatal lethality|MP:0008770,decreased survivor rate|MP:0009703,decreased birth body size
MGI:2662882	Hwq1<CBA/CaJ>	MP:0002833,increased heart weight
MGI:1861094	Hxd	MP:0009049,abnormal hallux morphology|MP:0009743,preaxial polydactyly|MP:0011091,prenatal lethality, complete penetrance
MGI:2675673	Hxl	MP:0000562,polydactyly
MGI:2675676	Hxl2	MP:0000562,polydactyly
MGI:1856911	hy1	MP:0000432,abnormal head morphology|MP:0000780,abnormal corpus callosum morphology|MP:0000781,decreased corpus callosum size|MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0000849,abnormal cerebellum morphology|MP:0000917,obstructive hydrocephaly|MP:0001353,increased aggression towards mice|MP:0001891,hydrocephaly|MP:0002082,postnatal lethality|MP:0002196,absent corpus callosum|MP:0002200,abnormal brain ventricular system morphology|MP:0002958,cerebral aqueductal stenosis|MP:0006254,thin cerebral cortex|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008770,decreased survivor rate|MP:0008912,nervous|MP:0009027,abnormal subarachnoid space morphology
MGI:1856912	hy2	MP:0001265,decreased body size|MP:0001891,hydrocephaly|MP:0001924,infertility
MGI:2658730	Hyal1<tm1Stn>	MP:0000166,abnormal chondrocyte morphology|MP:0000598,abnormal liver morphology|MP:0003560,osteoarthritis|MP:0003641,small lung|MP:0014429,increased hyaluronic acid level
MGI:3836764	Hyal2<tm1.1Bfla>	MP:0000098,abnormal vomer bone morphology|MP:0000101,absent ethmoid bone|MP:0000445,short snout|MP:0000457,maxilla hypoplasia|MP:0001385,pup cannibalization|MP:0001577,anemia|MP:0002083,premature death|MP:0002640,reticulocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003048,abnormal cervical vertebrae morphology|MP:0003179,thrombocytopenia|MP:0005097,polychromatophilia|MP:0005274,abnormal viscerocranium morphology|MP:0008273,abnormal intramembranous bone ossification|MP:0008770,decreased survivor rate|MP:0008807,increased liver iron level|MP:0008809,increased spleen iron level|MP:0009546,absent gastric milk in neonates|MP:0009652,abnormal palatal rugae morphology|MP:0009655,abnormal secondary palate development|MP:0010030,abnormal orbit morphology|MP:0010375,increased kidney iron level|MP:0010410,cor triatriatum sinistrum|MP:0010701,fusion of atlas and odontoid process|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011615,submucous cleft palate|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0011971,increased circulating lactate dehydrogenase level|MP:0013201,head mesenchyme hyperplasia|MP:0014427,increased circulating hyaluronic acid level|MP:0014429,increased hyaluronic acid level|MP:0021164,oral cleft|MP:0030030,Wormian bones|MP:0030303,small ethmoid bone
MGI:5574596	Hyal3<tm1.1(KOMP)Vlcg>	MP:0001510,abnormal coat appearance|MP:0005560,decreased circulating glucose level
MGI:6108181	Hyal3<tm1Btr>	MP:0002276,abnormal lung interstitium morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0006027,impaired lung alveolus development|MP:0010902,abnormal pulmonary alveolar sac morphology
MGI:5587051	Hyal4<tm2b(EUCOMM)Wtsi>	MP:0003795,abnormal bone structure|MP:0011962,increased cornea thickness
MGI:4398725	Hyal5<tm1Tba>	MP:0005389,reproductive system phenotype
MGI:6718314	Hyal6<em1(IMPC)H>	MP:0001304,cataract|MP:0005293,impaired glucose tolerance|MP:0013278,decreased fasting circulating glucose level
MGI:6361168	Hyal6<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6341927	Hycc1<em1(IMPC)Ccpcz>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000613,abnormal salivary gland morphology|MP:0000618,small salivary gland|MP:0000709,enlarged thymus|MP:0001404,no spontaneous movement|MP:0002311,abnormal inspiratory capacity|MP:0002753,dilated heart left ventricle|MP:0003394,increased cardiac output|MP:0005561,increased mean corpuscular hemoglobin|MP:0005567,decreased circulating total protein level|MP:0005627,increased circulating potassium level|MP:0005634,decreased circulating sodium level|MP:0010067,increased red blood cell distribution width|MP:0010895,increased lung compliance|MP:0011045,decreased lung elastance|MP:0011951,increased cardiac stroke volume|MP:0013279,increased fasting circulating glucose level
MGI:5693960	Hycc1<tm1Vlcg>	MP:0002169,no abnormal phenotype detected|MP:0005386,behavior/neurological phenotype
MGI:3817975	Hydcs1<MSM/Ms>	MP:0001891,hydrocephaly|MP:0011380,enlarged brain ventricles
MGI:1856913	Hydin<hy3>	MP:0000160,kyphosis|MP:0000438,abnormal cranium morphology|MP:0000439,enlarged cranium|MP:0000440,domed cranium|MP:0000743,muscle spasm|MP:0000787,abnormal telencephalon morphology|MP:0000825,dilated lateral ventricle|MP:0000852,small cerebellum|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0001914,hemorrhage|MP:0001925,male infertility|MP:0001947,abnormal mucociliary clearance|MP:0002061,abnormal aggression-related behavior|MP:0002065,abnormal fear/anxiety-related behavior|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002133,abnormal respiratory system physiology|MP:0002653,abnormal ependyma morphology|MP:0002741,small olfactory bulb|MP:0004421,enlarged parietal bone|MP:0005150,cachexia|MP:0005277,abnormal brainstem morphology|MP:0005537,abnormal cerebral aqueduct morphology|MP:0006254,thin cerebral cortex|MP:0009022,abnormal brain meninges morphology|MP:0009804,abnormal brain interventricular foramen morphology|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011059,abnormal ependyma motile cilium morphology|MP:0030029,wide cranial sutures
MGI:2386736	Hydin<hy3-Tg(Bdnf)459Ove>	MP:0000434,megacephaly|MP:0001265,decreased body size|MP:0001891,hydrocephaly|MP:0001947,abnormal mucociliary clearance|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011056,abnormal brain ependyma motile cilium morphology|MP:0011069,abnormal brain ependyma motile cilium physiology|MP:0011085,postnatal lethality, complete penetrance|MP:0011380,enlarged brain ventricles
MGI:3801608	Hydin<hyrh>	MP:0000440,domed cranium|MP:0001265,decreased body size|MP:0001867,rhinitis|MP:0001891,hydrocephaly|MP:0002082,postnatal lethality|MP:0003644,thymus atrophy
MGI:5573166	hydro	MP:0000063,decreased bone mineral density|MP:0000065,abnormal bone marrow cavity morphology|MP:0000195,decreased circulating calcium level|MP:0000519,hydronephrosis|MP:0001566,increased circulating phosphate level|MP:0002764,short tibia|MP:0003109,short femur|MP:0003797,abnormal compact bone morphology|MP:0004991,decreased bone strength|MP:0004993,decreased bone resorption|MP:0005390,skeleton phenotype|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0010968,decreased compact bone area|MP:0010971,abnormal periosteum morphology|MP:0020040,decreased bone ossification
MGI:6156495	Hyls1<em1(IMPC)Tcp>	MP:0000269,abnormal heart looping|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0003984,embryonic growth retardation|MP:0004357,long tibia|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0011953,prolonged PQ interval|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5286659	Hyou1<Tg(Tyr)2422BOve>	MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:3046998	Hyou1<tm1Oga>	MP:0003076,increased susceptibility to ischemic brain injury|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0011091,prenatal lethality, complete penetrance|MP:0013219,abnormal substantia nigra pars compacta morphology
MGI:2664816	Hypch<NZO/HlBom>	MP:0005178,increased circulating cholesterol level
MGI:3511256	Hyplip2<MRL/MpJ>	MP:0000186,decreased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005317,increased triglyceride level|MP:0005338,atherosclerotic lesions
MGI:3843359	Hypn2<C57BL/6>	MP:0002079,increased circulating insulin level
MGI:3843365	Hypn3<C57BL/6>	MP:0002079,increased circulating insulin level
MGI:2663486	Hypn<C57BL/6>	MP:0002079,increased circulating insulin level
MGI:2682420	Hypt<BPL/1J>	MP:0000231,hypertension
MGI:1861149	Iac	MP:0000438,abnormal cranium morphology|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001319,irregularly shaped pupil|MP:0002083,premature death|MP:0002100,abnormal tooth morphology|MP:0002638,abnormal pupillary reflex|MP:0005262,coloboma|MP:0006241,abnormal placement of pupils|MP:0011100,preweaning lethality, complete penetrance
MGI:6456042	Iah1<em1Kobam>	MP:0005370,liver/biliary system phenotype
MGI:5574600	Iah1<tm1b(EUCOMM)Hmgu>	MP:0002966,decreased circulating alkaline phosphatase level|MP:0003233,prolonged QT interval|MP:0009141,increased prepulse inhibition|MP:0009298,increased mesenteric fat pad weight|MP:0010570,prolonged ST segment
MGI:2656235	Iapp<tm1Sgm>	MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0001260,increased body weight|MP:0002079,increased circulating insulin level|MP:0004016,decreased bone mass|MP:0004984,increased osteoclast cell number|MP:0004992,increased bone resorption|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype
MGI:7493276	Iars1<em2Nsas>	MP:0001262,decreased body weight|MP:0005266,abnormal metabolism|MP:0005370,liver/biliary system phenotype|MP:0009355,increased liver triglyceride level|MP:0031116,microvesicular hepatic steatosis
MGI:6156430	Iars2<em1(IMPC)Tcp>	MP:0002092,abnormal eye morphology|MP:0002608,increased hematocrit|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:3574494	Ibdq1<SAMP1/YitFcs>	MP:0002581,abnormal ileum morphology|MP:0009482,ileum inflammation
MGI:3655693	Ibdq2<SAMP1/YitFcs>	MP:0003306,small intestinal inflammation
MGI:3796255	Ibsp<tm1Jeau>	MP:0000085,large anterior fontanelle|MP:0000120,malocclusion|MP:0000130,abnormal trabecular bone morphology|MP:0000458,abnormal mandible morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002689,abnormal molar morphology|MP:0002896,abnormal bone mineralization|MP:0002998,abnormal bone remodeling|MP:0003109,short femur|MP:0003420,delayed intramembranous bone ossification|MP:0003668,abnormal periodontal ligament morphology|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0004985,decreased osteoclast cell number|MP:0004986,abnormal osteoblast morphology|MP:0004989,decreased osteoblast cell number|MP:0004992,increased bone resorption|MP:0005358,abnormal incisor morphology|MP:0005382,craniofacial phenotype|MP:0005390,skeleton phenotype|MP:0009346,decreased trabecular bone thickness|MP:0010743,delayed cranial suture closure|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0010924,abnormal osteoid morphology|MP:0010929,increased osteoid thickness|MP:0011165,abnormal tooth root development|MP:0013624,decreased femur compact bone thickness|MP:0013631,decreased bone trabecular spacing|MP:0020010,decreased bone mineral density of femur|MP:0030131,abnormal periodontium morphology|MP:0030351,wide coronal suture|MP:0030357,wide lambdoid suture|MP:0030393,delayed fontanelle closure|MP:0030452,abnormal cementum mineralization|MP:0030466,alveolar process atrophy|MP:0030494,abnormal molar root morphology|MP:0030516,abnormal junctional epithelium morphology|MP:0030524,abnormal tooth root resorption|MP:0030541,misaligned incisors|MP:0030545,abnormal acellular cementum morphology
MGI:6358629	Ibtk<em1(IMPC)Hmgu>	MP:0002965,increased circulating serum albumin level
MGI:4129389	Ibtk<Gt(XF224)Byg>	MP:0005387,immune system phenotype|MP:0009333,abnormal splenocyte physiology
MGI:5806150	Ica1l<em1Jxia>	MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0009232,abnormal sperm nucleus morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology
MGI:6120743	Ica1l<tm1b(EUCOMM)Hmgu>	MP:0000274,enlarged heart|MP:0002092,abnormal eye morphology|MP:0009476,enlarged cecum
MGI:5696937	Ica1<tm1b(EUCOMM)Wtsi>	MP:0000494,abnormal cecum morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001402,decreased locomotor activity|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0009476,enlarged cecum
MGI:2662437	Ica1<tm1Mdos>	MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002444,abnormal T cell physiology|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005389,reproductive system phenotype
MGI:3605161	Icam1<tm1Alb>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0003627,abnormal leukocyte tethering or rolling|MP:0003628,abnormal leukocyte adhesion
MGI:1857183	Icam1<tm1Bay>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0001260,increased body weight|MP:0001325,abnormal retina morphology|MP:0001790,abnormal immune system physiology|MP:0002083,premature death|MP:0002792,abnormal retina vasculature morphology|MP:0003091,abnormal cell migration|MP:0003156,abnormal leukocyte migration|MP:0003304,large intestinal inflammation|MP:0003434,decreased susceptibility to induced choroidal neovascularization|MP:0003627,abnormal leukocyte tethering or rolling|MP:0003721,increased tumor growth/size|MP:0003957,abnormal nitric oxide homeostasis|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005253,abnormal eye physiology|MP:0005387,immune system phenotype|MP:0005559,increased circulating glucose level|MP:0005602,decreased angiogenesis|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0005621,abnormal cell physiology|MP:0008539,decreased susceptibility to induced colitis|MP:0008719,impaired neutrophil recruitment|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009858,abnormal cellular extravasation|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality
MGI:3588437	Icam1<tm1Cws>	MP:0002446,abnormal macrophage morphology
MGI:1857292	Icam1<tm1Jcgr>	MP:0000219,increased neutrophil cell number|MP:0002444,abnormal T cell physiology|MP:0002972,abnormal cardiac muscle contractility|MP:0005013,increased lymphocyte cell number|MP:0005387,immune system phenotype|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:2682009	Icam2<tm1Jcgr>	MP:0001952,increased airway responsiveness|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002465,abnormal eosinophil physiology
MGI:3806488	Icam4<tm1Jach>	MP:0000245,abnormal erythropoiesis|MP:0005397,hematopoietic system phenotype
MGI:6153368	Icam5<em1(IMPC)Wtsi>	MP:0002098,abnormal vibrissa morphology
MGI:3042494	Icam5<tm1(cre)Mmsh>	MP:0002063,abnormal learning/memory/conditioning|MP:0002634,abnormal sensorimotor gating|MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype
MGI:2156447	Ichs<C57BL/6J>	MP:0002531,abnormal type I hypersensitivity reaction
MGI:2156448	Ichs<C57BL/6JOlaHsd>	MP:0002531,abnormal type I hypersensitivity reaction
MGI:2183607	Icmt<tm1Hzo>	MP:0000596,abnormal liver development|MP:0000597,delayed hepatic development|MP:0001698,decreased embryo size|MP:0002123,abnormal definitive hematopoiesis|MP:0003717,pallor|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011877,absent liver|MP:0012235,abnormal liver bud morphology|MP:0012504,increased forebrain apoptosis|MP:0012505,increased neural tube apoptosis
MGI:3033709	Icmt<tm1Mbrg>	MP:0000352,decreased cell proliferation|MP:0002090,abnormal vision|MP:0002169,no abnormal phenotype detected|MP:0006069,abnormal retina neuronal layer morphology|MP:0008450,retina photoreceptor degeneration|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:2680650	Icmt<tm1Sgy>	MP:0001265,decreased body size|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2683493	Icosl<tm1Cdon>	MP:0000692,small spleen|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002145,abnormal T cell differentiation|MP:0002490,abnormal immunoglobulin level|MP:0002492,decreased IgE level|MP:0005466,abnormal T-helper 2 physiology|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008568,abnormal interleukin secretion|MP:0008750,abnormal interferon level
MGI:2673557	Icosl<tm1Kplm>	MP:0001800,abnormal humoral immune response|MP:0001807,decreased IgA level|MP:0002359,abnormal spleen germinal center morphology|MP:0002723,abnormal immune serum protein physiology|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008566,increased interferon-gamma secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008700,decreased interleukin-4 secretion
MGI:2669961	Icosl<tm1Mak>	MP:0000689,abnormal spleen morphology|MP:0001790,abnormal immune system physiology|MP:0001876,decreased inflammatory response|MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008482,decreased spleen germinal center number|MP:0008484,decreased spleen germinal center size|MP:0008495,decreased IgG1 level
MGI:4415349	Icos<tm1.1Wks>	MP:0000689,abnormal spleen morphology|MP:0001790,abnormal immune system physiology|MP:0001807,decreased IgA level|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002458,abnormal B cell number|MP:0002459,abnormal B cell physiology|MP:0004816,abnormal class switch recombination|MP:0004942,abnormal B cell selection|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008135,small Peyer's patches|MP:0008482,decreased spleen germinal center number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008700,decreased interleukin-4 secretion|MP:0008897,decreased IgG2c level|MP:0009058,decreased interleukin-21 secretion
MGI:3719635	Icos<tm1Dgry>	MP:0000217,abnormal leukocyte cell number|MP:0001790,abnormal immune system physiology|MP:0001805,decreased IgG level|MP:0002444,abnormal T cell physiology|MP:0005025,abnormal response to infection|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008093,abnormal memory B cell number|MP:0008097,increased plasma cell number|MP:0008098,decreased plasma cell number|MP:0008178,decreased germinal center B cell number|MP:0008568,abnormal interleukin secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion
MGI:2683635	Icos<tm1Flv>	MP:0001805,decreased IgG level|MP:0002217,small lymph nodes|MP:0002490,abnormal immunoglobulin level|MP:0002492,decreased IgE level|MP:0002870,decreased anti-insulin autoantibody level|MP:0003009,abnormal cytokine secretion|MP:0003726,decreased autoantibody level|MP:0004031,insulitis|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005018,decreased T cell number|MP:0005379,endocrine/exocrine gland phenotype|MP:0005387,immune system phenotype|MP:0005466,abnormal T-helper 2 physiology|MP:0008495,decreased IgG1 level|MP:0008567,decreased interferon-gamma secretion|MP:0008750,abnormal interferon level|MP:0008751,abnormal interleukin level|MP:0009168,decreased pancreatic islet number
MGI:2445839	Icos<tm1Mak>	MP:0000689,abnormal spleen morphology|MP:0001790,abnormal immune system physiology|MP:0001807,decreased IgA level|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002444,abnormal T cell physiology|MP:0002458,abnormal B cell number|MP:0002459,abnormal B cell physiology|MP:0002492,decreased IgE level|MP:0004816,abnormal class switch recombination|MP:0005095,decreased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008135,small Peyer's patches|MP:0008482,decreased spleen germinal center number|MP:0008484,decreased spleen germinal center size|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008897,decreased IgG2c level|MP:0009058,decreased interleukin-21 secretion
MGI:2683665	Icos<tm1Shr>	MP:0001805,decreased IgG level|MP:0002145,abnormal T cell differentiation|MP:0002359,abnormal spleen germinal center morphology|MP:0002490,abnormal immunoglobulin level|MP:0002492,decreased IgE level|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008502,increased IgG3 level|MP:0008751,abnormal interleukin level
MGI:3526880	Icos<tm1Tkan>	MP:0000496,abnormal small intestine morphology|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0008135,small Peyer's patches|MP:0008578,decreased circulating interferon-gamma level|MP:0008603,decreased circulating interleukin-4 level|MP:0010766,abnormal NK cell physiology
MGI:5804645	Icos<tm2b(EUCOMM)Wtsi>	MP:0002764,short tibia
MGI:7461545	Id1<em1(IMPC)Kmpc>	MP:0001399,hyperactivity|MP:0002764,short tibia|MP:0010067,increased red blood cell distribution width
MGI:3831561	Id1<tm1Xhsu>	MP:0004810,decreased hematopoietic stem cell number
MGI:2679939	Id1<tm1Zhu>	MP:0000061,fragile skeleton|MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0001175,abnormal lung morphology|MP:0001265,decreased body size|MP:0001273,decreased metastatic potential|MP:0001601,abnormal myelopoiesis|MP:0002397,abnormal bone marrow morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002875,decreased erythrocyte cell number|MP:0003070,increased vascular permeability|MP:0003179,thrombocytopenia|MP:0003447,decreased tumor growth/size|MP:0003631,nervous system phenotype|MP:0004810,decreased hematopoietic stem cell number|MP:0004984,increased osteoclast cell number|MP:0004991,decreased bone strength|MP:0005016,decreased lymphocyte cell number|MP:0005367,renal/urinary system phenotype|MP:0005369,muscle phenotype|MP:0005370,liver/biliary system phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0006050,pulmonary fibrosis|MP:0008396,abnormal osteoclast differentiation|MP:0009346,decreased trabecular bone thickness|MP:0010124,decreased bone mineral content|MP:0010373,myeloid hyperplasia|MP:0010537,tumor regression|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0010768,mortality/aging|MP:0010876,decreased bone volume|MP:0011140,decreased lung endothelial cell proliferation|MP:0011141,increased lung endothelial cell apoptosis|MP:0020321,increased vascular endothelial cell apoptosis
MGI:3806370	Id2<tm1Ago>	MP:0001265,decreased body size|MP:0001783,decreased white adipose tissue amount|MP:0005076,abnormal cell differentiation|MP:0005375,adipose tissue phenotype|MP:0008024,absent lymph nodes|MP:0008046,absent NK cells|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0009293,decreased inguinal fat pad weight|MP:0009295,decreased interscapular fat pad weight|MP:0011085,postnatal lethality, complete penetrance
MGI:5486127	Id2<tm1Gtbz>	MP:0002169,no abnormal phenotype detected
MGI:3838359	Id2<tm1Mais>	MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001790,abnormal immune system physiology|MP:0001882,abnormal lactation|MP:0003961,decreased lean body mass|MP:0008770,decreased survivor rate|MP:0020472,arrhythmic circadian behavior persistence|MP:0020473,abnormal circadian behavior phase
MGI:3830733	Id2<tm1Mcha>	MP:0000819,abnormal olfactory bulb morphology|MP:0001984,abnormal olfaction|MP:0002741,small olfactory bulb|MP:0003244,loss of dopaminergic neurons|MP:0003424,premature neuronal precursor differentiation|MP:0003631,nervous system phenotype|MP:0004279,abnormal rostral migratory stream morphology|MP:0004948,abnormal neuronal precursor proliferation
MGI:2384134	Id2<tm1Yyk>	MP:0000519,hydronephrosis|MP:0000526,small inner medullary pyramid|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001882,abnormal lactation|MP:0002219,decreased lymph node number|MP:0002379,abnormal oropharyngeal lymphoid tissue morphology|MP:0002831,absent Peyer's patches|MP:0003622,ischuria|MP:0005386,behavior/neurological phenotype|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0008024,absent lymph nodes|MP:0008040,decreased NK T cell number|MP:0008045,decreased NK cell number|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0009485,distended ileum|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011487,abnormal ureteropelvic junction morphology|MP:0011490,ureteropelvic junction stenosis|MP:0011503,distended jejunum
MGI:5486129	Id2<tm2.1Gtbz>	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:5796939	Id2<tm2b(EUCOMM)Wtsi>	MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level
MGI:6423846	Id3<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000774,decreased brain size|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001297,microphthalmia|MP:0001314,cornea opacity|MP:0001488,increased startle reflex|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002599,increased mean platelet volume|MP:0002989,small kidney|MP:0004952,increased spleen weight|MP:0009142,decreased prepulse inhibition|MP:0010067,increased red blood cell distribution width|MP:0010097,abnormal retina blood vessel morphology|MP:0020421,increased freezing behavior
MGI:3046425	Id3<tm1Cmu>	MP:0002145,abnormal T cell differentiation|MP:0002408,abnormal double-positive T cell morphology
MGI:4441450	Id3<tm1Pzg>	MP:0002169,no abnormal phenotype detected
MGI:2679967	Id3<tm1Zhu>	MP:0000623,decreased salivation|MP:0001346,abnormal lacrimal gland morphology|MP:0001870,salivary gland inflammation|MP:0002092,abnormal eye morphology|MP:0002145,abnormal T cell differentiation|MP:0002444,abnormal T cell physiology|MP:0002460,decreased immunoglobulin level|MP:0003725,increased autoantibody level|MP:0005093,decreased B cell proliferation|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0008880,lacrimal gland inflammation|MP:0020220,decreased tear production
MGI:5305600	Id3<tm2.1Cmu>	MP:0000715,decreased thymocyte number|MP:0005014,increased B cell number|MP:0008346,increased gamma-delta T cell number|MP:0010186,increased T follicular helper cell number
MGI:5009711	Id3<tm2.1Zhu>	MP:0000623,decreased salivation|MP:0002145,abnormal T cell differentiation|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008346,increased gamma-delta T cell number|MP:0008879,submandibular gland inflammation|MP:0010835,increased CD4-positive, alpha-beta memory T cell number|MP:0010838,increased CD8-positive, alpha-beta memory T cell number|MP:0013367,parotid gland inflammation
MGI:3579084	Id4<tm1Fsky>	MP:0000774,decreased brain size|MP:0000790,abnormal stratification in cerebral cortex|MP:0000808,abnormal hippocampus development|MP:0000823,abnormal lateral ventricle morphology|MP:0000913,abnormal brain development|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology|MP:0003232,abnormal forebrain development|MP:0003424,premature neuronal precursor differentiation|MP:0003795,abnormal bone structure|MP:0004276,abnormal medial ganglionic eminence morphology|MP:0004277,abnormal lateral ganglionic eminence morphology|MP:0004986,abnormal osteoblast morphology|MP:0005390,skeleton phenotype|MP:0006007,abnormal basal ganglion morphology|MP:0006395,abnormal epiphyseal plate morphology|MP:0008547,abnormal neocortex morphology|MP:0009115,abnormal fat cell morphology|MP:0009937,abnormal neuron differentiation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization
MGI:3505549	Id4<tm1Mais>	MP:0000774,decreased brain size|MP:0000785,telencephalon hypoplasia|MP:0000787,abnormal telencephalon morphology|MP:0000808,abnormal hippocampus development|MP:0001402,decreased locomotor activity|MP:0008547,abnormal neocortex morphology|MP:0009937,abnormal neuron differentiation|MP:0013908,small lateral ventricles
MGI:5645961	Id4<tm1Vdr>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0001126,abnormal ovary morphology|MP:0001130,abnormal ovarian folliculogenesis|MP:0003371,decreased circulating estrogen level|MP:0004905,decreased uterus weight|MP:0005181,decreased circulating estradiol level|MP:0008870,increased mature ovarian follicle number|MP:0011128,increased tertiary ovarian follicle number|MP:0013609,abnormal ovarian medulla morphology|MP:0013778,abnormal mammary gland myoepithelium morphology|MP:0013781,abnormal mammary gland luminal epithelium morphology|MP:0031239,increased atretic ovarian follicle number|MP:0031383,increased secondary ovarian follicle number
MGI:1861620	Idc	MP:0000373,belly spot|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001307,fused cornea and lens|MP:0001314,cornea opacity|MP:0001317,abnormal pupil morphology|MP:0001322,abnormal iris morphology|MP:0002083,premature death|MP:0002638,abnormal pupillary reflex|MP:0002794,lenticonus|MP:0005251,blepharitis|MP:0010263,total cataract|MP:0011100,preweaning lethality, complete penetrance
MGI:3038849	Idd10<C57BL/10SnJ>	MP:0002078,abnormal glucose homeostasis
MGI:3038835	Idd10<C57BL/6J>	MP:0002078,abnormal glucose homeostasis
MGI:3582438	Idd10<IIS/Shi>	MP:0002078,abnormal glucose homeostasis
MGI:3036810	Idd11<NOD/ShiLt>	MP:0002078,abnormal glucose homeostasis
MGI:3036813	Idd12<NOD/ShiLt>	MP:0002078,abnormal glucose homeostasis
MGI:3036815	Idd13<NOD/ShiLt>	MP:0003009,abnormal cytokine secretion|MP:0008042,abnormal NK T cell physiology
MGI:3036816	Idd13<NOR/Lt>	MP:0002078,abnormal glucose homeostasis
MGI:3036817	Idd14<NOD/ShiLt>	MP:0002078,abnormal glucose homeostasis
MGI:3036819	Idd15<NOD/ShiLt>	MP:0002078,abnormal glucose homeostasis
MGI:3579888	Idd16.1<ALR/LtJ>	MP:0001869,pancreas inflammation|MP:0002078,abnormal glucose homeostasis
MGI:3525333	Idd16<C57BL/6J>	MP:0002078,abnormal glucose homeostasis
MGI:2683526	Idd16<NOD/ShiLt>	MP:0002078,abnormal glucose homeostasis
MGI:3036822	Idd17<C57BL/10SnJ>	MP:0002078,abnormal glucose homeostasis
MGI:3038848	Idd17<C57BL/6J>	MP:0002078,abnormal glucose homeostasis
MGI:3036825	Idd19<NOD/ShiLt>	MP:0002078,abnormal glucose homeostasis
MGI:3036826	Idd19<PWK>	MP:0002078,abnormal glucose homeostasis
MGI:3036659	Idd1<NOD/ShiLt>	MP:0002078,abnormal glucose homeostasis
MGI:3037293	Idd1<NOD/Uf>	MP:0005580,periinsulitis|MP:0008074,increased CD4-positive, alpha-beta T cell number
MGI:2156392	Idd20<C3H/HeJ>	MP:0005376,homeostasis/metabolism phenotype
MGI:3606920	Idd21.1<ABH>	MP:0002078,abnormal glucose homeostasis
MGI:3606922	Idd21.2<ABH>	MP:0002078,abnormal glucose homeostasis
MGI:3606924	Idd21.3<ABH>	MP:0002078,abnormal glucose homeostasis
MGI:3033068	Idd21<NOD>	MP:0002078,abnormal glucose homeostasis
MGI:3525335	Idd23<C57BL/6J>	MP:0002078,abnormal glucose homeostasis
MGI:3603354	Idd25<NOR/Lt>	MP:0002078,abnormal glucose homeostasis
MGI:3603356	Idd26<NOR/Lt>	MP:0002078,abnormal glucose homeostasis
MGI:3036662	Idd2<NOD/Smrf>	MP:0008074,increased CD4-positive, alpha-beta T cell number
MGI:3037558	Idd2<NON/ShiLtJ>	MP:0002078,abnormal glucose homeostasis
MGI:3623817	Idd3<129S6/SvEvTac>	MP:0002078,abnormal glucose homeostasis
MGI:3764460	Idd3<A/J>	MP:0004803,increased susceptibility to autoimmune diabetes
MGI:2389019	Idd3<C57BL/6>	MP:0002078,abnormal glucose homeostasis|MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:3764464	Idd3<CAST/EiJ>	MP:0004803,increased susceptibility to autoimmune diabetes
MGI:3764466	Idd3<CZECHI/EiJ>	MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:2389018	Idd3<NOD>	MP:0001869,pancreas inflammation|MP:0002078,abnormal glucose homeostasis
MGI:3764462	Idd3<SWR/J>	MP:0004803,increased susceptibility to autoimmune diabetes
MGI:3702140	Idd4.3<C57L>	MP:0002451,abnormal macrophage physiology|MP:0003009,abnormal cytokine secretion|MP:0004803,increased susceptibility to autoimmune diabetes
MGI:3036666	Idd4<C57BL/6>	MP:0005348,increased T cell proliferation
MGI:3036665	Idd4<C57BL/6J>	MP:0001869,pancreas inflammation|MP:0002078,abnormal glucose homeostasis
MGI:3037298	Idd4<MSM>	MP:0002078,abnormal glucose homeostasis
MGI:3036664	Idd4<NOD>	MP:0002078,abnormal glucose homeostasis|MP:0003009,abnormal cytokine secretion|MP:0008040,decreased NK T cell number
MGI:3582441	Idd4<NOD/Jsd>	MP:0001869,pancreas inflammation|MP:0002078,abnormal glucose homeostasis
MGI:3582442	Idd4<NOR/LtJ>	MP:0001869,pancreas inflammation|MP:0002078,abnormal glucose homeostasis
MGI:3036875	Idd5.1<C57BL/10SnJ>	MP:0002078,abnormal glucose homeostasis
MGI:2158432	Idd5.1<C57BL/6J>	MP:0002078,abnormal glucose homeostasis
MGI:2158433	Idd5.1<NOD>	MP:0002078,abnormal glucose homeostasis
MGI:3036879	Idd5.2<C57BL/10SnJ>	MP:0002078,abnormal glucose homeostasis
MGI:2389017	Idd5<NOD>	MP:0002078,abnormal glucose homeostasis
MGI:3037291	Idd5<NOD/Uf>	MP:0005580,periinsulitis
MGI:3582459	Idd5<NOR/LtJ>	MP:0002078,abnormal glucose homeostasis
MGI:3711828	Idd6.1<C3H/HeJ>	MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:3711830	Idd6.2<C3H/HeJ>	MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0008045,decreased NK cell number
MGI:3710090	Idd6.2<NOD>	MP:0002145,abnormal T cell differentiation
MGI:3711832	Idd6.3<C3H/HeJ>	MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:3037121	Idd6<C3H/HeJ>	MP:0008045,decreased NK cell number|MP:0008567,decreased interferon-gamma secretion|MP:0008700,decreased interleukin-4 secretion
MGI:3036668	Idd6<C57BL/6>	MP:0001648,abnormal apoptosis
MGI:3582432	Idd6<C57BL/6JOrl>	MP:0002078,abnormal glucose homeostasis
MGI:3036667	Idd6<NOD>	MP:0005095,decreased T cell proliferation|MP:0006043,decreased apoptosis|MP:0010766,abnormal NK cell physiology
MGI:3037120	Idd6<NOD/ShiLt>	MP:0002078,abnormal glucose homeostasis
MGI:3037592	Idd6<NON/ShiLtJ>	MP:0002078,abnormal glucose homeostasis
MGI:3036765	Idd7<NOD/ShiLt>	MP:0002078,abnormal glucose homeostasis|MP:0005002,abnormal T cell clonal deletion
MGI:3036776	Idd8<NOD/ShiLt>	MP:0002078,abnormal glucose homeostasis
MGI:3036805	Idd9.1<C57BL/10SnJ>	MP:0002078,abnormal glucose homeostasis|MP:0008039,increased NK T cell number
MGI:3036807	Idd9.2<C57BL/10SnJ>	MP:0002078,abnormal glucose homeostasis
MGI:3036809	Idd9.3<C57BL/10SnJ>	MP:0002078,abnormal glucose homeostasis
MGI:3036800	Idd9<C57BL/10SnJ>	MP:0002078,abnormal glucose homeostasis
MGI:3582456	Idd9<NOD/Jsd>	MP:0001869,pancreas inflammation
MGI:3037574	Idd9<NOD/ShiLt>	MP:0002078,abnormal glucose homeostasis
MGI:3582457	Idd9<NOR/LtJ>	MP:0001869,pancreas inflammation
MGI:3530576	Ide<Gt(OST132429)Lex>	MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0003329,amyloid beta deposits|MP:0005293,impaired glucose tolerance
MGI:4431946	Ide<tm1a(EUCOMM)Wtsi>	MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0001153,small seminiferous tubules|MP:0001262,decreased body weight|MP:0002074,abnormal hair texture|MP:0002833,increased heart weight|MP:0002942,decreased circulating alanine transaminase level|MP:0003674,oxidative stress|MP:0004852,decreased testis weight|MP:0005179,decreased circulating cholesterol level|MP:0005358,abnormal incisor morphology|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0005632,decreased circulating aspartate transaminase level|MP:0008806,increased circulating amylase level|MP:0009325,necrospermia|MP:0010025,decreased total body fat amount|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0013601,increased testis apoptosis
MGI:5513791	Idh1<tm1b(EUCOMM)Wtsi>	MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5438251	Idh1<tm1Mak>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000333,decreased bone marrow cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002414,abnormal myeloblast morphology/development|MP:0002874,decreased hemoglobin content|MP:0004809,increased hematopoietic stem cell number|MP:0005017,decreased B cell number|MP:0005397,hematopoietic system phenotype|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008813,decreased common myeloid progenitor cell number|MP:0009278,abnormal bone marrow cell physiology|MP:0009642,abnormal blood homeostasis
MGI:5438253	Idh1<tm2Mak>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000333,decreased bone marrow cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002414,abnormal myeloblast morphology/development|MP:0002874,decreased hemoglobin content|MP:0004809,increased hematopoietic stem cell number|MP:0005017,decreased B cell number|MP:0005397,hematopoietic system phenotype|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008813,decreased common myeloid progenitor cell number|MP:0009278,abnormal bone marrow cell physiology|MP:0009642,abnormal blood homeostasis
MGI:5635887	Idh1<tm3Mak>	MP:0000163,abnormal cartilage morphology|MP:0000164,abnormal cartilage development|MP:0001265,decreased body size|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012514,pectus excavatum
MGI:5548944	Idh2<tm1b(EUCOMM)Hmgu>	MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content
MGI:5578147	Idh2<tm1Jwpk>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000141,abnormal vertebral body morphology|MP:0000160,kyphosis|MP:0003447,decreased tumor growth/size|MP:0003674,oxidative stress|MP:0004174,abnormal spine curvature|MP:0004703,abnormal vertebral column morphology|MP:0004984,increased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0009346,decreased trabecular bone thickness|MP:0010144,abnormal tumor vascularization|MP:0010639,abnormal tumor pathology|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0013630,increased bone trabecular spacing
MGI:6336121	Idh3a<em1(IMPC)Kmpc>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6355402	Idh3a<em1Jkn>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5792025	Idh3a<mpc201H>	MP:0006149,decreased visual acuity|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:5904256	Idh3b<em1(IMPC)J>	MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001925,male infertility|MP:0002574,increased vertical activity
MGI:6355403	Idh3b<em1Jkn>	MP:0005380,embryo phenotype|MP:0005391,vision/eye phenotype
MGI:6257659	Idh3g<em1(IMPC)Bay>	MP:0000689,abnormal spleen morphology
MGI:5696924	Idi1<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5429894	Idnk<tm1Lex>	MP:0009456,impaired cued conditioning behavior|MP:0020220,decreased tear production
MGI:5775113	Ido1<tm1.1Mkks>	MP:0001613,abnormal vasodilation|MP:0002842,increased systemic arterial blood pressure|MP:0002962,increased urine protein level|MP:0003699,abnormal female reproductive system physiology|MP:0005325,abnormal renal glomerulus morphology|MP:0005333,decreased heart rate|MP:0009661,abnormal pregnancy
MGI:3505776	Ido1<tm1Alm>	MP:0000221,decreased leukocyte cell number|MP:0002376,abnormal dendritic cell physiology|MP:0002446,abnormal macrophage morphology|MP:0002451,abnormal macrophage physiology|MP:0002660,abnormal caput epididymis morphology|MP:0003009,abnormal cytokine secretion|MP:0003596,epididymis inflammation|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0006035,abnormal mitochondrial morphology|MP:0008260,abnormal autophagy|MP:0008469,abnormal protein level|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008705,increased interleukin-6 secretion|MP:0008713,abnormal cytokine level|MP:0008872,abnormal physiological response to xenobiotic|MP:0009233,enlarged sperm head|MP:0009236,pinhead sperm|MP:0009243,hairpin sperm flagellum|MP:0009642,abnormal blood homeostasis|MP:0010959,abnormal oxidative phosphorylation|MP:0011629,decreased mitochondrial number|MP:0014046,abnormal mitophagy|MP:0030603,increased sperm number
MGI:7579075	Ido2<em1Lamn>	MP:0005616,decreased susceptibility to type IV hypersensitivity reaction
MGI:7579076	Ido2<em2Lamn>	MP:0005616,decreased susceptibility to type IV hypersensitivity reaction
MGI:5588193	Ido2<tm1.2Gcp>	MP:0002006,neoplasm|MP:0004946,abnormal regulatory T cell physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion
MGI:6474226	Ids<tm1Dkji>	MP:0000414,alopecia|MP:0000443,abnormal snout morphology|MP:0001259,abnormal body weight|MP:0001402,decreased locomotor activity|MP:0002083,premature death|MP:0002855,abnormal cochlear ganglion morphology|MP:0003172,abnormal lysosome physiology|MP:0003743,abnormal facial morphology|MP:0004288,abnormal spiral ligament morphology|MP:0004308,abnormal basilar membrane morphology|MP:0006018,abnormal tympanic membrane morphology|MP:0006021,abnormal Reissner membrane morphology|MP:0009840,abnormal foam cell morphology|MP:0011473,increased urine glycosaminoglycan level|MP:0011475,abnormal glycosaminoglycan level|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0030068,large face|MP:0030074,coarse facial features|MP:0030410,middle ear effusion|MP:0030808,abnormal hindlimb joint morphology|MP:0030811,abnormal hand joint morphology
MGI:5439833	Ids<tm1Eto>	MP:0000367,abnormal coat/ hair morphology|MP:0001296,macrophthalmia|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0003795,abnormal bone structure|MP:0008025,brain vacuoles|MP:0008428,abnormal spatial working memory|MP:0009877,exostosis|MP:0030074,coarse facial features|MP:0030188,round snout
MGI:3625122	Ids<tm1Muen>	MP:0000062,increased bone mineral density|MP:0000074,abnormal neurocranium morphology|MP:0000137,abnormal vertebrae morphology|MP:0000414,alopecia|MP:0000438,abnormal cranium morphology|MP:0000458,abnormal mandible morphology|MP:0000539,distended urinary bladder|MP:0000955,abnormal spinal cord morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0002083,premature death|MP:0002110,abnormal digit morphology|MP:0002152,abnormal brain morphology|MP:0002176,increased brain weight|MP:0002339,abnormal lymph node morphology|MP:0002832,coarse hair|MP:0002882,abnormal neuron morphology|MP:0002932,abnormal joint morphology|MP:0002936,joint swelling|MP:0002981,increased liver weight|MP:0002997,enlarged seminal vesicle|MP:0003172,abnormal lysosome physiology|MP:0003917,increased kidney weight|MP:0004214,abnormal long bone diaphysis morphology|MP:0004851,increased testis weight|MP:0004928,increased epididymis weight|MP:0004952,increased spleen weight|MP:0005059,lysosomal protein accumulation|MP:0005270,abnormal zygomatic bone morphology|MP:0005277,abnormal brainstem morphology|MP:0005298,abnormal clavicle morphology|MP:0005422,osteosclerosis|MP:0005503,abnormal tendon morphology|MP:0005508,abnormal skeleton morphology|MP:0005630,increased lung weight|MP:0008151,increased diameter of long bones|MP:0008525,decreased cranium height|MP:0009250,abnormal appendicular skeleton morphology|MP:0009728,abnormal calcaneum morphology|MP:0010123,increased bone mineral content|MP:0011473,increased urine glycosaminoglycan level|MP:0011475,abnormal glycosaminoglycan level|MP:0020039,increased bone ossification|MP:0020169,increased thyroid gland weight|MP:0030189,broad snout|MP:0030316,enlarged neurocranium|MP:0030776,calcified calcaneal tendon|MP:0030808,abnormal hindlimb joint morphology|MP:0030863,decreased joint mobility
MGI:7438343	Idua<em1(IMPC)Hmgu>	MP:0000443,abnormal snout morphology|MP:0000745,tremors|MP:0001200,thick skin|MP:0001312,abnormal cornea morphology|MP:0001325,abnormal retina morphology|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0004738,abnormal auditory brainstem response|MP:0005287,narrow eye opening|MP:0008810,increased circulating iron level|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0011886,increased circulating lipase level|MP:0011896,increased circulating unsaturated transferrin level|MP:0011965,decreased total retina thickness
MGI:6760604	Idua<m1Btlr>	MP:0000062,increased bone mineral density
MGI:4415188	Idua<tm1.1Kmke>	MP:0002083,premature death|MP:0003109,short femur|MP:0005058,abnormal lysosome morphology|MP:0005270,abnormal zygomatic bone morphology|MP:0005459,decreased percent body fat/body weight|MP:0008158,increased diameter of femur|MP:0009840,abnormal foam cell morphology|MP:0011473,increased urine glycosaminoglycan level|MP:0020011,increased bone mineral density of femur|MP:0030189,broad snout
MGI:2176236	Idua<tm1Clk>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000160,kyphosis|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000166,abnormal chondrocyte morphology|MP:0000416,sparse hair|MP:0000441,increased cranium width|MP:0000445,short snout|MP:0000558,abnormal tibia morphology|MP:0000603,pale liver|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0001260,increased body weight|MP:0001300,ocular hypertelorism|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001463,abnormal spatial learning|MP:0001489,decreased startle reflex|MP:0001511,disheveled coat|MP:0001570,abnormal circulating enzyme level|MP:0001732,postnatal growth retardation|MP:0002063,abnormal learning/memory/conditioning|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002882,abnormal neuron morphology|MP:0003461,abnormal response to novel object|MP:0003723,abnormal long bone morphology|MP:0004214,abnormal long bone diaphysis morphology|MP:0004988,increased osteoblast cell number|MP:0005059,lysosomal protein accumulation|MP:0006138,congestive heart failure|MP:0008432,abnormal long-term spatial reference memory|MP:0008770,decreased survivor rate|MP:0011473,increased urine glycosaminoglycan level|MP:0020242,increased autopod size|MP:0030037,prominent nasal bridge|MP:0030069,broad face|MP:0030796,hip dislocation
MGI:2651471	Idua<tm1Efn>	MP:0000026,abnormal inner ear morphology|MP:0000043,organ of Corti degeneration|MP:0000136,abnormal microglial cell morphology|MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000286,abnormal mitral valve morphology|MP:0000428,abnormal craniofacial morphology|MP:0000731,increased collagen deposition in the muscles|MP:0001462,abnormal avoidance learning behavior|MP:0001850,increased susceptibility to otitis media|MP:0001967,deafness|MP:0002083,premature death|MP:0002624,abnormal tricuspid valve morphology|MP:0002747,abnormal aortic valve morphology|MP:0002757,decreased vertical activity|MP:0002833,increased heart weight|MP:0002857,cochlear ganglion degeneration|MP:0003048,abnormal cervical vertebrae morphology|MP:0003211,abnormal aorta elastic fiber morphology|MP:0003393,decreased cardiac output|MP:0003691,abnormal microglial cell physiology|MP:0003898,abnormal QRS complex|MP:0003929,decreased heart rate variability|MP:0003974,abnormal endocardium morphology|MP:0004071,prolonged P wave|MP:0004084,abnormal cardiac muscle relaxation|MP:0004097,abnormal cerebellar cortex morphology|MP:0004362,cochlear hair cell degeneration|MP:0004469,abnormal zygomatic arch morphology|MP:0004595,abnormal mandibular condyloid process morphology|MP:0004740,sensorineural hearing loss|MP:0004864,spiral ligament degeneration|MP:0005058,abnormal lysosome morphology|MP:0005266,abnormal metabolism|MP:0005294,abnormal heart ventricle morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005358,abnormal incisor morphology|MP:0005534,decreased body temperature|MP:0005598,decreased heart ventricle muscle contractility|MP:0006033,abnormal external auditory canal morphology|MP:0006045,mitral valve regurgitation|MP:0006047,aortic valve regurgitation|MP:0006144,increased systemic arterial systolic blood pressure|MP:0009865,abnormal aorta smooth muscle morphology|MP:0010029,abnormal basicranium morphology|MP:0010392,prolonged QRS complex duration|MP:0010429,abnormal heart left ventricle outflow tract morphology|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010591,enlarged aortic valve|MP:0010593,thick aortic valve cusps|MP:0010618,enlarged mitral valve|MP:0010627,enlarged tricuspid valve|MP:0010724,thick interventricular septum|MP:0010941,abnormal foramen magnum morphology|MP:0011020,abnormal circadian temperature homeostasis|MP:0011021,abnormal circadian regulation of heart rate|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0020467,abnormal circadian behavior|MP:0021157,increased heart left ventricle wall thickness|MP:0021161,increased heart left ventricle posterior wall thickness|MP:0021163,increased heart left ventricle septal wall thickness
MGI:3717403	iec	MP:0000416,sparse hair|MP:0000418,focal hair loss|MP:0005389,reproductive system phenotype|MP:0008218,delayed emergence of vibrissae|MP:0010203,focal ventral hair loss|MP:0010771,integument phenotype
MGI:6154001	Ier3ip1<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0001529,abnormal vocalization|MP:0002941,increased circulating alanine transaminase level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7578873	Ier3ip1<tm1Arvn>	MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0008489,slow postnatal weight gain|MP:0009114,decreased pancreatic beta cell mass|MP:0009172,small pancreatic islets|MP:0009175,abnormal pancreatic beta cell differentiation|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0011820,decreased pancreatic beta cell proliferation|MP:0013279,increased fasting circulating glucose level|MP:0014117,increased pancreatic beta cell apoptosis|MP:0020352,abnormal endoplasmic reticulum physiology|MP:0020354,increased endoplasmic reticulum stress
MGI:4941879	Ier3<tm1Mxw>	MP:0000219,increased neutrophil cell number|MP:0000322,increased granulocyte number|MP:0001798,impaired macrophage phagocytosis|MP:0002451,abnormal macrophage physiology|MP:0002842,increased systemic arterial blood pressure|MP:0002908,delayed wound healing|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004974,decreased regulatory T cell number|MP:0005025,abnormal response to infection|MP:0005027,increased susceptibility to parasitic infection|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005591,decreased vasodilation|MP:0008539,decreased susceptibility to induced colitis|MP:0008556,abnormal tumor necrosis factor secretion|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0008872,abnormal physiological response to xenobiotic|MP:0010155,abnormal intestine physiology|MP:0010219,increased T-helper 17 cell number
MGI:3773690	Ier3<tm1Raku>	MP:0002625,heart left ventricle hypertrophy|MP:0002626,increased heart rate|MP:0002842,increased systemic arterial blood pressure|MP:0004564,increased myocardial fiber size|MP:0031633,decreased heart left ventricle muscle contractility
MGI:7425750	Ier5<em1(IMPC)Kmpc>	MP:0010053,decreased grip strength
MGI:6259585	Ier5l<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0002833,increased heart weight|MP:0003795,abnormal bone structure|MP:0005565,increased blood urea nitrogen level|MP:0010097,abnormal retina blood vessel morphology|MP:0010124,decreased bone mineral content
MGI:6201402	If1<l>	MP:0005025,abnormal response to infection|MP:0008548,abnormal circulating interferon level|MP:0008872,abnormal physiological response to xenobiotic|MP:0012290,abnormal slow-wave sleep pattern
MGI:6258578	Iffo2<em1(IMPC)J>	MP:0001488,increased startle reflex
MGI:3526580	Ifi202a<tm1Leng>	MP:0002169,no abnormal phenotype detected
MGI:6358241	Ifi204<tm1.1Cjul>	MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008565,decreased interferon-beta secretion|MP:0008576,decreased circulating interferon-beta level|MP:0008597,decreased circulating interleukin-6 level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008706,decreased interleukin-6 secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:5583087	Ifi204<tm1b(KOMP)Wtsi>	MP:0000274,enlarged heart|MP:0005387,immune system phenotype
MGI:7435543	Ifi205<em1(IMPC)Tcp>	MP:0002060,abnormal skin morphology|MP:0003179,thrombocytopenia
MGI:6153369	Ifi207<em1(IMPC)Wtsi>	MP:0005387,immune system phenotype|MP:0008469,abnormal protein level|MP:0008565,decreased interferon-beta secretion|MP:0020934,increased susceptibility to Retroviridae infection
MGI:6152501	Ifi208<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0002092,abnormal eye morphology
MGI:5548678	Ifi27l2a<tm1.1(KOMP)Vlcg>	MP:0001303,abnormal lens morphology|MP:0001312,abnormal cornea morphology|MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0005344,increased circulating bilirubin level|MP:0010097,abnormal retina blood vessel morphology|MP:0011999,abnormal tail length
MGI:3808494	Ifi27l2a<tm1(KOMP)Vlcg>	MP:0005387,immune system phenotype|MP:0010897,abnormal bronchiole epithelium morphology
MGI:5636940	Ifi27<tm1b(EUCOMM)Wtsi>	MP:0010052,increased grip strength
MGI:5582315	Ifi27<tm1Npm>	MP:0004883,abnormal vascular wound healing|MP:0005385,cardiovascular system phenotype
MGI:2178559	Ifi30<tm1Cres>	MP:0002452,abnormal professional antigen presenting cell physiology
MGI:6764596	Ifi35<em1Hhl>	MP:0008554,decreased circulating tumor necrosis factor level|MP:0008597,decreased circulating interleukin-6 level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:5513793	Ifi44<tm1b(KOMP)Wtsi>	MP:0000702,enlarged lymph nodes|MP:0002606,increased basophil cell number|MP:0005011,increased eosinophil cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008658,decreased interleukin-1 beta secretion|MP:0009142,decreased prepulse inhibition|MP:0020913,increased susceptibility to Riboviria infection|MP:0031222,decreased CXCL10 secretion
MGI:3027113	Ifi47<tm1Gat>	MP:0005027,increased susceptibility to parasitic infection|MP:0005387,immune system phenotype
MGI:6153741	Ifih1<em1(IMPC)Wtsi>	MP:0010092,increased circulating magnesium level
MGI:5617217	Ifih1<Rgsc422>	MP:0000217,abnormal leukocyte cell number|MP:0000322,increased granulocyte number|MP:0001246,mixed cellular infiltration to dermis|MP:0001732,postnatal growth retardation|MP:0001828,abnormal T cell activation|MP:0001844,autoimmune response|MP:0001846,increased inflammatory response|MP:0002082,postnatal lethality|MP:0002455,abnormal dendritic cell antigen presentation|MP:0002461,increased immunoglobulin level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002743,glomerulonephritis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004947,skin inflammation|MP:0005425,increased macrophage cell number|MP:0008097,increased plasma cell number|MP:0008126,increased dendritic cell number|MP:0008713,abnormal cytokine level|MP:0008721,abnormal chemokine level|MP:0008770,decreased survivor rate|MP:0011075,abnormal macrophage activation involved in immune response|MP:0031301,chronic liver inflammation
MGI:3663677	Ifih1<tm1.1Cln>	MP:0003009,abnormal cytokine secretion|MP:0008563,decreased interferon-alpha secretion|MP:0008565,decreased interferon-beta secretion|MP:0008706,decreased interleukin-6 secretion|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0020937,increased susceptibility to Picornaviridae infection
MGI:3801032	Ifih1<tm1Aki>	MP:0002376,abnormal dendritic cell physiology|MP:0005621,abnormal cell physiology|MP:0008750,abnormal interferon level|MP:0008751,abnormal interleukin level|MP:0020937,increased susceptibility to Picornaviridae infection
MGI:6257604	Ifit1bl2<em1(IMPC)Bay>	MP:0001417,decreased exploration in new environment|MP:0010097,abnormal retina blood vessel morphology
MGI:3808310	Ifit1<tm1(KOMP)Vlcg>	MP:0001847,brain inflammation|MP:0002444,abnormal T cell physiology|MP:0005150,cachexia|MP:0008750,abnormal interferon level|MP:0010768,mortality/aging|MP:0020913,increased susceptibility to Riboviria infection|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:5430603	Ifit2<tm1.1Ebsb>	MP:0002494,increased IgM level|MP:0002497,increased IgE level|MP:0008499,increased IgG1 level|MP:0008502,increased IgG3 level|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008597,decreased circulating interleukin-6 level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008648,decreased circulating interleukin-12b level|MP:0008706,decreased interleukin-6 secretion|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0020155,enhanced humoral immune response
MGI:5485056	Ifit2<tm1.1Gcs>	MP:0000755,hindlimb paralysis|MP:0001393,ataxia|MP:0008911,induced hyperactivity|MP:0020913,increased susceptibility to Riboviria infection|MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality
MGI:6156452	Ifit3<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000470,abnormal stomach morphology|MP:0001488,increased startle reflex|MP:0002060,abnormal skin morphology
MGI:4328297	Ifitm1<Gt(OST471536)Lex>	MP:0003858,enhanced coordination
MGI:5465441	Ifitm1<tm1.1Ieg>	MP:0000334,decreased granulocyte number|MP:0001525,impaired balance|MP:0002497,increased IgE level|MP:0002665,decreased circulating corticosterone level|MP:0002981,increased liver weight|MP:0005018,decreased T cell number|MP:0005180,abnormal circulating testosterone level|MP:0005289,increased oxygen consumption|MP:0005380,embryo phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype
MGI:5775001	Ifitm1<tm1b(EUCOMM)Wtsi>	MP:0000443,abnormal snout morphology|MP:0003960,increased lean body mass|MP:0004357,long tibia|MP:0010124,decreased bone mineral content
MGI:3803977	Ifitm3<tm1Masu>	MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0020913,increased susceptibility to Riboviria infection|MP:0020946,increased susceptibility to Orthomyxoviridae infection|MP:0031046,increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:6195290	Ifitm5<em1Pmof>	MP:0000065,abnormal bone marrow cavity morphology|MP:0000074,abnormal neurocranium morphology|MP:0000088,short mandible|MP:0000130,abnormal trabecular bone morphology|MP:0000150,abnormal rib morphology|MP:0000460,mandible hypoplasia|MP:0000547,short limbs|MP:0002109,abnormal limb morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003797,abnormal compact bone morphology|MP:0004214,abnormal long bone diaphysis morphology|MP:0004337,clavicle hypoplasia|MP:0004358,bowed tibia|MP:0004361,bowed ulna|MP:0004374,bowed radius|MP:0004624,abnormal thoracic cage morphology|MP:0004982,abnormal osteoclast morphology|MP:0005006,abnormal osteoblast physiology|MP:0006397,disorganized long bone epiphyseal plate|MP:0008271,abnormal bone ossification|MP:0008273,abnormal intramembranous bone ossification|MP:0010969,absent compact bone|MP:0011087,neonatal lethality, complete penetrance|MP:0011585,decreased alkaline phosphatase activity|MP:0011711,impaired osteoblast differentiation|MP:0020137,decreased bone mineralization
MGI:5608595	Ifitm5<tm1Nha>	MP:0000438,abnormal cranium morphology|MP:0000458,abnormal mandible morphology|MP:0001935,decreased litter size|MP:0002820,abnormal premaxilla morphology|MP:0004338,small clavicle|MP:0004358,bowed tibia|MP:0004361,bowed ulna|MP:0004374,bowed radius|MP:0004686,decreased length of long bones|MP:0005298,abnormal clavicle morphology|MP:0005508,abnormal skeleton morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0030275,thin frontal bone|MP:0030850,abnormal ilium body morphology
MGI:6195208	Ifitm5<tm1Pmof>	MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0001262,decreased body weight|MP:0003109,short femur|MP:0005390,skeleton phenotype|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0010879,decreased trabecular bone volume|MP:0010926,increased osteoid volume|MP:0010968,decreased compact bone area|MP:0011585,decreased alkaline phosphatase activity|MP:0013630,increased bone trabecular spacing
MGI:3722118	Ifna6<tm1Aki>	MP:0002169,no abnormal phenotype detected
MGI:3822164	Ifnar1<m1Btlr>	MP:0002451,abnormal macrophage physiology|MP:0005387,immune system phenotype|MP:0008563,decreased interferon-alpha secretion|MP:0008565,decreased interferon-beta secretion|MP:0020913,increased susceptibility to Riboviria infection|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020931,increased susceptibility to Adenoviridae infection|MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:5498008	Ifnar1<m2Btlr>	MP:0008565,decreased interferon-beta secretion
MGI:1930950	Ifnar1<tm1Agt>	MP:0000063,decreased bone mineral density|MP:0001406,abnormal gait|MP:0001793,abnormal susceptibility to infection|MP:0001845,abnormal inflammatory response|MP:0002376,abnormal dendritic cell physiology|MP:0002490,abnormal immunoglobulin level|MP:0002941,increased circulating alanine transaminase level|MP:0003009,abnormal cytokine secretion|MP:0003721,increased tumor growth/size|MP:0003888,liver hemorrhage|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004982,abnormal osteoclast morphology|MP:0005025,abnormal response to infection|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005202,lethargy|MP:0005387,immune system phenotype|MP:0005542,cornea vascularization|MP:0006414,decreased T cell apoptosis|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008248,abnormal mononuclear phagocyte morphology|MP:0008559,abnormal interferon-gamma secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008563,decreased interferon-alpha secretion|MP:0008565,decreased interferon-beta secretion|MP:0008617,increased circulating interleukin-12 level|MP:0008706,decreased interleukin-6 secretion|MP:0008713,abnormal cytokine level|MP:0008911,induced hyperactivity|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010766,abnormal NK cell physiology|MP:0013023,decreased Ly6C high monocyte number|MP:0020913,increased susceptibility to Riboviria infection|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020928,increased susceptibility to Poxviridae infection|MP:0020937,increased susceptibility to Picornaviridae infection|MP:0020946,increased susceptibility to Orthomyxoviridae infection|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0020950,decreased susceptibility to Coronaviridae infection|MP:0020952,increased susceptibility to Paramyxoviridae infection|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality|MP:0031046,increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality|MP:0031050,increased susceptibility to Paramyxoviridae infection induced morbidity/mortality
MGI:2667975	Ifnar1<tm1Pjh>	MP:0000218,increased leukocyte cell number|MP:0002021,increased incidence of induced tumors|MP:0002451,abnormal macrophage physiology|MP:0004499,increased incidence of tumors by chemical induction|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008045,decreased NK cell number|MP:0020937,increased susceptibility to Picornaviridae infection|MP:0020940,increased susceptibility to Togaviridae infection|MP:0031040,increased susceptibility to Picornaviridae infection induced morbidity/mortality|MP:0031042,increased susceptibility to Togaviridae infection induced morbidity/mortality
MGI:2655303	Ifnar1<tm1Uka>	MP:0001806,decreased IgM level|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008498,decreased IgG3 level
MGI:3841008	Ifnar2<m1Btlr>	MP:0002451,abnormal macrophage physiology|MP:0008563,decreased interferon-alpha secretion|MP:0008565,decreased interferon-beta secretion|MP:0020913,increased susceptibility to Riboviria infection|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020931,increased susceptibility to Adenoviridae infection|MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:2680693	Ifnar2<tm1Pjh>	MP:0001805,decreased IgG level|MP:0002021,increased incidence of induced tumors|MP:0004499,increased incidence of tumors by chemical induction|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008045,decreased NK cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008567,decreased interferon-gamma secretion
MGI:2386955	Ifnb1<tm1Acgp>	MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0002451,abnormal macrophage physiology|MP:0003721,increased tumor growth/size|MP:0003884,decreased macrophage cell number|MP:0005348,increased T cell proliferation|MP:0008208,decreased pro-B cell number|MP:0008211,decreased mature B cell number|MP:0008471,abnormal spleen primary B follicle morphology|MP:0008561,decreased tumor necrosis factor secretion|MP:0008576,decreased circulating interferon-beta level|MP:0008658,decreased interleukin-1 beta secretion|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0020928,increased susceptibility to Poxviridae infection
MGI:4357661	Ifnb1<tm1Lky>	MP:0002169,no abnormal phenotype detected
MGI:2657141	Ifnb1<tm1Tl>	MP:0000921,demyelination|MP:0002411,decreased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0003691,abnormal microglial cell physiology|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0006082,CNS inflammation|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008574,decreased circulating interferon-alpha level|MP:0008576,decreased circulating interferon-beta level|MP:0008699,increased interleukin-4 secretion
MGI:2678753	Ifnb1<tm1Ttg>	MP:0000063,decreased bone mineral density|MP:0004982,abnormal osteoclast morphology|MP:0005025,abnormal response to infection
MGI:5503222	Ifne<tm1.2Pjh>	MP:0001212,skin lesions|MP:0002412,increased susceptibility to bacterial infection|MP:0005389,reproductive system phenotype|MP:0008045,decreased NK cell number|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:6316120	Ifngr1<em1(IMPC)Mbp>	MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002699,abnormal vitreous body morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5806453	Ifngr1<m1Btlr>	MP:0001606,impaired hematopoiesis|MP:0003884,decreased macrophage cell number|MP:0005014,increased B cell number|MP:0008561,decreased tumor necrosis factor secretion
MGI:5558045	Ifngr1<tm1.1Rds>	MP:0002412,increased susceptibility to bacterial infection|MP:0008567,decreased interferon-gamma secretion|MP:0008670,decreased interleukin-12b secretion|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:4361521	Ifngr1<tm1.1Rost>	MP:0001273,decreased metastatic potential|MP:0005387,immune system phenotype|MP:0008578,decreased circulating interferon-gamma level|MP:0008618,decreased circulating interleukin-12 level|MP:0008721,abnormal chemokine level
MGI:5558049	Ifngr1<tm1.2Rds>	MP:0002412,increased susceptibility to bacterial infection|MP:0008670,decreased interleukin-12b secretion|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:1857286	Ifngr1<tm1Agt>	MP:0000066,osteoporosis|MP:0000135,decreased compact bone thickness|MP:0000333,decreased bone marrow cell number|MP:0000694,spleen hypoplasia|MP:0000920,abnormal myelination|MP:0001120,abnormal uterus morphology|MP:0001272,increased metastatic potential|MP:0001545,abnormal hematopoietic system physiology|MP:0001970,abnormal pain threshold|MP:0002166,abnormal tumor susceptibility|MP:0002401,abnormal lymphopoiesis|MP:0002411,decreased susceptibility to bacterial infection|MP:0002412,increased susceptibility to bacterial infection|MP:0002490,abnormal immunoglobulin level|MP:0003332,liver abscess|MP:0003360,abnormal depression-related behavior|MP:0003724,increased susceptibility to induced arthritis|MP:0003893,increased hepatocyte proliferation|MP:0004003,abnormal vascular endothelial cell physiology|MP:0004256,abnormal maternal decidual layer morphology|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004821,increased susceptibility to experimental autoimmune uveoretinitis|MP:0004824,decreased susceptibility to experimental autoimmune myasthenia gravis|MP:0004989,decreased osteoblast cell number|MP:0004993,decreased bone resorption|MP:0005016,decreased lymphocyte cell number|MP:0005025,abnormal response to infection|MP:0005027,increased susceptibility to parasitic infection|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005370,liver/biliary system phenotype|MP:0005387,immune system phenotype|MP:0005672,increased susceptibility to graft versus host disease|MP:0008054,abnormal uterine NK cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008396,abnormal osteoclast differentiation|MP:0008496,decreased IgG2a level|MP:0008498,decreased IgG3 level|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008596,increased circulating interleukin-6 level|MP:0008618,decreased circulating interleukin-12 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008705,increased interleukin-6 secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009099,abnormal uterine NK cell physiology|MP:0009336,increased splenocyte proliferation|MP:0009346,decreased trabecular bone thickness|MP:0009394,increased uterine NK cell number|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010138,arteritis|MP:0010139,aortitis|MP:0010144,abnormal tumor vascularization|MP:0010209,abnormal circulating chemokine level|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0011711,impaired osteoblast differentiation|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization|MP:0020913,increased susceptibility to Riboviria infection|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020928,increased susceptibility to Poxviridae infection|MP:0030483,decreased osteocyte number|MP:0030985,decreased circulating osteocalcin level|MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:5552972	Ifngr1<tm1Dmer>	MP:0005025,abnormal response to infection
MGI:1930965	Ifngr2<tm1Pbro>	MP:0002412,increased susceptibility to bacterial infection|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0004816,abnormal class switch recombination|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005466,abnormal T-helper 2 physiology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0030960,abnormal diapedesis
MGI:5751448	Ifng<tm1.1Hayg>	MP:0000221,decreased leukocyte cell number|MP:0000245,abnormal erythropoiesis|MP:0000333,decreased bone marrow cell number|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0001828,abnormal T cell activation|MP:0002144,abnormal B cell differentiation|MP:0002339,abnormal lymph node morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002416,abnormal proerythroblast morphology|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004809,increased hematopoietic stem cell number|MP:0005015,increased T cell number|MP:0005152,pancytopenia|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008255,decreased megakaryocyte cell number|MP:0008713,abnormal cytokine level|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0009395,increased nucleated erythrocyte cell number|MP:0010210,abnormal circulating cytokine level|MP:0011178,increased erythroblast number|MP:0013414,decreased myeloid cell number in bone marrow|MP:0013697,decreased granulocyte monocyte progenitor cell number|MP:0013705,decreased megakaryocyte-erythroid progenitor cell number
MGI:5695880	Ifng<tm1.1(KOMP)Vlcg>	MP:0001175,abnormal lung morphology|MP:0002608,increased hematocrit|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3665254	Ifng<tm1Lky>	MP:0005387,immune system phenotype
MGI:3831296	Ifng<tm1(Thy1)Weav>	MP:0002169,no abnormal phenotype detected
MGI:1857184	Ifng<tm1Ts>	MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000322,increased granulocyte number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001272,increased metastatic potential|MP:0001413,abnormal response to new environment|MP:0001793,abnormal susceptibility to infection|MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0001845,abnormal inflammatory response|MP:0001873,stomach inflammation|MP:0001876,decreased inflammatory response|MP:0001935,decreased litter size|MP:0001952,increased airway responsiveness|MP:0002006,neoplasm|MP:0002024,increased T cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0002052,decreased tumor incidence|MP:0002083,premature death|MP:0002335,decreased airway responsiveness|MP:0002356,abnormal spleen red pulp morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002376,abnormal dendritic cell physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002420,abnormal adaptive immunity|MP:0002425,abnormal susceptibility to autoimmune disorder|MP:0002451,abnormal macrophage physiology|MP:0002455,abnormal dendritic cell antigen presentation|MP:0002459,abnormal B cell physiology|MP:0002460,decreased immunoglobulin level|MP:0002490,abnormal immunoglobulin level|MP:0002492,decreased IgE level|MP:0002497,increased IgE level|MP:0002534,abnormal type IV hypersensitivity reaction|MP:0002743,glomerulonephritis|MP:0002757,decreased vertical activity|MP:0002871,albuminuria|MP:0003009,abnormal cytokine secretion|MP:0003186,abnormal redox activity|MP:0003459,increased fear-related response|MP:0003562,abnormal pancreatic beta cell physiology|MP:0003726,decreased autoantibody level|MP:0003957,abnormal nitric oxide homeostasis|MP:0004256,abnormal maternal decidual layer morphology|MP:0004752,decreased length of allograft survival|MP:0004795,decreased anti-nuclear antigen antibody level|MP:0004798,decreased anti-double stranded DNA antibody level|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005000,abnormal immune tolerance|MP:0005025,abnormal response to infection|MP:0005026,decreased susceptibility to parasitic infection|MP:0005027,increased susceptibility to parasitic infection|MP:0005040,abnormal MHC II cell surface expression on macrophages|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005164,abnormal response to injury|MP:0005351,decreased susceptibility to autoimmune disorder|MP:0005362,abnormal Langerhans cell physiology|MP:0005387,immune system phenotype|MP:0005501,abnormal skin physiology|MP:0005542,cornea vascularization|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0005671,abnormal response to transplant|MP:0008039,increased NK T cell number|MP:0008054,abnormal uterine NK cell morphology|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008466,enlarged mesenteric lymph nodes|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008499,increased IgG1 level|MP:0008567,decreased interferon-gamma secretion|MP:0008596,increased circulating interleukin-6 level|MP:0008660,increased interleukin-10 secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008663,increased interleukin-12 secretion|MP:0008681,increased interleukin-17 secretion|MP:0008687,increased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion|MP:0008713,abnormal cytokine level|MP:0008828,abnormal lymph node cell ratio|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009099,abnormal uterine NK cell physiology|MP:0009246,pale spleen|MP:0009336,increased splenocyte proliferation|MP:0009394,increased uterine NK cell number|MP:0009419,skeletal muscle fibrosis|MP:0009643,abnormal urine homeostasis|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0009828,increased tumor latency|MP:0010210,abnormal circulating cytokine level|MP:0010308,decreased tumor latency|MP:0010639,abnormal tumor pathology|MP:0010740,abnormal dendritic cell chemotaxis|MP:0010750,increased susceptibility to parasitic infection induced morbidity/mortality|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality|MP:0010760,abnormal macrophage chemotaxis|MP:0010766,abnormal NK cell physiology|MP:0012431,increased lymphoma incidence|MP:0013239,impaired skeletal muscle regeneration|MP:0014599,decreased susceptibility to hyperoxia-induced injury|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0030466,alveolar process atrophy|MP:0030960,abnormal diapedesis|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:3036127	Ifng<tm1Yiw>	MP:0000598,abnormal liver morphology|MP:0001654,hepatic necrosis|MP:0001656,focal hepatic necrosis|MP:0001860,liver inflammation|MP:0001876,decreased inflammatory response|MP:0002941,increased circulating alanine transaminase level|MP:0003257,abnormal abdominal wall morphology|MP:0003303,peritoneal inflammation|MP:0003699,abnormal female reproductive system physiology|MP:0004733,abnormal thoracic cavity morphology|MP:0004924,abnormal behavior|MP:0005151,diffuse hepatic necrosis|MP:0005324,ascites|MP:0006043,decreased apoptosis|MP:0008548,abnormal circulating interferon level|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:5317415	Ifng<tm3.1Lky>	MP:0002169,no abnormal phenotype detected
MGI:5585587	Ifnk<tm1.1(KOMP)Vlcg>	MP:0000452,abnormal mouth morphology|MP:0000691,enlarged spleen|MP:0012573,decreased susceptibility to chemically induced skin inflammation
MGI:6696076	Ifnl3<em1Mtba>	MP:0002418,increased susceptibility to viral infection|MP:0008548,abnormal circulating interferon level|MP:0020913,increased susceptibility to Riboviria infection|MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:5575899	Ifnl3<tm1.1(KOMP)Vlcg>	MP:0005633,increased circulating sodium level
MGI:5527612	Ifnlr1<tm1a(EUCOMM)Wtsi>	MP:0013406,abnormal epidermal immune compartment
MGI:6416070	Ifnlr1<tm1b(EUCOMM)Wtsi>	MP:0002418,increased susceptibility to viral infection|MP:0020913,increased susceptibility to Riboviria infection|MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:3775762	Ifnlr1<tm1Palu>	MP:0001793,abnormal susceptibility to infection|MP:0005387,immune system phenotype
MGI:3043556	Ifrd1<tm1Lah>	MP:0000750,abnormal muscle regeneration|MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0008853,decreased abdominal adipose tissue amount|MP:0009426,decreased soleus weight|MP:0011169,abnormal white fat cell differentation
MGI:7657419	Ifrd2<tm1.1Lah>	MP:0001262,decreased body weight|MP:0008853,decreased abdominal adipose tissue amount|MP:0010025,decreased total body fat amount|MP:0011169,abnormal white fat cell differentation
MGI:3578529	Ift122<sopb>	MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0000955,abnormal spinal cord morphology|MP:0001706,abnormal left-right axis patterning|MP:0002092,abnormal eye morphology|MP:0002151,abnormal neural tube morphology|MP:0004131,abnormal motile primary cilium morphology|MP:0004252,abnormal direction of heart looping|MP:0009743,preaxial polydactyly|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013202,abnormal cilium morphology|MP:0030312,enlarged pharyngeal arch
MGI:4432086	Ift122<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight
MGI:5560263	Ift140<b2b1283Clo>	MP:0000111,cleft palate|MP:0000562,polydactyly|MP:0000690,absent spleen|MP:0002633,persistent truncus arteriosus|MP:0003178,left pulmonary isomerism|MP:0003675,kidney cyst|MP:0004113,abnormal aortic arch morphology|MP:0004158,right aortic arch|MP:0010412,atrioventricular septal defect
MGI:4458412	Ift140<cauli>	MP:0000075,absent neurocranium|MP:0000080,abnormal exoccipital bone morphology|MP:0000150,abnormal rib morphology|MP:0000153,rib bifurcation|MP:0000269,abnormal heart looping|MP:0000281,abnormal interventricular septum morphology|MP:0000428,abnormal craniofacial morphology|MP:0000452,abnormal mouth morphology|MP:0000455,abnormal maxilla morphology|MP:0000457,maxilla hypoplasia|MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0001175,abnormal lung morphology|MP:0001293,anophthalmia|MP:0001688,abnormal somite development|MP:0002110,abnormal digit morphology|MP:0002151,abnormal neural tube morphology|MP:0002192,hydrops fetalis|MP:0002624,abnormal tricuspid valve morphology|MP:0002745,abnormal atrioventricular valve morphology|MP:0003051,curly tail|MP:0003052,omphalocele|MP:0003054,spina bifida|MP:0003138,absent tympanic ring|MP:0003720,abnormal neural tube closure|MP:0004458,absent alisphenoid bone|MP:0004476,absent palatine bone|MP:0004620,cervical vertebral fusion|MP:0004871,premaxilla hypoplasia|MP:0005294,abnormal heart ventricle morphology|MP:0005650,abnormal limb bud morphology|MP:0008149,abnormal costovertebral joint morphology|MP:0009698,heart hemorrhage|MP:0009877,exostosis|MP:0009883,palatal shelf hypoplasia|MP:0010728,fusion of atlas and occipital bones|MP:0010865,prenatal growth retardation|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0013203,abnormal primary cilium morphology|MP:0014280,forelimb oligodactyly|MP:0030385,decreased facial bone number|MP:0030386,facial bone hypoplasia
MGI:5311831	Ift140<tm1b(KOMP)Wtsi>	MP:0000452,abnormal mouth morphology|MP:0000914,exencephaly|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013167,abnormal hindlimb bud morphology
MGI:5311828	Ift140<tm1c(KOMP)Wtsi>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009237,kinked sperm flagellum|MP:0009239,short sperm flagellum|MP:0009376,abnormal manchette morphology|MP:0009837,abnormal sperm end piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0014465,abnormal sperm mitochondrial morphology|MP:0014685,spermiation failure|MP:0020451,decreased sperm progressive motility|MP:0020869,immotile sperm|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0031356,abnormal outer dense fiber morphology
MGI:4821824	Ift172<avc1>	MP:0000445,short snout|MP:0001891,hydrocephaly|MP:0002081,perinatal lethality|MP:0002135,abnormal kidney morphology|MP:0002282,abnormal trachea morphology|MP:0002764,short tibia|MP:0002765,short fibula|MP:0003109,short femur|MP:0003130,anal atresia|MP:0003276,esophageal atresia|MP:0004131,abnormal motile primary cilium morphology|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004686,decreased length of long bones|MP:0005325,abnormal renal glomerulus morphology|MP:0005385,cardiovascular system phenotype|MP:0008725,increased heart atrium size|MP:0008772,increased heart ventricle size|MP:0009743,preaxial polydactyly|MP:0009890,cleft secondary palate|MP:0010412,atrioventricular septal defect|MP:0010413,complete atrioventricular septal defect|MP:0010881,esophagus hypoplasia|MP:0010884,esophagus stenosis|MP:0011089,perinatal lethality, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0013202,abnormal cilium morphology
MGI:4420979	Ift172<tm1.1Rama>	MP:0001153,small seminiferous tubules|MP:0001326,retina degeneration|MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004543,abnormal sperm physiology|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008518,retina outer nuclear layer degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009237,kinked sperm flagellum|MP:0009377,ectopic manchette|MP:0009831,abnormal sperm midpiece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0012029,abnormal electroretinogram waveform feature|MP:0012144,decreased b-wave amplitude|MP:0014684,impaired spermiation|MP:0020813,abnormal photoreceptor outer segment disc membrane morphology|MP:0030943,abnormal centrosome morphology|MP:0031356,abnormal outer dense fiber morphology|MP:0031386,elongated manchette
MGI:4420980	Ift172<tm1.2Rama>	MP:0001672,abnormal embryo development|MP:0002151,abnormal neural tube morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:3829198	Ift172<tm1Lmgd>	MP:0000562,polydactyly|MP:0000787,abnormal telencephalon morphology|MP:0000830,abnormal diencephalon morphology|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0000933,abnormal rhombomere morphology|MP:0001293,anophthalmia|MP:0001706,abnormal left-right axis patterning|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003649,decreased heart right ventricle size|MP:0004252,abnormal direction of heart looping|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005157,holoprosencephaly|MP:0006126,abnormal cardiac outflow tract development|MP:0009266,abnormal mesendoderm development|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5692847	Ift172<tm2b(EUCOMM)Hmgu>	MP:0000266,abnormal heart morphology|MP:0000288,abnormal pericardium morphology|MP:0001672,abnormal embryo development|MP:0001700,abnormal embryo turning|MP:0001726,abnormal allantois morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002110,abnormal digit morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2682066	Ift172<wim>	MP:0000914,exencephaly|MP:0000925,abnormal floor plate morphology|MP:0000929,open neural tube|MP:0000955,abnormal spinal cord morphology|MP:0001706,abnormal left-right axis patterning|MP:0004132,absent embryonic cilia|MP:0004252,abnormal direction of heart looping|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013202,abnormal cilium morphology
MGI:3817268	Ift20<tm1.1Gjp>	MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003215,renal interstitial fibrosis|MP:0003675,kidney cyst|MP:0003917,increased kidney weight|MP:0004860,dilated kidney collecting duct|MP:0005565,increased blood urea nitrogen level|MP:0011440,increased kidney cell proliferation|MP:0011843,abnormal kidney collecting duct epithelium morphology|MP:0020384,absent kidney epithelial cell primary cilium
MGI:3817269	Ift20<tm1.2Gjp>	MP:0011091,prenatal lethality, complete penetrance
MGI:4431815	Ift20<tm1a(EUCOMM)Wtsi>	MP:0003019,increased circulating chloride level|MP:0005571,decreased lactate dehydrogenase level
MGI:4432759	Ift25<tm1a(EUCOMM)Wtsi>	MP:0000111,cleft palate|MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000562,polydactyly|MP:0001554,increased circulating free fatty acids level|MP:0001575,cyanosis|MP:0002151,abnormal neural tube morphology|MP:0002639,micrognathia|MP:0003052,omphalocele|MP:0003178,left pulmonary isomerism|MP:0003443,increased circulating glycerol level|MP:0004201,fetal growth retardation|MP:0004322,abnormal sternebra morphology|MP:0004924,abnormal behavior|MP:0005406,abnormal heart size|MP:0009703,decreased birth body size|MP:0009743,preaxial polydactyly|MP:0010103,small thoracic cage|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0011087,neonatal lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011673,unbalanced complete common atrioventricular canal
MGI:5426875	Ift25<tm1b(EUCOMM)Wtsi>	MP:0000111,cleft palate|MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000562,polydactyly|MP:0001575,cyanosis|MP:0002151,abnormal neural tube morphology|MP:0002639,micrognathia|MP:0003052,omphalocele|MP:0003178,left pulmonary isomerism|MP:0004201,fetal growth retardation|MP:0004322,abnormal sternebra morphology|MP:0005406,abnormal heart size|MP:0009703,decreased birth body size|MP:0009743,preaxial polydactyly|MP:0010103,small thoracic cage|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0011087,neonatal lethality, complete penetrance|MP:0011673,unbalanced complete common atrioventricular canal
MGI:4461616	Ift27<tm1a(EUCOMM)Hmgu>	MP:0000378,absent hair follicles|MP:0000380,small hair follicles|MP:0000382,underdeveloped hair follicles|MP:0002656,abnormal keratinocyte differentiation|MP:0003704,abnormal hair follicle development|MP:0005384,cellular phenotype|MP:0009584,decreased keratinocyte proliferation|MP:0010771,integument phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:5605397	Ift27<tm1b(EUCOMM)Hmgu>	MP:0000150,abnormal rib morphology|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000452,abnormal mouth morphology|MP:0000454,abnormal jaw morphology|MP:0000762,abnormal tongue morphology|MP:0001175,abnormal lung morphology|MP:0001575,cyanosis|MP:0001614,abnormal blood vessel morphology|MP:0002109,abnormal limb morphology|MP:0002233,abnormal nose morphology|MP:0002239,abnormal nasal septum morphology|MP:0002243,abnormal vomeronasal organ morphology|MP:0002282,abnormal trachea morphology|MP:0002639,micrognathia|MP:0003052,omphalocele|MP:0003755,abnormal palate morphology|MP:0004113,abnormal aortic arch morphology|MP:0004159,double aortic arch|MP:0004592,small mandible|MP:0004880,lung cyst|MP:0005358,abnormal incisor morphology|MP:0006197,ocular hypotelorism|MP:0009905,absent tongue|MP:0009907,decreased tongue size|MP:0010146,umbilical hernia|MP:0010406,common atrium|MP:0010458,pulmonary trunk hypoplasia|MP:0010853,abnormal lung position or orientation|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011250,abdominal situs ambiguus|MP:0011667,double outlet right ventricle with atrioventricular septal defect|MP:0011683,dual inferior vena cava|MP:0012085,midface hypoplasia|MP:0012285,misaligned sternebrae
MGI:5605398	Ift27<tm1c(EUCOMM)Hmgu>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0003950,abnormal plasma membrane morphology|MP:0004182,abnormal spermiation|MP:0004884,abnormal testis physiology|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008279,arrest of spermiogenesis|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009237,kinked sperm flagellum|MP:0009239,short sperm flagellum|MP:0009837,abnormal sperm end piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0014468,disorganized sperm mitochondrial sheath|MP:0020451,decreased sperm progressive motility|MP:0020869,immotile sperm|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0031351,abnormal sperm flagellum thickness|MP:0031356,abnormal outer dense fiber morphology
MGI:5692739	Ift43<tm1b(EUCOMM)Hmgu>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0001700,abnormal embryo turning|MP:0002151,abnormal neural tube morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0002965,increased circulating serum albumin level|MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0005178,increased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0005553,increased circulating creatinine level|MP:0005568,increased circulating total protein level|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5750956	Ift46<tm1Cnu>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0000928,incomplete rostral neuropore closure|MP:0001706,abnormal left-right axis patterning|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0004132,absent embryonic cilia|MP:0004251,failure of heart looping|MP:0004252,abnormal direction of heart looping|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012093,absent nodal flow|MP:0012270,cardiac edema
MGI:6257432	Ift52<em1(IMPC)Bay>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001718,abnormal visceral yolk sac morphology|MP:0001722,pale yolk sac|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003232,abnormal forebrain development|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5287036	Ift52<TgTn(sb-cHS4,Tyr)2501C-2Ove>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6364134	Ift56<em1(IMPC)J>	MP:0000111,cleft palate|MP:0000562,polydactyly|MP:0001404,no spontaneous movement|MP:0003385,abnormal body wall morphology|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:1856054	Ift56<hop>	MP:0001147,small testis|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001522,impaired swimming|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002084,abnormal developmental patterning|MP:0002151,abnormal neural tube morphology|MP:0002948,abnormal neuron specification|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004131,abnormal motile primary cilium morphology|MP:0004289,abnormal bony labyrinth|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0005367,renal/urinary system phenotype|MP:0006325,impaired hearing|MP:0006380,abnormal spermatid morphology|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009376,abnormal manchette morphology|MP:0009743,preaxial polydactyly|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011965,decreased total retina thickness|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856055	Ift56<hop-hpy>	MP:0000161,scoliosis|MP:0000562,polydactyly|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002083,premature death|MP:0002784,abnormal Sertoli cell morphology|MP:0005578,teratozoospermia|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3707373	Ift57<tm1Dwni>	MP:0000455,abnormal maxilla morphology|MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0000926,absent floor plate|MP:0000928,incomplete rostral neuropore closure|MP:0000929,open neural tube|MP:0000955,abnormal spinal cord morphology|MP:0001706,abnormal left-right axis patterning|MP:0001787,pericardial edema|MP:0002151,abnormal neural tube morphology|MP:0003984,embryonic growth retardation|MP:0004132,absent embryonic cilia|MP:0004180,failure of initiation of embryo turning|MP:0004188,delayed embryo turning|MP:0004190,abnormal direction of embryo turning|MP:0004203,abnormal cranial flexure morphology|MP:0004252,abnormal direction of heart looping|MP:0006197,ocular hypotelorism|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3707375	Ift57<tm2Dwni>	MP:0000455,abnormal maxilla morphology|MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0000926,absent floor plate|MP:0000928,incomplete rostral neuropore closure|MP:0000929,open neural tube|MP:0000955,abnormal spinal cord morphology|MP:0001706,abnormal left-right axis patterning|MP:0001787,pericardial edema|MP:0002151,abnormal neural tube morphology|MP:0003984,embryonic growth retardation|MP:0004132,absent embryonic cilia|MP:0004180,failure of initiation of embryo turning|MP:0004188,delayed embryo turning|MP:0004190,abnormal direction of embryo turning|MP:0004203,abnormal cranial flexure morphology|MP:0004252,abnormal direction of heart looping|MP:0006197,ocular hypotelorism|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:6257793	Ift70b<em1(IMPC)Bay>	MP:0000689,abnormal spleen morphology
MGI:5311374	Ift74<b2b796Clo>	MP:0000284,double outlet right ventricle|MP:0002132,abnormal respiratory system morphology|MP:0004133,heterotaxia|MP:0006063,abnormal inferior vena cava morphology|MP:0010406,common atrium|MP:0010412,atrioventricular septal defect|MP:0010975,abnormal lung lobe morphology|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5635223	Ift74<tm1b(EUCOMM)Hmgu>	MP:0001488,increased startle reflex|MP:0001513,limb grasping|MP:0001925,male infertility
MGI:6391391	Ift74<tm1c(EUCOMM)Hmgu>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004884,abnormal testis physiology|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008545,absent sperm flagellum|MP:0009230,abnormal sperm head morphology|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0014685,spermiation failure|MP:0020869,immotile sperm|MP:0031352,absent sperm axonemal central pair
MGI:3856827	Ift80<Gt(AN0245)Wtsi>	MP:0000150,abnormal rib morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000438,abnormal cranium morphology|MP:0001732,postnatal growth retardation|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0004686,decreased length of long bones|MP:0005352,small cranium|MP:0005367,renal/urinary system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005391,vision/eye phenotype|MP:0006397,disorganized long bone epiphyseal plate|MP:0009703,decreased birth body size|MP:0009743,preaxial polydactyly|MP:0010099,abnormal thoracic cage shape|MP:0010831,lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:4419694	Ift80<tm1a(KOMP)Wtsi>	MP:0000552,abnormal radius morphology|MP:0004509,abnormal pelvic girdle bone morphology|MP:0005108,abnormal ulna morphology|MP:0005565,increased blood urea nitrogen level|MP:0010067,increased red blood cell distribution width|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5701373	Ift80<tm1c(KOMP)Wtsi>	MP:0001260,increased body weight|MP:0013206,abnormal motile cilium morphology
MGI:5636927	Ift81<tm1b(EUCOMM)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001488,increased startle reflex|MP:0002792,abnormal retina vasculature morphology|MP:0005333,decreased heart rate|MP:0010053,decreased grip strength|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:6449235	Ift81<tm1c(EUCOMM)Wtsi>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004884,abnormal testis physiology|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009237,kinked sperm flagellum|MP:0009239,short sperm flagellum|MP:0009831,abnormal sperm midpiece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014468,disorganized sperm mitochondrial sheath|MP:0014685,spermiation failure|MP:0020550,multinucleated giant male germ cells|MP:0020869,immotile sperm|MP:0030590,abnormal sperm fibrous sheath morphology
MGI:3823090	Ift88<cbbs>	MP:0000562,polydactyly|MP:0000783,abnormal forebrain morphology|MP:0000787,abnormal telencephalon morphology|MP:0000914,exencephaly|MP:0001176,abnormal lung development|MP:0001178,pulmonary hypoplasia|MP:0002633,persistent truncus arteriosus|MP:0002925,abnormal cardiovascular development|MP:0003631,nervous system phenotype|MP:0003861,abnormal nervous system development|MP:0005262,coloboma|MP:0005388,respiratory system phenotype|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010406,common atrium|MP:0010436,abnormal coronary sinus morphology|MP:0010440,anomalous pulmonary venous connection|MP:0010521,absent pulmonary artery|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3027342	Ift88<fxo>	MP:0000562,polydactyly|MP:0000830,abnormal diencephalon morphology|MP:0000897,abnormal midbrain morphology|MP:0000925,abnormal floor plate morphology|MP:0000926,absent floor plate|MP:0001706,abnormal left-right axis patterning|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2157527	Ift88<Tg737Rpw>	MP:0000026,abnormal inner ear morphology|MP:0000554,abnormal carpal bone morphology|MP:0000562,polydactyly|MP:0000598,abnormal liver morphology|MP:0001511,disheveled coat|MP:0001732,postnatal growth retardation|MP:0001944,abnormal pancreas morphology|MP:0002693,abnormal pancreas physiology|MP:0002694,abnormal pancreas secretion|MP:0002928,abnormal bile duct morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0002988,decreased urine osmolality|MP:0003068,enlarged kidney|MP:0003333,liver fibrosis|MP:0003336,pancreas cyst|MP:0003675,kidney cyst|MP:0003723,abnormal long bone morphology|MP:0003840,abnormal coronal suture morphology|MP:0004247,small pancreas|MP:0004789,increased bile salt level|MP:0005104,abnormal tarsal bone morphology|MP:0005293,impaired glucose tolerance|MP:0005306,abnormal phalanx morphology|MP:0005560,decreased circulating glucose level|MP:0005650,abnormal limb bud morphology|MP:0008528,polycystic kidney|MP:0008986,abnormal liver parenchyma morphology|MP:0009050,dilated proximal convoluted tubule|MP:0009143,abnormal pancreatic duct morphology|MP:0009145,abnormal pancreatic acinus morphology|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009149,decreased pancreatic acinar cell number|MP:0009150,pancreatic acinar cell atrophy|MP:0009890,cleft secondary palate|MP:0010041,absent oval cells|MP:0010042,abnormal oval cell physiology|MP:0010773,supernumerary molars|MP:0011066,abnormal renal tubule epithelial cell primary cilium morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014093,decreased pancreatic primary cilium length|MP:0014094,decreased pancreatic primary cilium number
MGI:3710186	Ift88<tm1.1Bky>	MP:0000269,abnormal heart looping|MP:0004132,absent embryonic cilia|MP:0005312,pericardial effusion|MP:0013292,embryonic lethality prior to organogenesis
MGI:5505911	Ift88<tm1.1(KOMP)Vlcg>	MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:3710185	Ift88<tm1Bky>	MP:0000284,double outlet right ventricle|MP:0000286,abnormal mitral valve morphology|MP:0002427,disproportionate dwarf|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0009652,abnormal palatal rugae morphology|MP:0010412,atrioventricular septal defect|MP:0010413,complete atrioventricular septal defect|MP:0010614,abnormal mitral valve cusp morphology|MP:0013206,abnormal motile cilium morphology
MGI:1859153	Ift88<tm1Rpw>	MP:0000292,distended pericardium|MP:0000562,polydactyly|MP:0000930,wavy neural tube|MP:0001706,abnormal left-right axis patterning|MP:0002884,abnormal pharyngeal arch morphology|MP:0003232,abnormal forebrain development|MP:0003400,kinked neural tube|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0004132,absent embryonic cilia|MP:0004252,abnormal direction of heart looping|MP:0004574,broad limb buds|MP:0005650,abnormal limb bud morphology|MP:0006108,abnormal hindbrain development|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6356351	Iftap<tm1b(KOMP)Wtsi>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0004542,impaired acrosome reaction|MP:0005389,reproductive system phenotype|MP:0009230,abnormal sperm head morphology|MP:0009697,abnormal copulation behavior|MP:0010768,mortality/aging
MGI:6140227	Iftap<tm1Mnz>	MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:3056510	Igbp1<tm1Cbt>	MP:0000715,decreased thymocyte number
MGI:2656093	Igbp1<tm1Imku>	MP:0000715,decreased thymocyte number|MP:0001454,abnormal cued conditioning behavior|MP:0001463,abnormal spatial learning|MP:0002359,abnormal spleen germinal center morphology|MP:0002371,abnormal thymus cortex morphology|MP:0002459,abnormal B cell physiology|MP:0002460,decreased immunoglobulin level|MP:0003631,nervous system phenotype|MP:0004815,abnormal somatic hypermutation frequency|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0005093,decreased B cell proliferation|MP:0008174,decreased follicular B cell number|MP:0008209,decreased pre-B cell number|MP:0009543,abnormal thymus corticomedullary boundary morphology
MGI:2183925	Igdcc3<tm1.1Sms>	MP:0001405,impaired coordination
MGI:2180750	Igdcc3<tm1Sms>	MP:0001405,impaired coordination
MGI:6867809	Igdcc4<em1Bcgen>	MP:0020947,decreased susceptibility to Orthomyxoviridae infection|MP:0031045,decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:3051685	Igdmr<tm1Ace>	MP:0003123,paternal imprinting|MP:0011089,perinatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3576029	Igf1r<hyft>	MP:0000598,abnormal liver morphology|MP:0002192,hydrops fetalis
MGI:2386328	Igf1r<tm1.1Mhz>	MP:0001559,hyperglycemia|MP:0002833,increased heart weight|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype|MP:0010768,mortality/aging
MGI:2386329	Igf1r<tm1.2Mhz>	MP:0001262,decreased body weight|MP:0001953,respiratory failure|MP:0002108,abnormal muscle morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:1926486	Igf1r<tm1Arge>	MP:0000060,delayed bone ossification|MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000380,small hair follicles|MP:0000734,muscle hypoplasia|MP:0000954,decreased oligodendrocyte progenitor number|MP:0000955,abnormal spinal cord morphology|MP:0001177,atelectasis|MP:0001201,translucent skin|MP:0001218,thin epidermis|MP:0001238,thin epidermis stratum spinosum|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002089,abnormal postnatal growth/weight/body size|MP:0005277,abnormal brainstem morphology|MP:0009674,decreased birth weight|MP:0011087,neonatal lethality, complete penetrance
MGI:3818453	Igf1r<tm1Jcbr>	MP:0000774,decreased brain size|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002078,abnormal glucose homeostasis|MP:0002335,decreased airway responsiveness|MP:0002687,oligozoospermia|MP:0002833,increased heart weight|MP:0002891,increased insulin sensitivity|MP:0002981,increased liver weight|MP:0003893,increased hepatocyte proliferation|MP:0004852,decreased testis weight|MP:0004893,decreased adiponectin level|MP:0005159,azoospermia|MP:0005164,abnormal response to injury|MP:0005166,decreased susceptibility to injury|MP:0005335,abnormal gonadal fat pad morphology|MP:0005389,reproductive system phenotype|MP:0005559,increased circulating glucose level|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0006094,increased fat cell size|MP:0009115,abnormal fat cell morphology|MP:0010024,increased total body fat amount|MP:0010862,decreased respiratory mucosa goblet cell number|MP:0010897,abnormal bronchiole epithelium morphology|MP:0010901,abnormal pulmonary alveolar parenchyma morphology|MP:0020254,decreased collagen level|MP:0020344,abnormal susceptibility to injury induced morbidity/mortality
MGI:2386327	Igf1r<tm1Mhz>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0005376,homeostasis/metabolism phenotype
MGI:5306047	Igf1r<tm2.1Arge>	MP:0000031,abnormal cochlea morphology|MP:0000037,abnormal lateral semicircular canal morphology|MP:0001953,respiratory failure|MP:0002428,abnormal semicircular canal morphology|MP:0002858,abnormal posterior semicircular canal morphology|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0004289,abnormal bony labyrinth|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004396,decreased cochlear inner hair cell number|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004402,decreased cochlear outer hair cell number|MP:0004408,decreased cochlear hair cell number|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004589,abnormal cochlear hair cell development|MP:0010865,prenatal growth retardation|MP:0011061,abnormal inner hair cell kinocilium morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:2389580	Igf1r<tm2Arge>	MP:0000130,abnormal trabecular bone morphology|MP:0001533,abnormal skeleton physiology|MP:0001541,abnormal osteoclast physiology|MP:0004003,abnormal vascular endothelial cell physiology|MP:0004883,abnormal vascular wound healing|MP:0004985,decreased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0005006,abnormal osteoblast physiology|MP:0005508,abnormal skeleton morphology|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization|MP:0030279,thin neurocranium
MGI:3046882	Igf1sl1<C3H/HeJ>	MP:0000063,decreased bone mineral density|MP:0000141,abnormal vertebral body morphology|MP:0000559,abnormal femur morphology|MP:0001533,abnormal skeleton physiology|MP:0002139,abnormal hepatobiliary system physiology|MP:0003109,short femur|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005458,increased percent body fat/body weight|MP:0010025,decreased total body fat amount|MP:0020040,decreased bone ossification|MP:0021190,decreased bone mineral density of lumbar vertebrae
MGI:3046884	Igf1sl2<C3H/HeJ>	MP:0000062,increased bone mineral density|MP:0004702,increased circulating insulin-like growth factor I level|MP:0004984,increased osteoclast cell number|MP:0005568,increased circulating total protein level
MGI:3046886	Igf1sl3<C3H/HeJ>	MP:0004702,increased circulating insulin-like growth factor I level
MGI:2449287	Igf1<tm1.1Dlr>	MP:0001258,decreased body length|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0003429,insensitivity to growth hormone|MP:0003956,abnormal body size|MP:0005123,increased circulating growth hormone level|MP:0005560,decreased circulating glucose level|MP:0008489,slow postnatal weight gain|MP:0009674,decreased birth weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4459503	Igf1<tm1.1Nros>	MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005378,growth/size/body region phenotype|MP:0010768,mortality/aging
MGI:1926485	Igf1<tm1Arge>	MP:0000031,abnormal cochlea morphology|MP:0000039,abnormal otic capsule morphology|MP:0000060,delayed bone ossification|MP:0000130,abnormal trabecular bone morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000166,abnormal chondrocyte morphology|MP:0000734,muscle hypoplasia|MP:0000920,abnormal myelination|MP:0000939,decreased motor neuron number|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001175,abnormal lung morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002427,disproportionate dwarf|MP:0002855,abnormal cochlear ganglion morphology|MP:0002857,cochlear ganglion degeneration|MP:0003149,abnormal tectorial membrane morphology|MP:0003203,increased neuron apoptosis|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003704,abnormal hair follicle development|MP:0003986,small cochlear ganglion|MP:0004664,delayed inner ear development|MP:0004716,abnormal cochlear nerve morphology|MP:0004740,sensorineural hearing loss|MP:0004750,syndromic hearing loss|MP:0005123,increased circulating growth hormone level|MP:0005377,hearing/vestibular/ear phenotype|MP:0005508,abnormal skeleton morphology|MP:0008974,proportional dwarf|MP:0009946,abnormal olfactory bulb layer morphology|MP:0009947,abnormal olfactory bulb external plexiform layer morphology|MP:0009951,abnormal olfactory bulb mitral cell layer morphology|MP:0009954,abnormal mitral cell morphology|MP:0010810,increased type II pneumocyte number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014740,increased auditory brainstem response wave peak latency|MP:0014742,increased auditory brainstem response wave interpeak latency
MGI:2152423	Igf1<tm1Dlr>	MP:0002006,neoplasm|MP:0002079,increased circulating insulin level|MP:0002169,no abnormal phenotype detected|MP:0003447,decreased tumor growth/size|MP:0003918,decreased kidney weight|MP:0004201,fetal growth retardation|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005123,increased circulating growth hormone level|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005619,increased urine potassium level|MP:0005669,increased circulating leptin level|MP:0006144,increased systemic arterial systolic blood pressure|MP:0006316,increased urine sodium level|MP:0008489,slow postnatal weight gain|MP:0011090,perinatal lethality, incomplete penetrance
MGI:1857466	Igf1<tm1Ts>	MP:0002081,perinatal lethality|MP:0002088,abnormal embryonic growth/weight/body size|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002108,abnormal muscle morphology|MP:0002132,abnormal respiratory system morphology|MP:0002133,abnormal respiratory system physiology|MP:0002152,abnormal brain morphology|MP:0003633,abnormal nervous system physiology
MGI:3821756	Igf1<tm2.1Arge>	MP:0001262,decreased body weight|MP:0004701,decreased circulating insulin-like growth factor I level
MGI:4459505	Igf1<tm2.1Nros>	MP:0001175,abnormal lung morphology|MP:0001953,respiratory failure|MP:0009674,decreased birth weight|MP:0010819,primary atelectasis|MP:0011087,neonatal lethality, complete penetrance
MGI:3821754	Igf1<tm2Arge>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001924,infertility|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005389,reproductive system phenotype|MP:0006396,decreased long bone epiphyseal plate size|MP:0008770,decreased survivor rate|MP:0011088,neonatal lethality, incomplete penetrance
MGI:1861704	Igf1<tm2Ts>	MP:0001262,decreased body weight|MP:0002842,increased systemic arterial blood pressure|MP:0005120,decreased circulating growth hormone level|MP:0005560,decreased circulating glucose level|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0031635,increased heart left ventricle muscle contractility
MGI:6303615	Igf2bp1<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0011100,preweaning lethality, complete penetrance
MGI:3043746	Igf2bp1<Gt(OST33739)Lex>	MP:0000163,abnormal cartilage morphology|MP:0000352,decreased cell proliferation|MP:0000445,short snout|MP:0000477,abnormal intestine morphology|MP:0000478,delayed intestine development|MP:0000496,abnormal small intestine morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000528,delayed kidney development|MP:0000585,kinked tail|MP:0000694,spleen hypoplasia|MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000952,abnormal CNS glial cell morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001429,dehydration|MP:0001431,abnormal eating behavior|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0002427,disproportionate dwarf|MP:0002628,hepatic steatosis|MP:0003077,abnormal cell cycle|MP:0003424,premature neuronal precursor differentiation|MP:0003446,renal hypoplasia|MP:0004201,fetal growth retardation|MP:0004754,abnormal kidney collecting duct morphology|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0004921,decreased placenta weight|MP:0005325,abnormal renal glomerulus morphology|MP:0005655,increased aggression|MP:0008109,abnormal small intestinal microvillus morphology|MP:0008142,decreased small intestinal villus size|MP:0008770,decreased survivor rate|MP:0008802,abnormal intestinal smooth muscle morphology|MP:0008987,abnormal liver lobule morphology|MP:0009431,decreased fetal weight|MP:0009674,decreased birth weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012203,abnormal neuronal stem cell morphology|MP:0012207,decreased neuronal stem cell self-renewal|MP:0013795,abnormal colon goblet cell morphology
MGI:4128352	Igf2bp1<Gt(XL009)Byg>	MP:0005621,abnormal cell physiology
MGI:6281580	Igf2bp2<tm1Mini>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001661,extended life span|MP:0001783,decreased white adipose tissue amount|MP:0002052,decreased tumor incidence|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0002981,increased liver weight|MP:0003961,decreased lean body mass|MP:0004889,increased energy expenditure|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005560,decreased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009131,decreased white fat cell number|MP:0010025,decreased total body fat amount|MP:0011699,abnormal brown adipose tissue thermogenesis|MP:0012778,abnormal liver triglyceride level|MP:0013278,decreased fasting circulating glucose level|MP:0020520,whitened brown adipose tissue morphology|MP:0020523,decreased susceptibility to induced hypothermia|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5825102	Igf2bp3<em1(IMPC)J>	MP:0001488,increased startle reflex|MP:0005505,thrombocytosis|MP:0010052,increased grip strength
MGI:5505532	Igf2r<tm1.1(IGF2R)Arte>	MP:0001260,increased body weight|MP:0001264,increased body size|MP:0001935,decreased litter size|MP:0002833,increased heart weight|MP:0004920,increased placenta weight|MP:0004937,dilated heart|MP:0005378,growth/size/body region phenotype|MP:0008772,increased heart ventricle size|MP:0009085,abnormal uterine horn morphology|MP:0009087,dilated uterine horn|MP:0009432,increased fetal weight|MP:0009698,heart hemorrhage|MP:0010768,mortality/aging|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011873,enlarged uterine horn
MGI:2447858	Igf2r<tm1.1Rlj>	MP:0000585,kinked tail|MP:0000592,short tail|MP:0001176,abnormal lung development|MP:0001699,increased embryo size|MP:0003121,genetic imprinting|MP:0004260,enlarged placenta|MP:0011030,impaired branching involved in preterminal bronchiole morphogenesis|MP:0011091,prenatal lethality, complete penetrance
MGI:2181646	Igf2r<tm1Arge>	MP:0000274,enlarged heart|MP:0000275,heart hyperplasia|MP:0000562,polydactyly|MP:0000585,kinked tail|MP:0000599,enlarged liver|MP:0000676,abnormal body water content|MP:0001120,abnormal uterus morphology|MP:0001144,vagina atresia|MP:0001699,increased embryo size|MP:0001785,edema|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002833,increased heart weight|MP:0003068,enlarged kidney|MP:0004199,increased fetal size|MP:0004202,pulmonary hyperplasia|MP:0004260,enlarged placenta|MP:0004882,enlarged lung|MP:0004906,enlarged uterus|MP:0005141,liver hyperplasia|MP:0005238,increased brain size|MP:0005418,abnormal circulating hormone level|MP:0006138,congestive heart failure|MP:0008770,decreased survivor rate|MP:0009395,increased nucleated erythrocyte cell number|MP:0009673,increased birth weight|MP:0009702,increased birth body size|MP:0010724,thick interventricular septum|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0021157,increased heart left ventricle wall thickness
MGI:2447856	Igf2r<tm1Rlj>	MP:0002169,no abnormal phenotype detected|MP:0003121,genetic imprinting|MP:0005370,liver/biliary system phenotype
MGI:2181634	Igf2r<tm1Stw>	MP:0000274,enlarged heart|MP:0000281,abnormal interventricular septum morphology|MP:0000585,kinked tail|MP:0001144,vagina atresia|MP:0001435,absent suckling reflex|MP:0001575,cyanosis|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002833,increased heart weight|MP:0003126,abnormal external female genitalia morphology|MP:0004906,enlarged uterus|MP:0004920,increased placenta weight|MP:0005329,abnormal myocardium layer morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005418,abnormal circulating hormone level|MP:0008258,thin endometrium|MP:0008770,decreased survivor rate|MP:0009097,absent endometrial glands|MP:0009702,increased birth body size|MP:0010563,increased heart right ventricle size|MP:0011087,neonatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0031552,abnormal tricuspid valve development
MGI:2181637	Igf2r<tm1Wag>	MP:0000274,enlarged heart|MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0000585,kinked tail|MP:0001144,vagina atresia|MP:0001175,abnormal lung morphology|MP:0001953,respiratory failure|MP:0002088,abnormal embryonic growth/weight/body size|MP:0002190,disorganized myocardium|MP:0003122,maternal imprinting|MP:0003172,abnormal lysosome physiology|MP:0003416,premature bone ossification|MP:0004320,split sternum|MP:0004321,short sternum|MP:0004906,enlarged uterus|MP:0008271,abnormal bone ossification|MP:0011085,postnatal lethality, complete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:2181650	Igf2r<tm2Arge>	MP:0000274,enlarged heart|MP:0000275,heart hyperplasia|MP:0000562,polydactyly|MP:0000585,kinked tail|MP:0000599,enlarged liver|MP:0000676,abnormal body water content|MP:0001120,abnormal uterus morphology|MP:0001144,vagina atresia|MP:0001699,increased embryo size|MP:0001785,edema|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002833,increased heart weight|MP:0003068,enlarged kidney|MP:0004199,increased fetal size|MP:0004202,pulmonary hyperplasia|MP:0004260,enlarged placenta|MP:0004882,enlarged lung|MP:0004906,enlarged uterus|MP:0005141,liver hyperplasia|MP:0005238,increased brain size|MP:0005418,abnormal circulating hormone level|MP:0006138,congestive heart failure|MP:0008770,decreased survivor rate|MP:0009395,increased nucleated erythrocyte cell number|MP:0009673,increased birth weight|MP:0009702,increased birth body size|MP:0010724,thick interventricular septum|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0021157,increased heart left ventricle wall thickness
MGI:2445841	Igf2r<tm2Wag>	MP:0009431,decreased fetal weight
MGI:2677156	Igf2<tm1Rob>	MP:0000060,delayed bone ossification|MP:0000157,abnormal sternum morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000266,abnormal heart morphology|MP:0000562,polydactyly|MP:0001262,decreased body weight|MP:0001303,abnormal lens morphology|MP:0002833,increased heart weight|MP:0002981,increased liver weight|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003052,omphalocele|MP:0003122,maternal imprinting|MP:0003893,increased hepatocyte proliferation|MP:0003918,decreased kidney weight|MP:0004259,small placenta|MP:0004920,increased placenta weight|MP:0005294,abnormal heart ventricle morphology|MP:0005418,abnormal circulating hormone level|MP:0006113,abnormal heart septum morphology|MP:0009265,delayed eyelid fusion|MP:0009432,increased fetal weight|MP:0009674,decreased birth weight|MP:0011085,postnatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011394,increased fetal cardiomyocyte proliferation|MP:0013309,adrenal gland cyst
MGI:4880744	Igf2<tm1Snha>	MP:0000060,delayed bone ossification|MP:0000063,decreased bone mineral density|MP:0000065,abnormal bone marrow cavity morphology|MP:0000164,abnormal cartilage development|MP:0000558,abnormal tibia morphology|MP:0001732,postnatal growth retardation|MP:0002113,abnormal skeleton development|MP:0003122,maternal imprinting|MP:0003984,embryonic growth retardation|MP:0004148,increased compact bone thickness|MP:0004201,fetal growth retardation|MP:0004989,decreased osteoblast cell number|MP:0005508,abnormal skeleton morphology|MP:0008395,abnormal osteoblast differentiation|MP:0008396,abnormal osteoclast differentiation|MP:0009674,decreased birth weight|MP:0010867,abnormal bone trabecula morphology|MP:0010970,abnormal compact bone lamellar structure
MGI:2677155	Igf2<tm1Wrk>	MP:0001731,abnormal postnatal growth|MP:0003122,maternal imprinting|MP:0003984,embryonic growth retardation|MP:0004196,abnormal prenatal growth/weight/body size|MP:0004259,small placenta|MP:0004265,abnormal placental transport|MP:0004921,decreased placenta weight|MP:0009431,decreased fetal weight|MP:0009703,decreased birth body size
MGI:3521788	Igf2<tm2Wrk>	MP:0001265,decreased body size|MP:0003122,maternal imprinting
MGI:3521799	Igf2<tm3Wrk>	MP:0001265,decreased body size|MP:0003122,maternal imprinting
MGI:5310741	Igf2<tm4.1Wrk>	MP:0003787,abnormal imprinting
MGI:5309176	Igf2<tm4Wrk>	MP:0003787,abnormal imprinting|MP:0009674,decreased birth weight|MP:0010865,prenatal growth retardation
MGI:5635166	Igfals<tm1b(KOMP)Wtsi>	MP:0005178,increased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis
MGI:2386180	Igfals<tm1Yrb>	MP:0000559,abnormal femur morphology|MP:0001262,decreased body weight|MP:0001935,decreased litter size|MP:0003109,short femur|MP:0008152,decreased diameter of femur
MGI:2448461	Igfbp1<tm1Taub>	MP:0001654,hepatic necrosis|MP:0001656,focal hepatic necrosis|MP:0001860,liver inflammation|MP:0002628,hepatic steatosis|MP:0003887,increased hepatocyte apoptosis|MP:0005517,impaired liver regeneration|MP:0031324,delayed liver regeneration
MGI:3529585	Igfbp2<Gt(OST365171)Lex>	MP:0002169,no abnormal phenotype detected
MGI:2386117	Igfbp2<tm1Jep>	MP:0000692,small spleen|MP:0002834,decreased heart weight|MP:0002981,increased liver weight|MP:0003918,decreased kidney weight
MGI:2156008	Igfbp3q1<DU6i>	MP:0005416,abnormal circulating protein level
MGI:2157863	Igfbp3q2<DU6i>	MP:0005416,abnormal circulating protein level
MGI:5548945	Igfbp3<tm1b(KOMP)Wtsi>	MP:0002075,abnormal coat/hair pigmentation|MP:0002764,short tibia|MP:0002953,thick ventricular wall|MP:0003900,shortened QT interval|MP:0010571,shortened ST segment
MGI:3663361	Igfbp3<tm1Jep>	MP:0002792,abnormal retina vasculature morphology|MP:0003674,oxidative stress|MP:0005378,growth/size/body region phenotype|MP:0006309,decreased retina ganglion cell number|MP:0011965,decreased total retina thickness
MGI:4888286	Igfbp3<tm1Lex>	MP:0001260,increased body weight|MP:0001431,abnormal eating behavior|MP:0001783,decreased white adipose tissue amount|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002644,decreased circulating triglyceride level|MP:0002981,increased liver weight|MP:0004893,decreased adiponectin level|MP:0005559,increased circulating glucose level|MP:0008961,abnormal basal metabolism|MP:0009427,increased tibialis anterior weight|MP:0010226,increased quadriceps weight
MGI:3663362	Igfbp4<tm1Jep>	MP:0001262,decreased body weight|MP:0005293,impaired glucose tolerance|MP:0009674,decreased birth weight
MGI:3663363	Igfbp5<tm1Jep>	MP:0005378,growth/size/body region phenotype
MGI:7330354	Igfbp6<em1(IMPC)J>	MP:0002968,increased circulating alkaline phosphatase level|MP:0004738,abnormal auditory brainstem response|MP:0005635,decreased circulating bilirubin level
MGI:7290364	Igfbp6<em1Smoc>	MP:0005339,increased susceptibility to atherosclerosis|MP:0020333,enhanced leukocyte tethering or rolling
MGI:7290365	Igfbp6<em2Smoc>	MP:0005339,increased susceptibility to atherosclerosis
MGI:5618913	Igfbp7<tm1.1Dds>	MP:0000628,abnormal mammary gland development|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001262,decreased body weight|MP:0001935,decreased litter size|MP:0004047,abnormal milk composition|MP:0006270,abnormal mammary gland growth during lactation|MP:0006271,abnormal involution of the mammary gland|MP:0009506,abnormal mammary gland alveolus morphology|MP:0010174,decreased mammary gland epithelial cell proliferation|MP:0011704,decreased fibroblast proliferation|MP:0012075,impaired mammary gland growth during pregnancy|MP:0013782,abnormal mammary duct terminal end bud morphology
MGI:5609347	Igfbp7<tm1b(EUCOMM)Hmgu>	MP:0011239,abnormal skin coloration
MGI:6095183	Igfn1<em1(IMPC)J>	MP:0002169,no abnormal phenotype detected
MGI:3838715	Igh-7<tm1.1Lam>	MP:0002492,decreased IgE level|MP:0008211,decreased mature B cell number
MGI:3829432	Igh-7<tm1Gach>	MP:0002458,abnormal B cell number|MP:0002497,increased IgE level|MP:0008097,increased plasma cell number|MP:0008728,increased memory B cell number|MP:0014471,enhanced B cell migration
MGI:3838714	Igh-7<tm1Lam>	MP:0002492,decreased IgE level|MP:0008211,decreased mature B cell number
MGI:4461407	Igh-7<tm1Lcwu>	MP:0002492,decreased IgE level|MP:0008211,decreased mature B cell number
MGI:2387579	Igh-7<tm1Led>	MP:0005387,immune system phenotype|MP:0008723,impaired eosinophil recruitment
MGI:4950362	Igh-8<tm1.1Aak>	MP:0004816,abnormal class switch recombination
MGI:3622072	Igh-8<tm1Aak>	MP:0004816,abnormal class switch recombination
MGI:2158494	Igh-8<tm1Schr>	MP:0002412,increased susceptibility to bacterial infection|MP:0002493,increased IgG level|MP:0002494,increased IgM level
MGI:4950363	Igh-8<tm2.1Aak>	MP:0005387,immune system phenotype
MGI:3774279	Igh-8<tm2(Ighg1)Aak>	MP:0004816,abnormal class switch recombination|MP:0008498,decreased IgG3 level
MGI:1857185	Igha<tm1Grh>	MP:0001807,decreased IgA level|MP:0001828,abnormal T cell activation|MP:0002376,abnormal dendritic cell physiology|MP:0002490,abnormal immunoglobulin level|MP:0002492,decreased IgE level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0005027,increased susceptibility to parasitic infection|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008051,abnormal memory T cell physiology|MP:0008498,decreased IgG3 level|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008566,increased interferon-gamma secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008699,increased interleukin-4 secretion|MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:3046399	Igha<tm1(Myc)Janz>	MP:0002023,increased B cell derived lymphoma incidence|MP:0005154,increased B cell proliferation|MP:0008097,increased plasma cell number|MP:0008782,increased B cell apoptosis
MGI:2154386	Igha<tm2Grh>	MP:0004816,abnormal class switch recombination
MGI:4819235	Ighd<dmit>	MP:0002490,abnormal immunoglobulin level
MGI:3574367	Igh<deltaD>	MP:0000689,abnormal spleen morphology|MP:0001802,arrested B cell differentiation|MP:0002144,abnormal B cell differentiation|MP:0002460,decreased immunoglobulin level|MP:0002490,abnormal immunoglobulin level|MP:0002495,increased IgA level|MP:0005017,decreased B cell number|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008495,decreased IgG1 level
MGI:6114049	Ighd<M1Btlr>	MP:0002491,decreased IgD level|MP:0005017,decreased B cell number
MGI:6114054	Ighd<m2Btlr>	MP:0002491,decreased IgD level|MP:0005017,decreased B cell number
MGI:1857186	Ighd<tm1Cgn>	MP:0001790,abnormal immune system physiology|MP:0002492,decreased IgE level
MGI:3653691	Ighd<tm1Lam>	MP:0002459,abnormal B cell physiology|MP:0002495,increased IgA level|MP:0005017,decreased B cell number|MP:0005460,abnormal leukopoiesis|MP:0008497,decreased IgG2b level
MGI:6268355	Ighe<M1Btlr>	MP:0002492,decreased IgE level
MGI:6400764	Ighg1<em1Wliu>	MP:0002006,neoplasm|MP:0003725,increased autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0008097,increased plasma cell number|MP:0008099,abnormal plasma cell differentiation|MP:0008177,increased germinal center B cell number|MP:0008499,increased IgG1 level|MP:0020155,enhanced humoral immune response
MGI:2669501	Ighg1<tm1.1Ksho>	MP:0002459,abnormal B cell physiology|MP:0008495,decreased IgG1 level
MGI:5502698	Ighg1<tm1.1Pyu>	MP:0002497,increased IgE level|MP:0005387,immune system phenotype|MP:0005534,decreased body temperature|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008495,decreased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008897,decreased IgG2c level|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:2669500	Ighg1<tm1Ksho>	MP:0002459,abnormal B cell physiology|MP:0008094,absent memory B cells|MP:0008495,decreased IgG1 level
MGI:3837936	Ighg1<tm2Cgn>	MP:0004816,abnormal class switch recombination|MP:0008495,decreased IgG1 level
MGI:4850022	Ighg1<tm3Cgn>	MP:0004816,abnormal class switch recombination|MP:0008495,decreased IgG1 level
MGI:4850023	Ighg1<tm4Cgn>	MP:0005387,immune system phenotype
MGI:7627370	Ighg2c<em1Wliu>	MP:0002053,decreased incidence of induced tumors|MP:0002376,abnormal dendritic cell physiology|MP:0002451,abnormal macrophage physiology|MP:0003447,decreased tumor growth/size|MP:0004502,decreased incidence of tumors by chemical induction|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008099,abnormal plasma cell differentiation|MP:0008177,increased germinal center B cell number|MP:0008539,decreased susceptibility to induced colitis|MP:0008728,increased memory B cell number|MP:0008896,increased IgG2c level|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0011075,abnormal macrophage activation involved in immune response|MP:0013654,increased CD103-positive CD11b-low dendritic cell number
MGI:7627371	Ighg2c<em2Wliu>	MP:0001798,impaired macrophage phagocytosis|MP:0003721,increased tumor growth/size|MP:0008099,abnormal plasma cell differentiation|MP:0008178,decreased germinal center B cell number|MP:0008729,decreased memory B cell number|MP:0008897,decreased IgG2c level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011075,abnormal macrophage activation involved in immune response
MGI:4421672	Igh-J<tm1.1Lave>	MP:0001802,arrested B cell differentiation|MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0002490,abnormal immunoglobulin level|MP:0002493,increased IgG level|MP:0003132,increased pre-B cell number|MP:0004953,decreased spleen weight|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008186,increased pro-B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0009923,decreased transitional stage T1 B cell number|MP:0009926,decreased transitional stage T2 B cell number
MGI:3513167	Igh-J<tm1(3H9-VDJ)Mwg>	MP:0008766,abnormal B cell receptor editing
MGI:3665428	Igh-J<tm1Aigl>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004939,abnormal B cell morphology|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number
MGI:3581661	Igh-J<tm1Bds>	MP:0002169,no abnormal phenotype detected
MGI:5304723	Igh-J<tm1(CB20)Rhd>	MP:0002144,abnormal B cell differentiation|MP:0003724,increased susceptibility to induced arthritis|MP:0008181,increased marginal zone B cell number|MP:0008209,decreased pre-B cell number|MP:0008210,increased mature B cell number|MP:0008214,increased immature B cell number
MGI:1861941	Igh-J<tm1Cgn>	MP:0001802,arrested B cell differentiation|MP:0002144,abnormal B cell differentiation|MP:0008212,absent mature B cells
MGI:2388068	Igh-J<tm1Jkbv>	MP:0001802,arrested B cell differentiation|MP:0001806,decreased IgM level|MP:0003134,increased late pro-B cell number|MP:0006387,abnormal T cell number|MP:0008071,absent B cells|MP:0008212,absent mature B cells
MGI:3641272	Igh-J<tm1Khyk>	MP:0004977,increased B-1 B cell number|MP:0005397,hematopoietic system phenotype
MGI:2681436	Igh-J<tm1(VDJ-KL25)Zbz>	MP:0002493,increased IgG level|MP:0002494,increased IgM level
MGI:2681437	Igh-J<tm1(VDJ-VI10)Zbz>	MP:0002723,abnormal immune serum protein physiology
MGI:5550246	Igh-J<tm2.1(4E10)Lave>	MP:0001802,arrested B cell differentiation|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0008168,decreased B-1a cell number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:3762369	Igh-J<tm2(3H9-VDJ*)Mwg>	MP:0000694,spleen hypoplasia|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005017,decreased B cell number|MP:0008180,abnormal marginal zone B cell morphology|MP:0008181,increased marginal zone B cell number|MP:0008766,abnormal B cell receptor editing
MGI:5550247	Igh-J<tm3.1(48d)Lave>	MP:0001806,decreased IgM level|MP:0005387,immune system phenotype|MP:0008168,decreased B-1a cell number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level
MGI:3808989	Igh-J<tm3(3H9-VDJ*)Mwg>	MP:0004762,increased anti-double stranded DNA antibody level|MP:0008766,abnormal B cell receptor editing
MGI:7314213	Ighmbp2<em1Cll>	MP:0000938,motor neuron degeneration|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001510,abnormal coat appearance|MP:0001523,impaired righting response|MP:0001957,apnea|MP:0002269,muscular atrophy|MP:0002327,abnormal respiratory function|MP:0005574,decreased pulmonary respiratory rate|MP:0005576,decreased pulmonary ventilation|MP:0005585,increased tidal volume|MP:0009400,decreased skeletal muscle fiber size|MP:0011085,postnatal lethality, complete penetrance
MGI:7495583	Ighmbp2<em1Cx>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0001405,impaired coordination|MP:0001516,abnormal motor coordination/balance|MP:0001973,increased thermal nociceptive threshold|MP:0002269,muscular atrophy|MP:0003177,allodynia|MP:0003225,axonal dystrophy|MP:0005150,cachexia|MP:0005385,cardiovascular system phenotype|MP:0009413,skeletal muscle fiber atrophy|MP:0009434,paraparesis|MP:0010053,decreased grip strength|MP:0010239,decreased skeletal muscle weight|MP:0013138,thin body
MGI:6156604	Ighmbp2<em1(IMPC)Tcp>	MP:0002060,abnormal skin morphology|MP:0003068,enlarged kidney|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:7495802	Ighmbp2<em5Cx>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001516,abnormal motor coordination/balance|MP:0002269,muscular atrophy|MP:0003225,axonal dystrophy|MP:0008814,decreased nerve conduction velocity|MP:0010053,decreased grip strength
MGI:1857647	Ighmbp2<nmd>	MP:0000749,muscle degeneration|MP:0002083,premature death
MGI:1857648	Ighmbp2<nmd-2J>	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0000280,thin ventricular wall|MP:0000285,abnormal heart valve morphology|MP:0000749,muscle degeneration|MP:0000755,hindlimb paralysis|MP:0000938,motor neuron degeneration|MP:0001052,abnormal innervation pattern to muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001106,abnormal Schwann cell morphology|MP:0001263,weight loss|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001515,abnormal grip strength|MP:0001544,abnormal cardiovascular system physiology|MP:0002083,premature death|MP:0002279,abnormal diaphragm morphology|MP:0002795,dilated cardiomyopathy|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003137,abnormal impulse conducting system conduction|MP:0003140,dilated heart atrium|MP:0003828,pulmonary edema|MP:0003851,skeletal muscle interstitial fibrosis|MP:0003896,prolonged PR interval|MP:0003898,abnormal QRS complex|MP:0003928,increased heart rate variability|MP:0004071,prolonged P wave|MP:0004235,abnormal masseter muscle morphology|MP:0004239,abnormal temporalis muscle morphology|MP:0004566,myocardial fiber degeneration|MP:0005294,abnormal heart ventricle morphology|MP:0005333,decreased heart rate|MP:0005404,abnormal axon morphology|MP:0005574,decreased pulmonary respiratory rate|MP:0005608,cardiac interstitial fibrosis|MP:0006085,myocardium necrosis|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006267,abnormal intercalated disk morphology|MP:0008022,dilated heart ventricle|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009413,skeletal muscle fiber atrophy|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0010334,pleural effusion|MP:0020378,abnormal cell cytoskeleton morphology
MGI:4950361	Ighm<tm1.1Aak>	MP:0004816,abnormal class switch recombination|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0008186,increased pro-B cell number|MP:0008209,decreased pre-B cell number
MGI:4437126	Ighm<tm1.1(IGH-2)Cog>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002144,abnormal B cell differentiation|MP:0002217,small lymph nodes|MP:0004978,decreased B-1 B cell number|MP:0005014,increased B cell number|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0005154,increased B cell proliferation|MP:0005387,immune system phenotype|MP:0008097,increased plasma cell number|MP:0008099,abnormal plasma cell differentiation|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008186,increased pro-B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008498,decreased IgG3 level
MGI:3581517	Ighm<tm1(Bcl6)Rdf>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0002460,decreased immunoglobulin level|MP:0005153,abnormal B cell proliferation|MP:0008098,decreased plasma cell number|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008478,increased spleen white pulp amount|MP:0008481,increased spleen germinal center number
MGI:5297544	Ighm<tm1Bhe>	MP:0002471,abnormal complement pathway|MP:0002473,impaired complement classical pathway|MP:0002723,abnormal immune serum protein physiology
MGI:1857187	Ighm<tm1Cgn>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000488,abnormal intestinal epithelium morphology|MP:0000689,abnormal spleen morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001800,abnormal humoral immune response|MP:0001802,arrested B cell differentiation|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0001835,abnormal antigen presentation|MP:0001879,abnormal lymphatic vessel morphology|MP:0002133,abnormal respiratory system physiology|MP:0002144,abnormal B cell differentiation|MP:0002363,abnormal spleen marginal sinus morphology|MP:0002460,decreased immunoglobulin level|MP:0002492,decreased IgE level|MP:0003009,abnormal cytokine secretion|MP:0003724,increased susceptibility to induced arthritis|MP:0003797,abnormal compact bone morphology|MP:0004031,insulitis|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0004953,decreased spleen weight|MP:0004984,increased osteoclast cell number|MP:0005025,abnormal response to infection|MP:0005027,increased susceptibility to parasitic infection|MP:0005094,abnormal T cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005166,decreased susceptibility to injury|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0006387,abnormal T cell number|MP:0008071,absent B cells|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008127,decreased dendritic cell number|MP:0008201,absent follicular dendritic cells|MP:0008212,absent mature B cells|MP:0008213,absent immature B cells|MP:0008240,abnormal spleen marginal zone macrophage morphology|MP:0008241,abnormal metallophilic macrophage morphology|MP:0008401,abnormal CD8 positive, alpha-beta intraepithelial T cell morphology|MP:0008495,decreased IgG1 level|MP:0009346,decreased trabecular bone thickness|MP:0010965,decreased compact bone volume|MP:0014263,decreased spleen B cell follicle number
MGI:1934014	Ighm<tm1Che>	MP:0000689,abnormal spleen morphology|MP:0001790,abnormal immune system physiology|MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0002357,abnormal spleen white pulp morphology|MP:0002358,abnormal spleen periarteriolar lymphoid sheath morphology|MP:0002359,abnormal spleen germinal center morphology|MP:0002362,abnormal spleen marginal zone morphology|MP:0002459,abnormal B cell physiology|MP:0002495,increased IgA level|MP:0004977,increased B-1 B cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0008198,abnormal follicular dendritic cell antigen presentation|MP:0008241,abnormal metallophilic macrophage morphology|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008500,increased IgG2a level|MP:0008502,increased IgG3 level
MGI:3037070	Ighm<tm1Fbb>	MP:0005387,immune system phenotype|MP:0020913,increased susceptibility to Riboviria infection
MGI:2447178	Ighm<tm1Msn>	MP:0001806,decreased IgM level|MP:0001859,kidney inflammation|MP:0003725,increased autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005022,abnormal immature B cell morphology|MP:0008164,abnormal B-1a B cell morphology|MP:0008171,abnormal mature B cell morphology|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008495,decreased IgG1 level|MP:0008502,increased IgG3 level|MP:0008826,abnormal splenic cell ratio
MGI:3582575	Ighm<tm1Sls>	MP:0001805,decreased IgG level|MP:0002494,increased IgM level|MP:0004816,abnormal class switch recombination|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:3701077	Ighm<tm2.1Bgmn>	MP:0001790,abnormal immune system physiology|MP:0001802,arrested B cell differentiation|MP:0002460,decreased immunoglobulin level|MP:0008212,absent mature B cells
MGI:2445756	Ighm<tm2.1Che>	MP:0002169,no abnormal phenotype detected
MGI:3774509	Ighm<tm3Bgmn>	MP:0001806,decreased IgM level|MP:0004977,increased B-1 B cell number|MP:0005093,decreased B cell proliferation|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008217,abnormal B cell activation
MGI:3774510	Ighm<tm4Bgmn>	MP:0001806,decreased IgM level|MP:0004977,increased B-1 B cell number|MP:0005093,decreased B cell proliferation|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008217,abnormal B cell activation
MGI:3687002	Igh<tm11.1Cgn>	MP:0002144,abnormal B cell differentiation|MP:0005017,decreased B cell number|MP:0008186,increased pro-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number
MGI:5505302	Igh<tm1.1(b12)Nemz>	MP:0001806,decreased IgM level|MP:0005014,increased B cell number|MP:0008215,decreased immature B cell number
MGI:3815456	Igh<tm1.1Cog>	MP:0002169,no abnormal phenotype detected
MGI:3814340	Igh<tm1.1Hmj>	MP:0000694,spleen hypoplasia|MP:0002144,abnormal B cell differentiation|MP:0005387,immune system phenotype|MP:0008211,decreased mature B cell number|MP:0008760,abnormal immunoglobulin heavy chain V(D)J recombination
MGI:3702187	Igh<tm1.1Hws>	MP:0001806,decreased IgM level|MP:0002460,decreased immunoglobulin level|MP:0002494,increased IgM level|MP:0003133,increased early pro-B cell number|MP:0003134,increased late pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008215,decreased immature B cell number|MP:0008502,increased IgG3 level|MP:0014404,decreased late pro-B cell number
MGI:3702524	Igh<tm1.1Lnit>	MP:0002144,abnormal B cell differentiation
MGI:7435233	Igh<tm1.1(Rr361-HBB)Aak>	MP:0001807,decreased IgA level|MP:0002492,decreased IgE level|MP:0004816,abnormal class switch recombination|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level
MGI:3760655	Igh<tm1.1Rsky>	MP:0001806,decreased IgM level|MP:0004816,abnormal class switch recombination
MGI:3850722	Igh<tm1.1(Tag)Rwhe>	MP:0000691,enlarged spleen|MP:0002026,increased leukemia incidence|MP:0004939,abnormal B cell morphology|MP:0005014,increased B cell number|MP:0008102,lymph node hyperplasia|MP:0010337,increased chronic lymphocytic leukemia incidence
MGI:5140396	Igh<tm1.1Twin>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0002458,abnormal B cell number|MP:0004939,abnormal B cell morphology|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0008100,absent plasma cells|MP:0008168,decreased B-1a cell number|MP:0008174,decreased follicular B cell number|MP:0008180,abnormal marginal zone B cell morphology|MP:0008186,increased pro-B cell number|MP:0008193,abnormal marginal zone B cell physiology|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008498,decreased IgG3 level|MP:0009926,decreased transitional stage T2 B cell number
MGI:5553164	Igh<tm1.1Vmd>	MP:0002497,increased IgE level|MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype|MP:0008495,decreased IgG1 level|MP:0008498,decreased IgG3 level
MGI:3790800	Igh<tm12Cgn>	MP:0004815,abnormal somatic hypermutation frequency
MGI:3760662	Igh<tm1.2Rsky>	MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002460,decreased immunoglobulin level|MP:0002491,decreased IgD level|MP:0002492,decreased IgE level|MP:0004816,abnormal class switch recombination|MP:0004939,abnormal B cell morphology|MP:0005153,abnormal B cell proliferation|MP:0008168,decreased B-1a cell number|MP:0008171,abnormal mature B cell morphology|MP:0008181,increased marginal zone B cell number|MP:0008186,increased pro-B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008209,decreased pre-B cell number|MP:0008217,abnormal B cell activation|MP:0008499,increased IgG1 level
MGI:4439311	Igh<tm1Aak>	MP:0002144,abnormal B cell differentiation|MP:0005017,decreased B cell number|MP:0008186,increased pro-B cell number|MP:0008209,decreased pre-B cell number
MGI:2388483	Igh<tm1Cgn>	MP:0002144,abnormal B cell differentiation
MGI:2447194	Igh<tm1Cog>	MP:0001802,arrested B cell differentiation|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002460,decreased immunoglobulin level|MP:0002492,decreased IgE level|MP:0008071,absent B cells|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008760,abnormal immunoglobulin heavy chain V(D)J recombination
MGI:3624530	Igh<tm1Emo>	MP:0005387,immune system phenotype
MGI:3805804	Igh<tm1(Ighppc1-5)Cche>	MP:0003725,increased autoantibody level|MP:0005387,immune system phenotype
MGI:5609985	Igh<tm1(IGH)Vlcg>	MP:0001922,reduced male fertility
MGI:3692558	Igh<tm1Kplm>	MP:0002144,abnormal B cell differentiation|MP:0004940,abnormal B-1 B cell morphology|MP:0005014,increased B cell number
MGI:5305473	Igh<tm1Ktom>	MP:0002459,abnormal B cell physiology|MP:0002490,abnormal immunoglobulin level|MP:0008212,absent mature B cells
MGI:3830835	Igh<tm1Leck>	MP:0004939,abnormal B cell morphology|MP:0005017,decreased B cell number|MP:0005022,abnormal immature B cell morphology|MP:0008164,abnormal B-1a B cell morphology|MP:0008171,abnormal mature B cell morphology|MP:0008761,abnormal immunoglobulin light chain V-J recombination
MGI:3712224	Igh<tm1Mnz>	MP:0002459,abnormal B cell physiology|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0003077,abnormal cell cycle|MP:0005154,increased B cell proliferation|MP:0008782,increased B cell apoptosis
MGI:3574400	Igh<tm1(Myc)Janz>	MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0003448,abnormal tumor morphology|MP:0005154,increased B cell proliferation|MP:0008782,increased B cell apoptosis|MP:0010286,increased plasmacytoma incidence
MGI:3699130	Igh<tm1(PAX5)Mbu>	MP:0000266,abnormal heart morphology|MP:0000598,abnormal liver morphology|MP:0000613,abnormal salivary gland morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001175,abnormal lung morphology|MP:0001823,thymus hypoplasia|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002145,abnormal T cell differentiation|MP:0002339,abnormal lymph node morphology|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008186,increased pro-B cell number|MP:0012431,increased lymphoma incidence
MGI:3800383	Igh<tm1Rbr>	MP:0004939,abnormal B cell morphology
MGI:3773307	Igh<tm1(VH558)Mss>	MP:0002144,abnormal B cell differentiation
MGI:4818343	Igh<tm2.1Fwa>	MP:0002497,increased IgE level|MP:0004815,abnormal somatic hypermutation frequency|MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype|MP:0008211,decreased mature B cell number|MP:0008495,decreased IgG1 level
MGI:3757674	Igh<tm2.1Hws>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0003133,increased early pro-B cell number|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005017,decreased B cell number|MP:0008168,decreased B-1a cell number|MP:0008170,decreased B-1b cell number|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0014404,decreased late pro-B cell number
MGI:3850723	Igh<tm2.1(Tag)Rwhe>	MP:0000691,enlarged spleen|MP:0002026,increased leukemia incidence|MP:0004939,abnormal B cell morphology|MP:0005014,increased B cell number|MP:0008102,lymph node hyperplasia|MP:0010337,increased chronic lymphocytic leukemia incidence
MGI:2388486	Igh<tm2Cgn>	MP:0002144,abnormal B cell differentiation|MP:0008761,abnormal immunoglobulin light chain V-J recombination
MGI:3624531	Igh<tm2Emo>	MP:0000238,absent pre-B cells|MP:0002144,abnormal B cell differentiation
MGI:5609987	Igh<tm2(IGH)Vlcg>	MP:0001922,reduced male fertility
MGI:3712225	Igh<tm2Mnz>	MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0005154,increased B cell proliferation|MP:0005384,cellular phenotype
MGI:5609988	Igh<tm3.1(IGH)Vlcg>	MP:0001922,reduced male fertility
MGI:3609137	Igh<tm3.1Tim>	MP:0000172,abnormal bone marrow cell number|MP:0002144,abnormal B cell differentiation|MP:0008470,abnormal spleen B cell follicle morphology
MGI:2388492	Igh<tm3Cgn>	MP:0001790,abnormal immune system physiology|MP:0002144,abnormal B cell differentiation|MP:0008215,decreased immature B cell number
MGI:3822178	Igh<tm3Hws>	MP:0000333,decreased bone marrow cell number|MP:0000694,spleen hypoplasia|MP:0001806,decreased IgM level|MP:0002490,abnormal immunoglobulin level|MP:0002494,increased IgM level|MP:0005017,decreased B cell number|MP:0008174,decreased follicular B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008760,abnormal immunoglobulin heavy chain V(D)J recombination|MP:0014404,decreased late pro-B cell number
MGI:6696097	Igh<tm3(IGH)Vlcg>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0005389,reproductive system phenotype|MP:0031012,impaired sperm migration in female genital tract
MGI:3609136	Igh<tm3Tim>	MP:0000172,abnormal bone marrow cell number|MP:0002144,abnormal B cell differentiation|MP:0008470,abnormal spleen B cell follicle morphology
MGI:5320879	Igh<tm4.1Cog>	MP:0001807,decreased IgA level|MP:0002494,increased IgM level|MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype
MGI:5295439	Igh<tm4.1Fwa>	MP:0002144,abnormal B cell differentiation|MP:0008755,abnormal immunoglobulin V(D)J recombination
MGI:6696096	Igh<tm4.1(IGH,Adam6a,Adam6b)Vlcg>	MP:0005389,reproductive system phenotype
MGI:2388394	Igh<tm4Cgn>	MP:0002144,abnormal B cell differentiation
MGI:3653375	Igh<tm4Cog>	MP:0000692,small spleen|MP:0001806,decreased IgM level|MP:0002495,increased IgA level|MP:0002831,absent Peyer's patches|MP:0008474,absent spleen germinal center
MGI:3037893	Igh<tm5.1Cgn>	MP:0002144,abnormal B cell differentiation|MP:0002378,abnormal gut-associated lymphoid tissue morphology|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0005017,decreased B cell number|MP:0008171,abnormal mature B cell morphology|MP:0008182,decreased marginal zone B cell number|MP:0008186,increased pro-B cell number|MP:0008202,absent B-1 B cells|MP:0008203,absent B-1a cells|MP:0008204,absent B-1b cells|MP:0008215,decreased immature B cell number|MP:0008217,abnormal B cell activation|MP:0008474,absent spleen germinal center|MP:0008522,abnormal lymph node germinal center morphology
MGI:5295440	Igh<tm5.1Fwa>	MP:0002144,abnormal B cell differentiation|MP:0005387,immune system phenotype|MP:0008209,decreased pre-B cell number
MGI:3037892	Igh<tm5Cgn>	MP:0001802,arrested B cell differentiation|MP:0002144,abnormal B cell differentiation|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0005014,increased B cell number|MP:0008071,absent B cells|MP:0008171,abnormal mature B cell morphology|MP:0008175,absent follicular B cells|MP:0008183,absent marginal zone B cells|MP:0008186,increased pro-B cell number
MGI:5295441	Igh<tm6Fwa>	MP:0005387,immune system phenotype
MGI:5295442	Igh<tm7.1Fwa>	MP:0005387,immune system phenotype
MGI:3640325	Igh<tm7(VHB1-8)Cgn>	MP:0004815,abnormal somatic hypermutation frequency
MGI:3640326	Igh<tm8(VHB1-8)Cgn>	MP:0004815,abnormal somatic hypermutation frequency
MGI:3640327	Igh<tm9(VHB1-8)Cgn>	MP:0004815,abnormal somatic hypermutation frequency
MGI:3665278	Igh-V7183<tm1Cgn>	MP:0005387,immune system phenotype
MGI:3701360	Igh-V<tm1(Igh-Vx24)Hmb>	MP:0000351,increased cell proliferation|MP:0002024,increased T cell derived lymphoma incidence|MP:0006042,increased apoptosis|MP:0012431,increased lymphoma incidence
MGI:2385812	Igh-V<tm1Jjk>	MP:0002412,increased susceptibility to bacterial infection|MP:0002420,abnormal adaptive immunity
MGI:3652576	Igkc<tm1Bgmn>	MP:0000696,abnormal Peyer's patch morphology|MP:0001800,abnormal humoral immune response|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002458,abnormal B cell number
MGI:1857188	Igkc<tm1Cgn>	MP:0000694,spleen hypoplasia|MP:0002144,abnormal B cell differentiation|MP:0008210,increased mature B cell number|MP:0008211,decreased mature B cell number|MP:0008214,increased immature B cell number
MGI:3802625	Igkc<tm1Jkbv>	MP:0002144,abnormal B cell differentiation|MP:0002490,abnormal immunoglobulin level|MP:0003132,increased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008761,abnormal immunoglobulin light chain V-J recombination
MGI:3664449	Igkc<tm2(IGKC)Cgn>	MP:0002144,abnormal B cell differentiation|MP:0005387,immune system phenotype
MGI:3046652	Igkj1<tm1Mss>	MP:0002169,no abnormal phenotype detected
MGI:5305129	Igk-J<tm1.1Lave>	MP:0005387,immune system phenotype
MGI:3663520	Igk-J<tm1Cog>	MP:0002459,abnormal B cell physiology|MP:0005017,decreased B cell number
MGI:3775730	Igkrs<tm1Nemz>	MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008761,abnormal immunoglobulin light chain V-J recombination
MGI:5505300	Igk<tm1.1(b12)Nemz>	MP:0005387,immune system phenotype
MGI:3795280	Igk<tm1.1Cog>	MP:0000198,decreased circulating phosphate level|MP:0002901,increased urine phosphate level|MP:0002962,increased urine protein level|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0008822,decreased blood uric acid level|MP:0009810,increased urine uric acid level|MP:0011352,proximal convoluted tubule brush border loss
MGI:3829662	Igk<tm1Mss>	MP:0002169,no abnormal phenotype detected
MGI:3720251	Igk<tm2Ybgn>	MP:0008209,decreased pre-B cell number|MP:0008214,increased immature B cell number
MGI:2680012	Iglc1<tm1Ust>	MP:0002458,abnormal B cell number|MP:0005013,increased lymphocyte cell number
MGI:2657246	Iglc1<tm2Ust>	MP:0005017,decreased B cell number|MP:0008761,abnormal immunoglobulin light chain V-J recombination
MGI:1857189	Igll1<tm1Cgn>	MP:0000694,spleen hypoplasia|MP:0001805,decreased IgG level|MP:0002401,abnormal lymphopoiesis|MP:0002403,abnormal pre-B cell morphology|MP:0004939,abnormal B cell morphology|MP:0004976,abnormal B-1 B cell number|MP:0005017,decreased B cell number|MP:0008186,increased pro-B cell number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:6276893	Iglon5<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001399,hyperactivity|MP:0001447,abnormal nest building behavior|MP:0001525,impaired balance|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002574,increased vertical activity|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0003631,nervous system phenotype|MP:0009710,anhedonia|MP:0020379,abnormal sucrose solution preference
MGI:2662343	Igl<tm1Cgn>	MP:0005387,immune system phenotype
MGI:3706154	Ignpq1<HIGA/Nsc>	MP:0002495,increased IgA level
MGI:3706156	Ignpq2<HIGA/Nsc>	MP:0002495,increased IgA level
MGI:3706158	Ignpq3<HIGA/Nsc>	MP:0002743,glomerulonephritis|MP:0020519,renal glomerular immunoglobulin deposits
MGI:5544083	Igs1<tm11(CAG-Bgeo,-Edn2)Nat>	MP:0000111,cleft palate|MP:0000259,abnormal vascular development|MP:0000260,abnormal angiogenesis|MP:0000274,enlarged heart|MP:0000929,open neural tube|MP:0001325,abnormal retina morphology|MP:0001634,internal hemorrhage|MP:0002080,prenatal lethality|MP:0002082,postnatal lethality|MP:0002792,abnormal retina vasculature morphology|MP:0003099,retina detachment|MP:0003984,embryonic growth retardation|MP:0005039,hypoxia|MP:0006186,retina fibrosis|MP:0008507,thin retina ganglion layer|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0009264,failure of eyelid fusion|MP:0009385,abnormal dermal pigmentation|MP:0010097,abnormal retina blood vessel morphology|MP:0010098,abnormal retina blood vessel pattern|MP:0021107,retina fold
MGI:4412094	Igs1<tm2(CAG-Bgeo,-Ndp,-EGFP)Nat>	MP:0000260,abnormal angiogenesis|MP:0003984,embryonic growth retardation|MP:0009865,abnormal aorta smooth muscle morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:5314813	Igs1<tm4(CAG-Bgeo,-Vangl2)Nat>	MP:0005266,abnormal metabolism
MGI:5319537	Igs1<tm6(CAG-Bgeo,-Wnt5a)Nat>	MP:0002169,no abnormal phenotype detected
MGI:6718455	Igs2<em1(Alb-Golm1)Jdon>	MP:0004499,increased incidence of tumors by chemical induction|MP:0005165,increased susceptibility to injury|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:8220101	Igs2<em1(Rnu6-RNAi:mt-Cytb)Lixg>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0008871,abnormal ovarian follicle number
MGI:6456816	Igs2<em5(CAG-Mir802)Gpt>	MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0005293,impaired glucose tolerance|MP:0009114,decreased pancreatic beta cell mass|MP:0009175,abnormal pancreatic beta cell differentiation
MGI:4837736	Igs2<tm1(ACTB-EGFP,-tdTomato)Luo>	MP:0002169,no abnormal phenotype detected
MGI:5520969	Igs2<tm1(ACTB-EGFP,-tdTomato)Zng>	MP:0002169,no abnormal phenotype detected
MGI:5640626	Igs2<tm1(CAG-cas9*)Mmw>	MP:0002169,no abnormal phenotype detected
MGI:6507851	Igs2<tm1(CAG-Met)Zsu>	MP:0005379,endocrine/exocrine gland phenotype|MP:0009219,increased prostate intraepithelial neoplasia incidence
MGI:5660493	Igs2<tm1(CAG-mt-Keima)Fink>	MP:0002169,no abnormal phenotype detected
MGI:7314909	Igs2<tm1(CAG-Ptgs2os)Scrp>	MP:0008593,increased circulating interleukin-10 level|MP:0010210,abnormal circulating cytokine level
MGI:4837863	Igs2<tm2(ACTB-tdTomato,-EGFP)Luo>	MP:0002169,no abnormal phenotype detected
MGI:5520975	Igs2<tm2(ACTB-tdTomato,-EGFP)Zng>	MP:0002169,no abnormal phenotype detected
MGI:7407293	Igs47<em1(Rr325)Smun>	MP:0000060,delayed bone ossification|MP:0000111,cleft palate|MP:0000445,short snout|MP:0004686,decreased length of long bones|MP:0005371,limbs/digits/tail phenotype|MP:0011089,perinatal lethality, complete penetrance
MGI:5469286	Igs4<tm1Hsas>	MP:0010768,mortality/aging
MGI:5470394	Igs5<tm1(ACTB-tdTomato,-EGFP)Luo>	MP:0002169,no abnormal phenotype detected
MGI:5470395	Igs5<tm2.1(ACTB-EGFP,-tdTomato)Luo>	MP:0002169,no abnormal phenotype detected
MGI:5470396	Igs6<tm1(ACTB-tdTomato,-EGFP)Luo>	MP:0002169,no abnormal phenotype detected
MGI:5470397	Igs6<tm2(ACTB-EGFP,-tdTomato)Luo>	MP:0002169,no abnormal phenotype detected
MGI:3798884	Igs7<tm1(tetO-Apoe)Gaga>	MP:0005178,increased circulating cholesterol level|MP:0005339,increased susceptibility to atherosclerosis
MGI:5490616	Igs7<tm62.1(tetO-tdTomato)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5558051	Igs7<tm78.1(tetO-VSFPB1.2)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5558064	Igs7<tm79.1(tetO-hop/EGFP)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5558068	Igs7<tm82.1(tetO-EGFP)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5645698	Igs7<tm85.1(tetO-gltI/GFP*)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5558069	Igs7<tm90.1(tetO-COP4*/EGFP)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5645699	Igs7<tm92.1(tetO-ECFP*/Venus*)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5558086	Igs7<tm93.1(tetO-GCaMP6f)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5607576	Igs7<tm94.1(tetO-GCaMP6s)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5473422	Igs86<tm1.1Low>	MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype
MGI:5473420	Igs86<tm1Low>	MP:0001257,increased body length|MP:0001259,abnormal body weight|MP:0001260,increased body weight|MP:0001261,obese|MP:0001402,decreased locomotor activity|MP:0001433,polyphagia|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0003960,increased lean body mass|MP:0005290,decreased oxygen consumption|MP:0005331,insulin resistance|MP:0005455,increased susceptibility to weight gain|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0010024,increased total body fat amount|MP:0011940,decreased food intake|MP:0011957,decreased compensatory feeding amount
MGI:5584160	Igs8<tm1Jw>	MP:0002169,no abnormal phenotype detected
MGI:4364956	Igsf11<tm1a(KOMP)Wtsi>	MP:0003631,nervous system phenotype|MP:0011270,decreased excitatory postsynaptic current amplitude
MGI:5509325	Igsf11<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001925,male infertility|MP:0013279,increased fasting circulating glucose level
MGI:5897622	Igsf11<tm1d(KOMP)Wtsi>	MP:0001473,reduced long-term potentiation|MP:0003631,nervous system phenotype|MP:0011270,decreased excitatory postsynaptic current amplitude
MGI:2671049	Igsf1<tm1Zuk>	MP:0000633,abnormal pituitary gland morphology|MP:0001260,increased body weight|MP:0002169,no abnormal phenotype detected|MP:0003503,decreased activity of thyroid gland|MP:0005119,decreased circulating thyroid-stimulating hormone level|MP:0005134,decreased thyroid-stimulating hormone level|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005479,decreased circulating triiodothyronine level
MGI:5511724	Igsf21<tm2a(EUCOMM)Hmgu>	MP:0003631,nervous system phenotype|MP:0004792,abnormal synaptic vesicle number|MP:0005386,behavior/neurological phenotype|MP:0009142,decreased prepulse inhibition|MP:0014383,decreased miniature inhibitory postsynaptic current frequency
MGI:7626255	Igsf3<em1Laap>	MP:0001044,abnormal enteric nervous system morphology|MP:0001046,abnormal enteric neuron morphology|MP:0002184,abnormal innervation|MP:0008108,abnormal small intestinal villus morphology|MP:0008802,abnormal intestinal smooth muscle morphology|MP:0013007,abnormal vagal neural crest cell migration
MGI:3690127	Igsf5<tm1Ohbo>	MP:0002169,no abnormal phenotype detected
MGI:6140202	Igsf8<em1(IMPC)Wtsi>	MP:0005293,impaired glucose tolerance
MGI:6157961	Igsf8<tm1.2Osb>	MP:0005389,reproductive system phenotype
MGI:6107617	Igsf9b<em1(IMPC)J>	MP:0001319,irregularly shaped pupil|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002574,increased vertical activity
MGI:6101173	Igsf9<em1(IMPC)J>	MP:0001566,increased circulating phosphate level|MP:0005553,increased circulating creatinine level
MGI:3784989	Igsf9<tm1Kln>	MP:0002169,no abnormal phenotype detected|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003631,nervous system phenotype|MP:0009538,abnormal synapse morphology|MP:0014383,decreased miniature inhibitory postsynaptic current frequency
MGI:5614204	Igsf9<tm2Kln>	MP:0002169,no abnormal phenotype detected
MGI:2386795	Igtp<tm1Gvw>	MP:0005027,increased susceptibility to parasitic infection|MP:0005387,immune system phenotype|MP:0008577,increased circulating interferon-gamma level|MP:0008647,increased circulating interleukin-12b level
MGI:3842979	Ihh<tm1.1Dcha>	MP:0000164,abnormal cartilage development|MP:0002543,brachyphalangia|MP:0003419,delayed endochondral bone ossification|MP:0005306,abnormal phalanx morphology|MP:0006280,abnormal digit development|MP:0009250,abnormal appendicular skeleton morphology
MGI:1934258	Ihh<tm1Amc>	MP:0000088,short mandible|MP:0000130,abnormal trabecular bone morphology|MP:0000150,abnormal rib morphology|MP:0000164,abnormal cartilage development|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000462,abnormal digestive system morphology|MP:0000496,abnormal small intestine morphology|MP:0000547,short limbs|MP:0000592,short tail|MP:0000767,abnormal smooth muscle morphology|MP:0001048,absent enteric neurons|MP:0001255,decreased body height|MP:0001718,abnormal visceral yolk sac morphology|MP:0001953,respiratory failure|MP:0002110,abnormal digit morphology|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0002427,disproportionate dwarf|MP:0002657,chondrodystrophy|MP:0002731,megacolon|MP:0002764,short tibia|MP:0002765,short fibula|MP:0002896,abnormal bone mineralization|MP:0002926,aganglionic megacolon|MP:0002932,abnormal joint morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003271,abnormal duodenum morphology|MP:0003283,abnormal digestive organ placement|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003723,abnormal long bone morphology|MP:0004200,decreased fetal size|MP:0004340,short scapula|MP:0004351,short humerus|MP:0004359,short ulna|MP:0004672,short ribs|MP:0004686,decreased length of long bones|MP:0004989,decreased osteoblast cell number|MP:0005249,abnormal palatine bone morphology|MP:0005296,abnormal humerus morphology|MP:0005381,digestive/alimentary phenotype|MP:0005391,vision/eye phenotype|MP:0005508,abnormal skeleton morphology|MP:0006261,annular pancreas|MP:0006396,decreased long bone epiphyseal plate size|MP:0008271,abnormal bone ossification|MP:0008915,fused carpal bones|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011585,decreased alkaline phosphatase activity|MP:0014101,decreased chondrocyte proliferation|MP:0014105,abnormal chondrocyte differentiation|MP:0014321,short forelimb|MP:0021208,median cleft palate|MP:0021217,abnormal palatal shelf bone ossification
MGI:3609381	Ihh<tm1Blan>	MP:0000130,abnormal trabecular bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000157,abnormal sternum morphology|MP:0000163,abnormal cartilage morphology|MP:0000547,short limbs|MP:0002082,postnatal lethality|MP:0002110,abnormal digit morphology|MP:0002657,chondrodystrophy|MP:0003419,delayed endochondral bone ossification|MP:0003795,abnormal bone structure|MP:0004053,abnormal synchondrosis|MP:0006397,disorganized long bone epiphyseal plate|MP:0008271,abnormal bone ossification|MP:0010029,abnormal basicranium morphology|MP:0010969,absent compact bone
MGI:6116835	Iho1<tm1.2Atot>	MP:0006379,abnormal spermatocyte morphology
MGI:7439059	Iigp1c<em1Btlr>	MP:0001552,increased circulating triglyceride level|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0009355,increased liver triglyceride level|MP:0010360,decreased liver free fatty acids level|MP:0010951,abnormal lipid oxidation
MGI:6158427	Iigp1c<em1(IMPC)Hmgu>	MP:0001406,abnormal gait|MP:0001486,abnormal startle reflex|MP:0001566,increased circulating phosphate level|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002833,increased heart weight|MP:0010052,increased grip strength
MGI:7439057	Iigp1c<M1Btlr>	MP:0002628,hepatic steatosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0009355,increased liver triglyceride level
MGI:7439058	Iigp1c<M2Btlr>	MP:0009355,increased liver triglyceride level
MGI:3790313	Iigp1<tm1.1Jcho>	MP:0005027,increased susceptibility to parasitic infection
MGI:6712194	Ikbip<em1Bcgen>	MP:0001861,lung inflammation|MP:0008537,increased susceptibility to induced colitis|MP:0008553,increased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level|MP:0008713,abnormal cytokine level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0011079,decreased macrophage cytokine production
MGI:6444679	Ikbkb<em1Macc>	MP:0001828,abnormal T cell activation|MP:0004973,increased regulatory T cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008729,decreased memory B cell number|MP:0013762,abnormal effector T cell number
MGI:6758512	Ikbkb<em1Smoc>	MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
MGI:5691958	Ikbkb<M1Btlr>	MP:0002418,increased susceptibility to viral infection|MP:0002459,abnormal B cell physiology|MP:0005025,abnormal response to infection|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0020002,increased response to antigen
MGI:6304916	Ikbkb<M2Btlr>	MP:0010842,decreased central memory CD4-positive, alpha-beta T cell number
MGI:2678816	Ikbkb<tm1.1Cgn>	MP:0008706,decreased interleukin-6 secretion|MP:0011091,prenatal lethality, complete penetrance|MP:0013501,increased fibroblast apoptosis
MGI:4432305	Ikbkb<tm1a(EUCOMM)Wtsi>	MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2678815	Ikbkb<tm1Cgn>	MP:0001193,psoriasis|MP:0002169,no abnormal phenotype detected|MP:0004947,skin inflammation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3528765	Ikbkb<tm1Lex>	MP:0003799,impaired macrophage chemotaxis|MP:0008719,impaired neutrophil recruitment|MP:0008720,impaired neutrophil chemotaxis|MP:0011706,abnormal fibroblast migration|MP:0011708,decreased fibroblast cell migration|MP:0020416,decreased fibroblast chemotaxis
MGI:1857769	Ikbkb<tm1Mka>	MP:0000607,abnormal hepatocyte morphology|MP:0003103,liver degeneration|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1857761	Ikbkb<tm1Trk>	MP:0000607,abnormal hepatocyte morphology|MP:0003103,liver degeneration|MP:0003887,increased hepatocyte apoptosis|MP:0005621,abnormal cell physiology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0013501,increased fibroblast apoptosis
MGI:2386269	Ikbkb<tm1Ver>	MP:0000601,small liver|MP:0000608,dissociated hepatocytes|MP:0003103,liver degeneration|MP:0003887,increased hepatocyte apoptosis|MP:0003888,liver hemorrhage|MP:0005621,abnormal cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013501,increased fibroblast apoptosis
MGI:2652652	Ikbkb<tm2.1Cgn>	MP:0008706,decreased interleukin-6 secretion
MGI:2652651	Ikbkb<tm2Cgn>	MP:0004974,decreased regulatory T cell number|MP:0005370,liver/biliary system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008050,decreased memory T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:2445462	Ikbkb<tm2Mka>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0008182,decreased marginal zone B cell number|MP:0008217,abnormal B cell activation|MP:0008782,increased B cell apoptosis|MP:0009405,increased skeletal muscle fiber number|MP:0011080,increased macrophage apoptosis|MP:0030957,abnormal myotube morphology
MGI:3046788	Ikbke<tm1Aki>	MP:0002169,no abnormal phenotype detected
MGI:5006718	Ikbke<tm1Dgen>	MP:0002891,increased insulin sensitivity|MP:0004892,increased adiponectin level|MP:0005560,decreased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0010182,decreased susceptibility to weight gain
MGI:3707541	Ikbke<tm1Tman>	MP:0001263,weight loss|MP:0001861,lung inflammation|MP:0020414,abnormal fibroblast physiology|MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:3808877	Ikbkg<m1Btlr>	MP:0001923,reduced female fertility|MP:0004974,decreased regulatory T cell number|MP:0005159,azoospermia|MP:0005387,immune system phenotype|MP:0008561,decreased tumor necrosis factor secretion|MP:0010768,mortality/aging
MGI:4355682	Ikbkg<tm1.1Chtr>	MP:0000598,abnormal liver morphology|MP:0001654,hepatic necrosis|MP:0001860,liver inflammation|MP:0002169,no abnormal phenotype detected|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003333,liver fibrosis|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003887,increased hepatocyte apoptosis|MP:0003893,increased hepatocyte proliferation|MP:0005343,increased circulating aspartate transaminase level|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0008040,decreased NK T cell number|MP:0008042,abnormal NK T cell physiology|MP:0008045,decreased NK cell number|MP:0008553,increased circulating tumor necrosis factor level|MP:0008566,increased interferon-gamma secretion|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0010766,abnormal NK cell physiology|MP:0011009,increased circulating glutamate dehydrogenase level
MGI:5538732	Ikbkg<tm1.1Dwat>	MP:0000691,enlarged spleen|MP:0001209,spontaneous skin ulceration|MP:0001242,hyperkeratosis|MP:0002161,abnormal fertility/fecundity|MP:0003427,parakeratosis|MP:0005017,decreased B cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:2679024	Ikbkg<tm1.1Mpa>	MP:0000351,increased cell proliferation|MP:0000491,crypts of Lieberkuhn abscesses|MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0001845,abnormal inflammatory response|MP:0001860,liver inflammation|MP:0002144,abnormal B cell differentiation|MP:0002628,hepatic steatosis|MP:0002816,colitis|MP:0002941,increased circulating alanine transaminase level|MP:0003009,abnormal cytokine secretion|MP:0003331,increased hepatocellular carcinoma incidence|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005154,increased B cell proliferation|MP:0005560,decreased circulating glucose level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006042,increased apoptosis|MP:0006413,increased T cell apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008735,increased susceptibility to endotoxin shock|MP:0014341,abnormal hepatocyte mitochondrial morphology
MGI:3775942	Ikbkg<tm1Dwb>	MP:0001800,abnormal humoral immune response|MP:0008561,decreased tumor necrosis factor secretion|MP:0008670,decreased interleukin-12b secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:2386267	Ikbkg<tm1Mak>	MP:0003887,increased hepatocyte apoptosis|MP:0003888,liver hemorrhage|MP:0008705,increased interleukin-6 secretion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013501,increased fibroblast apoptosis
MGI:3620102	Ikbkg<tm1Mka>	MP:0000416,sparse hair|MP:0000598,abnormal liver morphology|MP:0000692,small spleen|MP:0000706,small thymus|MP:0000745,tremors|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001392,abnormal locomotor behavior|MP:0002398,abnormal bone marrow cell morphology/development|MP:0003427,parakeratosis|MP:0003454,erythroderma|MP:0003887,increased hepatocyte apoptosis|MP:0006042,increased apoptosis|MP:0008253,absent megakaryocytes|MP:0008843,absent subcutaneous adipose tissue|MP:0009580,increased keratinocyte apoptosis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2386324	Ikbkg<tm1Mpa>	MP:0000424,retarded hair growth|MP:0001192,scaly skin|MP:0001219,thick epidermis|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001233,abnormal epidermis suprabasal layer morphology|MP:0001732,postnatal growth retardation|MP:0002655,abnormal keratinocyte morphology|MP:0003427,parakeratosis|MP:0004947,skin inflammation|MP:0008561,decreased tumor necrosis factor secretion|MP:0008706,decreased interleukin-6 secretion|MP:0009385,abnormal dermal pigmentation|MP:0009387,abnormal epidermal pigmentation|MP:0009580,increased keratinocyte apoptosis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0013501,increased fibroblast apoptosis
MGI:6341961	Ik<em2(IMPC)Kmpc>	MP:0001312,abnormal cornea morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0010024,increased total body fat amount|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6200316	Ikzf1<m1Btlr>	MP:0002493,increased IgG level|MP:0004977,increased B-1 B cell number|MP:0005015,increased T cell number|MP:0005333,decreased heart rate|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0011719,abnormal natural killer cell mediated cytotoxicity|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0020002,increased response to antigen|MP:0020155,enhanced humoral immune response
MGI:6200322	Ikzf1<m2Btlr>	MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005333,decreased heart rate|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0008083,decreased single-positive T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6200327	Ikzf1<m3Btlr>	MP:0004977,increased B-1 B cell number|MP:0005015,increased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number
MGI:2669987	Ikzf1<plstc>	MP:0000208,decreased hematocrit|MP:0000334,decreased granulocyte number|MP:0000600,liver hypoplasia|MP:0000715,decreased thymocyte number|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0001802,arrested B cell differentiation|MP:0001823,thymus hypoplasia|MP:0002024,increased T cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002401,abnormal lymphopoiesis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005425,increased macrophage cell number|MP:0008070,absent T cells|MP:0008111,abnormal granulocyte differentiation|MP:0008113,abnormal macrophage differentiation|MP:0008186,increased pro-B cell number|MP:0008187,absent pro-B cells|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008941,reticulocytopenia|MP:0008973,decreased erythroid progenitor cell number|MP:0010373,myeloid hyperplasia|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011176,abnormal erythroblast morphology|MP:0011243,decreased fetal derived definitive erythrocyte cell number
MGI:2447787	Ikzf1<tm1.1(Pax5)Mbu>	MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0001823,thymus hypoplasia|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0005014,increased B cell number|MP:0005092,decreased double-positive T cell number|MP:0008186,increased pro-B cell number|MP:0012431,increased lymphoma incidence
MGI:5563075	Ikzf1<tm1.1Smale>	MP:0001823,thymus hypoplasia|MP:0002006,neoplasm|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0008168,decreased B-1a cell number|MP:0008170,decreased B-1b cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0010130,decreased DN1 thymic pro-T cell number
MGI:2667175	Ikzf1<tm1Kast>	MP:0002144,abnormal B cell differentiation|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0008168,decreased B-1a cell number|MP:0008170,decreased B-1b cell number|MP:0008217,abnormal B cell activation|MP:0008482,decreased spleen germinal center number|MP:0008498,decreased IgG3 level
MGI:2158738	Ikzf1<tm1Kge>	MP:0000238,absent pre-B cells|MP:0000240,extramedullary hematopoiesis|MP:0000333,decreased bone marrow cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0000711,thymus cortex hypoplasia|MP:0001265,decreased body size|MP:0001655,multifocal hepatic necrosis|MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0001861,lung inflammation|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002145,abnormal T cell differentiation|MP:0002343,abnormal lymph node cortex morphology|MP:0002348,abnormal lymph node medulla morphology|MP:0002367,abnormal thymus lobule morphology|MP:0002371,abnormal thymus cortex morphology|MP:0002375,abnormal thymus medulla morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002606,increased basophil cell number|MP:0002722,abnormal immune system organ morphology|MP:0002831,absent Peyer's patches|MP:0003850,abnormal thymocyte activation|MP:0005061,abnormal eosinophil morphology|MP:0005068,abnormal NK cell morphology|MP:0005348,increased T cell proliferation|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008071,absent B cells|MP:0008102,lymph node hyperplasia|MP:0008351,decreased gamma-delta intraepithelial T cell number|MP:0008465,absent mesenteric lymph nodes|MP:0008466,enlarged mesenteric lymph nodes|MP:0008475,intermingled spleen red and white pulp|MP:0008477,decreased spleen red pulp amount|MP:0008478,increased spleen white pulp amount|MP:0008542,enlarged cervical lymph nodes|MP:0008801,abnormal erythroid progenitor cell morphology|MP:0009395,increased nucleated erythrocyte cell number|MP:0009622,absent inguinal lymph nodes|MP:0009630,absent axillary lymph nodes|MP:0009633,absent cervical lymph nodes|MP:0010377,abnormal gut flora balance|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2447783	Ikzf1<tm1(Pax5)Mbu>	MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0002024,increased T cell derived lymphoma incidence|MP:0002145,abnormal T cell differentiation|MP:0002458,abnormal B cell number|MP:0003133,increased early pro-B cell number|MP:0005014,increased B cell number|MP:0005461,abnormal dendritic cell morphology
MGI:5563076	Ikzf1<tm2.1Smale>	MP:0000711,thymus cortex hypoplasia|MP:0001265,decreased body size|MP:0001823,thymus hypoplasia|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002145,abnormal T cell differentiation|MP:0002401,abnormal lymphopoiesis|MP:0002831,absent Peyer's patches|MP:0003132,increased pre-B cell number|MP:0005017,decreased B cell number|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0008046,absent NK cells|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008346,increased gamma-delta T cell number|MP:0008463,abnormal peripheral lymph node morphology|MP:0009622,absent inguinal lymph nodes|MP:0010132,decreased DN2 thymocyte number|MP:0010134,decreased DN3 thymocyte number|MP:0011816,decreased pre-pro B cell number|MP:0012431,increased lymphoma incidence
MGI:2158690	Ikzf1<tm2Kge>	MP:0000238,absent pre-B cells|MP:0000245,abnormal erythropoiesis|MP:0000334,decreased granulocyte number|MP:0000704,abnormal thymus development|MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0002831,absent Peyer's patches|MP:0005092,decreased double-positive T cell number|MP:0005348,increased T cell proliferation|MP:0008046,absent NK cells|MP:0008071,absent B cells|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0008125,abnormal dendritic cell number|MP:0008187,absent pro-B cells|MP:0008203,absent B-1a cells|MP:0008351,decreased gamma-delta intraepithelial T cell number|MP:0008354,decreased mature gamma-delta T cell number|MP:0008465,absent mesenteric lymph nodes|MP:0008826,abnormal splenic cell ratio|MP:0009339,decreased splenocyte number|MP:0009622,absent inguinal lymph nodes|MP:0009630,absent axillary lymph nodes|MP:0009633,absent cervical lymph nodes
MGI:5617012	Ikzf1<tm3.1Mbu>	MP:0002006,neoplasm|MP:0002024,increased T cell derived lymphoma incidence|MP:0002144,abnormal B cell differentiation|MP:0002458,abnormal B cell number|MP:0008186,increased pro-B cell number|MP:0008209,decreased pre-B cell number
MGI:5617014	Ikzf1<tm3Kge>	MP:0000238,absent pre-B cells|MP:0002024,increased T cell derived lymphoma incidence|MP:0002459,abnormal B cell physiology|MP:0008209,decreased pre-B cell number|MP:0008781,abnormal B cell apoptosis|MP:0014472,impaired B cell migration
MGI:6153889	Ikzf2<em2(IMPC)H>	MP:0001486,abnormal startle reflex|MP:0002102,abnormal ear morphology|MP:0005178,increased circulating cholesterol level
MGI:5792004	Ikzf2<mpc173H>	MP:0001314,cornea opacity|MP:0001967,deafness
MGI:4456473	Ikzf2<tm1.1Etms>	MP:0004946,abnormal regulatory T cell physiology
MGI:4355173	Ikzf2<tm1Kast>	MP:0001262,decreased body weight|MP:0005287,narrow eye opening|MP:0009651,abnormal eyelid development|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2388132	Ikzf3<tm1Kge>	MP:0000691,enlarged spleen|MP:0001806,decreased IgM level|MP:0001844,autoimmune response|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0002362,abnormal spleen marginal zone morphology|MP:0002497,increased IgE level|MP:0002533,abnormal type III hypersensitivity reaction|MP:0002743,glomerulonephritis|MP:0002962,increased urine protein level|MP:0003132,increased pre-B cell number|MP:0003725,increased autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004796,increased anti-histone antibody level|MP:0005017,decreased B cell number|MP:0005154,increased B cell proliferation|MP:0005265,abnormal blood urea nitrogen level|MP:0005348,increased T cell proliferation|MP:0005553,increased circulating creatinine level|MP:0008173,increased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008185,decreased naive B cell number|MP:0008481,increased spleen germinal center number|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0020519,renal glomerular immunoglobulin deposits
MGI:5008103	Ikzf3<tm1(KOMP)Vlcg>	MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0003179,thrombocytopenia|MP:0005016,decreased lymphocyte cell number|MP:0012361,decreased large unstained cell number
MGI:6148319	Ikzf4<em1(IMPC)Rbrc>	MP:0001402,decreased locomotor activity|MP:0002135,abnormal kidney morphology|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:6460134	Ikzf4<tm1.1Etms>	MP:0002499,chronic inflammation|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:6467011	Ikzf4<tm1Djr>	MP:0000496,abnormal small intestine morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002461,increased immunoglobulin level|MP:0002499,chronic inflammation|MP:0002500,granulomatous inflammation|MP:0002743,glomerulonephritis|MP:0003306,small intestinal inflammation|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004974,decreased regulatory T cell number|MP:0005015,increased T cell number|MP:0008141,decreased small intestinal microvillus size|MP:0008177,increased germinal center B cell number|MP:0008481,increased spleen germinal center number|MP:0010186,increased T follicular helper cell number|MP:0014262,increased spleen B cell follicle number
MGI:4419517	Ikzf5<tm1(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0003795,abnormal bone structure|MP:0010124,decreased bone mineral content|MP:0012362,increased large unstained cell number
MGI:3838223	Il10ra<m1Jskg>	MP:0002816,colitis
MGI:3528086	Il10ra<NZW>	MP:0002493,increased IgG level|MP:0004829,increased anti-chromatin antibody level
MGI:4437317	Il10ra<tm1.1Jack>	MP:0005027,increased susceptibility to parasitic infection|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0008553,increased circulating tumor necrosis factor level|MP:0008577,increased circulating interferon-gamma level|MP:0008599,increased circulating interleukin-2 level|MP:0008614,increased circulating interleukin-17 level|MP:0008617,increased circulating interleukin-12 level|MP:0008638,increased circulating interleukin-1 alpha level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008713,abnormal cytokine level|MP:0008721,abnormal chemokine level
MGI:5450726	Il10ra<tm1.1Tlg>	MP:0000717,abnormal lymphocyte cell number|MP:0001844,autoimmune response|MP:0004972,abnormal regulatory T cell number|MP:0005018,decreased T cell number|MP:0005387,immune system phenotype|MP:0009335,decreased splenocyte proliferation
MGI:4437318	Il10ra<tm1.2Jack>	MP:0005027,increased susceptibility to parasitic infection|MP:0008537,increased susceptibility to induced colitis|MP:0008553,increased circulating tumor necrosis factor level|MP:0008577,increased circulating interferon-gamma level|MP:0008596,increased circulating interleukin-6 level|MP:0008599,increased circulating interleukin-2 level|MP:0008614,increased circulating interleukin-17 level|MP:0008617,increased circulating interleukin-12 level|MP:0008638,increased circulating interleukin-1 alpha level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008713,abnormal cytokine level|MP:0008721,abnormal chemokine level|MP:0009481,cecum inflammation
MGI:5766765	Il10ra<tm1b(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0001489,decreased startle reflex|MP:0004738,abnormal auditory brainstem response|MP:0005016,decreased lymphocyte cell number|MP:0005292,improved glucose tolerance|MP:0005566,decreased blood urea nitrogen level
MGI:2182946	Il10rb<tm1Agt>	MP:0000218,increased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000489,abnormal large intestine morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000689,abnormal spleen morphology|MP:0000693,spleen hyperplasia|MP:0002816,colitis|MP:0002874,decreased hemoglobin content|MP:0003304,large intestinal inflammation|MP:0004952,increased spleen weight|MP:0005232,abnormal mesenteric lymph node morphology|MP:0008111,abnormal granulocyte differentiation|MP:0008566,increased interferon-gamma secretion|MP:0008681,increased interleukin-17 secretion|MP:0011224,abnormal lymph node medullary cord morphology
MGI:4364200	Il10rb<tm1a(KOMP)Wtsi>	MP:0005560,decreased circulating glucose level
MGI:4355198	Il10<tm1.1Karp>	MP:0002169,no abnormal phenotype detected
MGI:3521569	Il10<tm1.1Roer>	MP:0000693,spleen hyperplasia|MP:0001858,intestinal inflammation|MP:0002148,abnormal hypersensitivity reaction|MP:0002412,increased susceptibility to bacterial infection|MP:0002419,abnormal innate immunity|MP:0003009,abnormal cytokine secretion|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0008097,increased plasma cell number|MP:0008121,increased myeloid dendritic cell number|MP:0008250,abnormal myeloid leukocyte morphology|MP:0008594,decreased circulating interleukin-10 level|MP:0008735,increased susceptibility to endotoxin shock|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:1857199	Il10<tm1Cgn>	MP:0000130,abnormal trabecular bone morphology|MP:0000199,abnormal circulating serum albumin level|MP:0000216,absent erythroid progenitor cell|MP:0000322,increased granulocyte number|MP:0000479,abnormal enterocyte morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000489,abnormal large intestine morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000493,rectal prolapse|MP:0000495,abnormal colon morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000609,abnormal liver physiology|MP:0000708,thymus hyperplasia|MP:0000717,abnormal lymphocyte cell number|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001501,abnormal sleep pattern|MP:0001533,abnormal skeleton physiology|MP:0001547,abnormal lipid level|MP:0001570,abnormal circulating enzyme level|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0001732,postnatal growth retardation|MP:0001764,abnormal homeostasis|MP:0001770,abnormal iron level|MP:0001790,abnormal immune system physiology|MP:0001845,abnormal inflammatory response|MP:0001858,intestinal inflammation|MP:0001919,abnormal reproductive system physiology|MP:0001973,increased thermal nociceptive threshold|MP:0002052,decreased tumor incidence|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002335,decreased airway responsiveness|MP:0002497,increased IgE level|MP:0002499,chronic inflammation|MP:0002534,abnormal type IV hypersensitivity reaction|MP:0002724,enhanced wound healing|MP:0002727,decreased circulating insulin level|MP:0002810,microcytic anemia|MP:0002816,colitis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002891,increased insulin sensitivity|MP:0002896,abnormal bone mineralization|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0003009,abnormal cytokine secretion|MP:0003025,increased vasoconstriction|MP:0003026,decreased vasoconstriction|MP:0003037,increased myocardial infarct size|MP:0003109,short femur|MP:0003304,large intestinal inflammation|MP:0003306,small intestinal inflammation|MP:0003434,decreased susceptibility to induced choroidal neovascularization|MP:0003795,abnormal bone structure|MP:0003887,increased hepatocyte apoptosis|MP:0003957,abnormal nitric oxide homeostasis|MP:0004151,decreased circulating iron level|MP:0004504,decreased incidence of tumors by UV induction|MP:0004752,decreased length of allograft survival|MP:0004811,abnormal neuron physiology|MP:0004876,decreased mean systemic arterial blood pressure|MP:0004946,abnormal regulatory T cell physiology|MP:0004955,increased thymus weight|MP:0004991,decreased bone strength|MP:0005025,abnormal response to infection|MP:0005027,increased susceptibility to parasitic infection|MP:0005042,abnormal level of surface class II molecules|MP:0005095,decreased T cell proliferation|MP:0005150,cachexia|MP:0005178,increased circulating cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005281,increased fatty acids level|MP:0005362,abnormal Langerhans cell physiology|MP:0005387,immune system phenotype|MP:0005416,abnormal circulating protein level|MP:0005508,abnormal skeleton morphology|MP:0005554,decreased circulating creatinine level|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0006060,increased cerebral infarct size|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0008246,abnormal leukocyte morphology|MP:0008387,hypochromic anemia|MP:0008395,abnormal osteoblast differentiation|MP:0008469,abnormal protein level|MP:0008477,decreased spleen red pulp amount|MP:0008489,slow postnatal weight gain|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008537,increased susceptibility to induced colitis|MP:0008553,increased circulating tumor necrosis factor level|MP:0008566,increased interferon-gamma secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008595,abnormal circulating interleukin-6 level|MP:0008596,increased circulating interleukin-6 level|MP:0008599,increased circulating interleukin-2 level|MP:0008614,increased circulating interleukin-17 level|MP:0008617,increased circulating interleukin-12 level|MP:0008638,increased circulating interleukin-1 alpha level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008646,abnormal circulating interleukin-12b level|MP:0008713,abnormal cytokine level|MP:0008721,abnormal chemokine level|MP:0008735,increased susceptibility to endotoxin shock|MP:0008750,abnormal interferon level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0008808,decreased spleen iron level|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009310,increased large intestine adenocarcinoma incidence|MP:0009314,increased colon adenocarcinoma incidence|MP:0009346,decreased trabecular bone thickness|MP:0009355,increased liver triglyceride level|MP:0009481,cecum inflammation|MP:0009816,increased leukotriene level|MP:0010124,decreased bone mineral content|MP:0010155,abnormal intestine physiology|MP:0010869,decreased bone trabecula number|MP:0010873,decreased trabecular bone mass|MP:0010962,decreased compact bone mass|MP:0011049,impaired adaptive thermogenesis|MP:0011520,increased placental labyrinth size|MP:0012106,impaired exercise endurance|MP:0030466,alveolar process atrophy
MGI:3695482	Il10<tm1Flv>	MP:0002169,no abnormal phenotype detected
MGI:5301907	Il10<tm1Hbo>	MP:0002169,no abnormal phenotype detected
MGI:3697466	Il10<tm1Mhry>	MP:0001858,intestinal inflammation
MGI:3521568	Il10<tm1Roer>	MP:0000491,crypts of Lieberkuhn abscesses|MP:0000493,rectal prolapse|MP:0000511,abnormal intestinal mucosa morphology|MP:0000512,intestinal ulcer|MP:0001858,intestinal inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002148,abnormal hypersensitivity reaction|MP:0002169,no abnormal phenotype detected|MP:0002339,abnormal lymph node morphology|MP:0002534,abnormal type IV hypersensitivity reaction|MP:0002816,colitis|MP:0003009,abnormal cytokine secretion|MP:0003303,peritoneal inflammation|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004946,abnormal regulatory T cell physiology|MP:0005014,increased B cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008097,increased plasma cell number|MP:0008250,abnormal myeloid leukocyte morphology|MP:0008594,decreased circulating interleukin-10 level|MP:0008661,decreased interleukin-10 secretion|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5301908	Il10<tm2Hbo>	MP:0002169,no abnormal phenotype detected
MGI:3696059	Il10<tm2Roer>	MP:0001845,abnormal inflammatory response|MP:0003009,abnormal cytokine secretion|MP:0008735,increased susceptibility to endotoxin shock
MGI:2177774	Il11ra1<tm1Gos>	MP:0000259,abnormal vascular development|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0001713,decreased trophoblast giant cell number|MP:0001716,abnormal placenta labyrinth morphology|MP:0001729,impaired embryo implantation|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0003845,abnormal decidualization|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0005028,abnormal trophectoderm morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0005387,immune system phenotype|MP:0008053,abnormal NK cell differentiation|MP:0008054,abnormal uterine NK cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012530,abnormal decidua capsularis morphology
MGI:2177778	Il11ra1<tm1Wehi>	MP:0001712,abnormal placenta development|MP:0001729,impaired embryo implantation|MP:0001926,female infertility|MP:0003845,abnormal decidualization|MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0009397,increased trophoblast giant cell number|MP:0010768,mortality/aging|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012529,abnormal decidua basalis morphology|MP:0012530,abnormal decidua capsularis morphology
MGI:2177775	Il11ra1<tm2Gos>	MP:0001712,abnormal placenta development|MP:0001729,impaired embryo implantation|MP:0001935,decreased litter size|MP:0002161,abnormal fertility/fecundity|MP:0003718,maternal effect|MP:0003845,abnormal decidualization
MGI:7659208	Il11<tm1Moto>	MP:0000008,increased white adipose tissue amount|MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0001926,female infertility|MP:0003797,abnormal compact bone morphology|MP:0004016,decreased bone mass|MP:0004893,decreased adiponectin level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005378,growth/size/body region phenotype|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0009117,abnormal white fat cell morphology|MP:0009130,increased white fat cell number|MP:0011168,abnormal fat cell differentiation|MP:0011711,impaired osteoblast differentiation|MP:0011720,abnormal ossification involved in bone remodeling|MP:0020010,decreased bone mineral density of femur|MP:0020040,decreased bone ossification|MP:0021186,decreased bone mineral density of vertebrae|MP:0030009,increased bone marrow adipose tissue amount
MGI:7659210	Il11<tm2.1Moto>	MP:0000008,increased white adipose tissue amount|MP:0000063,decreased bone mineral density|MP:0004016,decreased bone mass|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0008588,abnormal circulating interleukin level|MP:0011720,abnormal ossification involved in bone remodeling|MP:0030985,decreased circulating osteocalcin level
MGI:7659209	Il11<tm2Moto>	MP:0001926,female infertility
MGI:6269359	Il12a<m1Btlr>	MP:0020916,increased susceptibility to Herpesvirales infection
MGI:5692894	Il12a<tm1b(EUCOMM)Hmgu>	MP:0001556,increased circulating HDL cholesterol level|MP:0004609,vertebral fusion
MGI:2388729	Il12a<tm1Cab>	MP:0008578,decreased circulating interferon-gamma level|MP:0008618,decreased circulating interleukin-12 level|MP:0010766,abnormal NK cell physiology
MGI:1857200	Il12a<tm1Jm>	MP:0004499,increased incidence of tumors by chemical induction|MP:0005027,increased susceptibility to parasitic infection|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010766,abnormal NK cell physiology
MGI:6718318	Il12b<em1(IMPC)H>	MP:0005293,impaired glucose tolerance
MGI:1857201	Il12b<tm1Jm>	MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002462,abnormal granulocyte physiology|MP:0003945,abnormal lymphocyte physiology|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005027,increased susceptibility to parasitic infection|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005465,abnormal T-helper 1 physiology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008567,decreased interferon-gamma secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0008682,decreased interleukin-17 secretion|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010766,abnormal NK cell physiology|MP:0030466,alveolar process atrophy
MGI:5572025	Il12rb1<tm1b(KOMP)Wtsi>	MP:0002874,decreased hemoglobin content|MP:0010025,decreased total body fat amount|MP:0011239,abnormal skin coloration|MP:0011959,abnormal eye posterior chamber depth
MGI:1857440	Il12rb1<tm1Jm>	MP:0002435,abnormal effector T cell morphology|MP:0003945,abnormal lymphocyte physiology|MP:0008567,decreased interferon-gamma secretion|MP:0008578,decreased circulating interferon-gamma level
MGI:1861950	Il12rb2<tm1Jm>	MP:0000688,lymphoid hyperplasia|MP:0001828,abnormal T cell activation|MP:0001860,liver inflammation|MP:0001870,salivary gland inflammation|MP:0002743,glomerulonephritis|MP:0003447,decreased tumor growth/size|MP:0003448,abnormal tumor morphology|MP:0003945,abnormal lymphocyte physiology|MP:0004794,increased anti-nuclear antigen antibody level|MP:0008217,abnormal B cell activation|MP:0008617,increased circulating interleukin-12 level|MP:0008705,increased interleukin-6 secretion|MP:0008714,increased lung carcinoma incidence|MP:0008879,submandibular gland inflammation|MP:0010144,abnormal tumor vascularization|MP:0010286,increased plasmacytoma incidence|MP:0010766,abnormal NK cell physiology|MP:0013367,parotid gland inflammation
MGI:3772443	Il13ra1<tm1Twy>	MP:0002335,decreased airway responsiveness|MP:0002492,decreased IgE level|MP:0002495,increased IgA level|MP:0003957,abnormal nitric oxide homeostasis|MP:0005011,increased eosinophil cell number|MP:0005025,abnormal response to infection|MP:0005026,decreased susceptibility to parasitic infection|MP:0005466,abnormal T-helper 2 physiology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008090,increased T-helper 2 cell number|MP:0008499,increased IgG1 level|MP:0008502,increased IgG3 level|MP:0008626,increased circulating interleukin-5 level|MP:0010768,mortality/aging
MGI:5317952	Il13ra1<tm1Zagh>	MP:0000704,abnormal thymus development|MP:0001602,impaired myelopoiesis
MGI:6120701	Il13ra2<tm1b(EUCOMM)Hmgu>	MP:0005628,decreased circulating potassium level
MGI:2653910	Il13ra2<tm1Gru>	MP:0002398,abnormal bone marrow cell morphology/development|MP:0002451,abnormal macrophage physiology|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0005165,increased susceptibility to injury|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008566,increased interferon-gamma secretion|MP:0008609,decreased circulating interleukin-13 level|MP:0008660,increased interleukin-10 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008973,decreased erythroid progenitor cell number|MP:0020344,abnormal susceptibility to injury induced morbidity/mortality|MP:0030002,increased lung apoptosis
MGI:1931822	Il13<tm1.1Anjm>	MP:0002455,abnormal dendritic cell antigen presentation|MP:0002492,decreased IgE level|MP:0002494,increased IgM level|MP:0005351,decreased susceptibility to autoimmune disorder|MP:0008091,decreased T-helper 2 cell number|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008115,abnormal dendritic cell differentiation|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008566,increased interferon-gamma secretion|MP:0008609,decreased circulating interleukin-13 level|MP:0008661,decreased interleukin-10 secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion
MGI:5569965	Il13<tm1.1(KOMP)Vlcg>	MP:0001556,increased circulating HDL cholesterol level|MP:0005575,increased pulmonary ventilation
MGI:1931821	Il13<tm1Anjm>	MP:0002500,granulomatous inflammation|MP:0003449,abnormal intestine goblet cell morphology|MP:0005012,decreased eosinophil cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0006050,pulmonary fibrosis|MP:0008568,abnormal interleukin secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0008712,decreased interleukin-9 secretion
MGI:1931804	Il13<tm2Anjm>	MP:0001793,abnormal susceptibility to infection|MP:0001835,abnormal antigen presentation|MP:0002411,decreased susceptibility to bacterial infection|MP:0002442,abnormal leukocyte physiology|MP:0002451,abnormal macrophage physiology|MP:0002492,decreased IgE level|MP:0002494,increased IgM level|MP:0002531,abnormal type I hypersensitivity reaction|MP:0003884,decreased macrophage cell number|MP:0004751,increased length of allograft survival|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005026,decreased susceptibility to parasitic infection|MP:0005027,increased susceptibility to parasitic infection|MP:0005164,abnormal response to injury|MP:0005166,decreased susceptibility to injury|MP:0005387,immune system phenotype|MP:0005466,abnormal T-helper 2 physiology|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0005671,abnormal response to transplant|MP:0008091,decreased T-helper 2 cell number|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008501,increased IgG2b level|MP:0008566,increased interferon-gamma secretion|MP:0008609,decreased circulating interleukin-13 level|MP:0008661,decreased interleukin-10 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0008719,impaired neutrophil recruitment|MP:0008721,abnormal chemokine level|MP:0008723,impaired eosinophil recruitment|MP:0009333,abnormal splenocyte physiology|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality
MGI:5426268	Il15<m1Hwata>	MP:0008038,abnormal NK T cell number|MP:0008040,decreased NK T cell number|MP:0008045,decreased NK cell number|MP:0008567,decreased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion
MGI:2176074	Il15ra<tm1.1Nsl>	MP:0001828,abnormal T cell activation|MP:0005094,abnormal T cell proliferation|MP:0005348,increased T cell proliferation|MP:0006412,abnormal T cell apoptosis|MP:0008040,decreased NK T cell number|MP:0008045,decreased NK cell number|MP:0008050,decreased memory T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0008101,lymph node hypoplasia|MP:0008687,increased interleukin-2 secretion|MP:0009541,increased thymocyte apoptosis
MGI:1934016	Il15ra<tm1Ama>	MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005095,decreased T cell proliferation|MP:0008040,decreased NK T cell number|MP:0008045,decreased NK cell number|MP:0008050,decreased memory T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008363,decreased CD8-positive, gamma-delta intraepithelial T cell number|MP:0010766,abnormal NK cell physiology
MGI:2176071	Il15ra<tm1Nsl>	MP:0002169,no abnormal phenotype detected
MGI:3822486	Il15ra<tm1Wjl>	MP:0002444,abnormal T cell physiology|MP:0005095,decreased T cell proliferation|MP:0008040,decreased NK T cell number|MP:0008045,decreased NK cell number|MP:0008050,decreased memory T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:5574316	Il15<tm1.1Iku>	MP:0005387,immune system phenotype
MGI:5636890	Il15<tm1b(EUCOMM)Hmgu>	MP:0000274,enlarged heart|MP:0001513,limb grasping|MP:0005293,impaired glucose tolerance|MP:0010052,increased grip strength
MGI:2136897	Il15<tm1Imx>	MP:0000685,abnormal immune system morphology|MP:0001262,decreased body weight|MP:0001790,abnormal immune system physiology|MP:0001793,abnormal susceptibility to infection|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002217,small lymph nodes|MP:0002376,abnormal dendritic cell physiology|MP:0002460,decreased immunoglobulin level|MP:0002619,abnormal lymphocyte morphology|MP:0003009,abnormal cytokine secretion|MP:0003845,abnormal decidualization|MP:0003995,abnormal uterine artery morphology|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004974,decreased regulatory T cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008045,decreased NK cell number|MP:0008047,absent uterine NK cells|MP:0008050,decreased memory T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008127,decreased dendritic cell number|MP:0008363,decreased CD8-positive, gamma-delta intraepithelial T cell number|MP:0008567,decreased interferon-gamma secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008827,abnormal thymus cell ratio|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality|MP:0031034,increased susceptibility to Poxviridae infection induced morbidity/mortality
MGI:3576925	Il16<tm1Korn>	MP:0002444,abnormal T cell physiology
MGI:6363415	Il17a<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0020421,increased freezing behavior
MGI:5438791	Il17a/Il17f<tm1.1Impr>	MP:0002435,abnormal effector T cell morphology|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0008346,increased gamma-delta T cell number|MP:0008348,absent gamma-delta T cells|MP:0008682,decreased interleukin-17 secretion
MGI:5438793	Il17a/Il17f<tm1.1Impr>	MP:0002435,abnormal effector T cell morphology|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0008346,increased gamma-delta T cell number|MP:0008348,absent gamma-delta T cells|MP:0008682,decreased interleukin-17 secretion
MGI:3796156	Il17a<tm1Cdon>	MP:0001806,decreased IgM level|MP:0002499,chronic inflammation|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008537,increased susceptibility to induced colitis|MP:0008682,decreased interleukin-17 secretion
MGI:2388010	Il17a<tm1Yiw>	MP:0000222,decreased neutrophil cell number|MP:0001790,abnormal immune system physiology|MP:0001805,decreased IgG level|MP:0002412,increased susceptibility to bacterial infection|MP:0002460,decreased immunoglobulin level|MP:0002492,decreased IgE level|MP:0005362,abnormal Langerhans cell physiology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008346,increased gamma-delta T cell number|MP:0008495,decreased IgG1 level|MP:0008567,decreased interferon-gamma secretion|MP:0008751,abnormal interleukin level|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009787,increased susceptibility to infection induced morbidity/mortality
MGI:7522234	Il17b<em1Cya>	MP:0000219,increased neutrophil cell number|MP:0008537,increased susceptibility to induced colitis|MP:0008713,abnormal cytokine level|MP:0011078,increased macrophage cytokine production
MGI:4965521	Il17b<Gt(371C12)Cmhd>	MP:0002412,increased susceptibility to bacterial infection|MP:0005011,increased eosinophil cell number|MP:0008090,increased T-helper 2 cell number|MP:0008537,increased susceptibility to induced colitis|MP:0008560,increased tumor necrosis factor secretion|MP:0008568,abnormal interleukin secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008672,increased interleukin-13 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0010180,increased susceptibility to weight loss
MGI:5297496	Il17c<tm1.1Cdon>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008567,decreased interferon-gamma secretion|MP:0008682,decreased interleukin-17 secretion
MGI:5007186	Il17c<tm1Lex>	MP:0001193,psoriasis|MP:0001216,abnormal epidermal layer morphology|MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009584,decreased keratinocyte proliferation
MGI:3833572	Il17f<tm1Awai>	MP:0001790,abnormal immune system physiology|MP:0008682,decreased interleukin-17 secretion
MGI:3796155	Il17f<tm1Cdon>	MP:0002499,chronic inflammation|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005087,decreased acute inflammation|MP:0008500,increased IgG2a level|MP:0008539,decreased susceptibility to induced colitis|MP:0008682,decreased interleukin-17 secretion
MGI:3830280	Il17f<tm1(Thy1)Weav>	MP:0002169,no abnormal phenotype detected
MGI:3830035	Il17f<tm1Yiw>	MP:0002412,increased susceptibility to bacterial infection
MGI:6430661	Il17ra<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002574,increased vertical activity|MP:0010053,decreased grip strength|MP:0010123,increased bone mineral content
MGI:5498882	Il17ra<tm1.2Kurs>	MP:0001193,psoriasis|MP:0004947,skin inflammation|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008346,increased gamma-delta T cell number|MP:0008568,abnormal interleukin secretion|MP:0008681,increased interleukin-17 secretion|MP:0008705,increased interleukin-6 secretion|MP:0010219,increased T-helper 17 cell number
MGI:2450882	Il17ra<tm1Koll>	MP:0000222,decreased neutrophil cell number|MP:0001876,decreased inflammatory response|MP:0002406,increased susceptibility to infection|MP:0003828,pulmonary edema|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008111,abnormal granulocyte differentiation|MP:0008671,abnormal interleukin-13 secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008701,abnormal interleukin-5 secretion|MP:0008712,decreased interleukin-9 secretion|MP:0008719,impaired neutrophil recruitment
MGI:4457616	Il17rb<tm1Anjm>	MP:0002492,decreased IgE level|MP:0005012,decreased eosinophil cell number|MP:0005027,increased susceptibility to parasitic infection
MGI:3809835	Il17rb<tm1Bud>	MP:0001876,decreased inflammatory response|MP:0008673,decreased interleukin-13 secretion|MP:0008703,decreased interleukin-5 secretion
MGI:4459522	Il17rb<tm1Lex>	MP:0008396,abnormal osteoclast differentiation|MP:0008703,decreased interleukin-5 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion
MGI:5426267	Il17rb<tm1Tgi>	MP:0002335,decreased airway responsiveness|MP:0008040,decreased NK T cell number|MP:0008539,decreased susceptibility to induced colitis|MP:0008568,abnormal interleukin secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0008712,decreased interleukin-9 secretion|MP:0010181,decreased susceptibility to weight loss
MGI:7425752	Il17rc<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001126,abnormal ovary morphology|MP:0001258,decreased body length|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002644,decreased circulating triglyceride level|MP:0002989,small kidney
MGI:4459513	Il17rc<tm1Lex>	MP:0001876,decreased inflammatory response|MP:0002169,no abnormal phenotype detected|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0008681,increased interleukin-17 secretion|MP:0008721,abnormal chemokine level
MGI:3709909	Il17rd<Gt(KST223)Byg>	MP:0000849,abnormal cerebellum morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012490,abnormal cochlear VIII nucleus morphology
MGI:5548769	Il17rd<tm1b(EUCOMM)Hmgu>	MP:0003921,abnormal heart left ventricle morphology
MGI:3574925	Il17rd<tm1Sla>	MP:0002169,no abnormal phenotype detected
MGI:5007190	Il17re<tm1Lex>	MP:0001193,psoriasis|MP:0003449,abnormal intestine goblet cell morphology|MP:0003453,abnormal keratinocyte physiology|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0008537,increased susceptibility to induced colitis|MP:0010180,increased susceptibility to weight loss
MGI:5568616	Il17re<tm1Sdl>	MP:0002412,increased susceptibility to bacterial infection|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:5569040	Il18bp<tm1.1(KOMP)Vlcg>	MP:0000220,increased monocyte cell number|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001263,weight loss|MP:0002339,abnormal lymph node morphology|MP:0002941,increased circulating alanine transaminase level|MP:0005014,increased B cell number|MP:0005152,pancytopenia|MP:0005387,immune system phenotype|MP:0005425,increased macrophage cell number|MP:0008251,abnormal phagocyte morphology|MP:0008577,increased circulating interferon-gamma level|MP:0008635,increased circulating interleukin-18 level|MP:0010209,abnormal circulating chemokine level|MP:0011075,abnormal macrophage activation involved in immune response|MP:0011890,increased circulating ferritin level
MGI:4399404	Il18bp<tm1(KOMP)Vlcg>	MP:0005378,growth/size/body region phenotype|MP:0008045,decreased NK cell number|MP:0008053,abnormal NK cell differentiation|MP:0008567,decreased interferon-gamma secretion|MP:0008577,increased circulating interferon-gamma level|MP:0012768,decreased KLRG1-positive NK cell number|MP:0013667,increased immature NK cell number|MP:0013672,decreased mature NK cell number
MGI:6152502	Il18r1<em1(IMPC)Mbp>	MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval
MGI:2136765	Il18r1<tm1Aki>	MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005465,abnormal T-helper 1 physiology|MP:0008567,decreased interferon-gamma secretion
MGI:6152737	Il18rap<em1(IMPC)Wtsi>	MP:0002073,abnormal hair growth|MP:0008935,decreased mean platelet volume
MGI:5766748	Il18rap<tm1b(KOMP)Wtsi>	MP:0001417,decreased exploration in new environment|MP:0001925,male infertility|MP:0011960,abnormal eye anterior chamber depth
MGI:3579137	Il18rap<tm1Yeh>	MP:0002442,abnormal leukocyte physiology|MP:0003009,abnormal cytokine secretion
MGI:2136769	Il18<tm1Aki>	MP:0000008,increased white adipose tissue amount|MP:0000136,abnormal microglial cell morphology|MP:0000465,gastrointestinal hemorrhage|MP:0001433,polyphagia|MP:0001873,stomach inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002792,abnormal retina vasculature morphology|MP:0003212,increased susceptibility to age related obesity|MP:0003921,abnormal heart left ventricle morphology|MP:0004890,decreased energy expenditure|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005290,decreased oxygen consumption|MP:0005458,increased percent body fat/body weight|MP:0005465,abnormal T-helper 1 physiology|MP:0006058,decreased cerebral infarct size|MP:0006185,retina hemorrhage|MP:0008002,hyperchlorhydria|MP:0008537,increased susceptibility to induced colitis|MP:0008567,decreased interferon-gamma secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0008636,decreased circulating interleukin-18 level|MP:0008720,impaired neutrophil chemotaxis|MP:0008908,increased total fat pad weight|MP:0010377,abnormal gut flora balance|MP:0031633,decreased heart left ventricle muscle contractility
MGI:2385814	Il18<tm1Khe>	MP:0002411,decreased susceptibility to bacterial infection|MP:0003957,abnormal nitric oxide homeostasis|MP:0005425,increased macrophage cell number|MP:0008037,abnormal T cell morphology|MP:0008044,increased NK cell number|MP:0008126,increased dendritic cell number|MP:0008553,increased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0008597,decreased circulating interleukin-6 level|MP:0008636,decreased circulating interleukin-18 level|MP:0008713,abnormal cytokine level|MP:0008734,decreased susceptibility to endotoxin shock
MGI:2683093	Il18<tm1Liew>	MP:0002412,increased susceptibility to bacterial infection|MP:0005027,increased susceptibility to parasitic infection|MP:0005044,sepsis|MP:0008750,abnormal interferon level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level
MGI:3757697	Il19<tm1Dnax>	MP:0005376,homeostasis/metabolism phenotype
MGI:5763407	Il19<tm2Vlcg>	MP:0005387,immune system phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008663,increased interleukin-12 secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0010180,increased susceptibility to weight loss|MP:0013298,increased susceptibility to colitis induced morbidity/mortality|MP:0013956,decreased colon length
MGI:5635224	Il1a<tm1b(EUCOMM)Wtsi>	MP:0000208,decreased hematocrit|MP:0001304,cataract|MP:0001488,increased startle reflex|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005419,decreased circulating serum albumin level
MGI:2157371	Il1a<tm1Yiw>	MP:0001273,decreased metastatic potential|MP:0005385,cardiovascular system phenotype|MP:0008639,decreased circulating interleukin-1 alpha level|MP:0008658,decreased interleukin-1 beta secretion|MP:0010144,abnormal tumor vascularization
MGI:2157804	Il1b<tm1Dch>	MP:0000920,abnormal myelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0005387,immune system phenotype|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008658,decreased interleukin-1 beta secretion|MP:0008831,abnormal insulin-like growth factor I level|MP:0030524,abnormal tooth root resorption
MGI:2157795	Il1b<tm1Lvp>	MP:0001273,decreased metastatic potential|MP:0001876,decreased inflammatory response|MP:0002410,decreased susceptibility to viral infection|MP:0002451,abnormal macrophage physiology|MP:0003447,decreased tumor growth/size|MP:0003829,impaired febrile response|MP:0003945,abnormal lymphocyte physiology|MP:0004824,decreased susceptibility to experimental autoimmune myasthenia gravis|MP:0005087,decreased acute inflammation|MP:0005166,decreased susceptibility to injury|MP:0005167,abnormal blood-brain barrier function|MP:0005387,immune system phenotype|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008658,decreased interleukin-1 beta secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008704,abnormal interleukin-6 secretion|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010144,abnormal tumor vascularization|MP:0020941,decreased susceptibility to Togaviridae infection|MP:0031041,decreased susceptibility to Togaviridae infection induced morbidity/mortality
MGI:2157396	Il1b<tm1Yiw>	MP:0002665,decreased circulating corticosterone level|MP:0003829,impaired febrile response|MP:0004883,abnormal vascular wound healing|MP:0008642,decreased circulating interleukin-1 beta level
MGI:6368874	Il1f10<tm1Gpa>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype
MGI:7425753	Il1r1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001304,cataract|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003917,increased kidney weight
MGI:7519061	Il1r1<em1Qizh>	MP:0003724,increased susceptibility to induced arthritis|MP:0008553,increased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level
MGI:5694158	Il1r1<tm1.1Rbl>	MP:0002169,no abnormal phenotype detected
MGI:5634709	Il1r1<tm1.2Quan>	MP:0002169,no abnormal phenotype detected
MGI:1861112	Il1r1<tm1Imx>	MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001263,weight loss|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002079,increased circulating insulin level|MP:0002272,abnormal nervous system electrophysiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0002724,enhanced wound healing|MP:0002865,increased growth rate|MP:0002981,increased liver weight|MP:0003053,delayed tooth eruption|MP:0003212,increased susceptibility to age related obesity|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003724,increased susceptibility to induced arthritis|MP:0003959,abnormal lean body mass|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0004702,increased circulating insulin-like growth factor I level|MP:0004822,decreased susceptibility to experimental autoimmune uveoretinitis|MP:0004883,abnormal vascular wound healing|MP:0004992,increased bone resorption|MP:0005044,sepsis|MP:0005190,osteomyelitis|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005387,immune system phenotype|MP:0005458,increased percent body fat/body weight|MP:0005554,decreased circulating creatinine level|MP:0005566,decreased blood urea nitrogen level|MP:0005669,increased circulating leptin level|MP:0006087,increased body mass index|MP:0008561,decreased tumor necrosis factor secretion|MP:0008597,decreased circulating interleukin-6 level|MP:0008635,increased circulating interleukin-18 level|MP:0008636,decreased circulating interleukin-18 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008706,decreased interleukin-6 secretion|MP:0008838,decreased transforming growth factor beta level|MP:0009285,increased gonadal fat pad weight|MP:0009286,increased abdominal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009298,increased mesenteric fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0009453,enhanced contextual conditioning behavior|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010024,increased total body fat amount|MP:0010378,increased respiratory quotient|MP:0013251,dental pulp necrosis|MP:0014441,decreased response to leptin
MGI:5633953	Il1r1<tm1Quan>	MP:0001845,abnormal inflammatory response|MP:0010762,abnormal microglial cell activation
MGI:1857441	Il1r1<tm1Roml>	MP:0000222,decreased neutrophil cell number|MP:0000313,abnormal cell death|MP:0002412,increased susceptibility to bacterial infection|MP:0002460,decreased immunoglobulin level|MP:0003436,decreased susceptibility to induced arthritis|MP:0003829,impaired febrile response|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005012,decreased eosinophil cell number|MP:0005018,decreased T cell number|MP:0005095,decreased T cell proliferation|MP:0005376,homeostasis/metabolism phenotype|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008597,decreased circulating interleukin-6 level|MP:0008706,decreased interleukin-6 secretion|MP:0008720,impaired neutrophil chemotaxis|MP:0010771,integument phenotype|MP:0031233,decreased circulating serum amyloid protein level
MGI:7643172	Il1r2<tm1.1Epi>	MP:0002420,abnormal adaptive immunity|MP:0002493,increased IgG level|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008483,increased spleen germinal center size|MP:0010186,increased T follicular helper cell number|MP:0012763,abnormal alpha-beta T cell number
MGI:5695974	Il1r2<tm1.1(KOMP)Vlcg>	MP:0004738,abnormal auditory brainstem response
MGI:7643174	Il1r2<tm1.2Epi>	MP:0001846,increased inflammatory response|MP:0002444,abnormal T cell physiology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008077,abnormal CD8-positive, alpha-beta T cell number|MP:0008596,increased circulating interleukin-6 level|MP:0008638,increased circulating interleukin-1 alpha level
MGI:4842437	Il1r2<tm1a(EUCOMM)Wtsi>	MP:0010052,increased grip strength
MGI:6303948	Il1r2<tm1Yiw>	MP:0002451,abnormal macrophage physiology|MP:0003724,increased susceptibility to induced arthritis|MP:0005387,immune system phenotype|MP:0011078,increased macrophage cytokine production|MP:0014708,increased synovial pannus formation
MGI:4414655	Il1rapl1<tm1.1Hesk>	MP:0000889,abnormal cerebellar molecular layer|MP:0002206,abnormal CNS synaptic transmission|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003107,abnormal response to novelty|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype
MGI:1934017	Il1rap<tm1Roml>	MP:0008706,decreased interleukin-6 secretion|MP:0010771,integument phenotype
MGI:3623124	Il1rl1<tm1Aki>	MP:0002169,no abnormal phenotype detected
MGI:2386675	Il1rl1<tm1Anjm>	MP:0002465,abnormal eosinophil physiology|MP:0002492,decreased IgE level|MP:0002500,granulomatous inflammation|MP:0004761,increased susceptibility to induced pancreatitis|MP:0005012,decreased eosinophil cell number|MP:0005466,abnormal T-helper 2 physiology|MP:0008568,abnormal interleukin secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion
MGI:3043989	Il1rl1<tm1Brl>	MP:0005011,increased eosinophil cell number|MP:0005025,abnormal response to infection|MP:0008703,decreased interleukin-5 secretion
MGI:6276866	Il1rl2<em1(IMPC)Mbp>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0002092,abnormal eye morphology|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:3762029	Il1rl2<tm1Hblu>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0002169,no abnormal phenotype detected|MP:0002339,abnormal lymph node morphology|MP:0002376,abnormal dendritic cell physiology|MP:0003884,decreased macrophage cell number|MP:0004973,increased regulatory T cell number|MP:0008347,decreased gamma-delta T cell number|MP:0008539,decreased susceptibility to induced colitis|MP:0008682,decreased interleukin-17 secretion|MP:0008712,decreased interleukin-9 secretion|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0011075,abnormal macrophage activation involved in immune response
MGI:4819784	Il1rn<tm1.1Cga>	MP:0003724,increased susceptibility to induced arthritis|MP:0005348,increased T cell proliferation|MP:0008566,increased interferon-gamma secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008681,increased interleukin-17 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion
MGI:2157398	Il1rn<tm1Dih>	MP:0001262,decreased body weight|MP:0001921,reduced fertility|MP:0002411,decreased susceptibility to bacterial infection|MP:0005088,increased acute inflammation|MP:0005179,decreased circulating cholesterol level|MP:0008592,decreased circulating interleukin-1 level|MP:0008596,increased circulating interleukin-6 level|MP:0008735,increased susceptibility to endotoxin shock|MP:0031234,increased circulating serum amyloid protein level
MGI:3038876	Il1rn<tm1Nick>	MP:0001193,psoriasis|MP:0001212,skin lesions|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001230,epidermal desquamation|MP:0001243,abnormal dermal layer morphology|MP:0001245,thick dermal layer|MP:0002083,premature death|MP:0002499,chronic inflammation|MP:0003279,aneurysm|MP:0003427,parakeratosis|MP:0003453,abnormal keratinocyte physiology|MP:0003561,rheumatoid arthritis|MP:0003711,pathological neovascularization|MP:0004947,skin inflammation|MP:0005387,immune system phenotype|MP:0006135,artery stenosis|MP:0010139,aortitis
MGI:3576926	Il1rn<tm1Sush>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002433,abnormal T-helper 1 cell morphology|MP:0002434,abnormal T-helper 2 cell morphology|MP:0002500,granulomatous inflammation|MP:0002722,abnormal immune system organ morphology|MP:0008115,abnormal dendritic cell differentiation|MP:0008125,abnormal dendritic cell number
MGI:2157397	Il1rn<tm1Yiw>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001777,abnormal body temperature homeostasis|MP:0003561,rheumatoid arthritis|MP:0004883,abnormal vascular wound healing|MP:0008681,increased interleukin-17 secretion
MGI:5548901	Il20ra<tm1.1(KOMP)Vlcg>	MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0010067,increased red blood cell distribution width
MGI:5302406	Il20ra<tm1.1Misc>	MP:0000062,increased bone mineral density|MP:0003795,abnormal bone structure|MP:0004993,decreased bone resorption|MP:0008396,abnormal osteoclast differentiation|MP:0009347,increased trabecular bone thickness|MP:0010875,increased bone volume
MGI:6152498	Il20rb<em2(IMPC)Mbp>	MP:0002092,abnormal eye morphology|MP:0002631,abnormal epididymis morphology|MP:0002941,increased circulating alanine transaminase level|MP:0004931,enlarged epididymis|MP:0009142,decreased prepulse inhibition
MGI:5692780	Il20rb<tm1b(KOMP)Wtsi>	MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology|MP:0002941,increased circulating alanine transaminase level|MP:0004931,enlarged epididymis
MGI:3757693	Il20rb<tm1Dnax>	MP:0003638,abnormal response/metabolism to endogenous compounds
MGI:4459515	Il20rb<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:3830304	Il20rb<tm1Uwe>	MP:0005078,abnormal cytotoxic T cell physiology|MP:0005348,increased T cell proliferation|MP:0005465,abnormal T-helper 1 physiology|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008049,increased memory T cell number|MP:0008566,increased interferon-gamma secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008687,increased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion
MGI:5007194	Il20<tm1Lex>	MP:0002534,abnormal type IV hypersensitivity reaction
MGI:6276943	Il21r<em1(IMPC)Mbp>	MP:0001415,increased exploration in new environment|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney
MGI:2182707	Il21r<tm1Day>	MP:0001793,abnormal susceptibility to infection|MP:0001828,abnormal T cell activation|MP:0002376,abnormal dendritic cell physiology|MP:0002444,abnormal T cell physiology|MP:0002492,decreased IgE level|MP:0002497,increased IgE level|MP:0003850,abnormal thymocyte activation|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005362,abnormal Langerhans cell physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008051,abnormal memory T cell physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008566,increased interferon-gamma secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008769,abnormal plasmacytoid dendritic cell physiology|MP:0009058,decreased interleukin-21 secretion|MP:0010766,abnormal NK cell physiology
MGI:3800291	Il21r<tm1Kopf>	MP:0000334,decreased granulocyte number|MP:0000685,abnormal immune system morphology|MP:0001790,abnormal immune system physiology|MP:0001807,decreased IgA level|MP:0002442,abnormal leukocyte physiology|MP:0002490,abnormal immunoglobulin level|MP:0002497,increased IgE level|MP:0002500,granulomatous inflammation|MP:0002607,decreased basophil cell number|MP:0003945,abnormal lymphocyte physiology|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005012,decreased eosinophil cell number|MP:0005387,immune system phenotype|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0008495,decreased IgG1 level|MP:0008723,impaired eosinophil recruitment
MGI:3528995	Il21r<tm1Lex>	MP:0001552,increased circulating triglyceride level
MGI:2446509	Il21r<tm1Wjl>	MP:0002490,abnormal immunoglobulin level|MP:0002497,increased IgE level|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005095,decreased T cell proliferation|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008682,decreased interleukin-17 secretion
MGI:5692648	Il21<tm1.1(KOMP)Mbp>	MP:0001148,enlarged testis
MGI:3528994	Il21<tm1Lex>	MP:0002145,abnormal T cell differentiation|MP:0002359,abnormal spleen germinal center morphology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008178,decreased germinal center B cell number|MP:0008192,abnormal germinal center B cell physiology|MP:0008343,abnormal gamma-delta T cell morphology|MP:0008482,decreased spleen germinal center number|MP:0008495,decreased IgG1 level|MP:0008751,abnormal interleukin level
MGI:3690462	Il21<tm1Llit>	MP:0002497,increased IgE level|MP:0004816,abnormal class switch recombination
MGI:5428706	Il21<tm1Nutt>	MP:0002169,no abnormal phenotype detected
MGI:5817816	Il22ra1<tm1.1Koll>	MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:4431742	Il22ra1<tm1a(EUCOMM)Wtsi>	MP:0005419,decreased circulating serum albumin level
MGI:5446694	Il22ra2<tm2Vlcg>	MP:0002816,colitis|MP:0003721,increased tumor growth/size|MP:0004499,increased incidence of tumors by chemical induction|MP:0010308,decreased tumor latency
MGI:3699310	Il22<tm1.1Lex>	MP:0000495,abnormal colon morphology|MP:0001245,thick dermal layer|MP:0001246,mixed cellular infiltration to dermis|MP:0001262,decreased body weight|MP:0001655,multifocal hepatic necrosis|MP:0001849,ear inflammation|MP:0001861,lung inflammation|MP:0001874,acanthosis|MP:0002816,colitis|MP:0003009,abnormal cytokine secretion|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005399,increased susceptibility to fungal infection|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008614,increased circulating interleukin-17 level|MP:0008618,decreased circulating interleukin-12 level|MP:0008639,decreased circulating interleukin-1 alpha level|MP:0008648,decreased circulating interleukin-12b level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010210,abnormal circulating cytokine level
MGI:3761615	Il22<tm1Flv>	MP:0001860,liver inflammation|MP:0002941,increased circulating alanine transaminase level|MP:0004499,increased incidence of tumors by chemical induction|MP:0005343,increased circulating aspartate transaminase level|MP:0008537,increased susceptibility to induced colitis|MP:0008735,increased susceptibility to endotoxin shock|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:4453827	Il22<tm1Jcrd>	MP:0000222,decreased neutrophil cell number|MP:0005387,immune system phenotype|MP:0008681,increased interleukin-17 secretion|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5509377	Il22<tm1Vlcg>	MP:0002060,abnormal skin morphology|MP:0002908,delayed wound healing|MP:0005023,abnormal wound healing
MGI:3830062	Il23a<tm1.1Thak>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005095,decreased T cell proliferation|MP:0008567,decreased interferon-gamma secretion|MP:0008682,decreased interleukin-17 secretion
MGI:3527219	Il23a<tm1Dnax>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0002451,abnormal macrophage physiology|MP:0002462,abnormal granulocyte physiology|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005018,decreased T cell number|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008347,decreased gamma-delta T cell number|MP:0008682,decreased interleukin-17 secretion|MP:0008751,abnormal interleukin level|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3625894	Il23a<tm1Gdy>	MP:0008537,increased susceptibility to induced colitis|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:3604398	Il23a<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:3036163	Il23a<tm1Ngh>	MP:0001807,decreased IgA level|MP:0001830,decreased activated T cell number|MP:0002412,increased susceptibility to bacterial infection|MP:0002460,decreased immunoglobulin level|MP:0002500,granulomatous inflammation|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008051,abnormal memory T cell physiology|MP:0008496,decreased IgG2a level|MP:0008539,decreased susceptibility to induced colitis|MP:0008588,abnormal circulating interleukin level|MP:0008614,increased circulating interleukin-17 level|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:4355925	Il23r<tm1.1Kuch>	MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008712,decreased interleukin-9 secretion
MGI:5619109	Il23r<tm1.1Ngh>	MP:0008539,decreased susceptibility to induced colitis|MP:0008588,abnormal circulating interleukin level|MP:0008614,increased circulating interleukin-17 level|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3665279	Il23r<tm1Dnax>	MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005387,immune system phenotype
MGI:3844602	Il23r<tm1Kuch>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008076,abnormal CD4-positive T cell differentiation
MGI:5085468	Il23r<tm2a(EUCOMM)Wtsi>	MP:0002941,increased circulating alanine transaminase level
MGI:5468967	Il24<tm1.1(KOMP)Vlcg>	MP:0002608,increased hematocrit|MP:0002833,increased heart weight|MP:0005564,increased hemoglobin content|MP:0005633,increased circulating sodium level
MGI:3757698	Il24<tm1Dnax>	MP:0005376,homeostasis/metabolism phenotype
MGI:6449048	Il25<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001148,enlarged testis|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0002092,abnormal eye morphology|MP:0002699,abnormal vitreous body morphology|MP:0010392,prolonged QRS complex duration
MGI:4442365	Il25<tm1.1Cdon>	MP:0000495,abnormal colon morphology|MP:0001861,lung inflammation|MP:0002411,decreased susceptibility to bacterial infection|MP:0005012,decreased eosinophil cell number|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008091,decreased T-helper 2 cell number|MP:0008539,decreased susceptibility to induced colitis|MP:0008561,decreased tumor necrosis factor secretion|MP:0008568,abnormal interleukin secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0008712,decreased interleukin-9 secretion|MP:0008722,abnormal chemokine secretion|MP:0010181,decreased susceptibility to weight loss
MGI:3720374	Il25<tm1Anjm>	MP:0002497,increased IgE level|MP:0005012,decreased eosinophil cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005232,abnormal mesenteric lymph node morphology|MP:0008568,abnormal interleukin secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008703,decreased interleukin-5 secretion
MGI:4442364	Il25<tm1Cdon>	MP:0000495,abnormal colon morphology|MP:0008539,decreased susceptibility to induced colitis|MP:0010181,decreased susceptibility to weight loss
MGI:3720348	Il25<tm1Dart>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0001858,intestinal inflammation|MP:0003449,abnormal intestine goblet cell morphology|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005015,increased T cell number|MP:0005025,abnormal response to infection|MP:0005027,increased susceptibility to parasitic infection|MP:0008496,decreased IgG2a level|MP:0008750,abnormal interferon level|MP:0008751,abnormal interleukin level|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3528904	Il25<tm1Lex>	MP:0001552,increased circulating triglyceride level
MGI:3525439	Il27ra<tm1Fjs>	MP:0002411,decreased susceptibility to bacterial infection|MP:0005013,increased lymphocyte cell number|MP:0005465,abnormal T-helper 1 physiology
MGI:3040914	Il27ra<tm1Mak>	MP:0001654,hepatic necrosis|MP:0002412,increased susceptibility to bacterial infection|MP:0002941,increased circulating alanine transaminase level|MP:0003724,increased susceptibility to induced arthritis|MP:0004822,decreased susceptibility to experimental autoimmune uveoretinitis|MP:0005027,increased susceptibility to parasitic infection|MP:0005165,increased susceptibility to injury|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005465,abnormal T-helper 1 physiology|MP:0008553,increased circulating tumor necrosis factor level|MP:0008566,increased interferon-gamma secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008578,decreased circulating interferon-gamma level|MP:0008596,increased circulating interleukin-6 level|MP:0008602,increased circulating interleukin-4 level|MP:0008617,increased circulating interleukin-12 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008699,increased interleukin-4 secretion|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:5694183	Il27<tm1b(EUCOMM)Wtsi>	MP:0010836,decreased CD4-positive, alpha-beta memory T cell number|MP:0013433,increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number
MGI:3842663	Il27<tm1Cua>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008076,abnormal CD4-positive T cell differentiation
MGI:5440910	Il27<tm1Lex>	MP:0008566,increased interferon-gamma secretion|MP:0008647,increased circulating interleukin-12b level|MP:0010750,increased susceptibility to parasitic infection induced morbidity/mortality
MGI:4352594	Il2<m1>	MP:0001828,abnormal T cell activation
MGI:6364029	Il2ra<M1J>	MP:0004946,abnormal regulatory T cell physiology
MGI:5766766	Il2ra<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000137,abnormal vertebrae morphology|MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0000495,abnormal colon morphology|MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0001258,decreased body length|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001469,abnormal contextual conditioning behavior|MP:0001566,increased circulating phosphate level|MP:0002591,decreased mean corpuscular volume|MP:0002757,decreased vertical activity|MP:0002834,decreased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003271,abnormal duodenum morphology|MP:0003896,prolonged PR interval|MP:0005016,decreased lymphocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005292,improved glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005566,decreased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0012362,increased large unstained cell number|MP:0020420,abnormal freezing behavior
MGI:1857192	Il2ra<tm1Dw>	MP:0000208,decreased hematocrit|MP:0000613,abnormal salivary gland morphology|MP:0000623,decreased salivation|MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001585,hemolytic anemia|MP:0001657,abnormal induced morbidity/mortality|MP:0001828,abnormal T cell activation|MP:0001861,lung inflammation|MP:0001870,salivary gland inflammation|MP:0002083,premature death|MP:0002221,abnormal lymph organ size|MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0002493,increased IgG level|MP:0002495,increased IgA level|MP:0002816,colitis|MP:0003304,large intestinal inflammation|MP:0004946,abnormal regulatory T cell physiology|MP:0005013,increased lymphocyte cell number|MP:0005036,diarrhea|MP:0005150,cachexia|MP:0008037,abnormal T cell morphology|MP:0008049,increased memory T cell number|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008880,lacrimal gland inflammation|MP:0009517,abnormal salivary gland duct morphology
MGI:6269414	Il2rb<m1Btlr>	MP:0005017,decreased B cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6285957	Il2rb<m2Btlr>	MP:0002497,increased IgE level
MGI:6285961	Il2rb<M3Btlr>	MP:0002494,increased IgM level|MP:0008037,abnormal T cell morphology|MP:0008040,decreased NK T cell number|MP:0008045,decreased NK cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0010848,decreased central memory CD8 positive, alpha-beta T cell number
MGI:5766767	Il2rb<tm1b(EUCOMM)Hmgu>	MP:0000367,abnormal coat/ hair morphology|MP:0000572,abnormal autopod morphology|MP:0001510,abnormal coat appearance|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002102,abnormal ear morphology
MGI:1857193	Il2rb<tm1Mak>	MP:0000219,increased neutrophil cell number|MP:0000322,increased granulocyte number|MP:0000653,abnormal sex gland morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001263,weight loss|MP:0001392,abnormal locomotor behavior|MP:0001823,thymus hypoplasia|MP:0001828,abnormal T cell activation|MP:0001829,increased activated T cell number|MP:0001860,liver inflammation|MP:0002074,abnormal hair texture|MP:0002083,premature death|MP:0002358,abnormal spleen periarteriolar lymphoid sheath morphology|MP:0002497,increased IgE level|MP:0002619,abnormal lymphocyte morphology|MP:0002722,abnormal immune system organ morphology|MP:0003135,increased erythroid progenitor cell number|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004827,increased susceptibility to autoimmune hemolytic anemia|MP:0004974,decreased regulatory T cell number|MP:0005002,abnormal T cell clonal deletion|MP:0005017,decreased B cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0005671,abnormal response to transplant|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008050,decreased memory T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008097,increased plasma cell number|MP:0008180,abnormal marginal zone B cell morphology|MP:0008217,abnormal B cell activation|MP:0008247,abnormal mononuclear cell morphology|MP:0008499,increased IgG1 level
MGI:5544782	Il2rg<tm1.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:1861947	Il2rg<tm1Cgn>	MP:0000694,spleen hypoplasia|MP:0001806,decreased IgM level|MP:0001823,thymus hypoplasia|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002492,decreased IgE level|MP:0002831,absent Peyer's patches|MP:0003850,abnormal thymocyte activation|MP:0004816,abnormal class switch recombination|MP:0005018,decreased T cell number|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005095,decreased T cell proliferation|MP:0008046,absent NK cells|MP:0008098,decreased plasma cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008246,abnormal leukocyte morphology|MP:0008348,absent gamma-delta T cells|MP:0008352,absent gamma-delta intraepithelial T cell|MP:0008356,abnormal gamma-delta T cell differentiation|MP:0008399,abnormal alpha-beta intraepithelial T cell morphology|MP:0008474,absent spleen germinal center|MP:0008479,decreased spleen white pulp amount
MGI:3690461	Il2rg<tm1Krf>	MP:0000715,decreased thymocyte number
MGI:2429736	Il2rg<tm1Sug>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000691,enlarged spleen|MP:0000706,small thymus|MP:0000711,thymus cortex hypoplasia|MP:0000715,decreased thymocyte number|MP:0000716,abnormal immune system cell morphology|MP:0001601,abnormal myelopoiesis|MP:0001802,arrested B cell differentiation|MP:0001805,decreased IgG level|MP:0001823,thymus hypoplasia|MP:0001927,abnormal estrous cycle|MP:0002217,small lymph nodes|MP:0002416,abnormal proerythroblast morphology|MP:0002490,abnormal immunoglobulin level|MP:0002722,abnormal immune system organ morphology|MP:0002723,abnormal immune serum protein physiology|MP:0004256,abnormal maternal decidual layer morphology|MP:0005016,decreased lymphocyte cell number|MP:0005018,decreased T cell number|MP:0005046,absent spleen white pulp|MP:0005389,reproductive system phenotype|MP:0005425,increased macrophage cell number|MP:0008046,absent NK cells|MP:0008047,absent uterine NK cells|MP:0008136,enlarged Peyer's patches|MP:0008254,increased megakaryocyte cell number|MP:0008498,decreased IgG3 level|MP:0008826,abnormal splenic cell ratio|MP:0009006,prolonged estrous cycle|MP:0009011,prolonged diestrus|MP:0009020,prolonged metestrus|MP:0010776,abnormal placenta metrial gland morphology|MP:0012529,abnormal decidua basalis morphology
MGI:1857455	Il2rg<tm1Wjl>	MP:0000494,abnormal cecum morphology|MP:0000693,spleen hyperplasia|MP:0000694,spleen hypoplasia|MP:0000706,small thymus|MP:0000708,thymus hyperplasia|MP:0002217,small lymph nodes|MP:0002376,abnormal dendritic cell physiology|MP:0002378,abnormal gut-associated lymphoid tissue morphology|MP:0002421,abnormal cell-mediated immunity|MP:0002423,abnormal mast cell physiology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002458,abnormal B cell number|MP:0002460,decreased immunoglobulin level|MP:0002464,abnormal basophil physiology|MP:0002619,abnormal lymphocyte morphology|MP:0002722,abnormal immune system organ morphology|MP:0002723,abnormal immune serum protein physiology|MP:0003850,abnormal thymocyte activation|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0005232,abnormal mesenteric lymph node morphology|MP:0008046,absent NK cells|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0008122,decreased myeloid dendritic cell number|MP:0008215,decreased immature B cell number|MP:0008348,absent gamma-delta T cells|MP:0008352,absent gamma-delta intraepithelial T cell|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008826,abnormal splenic cell ratio|MP:0009481,cecum inflammation|MP:0013592,small thymus cortex
MGI:3776426	Il2rg<tm2Cgn>	MP:0008045,decreased NK cell number
MGI:3852346	Il2<tm1.1Flv>	MP:0002425,abnormal susceptibility to autoimmune disorder
MGI:5449713	Il2<tm1.1Kasm>	MP:0005387,immune system phenotype|MP:0008615,decreased circulating interleukin-17 level|MP:0010954,abnormal cellular respiration
MGI:1857191	Il2<tm1Hor>	MP:0000172,abnormal bone marrow cell number|MP:0000208,decreased hematocrit|MP:0000488,abnormal intestinal epithelium morphology|MP:0000491,crypts of Lieberkuhn abscesses|MP:0000493,rectal prolapse|MP:0000512,intestinal ulcer|MP:0000604,amyloidosis|MP:0000613,abnormal salivary gland morphology|MP:0000623,decreased salivation|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0000717,abnormal lymphocyte cell number|MP:0001505,hunched posture|MP:0001577,anemia|MP:0001665,chronic diarrhea|MP:0001828,abnormal T cell activation|MP:0001829,increased activated T cell number|MP:0001846,increased inflammatory response|MP:0001853,heart inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001864,vascular inflammation|MP:0001869,pancreas inflammation|MP:0001870,salivary gland inflammation|MP:0002083,premature death|MP:0002424,abnormal reticulocyte morphology|MP:0002493,increased IgG level|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0002594,low mean erythrocyte cell number|MP:0002619,abnormal lymphocyte morphology|MP:0002816,colitis|MP:0003132,increased pre-B cell number|MP:0003293,rectal hemorrhage|MP:0003304,large intestinal inflammation|MP:0003850,abnormal thymocyte activation|MP:0003945,abnormal lymphocyte physiology|MP:0004751,increased length of allograft survival|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0004816,abnormal class switch recombination|MP:0004827,increased susceptibility to autoimmune hemolytic anemia|MP:0004946,abnormal regulatory T cell physiology|MP:0004973,increased regulatory T cell number|MP:0004974,decreased regulatory T cell number|MP:0005015,increased T cell number|MP:0005036,diarrhea|MP:0005042,abnormal level of surface class II molecules|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005089,decreased double-negative T cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005094,abnormal T cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005150,cachexia|MP:0005154,increased B cell proliferation|MP:0005344,increased circulating bilirubin level|MP:0005348,increased T cell proliferation|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005561,increased mean corpuscular hemoglobin|MP:0005671,abnormal response to transplant|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008097,increased plasma cell number|MP:0008102,lymph node hyperplasia|MP:0008177,increased germinal center B cell number|MP:0008186,increased pro-B cell number|MP:0008349,abnormal gamma-delta intraepithelial T cell morphology|MP:0008401,abnormal CD8 positive, alpha-beta intraepithelial T cell morphology|MP:0008466,enlarged mesenteric lymph nodes|MP:0008476,increased spleen red pulp amount|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008578,decreased circulating interferon-gamma level|MP:0008603,decreased circulating interleukin-4 level|MP:0008609,decreased circulating interleukin-13 level|MP:0008614,increased circulating interleukin-17 level|MP:0008880,lacrimal gland inflammation|MP:0009335,decreased splenocyte proliferation|MP:0009338,increased splenocyte number|MP:0009517,abnormal salivary gland duct morphology|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010210,abnormal circulating cytokine level|MP:0010219,increased T-helper 17 cell number|MP:0010954,abnormal cellular respiration|MP:0013795,abnormal colon goblet cell morphology|MP:0020912,abnormal susceptibility to Riboviria infection
MGI:5751157	Il31ra<tm1b(EUCOMM)Hmgu>	MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:3047479	Il31ra<tm1Jagr>	MP:0005387,immune system phenotype
MGI:3717594	Il31ra<tm1Ngh>	MP:0000333,decreased bone marrow cell number|MP:0000694,spleen hypoplasia|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002451,abnormal macrophage physiology|MP:0002497,increased IgE level|MP:0002500,granulomatous inflammation|MP:0005027,increased susceptibility to parasitic infection|MP:0005348,increased T cell proliferation|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008751,abnormal interleukin level
MGI:7647341	Il31<tm1.1Snak>	MP:0005387,immune system phenotype|MP:0010073,decreased pruritus
MGI:6120755	Il31<tm1b(EUCOMM)Wtsi>	MP:0002764,short tibia
MGI:5146687	Il33<Gt(IST10946B6)Tigm>	MP:0010768,mortality/aging
MGI:5548682	Il33<tm1.1(KOMP)Vlcg>	MP:0000367,abnormal coat/ hair morphology|MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval
MGI:5316127	Il33<tm1Aki>	MP:0002492,decreased IgE level|MP:0005012,decreased eosinophil cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005387,immune system phenotype|MP:0005466,abnormal T-helper 2 physiology|MP:0010862,decreased respiratory mucosa goblet cell number
MGI:5476737	Il33<tm1Amgn>	MP:0001819,abnormal immune cell physiology|MP:0005016,decreased lymphocyte cell number|MP:0005027,increased susceptibility to parasitic infection
MGI:4452857	Il33<tm1(KOMP)Vlcg>	MP:0000811,hippocampal neuron degeneration|MP:0001126,abnormal ovary morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001131,abnormal ovarian follicle morphology|MP:0002229,neurodegeneration|MP:0002574,increased vertical activity|MP:0002680,decreased corpora lutea number|MP:0002882,abnormal neuron morphology|MP:0003507,abnormal ovary physiology|MP:0003799,impaired macrophage chemotaxis|MP:0004000,impaired passive avoidance behavior|MP:0004250,tau protein deposits|MP:0008260,abnormal autophagy|MP:0008995,early reproductive senescence|MP:0011620,abnormal habituation to a new environment|MP:0014764,impaired double-strand DNA break repair|MP:0031391,increased locomotor activity|MP:0031420,decreased superovulation rate
MGI:4838250	Il33<tm1Snak>	MP:0001861,lung inflammation|MP:0001876,decreased inflammatory response|MP:0002335,decreased airway responsiveness|MP:0005387,immune system phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0008655,decreased interleukin-1 alpha secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:5829418	Il33<tm2.1(IL33)Arte>	MP:0005387,immune system phenotype
MGI:5438224	Il34<tm1b(EUCOMM)Wtsi>	MP:0000136,abnormal microglial cell morphology|MP:0003203,increased neuron apoptosis|MP:0005387,immune system phenotype|MP:0005398,decreased susceptibility to fungal infection|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008101,lymph node hypoplasia|MP:0008118,absent Langerhans cell|MP:0008119,decreased Langerhans cell number|MP:0008127,decreased dendritic cell number|MP:0008567,decreased interferon-gamma secretion|MP:0020943,increased susceptibility to Flaviviridae infection|MP:0031044,increased susceptibility to Flaviviridae infection induced morbidity/mortality
MGI:6272256	Il36a<tm1Yiw>	MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype|MP:0008713,abnormal cytokine level|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5007193	Il36g<tm1Lex>	MP:0000755,hindlimb paralysis|MP:0001798,impaired macrophage phagocytosis|MP:0002412,increased susceptibility to bacterial infection|MP:0002446,abnormal macrophage morphology|MP:0004973,increased regulatory T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008539,decreased susceptibility to induced colitis|MP:0008712,decreased interleukin-9 secretion|MP:0008713,abnormal cytokine level|MP:0008719,impaired neutrophil recruitment|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0011075,abnormal macrophage activation involved in immune response|MP:0011080,increased macrophage apoptosis|MP:0013648,increased CD11b-high dendritic cell number|MP:0014229,decreased alveolar macrophage number|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020946,increased susceptibility to Orthomyxoviridae infection|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality|MP:0031046,increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:6430668	Il36rn<em1(IMPC)Mbp>	MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney
MGI:3762028	Il36rn<tm1Hblu>	MP:0002169,no abnormal phenotype detected|MP:0012572,increased susceptibility to chemically induced skin inflammation
MGI:5476725	Il36rn<tm1Kopf>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0001190,reddish skin|MP:0001193,psoriasis|MP:0001194,dermatitis|MP:0001195,flaky skin|MP:0001242,hyperkeratosis|MP:0001874,acanthosis|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:3652833	Il3ra<m1>	MP:0005460,abnormal leukopoiesis|MP:0006410,abnormal common myeloid progenitor cell morphology
MGI:5609363	Il3<tm1.1(KOMP)Mbp>	MP:0001925,male infertility|MP:0001926,female infertility|MP:0010124,decreased bone mineral content
MGI:2446538	Il3<tm1Glli>	MP:0005027,increased susceptibility to parasitic infection|MP:0005215,abnormal pancreatic islet morphology|MP:0005462,abnormal mast cell differentiation|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction
MGI:6120692	Il4i1<tm1b(EUCOMM)Wtsi>	MP:0005628,decreased circulating potassium level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011886,increased circulating lipase level
MGI:3604399	Il4i1<tm1Lex>	MP:0001454,abnormal cued conditioning behavior
MGI:3038244	Il4/Il13<tm3Anjm>	MP:0001790,abnormal immune system physiology|MP:0001793,abnormal susceptibility to infection|MP:0001805,decreased IgG level|MP:0001876,decreased inflammatory response|MP:0002492,decreased IgE level|MP:0002500,granulomatous inflammation|MP:0003449,abnormal intestine goblet cell morphology|MP:0005011,increased eosinophil cell number|MP:0005026,decreased susceptibility to parasitic infection|MP:0005027,increased susceptibility to parasitic infection|MP:0005166,decreased susceptibility to injury|MP:0005351,decreased susceptibility to autoimmune disorder|MP:0005466,abnormal T-helper 2 physiology|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0008495,decreased IgG1 level|MP:0008500,increased IgG2a level|MP:0008567,decreased interferon-gamma secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008698,abnormal interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0009333,abnormal splenocyte physiology|MP:0009482,ileum inflammation|MP:0010750,increased susceptibility to parasitic infection induced morbidity/mortality
MGI:3038245	Il4/Il13<tm3Anjm>	MP:0001790,abnormal immune system physiology|MP:0001793,abnormal susceptibility to infection|MP:0001805,decreased IgG level|MP:0001876,decreased inflammatory response|MP:0002492,decreased IgE level|MP:0002500,granulomatous inflammation|MP:0003449,abnormal intestine goblet cell morphology|MP:0005011,increased eosinophil cell number|MP:0005026,decreased susceptibility to parasitic infection|MP:0005027,increased susceptibility to parasitic infection|MP:0005166,decreased susceptibility to injury|MP:0005351,decreased susceptibility to autoimmune disorder|MP:0005466,abnormal T-helper 2 physiology|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0008495,decreased IgG1 level|MP:0008500,increased IgG2a level|MP:0008567,decreased interferon-gamma secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008698,abnormal interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0009333,abnormal splenocyte physiology|MP:0009482,ileum inflammation|MP:0010750,increased susceptibility to parasitic infection induced morbidity/mortality
MGI:6268775	Il4ra<M1Btlr>	MP:0002492,decreased IgE level
MGI:6285886	Il4ra<M2Btlr>	MP:0002492,decreased IgE level
MGI:2657172	Il4ra<tm1Fbb>	MP:0000488,abnormal intestinal epithelium morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0001263,weight loss|MP:0001790,abnormal immune system physiology|MP:0001793,abnormal susceptibility to infection|MP:0001860,liver inflammation|MP:0002083,premature death|MP:0002406,increased susceptibility to infection|MP:0002451,abnormal macrophage physiology|MP:0002500,granulomatous inflammation|MP:0003009,abnormal cytokine secretion|MP:0003799,impaired macrophage chemotaxis|MP:0005027,increased susceptibility to parasitic infection|MP:0008091,decreased T-helper 2 cell number|MP:0008551,abnormal circulating interferon-gamma level|MP:0008602,increased circulating interleukin-4 level|MP:0008837,increased transforming growth factor beta level|MP:0010210,abnormal circulating cytokine level
MGI:1861951	Il4ra<tm1Sz>	MP:0000136,abnormal microglial cell morphology|MP:0001793,abnormal susceptibility to infection|MP:0002492,decreased IgE level|MP:0005027,increased susceptibility to parasitic infection|MP:0005466,abnormal T-helper 2 physiology|MP:0008495,decreased IgG1 level|MP:0008500,increased IgG2a level|MP:0008661,decreased interleukin-10 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion
MGI:2680722	Il4ra<tm1Tch>	MP:0001952,increased airway responsiveness|MP:0002405,respiratory system inflammation|MP:0002434,abnormal T-helper 2 cell morphology|MP:0002493,increased IgG level|MP:0002497,increased IgE level|MP:0002723,abnormal immune serum protein physiology|MP:0005095,decreased T cell proliferation
MGI:3689995	Il4ra<tm2Fbb>	MP:0005282,decreased fatty acids level|MP:0011014,decreased core body temperature
MGI:3720593	Il4ra<tm2Tch>	MP:0000220,increased monocyte cell number|MP:0001952,increased airway responsiveness|MP:0002264,abnormal bronchus morphology|MP:0002405,respiratory system inflammation|MP:0002497,increased IgE level|MP:0005011,increased eosinophil cell number|MP:0005466,abnormal T-helper 2 physiology|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008602,increased circulating interleukin-4 level|MP:0010861,increased respiratory mucosa goblet cell number
MGI:4455123	Il4ra<tm3.1Tch>	MP:0002497,increased IgE level|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008699,increased interleukin-4 secretion|MP:0011075,abnormal macrophage activation involved in immune response
MGI:2388164	Il4<tm1.1Wep>	MP:0002492,decreased IgE level|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008700,decreased interleukin-4 secretion|MP:0008723,impaired eosinophil recruitment
MGI:3664115	Il4<tm1(CD2)Irvr>	MP:0005384,cellular phenotype|MP:0005387,immune system phenotype
MGI:3686902	Il4<tm1(CD2)Mmrs>	MP:0002492,decreased IgE level|MP:0002607,decreased basophil cell number|MP:0008495,decreased IgG1 level|MP:0008700,decreased interleukin-4 secretion
MGI:1857194	Il4<tm1Cgn>	MP:0001800,abnormal humoral immune response|MP:0001844,autoimmune response|MP:0001870,salivary gland inflammation|MP:0002492,decreased IgE level|MP:0002500,granulomatous inflammation|MP:0003009,abnormal cytokine secretion|MP:0004031,insulitis|MP:0005310,abnormal salivary gland physiology|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005351,decreased susceptibility to autoimmune disorder|MP:0005387,immune system phenotype|MP:0005466,abnormal T-helper 2 physiology|MP:0005501,abnormal skin physiology|MP:0005559,increased circulating glucose level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008495,decreased IgG1 level|MP:0008500,increased IgG2a level|MP:0008872,abnormal physiological response to xenobiotic|MP:0008880,lacrimal gland inflammation
MGI:1934015	Il4<tm1Gru>	MP:0002169,no abnormal phenotype detected
MGI:2176268	Il4<tm1Kopf>	MP:0002492,decreased IgE level|MP:0002493,increased IgG level|MP:0005012,decreased eosinophil cell number|MP:0005025,abnormal response to infection|MP:0008495,decreased IgG1 level|MP:0008661,decreased interleukin-10 secretion|MP:0008697,decreased interleukin-3 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion
MGI:1857196	Il4<tm1Nnt>	MP:0000136,abnormal microglial cell morphology|MP:0001806,decreased IgM level|MP:0001873,stomach inflammation|MP:0002492,decreased IgE level|MP:0002495,increased IgA level|MP:0002500,granulomatous inflammation|MP:0005351,decreased susceptibility to autoimmune disorder|MP:0005466,abnormal T-helper 2 physiology|MP:0006082,CNS inflammation|MP:0008495,decreased IgG1 level|MP:0008566,increased interferon-gamma secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008698,abnormal interleukin-4 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion
MGI:2384290	Il4<tm1Rao>	MP:0002423,abnormal mast cell physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0008673,decreased interleukin-13 secretion|MP:0008700,decreased interleukin-4 secretion
MGI:4880750	Il4<tm2.1Kubo>	MP:0002335,decreased airway responsiveness|MP:0002492,decreased IgE level|MP:0008495,decreased IgG1 level|MP:0008672,increased interleukin-13 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion|MP:0008723,impaired eosinophil recruitment|MP:0008896,increased IgG2c level
MGI:1857195	Il4<tm2Nnt>	MP:0001793,abnormal susceptibility to infection|MP:0002136,abnormal kidney physiology|MP:0002455,abnormal dendritic cell antigen presentation|MP:0002492,decreased IgE level|MP:0005027,increased susceptibility to parasitic infection|MP:0005351,decreased susceptibility to autoimmune disorder|MP:0008115,abnormal dendritic cell differentiation|MP:0008495,decreased IgG1 level|MP:0008566,increased interferon-gamma secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0009333,abnormal splenocyte physiology|MP:0009482,ileum inflammation|MP:0010750,increased susceptibility to parasitic infection induced morbidity/mortality|MP:0030466,alveolar process atrophy
MGI:4880753	Il4<tm3.1Kubo>	MP:0008700,decreased interleukin-4 secretion
MGI:2180501	Il5ra<tm1Ktk>	MP:0001272,increased metastatic potential|MP:0001790,abnormal immune system physiology|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002401,abnormal lymphopoiesis|MP:0002460,decreased immunoglobulin level|MP:0002602,abnormal eosinophil cell number|MP:0004940,abnormal B-1 B cell morphology|MP:0004978,decreased B-1 B cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005093,decreased B cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008495,decreased IgG1 level|MP:0008498,decreased IgG3 level
MGI:5558083	Il5<tm1.1(icre)Lky>	MP:0008627,decreased circulating interleukin-5 level
MGI:3688245	Il5<tm1Anjm>	MP:0000359,abnormal mast cell morphology|MP:0001793,abnormal susceptibility to infection|MP:0002423,abnormal mast cell physiology|MP:0002492,decreased IgE level|MP:0002500,granulomatous inflammation|MP:0003449,abnormal intestine goblet cell morphology|MP:0005012,decreased eosinophil cell number|MP:0005027,increased susceptibility to parasitic infection
MGI:1861948	Il5<tm1Kopf>	MP:0000219,increased neutrophil cell number|MP:0001260,increased body weight|MP:0001376,abnormal mating receptivity|MP:0002335,decreased airway responsiveness|MP:0002500,granulomatous inflammation|MP:0003333,liver fibrosis|MP:0004260,enlarged placenta|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0008566,increased interferon-gamma secretion|MP:0009006,prolonged estrous cycle
MGI:5312092	Il5<tm1Ktk>	MP:0001272,increased metastatic potential|MP:0004940,abnormal B-1 B cell morphology|MP:0008703,decreased interleukin-5 secretion
MGI:3689810	Il5<tm3Anjm>	MP:0002500,granulomatous inflammation
MGI:6153742	Il6ra<em1(IMPC)Wtsi>	MP:0010067,increased red blood cell distribution width
MGI:4456449	Il6ra<tm1.1Drew>	MP:0000436,abnormal head movements|MP:0002169,no abnormal phenotype detected|MP:0002572,abnormal emotion/affect behavior|MP:0003631,nervous system phenotype|MP:0005087,decreased acute inflammation|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5556081	Il6ra<tm1.1(IL6R)Csk>	MP:0010214,abnormal circulating serum amyloid protein level
MGI:4847943	Il6ra<tm1.1Jcbr>	MP:0002714,increased glycogen catabolism rate|MP:0003058,increased insulin secretion|MP:0003059,decreased insulin secretion|MP:0005026,decreased susceptibility to parasitic infection|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005438,abnormal glycogen homeostasis|MP:0008553,increased circulating tumor necrosis factor level|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0010398,decreased liver glycogen level|MP:0030017,decreased adipocyte glucose uptake
MGI:5548361	Il6ra<tm1.1(KOMP)Vlcg>	MP:0009709,hydrometra
MGI:4456450	Il6ra<tm1.2Drew>	MP:0001845,abnormal inflammatory response|MP:0005023,abnormal wound healing
MGI:5550551	Il6ra<tm1.2Jcbr>	MP:0001860,liver inflammation|MP:0003447,decreased tumor growth/size|MP:0003887,increased hepatocyte apoptosis|MP:0004001,decreased hepatocyte proliferation|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005026,decreased susceptibility to parasitic infection|MP:0005343,increased circulating aspartate transaminase level|MP:0005378,growth/size/body region phenotype|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality
MGI:4454682	Il6ra<tm1Saj>	MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology
MGI:1931248	Il6st<tm1.1Wme>	MP:0001698,decreased embryo size|MP:0002088,abnormal embryonic growth/weight/body size|MP:0005378,growth/size/body region phenotype|MP:0011111,lethality during fetal growth through weaning, complete penetrance
MGI:2388476	Il6st<tm1Ard>	MP:0000217,abnormal leukocyte cell number|MP:0000228,abnormal thrombopoiesis|MP:0000351,increased cell proliferation|MP:0000462,abnormal digestive system morphology|MP:0000465,gastrointestinal hemorrhage|MP:0000493,rectal prolapse|MP:0000559,abnormal femur morphology|MP:0000997,abnormal synovial joint capsule morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001728,failure of embryo implantation|MP:0001805,decreased IgG level|MP:0001807,decreased IgA level|MP:0001846,increased inflammatory response|MP:0001852,conjunctivitis|MP:0001926,female infertility|MP:0002083,premature death|MP:0002417,abnormal megakaryocyte morphology|MP:0002460,decreased immunoglobulin level|MP:0002932,abnormal joint morphology|MP:0002936,joint swelling|MP:0003109,short femur|MP:0003179,thrombocytopenia|MP:0003282,gastric ulcer|MP:0003300,gastrointestinal ulcer|MP:0005027,increased susceptibility to parasitic infection|MP:0005390,skeleton phenotype|MP:0006271,abnormal involution of the mammary gland|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008152,decreased diameter of femur|MP:0008254,increased megakaryocyte cell number|MP:0008255,decreased megakaryocyte cell number|MP:0008537,increased susceptibility to induced colitis|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009481,cecum inflammation|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011086,postnatal lethality, incomplete penetrance|MP:0030863,decreased joint mobility
MGI:5474976	Il6st<tm1b(KOMP)Mbp>	MP:0005344,increased circulating bilirubin level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2388478	Il6st<tm1Ern>	MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000219,increased neutrophil cell number|MP:0000470,abnormal stomach morphology|MP:0000496,abnormal small intestine morphology|MP:0000691,enlarged spleen|MP:0001663,abnormal digestive system physiology|MP:0001845,abnormal inflammatory response|MP:0001873,stomach inflammation|MP:0003724,increased susceptibility to induced arthritis|MP:0003883,enlarged stomach|MP:0004984,increased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0008006,increased stomach pH|MP:0008539,decreased susceptibility to induced colitis|MP:0008596,increased circulating interleukin-6 level|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009346,decreased trabecular bone thickness|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010383,increased adenoma incidence|MP:0010792,abnormal stomach mucosa morphology
MGI:2176787	Il6st<tm1Kish>	MP:0000130,abnormal trabecular bone morphology|MP:0000168,abnormal bone marrow development|MP:0000195,decreased circulating calcium level|MP:0000280,thin ventricular wall|MP:0000547,short limbs|MP:0001265,decreased body size|MP:0001541,abnormal osteoclast physiology|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0001823,thymus hypoplasia|MP:0002082,postnatal lethality|MP:0002904,increased circulating parathyroid hormone level|MP:0003432,increased activity of parathyroid|MP:0003723,abnormal long bone morphology|MP:0004214,abnormal long bone diaphysis morphology|MP:0004358,bowed tibia|MP:0004361,bowed ulna|MP:0004371,bowed femur|MP:0004372,bowed fibula|MP:0004373,bowed humerus|MP:0004374,bowed radius|MP:0004810,decreased hematopoietic stem cell number|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0005006,abnormal osteoblast physiology|MP:0005508,abnormal skeleton morphology|MP:0008396,abnormal osteoclast differentiation|MP:0008439,abnormal cortical plate morphology|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0009395,increased nucleated erythrocyte cell number|MP:0010398,decreased liver glycogen level|MP:0011087,neonatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3511264	Il6st<tm1Mam>	MP:0006271,abnormal involution of the mammary gland
MGI:2386991	Il6st<tm1Thir>	MP:0000062,increased bone mineral density|MP:0000066,osteoporosis|MP:0000219,increased neutrophil cell number|MP:0000693,spleen hyperplasia|MP:0001828,abnormal T cell activation|MP:0001829,increased activated T cell number|MP:0002455,abnormal dendritic cell antigen presentation|MP:0002459,abnormal B cell physiology|MP:0002495,increased IgA level|MP:0003486,abnormal channel response intensity|MP:0003561,rheumatoid arthritis|MP:0003725,increased autoantibody level|MP:0003795,abnormal bone structure|MP:0003850,abnormal thymocyte activation|MP:0004215,abnormal myocardial fiber physiology|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005002,abnormal T cell clonal deletion|MP:0005006,abnormal osteoblast physiology|MP:0005014,increased B cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005402,abnormal action potential|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0008102,lymph node hyperplasia|MP:0008466,enlarged mesenteric lymph nodes|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008542,enlarged cervical lymph nodes|MP:0008566,increased interferon-gamma secretion|MP:0008700,decreased interleukin-4 secretion|MP:0009216,abnormal peritoneum morphology|MP:0009347,increased trabecular bone thickness|MP:0009623,enlarged inguinal lymph nodes|MP:0009631,enlarged axillary lymph nodes|MP:0010123,increased bone mineral content|MP:0020039,increased bone ossification|MP:0020080,increased bone mineralization
MGI:1931239	Il6st<tm1Wme>	MP:0000218,increased leukocyte cell number|MP:0000228,abnormal thrombopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000267,abnormal heart development|MP:0000715,decreased thymocyte number|MP:0000920,abnormal myelination|MP:0001106,abnormal Schwann cell morphology|MP:0002145,abnormal T cell differentiation|MP:0002490,abnormal immunoglobulin level|MP:0002493,increased IgG level|MP:0002497,increased IgE level|MP:0002658,abnormal liver regeneration|MP:0005294,abnormal heart ventricle morphology
MGI:2386993	Il6st<tm2Thir>	MP:0002398,abnormal bone marrow cell morphology/development|MP:0002455,abnormal dendritic cell antigen presentation|MP:0002494,increased IgM level|MP:0005006,abnormal osteoblast physiology|MP:0008168,decreased B-1a cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008567,decreased interferon-gamma secretion|MP:0011087,neonatal lethality, complete penetrance
MGI:2386998	Il6st<tm3Thir>	MP:0001807,decreased IgA level|MP:0002182,abnormal astrocyte morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0011087,neonatal lethality, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:3843614	Il6st<tm4Thir>	MP:0002169,no abnormal phenotype detected
MGI:5577062	Il6<tm1.1Jho>	MP:0000436,abnormal head movements|MP:0001260,increased body weight|MP:0001402,decreased locomotor activity|MP:0002572,abnormal emotion/affect behavior|MP:0005386,behavior/neurological phenotype|MP:0008918,microgliosis|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1857197	Il6<tm1Kopf>	MP:0000063,decreased bone mineral density|MP:0000136,abnormal microglial cell morphology|MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000281,abnormal interventricular septum morphology|MP:0000952,abnormal CNS glial cell morphology|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001458,abnormal object recognition memory|MP:0001463,abnormal spatial learning|MP:0001501,abnormal sleep pattern|MP:0001544,abnormal cardiovascular system physiology|MP:0001654,hepatic necrosis|MP:0001764,abnormal homeostasis|MP:0001792,impaired wound healing|MP:0001845,abnormal inflammatory response|MP:0002063,abnormal learning/memory/conditioning|MP:0002064,seizures|MP:0002078,abnormal glucose homeostasis|MP:0002145,abnormal T cell differentiation|MP:0002182,abnormal astrocyte morphology|MP:0002332,abnormal exercise endurance|MP:0002336,abnormal pulmonary gas exchange|MP:0002412,increased susceptibility to bacterial infection|MP:0002435,abnormal effector T cell morphology|MP:0002444,abnormal T cell physiology|MP:0002572,abnormal emotion/affect behavior|MP:0002573,behavioral despair|MP:0002711,decreased glucagon secretion|MP:0002753,dilated heart left ventricle|MP:0002801,abnormal long-term object recognition memory|MP:0002834,decreased heart weight|MP:0002882,abnormal neuron morphology|MP:0002908,delayed wound healing|MP:0002999,abnormal bone healing|MP:0003059,decreased insulin secretion|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003103,liver degeneration|MP:0003194,abnormal frequency of paradoxical sleep|MP:0003436,decreased susceptibility to induced arthritis|MP:0003459,increased fear-related response|MP:0003633,abnormal nervous system physiology|MP:0003634,abnormal glial cell morphology|MP:0003658,abnormal capillary morphology|MP:0004101,abnormal brain interneuron morphology|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004811,abnormal neuron physiology|MP:0005018,decreased T cell number|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005140,decreased cardiac muscle contractility|MP:0005166,decreased susceptibility to injury|MP:0005288,abnormal oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005294,abnormal heart ventricle morphology|MP:0005404,abnormal axon morphology|MP:0005533,increased body temperature|MP:0005559,increased circulating glucose level|MP:0006271,abnormal involution of the mammary gland|MP:0008208,decreased pro-B cell number|MP:0008518,retina outer nuclear layer degeneration|MP:0008537,increased susceptibility to induced colitis|MP:0008567,decreased interferon-gamma secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008704,abnormal interleukin-6 secretion|MP:0009410,abnormal skeletal muscle satellite cell proliferation|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010042,abnormal oval cell physiology|MP:0010211,abnormal acute phase protein level|MP:0012563,increased tumor incidence following infection|MP:0014315,decreased heart left ventricle anterior wall thickness|MP:0014316,decreased heart left ventricle posterior wall thickness|MP:0014367,impaired long-term object recognition memory|MP:0020340,abnormal inhibitory learning|MP:0020928,increased susceptibility to Poxviridae infection|MP:0021158,decreased heart left ventricle wall thickness|MP:0030587,abnormal pancreatic alpha cell mass|MP:0030945,abnormal myoblast migration|MP:0031391,increased locomotor activity
MGI:2182222	Il6<tm1Mur>	MP:0000130,abnormal trabecular bone morphology|MP:0000136,abnormal microglial cell morphology|MP:0000717,abnormal lymphocyte cell number|MP:0001541,abnormal osteoclast physiology|MP:0001845,abnormal inflammatory response|MP:0001847,brain inflammation|MP:0001905,abnormal dopamine level|MP:0002183,gliosis|MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0003691,abnormal microglial cell physiology|MP:0005027,increased susceptibility to parasitic infection|MP:0005387,immune system phenotype|MP:0008046,absent NK cells|MP:0008395,abnormal osteoblast differentiation|MP:0008396,abnormal osteoclast differentiation|MP:0008750,abnormal interferon level|MP:0010119,abnormal bone mineral density|MP:0011451,increased susceptibility to dopaminergic neuron neurotoxicity|MP:0013219,abnormal substantia nigra pars compacta morphology
MGI:2158764	Il6<tm1Poli>	MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000598,abnormal liver morphology|MP:0001259,abnormal body weight|MP:0001354,increased aggression towards male mice|MP:0001360,abnormal social investigation|MP:0001388,abnormal stationary movement|MP:0001463,abnormal spatial learning|MP:0001541,abnormal osteoclast physiology|MP:0001654,hepatic necrosis|MP:0001790,abnormal immune system physiology|MP:0001807,decreased IgA level|MP:0001876,decreased inflammatory response|MP:0001982,decreased chemically-elicited antinociception|MP:0002053,decreased incidence of induced tumors|MP:0002063,abnormal learning/memory/conditioning|MP:0002433,abnormal T-helper 1 cell morphology|MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology|MP:0002492,decreased IgE level|MP:0002734,abnormal mechanical nociception|MP:0002799,abnormal passive avoidance behavior|MP:0002998,abnormal bone remodeling|MP:0003326,liver failure|MP:0003829,impaired febrile response|MP:0004924,abnormal behavior|MP:0005153,abnormal B cell proliferation|MP:0005166,decreased susceptibility to injury|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005399,increased susceptibility to fungal infection|MP:0005449,abnormal food intake|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0005517,impaired liver regeneration|MP:0005643,decreased dopamine level|MP:0008500,increased IgG2a level|MP:0008593,increased circulating interleukin-10 level|MP:0008618,decreased circulating interleukin-12 level|MP:0008719,impaired neutrophil recruitment|MP:0009753,enhanced behavioral response to morphine|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010768,mortality/aging
MGI:3575127	Il7<hlb368>	MP:0000221,decreased leukocyte cell number|MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0000706,small thymus|MP:0001823,thymus hypoplasia|MP:0002831,absent Peyer's patches|MP:0003944,abnormal T cell subpopulation ratio|MP:0005018,decreased T cell number|MP:0008465,absent mesenteric lymph nodes|MP:0009624,small inguinal lymph nodes|MP:0009630,absent axillary lymph nodes|MP:0009633,absent cervical lymph nodes|MP:0009634,absent popliteal lymph nodes
MGI:3797070	Il7<m1Jyen>	MP:0000694,spleen hypoplasia|MP:0001823,thymus hypoplasia|MP:0005017,decreased B cell number|MP:0008083,decreased single-positive T cell number|MP:0008101,lymph node hypoplasia|MP:0008250,abnormal myeloid leukocyte morphology
MGI:4441349	Il7r<tm1.1(icre)Hrr>	MP:0002169,no abnormal phenotype detected
MGI:3758859	Il7r<tm1Abra>	MP:0000715,decreased thymocyte number|MP:0002145,abnormal T cell differentiation|MP:0005017,decreased B cell number|MP:0005091,increased double-positive T cell number|MP:0005094,abnormal T cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008050,decreased memory T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3038693	Il7r<tm1Iku>	MP:0000221,decreased leukocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0000694,spleen hypoplasia|MP:0000706,small thymus|MP:0001823,thymus hypoplasia|MP:0002144,abnormal B cell differentiation|MP:0002831,absent Peyer's patches|MP:0003944,abnormal T cell subpopulation ratio|MP:0004978,decreased B-1 B cell number|MP:0005016,decreased lymphocyte cell number|MP:0005018,decreased T cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008355,absent mature gamma-delta T cells|MP:0008356,abnormal gamma-delta T cell differentiation
MGI:1857198	Il7r<tm1Imx>	MP:0000694,spleen hypoplasia|MP:0000715,decreased thymocyte number|MP:0001802,arrested B cell differentiation|MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0008101,lymph node hypoplasia
MGI:5475476	Il7r<tm2Iku>	MP:0000714,increased thymocyte number|MP:0005014,increased B cell number|MP:0008037,abnormal T cell morphology|MP:0008040,decreased NK T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008346,increased gamma-delta T cell number
MGI:5518726	Il7<tm1.1Mysl>	MP:0000715,decreased thymocyte number|MP:0001802,arrested B cell differentiation|MP:0001823,thymus hypoplasia|MP:0002217,small lymph nodes|MP:0005018,decreased T cell number|MP:0005232,abnormal mesenteric lymph node morphology|MP:0005387,immune system phenotype
MGI:1857652	Il7<tm1Dnax>	MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001802,arrested B cell differentiation|MP:0001823,thymus hypoplasia|MP:0002831,absent Peyer's patches|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005016,decreased lymphocyte cell number|MP:0008024,absent lymph nodes
MGI:2156458	Il7<tm1Hms>	MP:0000333,decreased bone marrow cell number|MP:0000694,spleen hypoplasia|MP:0001823,thymus hypoplasia
MGI:5461219	Il7<tm2.1Iku>	MP:0002144,abnormal B cell differentiation|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008040,decreased NK T cell number|MP:0008042,abnormal NK T cell physiology
MGI:6430656	Il9<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001304,cataract|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002989,small kidney
MGI:6367977	Il9r<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001293,anophthalmia|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001364,decreased anxiety-related response|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:3589948	Il9r<tm1Jcrd>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004946,abnormal regulatory T cell physiology|MP:0005387,immune system phenotype|MP:0008086,increased T-helper 1 cell number
MGI:2656470	Il9<tm1Anjm>	MP:0000359,abnormal mast cell morphology|MP:0002500,granulomatous inflammation|MP:0003009,abnormal cytokine secretion|MP:0003449,abnormal intestine goblet cell morphology|MP:0005025,abnormal response to infection|MP:0005027,increased susceptibility to parasitic infection|MP:0005387,immune system phenotype|MP:0005584,abnormal enzyme/coenzyme activity
MGI:5568753	Il9<tm1Flv>	MP:0005027,increased susceptibility to parasitic infection
MGI:5568755	Il9<tm2.1Flv>	MP:0002169,no abnormal phenotype detected
MGI:3893035	Ildr1<Gt(D178D03)Wrst>	MP:0000026,abnormal inner ear morphology|MP:0000042,abnormal organ of Corti morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0001967,deafness|MP:0002622,abnormal cochlear hair cell morphology|MP:0002630,abnormal endocochlear potential|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004737,absent distortion product otoacoustic emissions|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005418,abnormal circulating hormone level|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5752280	Ildr1<tm1.1Lwa>	MP:0000043,organ of Corti degeneration|MP:0001967,deafness|MP:0003151,absent tunnel of Corti|MP:0004404,cochlear outer hair cell degeneration|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013808,abnormal tunnel of Corti morphology
MGI:4419159	Ildr1<tm1(KOMP)Wtsi>	MP:0000042,abnormal organ of Corti morphology|MP:0001967,deafness|MP:0002630,abnormal endocochlear potential|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004740,sensorineural hearing loss|MP:0005377,hearing/vestibular/ear phenotype|MP:0006358,absent pinna reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3814224	Ildr2<Dbsm1-DBA/2J>	MP:0001559,hyperglycemia
MGI:3820395	Ildr2<W87*>	MP:0002727,decreased circulating insulin level|MP:0003339,decreased pancreatic beta cell number|MP:0005293,impaired glucose tolerance|MP:0009114,decreased pancreatic beta cell mass|MP:0009175,abnormal pancreatic beta cell differentiation
MGI:4462358	Ilf2<tm1Pnk>	MP:0005387,immune system phenotype|MP:0008762,embryonic lethality
MGI:4878917	Ilf3<tm1.1Itl>	MP:0020931,increased susceptibility to Adenoviridae infection
MGI:3586304	Ilf3<tm1Pnk>	MP:0000746,weakness|MP:0000759,abnormal skeletal muscle morphology|MP:0000761,thin diaphragm muscle|MP:0001404,no spontaneous movement|MP:0001436,abnormal suckling behavior|MP:0001575,cyanosis|MP:0002280,abnormal intercostal muscle morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0005387,immune system phenotype|MP:0005426,tachypnea|MP:0006042,increased apoptosis|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0011087,neonatal lethality, complete penetrance
MGI:6379560	Ilkap<em1(IMPC)Tcp>	MP:0020870,decreased thigmotaxis
MGI:4164011	Ilkap<Gt(OST55141)Lex>	MP:0003858,enhanced coordination|MP:0003982,increased cholesterol level
MGI:5518827	Ilk<tm10.1Ref>	MP:0001719,absent vitelline blood vessels|MP:0003984,embryonic growth retardation|MP:0004188,delayed embryo turning|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance
MGI:5617258	Ilk<tm1.1(KOMP)Vlcg>	MP:0001303,abnormal lens morphology|MP:0001399,hyperactivity|MP:0001566,increased circulating phosphate level|MP:0001697,abnormal embryo size|MP:0002574,increased vertical activity|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2655773	Ilk<tm1Ref>	MP:0003886,abnormal embryonic epiblast morphology|MP:0004272,abnormal basement membrane morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2668459	Ilk<tm1Star>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000379,decreased hair follicle number|MP:0001192,scaly skin|MP:0001199,thin skin|MP:0001208,blistering|MP:0001216,abnormal epidermal layer morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001786,skin edema|MP:0001874,acanthosis|MP:0002073,abnormal hair growth|MP:0002083,premature death|MP:0002095,abnormal skin pigmentation|MP:0002113,abnormal skeleton development|MP:0002135,abnormal kidney morphology|MP:0002427,disproportionate dwarf|MP:0002655,abnormal keratinocyte morphology|MP:0002657,chondrodystrophy|MP:0002705,dilated renal tubule|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002871,albuminuria|MP:0002908,delayed wound healing|MP:0002962,increased urine protein level|MP:0003089,decreased skin tensile strength|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0003704,abnormal hair follicle development|MP:0004947,skin inflammation|MP:0005140,decreased cardiac muscle contractility|MP:0005178,increased circulating cholesterol level|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005608,cardiac interstitial fibrosis|MP:0006138,congestive heart failure|MP:0008060,abnormal podocyte slit diaphragm morphology|MP:0008139,fused podocyte foot processes|MP:0008140,podocyte foot process effacement|MP:0008770,decreased survivor rate|MP:0009584,decreased keratinocyte proliferation|MP:0011085,postnatal lethality, complete penetrance|MP:0011194,abnormal hair follicle physiology|MP:0011282,increased podocyte apoptosis|MP:0011294,renal glomerulus hypertrophy|MP:0011320,abnormal glomerular capillary morphology|MP:0011346,renal tubule atrophy|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011353,expanded mesangial matrix|MP:0011368,increased kidney apoptosis|MP:0011405,tubulointerstitial nephritis|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011483,renal glomerular synechia|MP:0011506,glomerular crescent|MP:0011753,decreased podocyte number|MP:0011856,abnormal glomerular filtration barrier function|MP:0011868,podocyte microvillus transformation|MP:0011869,detached podocyte|MP:0011925,abnormal heart echocardiography feature|MP:0012194,decreased keratinocyte migration
MGI:3653044	Ilk<tm3Ref>	MP:0000111,cleft palate|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000352,decreased cell proliferation|MP:0001178,pulmonary hypoplasia|MP:0002427,disproportionate dwarf|MP:0003077,abnormal cell cycle|MP:0004134,abnormal chest morphology|MP:0004200,decreased fetal size|MP:0006032,abnormal ureteric bud morphology|MP:0006396,decreased long bone epiphyseal plate size|MP:0006397,disorganized long bone epiphyseal plate|MP:0011087,neonatal lethality, complete penetrance|MP:0014696,decreased cell adhesion
MGI:4368006	Ilk<tm4.1Ref>	MP:0002169,no abnormal phenotype detected|MP:0010771,integument phenotype
MGI:4368009	Ilk<tm5.1Ref>	MP:0002169,no abnormal phenotype detected
MGI:4368010	Ilk<tm6.1Ref>	MP:0002169,no abnormal phenotype detected
MGI:4368011	Ilk<tm7.1Ref>	MP:0002169,no abnormal phenotype detected|MP:0005385,cardiovascular system phenotype|MP:0010771,integument phenotype
MGI:4368012	Ilk<tm8.1Ref>	MP:0000520,absent kidney|MP:0001438,aphagia|MP:0001505,hunched posture|MP:0003446,renal hypoplasia|MP:0003604,single kidney|MP:0003717,pallor|MP:0003722,absent ureter|MP:0005385,cardiovascular system phenotype|MP:0009703,decreased birth body size|MP:0010771,integument phenotype|MP:0011087,neonatal lethality, complete penetrance|MP:0011290,decreased nephron number|MP:0011846,decreased kidney collecting duct number
MGI:4368013	Ilk<tm9.1Ref>	MP:0000520,absent kidney|MP:0001438,aphagia|MP:0001505,hunched posture|MP:0003446,renal hypoplasia|MP:0003604,single kidney|MP:0003624,anuria|MP:0003717,pallor|MP:0003722,absent ureter|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005385,cardiovascular system phenotype|MP:0008487,abnormal mesonephros morphology|MP:0009703,decreased birth body size|MP:0010771,integument phenotype|MP:0010983,abnormal ureteric bud invasion|MP:0011087,neonatal lethality, complete penetrance|MP:0011290,decreased nephron number|MP:0011386,increased metanephric mesenchyme apoptosis|MP:0011846,decreased kidney collecting duct number
MGI:6156447	Ilrun<em1(IMPC)Tcp>	MP:0002060,abnormal skin morphology|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance
MGI:4944352	Ilrun<tm1a(KOMP)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0002644,decreased circulating triglyceride level|MP:0003059,decreased insulin secretion|MP:0003402,decreased liver weight|MP:0003976,decreased circulating VLDL triglyceride level|MP:0003981,decreased circulating phospholipid level|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level|MP:0010331,abnormal apolipoprotein level|MP:0010332,abnormal circulating apolipoprotein level|MP:0013245,abnormal lipid metabolism|MP:0020151,abnormal circulating non-HDL cholesterol level|MP:0020868,decreased lipogenesis
MGI:6285607	Ilvbl<em1(IMPC)Bay>	MP:0003075,abnormal response to CNS ischemic injury|MP:0005376,homeostasis/metabolism phenotype|MP:0008872,abnormal physiological response to xenobiotic|MP:0014812,abnormal brain physiology
MGI:2157088	Im1<Bioz:BP1>	MP:0001800,abnormal humoral immune response
MGI:2157092	Im2<Bioz:BP1>	MP:0001800,abnormal humoral immune response
MGI:3033072	Im3<Bioz:BP1>	MP:0001800,abnormal humoral immune response
MGI:3033074	Im4<Bioz:BP1>	MP:0001800,abnormal humoral immune response
MGI:3033076	Im5<Bioz:BP1>	MP:0001800,abnormal humoral immune response
MGI:3033078	Im6<Bioz:BP1>	MP:0001800,abnormal humoral immune response
MGI:3033084	Im7<Bioz:BP1>	MP:0001800,abnormal humoral immune response
MGI:3696451	Imab<NZB/BlNJ>	MP:0001354,increased aggression towards male mice
MGI:3720164	Imacq<C57BL/6J>	MP:0008873,increased physiological sensitivity to xenobiotic
MGI:3720165	Imacq<LP/J>	MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3583089	Imebt1<DU6>	MP:0002981,increased liver weight|MP:0003122,maternal imprinting|MP:0004952,increased spleen weight
MGI:3583091	Imebt2<DU6>	MP:0001260,increased body weight|MP:0002981,increased liver weight|MP:0003122,maternal imprinting|MP:0003917,increased kidney weight
MGI:3038492	Imgt1<KK/Ta>	MP:0005293,impaired glucose tolerance
MGI:2155943	Imh1<NZB>	MP:0002494,increased IgM level|MP:0004801,increased susceptibility to systemic lupus erythematosus
MGI:2155947	Imm1<NZW>	MP:0001790,abnormal immune system physiology
MGI:6306614	Immp2l<em1(IMPC)Bay>	MP:0001258,decreased body length|MP:0003961,decreased lean body mass|MP:0009142,decreased prepulse inhibition
MGI:5806308	Immp2l<m1Btlr>	MP:0001262,decreased body weight
MGI:2153986	Immp2l<Tg(HLA-A/H2-D)2Enge>	MP:0004918,abnormal negative T cell selection|MP:0004919,abnormal positive T cell selection|MP:0005078,abnormal cytotoxic T cell physiology
MGI:3765965	Immp2l<Tg(Tyr)979Ove>	MP:0001125,abnormal oocyte morphology|MP:0001126,abnormal ovary morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001131,abnormal ovarian follicle morphology|MP:0001132,absent mature ovarian follicles|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001379,abnormal penile erection|MP:0001921,reduced fertility|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005431,decreased oocyte number|MP:0010954,abnormal cellular respiration|MP:0010955,abnormal respiratory electron transport chain
MGI:3857179	Immt<Gt(AW0256)Wtsi>	MP:0000852,small cerebellum|MP:0000880,decreased Purkinje cell number|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001698,decreased embryo size|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002879,increased cellular sensitivity to X-ray irradiation induced cell death|MP:0003203,increased neuron apoptosis|MP:0003214,neurofibrillary tangles|MP:0003674,oxidative stress|MP:0003927,increased cellular glucose import|MP:0005289,increased oxygen consumption|MP:0005290,decreased oxygen consumption|MP:0005559,increased circulating glucose level|MP:0006036,abnormal mitochondrial physiology|MP:0008535,enlarged lateral ventricles|MP:0008963,increased carbon dioxide production|MP:0008964,decreased carbon dioxide production|MP:0010090,increased circulating creatine kinase level|MP:0010378,increased respiratory quotient|MP:0010379,decreased respiratory quotient|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0010959,abnormal oxidative phosphorylation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011448,decreased dopaminergic neuron number|MP:0011635,abnormal mitochondrial crista morphology|MP:0011637,abnormal mitochondrial matrix morphology|MP:0011971,increased circulating lactate dehydrogenase level|MP:0012307,impaired spatial learning|MP:0013243,abnormal carbohydrate metabolism|MP:0013405,increased circulating lactate level|MP:0013504,increased embryonic tissue cell apoptosis|MP:0014134,abnormal embryo morphology|MP:0014342,abnormal muscle fiber mitochondrial morphology|MP:0014345,abnormal neuron mitochondrial morphology|MP:0020083,decreased hippocampus volume
MGI:8260941	Imp3<tm1Tya>	MP:0002169,no abnormal phenotype detected
MGI:6469983	Impa1<Rgsc01827>	MP:0002169,no abnormal phenotype detected
MGI:6469955	Impa1<Rgsc01846>	MP:0000111,cleft palate|MP:0000762,abnormal tongue morphology|MP:0000914,exencephaly|MP:0001399,hyperactivity|MP:0002064,seizures|MP:0002083,premature death|MP:0004200,decreased fetal size|MP:0004592,small mandible|MP:0005382,craniofacial phenotype|MP:0005386,behavior/neurological phenotype|MP:0005587,abnormal Meckel's cartilage morphology|MP:0008146,asymmetric sternocostal joints|MP:0011090,perinatal lethality, incomplete penetrance|MP:0020469,prolonged circadian behavior period
MGI:3529209	Impa1<tm1Lex>	MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003631,nervous system phenotype|MP:0009849,increased vertical stereotypic behavior|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3530636	Impa2<Gt(OST203987)Lex>	MP:0002169,no abnormal phenotype detected
MGI:6469987	Impa2<Rgsc01362>	MP:0002169,no abnormal phenotype detected
MGI:5474837	Impa2<tm1.2Tohn>	MP:0000519,hydronephrosis|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0009141,increased prepulse inhibition
MGI:7425755	Impact<em1(IMPC)Ccpcz>	MP:0000702,enlarged lymph nodes|MP:0001175,abnormal lung morphology|MP:0001556,increased circulating HDL cholesterol level|MP:0002339,abnormal lymph node morphology|MP:0004122,abnormal sinus arrhythmia|MP:0004156,abnormal QT variability|MP:0004882,enlarged lung|MP:0005385,cardiovascular system phenotype|MP:0010506,prolonged RR interval|MP:0013279,increased fasting circulating glucose level
MGI:6710957	Impact<tm1.1Casb>	MP:0001262,decreased body weight|MP:0001783,decreased white adipose tissue amount|MP:0002891,increased insulin sensitivity|MP:0005290,decreased oxygen consumption|MP:0005534,decreased body temperature|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0011940,decreased food intake|MP:0013278,decreased fasting circulating glucose level
MGI:6113645	Impdh1<m1Btlr>	MP:0008515,thin retina outer nuclear layer|MP:0010235,abnormal retina inner limiting membrane morphology|MP:0010236,abnormal retina outer limiting membrane morphology|MP:0011965,decreased total retina thickness
MGI:2678364	Impdh1<tm1Bmi>	MP:0000716,abnormal immune system cell morphology|MP:0005095,decreased T cell proliferation
MGI:2678388	Impdh2<tm1Bmi>	MP:0000717,abnormal lymphocyte cell number|MP:0011092,embryonic lethality, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance
MGI:6693683	Impg1<em1Visu>	MP:0003729,abnormal photoreceptor outer segment morphology|MP:0005391,vision/eye phenotype
MGI:7490167	Impg2<em1(IMPC)Mbp>	MP:0002092,abnormal eye morphology|MP:0002941,increased circulating alanine transaminase level
MGI:6693686	Impg2<em1Visu>	MP:0002864,abnormal ocular fundus morphology|MP:0003727,abnormal retina layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008918,microgliosis
MGI:6466711	Impg2<em1Xjz>	MP:0001005,abnormal retina rod cell morphology|MP:0001006,abnormal retina cone cell morphology|MP:0001326,retina degeneration|MP:0003354,astrocytosis|MP:0008444,retina cone cell degeneration|MP:0008446,decreased retina cone cell number|MP:0008451,retina rod cell degeneration|MP:0008455,abnormal retina rod cell inner segment morphology|MP:0008515,thin retina outer nuclear layer|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0013258,abnormal extracellular matrix morphology|MP:0020354,increased endoplasmic reticulum stress|MP:0030940,impaired autophagy
MGI:6466713	Impg2<em2Xjz>	MP:0001326,retina degeneration|MP:0003354,astrocytosis|MP:0008444,retina cone cell degeneration|MP:0008451,retina rod cell degeneration|MP:0008515,thin retina outer nuclear layer
MGI:3603768	Imraq1<DBA/2J>	MP:0002493,increased IgG level
MGI:3790439	In(10)17Rk	MP:0001265,decreased body size|MP:0001924,infertility|MP:0005169,abnormal male meiosis|MP:0008974,proportional dwarf
MGI:3789619	In(10)6Rk	MP:0005169,abnormal male meiosis|MP:0010768,mortality/aging
MGI:5287112	In(10C1;Ccdc53)4Ove	MP:0001926,female infertility
MGI:3790442	In(11)20Rk	MP:0001935,decreased litter size|MP:0005389,reproductive system phenotype
MGI:3790226	In(11)2Dn	MP:0005389,reproductive system phenotype
MGI:3789695	In(1)12Rk	MP:0005169,abnormal male meiosis
MGI:7407295	In(11)2Smun	MP:0001925,male infertility|MP:0005306,abnormal phalanx morphology|MP:0005381,digestive/alimentary phenotype|MP:0010768,mortality/aging
MGI:7407296	In(11)3Smun	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:3789506	In(1)1Rk	MP:0005169,abnormal male meiosis
MGI:7407294	In(11Rr325)1Smun	MP:0000060,delayed bone ossification|MP:0000111,cleft palate|MP:0002110,abnormal digit morphology|MP:0003723,abnormal long bone morphology|MP:0005306,abnormal phalanx morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:2673211	In(11Trp53;11Wnt3)8Brd	MP:0011091,prenatal lethality, complete penetrance
MGI:3790093	In(12)25Rk	MP:0005169,abnormal male meiosis|MP:0011092,embryonic lethality, complete penetrance
MGI:3790083	In(1)24Rk	MP:0005169,abnormal male meiosis
MGI:3789970	In(13)31Rk	MP:0005169,abnormal male meiosis
MGI:3790078	In(14)22Rk	MP:0005169,abnormal male meiosis
MGI:3789504	In(15)18Rk	MP:0005169,abnormal male meiosis
MGI:2681474	In(15)21Rk	MP:0001921,reduced fertility|MP:0004901,decreased male germ cell number|MP:0005169,abnormal male meiosis
MGI:3790594	In(15)35Rk	MP:0005169,abnormal male meiosis
MGI:1861120	In(15)4H	MP:0000346,broad head|MP:0000367,abnormal coat/ hair morphology|MP:0000412,excessive hair|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001302,eyelids open at birth|MP:0001935,decreased litter size|MP:0004174,abnormal spine curvature|MP:0010234,abnormal vibrissa follicle morphology|MP:0012174,flat head|MP:0030075,hairy ears|MP:0030105,bushy muzzle
MGI:5287026	In(15Rictor;Slc1a3)1Ove	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:5287034	In(18E2;Smad4)3Ove	MP:0001672,abnormal embryo development
MGI:3789624	In(2)19Rk	MP:0005169,abnormal male meiosis|MP:0010768,mortality/aging
MGI:3789487	In(2)5Rk	MP:0001926,female infertility|MP:0005169,abnormal male meiosis|MP:0006204,embryonic lethality before implantation
MGI:4822472	In(2a;Itch)18H	MP:0000473,abnormal stomach glandular epithelium morphology|MP:0001212,skin lesions|MP:0001222,epidermal hyperplasia|MP:0001412,excessive scratching|MP:0001846,increased inflammatory response|MP:0001861,lung inflammation|MP:0001862,interstitial pneumonia|MP:0002083,premature death|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002276,abnormal lung interstitium morphology|MP:0002499,chronic inflammation|MP:0003426,pulmonary interstitial fibrosis|MP:0005039,hypoxia|MP:0005387,immune system phenotype|MP:0005409,darkened coat color|MP:0005493,stomach epithelial hyperplasia|MP:0008102,lymph node hyperplasia|MP:0008245,abnormal alveolar macrophage morphology|MP:0008476,increased spleen red pulp amount|MP:0009928,abnormal pinna hair pigmentation|MP:0010998,pulmonary alveolar proteinosis
MGI:5469615	In(2Atf2;Itga6)58Ddu	MP:0005371,limbs/digits/tail phenotype
MGI:3840855	In(2Hoxd11;Itga6)1Ddu	MP:0003048,abnormal cervical vertebrae morphology|MP:0004617,sacral vertebral transformation|MP:0004650,increased lumbar vertebrae number|MP:0008148,abnormal sternocostal joint morphology|MP:0010082,sternebra fusion
MGI:5469614	In(2Itga6)57Ddu	MP:0002544,brachydactyly|MP:0005306,abnormal phalanx morphology
MGI:4948261	In(2Itga6;Evx2)44Ddu	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000151,absent ribs|MP:0000572,abnormal autopod morphology|MP:0001539,decreased caudal vertebrae number|MP:0002764,short tibia|MP:0002823,abnormal rib development|MP:0003723,abnormal long bone morphology|MP:0004355,short radius|MP:0004359,short ulna|MP:0004647,decreased lumbar vertebrae number
MGI:5305739	In(2Lnpk;Itga6)47Ddu	MP:0002544,brachydactyly|MP:0005306,abnormal phalanx morphology|MP:0008730,fused phalanges
MGI:3789636	In(3)11Rk	MP:0005169,abnormal male meiosis
MGI:3790224	In(4)1Dn	MP:0005389,reproductive system phenotype
MGI:3789965	In(4)28Rk	MP:0005169,abnormal male meiosis|MP:0008762,embryonic lethality
MGI:3789975	In(4)32Rk	MP:0005169,abnormal male meiosis
MGI:3624517	In(4)56Rk	MP:0002080,prenatal lethality|MP:0002792,abnormal retina vasculature morphology|MP:0002864,abnormal ocular fundus morphology|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0005103,abnormal retina pigmentation|MP:0005551,abnormal eye electrophysiology|MP:0008450,retina photoreceptor degeneration
MGI:3789593	In(5)2Rk	MP:0005169,abnormal male meiosis|MP:0010768,mortality/aging
MGI:3790488	In(5)30Rk	MP:0005169,abnormal male meiosis
MGI:3789980	In(5)33Rk	MP:0005169,abnormal male meiosis
MGI:3789614	In(5)9Rk	MP:0001921,reduced fertility|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0005169,abnormal male meiosis|MP:0010768,mortality/aging
MGI:3026621	In(6)1J	MP:0002169,no abnormal phenotype detected
MGI:5287033	In(6Exoc4)2Ove	MP:0001672,abnormal embryo development
MGI:3789575	In(7)13Rk	MP:0005169,abnormal male meiosis
MGI:3622350	In(7)4Rl	MP:0006204,embryonic lethality before implantation
MGI:2681117	In(7Oca2;7Sox6)100H	MP:0000278,abnormal myocardial fiber morphology|MP:0000598,abnormal liver morphology|MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002123,abnormal definitive hematopoiesis|MP:0009395,increased nucleated erythrocyte cell number|MP:0010519,atrioventricular block|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3789913	In(8)14Rk	MP:0005169,abnormal male meiosis
MGI:3790524	In(8)34Rk	MP:0002082,postnatal lethality
MGI:3789699	In(9)26Rk	MP:0005169,abnormal male meiosis
MGI:2153917	In(9Bmp5;Myo6)5Rl	MP:0001394,circling|MP:0006325,impaired hearing|MP:0020084,short ears
MGI:3577101	inad	MP:0000556,abnormal hindlimb morphology|MP:0000755,hindlimb paralysis|MP:0000827,dilated third ventricle|MP:0000829,dilated fourth ventricle|MP:0000846,abnormal medulla oblongata morphology|MP:0001393,ataxia|MP:0001513,limb grasping|MP:0002083,premature death|MP:0003225,axonal dystrophy|MP:0003632,abnormal nervous system morphology|MP:0008283,small hippocampus|MP:0009434,paraparesis|MP:0010025,decreased total body fat amount
MGI:7461546	Inafm1<em1(IMPC)Kmpc>	MP:0005419,decreased circulating serum albumin level
MGI:3051627	Ina<tm1Jpj>	MP:0002169,no abnormal phenotype detected
MGI:6356370	Inava<tm1.1Itl>	MP:0000488,abnormal intestinal epithelium morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0008469,abnormal protein level|MP:0008537,increased susceptibility to induced colitis|MP:0011804,increased cell migration|MP:0014201,abnormal intestinal epithelium physiology
MGI:5292392	Inca1<tm1Cmt>	MP:0000240,extramedullary hematopoiesis|MP:0000689,abnormal spleen morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002495,increased IgA level|MP:0008254,increased megakaryocyte cell number|MP:0008470,abnormal spleen B cell follicle morphology|MP:0011704,decreased fibroblast proliferation
MGI:2386970	Incenp<tm1Khac>	MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002663,absent blastocoele|MP:0004964,absent inner cell mass|MP:0011092,embryonic lethality, complete penetrance
MGI:2674106	In(D4Mit117;D4Mit281)1Brd	MP:0002075,abnormal coat/hair pigmentation
MGI:2674107	In(D4Mit281;D4Mit51)2Brd	MP:0002075,abnormal coat/hair pigmentation
MGI:5548597	Inf2<tm1.1(KOMP)Vlcg>	MP:0000208,decreased hematocrit|MP:0000249,abnormal blood vessel physiology|MP:0002293,long gestation period|MP:0002842,increased systemic arterial blood pressure|MP:0003231,abnormal placenta vasculature|MP:0004201,fetal growth retardation|MP:0009431,decreased fetal weight|MP:0011521,decreased placental labyrinth size
MGI:2671711	inft2	MP:0001925,male infertility
MGI:2671710	inft3	MP:0001926,female infertility
MGI:2671707	inft4	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0009239,short sperm flagellum|MP:0020451,decreased sperm progressive motility
MGI:2671706	inft5	MP:0001925,male infertility
MGI:2671702	inft6	MP:0001922,reduced male fertility
MGI:2671699	inft7	MP:0001926,female infertility
MGI:2671697	inft8	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0020451,decreased sperm progressive motility
MGI:2671691	inft9	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0020451,decreased sperm progressive motility
MGI:3762907	Ing1<Gt(F066C08)Irpa>	MP:0005384,cellular phenotype|MP:0008009,delayed cellular replicative senescence|MP:0011703,increased fibroblast proliferation
MGI:3700145	Ing1<Gt(OST206270)Lex>	MP:0000715,decreased thymocyte number|MP:0001262,decreased body weight|MP:0002023,increased B cell derived lymphoma incidence|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0005621,abnormal cell physiology|MP:0009541,increased thymocyte apoptosis|MP:0011703,increased fibroblast proliferation|MP:0013501,increased fibroblast apoptosis
MGI:3619526	Ing1<tm1Avg>	MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001386,abnormal maternal nurturing|MP:0001658,increased mortality induced by gamma-irradiation|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0003077,abnormal cell cycle|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death
MGI:4879096	Ing2<tm1.1Ccha>	MP:0000693,spleen hyperplasia|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001154,seminiferous tubule degeneration|MP:0001158,abnormal prostate gland morphology|MP:0001925,male infertility|MP:0002032,increased sarcoma incidence|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005578,teratozoospermia|MP:0005621,abnormal cell physiology|MP:0006042,increased apoptosis|MP:0008261,arrest of male meiosis|MP:0009233,enlarged sperm head|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009321,increased histiocytic sarcoma incidence|MP:0009839,multiflagellated sperm|MP:0010769,abnormal survival|MP:0013538,increased Harderian gland adenoma incidence|MP:0020550,multinucleated giant male germ cells
MGI:5630067	Ing2<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0002590,increased mean corpuscular volume|MP:0002941,increased circulating alanine transaminase level|MP:0005344,increased circulating bilirubin level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6316191	Ing4<em1(IMPC)Tcp>	MP:0000219,increased neutrophil cell number|MP:0002060,abnormal skin morphology|MP:0002764,short tibia|MP:0002966,decreased circulating alkaline phosphatase level|MP:0002989,small kidney|MP:0003019,increased circulating chloride level|MP:0005419,decreased circulating serum albumin level|MP:0005633,increased circulating sodium level
MGI:3587932	Ing4<Gt(XG370)Byg>	MP:0008596,increased circulating interleukin-6 level|MP:0008705,increased interleukin-6 secretion|MP:0008721,abnormal chemokine level|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:6256540	Ing5<em1(IMPC)J>	MP:0000443,abnormal snout morphology|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005542,cornea vascularization|MP:0010392,prolonged QRS complex duration|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012121,sclerocornea|MP:0013279,increased fasting circulating glucose level
MGI:7596133	Ing5<tm1.1Avo>	MP:0000600,liver hypoplasia|MP:0000694,spleen hypoplasia|MP:0002416,abnormal proerythroblast morphology|MP:0004200,decreased fetal size|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011243,decreased fetal derived definitive erythrocyte cell number|MP:0011246,abnormal fetal liver hematopoietic progenitor cell morphology
MGI:5646303	Inh17	MP:0000745,tremors|MP:0001406,abnormal gait
MGI:5646306	Inh18	MP:0000745,tremors|MP:0001406,abnormal gait
MGI:5646301	Inh8	MP:0000745,tremors
MGI:7491749	Inha<em1Crah>	MP:0001125,abnormal oocyte morphology|MP:0001923,reduced female fertility|MP:0001934,increased litter size|MP:0003718,maternal effect|MP:0004855,increased ovary weight|MP:0004904,increased uterus weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0011124,increased primary ovarian follicle number|MP:0031411,increased ovulation rate|MP:0031421,increased superovulation rate|MP:0031424,enhanced female fertility
MGI:1857202	Inha<tm1Bay>	MP:0000069,kyphoscoliosis|MP:0000598,abnormal liver morphology|MP:0001131,abnormal ovarian follicle morphology|MP:0001148,enlarged testis|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0001661,extended life span|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002031,increased adrenal gland tumor incidence|MP:0002083,premature death|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0004834,ovary hemorrhage|MP:0004851,increased testis weight|MP:0004855,increased ovary weight|MP:0005150,cachexia|MP:0005151,diffuse hepatic necrosis|MP:0005152,pancytopenia|MP:0005182,increased circulating estradiol level|MP:0006262,increased testis tumor incidence|MP:0008000,increased ovary tumor incidence|MP:0009590,increased gonad tumor incidence|MP:0010792,abnormal stomach mucosa morphology|MP:0031301,chronic liver inflammation|MP:0031407,increased Sertoli cell proliferation
MGI:8214990	Inhba<em2Iimcb>	MP:0000537,abnormal urethra morphology|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001751,increased circulating luteinizing hormone level|MP:0001923,reduced female fertility|MP:0001927,abnormal estrous cycle|MP:0003129,persistent cloaca|MP:0006198,enophthalmos|MP:0008489,slow postnatal weight gain
MGI:1861957	Inhba<tm1Zuk>	MP:0000125,absent incisors|MP:0001260,increased body weight|MP:0001284,absent vibrissae|MP:0001435,absent suckling reflex|MP:0002631,abnormal epididymis morphology|MP:0003346,abnormal pectoral muscle morphology|MP:0003827,abnormal Wolffian duct morphology|MP:0004189,abnormal alveolar process morphology|MP:0004791,absent lower incisors|MP:0004933,abnormal epididymis epithelium morphology|MP:0009421,increased gastrocnemius weight|MP:0009890,cleft secondary palate|MP:0009894,absent hard palate|MP:0010226,increased quadriceps weight|MP:0010234,abnormal vibrissa follicle morphology|MP:0010238,increased skeletal muscle weight|MP:0011087,neonatal lethality, complete penetrance
MGI:2386671	Inhba<tm2Zuk>	MP:0000208,decreased hematocrit|MP:0000416,sparse hair|MP:0000417,short hair|MP:0000424,retarded hair growth|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001926,female infertility|MP:0002083,premature death|MP:0003529,enlarged clitoris|MP:0003599,large penis|MP:0004852,decreased testis weight|MP:0005382,craniofacial phenotype|MP:0005418,abnormal circulating hormone level|MP:0006198,enophthalmos|MP:0008975,delayed male fertility|MP:0009200,enlarged external male genitalia|MP:0010179,rough coat|MP:0010771,integument phenotype
MGI:3758877	Inhba<tm3Zuk>	MP:0002169,no abnormal phenotype detected
MGI:5695132	Inhbb<tm1b(EUCOMM)Hmgu>	MP:0001314,cornea opacity|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001523,impaired righting response|MP:0001529,abnormal vocalization|MP:0002092,abnormal eye morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002875,decreased erythrocyte cell number|MP:0005287,narrow eye opening|MP:0005344,increased circulating bilirubin level|MP:0005419,decreased circulating serum albumin level|MP:0005542,cornea vascularization|MP:0005553,increased circulating creatinine level|MP:0008259,abnormal optic disk morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:5319783	Inhbb<tm1Grid>	MP:0001314,cornea opacity|MP:0001385,pup cannibalization|MP:0001386,abnormal maternal nurturing|MP:0003153,early eyelid opening|MP:0005343,increased circulating aspartate transaminase level
MGI:1857203	Inhbb<tm1Jae>	MP:0000627,abnormal mammary gland morphology|MP:0001290,delayed eyelid opening|MP:0001302,eyelids open at birth|MP:0001313,increased incidence of corneal inflammation|MP:0001314,cornea opacity|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001923,reduced female fertility|MP:0002092,abnormal eye morphology|MP:0002293,long gestation period|MP:0003346,abnormal pectoral muscle morphology|MP:0006000,abnormal cornea epithelium morphology|MP:0008028,pregnancy-related premature death|MP:0009505,abnormal mammary gland lobule morphology|MP:0010238,increased skeletal muscle weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013718,galactostasis
MGI:3653269	Inhbc<tm1Zuk>	MP:0005370,liver/biliary system phenotype|MP:0005389,reproductive system phenotype|MP:0005419,decreased circulating serum albumin level
MGI:5319698	Inhbe/Inhbc<tm1Sjl>	MP:0002169,no abnormal phenotype detected
MGI:5319699	Inhbe/Inhbc<tm1Sjl>	MP:0002169,no abnormal phenotype detected
MGI:3706816	Inhbe<tm2Zuk>	MP:0002169,no abnormal phenotype detected
MGI:4438483	Inka1<tm1Will>	MP:0000914,exencephaly|MP:0001935,decreased litter size|MP:0011086,postnatal lethality, incomplete penetrance
MGI:7442114	Inka2<tm1b(KOMP)Wtsi>	MP:0003631,nervous system phenotype|MP:0009936,abnormal dendritic spine morphology|MP:0020337,abnormal pyramidal neuron dendrite morphology|MP:0021018,decreased dendritic spine number|MP:0021090,abnormal dendrite arborization pattern
MGI:6276987	Inmt<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology|MP:0005292,improved glucose tolerance
MGI:5548594	Ino80b<tm1.1(KOMP)Mbp>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6316629	Ino80c<em1(IMPC)J>	MP:0000266,abnormal heart morphology|MP:0000841,abnormal hindbrain morphology|MP:0001293,anophthalmia|MP:0001697,abnormal embryo size|MP:0002111,abnormal tail morphology|MP:0002574,increased vertical activity|MP:0003984,embryonic growth retardation|MP:0006203,eye hemorrhage|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6120804	Ino80d<tm1b(EUCOMM)Wtsi>	MP:0001402,decreased locomotor activity|MP:0001697,abnormal embryo size|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003960,increased lean body mass|MP:0003984,embryonic growth retardation|MP:0010025,decreased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:4433084	Ino80e<tm1a(EUCOMM)Wtsi>	MP:0001260,increased body weight|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype
MGI:5698242	Ino80<tm1.1Jland>	MP:0002169,no abnormal phenotype detected|MP:0005369,muscle phenotype
MGI:5698826	Ino80<tm1.1Schg>	MP:0001265,decreased body size|MP:0001513,limb grasping|MP:0001672,abnormal embryo development|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:5755269	Ino80<tm1.2Jland>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0012159,absent anterior visceral endoderm|MP:0012161,absent distal visceral endoderm
MGI:4436542	Ino80<tm1a(EUCOMM)Hmgu>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001529,abnormal vocalization|MP:0002059,abnormal seminal vesicle morphology|MP:0005655,increased aggression|MP:0010392,prolonged QRS complex duration|MP:0011100,preweaning lethality, complete penetrance
MGI:5548559	Ino80<tm1b(EUCOMM)Hmgu>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5698824	Ino80<tm1Schg>	MP:0001262,decreased body weight|MP:0002006,neoplasm|MP:0002083,premature death|MP:0003077,abnormal cell cycle|MP:0005384,cellular phenotype|MP:0005621,abnormal cell physiology|MP:0008008,early cellular replicative senescence|MP:0008057,abnormal DNA replication|MP:0008402,increased cellular sensitivity to alkylating agent induced cell death|MP:0008409,increased cellular sensitivity to hydroxyurea induced cell death|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0010207,abnormal telomere morphology|MP:0011704,decreased fibroblast proliferation|MP:0012734,abnormal response to radiation|MP:0014760,impaired DNA repair|MP:0014764,impaired double-strand DNA break repair
MGI:4363818	Inpp1<tm1a(KOMP)Wtsi>	MP:0001258,decreased body length|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0002411,decreased susceptibility to bacterial infection|MP:0003961,decreased lean body mass
MGI:5548354	Inpp1<tm1b(KOMP)Wtsi>	MP:0001312,abnormal cornea morphology
MGI:4462378	Inpp4a<tm1Tsak>	MP:0001262,decreased body weight|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0002690,akinesia|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003312,abnormal locomotor coordination|MP:0003492,abnormal involuntary movement|MP:0005323,dystonia
MGI:1934584	Inpp4a<wbl>	MP:0000811,hippocampal neuron degeneration|MP:0000852,small cerebellum|MP:0000873,thin external granule cell layer|MP:0000876,Purkinje cell degeneration|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001523,impaired righting response|MP:0011085,postnatal lethality, complete penetrance
MGI:5297505	Inpp4b<tm1.1Jva>	MP:0000066,osteoporosis|MP:0000130,abnormal trabecular bone morphology|MP:0002764,short tibia|MP:0002896,abnormal bone mineralization|MP:0003109,short femur|MP:0004351,short humerus|MP:0004359,short ulna|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0004992,increased bone resorption|MP:0008396,abnormal osteoclast differentiation|MP:0009347,increased trabecular bone thickness|MP:0010868,increased bone trabecula number|MP:0010876,decreased bone volume|MP:0020010,decreased bone mineral density of femur
MGI:6388355	Inpp5a<em1(IMPC)Tcp>	MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0003717,pallor|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration
MGI:3604476	Inpp5a<Gt(OST50073)Lex>	MP:0000852,small cerebellum|MP:0000876,Purkinje cell degeneration|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0002183,gliosis|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008770,decreased survivor rate|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2159609	Inpp5b<tm1Nbm>	MP:0000242,impaired fertilization|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology
MGI:2159620	Inpp5b<tm2.1Nbm>	MP:0001922,reduced male fertility|MP:0001925,male infertility
MGI:2159604	Inpp5b<tm2Nbm>	MP:0005389,reproductive system phenotype
MGI:5050823	Inpp5d<el20>	MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0000717,abnormal lymphocyte cell number|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0001953,respiratory failure|MP:0002083,premature death|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002461,increased immunoglobulin level|MP:0002494,increased IgM level|MP:0003179,thrombocytopenia|MP:0005016,decreased lymphocyte cell number|MP:0005425,increased macrophage cell number|MP:0008209,decreased pre-B cell number|MP:0008500,increased IgG2a level|MP:0008596,increased circulating interleukin-6 level
MGI:5563462	Inpp5d<m1Anu>	MP:0001182,lung hemorrhage|MP:0001861,lung inflammation|MP:0002023,increased B cell derived lymphoma incidence
MGI:3817458	Inpp5d<m1Btlr>	MP:0000691,enlarged spleen|MP:0000709,enlarged thymus|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0002463,abnormal neutrophil physiology|MP:0002465,abnormal eosinophil physiology|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005150,cachexia
MGI:5607764	Inpp5d<m2Btlr>	MP:0005017,decreased B cell number
MGI:6113622	Inpp5d<M3Btlr>	MP:0008045,decreased NK cell number
MGI:6286128	Inpp5d<m4Btlr>	MP:0008560,increased tumor necrosis factor secretion|MP:0008564,increased interferon-beta secretion
MGI:6286237	Inpp5d<m5Btlr>	MP:0001262,decreased body weight|MP:0002145,abnormal T cell differentiation|MP:0002619,abnormal lymphocyte morphology|MP:0004977,increased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005333,decreased heart rate|MP:0008045,decreased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0012765,decreased alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:3525663	Inpp5d<tm1.1Wgk>	MP:0000220,increased monocyte cell number|MP:0002442,abnormal leukocyte physiology|MP:0002445,abnormal mononuclear cell differentiation|MP:0005068,abnormal NK cell morphology|MP:0005673,decreased susceptibility to graft versus host disease|MP:0008044,increased NK cell number|MP:0008126,increased dendritic cell number
MGI:1861956	Inpp5d<tm1Dmt>	MP:0000218,increased leukocyte cell number|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001577,anemia|MP:0001953,respiratory failure|MP:0002083,premature death|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002442,abnormal leukocyte physiology|MP:0002551,abnormal blood coagulation|MP:0003179,thrombocytopenia|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005606,increased bleeding time|MP:0006298,abnormal platelet activation|MP:0008209,decreased pre-B cell number|MP:0008596,increased circulating interleukin-6 level|MP:0009549,decreased platelet aggregation
MGI:3715982	Inpp5d<tm1Rav>	MP:0001800,abnormal humoral immune response|MP:0002083,premature death|MP:0002493,increased IgG level|MP:0003725,increased autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004829,increased anti-chromatin antibody level|MP:0005026,decreased susceptibility to parasitic infection|MP:0005078,abnormal cytotoxic T cell physiology|MP:0008522,abnormal lymph node germinal center morphology|MP:0008568,abnormal interleukin secretion|MP:0008750,abnormal interferon level
MGI:2386884	Inpp5d<tm1Rkh>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000135,decreased compact bone thickness|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0000477,abnormal intestine morphology|MP:0000693,spleen hyperplasia|MP:0001175,abnormal lung morphology|MP:0001262,decreased body weight|MP:0001533,abnormal skeleton physiology|MP:0001541,abnormal osteoclast physiology|MP:0001601,abnormal myelopoiesis|MP:0001858,intestinal inflammation|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002401,abnormal lymphopoiesis|MP:0002421,abnormal cell-mediated immunity|MP:0002444,abnormal T cell physiology|MP:0002581,abnormal ileum morphology|MP:0003109,short femur|MP:0003449,abnormal intestine goblet cell morphology|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0003828,pulmonary edema|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004952,increased spleen weight|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0004991,decreased bone strength|MP:0005016,decreased lymphocyte cell number|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005508,abnormal skeleton morphology|MP:0006043,decreased apoptosis|MP:0008111,abnormal granulocyte differentiation|MP:0008112,abnormal monocyte differentiation|MP:0008208,decreased pro-B cell number|MP:0008396,abnormal osteoclast differentiation|MP:0008596,increased circulating interleukin-6 level|MP:0008751,abnormal interleukin level|MP:0008764,increased mast cell degranulation|MP:0008802,abnormal intestinal smooth muscle morphology|MP:0009278,abnormal bone marrow cell physiology|MP:0009346,decreased trabecular bone thickness|MP:0009482,ileum inflammation|MP:0010760,abnormal macrophage chemotaxis|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0014471,enhanced B cell migration
MGI:3830362	Inpp5d<tm1Wgk>	MP:0005673,decreased susceptibility to graft versus host disease
MGI:5296378	Inpp5e<m1Tc>	MP:0000914,exencephaly|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002151,abnormal neural tube morphology|MP:0003632,abnormal nervous system morphology
MGI:5548702	Inpp5e<tm1.1(KOMP)Vlcg>	MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0000783,abnormal forebrain morphology|MP:0000841,abnormal hindbrain morphology|MP:0000897,abnormal midbrain morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0002109,abnormal limb morphology|MP:0003720,abnormal neural tube closure|MP:0006203,eye hemorrhage|MP:0011100,preweaning lethality, complete penetrance
MGI:4360187	Inpp5e<tm1.2Ssch>	MP:0000111,cleft palate|MP:0000522,kidney cortex cyst|MP:0000914,exencephaly|MP:0001286,abnormal eye development|MP:0001293,anophthalmia|MP:0001890,anencephaly|MP:0002828,abnormal renal glomerular capsule morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0003419,delayed endochondral bone ossification|MP:0004320,split sternum|MP:0005306,abnormal phalanx morphology|MP:0008528,polycystic kidney|MP:0009744,postaxial polydactyly|MP:0009883,palatal shelf hypoplasia|MP:0009888,palatal shelves fail to meet at midline|MP:0011066,abnormal renal tubule epithelial cell primary cilium morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0013202,abnormal cilium morphology
MGI:4128518	Inpp5f<Gt(XL571)Byg>	MP:0001625,cardiac hypertrophy|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0004485,increased response of heart to induced stress
MGI:7425756	Inpp5j<em1(IMPC)Mbp>	MP:0001200,thick skin|MP:0001293,anophthalmia|MP:0002060,abnormal skin morphology
MGI:5789330	Inpp5j<tm1.1Cmit>	MP:0002169,no abnormal phenotype detected
MGI:5789329	Inpp5j<tm1Cmit>	MP:0002169,no abnormal phenotype detected
MGI:6257677	Inpp5k<em1(IMPC)H>	MP:0000219,increased neutrophil cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:3810936	Inpp5k<tm1Brd>	MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003983,decreased cholesterol level|MP:0004818,increased skeletal muscle mass|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0009642,abnormal blood homeostasis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:3530363	Inppl1<tm1Glas>	MP:0000445,short snout|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002118,abnormal lipid homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0005179,decreased circulating cholesterol level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level
MGI:5614359	Ins1<tm1.1(cre)Thor>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype
MGI:2181877	Ins1<tm1Jja>	MP:0003645,increased pancreatic beta cell number|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0009113,increased pancreatic beta cell mass
MGI:1857572	Ins2<Akita>	MP:0000063,decreased bone mineral density|MP:0000136,abnormal microglial cell morphology|MP:0000160,kyphosis|MP:0000218,increased leukocyte cell number|MP:0000266,abnormal heart morphology|MP:0000519,hydronephrosis|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001426,polydipsia|MP:0001433,polyphagia|MP:0001559,hyperglycemia|MP:0001732,postnatal growth retardation|MP:0001762,polyuria|MP:0002078,abnormal glucose homeostasis|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002644,decreased circulating triglyceride level|MP:0002690,akinesia|MP:0002693,abnormal pancreas physiology|MP:0002727,decreased circulating insulin level|MP:0002786,abnormal Leydig cell morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002871,albuminuria|MP:0002891,increased insulin sensitivity|MP:0002972,abnormal cardiac muscle contractility|MP:0003059,decreased insulin secretion|MP:0003070,increased vascular permeability|MP:0003339,decreased pancreatic beta cell number|MP:0003921,abnormal heart left ventricle morphology|MP:0004889,increased energy expenditure|MP:0005215,abnormal pancreatic islet morphology|MP:0005216,abnormal pancreatic alpha cell morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005241,abnormal retina ganglion layer morphology|MP:0005264,glomerulosclerosis|MP:0005289,increased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005527,increased renal glomerular filtration rate|MP:0005559,increased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0005671,abnormal response to transplant|MP:0006035,abnormal mitochondrial morphology|MP:0006069,abnormal retina neuronal layer morphology|MP:0008817,hematoma|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008963,increased carbon dioxide production|MP:0009114,decreased pancreatic beta cell mass|MP:0009172,small pancreatic islets|MP:0009255,degranulated pancreatic beta cells|MP:0009356,decreased liver triglyceride level|MP:0010379,decreased respiratory quotient|MP:0010724,thick interventricular septum|MP:0011320,abnormal glomerular capillary morphology|MP:0011353,expanded mesangial matrix|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011425,abnormal kidney interstitium morphology|MP:0011939,increased food intake|MP:0011941,increased fluid intake|MP:0014121,increased pancreatic islet cell apoptosis|MP:0014143,decreased body fat mass|MP:0020518,renal glomerular protein deposits|MP:0030005,increased retina apoptosis|MP:0030016,increased adipocyte glucose uptake|MP:0030017,decreased adipocyte glucose uptake|MP:0031414,decreased skeletal muscle triglyceride level|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:3713760	Ins2<C95S>	MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level|MP:0002083,premature death|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0003562,abnormal pancreatic beta cell physiology|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005215,abnormal pancreatic islet morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0009176,increased pancreatic alpha cell number|MP:0009254,disorganized pancreatic islets
MGI:6478807	Ins2<em#Arak>	MP:0001559,hyperglycemia|MP:0001762,polyuria|MP:0001764,abnormal homeostasis|MP:0005215,abnormal pancreatic islet morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0009172,small pancreatic islets
MGI:4950476	Ins2<tm1(cre/ERT2)Kcmm>	MP:0005376,homeostasis/metabolism phenotype
MGI:3521584	Ins2<tm1Delt>	MP:0001429,dehydration|MP:0001732,postnatal growth retardation|MP:0001759,increased urine glucose level|MP:0002575,increased circulating ketone body level|MP:0002628,hepatic steatosis|MP:0009172,small pancreatic islets|MP:0009174,absent pancreatic beta cells|MP:0009177,decreased pancreatic alpha cell number|MP:0011085,postnatal lethality, complete penetrance
MGI:2181878	Ins2<tm1Jja>	MP:0002078,abnormal glucose homeostasis|MP:0002869,increased anti-insulin autoantibody level|MP:0003058,increased insulin secretion|MP:0003645,increased pancreatic beta cell number|MP:0004031,insulitis|MP:0009113,increased pancreatic beta cell mass
MGI:3805819	Ins2<tm1Nagy>	MP:0002169,no abnormal phenotype detected
MGI:5494871	Ins2<tm1Rll>	MP:0005376,homeostasis/metabolism phenotype
MGI:5588153	Insc<tm1.2Cayo>	MP:0002622,abnormal cochlear hair cell morphology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology
MGI:5304348	Insc<tm1Jakn>	MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000913,abnormal brain development|MP:0002882,abnormal neuron morphology|MP:0004277,abnormal lateral ganglionic eminence morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0006254,thin cerebral cortex|MP:0008441,thin cortical plate|MP:0008457,abnormal cortical intermediate zone morphology|MP:0008535,enlarged lateral ventricles|MP:0008948,decreased neuron number
MGI:6341860	Insig1<em1(IMPC)Ccpcz>	MP:0000455,abnormal maxilla morphology|MP:0000538,abnormal urinary bladder morphology|MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0003020,decreased circulating chloride level|MP:0005278,abnormal cholesterol homeostasis|MP:0005293,impaired glucose tolerance|MP:0005561,increased mean corpuscular hemoglobin|MP:0005655,increased aggression|MP:0013279,increased fasting circulating glucose level|MP:0020421,increased freezing behavior
MGI:5568496	Insig1<tm1.1Aztc>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002644,decreased circulating triglyceride level|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0009117,abnormal white fat cell morphology|MP:0009285,increased gonadal fat pad weight|MP:0010934,increased subcutaneous adipose tissue amount|MP:0011169,abnormal white fat cell differentation
MGI:3603523	Insig1<tm1Mbjg>	MP:0005376,homeostasis/metabolism phenotype
MGI:6276878	Insig2<em1(IMPC)Hmgu>	MP:0001257,increased body length|MP:0005333,decreased heart rate
MGI:2661997	Insl3<tm1Imad>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001929,abnormal gametogenesis|MP:0002209,decreased germ cell number|MP:0002286,cryptorchism|MP:0003936,abnormal reproductive system development|MP:0005149,abnormal gubernaculum morphology|MP:0005386,behavior/neurological phenotype|MP:0031287,bilateral cryptorchism
MGI:2148889	Insl3<tm1Par>	MP:0001145,abnormal male reproductive system morphology|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002286,cryptorchism|MP:0002769,abnormal vas deferens morphology|MP:0005149,abnormal gubernaculum morphology|MP:0005386,behavior/neurological phenotype|MP:0009006,prolonged estrous cycle|MP:0014633,decreased spermatid number|MP:0020550,multinucleated giant male germ cells|MP:0031286,unilateral cryptorchism|MP:0031287,bilateral cryptorchism
MGI:3604599	Insl5<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:5445709	Insl5<tm1Imad>	MP:0001559,hyperglycemia|MP:0001762,polyuria|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0002727,decreased circulating insulin level|MP:0003339,decreased pancreatic beta cell number|MP:0005293,impaired glucose tolerance|MP:0005389,reproductive system phenotype|MP:0009172,small pancreatic islets
MGI:4431170	Insl6<tm1Imad>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0006362,abnormal male germ cell morphology|MP:0008280,abnormal male germ cell apoptosis
MGI:5576020	Insm1<tm1.1(GFP/cre)Mgn>	MP:0006208,lethality throughout fetal growth and development|MP:0009165,abnormal endocrine pancreas morphology|MP:0011400,lethality, complete penetrance|MP:0011910,decreased pancreatic endocrine progenitor cell proliferation|MP:0011911,abnormal pancreatic endocrine progenitor cell physiology|MP:0011932,abnormal endocrine pancreas development
MGI:4940047	Insm1<tm1.1Jga>	MP:0003203,increased neuron apoptosis|MP:0008789,abnormal olfactory epithelium morphology|MP:0008948,decreased neuron number|MP:0009937,abnormal neuron differentiation|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3656035	Insm1<tm1Cbm>	MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0003339,decreased pancreatic beta cell number|MP:0003816,abnormal pituitary gland development|MP:0003972,decreased pituitary hormone level|MP:0004141,abnormal enteroendocrine cell morphology|MP:0005128,decreased adrenocorticotropin level|MP:0005130,decreased follicle stimulating hormone level|MP:0005132,decreased luteinizing hormone level|MP:0005134,decreased thyroid-stimulating hormone level|MP:0005136,decreased growth hormone level|MP:0005138,decreased prolactin level|MP:0005361,small pituitary gland|MP:0008330,absent somatotrophs|MP:0008339,absent thyrotrophs|MP:0009169,pancreatic islet hypoplasia|MP:0009177,decreased pancreatic alpha cell number|MP:0009181,decreased pancreatic delta cell number|MP:0009185,increased PP cell number|MP:0009187,absent PP cells|MP:0009191,decreased pancreatic epsilon cell number|MP:0011087,neonatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011932,abnormal endocrine pancreas development|MP:0013220,increased pancreas apoptosis
MGI:7446800	Insm2<em1Tcai>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002727,decreased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0009642,abnormal blood homeostasis|MP:0013279,increased fasting circulating glucose level
MGI:2157923	Insq10<129/SvIr>	MP:0002079,increased circulating insulin level
MGI:2154156	Insq2<SM/J>	MP:0002079,increased circulating insulin level
MGI:2155298	Insq3<SM/J>	MP:0002079,increased circulating insulin level
MGI:2157898	Insq4<SM/J>	MP:0002079,increased circulating insulin level
MGI:2157902	Insq5<SM/J>	MP:0002727,decreased circulating insulin level
MGI:2154163	Insq6<C57BL/6>	MP:0002079,increased circulating insulin level
MGI:2154965	Insq7<C57BL/6>	MP:0002079,increased circulating insulin level
MGI:2156457	Insq8<C57BL/6>	MP:0002079,increased circulating insulin level
MGI:2157922	Insq9<C57BL/6>	MP:0002079,increased circulating insulin level
MGI:6268730	Insr<m1Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:6268734	Insr<M2Btlr>	MP:0003058,increased insulin secretion
MGI:3818849	Insr<Rgsc1777>	MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level
MGI:3811869	Insr<Rgsc294>	MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level|MP:0002079,increased circulating insulin level
MGI:3812540	Insr<Rgsc824>	MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level|MP:0002079,increased circulating insulin level|MP:0006353,increased glycosylated hemoglobin level
MGI:2653019	Insrr<tm1Dac>	MP:0002169,no abnormal phenotype detected
MGI:1857204	Insr<tm1Dac>	MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002893,ketoaciduria|MP:0003058,increased insulin secretion|MP:0005331,insulin resistance|MP:0009113,increased pancreatic beta cell mass|MP:0011085,postnatal lethality, complete penetrance
MGI:2149629	Insr<tm1Jja>	MP:0000599,enlarged liver|MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level|MP:0002079,increased circulating insulin level|MP:0002082,postnatal lethality|MP:0002628,hepatic steatosis|MP:0002893,ketoaciduria|MP:0009462,skeletal muscle hypotrophy|MP:0010025,decreased total body fat amount|MP:0010398,decreased liver glycogen level|MP:0011085,postnatal lethality, complete penetrance
MGI:2384332	Insr<tm1Khn>	MP:0000008,increased white adipose tissue amount|MP:0000199,abnormal circulating serum albumin level|MP:0000267,abnormal heart development|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0001156,abnormal spermatogenesis|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001426,polydipsia|MP:0001433,polyphagia|MP:0001544,abnormal cardiovascular system physiology|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001559,hyperglycemia|MP:0001732,postnatal growth retardation|MP:0001762,polyuria|MP:0001922,reduced male fertility|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002188,small heart|MP:0002216,abnormal seminiferous tubule morphology|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002680,decreased corpora lutea number|MP:0002687,oligozoospermia|MP:0002702,decreased circulating free fatty acids level|MP:0002773,decreased circulating luteinizing hormone level|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0002971,abnormal brown adipose tissue morphology|MP:0003023,decreased coronary flow rate|MP:0003058,increased insulin secretion|MP:0003059,decreased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0003393,decreased cardiac output|MP:0003631,nervous system phenotype|MP:0003839,abnormal insulin clearance|MP:0003916,decreased heart left ventricle weight|MP:0003959,abnormal lean body mass|MP:0004039,abnormal cardiac muscle cell glucose uptake|MP:0004565,decreased myocardial fiber size|MP:0004789,increased bile salt level|MP:0005215,abnormal pancreatic islet morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005281,increased fatty acids level|MP:0005289,increased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005317,increased triglyceride level|MP:0005331,insulin resistance|MP:0005334,abnormal fat pad morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0005536,decreased Leydig cell number|MP:0005559,increased circulating glucose level|MP:0005560,decreased circulating glucose level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005669,increased circulating leptin level|MP:0006319,abnormal epididymal fat pad morphology|MP:0009113,increased pancreatic beta cell mass|MP:0009114,decreased pancreatic beta cell mass|MP:0009124,increased brown fat cell lipid droplet size|MP:0009342,enlarged gallbladder|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010080,abnormal hepatocyte physiology|MP:0010097,abnormal retina blood vessel morphology|MP:0010098,abnormal retina blood vessel pattern|MP:0010398,decreased liver glycogen level|MP:0011129,decreased tertiary ovarian follicle number|MP:0011630,increased mitochondrial size|MP:0011943,abnormal circadian feeding behavior|MP:0013925,abnormal vascular plexus formation|MP:0014071,increased cardiac muscle glycogen level|MP:0014316,decreased heart left ventricle posterior wall thickness|MP:0014605,dark liver|MP:0030018,increased cardiac muscle cell glucose uptake|MP:0030020,decreased cardiac muscle cell glucose uptake|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3580001	Insr<tm1Shs>	MP:0000609,abnormal liver physiology|MP:0001559,hyperglycemia|MP:0001732,postnatal growth retardation|MP:0002079,increased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0010025,decreased total body fat amount|MP:0011085,postnatal lethality, complete penetrance|MP:0030971,ketoacidosis
MGI:6392387	Insyn1<em1Ssod>	MP:0000812,abnormal dentate gyrus morphology|MP:0001402,decreased locomotor activity|MP:0002272,abnormal nervous system electrophysiology|MP:0004811,abnormal neuron physiology|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0009939,abnormal hippocampus neuron morphology|MP:0012006,abnormal hippocampus physiology|MP:0020358,abnormal inhibitory synapse morphology
MGI:6385688	Insyn2b<em1(IMPC)J>	MP:0000198,decreased circulating phosphate level|MP:0000218,increased leukocyte cell number|MP:0001399,hyperactivity|MP:0002941,increased circulating alanine transaminase level|MP:0005559,increased circulating glucose level
MGI:5661967	Ints10<tm1b(KOMP)Wtsi>	MP:0000266,abnormal heart morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0002824,abnormal chorioallantoic fusion|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0005554,decreased circulating creatinine level|MP:0006243,impaired pupillary reflex|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:8276548	Ints11<tm1.2Shra>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5708213	Ints11<tm2b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:4432308	Ints12<tm1a(EUCOMM)Wtsi>	MP:0010092,increased circulating magnesium level|MP:0011100,preweaning lethality, complete penetrance
MGI:5637056	Ints12<tm1b(EUCOMM)Wtsi>	MP:0001552,increased circulating triglyceride level|MP:0003961,decreased lean body mass|MP:0010068,decreased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance
MGI:7578876	Ints15<em1Takas>	MP:0001286,abnormal eye development|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0001314,cornea opacity|MP:0002092,abnormal eye morphology|MP:0003727,abnormal retina layer morphology|MP:0005098,abnormal optic choroid morphology|MP:0006182,increased retina hemangioma incidence|MP:0008259,abnormal optic disk morphology|MP:0009392,retina gliosis|MP:0010097,abnormal retina blood vessel morphology|MP:0010768,mortality/aging
MGI:7578877	Ints15<em2Takas>	MP:0001286,abnormal eye development|MP:0001289,persistence of hyaloid vascular system|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001314,cornea opacity|MP:0001322,abnormal iris morphology|MP:0002092,abnormal eye morphology|MP:0005193,abnormal anterior eye segment morphology|MP:0006182,increased retina hemangioma incidence|MP:0008259,abnormal optic disk morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance|MP:0011481,anterior iris synechia|MP:0021107,retina fold|MP:0031428,lens dislocation
MGI:5286636	Ints1<Tg(Tyr)2364B-1aOve>	MP:0006204,embryonic lethality before implantation
MGI:3663683	Ints1<tm1Mnkm>	MP:0001730,embryonic growth arrest|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4362455	Ints2<tm1a(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6161377	Ints3<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001529,abnormal vocalization|MP:0002591,decreased mean corpuscular volume|MP:0003131,increased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005655,increased aggression|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5287494	Ints6<Tg(Tyr)2310FOve>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6161427	Ints7<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6414499	Ints8<em1(IMPC)Tcp>	MP:0002591,decreased mean corpuscular volume|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5796932	Ints9<tm1b(KOMP)Wtsi>	MP:0005562,decreased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0008806,increased circulating amylase level|MP:0011100,preweaning lethality, complete penetrance
MGI:5755448	Intu<dtm>	MP:0000166,abnormal chondrocyte morphology|MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003631,nervous system phenotype|MP:0005390,skeleton phenotype|MP:0008146,asymmetric sternocostal joints|MP:0008148,abnormal sternocostal joint morphology|MP:0008277,abnormal sternum ossification|MP:0009674,decreased birth weight|MP:0011065,abnormal kidney epithelial cell primary cilium morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011998,decreased embryonic cilium length|MP:0013197,decreased embryonic cilium number|MP:0013202,abnormal cilium morphology|MP:0013213,abnormal embryonic neuroepithelium primary cilium morphology
MGI:4441400	Intu<tm1.1Aliu>	MP:0002169,no abnormal phenotype detected
MGI:4441401	Intu<tm1.2Aliu>	MP:0000269,abnormal heart looping|MP:0000358,abnormal cell morphology|MP:0000562,polydactyly|MP:0000785,telencephalon hypoplasia|MP:0000831,diencephalon hyperplasia|MP:0000914,exencephaly|MP:0000926,absent floor plate|MP:0000927,small floor plate|MP:0000937,abnormal motor neuron morphology|MP:0001297,microphthalmia|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0001785,edema|MP:0001787,pericardial edema|MP:0002825,abnormal notochord morphology|MP:0004203,abnormal cranial flexure morphology|MP:0004574,broad limb buds|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005650,abnormal limb bud morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011998,decreased embryonic cilium length|MP:0013202,abnormal cilium morphology|MP:0021105,abnormal ventral interneuron 3 morphology
MGI:6360031	Invs<em1(IMPC)Bay>	MP:0001785,edema|MP:0001914,hemorrhage|MP:0011100,preweaning lethality, complete penetrance
MGI:1856915	Invs<inv>	MP:0000266,abnormal heart morphology|MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000477,abnormal intestine morphology|MP:0000522,kidney cortex cyst|MP:0000531,right pulmonary isomerism|MP:0000542,left-sided isomerism|MP:0000598,abnormal liver morphology|MP:0000611,jaundice|MP:0000644,dextrocardia|MP:0000689,abnormal spleen morphology|MP:0000694,spleen hypoplasia|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001944,abnormal pancreas morphology|MP:0002082,postnatal lethality|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0002766,situs inversus|MP:0002767,situs ambiguus|MP:0003178,left pulmonary isomerism|MP:0003197,nephrocalcinosis|MP:0003606,kidney failure|MP:0003675,kidney cyst|MP:0003917,increased kidney weight|MP:0004066,abnormal primitive node morphology|MP:0004110,transposition of great arteries|MP:0004158,right aortic arch|MP:0004159,double aortic arch|MP:0004190,abnormal direction of embryo turning|MP:0004194,abnormal kidney pelvis morphology|MP:0004252,abnormal direction of heart looping|MP:0004860,dilated kidney collecting duct|MP:0005083,abnormal biliary tract morphology|MP:0005215,abnormal pancreatic islet morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0005367,renal/urinary system phenotype|MP:0005388,respiratory system phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0005565,increased blood urea nitrogen level|MP:0006062,abnormal vena cava morphology|MP:0006117,aortic valve stenosis|MP:0008461,left atrial isomerism|MP:0008489,slow postnatal weight gain|MP:0008933,abnormal motile primary cilium physiology|MP:0009050,dilated proximal convoluted tubule|MP:0009144,dilated pancreatic duct|MP:0009145,abnormal pancreatic acinus morphology|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009149,decreased pancreatic acinar cell number|MP:0009254,disorganized pancreatic islets|MP:0010431,atrial situs inversus|MP:0010541,aorta hypoplasia|MP:0010808,right-sided stomach|MP:0010854,lung situs inversus|MP:0011250,abdominal situs ambiguus|MP:0011307,kidney medulla cyst|MP:0011308,kidney corticomedullary cyst|MP:0011341,abnormal loop of Henle descending limb morphology|MP:0011344,abnormal loop of Henle ascending limb thick segment morphology|MP:0011352,proximal convoluted tubule brush border loss|MP:0011425,abnormal kidney interstitium morphology|MP:0011501,increased glomerular capsule space|MP:0011682,renal glomerulus cyst|MP:0012027,abnormal embryonic cilium location or orientation
MGI:4353027	In(YLS)Lub	MP:0003702,abnormal chromosome morphology|MP:0005389,reproductive system phenotype
MGI:6718594	Ip6k1<em1Seyk>	MP:0002919,enhanced paired-pulse facilitation|MP:0002920,decreased paired-pulse facilitation|MP:0003631,nervous system phenotype|MP:0004770,abnormal synaptic vesicle recycling|MP:0008469,abnormal protein level|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0030950,abnormal synaptic vesicle exocytosis|MP:0030951,abnormal endocytosis
MGI:3530572	Ip6k1<Gt(OST137568)Lex>	MP:0002727,decreased circulating insulin level|MP:0005159,azoospermia|MP:0005293,impaired glucose tolerance|MP:0013600,testis degeneration
MGI:3775918	Ip6k1<tm1.1Snyd>	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005159,azoospermia|MP:0014636,decreased elongated spermatid number
MGI:5635272	Ip6k2<tm1.1Snyd>	MP:0002459,abnormal B cell physiology|MP:0004228,decreased cellular sensitivity to ionizing radiation induced cell death|MP:0008944,decreased sensitivity to induced cell death
MGI:4354090	Ip6k2<tm1Dlin>	MP:0000313,abnormal cell death|MP:0003010,decreased mortality induced by ionizing radiation|MP:0004499,increased incidence of tumors by chemical induction|MP:0004546,esophagus hyperplasia|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010948,abnormal double-strand DNA break repair|MP:0011703,increased fibroblast proliferation
MGI:5788648	Ip6k3<tm1.1Snyd>	MP:0000877,abnormal Purkinje cell morphology|MP:0000890,thin cerebellar molecular layer|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001935,decreased litter size|MP:0002804,abnormal motor learning|MP:0003245,abnormal GABAergic neuron morphology|MP:0003631,nervous system phenotype|MP:0004998,decreased CNS synapse formation|MP:0008143,abnormal dendrite morphology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0014812,abnormal brain physiology|MP:0021018,decreased dendritic spine number
MGI:3583918	Ipmk<tm1Yrk>	MP:0000913,abnormal brain development|MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5617259	Ipo11<tm1.1(KOMP)Vlcg>	MP:0001303,abnormal lens morphology|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0004151,decreased circulating iron level|MP:0005560,decreased circulating glucose level|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013279,increased fasting circulating glucose level|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014586,decreased egg cylinder size
MGI:3877413	Ipo13<Gt(XS0873)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6342428	Ipo4<em1(IMPC)J>	MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:6152503	Ipo7<em1(IMPC)Mbp>	MP:0000538,abnormal urinary bladder morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001293,anophthalmia|MP:0001404,no spontaneous movement|MP:0001415,increased exploration in new environment|MP:0001552,increased circulating triglyceride level|MP:0001566,increased circulating phosphate level|MP:0002060,abnormal skin morphology|MP:0002079,increased circulating insulin level|MP:0002092,abnormal eye morphology|MP:0002282,abnormal trachea morphology|MP:0002339,abnormal lymph node morphology|MP:0004957,abnormal blastocyst morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:5614578	Ipo8<tm1.1(KOMP)Vlcg>	MP:0001304,cataract|MP:0001417,decreased exploration in new environment|MP:0005561,increased mean corpuscular hemoglobin|MP:0008259,abnormal optic disk morphology|MP:0010053,decreased grip strength|MP:0010097,abnormal retina blood vessel morphology
MGI:6257741	Ipo9<em1(IMPC)Bay>	MP:0000266,abnormal heart morphology|MP:0001672,abnormal embryo development|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001726,abnormal allantois morphology|MP:0001785,edema|MP:0002824,abnormal chorioallantoic fusion|MP:0002861,abnormal tail bud morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5287024	Ipo9<TgTn(sb-cHS4,Tyr)2327COve>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3511861	Ippk<Gt(XA232)Byg>	MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:5696913	Ippk<tm1b(KOMP)Wtsi>	MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5532529	Ipp<tm1.1(KOMP)Vlcg>	MP:0000221,decreased leukocyte cell number|MP:0001523,impaired righting response|MP:0002968,increased circulating alkaline phosphatase level|MP:0003020,decreased circulating chloride level|MP:0005560,decreased circulating glucose level|MP:0011396,abnormal sleep behavior
MGI:1856916	ipv	MP:0001142,abnormal vagina orifice morphology|MP:0003315,abnormal perineum morphology|MP:0003540,imperforate hymen|MP:0009085,abnormal uterine horn morphology|MP:0009087,dilated uterine horn
MGI:5763150	Iqca1<em1(IMPC)J>	MP:0001312,abnormal cornea morphology|MP:0001488,increased startle reflex|MP:0002941,increased circulating alanine transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0010511,shortened PR interval|MP:0011954,shortened PQ interval
MGI:6459761	Iqca1<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6257418	Iqcb1<em1(IMPC)Bay>	MP:0002953,thick ventricular wall|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010579,increased heart left ventricle size|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011962,increased cornea thickness
MGI:4881009	Iqcb1<tm1a(EUCOMM)Hmgu>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001005,abnormal retina rod cell morphology|MP:0001006,abnormal retina cone cell morphology|MP:0001326,retina degeneration|MP:0002001,blindness|MP:0005253,abnormal eye physiology|MP:0005367,renal/urinary system phenotype|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0014658,absent a-wave|MP:0020439,absent b-wave|MP:0020813,abnormal photoreceptor outer segment disc membrane morphology
MGI:5548641	Iqce<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0000745,tremors|MP:0001392,abnormal locomotor behavior|MP:0001566,increased circulating phosphate level|MP:0002590,increased mean corpuscular volume|MP:0002764,short tibia|MP:0005016,decreased lymphocyte cell number|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0011965,decreased total retina thickness
MGI:6403881	Iqcf1<em1(IMPC)J>	MP:0005293,impaired glucose tolerance
MGI:5751515	Iqcf1<em1Zdq>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0004542,impaired acrosome reaction|MP:0005389,reproductive system phenotype
MGI:3050608	Iqcg<esgd12d>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008545,absent sperm flagellum|MP:0009239,short sperm flagellum
MGI:4431654	Iqcg<tm1a(EUCOMM)Wtsi>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002660,abnormal caput epididymis morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0005384,cellular phenotype|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0020869,immotile sperm
MGI:5635126	Iqcg<tm1b(EUCOMM)Wtsi>	MP:0001932,abnormal spermiogenesis|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype
MGI:6272676	Iqch<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0010053,decreased grip strength
MGI:7539523	Iqch<em2Alfon>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004543,abnormal sperm physiology|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009831,abnormal sperm midpiece morphology
MGI:5585265	Iqcj<em1(IMPC)J>	MP:0002590,increased mean corpuscular volume|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:7510086	Iqcm<em1(IMPC)Tcp>	MP:0000220,increased monocyte cell number|MP:0000642,enlarged adrenal glands|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:7413046	Iqcn<em1Cya>	MP:0001925,male infertility|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009377,ectopic manchette|MP:0009647,decreased fertilization frequency|MP:0031386,elongated manchette
MGI:2387945	Iqgap1<tm1Aber>	MP:0005210,disorganized stomach mucosa|MP:0010792,abnormal stomach mucosa morphology
MGI:5696896	Iqgap1<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0001417,decreased exploration in new environment|MP:0002764,short tibia|MP:0005013,increased lymphocyte cell number|MP:0010052,increased grip strength
MGI:5558039	Iqgap2<tm1b(KOMP)Wtsi>	MP:0001488,increased startle reflex|MP:0004738,abnormal auditory brainstem response|MP:0009142,decreased prepulse inhibition
MGI:3526416	Iqgap2<tm1Vs>	MP:0000606,decreased hepatocyte number|MP:0002083,premature death|MP:0002947,increased hemangioma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003887,increased hepatocyte apoptosis|MP:0005343,increased circulating aspartate transaminase level|MP:0014341,abnormal hepatocyte mitochondrial morphology
MGI:6257423	Iqgap3<em1(IMPC)Bay>	MP:0002626,increased heart rate|MP:0002953,thick ventricular wall|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4822241	Iqsec1<tm1.1Hck>	MP:0001899,absent long-term depression
MGI:6393275	Iqsec2<em1Alev>	MP:0002206,abnormal CNS synaptic transmission|MP:0003107,abnormal response to novelty|MP:0005386,behavior/neurological phenotype|MP:0012307,impaired spatial learning|MP:0020395,abnormal response to social novelty|MP:0031391,increased locomotor activity
MGI:6392156	Iqsec2<em1Csbg>	MP:0000951,sporadic seizures|MP:0001361,social withdrawal|MP:0001415,increased exploration in new environment|MP:0002566,abnormal sexual interaction|MP:0004996,abnormal CNS synapse formation|MP:0008428,abnormal spatial working memory|MP:0010053,decreased grip strength|MP:0012307,impaired spatial learning|MP:0012459,increased dentate gyrus size|MP:0020082,increased hippocampus volume|MP:0020573,abnormal corpus callosum size|MP:0031391,increased locomotor activity
MGI:6392157	Iqsec2<em1Frk>	MP:0000947,convulsive seizures|MP:0001363,increased anxiety-related response|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002566,abnormal sexual interaction|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0003354,astrocytosis|MP:0004101,abnormal brain interneuron morphology|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0011987,abnormal GABAergic neuron physiology|MP:0012348,decreased susceptibility to induction of seizure by inducing agent|MP:0020351,decreased vocalization|MP:0031391,increased locomotor activity
MGI:8257179	Iqsec3<em1Jwum>	MP:0014372,decreased miniature excitatory postsynaptic current amplitude|MP:0014376,decreased miniature excitatory postsynaptic current frequency|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude
MGI:8257180	Iqsec3<tm1c(KOMP)Wtsi>	MP:0001473,reduced long-term potentiation|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0009538,abnormal synapse morphology|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0020422,decreased freezing behavior|MP:0031333,decreased inhibitory postsynaptic current amplitude
MGI:5563212	Iqsec3<tm3b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0001402,decreased locomotor activity|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011965,decreased total retina thickness|MP:0013279,increased fasting circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:7413078	Iqub<em1Mngx>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0003631,nervous system phenotype|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0020451,decreased sperm progressive motility
MGI:7413079	Iqub<em2Mngx>	MP:0005389,reproductive system phenotype
MGI:7413080	Iqub<em3Mngx>	MP:0005389,reproductive system phenotype
MGI:5548891	Iqub<tm1.1(KOMP)Vlcg>	MP:0001925,male infertility
MGI:7425759	Irag1<em1(IMPC)Ccpcz>	MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0000266,abnormal heart morphology|MP:0000494,abnormal cecum morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001157,small seminal vesicle|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002188,small heart|MP:0002590,increased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0004952,increased spleen weight|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005419,decreased circulating serum albumin level|MP:0005505,thrombocytosis|MP:0005561,increased mean corpuscular hemoglobin|MP:0009476,enlarged cecum|MP:0010024,increased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0013279,increased fasting circulating glucose level|MP:0020421,increased freezing behavior
MGI:3525059	Irag1<tm1Jens>	MP:0000740,impaired smooth muscle contractility|MP:0002083,premature death|MP:0002843,decreased systemic arterial blood pressure|MP:0003285,gastric hypertrophy|MP:0003307,pyloric stenosis|MP:0005333,decreased heart rate|MP:0006001,abnormal intestinal transit time
MGI:5292572	Irag1<tm2.1Jens>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000462,abnormal digestive system morphology|MP:0002083,premature death|MP:0003157,impaired muscle relaxation|MP:0005595,abnormal vascular smooth muscle physiology
MGI:5692577	Irag2<tm1b(EUCOMM)Wtsi>	MP:0001510,abnormal coat appearance
MGI:5305277	Irak1<tm1.1Pcoh>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype|MP:0008563,decreased interferon-alpha secretion
MGI:5636906	Irak1<tm1b(EUCOMM)Hmgu>	MP:0010087,increased circulating fructosamine level
MGI:2384212	Irak1<tm1Jth>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis
MGI:3654141	Irak1<tm1Wpfl>	MP:0005621,abnormal cell physiology
MGI:5548123	Irak2<tm1.1Pcoh>	MP:0008563,decreased interferon-alpha secretion
MGI:3796171	Irak2<tm1Aki>	MP:0002451,abnormal macrophage physiology|MP:0008734,decreased susceptibility to endotoxin shock
MGI:5637137	Irak2<tm1b(EUCOMM)Wtsi>	MP:0002764,short tibia|MP:0002968,increased circulating alkaline phosphatase level|MP:0010024,increased total body fat amount
MGI:3848359	Irak2<tm1Jth>	MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008597,decreased circulating interleukin-6 level|MP:0008706,decreased interleukin-6 secretion|MP:0008721,abnormal chemokine level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:2384197	Irak3<tm1Flv>	MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000160,kyphosis|MP:0000219,increased neutrophil cell number|MP:0000685,abnormal immune system morphology|MP:0000696,abnormal Peyer's patch morphology|MP:0001265,decreased body size|MP:0001541,abnormal osteoclast physiology|MP:0001828,abnormal T cell activation|MP:0001845,abnormal inflammatory response|MP:0002145,abnormal T cell differentiation|MP:0002376,abnormal dendritic cell physiology|MP:0002419,abnormal innate immunity|MP:0002452,abnormal professional antigen presenting cell physiology|MP:0002869,increased anti-insulin autoantibody level|MP:0003797,abnormal compact bone morphology|MP:0004031,insulitis|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0004984,increased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0005293,impaired glucose tolerance|MP:0008136,enlarged Peyer's patches|MP:0008152,decreased diameter of femur|MP:0008560,increased tumor necrosis factor secretion|MP:0008669,increased interleukin-12b secretion|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0010879,decreased trabecular bone volume|MP:0013772,increased effector memory T-helper cell number
MGI:6367968	Irak4<em1(IMPC)Ccpcz>	MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002953,thick ventricular wall
MGI:3774129	Irak4<m1Btlr>	MP:0008561,decreased tumor necrosis factor secretion
MGI:3762874	Irak4<tm1Aki>	MP:0003009,abnormal cytokine secretion|MP:0005093,decreased B cell proliferation|MP:0005387,immune system phenotype|MP:0008561,decreased tumor necrosis factor secretion|MP:0008563,decreased interferon-alpha secretion|MP:0008670,decreased interleukin-12b secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:3712883	Irak4<tm1Gram>	MP:0003009,abnormal cytokine secretion|MP:0008722,abnormal chemokine secretion|MP:0020414,abnormal fibroblast physiology
MGI:3762911	Irak4<tm1Lix>	MP:0005087,decreased acute inflammation|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008563,decreased interferon-alpha secretion|MP:0008565,decreased interferon-beta secretion|MP:0008597,decreased circulating interleukin-6 level|MP:0008706,decreased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:2676448	Irak4<tm1Yeh>	MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0003009,abnormal cytokine secretion|MP:0005093,decreased B cell proliferation|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0008592,decreased circulating interleukin-1 level|MP:0008597,decreased circulating interleukin-6 level|MP:0008706,decreased interleukin-6 secretion|MP:0008713,abnormal cytokine level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0010766,abnormal NK cell physiology
MGI:3762878	Irak4<tm2Aki>	MP:0003009,abnormal cytokine secretion|MP:0005093,decreased B cell proliferation|MP:0005387,immune system phenotype|MP:0008561,decreased tumor necrosis factor secretion|MP:0008563,decreased interferon-alpha secretion|MP:0008670,decreased interleukin-12b secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:3713729	Irav1<DBA/2J>	MP:0002421,abnormal cell-mediated immunity|MP:0003009,abnormal cytokine secretion
MGI:5702744	Ireb2<tm1.1Eal>	MP:0000208,decreased hematocrit|MP:0000780,abnormal corpus callosum morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000832,abnormal thalamus morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0000904,abnormal superior colliculus morphology|MP:0000953,abnormal oligodendrocyte morphology|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001770,abnormal iron level|MP:0001973,increased thermal nociceptive threshold|MP:0002591,decreased mean corpuscular volume|MP:0002757,decreased vertical activity|MP:0002810,microcytic anemia|MP:0002874,decreased hemoglobin content|MP:0003179,thrombocytopenia|MP:0003631,nervous system phenotype|MP:0004102,abnormal dorsal striatum morphology|MP:0004147,increased porphyrin level|MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype|MP:0005404,abnormal axon morphology|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005637,abnormal iron homeostasis|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0005654,porphyria|MP:0008807,increased liver iron level|MP:0008935,decreased mean platelet volume|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0009978,abnormal cerebellum white matter morphology|MP:0010067,increased red blood cell distribution width|MP:0010375,increased kidney iron level|MP:0011890,increased circulating ferritin level|MP:0020338,abnormal hippocampal pyramidal neuron dendrite morphology|MP:0020365,increased brain iron level|MP:0020366,decreased brain iron level|MP:0020368,decreased heart iron level|MP:0020369,increased intestine iron level
MGI:3613523	Ireb2<tm1.1Mwh>	MP:0002169,no abnormal phenotype detected
MGI:3613524	Ireb2<tm1.2Mwh>	MP:0000208,decreased hematocrit|MP:0001392,abnormal locomotor behavior|MP:0002447,abnormal erythrocyte morphology|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003271,abnormal duodenum morphology|MP:0005637,abnormal iron homeostasis|MP:0008807,increased liver iron level|MP:0008808,decreased spleen iron level|MP:0020369,increased intestine iron level
MGI:3613022	Ireb2<tm1Mwh>	MP:0000208,decreased hematocrit|MP:0001392,abnormal locomotor behavior|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0005386,behavior/neurological phenotype|MP:0005637,abnormal iron homeostasis|MP:0008807,increased liver iron level|MP:0008808,decreased spleen iron level|MP:0020369,increased intestine iron level
MGI:2181660	Ireb2<tm1Roua>	MP:0000160,kyphosis|MP:0000208,decreased hematocrit|MP:0000745,tremors|MP:0000832,abnormal thalamus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000876,Purkinje cell degeneration|MP:0000880,decreased Purkinje cell number|MP:0000899,abnormal corpora quadrigemina morphology|MP:0001392,abnormal locomotor behavior|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001525,impaired balance|MP:0002591,decreased mean corpuscular volume|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0004742,abnormal vestibular system physiology|MP:0005156,bradykinesia|MP:0005370,liver/biliary system phenotype|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005637,abnormal iron homeostasis|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008807,increased liver iron level|MP:0008808,decreased spleen iron level|MP:0010053,decreased grip strength|MP:0011890,increased circulating ferritin level|MP:0020365,increased brain iron level|MP:0020369,increased intestine iron level
MGI:3811824	Irf1<M1Btlr>	MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008045,decreased NK cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008563,decreased interferon-alpha secretion|MP:0008565,decreased interferon-beta secretion|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:6269374	Irf1<m2Btlr>	MP:0004977,increased B-1 B cell number|MP:0008045,decreased NK cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:6269378	Irf1<M3Btlr>	MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:2429553	Irf1<tm1Cwe>	MP:0000685,abnormal immune system morphology|MP:0001790,abnormal immune system physiology|MP:0002451,abnormal macrophage physiology|MP:0002490,abnormal immunoglobulin level|MP:0003436,decreased susceptibility to induced arthritis|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005094,abnormal T cell proliferation|MP:0005390,skeleton phenotype|MP:0008037,abnormal T cell morphology|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008090,increased T-helper 2 cell number|MP:0008577,increased circulating interferon-gamma level|MP:0008578,decreased circulating interferon-gamma level|MP:0008590,abnormal circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008600,decreased circulating interleukin-2 level|MP:0008601,abnormal circulating interleukin-4 level|MP:0008602,increased circulating interleukin-4 level|MP:0008608,increased circulating interleukin-13 level|MP:0008623,increased circulating interleukin-3 level|MP:0008626,increased circulating interleukin-5 level|MP:0008713,abnormal cytokine level|MP:0008827,abnormal thymus cell ratio|MP:0009332,abnormal splenocyte morphology|MP:0020928,increased susceptibility to Poxviridae infection
MGI:1857205	Irf1<tm1Mak>	MP:0001573,abnormal circulating alanine transaminase level|MP:0002169,no abnormal phenotype detected|MP:0003945,abnormal lymphocyte physiology|MP:0004499,increased incidence of tumors by chemical induction|MP:0004883,abnormal vascular wound healing|MP:0005025,abnormal response to infection|MP:0005091,increased double-positive T cell number|MP:0005384,cellular phenotype|MP:0005387,immune system phenotype|MP:0006387,abnormal T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008567,decreased interferon-gamma secretion|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0012431,increased lymphoma incidence|MP:0014760,impaired DNA repair
MGI:4015249	Irf2bp2<Gt(IST11591C1)Tigm>	MP:0000598,abnormal liver morphology|MP:0001732,postnatal growth retardation|MP:0002416,abnormal proerythroblast morphology|MP:0002875,decreased erythrocyte cell number|MP:0004229,abnormal embryonic erythropoiesis|MP:0008973,decreased erythroid progenitor cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011178,increased erythroblast number
MGI:6257627	Irf2bpl<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:7490168	Irf2bpl<em2(IMPC)Bay>	MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2175949	Irf2<tm1Mak>	MP:0001190,reddish skin|MP:0001194,dermatitis|MP:0001212,skin lesions|MP:0001219,thick epidermis|MP:0001790,abnormal immune system physiology|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0005018,decreased T cell number|MP:0005025,abnormal response to infection|MP:0005093,decreased B cell proliferation|MP:0005114,premature hair loss|MP:0005387,immune system phenotype|MP:0008049,increased memory T cell number|MP:0008102,lymph node hyperplasia|MP:0008211,decreased mature B cell number|MP:0008496,decreased IgG2a level|MP:0009623,enlarged inguinal lymph nodes|MP:0009932,skin fibrosis
MGI:6276917	Irf3<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001399,hyperactivity|MP:0001566,increased circulating phosphate level|MP:0002135,abnormal kidney morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0002989,small kidney
MGI:3577601	Irf3<tm1Ttg>	MP:0001326,retina degeneration|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008519,thin retina outer plexiform layer|MP:0008548,abnormal circulating interferon level|MP:0011965,decreased total retina thickness|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0020937,increased susceptibility to Picornaviridae infection
MGI:6277061	Irf4<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001486,abnormal startle reflex|MP:0002339,abnormal lymph node morphology|MP:0004952,increased spleen weight|MP:0005016,decreased lymphocyte cell number
MGI:4456226	Irf4<m1Btlr>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype|MP:0008217,abnormal B cell activation
MGI:5789556	Irf4<M2Btlr>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0008217,abnormal B cell activation
MGI:3712352	Irf4<tm1.1Rdf>	MP:0002144,abnormal B cell differentiation|MP:0002459,abnormal B cell physiology|MP:0005093,decreased B cell proliferation|MP:0008474,absent spleen germinal center|MP:0008495,decreased IgG1 level
MGI:2387941	Irf4<tm1Mak>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000716,abnormal immune system cell morphology|MP:0001790,abnormal immune system physiology|MP:0001802,arrested B cell differentiation|MP:0002144,abnormal B cell differentiation|MP:0002166,abnormal tumor susceptibility|MP:0002339,abnormal lymph node morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002460,decreased immunoglobulin level|MP:0005013,increased lymphocyte cell number|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008100,absent plasma cells|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0008127,decreased dendritic cell number|MP:0008474,absent spleen germinal center|MP:0008523,absent lymph node germinal center|MP:0020913,increased susceptibility to Riboviria infection
MGI:3664434	Irf4<tm1Rdf>	MP:0001260,increased body weight|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0008033,impaired lipolysis|MP:0008964,decreased carbon dioxide production|MP:0009118,increased white fat cell size|MP:0009288,increased epididymal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0010954,abnormal cellular respiration|MP:0011014,decreased core body temperature|MP:0011049,impaired adaptive thermogenesis|MP:0011167,abnormal adipose tissue development|MP:0014142,increased body fat mass|MP:0014172,decreased fatty acid oxidation
MGI:6453611	Irf5<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:4460527	Irf5<tm1e(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0010836,decreased CD4-positive, alpha-beta memory T cell number
MGI:5291913	Irf5<tm1Ppr>	MP:0002169,no abnormal phenotype detected
MGI:3576384	Irf5<tm1Ttg>	MP:0002411,decreased susceptibility to bacterial infection|MP:0005025,abnormal response to infection|MP:0005387,immune system phenotype|MP:0005465,abnormal T-helper 1 physiology|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008563,decreased interferon-alpha secretion|MP:0008597,decreased circulating interleukin-6 level|MP:0008648,decreased circulating interleukin-12b level|MP:0008706,decreased interleukin-6 secretion
MGI:4457055	Irf6<clft1>	MP:0000452,abnormal mouth morphology|MP:0000556,abnormal hindlimb morphology|MP:0000564,syndactyly|MP:0003051,curly tail|MP:0004537,abnormal palatine bone horizontal plate morphology|MP:0005508,abnormal skeleton morphology|MP:0008730,fused phalanges|MP:0009441,delayed skin barrier formation|MP:0009884,palatal shelf fusion with tongue or mandible|MP:0009886,failure of palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0014321,short forelimb|MP:0030328,glossopalatal ankylosis
MGI:6153743	Irf6<em1(IMPC)Wtsi>	MP:0005343,increased circulating aspartate transaminase level|MP:0005553,increased circulating creatinine level|MP:0010090,increased circulating creatine kinase level
MGI:3522096	Irf6<Gt(OST398253)Lex>	MP:0000060,delayed bone ossification|MP:0000111,cleft palate|MP:0000438,abnormal cranium morphology|MP:0000445,short snout|MP:0000454,abnormal jaw morphology|MP:0000467,abnormal esophagus morphology|MP:0000566,synostosis|MP:0000592,short tail|MP:0001196,shiny skin|MP:0001198,tight skin|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001241,absent epidermis stratum corneum|MP:0002110,abnormal digit morphology|MP:0002656,abnormal keratinocyte differentiation|MP:0003935,abnormal craniofacial development|MP:0003941,abnormal skin development|MP:0004321,short sternum|MP:0004449,absent presphenoid bone|MP:0004592,small mandible|MP:0004596,abnormal mandibular angle morphology|MP:0004610,small vertebrae|MP:0004678,split xiphoid process|MP:0004686,decreased length of long bones|MP:0005306,abnormal phalanx morphology|MP:0005579,absent outer ear|MP:0009560,absent epidermis stratum granulosum|MP:0009583,increased keratinocyte proliferation|MP:0009653,abnormal palate development|MP:0009884,palatal shelf fusion with tongue or mandible|MP:0009886,failure of palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0011089,perinatal lethality, complete penetrance|MP:0013531,abnormal periderm development|MP:0013818,abnormal oral cavity morphology|MP:0014321,short forelimb|MP:0030188,round snout
MGI:5306935	Irf6<tm1.1Bcsl>	MP:0003941,abnormal skin development
MGI:6116703	Irf6<tm1Bcsl>	MP:0002100,abnormal tooth morphology|MP:0002576,abnormal enamel morphology|MP:0002577,reduced enamel thickness|MP:0002649,abnormal enamel rod pattern|MP:0002650,abnormal ameloblast morphology|MP:0002689,abnormal molar morphology|MP:0003932,abnormal molar crown morphology|MP:0004033,supernumerary teeth|MP:0005358,abnormal incisor morphology|MP:0006400,decreased molar number|MP:0010096,abnormal incisor color|MP:0030450,abnormal enamel mineralization|MP:0030457,abnormal molar cusp morphology|MP:0030494,abnormal molar root morphology|MP:0030496,taurodontia|MP:0030525,abnormal Hertwig epithelial root sheath morphology|MP:0030544,abnormal enamel development
MGI:3693324	Irf6<tm1Mjd>	MP:0000116,abnormal tooth development|MP:0000379,decreased hair follicle number|MP:0000452,abnormal mouth morphology|MP:0000547,short limbs|MP:0000592,short tail|MP:0001196,shiny skin|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001233,abnormal epidermis suprabasal layer morphology|MP:0001241,absent epidermis stratum corneum|MP:0001284,absent vibrissae|MP:0002116,abnormal craniofacial bone morphology|MP:0002655,abnormal keratinocyte morphology|MP:0003160,abnormal esophagus development|MP:0003935,abnormal craniofacial development|MP:0005358,abnormal incisor morphology|MP:0006280,abnormal digit development|MP:0009560,absent epidermis stratum granulosum|MP:0009884,palatal shelf fusion with tongue or mandible|MP:0009886,failure of palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5426868	Irf6<tm1Pts>	MP:0005382,craniofacial phenotype
MGI:4442855	Irf7<m1Btlr>	MP:0008563,decreased interferon-alpha secretion|MP:0008565,decreased interferon-beta secretion
MGI:5615723	Irf7<M2Btlr>	MP:0008576,decreased circulating interferon-beta level
MGI:4419590	Irf7<tm1(KOMP)Wtsi>	MP:0001325,abnormal retina morphology
MGI:3577089	Irf7<tm1Ttg>	MP:0002444,abnormal T cell physiology|MP:0008750,abnormal interferon level|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020937,increased susceptibility to Picornaviridae infection|MP:0020946,increased susceptibility to Orthomyxoviridae infection|MP:0031046,increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:4835995	Irf8<M1Btlr>	MP:0000219,increased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0003884,decreased macrophage cell number|MP:0008555,abnormal interferon secretion
MGI:6305310	Irf8<m2Btlr>	MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3578920	Irf8<myls>	MP:0000691,enlarged spleen|MP:0001601,abnormal myelopoiesis|MP:0005014,increased B cell number|MP:0008169,increased B-1b cell number|MP:0008173,increased follicular B cell number|MP:0008189,increased transitional stage B cell number
MGI:4939593	Irf8<tm1.1Hm>	MP:0002362,abnormal spleen marginal zone morphology|MP:0005014,increased B cell number|MP:0005387,immune system phenotype|MP:0008173,increased follicular B cell number|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008189,increased transitional stage B cell number|MP:0008206,increased B-2 B cell number
MGI:5446132	Irf8<tm1b(KOMP)Wtsi>	MP:0002590,increased mean corpuscular volume|MP:0002702,decreased circulating free fatty acids level|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0005561,increased mean corpuscular hemoglobin|MP:0005568,increased circulating total protein level|MP:0005633,increased circulating sodium level|MP:0013278,decreased fasting circulating glucose level
MGI:1926332	Irf8<tm1Hor>	MP:0000218,increased leukocyte cell number|MP:0000245,abnormal erythropoiesis|MP:0000321,increased bone marrow cell number|MP:0000322,increased granulocyte number|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0001800,abnormal humoral immune response|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002417,abnormal megakaryocyte morphology|MP:0002461,increased immunoglobulin level|MP:0004952,increased spleen weight|MP:0005013,increased lymphocyte cell number|MP:0005014,increased B cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005425,increased macrophage cell number|MP:0005481,increased chronic myelocytic leukemia incidence|MP:0008096,abnormal plasma cell number|MP:0008169,increased B-1b cell number|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008210,increased mature B cell number|MP:0008476,increased spleen red pulp amount|MP:0008567,decreased interferon-gamma secretion|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0012431,increased lymphoma incidence|MP:0020913,increased susceptibility to Riboviria infection|MP:0031058,hepatosplenomegaly
MGI:5618103	Irf8<tm2.1Hm>	MP:0002169,no abnormal phenotype detected
MGI:5806324	Irf9<M1Btlr>	MP:0008575,increased circulating interferon-beta level|MP:0012556,increased cell death
MGI:2446102	Irf9<tm1Ttg>	MP:0000063,decreased bone mineral density|MP:0002418,increased susceptibility to viral infection|MP:0008563,decreased interferon-alpha secretion
MGI:6355937	Irgc<em1(IMPC)Tcp>	MP:0000220,increased monocyte cell number|MP:0001289,persistence of hyaloid vascular system|MP:0001488,increased startle reflex|MP:0001925,male infertility|MP:0002092,abnormal eye morphology|MP:0009142,decreased prepulse inhibition
MGI:7311754	Irgc<em1Osb>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0009239,short sperm flagellum|MP:0020451,decreased sperm progressive motility|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0030976,impaired sperm penetration of zona pellucida
MGI:6153372	Irgm1<em1(IMPC)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0000208,decreased hematocrit|MP:0002092,abnormal eye morphology|MP:0002599,increased mean platelet volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0003960,increased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level|MP:0013278,decreased fasting circulating glucose level
MGI:3027112	Irgm1<tm1Gat>	MP:0002412,increased susceptibility to bacterial infection|MP:0005027,increased susceptibility to parasitic infection|MP:0005387,immune system phenotype|MP:0008577,increased circulating interferon-gamma level|MP:0008617,increased circulating interleukin-12 level
MGI:5775779	Irgm2<em1(IMPC)J>	MP:0001284,absent vibrissae|MP:0001303,abnormal lens morphology|MP:0001486,abnormal startle reflex|MP:0001510,abnormal coat appearance|MP:0002060,abnormal skin morphology|MP:0005419,decreased circulating serum albumin level|MP:0020870,decreased thigmotaxis
MGI:6784010	Irgm2<em1Myam>	MP:0005027,increased susceptibility to parasitic infection|MP:0010750,increased susceptibility to parasitic infection induced morbidity/mortality
MGI:7331504	Irgq<em1(IMPC)J>	MP:0005333,decreased heart rate|MP:0005635,decreased circulating bilirubin level|MP:0010506,prolonged RR interval
MGI:6273950	Irs1<em1(IMPC)H>	MP:0011100,preweaning lethality, complete penetrance|MP:0020421,increased freezing behavior
MGI:6268718	Irs1<m1Btlr>	MP:0001262,decreased body weight|MP:0002079,increased circulating insulin level
MGI:6268722	Irs1<m2Btlr>	MP:0001262,decreased body weight
MGI:5792013	Irs1<mpc178H>	MP:0000063,decreased bone mineral density|MP:0001732,postnatal growth retardation
MGI:3639880	Irs1<Sml>	MP:0000063,decreased bone mineral density|MP:0000559,abnormal femur morphology|MP:0000589,thin tail|MP:0000592,short tail|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002079,increased circulating insulin level|MP:0002111,abnormal tail morphology|MP:0002896,abnormal bone mineralization|MP:0003109,short femur|MP:0003795,abnormal bone structure|MP:0004984,increased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005459,decreased percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0006396,decreased long bone epiphyseal plate size|MP:0008974,proportional dwarf|MP:0009346,decreased trabecular bone thickness|MP:0010025,decreased total body fat amount|MP:0011711,impaired osteoblast differentiation|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0030439,decreased osteoblast proliferation
MGI:4837622	Irs1<smla>	MP:0001265,decreased body size|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0010768,mortality/aging
MGI:2136455	Irs1<tm1Jos>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002079,increased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005390,skeleton phenotype|MP:0005391,vision/eye phenotype|MP:0009674,decreased birth weight
MGI:3803962	Irs1<tm1Mfw>	MP:0005293,impaired glucose tolerance
MGI:2136643	Irs1<tm1Tka>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000167,decreased chondrocyte number|MP:0000186,decreased circulating HDL cholesterol level|MP:0000231,hypertension|MP:0000352,decreased cell proliferation|MP:0001262,decreased body weight|MP:0001541,abnormal osteoclast physiology|MP:0001547,abnormal lipid level|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001732,postnatal growth retardation|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002764,short tibia|MP:0002999,abnormal bone healing|MP:0003059,decreased insulin secretion|MP:0003109,short femur|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004201,fetal growth retardation|MP:0004883,abnormal vascular wound healing|MP:0004989,decreased osteoblast cell number|MP:0005006,abnormal osteoblast physiology|MP:0005076,abnormal cell differentiation|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005591,decreased vasodilation|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0006396,decreased long bone epiphyseal plate size|MP:0008033,impaired lipolysis|MP:0008396,abnormal osteoclast differentiation|MP:0009431,decreased fetal weight|MP:0010124,decreased bone mineral content|MP:0020010,decreased bone mineral density of femur
MGI:4430350	Irs1<tm2.1Mfw>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002079,increased circulating insulin level|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance
MGI:3803974	Irs1<tm2Tka>	MP:0002079,increased circulating insulin level|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype
MGI:4430351	Irs1<tm3.1Mfw>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0001262,decreased body weight
MGI:6268726	Irs2<M1Btlr>	MP:0001559,hyperglycemia|MP:0003058,increased insulin secretion
MGI:3713784	Irs2<tm1.1With>	MP:0001130,abnormal ovarian folliculogenesis|MP:0001131,abnormal ovarian follicle morphology|MP:0001132,absent mature ovarian follicles|MP:0002679,abnormal corpus luteum morphology|MP:0009433,polyovular ovarian follicle|MP:0011129,decreased tertiary ovarian follicle number|MP:0031018,decreased granulosa cell proliferation|MP:0031239,increased atretic ovarian follicle number
MGI:2158686	Irs2<tm1Mfw>	MP:0000188,abnormal circulating glucose level|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001131,abnormal ovarian follicle morphology|MP:0001134,absent corpus luteum|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001426,polydipsia|MP:0001433,polyphagia|MP:0001559,hyperglycemia|MP:0001560,abnormal circulating insulin level|MP:0001762,polyuria|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002773,decreased circulating luteinizing hormone level|MP:0002780,decreased circulating testosterone level|MP:0003339,decreased pancreatic beta cell number|MP:0005121,decreased circulating prolactin level|MP:0005181,decreased circulating estradiol level|MP:0005185,decreased circulating progesterone level|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005361,small pituitary gland|MP:0005418,abnormal circulating hormone level|MP:0005431,decreased oocyte number|MP:0005448,abnormal energy homeostasis|MP:0005669,increased circulating leptin level|MP:0006071,abnormal retina progenitor cell morphology|MP:0008335,decreased gonadotroph cell number|MP:0008368,small pituitary intermediate lobe|MP:0008450,retina photoreceptor degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment|MP:0008869,anovulation|MP:0009009,absent estrous cycle|MP:0009114,decreased pancreatic beta cell mass|MP:0009172,small pancreatic islets|MP:0009703,decreased birth body size|MP:0010024,increased total body fat amount|MP:0010399,decreased skeletal muscle glycogen level|MP:0011125,decreased primary ovarian follicle number|MP:0011965,decreased total retina thickness|MP:0014602,decreased female mating frequency|MP:0031422,failure of superovulation
MGI:2429574	Irs2<tm1Tka>	MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001556,increased circulating HDL cholesterol level|MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0003058,increased insulin secretion|MP:0004883,abnormal vascular wound healing|MP:0005076,abnormal cell differentiation|MP:0005178,increased circulating cholesterol level|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005378,growth/size/body region phenotype|MP:0005591,decreased vasodilation|MP:0006144,increased systemic arterial systolic blood pressure|MP:0009114,decreased pancreatic beta cell mass
MGI:3576079	Irs2<tm1With>	MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001433,polyphagia|MP:0002079,increased circulating insulin level|MP:0002169,no abnormal phenotype detected|MP:0003339,decreased pancreatic beta cell number|MP:0003970,abnormal prolactin level|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0009006,prolonged estrous cycle|MP:0009011,prolonged diestrus|MP:0009113,increased pancreatic beta cell mass|MP:0010024,increased total body fat amount
MGI:3497903	Irs2<tm2Mfw>	MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001426,polydipsia|MP:0001433,polyphagia|MP:0002075,abnormal coat/hair pigmentation|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0010024,increased total body fat amount|MP:0011939,increased food intake|MP:0013279,increased fasting circulating glucose level|MP:0020234,decreased basal metabolism
MGI:3497742	Irs2<tm2Tka>	MP:0001260,increased body weight|MP:0001261,obese|MP:0001552,increased circulating triglyceride level|MP:0002079,increased circulating insulin level|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0009114,decreased pancreatic beta cell mass|MP:0009288,increased epididymal fat pad weight|MP:0014441,decreased response to leptin
MGI:2149647	Irs3<tm1Lhd>	MP:0002169,no abnormal phenotype detected
MGI:5705105	Irs4<tm1.1Mfw>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0005559,increased circulating glucose level|MP:0010768,mortality/aging
MGI:2149726	Irs4<tm1Lhd>	MP:0001262,decreased body weight|MP:0001386,abnormal maternal nurturing|MP:0001732,postnatal growth retardation|MP:0001935,decreased litter size|MP:0002161,abnormal fertility/fecundity|MP:0005291,abnormal glucose tolerance|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005560,decreased circulating glucose level
MGI:5634290	Irx1<tm1.1(KOMP)Vlcg>	MP:0000428,abnormal craniofacial morphology|MP:0001402,decreased locomotor activity|MP:0001697,abnormal embryo size|MP:0003257,abnormal abdominal wall morphology|MP:0003984,embryonic growth retardation|MP:0005627,increased circulating potassium level|MP:0011100,preweaning lethality, complete penetrance|MP:0020870,decreased thigmotaxis
MGI:4399218	Irx1<tm1(KOMP)Vlcg>	MP:0000116,abnormal tooth development|MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002314,abnormal respiratory mechanics|MP:0003641,small lung|MP:0005359,growth retardation of incisors|MP:0009546,absent gastric milk in neonates|MP:0010993,decreased surfactant secretion|MP:0011087,neonatal lethality, complete penetrance|MP:0030080,small lower incisors|MP:0030089,short lower incisors|MP:0030136,abnormal lower incisor morphology|MP:0030453,abnormal odontoblast morphology|MP:0030471,abnormal ameloblast differentiation|MP:0030508,abnormal dental epithelium morphology|MP:0030518,abnormal outer dental epithelium morphology|MP:0030523,abnormal stratum intermedium morphology
MGI:2681629	Irx2<tm1Hui>	MP:0002169,no abnormal phenotype detected
MGI:6155634	Irx3<em2(IMPC)H>	MP:0000443,abnormal snout morphology|MP:0001312,abnormal cornea morphology|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content|MP:0013278,decreased fasting circulating glucose level
MGI:4882110	Irx3<tm1Hui>	MP:0001262,decreased body weight|MP:0002891,increased insulin sensitivity|MP:0003898,abnormal QRS complex|MP:0004116,abnormal atrioventricular bundle conduction|MP:0004889,increased energy expenditure|MP:0005292,improved glucose tolerance|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005670,abnormal white adipose tissue physiology|MP:0009269,decreased fat cell size|MP:0010392,prolonged QRS complex duration|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0011919,abnormal R wave|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:2180895	Irx4<tm1Jse>	MP:0000274,enlarged heart|MP:0002625,heart left ventricle hypertrophy|MP:0002795,dilated cardiomyopathy|MP:0005330,cardiomyopathy|MP:0005598,decreased heart ventricle muscle contractility|MP:0008727,increased heart right atrium size|MP:0011917,increased heart right atrium weight
MGI:3610374	Irx5<tm1Hui>	MP:0001265,decreased body size|MP:0005287,narrow eye opening|MP:0006075,abnormal retina cone bipolar cell morphology
MGI:6120760	Irx6<tm1b(KOMP)Mbp>	MP:0000598,abnormal liver morphology|MP:0001566,increased circulating phosphate level|MP:0002059,abnormal seminal vesicle morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0011239,abnormal skin coloration
MGI:5448232	Irx6<tm1Chow>	MP:0003734,abnormal retina inner plexiform layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0006073,abnormal retina bipolar cell morphology
MGI:4360978	Is(17;In2)1Gso	MP:0000519,hydronephrosis|MP:0000520,absent kidney|MP:0000536,hydroureter|MP:0000552,abnormal radius morphology|MP:0000553,absent radius|MP:0000554,abnormal carpal bone morphology|MP:0000555,absent carpal bone|MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0000566,synostosis|MP:0001922,reduced male fertility|MP:0002109,abnormal limb morphology|MP:0002115,abnormal limb bone morphology|MP:0002135,abnormal kidney morphology|MP:0002187,abnormal fibula morphology|MP:0002544,brachydactyly|MP:0003446,renal hypoplasia|MP:0003586,dilated ureter|MP:0005108,abnormal ulna morphology|MP:0005353,abnormal patella morphology|MP:0005409,darkened coat color|MP:0005430,absent fibula|MP:0008730,fused phalanges|MP:0008915,fused carpal bones|MP:0008919,fused tarsal bones|MP:0009729,absent tarsus bones|MP:0014320,abnormal autopod rotation
MGI:5585595	Isca1<tm1b(KOMP)Wtsi>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002757,decreased vertical activity|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014586,decreased egg cylinder size
MGI:3813096	Iscu<tm1(KOMP)Vlcg>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:3586990	Isg15<tm1Kpk>	MP:0000135,decreased compact bone thickness|MP:0004991,decreased bone strength|MP:0005387,immune system phenotype|MP:0010879,decreased trabecular bone volume|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization
MGI:7645451	Isg20<em1Cya>	MP:0001859,kidney inflammation|MP:0004041,increased susceptibility to kidney reperfusion injury|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level
MGI:1861689	Is(In8B2-8B3.1;6C1)1Tshir	MP:0000161,scoliosis|MP:0000428,abnormal craniofacial morphology|MP:0000440,domed cranium|MP:0000558,abnormal tibia morphology|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002544,brachydactyly|MP:0002764,short tibia|MP:0003048,abnormal cervical vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003139,patent ductus arteriosus|MP:0004337,clavicle hypoplasia|MP:0004600,abnormal vertebral transverse process morphology|MP:0004606,absent vertebral spinous process|MP:0004617,sacral vertebral transformation|MP:0005367,renal/urinary system phenotype|MP:0005508,abnormal skeleton morphology|MP:0006253,clinodactyly|MP:0006279,abnormal limb development|MP:0008829,triphalangia|MP:0008985,hemimelia|MP:0009743,preaxial polydactyly|MP:0010402,ventricular septal defect|MP:0010772,abnormal pollex morphology|MP:0012528,abnormal zone of polarizing activity morphology|MP:0030112,zygomatic bone hypoplasia|MP:0030835,abnormal ankle joint morphology
MGI:5523699	Isl1<Drsh>	MP:0000029,abnormal malleus morphology|MP:0001850,increased susceptibility to otitis media|MP:0003740,fusion of middle ear ossicles|MP:0005377,hearing/vestibular/ear phenotype|MP:0006018,abnormal tympanic membrane morphology|MP:0006325,impaired hearing|MP:0006358,absent pinna reflex|MP:0011092,embryonic lethality, complete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0030160,abnormal auditory bulla morphology|MP:0030410,middle ear effusion|MP:0030419,excessive cerumen
MGI:3837972	Isl1<tm1.1Whk>	MP:0001297,microphthalmia|MP:0001330,abnormal optic nerve morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0005391,vision/eye phenotype|MP:0006073,abnormal retina bipolar cell morphology|MP:0006219,optic nerve degeneration|MP:0006309,decreased retina ganglion cell number|MP:0008056,abnormal retina ganglion cell morphology|MP:0008106,decreased amacrine cell number|MP:0008511,thin retina inner nuclear layer|MP:0008513,thin retina inner plexiform layer|MP:0030005,increased retina apoptosis
MGI:3837978	Isl1<tm1.2Whk>	MP:0011100,preweaning lethality, complete penetrance
MGI:2182246	Isl1<tm1Tmj>	MP:0000267,abnormal heart development|MP:0000277,abnormal heart shape|MP:0000937,abnormal motor neuron morphology|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0001944,abnormal pancreas morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003105,abnormal heart atrium morphology|MP:0003872,absent heart right ventricle|MP:0004100,abnormal spinal cord interneuron morphology|MP:0004251,failure of heart looping|MP:0004787,abnormal dorsal aorta morphology|MP:0005215,abnormal pancreatic islet morphology|MP:0006055,abnormal vascular endothelial cell morphology|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009178,absent pancreatic alpha cells|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011265,abnormal pancreas mesenchyme morphology|MP:0012179,abnormal splanchnic mesoderm morphology|MP:0012703,decreased embryonic neuroepithelium thickness|MP:0013241,embryo tissue necrosis|MP:0013349,small Rathke's pouch|MP:0013351,abnormal Rathke's pouch development|MP:0014044,absent cardiac outflow tract
MGI:3797783	Isl1<tm2Gan>	MP:0001332,abnormal optic nerve innervation|MP:0004267,abnormal optic tract morphology|MP:0006221,optic nerve hypoplasia|MP:0008067,retina ganglion cell degeneration
MGI:3817457	Isl1<tm2Sev>	MP:0000965,abnormal sensory neuron morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:4418967	Isl1<tm3Sev>	MP:0002169,no abnormal phenotype detected
MGI:2447837	Isl2<tm1Arbr>	MP:0000937,abnormal motor neuron morphology
MGI:3056440	Isl2<tm1(Epha3)Grl>	MP:0002169,no abnormal phenotype detected
MGI:3797782	Isl2<tm1Gan>	MP:0002169,no abnormal phenotype detected
MGI:3046260	Isl2<tm2Slp>	MP:0000937,abnormal motor neuron morphology|MP:0001270,distended abdomen|MP:0002184,abnormal innervation|MP:0002948,abnormal neuron specification|MP:0011087,neonatal lethality, complete penetrance
MGI:3767806	Isl2<tm3.1(Mnx1-Lhx3)Slp>	MP:0000937,abnormal motor neuron morphology|MP:0000940,abnormal motor neuron innervation pattern|MP:0001953,respiratory failure|MP:0005404,abnormal axon morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:4413447	Islr2<tm1.1Ddg>	MP:0000937,abnormal motor neuron morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002081,perinatal lethality|MP:0002152,abnormal brain morphology|MP:0002882,abnormal neuron morphology|MP:0005404,abnormal axon morphology|MP:0008129,absent brain internal capsule|MP:0008415,abnormal neurite morphology|MP:0008948,decreased neuron number|MP:0009970,increased hippocampus pyramidal cell number
MGI:7425762	Islr<em1(IMPC)Hmgu>	MP:0009709,hydrometra
MGI:6119548	Islr<tm1b(EUCOMM)Wtsi>	MP:0002398,abnormal bone marrow cell morphology/development|MP:0004357,long tibia|MP:0004852,decreased testis weight|MP:0004986,abnormal osteoblast morphology|MP:0004988,increased osteoblast cell number|MP:0005390,skeleton phenotype|MP:0005397,hematopoietic system phenotype|MP:0008489,slow postnatal weight gain|MP:0008951,long radius|MP:0010924,abnormal osteoid morphology|MP:0010926,increased osteoid volume
MGI:6827291	Ism1<em1.1Kajs>	MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype
MGI:7425763	Ism1<em1(IMPC)Ccpcz>	MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001325,abnormal retina morphology|MP:0001529,abnormal vocalization|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002953,thick ventricular wall|MP:0002989,small kidney|MP:0003604,single kidney|MP:0003917,increased kidney weight|MP:0003961,decreased lean body mass|MP:0004924,abnormal behavior|MP:0005292,improved glucose tolerance|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008259,abnormal optic disk morphology|MP:0010935,increased airway resistance
MGI:6331113	Ist1<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response|MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance
MGI:3703167	Isx<tm1Shiv>	MP:0002169,no abnormal phenotype detected
MGI:6384859	Isy1<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0001728,failure of embryo implantation|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012058,abnormal morula morphology|MP:0013292,embryonic lethality prior to organogenesis
MGI:6257466	Isyna1<em1(IMPC)Bay>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0000564,syndactyly|MP:0001691,abnormal somite shape|MP:0001700,abnormal embryo turning|MP:0001718,abnormal visceral yolk sac morphology|MP:0001722,pale yolk sac|MP:0002080,prenatal lethality|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0002861,abnormal tail bud morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003720,abnormal neural tube closure|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1856612	It	MP:0000116,abnormal tooth development|MP:0001935,decreased litter size|MP:0004790,absent upper incisors|MP:0004791,absent lower incisors|MP:0005358,abnormal incisor morphology|MP:0008770,decreased survivor rate|MP:0011092,embryonic lethality, complete penetrance|MP:0030080,small lower incisors
MGI:3716202	ita	MP:0001284,absent vibrissae|MP:0001386,abnormal maternal nurturing|MP:0001923,reduced female fertility|MP:0003815,hairless
MGI:5563090	Itch<tm1.1Alta>	MP:0000218,increased leukocyte cell number|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001194,dermatitis|MP:0001212,skin lesions|MP:0001263,weight loss|MP:0001846,increased inflammatory response|MP:0001861,lung inflammation|MP:0002083,premature death|MP:0002221,abnormal lymph organ size|MP:0002401,abnormal lymphopoiesis|MP:0002490,abnormal immunoglobulin level|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0004946,abnormal regulatory T cell physiology|MP:0004973,increased regulatory T cell number|MP:0005011,increased eosinophil cell number|MP:0005387,immune system phenotype|MP:0005466,abnormal T-helper 2 physiology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008499,increased IgG1 level|MP:0008568,abnormal interleukin secretion|MP:0008660,increased interleukin-10 secretion|MP:0008672,increased interleukin-13 secretion|MP:0008681,increased interleukin-17 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion|MP:0012188,increased regulatory T cell apoptosis
MGI:5692595	Itch<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000194,increased circulating calcium level|MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000467,abnormal esophagus morphology|MP:0000691,enlarged spleen|MP:0000745,tremors|MP:0001417,decreased exploration in new environment|MP:0001486,abnormal startle reflex|MP:0001566,increased circulating phosphate level|MP:0002100,abnormal tooth morphology|MP:0002591,decreased mean corpuscular volume|MP:0002606,increased basophil cell number|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003068,enlarged kidney|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0004952,increased spleen weight|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005560,decreased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0005568,increased circulating total protein level|MP:0008806,increased circulating amylase level|MP:0009342,enlarged gallbladder|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level|MP:0010124,decreased bone mineral content|MP:0011496,abnormal head size|MP:0012362,increased large unstained cell number|MP:0013278,decreased fasting circulating glucose level
MGI:4839139	Itch<tm1(NCOM)Cmhd>	MP:0002590,increased mean corpuscular volume
MGI:6111974	Itfg2<em1(IMPC)J>	MP:0004222,iris synechia|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4235940	Itfg2<Gt(OST215121)Lex>	MP:0000693,spleen hyperplasia|MP:0001800,abnormal humoral immune response|MP:0002492,decreased IgE level|MP:0005014,increased B cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0008217,abnormal B cell activation|MP:0008482,decreased spleen germinal center number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0009333,abnormal splenocyte physiology|MP:0010187,decreased T follicular helper cell number
MGI:3574026	Itga10<tm1Ref>	MP:0000164,abnormal cartilage development|MP:0002764,short tibia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003409,decreased width of hypertrophic chondrocyte zone
MGI:6257665	Itga11<em1(IMPC)H>	MP:0000745,tremors|MP:0002100,abnormal tooth morphology|MP:0005560,decreased circulating glucose level|MP:0013278,decreased fasting circulating glucose level
MGI:6114060	Itga11<m1Btlr>	MP:0001262,decreased body weight
MGI:3714472	Itga11<tm1Dgul>	MP:0000352,decreased cell proliferation|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002100,abnormal tooth morphology|MP:0002576,abnormal enamel morphology|MP:0002818,abnormal dentin morphology|MP:0003053,delayed tooth eruption|MP:0003668,abnormal periodontal ligament morphology|MP:0004830,short incisors|MP:0005358,abnormal incisor morphology|MP:0005449,abnormal food intake|MP:0014698,decreased fibroblast adhesion|MP:0030460,enamel pits|MP:0030509,increased number of epithelial cell rests of Malassez
MGI:2451067	Itga1<tm1Gdnr>	MP:0002965,increased circulating serum albumin level|MP:0005165,increased susceptibility to injury|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005553,increased circulating creatinine level|MP:0008140,podocyte foot process effacement|MP:0011353,expanded mesangial matrix|MP:0011369,increased renal glomerulus apoptosis|MP:0011430,mesangiolysis
MGI:2670210	Itga2b<tm1(GFP/cre)Emam>	MP:0001577,anemia|MP:0002123,abnormal definitive hematopoiesis|MP:0003179,thrombocytopenia|MP:0003396,abnormal embryonic hematopoiesis|MP:0004809,increased hematopoietic stem cell number|MP:0005464,abnormal platelet physiology|MP:0014696,decreased cell adhesion
MGI:3717592	Itga2b<tm1Graf>	MP:0003179,thrombocytopenia|MP:0005389,reproductive system phenotype|MP:0006298,abnormal platelet activation
MGI:2385793	Itga2b<tm1Tlr>	MP:0000465,gastrointestinal hemorrhage|MP:0000691,enlarged spleen|MP:0001634,internal hemorrhage|MP:0001914,hemorrhage|MP:0002551,abnormal blood coagulation|MP:0002875,decreased erythrocyte cell number|MP:0005389,reproductive system phenotype|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0006298,abnormal platelet activation|MP:0009548,abnormal platelet aggregation|MP:0009549,decreased platelet aggregation|MP:0009676,abnormal hemostasis|MP:0014060,abnormal platelet alpha-granule morphology|MP:0031152,subcutaneous hemorrhage
MGI:2675420	Itga2<tm1.1Eck>	MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology|MP:0009548,abnormal platelet aggregation|MP:0009549,decreased platelet aggregation|MP:0014697,abnormal fibroblast adhesion|MP:0030578,decreased keratinocyte adhesion
MGI:5433752	Itga2<tm1.1Tkun>	MP:0002169,no abnormal phenotype detected|MP:0005464,abnormal platelet physiology|MP:0008935,decreased mean platelet volume|MP:0009549,decreased platelet aggregation
MGI:5548946	Itga2<tm1b(EUCOMM)Hmgu>	MP:0000745,tremors
MGI:2675418	Itga2<tm1Eck>	MP:0002169,no abnormal phenotype detected
MGI:2183401	Itga2<tm1Ztr>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0005464,abnormal platelet physiology|MP:0014696,decreased cell adhesion
MGI:7377676	Itga3<em1(IMPC)Mbp>	MP:0000428,abnormal craniofacial morphology|MP:0001711,abnormal placenta morphology|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0011100,preweaning lethality, complete penetrance
MGI:3833130	Itga3<tm1Hap>	MP:0001179,thick pulmonary interalveolar septum|MP:0003631,nervous system phenotype|MP:0004202,pulmonary hyperplasia|MP:0006050,pulmonary fibrosis|MP:0010810,increased type II pneumocyte number|MP:0010896,decreased lung compliance
MGI:1857792	Itga3<tm1Jak>	MP:0001429,dehydration|MP:0002989,small kidney|MP:0003675,kidney cyst|MP:0004754,abnormal kidney collecting duct morphology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004757,abnormal distal convoluted tubule morphology|MP:0005326,abnormal podocyte morphology|MP:0008138,absent podocyte foot process|MP:0010897,abnormal bronchiole epithelium morphology|MP:0011028,impaired branching involved in bronchus morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011359,decreased glomerular capillary number|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011509,dilated glomerular capillary|MP:0011846,decreased kidney collecting duct number
MGI:3843044	Itga3<tm1Rdav>	MP:0001473,reduced long-term potentiation|MP:0014370,impaired spatial working memory
MGI:3691084	Itga3<tm1Son>	MP:0000414,alopecia|MP:0001200,thick skin|MP:0001208,blistering|MP:0001785,edema|MP:0002724,enhanced wound healing|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0004947,skin inflammation|MP:0004969,pale kidney|MP:0005264,glomerulosclerosis|MP:0008140,podocyte foot process effacement|MP:0009050,dilated proximal convoluted tubule|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011402,renal cast|MP:0011409,increased renal glomerulus basement membrane thickness
MGI:1857206	Itga4<tm1Hyn>	MP:0000428,abnormal craniofacial morphology|MP:0001711,abnormal placenta morphology|MP:0001726,abnormal allantois morphology|MP:0002127,abnormal cardiovascular system morphology|MP:0004557,dilated allantois|MP:0009657,failure of chorioallantoic fusion|MP:0009698,heart hemorrhage|MP:0010551,abnormal coronary vessel morphology|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0031590,abnormal epicardium development
MGI:2180843	Itga4<tm1Jty>	MP:0009657,failure of chorioallantoic fusion|MP:0009698,heart hemorrhage|MP:0010555,absent epicardium|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0031590,abnormal epicardium development
MGI:4354168	Itga4<tm1Leg>	MP:0005621,abnormal cell physiology
MGI:3620620	Itga4<tm1Mgin>	MP:0000223,decreased monocyte cell number|MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0003799,impaired macrophage chemotaxis|MP:0003945,abnormal lymphocyte physiology|MP:0005621,abnormal cell physiology|MP:0008133,decreased Peyer's patch number
MGI:3830623	Itga4<tm1Mshi>	MP:0003156,abnormal leukocyte migration|MP:0003628,abnormal leukocyte adhesion|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008135,small Peyer's patches|MP:0008247,abnormal mononuclear cell morphology|MP:0009858,abnormal cellular extravasation
MGI:2684111	Itga4<tm1Tpa>	MP:0000218,increased leukocyte cell number|MP:0002123,abnormal definitive hematopoiesis|MP:0002144,abnormal B cell differentiation|MP:0002414,abnormal myeloblast morphology/development|MP:0002424,abnormal reticulocyte morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:1857207	Itga5<tm1Hyn>	MP:0001614,abnormal blood vessel morphology|MP:0001689,incomplete somite formation|MP:0001701,incomplete embryo turning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0004787,abnormal dorsal aorta morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005384,cellular phenotype|MP:0006323,abnormal extraembryonic mesoderm development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012173,short rostral-caudal axis|MP:0012183,decreased paraxial mesoderm size
MGI:4818933	Itga5<tm2.1Hyn>	MP:0001614,abnormal blood vessel morphology|MP:0001689,incomplete somite formation|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4818931	Itga5<tm2Hyn>	MP:0000788,abnormal cerebral cortex morphology|MP:0003139,patent ductus arteriosus|MP:0006009,abnormal neuronal migration|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3829393	Itga6<Gt(LST045)Byg>	MP:0005377,hearing/vestibular/ear phenotype
MGI:1857793	Itga6<tm1Egl>	MP:0000452,abnormal mouth morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0001191,abnormal skin condition|MP:0002152,abnormal brain morphology|MP:0002699,abnormal vitreous body morphology|MP:0004272,abnormal basement membrane morphology|MP:0006303,abnormal retina nerve fiber layer morphology|MP:0008442,disorganized cortical plate|MP:0011089,perinatal lethality, complete penetrance|MP:0030956,abnormal neuronal precursor cell migration
MGI:3050562	Itga6<tm1Son>	MP:0002339,abnormal lymph node morphology|MP:0002444,abnormal T cell physiology|MP:0005018,decreased T cell number
MGI:5563091	Itga6<tm2.1Egl>	MP:0001208,blistering|MP:0011089,perinatal lethality, complete penetrance
MGI:4439081	Itga6<tm2Egl>	MP:0000920,abnormal myelination|MP:0002651,abnormal sciatic nerve morphology|MP:0003721,increased tumor growth/size|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0005601,increased angiogenesis|MP:0010050,hypermyelination|MP:0010144,abnormal tumor vascularization|MP:0010768,mortality/aging|MP:0011730,increased myelin sheath thickness|MP:0011731,decreased myelin sheath thickness|MP:0011904,abnormal Schwann cell physiology
MGI:3512077	Itga7<tm1Burk>	MP:0000160,kyphosis|MP:0000751,myopathy|MP:0001614,abnormal blood vessel morphology|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002279,abnormal diaphragm morphology|MP:0002975,vascular smooth muscle hypertrophy|MP:0003852,skeletal muscle necrosis|MP:0005489,vascular smooth muscle hyperplasia|MP:0005592,abnormal vascular smooth muscle morphology|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:2153005	Itga7<tm1Umr>	MP:0000749,muscle degeneration|MP:0000752,dystrophic muscle|MP:0000759,abnormal skeletal muscle morphology|MP:0002279,abnormal diaphragm morphology|MP:0003081,abnormal soleus morphology|MP:0009399,increased skeletal muscle fiber size|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009413,skeletal muscle fiber atrophy|MP:0010090,increased circulating creatine kinase level|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011904,abnormal Schwann cell physiology
MGI:4948106	Itga8<tm1.1Rdav>	MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0005386,behavior/neurological phenotype
MGI:5509056	Itga8<tm1b(KOMP)Wtsi>	MP:0000194,increased circulating calcium level|MP:0001554,increased circulating free fatty acids level|MP:0002590,increased mean corpuscular volume|MP:0005560,decreased circulating glucose level|MP:0005633,increased circulating sodium level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2181699	Itga8<tm1Lfr>	MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000534,abnormal ureter morphology|MP:0001516,abnormal motor coordination/balance|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003091,abnormal cell migration|MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0003604,single kidney|MP:0003672,abnormal ureter development|MP:0003722,absent ureter|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004516,fused vestibular hair cell stereocilia|MP:0004517,decreased vestibular hair cell stereocilia number|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005367,renal/urinary system phenotype|MP:0010818,adhesive atelectasis|MP:0010825,abnormal lung saccule morphology|MP:0010856,dilated respiratory conducting tube|MP:0010977,fused right lung lobes|MP:0010983,abnormal ureteric bud invasion|MP:0011011,impaired lung lobe morphogenesis|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014696,decreased cell adhesion
MGI:2386308	Itga9<tm1Des>	MP:0001732,postnatal growth retardation|MP:0001952,increased airway responsiveness|MP:0001954,respiratory distress|MP:0003659,abnormal lymph circulation|MP:0003660,chylothorax|MP:0011085,postnatal lethality, complete penetrance
MGI:3832228	Itga9<tm2Des>	MP:0001952,increased airway responsiveness|MP:0002132,abnormal respiratory system morphology|MP:0002133,abnormal respiratory system physiology|MP:0002169,no abnormal phenotype detected|MP:0005023,abnormal wound healing|MP:0005388,respiratory system phenotype|MP:0005391,vision/eye phenotype|MP:0005543,decreased cornea thickness|MP:0006000,abnormal cornea epithelium morphology|MP:0020855,decreased cornea epithelium thickness
MGI:3810325	Itgad<tm1.1Zimm>	MP:0001790,abnormal immune system physiology|MP:0001793,abnormal susceptibility to infection|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0004952,increased spleen weight|MP:0005026,decreased susceptibility to parasitic infection|MP:0008617,increased circulating interleukin-12 level
MGI:3579559	Itgad<tm1Bll>	MP:0000717,abnormal lymphocyte cell number|MP:0001828,abnormal T cell activation|MP:0003944,abnormal T cell subpopulation ratio|MP:0005095,decreased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:5636943	Itgae<tm1b(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0003961,decreased lean body mass|MP:0005016,decreased lymphocyte cell number|MP:0012361,decreased large unstained cell number
MGI:2136817	Itgae<tm1Cmp>	MP:0005016,decreased lymphocyte cell number|MP:0005018,decreased T cell number
MGI:6750905	Itgal<em1(IMPC)H>	MP:0002941,increased circulating alanine transaminase level|MP:0004952,increased spleen weight|MP:0005343,increased circulating aspartate transaminase level
MGI:4888587	Itgal<tm1.1Mshi>	MP:0002217,small lymph nodes|MP:0003156,abnormal leukocyte migration|MP:0003628,abnormal leukocyte adhesion|MP:0005016,decreased lymphocyte cell number|MP:0020333,enhanced leukocyte tethering or rolling|MP:0030960,abnormal diapedesis
MGI:2661083	Itgal<tm1Bll>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0001845,abnormal inflammatory response|MP:0002463,abnormal neutrophil physiology|MP:0003156,abnormal leukocyte migration|MP:0003627,abnormal leukocyte tethering or rolling|MP:0003628,abnormal leukocyte adhesion|MP:0005011,increased eosinophil cell number|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005095,decreased T cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0009858,abnormal cellular extravasation
MGI:3582587	Itgal<tm1Hlz>	MP:0000222,decreased neutrophil cell number|MP:0000693,spleen hyperplasia|MP:0001800,abnormal humoral immune response|MP:0001828,abnormal T cell activation|MP:0003628,abnormal leukocyte adhesion|MP:0005016,decreased lymphocyte cell number|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0009858,abnormal cellular extravasation
MGI:2655183	Itgal<tm1Hogg>	MP:0000691,enlarged spleen|MP:0002217,small lymph nodes|MP:0002339,abnormal lymph node morphology|MP:0003156,abnormal leukocyte migration|MP:0003628,abnormal leukocyte adhesion|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:2181378	Itgal<tm1Mak>	MP:0003179,thrombocytopenia|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0008553,increased circulating tumor necrosis factor level|MP:0008593,increased circulating interleukin-10 level|MP:0008599,increased circulating interleukin-2 level|MP:0008734,decreased susceptibility to endotoxin shock
MGI:2429755	Itgal<tm1Wpfl>	MP:0001272,increased metastatic potential|MP:0002442,abnormal leukocyte physiology|MP:0003945,abnormal lymphocyte physiology|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005387,immune system phenotype|MP:0008102,lymph node hyperplasia
MGI:6153373	Itgam<em1(IMPC)Wtsi>	MP:0005561,increased mean corpuscular hemoglobin
MGI:5806334	Itgam<m1Btlr>	MP:0000222,decreased neutrophil cell number|MP:0001606,impaired hematopoiesis|MP:0003884,decreased macrophage cell number|MP:0008125,abnormal dendritic cell number|MP:0008524,increased plasmacytoid dendritic cell number
MGI:6285545	Itgam<m2Btlr>	MP:0013649,decreased CD11b-high dendritic cell number
MGI:6285549	Itgam<m3Btlr>	MP:0013649,decreased CD11b-high dendritic cell number
MGI:2157556	Itgam<tm1Bll>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000717,abnormal lymphocyte cell number|MP:0001828,abnormal T cell activation|MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0002467,impaired neutrophil phagocytosis|MP:0003156,abnormal leukocyte migration|MP:0003628,abnormal leukocyte adhesion|MP:0003944,abnormal T cell subpopulation ratio|MP:0005012,decreased eosinophil cell number|MP:0005095,decreased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0009858,abnormal cellular extravasation
MGI:1931533	Itgam<tm1Myd>	MP:0000219,increased neutrophil cell number|MP:0000222,decreased neutrophil cell number|MP:0001845,abnormal inflammatory response|MP:0002463,abnormal neutrophil physiology|MP:0002467,impaired neutrophil phagocytosis|MP:0003628,abnormal leukocyte adhesion|MP:0005011,increased eosinophil cell number|MP:0005065,abnormal neutrophil morphology|MP:0006043,decreased apoptosis|MP:0006058,decreased cerebral infarct size|MP:0009642,abnormal blood homeostasis|MP:0020332,impaired leukocyte tethering or rolling
MGI:3027319	Itgam<tm1Rws>	MP:0002451,abnormal macrophage physiology|MP:0003566,abnormal cell adhesion
MGI:1857889	Itgav<tm1Hyn>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000295,trabecula carnea hypoplasia|MP:0000433,microcephaly|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001787,pericardial edema|MP:0001891,hydrocephaly|MP:0001914,hemorrhage|MP:0001916,intracerebral hemorrhage|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002088,abnormal embryonic growth/weight/body size|MP:0002652,thin myocardium|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0003935,abnormal craniofacial development|MP:0003984,embryonic growth retardation|MP:0005031,abnormal trophoblast layer morphology|MP:0006346,small pharyngeal arch|MP:0009655,abnormal secondary palate development|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011521,decreased placental labyrinth size|MP:0031154,intestinal hemorrhage
MGI:3759837	Itgav<tm2.1Hyn>	MP:0001916,intracerebral hemorrhage
MGI:5806337	Itgax<M1Btlr>	MP:0001606,impaired hematopoiesis|MP:0008127,decreased dendritic cell number|MP:0008524,increased plasmacytoid dendritic cell number
MGI:4822468	Itgax<tm1.1(HBEGF)Ktak>	MP:0005025,abnormal response to infection
MGI:3579560	Itgax<tm1Bll>	MP:0002169,no abnormal phenotype detected|MP:0002412,increased susceptibility to bacterial infection|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005348,increased T cell proliferation|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008663,increased interleukin-12 secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008687,increased interleukin-2 secretion
MGI:3664566	Itgb1bp1<Gt(SA-IRES-betaGeo)10Pgr>	MP:0002169,no abnormal phenotype detected
MGI:3716519	Itgb1bp1<tm1Ref>	MP:0000060,delayed bone ossification|MP:0000074,abnormal neurocranium morphology|MP:0000085,large anterior fontanelle|MP:0000137,abnormal vertebrae morphology|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002750,exophthalmos|MP:0003723,abnormal long bone morphology|MP:0003840,abnormal coronal suture morphology|MP:0003843,abnormal sagittal suture morphology|MP:0004420,parietal bone hypoplasia|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004686,decreased length of long bones|MP:0004989,decreased osteoblast cell number|MP:0008271,abnormal bone ossification|MP:0011086,postnatal lethality, incomplete penetrance|MP:0030189,broad snout|MP:0030387,large posterior fontanelle|MP:0030431,wide metopic suture
MGI:2449013	Itgb1bp2<tm1Tron>	MP:0004484,abnormal response of heart to induced stress|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:6437042	Itgb1<em1(IMPC)Bay>	MP:0001399,hyperactivity|MP:0011100,preweaning lethality, complete penetrance
MGI:5296845	Itgb1<tm10.1Ref>	MP:0001672,abnormal embryo development|MP:0011400,lethality, complete penetrance
MGI:5296846	Itgb1<tm11.1Ref>	MP:0004502,decreased incidence of tumors by chemical induction|MP:0010771,integument phenotype|MP:0030578,decreased keratinocyte adhesion
MGI:3639561	Itgb1<tm1.1Efu>	MP:0004964,absent inner cell mass|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5296847	Itgb1<tm12.1Ref>	MP:0011092,embryonic lethality, complete penetrance
MGI:5430791	Itgb1<tm13.1Ref>	MP:0001672,abnormal embryo development|MP:0001727,abnormal embryo implantation|MP:0002663,absent blastocoele|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011400,lethality, complete penetrance
MGI:5529145	Itgb1<tm14.1Ref>	MP:0005621,abnormal cell physiology|MP:0011092,embryonic lethality, complete penetrance|MP:0011400,lethality, complete penetrance
MGI:5529154	Itgb1<tm15.1Ref>	MP:0005621,abnormal cell physiology|MP:0011092,embryonic lethality, complete penetrance
MGI:1926499	Itgb1<tm1Efu>	MP:0000379,decreased hair follicle number|MP:0000477,abnormal intestine morphology|MP:0000479,abnormal enterocyte morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000489,abnormal large intestine morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000496,abnormal small intestine morphology|MP:0000521,abnormal kidney cortex morphology|MP:0000525,renal tubular acidosis|MP:0001191,abnormal skin condition|MP:0001199,thin skin|MP:0001208,blistering|MP:0001216,abnormal epidermal layer morphology|MP:0001218,thin epidermis|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001402,decreased locomotor activity|MP:0001666,abnormal intestinal absorption|MP:0001785,edema|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0002791,steatorrhea|MP:0002828,abnormal renal glomerular capsule morphology|MP:0002840,abnormal lens fiber morphology|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0002989,small kidney|MP:0003017,decreased circulating bicarbonate level|MP:0003078,aphakia|MP:0003237,abnormal lens epithelium morphology|MP:0003704,abnormal hair follicle development|MP:0003949,abnormal circulating lipid level|MP:0004272,abnormal basement membrane morphology|MP:0004969,pale kidney|MP:0005325,abnormal renal glomerulus morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0008011,intestine polyps|MP:0008140,podocyte foot process effacement|MP:0009349,increased urine pH|MP:0009640,abnormal renal tubule epithelium morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011160,dermal-epidermal separation|MP:0011282,increased podocyte apoptosis|MP:0011320,abnormal glomerular capillary morphology|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011353,expanded mesangial matrix|MP:0011402,renal cast|MP:0011427,increased mesangial cell number|MP:0011430,mesangiolysis|MP:0011509,dilated glomerular capillary|MP:0012551,metabolic acidosis
MGI:2182640	Itgb1<tm1Ehi>	MP:0000266,abnormal heart morphology|MP:0000352,decreased cell proliferation|MP:0000428,abnormal craniofacial morphology|MP:0000914,exencephaly|MP:0000930,wavy neural tube|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001914,hemorrhage|MP:0003077,abnormal cell cycle|MP:0003400,kinked neural tube|MP:0003794,delayed somite formation|MP:0003984,embryonic growth retardation|MP:0005312,pericardial effusion|MP:0006042,increased apoptosis|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011264,abnormal cardiac mesenchyme morphology|MP:0011704,decreased fibroblast proliferation
MGI:2154540	Itgb1<tm1Lscd>	MP:0002718,abnormal inner cell mass morphology|MP:0004963,abnormal blastocoele morphology|MP:0004965,inner cell mass degeneration|MP:0005031,abnormal trophoblast layer morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology
MGI:3624804	Itgb1<tm1Mlkn>	MP:0004964,absent inner cell mass|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2156945	Itgb1<tm1Mll>	MP:0000627,abnormal mammary gland morphology|MP:0002741,small olfactory bulb|MP:0003631,nervous system phenotype|MP:0003648,abnormal radial glial cell morphology|MP:0004279,abnormal rostral migratory stream morphology|MP:0005379,endocrine/exocrine gland phenotype|MP:0006270,abnormal mammary gland growth during lactation|MP:0008030,abnormal Cajal-Retzius cell morphology|MP:0020391,radial glial endfoot detachment|MP:0030956,abnormal neuronal precursor cell migration
MGI:1926498	Itgb1<tm1Ref>	MP:0000022,abnormal ear shape|MP:0000023,abnormal ear position|MP:0000111,cleft palate|MP:0000164,abnormal cartilage development|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000166,abnormal chondrocyte morphology|MP:0000167,decreased chondrocyte number|MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000414,alopecia|MP:0000468,abnormal esophageal epithelium morphology|MP:0000648,absent sebaceous gland|MP:0001190,reddish skin|MP:0001198,tight skin|MP:0001208,blistering|MP:0001212,skin lesions|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001243,abnormal dermal layer morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001924,infertility|MP:0001954,respiratory distress|MP:0002073,abnormal hair growth|MP:0002083,premature death|MP:0002427,disproportionate dwarf|MP:0002655,abnormal keratinocyte morphology|MP:0002657,chondrodystrophy|MP:0002764,short tibia|MP:0002796,impaired skin barrier function|MP:0002896,abnormal bone mineralization|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0004351,short humerus|MP:0004686,decreased length of long bones|MP:0004867,decreased platelet calcium level|MP:0004947,skin inflammation|MP:0005035,perianal ulcer|MP:0005408,hypopigmentation|MP:0005464,abnormal platelet physiology|MP:0008151,increased diameter of long bones|MP:0008271,abnormal bone ossification|MP:0009004,progressive hair loss|MP:0009176,increased pancreatic alpha cell number|MP:0009254,disorganized pancreatic islets|MP:0009385,abnormal dermal pigmentation|MP:0011087,neonatal lethality, complete penetrance|MP:0011159,abnormal epidermal-dermal junction morphology|MP:0014101,decreased chondrocyte proliferation|MP:0014103,increased chondrocyte apoptosis|MP:0030575,decreased hair follicle cell proliferation
MGI:2656179	Itgb1<tm1Ross>	MP:0000208,decreased hematocrit|MP:0000278,abnormal myocardial fiber morphology|MP:0000520,absent kidney|MP:0000521,abnormal kidney cortex morphology|MP:0001762,polyuria|MP:0001855,abnormal atrial thrombosis|MP:0002135,abnormal kidney morphology|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0002953,thick ventricular wall|MP:0002988,decreased urine osmolality|MP:0002989,small kidney|MP:0003014,abnormal kidney medulla morphology|MP:0003141,cardiac fibrosis|MP:0003446,renal hypoplasia|MP:0003604,single kidney|MP:0003606,kidney failure|MP:0003626,kidney medulla hypoplasia|MP:0003918,decreased kidney weight|MP:0004039,abnormal cardiac muscle cell glucose uptake|MP:0004084,abnormal cardiac muscle relaxation|MP:0004485,increased response of heart to induced stress|MP:0004754,abnormal kidney collecting duct morphology|MP:0004860,dilated kidney collecting duct|MP:0004937,dilated heart|MP:0005294,abnormal heart ventricle morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005556,abnormal renal filtration rate|MP:0005565,increased blood urea nitrogen level|MP:0006138,congestive heart failure|MP:0008725,increased heart atrium size|MP:0009643,abnormal urine homeostasis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010019,liver vascular congestion|MP:0010334,pleural effusion|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011307,kidney medulla cyst|MP:0011368,increased kidney apoptosis|MP:0011417,abnormal renal transport|MP:0011440,increased kidney cell proliferation|MP:0013305,isosthenuria|MP:0031633,decreased heart left ventricle muscle contractility
MGI:2154543	Itgb1<tm1Son>	MP:0001544,abnormal cardiovascular system physiology|MP:0005369,muscle phenotype
MGI:3624805	Itgb1<tm2Mlkn>	MP:0005464,abnormal platelet physiology
MGI:2154544	Itgb1<tm2Son>	MP:0000428,abnormal craniofacial morphology|MP:0000432,abnormal head morphology|MP:0000460,mandible hypoplasia|MP:0000729,abnormal myogenesis|MP:0000759,abnormal skeletal muscle morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000929,open neural tube|MP:0000930,wavy neural tube|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001299,abnormal eye distance/ position|MP:0001504,abnormal posture|MP:0001575,cyanosis|MP:0001577,anemia|MP:0001706,abnormal left-right axis patterning|MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0001730,embryonic growth arrest|MP:0001914,hemorrhage|MP:0002109,abnormal limb morphology|MP:0002151,abnormal neural tube morphology|MP:0002152,abnormal brain morphology|MP:0002639,micrognathia|MP:0002884,abnormal pharyngeal arch morphology|MP:0003054,spina bifida|MP:0003400,kinked neural tube|MP:0003632,abnormal nervous system morphology|MP:0003717,pallor|MP:0003743,abnormal facial morphology|MP:0004174,abnormal spine curvature|MP:0004200,decreased fetal size|MP:0004819,decreased skeletal muscle mass|MP:0005385,cardiovascular system phenotype|MP:0006280,abnormal digit development|MP:0006337,abnormal first pharyngeal arch morphology|MP:0006341,small first pharyngeal arch|MP:0006344,small second pharyngeal arch|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009406,decreased skeletal muscle fiber number|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011708,decreased fibroblast cell migration|MP:0012263,decreased hindbrain size|MP:0012702,increased embryonic neuroepithelium thickness|MP:0014696,decreased cell adhesion|MP:0030957,abnormal myotube morphology
MGI:3624806	Itgb1<tm3Mlkn>	MP:0005664,decreased circulating noradrenaline level
MGI:2154539	Itgb1<tm3Ref>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3848527	Itgb1<tm5.1Ref>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:5296837	Itgb1<tm6.1Ref>	MP:0002169,no abnormal phenotype detected
MGI:5296838	Itgb1<tm7.1Ref>	MP:0002169,no abnormal phenotype detected
MGI:5296843	Itgb1<tm8.1Ref>	MP:0002169,no abnormal phenotype detected
MGI:5296844	Itgb1<tm9.1Ref>	MP:0002006,neoplasm|MP:0002169,no abnormal phenotype detected|MP:0010771,integument phenotype
MGI:3700210	Itgb2l<tm1Jhws>	MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype
MGI:3808883	Itgb2<M1Btlr>	MP:0005387,immune system phenotype|MP:0008053,abnormal NK cell differentiation|MP:0008567,decreased interferon-gamma secretion
MGI:6199651	Itgb2<m2Btlr>	MP:0008564,increased interferon-beta secretion
MGI:6199655	Itgb2<m3Btlr>	MP:0000222,decreased neutrophil cell number|MP:0001805,decreased IgG level|MP:0002497,increased IgE level|MP:0003884,decreased macrophage cell number|MP:0005017,decreased B cell number|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0008039,increased NK T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0008126,increased dendritic cell number|MP:0008127,decreased dendritic cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0013280,abnormal cytotoxic T cell cytolysis|MP:0020154,impaired humoral immune response
MGI:6286053	Itgb2<M4Btlr>	MP:0002145,abnormal T cell differentiation|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number
MGI:6286064	Itgb2<m5Btlr>	MP:0008169,increased B-1b cell number
MGI:5524988	Itgb2<tm1.1Arte>	MP:0000219,increased neutrophil cell number|MP:0000691,enlarged spleen|MP:0002444,abnormal T cell physiology|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005095,decreased T cell proliferation|MP:0008101,lymph node hypoplasia|MP:0008126,increased dendritic cell number
MGI:5426359	Itgb2<tm1.1Mskim>	MP:0002169,no abnormal phenotype detected
MGI:1857208	Itgb2<tm1Bay>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0000414,alopecia|MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0001186,pigmentation phenotype|MP:0001190,reddish skin|MP:0001191,abnormal skin condition|MP:0001192,scaly skin|MP:0001193,psoriasis|MP:0001194,dermatitis|MP:0001216,abnormal epidermal layer morphology|MP:0001222,epidermal hyperplasia|MP:0001243,abnormal dermal layer morphology|MP:0001246,mixed cellular infiltration to dermis|MP:0001325,abnormal retina morphology|MP:0001828,abnormal T cell activation|MP:0001876,decreased inflammatory response|MP:0002083,premature death|MP:0002356,abnormal spleen red pulp morphology|MP:0002606,increased basophil cell number|MP:0002792,abnormal retina vasculature morphology|MP:0003427,parakeratosis|MP:0003434,decreased susceptibility to induced choroidal neovascularization|MP:0003813,abnormal hair follicle dermal papilla morphology|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005015,increased T cell number|MP:0005253,abnormal eye physiology|MP:0005505,thrombocytosis|MP:0005559,increased circulating glucose level|MP:0008086,increased T-helper 1 cell number|MP:0008566,increased interferon-gamma secretion|MP:0008713,abnormal cytokine level|MP:0009675,orthokeratosis|MP:0010373,myeloid hyperplasia|MP:0010771,integument phenotype
MGI:1861705	Itgb2<tm2Bay>	MP:0000066,osteoporosis|MP:0000133,abnormal long bone metaphysis morphology|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000321,increased bone marrow cell number|MP:0000414,alopecia|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000716,abnormal immune system cell morphology|MP:0001190,reddish skin|MP:0001194,dermatitis|MP:0001209,spontaneous skin ulceration|MP:0001222,epidermal hyperplasia|MP:0001846,increased inflammatory response|MP:0001852,conjunctivitis|MP:0002221,abnormal lymph organ size|MP:0002411,decreased susceptibility to bacterial infection|MP:0002412,increased susceptibility to bacterial infection|MP:0002442,abnormal leukocyte physiology|MP:0002461,increased immunoglobulin level|MP:0002463,abnormal neutrophil physiology|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0003156,abnormal leukocyte migration|MP:0003628,abnormal leukocyte adhesion|MP:0003795,abnormal bone structure|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005065,abnormal neutrophil morphology|MP:0005087,decreased acute inflammation|MP:0005094,abnormal T cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008596,increased circulating interleukin-6 level|MP:0008623,increased circulating interleukin-3 level|MP:0008719,impaired neutrophil recruitment|MP:0010373,myeloid hyperplasia|MP:0010771,integument phenotype|MP:0010873,decreased trabecular bone mass|MP:0011090,perinatal lethality, incomplete penetrance|MP:0020010,decreased bone mineral density of femur|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization
MGI:5883322	Itgb3bp<em1(IMPC)J>	MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:7486275	Itgb3bp<tm1.1Tfw>	MP:0005389,reproductive system phenotype|MP:0010537,tumor regression|MP:0010639,abnormal tumor pathology|MP:0013151,abnormal incidence of induced tumors|MP:0014756,decreased tumor cell proliferation|MP:0014757,increased tumor cell death
MGI:5688572	Itgb3<tm1.1Wlbcr>	MP:0002169,no abnormal phenotype detected
MGI:3844533	Itgb3<tm1Aja>	MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0006298,abnormal platelet activation|MP:0009446,abnormal platelet dense granule physiology|MP:0031120,decreased susceptibility to induced thrombosis
MGI:2177827	Itgb3<tm1Drp>	MP:0002551,abnormal blood coagulation
MGI:2175913	Itgb3<tm1Hyn>	MP:0000195,decreased circulating calcium level|MP:0000208,decreased hematocrit|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000465,gastrointestinal hemorrhage|MP:0000691,enlarged spleen|MP:0001194,dermatitis|MP:0001541,abnormal osteoclast physiology|MP:0001577,anemia|MP:0001625,cardiac hypertrophy|MP:0001654,hepatic necrosis|MP:0001716,abnormal placenta labyrinth morphology|MP:0001914,hemorrhage|MP:0001923,reduced female fertility|MP:0002083,premature death|MP:0002451,abnormal macrophage physiology|MP:0002493,increased IgG level|MP:0002625,heart left ventricle hypertrophy|MP:0002640,reticulocytosis|MP:0002724,enhanced wound healing|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003091,abnormal cell migration|MP:0003566,abnormal cell adhesion|MP:0003710,abnormal physiological neovascularization|MP:0003718,maternal effect|MP:0003721,increased tumor growth/size|MP:0003799,impaired macrophage chemotaxis|MP:0003819,increased left ventricle diastolic pressure|MP:0003822,decreased left ventricle systolic pressure|MP:0003884,decreased macrophage cell number|MP:0003915,increased heart left ventricle weight|MP:0003946,renal necrosis|MP:0004014,abnormal uterine environment|MP:0004084,abnormal cardiac muscle relaxation|MP:0004148,increased compact bone thickness|MP:0004266,pale placenta|MP:0004485,increased response of heart to induced stress|MP:0004510,myositis|MP:0004898,uterine hemorrhage|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0005033,abnormal trophoblast giant cell morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0005387,immune system phenotype|MP:0005391,vision/eye phenotype|MP:0005422,osteosclerosis|MP:0005464,abnormal platelet physiology|MP:0005601,increased angiogenesis|MP:0005606,increased bleeding time|MP:0006298,abnormal platelet activation|MP:0008028,pregnancy-related premature death|MP:0008816,petechiae|MP:0008837,increased transforming growth factor beta level|MP:0009347,increased trabecular bone thickness|MP:0009584,decreased keratinocyte proliferation|MP:0009660,abnormal induced retina neovascularization|MP:0010144,abnormal tumor vascularization|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011514,skin hemorrhage|MP:0011515,purpura|MP:0031434,increased miscarriage rate
MGI:3721108	Itgb3<tm1Mgin>	MP:0000208,decreased hematocrit|MP:0000465,gastrointestinal hemorrhage|MP:0002590,increased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005561,increased mean corpuscular hemoglobin|MP:0005606,increased bleeding time|MP:0006298,abnormal platelet activation|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3844537	Itgb3<tm2Aja>	MP:0002169,no abnormal phenotype detected
MGI:3721109	Itgb3<tm2Mgin>	MP:0000465,gastrointestinal hemorrhage|MP:0002875,decreased erythrocyte cell number|MP:0005048,abnormal thrombosis|MP:0005561,increased mean corpuscular hemoglobin|MP:0005606,increased bleeding time|MP:0006298,abnormal platelet activation
MGI:3803794	Itgb4<tm1.1Mfel>	MP:0001208,blistering
MGI:2183630	Itgb4<tm1Efu>	MP:0000468,abnormal esophageal epithelium morphology|MP:0000764,abnormal tongue epithelium morphology|MP:0001191,abnormal skin condition|MP:0001208,blistering|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001233,abnormal epidermis suprabasal layer morphology|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001953,respiratory failure|MP:0003631,nervous system phenotype|MP:0005501,abnormal skin physiology|MP:0011087,neonatal lethality, complete penetrance|MP:0011160,dermal-epidermal separation
MGI:2181069	Itgb4<tm1Fgg>	MP:0000468,abnormal esophageal epithelium morphology|MP:0001208,blistering|MP:0001216,abnormal epidermal layer morphology|MP:0001429,dehydration|MP:0001438,aphagia|MP:0002060,abnormal skin morphology|MP:0008883,abnormal enterocyte proliferation|MP:0011089,perinatal lethality, complete penetrance|MP:0011160,dermal-epidermal separation|MP:0030578,decreased keratinocyte adhesion
MGI:3803792	Itgb4<tm1Mfel>	MP:0003871,abnormal myelin sheath morphology|MP:0005386,behavior/neurological phenotype
MGI:2152982	Itgb4<tm1Son>	MP:0000540,abnormal urinary bladder urothelium morphology|MP:0000579,abnormal nail morphology|MP:0000764,abnormal tongue epithelium morphology|MP:0001191,abnormal skin condition|MP:0001312,abnormal cornea morphology|MP:0001785,edema|MP:0002655,abnormal keratinocyte morphology|MP:0003631,nervous system phenotype|MP:0005387,immune system phenotype|MP:0008789,abnormal olfactory epithelium morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011160,dermal-epidermal separation
MGI:3524974	Itgb4<tm2Fgg>	MP:0005602,decreased angiogenesis|MP:0010771,integument phenotype
MGI:3573958	Itgb4<tm2Son>	MP:0001208,blistering|MP:0001849,ear inflammation|MP:0002655,abnormal keratinocyte morphology
MGI:4431871	Itgb5<tm1a(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0001325,abnormal retina morphology|MP:0002092,abnormal eye morphology|MP:0002608,increased hematocrit
MGI:2149063	Itgb5<tm1Des>	MP:0002169,no abnormal phenotype detected|MP:0002656,abnormal keratinocyte differentiation
MGI:6388385	Itgb6<em1(IMPC)Ccpcz>	MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001262,decreased body weight|MP:0001293,anophthalmia|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002100,abnormal tooth morphology|MP:0002110,abnormal digit morphology|MP:0002311,abnormal inspiratory capacity|MP:0002941,increased circulating alanine transaminase level|MP:0005627,increased circulating potassium level|MP:0010090,increased circulating creatine kinase level|MP:0010379,decreased respiratory quotient|MP:0010895,increased lung compliance|MP:0011045,decreased lung elastance|MP:0011048,decreased lung tissue damping|MP:0013129,abnormal tooth color|MP:0020421,increased freezing behavior
MGI:1926484	Itgb6<tm1Des>	MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000414,alopecia|MP:0001175,abnormal lung morphology|MP:0001183,overexpanded pulmonary alveolus|MP:0001790,abnormal immune system physiology|MP:0001958,emphysema|MP:0002405,respiratory system inflammation|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005166,decreased susceptibility to injury|MP:0008118,absent Langerhans cell|MP:0008119,decreased Langerhans cell number
MGI:1861953	Itgb7<tm1Cgn>	MP:0000336,decreased mast cell number|MP:0000685,abnormal immune system morphology|MP:0001790,abnormal immune system physiology|MP:0002378,abnormal gut-associated lymphoid tissue morphology|MP:0002389,abnormal Peyer's patch follicle morphology|MP:0002816,colitis|MP:0003156,abnormal leukocyte migration|MP:0003945,abnormal lymphocyte physiology|MP:0005012,decreased eosinophil cell number|MP:0005017,decreased B cell number|MP:0005025,abnormal response to infection|MP:0005027,increased susceptibility to parasitic infection|MP:0005387,immune system phenotype|MP:0008054,abnormal uterine NK cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008135,small Peyer's patches|MP:0008256,abnormal myometrium morphology|MP:0009394,increased uterine NK cell number|MP:0009397,increased trophoblast giant cell number|MP:0020332,impaired leukocyte tethering or rolling
MGI:3764672	Itgb7<tm1Mshi>	MP:0002816,colitis|MP:0003156,abnormal leukocyte migration|MP:0003628,abnormal leukocyte adhesion|MP:0008135,small Peyer's patches
MGI:6324151	Itgb8<tm1b(KOMP)Wtsi>	MP:0002966,decreased circulating alkaline phosphatase level|MP:0003020,decreased circulating chloride level|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005560,decreased circulating glucose level|MP:0005567,decreased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2182548	Itgb8<tm1Lfr>	MP:0000111,cleft palate|MP:0000260,abnormal angiogenesis|MP:0000264,failure of vascular branching|MP:0000266,abnormal heart morphology|MP:0000926,absent floor plate|MP:0001544,abnormal cardiovascular system physiology|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001722,pale yolk sac|MP:0001891,hydrocephaly|MP:0001916,intracerebral hemorrhage|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0003044,impaired basement membrane formation|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0003648,abnormal radial glial cell morphology|MP:0003658,abnormal capillary morphology|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004950,abnormal brain vasculature morphology|MP:0005244,hemopericardium|MP:0005294,abnormal heart ventricle morphology|MP:0006056,increased vascular endothelial cell number|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009888,palatal shelves fail to meet at midline|MP:0011085,postnatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011380,enlarged brain ventricles|MP:0011523,thin placenta labyrinth|MP:0012501,abnormal pericardial cavity morphology
MGI:6156296	Itgbl1<em1(IMPC)Kmpc>	MP:0001552,increased circulating triglyceride level|MP:0002059,abnormal seminal vesicle morphology
MGI:3775819	Itih4<tm1Mish>	MP:0002169,no abnormal phenotype detected
MGI:5708177	Itih4<tm3b(KOMP)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:7786763	Itih5<tm1Jmba>	MP:0001199,thin skin|MP:0001218,thin epidermis|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0005666,abnormal adipose tissue physiology|MP:0009584,decreased keratinocyte proliferation|MP:0011168,abnormal fat cell differentiation|MP:0014105,abnormal chondrocyte differentiation|MP:0014142,increased body fat mass
MGI:6423834	Itk<em1(IMPC)Mbp>	MP:0001488,increased startle reflex
MGI:5806309	Itk<m1Btlr>	MP:0000350,abnormal cell proliferation|MP:0002497,increased IgE level|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0011822,increased CD8-positive, alpha-beta memory T cell proliferation
MGI:6113416	Itk<m2Btlr>	MP:0005014,increased B cell number|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010839,decreased CD8-positive, alpha-beta memory T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:3528811	Itk<tm1Lex>	MP:0005014,increased B cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:2178820	Itk<tm1Litt>	MP:0004919,abnormal positive T cell selection|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005090,increased double-negative T cell number|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008037,abnormal T cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008688,decreased interleukin-2 secretion|MP:0008827,abnormal thymus cell ratio
MGI:2178928	Itk<tm1Ljb>	MP:0001828,abnormal T cell activation|MP:0002497,increased IgE level|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0008036,abnormal NK T cell morphology|MP:0008040,decreased NK T cell number|MP:0008049,increased memory T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008177,increased germinal center B cell number|MP:0008343,abnormal gamma-delta T cell morphology|MP:0008353,increased mature gamma-delta T cell number|MP:0008566,increased interferon-gamma secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008660,increased interleukin-10 secretion|MP:0008672,increased interleukin-13 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion
MGI:6467471	Itln1<em1Cya>	MP:0000066,osteoporosis|MP:0001541,abnormal osteoclast physiology|MP:0004214,abnormal long bone diaphysis morphology|MP:0004984,increased osteoclast cell number|MP:0008152,decreased diameter of femur|MP:0008553,increased circulating tumor necrosis factor level|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008638,increased circulating interleukin-1 alpha level|MP:0008713,abnormal cytokine level|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0013630,increased bone trabecular spacing|MP:0030439,decreased osteoblast proliferation|MP:0030985,decreased circulating osteocalcin level|MP:0031074,increased circulating type I collagen C-terminal telopeptide level
MGI:5007201	Itln1<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:5518652	Itm2a<tm1.1Buck>	MP:0002151,abnormal neural tube morphology|MP:0002169,no abnormal phenotype detected
MGI:5518653	Itm2a<tm1.2Buck>	MP:0002169,no abnormal phenotype detected
MGI:5518654	Itm2a<tm1Buck>	MP:0002169,no abnormal phenotype detected
MGI:3810987	Itm2b<tm1.1Ldad>	MP:0001458,abnormal object recognition memory|MP:0001473,reduced long-term potentiation|MP:0002152,abnormal brain morphology|MP:0008428,abnormal spatial working memory|MP:0009454,impaired contextual conditioning behavior|MP:0014367,impaired long-term object recognition memory|MP:0014370,impaired spatial working memory
MGI:4415610	Itm2b<tm2.1Ldad>	MP:0001458,abnormal object recognition memory|MP:0001473,reduced long-term potentiation|MP:0003631,nervous system phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0014370,impaired spatial working memory
MGI:4867871	Itm2b<tm3.1Ldad>	MP:0003631,nervous system phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0014367,impaired long-term object recognition memory|MP:0014370,impaired spatial working memory
MGI:6260167	Itm2c<em1Nutt>	MP:0002169,no abnormal phenotype detected
MGI:6257738	Itm2c<em2(IMPC)Tcp>	MP:0002764,short tibia|MP:0005278,abnormal cholesterol homeostasis
MGI:5548700	Itm2c<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6287401	Itpa<em#Drf>	MP:0001265,decreased body size|MP:0005385,cardiovascular system phenotype
MGI:4942407	Itpa<tm1Skmi>	MP:0000240,extramedullary hematopoiesis|MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000278,abnormal myocardial fiber morphology|MP:0000280,thin ventricular wall|MP:0000382,underdeveloped hair follicles|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001636,irregular heartbeat|MP:0001732,postnatal growth retardation|MP:0001951,abnormal breathing pattern|MP:0002188,small heart|MP:0002740,heart hypoplasia|MP:0004090,abnormal sarcomere morphology|MP:0004092,absent Z line|MP:0004901,decreased male germ cell number|MP:0005621,abnormal cell physiology|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3587933	Itpk1<Gt(DTM066)Byg>	MP:0000069,kyphoscoliosis|MP:0000150,abnormal rib morphology|MP:0000914,exencephaly|MP:0001698,decreased embryo size|MP:0003054,spina bifida|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0004734,small thoracic cavity|MP:0009929,meningomyelocele|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:2152168	Itpka<tm1Hssh>	MP:0003008,enhanced long-term potentiation
MGI:3039799	Itpkb<T-less>	MP:0001825,arrested T cell differentiation|MP:0002444,abnormal T cell physiology
MGI:2680720	Itpkb<tm1Ssch>	MP:0000416,sparse hair|MP:0000727,absent CD8-positive, alpha-beta T cells|MP:0001270,distended abdomen|MP:0001402,decreased locomotor activity|MP:0001732,postnatal growth retardation|MP:0001805,decreased IgG level|MP:0001824,abnormal thymus involution|MP:0001825,arrested T cell differentiation|MP:0002083,premature death|MP:0003790,absent CD4-positive, alpha-beta T cells|MP:0003850,abnormal thymocyte activation|MP:0005027,increased susceptibility to parasitic infection|MP:0005036,diarrhea|MP:0005091,increased double-positive T cell number|MP:0008070,absent T cells|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0009511,distended stomach|MP:0013587,absent thymus medulla
MGI:2683901	Itpkc<tm1Ssch>	MP:0002169,no abnormal phenotype detected
MGI:5823155	Itpr1<em1Drf>	MP:0001322,abnormal iris morphology
MGI:3715928	Itpr1<m1Asb>	MP:0002083,premature death|MP:0003492,abnormal involuntary movement
MGI:1856981	Itpr1<opt>	MP:0000746,weakness|MP:0001265,decreased body size|MP:0001392,abnormal locomotor behavior|MP:0001405,impaired coordination|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0002064,seizures|MP:0002880,opisthotonus|MP:0003059,decreased insulin secretion|MP:0003312,abnormal locomotor coordination|MP:0003631,nervous system phenotype|MP:0005293,impaired glucose tolerance|MP:0005621,abnormal cell physiology|MP:0011083,lethality at weaning, complete penetrance
MGI:5532199	Itpr1<tm1.1Kmik>	MP:0000849,abnormal cerebellum morphology|MP:0000890,thin cerebellar molecular layer|MP:0001393,ataxia|MP:0001899,absent long-term depression|MP:0002206,abnormal CNS synaptic transmission|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0006156,abnormal visual pursuit|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0010768,mortality/aging|MP:0014327,decreased Purkinje cell size
MGI:5766138	Itpr1<tm1.1(NCOM)Mfgc>	MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0004930,small epididymis|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2180360	Itpr1<tm1Tno>	MP:0000774,decreased brain size|MP:0001393,ataxia|MP:0002064,seizures|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003997,tonic-clonic seizures|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3640970	Itpr2<tm1.1Chen>	MP:0005385,cardiovascular system phenotype
MGI:3604623	Itpr2<tm1Kmik>	MP:0002169,no abnormal phenotype detected|MP:0013368,abnormal sweat gland physiology|MP:0013371,hypohidrosis
MGI:6423854	Itpr3<em1(IMPC)Mbp>	MP:0001258,decreased body length|MP:0001314,cornea opacity|MP:0002060,abnormal skin morphology
MGI:1857070	Itpr3<tf>	MP:0000367,abnormal coat/ hair morphology|MP:0000416,sparse hair|MP:0000427,abnormal hair cycle|MP:0000788,abnormal cerebral cortex morphology|MP:0001260,increased body weight|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001423,abnormal liquid preference|MP:0001441,increased grooming behavior|MP:0001529,abnormal vocalization|MP:0001985,abnormal gustatory system physiology|MP:0002073,abnormal hair growth|MP:0002196,absent corpus callosum|MP:0002199,abnormal brain commissure morphology|MP:0002865,increased growth rate|MP:0002969,impaired social transmission of food preference|MP:0003313,abnormal locomotor activation|MP:0008222,decreased hippocampal commissure size|MP:0008226,decreased anterior commissure size|MP:0008547,abnormal neocortex morphology|MP:0011000,abnormal allogrooming behavior|MP:0011941,increased fluid intake|MP:0012347,low sweet preference|MP:0013140,excessive vocalization
MGI:3653223	Itpr3<tf-Csh>	MP:0000367,abnormal coat/ hair morphology|MP:0002073,abnormal hair growth
MGI:1856207	Itpr3<tf-J>	MP:0000367,abnormal coat/ hair morphology|MP:0002073,abnormal hair growth
MGI:3604625	Itpr3<tm1Kmik>	MP:0002169,no abnormal phenotype detected
MGI:4880235	Itpr3<tm1(NCOM)Mfgc>	MP:0001423,abnormal liquid preference|MP:0001985,abnormal gustatory system physiology|MP:0011941,increased fluid intake|MP:0012347,low sweet preference
MGI:3833897	Itprid2<tm1Sawa>	MP:0001262,decreased body weight|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004892,increased adiponectin level|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005418,abnormal circulating hormone level|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008489,slow postnatal weight gain|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008965,increased basal metabolism|MP:0009269,decreased fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0011939,increased food intake|MP:0014169,decreased brown adipose tissue mass|MP:0030016,increased adipocyte glucose uptake|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis|MP:0031391,increased locomotor activity|MP:0031414,decreased skeletal muscle triglyceride level
MGI:7577021	Itpripl1<em1Smoc>	MP:0001146,abnormal testis morphology|MP:0002675,asthenozoospermia
MGI:4450972	Itprip<tm1.1Snyd>	MP:0005621,abnormal cell physiology|MP:0006060,increased cerebral infarct size|MP:0008943,increased sensitivity to induced cell death
MGI:6257669	Itsn1<em1(IMPC)H>	MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0002965,increased circulating serum albumin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005568,increased circulating total protein level|MP:0008806,increased circulating amylase level|MP:0008810,increased circulating iron level|MP:0009142,decreased prepulse inhibition|MP:0011239,abnormal skin coloration
MGI:2678392	Itsn1<Gt(pT1ATGBetageo)1Ruiz>	MP:0000774,decreased brain size|MP:0000780,abnormal corpus callosum morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001732,postnatal growth retardation|MP:0003005,abnormal hippocampal fimbria morphology|MP:0003006,abnormal hippocampal fornix morphology|MP:0003631,nervous system phenotype|MP:0008026,abnormal brain white matter morphology|MP:0008225,abnormal anterior commissure morphology|MP:0008226,decreased anterior commissure size|MP:0009454,impaired contextual conditioning behavior|MP:0011091,prenatal lethality, complete penetrance
MGI:3812034	Itsn1<tm1.1Mapr>	MP:0000358,abnormal cell morphology|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001739,abnormal adrenal gland secretion|MP:0002083,premature death|MP:0004770,abnormal synaptic vesicle recycling|MP:0008770,decreased survivor rate
MGI:3812035	Itsn1<tm2.1Mapr>	MP:0000358,abnormal cell morphology|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001739,abnormal adrenal gland secretion|MP:0002083,premature death|MP:0004770,abnormal synaptic vesicle recycling|MP:0008770,decreased survivor rate
MGI:5548439	Itsn2<tm1.1(KOMP)Vlcg>	MP:0000367,abnormal coat/ hair morphology|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment
MGI:5503193	Itsn2<tm1Egan>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:6188888	Itsn2<tm1Kure>	MP:0002871,albuminuria|MP:0008140,podocyte foot process effacement
MGI:3762332	Ity2a<MOLF/EiJ>	MP:0002411,decreased susceptibility to bacterial infection
MGI:3762334	Ity2b<MOLF/EiJ>	MP:0002411,decreased susceptibility to bacterial infection
MGI:2674302	Ity2<MOLF/EiJ>	MP:0002411,decreased susceptibility to bacterial infection
MGI:2154169	Ity3<C57BL/6J>	MP:0002411,decreased susceptibility to bacterial infection
MGI:2154171	Ity3<MOLF/EiJ>	MP:0002412,increased susceptibility to bacterial infection|MP:0003009,abnormal cytokine secretion
MGI:5548705	Ivd<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5569966	Ivl<tm1b(KOMP)Wtsi>	MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002152,abnormal brain morphology|MP:0010025,decreased total body fat amount
MGI:2386285	Ivl<tm1Dji>	MP:0002169,no abnormal phenotype detected
MGI:4820513	Ivns1abp<tm1Htno>	MP:0003222,increased cardiomyocyte apoptosis|MP:0005140,decreased cardiac muscle contractility|MP:0005324,ascites|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008943,increased sensitivity to induced cell death|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010334,pleural effusion|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6277993	Iws1<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6201357	Iws1<tm1.1Cop>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5538512	Izumo1r<tm1.1Salb>	MP:0001926,female infertility
MGI:4364095	Izumo1r<tm1a(KOMP)Wtsi>	MP:0000242,impaired fertilization|MP:0001926,female infertility
MGI:5548704	Izumo1r<tm1b(KOMP)Wtsi>	MP:0001926,female infertility
MGI:3512121	Izumo1r<tm1Salb>	MP:0002169,no abnormal phenotype detected
MGI:4363787	Izumo1r<tm2a(KOMP)Wtsi>	MP:0001926,female infertility|MP:0002833,increased heart weight|MP:0003019,increased circulating chloride level|MP:0003960,increased lean body mass|MP:0005560,decreased circulating glucose level|MP:0008805,decreased circulating amylase level|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level
MGI:5792910	Izumo1r<tm2c(KOMP)Wtsi>	MP:0005389,reproductive system phenotype
MGI:3576382	Izumo1<tm1Osb>	MP:0000242,impaired fertilization|MP:0001925,male infertility
MGI:6257778	Izumo2<em1(IMPC)Bay>	MP:0002626,increased heart rate|MP:0005599,increased cardiac muscle contractility
MGI:7310258	Izumo3<tm1Osb>	MP:0001922,reduced male fertility|MP:0008898,abnormal acrosome morphology
MGI:2682601	Jade1<Gt(pGT1,2,3)E148Vw>	MP:0011086,postnatal lethality, incomplete penetrance
MGI:5697312	Jade1<tm1b(KOMP)Wtsi>	MP:0001925,male infertility|MP:0001926,female infertility
MGI:7482646	Jade2<em1Cya>	MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003635,abnormal synaptic transmission|MP:0008432,abnormal long-term spatial reference memory|MP:0014367,impaired long-term object recognition memory|MP:0014376,decreased miniature excitatory postsynaptic current frequency|MP:0020508,decreased dendritic spine density
MGI:6156496	Jade2<em1(IMPC)Tcp>	MP:0000063,decreased bone mineral density|MP:0000157,abnormal sternum morphology|MP:0000692,small spleen|MP:0002059,abnormal seminal vesicle morphology|MP:0009142,decreased prepulse inhibition|MP:0010124,decreased bone mineral content|MP:0011874,enlarged urinary bladder|MP:0013278,decreased fasting circulating glucose level
MGI:7490169	Jade3<em1(IMPC)Tcp>	MP:0000266,abnormal heart morphology|MP:0001297,microphthalmia|MP:0002574,increased vertical activity|MP:0002599,increased mean platelet volume|MP:0002792,abnormal retina vasculature morphology|MP:0005293,impaired glucose tolerance|MP:0008528,polycystic kidney|MP:0009142,decreased prepulse inhibition|MP:0010097,abnormal retina blood vessel morphology
MGI:4346855	Jade3<Gt(XT0269)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:4360086	Jag1<Gt(betageo)1Byg>	MP:0002169,no abnormal phenotype detected
MGI:2386949	Jag1<Mhdahtu>	MP:0000042,abnormal organ of Corti morphology|MP:0000291,enlarged pericardium|MP:0001614,abnormal blood vessel morphology|MP:0001914,hemorrhage|MP:0002428,abnormal semicircular canal morphology|MP:0002622,abnormal cochlear hair cell morphology|MP:0002730,head shaking|MP:0003229,abnormal vitelline vasculature morphology|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0004249,abnormal crista ampullaris morphology|MP:0004395,increased cochlear inner hair cell number|MP:0004402,decreased cochlear outer hair cell number|MP:0005307,head tossing|MP:0005377,hearing/vestibular/ear phenotype|MP:0008488,abnormal semicircular canal ampulla morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4420947	Jag1<Ndr>	MP:0000259,abnormal vascular development|MP:0000445,short snout|MP:0000598,abnormal liver morphology|MP:0000609,abnormal liver physiology|MP:0000611,jaundice|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001306,small lens|MP:0001322,abnormal iris morphology|MP:0001410,head bobbing|MP:0001525,impaired balance|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0001914,hemorrhage|MP:0002083,premature death|MP:0002928,abnormal bile duct morphology|MP:0002929,abnormal bile duct development|MP:0002968,increased circulating alkaline phosphatase level|MP:0003717,pallor|MP:0003868,abnormal feces composition|MP:0004981,decreased neuronal precursor cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005419,decreased circulating serum albumin level|MP:0008489,slow postnatal weight gain|MP:0008947,increased neuron number|MP:0009820,abnormal liver vasculature morphology|MP:0009937,abnormal neuron differentiation|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010831,lethality, incomplete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012236,abnormal cholangiocyte morphology
MGI:2664255	Jag1<Ozz>	MP:0001394,circling|MP:0001410,head bobbing|MP:0002730,head shaking
MGI:1931798	Jag1<Slalom>	MP:0002151,abnormal neural tube morphology|MP:0002428,abnormal semicircular canal morphology|MP:0002730,head shaking|MP:0003229,abnormal vitelline vasculature morphology|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0004395,increased cochlear inner hair cell number|MP:0004402,decreased cochlear outer hair cell number|MP:0005356,positive geotaxis|MP:0008488,abnormal semicircular canal ampulla morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3848155	Jag1<tm1.1Loo>	MP:0002169,no abnormal phenotype detected
MGI:3577993	Jag1<tm1Frad>	MP:0000266,abnormal heart morphology|MP:0000272,abnormal aorta morphology|MP:0000273,overriding aortic valve|MP:0000276,heart right ventricle hypertrophy|MP:0000285,abnormal heart valve morphology|MP:0000414,alopecia|MP:0000486,abnormal pulmonary trunk morphology|MP:0000610,cholestasis|MP:0000611,jaundice|MP:0001262,decreased body weight|MP:0001654,hepatic necrosis|MP:0001732,postnatal growth retardation|MP:0002928,abnormal bile duct morphology|MP:0002929,abnormal bile duct development|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003888,liver hemorrhage|MP:0004772,abnormal bile secretion|MP:0004937,dilated heart|MP:0005178,increased circulating cholesterol level|MP:0005202,lethargy|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005397,hematopoietic system phenotype|MP:0006048,pulmonary valve regurgitation|MP:0006116,calcified aortic valve|MP:0006126,abnormal cardiac outflow tract development|MP:0006128,pulmonary valve stenosis|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008727,increased heart right atrium size|MP:0010402,ventricular septal defect|MP:0010551,abnormal coronary vessel morphology|MP:0010563,increased heart right ventricle size|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011290,decreased nephron number|MP:0011648,thick heart valve cusps|MP:0011971,increased circulating lactate dehydrogenase level|MP:0021159,increased heart right ventricle wall thickness|MP:0031114,increased circulating gamma-glutamyl transferase level
MGI:1857713	Jag1<tm1Grid>	MP:0000259,abnormal vascular development|MP:0001314,cornea opacity|MP:0001319,irregularly shaped pupil|MP:0001722,pale yolk sac|MP:0001914,hemorrhage|MP:0002092,abnormal eye morphology|MP:0004076,abnormal vitelline vascular remodeling|MP:0006241,abnormal placement of pupils|MP:0010714,iris coloboma|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3623344	Jag1<tm1Jlew>	MP:0002428,abnormal semicircular canal morphology|MP:0002622,abnormal cochlear hair cell morphology|MP:0003227,abnormal vascular branching morphogenesis|MP:0004201,fetal growth retardation|MP:0004325,absent vestibular hair cells|MP:0004333,abnormal utricular macula morphology|MP:0004395,increased cochlear inner hair cell number|MP:0004403,absent cochlear outer hair cells|MP:0005602,decreased angiogenesis
MGI:3693129	Jag1<tm2.1Grid>	MP:0000292,distended pericardium|MP:0001915,intracranial hemorrhage|MP:0004076,abnormal vitelline vascular remodeling|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3692444	Jag1<tm2Grid>	MP:0000097,short maxilla|MP:0000120,malocclusion|MP:0001265,decreased body size|MP:0001431,abnormal eating behavior|MP:0001614,abnormal blood vessel morphology|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0002083,premature death|MP:0003755,abnormal palate morphology|MP:0003760,decreased palatal length|MP:0004076,abnormal vitelline vascular remodeling|MP:0005592,abnormal vascular smooth muscle morphology|MP:0009654,abnormal primary palate development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012085,midface hypoplasia
MGI:5305601	Jag1<Yo>	MP:0002858,abnormal posterior semicircular canal morphology|MP:0003069,abnormal superior semicircular canal morphology|MP:0004402,decreased cochlear outer hair cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1857046	Jag2<sm>	MP:0000564,syndactyly|MP:0000572,abnormal autopod morphology|MP:0000585,kinked tail|MP:0001222,epidermal hyperplasia|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0001678,thick apical ectodermal ridge|MP:0001926,female infertility|MP:0002111,abnormal tail morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0003427,parakeratosis|MP:0005650,abnormal limb bud morphology|MP:0006280,abnormal digit development|MP:0008730,fused phalanges|MP:0008919,fused tarsal bones|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5636926	Jag2<tm1b(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:2657215	Jag2<tm1Grid>	MP:0000430,absent maxillary shelf|MP:0000431,absent palatine bone horizontal plate|MP:0000564,syndactyly|MP:0000703,abnormal thymus morphology|MP:0001575,cyanosis|MP:0001678,thick apical ectodermal ridge|MP:0001954,respiratory distress|MP:0002375,abnormal thymus medulla morphology|MP:0004395,increased cochlear inner hair cell number|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004401,increased cochlear outer hair cell number|MP:0004407,increased cochlear hair cell number|MP:0004492,abnormal orientation of inner hair cell stereociliary bundles|MP:0004497,decreased organ of Corti supporting cell number|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0004576,abnormal embryonic autopod plate morphology|MP:0005306,abnormal phalanx morphology|MP:0008347,decreased gamma-delta T cell number|MP:0008356,abnormal gamma-delta T cell differentiation|MP:0009884,palatal shelf fusion with tongue or mandible|MP:0009886,failure of palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0011085,postnatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0021210,bilateral cleft palate
MGI:4829505	Jag2<tm2.2Grid>	MP:0000111,cleft palate|MP:0000564,syndactyly|MP:0009884,palatal shelf fusion with tongue or mandible|MP:0011087,neonatal lethality, complete penetrance
MGI:5604904	Jagn1<tm1c(EUCOMM)Hmgu>	MP:0002463,abnormal neutrophil physiology|MP:0005065,abnormal neutrophil morphology|MP:0005399,increased susceptibility to fungal infection|MP:0008719,impaired neutrophil recruitment|MP:0008720,impaired neutrophil chemotaxis
MGI:5526094	Jak1<M1Mhda>	MP:0000063,decreased bone mineral density|MP:0000189,hypoglycemia|MP:0000194,increased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000414,alopecia|MP:0000598,abnormal liver morphology|MP:0000602,dilated liver sinusoidal space|MP:0000607,abnormal hepatocyte morphology|MP:0000691,enlarged spleen|MP:0001212,skin lesions|MP:0001243,abnormal dermal layer morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001849,ear inflammation|MP:0002111,abnormal tail morphology|MP:0002177,abnormal outer ear morphology|MP:0002439,abnormal plasma cell morphology|MP:0002461,increased immunoglobulin level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002591,decreased mean corpuscular volume|MP:0002642,anisocytosis|MP:0002810,microcytic anemia|MP:0002905,decreased circulating parathyroid hormone level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003131,increased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0003797,abnormal compact bone morphology|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004945,abnormal bone resorption|MP:0004947,skin inflammation|MP:0005141,liver hyperplasia|MP:0005179,decreased circulating cholesterol level|MP:0005318,decreased triglyceride level|MP:0005328,abnormal circulating creatinine level|MP:0005419,decreased circulating serum albumin level|MP:0005516,enhanced liver regeneration|MP:0005567,decreased circulating total protein level|MP:0008097,increased plasma cell number|MP:0008255,decreased megakaryocyte cell number|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008821,increased blood uric acid level|MP:0008935,decreased mean platelet volume|MP:0008956,decreased cellular hemoglobin content|MP:0009703,decreased birth body size|MP:0009820,abnormal liver vasculature morphology|MP:0010867,abnormal bone trabecula morphology|MP:0010869,decreased bone trabecula number|MP:0010965,decreased compact bone volume|MP:0011339,abnormal glomerular mesangium morphology|MP:0011467,decreased urine urea nitrogen level|MP:0011584,increased alkaline phosphatase activity
MGI:5688350	Jak1<tm1.1Kuw>	MP:0001957,apnea|MP:0004200,decreased fetal size|MP:0011087,neonatal lethality, complete penetrance
MGI:5688302	Jak1<tm1Kuw>	MP:0002169,no abnormal phenotype detected|MP:0006271,abnormal involution of the mammary gland
MGI:2448928	Jak1<tm1Rds>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001262,decreased body weight|MP:0001436,abnormal suckling behavior|MP:0001802,arrested B cell differentiation|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002401,abnormal lymphopoiesis|MP:0005017,decreased B cell number|MP:0005090,increased double-negative T cell number|MP:0011087,neonatal lethality, complete penetrance
MGI:5562422	Jak2<m1Dlbr>	MP:0001577,anemia|MP:0002875,decreased erythrocyte cell number|MP:0005397,hematopoietic system phenotype|MP:0005505,thrombocytosis|MP:0008254,increased megakaryocyte cell number|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4818800	Jak2<tm1.1Ble>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000322,increased granulocyte number|MP:0000691,enlarged spleen|MP:0001614,abnormal blood vessel morphology|MP:0002083,premature death|MP:0002447,abnormal erythrocyte morphology|MP:0002551,abnormal blood coagulation|MP:0002626,increased heart rate|MP:0002640,reticulocytosis|MP:0003131,increased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0005048,abnormal thrombosis|MP:0005426,tachypnea|MP:0005505,thrombocytosis|MP:0008254,increased megakaryocyte cell number|MP:0008713,abnormal cytokine level|MP:0011091,prenatal lethality, complete penetrance|MP:0013147,limb paralysis|MP:0020463,increased megakaryocyte progenitor cell number
MGI:4829538	Jak2<tm1.1Jlvl>	MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000322,increased granulocyte number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002083,premature death|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002608,increased hematocrit|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002813,microcytosis|MP:0003131,increased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0004151,decreased circulating iron level|MP:0005013,increased lymphocyte cell number|MP:0005097,polychromatophilia|MP:0005505,thrombocytosis|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008254,increased megakaryocyte cell number|MP:0008476,increased spleen red pulp amount|MP:0008479,decreased spleen white pulp amount|MP:0030025,giant platelets
MGI:3045147	Jak2<tm1.1Kuw>	MP:0000245,abnormal erythropoiesis|MP:0011091,prenatal lethality, complete penetrance
MGI:4818801	Jak2<tm1.2Ble>	MP:0000218,increased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001545,abnormal hematopoietic system physiology|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002356,abnormal spleen red pulp morphology|MP:0002417,abnormal megakaryocyte morphology|MP:0002608,increased hematocrit|MP:0003135,increased erythroid progenitor cell number|MP:0005397,hematopoietic system phenotype|MP:0008254,increased megakaryocyte cell number|MP:0010296,increased hemolymphoid system tumor incidence|MP:0011091,prenatal lethality, complete penetrance|MP:0020399,enhanced megakaryocyte emperipolesis
MGI:4836590	Jak2<tm1(JAK2)Argr>	MP:0000218,increased leukocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000229,abnormal megakaryocyte differentiation|MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0001545,abnormal hematopoietic system physiology|MP:0001577,anemia|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0004809,increased hematopoietic stem cell number|MP:0004810,decreased hematopoietic stem cell number|MP:0004952,increased spleen weight|MP:0005481,increased chronic myelocytic leukemia incidence|MP:0005505,thrombocytosis|MP:0005564,increased hemoglobin content|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008254,increased megakaryocyte cell number|MP:0008469,abnormal protein level|MP:0011747,myelofibrosis
MGI:2178844	Jak2<tm1Jni>	MP:0000229,abnormal megakaryocyte differentiation|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0001577,anemia|MP:0002875,decreased erythrocyte cell number|MP:0005397,hematopoietic system phenotype|MP:0005505,thrombocytosis|MP:0011091,prenatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3664597	Jak2<tm1Kf>	MP:0000245,abnormal erythropoiesis|MP:0001698,decreased embryo size|MP:0005397,hematopoietic system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0011092,embryonic lethality, complete penetrance
MGI:3045167	Jak2<tm1Kpf>	MP:0000239,absent common myeloid progenitor cells|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3045140	Jak2<tm1Kuw>	MP:0000628,abnormal mammary gland development|MP:0001923,reduced female fertility|MP:0001927,abnormal estrous cycle|MP:0001935,decreased litter size|MP:0001938,delayed sexual maturation|MP:0002169,no abnormal phenotype detected|MP:0002636,delayed vaginal opening|MP:0002680,decreased corpora lutea number|MP:0002773,decreased circulating luteinizing hormone level|MP:0003355,decreased ovulation rate|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology|MP:0004856,decreased ovary weight|MP:0005376,homeostasis/metabolism phenotype|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0006270,abnormal mammary gland growth during lactation|MP:0008976,delayed female fertility|MP:0009008,delayed estrous cycle|MP:0009011,prolonged diestrus|MP:0009015,short proestrus|MP:0009020,prolonged metestrus|MP:0010249,lactation failure
MGI:5320677	Jak2<tm1Mohi>	MP:0000065,abnormal bone marrow cavity morphology|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000333,decreased bone marrow cell number|MP:0000691,enlarged spleen|MP:0002356,abnormal spleen red pulp morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002608,increased hematocrit|MP:0002640,reticulocytosis|MP:0002813,microcytosis|MP:0002872,polycythemia|MP:0003131,increased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0004809,increased hematopoietic stem cell number|MP:0004952,increased spleen weight|MP:0005017,decreased B cell number|MP:0005505,thrombocytosis|MP:0005564,increased hemoglobin content|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008254,increased megakaryocyte cell number|MP:0008476,increased spleen red pulp amount|MP:0008479,decreased spleen white pulp amount|MP:0010373,myeloid hyperplasia|MP:0011746,spleen fibrosis|MP:0011747,myelofibrosis
MGI:5538395	Jak2<tm2.1Jlvl>	MP:0000218,increased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000322,increased granulocyte number|MP:0000333,decreased bone marrow cell number|MP:0000691,enlarged spleen|MP:0001601,abnormal myelopoiesis|MP:0002123,abnormal definitive hematopoiesis|MP:0002608,increased hematocrit|MP:0002640,reticulocytosis|MP:0002813,microcytosis|MP:0003131,increased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0004809,increased hematopoietic stem cell number|MP:0004952,increased spleen weight|MP:0005017,decreased B cell number|MP:0005505,thrombocytosis|MP:0005564,increased hemoglobin content|MP:0009278,abnormal bone marrow cell physiology|MP:0010373,myeloid hyperplasia|MP:0011179,decreased erythroblast number|MP:0011746,spleen fibrosis|MP:0011747,myelofibrosis
MGI:5566794	Jak2<tm2.1Kpf>	MP:0000601,small liver|MP:0003717,pallor|MP:0004229,abnormal embryonic erythropoiesis|MP:0005621,abnormal cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5538399	Jak2<tm2.2Jlvl>	MP:0000218,increased leukocyte cell number|MP:0000691,enlarged spleen|MP:0002872,polycythemia|MP:0005505,thrombocytosis
MGI:3611885	Jak3<bfy>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0002401,abnormal lymphopoiesis|MP:0003944,abnormal T cell subpopulation ratio|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005036,diarrhea
MGI:6336206	Jak3<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001304,cataract|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001404,no spontaneous movement|MP:0001417,decreased exploration in new environment|MP:0001711,abnormal placenta morphology|MP:0002151,abnormal neural tube morphology|MP:0002339,abnormal lymph node morphology|MP:0002699,abnormal vitreous body morphology|MP:0004924,abnormal behavior|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020870,decreased thigmotaxis
MGI:5615718	Jak3<m1Btlr>	MP:0000219,increased neutrophil cell number|MP:0001805,decreased IgG level|MP:0002497,increased IgE level|MP:0003944,abnormal T cell subpopulation ratio|MP:0005018,decreased T cell number|MP:0008045,decreased NK cell number|MP:0008082,increased single-positive T cell number|MP:0008083,decreased single-positive T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0020001,decreased response to antigen|MP:0020154,impaired humoral immune response|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:6108882	Jak3<m1J>	MP:0000692,small spleen|MP:0000706,small thymus|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight|MP:0005391,vision/eye phenotype
MGI:5468008	Jak3<M1Pgrs>	MP:0000691,enlarged spleen|MP:0000706,small thymus|MP:0002412,increased susceptibility to bacterial infection|MP:0004810,decreased hematopoietic stem cell number|MP:0005017,decreased B cell number|MP:0008045,decreased NK cell number|MP:0008071,absent B cells|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008567,decreased interferon-gamma secretion|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality
MGI:5615719	Jak3<m2Btlr>	MP:0005014,increased B cell number|MP:0008728,increased memory B cell number
MGI:5695010	Jak3<m3Btlr>	MP:0001606,impaired hematopoiesis|MP:0001805,decreased IgG level|MP:0003944,abnormal T cell subpopulation ratio|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005425,increased macrophage cell number|MP:0008045,decreased NK cell number|MP:0008083,decreased single-positive T cell number|MP:0008121,increased myeloid dendritic cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008729,decreased memory B cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0020154,impaired humoral immune response
MGI:6284798	Jak3<m4Btlr>	MP:0008074,increased CD4-positive, alpha-beta T cell number
MGI:6284802	Jak3<M5Btlr>	MP:0008040,decreased NK T cell number
MGI:6284807	Jak3<m6Btlr>	MP:0001805,decreased IgG level|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0020154,impaired humoral immune response
MGI:6284812	Jak3<M7Btlr>	MP:0008076,abnormal CD4-positive T cell differentiation
MGI:6305331	Jak3<m8Btlr>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008127,decreased dendritic cell number|MP:0008169,increased B-1b cell number|MP:0008207,decreased B-2 B cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0020001,decreased response to antigen|MP:0020154,impaired humoral immune response
MGI:3527456	Jak3<tm1Flv>	MP:0000691,enlarged spleen|MP:0001802,arrested B cell differentiation|MP:0001823,thymus hypoplasia|MP:0002217,small lymph nodes|MP:0005094,abnormal T cell proliferation|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:1857276	Jak3<tm1Ljb>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000245,abnormal erythropoiesis|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000694,spleen hypoplasia|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001601,abnormal myelopoiesis|MP:0001790,abnormal immune system physiology|MP:0001802,arrested B cell differentiation|MP:0001805,decreased IgG level|MP:0001823,thymus hypoplasia|MP:0001828,abnormal T cell activation|MP:0002145,abnormal T cell differentiation|MP:0002217,small lymph nodes|MP:0002357,abnormal spleen white pulp morphology|MP:0002376,abnormal dendritic cell physiology|MP:0002442,abnormal leukocyte physiology|MP:0002444,abnormal T cell physiology|MP:0002499,chronic inflammation|MP:0003945,abnormal lymphocyte physiology|MP:0004939,abnormal B cell morphology|MP:0005016,decreased lymphocyte cell number|MP:0005025,abnormal response to infection|MP:0005095,decreased T cell proliferation|MP:0005461,abnormal dendritic cell morphology|MP:0008024,absent lymph nodes|MP:0008071,absent B cells|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008101,lymph node hypoplasia|MP:0008115,abnormal dendritic cell differentiation|MP:0008122,decreased myeloid dendritic cell number|MP:0008135,small Peyer's patches|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008246,abnormal leukocyte morphology|MP:0008826,abnormal splenic cell ratio|MP:0008827,abnormal thymus cell ratio
MGI:3578806	Jak3<tm1Tks>	MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0000711,thymus cortex hypoplasia|MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0002144,abnormal B cell differentiation|MP:0002357,abnormal spleen white pulp morphology|MP:0002358,abnormal spleen periarteriolar lymphoid sheath morphology|MP:0002371,abnormal thymus cortex morphology|MP:0002375,abnormal thymus medulla morphology|MP:0002401,abnormal lymphopoiesis|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002442,abnormal leukocyte physiology|MP:0002444,abnormal T cell physiology|MP:0005017,decreased B cell number|MP:0005232,abnormal mesenteric lymph node morphology|MP:0006387,abnormal T cell number|MP:0008024,absent lymph nodes|MP:0008037,abnormal T cell morphology|MP:0008046,absent NK cells|MP:0008209,decreased pre-B cell number|MP:0009540,absent Hassall's corpuscle|MP:0009543,abnormal thymus corticomedullary boundary morphology|MP:0013588,small thymus medulla
MGI:3614703	Jak3<wil>	MP:0000221,decreased leukocyte cell number|MP:0000493,rectal prolapse|MP:0001802,arrested B cell differentiation|MP:0002083,premature death|MP:0003304,large intestinal inflammation|MP:0005036,diarrhea|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3665252	Jak3<X887Y>	MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0002339,abnormal lymph node morphology|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002619,abnormal lymphocyte morphology|MP:0002722,abnormal immune system organ morphology
MGI:4415497	Jakmip1<tm1(KOMP)Vlcg>	MP:0000849,abnormal cerebellum morphology|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001454,abnormal cued conditioning behavior|MP:0002063,abnormal learning/memory/conditioning|MP:0002272,abnormal nervous system electrophysiology|MP:0002557,abnormal social/conspecific interaction behavior|MP:0004102,abnormal dorsal striatum morphology|MP:0010698,abnormal impulsive behavior control|MP:0013140,excessive vocalization|MP:0021117,abnormal huddling behavior
MGI:6381361	Jakmip2<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0000218,increased leukocyte cell number|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0004738,abnormal auditory brainstem response|MP:0005559,increased circulating glucose level|MP:0005635,decreased circulating bilirubin level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6414769	Jakmip3<em1(IMPC)J>	MP:0002644,decreased circulating triglyceride level
MGI:6116683	Jam2<tm1.1(cre)Jrs>	MP:0008143,abnormal dendrite morphology
MGI:5516071	Jam2<tm1.1(KOMP)Mbp>	MP:0001325,abnormal retina morphology|MP:0002833,increased heart weight|MP:0005627,increased circulating potassium level|MP:0005633,increased circulating sodium level
MGI:5301450	Jam2<tm1.2Rha>	MP:0000321,increased bone marrow cell number|MP:0002398,abnormal bone marrow cell morphology/development|MP:0003992,increased mortality induced by ionizing radiation|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004989,decreased osteoblast cell number|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:3663271	Jam2<tm1Okud>	MP:0002169,no abnormal phenotype detected
MGI:5140157	Jam3<tm1.1Chav>	MP:0001273,decreased metastatic potential
MGI:5471366	Jam3<tm1.1(KOMP)Vlcg>	MP:0000759,abnormal skeletal muscle morphology|MP:0001925,male infertility|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011396,abnormal sleep behavior|MP:0013278,decreased fasting circulating glucose level
MGI:5140161	Jam3<tm1.2Chav>	MP:0001273,decreased metastatic potential|MP:0001925,male infertility|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5007203	Jam3<tm1Lex>	MP:0000222,decreased neutrophil cell number|MP:0000321,increased bone marrow cell number|MP:0000322,increased granulocyte number|MP:0001402,decreased locomotor activity|MP:0001575,cyanosis|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0002083,premature death|MP:0003135,increased erythroid progenitor cell number|MP:0004545,enlarged esophagus|MP:0004924,abnormal behavior|MP:0005159,azoospermia|MP:0005385,cardiovascular system phenotype|MP:0011090,perinatal lethality, incomplete penetrance|MP:0013891,increased common myeloid progenitor cell number
MGI:3055281	Jam3<tm1Rha>	MP:0000322,increased granulocyte number|MP:0000438,abnormal cranium morphology|MP:0000439,enlarged cranium|MP:0000745,tremors|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000825,dilated lateral ventricle|MP:0000917,obstructive hydrocephaly|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001406,abnormal gait|MP:0001511,disheveled coat|MP:0001663,abnormal digestive system physiology|MP:0001732,postnatal growth retardation|MP:0001861,lung inflammation|MP:0001891,hydrocephaly|MP:0001915,intracranial hemorrhage|MP:0001917,intraventricular hemorrhage|MP:0001925,male infertility|MP:0002082,postnatal lethality|MP:0002133,abnormal respiratory system physiology|MP:0002183,gliosis|MP:0002184,abnormal innervation|MP:0002216,abnormal seminiferous tubule morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002686,globozoospermia|MP:0004545,enlarged esophagus|MP:0005202,lethargy|MP:0006254,thin cerebral cortex|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014185,cerebellum atrophy|MP:0014812,abnormal brain physiology|MP:0031109,subarachnoid hemorrhage
MGI:6506225	Jaml<tm1Fnyi>	MP:0002962,increased urine protein level|MP:0005166,decreased susceptibility to injury|MP:0005264,glomerulosclerosis|MP:0011282,increased podocyte apoptosis|MP:0011561,renal glomerulus lipidosis|MP:0011753,decreased podocyte number|MP:0020153,abnormal urine albumin level
MGI:2655460	Jarid2<Gt(pGT1.8geo)6Pgr>	MP:0001785,edema|MP:0002080,prenatal lethality|MP:0003861,abnormal nervous system development
MGI:3710953	Jarid2<Gt(ROSA)1Gel>	MP:0000157,abnormal sternum morphology|MP:0000281,abnormal interventricular septum morphology|MP:0000284,double outlet right ventricle|MP:0000295,trabecula carnea hypoplasia|MP:0001698,decreased embryo size|MP:0001785,edema|MP:0001953,respiratory failure|MP:0002652,thin myocardium|MP:0004032,abnormal interventricular groove morphology|MP:0004056,abnormal myocardium compact layer morphology|MP:0004062,dilated heart right atrium|MP:0004624,abnormal thoracic cage morphology|MP:0005329,abnormal myocardium layer morphology|MP:0010402,ventricular septal defect|MP:0010551,abnormal coronary vessel morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011394,increased fetal cardiomyocyte proliferation
MGI:1856923	Jarid2<jumonji>	MP:0000245,abnormal erythropoiesis|MP:0000267,abnormal heart development|MP:0000278,abnormal myocardial fiber morphology|MP:0000292,distended pericardium|MP:0000598,abnormal liver morphology|MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0000602,dilated liver sinusoidal space|MP:0000606,decreased hepatocyte number|MP:0000609,abnormal liver physiology|MP:0000694,spleen hypoplasia|MP:0000928,incomplete rostral neuropore closure|MP:0001577,anemia|MP:0001654,hepatic necrosis|MP:0001698,decreased embryo size|MP:0001785,edema|MP:0001823,thymus hypoplasia|MP:0001914,hemorrhage|MP:0002123,abnormal definitive hematopoiesis|MP:0002151,abnormal neural tube morphology|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002621,delayed neural tube closure|MP:0003631,nervous system phenotype|MP:0003720,abnormal neural tube closure|MP:0003861,abnormal nervous system development|MP:0003921,abnormal heart left ventricle morphology|MP:0004201,fetal growth retardation|MP:0004837,abnormal neural fold formation|MP:0005657,abnormal neural plate morphology|MP:0008826,abnormal splenic cell ratio|MP:0008827,abnormal thymus cell ratio|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011243,decreased fetal derived definitive erythrocyte cell number
MGI:4362782	Jarid2<tm1a(KOMP)Wtsi>	MP:0001257,increased body length|MP:0005553,increased circulating creatinine level
MGI:3689383	Jarid2<tm1Yskl>	MP:0002169,no abnormal phenotype detected
MGI:6716237	Jazf1<em1Mgn>	MP:0010768,mortality/aging
MGI:5569067	Jazf1<tm1b(EUCOMM)Wtsi>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6690297	Jazf1<tm1c(EUCOMM)Wtsi>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0009114,decreased pancreatic beta cell mass|MP:0010147,abnormal endocrine pancreas physiology|MP:0013272,abnormal translation
MGI:1856613	jb	MP:0000416,sparse hair|MP:0000427,abnormal hair cycle|MP:0000947,convulsive seizures|MP:0001263,weight loss|MP:0001393,ataxia|MP:0001511,disheveled coat|MP:0001935,decreased litter size|MP:0002073,abnormal hair growth|MP:0002164,abnormal gland physiology|MP:0004831,long incisors|MP:0005114,premature hair loss|MP:0005358,abnormal incisor morphology|MP:0008861,abnormal hair shedding
MGI:6257454	Jcad<em1(IMPC)Bay>	MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:6355918	Jcad<tm1Kih>	MP:0001262,decreased body weight|MP:0003447,decreased tumor growth/size|MP:0005385,cardiovascular system phenotype|MP:0005602,decreased angiogenesis|MP:0010144,abnormal tumor vascularization
MGI:6192498	jcat	MP:0001304,cataract
MGI:2181559	Jchain<tm1Jse>	MP:0002459,abnormal B cell physiology|MP:0002495,increased IgA level|MP:0004047,abnormal milk composition|MP:0004773,abnormal bile composition|MP:0005027,increased susceptibility to parasitic infection|MP:0008864,abnormal intestinal secretion|MP:0020917,decreased susceptibility to Herpesvirales infection|MP:0031025,decreased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:2451101	Jchain<tm1Tl>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002495,increased IgA level
MGI:2451105	Jchain<tm2(Myc)Tl>	MP:0001800,abnormal humoral immune response
MGI:3641196	Jchain<tm3Tl>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001819,abnormal immune cell physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002459,abnormal B cell physiology|MP:0002473,impaired complement classical pathway|MP:0002495,increased IgA level|MP:0008098,decreased plasma cell number
MGI:1856615	jd	MP:0000397,abnormal guard hair morphology|MP:0000402,abnormal zigzag hair morphology|MP:0000416,sparse hair|MP:0000427,abnormal hair cycle|MP:0001510,abnormal coat appearance|MP:0008538,decreased zigzag hair amount|MP:0008861,abnormal hair shedding|MP:0010771,integument phenotype
MGI:5471474	Jdp2<tm1Aki>	MP:0000062,increased bone mineral density|MP:0000067,osteopetrosis|MP:0000130,abnormal trabecular bone morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0003109,short femur|MP:0003795,abnormal bone structure|MP:0004982,abnormal osteoclast morphology|MP:0005399,increased susceptibility to fungal infection|MP:0008396,abnormal osteoclast differentiation|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume
MGI:3808998	Jdp2<tm1Kkyo>	MP:0000351,increased cell proliferation|MP:0000592,short tail|MP:0001200,thick skin|MP:0002724,enhanced wound healing|MP:0003077,abnormal cell cycle|MP:0005076,abnormal cell differentiation|MP:0005501,abnormal skin physiology|MP:0009115,abnormal fat cell morphology
MGI:5445757	Jdp2<tm1Kmm>	MP:0002169,no abnormal phenotype detected
MGI:4849487	Jdp2<tm2Kkyo>	MP:0000592,short tail
MGI:1856922	jg	MP:0000585,kinked tail|MP:0001119,abnormal female reproductive system morphology|MP:0001127,small ovary|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001539,decreased caudal vertebrae number|MP:0001921,reduced fertility|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001933,abnormal litter size|MP:0001935,decreased litter size|MP:0002161,abnormal fertility/fecundity|MP:0002759,abnormal caudal vertebrae morphology|MP:0003698,abnormal male reproductive system physiology|MP:0004849,abnormal testis size|MP:0004853,abnormal ovary size|MP:0005225,abnormal vertebrae development|MP:0011100,preweaning lethality, complete penetrance
MGI:5437647	Jhy<Tg(Dlk1-lacZ)#aJvs>	MP:0000440,domed cranium|MP:0001263,weight loss|MP:0001393,ataxia|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0008535,enlarged lateral ventricles|MP:0011056,abnormal brain ependyma motile cilium morphology|MP:0030963,abnormal brain ependyma motile cilium location or orientation|MP:0030964,decreased brain ependyma motile cilium length|MP:0030966,decreased brain ependyma motile cilium number
MGI:4842320	Jmjd1c<tm1a(EUCOMM)Wtsi>	MP:0001322,abnormal iris morphology|MP:0002546,mydriasis|MP:0003036,vertebral transformation|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5544070	Jmjd1c<tm1Mtac>	MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0008995,early reproductive senescence|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014052,increased male germ cell apoptosis|MP:0014617,decreased spermatogonia number
MGI:6153375	Jmjd4<em1(IMPC)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0005358,abnormal incisor morphology|MP:0005561,increased mean corpuscular hemoglobin|MP:0010025,decreased total body fat amount|MP:0010088,decreased circulating fructosamine level|MP:0013278,decreased fasting circulating glucose level
MGI:5805230	Jmjd4<tm1.2Khh>	MP:0002169,no abnormal phenotype detected
MGI:3606752	Jmjd6<tm1.1Gbf>	MP:0010402,ventricular septal defect
MGI:5548491	Jmjd6<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0001488,increased startle reflex|MP:0001516,abnormal motor coordination/balance|MP:0002792,abnormal retina vasculature morphology|MP:0008935,decreased mean platelet volume|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:3580706	Jmjd6<tm1Gbf>	MP:0000245,abnormal erythropoiesis|MP:0000284,double outlet right ventricle|MP:0000477,abnormal intestine morphology|MP:0000484,abnormal pulmonary artery morphology|MP:0000527,abnormal kidney development|MP:0000706,small thymus|MP:0000914,exencephaly|MP:0001293,anophthalmia|MP:0001786,skin edema|MP:0001823,thymus hypoplasia|MP:0002132,abnormal respiratory system morphology|MP:0003717,pallor|MP:0004057,thin myocardium compact layer|MP:0004201,fetal growth retardation|MP:0005294,abnormal heart ventricle morphology|MP:0005384,cellular phenotype|MP:0009890,cleft secondary palate|MP:0010402,ventricular septal defect|MP:0010503,myocardial trabeculae hypoplasia|MP:0011075,abnormal macrophage activation involved in immune response|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011495,abnormal head shape
MGI:6153376	Jmjd7<em1(IMPC)Wtsi>	MP:0002079,increased circulating insulin level|MP:0008806,increased circulating amylase level
MGI:7386879	Jmjd8<em1Kaso>	MP:0001876,decreased inflammatory response|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005378,growth/size/body region phenotype|MP:0005670,abnormal white adipose tissue physiology|MP:0008642,decreased circulating interleukin-1 beta level|MP:0030016,increased adipocyte glucose uptake
MGI:5603571	Jmjd8<tm1.1(KOMP)Vlcg>	MP:0004151,decreased circulating iron level
MGI:4452995	Jmjd8<tm1(KOMP)Vlcg>	MP:0003658,abnormal capillary morphology|MP:0010954,abnormal cellular respiration
MGI:6724570	Jmy<tm1Smoc>	MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0009233,enlarged sperm head|MP:0020356,abnormal Sertoli cell barrier function|MP:0020451,decreased sperm progressive motility
MGI:2183252	Jph1<tm1Hta>	MP:0002841,impaired skeletal muscle contractility|MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0009411,abnormal skeletal muscle fiber triad morphology|MP:0009546,absent gastric milk in neonates|MP:0011087,neonatal lethality, complete penetrance
MGI:1891502	Jph2<tm1Hta>	MP:0000278,abnormal myocardial fiber morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001636,irregular heartbeat|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2181318	Jph3<tm1Hta>	MP:0001405,impaired coordination|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:3663386	Jph4<tm1Hta>	MP:0001828,abnormal T cell activation|MP:0004231,abnormal calcium ion homeostasis|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0008751,abnormal interleukin level
MGI:3832074	jpl	MP:0000745,tremors|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0003633,abnormal nervous system physiology
MGI:5788505	Jpt1<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:6473336	Jpx<em1Ehea>	MP:0005389,reproductive system phenotype
MGI:2447993	jrc	MP:0001297,microphthalmia|MP:0001304,cataract
MGI:1859954	Jsr	MP:0000137,abnormal vertebrae morphology|MP:0000154,rib fusion|MP:0000160,kyphosis|MP:0000161,scoliosis|MP:0000162,lordosis|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001258,decreased body length|MP:0001921,reduced fertility|MP:0004609,vertebral fusion|MP:0004610,small vertebrae|MP:0004623,thoracic vertebral fusion|MP:0004645,decreased vertebrae number|MP:0004652,small caudal vertebrae|MP:0004704,short vertebral column|MP:0005225,abnormal vertebrae development|MP:0005226,abnormal vertebral arch development
MGI:3768247	Jsrp1<tm1Zor>	MP:0000747,muscle weakness|MP:0002106,abnormal muscle physiology|MP:0012106,impaired exercise endurance
MGI:1856576	jt	MP:0000564,syndactyly|MP:0002110,abnormal digit morphology
MGI:5609346	Jtb<tm1b(EUCOMM)Hmgu>	MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration|MP:0013292,embryonic lethality prior to organogenesis
MGI:3832453	jt<Ectr>	MP:0000564,syndactyly|MP:0002110,abnormal digit morphology|MP:0004576,abnormal embryonic autopod plate morphology|MP:0006280,abnormal digit development
MGI:6150878	Junb<tm1b(EUCOMM)Hmgu>	MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0002151,abnormal neural tube morphology|MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0004952,increased spleen weight|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3036209	Junb<tm3Wag>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0001194,dermatitis|MP:0001200,thick skin|MP:0001209,spontaneous skin ulceration|MP:0001533,abnormal skeleton physiology|MP:0001846,increased inflammatory response|MP:0002083,premature death|MP:0002113,abnormal skeleton development|MP:0002497,increased IgE level|MP:0002743,glomerulonephritis|MP:0002764,short tibia|MP:0002871,albuminuria|MP:0002989,small kidney|MP:0004796,increased anti-histone antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004970,kidney atrophy|MP:0004982,abnormal osteoclast morphology|MP:0004985,decreased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0004991,decreased bone strength|MP:0004993,decreased bone resorption|MP:0005481,increased chronic myelocytic leukemia incidence|MP:0008097,increased plasma cell number|MP:0008140,podocyte foot process effacement|MP:0008271,abnormal bone ossification|MP:0008396,abnormal osteoclast differentiation|MP:0008596,increased circulating interleukin-6 level|MP:0008705,increased interleukin-6 secretion|MP:0011159,abnormal epidermal-dermal junction morphology|MP:0011320,abnormal glomerular capillary morphology|MP:0011405,tubulointerstitial nephritis|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011427,increased mesangial cell number|MP:0011567,increased renal glomerulus lobularity|MP:0020519,renal glomerular immunoglobulin deposits
MGI:2385829	Jund<tm1Mya>	MP:0000351,increased cell proliferation|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001860,liver inflammation|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002566,abnormal sexual interaction|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003077,abnormal cell cycle|MP:0003402,decreased liver weight|MP:0004486,decreased response of heart to induced stress|MP:0005120,decreased circulating growth hormone level|MP:0005136,decreased growth hormone level|MP:0005178,increased circulating cholesterol level|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005466,abnormal T-helper 2 physiology|MP:0005560,decreased circulating glucose level|MP:0005578,teratozoospermia|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008735,increased susceptibility to endotoxin shock|MP:0008907,decreased total fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0011704,decreased fibroblast proliferation|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:6276918	Jun<em1(IMPC)Mbp>	MP:0000428,abnormal craniofacial morphology|MP:0000702,enlarged lymph nodes|MP:0001293,anophthalmia|MP:0001399,hyperactivity|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002092,abnormal eye morphology|MP:0002151,abnormal neural tube morphology|MP:0002339,abnormal lymph node morphology|MP:0003984,embryonic growth retardation|MP:0009141,increased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:2384450	Jun<tm1Bdc>	MP:0003204,decreased neuron apoptosis
MGI:1857209	Jun<tm1Pa>	MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:2673694	Jun<tm1Rsjo>	MP:0001297,microphthalmia|MP:0001302,eyelids open at birth|MP:0001313,increased incidence of corneal inflammation|MP:0001792,impaired wound healing|MP:0002655,abnormal keratinocyte morphology|MP:0002908,delayed wound healing|MP:0003453,abnormal keratinocyte physiology|MP:0009264,failure of eyelid fusion|MP:0009584,decreased keratinocyte proliferation|MP:0009651,abnormal eyelid development|MP:0009859,eye opacity
MGI:2149630	Jun<tm1Wag>	MP:0000255,blood vessel congestion|MP:0000352,decreased cell proliferation|MP:0000596,abnormal liver development|MP:0000608,dissociated hepatocytes|MP:0000783,abnormal forebrain morphology|MP:0001654,hepatic necrosis|MP:0001785,edema|MP:0002633,persistent truncus arteriosus|MP:0002929,abnormal bile duct development|MP:0003674,oxidative stress|MP:0003887,increased hepatocyte apoptosis|MP:0004001,decreased hepatocyte proliferation|MP:0004158,right aortic arch|MP:0009395,increased nucleated erythrocyte cell number|MP:0010402,ventricular septal defect|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012752,abnormal cardiac neural crest cell migration|MP:0021160,decreased heart right ventricle wall thickness
MGI:2149755	Jun<tm2.1Wag>	MP:0000352,decreased cell proliferation|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0008236,decreased susceptibility to neuronal excitotoxicity|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death
MGI:2149757	Jun<tm3.1Wag>	MP:0002169,no abnormal phenotype detected
MGI:2445420	Jun<tm4Wag>	MP:0000160,kyphosis|MP:0000161,scoliosis|MP:0000284,double outlet right ventricle|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001302,eyelids open at birth|MP:0001861,lung inflammation|MP:0001958,emphysema|MP:0002658,abnormal liver regeneration|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0002747,abnormal aortic valve morphology|MP:0002748,abnormal pulmonary valve morphology|MP:0003204,decreased neuron apoptosis|MP:0003402,decreased liver weight|MP:0003631,nervous system phenotype|MP:0004160,retroesophageal right subclavian artery|MP:0004613,fusion of vertebral arches|MP:0004624,abnormal thoracic cage morphology|MP:0005385,cardiovascular system phenotype|MP:0006126,abnormal cardiac outflow tract development|MP:0008713,abnormal cytokine level|MP:0008752,abnormal tumor necrosis factor level|MP:0010402,ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010602,abnormal pulmonary valve cusp morphology|MP:0010605,thick pulmonary valve cusps|MP:0010617,thick mitral valve cusps|MP:0010768,mortality/aging|MP:0010899,abnormal pulmonary alveolar system morphology|MP:0010901,abnormal pulmonary alveolar parenchyma morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011659,interrupted aortic arch, type b|MP:0030002,increased lung apoptosis|MP:0031524,mitral valve hyperplasia|MP:0031526,thin right ventricle myocardium compact layer|MP:0031529,pulmonary valve hyperplasia|MP:0031581,semilunar valve hyperplasia
MGI:2660773	Jun<tm5.1(Junb)Wag>	MP:0000350,abnormal cell proliferation|MP:0001302,eyelids open at birth|MP:0001575,cyanosis|MP:0002633,persistent truncus arteriosus|MP:0005370,liver/biliary system phenotype|MP:0009264,failure of eyelid fusion|MP:0010402,ventricular septal defect|MP:0010454,abnormal truncus arteriosus septation|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5284971	Jun<tm6.1(Jund)Wag>	MP:0000352,decreased cell proliferation|MP:0000914,exencephaly|MP:0001302,eyelids open at birth|MP:0002151,abnormal neural tube morphology|MP:0002633,persistent truncus arteriosus|MP:0003674,oxidative stress|MP:0003984,embryonic growth retardation|MP:0005370,liver/biliary system phenotype|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5755302	Jup<tm1.1Chen>	MP:0001211,wrinkled skin|MP:0001218,thin epidermis|MP:0005385,cardiovascular system phenotype|MP:0005421,loose skin|MP:0005501,abnormal skin physiology|MP:0011087,neonatal lethality, complete penetrance
MGI:4947239	Jup<tm1.1Glr>	MP:0000278,abnormal myocardial fiber morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001853,heart inflammation|MP:0002083,premature death|MP:0002625,heart left ventricle hypertrophy|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003828,pulmonary edema|MP:0003920,abnormal heart right ventricle morphology|MP:0004090,abnormal sarcomere morphology|MP:0004093,diffuse Z line|MP:0004564,increased myocardial fiber size|MP:0005385,cardiovascular system phenotype|MP:0006267,abnormal intercalated disk morphology|MP:0008751,abnormal interleukin level|MP:0010563,increased heart right ventricle size|MP:0010579,increased heart left ventricle size|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5490517	Jup<tm1.1(KOMP)Vlcg>	MP:0000198,decreased circulating phosphate level|MP:0001523,impaired righting response|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0003064,decreased coping response|MP:0005564,increased hemoglobin content|MP:0011100,preweaning lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:5296511	Jup<tm1.1Shou>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0002083,premature death|MP:0002754,dilated heart right ventricle|MP:0003137,abnormal impulse conducting system conduction|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0003896,prolonged PR interval|MP:0004070,abnormal P wave|MP:0004564,increased myocardial fiber size|MP:0004937,dilated heart|MP:0005140,decreased cardiac muscle contractility|MP:0005294,abnormal heart ventricle morphology|MP:0005330,cardiomyopathy|MP:0008727,increased heart right atrium size|MP:0008950,ventricular tachycardia|MP:0010019,liver vascular congestion|MP:0010394,decreased QRS amplitude|MP:0010421,ventricular aneurysm|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010534,calcified myocardium|MP:0010632,cardiac muscle necrosis
MGI:4947240	Jup<tm1.2Glr>	MP:0008762,embryonic lethality
MGI:1857539	Jup<tm1Kem>	MP:0000267,abnormal heart development|MP:0000274,enlarged heart|MP:0000295,trabecula carnea hypoplasia|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000601,small liver|MP:0001208,blistering|MP:0001216,abnormal epidermal layer morphology|MP:0001218,thin epidermis|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001241,absent epidermis stratum corneum|MP:0001855,abnormal atrial thrombosis|MP:0002128,abnormal blood circulation|MP:0002652,thin myocardium|MP:0002796,impaired skin barrier function|MP:0003089,decreased skin tensile strength|MP:0003105,abnormal heart atrium morphology|MP:0004241,acantholysis|MP:0004259,small placenta|MP:0005244,hemopericardium|MP:0006268,absent cardiac desmosomes|MP:0010771,integument phenotype|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0020409,abnormal cardiac thrombosis|MP:0031147,abnormal ventricular thrombosis
MGI:1861958	Jup<tm1Ruiz>	MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000598,abnormal liver morphology|MP:0002128,abnormal blood circulation|MP:0002626,increased heart rate|MP:0002972,abnormal cardiac muscle contractility|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0005244,hemopericardium|MP:0006267,abnormal intercalated disk morphology|MP:0006268,absent cardiac desmosomes|MP:0010725,thin interventricular septum|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011168,abnormal fat cell differentiation|MP:0011925,abnormal heart echocardiography feature|MP:0012099,decreased spongiotrophoblast size
MGI:5755303	Jup<tm2.1Chen>	MP:0002169,no abnormal phenotype detected
MGI:4830598	KAL003	MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level
MGI:4830599	KAL004	MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level
MGI:4830600	KAL006	MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level
MGI:4830596	KAL007	MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level
MGI:3831292	Kalrn<tm1.1Npl>	MP:0001364,decreased anxiety-related response|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0003858,enhanced coordination|MP:0004811,abnormal neuron physiology|MP:0004998,decreased CNS synapse formation|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential|MP:0008143,abnormal dendrite morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0014379,decreased excitatory postsynaptic current frequency
MGI:4358076	Kalrn<tm1Ppen>	MP:0001399,hyperactivity|MP:0002557,abnormal social/conspecific interaction behavior|MP:0008428,abnormal spatial working memory|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009142,decreased prepulse inhibition|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0011003,reduced AMPA-mediated synaptic currents|MP:0014376,decreased miniature excitatory postsynaptic current frequency|MP:0031391,increased locomotor activity
MGI:5551305	Kalrn<tm2.1Npl>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001447,abnormal nest building behavior|MP:0001489,decreased startle reflex|MP:0001732,postnatal growth retardation|MP:0001746,abnormal pituitary secretion|MP:0003506,acromegaly|MP:0003631,nervous system phenotype|MP:0003838,abnormal milk ejection|MP:0004000,impaired passive avoidance behavior|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0004924,abnormal behavior|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008028,pregnancy-related premature death|MP:0008779,abnormal maternal behavior|MP:0010768,mortality/aging|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012010,parturition failure|MP:0030567,abnormal I band morphology
MGI:5551304	Kalrn<tm2Npl>	MP:0001405,impaired coordination|MP:0002169,no abnormal phenotype detected
MGI:7860796	Kank1<em1Cya>	MP:0003985,renal fibrosis|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0011534,granular kidney
MGI:6257642	Kank1<em1(IMPC)Bay>	MP:0000195,decreased circulating calcium level|MP:0009142,decreased prepulse inhibition|MP:0011960,abnormal eye anterior chamber depth
MGI:7748760	Kank4<em1Jhhu>	MP:0000259,abnormal vascular development|MP:0002128,abnormal blood circulation|MP:0002191,abnormal artery morphology|MP:0005367,renal/urinary system phenotype|MP:0012201,decreased endothelial cell proliferation
MGI:7751439	Kansl1<em1.1Cya>	MP:0003674,oxidative stress|MP:0005140,decreased cardiac muscle contractility|MP:0008260,abnormal autophagy|MP:0011091,prenatal lethality, complete penetrance|MP:0011925,abnormal heart echocardiography feature|MP:0012307,impaired spatial learning|MP:0014367,impaired long-term object recognition memory|MP:0020508,decreased dendritic spine density
MGI:7751438	Kansl1<em1Cya>	MP:0003674,oxidative stress|MP:0004811,abnormal neuron physiology|MP:0008260,abnormal autophagy|MP:0014046,abnormal mitophagy|MP:0014345,abnormal neuron mitochondrial morphology
MGI:6379553	Kansl1l<tm1b(EUCOMM)Wtsi>	MP:0001147,small testis|MP:0001148,enlarged testis|MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0011965,decreased total retina thickness
MGI:5699600	Kansl1<tm1b(EUCOMM)Hmgu>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002574,increased vertical activity|MP:0002804,abnormal motor learning|MP:0003858,enhanced coordination|MP:0003908,decreased stereotypic behavior|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0010025,decreased total body fat amount|MP:0014367,impaired long-term object recognition memory|MP:0020477,abnormal locomotor circadian rhythm
MGI:6455411	Kansl2<tm1c(EUCOMM)Wtsi>	MP:0001914,hemorrhage|MP:0001917,intraventricular hemorrhage|MP:0008535,enlarged lateral ventricles|MP:0011085,postnatal lethality, complete penetrance
MGI:6258443	Kansl3<em1(IMPC)J>	MP:0001713,decreased trophoblast giant cell number|MP:0001728,failure of embryo implantation|MP:0001730,embryonic growth arrest|MP:0002718,abnormal inner cell mass morphology|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0003886,abnormal embryonic epiblast morphology|MP:0005028,abnormal trophectoderm morphology|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011183,abnormal primitive endoderm morphology|MP:0012167,abnormal epigenetic regulation of gene expression|MP:0013292,embryonic lethality prior to organogenesis
MGI:6455408	Kansl3<tm1.1Max>	MP:0001914,hemorrhage|MP:0001917,intraventricular hemorrhage|MP:0008535,enlarged lateral ventricles|MP:0011085,postnatal lethality, complete penetrance
MGI:5565171	Kantr<tm1Vlcg>	MP:0000745,tremors
MGI:4344829	Kars1<Gt(AJ0130)Wtsi>	MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:5573275	Kars1<tm2b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5901859	Kash5<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0001402,decreased locomotor activity|MP:0001556,increased circulating HDL cholesterol level|MP:0001925,male infertility|MP:0001926,female infertility|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5700363	Kash5<tm1b(KOMP)Wtsi>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002777,absent ovarian follicles|MP:0004901,decreased male germ cell number|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0009451,abnormal chromosomal synapsis|MP:0013601,increased testis apoptosis|MP:0014764,impaired double-strand DNA break repair|MP:0030024,abnormal meiotic attachment of telomere to nuclear envelope
MGI:3836392	Kat14<Gt(OST388291)Lex>	MP:0001698,decreased embryo size|MP:0003077,abnormal cell cycle|MP:0006042,increased apoptosis|MP:0011092,embryonic lethality, complete penetrance|MP:0012701,increased embryonic neuroepithelium apoptosis
MGI:4363521	Kat14<tm1a(KOMP)Wtsi>	MP:0000161,scoliosis|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001286,abnormal eye development|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001322,abnormal iris morphology|MP:0001324,abnormal eye pigmentation|MP:0002092,abnormal eye morphology|MP:0002100,abnormal tooth morphology|MP:0002411,decreased susceptibility to bacterial infection|MP:0002697,abnormal eye size|MP:0002700,increased opacity of vitreous body|MP:0002874,decreased hemoglobin content|MP:0003671,abnormal eyelid aperture|MP:0003961,decreased lean body mass|MP:0004174,abnormal spine curvature|MP:0004609,vertebral fusion|MP:0004613,fusion of vertebral arches|MP:0004924,abnormal behavior|MP:0005176,eyelids fail to open|MP:0005270,abnormal zygomatic bone morphology|MP:0005300,abnormal cornea stroma morphology|MP:0005391,vision/eye phenotype|MP:0005542,cornea vascularization|MP:0010101,increased sacral vertebrae number|MP:0010124,decreased bone mineral content|MP:0010831,lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5910764	Kat14<tm1d(KOMP)Wtsi>	MP:0005391,vision/eye phenotype
MGI:2386309	Kat2a<tm1Nkt>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0001914,hemorrhage|MP:0003229,abnormal vitelline vasculature morphology|MP:0003720,abnormal neural tube closure|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2386279	Kat2a<tm1Roth>	MP:0000932,absent notochord|MP:0001680,abnormal mesoderm development|MP:0002151,abnormal neural tube morphology|MP:0003984,embryonic growth retardation|MP:0004647,decreased lumbar vertebrae number|MP:0006386,absent somites|MP:0008029,abnormal paraxial mesoderm morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011200,abnormal extraembryonic coelom morphology|MP:0011260,abnormal head mesenchyme morphology|MP:0012271,abnormal chordamesoderm morphology
MGI:3711317	Kat2a<tm2Roth>	MP:0000847,abnormal metencephalon morphology|MP:0000897,abnormal midbrain morphology|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0000929,open neural tube|MP:0000934,abnormal telencephalon development|MP:0001690,failure of somite differentiation|MP:0001698,decreased embryo size|MP:0005380,embryo phenotype|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3800307	Kat2a<tm3.1Roth>	MP:0001672,abnormal embryo development|MP:0002088,abnormal embryonic growth/weight/body size|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3801276	Kat2a<tm3.2Roth>	MP:0002169,no abnormal phenotype detected|MP:0005390,skeleton phenotype
MGI:3800306	Kat2a<tm3Roth>	MP:0000154,rib fusion|MP:0000480,increased rib number|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0001951,abnormal breathing pattern|MP:0003036,vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004647,decreased lumbar vertebrae number|MP:0004680,small xiphoid process|MP:0011085,postnatal lethality, complete penetrance|MP:0012282,abnormal sternebra number
MGI:6140207	Kat2b<em1(IMPC)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010067,increased red blood cell distribution width
MGI:2386307	Kat2b<tm1Nkt>	MP:0002169,no abnormal phenotype detected
MGI:2386280	Kat2b<tm1Roth>	MP:0002169,no abnormal phenotype detected
MGI:5707437	Kat5<tm1.1(KOMP)Vlcg>	MP:0002092,abnormal eye morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3526095	Kat5<tm1Jwl>	MP:0006204,embryonic lethality before implantation
MGI:3847653	Kat6a<tm1.1Glac>	MP:0000694,spleen hypoplasia|MP:0001262,decreased body weight|MP:0001823,thymus hypoplasia|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008215,decreased immature B cell number|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number
MGI:3626344	Kat6a<tm1Avo>	MP:0000111,cleft palate|MP:0000137,abnormal vertebrae morphology|MP:0000245,abnormal erythropoiesis|MP:0000266,abnormal heart morphology|MP:0000273,overriding aortic valve|MP:0000333,decreased bone marrow cell number|MP:0000428,abnormal craniofacial morphology|MP:0000486,abnormal pulmonary trunk morphology|MP:0000690,absent spleen|MP:0000704,abnormal thymus development|MP:0000705,athymia|MP:0000706,small thymus|MP:0001505,hunched posture|MP:0001575,cyanosis|MP:0001823,thymus hypoplasia|MP:0001914,hemorrhage|MP:0001921,reduced fertility|MP:0002123,abnormal definitive hematopoiesis|MP:0002184,abnormal innervation|MP:0002639,micrognathia|MP:0003048,abnormal cervical vertebrae morphology|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004110,transposition of great arteries|MP:0004113,abnormal aortic arch morphology|MP:0004160,retroesophageal right subclavian artery|MP:0004607,abnormal cervical atlas morphology|MP:0004618,thoracic vertebral transformation|MP:0004648,decreased thoracic vertebrae number|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0005089,decreased double-negative T cell number|MP:0005389,reproductive system phenotype|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0009395,increased nucleated erythrocyte cell number|MP:0009890,cleft secondary palate|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010412,atrioventricular septal defect|MP:0010432,common ventricle|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011659,interrupted aortic arch, type b
MGI:5705134	Kat6a<tm1b(EUCOMM)Wtsi>	MP:0000259,abnormal vascular development|MP:0004200,decreased fetal size|MP:0006208,lethality throughout fetal growth and development
MGI:5763051	Kat6a<tm1c(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:3629032	Kat6a<tm1Iki>	MP:0000239,absent common myeloid progenitor cells|MP:0000245,abnormal erythropoiesis|MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0001601,abnormal myelopoiesis|MP:0001786,skin edema|MP:0001914,hemorrhage|MP:0002111,abnormal tail morphology|MP:0003717,pallor|MP:0004810,decreased hematopoietic stem cell number|MP:0005017,decreased B cell number|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4418468	Kat6a<tm2.2Avo>	MP:0000266,abnormal heart morphology|MP:0000428,abnormal craniofacial morphology|MP:0003702,abnormal chromosome morphology|MP:0004160,retroesophageal right subclavian artery|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0010402,ventricular septal defect|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2679726	Kat6b<Gt(pKC199)1Pgr>	MP:0000023,abnormal ear position|MP:0000088,short mandible|MP:0000109,abnormal parietal bone morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000435,shortened head|MP:0000438,abnormal cranium morphology|MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000934,abnormal telencephalon development|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001732,postnatal growth retardation|MP:0002108,abnormal muscle morphology|MP:0002741,small olfactory bulb|MP:0003840,abnormal coronal suture morphology|MP:0005269,abnormal occipital bone morphology|MP:0005459,decreased percent body fat/body weight|MP:0006009,abnormal neuronal migration|MP:0006395,abnormal epiphyseal plate morphology|MP:0008439,abnormal cortical plate morphology|MP:0008969,abnormal nasolacrimal duct morphology|MP:0009038,decreased inferior colliculus size|MP:0009974,decreased cerebral cortex pyramidal cell number|MP:0010743,delayed cranial suture closure|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011504,abnormal limb long bone morphology
MGI:5702933	Kat6b<m1Mhda>	MP:0002169,no abnormal phenotype detected|MP:0011091,prenatal lethality, complete penetrance
MGI:4947690	Kat7<tm1.1Avo>	MP:0005384,cellular phenotype
MGI:4947692	Kat7<tm1.2Avo>	MP:0001614,abnormal blood vessel morphology|MP:0001688,abnormal somite development|MP:0001701,incomplete embryo turning|MP:0001723,disorganized yolk sac vascular plexus|MP:0001730,embryonic growth arrest|MP:0002925,abnormal cardiovascular development|MP:0003984,embryonic growth retardation|MP:0004068,dilated dorsal aorta|MP:0004076,abnormal vitelline vascular remodeling|MP:0004086,absent heartbeat|MP:0005384,cellular phenotype|MP:0009657,failure of chorioallantoic fusion|MP:0010355,abnormal first pharyngeal arch artery morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:6336207	Kat8<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000702,enlarged lymph nodes|MP:0001304,cataract|MP:0001402,decreased locomotor activity|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0004924,abnormal behavior|MP:0005178,increased circulating cholesterol level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0020870,decreased thigmotaxis
MGI:3810976	Kat8<tm1.1Avo>	MP:0003702,abnormal chromosome morphology|MP:0004760,increased mitotic index|MP:0010380,abnormal inner cell mass apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation|MP:0012117,decreased trophectoderm cell proliferation
MGI:6455412	Kat8<tm1.2Avo>	MP:0000788,abnormal cerebral cortex morphology|MP:0001914,hemorrhage|MP:0003719,abnormal pericyte morphology|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004950,abnormal brain vasculature morphology|MP:0005281,increased fatty acids level|MP:0008535,enlarged lateral ventricles|MP:0011085,postnatal lethality, complete penetrance|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance
MGI:3769362	Kat8<tm1Thl>	MP:0001125,abnormal oocyte morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0003674,oxidative stress|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0004856,decreased ovary weight|MP:0005389,reproductive system phenotype|MP:0005431,decreased oocyte number|MP:0008058,abnormal DNA repair|MP:0011704,decreased fibroblast proliferation|MP:0012167,abnormal epigenetic regulation of gene expression|MP:0020364,abnormal female germ cell physiology|MP:0031239,increased atretic ovarian follicle number|MP:0031474,increased female germ cell apoptosis
MGI:3769376	Kat8<tm2Thl>	MP:0001672,abnormal embryo development|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6156142	Katna1<em1(IMPC)Rbrc>	MP:0001148,enlarged testis|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4458514	Katna1<tm1a(KOMP)Wtsi>	MP:0003631,nervous system phenotype|MP:0004948,abnormal neuronal precursor proliferation|MP:0004980,increased neuronal precursor cell number|MP:0005386,behavior/neurological phenotype|MP:0011091,prenatal lethality, complete penetrance|MP:0020394,decreased neuronal precursor proliferation|MP:0030981,abnormal dentate gyrus subgranular zone morphology
MGI:5309172	Katnal1<1H>	MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0004852,decreased testis weight|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014633,decreased spermatid number|MP:0014636,decreased elongated spermatid number
MGI:6414512	Katnal1<em1(IMPC)Tcp>	MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002591,decreased mean corpuscular volume|MP:0002792,abnormal retina vasculature morphology|MP:0003068,enlarged kidney|MP:0003717,pallor|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011874,enlarged urinary bladder
MGI:6156497	Katnal2<em1(IMPC)Tcp>	MP:0000220,increased monocyte cell number|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001925,male infertility|MP:0001944,abnormal pancreas morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003883,enlarged stomach|MP:0011874,enlarged urinary bladder
MGI:7316544	Katnal2<em1Zhlu>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002631,abnormal epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0009230,abnormal sperm head morphology
MGI:6164198	Katnal2<m1Anu>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0006380,abnormal spermatid morphology|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009239,short sperm flagellum|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009833,absent sperm mitochondrial sheath|MP:0009838,abnormal sperm axoneme morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014685,spermiation failure|MP:0020550,multinucleated giant male germ cells|MP:0020869,immotile sperm|MP:0031356,abnormal outer dense fiber morphology|MP:0031373,abnormal manchette perinuclear ring morphology|MP:0031375,abnormal manchette disassembly|MP:0031386,elongated manchette
MGI:4842422	Katnal2<tm1a(EUCOMM)Wtsi>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014631,abnormal elongated spermatid morphology|MP:0014685,spermiation failure|MP:0020550,multinucleated giant male germ cells
MGI:6164199	Katnal2<tm1c(EUCOMM)Wtsi>	MP:0001925,male infertility|MP:0008892,abnormal sperm flagellum morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014631,abnormal elongated spermatid morphology|MP:0014685,spermiation failure|MP:0020550,multinucleated giant male germ cells|MP:0031386,elongated manchette
MGI:5428740	Katnb1<taily>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009376,abnormal manchette morphology|MP:0009761,abnormal meiotic spindle morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0009852,increased Sertoli cell phagocytosis|MP:0014633,decreased spermatid number|MP:0020451,decreased sperm progressive motility|MP:0031352,absent sperm axonemal central pair|MP:0031356,abnormal outer dense fiber morphology|MP:0031373,abnormal manchette perinuclear ring morphology|MP:0031375,abnormal manchette disassembly|MP:0031386,elongated manchette
MGI:4436305	Katnb1<tm1a(EUCOMM)Hmgu>	MP:0000245,abnormal erythropoiesis|MP:0000358,abnormal cell morphology|MP:0000603,pale liver|MP:0000774,decreased brain size|MP:0000783,abnormal forebrain morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001698,decreased embryo size|MP:0003241,loss of cortex neurons|MP:0003708,binucleate|MP:0004024,aneuploidy|MP:0004046,abnormal mitosis|MP:0004575,small limb buds|MP:0004948,abnormal neuronal precursor proliferation|MP:0004981,decreased neuronal precursor cell number|MP:0005157,holoprosencephaly|MP:0006254,thin cerebral cortex|MP:0008458,abnormal cortical ventricular zone morphology|MP:0009760,abnormal mitotic spindle morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0013203,abnormal primary cilium morphology|MP:0014134,abnormal embryo morphology|MP:0014178,increased brain apoptosis|MP:0020378,abnormal cell cytoskeleton morphology
MGI:5637074	Katnb1<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:6152454	Katnip<em1(IMPC)Mbp>	MP:0000639,abnormal adrenal gland morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001404,no spontaneous movement|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis
MGI:4128978	Katnip<Gt(RRG309)Byg>	MP:0000807,abnormal hippocampus morphology|MP:0000917,obstructive hydrocephaly|MP:0001891,hydrocephaly|MP:0002958,cerebral aqueductal stenosis|MP:0003631,nervous system phenotype|MP:0008535,enlarged lateral ventricles|MP:0013907,abnormal cerebrospinal fluid flow
MGI:5763628	kavh	MP:0000519,hydronephrosis|MP:0000520,absent kidney|MP:0001891,hydrocephaly|MP:0002102,abnormal ear morphology|MP:0003446,renal hypoplasia|MP:0003604,single kidney|MP:0005385,cardiovascular system phenotype|MP:0005565,increased blood urea nitrogen level|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4345581	Kazn<Gt(AN0881)Wtsi>	MP:0005389,reproductive system phenotype|MP:0010771,integument phenotype
MGI:4432650	Kazn<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0002942,decreased circulating alanine transaminase level|MP:0005632,decreased circulating aspartate transaminase level|MP:0010025,decreased total body fat amount
MGI:5703057	Kazn<tm1d(EUCOMM)Wtsi>	MP:0005389,reproductive system phenotype|MP:0010771,integument phenotype
MGI:6153377	Kbtbd11<em1(IMPC)Wtsi>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002059,abnormal seminal vesicle morphology|MP:0009709,hydrometra|MP:0020421,increased freezing behavior
MGI:7425765	Kbtbd12<em1(IMPC)Mbp>	MP:0000494,abnormal cecum morphology|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0009476,enlarged cecum
MGI:6469320	Kbtbd13<em1Coeo>	MP:0001260,increased body weight|MP:0003081,abnormal soleus morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003157,impaired muscle relaxation|MP:0009425,increased soleus weight|MP:0012059,thick diaphragm muscle
MGI:6379319	Kbtbd13<em1(IMPC)J>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6469291	Kbtbd13<tm1.1Coeo>	MP:0001262,decreased body weight|MP:0005369,muscle phenotype|MP:0009426,decreased soleus weight|MP:0010226,increased quadriceps weight
MGI:5806485	Kbtbd2<em1Btlr>	MP:0001262,decreased body weight|MP:0002079,increased circulating insulin level|MP:0005331,insulin resistance|MP:0013279,increased fasting circulating glucose level
MGI:5806297	Kbtbd2<m1Btlr>	MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003960,increased lean body mass|MP:0004893,decreased adiponectin level|MP:0005331,insulin resistance|MP:0005343,increased circulating aspartate transaminase level|MP:0005376,homeostasis/metabolism phenotype|MP:0005668,decreased circulating leptin level|MP:0005670,abnormal white adipose tissue physiology|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0013279,increased fasting circulating glucose level
MGI:5806298	Kbtbd2<m2Btlr>	MP:0001262,decreased body weight
MGI:7425766	Kbtbd3<em1(IMPC)Ccpcz>	MP:0000219,increased neutrophil cell number|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0010379,decreased respiratory quotient
MGI:5635225	Kbtbd7<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0003795,abnormal bone structure|MP:0004924,abnormal behavior|MP:0005344,increased circulating bilirubin level|MP:0010124,decreased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:6302753	Kbtbd8<em1(IMPC)Tcp>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0002764,short tibia|MP:0002941,increased circulating alanine transaminase level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0005343,increased circulating aspartate transaminase level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:2449300	Kcal1<CAST/EiJ>	MP:0011939,increased food intake
MGI:2449301	Kcal2<CAST/EiJ>	MP:0011939,increased food intake
MGI:2449422	Kcal3<C57BL/6J>	MP:0011939,increased food intake
MGI:4124894	Kcmf1<Gt(XE080)Byg>	MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:6158467	Kcna10<em3(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5574085	Kcna10<tm1Lex>	MP:0004812,abnormal linear vestibular evoked potential|MP:0004813,absent linear vestibular evoked potential|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856949	Kcna1<mceph>	MP:0000745,tremors|MP:0000771,abnormal brain size|MP:0000913,abnormal brain development|MP:0000947,convulsive seizures|MP:0001265,decreased body size|MP:0001349,excessive tearing|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0001488,increased startle reflex|MP:0001504,abnormal posture|MP:0001849,ear inflammation|MP:0001851,eye inflammation|MP:0001961,abnormal reflex|MP:0001963,abnormal hearing physiology|MP:0002064,seizures|MP:0002152,abnormal brain morphology|MP:0002176,increased brain weight|MP:0002182,abnormal astrocyte morphology|MP:0002566,abnormal sexual interaction|MP:0003997,tonic-clonic seizures|MP:0005238,increased brain size|MP:0008282,enlarged hippocampus|MP:0013468,chromodacryorrhea
MGI:2655686	Kcna1<tm1Jmay>	MP:0001516,abnormal motor coordination/balance|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0005386,behavior/neurological phenotype|MP:0011092,embryonic lethality, complete penetrance
MGI:1861959	Kcna1<tm1Tem>	MP:0000243,myoclonus|MP:0000745,tremors|MP:0000788,abnormal cerebral cortex morphology|MP:0000947,convulsive seizures|MP:0001392,abnormal locomotor behavior|MP:0001393,ataxia|MP:0001488,increased startle reflex|MP:0001504,abnormal posture|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0001544,abnormal cardiovascular system physiology|MP:0001849,ear inflammation|MP:0001851,eye inflammation|MP:0001963,abnormal hearing physiology|MP:0001982,decreased chemically-elicited antinociception|MP:0001994,increased blinking frequency|MP:0002064,seizures|MP:0002083,premature death|MP:0002206,abnormal CNS synaptic transmission|MP:0002272,abnormal nervous system electrophysiology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002913,abnormal PNS synaptic transmission|MP:0002918,abnormal paired-pulse facilitation|MP:0003137,abnormal impulse conducting system conduction|MP:0003483,decreased nerve fiber response threshold|MP:0003674,oxidative stress|MP:0003997,tonic-clonic seizures|MP:0003998,decreased thermal nociceptive threshold|MP:0004924,abnormal behavior|MP:0005333,decreased heart rate|MP:0005402,abnormal action potential|MP:0005654,porphyria|MP:0008282,enlarged hippocampus|MP:0008532,decreased chemical nociceptive threshold|MP:0009732,ventricular premature beat|MP:0010519,atrioventricular block|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014253,decreased paired-pulse ratio|MP:0014625,abnormal ictal brain wave pattern
MGI:6719245	Kcna2<em1(IMPC)H>	MP:0010067,increased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance
MGI:6304409	Kcna2<m1Btlr>	MP:0002083,premature death
MGI:4867185	Kcna2<Pgu>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002578,impaired ability to fire action potentials|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003463,abnormal single cell response|MP:0003631,nervous system phenotype|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0010053,decreased grip strength|MP:0010540,long stride length
MGI:3526017	Kcna2<tm1Tem>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001501,abnormal sleep pattern|MP:0001957,apnea|MP:0002064,seizures|MP:0002272,abnormal nervous system electrophysiology|MP:0002578,impaired ability to fire action potentials|MP:0002826,tonic seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003484,abnormal channel response|MP:0004994,abnormal brain wave pattern|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential|MP:0011085,postnatal lethality, complete penetrance|MP:0014625,abnormal ictal brain wave pattern
MGI:3042596	Kcna3<tm1Gvd>	MP:0001262,decreased body weight|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008965,increased basal metabolism|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:2679440	Kcna3<tm1Lys>	MP:0002169,no abnormal phenotype detected
MGI:2386331	Kcna4<tm1Lndn>	MP:0002064,seizures
MGI:6423841	Kcna5<em1(IMPC)Mbp>	MP:0001200,thick skin|MP:0002060,abnormal skin morphology
MGI:3694764	Kcna5<tm1Hket>	MP:0000136,abnormal microglial cell morphology|MP:0000350,abnormal cell proliferation|MP:0002272,abnormal nervous system electrophysiology|MP:0003488,decreased channel response intensity|MP:0003957,abnormal nitric oxide homeostasis
MGI:2384510	Kcna5<tm1(Kcna1)Lndn>	MP:0003026,decreased vasoconstriction|MP:0005595,abnormal vascular smooth muscle physiology|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5927763	Kcna6<em1(IMPC)J>	MP:0001415,increased exploration in new environment|MP:0002574,increased vertical activity
MGI:3528817	Kcna6<tm1Lex>	MP:0001552,increased circulating triglyceride level|MP:0001973,increased thermal nociceptive threshold
MGI:6385634	Kcna7<em1(IMPC)J>	MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval
MGI:3621902	Kcnab1<tm1Kwak>	MP:0003137,abnormal impulse conducting system conduction
MGI:3619233	Kcnab1<tm1Mes>	MP:0010768,mortality/aging
MGI:2181771	Kcnab1<tm1Sva>	MP:0001463,abnormal spatial learning|MP:0002272,abnormal nervous system electrophysiology|MP:0002969,impaired social transmission of food preference|MP:0003008,enhanced long-term potentiation|MP:0003412,abnormal afterhyperpolarization|MP:0005402,abnormal action potential|MP:0020340,abnormal inhibitory learning
MGI:6277034	Kcnab2<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001399,hyperactivity|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010052,increased grip strength
MGI:2179738	Kcnab2<tm1Kmc>	MP:0000745,tremors|MP:0000951,sporadic seizures|MP:0001265,decreased body size|MP:0001463,abnormal spatial learning|MP:0002063,abnormal learning/memory/conditioning|MP:0002083,premature death|MP:0002272,abnormal nervous system electrophysiology|MP:0003412,abnormal afterhyperpolarization|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0011014,decreased core body temperature|MP:0011049,impaired adaptive thermogenesis
MGI:2179739	Kcnab2<tm2Mes>	MP:0002169,no abnormal phenotype detected|MP:0005386,behavior/neurological phenotype
MGI:5695894	Kcnab3<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001175,abnormal lung morphology|MP:0002941,increased circulating alanine transaminase level|MP:0004882,enlarged lung|MP:0005278,abnormal cholesterol homeostasis|MP:0005343,increased circulating aspartate transaminase level
MGI:5695133	Kcnb1<tm1b(EUCOMM)Hmgu>	MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001415,increased exploration in new environment|MP:0002590,increased mean corpuscular volume|MP:0003960,increased lean body mass|MP:0005561,increased mean corpuscular hemoglobin
MGI:3774269	Kcnb1<tm1Dgen>	MP:0000189,hypoglycemia|MP:0002079,increased circulating insulin level|MP:0003058,increased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005292,improved glucose tolerance|MP:0008515,thin retina outer nuclear layer|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment|MP:0011965,decreased total retina thickness
MGI:5697048	Kcnb2<em1(IMPC)J>	MP:0000208,decreased hematocrit|MP:0001399,hyperactivity|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0005344,increased circulating bilirubin level
MGI:5429909	Kcnb2<tm1Lex>	MP:0000746,weakness|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001501,abnormal sleep pattern
MGI:2387957	Kcnc2<tm1Rudy>	MP:0000243,myoclonus|MP:0000951,sporadic seizures|MP:0001363,increased anxiety-related response|MP:0001501,abnormal sleep pattern|MP:0002064,seizures|MP:0002272,abnormal nervous system electrophysiology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003412,abnormal afterhyperpolarization|MP:0003997,tonic-clonic seizures|MP:0004994,abnormal brain wave pattern|MP:0005402,abnormal action potential
MGI:6257805	Kcnc3<em1(IMPC)Bay>	MP:0001399,hyperactivity|MP:0010052,increased grip strength
MGI:5697086	Kcnc3<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0011396,abnormal sleep behavior
MGI:2675309	Kcnc3<tm1Echa>	MP:0002169,no abnormal phenotype detected
MGI:5708278	Kcnd1<tm1.1(KOMP)Vlcg>	MP:0005630,increased lung weight
MGI:3653698	Kcnd2<tm1Jmn>	MP:0002736,abnormal nociception after inflammation|MP:0002738,hyperresponsive to tactile stimuli|MP:0002882,abnormal neuron morphology|MP:0003484,abnormal channel response|MP:0003998,decreased thermal nociceptive threshold
MGI:5644712	Kcnd3<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001486,abnormal startle reflex|MP:0002574,increased vertical activity|MP:0005566,decreased blood urea nitrogen level|MP:0010123,increased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:8266575	Kcnd3<em1Tfts>	MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype
MGI:3772775	Kcnd3<tm1Dgen>	MP:0005385,cardiovascular system phenotype
MGI:8266521	Kcnd3<tm1Tfts>	MP:0000876,Purkinje cell degeneration|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001516,abnormal motor coordination/balance|MP:0001524,impaired limb coordination|MP:0002574,increased vertical activity|MP:0003111,abnormal cell nucleus morphology|MP:0008546,abnormal vesicle-mediated transport|MP:0009512,abnormal cerebellar Golgi cell morphology|MP:0014331,abnormal Purkinje cell mitochondrial morphology|MP:0031391,increased locomotor activity|MP:0031687,dilated endoplasmic reticulum
MGI:2678338	Kcne1<2J>	MP:0001410,head bobbing|MP:0001967,deafness|MP:0004738,abnormal auditory brainstem response|MP:0005191,head tilt
MGI:1889639	Kcne1<pkr>	MP:0000026,abnormal inner ear morphology|MP:0001393,ataxia|MP:0001394,circling|MP:0001522,impaired swimming|MP:0001961,abnormal reflex|MP:0001967,deafness|MP:0002428,abnormal semicircular canal morphology|MP:0002894,abnormal otolith morphology|MP:0003149,abnormal tectorial membrane morphology|MP:0004397,absent cochlear inner hair cells|MP:0004403,absent cochlear outer hair cells|MP:0004405,absent cochlear hair cells|MP:0004530,absent outer hair cell stereocilia|MP:0004813,absent linear vestibular evoked potential|MP:0005307,head tossing|MP:0006024,collapsed Reissner membrane|MP:0008308,small scala media|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6287371	Kcne1<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000745,tremors|MP:0001364,decreased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0001454,abnormal cued conditioning behavior|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0001512,trunk curl|MP:0001523,impaired righting response|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002590,increased mean corpuscular volume|MP:0002757,decreased vertical activity|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0004924,abnormal behavior|MP:0005016,decreased lymphocyte cell number|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:3040614	Kcne1<tm1Rdn>	MP:0004215,abnormal myocardial fiber physiology
MGI:1857442	Kcne1<tm1Sfh>	MP:0000031,abnormal cochlea morphology|MP:0000034,abnormal inner ear vestibule morphology|MP:0000043,organ of Corti degeneration|MP:0000044,absent organ of Corti|MP:0000048,abnormal stria vascularis morphology|MP:0001394,circling|MP:0001395,bidirectional circling|MP:0001396,unidirectional circling|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001408,stereotypic behavior|MP:0001410,head bobbing|MP:0001429,dehydration|MP:0001489,decreased startle reflex|MP:0001504,abnormal posture|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0001524,impaired limb coordination|MP:0001663,abnormal digestive system physiology|MP:0002428,abnormal semicircular canal morphology|MP:0002608,increased hematocrit|MP:0002666,increased circulating aldosterone level|MP:0002857,cochlear ganglion degeneration|MP:0003019,increased circulating chloride level|MP:0003169,abnormal scala media morphology|MP:0003233,prolonged QT interval|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0003349,abnormal circulating renin level|MP:0003868,abnormal feces composition|MP:0003878,abnormal ear physiology|MP:0004119,hypokalemia|MP:0004249,abnormal crista ampullaris morphology|MP:0004324,vestibular hair cell degeneration|MP:0004331,vestibular saccular macula degeneration|MP:0004334,utricular macular degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004409,abnormal crista ampullaris neuroepithelium morphology|MP:0004742,abnormal vestibular system physiology|MP:0004775,abnormal vestibular dark cell morphology|MP:0004776,vestibular dark cell degeneration|MP:0004845,absent vestibuloocular reflex|MP:0005191,head tilt|MP:0005633,increased circulating sodium level|MP:0006024,collapsed Reissner membrane|MP:0006358,absent pinna reflex|MP:0006359,absent startle reflex|MP:0008997,increased blood osmolality
MGI:4431909	Kcne2<tm1a(EUCOMM)Wtsi>	MP:0000208,decreased hematocrit|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0001873,stomach inflammation|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004139,abnormal gastric parietal cell morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0004151,decreased circulating iron level|MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0005505,thrombocytosis|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008006,increased stomach pH|MP:0008388,hypochromic microcytic anemia|MP:0008808,decreased spleen iron level|MP:0010067,increased red blood cell distribution width|MP:0010092,increased circulating magnesium level|MP:0010383,increased adenoma incidence|MP:0011285,increased circulating erythropoietin level|MP:0011891,decreased circulating ferritin level|MP:0013569,gastric gland hyperplasia
MGI:3699589	Kcne2<tm1Gwab>	MP:0000473,abnormal stomach glandular epithelium morphology|MP:0000505,decreased digestive secretion|MP:0003883,enlarged stomach|MP:0004139,abnormal gastric parietal cell morphology|MP:0004731,increased circulating gastrin level|MP:0005376,homeostasis/metabolism phenotype|MP:0005381,digestive/alimentary phenotype|MP:0008001,hypochlorhydria|MP:0008003,achlorhydria|MP:0008006,increased stomach pH|MP:0013569,gastric gland hyperplasia|MP:0013578,abnormal stomach glandular region morphology
MGI:5766753	Kcne3<tm1.1(KOMP)Vlcg>	MP:0002092,abnormal eye morphology|MP:0005567,decreased circulating total protein level
MGI:4456241	Kcne3<tm1.1Tjj>	MP:0001663,abnormal digestive system physiology|MP:0002133,abnormal respiratory system physiology|MP:0008872,abnormal physiological response to xenobiotic|MP:0010155,abnormal intestine physiology
MGI:4947550	Kcne3<tm1Gwab>	MP:0000182,increased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000639,abnormal adrenal gland morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001846,increased inflammatory response|MP:0002666,increased circulating aldosterone level|MP:0003233,prolonged QT interval|MP:0005178,increased circulating cholesterol level|MP:0005381,digestive/alimentary phenotype|MP:0008950,ventricular tachycardia|MP:0010505,abnormal T wave
MGI:5292850	Kcne3<tm1(KOMP)Vlcg>	MP:0005402,abnormal action potential|MP:0006335,abnormal hearing electrophysiology
MGI:5819251	Kcne4<tm1Gwab>	MP:0003233,prolonged QT interval|MP:0005385,cardiovascular system phenotype|MP:0020345,abnormal myocardial fiber currents|MP:0020418,increased cardiac muscle relaxation
MGI:7641768	Kcne5<em1Mdcb>	MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0020345,abnormal myocardial fiber currents
MGI:3528821	Kcne5<tm1Lex>	MP:0001544,abnormal cardiovascular system physiology|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0020345,abnormal myocardial fiber currents
MGI:6283400	Kcnf1<em1(IMPC)H>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:7465000	Kcng1<em1(IMPC)Tcp>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002792,abnormal retina vasculature morphology|MP:0009142,decreased prepulse inhibition|MP:0010097,abnormal retina blood vessel morphology
MGI:6257602	Kcng2<em1(IMPC)Bay>	MP:0001399,hyperactivity|MP:0002833,increased heart weight|MP:0005140,decreased cardiac muscle contractility|MP:0005419,decreased circulating serum albumin level|MP:0011952,decreased cardiac stroke volume
MGI:5696904	Kcng4<tm1.1(KOMP)Vlcg>	MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology|MP:0005343,increased circulating aspartate transaminase level
MGI:3847491	Kcng4<tm1(KOMP)Vlcg>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0009230,abnormal sperm head morphology|MP:0009235,small sperm head|MP:0009239,short sperm flagellum|MP:0009325,necrospermia|MP:0009831,abnormal sperm midpiece morphology|MP:0014631,abnormal elongated spermatid morphology|MP:0014636,decreased elongated spermatid number|MP:0020451,decreased sperm progressive motility
MGI:5502738	Kcnh1<tm1.1Ruf>	MP:0001399,hyperactivity|MP:0003631,nervous system phenotype|MP:0004924,abnormal behavior
MGI:5430765	Kcnh1<tm1Lex>	MP:0003360,abnormal depression-related behavior
MGI:4417903	Kcnh2<tm1.1Hjd>	MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0000428,abnormal craniofacial morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001636,irregular heartbeat|MP:0001698,decreased embryo size|MP:0002128,abnormal blood circulation|MP:0004145,abnormal muscle electrophysiology|MP:0005312,pericardial effusion|MP:0006126,abnormal cardiac outflow tract development|MP:0006337,abnormal first pharyngeal arch morphology|MP:0006341,small first pharyngeal arch|MP:0010568,abnormal bulbus cordis morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012510,abnormal aortic sac morphology|MP:0012511,dilated aortic sac
MGI:2652959	Kcnh2<tm1Hjd>	MP:0005333,decreased heart rate
MGI:5445933	Kcnh3<tm1.1(KOMP)Vlcg>	MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0001554,increased circulating free fatty acids level|MP:0005564,increased hemoglobin content|MP:0013279,increased fasting circulating glucose level
MGI:4837119	Kcnh3<tm1.1Tije>	MP:0003463,abnormal single cell response|MP:0003466,decreased single cell response threshold
MGI:4837120	Kcnh3<tm1.2Tije>	MP:0000948,nonconvulsive seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003463,abnormal single cell response|MP:0003466,decreased single cell response threshold|MP:0005386,behavior/neurological phenotype|MP:0008840,abnormal spike wave discharge
MGI:4418359	Kcnh3<tm1Akmi>	MP:0002206,abnormal CNS synaptic transmission|MP:0002207,abnormal long-term potentiation|MP:0002801,abnormal long-term object recognition memory|MP:0008414,abnormal spatial reference memory|MP:0008428,abnormal spatial working memory
MGI:3604469	Kcnh5<tm1Dgen>	MP:0001486,abnormal startle reflex|MP:0002797,increased thigmotaxis
MGI:6280002	Kcnh6<em1Jkya>	MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002727,decreased circulating insulin level|MP:0003058,increased insulin secretion|MP:0003059,decreased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0003488,decreased channel response intensity|MP:0003562,abnormal pancreatic beta cell physiology|MP:0003564,abnormal insulin secretion|MP:0004231,abnormal calcium ion homeostasis|MP:0005293,impaired glucose tolerance|MP:0005402,abnormal action potential|MP:0005560,decreased circulating glucose level|MP:0009114,decreased pancreatic beta cell mass|MP:0009148,pancreas necrosis|MP:0009176,increased pancreatic alpha cell number|MP:0013279,increased fasting circulating glucose level|MP:0014121,increased pancreatic islet cell apoptosis|MP:0020354,increased endoplasmic reticulum stress
MGI:6280004	Kcnh6<em2Jkya>	MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003488,decreased channel response intensity|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005293,impaired glucose tolerance|MP:0005402,abnormal action potential|MP:0005560,decreased circulating glucose level|MP:0013279,increased fasting circulating glucose level
MGI:5695959	Kcnh6<tm1.1(KOMP)Vlcg>	MP:0000194,increased circulating calcium level|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002965,increased circulating serum albumin level|MP:0003068,enlarged kidney|MP:0005568,increased circulating total protein level
MGI:6273965	Kcnh7<em1(IMPC)Hmgu>	MP:0002757,decreased vertical activity
MGI:6152504	Kcnh8<em1(IMPC)Mbp>	MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0009709,hydrometra
MGI:7734730	Kcnh8<tm1.1Jmn>	MP:0003463,abnormal single cell response|MP:0005386,behavior/neurological phenotype
MGI:6279930	Kcnip1<em1(IMPC)H>	MP:0005011,increased eosinophil cell number|MP:0005560,decreased circulating glucose level
MGI:5702614	Kcnip1<tm1Zhzh>	MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003631,nervous system phenotype|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5613711	Kcnip2<tm1Jmn>	MP:0004215,abnormal myocardial fiber physiology|MP:0005385,cardiovascular system phenotype
MGI:2671134	Kcnip2<tm1Krc>	MP:0001636,irregular heartbeat|MP:0003137,abnormal impulse conducting system conduction|MP:0003897,abnormal ST segment
MGI:2679303	Kcnip3<tm1Bux>	MP:0001399,hyperactivity|MP:0001463,abnormal spatial learning|MP:0003008,enhanced long-term potentiation|MP:0003484,abnormal channel response|MP:0005316,abnormal response to tactile stimuli|MP:0005386,behavior/neurological phenotype|MP:0008469,abnormal protein level
MGI:3528874	Kcnip3<tm1Lex>	MP:0001363,increased anxiety-related response|MP:0005386,behavior/neurological phenotype|MP:0009453,enhanced contextual conditioning behavior
MGI:2179103	Kcnip3<tm1Pngr>	MP:0001973,increased thermal nociceptive threshold|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002736,abnormal nociception after inflammation|MP:0003043,hypoalgesia|MP:0005386,behavior/neurological phenotype|MP:0005498,hyporesponsive to tactile stimuli|MP:0008531,increased chemical nociceptive threshold
MGI:5793072	Kcnip3<tm2b(EUCOMM)Hmgu>	MP:0002764,short tibia
MGI:4419266	Kcnip4<tm1a(KOMP)Wtsi>	MP:0003179,thrombocytopenia
MGI:5692590	Kcnj10<tm1b(KOMP)Wtsi>	MP:0000745,tremors|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0002607,decreased basophil cell number|MP:0008935,decreased mean platelet volume|MP:0011100,preweaning lethality, complete penetrance
MGI:3761690	Kcnj10<tm1Kdmc>	MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000774,decreased brain size|MP:0000825,dilated lateral ventricle|MP:0000952,abnormal CNS glial cell morphology|MP:0000953,abnormal oligodendrocyte morphology|MP:0001265,decreased body size|MP:0001290,delayed eyelid opening|MP:0001393,ataxia|MP:0001523,impaired righting response|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology|MP:0002183,gliosis|MP:0002206,abnormal CNS synaptic transmission|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002923,increased post-tetanic potentiation|MP:0003008,enhanced long-term potentiation|MP:0003632,abnormal nervous system morphology|MP:0003633,abnormal nervous system physiology|MP:0003997,tonic-clonic seizures|MP:0005176,eyelids fail to open|MP:0005202,lethargy|MP:0005253,abnormal eye physiology|MP:0006254,thin cerebral cortex|MP:0008025,brain vacuoles|MP:0008027,abnormal spinal cord white matter morphology|MP:0008489,slow postnatal weight gain|MP:0008916,abnormal astrocyte physiology
MGI:2182467	Kcnj10<tm1Lst>	MP:0000031,abnormal cochlea morphology|MP:0000043,organ of Corti degeneration|MP:0000048,abnormal stria vascularis morphology|MP:0000745,tremors|MP:0000746,weakness|MP:0000755,hindlimb paralysis|MP:0000920,abnormal myelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0000955,abnormal spinal cord morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001429,dehydration|MP:0001504,abnormal posture|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0001762,polyuria|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002272,abnormal nervous system electrophysiology|MP:0002703,abnormal renal tubule morphology|MP:0002857,cochlear ganglion degeneration|MP:0002986,decreased urine calcium level|MP:0003149,abnormal tectorial membrane morphology|MP:0003169,abnormal scala media morphology|MP:0004298,vestibular ganglion degeneration|MP:0004324,vestibular hair cell degeneration|MP:0004331,vestibular saccular macula degeneration|MP:0004334,utricular macular degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004409,abnormal crista ampullaris neuroepithelium morphology|MP:0004410,absent endocochlear potential|MP:0004716,abnormal cochlear nerve morphology|MP:0005253,abnormal eye physiology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0005405,axon degeneration|MP:0005424,jerky movement|MP:0005551,abnormal eye electrophysiology|MP:0006021,abnormal Reissner membrane morphology|MP:0006024,collapsed Reissner membrane|MP:0006025,distended Reissner membrane|MP:0006316,increased urine sodium level|MP:0006325,impaired hearing|MP:0006358,absent pinna reflex|MP:0006359,absent startle reflex|MP:0006403,abnormal cochlear endolymph ionic homeostasis|MP:0008027,abnormal spinal cord white matter morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011471,decreased urine creatinine level|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5695116	Kcnj11<tm1b(EUCOMM)Wtsi>	MP:0002102,abnormal ear morphology|MP:0002874,decreased hemoglobin content|MP:0005293,impaired glucose tolerance|MP:0013278,decreased fasting circulating glucose level
MGI:2178821	Kcnj11<tm1Sse>	MP:0000189,hypoglycemia|MP:0000243,myoclonus|MP:0000947,convulsive seizures|MP:0001186,pigmentation phenotype|MP:0001363,increased anxiety-related response|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002078,abnormal glucose homeostasis|MP:0002572,abnormal emotion/affect behavior|MP:0002711,decreased glucagon secretion|MP:0002727,decreased circulating insulin level|MP:0002757,decreased vertical activity|MP:0002841,impaired skeletal muscle contractility|MP:0002891,increased insulin sensitivity|MP:0003061,decreased aerobic running capacity|MP:0003313,abnormal locomotor activation|MP:0003477,abnormal nerve fiber response|MP:0003479,abnormal nerve fiber response intensity|MP:0003646,increased muscle fatigability|MP:0003997,tonic-clonic seizures|MP:0004036,abnormal muscle relaxation|MP:0004875,increased mean systemic arterial blood pressure|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005402,abnormal action potential|MP:0005449,abnormal food intake|MP:0005522,increased circulating atrial natriuretic factor|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008414,abnormal spatial reference memory|MP:0008489,slow postnatal weight gain|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009287,decreased abdominal fat pad weight|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3056474	Kcnj11<Y12stop>	MP:0002711,decreased glucagon secretion|MP:0003058,increased insulin secretion
MGI:2183432	Kcnj12<tm1Swz>	MP:0005385,cardiovascular system phenotype
MGI:5638575	Kcnj13<tm1b(KOMP)Wtsi>	MP:0000111,cleft palate|MP:0001697,abnormal embryo size|MP:0001914,hemorrhage|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape
MGI:5312614	Kcnj13<tm1(KOMP)Vlcg>	MP:0000430,absent maxillary shelf|MP:0000431,absent palatine bone horizontal plate|MP:0001435,absent suckling reflex|MP:0004200,decreased fetal size|MP:0005388,respiratory system phenotype|MP:0009703,decreased birth body size|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0010825,abnormal lung saccule morphology|MP:0010827,small lung saccule|MP:0011087,neonatal lethality, complete penetrance
MGI:7510087	Kcnj15<em1(IMPC)Bay>	MP:0001417,decreased exploration in new environment|MP:0001566,increased circulating phosphate level|MP:0003731,abnormal retina outer nuclear layer morphology
MGI:5427676	Kcnj15<tm1Dgen>	MP:0001516,abnormal motor coordination/balance
MGI:4882146	Kcnj16<tm1Pess>	MP:0003477,abnormal nerve fiber response|MP:0004811,abnormal neuron physiology
MGI:2388372	Kcnj1<tm1Ges>	MP:0000519,hydronephrosis|MP:0001211,wrinkled skin|MP:0001426,polydipsia|MP:0001429,dehydration|MP:0001732,postnatal growth retardation|MP:0001762,polyuria|MP:0002608,increased hematocrit|MP:0002843,decreased systemic arterial blood pressure|MP:0002988,decreased urine osmolality|MP:0003653,decreased skin turgor|MP:0005528,decreased renal glomerular filtration rate|MP:0005633,increased circulating sodium level|MP:0009643,abnormal urine homeostasis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011296,decreased tubuloglomerular feedback response|MP:0012551,metabolic acidosis
MGI:2183430	Kcnj2<tm1Swz>	MP:0001429,dehydration|MP:0001436,abnormal suckling behavior|MP:0001575,cyanosis|MP:0001613,abnormal vasodilation|MP:0001954,respiratory distress|MP:0002110,abnormal digit morphology|MP:0008273,abnormal intramembranous bone ossification|MP:0009743,preaxial polydactyly|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0009897,decreased maxillary shelf size|MP:0011087,neonatal lethality, complete penetrance|MP:0030248,narrow maxilla|MP:0030266,small vomer bone
MGI:5695876	Kcnj3<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001513,limb grasping|MP:0002631,abnormal epididymis morphology|MP:0004924,abnormal behavior|MP:0004931,enlarged epididymis|MP:0005574,decreased pulmonary respiratory rate|MP:0005575,increased pulmonary ventilation|MP:0005576,decreased pulmonary ventilation|MP:0010378,increased respiratory quotient|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020870,decreased thigmotaxis
MGI:2447632	Kcnj3<tm1Kwn>	MP:0002626,increased heart rate|MP:0004215,abnormal myocardial fiber physiology
MGI:2181760	Kcnj5<tm1Clph>	MP:0001629,abnormal heart rate|MP:0002626,increased heart rate|MP:0005385,cardiovascular system phenotype
MGI:6144032	Kcnj6<em1.1Ktaka>	MP:0002272,abnormal nervous system electrophysiology|MP:0002573,behavioral despair
MGI:6274929	Kcnj6<em1(IMPC)H>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001523,impaired righting response|MP:0002590,increased mean corpuscular volume|MP:0008806,increased circulating amylase level
MGI:2183429	Kcnj6<tm1Stf>	MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003635,abnormal synaptic transmission|MP:0003997,tonic-clonic seizures|MP:0009358,environmentally induced seizures
MGI:1856525	Kcnj6<wv>	MP:0000745,tremors|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000854,abnormal cerebellum development|MP:0000864,abnormal cerebellum vermis morphology|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000877,abnormal Purkinje cell morphology|MP:0000879,increased Purkinje cell number|MP:0000880,decreased Purkinje cell number|MP:0000884,delaminated Purkinje cell layer|MP:0000885,ectopic Purkinje cell|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001146,abnormal testis morphology|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001386,abnormal maternal nurturing|MP:0001392,abnormal locomotor behavior|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0001765,abnormal ion homeostasis|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002204,abnormal synaptic neurotransmitter level|MP:0002206,abnormal CNS synaptic transmission|MP:0002216,abnormal seminiferous tubule morphology|MP:0002631,abnormal epididymis morphology|MP:0002674,abnormal sperm motility|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0003091,abnormal cell migration|MP:0003313,abnormal locomotor activation|MP:0003632,abnormal nervous system morphology|MP:0003997,tonic-clonic seizures|MP:0004097,abnormal cerebellar cortex morphology|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004144,hypotonia|MP:0004494,abnormal synaptic glutamate release|MP:0005159,azoospermia|MP:0005376,homeostasis/metabolism phenotype|MP:0005643,decreased dopamine level|MP:0006042,increased apoptosis|MP:0006097,abnormal cerebellar lobule formation|MP:0006098,absent cerebellar lobules|MP:0006362,abnormal male germ cell morphology|MP:0006380,abnormal spermatid morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008911,induced hyperactivity|MP:0008913,weaving|MP:0009268,absent cerebellum fissure|MP:0010011,ectopic hippocampus pyramidal cells|MP:0010323,retropulsion|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011448,decreased dopaminergic neuron number|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0011940,decreased food intake|MP:0012490,abnormal cochlear VIII nucleus morphology|MP:0012575,increased noradrenaline level|MP:0013219,abnormal substantia nigra pars compacta morphology|MP:0014746,abnormal hippocampal mossy fiber innervation pattern|MP:0030636,decreased taurine level
MGI:6389009	Kcnj8<em1Nich>	MP:0000272,abnormal aorta morphology|MP:0000274,enlarged heart|MP:0000477,abnormal intestine morphology|MP:0001263,weight loss|MP:0001596,hypotension|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0003394,increased cardiac output|MP:0003484,abnormal channel response|MP:0003921,abnormal heart left ventricle morphology|MP:0004564,increased myocardial fiber size|MP:0005590,increased vasodilation|MP:0005595,abnormal vascular smooth muscle physiology|MP:0006047,aortic valve regurgitation|MP:0006117,aortic valve stenosis|MP:0008770,decreased survivor rate|MP:0010575,aortic arch dilation|MP:0011925,abnormal heart echocardiography feature
MGI:3626348	Kcnj8<gnite>	MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:3720053	Kcnj8<mydy>	MP:0001658,increased mortality induced by gamma-irradiation|MP:0008735,increased susceptibility to endotoxin shock|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:3626350	Kcnj8<slmbr>	MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:3626349	Kcnj8<sltr>	MP:0020913,increased susceptibility to Riboviria infection|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:3848462	Kcnj8<sos>	MP:0008735,increased susceptibility to endotoxin shock
MGI:2180015	Kcnj8<tm1Sse>	MP:0000231,hypertension|MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0004215,abnormal myocardial fiber physiology|MP:0005385,cardiovascular system phenotype|MP:0005595,abnormal vascular smooth muscle physiology|MP:0031192,coronary artery spasm
MGI:5548379	Kcnj9<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0002606,increased basophil cell number
MGI:2676585	Kcnj9<tm1Kwn>	MP:0003635,abnormal synaptic transmission|MP:0005386,behavior/neurological phenotype
MGI:7411391	Kcnk12<em1(IMPC)J>	MP:0000194,increased circulating calcium level
MGI:5749943	Kcnk13<em1(IMPC)H>	MP:0000136,abnormal microglial cell morphology|MP:0000220,increased monocyte cell number|MP:0002590,increased mean corpuscular volume|MP:0002606,increased basophil cell number|MP:0003691,abnormal microglial cell physiology|MP:0010067,increased red blood cell distribution width
MGI:3808238	Kcnk15<tm1(KOMP)Vlcg>	MP:0002272,abnormal nervous system electrophysiology|MP:0004738,abnormal auditory brainstem response|MP:0005402,abnormal action potential|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:6094223	Kcnk16<em1(IMPC)J>	MP:0010053,decreased grip strength
MGI:3529263	Kcnk16<tm1.1Lex>	MP:0003058,increased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0013277,abnormal fasting circulating glucose level
MGI:5142525	Kcnk18<m1Ewis>	MP:0003412,abnormal afterhyperpolarization|MP:0004811,abnormal neuron physiology|MP:0005402,abnormal action potential
MGI:5548875	Kcnk18<tm1.1(KOMP)Vlcg>	MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis
MGI:5318213	Kcnk1<tm1.1Barh>	MP:0000198,decreased circulating phosphate level|MP:0002901,increased urine phosphate level|MP:0010110,abnormal renal phosphate reabsorption|MP:0011432,decreased urine flow rate
MGI:6268686	Kcnk2<em1(IMPC)H>	MP:0001392,abnormal locomotor behavior
MGI:3528830	Kcnk2<tm1Lex>	MP:0005385,cardiovascular system phenotype
MGI:3050220	Kcnk2<tm1Lzd>	MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003075,abnormal response to CNS ischemic injury|MP:0003076,increased susceptibility to ischemic brain injury|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009747,impaired behavioral response to xenobiotic|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:3774330	Kcnk3<tm1.1Daba>	MP:0003631,nervous system phenotype|MP:0005388,respiratory system phenotype|MP:0005402,abnormal action potential
MGI:5588399	Kcnk3<tm1.2Daba>	MP:0002169,no abnormal phenotype detected
MGI:3611768	Kcnk3<tm1Sgb>	MP:0001516,abnormal motor coordination/balance|MP:0002666,increased circulating aldosterone level
MGI:3050222	Kcnk4<tm1Lzd>	MP:0003631,nervous system phenotype
MGI:4123942	Kcnk5<Gt(KST024)Byg>	MP:0001943,abnormal respiration|MP:0014812,abnormal brain physiology
MGI:2673542	Kcnk5<Gt(pGT1.8TM)1Gray>	MP:0001262,decreased body weight|MP:0005556,abnormal renal filtration rate|MP:0006316,increased urine sodium level|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011459,increased urine chloride ion level
MGI:5474993	Kcnk6<tm1Tigm>	MP:0000231,hypertension|MP:0000250,abnormal vasoconstriction|MP:0004875,increased mean systemic arterial blood pressure|MP:0004878,increased systemic vascular resistance|MP:0005595,abnormal vascular smooth muscle physiology|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure
MGI:3808709	Kcnk7<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3774332	Kcnk9<tm1.1Daba>	MP:0003631,nervous system phenotype|MP:0005388,respiratory system phenotype|MP:0005402,abnormal action potential
MGI:3836776	Kcnk9<tm1.1Fles>	MP:0003631,nervous system phenotype
MGI:5588402	Kcnk9<tm1.2Daba>	MP:0002169,no abnormal phenotype detected
MGI:3757590	Kcnk9<tm1Wwis>	MP:0002169,no abnormal phenotype detected
MGI:6377207	Kcnma1<em1(IMPC)H>	MP:0000745,tremors|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0002102,abnormal ear morphology|MP:0002968,increased circulating alkaline phosphatase level
MGI:7639922	Kcnma1<em3Gpt>	MP:0005326,abnormal podocyte morphology|MP:0011445,abnormal renal protein reabsorption|MP:0011863,abnormal podocyte physiology
MGI:3050114	Kcnma1<tm1Ruth>	MP:0000745,tremors|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001522,impaired swimming|MP:0001663,abnormal digestive system physiology|MP:0001731,abnormal postnatal growth|MP:0001994,increased blinking frequency|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002578,impaired ability to fire action potentials|MP:0002807,abnormal eye blink conditioning behavior|MP:0002842,increased systemic arterial blood pressure|MP:0002916,increased synaptic depression|MP:0003868,abnormal feces composition|MP:0004037,increased muscle relaxation|MP:0004404,cochlear outer hair cell degeneration|MP:0004433,abnormal cochlear inner hair cell physiology|MP:0004597,increased susceptibility to noise-induced hearing loss|MP:0004628,Deiters cell degeneration|MP:0004737,absent distortion product otoacoustic emissions|MP:0004740,sensorineural hearing loss|MP:0004746,abnormal cochlear IHC afferent innervation pattern|MP:0005620,abnormal muscle contractility|MP:0006042,increased apoptosis|MP:0006324,abnormal cochlear nerve fiber response|MP:0006335,abnormal hearing electrophysiology|MP:0010386,abnormal urinary bladder physiology|MP:0011535,increased urination frequency|MP:0014406,increased or absent distortion product otoacoustic emission threshold
MGI:3053849	Kcnma1<tm1Rwa>	MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001396,unidirectional circling|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0003280,urinary incontinence|MP:0003484,abnormal channel response|MP:0004433,abnormal cochlear inner hair cell physiology|MP:0004925,decreased susceptibility to noise-induced hearing loss|MP:0005402,abnormal action potential|MP:0010386,abnormal urinary bladder physiology|MP:0011535,increased urination frequency
MGI:5485152	Kcnmb1<tm1Ltor>	MP:0003025,increased vasoconstriction
MGI:2654278	Kcnmb1<tm1Pong>	MP:0002842,increased systemic arterial blood pressure|MP:0003025,increased vasoconstriction|MP:0005595,abnormal vascular smooth muscle physiology
MGI:2385821	Kcnmb1<tm1Rwa>	MP:0000250,abnormal vasoconstriction|MP:0002833,increased heart weight|MP:0002842,increased systemic arterial blood pressure|MP:0002847,abnormal renal glomerular filtration rate|MP:0005377,hearing/vestibular/ear phenotype|MP:0005620,abnormal muscle contractility
MGI:5694679	Kcnmb2<tm1.1Clin>	MP:0002169,no abnormal phenotype detected
MGI:5694812	Kcnmb2<tm1.2Clin>	MP:0002578,impaired ability to fire action potentials|MP:0003484,abnormal channel response|MP:0005402,abnormal action potential
MGI:7429089	Kcnmb3<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity
MGI:6276881	Kcnmb4<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001399,hyperactivity|MP:0002339,abnormal lymph node morphology
MGI:3528858	Kcnmb4<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:3611890	Kcnmb4<tm1Rwa>	MP:0000948,nonconvulsive seizures|MP:0005402,abnormal action potential
MGI:3522422	Kcnn1<tm1.1Jpad>	MP:0003631,nervous system phenotype
MGI:5692764	Kcnn1<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0010024,increased total body fat amount|MP:0010067,increased red blood cell distribution width
MGI:1856469	Kcnn2<bc>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001524,impaired limb coordination|MP:0001925,male infertility|MP:0003312,abnormal locomotor coordination|MP:0003492,abnormal involuntary movement|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1855966	Kcnn2<bc-2J>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001524,impaired limb coordination|MP:0003312,abnormal locomotor coordination|MP:0005389,reproductive system phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1855967	Kcnn2<bc-3J>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001524,impaired limb coordination|MP:0001925,male infertility|MP:0003312,abnormal locomotor coordination|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1856480	Kcnn2<bc-4J>	MP:0000745,tremors|MP:0001406,abnormal gait|MP:0001524,impaired limb coordination|MP:0003312,abnormal locomotor coordination
MGI:4834267	Kcnn2<bc-6J>	MP:0000745,tremors|MP:0001406,abnormal gait|MP:0001925,male infertility|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5140330	Kcnn2<bc-7J>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001925,male infertility|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype
MGI:5140705	Kcnn2<bc-8J>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001393,ataxia
MGI:5140706	Kcnn2<bc-9J>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001393,ataxia
MGI:1856876	Kcnn2<fri>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001516,abnormal motor coordination/balance|MP:0001524,impaired limb coordination|MP:0001922,reduced male fertility|MP:0002757,decreased vertical activity|MP:0002800,abnormal short-term object recognition memory|MP:0003412,abnormal afterhyperpolarization|MP:0003463,abnormal single cell response|MP:0005389,reproductive system phenotype|MP:0008026,abnormal brain white matter morphology|MP:0008027,abnormal spinal cord white matter morphology|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3800578	Kcnn2<m1Btlr>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001505,hunched posture|MP:0001510,abnormal coat appearance|MP:0002566,abnormal sexual interaction
MGI:3522425	Kcnn2<tm1.1Jpad>	MP:0003412,abnormal afterhyperpolarization|MP:0005402,abnormal action potential
MGI:3522424	Kcnn2<tm1Jpad>	MP:0002169,no abnormal phenotype detected
MGI:3522587	Kcnn2<tm2Jpad>	MP:0001454,abnormal cued conditioning behavior|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0002206,abnormal CNS synaptic transmission|MP:0002912,abnormal excitatory postsynaptic potential|MP:0011091,prenatal lethality, complete penetrance
MGI:3522659	Kcnn3<tm1Jpad>	MP:0001957,apnea|MP:0003631,nervous system phenotype|MP:0008028,pregnancy-related premature death|MP:0012010,parturition failure|MP:0020844,abnormal pulmonary respiratory rate response
MGI:5437368	Kcnn3<tm2.2Jpad>	MP:0005402,abnormal action potential
MGI:7425767	Kcnn4<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000492,abnormal rectum morphology|MP:0000495,abnormal colon morphology|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001157,small seminal vesicle|MP:0001417,decreased exploration in new environment|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002100,abnormal tooth morphology|MP:0002110,abnormal digit morphology|MP:0002188,small heart|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002932,abnormal joint morphology|MP:0004952,increased spleen weight|MP:0009476,enlarged cecum|MP:0009709,hydrometra|MP:0010067,increased red blood cell distribution width|MP:0010090,increased circulating creatine kinase level|MP:0013279,increased fasting circulating glucose level|MP:0020421,increased freezing behavior
MGI:3795277	Kcnn4<tm1.1Jele>	MP:0001663,abnormal digestive system physiology
MGI:3521668	Kcnn4<tm1Jemn>	MP:0001545,abnormal hematopoietic system physiology|MP:0002444,abnormal T cell physiology|MP:0009531,increased parotid gland size
MGI:3722942	Kcnn4<tm1Rklr>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000248,macrocytosis|MP:0000266,abnormal heart morphology|MP:0000691,enlarged spleen|MP:0002590,increased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0002833,increased heart weight|MP:0003215,renal interstitial fibrosis|MP:0003921,abnormal heart left ventricle morphology|MP:0004875,increased mean systemic arterial blood pressure|MP:0004952,increased spleen weight|MP:0005166,decreased susceptibility to injury|MP:0005591,decreased vasodilation|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008809,increased spleen iron level|MP:0008850,increased hemoglobin concentration distribution width|MP:0009568,abnormal red blood cell deformability|MP:0031085,increased erythrocyte osmotic fragility
MGI:5490247	Kcnq1<m1Anu>	MP:0000745,tremors|MP:0001394,circling|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002880,opisthotonus|MP:0005307,head tossing|MP:0005424,jerky movement
MGI:4830272	Kcnq1ot1<tm1.1Ckan>	MP:0002169,no abnormal phenotype detected|MP:0003787,abnormal imprinting|MP:0005384,cellular phenotype|MP:0008877,abnormal DNA methylation
MGI:2429679	Kcnq1ot1<tm1.1Mjh>	MP:0001262,decreased body weight|MP:0001698,decreased embryo size|MP:0003122,maternal imprinting|MP:0003402,decreased liver weight|MP:0003918,decreased kidney weight|MP:0005631,decreased lung weight
MGI:3773017	Kcnq1ot1<tm1Tilg>	MP:0001263,weight loss|MP:0003787,abnormal imprinting
MGI:5431827	Kcnq1ot1<tm2.1Ckan>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0003787,abnormal imprinting|MP:0008877,abnormal DNA methylation
MGI:3772666	Kcnq1ot1<tm2Mjh>	MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0003787,abnormal imprinting|MP:0004259,small placenta
MGI:3773025	Kcnq1ot1<tm2Tilg>	MP:0003787,abnormal imprinting
MGI:3772668	Kcnq1ot1<tm3Mjh>	MP:0003121,genetic imprinting
MGI:3773032	Kcnq1ot1<tm3Tilg>	MP:0003787,abnormal imprinting
MGI:3773036	Kcnq1ot1<tm4Tilg>	MP:0003787,abnormal imprinting
MGI:1931858	Kcnq1<tm1Apf>	MP:0000034,abnormal inner ear vestibule morphology|MP:0000043,organ of Corti degeneration|MP:0000048,abnormal stria vascularis morphology|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001408,stereotypic behavior|MP:0001410,head bobbing|MP:0001411,spinning|MP:0001967,deafness|MP:0002428,abnormal semicircular canal morphology|MP:0002857,cochlear ganglion degeneration|MP:0002894,abnormal otolith morphology|MP:0003145,detached otolithic membrane|MP:0003149,abnormal tectorial membrane morphology|MP:0003883,enlarged stomach|MP:0004138,abnormal mucous neck cell morphology|MP:0004139,abnormal gastric parietal cell morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0004249,abnormal crista ampullaris morphology|MP:0004301,absent organ of Corti supporting cells|MP:0004308,abnormal basilar membrane morphology|MP:0004325,absent vestibular hair cells|MP:0004334,utricular macular degeneration|MP:0004364,thin stria vascularis|MP:0004405,absent cochlear hair cells|MP:0004427,abnormal vestibular labyrinth morphology|MP:0004518,absent vestibular hair cell stereocilia|MP:0004731,increased circulating gastrin level|MP:0005211,increased stomach mucosa thickness|MP:0005385,cardiovascular system phenotype|MP:0006024,collapsed Reissner membrane|MP:0008001,hypochlorhydria|MP:0008006,increased stomach pH|MP:0008308,small scala media|MP:0010799,stomach mucosa hyperplasia|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013566,dilated gastric gland
MGI:2680653	Kcnq1<tm1Kpfe>	MP:0000026,abnormal inner ear morphology|MP:0001395,bidirectional circling|MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0001523,impaired righting response|MP:0001625,cardiac hypertrophy|MP:0001967,deafness|MP:0002729,abnormal inner ear canal morphology|MP:0002833,increased heart weight|MP:0003233,prolonged QT interval|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0003896,prolonged PR interval|MP:0004070,abnormal P wave|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004409,abnormal crista ampullaris neuroepithelium morphology|MP:0006024,collapsed Reissner membrane|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology|MP:0006330,syndromic hearing impairment|MP:0006358,absent pinna reflex|MP:0010392,prolonged QRS complex duration|MP:0010505,abnormal T wave|MP:0010508,abnormal heart electrocardiography waveform feature
MGI:3056648	Kcnq1<tm2Kpfe>	MP:0000035,abnormal membranous labyrinth morphology|MP:0001262,decreased body weight|MP:0001395,bidirectional circling|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001410,head bobbing|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0003233,prolonged QT interval|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004737,absent distortion product otoacoustic emissions|MP:0006024,collapsed Reissner membrane|MP:0006330,syndromic hearing impairment|MP:0006358,absent pinna reflex|MP:0010505,abnormal T wave|MP:0010634,increased QRS amplitude|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3056651	Kcnq1<tm3Kpfe>	MP:0003233,prolonged QT interval|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype
MGI:3056652	Kcnq1<tm4Kpfe>	MP:0002169,no abnormal phenotype detected
MGI:2389447	Kcnq1<vtg-2J>	MP:0001394,circling|MP:0001967,deafness|MP:0005307,head tossing
MGI:3611473	Kcnq1<vtg-3J>	MP:0000031,abnormal cochlea morphology|MP:0000034,abnormal inner ear vestibule morphology|MP:0000745,tremors|MP:0001394,circling|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0002894,abnormal otolith morphology|MP:0005307,head tossing|MP:0010323,retropulsion
MGI:3662651	Kcnq1<vtg-4J>	MP:0001395,bidirectional circling|MP:0001967,deafness|MP:0005307,head tossing
MGI:2661797	Kcnq2<Nmf134>	MP:0001650,abnormal seizure response to electrical stimulation|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003631,nervous system phenotype
MGI:5607735	Kcnq2<tm1.1Avtz>	MP:0000807,abnormal hippocampus morphology|MP:0002083,premature death|MP:0002272,abnormal nervous system electrophysiology|MP:0003412,abnormal afterhyperpolarization|MP:0003997,tonic-clonic seizures|MP:0004994,abnormal brain wave pattern|MP:0005402,abnormal action potential|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6488172	Kcnq2<tm1.1Lvi>	MP:0000434,megacephaly|MP:0000859,abnormal somatosensory cortex morphology|MP:0000905,increased superior colliculus size|MP:0001417,decreased exploration in new environment|MP:0002083,premature death|MP:0003997,tonic-clonic seizures|MP:0005386,behavior/neurological phenotype|MP:0012307,impaired spatial learning|MP:0012443,increased corpus callosum size|MP:0012448,abnormal primary motor cortex morphology
MGI:4397592	Kcnq2<tm1.1Naas>	MP:0001265,decreased body size|MP:0001650,abnormal seizure response to electrical stimulation|MP:0002064,seizures|MP:0002083,premature death|MP:0003997,tonic-clonic seizures|MP:0004811,abnormal neuron physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3604594	Kcnq2<tm1Dgen>	MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003412,abnormal afterhyperpolarization|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2386963	Kcnq2<tm1Hsa>	MP:0001177,atelectasis|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:5629428	Kcnq2<tm2.1Snhr>	MP:0002272,abnormal nervous system electrophysiology|MP:0003996,clonic seizures|MP:0005386,behavior/neurological phenotype
MGI:5629465	Kcnq2<tm3.1Snhr>	MP:0003996,clonic seizures|MP:0011087,neonatal lethality, complete penetrance
MGI:6293857	Kcnq3<em1(IMPC)H>	MP:0000443,abnormal snout morphology|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0005565,increased blood urea nitrogen level
MGI:5607736	Kcnq3<tm1.1Avtz>	MP:0000807,abnormal hippocampus morphology|MP:0002272,abnormal nervous system electrophysiology
MGI:4397593	Kcnq3<tm1.1Naas>	MP:0000807,abnormal hippocampus morphology|MP:0001265,decreased body size|MP:0001650,abnormal seizure response to electrical stimulation|MP:0002064,seizures|MP:0002083,premature death|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3830636	Kcnq3<tm1Dgen>	MP:0003412,abnormal afterhyperpolarization|MP:0008872,abnormal physiological response to xenobiotic
MGI:3618993	Kcnq4<tm1.1Tjj>	MP:0004404,cochlear outer hair cell degeneration|MP:0004740,sensorineural hearing loss|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3620085	Kcnq4<tm1.2Tjj>	MP:0004404,cochlear outer hair cell degeneration|MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004737,absent distortion product otoacoustic emissions|MP:0004740,sensorineural hearing loss|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5478538	Kcnq5<tm1.1Tjj>	MP:0003412,abnormal afterhyperpolarization|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6357176	Kcns1<tm1.1Kcl>	MP:0002734,abnormal mechanical nociception|MP:0002738,hyperresponsive to tactile stimuli|MP:0003858,enhanced coordination|MP:0003998,decreased thermal nociceptive threshold|MP:0005407,hyperalgesia
MGI:3604400	Kcns2<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:6276930	Kcnt1<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001293,anophthalmia|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:7624374	Kcnt1<em1Lekk>	MP:0002064,seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging|MP:0011089,perinatal lethality, complete penetrance
MGI:7449379	Kcnt1<em1Nju>	MP:0002272,abnormal nervous system electrophysiology|MP:0002578,impaired ability to fire action potentials|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0020870,decreased thigmotaxis
MGI:7442161	Kcnt1<em1Pqt>	MP:0001265,decreased body size|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001447,abnormal nest building behavior|MP:0002064,seizures|MP:0002083,premature death|MP:0003460,decreased fear-related response|MP:0003997,tonic-clonic seizures|MP:0005386,behavior/neurological phenotype|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6509315	Kcnt1<em8Frk>	MP:0001399,hyperactivity|MP:0001447,abnormal nest building behavior|MP:0002064,seizures|MP:0002206,abnormal CNS synaptic transmission|MP:0002826,tonic seizures|MP:0003247,abnormal glutaminergic neuron morphology|MP:0003631,nervous system phenotype|MP:0003632,abnormal nervous system morphology|MP:0003997,tonic-clonic seizures|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0011987,abnormal GABAergic neuron physiology
MGI:5708320	Kcnt1<tm1.1Acsc>	MP:0002734,abnormal mechanical nociception
MGI:5694636	Kcnt1<tm1.1Clin>	MP:0002169,no abnormal phenotype detected
MGI:5708322	Kcnt1<tm1.2Acsc>	MP:0001402,decreased locomotor activity|MP:0001650,abnormal seizure response to electrical stimulation|MP:0002578,impaired ability to fire action potentials|MP:0002734,abnormal mechanical nociception|MP:0002804,abnormal motor learning|MP:0005386,behavior/neurological phenotype|MP:0010055,abnormal sensory neuron physiology
MGI:5908121	Kcnt1<tm1.2Clin>	MP:0003488,decreased channel response intensity|MP:0010072,increased pruritus
MGI:7328749	Kcnt1<tm1Dgen>	MP:0002272,abnormal nervous system electrophysiology|MP:0002797,increased thigmotaxis|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential
MGI:6313350	Kcnt2<em1(IMPC)Mbp>	MP:0000692,small spleen|MP:0001402,decreased locomotor activity|MP:0002989,small kidney|MP:0009453,enhanced contextual conditioning behavior
MGI:5694651	Kcnt2<tm1.1Clin>	MP:0002169,no abnormal phenotype detected
MGI:5908119	Kcnt2<tm1.2Clin>	MP:0005386,behavior/neurological phenotype
MGI:4949762	Kcnu1<tm1.1Clin>	MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype
MGI:4949763	Kcnu1<tm1.2Clin>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype
MGI:4437059	Kcnu1<tm1Cmsa>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0003666,impaired sperm capacitation|MP:0004542,impaired acrosome reaction|MP:0020451,decreased sperm progressive motility
MGI:6140006	Kcnv1<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0004222,iris synechia
MGI:3614803	Kcnv1<vibe>	MP:0000743,muscle spasm|MP:0000745,tremors|MP:0001393,ataxia
MGI:5586809	Kcnv2<tm1.1(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:6382425	Kcnv2<tm1.2(KOMP)Wtsi>	MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008453,decreased retina rod cell number|MP:0008515,thin retina outer nuclear layer|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment|MP:0011965,decreased total retina thickness|MP:0030005,increased retina apoptosis
MGI:3579811	Kcp<tm1Gdr>	MP:0003215,renal interstitial fibrosis|MP:0003639,abnormal response to vitamins|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3691856	Kcp<tm1Ysas>	MP:0002169,no abnormal phenotype detected
MGI:5751542	Kctd10<tm1.2Zji>	MP:0000260,abnormal angiogenesis|MP:0000285,abnormal heart valve morphology|MP:0000291,enlarged pericardium|MP:0002191,abnormal artery morphology|MP:0002652,thin myocardium|MP:0003229,abnormal vitelline vasculature morphology|MP:0003230,abnormal umbilical artery morphology|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004783,abnormal cardinal vein morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012730,abnormal internal carotid artery morphology
MGI:6200410	Kctd11<em1(IMPC)J>	MP:0003131,increased erythrocyte cell number|MP:0005564,increased hemoglobin content
MGI:5756044	Kctd12<tm1.1Bet>	MP:0001392,abnormal locomotor behavior|MP:0002272,abnormal nervous system electrophysiology|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential|MP:0009455,enhanced cued conditioning behavior|MP:0010771,integument phenotype
MGI:7367571	Kctd13<em1Djla>	MP:0000519,hydronephrosis|MP:0001147,small testis|MP:0001922,reduced male fertility|MP:0002286,cryptorchism|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0004910,decreased seminal vesicle weight|MP:0004929,decreased epididymis weight|MP:0005187,abnormal penis morphology|MP:0005188,small penis|MP:0005250,decreased Sertoli cell number|MP:0009104,small penile bone
MGI:6324167	Kctd13<em2(IMPC)Ics>	MP:0003631,nervous system phenotype|MP:0008283,small hippocampus|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0012474,decreased cingulate cortex size|MP:0012478,decreased secondary somatosensory cortex size
MGI:6111982	Kctd13<tm1.1(KOMP)Vlcg>	MP:0002206,abnormal CNS synaptic transmission|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005378,growth/size/body region phenotype|MP:0014376,decreased miniature excitatory postsynaptic current frequency|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0020338,abnormal hippocampal pyramidal neuron dendrite morphology|MP:0020357,abnormal excitatory synapse morphology|MP:0020508,decreased dendritic spine density|MP:0031391,increased locomotor activity
MGI:6281587	Kctd13<tm1.1Nk>	MP:0003631,nervous system phenotype|MP:0008283,small hippocampus|MP:0013909,small third ventricle
MGI:5548790	Kctd15<tm1b(EUCOMM)Wtsi>	MP:0000273,overriding aortic valve|MP:0001697,abnormal embryo size|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005385,cardiovascular system phenotype|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010484,bicuspid aortic valve|MP:0011100,preweaning lethality, complete penetrance|MP:0011940,decreased food intake
MGI:7573135	Kctd15<tm1c(EUCOMM)Wtsi>	MP:0000373,belly spot|MP:0005367,renal/urinary system phenotype|MP:0005385,cardiovascular system phenotype|MP:0010771,integument phenotype
MGI:6099097	Kctd16<tm1.1Bet>	MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior
MGI:6144262	Kctd17<em1(IMPC)H>	MP:0001284,absent vibrissae
MGI:7511806	Kctd19<em1Fcw>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:6198567	Kctd19<em1(IMPC)J>	MP:0001925,male infertility|MP:0002075,abnormal coat/hair pigmentation|MP:0005178,increased circulating cholesterol level|MP:0011953,prolonged PQ interval
MGI:6758821	Kctd19<em1Osb>	MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0009452,abnormal synaptonemal complex|MP:0010768,mortality/aging|MP:0014634,decreased round spermatid number|MP:0030935,increased primordial germ cell apoptosis
MGI:6758824	Kctd19<em2Osb>	MP:0001925,male infertility|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:5825137	Kctd1<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0000194,increased circulating calcium level|MP:0000218,increased leukocyte cell number|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0002574,increased vertical activity|MP:0002591,decreased mean corpuscular volume|MP:0002834,decreased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0005178,increased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0005542,cornea vascularization|MP:0005553,increased circulating creatinine level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0005568,increased circulating total protein level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0006203,eye hemorrhage|MP:0012121,sclerocornea
MGI:5910041	Kctd1<Mhdahst014>	MP:0000194,increased circulating calcium level|MP:0000208,decreased hematocrit|MP:0000745,tremors|MP:0001512,trunk curl|MP:0001577,anemia|MP:0001762,polyuria|MP:0002136,abnormal kidney physiology|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002965,increased circulating serum albumin level|MP:0002988,decreased urine osmolality|MP:0003020,decreased circulating chloride level|MP:0005441,increased urine calcium level|MP:0005507,tail dragging|MP:0005540,decreased urine albumin level|MP:0005553,increased circulating creatinine level|MP:0005559,increased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level|MP:0008806,increased circulating amylase level|MP:0009350,decreased urine pH|MP:0010053,decreased grip strength|MP:0010379,decreased respiratory quotient|MP:0011089,perinatal lethality, complete penetrance|MP:0011424,decreased urine uric acid level|MP:0011435,increased urine magnesium level|MP:0011585,decreased alkaline phosphatase activity|MP:0011940,decreased food intake
MGI:6502868	Kctd1<tm1c(EUCOMM)Wtsi>	MP:0002136,abnormal kidney physiology|MP:0003215,renal interstitial fibrosis|MP:0004757,abnormal distal convoluted tubule morphology|MP:0005367,renal/urinary system phenotype|MP:0005565,increased blood urea nitrogen level|MP:0009051,dilated distal convoluted tubule|MP:0010771,integument phenotype
MGI:6502870	Kctd1<tm1d(EUCOMM)Wtsi>	MP:0001186,pigmentation phenotype|MP:0003215,renal interstitial fibrosis|MP:0005385,cardiovascular system phenotype
MGI:6414510	Kctd2<em1(IMPC)Hmgu>	MP:0003179,thrombocytopenia
MGI:6388384	Kctd3<em1(IMPC)Tcp>	MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder
MGI:6283649	Kctd5<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0000274,enlarged heart|MP:0000928,incomplete rostral neuropore closure|MP:0001701,incomplete embryo turning|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0002884,abnormal pharyngeal arch morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0012099,decreased spongiotrophoblast size|MP:0012270,cardiac edema|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6257551	Kctd7<em2(IMPC)Bay>	MP:0002169,no abnormal phenotype detected|MP:0003795,abnormal bone structure|MP:0010025,decreased total body fat amount|MP:0013279,increased fasting circulating glucose level
MGI:6382731	Kctd9<em1Beij>	MP:0002942,decreased circulating alanine transaminase level|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005632,decreased circulating aspartate transaminase level|MP:0008044,increased NK cell number|MP:0008053,abnormal NK cell differentiation|MP:0010766,abnormal NK cell physiology|MP:0013667,increased immature NK cell number|MP:0013672,decreased mature NK cell number|MP:0013699,abnormal immature NK cell morphology|MP:0020950,decreased susceptibility to Coronaviridae infection|MP:0031047,decreased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:5784897	Kctd9<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0005561,increased mean corpuscular hemoglobin
MGI:5689886	Kdelr1<em1Btlr>	MP:0005016,decreased lymphocyte cell number
MGI:4843278	Kdelr1<m1Btlr>	MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0002619,abnormal lymphocyte morphology|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005025,abnormal response to infection|MP:0005387,immune system phenotype|MP:0008041,absent NK T cells|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0009923,decreased transitional stage T1 B cell number|MP:0009926,decreased transitional stage T2 B cell number|MP:0020913,increased susceptibility to Riboviria infection
MGI:6257520	Kdelr2<em1(IMPC)Bay>	MP:0000111,cleft palate|MP:0003385,abnormal body wall morphology|MP:0003795,abnormal bone structure|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5559501	Kdf1<shd>	MP:0000111,cleft palate|MP:0000445,short snout|MP:0000468,abnormal esophageal epithelium morphology|MP:0000547,short limbs|MP:0000556,abnormal hindlimb morphology|MP:0000764,abnormal tongue epithelium morphology|MP:0001198,tight skin|MP:0001219,thick epidermis|MP:0001241,absent epidermis stratum corneum|MP:0002111,abnormal tail morphology|MP:0002160,abnormal reproductive system morphology|MP:0002233,abnormal nose morphology|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0003938,abnormal ear development|MP:0009576,oral atresia|MP:0009583,increased keratinocyte proliferation|MP:0009884,palatal shelf fusion with tongue or mandible|MP:0011087,neonatal lethality, complete penetrance|MP:0014321,short forelimb
MGI:4432990	Kdf1<tm1a(EUCOMM)Wtsi>	MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function
MGI:4130376	Kdm1a<Gt(RRK075)Byg>	MP:0001695,abnormal gastrulation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011105,embryonic lethality between implantation and placentation, incomplete penetrance
MGI:3711205	Kdm1a<tm1.1Rsd>	MP:0003077,abnormal cell cycle|MP:0003631,nervous system phenotype|MP:0003816,abnormal pituitary gland development|MP:0003965,abnormal pituitary hormone level|MP:0003969,abnormal luteinizing hormone level|MP:0005134,decreased thyroid-stimulating hormone level|MP:0005136,decreased growth hormone level
MGI:5629420	Kdm1a<tm1.1Sbae>	MP:0005386,behavior/neurological phenotype|MP:0020471,abnormal circadian behavior persistence|MP:0020476,abnormal circardian behavior entrainment
MGI:5514399	Kdm1a<tm1.1Sho>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000245,abnormal erythropoiesis|MP:0000333,decreased bone marrow cell number|MP:0000334,decreased granulocyte number|MP:0000598,abnormal liver morphology|MP:0000603,pale liver|MP:0001265,decreased body size|MP:0001657,abnormal induced morbidity/mortality|MP:0001698,decreased embryo size|MP:0002123,abnormal definitive hematopoiesis|MP:0002416,abnormal proerythroblast morphology|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0004809,increased hematopoietic stem cell number|MP:0004810,decreased hematopoietic stem cell number|MP:0005152,pancytopenia|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008813,decreased common myeloid progenitor cell number|MP:0008941,reticulocytopenia|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011243,decreased fetal derived definitive erythrocyte cell number
MGI:3834629	Kdm1a<tm1.1Tche>	MP:0000267,abnormal heart development|MP:0000286,abnormal mitral valve morphology|MP:0009416,cardiac muscle degeneration|MP:0010418,perimembraneous ventricular septal defect|MP:0011089,perinatal lethality, complete penetrance|MP:0011111,lethality during fetal growth through weaning, complete penetrance
MGI:3711561	Kdm1a<tm1.2Rsd>	MP:0001695,abnormal gastrulation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011111,lethality during fetal growth through weaning, complete penetrance
MGI:3834630	Kdm1a<tm1.2Tche>	MP:0001694,absent egg cylinders|MP:0001696,failure to gastrulate|MP:0001730,embryonic growth arrest|MP:0002169,no abnormal phenotype detected|MP:0006042,increased apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5828154	Kdm1a<tm1Ebg>	MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0003216,absence seizures|MP:0003631,nervous system phenotype|MP:0003997,tonic-clonic seizures|MP:0004994,abnormal brain wave pattern|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:4880311	Kdm1a<tm1(NCOM)Mfgc>	MP:0000601,small liver|MP:0000692,small spleen|MP:0001402,decreased locomotor activity|MP:0002188,small heart|MP:0002599,increased mean platelet volume|MP:0002606,increased basophil cell number|MP:0002989,small kidney|MP:0003641,small lung|MP:0005011,increased eosinophil cell number|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:4359289	Kdm1b<tm1.1Tche>	MP:0001926,female infertility|MP:0003718,maternal effect
MGI:5697954	Kdm2a<tm1a(KOMP)Mtok>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5697958	Kdm2a<tm1d(KOMP)Mtok>	MP:0000269,abnormal heart looping|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0002188,small heart|MP:0002621,delayed neural tube closure|MP:0003203,increased neuron apoptosis|MP:0003984,embryonic growth retardation|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0009967,abnormal neuron proliferation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011827,impaired neuron differentiation|MP:0012744,increased neural crest cell apoptosis
MGI:4332105	Kdm2b<Gt(RRT043)Byg>	MP:0000266,abnormal heart morphology|MP:0000929,open neural tube|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0003400,kinked neural tube|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4950034	Kdm2b<tm1Nobu>	MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0000929,open neural tube|MP:0001265,decreased body size|MP:0001325,abnormal retina morphology|MP:0001915,intracranial hemorrhage|MP:0002687,oligozoospermia|MP:0003051,curly tail|MP:0004200,decreased fetal size|MP:0004948,abnormal neuronal precursor proliferation|MP:0010715,retina coloboma|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012091,increased midbrain size|MP:0012265,increased hindbrain size|MP:0012535,abnormal optic fissure closure|MP:0012678,absent fourth ventricle|MP:0012701,increased embryonic neuroepithelium apoptosis|MP:0013000,absent cerebral aqueduct|MP:0013199,increased head mesenchyme apoptosis
MGI:6277017	Kdm3a<em1(IMPC)Mbp>	MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001925,male infertility|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003795,abnormal bone structure|MP:0004924,abnormal behavior|MP:0006203,eye hemorrhage|MP:0009142,decreased prepulse inhibition|MP:0010124,decreased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:3764891	Kdm3a<Gt(YHA186)Byg>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001261,obese|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0009230,abnormal sperm head morphology|MP:0014636,decreased elongated spermatid number|MP:0031354,abnormal acrosome assembly
MGI:4438720	Kdm3a<tm1.1Jsak>	MP:0000008,increased white adipose tissue amount|MP:0001261,obese|MP:0001552,increased circulating triglyceride level|MP:0002079,increased circulating insulin level|MP:0002970,abnormal white adipose tissue morphology|MP:0005178,increased circulating cholesterol level|MP:0005331,insulin resistance|MP:0005455,increased susceptibility to weight gain|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0009288,increased epididymal fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0010378,increased respiratory quotient|MP:0011049,impaired adaptive thermogenesis
MGI:3840232	Kdm3a<tm1.1Yzha>	MP:0000005,increased brown adipose tissue amount|MP:0001156,abnormal spermatogenesis|MP:0001261,obese|MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002106,abnormal muscle physiology|MP:0002108,abnormal muscle morphology|MP:0002628,hepatic steatosis|MP:0002971,abnormal brown adipose tissue morphology|MP:0005178,increased circulating cholesterol level|MP:0005290,decreased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005458,increased percent body fat/body weight|MP:0005658,increased susceptibility to diet-induced obesity|MP:0009121,increased white fat cell lipid droplet size|MP:0011049,impaired adaptive thermogenesis|MP:0011698,abnormal brown adipose tissue physiology
MGI:4453574	Kdm3a<tm1Jxu>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0006380,abnormal spermatid morphology|MP:0014052,increased male germ cell apoptosis
MGI:6156493	Kdm3b<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0001258,decreased body length|MP:0001417,decreased exploration in new environment|MP:0001914,hemorrhage|MP:0002060,abnormal skin morphology|MP:0002590,increased mean corpuscular volume|MP:0003743,abnormal facial morphology|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6403638	Kdm3b<tm1Jxu>	MP:0001125,abnormal oocyte morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001729,impaired embryo implantation|MP:0001732,postnatal growth retardation|MP:0001926,female infertility|MP:0003355,decreased ovulation rate|MP:0003699,abnormal female reproductive system physiology|MP:0003845,abnormal decidualization|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005181,decreased circulating estradiol level|MP:0005389,reproductive system phenotype|MP:0008770,decreased survivor rate|MP:0009006,prolonged estrous cycle|MP:0009011,prolonged diestrus|MP:0009647,decreased fertilization frequency|MP:0009661,abnormal pregnancy|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5056131	Kdm4a<tm1Zpl>	MP:0002834,decreased heart weight|MP:0003921,abnormal heart left ventricle morphology|MP:0004486,decreased response of heart to induced stress|MP:0004565,decreased myocardial fiber size|MP:0005385,cardiovascular system phenotype|MP:0005599,increased cardiac muscle contractility
MGI:4999586	Kdm4b<tm1.1Okad>	MP:0000628,abnormal mammary gland development|MP:0000662,abnormal branching of the mammary ductal tree|MP:0002169,no abnormal phenotype detected|MP:0010174,decreased mammary gland epithelial cell proliferation
MGI:4999585	Kdm4b<tm1.2Okad>	MP:0002169,no abnormal phenotype detected
MGI:4433704	Kdm4b<tm1a(EUCOMM)Wtsi>	MP:0000771,abnormal brain size|MP:0001257,increased body length|MP:0002196,absent corpus callosum|MP:0004924,abnormal behavior|MP:0005553,increased circulating creatinine level|MP:0005567,decreased circulating total protein level|MP:0008535,enlarged lateral ventricles|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012460,decreased dentate gyrus size
MGI:5806952	Kdm4c<Gt(897)Tgen>	MP:0001262,decreased body weight|MP:0004502,decreased incidence of tumors by chemical induction|MP:0011400,lethality, complete penetrance
MGI:4362199	Kdm4c<tm1a(KOMP)Wtsi>	MP:0000194,increased circulating calcium level|MP:0000652,enlarged sebaceous gland|MP:0001262,decreased body weight|MP:0002965,increased circulating serum albumin level|MP:0005014,increased B cell number
MGI:5792836	Kdm4c<tm1d(KOMP)Wtsi>	MP:0005384,cellular phenotype|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5051955	Kdm4d<tm1Zuk>	MP:0001148,enlarged testis|MP:0001262,decreased body weight|MP:0005389,reproductive system phenotype|MP:0006308,enlarged seminiferous tubules|MP:0006380,abnormal spermatid morphology|MP:0008280,abnormal male germ cell apoptosis
MGI:3798768	Kdm5a<tm1.1Kael>	MP:0000219,increased neutrophil cell number|MP:0001265,decreased body size|MP:0002123,abnormal definitive hematopoiesis|MP:0003077,abnormal cell cycle|MP:0003492,abnormal involuntary movement|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004924,abnormal behavior|MP:0008008,early cellular replicative senescence|MP:0011087,neonatal lethality, complete penetrance
MGI:3798767	Kdm5a<tm1Kael>	MP:0002169,no abnormal phenotype detected|MP:0008008,early cellular replicative senescence
MGI:6153378	Kdm5b<em1(IMPC)Wtsi>	MP:0001258,decreased body length|MP:0006358,absent pinna reflex|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4329395	Kdm5b<Gt(RRO123)Byg>	MP:0000628,abnormal mammary gland development|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0002083,premature death|MP:0004905,decreased uterus weight|MP:0005181,decreased circulating estradiol level|MP:0008489,slow postnatal weight gain|MP:0010768,mortality/aging|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4459030	Kdm5c<Gt(E008C01)Wrst>	MP:0002169,no abnormal phenotype detected
MGI:3865669	Kdm5c<Gt(P026G11)Wrst>	MP:0000266,abnormal heart morphology|MP:0002084,abnormal developmental patterning
MGI:6163735	Kdm5c<tm1.2Yshi>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001353,increased aggression towards mice|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0002781,increased circulating testosterone level|MP:0005389,reproductive system phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0009936,abnormal dendritic spine morphology|MP:0010698,abnormal impulsive behavior control|MP:0012307,impaired spatial learning|MP:0020337,abnormal pyramidal neuron dendrite morphology|MP:0020508,decreased dendritic spine density|MP:0020512,abnormal dendritic mushroom spine morphology
MGI:6324173	Kdm5c<tm1d(EUCOMM)Hmgu>	MP:0000367,abnormal coat/ hair morphology|MP:0002591,decreased mean corpuscular volume|MP:0011100,preweaning lethality, complete penetrance|MP:0011960,abnormal eye anterior chamber depth
MGI:6361169	Kdm5d<em1Osb>	MP:0005389,reproductive system phenotype
MGI:4126347	Kdm6a<Gt(RRA094)Byg>	MP:0000266,abnormal heart morphology|MP:0000280,thin ventricular wall|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0001787,pericardial edema|MP:0002083,premature death|MP:0002188,small heart|MP:0002925,abnormal cardiovascular development|MP:0003232,abnormal forebrain development|MP:0003400,kinked neural tube|MP:0004251,failure of heart looping|MP:0009703,decreased birth body size|MP:0010503,myocardial trabeculae hypoplasia|MP:0010725,thin interventricular septum|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5499290	Kdm6a<tm1.1Afst>	MP:0000221,decreased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0001263,weight loss|MP:0001577,anemia|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002417,abnormal megakaryocyte morphology|MP:0002441,abnormal granulocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0003795,abnormal bone structure|MP:0004029,spontaneous chromosome breakage|MP:0004952,increased spleen weight|MP:0005014,increased B cell number|MP:0005397,hematopoietic system phenotype|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:5448754	Kdm6a<tm1.1Kaig>	MP:0002169,no abnormal phenotype detected|MP:0012185,abnormal muscle precursor cell morphology|MP:0013239,impaired skeletal muscle regeneration
MGI:5499291	Kdm6a<tm1.2Afst>	MP:0000267,abnormal heart development|MP:0000919,cranioschisis|MP:0001672,abnormal embryo development|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5448825	Kdm6a<tm1.2Kaig>	MP:0000267,abnormal heart development|MP:0000914,exencephaly|MP:0001177,atelectasis|MP:0001577,anemia|MP:0001954,respiratory distress|MP:0002825,abnormal notochord morphology|MP:0003720,abnormal neural tube closure|MP:0004073,caudal body truncation|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005380,embryo phenotype|MP:0011089,perinatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5438704	Kdm6a<tm1a(EUCOMM)Jhha>	MP:0003984,embryonic growth retardation|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5507843	Kdm6a<tm1b(EUCOMM)Jae>	MP:0000267,abnormal heart development|MP:0001732,postnatal growth retardation|MP:0002084,abnormal developmental patterning|MP:0003720,abnormal neural tube closure|MP:0003794,delayed somite formation|MP:0004180,failure of initiation of embryo turning|MP:0005389,reproductive system phenotype|MP:0009397,increased trophoblast giant cell number|MP:0009674,decreased birth weight|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5516011	Kdm6a<tm1b(EUCOMM)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000280,thin ventricular wall|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0001787,pericardial edema|MP:0002083,premature death|MP:0002188,small heart|MP:0002925,abnormal cardiovascular development|MP:0004251,failure of heart looping|MP:0009703,decreased birth body size|MP:0010503,myocardial trabeculae hypoplasia|MP:0010725,thin interventricular septum|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6192374	Kdm6a<tm1Cdcn>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000322,increased granulocyte number|MP:0000691,enlarged spleen|MP:0002083,premature death|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0004809,increased hematopoietic stem cell number|MP:0005481,increased chronic myelocytic leukemia incidence|MP:0008973,decreased erythroid progenitor cell number|MP:0009395,increased nucleated erythrocyte cell number|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0013663,increased myeloid cell number|MP:0013696,increased granulocyte monocyte progenitor cell number|MP:0013705,decreased megakaryocyte-erythroid progenitor cell number
MGI:5507836	Kdm6a<tm1c(EUCOMM)Jae>	MP:0002169,no abnormal phenotype detected
MGI:5516010	Kdm6a<tm1c(EUCOMM)Wtsi>	MP:0000111,cleft palate|MP:0000929,open neural tube|MP:0010768,mortality/aging|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012754,abnormal cranial neural crest cell morphology|MP:0013545,cleft hard palate
MGI:5448826	Kdm6a<tm2.1Kaig>	MP:0005369,muscle phenotype|MP:0012185,abnormal muscle precursor cell morphology|MP:0013239,impaired skeletal muscle regeneration
MGI:4125312	Kdm6b<Gt(XB814)Byg>	MP:0001575,cyanosis|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0010745,abnormal pre-Botzinger complex morphology|MP:0010746,abnormal pre-Botzinger complex physiology|MP:0011087,neonatal lethality, complete penetrance|MP:0014812,abnormal brain physiology
MGI:5792729	Kdm6b<tm1.1Cdcn>	MP:0000160,kyphosis|MP:0000164,abnormal cartilage development|MP:0000547,short limbs|MP:0001176,abnormal lung development|MP:0001575,cyanosis|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0004200,decreased fetal size|MP:0004351,short humerus|MP:0004686,decreased length of long bones|MP:0008395,abnormal osteoblast differentiation|MP:0009250,abnormal appendicular skeleton morphology|MP:0009431,decreased fetal weight|MP:0011087,neonatal lethality, complete penetrance|MP:0014101,decreased chondrocyte proliferation|MP:0014106,delayed chondrocyte differentiation|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization
MGI:5796917	Kdm6b<tm1.1Rbo>	MP:0003154,abnormal soft palate morphology|MP:0005382,craniofacial phenotype|MP:0005621,abnormal cell physiology|MP:0009653,abnormal palate development|MP:0009883,palatal shelf hypoplasia|MP:0009896,palatine bone horizontal plate hypoplasia|MP:0009898,maxillary shelf hypoplasia|MP:0011087,neonatal lethality, complete penetrance|MP:0012174,flat head|MP:0021213,complete cleft palate|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0021216,abnormal palatal mesenchymal cell differentiation|MP:0030224,abnormal soft palate muscle morphology
MGI:5708545	Kdm6b<tm1.1Rfw>	MP:0000351,increased cell proliferation|MP:0002058,neonatal lethality|MP:0002133,abnormal respiratory system physiology
MGI:4838334	Kdm6b<tm1Aki>	MP:0001175,abnormal lung morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0002081,perinatal lethality|MP:0005025,abnormal response to infection|MP:0008723,impaired eosinophil recruitment
MGI:5551612	Kdm6b<tm1Iwam>	MP:0002082,postnatal lethality
MGI:7301211	Kdm7a<em1Gpt>	MP:0000130,abnormal trabecular bone morphology|MP:0004985,decreased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0004993,decreased bone resorption|MP:0008396,abnormal osteoclast differentiation|MP:0010123,increased bone mineral content|MP:0010868,increased bone trabecula number|MP:0010872,increased trabecular bone mass|MP:0010878,increased trabecular bone volume|MP:0011168,abnormal fat cell differentiation|MP:0011710,enhanced osteoblast differentiation|MP:0013631,decreased bone trabecular spacing|MP:0020039,increased bone ossification|MP:0020080,increased bone mineralization|MP:0021030,decreased tumor necrosis factor (ligand) superfamily member 11 level|MP:0031008,decreased bone marrow adipose tissue amount
MGI:4432944	Kdm7a<tm1a(EUCOMM)Wtsi>	MP:0000377,abnormal hair follicle morphology|MP:0000647,abnormal sebaceous gland morphology|MP:0002111,abnormal tail morphology|MP:0003036,vertebral transformation|MP:0009759,abnormal hair follicle bulge morphology
MGI:3871554	Kdm8<Gt(AZ0518)Wtsi>	MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5311832	Kdm8<tm1.1Tasu>	MP:0002169,no abnormal phenotype detected
MGI:5311834	Kdm8<tm1.2Tasu>	MP:0001701,incomplete embryo turning|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4431607	Kdm8<tm1a(EUCOMM)Wtsi>	MP:0001260,increased body weight|MP:0002078,abnormal glucose homeostasis|MP:0005014,increased B cell number|MP:0005102,abnormal iris pigmentation|MP:0005316,abnormal response to tactile stimuli
MGI:5548680	Kdm8<tm1b(EUCOMM)Wtsi>	MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5311829	Kdm8<tm1Tasu>	MP:0000352,decreased cell proliferation|MP:0001698,decreased embryo size|MP:0002080,prenatal lethality|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3525660	Kdnw1<SM/J>	MP:0003917,increased kidney weight
MGI:3525685	Kdnw2<LG/J>	MP:0003917,increased kidney weight
MGI:3525691	Kdnw3<LG/J>	MP:0003917,increased kidney weight
MGI:5004965	Kdr<orv>	MP:0001092,abnormal trigeminal ganglion morphology|MP:0001622,abnormal vasculogenesis|MP:0001698,decreased embryo size|MP:0003861,abnormal nervous system development|MP:0006338,abnormal second pharyngeal arch morphology|MP:0009657,failure of chorioallantoic fusion|MP:0010642,absent third pharyngeal arch|MP:0010643,absent fourth pharyngeal arch|MP:0010939,abnormal mandibular prominence morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012756,impaired cranial neural crest cell differentiation|MP:0012757,abnormal cranial neural crest cell migration
MGI:4429911	Kdr<tm1.1Eia>	MP:0000259,abnormal vascular development|MP:0011092,embryonic lethality, complete penetrance
MGI:4367756	Kdr<tm1.1Jamb>	MP:0001312,abnormal cornea morphology|MP:0001879,abnormal lymphatic vessel morphology|MP:0004106,lymphatic vessel hyperplasia|MP:0004272,abnormal basement membrane morphology|MP:0005165,increased susceptibility to injury|MP:0008778,abnormal lymphangiogenesis
MGI:3530468	Kdr<tm1.1Msh>	MP:0000263,absent organized vascular network|MP:0001606,impaired hematopoiesis|MP:0001719,absent vitelline blood vessels|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5544800	Kdr<tm1.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:4367758	Kdr<tm1.2Jamb>	MP:0001672,abnormal embryo development
MGI:3840948	Kdr<tm1Eze>	MP:0005385,cardiovascular system phenotype
MGI:1857168	Kdr<tm1Jrt>	MP:0000263,absent organized vascular network|MP:0001606,impaired hematopoiesis|MP:0001698,decreased embryo size|MP:0001719,absent vitelline blood vessels|MP:0001721,absent visceral yolk sac blood islands|MP:0001726,abnormal allantois morphology|MP:0002085,abnormal embryonic tissue morphology|MP:0002123,abnormal definitive hematopoiesis|MP:0002169,no abnormal phenotype detected|MP:0004787,abnormal dorsal aorta morphology|MP:0006138,congestive heart failure|MP:0006323,abnormal extraembryonic mesoderm development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013241,embryo tissue necrosis
MGI:4422101	Kdr<tm1Wag>	MP:0000260,abnormal angiogenesis|MP:0000281,abnormal interventricular septum morphology|MP:0001265,decreased body size|MP:0003631,nervous system phenotype|MP:0004111,abnormal coronary artery morphology|MP:0005386,behavior/neurological phenotype|MP:0009698,heart hemorrhage|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5705394	Kdr<tm1Ykub>	MP:0004106,lymphatic vessel hyperplasia|MP:0010200,enlarged lymphatic vessel
MGI:3629041	Kdr<tm2.1Jrt>	MP:0001289,persistence of hyaloid vascular system|MP:0002792,abnormal retina vasculature morphology|MP:0005391,vision/eye phenotype|MP:0008513,thin retina inner plexiform layer|MP:0011965,decreased total retina thickness
MGI:3530469	Kdr<tm2.1Msh>	MP:0002169,no abnormal phenotype detected
MGI:3589627	Kdw1<FGS/Kist>	MP:0003918,decreased kidney weight
MGI:4948838	Keap1<tm1.1Sbis>	MP:0005166,decreased susceptibility to injury|MP:0006382,abnormal lung epithelium morphology|MP:0010809,abnormal club cell morphology
MGI:2681416	Keap1<tm1Mym>	MP:0000468,abnormal esophageal epithelium morphology|MP:0000472,abnormal stomach non-glandular epithelium morphology|MP:0000473,abnormal stomach glandular epithelium morphology|MP:0001192,scaly skin|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002691,small stomach|MP:0005211,increased stomach mucosa thickness|MP:0011085,postnatal lethality, complete penetrance
MGI:3828123	kec1	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology|MP:0011697,lens vacuoles
MGI:5632213	Keg1<tm1b(KOMP)Mbp>	MP:0000194,increased circulating calcium level|MP:0001399,hyperactivity|MP:0003131,increased erythrocyte cell number|MP:0005344,increased circulating bilirubin level|MP:0005564,increased hemoglobin content|MP:0020870,decreased thigmotaxis
MGI:5581644	Kel<tm1Slee>	MP:0000746,weakness|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0002590,increased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0005333,decreased heart rate|MP:0005404,abnormal axon morphology|MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008850,increased hemoglobin concentration distribution width|MP:0008954,abnormal cellular hemoglobin content|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010511,shortened PR interval|MP:0010738,abnormal internode morphology|MP:0011730,increased myelin sheath thickness|MP:0011731,decreased myelin sheath thickness|MP:0011954,shortened PQ interval|MP:0012367,decreased erythrocyte magnesium level|MP:0012370,decreased erythrocyte potassium level
MGI:6140208	Kera<em1(IMPC)Wtsi>	MP:0004599,abnormal vertebral arch morphology
MGI:2664936	Kera<tm1Cyl>	MP:0000222,decreased neutrophil cell number|MP:0001845,abnormal inflammatory response|MP:0004221,abnormal iridocorneal angle|MP:0005300,abnormal cornea stroma morphology|MP:0005543,decreased cornea thickness
MGI:3844604	Khdc3<tm1Dean>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0003718,maternal effect|MP:0005389,reproductive system phenotype
MGI:3692384	Khdrbs1<tm1Rchd>	MP:0000062,increased bone mineral density|MP:0000168,abnormal bone marrow development|MP:0001262,decreased body weight|MP:0001386,abnormal maternal nurturing|MP:0001533,abnormal skeleton physiology|MP:0001925,male infertility|MP:0002006,neoplasm|MP:0002998,abnormal bone remodeling|MP:0005006,abnormal osteoblast physiology|MP:0005605,increased bone mass|MP:0005666,abnormal adipose tissue physiology|MP:0005668,decreased circulating leptin level|MP:0009719,reduced cerebellar foliation|MP:0011090,perinatal lethality, incomplete penetrance|MP:0020011,increased bone mineral density of femur|MP:0021187,increased bone mineral density of vertebrae
MGI:3847811	Khdrbs2<Tg(LRRK2*R1441G)135Cjli>	MP:0001402,decreased locomotor activity|MP:0001663,abnormal digestive system physiology|MP:0002690,akinesia|MP:0002757,decreased vertical activity|MP:0003243,abnormal dopaminergic neuron morphology|MP:0003267,constipation|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0004250,tau protein deposits|MP:0005036,diarrhea|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0005643,decreased dopamine level|MP:0008260,abnormal autophagy|MP:0008493,alpha-synuclein inclusion body
MGI:5568964	Khdrbs2<tm1.1Schei>	MP:0000852,small cerebellum
MGI:5505896	Khdrbs3<tm1.2Dell>	MP:0001935,decreased litter size|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:5636948	Khdrbs3<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0002968,increased circulating alkaline phosphatase level
MGI:4867311	Khk<tm1.1Dtb>	MP:0000598,abnormal liver morphology|MP:0002079,increased circulating insulin level|MP:0005266,abnormal metabolism|MP:0005376,homeostasis/metabolism phenotype|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0005669,increased circulating leptin level|MP:0006319,abnormal epididymal fat pad morphology|MP:0009355,increased liver triglyceride level|MP:0009642,abnormal blood homeostasis|MP:0031265,increased susceptibility to hepatic steatosis
MGI:4398729	Khk<tm2Dtb>	MP:0000598,abnormal liver morphology|MP:0001423,abnormal liquid preference|MP:0002310,decreased susceptibility to hepatic steatosis|MP:0004890,decreased energy expenditure|MP:0005266,abnormal metabolism|MP:0005376,homeostasis/metabolism phenotype|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0005449,abnormal food intake|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0010400,increased liver glycogen level
MGI:7425770	Khsrp<em1(IMPC)Mbp>	MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0009552,urinary bladder obstruction|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width
MGI:5285092	Khsrp<tm1.1Cyc>	MP:0008564,increased interferon-beta secretion|MP:0020917,decreased susceptibility to Herpesvirales infection|MP:0031025,decreased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:5605821	Kics2<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000198,decreased circulating phosphate level|MP:0005179,decreased circulating cholesterol level|MP:0005565,increased blood urea nitrogen level
MGI:4820793	Kidins220<tm1.1Mvc>	MP:0008143,abnormal dendrite morphology|MP:0008762,embryonic lethality|MP:0009936,abnormal dendritic spine morphology
MGI:5527339	Kidins220<tm1.2Fces>	MP:0000774,decreased brain size|MP:0000939,decreased motor neuron number|MP:0001914,hemorrhage|MP:0002206,abnormal CNS synaptic transmission|MP:0003105,abnormal heart atrium morphology|MP:0003140,dilated heart atrium|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0004200,decreased fetal size|MP:0004950,abnormal brain vasculature morphology|MP:0005294,abnormal heart ventricle morphology|MP:0005404,abnormal axon morphology|MP:0008143,abnormal dendrite morphology|MP:0009937,abnormal neuron differentiation|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0030005,increased retina apoptosis
MGI:3043115	Kidpq1<L6>	MP:0003917,increased kidney weight
MGI:3043100	Kidpq2<L6>	MP:0003918,decreased kidney weight
MGI:3042939	Kidq1<L6>	MP:0003918,decreased kidney weight
MGI:3042936	Kidq2<L6>	MP:0003918,decreased kidney weight
MGI:3042947	Kidq3<L6>	MP:0003918,decreased kidney weight
MGI:3042971	Kidq4<L6>	MP:0003918,decreased kidney weight
MGI:3042977	Kidq5<L6>	MP:0003918,decreased kidney weight
MGI:3042985	Kidq6<L6>	MP:0003917,increased kidney weight
MGI:3042967	Kidq7<L6>	MP:0003918,decreased kidney weight
MGI:3711986	Kif11<Gt(XE579)Byg>	MP:0001730,embryonic growth arrest|MP:0009781,abnormal preimplantation embryo development|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance|MP:0012111,failure of morula compaction
MGI:3803280	Kif11<tm1Much>	MP:0001698,decreased embryo size|MP:0001728,failure of embryo implantation|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0006204,embryonic lethality before implantation
MGI:8242619	Kif12<em1Noh>	MP:0000609,abnormal liver physiology|MP:0001860,liver inflammation|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0002944,increased lactate dehydrogenase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003333,liver fibrosis|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0009355,increased liver triglyceride level|MP:0012602,increased alpha-fetoprotein level|MP:0014045,Mallory bodies|MP:0031116,microvesicular hepatic steatosis
MGI:6423850	Kif13a<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001304,cataract|MP:0001399,hyperactivity|MP:0001489,decreased startle reflex|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0004738,abnormal auditory brainstem response|MP:0009142,decreased prepulse inhibition|MP:0009709,hydrometra
MGI:3876729	Kif13a<Gt(AF0553)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5503119	Kif13a<tm1.1Noh>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002797,increased thigmotaxis|MP:0005386,behavior/neurological phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3876683	Kif13b<Gt(AF0005)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0020414,abnormal fibroblast physiology
MGI:5609275	Kif13b<tm1.1Noh>	MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0012329,increased circulating factor VIII level
MGI:5636925	Kif13b<tm1b(EUCOMM)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0000221,decreased leukocyte cell number|MP:0002968,increased circulating alkaline phosphatase level
MGI:5488954	Kif14<lag>	MP:0000352,decreased cell proliferation|MP:0000433,microcephaly|MP:0000745,tremors|MP:0000746,weakness|MP:0000788,abnormal cerebral cortex morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000851,cerebellum hypoplasia|MP:0000885,ectopic Purkinje cell|MP:0000921,demyelination|MP:0000955,abnormal spinal cord morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002175,decreased brain weight|MP:0002741,small olfactory bulb|MP:0003312,abnormal locomotor coordination|MP:0004097,abnormal cerebellar cortex morphology|MP:0006042,increased apoptosis|MP:0006254,thin cerebral cortex|MP:0008489,slow postnatal weight gain|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008917,abnormal oligodendrocyte physiology|MP:0009977,abnormal cerebellar granule cell migration|MP:0010012,ectopic cerebral cortex pyramidal cells|MP:0011085,postnatal lethality, complete penetrance
MGI:5488956	Kif14<tm1Tskk>	MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000921,demyelination|MP:0000955,abnormal spinal cord morphology|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0004097,abnormal cerebellar cortex morphology|MP:0006221,optic nerve hypoplasia|MP:0012174,flat head
MGI:7543356	Kif15<em1Lium>	MP:0002160,abnormal reproductive system morphology|MP:0003447,decreased tumor growth/size|MP:0004952,increased spleen weight|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008475,intermingled spleen red and white pulp|MP:0008476,increased spleen red pulp amount|MP:0008479,decreased spleen white pulp amount
MGI:6399903	Kif16b<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000495,abnormal colon morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0000759,abnormal skeletal muscle morphology|MP:0001157,small seminal vesicle|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0003271,abnormal duodenum morphology
MGI:4936840	Kif16b<tm1.2Noh>	MP:0001672,abnormal embryo development|MP:0001730,embryonic growth arrest|MP:0011092,embryonic lethality, complete penetrance|MP:0011183,abnormal primitive endoderm morphology|MP:0011184,absent embryonic epiblast
MGI:5427632	Kif17<tm1Noh>	MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001475,reduced long-term depression|MP:0001900,impaired synaptic plasticity|MP:0001902,reduced NMDA-mediated synaptic currents|MP:0004768,abnormal axonal transport|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0014367,impaired long-term object recognition memory
MGI:3050507	Kif18a<gcd2>	MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001156,abnormal spermatogenesis|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001929,abnormal gametogenesis|MP:0002209,decreased germ cell number|MP:0004045,abnormal cell cycle checkpoint function|MP:0004046,abnormal mitosis|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0005431,decreased oocyte number|MP:0005621,abnormal cell physiology|MP:0006042,increased apoptosis|MP:0006378,abnormal spermatogonia morphology|MP:0008392,decreased primordial germ cell number|MP:0008871,abnormal ovarian follicle number|MP:0009760,abnormal mitotic spindle morphology|MP:0009762,abnormal mitotic spindle assembly checkpoint|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0031020,premature ovarian failure
MGI:7705503	Kif18a<tm1.1Lgr>	MP:0005168,abnormal female meiosis|MP:0009564,abnormal meiotic configurations|MP:0009566,meiotic nondisjunction
MGI:5575486	Kif18a<tm1Zgwg>	MP:0000352,decreased cell proliferation|MP:0001152,increased Leydig cell number|MP:0001154,seminiferous tubule degeneration|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0003205,testicular atrophy|MP:0003830,abnormal testis development|MP:0004046,abnormal mitosis|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:4944522	Kif18b<tm1a(EUCOMM)Wtsi>	MP:0001552,increased circulating triglyceride level|MP:0011100,preweaning lethality, complete penetrance
MGI:5463445	Kif19a<tm1Noh>	MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0001926,female infertility|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0003574,abnormal oviduct morphology|MP:0003699,abnormal female reproductive system physiology|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011644,abnormal oviduct epithelium motile cilium morphology|MP:0030965,increased brain ependyma motile cilium length
MGI:5749650	Kif1a<lgdg>	MP:0000755,hindlimb paralysis|MP:0001265,decreased body size|MP:0003312,abnormal locomotor coordination|MP:0004263,abnormal limb posture|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5752892	Kif1a<lgdg-2J>	MP:0000755,hindlimb paralysis
MGI:3639347	Kif1a<tm1Noh>	MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001491,unresponsive to tactile stimuli|MP:0001516,abnormal motor coordination/balance|MP:0001525,impaired balance|MP:0003224,neuron degeneration|MP:0003633,abnormal nervous system physiology|MP:0004792,abnormal synaptic vesicle number|MP:0004793,abnormal synaptic vesicle clustering|MP:0005405,axon degeneration|MP:0005498,hyporesponsive to tactile stimuli|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4124759	Kif1b<Gt(XC445)Byg>	MP:0008762,embryonic lethality
MGI:5505909	Kif1b<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0001491,unresponsive to tactile stimuli|MP:0001697,abnormal embryo size|MP:0001914,hemorrhage|MP:0002109,abnormal limb morphology|MP:0002177,abnormal outer ear morphology|MP:0002574,increased vertical activity|MP:0003019,increased circulating chloride level|MP:0003743,abnormal facial morphology|MP:0005566,decreased blood urea nitrogen level|MP:0005633,increased circulating sodium level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0020870,decreased thigmotaxis
MGI:2387573	Kif1b<tm1Noh>	MP:0000162,lordosis|MP:0000748,progressive muscle weakness|MP:0000774,decreased brain size|MP:0000807,abnormal hippocampus morphology|MP:0001405,impaired coordination|MP:0001491,unresponsive to tactile stimuli|MP:0001516,abnormal motor coordination/balance|MP:0001953,respiratory failure|MP:0002199,abnormal brain commissure morphology|MP:0004768,abnormal axonal transport|MP:0004792,abnormal synaptic vesicle number|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005277,abnormal brainstem morphology|MP:0008948,decreased neuron number|MP:0011087,neonatal lethality, complete penetrance
MGI:2151177	Kif1c<Ltxs1>	MP:0002412,increased susceptibility to bacterial infection
MGI:3609229	Kif1c<Ltxs1-DBA/2NCr>	MP:0002409,decreased susceptibility to infection
MGI:3036095	Kif1c<Orch3-BALB/cByJ>	MP:0001875,testis inflammation
MGI:3036096	Kif1c<Orch3-DBA/2J>	MP:0001876,decreased inflammatory response
MGI:2180803	Kif1c<tm1Noh>	MP:0002169,no abnormal phenotype detected
MGI:5636934	Kif20a<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001402,decreased locomotor activity|MP:0002590,increased mean corpuscular volume|MP:0011100,preweaning lethality, complete penetrance
MGI:3578531	Kif20b<33cex>	MP:0000914,exencephaly|MP:0002152,abnormal brain morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6194344	Kif20b<ddvl>	MP:0000111,cleft palate|MP:0001293,anophthalmia|MP:0004201,fetal growth retardation
MGI:4888744	Kif20b<magoo>	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0000433,microcephaly|MP:0000445,short snout|MP:0000784,forebrain hypoplasia|MP:0000787,abnormal telencephalon morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0001297,microphthalmia|MP:0002058,neonatal lethality|MP:0002110,abnormal digit morphology|MP:0002741,small olfactory bulb|MP:0003203,increased neuron apoptosis|MP:0003451,absent olfactory bulb|MP:0003651,abnormal axon extension|MP:0004046,abnormal mitosis|MP:0004811,abnormal neuron physiology|MP:0004948,abnormal neuronal precursor proliferation|MP:0004981,decreased neuronal precursor cell number|MP:0005404,abnormal axon morphology|MP:0006254,thin cerebral cortex|MP:0008143,abnormal dendrite morphology|MP:0008415,abnormal neurite morphology|MP:0008442,disorganized cortical plate|MP:0008458,abnormal cortical ventricular zone morphology|MP:0008535,enlarged lateral ventricles|MP:0010714,iris coloboma|MP:0011085,postnatal lethality, complete penetrance|MP:0012138,decreased forebrain size|MP:0020337,abnormal pyramidal neuron dendrite morphology|MP:0020850,abnormal microtubule cytoskeleton morphology
MGI:5635264	Kif21a<tm1.1Ece>	MP:0000939,decreased motor neuron number|MP:0001052,abnormal innervation pattern to muscle|MP:0001061,abnormal oculomotor nerve morphology|MP:0001070,abnormal abducens nerve morphology|MP:0001344,blepharoptosis|MP:0002092,abnormal eye morphology|MP:0003203,increased neuron apoptosis|MP:0003651,abnormal axon extension|MP:0005247,abnormal extraocular muscle morphology|MP:0005404,abnormal axon morphology|MP:0013827,thin oculomotor nerve
MGI:5635226	Kif21a<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:5635265	Kif21a<tm2Ece>	MP:0002169,no abnormal phenotype detected
MGI:5635266	Kif21a<tm3Ece>	MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:4364527	Kif21b<tm1a(KOMP)Wtsi>	MP:0002942,decreased circulating alanine transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0005632,decreased circulating aspartate transaminase level
MGI:4431403	Kif21b<tm2a(KOMP)Wtsi>	MP:0005386,behavior/neurological phenotype|MP:0008143,abnormal dendrite morphology|MP:0009456,impaired cued conditioning behavior|MP:0009538,abnormal synapse morphology|MP:0012307,impaired spatial learning|MP:0020338,abnormal hippocampal pyramidal neuron dendrite morphology|MP:0020508,decreased dendritic spine density
MGI:3834595	Kif22<tm1.1Tya>	MP:0001672,abnormal embryo development|MP:0002083,premature death|MP:0003702,abnormal chromosome morphology|MP:0011104,embryonic lethality before implantation, incomplete penetrance
MGI:7522151	Kif23<tm1.1Igo>	MP:0002169,no abnormal phenotype detected
MGI:4415314	Kif26a<tm1.1Noh>	MP:0000495,abnormal colon morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002731,megacolon|MP:0003289,abnormal intestinal peristalsis|MP:0003651,abnormal axon extension|MP:0004948,abnormal neuronal precursor proliferation|MP:0005150,cachexia|MP:0005381,digestive/alimentary phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4459557	Kif26b<tm1.1Ryn>	MP:0000520,absent kidney|MP:0000521,abnormal kidney cortex morphology|MP:0000527,abnormal kidney development|MP:0002058,neonatal lethality|MP:0002989,small kidney|MP:0003604,single kidney|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0009641,kidney degeneration
MGI:6477625	Kif26b<tm1Ryn>	MP:0002058,neonatal lethality
MGI:5471275	Kif26b<tm2b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0002702,decreased circulating free fatty acids level|MP:0002833,increased heart weight|MP:0011100,preweaning lethality, complete penetrance
MGI:4318693	Kif27<Gt(OST441915)Lex>	MP:0001265,decreased body size|MP:0001850,increased susceptibility to otitis media|MP:0001891,hydrocephaly|MP:0001917,intraventricular hemorrhage|MP:0002083,premature death|MP:0002200,abnormal brain ventricular system morphology|MP:0002236,abnormal internal nares morphology|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0010752,impaired mucociliary clearance|MP:0030113,maxillary sinus inflammation
MGI:7425771	Kif28<em1(IMPC)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:7377677	Kif2a<em1(IMPC)Mbp>	MP:0001399,hyperactivity|MP:0001711,abnormal placenta morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:3623680	Kif2a<tm1Noh>	MP:0000783,abnormal forebrain morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000813,abnormal hippocampus layer morphology|MP:0000841,abnormal hindbrain morphology|MP:0000848,abnormal pons morphology|MP:0000849,abnormal cerebellum morphology|MP:0000897,abnormal midbrain morphology|MP:0000906,abnormal trigeminal V mesencephalic nucleus morphology|MP:0001436,abnormal suckling behavior|MP:0003651,abnormal axon extension|MP:0003684,abnormal inferior olivary complex morphology|MP:0003861,abnormal nervous system development|MP:0005404,abnormal axon morphology|MP:0006100,abnormal tegmentum morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0014554,delayed neuronal migration|MP:0020560,abnormal pontine nuclei morphology
MGI:6194715	Kif2b<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:7328589	Kif2c<em1Nju>	MP:0001475,reduced long-term depression|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008428,abnormal spatial working memory|MP:0009456,impaired cued conditioning behavior|MP:0009538,abnormal synapse morphology|MP:0009712,impaired conditioned place preference behavior|MP:0011269,increased excitatory postsynaptic current amplitude|MP:0020395,abnormal response to social novelty|MP:0020422,decreased freezing behavior|MP:0020507,increased dendritic spine density|MP:0020508,decreased dendritic spine density|MP:0020512,abnormal dendritic mushroom spine morphology
MGI:5766255	Kif2c<tm1.1(KOMP)Vlcg>	MP:0001552,increased circulating triglyceride level|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration
MGI:3580660	Kif3a<2a>	MP:0000955,abnormal spinal cord morphology|MP:0001706,abnormal left-right axis patterning|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1861960	Kif3a<tm1Gsn>	MP:0000269,abnormal heart looping|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001706,abnormal left-right axis patterning|MP:0001787,pericardial edema|MP:0002766,situs inversus|MP:0003720,abnormal neural tube closure|MP:0004066,abnormal primitive node morphology|MP:0004073,caudal body truncation|MP:0004132,absent embryonic cilia|MP:0004252,abnormal direction of heart looping|MP:0006279,abnormal limb development|MP:0006346,small pharyngeal arch|MP:0009328,delayed heart looping|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2181727	Kif3a<tm1Noh>	MP:0000269,abnormal heart looping|MP:0000292,distended pericardium|MP:0000930,wavy neural tube|MP:0001680,abnormal mesoderm development|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001706,abnormal left-right axis patterning|MP:0001891,hydrocephaly|MP:0002084,abnormal developmental patterning|MP:0004132,absent embryonic cilia|MP:0004252,abnormal direction of heart looping|MP:0005312,pericardial effusion|MP:0010500,myocardium hypoplasia|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012093,absent nodal flow|MP:0012509,neural tube degeneration
MGI:2386464	Kif3a<tm2Gsn>	MP:0000088,short mandible|MP:0000102,abnormal nasal bone morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000131,abnormal long bone epiphysis morphology|MP:0000150,abnormal rib morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000166,abnormal chondrocyte morphology|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0001156,abnormal spermatogenesis|MP:0001300,ocular hypertelorism|MP:0001925,male infertility|MP:0002116,abnormal craniofacial bone morphology|MP:0002196,absent corpus callosum|MP:0002239,abnormal nasal septum morphology|MP:0002427,disproportionate dwarf|MP:0002631,abnormal epididymis morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0002687,oligozoospermia|MP:0002820,abnormal premaxilla morphology|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0003935,abnormal craniofacial development|MP:0004623,thoracic vertebral fusion|MP:0004686,decreased length of long bones|MP:0004852,decreased testis weight|MP:0004911,absent mandibular condyloid process|MP:0004929,decreased epididymis weight|MP:0005249,abnormal palatine bone morphology|MP:0005297,spina bifida occulta|MP:0006380,abnormal spermatid morphology|MP:0006397,disorganized long bone epiphyseal plate|MP:0008272,abnormal endochondral bone ossification|MP:0008450,retina photoreceptor degeneration|MP:0008528,polycystic kidney|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009376,abnormal manchette morphology|MP:0009377,ectopic manchette|MP:0009838,abnormal sperm axoneme morphology|MP:0009890,cleft secondary palate|MP:0010029,abnormal basicranium morphology|MP:0012754,abnormal cranial neural crest cell morphology|MP:0012759,increased cranial neural crest cell proliferation|MP:0014468,disorganized sperm mitochondrial sheath|MP:0020849,abnormal actin cytoskeleton morphology|MP:0030251,broad frontonasal prominence|MP:0030269,absent mandibular ramus|MP:0030276,anterior cranium occultum|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0031356,abnormal outer dense fiber morphology|MP:0031373,abnormal manchette perinuclear ring morphology|MP:0031375,abnormal manchette disassembly|MP:0031386,elongated manchette
MGI:5548376	Kif3b<tm1b(EUCOMM)Wtsi>	MP:0010052,increased grip strength|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:2181744	Kif3b<tm1Noh>	MP:0000292,distended pericardium|MP:0000781,decreased corpus callosum size|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0000955,abnormal spinal cord morphology|MP:0001360,abnormal social investigation|MP:0001409,increased stereotypic behavior|MP:0001415,increased exploration in new environment|MP:0001441,increased grooming behavior|MP:0001475,reduced long-term depression|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001706,abnormal left-right axis patterning|MP:0001900,impaired synaptic plasticity|MP:0001902,reduced NMDA-mediated synaptic currents|MP:0003008,enhanced long-term potentiation|MP:0003461,abnormal response to novel object|MP:0004132,absent embryonic cilia|MP:0004252,abnormal direction of heart looping|MP:0009142,decreased prepulse inhibition|MP:0009936,abnormal dendritic spine morphology|MP:0009939,abnormal hippocampus neuron morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012307,impaired spatial learning|MP:0012445,thin hippocampus stratum radiatum|MP:0012775,abnormal brain weight|MP:0020512,abnormal dendritic mushroom spine morphology|MP:0020870,decreased thigmotaxis
MGI:5630064	Kif3c<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001489,decreased startle reflex|MP:0002968,increased circulating alkaline phosphatase level|MP:0011100,preweaning lethality, complete penetrance|MP:0011396,abnormal sleep behavior
MGI:2183787	Kif3c<tm1Gsn>	MP:0002169,no abnormal phenotype detected
MGI:2183788	Kif3c<tm2Gsn>	MP:0002169,no abnormal phenotype detected
MGI:2183789	Kif3c<tm3Gsn>	MP:0002169,no abnormal phenotype detected
MGI:7711987	Kif4<em1Noh>	MP:0000774,decreased brain size|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0002797,increased thigmotaxis|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0004200,decreased fetal size|MP:0004811,abnormal neuron physiology|MP:0008283,small hippocampus|MP:0008489,slow postnatal weight gain|MP:0009454,impaired contextual conditioning behavior|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011102,embryonic lethality, incomplete penetrance|MP:0012315,impaired learning|MP:0014367,impaired long-term object recognition memory|MP:0021019,increased dendritic spine number|MP:0021165,behavioral developmental delay
MGI:4331040	Kif4<Gt(AA0042)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:8270893	Kif5a<em1Kolb>	MP:0014649,increased susceptibility to nerve crush injury
MGI:5495649	Kif5a<tm1.1Noh>	MP:0011087,neonatal lethality, complete penetrance
MGI:5495650	Kif5a<tm1.2Noh>	MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0003631,nervous system phenotype|MP:0004008,abnormal GABA-mediated receptor currents|MP:0011085,postnatal lethality, complete penetrance|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude
MGI:5635227	Kif5a<tm1b(EUCOMM)Wtsi>	MP:0001491,unresponsive to tactile stimuli|MP:0001575,cyanosis|MP:0004738,abnormal auditory brainstem response|MP:0006243,impaired pupillary reflex|MP:0011100,preweaning lethality, complete penetrance
MGI:2656900	Kif5a<tm1Gsn>	MP:0000937,abnormal motor neuron morphology|MP:0001177,atelectasis|MP:0001575,cyanosis|MP:0001951,abnormal breathing pattern|MP:0003631,nervous system phenotype|MP:0008546,abnormal vesicle-mediated transport|MP:0011087,neonatal lethality, complete penetrance
MGI:3810072	Kif5b<tm1.1Njen>	MP:0011100,preweaning lethality, complete penetrance
MGI:3809821	Kif5b<tm1Njen>	MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0008546,abnormal vesicle-mediated transport
MGI:2159694	Kif5b<tm1Noh>	MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0005058,abnormal lysosome morphology|MP:0006035,abnormal mitochondrial morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7432901	Kif5c<tm1dIcs>	MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005568,increased circulating total protein level
MGI:3809823	Kif5c<tm1Gsn>	MP:0002169,no abnormal phenotype detected
MGI:1888955	Kif5c<tm1Noh>	MP:0000774,decreased brain size|MP:0000939,decreased motor neuron number|MP:0006006,increased sensory neuron number
MGI:4949203	Kif5c<tm2Gsn>	MP:0008546,abnormal vesicle-mediated transport
MGI:6341924	Kif6<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000774,decreased brain size|MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002152,abnormal brain morphology|MP:0002188,small heart|MP:0009709,hydrometra
MGI:6276219	Kif6<em1Rgray>	MP:0000440,domed cranium|MP:0000825,dilated lateral ventricle|MP:0001402,decreased locomotor activity|MP:0001505,hunched posture|MP:0001891,hydrocephaly|MP:0001915,intracranial hemorrhage|MP:0002083,premature death|MP:0005238,increased brain size|MP:0011056,abnormal brain ependyma motile cilium morphology
MGI:5554605	Kif6<Rgsc2221>	MP:0005385,cardiovascular system phenotype
MGI:6276221	Kif6<tm1c(KOMP)Mbp>	MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0001891,hydrocephaly
MGI:5498230	Kif7<b2b2254Clo>	MP:0000111,cleft palate|MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000914,exencephaly|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001891,hydrocephaly|MP:0003936,abnormal reproductive system development|MP:0004157,interrupted aortic arch|MP:0005170,cleft upper lip|MP:0009743,preaxial polydactyly|MP:0009744,postaxial polydactyly|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010460,pulmonary artery hypoplasia|MP:0010975,abnormal lung lobe morphology
MGI:5495412	Kif7<dda>	MP:0001178,pulmonary hypoplasia|MP:0002151,abnormal neural tube morphology|MP:0003924,diaphragmatic hernia|MP:0005508,abnormal skeleton morphology|MP:0006065,abnormal heart position or orientation|MP:0010402,ventricular septal defect|MP:0012059,thick diaphragm muscle|MP:0012060,diaphragm muscle hyperplasia|MP:0012061,abnormal diaphragm central tendon morphology|MP:0012251,abnormal diaphragm development
MGI:4355980	Kif7<maki>	MP:0000937,abnormal motor neuron morphology|MP:0002151,abnormal neural tube morphology|MP:0003924,diaphragmatic hernia|MP:0005192,increased motor neuron number|MP:0009743,preaxial polydactyly|MP:0011089,perinatal lethality, complete penetrance|MP:0012061,abnormal diaphragm central tendon morphology
MGI:4357956	Kif7<tm1.2Hui>	MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000157,abnormal sternum morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0001785,edema|MP:0009743,preaxial polydactyly|MP:0009937,abnormal neuron differentiation|MP:0011087,neonatal lethality, complete penetrance
MGI:4360052	Kif7<tm1Lex>	MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0000955,abnormal spinal cord morphology|MP:0001297,microphthalmia|MP:0001785,edema|MP:0005650,abnormal limb bud morphology|MP:0009743,preaxial polydactyly
MGI:6279904	Kif9<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000692,small spleen|MP:0001925,male infertility|MP:0002060,abnormal skin morphology
MGI:6511741	Kif9<em1Osb>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0003631,nervous system phenotype|MP:0005389,reproductive system phenotype|MP:0009647,decreased fertilization frequency|MP:0020451,decreased sperm progressive motility|MP:0030976,impaired sperm penetration of zona pellucida
MGI:6511743	Kif9<em2Osb>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0003631,nervous system phenotype|MP:0020451,decreased sperm progressive motility
MGI:4362297	Kifap3<tm1a(KOMP)Wtsi>	MP:0005293,impaired glucose tolerance|MP:0011100,preweaning lethality, complete penetrance
MGI:6150321	Kifbp<em1Hmy>	MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0001575,cyanosis|MP:0001672,abnormal embryo development|MP:0001954,respiratory distress|MP:0002175,decreased brain weight|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005390,skeleton phenotype|MP:0008226,decreased anterior commissure size|MP:0009946,abnormal olfactory bulb layer morphology|MP:0010059,olfactory bulb hypoplasia|MP:0011087,neonatal lethality, complete penetrance|MP:0013001,abnormal enteric neural crest cell morphology
MGI:6150323	Kifbp<em2Hmy>	MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0001575,cyanosis|MP:0001672,abnormal embryo development|MP:0001954,respiratory distress|MP:0002175,decreased brain weight|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005390,skeleton phenotype|MP:0008226,decreased anterior commissure size|MP:0009946,abnormal olfactory bulb layer morphology|MP:0010059,olfactory bulb hypoplasia|MP:0011087,neonatal lethality, complete penetrance|MP:0013001,abnormal enteric neural crest cell morphology
MGI:4939684	Kifbp<tm1a(KOMP)Wtsi>	MP:0000111,cleft palate|MP:0000602,dilated liver sinusoidal space|MP:0001015,small superior cervical ganglion|MP:0001093,small trigeminal ganglion|MP:0001711,abnormal placenta morphology|MP:0003019,increased circulating chloride level|MP:0003595,epididymal cyst|MP:0003686,abnormal eye muscle morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0004163,abnormal adenohypophysis morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013247,placenta necrosis|MP:0013832,thin vagus nerve|MP:0013834,thin hypoglossal nerve|MP:0013835,absent hypoglossal nerve|MP:0013848,subcutaneous edema|MP:0013873,abnormal ductus venosus morphology|MP:0013874,abnormal ductus venosus topology|MP:0013875,increased trigeminal neuroma incidence|MP:0013971,blood in lymph vessels|MP:0014002,absent extracranial vertebral artery segment|MP:0014006,absent posterior communicating artery|MP:0014018,embryo tumor|MP:0030975,placenta hemorrhage
MGI:6257810	Kifc1<em1(IMPC)Bay>	MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment
MGI:5635228	Kifc2<tm1.1(KOMP)Vlcg>	MP:0001289,persistence of hyaloid vascular system
MGI:2158351	Kifc2<tm1Gsn>	MP:0002169,no abnormal phenotype detected
MGI:5692580	Kifc3<tm1b(EUCOMM)Hmgu>	MP:0011962,increased cornea thickness
MGI:2158352	Kifc3<tm1Gsn>	MP:0005367,renal/urinary system phenotype|MP:0005391,vision/eye phenotype|MP:0005397,hematopoietic system phenotype
MGI:6382547	Kin<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0002626,increased heart rate|MP:0010507,shortened RR interval|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6382396	Kirrel1<em1(IMPC)Mbp>	MP:0001289,persistence of hyaloid vascular system|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001711,abnormal placenta morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0006203,eye hemorrhage|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:2388348	Kirrel1<Gt(VICTR20)20Lex>	MP:0001265,decreased body size|MP:0002083,premature death|MP:0002962,increased urine protein level|MP:0005325,abnormal renal glomerulus morphology|MP:0009050,dilated proximal convoluted tubule|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011353,expanded mesangial matrix|MP:0011427,increased mesangial cell number|MP:0011430,mesangiolysis|MP:0011682,renal glomerulus cyst
MGI:6356795	Kirrel1<tm1.2Geno>	MP:0002962,increased urine protein level|MP:0008059,abnormal podocyte foot process morphology|MP:0008060,abnormal podocyte slit diaphragm morphology|MP:0010107,abnormal renal reabsorption|MP:0011089,perinatal lethality, complete penetrance
MGI:6356799	Kirrel2<tm1.1Tbh>	MP:0002169,no abnormal phenotype detected|MP:0005367,renal/urinary system phenotype
MGI:5007205	Kirrel2<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:6285518	Kirrel2<tm2b(KOMP)Wtsi>	MP:0003631,nervous system phenotype|MP:0009948,abnormal olfactory bulb glomerular layer morphology
MGI:6285519	Kirrel2<tm2c(KOMP)Wtsi>	MP:0009948,abnormal olfactory bulb glomerular layer morphology
MGI:5517690	Kirrel3<tm1.1Jfcl>	MP:0002566,abnormal sexual interaction|MP:0003862,decreased aggression towards male mice|MP:0005394,taste/olfaction phenotype|MP:0009948,abnormal olfactory bulb glomerular layer morphology|MP:0011679,abnormal vomeronasal sensory neuron morphology
MGI:6356797	Kirrel3<tm1.1Tbh>	MP:0002169,no abnormal phenotype detected|MP:0005367,renal/urinary system phenotype
MGI:3764967	Kiss1r<Gt1Stei>	MP:0000837,abnormal hypothalamus morphology|MP:0000939,decreased motor neuron number|MP:0001127,small ovary|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001919,abnormal reproductive system physiology|MP:0001924,infertility|MP:0002160,abnormal reproductive system morphology|MP:0002566,abnormal sexual interaction|MP:0002773,decreased circulating luteinizing hormone level|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0004910,decreased seminal vesicle weight|MP:0005188,small penis|MP:0005189,abnormal anogenital distance|MP:0009856,failure of ejaculation
MGI:5558092	Kiss1r<tm1.1Aeh>	MP:0001144,vagina atresia|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0005132,decreased luteinizing hormone level|MP:0005159,azoospermia
MGI:5052305	Kiss1r<tm1.1(cre)Uboe>	MP:0002169,no abnormal phenotype detected
MGI:5617953	Kiss1r<tm1.1Hjn>	MP:0001127,small ovary|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0001931,abnormal oogenesis|MP:0001938,delayed sexual maturation|MP:0002636,delayed vaginal opening|MP:0002637,small uterus|MP:0002687,oligozoospermia|MP:0002773,decreased circulating luteinizing hormone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003379,absent sexual maturation|MP:0003967,abnormal follicle stimulating hormone level|MP:0003969,abnormal luteinizing hormone level|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0005188,small penis|MP:0005189,abnormal anogenital distance|MP:0008940,delayed balanopreputial separation
MGI:5696918	Kiss1r<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002059,abnormal seminal vesicle morphology|MP:0002135,abnormal kidney morphology|MP:0002631,abnormal epididymis morphology|MP:0002834,decreased heart weight|MP:0002989,small kidney|MP:0003558,absent uterus|MP:0003578,absent ovary|MP:0003642,absent seminal vesicle|MP:0003795,abnormal bone structure|MP:0003918,decreased kidney weight|MP:0003961,decreased lean body mass|MP:0004727,absent epididymis|MP:0004952,increased spleen weight|MP:0004955,increased thymus weight|MP:0005553,increased circulating creatinine level|MP:0006415,absent testes|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5316416	Kiss1r<tm1.1Lex>	MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0001116,small gonad|MP:0001119,abnormal female reproductive system morphology|MP:0001134,absent corpus luteum|MP:0001145,abnormal male reproductive system morphology|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001157,small seminal vesicle|MP:0001262,decreased body weight|MP:0001919,abnormal reproductive system physiology|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002160,abnormal reproductive system morphology|MP:0002607,decreased basophil cell number|MP:0002644,decreased circulating triglyceride level|MP:0002773,decreased circulating luteinizing hormone level|MP:0002774,small prostate gland|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0002965,increased circulating serum albumin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0003363,decreased circulating gonadotropin level|MP:0003402,decreased liver weight|MP:0003918,decreased kidney weight|MP:0003967,abnormal follicle stimulating hormone level|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0004905,decreased uterus weight|MP:0004910,decreased seminal vesicle weight|MP:0004929,decreased epididymis weight|MP:0004930,small epididymis|MP:0004952,increased spleen weight|MP:0004955,increased thymus weight|MP:0004962,decreased prostate gland weight|MP:0005012,decreased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005159,azoospermia|MP:0005179,decreased circulating cholesterol level|MP:0005188,small penis|MP:0005189,abnormal anogenital distance|MP:0005376,homeostasis/metabolism phenotype|MP:0005536,decreased Leydig cell number|MP:0005559,increased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0009642,abnormal blood homeostasis|MP:0013308,decreased adrenal gland weight|MP:0031239,increased atretic ovarian follicle number
MGI:3530566	Kiss1r<tm1Coll>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0001116,small gonad|MP:0001121,uterus hypoplasia|MP:0001127,small ovary|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001143,constricted vagina orifice|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001159,absent prostate gland|MP:0001380,decreased male mating frequency|MP:0001926,female infertility|MP:0001938,delayed sexual maturation|MP:0002636,delayed vaginal opening|MP:0002637,small uterus|MP:0002773,decreased circulating luteinizing hormone level|MP:0002780,decreased circulating testosterone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003363,decreased circulating gonadotropin level|MP:0003631,nervous system phenotype|MP:0003642,absent seminal vesicle|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0005159,azoospermia|MP:0005181,decreased circulating estradiol level|MP:0006401,absent male preputial gland|MP:0008261,arrest of male meiosis|MP:0008288,abnormal adrenal cortex morphology|MP:0008297,retention of the adrenal gland x-zone|MP:0008869,anovulation|MP:0009009,absent estrous cycle|MP:0014633,decreased spermatid number
MGI:3614434	Kiss1r<tm1Gstn>	MP:0001119,abnormal female reproductive system morphology|MP:0001121,uterus hypoplasia|MP:0001127,small ovary|MP:0001145,abnormal male reproductive system morphology|MP:0001153,small seminiferous tubules|MP:0001159,absent prostate gland|MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002161,abnormal fertility/fecundity|MP:0002637,small uterus|MP:0003344,mammary gland hypoplasia|MP:0003642,absent seminal vesicle|MP:0003918,decreased kidney weight|MP:0004852,decreased testis weight|MP:0004930,small epididymis|MP:0004955,increased thymus weight|MP:0005188,small penis|MP:0005389,reproductive system phenotype|MP:0005536,decreased Leydig cell number|MP:0006401,absent male preputial gland|MP:0008983,small vagina|MP:0009226,small uterine cervix
MGI:3762756	Kiss1r<tm1Rla>	MP:0001119,abnormal female reproductive system morphology|MP:0001134,absent corpus luteum|MP:0001145,abnormal male reproductive system morphology|MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002636,delayed vaginal opening|MP:0002716,small male preputial gland|MP:0002777,absent ovarian follicles|MP:0002780,decreased circulating testosterone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0005132,decreased luteinizing hormone level|MP:0005148,seminal vesicle hypoplasia|MP:0005189,abnormal anogenital distance|MP:0005536,decreased Leydig cell number|MP:0009009,absent estrous cycle|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014633,decreased spermatid number
MGI:5298495	Kiss1<tm1.1(cre/EGFP)Stei>	MP:0003631,nervous system phenotype
MGI:3715520	Kiss1<tm1Coll>	MP:0000618,small salivary gland|MP:0000639,abnormal adrenal gland morphology|MP:0000653,abnormal sex gland morphology|MP:0001119,abnormal female reproductive system morphology|MP:0001127,small ovary|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001142,abnormal vagina orifice morphology|MP:0001145,abnormal male reproductive system morphology|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001929,abnormal gametogenesis|MP:0001932,abnormal spermiogenesis|MP:0002163,abnormal gland morphology|MP:0002637,small uterus|MP:0002717,abnormal male preputial gland morphology|MP:0002773,decreased circulating luteinizing hormone level|MP:0002780,decreased circulating testosterone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003379,absent sexual maturation|MP:0003402,decreased liver weight|MP:0003572,abnormal uterus development|MP:0003918,decreased kidney weight|MP:0004109,abnormal Sertoli cell development|MP:0004852,decreased testis weight|MP:0004905,decreased uterus weight|MP:0005159,azoospermia|MP:0005181,decreased circulating estradiol level|MP:0005183,abnormal circulating estradiol level|MP:0005188,small penis|MP:0008297,retention of the adrenal gland x-zone|MP:0008869,anovulation|MP:0009009,absent estrous cycle|MP:0013317,abnormal seminal vesicle development|MP:0031239,increased atretic ovarian follicle number
MGI:3762755	Kiss1<tm1Rla>	MP:0001119,abnormal female reproductive system morphology|MP:0001134,absent corpus luteum|MP:0001140,abnormal vagina epithelium morphology|MP:0001145,abnormal male reproductive system morphology|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002016,ovary cyst|MP:0002636,delayed vaginal opening|MP:0002716,small male preputial gland|MP:0002777,absent ovarian follicles|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0005148,seminal vesicle hypoplasia|MP:0005189,abnormal anogenital distance|MP:0005536,decreased Leydig cell number|MP:0009009,absent estrous cycle|MP:0014633,decreased spermatid number
MGI:3576614	Kit<d18>	MP:0000373,belly spot
MGI:4839549	Kitl<M1Bao>	MP:0000373,belly spot|MP:0002075,abnormal coat/hair pigmentation|MP:0002938,white spotting|MP:0009379,abnormal foot pigmentation|MP:0009933,abnormal tail hair pigmentation
MGI:6199628	Kitl<m1Btlr>	MP:0000372,irregular coat pigmentation|MP:0005171,absent coat pigmentation
MGI:6200262	Kitl<m2Btlr>	MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0008237,abnormal ventral coat pigmentation
MGI:1856161	Kitl<Sl>	MP:0000336,decreased mast cell number|MP:0000370,head blaze|MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0000913,abnormal brain development|MP:0001189,absent skin pigmentation|MP:0001577,anemia|MP:0001924,infertility|MP:0002020,increased tumor incidence|MP:0002098,abnormal vibrissa morphology|MP:0002128,abnormal blood circulation|MP:0002875,decreased erythrocyte cell number|MP:0002939,head spot|MP:0003054,spina bifida|MP:0003717,pallor|MP:0004478,increased testicular teratoma incidence|MP:0005389,reproductive system phenotype|MP:0008857,myelencephalic blebs|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011279,decreased ear pigmentation|MP:0011568,decreased foot pigmentation
MGI:1857383	Kitl<Sl-10H>	MP:0000371,diluted coat color|MP:0001577,anemia|MP:0002938,white spotting|MP:0002939,head spot|MP:0009379,abnormal foot pigmentation|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2448751	Kitl<Sl-12R>	MP:0000371,diluted coat color|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0005171,absent coat pigmentation
MGI:5301902	Kitl<Sl-13H>	MP:0000373,belly spot|MP:0002075,abnormal coat/hair pigmentation|MP:0002082,postnatal lethality|MP:0002939,head spot|MP:0009933,abnormal tail hair pigmentation
MGI:5301915	Kitl<Sl-15H>	MP:0000373,belly spot|MP:0002075,abnormal coat/hair pigmentation|MP:0002082,postnatal lethality|MP:0002939,head spot|MP:0009933,abnormal tail hair pigmentation
MGI:1856171	Kitl<Sl-16J>	MP:0000371,diluted coat color|MP:0002938,white spotting
MGI:1857739	Kitl<Sl-17H>	MP:0000371,diluted coat color|MP:0000372,irregular coat pigmentation|MP:0000373,belly spot|MP:0001127,small ovary|MP:0001152,increased Leydig cell number|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002938,white spotting|MP:0002939,head spot|MP:0004901,decreased male germ cell number|MP:0005171,absent coat pigmentation|MP:0005431,decreased oocyte number|MP:0008392,decreased primordial germ cell number|MP:0010383,increased adenoma incidence
MGI:1856366	Kitl<Sl-18H>	MP:0000370,head blaze|MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0001577,anemia|MP:0002938,white spotting|MP:0002939,head spot|MP:0003717,pallor|MP:0005408,hypopigmentation|MP:0006205,embryonic lethality between implantation and somite formation|MP:0008762,embryonic lethality|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2652945	Kitl<Sl-18R>	MP:0002594,low mean erythrocyte cell number|MP:0002875,decreased erythrocyte cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:1856369	Kitl<Sl-19J>	MP:0005171,absent coat pigmentation
MGI:2447294	Kitl<Sl-1Neu>	MP:0000208,decreased hematocrit|MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0001923,reduced female fertility|MP:0002590,increased mean corpuscular volume|MP:0002811,macrocytic anemia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002939,head spot|MP:0005561,increased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011278,increased ear pigmentation
MGI:2682007	Kitl<Sl-20J>	MP:0000245,abnormal erythropoiesis|MP:0000373,belly spot|MP:0000603,pale liver|MP:0003717,pallor|MP:0004200,decreased fetal size|MP:0008393,absent primordial germ cells|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5301916	Kitl<Sl-21H>	MP:0000373,belly spot|MP:0001577,anemia|MP:0002075,abnormal coat/hair pigmentation|MP:0002939,head spot|MP:0009933,abnormal tail hair pigmentation|MP:0011085,postnatal lethality, complete penetrance
MGI:3616706	Kitl<Sl-21J>	MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0009379,abnormal foot pigmentation|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:3697523	Kitl<Sl-22J>	MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0005103,abnormal retina pigmentation|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0009379,abnormal foot pigmentation|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:2445944	Kitl<Sl-22R>	MP:0002590,increased mean corpuscular volume|MP:0002594,low mean erythrocyte cell number|MP:0002811,macrocytic anemia|MP:0002939,head spot|MP:0005397,hematopoietic system phenotype|MP:0005561,increased mean corpuscular hemoglobin|MP:0008237,abnormal ventral coat pigmentation|MP:0008392,decreased primordial germ cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3710263	Kitl<Sl-23J>	MP:0000371,diluted coat color|MP:0000373,belly spot
MGI:5313557	Kitl<sl-24J>	MP:0001265,decreased body size|MP:0002940,variable body spotting|MP:0005389,reproductive system phenotype|MP:0011277,decreased tail pigmentation|MP:0011568,decreased foot pigmentation
MGI:5301917	Kitl<Sl-26H>	MP:0000371,diluted coat color|MP:0002075,abnormal coat/hair pigmentation|MP:0002939,head spot
MGI:5301918	Kitl<Sl-27H>	MP:0000371,diluted coat color|MP:0002075,abnormal coat/hair pigmentation|MP:0011091,prenatal lethality, complete penetrance
MGI:2445945	Kitl<Sl-28R>	MP:0002590,increased mean corpuscular volume|MP:0002594,low mean erythrocyte cell number|MP:0002811,macrocytic anemia|MP:0002939,head spot|MP:0005561,increased mean corpuscular hemoglobin|MP:0008237,abnormal ventral coat pigmentation|MP:0008392,decreased primordial germ cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5314350	Kitl<Sl-29H>	MP:0002075,abnormal coat/hair pigmentation|MP:0002939,head spot|MP:0005171,absent coat pigmentation|MP:0009934,abnormal hind foot hair pigmentation
MGI:2447295	Kitl<Sl-2Neu>	MP:0000208,decreased hematocrit|MP:0000371,diluted coat color|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0002874,decreased hemoglobin content|MP:0002939,head spot
MGI:5301919	Kitl<Sl-30H>	MP:0000371,diluted coat color|MP:0009933,abnormal tail hair pigmentation|MP:0011092,embryonic lethality, complete penetrance
MGI:2445942	Kitl<Sl-30R>	MP:0000208,decreased hematocrit|MP:0002082,postnatal lethality|MP:0002590,increased mean corpuscular volume|MP:0002594,low mean erythrocyte cell number|MP:0002811,macrocytic anemia|MP:0002939,head spot|MP:0005561,increased mean corpuscular hemoglobin|MP:0008237,abnormal ventral coat pigmentation|MP:0008392,decreased primordial germ cell number
MGI:5301920	Kitl<Sl-31H>	MP:0000373,belly spot|MP:0002075,abnormal coat/hair pigmentation|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2445943	Kitl<Sl-31R>	MP:0002590,increased mean corpuscular volume|MP:0002594,low mean erythrocyte cell number|MP:0002811,macrocytic anemia|MP:0002939,head spot|MP:0005561,increased mean corpuscular hemoglobin|MP:0008237,abnormal ventral coat pigmentation|MP:0008392,decreased primordial germ cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5301921	Kitl<Sl-33H>	MP:0002075,abnormal coat/hair pigmentation|MP:0009933,abnormal tail hair pigmentation
MGI:1857351	Kitl<Sl-34H>	MP:0000371,diluted coat color|MP:0001577,anemia|MP:0002938,white spotting|MP:0011092,embryonic lethality, complete penetrance
MGI:1862027	Kitl<Sl-35H>	MP:0000371,diluted coat color
MGI:1862028	Kitl<Sl-36H>	MP:0000371,diluted coat color
MGI:2445948	Kitl<Sl-36R>	MP:0000208,decreased hematocrit|MP:0002590,increased mean corpuscular volume|MP:0002594,low mean erythrocyte cell number|MP:0002811,macrocytic anemia|MP:0002939,head spot|MP:0002982,abnormal primordial germ cell migration|MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008237,abnormal ventral coat pigmentation|MP:0008392,decreased primordial germ cell number|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0030934,decreased primordial germ cell proliferation
MGI:1862029	Kitl<Sl-37H>	MP:0000371,diluted coat color
MGI:1862030	Kitl<Sl-38H>	MP:0000371,diluted coat color
MGI:2445947	Kitl<Sl-39R>	MP:0000208,decreased hematocrit|MP:0002075,abnormal coat/hair pigmentation|MP:0002590,increased mean corpuscular volume|MP:0002594,low mean erythrocyte cell number|MP:0002811,macrocytic anemia|MP:0002939,head spot|MP:0002982,abnormal primordial germ cell migration|MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008237,abnormal ventral coat pigmentation|MP:0008391,abnormal primordial germ cell morphology|MP:0008392,decreased primordial germ cell number|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0030934,decreased primordial germ cell proliferation|MP:0030935,increased primordial germ cell apoptosis
MGI:2447306	Kitl<Sl-3Neu>	MP:0000371,diluted coat color|MP:0001923,reduced female fertility|MP:0002938,white spotting|MP:0005397,hematopoietic system phenotype|MP:0011278,increased ear pigmentation
MGI:2658691	Kitl<Sl-3R>	MP:0000371,diluted coat color|MP:0011091,prenatal lethality, complete penetrance
MGI:2445946	Kitl<Sl-42R>	MP:0000208,decreased hematocrit|MP:0002590,increased mean corpuscular volume|MP:0002594,low mean erythrocyte cell number|MP:0002811,macrocytic anemia|MP:0002939,head spot|MP:0005561,increased mean corpuscular hemoglobin|MP:0008237,abnormal ventral coat pigmentation|MP:0008392,decreased primordial germ cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2652949	Kitl<Sl-5R>	MP:0002594,low mean erythrocyte cell number|MP:0002875,decreased erythrocyte cell number|MP:0008392,decreased primordial germ cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:4431000	Kitl<sl-blz>	MP:0000370,head blaze|MP:0000371,diluted coat color|MP:0000373,belly spot
MGI:1856162	Kitl<Sl-Clo>	MP:0000371,diluted coat color|MP:0001144,vagina atresia|MP:0001921,reduced fertility|MP:0002075,abnormal coat/hair pigmentation|MP:0002940,variable body spotting
MGI:1856163	Kitl<Sl-con>	MP:0000324,increased mast cell number|MP:0001129,impaired ovarian folliculogenesis|MP:0001130,abnormal ovarian folliculogenesis|MP:0001188,hyperpigmentation|MP:0002075,abnormal coat/hair pigmentation|MP:0002095,abnormal skin pigmentation|MP:0005389,reproductive system phenotype|MP:0005431,decreased oocyte number
MGI:1856164	Kitl<Sl-d>	MP:0000208,decreased hematocrit|MP:0000336,decreased mast cell number|MP:0000371,diluted coat color|MP:0001577,anemia|MP:0001924,infertility|MP:0002075,abnormal coat/hair pigmentation|MP:0002590,increased mean corpuscular volume|MP:0002594,low mean erythrocyte cell number|MP:0002811,macrocytic anemia|MP:0002939,head spot|MP:0002982,abnormal primordial germ cell migration|MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008237,abnormal ventral coat pigmentation|MP:0008391,abnormal primordial germ cell morphology|MP:0008392,decreased primordial germ cell number|MP:0009783,abnormal melanoblast morphology|MP:0010768,mortality/aging|MP:0030934,decreased primordial germ cell proliferation|MP:0030935,increased primordial germ cell apoptosis
MGI:1856169	Kitl<sl-du>	MP:0000371,diluted coat color|MP:0001577,anemia|MP:0002940,variable body spotting
MGI:1856165	Kitl<Sl-gb>	MP:0002590,increased mean corpuscular volume|MP:0002594,low mean erythrocyte cell number|MP:0002811,macrocytic anemia|MP:0002939,head spot|MP:0002982,abnormal primordial germ cell migration|MP:0005561,increased mean corpuscular hemoglobin|MP:0008237,abnormal ventral coat pigmentation|MP:0008390,abnormal primordial germ cell proliferation|MP:0008391,abnormal primordial germ cell morphology|MP:0008392,decreased primordial germ cell number|MP:0008393,absent primordial germ cells|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0030935,increased primordial germ cell apoptosis
MGI:1856170	Kitl<Sl-J>	MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0001577,anemia|MP:0002216,abnormal seminiferous tubule morphology|MP:0002777,absent ovarian follicles|MP:0002938,white spotting|MP:0004478,increased testicular teratoma incidence|MP:0004806,absent germ cells|MP:0011089,perinatal lethality, complete penetrance
MGI:1856166	Kitl<Sl-m>	MP:0000371,diluted coat color|MP:0000465,gastrointestinal hemorrhage|MP:0001577,anemia|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0005171,absent coat pigmentation
MGI:1856167	Kitl<Sl-pan>	MP:0000371,diluted coat color|MP:0000372,irregular coat pigmentation|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001926,female infertility|MP:0002811,macrocytic anemia|MP:0002938,white spotting|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0005431,decreased oocyte number|MP:0008392,decreased primordial germ cell number
MGI:1856168	Kitl<Sl-so>	MP:0000371,diluted coat color|MP:0001577,anemia|MP:0002075,abnormal coat/hair pigmentation|MP:0005171,absent coat pigmentation|MP:0009933,abnormal tail hair pigmentation|MP:0011085,postnatal lethality, complete penetrance
MGI:1856172	Kitl<Sl-t>	MP:0000371,diluted coat color|MP:0002939,head spot|MP:0005171,absent coat pigmentation|MP:0005175,non-pigmented tail tip
MGI:5300819	Kitl<tm1.1Sjm>	MP:0000600,liver hypoplasia|MP:0001577,anemia|MP:0002875,decreased erythrocyte cell number|MP:0009278,abnormal bone marrow cell physiology|MP:0011089,perinatal lethality, complete penetrance|MP:0011182,decreased hematopoietic cell number
MGI:3664559	Kitl<tm1Pbes>	MP:0000336,decreased mast cell number|MP:0003992,increased mortality induced by ionizing radiation|MP:0005397,hematopoietic system phenotype|MP:0009642,abnormal blood homeostasis
MGI:4430867	Kitl<tm2.1Pbes>	MP:0000324,increased mast cell number|MP:0000352,decreased cell proliferation|MP:0004852,decreased testis weight|MP:0006410,abnormal common myeloid progenitor cell morphology
MGI:5300820	Kitl<tm2.1Sjm>	MP:0000333,decreased bone marrow cell number|MP:0000600,liver hypoplasia|MP:0001577,anemia|MP:0002875,decreased erythrocyte cell number|MP:0009278,abnormal bone marrow cell physiology|MP:0011182,decreased hematopoietic cell number
MGI:5306338	Kitl<tm2.2Sjm>	MP:0001577,anemia|MP:0011089,perinatal lethality, complete penetrance|MP:0011182,decreased hematopoietic cell number
MGI:4430868	Kitl<tm3.1Pbes>	MP:0000336,decreased mast cell number|MP:0000373,belly spot|MP:0000715,decreased thymocyte number|MP:0001922,reduced male fertility|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0004852,decreased testis weight|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005159,azoospermia|MP:0005171,absent coat pigmentation|MP:0008995,early reproductive senescence|MP:0009278,abnormal bone marrow cell physiology
MGI:5436087	Kit<M1Hmgu>	MP:0002591,decreased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin
MGI:3530308	Kit<Mhdasco1>	MP:0000208,decreased hematocrit|MP:0002075,abnormal coat/hair pigmentation|MP:0002447,abnormal erythrocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002811,macrocytic anemia|MP:0002875,decreased erythrocyte cell number|MP:0005389,reproductive system phenotype|MP:0005564,increased hemoglobin content
MGI:3530315	Kit<Mhdasco5>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000208,decreased hematocrit|MP:0002075,abnormal coat/hair pigmentation|MP:0002447,abnormal erythrocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002628,hepatic steatosis|MP:0002811,macrocytic anemia|MP:0002875,decreased erythrocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0005389,reproductive system phenotype|MP:0005564,increased hemoglobin content|MP:0008489,slow postnatal weight gain|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3530323	Kit<Mhdasow3>	MP:0000370,head blaze|MP:0000373,belly spot|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002075,abnormal coat/hair pigmentation
MGI:1859780	Kit<Ssm>	MP:0001577,anemia|MP:0001925,male infertility|MP:0002940,variable body spotting|MP:0011087,neonatal lethality, complete penetrance
MGI:2178059	Kit<tm1.1Bsm>	MP:0000336,decreased mast cell number|MP:0001126,abnormal ovary morphology|MP:0001128,ovary hyperplasia|MP:0001129,impaired ovarian folliculogenesis|MP:0001152,increased Leydig cell number|MP:0001155,arrest of spermatogenesis|MP:0001186,pigmentation phenotype|MP:0001751,increased circulating luteinizing hormone level|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002016,ovary cyst|MP:0002423,abnormal mast cell physiology|MP:0004901,decreased male germ cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0011129,decreased tertiary ovarian follicle number|MP:0031381,decreased secondary ovarian follicle number
MGI:5620943	Kit<tm1.1Gnf>	MP:0005376,homeostasis/metabolism phenotype
MGI:2449782	Kit<tm1Alf>	MP:0001119,abnormal female reproductive system morphology|MP:0001125,abnormal oocyte morphology|MP:0001130,abnormal ovarian folliculogenesis|MP:0001145,abnormal male reproductive system morphology|MP:0001577,anemia|MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002811,macrocytic anemia|MP:0002877,abnormal melanocyte morphology|MP:0002938,white spotting|MP:0002982,abnormal primordial germ cell migration|MP:0003717,pallor|MP:0004852,decreased testis weight|MP:0004929,decreased epididymis weight|MP:0005175,non-pigmented tail tip|MP:0006361,abnormal female germ cell morphology|MP:0006362,abnormal male germ cell morphology|MP:0008871,abnormal ovarian follicle number|MP:0009784,abnormal melanoblast migration|MP:0011087,neonatal lethality, complete penetrance|MP:0011121,decreased primordial ovarian follicle number
MGI:3045801	Kit<tm1Ber>	MP:0000336,decreased mast cell number|MP:0002075,abnormal coat/hair pigmentation|MP:0002938,white spotting|MP:0005171,absent coat pigmentation|MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0010016,variable depigmentation
MGI:3603004	Kit<tm1Bpr>	MP:0000336,decreased mast cell number|MP:0000462,abnormal digestive system morphology|MP:0000494,abnormal cecum morphology|MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001152,increased Leydig cell number|MP:0001186,pigmentation phenotype|MP:0001270,distended abdomen|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0003270,intestinal obstruction|MP:0004805,absent oocytes|MP:0005159,azoospermia|MP:0005171,absent coat pigmentation|MP:0009485,distended ileum|MP:0009515,increased gastrointestinal stromal tumor incidence|MP:0014237,decreased tumor-free survival time
MGI:2178053	Kit<tm1Bsm>	MP:0000336,decreased mast cell number|MP:0000373,belly spot|MP:0001186,pigmentation phenotype|MP:0001924,infertility|MP:0005171,absent coat pigmentation|MP:0005175,non-pigmented tail tip|MP:0009379,abnormal foot pigmentation
MGI:2181624	Kit<tm1Hntr>	MP:0001155,arrest of spermatogenesis|MP:0001186,pigmentation phenotype|MP:0001925,male infertility|MP:0001940,testis hypoplasia|MP:0002216,abnormal seminiferous tubule morphology|MP:0002685,abnormal spermatogonia proliferation|MP:0005378,growth/size/body region phenotype|MP:0005397,hematopoietic system phenotype
MGI:4939904	Kit<tm1Rosay>	MP:0000373,belly spot|MP:0002938,white spotting|MP:0011092,embryonic lethality, complete penetrance
MGI:3773048	Kit<tm1Shta>	MP:0000462,abnormal digestive system morphology|MP:0000467,abnormal esophagus morphology|MP:0002083,premature death|MP:0005389,reproductive system phenotype|MP:0009485,distended ileum|MP:0009511,distended stomach|MP:0009515,increased gastrointestinal stromal tumor incidence
MGI:3045802	Kit<tm2Ber>	MP:0000336,decreased mast cell number|MP:0002075,abnormal coat/hair pigmentation|MP:0002938,white spotting|MP:0005171,absent coat pigmentation|MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0010016,variable depigmentation|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2663995	Kit<tm2Bsm>	MP:0000324,increased mast cell number|MP:0000467,abnormal esophagus morphology|MP:0000494,abnormal cecum morphology|MP:0001188,hyperpigmentation|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0008764,increased mast cell degranulation|MP:0009476,enlarged cecum|MP:0009480,distended cecum|MP:0009485,distended ileum|MP:0009515,increased gastrointestinal stromal tumor incidence|MP:0009537,interstitial cells of Cajal hyperplasia|MP:0010801,abnormal myenteric nerve plexus morphology
MGI:3044953	Kit<tm3.1Bsm>	MP:0000208,decreased hematocrit|MP:0000336,decreased mast cell number|MP:0000694,spleen hypoplasia|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002416,abnormal proerythroblast morphology|MP:0002423,abnormal mast cell physiology|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008237,abnormal ventral coat pigmentation|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011178,increased erythroblast number|MP:0031276,abnormal stress erythropoiesis
MGI:3045803	Kit<tm3Ber>	MP:0000336,decreased mast cell number|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0001802,arrested B cell differentiation|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0002938,white spotting|MP:0005014,increased B cell number|MP:0005171,absent coat pigmentation|MP:0005381,digestive/alimentary phenotype|MP:0005389,reproductive system phenotype|MP:0008254,increased megakaryocyte cell number|MP:0009247,meteorism|MP:0010016,variable depigmentation|MP:0011084,lethality at weaning, incomplete penetrance
MGI:5442620	Kit<tm4.1Bsm>	MP:0000324,increased mast cell number|MP:0000414,alopecia|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0001190,reddish skin|MP:0002083,premature death|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002608,increased hematocrit|MP:0002872,polycythemia|MP:0003131,increased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0003447,decreased tumor growth/size|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009477,small cecum|MP:0009537,interstitial cells of Cajal hyperplasia|MP:0010279,increased gastrointestinal tumor incidence
MGI:5510143	Kit<tm5.1Bsm>	MP:0002083,premature death|MP:0002591,decreased mean corpuscular volume|MP:0003721,increased tumor growth/size|MP:0009537,interstitial cells of Cajal hyperplasia|MP:0010279,increased gastrointestinal tumor incidence|MP:0010831,lethality, incomplete penetrance
MGI:1856232	Kit<W>	MP:0000372,irregular coat pigmentation|MP:0001262,decreased body weight|MP:0001324,abnormal eye pigmentation|MP:0002075,abnormal coat/hair pigmentation|MP:0002080,prenatal lethality|MP:0002593,high mean erythrocyte cell number|MP:0002608,increased hematocrit|MP:0002811,macrocytic anemia|MP:0002940,variable body spotting|MP:0005171,absent coat pigmentation|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0010769,abnormal survival|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:1856234	Kit<W-17J>	MP:0002938,white spotting
MGI:1856235	Kit<W-18J>	MP:0002938,white spotting
MGI:1856233	Kit<W-19H>	MP:0001143,constricted vagina orifice|MP:0001732,postnatal growth retardation|MP:0002940,variable body spotting|MP:0005389,reproductive system phenotype|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3033407	Kit<W-1Bao>	MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0002940,variable body spotting|MP:0010016,variable depigmentation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1856236	Kit<W-20J>	MP:0002938,white spotting
MGI:1856237	Kit<W-24J>	MP:0002938,white spotting
MGI:1856238	Kit<W-25J>	MP:0002810,microcytic anemia
MGI:1856515	Kit<W-27H>	MP:0001577,anemia|MP:0002671,belted|MP:0011085,postnatal lethality, complete penetrance
MGI:1856513	Kit<W-28H>	MP:0001577,anemia|MP:0002938,white spotting|MP:0003717,pallor|MP:0011085,postnatal lethality, complete penetrance
MGI:1856514	Kit<W-29H>	MP:0000371,diluted coat color|MP:0002938,white spotting|MP:0005171,absent coat pigmentation
MGI:3033409	Kit<W-2Bao>	MP:0002216,abnormal seminiferous tubule morphology|MP:0002940,variable body spotting|MP:0005171,absent coat pigmentation
MGI:3779022	Kit<W-2Btlr>	MP:0000370,head blaze|MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0001186,pigmentation phenotype|MP:0002938,white spotting|MP:0002940,variable body spotting|MP:0005171,absent coat pigmentation|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:5306932	Kit<W-31H>	MP:0000373,belly spot|MP:0001189,absent skin pigmentation|MP:0002075,abnormal coat/hair pigmentation|MP:0002939,head spot|MP:0005171,absent coat pigmentation
MGI:5306933	Kit<W-32H>	MP:0000373,belly spot|MP:0001189,absent skin pigmentation|MP:0002075,abnormal coat/hair pigmentation|MP:0002939,head spot|MP:0005171,absent coat pigmentation
MGI:1856239	Kit<W-34J>	MP:0002872,polycythemia|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1856240	Kit<W-35J>	MP:0001147,small testis|MP:0002872,polycythemia|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1856509	Kit<W-36H>	MP:0001577,anemia|MP:0002938,white spotting|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1859700	Kit<W-36J>	MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1856241	Kit<W-37J>	MP:0000336,decreased mast cell number|MP:0000371,diluted coat color|MP:0000372,irregular coat pigmentation|MP:0002872,polycythemia|MP:0002938,white spotting|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5306934	Kit<W-38H>	MP:0000373,belly spot|MP:0002938,white spotting|MP:0002939,head spot|MP:0005171,absent coat pigmentation
MGI:1856343	Kit<W-38J>	MP:0001147,small testis|MP:0002872,polycythemia|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1862025	Kit<W-39H>	MP:0000370,head blaze|MP:0000373,belly spot|MP:0002075,abnormal coat/hair pigmentation|MP:0002938,white spotting|MP:0011091,prenatal lethality, complete penetrance
MGI:1856242	Kit<W-39J>	MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0001127,small ovary|MP:0001147,small testis|MP:0001921,reduced fertility|MP:0002811,macrocytic anemia|MP:0005171,absent coat pigmentation|MP:0008871,abnormal ovarian follicle number|MP:0008976,delayed female fertility|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3033410	Kit<W-3Bao>	MP:0000208,decreased hematocrit|MP:0000248,macrocytosis|MP:0000373,belly spot|MP:0002082,postnatal lethality|MP:0002216,abnormal seminiferous tubule morphology|MP:0002811,macrocytic anemia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002938,white spotting|MP:0002940,variable body spotting|MP:0003698,abnormal male reproductive system physiology|MP:0003717,pallor|MP:0004200,decreased fetal size|MP:0005171,absent coat pigmentation|MP:0005397,hematopoietic system phenotype|MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0009361,abnormal primordial ovarian follicle morphology
MGI:6304941	Kit<W-3Btlr>	MP:0002940,variable body spotting
MGI:1862026	Kit<W-40H>	MP:0002075,abnormal coat/hair pigmentation|MP:0002938,white spotting
MGI:1856243	Kit<W-40J>	MP:0001147,small testis|MP:0002872,polycythemia|MP:0005389,reproductive system phenotype|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1856244	Kit<W-41J>	MP:0000371,diluted coat color|MP:0000372,irregular coat pigmentation|MP:0000373,belly spot|MP:0001127,small ovary|MP:0002811,macrocytic anemia|MP:0005389,reproductive system phenotype|MP:0008871,abnormal ovarian follicle number
MGI:1856245	Kit<W-42J>	MP:0000336,decreased mast cell number|MP:0000371,diluted coat color|MP:0000372,irregular coat pigmentation|MP:0001147,small testis|MP:0002811,macrocytic anemia|MP:0002875,decreased erythrocyte cell number|MP:0002938,white spotting|MP:0005171,absent coat pigmentation|MP:0005389,reproductive system phenotype|MP:0008871,abnormal ovarian follicle number|MP:0011089,perinatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:1856246	Kit<W-43J>	MP:0001147,small testis|MP:0002081,perinatal lethality|MP:0002872,polycythemia
MGI:1856247	Kit<W-44J>	MP:0000372,irregular coat pigmentation|MP:0000373,belly spot|MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002938,white spotting|MP:0005397,hematopoietic system phenotype|MP:0008871,abnormal ovarian follicle number
MGI:1856248	Kit<W-45J>	MP:0002938,white spotting
MGI:1856249	Kit<W-49J>	MP:0002938,white spotting
MGI:3037427	Kit<W-4Bao>	MP:0005171,absent coat pigmentation
MGI:1856344	Kit<W-51J>	MP:0002938,white spotting
MGI:1856251	Kit<W-55J>	MP:0001577,anemia|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002938,white spotting|MP:0005171,absent coat pigmentation
MGI:1856253	Kit<W-57J>	MP:0000370,head blaze|MP:0000373,belly spot|MP:0001577,anemia
MGI:1856347	Kit<W-59J>	MP:0002938,white spotting
MGI:1856354	Kit<W-70J>	MP:0002938,white spotting
MGI:1856255	Kit<W-73J>	MP:0001577,anemia|MP:0002938,white spotting|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1856360	Kit<W-80J>	MP:0002938,white spotting
MGI:2176284	Kit<W-82J>	MP:0002075,abnormal coat/hair pigmentation|MP:0002095,abnormal skin pigmentation
MGI:5578537	Kit<W-84J>	MP:0002938,white spotting
MGI:5578539	Kit<W-85J>	MP:0002938,white spotting|MP:0005171,absent coat pigmentation|MP:0005377,hearing/vestibular/ear phenotype
MGI:1856256	Kit<W-a>	MP:0000373,belly spot|MP:0001577,anemia|MP:0002082,postnatal lethality|MP:0004034,belly blaze
MGI:3573757	Kit<Wads>	MP:0000043,organ of Corti degeneration|MP:0000048,abnormal stria vascularis morphology|MP:0000336,decreased mast cell number|MP:0000373,belly spot|MP:0001127,small ovary|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001967,deafness|MP:0002095,abnormal skin pigmentation|MP:0002216,abnormal seminiferous tubule morphology|MP:0002590,increased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002777,absent ovarian follicles|MP:0002811,macrocytic anemia|MP:0002875,decreased erythrocyte cell number|MP:0002939,head spot|MP:0002940,variable body spotting|MP:0004362,cochlear hair cell degeneration|MP:0004364,thin stria vascularis|MP:0004368,abnormal stria vascularis vasculature morphology|MP:0005171,absent coat pigmentation|MP:0005505,thrombocytosis|MP:0006010,absent strial intermediate cells|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856257	Kit<W-b>	MP:0000371,diluted coat color|MP:0001577,anemia|MP:0001924,infertility|MP:0002082,postnatal lethality|MP:0002938,white spotting|MP:0005171,absent coat pigmentation|MP:0008770,decreased survivor rate
MGI:1856258	Kit<W-bd>	MP:0002075,abnormal coat/hair pigmentation|MP:0002671,belted|MP:0005402,abnormal action potential|MP:0008031,decreased Cajal-Retzius cell number|MP:0009783,abnormal melanoblast morphology
MGI:5466404	Kit<W-Bs>	MP:0002940,variable body spotting|MP:0011092,embryonic lethality, complete penetrance
MGI:3778370	Kit<W-Btlr>	MP:0000336,decreased mast cell number|MP:0000373,belly spot|MP:0001186,pigmentation phenotype|MP:0001189,absent skin pigmentation|MP:0001924,infertility|MP:0005171,absent coat pigmentation
MGI:1856259	Kit<W-ct>	MP:0001577,anemia|MP:0002811,macrocytic anemia|MP:0005171,absent coat pigmentation|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1856260	Kit<W-e>	MP:0000371,diluted coat color|MP:0001577,anemia|MP:0002940,variable body spotting|MP:0002982,abnormal primordial germ cell migration|MP:0005171,absent coat pigmentation|MP:0008391,abnormal primordial germ cell morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0030934,decreased primordial germ cell proliferation
MGI:1856510	Kit<W-ei>	MP:0000372,irregular coat pigmentation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002075,abnormal coat/hair pigmentation|MP:0011089,perinatal lethality, complete penetrance
MGI:1856261	Kit<W-f>	MP:0000336,decreased mast cell number|MP:0000371,diluted coat color|MP:0000372,irregular coat pigmentation|MP:0000373,belly spot|MP:0002082,postnatal lethality|MP:0002811,macrocytic anemia|MP:0002875,decreased erythrocyte cell number|MP:0002938,white spotting|MP:0002939,head spot|MP:0005175,non-pigmented tail tip|MP:0005389,reproductive system phenotype
MGI:3760742	Kit<Whc1>	MP:0000208,decreased hematocrit|MP:0000370,head blaze|MP:0000373,belly spot|MP:0002075,abnormal coat/hair pigmentation|MP:0002082,postnatal lethality|MP:0002447,abnormal erythrocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002628,hepatic steatosis|MP:0002811,macrocytic anemia|MP:0002875,decreased erythrocyte cell number|MP:0005389,reproductive system phenotype|MP:0005564,increased hemoglobin content|MP:0008489,slow postnatal weight gain
MGI:1856262	Kit<W-j>	MP:0001156,abnormal spermatogenesis|MP:0001577,anemia|MP:0002082,postnatal lethality|MP:0002938,white spotting|MP:0005171,absent coat pigmentation
MGI:1856511	Kit<W-Jic>	MP:0000336,decreased mast cell number|MP:0000371,diluted coat color|MP:0002875,decreased erythrocyte cell number|MP:0002938,white spotting
MGI:1856512	Kit<W-n>	MP:0000336,decreased mast cell number|MP:0000371,diluted coat color|MP:0000372,irregular coat pigmentation|MP:0002811,macrocytic anemia|MP:0002938,white spotting|MP:0005171,absent coat pigmentation
MGI:5523955	Kit<Wps>	MP:0000373,belly spot|MP:0001186,pigmentation phenotype|MP:0001189,absent skin pigmentation|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0005171,absent coat pigmentation
MGI:1856263	Kit<W-pw>	MP:0001577,anemia|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002082,postnatal lethality|MP:0002938,white spotting|MP:0005171,absent coat pigmentation
MGI:1856516	Kit<W-rio>	MP:0002811,macrocytic anemia|MP:0002938,white spotting|MP:0003175,reversion by mitotic recombination|MP:0011089,perinatal lethality, complete penetrance
MGI:1856264	Kit<W-s>	MP:0001577,anemia|MP:0002938,white spotting|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:1856265	Kit<W-sh>	MP:0000336,decreased mast cell number|MP:0001586,abnormal erythrocyte cell number|MP:0001619,abnormal vascular permeability|MP:0002075,abnormal coat/hair pigmentation|MP:0002123,abnormal definitive hematopoiesis|MP:0002875,decreased erythrocyte cell number|MP:0002940,variable body spotting|MP:0005027,increased susceptibility to parasitic infection|MP:0005171,absent coat pigmentation|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0008765,decreased mast cell degranulation|MP:0009747,impaired behavioral response to xenobiotic|MP:0020523,decreased susceptibility to induced hypothermia
MGI:1856266	Kit<W-v>	MP:0000015,abnormal ear pigmentation|MP:0000031,abnormal cochlea morphology|MP:0000042,abnormal organ of Corti morphology|MP:0000048,abnormal stria vascularis morphology|MP:0000336,decreased mast cell number|MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0001262,decreased body weight|MP:0001921,reduced fertility|MP:0002075,abnormal coat/hair pigmentation|MP:0002811,macrocytic anemia|MP:0002855,abnormal cochlear ganglion morphology|MP:0002857,cochlear ganglion degeneration|MP:0002875,decreased erythrocyte cell number|MP:0002877,abnormal melanocyte morphology|MP:0002894,abnormal otolith morphology|MP:0002938,white spotting|MP:0002939,head spot|MP:0002940,variable body spotting|MP:0003143,enlarged otoliths|MP:0003149,abnormal tectorial membrane morphology|MP:0004324,vestibular hair cell degeneration|MP:0004364,thin stria vascularis|MP:0004365,abnormal strial basal cell morphology|MP:0004366,abnormal strial marginal cell morphology|MP:0004368,abnormal stria vascularis vasculature morphology|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004410,absent endocochlear potential|MP:0005075,abnormal melanosome morphology|MP:0005389,reproductive system phenotype|MP:0005606,increased bleeding time|MP:0006010,absent strial intermediate cells|MP:0006089,abnormal vestibular saccule morphology
MGI:3047218	Kit<W-vkd>	MP:0000333,decreased bone marrow cell number|MP:0000715,decreased thymocyte number|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002594,low mean erythrocyte cell number|MP:0005017,decreased B cell number
MGI:1856267	Kit<W-x>	MP:0002075,abnormal coat/hair pigmentation
MGI:3797918	Kiz<tm1.1Cpl>	MP:0002169,no abnormal phenotype detected
MGI:2670329	kkt	MP:0000069,kyphoscoliosis|MP:0000074,abnormal neurocranium morphology|MP:0000141,abnormal vertebral body morphology|MP:0000149,abnormal scapula morphology|MP:0000585,kinked tail|MP:0001265,decreased body size|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0001954,respiratory distress|MP:0002114,abnormal axial skeleton morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0004346,absent acromion|MP:0004600,abnormal vertebral transverse process morphology|MP:0004608,abnormal cervical axis morphology|MP:0004703,abnormal vertebral column morphology|MP:0008149,abnormal costovertebral joint morphology|MP:0008277,abnormal sternum ossification|MP:0010082,sternebra fusion
MGI:6294146	Klb<em1(IMPC)J>	MP:0001697,abnormal embryo size|MP:0003231,abnormal placenta vasculature|MP:0004258,abnormal placenta size|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5494481	Klb<tm1.1Akha>	MP:0000180,abnormal circulating cholesterol level|MP:0000188,abnormal circulating glucose level|MP:0001560,abnormal circulating insulin level|MP:0002727,decreased circulating insulin level|MP:0003457,abnormal circulating ketone body level|MP:0005179,decreased circulating cholesterol level|MP:0005450,abnormal energy expenditure|MP:0005667,abnormal circulating leptin level|MP:0010181,decreased susceptibility to weight loss|MP:0012320,abnormal body fat mass|MP:0030967,abnormal circulating adiponectin level
MGI:5446140	Klb<tm1.1Sakl>	MP:0002078,abnormal glucose homeostasis|MP:0002891,increased insulin sensitivity|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005666,abnormal adipose tissue physiology
MGI:5446141	Klb<tm1.2Sakl>	MP:0001262,decreased body weight|MP:0002078,abnormal glucose homeostasis|MP:0002644,decreased circulating triglyceride level
MGI:3587748	Klb<tm1Yin>	MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0005365,abnormal bile salt homeostasis|MP:0005675,small gallbladder
MGI:6113672	Klc1<m1Btlr>	MP:0001262,decreased body weight
MGI:2136259	Klc1<tm1Gsn>	MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0003225,axonal dystrophy|MP:0004250,tau protein deposits|MP:0004768,abnormal axonal transport|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0008026,abnormal brain white matter morphology|MP:0008027,abnormal spinal cord white matter morphology|MP:0008546,abnormal vesicle-mediated transport
MGI:7610562	Klc2<em1Jgao>	MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004402,decreased cochlear outer hair cell number|MP:0004404,cochlear outer hair cell degeneration|MP:0006035,abnormal mitochondrial morphology|MP:0006325,impaired hearing
MGI:4434042	Klc2<tm1e(EUCOMM)Wtsi>	MP:0001554,increased circulating free fatty acids level|MP:0004738,abnormal auditory brainstem response|MP:0006358,absent pinna reflex
MGI:6277999	Klc3<em1(IMPC)J>	MP:0002968,increased circulating alkaline phosphatase level
MGI:7596450	Klc3<em1Jvt>	MP:0002169,no abnormal phenotype detected
MGI:7596451	Klc3<em2Jvt>	MP:0002169,no abnormal phenotype detected
MGI:7596452	Klc3<em3Jvt>	MP:0002169,no abnormal phenotype detected
MGI:5763757	Kl<ecalc1>	MP:0000029,abnormal malleus morphology|MP:0000069,kyphoscoliosis|MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000559,abnormal femur morphology|MP:0001218,thin epidermis|MP:0001265,decreased body size|MP:0001505,hunched posture|MP:0001566,increased circulating phosphate level|MP:0001732,postnatal growth retardation|MP:0001861,lung inflammation|MP:0001958,emphysema|MP:0002083,premature death|MP:0003109,short femur|MP:0003195,calcinosis|MP:0003196,calcified skin|MP:0003197,nephrocalcinosis|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003946,renal necrosis|MP:0004676,wide ribs|MP:0005105,abnormal middle ear ossicle morphology|MP:0005106,abnormal incus morphology|MP:0005416,abnormal circulating protein level|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0006325,impaired hearing|MP:0006358,absent pinna reflex|MP:0006396,decreased long bone epiphyseal plate size|MP:0008373,short malleus|MP:0008374,abnormal malleus manubrium morphology|MP:0008375,short malleus manubrium|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009866,abnormal aorta wall morphology|MP:0010124,decreased bone mineral content|MP:0010522,calcified aorta|MP:0010923,calcified pulmonary alveolus|MP:0011584,increased alkaline phosphatase activity|MP:0012337,increased vitamin D level|MP:0013624,decreased femur compact bone thickness|MP:0020010,decreased bone mineral density of femur|MP:0030376,thick zygomatic arch|MP:0030405,small stapes obturator foramen|MP:0030584,skin atrophy
MGI:5763763	Kl<ecalc2>	MP:0000069,kyphoscoliosis|MP:0000559,abnormal femur morphology|MP:0001265,decreased body size|MP:0001505,hunched posture|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0003109,short femur|MP:0003195,calcinosis|MP:0004676,wide ribs|MP:0006325,impaired hearing|MP:0006358,absent pinna reflex|MP:0013624,decreased femur compact bone thickness|MP:0030376,thick zygomatic arch
MGI:6761423	Kl<em1Btlr>	MP:0002764,short tibia|MP:0003109,short femur|MP:0004692,small pubis
MGI:3530069	Klf10<tm1Sub>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000558,abnormal tibia morphology|MP:0004988,increased osteoblast cell number|MP:0004991,decreased bone strength|MP:0008156,decreased diameter of tibia|MP:0008271,abnormal bone ossification|MP:0010124,decreased bone mineral content|MP:0010867,abnormal bone trabecula morphology|MP:0010879,decreased trabecular bone volume|MP:0021182,decreased femoral compact bone area|MP:0030483,decreased osteocyte number
MGI:5317944	Klf10<tm1Wkle>	MP:0002014,increased papilloma incidence|MP:0003721,increased tumor growth/size|MP:0004499,increased incidence of tumors by chemical induction|MP:0009580,increased keratinocyte apoptosis|MP:0009583,increased keratinocyte proliferation|MP:0010308,decreased tumor latency
MGI:3513147	Klf11<tm1Czs>	MP:0002006,neoplasm|MP:0002169,no abnormal phenotype detected|MP:0005165,increased susceptibility to injury|MP:0005397,hematopoietic system phenotype|MP:0009221,uterus adenomyosis
MGI:6120703	Klf12<tm1b(EUCOMM)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005419,decreased circulating serum albumin level|MP:0011962,increased cornea thickness
MGI:4837928	Klf13<tm1Coll>	MP:0000221,decreased leukocyte cell number|MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0005016,decreased lymphocyte cell number|MP:0005561,increased mean corpuscular hemoglobin|MP:0010067,increased red blood cell distribution width
MGI:3839530	Klf13<tm1Kren>	MP:0000689,abnormal spleen morphology|MP:0000693,spleen hyperplasia|MP:0000708,thymus hyperplasia|MP:0000714,increased thymocyte number|MP:0000715,decreased thymocyte number|MP:0000716,abnormal immune system cell morphology|MP:0002722,abnormal immune system organ morphology|MP:0005091,increased double-positive T cell number|MP:0006387,abnormal T cell number|MP:0009338,increased splenocyte number|MP:0009341,decreased splenocyte apoptosis|MP:0009542,decreased thymocyte apoptosis
MGI:5907263	Klf14<em1Cgw>	MP:0002020,increased tumor incidence|MP:0002048,increased lung adenoma incidence|MP:0004024,aneuploidy|MP:0004025,polyploidy|MP:0004046,abnormal mitosis|MP:0004499,increased incidence of tumors by chemical induction|MP:0008866,chromosomal instability|MP:0012431,increased lymphoma incidence|MP:0030943,abnormal centrosome morphology
MGI:5695130	Klf14<tm1.1(KOMP)Vlcg>	MP:0002574,increased vertical activity|MP:0002941,increased circulating alanine transaminase level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010067,increased red blood cell distribution width
MGI:5882062	Klf14<tm1.1Yec>	MP:0000186,decreased circulating HDL cholesterol level
MGI:4359847	Klf15<hlb444>	MP:0001552,increased circulating triglyceride level
MGI:3054985	Klf15<tm1Jain>	MP:0000189,hypoglycemia|MP:0000260,abnormal angiogenesis|MP:0000272,abnormal aorta morphology|MP:0000274,enlarged heart|MP:0001863,blood vessel inflammation|MP:0002575,increased circulating ketone body level|MP:0002625,heart left ventricle hypertrophy|MP:0002712,increased circulating glucagon level|MP:0002753,dilated heart left ventricle|MP:0002844,aortic hypertrophy|MP:0002893,ketoaciduria|MP:0003383,abnormal gluconeogenesis|MP:0003441,increased glycerol level|MP:0003960,increased lean body mass|MP:0004485,increased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0004937,dilated heart|MP:0005266,abnormal metabolism|MP:0005292,improved glucose tolerance|MP:0005311,abnormal circulating amino acid level|MP:0005330,cardiomyopathy|MP:0005339,increased susceptibility to atherosclerosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005425,increased macrophage cell number|MP:0005560,decreased circulating glucose level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009871,abnormal aorta tunica adventitia morphology|MP:0009873,abnormal aorta tunica media morphology|MP:0010025,decreased total body fat amount|MP:0010080,abnormal hepatocyte physiology|MP:0010398,decreased liver glycogen level|MP:0010574,dilated aorta|MP:0010658,thoracic aorta aneurysm|MP:0010659,abdominal aorta aneurysm|MP:0013404,decreased circulating lactate level|MP:0031274,increased susceptibility to induced aneurysm formation|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5552963	Klf15<tm2Jain>	MP:0010768,mortality/aging
MGI:6198606	Klf16<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0000367,abnormal coat/ hair morphology|MP:0001284,absent vibrissae|MP:0001697,abnormal embryo size|MP:0002590,increased mean corpuscular volume|MP:0005560,decreased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005567,decreased circulating total protein level|MP:0010392,prolonged QRS complex duration|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1861107	Klf1<Nan>	MP:0000208,decreased hematocrit|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0002447,abnormal erythrocyte morphology|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004952,increased spleen weight|MP:0005097,polychromatophilia|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008807,increased liver iron level|MP:0008809,increased spleen iron level|MP:0009395,increased nucleated erythrocyte cell number|MP:0010375,increased kidney iron level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0031085,increased erythrocyte osmotic fragility
MGI:5529812	Klf1<tm1.1Ryan>	MP:0005397,hematopoietic system phenotype
MGI:1857557	Klf1<tm1Nimr>	MP:0000245,abnormal erythropoiesis|MP:0000601,small liver|MP:0000603,pale liver|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0002874,decreased hemoglobin content|MP:0005096,erythroblastosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1857162	Klf1<tm1Sho>	MP:0000245,abnormal erythropoiesis|MP:0001577,anemia|MP:0002447,abnormal erythrocyte morphology|MP:0004230,abnormal embryonic erythrocyte morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5750084	Klf2<tm1Hhn>	MP:0001634,internal hemorrhage|MP:0011091,prenatal lethality, complete penetrance
MGI:3639349	Klf2<tm1Jml>	MP:0000433,microcephaly|MP:0001577,anemia|MP:0001614,abnormal blood vessel morphology|MP:0001634,internal hemorrhage|MP:0001698,decreased embryo size|MP:0001914,hemorrhage|MP:0002085,abnormal embryonic tissue morphology|MP:0003279,aneurysm|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006055,abnormal vascular endothelial cell morphology|MP:0009873,abnormal aorta tunica media morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013241,embryo tissue necrosis
MGI:4355064	Klf2<tm1Khog>	MP:0002169,no abnormal phenotype detected
MGI:3047647	Klf2<tm1Ling>	MP:0000458,abnormal mandible morphology|MP:0000603,pale liver|MP:0001175,abnormal lung morphology|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0001722,pale yolk sac|MP:0001914,hemorrhage|MP:0003984,embryonic growth retardation|MP:0005387,immune system phenotype|MP:0009395,increased nucleated erythrocyte cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3765423	Klf2<tm1Mlkn>	MP:0001577,anemia|MP:0001722,pale yolk sac|MP:0002652,thin myocardium|MP:0003394,increased cardiac output|MP:0004086,absent heartbeat|MP:0004879,decreased systemic vascular resistance|MP:0005312,pericardial effusion|MP:0008070,absent T cells|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011951,increased cardiac stroke volume|MP:0031589,detached epicardium
MGI:4355063	Klf2<tm2Ling>	MP:0002145,abnormal T cell differentiation|MP:0002497,increased IgE level|MP:0005018,decreased T cell number|MP:0008082,increased single-positive T cell number|MP:0008499,increased IgG1 level|MP:0008699,increased interleukin-4 secretion|MP:0013026,decreased Ly6C low monocyte number
MGI:3872001	Klf3<Gt(CH0516)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0000233,abnormal blood flow velocity|MP:0001262,decreased body weight|MP:0002176,increased brain weight|MP:0002640,reticulocytosis|MP:0002833,increased heart weight|MP:0002981,increased liver weight|MP:0003394,increased cardiac output|MP:0003917,increased kidney weight|MP:0003921,abnormal heart left ventricle morphology|MP:0004876,decreased mean systemic arterial blood pressure|MP:0004952,increased spleen weight|MP:0005385,cardiovascular system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005630,increased lung weight|MP:0006044,tricuspid valve regurgitation|MP:0006048,pulmonary valve regurgitation|MP:0008726,increased heart left atrium size|MP:0008727,increased heart right atrium size|MP:0009287,decreased abdominal fat pad weight|MP:0010067,increased red blood cell distribution width|MP:0010563,increased heart right ventricle size|MP:0010768,mortality/aging|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4331780	Klf3<Gt(XS0187)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0001262,decreased body weight|MP:0002176,increased brain weight|MP:0002640,reticulocytosis|MP:0002833,increased heart weight|MP:0002981,increased liver weight|MP:0003394,increased cardiac output|MP:0003917,increased kidney weight|MP:0004952,increased spleen weight|MP:0005385,cardiovascular system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005630,increased lung weight|MP:0006044,tricuspid valve regurgitation|MP:0006048,pulmonary valve regurgitation|MP:0006117,aortic valve stenosis|MP:0008727,increased heart right atrium size|MP:0009287,decreased abdominal fat pad weight|MP:0010067,increased red blood cell distribution width|MP:0010563,increased heart right ventricle size|MP:0010593,thick aortic valve cusps|MP:0010768,mortality/aging|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5567987	Klf3<m1Cmhd>	MP:0000233,abnormal blood flow velocity|MP:0000281,abnormal interventricular septum morphology|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0001596,hypotension|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002176,increased brain weight|MP:0002640,reticulocytosis|MP:0002833,increased heart weight|MP:0002843,decreased systemic arterial blood pressure|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003394,increased cardiac output|MP:0003808,increased atrioventricular cushion size|MP:0003917,increased kidney weight|MP:0003921,abnormal heart left ventricle morphology|MP:0003922,abnormal heart right atrium morphology|MP:0003923,abnormal heart left atrium morphology|MP:0004876,decreased mean systemic arterial blood pressure|MP:0004952,increased spleen weight|MP:0005289,increased oxygen consumption|MP:0005385,cardiovascular system phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005599,increased cardiac muscle contractility|MP:0006117,aortic valve stenosis|MP:0006138,congestive heart failure|MP:0008726,increased heart left atrium size|MP:0008727,increased heart right atrium size|MP:0008817,hematoma|MP:0009287,decreased abdominal fat pad weight|MP:0009867,abnormal ascending aorta morphology|MP:0010127,hypervolemia|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010484,bicuspid aortic valve|MP:0010499,abnormal ventricle myocardium morphology|MP:0010593,thick aortic valve cusps|MP:0010595,abnormal aortic valve cusp morphology|MP:0010695,abnormal blood pressure regulation|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:4441459	Klf3<tm1(cre/ERT2)Pzg>	MP:0002169,no abnormal phenotype detected
MGI:3799368	Klf3<tm1Merc>	MP:0001924,infertility|MP:0005076,abnormal cell differentiation|MP:0005335,abnormal gonadal fat pad morphology|MP:0005337,abnormal retroperitoneal fat pad morphology|MP:0006319,abnormal epididymal fat pad morphology|MP:0008489,slow postnatal weight gain|MP:0008770,decreased survivor rate|MP:0010025,decreased total body fat amount|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6156298	Klf4<em1(IMPC)Kmpc>	MP:0010053,decreased grip strength
MGI:2664975	Klf4<tm1.1Khk>	MP:0000488,abnormal intestinal epithelium morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0013795,abnormal colon goblet cell morphology
MGI:2183936	Klf4<tm1Efu>	MP:0000764,abnormal tongue epithelium morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001429,dehydration|MP:0001436,abnormal suckling behavior|MP:0002796,impaired skin barrier function|MP:0003427,parakeratosis|MP:0011087,neonatal lethality, complete penetrance
MGI:2183917	Klf4<tm1Khk>	MP:0000468,abnormal esophageal epithelium morphology|MP:0000471,abnormal stomach epithelium morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000765,abnormal tongue squamous epithelium morphology|MP:0001212,skin lesions|MP:0001297,microphthalmia|MP:0001306,small lens|MP:0001320,small pupil|MP:0001792,impaired wound healing|MP:0002009,preneoplasia|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002169,no abnormal phenotype detected|MP:0002655,abnormal keratinocyte morphology|MP:0002656,abnormal keratinocyte differentiation|MP:0002780,decreased circulating testosterone level|MP:0002782,abnormal testes secretion|MP:0002840,abnormal lens fiber morphology|MP:0003093,abnormal cornea anterior stroma morphology|MP:0003285,gastric hypertrophy|MP:0003449,abnormal intestine goblet cell morphology|MP:0003892,abnormal gastric gland morphology|MP:0004109,abnormal Sertoli cell development|MP:0004137,abnormal gastric surface mucous cell morphology|MP:0004138,abnormal mucous neck cell morphology|MP:0004139,abnormal gastric parietal cell morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0004499,increased incidence of tumors by chemical induction|MP:0005251,blepharitis|MP:0005300,abnormal cornea stroma morphology|MP:0005301,abnormal cornea endothelium morphology|MP:0005389,reproductive system phenotype|MP:0006000,abnormal cornea epithelium morphology|MP:0006307,abnormal seminiferous tubule size|MP:0008521,abnormal Bowman membrane morphology|MP:0009583,increased keratinocyte proliferation|MP:0009612,thick epidermis suprabasal layer|MP:0009742,increased cornea stroma thickness|MP:0010203,focal ventral hair loss|MP:0010792,abnormal stomach mucosa morphology|MP:0011697,lens vacuoles|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0012101,acoria|MP:0012110,increased hair follicle number|MP:0012193,increased keratinocyte migration|MP:0013026,decreased Ly6C low monocyte number|MP:0013485,increased Paneth cell number|MP:0013527,absent conjunctiva goblet cells|MP:0013765,iris hyperplasia|MP:0014077,ectopic Paneth cells|MP:0020855,decreased cornea epithelium thickness|MP:0020862,increased cornea fragility|MP:0030574,increased hair follicle cell proliferation|MP:0030577,increased keratinocyte adhesion
MGI:3796190	Klf5<Gt(XB751)Byg>	MP:0002663,absent blastocoele|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005025,abnormal response to infection|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012113,decreased inner cell mass proliferation|MP:0012117,decreased trophectoderm cell proliferation
MGI:6200268	Klf5<M1Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:5551641	Klf5<tm1.1Jtd>	MP:0000659,prostate gland hyperplasia|MP:0001163,abnormal prostate gland anterior lobe morphology|MP:0002006,neoplasm|MP:0002169,no abnormal phenotype detected|MP:0003607,abnormal prostate gland physiology|MP:0004962,decreased prostate gland weight|MP:0009381,abnormal prostate gland dorsolateral lobe morphology
MGI:5141245	Klf5<tm1.1Jwel>	MP:0002663,absent blastocoele|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012113,decreased inner cell mass proliferation|MP:0012117,decreased trophectoderm cell proliferation
MGI:3806635	Klf5<tm1Jaw>	MP:0000351,increased cell proliferation|MP:0000381,enlarged hair follicles|MP:0000652,enlarged sebaceous gland|MP:0001176,abnormal lung development|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001306,small lens|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001320,small pupil|MP:0001322,abnormal iris morphology|MP:0001340,abnormal eyelid morphology|MP:0001346,abnormal lacrimal gland morphology|MP:0001728,failure of embryo implantation|MP:0001729,impaired embryo implantation|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0001954,respiratory distress|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002274,abnormal type I pneumocyte morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002579,disorganized secondary lens fibers|MP:0003237,abnormal lens epithelium morphology|MP:0003671,abnormal eyelid aperture|MP:0003845,abnormal decidualization|MP:0004481,abnormal conjunctival epithelium morphology|MP:0004780,abnormal surfactant secretion|MP:0005247,abnormal extraocular muscle morphology|MP:0005287,narrow eye opening|MP:0005300,abnormal cornea stroma morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0006167,eyelid edema|MP:0008880,lacrimal gland inflammation|MP:0009662,abnormal uterine receptivity|MP:0009666,abnormal embryo attachment|MP:0009742,increased cornea stroma thickness|MP:0009935,abnormal Meibomian gland acinus morphology|MP:0010814,absent alveolar lamellar bodies|MP:0010816,decreased type I pneumocyte number|MP:0010825,abnormal lung saccule morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011143,thick lung-associated mesenchyme|MP:0011481,anterior iris synechia|MP:0011482,posterior iris synechia|MP:0011962,increased cornea thickness|MP:0013385,abnormal Meibomian gland development|MP:0013391,abnormal Meibomian gland physiology|MP:0013394,abnormal palpebral conjunctiva morphology|MP:0013527,absent conjunctiva goblet cells|MP:0013754,abnormal ocular surface morphology|MP:0014147,lacrimal gland necrosis|MP:0020855,decreased cornea epithelium thickness
MGI:3038696	Klf5<tm1Rng>	MP:0000511,abnormal intestinal mucosa morphology|MP:0001625,cardiac hypertrophy|MP:0002834,decreased heart weight|MP:0003141,cardiac fibrosis|MP:0004486,decreased response of heart to induced stress|MP:0004883,abnormal vascular wound healing|MP:0005595,abnormal vascular smooth muscle physiology|MP:0005602,decreased angiogenesis|MP:0008108,abnormal small intestinal villus morphology|MP:0009866,abnormal aorta wall morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:3849301	Klf5<tm1Yfk>	MP:0001728,failure of embryo implantation|MP:0002718,abnormal inner cell mass morphology|MP:0005028,abnormal trophectoderm morphology|MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:4421792	Klf5<tm2.1Rng>	MP:0000278,abnormal myocardial fiber morphology|MP:0001263,weight loss|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002169,no abnormal phenotype detected|MP:0002834,decreased heart weight|MP:0003828,pulmonary edema|MP:0003921,abnormal heart left ventricle morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004484,abnormal response of heart to induced stress|MP:0005385,cardiovascular system phenotype|MP:0005573,increased pulmonary respiratory rate|MP:0005608,cardiac interstitial fibrosis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010018,pulmonary vascular congestion|MP:0010579,increased heart left ventricle size|MP:0010894,pulmonary alveolar edema|MP:0011163,increased wet-to-dry lung weight ratio
MGI:3715995	Klf6<tm1Fdmn>	MP:0000352,decreased cell proliferation|MP:0000596,abnormal liver development|MP:0001260,increased body weight|MP:0001265,decreased body size|MP:0001718,abnormal visceral yolk sac morphology|MP:0002981,increased liver weight|MP:0003229,abnormal vitelline vasculature morphology|MP:0003396,abnormal embryonic hematopoiesis|MP:0003717,pallor|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4361337	Klf6<tm1Fjs>	MP:0001163,abnormal prostate gland anterior lobe morphology|MP:0009734,abnormal prostate gland duct morphology|MP:0009736,abnormal prostate gland branching morphogenesis
MGI:5548730	Klf7<tm1b(EUCOMM)Hmgu>	MP:0000137,abnormal vertebrae morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001399,hyperactivity|MP:0001523,impaired righting response|MP:0002599,increased mean platelet volume|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0011100,preweaning lethality, complete penetrance
MGI:3581890	Klf7<tm1Rmz>	MP:0000778,abnormal nervous system tract morphology|MP:0000780,abnormal corpus callosum morphology|MP:0000787,abnormal telencephalon morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001491,unresponsive to tactile stimuli|MP:0001575,cyanosis|MP:0001956,hypopnea|MP:0002152,abnormal brain morphology|MP:0002741,small olfactory bulb|MP:0003005,abnormal hippocampal fimbria morphology|MP:0003651,abnormal axon extension|MP:0005236,abnormal olfactory nerve morphology|MP:0008227,absent anterior commissure|MP:0009546,absent gastric milk in neonates|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0012014,abnormal olfactory neuron innervation pattern|MP:0014750,abnormal retinal ganglion cell axon guidance
MGI:4331301	Klf8<Gt(AD0101)Wtsi>	MP:0002083,premature death|MP:0005397,hematopoietic system phenotype
MGI:3876652	Klf8<Gt(AD0932)Wtsi>	MP:0003984,embryonic growth retardation
MGI:2654224	Klf9<tm1Yfk>	MP:0001405,impaired coordination|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0009454,impaired contextual conditioning behavior
MGI:6357835	Klhdc10<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system|MP:0001399,hyperactivity|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005559,increased circulating glucose level
MGI:6343386	Klhdc10<tm1Hijo>	MP:0001876,decreased inflammatory response|MP:0008597,decreased circulating interleukin-6 level|MP:0008706,decreased interleukin-6 secretion|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:7425774	Klhdc1<em1(IMPC)Bay>	MP:0001513,limb grasping
MGI:4436518	Klhdc2<tm1a(EUCOMM)Hmgu>	MP:0000745,tremors|MP:0001260,increased body weight|MP:0001314,cornea opacity|MP:0001402,decreased locomotor activity
MGI:5548587	Klhdc2<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0000432,abnormal head morphology|MP:0000443,abnormal snout morphology|MP:0002060,abnormal skin morphology|MP:0005016,decreased lymphocyte cell number|MP:0005553,increased circulating creatinine level|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:5749454	Klhdc7a<tm1.1(KOMP)Vlcg>	MP:0002574,increased vertical activity
MGI:6285603	Klhdc7b<em1(IMPC)H>	MP:0001392,abnormal locomotor behavior|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0002102,abnormal ear morphology|MP:0004738,abnormal auditory brainstem response|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0009142,decreased prepulse inhibition
MGI:7330360	Klhdc8b<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response
MGI:5708238	Klhl10<tm1b(KOMP)Wtsi>	MP:0001925,male infertility
MGI:3040869	Klhl10<tm1Zuk>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002209,decreased germ cell number|MP:0002216,abnormal seminiferous tubule morphology|MP:0002784,abnormal Sertoli cell morphology
MGI:6156563	Klhl12<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0001258,decreased body length|MP:0001289,persistence of hyaloid vascular system|MP:0002768,small adrenal glands
MGI:6191749	Klhl14<tm1.1Jyw>	MP:0005387,immune system phenotype|MP:0008168,decreased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:7425776	Klhl17<em1(IMPC)Bay>	MP:0000443,abnormal snout morphology|MP:0000556,abnormal hindlimb morphology|MP:0001406,abnormal gait
MGI:6728081	Klhl17<em1Yph>	MP:0002574,increased vertical activity|MP:0009936,abnormal dendritic spine morphology|MP:0014373,increased miniature excitatory postsynaptic current amplitude|MP:0020395,abnormal response to social novelty|MP:0031391,increased locomotor activity
MGI:6470867	Klhl18<lowf>	MP:0004415,abnormal cochlear nerve compound action potential|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4362936	Klhl18<tm1a(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0010052,increased grip strength|MP:0010092,increased circulating magnesium level|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3664543	Klhl1/Atxn8os<tm1.1Mdk>	MP:0000890,thin cerebellar molecular layer|MP:0001405,impaired coordination|MP:0001406,abnormal gait
MGI:3664538	Klhl1/Atxn8os<tm1Mdk>	MP:0000890,thin cerebellar molecular layer|MP:0001405,impaired coordination
MGI:6341932	Klhl1<em1(IMPC)Ccpcz>	MP:0000160,kyphosis|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001415,increased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002631,abnormal epididymis morphology|MP:0004174,abnormal spine curvature|MP:0004931,enlarged epididymis
MGI:4127967	Klhl20<Gt(XF202)Byg>	MP:0001314,cornea opacity|MP:0002083,premature death|MP:0005165,increased susceptibility to injury|MP:0005391,vision/eye phenotype|MP:0005542,cornea vascularization|MP:0006000,abnormal cornea epithelium morphology|MP:0008852,retina neovascularization|MP:0020857,cornea epithelium hyperplasia
MGI:5286696	Klhl20<Tg(Tyr)2372E-3a3Ove>	MP:0002161,abnormal fertility/fecundity
MGI:4363013	Klhl21<tm1a(KOMP)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6782847	Klhl22<em1Cya>	MP:0003721,increased tumor growth/size|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010639,abnormal tumor pathology
MGI:6258564	Klhl22<em1(IMPC)J>	MP:0001303,abnormal lens morphology|MP:0001402,decreased locomotor activity|MP:0003961,decreased lean body mass
MGI:7428974	Klhl24<em1Xtan>	MP:0002169,no abnormal phenotype detected
MGI:7428975	Klhl24<em2Xtan>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0005114,premature hair loss|MP:0008469,abnormal protein level|MP:0010771,integument phenotype
MGI:6241429	Klhl25<m1Mhda>	MP:0013129,abnormal tooth color
MGI:5548861	Klhl29<tm1b(EUCOMM)Hmgu>	MP:0002626,increased heart rate|MP:0003233,prolonged QT interval|MP:0005599,increased cardiac muscle contractility|MP:0010379,decreased respiratory quotient|MP:0010570,prolonged ST segment|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012362,increased large unstained cell number
MGI:6355952	Klhl2<em1Esoh>	MP:0002136,abnormal kidney physiology|MP:0005376,homeostasis/metabolism phenotype
MGI:5771568	Klhl2<em1(IMPC)J>	MP:0002590,increased mean corpuscular volume
MGI:6355953	Klhl2<em2Esoh>	MP:0002136,abnormal kidney physiology|MP:0005376,homeostasis/metabolism phenotype
MGI:6163749	Klhl31<em1Eno>	MP:0000751,myopathy|MP:0001262,decreased body weight|MP:0004087,abnormal muscle fiber morphology|MP:0004089,dilated sarcoplasmic reticulum|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0004232,decreased muscle weight|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009412,skeletal muscle fiber degeneration|MP:0010053,decreased grip strength|MP:0010225,abnormal quadriceps morphology|MP:0011628,increased mitochondrial number
MGI:6258585	Klhl32<em1(IMPC)J>	MP:0002075,abnormal coat/hair pigmentation|MP:0005292,improved glucose tolerance|MP:0013278,decreased fasting circulating glucose level
MGI:5646378	Klhl3<tm1.1Esoh>	MP:0004217,salt-sensitive hypertension|MP:0012339,hyperkalemia|MP:0012551,metabolic acidosis
MGI:6393409	Klhl3<tm1.1Slin>	MP:0002666,increased circulating aldosterone level|MP:0003017,decreased circulating bicarbonate level|MP:0003019,increased circulating chloride level|MP:0003030,acidemia|MP:0005583,decreased renin activity|MP:0005618,decreased urine potassium level|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008872,abnormal physiological response to xenobiotic|MP:0012339,hyperkalemia|MP:0012551,metabolic acidosis
MGI:5637154	Klhl3<tm1b(KOMP)Wtsi>	MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002968,increased circulating alkaline phosphatase level|MP:0005627,increased circulating potassium level
MGI:6157453	Klhl3<tm2.1Esoh>	MP:0002135,abnormal kidney morphology|MP:0003019,increased circulating chloride level|MP:0003030,acidemia|MP:0004217,salt-sensitive hypertension|MP:0004757,abnormal distal convoluted tubule morphology|MP:0005627,increased circulating potassium level
MGI:6258650	Klhl40<em1(IMPC)J>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5769997	Klhl40<tm1.1Itl>	MP:0001265,decreased body size|MP:0004090,abnormal sarcomere morphology|MP:0008489,slow postnatal weight gain|MP:0009400,decreased skeletal muscle fiber size|MP:0011085,postnatal lethality, complete penetrance|MP:0020240,increased skeletal muscle cell apoptosis
MGI:4843038	Klhl40<tm1(KOMP)Vlcg>	MP:0000747,muscle weakness|MP:0000751,myopathy|MP:0000759,abnormal skeletal muscle morphology|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002106,abnormal muscle physiology|MP:0002188,small heart|MP:0002841,impaired skeletal muscle contractility|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0005333,decreased heart rate|MP:0011085,postnatal lethality, complete penetrance
MGI:4364947	Klhl41<tm1a(KOMP)Wtsi>	MP:0000556,abnormal hindlimb morphology|MP:0000751,myopathy|MP:0002279,abnormal diaphragm morphology|MP:0005386,behavior/neurological phenotype|MP:0008489,slow postnatal weight gain|MP:0011087,neonatal lethality, complete penetrance
MGI:6120798	Klhl42<tm1b(EUCOMM)Hmgu>	MP:0003960,increased lean body mass|MP:0005505,thrombocytosis|MP:0010123,increased bone mineral content
MGI:6317340	Klhl4<tm1Ali>	MP:0002169,no abnormal phenotype detected
MGI:5692709	Klhl5<tm1b(EUCOMM)Hmgu>	MP:0000150,abnormal rib morphology|MP:0001303,abnormal lens morphology|MP:0001312,abnormal cornea morphology|MP:0001552,increased circulating triglyceride level|MP:0002075,abnormal coat/hair pigmentation|MP:0002135,abnormal kidney morphology|MP:0002591,decreased mean corpuscular volume|MP:0008935,decreased mean platelet volume
MGI:6341885	Klhl6<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0001175,abnormal lung morphology|MP:0001944,abnormal pancreas morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002135,abnormal kidney morphology|MP:0002311,abnormal inspiratory capacity|MP:0003068,enlarged kidney|MP:0003450,enlarged pancreas|MP:0005015,increased T cell number|MP:0005016,decreased lymphocyte cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0013436,increased CD8-positive, naive alpha-beta T cell number|MP:0013763,increased T-helper cell number|MP:0013771,decreased effector memory T-helper cell number
MGI:5563461	Klhl6<m1Anu>	MP:0005017,decreased B cell number|MP:0008211,decreased mature B cell number|MP:0008214,increased immature B cell number
MGI:6200013	Klhl6<m1Btlr>	MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0008169,increased B-1b cell number|MP:0010842,decreased central memory CD4-positive, alpha-beta T cell number
MGI:6200017	Klhl6<m2Btlr>	MP:0005015,increased T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number
MGI:6269425	Klhl6<M3Btlr>	MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008167,increased B-1a cell number|MP:0012764,increased alpha-beta T cell number
MGI:6284782	Klhl6<m4Btlr>	MP:0004977,increased B-1 B cell number
MGI:6284786	Klhl6<M5Btlr>	MP:0004977,increased B-1 B cell number
MGI:6284790	Klhl6<m6Btlr>	MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0012764,increased alpha-beta T cell number
MGI:6284794	Klhl6<M7Btlr>	MP:0002144,abnormal B cell differentiation
MGI:6305808	Klhl6<M8Btlr>	MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number
MGI:3604864	Klhl6<tm1Sato>	MP:0000689,abnormal spleen morphology|MP:0000694,spleen hypoplasia|MP:0002144,abnormal B cell differentiation|MP:0002420,abnormal adaptive immunity|MP:0004953,decreased spleen weight|MP:0005017,decreased B cell number|MP:0008174,decreased follicular B cell number|MP:0008522,abnormal lymph node germinal center morphology
MGI:3604876	Klhl6<tm2Sato>	MP:0002144,abnormal B cell differentiation|MP:0005017,decreased B cell number|MP:0008522,abnormal lymph node germinal center morphology
MGI:6381997	Klhl9<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0003795,abnormal bone structure|MP:0010124,decreased bone mineral content
MGI:7438344	Klk10<em1(IMPC)Ccpcz>	MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0004122,abnormal sinus arrhythmia|MP:0005385,cardiovascular system phenotype|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0013772,increased effector memory T-helper cell number
MGI:6341896	Klk11<em1(IMPC)Ccpcz>	MP:0000438,abnormal cranium morphology|MP:0000598,abnormal liver morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002932,abnormal joint morphology
MGI:7614790	Klk11<em1Zlin>	MP:0001192,scaly skin|MP:0001242,hyperkeratosis|MP:0005380,embryo phenotype
MGI:6341825	Klk12<em1(IMPC)Ccpcz>	MP:0002135,abnormal kidney morphology|MP:0002932,abnormal joint morphology
MGI:6341887	Klk13<em1(IMPC)Ccpcz>	MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0002092,abnormal eye morphology|MP:0002941,increased circulating alanine transaminase level|MP:0008935,decreased mean platelet volume
MGI:5571350	Klk14<tm1.1(KOMP)Vlcg>	MP:0002959,increased urine microalbumin level|MP:0003795,abnormal bone structure|MP:0005560,decreased circulating glucose level
MGI:6341840	Klk15<em1(IMPC)Ccpcz>	MP:0000367,abnormal coat/ hair morphology|MP:0000438,abnormal cranium morphology|MP:0001402,decreased locomotor activity|MP:0002060,abnormal skin morphology|MP:0002932,abnormal joint morphology|MP:0009142,decreased prepulse inhibition|MP:0020421,increased freezing behavior
MGI:6488427	Klk1b5<em1Winu>	MP:0002169,no abnormal phenotype detected
MGI:3513115	Klk1<tm1Pmtn>	MP:0000266,abnormal heart morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0002833,increased heart weight|MP:0003393,decreased cardiac output|MP:0003916,decreased heart left ventricle weight|MP:0003995,abnormal uterine artery morphology|MP:0005591,decreased vasodilation|MP:0010725,thin interventricular septum|MP:0011952,decreased cardiac stroke volume|MP:0014316,decreased heart left ventricle posterior wall thickness|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4355346	Klk4<tm1.1Jpsi>	MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002576,abnormal enamel morphology|MP:0005376,homeostasis/metabolism phenotype
MGI:5567109	Klk4<tm1.1(KOMP)Vlcg>	MP:0000219,increased neutrophil cell number|MP:0002606,increased basophil cell number|MP:0005576,decreased pulmonary ventilation
MGI:7614802	Klk5<em1Mer>	MP:0002498,abnormal acute inflammation|MP:0010377,abnormal gut flora balance
MGI:5604101	Klk5<tm2b(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0001566,increased circulating phosphate level|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0004357,long tibia|MP:0004738,abnormal auditory brainstem response|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010067,increased red blood cell distribution width|MP:0010097,abnormal retina blood vessel morphology|MP:0011965,decreased total retina thickness
MGI:5517797	Klk6<tm1Arte>	MP:0002882,abnormal neuron morphology|MP:0005164,abnormal response to injury|MP:0008948,decreased neuron number|MP:0009808,decreased oligodendrocyte number
MGI:6444221	Klk6<tm1Gsot>	MP:0001876,decreased inflammatory response|MP:0002053,decreased incidence of induced tumors|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005501,abnormal skin physiology|MP:0008713,abnormal cytokine level|MP:0012573,decreased susceptibility to chemically induced skin inflammation
MGI:4843047	Klk7<tm1(KOMP)Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:6341912	Klk8<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002135,abnormal kidney morphology|MP:0005016,decreased lymphocyte cell number
MGI:2388384	Klk8<tm1Lth>	MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:2678312	Klk8<tm1Shio>	MP:0000807,abnormal hippocampus morphology|MP:0003245,abnormal GABAergic neuron morphology|MP:0003631,nervous system phenotype|MP:0004101,abnormal brain interneuron morphology|MP:0004998,decreased CNS synapse formation|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008571,abnormal synaptic bouton morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology
MGI:5548334	Klkb1<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001529,abnormal vocalization|MP:0004738,abnormal auditory brainstem response
MGI:4938303	Klkb1<tm1Tigm>	MP:0008817,hematoma|MP:0012359,increased partial thromboplastin time
MGI:1889570	Kl<kl>	MP:0000005,increased brown adipose tissue amount|MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000067,osteopetrosis|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000160,kyphosis|MP:0000189,hypoglycemia|MP:0000194,increased circulating calcium level|MP:0000217,abnormal leukocyte cell number|MP:0000249,abnormal blood vessel physiology|MP:0000285,abnormal heart valve morphology|MP:0000379,decreased hair follicle number|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000609,abnormal liver physiology|MP:0000876,Purkinje cell degeneration|MP:0000880,decreased Purkinje cell number|MP:0001132,absent mature ovarian follicles|MP:0001175,abnormal lung morphology|MP:0001191,abnormal skin condition|MP:0001218,thin epidermis|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001407,short stride length|MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0001544,abnormal cardiovascular system physiology|MP:0001732,postnatal growth retardation|MP:0001783,decreased white adipose tissue amount|MP:0001924,infertility|MP:0001929,abnormal gametogenesis|MP:0001958,emphysema|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002128,abnormal blood circulation|MP:0002216,abnormal seminiferous tubule morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002314,abnormal respiratory mechanics|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0003109,short femur|MP:0003195,calcinosis|MP:0003196,calcified skin|MP:0003199,calcified muscle|MP:0003205,testicular atrophy|MP:0003402,decreased liver weight|MP:0003633,abnormal nervous system physiology|MP:0003644,thymus atrophy|MP:0003674,oxidative stress|MP:0003786,premature aging|MP:0003795,abnormal bone structure|MP:0003991,arteriosclerosis|MP:0004163,abnormal adenohypophysis morphology|MP:0004833,ovary atrophy|MP:0004894,uterus atrophy|MP:0004982,abnormal osteoclast morphology|MP:0004985,decreased osteoclast cell number|MP:0004986,abnormal osteoblast morphology|MP:0004989,decreased osteoblast cell number|MP:0004993,decreased bone resorption|MP:0005006,abnormal osteoblast physiology|MP:0005017,decreased B cell number|MP:0005159,azoospermia|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005292,improved glucose tolerance|MP:0005333,decreased heart rate|MP:0005534,decreased body temperature|MP:0005586,decreased tidal volume|MP:0005665,increased circulating noradrenaline level|MP:0006133,calcified artery|MP:0006142,abnormal sinoatrial node conduction|MP:0006357,abnormal circulating mineral level|MP:0008261,arrest of male meiosis|MP:0008271,abnormal bone ossification|MP:0008325,abnormal gonadotroph morphology|MP:0008417,decreased somatotroph cell size|MP:0008436,decreased somatotroph secretory granule number|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009125,decreased brown fat cell lipid droplet size|MP:0009172,small pancreatic islets|MP:0009201,external male genitalia atrophy|MP:0009212,vulva atrophy|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010119,abnormal bone mineral density|MP:0010506,prolonged RR interval|MP:0010522,calcified aorta|MP:0010895,increased lung compliance|MP:0010900,abnormal pulmonary interalveolar septum morphology|MP:0010908,dilated pulmonary alveolar duct|MP:0010923,calcified pulmonary alveolus|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0012151,increased a-wave latency|MP:0012153,increased b-wave latency|MP:0013624,decreased femur compact bone thickness|MP:0014367,impaired long-term object recognition memory|MP:0020010,decreased bone mineral density of femur|MP:0020040,decreased bone ossification|MP:0031519,calcified aortic valve annulus|MP:0031521,calcified mitral valve annulus
MGI:5563457	Kl<m1Anu>	MP:0000194,increased circulating calcium level|MP:0000266,abnormal heart morphology|MP:0000470,abnormal stomach morphology|MP:0000521,abnormal kidney cortex morphology|MP:0000572,abnormal autopod morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000767,abnormal smooth muscle morphology|MP:0001429,dehydration|MP:0001914,hemorrhage|MP:0001954,respiratory distress|MP:0002123,abnormal definitive hematopoiesis|MP:0002135,abnormal kidney morphology|MP:0003014,abnormal kidney medulla morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0003271,abnormal duodenum morphology|MP:0003924,diaphragmatic hernia|MP:0004754,abnormal kidney collecting duct morphology|MP:0010870,absent bone trabeculae|MP:0013566,dilated gastric gland
MGI:5445244	Klra15<tm1.1Apma>	MP:0005070,impaired natural killer cell mediated cytotoxicity
MGI:4357862	Klra17<tm1.1Apma>	MP:0005025,abnormal response to infection|MP:0008524,increased plasmacytoid dendritic cell number|MP:0008563,decreased interferon-alpha secretion|MP:0008574,decreased circulating interferon-alpha level|MP:0008618,decreased circulating interleukin-12 level|MP:0008664,decreased interleukin-12 secretion|MP:0008769,abnormal plasmacytoid dendritic cell physiology|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:6196148	Klra1<tm1.1Wyok>	MP:0005397,hematopoietic system phenotype|MP:0011719,abnormal natural killer cell mediated cytotoxicity
MGI:4941892	Klra5<tm1.1Cgbr>	MP:0005387,immune system phenotype
MGI:5512899	Klra5<tm1.2Glec>	MP:0005387,immune system phenotype
MGI:2387148	Klra8<Cmv1-r>	MP:0001805,decreased IgG level|MP:0002494,increased IgM level|MP:0005027,increased susceptibility to parasitic infection|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008577,increased circulating interferon-gamma level|MP:0008700,decreased interleukin-4 secretion|MP:0008838,decreased transforming growth factor beta level|MP:0009787,increased susceptibility to infection induced morbidity/mortality|MP:0020917,decreased susceptibility to Herpesvirales infection
MGI:5755236	Klrb1b<tm1.1Apma>	MP:0010766,abnormal NK cell physiology
MGI:5811628	Klrb1<tm1b(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0000598,abnormal liver morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002135,abnormal kidney morphology|MP:0008173,increased follicular B cell number|MP:0008528,polycystic kidney|MP:0009476,enlarged cecum|MP:0010052,increased grip strength|MP:0010574,dilated aorta
MGI:5751068	Klrc1<tm1Mmka>	MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002941,increased circulating alanine transaminase level|MP:0005387,immune system phenotype|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008560,increased tumor necrosis factor secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion|MP:0020931,increased susceptibility to Adenoviridae infection|MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:6153384	Klrc3<em1(IMPC)Wtsi>	MP:0002160,abnormal reproductive system morphology|MP:0005553,increased circulating creatinine level
MGI:4880661	Klrd1<tm1.1Lll>	MP:0005387,immune system phenotype
MGI:3052750	Klre1<tm1Tgi>	MP:0005070,impaired natural killer cell mediated cytotoxicity
MGI:4460771	Klrg1<tm1Hpi>	MP:0002169,no abnormal phenotype detected
MGI:6314738	Klrg2<em1(IMPC)H>	MP:0000691,enlarged spleen
MGI:7425779	Klrk1<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002060,abnormal skin morphology
MGI:4355860	Klrk1<tm1.1Bpol>	MP:0000694,spleen hypoplasia|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0008053,abnormal NK cell differentiation|MP:0008566,increased interferon-gamma secretion|MP:0010766,abnormal NK cell physiology|MP:0020917,decreased susceptibility to Herpesvirales infection|MP:0031025,decreased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:3790957	Klrk1<tm1Dhr>	MP:0003080,increased natural killer cell mediated cytotoxicity|MP:0005070,impaired natural killer cell mediated cytotoxicity
MGI:5605730	Klrk1<tm2.1Bpol>	MP:0008053,abnormal NK cell differentiation|MP:0020917,decreased susceptibility to Herpesvirales infection
MGI:5515327	Kl<tm1.1Tel>	MP:0001566,increased circulating phosphate level|MP:0002904,increased circulating parathyroid hormone level|MP:0002905,decreased circulating parathyroid hormone level|MP:0005376,homeostasis/metabolism phenotype|MP:0005441,increased urine calcium level
MGI:5515329	Kl<tm1.2Tel>	MP:0000160,kyphosis|MP:0000194,increased circulating calcium level|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001566,increased circulating phosphate level|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003197,nephrocalcinosis|MP:0003985,renal fibrosis|MP:0011360,kidney cortex hypoplasia
MGI:3528832	Kl<tm1Lex>	MP:0000130,abnormal trabecular bone morphology|MP:0000194,increased circulating calcium level|MP:0000559,abnormal femur morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001566,increased circulating phosphate level|MP:0002083,premature death
MGI:2684400	Kl<tm1Yin>	MP:0000063,decreased bone mineral density|MP:0000131,abnormal long bone epiphysis morphology|MP:0000194,increased circulating calcium level|MP:0001262,decreased body weight|MP:0001566,increased circulating phosphate level|MP:0001732,postnatal growth retardation|MP:0001783,decreased white adipose tissue amount|MP:0002083,premature death|MP:0011228,abnormal vitamin D level
MGI:3653671	Kl<tm2Yin>	MP:0002083,premature death|MP:0003786,premature aging|MP:0005333,decreased heart rate|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5569396	Kmo<tm1.2Pjmi>	MP:0001764,abnormal homeostasis|MP:0005584,abnormal enzyme/coenzyme activity
MGI:4364232	Kmo<tm1a(KOMP)Wtsi>	MP:0001415,increased exploration in new environment|MP:0002573,behavioral despair|MP:0002797,increased thigmotaxis|MP:0013242,abnormal amino acid metabolism
MGI:5569394	Kmo<tm1Pjmi>	MP:0005584,abnormal enzyme/coenzyme activity
MGI:3849323	Kmt2a<tm1.1Brad>	MP:0000596,abnormal liver development|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0008813,decreased common myeloid progenitor cell number|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3839794	Kmt2a<tm1.1Erns>	MP:0000333,decreased bone marrow cell number|MP:0000812,abnormal dentate gyrus morphology|MP:0000913,abnormal brain development|MP:0001393,ataxia|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002182,abnormal astrocyte morphology|MP:0002741,small olfactory bulb|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0004981,decreased neuronal precursor cell number|MP:0005387,immune system phenotype|MP:0006099,thin cerebellar granule layer|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0009937,abnormal neuron differentiation|MP:0030956,abnormal neuronal precursor cell migration
MGI:5548103	Kmt2a<tm1.1Jjdh>	MP:0001265,decreased body size|MP:0004569,glossopharyngeal nerve hypoplasia|MP:0009879,abnormal arcus anterior morphology|MP:0010082,sternebra fusion|MP:0011704,decreased fibroblast proliferation
MGI:5317820	Kmt2a<tm1.1Mlc>	MP:0000600,liver hypoplasia|MP:0001505,hunched posture|MP:0001786,skin edema|MP:0001914,hemorrhage|MP:0002429,abnormal blood cell morphology/development|MP:0004810,decreased hematopoietic stem cell number|MP:0008008,early cellular replicative senescence|MP:0008813,decreased common myeloid progenitor cell number|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3701943	Kmt2a<tm1.1(Sh3gl1)Lcc>	MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0010373,myeloid hyperplasia
MGI:3839795	Kmt2a<tm1.2Erns>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3663920	Kmt2a<tm1(AFF1)Ksy>	MP:0000017,big ears|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000445,short snout|MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001505,hunched posture|MP:0002018,increased malignant tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002429,abnormal blood cell morphology/development|MP:0002619,abnormal lymphocyte morphology|MP:0003743,abnormal facial morphology|MP:0004924,abnormal behavior|MP:0005649,increased spleen neoplasm incidence|MP:0008186,increased pro-B cell number|MP:0009703,decreased birth body size|MP:0010179,rough coat|MP:0010373,myeloid hyperplasia|MP:0013176,abnormal tail position or orientation
MGI:3849322	Kmt2a<tm1Brad>	MP:0008209,decreased pre-B cell number|MP:0008813,decreased common myeloid progenitor cell number|MP:0009278,abnormal bone marrow cell physiology
MGI:3691062	Kmt2a<tm1Clgr>	MP:0001601,abnormal myelopoiesis|MP:0002006,neoplasm|MP:0002416,abnormal proerythroblast morphology|MP:0003036,vertebral transformation|MP:0003135,increased erythroid progenitor cell number|MP:0003345,decreased rib number|MP:0004617,sacral vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0005221,abnormal rostral-caudal axis patterning|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008029,abnormal paraxial mesoderm morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:3641250	Kmt2a<tm1Djab>	MP:0000154,rib fusion|MP:0004608,abnormal cervical axis morphology|MP:0004615,cervical vertebral transformation|MP:0009879,abnormal arcus anterior morphology|MP:0012284,increased sternebra number
MGI:5447014	Kmt2a<tm1(MLL1/ERT)Divo>	MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0002083,premature death|MP:0004049,increased acute promyelocytic leukemia incidence|MP:0010373,myeloid hyperplasia
MGI:3814567	Kmt2a<tm1Saam>	MP:0002026,increased leukemia incidence|MP:0011090,perinatal lethality, incomplete penetrance
MGI:1932081	Kmt2a<tm1Sjk>	MP:0000157,abnormal sternum morphology|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003036,vertebral transformation|MP:0003179,thrombocytopenia|MP:0003345,decreased rib number|MP:0004569,glossopharyngeal nerve hypoplasia|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0005017,decreased B cell number|MP:0009703,decreased birth body size|MP:0011092,embryonic lethality, complete penetrance|MP:0011808,abnormal myoblast differentiation
MGI:2177819	Kmt2a<tm1Vss>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0002823,abnormal rib development|MP:0003036,vertebral transformation|MP:0003048,abnormal cervical vertebrae morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004607,abnormal cervical atlas morphology|MP:0004608,abnormal cervical axis morphology|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004620,cervical vertebral fusion|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5561120	Kmt2a<tm2.1Mlc>	MP:0001786,skin edema|MP:0001914,hemorrhage|MP:0002396,abnormal hematopoietic system morphology/development|MP:0004810,decreased hematopoietic stem cell number|MP:0011092,embryonic lethality, complete penetrance
MGI:2671905	Kmt2a<tm2(MLLT3)Thr>	MP:0000017,big ears|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000448,pointed snout|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002023,increased B cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002080,prenatal lethality|MP:0002123,abnormal definitive hematopoiesis|MP:0002429,abnormal blood cell morphology/development|MP:0004969,pale kidney|MP:0008186,increased pro-B cell number|MP:0010296,increased hemolymphoid system tumor incidence|MP:0030066,short face
MGI:3528758	Kmt2a<tm2Sjk>	MP:0000218,increased leukocyte cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001658,increased mortality induced by gamma-irradiation|MP:0002021,increased incidence of induced tumors|MP:0002398,abnormal bone marrow cell morphology/development|MP:0003179,thrombocytopenia|MP:0008476,increased spleen red pulp amount|MP:0010373,myeloid hyperplasia
MGI:5561122	Kmt2a<tm3Mlc>	MP:0002169,no abnormal phenotype detected
MGI:5532297	Kmt2b<Gena263>	MP:0000269,abnormal heart looping|MP:0000432,abnormal head morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000914,exencephaly|MP:0001552,increased circulating triglyceride level|MP:0001700,abnormal embryo turning|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0003059,decreased insulin secretion|MP:0003984,embryonic growth retardation|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005312,pericardial effusion|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0009171,enlarged pancreatic islets|MP:0009289,decreased epididymal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0010024,increased total body fat amount|MP:0010359,increased liver free fatty acids level|MP:0011089,perinatal lethality, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0012157,rostral body truncation
MGI:5532298	Kmt2b<m1H>	MP:0002079,increased circulating insulin level|MP:0002981,increased liver weight|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0009289,decreased epididymal fat pad weight
MGI:3623310	Kmt2b<tm1.1Afst>	MP:0002169,no abnormal phenotype detected|MP:0005376,homeostasis/metabolism phenotype
MGI:3623312	Kmt2b<tm1.2Afst>	MP:0000929,open neural tube|MP:0001688,abnormal somite development|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0006042,increased apoptosis|MP:0011092,embryonic lethality, complete penetrance
MGI:3623309	Kmt2b<tm1Afst>	MP:0000929,open neural tube|MP:0001688,abnormal somite development|MP:0002079,increased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005370,liver/biliary system phenotype|MP:0005559,increased circulating glucose level|MP:0006042,increased apoptosis|MP:0009288,increased epididymal fat pad weight|MP:0011092,embryonic lethality, complete penetrance
MGI:5565082	Kmt2b<tm1Jjdh>	MP:0005384,cellular phenotype
MGI:4867487	Kmt2b<tm2.1Afst>	MP:0001672,abnormal embryo development|MP:0001730,embryonic growth arrest|MP:0001923,reduced female fertility|MP:0008877,abnormal DNA methylation
MGI:4128486	Kmt2c<Gt(XM083)Byg>	MP:0011089,perinatal lethality, complete penetrance
MGI:3693319	Kmt2c<tm1.1Jwle>	MP:0000352,decreased cell proliferation|MP:0001290,delayed eyelid opening|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0011102,embryonic lethality, incomplete penetrance
MGI:6442583	Kmt2d<bapa>	MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001441,increased grooming behavior|MP:0001485,abnormal pinna reflex|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002574,increased vertical activity|MP:0003064,decreased coping response|MP:0005498,hyporesponsive to tactile stimuli|MP:0031391,increased locomotor activity
MGI:4332076	Kmt2d<Gt(RRT024)Byg>	MP:0000097,short maxilla|MP:0000447,flattened snout|MP:0000812,abnormal dentate gyrus morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001458,abnormal object recognition memory|MP:0002729,abnormal inner ear canal morphology|MP:0002891,increased insulin sensitivity|MP:0004789,increased bile salt level|MP:0005292,improved glucose tolerance|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008285,abnormal hippocampus granule cell layer|MP:0008948,decreased neuron number|MP:0009454,impaired contextual conditioning behavior|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012307,impaired spatial learning|MP:0013292,embryonic lethality prior to organogenesis|MP:0014143,decreased body fat mass
MGI:4344935	Kmt2d<Gt(XT0709)Wtsi>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5585624	Kmt2d<tm1.1Kaig>	MP:0000270,abnormal heart tube morphology|MP:0000281,abnormal interventricular septum morphology|MP:0001780,decreased brown adipose tissue amount|MP:0001787,pericardial edema|MP:0001806,decreased IgM level|MP:0001953,respiratory failure|MP:0002108,abnormal muscle morphology|MP:0002144,abnormal B cell differentiation|MP:0002633,persistent truncus arteriosus|MP:0003984,embryonic growth retardation|MP:0004057,thin myocardium compact layer|MP:0004232,decreased muscle weight|MP:0005017,decreased B cell number|MP:0005154,increased B cell proliferation|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005560,decreased circulating glucose level|MP:0006386,absent somites|MP:0008174,decreased follicular B cell number|MP:0008177,increased germinal center B cell number|MP:0008211,decreased mature B cell number|MP:0008481,increased spleen germinal center number|MP:0008483,increased spleen germinal center size|MP:0008495,decreased IgG1 level|MP:0008948,decreased neuron number|MP:0011087,neonatal lethality, complete penetrance|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011170,abnormal brown fat cell differentiation|MP:0011390,abnormal fetal cardiomyocyte physiology|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0011827,impaired neuron differentiation|MP:0011925,abnormal heart echocardiography feature|MP:0012724,absent head fold
MGI:7858905	Kmt2d<tm1.2(IMPC)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0001258,decreased body length|MP:0002875,decreased erythrocyte cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0003020,decreased circulating chloride level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005634,decreased circulating sodium level|MP:0008806,increased circulating amylase level
MGI:7333014	Kmt2d<tm2.1Kaig>	MP:0000022,abnormal ear shape|MP:0000074,abnormal neurocranium morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0000111,cleft palate|MP:0000166,abnormal chondrocyte morphology|MP:0000440,domed cranium|MP:0000443,abnormal snout morphology|MP:0000460,mandible hypoplasia|MP:0001732,postnatal growth retardation|MP:0003056,abnormal hyoid bone morphology|MP:0004380,short frontal bone|MP:0004448,abnormal presphenoid bone morphology|MP:0004452,abnormal pterygoid process morphology|MP:0004462,small basisphenoid bone|MP:0004471,short nasal bone|MP:0004986,abnormal osteoblast morphology|MP:0005249,abnormal palatine bone morphology|MP:0005274,abnormal viscerocranium morphology|MP:0008272,abnormal endochondral bone ossification|MP:0010029,abnormal basicranium morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0012754,abnormal cranial neural crest cell morphology|MP:0030065,face hypoplasia|MP:0030069,broad face|MP:0030259,mandibular condyloid process hypoplasia|MP:0030320,abnormal temporal bone tympanic part morphology|MP:0030383,small presphenoid bone|MP:0031444,glossoptosis|MP:0031460,abnormal palatal shelf morphology
MGI:3835538	Kmt2e<tm1.1Hjf>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001658,increased mortality induced by gamma-irradiation|MP:0001823,thymus hypoplasia|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002217,small lymph nodes|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002401,abnormal lymphopoiesis|MP:0002414,abnormal myeloblast morphology/development|MP:0002686,globozoospermia|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0003884,decreased macrophage cell number|MP:0004810,decreased hematopoietic stem cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008813,decreased common myeloid progenitor cell number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:7858904	Kmt2e<tm1.2(IMPC)Wtsi>	MP:0002079,increased circulating insulin level|MP:0003961,decreased lean body mass|MP:0005561,increased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0006358,absent pinna reflex|MP:0010024,increased total body fat amount|MP:0010067,increased red blood cell distribution width
MGI:3835772	Kmt2e<tm1Apa>	MP:0000208,decreased hematocrit|MP:0000242,impaired fertilization|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002123,abnormal definitive hematopoiesis|MP:0002412,increased susceptibility to bacterial infection|MP:0002415,abnormal neutrophil differentiation|MP:0002463,abnormal neutrophil physiology|MP:0002594,low mean erythrocyte cell number|MP:0002662,abnormal cauda epididymis morphology|MP:0002675,asthenozoospermia|MP:0002874,decreased hemoglobin content|MP:0005251,blepharitis|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0008111,abnormal granulocyte differentiation|MP:0008850,increased hemoglobin concentration distribution width|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0010025,decreased total body fat amount|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0013320,dilated seminal vesicle|MP:0020451,decreased sperm progressive motility|MP:0030976,impaired sperm penetration of zona pellucida
MGI:3835592	Kmt2e<tm1Nik>	MP:0000219,increased neutrophil cell number|MP:0001732,postnatal growth retardation|MP:0002123,abnormal definitive hematopoiesis|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004809,increased hematopoietic stem cell number|MP:0004810,decreased hematopoietic stem cell number|MP:0005397,hematopoietic system phenotype|MP:0008040,decreased NK T cell number|MP:0008045,decreased NK cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3796614	Kmt5a<Gt(RRB075)Byg>	MP:0011092,embryonic lethality, complete penetrance
MGI:3842472	Kmt5a<tm1.1Dare>	MP:0002169,no abnormal phenotype detected
MGI:3842473	Kmt5a<tm1.2Dare>	MP:0003406,failure of zygotic cell division|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3810075	Kmt5b<tm1.1Jnw>	MP:0001265,decreased body size|MP:0002270,abnormal pulmonary alveolus morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4363450	Kmt5b<tm1a(KOMP)Wtsi>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001973,increased thermal nociceptive threshold|MP:0002942,decreased circulating alanine transaminase level|MP:0004647,decreased lumbar vertebrae number|MP:0010025,decreased total body fat amount|MP:0010101,increased sacral vertebrae number|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3810079	Kmt5c<tm1.1Jnw>	MP:0002169,no abnormal phenotype detected
MGI:6370161	Kncn<em2Wxi>	MP:0005377,hearing/vestibular/ear phenotype
MGI:3663685	Kndc1<tm1Mnkm>	MP:0003858,enhanced coordination|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004099,abnormal cerebellar glomerulus morphology|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0008143,abnormal dendrite morphology|MP:0010052,increased grip strength|MP:0010768,mortality/aging|MP:0020357,abnormal excitatory synapse morphology|MP:0020551,abnormal postsynaptic density morphology
MGI:3776034	Kng1<tm1Krmc>	MP:0002551,abnormal blood coagulation|MP:0012359,increased partial thromboplastin time|MP:0031120,decreased susceptibility to induced thrombosis
MGI:4840572	Kng2<tm2a(EUCOMM)Wtsi>	MP:0001257,increased body length|MP:0001413,abnormal response to new environment|MP:0005553,increased circulating creatinine level
MGI:3834126	Knk	MP:0000585,kinked tail|MP:0000592,short tail|MP:0000737,abnormal myotome development|MP:0001539,decreased caudal vertebrae number|MP:0001683,absent mesoderm|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0002085,abnormal embryonic tissue morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0002825,abnormal notochord morphology|MP:0003886,abnormal embryonic epiblast morphology|MP:0003954,abnormal Reichert's membrane morphology|MP:0003984,embryonic growth retardation|MP:0003988,disorganized embryonic tissue|MP:0004173,abnormal intervertebral disk morphology|MP:0004272,abnormal basement membrane morphology|MP:0004619,caudal vertebral fusion|MP:0004713,split notochord|MP:0006281,abnormal tail development|MP:0008533,abnormal anterior visceral endoderm morphology|MP:0008833,caudal hemivertebra|MP:0010126,abnormal distal visceral endoderm morphology|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:5563500	Knl1<m1Anu>	MP:0008762,embryonic lethality
MGI:5286641	Knl1<Tg(Tyr)2397HOve>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5692741	Knl1<tm1b(EUCOMM)Hmgu>	MP:0005293,impaired glucose tolerance|MP:0011100,preweaning lethality, complete penetrance
MGI:6358098	Knl1<tm1c(EUCOMM)Hmgu>	MP:0000433,microcephaly|MP:0000785,telencephalon hypoplasia|MP:0001265,decreased body size|MP:0002196,absent corpus callosum|MP:0003424,premature neuronal precursor differentiation|MP:0004981,decreased neuronal precursor cell number|MP:0006042,increased apoptosis|MP:0008441,thin cortical plate|MP:0008770,decreased survivor rate|MP:0008918,microgliosis|MP:0008948,decreased neuron number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013289,abnormal mitotic cytokinesis|MP:0014763,enhanced double-strand DNA break repair
MGI:5568481	Knop1<tm1b(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0003019,increased circulating chloride level|MP:0004952,increased spleen weight
MGI:5548420	Knstrn<tm1b(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0000745,tremors|MP:0002059,abnormal seminal vesicle morphology|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0005561,increased mean corpuscular hemoglobin|MP:0013279,increased fasting circulating glucose level
MGI:5544487	Knstrn<tm1d(KOMP)Wtsi>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002685,abnormal spermatogonia proliferation|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0013601,increased testis apoptosis
MGI:2679537	Kntc1<jgl>	MP:0000585,kinked tail
MGI:5588288	Kntc1<tm1b(EUCOMM)Hmgu>	MP:0005287,narrow eye opening|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:5510719	knyn	MP:0000108,midline facial cleft|MP:0000914,exencephaly|MP:0002151,abnormal neural tube morphology|MP:0009901,abnormal frontonasal prominence morphology
MGI:5049957	koro	MP:0012270,cardiac edema
MGI:3775202	Kpna1<Gt(P017E08)Wrst>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:5439493	Kpna1<tm1.2Yyo>	MP:0001120,abnormal uterus morphology|MP:0001935,decreased litter size|MP:0002682,decreased mature ovarian follicle number|MP:0002941,increased circulating alanine transaminase level|MP:0003179,thrombocytopenia|MP:0003572,abnormal uterus development|MP:0004514,dystocia|MP:0005179,decreased circulating cholesterol level|MP:0005185,decreased circulating progesterone level|MP:0005343,increased circulating aspartate transaminase level|MP:0005370,liver/biliary system phenotype|MP:0005389,reproductive system phenotype|MP:0008028,pregnancy-related premature death|MP:0008257,thin myometrium|MP:0013400,abnormal endometrial gland development|MP:0031137,vaginal hemorrhage
MGI:7512791	Kpna2<em1Alfon>	MP:0001265,decreased body size|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0020451,decreased sperm progressive motility
MGI:6152505	Kpna2<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001402,decreased locomotor activity|MP:0001404,no spontaneous movement|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0005278,abnormal cholesterol homeostasis|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7367175	Kpna3<em2Maoka>	MP:0005389,reproductive system phenotype
MGI:5004868	Kpna3<tm1Bdr>	MP:0002169,no abnormal phenotype detected
MGI:6188008	Kpna4<em1(IMPC)J>	MP:0000062,increased bone mineral density|MP:0001488,increased startle reflex|MP:0001529,abnormal vocalization
MGI:6507452	Kpna4<tm1Bdr>	MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:7367178	Kpna4<tm1Maoka>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0004542,impaired acrosome reaction|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0020451,decreased sperm progressive motility
MGI:6761438	Kpna6<em1Btlr>	MP:0002764,short tibia|MP:0003109,short femur
MGI:3856636	Kpna6<Gt(AJ0609)Wtsi>	MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001926,female infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0005250,decreased Sertoli cell number|MP:0005389,reproductive system phenotype|MP:0006379,abnormal spermatocyte morphology|MP:0006428,ectopic Sertoli cells|MP:0011101,prenatal lethality, incomplete penetrance|MP:0014634,decreased round spermatid number|MP:0020356,abnormal Sertoli cell barrier function
MGI:6761425	Kpna6<m1Btlr>	MP:0002764,short tibia
MGI:5004867	Kpna6<tm1Bdr>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001932,abnormal spermiogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002631,abnormal epididymis morphology|MP:0002660,abnormal caput epididymis morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0003718,maternal effect|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005250,decreased Sertoli cell number|MP:0006379,abnormal spermatocyte morphology|MP:0006428,ectopic Sertoli cells|MP:0009230,abnormal sperm head morphology|MP:0009661,abnormal pregnancy|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014052,increased male germ cell apoptosis|MP:0014634,decreased round spermatid number|MP:0014684,impaired spermiation|MP:0020356,abnormal Sertoli cell barrier function|MP:0020550,multinucleated giant male germ cells
MGI:6108355	Kpna7<tm1.1Sgao>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0003077,abnormal cell cycle|MP:0011104,embryonic lethality before implantation, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020364,abnormal female germ cell physiology
MGI:3617356	Kpnb1<Gt(Kpnb1)2Arak>	MP:0002169,no abnormal phenotype detected
MGI:3617354	Kpnb1<Gt(pU-hachi)1Arak>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5694123	Kpnb1<tm1.2Mfz>	MP:0005164,abnormal response to injury
MGI:7490170	Kprp<em1(IMPC)Mbp>	MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:6429935	Kprp<tm1Msug>	MP:0001216,abnormal epidermal layer morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0002060,abnormal skin morphology|MP:0002497,increased IgE level|MP:0002796,impaired skin barrier function|MP:0009598,thin epidermis stratum granulosum|MP:0009605,decreased keratohyalin granule number|MP:0012572,increased susceptibility to chemically induced skin inflammation
MGI:4433701	Kptn<tm1a(EUCOMM)Wtsi>	MP:0000194,increased circulating calcium level|MP:0000434,megacephaly|MP:0000438,abnormal cranium morphology|MP:0000439,enlarged cranium|MP:0000441,increased cranium width|MP:0000789,thickened cerebral cortex|MP:0001260,increased body weight|MP:0001363,increased anxiety-related response|MP:0002412,increased susceptibility to bacterial infection|MP:0002965,increased circulating serum albumin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0004924,abnormal behavior|MP:0005238,increased brain size|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0005568,increased circulating total protein level|MP:0008283,small hippocampus|MP:0008432,abnormal long-term spatial reference memory|MP:0010024,increased total body fat amount|MP:0011812,increased cranium length|MP:0011861,increased cranium height|MP:0012443,increased corpus callosum size|MP:0012449,increased primary motor cortex size|MP:0012461,increased brain internal capsule size|MP:0013908,small lateral ventricles|MP:0014812,abnormal brain physiology|MP:0020395,abnormal response to social novelty|MP:0020593,increased cerebral cortex cell number|MP:0020597,increased cerebral cortex total cell area|MP:0030262,frontal bossing|MP:0031391,increased locomotor activity
MGI:3579270	Kras<a>	MP:0002048,increased lung adenoma incidence
MGI:3579273	Kras<b>	MP:0010267,decreased lung tumor incidence
MGI:6149500	Kras<tm1.1Khai>	MP:0000218,increased leukocyte cell number|MP:0000495,abnormal colon morphology|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002006,neoplasm|MP:0002083,premature death|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002874,decreased hemoglobin content|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0013415,increased myeloid cell number in bone marrow|MP:0013663,increased myeloid cell number
MGI:3582830	Kras<tm1Bbd>	MP:0000350,abnormal cell proliferation|MP:0000659,prostate gland hyperplasia|MP:0001954,respiratory distress|MP:0002014,increased papilloma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002083,premature death|MP:0008716,increased lung non-small cell carcinoma incidence|MP:0008770,decreased survivor rate|MP:0009151,increased pancreatic ductal adenocarcinoma incidence|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0009828,increased tumor latency|MP:0010383,increased adenoma incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011702,abnormal fibroblast proliferation|MP:0013443,Harderian gland hyperplasia
MGI:2684280	Kras<tm1Epa>	MP:0002169,no abnormal phenotype detected
MGI:3581451	Kras<tm1(Hras)Rdl>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000231,hypertension|MP:0002795,dilated cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0004564,increased myocardial fiber size|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0031633,decreased heart left ventricle muscle contractility
MGI:1857551	Kras<tm1Mok>	MP:0000266,abnormal heart morphology|MP:0000280,thin ventricular wall|MP:0001698,decreased embryo size|MP:0002169,no abnormal phenotype detected|MP:0002188,small heart|MP:0002652,thin myocardium|MP:0003203,increased neuron apoptosis|MP:0003984,embryonic growth retardation|MP:0005370,liver/biliary system phenotype|MP:0005397,hematopoietic system phenotype|MP:0011091,prenatal lethality, complete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation
MGI:1857210	Kras<tm1Tyj>	MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0000603,pale liver|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0001787,pericardial edema|MP:0002123,abnormal definitive hematopoiesis|MP:0003717,pallor|MP:0004201,fetal growth retardation|MP:0006042,increased apoptosis|MP:0011091,prenatal lethality, complete penetrance
MGI:4830590	Kras<tm2(Kras)Rdl>	MP:0002169,no abnormal phenotype detected
MGI:2135928	Kras<tm2Tyj>	MP:0002014,increased papilloma incidence|MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0002038,increased carcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002051,increased skin papilloma incidence|MP:0002083,premature death|MP:0002264,abnormal bronchus morphology|MP:0003667,increased hemangiosarcoma incidence|MP:0004207,increased squamous cell carcinoma incidence|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0008014,increased lung tumor incidence|MP:0010309,increased mesothelioma incidence|MP:0010363,increased fibrosarcoma incidence|MP:0012431,increased lymphoma incidence
MGI:5645350	Kras<tm3Bbd>	MP:0011092,embryonic lethality, complete penetrance
MGI:2136169	Kras<tm3Tyj>	MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002051,increased skin papilloma incidence|MP:0002083,premature death|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0008014,increased lung tumor incidence
MGI:5649285	Kras<tm4.1Bbd>	MP:0000023,abnormal ear position|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000266,abnormal heart morphology|MP:0000275,heart hyperplasia|MP:0000316,cellular necrosis|MP:0000351,increased cell proliferation|MP:0000438,abnormal cranium morphology|MP:0000441,increased cranium width|MP:0000447,flattened snout|MP:0000691,enlarged spleen|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001300,ocular hypertelorism|MP:0001577,anemia|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002606,increased basophil cell number|MP:0003179,thrombocytopenia|MP:0003394,increased cardiac output|MP:0003743,abnormal facial morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004809,increased hematopoietic stem cell number|MP:0005011,increased eosinophil cell number|MP:0005599,increased cardiac muscle contractility|MP:0006321,increased myocardial fiber number|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008489,slow postnatal weight gain|MP:0009278,abnormal bone marrow cell physiology|MP:0010020,spleen vascular congestion|MP:0010594,thick aortic valve|MP:0011089,perinatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011861,increased cranium height|MP:0011862,decreased cranium length|MP:0012546,triangular face|MP:0013663,increased myeloid cell number|MP:0013696,increased granulocyte monocyte progenitor cell number
MGI:3044565	Kras<tm4.1Tyj>	MP:0000274,enlarged heart|MP:0000913,abnormal brain development|MP:0001698,decreased embryo size|MP:0003717,pallor|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012701,increased embryonic neuroepithelium apoptosis
MGI:2429948	Kras<tm4Tyj>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000284,double outlet right ventricle|MP:0000322,increased granulocyte number|MP:0000351,increased cell proliferation|MP:0000420,ruffled hair|MP:0000477,abnormal intestine morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000495,abnormal colon morphology|MP:0000599,enlarged liver|MP:0000600,liver hypoplasia|MP:0000652,enlarged sebaceous gland|MP:0000659,prostate gland hyperplasia|MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0000807,abnormal hippocampus morphology|MP:0000913,abnormal brain development|MP:0000952,abnormal CNS glial cell morphology|MP:0001126,abnormal ovary morphology|MP:0001175,abnormal lung morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001188,hyperpigmentation|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001270,distended abdomen|MP:0001272,increased metastatic potential|MP:0001544,abnormal cardiovascular system physiology|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0001716,abnormal placenta labyrinth morphology|MP:0001719,absent vitelline blood vessels|MP:0001722,pale yolk sac|MP:0001730,embryonic growth arrest|MP:0001785,edema|MP:0001846,increased inflammatory response|MP:0001861,lung inflammation|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0002006,neoplasm|MP:0002014,increased papilloma incidence|MP:0002020,increased tumor incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002051,increased skin papilloma incidence|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002138,abnormal hepatobiliary system morphology|MP:0002182,abnormal astrocyte morphology|MP:0002264,abnormal bronchus morphology|MP:0002267,abnormal bronchiole morphology|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002447,abnormal erythrocyte morphology|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002745,abnormal atrioventricular valve morphology|MP:0002877,abnormal melanocyte morphology|MP:0003277,increased esophageal papilloma incidence|MP:0003336,pancreas cyst|MP:0003447,decreased tumor growth/size|MP:0003448,abnormal tumor morphology|MP:0003449,abnormal intestine goblet cell morphology|MP:0003450,enlarged pancreas|MP:0003607,abnormal prostate gland physiology|MP:0003631,nervous system phenotype|MP:0003717,pallor|MP:0003721,increased tumor growth/size|MP:0003750,increased mouth tumor incidence|MP:0003752,increased oral papilloma incidence|MP:0003780,increased lip tumor incidence|MP:0003887,increased hepatocyte apoptosis|MP:0004229,abnormal embryonic erythropoiesis|MP:0004230,abnormal embryonic erythrocyte morphology|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0004950,abnormal brain vasculature morphology|MP:0004973,increased regulatory T cell number|MP:0005097,polychromatophilia|MP:0005150,cachexia|MP:0005324,ascites|MP:0005367,renal/urinary system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005380,embryo phenotype|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005630,increased lung weight|MP:0006093,arteriovenous malformation|MP:0006382,abnormal lung epithelium morphology|MP:0008014,increased lung tumor incidence|MP:0008018,increased facial tumor incidence|MP:0008019,increased liver tumor incidence|MP:0008476,increased spleen red pulp amount|MP:0008714,increased lung carcinoma incidence|MP:0008716,increased lung non-small cell carcinoma incidence|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009108,increased pancreas weight|MP:0009143,abnormal pancreatic duct morphology|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009151,increased pancreatic ductal adenocarcinoma incidence|MP:0009152,increased pancreatic intraepithelial neoplasia incidence|MP:0009153,increased pancreas tumor incidence|MP:0009171,enlarged pancreatic islets|MP:0009216,abnormal peritoneum morphology|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009221,uterus adenomyosis|MP:0009320,increased lymphoblastic lymphoma incidence|MP:0009336,increased splenocyte proliferation|MP:0009523,submandibular gland hyperplasia|MP:0009535,abnormal skin sebaceous gland morphology|MP:0009794,sebaceous gland hyperplasia|MP:0010275,increased melanoma incidence|MP:0010300,increased skin tumor incidence|MP:0010315,increased cholangiocarcinoma incidence|MP:0010373,myeloid hyperplasia|MP:0010402,ventricular septal defect|MP:0010588,conotruncal ridge hyperplasia|MP:0010768,mortality/aging|MP:0010771,integument phenotype|MP:0010856,dilated respiratory conducting tube|MP:0010910,bronchiolar epithelial hyperplasia|MP:0010943,abnormal bronchus epithelium morphology|MP:0010945,lung epithelium hyperplasia|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011028,impaired branching involved in bronchus morphogenesis|MP:0011032,impaired branching involved in terminal bronchiole morphogenesis|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011285,increased circulating erythropoietin level|MP:0013221,pancreatic acinar-to-ductal metaplasia|MP:0013415,increased myeloid cell number in bone marrow|MP:0013504,increased embryonic tissue cell apoptosis|MP:0013663,increased myeloid cell number|MP:0013795,abnormal colon goblet cell morphology|MP:0014076,absent Paneth cells|MP:0014237,decreased tumor-free survival time|MP:0030574,increased hair follicle cell proliferation
MGI:3813896	Kras<tm5Tyj>	MP:0008014,increased lung tumor incidence
MGI:2388884	Krcn1<SKC>	MP:0001312,abnormal cornea morphology
MGI:1861657	Krd	MP:0000520,absent kidney|MP:0000528,delayed kidney development|MP:0001328,disorganized retina layers|MP:0002082,postnatal lethality|MP:0003586,dilated ureter|MP:0003604,single kidney|MP:0003675,kidney cyst|MP:0003727,abnormal retina layer morphology|MP:0003918,decreased kidney weight|MP:0005551,abnormal eye electrophysiology|MP:0008489,slow postnatal weight gain|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0011093,embryonic lethality at implantation, complete penetrance|MP:0011290,decreased nephron number|MP:0011334,abnormal nephrogenic zone morphology|MP:0011360,kidney cortex hypoplasia|MP:0011376,abnormal kidney corticomedullary boundary morphology
MGI:7708055	Kremen1<em1(IMPC)Ccpcz>	MP:0000455,abnormal maxilla morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001120,abnormal uterus morphology|MP:0002100,abnormal tooth morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0004906,enlarged uterus|MP:0005343,increased circulating aspartate transaminase level|MP:0010099,abnormal thoracic cage shape
MGI:3804430	Kremen1<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3804431	Kremen2<tm1Cni>	MP:0002169,no abnormal phenotype detected
MGI:5897838	Kri1<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5583067	Krit1<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0000288,abnormal pericardium morphology|MP:0001333,absent optic nerve|MP:0001614,abnormal blood vessel morphology|MP:0001691,abnormal somite shape|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001706,abnormal left-right axis patterning|MP:0001726,abnormal allantois morphology|MP:0002092,abnormal eye morphology|MP:0002151,abnormal neural tube morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0002884,abnormal pharyngeal arch morphology|MP:0002941,increased circulating alanine transaminase level|MP:0003425,abnormal optic vesicle formation|MP:0003717,pallor|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0009806,abnormal otic vesicle morphology|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5297591	Krit1<tm1Arte>	MP:0002792,abnormal retina vasculature morphology|MP:0004950,abnormal brain vasculature morphology
MGI:2449693	Krit1<tm1Dmar>	MP:0000267,abnormal heart development|MP:0001701,incomplete embryo turning|MP:0001718,abnormal visceral yolk sac morphology|MP:0001730,embryonic growth arrest|MP:0002191,abnormal artery morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0004938,dilated vasculature|MP:0010574,dilated aorta|MP:0010662,abnormal intersomitic artery morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012495,pharyngeal arch artery stenosis
MGI:5532525	Krit1<tm1Kwhi>	MP:0000266,abnormal heart morphology|MP:0002083,premature death|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002652,thin myocardium|MP:0003140,dilated heart atrium|MP:0004125,abnormal venule morphology|MP:0004950,abnormal brain vasculature morphology|MP:0008022,dilated heart ventricle|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0031593,decreased cardiac jelly amount
MGI:4836712	Krit1<tm1Sfre>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3842434	Krt10<M1Btlr>	MP:0000410,waved hair
MGI:2652788	Krt10<tm1Der>	MP:0001192,scaly skin|MP:0001208,blistering|MP:0001212,skin lesions|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001242,hyperkeratosis|MP:0011087,neonatal lethality, complete penetrance
MGI:2180882	Krt10<tm1Tmm>	MP:0000020,scaly ears|MP:0000572,abnormal autopod morphology|MP:0000574,abnormal foot pad morphology|MP:0001190,reddish skin|MP:0001192,scaly skin|MP:0001195,flaky skin|MP:0001201,translucent skin|MP:0001208,blistering|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001233,abnormal epidermis suprabasal layer morphology|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001874,acanthosis|MP:0002060,abnormal skin morphology|MP:0002111,abnormal tail morphology|MP:0002406,increased susceptibility to infection|MP:0003089,decreased skin tensile strength|MP:0011087,neonatal lethality, complete penetrance
MGI:3056582	Krt10<tm2Tmm>	MP:0000420,ruffled hair|MP:0000652,enlarged sebaceous gland|MP:0001216,abnormal epidermal layer morphology|MP:0001222,epidermal hyperplasia|MP:0001233,abnormal epidermis suprabasal layer morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0002053,decreased incidence of induced tumors|MP:0002992,abnormal sebaceous lipid secretion|MP:0003849,greasy coat|MP:0009596,abnormal stratum corneum lipid matrix formation|MP:0009600,hypergranulosis|MP:0009606,increased keratohyalin granule size|MP:0013373,increased sebum secretion|MP:0013375,abnormal sebocyte morphology|MP:0013376,abnormal sebocyte differentiation|MP:0014056,increased sebocyte proliferation
MGI:5902155	Krt12<tm1.1(KRT12*L132P)Arte>	MP:0001312,abnormal cornea morphology|MP:0006000,abnormal cornea epithelium morphology|MP:0020854,increased cornea epithelium thickness|MP:0020859,disorganized cornea epithelium
MGI:3051854	Krt12<tm1Wwk>	MP:0006000,abnormal cornea epithelium morphology|MP:0020855,decreased cornea epithelium thickness
MGI:3624816	Krt12<tm3(cre)Wwk>	MP:0002169,no abnormal phenotype detected
MGI:6509649	Krt13<em1Hcha>	MP:0000468,abnormal esophageal epithelium morphology|MP:0000762,abnormal tongue morphology|MP:0000764,abnormal tongue epithelium morphology|MP:0030179,abnormal oral epithelium morphology
MGI:5708279	Krt14<tm1.1(KOMP)Vlcg>	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0001297,microphthalmia|MP:0001914,hemorrhage|MP:0003054,spina bifida|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:2653126	Krt14<tm1Der>	MP:0001208,blistering|MP:0002655,abnormal keratinocyte morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:2429386	Krt14<tm1Efu>	MP:0000467,abnormal esophagus morphology|MP:0001140,abnormal vagina epithelium morphology|MP:0001208,blistering|MP:0001231,abnormal epidermis stratum basale morphology|MP:0002282,abnormal trachea morphology|MP:0002655,abnormal keratinocyte morphology|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020855,decreased cornea epithelium thickness
MGI:3696658	Krt14<tm1(Krt10)Pko>	MP:0001216,abnormal epidermal layer morphology|MP:0001224,abnormal keratinocyte apoptosis|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0002051,increased skin papilloma incidence
MGI:2653130	Krt14<tm2Der>	MP:0001208,blistering|MP:0002655,abnormal keratinocyte morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:3847455	Krt15<tm1(KOMP)Vlcg>	MP:0000466,esophageal epithelium hyperplasia|MP:0001792,impaired wound healing|MP:0005164,abnormal response to injury
MGI:3808273	Krt16<tm1(KOMP)Vlcg>	MP:0000351,increased cell proliferation|MP:0000763,abnormal filiform papillae morphology|MP:0000764,abnormal tongue epithelium morphology|MP:0001200,thick skin|MP:0001212,skin lesions|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0002796,impaired skin barrier function|MP:0009674,decreased birth weight|MP:0010771,integument phenotype|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:7464110	Krt17<em1Cou>	MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging|MP:0010771,integument phenotype|MP:0014693,abnormal cell nucleus size
MGI:5501220	Krt17<tm1.1(KOMP)Vlcg>	MP:0000208,decreased hematocrit|MP:0002833,increased heart weight|MP:0002941,increased circulating alanine transaminase level|MP:0005564,increased hemoglobin content
MGI:2651542	Krt17<tm1Cou>	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000427,abnormal hair cycle|MP:0001284,absent vibrissae|MP:0003413,hair follicle degeneration|MP:0003809,abnormal hair shaft morphology|MP:0003812,abnormal hair medulla|MP:0003848,brittle hair|MP:0005072,abnormal hair follicle melanin granule morphology|MP:0010686,abnormal hair follicle matrix region morphology|MP:0010771,integument phenotype|MP:0011195,increased hair follicle apoptosis
MGI:2178045	Krt18<tm1Tmm>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0001656,focal hepatic necrosis|MP:0001860,liver inflammation|MP:0002628,hepatic steatosis|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003887,increased hepatocyte apoptosis|MP:0003888,liver hemorrhage|MP:0008019,increased liver tumor incidence|MP:0008866,chromosomal instability|MP:0008986,abnormal liver parenchyma morphology|MP:0014045,Mallory bodies
MGI:3760085	Krt19<tm1Alki>	MP:0004179,transmission ratio distortion|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009241,thick sperm flagellum|MP:0009377,ectopic manchette
MGI:3797107	Krt19<tm1(cre/ERT)Ggu>	MP:0002169,no abnormal phenotype detected
MGI:2178046	Krt19<tm2Mmt>	MP:0002169,no abnormal phenotype detected|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6341863	Krt1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001175,abnormal lung morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002631,abnormal epididymis morphology|MP:0002953,thick ventricular wall|MP:0003020,decreased circulating chloride level|MP:0004930,small epididymis|MP:0004952,increased spleen weight|MP:0008045,decreased NK cell number|MP:0010053,decreased grip strength|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013436,increased CD8-positive, naive alpha-beta T cell number|MP:0013772,increased effector memory T-helper cell number
MGI:3655853	Krt1<Mhdadsk12>	MP:0001188,hyperpigmentation|MP:0001192,scaly skin|MP:0001208,blistering|MP:0001230,epidermal desquamation|MP:0001242,hyperkeratosis|MP:0001429,dehydration|MP:0001874,acanthosis|MP:0002095,abnormal skin pigmentation|MP:0011085,postnatal lethality, complete penetrance
MGI:5495252	Krt1<tm1Tmm>	MP:0000886,abnormal cerebellar granule layer morphology|MP:0001263,weight loss|MP:0001622,abnormal vasculogenesis|MP:0002060,abnormal skin morphology|MP:0002429,abnormal blood cell morphology/development|MP:0002796,impaired skin barrier function|MP:0003070,increased vascular permeability|MP:0008568,abnormal interleukin secretion|MP:0008588,abnormal circulating interleukin level|MP:0008635,increased circulating interleukin-18 level|MP:0009594,abnormal corneocyte envelope morphology|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5927759	Krt23<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology
MGI:6151423	Krt25<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0010053,decreased grip strength
MGI:3799750	Krt25<M1Btlr>	MP:0000410,waved hair|MP:0008899,plush coat
MGI:3800570	Krt25<M2Btlr>	MP:0000410,waved hair
MGI:1856137	Krt25<Re>	MP:0000377,abnormal hair follicle morphology|MP:0000399,increased curvature of guard hairs|MP:0000410,waved hair|MP:0000652,enlarged sebaceous gland|MP:0001265,decreased body size|MP:0001274,curly vibrissae|MP:0002074,abnormal hair texture|MP:0003809,abnormal hair shaft morphology|MP:0010179,rough coat|MP:0010685,abnormal hair follicle inner root sheath morphology
MGI:3707007	Krt25<Rgsc573>	MP:0000410,waved hair|MP:0002098,abnormal vibrissa morphology
MGI:6156299	Krt26<em1(IMPC)Kmpc>	MP:0002059,abnormal seminal vesicle morphology|MP:0002110,abnormal digit morphology|MP:0002834,decreased heart weight|MP:0011239,abnormal skin coloration
MGI:6341921	Krt27<em1(IMPC)Ccpcz>	MP:0000162,lordosis|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology
MGI:1856138	Krt27<Re-wc>	MP:0000410,waved hair|MP:0002073,abnormal hair growth|MP:0002098,abnormal vibrissa morphology|MP:0003809,abnormal hair shaft morphology
MGI:3522000	Krt27<stpm>	MP:0000397,abnormal guard hair morphology|MP:0000402,abnormal zigzag hair morphology|MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0010179,rough coat|MP:0010771,integument phenotype
MGI:6341928	Krt28<em1(IMPC)Ccpcz>	MP:0000702,enlarged lymph nodes|MP:0002059,abnormal seminal vesicle morphology|MP:0002339,abnormal lymph node morphology
MGI:2682236	Krt2<Mhdadsk2>	MP:0000575,increased foot pad pigmentation|MP:0001192,scaly skin|MP:0001219,thick epidermis|MP:0002095,abnormal skin pigmentation|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation
MGI:4363845	Krt2<tm1a(KOMP)Wtsi>	MP:0001192,scaly skin|MP:0001222,epidermal hyperplasia|MP:0001233,abnormal epidermis suprabasal layer morphology|MP:0001242,hyperkeratosis|MP:0001874,acanthosis|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0004947,skin inflammation|MP:0009583,increased keratinocyte proliferation|MP:0009599,thick epidermis stratum granulosum|MP:0009600,hypergranulosis|MP:0009675,orthokeratosis|MP:0011278,increased ear pigmentation|MP:0030605,abnormal corneocyte morphology
MGI:5569081	Krt2<tm1b(KOMP)Wtsi>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0008528,polycystic kidney|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4881940	Krt31<tm1e(KOMP)Wtsi>	MP:0001510,abnormal coat appearance
MGI:6341960	Krt32<em1(IMPC)Kmpc>	MP:0001566,increased circulating phosphate level|MP:0002059,abnormal seminal vesicle morphology|MP:0005564,increased hemoglobin content|MP:0005565,increased blood urea nitrogen level|MP:0010124,decreased bone mineral content
MGI:6341917	Krt33a<em1(IMPC)Ccpcz>	MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0011047,increased lung tissue damping
MGI:3800558	Krt33a<Plsh>	MP:0000411,shiny fur
MGI:3800563	Krt33a<Plsh-2Btlr>	MP:0000411,shiny fur
MGI:3834208	Krt33a<Plsh-3Btlr>	MP:0001511,disheveled coat|MP:0003849,greasy coat|MP:0005387,immune system phenotype
MGI:6341937	Krt33b<em1(IMPC)Ccpcz>	MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002135,abnormal kidney morphology|MP:0003604,single kidney|MP:0005011,increased eosinophil cell number
MGI:6367958	Krt34<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001314,cornea opacity|MP:0001402,decreased locomotor activity|MP:0001556,increased circulating HDL cholesterol level|MP:0002339,abnormal lymph node morphology|MP:0003917,increased kidney weight
MGI:6156300	Krt35<em1(IMPC)Kmpc>	MP:0002059,abnormal seminal vesicle morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0011239,abnormal skin coloration
MGI:5882518	Krt36<tm1Hpt>	MP:0000763,abnormal filiform papillae morphology|MP:0001242,hyperkeratosis|MP:0002111,abnormal tail morphology
MGI:6208874	Krt40<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior
MGI:3695408	Krt4<Bcc1>	MP:0000371,diluted coat color|MP:0000762,abnormal tongue morphology|MP:0001732,postnatal growth retardation|MP:0003745,abnormal oral mucosa morphology|MP:0003751,oral leukoplakia|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3620120	Krt4<tm1Rak>	MP:0000466,esophageal epithelium hyperplasia|MP:0000468,abnormal esophageal epithelium morphology|MP:0000471,abnormal stomach epithelium morphology|MP:0000764,abnormal tongue epithelium morphology|MP:0001243,abnormal dermal layer morphology|MP:0002095,abnormal skin pigmentation|MP:0006000,abnormal cornea epithelium morphology|MP:0020854,increased cornea epithelium thickness|MP:0020857,cornea epithelium hyperplasia
MGI:5695976	Krt5<tm1.1(KOMP)Vlcg>	MP:0002339,abnormal lymph node morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2182612	Krt5<tm1Tmm>	MP:0000468,abnormal esophageal epithelium morphology|MP:0000470,abnormal stomach morphology|MP:0000572,abnormal autopod morphology|MP:0000764,abnormal tongue epithelium morphology|MP:0001216,abnormal epidermal layer morphology|MP:0002111,abnormal tail morphology|MP:0003755,abnormal palate morphology|MP:0009546,absent gastric milk in neonates|MP:0011087,neonatal lethality, complete penetrance
MGI:2385807	Krt6a/Krt6b<tm1Cou>	MP:0000467,abnormal esophagus morphology|MP:0000763,abnormal filiform papillae morphology|MP:0000764,abnormal tongue epithelium morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002655,abnormal keratinocyte morphology|MP:0003756,abnormal hard palate morphology|MP:0010771,integument phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0011940,decreased food intake
MGI:2385808	Krt6a/Krt6b<tm1Cou>	MP:0000467,abnormal esophagus morphology|MP:0000763,abnormal filiform papillae morphology|MP:0000764,abnormal tongue epithelium morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002655,abnormal keratinocyte morphology|MP:0003756,abnormal hard palate morphology|MP:0010771,integument phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0011940,decreased food intake
MGI:2386313	Krt6a<tm1Der>	MP:0002908,delayed wound healing
MGI:1855990	Krt71<Ca>	MP:0000410,waved hair|MP:0001274,curly vibrissae
MGI:1857521	Krt71<Ca-14J>	MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0001510,abnormal coat appearance
MGI:1857522	Krt71<Ca-15J>	MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0001510,abnormal coat appearance
MGI:1861608	Krt71<Ca-16J>	MP:0000410,waved hair|MP:0001274,curly vibrissae
MGI:5291635	Krt71<Ca-17J>	MP:0000410,waved hair|MP:0001274,curly vibrissae
MGI:5563234	Krt71<Ca-18J>	MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0005391,vision/eye phenotype
MGI:5586972	Krt71<Ca-19J>	MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0005377,hearing/vestibular/ear phenotype
MGI:5299232	Krt71<Ca-2H>	MP:0000410,waved hair|MP:0001274,curly vibrissae
MGI:1856487	Krt71<Ca-7J>	MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0001510,abnormal coat appearance|MP:0002098,abnormal vibrissa morphology
MGI:1856488	Krt71<Ca-8J>	MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0001510,abnormal coat appearance|MP:0002098,abnormal vibrissa morphology
MGI:1855991	Krt71<Ca-d>	MP:0000410,waved hair|MP:0000418,focal hair loss|MP:0001274,curly vibrissae|MP:0001510,abnormal coat appearance|MP:0009457,whorled hair
MGI:1855992	Krt71<Ca-J>	MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0001510,abnormal coat appearance
MGI:3044780	Krt71<Cal4>	MP:0000377,abnormal hair follicle morphology|MP:0000410,waved hair|MP:0001274,curly vibrissae
MGI:2681032	Krt71<Ca-Rin>	MP:0000377,abnormal hair follicle morphology|MP:0000410,waved hair|MP:0000652,enlarged sebaceous gland|MP:0001199,thin skin|MP:0003849,greasy coat|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0010179,rough coat|MP:0010685,abnormal hair follicle inner root sheath morphology
MGI:7481206	Krt71<em1(IMPC)Bay>	MP:0000367,abnormal coat/ hair morphology|MP:0001510,abnormal coat appearance|MP:0002075,abnormal coat/hair pigmentation
MGI:3693873	Krt71<Mhdarco12>	MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0010685,abnormal hair follicle inner root sheath morphology
MGI:3693874	Krt71<Mhdarco13>	MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0010685,abnormal hair follicle inner root sheath morphology
MGI:2679210	Krt71<rco3>	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0001274,curly vibrissae|MP:0003809,abnormal hair shaft morphology|MP:0003811,abnormal hair cortex morphology|MP:0010202,focal dorsal hair loss|MP:0010685,abnormal hair follicle inner root sheath morphology
MGI:2681099	Krt71<Rgsc689>	MP:0000410,waved hair|MP:0001274,curly vibrissae
MGI:6341947	Krt72<em1(IMPC)Ccpcz>	MP:0000160,kyphosis|MP:0000538,abnormal urinary bladder morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001147,small testis|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0004174,abnormal spine curvature|MP:0009709,hydrometra
MGI:5637188	Krt74<tm1b(EUCOMM)Wtsi>	MP:0002833,increased heart weight
MGI:6276990	Krt75<em1(IMPC)Mbp>	MP:0010024,increased total body fat amount
MGI:3762626	Krt75<tm1Der>	MP:0000377,abnormal hair follicle morphology|MP:0000579,abnormal nail morphology|MP:0002098,abnormal vibrissa morphology|MP:0003809,abnormal hair shaft morphology|MP:0003810,abnormal hair cuticle|MP:0003812,abnormal hair medulla|MP:0010179,rough coat
MGI:4363117	Krt76<tm1a(KOMP)Wtsi>	MP:0000416,sparse hair|MP:0000427,abnormal hair cycle|MP:0000575,increased foot pad pigmentation|MP:0000647,abnormal sebaceous gland morphology|MP:0000652,enlarged sebaceous gland|MP:0001195,flaky skin|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001242,hyperkeratosis|MP:0001510,abnormal coat appearance|MP:0002111,abnormal tail morphology|MP:0003427,parakeratosis|MP:0004947,skin inflammation|MP:0010179,rough coat|MP:0010206,pigment incontinence|MP:0011276,increased tail pigmentation
MGI:5576237	Krt77<em1(IMPC)J>	MP:0005633,increased circulating sodium level
MGI:8187527	Krt77<em1Vbm>	MP:0002169,no abnormal phenotype detected
MGI:5548947	Krt7<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0002702,decreased circulating free fatty acids level
MGI:5488745	Krt7<tm1Whim>	MP:0000351,increased cell proliferation|MP:0010386,abnormal urinary bladder physiology
MGI:5662436	Krt80<em1(IMPC)J>	MP:0001303,abnormal lens morphology|MP:0001314,cornea opacity|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0005560,decreased circulating glucose level
MGI:6324176	Krt86<em1(IMPC)Tcp>	MP:0001200,thick skin|MP:0001417,decreased exploration in new environment
MGI:6286373	Krt87<em1(IMPC)Wtsi>	MP:0005567,decreased circulating total protein level
MGI:5612829	Krt8<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0001417,decreased exploration in new environment|MP:0005292,improved glucose tolerance|MP:0009141,increased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:2178042	Krt8<tm1Rgo>	MP:0000240,extramedullary hematopoiesis|MP:0000488,abnormal intestinal epithelium morphology|MP:0000493,rectal prolapse|MP:0000495,abnormal colon morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001634,internal hemorrhage|MP:0001654,hepatic necrosis|MP:0001670,abnormal intestinal mineral absorption|MP:0001711,abnormal placenta morphology|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0002499,chronic inflammation|MP:0002628,hepatic steatosis|MP:0003888,liver hemorrhage|MP:0004264,abnormal extraembryonic tissue physiology|MP:0005031,abnormal trophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0005036,diarrhea|MP:0006372,impaired placental function|MP:0009429,decreased embryo weight|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0014682,increased polyploid hepatocyte number
MGI:5784550	Krt90<em1(IMPC)J>	MP:0001406,abnormal gait
MGI:3526848	Krt90<whnl>	MP:0000579,abnormal nail morphology|MP:0000583,long toenails|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0010102,increased caudal vertebrae number|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5572043	Krt9<tm1.1(KOMP)Vlcg>	MP:0008810,increased circulating iron level
MGI:4460538	Krt9<tm1(KOMP)Vlcg>	MP:0000574,abnormal foot pad morphology|MP:0001188,hyperpigmentation|MP:0001200,thick skin|MP:0001208,blistering|MP:0001219,thick epidermis|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001242,hyperkeratosis|MP:0001874,acanthosis|MP:0002051,increased skin papilloma incidence|MP:0002655,abnormal keratinocyte morphology|MP:0003717,pallor|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0009583,increased keratinocyte proliferation|MP:0009931,abnormal skin appearance
MGI:7385113	Krtap1-3<em1(IMPC)J>	MP:0000063,decreased bone mineral density
MGI:5692751	Krtap17-1<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0000186,decreased circulating HDL cholesterol level|MP:0000367,abnormal coat/ hair morphology|MP:0001192,scaly skin|MP:0001200,thick skin|MP:0001402,decreased locomotor activity|MP:0001510,abnormal coat appearance|MP:0002060,abnormal skin morphology|MP:0003917,increased kidney weight|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0010025,decreased total body fat amount
MGI:6385271	Krtap7-1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus
MGI:6341867	Krtap8-1<em1(IMPC)Ccpcz>	MP:0000162,lordosis|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001120,abnormal uterus morphology|MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0001489,decreased startle reflex|MP:0002311,abnormal inspiratory capacity|MP:0008040,decreased NK T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0009709,hydrometra|MP:0013764,decreased T-helper cell number
MGI:7425787	Krtap9-3<em1(IMPC)Bay>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0002797,increased thigmotaxis|MP:0004924,abnormal behavior|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6341857	Krtap9-5<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002100,abnormal tooth morphology|MP:0002135,abnormal kidney morphology|MP:0003917,increased kidney weight|MP:0013129,abnormal tooth color
MGI:6284515	Krtcap2<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0001556,increased circulating HDL cholesterol level|MP:0002574,increased vertical activity|MP:0004738,abnormal auditory brainstem response|MP:0004924,abnormal behavior|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0005632,decreased circulating aspartate transaminase level|MP:0005635,decreased circulating bilirubin level|MP:0020870,decreased thigmotaxis
MGI:2668901	Ksc1<C57BL/6NCrl>	MP:0002655,abnormal keratinocyte morphology
MGI:2668903	Ksc2<BALB/cAnNCrl>	MP:0002655,abnormal keratinocyte morphology
MGI:2670726	Ksr1<tm1Kole>	MP:0000352,decreased cell proliferation|MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000383,abnormal hair follicle orientation|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000427,abnormal hair cycle|MP:0001208,blistering|MP:0002006,neoplasm|MP:0003704,abnormal hair follicle development|MP:0003809,abnormal hair shaft morphology|MP:0005621,abnormal cell physiology|MP:0010685,abnormal hair follicle inner root sheath morphology
MGI:2387975	Ksr1<tm1Shaw>	MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002063,abnormal learning/memory/conditioning|MP:0003436,decreased susceptibility to induced arthritis|MP:0005076,abnormal cell differentiation|MP:0005095,decreased T cell proliferation|MP:0005386,behavior/neurological phenotype|MP:0006094,increased fat cell size|MP:0008414,abnormal spatial reference memory|MP:0009131,decreased white fat cell number|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior
MGI:5688498	Ksr2<m1Btlr>	MP:0001260,increased body weight
MGI:5429039	Ksr2<tm1Lex>	MP:0001261,obese|MP:0005458,increased percent body fat/body weight
MGI:5429066	Ksr2<tm2.1Lex>	MP:0001261,obese|MP:0005458,increased percent body fat/body weight
MGI:5708227	Kti12<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2183361	Ktn1<tm1.1Kpf>	MP:0002169,no abnormal phenotype detected
MGI:2183362	Ktn1<tm1.2Kpf>	MP:0002169,no abnormal phenotype detected
MGI:1861135	Kw	MP:0000585,kinked tail|MP:0001516,abnormal motor coordination/balance
MGI:3698769	Kwq13<CAST/EiJ>	MP:0003917,increased kidney weight
MGI:3698798	Kwq15<CAST/EiJ>	MP:0003918,decreased kidney weight
MGI:5466155	Kxd1<tm1Wli>	MP:0005384,cellular phenotype|MP:0010192,abnormal retina melanin granule morphology|MP:0010193,abnormal choroid melanin granule morphology|MP:0020432,decreased platelet dense granule number
MGI:5692699	Kyat1<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005419,decreased circulating serum albumin level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration|MP:0011965,decreased total retina thickness
MGI:6407422	Ky<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0000745,tremors|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001523,impaired righting response|MP:0004924,abnormal behavior|MP:0005559,increased circulating glucose level|MP:0010052,increased grip strength|MP:0010053,decreased grip strength
MGI:1856928	Ky<ky>	MP:0000069,kyphoscoliosis|MP:0000160,kyphosis|MP:0000749,muscle degeneration|MP:0000759,abnormal skeletal muscle morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001526,abnormal placing response|MP:0001921,reduced fertility|MP:0001951,abnormal breathing pattern|MP:0002269,muscular atrophy|MP:0002841,impaired skeletal muscle contractility|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003631,nervous system phenotype|MP:0003852,skeletal muscle necrosis|MP:0004243,abnormal motor nerve collateral sprouting|MP:0004684,intervertebral disk degeneration|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0006392,abnormal nucleus pulposus morphology|MP:0006393,absent nucleus pulposus|MP:0009424,decreased extensor digitorum longus weight|MP:0009426,decreased soleus weight
MGI:6285803	Kynu<em1Dunw>	MP:0000111,cleft palate|MP:0000137,abnormal vertebrae morphology|MP:0000266,abnormal heart morphology|MP:0000564,syndactyly|MP:0000576,clubfoot|MP:0001672,abnormal embryo development|MP:0002989,small kidney|MP:0003718,maternal effect|MP:0013242,abnormal amino acid metabolism
MGI:5827722	Kynu<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001304,cataract|MP:0001417,decreased exploration in new environment|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0005344,increased circulating bilirubin level
MGI:2448838	l10R1<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2448792	l10R2<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2448815	l10R3<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2448814	l10R4<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:3053576	l10R5<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:3053575	l10R6<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:3053574	l10R7<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:3053571	l10R8<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2671881	l11Jus10	MP:0011089,perinatal lethality, complete penetrance
MGI:2671882	l11Jus11	MP:0001694,absent egg cylinders|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2671883	l11Jus12	MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2671885	l11Jus14	MP:0001726,abnormal allantois morphology|MP:0003984,embryonic growth retardation|MP:0006065,abnormal heart position or orientation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2671887	l11Jus16	MP:0000269,abnormal heart looping|MP:0000284,double outlet right ventricle|MP:0000644,dextrocardia|MP:0002081,perinatal lethality|MP:0002766,situs inversus|MP:0004110,transposition of great arteries|MP:0010412,atrioventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011090,perinatal lethality, incomplete penetrance
MGI:2671888	l11Jus17	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2671889	l11Jus18	MP:0001914,hemorrhage|MP:0002088,abnormal embryonic growth/weight/body size|MP:0002128,abnormal blood circulation|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2671890	l11Jus19	MP:0000291,enlarged pericardium|MP:0002127,abnormal cardiovascular system morphology|MP:0002128,abnormal blood circulation|MP:0005244,hemopericardium|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2671872	l11Jus2	MP:0001694,absent egg cylinders|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2671891	l11Jus20	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2671892	l11Jus21	MP:0011086,postnatal lethality, incomplete penetrance
MGI:2671893	l11Jus22	MP:0011089,perinatal lethality, complete penetrance
MGI:2671894	l11Jus23	MP:0011089,perinatal lethality, complete penetrance
MGI:2671896	l11Jus24	MP:0011089,perinatal lethality, complete penetrance
MGI:2671897	l11Jus25	MP:0011100,preweaning lethality, complete penetrance
MGI:2671898	l11Jus26	MP:0011100,preweaning lethality, complete penetrance
MGI:2671899	l11Jus27	MP:0000267,abnormal heart development|MP:0002127,abnormal cardiovascular system morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2671900	l11Jus28	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2671901	l11Jus29	MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2671873	l11Jus3	MP:0001696,failure to gastrulate|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0003085,abnormal egg cylinder morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology
MGI:2671902	l11Jus30	MP:0011089,perinatal lethality, complete penetrance
MGI:2671903	l11Jus31	MP:0011089,perinatal lethality, complete penetrance
MGI:2671904	l11Jus32	MP:0011089,perinatal lethality, complete penetrance
MGI:2671906	l11Jus33	MP:0011089,perinatal lethality, complete penetrance
MGI:2671907	l11Jus34	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2671908	l11Jus35	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2671909	l11Jus36	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2671910	l11Jus37	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2671911	l11Jus38	MP:0001683,absent mesoderm|MP:0001696,failure to gastrulate|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2671912	l11Jus39	MP:0001914,hemorrhage|MP:0003400,kinked neural tube|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2671913	l11Jus40	MP:0011089,perinatal lethality, complete penetrance
MGI:2671914	l11Jus41	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2671915	l11Jus42	MP:0003085,abnormal egg cylinder morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology
MGI:2671916	l11Jus43	MP:0011089,perinatal lethality, complete penetrance
MGI:2671917	l11Jus44	MP:0011089,perinatal lethality, complete penetrance
MGI:2671918	l11Jus45	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2671919	l11Jus46	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2671920	l11Jus47	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2671921	l11Jus48	MP:0000585,kinked tail|MP:0002111,abnormal tail morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3034009	l11Jus49	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2671876	l11Jus5	MP:0002086,abnormal extraembryonic tissue morphology|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3034010	l11Jus50	MP:0001891,hydrocephaly|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2671923	l11Jus52	MP:0000428,abnormal craniofacial morphology|MP:0001265,decreased body size|MP:0011085,postnatal lethality, complete penetrance
MGI:2671924	l11Jus53	MP:0000428,abnormal craniofacial morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:2671925	l11Jus54	MP:0000428,abnormal craniofacial morphology|MP:0001265,decreased body size|MP:0011085,postnatal lethality, complete penetrance
MGI:2671926	l11Jus55	MP:0000428,abnormal craniofacial morphology|MP:0001265,decreased body size|MP:0011085,postnatal lethality, complete penetrance
MGI:2671927	l11Jus56	MP:0001265,decreased body size|MP:0011085,postnatal lethality, complete penetrance
MGI:2671928	l11Jus57	MP:0011089,perinatal lethality, complete penetrance
MGI:3034011	l11Jus58	MP:0011091,prenatal lethality, complete penetrance
MGI:3043663	l11Jus59	MP:0011100,preweaning lethality, complete penetrance
MGI:2671877	l11Jus6	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2671878	l11Jus7	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4999624	l11Jus74	MP:0011089,perinatal lethality, complete penetrance
MGI:2671880	l11Jus9	MP:0000783,abnormal forebrain morphology|MP:0001622,abnormal vasculogenesis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2670848	l15R10<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:3053572	l15R11<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2448818	l15R1<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:3053573	l15R12<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2448843	l15R2<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2448789	l15R7<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2448804	l15R8<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2448860	l15R9<1R>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1889534	l17Pas2	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5295191	L1cam<tm1.1Pfm>	MP:0003631,nervous system phenotype|MP:0005404,abnormal axon morphology|MP:0008056,abnormal retina ganglion cell morphology|MP:0014750,abnormal retinal ganglion cell axon guidance
MGI:3040294	L1cam<tm1.1Vlem>	MP:0001891,hydrocephaly|MP:0003631,nervous system phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2682895	L1cam<tm1Fmo>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0002206,abnormal CNS synaptic transmission|MP:0002574,increased vertical activity
MGI:2181735	L1cam<tm1Mtei>	MP:0000439,enlarged cranium|MP:0000807,abnormal hippocampus morphology|MP:0001106,abnormal Schwann cell morphology|MP:0001265,decreased body size|MP:0001524,impaired limb coordination|MP:0001891,hydrocephaly|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002733,abnormal thermal nociception|MP:0002882,abnormal neuron morphology|MP:0003631,nervous system phenotype|MP:0005316,abnormal response to tactile stimuli|MP:0005537,abnormal cerebral aqueduct morphology|MP:0006198,enophthalmos|MP:0006254,thin cerebral cortex|MP:0010053,decreased grip strength|MP:0011380,enlarged brain ventricles|MP:0012484,decreased corticospinal tract size|MP:0014185,cerebellum atrophy
MGI:1857443	L1cam<tm1Sor>	MP:0000583,long toenails|MP:0000755,hindlimb paralysis|MP:0000825,dilated lateral ventricle|MP:0000828,abnormal fourth ventricle morphology|MP:0000849,abnormal cerebellum morphology|MP:0000866,cerebellum vermis hypoplasia|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001349,excessive tearing|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001925,male infertility|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002075,abnormal coat/hair pigmentation|MP:0002152,abnormal brain morphology|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002797,increased thigmotaxis|MP:0002878,abnormal corticospinal tract morphology|MP:0002961,abnormal axon guidance|MP:0003631,nervous system phenotype|MP:0003651,abnormal axon extension|MP:0005389,reproductive system phenotype|MP:0005423,abnormal somatic nervous system physiology|MP:0005537,abnormal cerebral aqueduct morphology|MP:0006198,enophthalmos|MP:0006282,abnormal spinal cord dorsal horn morphology|MP:0008489,slow postnatal weight gain|MP:0008534,enlarged fourth ventricle|MP:0010768,mortality/aging|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3624137	L1cam<tm1(tTA)Msch>	MP:0000439,enlarged cranium|MP:0000807,abnormal hippocampus morphology|MP:0000822,abnormal brain ventricle morphology|MP:0001265,decreased body size|MP:0001360,abnormal social investigation|MP:0001441,increased grooming behavior|MP:0001891,hydrocephaly|MP:0005386,behavior/neurological phenotype|MP:0005537,abnormal cerebral aqueduct morphology|MP:0006254,thin cerebral cortex|MP:0011275,abnormal behavioral response to light|MP:0014185,cerebellum atrophy
MGI:5491824	L1cam<tm2.1Vlem>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging
MGI:5491825	L1cam<tm3.1Vlem>	MP:0001405,impaired coordination|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008415,abnormal neurite morphology|MP:0010768,mortality/aging
MGI:5491826	L1cam<tm4.1Vlem>	MP:0001405,impaired coordination|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008415,abnormal neurite morphology|MP:0010768,mortality/aging
MGI:3027871	l1Rk1	MP:0011092,embryonic lethality, complete penetrance
MGI:3027872	l1Rk2	MP:0011089,perinatal lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance
MGI:1933755	l1Rk3	MP:0002080,prenatal lethality
MGI:3027873	l1Rk4	MP:0011089,perinatal lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance
MGI:3027874	l1Rk5	MP:0011100,preweaning lethality, complete penetrance
MGI:3027875	l1Rk6	MP:0011092,embryonic lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:3027876	l1Rk7	MP:0011100,preweaning lethality, complete penetrance
MGI:3027877	l1Rk8	MP:0011100,preweaning lethality, complete penetrance
MGI:5008637	L1td1<tm1Yam>	MP:0002169,no abnormal phenotype detected
MGI:6156560	L2hgdh<em1(IMPC)Tcp>	MP:0001258,decreased body length|MP:0001417,decreased exploration in new environment|MP:0001925,male infertility|MP:0002092,abnormal eye morphology
MGI:3869865	L2hgdh<Gt(DC0625)Wtsi>	MP:0000953,abnormal oligodendrocyte morphology|MP:0002152,abnormal brain morphology|MP:0002574,increased vertical activity|MP:0002899,fatigue|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003634,abnormal glial cell morphology|MP:0003871,abnormal myelin sheath morphology|MP:0005332,abnormal amino acid level|MP:0008428,abnormal spatial working memory|MP:0011617,abnormal habituation|MP:0012307,impaired spatial learning|MP:0031391,increased locomotor activity
MGI:4840260	L3mbtl1<tm1.1Haho>	MP:0003631,nervous system phenotype|MP:0005384,cellular phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0010768,mortality/aging
MGI:5810650	L3mbtl2<tm1.2Haho>	MP:0001672,abnormal embryo development|MP:0003886,abnormal embryonic epiblast morphology|MP:0003984,embryonic growth retardation|MP:0006207,embryonic lethality during organogenesis
MGI:5472695	L3mbtl2<tm2a(EUCOMM)Wtsi>	MP:0003036,vertebral transformation|MP:0005031,abnormal trophoblast layer morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5754603	L3mbtl3<em2(IMPC)Tcp>	MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0001552,increased circulating triglyceride level|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0002060,abnormal skin morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:3579468	L3mbtl3<tm1Tmiy>	MP:0001577,anemia|MP:0002123,abnormal definitive hematopoiesis|MP:0011089,perinatal lethality, complete penetrance
MGI:3033967	l4Jus1	MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3033980	l4Jus10	MP:0011100,preweaning lethality, complete penetrance
MGI:3033981	l4Jus11	MP:0001683,absent mesoderm|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3033982	l4Jus12	MP:0002075,abnormal coat/hair pigmentation|MP:0002192,hydrops fetalis|MP:0011089,perinatal lethality, complete penetrance
MGI:3033983	l4Jus13	MP:0011089,perinatal lethality, complete penetrance
MGI:3033984	l4Jus14	MP:0011089,perinatal lethality, complete penetrance
MGI:3033985	l4Jus15	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3033986	l4Jus16	MP:0011100,preweaning lethality, complete penetrance
MGI:3033987	l4Jus17	MP:0011100,preweaning lethality, complete penetrance
MGI:3033988	l4Jus18	MP:0011100,preweaning lethality, complete penetrance
MGI:3033989	l4Jus19	MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:3033972	l4Jus2	MP:0000266,abnormal heart morphology|MP:0000913,abnormal brain development|MP:0000929,open neural tube|MP:0000934,abnormal telencephalon development|MP:0001688,abnormal somite development|MP:0001726,abnormal allantois morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3033990	l4Jus20	MP:0011089,perinatal lethality, complete penetrance
MGI:3033991	l4Jus21	MP:0011100,preweaning lethality, complete penetrance
MGI:3038760	l4Jus22	MP:0011091,prenatal lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:3043664	l4Jus23	MP:0011092,embryonic lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:3043665	l4Jus24	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:3046735	l4Jus25	MP:0000267,abnormal heart development|MP:0001698,decreased embryo size|MP:0001787,pericardial edema|MP:0002083,premature death|MP:0002127,abnormal cardiovascular system morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3577468	l4Jus26	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0003984,embryonic growth retardation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3577469	l4Jus27	MP:0011092,embryonic lethality, complete penetrance
MGI:3577470	l4Jus28	MP:0000428,abnormal craniofacial morphology|MP:0002127,abnormal cardiovascular system morphology|MP:0004188,delayed embryo turning|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3577471	l4Jus29	MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0003984,embryonic growth retardation|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance
MGI:3033973	l4Jus3	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3577472	l4Jus30	MP:0000428,abnormal craniofacial morphology|MP:0000934,abnormal telencephalon development|MP:0001698,decreased embryo size|MP:0002083,premature death|MP:0003984,embryonic growth retardation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3577474	l4Jus31	MP:0001265,decreased body size|MP:0002083,premature death|MP:0004924,abnormal behavior
MGI:3033974	l4Jus4	MP:0011100,preweaning lethality, complete penetrance
MGI:3033975	l4Jus5	MP:0011100,preweaning lethality, complete penetrance
MGI:3033976	l4Jus6	MP:0011100,preweaning lethality, complete penetrance
MGI:3033977	l4Jus7	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3033978	l4Jus8	MP:0011100,preweaning lethality, complete penetrance
MGI:3033979	l4Jus9	MP:0002085,abnormal embryonic tissue morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0014586,decreased egg cylinder size
MGI:2448839	l7R10<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2448837	l7R11<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2448836	l7R12<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2448842	l7R14<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2448800	l7R15<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2448840	l7R16<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2448841	l7R18<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2448819	l7R19<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2449595	l7R4<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2449597	l7R5<1R>	MP:0011085,postnatal lethality, complete penetrance
MGI:2448846	l7R7<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2448816	l7R8<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2448844	l7R9<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2448845	l7R9<2R>	MP:0011091,prenatal lethality, complete penetrance
MGI:3027884	l7Rk1	MP:0011100,preweaning lethality, complete penetrance
MGI:1856527	l7Rl2	MP:0006204,embryonic lethality before implantation
MGI:2449618	l7Rn1<1R>	MP:0011100,preweaning lethality, complete penetrance
MGI:2449620	l7Rn2<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2449624	l7Rn2<2R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2449625	l7Rn2<3R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2449646	l7Rn4<1R>	MP:0011091,prenatal lethality, complete penetrance
MGI:2449648	l7Rn4<2R>	MP:0011091,prenatal lethality, complete penetrance
MGI:6117843	Lacc1<em1Arkr>	MP:0002451,abnormal macrophage physiology|MP:0003186,abnormal redox activity|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008734,decreased susceptibility to endotoxin shock
MGI:6118040	Lacc1<em2Arkr>	MP:0002451,abnormal macrophage physiology|MP:0003186,abnormal redox activity|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008734,decreased susceptibility to endotoxin shock
MGI:6118041	Lacc1<em3Arkr>	MP:0002451,abnormal macrophage physiology|MP:0003186,abnormal redox activity|MP:0008641,increased circulating interleukin-1 beta level|MP:0008735,increased susceptibility to endotoxin shock
MGI:6118042	Lacc1<em4Arkr>	MP:0002451,abnormal macrophage physiology|MP:0003186,abnormal redox activity|MP:0008641,increased circulating interleukin-1 beta level|MP:0008735,increased susceptibility to endotoxin shock
MGI:4451304	Lacc1<tm1a(KOMP)Wtsi>	MP:0002446,abnormal macrophage morphology|MP:0002451,abnormal macrophage physiology|MP:0003186,abnormal redox activity|MP:0005282,decreased fatty acids level|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008658,decreased interleukin-1 beta secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0010954,abnormal cellular respiration|MP:0010959,abnormal oxidative phosphorylation
MGI:3820618	Lacrr1<129S2/SvHsd>	MP:0004022,abnormal cone electrophysiology
MGI:3793472	Lactb2<Tg(Igh-Meis1)2770Amb>	MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0001191,abnormal skin condition|MP:0001265,decreased body size|MP:0001511,disheveled coat|MP:0001614,abnormal blood vessel morphology|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0005202,lethargy|MP:0005334,abnormal fat pad morphology|MP:0005389,reproductive system phenotype|MP:0013317,abnormal seminal vesicle development|MP:0031116,microvesicular hepatic steatosis
MGI:8187926	Lactb<em1Susz>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0002136,abnormal kidney physiology|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0003917,increased kidney weight|MP:0005165,increased susceptibility to injury|MP:0005293,impaired glucose tolerance|MP:0005565,increased blood urea nitrogen level|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0013242,abnormal amino acid metabolism|MP:0013279,increased fasting circulating glucose level
MGI:5613656	Lactb<tm1.1(KOMP)Mbp>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000274,enlarged heart|MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0005179,decreased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0010097,abnormal retina blood vessel morphology
MGI:6188309	Lag3<tm1Daav>	MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0013762,abnormal effector T cell number
MGI:2176269	Lag3<tm1Doi>	MP:0000691,enlarged spleen|MP:0001515,abnormal grip strength|MP:0001905,abnormal dopamine level|MP:0001961,abnormal reflex|MP:0002444,abnormal T cell physiology|MP:0003243,abnormal dopaminergic neuron morphology|MP:0003447,decreased tumor growth/size|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0008493,alpha-synuclein inclusion body|MP:0010766,abnormal NK cell physiology
MGI:6257568	Lage3<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000219,increased neutrophil cell number
MGI:6693758	Laidx<em1.1Jbmu>	MP:0005389,reproductive system phenotype
MGI:6693759	Laidx<em1.2Jbmu>	MP:0005389,reproductive system phenotype
MGI:5308465	Lair1<tm1.1Jco>	MP:0000715,decreased thymocyte number|MP:0001829,increased activated T cell number|MP:0005011,increased eosinophil cell number|MP:0005014,increased B cell number|MP:0005505,thrombocytosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008126,increased dendritic cell number|MP:0008181,increased marginal zone B cell number|MP:0008495,decreased IgG1 level|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010835,increased CD4-positive, alpha-beta memory T cell number|MP:0010838,increased CD8-positive, alpha-beta memory T cell number
MGI:5308462	Lair1<tm1Jco>	MP:0002169,no abnormal phenotype detected|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level
MGI:3513837	Lalba<tm1.1(LALBA)Asty>	MP:0002169,no abnormal phenotype detected
MGI:3513836	Lalba<tm1Asty>	MP:0004047,abnormal milk composition
MGI:3513842	Lalba<tm1Jvt>	MP:0000627,abnormal mammary gland morphology|MP:0004047,abnormal milk composition
MGI:3046686	Lama1<GT(PST008)Byg>	MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011116,absent Reichert's membrane
MGI:4455292	Lama1<nmf223>	MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002864,abnormal ocular fundus morphology|MP:0003381,vitreal fibroplasia|MP:0005547,abnormal Muller cell morphology|MP:0005551,abnormal eye electrophysiology|MP:0008507,thin retina ganglion layer|MP:0008511,thin retina inner nuclear layer|MP:0010097,abnormal retina blood vessel morphology|MP:0010098,abnormal retina blood vessel pattern|MP:0010235,abnormal retina inner limiting membrane morphology|MP:0012671,retina spots
MGI:5426811	Lama1<tm1.1Arhi>	MP:0002169,no abnormal phenotype detected
MGI:3530457	Lama1<tm1.1Ekb>	MP:0002663,absent blastocoele|MP:0003954,abnormal Reichert's membrane morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011116,absent Reichert's membrane
MGI:3611213	Lama1<tm1.1Olf>	MP:0003984,embryonic growth retardation|MP:0005032,abnormal ectoplacental cone morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011116,absent Reichert's membrane|MP:0011186,abnormal visceral endoderm morphology|MP:0011187,abnormal parietal endoderm morphology|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5426812	Lama1<tm1.2Arhi>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011116,absent Reichert's membrane
MGI:3530455	Lama1<tm1Ekb>	MP:0002663,absent blastocoele|MP:0003954,abnormal Reichert's membrane morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011116,absent Reichert's membrane
MGI:3611212	Lama1<tm1Olf>	MP:0001289,persistence of hyaloid vascular system|MP:0001296,macrophthalmia|MP:0002169,no abnormal phenotype detected|MP:0002792,abnormal retina vasculature morphology|MP:0002864,abnormal ocular fundus morphology|MP:0003381,vitreal fibroplasia|MP:0005389,reproductive system phenotype|MP:0005547,abnormal Muller cell morphology|MP:0006069,abnormal retina neuronal layer morphology|MP:0008511,thin retina inner nuclear layer|MP:0008513,thin retina inner plexiform layer|MP:0008518,retina outer nuclear layer degeneration|MP:0009674,decreased birth weight|MP:0010097,abnormal retina blood vessel morphology|MP:0010098,abnormal retina blood vessel pattern|MP:0010235,abnormal retina inner limiting membrane morphology|MP:0010768,mortality/aging|MP:0012671,retina spots
MGI:5613672	Lama1<tm2b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0002792,abnormal retina vasculature morphology|MP:0002941,increased circulating alanine transaminase level|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:1856026	Lama2<dy>	MP:0000032,cochlear degeneration|MP:0000034,abnormal inner ear vestibule morphology|MP:0000042,abnormal organ of Corti morphology|MP:0000160,kyphosis|MP:0000161,scoliosis|MP:0000438,abnormal cranium morphology|MP:0000441,increased cranium width|MP:0000747,muscle weakness|MP:0000748,progressive muscle weakness|MP:0000751,myopathy|MP:0000752,dystrophic muscle|MP:0000754,paresis|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001106,abnormal Schwann cell morphology|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001516,abnormal motor coordination/balance|MP:0001547,abnormal lipid level|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002175,decreased brain weight|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002566,abnormal sexual interaction|MP:0002622,abnormal cochlear hair cell morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003851,skeletal muscle interstitial fibrosis|MP:0003982,increased cholesterol level|MP:0004121,abnormal sarcolemma morphology|MP:0004272,abnormal basement membrane morphology|MP:0004273,abnormal basal lamina morphology|MP:0004289,abnormal bony labyrinth|MP:0004300,abnormal organ of Corti supporting cell morphology|MP:0004325,absent vestibular hair cells|MP:0004363,stria vascularis degeneration|MP:0004405,absent cochlear hair cells|MP:0004716,abnormal cochlear nerve morphology|MP:0004768,abnormal axonal transport|MP:0004852,decreased testis weight|MP:0005124,increased circulating prolactin level|MP:0005150,cachexia|MP:0008814,decreased nerve conduction velocity|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009406,decreased skeletal muscle fiber number|MP:0009414,skeletal muscle fiber necrosis|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013239,impaired skeletal muscle regeneration|MP:0020380,abnormal galactolipid level|MP:0030979,decreased spinal cord weight
MGI:1856027	Lama2<dy-2J>	MP:0000438,abnormal cranium morphology|MP:0000441,increased cranium width|MP:0000752,dystrophic muscle|MP:0000755,hindlimb paralysis|MP:0000920,abnormal myelination|MP:0001262,decreased body weight|MP:0001475,reduced long-term depression|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0002880,opisthotonus|MP:0003008,enhanced long-term potentiation|MP:0004273,abnormal basal lamina morphology|MP:0005389,reproductive system phenotype|MP:0009403,increased variability of skeletal muscle fiber size|MP:0020452,abnormal axon radial sorting|MP:0031318,enhanced skeletal muscle regeneration
MGI:1857890	Lama2<dy-6J>	MP:0000160,kyphosis|MP:0000748,progressive muscle weakness|MP:0000752,dystrophic muscle|MP:0001393,ataxia
MGI:3581452	Lama2<dy-7J>	MP:0000743,muscle spasm|MP:0000751,myopathy|MP:0000752,dystrophic muscle|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001262,decreased body weight|MP:0001513,limb grasping|MP:0004273,abnormal basal lamina morphology|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009420,skeletal muscle endomysial fibrosis|MP:0010768,mortality/aging|MP:0031204,hindlimb paresis|MP:0031318,enhanced skeletal muscle regeneration
MGI:3848931	Lama2<dy-8J>	MP:0000751,myopathy|MP:0000755,hindlimb paralysis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6220701	Lama2<dy-Pas>	MP:0000069,kyphoscoliosis|MP:0000752,dystrophic muscle|MP:0000759,abnormal skeletal muscle morphology|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001961,abnormal reflex|MP:0002083,premature death|MP:0002566,abnormal sexual interaction|MP:0002932,abnormal joint morphology|MP:0005150,cachexia|MP:0005426,tachypnea|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009414,skeletal muscle fiber necrosis|MP:0030798,joint contracture
MGI:3522319	Lama2<tm1Eeng>	MP:0000747,muscle weakness|MP:0000749,muscle degeneration|MP:0000752,dystrophic muscle|MP:0000755,hindlimb paralysis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001513,limb grasping|MP:0002083,premature death|MP:0004510,myositis|MP:0005656,decreased aggression|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0013239,impaired skeletal muscle regeneration
MGI:2153004	Lama2<tm1Stk>	MP:0000711,thymus cortex hypoplasia|MP:0000743,muscle spasm|MP:0000751,myopathy|MP:0000752,dystrophic muscle|MP:0000759,abnormal skeletal muscle morphology|MP:0001146,abnormal testis morphology|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002216,abnormal seminiferous tubule morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003763,abnormal thymus physiology|MP:0004272,abnormal basement membrane morphology|MP:0004273,abnormal basal lamina morphology|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009543,abnormal thymus corticomedullary boundary morphology|MP:0014633,decreased spermatid number
MGI:5825195	Lama3<tm1.1Grsb>	MP:0001861,lung inflammation|MP:0005166,decreased susceptibility to injury|MP:0008469,abnormal protein level|MP:0008721,abnormal chemokine level|MP:0008752,abnormal tumor necrosis factor level|MP:0010936,decreased airway resistance|MP:0010950,abnormal lung hysteresivity|MP:0014226,abnormal alveolar macrophage physiology|MP:0014228,increased alveolar macrophage number|MP:0020253,increased collagen level|MP:0020344,abnormal susceptibility to injury induced morbidity/mortality
MGI:6121104	Lama3<tm1Arte>	MP:0000383,abnormal hair follicle orientation|MP:0000579,abnormal nail morphology|MP:0001200,thick skin|MP:0001208,blistering|MP:0001265,decreased body size|MP:0004947,skin inflammation|MP:0008854,bleb|MP:0009932,skin fibrosis|MP:0011160,dermal-epidermal separation|MP:0020253,increased collagen level
MGI:2154553	Lama3<tm1Crt>	MP:0001208,blistering|MP:0001216,abnormal epidermal layer morphology|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001235,disorganized suprabasal layer|MP:0001262,decreased body weight|MP:0002576,abnormal enamel morphology|MP:0002650,abnormal ameloblast morphology|MP:0002691,small stomach|MP:0011085,postnatal lethality, complete penetrance
MGI:5695884	Lama4<tm1.1(KOMP)Vlcg>	MP:0001314,cornea opacity|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002606,increased basophil cell number|MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2179127	Lama4<tm1Ktry>	MP:0000208,decreased hematocrit|MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000611,jaundice|MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0001107,decreased Schwann cell number|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001513,limb grasping|MP:0001522,impaired swimming|MP:0001524,impaired limb coordination|MP:0001525,impaired balance|MP:0001569,abnormal circulating bilirubin level|MP:0001577,anemia|MP:0001614,abnormal blood vessel morphology|MP:0001625,cardiac hypertrophy|MP:0001633,poor circulation|MP:0001634,internal hemorrhage|MP:0001914,hemorrhage|MP:0002625,heart left ventricle hypertrophy|MP:0002640,reticulocytosis|MP:0002651,abnormal sciatic nerve morphology|MP:0002753,dilated heart left ventricle|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003044,impaired basement membrane formation|MP:0003658,abnormal capillary morphology|MP:0003717,pallor|MP:0003871,abnormal myelin sheath morphology|MP:0003993,abnormal ventral spinal root morphology|MP:0003994,abnormal dorsal spinal root morphology|MP:0004120,cardiac ischemia|MP:0004122,abnormal sinus arrhythmia|MP:0004564,increased myocardial fiber size|MP:0004566,myocardial fiber degeneration|MP:0005039,hypoxia|MP:0005202,lethargy|MP:0005330,cardiomyopathy|MP:0005333,decreased heart rate|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011088,neonatal lethality, incomplete penetrance|MP:0020326,dilated capillary|MP:0020452,abnormal axon radial sorting
MGI:5646299	Lama5<b2b2966.1Clo>	MP:0000024,lowered ear position|MP:0000284,double outlet right ventricle|MP:0000484,abnormal pulmonary artery morphology|MP:0000520,absent kidney|MP:0000564,syndactyly|MP:0000572,abnormal autopod morphology|MP:0000650,mesocardia|MP:0000914,exencephaly|MP:0001265,decreased body size|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001823,thymus hypoplasia|MP:0002633,persistent truncus arteriosus|MP:0002705,dilated renal tubule|MP:0003051,curly tail|MP:0003178,left pulmonary isomerism|MP:0003675,kidney cyst|MP:0004157,interrupted aortic arch|MP:0004158,right aortic arch|MP:0004733,abnormal thoracic cavity morphology|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010460,pulmonary artery hypoplasia|MP:0010466,vascular ring|MP:0010487,abnormal right subclavian artery morphology
MGI:3624772	Lama5<Gt1Jhm>	MP:0000116,abnormal tooth development|MP:0000432,abnormal head morphology|MP:0000913,abnormal brain development|MP:0001175,abnormal lung morphology|MP:0001697,abnormal embryo size|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0003632,abnormal nervous system morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5792034	Lama5<mpc205H>	MP:0000182,increased circulating LDL cholesterol level|MP:0001548,hyperlipidemia|MP:0001556,increased circulating HDL cholesterol level|MP:0002136,abnormal kidney physiology|MP:0002705,dilated renal tubule|MP:0002828,abnormal renal glomerular capsule morphology|MP:0002962,increased urine protein level|MP:0003606,kidney failure|MP:0005178,increased circulating cholesterol level|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008140,podocyte foot process effacement|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011377,renal glomerulus fibrosis|MP:0011402,renal cast|MP:0011409,increased renal glomerulus basement membrane thickness
MGI:6407118	Lama5<tm1.1Mggte>	MP:0000379,decreased hair follicle number|MP:0000511,abnormal intestinal mucosa morphology|MP:0003704,abnormal hair follicle development|MP:0003813,abnormal hair follicle dermal papilla morphology|MP:0008108,abnormal small intestinal villus morphology|MP:0011159,abnormal epidermal-dermal junction morphology|MP:0014084,clubbed small intestinal villi
MGI:5692561	Lama5<tm1b(KOMP)Wtsi>	MP:0000274,enlarged heart|MP:0011100,preweaning lethality, complete penetrance
MGI:1934917	Lama5<tm1Jhm>	MP:0000075,absent neurocranium|MP:0000116,abnormal tooth development|MP:0000434,megacephaly|MP:0000477,abnormal intestine morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000564,syndactyly|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0001711,abnormal placenta morphology|MP:0002109,abnormal limb morphology|MP:0002989,small kidney|MP:0003044,impaired basement membrane formation|MP:0003449,abnormal intestine goblet cell morphology|MP:0003641,small lung|MP:0003722,absent ureter|MP:0004200,decreased fetal size|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005031,abnormal trophoblast layer morphology|MP:0005326,abnormal podocyte morphology|MP:0005327,abnormal mesangial cell morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009570,abnormal right lung morphology|MP:0010821,abnormal visceral pleura morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011320,abnormal glomerular capillary morphology|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011521,decreased placental labyrinth size
MGI:5555037	Lama5<tm1Lsor>	MP:0002494,increased IgM level|MP:0005014,increased B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008193,abnormal marginal zone B cell physiology|MP:0009922,increased transitional stage T1 B cell number|MP:0009926,decreased transitional stage T2 B cell number
MGI:3613037	Lama5<tm2Jhm>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3823246	Lama5<tm3Jhm>	MP:0001265,decreased body size|MP:0002083,premature death|MP:0002705,dilated renal tubule|MP:0002962,increased urine protein level|MP:0003068,enlarged kidney|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0005161,hematuria|MP:0005367,renal/urinary system phenotype|MP:0005565,increased blood urea nitrogen level|MP:0008528,polycystic kidney|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011368,increased kidney apoptosis
MGI:3708459	lamb	MP:0001489,decreased startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:7425789	Lamb1<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:3046687	Lamb1<GT(PST084)Byg>	MP:0001696,failure to gastrulate|MP:0002086,abnormal extraembryonic tissue morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011187,abnormal parietal endoderm morphology|MP:0012057,abnormal mural trophectoderm morphology
MGI:6107689	Lamb1<Lt>	MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001522,impaired swimming|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002980,abnormal postural reflex|MP:0003463,abnormal single cell response|MP:0003631,nervous system phenotype|MP:0004263,abnormal limb posture|MP:0005323,dystonia|MP:0005386,behavior/neurological phenotype|MP:0013179,wavy tail
MGI:6378616	Lamb2<em1Jhm>	MP:0005376,homeostasis/metabolism phenotype
MGI:5578541	Lamb2<npht>	MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0002135,abnormal kidney morphology|MP:0002136,abnormal kidney physiology|MP:0002962,increased urine protein level|MP:0005178,increased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0009640,abnormal renal tubule epithelium morphology|MP:0011409,increased renal glomerulus basement membrane thickness
MGI:2138070	Lamb2<tm1Jrs>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001005,abnormal retina rod cell morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001054,failure of neuromuscular synapse presynaptic differentiation|MP:0001055,failure of neuromuscular synapse postsynaptic differentiation|MP:0001325,abnormal retina morphology|MP:0001732,postnatal growth retardation|MP:0002743,glomerulonephritis|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0004835,abnormal miniature endplate potential|MP:0005202,lethargy|MP:0005240,abnormal amacrine cell morphology|MP:0005253,abnormal eye physiology|MP:0005547,abnormal Muller cell morphology|MP:0005551,abnormal eye electrophysiology|MP:0008106,decreased amacrine cell number|MP:0008139,fused podocyte foot processes|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment|MP:0009772,abnormal retina development|MP:0010235,abnormal retina inner limiting membrane morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011856,abnormal glomerular filtration barrier function|MP:0011965,decreased total retina thickness|MP:0030005,increased retina apoptosis
MGI:2179716	Lamb3<IAP>	MP:0000764,abnormal tongue epithelium morphology|MP:0001208,blistering|MP:0002251,abnormal nasopharynx morphology|MP:0002252,abnormal oropharynx morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011160,dermal-epidermal separation
MGI:5708309	Lamb3<tm1.1Hosc>	MP:0001208,blistering|MP:0001262,decreased body weight|MP:0002060,abnormal skin morphology|MP:0009931,abnormal skin appearance|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011159,abnormal epidermal-dermal junction morphology
MGI:5548979	Lamb3<tm1b(KOMP)Wtsi>	MP:0002060,abnormal skin morphology|MP:0002100,abnormal tooth morphology
MGI:2156186	Lamc1<Gt(Ex183)Byg>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6367833	Lamc1<tm1.1Ksek>	MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0011092,embryonic lethality, complete penetrance
MGI:5504480	Lamc1<tm1.1Strl>	MP:0005386,behavior/neurological phenotype
MGI:1934900	Lamc1<tm1Edg>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011183,abnormal primitive endoderm morphology|MP:0011206,absent visceral yolk sac
MGI:2683482	Lamc1<tm1Strl>	MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000756,forelimb paralysis|MP:0000920,abnormal myelination|MP:0001106,abnormal Schwann cell morphology|MP:0002169,no abnormal phenotype detected|MP:0002269,muscular atrophy|MP:0002651,abnormal sciatic nerve morphology|MP:0003993,abnormal ventral spinal root morphology|MP:0003994,abnormal dorsal spinal root morphology|MP:0004220,abnormal peripheral nervous system regeneration|MP:0005164,abnormal response to injury|MP:0020452,abnormal axon radial sorting
MGI:2183782	Lamc1<tm1Umr>	MP:0000519,hydronephrosis|MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000534,abnormal ureter morphology|MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0001265,decreased body size|MP:0001325,abnormal retina morphology|MP:0001915,intracranial hemorrhage|MP:0002160,abnormal reproductive system morphology|MP:0002264,abnormal bronchus morphology|MP:0002631,abnormal epididymis morphology|MP:0002828,abnormal renal glomerular capsule morphology|MP:0003557,absent vas deferens|MP:0003558,absent uterus|MP:0003604,single kidney|MP:0003606,kidney failure|MP:0003641,small lung|MP:0003642,absent seminal vesicle|MP:0003648,abnormal radial glial cell morphology|MP:0003675,kidney cyst|MP:0003720,abnormal neural tube closure|MP:0003826,abnormal Mullerian duct morphology|MP:0003827,abnormal Wolffian duct morphology|MP:0004200,decreased fetal size|MP:0004272,abnormal basement membrane morphology|MP:0004505,decreased renal glomerulus number|MP:0005325,abnormal renal glomerulus morphology|MP:0005623,abnormal meninges morphology|MP:0006254,thin cerebral cortex|MP:0008030,abnormal Cajal-Retzius cell morphology|MP:0008439,abnormal cortical plate morphology|MP:0009937,abnormal neuron differentiation|MP:0010451,kidney microaneurysm|MP:0010825,abnormal lung saccule morphology|MP:0010978,absent ureteric bud|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011143,thick lung-associated mesenchyme|MP:0011366,absent metanephros
MGI:6367834	Lamc1<tm2.1Ksek>	MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype
MGI:3609880	Lamc2<jeb>	MP:0000063,decreased bone mineral density|MP:0000578,ulcerated autopod|MP:0001190,reddish skin|MP:0001208,blistering|MP:0001209,spontaneous skin ulceration|MP:0001222,epidermal hyperplasia|MP:0001849,ear inflammation|MP:0001874,acanthosis|MP:0001954,respiratory distress|MP:0002060,abnormal skin morphology|MP:0003089,decreased skin tensile strength|MP:0004273,abnormal basal lamina morphology|MP:0005358,abnormal incisor morphology|MP:0009675,orthokeratosis|MP:0009827,skin detachment|MP:0010124,decreased bone mineral content|MP:0010936,decreased airway resistance|MP:0011045,decreased lung elastance|MP:0011159,abnormal epidermal-dermal junction morphology|MP:0011160,dermal-epidermal separation|MP:0030423,abnormal pinna cartilage morphology|MP:0030460,enamel pits
MGI:2679597	Lamc2<tm1Uit>	MP:0000462,abnormal digestive system morphology|MP:0000540,abnormal urinary bladder urothelium morphology|MP:0001208,blistering|MP:0001438,aphagia|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011160,dermal-epidermal separation
MGI:4941480	Lamc3<tm1.1Wjbr>	MP:0005240,abnormal amacrine cell morphology
MGI:4364864	Lamc3<tm1a(KOMP)Wtsi>	MP:0003179,thrombocytopenia|MP:0010052,increased grip strength
MGI:6276979	Lamp1<em1(IMPC)Mbp>	MP:0000218,increased leukocyte cell number|MP:0000692,small spleen|MP:0001148,enlarged testis|MP:0001325,abnormal retina morphology|MP:0001566,increased circulating phosphate level|MP:0002135,abnormal kidney morphology|MP:0002768,small adrenal glands|MP:0002989,small kidney|MP:0005013,increased lymphocyte cell number
MGI:3053864	Lamp1<tm1Psa>	MP:0002169,no abnormal phenotype detected
MGI:7339104	Lamp2<tm1.2Ces>	MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0001636,irregular heartbeat|MP:0002625,heart left ventricle hypertrophy|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003896,prolonged PR interval|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0005386,behavior/neurological phenotype|MP:0006142,abnormal sinoatrial node conduction|MP:0008260,abnormal autophagy|MP:0009703,decreased birth body size|MP:0010519,atrioventricular block|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014071,increased cardiac muscle glycogen level|MP:0031078,increased circulating troponin T level
MGI:5617956	Lamp2<tm1Amcu>	MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003325,decreased liver function|MP:0003887,increased hepatocyte apoptosis|MP:0003927,increased cellular glucose import|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005384,cellular phenotype|MP:0005455,increased susceptibility to weight gain|MP:0005459,decreased percent body fat/body weight|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008260,abnormal autophagy|MP:0008963,increased carbon dioxide production|MP:0009122,decreased white fat cell lipid droplet size|MP:0009125,decreased brown fat cell lipid droplet size|MP:0009283,decreased gonadal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0009746,enhanced behavioral response to xenobiotic|MP:0010378,increased respiratory quotient|MP:0010398,decreased liver glycogen level|MP:0013278,decreased fasting circulating glucose level|MP:0020103,decreased hepatic glucose production
MGI:2385811	Lamp2<tm1Psa>	MP:0000703,abnormal thymus morphology|MP:0001262,decreased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005311,abnormal circulating amino acid level|MP:0005621,abnormal cell physiology|MP:0006035,abnormal mitochondrial morphology|MP:0008475,intermingled spleen red and white pulp|MP:0010954,abnormal cellular respiration|MP:0014046,abnormal mitophagy|MP:0021157,increased heart left ventricle wall thickness|MP:0030940,impaired autophagy
MGI:7434942	Lamp3<em1Damme>	MP:0001952,increased airway responsiveness|MP:0004781,abnormal surfactant composition|MP:0004782,abnormal surfactant physiology|MP:0005388,respiratory system phenotype|MP:0005425,increased macrophage cell number|MP:0010768,mortality/aging|MP:0010813,abnormal alveolar lamellar body morphology|MP:0010935,increased airway resistance|MP:0010992,increased surfactant secretion
MGI:6156566	Lamp3<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology|MP:0002631,abnormal epididymis morphology
MGI:5766991	Lamp5<em1(IMPC)J>	MP:0005419,decreased circulating serum albumin level|MP:0013279,increased fasting circulating glucose level
MGI:7608054	Lamp5<em1Lmit>	MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0004101,abnormal brain interneuron morphology|MP:0004994,abnormal brain wave pattern|MP:0010768,mortality/aging|MP:0011620,abnormal habituation to a new environment|MP:0021020,neurite dystrophy
MGI:5635168	Lamtor1<tm1b(KOMP)Wtsi>	MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0002631,abnormal epididymis morphology|MP:0004832,enlarged ovary|MP:0004931,enlarged epididymis|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4888381	Lamtor1<tm1Moka>	MP:0001724,abnormal extraembryonic endoderm formation|MP:0001730,embryonic growth arrest|MP:0005058,abnormal lysosome morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology
MGI:3701993	Lamtor2<tm1.1Lah>	MP:0000352,decreased cell proliferation|MP:0001190,reddish skin|MP:0001191,abnormal skin condition|MP:0001216,abnormal epidermal layer morphology|MP:0001218,thin epidermis|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0002796,impaired skin barrier function|MP:0011087,neonatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3701832	Lamtor2<tm1.2Lah>	MP:0002085,abnormal embryonic tissue morphology|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6441124	Lamtor3<em1(IMPC)Hmgu>	MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance
MGI:6341931	Lamtor4<em1(IMPC)Ccpcz>	MP:0000150,abnormal rib morphology|MP:0000681,abnormal thyroid gland morphology|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001697,abnormal embryo size|MP:0004924,abnormal behavior|MP:0005355,enlarged thyroid gland|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0020870,decreased thigmotaxis
MGI:5614702	Lamtor5<tm1b(EUCOMM)Hmgu>	MP:0001510,abnormal coat appearance|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration|MP:0011965,decreased total retina thickness|MP:0013292,embryonic lethality prior to organogenesis
MGI:6369090	Lamtor5<tm1Lye>	MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005378,growth/size/body region phenotype|MP:0013279,increased fasting circulating glucose level
MGI:5804191	Lancl1<em1Vdd>	MP:0002169,no abnormal phenotype detected
MGI:5646273	Lancl1<tm1.1Pfw>	MP:0001156,abnormal spermatogenesis|MP:0001847,brain inflammation|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002229,neurodegeneration|MP:0002662,abnormal cauda epididymis morphology|MP:0002675,asthenozoospermia|MP:0002685,abnormal spermatogonia proliferation|MP:0002687,oligozoospermia|MP:0003186,abnormal redox activity|MP:0003203,increased neuron apoptosis|MP:0003205,testicular atrophy|MP:0003674,oxidative stress|MP:0004543,abnormal sperm physiology|MP:0004851,increased testis weight|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0006378,abnormal spermatogonia morphology|MP:0006379,abnormal spermatocyte morphology|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0011632,dilated mitochondrion|MP:0014052,increased male germ cell apoptosis|MP:0014465,abnormal sperm mitochondrial morphology|MP:0014467,increased sperm mitochondrial size|MP:0020451,decreased sperm progressive motility
MGI:5804215	Lancl2<em1Vdd>	MP:0002169,no abnormal phenotype detected
MGI:4431468	Lancl2<tm2a(KOMP)Wtsi>	MP:0002411,decreased susceptibility to bacterial infection|MP:0003884,decreased macrophage cell number|MP:0004974,decreased regulatory T cell number
MGI:5569052	Lancl2<tm2b(KOMP)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0002075,abnormal coat/hair pigmentation|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney
MGI:7580959	Lancl2<tm2c(KOMP)Wtsi>	MP:0002411,decreased susceptibility to bacterial infection|MP:0003884,decreased macrophage cell number|MP:0004974,decreased regulatory T cell number
MGI:6361217	Lancl3<em1(IMPC)H>	MP:0000063,decreased bone mineral density|MP:0002965,increased circulating serum albumin level
MGI:6100927	Lancl3<em1Vdd>	MP:0002169,no abnormal phenotype detected
MGI:6152753	Lao1<tm1Oka>	MP:0002412,increased susceptibility to bacterial infection|MP:0004047,abnormal milk composition|MP:0005379,endocrine/exocrine gland phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008751,abnormal interleukin level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0013148,mastitis
MGI:3702002	Lap3<tm1Klr>	MP:0005387,immune system phenotype
MGI:5548380	Laptm4a<tm1b(EUCOMM)Hmgu>	MP:0002764,short tibia|MP:0009141,increased prepulse inhibition|MP:0010570,prolonged ST segment|MP:0011965,decreased total retina thickness|MP:0013279,increased fasting circulating glucose level
MGI:6802143	Laptm4b<em1Huty>	MP:0003037,increased myocardial infarct size|MP:0005058,abnormal lysosome morphology|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0010768,mortality/aging|MP:0030940,impaired autophagy
MGI:5766156	Laptm4b<tm1e.1(KOMP)Wtsi>	MP:0000428,abnormal craniofacial morphology|MP:0000841,abnormal hindbrain morphology|MP:0000897,abnormal midbrain morphology|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0003720,abnormal neural tube closure|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4433224	Laptm5<tm1a(EUCOMM)Wtsi>	MP:0005561,increased mean corpuscular hemoglobin
MGI:3803960	Laptm5<tm1Jow>	MP:0001828,abnormal T cell activation|MP:0002534,abnormal type IV hypersensitivity reaction|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0008687,increased interleukin-2 secretion
MGI:2154172	Laq1<MRL>	MP:0005350,increased susceptibility to autoimmune disorder
MGI:1889325	Large1<enr-Tg(MbpReg)36Pop>	MP:0000160,kyphosis|MP:0000759,abnormal skeletal muscle morphology|MP:0000920,abnormal myelination|MP:0001106,abnormal Schwann cell morphology|MP:0001265,decreased body size|MP:0001504,abnormal posture|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002651,abnormal sciatic nerve morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004220,abnormal peripheral nervous system regeneration|MP:0004263,abnormal limb posture|MP:0009414,skeletal muscle fiber necrosis|MP:0009420,skeletal muscle endomysial fibrosis
MGI:6725092	Large1<m1Btlr>	MP:0004703,abnormal vertebral column morphology
MGI:1856965	Large1<myd>	MP:0000160,kyphosis|MP:0000278,abnormal myocardial fiber morphology|MP:0000749,muscle degeneration|MP:0000751,myopathy|MP:0000752,dystrophic muscle|MP:0000762,abnormal tongue morphology|MP:0000920,abnormal myelination|MP:0001077,abnormal spinal nerve morphology|MP:0001108,absent Schwann cells|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002108,abnormal muscle morphology|MP:0002279,abnormal diaphragm morphology|MP:0002795,dilated cardiomyopathy|MP:0003081,abnormal soleus morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003199,calcified muscle|MP:0003727,abnormal retina layer morphology|MP:0003795,abnormal bone structure|MP:0004510,myositis|MP:0004740,sensorineural hearing loss|MP:0005329,abnormal myocardium layer morphology|MP:0005551,abnormal eye electrophysiology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008515,thin retina outer nuclear layer|MP:0008520,disorganized retina outer plexiform layer|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009412,skeletal muscle fiber degeneration|MP:0009414,skeletal muscle fiber necrosis|MP:0010090,increased circulating creatine kinase level|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014742,increased auditory brainstem response wave interpeak latency|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:3799277	Large1<myd-3J>	MP:0000751,myopathy|MP:0001406,abnormal gait|MP:0001925,male infertility|MP:0005369,muscle phenotype|MP:0006069,abnormal retina neuronal layer morphology|MP:0009415,skeletal muscle degeneration
MGI:3510641	Large1<vls>	MP:0001265,decreased body size|MP:0002279,abnormal diaphragm morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002795,dilated cardiomyopathy|MP:0003081,abnormal soleus morphology|MP:0003381,vitreal fibroplasia|MP:0003727,abnormal retina layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005241,abnormal retina ganglion layer morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005551,abnormal eye electrophysiology|MP:0005553,increased circulating creatinine level|MP:0006069,abnormal retina neuronal layer morphology|MP:0006200,vitreous body deposition|MP:0008509,disorganized retina ganglion layer|MP:0008511,thin retina inner nuclear layer|MP:0008519,thin retina outer plexiform layer|MP:0008520,disorganized retina outer plexiform layer|MP:0010053,decreased grip strength
MGI:6257444	Large2<em1(IMPC)Bay>	MP:0002792,abnormal retina vasculature morphology|MP:0011965,decreased total retina thickness
MGI:4419876	Large2<tm1(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:6152506	Larp1<em1(IMPC)Mbp>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001147,small testis|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002599,increased mean platelet volume|MP:0003068,enlarged kidney|MP:0003984,embryonic growth retardation|MP:0005179,decreased circulating cholesterol level|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0011874,enlarged urinary bladder
MGI:6505556	Larp1<tm1c(EUCOMM)Hmgu>	MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype
MGI:6153479	Larp4b<em1(IMPC)Wtsi>	MP:0002079,increased circulating insulin level|MP:0002599,increased mean platelet volume|MP:0002874,decreased hemoglobin content
MGI:7519001	Larp4<tm1.1Rjma>	MP:0020414,abnormal fibroblast physiology
MGI:6257663	Larp6<em1(IMPC)Tcp>	MP:0001552,increased circulating triglyceride level|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002968,increased circulating alkaline phosphatase level
MGI:5463352	Larp7<tm1Ymat>	MP:0000929,open neural tube|MP:0004200,decreased fetal size|MP:0008392,decreased primordial germ cell number|MP:0011089,perinatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0030934,decreased primordial germ cell proliferation
MGI:5637014	Lars1<tm1b(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:3609236	Lar<SAMP1>	MP:0001800,abnormal humoral immune response
MGI:2441658	Lasp1<Tg(Col1a1-lacZ)1Ngma>	MP:0000111,cleft palate|MP:0000157,abnormal sternum morphology|MP:0000161,scoliosis|MP:0002111,abnormal tail morphology|MP:0003419,delayed endochondral bone ossification|MP:0003639,abnormal response to vitamins|MP:0004173,abnormal intervertebral disk morphology|MP:0004606,absent vertebral spinous process|MP:0004647,decreased lumbar vertebrae number|MP:0004706,short vertebral body|MP:0005226,abnormal vertebral arch development|MP:0005297,spina bifida occulta|MP:0006394,abnormal vertebral epiphyseal plate morphology|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3802612	Lasp1<tm1Chew>	MP:0000274,enlarged heart|MP:0000503,excessive digestive secretion|MP:0001148,enlarged testis|MP:0001157,small seminal vesicle|MP:0001262,decreased body weight|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype
MGI:3510698	Lat2<tm1Mal>	MP:0002423,abnormal mast cell physiology|MP:0004794,increased anti-nuclear antigen antibody level
MGI:3510962	Lat2<tm1Wz>	MP:0000693,spleen hyperplasia|MP:0002423,abnormal mast cell physiology|MP:0002444,abnormal T cell physiology|MP:0003009,abnormal cytokine secretion|MP:0003725,increased autoantibody level|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005348,increased T cell proliferation|MP:0008553,increased circulating tumor necrosis factor level|MP:0008566,increased interferon-gamma secretion|MP:0008596,increased circulating interleukin-6 level|MP:0008660,increased interleukin-10 secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0008764,increased mast cell degranulation|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:3693652	Lat2<tm2Wz>	MP:0000691,enlarged spleen|MP:0001829,increased activated T cell number|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology
MGI:5316132	Lat2<tm3.1Wz>	MP:0000691,enlarged spleen|MP:0002444,abnormal T cell physiology|MP:0005387,immune system phenotype|MP:0008049,increased memory T cell number|MP:0008566,increased interferon-gamma secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0008764,increased mast cell degranulation
MGI:6324168	Lat<em1(IMPC)Ics>	MP:0001486,abnormal startle reflex|MP:0002699,abnormal vitreous body morphology|MP:0005344,increased circulating bilirubin level
MGI:6153801	Lats1<em1(IMPC)H>	MP:0001402,decreased locomotor activity|MP:0002874,decreased hemoglobin content|MP:0002941,increased circulating alanine transaminase level|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0010053,decreased grip strength
MGI:5568586	Lats1<tm1.1Jfm>	MP:0002169,no abnormal phenotype detected
MGI:3840659	Lats1<tm1Noj>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002006,neoplasm|MP:0003448,abnormal tumor morphology|MP:0004046,abnormal mitosis|MP:0005621,abnormal cell physiology|MP:0009760,abnormal mitotic spindle morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011703,increased fibroblast proliferation|MP:0030943,abnormal centrosome morphology
MGI:1857685	Lats1<tm1Tx>	MP:0000628,abnormal mammary gland development|MP:0001119,abnormal female reproductive system morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001131,abnormal ovarian follicle morphology|MP:0001134,absent corpus luteum|MP:0001262,decreased body weight|MP:0001634,internal hemorrhage|MP:0001921,reduced fertility|MP:0001926,female infertility|MP:0002032,increased sarcoma incidence|MP:0002161,abnormal fertility/fecundity|MP:0002682,decreased mature ovarian follicle number|MP:0002773,decreased circulating luteinizing hormone level|MP:0005120,decreased circulating growth hormone level|MP:0005121,decreased circulating prolactin level|MP:0008000,increased ovary tumor incidence|MP:0009009,absent estrous cycle|MP:0009733,absent nipple|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0013348,adenohypophysis hyperplasia
MGI:5648494	Lats2<tm1.1Dupa>	MP:0002169,no abnormal phenotype detected
MGI:5568589	Lats2<tm1.1Jfm>	MP:0002169,no abnormal phenotype detected
MGI:3604602	Lats2<tm1Dgen>	MP:0001486,abnormal startle reflex|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3719818	Lats2<tm1Noj>	MP:0000736,delayed muscle development|MP:0000828,abnormal fourth ventricle morphology|MP:0000955,abnormal spinal cord morphology|MP:0001698,decreased embryo size|MP:0002188,small heart|MP:0002884,abnormal pharyngeal arch morphology|MP:0003707,increased cell nucleus count|MP:0003984,embryonic growth retardation|MP:0004025,polyploidy|MP:0004046,abnormal mitosis|MP:0011091,prenatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013182,increased spinal cord apoptosis|MP:0014239,abnormal intracellular organelle morphology|MP:0014693,abnormal cell nucleus size|MP:0030943,abnormal centrosome morphology
MGI:3056530	Lats2<tm1Raz>	MP:0000279,ventricular hypoplasia|MP:0000295,trabecula carnea hypoplasia|MP:0000350,abnormal cell proliferation|MP:0000352,decreased cell proliferation|MP:0000930,wavy neural tube|MP:0001914,hemorrhage|MP:0003105,abnormal heart atrium morphology|MP:0003984,embryonic growth retardation|MP:0004028,chromosome breakage|MP:0005244,hemopericardium|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2388631	Lat<tm1.1Lov>	MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001829,increased activated T cell number|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0002221,abnormal lymph organ size|MP:0002407,abnormal double-negative T cell morphology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002444,abnormal T cell physiology|MP:0002490,abnormal immunoglobulin level|MP:0002494,increased IgM level|MP:0002497,increased IgE level|MP:0003009,abnormal cytokine secretion|MP:0003725,increased autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0005348,increased T cell proliferation|MP:0008499,increased IgG1 level
MGI:2182312	Lat<tm1.1Mal>	MP:0000613,abnormal salivary gland morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0001262,decreased body weight|MP:0001823,thymus hypoplasia|MP:0001846,increased inflammatory response|MP:0001859,kidney inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001869,pancreas inflammation|MP:0001870,salivary gland inflammation|MP:0002346,abnormal lymph node secondary follicle morphology|MP:0002358,abnormal spleen periarteriolar lymphoid sheath morphology|MP:0002494,increased IgM level|MP:0002497,increased IgE level|MP:0002499,chronic inflammation|MP:0002619,abnormal lymphocyte morphology|MP:0002722,abnormal immune system organ morphology|MP:0002723,abnormal immune serum protein physiology|MP:0002743,glomerulonephritis|MP:0002871,albuminuria|MP:0003334,pancreas fibrosis|MP:0003944,abnormal T cell subpopulation ratio|MP:0003985,renal fibrosis|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004797,increased anti-erythrocyte antigen antibody level|MP:0004827,increased susceptibility to autoimmune hemolytic anemia|MP:0004829,increased anti-chromatin antibody level|MP:0004917,abnormal T cell selection|MP:0004952,increased spleen weight|MP:0005011,increased eosinophil cell number|MP:0005014,increased B cell number|MP:0005092,decreased double-positive T cell number|MP:0005094,abnormal T cell proliferation|MP:0005348,increased T cell proliferation|MP:0005466,abnormal T-helper 2 physiology|MP:0005565,increased blood urea nitrogen level|MP:0008049,increased memory T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008090,increased T-helper 2 cell number|MP:0008097,increased plasma cell number|MP:0008217,abnormal B cell activation|MP:0008356,abnormal gamma-delta T cell differentiation|MP:0008481,increased spleen germinal center number|MP:0008499,increased IgG1 level|MP:0008522,abnormal lymph node germinal center morphology|MP:0008566,increased interferon-gamma secretion|MP:0008699,increased interleukin-4 secretion|MP:0010140,phlebitis|MP:0020519,renal glomerular immunoglobulin deposits
MGI:3611936	Lat<tm1Bpay>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001825,arrested T cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0005387,immune system phenotype|MP:0009548,abnormal platelet aggregation
MGI:1857812	Lat<tm1Les>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001825,arrested T cell differentiation|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0008037,abnormal T cell morphology
MGI:2183741	Lat<tm2.1Lov>	MP:0000706,small thymus|MP:0002145,abnormal T cell differentiation|MP:0005018,decreased T cell number
MGI:3510778	Lat<tm2.1Mal>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000727,absent CD8-positive, alpha-beta T cells|MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0001828,abnormal T cell activation|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0002357,abnormal spleen white pulp morphology|MP:0002358,abnormal spleen periarteriolar lymphoid sheath morphology|MP:0002401,abnormal lymphopoiesis|MP:0002434,abnormal T-helper 2 cell morphology|MP:0002439,abnormal plasma cell morphology|MP:0002461,increased immunoglobulin level|MP:0002497,increased IgE level|MP:0002619,abnormal lymphocyte morphology|MP:0002722,abnormal immune system organ morphology|MP:0003790,absent CD4-positive, alpha-beta T cells|MP:0003850,abnormal thymocyte activation|MP:0005014,increased B cell number|MP:0005092,decreased double-positive T cell number|MP:0008217,abnormal B cell activation|MP:0008344,abnormal mature gamma-delta T cell morphology|MP:0008353,increased mature gamma-delta T cell number|MP:0008356,abnormal gamma-delta T cell differentiation|MP:0008499,increased IgG1 level|MP:0008699,increased interleukin-4 secretion
MGI:3510779	Lat<tm3.1Mal>	MP:0000727,absent CD8-positive, alpha-beta T cells|MP:0001825,arrested T cell differentiation|MP:0003790,absent CD4-positive, alpha-beta T cells|MP:0003850,abnormal thymocyte activation|MP:0005015,increased T cell number|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0008355,absent mature gamma-delta T cells|MP:0008356,abnormal gamma-delta T cell differentiation|MP:0008826,abnormal splenic cell ratio|MP:0008827,abnormal thymus cell ratio|MP:0008828,abnormal lymph node cell ratio
MGI:3510782	Lat<tm4.1Mal>	MP:0000727,absent CD8-positive, alpha-beta T cells|MP:0001825,arrested T cell differentiation|MP:0002619,abnormal lymphocyte morphology|MP:0003790,absent CD4-positive, alpha-beta T cells|MP:0003850,abnormal thymocyte activation|MP:0005018,decreased T cell number|MP:0005048,abnormal thrombosis|MP:0005092,decreased double-positive T cell number|MP:0008355,absent mature gamma-delta T cells|MP:0008356,abnormal gamma-delta T cell differentiation|MP:0008826,abnormal splenic cell ratio|MP:0008827,abnormal thymus cell ratio|MP:0008828,abnormal lymph node cell ratio|MP:0009549,decreased platelet aggregation
MGI:4357969	Lat<tm5.1Mal>	MP:0001825,arrested T cell differentiation
MGI:3805830	Lat<tm6.1(HBEGF/EGFP)Mal>	MP:0001828,abnormal T cell activation|MP:0005466,abnormal T-helper 2 physiology|MP:0008567,decreased interferon-gamma secretion
MGI:4357957	Lat<tm8.1(CD2,-ECFP)Mal>	MP:0001825,arrested T cell differentiation|MP:0002619,abnormal lymphocyte morphology|MP:0005090,increased double-negative T cell number|MP:0008757,abnormal T cell receptor gamma chain V-J recombination|MP:0008759,abnormal T cell receptor delta chain V(D)J recombination
MGI:5547536	Lat<tm9Mal>	MP:0000685,abnormal immune system morphology|MP:0001790,abnormal immune system physiology|MP:0002401,abnormal lymphopoiesis|MP:0002458,abnormal B cell number|MP:0008090,increased T-helper 2 cell number
MGI:3579135	Lax1<tm1Wz>	MP:0001828,abnormal T cell activation|MP:0002359,abnormal spleen germinal center morphology|MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0002497,increased IgE level|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008826,abnormal splenic cell ratio|MP:0014469,abnormal B cell calcium ion homeostasis
MGI:6693354	Layn<em1Romd>	MP:0003721,increased tumor growth/size|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005387,immune system phenotype
MGI:6693357	Layn<em2Romd>	MP:0003721,increased tumor growth/size
MGI:3834857	Lbca1<C57BL/6Igc>	MP:0005154,increased B cell proliferation|MP:0008217,abnormal B cell activation
MGI:3834859	Lbca2<C57BL/6Igc>	MP:0005154,increased B cell proliferation|MP:0008217,abnormal B cell activation
MGI:5511013	Lbh<tm1.1Kbri>	MP:0002169,no abnormal phenotype detected
MGI:5511022	Lbh<tm1.2Kbri>	MP:0000628,abnormal mammary gland development|MP:0001935,decreased litter size|MP:0003344,mammary gland hypoplasia|MP:0006270,abnormal mammary gland growth during lactation|MP:0006271,abnormal involution of the mammary gland|MP:0009506,abnormal mammary gland alveolus morphology|MP:0012075,impaired mammary gland growth during pregnancy
MGI:2656894	Lbm10<MRL/MpJ>	MP:0002089,abnormal postnatal growth/weight/body size
MGI:3698519	Lbm15<C57BL/6J>	MP:0003960,increased lean body mass
MGI:2656821	Lbm1<MRL/MpJ>	MP:0002089,abnormal postnatal growth/weight/body size
MGI:2656823	Lbm2<MRL/MpJ>	MP:0002089,abnormal postnatal growth/weight/body size
MGI:2656835	Lbm3<MRL/MpJ>	MP:0002089,abnormal postnatal growth/weight/body size
MGI:2656837	Lbm4<MRL/MpJ>	MP:0002089,abnormal postnatal growth/weight/body size
MGI:2656841	Lbm5<MRL/MpJ>	MP:0002089,abnormal postnatal growth/weight/body size
MGI:2656847	Lbm6<MRL/MpJ>	MP:0002089,abnormal postnatal growth/weight/body size
MGI:2656891	Lbm7<MRL/MpJ>	MP:0002089,abnormal postnatal growth/weight/body size
MGI:2656877	Lbm8<MRL/MpJ>	MP:0002089,abnormal postnatal growth/weight/body size
MGI:2656880	Lbm9<MRL/MpJ>	MP:0002089,abnormal postnatal growth/weight/body size
MGI:5636928	Lbp<tm1b(EUCOMM)Hmgu>	MP:0004952,increased spleen weight|MP:0005012,decreased eosinophil cell number|MP:0010087,increased circulating fructosamine level|MP:0013279,increased fasting circulating glucose level
MGI:1857975	Lbp<tm1Buru>	MP:0000609,abnormal liver physiology|MP:0002419,abnormal innate immunity|MP:0002463,abnormal neutrophil physiology|MP:0002498,abnormal acute inflammation|MP:0002723,abnormal immune serum protein physiology|MP:0003957,abnormal nitric oxide homeostasis|MP:0005166,decreased susceptibility to injury|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0008556,abnormal tumor necrosis factor secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008721,abnormal chemokine level|MP:0009642,abnormal blood homeostasis
MGI:1857976	Lbp<tm1Jack>	MP:0002412,increased susceptibility to bacterial infection
MGI:6383386	Lbr<em1(IMPC)Tcp>	MP:0000063,decreased bone mineral density|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000367,abnormal coat/ hair morphology|MP:0000438,abnormal cranium morphology|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000702,enlarged lymph nodes|MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0001258,decreased body length|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002110,abnormal digit morphology|MP:0002111,abnormal tail morphology|MP:0002764,short tibia|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0005016,decreased lymphocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0006243,impaired pupillary reflex|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3809824	Lbr<Gt(XE569)Byg>	MP:0000150,abnormal rib morphology|MP:0000161,scoliosis|MP:0000702,enlarged lymph nodes|MP:0001121,uterus hypoplasia|MP:0001242,hyperkeratosis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002083,premature death|MP:0002183,gliosis|MP:0002441,abnormal granulocyte morphology|MP:0002619,abnormal lymphocyte morphology|MP:0003203,increased neuron apoptosis|MP:0005065,abnormal neutrophil morphology|MP:0005253,abnormal eye physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0008111,abnormal granulocyte differentiation|MP:0008535,enlarged lateral ventricles|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008890,abnormal nuclear lamina morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0031678,increased micronucleus incidence
MGI:1856063	Lbr<ic>	MP:0000422,delayed hair appearance|MP:0001143,constricted vagina orifice|MP:0001191,abnormal skin condition|MP:0001192,scaly skin|MP:0001216,abnormal epidermal layer morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001282,short vibrissae|MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001943,abnormal respiration|MP:0002073,abnormal hair growth|MP:0002082,postnatal lethality|MP:0002098,abnormal vibrissa morphology|MP:0002286,cryptorchism|MP:0002670,absent scrotum|MP:0003111,abnormal cell nucleus morphology|MP:0006038,increased mitochondrial fission|MP:0009606,increased keratohyalin granule size|MP:0009611,epidermis stratum spinosum hyperplasia|MP:0013178,tail necrosis|MP:0020351,decreased vocalization
MGI:2447850	Lbr<ic-2J>	MP:0000367,abnormal coat/ hair morphology|MP:0000716,abnormal immune system cell morphology|MP:0001216,abnormal epidermal layer morphology|MP:0001265,decreased body size|MP:0002080,prenatal lethality|MP:0002081,perinatal lethality|MP:0002429,abnormal blood cell morphology/development|MP:0003632,abnormal nervous system morphology
MGI:2447851	Lbr<ic-3J>	MP:0000367,abnormal coat/ hair morphology|MP:0000716,abnormal immune system cell morphology|MP:0001216,abnormal epidermal layer morphology|MP:0001265,decreased body size|MP:0002080,prenatal lethality|MP:0002081,perinatal lethality|MP:0002429,abnormal blood cell morphology/development|MP:0003632,abnormal nervous system morphology
MGI:1856064	Lbr<ic-J>	MP:0000130,abnormal trabecular bone morphology|MP:0000416,sparse hair|MP:0000564,syndactyly|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000825,dilated lateral ventricle|MP:0001192,scaly skin|MP:0001222,epidermal hyperplasia|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0002135,abnormal kidney morphology|MP:0002415,abnormal neutrophil differentiation|MP:0002441,abnormal granulocyte morphology|MP:0002619,abnormal lymphocyte morphology|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003111,abnormal cell nucleus morphology|MP:0003215,renal interstitial fibrosis|MP:0003725,increased autoantibody level|MP:0003853,dry skin|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004829,increased anti-chromatin antibody level|MP:0005061,abnormal eosinophil morphology|MP:0005065,abnormal neutrophil morphology|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0009675,orthokeratosis|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0030571,dilated piliary canal
MGI:5308091	Lbr<lym3>	MP:0000221,decreased leukocyte cell number|MP:0000694,spleen hypoplasia|MP:0000717,abnormal lymphocyte cell number|MP:0001823,thymus hypoplasia|MP:0002429,abnormal blood cell morphology/development|MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0002619,abnormal lymphocyte morphology|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005065,abnormal neutrophil morphology|MP:0005095,decreased T cell proliferation|MP:0005390,skeleton phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008101,lymph node hypoplasia
MGI:2155968	Lbw2<NZB/BlScr>	MP:0002083,premature death|MP:0002743,glomerulonephritis|MP:0003725,increased autoantibody level|MP:0004829,increased anti-chromatin antibody level|MP:0004952,increased spleen weight
MGI:2155969	Lbw2<NZW/LacScr>	MP:0001785,edema|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002962,increased urine protein level|MP:0003726,decreased autoantibody level|MP:0010768,mortality/aging
MGI:2156283	Lbw3<NZW/LacScr>	MP:0002083,premature death
MGI:2156532	Lbw4<NZW/LacScr>	MP:0002460,decreased immunoglobulin level
MGI:2156880	Lbw5<NZW/LacScr>	MP:0004801,increased susceptibility to systemic lupus erythematosus
MGI:2445558	Lbw6<NZW/LacScr>	MP:0004801,increased susceptibility to systemic lupus erythematosus
MGI:2154175	Lbw7<NZB/BlScr>	MP:0004801,increased susceptibility to systemic lupus erythematosus
MGI:3033087	Lbw8<NZB/BlScr>	MP:0005350,increased susceptibility to autoimmune disorder
MGI:6864154	Lbx1<em1Mwil>	MP:0000939,decreased motor neuron number|MP:0000955,abnormal spinal cord morphology|MP:0002746,abnormal semilunar valve morphology|MP:0002764,short tibia|MP:0004610,small vertebrae|MP:0004704,short vertebral column|MP:0005371,limbs/digits/tail phenotype|MP:0006282,abnormal spinal cord dorsal horn morphology|MP:0008725,increased heart atrium size|MP:0008948,decreased neuron number|MP:0011089,perinatal lethality, complete penetrance|MP:0021094,abnormal dorsal interneuron 3 morphology|MP:0021095,abnormal dorsal interneuron 4 morphology|MP:0021096,abnormal dorsal interneuron 5 morphology|MP:0021157,increased heart left ventricle wall thickness
MGI:5304400	Lbx1<tm1.1Khan>	MP:0000759,abnormal skeletal muscle morphology|MP:0001265,decreased body size|MP:0002169,no abnormal phenotype detected|MP:0003090,abnormal muscle precursor cell migration
MGI:2182635	Lbx1<tm1Gld>	MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000729,abnormal myogenesis|MP:0000759,abnormal skeletal muscle morphology|MP:0003090,abnormal muscle precursor cell migration|MP:0003245,abnormal GABAergic neuron morphology|MP:0003247,abnormal glutaminergic neuron morphology|MP:0004819,decreased skeletal muscle mass|MP:0005369,muscle phenotype|MP:0006284,absent hypaxial muscle|MP:0011089,perinatal lethality, complete penetrance|MP:0021206,abnormal limb muscle morphology
MGI:5304404	Lbx1<tm1Khan>	MP:0011087,neonatal lethality, complete penetrance
MGI:2386948	Lbx1<tm1Thbr>	MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000755,hindlimb paralysis|MP:0000756,forelimb paralysis|MP:0001730,embryonic growth arrest|MP:0002151,abnormal neural tube morphology|MP:0002953,thick ventricular wall|MP:0003090,abnormal muscle precursor cell migration|MP:0003631,nervous system phenotype|MP:0003994,abnormal dorsal spinal root morphology|MP:0005369,muscle phenotype|MP:0006282,abnormal spinal cord dorsal horn morphology|MP:0010551,abnormal coronary vessel morphology|MP:0010724,thick interventricular septum|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0021206,abnormal limb muscle morphology
MGI:3712795	Lbx2<tm1Fchn>	MP:0010768,mortality/aging
MGI:3863997	Lca5<Gt(AG0283)Wtsi>	MP:0003631,nervous system phenotype|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005103,abnormal retina pigmentation|MP:0005253,abnormal eye physiology|MP:0008582,short photoreceptor inner segment|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment
MGI:6336078	Lca5l<em1(IMPC)Ics>	MP:0000208,decreased hematocrit|MP:0001925,male infertility|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0005178,increased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0011964,increased total retina thickness
MGI:2180695	Lcat<tm1Hgc>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000639,abnormal adrenal gland morphology|MP:0001547,abnormal lipid level|MP:0002118,abnormal lipid homeostasis|MP:0003982,increased cholesterol level|MP:0003983,decreased cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005325,abnormal renal glomerulus morphology|MP:0005416,abnormal circulating protein level|MP:0011353,expanded mesangial matrix|MP:0011427,increased mesangial cell number
MGI:2445879	Lcat<tm1Nsa>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001547,abnormal lipid level|MP:0001552,increased circulating triglyceride level|MP:0001585,hemolytic anemia|MP:0002640,reticulocytosis|MP:0002962,increased urine protein level|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005264,glomerulosclerosis|MP:0005278,abnormal cholesterol homeostasis|MP:0005325,abnormal renal glomerulus morphology|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005391,vision/eye phenotype|MP:0005397,hematopoietic system phenotype|MP:0006084,abnormal circulating phospholipid level|MP:0011312,abnormal kidney afferent arteriole morphology|MP:0011353,expanded mesangial matrix|MP:0011427,increased mesangial cell number|MP:0031084,decreased erythrocyte osmotic fragility
MGI:5637025	Lce1f<tm1b(KOMP)Wtsi>	MP:0003795,abnormal bone structure|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5637007	Lce1m<tm1b(EUCOMM)Wtsi>	MP:0005553,increased circulating creatinine level
MGI:2152771	Lch	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:2387761	Lch2	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:3831661	Lck<m1Btlr>	MP:0001823,thymus hypoplasia|MP:0003644,thymus atrophy|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation
MGI:5528710	Lck<m2Btlr>	MP:0001805,decreased IgG level|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:5615964	Lck<m3Btlr>	MP:0001829,increased activated T cell number|MP:0003944,abnormal T cell subpopulation ratio|MP:0008082,increased single-positive T cell number|MP:0008083,decreased single-positive T cell number
MGI:4358985	Lck<tm1.1Litt>	MP:0000703,abnormal thymus morphology|MP:0002490,abnormal immunoglobulin level|MP:0002619,abnormal lymphocyte morphology
MGI:3690319	Lck<tm1Dbs>	MP:0000715,decreased thymocyte number|MP:0002145,abnormal T cell differentiation|MP:0002407,abnormal double-negative T cell morphology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005018,decreased T cell number|MP:0005095,decreased T cell proliferation
MGI:1857211	Lck<tm1Mak>	MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0002407,abnormal double-negative T cell morphology|MP:0002494,increased IgM level|MP:0002619,abnormal lymphocyte morphology|MP:0003644,thymus atrophy|MP:0003850,abnormal thymocyte activation|MP:0005018,decreased T cell number|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005092,decreased double-positive T cell number|MP:0008037,abnormal T cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008081,abnormal single-positive T cell number|MP:0008347,decreased gamma-delta T cell number|MP:0008351,decreased gamma-delta intraepithelial T cell number|MP:0008399,abnormal alpha-beta intraepithelial T cell morphology|MP:0008495,decreased IgG1 level|MP:0008500,increased IgG2a level|MP:0008502,increased IgG3 level|MP:0008894,abnormal intraepithelial T cell morphology|MP:0008895,abnormal intraepithelial T cell number
MGI:2178627	Lcl	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002092,abnormal eye morphology
MGI:6277046	Lclat1<em1(IMPC)Mbp>	MP:0002590,increased mean corpuscular volume|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005561,increased mean corpuscular hemoglobin
MGI:5317904	Lclat1<tm1Arai>	MP:0002118,abnormal lipid homeostasis
MGI:4836722	Lclat1<tm1Yugs>	MP:0001399,hyperactivity|MP:0001426,polydipsia|MP:0001433,polyphagia|MP:0002118,abnormal lipid homeostasis|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009122,decreased white fat cell lipid droplet size|MP:0009125,decreased brown fat cell lipid droplet size|MP:0010378,increased respiratory quotient|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0014146,decreased white adipose tissue mass|MP:0014169,decreased brown adipose tissue mass|MP:0014171,increased fatty acid oxidation
MGI:6156144	Lcmt1<em1(IMPC)Rbrc>	MP:0000266,abnormal heart morphology|MP:0001565,abnormal circulating phosphate level|MP:0003313,abnormal locomotor activation|MP:0004952,increased spleen weight|MP:0011100,preweaning lethality, complete penetrance|MP:0012362,increased large unstained cell number
MGI:3762662	Lcmt1<Gt(A050A04)Wrst>	MP:0011100,preweaning lethality, complete penetrance
MGI:3875917	Lcmt1<Gt(CSC099)Byg>	MP:0002079,increased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5287256	Lcmt1<TgTn(sb-cHS4,Tyr)2524BOve>	MP:0000520,absent kidney
MGI:5708229	Lcn10<tm1.1(KOMP)Vlcg>	MP:0003070,increased vascular permeability|MP:0005385,cardiovascular system phenotype|MP:0008735,increased susceptibility to endotoxin shock|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:7512908	Lcn12<em1(IMPC)Hmgu>	MP:0000745,tremors
MGI:3525578	Lcn2<tm1Aade>	MP:0000005,increased brown adipose tissue amount|MP:0000008,increased white adipose tissue amount|MP:0000182,increased circulating LDL cholesterol level|MP:0002079,increased circulating insulin level|MP:0002412,increased susceptibility to bacterial infection|MP:0002628,hepatic steatosis|MP:0002833,increased heart weight|MP:0002981,increased liver weight|MP:0003917,increased kidney weight|MP:0004952,increased spleen weight|MP:0005044,sepsis|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005658,increased susceptibility to diet-induced obesity|MP:0006094,increased fat cell size|MP:0009355,increased liver triglyceride level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011049,impaired adaptive thermogenesis|MP:0013279,increased fasting circulating glucose level|MP:0030968,decreased circulating adiponectin level
MGI:5588291	Lcn2<tm1b(KOMP)Wtsi>	MP:0002590,increased mean corpuscular volume|MP:0002833,increased heart weight|MP:0002959,increased urine microalbumin level|MP:0004151,decreased circulating iron level|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:3620000	Lcn2<tm1Mak>	MP:0001923,reduced female fertility|MP:0002412,increased susceptibility to bacterial infection|MP:0005367,renal/urinary system phenotype
MGI:5052158	Lcn2<tm1Mrgr>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000245,abnormal erythropoiesis|MP:0000321,increased bone marrow cell number|MP:0000693,spleen hyperplasia|MP:0000708,thymus hyperplasia|MP:0001601,abnormal myelopoiesis|MP:0002423,abnormal mast cell physiology|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0003179,thrombocytopenia|MP:0005013,increased lymphocyte cell number|MP:0005014,increased B cell number|MP:0005397,hematopoietic system phenotype|MP:0005425,increased macrophage cell number|MP:0005561,increased mean corpuscular hemoglobin|MP:0006043,decreased apoptosis|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009338,increased splenocyte number|MP:0009542,decreased thymocyte apoptosis|MP:0010373,myeloid hyperplasia|MP:0011178,increased erythroblast number
MGI:6121435	Lcn6<tm1.1Ylzh>	MP:0004231,abnormal calcium ion homeostasis|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0013288,premature acrosome reaction
MGI:6711616	Lcn8<em1Jgao>	MP:0002675,asthenozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0009230,abnormal sperm head morphology|MP:0009234,absent sperm head|MP:0009238,coiled sperm flagellum|MP:0013288,premature acrosome reaction|MP:0020451,decreased sperm progressive motility
MGI:6711618	Lcn9<em1Jgao>	MP:0005389,reproductive system phenotype
MGI:7780140	Lcn9<em1Osb>	MP:0005389,reproductive system phenotype
MGI:7780149	Lcn9<em2Osb>	MP:0001922,reduced male fertility|MP:0030978,impaired binding of sperm to zona pellucida
MGI:6423309	Lcorl<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0004738,abnormal auditory brainstem response|MP:0005333,decreased heart rate|MP:0005655,increased aggression|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:8169560	Lcorl<em1Jke>	MP:0001732,postnatal growth retardation|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003960,increased lean body mass|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005292,improved glucose tolerance|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009703,decreased birth body size|MP:0010378,increased respiratory quotient|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake|MP:0012106,impaired exercise endurance|MP:0014143,decreased body fat mass|MP:0031391,increased locomotor activity
MGI:6267011	Lcor<tm1.2Hko>	MP:0011091,prenatal lethality, complete penetrance
MGI:6267012	Lcor<tm2.2Hko>	MP:0011091,prenatal lethality, complete penetrance
MGI:5635229	Lcp1<tm1e.1(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:4457016	Lcp1<tm1Erjb>	MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology|MP:0005387,immune system phenotype|MP:0008652,decreased interleukin-1 secretion
MGI:5491498	Lcp2<m1Khoe>	MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0010766,abnormal NK cell physiology
MGI:3850705	Lcp2<tm1.1Wz>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0002145,abnormal T cell differentiation|MP:0002435,abnormal effector T cell morphology|MP:0003944,abnormal T cell subpopulation ratio|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0005090,increased double-negative T cell number|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008101,lymph node hypoplasia|MP:0008688,decreased interleukin-2 secretion
MGI:5766747	Lcp2<tm1b(KOMP)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0011100,preweaning lethality, complete penetrance
MGI:2180002	Lcp2<tm1Gak>	MP:0006298,abnormal platelet activation|MP:0009549,decreased platelet aggregation|MP:0011090,perinatal lethality, incomplete penetrance
MGI:2447170	Lcp2<tm1Geha>	MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0008044,increased NK cell number|MP:0008567,decreased interferon-gamma secretion
MGI:3623388	Lcp2<tm2Gak>	MP:0001823,thymus hypoplasia|MP:0006414,decreased T cell apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008346,increased gamma-delta T cell number
MGI:3778759	Lcp2<tm3Gak>	MP:0001828,abnormal T cell activation|MP:0002407,abnormal double-negative T cell morphology|MP:0003944,abnormal T cell subpopulation ratio|MP:0004918,abnormal negative T cell selection|MP:0008040,decreased NK T cell number
MGI:3778760	Lcp2<tm4Gak>	MP:0001828,abnormal T cell activation|MP:0002407,abnormal double-negative T cell morphology|MP:0003944,abnormal T cell subpopulation ratio|MP:0004918,abnormal negative T cell selection|MP:0008040,decreased NK T cell number
MGI:3842651	Lcp2<tm5(Lat/Lcp2)Gak>	MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0003850,abnormal thymocyte activation|MP:0005092,decreased double-positive T cell number|MP:0008083,decreased single-positive T cell number
MGI:3614800	Lcp2<twm>	MP:0000715,decreased thymocyte number|MP:0001825,arrested T cell differentiation|MP:0001844,autoimmune response|MP:0002408,abnormal double-positive T cell morphology|MP:0002444,abnormal T cell physiology|MP:0002493,increased IgG level|MP:0002497,increased IgE level|MP:0004918,abnormal negative T cell selection|MP:0004919,abnormal positive T cell selection|MP:0005018,decreased T cell number
MGI:3716488	Lctlp1<DBA/1J>	MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:3716489	Lctlp1<FVB/NJ>	MP:0003724,increased susceptibility to induced arthritis
MGI:3716490	Lctlp2<DBA/1J>	MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:3716491	Lctlp2<FVB/NJ>	MP:0003724,increased susceptibility to induced arthritis
MGI:6274975	Lctl<tm1.1Gwis>	MP:0001303,abnormal lens morphology|MP:0005545,abnormal lens development|MP:0010255,cortical cataract
MGI:5007213	Lctl<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:5704514	Lct<tm1b(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0011965,decreased total retina thickness
MGI:6336142	Ldaf1<em1(IMPC)Kmpc>	MP:0001297,microphthalmia|MP:0001399,hyperactivity|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0003271,abnormal duodenum morphology
MGI:5637035	Ldah<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology
MGI:4399711	Ldah<tm1(KOMP)Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:5804186	Ldah<tm1Mrtn>	MP:0003212,increased susceptibility to age related obesity|MP:0006325,impaired hearing|MP:0009219,increased prostate intraepithelial neoplasia incidence
MGI:5501525	Ldb1<tm1.1Gsv>	MP:0000259,abnormal vascular development|MP:0001718,abnormal visceral yolk sac morphology|MP:0004229,abnormal embryonic erythropoiesis
MGI:2449177	Ldb1<tm1Lmgd>	MP:0000266,abnormal heart morphology|MP:0000428,abnormal craniofacial morphology|MP:0000474,abnormal foregut morphology|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0001721,absent visceral yolk sac blood islands|MP:0001726,abnormal allantois morphology|MP:0001730,embryonic growth arrest|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0002230,abnormal primitive streak formation|MP:0002231,abnormal primitive streak morphology|MP:0002396,abnormal hematopoietic system morphology/development|MP:0003087,absent allantois|MP:0003400,kinked neural tube|MP:0004713,split notochord|MP:0005657,abnormal neural plate morphology|MP:0008391,abnormal primordial germ cell morphology|MP:0009657,failure of chorioallantoic fusion|MP:0011092,embryonic lethality, complete penetrance|MP:0011388,absent heart|MP:0011733,fused somites|MP:0012133,absent midbrain-hindbrain boundary|MP:0012135,embryonic-extraembryonic boundary constriction|MP:0012156,rostral-caudal axis duplication|MP:0012157,rostral body truncation|MP:0012181,increased somite number|MP:0012792,abnormal rhombomere 3 morphology|MP:0012800,abnormal rhombomere 5 morphology
MGI:3714803	Ldb1<tm1Witz>	MP:0002083,premature death|MP:0002705,dilated renal tubule|MP:0002871,albuminuria|MP:0008059,abnormal podocyte foot process morphology|MP:0008140,podocyte foot process effacement|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011363,renal glomerulus atrophy|MP:0011402,renal cast|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011455,absent glomerular endothelium fenestra|MP:0011483,renal glomerular synechia
MGI:3719683	Ldb1<tm2Lmgd>	MP:0000852,small cerebellum|MP:0000853,absent cerebellar foliation|MP:0000880,decreased Purkinje cell number
MGI:3528495	Ldb2<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:2652058	Ldb3<tm1Chen>	MP:0000747,muscle weakness|MP:0000751,myopathy|MP:0000759,abnormal skeletal muscle morphology|MP:0001524,impaired limb coordination|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0003158,dysphagia|MP:0005329,abnormal myocardium layer morphology|MP:0010021,heart vascular congestion|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5636977	Ldb3<tm2b(EUCOMM)Hmgu>	MP:0000428,abnormal craniofacial morphology|MP:0001157,small seminal vesicle|MP:0001402,decreased locomotor activity|MP:0002606,increased basophil cell number|MP:0003068,enlarged kidney|MP:0010392,prolonged QRS complex duration|MP:0011100,preweaning lethality, complete penetrance|MP:0012362,increased large unstained cell number
MGI:2652070	Ldb3<tm2Chen>	MP:0000751,myopathy|MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0003141,cardiac fibrosis|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009413,skeletal muscle fiber atrophy|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2652078	Ldb3<tm3Chen>	MP:0000751,myopathy|MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0003141,cardiac fibrosis|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009413,skeletal muscle fiber atrophy|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3832388	Ldb3<tm4Chen>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000280,thin ventricular wall|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003920,abnormal heart right ventricle morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004091,abnormal Z line morphology|MP:0005294,abnormal heart ventricle morphology|MP:0010519,atrioventricular block|MP:0010725,thin interventricular septum|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:4949671	Ldb3<tm5.2Chen>	MP:0005385,cardiovascular system phenotype
MGI:4949672	Ldb3<tm6.2Chen>	MP:0000266,abnormal heart morphology|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003915,increased heart left ventricle weight|MP:0004091,abnormal Z line morphology|MP:0004485,increased response of heart to induced stress|MP:0005140,decreased cardiac muscle contractility|MP:0010563,increased heart right ventricle size|MP:0010579,increased heart left ventricle size|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014316,decreased heart left ventricle posterior wall thickness
MGI:3776298	Ldha<a-m11Neu>	MP:0011085,postnatal lethality, complete penetrance
MGI:3776296	Ldha<a-m12Neu>	MP:0011085,postnatal lethality, complete penetrance
MGI:2384559	Ldha<a-m1Neu>	MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0000693,spleen hyperplasia|MP:0001585,hemolytic anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002981,increased liver weight|MP:0004952,increased spleen weight|MP:0005344,increased circulating bilirubin level|MP:0005630,increased lung weight|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008246,abnormal leukocyte morphology
MGI:3776262	Ldha<a-m2Neu>	MP:0005397,hematopoietic system phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3776263	Ldha<a-m3Neu>	MP:0001265,decreased body size|MP:0002874,decreased hemoglobin content|MP:0005397,hematopoietic system phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3776264	Ldha<a-m4Neu>	MP:0005397,hematopoietic system phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3776265	Ldha<a-m5Neu>	MP:0002169,no abnormal phenotype detected
MGI:3776266	Ldha<a-m6Neu>	MP:0002169,no abnormal phenotype detected|MP:0005397,hematopoietic system phenotype
MGI:3776295	Ldha<a-m7Neu>	MP:0005584,abnormal enzyme/coenzyme activity|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3776269	Ldha<a-m9Neu>	MP:0005584,abnormal enzyme/coenzyme activity
MGI:2384558	Ldha<b>	MP:0002169,no abnormal phenotype detected
MGI:6393531	Ldhal6b<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response
MGI:6830920	Ldhal6b<em1Osb>	MP:0005389,reproductive system phenotype
MGI:2449589	Ldha<l7R2-1R>	MP:0011100,preweaning lethality, complete penetrance
MGI:4432392	Ldha<tm1a(EUCOMM)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0002942,decreased circulating alanine transaminase level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005571,decreased lactate dehydrogenase level|MP:0010025,decreased total body fat amount
MGI:8242645	Ldhb<tm1.2Choy>	MP:0002855,abnormal cochlear ganglion morphology|MP:0004402,decreased cochlear outer hair cell number|MP:0004488,type II spiral ligament fibrocyte degeneration|MP:0004490,type IV spiral ligament fibrocyte degeneration|MP:0004523,decreased cochlear hair cell stereocilia number|MP:0004748,increased susceptibility to age-related hearing loss|MP:0006042,increased apoptosis|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014345,abnormal neuron mitochondrial morphology
MGI:5637210	Ldhb<tm1b(KOMP)Wtsi>	MP:0006358,absent pinna reflex
MGI:3775042	Ldhc<tm1Erg>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0004543,abnormal sperm physiology|MP:0004884,abnormal testis physiology|MP:0005389,reproductive system phenotype
MGI:5692870	Ldlrad1<tm1b(KOMP)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0011239,abnormal skin coloration
MGI:6509990	Ldlrad3<em1Diam>	MP:0020941,decreased susceptibility to Togaviridae infection
MGI:6509991	Ldlrad3<em2Diam>	MP:0020941,decreased susceptibility to Togaviridae infection
MGI:5636938	Ldlrad4<tm1b(EUCOMM)Wtsi>	MP:0000223,decreased monocyte cell number|MP:0002941,increased circulating alanine transaminase level
MGI:3529295	Ldlrap1<Gt(OST149604)Lex>	MP:0000182,increased circulating LDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:2670480	Ldlrap1<tm1Her>	MP:0000181,abnormal circulating LDL cholesterol level|MP:0000182,increased circulating LDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0005178,increased circulating cholesterol level
MGI:2683091	Ldlr<Hlb301>	MP:0001556,increased circulating HDL cholesterol level|MP:0002830,gallstones|MP:0003099,retina detachment|MP:0004778,increased macrophage derived foam cell number|MP:0005178,increased circulating cholesterol level|MP:0005339,increased susceptibility to atherosclerosis|MP:0005376,homeostasis/metabolism phenotype
MGI:3811877	Ldlr<Rgsc366>	MP:0005178,increased circulating cholesterol level
MGI:5695977	Ldlr<tm1b(EUCOMM)Wtsi>	MP:0001556,increased circulating HDL cholesterol level|MP:0004738,abnormal auditory brainstem response|MP:0005178,increased circulating cholesterol level|MP:0008810,increased circulating iron level|MP:0010052,increased grip strength|MP:0011897,decreased circulating unsaturated transferrin level
MGI:1857212	Ldlr<tm1Her>	MP:0000136,abnormal microglial cell morphology|MP:0000180,abnormal circulating cholesterol level|MP:0000181,abnormal circulating LDL cholesterol level|MP:0000182,increased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000187,abnormal triglyceride level|MP:0000414,alopecia|MP:0000609,abnormal liver physiology|MP:0000639,abnormal adrenal gland morphology|MP:0000807,abnormal hippocampus morphology|MP:0000952,abnormal CNS glial cell morphology|MP:0001192,scaly skin|MP:0001200,thick skin|MP:0001261,obese|MP:0001463,abnormal spatial learning|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001556,increased circulating HDL cholesterol level|MP:0001559,hyperglycemia|MP:0001860,liver inflammation|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0002182,abnormal astrocyte morphology|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002665,decreased circulating corticosterone level|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003329,amyloid beta deposits|MP:0003333,liver fibrosis|MP:0003674,oxidative stress|MP:0003718,maternal effect|MP:0003887,increased hepatocyte apoptosis|MP:0003961,decreased lean body mass|MP:0003975,increased circulating VLDL triglyceride level|MP:0003982,increased cholesterol level|MP:0004112,abnormal arteriole morphology|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology|MP:0005278,abnormal cholesterol homeostasis|MP:0005293,impaired glucose tolerance|MP:0005311,abnormal circulating amino acid level|MP:0005331,insulin resistance|MP:0005334,abnormal fat pad morphology|MP:0005338,atherosclerotic lesions|MP:0005339,increased susceptibility to atherosclerosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005416,abnormal circulating protein level|MP:0005455,increased susceptibility to weight gain|MP:0005458,increased percent body fat/body weight|MP:0005559,increased circulating glucose level|MP:0006238,abnormal choriocapillaris morphology|MP:0008431,abnormal short-term spatial reference memory|MP:0008553,increased circulating tumor necrosis factor level|MP:0008571,abnormal synaptic bouton morphology|MP:0008584,photoreceptor outer segment degeneration|MP:0008594,decreased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0009355,increased liver triglyceride level|MP:0009538,abnormal synapse morphology|MP:0010027,increased liver cholesterol level|MP:0010052,increased grip strength|MP:0010182,decreased susceptibility to weight gain|MP:0014370,impaired spatial working memory|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis|MP:0031391,increased locomotor activity
MGI:3691296	Ldlr<tm1(LDLR)Mae>	MP:0000186,decreased circulating HDL cholesterol level|MP:0003949,abnormal circulating lipid level|MP:0005179,decreased circulating cholesterol level
MGI:3775951	Ldlr<tm2(AFP)Alb>	MP:0002169,no abnormal phenotype detected
MGI:5691781	Ldoc1<tm1.1Tmki>	MP:0001386,abnormal maternal nurturing|MP:0001711,abnormal placenta morphology|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0005186,increased circulating progesterone level|MP:0011384,abnormal progesterone level|MP:0012008,delayed parturition|MP:0030989,decreased spongiotrophoblast cell number
MGI:7336225	Leap2<em1Jmz>	MP:0001431,abnormal eating behavior|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003961,decreased lean body mass|MP:0004890,decreased energy expenditure|MP:0005137,increased growth hormone level|MP:0005290,decreased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0011939,increased food intake|MP:0020234,decreased basal metabolism|MP:0031115,macrovesicular hepatic steatosis|MP:0031392,hypoactivity
MGI:6404110	Leat1<Tg(Tyr)442Ove>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0003550,short perineum|MP:0003718,maternal effect
MGI:1856617	lec	MP:0000474,abnormal foregut morphology|MP:0001575,cyanosis|MP:0003160,abnormal esophagus development|MP:0003321,tracheoesophageal fistula
MGI:3045975	Lect2<tm1Ymg>	MP:0001860,liver inflammation|MP:0002442,abnormal leukocyte physiology|MP:0003009,abnormal cytokine secretion|MP:0005015,increased T cell number|MP:0006413,increased T cell apoptosis
MGI:5708280	Lef1<tm1.1(KOMP)Vlcg>	MP:0000220,increased monocyte cell number|MP:0000428,abnormal craniofacial morphology|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:1926601	Lef1<tm1Rug>	MP:0000094,absent alveolar process|MP:0000118,arrest of tooth development|MP:0000125,absent incisors|MP:0000364,abnormal vascular regression|MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000382,underdeveloped hair follicles|MP:0000394,absent hair follicle melanin granules|MP:0000414,alopecia|MP:0000448,pointed snout|MP:0000629,absent mammary gland|MP:0000814,absent dentate gyrus|MP:0000862,absent barrels in primary somatosensory cortex|MP:0000908,absent mesencephalic trigeminal nucleus|MP:0001199,thin skin|MP:0001265,decreased body size|MP:0001284,absent vibrissae|MP:0001289,persistence of hyaloid vascular system|MP:0002792,abnormal retina vasculature morphology|MP:0003704,abnormal hair follicle development|MP:0003931,absent molars|MP:0004790,absent upper incisors|MP:0004791,absent lower incisors|MP:0005387,immune system phenotype|MP:0008262,abnormal hippocampus region morphology|MP:0008843,absent subcutaneous adipose tissue|MP:0009097,absent endometrial glands|MP:0011085,postnatal lethality, complete penetrance|MP:0013400,abnormal endometrial gland development|MP:0013785,abnormal mammary gland bud morphology|MP:0030610,absent teeth
MGI:1933764	Lef1<tm2Rug>	MP:0000808,abnormal hippocampus development|MP:0000809,absent hippocampus|MP:0000814,absent dentate gyrus|MP:0002152,abnormal brain morphology
MGI:5638562	Lefty1<tm1b(KOMP)Wtsi>	MP:0001406,abnormal gait|MP:0005627,increased circulating potassium level|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:2179534	Lefty1<tm1Hmd>	MP:0000266,abnormal heart morphology|MP:0000284,double outlet right ventricle|MP:0000542,left-sided isomerism|MP:0000598,abnormal liver morphology|MP:0002264,abnormal bronchus morphology|MP:0002725,abnormal vein morphology|MP:0002766,situs inversus|MP:0003178,left pulmonary isomerism|MP:0004110,transposition of great arteries|MP:0004158,right aortic arch|MP:0006063,abnormal inferior vena cava morphology|MP:0006065,abnormal heart position or orientation|MP:0006123,tricuspid valve atresia|MP:0006126,abnormal cardiac outflow tract development|MP:0008461,left atrial isomerism|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010413,complete atrioventricular septal defect|MP:0010425,abnormal heart and great vessel attachment|MP:0010668,abnormal hepatic portal vein morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011255,abnormal anterior visceral endoderm cell migration|MP:0011327,abnormal left renal vein morphology|MP:0011569,abnormal azygos vein morphology
MGI:2449694	Lefty1<tm1Sla>	MP:0003178,left pulmonary isomerism
MGI:2179551	Lefty2<tm1Hmd>	MP:0000932,absent notochord|MP:0001672,abnormal embryo development|MP:0001675,abnormal ectoderm development|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0002084,abnormal developmental patterning|MP:0002231,abnormal primitive streak morphology|MP:0006386,absent somites|MP:0009331,absent primitive node|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011257,abnormal head fold morphology|MP:0011388,absent heart
MGI:2183818	Lefty2<tm2Hmd>	MP:0000266,abnormal heart morphology|MP:0000284,double outlet right ventricle|MP:0000542,left-sided isomerism|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0001706,abnormal left-right axis patterning|MP:0003284,abnormal large intestine placement|MP:0003342,accessory spleen|MP:0003872,absent heart right ventricle|MP:0004110,transposition of great arteries|MP:0005388,respiratory system phenotype|MP:0006063,abnormal inferior vena cava morphology|MP:0006123,tricuspid valve atresia|MP:0008461,left atrial isomerism|MP:0010413,complete atrioventricular septal defect|MP:0010426,abnormal heart and great artery attachment|MP:0010668,abnormal hepatic portal vein morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3033948	Leg1<MOLD/Rk>	MP:0001661,extended life span
MGI:6459762	Lelp1<em1Osb>	MP:0005389,reproductive system phenotype
MGI:7444804	Lemd2<em1Eno>	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0000280,thin ventricular wall|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0003140,dilated heart atrium|MP:0003141,cardiac fibrosis|MP:0003896,prolonged PR interval|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005369,muscle phenotype|MP:0008022,dilated heart ventricle|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010392,prolonged QRS complex duration|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010519,atrioventricular block|MP:0011925,abnormal heart echocardiography feature
MGI:6257680	Lemd2<em1(IMPC)Bay>	MP:0000689,abnormal spleen morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011959,abnormal eye posterior chamber depth|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:7444807	Lemd2<em2Eno>	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0001265,decreased body size|MP:0001544,abnormal cardiovascular system physiology|MP:0002795,dilated cardiomyopathy|MP:0003140,dilated heart atrium|MP:0004215,abnormal myocardial fiber physiology|MP:0008022,dilated heart ventricle|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011925,abnormal heart echocardiography feature
MGI:3871218	Lemd2<Gt(DD0639)Wtsi>	MP:0000267,abnormal heart development|MP:0000841,abnormal hindbrain morphology|MP:0000897,abnormal midbrain morphology|MP:0000929,open neural tube|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001577,anemia|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0001915,intracranial hemorrhage|MP:0002652,thin myocardium|MP:0003935,abnormal craniofacial development|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005369,muscle phenotype|MP:0006069,abnormal retina neuronal layer morphology|MP:0006301,abnormal mesenchyme morphology|MP:0006346,small pharyngeal arch|MP:0008932,abnormal embryonic tissue physiology|MP:0010503,myocardial trabeculae hypoplasia|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011827,impaired neuron differentiation|MP:0012701,increased embryonic neuroepithelium apoptosis|MP:0012706,decreased embryonic neuroepithelial cell proliferation|MP:0013906,absent embryonic telencephalon|MP:0031328,delayed skeletal muscle regeneration
MGI:7425790	Lemd3<em1(IMPC)Bay>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0002953,thick ventricular wall|MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0020870,decreased thigmotaxis
MGI:3703328	Lemd3<Gt(XST167)Byg>	MP:0000259,abnormal vascular development|MP:0000291,enlarged pericardium|MP:0001722,pale yolk sac|MP:0003111,abnormal cell nucleus morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:4950249	Leo1<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5447548	Lep<m1Btlr>	MP:0001261,obese|MP:0014142,increased body fat mass
MGI:4880027	Lep<m1Yst>	MP:0000005,increased brown adipose tissue amount|MP:0000008,increased white adipose tissue amount|MP:0000603,pale liver|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001261,obese|MP:0001431,abnormal eating behavior|MP:0001552,increased circulating triglyceride level|MP:0001762,polyuria|MP:0001924,infertility|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002833,increased heart weight|MP:0002981,increased liver weight|MP:0003867,increased defecation amount|MP:0003917,increased kidney weight|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005335,abnormal gonadal fat pad morphology|MP:0005425,increased macrophage cell number|MP:0005534,decreased body temperature|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0009118,increased white fat cell size|MP:0009124,increased brown fat cell lipid droplet size|MP:0009130,increased white fat cell number|MP:0009292,increased inguinal fat pad weight|MP:0010024,increased total body fat amount
MGI:5789539	Lep<m2Btlr>	MP:0001261,obese
MGI:1856424	Lep<ob>	MP:0000067,osteopetrosis|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000180,abnormal circulating cholesterol level|MP:0000182,increased circulating LDL cholesterol level|MP:0000188,abnormal circulating glucose level|MP:0000189,hypoglycemia|MP:0000278,abnormal myocardial fiber morphology|MP:0000343,abnormal response to cardiac infarction|MP:0000477,abnormal intestine morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001134,absent corpus luteum|MP:0001142,abnormal vagina orifice morphology|MP:0001216,abnormal epidermal layer morphology|MP:0001257,increased body length|MP:0001258,decreased body length|MP:0001259,abnormal body weight|MP:0001260,increased body weight|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001272,increased metastatic potential|MP:0001402,decreased locomotor activity|MP:0001433,polyphagia|MP:0001501,abnormal sleep pattern|MP:0001544,abnormal cardiovascular system physiology|MP:0001547,abnormal lipid level|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001556,increased circulating HDL cholesterol level|MP:0001559,hyperglycemia|MP:0001596,hypotension|MP:0001663,abnormal digestive system physiology|MP:0001731,abnormal postnatal growth|MP:0001744,hypersecretion of corticosterone|MP:0001745,increased circulating corticosterone level|MP:0001759,increased urine glucose level|MP:0001762,polyuria|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001922,reduced male fertility|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001970,abnormal pain threshold|MP:0001973,increased thermal nociceptive threshold|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002108,abnormal muscle morphology|MP:0002113,abnormal skeleton development|MP:0002164,abnormal gland physiology|MP:0002310,decreased susceptibility to hepatic steatosis|MP:0002397,abnormal bone marrow morphology|MP:0002498,abnormal acute inflammation|MP:0002625,heart left ventricle hypertrophy|MP:0002628,hepatic steatosis|MP:0002780,decreased circulating testosterone level|MP:0002792,abnormal retina vasculature morphology|MP:0002833,increased heart weight|MP:0002865,increased growth rate|MP:0002871,albuminuria|MP:0002882,abnormal neuron morphology|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0002970,abnormal white adipose tissue morphology|MP:0002981,increased liver weight|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003058,increased insulin secretion|MP:0003059,decreased insulin secretion|MP:0003068,enlarged kidney|MP:0003077,abnormal cell cycle|MP:0003109,short femur|MP:0003177,allodynia|MP:0003194,abnormal frequency of paradoxical sleep|MP:0003215,renal interstitial fibrosis|MP:0003333,liver fibrosis|MP:0003339,decreased pancreatic beta cell number|MP:0003503,decreased activity of thyroid gland|MP:0003562,abnormal pancreatic beta cell physiology|MP:0003564,abnormal insulin secretion|MP:0003631,nervous system phenotype|MP:0003645,increased pancreatic beta cell number|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003674,oxidative stress|MP:0003691,abnormal microglial cell physiology|MP:0003806,abnormal nucleotide metabolism|MP:0003887,increased hepatocyte apoptosis|MP:0003917,increased kidney weight|MP:0003953,abnormal hormone level|MP:0003960,increased lean body mass|MP:0003961,decreased lean body mass|MP:0003963,abnormal corticosterone level|MP:0003982,increased cholesterol level|MP:0004016,decreased bone mass|MP:0004112,abnormal arteriole morphology|MP:0004183,abnormal sympathetic nervous system physiology|MP:0004215,abnormal myocardial fiber physiology|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004351,short humerus|MP:0004564,increased myocardial fiber size|MP:0004686,decreased length of long bones|MP:0004819,decreased skeletal muscle mass|MP:0004847,abnormal liver weight|MP:0004852,decreased testis weight|MP:0004883,abnormal vascular wound healing|MP:0004910,decreased seminal vesicle weight|MP:0004924,abnormal behavior|MP:0005095,decreased T cell proliferation|MP:0005129,increased adrenocorticotropin level|MP:0005140,decreased cardiac muscle contractility|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005215,abnormal pancreatic islet morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005264,glomerulosclerosis|MP:0005288,abnormal oxygen consumption|MP:0005289,increased oxygen consumption|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005326,abnormal podocyte morphology|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005407,hyperalgesia|MP:0005418,abnormal circulating hormone level|MP:0005449,abnormal food intake|MP:0005452,abnormal adipose tissue amount|MP:0005458,increased percent body fat/body weight|MP:0005491,pancreatic islet hyperplasia|MP:0005534,decreased body temperature|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0005605,increased bone mass|MP:0005620,abnormal muscle contractility|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0006319,abnormal epididymal fat pad morphology|MP:0008045,decreased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008396,abnormal osteoclast differentiation|MP:0008439,abnormal cortical plate morphology|MP:0008469,abnormal protein level|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008705,increased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0008814,decreased nerve conduction velocity|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009006,prolonged estrous cycle|MP:0009011,prolonged diestrus|MP:0009017,prolonged estrus|MP:0009108,increased pancreas weight|MP:0009113,increased pancreatic beta cell mass|MP:0009114,decreased pancreatic beta cell mass|MP:0009115,abnormal fat cell morphology|MP:0009131,decreased white fat cell number|MP:0009167,increased pancreatic islet number|MP:0009171,enlarged pancreatic islets|MP:0009172,small pancreatic islets|MP:0009254,disorganized pancreatic islets|MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009294,increased interscapular fat pad weight|MP:0009339,decreased splenocyte number|MP:0009355,increased liver triglyceride level|MP:0009356,decreased liver triglyceride level|MP:0009400,decreased skeletal muscle fiber size|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009436,fragmentation of sleep/wake states|MP:0009643,abnormal urine homeostasis|MP:0010027,increased liver cholesterol level|MP:0010080,abnormal hepatocyte physiology|MP:0010955,abnormal respiratory electron transport chain|MP:0011049,impaired adaptive thermogenesis|MP:0011067,abnormal somatostatin level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011125,decreased primary ovarian follicle number|MP:0011294,renal glomerulus hypertrophy|MP:0011353,expanded mesangial matrix|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011430,mesangiolysis|MP:0011478,abnormal urine catecholamine level|MP:0011939,increased food intake|MP:0011940,decreased food intake|MP:0012703,decreased embryonic neuroepithelium thickness|MP:0012706,decreased embryonic neuroepithelial cell proliferation|MP:0013279,increased fasting circulating glucose level|MP:0013795,abnormal colon goblet cell morphology|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014568,decreased circulating pancreatic peptide level|MP:0031115,macrovesicular hepatic steatosis|MP:0031381,decreased secondary ovarian follicle number
MGI:3847119	Lepr<brta>	MP:0001261,obese|MP:0001559,hyperglycemia|MP:0001924,infertility
MGI:1856009	Lepr<db>	MP:0000003,abnormal adipose tissue morphology|MP:0000180,abnormal circulating cholesterol level|MP:0000182,increased circulating LDL cholesterol level|MP:0000188,abnormal circulating glucose level|MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0000259,abnormal vascular development|MP:0000272,abnormal aorta morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0000343,abnormal response to cardiac infarction|MP:0000488,abnormal intestinal epithelium morphology|MP:0000592,short tail|MP:0000939,decreased motor neuron number|MP:0001119,abnormal female reproductive system morphology|MP:0001120,abnormal uterus morphology|MP:0001143,constricted vagina orifice|MP:0001258,decreased body length|MP:0001260,increased body weight|MP:0001261,obese|MP:0001263,weight loss|MP:0001272,increased metastatic potential|MP:0001380,decreased male mating frequency|MP:0001402,decreased locomotor activity|MP:0001426,polydipsia|MP:0001431,abnormal eating behavior|MP:0001433,polyphagia|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001544,abnormal cardiovascular system physiology|MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001556,increased circulating HDL cholesterol level|MP:0001559,hyperglycemia|MP:0001560,abnormal circulating insulin level|MP:0001661,extended life span|MP:0001663,abnormal digestive system physiology|MP:0001745,increased circulating corticosterone level|MP:0001762,polyuria|MP:0001859,kidney inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001899,absent long-term depression|MP:0001926,female infertility|MP:0002063,abnormal learning/memory/conditioning|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002113,abnormal skeleton development|MP:0002128,abnormal blood circulation|MP:0002135,abnormal kidney morphology|MP:0002206,abnormal CNS synaptic transmission|MP:0002306,abnormal functional residual capacity|MP:0002314,abnormal respiratory mechanics|MP:0002333,abnormal lung compliance|MP:0002498,abnormal acute inflammation|MP:0002575,increased circulating ketone body level|MP:0002625,heart left ventricle hypertrophy|MP:0002628,hepatic steatosis|MP:0002637,small uterus|MP:0002644,decreased circulating triglyceride level|MP:0002693,abnormal pancreas physiology|MP:0002710,increased glucagon secretion|MP:0002727,decreased circulating insulin level|MP:0002805,abnormal conditioned taste aversion behavior|MP:0002843,decreased systemic arterial blood pressure|MP:0002871,albuminuria|MP:0002908,delayed wound healing|MP:0002962,increased urine protein level|MP:0002970,abnormal white adipose tissue morphology|MP:0002981,increased liver weight|MP:0003025,increased vasoconstriction|MP:0003068,enlarged kidney|MP:0003109,short femur|MP:0003333,liver fibrosis|MP:0003393,decreased cardiac output|MP:0003562,abnormal pancreatic beta cell physiology|MP:0003632,abnormal nervous system morphology|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003645,increased pancreatic beta cell number|MP:0003651,abnormal axon extension|MP:0003718,maternal effect|MP:0003806,abnormal nucleotide metabolism|MP:0003819,increased left ventricle diastolic pressure|MP:0003871,abnormal myelin sheath morphology|MP:0003887,increased hepatocyte apoptosis|MP:0003917,increased kidney weight|MP:0003949,abnormal circulating lipid level|MP:0003953,abnormal hormone level|MP:0003961,decreased lean body mass|MP:0003982,increased cholesterol level|MP:0003985,renal fibrosis|MP:0004120,cardiac ischemia|MP:0004193,abnormal kidney papilla morphology|MP:0004195,abnormal kidney calyx morphology|MP:0004260,enlarged placenta|MP:0004564,increased myocardial fiber size|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0004883,abnormal vascular wound healing|MP:0004896,abnormal endometrium morphology|MP:0004905,decreased uterus weight|MP:0004924,abnormal behavior|MP:0005140,decreased cardiac muscle contractility|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005215,abnormal pancreatic islet morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005257,abnormal intraocular pressure|MP:0005264,glomerulosclerosis|MP:0005288,abnormal oxygen consumption|MP:0005290,decreased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005293,impaired glucose tolerance|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005331,insulin resistance|MP:0005333,decreased heart rate|MP:0005376,homeostasis/metabolism phenotype|MP:0005403,abnormal nerve conduction|MP:0005404,abnormal axon morphology|MP:0005449,abnormal food intake|MP:0005455,increased susceptibility to weight gain|MP:0005458,increased percent body fat/body weight|MP:0005491,pancreatic islet hyperplasia|MP:0005534,decreased body temperature|MP:0005540,decreased urine albumin level|MP:0005551,abnormal eye electrophysiology|MP:0005553,increased circulating creatinine level|MP:0005557,increased creatinine clearance|MP:0005559,increased circulating glucose level|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0005576,decreased pulmonary ventilation|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005645,abnormal hypothalamus physiology|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006319,abnormal epididymal fat pad morphology|MP:0006353,increased glycosylated hemoglobin level|MP:0008246,abnormal leukocyte morphology|MP:0008396,abnormal osteoclast differentiation|MP:0008414,abnormal spatial reference memory|MP:0008596,increased circulating interleukin-6 level|MP:0008705,increased interleukin-6 secretion|MP:0008721,abnormal chemokine level|MP:0008722,abnormal chemokine secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0008751,abnormal interleukin level|MP:0008869,anovulation|MP:0008962,abnormal carbon dioxide production|MP:0008964,decreased carbon dioxide production|MP:0009009,absent estrous cycle|MP:0009021,absent estrus|MP:0009113,increased pancreatic beta cell mass|MP:0009118,increased white fat cell size|MP:0009285,increased gonadal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0009642,abnormal blood homeostasis|MP:0009673,increased birth weight|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009815,decreased prostaglandin level|MP:0010024,increased total body fat amount|MP:0010875,increased bone volume|MP:0010934,increased subcutaneous adipose tissue amount|MP:0010955,abnormal respiratory electron transport chain|MP:0010957,abnormal aerobic respiration|MP:0011014,decreased core body temperature|MP:0011049,impaired adaptive thermogenesis|MP:0011067,abnormal somatostatin level|MP:0011294,renal glomerulus hypertrophy|MP:0011339,abnormal glomerular mesangium morphology|MP:0011353,expanded mesangial matrix|MP:0011501,increased glomerular capsule space|MP:0011939,increased food intake|MP:0013246,abnormal peptide metabolism|MP:0013279,increased fasting circulating glucose level|MP:0014121,increased pancreatic islet cell apoptosis|MP:0014142,increased body fat mass|MP:0014441,decreased response to leptin|MP:0020089,increased susceptibility to diet-induced non-insulin dependent diabetes|MP:0020477,abnormal locomotor circadian rhythm|MP:0020518,renal glomerular protein deposits|MP:0020519,renal glomerular immunoglobulin deposits|MP:0030968,decreased circulating adiponectin level|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis|MP:0031269,increased susceptibility to diet-induced hepatic steatosis
MGI:2448674	Lepr<db-1R>	MP:0001260,increased body weight|MP:0001261,obese
MGI:3784992	Lepr<Db-2Btlr>	MP:0001260,increased body weight|MP:0001261,obese|MP:0001924,infertility
MGI:1856010	Lepr<db-2J>	MP:0001143,constricted vagina orifice|MP:0001380,decreased male mating frequency|MP:0001926,female infertility|MP:0002637,small uterus|MP:0002716,small male preputial gland|MP:0003953,abnormal hormone level|MP:0005130,decreased follicle stimulating hormone level|MP:0009010,abnormal diestrus|MP:0009019,abnormal metestrus
MGI:1856012	Lepr<db-3J>	MP:0000188,abnormal circulating glucose level|MP:0000189,hypoglycemia|MP:0001260,increased body weight|MP:0001261,obese|MP:0001263,weight loss|MP:0001433,polyphagia|MP:0001559,hyperglycemia|MP:0001560,abnormal circulating insulin level|MP:0001924,infertility|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002712,increased circulating glucagon level|MP:0002891,increased insulin sensitivity|MP:0003645,increased pancreatic beta cell number|MP:0005220,abnormal exocrine pancreas morphology|MP:0005491,pancreatic islet hyperplasia|MP:0009176,increased pancreatic alpha cell number
MGI:2683234	Lepr<db-5J>	MP:0000188,abnormal circulating glucose level|MP:0001261,obese|MP:0001263,weight loss|MP:0001433,polyphagia|MP:0001559,hyperglycemia|MP:0001869,pancreas inflammation|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005215,abnormal pancreatic islet morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005455,increased susceptibility to weight gain|MP:0005458,increased percent body fat/body weight|MP:0005491,pancreatic islet hyperplasia|MP:0005580,periinsulitis|MP:0005669,increased circulating leptin level|MP:0009255,degranulated pancreatic beta cells
MGI:3770610	Lepr<db-9J>	MP:0000642,enlarged adrenal glands|MP:0000643,absent adrenal medulla|MP:0001264,increased body size|MP:0001559,hyperglycemia|MP:0001923,reduced female fertility|MP:0002628,hepatic steatosis|MP:0002680,decreased corpora lutea number|MP:0002682,decreased mature ovarian follicle number|MP:0002727,decreased circulating insulin level|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005431,decreased oocyte number|MP:0008295,abnormal adrenal gland zona reticularis morphology|MP:0009255,degranulated pancreatic beta cells|MP:0010400,increased liver glycogen level
MGI:1856011	Lepr<db-ad>	MP:0001260,increased body weight|MP:0001762,polyuria|MP:0002079,increased circulating insulin level|MP:0005559,increased circulating glucose level|MP:0011939,increased food intake
MGI:3784988	Lepr<Db-Btlr>	MP:0001260,increased body weight|MP:0001261,obese|MP:0001559,hyperglycemia|MP:0001924,infertility
MGI:2151179	Lepr<db-dmpg>	MP:0001261,obese|MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0005217,abnormal pancreatic beta cell morphology
MGI:3714780	Lepr<db-lb>	MP:0001261,obese|MP:0001547,abnormal lipid level|MP:0002628,hepatic steatosis|MP:0004875,increased mean systemic arterial blood pressure|MP:0005331,insulin resistance|MP:0008821,increased blood uric acid level|MP:0031602,white adipose tissue inflammation
MGI:2182820	Lepr<db-NCSU>	MP:0001261,obese|MP:0001426,polydipsia|MP:0001433,polyphagia|MP:0001759,increased urine glucose level|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level
MGI:7545269	Lepr<db-Nokl>	MP:0000182,increased circulating LDL cholesterol level|MP:0000592,short tail|MP:0001261,obese|MP:0001402,decreased locomotor activity|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0001925,male infertility|MP:0002079,increased circulating insulin level|MP:0005178,increased circulating cholesterol level|MP:0005288,abnormal oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005669,increased circulating leptin level|MP:0006353,increased glycosylated hemoglobin level|MP:0008962,abnormal carbon dioxide production|MP:0009118,increased white fat cell size|MP:0009285,increased gonadal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0010934,increased subcutaneous adipose tissue amount|MP:0011014,decreased core body temperature|MP:0011939,increased food intake|MP:0013246,abnormal peptide metabolism|MP:0013279,increased fasting circulating glucose level|MP:0014142,increased body fat mass|MP:0020089,increased susceptibility to diet-induced non-insulin dependent diabetes|MP:0020477,abnormal locomotor circadian rhythm|MP:0030968,decreased circulating adiponectin level|MP:0031269,increased susceptibility to diet-induced hepatic steatosis
MGI:1856013	Lepr<db-Pas>	MP:0000005,increased brown adipose tissue amount|MP:0000592,short tail|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001261,obese|MP:0001433,polyphagia|MP:0001559,hyperglycemia|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002079,increased circulating insulin level|MP:0003109,short femur|MP:0004232,decreased muscle weight|MP:0005178,increased circulating cholesterol level|MP:0010024,increased total body fat amount
MGI:2151180	Lepr<db-rlpy>	MP:0001261,obese|MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0005217,abnormal pancreatic beta cell morphology
MGI:2151178	Lepr<db-rtnd>	MP:0001261,obese|MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0005217,abnormal pancreatic beta cell morphology
MGI:2182842	Lepr<KK>	MP:0001260,increased body weight|MP:0001261,obese|MP:0002079,increased circulating insulin level|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level
MGI:6304291	Lepr<m10Btlr>	MP:0001260,increased body weight
MGI:5563456	Lepr<m1Anu>	MP:0001261,obese
MGI:5780195	Lepr<m1Clo>	MP:0001261,obese|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0002628,hepatic steatosis|MP:0005491,pancreatic islet hyperplasia
MGI:3817472	Lepr<m3Btlr>	MP:0001261,obese|MP:0001924,infertility|MP:0005376,homeostasis/metabolism phenotype
MGI:4442910	Lepr<m4Btlr>	MP:0001260,increased body weight
MGI:4839995	Lepr<m5Btlr>	MP:0000005,increased brown adipose tissue amount|MP:0001260,increased body weight|MP:0001261,obese|MP:0001402,decreased locomotor activity|MP:0001431,abnormal eating behavior|MP:0002079,increased circulating insulin level|MP:0002981,increased liver weight|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005669,increased circulating leptin level|MP:0008964,decreased carbon dioxide production|MP:0009298,increased mesenteric fat pad weight|MP:0010024,increased total body fat amount|MP:0010045,increased omental fat pad weight|MP:0010379,decreased respiratory quotient|MP:0011020,abnormal circadian temperature homeostasis
MGI:5609704	Lepr<m6Btlr>	MP:0001260,increased body weight
MGI:5806340	Lepr<m7Btlr>	MP:0002497,increased IgE level|MP:0005559,increased circulating glucose level|MP:0012555,decreased cell death|MP:0020001,decreased response to antigen
MGI:6269382	Lepr<m8Btlr>	MP:0001260,increased body weight|MP:0001261,obese|MP:0001405,impaired coordination|MP:0001525,impaired balance|MP:0002628,hepatic steatosis|MP:0002764,short tibia|MP:0004509,abnormal pelvic girdle bone morphology|MP:0005333,decreased heart rate|MP:0005458,increased percent body fat/body weight|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0014142,increased body fat mass
MGI:6286253	Lepr<m9Btlr>	MP:0001260,increased body weight
MGI:5637030	Leprotl1<tm1b(EUCOMM)Hmgu>	MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001513,limb grasping|MP:0001566,increased circulating phosphate level|MP:0002626,increased heart rate|MP:0002941,increased circulating alanine transaminase level|MP:0002953,thick ventricular wall|MP:0002968,increased circulating alkaline phosphatase level|MP:0003921,abnormal heart left ventricle morphology|MP:0004924,abnormal behavior|MP:0005599,increased cardiac muscle contractility|MP:0020870,decreased thigmotaxis
MGI:7662966	Leprot<tm1.2Damj>	MP:0000013,abnormal adipose tissue distribution|MP:0001876,decreased inflammatory response|MP:0002891,increased insulin sensitivity|MP:0003983,decreased cholesterol level|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0009285,increased gonadal fat pad weight|MP:0010934,increased subcutaneous adipose tissue amount|MP:0011940,decreased food intake|MP:0014434,decreased cytokine level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:4364337	Leprot<tm2a(KOMP)Wtsi>	MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010123,increased bone mineral content|MP:0011939,increased food intake
MGI:1888983	Lepr<Tg(Mth11)1Aig>	MP:0000599,enlarged liver|MP:0001261,obese|MP:0001426,polydipsia|MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level|MP:0001762,polyuria|MP:0002079,increased circulating insulin level
MGI:3511284	Lepr<tm1.1Chua>	MP:0000188,abnormal circulating glucose level|MP:0001260,increased body weight|MP:0001261,obese|MP:0001385,pup cannibalization|MP:0001402,decreased locomotor activity|MP:0001433,polyphagia|MP:0001727,abnormal embryo implantation|MP:0001777,abnormal body temperature homeostasis|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002079,increased circulating insulin level|MP:0002169,no abnormal phenotype detected|MP:0002272,abnormal nervous system electrophysiology|MP:0002907,abnormal parturition|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003058,increased insulin secretion|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003960,increased lean body mass|MP:0003961,decreased lean body mass|MP:0004183,abnormal sympathetic nervous system physiology|MP:0004514,dystocia|MP:0004811,abnormal neuron physiology|MP:0004890,decreased energy expenditure|MP:0005120,decreased circulating growth hormone level|MP:0005290,decreased oxygen consumption|MP:0005334,abnormal fat pad morphology|MP:0005335,abnormal gonadal fat pad morphology|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005450,abnormal energy expenditure|MP:0005457,abnormal percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005661,decreased circulating adrenaline level|MP:0005664,decreased circulating noradrenaline level|MP:0005669,increased circulating leptin level|MP:0006319,abnormal epididymal fat pad morphology|MP:0008329,decreased somatotroph cell number|MP:0008902,abnormal renal fat pad morphology|MP:0008903,abnormal mesenteric fat pad morphology|MP:0009285,increased gonadal fat pad weight|MP:0009288,increased epididymal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0010024,increased total body fat amount|MP:0010149,abnormal synaptic dopamine release|MP:0010831,lethality, incomplete penetrance|MP:0010934,increased subcutaneous adipose tissue amount|MP:0011014,decreased core body temperature|MP:0011939,increased food intake|MP:0012008,delayed parturition|MP:0014441,decreased response to leptin
MGI:2176775	Lepr<tm1.1Rck>	MP:0001261,obese
MGI:5049781	Lepr<tm1.1Rll>	MP:0005027,increased susceptibility to parasitic infection|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0008885,increased enterocyte apoptosis
MGI:3511285	Lepr<tm1.2Chua>	MP:0001260,increased body weight|MP:0001261,obese|MP:0001433,polyphagia|MP:0001559,hyperglycemia|MP:0001924,infertility|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0005455,increased susceptibility to weight gain|MP:0011049,impaired adaptive thermogenesis
MGI:5692557	Lepr<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000194,increased circulating calcium level|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000599,enlarged liver|MP:0000745,tremors|MP:0001157,small seminal vesicle|MP:0001363,increased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001512,trunk curl|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001556,increased circulating HDL cholesterol level|MP:0001566,increased circulating phosphate level|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002590,increased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002608,increased hematocrit|MP:0002644,decreased circulating triglyceride level|MP:0002834,decreased heart weight|MP:0002941,increased circulating alanine transaminase level|MP:0002965,increased circulating serum albumin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003020,decreased circulating chloride level|MP:0003179,thrombocytopenia|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0004953,decreased spleen weight|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005559,increased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0005568,increased circulating total protein level|MP:0005627,increased circulating potassium level|MP:0008806,increased circulating amylase level|MP:0008810,increased circulating iron level|MP:0010024,increased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010087,increased circulating fructosamine level|MP:0010124,decreased bone mineral content
MGI:3511283	Lepr<tm1Chua>	MP:0001261,obese|MP:0001433,polyphagia|MP:0001924,infertility|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0005455,increased susceptibility to weight gain|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0011049,impaired adaptive thermogenesis
MGI:5426228	Lepr<tm1Jke>	MP:0001261,obese|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001431,abnormal eating behavior|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002644,decreased circulating triglyceride level|MP:0002712,increased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003058,increased insulin secretion|MP:0003383,abnormal gluconeogenesis|MP:0005178,increased circulating cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005290,decreased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005560,decreased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0008963,increased carbon dioxide production|MP:0008964,decreased carbon dioxide production|MP:0009355,increased liver triglyceride level|MP:0009356,decreased liver triglyceride level|MP:0010024,increased total body fat amount|MP:0010025,decreased total body fat amount|MP:0010378,increased respiratory quotient|MP:0010379,decreased respiratory quotient|MP:0020087,increased susceptibility to non-insulin-dependent diabetes
MGI:2653294	Lepr<tm1Mgmj>	MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001261,obese|MP:0001433,polyphagia|MP:0001552,increased circulating triglyceride level|MP:0001882,abnormal lactation|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002843,decreased systemic arterial blood pressure|MP:0004883,abnormal vascular wound healing|MP:0005450,abnormal energy expenditure|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0009008,delayed estrous cycle|MP:0009009,absent estrous cycle|MP:0009021,absent estrus
MGI:2176774	Lepr<tm1Rck>	MP:0001261,obese|MP:0002169,no abnormal phenotype detected|MP:0005669,increased circulating leptin level|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3822311	Lepr<tm1Yli>	MP:0000188,abnormal circulating glucose level|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001261,obese|MP:0001402,decreased locomotor activity|MP:0001433,polyphagia|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002079,increased circulating insulin level|MP:0005288,abnormal oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005458,increased percent body fat/body weight|MP:0005535,abnormal body temperature|MP:0005669,increased circulating leptin level|MP:0011049,impaired adaptive thermogenesis
MGI:3713767	Lepr<tm2Mgmj>	MP:0001262,decreased body weight|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005334,abnormal fat pad morphology|MP:0005668,decreased circulating leptin level|MP:0009283,decreased gonadal fat pad weight
MGI:3822312	Lepr<tm2Yli>	MP:0000188,abnormal circulating glucose level|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001261,obese|MP:0001402,decreased locomotor activity|MP:0001433,polyphagia|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002079,increased circulating insulin level|MP:0005288,abnormal oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005458,increased percent body fat/body weight|MP:0005535,abnormal body temperature|MP:0005669,increased circulating leptin level|MP:0011049,impaired adaptive thermogenesis
MGI:4820542	Lepr<tm3.1Yli>	MP:0002079,increased circulating insulin level|MP:0003212,increased susceptibility to age related obesity|MP:0003313,abnormal locomotor activation|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005288,abnormal oxygen consumption|MP:0005449,abnormal food intake|MP:0005458,increased percent body fat/body weight|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0005669,increased circulating leptin level
MGI:3773731	Lepr<tm3(cre)Mgmj>	MP:0005378,growth/size/body region phenotype
MGI:4843181	Lepr<tm4Mgmj>	MP:0001119,abnormal female reproductive system morphology|MP:0001258,decreased body length|MP:0001260,increased body weight|MP:0001431,abnormal eating behavior|MP:0001926,female infertility|MP:0002079,increased circulating insulin level|MP:0003109,short femur|MP:0003961,decreased lean body mass|MP:0005095,decreased T cell proliferation|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005458,increased percent body fat/body weight|MP:0005534,decreased body temperature|MP:0005559,increased circulating glucose level|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0009009,absent estrous cycle|MP:0009021,absent estrus|MP:0009339,decreased splenocyte number
MGI:5301119	Lepr<tm5Mgmj>	MP:0001260,increased body weight|MP:0001431,abnormal eating behavior|MP:0001927,abnormal estrous cycle|MP:0003564,abnormal insulin secretion|MP:0005289,increased oxygen consumption|MP:0005331,insulin resistance|MP:0005389,reproductive system phenotype|MP:0005669,increased circulating leptin level|MP:0010024,increased total body fat amount|MP:0011939,increased food intake|MP:0031419,delayed estrus
MGI:5707692	Lep<tm1.1Gvcao>	MP:0001261,obese|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002773,decreased circulating luteinizing hormone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003973,increased pituitary hormone level|MP:0005120,decreased circulating growth hormone level|MP:0005121,decreased circulating prolactin level|MP:0005379,endocrine/exocrine gland phenotype|MP:0005668,decreased circulating leptin level
MGI:5707695	Lep<tm1.2Gvcao>	MP:0001260,increased body weight|MP:0001261,obese|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003972,decreased pituitary hormone level|MP:0005121,decreased circulating prolactin level|MP:0005668,decreased circulating leptin level|MP:0008329,decreased somatotroph cell number
MGI:5616351	Lep<tm1b(EUCOMM)Hmgu>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001510,abnormal coat appearance|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002757,decreased vertical activity|MP:0002764,short tibia|MP:0002834,decreased heart weight|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0004953,decreased spleen weight|MP:0005333,decreased heart rate|MP:0010053,decreased grip strength|MP:0010392,prolonged QRS complex duration|MP:0011951,increased cardiac stroke volume|MP:0011959,abnormal eye posterior chamber depth|MP:0011962,increased cornea thickness|MP:0011965,decreased total retina thickness
MGI:3039277	Lep<tm1Kry>	MP:0001261,obese|MP:0005605,increased bone mass
MGI:7608256	Letm1<em1(IMPC)Hmgu>	MP:0000745,tremors|MP:0002135,abnormal kidney morphology|MP:0009142,decreased prepulse inhibition
MGI:3870303	Letm1<Gt(CC0204)Wtsi>	MP:0000609,abnormal liver physiology|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0002078,abnormal glucose homeostasis|MP:0002152,abnormal brain morphology|MP:0002834,decreased heart weight|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003984,embryonic growth retardation|MP:0005290,decreased oxygen consumption|MP:0005382,craniofacial phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006036,abnormal mitochondrial physiology|MP:0011092,embryonic lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0013242,abnormal amino acid metabolism
MGI:3871268	Letm1<Gt(DD0926)Wtsi>	MP:0000609,abnormal liver physiology|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0002078,abnormal glucose homeostasis|MP:0002152,abnormal brain morphology|MP:0002834,decreased heart weight|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003984,embryonic growth retardation|MP:0005290,decreased oxygen consumption|MP:0005382,craniofacial phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006036,abnormal mitochondrial physiology|MP:0011092,embryonic lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0013242,abnormal amino acid metabolism
MGI:6336122	Letmd1<em1(IMPC)Kmpc>	MP:0000063,decreased bone mineral density|MP:0001489,decreased startle reflex|MP:0002833,increased heart weight|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0013279,increased fasting circulating glucose level|MP:0020421,increased freezing behavior
MGI:6887450	Letmd1<em1Mbp>	MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0004890,decreased energy expenditure|MP:0005288,abnormal oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0011015,decreased body surface temperature|MP:0011049,impaired adaptive thermogenesis|MP:0011698,abnormal brown adipose tissue physiology|MP:0011699,abnormal brown adipose tissue thermogenesis|MP:0014142,increased body fat mass|MP:0020426,abnormal beige fat cell physiology|MP:0020520,whitened brown adipose tissue morphology|MP:0020522,decreased susceptibility to xenobiotic induced hyperthermia
MGI:5910740	Lexis1<tm1.1Pton>	MP:0002628,hepatic steatosis|MP:0010027,increased liver cholesterol level
MGI:3777551	Lfng<m1Btlr>	MP:0000585,kinked tail|MP:0000592,short tail|MP:0001921,reduced fertility|MP:0004609,vertebral fusion
MGI:5426216	Lfng<tm1.1Dihz>	MP:0005380,embryo phenotype|MP:0005390,skeleton phenotype|MP:0010768,mortality/aging
MGI:4418228	Lfng<tm1.2Egan>	MP:0000592,short tail|MP:0001176,abnormal lung development|MP:0001688,abnormal somite development|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002823,abnormal rib development|MP:0004007,abnormal lung vasculature morphology|MP:0006027,impaired lung alveolus development|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1933734	Lfng<tm1Grid>	MP:0000137,abnormal vertebrae morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000963,fused dorsal root ganglion|MP:0001926,female infertility|MP:0002792,abnormal retina vasculature morphology|MP:0003345,decreased rib number|MP:0004624,abnormal thoracic cage morphology|MP:0004646,decreased cervical vertebrae number|MP:0005223,abnormal dorsal-ventral polarity of the somites|MP:0005377,hearing/vestibular/ear phenotype|MP:0008148,abnormal sternocostal joint morphology|MP:0008149,abnormal costovertebral joint morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:1933737	Lfng<tm1Rjo>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000592,short tail|MP:0001119,abnormal female reproductive system morphology|MP:0001125,abnormal oocyte morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001130,abnormal ovarian folliculogenesis|MP:0001131,abnormal ovarian follicle morphology|MP:0001539,decreased caudal vertebrae number|MP:0001672,abnormal embryo development|MP:0001688,abnormal somite development|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001929,abnormal gametogenesis|MP:0002082,postnatal lethality|MP:0002114,abnormal axial skeleton morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0003396,abnormal embryonic hematopoiesis|MP:0004073,caudal body truncation|MP:0004609,vertebral fusion|MP:0004653,absent caudal vertebrae|MP:0005168,abnormal female meiosis|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005225,abnormal vertebrae development|MP:0005227,abnormal vertebral body development|MP:0005380,embryo phenotype|MP:0005390,skeleton phenotype|MP:0006029,abnormal sclerotome morphology|MP:0008530,abnormal rostral-caudal patterning of the somites|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0021138,abnormal multifidus muscle morphology
MGI:3775061	Lfng<tm1Seco>	MP:0000154,rib fusion|MP:0000585,kinked tail|MP:0001258,decreased body length|MP:0001688,abnormal somite development|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0005222,abnormal somite size|MP:0008530,abnormal rostral-caudal patterning of the somites
MGI:2446819	Lfp1<CS>	MP:0020469,prolonged circadian behavior period
MGI:2446821	Lfp2<CS>	MP:0020469,prolonged circadian behavior period
MGI:2446823	Lfp3<CS>	MP:0020469,prolonged circadian behavior period
MGI:3512205	Lfq1<M16i>	MP:0010769,abnormal survival
MGI:3512197	Lfq2<M16i>	MP:0010769,abnormal survival
MGI:3512239	Lfq3<M16i>	MP:0010769,abnormal survival
MGI:1856932	lg	MP:0001286,abnormal eye development|MP:0001302,eyelids open at birth|MP:0009263,abnormal eyelid fusion
MGI:5305940	Lgals12<tm1Ftl>	MP:0000679,increased percent water in carcass|MP:0002079,increased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003441,increased glycerol level|MP:0003953,abnormal hormone level|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005318,decreased triglyceride level|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005668,decreased circulating leptin level|MP:0005670,abnormal white adipose tissue physiology|MP:0008034,enhanced lipolysis|MP:0009133,decreased white fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0010358,abnormal free fatty acids level|MP:0014169,decreased brown adipose tissue mass
MGI:2181809	Lgals1<tm1Rob>	MP:0000736,delayed muscle development|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000965,abnormal sensory neuron morphology|MP:0000969,abnormal nociceptor morphology|MP:0000972,abnormal mechanoreceptor morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001363,increased anxiety-related response|MP:0001973,increased thermal nociceptive threshold|MP:0002557,abnormal social/conspecific interaction behavior|MP:0003009,abnormal cytokine secretion|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005236,abnormal olfactory nerve morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion|MP:0010768,mortality/aging
MGI:5052166	Lgals2<tm1.1Cfg>	MP:0000218,increased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0001790,abnormal immune system physiology|MP:0005013,increased lymphocyte cell number|MP:0005015,increased T cell number|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0006043,decreased apoptosis|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008476,increased spleen red pulp amount|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level|MP:0010155,abnormal intestine physiology|MP:0020155,enhanced humoral immune response
MGI:3522338	Lgals3bp<tm1Megt>	MP:0008560,increased tumor necrosis factor secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008617,increased circulating interleukin-12 level|MP:0008735,increased susceptibility to endotoxin shock
MGI:7464949	Lgals3<em1Vari>	MP:0004991,decreased bone strength|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype|MP:0009347,increased trabecular bone thickness|MP:0010868,increased bone trabecula number|MP:0010872,increased trabecular bone mass|MP:0010875,increased bone volume|MP:0010878,increased trabecular bone volume|MP:0010932,increased trabecular bone connectivity density|MP:0010964,increased compact bone volume|MP:0013615,increased volumetric bone mineral density|MP:0013620,increased internal diameter of femur|MP:0013631,decreased bone trabecular spacing|MP:0021187,increased bone mineral density of vertebrae
MGI:2386938	Lgals3<tm1Ftl>	MP:0000223,decreased monocyte cell number|MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0001156,abnormal spermatogenesis|MP:0001656,focal hepatic necrosis|MP:0001847,brain inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002216,abnormal seminiferous tubule morphology|MP:0002376,abnormal dendritic cell physiology|MP:0002436,abnormal CD8-positive, alpha-beta cytotoxic T cell morphology|MP:0002442,abnormal leukocyte physiology|MP:0002451,abnormal macrophage physiology|MP:0002493,increased IgG level|MP:0002620,abnormal monocyte morphology|MP:0002628,hepatic steatosis|MP:0002781,increased circulating testosterone level|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003205,testicular atrophy|MP:0003303,peritoneal inflammation|MP:0003306,small intestinal inflammation|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003333,liver fibrosis|MP:0003674,oxidative stress|MP:0003884,decreased macrophage cell number|MP:0004109,abnormal Sertoli cell development|MP:0004852,decreased testis weight|MP:0004884,abnormal testis physiology|MP:0004901,decreased male germ cell number|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005025,abnormal response to infection|MP:0005027,increased susceptibility to parasitic infection|MP:0008555,abnormal interferon secretion|MP:0008669,increased interleukin-12b secretion|MP:0009355,increased liver triglyceride level|MP:0011080,increased macrophage apoptosis|MP:0014045,Mallory bodies|MP:0014052,increased male germ cell apoptosis
MGI:2183057	Lgals3<tm1Poi>	MP:0000062,increased bone mineral density|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000334,decreased granulocyte number|MP:0001260,increased body weight|MP:0001358,increased aggression towards inanimate objects|MP:0001388,abnormal stationary movement|MP:0001402,decreased locomotor activity|MP:0001798,impaired macrophage phagocytosis|MP:0001861,lung inflammation|MP:0002136,abnormal kidney physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002557,abnormal social/conspecific interaction behavior|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003799,impaired macrophage chemotaxis|MP:0005044,sepsis|MP:0005166,decreased susceptibility to injury|MP:0005389,reproductive system phenotype|MP:0008560,increased tumor necrosis factor secretion|MP:0008705,increased interleukin-6 secretion|MP:0008719,impaired neutrophil recruitment|MP:0009456,impaired cued conditioning behavior|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010024,increased total body fat amount|MP:0010768,mortality/aging|MP:0010771,integument phenotype|MP:0020467,abnormal circadian behavior
MGI:4432104	Lgals7<tm1a(EUCOMM)Wtsi>	MP:0001554,increased circulating free fatty acids level|MP:0003443,increased circulating glycerol level
MGI:6188114	Lgals7<tm1Ijmfp>	MP:0001203,increased sensitivity to skin irradiation|MP:0002908,delayed wound healing|MP:0009580,increased keratinocyte apoptosis|MP:0009583,increased keratinocyte proliferation|MP:0012194,decreased keratinocyte migration
MGI:3530228	Lgals8<Gt(OST314218)Lex>	MP:0001399,hyperactivity
MGI:4842980	Lgals8<tm1(KOMP)Vlcg>	MP:0008778,abnormal lymphangiogenesis|MP:0020917,decreased susceptibility to Herpesvirales infection
MGI:5052339	Lgals9<tm1.1Cfg>	MP:0000219,increased neutrophil cell number|MP:0000693,spleen hyperplasia|MP:0000696,abnormal Peyer's patch morphology|MP:0000708,thymus hyperplasia|MP:0005013,increased lymphocyte cell number|MP:0005154,increased B cell proliferation|MP:0005378,growth/size/body region phenotype|MP:0008102,lymph node hyperplasia|MP:0008483,increased spleen germinal center size|MP:0008522,abnormal lymph node germinal center morphology|MP:0020155,enhanced humoral immune response
MGI:3778171	Lgals9<tm1Glp>	MP:0003724,increased susceptibility to induced arthritis|MP:0004974,decreased regulatory T cell number|MP:0008086,increased T-helper 1 cell number
MGI:3527683	Lgaq1<M16i>	MP:0002865,increased growth rate
MGI:3526994	Lgaq2<M16i>	MP:0002865,increased growth rate
MGI:3526974	Lgaq3<M16i>	MP:0002865,increased growth rate
MGI:3527002	Lgaq4<M16i>	MP:0002865,increased growth rate
MGI:3527675	Lgaq5<M16i>	MP:0002865,increased growth rate
MGI:3521885	Lgdr1<BALB/cJ>	MP:0005319,abnormal enzyme/coenzyme level
MGI:3521887	Lgdr2<BALB/cJ>	MP:0005319,abnormal enzyme/coenzyme level
MGI:1856933	lgh	MP:0001212,skin lesions|MP:0005389,reproductive system phenotype|MP:0006366,absent zigzag hairs
MGI:5317113	Lgi1<tm1.1Ics>	MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001438,aphagia|MP:0001496,audiogenic seizures|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0002690,akinesia|MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0003997,tonic-clonic seizures|MP:0004098,abnormal cerebellar granule cell morphology|MP:0008840,abnormal spike wave discharge|MP:0009358,environmentally induced seizures|MP:0010025,decreased total body fat amount|MP:0011085,postnatal lethality, complete penetrance|MP:0014625,abnormal ictal brain wave pattern
MGI:4437105	Lgi1<tm1Mafu>	MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002083,premature death|MP:0002826,tonic seizures|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003631,nervous system phenotype|MP:0003996,clonic seizures|MP:0003997,tonic-clonic seizures|MP:0014372,decreased miniature excitatory postsynaptic current amplitude
MGI:6275636	Lgi1<tm2.1Jkc>	MP:0000788,abnormal cerebral cortex morphology|MP:0002064,seizures|MP:0003631,nervous system phenotype|MP:0008547,abnormal neocortex morphology
MGI:7444283	Lgi2<tm1.2Mejr>	MP:0002169,no abnormal phenotype detected
MGI:6276969	Lgi3<em1(IMPC)Mbp>	MP:0001200,thick skin|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney
MGI:7331636	Lgi3<tm1.2Mejr>	MP:0002882,abnormal neuron morphology|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010737,abnormal juxtaparanode morphology|MP:0010768,mortality/aging
MGI:1856594	Lgi4<clp>	MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001265,decreased body size|MP:0001386,abnormal maternal nurturing|MP:0001392,abnormal locomotor behavior|MP:0001504,abnormal posture|MP:0001523,impaired righting response|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0002566,abnormal sexual interaction|MP:0002651,abnormal sciatic nerve morphology|MP:0003632,abnormal nervous system morphology|MP:0003723,abnormal long bone morphology|MP:0003871,abnormal myelin sheath morphology|MP:0005369,muscle phenotype|MP:0005404,abnormal axon morphology|MP:0008155,decreased diameter of radius|MP:0008157,decreased diameter of ulna|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4441311	Lgi4<tm1.1Jrb>	MP:0000921,demyelination
MGI:5695950	Lgi4<tm1.1(KOMP)Vlcg>	MP:0000428,abnormal craniofacial morphology|MP:0001297,microphthalmia|MP:0001399,hyperactivity|MP:0003743,abnormal facial morphology|MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0020870,decreased thigmotaxis
MGI:4439269	Lgi4<tm1Sjm>	MP:0000550,abnormal forelimb morphology|MP:0000921,demyelination|MP:0001105,abnormal PNS glial cell morphology|MP:0001106,abnormal Schwann cell morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002651,abnormal sciatic nerve morphology|MP:0003634,abnormal glial cell morphology|MP:0003690,abnormal glial cell physiology|MP:0011088,neonatal lethality, incomplete penetrance
MGI:1856934	lgl	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0000550,abnormal forelimb morphology|MP:0000552,abnormal radius morphology|MP:0000554,abnormal carpal bone morphology|MP:0000556,abnormal hindlimb morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000913,abnormal brain development|MP:0001891,hydrocephaly|MP:0003755,abnormal palate morphology|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005170,cleft upper lip|MP:0005230,ectrodactyly|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008797,facial cleft|MP:0009944,abnormal olfactory lobe morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0030206,thin nasal septum
MGI:1857108	lg<Ml>	MP:0001302,eyelids open at birth|MP:0009651,abnormal eyelid development
MGI:5766170	Lgmn<tm1b(NCOM)Mfgc>	MP:0001258,decreased body length|MP:0002764,short tibia|MP:0009142,decreased prepulse inhibition
MGI:4415342	Lgmn<tm1Cptr>	MP:0000519,hydronephrosis|MP:0000691,enlarged spleen|MP:0002136,abnormal kidney physiology|MP:0002420,abnormal adaptive immunity|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0003215,renal interstitial fibrosis|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004969,pale kidney|MP:0005059,lysosomal protein accumulation|MP:0005325,abnormal renal glomerulus morphology|MP:0005528,decreased renal glomerular filtration rate|MP:0005553,increased circulating creatinine level|MP:0008489,slow postnatal weight gain|MP:0008561,decreased tumor necrosis factor secretion|MP:0008670,decreased interleukin-12b secretion|MP:0008706,decreased interleukin-6 secretion|MP:0011346,renal tubule atrophy|MP:0011379,abnormal kidney outer medulla outer stripe morphology|MP:0011423,kidney cortex atrophy|MP:0011425,abnormal kidney interstitium morphology|MP:0011682,renal glomerulus cyst
MGI:2676125	Lgmn<tm1Ihn>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002447,abnormal erythrocyte morphology|MP:0002451,abnormal macrophage physiology|MP:0002640,reticulocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002981,increased liver weight|MP:0004952,increased spleen weight|MP:0005013,increased lymphocyte cell number|MP:0005060,accumulation of giant lysosomes in kidney/renal tubule cells|MP:0005387,immune system phenotype|MP:0005533,increased body temperature|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008489,slow postnatal weight gain|MP:0008553,increased circulating tumor necrosis factor level|MP:0010766,abnormal NK cell physiology|MP:0014606,dark spleen
MGI:3527687	Lgq1<M16i>	MP:0002865,increased growth rate
MGI:3526992	Lgq2<M16i>	MP:0002865,increased growth rate
MGI:3527000	Lgq3<M16i>	MP:0002865,increased growth rate
MGI:3526972	Lgq4<M16i>	MP:0002865,increased growth rate
MGI:3526963	Lgq5<M16i>	MP:0002865,increased growth rate
MGI:3527024	Lgq6<M16i>	MP:0002865,increased growth rate
MGI:1856935	lgr	MP:0000371,diluted coat color|MP:0000372,irregular coat pigmentation|MP:0001851,eye inflammation|MP:0003956,abnormal body size|MP:0005366,variegated coat color
MGI:3790207	Lgr4<Gt(LST020)Byg>	MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001306,small lens|MP:0001312,abnormal cornea morphology|MP:0001313,increased incidence of corneal inflammation|MP:0001314,cornea opacity|MP:0001325,abnormal retina morphology|MP:0002546,mydriasis|MP:0002579,disorganized secondary lens fibers|MP:0003092,decreased cornea stroma thickness|MP:0003984,embryonic growth retardation|MP:0004221,abnormal iridocorneal angle|MP:0004223,hypoplastic trabecular meshwork|MP:0005193,abnormal anterior eye segment morphology|MP:0005204,abnormal canal of Schlemm morphology|MP:0005300,abnormal cornea stroma morphology|MP:0005542,cornea vascularization|MP:0005543,decreased cornea thickness|MP:0005544,cornea deposits|MP:0006000,abnormal cornea epithelium morphology|MP:0006226,iris hypoplasia|MP:0006230,iris stroma hypoplasia|MP:0008067,retina ganglion cell degeneration|MP:0008511,thin retina inner nuclear layer|MP:0008512,disorganized retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008516,disorganized retina outer nuclear layer|MP:0008770,decreased survivor rate|MP:0011481,anterior iris synechia|MP:0013743,ciliary body hypoplasia|MP:0014707,increased corneal pannus formation|MP:0020855,decreased cornea epithelium thickness|MP:0020858,cornea epithelium hypoplasia
MGI:3052121	Lgr4<Gt(pGT0TMpfs)1Wcs>	MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001924,infertility|MP:0001925,male infertility|MP:0002135,abnormal kidney morphology|MP:0002631,abnormal epididymis morphology|MP:0003402,decreased liver weight|MP:0003595,epididymal cyst|MP:0003918,decreased kidney weight|MP:0004728,abnormal efferent ductules of testis morphology|MP:0004884,abnormal testis physiology|MP:0004906,enlarged uterus|MP:0004932,epididymis hypoplasia|MP:0004933,abnormal epididymis epithelium morphology|MP:0006319,abnormal epididymal fat pad morphology|MP:0006416,abnormal rete testis morphology|MP:0006417,rete testis obstruction|MP:0009248,small caput epididymis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014193,decreased epididymal cell proliferation
MGI:3709988	Lgr4<Gt(pU-21)1Kymm>	MP:0001146,abnormal testis morphology|MP:0001732,postnatal growth retardation|MP:0001919,abnormal reproductive system physiology|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002160,abnormal reproductive system morphology|MP:0002631,abnormal epididymis morphology|MP:0002660,abnormal caput epididymis morphology|MP:0002673,abnormal sperm number|MP:0002675,asthenozoospermia|MP:0004851,increased testis weight|MP:0004929,decreased epididymis weight|MP:0006423,dilated rete testis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011750,abnormal seminiferous tubule epithelium morphology
MGI:5635820	Lgr4<tm1.1(cre/ERT2)Npa>	MP:0000379,decreased hair follicle number|MP:0001218,thin epidermis|MP:0002705,dilated renal tubule|MP:0003675,kidney cyst|MP:0003941,abnormal skin development|MP:0005367,renal/urinary system phenotype|MP:0010155,abnormal intestine physiology|MP:0010158,abnormal intestine development|MP:0011006,abnormal epidermal stem cell proliferation|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011499,abnormal glomerular capsule space morphology
MGI:3762639	Lgr4<tm1.1Knis>	MP:0001302,eyelids open at birth|MP:0002083,premature death|MP:0005378,growth/size/body region phenotype|MP:0008142,decreased small intestinal villus size|MP:0010157,abnormal small intestinal crypt cell proliferation|MP:0010768,mortality/aging
MGI:3762641	Lgr4<tm1.2Knis>	MP:0001302,eyelids open at birth|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0003446,renal hypoplasia|MP:0003453,abnormal keratinocyte physiology|MP:0003675,kidney cyst|MP:0003881,abnormal nephron morphology|MP:0003918,decreased kidney weight|MP:0004505,decreased renal glomerulus number|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005553,increased circulating creatinine level|MP:0008528,polycystic kidney|MP:0009431,decreased fetal weight|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011365,small metanephros|MP:0011368,increased kidney apoptosis|MP:0011457,abnormal metanephric ureteric bud development
MGI:6156314	Lgr5<em1(IMPC)Kmpc>	MP:0000111,cleft palate|MP:0001404,no spontaneous movement|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013648,increased CD11b-high dendritic cell number|MP:0013890,increased CD8-positive, CD25-positive alpha-beta T cell number
MGI:5635821	Lgr5<tm1.1(cre/ERT2)Npa>	MP:0005367,renal/urinary system phenotype|MP:0005381,digestive/alimentary phenotype|MP:0010771,integument phenotype|MP:0011089,perinatal lethality, complete penetrance
MGI:3512420	Lgr5<tm1Ah>	MP:0000762,abnormal tongue morphology|MP:0001270,distended abdomen|MP:0001436,abnormal suckling behavior|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0009546,absent gastric milk in neonates|MP:0011087,neonatal lethality, complete penetrance|MP:0013264,tongue ankylosis
MGI:3764660	Lgr5<tm1(cre/ERT2)Cle>	MP:0005381,digestive/alimentary phenotype|MP:0014201,abnormal intestinal epithelium physiology
MGI:5285688	Lgr5<tm2.1Cle>	MP:0005381,digestive/alimentary phenotype
MGI:5294798	Lgr5<tm2(Hbegf/EGFP)Fjs>	MP:0005381,digestive/alimentary phenotype
MGI:7425792	Lgr6<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002100,abnormal tooth morphology|MP:0005013,increased lymphocyte cell number|MP:0010025,decreased total body fat amount
MGI:4438348	Lgr6<tm1Cle>	MP:0002169,no abnormal phenotype detected
MGI:4438349	Lgr6<tm2.1(cre/ERT2)Cle>	MP:0002169,no abnormal phenotype detected
MGI:1857110	lg<St>	MP:0001286,abnormal eye development|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001302,eyelids open at birth|MP:0001304,cataract|MP:0002092,abnormal eye morphology|MP:0009651,abnormal eyelid development
MGI:1857109	lg<Stn>	MP:0001286,abnormal eye development|MP:0001302,eyelids open at birth|MP:0001312,abnormal cornea morphology|MP:0001325,abnormal retina morphology|MP:0011697,lens vacuoles
MGI:2680578	Lgt	MP:0000371,diluted coat color|MP:0002095,abnormal skin pigmentation
MGI:2656865	Lgth6<MRL/MpJ>	MP:0010024,increased total body fat amount
MGI:3522112	Lhb<tm1Kmr>	MP:0001116,small gonad|MP:0001119,abnormal female reproductive system morphology|MP:0001121,uterus hypoplasia|MP:0001127,small ovary|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001145,abnormal male reproductive system morphology|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001157,small seminal vesicle|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001929,abnormal gametogenesis|MP:0002016,ovary cyst|MP:0002774,small prostate gland|MP:0002779,abnormal sex gland secretion|MP:0002780,decreased circulating testosterone level|MP:0003527,small vulva|MP:0004930,small epididymis|MP:0005159,azoospermia|MP:0005181,decreased circulating estradiol level|MP:0005185,decreased circulating progesterone level|MP:0005431,decreased oocyte number|MP:0005536,decreased Leydig cell number|MP:0008258,thin endometrium|MP:0008280,abnormal male germ cell apoptosis|MP:0009009,absent estrous cycle|MP:0009202,small external male genitalia|MP:0009363,abnormal tertiary ovarian follicle morphology|MP:0013602,abnormal Leydig cell differentiation|MP:0013737,small bulbourethral gland|MP:0014636,decreased elongated spermatid number
MGI:5538310	Lhcgr<tm1.1Pnara>	MP:0001152,increased Leydig cell number|MP:0002773,decreased circulating luteinizing hormone level|MP:0002781,increased circulating testosterone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0002997,enlarged seminal vesicle|MP:0003378,early sexual maturation|MP:0004852,decreased testis weight|MP:0004909,increased seminal vesicle weight|MP:0004928,increased epididymis weight|MP:0004958,enlarged prostate gland|MP:0004961,increased prostate gland weight|MP:0005389,reproductive system phenotype|MP:0011385,abnormal testosterone level|MP:0011533,increased urine major urinary protein level|MP:0013604,abnormal adult Leydig cell differentiation
MGI:2181999	Lhcgr<tm1Hht>	MP:0000642,enlarged adrenal glands|MP:0000664,small prostate gland anterior lobe|MP:0000671,bulbourethral gland hypoplasia|MP:0000691,enlarged spleen|MP:0001119,abnormal female reproductive system morphology|MP:0001120,abnormal uterus morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001145,abnormal male reproductive system morphology|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001157,small seminal vesicle|MP:0001158,abnormal prostate gland morphology|MP:0001262,decreased body weight|MP:0001378,abnormal ejaculation|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001919,abnormal reproductive system physiology|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002254,reproductive system inflammation|MP:0002286,cryptorchism|MP:0002566,abnormal sexual interaction|MP:0002636,delayed vaginal opening|MP:0002660,abnormal caput epididymis morphology|MP:0002687,oligozoospermia|MP:0002780,decreased circulating testosterone level|MP:0002785,absent Leydig cells|MP:0003596,epididymis inflammation|MP:0003608,prostate gland inflammation|MP:0003611,scrotum hypoplasia|MP:0003917,increased kidney weight|MP:0004543,abnormal sperm physiology|MP:0004852,decreased testis weight|MP:0004932,epididymis hypoplasia|MP:0005147,prostate gland hypoplasia|MP:0005148,seminal vesicle hypoplasia|MP:0005188,small penis|MP:0005189,abnormal anogenital distance|MP:0005536,decreased Leydig cell number|MP:0009009,absent estrous cycle|MP:0009021,absent estrus|MP:0009081,thin uterus|MP:0009088,thin uterine horn|MP:0009097,absent endometrial glands|MP:0009201,external male genitalia atrophy|MP:0009214,vas deferens hypoplasia|MP:0013307,increased adrenal gland weight|MP:0014269,decreased testes secretion|MP:0014270,decreased ovary secretion
MGI:4399374	Lhcgr<tm1(KOMP)Vlcg>	MP:0000218,increased leukocyte cell number|MP:0000601,small liver|MP:0000692,small spleen|MP:0000706,small thymus|MP:0000774,decreased brain size|MP:0002188,small heart|MP:0002591,decreased mean corpuscular volume|MP:0002691,small stomach|MP:0003179,thrombocytopenia|MP:0003641,small lung|MP:0005013,increased lymphocyte cell number
MGI:2181998	Lhcgr<tm1Zmlei>	MP:0000010,abnormal abdominal fat pad morphology|MP:0001119,abnormal female reproductive system morphology|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001142,abnormal vagina orifice morphology|MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001157,small seminal vesicle|MP:0001260,increased body weight|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001940,testis hypoplasia|MP:0002216,abnormal seminiferous tubule morphology|MP:0002286,cryptorchism|MP:0002631,abnormal epididymis morphology|MP:0002660,abnormal caput epididymis morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0002774,small prostate gland|MP:0002780,decreased circulating testosterone level|MP:0003531,abnormal vagina development|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0004910,decreased seminal vesicle weight|MP:0004929,decreased epididymis weight|MP:0004930,small epididymis|MP:0004932,epididymis hypoplasia|MP:0004933,abnormal epididymis epithelium morphology|MP:0005147,prostate gland hypoplasia|MP:0005148,seminal vesicle hypoplasia|MP:0005181,decreased circulating estradiol level|MP:0005182,increased circulating estradiol level|MP:0005185,decreased circulating progesterone level|MP:0005188,small penis|MP:0005189,abnormal anogenital distance|MP:0005536,decreased Leydig cell number|MP:0008257,thin myometrium|MP:0008258,thin endometrium|MP:0009009,absent estrous cycle|MP:0009081,thin uterus|MP:0009096,decreased endometrial gland number|MP:0013604,abnormal adult Leydig cell differentiation|MP:0014052,increased male germ cell apoptosis|MP:0014193,decreased epididymal cell proliferation|MP:0031379,ambiguous external female genitalia
MGI:5766133	Lhfpl1<tm1.1(NCOM)Mfgc>	MP:0002059,abnormal seminal vesicle morphology
MGI:4880679	Lhfpl2<vgim>	MP:0001119,abnormal female reproductive system morphology|MP:0001120,abnormal uterus morphology|MP:0001136,dilated uterine cervix|MP:0001139,abnormal vagina morphology|MP:0001144,vagina atresia|MP:0001314,cornea opacity|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0002059,abnormal seminal vesicle morphology|MP:0002638,abnormal pupillary reflex|MP:0002750,exophthalmos|MP:0002769,abnormal vas deferens morphology|MP:0003315,abnormal perineum morphology|MP:0003531,abnormal vagina development|MP:0003936,abnormal reproductive system development|MP:0004906,enlarged uterus|MP:0008511,thin retina inner nuclear layer|MP:0009085,abnormal uterine horn morphology|MP:0009208,abnormal female genitalia morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013852,abnormal Mullerian duct topology|MP:0014017,abnormal Wolffian duct connection
MGI:6719269	Lhfpl4<em1(IMPC)H>	MP:0002942,decreased circulating alanine transaminase level
MGI:6154882	Lhfpl4<tm1Lex>	MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0010768,mortality/aging|MP:0014382,increased miniature inhibitory postsynaptic current frequency|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude|MP:0020551,abnormal postsynaptic density morphology
MGI:3055797	Lhfpl5<hscy>	MP:0000043,organ of Corti degeneration|MP:0001394,circling|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0002730,head shaking|MP:0003986,small cochlear ganglion|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3611475	Lhfpl5<hscy-2J>	MP:0001394,circling|MP:0001395,bidirectional circling|MP:0001525,impaired balance|MP:0001967,deafness|MP:0002730,head shaking|MP:0005191,head tilt|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3718054	Lhfpl5<tm1Kjn>	MP:0001395,bidirectional circling|MP:0001967,deafness|MP:0003631,nervous system phenotype|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0005307,head tossing|MP:0005377,hearing/vestibular/ear phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:7425793	Lhfpl6<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001402,decreased locomotor activity|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology
MGI:8261238	Lhpp<em1Lizh>	MP:0001364,decreased anxiety-related response
MGI:8261242	Lhpp<tm1.1Qixu>	MP:0001364,decreased anxiety-related response
MGI:8261237	Lhpp<tm1Qixu>	MP:0001364,decreased anxiety-related response
MGI:7424850	Lhx1os<em1Shx>	MP:0002169,no abnormal phenotype detected
MGI:4432952	Lhx1<tm1a(EUCOMM)Wtsi>	MP:0002966,decreased circulating alkaline phosphatase level
MGI:1857848	Lhx1<tm1Bhr>	MP:0000520,absent kidney|MP:0000913,abnormal brain development|MP:0000955,abnormal spinal cord morphology|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001726,abnormal allantois morphology|MP:0002169,no abnormal phenotype detected|MP:0002174,abnormal gastrulation movements|MP:0002230,abnormal primitive streak formation|MP:0003085,abnormal egg cylinder morphology|MP:0003578,absent ovary|MP:0004066,abnormal primitive node morphology|MP:0004557,dilated allantois|MP:0004559,small allantois|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005644,agonadal|MP:0006108,abnormal hindbrain development|MP:0006415,absent testes|MP:0009579,acephaly|MP:0011089,perinatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012087,absent midbrain|MP:0012135,embryonic-extraembryonic boundary constriction|MP:0012136,absent forebrain|MP:0012156,rostral-caudal axis duplication|MP:0012276,absent prechordal mesoderm|MP:0012685,abnormal primitive streak elongation|MP:0030324,abnormal anterior head development
MGI:2385716	Lhx1<tm2.1Bhr>	MP:0002169,no abnormal phenotype detected
MGI:2385728	Lhx1<tm3.1Bhr>	MP:0002151,abnormal neural tube morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012087,absent midbrain|MP:0012135,embryonic-extraembryonic boundary constriction|MP:0012136,absent forebrain|MP:0012685,abnormal primitive streak elongation|MP:0030324,abnormal anterior head development
MGI:3719681	Lhx1<tm4Bhr>	MP:0011087,neonatal lethality, complete penetrance
MGI:4399043	Lhx2<tm1.1Ddmo>	MP:0000785,telencephalon hypoplasia|MP:0000787,abnormal telencephalon morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0003631,nervous system phenotype|MP:0005267,abnormal olfactory cortex morphology|MP:0008547,abnormal neocortex morphology
MGI:4453328	Lhx2<tm1.1Lcar>	MP:0001293,anophthalmia|MP:0002073,abnormal hair growth|MP:0003425,abnormal optic vesicle formation|MP:0005391,vision/eye phenotype|MP:0008858,abnormal hair cycle anagen phase
MGI:3772172	Lhx2<tm1.1Monu>	MP:0000788,abnormal cerebral cortex morphology
MGI:1890208	Lhx2<tm1Dra>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0000784,forebrain hypoplasia|MP:0000787,abnormal telencephalon morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000809,absent hippocampus|MP:0000819,abnormal olfactory bulb morphology|MP:0001286,abnormal eye development|MP:0001293,anophthalmia|MP:0001577,anemia|MP:0002192,hydrops fetalis|MP:0003078,aphakia|MP:0003425,abnormal optic vesicle formation|MP:0003717,pallor|MP:0006007,abnormal basal ganglion morphology|MP:0008439,abnormal cortical plate morphology|MP:0008547,abnormal neocortex morphology|MP:0008973,decreased erythroid progenitor cell number|MP:0009773,absent retina|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012170,absent optic placodes|MP:0030047,flat forehead
MGI:4453327	Lhx2<tm1Lcar>	MP:0000379,decreased hair follicle number|MP:0000382,underdeveloped hair follicles|MP:0001293,anophthalmia|MP:0001577,anemia
MGI:3772179	Lhx2<tm1Monu>	MP:0000788,abnormal cerebral cortex morphology|MP:0000934,abnormal telencephalon development|MP:0002073,abnormal hair growth|MP:0008858,abnormal hair cycle anagen phase
MGI:4941330	Lhx3<tm1.1Sjr>	MP:0000428,abnormal craniofacial morphology|MP:0000633,abnormal pituitary gland morphology|MP:0001120,abnormal uterus morphology|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001157,small seminal vesicle|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0001938,delayed sexual maturation|MP:0002083,premature death|MP:0002161,abnormal fertility/fecundity|MP:0002637,small uterus|MP:0002774,small prostate gland|MP:0002779,abnormal sex gland secretion|MP:0003503,decreased activity of thyroid gland|MP:0003572,abnormal uterus development|MP:0003965,abnormal pituitary hormone level|MP:0004696,abnormal thyroid follicle morphology|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004905,decreased uterus weight|MP:0005121,decreased circulating prolactin level|MP:0005128,decreased adrenocorticotropin level|MP:0005130,decreased follicle stimulating hormone level|MP:0005132,decreased luteinizing hormone level|MP:0005138,decreased prolactin level|MP:0005150,cachexia|MP:0005159,azoospermia|MP:0005377,hearing/vestibular/ear phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0005478,decreased circulating thyroxine level|MP:0008332,decreased lactotroph cell number|MP:0008335,decreased gonadotroph cell number|MP:0008365,adenohypophysis hypoplasia|MP:0008770,decreased survivor rate|MP:0009205,abnormal internal male genitalia morphology|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3513299	Lhx3<tm1(cre)Slp>	MP:0008320,absent adenohypophysis|MP:0008368,small pituitary intermediate lobe|MP:0013351,abnormal Rathke's pouch development|MP:0013352,abnormal Rathke's pouch apoptosis
MGI:2385819	Lhx3<tm1Lmgd>	MP:0003631,nervous system phenotype|MP:0003816,abnormal pituitary gland development|MP:0005128,decreased adrenocorticotropin level|MP:0005132,decreased luteinizing hormone level|MP:0005134,decreased thyroid-stimulating hormone level|MP:0005136,decreased growth hormone level|MP:0008299,adrenal cortical hyperplasia|MP:0008320,absent adenohypophysis|MP:0008327,abnormal corticotroph morphology|MP:0008330,absent somatotrophs|MP:0008333,absent lactotrophs|MP:0008335,decreased gonadotroph cell number|MP:0008339,absent thyrotrophs|MP:0008367,absent pituitary intermediate lobe|MP:0011091,prenatal lethality, complete penetrance|MP:0013351,abnormal Rathke's pouch development
MGI:2385815	Lhx4<tm1Ssp>	MP:0001175,abnormal lung morphology|MP:0002329,abnormal blood gas level|MP:0003631,nervous system phenotype|MP:0005134,decreased thyroid-stimulating hormone level|MP:0005136,decreased growth hormone level|MP:0008321,small adenohypophysis|MP:0008335,decreased gonadotroph cell number|MP:0010819,primary atelectasis|MP:0010890,decreased alveolar lamellar body number|MP:0011089,perinatal lethality, complete penetrance|MP:0013349,small Rathke's pouch|MP:0013351,abnormal Rathke's pouch development
MGI:7608119	Lhx5as1<em1Jzx>	MP:0001473,reduced long-term potentiation|MP:0008428,abnormal spatial working memory|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0012307,impaired spatial learning|MP:0014372,decreased miniature excitatory postsynaptic current amplitude
MGI:6341831	Lhx5<em1(IMPC)Ccpcz>	MP:0000218,increased leukocyte cell number|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001157,small seminal vesicle|MP:0001404,no spontaneous movement|MP:0002059,abnormal seminal vesicle morphology|MP:0002100,abnormal tooth morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:2152620	Lhx5<tm1Lmgd>	MP:0000808,abnormal hippocampus development|MP:0000814,absent dentate gyrus|MP:0000815,abnormal Ammon gyrus morphology|MP:0001575,cyanosis|MP:0002961,abnormal axon guidance|MP:0004948,abnormal neuronal precursor proliferation|MP:0006009,abnormal neuronal migration|MP:0008223,absent hippocampal commissure|MP:0008934,absent choroid plexus|MP:0009324,absent hippocampal fimbria|MP:0011085,postnatal lethality, complete penetrance
MGI:5572026	Lhx6<tm1b(KOMP)Wtsi>	MP:0001402,decreased locomotor activity|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4365737	Lhx6<tm1(cre/ERT2)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:3702513	Lhx6<tm1Vpa>	MP:0002169,no abnormal phenotype detected
MGI:3702518	Lhx6<tm2Vpa>	MP:0000746,weakness|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004101,abnormal brain interneuron morphology|MP:0006009,abnormal neuronal migration|MP:0008948,decreased neuron number|MP:0011085,postnatal lethality, complete penetrance|MP:0014553,decreased neuronal migration
MGI:3588411	Lhx8<tm1Awan>	MP:0000111,cleft palate|MP:0001038,abnormal cholinergic neuron morphology|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2182594	Lhx8<tm1Lmgd>	MP:0000934,abnormal telencephalon development|MP:0001038,abnormal cholinergic neuron morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0002083,premature death|MP:0002777,absent ovarian follicles|MP:0004805,absent oocytes|MP:0004833,ovary atrophy|MP:0005382,craniofacial phenotype|MP:0005389,reproductive system phenotype|MP:0005431,decreased oocyte number|MP:0009085,abnormal uterine horn morphology|MP:0009093,oocyte degeneration|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011121,decreased primordial ovarian follicle number|MP:0011122,absent primordial ovarian follicles|MP:0013507,increased ovary apoptosis|MP:0013607,ovary fibrosis|MP:0014046,abnormal mitophagy|MP:0014764,impaired double-strand DNA break repair|MP:0030941,enhanced autophagy|MP:0031020,premature ovarian failure
MGI:3603531	Lhx8<tm1Vpa>	MP:0000111,cleft palate|MP:0001038,abnormal cholinergic neuron morphology|MP:0001262,decreased body weight|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0004102,abnormal dorsal striatum morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5620763	Lhx9<tm1.1(cre/ERT2)Gan>	MP:0001265,decreased body size|MP:0001926,female infertility|MP:0005652,sex reversal
MGI:1888554	Lhx9<tm1Lmgd>	MP:0001119,abnormal female reproductive system morphology|MP:0001145,abnormal male reproductive system morphology|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001939,secondary sex reversal|MP:0002211,abnormal primary sex determination|MP:0002780,decreased circulating testosterone level|MP:0003578,absent ovary|MP:0004894,uterus atrophy|MP:0004895,vagina atrophy|MP:0005181,decreased circulating estradiol level|MP:0005644,agonadal|MP:0006415,absent testes|MP:0009009,absent estrous cycle|MP:0030934,decreased primordial germ cell proliferation
MGI:2386633	Lhyp<C3H/HeJ>	MP:0002295,abnormal pulmonary circulation
MGI:2386635	Lhyp<C3H/HeOuJ>	MP:0002295,abnormal pulmonary circulation
MGI:2386632	Lhyp<C57BL/6J>	MP:0002295,abnormal pulmonary circulation
MGI:1861199	Li	MP:0001262,decreased body weight|MP:0001698,decreased embryo size|MP:0009659,striated fur|MP:0009674,decreased birth weight|MP:0011091,prenatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3604482	Lias<Gt(OST266609)Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:3578174	Lias<nehe>	MP:0000433,microcephaly|MP:0000784,forebrain hypoplasia|MP:0000785,telencephalon hypoplasia|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0002152,abnormal brain morphology|MP:0003984,embryonic growth retardation|MP:0004387,abnormal prechordal plate morphology|MP:0004937,dilated heart|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012138,decreased forebrain size|MP:0012157,rostral body truncation
MGI:3604218	Lias<tm1Mae>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0012604,decreased glutathione level
MGI:5634509	Liat1<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0001399,hyperactivity|MP:0002941,increased circulating alanine transaminase level|MP:0005566,decreased blood urea nitrogen level
MGI:2179254	Lifespan1<C3H/HeJ>	MP:0001661,extended life span
MGI:2179255	Lifespan2<DBA/2J>	MP:0001661,extended life span
MGI:5548949	Lifr<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment|MP:0002152,abnormal brain morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:2651561	Lifr<tm1Cgre>	MP:0000939,decreased motor neuron number|MP:0001262,decreased body weight|MP:0011087,neonatal lethality, complete penetrance
MGI:1857213	Lifr<tm1Imx>	MP:0000063,decreased bone mineral density|MP:0000516,abnormal renal/urinary system morphology|MP:0000519,hydronephrosis|MP:0000527,abnormal kidney development|MP:0000534,abnormal ureter morphology|MP:0000536,hydroureter|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001265,decreased body size|MP:0001711,abnormal placenta morphology|MP:0002135,abnormal kidney morphology|MP:0002182,abnormal astrocyte morphology|MP:0002286,cryptorchism|MP:0002989,small kidney|MP:0003073,abnormal metacarpal bone morphology|MP:0003446,renal hypoplasia|MP:0003723,abnormal long bone morphology|MP:0004200,decreased fetal size|MP:0004505,decreased renal glomerulus number|MP:0004984,increased osteoclast cell number|MP:0010400,increased liver glycogen level|MP:0010876,decreased bone volume|MP:0011087,neonatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance|MP:0011290,decreased nephron number|MP:0011426,abnormal ureter smooth muscle morphology|MP:0011486,ectopic ureter|MP:0011797,blind ureter
MGI:3574767	Lif<tm1Cgre>	MP:0001120,abnormal uterus morphology|MP:0002446,abnormal macrophage morphology|MP:0005011,increased eosinophil cell number|MP:0009394,increased uterine NK cell number
MGI:2181618	Lif<tm1Phb>	MP:0001265,decreased body size|MP:0001728,failure of embryo implantation|MP:0001926,female infertility|MP:0004810,decreased hematopoietic stem cell number|MP:0005095,decreased T cell proliferation|MP:0005397,hematopoietic system phenotype|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0009662,abnormal uterine receptivity|MP:0009665,abnormal embryo apposition|MP:0009666,abnormal embryo attachment
MGI:2177780	Lif<tm1Stw>	MP:0000221,decreased leukocyte cell number|MP:0000607,abnormal hepatocyte morphology|MP:0000745,tremors|MP:0000939,decreased motor neuron number|MP:0000952,abnormal CNS glial cell morphology|MP:0001120,abnormal uterus morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001492,abnormal pilomotor reflex|MP:0001541,abnormal osteoclast physiology|MP:0001614,abnormal blood vessel morphology|MP:0001654,hepatic necrosis|MP:0001728,failure of embryo implantation|MP:0001732,postnatal growth retardation|MP:0001881,abnormal mammary gland physiology|MP:0001926,female infertility|MP:0002182,abnormal astrocyte morphology|MP:0002644,decreased circulating triglyceride level|MP:0002664,decreased circulating adrenocorticotropin level|MP:0002792,abnormal retina vasculature morphology|MP:0002941,increased circulating alanine transaminase level|MP:0003179,thrombocytopenia|MP:0003631,nervous system phenotype|MP:0003634,abnormal glial cell morphology|MP:0003658,abnormal capillary morphology|MP:0003888,liver hemorrhage|MP:0004702,increased circulating insulin-like growth factor I level|MP:0004950,abnormal brain vasculature morphology|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0004992,increased bone resorption|MP:0005036,diarrhea|MP:0005039,hypoxia|MP:0005088,increased acute inflammation|MP:0005166,decreased susceptibility to injury|MP:0005343,increased circulating aspartate transaminase level|MP:0005508,abnormal skeleton morphology|MP:0005669,increased circulating leptin level|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0006271,abnormal involution of the mammary gland|MP:0008396,abnormal osteoclast differentiation|MP:0008553,increased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008661,decreased interleukin-10 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0009503,abnormal mammary gland duct morphology|MP:0009506,abnormal mammary gland alveolus morphology|MP:0009660,abnormal induced retina neovascularization|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010019,liver vascular congestion|MP:0010180,increased susceptibility to weight loss|MP:0010876,decreased bone volume|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014273,abnormal skin vasculature morphology|MP:0014599,decreased susceptibility to hyperoxia-induced injury|MP:0020161,increased vascular endothelial cell proliferation|MP:0031234,increased circulating serum amyloid protein level
MGI:5510743	Lig1<m1Anu>	MP:0000603,pale liver|MP:0001577,anemia|MP:0009395,increased nucleated erythrocyte cell number
MGI:2179227	Lig1<tm1Dwm>	MP:0000208,decreased hematocrit|MP:0000215,absent erythrocytes|MP:0000245,abnormal erythropoiesis|MP:0000248,macrocytosis|MP:0000321,increased bone marrow cell number|MP:0000596,abnormal liver development|MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0002123,abnormal definitive hematopoiesis|MP:0002429,abnormal blood cell morphology/development|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0005384,cellular phenotype|MP:0008057,abnormal DNA replication|MP:0008866,chromosomal instability|MP:0008973,decreased erythroid progenitor cell number|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:2179196	Lig1<tm2Dwm>	MP:0000245,abnormal erythropoiesis|MP:0001577,anemia|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2183413	Lig1<tm3Dwm>	MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002020,increased tumor incidence|MP:0002640,reticulocytosis|MP:0003763,abnormal thymus physiology|MP:0005397,hematopoietic system phenotype|MP:0008737,abnormal spleen physiology|MP:0008866,chromosomal instability|MP:0009278,abnormal bone marrow cell physiology|MP:0009308,increased adenocarcinoma incidence|MP:0011704,decreased fibroblast proliferation|MP:0012431,increased lymphoma incidence
MGI:4946931	Lig3<tm1.1Pmc>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000280,thin ventricular wall|MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000852,small cerebellum|MP:0000854,abnormal cerebellum development|MP:0001393,ataxia|MP:0001544,abnormal cardiovascular system physiology|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology|MP:0003140,dilated heart atrium|MP:0004948,abnormal neuronal precursor proliferation|MP:0005140,decreased cardiac muscle contractility|MP:0008022,dilated heart ventricle|MP:0008058,abnormal DNA repair|MP:0008916,abnormal astrocyte physiology|MP:0008924,decreased cerebellar granule cell number|MP:0009808,decreased oligodendrocyte number|MP:0009937,abnormal neuron differentiation|MP:0010954,abnormal cellular respiration|MP:0011085,postnatal lethality, complete penetrance|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:3629052	Lig3<tm1Czhu>	MP:0001698,decreased embryo size|MP:0003701,elevated level of mitotic sister chromatid exchange|MP:0003984,embryonic growth retardation|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance
MGI:7627385	Lig4<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0003917,increased kidney weight|MP:0004906,enlarged uterus
MGI:6269393	Lig4<m1Btlr>	MP:0001805,decreased IgG level|MP:0002491,decreased IgD level|MP:0005017,decreased B cell number|MP:0008044,increased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0020154,impaired humoral immune response
MGI:6269402	Lig4<m2Btlr>	MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number
MGI:3714783	Lig4<tiny>	MP:0000333,decreased bone marrow cell number|MP:0000727,absent CD8-positive, alpha-beta T cells|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002416,abnormal proerythroblast morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0014760,impaired DNA repair
MGI:1857732	Lig4<tm1Fwa>	MP:0000352,decreased cell proliferation|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0000830,abnormal diencephalon morphology|MP:0001802,arrested B cell differentiation|MP:0001825,arrested T cell differentiation|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002401,abnormal lymphopoiesis|MP:0004028,chromosome breakage|MP:0004030,induced chromosome breakage|MP:0004077,abnormal striatum morphology|MP:0004200,decreased fetal size|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0005277,abnormal brainstem morphology|MP:0005397,hematopoietic system phenotype|MP:0005621,abnormal cell physiology|MP:0006254,thin cerebral cortex|MP:0008866,chromosomal instability|MP:0011091,prenatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012504,increased forebrain apoptosis|MP:0013182,increased spinal cord apoptosis
MGI:1857720	Lig4<tm1Icrf>	MP:0003203,increased neuron apoptosis|MP:0005384,cellular phenotype|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3831168	Lig4<tm1Pmc>	MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000913,abnormal brain development|MP:0001393,ataxia|MP:0002175,decreased brain weight|MP:0003631,nervous system phenotype|MP:0003861,abnormal nervous system development|MP:0014760,impaired DNA repair|MP:0014764,impaired double-strand DNA break repair
MGI:4437270	Lig4<tm2.1Fwa>	MP:0000685,abnormal immune system morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0000716,abnormal immune system cell morphology|MP:0000717,abnormal lymphocyte cell number|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001790,abnormal immune system physiology|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0001828,abnormal T cell activation|MP:0001858,intestinal inflammation|MP:0001860,liver inflammation|MP:0001921,reduced fertility|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002460,decreased immunoglobulin level|MP:0002722,abnormal immune system organ morphology|MP:0004029,spontaneous chromosome breakage|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004829,increased anti-chromatin antibody level|MP:0004941,abnormal regulatory T cell morphology|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight|MP:0005017,decreased B cell number|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0005621,abnormal cell physiology|MP:0006283,increased medulloblastoma incidence|MP:0006413,increased T cell apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008217,abnormal B cell activation|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008567,decreased interferon-gamma secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008754,abnormal T cell receptor V(D)J recombination|MP:0008758,abnormal T cell receptor beta chain V(D)J recombination|MP:0008866,chromosomal instability|MP:0009314,increased colon adenocarcinoma incidence|MP:0009339,decreased splenocyte number
MGI:4437900	Lig4<tm3.1Fwa>	MP:0004816,abnormal class switch recombination
MGI:2386122	Lilrb4a<tm1Eol>	MP:0000716,abnormal immune system cell morphology|MP:0001790,abnormal immune system physiology|MP:0001846,increased inflammatory response|MP:0002133,abnormal respiratory system physiology|MP:0002169,no abnormal phenotype detected|MP:0002442,abnormal leukocyte physiology|MP:0002492,decreased IgE level|MP:0005425,increased macrophage cell number|MP:0008097,increased plasma cell number|MP:0008713,abnormal cytokine level|MP:0008750,abnormal interferon level|MP:0008751,abnormal interleukin level|MP:0008764,increased mast cell degranulation|MP:0009858,abnormal cellular extravasation
MGI:2653049	Lilrb4a<tm1Hrk>	MP:0002423,abnormal mast cell physiology|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008764,increased mast cell degranulation
MGI:3818260	Lilrb4a<tm1Ttk>	MP:0002455,abnormal dendritic cell antigen presentation|MP:0005672,increased susceptibility to graft versus host disease
MGI:6385151	Lilrb4b<em1(IMPC)J>	MP:0002833,increased heart weight|MP:0010507,shortened RR interval
MGI:5304394	Lim2<Aca47>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001306,small lens|MP:0002697,abnormal eye size|MP:0002840,abnormal lens fiber morphology|MP:0005391,vision/eye phenotype|MP:0010254,nuclear cataract
MGI:3530610	Lim2<Gt(OST98930)Lex>	MP:0001303,abnormal lens morphology|MP:0001306,small lens
MGI:1862040	Lim2<To3>	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0002579,disorganized secondary lens fibers|MP:0002699,abnormal vitreous body morphology|MP:0002840,abnormal lens fiber morphology|MP:0008841,ruptured lens capsule|MP:0010263,total cataract|MP:0011697,lens vacuoles
MGI:6192725	Lima1<tm1.1Blsg>	MP:0002647,decreased intestinal cholesterol absorption|MP:0005179,decreased circulating cholesterol level
MGI:5488778	Lima1<tm1b(KOMP)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance|MP:0020870,decreased thigmotaxis
MGI:6192724	Lima1<tm1Blsg>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0002647,decreased intestinal cholesterol absorption|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005376,homeostasis/metabolism phenotype|MP:0010026,decreased liver cholesterol level
MGI:7580925	Limch1<em1Coop>	MP:0000747,muscle weakness|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003157,impaired muscle relaxation|MP:0004231,abnormal calcium ion homeostasis|MP:0005369,muscle phenotype|MP:0010053,decreased grip strength
MGI:5588284	Limch1<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011396,abnormal sleep behavior
MGI:6257579	Limd1<em1(IMPC)H>	MP:0002599,increased mean platelet volume|MP:0002606,increased basophil cell number|MP:0002966,decreased circulating alkaline phosphatase level|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0010053,decreased grip strength|MP:0010511,shortened PR interval
MGI:3699087	Limd1<tm1Gdl>	MP:0001541,abnormal osteoclast physiology|MP:0002451,abnormal macrophage physiology|MP:0004983,abnormal osteoclast cell number
MGI:7425797	Lime1<em1(IMPC)Hmgu>	MP:0002135,abnormal kidney morphology
MGI:3762394	Lime1<tm1.1Mal>	MP:0005387,immune system phenotype
MGI:2679321	Limk1<tm1Zpj>	MP:0000807,abnormal hippocampus morphology|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001454,abnormal cued conditioning behavior|MP:0002062,abnormal associative learning|MP:0002063,abnormal learning/memory/conditioning|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002152,abnormal brain morphology|MP:0002207,abnormal long-term potentiation|MP:0002574,increased vertical activity|MP:0020849,abnormal actin cytoskeleton morphology
MGI:4176477	Limk2<Gt(OST80053)Lex>	MP:0001302,eyelids open at birth|MP:0001312,abnormal cornea morphology|MP:0001313,increased incidence of corneal inflammation|MP:0006000,abnormal cornea epithelium morphology|MP:0008852,retina neovascularization|MP:0009264,failure of eyelid fusion|MP:0009651,abnormal eyelid development|MP:0031212,decreased eye anterior chamber depth
MGI:2180767	Limk2<tm1.1Tnak>	MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0004505,decreased renal glomerulus number|MP:0004852,decreased testis weight|MP:0006379,abnormal spermatocyte morphology|MP:0014052,increased male germ cell apoptosis
MGI:4431692	Limk2<tm1a(EUCOMM)Wtsi>	MP:0001260,increased body weight|MP:0003313,abnormal locomotor activation|MP:0004357,long tibia
MGI:3612836	Limk2<whe>	MP:0000088,short mandible|MP:0001313,increased incidence of corneal inflammation|MP:0001314,cornea opacity|MP:0003153,early eyelid opening|MP:0005375,adipose tissue phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005390,skeleton phenotype|MP:0005542,cornea vascularization|MP:0011481,anterior iris synechia|MP:0030166,increased inner canthal distance
MGI:3576923	Lims1<tm1.1Chen>	MP:0000343,abnormal response to cardiac infarction|MP:0003037,increased myocardial infarct size|MP:0005140,decreased cardiac muscle contractility|MP:0005385,cardiovascular system phenotype
MGI:3577473	Lims1<tm1.2Chen>	MP:0000313,abnormal cell death|MP:0000352,decreased cell proliferation|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0003085,abnormal egg cylinder morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011198,absent proamniotic cavity
MGI:3584173	Lims1<tm1Ref>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3584172	Lims1<tm2Ref>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3618371	Lims1<tm3Ref>	MP:0002169,no abnormal phenotype detected
MGI:4867246	Lims2<tm1.1Chen>	MP:0000343,abnormal response to cardiac infarction|MP:0003037,increased myocardial infarct size|MP:0005140,decreased cardiac muscle contractility|MP:0005385,cardiovascular system phenotype
MGI:3618381	Lims2<tm1.1Ref>	MP:0002169,no abnormal phenotype detected
MGI:3615345	Lims2<tm1Ref>	MP:0002169,no abnormal phenotype detected
MGI:5500060	Lin28a<tm1.1Gqda>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001921,reduced fertility|MP:0002078,abnormal glucose homeostasis|MP:0002209,decreased germ cell number|MP:0005369,muscle phenotype|MP:0005621,abnormal cell physiology|MP:0009429,decreased embryo weight|MP:0009431,decreased fetal weight|MP:0010025,decreased total body fat amount|MP:0010402,ventricular septal defect|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5519953	Lin28a<tm1.2Gqda>	MP:0002169,no abnormal phenotype detected
MGI:4849371	Lin28a<tm1Egm>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001380,decreased male mating frequency|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002209,decreased germ cell number|MP:0002687,oligozoospermia|MP:0002780,decreased circulating testosterone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0004856,decreased ovary weight|MP:0005431,decreased oocyte number|MP:0008392,decreased primordial germ cell number|MP:0009674,decreased birth weight|MP:0011085,postnatal lethality, complete penetrance|MP:0011121,decreased primordial ovarian follicle number
MGI:5294611	Lin28a<tm1Gqda>	MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005378,growth/size/body region phenotype
MGI:5519055	Lin28b<tm1.1Gqda>	MP:0001265,decreased body size
MGI:5519954	Lin28b<tm1.2Gqda>	MP:0002169,no abnormal phenotype detected
MGI:5629322	Lin28b<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment
MGI:5519037	Lin28b<tm1Gqda>	MP:0001265,decreased body size|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005369,muscle phenotype
MGI:6306929	Lin52<em1(IMPC)J>	MP:0002590,increased mean corpuscular volume|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:7574252	Lin54<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:2447803	Lin7a<tm1Dsb>	MP:0002169,no abnormal phenotype detected
MGI:2447804	Lin7b<tm1Dsb>	MP:0002169,no abnormal phenotype detected
MGI:3611209	Lin7c<tm1Dsb>	MP:0001262,decreased body weight|MP:0001762,polyuria|MP:0002135,abnormal kidney morphology|MP:0002136,abnormal kidney physiology|MP:0002705,dilated renal tubule|MP:0002988,decreased urine osmolality|MP:0003215,renal interstitial fibrosis|MP:0003604,single kidney|MP:0003918,decreased kidney weight|MP:0005558,decreased creatinine clearance|MP:0005565,increased blood urea nitrogen level|MP:0006316,increased urine sodium level|MP:0008528,polycystic kidney|MP:0009640,abnormal renal tubule epithelium morphology|MP:0011368,increased kidney apoptosis
MGI:3790689	Lin7c<tm2Dsb>	MP:0002169,no abnormal phenotype detected|MP:0002705,dilated renal tubule|MP:0003215,renal interstitial fibrosis|MP:0003918,decreased kidney weight|MP:0011368,increased kidney apoptosis
MGI:4129434	Lin9<Gt(RRI306)Byg>	MP:0001672,abnormal embryo development|MP:0003087,absent allantois|MP:0004965,inner cell mass degeneration|MP:0005030,absent amnion|MP:0009593,absent chorion|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011184,absent embryonic epiblast|MP:0012114,absent inner cell mass proliferation
MGI:4819561	Lin9<tm1.1Sgau>	MP:0000496,abnormal small intestine morphology|MP:0002083,premature death|MP:0003111,abnormal cell nucleus morphology|MP:0004046,abnormal mitosis|MP:0008108,abnormal small intestinal villus morphology|MP:0009762,abnormal mitotic spindle assembly checkpoint|MP:0010157,abnormal small intestinal crypt cell proliferation|MP:0011704,decreased fibroblast proliferation|MP:0030943,abnormal centrosome morphology
MGI:4819562	Lin9<tm1.2Sgau>	MP:0011100,preweaning lethality, complete penetrance
MGI:3663755	Lin9<tm1Orc>	MP:0001260,increased body weight
MGI:3623893	Lingo1<tm1Shmi>	MP:0000920,abnormal myelination
MGI:6156326	Lingo2<em1(IMPC)Kmpc>	MP:0000598,abnormal liver morphology|MP:0001120,abnormal uterus morphology|MP:0001257,increased body length|MP:0003960,increased lean body mass|MP:0004357,long tibia|MP:0009709,hydrometra|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:6287372	Lingo3<em1(IMPC)Wtsi>	MP:0001325,abnormal retina morphology|MP:0001406,abnormal gait
MGI:5049956	linio	MP:0012270,cardiac edema
MGI:5910408	Lins1<em1(IMPC)J>	MP:0001304,cataract|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6364606	Lipa<tm1c(EUCOMM)Hmgu>	MP:0000182,increased circulating LDL cholesterol level|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0001860,liver inflammation|MP:0002575,increased circulating ketone body level|MP:0002628,hepatic steatosis|MP:0002891,increased insulin sensitivity|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003333,liver fibrosis|MP:0005178,increased circulating cholesterol level|MP:0005283,increased unsaturated fatty acids level|MP:0005285,decreased unsaturated fatty acids level|MP:0005292,improved glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005375,adipose tissue phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009283,decreased gonadal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0010378,increased respiratory quotient|MP:0010951,abnormal lipid oxidation|MP:0010958,abnormal tricarboxylic acid cycle|MP:0011582,decreased triglyceride lipase activity|MP:0013243,abnormal carbohydrate metabolism|MP:0030973,impaired gluconeogenesis
MGI:2451080	Lipa<tm1Hodu>	MP:0000182,increased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000477,abnormal intestine morphology|MP:0000496,abnormal small intestine morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000639,abnormal adrenal gland morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000820,abnormal choroid plexus morphology|MP:0001175,abnormal lung morphology|MP:0001262,decreased body weight|MP:0001547,abnormal lipid level|MP:0001554,increased circulating free fatty acids level|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0001861,lung inflammation|MP:0001958,emphysema|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002499,chronic inflammation|MP:0002628,hepatic steatosis|MP:0002971,abnormal brown adipose tissue morphology|MP:0002981,increased liver weight|MP:0003271,abnormal duodenum morphology|MP:0004002,abnormal jejunum morphology|MP:0004952,increased spleen weight|MP:0004969,pale kidney|MP:0005331,insulin resistance|MP:0005336,abnormal inguinal fat pad morphology|MP:0005337,abnormal retroperitoneal fat pad morphology|MP:0005490,increased club cell number|MP:0006320,abnormal interscapular fat pad morphology|MP:0008108,abnormal small intestinal villus morphology|MP:0008114,abnormal Kupffer cell morphology|MP:0008245,abnormal alveolar macrophage morphology|MP:0008466,enlarged mesenteric lymph nodes|MP:0008843,absent subcutaneous adipose tissue|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008989,abnormal liver sinusoid morphology|MP:0009124,increased brown fat cell lipid droplet size|MP:0009132,abnormal white fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0010810,increased type II pneumocyte number|MP:0011939,increased food intake|MP:0031058,hepatosplenomegaly
MGI:1857182	Lipc<tm1Unc>	MP:0000180,abnormal circulating cholesterol level|MP:0001127,small ovary|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0001919,abnormal reproductive system physiology|MP:0001935,decreased litter size|MP:0002665,decreased circulating corticosterone level|MP:0003355,decreased ovulation rate|MP:0005178,increased circulating cholesterol level|MP:0006084,abnormal circulating phospholipid level
MGI:5692897	Lipe<tm1b(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0001399,hyperactivity|MP:0001925,male infertility|MP:0002079,increased circulating insulin level|MP:0003917,increased kidney weight
MGI:2652711	Lipe<tm1Gam>	MP:0000005,increased brown adipose tissue amount|MP:0000010,abnormal abdominal fat pad morphology|MP:0000180,abnormal circulating cholesterol level|MP:0001553,abnormal circulating free fatty acids level|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002631,abnormal epididymis morphology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005559,increased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0006380,abnormal spermatid morphology|MP:0009115,abnormal fat cell morphology|MP:0009356,decreased liver triglyceride level|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014636,decreased elongated spermatid number
MGI:2181610	Lipe<tm1Ishi>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002702,decreased circulating free fatty acids level|MP:0002970,abnormal white adipose tissue morphology|MP:0002971,abnormal brown adipose tissue morphology|MP:0003442,decreased circulating glycerol level|MP:0005178,increased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005317,increased triglyceride level|MP:0005378,growth/size/body region phenotype|MP:0005559,increased circulating glucose level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005670,abnormal white adipose tissue physiology|MP:0006094,increased fat cell size|MP:0011750,abnormal seminiferous tubule epithelium morphology
MGI:2677463	Lipe<tm1Land>	MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0001783,decreased white adipose tissue amount|MP:0001925,male infertility|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0002687,oligozoospermia|MP:0005289,increased oxygen consumption|MP:0005331,insulin resistance|MP:0005491,pancreatic islet hyperplasia|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005666,abnormal adipose tissue physiology|MP:0005668,decreased circulating leptin level|MP:0008032,abnormal lipolysis|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009113,increased pancreatic beta cell mass|MP:0009117,abnormal white fat cell morphology|MP:0010399,decreased skeletal muscle glycogen level|MP:0011939,increased food intake|MP:0014476,abnormal feces lipid level|MP:0030968,decreased circulating adiponectin level|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:2388334	Lipe<tm1Rze>	MP:0000187,abnormal triglyceride level|MP:0001547,abnormal lipid level|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0005266,abnormal metabolism|MP:0005280,abnormal fatty acids level|MP:0005317,increased triglyceride level|MP:0005559,increased circulating glucose level|MP:0005670,abnormal white adipose tissue physiology|MP:0009356,decreased liver triglyceride level|MP:0011698,abnormal brown adipose tissue physiology|MP:0020101,abnormal hepatic glucose production|MP:0030968,decreased circulating adiponectin level|MP:0031417,decreased cardiac muscle triglyceride level
MGI:3832721	Lipe<tm2Rze>	MP:0002078,abnormal glucose homeostasis|MP:0003564,abnormal insulin secretion|MP:0003961,decreased lean body mass|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0005458,increased percent body fat/body weight|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0009113,increased pancreatic beta cell mass
MGI:2653887	Lipg<tm1Chan>	MP:0001556,increased circulating HDL cholesterol level|MP:0003980,increased circulating phospholipid level|MP:0005178,increased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis
MGI:2450672	Lipg<tm1Tq>	MP:0000184,abnormal circulating HDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0003980,increased circulating phospholipid level|MP:0004003,abnormal vascular endothelial cell physiology|MP:0005178,increased circulating cholesterol level
MGI:5294787	Liph<tm1Aoki>	MP:0000367,abnormal coat/ hair morphology|MP:0000410,waved hair|MP:0001279,wavy vibrissae|MP:0003810,abnormal hair cuticle|MP:0003812,abnormal hair medulla|MP:0003846,matted coat|MP:0008731,abnormal hair shaft melanin granule morphology|MP:0010685,abnormal hair follicle inner root sheath morphology
MGI:2450247	Lipi<lpd1>	MP:0000424,retarded hair growth|MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001552,increased circulating triglyceride level|MP:0002082,postnatal lethality|MP:0002628,hepatic steatosis|MP:0009355,increased liver triglyceride level
MGI:6360918	Lipm<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0011100,preweaning lethality, complete penetrance
MGI:5576043	Lipn<tm1.1(KOMP)Vlcg>	MP:0005560,decreased circulating glucose level
MGI:3037994	Lipq1<C57BL/6By>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3035983	Lipq2<BALB/cJ>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3037996	Lipq3<C57BL/6By>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:6257750	Lipt1<em1(IMPC)Bay>	MP:0000689,abnormal spleen morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:6448947	Lipt1<em1Utsw>	MP:0001698,decreased embryo size|MP:0003717,pallor|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7514734	Lipt2<em1(IMPC)Bay>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0000432,abnormal head morphology|MP:0001691,abnormal somite shape|MP:0001697,abnormal embryo size|MP:0001722,pale yolk sac|MP:0002151,abnormal neural tube morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0002861,abnormal tail bud morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0003717,pallor|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0005650,abnormal limb bud morphology|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2156006	Listr1<BALB/cByJ>	MP:0002411,decreased susceptibility to bacterial infection
MGI:2389299	Listr2<C57BL/6ByJ>	MP:0002411,decreased susceptibility to bacterial infection
MGI:6887477	Litaf<tm1.1Cwc>	MP:0003172,abnormal lysosome physiology|MP:0005384,cellular phenotype|MP:0013147,limb paralysis|MP:0020848,abnormal exocytosis|MP:0020851,abnormal vacuole morphology
MGI:5433218	Litaf<tm1.1Ics>	MP:0000921,demyelination|MP:0003631,nervous system phenotype|MP:0003799,impaired macrophage chemotaxis|MP:0005165,increased susceptibility to injury|MP:0005425,increased macrophage cell number
MGI:6887479	Litaf<tm1.2Cwc>	MP:0003172,abnormal lysosome physiology|MP:0020848,abnormal exocytosis|MP:0020851,abnormal vacuole morphology
MGI:3687962	Litaf<tm1Samr>	MP:0003009,abnormal cytokine secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:7868147	Litchi<em1Jnch>	MP:0000747,muscle weakness|MP:0001405,impaired coordination|MP:0002946,delayed axon extension|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0010053,decreased grip strength|MP:0010768,mortality/aging|MP:0020336,abnormal motor neuron dendrite morphology|MP:0021090,abnormal dendrite arborization pattern
MGI:2682409	Lith10<DBA/2J>	MP:0002830,gallstones
MGI:2682411	Lith11<DBA/2J>	MP:0002830,gallstones
MGI:2675448	Lith12<CAST/EiJ>	MP:0002118,abnormal lipid homeostasis
MGI:3576876	Lith12<PERA/EiJ>	MP:0002830,gallstones
MGI:2675447	Lith13<129S1/SvImJ>	MP:0002118,abnormal lipid homeostasis
MGI:2675450	Lith14<CAST/EiJ>	MP:0002118,abnormal lipid homeostasis
MGI:3576878	Lith15<PERA/EiJ>	MP:0002830,gallstones
MGI:3576880	Lith16<PERA/EiJ>	MP:0002830,gallstones
MGI:3577242	Lith17<SM/J>	MP:0002830,gallstones
MGI:3577245	Lith18<SM/J>	MP:0002830,gallstones
MGI:3577247	Lith19<SM/J>	MP:0002830,gallstones
MGI:2446828	Lith1<C57L/J>	MP:0002830,gallstones
MGI:3577251	Lith20<SM/J>	MP:0002830,gallstones
MGI:3577252	Lith21<NZB/BlNJ>	MP:0002830,gallstones
MGI:2682406	Lith24<DBA/2J>	MP:0002830,gallstones
MGI:2675440	Lith25<CAST/EiJ>	MP:0002118,abnormal lipid homeostasis|MP:0002830,gallstones
MGI:3576883	Lith28<PERA/EiJ>	MP:0002830,gallstones
MGI:3576882	Lith29<PERA/EiJ>	MP:0002830,gallstones
MGI:2446826	Lith2<C57L/J>	MP:0002830,gallstones
MGI:3052788	Lith3<AKR/J>	MP:0002830,gallstones
MGI:3576885	Lith4<PERA/EiJ>	MP:0002830,gallstones
MGI:2176826	Lith5<SWR/J>	MP:0002830,gallstones
MGI:2681420	Lith7<I/LnJ>	MP:0002830,gallstones
MGI:2681422	Lith8<I/LnJ>	MP:0002830,gallstones
MGI:2681423	Lith9<PERA/EiJ>	MP:0002830,gallstones
MGI:3778072	Litsq1<129S1/SvImJ>	MP:0001934,increased litter size
MGI:2156749	Livq1<MH>	MP:0002981,increased liver weight
MGI:3035990	Livq2<MH>	MP:0002981,increased liver weight
MGI:3035992	Livq3<MH>	MP:0003402,decreased liver weight
MGI:4256026	Lix1<Gt(OST262711)Lex>	MP:0002169,no abnormal phenotype detected
MGI:7327094	Lkaaear1<em1(IMPC)J>	MP:0001925,male infertility
MGI:3044409	lla<SL/Kh>	MP:0012431,increased lymphoma incidence
MGI:6437831	Llcfc1<em2Osb>	MP:0001925,male infertility|MP:0031010,failure of sperm-egg fusion
MGI:6437832	Llcfc1<em3Osb>	MP:0001925,male infertility
MGI:5569060	Llcfc1<tm1.1(KOMP)Vlcg>	MP:0001925,male infertility|MP:0005344,increased circulating bilirubin level
MGI:3039269	Llgl1<tm1.1Vv>	MP:0000440,domed cranium|MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0000788,abnormal cerebral cortex morphology|MP:0000825,dilated lateral ventricle|MP:0001891,hydrocephaly|MP:0001917,intraventricular hemorrhage|MP:0004077,abnormal striatum morphology|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0004950,abnormal brain vasculature morphology|MP:0004980,increased neuronal precursor cell number|MP:0008948,decreased neuron number|MP:0009937,abnormal neuron differentiation|MP:0011087,neonatal lethality, complete penetrance|MP:0012676,dilated brain ventricle
MGI:3039268	Llgl1<tm1Vv>	MP:0000440,domed cranium|MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0000788,abnormal cerebral cortex morphology|MP:0000825,dilated lateral ventricle|MP:0001891,hydrocephaly|MP:0001917,intraventricular hemorrhage|MP:0004077,abnormal striatum morphology|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0004950,abnormal brain vasculature morphology|MP:0004980,increased neuronal precursor cell number|MP:0008948,decreased neuron number|MP:0009937,abnormal neuron differentiation|MP:0011087,neonatal lethality, complete penetrance|MP:0012676,dilated brain ventricle
MGI:4331862	Llgl2<Gt(XS0846)Wtsi>	MP:0001716,abnormal placenta labyrinth morphology|MP:0004259,small placenta|MP:0004921,decreased placenta weight|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009431,decreased fetal weight|MP:0009703,decreased birth body size|MP:0010771,integument phenotype|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011521,decreased placental labyrinth size|MP:0011522,abnormal placental labyrinth villi morphology|MP:0011525,abnormal placenta intervillous maternal lacunae morphology|MP:0011526,abnormal placenta fetal blood space morphology|MP:0011528,abnormal placental labyrinth villi branching morphogenesis|MP:0011529,increased placenta intervillous maternal lacunae size
MGI:5635230	Llgl2<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001488,increased startle reflex|MP:0011100,preweaning lethality, complete penetrance
MGI:4123879	Lman1<Gt(XST010)Byg>	MP:0005376,homeostasis/metabolism phenotype|MP:0005384,cellular phenotype|MP:0005416,abnormal circulating protein level|MP:0005632,decreased circulating aspartate transaminase level|MP:0008469,abnormal protein level|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0010768,mortality/aging|MP:0010831,lethality, incomplete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012328,decreased circulating factor VIII level
MGI:5501339	Lman1<tm1c(KOMP)Wtsi>	MP:0004720,abnormal platelet morphology|MP:0009642,abnormal blood homeostasis
MGI:6286369	Lman2<em1(IMPC)Wtsi>	MP:0001489,decreased startle reflex|MP:0005553,increased circulating creatinine level|MP:0010025,decreased total body fat amount
MGI:7481207	Lman2l<em1(IMPC)Bay>	MP:0001175,abnormal lung morphology|MP:0001392,abnormal locomotor behavior|MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance
MGI:2155873	Lmb1<C57BL/6Scr>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004952,increased spleen weight|MP:0005090,increased double-negative T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:2155872	Lmb1<MRL/MpScr>	MP:0000702,enlarged lymph nodes
MGI:2156221	Lmb2<MRL/MpScr>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005089,decreased double-negative T cell number
MGI:2158218	Lmb4<MRL/MpScr>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes
MGI:3042461	Lmblgq1<M16i>	MP:0002764,short tibia|MP:0003109,short femur|MP:0004351,short humerus|MP:0004359,short ulna
MGI:3042463	Lmblgq2<M16i>	MP:0004350,long humerus|MP:0004370,long ulna
MGI:3042465	Lmblgq3<M16i>	MP:0002764,short tibia|MP:0003109,short femur|MP:0004351,short humerus|MP:0004359,short ulna
MGI:3042467	Lmblgq4<M16i>	MP:0002764,short tibia|MP:0003109,short femur|MP:0004351,short humerus
MGI:3042469	Lmblgq5<M16i>	MP:0004348,long femur|MP:0004357,long tibia|MP:0004370,long ulna
MGI:3042471	Lmblgq6<M16i>	MP:0004348,long femur|MP:0004350,long humerus|MP:0004357,long tibia|MP:0005108,abnormal ulna morphology
MGI:6303829	Lmbr1l<em1Btlr>	MP:0000221,decreased leukocyte cell number|MP:0000223,decreased monocyte cell number|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002491,decreased IgD level|MP:0002494,increased IgM level|MP:0002619,abnormal lymphocyte morphology|MP:0005016,decreased lymphocyte cell number|MP:0005018,decreased T cell number|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005078,abnormal cytotoxic T cell physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0011181,increased hematopoietic cell number|MP:0012762,abnormal alpha-beta T cell morphology|MP:0013893,decreased common lymphocyte progenitor cell number|MP:0020154,impaired humoral immune response
MGI:6303733	Lmbr1l<m1Btlr>	MP:0000219,increased neutrophil cell number|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002145,abnormal T cell differentiation|MP:0002492,decreased IgE level|MP:0004977,increased B-1 B cell number|MP:0005018,decreased T cell number|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005425,increased macrophage cell number|MP:0008040,decreased NK T cell number|MP:0008045,decreased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008127,decreased dendritic cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0020154,impaired humoral immune response
MGI:6305080	Lmbr1l<m2Btlr>	MP:0010841,increased central memory CD4-positive, alpha-beta T cell number
MGI:3604480	Lmbr1l<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3604603	Lmbr1<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3579991	Lmbr1<tm1Kng>	MP:0000554,abnormal carpal bone morphology|MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0002543,brachyphalangia
MGI:6682025	Lmbrd1<tm1.1Bvs>	MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5559223	Lmbrd1<tm1.1Ntum>	MP:0004039,abnormal cardiac muscle cell glucose uptake|MP:0030018,increased cardiac muscle cell glucose uptake
MGI:5513795	Lmbrd1<tm1b(EUCOMM)Hmgu>	MP:0001697,abnormal embryo size|MP:0005559,increased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5771567	Lmcd1<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0009142,decreased prepulse inhibition|MP:0010124,decreased bone mineral content
MGI:1856820	Lmf1<cld>	MP:0001182,lung hemorrhage|MP:0001402,decreased locomotor activity|MP:0001552,increased circulating triglyceride level|MP:0001575,cyanosis|MP:0001634,internal hemorrhage|MP:0002082,postnatal lethality|MP:0003717,pallor|MP:0003888,liver hemorrhage|MP:0005178,increased circulating cholesterol level|MP:0008489,slow postnatal weight gain|MP:0009698,heart hemorrhage|MP:0009699,hyperchylomicronemia|MP:0011579,decreased lipoprotein lipase activity|MP:0011582,decreased triglyceride lipase activity
MGI:7564551	Lmf1<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:4226427	Lmf1<Gt(OST195742)Lex>	MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0005178,increased circulating cholesterol level|MP:0011085,postnatal lethality, complete penetrance|MP:0011579,decreased lipoprotein lipase activity|MP:0011582,decreased triglyceride lipase activity
MGI:3848037	Lmna<Dhe>	MP:0000049,abnormal middle ear morphology|MP:0000063,decreased bone mineral density|MP:0000074,abnormal neurocranium morphology|MP:0000097,short maxilla|MP:0000120,malocclusion|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000438,abnormal cranium morphology|MP:0000445,short snout|MP:0000460,mandible hypoplasia|MP:0000762,abnormal tongue morphology|MP:0001195,flaky skin|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001566,increased circulating phosphate level|MP:0001850,increased susceptibility to otitis media|MP:0001923,reduced female fertility|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0002102,abnormal ear morphology|MP:0002111,abnormal tail morphology|MP:0002251,abnormal nasopharynx morphology|MP:0002655,abnormal keratinocyte morphology|MP:0002750,exophthalmos|MP:0002835,abnormal cranial suture morphology|MP:0002896,abnormal bone mineralization|MP:0003077,abnormal cell cycle|MP:0003330,abnormal auditory tube morphology|MP:0003756,abnormal hard palate morphology|MP:0003786,premature aging|MP:0003840,abnormal coronal suture morphology|MP:0003841,abnormal lambdoid suture morphology|MP:0003843,abnormal sagittal suture morphology|MP:0003878,abnormal ear physiology|MP:0004024,aneuploidy|MP:0004046,abnormal mitosis|MP:0004736,abnormal distortion product otoacoustic emission|MP:0005352,small cranium|MP:0006018,abnormal tympanic membrane morphology|MP:0006197,ocular hypotelorism|MP:0006213,shallow orbits|MP:0006325,impaired hearing|MP:0008057,abnormal DNA replication|MP:0008244,abnormal peritoneal macrophage morphology|MP:0008525,decreased cranium height|MP:0008526,decreased cranium width|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008858,abnormal hair cycle anagen phase|MP:0008890,abnormal nuclear lamina morphology|MP:0009388,abnormal epidermal melanocyte morphology|MP:0009675,orthokeratosis|MP:0009762,abnormal mitotic spindle assembly checkpoint|MP:0010025,decreased total body fat amount|MP:0010031,abnormal cranium size|MP:0010043,abnormal frontonasal suture morphology|MP:0010124,decreased bone mineral content|MP:0010179,rough coat|MP:0011704,decreased fibroblast proliferation|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013193,sebaceous gland hypoplasia|MP:0014516,abnormal middle ear development|MP:0014693,abnormal cell nucleus size|MP:0020084,short ears|MP:0020137,decreased bone mineralization|MP:0020900,abnormal middle ear epithelium morphology|MP:0020903,increased middle ear goblet cell number|MP:0030090,short upper incisors|MP:0030160,abnormal auditory bulla morphology|MP:0030413,tympanic membrane retraction
MGI:7518551	Lmna<em1Fenz>	MP:0000182,increased circulating LDL cholesterol level|MP:0001260,increased body weight|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005336,abnormal inguinal fat pad morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0005375,adipose tissue phenotype|MP:0009286,increased abdominal fat pad weight|MP:0009302,increased renal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0010955,abnormal respiratory electron transport chain|MP:0014146,decreased white adipose tissue mass|MP:0014170,increased brown adipose tissue mass
MGI:4974489	Lmna<Gt(S7-1F1)Sor>	MP:0000189,hypoglycemia|MP:0000267,abnormal heart development|MP:0000747,muscle weakness|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001436,abnormal suckling behavior|MP:0001443,poor grooming|MP:0001505,hunched posture|MP:0001732,postnatal growth retardation|MP:0002169,no abnormal phenotype detected|MP:0002575,increased circulating ketone body level|MP:0003916,decreased heart left ventricle weight|MP:0003978,decreased circulating carnitine level|MP:0004071,prolonged P wave|MP:0004565,decreased myocardial fiber size|MP:0005333,decreased heart rate|MP:0005382,craniofacial phenotype|MP:0005390,skeleton phenotype|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009247,meteorism|MP:0009400,decreased skeletal muscle fiber size|MP:0009402,decreased skeletal muscle fiber diameter|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0010227,decreased quadriceps weight|MP:0010398,decreased liver glycogen level|MP:0010506,prolonged RR interval|MP:0010768,mortality/aging|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011014,decreased core body temperature|MP:0011085,postnatal lethality, complete penetrance|MP:0011168,abnormal fat cell differentiation|MP:0013404,decreased circulating lactate level
MGI:5571497	Lmna<tm10Lgf>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging
MGI:6423596	Lmna<tm1.1Bliu>	MP:0001263,weight loss|MP:0001613,abnormal vasodilation|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0010996,increased aorta wall thickness
MGI:5752218	Lmna<tm11Lgf>	MP:0000469,abnormal esophageal squamous epithelium morphology|MP:0000495,abnormal colon morphology|MP:0001038,abnormal cholinergic neuron morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0002083,premature death|MP:0003159,abnormal esophageal smooth muscle morphology|MP:0003631,nervous system phenotype|MP:0004548,dilated esophagus|MP:0005390,skeleton phenotype|MP:0009480,distended cecum|MP:0009536,abnormal interstitial cell of Cajal morphology|MP:0011570,esophageal achalasia
MGI:5295747	Lmna<tm1.1Otin>	MP:0000063,decreased bone mineral density|MP:0000135,decreased compact bone thickness|MP:0000160,kyphosis|MP:0000189,hypoglycemia|MP:0000377,abnormal hair follicle morphology|MP:0000692,small spleen|MP:0000706,small thymus|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001924,infertility|MP:0001926,female infertility|MP:0002083,premature death|MP:0002687,oligozoospermia|MP:0002727,decreased circulating insulin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003111,abnormal cell nucleus morphology|MP:0003786,premature aging|MP:0003795,abnormal bone structure|MP:0003814,vascular smooth muscle hypoplasia|MP:0005123,increased circulating growth hormone level|MP:0005333,decreased heart rate|MP:0005352,small cranium|MP:0005560,decreased circulating glucose level|MP:0005595,abnormal vascular smooth muscle physiology|MP:0005621,abnormal cell physiology|MP:0005668,decreased circulating leptin level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009105,penis prolapse|MP:0009642,abnormal blood homeostasis|MP:0009871,abnormal aorta tunica adventitia morphology|MP:0010053,decreased grip strength|MP:0010392,prolonged QRS complex duration|MP:0010522,calcified aorta|MP:0010523,calcified thoracic aorta|MP:0010524,calcified aortic arch|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0013466,keratoconjunctivitis sicca|MP:0030080,small lower incisors|MP:0030969,increased circulating adiponectin level|MP:0031253,lordokyphosis
MGI:7260353	Lmna<tm1.1Vde>	MP:0003631,nervous system phenotype|MP:0004142,abnormal muscle tone|MP:0005386,behavior/neurological phenotype|MP:0012107,enhanced exercise endurance
MGI:5575529	Lmna<tm1.1Yxz>	MP:0002169,no abnormal phenotype detected
MGI:5806143	Lmna<tm12Lgf>	MP:0009865,abnormal aorta smooth muscle morphology|MP:0009871,abnormal aorta tunica adventitia morphology
MGI:5575530	Lmna<tm1.2Yxz>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0009400,decreased skeletal muscle fiber size|MP:0011085,postnatal lethality, complete penetrance
MGI:5548950	Lmna<tm1b(EUCOMM)Wtsi>	MP:0001312,abnormal cornea morphology|MP:0002764,short tibia|MP:0005292,improved glucose tolerance|MP:0008259,abnormal optic disk morphology|MP:0009825,cornea ulcer|MP:0011100,preweaning lethality, complete penetrance
MGI:6423595	Lmna<tm1Bliu>	MP:0000066,osteoporosis|MP:0001263,weight loss|MP:0001613,abnormal vasodilation|MP:0002083,premature death|MP:0002191,abnormal artery morphology|MP:0002795,dilated cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0003393,decreased cardiac output|MP:0003710,abnormal physiological neovascularization|MP:0003786,premature aging|MP:0005333,decreased heart rate|MP:0005338,atherosclerotic lesions|MP:0006057,decreased vascular endothelial cell number|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0010996,increased aorta wall thickness|MP:0012106,impaired exercise endurance|MP:0013630,increased bone trabecular spacing|MP:0020329,decreased capillary density|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3527206	Lmna<tm1Gbon>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000748,progressive muscle weakness|MP:0000752,dystrophic muscle|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001505,hunched posture|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002279,abnormal diaphragm morphology|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0003081,abnormal soleus morphology|MP:0003082,abnormal gastrocnemius morphology|MP:0003083,abnormal tibialis anterior morphology|MP:0003137,abnormal impulse conducting system conduction|MP:0003140,dilated heart atrium|MP:0003141,cardiac fibrosis|MP:0003358,abnormal hypaxial muscle morphology|MP:0003896,prolonged PR interval|MP:0005140,decreased cardiac muscle contractility|MP:0005156,bradykinesia|MP:0005317,increased triglyceride level|MP:0005426,tachypnea|MP:0005560,decreased circulating glucose level|MP:0006085,myocardium necrosis|MP:0009419,skeletal muscle fibrosis|MP:0010392,prolonged QRS complex duration|MP:0010520,sinoatrial block|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3587791	Lmna<tm1Lgf>	MP:0000063,decreased bone mineral density|MP:0000150,abnormal rib morphology|MP:0000160,kyphosis|MP:0000438,abnormal cranium morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002639,micrognathia|MP:0002835,abnormal cranial suture morphology|MP:0002896,abnormal bone mineralization|MP:0003111,abnormal cell nucleus morphology|MP:0003795,abnormal bone structure|MP:0004469,abnormal zygomatic arch morphology|MP:0004675,rib fractures|MP:0005386,behavior/neurological phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005508,abnormal skeleton morphology|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008853,decreased abdominal adipose tissue amount|MP:0010025,decreased total body fat amount|MP:0020137,decreased bone mineralization|MP:0030029,wide cranial sutures
MGI:5295746	Lmna<tm1Otin>	MP:0002169,no abnormal phenotype detected
MGI:5695312	Lmna<tm1Rben>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001930,abnormal meiosis|MP:0002160,abnormal reproductive system morphology|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0009451,abnormal chromosomal synapsis|MP:0014764,impaired double-strand DNA break repair
MGI:2177930	Lmna<tm1Stw>	MP:0000069,kyphoscoliosis|MP:0000692,small spleen|MP:0000747,muscle weakness|MP:0000749,muscle degeneration|MP:0000752,dystrophic muscle|MP:0000920,abnormal myelination|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0001783,decreased white adipose tissue amount|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002644,decreased circulating triglyceride level|MP:0002651,abnormal sciatic nerve morphology|MP:0003111,abnormal cell nucleus morphology|MP:0003644,thymus atrophy|MP:0005159,azoospermia|MP:0005331,insulin resistance|MP:0005370,liver/biliary system phenotype|MP:0005375,adipose tissue phenotype|MP:0005404,abnormal axon morphology|MP:0005560,decreased circulating glucose level|MP:0008261,arrest of male meiosis|MP:0010053,decreased grip strength|MP:0014693,abnormal cell nucleus size
MGI:5306919	Lmna<tm2.1Gbon>	MP:0000189,hypoglycemia|MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000278,abnormal myocardial fiber morphology|MP:0000733,abnormal muscle development|MP:0001263,weight loss|MP:0001406,abnormal gait|MP:0001625,cardiac hypertrophy|MP:0001732,postnatal growth retardation|MP:0001783,decreased white adipose tissue amount|MP:0002083,premature death|MP:0002727,decreased circulating insulin level|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002834,decreased heart weight|MP:0003141,cardiac fibrosis|MP:0003828,pulmonary edema|MP:0003896,prolonged PR interval|MP:0004090,abnormal sarcomere morphology|MP:0004924,abnormal behavior|MP:0005076,abnormal cell differentiation|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0006138,congestive heart failure|MP:0008489,slow postnatal weight gain|MP:0008725,increased heart atrium size|MP:0009400,decreased skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009416,cardiac muscle degeneration|MP:0009643,abnormal urine homeostasis|MP:0010392,prolonged QRS complex duration|MP:0011085,postnatal lethality, complete penetrance|MP:0011925,abnormal heart echocardiography feature
MGI:3620627	Lmna<tm2Lgf>	MP:0002169,no abnormal phenotype detected
MGI:2662836	Lmna<tm2Stw>	MP:0000021,prominent ears|MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000130,abnormal trabecular bone morphology|MP:0000149,abnormal scapula morphology|MP:0000266,abnormal heart morphology|MP:0000379,decreased hair follicle number|MP:0001116,small gonad|MP:0001242,hyperkeratosis|MP:0001244,thin dermal layer|MP:0001255,decreased body height|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0002060,abnormal skin morphology|MP:0002083,premature death|MP:0002188,small heart|MP:0002269,muscular atrophy|MP:0002639,micrognathia|MP:0003111,abnormal cell nucleus morphology|MP:0003159,abnormal esophageal smooth muscle morphology|MP:0003548,pulmonary hypertension|MP:0003786,premature aging|MP:0004565,decreased myocardial fiber size|MP:0004567,decreased myocardial fiber number|MP:0004680,small xiphoid process|MP:0005358,abnormal incisor morphology|MP:0005371,limbs/digits/tail phenotype|MP:0008843,absent subcutaneous adipose tissue|MP:0009415,skeletal muscle degeneration|MP:0009416,cardiac muscle degeneration|MP:0013192,decreased sebaceous gland number|MP:0013458,decreased eccrine gland number
MGI:3817495	Lmna<tm3Lgf>	MP:0000063,decreased bone mineral density|MP:0000160,kyphosis|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0002083,premature death|MP:0002114,abnormal axial skeleton morphology|MP:0003111,abnormal cell nucleus morphology|MP:0004675,rib fractures|MP:0005390,skeleton phenotype|MP:0005459,decreased percent body fat/body weight|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008853,decreased abdominal adipose tissue amount|MP:0010025,decreased total body fat amount
MGI:3588578	Lmna<tm3Stw>	MP:0000278,abnormal myocardial fiber morphology|MP:0001402,decreased locomotor activity|MP:0001511,disheveled coat|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002652,thin myocardium|MP:0002795,dilated cardiomyopathy|MP:0003896,prolonged PR interval|MP:0004566,myocardial fiber degeneration|MP:0005333,decreased heart rate|MP:0005608,cardiac interstitial fibrosis|MP:0009416,cardiac muscle degeneration|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3837135	Lmna<tm4Lgf>	MP:0001262,decreased body weight|MP:0002083,premature death|MP:0003111,abnormal cell nucleus morphology|MP:0004675,rib fractures
MGI:5750954	Lmna<tm4Stw>	MP:0000585,kinked tail|MP:0000752,dystrophic muscle|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0002169,no abnormal phenotype detected|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0011085,postnatal lethality, complete penetrance
MGI:4457607	Lmna<tm5Lgf>	MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003111,abnormal cell nucleus morphology|MP:0003141,cardiac fibrosis|MP:0005390,skeleton phenotype|MP:0008770,decreased survivor rate|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4457608	Lmna<tm6Lgf>	MP:0001262,decreased body weight|MP:0003111,abnormal cell nucleus morphology
MGI:4840061	Lmna<tm7Lgf>	MP:0003111,abnormal cell nucleus morphology|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:4868581	Lmna<tm8Lgf>	MP:0003111,abnormal cell nucleus morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0005375,adipose tissue phenotype|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype|MP:0005598,decreased heart ventricle muscle contractility|MP:0010768,mortality/aging
MGI:5571496	Lmna<tm9Lgf>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging
MGI:3050819	Lmnb1<Gt(XA130)Byg>	MP:0000060,delayed bone ossification|MP:0000352,decreased cell proliferation|MP:0000438,abnormal cranium morphology|MP:0001175,abnormal lung morphology|MP:0001184,absent pulmonary alveoli|MP:0001698,decreased embryo size|MP:0001953,respiratory failure|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003111,abnormal cell nucleus morphology|MP:0003840,abnormal coronal suture morphology|MP:0003843,abnormal sagittal suture morphology|MP:0004174,abnormal spine curvature|MP:0005076,abnormal cell differentiation|MP:0011087,neonatal lethality, complete penetrance
MGI:5285669	Lmnb1<tm1.1Sgy>	MP:0010768,mortality/aging
MGI:5517590	Lmnb1<tm1.2Sgy>	MP:0002882,abnormal neuron morphology
MGI:4432859	Lmnb1<tm1a(EUCOMM)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0001262,decreased body weight|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005561,increased mean corpuscular hemoglobin
MGI:5301968	Lmnb1<tm1Yxz>	MP:0000433,microcephaly|MP:0000761,thin diaphragm muscle|MP:0000790,abnormal stratification in cerebral cortex|MP:0001698,decreased embryo size|MP:0001953,respiratory failure|MP:0002270,abnormal pulmonary alveolus morphology|MP:0004200,decreased fetal size|MP:0004948,abnormal neuronal precursor proliferation|MP:0006009,abnormal neuronal migration|MP:0011087,neonatal lethality, complete penetrance|MP:0012055,abnormal phrenic nerve innervation pattern to diaphragm
MGI:5517592	Lmnb1<tm2Sgy>	MP:0000438,abnormal cranium morphology|MP:0000774,decreased brain size|MP:0000790,abnormal stratification in cerebral cortex|MP:0001176,abnormal lung development|MP:0002882,abnormal neuron morphology|MP:0003111,abnormal cell nucleus morphology|MP:0006027,impaired lung alveolus development|MP:0011087,neonatal lethality, complete penetrance|MP:0012089,decreased midbrain size|MP:0012174,flat head
MGI:5285673	Lmnb2<tm1.1Sgy>	MP:0010768,mortality/aging
MGI:4362469	Lmnb2<tm1a(KOMP)Wtsi>	MP:0005553,increased circulating creatinine level
MGI:4440427	Lmnb2<tm1Ccof>	MP:0000774,decreased brain size|MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000813,abnormal hippocampus layer morphology|MP:0000849,abnormal cerebellum morphology|MP:0000853,absent cerebellar foliation|MP:0000873,thin external granule cell layer|MP:0004948,abnormal neuronal precursor proliferation|MP:0006009,abnormal neuronal migration|MP:0008439,abnormal cortical plate morphology|MP:0009718,absent Purkinje cell layer|MP:0011087,neonatal lethality, complete penetrance
MGI:5301971	Lmnb2<tm1Yxz>	MP:0000790,abnormal stratification in cerebral cortex|MP:0001953,respiratory failure|MP:0004948,abnormal neuronal precursor proliferation|MP:0006009,abnormal neuronal migration|MP:0011087,neonatal lethality, complete penetrance
MGI:5517594	Lmnb2<tm2Sgy>	MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:6382778	Lmo1<tm1b(KOMP)Mbp>	MP:0001325,abnormal retina morphology|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0002757,decreased vertical activity|MP:0004924,abnormal behavior|MP:0009142,decreased prepulse inhibition|MP:0020870,decreased thigmotaxis
MGI:3035822	Lmo1<tm1Thr>	MP:0002169,no abnormal phenotype detected
MGI:3035823	Lmo1<tm2Thr>	MP:0002169,no abnormal phenotype detected
MGI:2177821	Lmo2<tm1Thr>	MP:0000292,distended pericardium|MP:0000313,abnormal cell death|MP:0001698,decreased embryo size|MP:0001721,absent visceral yolk sac blood islands|MP:0001722,pale yolk sac|MP:0001726,abnormal allantois morphology|MP:0002151,abnormal neural tube morphology|MP:0003396,abnormal embryonic hematopoiesis|MP:0003717,pallor|MP:0003794,delayed somite formation|MP:0004188,delayed embryo turning|MP:0004787,abnormal dorsal aorta morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012131,small visceral yolk sac|MP:0012173,short rostral-caudal axis
MGI:2671438	Lmo2<tm2(cre)Thr>	MP:0000223,decreased monocyte cell number|MP:0000334,decreased granulocyte number|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002590,increased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0006410,abnormal common myeloid progenitor cell morphology
MGI:3584123	Lmo2<tm4Thr>	MP:0002080,prenatal lethality
MGI:3035824	Lmo3<tm1Thr>	MP:0002169,no abnormal phenotype detected
MGI:3035825	Lmo3<tm2Thr>	MP:0002169,no abnormal phenotype detected
MGI:4329381	Lmo4<Gt(RRO142)Byg>	MP:0008911,induced hyperactivity|MP:0009754,enhanced behavioral response to cocaine
MGI:3574586	Lmo4<tm1.1Gng>	MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0001302,eyelids open at birth|MP:0001698,decreased embryo size|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004838,abnormal neural fold elevation formation|MP:0011091,prenatal lethality, complete penetrance|MP:0012686,everted embryonic neuroepithelium|MP:0012701,increased embryonic neuroepithelium apoptosis|MP:0012704,abnormal embryonic neuroepithelial cell proliferation
MGI:4421413	Lmo4<tm1Gan>	MP:0000036,absent semicircular canals|MP:0000914,exencephaly|MP:0003104,acrania|MP:0003148,decreased cochlea coiling|MP:0003720,abnormal neural tube closure|MP:0003938,abnormal ear development|MP:0004310,small otic vesicle|MP:0006011,abnormal endolymphatic duct morphology|MP:0008488,abnormal semicircular canal ampulla morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:3664560	Lmo4<tm1Gng>	MP:0000861,disorganized barrel cortex
MGI:3035911	Lmo4<tm1Sho>	MP:0005382,craniofacial phenotype
MGI:3513311	Lmo4<tm1Slp>	MP:0002378,abnormal gut-associated lymphoid tissue morphology|MP:0002401,abnormal lymphopoiesis|MP:0002412,increased susceptibility to bacterial infection|MP:0002498,abnormal acute inflammation|MP:0003945,abnormal lymphocyte physiology|MP:0008133,decreased Peyer's patch number
MGI:4421414	Lmo4<tm2.1Gan>	MP:0000026,abnormal inner ear morphology|MP:0000036,absent semicircular canals|MP:0008488,abnormal semicircular canal ampulla morphology
MGI:3035914	Lmo4<tm2Sho>	MP:0000104,abnormal sphenoid bone morphology|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001056,abnormal cranial nerve morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0004449,absent presphenoid bone|MP:0004568,fusion of glossopharyngeal and vagus nerve|MP:0004620,cervical vertebral fusion|MP:0008148,abnormal sternocostal joint morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3035916	Lmo4<tm3Sho>	MP:0005382,craniofacial phenotype
MGI:3851221	Lmo7<tm1Miyo>	MP:0002027,increased lung adenocarcinoma incidence|MP:0006382,abnormal lung epithelium morphology
MGI:3639949	Lmo7<tm1Tilg>	MP:0001262,decreased body weight|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003998,decreased thermal nociceptive threshold|MP:0005103,abnormal retina pigmentation|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6794057	Lmod1<em1(IMPC)J>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:8174728	Lmod1<em1Jomm>	MP:0000477,abnormal intestine morphology|MP:0000519,hydronephrosis|MP:0000538,abnormal urinary bladder morphology|MP:0000539,distended urinary bladder|MP:0000543,absent urinary bladder urothelium|MP:0000767,abnormal smooth muscle morphology|MP:0002106,abnormal muscle physiology|MP:0003290,intestinal hypoperistalsis|MP:0004006,impaired contractility of jejunal smooth muscle|MP:0009511,distended stomach|MP:0009854,impaired gastric peristalsis|MP:0011480,impaired ureteric peristalsis|MP:0011774,abnormal urinary bladder detrusor smooth muscle morphology|MP:0013916,decreased intestine length|MP:0020849,abnormal actin cytoskeleton morphology
MGI:8174731	Lmod1<em2Jomm>	MP:0002169,no abnormal phenotype detected
MGI:3812792	Lmod2<tm1(KOMP)Vlcg>	MP:0000278,abnormal myocardial fiber morphology|MP:0000280,thin ventricular wall|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0004937,dilated heart|MP:0005140,decreased cardiac muscle contractility|MP:0005294,abnormal heart ventricle morphology|MP:0006267,abnormal intercalated disk morphology|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011629,decreased mitochondrial number|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014730,abnormal myocardial fiber myofibril morphology|MP:0021158,decreased heart left ventricle wall thickness
MGI:5789380	Lmod2<Tn(pb-Act-RFP)1.1Zhu>	MP:0000278,abnormal myocardial fiber morphology|MP:0000280,thin ventricular wall|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001512,trunk curl|MP:0001636,irregular heartbeat|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003233,prolonged QT interval|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0004146,absent M line|MP:0005140,decreased cardiac muscle contractility|MP:0006138,congestive heart failure|MP:0006267,abnormal intercalated disk morphology|MP:0008022,dilated heart ventricle
MGI:5701345	Lmod3<em1Eno>	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005150,cachexia|MP:0009400,decreased skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010240,decreased skeletal muscle size|MP:0010401,increased skeletal muscle glycogen level
MGI:6152507	Lmod3<em1(IMPC)Mbp>	MP:0000063,decreased bone mineral density|MP:0000186,decreased circulating HDL cholesterol level|MP:0000219,increased neutrophil cell number|MP:0000274,enlarged heart|MP:0000538,abnormal urinary bladder morphology|MP:0000639,abnormal adrenal gland morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0000759,abnormal skeletal muscle morphology|MP:0001258,decreased body length|MP:0001402,decreased locomotor activity|MP:0001404,no spontaneous movement|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0001529,abnormal vocalization|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002079,increased circulating insulin level|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002188,small heart|MP:0002608,increased hematocrit|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0003131,increased erythrocyte cell number|MP:0003960,increased lean body mass|MP:0003961,decreased lean body mass|MP:0005016,decreased lymphocyte cell number|MP:0005278,abnormal cholesterol homeostasis|MP:0005292,improved glucose tolerance|MP:0005333,decreased heart rate|MP:0005564,increased hemoglobin content|MP:0005565,increased blood urea nitrogen level|MP:0009142,decreased prepulse inhibition|MP:0009709,hydrometra|MP:0010024,increased total body fat amount|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0011874,enlarged urinary bladder
MGI:5774799	Lmod3<Tn(pb-Act-RFP)1.1Zhu>	MP:0000747,muscle weakness|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003961,decreased lean body mass|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0009413,skeletal muscle fiber atrophy|MP:0010053,decreased grip strength
MGI:2661182	Lmr10<BALB/cHeA>	MP:0002497,increased IgE level
MGI:2661183	Lmr10<CcS20/Dem>	MP:0002492,decreased IgE level
MGI:2661186	Lmr11<CcS20/Dem>	MP:0008596,increased circulating interleukin-6 level
MGI:2661191	Lmr12<BALB/cHeA>	MP:0002492,decreased IgE level
MGI:2661192	Lmr12<CcS16/Dem>	MP:0002497,increased IgE level|MP:0008602,increased circulating interleukin-4 level
MGI:2661193	Lmr13<BALB/cHeA>	MP:0002492,decreased IgE level
MGI:2661194	Lmr13<CcS16/Dem>	MP:0001212,skin lesions
MGI:2661195	Lmr14<BALB/cHeA>	MP:0000693,spleen hyperplasia
MGI:2661196	Lmr14<CcS16/Dem>	MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0008577,increased circulating interferon-gamma level
MGI:2661218	Lmr15<CcS16/Dem>	MP:0000599,enlarged liver|MP:0008578,decreased circulating interferon-gamma level
MGI:3625874	Lmr17<CcS20/Dem>	MP:0008553,increased circulating tumor necrosis factor level
MGI:3625875	Lmr18<BALB/cHeA>	MP:0009335,decreased splenocyte proliferation
MGI:2446908	Lmr1<BALB/c>	MP:0005027,increased susceptibility to parasitic infection
MGI:2446909	Lmr1<C57BL/6J>	MP:0005026,decreased susceptibility to parasitic infection
MGI:2446906	Lmr2<BALB/c>	MP:0005027,increased susceptibility to parasitic infection
MGI:2446907	Lmr2<C57BL/6J>	MP:0005026,decreased susceptibility to parasitic infection
MGI:2661162	Lmr3<BALB/cHeA>	MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0002497,increased IgE level|MP:0008752,abnormal tumor necrosis factor level
MGI:2661165	Lmr4<BALB/cHeA>	MP:0001212,skin lesions
MGI:2661168	Lmr5<BALB/cHeA>	MP:0001212,skin lesions|MP:0002497,increased IgE level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level
MGI:2661169	Lmr5<CcS5/Dem>	MP:0008617,increased circulating interleukin-12 level
MGI:2661172	Lmr7<BALB/cHeA>	MP:0009335,decreased splenocyte proliferation
MGI:2661173	Lmr7<CcS5/Dem>	MP:0000693,spleen hyperplasia
MGI:2661177	Lmr8<BALB/cHeA>	MP:0000693,spleen hyperplasia|MP:0002497,increased IgE level
MGI:2661179	Lmr9<BALB/cHeA>	MP:0002497,increased IgE level
MGI:2661180	Lmr9<CcS20/Dem>	MP:0002492,decreased IgE level|MP:0008596,increased circulating interleukin-6 level
MGI:3603285	Lmrq4<C57BL/10Sn>	MP:0005026,decreased susceptibility to parasitic infection
MGI:6316125	Lmtk2<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001925,male infertility|MP:0002135,abnormal kidney morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0002989,small kidney|MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval
MGI:3699255	Lmtk2<tm1Tya>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0003631,nervous system phenotype|MP:0005159,azoospermia|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5618022	Lmtk3<tm1Tya>	MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0001764,abnormal homeostasis|MP:0001921,reduced fertility|MP:0002566,abnormal sexual interaction|MP:0002574,increased vertical activity|MP:0003063,increased coping response|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0009746,enhanced behavioral response to xenobiotic|MP:0011939,increased food intake|MP:0031391,increased locomotor activity
MGI:5423982	Lmx1a<bsd>	MP:0000031,abnormal cochlea morphology|MP:0000034,abnormal inner ear vestibule morphology|MP:0000036,absent semicircular canals|MP:0000373,belly spot|MP:0001399,hyperactivity|MP:0001523,impaired righting response|MP:0001526,abnormal placing response|MP:0001967,deafness|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0005307,head tossing|MP:0006012,dilated endolymphatic duct|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology|MP:0006286,inner ear hypoplasia|MP:0006358,absent pinna reflex|MP:0008307,short scala media|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856494	Lmx1a<dr>	MP:0000923,abnormal roof plate morphology|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001891,hydrocephaly|MP:0001967,deafness|MP:0002151,abnormal neural tube morphology|MP:0002671,belted|MP:0004289,abnormal bony labyrinth|MP:0005307,head tossing
MGI:3695745	Lmx1a<dr-10J>	MP:0000026,abnormal inner ear morphology|MP:0000031,abnormal cochlea morphology|MP:0000035,abnormal membranous labyrinth morphology|MP:0000585,kinked tail|MP:0000592,short tail|MP:0000774,decreased brain size|MP:0001265,decreased body size|MP:0001395,bidirectional circling|MP:0002161,abnormal fertility/fecundity|MP:0002428,abnormal semicircular canal morphology|MP:0003938,abnormal ear development|MP:0004315,absent vestibular saccule|MP:0004369,absent utricle|MP:0004426,abnormal cochlear labyrinth morphology|MP:0004750,syndromic hearing loss|MP:0005307,head tossing|MP:0009719,reduced cerebellar foliation|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3719028	Lmx1a<dr-11J>	MP:0000585,kinked tail|MP:0000592,short tail|MP:0001265,decreased body size|MP:0001395,bidirectional circling|MP:0002161,abnormal fertility/fecundity|MP:0005307,head tossing
MGI:1856497	Lmx1a<dr-2J>	MP:0000373,belly spot|MP:0000592,short tail|MP:0001121,uterus hypoplasia|MP:0001393,ataxia|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0001967,deafness|MP:0005307,head tossing
MGI:1856498	Lmx1a<dr-6J>	MP:0000592,short tail|MP:0001121,uterus hypoplasia|MP:0001393,ataxia|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001523,impaired righting response|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001967,deafness|MP:0002671,belted|MP:0002938,white spotting
MGI:2158234	Lmx1a<dr-7J>	MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0000869,abnormal cerebellum posterior vermis morphology
MGI:2157969	Lmx1a<dr-8J>	MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0000869,abnormal cerebellum posterior vermis morphology
MGI:1888413	Lmx1a<dr-J>	MP:0000077,abnormal interparietal bone morphology|MP:0000109,abnormal parietal bone morphology|MP:0000350,abnormal cell proliferation|MP:0000373,belly spot|MP:0000566,synostosis|MP:0000592,short tail|MP:0000808,abnormal hippocampus development|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000854,abnormal cerebellum development|MP:0000857,abnormal cerebellar foliation|MP:0000923,abnormal roof plate morphology|MP:0000933,abnormal rhombomere morphology|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0001096,abnormal glossopharyngeal ganglion morphology|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001924,infertility|MP:0001967,deafness|MP:0002082,postnatal lethality|MP:0002862,abnormal righting response|MP:0003054,spina bifida|MP:0005226,abnormal vertebral arch development|MP:0005307,head tossing|MP:0005621,abnormal cell physiology|MP:0006009,abnormal neuronal migration|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0011091,prenatal lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012792,abnormal rhombomere 3 morphology|MP:0012796,abnormal rhombomere 4 morphology|MP:0012800,abnormal rhombomere 5 morphology
MGI:3691298	Lmx1a<dr-kjmi>	MP:0000592,short tail|MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0000869,abnormal cerebellum posterior vermis morphology|MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0002938,white spotting
MGI:1856495	Lmx1a<dr-sst>	MP:0000592,short tail|MP:0000854,abnormal cerebellum development|MP:0000857,abnormal cerebellar foliation|MP:0001399,hyperactivity|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0001967,deafness|MP:0002083,premature death|MP:0002938,white spotting|MP:0006281,abnormal tail development|MP:0008854,bleb|MP:0009393,abnormal resting posture|MP:0010768,mortality/aging
MGI:5423987	Lmx1a<mtl>	MP:0000026,abnormal inner ear morphology|MP:0000036,absent semicircular canals|MP:0000373,belly spot|MP:0000592,short tail|MP:0001399,hyperactivity|MP:0001523,impaired righting response|MP:0001526,abnormal placing response|MP:0001967,deafness|MP:0002978,absent otoliths|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004427,abnormal vestibular labyrinth morphology|MP:0005307,head tossing|MP:0006012,dilated endolymphatic duct|MP:0006014,dilated endolymphatic sac|MP:0006030,abnormal otic vesicle development|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology|MP:0006358,absent pinna reflex|MP:0008307,short scala media|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5287979	Lmx1a<tm1.1Tpe>	MP:0011448,decreased dopaminergic neuron number
MGI:5287977	Lmx1a<tm1Ics>	MP:0009937,abnormal neuron differentiation|MP:0011448,decreased dopaminergic neuron number
MGI:2178439	Lmx1b<Icst>	MP:0000850,absent cerebellum|MP:0001296,macrophthalmia|MP:0001314,cornea opacity|MP:0001316,cornea scarring|MP:0001319,irregularly shaped pupil|MP:0001322,abnormal iris morphology|MP:0001330,abnormal optic nerve morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0004221,abnormal iridocorneal angle|MP:0004284,abnormal Descemet membrane morphology|MP:0005258,ocular hypertension|MP:0005301,abnormal cornea endothelium morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005542,cornea vascularization|MP:0009274,buphthalmos|MP:0009825,cornea ulcer|MP:0011089,perinatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011481,anterior iris synechia|MP:0012000,abnormal limb position
MGI:4818484	Lmx1b<tm1Bbs>	MP:0002169,no abnormal phenotype detected
MGI:2158463	Lmx1b<tm1Rjo>	MP:0000077,abnormal interparietal bone morphology|MP:0000084,abnormal fontanelle morphology|MP:0000164,abnormal cartilage development|MP:0000788,abnormal cerebral cortex morphology|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000904,abnormal superior colliculus morphology|MP:0000913,abnormal brain development|MP:0000939,decreased motor neuron number|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001297,microphthalmia|MP:0001312,abnormal cornea morphology|MP:0001319,irregularly shaped pupil|MP:0001436,abnormal suckling behavior|MP:0002084,abnormal developmental patterning|MP:0002835,abnormal cranial suture morphology|MP:0002882,abnormal neuron morphology|MP:0002892,decreased superior colliculus size|MP:0002989,small kidney|MP:0003237,abnormal lens epithelium morphology|MP:0003243,abnormal dopaminergic neuron morphology|MP:0004096,abnormal midbrain-hindbrain boundary development|MP:0004343,small scapula|MP:0004360,absent ulna|MP:0004443,absent supraoccipital bone|MP:0004508,abnormal pectoral girdle bone morphology|MP:0004688,absent ilium|MP:0004694,absent patella|MP:0004981,decreased neuronal precursor cell number|MP:0005099,abnormal ciliary body morphology|MP:0005193,abnormal anterior eye segment morphology|MP:0005208,abnormal iris stroma morphology|MP:0005298,abnormal clavicle morphology|MP:0005300,abnormal cornea stroma morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005542,cornea vascularization|MP:0006104,abnormal tectum morphology|MP:0006105,small tectum|MP:0006230,iris stroma hypoplasia|MP:0008059,abnormal podocyte foot process morphology|MP:0008061,absent podocyte slit diaphragm|MP:0008138,absent podocyte foot process|MP:0008494,absence of all nails|MP:0008947,increased neuron number|MP:0009637,abnormal pretectal region morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011320,abnormal glomerular capillary morphology|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011455,absent glomerular endothelium fenestra|MP:0012133,absent midbrain-hindbrain boundary|MP:0012785,decreased rhombomere 1 size|MP:0013743,ciliary body hypoplasia|MP:0031212,decreased eye anterior chamber depth
MGI:3696968	Lmx1b<tm1Zfc>	MP:0001364,decreased anxiety-related response|MP:0001375,abnormal mating preference|MP:0001469,abnormal contextual conditioning behavior|MP:0001898,abnormal long-term depression|MP:0002207,abnormal long-term potentiation|MP:0003631,nervous system phenotype|MP:0003877,abnormal serotonergic neuron morphology|MP:0003990,decreased neurotransmitter release|MP:0004861,abnormal Raphe nucleus morphology|MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype|MP:0008432,abnormal long-term spatial reference memory|MP:0010070,decreased serotonin level|MP:0020351,decreased vocalization
MGI:3849050	Lmx1b<tm2(cre/ERT2)Rjo>	MP:0002169,no abnormal phenotype detected
MGI:3849051	Lmx1b<tm3(cre/ERT2)Rjo>	MP:0006279,abnormal limb development
MGI:3714802	Lmx1b<tm4.1Rjo>	MP:0002705,dilated renal tubule|MP:0002871,albuminuria|MP:0003606,kidney failure|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0008059,abnormal podocyte foot process morphology|MP:0008061,absent podocyte slit diaphragm|MP:0008140,podocyte foot process effacement|MP:0011085,postnatal lethality, complete penetrance|MP:0011402,renal cast|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011483,renal glomerular synechia
MGI:6866922	Lncbar<em1Bcgen>	MP:0003203,increased neuron apoptosis|MP:0004980,increased neuronal precursor cell number|MP:0008547,abnormal neocortex morphology
MGI:7386898	Lncenc1<em1Smoc>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0002644,decreased circulating triglyceride level|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005367,renal/urinary system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009133,decreased white fat cell size|MP:0009136,decreased brown fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0010026,decreased liver cholesterol level|MP:0010379,decreased respiratory quotient|MP:0014169,decreased brown adipose tissue mass|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:7386899	Lncenc1<em2Smoc>	MP:0002644,decreased circulating triglyceride level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005367,renal/urinary system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009136,decreased brown fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0010025,decreased total body fat amount|MP:0014169,decreased brown adipose tissue mass
MGI:5565174	Lncenc1<tm1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:5563545	Lncpint<tm1Vlcg>	MP:0000159,abnormal xiphoid process morphology|MP:0000414,alopecia|MP:0000748,progressive muscle weakness|MP:0000757,herniated abdominal wall|MP:0001262,decreased body weight|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0003704,abnormal hair follicle development|MP:0003786,premature aging|MP:0003961,decreased lean body mass|MP:0004819,decreased skeletal muscle mass|MP:0008770,decreased survivor rate|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009422,decreased gastrocnemius weight|MP:0009428,decreased tibialis anterior weight|MP:0009932,skin fibrosis|MP:0014143,decreased body fat mass|MP:0020010,decreased bone mineral density of femur|MP:0031253,lordokyphosis
MGI:6385064	Lncpnky<tm1.1Dalm>	MP:0000788,abnormal cerebral cortex morphology|MP:0008547,abnormal neocortex morphology|MP:0008947,increased neuron number|MP:0012204,abnormal neuronal stem cell physiology
MGI:6385065	Lncpnky<tm1.2Dalm>	MP:0006254,thin cerebral cortex|MP:0008948,decreased neuron number|MP:0012204,abnormal neuronal stem cell physiology
MGI:7571572	Lncucc1<em1Bwu>	MP:0008537,increased susceptibility to induced colitis|MP:0008883,abnormal enterocyte proliferation|MP:0008885,increased enterocyte apoptosis|MP:0010155,abnormal intestine physiology|MP:0013297,abnormal susceptibility to colitis induced morbidity/mortality|MP:0013956,decreased colon length
MGI:6480016	Lnhrt<tm1.1Koho>	MP:0004064,decreased susceptibility to induced muscular atrophy|MP:0004565,decreased myocardial fiber size|MP:0005385,cardiovascular system phenotype|MP:0005598,decreased heart ventricle muscle contractility|MP:0010725,thin interventricular septum
MGI:3052183	Lnopy1<DBA/2J>	MP:0001304,cataract
MGI:3052185	Lnopy2<C57BL/6J>	MP:0001304,cataract
MGI:4397580	Lnpep<tm1.1Sych>	MP:0001405,impaired coordination|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory
MGI:5696923	Lnpep<tm1b(KOMP)Wtsi>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002059,abnormal seminal vesicle morphology
MGI:2387151	Lnpep<tm1Ske>	MP:0000274,enlarged heart|MP:0001780,decreased brown adipose tissue amount|MP:0002078,abnormal glucose homeostasis|MP:0002891,increased insulin sensitivity|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0009122,decreased white fat cell lipid droplet size|MP:0009133,decreased white fat cell size|MP:0010025,decreased total body fat amount|MP:0011016,increased core body temperature|MP:0030968,decreased circulating adiponectin level
MGI:6467484	Lnpk<em1(IMPC)Bay>	MP:0001399,hyperactivity|MP:0002574,increased vertical activity
MGI:1857660	Lnpk<Ul>	MP:0000060,delayed bone ossification|MP:0000558,abnormal tibia morphology|MP:0001925,male infertility|MP:0002082,postnatal lethality|MP:0002109,abnormal limb morphology|MP:0002187,abnormal fibula morphology|MP:0002764,short tibia|MP:0002765,short fibula|MP:0003072,abnormal metatarsal bone morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0004355,short radius|MP:0004358,bowed tibia|MP:0004359,short ulna|MP:0005606,increased bleeding time|MP:0030886,decreased radius size
MGI:8228037	Lnx1<tm1Henk>	MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0002961,abnormal axon guidance|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0008571,abnormal synaptic bouton morphology|MP:0008960,abnormal axon pruning|MP:0014254,increased paired-pulse ratio|MP:0014745,abnormal hippocampal mossy fiber infrapyramidal bundle morphology|MP:0020360,abnormal asymmetric synapse morphology|MP:0020507,increased dendritic spine density|MP:0020512,abnormal dendritic mushroom spine morphology|MP:0020551,abnormal postsynaptic density morphology
MGI:5007219	Lnx1<tm1Lex>	MP:0008169,increased B-1b cell number
MGI:2680129	Loca1<C57BL/6J>	MP:0002574,increased vertical activity|MP:0031391,increased locomotor activity
MGI:2680130	Loca2<129S6/SvEvTac>	MP:0031391,increased locomotor activity
MGI:2669266	Loco1<KJR/Ms>	MP:0001399,hyperactivity
MGI:2669268	Loco2<KJR/Ms>	MP:0001399,hyperactivity
MGI:5692729	Lonp1<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001556,increased circulating HDL cholesterol level|MP:0004151,decreased circulating iron level|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:5707160	Lonp1<tm1Otin>	MP:0001698,decreased embryo size|MP:0002718,abnormal inner cell mass morphology|MP:0003984,embryonic growth retardation|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005033,abnormal trophoblast giant cell morphology|MP:0011105,embryonic lethality between implantation and placentation, incomplete penetrance|MP:0011639,decreased mitochondrial DNA content
MGI:6306617	Lonrf2<em2(IMPC)H>	MP:0000194,increased circulating calcium level|MP:0005293,impaired glucose tolerance|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0013279,increased fasting circulating glucose level
MGI:4363930	Lonrf3<tm1a(KOMP)Wtsi>	MP:0000194,increased circulating calcium level|MP:0001554,increased circulating free fatty acids level|MP:0010092,increased circulating magnesium level
MGI:2154180	Lore1<LS>	MP:0001523,impaired righting response
MGI:2154179	Lore1<SS>	MP:0002863,improved righting response|MP:0003633,abnormal nervous system physiology|MP:0009642,abnormal blood homeostasis
MGI:2155063	Lore2<LS>	MP:0001523,impaired righting response
MGI:2155064	Lore2<SS>	MP:0002863,improved righting response|MP:0009642,abnormal blood homeostasis
MGI:2389051	Lore4<LS>	MP:0001523,impaired righting response
MGI:2389052	Lore4<SS>	MP:0002863,improved righting response|MP:0003633,abnormal nervous system physiology
MGI:2389053	Lore5<ILS>	MP:0001523,impaired righting response
MGI:2389054	Lore5<SS>	MP:0002863,improved righting response
MGI:2154184	Lore8<C57BL/6Ibg>	MP:0001523,impaired righting response
MGI:5605843	Loricrin<tm1.1(KOMP)Vlcg>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002060,abnormal skin morphology|MP:0002098,abnormal vibrissa morphology|MP:0003917,increased kidney weight|MP:0004906,enlarged uterus|MP:0004952,increased spleen weight|MP:0005292,improved glucose tolerance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2384073	Loricrin<tm1Der>	MP:0001191,abnormal skin condition|MP:0001201,translucent skin|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001265,decreased body size|MP:0002796,impaired skin barrier function|MP:0003089,decreased skin tensile strength|MP:0003454,erythroderma
MGI:2156811	Lorp1<SS>	MP:0002863,improved righting response
MGI:5313524	Lox<b2b370.2Clo>	MP:0000276,heart right ventricle hypertrophy|MP:0001614,abnormal blood vessel morphology|MP:0002625,heart left ventricle hypertrophy|MP:0003924,diaphragmatic hernia|MP:0010457,pulmonary artery stenosis|MP:0010471,supravalvar aortic stenosis
MGI:6362805	Lox<em1(IMPC)Mbp>	MP:0001711,abnormal placenta morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0002989,small kidney|MP:0011100,preweaning lethality, complete penetrance
MGI:5792020	Loxhd1<mpc188H>	MP:0001967,deafness
MGI:5792077	Loxhd1<mpc231H>	MP:0001967,deafness
MGI:3708447	Loxhd1<sba>	MP:0001489,decreased startle reflex|MP:0002622,abnormal cochlear hair cell morphology|MP:0002857,cochlear ganglion degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004737,absent distortion product otoacoustic emissions|MP:0004738,abnormal auditory brainstem response|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:7516680	Loxl1<em1Andm>	MP:0000493,rectal prolapse|MP:0005577,uterus prolapse
MGI:7516683	Loxl1<em2Andm>	MP:0000493,rectal prolapse|MP:0005577,uterus prolapse
MGI:7516686	Loxl1<em3Andm>	MP:0000493,rectal prolapse|MP:0005577,uterus prolapse
MGI:7516689	Loxl1<em4Andm>	MP:0000493,rectal prolapse|MP:0005577,uterus prolapse
MGI:7516692	Loxl1<em5Andm>	MP:0000493,rectal prolapse|MP:0005577,uterus prolapse
MGI:5445673	Loxl1<tm1.1(KOMP)Vlcg>	MP:0000947,convulsive seizures|MP:0001325,abnormal retina morphology|MP:0005567,decreased circulating total protein level|MP:0011396,abnormal sleep behavior|MP:0013279,increased fasting circulating glucose level
MGI:3033883	Loxl1<tm1Tili>	MP:0000477,abnormal intestine morphology|MP:0000493,rectal prolapse|MP:0001136,dilated uterine cervix|MP:0001183,overexpanded pulmonary alveolus|MP:0001322,abnormal iris morphology|MP:0002840,abnormal lens fiber morphology|MP:0005099,abnormal ciliary body morphology|MP:0005205,abnormal eye anterior chamber morphology|MP:0005421,loose skin|MP:0005577,uterus prolapse|MP:0008418,abnormal cutaneous elastic fiber morphology|MP:0010252,anterior subcapsular cataract|MP:0010856,dilated respiratory conducting tube
MGI:6358630	Loxl2<em1(IMPC)H>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5750228	Loxl2<tm1.2Acan>	MP:0000281,abnormal interventricular septum morphology|MP:0001575,cyanosis|MP:0001876,decreased inflammatory response|MP:0002656,abnormal keratinocyte differentiation|MP:0003447,decreased tumor growth/size|MP:0004502,decreased incidence of tumors by chemical induction|MP:0009820,abnormal liver vasculature morphology|MP:0010639,abnormal tumor pathology|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance
MGI:5750162	Loxl3<tm1.1Jgao>	MP:0000088,short mandible|MP:0000098,abnormal vomer bone morphology|MP:0000111,cleft palate|MP:0000141,abnormal vertebral body morphology|MP:0000428,abnormal craniofacial morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0004134,abnormal chest morphology|MP:0004174,abnormal spine curvature|MP:0004703,abnormal vertebral column morphology|MP:0005227,abnormal vertebral body development|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0005391,vision/eye phenotype|MP:0009653,abnormal palate development|MP:0009886,failure of palatal shelf elevation|MP:0009888,palatal shelves fail to meet at midline|MP:0010771,integument phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:6867825	Loxl4<em1Bcgen>	MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype
MGI:5708208	Loxl4<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0002968,increased circulating alkaline phosphatase level
MGI:6401446	Lox<tm1.1Khki>	MP:0004499,increased incidence of tumors by chemical induction|MP:0005013,increased lymphocyte cell number|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010308,decreased tumor latency
MGI:2657016	Lox<tm1Ikh>	MP:0003089,decreased skin tensile strength|MP:0003907,decreased aorta elastin content|MP:0003924,diaphragmatic hernia|MP:0005243,hemothorax|MP:0005435,hemoperitoneum|MP:0006083,abnormal blood vessel elastic tissue morphology|MP:0006278,aortic aneurysm|MP:0009862,abnormal aorta elastic tissue morphology|MP:0009865,abnormal aorta smooth muscle morphology|MP:0009866,abnormal aorta wall morphology|MP:0009868,abnormal descending thoracic aorta morphology|MP:0010997,decreased aorta wall thickness|MP:0011089,perinatal lethality, complete penetrance|MP:0012061,abnormal diaphragm central tendon morphology|MP:0012251,abnormal diaphragm development
MGI:3610732	Lox<tm1Soin>	MP:0000233,abnormal blood flow velocity|MP:0000484,abnormal pulmonary artery morphology|MP:0001177,atelectasis|MP:0001178,pulmonary hypoplasia|MP:0001402,decreased locomotor activity|MP:0001436,abnormal suckling behavior|MP:0001575,cyanosis|MP:0001914,hemorrhage|MP:0001958,emphysema|MP:0002279,abnormal diaphragm morphology|MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0003924,diaphragmatic hernia|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005631,decreased lung weight|MP:0006049,semilunar valve regurgitation|MP:0006278,aortic aneurysm|MP:0008418,abnormal cutaneous elastic fiber morphology|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0009862,abnormal aorta elastic tissue morphology|MP:0009865,abnormal aorta smooth muscle morphology|MP:0010463,aorta stenosis|MP:0010856,dilated respiratory conducting tube|MP:0010897,abnormal bronchiole epithelium morphology|MP:0010911,abnormal pulmonary acinus morphology|MP:0011032,impaired branching involved in terminal bronchiole morphogenesis|MP:0011034,impaired branching involved in respiratory bronchiole morphogenesis|MP:0011089,perinatal lethality, complete penetrance
MGI:5503990	Lpar1<mpc125H>	MP:0000063,decreased bone mineral density|MP:0001262,decreased body weight|MP:0014143,decreased body fat mass
MGI:5635231	Lpar1<tm1b(EUCOMM)Wtsi>	MP:0001304,cataract|MP:0005292,improved glucose tolerance|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:1931154	Lpar1<tm1Jch>	MP:0000445,short snout|MP:0000914,exencephaly|MP:0001106,abnormal Schwann cell morphology|MP:0001107,decreased Schwann cell number|MP:0001265,decreased body size|MP:0001300,ocular hypertelorism|MP:0001436,abnormal suckling behavior|MP:0001732,postnatal growth retardation|MP:0001914,hemorrhage|MP:0002651,abnormal sciatic nerve morphology|MP:0005385,cardiovascular system phenotype|MP:0010025,decreased total body fat amount|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2687056	Lpar1<tm1Mcox>	MP:0000428,abnormal craniofacial morphology|MP:0000445,short snout|MP:0001255,decreased body height|MP:0001300,ocular hypertelorism|MP:0001402,decreased locomotor activity|MP:0001906,increased dopamine level|MP:0003631,nervous system phenotype|MP:0004831,long incisors|MP:0005322,abnormal serotonin level|MP:0005332,abnormal amino acid level|MP:0006086,decreased body mass index|MP:0009142,decreased prepulse inhibition|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5426538	Lpar2<tm1Dgen>	MP:0001861,lung inflammation|MP:0001952,increased airway responsiveness|MP:0002376,abnormal dendritic cell physiology|MP:0002497,increased IgE level|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008560,increased tumor necrosis factor secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008672,increased interleukin-13 secretion|MP:0010935,increased airway resistance
MGI:2387979	Lpar2<tm1Jch>	MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:3579139	Lpar3<tm1Jch>	MP:0000230,abnormal systemic arterial blood pressure|MP:0001711,abnormal placenta morphology|MP:0001729,impaired embryo implantation|MP:0001935,decreased litter size|MP:0002293,long gestation period|MP:0009352,impaired spacing of implantation sites|MP:0009649,delayed embryo implantation|MP:0009815,decreased prostaglandin level
MGI:5635232	Lpar4<tm1.1(KOMP)Vlcg>	MP:0010053,decreased grip strength|MP:0011436,decreased urine magnesium level
MGI:4868215	Lpar4<tm1Sati>	MP:0000087,absent mandible|MP:0000230,abnormal systemic arterial blood pressure|MP:0001182,lung hemorrhage|MP:0001634,internal hemorrhage|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001784,abnormal fluid regulation|MP:0001786,skin edema|MP:0001914,hemorrhage|MP:0003052,omphalocele|MP:0003719,abnormal pericyte morphology|MP:0003814,vascular smooth muscle hypoplasia|MP:0004038,lymphangiectasis|MP:0004200,decreased fetal size|MP:0005244,hemopericardium|MP:0005312,pericardial effusion|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0009858,abnormal cellular extravasation|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014273,abnormal skin vasculature morphology
MGI:5431493	Lpar5<tm1Jch>	MP:0005498,hyporesponsive to tactile stimuli
MGI:5527440	Lpar5<tm1Zcv>	MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001970,abnormal pain threshold|MP:0001973,increased thermal nociceptive threshold|MP:0002062,abnormal associative learning|MP:0002574,increased vertical activity|MP:0002736,abnormal nociception after inflammation|MP:0003858,enhanced coordination|MP:0005386,behavior/neurological phenotype|MP:0012306,enhanced spatial learning
MGI:7665329	Lpar6<tm1.1Bcz>	MP:0000540,abnormal urinary bladder urothelium morphology|MP:0004499,increased incidence of tumors by chemical induction
MGI:5471392	Lpar6<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0002941,increased circulating alanine transaminase level|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:6276060	Lpar6<tm1.1Sati>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0009858,abnormal cellular extravasation
MGI:7608070	Lpar6<tm1Dgen>	MP:0000230,abnormal systemic arterial blood pressure|MP:0002792,abnormal retina vasculature morphology|MP:0005385,cardiovascular system phenotype|MP:0010097,abnormal retina blood vessel morphology
MGI:3858301	Lpcat1<Gt(BC0405)Wtsi>	MP:0001175,abnormal lung morphology|MP:0001177,atelectasis|MP:0001182,lung hemorrhage|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0004782,abnormal surfactant physiology|MP:0011087,neonatal lethality, complete penetrance
MGI:2388243	Lpcat1<rd11>	MP:0001326,retina degeneration|MP:0002090,abnormal vision|MP:0002792,abnormal retina vasculature morphology|MP:0002864,abnormal ocular fundus morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0004777,abnormal phospholipid level|MP:0005551,abnormal eye electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008519,thin retina outer plexiform layer|MP:0008585,absent photoreceptor outer segment|MP:0011965,decreased total retina thickness|MP:0012029,abnormal electroretinogram waveform feature|MP:0012144,decreased b-wave amplitude
MGI:4830270	Lpcat1<rd11-2J>	MP:0001326,retina degeneration|MP:0002864,abnormal ocular fundus morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0004777,abnormal phospholipid level|MP:0005551,abnormal eye electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration
MGI:7639813	Lpcat1<tm1.1Tksh>	MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype
MGI:6120782	Lpcat1<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0002546,mydriasis|MP:0002792,abnormal retina vasculature morphology|MP:0006243,impaired pupillary reflex
MGI:5635235	Lpcat2b<tm1b(KOMP)Mbp>	MP:0005544,cornea deposits
MGI:6278528	Lpcat2<em1(IMPC)J>	MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0010052,increased grip strength
MGI:6343500	Lpcat2<tm1.1Tksh>	MP:0004777,abnormal phospholipid level|MP:0005498,hyporesponsive to tactile stimuli|MP:0005584,abnormal enzyme/coenzyme activity|MP:0013245,abnormal lipid metabolism|MP:0020955,increased mechanical nociceptive threshold
MGI:4433127	Lpcat3<tm1a(EUCOMM)Wtsi>	MP:0005560,decreased circulating glucose level|MP:0011085,postnatal lethality, complete penetrance|MP:0013245,abnormal lipid metabolism
MGI:5822780	Lpcat3<tm1c(EUCOMM)Wtsi>	MP:0000479,abnormal enterocyte morphology|MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0001547,abnormal lipid level|MP:0001732,postnatal growth retardation|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0003976,decreased circulating VLDL triglyceride level|MP:0004777,abnormal phospholipid level|MP:0005560,decreased circulating glucose level|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0010332,abnormal circulating apolipoprotein level|MP:0021045,decreased circulating VLDL phospholipid level
MGI:5829401	Lpgat1<em1(IMPC)J>	MP:0001325,abnormal retina morphology|MP:0001363,increased anxiety-related response|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002075,abnormal coat/hair pigmentation|MP:0002574,increased vertical activity|MP:0010097,abnormal retina blood vessel morphology|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4361554	Lpin1<20884>	MP:0000921,demyelination|MP:0001406,abnormal gait|MP:0002651,abnormal sciatic nerve morphology|MP:0003871,abnormal myelin sheath morphology|MP:0005402,abnormal action potential|MP:0008814,decreased nerve conduction velocity|MP:0010052,increased grip strength|MP:0030863,decreased joint mobility
MGI:1856603	Lpin1<fld>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000187,abnormal triglyceride level|MP:0000272,abnormal aorta morphology|MP:0000420,ruffled hair|MP:0000424,retarded hair growth|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0001105,abnormal PNS glial cell morphology|MP:0001106,abnormal Schwann cell morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0001406,abnormal gait|MP:0001511,disheveled coat|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0001524,impaired limb coordination|MP:0001547,abnormal lipid level|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002073,abnormal hair growth|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002651,abnormal sciatic nerve morphology|MP:0002971,abnormal brown adipose tissue morphology|MP:0003059,decreased insulin secretion|MP:0003383,abnormal gluconeogenesis|MP:0003871,abnormal myelin sheath morphology|MP:0003961,decreased lean body mass|MP:0003975,increased circulating VLDL triglyceride level|MP:0003982,increased cholesterol level|MP:0004129,abnormal respiratory quotient|MP:0004777,abnormal phospholipid level|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005266,abnormal metabolism|MP:0005278,abnormal cholesterol homeostasis|MP:0005281,increased fatty acids level|MP:0005282,decreased fatty acids level|MP:0005293,impaired glucose tolerance|MP:0005317,increased triglyceride level|MP:0005318,decreased triglyceride level|MP:0005319,abnormal enzyme/coenzyme level|MP:0005331,insulin resistance|MP:0005334,abnormal fat pad morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005402,abnormal action potential|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0005440,increased glycogen level|MP:0005559,increased circulating glucose level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005668,decreased circulating leptin level|MP:0005670,abnormal white adipose tissue physiology|MP:0006319,abnormal epididymal fat pad morphology|MP:0006379,abnormal spermatocyte morphology|MP:0008770,decreased survivor rate|MP:0008814,decreased nerve conduction velocity|MP:0008976,delayed female fertility|MP:0009115,abnormal fat cell morphology|MP:0009122,decreased white fat cell lipid droplet size|MP:0009125,decreased brown fat cell lipid droplet size|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009295,decreased interscapular fat pad weight|MP:0009355,increased liver triglyceride level|MP:0009356,decreased liver triglyceride level|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011579,decreased lipoprotein lipase activity|MP:0011582,decreased triglyceride lipase activity|MP:0011591,decreased hormone-sensitive lipase activity|MP:0011698,abnormal brown adipose tissue physiology|MP:0014146,decreased white adipose tissue mass|MP:0014169,decreased brown adipose tissue mass
MGI:1857584	Lpin1<fld-2J>	MP:0000599,enlarged liver|MP:0000745,tremors|MP:0000958,peripheral nervous system degeneration|MP:0001406,abnormal gait|MP:0001925,male infertility|MP:0002628,hepatic steatosis|MP:0005331,insulin resistance|MP:0005668,decreased circulating leptin level|MP:0009115,abnormal fat cell morphology|MP:0009122,decreased white fat cell lipid droplet size|MP:0009125,decreased brown fat cell lipid droplet size|MP:0014143,decreased body fat mass|MP:0014146,decreased white adipose tissue mass|MP:0014169,decreased brown adipose tissue mass
MGI:3799353	Lpin1<tm1Rchr>	MP:0000921,demyelination|MP:0001106,abnormal Schwann cell morphology|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002272,abnormal nervous system electrophysiology|MP:0002651,abnormal sciatic nerve morphology|MP:0005402,abnormal action potential|MP:0008814,decreased nerve conduction velocity
MGI:5513796	Lpin2<tm1b(KOMP)Wtsi>	MP:0000702,enlarged lymph nodes|MP:0002599,increased mean platelet volume|MP:0002874,decreased hemoglobin content|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0009142,decreased prepulse inhibition|MP:0009709,hydrometra|MP:0010067,increased red blood cell distribution width|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5640713	Lpin2<tm1Reue>	MP:0000745,tremors|MP:0000849,abnormal cerebellum morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0001393,ataxia|MP:0001525,impaired balance|MP:0001577,anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002874,decreased hemoglobin content|MP:0005335,abnormal gonadal fat pad morphology|MP:0005387,immune system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009355,increased liver triglyceride level|MP:0010067,increased red blood cell distribution width|MP:0013278,decreased fasting circulating glucose level
MGI:5548504	Lpin3<tm1b(KOMP)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0001529,abnormal vocalization|MP:0002606,increased basophil cell number|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number
MGI:6343243	Lpin3<tm1Reue>	MP:0001262,decreased body weight|MP:0005318,decreased triglyceride level|MP:0005376,homeostasis/metabolism phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0011167,abnormal adipose tissue development|MP:0011168,abnormal fat cell differentiation
MGI:2651805	Lpl<tm1Bres>	MP:0000003,abnormal adipose tissue morphology|MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000598,abnormal liver morphology|MP:0000759,abnormal skeletal muscle morphology|MP:0001260,increased body weight|MP:0001552,increased circulating triglyceride level|MP:0001575,cyanosis|MP:0002118,abnormal lipid homeostasis|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003658,abnormal capillary morphology|MP:0003717,pallor|MP:0003975,increased circulating VLDL triglyceride level|MP:0003982,increased cholesterol level|MP:0004007,abnormal lung vasculature morphology|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005317,increased triglyceride level|MP:0008908,increased total fat pad weight|MP:0011087,neonatal lethality, complete penetrance
MGI:3045235	Lpl<tm1Ijg>	MP:0001544,abnormal cardiovascular system physiology|MP:0001547,abnormal lipid level|MP:0001552,increased circulating triglyceride level|MP:0002078,abnormal glucose homeostasis|MP:0003141,cardiac fibrosis|MP:0003819,increased left ventricle diastolic pressure|MP:0003820,increased left ventricle systolic pressure|MP:0003975,increased circulating VLDL triglyceride level|MP:0005282,decreased fatty acids level|MP:0005608,cardiac interstitial fibrosis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0030018,increased cardiac muscle cell glucose uptake|MP:0031417,decreased cardiac muscle triglyceride level|MP:0031633,decreased heart left ventricle muscle contractility
MGI:2429315	Lpl<tm1Sem>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001177,atelectasis|MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0002118,abnormal lipid homeostasis|MP:0003975,increased circulating VLDL triglyceride level|MP:0003980,increased circulating phospholipid level|MP:0005178,increased circulating cholesterol level|MP:0010018,pulmonary vascular congestion|MP:0010019,liver vascular congestion|MP:0011087,neonatal lethality, complete penetrance
MGI:3621990	Lpn1<NZB>	MP:0001859,kidney inflammation|MP:0002962,increased urine protein level
MGI:3621995	Lpn2<NZW>	MP:0001859,kidney inflammation|MP:0002962,increased urine protein level
MGI:7331667	Lpo<em1Zlu>	MP:0000266,abnormal heart morphology|MP:0000280,thin ventricular wall|MP:0000511,abnormal intestinal mucosa morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000846,abnormal medulla oblongata morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001259,abnormal body weight|MP:0001846,increased inflammatory response|MP:0001856,myocarditis|MP:0001858,intestinal inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001863,blood vessel inflammation|MP:0001869,pancreas inflammation|MP:0001873,stomach inflammation|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002064,seizures|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002267,abnormal bronchiole morphology|MP:0002743,glomerulonephritis|MP:0002795,dilated cardiomyopathy|MP:0003225,axonal dystrophy|MP:0003251,gallbladder inflammation|MP:0003449,abnormal intestine goblet cell morphology|MP:0003991,arteriosclerosis|MP:0004510,myositis|MP:0004843,abnormal Paneth cell morphology|MP:0005338,atherosclerotic lesions|MP:0008714,increased lung carcinoma incidence|MP:0008772,increased heart ventricle size|MP:0008986,abnormal liver parenchyma morphology|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009321,increased histiocytic sarcoma incidence|MP:0009820,abnormal liver vasculature morphology|MP:0010138,arteritis|MP:0010139,aortitis|MP:0010152,abnormal brain ependyma morphology|MP:0010861,increased respiratory mucosa goblet cell number|MP:0010899,abnormal pulmonary alveolar system morphology|MP:0010934,increased subcutaneous adipose tissue amount|MP:0011380,enlarged brain ventricles|MP:0012431,increased lymphoma incidence|MP:0013148,mastitis|MP:0013485,increased Paneth cell number|MP:0014221,increased colon goblet cell number|MP:0014224,increased ileal goblet cell number|MP:0020411,increased abdominal adipose tissue amount|MP:0031118,cardiovalvulitis
MGI:5548663	Lpo<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology
MGI:3046330	Lppl1<C57BL/6J>	MP:0002442,abnormal leukocyte physiology
MGI:6120784	Lpp<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000598,abnormal liver morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0001566,increased circulating phosphate level|MP:0002792,abnormal retina vasculature morphology|MP:0008259,abnormal optic disk morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3834596	Lpp<tm1Wjmv>	MP:0000313,abnormal cell death|MP:0001792,impaired wound healing|MP:0001923,reduced female fertility|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging|MP:0011090,perinatal lethality, incomplete penetrance
MGI:2155879	Lprm1<MRL/MpJ>	MP:0001864,vascular inflammation
MGI:2155325	Lprm2<MRL/MpJ>	MP:0001864,vascular inflammation
MGI:2389370	Lprm3<MRL/MpJ>	MP:0002743,glomerulonephritis
MGI:2156224	Lprm4<MRL/MpJ>	MP:0000691,enlarged spleen
MGI:2389373	Lprm5<MRL/MpJ>	MP:0001800,abnormal humoral immune response
MGI:3511301	Lprq1<MRL/MpJ>	MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:3511303	Lprq2<MRL/MpJ>	MP:0000186,decreased circulating HDL cholesterol level
MGI:3511884	Lprq3<NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level|MP:0005416,abnormal circulating protein level
MGI:3511886	Lprq4<NZB/BlNJ>	MP:0000180,abnormal circulating cholesterol level|MP:0001556,increased circulating HDL cholesterol level
MGI:3046331	Lptl1<DBA/2J>	MP:0008752,abnormal tumor necrosis factor level
MGI:3046333	Lptl2<DBA/2J>	MP:0008752,abnormal tumor necrosis factor level
MGI:5692788	Lpxn<tm1b(EUCOMM)Hmgu>	MP:0001806,decreased IgM level|MP:0005387,immune system phenotype|MP:0008099,abnormal plasma cell differentiation
MGI:6101511	Lpy	MP:0000029,abnormal malleus morphology|MP:0001967,deafness|MP:0005105,abnormal middle ear ossicle morphology|MP:0008374,abnormal malleus manubrium morphology|MP:0010325,abnormal malleus head morphology|MP:0030394,abnormal incus short process morphology|MP:0030407,abnormal stapes crus morpholgy
MGI:1856942	lr	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0031428,lens dislocation
MGI:3578553	lra3b	MP:0004252,abnormal direction of heart looping
MGI:6316150	Lratd2<em1(IMPC)Ccpcz>	MP:0001325,abnormal retina morphology|MP:0002591,decreased mean corpuscular volume|MP:0005012,decreased eosinophil cell number|MP:0005568,increased circulating total protein level|MP:0008206,increased B-2 B cell number|MP:0008935,decreased mean platelet volume
MGI:3777017	Lrat<tm1.1Bok>	MP:0005551,abnormal eye electrophysiology|MP:0008587,short photoreceptor outer segment|MP:0011232,abnormal vitamin A level
MGI:5708196	Lrat<tm1.1(KOMP)Vlcg>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3777016	Lrat<tm1Bok>	MP:0005551,abnormal eye electrophysiology|MP:0008587,short photoreceptor outer segment|MP:0011232,abnormal vitamin A level
MGI:3038935	Lrat<tm1Kpal>	MP:0001004,abnormal retina photoreceptor morphology|MP:0005391,vision/eye phenotype|MP:0008444,retina cone cell degeneration|MP:0008449,abnormal retina cone cell outer segment morphology|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment|MP:0011233,abnormal vitamin A metabolism
MGI:3612421	Lrat<tm1Log>	MP:0001146,abnormal testis morphology|MP:0001940,testis hypoplasia|MP:0002687,oligozoospermia|MP:0003205,testicular atrophy|MP:0009257,dilated seminiferous tubule|MP:0011232,abnormal vitamin A level|MP:0011234,abnormal retinol level
MGI:6303966	Lrba<em1Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:6153482	Lrba<em1(IMPC)Wtsi>	MP:0000023,abnormal ear position|MP:0000194,increased circulating calcium level|MP:0001556,increased circulating HDL cholesterol level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003020,decreased circulating chloride level|MP:0005178,increased circulating cholesterol level|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005568,increased circulating total protein level|MP:0006358,absent pinna reflex|MP:0008806,increased circulating amylase level
MGI:6303985	Lrba<em2Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:6303988	Lrba<em3Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:4173110	Lrba<Gt(OST69142)Lex>	MP:0004751,increased length of allograft survival|MP:0004973,increased regulatory T cell number|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005673,decreased susceptibility to graft versus host disease|MP:0010766,abnormal NK cell physiology|MP:0013663,increased myeloid cell number
MGI:6303944	Lrba<m1Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:6303962	Lrba<m2Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:6121113	Lrch1<em1Hwa>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005387,immune system phenotype|MP:0009858,abnormal cellular extravasation
MGI:6152508	Lrch2<em1(IMPC)Mbp>	MP:0001293,anophthalmia|MP:0001402,decreased locomotor activity|MP:0002092,abnormal eye morphology
MGI:4129812	Lrch2<Gt(RRI232)Byg>	MP:0002169,no abnormal phenotype detected
MGI:7434711	Lrch3<em1(IMPC)J>	MP:0001258,decreased body length
MGI:6459766	Lrcol1<em1Osb>	MP:0005389,reproductive system phenotype
MGI:3042611	Lrdg1<BALB/cByJ>	MP:0001326,retina degeneration
MGI:3042613	Lrdg2<BALB/cByJ>	MP:0001326,retina degeneration
MGI:2156890	Lrdm1<MRL/MpJ>	MP:0001859,kidney inflammation
MGI:3036002	Lrdm2<MRL/MpJ>	MP:0001859,kidney inflammation
MGI:3761369	Lrfn2<Tg(CD2-Myb/en)5Kmw>	MP:0000692,small spleen|MP:0000706,small thymus|MP:0002339,abnormal lymph node morphology|MP:0002371,abnormal thymus cortex morphology|MP:0002375,abnormal thymus medulla morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0005095,decreased T cell proliferation|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:5904006	Lrfn2<tm1.1Jaru>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000245,abnormal erythropoiesis|MP:0000334,decreased granulocyte number|MP:0000807,abnormal hippocampus morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001360,abnormal social investigation|MP:0001361,social withdrawal|MP:0001409,increased stereotypic behavior|MP:0001488,increased startle reflex|MP:0002206,abnormal CNS synaptic transmission|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003008,enhanced long-term potentiation|MP:0003131,increased erythrocyte cell number|MP:0004859,abnormal synaptic plasticity|MP:0005016,decreased lymphocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0008973,decreased erythroid progenitor cell number|MP:0009142,decreased prepulse inhibition|MP:0009453,enhanced contextual conditioning behavior|MP:0009538,abnormal synapse morphology|MP:0009936,abnormal dendritic spine morphology|MP:0011286,decreased circulating erythropoietin level|MP:0012306,enhanced spatial learning|MP:0013660,abnormal bone marrow hematopoietic cell morphology|MP:0014376,decreased miniature excitatory postsynaptic current frequency|MP:0020338,abnormal hippocampal pyramidal neuron dendrite morphology|MP:0020351,decreased vocalization|MP:0020421,increased freezing behavior|MP:0020551,abnormal postsynaptic density morphology
MGI:5582440	Lrfn3<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis
MGI:4887760	Lrfn3<tm1(KOMP)Vlcg>	MP:0003631,nervous system phenotype|MP:0009538,abnormal synapse morphology|MP:0014375,increased miniature excitatory postsynaptic current frequency|MP:0014382,increased miniature inhibitory postsynaptic current frequency|MP:0020551,abnormal postsynaptic density morphology
MGI:3799757	Lrfn4<tm1(KOMP)Vlcg>	MP:0001402,decreased locomotor activity|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005386,behavior/neurological phenotype|MP:0008035,behavioral arrest|MP:0020357,abnormal excitatory synapse morphology
MGI:7467316	Lrfn5<em1(IMPC)Tcp>	MP:0002092,abnormal eye morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003131,increased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010097,abnormal retina blood vessel morphology|MP:0020870,decreased thigmotaxis
MGI:6196322	Lrg1<tm1.1Tnaka>	MP:0003721,increased tumor growth/size
MGI:5645723	Lrguk<Kaos>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004029,spontaneous chromosome breakage|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008545,absent sperm flagellum|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009239,short sperm flagellum|MP:0009376,abnormal manchette morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0014684,impaired spermiation|MP:0031373,abnormal manchette perinuclear ring morphology
MGI:6342842	Lrif1<em1(IMPC)J>	MP:0005561,increased mean corpuscular hemoglobin
MGI:5551790	Lrig1<Gt(GST4169C6)Lex>	MP:0005377,hearing/vestibular/ear phenotype|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014406,increased or absent distortion product otoacoustic emission threshold|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:5563390	Lrig1<m1Anu>	MP:0005387,immune system phenotype
MGI:4947937	Lrig1<tm1.1(cre/ERT2)Rjc>	MP:0002169,no abnormal phenotype detected
MGI:4431776	Lrig1<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000384,distorted hair follicle pattern|MP:0000427,abnormal hair cycle|MP:0001191,abnormal skin condition|MP:0001192,scaly skin|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001242,hyperkeratosis|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001511,disheveled coat|MP:0002111,abnormal tail morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002942,decreased circulating alanine transaminase level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0004609,vertebral fusion|MP:0004613,fusion of vertebral arches|MP:0004738,abnormal auditory brainstem response|MP:0004924,abnormal behavior|MP:0005632,decreased circulating aspartate transaminase level|MP:0008861,abnormal hair shedding|MP:0010025,decreased total body fat amount|MP:0010678,abnormal skin adnexa morphology|MP:0010771,integument phenotype
MGI:2675424	Lrig1<tm1Ita>	MP:0000414,alopecia|MP:0000588,thick tail|MP:0001192,scaly skin|MP:0001193,psoriasis|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0002060,abnormal skin morphology|MP:0002656,abnormal keratinocyte differentiation|MP:0003427,parakeratosis|MP:0003631,nervous system phenotype|MP:0003743,abnormal facial morphology|MP:0009583,increased keratinocyte proliferation
MGI:4128231	Lrig2<Gt(RST656)Byg>	MP:0005377,hearing/vestibular/ear phenotype|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:5553453	Lrig2<tm1.1Hhed>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001504,abnormal posture|MP:0001510,abnormal coat appearance|MP:0001846,increased inflammatory response|MP:0002053,decreased incidence of induced tumors|MP:0002083,premature death|MP:0005202,lethargy|MP:0005384,cellular phenotype
MGI:7425799	Lrig3<em1(IMPC)Ccpcz>	MP:0000137,abnormal vertebrae morphology|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000438,abnormal cranium morphology|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0000759,abnormal skeletal muscle morphology|MP:0001406,abnormal gait|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002060,abnormal skin morphology|MP:0002110,abnormal digit morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003917,increased kidney weight|MP:0003921,abnormal heart left ventricle morphology|MP:0004599,abnormal vertebral arch morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0011971,increased circulating lactate dehydrogenase level
MGI:3829384	Lrig3<Gt(LST016)Byg>	MP:0000037,abnormal lateral semicircular canal morphology|MP:0000428,abnormal craniofacial morphology|MP:0000445,short snout|MP:0001394,circling|MP:0003162,decreased lateral semicircular canal size|MP:0003938,abnormal ear development|MP:0005307,head tossing|MP:0005377,hearing/vestibular/ear phenotype
MGI:3829388	Lrig3<tm1.1Good>	MP:0000037,abnormal lateral semicircular canal morphology|MP:0000428,abnormal craniofacial morphology|MP:0003164,decreased posterior semicircular canal size
MGI:5911996	Lrig3<tm1.1Hhed>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002626,increased heart rate|MP:0002727,decreased circulating insulin level|MP:0002842,increased systemic arterial blood pressure|MP:0003393,decreased cardiac output|MP:0003442,decreased circulating glycerol level|MP:0003921,abnormal heart left ventricle morphology|MP:0011952,decreased cardiac stroke volume|MP:0020204,abnormal heart left ventricle weight
MGI:6151090	Lrit1<tm1b(EUCOMM)Hmgu>	MP:0004022,abnormal cone electrophysiology|MP:0005391,vision/eye phenotype|MP:0009619,abnormal optokinetic reflex
MGI:6276961	Lrit3<em1(IMPC)Mbp>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0020870,decreased thigmotaxis
MGI:5629558	Lrit3<tm1Lex>	MP:0002090,abnormal vision|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0006069,abnormal retina neuronal layer morphology|MP:0008511,thin retina inner nuclear layer|MP:0012144,decreased b-wave amplitude|MP:0012145,increased a-wave amplitude|MP:0012147,increased a-wave implicit time|MP:0012150,increased b-wave implicit time
MGI:5903616	Lrit3<tvrm257>	MP:0004022,abnormal cone electrophysiology|MP:0012144,decreased b-wave amplitude
MGI:3640787	lrm1	MP:0000531,right pulmonary isomerism|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0001785,edema|MP:0002766,situs inversus|MP:0010808,right-sided stomach
MGI:3640790	lrm2	MP:0000531,right pulmonary isomerism|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0001785,edema|MP:0002766,situs inversus|MP:0003178,left pulmonary isomerism|MP:0010807,abnormal stomach position or orientation
MGI:5006791	Lrmda<tm1e(EUCOMM)Wtsi>	MP:0005553,increased circulating creatinine level|MP:0010052,increased grip strength
MGI:2154212	Lrncs1<DBA/2J>	MP:0001454,abnormal cued conditioning behavior
MGI:2155156	Lrnx10<C57BL/6J>	MP:0002065,abnormal fear/anxiety-related behavior
MGI:2155305	Lrnx7<C57BL/6J>	MP:0002065,abnormal fear/anxiety-related behavior
MGI:2158219	Lrnx8<C57BL/6J>	MP:0002065,abnormal fear/anxiety-related behavior
MGI:2429581	Lrnx9<DBA/2J>	MP:0002065,abnormal fear/anxiety-related behavior
MGI:7301746	Lrp12<em1Gpt>	MP:0005015,increased T cell number|MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008537,increased susceptibility to induced colitis|MP:0011804,increased cell migration|MP:0020213,enhanced leukocyte migration
MGI:7510088	Lrp12<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5437079	Lrp1<b2b1554Clo>	MP:0000757,herniated abdominal wall|MP:0003052,omphalocele|MP:0003385,abnormal body wall morphology|MP:0003924,diaphragmatic hernia|MP:0010224,abnormal heart ventricle outflow tract morphology|MP:0010412,atrioventricular septal defect
MGI:6273952	Lrp1b<em1(IMPC)Hmgu>	MP:0008810,increased circulating iron level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011939,increased food intake
MGI:3045402	Lrp1b<tm1Her>	MP:0002169,no abnormal phenotype detected
MGI:4459742	Lrp1b<tm1Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:4459800	Lrp1b<tm2Wtsi>	MP:0011092,embryonic lethality, complete penetrance
MGI:5494466	Lrp1<tm1.1(KOMP)Wtsi>	MP:0000428,abnormal craniofacial morphology|MP:0000783,abnormal forebrain morphology|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001697,abnormal embryo size|MP:0001914,hemorrhage|MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0005650,abnormal limb bud morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:3830336	Lrp1<tm1Ajmr>	MP:0002169,no abnormal phenotype detected
MGI:2178192	Lrp1<tm1Her>	MP:0001634,internal hemorrhage|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3830330	Lrp1<tm2Ajmr>	MP:0000598,abnormal liver morphology
MGI:2180880	Lrp1<tm2Her>	MP:0000160,kyphosis|MP:0000189,hypoglycemia|MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000609,abnormal liver physiology|MP:0000745,tremors|MP:0000746,weakness|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001473,reduced long-term potentiation|MP:0001504,abnormal posture|MP:0001512,trunk curl|MP:0001513,limb grasping|MP:0001524,impaired limb coordination|MP:0001547,abnormal lipid level|MP:0001732,postnatal growth retardation|MP:0001777,abnormal body temperature homeostasis|MP:0001780,decreased brown adipose tissue amount|MP:0001847,brain inflammation|MP:0001921,reduced fertility|MP:0002062,abnormal associative learning|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002152,abnormal brain morphology|MP:0002229,neurodegeneration|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003026,decreased vasoconstriction|MP:0003631,nervous system phenotype|MP:0003949,abnormal circulating lipid level|MP:0004111,abnormal coronary artery morphology|MP:0004263,abnormal limb posture|MP:0004883,abnormal vascular wound healing|MP:0004889,increased energy expenditure|MP:0005140,decreased cardiac muscle contractility|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005318,decreased triglyceride level|MP:0005334,abnormal fat pad morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005416,abnormal circulating protein level|MP:0005452,abnormal adipose tissue amount|MP:0005560,decreased circulating glucose level|MP:0005595,abnormal vascular smooth muscle physiology|MP:0005608,cardiac interstitial fibrosis|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005666,abnormal adipose tissue physiology|MP:0005668,decreased circulating leptin level|MP:0006047,aortic valve regurgitation|MP:0006263,decreased systemic arterial diastolic blood pressure|MP:0006265,increased pulse pressure|MP:0009116,abnormal brown fat cell morphology|MP:0009133,decreased white fat cell size|MP:0009136,decreased brown fat cell size|MP:0009137,decreased brown fat lipid droplet number|MP:0009289,decreased epididymal fat pad weight|MP:0009295,decreased interscapular fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0009538,abnormal synapse morphology|MP:0009642,abnormal blood homeostasis|MP:0009862,abnormal aorta elastic tissue morphology|MP:0009865,abnormal aorta smooth muscle morphology|MP:0009867,abnormal ascending aorta morphology|MP:0009873,abnormal aorta tunica media morphology|MP:0010025,decreased total body fat amount|MP:0010161,decreased brain cholesterol level|MP:0010180,increased susceptibility to weight loss|MP:0010470,dilated ascending aorta|MP:0010579,increased heart left ventricle size|MP:0011015,decreased body surface temperature|MP:0011049,impaired adaptive thermogenesis|MP:0011575,dilated aorta bulb|MP:0011749,perivascular fibrosis|MP:0011925,abnormal heart echocardiography feature|MP:0011939,increased food intake|MP:0012329,increased circulating factor VIII level|MP:0020508,decreased dendritic spine density|MP:0031165,increased circulating von Willebrand factor level|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:3830332	Lrp1<tm3Ajmr>	MP:0000606,decreased hepatocyte number|MP:0003103,liver degeneration|MP:0008988,abnormal liver perisinusoidal space morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3830333	Lrp1<tm4Ajmr>	MP:0002169,no abnormal phenotype detected
MGI:5433527	Lrp1<tm5Ajmr>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5433528	Lrp1<tm6Ajmr>	MP:0002169,no abnormal phenotype detected
MGI:5433186	Lrp2<27SH>	MP:0000111,cleft palate|MP:0000783,abnormal forebrain morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0001293,anophthalmia|MP:0002092,abnormal eye morphology|MP:0002152,abnormal brain morphology|MP:0002741,small olfactory bulb|MP:0004872,absent nasal septum|MP:0005157,holoprosencephaly|MP:0009267,abnormal cerebellum fissure morphology|MP:0030046,round forehead
MGI:5489925	Lrp2<b2b1625.2Clo>	MP:0003052,omphalocele|MP:0010466,vascular ring|MP:0011661,persistent truncus arteriosus type i
MGI:5560499	Lrp2<b2b2671Clo>	MP:0000276,heart right ventricle hypertrophy|MP:0000445,short snout|MP:0000519,hydronephrosis|MP:0000585,kinked tail|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001823,thymus hypoplasia|MP:0002625,heart left ventricle hypertrophy|MP:0002633,persistent truncus arteriosus|MP:0002639,micrognathia|MP:0003675,kidney cyst|MP:0004056,abnormal myocardium compact layer morphology|MP:0004113,abnormal aortic arch morphology|MP:0004158,right aortic arch|MP:0010146,umbilical hernia|MP:0010402,ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect
MGI:3799273	Lrp2<m267Asp>	MP:0000788,abnormal cerebral cortex morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000821,choroid plexus hyperplasia|MP:0000830,abnormal diencephalon morphology|MP:0000914,exencephaly|MP:0001405,impaired coordination|MP:0001775,abnormal selenium level|MP:0002962,increased urine protein level|MP:0006357,abnormal circulating mineral level|MP:0011603,decreased glutathione peroxidase activity|MP:0011770,increased urine selenium level
MGI:1931859	Lrp2<tm1Her>	MP:0000445,short snout|MP:0000787,abnormal telencephalon morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000914,exencephaly|MP:0000936,small embryonic telencephalon|MP:0001123,dilated uterus|MP:0001146,abnormal testis morphology|MP:0001177,atelectasis|MP:0001183,overexpanded pulmonary alveolus|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001575,cyanosis|MP:0001698,decreased embryo size|MP:0001775,abnormal selenium level|MP:0001953,respiratory failure|MP:0001958,emphysema|MP:0001963,abnormal hearing physiology|MP:0002133,abnormal respiratory system physiology|MP:0002196,absent corpus callosum|MP:0002621,delayed neural tube closure|MP:0002781,increased circulating testosterone level|MP:0002962,increased urine protein level|MP:0003232,abnormal forebrain development|MP:0003451,absent olfactory bulb|MP:0003509,increased circulating dihydrotestosterone level|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003830,abnormal testis development|MP:0003878,abnormal ear physiology|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004366,abnormal strial marginal cell morphology|MP:0004748,increased susceptibility to age-related hearing loss|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005157,holoprosencephaly|MP:0005274,abnormal viscerocranium morphology|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0006042,increased apoptosis|MP:0006325,impaired hearing|MP:0009643,abnormal urine homeostasis|MP:0009708,vaginal septum|MP:0011089,perinatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011555,increased urine microglobulin level|MP:0011603,decreased glutathione peroxidase activity|MP:0011770,increased urine selenium level|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0030047,flat forehead|MP:0031286,unilateral cryptorchism
MGI:2449765	Lrp2<tm1Tew>	MP:0000195,decreased circulating calcium level|MP:0000352,decreased cell proliferation|MP:0001296,macrophthalmia|MP:0001303,abnormal lens morphology|MP:0001330,abnormal optic nerve morphology|MP:0002092,abnormal eye morphology|MP:0002196,absent corpus callosum|MP:0002698,abnormal sclera morphology|MP:0002896,abnormal bone mineralization|MP:0002904,increased circulating parathyroid hormone level|MP:0002962,increased urine protein level|MP:0002998,abnormal bone remodeling|MP:0003101,high myopia|MP:0003102,sclera thinning|MP:0003631,nervous system phenotype|MP:0004992,increased bone resorption|MP:0005103,abnormal retina pigmentation|MP:0005195,abnormal posterior eye segment morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005257,abnormal intraocular pressure|MP:0005376,homeostasis/metabolism phenotype|MP:0005391,vision/eye phenotype|MP:0006073,abnormal retina bipolar cell morphology|MP:0006197,ocular hypotelorism|MP:0006241,abnormal placement of pupils|MP:0006309,decreased retina ganglion cell number|MP:0008143,abnormal dendrite morphology|MP:0008511,thin retina inner nuclear layer|MP:0008513,thin retina inner plexiform layer|MP:0008515,thin retina outer nuclear layer|MP:0009445,osteomalacia|MP:0009643,abnormal urine homeostasis|MP:0010107,abnormal renal reabsorption|MP:0010124,decreased bone mineral content|MP:0011228,abnormal vitamin D level|MP:0011965,decreased total retina thickness|MP:0030005,increased retina apoptosis
MGI:5426261	Lrp2<tm3Tew>	MP:0005157,holoprosencephaly|MP:0005367,renal/urinary system phenotype|MP:0011090,perinatal lethality, incomplete penetrance
MGI:7794395	Lrp3<em1Cya>	MP:0003560,osteoarthritis|MP:0003724,increased susceptibility to induced arthritis|MP:0003998,decreased thermal nociceptive threshold|MP:0005178,increased circulating cholesterol level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0013304,osteophytes
MGI:3580702	Lrp4<dan>	MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000580,deformed nails|MP:0001265,decreased body size|MP:0001382,abnormal nursing|MP:0001505,hunched posture|MP:0001510,abnormal coat appearance|MP:0002544,brachydactyly|MP:0004083,polysyndactyly|MP:0005382,craniofacial phenotype
MGI:2661383	Lrp4<mdig>	MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000580,deformed nails|MP:0001382,abnormal nursing|MP:0002544,brachydactyly|MP:0004083,polysyndactyly|MP:0005382,craniofacial phenotype
MGI:4418458	Lrp4<mdig-2J>	MP:0000565,oligodactyly|MP:0002111,abnormal tail morphology|MP:0006369,supernumerary incisors
MGI:5688522	Lrp4<mdig-3J>	MP:0001265,decreased body size|MP:0001921,reduced fertility|MP:0002100,abnormal tooth morphology|MP:0002110,abnormal digit morphology|MP:0002544,brachydactyly|MP:0004174,abnormal spine curvature|MP:0008730,fused phalanges
MGI:3707955	Lrp4<mitt>	MP:0000116,abnormal tooth development|MP:0000520,absent kidney|MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0000568,ectopic digits|MP:0000937,abnormal motor neuron morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001054,failure of neuromuscular synapse presynaptic differentiation|MP:0001055,failure of neuromuscular synapse postsynaptic differentiation|MP:0001078,abnormal phrenic nerve morphology|MP:0001177,atelectasis|MP:0001404,no spontaneous movement|MP:0001575,cyanosis|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0001953,respiratory failure|MP:0002098,abnormal vibrissa morphology|MP:0002110,abnormal digit morphology|MP:0002772,brachypodia|MP:0003604,single kidney|MP:0003641,small lung|MP:0003704,abnormal hair follicle development|MP:0004639,fused metacarpal bones|MP:0004642,fused metatarsal bones|MP:0011087,neonatal lethality, complete penetrance|MP:0013785,abnormal mammary gland bud morphology
MGI:3707726	Lrp4<mte>	MP:0000116,abnormal tooth development|MP:0000520,absent kidney|MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0000568,ectopic digits|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001054,failure of neuromuscular synapse presynaptic differentiation|MP:0001055,failure of neuromuscular synapse postsynaptic differentiation|MP:0001078,abnormal phrenic nerve morphology|MP:0001177,atelectasis|MP:0001404,no spontaneous movement|MP:0001575,cyanosis|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0001953,respiratory failure|MP:0002098,abnormal vibrissa morphology|MP:0002110,abnormal digit morphology|MP:0002772,brachypodia|MP:0003604,single kidney|MP:0003641,small lung|MP:0003704,abnormal hair follicle development|MP:0004639,fused metacarpal bones|MP:0004642,fused metatarsal bones|MP:0011087,neonatal lethality, complete penetrance|MP:0013785,abnormal mammary gland bud morphology
MGI:5440737	Lrp4<tm1.1Line>	MP:0000937,abnormal motor neuron morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001575,cyanosis|MP:0002914,abnormal endplate potential|MP:0003631,nervous system phenotype|MP:0004835,abnormal miniature endplate potential|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance
MGI:6343233	Lrp4<tm1.1Pg>	MP:0004149,increased bone strength|MP:0005367,renal/urinary system phenotype|MP:0005369,muscle phenotype|MP:0005390,skeleton phenotype|MP:0008158,increased diameter of femur|MP:0008753,abnormal osteocyte morphology|MP:0009347,increased trabecular bone thickness|MP:0009642,abnormal blood homeostasis|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0010932,increased trabecular bone connectivity density|MP:0013623,increased femur compact bone thickness|MP:0013631,decreased bone trabecular spacing|MP:0020039,increased bone ossification|MP:0030278,thick neurocranium
MGI:3621893	Lrp4<tm1Her>	MP:0000166,abnormal chondrocyte morphology|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000562,polydactyly|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001678,thick apical ectodermal ridge|MP:0001731,abnormal postnatal growth|MP:0002110,abnormal digit morphology|MP:0002576,abnormal enamel morphology|MP:0005358,abnormal incisor morphology|MP:0006369,supernumerary incisors|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4455050	Lrp4<tm2Her>	MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001054,failure of neuromuscular synapse presynaptic differentiation|MP:0001055,failure of neuromuscular synapse postsynaptic differentiation|MP:0003604,single kidney|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005358,abnormal incisor morphology|MP:0006032,abnormal ureteric bud morphology|MP:0006369,supernumerary incisors|MP:0010983,abnormal ureteric bud invasion|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011298,ureter hypoplasia|MP:0011387,absent metanephric mesenchyme|MP:0030457,abnormal molar cusp morphology
MGI:5561037	Lrp4<tm3Her>	MP:0003631,nervous system phenotype
MGI:7466960	Lrp5<em1Xjz>	MP:0005602,decreased angiogenesis|MP:0009772,abnormal retina development
MGI:3530598	Lrp5<Gt(OST164883)Lex>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000255,blood vessel congestion|MP:0001262,decreased body weight|MP:0002792,abnormal retina vasculature morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003070,increased vascular permeability|MP:0003795,abnormal bone structure|MP:0004016,decreased bone mass|MP:0004214,abnormal long bone diaphysis morphology|MP:0004993,decreased bone resorption|MP:0010873,decreased trabecular bone mass|MP:0010962,decreased compact bone mass|MP:0020010,decreased bone mineral density of femur|MP:0020040,decreased bone ossification
MGI:6760632	Lrp5<m1Btlr>	MP:0000061,fragile skeleton|MP:0000063,decreased bone mineral density|MP:0004016,decreased bone mass
MGI:6760633	Lrp5<m2Btlr>	MP:0000063,decreased bone mineral density
MGI:6760634	Lrp5<m3Btlr>	MP:0000063,decreased bone mineral density
MGI:6760635	Lrp5<m4Btlr>	MP:0000062,increased bone mineral density
MGI:3774282	Lrp5<r18>	MP:0002792,abnormal retina vasculature morphology
MGI:4453212	Lrp5<tm1.1Mawa>	MP:0005605,increased bone mass
MGI:5299215	Lrp5<tm1.1Vari>	MP:0002169,no abnormal phenotype detected
MGI:5299217	Lrp5<tm1.2Vari>	MP:0004016,decreased bone mass|MP:0005390,skeleton phenotype
MGI:3604604	Lrp5<tm1Dgen>	MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001914,hemorrhage|MP:0002090,abnormal vision|MP:0002183,gliosis|MP:0002792,abnormal retina vasculature morphology|MP:0002797,increased thigmotaxis|MP:0003727,abnormal retina layer morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005602,decreased angiogenesis|MP:0006303,abnormal retina nerve fiber layer morphology|MP:0008067,retina ganglion cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008512,disorganized retina inner nuclear layer|MP:0008513,thin retina inner plexiform layer|MP:0008515,thin retina outer nuclear layer|MP:0008516,disorganized retina outer nuclear layer|MP:0008519,thin retina outer plexiform layer|MP:0008520,disorganized retina outer plexiform layer|MP:0009772,abnormal retina development|MP:0010097,abnormal retina blood vessel morphology|MP:0011965,decreased total retina thickness|MP:0012035,abnormal b-wave shape|MP:0013925,abnormal vascular plexus formation|MP:0021107,retina fold|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:3612485	Lrp5<tm1Grw>	MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000130,abnormal trabecular bone morphology|MP:0003795,abnormal bone structure|MP:0004016,decreased bone mass|MP:0004985,decreased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0004991,decreased bone strength|MP:0005006,abnormal osteoblast physiology|MP:0010124,decreased bone mineral content|MP:0010873,decreased trabecular bone mass|MP:0010876,decreased bone volume|MP:0010962,decreased compact bone mass|MP:0013639,decreased bone stiffness|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization
MGI:3046356	Lrp5<tm1Jfh>	MP:0005306,abnormal phalanx morphology
MGI:2448955	Lrp5<tm1Jsak>	MP:0000559,abnormal femur morphology|MP:0000609,abnormal liver physiology|MP:0002109,abnormal limb morphology|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003982,increased cholesterol level|MP:0004231,abnormal calcium ion homeostasis|MP:0005145,increased circulating VLDL cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0008152,decreased diameter of femur|MP:0008156,decreased diameter of tibia|MP:0030281,thin parietal bone
MGI:2183279	Lrp5<tm1Kry>	MP:0000060,delayed bone ossification|MP:0000130,abnormal trabecular bone morphology|MP:0001286,abnormal eye development|MP:0001289,persistence of hyaloid vascular system|MP:0002792,abnormal retina vasculature morphology|MP:0002896,abnormal bone mineralization|MP:0004016,decreased bone mass|MP:0004989,decreased osteoblast cell number|MP:0005006,abnormal osteoblast physiology|MP:0005390,skeleton phenotype|MP:0006043,decreased apoptosis|MP:0008271,abnormal bone ossification|MP:0010069,increased serotonin level|MP:0010070,decreased serotonin level|MP:0010876,decreased bone volume|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3663738	Lrp5<tm1Lex>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0001289,persistence of hyaloid vascular system
MGI:4453217	Lrp5<tm1Mawa>	MP:0005390,skeleton phenotype|MP:0005605,increased bone mass
MGI:4453222	Lrp5<tm2.1Mawa>	MP:0005605,increased bone mass
MGI:3837394	Lrp5<tm2Kry>	MP:0004016,decreased bone mass|MP:0004989,decreased osteoblast cell number|MP:0005322,abnormal serotonin level|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0005391,vision/eye phenotype|MP:0020040,decreased bone ossification|MP:0030439,decreased osteoblast proliferation
MGI:4453225	Lrp5<tm2Mawa>	MP:0005390,skeleton phenotype|MP:0005605,increased bone mass
MGI:5014216	Lrp5<tm3.1Mawa>	MP:0004016,decreased bone mass|MP:0005390,skeleton phenotype
MGI:5014217	Lrp5<tm3.2Mawa>	MP:0004016,decreased bone mass|MP:0010867,abnormal bone trabecula morphology
MGI:3837395	Lrp5<tm3(Lrp5*)Kry>	MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0005605,increased bone mass|MP:0010070,decreased serotonin level|MP:0020039,increased bone ossification
MGI:5902782	Lrp5<tvrm111B>	MP:0001289,persistence of hyaloid vascular system|MP:0002792,abnormal retina vasculature morphology|MP:0004022,abnormal cone electrophysiology|MP:0006069,abnormal retina neuronal layer morphology|MP:0010124,decreased bone mineral content|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0013618,decreased areal bone mineral density|MP:0014179,abnormal blood-retina barrier function
MGI:1861309	Lrp6<Cd>	MP:0000060,delayed bone ossification|MP:0000107,abnormal frontal bone morphology|MP:0000116,abnormal tooth development|MP:0000119,abnormal tooth eruption|MP:0000128,growth retardation of molars|MP:0000137,abnormal vertebrae morphology|MP:0000416,sparse hair|MP:0000436,abnormal head movements|MP:0000438,abnormal cranium morphology|MP:0000585,kinked tail|MP:0000914,exencephaly|MP:0001265,decreased body size|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001510,abnormal coat appearance|MP:0001688,abnormal somite development|MP:0001732,postnatal growth retardation|MP:0002177,abnormal outer ear morphology|MP:0002233,abnormal nose morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0004609,vertebral fusion|MP:0004619,caudal vertebral fusion|MP:0004652,small caudal vertebrae|MP:0004830,short incisors|MP:0005352,small cranium|MP:0006400,decreased molar number|MP:0006402,small molars|MP:0008832,hemivertebra|MP:0009703,decreased birth body size|MP:0010743,delayed cranial suture closure|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance|MP:0011495,abnormal head shape|MP:0011732,decreased somite size|MP:0012078,abnormal tail ring morphology|MP:0030080,small lower incisors|MP:0030083,long upper incisors|MP:0030279,thin neurocranium|MP:0030457,abnormal molar cusp morphology
MGI:2156191	Lrp6<Gt(Ex187)Byg>	MP:0000063,decreased bone mineral density|MP:0000138,absent vertebrae|MP:0000849,abnormal cerebellum morphology|MP:0000897,abnormal midbrain morphology|MP:0000914,exencephaly|MP:0001677,absent apical ectodermal ridge|MP:0001689,incomplete somite formation|MP:0002110,abnormal digit morphology|MP:0002861,abnormal tail bud morphology|MP:0003054,spina bifida|MP:0003126,abnormal external female genitalia morphology|MP:0003445,sirenomelia|MP:0009039,absent inferior colliculus|MP:0009199,abnormal external male genitalia morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0012062,small tail bud|MP:0012132,abnormal midbrain-hindbrain boundary morphology|MP:0012184,absent paraxial mesoderm|MP:0014280,forelimb oligodactyly
MGI:4123883	Lrp6<Gt(LST067)Byg>	MP:0000598,abnormal liver morphology|MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0002118,abnormal lipid homeostasis|MP:0002891,increased insulin sensitivity|MP:0002971,abnormal brown adipose tissue morphology|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009127,increased brown fat cell number|MP:0009356,decreased liver triglyceride level|MP:0020523,decreased susceptibility to induced hypothermia|MP:0030969,increased circulating adiponectin level
MGI:3043026	Lrp6<Gw>	MP:0000432,abnormal head morphology|MP:0000585,kinked tail|MP:0000783,abnormal forebrain morphology|MP:0000784,forebrain hypoplasia|MP:0000787,abnormal telencephalon morphology|MP:0000914,exencephaly|MP:0001698,decreased embryo size|MP:0003232,abnormal forebrain development
MGI:5505502	Lrp6<m10Bei>	MP:0000914,exencephaly|MP:0003054,spina bifida|MP:0003720,abnormal neural tube closure|MP:0008784,craniorachischisis
MGI:2673982	Lrp6<rs>	MP:0000060,delayed bone ossification|MP:0000066,osteoporosis|MP:0000137,abnormal vertebrae morphology|MP:0000154,rib fusion|MP:0000565,oligodactyly|MP:0000592,short tail|MP:0000963,fused dorsal root ganglion|MP:0001689,incomplete somite formation|MP:0003051,curly tail|MP:0004599,abnormal vertebral arch morphology|MP:0005223,abnormal dorsal-ventral polarity of the somites|MP:0005297,spina bifida occulta|MP:0008029,abnormal paraxial mesoderm morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012547,spina bifida cystica
MGI:3577510	Lrp6<skax26>	MP:0000585,kinked tail|MP:0003051,curly tail|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles
MGI:5299216	Lrp6<tm1.1Vari>	MP:0000060,delayed bone ossification|MP:0002169,no abnormal phenotype detected|MP:0005390,skeleton phenotype
MGI:4415718	Lrp6<tm1.2Cjz>	MP:0000111,cleft palate|MP:0000547,short limbs|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000562,polydactyly|MP:0000592,short tail|MP:0000914,exencephaly|MP:0001286,abnormal eye development|MP:0001297,microphthalmia|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0003054,spina bifida|MP:0003126,abnormal external female genitalia morphology|MP:0003445,sirenomelia|MP:0005170,cleft upper lip|MP:0009199,abnormal external male genitalia morphology|MP:0009264,failure of eyelid fusion|MP:0009908,protruding tongue|MP:0010715,retina coloboma|MP:0014280,forelimb oligodactyly
MGI:5299218	Lrp6<tm1.2Vari>	MP:0011087,neonatal lethality, complete penetrance
MGI:5621006	Lrp6<tm1Arma>	MP:0000182,increased circulating LDL cholesterol level|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0001860,liver inflammation|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0003333,liver fibrosis|MP:0003975,increased circulating VLDL triglyceride level|MP:0003982,increased cholesterol level|MP:0005280,abnormal fatty acids level|MP:0005331,insulin resistance|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level
MGI:1861964	Lrp8<tm1Her>	MP:0000313,abnormal cell death|MP:0000788,abnormal cerebral cortex morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000813,abnormal hippocampus layer morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000852,small cerebellum|MP:0000877,abnormal Purkinje cell morphology|MP:0000913,abnormal brain development|MP:0001156,abnormal spermatogenesis|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004279,abnormal rostral migratory stream morphology|MP:0004543,abnormal sperm physiology|MP:0006009,abnormal neuronal migration|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008892,abnormal sperm flagellum morphology|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009243,hairpin sperm flagellum|MP:0009719,reduced cerebellar foliation|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology
MGI:3603433	Lrp8<tm2.1Her>	MP:0000313,abnormal cell death|MP:0000939,decreased motor neuron number|MP:0002169,no abnormal phenotype detected|MP:0003224,neuron degeneration
MGI:3603434	Lrp8<tm3Her>	MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation
MGI:3619603	Lrp8<tm4Her>	MP:0000788,abnormal cerebral cortex morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000813,abnormal hippocampus layer morphology|MP:0001469,abnormal contextual conditioning behavior|MP:0001922,reduced male fertility|MP:0006009,abnormal neuronal migration|MP:0008414,abnormal spatial reference memory
MGI:3698275	Lrp8<tm5Her>	MP:0003224,neuron degeneration|MP:0006009,abnormal neuronal migration
MGI:1857214	Lrpap1<tm1Her>	MP:0000681,abnormal thyroid gland morphology|MP:0001463,abnormal spatial learning|MP:0002136,abnormal kidney physiology|MP:0002876,abnormal thyroid gland physiology|MP:0004101,abnormal brain interneuron morphology|MP:0005416,abnormal circulating protein level|MP:0005621,abnormal cell physiology
MGI:4366260	Lrpap1<tm1Vln>	MP:0001935,decreased litter size|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3857306	Lrpprc<Gt(AX0080)Wtsi>	MP:0003984,embryonic growth retardation|MP:0006207,embryonic lethality during organogenesis
MGI:5438912	Lrpprc<tm1.1Lrsn>	MP:0000274,enlarged heart|MP:0002083,premature death|MP:0006036,abnormal mitochondrial physiology|MP:0011630,increased mitochondrial size|MP:0030937,increased mitochondrial DNA content
MGI:5438913	Lrpprc<tm1.2Lrsn>	MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:4363281	Lrpprc<tm1a(KOMP)Wtsi>	MP:0005561,increased mean corpuscular hemoglobin
MGI:6149202	Lrr1<em1(IMPC)H>	MP:0000745,tremors|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5708253	Lrrc10<tm1.1(KOMP)Vlcg>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3809940	Lrrc10<tm1Sgt>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0005140,decreased cardiac muscle contractility|MP:0005385,cardiovascular system phenotype|MP:0010768,mortality/aging
MGI:5493277	Lrrc15<tm1b(KOMP)Wtsi>	MP:0002833,increased heart weight|MP:0005292,improved glucose tolerance|MP:0020870,decreased thigmotaxis
MGI:6341829	Lrrc17<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001402,decreased locomotor activity|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0005084,abnormal gallbladder morphology|MP:0009342,enlarged gallbladder|MP:0020421,increased freezing behavior
MGI:6281582	Lrrc19<tm1Ryag>	MP:0002412,increased susceptibility to bacterial infection|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008597,decreased circulating interleukin-6 level
MGI:6877114	Lrrc23<em1Mngx>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0005388,respiratory system phenotype|MP:0009838,abnormal sperm axoneme morphology|MP:0020451,decreased sperm progressive motility|MP:0031438,abnormal sperm radial spoke morphology
MGI:6877115	Lrrc23<em2Mngx>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0020451,decreased sperm progressive motility|MP:0031438,abnormal sperm radial spoke morphology
MGI:4944543	Lrrc23<tm1a(EUCOMM)Wtsi>	MP:0001925,male infertility|MP:0005553,increased circulating creatinine level
MGI:6514757	Lrrc25<em1Cya>	MP:0001625,cardiac hypertrophy|MP:0001853,heart inflammation|MP:0003141,cardiac fibrosis|MP:0004485,increased response of heart to induced stress|MP:0008752,abnormal tumor necrosis factor level|MP:0008837,increased transforming growth factor beta level|MP:0031633,decreased heart left ventricle muscle contractility
MGI:6107883	Lrrc26<tm1.1(KOMP)Vlcg>	MP:0005310,abnormal salivary gland physiology
MGI:7439819	Lrrc28<em1(IMPC)J>	MP:0000194,increased circulating calcium level
MGI:5513798	Lrrc2<tm1b(EUCOMM)Wtsi>	MP:0009142,decreased prepulse inhibition
MGI:6148320	Lrrc30<em1(IMPC)Rbrc>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology
MGI:5544317	Lrrc32<tm1.1Hfuj>	MP:0004946,abnormal regulatory T cell physiology|MP:0005387,immune system phenotype
MGI:7314986	Lrrc32<tm1Zhli>	MP:0000111,cleft palate|MP:0009546,absent gastric milk in neonates|MP:0009655,abnormal secondary palate development|MP:0009889,persistence of medial edge epithelium during palatal shelf fusion|MP:0011087,neonatal lethality, complete penetrance
MGI:6476971	Lrrc34<em1Doson>	MP:0005389,reproductive system phenotype
MGI:6195015	Lrrc36<tm1.1Osb>	MP:0002169,no abnormal phenotype detected
MGI:7435544	Lrrc38<em1(IMPC)Tcp>	MP:0001126,abnormal ovary morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003131,increased erythrocyte cell number|MP:0010097,abnormal retina blood vessel morphology
MGI:4439362	Lrrc3b<tm1.1Reed>	MP:0003631,nervous system phenotype
MGI:6120801	Lrrc3<tm1b(EUCOMM)Hmgu>	MP:0000194,increased circulating calcium level|MP:0001257,increased body length|MP:0001399,hyperactivity|MP:0001566,increased circulating phosphate level|MP:0005016,decreased lymphocyte cell number|MP:0010053,decreased grip strength
MGI:6161420	Lrrc41<em1(IMPC)J>	MP:0000194,increased circulating calcium level|MP:0000367,abnormal coat/ hair morphology|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0001529,abnormal vocalization|MP:0002757,decreased vertical activity|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0005559,increased circulating glucose level
MGI:7366928	Lrrc46<em1Cya>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009376,abnormal manchette morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0014467,increased sperm mitochondrial size|MP:0020869,immotile sperm|MP:0030591,absent sperm fibrous sheath|MP:0031352,absent sperm axonemal central pair|MP:0031356,abnormal outer dense fiber morphology|MP:0031386,elongated manchette
MGI:5646003	Lrrc49<tm1b(EUCOMM)Wtsi>	MP:0002757,decreased vertical activity|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011396,abnormal sleep behavior
MGI:6423090	Lrrc4b<em1(IMPC)J>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002574,increased vertical activity|MP:0002608,increased hematocrit|MP:0002797,increased thigmotaxis|MP:0003795,abnormal bone structure|MP:0004924,abnormal behavior|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6501150	Lrrc4b<tm1Lex>	MP:0000774,decreased brain size|MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001431,abnormal eating behavior|MP:0001473,reduced long-term potentiation|MP:0001732,postnatal growth retardation|MP:0002152,abnormal brain morphology|MP:0002574,increased vertical activity|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0004994,abnormal brain wave pattern|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0010768,mortality/aging|MP:0010831,lethality, incomplete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011269,increased excitatory postsynaptic current amplitude|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0012307,impaired spatial learning|MP:0014379,decreased excitatory postsynaptic current frequency|MP:0014621,abnormal brain alpha wave pattern|MP:0014623,abnormal brain theta wave pattern|MP:0020527,small thalamus|MP:0020870,decreased thigmotaxis|MP:0031391,increased locomotor activity
MGI:5007224	Lrrc4c<tm1Lex>	MP:0008596,increased circulating interleukin-6 level
MGI:3848335	Lrrc4<tm1Lex>	MP:0001399,hyperactivity|MP:0005377,hearing/vestibular/ear phenotype|MP:0006359,absent startle reflex|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:5616358	Lrrc51<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011239,abnormal skin coloration
MGI:5792928	Lrrc52<tm1.1(KOMP)Vlcg>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0004543,abnormal sperm physiology
MGI:7301779	Lrrc55<em3Gpt>	MP:0005326,abnormal podocyte morphology|MP:0011445,abnormal renal protein reabsorption|MP:0011863,abnormal podocyte physiology
MGI:6477292	Lrrc55os<em1Caox>	MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0008576,decreased circulating interferon-beta level|MP:0020913,increased susceptibility to Riboviria infection|MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality
MGI:8276963	Lrrc56<em1Cya>	MP:0000644,dextrocardia|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000825,dilated lateral ventricle|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0004133,heterotaxia|MP:0006254,thin cerebral cortex|MP:0008892,abnormal sperm flagellum morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0010752,impaired mucociliary clearance|MP:0010808,right-sided stomach|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011248,visceral organ asymmetry|MP:0011252,situs inversus totalis|MP:0020869,immotile sperm|MP:0030049,prominent forehead|MP:0030245,round head
MGI:6257482	Lrrc56<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001175,abnormal lung morphology|MP:0001925,male infertility|MP:0002060,abnormal skin morphology|MP:0002941,increased circulating alanine transaminase level|MP:0004085,abnormal heartbeat|MP:0006065,abnormal heart position or orientation
MGI:7411383	Lrrc63<em1(IMPC)J>	MP:0001488,increased startle reflex|MP:0002098,abnormal vibrissa morphology
MGI:4458520	Lrrc71<tm1a(KOMP)Wtsi>	MP:0001925,male infertility
MGI:6377429	Lrrc78<em1(IMPC)J>	MP:0000195,decreased circulating calcium level
MGI:6492209	Lrrc7<Tg(Myl2-TSPYL)1Sich>	MP:0001265,decreased body size|MP:0001353,increased aggression towards mice|MP:0001360,abnormal social investigation|MP:0001405,impaired coordination|MP:0001429,dehydration|MP:0002082,postnatal lethality|MP:0002797,increased thigmotaxis|MP:0008415,abnormal neurite morphology|MP:0008428,abnormal spatial working memory|MP:0020338,abnormal hippocampal pyramidal neuron dendrite morphology
MGI:5297824	Lrrc7<tm1.1Mabk>	MP:0001262,decreased body weight|MP:0001353,increased aggression towards mice|MP:0001447,abnormal nest building behavior|MP:0001475,reduced long-term depression|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002797,increased thigmotaxis|MP:0003313,abnormal locomotor activation|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0004924,abnormal behavior|MP:0008431,abnormal short-term spatial reference memory|MP:0009142,decreased prepulse inhibition|MP:0009936,abnormal dendritic spine morphology|MP:0011396,abnormal sleep behavior|MP:0031391,increased locomotor activity
MGI:6467352	Lrrc8a<em1Uia>	MP:0001399,hyperactivity|MP:0004889,increased energy expenditure|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005375,adipose tissue phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0009115,abnormal fat cell morphology|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0010025,decreased total body fat amount
MGI:5581436	Lrrc8a<tm1.1Geha>	MP:0000410,waved hair|MP:0000519,hydronephrosis|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0000759,abnormal skeletal muscle morphology|MP:0001134,absent corpus luteum|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0001924,infertility|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002375,abnormal thymus medulla morphology|MP:0002444,abnormal T cell physiology|MP:0002703,abnormal renal tubule morphology|MP:0003763,abnormal thymus physiology|MP:0004917,abnormal T cell selection|MP:0004973,increased regulatory T cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0005376,homeostasis/metabolism phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008182,decreased marginal zone B cell number|MP:0008186,increased pro-B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008209,decreased pre-B cell number|MP:0008215,decreased immature B cell number|MP:0008500,increased IgG2a level|MP:0009434,paraparesis|MP:0009541,increased thymocyte apoptosis|MP:0010132,decreased DN2 thymocyte number|MP:0010134,decreased DN3 thymocyte number|MP:0010136,decreased DN4 thymocyte number|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013592,small thymus cortex|MP:0013741,absent thymus corticomedullary boundary|MP:0014180,abnormal thymus apoptosis
MGI:5708254	Lrrc8a<tm1.1(KOMP)Vlcg>	MP:0000428,abnormal craniofacial morphology|MP:0001175,abnormal lung morphology|MP:0001293,anophthalmia|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0004882,enlarged lung|MP:0011100,preweaning lethality, complete penetrance
MGI:6456563	Lrrc8b<em1Bcgen>	MP:0005387,immune system phenotype
MGI:6152509	Lrrc8c<em1(IMPC)Mbp>	MP:0000195,decreased circulating calcium level|MP:0000689,abnormal spleen morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002092,abnormal eye morphology|MP:0005419,decreased circulating serum albumin level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6099025	Lrrc8c<tm1Maim>	MP:0001783,decreased white adipose tissue amount|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0005659,decreased susceptibility to diet-induced obesity
MGI:6456565	Lrrc8d<em1Bcgen>	MP:0005387,immune system phenotype
MGI:4849425	Lrrc8d<tm1a(EUCOMM)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level
MGI:6456566	Lrrc8e<em1Bcgen>	MP:0002418,increased susceptibility to viral infection|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008565,decreased interferon-beta secretion|MP:0008576,decreased circulating interferon-beta level|MP:0009791,increased susceptibility to viral infection induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0010210,abnormal circulating cytokine level
MGI:5605784	Lrrcc1<tm1b(EUCOMM)Wtsi>	MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002152,abnormal brain morphology|MP:0002875,decreased erythrocyte cell number
MGI:7641857	Lrrd1<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5696891	Lrrfip1<tm1.1(KOMP)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0002644,decreased circulating triglyceride level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005567,decreased circulating total protein level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration
MGI:7711345	Lrriq1<em1Ysato>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0014052,increased male germ cell apoptosis
MGI:6760630	Lrrk1<m1Btlr>	MP:0000062,increased bone mineral density|MP:0002764,short tibia|MP:0003109,short femur|MP:0004692,small pubis
MGI:6760631	Lrrk1<M2Btlr>	MP:0002764,short tibia|MP:0003109,short femur|MP:0005390,skeleton phenotype
MGI:4940302	Lrrk1<tm1.1Mjff>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5568128	Lrrk1<tm1.1Smo>	MP:0000062,increased bone mineral density|MP:0000065,abnormal bone marrow cavity morphology|MP:0000067,osteopetrosis|MP:0000130,abnormal trabecular bone morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0001255,decreased body height|MP:0001541,abnormal osteoclast physiology|MP:0002764,short tibia|MP:0002896,abnormal bone mineralization|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003109,short femur|MP:0003723,abnormal long bone morphology|MP:0003743,abnormal facial morphology|MP:0004148,increased compact bone thickness|MP:0004984,increased osteoclast cell number|MP:0004993,decreased bone resorption|MP:0005376,homeostasis/metabolism phenotype|MP:0005382,craniofacial phenotype|MP:0005390,skeleton phenotype|MP:0005422,osteosclerosis|MP:0009347,increased trabecular bone thickness|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0012072,decreased susceptibility to osteoporosis
MGI:5692778	Lrrk1<tm1b(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0000443,abnormal snout morphology|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0000552,abnormal radius morphology|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0001340,abnormal eyelid morphology|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0001556,increased circulating HDL cholesterol level|MP:0001566,increased circulating phosphate level|MP:0002100,abnormal tooth morphology|MP:0002187,abnormal fibula morphology|MP:0002764,short tibia|MP:0002932,abnormal joint morphology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0003961,decreased lean body mass|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004952,increased spleen weight|MP:0005012,decreased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005108,abnormal ulna morphology|MP:0005178,increased circulating cholesterol level|MP:0005270,abnormal zygomatic bone morphology|MP:0005296,abnormal humerus morphology|MP:0005298,abnormal clavicle morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0008810,increased circulating iron level|MP:0010024,increased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010090,increased circulating creatine kinase level|MP:0010123,increased bone mineral content|MP:0030610,absent teeth
MGI:4414662	Lrrk2<tm1.1Cai>	MP:0003631,nervous system phenotype|MP:0005060,accumulation of giant lysosomes in kidney/renal tubule cells|MP:0005404,abnormal axon morphology|MP:0008415,abnormal neurite morphology|MP:0008546,abnormal vesicle-mediated transport|MP:0008918,microgliosis|MP:0030949,abnormal Golgi vesicle transport
MGI:6273307	Lrrk2<tm1.1Dlbe>	MP:0002910,abnormal excitatory postsynaptic currents|MP:0009936,abnormal dendritic spine morphology|MP:0011267,abnormal excitatory postsynaptic current amplitude|MP:0014378,increased excitatory postsynaptic current frequency
MGI:5750894	Lrrk2<tm1.1Hlme>	MP:0001392,abnormal locomotor behavior|MP:0001516,abnormal motor coordination/balance|MP:0001547,abnormal lipid level|MP:0001905,abnormal dopamine level|MP:0003858,enhanced coordination|MP:0004250,tau protein deposits|MP:0005367,renal/urinary system phenotype|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0006037,abnormal mitochondrial fission|MP:0010149,abnormal synaptic dopamine release|MP:0011629,decreased mitochondrial number|MP:0011632,dilated mitochondrion|MP:0011633,abnormal mitochondrial shape|MP:0011635,abnormal mitochondrial crista morphology|MP:0031391,increased locomotor activity
MGI:4943782	Lrrk2<tm1.1Mjff>	MP:0005390,skeleton phenotype
MGI:5295368	Lrrk2<tm1.1Npa>	MP:0003631,nervous system phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0006143,increased systemic arterial diastolic blood pressure
MGI:4356349	Lrrk2<tm1.1Shn>	MP:0001739,abnormal adrenal gland secretion|MP:0003631,nervous system phenotype|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005402,abnormal action potential|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009747,impaired behavioral response to xenobiotic|MP:0009750,impaired behavioral response to addictive substance|MP:0030949,abnormal Golgi vesicle transport
MGI:5295370	Lrrk2<tm1.2Npa>	MP:0002135,abnormal kidney morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002705,dilated renal tubule|MP:0002962,increased urine protein level|MP:0003631,nervous system phenotype|MP:0003917,increased kidney weight|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0008842,lipofuscinosis
MGI:4357791	Lrrk2<tm1Arte>	MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0004980,increased neuronal precursor cell number|MP:0008143,abnormal dendrite morphology
MGI:5008465	Lrrk2<tm1Mjfa>	MP:0003651,abnormal axon extension|MP:0008415,abnormal neurite morphology
MGI:3514169	Lrrk2<tm1Tmd>	MP:0000414,alopecia|MP:0001441,increased grooming behavior|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6273308	Lrrk2<tm2.1Dlbe>	MP:0003631,nervous system phenotype
MGI:5295371	Lrrk2<tm2.1Npa>	MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0003917,increased kidney weight|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0008842,lipofuscinosis
MGI:4460960	Lrrk2<tm2.1Shn>	MP:0001859,kidney inflammation|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003631,nervous system phenotype|MP:0003918,decreased kidney weight|MP:0004153,increased renal tubule apoptosis|MP:0004970,kidney atrophy|MP:0008260,abnormal autophagy|MP:0008842,lipofuscinosis|MP:0011368,increased kidney apoptosis|MP:0011369,increased renal glomerulus apoptosis|MP:0011534,granular kidney
MGI:5644525	Lrrk2<tm2Arte>	MP:0002169,no abnormal phenotype detected
MGI:5008466	Lrrk2<tm2Mjfa>	MP:0003631,nervous system phenotype
MGI:5553130	Lrrk2<tm3.1Mjfa>	MP:0002169,no abnormal phenotype detected
MGI:4460961	Lrrk2<tm3.1Shn>	MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003631,nervous system phenotype|MP:0003918,decreased kidney weight|MP:0004970,kidney atrophy|MP:0011534,granular kidney
MGI:6273209	Lrrk2<tm4.1Arte>	MP:0004101,abnormal brain interneuron morphology|MP:0004102,abnormal dorsal striatum morphology
MGI:7593845	Lrrn1<em1Dri>	MP:0003169,abnormal scala media morphology|MP:0004395,increased cochlear inner hair cell number
MGI:7593846	Lrrn1<em2Dri>	MP:0003169,abnormal scala media morphology|MP:0004395,increased cochlear inner hair cell number
MGI:7593847	Lrrn1<em3Dri>	MP:0003169,abnormal scala media morphology|MP:0004395,increased cochlear inner hair cell number
MGI:5007226	Lrrn1<tm1Lex>	MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment
MGI:5007227	Lrrn2<tm1Lex>	MP:0004924,abnormal behavior
MGI:6336123	Lrrn3<em1(IMPC)Kmpc>	MP:0000063,decreased bone mineral density|MP:0002075,abnormal coat/hair pigmentation|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5007228	Lrrn3<tm1Lex>	MP:0005292,improved glucose tolerance|MP:0005458,increased percent body fat/body weight
MGI:7425802	Lrrn4cl<em1(IMPC)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5428888	Lrrn4<tm1Ami>	MP:0001463,abnormal spatial learning|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior
MGI:6276991	Lrrtm1<em1(IMPC)Mbp>	MP:0000220,increased monocyte cell number|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001415,increased exploration in new environment|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:5085889	Lrrtm1<tm1.1Jaru>	MP:0001360,abnormal social investigation|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002572,abnormal emotion/affect behavior|MP:0002574,increased vertical activity|MP:0002797,increased thigmotaxis|MP:0004769,abnormal synaptic vesicle morphology|MP:0006254,thin cerebral cortex|MP:0008283,small hippocampus|MP:0008428,abnormal spatial working memory|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0009453,enhanced contextual conditioning behavior|MP:0009455,enhanced cued conditioning behavior|MP:0009538,abnormal synapse morphology|MP:0020510,increased dendritic spine length
MGI:3836788	Lrrtm1<tm1Amcr>	MP:0002169,no abnormal phenotype detected
MGI:6277048	Lrrtm2<em1(IMPC)Mbp>	MP:0000274,enlarged heart|MP:0000538,abnormal urinary bladder morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001175,abnormal lung morphology|MP:0001399,hyperactivity|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0003068,enlarged kidney|MP:0005084,abnormal gallbladder morphology|MP:0009552,urinary bladder obstruction
MGI:6191636	Lrrtm3<tm1Msa>	MP:0002169,no abnormal phenotype detected|MP:0002206,abnormal CNS synaptic transmission|MP:0002915,abnormal synaptic depression|MP:0002920,decreased paired-pulse facilitation|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005402,abnormal action potential|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0020508,decreased dendritic spine density
MGI:5521326	Lrrtm4<tm1Amcr>	MP:0000812,abnormal dentate gyrus morphology|MP:0002912,abnormal excitatory postsynaptic potential|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004998,decreased CNS synapse formation
MGI:6860358	Lrsam1<em1(IMPC)Bay>	MP:0006203,eye hemorrhage|MP:0009142,decreased prepulse inhibition
MGI:4130281	Lrsam1<Gt(RRK239)Byg>	MP:0002169,no abnormal phenotype detected
MGI:4329496	Lrsam1<Gt(RRK461)Byg>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0004263,abnormal limb posture|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0008814,decreased nerve conduction velocity
MGI:7378323	Lrtm2<tm1.1Jaru>	MP:0001262,decreased body weight|MP:0003063,increased coping response|MP:0003107,abnormal response to novelty|MP:0003461,abnormal response to novel object|MP:0003858,enhanced coordination|MP:0005386,behavior/neurological phenotype|MP:0010070,decreased serotonin level|MP:0012575,increased noradrenaline level|MP:0020875,decreased nervous system dopamine level|MP:0021111,decreased social investigation
MGI:3773703	Lsamp<tm1Afpi>	MP:0001415,increased exploration in new environment
MGI:4867852	Lsamp<tm1Jinn>	MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001440,abnormal grooming behavior|MP:0001522,impaired swimming|MP:0002557,abnormal social/conspecific interaction behavior|MP:0003862,decreased aggression towards male mice|MP:0031391,increased locomotor activity
MGI:1861623	Lse	MP:0000022,abnormal ear shape|MP:0000024,lowered ear position|MP:0000030,abnormal tympanic ring morphology|MP:0001265,decreased body size|MP:0001286,abnormal eye development|MP:0001314,cornea opacity|MP:0002081,perinatal lethality|MP:0002085,abnormal embryonic tissue morphology|MP:0002750,exophthalmos|MP:0002884,abnormal pharyngeal arch morphology|MP:0005269,abnormal occipital bone morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005382,craniofacial phenotype|MP:0006020,decreased tympanic ring size|MP:0006033,abnormal external auditory canal morphology|MP:0009703,decreased birth body size|MP:0009744,postaxial polydactyly|MP:0009890,cleft secondary palate|MP:0009896,palatine bone horizontal plate hypoplasia|MP:0009917,abnormal hyoid bone body morphology|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013466,keratoconjunctivitis sicca|MP:0014517,abnormal outer ear development|MP:0020854,increased cornea epithelium thickness|MP:0020859,disorganized cornea epithelium|MP:0030119,abnormal retrotympanic process morphology|MP:0030160,abnormal auditory bulla morphology
MGI:7425803	Lsg1<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:3050653	lsgd9a	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility
MGI:3487142	Lskcn2<DBA/2J>	MP:0002123,abnormal definitive hematopoiesis
MGI:3779060	Lskpf1<CBA/H>	MP:0002398,abnormal bone marrow cell morphology/development
MGI:3779064	Lskpf2<CBA/H>	MP:0002398,abnormal bone marrow cell morphology/development
MGI:3779067	Lskpf3<C57BL/6Ola>	MP:0002398,abnormal bone marrow cell morphology/development
MGI:4362146	Lsm11<tm1a(KOMP)Wtsi>	MP:0005561,increased mean corpuscular hemoglobin
MGI:7537132	Lsm12<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:5548532	Lsm14a<tm1b(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0002606,increased basophil cell number|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004738,abnormal auditory brainstem response
MGI:4950120	Lsm14b<tm1a(KOMP)Mbp>	MP:0001125,abnormal oocyte morphology|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0005168,abnormal female meiosis|MP:0005389,reproductive system phenotype|MP:0009093,oocyte degeneration|MP:0009647,decreased fertilization frequency|MP:0009769,abnormal meiotic spindle assembly checkpoint|MP:0013272,abnormal translation|MP:0014443,impaired polar body extrusion|MP:0031420,decreased superovulation rate
MGI:5694186	Lsm14b<tm1b(KOMP)Mbp>	MP:0001926,female infertility|MP:0005562,decreased mean corpuscular hemoglobin
MGI:5548536	Lsm1<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0002590,increased mean corpuscular volume|MP:0002953,thick ventricular wall|MP:0002968,increased circulating alkaline phosphatase level|MP:0004738,abnormal auditory brainstem response|MP:0005633,increased circulating sodium level|MP:0010052,increased grip strength|MP:0010053,decreased grip strength|MP:0010574,dilated aorta|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6414498	Lsm2<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity|MP:0001727,abnormal embryo implantation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:6194617	Lsm3<em1Caox>	MP:0008573,increased circulating interferon-alpha level|MP:0008575,increased circulating interferon-beta level|MP:0008596,increased circulating interleukin-6 level|MP:0020914,decreased susceptibility to Riboviria infection|MP:0020947,decreased susceptibility to Orthomyxoviridae infection|MP:0031023,decreased susceptibility to Riboviria infection induced morbidity/mortality
MGI:3029428	Lsm4<Gt(geo)G101Ref>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6276931	Lsm8<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001157,small seminal vesicle|MP:0002059,abnormal seminal vesicle morphology|MP:0002339,abnormal lymph node morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002965,increased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005568,increased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:1888973	Lsp1<tm1Jejb>	MP:0000685,abnormal immune system morphology|MP:0002401,abnormal lymphopoiesis|MP:0002442,abnormal leukocyte physiology|MP:0005425,increased macrophage cell number|MP:0008720,impaired neutrophil chemotaxis|MP:0009858,abnormal cellular extravasation
MGI:3829727	Lspcq1<PWK/PhJ>	MP:0002687,oligozoospermia
MGI:3795768	Lsq1<C57BL/6J>	MP:0002128,abnormal blood circulation|MP:0003852,skeletal muscle necrosis
MGI:3612035	Lsr1<A/J>	MP:0002412,increased susceptibility to bacterial infection
MGI:3612037	Lsr1<C57BL/6J>	MP:0002411,decreased susceptibility to bacterial infection
MGI:3623628	Lsr<tm1Mdar>	MP:0000600,liver hypoplasia|MP:0001191,abnormal skin condition|MP:0001914,hemorrhage|MP:0001925,male infertility|MP:0003717,pallor|MP:0004200,decreased fetal size|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:6849722	Lss<em1Zhaol>	MP:0001306,small lens|MP:0002579,disorganized secondary lens fibers|MP:0002840,abnormal lens fiber morphology|MP:0005545,abnormal lens development|MP:0011087,neonatal lethality, complete penetrance|MP:0031345,developmental cataract
MGI:5561557	Lss<tm1b(KOMP)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0001303,abnormal lens morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5569039	Lst1<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001552,increased circulating triglyceride level|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount
MGI:4415420	Lst1<tm1(KOMP)Vlcg>	MP:0005387,immune system phenotype|MP:0020946,increased susceptibility to Orthomyxoviridae infection|MP:0031046,increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:1856618	lt	MP:0000402,abnormal zigzag hair morphology|MP:0000411,shiny fur|MP:0001274,curly vibrissae|MP:0001510,abnormal coat appearance|MP:0002074,abnormal hair texture|MP:0003809,abnormal hair shaft morphology
MGI:6153769	Lta4h<em2(IMPC)Wtsi>	MP:0001257,increased body length
MGI:2182082	Lta4h<tm1Bhk>	MP:0005087,decreased acute inflammation|MP:0005597,decreased susceptibility to type I hypersensitivity reaction
MGI:3575123	Lta<hlb382>	MP:0000218,increased leukocyte cell number|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002722,abnormal immune system organ morphology|MP:0002831,absent Peyer's patches|MP:0008024,absent lymph nodes|MP:0008045,decreased NK cell number|MP:0008169,increased B-1b cell number|MP:0008183,absent marginal zone B cells|MP:0008190,decreased transitional stage B cell number|MP:0008234,absent spleen marginal zone|MP:0008465,absent mesenteric lymph nodes|MP:0008474,absent spleen germinal center
MGI:5695877	Lta<tm1.1(KOMP)Vlcg>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0001258,decreased body length|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005575,increased pulmonary ventilation|MP:0012124,increased bronchoconstrictive response
MGI:3652393	Lta<tm1.1Sned>	MP:0000685,abnormal immune system morphology|MP:0000691,enlarged spleen|MP:0001800,abnormal humoral immune response|MP:0002401,abnormal lymphopoiesis|MP:0002831,absent Peyer's patches|MP:0004816,abnormal class switch recombination|MP:0008479,decreased spleen white pulp amount|MP:0008552,abnormal circulating tumor necrosis factor level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:1857215	Lta<tm1Dch>	MP:0000217,abnormal leukocyte cell number|MP:0000218,increased leukocyte cell number|MP:0000689,abnormal spleen morphology|MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0002339,abnormal lymph node morphology|MP:0002345,abnormal lymph node primary follicle morphology|MP:0002358,abnormal spleen periarteriolar lymphoid sheath morphology|MP:0002375,abnormal thymus medulla morphology|MP:0002377,abnormal mucosa-associated lymphoid tissue morphology|MP:0002450,abnormal lymph organ development|MP:0002494,increased IgM level|MP:0002619,abnormal lymphocyte morphology|MP:0002723,abnormal immune serum protein physiology|MP:0002831,absent Peyer's patches|MP:0003009,abnormal cytokine secretion|MP:0004816,abnormal class switch recombination|MP:0005014,increased B cell number|MP:0005018,decreased T cell number|MP:0005370,liver/biliary system phenotype|MP:0008234,absent spleen marginal zone|MP:0008465,absent mesenteric lymph nodes|MP:0008474,absent spleen germinal center|MP:0008479,decreased spleen white pulp amount|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0009544,abnormal thymus epithelium morphology|MP:0009622,absent inguinal lymph nodes|MP:0009630,absent axillary lymph nodes|MP:0009633,absent cervical lymph nodes|MP:0009634,absent popliteal lymph nodes|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0013588,small thymus medulla|MP:0014263,decreased spleen B cell follicle number
MGI:1860954	Lta<tm1Jods>	MP:0000689,abnormal spleen morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002722,abnormal immune system organ morphology|MP:0002831,absent Peyer's patches|MP:0005013,increased lymphocyte cell number|MP:0008464,absent peripheral lymph nodes|MP:0009544,abnormal thymus epithelium morphology
MGI:1860957	Lta<tm1Tab>	MP:0000218,increased leukocyte cell number|MP:0001800,abnormal humoral immune response|MP:0001807,decreased IgA level|MP:0002494,increased IgM level|MP:0002831,absent Peyer's patches|MP:0004952,increased spleen weight|MP:0005026,decreased susceptibility to parasitic infection|MP:0008024,absent lymph nodes|MP:0008234,absent spleen marginal zone|MP:0008479,decreased spleen white pulp amount|MP:0008561,decreased tumor necrosis factor secretion
MGI:2182272	Lta/Tnf<tm1Eug>	MP:0000218,increased leukocyte cell number|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001501,abnormal sleep pattern|MP:0001798,impaired macrophage phagocytosis|MP:0001800,abnormal humoral immune response|MP:0001807,decreased IgA level|MP:0002362,abnormal spleen marginal zone morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002494,increased IgM level|MP:0002628,hepatic steatosis|MP:0002831,absent Peyer's patches|MP:0002833,increased heart weight|MP:0002981,increased liver weight|MP:0003436,decreased susceptibility to induced arthritis|MP:0004357,long tibia|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004952,increased spleen weight|MP:0005014,increased B cell number|MP:0005018,decreased T cell number|MP:0005026,decreased susceptibility to parasitic infection|MP:0005027,increased susceptibility to parasitic infection|MP:0005165,increased susceptibility to injury|MP:0005658,increased susceptibility to diet-induced obesity|MP:0006087,increased body mass index|MP:0008024,absent lymph nodes|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008498,decreased IgG3 level|MP:0008567,decreased interferon-gamma secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0020913,increased susceptibility to Riboviria infection|MP:0020928,increased susceptibility to Poxviridae infection
MGI:2182273	Lta/Tnf<tm1Eug>	MP:0000218,increased leukocyte cell number|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001501,abnormal sleep pattern|MP:0001798,impaired macrophage phagocytosis|MP:0001800,abnormal humoral immune response|MP:0001807,decreased IgA level|MP:0002362,abnormal spleen marginal zone morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002494,increased IgM level|MP:0002628,hepatic steatosis|MP:0002831,absent Peyer's patches|MP:0002833,increased heart weight|MP:0002981,increased liver weight|MP:0003436,decreased susceptibility to induced arthritis|MP:0004357,long tibia|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004952,increased spleen weight|MP:0005014,increased B cell number|MP:0005018,decreased T cell number|MP:0005026,decreased susceptibility to parasitic infection|MP:0005165,increased susceptibility to injury|MP:0005658,increased susceptibility to diet-induced obesity|MP:0006087,increased body mass index|MP:0008024,absent lymph nodes|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008498,decreased IgG3 level|MP:0008567,decreased interferon-gamma secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0020913,increased susceptibility to Riboviria infection|MP:0020928,increased susceptibility to Poxviridae infection
MGI:2447728	Lta/Tnf<tm1Fda>	MP:0002412,increased susceptibility to bacterial infection|MP:0008561,decreased tumor necrosis factor secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:2447729	Lta/Tnf<tm1Fda>	MP:0002412,increased susceptibility to bacterial infection|MP:0008561,decreased tumor necrosis factor secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:2384505	Lta/Tnf<tm1Jods>	MP:0000218,increased leukocyte cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002357,abnormal spleen white pulp morphology|MP:0002460,decreased immunoglobulin level|MP:0002831,absent Peyer's patches|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0008024,absent lymph nodes|MP:0008343,abnormal gamma-delta T cell morphology
MGI:2384506	Lta/Tnf<tm1Jods>	MP:0000218,increased leukocyte cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002357,abnormal spleen white pulp morphology|MP:0002460,decreased immunoglobulin level|MP:0002831,absent Peyer's patches|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0008024,absent lymph nodes|MP:0008343,abnormal gamma-delta T cell morphology
MGI:2385786	Ltb4r1<tm1Adl>	MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology|MP:0003156,abnormal leukocyte migration|MP:0003628,abnormal leukocyte adhesion|MP:0008720,impaired neutrophil chemotaxis|MP:0008723,impaired eosinophil recruitment
MGI:2385781	Ltb4r1<tm1Bodd>	MP:0003436,decreased susceptibility to induced arthritis|MP:0005351,decreased susceptibility to autoimmune disorder|MP:0008720,impaired neutrophil chemotaxis|MP:0014706,decreased synovial pannus formation
MGI:3701260	Ltb4r1<tm1Tksh>	MP:0000352,decreased cell proliferation|MP:0001785,edema|MP:0001861,lung inflammation|MP:0002133,abnormal respiratory system physiology|MP:0002335,decreased airway responsiveness|MP:0002423,abnormal mast cell physiology|MP:0002462,abnormal granulocyte physiology|MP:0002492,decreased IgE level|MP:0003009,abnormal cytokine secretion|MP:0003953,abnormal hormone level|MP:0005012,decreased eosinophil cell number|MP:0005597,decreased susceptibility to type I hypersensitivity reaction
MGI:4822400	Ltb4r2<tm1Bodd>	MP:0003436,decreased susceptibility to induced arthritis|MP:0005387,immune system phenotype
MGI:3785609	Ltb4r2<tm1Tksh>	MP:0001785,edema|MP:0002423,abnormal mast cell physiology|MP:0005597,decreased susceptibility to type I hypersensitivity reaction
MGI:5316784	Ltbp1<b2b1000Clo>	MP:0000284,double outlet right ventricle|MP:0002633,persistent truncus arteriosus|MP:0002705,dilated renal tubule|MP:0004157,interrupted aortic arch|MP:0004158,right aortic arch|MP:0008528,polycystic kidney|MP:0010466,vascular ring|MP:0011682,renal glomerulus cyst
MGI:4433604	Ltbp1<tm1a(EUCOMM)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000218,increased leukocyte cell number|MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0000552,abnormal radius morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002100,abnormal tooth morphology|MP:0002942,decreased circulating alanine transaminase level|MP:0004151,decreased circulating iron level|MP:0005108,abnormal ulna morphology|MP:0005179,decreased circulating cholesterol level|MP:0005358,abnormal incisor morphology|MP:0005419,decreased circulating serum albumin level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0005565,increased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0005632,decreased circulating aspartate transaminase level|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content
MGI:3778910	Ltbp1<tm1Rawe>	MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000438,abnormal cranium morphology|MP:0000445,short snout|MP:0000454,abnormal jaw morphology|MP:0003333,liver fibrosis|MP:0004447,small basioccipital bone|MP:0004462,small basisphenoid bone|MP:0030136,abnormal lower incisor morphology
MGI:3765966	Ltbp1<tm1Veto>	MP:0001575,cyanosis|MP:0002633,persistent truncus arteriosus|MP:0004111,abnormal coronary artery morphology|MP:0004157,interrupted aortic arch|MP:0004158,right aortic arch|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0010406,common atrium|MP:0010418,perimembraneous ventricular septal defect|MP:0010454,abnormal truncus arteriosus septation|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012747,abnormal cardiac neural crest cell morphology
MGI:5774718	Ltbp1<tm1Vlcg>	MP:0010771,integument phenotype
MGI:3765968	Ltbp1<tm2Veto>	MP:0001575,cyanosis|MP:0002633,persistent truncus arteriosus|MP:0004157,interrupted aortic arch|MP:0004158,right aortic arch|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0010406,common atrium|MP:0010418,perimembraneous ventricular septal defect|MP:0010454,abnormal truncus arteriosus septation|MP:0010472,abnormal ascending aorta and coronary artery attachment|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012747,abnormal cardiac neural crest cell morphology
MGI:5698977	Ltbp2<tm1.2Tynk>	MP:0001322,abnormal iris morphology|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0010768,mortality/aging|MP:0014176,abnormal cilary zonule morphology|MP:0031428,lens dislocation
MGI:2387012	Ltbp2<tm1Ship>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5635878	Ltbp2<tm2b(KOMP)Wtsi>	MP:0013279,increased fasting circulating glucose level
MGI:5816840	Ltbp3<blfc>	MP:0001265,decreased body size|MP:0001300,ocular hypertelorism|MP:0002092,abnormal eye morphology|MP:0002233,abnormal nose morphology|MP:0010714,iris coloboma|MP:0011110,preweaning lethality, incomplete penetrance|MP:0030066,short face|MP:0030104,round orbits
MGI:7577023	Ltbp3<em1(IMPC)Ccpcz>	MP:0000160,kyphosis|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0000689,abnormal spleen morphology|MP:0002060,abnormal skin morphology|MP:0002100,abnormal tooth morphology|MP:0002135,abnormal kidney morphology|MP:0002764,short tibia|MP:0004174,abnormal spine curvature|MP:0005270,abnormal zygomatic bone morphology|MP:0008528,polycystic kidney|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0010053,decreased grip strength|MP:0010379,decreased respiratory quotient|MP:0013129,abnormal tooth color
MGI:3723580	Ltbp3<m1Btlr>	MP:0000160,kyphosis|MP:0000428,abnormal craniofacial morphology|MP:0000755,hindlimb paralysis|MP:0001349,excessive tearing|MP:0001732,postnatal growth retardation|MP:0004053,abnormal synchondrosis
MGI:2180017	Ltbp3<tm1Bdvc>	MP:0000074,abnormal neurocranium morphology|MP:0000079,abnormal basioccipital bone morphology|MP:0000097,short maxilla|MP:0000106,abnormal basisphenoid bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000120,malocclusion|MP:0000130,abnormal trabecular bone morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000160,kyphosis|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002116,abnormal craniofacial bone morphology|MP:0002576,abnormal enamel morphology|MP:0002577,reduced enamel thickness|MP:0002932,abnormal joint morphology|MP:0002998,abnormal bone remodeling|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003416,premature bone ossification|MP:0003560,osteoarthritis|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004686,decreased length of long bones|MP:0005422,osteosclerosis|MP:0010029,abnormal basicranium morphology|MP:0010099,abnormal thoracic cage shape|MP:0010208,prognathia|MP:0010747,abnormal enamel organ morphology|MP:0010872,increased trabecular bone mass|MP:0010941,abnormal foramen magnum morphology|MP:0014166,ectopic cranial bone|MP:0030245,round head|MP:0030264,occipital bossing|MP:0030420,short basicranium|MP:0030541,misaligned incisors
MGI:7425804	Ltbp4<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000220,increased monocyte cell number|MP:0000691,enlarged spleen|MP:0002607,decreased basophil cell number|MP:0002792,abnormal retina vasculature morphology|MP:0010053,decreased grip strength|MP:0010097,abnormal retina blood vessel morphology
MGI:4352296	Ltbp4<Gt(E301B04)Wrst>	MP:0000272,abnormal aorta morphology|MP:0000274,enlarged heart|MP:0000276,heart right ventricle hypertrophy|MP:0000281,abnormal interventricular septum morphology|MP:0000493,rectal prolapse|MP:0001175,abnormal lung morphology|MP:0001177,atelectasis|MP:0001244,thin dermal layer|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001544,abnormal cardiovascular system physiology|MP:0001954,respiratory distress|MP:0001958,emphysema|MP:0002060,abnormal skin morphology|MP:0002133,abnormal respiratory system physiology|MP:0002796,impaired skin barrier function|MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0003211,abnormal aorta elastic fiber morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0010899,abnormal pulmonary alveolar system morphology|MP:0010996,increased aorta wall thickness|MP:0011086,postnatal lethality, incomplete penetrance|MP:0021159,increased heart right ventricle wall thickness
MGI:2388061	Ltbp4<Gt(U3Cre)1Vmel>	MP:0000272,abnormal aorta morphology|MP:0000274,enlarged heart|MP:0000281,abnormal interventricular septum morphology|MP:0000493,rectal prolapse|MP:0000495,abnormal colon morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000512,intestinal ulcer|MP:0000691,enlarged spleen|MP:0001175,abnormal lung morphology|MP:0001177,atelectasis|MP:0001183,overexpanded pulmonary alveolus|MP:0001954,respiratory distress|MP:0001958,emphysema|MP:0002060,abnormal skin morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002816,colitis|MP:0002833,increased heart weight|MP:0002952,ventricular cardiomyopathy|MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0003211,abnormal aorta elastic fiber morphology|MP:0003305,proctitis|MP:0003449,abnormal intestine goblet cell morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004564,increased myocardial fiber size|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0004882,enlarged lung|MP:0005330,cardiomyopathy|MP:0005621,abnormal cell physiology|MP:0008022,dilated heart ventricle|MP:0009310,increased large intestine adenocarcinoma incidence|MP:0010279,increased gastrointestinal tumor incidence|MP:0010768,mortality/aging|MP:0010895,increased lung compliance|MP:0010899,abnormal pulmonary alveolar system morphology|MP:0010900,abnormal pulmonary interalveolar septum morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5578031	Ltbr<m1Btlr>	MP:0001800,abnormal humoral immune response|MP:0002459,abnormal B cell physiology
MGI:6113397	Ltbr<m2Btlr>	MP:0001800,abnormal humoral immune response|MP:0020174,abnormal IgG level
MGI:6197810	Ltbr<m3Btlr>	MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0008039,increased NK T cell number
MGI:6199067	Ltbr<m4Btlr>	MP:0004977,increased B-1 B cell number|MP:0005014,increased B cell number|MP:0008045,decreased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0012765,decreased alpha-beta T cell number
MGI:5318395	Ltbr<tm1.1Thhe>	MP:0002169,no abnormal phenotype detected|MP:0002451,abnormal macrophage physiology
MGI:4453317	Ltbr<tm1Avt>	MP:0000222,decreased neutrophil cell number|MP:0000495,abnormal colon morphology|MP:0001263,weight loss|MP:0002412,increased susceptibility to bacterial infection|MP:0005387,immune system phenotype|MP:0008721,abnormal chemokine level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:2384140	Ltbr<tm1Kpf>	MP:0000222,decreased neutrophil cell number|MP:0000685,abnormal immune system morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001790,abnormal immune system physiology|MP:0002358,abnormal spleen periarteriolar lymphoid sheath morphology|MP:0002492,decreased IgE level|MP:0002722,abnormal immune system organ morphology|MP:0002831,absent Peyer's patches|MP:0005013,increased lymphocyte cell number|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005387,immune system phenotype|MP:0008183,absent marginal zone B cells|MP:0008343,abnormal gamma-delta T cell morphology|MP:0008464,absent peripheral lymph nodes|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008479,decreased spleen white pulp amount|MP:0008682,decreased interleukin-17 secretion
MGI:5013450	Ltbr<tm1Mmat>	MP:0000689,abnormal spleen morphology|MP:0002375,abnormal thymus medulla morphology|MP:0002619,abnormal lymphocyte morphology|MP:0008201,absent follicular dendritic cells|MP:0008465,absent mesenteric lymph nodes|MP:0008474,absent spleen germinal center|MP:0009544,abnormal thymus epithelium morphology|MP:0013588,small thymus medulla
MGI:2388016	Ltb<tm1Avt>	MP:0002420,abnormal adaptive immunity|MP:0008135,small Peyer's patches|MP:0008182,decreased marginal zone B cell number|MP:0008201,absent follicular dendritic cells|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008473,abnormal spleen follicular dendritic cell network|MP:0008482,decreased spleen germinal center number|MP:0008484,decreased spleen germinal center size
MGI:1860955	Ltb<tm1Flv>	MP:0000689,abnormal spleen morphology|MP:0001800,abnormal humoral immune response|MP:0001807,decreased IgA level|MP:0002356,abnormal spleen red pulp morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002831,absent Peyer's patches|MP:0005232,abnormal mesenteric lymph node morphology|MP:0008464,absent peripheral lymph nodes|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:1860970	Ltb<tm1Kpf>	MP:0000218,increased leukocyte cell number|MP:0000495,abnormal colon morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0001175,abnormal lung morphology|MP:0001263,weight loss|MP:0001805,decreased IgG level|MP:0002356,abnormal spleen red pulp morphology|MP:0002359,abnormal spleen germinal center morphology|MP:0002362,abnormal spleen marginal zone morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002494,increased IgM level|MP:0002816,colitis|MP:0002831,absent Peyer's patches|MP:0004816,abnormal class switch recombination|MP:0005013,increased lymphocyte cell number|MP:0005232,abnormal mesenteric lymph node morphology|MP:0008201,absent follicular dendritic cells|MP:0008234,absent spleen marginal zone|MP:0008473,abnormal spleen follicular dendritic cell network|MP:0008479,decreased spleen white pulp amount|MP:0009622,absent inguinal lymph nodes|MP:0009628,absent brachial lymph nodes|MP:0009630,absent axillary lymph nodes|MP:0009633,absent cervical lymph nodes|MP:0009634,absent popliteal lymph nodes|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0014263,decreased spleen B cell follicle number
MGI:2384499	Ltb<tm1Krn>	MP:0000689,abnormal spleen morphology|MP:0000693,spleen hyperplasia|MP:0001800,abnormal humoral immune response|MP:0002494,increased IgM level|MP:0002831,absent Peyer's patches|MP:0005027,increased susceptibility to parasitic infection|MP:0005232,abnormal mesenteric lymph node morphology|MP:0008464,absent peripheral lymph nodes|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0009633,absent cervical lymph nodes|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:2446566	Ltb/Tnf/Lta<tm1Dvk>	MP:0000218,increased leukocyte cell number|MP:0000689,abnormal spleen morphology|MP:0001805,decreased IgG level|MP:0002412,increased susceptibility to bacterial infection|MP:0002831,absent Peyer's patches|MP:0004816,abnormal class switch recombination|MP:0008024,absent lymph nodes|MP:0008234,absent spleen marginal zone|MP:0008465,absent mesenteric lymph nodes|MP:0008474,absent spleen germinal center|MP:0008479,decreased spleen white pulp amount|MP:0009622,absent inguinal lymph nodes|MP:0009628,absent brachial lymph nodes|MP:0009630,absent axillary lymph nodes|MP:0009634,absent popliteal lymph nodes|MP:0014263,decreased spleen B cell follicle number
MGI:2446567	Ltb/Tnf/Lta<tm1Dvk>	MP:0000218,increased leukocyte cell number|MP:0000689,abnormal spleen morphology|MP:0001805,decreased IgG level|MP:0002412,increased susceptibility to bacterial infection|MP:0002831,absent Peyer's patches|MP:0004816,abnormal class switch recombination|MP:0008024,absent lymph nodes|MP:0008234,absent spleen marginal zone|MP:0008465,absent mesenteric lymph nodes|MP:0008474,absent spleen germinal center|MP:0008479,decreased spleen white pulp amount|MP:0009622,absent inguinal lymph nodes|MP:0009628,absent brachial lymph nodes|MP:0009630,absent axillary lymph nodes|MP:0009634,absent popliteal lymph nodes|MP:0014263,decreased spleen B cell follicle number
MGI:2446568	Ltb/Tnf/Lta<tm1Dvk>	MP:0000218,increased leukocyte cell number|MP:0000689,abnormal spleen morphology|MP:0001805,decreased IgG level|MP:0002412,increased susceptibility to bacterial infection|MP:0002831,absent Peyer's patches|MP:0004816,abnormal class switch recombination|MP:0008024,absent lymph nodes|MP:0008234,absent spleen marginal zone|MP:0008465,absent mesenteric lymph nodes|MP:0008474,absent spleen germinal center|MP:0008479,decreased spleen white pulp amount|MP:0009622,absent inguinal lymph nodes|MP:0009628,absent brachial lymph nodes|MP:0009630,absent axillary lymph nodes|MP:0009634,absent popliteal lymph nodes|MP:0014263,decreased spleen B cell follicle number
MGI:2446564	Ltb/Tnf<tm1.1Dvk>	MP:0000689,abnormal spleen morphology|MP:0002831,absent Peyer's patches|MP:0005232,abnormal mesenteric lymph node morphology|MP:0008179,absent germinal center B cells|MP:0008201,absent follicular dendritic cells|MP:0008234,absent spleen marginal zone|MP:0008464,absent peripheral lymph nodes|MP:0008475,intermingled spleen red and white pulp|MP:0009622,absent inguinal lymph nodes|MP:0009628,absent brachial lymph nodes|MP:0009630,absent axillary lymph nodes|MP:0009633,absent cervical lymph nodes|MP:0009634,absent popliteal lymph nodes
MGI:2446565	Ltb/Tnf<tm1.1Dvk>	MP:0000689,abnormal spleen morphology|MP:0002831,absent Peyer's patches|MP:0005232,abnormal mesenteric lymph node morphology|MP:0008179,absent germinal center B cells|MP:0008201,absent follicular dendritic cells|MP:0008234,absent spleen marginal zone|MP:0008464,absent peripheral lymph nodes|MP:0008475,intermingled spleen red and white pulp|MP:0009622,absent inguinal lymph nodes|MP:0009628,absent brachial lymph nodes|MP:0009630,absent axillary lymph nodes|MP:0009633,absent cervical lymph nodes|MP:0009634,absent popliteal lymph nodes
MGI:3029254	Ltc4s<tm1Blam>	MP:0001844,autoimmune response|MP:0002148,abnormal hypersensitivity reaction|MP:0002405,respiratory system inflammation|MP:0002531,abnormal type I hypersensitivity reaction|MP:0003071,decreased vascular permeability|MP:0005387,immune system phenotype|MP:0005501,abnormal skin physiology|MP:0005597,decreased susceptibility to type I hypersensitivity reaction
MGI:5707372	Ltf<tm1.1Smoc>	MP:0002169,no abnormal phenotype detected
MGI:5707374	Ltf<tm1.2Smoc>	MP:0000351,increased cell proliferation|MP:0004499,increased incidence of tumors by chemical induction|MP:0006043,decreased apoptosis
MGI:2448243	Ltf<tm1Omc>	MP:0005397,hematopoietic system phenotype|MP:0005637,abnormal iron homeostasis|MP:0008807,increased liver iron level|MP:0008808,decreased spleen iron level|MP:0008810,increased circulating iron level
MGI:7425806	Ltk<em1(IMPC)H>	MP:0001556,increased circulating HDL cholesterol level|MP:0002965,increased circulating serum albumin level|MP:0005568,increased circulating total protein level
MGI:3838106	Ltn1<Gt(RRR322)Byg>	MP:0008762,embryonic lethality
MGI:3838105	Ltn1<lister>	MP:0000750,abnormal muscle regeneration|MP:0000753,paralysis|MP:0000938,motor neuron degeneration|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0002269,muscular atrophy|MP:0002882,abnormal neuron morphology|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0004262,abnormal physical strength|MP:0004811,abnormal neuron physiology|MP:0005156,bradykinesia|MP:0008415,abnormal neurite morphology|MP:0008489,slow postnatal weight gain|MP:0008913,weaving|MP:0009400,decreased skeletal muscle fiber size|MP:0009434,paraparesis|MP:0010053,decreased grip strength
MGI:6304241	Ltn1<tm1b(EUCOMM)Hmgu>	MP:0001262,decreased body weight|MP:0001312,abnormal cornea morphology|MP:0001404,no spontaneous movement|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010053,decreased grip strength|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010935,increased airway resistance|MP:0011044,increased lung elastance|MP:0011047,increased lung tissue damping|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020421,increased freezing behavior
MGI:2669867	Ltry<NZB/BlNJ>	MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002773,decreased circulating luteinizing hormone level
MGI:3587049	Ltsd8<O20/A>	MP:0003448,abnormal tumor morphology
MGI:3721711	Ltsw1<SEG/Pas>	MP:0004852,decreased testis weight
MGI:3721714	Ltsw2<SEG/Pas>	MP:0004852,decreased testis weight
MGI:6294725	Ltv1<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012129,failure of blastocyst formation
MGI:3609217	Ltxs2<DBA/2NCr>	MP:0002409,decreased susceptibility to infection
MGI:3609219	Ltxs3<DBA/2NCr>	MP:0002409,decreased susceptibility to infection
MGI:6306461	Luc7l3<em1(IMPC)J>	MP:0002941,increased circulating alanine transaminase level|MP:0003131,increased erythrocyte cell number|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6277019	Luc7l<em1(IMPC)Mbp>	MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002188,small heart|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0003131,increased erythrocyte cell number
MGI:3056899	Luc7l<Gt(pUHachi)8070Imeg>	MP:0002169,no abnormal phenotype detected
MGI:5695885	Lum<tm1.1(KOMP)Vlcg>	MP:0002111,abnormal tail morphology|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0011100,preweaning lethality, complete penetrance
MGI:2153008	Lum<tm1Chak>	MP:0001212,skin lesions|MP:0001243,abnormal dermal layer morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001648,abnormal apoptosis|MP:0003089,decreased skin tensile strength|MP:0003092,decreased cornea stroma thickness|MP:0003094,abnormal cornea posterior stroma morphology|MP:0003095,abnormal cornea stroma development|MP:0003096,increased corneal light-scattering|MP:0003102,sclera thinning|MP:0005300,abnormal cornea stroma morphology|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0005421,loose skin|MP:0005503,abnormal tendon morphology|MP:0009275,bruising|MP:0011703,increased fibroblast proliferation|MP:0013502,decreased fibroblast apoptosis
MGI:2181377	Lum<tm1Wwk>	MP:0000222,decreased neutrophil cell number|MP:0001191,abnormal skin condition|MP:0001314,cornea opacity|MP:0001510,abnormal coat appearance|MP:0001845,abnormal inflammatory response|MP:0001922,reduced male fertility|MP:0002908,delayed wound healing|MP:0003094,abnormal cornea posterior stroma morphology|MP:0005543,decreased cornea thickness|MP:0020861,abnormal cornea wound healing
MGI:6281355	Lurap1<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001566,increased circulating phosphate level|MP:0003795,abnormal bone structure|MP:0010052,increased grip strength
MGI:6304264	Lurap1l<em1(IMPC)J>	MP:0009141,increased prepulse inhibition
MGI:3818454	Luzp1<tm1Acch>	MP:0000284,double outlet right ventricle|MP:0000841,abnormal hindbrain morphology|MP:0000848,abnormal pons morphology|MP:0000914,exencephaly|MP:0000923,abnormal roof plate morphology|MP:0000928,incomplete rostral neuropore closure|MP:0001575,cyanosis|MP:0001890,anencephaly|MP:0003052,omphalocele|MP:0004110,transposition of great arteries|MP:0009264,failure of eyelid fusion|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0010402,ventricular septal defect|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011256,abnormal neural fold morphology|MP:0011380,enlarged brain ventricles|MP:0012261,increased hindbrain apoptosis|MP:0012525,abnormal rhombic lip morphology
MGI:3043852	Luzp2<tm1Dkj>	MP:0002169,no abnormal phenotype detected
MGI:6343490	Lvrn<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:1856619	Lvs	MP:0001925,male infertility|MP:0005578,teratozoospermia
MGI:3042943	Lwq14<L6>	MP:0003402,decreased liver weight
MGI:3042949	Lwq15<L6>	MP:0003402,decreased liver weight
MGI:3042930	Lwq16<L6>	MP:0003402,decreased liver weight
MGI:3043108	Lwq17<L6>	MP:0003402,decreased liver weight
MGI:3042963	Lwq18<L6>	MP:0003402,decreased liver weight
MGI:3042981	Lwq19<L6>	MP:0003402,decreased liver weight
MGI:3043119	Lwq20<L6>	MP:0003402,decreased liver weight
MGI:3042973	Lwq21<L6>	MP:0003402,decreased liver weight
MGI:3042969	Lwq22<L6>	MP:0003402,decreased liver weight
MGI:3043128	Lwq23<L6>	MP:0003402,decreased liver weight
MGI:3723158	Lwq24<NMRI8/Fbn>	MP:0002981,increased liver weight
MGI:3698804	Lwq9<CAST/EiJ>	MP:0002981,increased liver weight
MGI:1856944	Lx	MP:0000459,abnormal presacral vertebrae morphology|MP:0000519,hydronephrosis|MP:0000520,absent kidney|MP:0000536,hydroureter|MP:0000556,abnormal hindlimb morphology|MP:0000562,polydactyly|MP:0000565,oligodactyly|MP:0001265,decreased body size|MP:0001524,impaired limb coordination|MP:0002110,abnormal digit morphology|MP:0002135,abnormal kidney morphology|MP:0002160,abnormal reproductive system morphology|MP:0002728,absent tibia|MP:0002772,brachypodia|MP:0003068,enlarged kidney|MP:0003230,abnormal umbilical artery morphology|MP:0003586,dilated ureter|MP:0005104,abnormal tarsal bone morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013169,small hindlimb buds|MP:0031204,hindlimb paresis
MGI:2152570	Lxl	MP:0000562,polydactyly
MGI:2386941	Lxl2	MP:0000562,polydactyly|MP:0002109,abnormal limb morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:3622076	Lxn<tm1Yari>	MP:0001973,increased thermal nociceptive threshold
MGI:3036306	Lxw1<BXSB/Scr>	MP:0004829,increased anti-chromatin antibody level
MGI:3036312	Lxw2<NZW/LacScr>	MP:0002743,glomerulonephritis
MGI:3036328	Lxw3<NZW/LacScr>	MP:0004829,increased anti-chromatin antibody level
MGI:3036330	Lxw4<NZW/LacScr>	MP:0002082,postnatal lethality
MGI:3036331	Lxw5<BXSB/Scr>	MP:0000691,enlarged spleen
MGI:3036334	Lxw6<NZW/LacScr>	MP:0000691,enlarged spleen
MGI:2651374	Ly6a<tm1Grau>	MP:0002169,no abnormal phenotype detected
MGI:2449938	Ly6a<tm1Pmf>	MP:0000066,osteoporosis|MP:0000223,decreased monocyte cell number|MP:0000334,decreased granulocyte number|MP:0002123,abnormal definitive hematopoiesis|MP:0002490,abnormal immunoglobulin level|MP:0003179,thrombocytopenia|MP:0004985,decreased osteoclast cell number|MP:0004991,decreased bone strength|MP:0005006,abnormal osteoblast physiology|MP:0005013,increased lymphocyte cell number|MP:0005094,abnormal T cell proliferation|MP:0005606,increased bleeding time|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008250,abnormal myeloid leukocyte morphology|MP:0008255,decreased megakaryocyte cell number|MP:0008395,abnormal osteoblast differentiation|MP:0008396,abnormal osteoclast differentiation|MP:0009115,abnormal fat cell morphology|MP:0010124,decreased bone mineral content|MP:0010768,mortality/aging|MP:0010869,decreased bone trabecula number|MP:0010927,decreased osteoid volume|MP:0011091,prenatal lethality, complete penetrance|MP:0020040,decreased bone ossification
MGI:3510673	Ly6a<tm2(RUNX1)Grau>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000239,absent common myeloid progenitor cells|MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0001209,spontaneous skin ulceration|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0003135,increased erythroid progenitor cell number|MP:0004207,increased squamous cell carcinoma incidence|MP:0005097,polychromatophilia|MP:0008470,abnormal spleen B cell follicle morphology|MP:0010373,myeloid hyperplasia
MGI:6361282	Ly6d<em1(IMPC)J>	MP:0002574,increased vertical activity
MGI:6257564	Ly6e<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0001722,pale yolk sac|MP:0002080,prenatal lethality|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0011100,preweaning lethality, complete penetrance
MGI:6448980	Ly6e<tm1c(EUCOMM)Hmgu>	MP:0000222,decreased neutrophil cell number|MP:0000598,abnormal liver morphology|MP:0000603,pale liver|MP:0001654,hepatic necrosis|MP:0001876,decreased inflammatory response|MP:0002941,increased circulating alanine transaminase level|MP:0003884,decreased macrophage cell number|MP:0005017,decreased B cell number|MP:0008045,decreased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008127,decreased dendritic cell number|MP:0008247,abnormal mononuclear cell morphology|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:2429638	Ly6e<tm1Zmt>	MP:0000274,enlarged heart|MP:0000281,abnormal interventricular septum morphology|MP:0001740,failure of adrenal epinephrine secretion|MP:0002795,dilated cardiomyopathy|MP:0003140,dilated heart atrium|MP:0005294,abnormal heart ventricle morphology|MP:0008288,abnormal adrenal cortex morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012574,decreased noradrenaline level
MGI:7386928	Ly6g5b<em1(IMPC)J>	MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount
MGI:6120778	Ly6g6d<tm1b(EUCOMM)Hmgu>	MP:0002599,increased mean platelet volume|MP:0002834,decreased heart weight|MP:0003179,thrombocytopenia
MGI:7425807	Ly6g6f<em1(IMPC)Hmgu>	MP:0005333,decreased heart rate
MGI:6330745	Ly6g<tm2621(cre)Arte>	MP:0005387,immune system phenotype
MGI:5618096	Ly6k<tm1Osb>	MP:0001925,male infertility|MP:0005389,reproductive system phenotype|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031012,impaired sperm migration in female genital tract
MGI:7524667	Ly6l<em1(IMPC)Tcp>	MP:0002092,abnormal eye morphology|MP:0002792,abnormal retina vasculature morphology|MP:0005564,increased hemoglobin content|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5433322	Ly75<tm1.1(HBEGF/EGFP)Ksat>	MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3575119	Ly75<tm1Mnz>	MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005078,abnormal cytotoxic T cell physiology
MGI:5287791	Ly86<tm1a(KOMP)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0002833,increased heart weight|MP:0003960,increased lean body mass|MP:0005013,increased lymphocyte cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0010025,decreased total body fat amount
MGI:3641422	Ly86<tm1Kmiy>	MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0005093,decreased B cell proliferation|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:6200370	Ly96<m1Btlr>	MP:0008561,decreased tumor necrosis factor secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0011081,decreased macrophage apoptosis
MGI:3053109	Ly96<tm1Kmiy>	MP:0001819,abnormal immune cell physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0005093,decreased B cell proliferation|MP:0008561,decreased tumor necrosis factor secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008719,impaired neutrophil recruitment|MP:0008734,decreased susceptibility to endotoxin shock
MGI:3618122	Ly9<tm1Mckn>	MP:0002434,abnormal T-helper 2 cell morphology|MP:0003009,abnormal cytokine secretion|MP:0005095,decreased T cell proliferation
MGI:6361103	Lyar<em1(IMPC)J>	MP:0005293,impaired glucose tolerance|MP:0005343,increased circulating aspartate transaminase level
MGI:4128951	Lyar<Gt(RRG292)Byg>	MP:0011704,decreased fibroblast proliferation
MGI:4415415	Lyg1<tm1(KOMP)Vlcg>	MP:0003721,increased tumor growth/size|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008567,decreased interferon-gamma secretion
MGI:3693950	Lyl1<tm1Fsky>	MP:0001802,arrested B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0003179,thrombocytopenia|MP:0005017,decreased B cell number|MP:0005397,hematopoietic system phenotype|MP:0008208,decreased pro-B cell number|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:5050110	Lyl1<tm1Mago>	MP:0003179,thrombocytopenia|MP:0005397,hematopoietic system phenotype|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:3778974	Lynf2<O20/A>	MP:0002498,abnormal acute inflammation
MGI:3778977	Lynf4<C57BL/10J>	MP:0002498,abnormal acute inflammation
MGI:5501039	Lyn<m1Anu>	MP:0005017,decreased B cell number
MGI:5603319	Lyn<M1Btlr>	MP:0000219,increased neutrophil cell number|MP:0005017,decreased B cell number
MGI:5563397	Lyn<m2Anu>	MP:0008211,decreased mature B cell number|MP:0008214,increased immature B cell number
MGI:5613173	Lyn<M2Btlr>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0020154,impaired humoral immune response
MGI:5806331	Lyn<M3Btlr>	MP:0001606,impaired hematopoiesis|MP:0004977,increased B-1 B cell number|MP:0005018,decreased T cell number|MP:0005425,increased macrophage cell number|MP:0008126,increased dendritic cell number
MGI:6285919	Lyn<m4Btlr>	MP:0001805,decreased IgG level|MP:0020154,impaired humoral immune response
MGI:3832561	Lyn<mld4>	MP:0000219,increased neutrophil cell number|MP:0000694,spleen hypoplasia|MP:0001601,abnormal myelopoiesis|MP:0002494,increased IgM level|MP:0002497,increased IgE level|MP:0002743,glomerulonephritis|MP:0003135,increased erythroid progenitor cell number|MP:0003303,peritoneal inflammation|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004939,abnormal B cell morphology|MP:0005015,increased T cell number|MP:0005425,increased macrophage cell number|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008217,abnormal B cell activation|MP:0020519,renal glomerular immunoglobulin deposits
MGI:5545812	Lyn<tm1.1Calo>	MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001212,skin lesions|MP:0001828,abnormal T cell activation|MP:0001829,increased activated T cell number|MP:0001846,increased inflammatory response|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002083,premature death|MP:0002376,abnormal dendritic cell physiology|MP:0002442,abnormal leukocyte physiology|MP:0002743,glomerulonephritis|MP:0003725,increased autoantibody level|MP:0004947,skin inflammation|MP:0005015,increased T cell number|MP:0008097,increased plasma cell number|MP:0008102,lymph node hyperplasia|MP:0008126,increased dendritic cell number|MP:0008553,increased circulating tumor necrosis factor level|MP:0008577,increased circulating interferon-gamma level|MP:0008596,increased circulating interleukin-6 level|MP:0008614,increased circulating interleukin-17 level|MP:0008617,increased circulating interleukin-12 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0010209,abnormal circulating chemokine level|MP:0010210,abnormal circulating cytokine level|MP:0010373,myeloid hyperplasia|MP:0020519,renal glomerular immunoglobulin deposits
MGI:2157129	Lyn<tm1Ard>	MP:0000219,increased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000324,increased mast cell number|MP:0000691,enlarged spleen|MP:0000694,spleen hypoplasia|MP:0001601,abnormal myelopoiesis|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0002606,increased basophil cell number|MP:0002743,glomerulonephritis|MP:0002871,albuminuria|MP:0003179,thrombocytopenia|MP:0003303,peritoneal inflammation|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004939,abnormal B cell morphology|MP:0005015,increased T cell number|MP:0005042,abnormal level of surface class II molecules|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008217,abnormal B cell activation|MP:0008477,decreased spleen red pulp amount|MP:0008479,decreased spleen white pulp amount|MP:0008501,increased IgG2b level|MP:0010215,abnormal circulating complement protein level|MP:0020519,renal glomerular immunoglobulin deposits
MGI:5756074	Lyn<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000186,decreased circulating HDL cholesterol level|MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000455,abnormal maxilla morphology|MP:0000691,enlarged spleen|MP:0000706,small thymus|MP:0001325,abnormal retina morphology|MP:0001406,abnormal gait|MP:0002599,increased mean platelet volume|MP:0002644,decreased circulating triglyceride level|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0004952,increased spleen weight|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005565,increased blood urea nitrogen level|MP:0010067,increased red blood cell distribution width|MP:0012362,increased large unstained cell number
MGI:2157016	Lyn<tm1Mhi>	MP:0000219,increased neutrophil cell number|MP:0004953,decreased spleen weight
MGI:1861966	Lyn<tm1Sor>	MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0001845,abnormal inflammatory response|MP:0001860,liver inflammation|MP:0002376,abnormal dendritic cell physiology|MP:0002416,abnormal proerythroblast morphology|MP:0002451,abnormal macrophage physiology|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002743,glomerulonephritis|MP:0003135,increased erythroid progenitor cell number|MP:0003691,abnormal microglial cell physiology|MP:0003725,increased autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005154,increased B cell proliferation|MP:0005264,glomerulosclerosis|MP:0008097,increased plasma cell number|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008211,decreased mature B cell number|MP:0008499,increased IgG1 level|MP:0008501,increased IgG2b level|MP:0008577,increased circulating interferon-gamma level|MP:0008596,increased circulating interleukin-6 level|MP:0008614,increased circulating interleukin-17 level|MP:0008617,increased circulating interleukin-12 level|MP:0008721,abnormal chemokine level|MP:0010209,abnormal circulating chemokine level|MP:0010210,abnormal circulating cytokine level|MP:0010373,myeloid hyperplasia|MP:0011294,renal glomerulus hypertrophy|MP:0011512,mesangial cell interposition|MP:0020518,renal glomerular protein deposits
MGI:2386196	Lyn<tm1Tya>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001577,anemia|MP:0002083,premature death|MP:0002459,abnormal B cell physiology|MP:0002461,increased immunoglobulin level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002743,glomerulonephritis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004816,abnormal class switch recombination|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0008135,small Peyer's patches|MP:0008478,increased spleen white pulp amount
MGI:3837125	Lyn<weeb>	MP:0000693,spleen hyperplasia|MP:0001860,liver inflammation|MP:0002494,increased IgM level|MP:0002743,glomerulonephritis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005154,increased B cell proliferation|MP:0005264,glomerulosclerosis|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008211,decreased mature B cell number|MP:0011294,renal glomerulus hypertrophy|MP:0011512,mesangial cell interposition|MP:0014350,disorganized spleen B cell follicle
MGI:3716630	Lynx1<tm1Htz>	MP:0000780,abnormal corpus callosum morphology|MP:0000783,abnormal forebrain morphology|MP:0000841,abnormal hindbrain morphology|MP:0000849,abnormal cerebellum morphology|MP:0001454,abnormal cued conditioning behavior|MP:0001516,abnormal motor coordination/balance|MP:0002920,decreased paired-pulse facilitation|MP:0003224,neuron degeneration|MP:0003633,abnormal nervous system physiology|MP:0004077,abnormal striatum morphology|MP:0004102,abnormal dorsal striatum morphology|MP:0005405,axon degeneration|MP:0008025,brain vacuoles|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:3840549	Lypd1<tm1.1Tmj>	MP:0001363,increased anxiety-related response|MP:0001454,abnormal cued conditioning behavior|MP:0002799,abnormal passive avoidance behavior|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003459,increased fear-related response|MP:0005386,behavior/neurological phenotype
MGI:5548620	Lypd3<tm1.1(KOMP)Vlcg>	MP:0001552,increased circulating triglyceride level|MP:0005565,increased blood urea nitrogen level|MP:0010378,increased respiratory quotient|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011939,increased food intake
MGI:4399526	Lypd3<tm1(KOMP)Vlcg>	MP:0001262,decreased body weight|MP:0002006,neoplasm|MP:0002908,delayed wound healing|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005459,decreased percent body fat/body weight|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008853,decreased abdominal adipose tissue amount|MP:0010771,integument phenotype|MP:0011940,decreased food intake|MP:0014143,decreased body fat mass
MGI:7435025	Lypd4<em1Eyx>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0009647,decreased fertilization frequency|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031012,impaired sperm migration in female genital tract
MGI:5548612	Lypd6b<tm1b(KOMP)Wtsi>	MP:0000198,decreased circulating phosphate level|MP:0005419,decreased circulating serum albumin level|MP:0005565,increased blood urea nitrogen level
MGI:5583075	Lypd6<tm1b(KOMP)Wtsi>	MP:0001102,small superior vagus ganglion|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001192,scaly skin|MP:0001200,thick skin|MP:0002060,abnormal skin morphology|MP:0009709,hydrometra|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5006989	Lypd8<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:6508395	Lypd8<tm2Ktak>	MP:0000488,abnormal intestinal epithelium morphology|MP:0000495,abnormal colon morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0003868,abnormal feces composition|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0008537,increased susceptibility to induced colitis|MP:0013298,increased susceptibility to colitis induced morbidity/mortality
MGI:6509047	Lypd9<em1Juhu>	MP:0005389,reproductive system phenotype
MGI:5609345	Lypla1<tm1b(EUCOMM)Hmgu>	MP:0000195,decreased circulating calcium level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0005567,decreased circulating total protein level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:6514395	Lypla1<tm1Sem>	MP:0000272,abnormal aorta morphology|MP:0003710,abnormal physiological neovascularization|MP:0004003,abnormal vascular endothelial cell physiology|MP:0020317,abnormal vascular endothelial cell adhesion
MGI:6856579	Lyplal1<em1Espel>	MP:0001552,increased circulating triglyceride level|MP:0001783,decreased white adipose tissue amount|MP:0002078,abnormal glucose homeostasis|MP:0002942,decreased circulating alanine transaminase level|MP:0005376,homeostasis/metabolism phenotype|MP:0005632,decreased circulating aspartate transaminase level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009133,decreased white fat cell size|MP:0009356,decreased liver triglyceride level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:4363255	Lyplal1<tm1a(KOMP)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level|MP:0004609,vertebral fusion
MGI:5548788	Lyplal1<tm1b(KOMP)Wtsi>	MP:0001529,abnormal vocalization|MP:0002591,decreased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0006203,eye hemorrhage|MP:0010052,increased grip strength
MGI:3609038	Lyr2<SL/Ni>	MP:0010268,decreased lymphoma incidence
MGI:3609049	Lyr3<BALB/cHeA>	MP:0002879,increased cellular sensitivity to X-ray irradiation induced cell death
MGI:3609032	Lyr<BALB/cHeA>	MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0012431,increased lymphoma incidence
MGI:3609034	Lyr<STS/A>	MP:0010268,decreased lymphoma incidence
MGI:7384326	Lyset<em1Janc>	MP:0002410,decreased susceptibility to viral infection|MP:0005058,abnormal lysosome morphology|MP:0005319,abnormal enzyme/coenzyme level|MP:0020261,increased beta-galactosidase level
MGI:7384329	Lyset<em2Janc>	MP:0002410,decreased susceptibility to viral infection|MP:0005058,abnormal lysosome morphology|MP:0005319,abnormal enzyme/coenzyme level|MP:0020261,increased beta-galactosidase level
MGI:6381415	Lysmd1<em1(IMPC)J>	MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:6258895	Lysmd3<em1Hwv>	MP:0002169,no abnormal phenotype detected
MGI:3918322	Lysmd3<Gt(E201G10)Wrst>	MP:0002169,no abnormal phenotype detected
MGI:1855968	Lyst<bg>	MP:0000885,ectopic Purkinje cell|MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001183,overexpanded pulmonary alveolus|MP:0001760,abnormal urine enzyme level|MP:0001958,emphysema|MP:0002021,increased incidence of induced tumors|MP:0002166,abnormal tumor susceptibility|MP:0002275,abnormal type II pneumocyte morphology|MP:0002619,abnormal lymphocyte morphology|MP:0002762,ectopic cerebellar granule cells|MP:0002763,ectopic Bergmann glia cells|MP:0002877,abnormal melanocyte morphology|MP:0003172,abnormal lysosome physiology|MP:0003173,decreased lysosomal enzyme secretion|MP:0003917,increased kidney weight|MP:0004844,abnormal vestibuloocular reflex|MP:0005027,increased susceptibility to parasitic infection|MP:0005058,abnormal lysosome morphology|MP:0005059,lysosomal protein accumulation|MP:0005060,accumulation of giant lysosomes in kidney/renal tubule cells|MP:0005061,abnormal eosinophil morphology|MP:0005065,abnormal neutrophil morphology|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005075,abnormal melanosome morphology|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0006027,impaired lung alveolus development|MP:0006050,pulmonary fibrosis|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0009273,abnormal hair shaft melanin granule shape|MP:0009746,enhanced behavioral response to xenobiotic|MP:0010011,ectopic hippocampus pyramidal cells|MP:0010766,abnormal NK cell physiology|MP:0010815,enlarged alveolar lamellar bodies|MP:0010922,alveolitis|MP:0014745,abnormal hippocampal mossy fiber infrapyramidal bundle morphology|MP:0030917,enlarged melanosome
MGI:6114069	Lyst<bg-10Btlr>	MP:0000371,diluted coat color
MGI:1856471	Lyst<bg-10J>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0002095,abnormal skin pigmentation|MP:0005172,decreased eye pigmentation|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:6200258	Lyst<bg-11Btlr>	MP:0000371,diluted coat color
MGI:1856472	Lyst<bg-11J>	MP:0000371,diluted coat color|MP:0002075,abnormal coat/hair pigmentation|MP:0005408,hypopigmentation
MGI:2672943	Lyst<bg-14J>	MP:0000371,diluted coat color
MGI:3620135	Lyst<bg-16J>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0002095,abnormal skin pigmentation|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:5661588	Lyst<bg-18J>	MP:0000371,diluted coat color
MGI:3779040	Lyst<bg-2Btlr>	MP:0000371,diluted coat color|MP:0010766,abnormal NK cell physiology|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:1855970	Lyst<bg-2J>	MP:0000371,diluted coat color|MP:0000745,tremors|MP:0000858,abnormal metastatic potential|MP:0000880,decreased Purkinje cell number|MP:0001273,decreased metastatic potential|MP:0001324,abnormal eye pigmentation|MP:0001406,abnormal gait|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0001793,abnormal susceptibility to infection|MP:0005172,decreased eye pigmentation|MP:0005398,decreased susceptibility to fungal infection|MP:0009434,paraparesis|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:3826359	Lyst<bg-3Btlr>	MP:0000371,diluted coat color
MGI:5607168	Lyst<bg-4Btlr>	MP:0000371,diluted coat color
MGI:5615966	Lyst<bg-5Btlr>	MP:0001798,impaired macrophage phagocytosis
MGI:5632154	Lyst<bg-6Btlr>	MP:0020916,increased susceptibility to Herpesvirales infection
MGI:5775024	Lyst<bg-7Btlr>	MP:0000371,diluted coat color
MGI:5789550	Lyst<bg-8Btlr>	MP:0000371,diluted coat color
MGI:1856470	Lyst<bg-8J>	MP:0000371,diluted coat color|MP:0002075,abnormal coat/hair pigmentation|MP:0005408,hypopigmentation
MGI:5789566	Lyst<bg-9Btlr>	MP:0000371,diluted coat color
MGI:3779035	Lyst<bg-Btlr>	MP:0000371,diluted coat color|MP:0002412,increased susceptibility to bacterial infection|MP:0009379,abnormal foot pigmentation|MP:0010766,abnormal NK cell physiology|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:3620573	Lyst<bg-grey>	MP:0000371,diluted coat color|MP:0000394,absent hair follicle melanin granules|MP:0001243,abnormal dermal layer morphology|MP:0002060,abnormal skin morphology|MP:0002877,abnormal melanocyte morphology|MP:0003727,abnormal retina layer morphology|MP:0004381,abnormal hair follicle melanocyte morphology|MP:0005071,enlarged hair follicle melanin granules|MP:0005075,abnormal melanosome morphology|MP:0005102,abnormal iris pigmentation|MP:0005199,abnormal iris pigment epithelium|MP:0005201,abnormal retina pigment epithelium morphology|MP:0008020,abnormal dermal mast cell morphology
MGI:1855969	Lyst<bg-J>	MP:0000745,tremors|MP:0000880,decreased Purkinje cell number|MP:0001322,abnormal iris morphology|MP:0001406,abnormal gait|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0002441,abnormal granulocyte morphology|MP:0003173,decreased lysosomal enzyme secretion|MP:0003884,decreased macrophage cell number|MP:0004221,abnormal iridocorneal angle|MP:0004725,decreased platelet serotonin level|MP:0004844,abnormal vestibuloocular reflex|MP:0005065,abnormal neutrophil morphology|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005102,abnormal iris pigmentation|MP:0005194,abnormal anterior uvea morphology|MP:0005199,abnormal iris pigment epithelium|MP:0005205,abnormal eye anterior chamber morphology|MP:0005208,abnormal iris stroma morphology|MP:0005391,vision/eye phenotype|MP:0005606,increased bleeding time|MP:0009434,paraparesis|MP:0009448,decreased platelet ATP level|MP:0009557,decreased platelet ADP level
MGI:1855971	Lyst<bg-Lac>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0005058,abnormal lysosome morphology|MP:0005172,decreased eye pigmentation|MP:0008041,absent NK T cells|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:2660913	Lyst<bg-slt>	MP:0000371,diluted coat color|MP:0000423,delayed hair regrowth|MP:0005100,abnormal choroid pigmentation|MP:0005101,abnormal ciliary body pigmentation|MP:0005102,abnormal iris pigmentation|MP:0005103,abnormal retina pigmentation|MP:0005114,premature hair loss
MGI:5513800	Lyst<tm1b(EUCOMM)Wtsi>	MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0002075,abnormal coat/hair pigmentation|MP:0002590,increased mean corpuscular volume|MP:0005561,increased mean corpuscular hemoglobin|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:3697676	Lyve1<tm1Dgjk>	MP:0005387,immune system phenotype
MGI:3697727	Lyve1<tm1Lhua>	MP:0003659,abnormal lymph circulation|MP:0004038,lymphangiectasis
MGI:2654931	Lyz2<tm1.1Graf>	MP:0001846,increased inflammatory response|MP:0005319,abnormal enzyme/coenzyme level
MGI:1934631	Lyz2<tm1(cre)Ifo>	MP:0000691,enlarged spleen
MGI:3834185	Lyz2<tm1(HBEGF)Mtka>	MP:0000420,ruffled hair|MP:0000598,abnormal liver morphology|MP:0001182,lung hemorrhage|MP:0001402,decreased locomotor activity|MP:0001505,hunched posture|MP:0001953,respiratory failure|MP:0002083,premature death|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002276,abnormal lung interstitium morphology|MP:0004780,abnormal surfactant secretion|MP:0008245,abnormal alveolar macrophage morphology|MP:0010812,absent type II pneumocytes|MP:0011971,increased circulating lactate dehydrogenase level
MGI:4415498	Lyz3<tm1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0001257,increased body length|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level
MGI:6194716	Lyzl1<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6188298	Lyzl1<em1Qsh>	MP:0005389,reproductive system phenotype
MGI:5007238	Lyzl1<tm1Lex>	MP:0005333,decreased heart rate
MGI:6195016	Lyzl4<tm1.1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6195017	Lyzl6<tm1.1Osb>	MP:0002169,no abnormal phenotype detected
MGI:1856945	lz	MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0001386,abnormal maternal nurturing|MP:0001923,reduced female fertility|MP:0001925,male infertility
MGI:7435271	Lztfl1<tm1.1Zpl>	MP:0000120,malocclusion|MP:0001144,vagina atresia|MP:0001261,obese|MP:0001326,retina degeneration
MGI:7435274	Lztfl1<tm1.2Zpl>	MP:0001261,obese|MP:0001944,abnormal pancreas morphology|MP:0002169,no abnormal phenotype detected|MP:0002628,hepatic steatosis|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005491,pancreatic islet hyperplasia|MP:0009500,abnormal interlobular bile duct morphology
MGI:7435277	Lztfl1<tm1.3Zpl>	MP:0000120,malocclusion|MP:0001144,vagina atresia|MP:0001258,decreased body length|MP:0001261,obese|MP:0001326,retina degeneration|MP:0001944,abnormal pancreas morphology|MP:0002628,hepatic steatosis|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005367,renal/urinary system phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0008450,retina photoreceptor degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0009500,abnormal interlobular bile duct morphology|MP:0009703,decreased birth body size|MP:0010024,increased total body fat amount|MP:0011939,increased food intake|MP:0011998,decreased embryonic cilium length
MGI:4363232	Lztfl1<tm1e(KOMP)Wtsi>	MP:0000008,increased white adipose tissue amount|MP:0001260,increased body weight|MP:0001261,obese|MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0002662,abnormal cauda epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0005578,teratozoospermia|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008535,enlarged lateral ventricles|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009239,short sperm flagellum|MP:0009647,decreased fertilization frequency|MP:0009837,abnormal sperm end piece morphology|MP:0010934,increased subcutaneous adipose tissue amount|MP:0011380,enlarged brain ventricles|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0014631,abnormal elongated spermatid morphology|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0031351,abnormal sperm flagellum thickness|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:7435267	Lztfl1<tm1Zpl>	MP:0000120,malocclusion|MP:0001144,vagina atresia|MP:0001261,obese|MP:0001326,retina degeneration|MP:0003984,embryonic growth retardation|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:8163714	Lztr1<em1Tumg>	MP:0001625,cardiac hypertrophy|MP:0031152,subcutaneous hemorrhage
MGI:8163715	Lztr1<em2Tumg>	MP:0000240,extramedullary hematopoiesis|MP:0000438,abnormal cranium morphology|MP:0000691,enlarged spleen|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001300,ocular hypertelorism|MP:0001625,cardiac hypertrophy|MP:0001879,abnormal lymphatic vessel morphology|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002192,hydrops fetalis|MP:0002833,increased heart weight|MP:0003917,increased kidney weight|MP:0004380,short frontal bone|MP:0004471,short nasal bone|MP:0005352,small cranium|MP:0008770,decreased survivor rate|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011862,decreased cranium length|MP:0030166,increased inner canthal distance|MP:0030384,short facial bone|MP:0031152,subcutaneous hemorrhage
MGI:4432946	Lztr1<tm1a(EUCOMM)Wtsi>	MP:0000351,increased cell proliferation|MP:0000438,abnormal cranium morphology|MP:0000441,increased cranium width|MP:0000443,abnormal snout morphology|MP:0001262,decreased body weight|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0003743,abnormal facial morphology|MP:0004472,broad nasal bone|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0008525,decreased cranium height|MP:0010067,increased red blood cell distribution width|MP:0010832,lethality during fetal growth through weaning|MP:0011100,preweaning lethality, complete penetrance|MP:0011925,abnormal heart echocardiography feature|MP:0011951,increased cardiac stroke volume|MP:0030280,short parietal bone
MGI:3706174	Lzts1<tm1Cro>	MP:0002020,increased tumor incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0002038,increased carcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0003077,abnormal cell cycle|MP:0003331,increased hepatocellular carcinoma incidence|MP:0008010,increased gastric adenocarcinoma incidence|MP:0010299,increased mammary gland tumor incidence|MP:0010301,increased stomach tumor incidence|MP:0011704,decreased fibroblast proliferation|MP:0012431,increased lymphoma incidence|MP:0013501,increased fibroblast apoptosis|MP:0020414,abnormal fibroblast physiology
MGI:5700365	Lzts1<tm1Kso>	MP:0001363,increased anxiety-related response|MP:0001458,abnormal object recognition memory|MP:0002020,increased tumor incidence|MP:0002206,abnormal CNS synaptic transmission|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004996,abnormal CNS synapse formation|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory|MP:0009936,abnormal dendritic spine morphology|MP:0011273,prolonged excitatory postsynaptic current decay time
MGI:5302222	Lzts2<tm1.1Zsu>	MP:0000516,abnormal renal/urinary system morphology|MP:0000519,hydronephrosis|MP:0000534,abnormal ureter morphology|MP:0000536,hydroureter|MP:0002059,abnormal seminal vesicle morphology|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0002990,short ureter|MP:0003586,dilated ureter|MP:0003675,kidney cyst|MP:0003827,abnormal Wolffian duct morphology|MP:0003942,abnormal urinary system development|MP:0004017,duplex kidney|MP:0004967,abnormal kidney epithelium morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0009085,abnormal uterine horn morphology|MP:0010980,ectopic ureteric bud|MP:0011493,double ureter|MP:0011803,double kidney pelvis|MP:0013320,dilated seminal vesicle
MGI:4829471	M10.17.7Djba	MP:0000559,abnormal femur morphology|MP:0010124,decreased bone mineral content|MP:0020010,decreased bone mineral density of femur
MGI:4829470	m10.6.6Djba	MP:0001262,decreased body weight|MP:0003795,abnormal bone structure|MP:0010124,decreased bone mineral content
MGI:5306137	m1078Lja	MP:0001147,small testis|MP:0004901,decreased male germ cell number
MGI:5510772	m10Anu	MP:0000519,hydronephrosis|MP:0000520,absent kidney|MP:0000534,abnormal ureter morphology|MP:0000536,hydroureter|MP:0002135,abnormal kidney morphology|MP:0002706,abnormal kidney size|MP:0011493,double ureter
MGI:4829663	m12137Asr	MP:0001260,increased body weight|MP:0004985,decreased osteoclast cell number|MP:0010123,increased bone mineral content|MP:0013617,increased areal bone mineral density|MP:0020039,increased bone ossification
MGI:3776548	m12184Asr	MP:0001260,increased body weight|MP:0010123,increased bone mineral content|MP:0013617,increased areal bone mineral density
MGI:3849693	m128-7Tpo	MP:0011092,embryonic lethality, complete penetrance
MGI:5559486	m12Anu	MP:0000026,abnormal inner ear morphology|MP:0001967,deafness|MP:0002857,cochlear ganglion degeneration|MP:0003151,absent tunnel of Corti|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004402,decreased cochlear outer hair cell number|MP:0004404,cochlear outer hair cell degeneration|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0005377,hearing/vestibular/ear phenotype|MP:0006325,impaired hearing
MGI:5505537	m12Bei	MP:0000565,oligodactyly|MP:0002109,abnormal limb morphology|MP:0003052,omphalocele|MP:0003054,spina bifida|MP:0012260,encephalomeningocele
MGI:3823051	M14104Asr	MP:0001262,decreased body weight|MP:0004016,decreased bone mass|MP:0008152,decreased diameter of femur|MP:0008156,decreased diameter of tibia|MP:0013615,increased volumetric bone mineral density
MGI:3799302	m154Asp	MP:0000788,abnormal cerebral cortex morphology|MP:0000951,sporadic seizures|MP:0002081,perinatal lethality|MP:0002083,premature death
MGI:3823079	M1665Asr	MP:0000062,increased bone mineral density|MP:0001260,increased body weight|MP:0003960,increased lean body mass
MGI:3849696	m174-16Tpo	MP:0011085,postnatal lethality, complete penetrance
MGI:3849699	m183-15Tpo	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5510735	m1Anu	MP:0000428,abnormal craniofacial morphology|MP:0000564,syndactyly
MGI:4329148	M1ap<Gt(RRO290)Byg>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005169,abnormal male meiosis|MP:0006362,abnormal male germ cell morphology|MP:0008261,arrest of male meiosis|MP:0008280,abnormal male germ cell apoptosis|MP:0011751,abnormal X-Y chromosome synapsis during male meiosis|MP:0014764,impaired double-strand DNA break repair
MGI:3578537	m1ec	MP:0001730,embryonic growth arrest|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3801146	m1Hefl	MP:0005017,decreased B cell number
MGI:5544345	m1Nish	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0002217,small lymph nodes|MP:0002831,absent Peyer's patches|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008045,decreased NK cell number|MP:0008053,abnormal NK cell differentiation|MP:0008071,absent B cells|MP:0008202,absent B-1 B cells|MP:0008205,absent B-2 B cells|MP:0008215,decreased immature B cell number
MGI:4830092	m1Sapc	MP:0001061,abnormal oculomotor nerve morphology
MGI:4829403	m2.10.5Djba	MP:0001189,absent skin pigmentation
MGI:3823083	M2195Asr	MP:0001262,decreased body weight|MP:0004016,decreased bone mass|MP:0010124,decreased bone mineral content
MGI:3849702	m251-2Tpo	MP:0010768,mortality/aging
MGI:3799304	m251Asp	MP:0000562,polydactyly|MP:0000788,abnormal cerebral cortex morphology|MP:0002081,perinatal lethality
MGI:3849704	m283-1Tpo	MP:0010768,mortality/aging
MGI:4829474	M2.8.3Djba	MP:0004083,polysyndactyly
MGI:4829401	m2.8.6Djba	MP:0000063,decreased bone mineral density|MP:0001262,decreased body weight|MP:0002095,abnormal skin pigmentation|MP:0003795,abnormal bone structure|MP:0003849,greasy coat|MP:0010124,decreased bone mineral content|MP:0020010,decreased bone mineral density of femur
MGI:3849705	m289-5Tpo	MP:0010768,mortality/aging
MGI:5510746	m2Anu	MP:0000519,hydronephrosis|MP:0000520,absent kidney|MP:0000534,abnormal ureter morphology|MP:0000536,hydroureter|MP:0002135,abnormal kidney morphology|MP:0011493,double ureter
MGI:4948854	m2H	MP:0000592,short tail|MP:0003641,small lung|MP:0010975,abnormal lung lobe morphology|MP:0011024,abnormal branching involved in lung morphogenesis
MGI:3801147	m2Hefl	MP:0008070,absent T cells|MP:0008071,absent B cells
MGI:4830601	m2Jrt	MP:0000195,decreased circulating calcium level
MGI:4830094	m2Sapc	MP:0001061,abnormal oculomotor nerve morphology
MGI:4455206	m3140Ddg	MP:0001077,abnormal spinal nerve morphology|MP:0003632,abnormal nervous system morphology|MP:0005404,abnormal axon morphology
MGI:3799306	m357Asp	MP:0000784,forebrain hypoplasia|MP:0000898,midbrain hyperplasia|MP:0003743,abnormal facial morphology
MGI:4829468	M3.8.6Djba	MP:0031073,decreased circulating type I collagen C-terminal telopeptide level
MGI:5510749	m3Anu	MP:0000519,hydronephrosis|MP:0000534,abnormal ureter morphology|MP:0000536,hydroureter|MP:0002135,abnormal kidney morphology|MP:0003584,bifid ureter|MP:0011493,double ureter
MGI:3801148	m3Hefl	MP:0008045,decreased NK cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3799309	m412Asp	MP:0000788,abnormal cerebral cortex morphology
MGI:4829404	M4.8.4Djba	MP:0001382,abnormal nursing|MP:0001394,circling|MP:0001399,hyperactivity|MP:0002968,increased circulating alkaline phosphatase level
MGI:5510752	m4Anu	MP:0011142,abnormal lung-associated mesenchyme development
MGI:3801149	m4Hefl	MP:0005018,decreased T cell number
MGI:4830096	m4Sapc	MP:0000259,abnormal vascular development|MP:0009450,abnormal axon fasciculation
MGI:5049963	m51206CHubr	MP:0012270,cardiac edema
MGI:5049962	m51208Hubr	MP:0000841,abnormal hindbrain morphology
MGI:4829400	m5.27.7Djba	MP:0000063,decreased bone mineral density|MP:0010124,decreased bone mineral content|MP:0020010,decreased bone mineral density of femur
MGI:4829391	M5.37.5Djba	MP:0000063,decreased bone mineral density|MP:0000558,abnormal tibia morphology|MP:0010124,decreased bone mineral content
MGI:4455207	m574Ddg	MP:0000961,abnormal dorsal root ganglion morphology|MP:0003632,abnormal nervous system morphology
MGI:5049961	m596223Hubr	MP:0012270,cardiac edema
MGI:5510755	m5Anu	MP:0011142,abnormal lung-associated mesenchyme development
MGI:3801150	m5Hefl	MP:0005018,decreased T cell number
MGI:4829967	m5Sapc	MP:0000373,belly spot|MP:0000929,open neural tube|MP:0000937,abnormal motor neuron morphology|MP:0000966,decreased sensory neuron number|MP:0003051,curly tail
MGI:4829469	m6.11.6Djba	MP:0001262,decreased body weight|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0010124,decreased bone mineral content
MGI:4829472	M6.5.3Djba	MP:0001262,decreased body weight
MGI:4829394	M6.5.5Djba	MP:0000558,abnormal tibia morphology|MP:0003795,abnormal bone structure|MP:0020010,decreased bone mineral density of femur
MGI:4829402	M6.9.5Djba	MP:0000062,increased bone mineral density|MP:0002938,white spotting|MP:0003960,increased lean body mass|MP:0010123,increased bone mineral content
MGI:5510760	m6Anu	MP:0001147,small testis|MP:0006418,abnormal testis cord formation|MP:0006419,disorganized testis cords
MGI:6277060	M6pr<em1(IMPC)Mbp>	MP:0000692,small spleen|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0004924,abnormal behavior|MP:0006203,eye hemorrhage|MP:0020870,decreased thigmotaxis
MGI:3653697	M6pr<tm1Hlk>	MP:0003174,increased lysosomal enzyme secretion|MP:0005059,lysosomal protein accumulation|MP:0005390,skeleton phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009643,abnormal urine homeostasis
MGI:2429535	M6pr<tm1Psa>	MP:0005319,abnormal enzyme/coenzyme level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4830000	m6Sapc	MP:0001056,abnormal cranial nerve morphology
MGI:5446182	M7321Wlst	MP:0000228,abnormal thrombopoiesis|MP:0005505,thrombocytosis
MGI:5446188	M7323Wlst	MP:0005397,hematopoietic system phenotype|MP:0005505,thrombocytosis
MGI:5446185	M7324Wlst	MP:0000228,abnormal thrombopoiesis|MP:0003179,thrombocytopenia
MGI:5446189	M7325Wlst	MP:0000228,abnormal thrombopoiesis|MP:0005505,thrombocytosis
MGI:5510763	m7Anu	MP:0001147,small testis|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0006418,abnormal testis cord formation
MGI:4829987	m7Sapc	MP:0000934,abnormal telencephalon development|MP:0000937,abnormal motor neuron morphology|MP:0001071,abnormal facial nerve morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0003720,abnormal neural tube closure
MGI:5510766	m8Anu	MP:0003051,curly tail|MP:0008730,fused phalanges
MGI:5510769	m9Anu	MP:0001324,abnormal eye pigmentation
MGI:7867729	Mab21l1<em1Drf>	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001312,abnormal cornea morphology|MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0001330,abnormal optic nerve morphology|MP:0002092,abnormal eye morphology|MP:0005099,abnormal ciliary body morphology|MP:0005193,abnormal anterior eye segment morphology|MP:0005195,abnormal posterior eye segment morphology|MP:0005197,abnormal uvea morphology|MP:0006218,large optic disk|MP:0008259,abnormal optic disk morphology
MGI:2654257	Mab21l1<tm1Nao>	MP:0001297,microphthalmia|MP:0001312,abnormal cornea morphology|MP:0001325,abnormal retina morphology|MP:0001925,male infertility|MP:0002716,small male preputial gland|MP:0002717,abnormal male preputial gland morphology|MP:0003078,aphakia|MP:0005193,abnormal anterior eye segment morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005261,aniridia|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0009725,absent lens vesicle|MP:0011962,increased cornea thickness|MP:0011964,increased total retina thickness|MP:0012168,abnormal optic placode morphology|MP:0013742,absent ciliary body
MGI:6276927	Mab21l2<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001404,no spontaneous movement|MP:0001711,abnormal placenta morphology|MP:0002092,abnormal eye morphology|MP:0002151,abnormal neural tube morphology|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0005554,decreased circulating creatinine level|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:3511363	Mab21l2<tm1Nao>	MP:0001325,abnormal retina morphology|MP:0003052,omphalocele|MP:0003078,aphakia|MP:0003384,abnormal ventral body wall morphology|MP:0003425,abnormal optic vesicle formation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0006065,abnormal heart position or orientation|MP:0006071,abnormal retina progenitor cell morphology|MP:0009725,absent lens vesicle|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3828998	Macf1<tm1Efu>	MP:0001325,abnormal retina morphology|MP:0002908,delayed wound healing|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0006069,abnormal retina neuronal layer morphology|MP:0006073,abnormal retina bipolar cell morphology|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008583,absent photoreceptor inner segment|MP:0008585,absent photoreceptor outer segment|MP:0009772,abnormal retina development|MP:0011380,enlarged brain ventricles|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0012194,decreased keratinocyte migration|MP:0014059,abnormal photoreceptor connecting cilium morphology|MP:0020439,absent b-wave|MP:0030577,increased keratinocyte adhesion
MGI:3652899	Macf1<tm1Liem>	MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001730,embryonic growth arrest|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5554912	Macir<tm1.1(KOMP)Vlcg>	MP:0002941,increased circulating alanine transaminase level|MP:0003019,increased circulating chloride level|MP:0005627,increased circulating potassium level|MP:0005633,increased circulating sodium level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:6794036	Maco1<em1(IMPC)J>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6140210	Macrod1<em1(IMPC)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract
MGI:5445674	Macrod2<tm1.1(KOMP)Vlcg>	MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0005560,decreased circulating glucose level|MP:0005564,increased hemoglobin content|MP:0005565,increased blood urea nitrogen level|MP:0013279,increased fasting circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:4415493	Macrod2<tm1(KOMP)Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:6726546	Macroh2a1<tm1.1Oxbo>	MP:0000208,decreased hematocrit|MP:0000222,decreased neutrophil cell number|MP:0002942,decreased circulating alanine transaminase level|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005632,decreased circulating aspartate transaminase level|MP:0008943,increased sensitivity to induced cell death|MP:0013663,increased myeloid cell number
MGI:5485999	Macroh2a1<tm1Mbou>	MP:0010768,mortality/aging|MP:0031115,macrovesicular hepatic steatosis
MGI:3522572	Macroh2a1<tm1Peh>	MP:0002169,no abnormal phenotype detected
MGI:6441118	Macroh2a2<em1(IMPC)Hmgu>	MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0001402,decreased locomotor activity|MP:0002135,abnormal kidney morphology|MP:0003402,decreased liver weight|MP:0004151,decreased circulating iron level|MP:0005179,decreased circulating cholesterol level|MP:0010052,increased grip strength
MGI:5565229	Macroh2a2<tm1.1Peh>	MP:0002169,no abnormal phenotype detected
MGI:3697324	Mad1l1<tm1.1Ktj>	MP:0002020,increased tumor incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0002036,increased rhabdomyosarcoma incidence|MP:0002038,increased carcinoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003667,increased hemangiosarcoma incidence|MP:0003789,increased osteosarcoma incidence|MP:0004023,abnormal chromosome number|MP:0004024,aneuploidy|MP:0005621,abnormal cell physiology|MP:0009762,abnormal mitotic spindle assembly checkpoint|MP:0011091,prenatal lethality, complete penetrance
MGI:6356607	Mad2l1bp<tm1.1Itl>	MP:0000609,abnormal liver physiology|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0004024,aneuploidy|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009356,decreased liver triglyceride level|MP:0010080,abnormal hepatocyte physiology|MP:0010398,decreased liver glycogen level|MP:0010768,mortality/aging|MP:0030951,abnormal endocytosis
MGI:6356611	Mad2l1bp<tm1.2Itl>	MP:0000607,abnormal hepatocyte morphology|MP:0001732,postnatal growth retardation|MP:0004024,aneuploidy|MP:0004025,polyploidy|MP:0004046,abnormal mitosis|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0004760,increased mitotic index|MP:0005369,muscle phenotype|MP:0009703,decreased birth body size|MP:0010398,decreased liver glycogen level|MP:0011087,neonatal lethality, complete penetrance|MP:0011167,abnormal adipose tissue development|MP:0011704,decreased fibroblast proliferation|MP:0013501,increased fibroblast apoptosis|MP:0030017,decreased adipocyte glucose uptake
MGI:2178781	Mad2l1<tm1Sorg>	MP:0001698,decreased embryo size|MP:0002021,increased incidence of induced tumors|MP:0002027,increased lung adenocarcinoma incidence|MP:0002085,abnormal embryonic tissue morphology|MP:0004023,abnormal chromosome number|MP:0004024,aneuploidy|MP:0004028,chromosome breakage|MP:0004046,abnormal mitosis|MP:0004965,inner cell mass degeneration|MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0005621,abnormal cell physiology|MP:0008481,increased spleen germinal center number|MP:0009762,abnormal mitotic spindle assembly checkpoint|MP:0010380,abnormal inner cell mass apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5498674	Mad2l1<tm2Sorg>	MP:0000377,abnormal hair follicle morphology|MP:0001216,abnormal epidermal layer morphology|MP:0001242,hyperkeratosis|MP:0003815,hairless|MP:0004024,aneuploidy|MP:0005501,abnormal skin physiology|MP:0009759,abnormal hair follicle bulge morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011194,abnormal hair follicle physiology
MGI:3512941	Mad2l2<repro22>	MP:0000339,decreased enterocyte cell number|MP:0000352,decreased cell proliferation|MP:0001127,small ovary|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002777,absent ovarian follicles|MP:0004806,absent germ cells|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0005431,decreased oocyte number|MP:0008392,decreased primordial germ cell number|MP:0008885,increased enterocyte apoptosis|MP:0010865,prenatal growth retardation|MP:0011102,embryonic lethality, incomplete penetrance
MGI:5704065	Mad2l2<tm1.1Mpz>	MP:0001116,small gonad|MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002777,absent ovarian follicles|MP:0002784,abnormal Sertoli cell morphology|MP:0002982,abnormal primordial germ cell migration|MP:0003077,abnormal cell cycle|MP:0003578,absent ovary|MP:0004200,decreased fetal size|MP:0004806,absent germ cells|MP:0006428,ectopic Sertoli cells|MP:0008391,abnormal primordial germ cell morphology|MP:0008392,decreased primordial germ cell number|MP:0008393,absent primordial germ cells|MP:0008489,slow postnatal weight gain|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0012167,abnormal epigenetic regulation of gene expression|MP:0030935,increased primordial germ cell apoptosis
MGI:5769977	Mad2l2<tm1Mpz>	MP:0011610,abnormal primordial germ cell apoptosis
MGI:5505390	Mad2l2<tm1Ymu>	MP:0000746,weakness|MP:0001127,small ovary|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0002777,absent ovarian follicles|MP:0003631,nervous system phenotype|MP:0004833,ovary atrophy|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0008392,decreased primordial germ cell number|MP:0008393,absent primordial germ cells|MP:0009703,decreased birth body size|MP:0010948,abnormal double-strand DNA break repair|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0012504,increased forebrain apoptosis|MP:0030935,increased primordial germ cell apoptosis
MGI:4941725	Madcam1<tm1.2Nwag>	MP:0001807,decreased IgA level|MP:0002459,abnormal B cell physiology|MP:0005017,decreased B cell number|MP:0008097,increased plasma cell number|MP:0008098,decreased plasma cell number|MP:0008135,small Peyer's patches
MGI:5704429	Madd<tm1Bpra>	MP:0001559,hyperglycemia|MP:0001944,abnormal pancreas morphology|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005215,abnormal pancreatic islet morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0013279,increased fasting circulating glucose level
MGI:3762127	Madd<tm1Ytk>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0001953,respiratory failure|MP:0002578,impaired ability to fire action potentials|MP:0002910,abnormal excitatory postsynaptic currents|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004769,abnormal synaptic vesicle morphology|MP:0004792,abnormal synaptic vesicle number|MP:0005498,hyporesponsive to tactile stimuli|MP:0010819,primary atelectasis|MP:0011087,neonatal lethality, complete penetrance|MP:0011268,biphasic excitatory postsynaptic current amplitude
MGI:3691058	Maea<Gt(XG702)Byg>	MP:0000245,abnormal erythropoiesis|MP:0003717,pallor|MP:0003884,decreased macrophage cell number|MP:0004200,decreased fetal size|MP:0009395,increased nucleated erythrocyte cell number|MP:0011089,perinatal lethality, complete penetrance
MGI:5588275	Maea<tm1b(EUCOMM)Wtsi>	MP:0001510,abnormal coat appearance|MP:0011100,preweaning lethality, complete penetrance
MGI:3795667	Mael<tm1Bort>	MP:0001147,small testis|MP:0001925,male infertility|MP:0005169,abnormal male meiosis|MP:0006379,abnormal spermatocyte morphology|MP:0008878,abnormal DNA methylation during gametogenesis|MP:0014052,increased male germ cell apoptosis
MGI:4837337	Maf1<tm1.1Lnh>	MP:0001258,decreased body length|MP:0001661,extended life span|MP:0001732,postnatal growth retardation|MP:0001764,abnormal homeostasis|MP:0001906,increased dopamine level|MP:0001921,reduced fertility|MP:0002118,abnormal lipid homeostasis|MP:0002891,increased insulin sensitivity|MP:0003961,decreased lean body mass|MP:0003981,decreased circulating phospholipid level|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005332,abnormal amino acid level|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008489,slow postnatal weight gain|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009130,increased white fat cell number|MP:0009133,decreased white fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0010046,decreased omental fat pad weight|MP:0011590,increased hormone-sensitive lipase activity|MP:0011940,decreased food intake|MP:0020237,increased proline level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:4868452	Mafa<tm1.1Eyc>	MP:0002169,no abnormal phenotype detected
MGI:3581892	Mafa<tm1Staka>	MP:0001732,postnatal growth retardation|MP:0001759,increased urine glucose level|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level
MGI:6471912	Mafb<em1Hts>	MP:0002169,no abnormal phenotype detected|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0008059,abnormal podocyte foot process morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011353,expanded mesangial matrix
MGI:6401825	Mafb<em1Staka>	MP:0001262,decreased body weight|MP:0002703,abnormal renal tubule morphology|MP:0002959,increased urine microalbumin level|MP:0005264,glomerulosclerosis|MP:0008140,podocyte foot process effacement|MP:0011868,podocyte microvillus transformation
MGI:1856419	Mafb<kr>	MP:0000026,abnormal inner ear morphology|MP:0000035,abnormal membranous labyrinth morphology|MP:0000041,absent endolymphatic duct|MP:0000933,abnormal rhombomere morphology|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002151,abnormal neural tube morphology|MP:0002428,abnormal semicircular canal morphology|MP:0003077,abnormal cell cycle|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0004045,abnormal cell cycle checkpoint function|MP:0004289,abnormal bony labyrinth|MP:0005307,head tossing|MP:0006011,abnormal endolymphatic duct morphology|MP:0006030,abnormal otic vesicle development|MP:0006108,abnormal hindbrain development|MP:0006287,inner ear cyst|MP:0009913,abnormal hyoid bone greater horn morphology|MP:0010395,abnormal pharyngeal arch development|MP:0010396,ectopic pharyngeal arch|MP:0010397,abnormal otic capsule development|MP:0012796,abnormal rhombomere 4 morphology|MP:0012800,abnormal rhombomere 5 morphology|MP:0014167,ectopic bone
MGI:2157803	Mafb<m1Gsb>	MP:0011932,abnormal endocrine pancreas development
MGI:5581666	Mafb<tm1.1Good>	MP:0002169,no abnormal phenotype detected
MGI:7256734	Mafb<tm1.1Mardu>	MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005390,skeleton phenotype
MGI:5581668	Mafb<tm1.2Good>	MP:0000527,abnormal kidney development|MP:0000841,abnormal hindbrain morphology|MP:0001052,abnormal innervation pattern to muscle|MP:0001061,abnormal oculomotor nerve morphology|MP:0001070,abnormal abducens nerve morphology|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0004568,fusion of glossopharyngeal and vagus nerve|MP:0006287,inner ear cyst|MP:0011087,neonatal lethality, complete penetrance|MP:0013849,absent abducens nerve
MGI:7256738	Mafb<tm1.2Mardu>	MP:0005390,skeleton phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:3663168	Mafb<tm1Jeng>	MP:0000522,kidney cortex cyst|MP:0000533,kidney hemorrhage|MP:0002135,abnormal kidney morphology|MP:0002703,abnormal renal tubule morphology|MP:0003624,anuria|MP:0004153,increased renal tubule apoptosis|MP:0004505,decreased renal glomerulus number|MP:0005387,immune system phenotype|MP:0005553,increased circulating creatinine level|MP:0006287,inner ear cyst|MP:0008139,fused podocyte foot processes|MP:0011087,neonatal lethality, complete penetrance
MGI:2677917	Mafb<tm1Mhs>	MP:0001575,cyanosis|MP:0001943,abnormal respiration|MP:0001951,abnormal breathing pattern|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0001957,apnea|MP:0003631,nervous system phenotype|MP:0005277,abnormal brainstem morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0014812,abnormal brain physiology
MGI:6276966	Maf<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0001126,abnormal ovary morphology|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0004832,enlarged ovary|MP:0004848,abnormal liver size|MP:0005344,increased circulating bilirubin level|MP:0009142,decreased prepulse inhibition|MP:0009552,urinary bladder obstruction|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0020421,increased freezing behavior
MGI:3711715	Maf<ENU424>	MP:0010254,nuclear cataract
MGI:2663639	Maff<tm1.1Jeng>	MP:0002169,no abnormal phenotype detected
MGI:2663638	Maff<tm1Jeng>	MP:0002169,no abnormal phenotype detected
MGI:2386717	Mafg<tm1Jeng>	MP:0000229,abnormal megakaryocyte differentiation|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0003179,thrombocytopenia|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2385844	Mafk<tm1Sho>	MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype
MGI:2654153	Maf<Ofl>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001288,abnormal lens induction|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001320,small pupil|MP:0001759,increased urine glucose level|MP:0002135,abnormal kidney morphology|MP:0002638,abnormal pupillary reflex|MP:0002704,tubular nephritis|MP:0002705,dilated renal tubule|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2148636	Maf<tm1Glm>	MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0005391,vision/eye phenotype|MP:0005545,abnormal lens development|MP:0008700,decreased interleukin-4 secretion|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:2148635	Maf<tm1Gsb>	MP:0000435,shortened head|MP:0000746,weakness|MP:0001292,abnormal lens vesicle development|MP:0001306,small lens|MP:0001431,abnormal eating behavior|MP:0005301,abnormal cornea endothelium morphology|MP:0005545,abnormal lens development|MP:0011087,neonatal lethality, complete penetrance|MP:0011962,increased cornea thickness
MGI:2148637	Maf<tm1Mym>	MP:0002840,abnormal lens fiber morphology|MP:0005545,abnormal lens development|MP:0011085,postnatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:7516747	Mageb4<em1Zhpw>	MP:0005389,reproductive system phenotype
MGI:7516757	Mageb4<em2Zhpw>	MP:0005389,reproductive system phenotype
MGI:6276855	Maged1<em1(IMPC)Mbp>	MP:0001402,decreased locomotor activity|MP:0002757,decreased vertical activity|MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval|MP:0020421,increased freezing behavior
MGI:4437118	Maged1<tm1.1Urfm>	MP:0001011,abnormal superior cervical ganglion morphology|MP:0003204,decreased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0005253,abnormal eye physiology|MP:0008752,abnormal tumor necrosis factor level|MP:0008859,abnormal hair cycle catagen phase|MP:0009253,abnormal sympathetic neuron physiology
MGI:5426784	Maged1<tm1Tnab>	MP:0001361,social withdrawal|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002573,behavioral despair|MP:0005322,abnormal serotonin level|MP:0005386,behavior/neurological phenotype|MP:0009710,anhedonia|MP:0010069,increased serotonin level|MP:0010070,decreased serotonin level
MGI:5512987	Maged1<tm1Xgao>	MP:0020467,abnormal circadian behavior|MP:0020470,shortened circadian behavior period|MP:0020476,abnormal circardian behavior entrainment
MGI:6153485	Magee2<em1(IMPC)Wtsi>	MP:0000434,megacephaly|MP:0000905,increased superior colliculus size|MP:0003631,nervous system phenotype|MP:0005238,increased brain size|MP:0005378,growth/size/body region phenotype|MP:0008228,increased anterior commissure size|MP:0012449,increased primary motor cortex size|MP:0012451,abnormal retrosplenial granular cortex morphology|MP:0012452,increased retrosplenial granular cortex size|MP:0012465,increased hippocampal fimbria size|MP:0020534,increased pons size
MGI:6740462	Magel2<em2(IMPC)H>	MP:0001392,abnormal locomotor behavior|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level
MGI:4849506	Magel2<tm1.1Mus>	MP:0001262,decreased body weight|MP:0001436,abnormal suckling behavior|MP:0001752,abnormal hypothalamus secretion|MP:0003631,nervous system phenotype|MP:0005560,decreased circulating glucose level|MP:0009546,absent gastric milk in neonates|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3760092	Magel2<tm1Stw>	MP:0000161,scoliosis|MP:0001261,obese|MP:0001385,pup cannibalization|MP:0001402,decreased locomotor activity|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002636,delayed vaginal opening|MP:0002679,abnormal corpus luteum morphology|MP:0002757,decreased vertical activity|MP:0002780,decreased circulating testosterone level|MP:0003122,maternal imprinting|MP:0003961,decreased lean body mass|MP:0005378,growth/size/body region phenotype|MP:0005388,respiratory system phenotype|MP:0008260,abnormal autophagy|MP:0008544,impaired olfaction|MP:0008995,early reproductive senescence|MP:0009006,prolonged estrous cycle|MP:0009008,delayed estrous cycle|MP:0009013,abnormal proestrus|MP:0009399,increased skeletal muscle fiber size|MP:0009400,decreased skeletal muscle fiber size|MP:0009417,skeletal muscle atrophy|MP:0010053,decreased grip strength|MP:0010239,decreased skeletal muscle weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011957,decreased compensatory feeding amount|MP:0014142,increased body fat mass|MP:0020467,abnormal circadian behavior|MP:0020477,abnormal locomotor circadian rhythm
MGI:3530498	Magi1<Gt(OST33326)Lex>	MP:0011131,abnormal lung endothelial cell physiology
MGI:6356800	Magi1<tm1Itl>	MP:0002169,no abnormal phenotype detected
MGI:5439615	Magi2<tm1.1Knis>	MP:0003624,anuria|MP:0005553,increased circulating creatinine level|MP:0008059,abnormal podocyte foot process morphology|MP:0008060,abnormal podocyte slit diaphragm morphology|MP:0008139,fused podocyte foot processes|MP:0011085,postnatal lethality, complete penetrance
MGI:5508897	Magi2<tm1Key>	MP:0000523,cortical renal glomerulopathies|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0003631,nervous system phenotype|MP:0005264,glomerulosclerosis|MP:0005326,abnormal podocyte morphology|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008060,abnormal podocyte slit diaphragm morphology|MP:0008137,absent podocytes|MP:0008140,podocyte foot process effacement|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0011346,renal tubule atrophy|MP:0011353,expanded mesangial matrix|MP:0011402,renal cast|MP:0011405,tubulointerstitial nephritis|MP:0011455,absent glomerular endothelium fenestra|MP:0011498,abnormal glomerular capsule parietal layer morphology|MP:0011506,glomerular crescent|MP:0011856,abnormal glomerular filtration barrier function|MP:0011868,podocyte microvillus transformation|MP:0011871,podocyte hypertrophy
MGI:3716218	Magi2<tm1Yhat>	MP:0002882,abnormal neuron morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:6403694	Magix<em1(IMPC)Hmgu>	MP:0000221,decreased leukocyte cell number|MP:0002599,increased mean platelet volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005553,increased circulating creatinine level
MGI:5792042	Mag<mpc225H>	MP:0001406,abnormal gait
MGI:4345363	Magoh<Gt(AG0150)Wtsi>	MP:0000774,decreased brain size|MP:0001262,decreased body weight|MP:0005408,hypopigmentation|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3852964	Magoh<Gt(AT0027)Wtsi>	MP:0000774,decreased brain size|MP:0001262,decreased body weight|MP:0005408,hypopigmentation|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4462402	Magoh<Mos2>	MP:0000774,decreased brain size|MP:0000913,abnormal brain development|MP:0001262,decreased body weight|MP:0003202,abnormal neuron apoptosis|MP:0003984,embryonic growth retardation|MP:0005408,hypopigmentation|MP:0006254,thin cerebral cortex|MP:0008770,decreased survivor rate|MP:0008948,decreased neuron number|MP:0009760,abnormal mitotic spindle morphology|MP:0009967,abnormal neuron proliferation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011724,ectopic cortical neuron|MP:0012138,decreased forebrain size|MP:0014178,increased brain apoptosis|MP:0020069,decreased neocortex size
MGI:5638555	Magoh<tm1c(KOMP)Dlsi>	MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0002169,no abnormal phenotype detected|MP:0006254,thin cerebral cortex
MGI:5638556	Magoh<tm1d(KOMP)Dlsi>	MP:0000373,belly spot|MP:0000774,decreased brain size|MP:0005408,hypopigmentation|MP:0006254,thin cerebral cortex|MP:0010768,mortality/aging
MGI:6279902	Magt1<em1(IMPC)Tcp>	MP:0002059,abnormal seminal vesicle morphology
MGI:6155597	Magt1<Gt(IST13422E1)Tigm>	MP:0004939,abnormal B cell morphology|MP:0005014,increased B cell number|MP:0005018,decreased T cell number|MP:0005154,increased B cell proliferation|MP:0008098,decreased plasma cell number|MP:0008181,increased marginal zone B cell number
MGI:4228404	Magt1<Gt(OST199678)Lex>	MP:0002169,no abnormal phenotype detected
MGI:5576044	Mag<tm1.1(KOMP)Vlcg>	MP:0000221,decreased leukocyte cell number|MP:0000947,convulsive seizures|MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0003064,decreased coping response|MP:0004738,abnormal auditory brainstem response|MP:0011396,abnormal sleep behavior
MGI:2384092	Mag<tm1Mtg>	MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0001106,abnormal Schwann cell morphology|MP:0003631,nervous system phenotype|MP:0003871,abnormal myelin sheath morphology|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0012674,tomacula|MP:0013438,dysmyelination
MGI:3053091	Mag<tm1Pop>	MP:0000920,abnormal myelination
MGI:1857216	Mag<tm1Rod>	MP:0000745,tremors|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001440,abnormal grooming behavior|MP:0001489,decreased startle reflex|MP:0003863,decreased aggression towards mice|MP:0005154,increased B cell proliferation|MP:0005404,abnormal axon morphology|MP:0009142,decreased prepulse inhibition
MGI:6764555	Majin<em1Smtb>	MP:0001147,small testis|MP:0004805,absent oocytes|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis
MGI:6764556	Majin<em2Smtb>	MP:0001147,small testis|MP:0004805,absent oocytes|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis
MGI:6140010	Mak16<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2179972	Mak<tm1Yshk>	MP:0001935,decreased litter size|MP:0002675,asthenozoospermia
MGI:5496055	Malat1<tm1.2Dlsp>	MP:0001847,brain inflammation|MP:0002169,no abnormal phenotype detected|MP:0003076,increased susceptibility to ischemic brain injury|MP:0003633,abnormal nervous system physiology|MP:0006060,increased cerebral infarct size|MP:0014178,increased brain apoptosis
MGI:3770630	malf	MP:0000018,small ears|MP:0000022,abnormal ear shape|MP:0000023,abnormal ear position|MP:0000024,lowered ear position|MP:0002177,abnormal outer ear morphology|MP:0008862,asymmetric snout
MGI:2154956	Malrd1<C57BL/6ByJ>	MP:0000183,decreased circulating LDL cholesterol level|MP:0002139,abnormal hepatobiliary system physiology|MP:0005085,abnormal gallbladder physiology|MP:0005146,decreased circulating VLDL cholesterol level
MGI:6423070	Malrd1<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001293,anophthalmia|MP:0002092,abnormal eye morphology|MP:0002699,abnormal vitreous body morphology
MGI:5640788	Malt1<m1Btlr>	MP:0020154,impaired humoral immune response
MGI:5688602	Malt1<m2Btlr>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0020154,impaired humoral immune response
MGI:5688603	Malt1<m3Btlr>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0020154,impaired humoral immune response
MGI:3639305	Malt1<tm1Mak>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002376,abnormal dendritic cell physiology|MP:0005095,decreased T cell proliferation
MGI:2684761	Malt1<tm1Vmd>	MP:0000685,abnormal immune system morphology|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002362,abnormal spleen marginal zone morphology|MP:0002407,abnormal double-negative T cell morphology|MP:0002460,decreased immunoglobulin level|MP:0005094,abnormal T cell proliferation|MP:0008203,absent B-1a cells|MP:0008688,decreased interleukin-2 secretion
MGI:3053860	Mal<tm1Nsw>	MP:0000920,abnormal myelination|MP:0001330,abnormal optic nerve morphology
MGI:3621180	Maml1<tm1Lizw>	MP:0001265,decreased body size|MP:0004201,fetal growth retardation|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009414,skeletal muscle fiber necrosis|MP:0011085,postnatal lethality, complete penetrance
MGI:3714162	Maml1<tm1Mkit>	MP:0000715,decreased thymocyte number|MP:0000752,dystrophic muscle|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0005090,increased double-negative T cell number|MP:0008182,decreased marginal zone B cell number|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5301728	Maml3<tm1Mkit>	MP:0002169,no abnormal phenotype detected
MGI:5766132	Mamld1<tm1.1(NCOM)Mfgc>	MP:0000218,increased leukocyte cell number|MP:0001258,decreased body length|MP:0002764,short tibia|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005013,increased lymphocyte cell number|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010379,decreased respiratory quotient
MGI:5467328	Mamld1<tm1Tsga>	MP:0005389,reproductive system phenotype
MGI:5313409	Mamstr<tm1.1Eno>	MP:0013239,impaired skeletal muscle regeneration
MGI:5313410	Mamstr<tm1.2Eno>	MP:0013239,impaired skeletal muscle regeneration
MGI:3703789	Man1a2<tm1.1Ahe>	MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001179,thick pulmonary interalveolar septum|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002270,abnormal pulmonary alveolus morphology|MP:0010909,pulmonary alveolar hemorrhage|MP:0011087,neonatal lethality, complete penetrance
MGI:6257674	Man1b1<em1(IMPC)Bay>	MP:0010579,increased heart left ventricle size|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6273945	Man2a1<em1(IMPC)Hmgu>	MP:0000195,decreased circulating calcium level|MP:0000494,abnormal cecum morphology|MP:0002599,increased mean platelet volume|MP:0002699,abnormal vitreous body morphology|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0003394,increased cardiac output|MP:0004151,decreased circulating iron level|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005566,decreased blood urea nitrogen level|MP:0008806,increased circulating amylase level|MP:0010067,increased red blood cell distribution width
MGI:2158937	Man2a1<tm1Jxm>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001790,abnormal immune system physiology|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002083,premature death|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002447,abnormal erythrocyte morphology|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002723,abnormal immune serum protein physiology|MP:0002743,glomerulonephritis|MP:0002962,increased urine protein level|MP:0003985,renal fibrosis|MP:0004809,increased hematopoietic stem cell number|MP:0005005,abnormal self tolerance|MP:0005161,hematuria|MP:0005325,abnormal renal glomerulus morphology|MP:0005387,immune system phenotype|MP:0005502,abnormal renal/urinary system physiology|MP:0008049,increased memory T cell number|MP:0020519,renal glomerular immunoglobulin deposits|MP:0031084,decreased erythrocyte osmotic fragility
MGI:2158829	Man2a2<tm1Mfu>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002687,oligozoospermia
MGI:3584185	Man2b1<tm1Psa>	MP:0000031,abnormal cochlea morphology|MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0001004,abnormal retina photoreceptor morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001262,decreased body weight|MP:0001417,decreased exploration in new environment|MP:0001460,abnormal olfactory discrimination memory|MP:0001463,abnormal spatial learning|MP:0001764,abnormal homeostasis|MP:0002092,abnormal eye morphology|MP:0002356,abnormal spleen red pulp morphology|MP:0002799,abnormal passive avoidance behavior|MP:0002855,abnormal cochlear ganglion morphology|MP:0002856,abnormal vestibular ganglion morphology|MP:0002882,abnormal neuron morphology|MP:0003008,enhanced long-term potentiation|MP:0003634,abnormal glial cell morphology|MP:0003686,abnormal eye muscle morphology|MP:0004081,abnormal globus pallidus morphology|MP:0004292,abnormal spiral ligament fibrocyte morphology|MP:0005058,abnormal lysosome morphology|MP:0005277,abnormal brainstem morphology|MP:0005300,abnormal cornea stroma morphology|MP:0005301,abnormal cornea endothelium morphology|MP:0005404,abnormal axon morphology|MP:0005508,abnormal skeleton morphology|MP:0008114,abnormal Kupffer cell morphology|MP:0008265,abnormal hippocampus CA2 region morphology|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009640,abnormal renal tubule epithelium morphology|MP:0009643,abnormal urine homeostasis
MGI:5513801	Man2b2<tm1b(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0002768,small adrenal glands|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005419,decreased circulating serum albumin level|MP:0005559,increased circulating glucose level|MP:0005567,decreased circulating total protein level|MP:0010088,decreased circulating fructosamine level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5564742	Man2c1<tm1.1Tbec>	MP:0000607,abnormal hepatocyte morphology|MP:0000780,abnormal corpus callosum morphology|MP:0001785,edema|MP:0002628,hepatic steatosis|MP:0003005,abnormal hippocampal fimbria morphology|MP:0003224,neuron degeneration|MP:0003271,abnormal duodenum morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0005381,digestive/alimentary phenotype|MP:0005440,increased glycogen level|MP:0008025,brain vacuoles|MP:0008026,abnormal brain white matter morphology|MP:0008108,abnormal small intestinal villus morphology|MP:0008128,abnormal brain internal capsule morphology|MP:0008547,abnormal neocortex morphology|MP:0008882,abnormal enterocyte physiology|MP:0008917,abnormal oligodendrocyte physiology|MP:0010400,increased liver glycogen level|MP:0010762,abnormal microglial cell activation|MP:0011377,renal glomerulus fibrosis
MGI:3617002	Manba<tm1Khf>	MP:0000607,abnormal hepatocyte morphology|MP:0000798,abnormal frontal lobe morphology|MP:0000815,abnormal Ammon gyrus morphology|MP:0000818,abnormal amygdala morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000955,abnormal spinal cord morphology|MP:0002703,abnormal renal tubule morphology|MP:0003172,abnormal lysosome physiology|MP:0003271,abnormal duodenum morphology|MP:0004077,abnormal striatum morphology|MP:0004696,abnormal thyroid follicle morphology|MP:0004933,abnormal epididymis epithelium morphology|MP:0005386,behavior/neurological phenotype|MP:0008114,abnormal Kupffer cell morphology|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0009979,abnormal cerebellum deep nucleus morphology|MP:0031148,abnormal liver sinusoidal endothelial cell morphology
MGI:4362994	Maneal<tm1a(KOMP)Wtsi>	MP:0005561,increased mean corpuscular hemoglobin
MGI:4362648	Manf<tm1a(KOMP)Wtsi>	MP:0001265,decreased body size|MP:0001426,polydipsia|MP:0001559,hyperglycemia|MP:0001732,postnatal growth retardation|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0003339,decreased pancreatic beta cell number|MP:0003631,nervous system phenotype|MP:0004201,fetal growth retardation|MP:0005334,abnormal fat pad morphology|MP:0006009,abnormal neuronal migration|MP:0006254,thin cerebral cortex|MP:0008415,abnormal neurite morphology|MP:0008439,abnormal cortical plate morphology|MP:0008441,thin cortical plate|MP:0008457,abnormal cortical intermediate zone morphology|MP:0008489,slow postnatal weight gain|MP:0009114,decreased pancreatic beta cell mass|MP:0009168,decreased pancreatic islet number|MP:0009175,abnormal pancreatic beta cell differentiation|MP:0012203,abnormal neuronal stem cell morphology|MP:0013220,increased pancreas apoptosis|MP:0013272,abnormal translation|MP:0020599,increased cerebral cortex cell density
MGI:6157444	Manf<tm1c(KOMP)Wtsi>	MP:0001559,hyperglycemia|MP:0002727,decreased circulating insulin level|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:3528358	Manln11<LG/J>	MP:0004593,long mandible
MGI:3528362	Manln13<LG/J>	MP:0004593,long mandible
MGI:3528364	Manln14<LG/J>	MP:0004593,long mandible
MGI:3528368	Manln16<LG/J>	MP:0004593,long mandible
MGI:3528370	Manln17<LG/J>	MP:0004593,long mandible
MGI:3528372	Manln18<LG/J>	MP:0004593,long mandible
MGI:3528375	Manln19<SM/J>	MP:0004593,long mandible
MGI:3528338	Manln1<LG/J>	MP:0004593,long mandible
MGI:3528342	Manln3<LG/J>	MP:0004593,long mandible
MGI:3528346	Manln5<LG/J>	MP:0004593,long mandible
MGI:3528348	Manln6<LG/J>	MP:0004593,long mandible
MGI:3528352	Manln8<LG/J>	MP:0004593,long mandible
MGI:3528354	Manln9<LG/J>	MP:0004593,long mandible
MGI:5565175	Mannr<tm1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:3777146	Manr1<129P3/J>	MP:0001982,decreased chemically-elicited antinociception|MP:0002733,abnormal thermal nociception
MGI:3777145	Manr1<C57BL/J>	MP:0001981,increased chemically-elicited antinociception|MP:0002733,abnormal thermal nociception
MGI:6120810	Mansc4<tm1b(KOMP)Wtsi>	MP:0005344,increased circulating bilirubin level
MGI:3057337	Maoa<K284stop>	MP:0001354,increased aggression towards male mice|MP:0001402,decreased locomotor activity
MGI:2180818	Maoa<Tg(H2-K1-Ifnb1)8Seif>	MP:0000788,abnormal cerebral cortex morphology|MP:0000937,abnormal motor neuron morphology|MP:0001354,increased aggression towards male mice|MP:0001357,increased aggression towards humans|MP:0001360,abnormal social investigation|MP:0001400,hyperresponsive|MP:0001410,head bobbing|MP:0001431,abnormal eating behavior|MP:0001440,abnormal grooming behavior|MP:0001501,abnormal sleep pattern|MP:0001505,hunched posture|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0001906,increased dopamine level|MP:0002272,abnormal nervous system electrophysiology|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002566,abnormal sexual interaction|MP:0003360,abnormal depression-related behavior|MP:0003459,increased fear-related response|MP:0004924,abnormal behavior|MP:0005418,abnormal circulating hormone level|MP:0010069,increased serotonin level|MP:0012575,increased noradrenaline level
MGI:4946240	Maoa<tm1Shih>	MP:0003822,decreased left ventricle systolic pressure|MP:0004215,abnormal myocardial fiber physiology|MP:0004486,decreased response of heart to induced stress
MGI:2180752	Maob<tm1Shih>	MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0009643,abnormal urine homeostasis|MP:0011452,decreased susceptibility to dopaminergic neuron neurotoxicity|MP:0031391,increased locomotor activity
MGI:5774956	Map1a<m1J>	MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000890,thin cerebellar molecular layer|MP:0001393,ataxia|MP:0003631,nervous system phenotype|MP:0005404,abnormal axon morphology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0010733,abnormal axon initial segment morphology
MGI:5774957	Map1a<tm1.2(KOMP)Mbp>	MP:0000876,Purkinje cell degeneration|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0010733,abnormal axon initial segment morphology|MP:0020850,abnormal microtubule cytoskeleton morphology
MGI:2148182	Map1b<Gt(IRESBetageo)2Pgr>	MP:0000780,abnormal corpus callosum morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000849,abnormal cerebellum morphology|MP:0000857,abnormal cerebellar foliation|MP:0001491,unresponsive to tactile stimuli|MP:0004263,abnormal limb posture|MP:0008443,absent subplate|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0011087,neonatal lethality, complete penetrance
MGI:3575407	Map1b<tm1Prop>	MP:0000422,delayed hair appearance|MP:0000781,decreased corpus callosum size|MP:0000794,abnormal parietal lobe morphology|MP:0000807,abnormal hippocampus morphology|MP:0000920,abnormal myelination|MP:0001061,abnormal oculomotor nerve morphology|MP:0001262,decreased body weight|MP:0001290,delayed eyelid opening|MP:0001344,blepharoptosis|MP:0001417,decreased exploration in new environment|MP:0001429,dehydration|MP:0001921,reduced fertility|MP:0002092,abnormal eye morphology|MP:0002196,absent corpus callosum|MP:0003651,abnormal axon extension|MP:0004167,abnormal cingulate gyrus morphology|MP:0005403,abnormal nerve conduction|MP:0005404,abnormal axon morphology|MP:0008223,absent hippocampal commissure|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2152745	Map1b<tm1Rak>	MP:0000556,abnormal hindlimb morphology|MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000807,abnormal hippocampus morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000849,abnormal cerebellum morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001286,abnormal eye development|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0005202,lethargy|MP:0006149,decreased visual acuity|MP:0008512,disorganized retina inner nuclear layer|MP:0008516,disorganized retina outer nuclear layer|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:3774111	Map1lc3b<tm1Mrab>	MP:0003449,abnormal intestine goblet cell morphology|MP:0005389,reproductive system phenotype|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010768,mortality/aging
MGI:4948361	Map1s<tm1.1Lliu>	MP:0000278,abnormal myocardial fiber morphology|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0030939,abnormal autophagosome formation
MGI:7425810	Map2k1<em1(IMPC)H>	MP:0011100,preweaning lethality, complete penetrance
MGI:2178132	Map2k1<Gt(ROSABetageo)J2Chrn>	MP:0000260,abnormal angiogenesis|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0001722,pale yolk sac|MP:0003091,abnormal cell migration|MP:0003544,abnormal vascular endothelial cell migration|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004259,small placenta|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0013241,embryo tissue necrosis
MGI:5504393	Map2k1<tm1.1Bacc>	MP:0001717,absent ectoplacental cone|MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3714919	Map2k1<tm1.1Chrn>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6157680	Map2k1<tm2.1Chrn>	MP:0010160,increased oligodendrocyte number|MP:0010457,pulmonary artery stenosis|MP:0011812,increased cranium length|MP:0012065,increased astrocyte number
MGI:4434127	Map2k2<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0010025,decreased total body fat amount
MGI:2668345	Map2k2<tm1Chrn>	MP:0002169,no abnormal phenotype detected
MGI:1857752	Map2k3<tm1Flv>	MP:0002412,increased susceptibility to bacterial infection|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0006414,decreased T cell apoptosis|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3769117	Map2k4<tm1Ctr>	MP:0000745,tremors|MP:0000781,decreased corpus callosum size|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000877,abnormal Purkinje cell morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001523,impaired righting response|MP:0001732,postnatal growth retardation|MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0008226,decreased anterior commissure size|MP:0009937,abnormal neuron differentiation|MP:0011085,postnatal lethality, complete penetrance
MGI:2183040	Map2k4<tm1Flv>	MP:0011092,embryonic lethality, complete penetrance
MGI:1861969	Map2k4<tm1Lizon>	MP:0000596,abnormal liver development|MP:0000602,dilated liver sinusoidal space|MP:0000606,decreased hepatocyte number|MP:0003717,pallor|MP:0003887,increased hepatocyte apoptosis|MP:0003888,liver hemorrhage|MP:0011091,prenatal lethality, complete penetrance|MP:0012235,abnormal liver bud morphology
MGI:1857536	Map2k4<tm1Pngr>	MP:0000596,abnormal liver development|MP:0001577,anemia|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3526901	Map2k5<tm1Ctr>	MP:0000267,abnormal heart development|MP:0000292,distended pericardium|MP:0000298,absent atrioventricular cushions|MP:0000352,decreased cell proliferation|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002169,no abnormal phenotype detected|MP:0002189,abnormal myocardial trabeculae morphology|MP:0006042,increased apoptosis|MP:0010454,abnormal truncus arteriosus septation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2673716	Map2k6<tm1Flv>	MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0009258,abnormal thymocyte apoptosis
MGI:3687978	Map2k6<tm1Ina>	MP:0006043,decreased apoptosis
MGI:4948950	Map2k7<tm1.1Twad>	MP:0001302,eyelids open at birth|MP:0002169,no abnormal phenotype detected
MGI:4842504	Map2k7<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:2183768	Map2k7<tm1Flv>	MP:0011092,embryonic lethality, complete penetrance
MGI:5444459	Map2k7<tm1Pngr>	MP:0008428,abnormal spatial working memory
MGI:5297854	Map2k7<tm1Rjd>	MP:0003631,nervous system phenotype
MGI:5320479	Map2k7<tm2.1Rjd>	MP:0011092,embryonic lethality, complete penetrance
MGI:3512900	Map2<repro4>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002208,abnormal germ cell morphology|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0008279,arrest of spermiogenesis|MP:0014634,decreased round spermatid number
MGI:2152587	Map2<tm1Noh>	MP:0000807,abnormal hippocampus morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0001262,decreased body weight
MGI:3653757	Map2<tm1Zhku>	MP:0001469,abnormal contextual conditioning behavior|MP:0003460,decreased fear-related response
MGI:5548463	Map3k10<tm1b(EUCOMM)Hmgu>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3800582	Map3k10<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:4999723	Map3k11<m1J>	MP:0000116,abnormal tooth development|MP:0001216,abnormal epidermal layer morphology|MP:0002100,abnormal tooth morphology|MP:0002819,abnormal dental pulp cavity morphology|MP:0009931,abnormal skin appearance|MP:0011084,lethality at weaning, incomplete penetrance
MGI:3526217	Map3k11<tm1Rjd>	MP:0001218,thin epidermis|MP:0005384,cellular phenotype
MGI:3760641	Map3k12<Gt(RRN366)Byg>	MP:0008227,absent anterior commissure|MP:0010654,slow Wallerian degeneration
MGI:5440722	Map3k12<tm1.1Adia>	MP:0010654,slow Wallerian degeneration
MGI:5294468	Map3k12<tm1.1Lewc>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0003204,decreased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0005192,increased motor neuron number|MP:0009937,abnormal neuron differentiation
MGI:5440724	Map3k12<tm1.2Adia>	MP:0002081,perinatal lethality|MP:0010654,slow Wallerian degeneration
MGI:5811622	Map3k12<tm1b(EUCOMM)Hmgu>	MP:0005553,increased circulating creatinine level|MP:0010579,increased heart left ventricle size|MP:0011100,preweaning lethality, complete penetrance
MGI:5812286	Map3k12<tm1Lbh>	MP:0003651,abnormal axon extension|MP:0005621,abnormal cell physiology
MGI:5294467	Map3k12<tm1Lewc>	MP:0006309,decreased retina ganglion cell number
MGI:3692456	Map3k12<tm1Shir>	MP:0000781,decreased corpus callosum size|MP:0000788,abnormal cerebral cortex morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0002152,abnormal brain morphology|MP:0005237,abnormal olfactory tract morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008026,abnormal brain white matter morphology|MP:0008128,abnormal brain internal capsule morphology|MP:0008225,abnormal anterior commissure morphology|MP:0008232,abnormal cingulum morphology|MP:0010859,abnormal anterior commissure pars anterior morphology|MP:0010860,abnormal anterior commissure pars posterior morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0014553,decreased neuronal migration
MGI:4362915	Map3k13<tm1a(KOMP)Wtsi>	MP:0003651,abnormal axon extension|MP:0005621,abnormal cell physiology
MGI:6780081	Map3k13<tm1b(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:1858522	Map3k14<aly>	MP:0000336,decreased mast cell number|MP:0000488,abnormal intestinal epithelium morphology|MP:0000613,abnormal salivary gland morphology|MP:0000628,abnormal mammary gland development|MP:0000685,abnormal immune system morphology|MP:0000706,small thymus|MP:0001790,abnormal immune system physiology|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0001828,abnormal T cell activation|MP:0001846,increased inflammatory response|MP:0001859,kidney inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001869,pancreas inflammation|MP:0002083,premature death|MP:0002138,abnormal hepatobiliary system morphology|MP:0002375,abnormal thymus medulla morphology|MP:0002376,abnormal dendritic cell physiology|MP:0002401,abnormal lymphopoiesis|MP:0002406,increased susceptibility to infection|MP:0002455,abnormal dendritic cell antigen presentation|MP:0002492,decreased IgE level|MP:0002619,abnormal lymphocyte morphology|MP:0002831,absent Peyer's patches|MP:0002928,abnormal bile duct morphology|MP:0003253,dilated bile duct|MP:0003254,bile duct inflammation|MP:0003255,bile duct proliferation|MP:0003449,abnormal intestine goblet cell morphology|MP:0004751,increased length of allograft survival|MP:0004839,bile duct hyperplasia|MP:0004974,decreased regulatory T cell number|MP:0005011,increased eosinophil cell number|MP:0005017,decreased B cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0008024,absent lymph nodes|MP:0008036,abnormal NK T cell morphology|MP:0008040,decreased NK T cell number|MP:0008127,decreased dendritic cell number|MP:0008201,absent follicular dendritic cells|MP:0008234,absent spleen marginal zone|MP:0008397,abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology|MP:0008471,abnormal spleen primary B follicle morphology|MP:0008578,decreased circulating interferon-gamma level|MP:0008603,decreased circulating interleukin-4 level|MP:0008880,lacrimal gland inflammation|MP:0008904,abnormal mammary fat pad morphology|MP:0009297,decreased mammary fat pad weight|MP:0009543,abnormal thymus corticomedullary boundary morphology|MP:0010768,mortality/aging|MP:0013741,absent thymus corticomedullary boundary|MP:0014130,thymus cyst|MP:0014263,decreased spleen B cell follicle number
MGI:4357692	Map3k14<m1Btlr>	MP:0001802,arrested B cell differentiation|MP:0001805,decreased IgG level|MP:0004816,abnormal class switch recombination|MP:0005017,decreased B cell number|MP:0008024,absent lymph nodes|MP:0008217,abnormal B cell activation
MGI:5903065	Map3k14<tm1.1Gne>	MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002490,abnormal immunoglobulin level|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0005387,immune system phenotype|MP:0008133,decreased Peyer's patch number|MP:0008178,decreased germinal center B cell number|MP:0008495,decreased IgG1 level
MGI:5903085	Map3k14<tm1.2Gne>	MP:0001807,decreased IgA level|MP:0002362,abnormal spleen marginal zone morphology|MP:0002459,abnormal B cell physiology|MP:0002831,absent Peyer's patches|MP:0005017,decreased B cell number|MP:0008174,decreased follicular B cell number|MP:0008178,decreased germinal center B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008207,decreased B-2 B cell number|MP:0008827,abnormal thymus cell ratio|MP:0009622,absent inguinal lymph nodes|MP:0009629,small brachial lymph nodes|MP:0009632,small axillary lymph nodes|MP:0009634,absent popliteal lymph nodes|MP:0009923,decreased transitional stage T1 B cell number|MP:0009926,decreased transitional stage T2 B cell number
MGI:2387668	Map3k14<tm1Rds>	MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0001807,decreased IgA level|MP:0002460,decreased immunoglobulin level|MP:0002831,absent Peyer's patches|MP:0004816,abnormal class switch recombination|MP:0008024,absent lymph nodes|MP:0008465,absent mesenteric lymph nodes|MP:0008497,decreased IgG2b level|MP:0009622,absent inguinal lymph nodes|MP:0009630,absent axillary lymph nodes|MP:0009633,absent cervical lymph nodes|MP:0009634,absent popliteal lymph nodes
MGI:5644160	Map3k15<tm1Hijo>	MP:0000231,hypertension|MP:0002136,abnormal kidney physiology|MP:0004217,salt-sensitive hypertension|MP:0005376,homeostasis/metabolism phenotype|MP:0005621,abnormal cell physiology|MP:0006144,increased systemic arterial systolic blood pressure
MGI:1857335	Map3k1<Ga>	MP:0001302,eyelids open at birth|MP:0001314,cornea opacity|MP:0009651,abnormal eyelid development
MGI:5502228	Map3k1<goya>	MP:0000043,organ of Corti degeneration|MP:0001297,microphthalmia|MP:0001485,abnormal pinna reflex|MP:0001967,deafness|MP:0002092,abnormal eye morphology|MP:0002750,exophthalmos|MP:0003153,early eyelid opening|MP:0003727,abnormal retina layer morphology|MP:0004401,increased cochlear outer hair cell number|MP:0004404,cochlear outer hair cell degeneration|MP:0005253,abnormal eye physiology|MP:0005377,hearing/vestibular/ear phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4451248	Map3k1<tm1a(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0001554,increased circulating free fatty acids level|MP:0003960,increased lean body mass|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:2179711	Map3k1<tm1Glj>	MP:0001302,eyelids open at birth|MP:0001853,heart inflammation|MP:0003222,increased cardiomyocyte apoptosis|MP:0003921,abnormal heart left ventricle morphology|MP:0004485,increased response of heart to induced stress|MP:0004883,abnormal vascular wound healing|MP:0005387,immune system phenotype|MP:0005595,abnormal vascular smooth muscle physiology|MP:0005598,decreased heart ventricle muscle contractility|MP:0006138,congestive heart failure|MP:0009651,abnormal eyelid development|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011707,impaired fibroblast cell migration
MGI:2676654	Map3k1<tm1Yxia>	MP:0000043,organ of Corti degeneration|MP:0001302,eyelids open at birth|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0001340,abnormal eyelid morphology|MP:0001967,deafness|MP:0002655,abnormal keratinocyte morphology|MP:0003153,early eyelid opening|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004396,decreased cochlear inner hair cell number|MP:0004401,increased cochlear outer hair cell number|MP:0004404,cochlear outer hair cell degeneration|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005300,abnormal cornea stroma morphology|MP:0005547,abnormal Muller cell morphology|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008852,retina neovascularization|MP:0009263,abnormal eyelid fusion|MP:0009392,retina gliosis|MP:0009651,abnormal eyelid development|MP:0009742,increased cornea stroma thickness|MP:0009772,abnormal retina development|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013745,abnormal eyelid margin morphology|MP:0030005,increased retina apoptosis
MGI:5903727	Map3k20<em1Smun>	MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012270,cardiac edema
MGI:5903729	Map3k20<em2Smun>	MP:0000556,abnormal hindlimb morphology|MP:0000562,polydactyly|MP:0004509,abnormal pelvic girdle bone morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005390,skeleton phenotype
MGI:2183907	Map3k2<tm1Bisu>	MP:0001828,abnormal T cell activation|MP:0003009,abnormal cytokine secretion|MP:0005348,increased T cell proliferation
MGI:5469064	Map3k2<tm1Rdbr>	MP:0001935,decreased litter size|MP:0004486,decreased response of heart to induced stress
MGI:2178133	Map3k3<tm1Bisu>	MP:0000259,abnormal vascular development|MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000295,trabecula carnea hypoplasia|MP:0000433,microcephaly|MP:0003105,abnormal heart atrium morphology|MP:0004076,abnormal vitelline vascular remodeling|MP:0005329,abnormal myocardium layer morphology|MP:0005602,decreased angiogenesis|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3840862	Map3k3<tm1Kuro>	MP:0000715,decreased thymocyte number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion
MGI:4361339	Map3k4<byg>	MP:0000914,exencephaly|MP:0001785,edema|MP:0002211,abnormal primary sex determination|MP:0002995,primary sex reversal|MP:0002996,ovotestis|MP:0003054,spina bifida|MP:0003830,abnormal testis development|MP:0005389,reproductive system phenotype|MP:0006418,abnormal testis cord formation|MP:0006424,absent testis cords|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3044978	Map3k4<tm1Flv>	MP:0001265,decreased body size|MP:0002995,primary sex reversal|MP:0005465,abnormal T-helper 1 physiology|MP:0008567,decreased interferon-gamma secretion|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3604209	Map3k4<tm1Glj>	MP:0000137,abnormal vertebrae morphology|MP:0000157,abnormal sternum morphology|MP:0000161,scoliosis|MP:0000914,exencephaly|MP:0001925,male infertility|MP:0002151,abnormal neural tube morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002759,abnormal caudal vertebrae morphology|MP:0003052,omphalocele|MP:0003054,spina bifida|MP:0003345,decreased rib number|MP:0008146,asymmetric sternocostal joints|MP:0008784,craniorachischisis|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3046838	Map3k5<tm1Hijo>	MP:0000343,abnormal response to cardiac infarction|MP:0004486,decreased response of heart to induced stress|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008944,decreased sensitivity to induced cell death|MP:0010768,mortality/aging
MGI:3843985	Map3k6<tm1Hijo>	MP:0002006,neoplasm|MP:0004499,increased incidence of tumors by chemical induction|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009581,decreased keratinocyte apoptosis|MP:0010771,integument phenotype
MGI:3608889	Map3k7<Gt(XB444)Byg>	MP:0000259,abnormal vascular development|MP:0000266,abnormal heart morphology|MP:0000364,abnormal vascular regression|MP:0000433,microcephaly|MP:0000592,short tail|MP:0000929,open neural tube|MP:0000930,wavy neural tube|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001785,edema|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0002188,small heart|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0004057,thin myocardium compact layer|MP:0004076,abnormal vitelline vascular remodeling|MP:0004787,abnormal dorsal aorta morphology|MP:0005592,abnormal vascular smooth muscle morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013241,embryo tissue necrosis
MGI:3664194	Map3k7<tm1.1Aki>	MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011705,absent fibroblast proliferation
MGI:7450973	Map3k7<tm1.1Arte>	MP:0000219,increased neutrophil cell number|MP:0000691,enlarged spleen|MP:0003884,decreased macrophage cell number|MP:0005013,increased lymphocyte cell number|MP:0005014,increased B cell number|MP:0008561,decreased tumor necrosis factor secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008670,decreased interleukin-12b secretion|MP:0008706,decreased interleukin-6 secretion|MP:0009338,increased splenocyte number|MP:0009623,enlarged inguinal lymph nodes|MP:0009631,enlarged axillary lymph nodes
MGI:5576979	Map3k7<tm1.1Gkl>	MP:0001846,increased inflammatory response|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008594,decreased circulating interleukin-10 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008657,increased interleukin-1 beta secretion|MP:0008660,increased interleukin-10 secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3696053	Map3k7<tm1.1Mds>	MP:0001614,abnormal blood vessel morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5576980	Map3k7<tm1.2Gkl>	MP:0011091,prenatal lethality, complete penetrance
MGI:3664193	Map3k7<tm1Aki>	MP:0000259,abnormal vascular development|MP:0000477,abnormal intestine morphology|MP:0000493,rectal prolapse|MP:0000495,abnormal colon morphology|MP:0000512,intestinal ulcer|MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001656,focal hepatic necrosis|MP:0001665,chronic diarrhea|MP:0001828,abnormal T cell activation|MP:0001860,liver inflammation|MP:0002083,premature death|MP:0002816,colitis|MP:0002928,abnormal bile duct morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003229,abnormal vitelline vasculature morphology|MP:0003255,bile duct proliferation|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003333,liver fibrosis|MP:0003449,abnormal intestine goblet cell morphology|MP:0003829,impaired febrile response|MP:0003887,increased hepatocyte apoptosis|MP:0003893,increased hepatocyte proliferation|MP:0004946,abnormal regulatory T cell physiology|MP:0004972,abnormal regulatory T cell number|MP:0004975,absent regulatory T cells|MP:0005018,decreased T cell number|MP:0005095,decreased T cell proliferation|MP:0005202,lethargy|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005415,intrahepatic cholestasis|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005602,decreased angiogenesis|MP:0006042,increased apoptosis|MP:0008037,abnormal T cell morphology|MP:0008040,decreased NK T cell number|MP:0008049,increased memory T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0008350,increased gamma-delta intraepithelial T cell number|MP:0008399,abnormal alpha-beta intraepithelial T cell morphology|MP:0008566,increased interferon-gamma secretion|MP:0008681,increased interleukin-17 secretion|MP:0008713,abnormal cytokine level|MP:0008895,abnormal intraepithelial T cell number|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0011009,increased circulating glutamate dehydrogenase level|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014201,abnormal intestinal epithelium physiology
MGI:5548462	Map3k7<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3696052	Map3k7<tm1Mds>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5514175	Map3k7<tm1Mis>	MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000428,abnormal craniofacial morphology|MP:0008525,decreased cranium height|MP:0009655,abnormal secondary palate development|MP:0009883,palatal shelf hypoplasia|MP:0009886,failure of palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance
MGI:3665138	Map3k7<tm1Zjc>	MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0009541,increased thymocyte apoptosis
MGI:3795881	Map3k8<M1Btlr>	MP:0005025,abnormal response to infection|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0008556,abnormal tumor necrosis factor secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008563,decreased interferon-alpha secretion|MP:0008565,decreased interferon-beta secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008669,increased interleukin-12b secretion|MP:0008706,decreased interleukin-6 secretion|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5582496	Map3k8<m2Btlr>	MP:0005025,abnormal response to infection
MGI:5688599	Map3k8<m3Btlr>	MP:0008561,decreased tumor necrosis factor secretion|MP:0011079,decreased macrophage cytokine production
MGI:6113556	Map3k8<M4Btlr>	MP:0008561,decreased tumor necrosis factor secretion
MGI:5476710	Map3k8<tm1.1Gkl>	MP:0000495,abnormal colon morphology|MP:0002006,neoplasm|MP:0003721,increased tumor growth/size|MP:0004499,increased incidence of tumors by chemical induction|MP:0005376,homeostasis/metabolism phenotype|MP:0008883,abnormal enterocyte proliferation|MP:0014234,decreased enterocyte apoptosis
MGI:5476711	Map3k8<tm1.2Gkl>	MP:0000495,abnormal colon morphology|MP:0003293,rectal hemorrhage|MP:0003721,increased tumor growth/size|MP:0004499,increased incidence of tumors by chemical induction|MP:0005036,diarrhea|MP:0008561,decreased tumor necrosis factor secretion|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008883,abnormal enterocyte proliferation|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0013956,decreased colon length|MP:0014234,decreased enterocyte apoptosis
MGI:5558152	Map3k8<tm1b(KOMP)Wtsi>	MP:0001120,abnormal uterus morphology
MGI:2388714	Map3k8<tm1Pnt>	MP:0005387,immune system phenotype|MP:0008561,decreased tumor necrosis factor secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:3055130	Map3k8<tm1Tmat>	MP:0002455,abnormal dendritic cell antigen presentation|MP:0002492,decreased IgE level|MP:0003009,abnormal cytokine secretion|MP:0005348,increased T cell proliferation|MP:0008495,decreased IgG1 level|MP:0008500,increased IgG2a level
MGI:6386308	Map3k9<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0006203,eye hemorrhage
MGI:3800581	Map3k9<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:7865835	Map4<em1Coop>	MP:0001262,decreased body weight|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0005369,muscle phenotype|MP:0010053,decreased grip strength
MGI:7865836	Map4<em2Coop>	MP:0005369,muscle phenotype|MP:0010053,decreased grip strength
MGI:2157047	Map4<Gt(pGT1.8geo)2Pgr>	MP:0002169,no abnormal phenotype detected
MGI:5563448	Map4k1<m1Anu>	MP:0005387,immune system phenotype
MGI:3850713	Map4k1<tm1Ssaw>	MP:0002376,abnormal dendritic cell physiology|MP:0002455,abnormal dendritic cell antigen presentation|MP:0008560,increased tumor necrosis factor secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008663,increased interleukin-12 secretion|MP:0008705,increased interleukin-6 secretion
MGI:3695423	Map4k1<tm1Tht>	MP:0001800,abnormal humoral immune response|MP:0003009,abnormal cytokine secretion|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005348,increased T cell proliferation
MGI:4329479	Map4k3<Gt(RRO270)Byg>	MP:0001806,decreased IgM level|MP:0002460,decreased immunoglobulin level|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008567,decreased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0010221,abnormal T-helper 17 cell differentiation
MGI:1933044	Map4k4<tm1Eys>	MP:0002231,abnormal primitive streak morphology|MP:0003445,sirenomelia|MP:0003984,embryonic growth retardation|MP:0006386,absent somites|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012739,abnormal anterior primitive streak morphology
MGI:3530833	Map4k5<Gt(OST218153)Lex>	MP:0003043,hypoalgesia|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008499,increased IgG1 level
MGI:6120759	Map4k5<tm1b(EUCOMM)Hmgu>	MP:0001258,decreased body length|MP:0002135,abnormal kidney morphology|MP:0002764,short tibia
MGI:3663310	Map4k5<tm1Jhk>	MP:0005584,abnormal enzyme/coenzyme activity|MP:0005621,abnormal cell physiology
MGI:2388040	Map6<tm1Job>	MP:0001361,social withdrawal|MP:0001363,increased anxiety-related response|MP:0001384,abnormal pup retrieval|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001501,abnormal sleep pattern|MP:0001900,impaired synaptic plasticity|MP:0002690,akinesia|MP:0003631,nervous system phenotype|MP:0004792,abnormal synaptic vesicle number|MP:0005656,decreased aggression|MP:0008911,induced hyperactivity|MP:0009142,decreased prepulse inhibition|MP:0011088,neonatal lethality, incomplete penetrance|MP:0013894,abnormal behavioral response to amphetamine
MGI:5927681	Map7d1<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:3876735	Map7d2<Gt(AF0577)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:6764606	Map7d3<em1Nju>	MP:0005389,reproductive system phenotype
MGI:7562383	Map7<em1(IMPC)Tcp>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002092,abnormal eye morphology|MP:0004085,abnormal heartbeat|MP:0004738,abnormal auditory brainstem response|MP:0009142,decreased prepulse inhibition
MGI:2148221	Map7<Gt(ROSABetageo)1Sor>	MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001153,small seminiferous tubules|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002209,decreased germ cell number|MP:0002216,abnormal seminiferous tubule morphology|MP:0002784,abnormal Sertoli cell morphology|MP:0004852,decreased testis weight|MP:0004930,small epididymis|MP:0006380,abnormal spermatid morphology
MGI:1889849	Map7<mshi>	MP:0001152,increased Leydig cell number|MP:0001153,small seminiferous tubules|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0004752,decreased length of allograft survival|MP:0004852,decreased testis weight|MP:0006428,ectopic Sertoli cells|MP:0008261,arrest of male meiosis|MP:0011750,abnormal seminiferous tubule epithelium morphology
MGI:6502641	Map9<tm1.1Bcgen>	MP:0000495,abnormal colon morphology|MP:0004499,increased incidence of tumors by chemical induction|MP:0012436,increased colon tumor incidence
MGI:6502642	Map9<tm1.2Bcgen>	MP:0002006,neoplasm|MP:0004024,aneuploidy|MP:0008866,chromosomal instability|MP:0030943,abnormal centrosome morphology|MP:0030944,abnormal pericentriolar material morphology
MGI:2176237	Mapk10<tm1Flv>	MP:0000313,abnormal cell death|MP:0001051,abnormal somatic motor system morphology|MP:0001405,impaired coordination|MP:0001905,abnormal dopamine level|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0003204,decreased neuron apoptosis|MP:0005385,cardiovascular system phenotype|MP:0008236,decreased susceptibility to neuronal excitotoxicity|MP:0011452,decreased susceptibility to dopaminergic neuron neurotoxicity
MGI:5636964	Mapk11<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment
MGI:4839280	Mapk11<tm1Jda>	MP:0005387,immune system phenotype
MGI:3609429	Mapk11<tm1Jsca>	MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0011394,increased fetal cardiomyocyte proliferation|MP:0031526,thin right ventricle myocardium compact layer
MGI:3769124	Mapk11<tm1Okee>	MP:0002169,no abnormal phenotype detected
MGI:5548088	Mapk11<tm2.1Lex>	MP:0005369,muscle phenotype
MGI:3621932	Mapk11<tm2Jsca>	MP:0002169,no abnormal phenotype detected
MGI:3529026	Mapk11<tm2Lex>	MP:0005369,muscle phenotype|MP:0005384,cellular phenotype|MP:0005385,cardiovascular system phenotype
MGI:3769125	Mapk11<tm2Okee>	MP:0005376,homeostasis/metabolism phenotype
MGI:5548089	Mapk12<tm1.1Lex>	MP:0005369,muscle phenotype
MGI:3615494	Mapk12<tm1Cnd>	MP:0002169,no abnormal phenotype detected
MGI:3529030	Mapk12<tm1Lex>	MP:0005369,muscle phenotype|MP:0005602,decreased angiogenesis|MP:0006039,decreased mitochondrial fission
MGI:6257497	Mapk13<em1(IMPC)Hmgu>	MP:0005553,increased circulating creatinine level
MGI:3615495	Mapk13<tm1Cnd>	MP:0002169,no abnormal phenotype detected
MGI:3837446	Mapk13<tm2.1Lex>	MP:0002079,increased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003058,increased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005292,improved glucose tolerance|MP:0005369,muscle phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity
MGI:3706998	Mapk14<tm1.1Dvb>	MP:0005560,decreased circulating glucose level|MP:0006207,embryonic lethality during organogenesis|MP:0011819,increased pancreatic beta cell proliferation|MP:0011820,decreased pancreatic beta cell proliferation
MGI:5548094	Mapk14<tm1.1Lex>	MP:0004087,abnormal muscle fiber morphology|MP:0011808,abnormal myoblast differentiation|MP:0030947,increased myoblast proliferation|MP:0030959,abnormal myoblast fusion
MGI:3525575	Mapk14<tm1.1Otsu>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3525576	Mapk14<tm1.2Otsu>	MP:0000160,kyphosis|MP:0000274,enlarged heart|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0002169,no abnormal phenotype detected|MP:0002764,short tibia|MP:0002833,increased heart weight|MP:0003109,short femur|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004485,increased response of heart to induced stress|MP:0004610,small vertebrae|MP:0005140,decreased cardiac muscle contractility|MP:0005376,homeostasis/metabolism phenotype|MP:0006396,decreased long bone epiphyseal plate size|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3620096	Mapk14<tm1Gab>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3837139	Mapk14<tm1Jda>	MP:0005090,increased double-negative T cell number|MP:0005095,decreased T cell proliferation|MP:0005465,abnormal T-helper 1 physiology|MP:0008563,decreased interferon-alpha secretion|MP:0008567,decreased interferon-gamma secretion
MGI:3529043	Mapk14<tm1Lex>	MP:0004215,abnormal myocardial fiber physiology|MP:0005369,muscle phenotype|MP:0005384,cellular phenotype|MP:0005385,cardiovascular system phenotype
MGI:2177830	Mapk14<tm1Mka>	MP:0000245,abnormal erythropoiesis|MP:0000343,abnormal response to cardiac infarction|MP:0000601,small liver|MP:0000603,pale liver|MP:0001577,anemia|MP:0001722,pale yolk sac|MP:0003038,decreased myocardial infarct size|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:2177832	Mapk14<tm1Mms>	MP:0000260,abnormal angiogenesis|MP:0001711,abnormal placenta morphology|MP:0001713,decreased trophoblast giant cell number|MP:0003403,absent placental labyrinth|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0005397,hematopoietic system phenotype|MP:0005621,abnormal cell physiology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012099,decreased spongiotrophoblast size
MGI:2177831	Mapk14<tm1Nbr>	MP:0000293,absent myocardial trabeculae|MP:0001633,poor circulation|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001722,pale yolk sac|MP:0002652,thin myocardium|MP:0003231,abnormal placenta vasculature|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0005031,abnormal trophoblast layer morphology|MP:0005140,decreased cardiac muscle contractility|MP:0006372,impaired placental function|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis|MP:0014012,abnormal cranial blood vasculature morphology|MP:0031611,decreased fetal cardiomyocyte number
MGI:3769126	Mapk14<tm1Okee>	MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3715522	Mapk14<tm2Nbr>	MP:0000351,increased cell proliferation|MP:0001175,abnormal lung morphology|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0003077,abnormal cell cycle|MP:0006382,abnormal lung epithelium morphology
MGI:5288509	Mapk14<tm3.1(Mapk11)Nbr>	MP:0003984,embryonic growth retardation|MP:0005031,abnormal trophoblast layer morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011521,decreased placental labyrinth size
MGI:5635241	Mapk15<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001486,abnormal startle reflex|MP:0002075,abnormal coat/hair pigmentation|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0013278,decreased fasting circulating glucose level
MGI:3686888	Mapk1<tm1.1Hed>	MP:0003944,abnormal T cell subpopulation ratio|MP:0005319,abnormal enzyme/coenzyme level|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3759775	Mapk1<tm1.1Kuta>	MP:0001265,decreased body size|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5293422	Mapk1<tm1.2Kuta>	MP:0001353,increased aggression towards mice|MP:0001360,abnormal social investigation|MP:0001361,social withdrawal|MP:0001364,decreased anxiety-related response|MP:0001382,abnormal nursing|MP:0001386,abnormal maternal nurturing|MP:0001447,abnormal nest building behavior|MP:0003107,abnormal response to novelty|MP:0003354,astrocytosis|MP:0003461,abnormal response to novel object|MP:0005394,taste/olfaction phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior
MGI:4432537	Mapk1<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:3803954	Mapk1<tm1Gela>	MP:0000097,short maxilla|MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0000457,maxilla hypoplasia|MP:0000458,abnormal mandible morphology|MP:0000460,mandible hypoplasia|MP:0000681,abnormal thyroid gland morphology|MP:0000703,abnormal thymus morphology|MP:0000762,abnormal tongue morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0002633,persistent truncus arteriosus|MP:0002639,micrognathia|MP:0004136,abnormal tongue muscle morphology|MP:0004592,small mandible|MP:0004594,abnormal mandibular coronoid process morphology|MP:0004596,abnormal mandibular angle morphology|MP:0005382,craniofacial phenotype|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006254,thin cerebral cortex|MP:0009886,failure of palatal shelf elevation|MP:0009907,decreased tongue size|MP:0009937,abnormal neuron differentiation|MP:0010402,ventricular septal defect|MP:0011087,neonatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0021213,complete cleft palate|MP:0030026,small Meckel's cartilage|MP:0030209,abnormal extrinsic tongue muscle morphology|MP:0030258,small mandibular condyloid process|MP:0031443,abnormal tongue position
MGI:3686887	Mapk1<tm1Hed>	MP:0003944,abnormal T cell subpopulation ratio|MP:0004919,abnormal positive T cell selection|MP:0005091,increased double-positive T cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3759774	Mapk1<tm1Kuta>	MP:0001454,abnormal cued conditioning behavior|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:2683190	Mapk1<tm1Melo>	MP:0001625,cardiac hypertrophy|MP:0001698,decreased embryo size|MP:0001705,abnormal proximal-distal axis patterning|MP:0001717,absent ectoplacental cone|MP:0002084,abnormal developmental patterning|MP:0002582,disorganized extraembryonic tissue|MP:0002583,absent extraembryonic ectoderm|MP:0003037,increased myocardial infarct size|MP:0003222,increased cardiomyocyte apoptosis|MP:0003393,decreased cardiac output|MP:0005031,abnormal trophoblast layer morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011704,decreased fibroblast proliferation|MP:0012056,abnormal polar trophectoderm morphology
MGI:3055889	Mapk1<tm1Moga>	MP:0001712,abnormal placenta development|MP:0002652,thin myocardium|MP:0003984,embryonic growth retardation|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011523,thin placenta labyrinth
MGI:3686889	Mapk1<tm2Hed>	MP:0004179,transmission ratio distortion|MP:0011091,prenatal lethality, complete penetrance
MGI:3055890	Mapk1<tm2Moga>	MP:0000266,abnormal heart morphology|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5640774	Mapk3<m1Btlr>	MP:0008658,decreased interleukin-1 beta secretion
MGI:3042006	Mapk3<tm1Gela>	MP:0003009,abnormal cytokine secretion|MP:0003631,nervous system phenotype|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005380,embryo phenotype|MP:0010768,mortality/aging|MP:0031391,increased locomotor activity
MGI:2183906	Mapk3<tm1Gpg>	MP:0001473,reduced long-term potentiation|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002798,abnormal active avoidance behavior|MP:0002799,abnormal passive avoidance behavior|MP:0003631,nervous system phenotype|MP:0005018,decreased T cell number|MP:0005095,decreased T cell proliferation|MP:0005369,muscle phenotype|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging|MP:0011704,decreased fibroblast proliferation|MP:0031391,increased locomotor activity
MGI:5620956	Mapk4<tm1Melo>	MP:0002169,no abnormal phenotype detected
MGI:6382404	Mapk6<em1(IMPC)Mbp>	MP:0000774,decreased brain size|MP:0001293,anophthalmia|MP:0001304,cataract|MP:0001404,no spontaneous movement|MP:0001488,increased startle reflex|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0001925,male infertility|MP:0002092,abnormal eye morphology|MP:0002152,abnormal brain morphology|MP:0002699,abnormal vitreous body morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4365549	Mapk6<tm1Melo>	MP:0000160,kyphosis|MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001178,pulmonary hypoplasia|MP:0001405,impaired coordination|MP:0001491,unresponsive to tactile stimuli|MP:0001529,abnormal vocalization|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002275,abnormal type II pneumocyte morphology|MP:0002834,decreased heart weight|MP:0003402,decreased liver weight|MP:0005162,carpoptosis|MP:0005631,decreased lung weight|MP:0009431,decreased fetal weight|MP:0009674,decreased birth weight|MP:0010825,abnormal lung saccule morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0020863,abnormal suckling reflex
MGI:5554435	Mapk7<b2b2346Clo>	MP:0000284,double outlet right ventricle|MP:0000519,hydronephrosis|MP:0004056,abnormal myocardium compact layer morphology|MP:0008528,polycystic kidney|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5538262	Mapk7<tm1.1Ctr>	MP:0013501,increased fibroblast apoptosis
MGI:3040181	Mapk7<tm1.1Jdl>	MP:0003229,abnormal vitelline vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3040180	Mapk7<tm1Jdl>	MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000295,trabecula carnea hypoplasia|MP:0001614,abnormal blood vessel morphology|MP:0001619,abnormal vascular permeability|MP:0001648,abnormal apoptosis|MP:0001914,hemorrhage|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0003229,abnormal vitelline vasculature morphology|MP:0003974,abnormal endocardium morphology|MP:0004566,myocardial fiber degeneration|MP:0005150,cachexia|MP:0005191,head tilt|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3623627	Mapk7<tm1Jsca>	MP:0000260,abnormal angiogenesis|MP:0000432,abnormal head morphology|MP:0000913,abnormal brain development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001914,hemorrhage|MP:0001916,intracerebral hemorrhage|MP:0002652,thin myocardium|MP:0003119,abnormal digestive system development|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0006341,small first pharyngeal arch|MP:0006344,small second pharyngeal arch|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011260,abnormal head mesenchyme morphology|MP:0012252,abnormal septum transversum morphology
MGI:2183604	Mapk7<tm1Kda>	MP:0000259,abnormal vascular development|MP:0000264,failure of vascular branching|MP:0000267,abnormal heart development|MP:0000295,trabecula carnea hypoplasia|MP:0001698,decreased embryo size|MP:0001719,absent vitelline blood vessels|MP:0001722,pale yolk sac|MP:0001787,pericardial edema|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0003920,abnormal heart right ventricle morphology|MP:0004076,abnormal vitelline vascular remodeling|MP:0004251,failure of heart looping|MP:0004787,abnormal dorsal aorta morphology|MP:0005592,abnormal vascular smooth muscle morphology|MP:0005602,decreased angiogenesis|MP:0006055,abnormal vascular endothelial cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2445409	Mapk7<tm1Wnt>	MP:0000259,abnormal vascular development|MP:0000264,failure of vascular branching|MP:0000292,distended pericardium|MP:0000295,trabecula carnea hypoplasia|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0001730,embryonic growth arrest|MP:0002188,small heart|MP:0002625,heart left ventricle hypertrophy|MP:0002652,thin myocardium|MP:0003542,abnormal vascular endothelial cell development|MP:0003649,decreased heart right ventricle size|MP:0003717,pallor|MP:0003974,abnormal endocardium morphology|MP:0004076,abnormal vitelline vascular remodeling|MP:0004787,abnormal dorsal aorta morphology|MP:0005602,decreased angiogenesis|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012253,abnormal intersomitic vessel morphology
MGI:3613487	Mapk8ip1<tm1Plhn>	MP:0006059,decreased susceptibility to ischemic brain injury
MGI:2183313	Mapk8ip1<tm1Rjd>	MP:0002888,abnormal NMDA-mediated synaptic currents|MP:0005376,homeostasis/metabolism phenotype|MP:0008236,decreased susceptibility to neuronal excitotoxicity
MGI:2182967	Mapk8ip1<tm1Wae>	MP:0000313,abnormal cell death|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4360022	Mapk8ip1<tm2.1Rjd>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype
MGI:4829783	Mapk8ip1<tm3.1Rjd>	MP:0000598,abnormal liver morphology|MP:0002891,increased insulin sensitivity|MP:0003383,abnormal gluconeogenesis|MP:0003402,decreased liver weight|MP:0005668,decreased circulating leptin level|MP:0009356,decreased liver triglyceride level|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:4867721	Mapk8ip2<tm1.1Gol>	MP:0000877,abnormal Purkinje cell morphology|MP:0000890,thin cerebellar molecular layer|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0001921,reduced fertility|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003234,enhanced NMDA-mediated synaptic currents|MP:0003631,nervous system phenotype|MP:0004495,decreased synaptic glutamate release|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0005394,taste/olfaction phenotype|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0010053,decreased grip strength|MP:0011003,reduced AMPA-mediated synaptic currents
MGI:3759989	Mapk8ip2<tm1Rjd>	MP:0001265,decreased body size|MP:0001925,male infertility|MP:0002888,abnormal NMDA-mediated synaptic currents
MGI:3818508	Mapk8ip3<tm1.1Ysok>	MP:0008219,abnormal dorsal telencephalic commissure morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3527900	Mapk8ip3<tm1Plhn>	MP:0000780,abnormal corpus callosum morphology|MP:0000787,abnormal telencephalon morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000792,abnormal cortical marginal zone morphology|MP:0000794,abnormal parietal lobe morphology|MP:0000798,abnormal frontal lobe morphology|MP:0000807,abnormal hippocampus morphology|MP:0000830,abnormal diencephalon morphology|MP:0000832,abnormal thalamus morphology|MP:0000934,abnormal telencephalon development|MP:0000952,abnormal CNS glial cell morphology|MP:0001176,abnormal lung development|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002961,abnormal axon guidance|MP:0003005,abnormal hippocampal fimbria morphology|MP:0004007,abnormal lung vasculature morphology|MP:0004267,abnormal optic tract morphology|MP:0006009,abnormal neuronal migration|MP:0008225,abnormal anterior commissure morphology|MP:0008440,abnormal subplate morphology|MP:0008441,thin cortical plate|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0010825,abnormal lung saccule morphology|MP:0010859,abnormal anterior commissure pars anterior morphology|MP:0010860,abnormal anterior commissure pars posterior morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0020546,increased hippocampal fornix size|MP:0020549,increased optic chiasm size
MGI:3053053	Mapk8ip3<tm1Rjd>	MP:0000774,decreased brain size|MP:0000825,dilated lateral ventricle|MP:0000934,abnormal telencephalon development|MP:0001177,atelectasis|MP:0001179,thick pulmonary interalveolar septum|MP:0001953,respiratory failure|MP:0002199,abnormal brain commissure morphology|MP:0002206,abnormal CNS synaptic transmission|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002316,anoxia|MP:0002961,abnormal axon guidance|MP:0011089,perinatal lethality, complete penetrance
MGI:3818507	Mapk8ip3<tm1Ysok>	MP:0002169,no abnormal phenotype detected|MP:0008219,abnormal dorsal telencephalic commissure morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5494695	Mapk8<tm1.1Jcbr>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0009283,decreased gonadal fat pad weight|MP:0010378,increased respiratory quotient|MP:0011940,decreased food intake
MGI:2176239	Mapk8<tm1Flv>	MP:0001218,thin epidermis|MP:0001231,abnormal epidermis stratum basale morphology|MP:0003009,abnormal cytokine secretion|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0003223,decreased cardiomyocyte apoptosis|MP:0004485,increased response of heart to induced stress|MP:0004499,increased incidence of tumors by chemical induction|MP:0005140,decreased cardiac muscle contractility|MP:0005329,abnormal myocardium layer morphology|MP:0005348,increased T cell proliferation|MP:0005370,liver/biliary system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0009603,absent keratohyalin granules
MGI:4441327	Mapk8<tm1Jcbr>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005120,decreased circulating growth hormone level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005480,increased circulating triiodothyronine level|MP:0005560,decreased circulating glucose level|MP:0009356,decreased liver triglyceride level|MP:0011940,decreased food intake|MP:0030969,increased circulating adiponectin level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:2384141	Mapk8<tm1Wag>	MP:0001828,abnormal T cell activation|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005095,decreased T cell proliferation|MP:0005292,improved glucose tolerance|MP:0005391,vision/eye phenotype|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0006414,decreased T cell apoptosis|MP:0008445,increased retina cone cell number|MP:0008452,increased retina rod cell number|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009115,abnormal fat cell morphology|MP:0009288,increased epididymal fat pad weight|MP:0010025,decreased total body fat amount|MP:0012146,increased b-wave amplitude
MGI:2176243	Mapk9<tm1Flv>	MP:0000609,abnormal liver physiology|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0002655,abnormal keratinocyte morphology|MP:0005166,decreased susceptibility to injury|MP:0005385,cardiovascular system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0009604,increased keratohyalin granule number|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:2183601	Mapk9<tm1Mka>	MP:0001473,reduced long-term potentiation|MP:0001828,abnormal T cell activation|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002920,decreased paired-pulse facilitation|MP:0002922,decreased post-tetanic potentiation|MP:0003223,decreased cardiomyocyte apoptosis|MP:0005095,decreased T cell proliferation|MP:0005329,abnormal myocardium layer morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005445,abnormal neurotransmitter secretion|MP:0006414,decreased T cell apoptosis|MP:0008872,abnormal physiological response to xenobiotic
MGI:4820336	Mapkap1<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0011962,increased cornea thickness|MP:0011965,decreased total retina thickness
MGI:5548828	Mapkap1<tm1b(EUCOMM)Wtsi>	MP:0001697,abnormal embryo size|MP:0002753,dilated heart left ventricle|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:3759854	Mapkap1<tm1Bisu>	MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0011091,prenatal lethality, complete penetrance|MP:0013501,increased fibroblast apoptosis
MGI:6357678	Mapkapk2<tm1.1Gkl>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:5528531	Mapkapk2<tm1.1Yaff>	MP:0002169,no abnormal phenotype detected
MGI:6357679	Mapkapk2<tm1.2Gkl>	MP:0004502,decreased incidence of tumors by chemical induction|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion
MGI:5548388	Mapkapk2<tm1b(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0002932,abnormal joint morphology|MP:0003795,abnormal bone structure|MP:0005011,increased eosinophil cell number|MP:0005298,abnormal clavicle morphology|MP:0005559,increased circulating glucose level|MP:0008259,abnormal optic disk morphology|MP:0012362,increased large unstained cell number
MGI:3604570	Mapkapk2<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:2179724	Mapkapk2<tm1Mgl>	MP:0000343,abnormal response to cardiac infarction|MP:0001798,impaired macrophage phagocytosis|MP:0002412,increased susceptibility to bacterial infection|MP:0003009,abnormal cytokine secretion|MP:0003038,decreased myocardial infarct size|MP:0003223,decreased cardiomyocyte apoptosis|MP:0008243,abnormal macrophage derived foam cell morphology|MP:0008483,increased spleen germinal center size|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008713,abnormal cytokine level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:6341844	Mapkapk3<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002060,abnormal skin morphology
MGI:3698628	Mapkapk3<tm1.1Lex>	MP:0005387,immune system phenotype
MGI:5692611	Mapkapk5<tm1b(EUCOMM)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:2680287	Mapkapk5<tm1Mgl>	MP:0002169,no abnormal phenotype detected
MGI:3698841	Mapkapk5<tm1Pqs>	MP:0002051,increased skin papilloma incidence|MP:0002083,premature death|MP:0008009,delayed cellular replicative senescence
MGI:5548464	Mapkbp1<tm1b(EUCOMM)Hmgu>	MP:0001566,increased circulating phosphate level|MP:0002833,increased heart weight|MP:0003917,increased kidney weight|MP:0004952,increased spleen weight|MP:0005293,impaired glucose tolerance|MP:0005565,increased blood urea nitrogen level
MGI:4432919	Mapre3<tm1a(EUCOMM)Wtsi>	MP:0002608,increased hematocrit
MGI:5780100	Mapre3<tm1c(EUCOMM)Wtsi>	MP:0001619,abnormal vascular permeability
MGI:5440079	Mapt<tm1.1Cole>	MP:0005386,behavior/neurological phenotype
MGI:5776229	Mapt<tm1.1(FUS)Neas>	MP:0003631,nervous system phenotype
MGI:6414668	Mapt<tm1.1(MAPT)Tcs>	MP:0003631,nervous system phenotype
MGI:3720198	Mapt<tm1Aha>	MP:0005404,abnormal axon morphology
MGI:5615650	Mapt<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001417,decreased exploration in new environment|MP:0002792,abnormal retina vasculature morphology|MP:0008528,polycystic kidney|MP:0010053,decreased grip strength|MP:0010097,abnormal retina blood vessel morphology|MP:0011941,increased fluid intake|MP:0011965,decreased total retina thickness
MGI:2670768	Mapt<tm1(EGFP)Klt>	MP:0001473,reduced long-term potentiation|MP:0002169,no abnormal phenotype detected|MP:0002804,abnormal motor learning|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0012306,enhanced spatial learning
MGI:3590681	Mapt<tm1(Ewsr1/Etv4)Arbr>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0000965,abnormal sensory neuron morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0003651,abnormal axon extension|MP:0008486,decreased muscle spindle number
MGI:2385630	Mapt<tm1Hnd>	MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0003651,abnormal axon extension|MP:0008143,abnormal dendrite morphology
MGI:3768527	Mapt<tm1(MAPT)Vln>	MP:0000351,increased cell proliferation|MP:0001364,decreased anxiety-related response|MP:0001516,abnormal motor coordination/balance|MP:0003631,nervous system phenotype|MP:0003651,abnormal axon extension|MP:0008143,abnormal dendrite morphology|MP:0008282,enlarged hippocampus|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0014368,enhanced long-term object recognition memory
MGI:3043293	Mapt<tm1(Mecp2)Jae>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001304,cataract|MP:0001363,increased anxiety-related response|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001412,excessive scratching|MP:0001454,abnormal cued conditioning behavior|MP:0001458,abnormal object recognition memory|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0001511,disheveled coat|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0002062,abnormal associative learning|MP:0002169,no abnormal phenotype detected|MP:0002566,abnormal sexual interaction|MP:0002919,enhanced paired-pulse facilitation|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005150,cachexia|MP:0010768,mortality/aging
MGI:2138030	Mapt<tm1Noh>	MP:0005404,abnormal axon morphology
MGI:5550516	Mapt<tm1(Sema3e)Yuyo>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0008571,abnormal synaptic bouton morphology
MGI:5298877	Mapt<tm1(Setdb1)Akba>	MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging
MGI:5440076	Mapt<tm2.1Cole>	MP:0001399,hyperactivity|MP:0003631,nervous system phenotype|MP:0004768,abnormal axonal transport|MP:0005386,behavior/neurological phenotype
MGI:5776230	Mapt<tm2.1(FUS)Neas>	MP:0000938,motor neuron degeneration|MP:0000940,abnormal motor neuron innervation pattern|MP:0001053,abnormal neuromuscular synapse morphology|MP:0003354,astrocytosis|MP:0008918,microgliosis
MGI:4442945	Mapt<tm2.1(RHOA*)Klt>	MP:0000859,abnormal somatosensory cortex morphology|MP:0003204,decreased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0008947,increased neuron number
MGI:3590682	Mapt<tm2Arbr>	MP:0000961,abnormal dorsal root ganglion morphology
MGI:3793311	Mapt<tm2(cre)Aha>	MP:0003631,nervous system phenotype
MGI:5776260	Mapt<tm2(FUS)Neas>	MP:0000938,motor neuron degeneration|MP:0001053,abnormal neuromuscular synapse morphology
MGI:3844981	Mapt<tm2(Hdac1)Jae>	MP:0009940,abnormal hippocampus pyramidal cell morphology
MGI:5776232	Mapt<tm3.1(FUS)Neas>	MP:0000938,motor neuron degeneration|MP:0000940,abnormal motor neuron innervation pattern|MP:0001053,abnormal neuromuscular synapse morphology|MP:0002915,abnormal synaptic depression|MP:0003083,abnormal tibialis anterior morphology|MP:0003354,astrocytosis|MP:0003635,abnormal synaptic transmission|MP:0004090,abnormal sarcomere morphology|MP:0008571,abnormal synaptic bouton morphology|MP:0008918,microgliosis|MP:0009434,paraparesis
MGI:3797111	Mapt<tm3(cre/PGR)Aha>	MP:0002169,no abnormal phenotype detected
MGI:5776261	Mapt<tm3(FUS)Neas>	MP:0000938,motor neuron degeneration|MP:0001053,abnormal neuromuscular synapse morphology
MGI:3844982	Mapt<tm3(Hdac2)Jae>	MP:0000812,abnormal dentate gyrus morphology|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008428,abnormal spatial working memory|MP:0009454,impaired contextual conditioning behavior|MP:0009940,abnormal hippocampus pyramidal cell morphology
MGI:3848811	Mapt<tm3(Sema3e)Arbr>	MP:0000940,abnormal motor neuron innervation pattern|MP:0005386,behavior/neurological phenotype
MGI:1861975	Mar1<tm1Wtg>	MP:0001790,abnormal immune system physiology|MP:0004815,abnormal somatic hypermutation frequency
MGI:6194717	Marchf11<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:3706321	Marchf1<tm1.1Sish>	MP:0002145,abnormal T cell differentiation|MP:0002455,abnormal dendritic cell antigen presentation|MP:0002459,abnormal B cell physiology|MP:0004974,decreased regulatory T cell number|MP:0005042,abnormal level of surface class II molecules|MP:0005387,immune system phenotype|MP:0005461,abnormal dendritic cell morphology|MP:0008561,decreased tumor necrosis factor secretion|MP:0008664,decreased interleukin-12 secretion
MGI:6490470	Marchf2<em1Cnu>	MP:0002410,decreased susceptibility to viral infection|MP:0002411,decreased susceptibility to bacterial infection|MP:0008553,increased circulating tumor necrosis factor level|MP:0008575,increased circulating interferon-beta level|MP:0008596,increased circulating interleukin-6 level|MP:0008617,increased circulating interleukin-12 level|MP:0008663,increased interleukin-12 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:7490172	Marchf2<em1(IMPC)Mbp>	MP:0002060,abnormal skin morphology|MP:0005293,impaired glucose tolerance|MP:0005564,increased hemoglobin content
MGI:6269174	Marchf3<em1Hbsh>	MP:0009787,increased susceptibility to infection induced morbidity/mortality|MP:0010210,abnormal circulating cytokine level|MP:0020148,abnormal susceptibility to induced morbidity/mortality
MGI:6358620	Marchf3<tm1b(EUCOMM)Hmgu>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0004906,enlarged uterus|MP:0009453,enhanced contextual conditioning behavior|MP:0013279,increased fasting circulating glucose level
MGI:6406741	Marchf5<tm1.1Ygi>	MP:0001402,decreased locomotor activity|MP:0001442,decreased grooming behavior|MP:0002882,abnormal neuron morphology|MP:0003354,astrocytosis|MP:0003674,oxidative stress|MP:0004777,abnormal phospholipid level|MP:0006035,abnormal mitochondrial morphology|MP:0008431,abnormal short-term spatial reference memory|MP:0011631,decreased mitochondrial size|MP:0011635,abnormal mitochondrial crista morphology|MP:0011637,abnormal mitochondrial matrix morphology|MP:0020448,increased microglial cell activation
MGI:4433802	Marchf5<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0008575,increased circulating interferon-beta level|MP:0008596,increased circulating interleukin-6 level|MP:0011091,prenatal lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0031023,decreased susceptibility to Riboviria infection induced morbidity/mortality
MGI:6274924	Marchf6<tm1b(EUCOMM)Hmgu>	MP:0000443,abnormal snout morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0001925,male infertility|MP:0002764,short tibia|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0005293,impaired glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008935,decreased mean platelet volume|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0011045,decreased lung elastance|MP:0013279,increased fasting circulating glucose level|MP:0013764,decreased T-helper cell number|MP:0020421,increased freezing behavior
MGI:3530008	Marchf7<Gt(ROSABetageo)1Summ>	MP:0000780,abnormal corpus callosum morphology|MP:0000955,abnormal spinal cord morphology|MP:0002229,neurodegeneration|MP:0003009,abnormal cytokine secretion|MP:0005348,increased T cell proliferation|MP:0008660,increased interleukin-10 secretion|MP:0008751,abnormal interleukin level
MGI:6147531	Marchf8<em2(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001552,increased circulating triglyceride level|MP:0002590,increased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0005012,decreased eosinophil cell number|MP:0005561,increased mean corpuscular hemoglobin
MGI:5819100	Marchf8<tm1.1Lkle>	MP:0005387,immune system phenotype
MGI:4452800	Marchf9<tm1a(EUCOMM)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001262,decreased body weight|MP:0001391,abnormal tail movements|MP:0002896,abnormal bone mineralization|MP:0003795,abnormal bone structure|MP:0005017,decreased B cell number
MGI:2176277	Marcksl1<tm1Fsh>	MP:0002451,abnormal macrophage physiology
MGI:2176278	Marcksl1<tm1Stl>	MP:0000774,decreased brain size|MP:0000914,exencephaly|MP:0001325,abnormal retina morphology|MP:0001891,hydrocephaly|MP:0002151,abnormal neural tube morphology|MP:0002152,abnormal brain morphology|MP:0002161,abnormal fertility/fecundity|MP:0002196,absent corpus callosum|MP:0003054,spina bifida|MP:0006254,thin cerebral cortex|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011380,enlarged brain ventricles|MP:0011965,decreased total retina thickness
MGI:2176302	Marcks<tm1Pjb>	MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000780,abnormal corpus callosum morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000792,abnormal cortical marginal zone morphology|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001265,decreased body size|MP:0001325,abnormal retina morphology|MP:0001436,abnormal suckling behavior|MP:0002199,abnormal brain commissure morphology|MP:0003052,omphalocele|MP:0003104,acrania|MP:0008221,abnormal hippocampal commissure morphology|MP:0008225,abnormal anterior commissure morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011723,ectopic neuron|MP:0012676,dilated brain ventricle|MP:0030178,abnormal scalp morphology
MGI:5692900	Marcks<tm2b(KOMP)Wtsi>	MP:0001510,abnormal coat appearance|MP:0005632,decreased circulating aspartate transaminase level
MGI:3690644	Marco<tm1Ktry>	MP:0001798,impaired macrophage phagocytosis|MP:0001846,increased inflammatory response|MP:0002362,abnormal spleen marginal zone morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5538543	Marco<tm1Spt>	MP:0002376,abnormal dendritic cell physiology|MP:0008566,increased interferon-gamma secretion|MP:0010740,abnormal dendritic cell chemotaxis
MGI:5701720	Marco<tm2b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0002968,increased circulating alkaline phosphatase level|MP:0004357,long tibia
MGI:6285601	Marf1<em1(IMPC)Bay>	MP:0001392,abnormal locomotor behavior|MP:0001925,male infertility|MP:0001926,female infertility
MGI:3857057	Marf1<Gt(AS0671)Wtsi>	MP:0001926,female infertility
MGI:3512917	Marf1<m1Rpg>	MP:0001926,female infertility|MP:0010767,abnormal female meiosis I arrest
MGI:3045774	Marif1<C57BL/10J>	MP:0002723,abnormal immune serum protein physiology|MP:0008561,decreased tumor necrosis factor secretion|MP:0008664,decreased interleukin-12 secretion
MGI:3045776	Marif2<C57BL/10J>	MP:0002723,abnormal immune serum protein physiology|MP:0008560,increased tumor necrosis factor secretion|MP:0008664,decreased interleukin-12 secretion
MGI:3045778	Marif3<C57BL/10J>	MP:0008663,increased interleukin-12 secretion
MGI:5823379	Mark1<em#Akiki>	MP:0005388,respiratory system phenotype
MGI:2665175	Mark2<Gt(pSABetageo)38Bss>	MP:0000274,enlarged heart|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0001924,infertility|MP:0002680,decreased corpora lutea number|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0004882,enlarged lung|MP:0004905,decreased uterus weight|MP:0004910,decreased seminal vesicle weight|MP:0004929,decreased epididymis weight|MP:0005121,decreased circulating prolactin level|MP:0005139,increased prolactin level|MP:0005185,decreased circulating progesterone level|MP:0005238,increased brain size|MP:0005361,small pituitary gland
MGI:2182819	Mark2<tm1Hpw>	MP:0000189,hypoglycemia|MP:0000315,hemoglobinuria|MP:0000493,rectal prolapse|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001431,abnormal eating behavior|MP:0001732,postnatal growth retardation|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0001790,abnormal immune system physiology|MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0001859,kidney inflammation|MP:0001861,lung inflammation|MP:0001870,salivary gland inflammation|MP:0001935,decreased litter size|MP:0002078,abnormal glucose homeostasis|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0002743,glomerulonephritis|MP:0002891,increased insulin sensitivity|MP:0002962,increased urine protein level|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004889,increased energy expenditure|MP:0004952,increased spleen weight|MP:0005014,increased B cell number|MP:0005093,decreased B cell proliferation|MP:0005154,increased B cell proliferation|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008102,lymph node hyperplasia|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008498,decreased IgG3 level|MP:0008566,increased interferon-gamma secretion|MP:0008699,increased interleukin-4 secretion|MP:0008965,increased basal metabolism|MP:0009429,decreased embryo weight|MP:0010182,decreased susceptibility to weight gain|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011320,abnormal glomerular capillary morphology|MP:0011427,increased mesangial cell number|MP:0011567,increased renal glomerulus lobularity|MP:0030016,increased adipocyte glucose uptake|MP:0030968,decreased circulating adiponectin level|MP:0031270,decreased susceptibility to age-related hepatic steatosis
MGI:3836595	Mark3<tm1Hpw>	MP:0000189,hypoglycemia|MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0002082,postnatal lethality|MP:0002727,decreased circulating insulin level|MP:0004185,abnormal adipocyte glucose uptake|MP:0004889,increased energy expenditure|MP:0005266,abnormal metabolism|MP:0005292,improved glucose tolerance|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0010025,decreased total body fat amount|MP:0010398,decreased liver glycogen level|MP:0030969,increased circulating adiponectin level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:6152512	Mark4<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001120,abnormal uterus morphology|MP:0001147,small testis|MP:0001297,microphthalmia|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002574,increased vertical activity
MGI:4125782	Mark4<Gt(XG191)Byg>	MP:0001399,hyperactivity|MP:0001433,polyphagia|MP:0002078,abnormal glucose homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0004889,increased energy expenditure|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008963,increased carbon dioxide production|MP:0009125,decreased brown fat cell lipid droplet size|MP:0010025,decreased total body fat amount|MP:0010378,increased respiratory quotient|MP:0011941,increased fluid intake
MGI:3590522	Marq1<DBA/2J>	MP:0009749,enhanced behavioral response to addictive substance
MGI:3590524	Marq2<DBA/2J>	MP:0009749,enhanced behavioral response to addictive substance
MGI:3590526	Marq3<DBA/2J>	MP:0009750,impaired behavioral response to addictive substance
MGI:3590528	Marq4<DBA/2J>	MP:0009749,enhanced behavioral response to addictive substance
MGI:3590530	Marq5<DBA/2J>	MP:0009749,enhanced behavioral response to addictive substance
MGI:7425814	Mars1<em1(IMPC)Bay>	MP:0001392,abnormal locomotor behavior|MP:0011100,preweaning lethality, complete penetrance
MGI:5608699	Mars2<tm1.1(KOMP)Vlcg>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0003961,decreased lean body mass|MP:0009331,absent primitive node|MP:0010024,increased total body fat amount|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011436,decreased urine magnesium level|MP:0012724,absent head fold|MP:0013278,decreased fasting circulating glucose level|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:6377090	Marveld1<tm1.1Liy>	MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000877,abnormal Purkinje cell morphology|MP:0000952,abnormal CNS glial cell morphology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0009977,abnormal cerebellar granule cell migration
MGI:6377092	Marveld1<tm1.2Liy>	MP:0000790,abnormal stratification in cerebral cortex|MP:0000873,thin external granule cell layer|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000952,abnormal CNS glial cell morphology|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001504,abnormal posture|MP:0001522,impaired swimming|MP:0001973,increased thermal nociceptive threshold|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration|MP:0003313,abnormal locomotor activation|MP:0006009,abnormal neuronal migration|MP:0008143,abnormal dendrite morphology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008948,decreased neuron number|MP:0009538,abnormal synapse morphology|MP:0009956,abnormal cerebellar layer morphology|MP:0009977,abnormal cerebellar granule cell migration|MP:0010387,abnormal Bergmann glial cell morphology|MP:0012307,impaired spatial learning
MGI:5550095	Marveld2<tm1.1Sria>	MP:0000042,abnormal organ of Corti morphology|MP:0000048,abnormal stria vascularis morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0001260,increased body weight|MP:0001967,deafness|MP:0002833,increased heart weight|MP:0002857,cochlear ganglion degeneration|MP:0002981,increased liver weight|MP:0003917,increased kidney weight|MP:0004333,abnormal utricular macula morphology|MP:0004362,cochlear hair cell degeneration|MP:0004364,thin stria vascularis|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004696,abnormal thyroid follicle morphology|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004750,syndromic hearing loss|MP:0004952,increased spleen weight|MP:0005377,hearing/vestibular/ear phenotype|MP:0008789,abnormal olfactory epithelium morphology|MP:0009517,abnormal salivary gland duct morphology|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5637157	Marveld2<tm1b(EUCOMM)Wtsi>	MP:0000274,enlarged heart|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0002102,abnormal ear morphology|MP:0004738,abnormal auditory brainstem response|MP:0009142,decreased prepulse inhibition
MGI:6156852	Marveld2<tm1Sats>	MP:0001967,deafness|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004736,abnormal distortion product otoacoustic emission|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0006358,absent pinna reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:7645612	Marveld3<em1Cepi>	MP:0005379,endocrine/exocrine gland phenotype
MGI:7425815	Marveld3<em1(IMPC)Ccpcz>	MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002110,abnormal digit morphology|MP:0003036,vertebral transformation|MP:0003917,increased kidney weight|MP:0003961,decreased lean body mass|MP:0004599,abnormal vertebral arch morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:7645616	Marveld3<em2Cepi>	MP:0005379,endocrine/exocrine gland phenotype
MGI:7645617	Marveld3<em3Cepi>	MP:0005379,endocrine/exocrine gland phenotype
MGI:5696938	Mas1<tm1.1(KOMP)Vlcg>	MP:0002764,short tibia|MP:0003795,abnormal bone structure|MP:0010123,increased bone mineral content
MGI:2158808	Mas1<tm1Bdr>	MP:0001363,increased anxiety-related response|MP:0002828,abnormal renal glomerular capsule morphology|MP:0002871,albuminuria|MP:0002959,increased urine microalbumin level|MP:0003008,enhanced long-term potentiation|MP:0003215,renal interstitial fibrosis|MP:0003631,nervous system phenotype|MP:0005325,abnormal renal glomerulus morphology|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005526,decreased renal plasma flow rate|MP:0005527,increased renal glomerular filtration rate|MP:0005531,increased renal vascular resistance|MP:0005557,increased creatinine clearance|MP:0006317,decreased urine sodium level|MP:0008055,increased urine osmolality|MP:0011377,renal glomerulus fibrosis|MP:0011432,decreased urine flow rate
MGI:5544601	Masp1<tm1.1(KOMP)Vlcg>	MP:0001258,decreased body length|MP:0001319,irregularly shaped pupil|MP:0001399,hyperactivity|MP:0002968,increased circulating alkaline phosphatase level|MP:0005333,decreased heart rate|MP:0005633,increased circulating sodium level|MP:0009142,decreased prepulse inhibition|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:3790322	Masp1<tm1Tefu>	MP:0001262,decreased body weight|MP:0002472,impaired complement alternative pathway|MP:0008770,decreased survivor rate|MP:0009062,impaired lectin complement pathway
MGI:3814550	Masp2<tm1Tefu>	MP:0002471,abnormal complement pathway
MGI:5007776	Masp2<tm1Wjsc>	MP:0003038,decreased myocardial infarct size|MP:0005166,decreased susceptibility to injury|MP:0009062,impaired lectin complement pathway
MGI:6356292	Mast1<em1Dak>	MP:0000851,cerebellum hypoplasia|MP:0000890,thin cerebellar molecular layer|MP:0002184,abnormal innervation|MP:0003203,increased neuron apoptosis|MP:0006099,thin cerebellar granule layer|MP:0006254,thin cerebral cortex|MP:0011087,neonatal lethality, complete penetrance|MP:0012443,increased corpus callosum size
MGI:6356293	Mast1<em2Dak>	MP:0003631,nervous system phenotype
MGI:4363089	Mast2<tm1a(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0010123,increased bone mineral content
MGI:5635248	Mast3<tm1.1(KOMP)Wtsi>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0002968,increased circulating alkaline phosphatase level
MGI:7327411	Mast4<em1Sjkm>	MP:0000116,abnormal tooth development|MP:0000120,malocclusion|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002576,abnormal enamel morphology|MP:0002649,abnormal enamel rod pattern|MP:0002650,abnormal ameloblast morphology|MP:0002685,abnormal spermatogonia proliferation|MP:0002687,oligozoospermia|MP:0004831,long incisors|MP:0011416,abnormal testis interstitial tissue morphology|MP:0013601,increased testis apoptosis|MP:0030136,abnormal lower incisor morphology|MP:0030450,abnormal enamel mineralization|MP:0030459,abnormal tooth attrition|MP:0030471,abnormal ameloblast differentiation|MP:0030541,misaligned incisors|MP:0030544,abnormal enamel development
MGI:5563453	Mast4<m1Anu>	MP:0000120,malocclusion|MP:0005387,immune system phenotype
MGI:5556126	Mastl<tm1.1Mama>	MP:0004046,abnormal mitosis|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0009760,abnormal mitotic spindle morphology|MP:0011704,decreased fibroblast proliferation
MGI:5556127	Mastl<tm1.2Mama>	MP:0011092,embryonic lethality, complete penetrance
MGI:2388143	Mat1a<tm1Jmm>	MP:0000598,abnormal liver morphology|MP:0000609,abnormal liver physiology|MP:0001860,liver inflammation|MP:0002981,increased liver weight|MP:0030644,increased circulating methionine level|MP:0031115,macrovesicular hepatic steatosis
MGI:4435877	Mat2a<tm1a(EUCOMM)Hmgu>	MP:0009142,decreased prepulse inhibition
MGI:5550596	Mat2a<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:7287849	Matcap1<em1Nki>	MP:0000774,decreased brain size|MP:0000852,small cerebellum|MP:0002741,small olfactory bulb
MGI:2180863	Matk<tm1Hua>	MP:0002169,no abnormal phenotype detected
MGI:3526800	Matk<tm1Sor>	MP:0001545,abnormal hematopoietic system physiology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0004809,increased hematopoietic stem cell number|MP:0005397,hematopoietic system phenotype
MGI:2668016	Matk<tm1Suda>	MP:0002169,no abnormal phenotype detected
MGI:2153042	Matn1<tm1Goe>	MP:0003055,abnormal long bone epiphyseal plate morphology
MGI:2153051	Matn1<tm1Ref>	MP:0005390,skeleton phenotype
MGI:3050541	Matn2<tm1Asz>	MP:0002169,no abnormal phenotype detected
MGI:3028891	Matn3<tm1Asz>	MP:0005390,skeleton phenotype
MGI:3663272	Matn3<tm1Brd>	MP:0003560,osteoarthritis|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0005605,increased bone mass
MGI:3759029	Matn3<tm1Mbri>	MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000166,abnormal chondrocyte morphology|MP:0000547,short limbs|MP:0001262,decreased body weight|MP:0002427,disproportionate dwarf|MP:0002764,short tibia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003723,abnormal long bone morphology|MP:0014101,decreased chondrocyte proliferation|MP:0014103,increased chondrocyte apoptosis
MGI:6721399	Matn4<tm1.1Asz>	MP:0004810,decreased hematopoietic stem cell number|MP:0011902,increased hematopoietic stem cell proliferation
MGI:6490339	Matr3<em1Tcp>	MP:0000852,small cerebellum|MP:0000876,Purkinje cell degeneration|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002083,premature death|MP:0002757,decreased vertical activity|MP:0003354,astrocytosis|MP:0005405,axon degeneration|MP:0009400,decreased skeletal muscle fiber size|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0010047,axonal spheroids|MP:0010053,decreased grip strength|MP:0020448,increased microglial cell activation
MGI:6500996	Matr3<em3Tcp>	MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0011087,neonatal lethality, complete penetrance
MGI:6500998	Matr3<em4Tcp>	MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0011087,neonatal lethality, complete penetrance
MGI:6500999	Matr3<em5Tcp>	MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0011087,neonatal lethality, complete penetrance
MGI:3514145	Matr3<Gt(RRR075)Byg>	MP:0000285,abnormal heart valve morphology|MP:0003139,patent ductus arteriosus|MP:0003387,aorta coarctation|MP:0004113,abnormal aortic arch morphology|MP:0004157,interrupted aortic arch|MP:0010402,ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010429,abnormal heart left ventricle outflow tract morphology|MP:0010484,bicuspid aortic valve|MP:0010485,aortic arch hypoplasia|MP:0010527,bicuspid pulmonary valve|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance|MP:0011666,double outlet right ventricle, ventricular defect committed to aorta|MP:0011668,double outlet right ventricle, Taussig bing type|MP:0012515,abnormal heart apex morphology
MGI:5638624	Mau2<tm1.1Hpt>	MP:0000024,lowered ear position|MP:0000088,short mandible|MP:0000438,abnormal cranium morphology|MP:0000454,abnormal jaw morphology|MP:0001302,eyelids open at birth|MP:0002169,no abnormal phenotype detected|MP:0003935,abnormal craniofacial development|MP:0004592,small mandible|MP:0006411,upturned snout|MP:0011262,abnormal pharyngeal arch mesenchyme morphology|MP:0012523,abnormal upper lip morphology|MP:0012760,decreased cranial neural crest cell proliferation|MP:0030065,face hypoplasia
MGI:5636690	Mau2<tm1.2Hpt>	MP:0002169,no abnormal phenotype detected|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5637081	Mau2<tm1b(KOMP)Wtsi>	MP:0001258,decreased body length|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0003036,vertebral transformation|MP:0006358,absent pinna reflex|MP:0011100,preweaning lethality, complete penetrance
MGI:6276904	Mavs<em1(IMPC)Mbp>	MP:0000063,decreased bone mineral density
MGI:3773161	Mavs<tm1Aki>	MP:0000691,enlarged spleen|MP:0001805,decreased IgG level|MP:0001847,brain inflammation|MP:0002376,abnormal dendritic cell physiology|MP:0002451,abnormal macrophage physiology|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0003009,abnormal cytokine secretion|MP:0003224,neuron degeneration|MP:0004811,abnormal neuron physiology|MP:0005025,abnormal response to infection|MP:0005387,immune system phenotype|MP:0006082,CNS inflammation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008126,increased dendritic cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008500,increased IgG2a level|MP:0008548,abnormal circulating interferon level|MP:0008553,increased circulating tumor necrosis factor level|MP:0008563,decreased interferon-alpha secretion|MP:0008565,decreased interferon-beta secretion|MP:0008574,decreased circulating interferon-alpha level|MP:0008576,decreased circulating interferon-beta level|MP:0008577,increased circulating interferon-gamma level|MP:0008578,decreased circulating interferon-gamma level|MP:0008596,increased circulating interleukin-6 level|MP:0008597,decreased circulating interleukin-6 level|MP:0008670,decreased interleukin-12b secretion|MP:0008706,decreased interleukin-6 secretion|MP:0020937,increased susceptibility to Picornaviridae infection|MP:0020943,increased susceptibility to Flaviviridae infection|MP:0031044,increased susceptibility to Flaviviridae infection induced morbidity/mortality
MGI:5308082	Mavs<tm1Camb>	MP:0005093,decreased B cell proliferation|MP:0008561,decreased tumor necrosis factor secretion|MP:0008664,decreased interleukin-12 secretion|MP:0014469,abnormal B cell calcium ion homeostasis
MGI:3799298	Mavs<tm1Tsc>	MP:0008565,decreased interferon-beta secretion
MGI:3654145	Mavs<tm1Zjc>	MP:0002376,abnormal dendritic cell physiology|MP:0002419,abnormal innate immunity|MP:0002451,abnormal macrophage physiology|MP:0008548,abnormal circulating interferon level|MP:0020913,increased susceptibility to Riboviria infection
MGI:2159363	Max<tm1Rdp>	MP:0001675,abnormal ectoderm development|MP:0001685,abnormal endoderm development|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:6336151	Maz<em1(IMPC)Ics>	MP:0000432,abnormal head morphology|MP:0000781,decreased corpus callosum size|MP:0001417,decreased exploration in new environment|MP:0004738,abnormal auditory brainstem response|MP:0012462,decreased brain internal capsule size|MP:0012474,decreased cingulate cortex size|MP:0012477,increased secondary somatosensory cortex size|MP:0012482,decreased habenula size|MP:0013908,small lateral ventricles
MGI:6197212	Maz<em#Mhll>	MP:0000520,absent kidney|MP:0001925,male infertility|MP:0003105,abnormal heart atrium morphology|MP:0003446,renal hypoplasia|MP:0003604,single kidney|MP:0003617,urinary bladder hypoplasia|MP:0004201,fetal growth retardation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011923,abnormal bladder urine volume
MGI:6152513	Mb21d2<em1(IMPC)Mbp>	MP:0000639,abnormal adrenal gland morphology|MP:0000689,abnormal spleen morphology
MGI:6153488	Mbd1<em1(IMPC)Wtsi>	MP:0000162,lordosis|MP:0001926,female infertility|MP:0003036,vertebral transformation|MP:0005561,increased mean corpuscular hemoglobin
MGI:2664084	Mbd1<tm1Fhg>	MP:0000808,abnormal hippocampus development|MP:0000812,abnormal dentate gyrus morphology|MP:0001463,abnormal spatial learning|MP:0002175,decreased brain weight|MP:0002207,abnormal long-term potentiation|MP:0004024,aneuploidy|MP:0004028,chromosome breakage|MP:0005386,behavior/neurological phenotype|MP:0008866,chromosomal instability|MP:0009937,abnormal neuron differentiation
MGI:6257787	Mbd2<em1(IMPC)Bay>	MP:0001325,abnormal retina morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0011962,increased cornea thickness
MGI:2388002	Mbd2<tm1Bh>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001384,abnormal pup retrieval|MP:0001386,abnormal maternal nurturing|MP:0001559,hyperglycemia|MP:0001764,abnormal homeostasis|MP:0001870,salivary gland inflammation|MP:0001935,decreased litter size|MP:0002435,abnormal effector T cell morphology|MP:0002436,abnormal CD8-positive, alpha-beta cytotoxic T cell morphology|MP:0004031,insulitis|MP:0005215,abnormal pancreatic islet morphology|MP:0005348,increased T cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008086,increased T-helper 1 cell number|MP:0008090,increased T-helper 2 cell number
MGI:3526075	Mbd3l1<tm1Gpp>	MP:0002169,no abnormal phenotype detected
MGI:3814990	Mbd3l2<tm1Gpp>	MP:0002169,no abnormal phenotype detected
MGI:2388006	Mbd3<tm1Bh>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4887391	Mbd3<tm2Bh>	MP:0003721,increased tumor growth/size|MP:0004499,increased incidence of tumors by chemical induction|MP:0008537,increased susceptibility to induced colitis|MP:0010157,abnormal small intestinal crypt cell proliferation
MGI:2684311	Mbd4/Ift122<tm1Abc>	MP:0000274,enlarged heart|MP:0000432,abnormal head morphology|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001286,abnormal eye development|MP:0001706,abnormal left-right axis patterning|MP:0001914,hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0002766,situs inversus|MP:0003257,abnormal abdominal wall morphology|MP:0004045,abnormal cell cycle checkpoint function|MP:0004083,polysyndactyly|MP:0004132,absent embryonic cilia|MP:0004188,delayed embryo turning|MP:0004252,abnormal direction of heart looping|MP:0005192,increased motor neuron number|MP:0005230,ectrodactyly|MP:0006279,abnormal limb development|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008944,decreased sensitivity to induced cell death|MP:0010395,abnormal pharyngeal arch development|MP:0010808,right-sided stomach|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011998,decreased embryonic cilium length|MP:0012531,delayed limb development|MP:0012720,elongated neck|MP:0013202,abnormal cilium morphology|MP:0021105,abnormal ventral interneuron 3 morphology
MGI:4888288	Mbd4/Ift122<tm1Abc>	MP:0000274,enlarged heart|MP:0000432,abnormal head morphology|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001286,abnormal eye development|MP:0001706,abnormal left-right axis patterning|MP:0001914,hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0002766,situs inversus|MP:0003257,abnormal abdominal wall morphology|MP:0004045,abnormal cell cycle checkpoint function|MP:0004083,polysyndactyly|MP:0004132,absent embryonic cilia|MP:0004188,delayed embryo turning|MP:0004252,abnormal direction of heart looping|MP:0005192,increased motor neuron number|MP:0005230,ectrodactyly|MP:0006279,abnormal limb development|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008944,decreased sensitivity to induced cell death|MP:0010395,abnormal pharyngeal arch development|MP:0010808,right-sided stomach|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011998,decreased embryonic cilium length|MP:0012531,delayed limb development|MP:0012720,elongated neck|MP:0013202,abnormal cilium morphology|MP:0021105,abnormal ventral interneuron 3 morphology
MGI:2183491	Mbd4<tm1Bird>	MP:0005621,abnormal cell physiology
MGI:2447611	Mbd4<tm1Wed>	MP:0005621,abnormal cell physiology|MP:0008877,abnormal DNA methylation
MGI:2684310	Mbd4<tm2Abc>	MP:0004045,abnormal cell cycle checkpoint function|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008944,decreased sensitivity to induced cell death
MGI:3923358	Mbd5<Gt(Ayu21-B205)Imeg>	MP:0000102,abnormal nasal bone morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001360,abnormal social investigation|MP:0001405,impaired coordination|MP:0001441,increased grooming behavior|MP:0002063,abnormal learning/memory/conditioning|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003461,abnormal response to novel object|MP:0005386,behavior/neurological phenotype|MP:0008415,abnormal neurite morphology|MP:0008853,decreased abdominal adipose tissue amount|MP:0010053,decreased grip strength|MP:0010771,integument phenotype|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5466579	Mbd5<tm1.1Gxu>	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005120,decreased circulating growth hormone level|MP:0011085,postnatal lethality, complete penetrance
MGI:5466580	Mbd5<tm1.2Gxu>	MP:0000189,hypoglycemia|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002078,abnormal glucose homeostasis|MP:0002176,increased brain weight|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005136,decreased growth hormone level|MP:0005150,cachexia|MP:0005292,improved glucose tolerance|MP:0005361,small pituitary gland|MP:0005560,decreased circulating glucose level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009283,decreased gonadal fat pad weight|MP:0011085,postnatal lethality, complete penetrance
MGI:5692774	Mbd5<tm1b(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002764,short tibia|MP:0003769,abnormal lip morphology|MP:0005016,decreased lymphocyte cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness
MGI:5548367	Mbd6<tm1.1(KOMP)Vlcg>	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0001258,decreased body length|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003054,spina bifida|MP:0003917,increased kidney weight|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:6752552	Mb<em1Shad>	MP:0001392,abnormal locomotor behavior|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0020330,increased capillary density
MGI:6317348	Mbip<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0001727,abnormal embryo implantation|MP:0005343,increased circulating aspartate transaminase level|MP:0010052,increased grip strength|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2669833	Mbis1<NOD/ShiLt>	MP:0002412,increased susceptibility to bacterial infection
MGI:2669834	Mbis2<BALB/c>	MP:0002412,increased susceptibility to bacterial infection
MGI:2669836	Mbis3<BALB/c>	MP:0002412,increased susceptibility to bacterial infection
MGI:2669839	Mbis4<NOD/ShiLt>	MP:0002412,increased susceptibility to bacterial infection
MGI:2670117	Mbl1<tm1.1Mnz>	MP:0005387,immune system phenotype
MGI:3043898	Mbl1<tm1Kata>	MP:0008554,decreased circulating tumor necrosis factor level|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:3834180	Mbl1<tm1Rala>	MP:0001806,decreased IgM level|MP:0002490,abnormal immunoglobulin level|MP:0005027,increased susceptibility to parasitic infection|MP:0008497,decreased IgG2b level|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008502,increased IgG3 level
MGI:8186384	Mblac1<em1Rbl>	MP:0005266,abnormal metabolism
MGI:3052922	Mbnl1<tm1Sws>	MP:0001304,cataract|MP:0002106,abnormal muscle physiology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:3774137	Mbnl2<Gt(RRK149)Byg>	MP:0000162,lordosis|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003157,impaired muscle relaxation|MP:0003851,skeletal muscle interstitial fibrosis|MP:0009400,decreased skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:3688251	Mbnl2<Gt(XB595)Byg>	MP:0005369,muscle phenotype
MGI:5616630	Mbnl2<tm1.1Sws>	MP:0001265,decreased body size|MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002206,abnormal CNS synaptic transmission|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003997,tonic-clonic seizures|MP:0005369,muscle phenotype|MP:0008414,abnormal spatial reference memory|MP:0009436,fragmentation of sleep/wake states|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012287,increased frequency of paradoxical sleep|MP:0012288,abnormal paradoxical sleep pattern
MGI:5518844	Mbnl3<tm1.1Sws>	MP:0009400,decreased skeletal muscle fiber size|MP:0009406,decreased skeletal muscle fiber number|MP:0010053,decreased grip strength|MP:0013239,impaired skeletal muscle regeneration
MGI:6279921	Mboat1<em1(IMPC)Bay>	MP:0001488,increased startle reflex|MP:0009142,decreased prepulse inhibition
MGI:6158487	Mboat2<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002339,abnormal lymph node morphology|MP:0009142,decreased prepulse inhibition|MP:0020421,increased freezing behavior
MGI:3790106	Mboat4<tm1Jagu>	MP:0004889,increased energy expenditure|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0010025,decreased total body fat amount|MP:0011611,abnormal circulating ghrelin level|MP:0011939,increased food intake
MGI:4442482	Mboat4<tm1Vlcg>	MP:0005120,decreased circulating growth hormone level|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011613,decreased circulating ghrelin level
MGI:5613666	Mboat4<tm2b(EUCOMM)Hmgu>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology
MGI:5305990	Mboat4<tm2Vlcg>	MP:0004789,increased bile salt level|MP:0005186,increased circulating progesterone level|MP:0005378,growth/size/body region phenotype|MP:0005418,abnormal circulating hormone level|MP:0009642,abnormal blood homeostasis
MGI:4363399	Mboat7<tm1a(KOMP)Wtsi>	MP:0000440,domed cranium|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001431,abnormal eating behavior|MP:0001492,abnormal pilomotor reflex|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0005202,lethargy|MP:0010831,lethality, incomplete penetrance|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5509338	Mboat7<tm1Arai>	MP:0000784,forebrain hypoplasia|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0001265,decreased body size|MP:0002083,premature death|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0005281,increased fatty acids level|MP:0005282,decreased fatty acids level|MP:0006009,abnormal neuronal migration|MP:0008283,small hippocampus|MP:0008415,abnormal neurite morphology|MP:0009937,abnormal neuron differentiation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5637092	Mboat7<tm1b(KOMP)Wtsi>	MP:0001157,small seminal vesicle|MP:0003961,decreased lean body mass|MP:0005013,increased lymphocyte cell number|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5429211	Mboat7<tm1Lex>	MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0001265,decreased body size|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0011495,abnormal head shape
MGI:3708458	Mbp<jve>	MP:0000745,tremors|MP:0000780,abnormal corpus callosum morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001489,decreased startle reflex|MP:0002083,premature death|MP:0002826,tonic seizures|MP:0003216,absence seizures|MP:0005402,abnormal action potential|MP:0008026,abnormal brain white matter morphology|MP:0009358,environmentally induced seizures|MP:0009978,abnormal cerebellum white matter morphology|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856159	Mbp<shi>	MP:0000745,tremors|MP:0000754,paresis|MP:0000755,hindlimb paralysis|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001386,abnormal maternal nurturing|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001496,audiogenic seizures|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002826,tonic seizures|MP:0002882,abnormal neuron morphology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003871,abnormal myelin sheath morphology|MP:0003983,decreased cholesterol level|MP:0004768,abnormal axonal transport|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004813,absent linear vestibular evoked potential|MP:0004814,reduced linear vestibular evoked potential|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008814,decreased nerve conduction velocity|MP:0009358,environmentally induced seizures|MP:0010161,decreased brain cholesterol level|MP:0020938,decreased susceptibility to Picornaviridae infection
MGI:3050954	Mbp<shi-J>	MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0001393,ataxia|MP:0003871,abnormal myelin sheath morphology|MP:0005391,vision/eye phenotype|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014742,increased auditory brainstem response wave interpeak latency
MGI:1857657	Mbp<shi-mld+>	MP:0000745,tremors|MP:0000921,demyelination|MP:0000947,convulsive seizures|MP:0003171,phenotypic reversion|MP:0003175,reversion by mitotic recombination
MGI:1856160	Mbp<shi-mld>	MP:0000745,tremors|MP:0000951,sporadic seizures|MP:0002083,premature death|MP:0004924,abnormal behavior
MGI:3586965	Mbp<tm1Atc>	MP:0000920,abnormal myelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0002206,abnormal CNS synaptic transmission
MGI:5646566	Mbt1	MP:0001364,decreased anxiety-related response
MGI:5646567	Mbt2	MP:0001364,decreased anxiety-related response
MGI:5646568	Mbt3	MP:0001364,decreased anxiety-related response
MGI:4940055	Mbtd1<tm1Homy>	MP:0000077,abnormal interparietal bone morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000596,abnormal liver development|MP:0000600,liver hypoplasia|MP:0003048,abnormal cervical vertebrae morphology|MP:0003841,abnormal lambdoid suture morphology|MP:0004174,abnormal spine curvature|MP:0004607,abnormal cervical atlas morphology|MP:0004608,abnormal cervical axis morphology|MP:0004620,cervical vertebral fusion|MP:0004624,abnormal thoracic cage morphology|MP:0004703,abnormal vertebral column morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0005508,abnormal skeleton morphology|MP:0008149,abnormal costovertebral joint morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0030286,occipital bone hypoplasia|MP:0030289,flat occipital bone
MGI:4455993	Mbtd1<tm2a(EUCOMM)Wtsi>	MP:0002834,decreased heart weight
MGI:2159004	Mb<tm1Jsc>	MP:0000266,abnormal heart morphology|MP:0001574,abnormal oxygen level|MP:0002608,increased hematocrit|MP:0003022,increased coronary flow rate|MP:0005564,increased hemoglobin content|MP:0020330,increased capillary density
MGI:2159349	Mb<tm1Wlm>	MP:0001622,abnormal vasculogenesis|MP:0001625,cardiac hypertrophy|MP:0001698,decreased embryo size|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002625,heart left ventricle hypertrophy|MP:0002652,thin myocardium|MP:0003081,abnormal soleus morphology|MP:0003646,increased muscle fatigability|MP:0003957,abnormal nitric oxide homeostasis|MP:0003984,embryonic growth retardation|MP:0005039,hypoxia|MP:0005266,abnormal metabolism|MP:0005312,pericardial effusion|MP:0005329,abnormal myocardium layer morphology|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005598,decreased heart ventricle muscle contractility|MP:0005601,increased angiogenesis|MP:0006138,congestive heart failure|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:2156182	Mbtps1<Gt(PST115)Byg>	MP:0001674,abnormal germ layer development|MP:0004965,inner cell mass degeneration|MP:0011093,embryonic lethality at implantation, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6304283	Mbtps1<m2Btlr>	MP:0000372,irregular coat pigmentation
MGI:2156485	Mbtps1<tm1.1Jdh>	MP:0011100,preweaning lethality, complete penetrance
MGI:2156484	Mbtps1<tm1Jdh>	MP:0000061,fragile skeleton|MP:0000063,decreased bone mineral density|MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000134,abnormal compact bone thickness|MP:0000135,decreased compact bone thickness|MP:0000161,scoliosis|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0001533,abnormal skeleton physiology|MP:0002109,abnormal limb morphology|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0002118,abnormal lipid homeostasis|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002644,decreased circulating triglyceride level|MP:0002657,chondrodystrophy|MP:0002896,abnormal bone mineralization|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0004134,abnormal chest morphology|MP:0004989,decreased osteoblast cell number|MP:0005179,decreased circulating cholesterol level|MP:0005342,abnormal intestinal lipid absorption|MP:0005352,small cranium|MP:0005508,abnormal skeleton morphology|MP:0008271,abnormal bone ossification|MP:0008275,failure of endochondral bone ossification|MP:0009250,abnormal appendicular skeleton morphology|MP:0009356,decreased liver triglyceride level|MP:0009703,decreased birth body size|MP:0009908,protruding tongue|MP:0010879,decreased trabecular bone volume|MP:0010965,decreased compact bone volume|MP:0011087,neonatal lethality, complete penetrance|MP:0013616,decreased volumetric bone mineral density|MP:0014103,increased chondrocyte apoptosis|MP:0020137,decreased bone mineralization|MP:0030420,short basicranium
MGI:3652524	Mbtps1<wrt>	MP:0000182,increased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001923,reduced female fertility|MP:0002075,abnormal coat/hair pigmentation|MP:0002411,decreased susceptibility to bacterial infection|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005179,decreased circulating cholesterol level|MP:0005408,hypopigmentation|MP:0005621,abnormal cell physiology|MP:0008537,increased susceptibility to induced colitis|MP:0008657,increased interleukin-1 beta secretion|MP:0008705,increased interleukin-6 secretion|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:7614892	Mbtps2<em1Sapo>	MP:0000130,abnormal trabecular bone morphology|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype|MP:0006205,embryonic lethality between implantation and somite formation|MP:0006433,abnormal articular cartilage morphology|MP:0011692,increased chondrocyte number|MP:0014025,decreased subchondral bone mineral content|MP:0020137,decreased bone mineralization|MP:0030486,abnormal osteocyte canaliculus morphology
MGI:7614893	Mbtps2<em2Sapo>	MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype|MP:0006205,embryonic lethality between implantation and somite formation|MP:0006396,decreased long bone epiphyseal plate size|MP:0006433,abnormal articular cartilage morphology|MP:0030486,abnormal osteocyte canaliculus morphology
MGI:5646572	Mbtr2	MP:0001364,decreased anxiety-related response
MGI:5646564	Mbtr3	MP:0001364,decreased anxiety-related response
MGI:1856948	mc	MP:0000410,waved hair|MP:0001510,abnormal coat appearance|MP:0001926,female infertility
MGI:1856028	Mc1r<e>	MP:0001224,abnormal keratinocyte apoptosis|MP:0001968,abnormal touch/nociception|MP:0001970,abnormal pain threshold|MP:0002095,abnormal skin pigmentation|MP:0003136,yellow coat color|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0004270,analgesia|MP:0004382,abnormal hair follicle melanogenesis|MP:0005077,abnormal melanogenesis|MP:0006370,abnormal hair follicle pheomelanosome pheomelanin content
MGI:3042897	Mc1r<e-J>	MP:0001186,pigmentation phenotype|MP:0001970,abnormal pain threshold|MP:0003136,yellow coat color
MGI:1856029	Mc1r<E-so>	MP:0001188,hyperpigmentation|MP:0002095,abnormal skin pigmentation|MP:0005409,darkened coat color
MGI:1856364	Mc1r<E-so3J>	MP:0005409,darkened coat color|MP:0009928,abnormal pinna hair pigmentation
MGI:5577146	Mc1r<E-So4J>	MP:0005409,darkened coat color|MP:0009928,abnormal pinna hair pigmentation|MP:0009933,abnormal tail hair pigmentation
MGI:5049874	Mc1r<m1Btlr>	MP:0002075,abnormal coat/hair pigmentation
MGI:5791971	Mc1r<mpc59H>	MP:0003136,yellow coat color
MGI:1857788	Mc1r<taw>	MP:0002075,abnormal coat/hair pigmentation|MP:0002095,abnormal skin pigmentation|MP:0003136,yellow coat color|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:5692921	Mc1r<tm1.1(KOMP)Vlcg>	MP:0002075,abnormal coat/hair pigmentation
MGI:5770883	Mc1r<tm1.1Mymi>	MP:0001186,pigmentation phenotype|MP:0003136,yellow coat color|MP:0009388,abnormal epidermal melanocyte morphology
MGI:3764974	Mc2r<tm1Dchi>	MP:0000189,hypoglycemia|MP:0000640,adrenal gland hypoplasia|MP:0001748,increased circulating adrenocorticotropin level|MP:0002078,abnormal glucose homeostasis|MP:0002665,decreased circulating corticosterone level|MP:0002667,decreased circulating aldosterone level|MP:0003019,increased circulating chloride level|MP:0003383,abnormal gluconeogenesis|MP:0004952,increased spleen weight|MP:0004955,increased thymus weight|MP:0005202,lethargy|MP:0005333,decreased heart rate|MP:0005627,increased circulating potassium level|MP:0005661,decreased circulating adrenaline level|MP:0008294,abnormal adrenal gland zona fasciculata morphology|MP:0010025,decreased total body fat amount|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013565,abnormal adrenal gland capsule morphology
MGI:5427678	Mc2r<tm1Dgen>	MP:0000640,adrenal gland hypoplasia|MP:0001363,increased anxiety-related response|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0005459,decreased percent body fat/body weight|MP:0008299,adrenal cortical hyperplasia|MP:0009137,decreased brown fat lipid droplet number|MP:0031391,increased locomotor activity
MGI:6423853	Mc3r<em1(IMPC)Mbp>	MP:0000063,decreased bone mineral density|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001258,decreased body length|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002834,decreased heart weight|MP:0002989,small kidney|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5302394	Mc3r<tm1Butl>	MP:0001402,decreased locomotor activity|MP:0001846,increased inflammatory response|MP:0002079,increased circulating insulin level|MP:0002644,decreased circulating triglyceride level|MP:0003313,abnormal locomotor activation|MP:0003961,decreased lean body mass|MP:0004890,decreased energy expenditure|MP:0005376,homeostasis/metabolism phenotype|MP:0005448,abnormal energy homeostasis|MP:0005452,abnormal adipose tissue amount|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005667,abnormal circulating leptin level|MP:0005669,increased circulating leptin level|MP:0010024,increased total body fat amount|MP:0010379,decreased respiratory quotient|MP:0012320,abnormal body fat mass|MP:0014573,increased circulating resistin level
MGI:2183579	Mc3r<tm1Cone>	MP:0001260,increased body weight|MP:0001261,obese|MP:0004129,abnormal respiratory quotient|MP:0005449,abnormal food intake|MP:0010024,increased total body fat amount|MP:0011957,decreased compensatory feeding amount
MGI:3529251	Mc3r<tm1Lex>	MP:0005458,increased percent body fat/body weight
MGI:2183582	Mc3r<tm1Lvp>	MP:0001258,decreased body length|MP:0001260,increased body weight|MP:0001402,decreased locomotor activity|MP:0001431,abnormal eating behavior|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002079,increased circulating insulin level|MP:0003109,short femur|MP:0003961,decreased lean body mass|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0009116,abnormal brown fat cell morphology|MP:0009118,increased white fat cell size|MP:0009128,decreased brown fat cell number|MP:0010024,increased total body fat amount
MGI:2671841	Mc4r<Glu3>	MP:0001260,increased body weight|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0005455,increased susceptibility to weight gain|MP:0005458,increased percent body fat/body weight
MGI:3687867	Mc4r<I194F>	MP:0001260,increased body weight|MP:0001261,obese|MP:0005455,increased susceptibility to weight gain
MGI:3723065	Mc4r<m1Btlr>	MP:0001260,increased body weight|MP:0001261,obese
MGI:5619128	Mc4r<m2Btlr>	MP:0001260,increased body weight
MGI:5695266	Mc4r<m3Btlr>	MP:0001260,increased body weight
MGI:6114074	Mc4r<M4Btlr>	MP:0001260,increased body weight
MGI:6200035	Mc4r<M5Btlr>	MP:0001260,increased body weight
MGI:6304420	Mc4r<M6Btlr>	MP:0001260,increased body weight
MGI:6305820	Mc4r<m7Btlr>	MP:0001260,increased body weight
MGI:5699976	Mc4r<Mhdahwe13>	MP:0001260,increased body weight
MGI:3603635	Mc4r<Pkcp>	MP:0006087,increased body mass index
MGI:5703936	Mc4r<tm1.1Fbz>	MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001261,obese|MP:0001433,polyphagia|MP:0003960,increased lean body mass|MP:0003961,decreased lean body mass|MP:0004889,increased energy expenditure|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0009286,increased abdominal fat pad weight
MGI:2183586	Mc4r<tm1Dhu>	MP:0001260,increased body weight|MP:0001264,increased body size|MP:0001433,polyphagia|MP:0001559,hyperglycemia|MP:0001921,reduced fertility|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0003313,abnormal locomotor activation|MP:0004985,decreased osteoclast cell number|MP:0005449,abnormal food intake|MP:0005605,increased bone mass|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0020473,abnormal circadian behavior phase
MGI:5428998	Mc4r<tm1Lex>	MP:0005458,increased percent body fat/body weight
MGI:3512050	Mc4r<tm1Lowl>	MP:0000231,hypertension|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001261,obese|MP:0001433,polyphagia|MP:0001554,increased circulating free fatty acids level|MP:0001860,liver inflammation|MP:0002079,increased circulating insulin level|MP:0002169,no abnormal phenotype detected|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003333,liver fibrosis|MP:0003960,increased lean body mass|MP:0005288,abnormal oxygen consumption|MP:0005290,decreased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005388,respiratory system phenotype|MP:0005449,abnormal food intake|MP:0005455,increased susceptibility to weight gain|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0008596,increased circulating interleukin-6 level|MP:0009355,increased liver triglyceride level|MP:0010024,increased total body fat amount|MP:0030968,decreased circulating adiponectin level|MP:0031116,microvesicular hepatic steatosis|MP:0031602,white adipose tissue inflammation
MGI:6405040	Mc4r<tm1Matsu>	MP:0001860,liver inflammation|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003333,liver fibrosis|MP:0005178,increased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0009355,increased liver triglyceride level|MP:0011939,increased food intake|MP:0030678,increased hydroxyproline level
MGI:5484616	Mc4r<tm2.1Lowl>	MP:0001257,increased body length|MP:0001261,obese|MP:0001433,polyphagia|MP:0003960,increased lean body mass|MP:0010024,increased total body fat amount
MGI:5484615	Mc4r<tm2Lowl>	MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001261,obese|MP:0001433,polyphagia|MP:0010024,increased total body fat amount
MGI:3687868	Mc4r<Y302C>	MP:0001260,increased body weight|MP:0001261,obese|MP:0005455,increased susceptibility to weight gain
MGI:6449053	Mc5r<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001304,cataract|MP:0002152,abnormal brain morphology|MP:0002699,abnormal vitreous body morphology|MP:0005238,increased brain size
MGI:3606007	Mc5r<tm1Cone>	MP:0000367,abnormal coat/ hair morphology|MP:0001348,abnormal lacrimal gland physiology|MP:0002992,abnormal sebaceous lipid secretion|MP:0003862,decreased aggression towards male mice|MP:0011049,impaired adaptive thermogenesis|MP:0013476,abnormal Harderian gland porphyrin secretion
MGI:5692763	Mcam<tm1.1(KOMP)Wtsi>	MP:0002574,increased vertical activity|MP:0003795,abnormal bone structure|MP:0010123,increased bone mineral content
MGI:3528863	Mcam<tm1Lex>	MP:0005025,abnormal response to infection|MP:0008713,abnormal cytokine level|MP:0011079,decreased macrophage cytokine production
MGI:5445382	Mcam<tm1Yanx>	MP:0005602,decreased angiogenesis
MGI:5466512	Mcat<tm1.1Ssmi>	MP:0000160,kyphosis|MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000414,alopecia|MP:0000493,rectal prolapse|MP:0000691,enlarged spleen|MP:0000745,tremors|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001412,excessive scratching|MP:0001417,decreased exploration in new environment|MP:0001431,abnormal eating behavior|MP:0001510,abnormal coat appearance|MP:0001573,abnormal circulating alanine transaminase level|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0001783,decreased white adipose tissue amount|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002118,abnormal lipid homeostasis|MP:0002169,no abnormal phenotype detected|MP:0002424,abnormal reticulocyte morphology|MP:0002575,increased circulating ketone body level|MP:0002590,increased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002722,abnormal immune system organ morphology|MP:0002757,decreased vertical activity|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003019,increased circulating chloride level|MP:0003293,rectal hemorrhage|MP:0003656,abnormal erythrocyte physiology|MP:0003853,dry skin|MP:0005016,decreased lymphocyte cell number|MP:0005381,digestive/alimentary phenotype|MP:0005386,behavior/neurological phenotype|MP:0005534,decreased body temperature|MP:0005559,increased circulating glucose level|MP:0006036,abnormal mitochondrial physiology|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0010053,decreased grip strength|MP:0010067,increased red blood cell distribution width|MP:0010072,increased pruritus|MP:0010401,increased skeletal muscle glycogen level|MP:0010954,abnormal cellular respiration|MP:0012106,impaired exercise endurance|MP:0013405,increased circulating lactate level
MGI:6257710	Mccc1<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness
MGI:5817349	Mccc2<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0002591,decreased mean corpuscular volume|MP:0003131,increased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0009141,increased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:3889488	Mcc<Gt(D062B07)Wrst>	MP:0002169,no abnormal phenotype detected
MGI:4335844	Mcc<Gt(W197F04)Wrst>	MP:0002169,no abnormal phenotype detected
MGI:6455797	Mcc<tm1.1Maija>	MP:0009310,increased large intestine adenocarcinoma incidence
MGI:6455801	Mcc<tm1.2Maija>	MP:0014760,impaired DNA repair
MGI:3706144	Mcdq1<A/J>	MP:0003932,abnormal molar crown morphology
MGI:3706143	Mcdq1<SM/J>	MP:0003932,abnormal molar crown morphology
MGI:7543594	Mcemp1<em1Jngj>	MP:0002531,abnormal type I hypersensitivity reaction|MP:0005462,abnormal mast cell differentiation
MGI:4436065	Mcf2l<tm1a(EUCOMM)Hmgu>	MP:0001566,increased circulating phosphate level|MP:0002965,increased circulating serum albumin level
MGI:2388053	Mcf2<tm1Ehi>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0008143,abnormal dendrite morphology
MGI:5544759	Mcfd2<tm1Dgi>	MP:0005416,abnormal circulating protein level|MP:0005632,decreased circulating aspartate transaminase level|MP:0008469,abnormal protein level|MP:0012328,decreased circulating factor VIII level
MGI:1857319	Mchm1	MP:0000371,diluted coat color|MP:0001265,decreased body size
MGI:3622239	Mchq1<SM/J>	MP:0005561,increased mean corpuscular hemoglobin
MGI:6286319	Mchr1<M1Btlr>	MP:0001262,decreased body weight
MGI:3778893	Mchr1<tm1.1Blak>	MP:0001501,abnormal sleep pattern|MP:0003194,abnormal frequency of paradoxical sleep|MP:0009747,impaired behavioral response to xenobiotic
MGI:3603521	Mchr1<tm1Blak>	MP:0002272,abnormal nervous system electrophysiology|MP:0002799,abnormal passive avoidance behavior|MP:0005659,decreased susceptibility to diet-induced obesity
MGI:3527904	Mchr1<tm1Dgam>	MP:0001262,decreased body weight|MP:0001433,polyphagia|MP:0002626,increased heart rate|MP:0005450,abnormal energy expenditure|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0010025,decreased total body fat amount|MP:0011020,abnormal circadian temperature homeostasis|MP:0031391,increased locomotor activity
MGI:3528891	Mchr1<tm1Lex>	MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0005459,decreased percent body fat/body weight|MP:0005533,increased body temperature|MP:0010070,decreased serotonin level|MP:0010167,decreased response to stress-induced hyperthermia
MGI:3043698	Mchr1<tm1Ohl>	MP:0000066,osteoporosis|MP:0000135,decreased compact bone thickness|MP:0010962,decreased compact bone mass|MP:0031074,increased circulating type I collagen C-terminal telopeptide level
MGI:2451034	Mchr1<tm1Sqn>	MP:0001433,polyphagia|MP:0001745,increased circulating corticosterone level|MP:0003953,abnormal hormone level|MP:0003960,increased lean body mass|MP:0005266,abnormal metabolism|MP:0005376,homeostasis/metabolism phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005471,decreased thyroxine level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0010379,decreased respiratory quotient|MP:0011941,increased fluid intake|MP:0031391,increased locomotor activity
MGI:3621901	Mchr1<tm1Yush>	MP:0001263,weight loss|MP:0002727,decreased circulating insulin level|MP:0005450,abnormal energy expenditure|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008489,slow postnatal weight gain|MP:0010025,decreased total body fat amount|MP:0011939,increased food intake
MGI:6343523	Mcidas<em1Sroy>	MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002082,postnatal lethality|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0005076,abnormal cell differentiation|MP:0005388,respiratory system phenotype|MP:0008770,decreased survivor rate|MP:0011056,abnormal brain ependyma motile cilium morphology|MP:0011644,abnormal oviduct epithelium motile cilium morphology|MP:0013206,abnormal motile cilium morphology
MGI:6157333	Mcidas<em2(IMPC)Tcp>	MP:0000218,increased leukocyte cell number|MP:0000689,abnormal spleen morphology|MP:0001489,decreased startle reflex|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002574,increased vertical activity|MP:0002941,increased circulating alanine transaminase level|MP:0003961,decreased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005568,increased circulating total protein level|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength
MGI:6279907	Mcl1<em1(IMPC)Mbp>	MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001891,hydrocephaly|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0002590,increased mean corpuscular volume|MP:0003984,embryonic growth retardation|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:4840274	Mcl1<tm1Dmta>	MP:0002144,abnormal B cell differentiation|MP:0005387,immune system phenotype|MP:0008094,absent memory B cells|MP:0008178,decreased germinal center B cell number|MP:0008179,absent germinal center B cells|MP:0008185,decreased naive B cell number|MP:0008495,decreased IgG1 level|MP:0008729,decreased memory B cell number
MGI:2159362	Mcl1<tm1Sjk>	MP:0001730,embryonic growth arrest|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0005380,embryo phenotype|MP:0009666,abnormal embryo attachment|MP:0011093,embryonic lethality at implantation, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance
MGI:3837368	Mcl1<tm1Yen>	MP:0002408,abnormal double-positive T cell morphology|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005089,decreased double-negative T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number
MGI:3800294	Mcl1<tm1Ywh>	MP:0000222,decreased neutrophil cell number|MP:0000334,decreased granulocyte number|MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0002463,abnormal neutrophil physiology|MP:0005011,increased eosinophil cell number|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0005091,increased double-positive T cell number|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0006413,increased T cell apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008719,impaired neutrophil recruitment
MGI:2684151	Mcl1<tm3Sjk>	MP:0000208,decreased hematocrit|MP:0000336,decreased mast cell number|MP:0001876,decreased inflammatory response|MP:0002169,no abnormal phenotype detected|MP:0002607,decreased basophil cell number|MP:0002811,macrocytic anemia|MP:0002875,decreased erythrocyte cell number|MP:0005397,hematopoietic system phenotype|MP:0005597,decreased susceptibility to type I hypersensitivity reaction
MGI:3615656	Mclr<SWR/J>	MP:0002024,increased T cell derived lymphoma incidence
MGI:5296322	Mcm10<tm1Hlee>	MP:0000352,decreased cell proliferation|MP:0001730,embryonic growth arrest|MP:0002718,abnormal inner cell mass morphology|MP:0004957,abnormal blastocyst morphology|MP:0004963,abnormal blastocoele morphology|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:4839016	Mcm10<tm1(NCOM)Cmhd>	MP:0002942,decreased circulating alanine transaminase level
MGI:3863806	Mcm2<Gt(AB0178)Wtsi>	MP:0002447,abnormal erythrocyte morphology|MP:0008866,chromosomal instability|MP:0011091,prenatal lethality, complete penetrance
MGI:3818719	Mcm2<tm1(cre/ERT2)Scpr>	MP:0000416,sparse hair|MP:0000691,enlarged spleen|MP:0000747,muscle weakness|MP:0001402,decreased locomotor activity|MP:0001505,hunched posture|MP:0001951,abnormal breathing pattern|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0002447,abnormal erythrocyte morphology|MP:0003077,abnormal cell cycle|MP:0003111,abnormal cell nucleus morphology|MP:0003269,colon polyps|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0008011,intestine polyps|MP:0008108,abnormal small intestinal villus morphology|MP:0010025,decreased total body fat amount|MP:0014127,increased thymoma incidence
MGI:3820530	Mcm2<tm2Scpr>	MP:0002169,no abnormal phenotype detected
MGI:3583894	Mcm3ap<tm1Imku>	MP:0001805,decreased IgG level|MP:0002359,abnormal spleen germinal center morphology|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0008093,abnormal memory B cell number|MP:0008178,decreased germinal center B cell number|MP:0008192,abnormal germinal center B cell physiology
MGI:3794112	Mcm3ap<tm2Imku>	MP:0011092,embryonic lethality, complete penetrance
MGI:4330835	Mcm3<Gt(RRR002)Byg>	MP:0002447,abnormal erythrocyte morphology|MP:0008866,chromosomal instability|MP:0011091,prenatal lethality, complete penetrance
MGI:5907491	Mcm3<tm1.1Geno>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000609,abnormal liver physiology|MP:0001272,increased metastatic potential|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0002416,abnormal proerythroblast morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002874,decreased hemoglobin content|MP:0003077,abnormal cell cycle|MP:0003717,pallor|MP:0004200,decreased fetal size|MP:0004809,increased hematopoietic stem cell number|MP:0006042,increased apoptosis|MP:0010308,decreased tumor latency|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011178,increased erythroblast number|MP:0011243,decreased fetal derived definitive erythrocyte cell number|MP:0011903,decreased hematopoietic stem cell proliferation|MP:0011913,abnormal reticulocyte cell number|MP:0012431,increased lymphoma incidence|MP:0021086,decreased DNA replication
MGI:5907492	Mcm3<tm1.2Geno>	MP:0001272,increased metastatic potential|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0010308,decreased tumor latency|MP:0011091,prenatal lethality, complete penetrance|MP:0012431,increased lymphoma incidence
MGI:3696791	Mcm4<chaos3>	MP:0000352,decreased cell proliferation|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002083,premature death|MP:0002447,abnormal erythrocyte morphology|MP:0003077,abnormal cell cycle|MP:0003331,increased hepatocellular carcinoma incidence|MP:0008866,chromosomal instability|MP:0010299,increased mammary gland tumor incidence|MP:0012431,increased lymphoma incidence|MP:0014693,abnormal cell nucleus size|MP:0031678,increased micronucleus incidence
MGI:3696796	Mcm4<Gt(RRE056)Byg>	MP:0002169,no abnormal phenotype detected|MP:0002447,abnormal erythrocyte morphology|MP:0008866,chromosomal instability|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:5473704	Mcm4<Sdla>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002020,increased tumor incidence|MP:0002640,reticulocytosis|MP:0004029,spontaneous chromosome breakage|MP:0004030,induced chromosome breakage|MP:0010130,decreased DN1 thymic pro-T cell number|MP:0010336,increased acute lymphoblastic leukemia incidence|MP:0011092,embryonic lethality, complete penetrance
MGI:5630062	Mcm4<tm1b(KOMP)Mbp>	MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5563450	Mcm5<m1Anu>	MP:0008762,embryonic lethality
MGI:3878139	Mcm6<Gt(YHD248)Byg>	MP:0002447,abnormal erythrocyte morphology|MP:0008866,chromosomal instability|MP:0011091,prenatal lethality, complete penetrance
MGI:3880493	Mcm7<Gt(YTA285)Byg>	MP:0002447,abnormal erythrocyte morphology|MP:0008866,chromosomal instability|MP:0011091,prenatal lethality, complete penetrance
MGI:5439837	Mcm8<tm1.1Geno>	MP:0001125,abnormal oocyte morphology|MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001132,absent mature ovarian follicles|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0003205,testicular atrophy|MP:0004025,polyploidy|MP:0004029,spontaneous chromosome breakage|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005431,decreased oocyte number|MP:0008000,increased ovary tumor incidence|MP:0008057,abnormal DNA replication|MP:0008261,arrest of male meiosis|MP:0008280,abnormal male germ cell apoptosis|MP:0009092,endometrium hyperplasia|MP:0009362,abnormal primary ovarian follicle morphology|MP:0011704,decreased fibroblast proliferation|MP:0013539,increased ovary adenoma incidence|MP:0014764,impaired double-strand DNA break repair|MP:0031678,increased micronucleus incidence
MGI:3857270	Mcm9<Gt(AW0655)Wtsi>	MP:0001128,ovary hyperplasia|MP:0001147,small testis|MP:0001926,female infertility|MP:0002020,increased tumor incidence|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0003331,increased hepatocellular carcinoma incidence|MP:0004901,decreased male germ cell number|MP:0008000,increased ovary tumor incidence|MP:0008261,arrest of male meiosis|MP:0010383,increased adenoma incidence|MP:0010768,mortality/aging|MP:0014619,absent spermatogonia|MP:0031020,premature ovarian failure
MGI:4126968	Mcm9<Gt(XG743)Byg>	MP:0001147,small testis|MP:0002020,increased tumor incidence|MP:0002123,abnormal definitive hematopoiesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0003077,abnormal cell cycle|MP:0003331,increased hepatocellular carcinoma incidence|MP:0004029,spontaneous chromosome breakage|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0005431,decreased oocyte number|MP:0006361,abnormal female germ cell morphology|MP:0008000,increased ovary tumor incidence|MP:0008008,early cellular replicative senescence|MP:0008261,arrest of male meiosis|MP:0008392,decreased primordial germ cell number|MP:0008871,abnormal ovarian follicle number|MP:0010768,mortality/aging|MP:0011121,decreased primordial ovarian follicle number|MP:0014619,absent spermatogonia
MGI:5439838	Mcm9<tm1.1Geno>	MP:0001926,female infertility|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0004025,polyploidy|MP:0004029,spontaneous chromosome breakage|MP:0005389,reproductive system phenotype|MP:0008057,abnormal DNA replication|MP:0008280,abnormal male germ cell apoptosis|MP:0011704,decreased fibroblast proliferation|MP:0031678,increased micronucleus incidence
MGI:5763071	Mcmbp<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0002591,decreased mean corpuscular volume|MP:0003961,decreased lean body mass|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5892145	Mcmdc2<tm3b(EUCOMM)Hmgu>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001930,abnormal meiosis|MP:0004805,absent oocytes|MP:0004833,ovary atrophy|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0009452,abnormal synaptonemal complex|MP:0014764,impaired double-strand DNA break repair
MGI:5050099	Mcoln1<tm1Asoy>	MP:0000470,abnormal stomach morphology|MP:0000755,hindlimb paralysis|MP:0001732,postnatal growth retardation|MP:0003883,enlarged stomach|MP:0004139,abnormal gastric parietal cell morphology|MP:0004731,increased circulating gastrin level|MP:0008006,increased stomach pH
MGI:3794204	Mcoln1<tm1Sasl>	MP:0000539,distended urinary bladder|MP:0000746,weakness|MP:0000755,hindlimb paralysis|MP:0000774,decreased brain size|MP:0001262,decreased body weight|MP:0001270,distended abdomen|MP:0001326,retina degeneration|MP:0001330,abnormal optic nerve morphology|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002451,abnormal macrophage physiology|MP:0002795,dilated cardiomyopathy|MP:0003632,abnormal nervous system morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004731,increased circulating gastrin level|MP:0004819,decreased skeletal muscle mass|MP:0005202,lethargy|MP:0008511,thin retina inner nuclear layer|MP:0008513,thin retina inner plexiform layer|MP:0008843,absent subcutaneous adipose tissue|MP:0010792,abnormal stomach mucosa morphology
MGI:5881907	Mcoln2<tm1e.1(KOMP)Wtsi>	MP:0002419,abnormal innate immunity|MP:0003799,impaired macrophage chemotaxis|MP:0008720,impaired neutrophil chemotaxis|MP:0008721,abnormal chemokine level|MP:0008722,abnormal chemokine secretion
MGI:5319089	Mcoln3<tm1.1Hels>	MP:0005377,hearing/vestibular/ear phenotype
MGI:1856230	Mcoln3<Va>	MP:0000048,abnormal stria vascularis morphology|MP:0000371,diluted coat color|MP:0000421,mottled coat|MP:0001386,abnormal maternal nurturing|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001401,jumpy|MP:0001405,impaired coordination|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0001921,reduced fertility|MP:0001967,deafness|MP:0002622,abnormal cochlear hair cell morphology|MP:0002826,tonic seizures|MP:0002856,abnormal vestibular ganglion morphology|MP:0002857,cochlear ganglion degeneration|MP:0002938,white spotting|MP:0002939,head spot|MP:0003150,detached tectorial membrane|MP:0003312,abnormal locomotor coordination|MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0004249,abnormal crista ampullaris morphology|MP:0004362,cochlear hair cell degeneration|MP:0004591,enlarged tectorial membrane|MP:0005307,head tossing|MP:0005366,variegated coat color|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856231	Mcoln3<Va-J>	MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0000421,mottled coat|MP:0001967,deafness|MP:0002938,white spotting|MP:0002939,head spot|MP:0005175,non-pigmented tail tip|MP:0005366,variegated coat color|MP:0005386,behavior/neurological phenotype|MP:0009379,abnormal foot pigmentation|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4332146	Mcph1<Gt(RRO608)Byg>	MP:0002083,premature death|MP:0003702,abnormal chromosome morphology|MP:0004046,abnormal mitosis|MP:0005389,reproductive system phenotype|MP:0008770,decreased survivor rate
MGI:3056375	Mcph1<Tg(HLA-A2.1)1Enge>	MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005000,abnormal immune tolerance|MP:0005387,immune system phenotype
MGI:5308745	Mcph1<tm1.1Zqw>	MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000913,abnormal brain development|MP:0001924,infertility|MP:0003077,abnormal cell cycle|MP:0003203,increased neuron apoptosis|MP:0003205,testicular atrophy|MP:0003702,abnormal chromosome morphology|MP:0004046,abnormal mitosis|MP:0004833,ovary atrophy|MP:0004948,abnormal neuronal precursor proliferation|MP:0006254,thin cerebral cortex|MP:0008441,thin cortical plate|MP:0008457,abnormal cortical intermediate zone morphology|MP:0008547,abnormal neocortex morphology|MP:0009760,abnormal mitotic spindle morphology|MP:0009937,abnormal neuron differentiation
MGI:4429492	Mcph1<tm1.2Kali>	MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001658,increased mortality induced by gamma-irradiation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002216,abnormal seminiferous tubule morphology|MP:0002444,abnormal T cell physiology|MP:0002777,absent ovarian follicles|MP:0004030,induced chromosome breakage|MP:0004856,decreased ovary weight|MP:0004901,decreased male germ cell number|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis|MP:0011090,perinatal lethality, incomplete penetrance|MP:0014052,increased male germ cell apoptosis|MP:0014633,decreased spermatid number
MGI:4431685	Mcph1<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000433,microcephaly|MP:0001116,small gonad|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001324,abnormal eye pigmentation|MP:0001328,disorganized retina layers|MP:0001973,increased thermal nociceptive threshold|MP:0002160,abnormal reproductive system morphology|MP:0002161,abnormal fertility/fecundity|MP:0003961,decreased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005014,increased B cell number|MP:0005205,abnormal eye anterior chamber morphology|MP:0005300,abnormal cornea stroma morphology|MP:0005542,cornea vascularization|MP:0006358,absent pinna reflex|MP:0008866,chromosomal instability|MP:0010124,decreased bone mineral content|MP:0010869,decreased bone trabecula number|MP:0010873,decreased trabecular bone mass|MP:0010879,decreased trabecular bone volume|MP:0011962,increased cornea thickness|MP:0012538,persistent hyaloid artery
MGI:3505765	Mcpt1<tm1Hrpm>	MP:0000359,abnormal mast cell morphology|MP:0005027,increased susceptibility to parasitic infection|MP:0006043,decreased apoptosis|MP:0008554,decreased circulating tumor necrosis factor level
MGI:2673094	Mcpt4<tm1Mabr>	MP:0002423,abnormal mast cell physiology|MP:0002551,abnormal blood coagulation
MGI:4830320	Mcpt8<tm1.1(HBEGF)Hkar>	MP:0002607,decreased basophil cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005387,immune system phenotype
MGI:4453021	Mcrip1<tm1(KOMP)Vlcg>	MP:0001177,atelectasis|MP:0001262,decreased body weight|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002270,abnormal pulmonary alveolus morphology|MP:0005426,tachypnea|MP:0010813,abnormal alveolar lamellar body morphology|MP:0010889,small alveolar lamellar bodies|MP:0010890,decreased alveolar lamellar body number|MP:0010993,decreased surfactant secretion|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012167,abnormal epigenetic regulation of gene expression
MGI:6845074	Mcrip2<em1Eno>	MP:0005369,muscle phenotype|MP:0011049,impaired adaptive thermogenesis|MP:0011698,abnormal brown adipose tissue physiology|MP:0020520,whitened brown adipose tissue morphology
MGI:3612263	Mcr<NC>	MP:0031395,cutaneous mastocytosis
MGI:5581465	Mcrs1<tm1.1(KOMP)Vlcg>	MP:0001728,failure of embryo implantation|MP:0002718,abnormal inner cell mass morphology|MP:0003019,increased circulating chloride level|MP:0003886,abnormal embryonic epiblast morphology|MP:0004964,absent inner cell mass|MP:0005028,abnormal trophectoderm morphology|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012113,decreased inner cell mass proliferation|MP:0013292,embryonic lethality prior to organogenesis
MGI:5787979	Mcrs1<tm1.1Ndj>	MP:0002169,no abnormal phenotype detected
MGI:5787981	Mcrs1<tm1.2Ndj>	MP:0011092,embryonic lethality, complete penetrance
MGI:6192114	Mctp1<dwnd>	MP:0000031,abnormal cochlea morphology|MP:0001394,circling|MP:0002622,abnormal cochlear hair cell morphology|MP:0003169,abnormal scala media morphology|MP:0004317,small vestibular saccule|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0006089,abnormal vestibular saccule morphology|MP:0008308,small scala media|MP:0009259,abnormal vestibular saccule duct morphology|MP:0010768,mortality/aging|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013911,fused vestibular saccule and utricle
MGI:6152514	Mctp1<em1(IMPC)Mbp>	MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype
MGI:6152515	Mcts1<em1(IMPC)Mbp>	MP:0000691,enlarged spleen|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0002092,abnormal eye morphology
MGI:5637017	Mcub<tm1b(KOMP)Mbp>	MP:0001284,absent vibrissae|MP:0001523,impaired righting response
MGI:4022473	Mcu<Gt(IST11669F8)Tigm>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0005376,homeostasis/metabolism phenotype|MP:0005384,cellular phenotype|MP:0005385,cardiovascular system phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0010053,decreased grip strength|MP:0012106,impaired exercise endurance|MP:0013405,increased circulating lactate level
MGI:6257619	Mcur1<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity
MGI:5910730	Mcur1<tm1c(KOMP)Wtsi>	MP:0001265,decreased body size|MP:0006036,abnormal mitochondrial physiology|MP:0008965,increased basal metabolism|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011134,decreased lung endothelial cell migration|MP:0011140,decreased lung endothelial cell proliferation
MGI:5779563	Mcu<tm1.1Jmol>	MP:0000278,abnormal myocardial fiber morphology|MP:0003038,decreased myocardial infarct size|MP:0003061,decreased aerobic running capacity|MP:0003223,decreased cardiomyocyte apoptosis|MP:0004215,abnormal myocardial fiber physiology|MP:0005370,liver/biliary system phenotype|MP:0005384,cellular phenotype|MP:0005385,cardiovascular system phenotype|MP:0005598,decreased heart ventricle muscle contractility|MP:0006036,abnormal mitochondrial physiology|MP:0011134,decreased lung endothelial cell migration|MP:0011140,decreased lung endothelial cell proliferation|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:5637176	Mcu<tm1b(EUCOMM)Hmgu>	MP:0001556,increased circulating HDL cholesterol level|MP:0003961,decreased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:5692853	Mcu<tm1c(EUCOMM)Hmgu>	MP:0005384,cellular phenotype|MP:0006036,abnormal mitochondrial physiology
MGI:3622242	Mcvq1<SM/J>	MP:0002590,increased mean corpuscular volume
MGI:3622247	Mcvq3<SM/J>	MP:0002590,increased mean corpuscular volume
MGI:6279909	Mdc1<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity|MP:0001925,male infertility|MP:0003393,decreased cardiac output|MP:0003921,abnormal heart left ventricle morphology|MP:0011952,decreased cardiac stroke volume
MGI:3799747	Mdc1<Gt(OST441263)Lex>	MP:0000352,decreased cell proliferation|MP:0000692,small spleen|MP:0000706,small thymus|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002687,oligozoospermia|MP:0003992,increased mortality induced by ionizing radiation|MP:0004029,spontaneous chromosome breakage|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0004816,abnormal class switch recombination|MP:0014764,impaired double-strand DNA break repair
MGI:2155446	Mdfi<tm1Krt>	MP:0000141,abnormal vertebral body morphology|MP:0000150,abnormal rib morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000585,kinked tail|MP:0000930,wavy neural tube|MP:0001265,decreased body size|MP:0001701,incomplete embryo turning|MP:0001713,decreased trophoblast giant cell number|MP:0001954,respiratory distress|MP:0002114,abnormal axial skeleton morphology|MP:0002621,delayed neural tube closure|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0003345,decreased rib number|MP:0003984,embryonic growth retardation|MP:0004601,abnormal vertebral spinous process morphology|MP:0004677,truncated ribs|MP:0006029,abnormal sclerotome morphology|MP:0008148,abnormal sternocostal joint morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4878863	Mdga1<tm1.1Tymo>	MP:0003631,nervous system phenotype|MP:0006009,abnormal neuronal migration
MGI:1889308	Mdga2<Adp>	MP:0000445,short snout|MP:0000554,abnormal carpal bone morphology|MP:0000566,synostosis|MP:0000572,abnormal autopod morphology|MP:0002111,abnormal tail morphology|MP:0005650,abnormal limb bud morphology|MP:0006280,abnormal digit development|MP:0008877,abnormal DNA methylation|MP:0030191,narrow snout
MGI:5906301	Mdga2<Tg(Prnp-PFN1*G118V)838Kiaei>	MP:0000160,kyphosis|MP:0000745,tremors|MP:0000748,progressive muscle weakness|MP:0000755,hindlimb paralysis|MP:0000938,motor neuron degeneration|MP:0000955,abnormal spinal cord morphology|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002651,abnormal sciatic nerve morphology|MP:0003354,astrocytosis|MP:0003993,abnormal ventral spinal root morphology|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005402,abnormal action potential|MP:0005405,axon degeneration|MP:0008918,microgliosis|MP:0009417,skeletal muscle atrophy|MP:0010653,abnormal Wallerian degeneration|MP:0012051,spasticity|MP:0014603,neuromuscular synapse degeneration|MP:0020336,abnormal motor neuron dendrite morphology|MP:0030835,abnormal ankle joint morphology
MGI:1933639	Mdh1<am1H>	MP:0005584,abnormal enzyme/coenzyme activity|MP:0011091,prenatal lethality, complete penetrance
MGI:6257763	Mdh1b<em1(IMPC)Bay>	MP:0003733,abnormal retina inner nuclear layer morphology
MGI:6257732	Mdh1<em1(IMPC)Bay>	MP:0001417,decreased exploration in new environment|MP:0002884,abnormal pharyngeal arch morphology|MP:0002953,thick ventricular wall|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6257531	Mdh2<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0002151,abnormal neural tube morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5493326	Mdk<tm1.1(KOMP)Mbp>	MP:0001523,impaired righting response|MP:0001556,increased circulating HDL cholesterol level|MP:0002591,decreased mean corpuscular volume|MP:0003019,increased circulating chloride level|MP:0005178,increased circulating cholesterol level|MP:0005633,increased circulating sodium level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2178959	Mdk<tm1Tmu>	MP:0000606,decreased hepatocyte number|MP:0000808,abnormal hippocampus development|MP:0000812,abnormal dentate gyrus morphology|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001570,abnormal circulating enzyme level|MP:0001963,abnormal hearing physiology|MP:0002063,abnormal learning/memory/conditioning|MP:0002704,tubular nephritis|MP:0003402,decreased liver weight|MP:0003606,kidney failure|MP:0003884,decreased macrophage cell number|MP:0005023,abnormal wound healing|MP:0005386,behavior/neurological phenotype|MP:0005643,decreased dopamine level|MP:0006055,abnormal vascular endothelial cell morphology|MP:0008720,impaired neutrophil chemotaxis|MP:0009142,decreased prepulse inhibition|MP:0010760,abnormal macrophage chemotaxis
MGI:3587061	mdlk1<MOLF/Ei>	MP:0003787,abnormal imprinting
MGI:6156327	Mdm1<em1(IMPC)Kmpc>	MP:0002764,short tibia
MGI:5905614	Mdm1<m1J>	MP:0001326,retina degeneration|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005103,abnormal retina pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005549,retina pigment epithelium hyperplasia|MP:0005551,abnormal eye electrophysiology|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment
MGI:2156188	Mdm2<Gt(Ex65)Byg>	MP:0011092,embryonic lethality, complete penetrance
MGI:2673928	Mdm2<tm1.1Mep>	MP:0011091,prenatal lethality, complete penetrance
MGI:4836988	Mdm2<tm1.1Ypz>	MP:0000351,increased cell proliferation
MGI:1857463	Mdm2<tm1Bay>	MP:0001658,increased mortality induced by gamma-irradiation|MP:0002085,abnormal embryonic tissue morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:1857945	Mdm2<tm1Glo>	MP:0000575,increased foot pad pigmentation|MP:0001545,abnormal hematopoietic system physiology|MP:0002085,abnormal embryonic tissue morphology|MP:0003992,increased mortality induced by ionizing radiation|MP:0005621,abnormal cell physiology|MP:0009687,empty decidua capsularis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2673927	Mdm2<tm1Mep>	MP:0001658,increased mortality induced by gamma-irradiation|MP:0005378,growth/size/body region phenotype
MGI:2385452	Mdm2<tm1Snj>	MP:0002169,no abnormal phenotype detected
MGI:3763432	Mdm2<tm1Ypz>	MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2385439	Mdm2<tm2.1Glo>	MP:0002169,no abnormal phenotype detected
MGI:5446921	Mdm2<tm2.1Snj>	MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002135,abnormal kidney morphology|MP:0003010,decreased mortality induced by ionizing radiation|MP:0003077,abnormal cell cycle|MP:0006043,decreased apoptosis|MP:0009542,decreased thymocyte apoptosis
MGI:2385443	Mdm2<tm2.3Glo>	MP:0011091,prenatal lethality, complete penetrance
MGI:4835494	Mdm2<tm3.1Glo>	MP:0001883,increased mammary adenocarcinoma incidence|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0004228,decreased cellular sensitivity to ionizing radiation induced cell death|MP:0011703,increased fibroblast proliferation|MP:0012431,increased lymphoma incidence
MGI:5446922	Mdm2<tm3.1Snj>	MP:0005384,cellular phenotype|MP:0005387,immune system phenotype|MP:0010318,increased salivary gland tumor incidence
MGI:4835495	Mdm2<tm4.1Glo>	MP:0002032,increased sarcoma incidence|MP:0005384,cellular phenotype
MGI:1861977	Mdm4<Gt(VICTR20)7Lex>	MP:0000352,decreased cell proliferation|MP:0000785,telencephalon hypoplasia|MP:0000825,dilated lateral ventricle|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0003077,abnormal cell cycle|MP:0003717,pallor|MP:0003720,abnormal neural tube closure|MP:0003861,abnormal nervous system development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:6200383	Mdm4<m1Btlr>	MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0008083,decreased single-positive T cell number
MGI:6285944	Mdm4<m2Btlr>	MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3850668	Mdm4<tm1.1Wahl>	MP:0000218,increased leukocyte cell number|MP:0002006,neoplasm|MP:0003010,decreased mortality induced by ionizing radiation|MP:0003131,increased erythrocyte cell number|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0005505,thrombocytosis|MP:0009542,decreased thymocyte apoptosis
MGI:2183485	Mdm4<tm1Glo>	MP:0000352,decreased cell proliferation|MP:0000575,increased foot pad pigmentation|MP:0003992,increased mortality induced by ionizing radiation|MP:0005621,abnormal cell physiology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5141749	Mdm4<tm1Zmy>	MP:0000267,abnormal heart development|MP:0000352,decreased cell proliferation|MP:0001698,decreased embryo size|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0006386,absent somites|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3612474	Mdm4<tm2.1Glo>	MP:0011091,prenatal lethality, complete penetrance
MGI:5142291	Mdm4<tm3.1Glo>	MP:0010768,mortality/aging|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3615645	Mdmg1<BALB/cBy>	MP:0004595,abnormal mandibular condyloid process morphology
MGI:3054078	Mdmsc1<Comp9>	MP:0002108,abnormal muscle morphology
MGI:3054080	Mdmsc2<Comp9>	MP:0002108,abnormal muscle morphology
MGI:3054082	Mdmsc3<Comp9>	MP:0002108,abnormal muscle morphology
MGI:3054084	Mdmsc4<Comp9>	MP:0002108,abnormal muscle morphology
MGI:3054086	Mdmsc5<Comp9>	MP:0002108,abnormal muscle morphology
MGI:3054088	Mdmsc6<Comp9>	MP:0002108,abnormal muscle morphology
MGI:5576045	Mdp1<tm1.1(KOMP)Vlcg>	MP:0001510,abnormal coat appearance
MGI:6156600	Me1<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0002968,increased circulating alkaline phosphatase level|MP:0005292,improved glucose tolerance|MP:0009142,decreased prepulse inhibition
MGI:3664328	Me1<n>	MP:0001262,decreased body weight|MP:0005449,abnormal food intake|MP:0005584,abnormal enzyme/coenzyme activity|MP:0010768,mortality/aging
MGI:5692786	Me2<tm1b(EUCOMM)Hmgu>	MP:0002059,abnormal seminal vesicle morphology
MGI:5629317	Me3<tm1b(KOMP)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:1856075	mea	MP:0000585,kinked tail|MP:0000592,short tail|MP:0000745,tremors|MP:0000754,paresis|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000854,abnormal cerebellum development|MP:0000857,abnormal cerebellar foliation|MP:0000873,thin external granule cell layer|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000889,abnormal cerebellar molecular layer|MP:0001406,abnormal gait|MP:0001539,decreased caudal vertebrae number|MP:0001731,abnormal postnatal growth|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0004609,vertebral fusion|MP:0004619,caudal vertebral fusion|MP:0005226,abnormal vertebral arch development|MP:0005389,reproductive system phenotype|MP:0006097,abnormal cerebellar lobule formation|MP:0006099,thin cerebellar granule layer
MGI:1856077	mea<2J>	MP:0000585,kinked tail|MP:0000592,short tail|MP:0001406,abnormal gait
MGI:1856076	mea<J>	MP:0000585,kinked tail|MP:0000592,short tail|MP:0001406,abnormal gait
MGI:5755090	Meak7<em3(IMPC)Tcp>	MP:0001175,abnormal lung morphology|MP:0002060,abnormal skin morphology|MP:0002631,abnormal epididymis morphology
MGI:6361166	Mecom<em1(IMPC)J>	MP:0003179,thrombocytopenia|MP:0011100,preweaning lethality, complete penetrance
MGI:2158381	Mecom<Jbo>	MP:0000292,distended pericardium|MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0000783,abnormal forebrain morphology|MP:0001262,decreased body weight|MP:0001485,abnormal pinna reflex|MP:0001850,increased susceptibility to otitis media|MP:0001967,deafness|MP:0002405,respiratory system inflammation|MP:0002415,abnormal neutrophil differentiation|MP:0002544,brachydactyly|MP:0005377,hearing/vestibular/ear phenotype|MP:0005387,immune system phenotype|MP:0006018,abnormal tympanic membrane morphology|MP:0006279,abnormal limb development|MP:0006325,impaired hearing|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0030226,middle ear polyps|MP:0030410,middle ear effusion|MP:0030414,tympanic membrane perforation|MP:0031434,increased miscarriage rate
MGI:3849414	Mecom<tm1.1Miku>	MP:0001722,pale yolk sac|MP:0001786,skin edema|MP:0001914,hemorrhage|MP:0003229,abnormal vitelline vasculature morphology|MP:0004720,abnormal platelet morphology|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011246,abnormal fetal liver hematopoietic progenitor cell morphology
MGI:5301305	Mecom<tm1Aspe>	MP:0000063,decreased bone mineral density|MP:0000069,kyphoscoliosis|MP:0000120,malocclusion|MP:0000160,kyphosis|MP:0000162,lordosis|MP:0000218,increased leukocyte cell number|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002006,neoplasm|MP:0002398,abnormal bone marrow cell morphology/development|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003179,thrombocytopenia|MP:0003419,delayed endochondral bone ossification|MP:0004173,abnormal intervertebral disk morphology|MP:0004174,abnormal spine curvature|MP:0004263,abnormal limb posture|MP:0004600,abnormal vertebral transverse process morphology|MP:0004602,abnormal vertebral articular process morphology|MP:0004609,vertebral fusion|MP:0004619,caudal vertebral fusion|MP:0004621,lumbar vertebral fusion|MP:0004622,sacral vertebral fusion|MP:0004684,intervertebral disk degeneration|MP:0004810,decreased hematopoietic stem cell number|MP:0004991,decreased bone strength|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0005397,hematopoietic system phenotype|MP:0005504,abnormal ligament morphology|MP:0006393,absent nucleus pulposus|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008489,slow postnatal weight gain|MP:0009346,decreased trabecular bone thickness|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0009877,exostosis|MP:0010113,abnormal sacrum morphology|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0010933,decreased trabecular bone connectivity density|MP:0011642,abnormal bone collagen fibril morphology|MP:0011643,abnormal tendon collagen fibril morphology|MP:0013176,abnormal tail position or orientation|MP:0013630,increased bone trabecular spacing|MP:0031253,lordokyphosis
MGI:3849413	Mecom<tm1Miku>	MP:0001786,skin edema|MP:0001914,hemorrhage|MP:0003179,thrombocytopenia|MP:0004720,abnormal platelet morphology|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:1857461	Mecom<tm1Mmor>	MP:0000269,abnormal heart looping|MP:0000291,enlarged pericardium|MP:0000295,trabecula carnea hypoplasia|MP:0000737,abnormal myotome development|MP:0000830,abnormal diencephalon morphology|MP:0000936,small embryonic telencephalon|MP:0001077,abnormal spinal nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001093,small trigeminal ganglion|MP:0001097,abnormal superior glossopharyngeal ganglion morphology|MP:0001101,abnormal superior vagus ganglion morphology|MP:0001689,incomplete somite formation|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0001914,hemorrhage|MP:0002884,abnormal pharyngeal arch morphology|MP:0003631,nervous system phenotype|MP:0003873,pharyngeal arch hypoplasia|MP:0004266,pale placenta|MP:0005029,abnormal amnion morphology|MP:0006295,absent sclerotome|MP:0008487,abnormal mesonephros morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012184,absent paraxial mesoderm|MP:0012235,abnormal liver bud morphology|MP:0012249,absent myotome|MP:0013166,small forelimb buds|MP:0013168,absent hindlimb buds
MGI:5301306	Mecom<tm2.1Aspe>	MP:0002398,abnormal bone marrow cell morphology/development|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008813,decreased common myeloid progenitor cell number
MGI:5301308	Mecom<tm2.2Aspe>	MP:0000221,decreased leukocyte cell number|MP:0000266,abnormal heart morphology|MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000746,weakness|MP:0001263,weight loss|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002633,persistent truncus arteriosus|MP:0002722,abnormal immune system organ morphology|MP:0003179,thrombocytopenia|MP:0004157,interrupted aortic arch|MP:0004810,decreased hematopoietic stem cell number|MP:0005017,decreased B cell number|MP:0010018,pulmonary vascular congestion|MP:0010402,ventricular septal defect|MP:0011085,postnatal lethality, complete penetrance|MP:0014399,decreased hematopoietic precursor cell number
MGI:5306622	Mecom<tm2Miku>	MP:0002169,no abnormal phenotype detected
MGI:6472627	Mecp2<em1Jlzn>	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001951,abnormal breathing pattern|MP:0001957,apnea|MP:0002064,seizures|MP:0002083,premature death|MP:0002804,abnormal motor learning|MP:0004924,abnormal behavior|MP:0005573,increased pulmonary respiratory rate|MP:0009358,environmentally induced seizures|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0020870,decreased thigmotaxis
MGI:2137311	Mecp2<tm1.1Bird>	MP:0000120,malocclusion|MP:0000182,increased circulating LDL cholesterol level|MP:0000454,abnormal jaw morphology|MP:0000745,tremors|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000913,abnormal brain development|MP:0001260,increased body weight|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001360,abnormal social investigation|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001489,decreased startle reflex|MP:0001511,disheveled coat|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0001552,increased circulating triglyceride level|MP:0001629,abnormal heart rate|MP:0001636,irregular heartbeat|MP:0001951,abnormal breathing pattern|MP:0001963,abnormal hearing physiology|MP:0002064,seizures|MP:0002083,premature death|MP:0002100,abnormal tooth morphology|MP:0002175,decreased brain weight|MP:0002204,abnormal synaptic neurotransmitter level|MP:0002272,abnormal nervous system electrophysiology|MP:0002286,cryptorchism|MP:0003312,abnormal locomotor coordination|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0003646,increased muscle fatigability|MP:0003928,increased heart rate variability|MP:0004183,abnormal sympathetic nervous system physiology|MP:0004792,abnormal synaptic vesicle number|MP:0004998,decreased CNS synapse formation|MP:0005178,increased circulating cholesterol level|MP:0005202,lethargy|MP:0005333,decreased heart rate|MP:0005386,behavior/neurological phenotype|MP:0005534,decreased body temperature|MP:0005573,increased pulmonary respiratory rate|MP:0006277,abnormal parasympathetic nervous system physiology|MP:0008428,abnormal spatial working memory|MP:0008908,increased total fat pad weight|MP:0008948,decreased neuron number|MP:0009355,increased liver triglyceride level|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0009732,ventricular premature beat|MP:0010053,decreased grip strength|MP:0010070,decreased serotonin level|MP:0010162,increased brain cholesterol level|MP:0010382,abnormal dosage compensation, by inactivation of X chromosome|MP:0010519,atrioventricular block|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0012006,abnormal hippocampus physiology|MP:0012574,decreased noradrenaline level|MP:0014376,decreased miniature excitatory postsynaptic current frequency|MP:0014812,abnormal brain physiology
MGI:5584016	Mecp2<tm1.1Dhy>	MP:0000418,focal hair loss|MP:0001212,skin lesions|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001406,abnormal gait|MP:0001441,increased grooming behavior|MP:0001513,limb grasping|MP:0002064,seizures|MP:0002083,premature death|MP:0004924,abnormal behavior|MP:0005378,growth/size/body region phenotype|MP:0009939,abnormal hippocampus neuron morphology
MGI:4830980	Mecp2<tm1.1Irsf>	MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001473,reduced long-term potentiation|MP:0001513,limb grasping|MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002833,increased heart weight|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002981,increased liver weight|MP:0003233,prolonged QT interval|MP:0003997,tonic-clonic seizures|MP:0005202,lethargy|MP:0005573,increased pulmonary respiratory rate|MP:0009454,impaired contextual conditioning behavior
MGI:2158354	Mecp2<tm1.1Jae>	MP:0000745,tremors|MP:0000774,decreased brain size|MP:0000819,abnormal olfactory bulb morphology|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001492,abnormal pilomotor reflex|MP:0001943,abnormal respiration|MP:0001951,abnormal breathing pattern|MP:0001957,apnea|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002804,abnormal motor learning|MP:0002882,abnormal neuron morphology|MP:0003212,increased susceptibility to age related obesity|MP:0004924,abnormal behavior|MP:0004994,abnormal brain wave pattern|MP:0005150,cachexia|MP:0005202,lethargy|MP:0005376,homeostasis/metabolism phenotype|MP:0005402,abnormal action potential|MP:0005426,tachypnea|MP:0005535,abnormal body temperature|MP:0008265,abnormal hippocampus CA2 region morphology|MP:0009355,increased liver triglyceride level|MP:0010162,increased brain cholesterol level
MGI:5310727	Mecp2<tm1.1Joez>	MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002064,seizures|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002690,akinesia|MP:0002804,abnormal motor learning|MP:0004924,abnormal behavior|MP:0004994,abnormal brain wave pattern|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0010768,mortality/aging|MP:0014621,abnormal brain alpha wave pattern|MP:0014624,abnormal brain delta wave pattern
MGI:5568206	Mecp2<tm1.1Jtc>	MP:0000420,ruffled hair|MP:0001259,abnormal body weight|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001409,increased stereotypic behavior|MP:0001513,limb grasping|MP:0001943,abnormal respiration|MP:0001951,abnormal breathing pattern|MP:0002083,premature death|MP:0003459,increased fear-related response|MP:0003997,tonic-clonic seizures|MP:0005202,lethargy|MP:0008489,slow postnatal weight gain|MP:0010053,decreased grip strength|MP:0014367,impaired long-term object recognition memory
MGI:5302542	Mecp2<tm1.1Meg>	MP:0003107,abnormal response to novelty|MP:0003461,abnormal response to novel object|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0008143,abnormal dendrite morphology|MP:0014384,increased miniature inhibitory postsynaptic current amplitude
MGI:5427621	Mecp2<tm1.1Mitoh>	MP:0001711,abnormal placenta morphology|MP:0003631,nervous system phenotype|MP:0009658,increased placenta apoptosis|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4949886	Mecp2<tm1.1Vnar>	MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000849,abnormal cerebellum morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001925,male infertility|MP:0004170,abnormal orbitofrontal cortex morphology|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0008143,abnormal dendrite morphology|MP:0010768,mortality/aging
MGI:2137555	Mecp2<tm1Bird>	MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001447,abnormal nest building behavior|MP:0001454,abnormal cued conditioning behavior|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0001489,decreased startle reflex|MP:0001513,limb grasping|MP:0001951,abnormal breathing pattern|MP:0001954,respiratory distress|MP:0001957,apnea|MP:0001968,abnormal touch/nociception|MP:0001973,increased thermal nociceptive threshold|MP:0002064,seizures|MP:0002083,premature death|MP:0002100,abnormal tooth morphology|MP:0002272,abnormal nervous system electrophysiology|MP:0002286,cryptorchism|MP:0002574,increased vertical activity|MP:0003631,nervous system phenotype|MP:0003997,tonic-clonic seizures|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005388,respiratory system phenotype|MP:0005586,decreased tidal volume|MP:0009141,increased prepulse inhibition|MP:0009142,decreased prepulse inhibition|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0009456,impaired cued conditioning behavior|MP:0010053,decreased grip strength|MP:0010768,mortality/aging|MP:0014274,decreased respiration|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude
MGI:2183727	Mecp2<tm1Hzo>	MP:0000160,kyphosis|MP:0000745,tremors|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001408,stereotypic behavior|MP:0001409,increased stereotypic behavior|MP:0001511,disheveled coat|MP:0002064,seizures|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002757,decreased vertical activity|MP:0003111,abnormal cell nucleus morphology|MP:0003849,greasy coat|MP:0004924,abnormal behavior
MGI:2158353	Mecp2<tm1Jae>	MP:0000745,tremors|MP:0000774,decreased brain size|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001492,abnormal pilomotor reflex|MP:0001943,abnormal respiration|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002882,abnormal neuron morphology|MP:0003212,increased susceptibility to age related obesity|MP:0003233,prolonged QT interval|MP:0003928,increased heart rate variability|MP:0004085,abnormal heartbeat|MP:0004485,increased response of heart to induced stress|MP:0004924,abnormal behavior|MP:0005150,cachexia|MP:0005333,decreased heart rate|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005388,respiratory system phenotype|MP:0005534,decreased body temperature|MP:0008265,abnormal hippocampus CA2 region morphology|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat
MGI:3583768	Mecp2<tm1Jchr>	MP:0000745,tremors|MP:0001402,decreased locomotor activity|MP:0001409,increased stereotypic behavior|MP:0002083,premature death
MGI:6270401	Mecp2<tm1Nlnd>	MP:0000745,tremors|MP:0001260,increased body weight|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0003646,increased muscle fatigability|MP:0004811,abnormal neuron physiology|MP:0004924,abnormal behavior|MP:0008428,abnormal spatial working memory|MP:0008489,slow postnatal weight gain|MP:0009456,impaired cued conditioning behavior|MP:0010053,decreased grip strength|MP:0010768,mortality/aging
MGI:3800596	Mecp2<tm1Pplt>	MP:0000120,malocclusion|MP:0000745,tremors|MP:0000951,sporadic seizures|MP:0001263,weight loss|MP:0001364,decreased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0001511,disheveled coat|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0001954,respiratory distress|MP:0002062,abnormal associative learning|MP:0002065,abnormal fear/anxiety-related behavior|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002098,abnormal vibrissa morphology|MP:0002175,decreased brain weight|MP:0002757,decreased vertical activity|MP:0005202,lethargy|MP:0005386,behavior/neurological phenotype
MGI:4949848	Mecp2<tm1Vnar>	MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000849,abnormal cerebellum morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001925,male infertility|MP:0004170,abnormal orbitofrontal cortex morphology|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0008143,abnormal dendrite morphology|MP:0010768,mortality/aging
MGI:3840527	Mecp2<tm2.1Jae>	MP:0001260,increased body weight|MP:0001402,decreased locomotor activity
MGI:5310728	Mecp2<tm2.1Joez>	MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0010768,mortality/aging
MGI:5529372	Mecp2<tm2.1Meg>	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0004924,abnormal behavior
MGI:3700191	Mecp2<tm2Bird>	MP:0000745,tremors|MP:0001261,obese|MP:0001473,reduced long-term potentiation|MP:0001513,limb grasping|MP:0001629,abnormal heart rate|MP:0001943,abnormal respiration|MP:0001951,abnormal breathing pattern|MP:0001957,apnea|MP:0002083,premature death|MP:0003233,prolonged QT interval|MP:0003928,increased heart rate variability|MP:0004085,abnormal heartbeat|MP:0004485,increased response of heart to induced stress|MP:0004924,abnormal behavior|MP:0005333,decreased heart rate|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005534,decreased body temperature|MP:0009732,ventricular premature beat|MP:0010519,atrioventricular block
MGI:4938309	Mecp2<tm3.1Bird>	MP:0001262,decreased body weight|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002169,no abnormal phenotype detected
MGI:3840525	Mecp2<tm3.1Jae>	MP:0001399,hyperactivity|MP:0002176,increased brain weight
MGI:5538511	Mecp2<tm3Meg>	MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002175,decreased brain weight|MP:0002906,increased susceptibility to pharmacologically induced seizures
MGI:5529361	Mecp2<tm4.1Bird>	MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002804,abnormal motor learning|MP:0004924,abnormal behavior
MGI:5529365	Mecp2<tm5.1Bird>	MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0004924,abnormal behavior
MGI:5702868	Mecp2<tm6.1Bird>	MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002804,abnormal motor learning|MP:0004924,abnormal behavior
MGI:6357890	Mecr<tm1.1(fabI)Akast>	MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001712,abnormal placenta development|MP:0001713,decreased trophoblast giant cell number|MP:0001716,abnormal placenta labyrinth morphology|MP:0001722,pale yolk sac|MP:0003229,abnormal vitelline vasculature morphology|MP:0003717,pallor|MP:0004085,abnormal heartbeat|MP:0004086,absent heartbeat|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0005406,abnormal heart size|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011525,abnormal placenta intervillous maternal lacunae morphology|MP:0011526,abnormal placenta fetal blood space morphology|MP:0011527,disorganized placental labyrinth|MP:0012082,delayed heart development|MP:0030989,decreased spongiotrophoblast cell number
MGI:4432643	Mecr<tm1a(EUCOMM)Wtsi>	MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0001914,hemorrhage|MP:0003717,pallor|MP:0011091,prenatal lethality, complete penetrance
MGI:6357882	Mecr<tm1d(EUCOMM)Wtsi>	MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011525,abnormal placenta intervillous maternal lacunae morphology|MP:0011526,abnormal placenta fetal blood space morphology|MP:0011527,disorganized placental labyrinth
MGI:5766989	Med10<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0002590,increased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004738,abnormal auditory brainstem response|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5471426	Med11<tm1.1(KOMP)Vlcg>	MP:0000195,decreased circulating calcium level|MP:0002861,abnormal tail bud morphology|MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6164012	Med12l<em1(IMPC)J>	MP:0001319,irregularly shaped pupil|MP:0001392,abnormal locomotor behavior|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002941,increased circulating alanine transaminase level|MP:0010053,decreased grip strength
MGI:4839485	Med12<tm1.1Hsch>	MP:0000074,abnormal neurocranium morphology|MP:0000914,exencephaly|MP:0002151,abnormal neural tube morphology|MP:0002169,no abnormal phenotype detected|MP:0003051,curly tail|MP:0004601,abnormal vertebral spinous process morphology|MP:0004603,absent vertebral arch|MP:0008784,craniorachischisis|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4839486	Med12<tm1.2Hsch>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012159,absent anterior visceral endoderm
MGI:4839484	Med12<tm1Hsch>	MP:0000267,abnormal heart development|MP:0000929,open neural tube|MP:0001688,abnormal somite development|MP:0001691,abnormal somite shape|MP:0002151,abnormal neural tube morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0002950,abnormal neural crest cell migration|MP:0003400,kinked neural tube|MP:0004073,caudal body truncation|MP:0004251,failure of heart looping|MP:0005223,abnormal dorsal-ventral polarity of the somites|MP:0006337,abnormal first pharyngeal arch morphology|MP:0006345,absent second pharyngeal arch|MP:0010642,absent third pharyngeal arch|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011260,abnormal head mesenchyme morphology|MP:0011732,decreased somite size
MGI:6341950	Med13l<em1(IMPC)Mbp>	MP:0000428,abnormal craniofacial morphology|MP:0001297,microphthalmia|MP:0001614,abnormal blood vessel morphology|MP:0001785,edema|MP:0003743,abnormal facial morphology|MP:0003984,embryonic growth retardation
MGI:5431516	Med13<tm1Eno>	MP:0000005,increased brown adipose tissue amount|MP:0001260,increased body weight|MP:0001552,increased circulating triglyceride level|MP:0002079,increased circulating insulin level|MP:0002981,increased liver weight|MP:0003960,increased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005385,cardiovascular system phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0009118,increased white fat cell size|MP:0009355,increased liver triglyceride level|MP:0010024,increased total body fat amount|MP:0020411,increased abdominal adipose tissue amount
MGI:4336954	Med14<Gt(A055C04)Wrst>	MP:0002169,no abnormal phenotype detected
MGI:7788880	Med15<tm1c(KOMP)Wtsi>	MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003926,decreased cellular glucose uptake|MP:0005293,impaired glucose tolerance|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0009175,abnormal pancreatic beta cell differentiation|MP:0010147,abnormal endocrine pancreas physiology|MP:0011629,decreased mitochondrial number|MP:0011630,increased mitochondrial size|MP:0011819,increased pancreatic beta cell proliferation|MP:0020423,abnormal mitochondrial biogenesis
MGI:5558160	Med16<tm1b(KOMP)Wtsi>	MP:0000603,pale liver|MP:0001697,abnormal embryo size|MP:0001722,pale yolk sac|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0011100,preweaning lethality, complete penetrance
MGI:5692803	Med17<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:4432982	Med18<tm1a(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0003062,abnormal coping response
MGI:4432772	Med19<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6502866	Med19<tm1c(EUCOMM)Wtsi>	MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000609,abnormal liver physiology|MP:0001260,increased body weight|MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002970,abnormal white adipose tissue morphology|MP:0002981,increased liver weight|MP:0003960,increased lean body mass|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005378,growth/size/body region phenotype|MP:0005670,abnormal white adipose tissue physiology|MP:0006320,abnormal interscapular fat pad morphology|MP:0008033,impaired lipolysis|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009131,decreased white fat cell number|MP:0009132,abnormal white fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0011174,lipodystrophy|MP:0011698,abnormal brown adipose tissue physiology|MP:0014143,decreased body fat mass|MP:0014146,decreased white adipose tissue mass|MP:0020520,whitened brown adipose tissue morphology|MP:0031600,increased white adipose tissue apoptosis|MP:0031602,white adipose tissue inflammation
MGI:2684191	Med1<tm1.1Mpk>	MP:0000266,abnormal heart morphology|MP:0000279,ventricular hypoplasia|MP:0000280,thin ventricular wall|MP:0000295,trabecula carnea hypoplasia|MP:0001286,abnormal eye development|MP:0002109,abnormal limb morphology|MP:0006372,impaired placental function|MP:0008253,absent megakaryocytes|MP:0009395,increased nucleated erythrocyte cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1861123	Med1<tm1Jkr>	MP:0000279,ventricular hypoplasia|MP:0000280,thin ventricular wall|MP:0000295,trabecula carnea hypoplasia|MP:0000602,dilated liver sinusoidal space|MP:0001544,abnormal cardiovascular system physiology|MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002123,abnormal definitive hematopoiesis|MP:0002127,abnormal cardiovascular system morphology|MP:0002652,thin myocardium|MP:0002925,abnormal cardiovascular development|MP:0003070,increased vascular permeability|MP:0003231,abnormal placenta vasculature|MP:0003237,abnormal lens epithelium morphology|MP:0003542,abnormal vascular endothelial cell development|MP:0003984,embryonic growth retardation|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0005103,abnormal retina pigmentation|MP:0005312,pericardial effusion|MP:0005545,abnormal lens development|MP:0005601,increased angiogenesis|MP:0008253,absent megakaryocytes|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0010500,myocardium hypoplasia|MP:0010503,myocardial trabeculae hypoplasia|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2684189	Med1<tm1Mpk>	MP:0000266,abnormal heart morphology|MP:0000280,thin ventricular wall|MP:0000295,trabecula carnea hypoplasia|MP:0001286,abnormal eye development|MP:0002109,abnormal limb morphology|MP:0003984,embryonic growth retardation|MP:0009395,increased nucleated erythrocyte cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1861125	Med1<tm1Rgr>	MP:0000274,enlarged heart|MP:0000280,thin ventricular wall|MP:0000295,trabecula carnea hypoplasia|MP:0000433,microcephaly|MP:0000596,abnormal liver development|MP:0000934,abnormal telencephalon development|MP:0001255,decreased body height|MP:0001265,decreased body size|MP:0001544,abnormal cardiovascular system physiology|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001732,postnatal growth retardation|MP:0002127,abnormal cardiovascular system morphology|MP:0002152,abnormal brain morphology|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002264,abnormal bronchus morphology|MP:0002740,heart hypoplasia|MP:0003077,abnormal cell cycle|MP:0003202,abnormal neuron apoptosis|MP:0003232,abnormal forebrain development|MP:0003503,decreased activity of thyroid gland|MP:0003632,abnormal nervous system morphology|MP:0004057,thin myocardium compact layer|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005134,decreased thyroid-stimulating hormone level|MP:0005266,abnormal metabolism|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level|MP:0006062,abnormal vena cava morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:3511276	Med1<tm2Jkr>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000280,thin ventricular wall|MP:0000607,abnormal hepatocyte morphology|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0003140,dilated heart atrium|MP:0003222,increased cardiomyocyte apoptosis|MP:0003828,pulmonary edema|MP:0004091,abnormal Z line morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0011925,abnormal heart echocardiography feature|MP:0012270,cardiac edema|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014390,decreased myocardial fiber mitochondrial DNA content
MGI:4443002	Med1<tm2Rgr>	MP:0000628,abnormal mammary gland development|MP:0000662,abnormal branching of the mammary ductal tree|MP:0009504,abnormal mammary gland epithelium morphology|MP:0010174,decreased mammary gland epithelial cell proliferation
MGI:5696880	Med1<tm3b(EUCOMM)Wtsi>	MP:0001102,small superior vagus ganglion|MP:0001697,abnormal embryo size|MP:0001722,pale yolk sac|MP:0002092,abnormal eye morphology|MP:0003717,pallor|MP:0004258,abnormal placenta size|MP:0004906,enlarged uterus|MP:0009709,hydrometra|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5643678	Med20<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0001303,abnormal lens morphology|MP:0001728,failure of embryo implantation|MP:0003693,abnormal blastocyst hatching|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0005028,abnormal trophectoderm morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011184,absent embryonic epiblast|MP:0011185,absent primitive endoderm|MP:0012102,absent trophectoderm|MP:0013292,embryonic lethality prior to organogenesis
MGI:2445456	Med21<tm1Ryng>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5497346	Med22<tm1a(EUCOMM)Hmgu>	MP:0005367,renal/urinary system phenotype|MP:0011100,preweaning lethality, complete penetrance
MGI:5008031	Med22<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6503811	Med22<tm1c(EUCOMM)Hmgu>	MP:0002083,premature death|MP:0002705,dilated renal tubule|MP:0002871,albuminuria|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0005165,increased susceptibility to injury|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005565,increased blood urea nitrogen level|MP:0008140,podocyte foot process effacement|MP:0011282,increased podocyte apoptosis|MP:0011346,renal tubule atrophy|MP:0011402,renal cast|MP:0011753,decreased podocyte number|MP:0011899,podocyte vacuoles
MGI:6153490	Med23<em1(IMPC)Wtsi>	MP:0001556,increased circulating HDL cholesterol level|MP:0001711,abnormal placenta morphology|MP:0002836,abnormal chorion morphology|MP:0003960,increased lean body mass|MP:0005031,abnormal trophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level|MP:0010124,decreased bone mineral content|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:5004967	Med23<snouty>	MP:0001092,abnormal trigeminal ganglion morphology|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0003861,abnormal nervous system development|MP:0006345,absent second pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012756,impaired cranial neural crest cell differentiation|MP:0013268,second pharyngeal arch hypoplasia|MP:0030249,small frontonasal prominence
MGI:5568337	Med23<tm1.1Pkb>	MP:0002169,no abnormal phenotype detected
MGI:5441005	Med23<tm1Berk>	MP:0000259,abnormal vascular development|MP:0003861,abnormal nervous system development|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6502590	Med23<tm1c(KOMP)Wtsi>	MP:0000030,abnormal tympanic ring morphology|MP:0000111,cleft palate|MP:0000116,abnormal tooth development|MP:0000128,growth retardation of molars|MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0000460,mandible hypoplasia|MP:0000762,abnormal tongue morphology|MP:0001436,abnormal suckling behavior|MP:0001954,respiratory distress|MP:0002639,micrognathia|MP:0003631,nervous system phenotype|MP:0004424,temporal bone hypoplasia|MP:0004476,absent palatine bone|MP:0004592,small mandible|MP:0004869,frontal bone hypoplasia|MP:0005359,growth retardation of incisors|MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006337,abnormal first pharyngeal arch morphology|MP:0009655,abnormal secondary palate development|MP:0009883,palatal shelf hypoplasia|MP:0009886,failure of palatal shelf elevation|MP:0009888,palatal shelves fail to meet at midline|MP:0009901,abnormal frontonasal prominence morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0030080,small lower incisors|MP:0030170,absent mandibular symphysis|MP:0030259,mandibular condyloid process hypoplasia|MP:0030374,Meckel's cartilage hypoplasia|MP:0030467,abnormal cranial cartilage development|MP:0031444,glossoptosis|MP:0031449,abnormal nasal cartilage morphology|MP:0031450,nasal cartilage hypoplasia
MGI:5441008	Med23<tm1Gwan>	MP:0005076,abnormal cell differentiation
MGI:2446465	Med24<tm1Rgr>	MP:0000279,ventricular hypoplasia|MP:0000280,thin ventricular wall|MP:0000295,trabecula carnea hypoplasia|MP:0000929,open neural tube|MP:0001577,anemia|MP:0001614,abnormal blood vessel morphology|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0002151,abnormal neural tube morphology|MP:0002740,heart hypoplasia|MP:0004085,abnormal heartbeat|MP:0004229,abnormal embryonic erythropoiesis|MP:0004787,abnormal dorsal aorta morphology|MP:0005621,abnormal cell physiology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5615649	Med25<tm1b(KOMP)Wtsi>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002591,decreased mean corpuscular volume|MP:0002764,short tibia|MP:0004738,abnormal auditory brainstem response|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness
MGI:6257759	Med27<em1(IMPC)Bay>	MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5548528	Med28<tm1.1(KOMP)Vlcg>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001257,increased body length|MP:0001697,abnormal embryo size|MP:0004738,abnormal auditory brainstem response|MP:0005419,decreased circulating serum albumin level|MP:0010378,increased respiratory quotient|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6111945	Med28<tm1.1Vra>	MP:0002399,abnormal pluripotent precursor cell morphology
MGI:6111946	Med28<tm1.2Vra>	MP:0001694,absent egg cylinders|MP:0002582,disorganized extraembryonic tissue|MP:0004957,abnormal blastocyst morphology|MP:0011093,embryonic lethality at implantation, complete penetrance|MP:0011184,absent embryonic epiblast|MP:0012114,absent inner cell mass proliferation
MGI:5306897	Med30<m1Btlr>	MP:0000278,abnormal myocardial fiber morphology|MP:0001577,anemia|MP:0001634,internal hemorrhage|MP:0002083,premature death|MP:0003135,increased erythroid progenitor cell number|MP:0003141,cardiac fibrosis|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005150,cachexia|MP:0005330,cardiomyopathy|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006085,myocardium necrosis|MP:0006138,congestive heart failure|MP:0030567,abnormal I band morphology
MGI:2671886	Med31<l11Jus15>	MP:0000164,abnormal cartilage development|MP:0000352,decreased cell proliferation|MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0001785,edema|MP:0002088,abnormal embryonic growth/weight/body size|MP:0003054,spina bifida|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004200,decreased fetal size|MP:0005352,small cranium|MP:0005377,hearing/vestibular/ear phenotype|MP:0005385,cardiovascular system phenotype|MP:0005508,abnormal skeleton morphology|MP:0006279,abnormal limb development|MP:0010103,small thoracic cage|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0020040,decreased bone ossification
MGI:5560553	Mef2a<tm1.1Limm>	MP:0002169,no abnormal phenotype detected|MP:0005386,behavior/neurological phenotype
MGI:2429769	Mef2a<tm1Eno>	MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002754,dilated heart right ventricle|MP:0005333,decreased heart rate|MP:0005369,muscle phenotype|MP:0005388,respiratory system phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6400970	Mef2b<tm1.1Rdf>	MP:0008171,abnormal mature B cell morphology|MP:0008178,decreased germinal center B cell number
MGI:5805681	Mef2b<tm2b(EUCOMM)Hmgu>	MP:0000443,abnormal snout morphology
MGI:6400973	Mef2b<tm2Rdf>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002023,increased B cell derived lymphoma incidence|MP:0008171,abnormal mature B cell morphology|MP:0008177,increased germinal center B cell number|MP:0008466,enlarged mesenteric lymph nodes
MGI:5571303	Mef2c<m1Anu>	MP:0002080,prenatal lethality|MP:0002169,no abnormal phenotype detected
MGI:3603183	Mef2c<tm1.1Jjs>	MP:0000279,ventricular hypoplasia|MP:0003984,embryonic growth retardation|MP:0031545,increased sinoatrial node size
MGI:5606040	Mef2c<tm1.1Wtp>	MP:0002081,perinatal lethality
MGI:1857491	Mef2c<tm1Eno>	MP:0000259,abnormal vascular development|MP:0000267,abnormal heart development|MP:0000279,ventricular hypoplasia|MP:0000280,thin ventricular wall|MP:0000295,trabecula carnea hypoplasia|MP:0001614,abnormal blood vessel morphology|MP:0001689,incomplete somite formation|MP:0002123,abnormal definitive hematopoiesis|MP:0002127,abnormal cardiovascular system morphology|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0003228,abnormal sinus venosus morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003542,abnormal vascular endothelial cell development|MP:0003974,abnormal endocardium morphology|MP:0003984,embryonic growth retardation|MP:0004068,dilated dorsal aorta|MP:0004251,failure of heart looping|MP:0004787,abnormal dorsal aorta morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005598,decreased heart ventricle muscle contractility|MP:0008278,failure of sternum ossification|MP:0010768,mortality/aging|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3603182	Mef2c<tm1Jjs>	MP:0000522,kidney cortex cyst|MP:0002705,dilated renal tubule|MP:0009050,dilated proximal convoluted tubule|MP:0009051,dilated distal convoluted tubule|MP:0011440,increased kidney cell proliferation
MGI:3718323	Mef2c<tm2Eno>	MP:0008178,decreased germinal center B cell number
MGI:5767098	Mef2d<tm1.2Tfur>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0005391,vision/eye phenotype|MP:0006068,abnormal retina horizontal cell morphology|MP:0006073,abnormal retina bipolar cell morphology|MP:0006075,abnormal retina cone bipolar cell morphology|MP:0008446,decreased retina cone cell number|MP:0008450,retina photoreceptor degeneration|MP:0008453,decreased retina rod cell number|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008587,short photoreceptor outer segment|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0014333,short retina cone cell outer segment|MP:0014336,short retina rod cell outer segment
MGI:3718322	Mef2d<tm1Eno>	MP:0009409,abnormal skeletal muscle fiber type ratio
MGI:3774341	Mef2d<tm3Eno>	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005397,hematopoietic system phenotype|MP:0005406,abnormal heart size
MGI:5465109	Mefv<tm1Bhk>	MP:0005387,immune system phenotype|MP:0008657,increased interleukin-1 beta secretion|MP:0008684,increased interleukin-18 secretion
MGI:2655791	Mefv<tm1Chae>	MP:0001777,abnormal body temperature homeostasis|MP:0001846,increased inflammatory response|MP:0008735,increased susceptibility to endotoxin shock|MP:0011081,decreased macrophage apoptosis
MGI:5007916	Mefv<tm2.1(MEFV)Chae>	MP:0003698,abnormal male reproductive system physiology
MGI:5007912	Mefv<tm3.1(MEFV)Chae>	MP:0000218,increased leukocyte cell number|MP:0001194,dermatitis|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001846,increased inflammatory response|MP:0002993,autoimmune arthritis|MP:0005150,cachexia
MGI:5007913	Mefv<tm4.1(MEFV)Chae>	MP:0000218,increased leukocyte cell number|MP:0001194,dermatitis|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001846,increased inflammatory response|MP:0002993,autoimmune arthritis|MP:0005150,cachexia
MGI:5007914	Mefv<tm5.1(MEFV)Chae>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001192,scaly skin|MP:0001194,dermatitis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0001846,increased inflammatory response|MP:0001860,liver inflammation|MP:0002169,no abnormal phenotype detected|MP:0002359,abnormal spleen germinal center morphology|MP:0002933,joint inflammation|MP:0002993,autoimmune arthritis|MP:0003009,abnormal cytokine secretion|MP:0004947,skin inflammation|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005150,cachexia|MP:0005425,increased macrophage cell number|MP:0008553,increased circulating tumor necrosis factor level|MP:0008566,increased interferon-gamma secretion|MP:0008596,increased circulating interleukin-6 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008654,increased interleukin-1 alpha secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008660,increased interleukin-10 secretion|MP:0008663,increased interleukin-12 secretion|MP:0008669,increased interleukin-12b secretion|MP:0008672,increased interleukin-13 secretion|MP:0008681,increased interleukin-17 secretion|MP:0008687,increased interleukin-2 secretion|MP:0008697,decreased interleukin-3 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion|MP:0008711,increased interleukin-9 secretion|MP:0011085,postnatal lethality, complete penetrance
MGI:5007915	Mefv<tm6Chae>	MP:0002169,no abnormal phenotype detected
MGI:2177961	Meg3<Gt(pGTi)216Gos>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002082,postnatal lethality|MP:0002427,disproportionate dwarf|MP:0003122,maternal imprinting|MP:0003787,abnormal imprinting|MP:0004201,fetal growth retardation|MP:0010768,mortality/aging|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3763115	Meg3<tm1.1Jvs>	MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0010768,mortality/aging
MGI:4840060	Meg3<tm1Itl>	MP:0000733,abnormal muscle development|MP:0001953,respiratory failure|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003123,paternal imprinting|MP:0003787,abnormal imprinting|MP:0004921,decreased placenta weight|MP:0005380,embryo phenotype|MP:0009431,decreased fetal weight|MP:0011089,perinatal lethality, complete penetrance
MGI:3763107	Meg3<tm1Jvs>	MP:0001265,decreased body size|MP:0003122,maternal imprinting|MP:0003787,abnormal imprinting|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3842511	Meg3<tm1Kono>	MP:0001262,decreased body weight|MP:0001654,hepatic necrosis|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002270,abnormal pulmonary alveolus morphology|MP:0008770,decreased survivor rate|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5320335	Megf10<tm1a(KOMP)Jrs>	MP:0005240,abnormal amacrine cell morphology|MP:0006068,abnormal retina horizontal cell morphology
MGI:4454190	Megf10<tm1(KOMP)Vlcg>	MP:0000849,abnormal cerebellum morphology|MP:0008916,abnormal astrocyte physiology|MP:0012261,increased hindbrain apoptosis
MGI:4431993	Megf11<tm1a(EUCOMM)Wtsi>	MP:0006068,abnormal retina horizontal cell morphology
MGI:7425818	Megf6<em1(IMPC)Kmpc>	MP:0000063,decreased bone mineral density|MP:0003960,increased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5437080	Megf8<b2b1702.2Clo>	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0000531,right pulmonary isomerism|MP:0000644,dextrocardia|MP:0000694,spleen hypoplasia|MP:0001265,decreased body size|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001823,thymus hypoplasia|MP:0002639,micrognathia|MP:0003052,omphalocele|MP:0004110,transposition of great arteries|MP:0004133,heterotaxia|MP:0008816,petechiae|MP:0010412,atrioventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010476,coronary fistula|MP:0010808,right-sided stomach|MP:0011666,double outlet right ventricle, ventricular defect committed to aorta|MP:0011668,double outlet right ventricle, Taussig bing type
MGI:5311364	Megf8<b2b288Clo>	MP:0000111,cleft palate|MP:0000445,short snout|MP:0000644,dextrocardia|MP:0001293,anophthalmia|MP:0002639,micrognathia|MP:0004133,heterotaxia|MP:0010413,complete atrioventricular septal defect|MP:0011665,d-loop transposition of the great arteries|MP:0011666,double outlet right ventricle, ventricular defect committed to aorta
MGI:4339047	Megf8<Gt(G037A09)Wrst>	MP:0000060,delayed bone ossification|MP:0000286,abnormal mitral valve morphology|MP:0000572,abnormal autopod morphology|MP:0001785,edema|MP:0002624,abnormal tricuspid valve morphology|MP:0002745,abnormal atrioventricular valve morphology|MP:0003105,abnormal heart atrium morphology|MP:0004190,abnormal direction of embryo turning|MP:0004252,abnormal direction of heart looping|MP:0004320,split sternum|MP:0004624,abnormal thoracic cage morphology|MP:0005385,cardiovascular system phenotype|MP:0006126,abnormal cardiac outflow tract development|MP:0009743,preaxial polydactyly|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010449,heart right ventricle outflow tract stenosis|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3722325	Megf8<hlb611>	MP:0000295,trabecula carnea hypoplasia|MP:0000531,right pulmonary isomerism|MP:0000534,abnormal ureter morphology|MP:0000562,polydactyly|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0000690,absent spleen|MP:0002766,situs inversus|MP:0003342,accessory spleen|MP:0003446,renal hypoplasia|MP:0003921,abnormal heart left ventricle morphology|MP:0004110,transposition of great arteries|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0004190,abnormal direction of embryo turning|MP:0004252,abnormal direction of heart looping|MP:0005380,embryo phenotype|MP:0005397,hematopoietic system phenotype|MP:0006061,right atrial isomerism|MP:0006065,abnormal heart position or orientation|MP:0006113,abnormal heart septum morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0009743,preaxial polydactyly|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010412,atrioventricular septal defect|MP:0010413,complete atrioventricular septal defect|MP:0010426,abnormal heart and great artery attachment|MP:0010437,absent coronary sinus|MP:0010440,anomalous pulmonary venous connection|MP:0010807,abnormal stomach position or orientation|MP:0010808,right-sided stomach|MP:0010854,lung situs inversus|MP:0031284,abdominal situs abnormality
MGI:4455205	Megf8<m687Ddg>	MP:0001065,abnormal trigeminal nerve morphology|MP:0001077,abnormal spinal nerve morphology|MP:0003632,abnormal nervous system morphology|MP:0009450,abnormal axon fasciculation|MP:0009798,abnormal ophthalmic nerve morphology
MGI:5558914	Megf8<tm1.1Ddg>	MP:0000060,delayed bone ossification|MP:0000286,abnormal mitral valve morphology|MP:0000572,abnormal autopod morphology|MP:0000914,exencephaly|MP:0001065,abnormal trigeminal nerve morphology|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001077,abnormal spinal nerve morphology|MP:0001785,edema|MP:0002624,abnormal tricuspid valve morphology|MP:0003105,abnormal heart atrium morphology|MP:0003651,abnormal axon extension|MP:0004190,abnormal direction of embryo turning|MP:0004252,abnormal direction of heart looping|MP:0004320,split sternum|MP:0004624,abnormal thoracic cage morphology|MP:0005385,cardiovascular system phenotype|MP:0006126,abnormal cardiac outflow tract development|MP:0009450,abnormal axon fasciculation|MP:0009743,preaxial polydactyly|MP:0009798,abnormal ophthalmic nerve morphology|MP:0009799,abnormal maxillary nerve morphology|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010449,heart right ventricle outflow tract stenosis|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012531,delayed limb development
MGI:5558931	Megf8<tm1.2Ddg>	MP:0003631,nervous system phenotype|MP:0005371,limbs/digits/tail phenotype|MP:0005385,cardiovascular system phenotype|MP:0009450,abnormal axon fasciculation|MP:0009798,abnormal ophthalmic nerve morphology
MGI:3050511	mei11b	MP:0001926,female infertility|MP:0005168,abnormal female meiosis
MGI:7523296	Mei1<em1(IMPC)Bay>	MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0001925,male infertility|MP:0001926,female infertility|MP:0010124,decreased bone mineral content
MGI:2176973	Mei1<m1Jcs>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis
MGI:3050584	mei2-7	MP:0001146,abnormal testis morphology|MP:0001925,male infertility|MP:0008261,arrest of male meiosis
MGI:6449036	Mei4<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002989,small kidney|MP:0005343,increased circulating aspartate transaminase level
MGI:4818799	Mei4<tm1Bdm>	MP:0001146,abnormal testis morphology|MP:0001929,abnormal gametogenesis|MP:0001930,abnormal meiosis|MP:0002160,abnormal reproductive system morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0002631,abnormal epididymis morphology|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005380,embryo phenotype|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0008871,abnormal ovarian follicle number|MP:0009205,abnormal internal male genitalia morphology|MP:0009451,abnormal chromosomal synapsis|MP:0009452,abnormal synaptonemal complex|MP:0011121,decreased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number|MP:0013601,increased testis apoptosis
MGI:3050519	mei7	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001929,abnormal gametogenesis|MP:0008261,arrest of male meiosis
MGI:4367077	Meig1<tm1.1Zzha>	MP:0001925,male infertility|MP:0002631,abnormal epididymis morphology|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0008279,arrest of spermiogenesis|MP:0008545,absent sperm flagellum|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0020869,immotile sperm|MP:0031374,abnormal manchette assembly
MGI:4367078	Meig1<tm1.2Zzha>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0005159,azoospermia|MP:0008545,absent sperm flagellum|MP:0009230,abnormal sperm head morphology|MP:0009838,abnormal sperm axoneme morphology
MGI:4421665	Meig1<tm1Shpi>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009233,enlarged sperm head|MP:0014052,increased male germ cell apoptosis|MP:0020869,immotile sperm
MGI:5688710	Meikin<tm1Yow>	MP:0001925,male infertility|MP:0001926,female infertility|MP:0002687,oligozoospermia|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0006380,abnormal spermatid morphology|MP:0008261,arrest of male meiosis|MP:0009451,abnormal chromosomal synapsis|MP:0014443,impaired polar body extrusion
MGI:5559212	Meiob<tm1.1Ics>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001930,abnormal meiosis|MP:0004805,absent oocytes|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005431,decreased oocyte number|MP:0013507,increased ovary apoptosis|MP:0014052,increased male germ cell apoptosis|MP:0014764,impaired double-strand DNA break repair
MGI:6423285	Meiob<tm1.1Jw>	MP:0010948,abnormal double-strand DNA break repair
MGI:4362869	Meioc<tm1a(KOMP)Wtsi>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002777,absent ovarian follicles|MP:0004805,absent oocytes|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005431,decreased oocyte number|MP:0008261,arrest of male meiosis|MP:0009452,abnormal synaptonemal complex|MP:0010767,abnormal female meiosis I arrest|MP:0010948,abnormal double-strand DNA break repair|MP:0014052,increased male germ cell apoptosis
MGI:5796294	Meioc<tm1c(KOMP)Wtsi>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002777,absent ovarian follicles|MP:0005159,azoospermia
MGI:6488129	Meiosin<em1Keish>	MP:0001940,testis hypoplasia|MP:0002682,decreased mature ovarian follicle number|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis|MP:0008967,absent chiasmata formation|MP:0009452,abnormal synaptonemal complex|MP:0009564,abnormal meiotic configurations|MP:0010767,abnormal female meiosis I arrest|MP:0013236,ovary degeneration|MP:0014052,increased male germ cell apoptosis
MGI:7664086	Meis1<em1Rihw>	MP:0001402,decreased locomotor activity|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005388,respiratory system phenotype|MP:0014638,increased sleep duration|MP:0020478,abnormal circadian sleep/wake cycle
MGI:5609342	Meis1<tm1b(EUCOMM)Hmgu>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0009142,decreased prepulse inhibition|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:3578637	Meis1<tm1Mtor>	MP:0000239,absent common myeloid progenitor cells|MP:0000600,liver hypoplasia|MP:0001297,microphthalmia|MP:0001606,impaired hematopoiesis|MP:0001614,abnormal blood vessel morphology|MP:0001914,hemorrhage|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0003714,absent platelets|MP:0003717,pallor|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3029063	Meis1<tm1Ngc>	MP:0000260,abnormal angiogenesis|MP:0000266,abnormal heart morphology|MP:0000598,abnormal liver morphology|MP:0001175,abnormal lung morphology|MP:0001306,small lens|MP:0001325,abnormal retina morphology|MP:0001914,hemorrhage|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0003227,abnormal vascular branching morphogenesis|MP:0003658,abnormal capillary morphology|MP:0005371,limbs/digits/tail phenotype|MP:0008253,absent megakaryocytes|MP:0008813,decreased common myeloid progenitor cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0020327,abnormal capillary branching pattern
MGI:5689566	Meis1<tm2.1Mtor>	MP:0001297,microphthalmia|MP:0001914,hemorrhage|MP:0003717,pallor|MP:0008253,absent megakaryocytes|MP:0010402,ventricular septal defect
MGI:5464994	Meis1<tm2Ngc>	MP:0002398,abnormal bone marrow cell morphology/development|MP:0003674,oxidative stress|MP:0004809,increased hematopoietic stem cell number|MP:0008813,decreased common myeloid progenitor cell number|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:5689568	Meis1<tm3.1(cre/ERT2)Mtor>	MP:0001297,microphthalmia|MP:0001914,hemorrhage|MP:0003717,pallor
MGI:5911947	Meis2<tm1.1Zkoz>	MP:0000430,absent maxillary shelf|MP:0000431,absent palatine bone horizontal plate|MP:0003755,abnormal palate morphology|MP:0004136,abnormal tongue muscle morphology|MP:0008273,abnormal intramembranous bone ossification|MP:0009652,abnormal palatal rugae morphology|MP:0009885,abnormal palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0009907,decreased tongue size|MP:0011615,submucous cleft palate|MP:0013546,cleft soft palate|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0031458,absent palate bones
MGI:5911948	Meis2<tm1.2Zkoz>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001065,abnormal trigeminal nerve morphology|MP:0001071,abnormal facial nerve morphology|MP:0001072,abnormal vestibulocochlear nerve morphology|MP:0001093,small trigeminal ganglion|MP:0001312,abnormal cornea morphology|MP:0001340,abnormal eyelid morphology|MP:0001577,anemia|MP:0001914,hemorrhage|MP:0002633,persistent truncus arteriosus|MP:0003887,increased hepatocyte apoptosis|MP:0003984,embryonic growth retardation|MP:0004200,decreased fetal size|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012250,absent heart valves|MP:0013183,absent trigeminal ganglion|MP:0013504,increased embryonic tissue cell apoptosis
MGI:6342889	Meis3<tm1b(EUCOMM)Hmgu>	MP:0000538,abnormal urinary bladder morphology|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001297,microphthalmia|MP:0001399,hyperactivity|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002100,abnormal tooth morphology|MP:0002764,short tibia|MP:0005293,impaired glucose tolerance|MP:0011045,decreased lung elastance|MP:0011048,decreased lung tissue damping|MP:0011625,cystolithiasis|MP:0013129,abnormal tooth color
MGI:5750925	Melk<tm1.1Flev>	MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005518,abnormal pancreas regeneration
MGI:2154229	Melm1<BALB/cJ>	MP:0009828,increased tumor latency
MGI:2154228	Melm1<C57BL/6J>	MP:0010300,increased skin tumor incidence
MGI:2154231	Melm2<BALB/cJ>	MP:0009828,increased tumor latency
MGI:2154230	Melm2<C57BL/6J>	MP:0010300,increased skin tumor incidence
MGI:3036032	Melm3<BALB/cJ>	MP:0009828,increased tumor latency
MGI:3036033	Melm3<C57BL/6J>	MP:0010300,increased skin tumor incidence
MGI:3691276	Meltf<tm1Drrn>	MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype
MGI:5648811	Memo1<m1Will>	MP:0000039,abnormal otic capsule morphology|MP:0000074,abnormal neurocranium morphology|MP:0000111,cleft palate|MP:0000430,absent maxillary shelf|MP:0000431,absent palatine bone horizontal plate|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000457,maxilla hypoplasia|MP:0001622,abnormal vasculogenesis|MP:0001914,hemorrhage|MP:0002116,abnormal craniofacial bone morphology|MP:0004450,presphenoid bone hypoplasia|MP:0004461,basisphenoid bone hypoplasia|MP:0004871,premaxilla hypoplasia|MP:0005602,decreased angiogenesis|MP:0006207,embryonic lethality during organogenesis|MP:0008271,abnormal bone ossification|MP:0008272,abnormal endochondral bone ossification|MP:0008275,failure of endochondral bone ossification|MP:0009546,absent gastric milk in neonates|MP:0009886,failure of palatal shelf elevation|MP:0009892,palate bone hypoplasia|MP:0011100,preweaning lethality, complete penetrance|MP:0013807,generalized edema|MP:0030027,basioccipital bone hypoplasia|MP:0030033,abnormal nasal bridge morphology|MP:0030467,abnormal cranial cartilage development
MGI:5559022	Memo1<tm1.1Neh>	MP:0000160,kyphosis|MP:0000194,increased circulating calcium level|MP:0000414,alopecia|MP:0000653,abnormal sex gland morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001783,decreased white adipose tissue amount|MP:0001961,abnormal reflex|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0002891,increased insulin sensitivity|MP:0002904,increased circulating parathyroid hormone level|MP:0005159,azoospermia|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0012337,increased vitamin D level
MGI:5008015	Memo1<tm1a(EUCOMM)Wtsi>	MP:0001512,trunk curl|MP:0011100,preweaning lethality, complete penetrance
MGI:5548676	Memo1<tm1b(EUCOMM)Wtsi>	MP:0000288,abnormal pericardium morphology|MP:0000440,domed cranium|MP:0001491,unresponsive to tactile stimuli|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002953,thick ventricular wall|MP:0009890,cleft secondary palate|MP:0011100,preweaning lethality, complete penetrance|MP:0030033,abnormal nasal bridge morphology
MGI:5896997	Memo1<tm1c(EUCOMM)Wtsi>	MP:0000111,cleft palate|MP:0000440,domed cranium|MP:0002116,abnormal craniofacial bone morphology|MP:0004450,presphenoid bone hypoplasia|MP:0004462,small basisphenoid bone|MP:0004871,premaxilla hypoplasia|MP:0008272,abnormal endochondral bone ossification|MP:0009546,absent gastric milk in neonates|MP:0009896,palatine bone horizontal plate hypoplasia|MP:0009898,maxillary shelf hypoplasia|MP:0011100,preweaning lethality, complete penetrance|MP:0030033,abnormal nasal bridge morphology|MP:0030351,wide coronal suture|MP:0030431,wide metopic suture
MGI:2158698	Men1<tm1.1Ctre>	MP:0002027,increased lung adenocarcinoma incidence|MP:0002031,increased adrenal gland tumor incidence|MP:0002050,increased pheochromocytoma incidence|MP:0003430,increased pancreatic islet cell adenoma incidence|MP:0003495,increased parathyroid adenoma incidence|MP:0005491,pancreatic islet hyperplasia|MP:0006262,increased testis tumor incidence|MP:0008014,increased lung tumor incidence|MP:0009153,increased pancreas tumor incidence|MP:0010288,increased gland tumor incidence|MP:0010316,increased thyroid tumor incidence|MP:0010320,increased pituitary gland tumor incidence|MP:0010321,increased parathyroid gland tumor incidence|MP:0010350,increased pituitary adenohypophysis tumor incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2384622	Men1<tm1.1Gfk>	MP:0000633,abnormal pituitary gland morphology|MP:0001152,increased Leydig cell number|MP:0001944,abnormal pancreas morphology|MP:0002041,increased pituitary adenoma incidence|MP:0003364,increased insulinoma incidence|MP:0003365,increased glucagonoma incidence|MP:0003493,parathyroid gland hyperplasia|MP:0003495,increased parathyroid adenoma incidence|MP:0003498,thyroid gland hyperplasia|MP:0003505,increased prolactinoma incidence|MP:0005491,pancreatic islet hyperplasia|MP:0008000,increased ovary tumor incidence|MP:0009043,increased pancreas adenoma incidence|MP:0009044,increased adrenal gland adenoma incidence|MP:0009592,increased Leydig cell tumor incidence
MGI:2664873	Men1<tm1.1Zqw>	MP:0003720,abnormal neural tube closure|MP:0005076,abnormal cell differentiation|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2683274	Men1<tm1.2Ctre>	MP:0000106,abnormal basisphenoid bone morphology|MP:0000150,abnormal rib morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000157,abnormal sternum morphology|MP:0000194,increased circulating calcium level|MP:0000443,abnormal snout morphology|MP:0000445,short snout|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002079,increased circulating insulin level|MP:0002169,no abnormal phenotype detected|MP:0002823,abnormal rib development|MP:0003112,enlarged parathyroid gland|MP:0003364,increased insulinoma incidence|MP:0004452,abnormal pterygoid process morphology|MP:0005390,skeleton phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0005560,decreased circulating glucose level|MP:0008277,abnormal sternum ossification|MP:0009247,meteorism|MP:0009546,absent gastric milk in neonates|MP:0009642,abnormal blood homeostasis|MP:0009655,abnormal secondary palate development|MP:0009883,palatal shelf hypoplasia|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0010819,primary atelectasis|MP:0011089,perinatal lethality, complete penetrance|MP:0021210,bilateral cleft palate|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0021216,abnormal palatal mesenchymal cell differentiation|MP:0021217,abnormal palatal shelf bone ossification|MP:0030291,short soft palate
MGI:2675250	Men1<tm1.2Zqw>	MP:0000189,hypoglycemia|MP:0001672,abnormal embryo development|MP:0001712,abnormal placenta development|MP:0001729,impaired embryo implantation|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002079,increased circulating insulin level|MP:0003364,increased insulinoma incidence|MP:0003845,abnormal decidualization|MP:0003984,embryonic growth retardation|MP:0005033,abnormal trophoblast giant cell morphology|MP:0005491,pancreatic islet hyperplasia|MP:0008876,decreased uterine NK cell number|MP:0008877,abnormal DNA methylation|MP:0013401,increased endometrial gland number|MP:0031434,increased miscarriage rate
MGI:2158697	Men1<tm1Ctre>	MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001869,pancreas inflammation|MP:0001944,abnormal pancreas morphology|MP:0002027,increased lung adenocarcinoma incidence|MP:0002031,increased adrenal gland tumor incidence|MP:0002038,increased carcinoma incidence|MP:0002041,increased pituitary adenoma incidence|MP:0002050,increased pheochromocytoma incidence|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002693,abnormal pancreas physiology|MP:0003336,pancreas cyst|MP:0003364,increased insulinoma incidence|MP:0003495,increased parathyroid adenoma incidence|MP:0003496,increased thyroid adenoma incidence|MP:0003505,increased prolactinoma incidence|MP:0003935,abnormal craniofacial development|MP:0003984,embryonic growth retardation|MP:0005215,abnormal pancreatic islet morphology|MP:0005491,pancreatic islet hyperplasia|MP:0005560,decreased circulating glucose level|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009148,pancreas necrosis|MP:0009153,increased pancreas tumor incidence|MP:0009171,enlarged pancreatic islets|MP:0010301,increased stomach tumor incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013528,thyroid gland cyst
MGI:2384620	Men1<tm1Gfk>	MP:0003364,increased insulinoma incidence|MP:0003505,increased prolactinoma incidence|MP:0005491,pancreatic islet hyperplasia|MP:0009153,increased pancreas tumor incidence
MGI:3608952	Men1<tm1Mmey>	MP:0000189,hypoglycemia|MP:0003645,increased pancreatic beta cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5461232	Men1<tm1Rvt>	MP:0000194,increased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0001152,increased Leydig cell number|MP:0001745,increased circulating corticosterone level|MP:0002020,increased tumor incidence|MP:0003430,increased pancreatic islet cell adenoma incidence|MP:0003493,parathyroid gland hyperplasia|MP:0003495,increased parathyroid adenoma incidence|MP:0005376,homeostasis/metabolism phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0006262,increased testis tumor incidence|MP:0008000,increased ovary tumor incidence|MP:0010316,increased thyroid tumor incidence|MP:0010320,increased pituitary gland tumor incidence|MP:0010321,increased parathyroid gland tumor incidence|MP:0010350,increased pituitary adenohypophysis tumor incidence|MP:0010366,increased adrenal cortical tumor incidence|MP:0011092,embryonic lethality, complete penetrance|MP:0014237,decreased tumor-free survival time
MGI:2664869	Men1<tm1Zqw>	MP:0000280,thin ventricular wall|MP:0000295,trabecula carnea hypoplasia|MP:0000597,delayed hepatic development|MP:0000636,enlarged pituitary gland|MP:0000642,enlarged adrenal glands|MP:0000914,exencephaly|MP:0001148,enlarged testis|MP:0001698,decreased embryo size|MP:0001914,hemorrhage|MP:0002031,increased adrenal gland tumor incidence|MP:0002085,abnormal embryonic tissue morphology|MP:0002404,increased intestinal adenoma incidence|MP:0003364,increased insulinoma incidence|MP:0003365,increased glucagonoma incidence|MP:0003430,increased pancreatic islet cell adenoma incidence|MP:0003495,increased parathyroid adenoma incidence|MP:0003498,thyroid gland hyperplasia|MP:0003505,increased prolactinoma incidence|MP:0003720,abnormal neural tube closure|MP:0004832,enlarged ovary|MP:0006262,increased testis tumor incidence|MP:0008000,increased ovary tumor incidence|MP:0009044,increased adrenal gland adenoma incidence|MP:0009153,increased pancreas tumor incidence|MP:0009590,increased gonad tumor incidence|MP:0009592,increased Leydig cell tumor incidence|MP:0010279,increased gastrointestinal tumor incidence|MP:0010288,increased gland tumor incidence|MP:0010299,increased mammary gland tumor incidence|MP:0010301,increased stomach tumor incidence|MP:0010316,increased thyroid tumor incidence|MP:0010346,increased thyroid carcinoma incidence|MP:0010348,increased pancreatic islet cell carcinoma incidence|MP:0010350,increased pituitary adenohypophysis tumor incidence|MP:0010366,increased adrenal cortical tumor incidence|MP:0010390,increased adrenocortical adenoma incidence|MP:0010725,thin interventricular septum|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3810641	Men1<tm2.1Gfk>	MP:0000633,abnormal pituitary gland morphology|MP:0002041,increased pituitary adenoma incidence|MP:0003364,increased insulinoma incidence|MP:0003495,increased parathyroid adenoma incidence|MP:0003498,thyroid gland hyperplasia|MP:0008000,increased ovary tumor incidence|MP:0009043,increased pancreas adenoma incidence|MP:0009592,increased Leydig cell tumor incidence
MGI:5296656	Men1<tm2.1Mmey>	MP:0002083,premature death|MP:0002693,abnormal pancreas physiology|MP:0003364,increased insulinoma incidence|MP:0005215,abnormal pancreatic islet morphology|MP:0005491,pancreatic islet hyperplasia
MGI:5780171	Meox1<squig>	MP:0000592,short tail|MP:0002111,abnormal tail morphology|MP:0003051,curly tail
MGI:2674268	Meox1<Tg(Mx1-TAX)2627Arnh>	MP:0000154,rib fusion|MP:0002823,abnormal rib development|MP:0004609,vertebral fusion|MP:0005225,abnormal vertebrae development|MP:0008832,hemivertebra
MGI:2674273	Meox1<tm1Bmk>	MP:0000154,rib fusion|MP:0002823,abnormal rib development|MP:0004609,vertebral fusion|MP:0005225,abnormal vertebrae development|MP:0008832,hemivertebra
MGI:3046541	Meox2<fla>	MP:0000759,abnormal skeletal muscle morphology|MP:0002652,thin myocardium|MP:0003082,abnormal gastrocnemius morphology|MP:0005390,skeleton phenotype|MP:0008257,thin myometrium|MP:0030798,joint contracture
MGI:2674242	Meox2<tm1Vpa>	MP:0000729,abnormal myogenesis|MP:0000733,abnormal muscle development|MP:0000759,abnormal skeletal muscle morphology|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002109,abnormal limb morphology|MP:0004263,abnormal limb posture|MP:0004819,decreased skeletal muscle mass|MP:0005369,muscle phenotype|MP:0008770,decreased survivor rate|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009890,cleft secondary palate|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4455495	Mep1a<tm1a(KOMP)Wtsi>	MP:0003795,abnormal bone structure|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0013278,decreased fasting circulating glucose level
MGI:3833886	Mep1a<tm1Bond>	MP:0001777,abnormal body temperature homeostasis|MP:0001935,decreased litter size|MP:0002442,abnormal leukocyte physiology|MP:0002703,abnormal renal tubule morphology|MP:0005265,abnormal blood urea nitrogen level|MP:0005328,abnormal circulating creatinine level|MP:0005502,abnormal renal/urinary system physiology|MP:0008537,increased susceptibility to induced colitis|MP:0008596,increased circulating interleukin-6 level|MP:0008640,abnormal circulating interleukin-1 beta level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008713,abnormal cytokine level|MP:0008721,abnormal chemokine level|MP:0008752,abnormal tumor necrosis factor level|MP:0009642,abnormal blood homeostasis|MP:0009646,urinary bladder inflammation|MP:0011352,proximal convoluted tubule brush border loss
MGI:6104259	Mep1b<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:2450870	Mep1b<tm1Bond>	MP:0001260,increased body weight|MP:0001876,decreased inflammatory response|MP:0001935,decreased litter size|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005554,decreased circulating creatinine level|MP:0005566,decreased blood urea nitrogen level|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011352,proximal convoluted tubule brush border loss
MGI:5614581	Mepce<tm1.1(KOMP)Vlcg>	MP:0002574,increased vertical activity|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2448895	Mepe<tm1Tbrw>	MP:0000130,abnormal trabecular bone morphology|MP:0001533,abnormal skeleton physiology|MP:0004982,abnormal osteoclast morphology|MP:0004988,increased osteoblast cell number|MP:0010878,increased trabecular bone volume|MP:0020080,increased bone mineralization
MGI:2651819	Mertk<nmf12>	MP:0001325,abnormal retina morphology|MP:0001327,decreased retina photoreceptor cell number|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0005103,abnormal retina pigmentation|MP:0005551,abnormal eye electrophysiology|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008752,abnormal tumor necrosis factor level|MP:0011965,decreased total retina thickness|MP:0030005,increased retina apoptosis
MGI:2387768	Mertk<tm1Gkm>	MP:0000496,abnormal small intestine morphology|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0002792,abnormal retina vasculature morphology|MP:0003726,decreased autoantibody level|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0004031,insulitis|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005018,decreased T cell number|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005548,retina pigment epithelium atrophy|MP:0005673,decreased susceptibility to graft versus host disease|MP:0006413,increased T cell apoptosis|MP:0008247,abnormal mononuclear cell morphology|MP:0008451,retina rod cell degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008584,photoreceptor outer segment degeneration|MP:0008586,disorganized photoreceptor outer segment|MP:0008735,increased susceptibility to endotoxin shock|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:2387765	Mertk<tm1Grl>	MP:0000691,enlarged spleen|MP:0001144,vagina atresia|MP:0002001,blindness|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005385,cardiovascular system phenotype|MP:0008450,retina photoreceptor degeneration|MP:0008586,disorganized photoreceptor outer segment|MP:0009853,decreased Sertoli cell phagocytosis
MGI:3609164	Mertk<tm1Lex>	MP:0009549,decreased platelet aggregation|MP:0031120,decreased susceptibility to induced thrombosis
MGI:4939501	Mesd<tm1Bch>	MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0011186,abnormal visceral endoderm morphology|MP:0011187,abnormal parietal endoderm morphology|MP:0011189,small embryonic epiblast
MGI:5568739	Mesd<tm2.1Bch>	MP:0001683,absent mesoderm|MP:0001696,failure to gastrulate|MP:0011189,small embryonic epiblast
MGI:5565358	Mesd<tm2Bch>	MP:0005370,liver/biliary system phenotype
MGI:2386200	Mesp1/Mesp2<tm1Ysa>	MP:0001614,abnormal blood vessel morphology|MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0001683,absent mesoderm|MP:0001685,abnormal endoderm development|MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0002230,abnormal primitive streak formation|MP:0006386,absent somites|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011388,absent heart|MP:0012184,absent paraxial mesoderm
MGI:2386201	Mesp1/Mesp2<tm1Ysa>	MP:0001614,abnormal blood vessel morphology|MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0001683,absent mesoderm|MP:0001685,abnormal endoderm development|MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0002230,abnormal primitive streak formation|MP:0006386,absent somites|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011388,absent heart|MP:0012184,absent paraxial mesoderm
MGI:2182080	Mesp1<tm3Ysa>	MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0000270,abnormal heart tube morphology|MP:0000433,microcephaly|MP:0001680,abnormal mesoderm development|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002151,abnormal neural tube morphology|MP:0002231,abnormal primitive streak morphology|MP:0002621,delayed neural tube closure|MP:0003984,embryonic growth retardation|MP:0004180,failure of initiation of embryo turning|MP:0004187,cardia bifida|MP:0004188,delayed embryo turning|MP:0004837,abnormal neural fold formation|MP:0008029,abnormal paraxial mesoderm morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011732,decreased somite size|MP:0012278,abnormal cardiogenic mesoderm morphology
MGI:3702007	Mesp1<tm4Ysa>	MP:0003988,disorganized embryonic tissue|MP:0006386,absent somites|MP:0011091,prenatal lethality, complete penetrance|MP:0011388,absent heart
MGI:3707537	Mesp2<tm10Ysa>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0005225,abnormal vertebrae development
MGI:3707596	Mesp2<tm11Ysa>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0001688,abnormal somite development|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0004613,fusion of vertebral arches
MGI:3817238	Mesp2<tm12Ysa>	MP:0000137,abnormal vertebrae morphology|MP:0000154,rib fusion|MP:0002081,perinatal lethality|MP:0004704,short vertebral column|MP:0005508,abnormal skeleton morphology
MGI:3715271	Mesp2<tm13.1(cre/Esr1*)Ysa>	MP:0000137,abnormal vertebrae morphology|MP:0000154,rib fusion|MP:0000592,short tail|MP:0001258,decreased body length|MP:0001688,abnormal somite development|MP:0001689,incomplete somite formation|MP:0004613,fusion of vertebral arches|MP:0004704,short vertebral column|MP:0008530,abnormal rostral-caudal patterning of the somites|MP:0012728,abnormal somite border morphology
MGI:3715268	Mesp2<tm13(cre/Esr1*)Ysa>	MP:0000137,abnormal vertebrae morphology|MP:0001688,abnormal somite development
MGI:3817245	Mesp2<tm14Ysa>	MP:0005390,skeleton phenotype
MGI:4454334	Mesp2<tm15.1(Lfng)Ysa>	MP:0001688,abnormal somite development
MGI:4867475	Mesp2<tm16.1(Rbpj*)Ysa>	MP:0005380,embryo phenotype|MP:0005390,skeleton phenotype
MGI:4867476	Mesp2<tm17.1(VP16/Rbpj)Ysa>	MP:0000137,abnormal vertebrae morphology|MP:0004609,vertebral fusion|MP:0005390,skeleton phenotype|MP:0008530,abnormal rostral-caudal patterning of the somites
MGI:5494254	Mesp2<tm18Ysa>	MP:0002169,no abnormal phenotype detected
MGI:2137558	Mesp2<tm1Ysa>	MP:0000137,abnormal vertebrae morphology|MP:0000154,rib fusion|MP:0000963,fused dorsal root ganglion|MP:0001258,decreased body length|MP:0001688,abnormal somite development|MP:0001689,incomplete somite formation|MP:0002632,vestigial tail|MP:0003054,spina bifida|MP:0003651,abnormal axon extension|MP:0003794,delayed somite formation|MP:0004206,abnormal dermomyotome development|MP:0004605,abnormal vertebral lamina morphology|MP:0004609,vertebral fusion|MP:0004613,fusion of vertebral arches|MP:0004620,cervical vertebral fusion|MP:0004621,lumbar vertebral fusion|MP:0004683,absent intervertebral disk|MP:0005369,muscle phenotype|MP:0006029,abnormal sclerotome morphology|MP:0006386,absent somites|MP:0008029,abnormal paraxial mesoderm morphology|MP:0008530,abnormal rostral-caudal patterning of the somites|MP:0010771,integument phenotype|MP:0011087,neonatal lethality, complete penetrance|MP:0012728,abnormal somite border morphology
MGI:2182179	Mesp2<tm2(Mesp1)Ysa>	MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0001265,decreased body size|MP:0002114,abnormal axial skeleton morphology
MGI:2386844	Mesp2<tm4Ysa>	MP:0001688,abnormal somite development|MP:0004600,abnormal vertebral transverse process morphology|MP:0004604,abnormal vertebral pedicle morphology|MP:0004605,abnormal vertebral lamina morphology
MGI:2386850	Mesp2<tm5(Notch1)Ysa>	MP:0004599,abnormal vertebral arch morphology
MGI:3702019	Mesp2<tm7.1(mespb)Ysa>	MP:0000585,kinked tail|MP:0010768,mortality/aging
MGI:3702191	Mesp2<tm7(mespb)Ysa>	MP:0000154,rib fusion|MP:0001688,abnormal somite development|MP:0004609,vertebral fusion|MP:0008530,abnormal rostral-caudal patterning of the somites|MP:0012728,abnormal somite border morphology
MGI:3707530	Mesp2<tm8Ysa>	MP:0000154,rib fusion
MGI:3707532	Mesp2<tm9Ysa>	MP:0000154,rib fusion
MGI:2181803	Mest<tm1Masu>	MP:0001262,decreased body weight|MP:0001384,abnormal pup retrieval|MP:0001386,abnormal maternal nurturing|MP:0001698,decreased embryo size|MP:0002189,abnormal myocardial trabeculae morphology|MP:0003122,maternal imprinting|MP:0004200,decreased fetal size|MP:0004259,small placenta|MP:0004921,decreased placenta weight|MP:0005329,abnormal myocardium layer morphology|MP:0005390,skeleton phenotype|MP:0009431,decreased fetal weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:7517093	Metap1<em1(IMPC)Tcp>	MP:0000692,small spleen|MP:0001926,female infertility|MP:0002792,abnormal retina vasculature morphology|MP:0003900,shortened QT interval|MP:0005560,decreased circulating glucose level|MP:0010097,abnormal retina blood vessel morphology|MP:0020870,decreased thigmotaxis
MGI:3663889	Metap2<tm1.1Ccr>	MP:0000259,abnormal vascular development|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0003988,disorganized embryonic tissue|MP:0004787,abnormal dorsal aorta morphology|MP:0006057,decreased vascular endothelial cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012253,abnormal intersomitic vessel morphology|MP:0013241,embryo tissue necrosis
MGI:3663890	Metap2<tm1.2Ccr>	MP:0000352,decreased cell proliferation|MP:0001683,absent mesoderm|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:2156626	Met<Par4>	MP:0010267,decreased lung tumor incidence
MGI:7425819	Metrn<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002060,abnormal skin morphology
MGI:6367587	Metrnl<tm1d(KOMP)Wtsi>	MP:0001805,decreased IgG level|MP:0001859,kidney inflammation|MP:0001860,liver inflammation|MP:0002494,increased IgM level|MP:0008735,increased susceptibility to endotoxin shock|MP:0009080,uterus inflammation|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:6388733	Metrn<tm1.1Kong>	MP:0001685,abnormal endoderm development|MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0009266,abnormal mesendoderm development|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:7310345	Mettl13<tm1Kmgen>	MP:0001152,increased Leydig cell number|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0031287,bilateral cryptorchism
MGI:6356357	Mettl14<em1Chhe>	MP:0001147,small testis|MP:0001925,male infertility|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0012167,abnormal epigenetic regulation of gene expression|MP:0013272,abnormal translation|MP:0014619,absent spermatogonia
MGI:6156572	Mettl14<em1(IMPC)Tcp>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001120,abnormal uterus morphology|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6358166	Mettl14<tm1.1Czhao>	MP:0003690,abnormal glial cell physiology|MP:0006254,thin cerebral cortex|MP:0008948,decreased neuron number|MP:0011085,postnatal lethality, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0020388,decreased radial glial cell number
MGI:6358167	Mettl14<tm1.2Czhao>	MP:0003424,premature neuronal precursor differentiation|MP:0008877,abnormal DNA methylation|MP:0011091,prenatal lethality, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0012204,abnormal neuronal stem cell physiology
MGI:7335017	Mettl15<em1Pvs>	MP:0000189,hypoglycemia|MP:0003998,decreased thermal nociceptive threshold|MP:0008008,early cellular replicative senescence|MP:0012315,impaired learning|MP:0030937,increased mitochondrial DNA content
MGI:6199131	Mettl16<em1Embrp>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:6199132	Mettl16<em2Embrp>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:5583061	Mettl16<tm1b(KOMP)Mbp>	MP:0000208,decreased hematocrit|MP:0001556,increased circulating HDL cholesterol level|MP:0002075,abnormal coat/hair pigmentation|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0011100,preweaning lethality, complete penetrance|MP:0011471,decreased urine creatinine level|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6305181	Mettl18<em1(IMPC)J>	MP:0001513,limb grasping|MP:0002110,abnormal digit morphology|MP:0003960,increased lean body mass|MP:0005293,impaired glucose tolerance|MP:0010053,decreased grip strength|MP:0013279,increased fasting circulating glucose level
MGI:7859737	Mettl1<em1Bcgen>	MP:0000130,abnormal trabecular bone morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000547,short limbs|MP:0001265,decreased body size|MP:0003109,short femur|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003926,decreased cellular glucose uptake|MP:0004351,short humerus|MP:0004986,abnormal osteoblast morphology|MP:0005289,increased oxygen consumption|MP:0005621,abnormal cell physiology|MP:0006036,abnormal mitochondrial physiology|MP:0008271,abnormal bone ossification|MP:0008272,abnormal endochondral bone ossification|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0010954,abnormal cellular respiration|MP:0013630,increased bone trabecular spacing|MP:0014101,decreased chondrocyte proliferation|MP:0014245,increased cellular ATP level|MP:0020010,decreased bone mineral density of femur|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization
MGI:6887873	Mettl21a<em1Syu>	MP:0005389,reproductive system phenotype
MGI:6279318	Mettl21c<tm1.1Krug>	MP:0000747,muscle weakness|MP:0002106,abnormal muscle physiology|MP:0008260,abnormal autophagy|MP:0012106,impaired exercise endurance
MGI:5703085	Mettl22<tm1.1(KOMP)Vlcg>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:7425820	Mettl23<em1(IMPC)Hmgu>	MP:0000432,abnormal head morphology|MP:0000691,enlarged spleen|MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0002599,increased mean platelet volume|MP:0003960,increased lean body mass|MP:0004924,abnormal behavior|MP:0004952,increased spleen weight|MP:0008259,abnormal optic disk morphology|MP:0011496,abnormal head size|MP:0011896,increased circulating unsaturated transferrin level|MP:0011964,increased total retina thickness|MP:0020870,decreased thigmotaxis
MGI:6342883	Mettl23<em1Ogu>	MP:0001935,decreased litter size|MP:0008770,decreased survivor rate|MP:0008877,abnormal DNA methylation|MP:0011086,postnatal lethality, incomplete penetrance
MGI:7388493	Mettl23<em1Tiwata>	MP:0001059,optic nerve atrophy|MP:0004021,abnormal rod electrophysiology|MP:0005391,vision/eye phenotype|MP:0008067,retina ganglion cell degeneration|MP:0008507,thin retina ganglion layer
MGI:7388494	Mettl23<em2Tiwata>	MP:0001059,optic nerve atrophy|MP:0004021,abnormal rod electrophysiology|MP:0005391,vision/eye phenotype|MP:0008067,retina ganglion cell degeneration|MP:0008507,thin retina ganglion layer
MGI:4363211	Mettl24<tm1a(KOMP)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010123,increased bone mineral content
MGI:6414520	Mettl25<em1(IMPC)Bay>	MP:0004952,increased spleen weight|MP:0010123,increased bone mineral content
MGI:5607537	Mettl26<tm1.1(KOMP)Vlcg>	MP:0002135,abnormal kidney morphology|MP:0010024,increased total body fat amount
MGI:5903740	Mettl2<em1Nju>	MP:0005621,abnormal cell physiology|MP:0010768,mortality/aging
MGI:6356356	Mettl3<em1Chhe>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002685,abnormal spermatogonia proliferation|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0006362,abnormal male germ cell morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0012167,abnormal epigenetic regulation of gene expression|MP:0013272,abnormal translation|MP:0014617,decreased spermatogonia number|MP:0014619,absent spermatogonia
MGI:5754605	Mettl3<em1(IMPC)Tcp>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6491677	Mettl3<tm1.1Jhha>	MP:0001125,abnormal oocyte morphology|MP:0001126,abnormal ovary morphology|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002687,oligozoospermia|MP:0005168,abnormal female meiosis|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0005431,decreased oocyte number|MP:0013600,testis degeneration
MGI:5911703	Mettl3<tm1Jhha>	MP:0001672,abnormal embryo development|MP:0003085,abnormal egg cylinder morphology|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:6358564	Mettl4<em1Dfel>	MP:0000221,decreased leukocyte cell number|MP:0000428,abnormal craniofacial morphology|MP:0000691,enlarged spleen|MP:0001293,anophthalmia|MP:0001577,anemia|MP:0001921,reduced fertility|MP:0013139,moribund
MGI:6273953	Mettl5<em1(IMPC)Hmgu>	MP:0000208,decreased hematocrit|MP:0000432,abnormal head morphology|MP:0000438,abnormal cranium morphology|MP:0001258,decreased body length|MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001312,abnormal cornea morphology|MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002608,increased hematocrit|MP:0002699,abnormal vitreous body morphology|MP:0002757,decreased vertical activity|MP:0002792,abnormal retina vasculature morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004222,iris synechia|MP:0004738,abnormal auditory brainstem response|MP:0004924,abnormal behavior|MP:0004952,increased spleen weight|MP:0005566,decreased blood urea nitrogen level|MP:0006243,impaired pupillary reflex|MP:0008259,abnormal optic disk morphology|MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020870,decreased thigmotaxis
MGI:6488597	Mettl5<em1Schne>	MP:0000102,abnormal nasal bone morphology|MP:0000428,abnormal craniofacial morphology|MP:0001154,seminiferous tubule degeneration|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001925,male infertility|MP:0002699,abnormal vitreous body morphology|MP:0002757,decreased vertical activity|MP:0006378,abnormal spermatogonia morphology|MP:0010743,delayed cranial suture closure|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6108888	Mettl6<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0013279,increased fasting circulating glucose level
MGI:5903741	Mettl6<em1Nju>	MP:0005621,abnormal cell physiology|MP:0010768,mortality/aging
MGI:5903742	Mettl8<em1Nju>	MP:0005621,abnormal cell physiology|MP:0010768,mortality/aging
MGI:6693500	Mettl9<em1Yshk>	MP:0008877,abnormal DNA methylation
MGI:3041137	Met<tm1.1Sst>	MP:0000596,abnormal liver development|MP:0011091,prenatal lethality, complete penetrance
MGI:1857655	Met<tm1Cbm>	MP:0000601,small liver|MP:0000729,abnormal myogenesis|MP:0000761,thin diaphragm muscle|MP:0000762,abnormal tongue morphology|MP:0001712,abnormal placenta development|MP:0001713,decreased trophoblast giant cell number|MP:0001716,abnormal placenta labyrinth morphology|MP:0002279,abnormal diaphragm morphology|MP:0003090,abnormal muscle precursor cell migration|MP:0003359,hypaxial muscle hypoplasia|MP:0003402,decreased liver weight|MP:0003924,diaphragmatic hernia|MP:0004200,decreased fetal size|MP:0008986,abnormal liver parenchyma morphology|MP:0009907,decreased tongue size|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012251,abnormal diaphragm development|MP:0030208,abnormal intrinsic tongue muscle morphology
MGI:1858019	Met<tm1Cpo>	MP:0000733,abnormal muscle development|MP:0001698,decreased embryo size|MP:0003631,nervous system phenotype|MP:0003651,abnormal axon extension|MP:0004136,abnormal tongue muscle morphology|MP:0004259,small placenta|MP:0004266,pale placenta|MP:0004811,abnormal neuron physiology|MP:0004846,absent skeletal muscle|MP:0005369,muscle phenotype|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011883,absent diaphragm
MGI:3521826	Met<tm1Gvw>	MP:0000519,hydronephrosis|MP:0002020,increased tumor incidence|MP:0002038,increased carcinoma incidence|MP:0002743,glomerulonephritis|MP:0004028,chromosome breakage|MP:0004207,increased squamous cell carcinoma incidence|MP:0009321,increased histiocytic sarcoma incidence|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012431,increased lymphoma incidence
MGI:3510618	Met<tm1Kln>	MP:0000596,abnormal liver development|MP:0000602,dilated liver sinusoidal space|MP:0000729,abnormal myogenesis|MP:0001051,abnormal somatic motor system morphology|MP:0003402,decreased liver weight|MP:0004197,abnormal fetal growth/weight/body size|MP:0004259,small placenta|MP:0004819,decreased skeletal muscle mass|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0030945,abnormal myoblast migration
MGI:3041135	Met<tm1Sst>	MP:0000788,abnormal cerebral cortex morphology|MP:0000860,abnormal primary somatosensory cortex morphology|MP:0001176,abnormal lung development|MP:0001183,overexpanded pulmonary alveolus|MP:0001792,impaired wound healing|MP:0001958,emphysema|MP:0002063,abnormal learning/memory/conditioning|MP:0002169,no abnormal phenotype detected|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003326,liver failure|MP:0003562,abnormal pancreatic beta cell physiology|MP:0003887,increased hepatocyte apoptosis|MP:0003888,liver hemorrhage|MP:0004077,abnormal striatum morphology|MP:0004101,abnormal brain interneuron morphology|MP:0004170,abnormal orbitofrontal cortex morphology|MP:0005164,abnormal response to injury|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005386,behavior/neurological phenotype|MP:0005517,impaired liver regeneration|MP:0005559,increased circulating glucose level|MP:0009114,decreased pancreatic beta cell mass|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0010080,abnormal hepatocyte physiology|MP:0010825,abnormal lung saccule morphology|MP:0011820,decreased pancreatic beta cell proliferation|MP:0020344,abnormal susceptibility to injury induced morbidity/mortality
MGI:1858021	Met<tm2Cpo>	MP:0000550,abnormal forelimb morphology|MP:0001732,postnatal growth retardation|MP:0004819,decreased skeletal muscle mass|MP:0009434,paraparesis|MP:0011087,neonatal lethality, complete penetrance
MGI:3521827	Met<tm2Gvw>	MP:0000519,hydronephrosis|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0002743,glomerulonephritis|MP:0003667,increased hemangiosarcoma incidence|MP:0004028,chromosome breakage|MP:0009321,increased histiocytic sarcoma incidence|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012431,increased lymphoma incidence
MGI:3510619	Met<tm2Kln>	MP:0000596,abnormal liver development|MP:0000602,dilated liver sinusoidal space|MP:0000729,abnormal myogenesis|MP:0000940,abnormal motor neuron innervation pattern|MP:0001051,abnormal somatic motor system morphology|MP:0001953,respiratory failure|MP:0002279,abnormal diaphragm morphology|MP:0003402,decreased liver weight|MP:0004197,abnormal fetal growth/weight/body size|MP:0004819,decreased skeletal muscle mass|MP:0005380,embryo phenotype|MP:0011087,neonatal lethality, complete penetrance|MP:0030945,abnormal myoblast migration
MGI:1858022	Met<tm3Cpo>	MP:0002169,no abnormal phenotype detected
MGI:3521829	Met<tm3Gvw>	MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0003667,increased hemangiosarcoma incidence|MP:0004028,chromosome breakage
MGI:3510620	Met<tm3Kln>	MP:0002169,no abnormal phenotype detected
MGI:3521830	Met<tm4Gvw>	MP:0000519,hydronephrosis|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002743,glomerulonephritis|MP:0003667,increased hemangiosarcoma incidence|MP:0004028,chromosome breakage|MP:0004207,increased squamous cell carcinoma incidence|MP:0010299,increased mammary gland tumor incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012043,increased myoepithelioma incidence|MP:0012431,increased lymphoma incidence
MGI:3708982	Met<tm5Gvw>	MP:0002006,neoplasm|MP:0010768,mortality/aging
MGI:6430337	Mex3a<tm1.1(KOMP)Vlcg>	MP:0000477,abnormal intestine morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001429,dehydration|MP:0001732,postnatal growth retardation|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0005202,lethargy|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010157,abnormal small intestinal crypt cell proliferation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013486,decreased Paneth cell number|MP:0014082,decreased small intestinal villus height|MP:0014201,abnormal intestinal epithelium physiology|MP:0014353,abnormal gastrointestinal brush cell morphology
MGI:5638673	Mex3b<tm1.1Mbld>	MP:0001922,reduced male fertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002776,increased Sertoli cell number|MP:0005378,growth/size/body region phenotype|MP:0010768,mortality/aging|MP:0020142,increased anti-sperm antibody level|MP:0020356,abnormal Sertoli cell barrier function
MGI:5638674	Mex3b<tm1.2Mbld>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001798,impaired macrophage phagocytosis|MP:0001921,reduced fertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0002776,increased Sertoli cell number|MP:0008868,abnormal granulosa cell morphology|MP:0009853,decreased Sertoli cell phagocytosis|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0020355,abnormal Sertoli cell barrier morphology|MP:0020356,abnormal Sertoli cell barrier function
MGI:5766754	Mex3b<tm1b(KOMP)Wtsi>	MP:0000137,abnormal vertebrae morphology|MP:0001126,abnormal ovary morphology|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0002100,abnormal tooth morphology|MP:0002135,abnormal kidney morphology|MP:0003036,vertebral transformation|MP:0004599,abnormal vertebral arch morphology|MP:0020421,increased freezing behavior
MGI:3764947	Mex3c<Gt(DD0642)Wtsi>	MP:0001258,decreased body length|MP:0001575,cyanosis|MP:0001732,postnatal growth retardation|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002764,short tibia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005123,increased circulating growth hormone level|MP:0006396,decreased long bone epiphyseal plate size|MP:0008831,abnormal insulin-like growth factor I level|MP:0010768,mortality/aging|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5613894	Mex3c<tm1Aki>	MP:0001265,decreased body size|MP:0003009,abnormal cytokine secretion|MP:0008565,decreased interferon-beta secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008706,decreased interleukin-6 secretion
MGI:6403491	Mexis<tm1.1Pton>	MP:0002118,abnormal lipid homeostasis|MP:0003193,decreased cholesterol efflux|MP:0003982,increased cholesterol level|MP:0004778,increased macrophage derived foam cell number
MGI:4364362	Mfap2<tm1a(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0001260,increased body weight|MP:0001559,hyperglycemia|MP:0005014,increased B cell number|MP:0005017,decreased B cell number|MP:0005331,insulin resistance|MP:0005425,increased macrophage cell number|MP:0008121,increased myeloid dendritic cell number|MP:0009285,increased gonadal fat pad weight|MP:0009338,increased splenocyte number|MP:0010879,decreased trabecular bone volume|MP:0013279,increased fasting circulating glucose level|MP:0013693,abnormal hemopoiesis|MP:0030007,abnormal bone marrow adipose tissue morphology|MP:0030009,increased bone marrow adipose tissue amount
MGI:3790750	Mfap2<tm1Mech>	MP:0000223,decreased monocyte cell number|MP:0003179,thrombocytopenia|MP:0003884,decreased macrophage cell number|MP:0005385,cardiovascular system phenotype|MP:0005606,increased bleeding time|MP:0031120,decreased susceptibility to induced thrombosis
MGI:5787993	Mfap4<tm1Ascr>	MP:0001175,abnormal lung morphology|MP:0002327,abnormal respiratory function|MP:0010895,increased lung compliance|MP:0010901,abnormal pulmonary alveolar parenchyma morphology|MP:0010937,increased total lung capacity|MP:0011045,decreased lung elastance
MGI:5766171	Mfap4<tm1b(NCOM)Mfgc>	MP:0000702,enlarged lymph nodes
MGI:5551608	Mfap5<tm1Mech>	MP:0000222,decreased neutrophil cell number|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005390,skeleton phenotype
MGI:3604765	Mfe5q1<M16>	MP:0005449,abnormal food intake
MGI:3604787	Mfeq1<M16>	MP:0005449,abnormal food intake
MGI:3857630	Mff<Gt(AZ0438)Wtsi>	MP:0001657,abnormal induced morbidity/mortality|MP:0003038,decreased myocardial infarct size|MP:0006035,abnormal mitochondrial morphology|MP:0006043,decreased apoptosis|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011629,decreased mitochondrial number|MP:0011630,increased mitochondrial size|MP:0011632,dilated mitochondrion|MP:0014467,increased sperm mitochondrial size
MGI:3578644	Mfge8<Gt(KST227)Byg>	MP:0000691,enlarged spleen|MP:0001798,impaired macrophage phagocytosis|MP:0001922,reduced male fertility|MP:0002136,abnormal kidney physiology|MP:0003710,abnormal physiological neovascularization|MP:0006271,abnormal involution of the mammary gland|MP:0009503,abnormal mammary gland duct morphology|MP:0013148,mastitis
MGI:3717588	Mfge8<tm1Mcu>	MP:0000691,enlarged spleen
MGI:3044898	Mfge8<tm1Osa>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0001798,impaired macrophage phagocytosis|MP:0001882,abnormal lactation|MP:0004047,abnormal milk composition|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004952,increased spleen weight|MP:0005387,immune system phenotype|MP:0006270,abnormal mammary gland growth during lactation|MP:0006271,abnormal involution of the mammary gland|MP:0008478,increased spleen white pulp amount|MP:0013716,hypolactation|MP:0014347,increased spleen B cell follicle size
MGI:2675967	Mfge8<tm1Shur>	MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002631,abnormal epididymis morphology|MP:0003566,abnormal cell adhesion|MP:0004934,epididymis epithelium degeneration|MP:0009824,spermatic granuloma|MP:0030978,impaired binding of sperm to zona pellucida
MGI:7523297	Mfhas1<em1(IMPC)Bay>	MP:0001392,abnormal locomotor behavior
MGI:3604770	Mfi5q1<M16>	MP:0005449,abnormal food intake
MGI:3604783	Mfi7q1<M16>	MP:0005449,abnormal food intake
MGI:3604785	Mfiq1<M16>	MP:0005449,abnormal food intake
MGI:3604793	Mfiq2<M16>	MP:0005449,abnormal food intake
MGI:3604767	Mfiq3<M16>	MP:0005449,abnormal food intake
MGI:3604791	Mfiq4<M16>	MP:0005449,abnormal food intake
MGI:3604760	Mfiq5<M16>	MP:0005449,abnormal food intake
MGI:6414496	Mfn1<em1(IMPC)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:5440838	Mfn1<tm1.1Arte>	MP:0002169,no abnormal phenotype detected
MGI:2450304	Mfn1<tm1Dcc>	MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3779080	Mfn1<tm2Dcc>	MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004930,small epididymis|MP:0005384,cellular phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0006038,increased mitochondrial fission|MP:0006362,abnormal male germ cell morphology|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0020362,abnormal male germ cell physiology|MP:0030937,increased mitochondrial DNA content
MGI:7327650	Mfn2<em1Cya>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0005169,abnormal male meiosis|MP:0009232,abnormal sperm nucleus morphology|MP:0009237,kinked sperm flagellum|MP:0009832,abnormal sperm mitochondrial sheath morphology
MGI:8272328	Mfn2<em1Dabsa>	MP:0005370,liver/biliary system phenotype|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0005668,decreased circulating leptin level|MP:0006035,abnormal mitochondrial morphology|MP:0011631,decreased mitochondrial size|MP:0011636,disorganized mitochondrial cristae|MP:0014396,decreased fat cell mitochondrial DNA content|MP:0014398,abnormal fat cell mitochondrial morphology|MP:0030968,decreased circulating adiponectin level
MGI:5440839	Mfn2<tm1.1Arte>	MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0002083,premature death|MP:0002184,abnormal innervation|MP:0002757,decreased vertical activity|MP:0003313,abnormal locomotor activation|MP:0004811,abnormal neuron physiology|MP:0005643,decreased dopamine level|MP:0010069,increased serotonin level|MP:0010955,abnormal respiratory electron transport chain|MP:0013219,abnormal substantia nigra pars compacta morphology
MGI:4442975	Mfn2<tm1.1Balo>	MP:0004768,abnormal axonal transport|MP:0006036,abnormal mitochondrial physiology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5445195	Mfn2<tm1.1Mzhe>	MP:0000278,abnormal myocardial fiber morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004485,increased response of heart to induced stress|MP:0005598,decreased heart ventricle muscle contractility|MP:0006035,abnormal mitochondrial morphology|MP:0008260,abnormal autophagy|MP:0008842,lipofuscinosis|MP:0010954,abnormal cellular respiration|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0031645,increased myocardial fiber apoptosis
MGI:5692821	Mfn2<tm1b(EUCOMM)Wtsi>	MP:0001406,abnormal gait|MP:0003961,decreased lean body mass|MP:0011100,preweaning lethality, complete penetrance
MGI:2450306	Mfn2<tm1Dcc>	MP:0001698,decreased embryo size|MP:0001713,decreased trophoblast giant cell number|MP:0005031,abnormal trophoblast layer morphology|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3713113	Mfn2<tm2Dcc>	MP:0004768,abnormal axonal transport|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology
MGI:3779081	Mfn2<tm3Dcc>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0004930,small epididymis|MP:0005384,cellular phenotype|MP:0005578,teratozoospermia|MP:0006035,abnormal mitochondrial morphology|MP:0006038,increased mitochondrial fission|MP:0006362,abnormal male germ cell morphology|MP:0006379,abnormal spermatocyte morphology|MP:0006380,abnormal spermatid morphology|MP:0009230,abnormal sperm head morphology|MP:0009234,absent sperm head|MP:0009238,coiled sperm flagellum|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0013601,increased testis apoptosis|MP:0014052,increased male germ cell apoptosis|MP:0014634,decreased round spermatid number|MP:0020362,abnormal male germ cell physiology|MP:0030937,increased mitochondrial DNA content
MGI:7425823	Mfng<em1(IMPC)Ccpcz>	MP:0000160,kyphosis|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001147,small testis|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0004174,abnormal spine curvature|MP:0008040,decreased NK T cell number|MP:0009709,hydrometra
MGI:5052270	Mfng<tm1.1Cfg>	MP:0000222,decreased neutrophil cell number|MP:0001570,abnormal circulating enzyme level|MP:0003884,decreased macrophage cell number|MP:0005013,increased lymphocyte cell number|MP:0005014,increased B cell number|MP:0005154,increased B cell proliferation|MP:0008211,decreased mature B cell number|MP:0012355,decreased prothrombin time|MP:0012358,decreased partial thromboplastin time|MP:0012616,increased circulating factor IX level|MP:0020985,increased circulating factor XI level
MGI:3842454	Mfng<tm1.1Heed>	MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:3838347	Mfng<tm1Cjg>	MP:0008180,abnormal marginal zone B cell morphology
MGI:3849429	Mfng<tm1Seco>	MP:0002169,no abnormal phenotype detected
MGI:1888705	Mfrp<rd6>	MP:0001326,retina degeneration|MP:0002092,abnormal eye morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005391,vision/eye phenotype|MP:0008450,retina photoreceptor degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0010081,posterior microphthalmia|MP:0012671,retina spots|MP:0014657,decreased cornea curvature|MP:0020866,abnormal lipogenesis
MGI:6794097	Mfrp<rd6-2J>	MP:0001326,retina degeneration|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0012671,retina spots
MGI:5312653	Mfrp<rdx>	MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0002864,abnormal ocular fundus morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005391,vision/eye phenotype|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008586,disorganized photoreceptor outer segment
MGI:2673985	Mfs	MP:0005389,reproductive system phenotype|MP:0010231,transverse fur striping
MGI:5583062	Mfsd10<tm1.1(KOMP)Vlcg>	MP:0000221,decreased leukocyte cell number
MGI:5910264	Mfsd12<em1Pav>	MP:0012017,grizzled coat color
MGI:1856888	Mfsd12<gr>	MP:0000371,diluted coat color|MP:0000438,abnormal cranium morphology|MP:0000454,abnormal jaw morphology|MP:0000585,kinked tail|MP:0001259,abnormal body weight|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001928,abnormal ovulation|MP:0002083,premature death|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002111,abnormal tail morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0003355,decreased ovulation rate|MP:0005171,absent coat pigmentation|MP:0005508,abnormal skeleton morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5763015	Mfsd14a<tm1Coll>	MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0004910,decreased seminal vesicle weight|MP:0005389,reproductive system phenotype|MP:0008839,absent acrosome|MP:0009230,abnormal sperm head morphology|MP:0009833,absent sperm mitochondrial sheath
MGI:6313359	Mfsd1<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001147,small testis|MP:0001289,persistence of hyaloid vascular system|MP:0001293,anophthalmia|MP:0002092,abnormal eye morphology|MP:0002599,increased mean platelet volume|MP:0002644,decreased circulating triglyceride level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0005016,decreased lymphocyte cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0010067,increased red blood cell distribution width|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4939721	Mfsd1<tm1a(KOMP)Wtsi>	MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0002941,increased circulating alanine transaminase level|MP:0003333,liver fibrosis|MP:0005343,increased circulating aspartate transaminase level|MP:0008019,increased liver tumor incidence|MP:0008986,abnormal liver parenchyma morphology|MP:0008988,abnormal liver perisinusoidal space morphology|MP:0008989,abnormal liver sinusoid morphology|MP:0009820,abnormal liver vasculature morphology|MP:0011009,increased circulating glutamate dehydrogenase level|MP:0031148,abnormal liver sinusoidal endothelial cell morphology
MGI:6379069	Mfsd1<tm1d(KOMP)Wtsi>	MP:0000598,abnormal liver morphology
MGI:5583066	Mfsd2a<tm1b(KOMP)Wtsi>	MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001697,abnormal embryo size|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5805836	Mfsd2a<tm1c(KOMP)Wtsi>	MP:0001297,microphthalmia|MP:0002169,no abnormal phenotype detected|MP:0005376,homeostasis/metabolism phenotype
MGI:5474960	Mfsd2a<tm1Dls>	MP:0000598,abnormal liver morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001326,retina degeneration|MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0002118,abnormal lipid homeostasis|MP:0002310,decreased susceptibility to hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002757,decreased vertical activity|MP:0003631,nervous system phenotype|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003961,decreased lean body mass|MP:0004889,increased energy expenditure|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005253,abnormal eye physiology|MP:0005283,increased unsaturated fatty acids level|MP:0005285,decreased unsaturated fatty acids level|MP:0005318,decreased triglyceride level|MP:0005376,homeostasis/metabolism phenotype|MP:0005391,vision/eye phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0008516,disorganized retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0009133,decreased white fat cell size|MP:0009392,retina gliosis|MP:0010025,decreased total body fat amount|MP:0010378,increased respiratory quotient|MP:0010762,abnormal microglial cell activation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014171,increased fatty acid oxidation|MP:0014812,abnormal brain physiology
MGI:5007245	Mfsd2a<tm1Lex>	MP:0004003,abnormal vascular endothelial cell physiology|MP:0005385,cardiovascular system phenotype|MP:0008546,abnormal vesicle-mediated transport|MP:0031384,impaired blood-brain barrier function
MGI:4362372	Mfsd2b<tm1a(KOMP)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0000226,abnormal mean corpuscular volume|MP:0000691,enlarged spleen|MP:0002875,decreased erythrocyte cell number|MP:0004151,decreased circulating iron level|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0005561,increased mean corpuscular hemoglobin|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008941,reticulocytopenia|MP:0010074,stomatocytosis|MP:0010163,hemolysis|MP:0012232,abnormal ceramide level|MP:0020116,increased sphingosine level|MP:0020117,decreased sphingosine level|MP:0031276,abnormal stress erythropoiesis
MGI:6104251	Mfsd4b4<em1(IMPC)J>	MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002966,decreased circulating alkaline phosphatase level
MGI:7786588	Mfsd6l<em1Fzh>	MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0020451,decreased sperm progressive motility
MGI:6157951	Mfsd6<tm1Ryosh>	MP:0002442,abnormal leukocyte physiology|MP:0004751,increased length of allograft survival|MP:0005378,growth/size/body region phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype
MGI:4456699	Mfsd8<tm1a(EUCOMM)Hmgu>	MP:0000278,abnormal myocardial fiber morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0002135,abnormal kidney morphology|MP:0003354,astrocytosis|MP:0003632,abnormal nervous system morphology|MP:0005058,abnormal lysosome morphology|MP:0006082,CNS inflammation|MP:0008450,retina photoreceptor degeneration|MP:0008918,microgliosis
MGI:5637063	Mfsd8<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002792,abnormal retina vasculature morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0006243,impaired pupillary reflex
MGI:3916168	Mga<Gt(E153E01)Wrst>	MP:0001713,decreased trophoblast giant cell number|MP:0002399,abnormal pluripotent precursor cell morphology|MP:0003886,abnormal embryonic epiblast morphology|MP:0004964,absent inner cell mass|MP:0004965,inner cell mass degeneration|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009687,empty decidua capsularis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012743,increased inner cell mass apoptosis|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3797062	Mgam<tm1Lex>	MP:0002715,decreased glycogen catabolism rate|MP:0002727,decreased circulating insulin level|MP:0005266,abnormal metabolism|MP:0005584,abnormal enzyme/coenzyme activity
MGI:7620185	Mgarp<tm1Szha>	MP:0005404,abnormal axon morphology|MP:0008143,abnormal dendrite morphology
MGI:5613671	Mgat1<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0010068,decreased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance|MP:0011952,decreased cardiac stroke volume
MGI:1857217	Mgat1<tm1Jxm>	MP:0000259,abnormal vascular development|MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0001577,anemia|MP:0001689,incomplete somite formation|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001706,abnormal left-right axis patterning|MP:0001730,embryonic growth arrest|MP:0001914,hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0002766,situs inversus|MP:0004252,abnormal direction of heart looping|MP:0006055,abnormal vascular endothelial cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013176,abnormal tail position or orientation
MGI:1857564	Mgat1<tm1Pst>	MP:0000928,incomplete rostral neuropore closure|MP:0001689,incomplete somite formation|MP:0001698,decreased embryo size|MP:0001914,hemorrhage|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012707,incomplete caudal neuropore closure
MGI:3514311	Mgat1<tm2Jxm>	MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001931,abnormal oogenesis|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002631,abnormal epididymis morphology|MP:0003696,abnormal zona pellucida morphology|MP:0004852,decreased testis weight|MP:0004884,abnormal testis physiology|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0006362,abnormal male germ cell morphology|MP:0009375,thin zona pellucida|MP:0014052,increased male germ cell apoptosis|MP:0014636,decreased elongated spermatid number|MP:0020550,multinucleated giant male germ cells
MGI:2667740	Mgat2<tm1.1Jxm>	MP:0000060,delayed bone ossification|MP:0000063,decreased bone mineral density|MP:0000069,kyphoscoliosis|MP:0000189,hypoglycemia|MP:0000195,decreased circulating calcium level|MP:0000465,gastrointestinal hemorrhage|MP:0000493,rectal prolapse|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000733,abnormal muscle development|MP:0000745,tremors|MP:0000753,paralysis|MP:0001146,abnormal testis morphology|MP:0001265,decreased body size|MP:0001386,abnormal maternal nurturing|MP:0001392,abnormal locomotor behavior|MP:0001516,abnormal motor coordination/balance|MP:0001577,anemia|MP:0001664,abnormal digestion|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002144,abnormal B cell differentiation|MP:0002590,increased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002743,glomerulonephritis|MP:0002913,abnormal PNS synaptic transmission|MP:0002962,increased urine protein level|MP:0003631,nervous system phenotype|MP:0003743,abnormal facial morphology|MP:0004200,decreased fetal size|MP:0005018,decreased T cell number|MP:0005159,azoospermia|MP:0005161,hematuria|MP:0005567,decreased circulating total protein level|MP:0008261,arrest of male meiosis|MP:0010053,decreased grip strength|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012359,increased partial thromboplastin time
MGI:1857830	Mgat3<tm1Jxm>	MP:0002169,no abnormal phenotype detected
MGI:1857829	Mgat3<tm1Pst>	MP:0003402,decreased liver weight|MP:0004001,decreased hepatocyte proliferation|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005517,impaired liver regeneration
MGI:3698839	Mgat4a<tm1.1Jxm>	MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001559,hyperglycemia|MP:0001560,abnormal circulating insulin level|MP:0002628,hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0003926,decreased cellular glucose uptake|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005455,increased susceptibility to weight gain|MP:0005559,increased circulating glucose level|MP:0009642,abnormal blood homeostasis
MGI:5578604	Mgat4b<tm1.1Jxm>	MP:0000218,increased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0002590,increased mean corpuscular volume|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005416,abnormal circulating protein level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005606,increased bleeding time|MP:0010068,decreased red blood cell distribution width|MP:0012222,decreased circulating prothrombin level|MP:0012328,decreased circulating factor VIII level|MP:0012359,increased partial thromboplastin time|MP:0012615,decreased circulating factor IX level|MP:0031164,decreased circulating von Willebrand factor level
MGI:3699595	Mgat4b<tm1Jxm>	MP:0002169,no abnormal phenotype detected
MGI:6361136	Mgat4d<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5548545	Mgat4d<tm1b(KOMP)Wtsi>	MP:0000467,abnormal esophagus morphology|MP:0000689,abnormal spleen morphology
MGI:5052168	Mgat5b<tm1.1Cfg>	MP:0001154,seminiferous tubule degeneration|MP:0002397,abnormal bone marrow morphology|MP:0005559,increased circulating glucose level|MP:0008209,decreased pre-B cell number|MP:0008501,increased IgG2b level|MP:0009640,abnormal renal tubule epithelium morphology|MP:0020155,enhanced humoral immune response
MGI:5442815	Mgat5b<tm1.1Itl>	MP:0001764,abnormal homeostasis
MGI:5523679	Mgat5b<tm1Nta>	MP:0000921,demyelination|MP:0001847,brain inflammation|MP:0003354,astrocytosis|MP:0005166,decreased susceptibility to injury|MP:0010160,increased oligodendrocyte number
MGI:2152619	Mgat5<tm1Jwd>	MP:0001273,decreased metastatic potential|MP:0001386,abnormal maternal nurturing|MP:0001764,abnormal homeostasis|MP:0001845,abnormal inflammatory response|MP:0002442,abnormal leukocyte physiology|MP:0002444,abnormal T cell physiology|MP:0003447,decreased tumor growth/size|MP:0005325,abnormal renal glomerulus morphology|MP:0008560,increased tumor necrosis factor secretion|MP:0008660,increased interleukin-10 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0009828,increased tumor latency
MGI:3772357	mgb	MP:0000519,hydronephrosis|MP:0000538,abnormal urinary bladder morphology|MP:0000539,distended urinary bladder|MP:0000598,abnormal liver morphology|MP:0001562,abnormal circulating calcium level|MP:0001756,abnormal urination|MP:0002083,premature death|MP:0003019,increased circulating chloride level|MP:0003586,dilated ureter|MP:0003624,anuria|MP:0003630,abnormal urothelium morphology|MP:0003942,abnormal urinary system development|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level|MP:0011085,postnatal lethality, complete penetrance|MP:0011774,abnormal urinary bladder detrusor smooth muscle morphology
MGI:3521877	Mgdr1<C3H/HeJ>	MP:0005319,abnormal enzyme/coenzyme level
MGI:3521879	Mgdr2<C3H/HeJ>	MP:0005319,abnormal enzyme/coenzyme level
MGI:3708384	mge	MP:0001489,decreased startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5510723	Mgl2<tm1.1(HBEGF/EGFP)Aiwsk>	MP:0000701,abnormal lymph node size|MP:0001790,abnormal immune system physiology|MP:0002434,abnormal T-helper 2 cell morphology|MP:0005017,decreased B cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005389,reproductive system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008119,decreased Langerhans cell number|MP:0008127,decreased dendritic cell number|MP:0008700,decreased interleukin-4 secretion|MP:0010768,mortality/aging
MGI:3604789	Mglcq1<M16>	MP:0005559,increased circulating glucose level
MGI:6273958	Mgll<em1(IMPC)Hmgu>	MP:0001402,decreased locomotor activity|MP:0002599,increased mean platelet volume
MGI:3530905	Mgll<Gt(OST113734)Lex>	MP:0001973,increased thermal nociceptive threshold|MP:0001982,decreased chemically-elicited antinociception|MP:0003043,hypoalgesia|MP:0005282,decreased fatty acids level|MP:0005498,hyporesponsive to tactile stimuli|MP:0005533,increased body temperature|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009747,impaired behavioral response to xenobiotic
MGI:5009247	Mgll<tm1.1Rzim>	MP:0001399,hyperactivity|MP:0001431,abnormal eating behavior|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003442,decreased circulating glycerol level|MP:0003458,decreased circulating ketone body level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005378,growth/size/body region phenotype|MP:0008032,abnormal lipolysis|MP:0008033,impaired lipolysis|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009356,decreased liver triglyceride level
MGI:5825054	Mgme1<em1(IMPC)J>	MP:0002075,abnormal coat/hair pigmentation|MP:0003960,increased lean body mass|MP:0005292,improved glucose tolerance|MP:0005561,increased mean corpuscular hemoglobin|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0013279,increased fasting circulating glucose level
MGI:6150911	Mgme1<tm1.1Lrsn>	MP:0011639,decreased mitochondrial DNA content
MGI:6150912	Mgme1<tm1.2Lrsn>	MP:0001577,anemia|MP:0002874,decreased hemoglobin content|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0011639,decreased mitochondrial DNA content
MGI:5696939	Mgmt<tm1b(EUCOMM)Wtsi>	MP:0005565,increased blood urea nitrogen level|MP:0009142,decreased prepulse inhibition
MGI:1930999	Mgmt<tm1Lds>	MP:0005165,increased susceptibility to injury|MP:0005559,increased circulating glucose level|MP:0009172,small pancreatic islets
MGI:1857949	Mgmt<tm1Mse>	MP:0002024,increased T cell derived lymphoma incidence|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:1934912	Mgp<tm1Kry>	MP:0000063,decreased bone mineral density|MP:0000530,abnormal kidney vasculature morphology|MP:0001175,abnormal lung morphology|MP:0001255,decreased body height|MP:0001265,decreased body size|MP:0001634,internal hemorrhage|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002191,abnormal artery morphology|MP:0002626,increased heart rate|MP:0002989,small kidney|MP:0002998,abnormal bone remodeling|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0003211,abnormal aorta elastic fiber morphology|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003641,small lung|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003917,increased kidney weight|MP:0004007,abnormal lung vasculature morphology|MP:0004016,decreased bone mass|MP:0005006,abnormal osteoblast physiology|MP:0005325,abnormal renal glomerulus morphology|MP:0006093,arteriovenous malformation|MP:0006116,calcified aortic valve|MP:0006133,calcified artery|MP:0006395,abnormal epiphyseal plate morphology|MP:0008489,slow postnatal weight gain|MP:0009346,decreased trabecular bone thickness|MP:0009865,abnormal aorta smooth muscle morphology|MP:0009873,abnormal aorta tunica media morphology|MP:0010480,pulmonary arteriovenous malformation|MP:0010522,calcified aorta|MP:0010869,decreased bone trabecula number|MP:0010873,decreased trabecular bone mass|MP:0010876,decreased bone volume|MP:0010962,decreased compact bone mass|MP:0010988,abnormal bronchial cartilage morphology|MP:0011320,abnormal glomerular capillary morphology|MP:0020040,decreased bone ossification|MP:0030984,increased circulating osteocalcin level
MGI:6156581	Mgrn1<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000219,increased neutrophil cell number|MP:0000438,abnormal cranium morphology|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001944,abnormal pancreas morphology|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002102,abnormal ear morphology|MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0004738,abnormal auditory brainstem response|MP:0004952,increased spleen weight|MP:0005013,increased lymphocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0005344,increased circulating bilirubin level|MP:0005561,increased mean corpuscular hemoglobin|MP:0010124,decreased bone mineral content|MP:0010393,shortened QRS complex duration|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration|MP:0011874,enlarged urinary bladder|MP:0020421,increased freezing behavior
MGI:3701336	Mgrn1<Gt(XC712)Byg>	MP:0002075,abnormal coat/hair pigmentation|MP:0005380,embryo phenotype
MGI:1856070	Mgrn1<md>	MP:0005409,darkened coat color
MGI:1856072	Mgrn1<md-2J>	MP:0000284,double outlet right ventricle|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0001706,abnormal left-right axis patterning|MP:0001914,hemorrhage|MP:0002075,abnormal coat/hair pigmentation|MP:0002652,thin myocardium|MP:0002766,situs inversus|MP:0003178,left pulmonary isomerism|MP:0004158,right aortic arch|MP:0005312,pericardial effusion|MP:0006138,congestive heart failure|MP:0010334,pleural effusion|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010426,abnormal heart and great artery attachment|MP:0010436,abnormal coronary sinus morphology|MP:0010488,abnormal left subclavian artery morphology|MP:0010854,lung situs inversus|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1856518	Mgrn1<md-4J>	MP:0002075,abnormal coat/hair pigmentation|MP:0005409,darkened coat color
MGI:1856519	Mgrn1<md-5J>	MP:0002075,abnormal coat/hair pigmentation|MP:0005409,darkened coat color
MGI:1856520	Mgrn1<md-6J>	MP:0002075,abnormal coat/hair pigmentation|MP:0005409,darkened coat color
MGI:1856071	Mgrn1<md-nc>	MP:0000284,double outlet right ventricle|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0000747,muscle weakness|MP:0001274,curly vibrissae|MP:0001706,abnormal left-right axis patterning|MP:0001914,hemorrhage|MP:0001935,decreased litter size|MP:0002080,prenatal lethality|MP:0002083,premature death|MP:0002652,thin myocardium|MP:0002654,spongiform encephalopathy|MP:0002766,situs inversus|MP:0003178,left pulmonary isomerism|MP:0003354,astrocytosis|MP:0004158,right aortic arch|MP:0005312,pericardial effusion|MP:0005409,darkened coat color|MP:0006138,congestive heart failure|MP:0008025,brain vacuoles|MP:0010334,pleural effusion|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010426,abnormal heart and great artery attachment|MP:0010436,abnormal coronary sinus morphology|MP:0010488,abnormal left subclavian artery morphology|MP:0010854,lung situs inversus|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6360916	Mgst1<em1(IMPC)J>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:6384679	Mgst1<tm1Kini>	MP:0011092,embryonic lethality, complete penetrance
MGI:6276883	Mgst2<em1(IMPC)Mbp>	MP:0000494,abnormal cecum morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001293,anophthalmia|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0009476,enlarged cecum
MGI:5908940	Mgst2<Gt(OST22210)Lex>	MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0013502,decreased fibroblast apoptosis|MP:0031601,decreased endoplasmic reticulum stress
MGI:4362930	Mgst3<tm1a(KOMP)Wtsi>	MP:0002590,increased mean corpuscular volume|MP:0002591,decreased mean corpuscular volume
MGI:2681160	Mhdaabe025	MP:0005307,head tossing
MGI:2681186	Mhdaabe10	MP:0005307,head tossing
MGI:2681199	Mhdaabe18	MP:0005307,head tossing
MGI:2681198	Mhdaabe19	MP:0005307,head tossing
MGI:3530485	Mhdaali026	MP:0002109,abnormal limb morphology
MGI:3530493	Mhdaali028	MP:0002109,abnormal limb morphology
MGI:2681266	Mhdaali029	MP:0000373,belly spot|MP:0000562,polydactyly
MGI:2681240	Mhdaali031	MP:0000564,syndactyly
MGI:2681241	Mhdaali11	MP:0002110,abnormal digit morphology
MGI:5615408	Mhdaali12	MP:0002110,abnormal digit morphology
MGI:2681692	Mhdaali13	MP:0000564,syndactyly|MP:0002110,abnormal digit morphology
MGI:2681698	Mhdaali15	MP:0000564,syndactyly
MGI:3530507	Mhdaali19	MP:0000373,belly spot|MP:0000562,polydactyly
MGI:3530512	Mhdaali20	MP:0000373,belly spot|MP:0000562,polydactyly
MGI:5615414	Mhdaali22	MP:0002110,abnormal digit morphology
MGI:3530517	Mhdaali23	MP:0006280,abnormal digit development
MGI:3530523	Mhdaali24	MP:0006280,abnormal digit development
MGI:3530527	Mhdaali25	MP:0002109,abnormal limb morphology
MGI:2681255	Mhdaali4	MP:0000583,long toenails
MGI:2681258	Mhdaali7	MP:0000564,syndactyly
MGI:5424898	Mhdabap001	MP:0002968,increased circulating alkaline phosphatase level
MGI:5424900	Mhdabap003	MP:0000194,increased circulating calcium level|MP:0002968,increased circulating alkaline phosphatase level
MGI:5424903	Mhdabap009	MP:0001265,decreased body size|MP:0001394,circling|MP:0002968,increased circulating alkaline phosphatase level
MGI:5424907	Mhdabap16	MP:0002968,increased circulating alkaline phosphatase level
MGI:5424908	Mhdabap17	MP:0001265,decreased body size|MP:0002968,increased circulating alkaline phosphatase level
MGI:5424909	Mhdabap18	MP:0002968,increased circulating alkaline phosphatase level
MGI:5424910	Mhdabap19	MP:0002968,increased circulating alkaline phosphatase level
MGI:5424911	Mhdabap21	MP:0000203,abnormal circulating aspartate transaminase level|MP:0002941,increased circulating alanine transaminase level|MP:0002966,decreased circulating alkaline phosphatase level
MGI:5424912	Mhdabap22	MP:0002966,decreased circulating alkaline phosphatase level
MGI:5424977	Mhdabch10	MP:0000194,increased circulating calcium level
MGI:5424974	Mhdabch6	MP:0000194,increased circulating calcium level
MGI:5424975	Mhdabch8	MP:0000194,increased circulating calcium level
MGI:5424976	Mhdabch9	MP:0000194,increased circulating calcium level
MGI:3530531	Mhdacco2	MP:0000410,waved hair
MGI:2681723	Mhdadcc2	MP:0000373,belly spot|MP:0000585,kinked tail|MP:0005409,darkened coat color
MGI:2681792	Mhdadsk6	MP:0000575,increased foot pad pigmentation|MP:0000583,long toenails|MP:0011091,prenatal lethality, complete penetrance|MP:0011276,increased tail pigmentation
MGI:2682215	Mhdadsk8	MP:0000575,increased foot pad pigmentation|MP:0000579,abnormal nail morphology|MP:0005409,darkened coat color|MP:0011091,prenatal lethality, complete penetrance
MGI:2682717	Mhdakta1	MP:0000585,kinked tail
MGI:2682718	Mhdakta12	MP:0000585,kinked tail
MGI:2682719	Mhdakta18	MP:0000585,kinked tail
MGI:2682720	Mhdakta19	MP:0000373,belly spot|MP:0000585,kinked tail
MGI:2682721	Mhdakta20	MP:0000585,kinked tail
MGI:2682722	Mhdakta21	MP:0000585,kinked tail
MGI:2682723	Mhdakta24	MP:0000585,kinked tail
MGI:2682724	Mhdakta26	MP:0000585,kinked tail
MGI:2682725	Mhdakta28	MP:0000585,kinked tail
MGI:2682726	Mhdakta29	MP:0000585,kinked tail
MGI:2682727	Mhdakta30	MP:0000585,kinked tail
MGI:2682728	Mhdakta31	MP:0000585,kinked tail
MGI:2682729	Mhdakta32	MP:0000585,kinked tail
MGI:2682730	Mhdakta33	MP:0000585,kinked tail
MGI:2682731	Mhdakta35	MP:0000585,kinked tail
MGI:2682732	Mhdakta36	MP:0000585,kinked tail
MGI:2682733	Mhdakta38	MP:0000585,kinked tail
MGI:2682734	Mhdakta39	MP:0000585,kinked tail
MGI:2682735	Mhdakta5	MP:0000585,kinked tail
MGI:3530298	Mhdarco008	MP:0000410,waved hair|MP:0002073,abnormal hair growth|MP:0002075,abnormal coat/hair pigmentation
MGI:5425010	Mhdasca1	MP:0000194,increased circulating calcium level
MGI:2682768	Mhdasco6	MP:0000370,head blaze
MGI:2682770	Mhdasco7	MP:0000373,belly spot|MP:0002098,abnormal vibrissa morphology|MP:0009379,abnormal foot pigmentation|MP:0011277,decreased tail pigmentation
MGI:5752270	Mhdasma6	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation
MGI:2682782	Mhdawbe5	MP:0001394,circling
MGI:3530340	Mhdawbs010	MP:0002075,abnormal coat/hair pigmentation
MGI:2682860	Mhdawbs011	MP:0000373,belly spot
MGI:3530349	Mhdawbs1	MP:0000373,belly spot|MP:0000585,kinked tail|MP:0001262,decreased body weight
MGI:2682862	Mhdawbs3	MP:0000373,belly spot
MGI:3530586	Mhdawbs5	MP:0000373,belly spot
MGI:3530604	Mhdawbs9	MP:0002075,abnormal coat/hair pigmentation
MGI:3512498	Mhstq1<M. macedonius>	MP:0001147,small testis|MP:0001169,abnormal bulbourethral gland morphology|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002717,abnormal male preputial gland morphology|MP:0004852,decreased testis weight|MP:0008279,arrest of spermiogenesis|MP:0008545,absent sperm flagellum|MP:0009230,abnormal sperm head morphology
MGI:3512501	Mhstq2<M. macedonius>	MP:0001153,small seminiferous tubules|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0003179,thrombocytopenia|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0009230,abnormal sperm head morphology|MP:0009234,absent sperm head
MGI:5290109	Mia2<cpto>	MP:0000186,decreased circulating HDL cholesterol level|MP:0002644,decreased circulating triglyceride level|MP:0003976,decreased circulating VLDL triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:6358034	Mia2<tm1.1Zhxu>	MP:0013292,embryonic lethality prior to organogenesis
MGI:6358033	Mia2<tm1Zhxu>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0001265,decreased body size|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level
MGI:5007248	Mia3<tm1Lex>	MP:0000060,delayed bone ossification|MP:0000164,abnormal cartilage development|MP:0000166,abnormal chondrocyte morphology|MP:0000358,abnormal cell morphology|MP:0000445,short snout|MP:0000547,short limbs|MP:0001243,abnormal dermal layer morphology|MP:0001634,internal hemorrhage|MP:0001785,edema|MP:0001953,respiratory failure|MP:0002113,abnormal skeleton development|MP:0002427,disproportionate dwarf|MP:0003089,decreased skin tensile strength|MP:0004200,decreased fetal size|MP:0004989,decreased osteoblast cell number|MP:0005621,abnormal cell physiology|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0009780,abnormal chondrocyte physiology|MP:0010870,absent bone trabeculae|MP:0011089,perinatal lethality, complete penetrance|MP:0020138,delayed bone mineralization
MGI:2159701	Mia<tm1Rbu>	MP:0000166,abnormal chondrocyte morphology|MP:0005379,endocrine/exocrine gland phenotype|MP:0005390,skeleton phenotype|MP:0010771,integument phenotype
MGI:6148230	Miat<tm1Shna>	MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0020876,increased nervous system dopamine level|MP:0031303,enhanced behavioral response to methamphetamine|MP:0031391,increased locomotor activity
MGI:3607998	Mib1<tm1Art>	MP:0000269,abnormal heart looping|MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0001614,abnormal blood vessel morphology|MP:0001689,incomplete somite formation|MP:0001690,failure of somite differentiation|MP:0001691,abnormal somite shape|MP:0001787,pericardial edema|MP:0003229,abnormal vitelline vasculature morphology|MP:0003400,kinked neural tube|MP:0003424,premature neuronal precursor differentiation|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0006345,absent second pharyngeal arch|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3603514	Mib1<tm1Kong>	MP:0000260,abnormal angiogenesis|MP:0000262,poor arterial differentiation|MP:0000272,abnormal aorta morphology|MP:0000292,distended pericardium|MP:0000364,abnormal vascular regression|MP:0001718,abnormal visceral yolk sac morphology|MP:0002123,abnormal definitive hematopoiesis|MP:0002128,abnormal blood circulation|MP:0002151,abnormal neural tube morphology|MP:0002188,small heart|MP:0002825,abnormal notochord morphology|MP:0003400,kinked neural tube|MP:0003424,premature neuronal precursor differentiation|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004251,failure of heart looping|MP:0004787,abnormal dorsal aorta morphology|MP:0005223,abnormal dorsal-ventral polarity of the somites|MP:0006345,absent second pharyngeal arch|MP:0008029,abnormal paraxial mesoderm morphology|MP:0008762,embryonic lethality|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011733,fused somites|MP:0012253,abnormal intersomitic vessel morphology|MP:0012254,absent intersomitic vessels
MGI:3804448	Mib1<tm2Kong>	MP:0000364,abnormal vascular regression|MP:0000379,decreased hair follicle number|MP:0000564,syndactyly|MP:0000852,small cerebellum|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000952,abnormal CNS glial cell morphology|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001265,decreased body size|MP:0001719,absent vitelline blood vessels|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0003414,epidermal cyst|MP:0003815,hairless|MP:0003934,abnormal pancreas development|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004787,abnormal dorsal aorta morphology|MP:0005114,premature hair loss|MP:0005312,pericardial effusion|MP:0005385,cardiovascular system phenotype|MP:0006280,abnormal digit development|MP:0008730,fused phalanges|MP:0009163,absent pancreatic duct|MP:0009175,abnormal pancreatic beta cell differentiation|MP:0009719,reduced cerebellar foliation|MP:0009874,abnormal interdigital cell death|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014554,delayed neuronal migration
MGI:4431678	Mib2<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0002092,abnormal eye morphology|MP:0003961,decreased lean body mass|MP:0005566,decreased blood urea nitrogen level|MP:0008805,decreased circulating amylase level|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength
MGI:3652500	Mib2<tm1Art>	MP:0000914,exencephaly|MP:0011102,embryonic lethality, incomplete penetrance
MGI:3804450	Mib2<tm1Kong>	MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype
MGI:7610556	Mical1<tm1.1Past>	MP:0003631,nervous system phenotype
MGI:7610558	Mical1<tm1.2Past>	MP:0000358,abnormal cell morphology|MP:0002184,abnormal innervation|MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0004085,abnormal heartbeat|MP:0004769,abnormal synaptic vesicle morphology|MP:0005385,cardiovascular system phenotype|MP:0008415,abnormal neurite morphology|MP:0009538,abnormal synapse morphology|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0014744,abnormal hippocampal mossy fiber suprapyramidal bundle morphology|MP:0014745,abnormal hippocampal mossy fiber infrapyramidal bundle morphology
MGI:6156431	Mical2<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001126,abnormal ovary morphology|MP:0001297,microphthalmia|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002188,small heart|MP:0002989,small kidney|MP:0003961,decreased lean body mass|MP:0004906,enlarged uterus|MP:0009142,decreased prepulse inhibition|MP:0011874,enlarged urinary bladder
MGI:6188966	Mical3<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0001399,hyperactivity|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0004738,abnormal auditory brainstem response|MP:0005561,increased mean corpuscular hemoglobin
MGI:5708246	Micos13<tm1.1(KOMP)Vlcg>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000198,decreased circulating phosphate level|MP:0005179,decreased circulating cholesterol level|MP:0005554,decreased circulating creatinine level|MP:0005566,decreased blood urea nitrogen level
MGI:6158962	Micu1<em#Fink>	MP:0000854,abnormal cerebellum development|MP:0000913,abnormal brain development|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0002106,abnormal muscle physiology|MP:0003674,oxidative stress|MP:0005017,decreased B cell number|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0008174,decreased follicular B cell number|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008782,increased B cell apoptosis|MP:0009406,decreased skeletal muscle fiber number|MP:0009703,decreased birth body size|MP:0010053,decreased grip strength|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013405,increased circulating lactate level
MGI:6473467	Micu1<tm1bNarl>	MP:0000223,decreased monocyte cell number|MP:0000443,abnormal snout morphology|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0001697,abnormal embryo size|MP:0004357,long tibia|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008935,decreased mean platelet volume|MP:0010024,increased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011999,abnormal tail length
MGI:3531108	Micu2<Gt(OST409343)Lex>	MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0006036,abnormal mitochondrial physiology|MP:0008726,increased heart left atrium size|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009870,abnormal abdominal aorta morphology|MP:0011631,decreased mitochondrial size|MP:0012557,decreased calcium uptake by cardiac muscle|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0020419,decreased cardiac muscle relaxation|MP:0031274,increased susceptibility to induced aneurysm formation
MGI:4434182	Micu2<tm1a(EUCOMM)Wtsi>	MP:0005419,decreased circulating serum albumin level|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level
MGI:6152516	Micu3<em1(IMPC)Mbp>	MP:0002059,abnormal seminal vesicle morphology|MP:0003642,absent seminal vesicle|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount
MGI:6276957	Mid1<em1(IMPC)Mbp>	MP:0001289,persistence of hyaloid vascular system|MP:0002135,abnormal kidney morphology|MP:0002833,increased heart weight|MP:0002989,small kidney|MP:0003960,increased lean body mass|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount|MP:0020421,increased freezing behavior
MGI:5548557	Mid1ip1<tm1.1(KOMP)Vlcg>	MP:0002574,increased vertical activity|MP:0003917,increased kidney weight
MGI:5562687	Mid1<tm1Aash>	MP:0000780,abnormal corpus callosum morphology|MP:0005380,embryo phenotype|MP:0005404,abnormal axon morphology
MGI:4437430	Mid1<tm1Mero>	MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000885,ectopic Purkinje cell|MP:0000913,abnormal brain development|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001488,increased startle reflex|MP:0001524,impaired limb coordination|MP:0002063,abnormal learning/memory/conditioning|MP:0002152,abnormal brain morphology|MP:0002804,abnormal motor learning|MP:0003864,abnormal midbrain development|MP:0004096,abnormal midbrain-hindbrain boundary development|MP:0004097,abnormal cerebellar cortex morphology|MP:0005369,muscle phenotype|MP:0006097,abnormal cerebellar lobule formation|MP:0006104,abnormal tectum morphology|MP:0009038,decreased inferior colliculus size|MP:0009267,abnormal cerebellum fissure morphology|MP:0009964,abnormal cerebellum lobule morphology|MP:0009988,abnormal cerebellum vermis lobule I morphology|MP:0009989,abnormal cerebellum vermis lobule II morphology|MP:0009990,abnormal cerebellum vermis lobule III morphology|MP:0012132,abnormal midbrain-hindbrain boundary morphology
MGI:5548454	Mid2<tm1b(KOMP)Wtsi>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001192,scaly skin|MP:0002060,abnormal skin morphology
MGI:6479049	Mideas<em1Shmc>	MP:0000215,absent erythrocytes|MP:0000277,abnormal heart shape|MP:0000291,enlarged pericardium|MP:0002740,heart hypoplasia|MP:0004046,abnormal mitosis|MP:0004201,fetal growth retardation|MP:0005370,liver/biliary system phenotype|MP:0005387,immune system phenotype|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:6257757	Midn<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5287264	Midn<Tg(Tyr)2261EOve>	MP:0000111,cleft palate|MP:0001127,small ovary
MGI:6152517	Mief1<em1(IMPC)Mbp>	MP:0000639,abnormal adrenal gland morphology
MGI:4431567	Mier1<tm1a(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001512,trunk curl|MP:0001529,abnormal vocalization|MP:0002702,decreased circulating free fatty acids level|MP:0004924,abnormal behavior|MP:0005560,decreased circulating glucose level
MGI:6120739	Mif4gd<tm1b(KOMP)Wtsi>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0010123,increased bone mineral content
MGI:2176337	Mif<tm1Dvd>	MP:0002411,decreased susceptibility to bacterial infection|MP:0003037,increased myocardial infarct size|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005027,increased susceptibility to parasitic infection|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008699,increased interleukin-4 secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0031217,increased susceptibility to myocardial ischemic injury
MGI:2673280	Mif<tm1Gfr>	MP:0004499,increased incidence of tumors by chemical induction|MP:0004759,decreased mitotic index|MP:0010363,increased fibrosarcoma incidence|MP:0011704,decreased fibroblast proliferation
MGI:2661491	Mif<tm1Mky>	MP:0001845,abnormal inflammatory response|MP:0002169,no abnormal phenotype detected|MP:0002855,abnormal cochlear ganglion morphology|MP:0003009,abnormal cytokine secretion|MP:0004402,decreased cochlear outer hair cell number|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0005012,decreased eosinophil cell number|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3842525	Mif<tm2Gfr>	MP:0004499,increased incidence of tumors by chemical induction|MP:0011704,decreased fibroblast proliferation
MGI:5567110	Miga1<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0002757,decreased vertical activity|MP:0002968,increased circulating alkaline phosphatase level
MGI:4362858	Miga2<tm1a(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000208,decreased hematocrit|MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0000455,abnormal maxilla morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0002100,abnormal tooth morphology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002797,increased thigmotaxis|MP:0002874,decreased hemoglobin content|MP:0003961,decreased lean body mass|MP:0004924,abnormal behavior|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0005571,decreased lactate dehydrogenase level|MP:0005632,decreased circulating aspartate transaminase level|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0014414,increased depression-related behavior|MP:0014416,decreased social novelty preference
MGI:6112036	Miga2<tm1c(KOMP)Wtsi>	MP:0000685,abnormal immune system morphology|MP:0000818,abnormal amygdala morphology|MP:0001363,increased anxiety-related response|MP:0002152,abnormal brain morphology|MP:0002797,increased thigmotaxis|MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0009642,abnormal blood homeostasis|MP:0012479,increased amygdala size|MP:0014527,increased amino acid level|MP:0031487,increased circulating hypoxanthine level|MP:0031490,increased circulating xanthine level
MGI:5692852	Milr1<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0004924,abnormal behavior|MP:0010097,abnormal retina blood vessel morphology|MP:0020870,decreased thigmotaxis
MGI:4820795	Milr1<tm1Shib>	MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008765,decreased mast cell degranulation
MGI:5754580	Minar1<em1(IMPC)Tcp>	MP:0000703,abnormal thymus morphology
MGI:5637144	Minar2<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000198,decreased circulating phosphate level|MP:0001258,decreased body length|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0002757,decreased vertical activity|MP:0003244,loss of dopaminergic neurons|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005156,bradykinesia|MP:0005560,decreased circulating glucose level|MP:0006358,absent pinna reflex|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:4433829	Mindy1<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0002702,decreased circulating free fatty acids level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003313,abnormal locomotor activation|MP:0003442,decreased circulating glycerol level|MP:0005564,increased hemoglobin content
MGI:6149160	Mindy2<em1(IMPC)H>	MP:0003961,decreased lean body mass|MP:0005333,decreased heart rate|MP:0010024,increased total body fat amount|MP:0010123,increased bone mineral content|MP:0010506,prolonged RR interval
MGI:6149204	Mindy4<em1(IMPC)H>	MP:0001392,abnormal locomotor behavior
MGI:6156466	Mink1<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000702,enlarged lymph nodes|MP:0001297,microphthalmia|MP:0002060,abnormal skin morphology|MP:0002100,abnormal tooth morphology|MP:0002637,small uterus|MP:0003068,enlarged kidney
MGI:6474250	Mink1<tm1.2Lgrl>	MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0009446,abnormal platelet dense granule physiology|MP:0009549,decreased platelet aggregation|MP:0031120,decreased susceptibility to induced thrombosis
MGI:6865735	Minpp1<em1Vca>	MP:0002175,decreased brain weight|MP:0004811,abnormal neuron physiology|MP:0006254,thin cerebral cortex
MGI:2385788	Minpp1<tm1Prr>	MP:0002169,no abnormal phenotype detected
MGI:2178160	Minute	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002088,abnormal embryonic growth/weight/body size|MP:0003787,abnormal imprinting|MP:0003984,embryonic growth retardation|MP:0004201,fetal growth retardation|MP:0004257,abnormal placenta weight|MP:0004920,increased placenta weight|MP:0004921,decreased placenta weight|MP:0009429,decreased embryo weight|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011495,abnormal head shape
MGI:6887905	Mios<tm1Pfw>	MP:0000774,decreased brain size|MP:0000783,abnormal forebrain morphology|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008917,abnormal oligodendrocyte physiology|MP:0009808,decreased oligodendrocyte number|MP:0013438,dysmyelination
MGI:6267379	Miox<tm1Ysk>	MP:0005166,decreased susceptibility to injury|MP:0010181,decreased susceptibility to weight loss
MGI:1857104	Mip<Cat-Fr>	MP:0001304,cataract|MP:0001306,small lens|MP:0002840,abnormal lens fiber morphology
MGI:1857105	Mip<Cat-Lop>	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001306,small lens|MP:0002840,abnormal lens fiber morphology|MP:0010263,total cataract
MGI:2657065	Mip<Cat-Tohm>	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology|MP:0003237,abnormal lens epithelium morphology|MP:0031345,developmental cataract
MGI:1860482	Mip<Cts>	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001309,hydropic eye lens fibers|MP:0002840,abnormal lens fiber morphology|MP:0005545,abnormal lens development|MP:0011697,lens vacuoles|MP:0031345,developmental cataract
MGI:6276854	Mipep<em1(IMPC)Mbp>	MP:0001488,increased startle reflex|MP:0002965,increased circulating serum albumin level|MP:0009709,hydrometra|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:8190793	Mipep<tm1.1Yhig>	MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0001846,increased inflammatory response|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0002970,abnormal white adipose tissue morphology|MP:0002981,increased liver weight|MP:0004952,increased spleen weight|MP:0005018,decreased T cell number|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005425,increased macrophage cell number|MP:0005559,increased circulating glucose level|MP:0009124,increased brown fat cell lipid droplet size|MP:0011169,abnormal white fat cell differentation|MP:0011170,abnormal brown fat cell differentiation|MP:0011698,abnormal brown adipose tissue physiology|MP:0014146,decreased white adipose tissue mass|MP:0014396,decreased fat cell mitochondrial DNA content|MP:0014398,abnormal fat cell mitochondrial morphology|MP:0014433,increased cytokine level|MP:0020520,whitened brown adipose tissue morphology|MP:0031602,white adipose tissue inflammation
MGI:1861978	Mip<Gt(OST1231)Lex>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0005253,abnormal eye physiology
MGI:1856608	Mip<Hfi>	MP:0001309,hydropic eye lens fibers|MP:0010263,total cataract
MGI:5605791	Mipol1<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001402,decreased locomotor activity|MP:0002792,abnormal retina vasculature morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0009142,decreased prepulse inhibition|MP:0010097,abnormal retina blood vessel morphology|MP:0011886,increased circulating lipase level
MGI:6156328	Mir100<em1(IMPC)Kmpc>	MP:0002075,abnormal coat/hair pigmentation|MP:0011239,abnormal skin coloration
MGI:6393579	Mir100<em1Nju>	MP:0001860,liver inflammation|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0020427,increased hepatocyte karyomegaly
MGI:5567937	Mir10a<tm1.1Ahl>	MP:0002169,no abnormal phenotype detected
MGI:5314976	Mir10a<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:7564075	Mir10b<em1Rosay>	MP:0000488,abnormal intestinal epithelium morphology|MP:0001559,hyperglycemia|MP:0003304,large intestinal inflammation|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005455,increased susceptibility to weight gain|MP:0005658,increased susceptibility to diet-induced obesity|MP:0006001,abnormal intestinal transit time|MP:0009854,impaired gastric peristalsis|MP:0010155,abnormal intestine physiology
MGI:5314972	Mir10b<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:5448652	Mir122<tm1.1Apts>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000220,increased monocyte cell number|MP:0000598,abnormal liver morphology|MP:0001860,liver inflammation|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003333,liver fibrosis|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005425,increased macrophage cell number|MP:0008596,increased circulating interleukin-6 level|MP:0008990,abnormal Ito cell morphology|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0010398,decreased liver glycogen level
MGI:5448467	Mir122<tm1.1Kgh>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001570,abnormal circulating enzyme level|MP:0001860,liver inflammation|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003333,liver fibrosis|MP:0003721,increased tumor growth/size|MP:0004789,increased bile salt level|MP:0005179,decreased circulating cholesterol level|MP:0008596,increased circulating interleukin-6 level|MP:0009355,increased liver triglyceride level
MGI:5448466	Mir122<tm1.2Kgh>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000609,abnormal liver physiology|MP:0001570,abnormal circulating enzyme level|MP:0001860,liver inflammation|MP:0002118,abnormal lipid homeostasis|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003255,bile duct proliferation|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003333,liver fibrosis|MP:0004789,increased bile salt level|MP:0005179,decreased circulating cholesterol level|MP:0008019,increased liver tumor incidence|MP:0008560,increased tumor necrosis factor secretion|MP:0008596,increased circulating interleukin-6 level|MP:0008705,increased interleukin-6 secretion|MP:0009355,increased liver triglyceride level|MP:0010042,abnormal oval cell physiology|MP:0010398,decreased liver glycogen level|MP:0031116,microvesicular hepatic steatosis
MGI:5307015	Mir124a-1hg<tm1Tfur>	MP:0000774,decreased brain size|MP:0001006,abnormal retina cone cell morphology|MP:0001513,limb grasping|MP:0002175,decreased brain weight|MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0004022,abnormal cone electrophysiology|MP:0006072,abnormal retina apoptosis|MP:0008446,decreased retina cone cell number|MP:0009938,abnormal hippocampus granule cell morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:7461659	Mir124a-2<tm1.1Tfur>	MP:0002169,no abnormal phenotype detected
MGI:5314980	Mir124a-3<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:7461660	Mir124a-3<tm1.1Tfur>	MP:0002169,no abnormal phenotype detected
MGI:5770229	Mir125a<tm1Smoc>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004946,abnormal regulatory T cell physiology|MP:0004974,decreased regulatory T cell number|MP:0005387,immune system phenotype|MP:0008566,increased interferon-gamma secretion|MP:0008681,increased interleukin-17 secretion
MGI:7764896	Mir126a<tm2.1Smoc>	MP:0000691,enlarged spleen|MP:0001193,psoriasis|MP:0001194,dermatitis|MP:0001874,acanthosis|MP:0005501,abnormal skin physiology|MP:0008086,increased T-helper 1 cell number|MP:0008091,decreased T-helper 2 cell number|MP:0010219,increased T-helper 17 cell number
MGI:5789789	Mir127<tm1.1Acfs>	MP:0001716,abnormal placenta labyrinth morphology|MP:0001732,postnatal growth retardation|MP:0004201,fetal growth retardation|MP:0004265,abnormal placental transport|MP:0004920,increased placenta weight|MP:0004921,decreased placenta weight|MP:0009703,decreased birth body size|MP:0010768,mortality/aging|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011526,abnormal placenta fetal blood space morphology
MGI:5563794	Mir128-1<tm1.2Ans>	MP:0002169,no abnormal phenotype detected
MGI:5563796	Mir128-2<tm1.1Ans>	MP:0001399,hyperactivity|MP:0002064,seizures|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002574,increased vertical activity|MP:0005402,abnormal action potential|MP:0021019,increased dendritic spine number
MGI:5563797	Mir128-2<tm1.2Ans>	MP:0001399,hyperactivity|MP:0002064,seizures|MP:0002083,premature death|MP:0002574,increased vertical activity
MGI:5314981	Mir129-1<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:6156329	Mir129-2<em1(IMPC)Kmpc>	MP:0002075,abnormal coat/hair pigmentation|MP:0002764,short tibia|MP:0002833,increased heart weight|MP:0003961,decreased lean body mass|MP:0004174,abnormal spine curvature|MP:0004599,abnormal vertebral arch morphology|MP:0005293,impaired glucose tolerance|MP:0005567,decreased circulating total protein level|MP:0010024,increased total body fat amount|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:5314956	Mir130a<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:3822154	Mir133a-1<tm1.1Eno>	MP:0002169,no abnormal phenotype detected
MGI:3822152	Mir133a-1<tm1Eno>	MP:0002169,no abnormal phenotype detected
MGI:3822158	Mir133a-2<tm1.1Eno>	MP:0002169,no abnormal phenotype detected
MGI:5433550	Mir133b<tm1.2Gfng>	MP:0002169,no abnormal phenotype detected
MGI:5314945	Mir135b<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:5314982	Mir137<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:6118102	Mir137<tm1.2Mtm>	MP:0010768,mortality/aging|MP:0011092,embryonic lethality, complete penetrance
MGI:5314770	Mir137<tm1Mtm>	MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging|MP:0011092,embryonic lethality, complete penetrance
MGI:5314968	Mir138-1<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:5314983	Mir138-2<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:6370186	Mir139<em1Jwli>	MP:0004499,increased incidence of tumors by chemical induction|MP:0005036,diarrhea|MP:0008537,increased susceptibility to induced colitis|MP:0008713,abnormal cytokine level|MP:0008883,abnormal enterocyte proliferation|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0013298,increased susceptibility to colitis induced morbidity/mortality|MP:0013956,decreased colon length|MP:0014234,decreased enterocyte apoptosis
MGI:6359823	Mir140<em1Asah>	MP:0008525,decreased cranium height
MGI:6405410	Mir140<em1Tkob>	MP:0000060,delayed bone ossification|MP:0000164,abnormal cartilage development|MP:0000445,short snout|MP:0001265,decreased body size|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0004471,short nasal bone|MP:0004670,small vertebral body|MP:0006395,abnormal epiphyseal plate morphology|MP:0011175,platyspondylia|MP:0020137,decreased bone mineralization
MGI:4461000	Mir140<tm1.1Asah>	MP:0000097,short maxilla|MP:0000440,domed cranium|MP:0000445,short snout|MP:0001255,decreased body height|MP:0001262,decreased body weight|MP:0001533,abnormal skeleton physiology|MP:0001732,postnatal growth retardation|MP:0003560,osteoarthritis|MP:0003724,increased susceptibility to induced arthritis|MP:0004471,short nasal bone|MP:0004686,decreased length of long bones|MP:0005390,skeleton phenotype|MP:0005508,abnormal skeleton morphology|MP:0006396,decreased long bone epiphyseal plate size|MP:0009780,abnormal chondrocyte physiology
MGI:5086252	Mir140<tm1.1Tkob>	MP:0000445,short snout|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002113,abnormal skeleton development|MP:0002764,short tibia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0004462,small basisphenoid bone|MP:0004686,decreased length of long bones|MP:0006396,decreased long bone epiphyseal plate size|MP:0008525,decreased cranium height|MP:0010029,abnormal basicranium morphology
MGI:4059881	Mir142hg<Gt(IST11580H2)Tigm>	MP:0000219,increased neutrophil cell number|MP:0000691,enlarged spleen|MP:0002123,abnormal definitive hematopoiesis|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005461,abnormal dendritic cell morphology|MP:0008115,abnormal dendritic cell differentiation|MP:0008126,increased dendritic cell number|MP:0008127,decreased dendritic cell number|MP:0009278,abnormal bone marrow cell physiology
MGI:5752051	Mir142<tm1.1Sbel>	MP:0000221,decreased leukocyte cell number|MP:0000223,decreased monocyte cell number|MP:0002599,increased mean platelet volume|MP:0003179,thrombocytopenia|MP:0005012,decreased eosinophil cell number|MP:0005016,decreased lymphocyte cell number
MGI:5585622	Mir142<tm1Teyo>	MP:0008765,decreased mast cell degranulation|MP:0010768,mortality/aging
MGI:4359259	Mir143<tm1.1Eno>	MP:0004883,abnormal vascular wound healing
MGI:5319992	Mir143<tm1Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:4829379	Mir144/Mir451a<tm1.1Mjwe>	MP:0000693,spleen hyperplasia|MP:0001577,anemia|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002874,decreased hemoglobin content|MP:0004952,increased spleen weight|MP:0005097,polychromatophilia|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0008872,abnormal physiological response to xenobiotic|MP:0010067,increased red blood cell distribution width|MP:0011171,increased number of Heinz bodies|MP:0011594,decreased catalase activity
MGI:4829380	Mir144/Mir451a<tm1.1Mjwe>	MP:0000693,spleen hyperplasia|MP:0001577,anemia|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002874,decreased hemoglobin content|MP:0004952,increased spleen weight|MP:0005097,polychromatophilia|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0008872,abnormal physiological response to xenobiotic|MP:0010067,increased red blood cell distribution width|MP:0011171,increased number of Heinz bodies|MP:0011594,decreased catalase activity
MGI:4829617	Mir144/Mir451a<tm1.2Doca>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002642,anisocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010067,increased red blood cell distribution width
MGI:4829618	Mir144/Mir451a<tm1.2Doca>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002642,anisocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010067,increased red blood cell distribution width
MGI:4359260	Mir145a<tm1Eno>	MP:0001394,circling|MP:0001405,impaired coordination|MP:0001614,abnormal blood vessel morphology|MP:0002064,seizures|MP:0002834,decreased heart weight|MP:0002976,vascular smooth muscle hypotrophy|MP:0004876,decreased mean systemic arterial blood pressure|MP:0004883,abnormal vascular wound healing|MP:0005294,abnormal heart ventricle morphology|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:6359886	Mir146b<tm1.1Lfl>	MP:0005387,immune system phenotype
MGI:4882045	Mir146<tm1.1Bal>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000223,decreased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000321,increased bone marrow cell number|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001790,abnormal immune system physiology|MP:0001828,abnormal T cell activation|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002401,abnormal lymphopoiesis|MP:0002451,abnormal macrophage physiology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0004946,abnormal regulatory T cell physiology|MP:0004952,increased spleen weight|MP:0004973,increased regulatory T cell number|MP:0005000,abnormal immune tolerance|MP:0005016,decreased lymphocyte cell number|MP:0005649,increased spleen neoplasm incidence|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008657,increased interleukin-1 beta secretion|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0009317,increased follicular lymphoma incidence|MP:0009439,increased myeloid sarcoma incidence|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010373,myeloid hyperplasia|MP:0011076,increased macrophage nitric oxide production|MP:0011747,myelofibrosis
MGI:6359885	Mir146<tm1.1Lfl>	MP:0002493,increased IgG level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005387,immune system phenotype|MP:0008097,increased plasma cell number|MP:0008177,increased germinal center B cell number|MP:0008499,increased IgG1 level|MP:0010186,increased T follicular helper cell number
MGI:5463574	Mir146<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:5049868	Mir146<tm2.1Bal>	MP:0000208,decreased hematocrit|MP:0000223,decreased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001577,anemia|MP:0001790,abnormal immune system physiology|MP:0001828,abnormal T cell activation|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0002451,abnormal macrophage physiology|MP:0002874,decreased hemoglobin content|MP:0003179,thrombocytopenia|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004952,increased spleen weight|MP:0005000,abnormal immune tolerance|MP:0005016,decreased lymphocyte cell number|MP:0005088,increased acute inflammation|MP:0005387,immune system phenotype|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008481,increased spleen germinal center number|MP:0008483,increased spleen germinal center size|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008657,increased interleukin-1 beta secretion|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0009278,abnormal bone marrow cell physiology|MP:0009317,increased follicular lymphoma incidence|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010296,increased hemolymphoid system tumor incidence|MP:0010373,myeloid hyperplasia|MP:0011076,increased macrophage nitric oxide production
MGI:7544886	Mir147<tm1.2Xyn>	MP:0005387,immune system phenotype
MGI:6720859	Mir148a<tm2942.1Arte>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002459,abnormal B cell physiology|MP:0008097,increased plasma cell number|MP:0008098,decreased plasma cell number|MP:0008728,increased memory B cell number|MP:0013940,abnormal plasmablast number|MP:0020154,impaired humoral immune response
MGI:6731011	Mir148a<tm2942.2Arte>	MP:0002459,abnormal B cell physiology|MP:0003926,decreased cellular glucose uptake|MP:0008098,decreased plasma cell number
MGI:6455680	Mir149<em1Ydw>	MP:0003887,increased hepatocyte apoptosis|MP:0003893,increased hepatocyte proliferation|MP:0005343,increased circulating aspartate transaminase level|MP:0008735,increased susceptibility to endotoxin shock
MGI:3763431	Mir150<tm1Rsky>	MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0004977,increased B-1 B cell number|MP:0008207,decreased B-2 B cell number|MP:0008499,increased IgG1 level|MP:0008501,increased IgG2b level
MGI:3709881	Mir155<tm1.1Brd>	MP:0002376,abnormal dendritic cell physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002433,abnormal T-helper 1 cell morphology|MP:0004974,decreased regulatory T cell number|MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008090,increased T-helper 2 cell number|MP:0008495,decreased IgG1 level
MGI:5616592	Mir155<tm1.1Ggard>	MP:0002169,no abnormal phenotype detected
MGI:3763386	Mir155<tm1.1Rsky>	MP:0001800,abnormal humoral immune response|MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0003009,abnormal cytokine secretion|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004974,decreased regulatory T cell number|MP:0008178,decreased germinal center B cell number|MP:0008192,abnormal germinal center B cell physiology|MP:0008706,decreased interleukin-6 secretion|MP:0010220,decreased T-helper 17 cell number|MP:0010221,abnormal T-helper 17 cell differentiation|MP:0013771,decreased effector memory T-helper cell number
MGI:3709880	Mir155<tm1Brd>	MP:0001175,abnormal lung morphology|MP:0001806,decreased IgM level|MP:0001858,intestinal inflammation|MP:0001861,lung inflammation|MP:0002267,abnormal bronchiole morphology|MP:0002459,abnormal B cell physiology|MP:0003009,abnormal cytokine secretion|MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype
MGI:3709846	Mir155<tm1Rsky>	MP:0000685,abnormal immune system morphology|MP:0001790,abnormal immune system physiology|MP:0001800,abnormal humoral immune response|MP:0002378,abnormal gut-associated lymphoid tissue morphology|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0003009,abnormal cytokine secretion|MP:0004816,abnormal class switch recombination|MP:0008482,decreased spleen germinal center number|MP:0008484,decreased spleen germinal center size|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008660,increased interleukin-10 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008866,chromosomal instability
MGI:5576230	Mir181d<tm1.1Oers>	MP:0005015,increased T cell number|MP:0005387,immune system phenotype
MGI:5702430	Mir182<tm1.1Dgk>	MP:0002169,no abnormal phenotype detected
MGI:4359274	Mir182<tm1Iwai>	MP:0005391,vision/eye phenotype
MGI:6694196	Mir183<em1Jzb>	MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:5584322	Mir184<tm1Ics>	MP:0002079,increased circulating insulin level|MP:0003058,increased insulin secretion|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0009113,increased pancreatic beta cell mass|MP:0011819,increased pancreatic beta cell proliferation|MP:0013278,decreased fasting circulating glucose level
MGI:6363070	Mir185<em1Smoc>	MP:0000062,increased bone mineral density|MP:0005378,growth/size/body region phenotype|MP:0009347,increased trabecular bone thickness|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume|MP:0010933,decreased trabecular bone connectivity density|MP:0011584,increased alkaline phosphatase activity|MP:0011710,enhanced osteoblast differentiation|MP:0012072,decreased susceptibility to osteoporosis|MP:0013631,decreased bone trabecular spacing|MP:0020039,increased bone ossification|MP:0030438,increased osteoblast proliferation
MGI:5314975	Mir187<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:5763032	Mir188<em1Xhl>	MP:0002113,abnormal skeleton development|MP:0004149,increased bone strength|MP:0004988,increased osteoblast cell number|MP:0009115,abnormal fat cell morphology|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume|MP:0010878,increased trabecular bone volume|MP:0011168,abnormal fat cell differentiation|MP:0013621,decreased internal diameter of femur|MP:0013623,increased femur compact bone thickness|MP:0013631,decreased bone trabecular spacing|MP:0013640,increased bone stiffness|MP:0020039,increased bone ossification
MGI:5314984	Mir188<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:5648414	Mir18<tm1.1Aven>	MP:0002169,no abnormal phenotype detected
MGI:5568207	Mir192<tm1.1Rnat>	MP:0002135,abnormal kidney morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0006315,abnormal urine protein level|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0011338,abnormal mesangial matrix morphology
MGI:5517481	Mir193b<tm1.1Mam>	MP:0002169,no abnormal phenotype detected
MGI:5750969	Mir193b<tm1.2Mam>	MP:0009504,abnormal mammary gland epithelium morphology|MP:0010172,abnormal mammary gland epithelium physiology|MP:0012073,premature mammary gland growth during pregnancy
MGI:5314985	Mir194-2<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:6690843	Mir195a<tm1Narl>	MP:0031384,impaired blood-brain barrier function
MGI:7781896	Mir195b<em1Dfra>	MP:0005621,abnormal cell physiology
MGI:5315604	Mir196a-1<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:5805880	Mir196a-1<tm1.1Wtsi>	MP:0004672,short ribs|MP:0010113,abnormal sacrum morphology
MGI:5805881	Mir196a-2<tm1.1Wtsi>	MP:0004616,lumbar vertebral transformation|MP:0004617,sacral vertebral transformation|MP:0010113,abnormal sacrum morphology
MGI:5805882	Mir196b<tm1.1Wtsi>	MP:0004616,lumbar vertebral transformation|MP:0004617,sacral vertebral transformation|MP:0010113,abnormal sacrum morphology
MGI:5314987	Mir199a-1<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:6357166	Mir199a-2<tm1Kinn>	MP:0000745,tremors|MP:0000774,decreased brain size|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001492,abnormal pilomotor reflex|MP:0001951,abnormal breathing pattern|MP:0002083,premature death|MP:0002882,abnormal neuron morphology|MP:0008283,small hippocampus|MP:0009939,abnormal hippocampus neuron morphology
MGI:5575741	Mir1a-1<tm1Dsr>	MP:0001544,abnormal cardiovascular system physiology|MP:0003233,prolonged QT interval|MP:0003898,abnormal QRS complex|MP:0004070,abnormal P wave|MP:0004122,abnormal sinus arrhythmia|MP:0008022,dilated heart ventricle|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010768,mortality/aging|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance
MGI:5575740	Mir1a-2<tm1Dsr>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001544,abnormal cardiovascular system physiology|MP:0001787,pericardial edema|MP:0001855,abnormal atrial thrombosis|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0004937,dilated heart|MP:0005329,abnormal myocardium layer morphology|MP:0005333,decreased heart rate|MP:0010392,prolonged QRS complex duration|MP:0010402,ventricular septal defect|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010769,abnormal survival|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance
MGI:7511896	Mir202<em1Hncs>	MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002687,oligozoospermia|MP:0004901,decreased male germ cell number|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0008967,absent chiasmata formation|MP:0009451,abnormal chromosomal synapsis|MP:0009452,abnormal synaptonemal complex|MP:0011751,abnormal X-Y chromosome synapsis during male meiosis|MP:0014052,increased male germ cell apoptosis|MP:0020550,multinucleated giant male germ cells
MGI:5698058	Mir203<tm1.1Yir>	MP:0002169,no abnormal phenotype detected
MGI:5698456	Mir203<tm1.2Yir>	MP:0001200,thick skin|MP:0004499,increased incidence of tumors by chemical induction|MP:0010308,decreased tumor latency
MGI:7310317	Mir204<tm1Liam>	MP:0002136,abnormal kidney physiology|MP:0002871,albuminuria|MP:0003215,renal interstitial fibrosis|MP:0005165,increased susceptibility to injury|MP:0011316,abnormal kidney interlobular artery morphology|MP:0021052,abnormal renal arterial blood pressure regulation
MGI:6358377	Mir205<em1Oers>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype
MGI:6358384	Mir205hg<tm1.1Oers>	MP:0000706,small thymus|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0003631,nervous system phenotype|MP:0005121,decreased circulating prolactin level|MP:0005136,decreased growth hormone level|MP:0005376,homeostasis/metabolism phenotype
MGI:6358380	Mir205hg<tm1Oers>	MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0004956,decreased thymus weight
MGI:5314948	Mir205<tm1.1Mtm>	MP:0005121,decreased circulating prolactin level|MP:0005378,growth/size/body region phenotype|MP:0008762,embryonic lethality
MGI:5568716	Mir205<tm1.2Mtm>	MP:0001199,thin skin|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0003853,dry skin|MP:0003941,abnormal skin development|MP:0010771,integument phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5551770	Mir205<tm1.2Yir>	MP:0000367,abnormal coat/ hair morphology|MP:0000377,abnormal hair follicle morphology|MP:0000746,weakness|MP:0001218,thin epidermis|MP:0001663,abnormal digestive system physiology|MP:0003704,abnormal hair follicle development|MP:0005501,abnormal skin physiology|MP:0010771,integument phenotype|MP:0011085,postnatal lethality, complete penetrance
MGI:4418173	Mir206<tm1Eno>	MP:0004243,abnormal motor nerve collateral sprouting
MGI:4359822	Mir208a<tm1.1Dzw>	MP:0003896,prolonged PR interval|MP:0005385,cardiovascular system phenotype|MP:0010510,absent P wave|MP:0010519,atrioventricular block
MGI:3709980	Mir208a<tm1.1Eno>	MP:0001544,abnormal cardiovascular system physiology|MP:0003921,abnormal heart left ventricle morphology|MP:0004090,abnormal sarcomere morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005329,abnormal myocardium layer morphology
MGI:4442866	Mir208b<tm1.1Eno>	MP:0002169,no abnormal phenotype detected
MGI:5314949	Mir210<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:5555932	Mir210<tm1.1Wtsi>	MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004829,increased anti-chromatin antibody level|MP:0005387,immune system phenotype|MP:0008178,decreased germinal center B cell number
MGI:5314656	Mir210<tm1Mtm>	MP:0002135,abnormal kidney morphology|MP:0005367,renal/urinary system phenotype|MP:0011290,decreased nephron number
MGI:6275029	Mir214<tm1.1Eno>	MP:0000343,abnormal response to cardiac infarction|MP:0003037,increased myocardial infarct size|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0005385,cardiovascular system phenotype
MGI:6361469	Mir216a<em1Uf>	MP:0004761,increased susceptibility to induced pancreatitis|MP:0013221,pancreatic acinar-to-ductal metaplasia
MGI:6361472	Mir216a<em2Uf>	MP:0004761,increased susceptibility to induced pancreatitis|MP:0013221,pancreatic acinar-to-ductal metaplasia
MGI:6361477	Mir216b<em1Uf>	MP:0004761,increased susceptibility to induced pancreatitis|MP:0013221,pancreatic acinar-to-ductal metaplasia
MGI:6361480	Mir217<em1Uf>	MP:0004761,increased susceptibility to induced pancreatitis|MP:0013221,pancreatic acinar-to-ductal metaplasia
MGI:6361485	Mir217<em2Uf>	MP:0004761,increased susceptibility to induced pancreatitis|MP:0013221,pancreatic acinar-to-ductal metaplasia
MGI:5314974	Mir219a-2<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:4881915	Mir21a<tm1.1Eno>	MP:0002833,increased heart weight|MP:0005385,cardiovascular system phenotype
MGI:5302027	Mir21a<tm1.1Mer>	MP:0003009,abnormal cytokine secretion|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008566,increased interferon-gamma secretion|MP:0008663,increased interleukin-12 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008713,abnormal cytokine level|MP:0008750,abnormal interferon level|MP:0008751,abnormal interleukin level
MGI:5314971	Mir21a<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:5319685	Mir21a<tm1.1Sho>	MP:0004042,decreased susceptibility to kidney reperfusion injury
MGI:5514060	Mir21a<tm1.1Zqy>	MP:0000249,abnormal blood vessel physiology|MP:0003907,decreased aorta elastin content|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005591,decreased vasodilation|MP:0006263,decreased systemic arterial diastolic blood pressure|MP:0010468,abnormal thoracic aorta morphology|MP:0011640,abnormal aorta collagen fibril morphology
MGI:5014257	Mir21a<tm1Yoli>	MP:0004502,decreased incidence of tumors by chemical induction|MP:0005501,abnormal skin physiology|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010639,abnormal tumor pathology
MGI:3811186	Mir223<tm1Fcam>	MP:0000219,increased neutrophil cell number|MP:0000322,increased granulocyte number|MP:0001861,lung inflammation|MP:0002415,abnormal neutrophil differentiation|MP:0002462,abnormal granulocyte physiology|MP:0002463,abnormal neutrophil physiology|MP:0005088,increased acute inflammation
MGI:5317341	Mir22<tm1.1Arod>	MP:0001544,abnormal cardiovascular system physiology|MP:0003141,cardiac fibrosis|MP:0005140,decreased cardiac muscle contractility|MP:0005385,cardiovascular system phenotype|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:5585450	Mir22<tm1.2Dzw>	MP:0004485,increased response of heart to induced stress|MP:0004486,decreased response of heart to induced stress|MP:0005385,cardiovascular system phenotype
MGI:6274717	Mir22<tm1Boet>	MP:0001262,decreased body weight|MP:0001783,decreased white adipose tissue amount|MP:0002702,decreased circulating free fatty acids level|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005668,decreased circulating leptin level|MP:0009133,decreased white fat cell size|MP:0014171,increased fatty acid oxidation
MGI:5314978	Mir23b<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:6287970	Mir27a<em1Bge>	MP:0002411,decreased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0008469,abnormal protein level|MP:0014537,increased calcium level|MP:0030941,enhanced autophagy
MGI:6455505	Mir29a<em1Smoc>	MP:0001663,abnormal digestive system physiology|MP:0003043,hypoalgesia
MGI:5817372	Mir301<tm1Yoli>	MP:0002052,decreased tumor incidence|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005671,abnormal response to transplant
MGI:7738842	Mir30a<em1Hars>	MP:0005666,abnormal adipose tissue physiology
MGI:5314959	Mir30c-1<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:5314955	Mir30e<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:6358205	Mir31<em1Nju>	MP:0000627,abnormal mammary gland morphology|MP:0000628,abnormal mammary gland development|MP:0001881,abnormal mammary gland physiology|MP:0004135,abnormal mammary gland embryonic development|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0009506,abnormal mammary gland alveolus morphology|MP:0013716,hypolactation|MP:0013782,abnormal mammary duct terminal end bud morphology
MGI:6358206	Mir31<tm1.1Smoc>	MP:0000628,abnormal mammary gland development|MP:0009506,abnormal mammary gland alveolus morphology
MGI:5314966	Mir320<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:5319975	Mir320<tm1Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5314988	Mir322<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:7386874	Mir324<em1Dayn>	MP:0002206,abnormal CNS synaptic transmission
MGI:5463397	Mir325<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:7734949	Mir326<em1Qiuj>	MP:0003204,decreased neuron apoptosis|MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury
MGI:7302297	Mir32<em1Gpt>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000609,abnormal liver physiology|MP:0002891,increased insulin sensitivity|MP:0002942,decreased circulating alanine transaminase level|MP:0003402,decreased liver weight|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005632,decreased circulating aspartate transaminase level|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level|MP:0013245,abnormal lipid metabolism|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis|MP:0031601,decreased endoplasmic reticulum stress
MGI:6403348	Mir338<em1Zchn>	MP:0004985,decreased osteoclast cell number|MP:0009278,abnormal bone marrow cell physiology|MP:0009347,increased trabecular bone thickness|MP:0010878,increased trabecular bone volume
MGI:5314954	Mir339<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:4837623	Mir33<tm1.1Koho>	MP:0001556,increased circulating HDL cholesterol level|MP:0002451,abnormal macrophage physiology|MP:0005178,increased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis
MGI:5305966	Mir34a<tm1.1Aven>	MP:0004948,abnormal neuronal precursor proliferation
MGI:5308792	Mir34a<tm1.1Lhe>	MP:0005384,cellular phenotype|MP:0005621,abnormal cell physiology
MGI:5751473	Mir34a<tm1.2Arte>	MP:0000716,abnormal immune system cell morphology|MP:0000745,tremors|MP:0001406,abnormal gait|MP:0001489,decreased startle reflex|MP:0002574,increased vertical activity|MP:0003043,hypoalgesia|MP:0005014,increased B cell number|MP:0005389,reproductive system phenotype|MP:0005574,decreased pulmonary respiratory rate|MP:0005576,decreased pulmonary ventilation|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0010768,mortality/aging
MGI:5320795	Mir34a<tm1.2Aven>	MP:0002169,no abnormal phenotype detected
MGI:5293762	Mir34a<tm1Hher>	MP:0004499,increased incidence of tumors by chemical induction
MGI:5320061	Mir350<tm1Wtsi>	MP:0003921,abnormal heart left ventricle morphology
MGI:3842147	Mir375<tm1Stf>	MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002710,increased glucagon secretion|MP:0002712,increased circulating glucagon level|MP:0003058,increased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0003383,abnormal gluconeogenesis|MP:0005215,abnormal pancreatic islet morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005559,increased circulating glucose level|MP:0009114,decreased pancreatic beta cell mass|MP:0009176,increased pancreatic alpha cell number|MP:0009254,disorganized pancreatic islets
MGI:5448834	Mir378a<tm1.1Eno>	MP:0001552,increased circulating triglyceride level|MP:0001783,decreased white adipose tissue amount|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0006036,abnormal mitochondrial physiology|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009133,decreased white fat cell size|MP:0010025,decreased total body fat amount|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:6724587	Mir378b<em#Yoo>	MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008722,abnormal chemokine secretion|MP:0020186,abnormal susceptibility to bacterial infection|MP:0031424,enhanced female fertility
MGI:7435009	Mir379<em1Rnat>	MP:0002136,abnormal kidney physiology|MP:0008872,abnormal physiological response to xenobiotic
MGI:7616225	Mir409<em1Iclb>	MP:0003038,decreased myocardial infarct size|MP:0003710,abnormal physiological neovascularization|MP:0031216,decreased susceptibility to myocardial ischemic injury
MGI:6369665	Mir425<em1Nju>	MP:0003244,loss of dopaminergic neurons|MP:0008560,increased tumor necrosis factor secretion|MP:0009747,impaired behavioral response to xenobiotic|MP:0011451,increased susceptibility to dopaminergic neuron neurotoxicity
MGI:6360139	Mir449a<em1Xzhg>	MP:0002169,no abnormal phenotype detected
MGI:6360140	Mir449a<em2Xzhg>	MP:0002169,no abnormal phenotype detected
MGI:4829620	Mir451a<tm1.2Doca>	MP:0000208,decreased hematocrit|MP:0000691,enlarged spleen|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002875,decreased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0010067,increased red blood cell distribution width
MGI:4829385	Mir451a<tm1Eno>	MP:0000691,enlarged spleen|MP:0001586,abnormal erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0011241,abnormal fetal derived definitive erythrocyte cell number
MGI:6694021	Mir455<em1Zhizh>	MP:0000163,abnormal cartilage morphology|MP:0000166,abnormal chondrocyte morphology
MGI:7543974	Mir485<em1Ycao>	MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0009119,increased brown fat cell size|MP:0009128,decreased brown fat cell number
MGI:7782629	Mir497<em1Hgyu>	MP:0008537,increased susceptibility to induced colitis
MGI:4442864	Mir499<tm1.1Eno>	MP:0002169,no abnormal phenotype detected
MGI:7567435	Mir501<tm1Rchen>	MP:0003461,abnormal response to novel object|MP:0012006,abnormal hippocampus physiology|MP:0014256,decreased paired-pulse inhibition|MP:0014378,increased excitatory postsynaptic current frequency|MP:0020335,abnormal dentate gyrus neuron dendrite morphology|MP:0020395,abnormal response to social novelty|MP:0020508,decreased dendritic spine density|MP:0021009,abnormal synaptic physiology|MP:0021111,decreased social investigation
MGI:7494278	Mir503hg<em1Jina>	MP:0000231,hypertension|MP:0000274,enlarged heart|MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003915,increased heart left ventricle weight|MP:0004564,increased myocardial fiber size|MP:0005385,cardiovascular system phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0021157,increased heart left ventricle wall thickness
MGI:6444855	Mir505<em1Xhj>	MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001934,increased litter size|MP:0002681,increased corpora lutea number|MP:0002865,increased growth rate|MP:0003378,early sexual maturation|MP:0004514,dystocia|MP:0004855,increased ovary weight|MP:0004904,increased uterus weight|MP:0008994,early vaginal opening
MGI:6393612	Mir511<em1Clib>	MP:0002451,abnormal macrophage physiology|MP:0005381,digestive/alimentary phenotype|MP:0008539,decreased susceptibility to induced colitis
MGI:7712843	Mir582<em1Minz>	MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004979,abnormal neuronal precursor cell number|MP:0012203,abnormal neuronal stem cell morphology|MP:0012207,decreased neuronal stem cell self-renewal
MGI:7310355	Mir592<em1Jzhan>	MP:0000136,abnormal microglial cell morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001405,impaired coordination|MP:0001441,increased grooming behavior|MP:0001730,embryonic growth arrest|MP:0002797,increased thigmotaxis|MP:0003203,increased neuron apoptosis|MP:0003354,astrocytosis|MP:0003461,abnormal response to novel object|MP:0003861,abnormal nervous system development|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0008948,decreased neuron number|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011827,impaired neuron differentiation|MP:0012065,increased astrocyte number|MP:0020395,abnormal response to social novelty|MP:0021111,decreased social investigation
MGI:5314957	Mir688<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:5314941	Mir7-2<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:6477601	Mir743<em1Utr>	MP:0005389,reproductive system phenotype
MGI:5314964	Mir7b<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:6456808	Mir802<em3Gpt>	MP:0001560,abnormal circulating insulin level|MP:0002079,increased circulating insulin level|MP:0003058,increased insulin secretion|MP:0003645,increased pancreatic beta cell number|MP:0005292,improved glucose tolerance|MP:0009175,abnormal pancreatic beta cell differentiation
MGI:5314967	Mir9-1<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:5648466	Mir92-1<tm1.1Aven>	MP:0002169,no abnormal phenotype detected
MGI:5706715	Mir92-1<tm1.1Sdim>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002543,brachyphalangia|MP:0002764,short tibia|MP:0005352,small cranium|MP:0005385,cardiovascular system phenotype|MP:0005390,skeleton phenotype|MP:0005397,hematopoietic system phenotype|MP:0009431,decreased fetal weight|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5706713	Mir92-1<tm1Sdim>	MP:0010768,mortality/aging
MGI:7302312	Mir92b<em22Gpt>	MP:0000759,abnormal skeletal muscle morphology|MP:0002891,increased insulin sensitivity|MP:0003960,increased lean body mass|MP:0005292,improved glucose tolerance|MP:0005369,muscle phenotype|MP:0010238,increased skeletal muscle weight|MP:0010401,increased skeletal muscle glycogen level|MP:0012107,enhanced exercise endurance|MP:0014143,decreased body fat mass
MGI:5750948	Mir9-2hg<tm1Cpp>	MP:0002169,no abnormal phenotype detected
MGI:5314973	Mir9-2<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:4949252	Mir9-2<tm1Sia>	MP:0002083,premature death|MP:0003631,nervous system phenotype
MGI:4949259	Mir9-3<tm1Sia>	MP:0001925,male infertility|MP:0001926,female infertility|MP:0003631,nervous system phenotype
MGI:4354110	Mir96<Dmdo>	MP:0001394,circling|MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0001485,abnormal pinna reflex|MP:0001967,deafness|MP:0004362,cochlear hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004408,decreased cochlear hair cell number|MP:0004416,absent cochlear nerve compound action potential|MP:0004417,decreased cochlear nerve compound action potential|MP:0004516,fused vestibular hair cell stereocilia|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0006325,impaired hearing|MP:0006358,absent pinna reflex
MGI:5817459	Mir96<tm2.1Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:3719204	Mirb<SWR/J>	MP:0005638,hemochromatosis
MGI:6117136	Mirc11<tm1Rdhl>	MP:0001602,impaired myelopoiesis|MP:0002144,abnormal B cell differentiation|MP:0005014,increased B cell number|MP:0005387,immune system phenotype|MP:0008097,increased plasma cell number|MP:0008173,increased follicular B cell number|MP:0008186,increased pro-B cell number|MP:0008210,increased mature B cell number|MP:0008214,increased immature B cell number|MP:0008813,decreased common myeloid progenitor cell number|MP:0009922,increased transitional stage T1 B cell number|MP:0011815,increased pre-pro B cell number|MP:0013662,decreased myeloid cell number|MP:0013892,increased common lymphocyte progenitor cell number
MGI:5296851	Mirc12<tm1.1Doca>	MP:0002416,abnormal proerythroblast morphology|MP:0005397,hematopoietic system phenotype|MP:0011178,increased erythroblast number
MGI:5315598	Mirc13<tm1.1Mtm>	MP:0003402,decreased liver weight|MP:0004777,abnormal phospholipid level|MP:0004789,increased bile salt level|MP:0005266,abnormal metabolism|MP:0005286,decreased saturated fatty acids level|MP:0005378,growth/size/body region phenotype|MP:0009356,decreased liver triglyceride level|MP:0009823,abnormal sphingomyelin level|MP:0010768,mortality/aging|MP:0011075,abnormal macrophage activation involved in immune response|MP:0013245,abnormal lipid metabolism|MP:0013278,decreased fasting circulating glucose level|MP:0014608,abnormal lipid transport|MP:0020582,increased ceramide level|MP:0020868,decreased lipogenesis|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:6828804	Mirc13<tm1Biat>	MP:0000188,abnormal circulating glucose level|MP:0002078,abnormal glucose homeostasis|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0014116,abnormal pancreatic beta cell apoptosis
MGI:5315148	Mirc13<tm1Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5515722	Mirc14<tm1.1Ankr>	MP:0002145,abnormal T cell differentiation|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0008036,abnormal NK T cell morphology|MP:0008040,decreased NK T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008399,abnormal alpha-beta intraepithelial T cell morphology|MP:0008567,decreased interferon-gamma secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008700,decreased interleukin-4 secretion
MGI:5467776	Mirc14<tm1.1Czc>	MP:0001823,thymus hypoplasia|MP:0005092,decreased double-positive T cell number
MGI:5528987	Mirc14<tm1.1Flv>	MP:0008040,decreased NK T cell number
MGI:5467791	Mirc14<tm1.2Czc>	MP:0000715,decreased thymocyte number|MP:0005017,decreased B cell number|MP:0005092,decreased double-positive T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008178,decreased germinal center B cell number|MP:0008181,increased marginal zone B cell number|MP:0009828,increased tumor latency|MP:0010134,decreased DN3 thymocyte number
MGI:5528993	Mirc14<tm1.2Flv>	MP:0000715,decreased thymocyte number|MP:0002145,abnormal T cell differentiation|MP:0002444,abnormal T cell physiology|MP:0005017,decreased B cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0008040,decreased NK T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008754,abnormal T cell receptor V(D)J recombination|MP:0009542,decreased thymocyte apoptosis|MP:0010130,decreased DN1 thymic pro-T cell number
MGI:5467793	Mirc15<tm1.2Czc>	MP:0005387,immune system phenotype
MGI:5528992	Mirc15<tm1.2Flv>	MP:0002169,no abnormal phenotype detected
MGI:5467795	Mirc16<tm1.2Czc>	MP:0005387,immune system phenotype|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:5528991	Mirc16<tm1.2Flv>	MP:0002169,no abnormal phenotype detected
MGI:5521494	Mirc19<tm1.1Arte>	MP:0002169,no abnormal phenotype detected
MGI:4868242	Mirc19<tm1.1Kcho>	MP:0003718,maternal effect|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0006270,abnormal mammary gland growth during lactation|MP:0009503,abnormal mammary gland duct morphology|MP:0009506,abnormal mammary gland alveolus morphology|MP:0013716,hypolactation|MP:0014057,abnormal mammary gland stroma morphology
MGI:5521495	Mirc19<tm1.2Arte>	MP:0002912,abnormal excitatory postsynaptic potential|MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0008143,abnormal dendrite morphology
MGI:4868401	Mirc19<tm1Rhg>	MP:0008143,abnormal dendrite morphology
MGI:5648400	Mirc1<tm1.1Aven>	MP:0000060,delayed bone ossification|MP:0000692,small spleen|MP:0001262,decreased body weight|MP:0002543,brachyphalangia|MP:0004609,vertebral fusion|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0005017,decreased B cell number|MP:0005221,abnormal rostral-caudal axis patterning|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008782,increased B cell apoptosis|MP:0008915,fused carpal bones|MP:0011090,perinatal lethality, incomplete penetrance|MP:0012765,decreased alpha-beta T cell number|MP:0013662,decreased myeloid cell number
MGI:3793628	Mirc1<tm1.1Tyj>	MP:0002169,no abnormal phenotype detected
MGI:3790968	Mirc1<tm1.2Tyj>	MP:0000060,delayed bone ossification|MP:0000111,cleft palate|MP:0000281,abnormal interventricular septum morphology|MP:0000284,double outlet right ventricle|MP:0000433,microcephaly|MP:0000564,syndactyly|MP:0001178,pulmonary hypoplasia|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0002144,abnormal B cell differentiation|MP:0002543,brachyphalangia|MP:0003036,vertebral transformation|MP:0003419,delayed endochondral bone ossification|MP:0003420,delayed intramembranous bone ossification|MP:0003649,decreased heart right ventricle size|MP:0003855,abnormal forelimb zeugopod morphology|MP:0003857,abnormal hindlimb zeugopod morphology|MP:0004609,vertebral fusion|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004620,cervical vertebral fusion|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005306,abnormal phalanx morphology|MP:0008209,decreased pre-B cell number|MP:0008782,increased B cell apoptosis|MP:0008915,fused carpal bones|MP:0009429,decreased embryo weight|MP:0010402,ventricular septal defect|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance
MGI:3795517	Mirc1<tm1.3Tyj>	MP:0000281,abnormal interventricular septum morphology|MP:0001178,pulmonary hypoplasia|MP:0001698,decreased embryo size|MP:0002144,abnormal B cell differentiation|MP:0008209,decreased pre-B cell number|MP:0008782,increased B cell apoptosis|MP:0009429,decreased embryo weight|MP:0011087,neonatal lethality, complete penetrance
MGI:3795513	Mirc1<tm1Tyj>	MP:0008209,decreased pre-B cell number|MP:0008760,abnormal immunoglobulin heavy chain V(D)J recombination|MP:0008782,increased B cell apoptosis
MGI:5648458	Mirc1<tm2.1Aven>	MP:0004609,vertebral fusion|MP:0005017,decreased B cell number|MP:0011090,perinatal lethality, incomplete penetrance|MP:0013662,decreased myeloid cell number
MGI:5648471	Mirc1<tm3.1Aven>	MP:0000060,delayed bone ossification|MP:0000692,small spleen|MP:0001262,decreased body weight|MP:0002543,brachyphalangia|MP:0003036,vertebral transformation|MP:0004609,vertebral fusion|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0005017,decreased B cell number|MP:0005221,abnormal rostral-caudal axis patterning|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008782,increased B cell apoptosis|MP:0008915,fused carpal bones|MP:0011090,perinatal lethality, incomplete penetrance|MP:0012765,decreased alpha-beta T cell number|MP:0013662,decreased myeloid cell number
MGI:5648475	Mirc1<tm4.1Aven>	MP:0000060,delayed bone ossification|MP:0000111,cleft palate|MP:0001178,pulmonary hypoplasia|MP:0001262,decreased body weight|MP:0002543,brachyphalangia|MP:0004609,vertebral fusion|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0005306,abnormal phalanx morphology|MP:0008915,fused carpal bones|MP:0011089,perinatal lethality, complete penetrance
MGI:5795955	Mirc20<tm1.1Blel>	MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0003424,premature neuronal precursor differentiation|MP:0004980,increased neuronal precursor cell number|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012702,increased embryonic neuroepithelium thickness|MP:0012705,increased embryonic neuroepithelial cell proliferation|MP:0014134,abnormal embryo morphology|MP:0014178,increased brain apoptosis
MGI:5792833	Mirc20<tm1.1Eem>	MP:0005385,cardiovascular system phenotype
MGI:5320799	Mirc21<tm1.1Aven>	MP:0002169,no abnormal phenotype detected
MGI:5427919	Mirc21<tm1.1Kry>	MP:0000062,increased bone mineral density|MP:0002113,abnormal skeleton development|MP:0002896,abnormal bone mineralization|MP:0004148,increased compact bone thickness|MP:0004988,increased osteoblast cell number|MP:0005390,skeleton phenotype|MP:0005605,increased bone mass|MP:0010964,increased compact bone volume|MP:0011710,enhanced osteoblast differentiation|MP:0030438,increased osteoblast proliferation
MGI:5308794	Mirc21<tm1.1Lhe>	MP:0005621,abnormal cell physiology
MGI:6287756	Mirc23<tm1.1Shbk>	MP:0005391,vision/eye phenotype
MGI:5315535	Mirc25<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:5315533	Mirc26<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:7411323	Mirc27<em1Hhzg>	MP:0002006,neoplasm|MP:0005387,immune system phenotype
MGI:5315600	Mirc27<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:5315601	Mirc28<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:5451058	Mirc29<tm1.1Cwh>	MP:0005387,immune system phenotype
MGI:5315603	Mirc29<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:6367595	Mirc29<tm1.1Wtsi>	MP:0001262,decreased body weight|MP:0003622,ischuria|MP:0005385,cardiovascular system phenotype
MGI:3790966	Mirc2<tm1.1Tyj>	MP:0002169,no abnormal phenotype detected
MGI:3795501	Mirc2<tm1Tyj>	MP:0002169,no abnormal phenotype detected
MGI:7411324	Mirc30<em1Hhzg>	MP:0003132,increased pre-B cell number|MP:0004952,increased spleen weight|MP:0005014,increased B cell number|MP:0005068,abnormal NK cell morphology|MP:0008186,increased pro-B cell number|MP:0010337,increased chronic lymphocytic leukemia incidence
MGI:5315605	Mirc30<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:4437043	Mirc30<tm1.1Rdf>	MP:0002023,increased B cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0005014,increased B cell number|MP:0008167,increased B-1a cell number|MP:0008478,increased spleen white pulp amount
MGI:4437041	Mirc30<tm1.2Rdf>	MP:0002023,increased B cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0005014,increased B cell number|MP:0005153,abnormal B cell proliferation|MP:0008167,increased B-1a cell number|MP:0008478,increased spleen white pulp amount
MGI:5560203	Mirc31<tm1.1Aru>	MP:0000477,abnormal intestine morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000496,abnormal small intestine morphology|MP:0013486,decreased Paneth cell number
MGI:5315606	Mirc31<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:5569518	Mirc31<tm1.1Sjm>	MP:0003631,nervous system phenotype
MGI:5648483	Mirc32<tm1.1Jtm>	MP:0000495,abnormal colon morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000512,intestinal ulcer|MP:0001652,colonic necrosis|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0008537,increased susceptibility to induced colitis|MP:0020148,abnormal susceptibility to induced morbidity/mortality|MP:0031319,impaired intestine regeneration
MGI:4359265	Mirc32<tm1.2Eno>	MP:0001394,circling|MP:0001405,impaired coordination|MP:0001614,abnormal blood vessel morphology|MP:0002064,seizures|MP:0002976,vascular smooth muscle hypotrophy|MP:0004883,abnormal vascular wound healing|MP:0005592,abnormal vascular smooth muscle morphology|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5648485	Mirc32<tm1.2Jtm>	MP:0000495,abnormal colon morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000512,intestinal ulcer|MP:0001652,colonic necrosis|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0008537,increased susceptibility to induced colitis|MP:0020148,abnormal susceptibility to induced morbidity/mortality|MP:0031319,impaired intestine regeneration
MGI:4443000	Mirc32<tm1Gcon>	MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005595,abnormal vascular smooth muscle physiology|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0009865,abnormal aorta smooth muscle morphology|MP:0009872,abnormal aorta tunica intima morphology|MP:0009873,abnormal aorta tunica media morphology
MGI:5648481	Mirc32<tm1Jtm>	MP:0002169,no abnormal phenotype detected
MGI:4359903	Mirc32<tm1Thbr>	MP:0002191,abnormal artery morphology|MP:0002891,increased insulin sensitivity|MP:0002976,vascular smooth muscle hypotrophy|MP:0003026,decreased vasoconstriction|MP:0004883,abnormal vascular wound healing|MP:0005292,improved glucose tolerance|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006263,decreased systemic arterial diastolic blood pressure|MP:0006264,decreased systemic arterial systolic blood pressure
MGI:7264934	Mirc33<em1Smoc>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0001935,decreased litter size|MP:0002636,delayed vaginal opening|MP:0002680,decreased corpora lutea number|MP:0002773,decreased circulating luteinizing hormone level|MP:0003348,hypopituitarism|MP:0003355,decreased ovulation rate|MP:0003507,abnormal ovary physiology|MP:0004856,decreased ovary weight|MP:0004905,decreased uterus weight|MP:0005133,increased luteinizing hormone level|MP:0005185,decreased circulating progesterone level|MP:0005319,abnormal enzyme/coenzyme level|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005646,abnormal pituitary gland physiology|MP:0008546,abnormal vesicle-mediated transport|MP:0009011,prolonged diestrus|MP:0009018,short estrus|MP:0009047,short metestrus|MP:0009647,decreased fertilization frequency|MP:0014602,decreased female mating frequency|MP:0020848,abnormal exocytosis
MGI:5451057	Mirc33<tm1.1Cwh>	MP:0000694,spleen hypoplasia|MP:0001823,thymus hypoplasia|MP:0002083,premature death|MP:0002223,lymphoid hypoplasia|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0008037,abnormal T cell morphology|MP:0008086,increased T-helper 1 cell number|MP:0008101,lymph node hypoplasia|MP:0008566,increased interferon-gamma secretion|MP:0008681,increased interleukin-17 secretion
MGI:6367594	Mirc33<tm1.1Wtsi>	MP:0000160,kyphosis|MP:0000231,hypertension|MP:0000266,abnormal heart morphology|MP:0000272,abnormal aorta morphology|MP:0000484,abnormal pulmonary artery morphology|MP:0000539,distended urinary bladder|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001505,hunched posture|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0001924,infertility|MP:0002001,blindness|MP:0002083,premature death|MP:0003622,ischuria|MP:0003630,abnormal urothelium morphology|MP:0005165,increased susceptibility to injury|MP:0005258,ocular hypertension|MP:0005554,decreased circulating creatinine level|MP:0009269,decreased fat cell size|MP:0009871,abnormal aorta tunica adventitia morphology|MP:0010996,increased aorta wall thickness|MP:0011628,increased mitochondrial number|MP:0011631,decreased mitochondrial size|MP:0030937,increased mitochondrial DNA content
MGI:5312902	Mirc33<tm1Bdes>	MP:0001824,abnormal thymus involution
MGI:6696374	Mirc34<em1Jnch>	MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:5469885	Mirc34<tm1.1Cxu>	MP:0005389,reproductive system phenotype
MGI:3881348	Mirc35hg<Gt(D016D06)Wrst>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001006,abnormal retina cone cell morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001326,retina degeneration|MP:0001393,ataxia|MP:0001394,circling|MP:0001406,abnormal gait|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0005653,phototoxicity|MP:0008446,decreased retina cone cell number|MP:0008515,thin retina outer nuclear layer|MP:0009538,abnormal synapse morphology
MGI:7539557	Mirc35<tm1.1Pern>	MP:0000972,abnormal mechanoreceptor morphology|MP:0020954,decreased mechanical nociceptive threshold
MGI:5614047	Mirc36<tm1.1Jcav>	MP:0000189,hypoglycemia|MP:0001436,abnormal suckling behavior|MP:0001732,postnatal growth retardation|MP:0002078,abnormal glucose homeostasis|MP:0003458,decreased circulating ketone body level|MP:0003564,abnormal insulin secretion|MP:0005560,decreased circulating glucose level|MP:0010400,increased liver glycogen level|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5902976	Mirc37<tm1Boet>	MP:0002169,no abnormal phenotype detected
MGI:3790969	Mirc3<tm1.1Tyj>	MP:0011091,prenatal lethality, complete penetrance
MGI:3795503	Mirc3<tm1Tyj>	MP:0002169,no abnormal phenotype detected
MGI:6150922	Mirc40<tm1Jzb>	MP:0001006,abnormal retina cone cell morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008515,thin retina outer nuclear layer|MP:0010097,abnormal retina blood vessel morphology|MP:0014333,short retina cone cell outer segment|MP:0020448,increased microglial cell activation
MGI:6359860	Mirc53<tm1.1Gning>	MP:0005166,decreased susceptibility to injury
MGI:6765923	Mirc54<tm1.1Syu>	MP:0002644,decreased circulating triglyceride level|MP:0002891,increased insulin sensitivity|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009133,decreased white fat cell size|MP:0009356,decreased liver triglyceride level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3826824	Mirc55<tm1.1Cjku>	MP:0001786,skin edema|MP:0001914,hemorrhage|MP:0005602,decreased angiogenesis|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3809690	Mirc55<tm1.1Eno>	MP:0000259,abnormal vascular development|MP:0000343,abnormal response to cardiac infarction|MP:0001176,abnormal lung development|MP:0001245,thick dermal layer|MP:0001785,edema|MP:0001914,hemorrhage|MP:0001923,reduced female fertility|MP:0002792,abnormal retina vasculature morphology|MP:0003131,increased erythrocyte cell number|MP:0005602,decreased angiogenesis|MP:0006055,abnormal vascular endothelial cell morphology|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0020316,decreased vascular endothelial cell proliferation
MGI:5285428	Mirc5<tm1Jae>	MP:0001127,small ovary|MP:0001672,abnormal embryo development|MP:0001688,abnormal somite development|MP:0001926,female infertility|MP:0002209,decreased germ cell number|MP:0002216,abnormal seminiferous tubule morphology|MP:0002621,delayed neural tube closure|MP:0002777,absent ovarian follicles|MP:0002982,abnormal primordial germ cell migration|MP:0003984,embryonic growth retardation|MP:0004188,delayed embryo turning|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0005431,decreased oocyte number|MP:0008392,decreased primordial germ cell number|MP:0008871,abnormal ovarian follicle number|MP:0009656,delayed chorioallantoic fusion|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011121,decreased primordial ovarian follicle number
MGI:5315602	Mirc6<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:5907298	Mirc6<tm1.1Mzhu>	MP:0002169,no abnormal phenotype detected|MP:0003123,paternal imprinting|MP:0004087,abnormal muscle fiber morphology|MP:0009461,skeletal muscle hypertrophy
MGI:5314965	Mirlet7d<tm1.1Mtm>	MP:0010768,mortality/aging
MGI:5441069	Mis18a<tm1.2Kiik>	MP:0004046,abnormal mitosis|MP:0004965,inner cell mass degeneration|MP:0008877,abnormal DNA methylation|MP:0009850,embryonic lethality between implantation and placentation|MP:0012113,decreased inner cell mass proliferation|MP:0013504,increased embryonic tissue cell apoptosis
MGI:4432385	Mis18bp1<tm1a(EUCOMM)Wtsi>	MP:0002111,abnormal tail morphology
MGI:7330166	Misfadt<em1Psv>	MP:0001125,abnormal oocyte morphology|MP:0005389,reproductive system phenotype
MGI:7432687	Misfa<em1Kei>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0009237,kinked sperm flagellum|MP:0009647,decreased fertilization frequency
MGI:7432732	Misfa<em2Kei>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0009647,decreased fertilization frequency
MGI:7432755	Misfa<em5Kei>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0009237,kinked sperm flagellum|MP:0009647,decreased fertilization frequency|MP:0009832,abnormal sperm mitochondrial sheath morphology
MGI:7486552	Misp<em2Nsas>	MP:0000512,intestinal ulcer|MP:0003292,melena|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005381,digestive/alimentary phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0008751,abnormal interleukin level|MP:0008838,decreased transforming growth factor beta level|MP:0008883,abnormal enterocyte proliferation|MP:0010180,increased susceptibility to weight loss|MP:0014222,decreased colon goblet cell number|MP:0031319,impaired intestine regeneration
MGI:7388256	Mitd1<em1(IMPC)J>	MP:0003961,decreased lean body mass
MGI:1856085	Mitf<Mi>	MP:0000031,abnormal cochlea morphology|MP:0000048,abnormal stria vascularis morphology|MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000336,decreased mast cell number|MP:0000373,belly spot|MP:0001265,decreased body size|MP:0001286,abnormal eye development|MP:0001297,microphthalmia|MP:0001333,absent optic nerve|MP:0002075,abnormal coat/hair pigmentation|MP:0002082,postnatal lethality|MP:0002423,abnormal mast cell physiology|MP:0002622,abnormal cochlear hair cell morphology|MP:0002938,white spotting|MP:0002939,head spot|MP:0003169,abnormal scala media morphology|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0005098,abnormal optic choroid morphology|MP:0005099,abnormal ciliary body morphology|MP:0005103,abnormal retina pigmentation|MP:0005171,absent coat pigmentation|MP:0005172,decreased eye pigmentation|MP:0005176,eyelids fail to open|MP:0005195,abnormal posterior eye segment morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005262,coloboma|MP:0005508,abnormal skeleton morphology|MP:0005541,abnormal iris stromal pigmentation|MP:0006069,abnormal retina neuronal layer morphology|MP:0006089,abnormal vestibular saccule morphology|MP:0008770,decreased survivor rate|MP:0010070,decreased serotonin level
MGI:1856086	Mitf<Mi-b>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0001325,abnormal retina morphology|MP:0003798,abnormal Harderian gland pigmentation|MP:0005100,abnormal choroid pigmentation|MP:0005171,absent coat pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005253,abnormal eye physiology|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation|MP:0014164,abnormal ciliary process morphology|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:1856089	Mitf<mi-bw>	MP:0000048,abnormal stria vascularis morphology|MP:0000394,absent hair follicle melanin granules|MP:0001963,abnormal hearing physiology|MP:0004364,thin stria vascularis|MP:0005171,absent coat pigmentation|MP:0006010,absent strial intermediate cells|MP:0009783,abnormal melanoblast morphology|MP:0009784,abnormal melanoblast migration|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012023,decreased melanocyte number
MGI:1857423	Mitf<mi-bws>	MP:0002938,white spotting
MGI:1856532	Mitf<mi-ce>	MP:0000026,abnormal inner ear morphology|MP:0001286,abnormal eye development|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001324,abnormal eye pigmentation|MP:0001927,abnormal estrous cycle|MP:0002161,abnormal fertility/fecundity|MP:0002622,abnormal cochlear hair cell morphology|MP:0004364,thin stria vascularis|MP:0005172,decreased eye pigmentation
MGI:2662140	Mitf<Mi-Crc>	MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0001297,microphthalmia|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002940,variable body spotting|MP:0005102,abnormal iris pigmentation|MP:0005171,absent coat pigmentation|MP:0005172,decreased eye pigmentation|MP:0005175,non-pigmented tail tip|MP:0005176,eyelids fail to open
MGI:1856090	Mitf<mi-di>	MP:0000067,osteopetrosis|MP:0000689,abnormal spleen morphology|MP:0001004,abnormal retina photoreceptor morphology|MP:0001297,microphthalmia|MP:0002356,abnormal spleen red pulp morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002359,abnormal spleen germinal center morphology|MP:0002699,abnormal vitreous body morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0005171,absent coat pigmentation|MP:0005172,decreased eye pigmentation|MP:0008585,absent photoreceptor outer segment|MP:0009772,abnormal retina development
MGI:1857751	Mitf<mi-enu122>	MP:0000372,irregular coat pigmentation|MP:0001297,microphthalmia|MP:0005103,abnormal retina pigmentation|MP:0005172,decreased eye pigmentation|MP:0009379,abnormal foot pigmentation|MP:0011277,decreased tail pigmentation
MGI:2148646	Mitf<mi-enu198>	MP:0001297,microphthalmia|MP:0005171,absent coat pigmentation|MP:0005172,decreased eye pigmentation|MP:0008480,absent eye pigmentation
MGI:6162028	Mitf<mi-enu22(398)>	MP:0000373,belly spot|MP:0002938,white spotting|MP:0005391,vision/eye phenotype
MGI:3040389	Mitf<mi-enu5>	MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0001297,microphthalmia|MP:0001382,abnormal nursing|MP:0001485,abnormal pinna reflex|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002938,white spotting|MP:0002939,head spot|MP:0005171,absent coat pigmentation|MP:0005390,skeleton phenotype|MP:0006358,absent pinna reflex
MGI:1856094	Mitf<mi-ew>	MP:0000067,osteopetrosis|MP:0001297,microphthalmia|MP:0005171,absent coat pigmentation|MP:0009877,exostosis
MGI:2178353	Mitf<Mi-H>	MP:0000372,irregular coat pigmentation|MP:0001293,anophthalmia|MP:0001322,abnormal iris morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0002095,abnormal skin pigmentation|MP:0005171,absent coat pigmentation|MP:0009379,abnormal foot pigmentation|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:2175885	Mitf<Mi-Mee>	MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0004269,abnormal optic cup morphology|MP:0005102,abnormal iris pigmentation|MP:0005103,abnormal retina pigmentation|MP:0005171,absent coat pigmentation|MP:0005172,decreased eye pigmentation|MP:0006243,impaired pupillary reflex|MP:0011697,lens vacuoles
MGI:3040390	Mitf<mi-Mhdabcc2>	MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0001297,microphthalmia|MP:0001382,abnormal nursing|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002938,white spotting|MP:0002939,head spot|MP:0005171,absent coat pigmentation
MGI:1856087	Mitf<Mi-Or>	MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000133,abnormal long bone metaphysis morphology|MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001541,abnormal osteoclast physiology|MP:0001926,female infertility|MP:0002083,premature death|MP:0002939,head spot|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0004686,decreased length of long bones|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0004985,decreased osteoclast cell number|MP:0005171,absent coat pigmentation|MP:0005172,decreased eye pigmentation|MP:0005176,eyelids fail to open|MP:0005358,abnormal incisor morphology|MP:0005422,osteosclerosis|MP:0006395,abnormal epiphyseal plate morphology|MP:0010932,increased trabecular bone connectivity density|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:1856091	Mitf<mi-rw>	MP:0001297,microphthalmia|MP:0001324,abnormal eye pigmentation|MP:0002075,abnormal coat/hair pigmentation|MP:0002697,abnormal eye size|MP:0005172,decreased eye pigmentation
MGI:1856092	Mitf<mi-sp>	MP:0001186,pigmentation phenotype|MP:0005408,hypopigmentation
MGI:1858053	Mitf<mi-tg>	MP:0001297,microphthalmia|MP:0002423,abnormal mast cell physiology|MP:0002877,abnormal melanocyte morphology|MP:0004381,abnormal hair follicle melanocyte morphology|MP:0005102,abnormal iris pigmentation|MP:0005171,absent coat pigmentation|MP:0006226,iris hypoplasia|MP:0010070,decreased serotonin level|MP:0013743,ciliary body hypoplasia
MGI:2449916	Mitf<mi-vga9>	MP:0001297,microphthalmia|MP:0005171,absent coat pigmentation|MP:0005201,abnormal retina pigment epithelium morphology
MGI:1856095	Mitf<mi-vit>	MP:0000371,diluted coat color|MP:0000377,abnormal hair follicle morphology|MP:0002877,abnormal melanocyte morphology|MP:0002938,white spotting|MP:0003099,retina detachment|MP:0004021,abnormal rod electrophysiology|MP:0004201,fetal growth retardation|MP:0005102,abnormal iris pigmentation|MP:0005103,abnormal retina pigmentation|MP:0005171,absent coat pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005362,abnormal Langerhans cell physiology|MP:0008447,absent retina cone cells|MP:0008450,retina photoreceptor degeneration|MP:0008454,absent retina rod cells|MP:0010016,variable depigmentation
MGI:1856088	Mitf<Mi-wh>	MP:0000031,abnormal cochlea morphology|MP:0000048,abnormal stria vascularis morphology|MP:0000371,diluted coat color|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002622,abnormal cochlear hair cell morphology|MP:0002938,white spotting|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0005098,abnormal optic choroid morphology|MP:0005102,abnormal iris pigmentation|MP:0005103,abnormal retina pigmentation|MP:0005171,absent coat pigmentation|MP:0005172,decreased eye pigmentation|MP:0005195,abnormal posterior eye segment morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005390,skeleton phenotype|MP:0005607,decreased bleeding time|MP:0006069,abnormal retina neuronal layer morphology|MP:0006089,abnormal vestibular saccule morphology|MP:0006159,ocular albinism|MP:0009379,abnormal foot pigmentation|MP:0011277,decreased tail pigmentation|MP:0012535,abnormal optic fissure closure
MGI:1856093	Mitf<Mi-ws>	MP:0000373,belly spot|MP:0001286,abnormal eye development|MP:0001297,microphthalmia|MP:0001324,abnormal eye pigmentation|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0002697,abnormal eye size|MP:0002938,white spotting|MP:0005171,absent coat pigmentation|MP:0005172,decreased eye pigmentation
MGI:2662152	Mitf<mi-x>	MP:0001324,abnormal eye pigmentation|MP:0002075,abnormal coat/hair pigmentation
MGI:2148647	Mitf<mi-x39>	MP:0000372,irregular coat pigmentation|MP:0000373,belly spot|MP:0001297,microphthalmia|MP:0005171,absent coat pigmentation|MP:0005172,decreased eye pigmentation
MGI:2178357	Mitf<Rorp>	MP:0000371,diluted coat color|MP:0001325,abnormal retina morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002546,mydriasis|MP:0005102,abnormal iris pigmentation|MP:0005171,absent coat pigmentation|MP:0005262,coloboma|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:6287154	Mitf<Tg(Tff3-Tmem207)2Tamo>	MP:0001859,kidney inflammation|MP:0002705,dilated renal tubule|MP:0003215,renal interstitial fibrosis|MP:0003327,liver cyst|MP:0003336,pancreas cyst|MP:0004194,abnormal kidney pelvis morphology|MP:0004755,abnormal loop of Henle morphology|MP:0005553,increased circulating creatinine level|MP:0008528,polycystic kidney|MP:0011346,renal tubule atrophy|MP:0011501,increased glomerular capsule space
MGI:3774160	Mitf<tm1.1Arnh>	MP:0005366,variegated coat color
MGI:3774164	Mitf<tm1.2Arnh>	MP:0003171,phenotypic reversion
MGI:3774153	Mitf<tm1Arnh>	MP:0000372,irregular coat pigmentation|MP:0005171,absent coat pigmentation|MP:0005391,vision/eye phenotype
MGI:5050699	Mitf<tm3.1Arnh>	MP:0002169,no abnormal phenotype detected
MGI:5050701	Mitf<tm4.1Arnh>	MP:0001186,pigmentation phenotype
MGI:5050700	Mitf<tm4Arnh>	MP:0000373,belly spot|MP:0005391,vision/eye phenotype
MGI:5050703	Mitf<tm5.1Arnh>	MP:0001186,pigmentation phenotype
MGI:5050702	Mitf<tm5Arnh>	MP:0001186,pigmentation phenotype|MP:0005391,vision/eye phenotype
MGI:5050705	Mitf<tm6.1Arnh>	MP:0001186,pigmentation phenotype
MGI:5050704	Mitf<tm6Arnh>	MP:0000373,belly spot|MP:0005391,vision/eye phenotype
MGI:5050706	Mitf<tm7Arnh>	MP:0000373,belly spot|MP:0005391,vision/eye phenotype
MGI:3603632	Mity	MP:0001257,increased body length|MP:0006087,increased body mass index
MGI:3054823	mix	MP:0000043,organ of Corti degeneration|MP:0001394,circling|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0001925,male infertility|MP:0001961,abnormal reflex|MP:0001967,deafness|MP:0003168,abnormal scala vestibuli morphology|MP:0003637,cochlear ganglion hypoplasia|MP:0004324,vestibular hair cell degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004363,stria vascularis degeneration|MP:0004403,absent cochlear outer hair cells|MP:0005307,head tossing|MP:0006013,absent endolymphatic sac|MP:0006021,abnormal Reissner membrane morphology
MGI:7641808	Mix23<em1Osb>	MP:0005389,reproductive system phenotype
MGI:2387829	Mixl1<tm1.1Robb>	MP:0000474,abnormal foregut morphology|MP:0001672,abnormal embryo development|MP:0001688,abnormal somite development|MP:0002085,abnormal embryonic tissue morphology|MP:0002231,abnormal primitive streak morphology|MP:0002825,abnormal notochord morphology|MP:0004556,enlarged allantois|MP:0004837,abnormal neural fold formation|MP:0004838,abnormal neural fold elevation formation|MP:0005029,abnormal amnion morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0009331,absent primitive node|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012081,absent heart tube|MP:0012086,absent hindgut|MP:0012173,short rostral-caudal axis|MP:0012183,decreased paraxial mesoderm size|MP:0012739,abnormal anterior primitive streak morphology
MGI:2387828	Mixl1<tm1Robb>	MP:0000474,abnormal foregut morphology|MP:0001672,abnormal embryo development|MP:0001688,abnormal somite development|MP:0002085,abnormal embryonic tissue morphology|MP:0002231,abnormal primitive streak morphology|MP:0002825,abnormal notochord morphology|MP:0004556,enlarged allantois|MP:0004838,abnormal neural fold elevation formation|MP:0005029,abnormal amnion morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0009331,absent primitive node|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011256,abnormal neural fold morphology|MP:0011260,abnormal head mesenchyme morphology|MP:0012081,absent heart tube|MP:0012086,absent hindgut|MP:0012173,short rostral-caudal axis|MP:0012183,decreased paraxial mesoderm size|MP:0012739,abnormal anterior primitive streak morphology
MGI:5695662	Mki67<em1Dfis>	MP:0003721,increased tumor growth/size|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005387,immune system phenotype
MGI:7490173	Mki67<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0002060,abnormal skin morphology|MP:0002590,increased mean corpuscular volume|MP:0002606,increased basophil cell number|MP:0002875,decreased erythrocyte cell number|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005561,increased mean corpuscular hemoglobin|MP:0010067,increased red blood cell distribution width
MGI:5661511	Mki67<tm1.1Cle>	MP:0002169,no abnormal phenotype detected
MGI:3608879	Mkks<Gt(OST367255)Lex>	MP:0000914,exencephaly|MP:0001302,eyelids open at birth|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004512,anosmia|MP:0004737,absent distortion product otoacoustic emissions|MP:0006358,absent pinna reflex|MP:0008789,abnormal olfactory epithelium morphology|MP:0030962,abnormal inner hair cell kinocilium location or orientation|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:3526444	Mkks<tm1Vcs>	MP:0001261,obese|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001925,male infertility|MP:0001984,abnormal olfaction|MP:0002842,increased systemic arterial blood pressure|MP:0005371,limbs/digits/tail phenotype|MP:0005656,decreased aggression|MP:0005669,increased circulating leptin level|MP:0006254,thin cerebral cortex|MP:0008283,small hippocampus|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0008545,absent sperm flagellum|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012468,decreased striatum size|MP:0020351,decreased vocalization|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:4321123	Mkln1<Gt(OST448976)Lex>	MP:0000371,diluted coat color|MP:0003245,abnormal GABAergic neuron morphology|MP:0003631,nervous system phenotype|MP:0012006,abnormal hippocampus physiology
MGI:3052673	Mknk1<tm1Fuku>	MP:0002169,no abnormal phenotype detected
MGI:3052675	Mknk2<tm1Fuku>	MP:0002169,no abnormal phenotype detected
MGI:3665258	Mkrn1<Gt(RRB087)Byg>	MP:0002169,no abnormal phenotype detected
MGI:6140212	Mkrn2<em1(IMPC)Wtsi>	MP:0001925,male infertility|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:6163817	Mkrn2<tm1.1Bhj>	MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0008839,absent acrosome|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0014633,decreased spermatid number|MP:0014685,spermiation failure|MP:0031356,abnormal outer dense fiber morphology|MP:0031389,abnormal ectoplasmic specialization morphology
MGI:5548531	Mkrn2<tm1b(KOMP)Wtsi>	MP:0001925,male infertility|MP:0004738,abnormal auditory brainstem response|MP:0005343,increased circulating aspartate transaminase level|MP:0013410,decreased dendritic epidermal T cell number
MGI:6156558	Mkrn3<em1(IMPC)Tcp>	MP:0013278,decreased fasting circulating glucose level
MGI:6704950	Mkrn3<em1Rhu>	MP:0001262,decreased body weight|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001927,abnormal estrous cycle|MP:0003122,maternal imprinting|MP:0003378,early sexual maturation|MP:0008994,early vaginal opening|MP:0031399,early balanopreputial separation
MGI:4821832	Mks1<avc6>	MP:0002081,perinatal lethality|MP:0010413,complete atrioventricular septal defect
MGI:4887578	Mks1<hlb614>	MP:0000111,cleft palate|MP:0000157,abnormal sternum morphology|MP:0000428,abnormal craniofacial morphology|MP:0000440,domed cranium|MP:0000448,pointed snout|MP:0000460,mandible hypoplasia|MP:0000562,polydactyly|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0000690,absent spleen|MP:0000925,abnormal floor plate morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002151,abnormal neural tube morphology|MP:0002188,small heart|MP:0002622,abnormal cochlear hair cell morphology|MP:0002828,abnormal renal glomerular capsule morphology|MP:0003068,enlarged kidney|MP:0003327,liver cyst|MP:0003342,accessory spleen|MP:0003675,kidney cyst|MP:0004017,duplex kidney|MP:0004110,transposition of great arteries|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0004252,abnormal direction of heart looping|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0005170,cleft upper lip|MP:0005312,pericardial effusion|MP:0005388,respiratory system phenotype|MP:0006198,enophthalmos|MP:0008272,abnormal endochondral bone ossification|MP:0009743,preaxial polydactyly|MP:0010772,abnormal pollex morphology|MP:0010807,abnormal stomach position or orientation|MP:0011998,decreased embryonic cilium length|MP:0012093,absent nodal flow|MP:0012667,split sternal manubrium|MP:0013197,decreased embryonic cilium number|MP:0020383,decreased kidney epithelial cell primary cilium length
MGI:4410614	Mks1<krc>	MP:0000078,abnormal supraoccipital bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000109,abnormal parietal bone morphology|MP:0000111,cleft palate|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000269,abnormal heart looping|MP:0000522,kidney cortex cyst|MP:0000572,abnormal autopod morphology|MP:0000914,exencephaly|MP:0000925,abnormal floor plate morphology|MP:0001178,pulmonary hypoplasia|MP:0001891,hydrocephaly|MP:0002151,abnormal neural tube morphology|MP:0002160,abnormal reproductive system morphology|MP:0002928,abnormal bile duct morphology|MP:0002929,abnormal bile duct development|MP:0003068,enlarged kidney|MP:0003582,abnormal ovary development|MP:0003670,dilated renal glomerular capsule|MP:0003723,abnormal long bone morphology|MP:0003942,abnormal urinary system development|MP:0004131,abnormal motile primary cilium morphology|MP:0004133,heterotaxia|MP:0004252,abnormal direction of heart looping|MP:0004321,short sternum|MP:0004450,presphenoid bone hypoplasia|MP:0004539,absent maxilla|MP:0004624,abnormal thoracic cage morphology|MP:0004686,decreased length of long bones|MP:0004860,dilated kidney collecting duct|MP:0008528,polycystic kidney|MP:0009743,preaxial polydactyly|MP:0010977,fused right lung lobes|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011293,dilated nephron|MP:0011344,abnormal loop of Henle ascending limb thick segment morphology|MP:0011727,ectopic ovary|MP:0013203,abnormal primary cilium morphology
MGI:4433029	Mks1<tm1a(EUCOMM)Wtsi>	MP:0000084,abnormal fontanelle morphology|MP:0000274,enlarged heart|MP:0000351,increased cell proliferation|MP:0000358,abnormal cell morphology|MP:0000413,polyphalangy|MP:0000562,polydactyly|MP:0000579,abnormal nail morphology|MP:0000644,dextrocardia|MP:0000788,abnormal cerebral cortex morphology|MP:0000866,cerebellum vermis hypoplasia|MP:0000928,incomplete rostral neuropore closure|MP:0001178,pulmonary hypoplasia|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001300,ocular hypertelorism|MP:0001575,cyanosis|MP:0001700,abnormal embryo turning|MP:0001785,edema|MP:0001891,hydrocephaly|MP:0002092,abnormal eye morphology|MP:0002102,abnormal ear morphology|MP:0002152,abnormal brain morphology|MP:0002639,micrognathia|MP:0002766,situs inversus|MP:0003052,omphalocele|MP:0003068,enlarged kidney|MP:0003178,left pulmonary isomerism|MP:0003203,increased neuron apoptosis|MP:0003232,abnormal forebrain development|MP:0003333,liver fibrosis|MP:0003675,kidney cyst|MP:0003723,abnormal long bone morphology|MP:0004686,decreased length of long bones|MP:0005170,cleft upper lip|MP:0005269,abnormal occipital bone morphology|MP:0005537,abnormal cerebral aqueduct morphology|MP:0008534,enlarged fourth ventricle|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008547,abnormal neocortex morphology|MP:0009743,preaxial polydactyly|MP:0011059,abnormal ependyma motile cilium morphology|MP:0011066,abnormal renal tubule epithelial cell primary cilium morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011440,increased kidney cell proliferation|MP:0014274,decreased respiration|MP:0014278,semilobar holoprosencephaly|MP:0030309,abnormal posterior cranial fossa morphology
MGI:4461224	Mkx<tm1.1Asah>	MP:0005503,abnormal tendon morphology
MGI:5287572	Mkx<tm1.2Jian>	MP:0005503,abnormal tendon morphology|MP:0013179,wavy tail|MP:0030799,abnormal tendon sheath morphology
MGI:4461226	Mkx<tm1Asah>	MP:0005503,abnormal tendon morphology
MGI:4887450	Mkx<tm1Miu>	MP:0005503,abnormal tendon morphology
MGI:1856957	ml	MP:0000920,abnormal myelination|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5476663	Mlana<tm1.2Bee>	MP:0000367,abnormal coat/ hair morphology|MP:0000371,diluted coat color|MP:0001186,pigmentation phenotype|MP:0004381,abnormal hair follicle melanocyte morphology
MGI:5548766	Mlc1<tm1.1(KOMP)Vlcg>	MP:0001120,abnormal uterus morphology|MP:0002176,increased brain weight
MGI:7526308	Mlc1<tm1.1(tetO)Kftnk>	MP:0000780,abnormal corpus callosum morphology|MP:0001393,ataxia|MP:0002182,abnormal astrocyte morphology|MP:0003354,astrocytosis|MP:0003871,abnormal myelin sheath morphology|MP:0005389,reproductive system phenotype|MP:0008025,brain vacuoles|MP:0008026,abnormal brain white matter morphology|MP:0008489,slow postnatal weight gain
MGI:6105932	Mlc1<tm1.1Vdk>	MP:0002176,increased brain weight|MP:0002182,abnormal astrocyte morphology|MP:0003871,abnormal myelin sheath morphology|MP:0005238,increased brain size|MP:0005386,behavior/neurological phenotype|MP:0008025,brain vacuoles|MP:0008916,abnormal astrocyte physiology|MP:0011854,cerebral edema
MGI:5618264	Mlc1<tm1.2Nune>	MP:0003690,abnormal glial cell physiology|MP:0003871,abnormal myelin sheath morphology|MP:0008025,brain vacuoles|MP:0008917,abnormal oligodendrocyte physiology
MGI:7526307	Mlc1<tm1(tetO)Kftnk>	MP:0000849,abnormal cerebellum morphology|MP:0001785,edema|MP:0002182,abnormal astrocyte morphology|MP:0003871,abnormal myelin sheath morphology|MP:0005386,behavior/neurological phenotype|MP:0008025,brain vacuoles|MP:0008026,abnormal brain white matter morphology
MGI:3701687	Mlca1<DBA/2J>	MP:0031391,increased locomotor activity
MGI:3701689	Mlca2<DBA/2J>	MP:0031391,increased locomotor activity
MGI:7612218	Mldhr<em1Zhgn>	MP:0002078,abnormal glucose homeostasis|MP:0005289,increased oxygen consumption|MP:0005621,abnormal cell physiology|MP:0010958,abnormal tricarboxylic acid cycle|MP:0013405,increased circulating lactate level|MP:0014143,decreased body fat mass|MP:0014245,increased cellular ATP level
MGI:7612222	Mldhr<tm1Zhgn>	MP:0000753,paralysis|MP:0001393,ataxia|MP:0002064,seizures|MP:0010727,increased glioblastoma incidence
MGI:4461689	Mlec<tm1a(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0003960,increased lean body mass|MP:0005477,increased circulating thyroxine level|MP:0010123,increased bone mineral content
MGI:3604762	Mlepq1<M16>	MP:0005668,decreased circulating leptin level
MGI:3604795	Mlepq2<M16>	MP:0005669,increased circulating leptin level
MGI:6257884	Mlf1<tm1Swm>	MP:0005014,increased B cell number|MP:0009341,decreased splenocyte apoptosis
MGI:6200234	Mlh1<m1Btlr>	MP:0001800,abnormal humoral immune response|MP:0002494,increased IgM level
MGI:6200239	Mlh1<m2Btlr>	MP:0001800,abnormal humoral immune response|MP:0002492,decreased IgE level|MP:0002494,increased IgM level
MGI:6200245	Mlh1<m3Btlr>	MP:0001800,abnormal humoral immune response|MP:0002492,decreased IgE level|MP:0002494,increased IgM level
MGI:5692538	Mlh1<tm1b(EUCOMM)Hmgu>	MP:0001147,small testis|MP:0001304,cataract|MP:0001925,male infertility|MP:0002941,increased circulating alanine transaminase level|MP:0004952,increased spleen weight|MP:0005343,increased circulating aspartate transaminase level
MGI:1857946	Mlh1<tm1Lisk>	MP:0001127,small ovary|MP:0001130,abnormal ovarian folliculogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002083,premature death|MP:0002404,increased intestinal adenoma incidence|MP:0002680,decreased corpora lutea number|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0008966,abnormal chiasmata formation|MP:0009222,increased uterus tumor incidence|MP:0010300,increased skin tumor incidence|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012431,increased lymphoma incidence
MGI:1930998	Mlh1<tm1Mse>	MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence
MGI:1858054	Mlh1<tm1Rak>	MP:0001147,small testis|MP:0001648,abnormal apoptosis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002038,increased carcinoma incidence|MP:0002083,premature death|MP:0002404,increased intestinal adenoma incidence|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0004207,increased squamous cell carcinoma incidence|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0008261,arrest of male meiosis|MP:0008714,increased lung carcinoma incidence|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008944,decreased sensitivity to induced cell death|MP:0009308,increased adenocarcinoma incidence|MP:0009309,increased small intestine adenocarcinoma incidence|MP:0010279,increased gastrointestinal tumor incidence|MP:0010300,increased skin tumor incidence|MP:0010383,increased adenoma incidence|MP:0012431,increased lymphoma incidence
MGI:3783409	Mlh1<tm1Wed>	MP:0001925,male infertility|MP:0001926,female infertility|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0002687,oligozoospermia|MP:0004208,increased basal cell carcinoma incidence|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis|MP:0009761,abnormal meiotic spindle morphology|MP:0012431,increased lymphoma incidence
MGI:5695903	Mlh3<tm1.1(KOMP)Vlcg>	MP:0001925,male infertility|MP:0001926,female infertility
MGI:2384218	Mlh3<tm1Lpkn>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001929,abnormal gametogenesis|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis
MGI:5907348	Mlip<tm1.1(cre)Dzw>	MP:0001544,abnormal cardiovascular system physiology|MP:0002753,dilated heart left ventricle|MP:0003141,cardiac fibrosis|MP:0003915,increased heart left ventricle weight|MP:0004484,abnormal response of heart to induced stress|MP:0004485,increased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility
MGI:7425832	Mlkl<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002060,abnormal skin morphology
MGI:5538612	Mlkl<em1Jhan>	MP:0002451,abnormal macrophage physiology|MP:0005166,decreased susceptibility to injury|MP:0005387,immune system phenotype|MP:0008944,decreased sensitivity to induced cell death|MP:0010768,mortality/aging
MGI:5695009	Mlkl<m1Btlr>	MP:0001876,decreased inflammatory response|MP:0012555,decreased cell death
MGI:5789564	Mlkl<m2Btlr>	MP:0001876,decreased inflammatory response|MP:0012555,decreased cell death
MGI:5789563	Mlkl<m3Btlr>	MP:0001876,decreased inflammatory response|MP:0012555,decreased cell death
MGI:6285950	Mlkl<M4Btlr>	MP:0006043,decreased apoptosis
MGI:5614464	Mlkl<tm1.2Wsa>	MP:0008944,decreased sensitivity to induced cell death
MGI:6313349	Mllt10<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000428,abnormal craniofacial morphology|MP:0000494,abnormal cecum morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001126,abnormal ovary morphology|MP:0001258,decreased body length|MP:0001297,microphthalmia|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002060,abnormal skin morphology|MP:0002151,abnormal neural tube morphology|MP:0002339,abnormal lymph node morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0003231,abnormal placenta vasculature|MP:0003743,abnormal facial morphology|MP:0004738,abnormal auditory brainstem response|MP:0004832,enlarged ovary|MP:0005016,decreased lymphocyte cell number|MP:0008797,facial cleft|MP:0009476,enlarged cecum|MP:0011100,preweaning lethality, complete penetrance
MGI:5706747	Mllt10<tm1Saam>	MP:0005621,abnormal cell physiology
MGI:7434268	Mllt11<tm1c(KOMP)Mbp>	MP:0000780,abnormal corpus callosum morphology|MP:0000781,decreased corpus callosum size|MP:0000790,abnormal stratification in cerebral cortex|MP:0006009,abnormal neuronal migration|MP:0006254,thin cerebral cortex|MP:0008026,abnormal brain white matter morphology|MP:0008415,abnormal neurite morphology|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0020337,abnormal pyramidal neuron dendrite morphology|MP:0021090,abnormal dendrite arborization pattern
MGI:3714136	Mllt1<tm1Dw>	MP:0002169,no abnormal phenotype detected|MP:0011092,embryonic lethality, complete penetrance
MGI:2388982	Mllt3<tm1.1Thr>	MP:0000157,abnormal sternum morphology|MP:0001265,decreased body size|MP:0002084,abnormal developmental patterning|MP:0003036,vertebral transformation|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003345,decreased rib number|MP:0004607,abnormal cervical atlas morphology|MP:0004615,cervical vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0005390,skeleton phenotype|MP:0005397,hematopoietic system phenotype|MP:0008146,asymmetric sternocostal joints|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5548595	Mllt3<tm1b(EUCOMM)Hmgu>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0003179,thrombocytopenia|MP:0003918,decreased kidney weight|MP:0005298,abnormal clavicle morphology|MP:0008806,increased circulating amylase level|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:2388981	Mllt3<tm1Thr>	MP:0001265,decreased body size|MP:0002084,abnormal developmental patterning|MP:0003036,vertebral transformation|MP:0003048,abnormal cervical vertebrae morphology|MP:0003345,decreased rib number|MP:0004174,abnormal spine curvature|MP:0004607,abnormal cervical atlas morphology|MP:0004608,abnormal cervical axis morphology|MP:0004618,thoracic vertebral transformation|MP:0004620,cervical vertebral fusion|MP:0004648,decreased thoracic vertebrae number|MP:0004703,abnormal vertebral column morphology|MP:0005397,hematopoietic system phenotype|MP:0008146,asymmetric sternocostal joints|MP:0008277,abnormal sternum ossification|MP:0008922,abnormal cervical rib|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:6156510	Mllt6<em1(IMPC)Tcp>	MP:0000063,decreased bone mineral density|MP:0000219,increased neutrophil cell number|MP:0000470,abnormal stomach morphology|MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0001120,abnormal uterus morphology|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002599,increased mean platelet volume|MP:0002768,small adrenal glands|MP:0004952,increased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0009142,decreased prepulse inhibition
MGI:3856248	Mllt6<Gt(AC0433)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:1856674	Mlph<ln>	MP:0000371,diluted coat color|MP:0001186,pigmentation phenotype
MGI:5688600	Mlph<ln-2Btlr>	MP:0000371,diluted coat color
MGI:3784966	Mlph<ln-Btlr>	MP:0000371,diluted coat color|MP:0005387,immune system phenotype
MGI:3696568	Mlrrq<DBA/2>	MP:0005026,decreased susceptibility to parasitic infection
MGI:3528742	Mlst8<tm1Lex>	MP:0000267,abnormal heart development|MP:0000913,abnormal brain development|MP:0000934,abnormal telencephalon development|MP:0001634,internal hemorrhage|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004938,dilated vasculature|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011524,thick placenta labyrinth
MGI:3043871	Mlxipl<tm1Kuy>	MP:0000609,abnormal liver physiology|MP:0001263,weight loss|MP:0001668,abnormal intestinal fructose absorption|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0001925,male infertility|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002675,asthenozoospermia|MP:0002702,decreased circulating free fatty acids level|MP:0002981,increased liver weight|MP:0005036,diarrhea|MP:0005179,decreased circulating cholesterol level|MP:0005282,decreased fatty acids level|MP:0005331,insulin resistance|MP:0005534,decreased body temperature|MP:0005559,increased circulating glucose level|MP:0005560,decreased circulating glucose level|MP:0009289,decreased epididymal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0009480,distended cecum|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010400,increased liver glycogen level|MP:0011940,decreased food intake|MP:0012311,decreased defecation amount|MP:0013955,increased colon length|MP:0020869,immotile sperm|MP:0031236,increased cecum weight
MGI:5705614	Mlxip<tm1.2Lchan>	MP:0002106,abnormal muscle physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0010379,decreased respiratory quotient|MP:0012107,enhanced exercise endurance|MP:0013405,increased circulating lactate level|MP:0014171,increased fatty acid oxidation|MP:0030673,increased circulating alanine level
MGI:5614589	Mlx<tm1.1(KOMP)Vlcg>	MP:0001488,increased startle reflex|MP:0001759,increased urine glucose level|MP:0001925,male infertility|MP:0002591,decreased mean corpuscular volume|MP:0003960,increased lean body mass|MP:0005560,decreased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005633,increased circulating sodium level|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0013279,increased fasting circulating glucose level
MGI:7444087	Mlx<tm1.1Rne>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia
MGI:5907738	Mlx<tm1.2Rne>	MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0004929,decreased epididymis weight|MP:0005578,teratozoospermia|MP:0013239,impaired skeletal muscle regeneration|MP:0020450,abnormal sperm progressive motility
MGI:3769013	Mlycd<tm1Jish>	MP:0002078,abnormal glucose homeostasis|MP:0002128,abnormal blood circulation|MP:0003394,increased cardiac output
MGI:5825155	Mmaa<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0001258,decreased body length|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001926,female infertility|MP:0002075,abnormal coat/hair pigmentation|MP:0002590,increased mean corpuscular volume|MP:0002757,decreased vertical activity|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0005333,decreased heart rate|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005505,thrombocytosis|MP:0005561,increased mean corpuscular hemoglobin|MP:0005567,decreased circulating total protein level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010024,increased total body fat amount|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content|MP:0010506,prolonged RR interval|MP:0020870,decreased thigmotaxis
MGI:6435666	Mmab<em1(IMPC)Hmgu>	MP:0000689,abnormal spleen morphology|MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance
MGI:6491443	Mmachc<em1.1Poche>	MP:0000428,abnormal craniofacial morphology|MP:0001293,anophthalmia|MP:0001700,abnormal embryo turning|MP:0004200,decreased fetal size|MP:0010422,heart right ventricle hypoplasia|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:6491439	Mmachc<em1Poche>	MP:0005382,craniofacial phenotype
MGI:3857614	Mmachc<Gt(AZ0348)Wtsi>	MP:0001729,impaired embryo implantation|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0004179,transmission ratio distortion|MP:0005266,abnormal metabolism|MP:0005389,reproductive system phenotype|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012117,decreased trophectoderm cell proliferation|MP:0012128,abnormal blastocyst formation|MP:0012335,increased circulating homocysteine level
MGI:5766143	Mmachc<tm1.1(NCOM)Mfgc>	MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0000702,enlarged lymph nodes|MP:0000914,exencephaly|MP:0000955,abnormal spinal cord morphology|MP:0001175,abnormal lung morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001697,abnormal embryo size|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0002631,abnormal epididymis morphology|MP:0002989,small kidney|MP:0003717,pallor|MP:0004200,decreased fetal size|MP:0005294,abnormal heart ventricle morphology|MP:0008797,facial cleft|MP:0009887,abnormal palatal shelf fusion at midline|MP:0010402,ventricular septal defect|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6384588	Mmd<em1(IMPC)Hmgu>	MP:0001258,decreased body length|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0002699,abnormal vitreous body morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0005343,increased circulating aspartate transaminase level|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0011965,decreased total retina thickness
MGI:6696444	Mmd<tm1Beij>	MP:0003436,decreased susceptibility to induced arthritis|MP:0008113,abnormal macrophage differentiation|MP:0009624,small inguinal lymph nodes|MP:0011080,increased macrophage apoptosis
MGI:6277007	Mme<em1(IMPC)Mbp>	MP:0001566,increased circulating phosphate level
MGI:3043380	Mmel1<tm1Ldg>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0001925,male infertility
MGI:2137696	Mme<tm1Cge>	MP:0000604,amyloidosis|MP:0001194,dermatitis|MP:0001786,skin edema|MP:0005151,diffuse hepatic necrosis|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0005416,abnormal circulating protein level|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0010738,abnormal internode morphology|MP:0011730,increased myelin sheath thickness
MGI:5805685	Mmgt2<tm1b(EUCOMM)Wtsi>	MP:0002075,abnormal coat/hair pigmentation|MP:0002606,increased basophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005293,impaired glucose tolerance
MGI:4365989	Mmp10<tm1Jkmg>	MP:0001182,lung hemorrhage|MP:0001861,lung inflammation|MP:0002412,increased susceptibility to bacterial infection
MGI:3604401	Mmp10<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:6120817	Mmp11<tm1b(EUCOMM)Hmgu>	MP:0000220,increased monocyte cell number|MP:0002111,abnormal tail morphology|MP:0005419,decreased circulating serum albumin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011239,abnormal skin coloration|MP:0011965,decreased total retina thickness
MGI:2387934	Mmp11<tm1Mrio>	MP:0004502,decreased incidence of tumors by chemical induction|MP:0004883,abnormal vascular wound healing
MGI:2386174	Mmp12<tm1Sds>	MP:0000920,abnormal myelination|MP:0001935,decreased litter size|MP:0002451,abnormal macrophage physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009808,decreased oligodendrocyte number
MGI:7425834	Mmp13<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002764,short tibia|MP:0002968,increased circulating alkaline phosphatase level|MP:0003233,prolonged QT interval|MP:0005333,decreased heart rate|MP:0005634,decreased circulating sodium level|MP:0010506,prolonged RR interval
MGI:3521938	Mmp13<tm1.1Werb>	MP:0000130,abnormal trabecular bone morphology|MP:0003408,increased width of hypertrophic chondrocyte zone
MGI:3706953	Mmp13<tm1Jdar>	MP:0000164,abnormal cartilage development|MP:0000352,decreased cell proliferation|MP:0002908,delayed wound healing|MP:0002999,abnormal bone healing|MP:0005602,decreased angiogenesis
MGI:3521852	Mmp13<tm1Smk>	MP:0000060,delayed bone ossification|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0003109,short femur|MP:0006398,increased long bone epiphyseal plate size|MP:0010872,increased trabecular bone mass
MGI:3521687	Mmp13<tm1Werb>	MP:0000130,abnormal trabecular bone morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0010771,integument phenotype
MGI:3784968	Mmp14<m1Btlr>	MP:0000445,short snout|MP:0001262,decreased body weight|MP:0001296,macrophthalmia|MP:0001924,infertility|MP:0002083,premature death|MP:0002089,abnormal postnatal growth/weight/body size|MP:0008525,decreased cranium height|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3763359	Mmp14<sabe>	MP:0000018,small ears|MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000440,domed cranium|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0002750,exophthalmos|MP:0005391,vision/eye phenotype|MP:0005458,increased percent body fat/body weight|MP:0008525,decreased cranium height|MP:0008526,decreased cranium width|MP:0008529,enlarged optic nerve|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0030245,round head
MGI:2445723	Mmp14<tm1Hbh>	MP:0000060,delayed bone ossification|MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000074,abnormal neurocranium morphology|MP:0000077,abnormal interparietal bone morphology|MP:0000084,abnormal fontanelle morphology|MP:0000109,abnormal parietal bone morphology|MP:0000130,abnormal trabecular bone morphology|MP:0000160,kyphosis|MP:0000162,lordosis|MP:0000163,abnormal cartilage morphology|MP:0000164,abnormal cartilage development|MP:0000166,abnormal chondrocyte morphology|MP:0000418,focal hair loss|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000550,abnormal forelimb morphology|MP:0001178,pulmonary hypoplasia|MP:0001183,overexpanded pulmonary alveolus|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001533,abnormal skeleton physiology|MP:0001541,abnormal osteoclast physiology|MP:0002083,premature death|MP:0002113,abnormal skeleton development|MP:0002268,abnormal terminal bronchiole morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002427,disproportionate dwarf|MP:0002835,abnormal cranial suture morphology|MP:0002932,abnormal joint morphology|MP:0002993,autoimmune arthritis|MP:0002998,abnormal bone remodeling|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0003379,absent sexual maturation|MP:0003723,abnormal long bone morphology|MP:0004351,short humerus|MP:0004686,decreased length of long bones|MP:0005150,cachexia|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006027,impaired lung alveolus development|MP:0008271,abnormal bone ossification|MP:0009419,skeletal muscle fibrosis|MP:0009932,skin fibrosis|MP:0010030,abnormal orbit morphology|MP:0010809,abnormal club cell morphology|MP:0010856,dilated respiratory conducting tube|MP:0010905,absent alveolar pores|MP:0010908,dilated pulmonary alveolar duct|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011711,impaired osteoblast differentiation|MP:0011862,decreased cranium length
MGI:2386246	Mmp14<tm1Ktry>	MP:0000074,abnormal neurocranium morphology|MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000116,abnormal tooth development|MP:0000120,malocclusion|MP:0000164,abnormal cartilage development|MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000547,short limbs|MP:0001175,abnormal lung morphology|MP:0001183,overexpanded pulmonary alveolus|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0002114,abnormal axial skeleton morphology|MP:0002267,abnormal bronchiole morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002376,abnormal dendritic cell physiology|MP:0002835,abnormal cranial suture morphology|MP:0002896,abnormal bone mineralization|MP:0003053,delayed tooth eruption|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003641,small lung|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004592,small mandible|MP:0004830,short incisors|MP:0005150,cachexia|MP:0005358,abnormal incisor morphology|MP:0005421,loose skin|MP:0005602,decreased angiogenesis|MP:0008271,abnormal bone ossification|MP:0009520,decreased submandibular gland size|MP:0011083,lethality at weaning, complete penetrance|MP:0011085,postnatal lethality, complete penetrance|MP:0013542,abnormal submandibular gland branching morphogenesis|MP:0030077,small cranial cavity|MP:0030089,short lower incisors|MP:0030090,short upper incisors|MP:0030137,abnormal upper incisor morphology|MP:0030225,abnormal cranial vertex morphology
MGI:3046860	Mmp14<tm1Noda>	MP:0002169,no abnormal phenotype detected
MGI:3687379	Mmp14<tm1Ski>	MP:0000527,abnormal kidney development|MP:0001265,decreased body size|MP:0001533,abnormal skeleton physiology|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002932,abnormal joint morphology|MP:0002989,small kidney|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003851,skeletal muscle interstitial fibrosis|MP:0004193,abnormal kidney papilla morphology|MP:0004272,abnormal basement membrane morphology|MP:0004505,decreased renal glomerulus number|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0009399,increased skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0011360,kidney cortex hypoplasia|MP:0011376,abnormal kidney corticomedullary boundary morphology|MP:0011441,decreased kidney cell proliferation
MGI:5520085	Mmp14<tm1Stjw>	MP:0000063,decreased bone mineral density|MP:0000163,abnormal cartilage morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002932,abnormal joint morphology|MP:0003420,delayed intramembranous bone ossification|MP:0005375,adipose tissue phenotype|MP:0005390,skeleton phenotype|MP:0008271,abnormal bone ossification|MP:0010743,delayed cranial suture closure|MP:0011156,abnormal hypodermis fat layer morphology|MP:0030009,increased bone marrow adipose tissue amount
MGI:5605746	Mmp15<tm1b(KOMP)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0000467,abnormal esophagus morphology|MP:0000681,abnormal thyroid gland morphology|MP:0000691,enlarged spleen|MP:0000705,athymia|MP:0001293,anophthalmia|MP:0001944,abnormal pancreas morphology|MP:0002282,abnormal trachea morphology|MP:0008024,absent lymph nodes|MP:0011239,abnormal skin coloration
MGI:4868411	Mmp15<tm1Kohl>	MP:0002169,no abnormal phenotype detected
MGI:5548416	Mmp16<tm1b(EUCOMM)Wtsi>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0002092,abnormal eye morphology|MP:0003043,hypoalgesia|MP:0020955,increased mechanical nociceptive threshold
MGI:3604479	Mmp16<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3771975	Mmp16<tm1Khol>	MP:0001732,postnatal growth retardation|MP:0004351,short humerus|MP:0011862,decreased cranium length
MGI:3604575	Mmp17<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3777020	Mmp17<tm1Ski>	MP:0003620,oliguria|MP:0004193,abnormal kidney papilla morphology|MP:0004754,abnormal kidney collecting duct morphology|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0008055,increased urine osmolality|MP:0010768,mortality/aging|MP:0010981,abnormal branching involved in ureteric bud morphogenesis|MP:0011737,hypodipsia|MP:0011942,decreased fluid intake
MGI:3505589	Mmp19<tm1Amp>	MP:0004502,decreased incidence of tumors by chemical induction|MP:0005334,abnormal fat pad morphology|MP:0005658,increased susceptibility to diet-induced obesity|MP:0006094,increased fat cell size|MP:0009285,increased gonadal fat pad weight
MGI:5509300	Mmp19<tm1Rase>	MP:0001828,abnormal T cell activation|MP:0001876,decreased inflammatory response|MP:0002145,abnormal T cell differentiation|MP:0005091,increased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008713,abnormal cytokine level
MGI:5514177	Mmp1a<tm1Otin>	MP:0001876,decreased inflammatory response|MP:0003447,decreased tumor growth/size|MP:0003448,abnormal tumor morphology|MP:0004502,decreased incidence of tumors by chemical induction|MP:0008566,increased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion|MP:0008654,increased interleukin-1 alpha secretion|MP:0008681,increased interleukin-17 secretion|MP:0008687,increased interleukin-2 secretion
MGI:6367975	Mmp20<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001157,small seminal vesicle|MP:0001262,decreased body weight|MP:0002059,abnormal seminal vesicle morphology|MP:0002100,abnormal tooth morphology|MP:0003961,decreased lean body mass|MP:0009141,increased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010379,decreased respiratory quotient|MP:0013129,abnormal tooth color
MGI:2447874	Mmp20<tm1Jdb>	MP:0002100,abnormal tooth morphology|MP:0002576,abnormal enamel morphology|MP:0002577,reduced enamel thickness|MP:0002648,delaminated enamel|MP:0002649,abnormal enamel rod pattern|MP:0002650,abnormal ameloblast morphology
MGI:5554438	Mmp21<b2b2458Clo>	MP:0000284,double outlet right ventricle|MP:0000531,right pulmonary isomerism|MP:0000598,abnormal liver morphology|MP:0002639,micrognathia|MP:0004110,transposition of great arteries|MP:0004133,heterotaxia|MP:0010412,atrioventricular septal defect|MP:0010422,heart right ventricle hypoplasia|MP:0010808,right-sided stomach|MP:0011665,d-loop transposition of the great arteries|MP:0011667,double outlet right ventricle with atrioventricular septal defect|MP:0011668,double outlet right ventricle, Taussig bing type
MGI:5311376	Mmp21<b2b873Clo>	MP:0004133,heterotaxia|MP:0006123,tricuspid valve atresia|MP:0010402,ventricular septal defect|MP:0011665,d-loop transposition of the great arteries
MGI:4365393	Mmp24<tm1Otin>	MP:0002736,abnormal nociception after inflammation|MP:0003651,abnormal axon extension|MP:0003998,decreased thermal nociceptive threshold|MP:0005404,abnormal axon morphology|MP:0008763,abnormal mast cell degranulation|MP:0008764,increased mast cell degranulation
MGI:3028827	Mmp24<tm1Ski>	MP:0000955,abnormal spinal cord morphology|MP:0001364,decreased anxiety-related response|MP:0001961,abnormal reflex|MP:0001970,abnormal pain threshold|MP:0002734,abnormal mechanical nociception|MP:0003858,enhanced coordination
MGI:7434718	Mmp25<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number
MGI:5212225	Mmp25<Gt(IST14198E10)Tigm>	MP:0002463,abnormal neutrophil physiology|MP:0002493,increased IgG level|MP:0004950,abnormal brain vasculature morphology|MP:0005602,decreased angiogenesis|MP:0008639,decreased circulating interleukin-1 alpha level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0010210,abnormal circulating cytokine level|MP:0011075,abnormal macrophage activation involved in immune response
MGI:3836773	Mmp28<tm1Mani>	MP:0002411,decreased susceptibility to bacterial infection|MP:0003009,abnormal cytokine secretion|MP:0008560,increased tumor necrosis factor secretion|MP:0008705,increased interleukin-6 secretion|MP:0008719,impaired neutrophil recruitment|MP:0008722,abnormal chemokine secretion|MP:0010760,abnormal macrophage chemotaxis
MGI:6313360	Mmp2<em1(IMPC)Mbp>	MP:0000470,abnormal stomach morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001258,decreased body length|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002626,increased heart rate|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0003795,abnormal bone structure|MP:0003883,enlarged stomach|MP:0009142,decreased prepulse inhibition|MP:0010124,decreased bone mineral content
MGI:2386252	Mmp2<tm1Ito>	MP:0000063,decreased bone mineral density|MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000130,abnormal trabecular bone morphology|MP:0000260,abnormal angiogenesis|MP:0000343,abnormal response to cardiac infarction|MP:0000438,abnormal cranium morphology|MP:0000445,short snout|MP:0001265,decreased body size|MP:0001544,abnormal cardiovascular system physiology|MP:0001732,postnatal growth retardation|MP:0001845,abnormal inflammatory response|MP:0001847,brain inflammation|MP:0001876,decreased inflammatory response|MP:0002006,neoplasm|MP:0002113,abnormal skeleton development|MP:0002169,no abnormal phenotype detected|MP:0002753,dilated heart left ventricle|MP:0002993,autoimmune arthritis|MP:0003447,decreased tumor growth/size|MP:0003797,abnormal compact bone morphology|MP:0003840,abnormal coronal suture morphology|MP:0003841,abnormal lambdoid suture morphology|MP:0003843,abnormal sagittal suture morphology|MP:0004686,decreased length of long bones|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004985,decreased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0005595,abnormal vascular smooth muscle physiology|MP:0005602,decreased angiogenesis|MP:0006027,impaired lung alveolus development|MP:0006433,abnormal articular cartilage morphology|MP:0009278,abnormal bone marrow cell physiology|MP:0009660,abnormal induced retina neovascularization|MP:0010876,decreased bone volume|MP:0030166,increased inner canthal distance|MP:0030189,broad snout|MP:0030360,coronal suture sclerosis|MP:0030361,lambdoid suture sclerosis|MP:0030362,sagittal suture sclerosis
MGI:2386262	Mmp3<tm1Mrl>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002908,delayed wound healing|MP:0002933,joint inflammation|MP:0002993,autoimmune arthritis|MP:0003560,osteoarthritis|MP:0003945,abnormal lymphocyte physiology|MP:0004835,abnormal miniature endplate potential|MP:0005166,decreased susceptibility to injury|MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction
MGI:1857932	Mmp7<tm1Lmm>	MP:0000343,abnormal response to cardiac infarction|MP:0000512,intestinal ulcer|MP:0001263,weight loss|MP:0001792,impaired wound healing|MP:0002020,increased tumor incidence|MP:0002411,decreased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0003799,impaired macrophage chemotaxis|MP:0003901,abnormal PR interval|MP:0005036,diarrhea|MP:0005166,decreased susceptibility to injury|MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype|MP:0006142,abnormal sinoatrial node conduction|MP:0008537,increased susceptibility to induced colitis|MP:0008561,decreased tumor necrosis factor secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0009660,abnormal induced retina neovascularization|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:5471364	Mmp8<tm1.1(KOMP)Vlcg>	MP:0002702,decreased circulating free fatty acids level|MP:0002833,increased heart weight
MGI:2681103	Mmp8<tm1Otin>	MP:0001845,abnormal inflammatory response|MP:0002014,increased papilloma incidence|MP:0002020,increased tumor incidence|MP:0002412,increased susceptibility to bacterial infection|MP:0002499,chronic inflammation|MP:0005387,immune system phenotype|MP:0010363,increased fibrosarcoma incidence
MGI:8209555	Mmp9<em1Iimcb>	MP:0003008,enhanced long-term potentiation|MP:0005389,reproductive system phenotype|MP:0009936,abnormal dendritic spine morphology|MP:0010768,mortality/aging|MP:0012318,slow extinction of fear memory|MP:0020507,increased dendritic spine density|MP:0020511,decreased dendritic spine length
MGI:3609228	Mmp9<tm1Amr>	MP:0003038,decreased myocardial infarct size
MGI:3046278	Mmp9<tm1Arnd>	MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0003070,increased vascular permeability|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0009814,increased prostaglandin level|MP:0030756,decreased histamine level
MGI:5548952	Mmp9<tm1b(EUCOMM)Wtsi>	MP:0002764,short tibia
MGI:3046275	Mmp9<tm1Itoh>	MP:0001273,decreased metastatic potential
MGI:1932294	Mmp9<tm1Tvu>	MP:0000060,delayed bone ossification|MP:0000067,osteopetrosis|MP:0000130,abnormal trabecular bone morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000220,increased monocyte cell number|MP:0000229,abnormal megakaryocyte differentiation|MP:0000260,abnormal angiogenesis|MP:0000343,abnormal response to cardiac infarction|MP:0000920,abnormal myelination|MP:0001260,increased body weight|MP:0001473,reduced long-term potentiation|MP:0001602,impaired myelopoiesis|MP:0001606,impaired hematopoiesis|MP:0001856,myocarditis|MP:0001861,lung inflammation|MP:0001876,decreased inflammatory response|MP:0002052,decreased tumor incidence|MP:0002376,abnormal dendritic cell physiology|MP:0002411,decreased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0002492,decreased IgE level|MP:0002497,increased IgE level|MP:0002764,short tibia|MP:0002839,increased susceptibility to dystrophic cardiac calcinosis|MP:0002908,delayed wound healing|MP:0002933,joint inflammation|MP:0002936,joint swelling|MP:0003009,abnormal cytokine secretion|MP:0003043,hypoalgesia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003072,abnormal metatarsal bone morphology|MP:0003109,short femur|MP:0003137,abnormal impulse conducting system conduction|MP:0003141,cardiac fibrosis|MP:0003204,decreased neuron apoptosis|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003436,decreased susceptibility to induced arthritis|MP:0003448,abnormal tumor morphology|MP:0003449,abnormal intestine goblet cell morphology|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003710,abnormal physiological neovascularization|MP:0004215,abnormal myocardial fiber physiology|MP:0004686,decreased length of long bones|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004883,abnormal vascular wound healing|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005025,abnormal response to infection|MP:0005140,decreased cardiac muscle contractility|MP:0005166,decreased susceptibility to injury|MP:0005348,increased T cell proliferation|MP:0005362,abnormal Langerhans cell physiology|MP:0005387,immune system phenotype|MP:0005425,increased macrophage cell number|MP:0005595,abnormal vascular smooth muscle physiology|MP:0005600,increased heart ventricle muscle contractility|MP:0005601,increased angiogenesis|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0006072,abnormal retina apoptosis|MP:0008090,increased T-helper 2 cell number|MP:0008127,decreased dendritic cell number|MP:0008246,abnormal leukocyte morphology|MP:0008539,decreased susceptibility to induced colitis|MP:0008566,increased interferon-gamma secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008575,increased circulating interferon-beta level|MP:0008577,increased circulating interferon-gamma level|MP:0008594,decreased circulating interleukin-10 level|MP:0008672,increased interleukin-13 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion|MP:0008721,abnormal chemokine level|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009278,abnormal bone marrow cell physiology|MP:0009427,increased tibialis anterior weight|MP:0009454,impaired contextual conditioning behavior|MP:0009660,abnormal induced retina neovascularization|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0009808,decreased oligodendrocyte number|MP:0010724,thick interventricular septum|MP:0020937,increased susceptibility to Picornaviridae infection|MP:0020944,decreased susceptibility to Flaviviridae infection|MP:0021161,increased heart left ventricle posterior wall thickness|MP:0031040,increased susceptibility to Picornaviridae infection induced morbidity/mortality|MP:0031043,decreased susceptibility to Flaviviridae infection induced morbidity/mortality|MP:0031273,decreased susceptibility to induced aneurysm formation|MP:0031385,enhanced blood-brain barrier function
MGI:5548605	Mmrn1<tm1b(EUCOMM)Hmgu>	MP:0001925,male infertility|MP:0012362,increased large unstained cell number
MGI:7266885	Mmrn1<tm1d(EUCOMM)Hmgu>	MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology|MP:0006298,abnormal platelet activation|MP:0031120,decreased susceptibility to induced thrombosis
MGI:6711429	Mmrn2<tm1Monm>	MP:0003070,increased vascular permeability|MP:0010097,abnormal retina blood vessel morphology|MP:0010144,abnormal tumor vascularization
MGI:4433323	Mms22l<tm1a(EUCOMM)Wtsi>	MP:0006358,absent pinna reflex|MP:0008762,embryonic lethality|MP:0010770,preweaning lethality
MGI:7431125	Mmut<em1Cpv>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0011086,postnatal lethality, incomplete penetrance|MP:0030630,increased circulating methylmalonic acid level
MGI:7431126	Mmut<em2Cpv>	MP:0001732,postnatal growth retardation|MP:0010768,mortality/aging|MP:0030630,increased circulating methylmalonic acid level
MGI:6157363	Mmut<tm1.1Mrb>	MP:0001263,weight loss|MP:0001732,postnatal growth retardation|MP:0003031,acidosis|MP:0003979,increased circulating carnitine level|MP:0005280,abnormal fatty acids level|MP:0005309,increased circulating ammonia level|MP:0010768,mortality/aging|MP:0030614,methylmalonic aciduria|MP:0030655,increased circulating glycine level
MGI:3840300	Mmut<tm1Cpv>	MP:0000598,abnormal liver morphology|MP:0001182,lung hemorrhage|MP:0001262,decreased body weight|MP:0001429,dehydration|MP:0001732,postnatal growth retardation|MP:0001944,abnormal pancreas morphology|MP:0001954,respiratory distress|MP:0002152,abnormal brain morphology|MP:0002628,hepatic steatosis|MP:0003030,acidemia|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005220,abnormal exocrine pancreas morphology|MP:0005311,abnormal circulating amino acid level|MP:0008770,decreased survivor rate|MP:0009642,abnormal blood homeostasis|MP:0010028,aciduria|MP:0010955,abnormal respiratory electron transport chain|MP:0010958,abnormal tricarboxylic acid cycle|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011405,tubulointerstitial nephritis|MP:0014341,abnormal hepatocyte mitochondrial morphology|MP:0030612,organic aciduria
MGI:3026839	Mmut<tm1Pai>	MP:0001402,decreased locomotor activity|MP:0001436,abnormal suckling behavior|MP:0001954,respiratory distress|MP:0003979,increased circulating carnitine level|MP:0008986,abnormal liver parenchyma morphology|MP:0009546,absent gastric milk in neonates|MP:0011087,neonatal lethality, complete penetrance|MP:0030614,methylmalonic aciduria
MGI:1856958	mn	MP:0000432,abnormal head morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002082,postnatal lethality|MP:0002089,abnormal postnatal growth/weight/body size|MP:0004197,abnormal fetal growth/weight/body size
MGI:3580381	Mn1<tm1Ecz>	MP:0000077,abnormal interparietal bone morphology|MP:0000078,abnormal supraoccipital bone morphology|MP:0000099,absent vomer bone|MP:0000104,abnormal sphenoid bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000109,abnormal parietal bone morphology|MP:0001436,abnormal suckling behavior|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002006,neoplasm|MP:0002835,abnormal cranial suture morphology|MP:0004424,temporal bone hypoplasia|MP:0004450,presphenoid bone hypoplasia|MP:0004452,abnormal pterygoid process morphology|MP:0004455,pterygoid bone hypoplasia|MP:0004458,absent alisphenoid bone|MP:0004460,alisphenoid bone hypoplasia|MP:0004461,basisphenoid bone hypoplasia|MP:0004899,absent temporal bone squamous part|MP:0005202,lethargy|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0009892,palate bone hypoplasia|MP:0009896,palatine bone horizontal plate hypoplasia|MP:0009898,maxillary shelf hypoplasia|MP:0009900,vomer bone hypoplasia|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0030275,thin frontal bone|MP:0030277,thin interparietal bone|MP:0030281,thin parietal bone|MP:0030432,large cranial foramen ovale|MP:0030433,large foramen rotundum
MGI:2388119	Mnat1<tm1Tpm>	MP:0002085,abnormal embryonic tissue morphology|MP:0004965,inner cell mass degeneration|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3707001	Mnat1<tm2Tpm>	MP:0002169,no abnormal phenotype detected
MGI:4332240	Mnd1<Gt(RRS590)Byg>	MP:0001156,abnormal spermatogenesis|MP:0001929,abnormal gametogenesis|MP:0005169,abnormal male meiosis
MGI:6860355	Mndal<em1(IMPC)Bay>	MP:0001325,abnormal retina morphology|MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance
MGI:6302755	Mndal<em1(IMPC)Wtsi>	MP:0001406,abnormal gait|MP:0011100,preweaning lethality, complete penetrance
MGI:2663058	Mndl1<SM/J>	MP:0000088,short mandible
MGI:2663061	Mndl2<A/J>	MP:0004593,long mandible
MGI:2154232	Mnek1a<CAST/Ei>	MP:0000208,decreased hematocrit|MP:0003917,increased kidney weight
MGI:2154980	Mnek1b<C57BL/6J>	MP:0000208,decreased hematocrit
MGI:2675072	Mnek1c<CAST/Ei>	MP:0003917,increased kidney weight
MGI:1856961	mneu	MP:0000746,weakness|MP:0001265,decreased body size|MP:0001524,impaired limb coordination|MP:0002082,postnatal lethality|MP:0002089,abnormal postnatal growth/weight/body size|MP:0003633,abnormal nervous system physiology|MP:0004924,abnormal behavior|MP:0005403,abnormal nerve conduction
MGI:2449294	Mnic1<CAST/EiJ>	MP:0001431,abnormal eating behavior|MP:0011939,increased food intake
MGI:2449295	Mnic2<CAST/EiJ>	MP:0001431,abnormal eating behavior
MGI:2449296	Mnic3<CAST/EiJ>	MP:0001431,abnormal eating behavior
MGI:2449288	Mnif1<C57BL/6J>	MP:0001431,abnormal eating behavior
MGI:2449293	Mnif2<CAST/EiJ>	MP:0001431,abnormal eating behavior
MGI:2449290	Mnif3<C57BL/6J>	MP:0001431,abnormal eating behavior
MGI:3036045	Mnotch<129X1/SvJ>	MP:0002114,abnormal axial skeleton morphology
MGI:3036044	Mnotch<C57BL/6J>	MP:0002114,abnormal axial skeleton morphology
MGI:5425368	Mns1<tm1Jw>	MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002631,abnormal epididymis morphology|MP:0002687,oligozoospermia|MP:0003178,left pulmonary isomerism|MP:0004852,decreased testis weight|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0009237,kinked sperm flagellum|MP:0009239,short sperm flagellum|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0010831,lethality, incomplete penetrance|MP:0010854,lung situs inversus|MP:0011050,abnormal respiratory motile cilium morphology|MP:0020869,immotile sperm|MP:0030591,absent sperm fibrous sheath|MP:0031356,abnormal outer dense fiber morphology
MGI:3613761	Mntm	MP:0020470,shortened circadian behavior period
MGI:3044352	Mnt<tm1.1Awb>	MP:0000074,abnormal neurocranium morphology|MP:0000111,cleft palate|MP:0001731,abnormal postnatal growth|MP:0004200,decreased fetal size|MP:0004384,small interparietal bone|MP:0004441,small occipital bone|MP:0004476,absent palatine bone|MP:0004592,small mandible|MP:0005274,abnormal viscerocranium morphology|MP:0005352,small cranium|MP:0005389,reproductive system phenotype|MP:0009546,absent gastric milk in neonates|MP:0009703,decreased birth body size|MP:0009886,failure of palatal shelf elevation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2678322	Mnt<tm1.1Phu>	MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0005621,abnormal cell physiology|MP:0011085,postnatal lethality, complete penetrance
MGI:2678321	Mnt<tm1Phu>	MP:0001883,increased mammary adenocarcinoma incidence
MGI:2447781	Mnx1<tm1Jhk>	MP:0002184,abnormal innervation|MP:0003339,decreased pancreatic beta cell number|MP:0003562,abnormal pancreatic beta cell physiology|MP:0003934,abnormal pancreas development|MP:0004200,decreased fetal size|MP:0005215,abnormal pancreatic islet morphology|MP:0005218,abnormal pancreatic delta cell morphology|MP:0005387,immune system phenotype|MP:0009172,small pancreatic islets|MP:0011087,neonatal lethality, complete penetrance|MP:0014747,abnormal motor neuron axon guidance
MGI:4359084	Mnx1<tm1Slp>	MP:0002169,no abnormal phenotype detected
MGI:2182358	Mnx1<tm1Tmj>	MP:0000761,thin diaphragm muscle|MP:0000937,abnormal motor neuron morphology|MP:0003271,abnormal duodenum morphology|MP:0003339,decreased pancreatic beta cell number|MP:0003631,nervous system phenotype|MP:0003934,abnormal pancreas development|MP:0005215,abnormal pancreatic islet morphology|MP:0005404,abnormal axon morphology|MP:0009181,decreased pancreatic delta cell number|MP:0010819,primary atelectasis|MP:0011087,neonatal lethality, complete penetrance
MGI:2182361	Mnx1<tm2Tmj>	MP:0000761,thin diaphragm muscle|MP:0000937,abnormal motor neuron morphology|MP:0001076,abnormal hypoglossal nerve morphology|MP:0003631,nervous system phenotype|MP:0005404,abnormal axon morphology|MP:0010819,primary atelectasis|MP:0011087,neonatal lethality, complete penetrance
MGI:2182363	Mnx1<tm3Tmj>	MP:0000761,thin diaphragm muscle|MP:0000937,abnormal motor neuron morphology|MP:0003631,nervous system phenotype|MP:0005404,abnormal axon morphology|MP:0010819,primary atelectasis|MP:0011087,neonatal lethality, complete penetrance
MGI:2447793	Mnx1<tm4(cre)Tmj>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0009400,decreased skeletal muscle fiber size
MGI:6104254	Moap1<tm1Vcy>	MP:0008891,decreased hepatocyte apoptosis
MGI:6414514	Mob1a<em1(IMPC)Bay>	MP:0001257,increased body length
MGI:3870385	Mob1b<Gt(CC0690)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5692721	Mob2<tm1b(KOMP)Wtsi>	MP:0001488,increased startle reflex|MP:0011100,preweaning lethality, complete penetrance
MGI:6794050	Mob4<em1(IMPC)J>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:3613469	Mobp<tm1Irg>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:3042483	Mobp<tm1Sak>	MP:0000920,abnormal myelination|MP:0005386,behavior/neurological phenotype
MGI:3042291	Mobq1<129P3/J>	MP:0001262,decreased body weight|MP:0005179,decreased circulating cholesterol level|MP:0010025,decreased total body fat amount|MP:0011582,decreased triglyceride lipase activity
MGI:3042293	Mobq1<BALB/cJ>	MP:0001262,decreased body weight|MP:0005179,decreased circulating cholesterol level|MP:0010025,decreased total body fat amount
MGI:2429528	Mobq3<SPRET/EiJ>	MP:0005334,abnormal fat pad morphology
MGI:2155132	Mobq5<CAST/EiJ>	MP:0002078,abnormal glucose homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0005179,decreased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0011939,increased food intake
MGI:2155134	Mobq6<CAST/EiJ>	MP:0005659,decreased susceptibility to diet-induced obesity
MGI:2157461	Mobq8<CAST/EiJ>	MP:0000008,increased white adipose tissue amount
MGI:6336104	Mocos<em2(IMPC)Ics>	MP:0000208,decreased hematocrit|MP:0000519,hydronephrosis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001385,pup cannibalization|MP:0001556,increased circulating HDL cholesterol level|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0001859,kidney inflammation|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002176,increased brain weight|MP:0002705,dilated renal tubule|MP:0002708,nephrolithiasis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002942,decreased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0002989,small kidney|MP:0003186,abnormal redox activity|MP:0003215,renal interstitial fibrosis|MP:0003402,decreased liver weight|MP:0003587,ureter obstruction|MP:0003606,kidney failure|MP:0003918,decreased kidney weight|MP:0004153,increased renal tubule apoptosis|MP:0004154,renal tubular necrosis|MP:0004194,abnormal kidney pelvis morphology|MP:0004754,abnormal kidney collecting duct morphology|MP:0004860,dilated kidney collecting duct|MP:0004969,pale kidney|MP:0005178,increased circulating cholesterol level|MP:0005266,abnormal metabolism|MP:0005325,abnormal renal glomerulus morphology|MP:0005378,growth/size/body region phenotype|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008822,decreased blood uric acid level|MP:0009350,decreased urine pH|MP:0009640,abnormal renal tubule epithelium morphology|MP:0010024,increased total body fat amount|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011167,abnormal adipose tissue development|MP:0011320,abnormal glomerular capillary morphology|MP:0011335,abnormal kidney pelvis smooth muscle morphology|MP:0011336,abnormal kidney pelvis urothelium morphology|MP:0011346,renal tubule atrophy|MP:0011402,renal cast|MP:0011405,tubulointerstitial nephritis|MP:0011413,colorless urine|MP:0011440,increased kidney cell proliferation|MP:0013242,abnormal amino acid metabolism|MP:0013245,abnormal lipid metabolism|MP:0031479,increased urine xanthine level|MP:0031484,increased urine hypoxanthine level|MP:0031487,increased circulating hypoxanthine level|MP:0031490,increased circulating xanthine level
MGI:2659140	Mocs1<tm1Jre>	MP:0001265,decreased body size|MP:0001274,curly vibrissae|MP:0003311,aminoaciduria|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009643,abnormal urine homeostasis|MP:0011085,postnatal lethality, complete penetrance|MP:0011424,decreased urine uric acid level|MP:0020400,cystinuria|MP:0020405,taurinuria|MP:0031479,increased urine xanthine level
MGI:5548433	Mocs2<tm1b(EUCOMM)Wtsi>	MP:0001258,decreased body length|MP:0001289,persistence of hyaloid vascular system|MP:0005634,decreased circulating sodium level|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:4881158	Mocs2<tm1(KOMP)Vlcg>	MP:0000315,hemoglobinuria|MP:0000746,weakness|MP:0000747,muscle weakness|MP:0001195,flaky skin|MP:0001211,wrinkled skin|MP:0001265,decreased body size|MP:0001274,curly vibrissae|MP:0001732,postnatal growth retardation|MP:0002073,abnormal hair growth|MP:0002098,abnormal vibrissa morphology|MP:0002708,nephrolithiasis|MP:0002962,increased urine protein level|MP:0003203,increased neuron apoptosis|MP:0003606,kidney failure|MP:0003622,ischuria|MP:0004194,abnormal kidney pelvis morphology|MP:0004754,abnormal kidney collecting duct morphology|MP:0005553,increased circulating creatinine level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008489,slow postnatal weight gain|MP:0008822,decreased blood uric acid level|MP:0009552,urinary bladder obstruction|MP:0009642,abnormal blood homeostasis|MP:0011085,postnatal lethality, complete penetrance|MP:0011419,erythrocyturia|MP:0011424,decreased urine uric acid level|MP:0011625,cystolithiasis|MP:0020400,cystinuria|MP:0031479,increased urine xanthine level|MP:0031484,increased urine hypoxanthine level
MGI:5585501	moct	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001309,hydropic eye lens fibers
MGI:3037096	Modc1<C3H/HeJ>	MP:0002052,decreased tumor incidence
MGI:3618854	Modc2<BALB/cJ>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:2389304	Modm<BALB/cByJ>	MP:0008877,abnormal DNA methylation
MGI:2389305	Modm<C57BL/6ByJ>	MP:0008877,abnormal DNA methylation
MGI:6399911	Mogat1<em1(IMPC)Hmgu>	MP:0001510,abnormal coat appearance|MP:0011874,enlarged urinary bladder|MP:0011965,decreased total retina thickness
MGI:5785005	Mogat1<tm1Far>	MP:0001262,decreased body weight|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype
MGI:6276905	Mogat2<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0009142,decreased prepulse inhibition
MGI:4415181	Mogat2<tm1.1Ryyo>	MP:0002644,decreased circulating triglyceride level|MP:0005381,digestive/alimentary phenotype
MGI:3848538	Mogat2<tm1Far>	MP:0000183,decreased circulating LDL cholesterol level|MP:0002310,decreased susceptibility to hepatic steatosis|MP:0002323,decreased susceptibility to hyperlipidemia|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005342,abnormal intestinal lipid absorption|MP:0005459,decreased percent body fat/body weight|MP:0005533,increased body temperature|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009128,decreased brown fat cell number
MGI:5637101	Mogs<tm1.1(KOMP)Vlcg>	MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration|MP:0013292,embryonic lethality prior to organogenesis
MGI:3808372	Mogs<tm1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0000467,abnormal esophagus morphology|MP:0000681,abnormal thyroid gland morphology|MP:0000709,enlarged thymus|MP:0001293,anophthalmia|MP:0001944,abnormal pancreas morphology|MP:0002282,abnormal trachea morphology|MP:0002544,brachydactyly|MP:0005313,absent adrenal gland|MP:0008024,absent lymph nodes|MP:0011100,preweaning lethality, complete penetrance
MGI:2675017	Mog<tm1Dpd>	MP:0003631,nervous system phenotype|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005387,immune system phenotype
MGI:2683672	Mog<tm1Reid>	MP:0003009,abnormal cytokine secretion|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005348,increased T cell proliferation|MP:0005465,abnormal T-helper 1 physiology|MP:0008687,increased interleukin-2 secretion|MP:0008705,increased interleukin-6 secretion
MGI:3607567	Mohg1<CAST/EiJ>	MP:0006086,decreased body mass index
MGI:3656296	Mohg4<CAST/EiJ>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0008907,decreased total fat pad weight
MGI:3656299	Mohg5<CAST/EiJ>	MP:0000592,short tail|MP:0001258,decreased body length
MGI:3656305	Mohg6<CAST/EiJ>	MP:0000592,short tail|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0010025,decreased total body fat amount
MGI:3656372	Mohg7<CAST/EiJ>	MP:0000592,short tail|MP:0001262,decreased body weight|MP:0006086,decreased body mass index|MP:0008907,decreased total fat pad weight|MP:0010025,decreased total body fat amount
MGI:3656376	Mohg8<CAST/EiJ>	MP:0000592,short tail|MP:0001258,decreased body length|MP:0001262,decreased body weight
MGI:3656390	Mohg9<CAST/EiJ>	MP:0010025,decreased total body fat amount
MGI:2156744	Mol1<BALB/cByJ>	MP:0005093,decreased B cell proliferation
MGI:2154431	Mol2<DBA/2N>	MP:0001846,increased inflammatory response
MGI:3723022	Mom21<BTBR>	MP:0010279,increased gastrointestinal tumor incidence
MGI:3723023	Mom7<AKR>	MP:0010279,increased gastrointestinal tumor incidence
MGI:3586550	MommeD3	MP:0011091,prenatal lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:5662453	Mon1a<em1(IMPC)J>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001486,abnormal startle reflex|MP:0013278,decreased fasting circulating glucose level
MGI:6241417	Mon1b<em1(IMPC)J>	MP:0002075,abnormal coat/hair pigmentation|MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin
MGI:6163850	Mon2<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002833,increased heart weight|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3037108	Moo1<BTBR>	MP:0001260,increased body weight
MGI:3037111	Moo2<C57BL/6J>	MP:0001260,increased body weight
MGI:2156652	Mop1<C57BL/6J>	MP:0002553,preference for addictive substance
MGI:2158228	Mop2<C57BL/6J>	MP:0002553,preference for addictive substance
MGI:2158229	Mop2<DBA/2J>	MP:0002553,preference for addictive substance
MGI:2154236	Mop3<C57BL/6J>	MP:0002554,aversion to addictive substance
MGI:2155893	Mopkd1<DBA/2J>	MP:0008528,polycystic kidney
MGI:2429585	Mopkd2<CAST/EiJ>	MP:0008528,polycystic kidney
MGI:1857787	Morc1<Tg(Tyr)1Az>	MP:0001147,small testis|MP:0001648,abnormal apoptosis|MP:0001925,male infertility|MP:0003360,abnormal depression-related behavior|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005386,behavior/neurological phenotype|MP:0008261,arrest of male meiosis
MGI:6140214	Morc2a<em1(IMPC)Wtsi>	MP:0000026,abnormal inner ear morphology|MP:0000049,abnormal middle ear morphology|MP:0000075,absent neurocranium|MP:0000104,abnormal sphenoid bone morphology|MP:0000141,abnormal vertebral body morphology|MP:0000149,abnormal scapula morphology|MP:0000150,abnormal rib morphology|MP:0000186,decreased circulating HDL cholesterol level|MP:0000282,abnormal interatrial septum morphology|MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000432,abnormal head morphology|MP:0000454,abnormal jaw morphology|MP:0000550,abnormal forelimb morphology|MP:0000552,abnormal radius morphology|MP:0000553,absent radius|MP:0000554,abnormal carpal bone morphology|MP:0000565,oligodactyly|MP:0000598,abnormal liver morphology|MP:0000613,abnormal salivary gland morphology|MP:0000614,absent salivary gland|MP:0000632,abnormal pineal gland morphology|MP:0000633,abnormal pituitary gland morphology|MP:0000639,abnormal adrenal gland morphology|MP:0000681,abnormal thyroid gland morphology|MP:0000705,athymia|MP:0000706,small thymus|MP:0000783,abnormal forebrain morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000841,abnormal hindbrain morphology|MP:0001014,absent superior cervical ganglion|MP:0001067,absent mandibular nerve|MP:0001093,small trigeminal ganglion|MP:0001127,small ovary|MP:0001146,abnormal testis morphology|MP:0001303,abnormal lens morphology|MP:0001916,intracerebral hemorrhage|MP:0002152,abnormal brain morphology|MP:0002237,abnormal nasal cavity morphology|MP:0002239,abnormal nasal septum morphology|MP:0002243,abnormal vomeronasal organ morphology|MP:0002279,abnormal diaphragm morphology|MP:0002633,persistent truncus arteriosus|MP:0002768,small adrenal glands|MP:0002951,small thyroid gland|MP:0002989,small kidney|MP:0003078,aphakia|MP:0003327,liver cyst|MP:0003686,abnormal eye muscle morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0003827,abnormal Wolffian duct morphology|MP:0003924,diaphragmatic hernia|MP:0003984,embryonic growth retardation|MP:0004158,right aortic arch|MP:0004234,abnormal masticatory muscle morphology|MP:0004247,small pancreas|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0004352,absent humerus|MP:0004440,absent occipital bone|MP:0004463,basisphenoid bone foramen|MP:0004599,abnormal vertebral arch morphology|MP:0004666,absent stapedial artery|MP:0004668,absent vertebral body|MP:0004790,absent upper incisors|MP:0005105,abnormal middle ear ossicle morphology|MP:0005107,abnormal stapes morphology|MP:0005108,abnormal ulna morphology|MP:0005157,holoprosencephaly|MP:0005236,abnormal olfactory nerve morphology|MP:0005269,abnormal occipital bone morphology|MP:0005296,abnormal humerus morphology|MP:0005298,abnormal clavicle morphology|MP:0005315,absent pituitary gland|MP:0005358,abnormal incisor morphology|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006033,abnormal external auditory canal morphology|MP:0006063,abnormal inferior vena cava morphology|MP:0006425,absent Mullerian ducts|MP:0008128,abnormal brain internal capsule morphology|MP:0008797,facial cleft|MP:0008923,thoracoschisis|MP:0009073,absent Wolffian ducts|MP:0009495,abnormal common bile duct morphology|MP:0009569,abnormal left lung morphology|MP:0009570,abnormal right lung morphology|MP:0009707,absent external auditory canal|MP:0009771,absent optic chiasm|MP:0009820,abnormal liver vasculature morphology|MP:0009904,tongue hypoplasia|MP:0009917,abnormal hyoid bone body morphology|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010434,double inlet heart right ventricle|MP:0010465,aberrant origin of the right subclavian artery|MP:0010496,abnormal pectinate muscle morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0013816,absent digastric muscle|MP:0013822,abnormal anterior cerebral artery morphology|MP:0013823,absent segment of anterior cerebral artery|MP:0013830,abnormal intrathoracic topology of vagus nerve|MP:0013836,abnormal hypoglossal nerve topology|MP:0013848,subcutaneous edema|MP:0013851,abnormal Wolffian duct topology|MP:0013854,abnormal celiac artery morphology|MP:0013859,abnormal vitelline vein connection|MP:0013865,abnormal dorsal pancreas topology|MP:0013874,abnormal ductus venosus topology|MP:0013875,increased trigeminal neuroma incidence|MP:0013876,absent ductus venosus valve|MP:0013914,absent intracranial segment of vertebral artery|MP:0013927,abnormal facial nerve topology|MP:0013929,absent eye muscles|MP:0013931,abnormal olfactory bulb position|MP:0013932,fragmented Meckel's cartilage|MP:0013936,abnormal thymus topology|MP:0013943,abnormal ureter topology|MP:0013952,retroesophageal left subclavian artery|MP:0013953,left sided brachiocephalic trunk|MP:0013967,abnormal infrahyoid muscle connection|MP:0013969,reduced sympathetic cervical ganglion size|MP:0013970,absent connection between subcutaneous lymph vessels and lymph sac|MP:0013971,blood in lymph vessels|MP:0013979,abnormal subclavian artery origin|MP:0013987,absent intrahepatic inferior vena cava segment|MP:0013992,persistent dorsal ophthalmic artery|MP:0013996,abnormal vertebral artery origin|MP:0013997,abnormal internal carotid artery topology|MP:0014006,absent posterior communicating artery|MP:0014021,heterochrony|MP:0014023,abnormal intestine placement|MP:0014110,absent ventral pancreas|MP:0014111,small ventral pancreas|MP:0014113,small dorsal pancreas|MP:0020301,short tongue
MGI:7579187	Morc2a<em1Snupy>	MP:0000880,decreased Purkinje cell number|MP:0000920,abnormal myelination|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0003203,increased neuron apoptosis|MP:0005113,decreased spinal cord ventral horn cell number|MP:0005369,muscle phenotype|MP:0005402,abnormal action potential|MP:0008814,decreased nerve conduction velocity|MP:0009413,skeletal muscle fiber atrophy|MP:0009417,skeletal muscle atrophy|MP:0009434,paraparesis|MP:0011091,prenatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0014114,abnormal cognition|MP:0014185,cerebellum atrophy
MGI:7423695	Morc2a<tm1.1Pngr>	MP:0000440,domed cranium|MP:0000899,abnormal corpora quadrigemina morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0004811,abnormal neuron physiology|MP:0005238,increased brain size|MP:0005386,behavior/neurological phenotype|MP:0009453,enhanced contextual conditioning behavior|MP:0010053,decreased grip strength|MP:0012091,increased midbrain size
MGI:7423696	Morc2a<tm1.2Pngr>	MP:0001698,decreased embryo size|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5637080	Morc2a<tm1b(KOMP)Wtsi>	MP:0001406,abnormal gait|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6117872	Morc2b<tm1Jw>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001930,abnormal meiosis|MP:0004805,absent oocytes|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0008261,arrest of male meiosis|MP:0009451,abnormal chromosomal synapsis|MP:0014052,increased male germ cell apoptosis|MP:0014764,impaired double-strand DNA break repair|MP:0031474,increased female germ cell apoptosis
MGI:5819216	Morc3<tm1b(EUCOMM)Hmgu>	MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0001417,decreased exploration in new environment|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0005016,decreased lymphocyte cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0011100,preweaning lethality, complete penetrance|MP:0012362,increased large unstained cell number
MGI:3765156	Morc3<tm1Noin>	MP:0005380,embryo phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:6276942	Morc4<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0003900,shortened QT interval|MP:0005553,increased circulating creatinine level
MGI:3583110	Mord2<NZW/LacJ>	MP:0003455,decreased susceptibility to induced retina damage
MGI:3583111	Mord3<C57BL/6J>	MP:0003455,decreased susceptibility to induced retina damage
MGI:3576922	Morf4l1<tm1Kto>	MP:0000352,decreased cell proliferation|MP:0001199,thin skin|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001625,cardiac hypertrophy|MP:0001786,skin edema|MP:0001953,respiratory failure|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003717,pallor|MP:0004200,decreased fetal size|MP:0010017,visceral vascular congestion|MP:0010018,pulmonary vascular congestion|MP:0010019,liver vascular congestion|MP:0010020,spleen vascular congestion|MP:0011089,perinatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0031131,myocardial fiber disarray
MGI:3581793	Morf4l2<tm1.1Kto>	MP:0002169,no abnormal phenotype detected
MGI:6361170	Morn3<em1Osb>	MP:0005389,reproductive system phenotype
MGI:2154243	Morph1<DBA/2J>	MP:0001981,increased chemically-elicited antinociception
MGI:2157099	Morph2<DBA/2J>	MP:0001981,increased chemically-elicited antinociception
MGI:2157101	Morph3<DBA/2J>	MP:0001981,increased chemically-elicited antinociception
MGI:2157838	Morph4<DBA/2J>	MP:0001981,increased chemically-elicited antinociception
MGI:6358426	Morrbid<em1Flv>	MP:0000222,decreased neutrophil cell number|MP:0001601,abnormal myelopoiesis|MP:0002412,increased susceptibility to bacterial infection|MP:0002442,abnormal leukocyte physiology|MP:0002463,abnormal neutrophil physiology|MP:0002465,abnormal eosinophil physiology|MP:0005012,decreased eosinophil cell number|MP:0005387,immune system phenotype|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0013023,decreased Ly6C high monocyte number|MP:0013026,decreased Ly6C low monocyte number
MGI:2154245	Mors1<BALB/cJ>	MP:0002161,abnormal fertility/fecundity
MGI:2155393	Mors2<BALB/cJ>	MP:0002161,abnormal fertility/fecundity
MGI:6782393	Mosmo<em1Rroh>	MP:0000284,double outlet right ventricle|MP:0000531,right pulmonary isomerism|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0000914,exencephaly|MP:0002633,persistent truncus arteriosus|MP:0002764,short tibia|MP:0002766,situs inversus|MP:0004110,transposition of great arteries|MP:0004133,heterotaxia|MP:0004320,split sternum|MP:0006065,abnormal heart position or orientation|MP:0006113,abnormal heart septum morphology|MP:0009743,preaxial polydactyly|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010854,lung situs inversus|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0031284,abdominal situs abnormality
MGI:4362521	Mospd1<tm1a(KOMP)Wtsi>	MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:6690853	Mospd2<tm1.2Geno>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0002444,abnormal T cell physiology|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005387,immune system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008567,decreased interferon-gamma secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008699,increased interleukin-4 secretion|MP:0013023,decreased Ly6C high monocyte number|MP:0013662,decreased myeloid cell number|MP:0020212,impaired leukocyte migration
MGI:3510668	Mospd3<Gt(PT1-ATG)124Wrst>	MP:0000279,ventricular hypoplasia|MP:0000295,trabecula carnea hypoplasia|MP:0000486,abnormal pulmonary trunk morphology|MP:0002754,dilated heart right ventricle|MP:0004061,papillary muscle hypoplasia|MP:0005385,cardiovascular system phenotype|MP:0010428,abnormal heart right ventricle outflow tract morphology|MP:0010499,abnormal ventricle myocardium morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0021160,decreased heart right ventricle wall thickness
MGI:5635170	Mos<tm1.1(KOMP)Vlcg>	MP:0002833,increased heart weight|MP:0003795,abnormal bone structure
MGI:1857218	Mos<tm1Ev>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002016,ovary cyst|MP:0005168,abnormal female meiosis|MP:0005389,reproductive system phenotype|MP:0009761,abnormal meiotic spindle morphology|MP:0012736,abnormal polar body morphology
MGI:3640947	Mos<tm1Gvw>	MP:0001923,reduced female fertility|MP:0005168,abnormal female meiosis|MP:0009443,parthenogenesis|MP:0009761,abnormal meiotic spindle morphology|MP:0012737,abnormal primary polar body morphology
MGI:2429547	Mos<tm1Sia>	MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0002627,increased teratoma incidence|MP:0005168,abnormal female meiosis
MGI:3056349	Motr1<AKR/J>	MP:0006069,abnormal retina neuronal layer morphology|MP:0006070,increased retina photoreceptor cell number
MGI:7425836	Mov10<em1(IMPC)Tcp>	MP:0001325,abnormal retina morphology|MP:0002060,abnormal skin morphology|MP:0002792,abnormal retina vasculature morphology|MP:0009142,decreased prepulse inhibition|MP:0010097,abnormal retina blood vessel morphology|MP:0020421,increased freezing behavior
MGI:5161082	Mov10<Gt(IST13267G7)Tigm>	MP:0001363,increased anxiety-related response|MP:0005386,behavior/neurological phenotype|MP:0008143,abnormal dendrite morphology|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance|MP:0031391,increased locomotor activity
MGI:4457261	Mov10l1<tm1.2Eno>	MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001925,male infertility|MP:0003698,abnormal male reproductive system physiology|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis|MP:0014636,decreased elongated spermatid number
MGI:4457276	Mov10l1<tm1.2Jw>	MP:0001147,small testis|MP:0001925,male infertility|MP:0003698,abnormal male reproductive system physiology|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0008878,abnormal DNA methylation during gametogenesis
MGI:5502314	Moxd1<tm2b(KOMP)Wtsi>	MP:0001488,increased startle reflex|MP:0005633,increased circulating sodium level
MGI:1861183	Mp	MP:0000018,small ears|MP:0000564,syndactyly|MP:0001004,abnormal retina photoreceptor morphology|MP:0001005,abnormal retina rod cell morphology|MP:0001262,decreased body weight|MP:0001286,abnormal eye development|MP:0001297,microphthalmia|MP:0001306,small lens|MP:0001328,disorganized retina layers|MP:0002698,abnormal sclera morphology|MP:0002699,abnormal vitreous body morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005099,abnormal ciliary body morphology|MP:0005176,eyelids fail to open|MP:0005241,abnormal retina ganglion layer morphology|MP:0005371,limbs/digits/tail phenotype|MP:0006069,abnormal retina neuronal layer morphology|MP:0008730,fused phalanges|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009772,abnormal retina development
MGI:5503988	mp107H	MP:0002932,abnormal joint morphology|MP:0005508,abnormal skeleton morphology
MGI:5791982	mp95H	MP:0001393,ataxia
MGI:5791989	mp97H	MP:0002766,situs inversus
MGI:3713348	Mpaps1<C57BL/6J>	MP:0001293,anophthalmia|MP:0001297,microphthalmia
MGI:5791990	mpc107H	MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level
MGI:5791991	mpc111H	MP:0000063,decreased bone mineral density
MGI:5503989	mpc116H	MP:0002115,abnormal limb bone morphology
MGI:5791992	mpc119H	MP:0001146,abnormal testis morphology|MP:0014143,decreased body fat mass
MGI:5791994	mpc121H	MP:0000745,tremors|MP:0010053,decreased grip strength
MGI:5791995	mpc131H	MP:0000198,decreased circulating phosphate level|MP:0001262,decreased body weight|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level
MGI:5791996	mpc134H	MP:0005343,increased circulating aspartate transaminase level
MGI:5791999	mpc162H	MP:0006149,decreased visual acuity
MGI:5792000	mpc165H	MP:0005293,impaired glucose tolerance
MGI:5792001	mpc168H	MP:0005293,impaired glucose tolerance
MGI:5792003	mpc172H	MP:0005293,impaired glucose tolerance
MGI:5792005	mpc174H	MP:0002075,abnormal coat/hair pigmentation
MGI:5792016	mpc184H	MP:0014143,decreased body fat mass
MGI:5792017	mpc185H	MP:0014143,decreased body fat mass
MGI:5792533	mpc186H	MP:0002628,hepatic steatosis
MGI:5792021	mpc190H	MP:0001967,deafness|MP:0005293,impaired glucose tolerance
MGI:5903307	Mpc1<tm1c(EUCOMM)Wtsi>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001262,decreased body weight|MP:0001326,retina degeneration|MP:0002078,abnormal glucose homeostasis|MP:0002575,increased circulating ketone body level|MP:0002644,decreased circulating triglyceride level|MP:0002891,increased insulin sensitivity|MP:0003383,abnormal gluconeogenesis|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005179,decreased circulating cholesterol level|MP:0005253,abnormal eye physiology|MP:0005266,abnormal metabolism|MP:0005292,improved glucose tolerance|MP:0005317,increased triglyceride level|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005547,abnormal Muller cell morphology|MP:0005560,decreased circulating glucose level|MP:0006036,abnormal mitochondrial physiology|MP:0008513,thin retina inner plexiform layer|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment|MP:0010379,decreased respiratory quotient|MP:0013405,increased circulating lactate level|MP:0014171,increased fatty acid oxidation|MP:0020813,abnormal photoreceptor outer segment disc membrane morphology
MGI:5792119	mpc201H	MP:0005293,impaired glucose tolerance
MGI:5792028	mpc202H	MP:0004748,increased susceptibility to age-related hearing loss
MGI:5792030	mpc203H	MP:0000745,tremors|MP:0001406,abnormal gait|MP:0004748,increased susceptibility to age-related hearing loss
MGI:5792041	mpc225H	MP:0001406,abnormal gait|MP:0005293,impaired glucose tolerance
MGI:5792043	mpc227H	MP:0001967,deafness
MGI:5792075	mpc231H	MP:0001967,deafness|MP:0013279,increased fasting circulating glucose level
MGI:5792081	mpc233H	MP:0001265,decreased body size|MP:0001399,hyperactivity
MGI:5792082	mpc234H	MP:0013279,increased fasting circulating glucose level
MGI:5792087	mpc244H	MP:0001393,ataxia|MP:0004924,abnormal behavior
MGI:5792089	mpc253H	MP:0002816,colitis
MGI:5792090	mpc256H	MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level
MGI:5792095	mpc267H	MP:0014638,increased sleep duration
MGI:5792098	mpc274H	MP:0002075,abnormal coat/hair pigmentation
MGI:5792099	mpc275H	MP:0000585,kinked tail
MGI:5792100	mpc276H	MP:0014638,increased sleep duration
MGI:5792101	mpc282H	MP:0001759,increased urine glucose level|MP:0005293,impaired glucose tolerance
MGI:5792104	mpc285H	MP:0000034,abnormal inner ear vestibule morphology|MP:0001967,deafness|MP:0005293,impaired glucose tolerance|MP:0006243,impaired pupillary reflex
MGI:5792106	mpc286H	MP:0005293,impaired glucose tolerance|MP:0014143,decreased body fat mass
MGI:5792108	mpc290H	MP:0000428,abnormal craniofacial morphology|MP:0001967,deafness|MP:0003961,decreased lean body mass|MP:0014143,decreased body fat mass
MGI:5792109	mpc291H	MP:0005293,impaired glucose tolerance
MGI:5792110	mpc292H	MP:0000745,tremors|MP:0001513,limb grasping
MGI:5792112	mpc295H	MP:0000611,jaundice
MGI:5792113	mpc298H	MP:0001326,retina degeneration
MGI:5634969	Mpc2<em1Finc>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5635078	Mpc2<em2Finc>	MP:0002575,increased circulating ketone body level|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005559,increased circulating glucose level|MP:0006036,abnormal mitochondrial physiology|MP:0010768,mortality/aging|MP:0013405,increased circulating lactate level
MGI:5792114	mpc303H	MP:0001513,limb grasping
MGI:5792115	mpc312H	MP:0000034,abnormal inner ear vestibule morphology|MP:0001967,deafness|MP:0005293,impaired glucose tolerance
MGI:5791972	mpc63H	MP:0000745,tremors
MGI:5791973	mpc66H	MP:0001406,abnormal gait
MGI:5791974	mpc81H	MP:0002075,abnormal coat/hair pigmentation|MP:0014143,decreased body fat mass
MGI:5791976	mpc87H	MP:0000519,hydronephrosis|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule
MGI:5791988	mpc96H	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001265,decreased body size|MP:0001304,cataract|MP:0006325,impaired hearing
MGI:3603233	Mpdk1<CAST/Ei>	MP:0002706,abnormal kidney size|MP:0003917,increased kidney weight
MGI:3603235	Mpdk2<CAST/Ei>	MP:0002706,abnormal kidney size|MP:0003254,bile duct inflammation|MP:0003917,increased kidney weight
MGI:3603237	Mpdk3<CAST/Ei>	MP:0002706,abnormal kidney size|MP:0003917,increased kidney weight
MGI:3603239	Mpdk4<CAST/Ei>	MP:0002706,abnormal kidney size|MP:0003917,increased kidney weight
MGI:3603241	Mpdk5<CAST/Ei>	MP:0002706,abnormal kidney size|MP:0003917,increased kidney weight
MGI:3603243	Mpdk6<CAST/Ei>	MP:0003253,dilated bile duct
MGI:3603246	Mpdk7<CAST/Ei>	MP:0003254,bile duct inflammation
MGI:3603248	Mpdk8<CAST/Ei>	MP:0003254,bile duct inflammation
MGI:5571597	Mpdz<em1(IMPC)J>	MP:0001325,abnormal retina morphology|MP:0001489,decreased startle reflex|MP:0002792,abnormal retina vasculature morphology|MP:0002833,increased heart weight|MP:0004738,abnormal auditory brainstem response|MP:0005292,improved glucose tolerance|MP:0005627,increased circulating potassium level|MP:0010053,decreased grip strength|MP:0010097,abnormal retina blood vessel morphology
MGI:4125903	Mpdz<Gt(XG734)Byg>	MP:0002570,alcohol aversion|MP:0003546,decreased alcohol consumption|MP:0009775,increased behavioral withdrawal response
MGI:6281023	Mpeg1<tm1Pod>	MP:0009785,abnormal susceptibility to infection induced morbidity/mortality
MGI:4432493	Mpg<tm1a(EUCOMM)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level
MGI:2675730	Mpg<tm1Lds>	MP:0001844,autoimmune response|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005387,immune system phenotype|MP:0005559,increased circulating glucose level|MP:0006042,increased apoptosis|MP:0009172,small pancreatic islets
MGI:2148592	Mpg<tm1Rhe>	MP:0003562,abnormal pancreatic beta cell physiology|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005334,abnormal fat pad morphology|MP:0005559,increased circulating glucose level|MP:0008034,enhanced lipolysis|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008872,abnormal physiological response to xenobiotic|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009488,abnormal pancreatic islet cell apoptosis
MGI:6258450	Mphosph10<em1(IMPC)J>	MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6316624	Mphosph8<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:7423697	Mphosph8<tm1c(EUCOMM)Wtsi>	MP:0000440,domed cranium|MP:0000899,abnormal corpora quadrigemina morphology|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0005238,increased brain size
MGI:7423698	Mphosph8<tm1d(EUCOMM)Wtsi>	MP:0011092,embryonic lethality, complete penetrance
MGI:6324155	Mphosph9<tm1e.1(EUCOMM)Hmgu>	MP:0008806,increased circulating amylase level|MP:0009141,increased prepulse inhibition
MGI:5512767	Mpig6b<tm1.1Arte>	MP:0000229,abnormal megakaryocyte differentiation|MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0002356,abnormal spleen red pulp morphology|MP:0002397,abnormal bone marrow morphology|MP:0002599,increased mean platelet volume|MP:0003179,thrombocytopenia|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0008254,increased megakaryocyte cell number|MP:0009448,decreased platelet ATP level|MP:0009549,decreased platelet aggregation|MP:0011746,spleen fibrosis|MP:0011747,myelofibrosis
MGI:5569070	Mpig6b<tm1.1(KOMP)Vlcg>	MP:0000198,decreased circulating phosphate level|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002599,increased mean platelet volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0004952,increased spleen weight|MP:0005573,increased pulmonary respiratory rate|MP:0012125,decreased bronchoconstrictive response
MGI:3628756	Mpi<Gt(OST90588)Lex>	MP:0000259,abnormal vascular development|MP:0000260,abnormal angiogenesis|MP:0000350,abnormal cell proliferation|MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0001719,absent vitelline blood vessels|MP:0002824,abnormal chorioallantoic fusion|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0004188,delayed embryo turning|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0005621,abnormal cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:4432151	Mpi<tm1a(EUCOMM)Wtsi>	MP:0002896,abnormal bone mineralization|MP:0009141,increased prepulse inhibition
MGI:6442537	Mpl<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001529,abnormal vocalization|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002397,abnormal bone marrow morphology|MP:0002997,enlarged seminal vesicle|MP:0003921,abnormal heart left ventricle morphology
MGI:2680465	Mpl<hlb219>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002123,abnormal definitive hematopoiesis|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0005505,thrombocytosis|MP:0005606,increased bleeding time|MP:0008255,decreased megakaryocyte cell number|MP:0008813,decreased common myeloid progenitor cell number|MP:0010210,abnormal circulating cytokine level
MGI:7518886	Mplkip<em1Nimo>	MP:0005378,growth/size/body region phenotype
MGI:7518887	Mplkip<em2Nimo>	MP:0000416,sparse hair|MP:0000774,decreased brain size|MP:0001516,abnormal motor coordination/balance|MP:0002065,abnormal fear/anxiety-related behavior|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003360,abnormal depression-related behavior|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008489,slow postnatal weight gain|MP:0010768,mortality/aging|MP:0011101,prenatal lethality, incomplete penetrance|MP:0031391,increased locomotor activity
MGI:5569045	Mplkip<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0000443,abnormal snout morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001258,decreased body length|MP:0001944,abnormal pancreas morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002833,increased heart weight|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:2686901	Mpl<tm1Fjs>	MP:0002123,abnormal definitive hematopoiesis|MP:0002413,abnormal megakaryocyte progenitor cell morphology
MGI:2660810	Mpl<tm1Mwm>	MP:0002599,increased mean platelet volume|MP:0003179,thrombocytopenia|MP:0005387,immune system phenotype|MP:0008253,absent megakaryocytes
MGI:2660811	Mpl<tm1Wsa>	MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0003179,thrombocytopenia|MP:0004810,decreased hematopoietic stem cell number|MP:0005387,immune system phenotype|MP:0008253,absent megakaryocytes|MP:0010209,abnormal circulating chemokine level
MGI:5607579	Mpl<tm2.1Wsa>	MP:0000691,enlarged spleen|MP:0002417,abnormal megakaryocyte morphology|MP:0005505,thrombocytosis|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008254,increased megakaryocyte cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0011902,increased hematopoietic stem cell proliferation
MGI:5607583	Mpl<tm2.2Wsa>	MP:0003179,thrombocytopenia
MGI:7384385	Mpnd<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0002965,increased circulating serum albumin level
MGI:2385836	Mpo<tm1Lus>	MP:0000220,increased monocyte cell number|MP:0001876,decreased inflammatory response|MP:0002463,abnormal neutrophil physiology|MP:0004087,abnormal muscle fiber morphology|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005044,sepsis|MP:0005164,abnormal response to injury|MP:0005338,atherosclerotic lesions|MP:0005399,increased susceptibility to fungal infection|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:2176344	Mpo<tm1Mae>	MP:0002463,abnormal neutrophil physiology|MP:0005266,abnormal metabolism|MP:0005399,increased susceptibility to fungal infection
MGI:6399894	Mpp1<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001262,decreased body weight|MP:0001293,anophthalmia|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0011045,decreased lung elastance|MP:0013763,increased T-helper cell number|MP:0013771,decreased effector memory T-helper cell number|MP:0013772,increased effector memory T-helper cell number
MGI:4412070	Mpp1<tm1Ahc>	MP:0001935,decreased litter size|MP:0002463,abnormal neutrophil physiology|MP:0008720,impaired neutrophil chemotaxis
MGI:6148225	Mpp2<tm1b(KOMP)Wtsi>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005293,impaired glucose tolerance|MP:0011965,decreased total retina thickness
MGI:5529041	Mpp3<tm1.1Wij>	MP:0000788,abnormal cerebral cortex morphology|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0004760,increased mitotic index|MP:0006009,abnormal neuronal migration|MP:0009760,abnormal mitotic spindle morphology|MP:0010236,abnormal retina outer limiting membrane morphology|MP:0012029,abnormal electroretinogram waveform feature|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:5692608	Mpp3<tm1b(EUCOMM)Wtsi>	MP:0002953,thick ventricular wall|MP:0003921,abnormal heart left ventricle morphology|MP:0005560,decreased circulating glucose level|MP:0005599,increased cardiac muscle contractility
MGI:3711731	Mpp4<tm1Tili>	MP:0001004,abnormal retina photoreceptor morphology|MP:0004021,abnormal rod electrophysiology
MGI:3624689	Mpp4<tm1Wij>	MP:0001325,abnormal retina morphology|MP:0003950,abnormal plasma membrane morphology
MGI:5789904	Mpped2<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0001488,increased startle reflex
MGI:6143823	Mprip<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002968,increased circulating alkaline phosphatase level|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5560820	Mpst<tm1.1Nori>	MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001922,reduced male fertility|MP:0003631,nervous system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010069,increased serotonin level
MGI:5692799	Mpst<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment
MGI:5560811	Mpst<tm1Nori>	MP:0001152,increased Leydig cell number|MP:0001925,male infertility|MP:0001940,testis hypoplasia|MP:0005389,reproductive system phenotype|MP:0006379,abnormal spermatocyte morphology
MGI:2656755	Mptp1<C57BL/6J>	MP:0000836,abnormal substantia nigra morphology
MGI:2656756	Mptp1<Swiss Webster>	MP:0000836,abnormal substantia nigra morphology
MGI:7314446	Mptx2<em1Yoxi>	MP:0002412,increased susceptibility to bacterial infection
MGI:1857300	Mpv17	MP:0000031,abnormal cochlea morphology|MP:0000043,organ of Corti degeneration|MP:0000231,hypertension|MP:0000379,decreased hair follicle number|MP:0000523,cortical renal glomerulopathies|MP:0000607,abnormal hepatocyte morphology|MP:0000647,abnormal sebaceous gland morphology|MP:0001199,thin skin|MP:0001218,thin epidermis|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001577,anemia|MP:0001762,polyuria|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0002626,increased heart rate|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002857,cochlear ganglion degeneration|MP:0002871,albuminuria|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0002962,increased urine protein level|MP:0002988,decreased urine osmolality|MP:0003169,abnormal scala media morphology|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0003637,cochlear ganglion hypoplasia|MP:0003917,increased kidney weight|MP:0004363,stria vascularis degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004738,abnormal auditory brainstem response|MP:0004740,sensorineural hearing loss|MP:0004864,spiral ligament degeneration|MP:0005150,cachexia|MP:0005178,increased circulating cholesterol level|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005384,cellular phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005502,abnormal renal/urinary system physiology|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0006316,increased urine sodium level|MP:0008139,fused podocyte foot processes|MP:0008140,podocyte foot process effacement|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008987,abnormal liver lobule morphology|MP:0008989,abnormal liver sinusoid morphology|MP:0008993,abnormal portal triad morphology|MP:0009641,kidney degeneration|MP:0009642,abnormal blood homeostasis|MP:0010090,increased circulating creatine kinase level|MP:0011157,abnormal hypodermis muscle layer morphology|MP:0011294,renal glomerulus hypertrophy|MP:0011320,abnormal glomerular capillary morphology|MP:0011353,expanded mesangial matrix|MP:0011632,dilated mitochondrion|MP:0011635,abnormal mitochondrial crista morphology|MP:0011639,decreased mitochondrial DNA content|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012725,small sebaceous gland|MP:0013405,increased circulating lactate level|MP:0014386,decreased muscle fiber mitochondrial DNA content|MP:0014388,decreased hepatocyte mitochondrial DNA content
MGI:5750696	Mpv17<em1(IMPC)J>	MP:0002833,increased heart weight|MP:0003179,thrombocytopenia|MP:0005560,decreased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level
MGI:5707441	Mpv17l2<tm1.1(KOMP)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001891,hydrocephaly|MP:0002075,abnormal coat/hair pigmentation|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount
MGI:6865789	Mpv17l<em1Riida>	MP:0005292,improved glucose tolerance|MP:0009171,enlarged pancreatic islets
MGI:3609371	Mpvq1<SM/J>	MP:0002599,increased mean platelet volume
MGI:3609362	Mpvq2<SM/J>	MP:0002599,increased mean platelet volume
MGI:5754548	Mpz<em1(IMPC)Tcp>	MP:0000745,tremors|MP:0001175,abnormal lung morphology|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0002060,abnormal skin morphology|MP:0002599,increased mean platelet volume|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0013278,decreased fasting circulating glucose level
MGI:6507873	Mpzl1<em1Ambt>	MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0008489,slow postnatal weight gain|MP:0010768,mortality/aging
MGI:4283287	Mpzl1<Gt(OST332232)Lex>	MP:0002169,no abnormal phenotype detected
MGI:5695917	Mpzl1<tm1.1(KOMP)Vlcg>	MP:0009142,decreased prepulse inhibition|MP:0010123,increased bone mineral content
MGI:8233581	Mpzl2<em1Shuy>	MP:0003631,nervous system phenotype|MP:0004404,cochlear outer hair cell degeneration|MP:0004465,degeneration of organ of Corti supporting cells|MP:0004628,Deiters cell degeneration|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014406,increased or absent distortion product otoacoustic emission threshold
MGI:5636941	Mpzl2<tm1b(EUCOMM)Hmgu>	MP:0001406,abnormal gait|MP:0002075,abnormal coat/hair pigmentation|MP:0002102,abnormal ear morphology|MP:0004357,long tibia|MP:0010024,increased total body fat amount|MP:0010067,increased red blood cell distribution width
MGI:5007250	Mpzl2<tm1Lex>	MP:0005017,decreased B cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:1857012	Mpzl3<rc>	MP:0000063,decreased bone mineral density|MP:0000160,kyphosis|MP:0000194,increased circulating calcium level|MP:0000278,abnormal myocardial fiber morphology|MP:0000321,increased bone marrow cell number|MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000382,underdeveloped hair follicles|MP:0000414,alopecia|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0001194,dermatitis|MP:0001209,spontaneous skin ulceration|MP:0001212,skin lesions|MP:0001222,epidermal hyperplasia|MP:0001263,weight loss|MP:0001386,abnormal maternal nurturing|MP:0001510,abnormal coat appearance|MP:0001511,disheveled coat|MP:0001614,abnormal blood vessel morphology|MP:0001732,postnatal growth retardation|MP:0001860,liver inflammation|MP:0002060,abnormal skin morphology|MP:0003413,hair follicle degeneration|MP:0003795,abnormal bone structure|MP:0003848,brittle hair|MP:0003849,greasy coat|MP:0003875,abnormal hair follicle regression|MP:0004381,abnormal hair follicle melanocyte morphology|MP:0004566,myocardial fiber degeneration|MP:0005081,abnormal dermis reticular layer morphology|MP:0009545,abnormal dermis papillary layer morphology|MP:0009793,sebaceous gland hypertrophy|MP:0009932,skin fibrosis|MP:0010025,decreased total body fat amount|MP:0010179,rough coat|MP:0010206,pigment incontinence|MP:0010699,dilated hair follicle|MP:0020010,decreased bone mineral density of femur
MGI:1856627	Mpzl3<ruf>	MP:0000367,abnormal coat/ hair morphology|MP:0000647,abnormal sebaceous gland morphology|MP:0000652,enlarged sebaceous gland|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001510,abnormal coat appearance|MP:0001511,disheveled coat|MP:0002060,abnormal skin morphology|MP:0002074,abnormal hair texture|MP:0002991,abnormal sebaceous gland physiology|MP:0002992,abnormal sebaceous lipid secretion|MP:0003809,abnormal hair shaft morphology|MP:0003848,brittle hair
MGI:4454034	Mpzl3<tm1(KOMP)Mbp>	MP:0000414,alopecia|MP:0000652,enlarged sebaceous gland|MP:0001209,spontaneous skin ulceration|MP:0001212,skin lesions|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001245,thick dermal layer|MP:0001262,decreased body weight|MP:0001280,loss of vibrissae|MP:0001511,disheveled coat|MP:0001614,abnormal blood vessel morphology|MP:0001874,acanthosis|MP:0002991,abnormal sebaceous gland physiology|MP:0003427,parakeratosis|MP:0003809,abnormal hair shaft morphology|MP:0003849,greasy coat|MP:0004947,skin inflammation|MP:0005335,abnormal gonadal fat pad morphology|MP:0006319,abnormal epididymal fat pad morphology|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009133,decreased white fat cell size|MP:0009600,hypergranulosis|MP:0009675,orthokeratosis|MP:0009792,seborrheic dermatitis|MP:0009793,sebaceous gland hypertrophy|MP:0013373,increased sebum secretion|MP:0030571,dilated piliary canal
MGI:5898283	Mpzl3<tm1Tacz>	MP:0000414,alopecia|MP:0000598,abnormal liver morphology|MP:0000609,abnormal liver physiology|MP:0000652,enlarged sebaceous gland|MP:0001212,skin lesions|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001433,polyphagia|MP:0002075,abnormal coat/hair pigmentation|MP:0002106,abnormal muscle physiology|MP:0002108,abnormal muscle morphology|MP:0002644,decreased circulating triglyceride level|MP:0002665,decreased circulating corticosterone level|MP:0002702,decreased circulating free fatty acids level|MP:0003068,enlarged kidney|MP:0003960,increased lean body mass|MP:0003981,decreased circulating phospholipid level|MP:0004889,increased energy expenditure|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005534,decreased body temperature|MP:0005620,abnormal muscle contractility|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008965,increased basal metabolism|MP:0009356,decreased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0010378,increased respiratory quotient|MP:0014143,decreased body fat mass|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis|MP:0031391,increased locomotor activity
MGI:5490251	Mpz<m1Anu>	MP:0000745,tremors|MP:0001406,abnormal gait|MP:0001513,limb grasping
MGI:6199507	Mpz<m1Btlr>	MP:0001393,ataxia|MP:0001513,limb grasping|MP:0004263,abnormal limb posture
MGI:5824069	Mpz<tm1.1Wra>	MP:0001405,impaired coordination|MP:0013438,dysmyelination|MP:0020452,abnormal axon radial sorting
MGI:2384133	Mpz<tm1Msch>	MP:0000220,increased monocyte cell number|MP:0000745,tremors|MP:0000746,weakness|MP:0000753,paralysis|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001106,abnormal Schwann cell morphology|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001522,impaired swimming|MP:0001844,autoimmune response|MP:0002882,abnormal neuron morphology|MP:0003009,abnormal cytokine secretion|MP:0003224,neuron degeneration|MP:0003312,abnormal locomotor coordination|MP:0003633,abnormal nervous system physiology|MP:0003871,abnormal myelin sheath morphology|MP:0005403,abnormal nerve conduction|MP:0005425,increased macrophage cell number|MP:0005465,abnormal T-helper 1 physiology|MP:0010742,increased Schwann cell number|MP:0010760,abnormal macrophage chemotaxis|MP:0013438,dysmyelination
MGI:5909317	Mpz<tm3.1Wra>	MP:0000745,tremors|MP:0001106,abnormal Schwann cell morphology|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0002651,abnormal sciatic nerve morphology|MP:0003871,abnormal myelin sheath morphology|MP:0005402,abnormal action potential|MP:0008814,decreased nerve conduction velocity|MP:0011731,decreased myelin sheath thickness|MP:0011906,increased Schwann cell proliferation|MP:0013438,dysmyelination|MP:0020354,increased endoplasmic reticulum stress
MGI:3844951	Mpz<ttrr>	MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000921,demyelination|MP:0001406,abnormal gait|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002083,premature death
MGI:6441123	Mr1<em1(IMPC)H>	MP:0000198,decreased circulating phosphate level|MP:0005554,decreased circulating creatinine level
MGI:3664578	Mr1<tm1Gfn>	MP:0002459,abnormal B cell physiology|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0006387,abnormal T cell number|MP:0020186,abnormal susceptibility to bacterial infection
MGI:5526063	Mrap2<tm1.1Maj>	MP:0000005,increased brown adipose tissue amount|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001261,obese|MP:0001433,polyphagia|MP:0001666,abnormal intestinal absorption|MP:0002628,hepatic steatosis|MP:0003961,decreased lean body mass|MP:0003962,abnormal adrenaline level|MP:0003964,abnormal noradrenaline level|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005455,increased susceptibility to weight gain|MP:0005458,increased percent body fat/body weight|MP:0005669,increased circulating leptin level|MP:0009118,increased white fat cell size|MP:0010024,increased total body fat amount|MP:0011939,increased food intake|MP:0011958,increased compensatory feeding amount
MGI:5526064	Mrap2<tm1.2Maj>	MP:0001261,obese|MP:0005455,increased susceptibility to weight gain
MGI:4434054	Mrap2<tm1a(EUCOMM)Wtsi>	MP:0000194,increased circulating calcium level|MP:0002079,increased circulating insulin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0010024,increased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010124,decreased bone mineral content|MP:0013279,increased fasting circulating glucose level
MGI:6356810	Mrap<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0001697,abnormal embryo size|MP:0002060,abnormal skin morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:6363203	Mrap<tm1.2Geno>	MP:0002665,decreased circulating corticosterone level|MP:0002768,small adrenal glands|MP:0005129,increased adrenocorticotropin level|MP:0005376,homeostasis/metabolism phenotype|MP:0006027,impaired lung alveolus development|MP:0009546,absent gastric milk in neonates|MP:0010398,decreased liver glycogen level|MP:0010819,primary atelectasis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0013310,abnormal adrenal gland development|MP:0013565,abnormal adrenal gland capsule morphology
MGI:6741025	Mras<em1(IMPC)H>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002797,increased thigmotaxis|MP:0003960,increased lean body mass|MP:0004924,abnormal behavior|MP:0005553,increased circulating creatinine level|MP:0010025,decreased total body fat amount
MGI:3530902	Mras<Gt(OST108223)Lex>	MP:0002169,no abnormal phenotype detected|MP:0005017,decreased B cell number
MGI:2656742	Mrc1<tm1Jub>	MP:0001729,impaired embryo implantation|MP:0001751,increased circulating luteinizing hormone level|MP:0001935,decreased litter size|MP:0003369,abnormal circulating estrogen level|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2448258	Mrc1<tm1Mnz>	MP:0000322,increased granulocyte number|MP:0002451,abnormal macrophage physiology|MP:0005018,decreased T cell number|MP:0005026,decreased susceptibility to parasitic infection|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality
MGI:2677819	Mrc2<tm1Bug>	MP:0002169,no abnormal phenotype detected
MGI:3722867	Mrc2<tm1Cmi>	MP:0011708,decreased fibroblast cell migration
MGI:5320419	Mre11a<tm1.1Rchd>	MP:0001658,increased mortality induced by gamma-irradiation|MP:0004045,abnormal cell cycle checkpoint function|MP:0004760,increased mitotic index|MP:0004816,abnormal class switch recombination|MP:0005389,reproductive system phenotype|MP:0008866,chromosomal instability|MP:0010768,mortality/aging
MGI:3839938	Mre11a<tm1Dof>	MP:0000267,abnormal heart development|MP:0001672,abnormal embryo development|MP:0001730,embryonic growth arrest|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3027036	Mre11a<tm1Jpt>	MP:0001923,reduced female fertility|MP:0002006,neoplasm|MP:0003718,maternal effect|MP:0004028,chromosome breakage|MP:0004030,induced chromosome breakage|MP:0004045,abnormal cell cycle checkpoint function|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0004228,decreased cellular sensitivity to ionizing radiation induced cell death|MP:0008866,chromosomal instability
MGI:6272743	Mre11a<tm3.1Dof>	MP:0011092,embryonic lethality, complete penetrance
MGI:6378717	Mreg<tm1b(EUCOMM)Hmgu>	MP:0001258,decreased body length|MP:0002339,abnormal lymph node morphology|MP:0004738,abnormal auditory brainstem response|MP:0009142,decreased prepulse inhibition
MGI:3513671	Mrfap1<tm1Kto>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype
MGI:6258432	Mrgbp<em1(IMPC)J>	MP:0001513,limb grasping|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6156568	Mrgprb2<em1(IMPC)Tcp>	MP:0000598,abnormal liver morphology|MP:0000692,small spleen|MP:0001126,abnormal ovary morphology|MP:0001417,decreased exploration in new environment|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002768,small adrenal glands|MP:0002989,small kidney|MP:0008528,polycystic kidney|MP:0011874,enlarged urinary bladder
MGI:5749280	Mrgprb2<em1Xzd>	MP:0001876,decreased inflammatory response|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008765,decreased mast cell degranulation
MGI:3721921	Mrgprb4<tm1And>	MP:0002169,no abnormal phenotype detected
MGI:3852395	Mrgprd<tm1.1(cre)And>	MP:0001973,increased thermal nociceptive threshold|MP:0003463,abnormal single cell response|MP:0005498,hyporesponsive to tactile stimuli
MGI:5661963	Mrgprd<tm1b(EUCOMM)Hmgu>	MP:0010511,shortened PR interval
MGI:3521853	Mrgprd<tm1Mjz>	MP:0001973,increased thermal nociceptive threshold|MP:0003463,abnormal single cell response|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005498,hyporesponsive to tactile stimuli
MGI:4439026	Mrgprd<tm4.1(COP4)Mjz>	MP:0002169,no abnormal phenotype detected
MGI:5050632	Mrgprd<tm5Mjz>	MP:0002169,no abnormal phenotype detected|MP:0002626,increased heart rate|MP:0002795,dilated cardiomyopathy|MP:0003393,decreased cardiac output|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0004937,dilated heart|MP:0005140,decreased cardiac muscle contractility|MP:0005590,increased vasodilation|MP:0008726,increased heart left atrium size|MP:0010579,increased heart left ventricle size|MP:0010613,abnormal mitral valve annulus morphology|MP:0010725,thin interventricular septum|MP:0011925,abnormal heart echocardiography feature|MP:0021158,decreased heart left ventricle wall thickness|MP:0031511,globular heart
MGI:5617260	Mrgpre<tm1.1(KOMP)Vlcg>	MP:0011436,decreased urine magnesium level
MGI:5646195	Mrgpre<tm1Dgen>	MP:0003177,allodynia|MP:0005386,behavior/neurological phenotype
MGI:6200361	Mrgprg<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation
MGI:7639969	Mrgprx1<em1Cao>	MP:0004811,abnormal neuron physiology|MP:0010073,decreased pruritus
MGI:6156593	Mrgprx1<em1(IMPC)Tcp>	MP:0002060,abnormal skin morphology
MGI:7425837	Mri1<em1(IMPC)Bay>	MP:0004952,increased spleen weight
MGI:5705514	Mrln<em1Eno>	MP:0002106,abnormal muscle physiology|MP:0004231,abnormal calcium ion homeostasis|MP:0012107,enhanced exercise endurance
MGI:6113278	Mrln<tm1.1Nju>	MP:0009406,decreased skeletal muscle fiber number|MP:0013239,impaired skeletal muscle regeneration
MGI:5472694	Mrm1<tm2a(EUCOMM)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6257610	Mrm2<em1(IMPC)Bay>	MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness|MP:0013292,embryonic lethality prior to organogenesis
MGI:5516076	Mrm3<tm1.1(KOMP)Vlcg>	MP:0001698,decreased embryo size|MP:0003795,abnormal bone structure|MP:0003984,embryonic growth retardation|MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6711595	Mrnip<em1Nju>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005169,abnormal male meiosis|MP:0009451,abnormal chromosomal synapsis|MP:0011750,abnormal seminiferous tubule epithelium morphology
MGI:4431715	Mrnip<tm1a(EUCOMM)Wtsi>	MP:0001399,hyperactivity
MGI:8192118	Mroh2b<tm1.1Mkob>	MP:0004179,transmission ratio distortion|MP:0006380,abnormal spermatid morphology|MP:0014257,embryonic lethality prior to tooth bud stage, complete penetrance
MGI:8192116	Mroh2b<tm1Mkob>	MP:0004179,transmission ratio distortion|MP:0014257,embryonic lethality prior to tooth bud stage, complete penetrance
MGI:5637041	Mroh4<tm1b(KOMP)Wtsi>	MP:0001510,abnormal coat appearance
MGI:7641858	Mroh7<em1Osb>	MP:0005389,reproductive system phenotype
MGI:7425838	Mroh8<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen
MGI:5302347	Mroh9<tm1a(EUCOMM)Wtsi>	MP:0001925,male infertility
MGI:3831006	Mro<tm1H>	MP:0005389,reproductive system phenotype
MGI:6156503	Mrpl12<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0002135,abnormal kidney morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7645355	Mrpl12<em1Smoc>	MP:0006035,abnormal mitochondrial morphology|MP:0009640,abnormal renal tubule epithelium morphology|MP:0011632,dilated mitochondrion|MP:0011635,abnormal mitochondrial crista morphology
MGI:5703084	Mrpl18<tm1.1(KOMP)Vlcg>	MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5603347	Mrpl22<tm1b(KOMP)Mbp>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0003087,absent allantois|MP:0003886,abnormal embryonic epiblast morphology|MP:0003984,embryonic growth retardation|MP:0004045,abnormal cell cycle checkpoint function|MP:0005384,cellular phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006243,impaired pupillary reflex|MP:0009331,absent primitive node|MP:0010955,abnormal respiratory electron transport chain|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011635,abnormal mitochondrial crista morphology|MP:0012724,absent head fold|MP:0013279,increased fasting circulating glucose level|MP:0013292,embryonic lethality prior to organogenesis|MP:0014246,decreased cellular ATP level|MP:0014586,decreased egg cylinder size
MGI:6144261	Mrpl23<em1(IMPC)H>	MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content
MGI:5694166	Mrpl23<tm2b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5692771	Mrpl33<tm1b(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7408163	Mrpl39<em1(IMPC)J>	MP:0003896,prolonged PR interval|MP:0004738,abnormal auditory brainstem response|MP:0005554,decreased circulating creatinine level|MP:0005559,increased circulating glucose level|MP:0005635,decreased circulating bilirubin level|MP:0011100,preweaning lethality, complete penetrance
MGI:4938306	Mrpl3<dcr>	MP:0000811,hippocampal neuron degeneration|MP:0001505,hunched posture|MP:0001511,disheveled coat|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0003076,increased susceptibility to ischemic brain injury|MP:0003354,astrocytosis|MP:0005150,cachexia|MP:0005202,lethargy|MP:0005385,cardiovascular system phenotype|MP:0008025,brain vacuoles|MP:0008912,nervous|MP:0012307,impaired spatial learning|MP:0012315,impaired learning
MGI:5662430	Mrpl3<em1(IMPC)J>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002968,increased circulating alkaline phosphatase level|MP:0003087,absent allantois|MP:0003886,abnormal embryonic epiblast morphology|MP:0003984,embryonic growth retardation|MP:0004045,abnormal cell cycle checkpoint function|MP:0005344,increased circulating bilirubin level|MP:0005384,cellular phenotype|MP:0005564,increased hemoglobin content|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0009331,absent primitive node|MP:0010955,abnormal respiratory electron transport chain|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011635,abnormal mitochondrial crista morphology|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014246,decreased cellular ATP level|MP:0014586,decreased egg cylinder size
MGI:6279932	Mrpl41<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity|MP:0001695,abnormal gastrulation|MP:0002230,abnormal primitive streak formation|MP:0002582,disorganized extraembryonic tissue|MP:0003984,embryonic growth retardation|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0014586,decreased egg cylinder size
MGI:5286665	Mrpl41<Tg(Tyr)2356A-2b1Ove>	MP:0001672,abnormal embryo development
MGI:5662419	Mrpl44<em1(IMPC)J>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0003087,absent allantois|MP:0003886,abnormal embryonic epiblast morphology|MP:0003984,embryonic growth retardation|MP:0004045,abnormal cell cycle checkpoint function|MP:0005384,cellular phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0009331,absent primitive node|MP:0010955,abnormal respiratory electron transport chain|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011635,abnormal mitochondrial crista morphology|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014246,decreased cellular ATP level|MP:0014586,decreased egg cylinder size
MGI:5708224	Mrpl47<tm1.1(KOMP)Vlcg>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5565611	Mrpl51<tm1.1(KOMP)Vlcg>	MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance|MP:0011435,increased urine magnesium level|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5646002	Mrpl58<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000208,decreased hematocrit|MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:6842911	Mrps12<em1.2Afi>	MP:0000607,abnormal hepatocyte morphology|MP:0003893,increased hepatocyte proliferation|MP:0003982,increased cholesterol level|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0013272,abnormal translation|MP:0030937,increased mitochondrial DNA content
MGI:6257831	Mrps12<em1(IMPC)Bay>	MP:0001417,decreased exploration in new environment|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6842913	Mrps12<em2.2Afi>	MP:0002188,small heart|MP:0002795,dilated cardiomyopathy|MP:0005140,decreased cardiac muscle contractility|MP:0005384,cellular phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0010578,abnormal heart left ventricle size|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0013272,abnormal translation
MGI:5705873	Mrps18c<tm1.1(KOMP)Vlcg>	MP:0000208,decreased hematocrit|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002080,prenatal lethality|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003087,absent allantois|MP:0003886,abnormal embryonic epiblast morphology|MP:0003984,embryonic growth retardation|MP:0004045,abnormal cell cycle checkpoint function|MP:0005384,cellular phenotype|MP:0005554,decreased circulating creatinine level|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0009331,absent primitive node|MP:0010955,abnormal respiratory electron transport chain|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011635,abnormal mitochondrial crista morphology|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014246,decreased cellular ATP level|MP:0014586,decreased egg cylinder size
MGI:4433908	Mrps21<tm1e(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5705875	Mrps22<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0001399,hyperactivity|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0003087,absent allantois|MP:0003886,abnormal embryonic epiblast morphology|MP:0003961,decreased lean body mass|MP:0003984,embryonic growth retardation|MP:0004045,abnormal cell cycle checkpoint function|MP:0005384,cellular phenotype|MP:0005554,decreased circulating creatinine level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0009331,absent primitive node|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010955,abnormal respiratory electron transport chain|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011091,prenatal lethality, complete penetrance|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011635,abnormal mitochondrial crista morphology|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014246,decreased cellular ATP level
MGI:5445931	Mrps25<tm1.1(KOMP)Vlcg>	MP:0000195,decreased circulating calcium level|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001730,embryonic growth arrest|MP:0002582,disorganized extraembryonic tissue|MP:0002833,increased heart weight|MP:0003984,embryonic growth retardation|MP:0005560,decreased circulating glucose level|MP:0005633,increased circulating sodium level|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5763565	Mrps34<m1Anu>	MP:0001625,cardiac hypertrophy|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0003333,liver fibrosis|MP:0005290,decreased oxygen consumption|MP:0005599,increased cardiac muscle contractility|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0013272,abnormal translation|MP:0014238,abnormal ribosome morphology
MGI:4433487	Mrps35<tm1a(EUCOMM)Wtsi>	MP:0002896,abnormal bone mineralization|MP:0003795,abnormal bone structure|MP:0005553,increased circulating creatinine level
MGI:6342898	Mrps36<em1(IMPC)Bay>	MP:0001297,microphthalmia|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011959,abnormal eye posterior chamber depth
MGI:5548689	Mrps5<tm1b(EUCOMM)Wtsi>	MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:7464491	mrs1	MP:0001325,abnormal retina morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0031198,retina inner nuclear layer degeneration
MGI:6414516	Mrs2<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity
MGI:6514834	Mrs2<em1Muma>	MP:0000607,abnormal hepatocyte morphology|MP:0003186,abnormal redox activity|MP:0006036,abnormal mitochondrial physiology|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009642,abnormal blood homeostasis|MP:0010080,abnormal hepatocyte physiology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011628,increased mitochondrial number|MP:0011633,abnormal mitochondrial shape
MGI:3662669	Mrtfa<tm1Eno>	MP:0001882,abnormal lactation|MP:0006270,abnormal mammary gland growth during lactation|MP:0006271,abnormal involution of the mammary gland|MP:0013718,galactostasis|MP:0013719,pale mammary gland|MP:0013778,abnormal mammary gland myoepithelium morphology|MP:0013779,abnormal mammary gland myoepithelium physiology|MP:0014126,increased mammary gland apoptosis
MGI:3665132	Mrtfa<tm1Swm>	MP:0000627,abnormal mammary gland morphology|MP:0001787,pericardial edema|MP:0001881,abnormal mammary gland physiology|MP:0001882,abnormal lactation|MP:0003140,dilated heart atrium|MP:0006035,abnormal mitochondrial morphology|MP:0006085,myocardium necrosis|MP:0006126,abnormal cardiac outflow tract development|MP:0006271,abnormal involution of the mammary gland|MP:0008022,dilated heart ventricle|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009506,abnormal mammary gland alveolus morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013718,galactostasis|MP:0013719,pale mammary gland|MP:0013779,abnormal mammary gland myoepithelium physiology|MP:0014126,increased mammary gland apoptosis|MP:0014342,abnormal muscle fiber mitochondrial morphology
MGI:6360207	Mrtfb<em1Dsr>	MP:0005294,abnormal heart ventricle morphology
MGI:3587937	Mrtfb<Gt(RRJ478)Byg>	MP:0000266,abnormal heart morphology|MP:0000284,double outlet right ventricle|MP:0000598,abnormal liver morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001722,pale yolk sac|MP:0001785,edema|MP:0002633,persistent truncus arteriosus|MP:0002652,thin myocardium|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0003888,liver hemorrhage|MP:0004157,interrupted aortic arch|MP:0004158,right aortic arch|MP:0006138,congestive heart failure|MP:0010402,ventricular septal defect|MP:0010652,absent aorticopulmonary septum|MP:0010666,abnormal vitelline vein morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012751,impaired cardiac neural crest cell differentiation
MGI:5438551	Mrtfb<tm1.1Msp>	MP:0001182,lung hemorrhage|MP:0001634,internal hemorrhage|MP:0002191,abnormal artery morphology|MP:0003279,aneurysm|MP:0003888,liver hemorrhage|MP:0006126,abnormal cardiac outflow tract development|MP:0006278,aortic aneurysm|MP:0009868,abnormal descending thoracic aorta morphology|MP:0009873,abnormal aorta tunica media morphology|MP:0010574,dilated aorta|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012729,abnormal common carotid artery morphology|MP:0013187,dilated basilar artery|MP:0014696,decreased cell adhesion|MP:0030338,dilated third pharyngeal arch artery
MGI:3608959	Mrtfb<tm1Eno>	MP:0000284,double outlet right ventricle|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0002652,thin myocardium|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0003814,vascular smooth muscle hypoplasia|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0006355,abnormal sixth pharyngeal arch artery morphology|MP:0010418,perimembraneous ventricular septal defect|MP:0010425,abnormal heart and great vessel attachment|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4818683	Mrtfb<tm2.1Eno>	MP:0002169,no abnormal phenotype detected
MGI:6158503	Ms4a12<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology|MP:0002941,increased circulating alanine transaminase level
MGI:6194718	Ms4a13<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:3640301	Ms4a1<tm1Msn>	MP:0005387,immune system phenotype
MGI:3038963	Ms4a1<tm1Tft>	MP:0002458,abnormal B cell number|MP:0002459,abnormal B cell physiology|MP:0004978,decreased B-1 B cell number|MP:0005387,immune system phenotype|MP:0008189,increased transitional stage B cell number|MP:0014469,abnormal B cell calcium ion homeostasis
MGI:3583705	Ms4a2<tm1Chr>	MP:0002423,abnormal mast cell physiology|MP:0005597,decreased susceptibility to type I hypersensitivity reaction
MGI:3664659	Ms4a2<tm1Knt>	MP:0002423,abnormal mast cell physiology|MP:0003009,abnormal cytokine secretion|MP:0005597,decreased susceptibility to type I hypersensitivity reaction
MGI:5692795	Ms4a3<tm1.1(KOMP)Vlcg>	MP:0002631,abnormal epididymis morphology
MGI:7425840	Ms4a4a<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0009453,enhanced contextual conditioning behavior
MGI:6695798	Ms4a4a<em1Wwz>	MP:0002451,abnormal macrophage physiology|MP:0005012,decreased eosinophil cell number|MP:0008673,decreased interleukin-13 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008723,impaired eosinophil recruitment
MGI:6432397	Ms4a4d<em1(IMPC)J>	MP:0001556,increased circulating HDL cholesterol level|MP:0001566,increased circulating phosphate level|MP:0005178,increased circulating cholesterol level
MGI:6384846	Ms4a6d<em1Cya>	MP:0008734,decreased susceptibility to endotoxin shock
MGI:7618316	Ms4a6d<em1Ywch>	MP:0008734,decreased susceptibility to endotoxin shock
MGI:7618318	Ms4a6d<em2Ywch>	MP:0008734,decreased susceptibility to endotoxin shock
MGI:7640119	Ms4a7<em1.1Jddl>	MP:0000598,abnormal liver morphology|MP:0002451,abnormal macrophage physiology|MP:0002942,decreased circulating alanine transaminase level|MP:0003884,decreased macrophage cell number|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0005632,decreased circulating aspartate transaminase level|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008658,decreased interleukin-1 beta secretion|MP:0008891,decreased hepatocyte apoptosis|MP:0014434,decreased cytokine level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:7640117	Ms4a7<em1Jddl>	MP:0000598,abnormal liver morphology|MP:0002942,decreased circulating alanine transaminase level|MP:0005632,decreased circulating aspartate transaminase level|MP:0008554,decreased circulating tumor necrosis factor level|MP:0014434,decreased cytokine level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:7568031	Ms4a8a<em1(IMPC)Tcp>	MP:0000220,increased monocyte cell number
MGI:5569075	Msantd1<tm1.1(KOMP)Vlcg>	MP:0010053,decreased grip strength
MGI:6324367	Msantd2<em1(IMPC)J>	MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0002757,decreased vertical activity|MP:0002797,increased thigmotaxis
MGI:7330221	Msantd3<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0004738,abnormal auditory brainstem response
MGI:3655692	Msc<tm1Eno>	MP:0002169,no abnormal phenotype detected
MGI:1933263	Msgn1<tm1Wb>	MP:0000138,absent vertebrae|MP:0000151,absent ribs|MP:0000737,abnormal myotome development|MP:0000962,disorganized dorsal root ganglion|MP:0001689,incomplete somite formation|MP:0003048,abnormal cervical vertebrae morphology|MP:0003400,kinked neural tube|MP:0003401,enlarged tail bud|MP:0003456,absent tail|MP:0004197,abnormal fetal growth/weight/body size|MP:0004620,cervical vertebral fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011732,decreased somite size|MP:0012182,abnormal presomitic mesoderm morphology|MP:0012184,absent paraxial mesoderm|MP:0012277,increased tail bud apoptosis|MP:0012707,incomplete caudal neuropore closure
MGI:1858055	Msh2<tm1Htr>	MP:0001845,abnormal inflammatory response|MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0003667,increased hemangiosarcoma incidence|MP:0003789,increased osteosarcoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0004815,abnormal somatic hypermutation frequency|MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype|MP:0008014,increased lung tumor incidence|MP:0008019,increased liver tumor incidence|MP:0008495,decreased IgG1 level|MP:0008498,decreased IgG3 level|MP:0009222,increased uterus tumor incidence|MP:0009277,increased brain tumor incidence|MP:0010279,increased gastrointestinal tumor incidence|MP:0010299,increased mammary gland tumor incidence|MP:0010300,increased skin tumor incidence|MP:0012431,increased lymphoma incidence
MGI:1857940	Msh2<tm1Mak>	MP:0002083,premature death|MP:0004815,abnormal somatic hypermutation frequency|MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype|MP:0012431,increased lymphoma incidence
MGI:2151801	Msh2<tm1Rak>	MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0003269,colon polyps|MP:0003324,increased liver adenoma incidence|MP:0004816,abnormal class switch recombination|MP:0008211,decreased mature B cell number|MP:0010279,increased gastrointestinal tumor incidence|MP:0012431,increased lymphoma incidence
MGI:2680817	Msh2<tm1Wed>	MP:0001805,decreased IgG level|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0004816,abnormal class switch recombination|MP:0008770,decreased survivor rate|MP:0009828,increased tumor latency|MP:0012431,increased lymphoma incidence|MP:0014766,impaired mismatch repair
MGI:2387935	Msh2<tm1Whl>	MP:0002083,premature death|MP:0003448,abnormal tumor morphology|MP:0004207,increased squamous cell carcinoma incidence|MP:0009320,increased lymphoblastic lymphoma incidence|MP:0010279,increased gastrointestinal tumor incidence|MP:0010300,increased skin tumor incidence
MGI:4460262	Msh2<tm2.1Rak>	MP:0002006,neoplasm|MP:0002083,premature death|MP:0002404,increased intestinal adenoma incidence|MP:0009309,increased small intestine adenocarcinoma incidence|MP:0009797,abnormal mismatch repair|MP:0010279,increased gastrointestinal tumor incidence|MP:0012431,increased lymphoma incidence
MGI:4460263	Msh2<tm2.2Rak>	MP:0002083,premature death|MP:0010279,increased gastrointestinal tumor incidence|MP:0012431,increased lymphoma incidence|MP:0014766,impaired mismatch repair
MGI:6313353	Msh3<em1(IMPC)Mbp>	MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0003068,enlarged kidney
MGI:2151802	Msh3<tm1Htr>	MP:0002006,neoplasm
MGI:1858056	Msh3<tm1Rak>	MP:0002957,increased intestinal adenocarcinoma incidence|MP:0010768,mortality/aging|MP:0014766,impaired mismatch repair
MGI:2179034	Msh4<tm1Wed>	MP:0001127,small ovary|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002209,decreased germ cell number|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0005386,behavior/neurological phenotype
MGI:7260342	Msh5<em1Jzc>	MP:0001131,abnormal ovarian follicle morphology|MP:0001926,female infertility|MP:0004805,absent oocytes|MP:0004833,ovary atrophy
MGI:5629311	Msh5<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0001303,abnormal lens morphology|MP:0001488,increased startle reflex|MP:0011896,increased circulating unsaturated transferrin level
MGI:2179022	Msh5<tm1Htr>	MP:0001127,small ovary|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002777,absent ovarian follicles|MP:0004805,absent oocytes|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0008261,arrest of male meiosis|MP:0009452,abnormal synaptonemal complex|MP:0012411,increased granulosa cell tumor incidence|MP:0014052,increased male germ cell apoptosis
MGI:1858057	Msh5<tm1Rak>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002016,ovary cyst|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0005431,decreased oocyte number|MP:0013236,ovary degeneration|MP:0013605,abnormal ovarian bursa morphology
MGI:6114079	Msh6<m1Btlr>	MP:0002492,decreased IgE level
MGI:2151803	Msh6<tm1Htr>	MP:0009222,increased uterus tumor incidence|MP:0010279,increased gastrointestinal tumor incidence|MP:0010296,increased hemolymphoid system tumor incidence|MP:0010300,increased skin tumor incidence|MP:0012431,increased lymphoma incidence|MP:0014237,decreased tumor-free survival time
MGI:1858014	Msh6<tm1Rak>	MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0010279,increased gastrointestinal tumor incidence|MP:0012431,increased lymphoma incidence
MGI:3653701	Msh6<tm1Wed>	MP:0002020,increased tumor incidence|MP:0002404,increased intestinal adenoma incidence|MP:0004208,increased basal cell carcinoma incidence|MP:0012431,increased lymphoma incidence|MP:0014237,decreased tumor-free survival time
MGI:5471313	Msi1<tm1.1(cre/ERT2)Njen>	MP:0001891,hydrocephaly|MP:0002169,no abnormal phenotype detected
MGI:2450917	Msi1<tm1Okn>	MP:0000074,abnormal neurocranium morphology|MP:0000780,abnormal corpus callosum morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000825,dilated lateral ventricle|MP:0001393,ataxia|MP:0001429,dehydration|MP:0001785,edema|MP:0001891,hydrocephaly|MP:0001916,intracerebral hemorrhage|MP:0002083,premature death|MP:0002653,abnormal ependyma morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0008450,retina photoreceptor degeneration|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment|MP:0030005,increased retina apoptosis
MGI:6430649	Msi2<em1(IMPC)Mbp>	MP:0000221,decreased leukocyte cell number|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000774,decreased brain size|MP:0001258,decreased body length|MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0001552,increased circulating triglyceride level|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002175,decreased brain weight|MP:0002599,increased mean platelet volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0002989,small kidney|MP:0003961,decreased lean body mass|MP:0004953,decreased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0006203,eye hemorrhage|MP:0010024,increased total body fat amount|MP:0013278,decreased fasting circulating glucose level
MGI:3923429	Msi2<Gt(Ayu21-T2)Imeg>	MP:0001265,decreased body size|MP:0002082,postnatal lethality|MP:0003447,decreased tumor growth/size|MP:0004810,decreased hematopoietic stem cell number
MGI:3893933	Msi2<Gt(E035H03)Wrst>	MP:0000221,decreased leukocyte cell number|MP:0000334,decreased granulocyte number|MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0000706,small thymus|MP:0001262,decreased body weight|MP:0001823,thymus hypoplasia|MP:0002161,abnormal fertility/fecundity|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002875,decreased erythrocyte cell number|MP:0003884,decreased macrophage cell number|MP:0004810,decreased hematopoietic stem cell number|MP:0005017,decreased B cell number|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005397,hematopoietic system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008250,abnormal myeloid leukocyte morphology|MP:0008813,decreased common myeloid progenitor cell number|MP:0010132,decreased DN2 thymocyte number|MP:0010134,decreased DN3 thymocyte number|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5588139	Msi2<tm1.1Cjl>	MP:0000333,decreased bone marrow cell number|MP:0000694,spleen hypoplasia|MP:0004810,decreased hematopoietic stem cell number|MP:0004953,decreased spleen weight|MP:0005387,immune system phenotype|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:3663693	Mskt1<C57BL/6J>	MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0001257,increased body length|MP:0004348,long femur|MP:0004357,long tibia
MGI:3663694	Mskt1<DBA/2J>	MP:0000559,abnormal femur morphology|MP:0001260,increased body weight|MP:0006087,increased body mass index
MGI:3663695	Mskt2<C57BL/6J>	MP:0000558,abnormal tibia morphology|MP:0001257,increased body length|MP:0002968,increased circulating alkaline phosphatase level|MP:0009421,increased gastrocnemius weight
MGI:3663698	Mskt3<DBA/2J>	MP:0000558,abnormal tibia morphology|MP:0001257,increased body length|MP:0004348,long femur
MGI:3663699	Mskt4<C57BL/6J>	MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0003083,abnormal tibialis anterior morphology|MP:0009421,increased gastrocnemius weight
MGI:3663701	Mskt5<C57BL/6J>	MP:0001260,increased body weight|MP:0006087,increased body mass index
MGI:3663702	Mskt5<DBA/2J>	MP:0000559,abnormal femur morphology|MP:0003083,abnormal tibialis anterior morphology
MGI:3663704	Mskt6<DBA/2J>	MP:0000559,abnormal femur morphology|MP:0001257,increased body length|MP:0004348,long femur|MP:0004357,long tibia
MGI:3663706	Mskt7<DBA/2J>	MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0006087,increased body mass index
MGI:3663707	Mskt8<C57BL/6J>	MP:0000559,abnormal femur morphology
MGI:3663710	Mskt9<DBA/2J>	MP:0000559,abnormal femur morphology
MGI:6153493	Msl1<em1(IMPC)Wtsi>	MP:0006358,absent pinna reflex|MP:0010124,decreased bone mineral content
MGI:5903077	Msl3<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:5616368	Mslnl<tm1b(EUCOMM)Wtsi>	MP:0000223,decreased monocyte cell number
MGI:2387955	Msln<tm1Ipa>	MP:0002169,no abnormal phenotype detected
MGI:5049954	mslsHubr	MP:0012270,cardiac edema
MGI:5703086	Msmb<tm1b(EUCOMM)Hmgu>	MP:0010097,abnormal retina blood vessel morphology|MP:0011239,abnormal skin coloration
MGI:3574429	Msmb<tm1Xuan>	MP:0000702,enlarged lymph nodes|MP:0001272,increased metastatic potential|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0009739,enlarged prostate gland dorsolateral lobe|MP:0031357,enlarged prostate gland ventral lobe
MGI:6771334	Msmp<em1Jzx>	MP:0001860,liver inflammation|MP:0002942,decreased circulating alanine transaminase level|MP:0005166,decreased susceptibility to injury|MP:0008113,abnormal macrophage differentiation|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008597,decreased circulating interleukin-6 level|MP:0008838,decreased transforming growth factor beta level|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:3609166	Msmr1<MSM/Ms>	MP:0010268,decreased lymphoma incidence
MGI:3609167	Msmr1<SL/Kh>	MP:0012431,increased lymphoma incidence
MGI:3609168	Msmr2<MSM/Ms>	MP:0010268,decreased lymphoma incidence
MGI:3609169	Msmr2<SL/Kh>	MP:0012431,increased lymphoma incidence
MGI:5632533	Msn<tm1b(EUCOMM)Hmgu>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0002590,increased mean corpuscular volume|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0005561,increased mean corpuscular hemoglobin|MP:0006243,impaired pupillary reflex
MGI:3630284	Msn<tm1Sts>	MP:0000222,decreased neutrophil cell number|MP:0001183,overexpanded pulmonary alveolus|MP:0002169,no abnormal phenotype detected|MP:0005012,decreased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005165,increased susceptibility to injury|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0010856,dilated respiratory conducting tube|MP:0020212,impaired leukocyte migration
MGI:1857874	Msr1<tm1Csk>	MP:0002451,abnormal macrophage physiology|MP:0008565,decreased interferon-beta secretion|MP:0008663,increased interleukin-12 secretion|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:2177027	Msra<tm1Jmo>	MP:0001406,abnormal gait|MP:0002083,premature death|MP:0003674,oxidative stress|MP:0005319,abnormal enzyme/coenzyme level|MP:0005378,growth/size/body region phenotype
MGI:3529701	Msrb1<Gt(OST336894)Lex>	MP:0003674,oxidative stress|MP:0010768,mortality/aging
MGI:5490902	Msrb1<tm1.1Rlev>	MP:0005378,growth/size/body region phenotype
MGI:5569504	Msrb3<tm1Hyk>	MP:0001967,deafness|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004530,absent outer hair cell stereocilia|MP:0005377,hearing/vestibular/ear phenotype|MP:0005384,cellular phenotype|MP:0006042,increased apoptosis|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3579902	msrvh1<C57BL/6>	MP:0000530,abnormal kidney vasculature morphology
MGI:5312367	Mss51<tm1(KOMP)Vlcg>	MP:0002079,increased circulating insulin level|MP:0002108,abnormal muscle morphology|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0003061,decreased aerobic running capacity|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0009293,decreased inguinal fat pad weight|MP:0010401,increased skeletal muscle glycogen level|MP:0011633,abnormal mitochondrial shape|MP:0011635,abnormal mitochondrial crista morphology|MP:0013279,increased fasting circulating glucose level|MP:0030937,increased mitochondrial DNA content
MGI:1857882	Mst1r<Fv2-s>	MP:0000691,enlarged spleen|MP:0020934,increased susceptibility to Retroviridae infection|MP:0020935,decreased susceptibility to Retroviridae infection
MGI:2386421	Mst1r<tm1.1Sew>	MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0002451,abnormal macrophage physiology|MP:0002534,abnormal type IV hypersensitivity reaction|MP:0005088,increased acute inflammation|MP:0008735,increased susceptibility to endotoxin shock|MP:0031420,decreased superovulation rate
MGI:2180765	Mst1r<tm1Ber>	MP:0001846,increased inflammatory response|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002534,abnormal type IV hypersensitivity reaction|MP:0005387,immune system phenotype
MGI:2386413	Mst1r<tm1Sew>	MP:0002411,decreased susceptibility to bacterial infection
MGI:2180761	Mst1r<tm1Sjd>	MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5607440	Mst1r<tm2(Mst1r*)Sew>	MP:0001654,hepatic necrosis|MP:0002941,increased circulating alanine transaminase level|MP:0004953,decreased spleen weight|MP:0008566,increased interferon-gamma secretion|MP:0008577,increased circulating interferon-gamma level|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0020934,increased susceptibility to Retroviridae infection
MGI:2445230	Mst1<tm1Jab>	MP:0000607,abnormal hepatocyte morphology|MP:0002451,abnormal macrophage physiology|MP:0005370,liver/biliary system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008537,increased susceptibility to induced colitis
MGI:4431447	Mst1<tm1(KOMP)Wtsi>	MP:0005561,increased mean corpuscular hemoglobin
MGI:1857404	Mstn<Cmpt>	MP:0001260,increased body weight|MP:0002108,abnormal muscle morphology|MP:0002841,impaired skeletal muscle contractility|MP:0004818,increased skeletal muscle mass|MP:0005451,abnormal body composition
MGI:7541407	Mstn<em1(IMPC)Hmgu>	MP:0000691,enlarged spleen|MP:0000759,abnormal skeletal muscle morphology|MP:0001406,abnormal gait|MP:0002834,decreased heart weight|MP:0003402,decreased liver weight|MP:0004953,decreased spleen weight|MP:0010052,increased grip strength
MGI:3838011	Mstn<lean>	MP:0001262,decreased body weight|MP:0002078,abnormal glucose homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003383,abnormal gluconeogenesis|MP:0003960,increased lean body mass|MP:0004893,decreased adiponectin level|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005331,insulin resistance|MP:0005459,decreased percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0008552,abnormal circulating tumor necrosis factor level|MP:0008554,decreased circulating tumor necrosis factor level|MP:0009289,decreased epididymal fat pad weight|MP:0009421,increased gastrocnemius weight|MP:0010226,increased quadriceps weight|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5425956	Mstn<tm1.1Mgs>	MP:0000759,abnormal skeletal muscle morphology|MP:0001260,increased body weight|MP:0002106,abnormal muscle physiology|MP:0003674,oxidative stress|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009461,skeletal muscle hypertrophy|MP:0010238,increased skeletal muscle weight
MGI:3620058	Mstn<tm1.1Swel>	MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0002106,abnormal muscle physiology|MP:0003397,increased muscle weight
MGI:2661073	Mstn<tm1Mgs>	MP:0001260,increased body weight|MP:0002108,abnormal muscle morphology|MP:0003397,increased muscle weight|MP:0009399,increased skeletal muscle fiber size|MP:0009461,skeletal muscle hypertrophy
MGI:2148177	Mstn<tm1Sjl>	MP:0000559,abnormal femur morphology|MP:0001260,increased body weight|MP:0001264,increased body size|MP:0001547,abnormal lipid level|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002833,increased heart weight|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003109,short femur|MP:0003397,increased muscle weight|MP:0003398,increased skeletal muscle size|MP:0003402,decreased liver weight|MP:0003918,decreased kidney weight|MP:0003953,abnormal hormone level|MP:0004148,increased compact bone thickness|MP:0004627,abnormal trochanter morphology|MP:0004818,increased skeletal muscle mass|MP:0005668,decreased circulating leptin level|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009301,decreased parametrial fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0009399,increased skeletal muscle fiber size|MP:0009401,increased skeletal muscle fiber diameter|MP:0009405,increased skeletal muscle fiber number|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0010226,increased quadriceps weight|MP:0011939,increased food intake|MP:0020011,increased bone mineral density of femur
MGI:3711219	Mstn<tm1Swel>	MP:0004818,increased skeletal muscle mass|MP:0009401,increased skeletal muscle fiber diameter
MGI:3778375	Mstn<tm2Sjl>	MP:0004818,increased skeletal muscle mass|MP:0009401,increased skeletal muscle fiber diameter|MP:0009405,increased skeletal muscle fiber number
MGI:5898564	Mstn<tm3.1Sjl>	MP:0000759,abnormal skeletal muscle morphology|MP:0003953,abnormal hormone level|MP:0005369,muscle phenotype|MP:0009459,skeletal muscle hyperplasia|MP:0009461,skeletal muscle hypertrophy|MP:0010238,increased skeletal muscle weight
MGI:6257438	Msto1<em1(IMPC)Tcp>	MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0001258,decreased body length|MP:0001552,increased circulating triglyceride level|MP:0002059,abnormal seminal vesicle morphology|MP:0003068,enlarged kidney|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3723197	Mswtq1<NMRI8/Fbn>	MP:0004232,decreased muscle weight
MGI:1933766	Msx1<tm1Bero>	MP:0000094,absent alveolar process|MP:0000114,cleft chin|MP:0000125,absent incisors|MP:0000128,growth retardation of molars|MP:0000435,shortened head|MP:0000438,abnormal cranium morphology|MP:0000445,short snout|MP:0000827,dilated third ventricle|MP:0000829,dilated fourth ventricle|MP:0000830,abnormal diencephalon morphology|MP:0000923,abnormal roof plate morphology|MP:0001575,cyanosis|MP:0001891,hydrocephaly|MP:0001954,respiratory distress|MP:0002152,abnormal brain morphology|MP:0002199,abnormal brain commissure morphology|MP:0003110,absent malleus processus brevis|MP:0003755,abnormal palate morphology|MP:0003931,absent molars|MP:0005371,limbs/digits/tail phenotype|MP:0008947,increased neuron number|MP:0009716,abnormal subcommissural organ morphology|MP:0009883,palatal shelf hypoplasia|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance
MGI:5463966	Msx1<tm1b(KOMP)Wtsi>	MP:0000111,cleft palate|MP:0001554,increased circulating free fatty acids level|MP:0001575,cyanosis|MP:0002833,increased heart weight|MP:0003743,abnormal facial morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0020870,decreased thigmotaxis
MGI:3769671	Msx1<tm1Rem>	MP:0000111,cleft palate
MGI:1926386	Msx1<tm1Rilm>	MP:0000082,overlapping parietal bones|MP:0000085,large anterior fontanelle|MP:0000088,short mandible|MP:0000090,absent premaxilla|MP:0000094,absent alveolar process|MP:0000097,short maxilla|MP:0000107,abnormal frontal bone morphology|MP:0000111,cleft palate|MP:0000128,growth retardation of molars|MP:0000430,absent maxillary shelf|MP:0000431,absent palatine bone horizontal plate|MP:0000438,abnormal cranium morphology|MP:0000458,abnormal mandible morphology|MP:0001575,cyanosis|MP:0001951,abnormal breathing pattern|MP:0002100,abnormal tooth morphology|MP:0003110,absent malleus processus brevis|MP:0003842,abnormal metopic suture morphology|MP:0004470,small nasal bone|MP:0004790,absent upper incisors|MP:0004791,absent lower incisors|MP:0005385,cardiovascular system phenotype|MP:0008373,short malleus|MP:0009546,absent gastric milk in neonates|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance|MP:0030187,abnormal epitympanic recess morphology
MGI:5613191	Msx1<tm3.1Bero>	MP:0002169,no abnormal phenotype detected
MGI:5532713	Msx2<m1Btlr>	MP:0000414,alopecia|MP:0000423,delayed hair regrowth|MP:0001297,microphthalmia|MP:0008861,abnormal hair shedding
MGI:3795775	Msx2<tm1.1Yvla>	MP:0000414,alopecia|MP:0000854,abnormal cerebellum development|MP:0002113,abnormal skeleton development|MP:0003984,embryonic growth retardation
MGI:3769672	Msx2<tm1Rem>	MP:0000074,abnormal neurocranium morphology|MP:0000414,alopecia
MGI:1926381	Msx2<tm1Rilm>	MP:0000017,big ears|MP:0000063,decreased bone mineral density|MP:0000074,abnormal neurocranium morphology|MP:0000107,abnormal frontal bone morphology|MP:0000120,malocclusion|MP:0000126,brittle teeth|MP:0000127,degenerate molars|MP:0000129,ameloblast degeneration|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000167,decreased chondrocyte number|MP:0000414,alopecia|MP:0000579,abnormal nail morphology|MP:0000580,deformed nails|MP:0000583,long toenails|MP:0000854,abnormal cerebellum development|MP:0000866,cerebellum vermis hypoplasia|MP:0000867,abnormal cerebellum anterior vermis morphology|MP:0000870,absent cerebellum vermis lobule VIII|MP:0000871,absent cerebellum vermis lobule IX|MP:0000884,delaminated Purkinje cell layer|MP:0000887,delaminated cerebellar granule layer|MP:0001274,curly vibrissae|MP:0001282,short vibrissae|MP:0001286,abnormal eye development|MP:0001292,abnormal lens vesicle development|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001306,small lens|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0002092,abnormal eye morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002657,chondrodystrophy|MP:0002764,short tibia|MP:0002826,tonic seizures|MP:0003109,short femur|MP:0003425,abnormal optic vesicle formation|MP:0003631,nervous system phenotype|MP:0004135,abnormal mammary gland embryonic development|MP:0004378,frontal bone foramen|MP:0004384,small interparietal bone|MP:0004444,small supraoccipital bone|MP:0004985,decreased osteoclast cell number|MP:0005114,premature hair loss|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005287,narrow eye opening|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0006200,vitreous body deposition|MP:0008271,abnormal bone ossification|MP:0009250,abnormal appendicular skeleton morphology|MP:0009742,increased cornea stroma thickness|MP:0010747,abnormal enamel organ morphology|MP:0010768,mortality/aging|MP:0010771,integument phenotype|MP:0011481,anterior iris synechia|MP:0011962,increased cornea thickness|MP:0012401,long nails|MP:0012405,abnormal nail matrix morphology|MP:0013765,iris hyperplasia|MP:0020855,decreased cornea epithelium thickness|MP:0021107,retina fold|MP:0030522,abnormal stellate reticulum morphology|MP:0030523,abnormal stratum intermedium morphology
MGI:3795774	Msx2<tm1Yvla>	MP:0002169,no abnormal phenotype detected
MGI:6120690	Msx3<tm1b(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0000280,thin ventricular wall
MGI:2389488	Mt3<tm1Rpa>	MP:0000192,abnormal mineral level|MP:0000807,abnormal hippocampus morphology|MP:0000815,abnormal Ammon gyrus morphology|MP:0000832,abnormal thalamus morphology|MP:0002182,abnormal astrocyte morphology|MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0002906,increased susceptibility to pharmacologically induced seizures
MGI:7481208	Mta1<em1(IMPC)Ccpcz>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001157,small seminal vesicle|MP:0001404,no spontaneous movement|MP:0002059,abnormal seminal vesicle morphology|MP:0002953,thick ventricular wall|MP:0005599,increased cardiac muscle contractility|MP:0010574,dilated aorta|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4842891	Mta1<tm1a(EUCOMM)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0001262,decreased body weight|MP:0001539,decreased caudal vertebrae number|MP:0001552,increased circulating triglyceride level|MP:0002896,abnormal bone mineralization|MP:0003179,thrombocytopenia|MP:0004647,decreased lumbar vertebrae number|MP:0004924,abnormal behavior|MP:0010101,increased sacral vertebrae number|MP:0010768,mortality/aging
MGI:4367891	Mta1<tm1Raku>	MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0005391,vision/eye phenotype|MP:0009772,abnormal retina development
MGI:3798815	Mta2<tm1.1Yzha>	MP:0000379,decreased hair follicle number|MP:0000428,abnormal craniofacial morphology|MP:0001194,dermatitis|MP:0001212,skin lesions|MP:0001242,hyperkeratosis|MP:0001265,decreased body size|MP:0001860,liver inflammation|MP:0001874,acanthosis|MP:0001926,female infertility|MP:0002083,premature death|MP:0002114,abnormal axial skeleton morphology|MP:0002743,glomerulonephritis|MP:0002941,increased circulating alanine transaminase level|MP:0002962,increased urine protein level|MP:0003725,increased autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004947,skin inflammation|MP:0005348,increased T cell proliferation|MP:0005376,homeostasis/metabolism phenotype|MP:0008577,increased circulating interferon-gamma level|MP:0008599,increased circulating interleukin-2 level|MP:0008602,increased circulating interleukin-4 level|MP:0008770,decreased survivor rate|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011164,panniculitis|MP:0011427,increased mesangial cell number|MP:0011440,increased kidney cell proliferation
MGI:4432219	Mta2<tm1a(EUCOMM)Wtsi>	MP:0011102,embryonic lethality, incomplete penetrance
MGI:3798814	Mta2<tm1Yzha>	MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype
MGI:4419906	Mta3<tm3a(KOMP)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0001262,decreased body weight|MP:0001512,trunk curl|MP:0002875,decreased erythrocyte cell number|MP:0002896,abnormal bone mineralization|MP:0002968,increased circulating alkaline phosphatase level|MP:0003062,abnormal coping response|MP:0005179,decreased circulating cholesterol level|MP:0009142,decreased prepulse inhibition
MGI:6358192	Mta3<tm3d(KOMP)Wtsi>	MP:0010768,mortality/aging
MGI:6313357	Mtap<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001304,cataract|MP:0001718,abnormal visceral yolk sac morphology|MP:0001726,abnormal allantois morphology|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology|MP:0002699,abnormal vitreous body morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:3514132	Mtap<Gt(RRK081)Byg>	MP:0000598,abnormal liver morphology|MP:0002264,abnormal bronchus morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0010138,arteritis|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:6402891	Mtarc1<em1(IMPC)H>	MP:0001566,increased circulating phosphate level|MP:0004952,increased spleen weight|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level
MGI:7623614	Mtarc1<tm1.1Vlcg>	MP:0000598,abnormal liver morphology|MP:0002942,decreased circulating alanine transaminase level|MP:0004777,abnormal phospholipid level|MP:0005370,liver/biliary system phenotype|MP:0009356,decreased liver triglyceride level
MGI:7623620	Mtarc2<tm1.1Vlcg>	MP:0000755,hindlimb paralysis|MP:0001262,decreased body weight|MP:0014143,decreased body fat mass
MGI:4435988	Mtarc2<tm2a(EUCOMM)Hmgu>	MP:0001262,decreased body weight
MGI:4355536	mt-Atp8<m1>	MP:0001363,increased anxiety-related response
MGI:3510115	Mtbcq1<NMRI8/Fbn>	MP:0001260,increased body weight
MGI:3723163	Mtbcq2<NMRI8/Fbn>	MP:0001260,increased body weight|MP:0002981,increased liver weight|MP:0003397,increased muscle weight|MP:0004952,increased spleen weight|MP:0005458,increased percent body fat/body weight|MP:0010024,increased total body fat amount
MGI:3723166	Mtbcq3<NMRI8/Fbn>	MP:0001260,increased body weight
MGI:3723168	Mtbcq4<NMRI8/Fbn>	MP:0001260,increased body weight|MP:0002981,increased liver weight|MP:0003397,increased muscle weight|MP:0005458,increased percent body fat/body weight|MP:0009286,increased abdominal fat pad weight
MGI:3723183	Mtbcq5<NMRI8/Fbn>	MP:0001262,decreased body weight
MGI:3723187	Mtbcq6<NMRI8/Fbn>	MP:0001262,decreased body weight|MP:0003402,decreased liver weight|MP:0003918,decreased kidney weight|MP:0005459,decreased percent body fat/body weight|MP:0010025,decreased total body fat amount
MGI:3723189	Mtbcq7<NMRI8/Fbn>	MP:0004232,decreased muscle weight|MP:0005458,increased percent body fat/body weight|MP:0010024,increased total body fat amount
MGI:3723191	Mtbcq8<NMRI8/Fbn>	MP:0001260,increased body weight
MGI:3794647	Mtbp<tm1Glo>	MP:0002006,neoplasm|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5566663	Mtch2<tm1Atgr>	MP:0001672,abnormal embryo development|MP:0001680,abnormal mesoderm development|MP:0001683,absent mesoderm|MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0002582,disorganized extraembryonic tissue|MP:0005030,absent amnion|MP:0009593,absent chorion|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:5548706	Mtch2<tm1b(EUCOMM)Hmgu>	MP:0000137,abnormal vertebrae morphology|MP:0000220,increased monocyte cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3853016	Mtcl1<Gt(AT0556)Wtsi>	MP:0000876,Purkinje cell degeneration|MP:0001262,decreased body weight|MP:0001516,abnormal motor coordination/balance|MP:0001926,female infertility|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0010047,axonal spheroids|MP:0010733,abnormal axon initial segment morphology|MP:0010768,mortality/aging
MGI:6154024	Mtcl1<tm1.1Atsuz>	MP:0000876,Purkinje cell degeneration|MP:0001516,abnormal motor coordination/balance|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0010047,axonal spheroids|MP:0010733,abnormal axon initial segment morphology|MP:0014329,abnormal Purkinje cell axon morphology
MGI:7425998	Mtcl2<em1(IMPC)Bay>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0011965,decreased total retina thickness
MGI:3777237	mt-Co1<m1Jiha>	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0000751,myopathy|MP:0001262,decreased body weight|MP:0001614,abnormal blood vessel morphology|MP:0001732,postnatal growth retardation|MP:0001785,edema|MP:0001853,heart inflammation|MP:0003921,abnormal heart left ventricle morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0004566,myocardial fiber degeneration|MP:0005330,cardiomyopathy|MP:0005608,cardiac interstitial fibrosis|MP:0008775,abnormal heart ventricle pressure|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0013405,increased circulating lactate level
MGI:4124379	Mtdh<Gt(XB780)Byg>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005389,reproductive system phenotype|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:5662532	Mtdh<tm1.1Dsar>	MP:0002169,no abnormal phenotype detected
MGI:5662534	Mtdh<tm1.2Dsar>	MP:0001935,decreased litter size|MP:0004502,decreased incidence of tumors by chemical induction|MP:0008658,decreased interleukin-1 beta secretion|MP:0008706,decreased interleukin-6 secretion|MP:0010266,decreased liver tumor incidence|MP:0010267,decreased lung tumor incidence|MP:0010282,decreased organ/body region tumor incidence|MP:0011986,decreased macrophage proliferation|MP:0012419,decreased cardiovascular system tumor incidence
MGI:3849455	Mterf2<Gt(OST453159)Lex>	MP:0000747,muscle weakness|MP:0001262,decreased body weight|MP:0008414,abnormal spatial reference memory|MP:0010954,abnormal cellular respiration|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0010958,abnormal tricarboxylic acid cycle|MP:0011628,increased mitochondrial number|MP:0011630,increased mitochondrial size|MP:0012106,impaired exercise endurance|MP:0014394,increased skeletal muscle fiber mitochondrial DNA content|MP:0030937,increased mitochondrial DNA content
MGI:3839255	Mterf3<tm1.1Lrsn>	MP:0000274,enlarged heart|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0005330,cardiomyopathy|MP:0006036,abnormal mitochondrial physiology|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:3839256	Mterf3<tm1.2Lrsn>	MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5288505	Mterf4<tm1.1Lrsn>	MP:0000274,enlarged heart|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0004215,abnormal myocardial fiber physiology|MP:0005330,cardiomyopathy|MP:0006036,abnormal mitochondrial physiology|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:5288506	Mterf4<tm1.2Lrsn>	MP:0001698,decreased embryo size|MP:0011092,embryonic lethality, complete penetrance|MP:0011388,absent heart|MP:0011389,absent optic disk
MGI:2388802	Mtes1<AKR/J>	MP:0010299,increased mammary gland tumor incidence
MGI:2155608	Mtf1<Thyls-BALB/c>	MP:0002024,increased T cell derived lymphoma incidence|MP:0004500,increased incidence of tumors by ionizing radiation induction
MGI:5515625	Mtf1<tm1b(KOMP)Wtsi>	MP:0000428,abnormal craniofacial morphology|MP:0000783,abnormal forebrain morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0005343,increased circulating aspartate transaminase level|MP:0005560,decreased circulating glucose level|MP:0005627,increased circulating potassium level|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:2182939	Mtf1<tm1Wsc>	MP:0000602,dilated liver sinusoidal space|MP:0001654,hepatic necrosis|MP:0008402,increased cellular sensitivity to alkylating agent induced cell death|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3609186	Mtf1<tm2Wsc>	MP:0000609,abnormal liver physiology
MGI:2678466	Mtf2<Gt(U3Betageo)1Ruiz>	MP:0000157,abnormal sternum morphology|MP:0000480,increased rib number|MP:0001265,decreased body size|MP:0002114,abnormal axial skeleton morphology|MP:0003036,vertebral transformation|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004659,abnormal odontoid process morphology|MP:0008009,delayed cellular replicative senescence|MP:0011085,postnatal lethality, complete penetrance
MGI:3700158	Mtf2<Gt(XD143)Byg>	MP:0000157,abnormal sternum morphology|MP:0000160,kyphosis|MP:0000480,increased rib number|MP:0000585,kinked tail|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0001935,decreased litter size|MP:0003036,vertebral transformation|MP:0005358,abnormal incisor morphology|MP:0005380,embryo phenotype|MP:0030541,misaligned incisors
MGI:4946491	Mtf2<tm1.1Hko>	MP:0000157,abnormal sternum morphology|MP:0000480,increased rib number|MP:0003036,vertebral transformation|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004659,abnormal odontoid process morphology|MP:0008009,delayed cellular replicative senescence
MGI:7704181	Mtfmt<em1Heb>	MP:0000598,abnormal liver morphology|MP:0000609,abnormal liver physiology|MP:0001876,decreased inflammatory response|MP:0002078,abnormal glucose homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002891,increased insulin sensitivity|MP:0002942,decreased circulating alanine transaminase level|MP:0003984,embryonic growth retardation|MP:0005292,improved glucose tolerance|MP:0005318,decreased triglyceride level|MP:0006036,abnormal mitochondrial physiology|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009289,decreased epididymal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0011092,embryonic lethality, complete penetrance|MP:0011632,dilated mitochondrion|MP:0011633,abnormal mitochondrial shape
MGI:7596142	Mtfp1<tm1.2Wait>	MP:0000274,enlarged heart|MP:0000280,thin ventricular wall|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0005294,abnormal heart ventricle morphology|MP:0006036,abnormal mitochondrial physiology|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0010018,pulmonary vascular congestion|MP:0010725,thin interventricular septum|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3530581	Mtfr1<Gt(OST6261)Lex>	MP:0008412,increased cellular sensitivity to oxidative stress|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport
MGI:6257707	Mtg1<em1(IMPC)Bay>	MP:0002626,increased heart rate|MP:0010507,shortened RR interval|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0020870,decreased thigmotaxis
MGI:6362669	Mtg1<em1Ywxu>	MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0004485,increased response of heart to induced stress|MP:0005599,increased cardiac muscle contractility|MP:0005630,increased lung weight|MP:0006321,increased myocardial fiber number|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport
MGI:6257411	Mtg2<em1(IMPC)Bay>	MP:0002792,abnormal retina vasculature morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3497846	Mtgq1<NMRI8/Fbn>	MP:0001260,increased body weight
MGI:3723142	Mtgq2<NMRI8/Fbn>	MP:0001260,increased body weight
MGI:3723144	Mtgq3<NMRI8/Fbn>	MP:0001260,increased body weight
MGI:3510210	Mtgq4<NMRI8/Fbn>	MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0002981,increased liver weight|MP:0003397,increased muscle weight|MP:0003917,increased kidney weight|MP:0004952,increased spleen weight|MP:0005458,increased percent body fat/body weight|MP:0010024,increased total body fat amount
MGI:3497848	Mtgq5<NMRI8/Fbn>	MP:0001260,increased body weight
MGI:3837220	Mthfd1<Gt(XB175)Byg>	MP:0001260,increased body weight|MP:0003806,abnormal nucleotide metabolism|MP:0005319,abnormal enzyme/coenzyme level|MP:0005332,abnormal amino acid level|MP:0011092,embryonic lethality, complete penetrance
MGI:5470152	Mthfd1l<tm1b(EUCOMM)Wtsi>	MP:0000432,abnormal head morphology|MP:0000433,microcephaly|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0000930,wavy neural tube|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0002151,abnormal neural tube morphology|MP:0003984,embryonic growth retardation|MP:0006337,abnormal first pharyngeal arch morphology|MP:0008762,embryonic lethality|MP:0008784,craniorachischisis|MP:0010939,abnormal mandibular prominence morphology|MP:0010940,abnormal maxillary prominence morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011495,abnormal head shape
MGI:5521203	Mthfd1<tm1.1Rzn>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000266,abnormal heart morphology|MP:0000929,open neural tube|MP:0000930,wavy neural tube|MP:0001260,increased body weight|MP:0001698,decreased embryo size|MP:0002861,abnormal tail bud morphology|MP:0003400,kinked neural tube|MP:0003718,maternal effect|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0005376,homeostasis/metabolism phenotype|MP:0005621,abnormal cell physiology|MP:0006386,absent somites|MP:0009768,impaired somite development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011230,abnormal folic acid level|MP:0012062,small tail bud
MGI:5751155	Mthfd1<tm2b(KOMP)Wtsi>	MP:0005419,decreased circulating serum albumin level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5548566	Mthfd2l<tm1b(EUCOMM)Wtsi>	MP:0000274,enlarged heart|MP:0002060,abnormal skin morphology|MP:0003960,increased lean body mass
MGI:6120705	Mthfd2<tm1b(EUCOMM)Wtsi>	MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0000603,pale liver|MP:0001297,microphthalmia|MP:0001672,abnormal embryo development|MP:0001697,abnormal embryo size|MP:0001722,pale yolk sac|MP:0001725,abnormal umbilical cord morphology|MP:0002092,abnormal eye morphology|MP:0002626,increased heart rate|MP:0002942,decreased circulating alanine transaminase level|MP:0002953,thick ventricular wall|MP:0003717,pallor|MP:0003743,abnormal facial morphology|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0005632,decreased circulating aspartate transaminase level|MP:0010052,increased grip strength|MP:0010579,increased heart left ventricle size|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:2180800	Mthfd2<tm1Rmk>	MP:0000601,small liver|MP:0000603,pale liver|MP:0001698,decreased embryo size|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2385823	Mthfr<tm1Rzn>	MP:0000160,kyphosis|MP:0000416,sparse hair|MP:0000585,kinked tail|MP:0000592,short tail|MP:0000852,small cerebellum|MP:0000884,delaminated Purkinje cell layer|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001938,delayed sexual maturation|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002750,exophthalmos|MP:0005376,homeostasis/metabolism phenotype|MP:0009642,abnormal blood homeostasis|MP:0012335,increased circulating homocysteine level|MP:0031116,microvesicular hepatic steatosis
MGI:4130253	Mthfs<Gt(RRK291)Byg>	MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0011092,embryonic lethality, complete penetrance|MP:0011230,abnormal folic acid level
MGI:5548911	Mthfsl<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0010053,decreased grip strength
MGI:5613653	Mtif3<tm1b(EUCOMM)Wtsi>	MP:0000198,decreased circulating phosphate level|MP:0001417,decreased exploration in new environment|MP:0003019,increased circulating chloride level|MP:0011100,preweaning lethality, complete penetrance
MGI:7565504	Mtif3<tm1c(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0002833,increased heart weight|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0009400,decreased skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010725,thin interventricular septum|MP:0014316,decreased heart left ventricle posterior wall thickness
MGI:7580965	Mtif3<tm1d(EUCOMM)Wtsi>	MP:0006206,embryonic lethality between somite formation and embryo turning
MGI:6191656	Mtln<em1Rlbd>	MP:0010630,abnormal cardiac muscle tissue morphology|MP:0010959,abnormal oxidative phosphorylation|MP:0014174,decreased fatty acid beta-oxidation
MGI:3531156	Mtm1<Gt(OST290577)Lex>	MP:0000751,myopathy|MP:0001262,decreased body weight|MP:0003674,oxidative stress|MP:0004091,abnormal Z line morphology|MP:0004232,decreased muscle weight|MP:0006036,abnormal mitochondrial physiology|MP:0009400,decreased skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010053,decreased grip strength|MP:0030940,impaired autophagy
MGI:2450997	Mtm1<tm1.1Jman>	MP:0000160,kyphosis|MP:0000748,progressive muscle weakness|MP:0000751,myopathy|MP:0000755,hindlimb paralysis|MP:0001402,decreased locomotor activity|MP:0001732,postnatal growth retardation|MP:0001954,respiratory distress|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002269,muscular atrophy|MP:0002757,decreased vertical activity|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004262,abnormal physical strength|MP:0005150,cachexia|MP:0009417,skeletal muscle atrophy|MP:0009422,decreased gastrocnemius weight|MP:0010053,decreased grip strength|MP:0011090,perinatal lethality, incomplete penetrance|MP:0014344,abnormal skeletal muscle fiber mitochondrial morphology
MGI:3720064	Mtm1<tm1.2Jman>	MP:0000751,myopathy|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009413,skeletal muscle fiber atrophy
MGI:5307232	Mtm1<tm1Itl>	MP:0000748,progressive muscle weakness|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001529,abnormal vocalization|MP:0001544,abnormal cardiovascular system physiology|MP:0001922,reduced male fertility|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002133,abnormal respiratory system physiology|MP:0003082,abnormal gastrocnemius morphology|MP:0004819,decreased skeletal muscle mass|MP:0005370,liver/biliary system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009400,decreased skeletal muscle fiber size|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009417,skeletal muscle atrophy|MP:0009422,decreased gastrocnemius weight|MP:0009428,decreased tibialis anterior weight|MP:0010227,decreased quadriceps weight
MGI:7543966	Mtmr10<em1(IMPC)Mbp>	MP:0009142,decreased prepulse inhibition
MGI:6489291	Mtmr10<em1Mem>	MP:0010768,mortality/aging
MGI:6399904	Mtmr11<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001200,thick skin|MP:0002059,abnormal seminal vesicle morphology
MGI:5692827	Mtmr12<tm1b(KOMP)Wtsi>	MP:0010053,decreased grip strength|MP:0011965,decreased total retina thickness
MGI:4412297	Mtmr14<tm1Ckq>	MP:0000242,impaired fertilization|MP:0000266,abnormal heart morphology|MP:0000740,impaired smooth muscle contractility|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001405,impaired coordination|MP:0001922,reduced male fertility|MP:0002106,abnormal muscle physiology|MP:0002269,muscular atrophy|MP:0002675,asthenozoospermia|MP:0002841,impaired skeletal muscle contractility|MP:0002972,abnormal cardiac muscle contractility|MP:0003646,increased muscle fatigability|MP:0004036,abnormal muscle relaxation|MP:0004089,dilated sarcoplasmic reticulum|MP:0004231,abnormal calcium ion homeostasis|MP:0004542,impaired acrosome reaction|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0005620,abnormal muscle contractility|MP:0009230,abnormal sperm head morphology|MP:0009239,short sperm flagellum|MP:0009243,hairpin sperm flagellum|MP:0009647,decreased fertilization frequency|MP:0009831,abnormal sperm midpiece morphology|MP:0009836,abnormal sperm principal piece morphology|MP:0012106,impaired exercise endurance|MP:0014052,increased male germ cell apoptosis|MP:0014142,increased body fat mass
MGI:3604577	Mtmr1<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:5708190	Mtmr1<tm2b(KOMP)Wtsi>	MP:0002599,increased mean platelet volume|MP:0010024,increased total body fat amount|MP:0010067,increased red blood cell distribution width
MGI:6386315	Mtmr2<em1(IMPC)Hmgu>	MP:0001489,decreased startle reflex|MP:0002599,increased mean platelet volume|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level
MGI:3513454	Mtmr2<tm1.1Abol>	MP:0000572,abnormal autopod morphology|MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002651,abnormal sciatic nerve morphology|MP:0005403,abnormal nerve conduction|MP:0005405,axon degeneration|MP:0010540,long stride length|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3513251	Mtmr2<tm1Abol>	MP:0000920,abnormal myelination|MP:0002651,abnormal sciatic nerve morphology
MGI:3604478	Mtmr2<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3612427	Mtmr2<tm1Ueli>	MP:0000920,abnormal myelination|MP:0001513,limb grasping|MP:0003631,nervous system phenotype
MGI:3529241	Mtmr3<Gt(OST416539)Lex>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005293,impaired glucose tolerance
MGI:5630070	Mtmr3<tm1b(EUCOMM)Hmgu>	MP:0001488,increased startle reflex|MP:0002591,decreased mean corpuscular volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0005293,impaired glucose tolerance|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005627,increased circulating potassium level|MP:0006243,impaired pupillary reflex|MP:0009142,decreased prepulse inhibition
MGI:4433302	Mtmr4<tm1a(EUCOMM)Wtsi>	MP:0002492,decreased IgE level
MGI:7425017	Mtmr6<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001402,decreased locomotor activity
MGI:7488201	Mtmr9<tm1Wum>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0002064,seizures|MP:0002100,abnormal tooth morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3831873	mt-Nd2<m1>	MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0010954,abnormal cellular respiration
MGI:3777241	mt-Nd6<m1Dwa>	MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport
MGI:4834201	mt-Nd6<m2Jiha>	MP:0002006,neoplasm|MP:0005391,vision/eye phenotype|MP:0005416,abnormal circulating protein level|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0012552,lactic acidosis
MGI:5469319	mt-Nd6<m3Dwa>	MP:0001330,abnormal optic nerve morphology|MP:0001363,increased anxiety-related response|MP:0001409,increased stereotypic behavior|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003631,nervous system phenotype|MP:0003674,oxidative stress|MP:0004994,abnormal brain wave pattern|MP:0005551,abnormal eye electrophysiology|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006038,increased mitochondrial fission|MP:0008056,abnormal retina ganglion cell morphology|MP:0010954,abnormal cellular respiration|MP:0010955,abnormal respiratory electron transport chain|MP:0011731,decreased myelin sheath thickness|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0014416,decreased social novelty preference|MP:0014623,abnormal brain theta wave pattern|MP:0014624,abnormal brain delta wave pattern|MP:0020421,increased freezing behavior|MP:0021111,decreased social investigation
MGI:8245356	Mtnr1a<em1Stko>	MP:0000130,abnormal trabecular bone morphology|MP:0004016,decreased bone mass|MP:0004984,increased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0004992,increased bone resorption|MP:0005006,abnormal osteoblast physiology|MP:0005441,increased urine calcium level|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0011711,impaired osteoblast differentiation|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization|MP:0030439,decreased osteoblast proliferation
MGI:2450160	Mtnr1a<tm1Rep>	MP:0004811,abnormal neuron physiology|MP:0006309,decreased retina ganglion cell number|MP:0008450,retina photoreceptor degeneration|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:5548779	Mtnr1b<tm1.1(KOMP)Vlcg>	MP:0005292,improved glucose tolerance|MP:0013279,increased fasting circulating glucose level
MGI:2450159	Mtnr1b<tm1Drw>	MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002169,no abnormal phenotype detected|MP:0008432,abnormal long-term spatial reference memory
MGI:4336382	Mto1<Gt(G019A03)Wrst>	MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001489,decreased startle reflex|MP:0001516,abnormal motor coordination/balance|MP:0001636,irregular heartbeat|MP:0002833,increased heart weight|MP:0003233,prolonged QT interval|MP:0003461,abnormal response to novel object|MP:0004089,dilated sarcoplasmic reticulum|MP:0004566,myocardial fiber degeneration|MP:0004937,dilated heart|MP:0005330,cardiomyopathy|MP:0005333,decreased heart rate|MP:0006036,abnormal mitochondrial physiology|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009732,ventricular premature beat|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0009777,abnormal behavioral response to anesthetic|MP:0010052,increased grip strength|MP:0010392,prolonged QRS complex duration|MP:0010394,decreased QRS amplitude|MP:0010519,atrioventricular block|MP:0010520,sinoatrial block|MP:0010632,cardiac muscle necrosis|MP:0011634,abnormal mitochondrial inner membrane morphology|MP:0014390,decreased myocardial fiber mitochondrial DNA content|MP:0031391,increased locomotor activity
MGI:5484589	Mtor<chino>	MP:0001265,decreased body size|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0009339,decreased splenocyte number
MGI:1889297	Mtor<flat>	MP:0000783,abnormal forebrain morphology|MP:0000784,forebrain hypoplasia|MP:0000830,abnormal diencephalon morphology|MP:0000897,abnormal midbrain morphology|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0003984,embryonic growth retardation|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0013906,absent embryonic telencephalon
MGI:3529989	Mtor<Gt(OST92090)Lex>	MP:0005033,abnormal trophoblast giant cell morphology|MP:0012114,absent inner cell mass proliferation
MGI:4820819	Mtor<tm1.1Clyn>	MP:0002106,abnormal muscle physiology|MP:0003961,decreased lean body mass|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0008762,embryonic lethality|MP:0010024,increased total body fat amount|MP:0010239,decreased skeletal muscle weight
MGI:5707218	Mtor<tm1.1Gcon>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0003222,increased cardiomyocyte apoptosis|MP:0004090,abnormal sarcomere morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004485,increased response of heart to induced stress|MP:0004565,decreased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005324,ascites|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006036,abnormal mitochondrial physiology|MP:0006138,congestive heart failure|MP:0008260,abnormal autophagy|MP:0008725,increased heart atrium size|MP:0008772,increased heart ventricle size|MP:0010334,pleural effusion|MP:0010725,thin interventricular septum|MP:0011632,dilated mitochondrion|MP:0013272,abnormal translation|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0021158,decreased heart left ventricle wall thickness
MGI:3512186	Mtor<tm1.1Koz>	MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0002584,small ectoplacental cone|MP:0003984,embryonic growth retardation|MP:0004965,inner cell mass degeneration|MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4889218	Mtor<tm1.1Lgm>	MP:0005378,growth/size/body region phenotype|MP:0005387,immune system phenotype
MGI:3850506	Mtor<tm1.2Koz>	MP:0000160,kyphosis|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002108,abnormal muscle morphology|MP:0002145,abnormal T cell differentiation|MP:0002279,abnormal diaphragm morphology|MP:0003081,abnormal soleus morphology|MP:0003082,abnormal gastrocnemius morphology|MP:0003083,abnormal tibialis anterior morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003646,increased muscle fatigability|MP:0003944,abnormal T cell subpopulation ratio|MP:0004036,abnormal muscle relaxation|MP:0004263,abnormal limb posture|MP:0004973,increased regulatory T cell number|MP:0005095,decreased T cell proliferation|MP:0005288,abnormal oxygen consumption|MP:0005290,decreased oxygen consumption|MP:0005560,decreased circulating glucose level|MP:0005620,abnormal muscle contractility|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008827,abnormal thymus cell ratio|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009412,skeletal muscle fiber degeneration|MP:0009415,skeletal muscle degeneration|MP:0010401,increased skeletal muscle glycogen level|MP:0011629,decreased mitochondrial number|MP:0014274,decreased respiration|MP:0021206,abnormal limb muscle morphology
MGI:5425404	Mtor<tm1.2Seq>	MP:0011091,prenatal lethality, complete penetrance
MGI:4432158	Mtor<tm1a(EUCOMM)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0000183,decreased circulating LDL cholesterol level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005566,decreased blood urea nitrogen level|MP:0011100,preweaning lethality, complete penetrance
MGI:4820591	Mtor<tm1Koz>	MP:0000920,abnormal myelination|MP:0001106,abnormal Schwann cell morphology|MP:0001107,decreased Schwann cell number|MP:0001516,abnormal motor coordination/balance|MP:0003871,abnormal myelin sheath morphology|MP:0005404,abnormal axon morphology|MP:0008814,decreased nerve conduction velocity|MP:0010738,abnormal internode morphology|MP:0010739,abnormal axolemma morphology
MGI:4889219	Mtor<tm1Lgm>	MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000692,small spleen|MP:0000715,decreased thymocyte number|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0005017,decreased B cell number|MP:0005092,decreased double-positive T cell number|MP:0005093,decreased B cell proliferation|MP:0008037,abnormal T cell morphology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008098,decreased plasma cell number|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0009335,decreased splenocyte proliferation|MP:0009341,decreased splenocyte apoptosis|MP:0009923,decreased transitional stage T1 B cell number|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014472,impaired B cell migration
MGI:3052669	Mtor<tm1Yam>	MP:0001695,abnormal gastrulation|MP:0005031,abnormal trophoblast layer morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:5708206	Mtpap<tm1.1(KOMP)Vlcg>	MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0003131,increased erythrocyte cell number|MP:0005554,decreased circulating creatinine level|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014586,decreased egg cylinder size
MGI:8161057	Mtrex<tm1.1Hyfn>	MP:0001125,abnormal oocyte morphology|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0005168,abnormal female meiosis|MP:0008887,abnormal splicing factor domain morphology|MP:0009375,thin zona pellucida
MGI:3783752	mt-Rnr2<m1Dwa>	MP:0000278,abnormal myocardial fiber morphology|MP:0000422,delayed hair appearance|MP:0000751,myopathy|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002795,dilated cardiomyopathy|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003105,abnormal heart atrium morphology|MP:0004201,fetal growth retardation|MP:0008725,increased heart atrium size|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:6285600	Mtrr<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:3526159	Mtrr<Gt(XG334)Byg>	MP:0001262,decreased body weight|MP:0005332,abnormal amino acid level|MP:0006076,abnormal circulating homocysteine level|MP:0012335,increased circulating homocysteine level|MP:0030645,decreased circulating methionine level
MGI:2180496	Mtr<tm1Lcb>	MP:0011092,embryonic lethality, complete penetrance|MP:0012335,increased circulating homocysteine level|MP:0030644,increased circulating methionine level
MGI:3875890	Mtss1<Gt(CSC156)Byg>	MP:0000218,increased leukocyte cell number|MP:0000358,abnormal cell morphology|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001846,increased inflammatory response|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0002458,abnormal B cell number|MP:0002459,abnormal B cell physiology|MP:0003132,increased pre-B cell number|MP:0005621,abnormal cell physiology|MP:0008215,decreased immature B cell number|MP:0011707,impaired fibroblast cell migration|MP:0014698,decreased fibroblast adhesion
MGI:4128729	Mtss1<Gt(RRI034)Byg>	MP:0008528,polycystic kidney|MP:0011440,increased kidney cell proliferation
MGI:5319219	Mtss1<tm1Pla>	MP:0001762,polyuria|MP:0002083,premature death|MP:0002705,dilated renal tubule|MP:0002968,increased circulating alkaline phosphatase level|MP:0003985,renal fibrosis|MP:0005264,glomerulosclerosis|MP:0009641,kidney degeneration|MP:0010124,decreased bone mineral content|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011435,increased urine magnesium level|MP:0011941,increased fluid intake
MGI:4840989	Mtss2<tm1a(KOMP)Wtsi>	MP:0001566,increased circulating phosphate level|MP:0005559,increased circulating glucose level
MGI:5606283	mt-Tk<m1>	MP:0000747,muscle weakness|MP:0001258,decreased body length|MP:0004805,absent oocytes|MP:0005367,renal/urinary system phenotype|MP:0010955,abnormal respiratory electron transport chain
MGI:7614770	mt-Tl1<m1Jiha>	MP:0000609,abnormal liver physiology|MP:0001260,increased body weight|MP:0001552,increased circulating triglyceride level|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0004087,abnormal muscle fiber morphology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0005566,decreased blood urea nitrogen level|MP:0006036,abnormal mitochondrial physiology|MP:0011631,decreased mitochondrial size|MP:0011635,abnormal mitochondrial crista morphology|MP:0013405,increased circulating lactate level
MGI:2386838	Mttp<tm1Chan>	MP:0000180,abnormal circulating cholesterol level|MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000187,abnormal triglyceride level|MP:0003976,decreased circulating VLDL triglyceride level|MP:0005146,decreased circulating VLDL cholesterol level
MGI:2152201	Mttp<tm1Sgy>	MP:0000180,abnormal circulating cholesterol level|MP:0000183,decreased circulating LDL cholesterol level|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0001547,abnormal lipid level|MP:0001722,pale yolk sac|MP:0001914,hemorrhage|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0002875,decreased erythrocyte cell number|MP:0003949,abnormal circulating lipid level|MP:0003984,embryonic growth retardation|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011204,abnormal visceral yolk sac blood island morphology|MP:0013241,embryo tissue necrosis|MP:0020515,abnormal visceral yolk sac endoderm morphology
MGI:2152202	Mttp<tm2Sgy>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000609,abnormal liver physiology|MP:0002644,decreased circulating triglyceride level|MP:0002981,increased liver weight|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005416,abnormal circulating protein level|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level
MGI:5548560	Mturn<tm1.1(KOMP)Vlcg>	MP:0000062,increased bone mineral density|MP:0000367,abnormal coat/ hair morphology|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:4126369	Mtus1<Gt(RRA048)Byg>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000351,increased cell proliferation|MP:0000358,abnormal cell morphology|MP:0000688,lymphoid hyperplasia|MP:0001260,increased body weight|MP:0001577,anemia|MP:0001625,cardiac hypertrophy|MP:0001870,salivary gland inflammation|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0002743,glomerulonephritis|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0004031,insulitis|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0005013,increased lymphocyte cell number|MP:0005385,cardiovascular system phenotype
MGI:3579297	Mtv2<a>	MP:0001883,increased mammary adenocarcinoma incidence|MP:0001884,mammary gland alveolar hyperplasia
MGI:3696552	Mtv7<BALB/c>	MP:0003724,increased susceptibility to induced arthritis
MGI:3696551	Mtv7<DBA/2>	MP:0003436,decreased susceptibility to induced arthritis
MGI:7738705	Mtv8<em1Tvg>	MP:0005387,immune system phenotype
MGI:6314758	Mtx2<em1(IMPC)J>	MP:0000062,increased bone mineral density|MP:0000221,decreased leukocyte cell number|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0005560,decreased circulating glucose level|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:6810154	Muc13<tm1.1Mamg>	MP:0000208,decreased hematocrit|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000512,intestinal ulcer|MP:0003293,rectal hemorrhage|MP:0003304,large intestinal inflammation|MP:0003306,small intestinal inflammation|MP:0005036,diarrhea|MP:0008537,increased susceptibility to induced colitis|MP:0008883,abnormal enterocyte proliferation|MP:0008885,increased enterocyte apoptosis|MP:0010180,increased susceptibility to weight loss|MP:0013298,increased susceptibility to colitis induced morbidity/mortality|MP:0013799,abnormal intestinal goblet cell physiology
MGI:3840843	Muc16<tm1Bhr>	MP:0001934,increased litter size
MGI:1857043	Muc19<sld>	MP:0004035,abnormal sublingual gland morphology|MP:0005350,increased susceptibility to autoimmune disorder
MGI:5515435	Muc19<tm2Culp>	MP:0004035,abnormal sublingual gland morphology
MGI:4399063	Muc1<tm1.1(cre/ERT2)Lcm>	MP:0002169,no abnormal phenotype detected
MGI:2447730	Muc1<tm1Gend>	MP:0000505,decreased digestive secretion|MP:0002647,decreased intestinal cholesterol absorption|MP:0002830,gallstones|MP:0003447,decreased tumor growth/size|MP:0005085,abnormal gallbladder physiology|MP:0005342,abnormal intestinal lipid absorption|MP:0005391,vision/eye phenotype
MGI:5471473	Muc2<eey>	MP:0000218,increased leukocyte cell number|MP:0000493,rectal prolapse|MP:0000495,abnormal colon morphology|MP:0002006,neoplasm|MP:0002083,premature death|MP:0003292,melena|MP:0003449,abnormal intestine goblet cell morphology|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0008537,increased susceptibility to induced colitis|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008883,abnormal enterocyte proliferation|MP:0008885,increased enterocyte apoptosis|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009482,ileum inflammation|MP:0011632,dilated mitochondrion|MP:0011635,abnormal mitochondrial crista morphology|MP:0020354,increased endoplasmic reticulum stress
MGI:4820425	Muc2<keny>	MP:0000702,enlarged lymph nodes|MP:0001663,abnormal digestive system physiology|MP:0005036,diarrhea
MGI:3851216	Muc2<M1Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:4442897	Muc2<m2Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:6113610	Muc2<m3Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:2183923	Muc2<tm1Avel>	MP:0000351,increased cell proliferation|MP:0000465,gastrointestinal hemorrhage|MP:0000477,abnormal intestine morphology|MP:0000479,abnormal enterocyte morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0002816,colitis|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0003091,abnormal cell migration|MP:0003304,large intestinal inflammation|MP:0003449,abnormal intestine goblet cell morphology|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005621,abnormal cell physiology|MP:0008883,abnormal enterocyte proliferation|MP:0010155,abnormal intestine physiology|MP:0014234,decreased enterocyte apoptosis
MGI:3614806	Muc2<wnn>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000493,rectal prolapse|MP:0000495,abnormal colon morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000512,intestinal ulcer|MP:0001552,increased circulating triglyceride level|MP:0001663,abnormal digestive system physiology|MP:0001666,abnormal intestinal absorption|MP:0002006,neoplasm|MP:0002083,premature death|MP:0002816,colitis|MP:0003292,melena|MP:0003293,rectal hemorrhage|MP:0003449,abnormal intestine goblet cell morphology|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005013,increased lymphocyte cell number|MP:0005036,diarrhea|MP:0008537,increased susceptibility to induced colitis|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008672,increased interleukin-13 secretion|MP:0008883,abnormal enterocyte proliferation|MP:0008885,increased enterocyte apoptosis|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009482,ileum inflammation|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010155,abnormal intestine physiology|MP:0010180,increased susceptibility to weight loss|MP:0011632,dilated mitochondrion|MP:0011635,abnormal mitochondrial crista morphology|MP:0013956,decreased colon length|MP:0020354,increased endoplasmic reticulum stress
MGI:5776697	Muc3a<em1(IMPC)J>	MP:0010053,decreased grip strength
MGI:6423091	Muc4<PWK/PhJ>	MP:0020185,abnormal susceptibility to viral infection
MGI:5829375	Muc4<tm1Skb>	MP:0004502,decreased incidence of tumors by chemical induction|MP:0008539,decreased susceptibility to induced colitis|MP:0013299,decreased susceptibility to colitis induced morbidity/mortality
MGI:6416171	Muc4<tm1Unc>	MP:0001262,decreased body weight|MP:0001954,respiratory distress|MP:0020940,increased susceptibility to Togaviridae infection|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:5295259	Muc5ac<tm1.1Evns>	MP:0001314,cornea opacity|MP:0003449,abnormal intestine goblet cell morphology|MP:0005027,increased susceptibility to parasitic infection|MP:0005253,abnormal eye physiology|MP:0008577,increased circulating interferon-gamma level|MP:0012164,abnormal conjunctiva goblet cell morphology
MGI:5692552	Muc5ac<tm2b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration
MGI:6404511	Muc5b<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001489,decreased startle reflex|MP:0002060,abnormal skin morphology|MP:0009142,decreased prepulse inhibition
MGI:5576290	Muc5b<tm1.2Evns>	MP:0000049,abnormal middle ear morphology|MP:0001732,postnatal growth retardation|MP:0001798,impaired macrophage phagocytosis|MP:0001850,increased susceptibility to otitis media|MP:0001951,abnormal breathing pattern|MP:0002083,premature death|MP:0002405,respiratory system inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0002452,abnormal professional antigen presenting cell physiology|MP:0005044,sepsis|MP:0005576,decreased pulmonary ventilation|MP:0008691,decreased interleukin-23 secretion|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010752,impaired mucociliary clearance|MP:0011080,increased macrophage apoptosis|MP:0012549,hypoxemia|MP:0030410,middle ear effusion
MGI:2180118	Mug1<tm1Vln>	MP:0001654,hepatic necrosis|MP:0001860,liver inflammation|MP:0008713,abnormal cytokine level|MP:0008806,increased circulating amylase level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011886,increased circulating lipase level
MGI:5004963	mul	MP:0000914,exencephaly|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001096,abnormal glossopharyngeal ganglion morphology|MP:0001698,decreased embryo size|MP:0003861,abnormal nervous system development|MP:0005385,cardiovascular system phenotype|MP:0006346,small pharyngeal arch|MP:0008784,craniorachischisis|MP:0011089,perinatal lethality, complete penetrance
MGI:7486477	Mul1<tm1.1Hmmc>	MP:0005451,abnormal body composition
MGI:3617395	Mupm1<BALB/cJPt>	MP:0001760,abnormal urine enzyme level
MGI:3588581	Mus81<tm1Chmg>	MP:0000352,decreased cell proliferation|MP:0005385,cardiovascular system phenotype|MP:0008058,abnormal DNA repair|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008943,increased sensitivity to induced cell death|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:3785405	Mus81<tm1Esse>	MP:0000233,abnormal blood flow velocity|MP:0000272,abnormal aorta morphology|MP:0001175,abnormal lung morphology|MP:0001183,overexpanded pulmonary alveolus|MP:0001544,abnormal cardiovascular system physiology|MP:0001634,internal hemorrhage|MP:0001846,increased inflammatory response|MP:0001861,lung inflammation|MP:0001958,emphysema|MP:0002625,heart left ventricle hypertrophy|MP:0002747,abnormal aortic valve morphology|MP:0003395,abnormal subclavian artery morphology|MP:0003819,increased left ventricle diastolic pressure|MP:0004044,aortic dissection|MP:0005244,hemopericardium|MP:0006047,aortic valve regurgitation|MP:0006117,aortic valve stenosis|MP:0006265,increased pulse pressure|MP:0006278,aortic aneurysm|MP:0008657,increased interleukin-1 beta secretion|MP:0008775,abnormal heart ventricle pressure|MP:0009862,abnormal aorta elastic tissue morphology|MP:0009866,abnormal aorta wall morphology|MP:0009871,abnormal aorta tunica adventitia morphology|MP:0009873,abnormal aorta tunica media morphology|MP:0010468,abnormal thoracic aorta morphology|MP:0010470,dilated ascending aorta|MP:0010661,ascending aorta aneurysm|MP:0010996,increased aorta wall thickness|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011951,increased cardiac stroke volume
MGI:3050210	Mus81<tm1Raz>	MP:0001658,increased mortality induced by gamma-irradiation|MP:0002023,increased B cell derived lymphoma incidence|MP:0002038,increased carcinoma incidence|MP:0002083,premature death|MP:0004028,chromosome breakage|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010383,increased adenoma incidence|MP:0012431,increased lymphoma incidence
MGI:3621908	Musk<tm1.1Vwi>	MP:0011087,neonatal lethality, complete penetrance
MGI:5763564	Musk<tm1.2Ics>	MP:0000160,kyphosis|MP:0000748,progressive muscle weakness|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001953,respiratory failure|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003646,increased muscle fatigability|MP:0003651,abnormal axon extension|MP:0004174,abnormal spine curvature|MP:0008415,abnormal neurite morphology|MP:0010053,decreased grip strength|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012055,abnormal phrenic nerve innervation pattern to diaphragm
MGI:1929066	Musk<tm1Gdy>	MP:0000940,abnormal motor neuron innervation pattern|MP:0001052,abnormal innervation pattern to muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001054,failure of neuromuscular synapse presynaptic differentiation|MP:0001055,failure of neuromuscular synapse postsynaptic differentiation|MP:0001404,no spontaneous movement|MP:0001491,unresponsive to tactile stimuli|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0011087,neonatal lethality, complete penetrance
MGI:2449789	Musk<tm1Vwi>	MP:0000160,kyphosis|MP:0000747,muscle weakness|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001263,weight loss|MP:0002083,premature death|MP:0010053,decreased grip strength|MP:0012055,abnormal phrenic nerve innervation pattern to diaphragm
MGI:3815474	Musk<tm2Vwi>	MP:0005369,muscle phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging
MGI:5473008	Mustn1<tm1a(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:7616867	Mustn1<tm1d(EUCOMM)Wtsi>	MP:0005165,increased susceptibility to injury|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0009419,skeletal muscle fibrosis|MP:0010768,mortality/aging
MGI:5433687	Mut1045	MP:0000440,domed cranium|MP:0001265,decreased body size|MP:0001923,reduced female fertility|MP:0005409,darkened coat color|MP:0009703,decreased birth body size
MGI:5433024	Mut1048	MP:0000585,kinked tail|MP:0000592,short tail|MP:0001265,decreased body size|MP:0009703,decreased birth body size|MP:0009934,abnormal hind foot hair pigmentation|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5433690	Mut1064	MP:0001265,decreased body size|MP:0001410,head bobbing|MP:0006204,embryonic lethality before implantation|MP:0009703,decreased birth body size
MGI:5433691	Mut1069	MP:0001265,decreased body size|MP:0009703,decreased birth body size|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:5439915	Mut1083	MP:0001265,decreased body size|MP:0001410,head bobbing|MP:0002080,prenatal lethality
MGI:5439934	Mut1091	MP:0001265,decreased body size|MP:0008527,embryonic lethality at implantation|MP:0009703,decreased birth body size
MGI:5439937	Mut1139	MP:0000585,kinked tail|MP:0008527,embryonic lethality at implantation|MP:0011568,decreased foot pigmentation
MGI:5426406	Mut1152	MP:0000440,domed cranium|MP:0001265,decreased body size|MP:0002092,abnormal eye morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:5427409	Mut1154	MP:0000440,domed cranium|MP:0001265,decreased body size|MP:0001299,abnormal eye distance/ position|MP:0003935,abnormal craniofacial development|MP:0008762,embryonic lethality|MP:0009703,decreased birth body size
MGI:5440917	Mut1170	MP:0000592,short tail|MP:0003054,spina bifida|MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:5439981	Mut1231	MP:0000414,alopecia|MP:0001211,wrinkled skin|MP:0001274,curly vibrissae|MP:0003815,hairless|MP:0006204,embryonic lethality before implantation
MGI:5427414	Mut1264	MP:0000438,abnormal cranium morphology|MP:0000574,abnormal foot pad morphology|MP:0000585,kinked tail|MP:0000592,short tail|MP:0000914,exencephaly|MP:0001265,decreased body size|MP:0001410,head bobbing|MP:0006204,embryonic lethality before implantation|MP:0009703,decreased birth body size
MGI:5427419	Mut1275	MP:0002080,prenatal lethality
MGI:5427423	Mut1293	MP:0000440,domed cranium|MP:0001265,decreased body size|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002102,abnormal ear morphology|MP:0002750,exophthalmos|MP:0005508,abnormal skeleton morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:5429756	Mut1305	MP:0000440,domed cranium|MP:0001265,decreased body size|MP:0009703,decreased birth body size|MP:0011092,embryonic lethality, complete penetrance|MP:0030930,decreased digit pigmentation
MGI:5428963	Mut1397	MP:0000585,kinked tail|MP:0000592,short tail|MP:0002111,abnormal tail morphology|MP:0008762,embryonic lethality
MGI:5442340	Mut1446	MP:0000414,alopecia|MP:0001212,skin lesions|MP:0001262,decreased body weight|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:5429757	Mut1454	MP:0000585,kinked tail|MP:0000592,short tail|MP:0001265,decreased body size|MP:0001410,head bobbing|MP:0008913,weaving|MP:0009703,decreased birth body size|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5470112	Mut1488	MP:0000440,domed cranium|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0009674,decreased birth weight|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0030930,decreased digit pigmentation
MGI:5442354	Mut1544	MP:0000440,domed cranium|MP:0001262,decreased body weight|MP:0009275,bruising|MP:0009674,decreased birth weight|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:5470118	Mut1556	MP:0000373,belly spot|MP:0000574,abnormal foot pad morphology|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001262,decreased body weight|MP:0001410,head bobbing|MP:0009674,decreased birth weight|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5470123	Mut1602	MP:0000574,abnormal foot pad morphology|MP:0000592,short tail|MP:0001262,decreased body weight|MP:0001410,head bobbing|MP:0009674,decreased birth weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:5471522	Mut1679	MP:0000111,cleft palate|MP:0000440,domed cranium|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001410,head bobbing|MP:0002080,prenatal lethality|MP:0009674,decreased birth weight|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance|MP:0011568,decreased foot pigmentation
MGI:5484617	Mut1681	MP:0000440,domed cranium|MP:0000574,abnormal foot pad morphology|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001265,decreased body size|MP:0001410,head bobbing|MP:0006204,embryonic lethality before implantation|MP:0009703,decreased birth body size
MGI:5484618	Mut1696	MP:0001265,decreased body size|MP:0001410,head bobbing|MP:0002080,prenatal lethality|MP:0009703,decreased birth body size
MGI:5484622	Mut1704	MP:0000440,domed cranium|MP:0000564,syndactyly|MP:0001265,decreased body size|MP:0009703,decreased birth body size
MGI:5484621	Mut1756	MP:0000418,focal hair loss|MP:0010203,focal ventral hair loss
MGI:5426404	Mut495	MP:0000575,increased foot pad pigmentation|MP:0002110,abnormal digit morphology|MP:0002160,abnormal reproductive system morphology|MP:0030930,decreased digit pigmentation
MGI:5426405	Mut549	MP:0000445,short snout|MP:0000592,short tail|MP:0009703,decreased birth body size|MP:0009934,abnormal hind foot hair pigmentation
MGI:5427399	Mut579	MP:0000445,short snout|MP:0000454,abnormal jaw morphology|MP:0001297,microphthalmia|MP:0008762,embryonic lethality
MGI:5428951	Mut607	MP:0000023,abnormal ear position|MP:0000373,belly spot|MP:0000585,kinked tail|MP:0002082,postnatal lethality|MP:0011568,decreased foot pigmentation
MGI:5427404	Mut640	MP:0001265,decreased body size|MP:0005409,darkened coat color|MP:0006204,embryonic lethality before implantation|MP:0009674,decreased birth weight|MP:0011279,decreased ear pigmentation
MGI:5429755	Mut778	MP:0000440,domed cranium|MP:0000914,exencephaly|MP:0001265,decreased body size|MP:0002160,abnormal reproductive system morphology|MP:0005409,darkened coat color|MP:0009703,decreased birth body size|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5428958	Mut810	MP:0001265,decreased body size|MP:0001410,head bobbing|MP:0001919,abnormal reproductive system physiology|MP:0005424,jerky movement|MP:0011092,embryonic lethality, complete penetrance
MGI:5430731	Mut873	MP:0000440,domed cranium|MP:0001265,decreased body size|MP:0009703,decreased birth body size|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5430732	Mut921	MP:0000438,abnormal cranium morphology|MP:0001265,decreased body size|MP:0009703,decreased birth body size|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5432505	Mut955	MP:0001410,head bobbing|MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:5432515	Mut960	MP:0001410,head bobbing|MP:0005424,jerky movement|MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:5450857	Muth1	MP:0000414,alopecia|MP:0002080,prenatal lethality|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5646384	Muts1/14	MP:0000562,polydactyly|MP:0001297,microphthalmia|MP:0009703,decreased birth body size|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3043929	Mutyh<tm1Jhmi>	MP:0002006,neoplasm
MGI:5476928	Mutyh<tm1Yun>	MP:0008236,decreased susceptibility to neuronal excitotoxicity
MGI:1861226	Mv	MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001688,abnormal somite development|MP:0001691,abnormal somite shape|MP:0002058,neonatal lethality|MP:0002111,abnormal tail morphology|MP:0002114,abnormal axial skeleton morphology|MP:0004200,decreased fetal size|MP:0004624,abnormal thoracic cage morphology|MP:0004703,abnormal vertebral column morphology
MGI:5436083	Mvd003	MP:0002591,decreased mean corpuscular volume
MGI:5436084	Mvd005	MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin
MGI:5436085	Mvd007	MP:0002591,decreased mean corpuscular volume|MP:0010831,lethality, incomplete penetrance
MGI:5436086	Mvd009	MP:0002591,decreased mean corpuscular volume
MGI:5436088	Mvd016	MP:0002591,decreased mean corpuscular volume|MP:0003131,increased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin
MGI:5436089	Mvd017	MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin
MGI:5436090	Mvd018	MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin
MGI:5436091	Mvd019	MP:0002591,decreased mean corpuscular volume
MGI:5436092	Mvd021	MP:0002591,decreased mean corpuscular volume
MGI:5436093	Mvd023	MP:0000208,decreased hematocrit|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content
MGI:6196088	Mvd<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5754606	Mvk<em1(IMPC)Tcp>	MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0001297,microphthalmia|MP:0001697,abnormal embryo size|MP:0004930,small epididymis|MP:0009709,hydrometra|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:8246877	Mvk<em1Mijr>	MP:0005584,abnormal enzyme/coenzyme activity
MGI:8246878	Mvk<em2Mijr>	MP:0011091,prenatal lethality, complete penetrance
MGI:8246879	Mvk<em3Mijr>	MP:0011091,prenatal lethality, complete penetrance
MGI:8246880	Mvk<em4Mijr>	MP:0005584,abnormal enzyme/coenzyme activity|MP:0011091,prenatal lethality, complete penetrance
MGI:4229560	Mvk<Gt(OST201716)Lex>	MP:0000061,fragile skeleton|MP:0000222,decreased neutrophil cell number|MP:0000333,decreased bone marrow cell number|MP:0000420,ruffled hair|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001402,decreased locomotor activity|MP:0001510,abnormal coat appearance|MP:0001764,abnormal homeostasis|MP:0001777,abnormal body temperature homeostasis|MP:0002417,abnormal megakaryocyte morphology|MP:0002496,increased IgD level|MP:0005387,immune system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005656,decreased aggression|MP:0008011,intestine polyps|MP:0008553,increased circulating tumor necrosis factor level|MP:0011091,prenatal lethality, complete penetrance|MP:0014713,abnormal erythrocyte basophilic stippling|MP:0020171,abnormal IgA level
MGI:3978136	Mvp<Gt(IST10954E2)Tigm>	MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0002882,abnormal neuron morphology|MP:0003631,nervous system phenotype|MP:0004166,abnormal limbic system morphology|MP:0004167,abnormal cingulate gyrus morphology|MP:0005386,behavior/neurological phenotype|MP:0008283,small hippocampus|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008535,enlarged lateral ventricles|MP:0009939,abnormal hippocampus neuron morphology|MP:0012450,decreased primary motor cortex size|MP:0012460,decreased dentate gyrus size|MP:0012474,decreased cingulate cortex size|MP:0012476,decreased piriform cortex size|MP:0012478,decreased secondary somatosensory cortex size|MP:0014372,decreased miniature excitatory postsynaptic current amplitude|MP:0020508,decreased dendritic spine density|MP:0020527,small thalamus
MGI:2447742	Mvp<tm1Wie>	MP:0002169,no abnormal phenotype detected
MGI:5436099	mvu008	MP:0002590,increased mean corpuscular volume|MP:0005561,increased mean corpuscular hemoglobin
MGI:3796083	Mvwf2<CASA/RkJ>	MP:0031165,increased circulating von Willebrand factor level
MGI:3617420	Mvwf<RIIIS/J>	MP:0031164,decreased circulating von Willebrand factor level
MGI:2156710	Mwq1<DU6i>	MP:0002108,abnormal muscle morphology
MGI:3036057	Mwq2<DU6i>	MP:0002108,abnormal muscle morphology
MGI:3036055	Mwq3<DU6i>	MP:0002108,abnormal muscle morphology
MGI:2389240	Mwq4<DU6i>	MP:0002108,abnormal muscle morphology
MGI:3036059	Mwq5<DU6i>	MP:0002108,abnormal muscle morphology
MGI:3715151	Mx1<r>	MP:0001793,abnormal susceptibility to infection|MP:0020947,decreased susceptibility to Orthomyxoviridae infection|MP:0031045,decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:3715154	Mx1<s1>	MP:0001793,abnormal susceptibility to infection|MP:0008244,abnormal peritoneal macrophage morphology|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0020946,increased susceptibility to Orthomyxoviridae infection|MP:0031046,increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:3715155	Mx1<s2>	MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:4431734	Mx1<tm1a(EUCOMM)Wtsi>	MP:0003960,increased lean body mass
MGI:6324169	Mx2<em1(IMPC)Ics>	MP:0001486,abnormal startle reflex|MP:0002699,abnormal vitreous body morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005344,increased circulating bilirubin level
MGI:2387993	Mxd1<tm1Rne>	MP:0000322,increased granulocyte number|MP:0002459,abnormal B cell physiology|MP:0005387,immune system phenotype|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008250,abnormal myeloid leukocyte morphology
MGI:2183621	Mxd3<tm1Rne>	MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death
MGI:6879485	Mxd4<em1(IMPC)J>	MP:0000194,increased circulating calcium level|MP:0000218,increased leukocyte cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0010392,prolonged QRS complex duration
MGI:1857929	Mxi1<tm1Rdp>	MP:0000691,enlarged spleen|MP:0001158,abnormal prostate gland morphology|MP:0001167,prostate gland epithelial hyperplasia|MP:0002083,premature death|MP:0002619,abnormal lymphocyte morphology|MP:0004499,increased incidence of tumors by chemical induction|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005348,increased T cell proliferation|MP:0005621,abnormal cell physiology|MP:0008478,increased spleen white pulp amount|MP:0009641,kidney degeneration|MP:0011363,renal glomerulus atrophy|MP:0011423,kidney cortex atrophy|MP:0011501,increased glomerular capsule space
MGI:4433751	Mxra7<tm1a(EUCOMM)Wtsi>	MP:0000229,abnormal megakaryocyte differentiation|MP:0001792,impaired wound healing|MP:0002417,abnormal megakaryocyte morphology|MP:0002908,delayed wound healing|MP:0003179,thrombocytopenia|MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology|MP:0006298,abnormal platelet activation|MP:0008255,decreased megakaryocyte cell number|MP:0009586,increased platelet aggregation|MP:0011704,decreased fibroblast proliferation|MP:0011708,decreased fibroblast cell migration|MP:0014699,increased fibroblast adhesion|MP:0020414,abnormal fibroblast physiology
MGI:5548547	Mxra7<tm1b(EUCOMM)Wtsi>	MP:0002764,short tibia|MP:0010090,increased circulating creatine kinase level
MGI:6378753	Mxra8<em1Diam>	MP:0001876,decreased inflammatory response|MP:0008713,abnormal cytokine level|MP:0020941,decreased susceptibility to Togaviridae infection
MGI:6200400	Mxra8<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0002075,abnormal coat/hair pigmentation
MGI:6378754	Mxra8<em2Diam>	MP:0020941,decreased susceptibility to Togaviridae infection
MGI:4288408	Mxra8<Gt(OST346428)Lex>	MP:0002169,no abnormal phenotype detected
MGI:4867909	Myb<boo>	MP:0000222,decreased neutrophil cell number|MP:0000245,abnormal erythropoiesis|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002123,abnormal definitive hematopoiesis|MP:0002144,abnormal B cell differentiation|MP:0002417,abnormal megakaryocyte morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002640,reticulocytosis|MP:0004229,abnormal embryonic erythropoiesis|MP:0004809,increased hematopoietic stem cell number|MP:0005097,polychromatophilia|MP:0005505,thrombocytosis|MP:0008246,abnormal leukocyte morphology|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008254,increased megakaryocyte cell number|MP:0008476,increased spleen red pulp amount|MP:0008479,decreased spleen white pulp amount|MP:0009395,increased nucleated erythrocyte cell number|MP:0010178,increased number of Howell-Jolly bodies
MGI:5548364	Mybbp1a<tm1b(EUCOMM)Hmgu>	MP:0001488,increased startle reflex|MP:0002608,increased hematocrit|MP:0002968,increased circulating alkaline phosphatase level|MP:0003131,increased erythrocyte cell number|MP:0005505,thrombocytosis|MP:0005564,increased hemoglobin content|MP:0005633,increased circulating sodium level|MP:0011100,preweaning lethality, complete penetrance
MGI:5466388	Mybbp1a<tm1Fbla>	MP:0009781,abnormal preimplantation embryo development|MP:0011092,embryonic lethality, complete penetrance|MP:0012129,failure of blastocyst formation
MGI:3512907	Mybl1<repro9>	MP:0001147,small testis|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0008280,abnormal male germ cell apoptosis|MP:0009452,abnormal synaptonemal complex|MP:0014764,impaired double-strand DNA break repair
MGI:3709838	Mybl1<tm1.1Wtsn>	MP:0002169,no abnormal phenotype detected
MGI:2447613	Mybl1<tm1Epr>	MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001211,wrinkled skin|MP:0001265,decreased body size|MP:0001382,abnormal nursing|MP:0001505,hunched posture|MP:0001732,postnatal growth retardation|MP:0001800,abnormal humoral immune response|MP:0001925,male infertility|MP:0002362,abnormal spleen marginal zone morphology|MP:0002784,abnormal Sertoli cell morphology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005017,decreased B cell number|MP:0005159,azoospermia|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0006270,abnormal mammary gland growth during lactation|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008476,increased spleen red pulp amount|MP:0008482,decreased spleen germinal center number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008498,decreased IgG3 level|MP:0009452,abnormal synaptonemal complex|MP:0009504,abnormal mammary gland epithelium morphology|MP:0014052,increased male germ cell apoptosis
MGI:5577181	Mybl2<tm1.1Epr>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000333,decreased bone marrow cell number|MP:0001601,abnormal myelopoiesis|MP:0003077,abnormal cell cycle|MP:0003179,thrombocytopenia|MP:0004810,decreased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0009339,decreased splenocyte number|MP:0011180,abnormal hematopoietic cell number|MP:0011903,decreased hematopoietic stem cell proliferation
MGI:3610476	Mybl2<tm1.1Jof>	MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000321,increased bone marrow cell number|MP:0000322,increased granulocyte number|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0002026,increased leukemia incidence|MP:0002169,no abnormal phenotype detected|MP:0002447,abnormal erythrocyte morphology|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002875,decreased erythrocyte cell number|MP:0003077,abnormal cell cycle|MP:0003179,thrombocytopenia|MP:0005505,thrombocytosis|MP:0008254,increased megakaryocyte cell number|MP:0010178,increased number of Howell-Jolly bodies|MP:0010373,myeloid hyperplasia
MGI:5695870	Mybl2<tm1.1(KOMP)Vlcg>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3610475	Mybl2<tm1Jof>	MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:2445746	Mybl2<tm1Sis>	MP:0002718,abnormal inner cell mass morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3574289	Myb<M303V>	MP:0000229,abnormal megakaryocyte differentiation|MP:0000239,absent common myeloid progenitor cells|MP:0000248,macrocytosis|MP:0000321,increased bone marrow cell number|MP:0000715,decreased thymocyte number|MP:0001577,anemia|MP:0001802,arrested B cell differentiation|MP:0001825,arrested T cell differentiation|MP:0002875,decreased erythrocyte cell number|MP:0003405,abnormal platelet shape|MP:0004809,increased hematopoietic stem cell number|MP:0005012,decreased eosinophil cell number|MP:0005017,decreased B cell number|MP:0005505,thrombocytosis|MP:0008083,decreased single-positive T cell number
MGI:7621904	Mybpc1<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:7256880	Mybpc1<em1Lbmc>	MP:0000160,kyphosis|MP:0000745,tremors|MP:0001265,decreased body size|MP:0002058,neonatal lethality|MP:0002082,postnatal lethality|MP:0004090,abnormal sarcomere morphology|MP:0004819,decreased skeletal muscle mass|MP:0010053,decreased grip strength
MGI:7331608	Mybpc2<tm1Ssad>	MP:0000747,muscle weakness|MP:0002106,abnormal muscle physiology|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003157,impaired muscle relaxation|MP:0004144,hypotonia|MP:0004246,abnormal extensor digitorum longus morphology|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005620,abnormal muscle contractility|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010053,decreased grip strength|MP:0012106,impaired exercise endurance
MGI:2654420	Mybpc3<tm1.1Jse>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0002190,disorganized myocardium|MP:0002625,heart left ventricle hypertrophy|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0002837,dystrophic cardiac calcinosis|MP:0002953,thick ventricular wall|MP:0003141,cardiac fibrosis|MP:0003921,abnormal heart left ventricle morphology|MP:0004058,abnormal ventricle papillary muscle morphology|MP:0004063,dilated heart left atrium|MP:0004094,abnormal M line morphology|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis
MGI:4435924	Mybpc3<tm1a(EUCOMM)Hmgu>	MP:0001413,abnormal response to new environment|MP:0002833,increased heart weight|MP:0003019,increased circulating chloride level|MP:0008805,decreased circulating amylase level
MGI:6120684	Mybpc3<tm1b(EUCOMM)Hmgu>	MP:0003233,prolonged QT interval|MP:0010392,prolonged QRS complex duration|MP:0010511,shortened PR interval
MGI:2654419	Mybpc3<tm1Jse>	MP:0000274,enlarged heart|MP:0002625,heart left ventricle hypertrophy|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0002837,dystrophic cardiac calcinosis|MP:0002953,thick ventricular wall|MP:0002972,abnormal cardiac muscle contractility|MP:0003141,cardiac fibrosis|MP:0003921,abnormal heart left ventricle morphology|MP:0004058,abnormal ventricle papillary muscle morphology|MP:0004063,dilated heart left atrium|MP:0004084,abnormal cardiac muscle relaxation|MP:0004094,abnormal M line morphology|MP:0004564,increased myocardial fiber size|MP:0005599,increased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0011952,decreased cardiac stroke volume|MP:0014731,disorganized myocardial fiber myofibrils|MP:0031131,myocardial fiber disarray|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3606208	Mybpc3<tm1Lcrr>	MP:0001625,cardiac hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0002972,abnormal cardiac muscle contractility|MP:0003157,impaired muscle relaxation|MP:0005140,decreased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis
MGI:3526881	Mybpc3<tm1Rmos>	MP:0000266,abnormal heart morphology|MP:0001625,cardiac hypertrophy|MP:0002753,dilated heart left ventricle|MP:0004215,abnormal myocardial fiber physiology|MP:0004485,increased response of heart to induced stress|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0031131,myocardial fiber disarray|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4836388	Mybpc3<tm2.1Lcrr>	MP:0002625,heart left ventricle hypertrophy|MP:0002833,increased heart weight|MP:0003921,abnormal heart left ventricle morphology|MP:0004084,abnormal cardiac muscle relaxation|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0011925,abnormal heart echocardiography feature
MGI:5523781	Mybpc3<tm2.1Rmos>	MP:0003141,cardiac fibrosis|MP:0003921,abnormal heart left ventricle morphology|MP:0004485,increased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0005385,cardiovascular system phenotype|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0031131,myocardial fiber disarray
MGI:7437915	Mybph<em1(IMPC)J>	MP:0000063,decreased bone mineral density
MGI:4364468	Mybphl<tm1a(KOMP)Wtsi>	MP:0000783,abnormal forebrain morphology|MP:0001303,abnormal lens morphology|MP:0001914,hemorrhage|MP:0003078,aphakia|MP:0003686,abnormal eye muscle morphology|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0004613,fusion of vertebral arches|MP:0009770,abnormal optic chiasm morphology|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013971,blood in lymph vessels|MP:0014001,abnormal vertebral artery topology
MGI:5548569	Mybphl<tm1b(KOMP)Wtsi>	MP:0000111,cleft palate|MP:0000150,abnormal rib morphology|MP:0000520,absent kidney|MP:0000602,dilated liver sinusoidal space|MP:0000681,abnormal thyroid gland morphology|MP:0000703,abnormal thymus morphology|MP:0000783,abnormal forebrain morphology|MP:0003722,absent ureter|MP:0003827,abnormal Wolffian duct morphology|MP:0004613,fusion of vertebral arches|MP:0006063,abnormal inferior vena cava morphology|MP:0009495,abnormal common bile duct morphology|MP:0010420,muscular ventricular septal defect|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011683,dual inferior vena cava|MP:0013186,abnormal basilar artery morphology|MP:0013840,absent segment of posterior cerebral artery|MP:0013848,subcutaneous edema|MP:0013877,abnormal ductus venosus valve morphology|MP:0013967,abnormal infrahyoid muscle connection|MP:0013971,blood in lymph vessels|MP:0014001,abnormal vertebral artery topology|MP:0014017,abnormal Wolffian duct connection
MGI:3047076	Myb<tm1.1Cgn>	MP:0001577,anemia|MP:0001802,arrested B cell differentiation|MP:0004978,decreased B-1 B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3037362	Myb<tm1.1Jof>	MP:0002169,no abnormal phenotype detected
MGI:5692903	Myb<tm1b(KOMP)Wtsi>	MP:0001785,edema|MP:0001914,hemorrhage|MP:0003054,spina bifida|MP:0003717,pallor|MP:0009931,abnormal skin appearance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3047075	Myb<tm1Cgn>	MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008347,decreased gamma-delta T cell number
MGI:3497746	Myb<tm1Epr>	MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0002407,abnormal double-negative T cell morphology|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:2677048	Myb<tm1Jof>	MP:0000245,abnormal erythropoiesis|MP:0000596,abnormal liver development|MP:0000715,decreased thymocyte number|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002407,abnormal double-negative T cell morphology|MP:0002414,abnormal myeloblast morphology/development|MP:0008254,increased megakaryocyte cell number
MGI:2662859	Myb<tm1Ssp>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000260,abnormal angiogenesis|MP:0000601,small liver|MP:0001577,anemia|MP:0002123,abnormal definitive hematopoiesis|MP:0003717,pallor|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0008989,abnormal liver sinusoid morphology|MP:0009395,increased nucleated erythrocyte cell number|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4457094	Myb<tm2.2Epr>	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0010768,mortality/aging
MGI:7425845	Mycbp2<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001293,anophthalmia|MP:0001711,abnormal placenta morphology|MP:0002092,abnormal eye morphology|MP:0003231,abnormal placenta vasculature|MP:0011100,preweaning lethality, complete penetrance
MGI:3849603	Mycbp2<m274-4Tpo>	MP:0001505,hunched posture|MP:0001954,respiratory distress|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0011087,neonatal lethality, complete penetrance
MGI:3777465	Mycbp2<magsp>	MP:0000940,abnormal motor neuron innervation pattern
MGI:3777464	Mycbp2<mgln>	MP:0000937,abnormal motor neuron morphology|MP:0000940,abnormal motor neuron innervation pattern|MP:0000965,abnormal sensory neuron morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001077,abnormal spinal nerve morphology|MP:0003651,abnormal axon extension
MGI:3760640	Mycbp2<tm1.1Adia>	MP:0000781,decreased corpus callosum size|MP:0000807,abnormal hippocampus morphology|MP:0000825,dilated lateral ventricle|MP:0000830,abnormal diencephalon morphology|MP:0000832,abnormal thalamus morphology|MP:0000897,abnormal midbrain morphology|MP:0000937,abnormal motor neuron morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001078,abnormal phrenic nerve morphology|MP:0002152,abnormal brain morphology|MP:0002184,abnormal innervation|MP:0002279,abnormal diaphragm morphology|MP:0002961,abnormal axon guidance|MP:0003241,loss of cortex neurons|MP:0003632,abnormal nervous system morphology|MP:0004082,abnormal habenula morphology|MP:0004101,abnormal brain interneuron morphology|MP:0004165,abnormal lateral geniculate nucleus morphology|MP:0008128,abnormal brain internal capsule morphology|MP:0008227,absent anterior commissure|MP:0011087,neonatal lethality, complete penetrance
MGI:4939601	Mycbp2<tm1.1Klsc>	MP:0000955,abnormal spinal cord morphology|MP:0003998,decreased thermal nociceptive threshold|MP:0010769,abnormal survival
MGI:3760639	Mycbp2<tm1Adia>	MP:0000780,abnormal corpus callosum morphology|MP:0000781,decreased corpus callosum size|MP:0000807,abnormal hippocampus morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0002961,abnormal axon guidance|MP:0005388,respiratory system phenotype|MP:0008535,enlarged lateral ventricles|MP:0011090,perinatal lethality, incomplete penetrance
MGI:8209213	Mycbpap<em1Osb>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009239,short sperm flagellum|MP:0014052,increased male germ cell apoptosis|MP:0014636,decreased elongated spermatid number|MP:0020869,immotile sperm|MP:0031386,elongated manchette
MGI:6156335	Myc<em1(IMPC)Kmpc>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0001488,increased startle reflex|MP:0003795,abnormal bone structure|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011942,decreased fluid intake
MGI:3625700	Myci1<BXSB/Slc>	MP:0000343,abnormal response to cardiac infarction
MGI:3625702	Myci2<BXSB/Slc>	MP:0000343,abnormal response to cardiac infarction
MGI:5550274	Mycl<tm1.1Kmm>	MP:0002376,abnormal dendritic cell physiology|MP:0008127,decreased dendritic cell number|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:4818995	Mycl<tm1.1Rne>	MP:0002169,no abnormal phenotype detected
MGI:2178221	Mycl<tm1Rdp>	MP:0002169,no abnormal phenotype detected
MGI:2385432	Mycn<tm1.1Nagy>	MP:0002169,no abnormal phenotype detected
MGI:2388718	Mycn<tm1.1Psk>	MP:0011091,prenatal lethality, complete penetrance
MGI:2178216	Mycn<tm1Fwa>	MP:0000267,abnormal heart development|MP:0000295,trabecula carnea hypoplasia|MP:0000596,abnormal liver development|MP:0000598,abnormal liver morphology|MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0000964,small dorsal root ganglion|MP:0001081,abnormal cranial ganglia morphology|MP:0001093,small trigeminal ganglion|MP:0001292,abnormal lens vesicle development|MP:0001698,decreased embryo size|MP:0003425,abnormal optic vesicle formation|MP:0003887,increased hepatocyte apoptosis|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004784,abnormal anterior cardinal vein morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0006408,dorsal root ganglion hypoplasia|MP:0008487,abnormal mesonephros morphology|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2178220	Mycn<tm1Jrt>	MP:0001175,abnormal lung morphology|MP:0001404,no spontaneous movement|MP:0001954,respiratory distress|MP:0011087,neonatal lethality, complete penetrance
MGI:2179462	Mycn<tm1Knd>	MP:0000295,trabecula carnea hypoplasia|MP:0000470,abnormal stomach morphology|MP:0000596,abnormal liver development|MP:0000601,small liver|MP:0000964,small dorsal root ganglion|MP:0001258,decreased body length|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0002151,abnormal neural tube morphology|MP:0002152,abnormal brain morphology|MP:0002188,small heart|MP:0002652,thin myocardium|MP:0003631,nervous system phenotype|MP:0005650,abnormal limb bud morphology|MP:0006279,abnormal limb development|MP:0010432,common ventricle|MP:0011028,impaired branching involved in bronchus morphogenesis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2178228	Mycn<tm1Nagy>	MP:0004609,vertebral fusion
MGI:1857492	Mycn<tm1Par>	MP:0000488,abnormal intestinal epithelium morphology|MP:0000489,abnormal large intestine morphology|MP:0000785,telencephalon hypoplasia|MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0000846,abnormal medulla oblongata morphology|MP:0000962,disorganized dorsal root ganglion|MP:0000964,small dorsal root ganglion|MP:0001081,abnormal cranial ganglia morphology|MP:0001093,small trigeminal ganglion|MP:0001176,abnormal lung development|MP:0001178,pulmonary hypoplasia|MP:0001577,anemia|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0001914,hemorrhage|MP:0002652,thin myocardium|MP:0003232,abnormal forebrain development|MP:0003827,abnormal Wolffian duct morphology|MP:0003984,embryonic growth retardation|MP:0004068,dilated dorsal aorta|MP:0004787,abnormal dorsal aorta morphology|MP:0008487,abnormal mesonephros morphology|MP:0010986,abnormal mesonephric mesenchyme morphology|MP:0011028,impaired branching involved in bronchus morphogenesis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011412,gonadal ridge hypoplasia|MP:0011875,absent stomach|MP:0013267,first pharyngeal arch hypoplasia
MGI:2388717	Mycn<tm1Psk>	MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000854,abnormal cerebellum development|MP:0000857,abnormal cerebellar foliation|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000880,decreased Purkinje cell number|MP:0000885,ectopic Purkinje cell|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001297,microphthalmia|MP:0001732,postnatal growth retardation|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0003424,premature neuronal precursor differentiation|MP:0003631,nervous system phenotype|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0004981,decreased neuronal precursor cell number|MP:0006382,abnormal lung epithelium morphology|MP:0008458,abnormal cortical ventricular zone morphology|MP:0008770,decreased survivor rate|MP:0009937,abnormal neuron differentiation|MP:0010811,decreased type II pneumocyte number|MP:0010816,decreased type I pneumocyte number|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012703,decreased embryonic neuroepithelium thickness
MGI:2385433	Mycn<tm2.1Nagy>	MP:0000585,kinked tail|MP:0004609,vertebral fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2178229	Mycn<tm2Nagy>	MP:0000585,kinked tail|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6696430	Myct1<em1Choi>	MP:0003447,decreased tumor growth/size|MP:0003710,abnormal physiological neovascularization|MP:0004974,decreased regulatory T cell number|MP:0005385,cardiovascular system phenotype|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010144,abnormal tumor vascularization|MP:0020202,abnormal macrophage cell number
MGI:6152520	Myct1<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001293,anophthalmia|MP:0001399,hyperactivity|MP:0002092,abnormal eye morphology|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010067,increased red blood cell distribution width
MGI:5006706	Myc<tm1.1Cksn>	MP:0005387,immune system phenotype
MGI:5433313	Myc<tm1.1Dlev>	MP:0002169,no abnormal phenotype detected
MGI:3640383	Myc<tm1.1Dmlo>	MP:0002169,no abnormal phenotype detected
MGI:5444112	Myc<tm1.1Itl>	MP:0000477,abnormal intestine morphology|MP:0003449,abnormal intestine goblet cell morphology|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005164,abnormal response to injury|MP:0008142,decreased small intestinal villus size|MP:0008882,abnormal enterocyte physiology|MP:0008883,abnormal enterocyte proliferation|MP:0010802,abnormal intestinal enteroendocrine cell morphology|MP:0013486,decreased Paneth cell number
MGI:5447463	Myc<tm1.1(MYC)Gwbk>	MP:0002169,no abnormal phenotype detected
MGI:2178232	Myc<tm1.1(Nmyc1)Fwa>	MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001575,cyanosis|MP:0005387,immune system phenotype|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2177578	Myc<tm1Atp>	MP:0000216,absent erythroid progenitor cell|MP:0000239,absent common myeloid progenitor cells|MP:0000333,decreased bone marrow cell number|MP:0000592,short tail|MP:0000687,small lymphoid organs|MP:0000694,spleen hypoplasia|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001715,placental labyrinth hypoplasia|MP:0001722,pale yolk sac|MP:0001732,postnatal growth retardation|MP:0001783,decreased white adipose tissue amount|MP:0002223,lymphoid hypoplasia|MP:0002836,abnormal chorion morphology|MP:0004200,decreased fetal size|MP:0005031,abnormal trophoblast layer morphology|MP:0005095,decreased T cell proliferation|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0008050,decreased memory T cell number|MP:0008101,lymph node hypoplasia|MP:0010766,abnormal NK cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0011705,absent fibroblast proliferation
MGI:2178196	Myc<tm1Brd>	MP:0000274,enlarged heart|MP:0000292,distended pericardium|MP:0000929,open neural tube|MP:0001700,abnormal embryo turning|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2388702	Myc<tm1Jlc>	MP:0000259,abnormal vascular development|MP:0000260,abnormal angiogenesis|MP:0000352,decreased cell proliferation|MP:0001622,abnormal vasculogenesis|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0002052,decreased tumor incidence|MP:0004229,abnormal embryonic erythropoiesis|MP:0004787,abnormal dorsal aorta morphology|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number
MGI:3583919	Myc<tm1Lbox>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0004952,increased spleen weight|MP:0005014,increased B cell number|MP:0005018,decreased T cell number|MP:0005154,increased B cell proliferation|MP:0008782,increased B cell apoptosis
MGI:2178231	Myc<tm1(Nmyc1)Fwa>	MP:0011091,prenatal lethality, complete penetrance
MGI:3773711	Myc<tm1Slek>	MP:0002169,no abnormal phenotype detected
MGI:2177581	Myc<tm2.1Atp>	MP:0000598,abnormal liver morphology|MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0001262,decreased body weight|MP:0001606,impaired hematopoiesis|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0001944,abnormal pancreas morphology|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002416,abnormal proerythroblast morphology|MP:0003934,abnormal pancreas development|MP:0005095,decreased T cell proliferation|MP:0005370,liver/biliary system phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008973,decreased erythroid progenitor cell number|MP:0009106,abnormal pancreas size|MP:0009109,decreased pancreas weight|MP:0009111,pancreas hypoplasia|MP:0009143,abnormal pancreatic duct morphology|MP:0009145,abnormal pancreatic acinus morphology|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009158,absent pancreatic acinar cells|MP:0010768,mortality/aging|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011705,absent fibroblast proliferation
MGI:3640384	Myc<tm2Dmlo>	MP:0002169,no abnormal phenotype detected
MGI:2178233	Myc<tm2Fwa>	MP:0000029,abnormal malleus morphology|MP:0000107,abnormal frontal bone morphology|MP:0000109,abnormal parietal bone morphology|MP:0000373,belly spot|MP:0000445,short snout|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002169,no abnormal phenotype detected|MP:0002940,variable body spotting|MP:0004470,small nasal bone|MP:0004471,short nasal bone|MP:0004738,abnormal auditory brainstem response|MP:0005093,decreased B cell proliferation|MP:0005105,abnormal middle ear ossicle morphology|MP:0005352,small cranium|MP:0006326,conductive hearing impairment|MP:0006358,absent pinna reflex|MP:0008372,small malleus|MP:0008375,short malleus manubrium
MGI:3720516	Myc<tm37Mnz>	MP:0004030,induced chromosome breakage
MGI:3720515	Myc<tm39Mnz>	MP:0004029,spontaneous chromosome breakage
MGI:3775386	Myc<tm3(Tcrb)Fwa>	MP:0008758,abnormal T cell receptor beta chain V(D)J recombination
MGI:4352684	Myc<tm4.1Fwa>	MP:0004030,induced chromosome breakage
MGI:7281146	Myd88<em1.1Rsky>	MP:0000691,enlarged spleen|MP:0002494,increased IgM level|MP:0004815,abnormal somatic hypermutation frequency|MP:0005154,increased B cell proliferation|MP:0005397,hematopoietic system phenotype|MP:0008097,increased plasma cell number|MP:0008177,increased germinal center B cell number|MP:0008826,abnormal splenic cell ratio
MGI:3641234	Myd88<lkd>	MP:0002419,abnormal innate immunity|MP:0002420,abnormal adaptive immunity|MP:0002421,abnormal cell-mediated immunity|MP:0002451,abnormal macrophage physiology|MP:0005387,immune system phenotype
MGI:4422086	Myd88<m3Btlr>	MP:0005387,immune system phenotype
MGI:6113640	Myd88<M4Btlr>	MP:0008561,decreased tumor necrosis factor secretion
MGI:3641255	Myd88<poc>	MP:0001790,abnormal immune system physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0005387,immune system phenotype|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:4421295	Myd88<tm1.1Defr>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000753,paralysis|MP:0000921,demyelination|MP:0002451,abnormal macrophage physiology|MP:0003691,abnormal microglial cell physiology|MP:0003884,decreased macrophage cell number|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008567,decreased interferon-gamma secretion|MP:0010845,decreased effector memory CD4-positive, alpha-beta T cell number|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:5616077	Myd88<tm1.1Medz>	MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005465,abnormal T-helper 1 physiology|MP:0008051,abnormal memory T cell physiology|MP:0010222,abnormal T-helper 17 cell physiology
MGI:5304811	Myd88<tm1.1Papr>	MP:0005389,reproductive system phenotype
MGI:4434029	Myd88<tm1a(EUCOMM)Wtsi>	MP:0001260,increased body weight|MP:0002591,decreased mean corpuscular volume
MGI:2385681	Myd88<tm1Aki>	MP:0000479,abnormal enterocyte morphology|MP:0001559,hyperglycemia|MP:0001790,abnormal immune system physiology|MP:0001805,decreased IgG level|MP:0001876,decreased inflammatory response|MP:0002078,abnormal glucose homeostasis|MP:0002133,abnormal respiratory system physiology|MP:0002334,abnormal airway responsiveness|MP:0002376,abnormal dendritic cell physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002419,abnormal innate immunity|MP:0002444,abnormal T cell physiology|MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0003009,abnormal cytokine secretion|MP:0003293,rectal hemorrhage|MP:0003436,decreased susceptibility to induced arthritis|MP:0003562,abnormal pancreatic beta cell physiology|MP:0003633,abnormal nervous system physiology|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005025,abnormal response to infection|MP:0005026,decreased susceptibility to parasitic infection|MP:0005093,decreased B cell proliferation|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0006042,increased apoptosis|MP:0006071,abnormal retina progenitor cell morphology|MP:0006334,abnormal susceptibility to hearing loss|MP:0008042,abnormal NK T cell physiology|MP:0008115,abnormal dendritic cell differentiation|MP:0008126,increased dendritic cell number|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008499,increased IgG1 level|MP:0008537,increased susceptibility to induced colitis|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008563,decreased interferon-alpha secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008670,decreased interleukin-12b secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008713,abnormal cytokine level|MP:0008722,abnormal chemokine secretion|MP:0008750,abnormal interferon level|MP:0008752,abnormal tumor necrosis factor level|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008882,abnormal enterocyte physiology|MP:0009114,decreased pancreatic beta cell mass|MP:0009172,small pancreatic islets|MP:0009937,abnormal neuron differentiation|MP:0010266,decreased liver tumor incidence|MP:0010377,abnormal gut flora balance|MP:0010766,abnormal NK cell physiology|MP:0020186,abnormal susceptibility to bacterial infection|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020937,increased susceptibility to Picornaviridae infection|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality|MP:0031054,bronchiolitis
MGI:3809600	Myd88<tm1Defr>	MP:0002376,abnormal dendritic cell physiology|MP:0002455,abnormal dendritic cell antigen presentation|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008115,abnormal dendritic cell differentiation|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008597,decreased circulating interleukin-6 level|MP:0008648,decreased circulating interleukin-12b level|MP:0008897,decreased IgG2c level|MP:0010377,abnormal gut flora balance|MP:0010766,abnormal NK cell physiology
MGI:5442766	Myd88<tm1Hlz>	MP:0000222,decreased neutrophil cell number|MP:0002941,increased circulating alanine transaminase level|MP:0002942,decreased circulating alanine transaminase level|MP:0005165,increased susceptibility to injury|MP:0005343,increased circulating aspartate transaminase level|MP:0005387,immune system phenotype|MP:0005632,decreased circulating aspartate transaminase level|MP:0008553,increased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008594,decreased circulating interleukin-10 level|MP:0008597,decreased circulating interleukin-6 level|MP:0008648,decreased circulating interleukin-12b level|MP:0008661,decreased interleukin-10 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008721,abnormal chemokine level|MP:0010209,abnormal circulating chemokine level|MP:0031225,decreased CXCL10 level
MGI:4367063	Myd88<tm1Jcbr>	MP:0001258,decreased body length|MP:0001402,decreased locomotor activity|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0004889,increased energy expenditure|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008906,abnormal parametrial fat pad morphology|MP:0009269,decreased fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0010025,decreased total body fat amount|MP:0011940,decreased food intake
MGI:6273959	Mydgf<em1(IMPC)Hmgu>	MP:0010053,decreased grip strength
MGI:5688472	Mydgf<tm1Kcw>	MP:0000343,abnormal response to cardiac infarction|MP:0001876,decreased inflammatory response|MP:0003037,increased myocardial infarct size|MP:0005385,cardiovascular system phenotype
MGI:5607534	Myef2<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5509335	Myf5<tm1(cre/Esr1*)Trdo>	MP:0002169,no abnormal phenotype detected
MGI:3710099	Myf5<tm1(cre)Mrc>	MP:0002169,no abnormal phenotype detected
MGI:1857219	Myf5<tm1Jae>	MP:0000153,rib bifurcation|MP:0000737,abnormal myotome development|MP:0001688,abnormal somite development|MP:0001953,respiratory failure|MP:0002108,abnormal muscle morphology|MP:0004321,short sternum|MP:0004613,fusion of vertebral arches|MP:0004672,short ribs|MP:0008148,abnormal sternocostal joint morphology|MP:0008277,abnormal sternum ossification|MP:0011087,neonatal lethality, complete penetrance|MP:0012249,absent myotome
MGI:1857973	Myf5<tm1Pas>	MP:0000759,abnormal skeletal muscle morphology|MP:0003090,abnormal muscle precursor cell migration|MP:0003794,delayed somite formation|MP:0003818,abnormal eye muscle development|MP:0012249,absent myotome|MP:0030171,absent extraocular muscles
MGI:2135563	Myf5<tm1(Pdgfa)Sor>	MP:0000150,abnormal rib morphology|MP:0000480,increased rib number|MP:0004613,fusion of vertebral arches|MP:0004624,abnormal thoracic cage morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3055340	Myf5<tm1Tajb>	MP:0000759,abnormal skeletal muscle morphology|MP:0003090,abnormal muscle precursor cell migration|MP:0003818,abnormal eye muscle development|MP:0012249,absent myotome
MGI:2449208	Myf5<tm2(Fgf6)Thbr>	MP:0005390,skeleton phenotype
MGI:1933774	Myf5<tm2(Myog)Jae>	MP:0000737,abnormal myotome development|MP:0002169,no abnormal phenotype detected|MP:0005390,skeleton phenotype
MGI:5581636	Myf5<tm2Pas>	MP:0001943,abnormal respiration|MP:0002823,abnormal rib development|MP:0011087,neonatal lethality, complete penetrance
MGI:2135564	Myf5<tm2(Pdgfa)Sor>	MP:0000150,abnormal rib morphology|MP:0000480,increased rib number|MP:0000737,abnormal myotome development|MP:0002823,abnormal rib development|MP:0003048,abnormal cervical vertebrae morphology|MP:0004620,cervical vertebral fusion|MP:0004624,abnormal thoracic cage morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0020039,increased bone ossification
MGI:3055343	Myf5<tm2Tajb>	MP:0000750,abnormal muscle regeneration|MP:0000759,abnormal skeletal muscle morphology|MP:0003090,abnormal muscle precursor cell migration|MP:0003818,abnormal eye muscle development|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0009401,increased skeletal muscle fiber diameter|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009410,abnormal skeletal muscle satellite cell proliferation|MP:0009419,skeletal muscle fibrosis|MP:0012249,absent myotome
MGI:2449231	Myf5<tm3.1Thbr>	MP:0000737,abnormal myotome development|MP:0005390,skeleton phenotype
MGI:2135565	Myf5<tm3(cre)Sor>	MP:0002823,abnormal rib development|MP:0004620,cervical vertebral fusion|MP:0004623,thoracic vertebral fusion
MGI:3850150	Myf5<tm3(Myod1)Tajb>	MP:0005391,vision/eye phenotype
MGI:2135568	Myf5<tm4(Myod1)Sor>	MP:0005369,muscle phenotype|MP:0005390,skeleton phenotype
MGI:3487371	Myf6<tm1(cre)Mrc>	MP:0002169,no abnormal phenotype detected
MGI:1913092	Myf6<tm1Eno>	MP:0000150,abnormal rib morphology|MP:0000153,rib bifurcation|MP:0000737,abnormal myotome development|MP:0002823,abnormal rib development|MP:0004672,short ribs|MP:0005247,abnormal extraocular muscle morphology|MP:0005369,muscle phenotype
MGI:1927607	Myf6<tm1Thbr>	MP:0000150,abnormal rib morphology|MP:0001688,abnormal somite development|MP:0002108,abnormal muscle morphology|MP:0004672,short ribs|MP:0008148,abnormal sternocostal joint morphology|MP:0008277,abnormal sternum ossification|MP:0011087,neonatal lethality, complete penetrance
MGI:1857220	Myf6<tm1Wb>	MP:0000150,abnormal rib morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000737,abnormal myotome development|MP:0001954,respiratory distress|MP:0002280,abnormal intercostal muscle morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003939,abnormal myotome morphology|MP:0004672,short ribs|MP:0004677,truncated ribs|MP:0008148,abnormal sternocostal joint morphology|MP:0008277,abnormal sternum ossification|MP:0011087,neonatal lethality, complete penetrance
MGI:4414758	Myg1<tm1Mphi>	MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001413,abnormal response to new environment|MP:0002757,decreased vertical activity|MP:0002797,increased thigmotaxis|MP:0003963,abnormal corticosterone level
MGI:5552947	Myh10<b2b2437Clo>	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000438,abnormal cranium morphology|MP:0000914,exencephaly|MP:0002639,micrognathia|MP:0004056,abnormal myocardium compact layer morphology|MP:0005170,cleft upper lip|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:6108305	Myh10<ehc>	MP:0000284,double outlet right ventricle|MP:0000440,domed cranium|MP:0001785,edema|MP:0001891,hydrocephaly|MP:0003105,abnormal heart atrium morphology|MP:0004056,abnormal myocardium compact layer morphology|MP:0005244,hemopericardium|MP:0005294,abnormal heart ventricle morphology|MP:0005312,pericardial effusion|MP:0009698,heart hemorrhage|MP:0010402,ventricular septal defect|MP:0010499,abnormal ventricle myocardium morphology|MP:0010503,myocardial trabeculae hypoplasia|MP:0010561,absent coronary vessels|MP:0010725,thin interventricular septum|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012515,abnormal heart apex morphology
MGI:5604248	Myh10<em1(IMPC)J>	MP:0000288,abnormal pericardium morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration|MP:0013279,increased fasting circulating glucose level|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:2386439	Myh10<tm1Rsad>	MP:0001625,cardiac hypertrophy
MGI:2386445	Myh10<tm2Rsad>	MP:0000266,abnormal heart morphology|MP:0000273,overriding aortic valve|MP:0000280,thin ventricular wall|MP:0000284,double outlet right ventricle|MP:0000440,domed cranium|MP:0000828,abnormal fourth ventricle morphology|MP:0000955,abnormal spinal cord morphology|MP:0001325,abnormal retina morphology|MP:0001436,abnormal suckling behavior|MP:0001891,hydrocephaly|MP:0002747,abnormal aortic valve morphology|MP:0004056,abnormal myocardium compact layer morphology|MP:0004062,dilated heart right atrium|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0006096,absent retina bipolar cells|MP:0006126,abnormal cardiac outflow tract development|MP:0006138,congestive heart failure|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0009701,abnormal birth body size|MP:0010019,liver vascular congestion|MP:0010418,perimembraneous ventricular septal defect|MP:0010449,heart right ventricle outflow tract stenosis|MP:0010561,absent coronary vessels|MP:0011087,neonatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011392,increased fetal cardiomyocyte apoptosis|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0014605,dark liver|MP:0031511,globular heart|MP:0031550,abnormal atrioventricular valve development|MP:0031609,increased fetal cardiomyocyte size|MP:0031611,decreased fetal cardiomyocyte number|MP:0031613,fetal cardiomyocyte disarray
MGI:3052112	Myh10<tm3.1Rsad>	MP:0000111,cleft palate|MP:0000157,abnormal sternum morphology|MP:0000284,double outlet right ventricle|MP:0000299,failure of atrioventricular cushion closure|MP:0000602,dilated liver sinusoidal space|MP:0000761,thin diaphragm muscle|MP:0003052,omphalocele|MP:0003888,liver hemorrhage|MP:0003924,diaphragmatic hernia|MP:0004320,split sternum|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0005385,cardiovascular system phenotype|MP:0006043,decreased apoptosis|MP:0006126,abnormal cardiac outflow tract development|MP:0006138,congestive heart failure|MP:0009886,failure of palatal shelf elevation|MP:0010019,liver vascular congestion|MP:0010146,umbilical hernia|MP:0010579,increased heart left ventricle size|MP:0010585,abnormal conotruncal ridge morphology|MP:0010912,herniated liver|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011660,ectopia cordis|MP:0012251,abnormal diaphragm development|MP:0013283,failure of ventral body wall closure|MP:0013807,generalized edema|MP:0031462,decreased palatal shelf size|MP:0031550,abnormal atrioventricular valve development
MGI:3052104	Myh10<tm3Rsad>	MP:0000788,abnormal cerebral cortex morphology|MP:0000828,abnormal fourth ventricle morphology|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001071,abnormal facial nerve morphology|MP:0001393,ataxia|MP:0001525,impaired balance|MP:0001891,hydrocephaly|MP:0005294,abnormal heart ventricle morphology|MP:0005378,growth/size/body region phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0014327,decreased Purkinje cell size|MP:0014553,decreased neuronal migration
MGI:3664764	Myh10<tm4Rsad>	MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0000828,abnormal fourth ventricle morphology|MP:0001891,hydrocephaly|MP:0004215,abnormal myocardial fiber physiology|MP:0005537,abnormal cerebral aqueduct morphology|MP:0006009,abnormal neuronal migration|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012676,dilated brain ventricle
MGI:3664765	Myh10<tm5Rsad>	MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000885,ectopic Purkinje cell|MP:0001405,impaired coordination|MP:0003631,nervous system phenotype|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:3775953	Myh10<tm6(Myh9/GFP)Rsad>	MP:0000284,double outlet right ventricle|MP:0000857,abnormal cerebellar foliation|MP:0001625,cardiac hypertrophy|MP:0002795,dilated cardiomyopathy|MP:0003631,nervous system phenotype|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006009,abnormal neuronal migration|MP:0006126,abnormal cardiac outflow tract development|MP:0008770,decreased survivor rate|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0010402,ventricular septal defect|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0031609,increased fetal cardiomyocyte size|MP:0031611,decreased fetal cardiomyocyte number
MGI:4443039	Myh10<tm7Rsad>	MP:0000854,abnormal cerebellum development|MP:0001392,abnormal locomotor behavior|MP:0001853,heart inflammation|MP:0001855,abnormal atrial thrombosis|MP:0001891,hydrocephaly|MP:0003137,abnormal impulse conducting system conduction|MP:0003222,increased cardiomyocyte apoptosis|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0005385,cardiovascular system phenotype|MP:0005608,cardiac interstitial fibrosis|MP:0006254,thin cerebral cortex|MP:0006267,abnormal intercalated disk morphology|MP:0008535,enlarged lateral ventricles|MP:0009688,abnormal spinal cord central canal morphology|MP:0010402,ventricular septal defect|MP:0011085,postnatal lethality, complete penetrance
MGI:5518638	Myh10<tm8Rsad>	MP:0002169,no abnormal phenotype detected
MGI:5582321	Myh11<tm1.1Dmmz>	MP:0003026,decreased vasoconstriction|MP:0004883,abnormal vascular wound healing|MP:0005385,cardiovascular system phenotype|MP:0005595,abnormal vascular smooth muscle physiology|MP:0014696,decreased cell adhesion|MP:0031510,increased vascular smooth muscle cell proliferation
MGI:5305173	Myh11<tm1.1Rng>	MP:0011085,postnatal lethality, complete penetrance
MGI:2656492	Myh11<tm1Bdr>	MP:0000280,thin ventricular wall|MP:0000364,abnormal vascular regression|MP:0000538,abnormal urinary bladder morphology|MP:0000539,distended urinary bladder|MP:0000741,impaired contractility of urinary bladder detrusor smooth muscle|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003290,intestinal hypoperistalsis|MP:0003352,increased circulating renin level|MP:0003624,anuria|MP:0003717,pallor|MP:0004876,decreased mean systemic arterial blood pressure|MP:0008489,slow postnatal weight gain|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3576856	Myh11<tm1Peri>	MP:0000740,impaired smooth muscle contractility|MP:0002328,abnormal airway resistance|MP:0012125,decreased bronchoconstrictive response
MGI:3821724	Myh11<tm2Peri>	MP:0000462,abnormal digestive system morphology|MP:0000519,hydronephrosis|MP:0000539,distended urinary bladder|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0003622,ischuria|MP:0004090,abnormal sarcomere morphology|MP:0005620,abnormal muscle contractility|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4887985	Myh14<tm1Rsad>	MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype
MGI:4948885	Myh14<tm2Rsad>	MP:0012431,increased lymphoma incidence
MGI:7431485	Myh15<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number
MGI:5617788	Myh1<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000221,decreased leukocyte cell number|MP:0001417,decreased exploration in new environment|MP:0001486,abnormal startle reflex|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0003795,abnormal bone structure|MP:0003870,decreased urine glucose level|MP:0004738,abnormal auditory brainstem response|MP:0005564,increased hemoglobin content|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0011396,abnormal sleep behavior|MP:0011436,decreased urine magnesium level|MP:0011471,decreased urine creatinine level|MP:0020870,decreased thigmotaxis
MGI:2183827	Myh1<tm1Lnwd>	MP:0000160,kyphosis|MP:0000747,muscle weakness|MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0002841,impaired skeletal muscle contractility|MP:0004819,decreased skeletal muscle mass|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0010053,decreased grip strength|MP:0011940,decreased food intake|MP:0011942,decreased fluid intake
MGI:6433995	Myh2<em1(IMPC)Bay>	MP:0010123,increased bone mineral content
MGI:6695299	Myh3<tm1.2Sajm>	MP:0001262,decreased body weight|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009405,increased skeletal muscle fiber number|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0010239,decreased skeletal muscle weight|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012185,abnormal muscle precursor cell morphology|MP:0030972,increased myoblast apoptosis
MGI:4839531	Myh4<arl>	MP:0000755,hindlimb paralysis|MP:0001406,abnormal gait|MP:0002269,muscular atrophy|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004510,myositis|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009412,skeletal muscle fiber degeneration
MGI:2183830	Myh4<tm1Lnwd>	MP:0000747,muscle weakness|MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004819,decreased skeletal muscle mass|MP:0009399,increased skeletal muscle fiber size|MP:0009406,decreased skeletal muscle fiber number|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009413,skeletal muscle fiber atrophy|MP:0010053,decreased grip strength
MGI:8210452	Myh6<em1(MYH7*R403Q)Eno>	MP:0000274,enlarged heart|MP:0001625,cardiac hypertrophy|MP:0003141,cardiac fibrosis|MP:0005330,cardiomyopathy|MP:0005608,cardiac interstitial fibrosis|MP:0008725,increased heart atrium size|MP:0011085,postnatal lethality, complete penetrance|MP:0031131,myocardial fiber disarray
MGI:6356699	Myh6<tm1.1Jpsc>	MP:0001625,cardiac hypertrophy|MP:0005385,cardiovascular system phenotype|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:3690299	Myh6<tm1Ces>	MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0004084,abnormal cardiac muscle relaxation|MP:0005140,decreased cardiac muscle contractility
MGI:2182704	Myh6<tm1Jse>	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0001636,irregular heartbeat|MP:0001855,abnormal atrial thrombosis|MP:0002190,disorganized myocardium|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002837,dystrophic cardiac calcinosis|MP:0003105,abnormal heart atrium morphology|MP:0003140,dilated heart atrium|MP:0003141,cardiac fibrosis|MP:0003313,abnormal locomotor activation|MP:0003393,decreased cardiac output|MP:0003921,abnormal heart left ventricle morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006085,myocardium necrosis|MP:0008775,abnormal heart ventricle pressure|MP:0011085,postnatal lethality, complete penetrance|MP:0021158,decreased heart left ventricle wall thickness|MP:0031131,myocardial fiber disarray|MP:0031635,increased heart left ventricle muscle contractility
MGI:3652543	Myh6<tm1Rbns>	MP:0003141,cardiac fibrosis|MP:0003821,decreased left ventricle diastolic pressure|MP:0003822,decreased left ventricle systolic pressure|MP:0005140,decreased cardiac muscle contractility|MP:0005294,abnormal heart ventricle morphology|MP:0005329,abnormal myocardium layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014730,abnormal myocardial fiber myofibril morphology|MP:0014733,decreased myocardial fiber myofibril length
MGI:3690300	Myh6<tm2Ces>	MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0005140,decreased cardiac muscle contractility
MGI:3664197	Myh6<tm2Jse>	MP:0001625,cardiac hypertrophy|MP:0002953,thick ventricular wall|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0004215,abnormal myocardial fiber physiology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005599,increased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0008725,increased heart atrium size|MP:0010534,calcified myocardium|MP:0011085,postnatal lethality, complete penetrance|MP:0011925,abnormal heart echocardiography feature|MP:0031131,myocardial fiber disarray
MGI:4837367	Myh6<tm3.1Jse>	MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0002953,thick ventricular wall|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0005330,cardiomyopathy|MP:0005599,increased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0008725,increased heart atrium size|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0010534,calcified myocardium|MP:0011085,postnatal lethality, complete penetrance|MP:0011925,abnormal heart echocardiography feature|MP:0031131,myocardial fiber disarray
MGI:6712699	Myh7b<em1Eno>	MP:0005385,cardiovascular system phenotype
MGI:5013737	Myh7b<tm1a(KOMP)Wtsi>	MP:0005179,decreased circulating cholesterol level|MP:0010067,increased red blood cell distribution width
MGI:6360203	Myh7<em1Dsr>	MP:0002169,no abnormal phenotype detected|MP:0006138,congestive heart failure|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6302756	Myh8<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000208,decreased hematocrit|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder
MGI:3511350	Myh9<Gt(Betageo-btk)1Dash>	MP:0005367,renal/urinary system phenotype|MP:0005397,hematopoietic system phenotype|MP:0006325,impaired hearing|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3641195	Myh9<Gt(RRE342)Byg>	MP:0002169,no abnormal phenotype detected|MP:0011091,prenatal lethality, complete penetrance
MGI:5551833	Myh9<tm1.1Dash>	MP:0000228,abnormal thrombopoiesis|MP:0000229,abnormal megakaryocyte differentiation|MP:0002840,abnormal lens fiber morphology|MP:0002871,albuminuria|MP:0003179,thrombocytopenia|MP:0004720,abnormal platelet morphology|MP:0005161,hematuria|MP:0005264,glomerulosclerosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0008140,podocyte foot process effacement|MP:0011091,prenatal lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3843980	Myh9<tm1.1Gac>	MP:0002551,abnormal blood coagulation|MP:0002871,albuminuria|MP:0003179,thrombocytopenia|MP:0003405,abnormal platelet shape|MP:0004720,abnormal platelet morphology|MP:0005165,increased susceptibility to injury|MP:0005264,glomerulosclerosis|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0008139,fused podocyte foot processes|MP:0008140,podocyte foot process effacement|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011402,renal cast|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011868,podocyte microvillus transformation
MGI:5285646	Myh9<tm1.1Mjk>	MP:0001304,cataract|MP:0001313,increased incidence of corneal inflammation|MP:0002417,abnormal megakaryocyte morphology|MP:0002840,abnormal lens fiber morphology|MP:0002871,albuminuria|MP:0003179,thrombocytopenia|MP:0004720,abnormal platelet morphology|MP:0004748,increased susceptibility to age-related hearing loss|MP:0005065,abnormal neutrophil morphology|MP:0005253,abnormal eye physiology|MP:0005264,glomerulosclerosis|MP:0005542,cornea vascularization|MP:0005606,increased bleeding time|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5489745	Myh9<tm1.2Gac>	MP:0005397,hematopoietic system phenotype
MGI:3522434	Myh9<tm1Maco>	MP:0001674,abnormal germ layer development|MP:0001696,failure to gastrulate|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology
MGI:4829688	Myh9<tm1(mCherry/MYH9)Rsad>	MP:0002169,no abnormal phenotype detected
MGI:4829689	Myh9<tm2(GFP/MYH10)Rsad>	MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0001722,pale yolk sac|MP:0003091,abnormal cell migration|MP:0003227,abnormal vascular branching morphogenesis|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004258,abnormal placenta size|MP:0004950,abnormal brain vasculature morphology|MP:0005380,embryo phenotype|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014698,decreased fibroblast adhesion|MP:0020849,abnormal actin cytoskeleton morphology
MGI:4829690	Myh9<tm3(GFP/MYH9/MYH10)Rsad>	MP:0001722,pale yolk sac|MP:0003091,abnormal cell migration|MP:0003229,abnormal vitelline vasculature morphology|MP:0005380,embryo phenotype|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011523,thin placenta labyrinth|MP:0014698,decreased fibroblast adhesion|MP:0020849,abnormal actin cytoskeleton morphology
MGI:4829691	Myh9<tm4(GFP/MYH10/MYH9)Rsad>	MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0001722,pale yolk sac|MP:0003091,abnormal cell migration|MP:0003229,abnormal vitelline vasculature morphology|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004258,abnormal placenta size|MP:0005380,embryo phenotype|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014698,decreased fibroblast adhesion|MP:0020849,abnormal actin cytoskeleton morphology
MGI:4838521	Myh9<tm5Rsad>	MP:0002444,abnormal T cell physiology|MP:0002871,albuminuria|MP:0003156,abnormal leukocyte migration|MP:0003628,abnormal leukocyte adhesion|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005264,glomerulosclerosis|MP:0005326,abnormal podocyte morphology|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008140,podocyte foot process effacement|MP:0008828,abnormal lymph node cell ratio
MGI:5285571	Myh9<tm6.1(EGFP/MYH9*)Rsad>	MP:0001698,decreased embryo size|MP:0002551,abnormal blood coagulation|MP:0003179,thrombocytopenia|MP:0003984,embryonic growth retardation|MP:0004720,abnormal platelet morphology|MP:0005065,abnormal neutrophil morphology|MP:0005606,increased bleeding time|MP:0008254,increased megakaryocyte cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011525,abnormal placenta intervillous maternal lacunae morphology|MP:0011526,abnormal placenta fetal blood space morphology
MGI:5285643	Myh9<tm7.1Rsad>	MP:0001304,cataract|MP:0002417,abnormal megakaryocyte morphology|MP:0002871,albuminuria|MP:0003179,thrombocytopenia|MP:0004720,abnormal platelet morphology|MP:0005065,abnormal neutrophil morphology|MP:0005264,glomerulosclerosis|MP:0005606,increased bleeding time|MP:0008254,increased megakaryocyte cell number
MGI:5285645	Myh9<tm8.1Rsad>	MP:0005264,glomerulosclerosis
MGI:7545560	Myhas<tm1Bcgen>	MP:0000747,muscle weakness|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009417,skeletal muscle atrophy|MP:0009422,decreased gastrocnemius weight|MP:0009424,decreased extensor digitorum longus weight|MP:0009428,decreased tibialis anterior weight
MGI:4433200	Myl12b<tm1a(EUCOMM)Wtsi>	MP:0000208,decreased hematocrit|MP:0001262,decreased body weight|MP:0002874,decreased hemoglobin content|MP:0003019,increased circulating chloride level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0005628,decreased circulating potassium level|MP:0005633,increased circulating sodium level
MGI:2677883	Myl1<tm1Nros>	MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001698,decreased embryo size|MP:0001724,abnormal extraembryonic endoderm formation|MP:0001730,embryonic growth arrest|MP:0008770,decreased survivor rate|MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance|MP:0011201,abnormal visceral yolk sac cavity morphology
MGI:1931137	Myl1<tm2(cre)Sjb>	MP:0002169,no abnormal phenotype detected
MGI:5426524	Myl2<tm1.1Chen>	MP:0005385,cardiovascular system phenotype|MP:0010768,mortality/aging
MGI:5629324	Myl2<tm1b(EUCOMM)Hmgu>	MP:0001284,absent vibrissae|MP:0002966,decreased circulating alkaline phosphatase level|MP:0011100,preweaning lethality, complete penetrance
MGI:3047382	Myl2<tm1(Hand1)Tana>	MP:0000267,abnormal heart development|MP:0003984,embryonic growth retardation|MP:0004032,abnormal interventricular groove morphology|MP:0004057,thin myocardium compact layer|MP:0010432,common ventricle|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5426525	Myl2<tm2.1Chen>	MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0002837,dystrophic cardiac calcinosis|MP:0003141,cardiac fibrosis|MP:0004091,abnormal Z line morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004485,increased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0005598,decreased heart ventricle muscle contractility|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0010579,increased heart left ventricle size|MP:0010725,thin interventricular septum
MGI:6153495	Myl3<em1(IMPC)Wtsi>	MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount
MGI:4452746	Myl3<tm1a(EUCOMM)Hmgu>	MP:0003560,osteoarthritis|MP:0003724,increased susceptibility to induced arthritis|MP:0009780,abnormal chondrocyte physiology
MGI:4431641	Myl4<tm1a(EUCOMM)Wtsi>	MP:0001399,hyperactivity|MP:0004924,abnormal behavior|MP:0008810,increased circulating iron level
MGI:2668722	Myl7<tm1(cre)Krc>	MP:0000269,abnormal heart looping|MP:0000270,abnormal heart tube morphology|MP:0000295,trabecula carnea hypoplasia|MP:0000297,abnormal atrioventricular cushion morphology|MP:0001622,abnormal vasculogenesis|MP:0001629,abnormal heart rate|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0001730,embryonic growth arrest|MP:0001787,pericardial edema|MP:0002753,dilated heart left ventricle|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0006126,abnormal cardiac outflow tract development|MP:0008725,increased heart atrium size|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0010502,ventricle myocardium hypoplasia|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012253,abnormal intersomitic vessel morphology|MP:0014731,disorganized myocardial fiber myofibrils
MGI:6728819	Myl9<tm1.1Mzhu>	MP:0000477,abnormal intestine morphology|MP:0000539,distended urinary bladder|MP:0001265,decreased body size|MP:0011085,postnatal lethality, complete penetrance
MGI:6728817	Myl9<tm1Mzhu>	MP:0000740,impaired smooth muscle contractility|MP:0002083,premature death|MP:0003289,abnormal intestinal peristalsis|MP:0004002,abnormal jejunum morphology|MP:0004006,impaired contractility of jejunal smooth muscle|MP:0005595,abnormal vascular smooth muscle physiology|MP:0009865,abnormal aorta smooth muscle morphology|MP:0011503,distended jejunum|MP:0011881,distended duodenum|MP:0014605,dark liver
MGI:5576056	Mylip<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002968,increased circulating alkaline phosphatase level|MP:0005561,increased mean corpuscular hemoglobin|MP:0010052,increased grip strength
MGI:3612478	Mylk2<tm1Jtst>	MP:0002841,impaired skeletal muscle contractility
MGI:5569908	Mylk3<tm1.1Hkas>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0002833,increased heart weight|MP:0003921,abnormal heart left ventricle morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004485,increased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0006138,congestive heart failure|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010392,prolonged QRS complex duration|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010725,thin interventricular septum|MP:0010754,abnormal heart left ventricle pressure|MP:0012735,abnormal response to exercise
MGI:4881763	Mylk3<tm1.1Jtst>	MP:0005385,cardiovascular system phenotype
MGI:4881762	Mylk3<tm1Jtst>	MP:0000276,heart right ventricle hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0002833,increased heart weight|MP:0003915,increased heart left ventricle weight|MP:0003921,abnormal heart left ventricle morphology|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0010632,cardiac muscle necrosis|MP:0010724,thick interventricular septum
MGI:5901850	Mylk4<em1(IMPC)J>	MP:0001304,cataract|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:7647256	Mylk4<em1Yima>	MP:0001262,decreased body weight|MP:0002106,abnormal muscle physiology
MGI:7647257	Mylk4<em2Yima>	MP:0001262,decreased body weight|MP:0002106,abnormal muscle physiology
MGI:5563563	Mylk<tm1.1Bph>	MP:0000496,abnormal small intestine morphology|MP:0000740,impaired smooth muscle contractility|MP:0002169,no abnormal phenotype detected|MP:0005378,growth/size/body region phenotype|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3620051	Mylk<tm1Avs>	MP:0004036,abnormal muscle relaxation|MP:0005620,abnormal muscle contractility
MGI:2662927	Mylk<tm1Dmw>	MP:0005166,decreased susceptibility to injury
MGI:3820656	Mylk<tm1Mzhu>	MP:0000477,abnormal intestine morphology|MP:0001270,distended abdomen|MP:0001663,abnormal digestive system physiology|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002843,decreased systemic arterial blood pressure|MP:0003289,abnormal intestinal peristalsis|MP:0003306,small intestinal inflammation|MP:0003622,ischuria|MP:0003866,abnormal defecation|MP:0004703,abnormal vertebral column morphology|MP:0006263,decreased systemic arterial diastolic blood pressure|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0008802,abnormal intestinal smooth muscle morphology|MP:0009485,distended ileum|MP:0010386,abnormal urinary bladder physiology|MP:0011082,abnormal gastrointestinal motility|MP:0011503,distended jejunum|MP:0011940,decreased food intake
MGI:3774323	Mylpf<tm1Jdp>	MP:0001262,decreased body weight|MP:0001953,respiratory failure|MP:0004846,absent skeletal muscle|MP:0005385,cardiovascular system phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:4841439	Mymk<tm1e(KOMP)Wtsi>	MP:0000160,kyphosis|MP:0000733,abnormal muscle development|MP:0000753,paralysis|MP:0006042,increased apoptosis|MP:0011085,postnatal lethality, complete penetrance|MP:0011808,abnormal myoblast differentiation|MP:0030959,abnormal myoblast fusion
MGI:5903202	Mymx<em1Shcs>	MP:0000747,muscle weakness|MP:0000759,abnormal skeletal muscle morphology|MP:0001575,cyanosis|MP:0002108,abnormal muscle morphology|MP:0002109,abnormal limb morphology|MP:0002280,abnormal intercostal muscle morphology|MP:0004174,abnormal spine curvature|MP:0009431,decreased fetal weight|MP:0010819,primary atelectasis|MP:0011087,neonatal lethality, complete penetrance|MP:0012269,nuchal edema|MP:0021206,abnormal limb muscle morphology|MP:0030959,abnormal myoblast fusion
MGI:5903203	Mymx<em2Shcs>	MP:0011087,neonatal lethality, complete penetrance
MGI:8247877	Mymx<em3Eno>	MP:0001732,postnatal growth retardation|MP:0001953,respiratory failure|MP:0004087,abnormal muscle fiber morphology|MP:0004090,abnormal sarcomere morphology|MP:0005039,hypoxia|MP:0009412,skeletal muscle fiber degeneration|MP:0009546,absent gastric milk in neonates|MP:0010240,decreased skeletal muscle size|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0030959,abnormal myoblast fusion
MGI:6314809	Mynn<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0001289,persistence of hyaloid vascular system|MP:0001399,hyperactivity|MP:0005343,increased circulating aspartate transaminase level|MP:0010124,decreased bone mineral content
MGI:5578506	Myo10<m1J>	MP:0000373,belly spot|MP:0000564,syndactyly|MP:0000914,exencephaly|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001289,persistence of hyaloid vascular system|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001314,cornea opacity|MP:0001698,decreased embryo size|MP:0001914,hemorrhage|MP:0002092,abnormal eye morphology|MP:0002152,abnormal brain morphology|MP:0002938,white spotting|MP:0003104,acrania|MP:0005174,abnormal tail pigmentation|MP:0005386,behavior/neurological phenotype|MP:0005545,abnormal lens development|MP:0008730,fused phalanges|MP:0008770,decreased survivor rate|MP:0008784,craniorachischisis|MP:0009264,failure of eyelid fusion|MP:0010714,iris coloboma|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0011277,decreased tail pigmentation|MP:0011877,absent liver
MGI:4362586	Myo10<tm1a(KOMP)Wtsi>	MP:0000373,belly spot|MP:0000564,syndactyly|MP:0000585,kinked tail|MP:0000914,exencephaly|MP:0001289,persistence of hyaloid vascular system|MP:0002938,white spotting|MP:0008770,decreased survivor rate|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance
MGI:6115837	Myo10<tm1c(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:6115841	Myo10<tm1d(KOMP)Wtsi>	MP:0000373,belly spot|MP:0000564,syndactyly|MP:0000585,kinked tail|MP:0000914,exencephaly|MP:0001262,decreased body weight|MP:0001289,persistence of hyaloid vascular system|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002938,white spotting|MP:0003227,abnormal vascular branching morphogenesis|MP:0005386,behavior/neurological phenotype|MP:0008770,decreased survivor rate|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance
MGI:4362966	Myo10<tm2(KOMP)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001307,fused cornea and lens|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0001413,abnormal response to new environment|MP:0002075,abnormal coat/hair pigmentation|MP:0002110,abnormal digit morphology|MP:0002111,abnormal tail morphology|MP:0005554,decreased circulating creatinine level|MP:0006243,impaired pupillary reflex|MP:0008730,fused phalanges
MGI:5529106	Myo15a<m1Btlr>	MP:0001394,circling|MP:0001405,impaired coordination|MP:0001410,head bobbing|MP:0005191,head tilt
MGI:6114085	Myo15a<m2Btlr>	MP:0001393,ataxia|MP:0001394,circling|MP:0005191,head tilt
MGI:5792022	Myo15a<mpc190H>	MP:0001967,deafness
MGI:1857036	Myo15a<sh2>	MP:0000042,abnormal organ of Corti morphology|MP:0000043,organ of Corti degeneration|MP:0000048,abnormal stria vascularis morphology|MP:0001394,circling|MP:0001967,deafness|MP:0002622,abnormal cochlear hair cell morphology|MP:0002730,head shaking|MP:0002855,abnormal cochlear ganglion morphology|MP:0002857,cochlear ganglion degeneration|MP:0003149,abnormal tectorial membrane morphology|MP:0004333,abnormal utricular macula morphology|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004531,short outer hair cell stereocilia|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004536,short inner hair cell stereocilia|MP:0004577,abnormal cochlear hair cell inter-stereocilial links morphology
MGI:2135915	Myo15a<sh2-2J>	MP:0001394,circling|MP:0001967,deafness
MGI:3047636	Myo15a<sh2-3J>	MP:0001394,circling|MP:0001410,head bobbing|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003637,cochlear ganglion hypoplasia|MP:0004405,absent cochlear hair cells|MP:0005377,hearing/vestibular/ear phenotype
MGI:5806093	Myo15a<tm1.1Jebd>	MP:0001967,deafness|MP:0002622,abnormal cochlear hair cell morphology|MP:0004362,cochlear hair cell degeneration|MP:0004433,abnormal cochlear inner hair cell physiology|MP:0004524,short cochlear hair cell stereocilia|MP:0004525,thin cochlear hair cell stereocilia|MP:0004737,absent distortion product otoacoustic emissions|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4431637	Myo15a<tm1a(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0006358,absent pinna reflex|MP:0010024,increased total body fat amount|MP:0010052,increased grip strength
MGI:4419827	Myo18a<tm1a(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5513803	Myo18a<tm1b(KOMP)Wtsi>	MP:0000603,pale liver|MP:0001697,abnormal embryo size|MP:0001722,pale yolk sac|MP:0003717,pallor|MP:0004087,abnormal muscle fiber morphology|MP:0004090,abnormal sarcomere morphology|MP:0004258,abnormal placenta size|MP:0005650,abnormal limb bud morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0030566,abnormal A band morphology
MGI:6342448	Myo18a<tm1d(KOMP)Wtsi>	MP:0011092,embryonic lethality, complete penetrance
MGI:6324170	Myo18b<em2(IMPC)Ics>	MP:0001552,increased circulating triglyceride level|MP:0004738,abnormal auditory brainstem response|MP:0011100,preweaning lethality, complete penetrance
MGI:3829997	Myo18b<tm1Jyo>	MP:0001634,internal hemorrhage|MP:0004062,dilated heart right atrium|MP:0004783,abnormal cardinal vein morphology|MP:0005312,pericardial effusion|MP:0005329,abnormal myocardium layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0031613,fetal cardiomyocyte disarray
MGI:7425846	Myo1a<em1(IMPC)Bay>	MP:0001513,limb grasping|MP:0011960,abnormal eye anterior chamber depth|MP:0011962,increased cornea thickness
MGI:3587749	Myo1a<tm1Mtys>	MP:0005377,hearing/vestibular/ear phenotype|MP:0008142,decreased small intestinal villus size
MGI:7356594	Myo1b<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0001510,abnormal coat appearance|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5515767	Myo1c<tm1.1Biat>	MP:0000062,increased bone mineral density|MP:0000248,macrocytosis|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0005384,cellular phenotype|MP:0005561,increased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:3603408	Myo1c<tm1Pgg>	MP:0004438,abnormal vestibular hair cell physiology
MGI:6268688	Myo1d<em1Btlr>	MP:0005381,digestive/alimentary phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0010180,increased susceptibility to weight loss|MP:0013298,increased susceptibility to colitis induced morbidity/mortality
MGI:5775818	Myo1d<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001489,decreased startle reflex|MP:0004738,abnormal auditory brainstem response
MGI:6268405	Myo1d<m1Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:6268406	Myo1d<m2Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:6268407	Myo1d<m3Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:6268408	Myo1d<m4Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:3526864	Myo1e<Gt(ROSA)74Sor>	MP:0000208,decreased hematocrit|MP:0001577,anemia|MP:0001614,abnormal blood vessel morphology|MP:0001914,hemorrhage|MP:0002640,reticulocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005097,polychromatophilia|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4441413	Myo1e<tm1.1Flv>	MP:0000315,hemoglobinuria|MP:0002847,abnormal renal glomerular filtration rate|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0003068,enlarged kidney|MP:0003215,renal interstitial fibrosis|MP:0003917,increased kidney weight|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004969,pale kidney|MP:0005161,hematuria|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005565,increased blood urea nitrogen level|MP:0008059,abnormal podocyte foot process morphology|MP:0008140,podocyte foot process effacement|MP:0009643,abnormal urine homeostasis|MP:0011320,abnormal glomerular capillary morphology|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011352,proximal convoluted tubule brush border loss|MP:0011353,expanded mesangial matrix|MP:0011402,renal cast|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011418,leukocyturia|MP:0011868,podocyte microvillus transformation
MGI:4441412	Myo1e<tm1Flv>	MP:0002871,albuminuria|MP:0005264,glomerulosclerosis|MP:0008059,abnormal podocyte foot process morphology|MP:0008140,podocyte foot process effacement|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011402,renal cast|MP:0011409,increased renal glomerulus basement membrane thickness
MGI:3664779	Myo1f<tm1.1Flv>	MP:0008720,impaired neutrophil chemotaxis|MP:0014695,increased cell adhesion
MGI:7425847	Myo1g<em1(IMPC)Ccpcz>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0003917,increased kidney weight|MP:0005635,decreased circulating bilirubin level|MP:0010052,increased grip strength
MGI:5581464	Myo1g<tm1.2Mfk>	MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0005014,increased B cell number|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0008561,decreased tumor necrosis factor secretion|MP:0014472,impaired B cell migration
MGI:5635249	Myo1h<tm1b(KOMP)Wtsi>	MP:0001516,abnormal motor coordination/balance|MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011436,decreased urine magnesium level
MGI:4849286	Myo3a<tm1.1Mckg>	MP:0004398,cochlear inner hair cell degeneration|MP:0004402,decreased cochlear outer hair cell number|MP:0004404,cochlear outer hair cell degeneration|MP:0004408,decreased cochlear hair cell number|MP:0005377,hearing/vestibular/ear phenotype|MP:0006325,impaired hearing
MGI:5634293	Myo3a<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0004738,abnormal auditory brainstem response|MP:0005293,impaired glucose tolerance|MP:0020870,decreased thigmotaxis
MGI:7581077	Myo3a<tm1Pgg>	MP:0005377,hearing/vestibular/ear phenotype
MGI:5603355	Myo3b<tm1b(EUCOMM)Hmgu>	MP:0000221,decreased leukocyte cell number|MP:0000947,convulsive seizures|MP:0002833,increased heart weight|MP:0003795,abnormal bone structure|MP:0010123,increased bone mineral content
MGI:7581078	Myo3b<tm1Pgg>	MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0005377,hearing/vestibular/ear phenotype
MGI:1856004	Myo5a<d>	MP:0002877,abnormal melanocyte morphology
MGI:5301901	Myo5a<d-105H>	MP:0002075,abnormal coat/hair pigmentation
MGI:1856007	Myo5a<d-15H>	MP:0000371,diluted coat color|MP:0002064,seizures|MP:0002880,opisthotonus|MP:0005386,behavior/neurological phenotype|MP:0011085,postnatal lethality, complete penetrance
MGI:2658702	Myo5a<d+16J>	MP:0003176,reversion by viral sequence excision
MGI:1891639	Myo5a<d+17J>	MP:0003176,reversion by viral sequence excision
MGI:1858058	Myo5a<d+18J>	MP:0003176,reversion by viral sequence excision
MGI:3777923	Myo5a<d-2Btlr>	MP:0000371,diluted coat color|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype
MGI:1891626	Myo5a<d+2J>	MP:0002075,abnormal coat/hair pigmentation|MP:0003171,phenotypic reversion|MP:0003176,reversion by viral sequence excision
MGI:5300687	Myo5a<d-50H>	MP:0002880,opisthotonus
MGI:5300688	Myo5a<d-51H>	MP:0002880,opisthotonus
MGI:5300689	Myo5a<d-52H>	MP:0002169,no abnormal phenotype detected
MGI:5300690	Myo5a<d-53H>	MP:0002880,opisthotonus
MGI:5300692	Myo5a<d-61H>	MP:0002169,no abnormal phenotype detected
MGI:5300693	Myo5a<d-78H>	MP:0002169,no abnormal phenotype detected
MGI:5300694	Myo5a<d-80H>	MP:0002880,opisthotonus
MGI:5300695	Myo5a<d-82H>	MP:0002880,opisthotonus
MGI:5300696	Myo5a<d-83H>	MP:0002880,opisthotonus
MGI:5300697	Myo5a<d-84H>	MP:0002880,opisthotonus
MGI:5313292	Myo5a<d-85H>	MP:0002880,opisthotonus
MGI:5300698	Myo5a<d-86H>	MP:0002880,opisthotonus
MGI:3777919	Myo5a<d-Btlr>	MP:0000371,diluted coat color|MP:0005387,immune system phenotype
MGI:3583341	Myo5a<d+Ha>	MP:0003176,reversion by viral sequence excision
MGI:1856407	Myo5a<d-J>	MP:0000371,diluted coat color|MP:0002075,abnormal coat/hair pigmentation
MGI:1856005	Myo5a<d-l>	MP:0000371,diluted coat color|MP:0001523,impaired righting response|MP:0001524,impaired limb coordination|MP:0001525,impaired balance|MP:0002880,opisthotonus|MP:0003996,clonic seizures
MGI:1858077	Myo5a<d-l20J>	MP:0000371,diluted coat color|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002075,abnormal coat/hair pigmentation|MP:0002082,postnatal lethality|MP:0002880,opisthotonus|MP:0003492,abnormal involuntary movement|MP:0005387,immune system phenotype
MGI:3577027	Myo5a<d-l31J>	MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death
MGI:4887399	Myo5a<d-l32J>	MP:0000371,diluted coat color|MP:0001393,ataxia|MP:0001525,impaired balance|MP:0002083,premature death|MP:0002880,opisthotonus|MP:0003996,clonic seizures|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4940062	Myo5a<d-l33J>	MP:0000371,diluted coat color|MP:0001393,ataxia|MP:0002083,premature death|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5607604	Myo5a<d-l34J>	MP:0000371,diluted coat color|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001394,circling|MP:0001525,impaired balance|MP:0002083,premature death|MP:0002880,opisthotonus|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5608666	Myo5a<d-l35J>	MP:0000371,diluted coat color|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0011083,lethality at weaning, complete penetrance
MGI:1856008	Myo5a<d-n>	MP:0000371,diluted coat color|MP:0000849,abnormal cerebellum morphology|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001475,reduced long-term depression|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002075,abnormal coat/hair pigmentation|MP:0002807,abnormal eye blink conditioning behavior|MP:0003312,abnormal locomotor coordination|MP:0003996,clonic seizures|MP:0005386,behavior/neurological phenotype|MP:0008489,slow postnatal weight gain|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:3777941	Myo5a<d-n2Btlr>	MP:0000015,abnormal ear pigmentation|MP:0000243,myoclonus|MP:0000371,diluted coat color|MP:0001523,impaired righting response|MP:0002880,opisthotonus|MP:0004263,abnormal limb posture|MP:0005174,abnormal tail pigmentation|MP:0009379,abnormal foot pigmentation|MP:0011083,lethality at weaning, complete penetrance
MGI:1860204	Myo5a<d-n2J>	MP:0000371,diluted coat color|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death
MGI:5515382	Myo5a<d-n3Btlr>	MP:0000371,diluted coat color|MP:0001523,impaired righting response|MP:0002880,opisthotonus
MGI:3777927	Myo5a<d-nBtlr>	MP:0000015,abnormal ear pigmentation|MP:0000243,myoclonus|MP:0000371,diluted coat color|MP:0001523,impaired righting response|MP:0002880,opisthotonus|MP:0003631,nervous system phenotype|MP:0004263,abnormal limb posture|MP:0005174,abnormal tail pigmentation|MP:0009379,abnormal foot pigmentation|MP:0011083,lethality at weaning, complete penetrance
MGI:5427465	Myo5a<m1163Lja>	MP:0001393,ataxia
MGI:3798432	Myo5a<rgsc11>	MP:0000371,diluted coat color
MGI:3798896	Myo5a<rgsc152>	MP:0000371,diluted coat color
MGI:3799143	Myo5a<rgsc229>	MP:0000371,diluted coat color
MGI:3799150	Myo5a<rgsc235>	MP:0000371,diluted coat color
MGI:3800448	Myo5a<rgsc379>	MP:0000371,diluted coat color
MGI:3800485	Myo5a<rgsc388>	MP:0000371,diluted coat color
MGI:3801067	Myo5a<rgsc432>	MP:0000371,diluted coat color
MGI:3801101	Myo5a<rgsc450>	MP:0000371,diluted coat color
MGI:3798499	Myo5a<rgsc52>	MP:0000371,diluted coat color
MGI:3808819	Myo5a<rgsc593>	MP:0000371,diluted coat color
MGI:3808168	Myo5a<rgsc705>	MP:0000371,diluted coat color
MGI:3808763	Myo5a<rgsc940>	MP:0000371,diluted coat color
MGI:5641704	Myo5a<tm1a(KOMP)Wtsi>	MP:0000371,diluted coat color|MP:0001399,hyperactivity|MP:0002075,abnormal coat/hair pigmentation|MP:0004381,abnormal hair follicle melanocyte morphology|MP:0004924,abnormal behavior|MP:0005072,abnormal hair follicle melanin granule morphology|MP:0005075,abnormal melanosome morphology|MP:0009387,abnormal epidermal pigmentation|MP:0009388,abnormal epidermal melanocyte morphology
MGI:4363512	Myo5a<tm1e(KOMP)Wtsi>	MP:0000371,diluted coat color|MP:0000427,abnormal hair cycle|MP:0005397,hematopoietic system phenotype|MP:0005408,hypopigmentation|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5790962	Myo5b<tm1.1Cle>	MP:0000479,abnormal enterocyte morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0001263,weight loss|MP:0001429,dehydration|MP:0005036,diarrhea|MP:0008108,abnormal small intestinal villus morphology|MP:0008109,abnormal small intestinal microvillus morphology|MP:0014078,small intestinal villus atrophy|MP:0014080,fused small intestinal villi
MGI:4461468	Myo5b<tm1a(KOMP)Wtsi>	MP:0000189,hypoglycemia|MP:0000479,abnormal enterocyte morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0001211,wrinkled skin|MP:0001262,decreased body weight|MP:0005036,diarrhea|MP:0008109,abnormal small intestinal microvillus morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:5449854	Myo6<chl>	MP:0000043,organ of Corti degeneration|MP:0000044,absent organ of Corti|MP:0001967,deafness|MP:0002833,increased heart weight|MP:0002857,cochlear ganglion degeneration|MP:0004324,vestibular hair cell degeneration|MP:0004328,decreased vestibular hair cell number|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004492,abnormal orientation of inner hair cell stereociliary bundles|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004516,fused vestibular hair cell stereocilia|MP:0004529,decreased outer hair cell stereocilia number|MP:0004534,decreased inner hair cell stereocilia number|MP:0004742,abnormal vestibular system physiology|MP:0005330,cardiomyopathy|MP:0006325,impaired hearing|MP:0006358,absent pinna reflex|MP:0011062,abnormal outer hair cell kinocilium morphology|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6431142	Myo6<em1Bcgen>	MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0001967,deafness|MP:0004362,cochlear hair cell degeneration|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004533,fused inner hair cell stereocilia|MP:0005307,head tossing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6257724	Myo6<em1(IMPC)Tcp>	MP:0000063,decreased bone mineral density|MP:0000157,abnormal sternum morphology|MP:0000221,decreased leukocyte cell number|MP:0000470,abnormal stomach morphology|MP:0001120,abnormal uterus morphology|MP:0001258,decreased body length|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0001486,abnormal startle reflex|MP:0001566,increased circulating phosphate level|MP:0002590,increased mean corpuscular volume|MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0003896,prolonged PR interval|MP:0003960,increased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0004924,abnormal behavior|MP:0005333,decreased heart rate|MP:0005628,decreased circulating potassium level|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0010506,prolonged RR interval|MP:0011874,enlarged urinary bladder
MGI:6153148	Myo6<ksv>	MP:0001394,circling|MP:0001399,hyperactivity|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0004523,decreased cochlear hair cell stereocilia number|MP:0004528,fused outer hair cell stereocilia|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004533,fused inner hair cell stereocilia|MP:0004738,abnormal auditory brainstem response|MP:0006325,impaired hearing|MP:0010015,abnormal cuticular plate morphology|MP:0011060,abnormal kinocilium morphology
MGI:4458386	Myo6<M1Btlr>	MP:0001395,bidirectional circling|MP:0001410,head bobbing|MP:0005191,head tilt
MGI:5615724	Myo6<m2Btlr>	MP:0001394,circling|MP:0001399,hyperactivity|MP:0005307,head tossing
MGI:1913078	Myo6<Mhdatlc>	MP:0001394,circling|MP:0001525,impaired balance|MP:0001526,abnormal placing response|MP:0004324,vestibular hair cell degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004589,abnormal cochlear hair cell development|MP:0005307,head tossing|MP:0006358,absent pinna reflex|MP:0010323,retropulsion
MGI:5792103	Myo6<mpc285H>	MP:0000034,abnormal inner ear vestibule morphology|MP:0001967,deafness
MGI:6160069	Myo6<rsv>	MP:0000043,organ of Corti degeneration|MP:0001395,bidirectional circling|MP:0001525,impaired balance|MP:0002857,cochlear ganglion degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004528,fused outer hair cell stereocilia|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004533,fused inner hair cell stereocilia|MP:0005307,head tossing|MP:0006358,absent pinna reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856555	Myo6<sv>	MP:0000032,cochlear degeneration|MP:0000043,organ of Corti degeneration|MP:0001265,decreased body size|MP:0001394,circling|MP:0001395,bidirectional circling|MP:0001399,hyperactivity|MP:0001408,stereotypic behavior|MP:0001410,head bobbing|MP:0001522,impaired swimming|MP:0001921,reduced fertility|MP:0001961,abnormal reflex|MP:0001967,deafness|MP:0002857,cochlear ganglion degeneration|MP:0002895,abnormal otolithic membrane morphology|MP:0003150,detached tectorial membrane|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0004298,vestibular ganglion degeneration|MP:0004324,vestibular hair cell degeneration|MP:0004331,vestibular saccular macula degeneration|MP:0004334,utricular macular degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004363,stria vascularis degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004409,abnormal crista ampullaris neuroepithelium morphology|MP:0004416,absent cochlear nerve compound action potential|MP:0004528,fused outer hair cell stereocilia|MP:0004533,fused inner hair cell stereocilia|MP:0004813,absent linear vestibular evoked potential|MP:0004814,reduced linear vestibular evoked potential|MP:0005307,head tossing|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology
MGI:3618347	Myo6<sv-2J>	MP:0001394,circling|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0005307,head tossing
MGI:3707504	Myo6<sv-3J>	MP:0001394,circling|MP:0005191,head tilt
MGI:3789637	Myo6<sv-4J>	MP:0001394,circling|MP:0001967,deafness|MP:0002730,head shaking|MP:0005307,head tossing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3708361	Myo6<twt>	MP:0001394,circling|MP:0001399,hyperactivity|MP:0001489,decreased startle reflex|MP:0001522,impaired swimming|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004523,decreased cochlear hair cell stereocilia number|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2155417	Myo7a<26SB>	MP:0000045,abnormal hair cell morphology|MP:0001963,abnormal hearing physiology
MGI:2155420	Myo7a<3336SB>	MP:0000045,abnormal hair cell morphology|MP:0001963,abnormal hearing physiology
MGI:2155421	Myo7a<4494SB>	MP:0000045,abnormal hair cell morphology|MP:0001963,abnormal hearing physiology
MGI:2155422	Myo7a<4626SB>	MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004402,decreased cochlear outer hair cell number|MP:0004404,cochlear outer hair cell degeneration|MP:0004415,abnormal cochlear nerve compound action potential|MP:0004466,short cochlear outer hair cells|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004577,abnormal cochlear hair cell inter-stereocilial links morphology|MP:0004582,absent cochlear hair bundle ankle links|MP:0004748,increased susceptibility to age-related hearing loss|MP:0006325,impaired hearing
MGI:2155423	Myo7a<816SB>	MP:0000045,abnormal hair cell morphology|MP:0001963,abnormal hearing physiology|MP:0004413,absent cochlear microphonics|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0006388,abnormal auditory summating potential
MGI:5487403	Myo7a<dmbo2>	MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004534,decreased inner hair cell stereocilia number|MP:0005377,hearing/vestibular/ear phenotype|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5487402	Myo7a<ewaso>	MP:0001394,circling|MP:0001512,trunk curl|MP:0004362,cochlear hair cell degeneration|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004492,abnormal orientation of inner hair cell stereociliary bundles|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004517,decreased vestibular hair cell stereocilia number|MP:0004529,decreased outer hair cell stereocilia number|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004533,fused inner hair cell stereocilia|MP:0004534,decreased inner hair cell stereocilia number|MP:0004598,abnormal cochlear basement membrane morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3511858	Myo7a<Hdb>	MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004533,fused inner hair cell stereocilia|MP:0004534,decreased inner hair cell stereocilia number|MP:0004767,increased cochlear nerve compound action potential
MGI:5582747	Myo7a<m1Btlr>	MP:0001394,circling|MP:0001399,hyperactivity|MP:0005307,head tossing
MGI:5791997	Myo7a<mpc142H>	MP:0000034,abnormal inner ear vestibule morphology|MP:0001967,deafness
MGI:3708382	Myo7a<polka>	MP:0001394,circling|MP:0001489,decreased startle reflex|MP:0001522,impaired swimming|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004524,short cochlear hair cell stereocilia|MP:0004737,absent distortion product otoacoustic emissions|MP:0005201,abnormal retina pigment epithelium morphology|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856716	Myo7a<sh1>	MP:0000042,abnormal organ of Corti morphology|MP:0001363,increased anxiety-related response|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001522,impaired swimming|MP:0001922,reduced male fertility|MP:0001967,deafness|MP:0002183,gliosis|MP:0002622,abnormal cochlear hair cell morphology|MP:0002857,cochlear ganglion degeneration|MP:0003878,abnormal ear physiology|MP:0004331,vestibular saccular macula degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004363,stria vascularis degeneration|MP:0004632,abnormal cochlear OHC efferent innervation pattern|MP:0004813,absent linear vestibular evoked potential|MP:0004924,abnormal behavior|MP:0005307,head tossing|MP:0005424,jerky movement|MP:0006358,absent pinna reflex|MP:0006409,vestibular ganglion hypoplasia|MP:0008489,slow postnatal weight gain|MP:0011939,increased food intake|MP:0011941,increased fluid intake
MGI:3587421	Myo7a<sh1-11J>	MP:0001005,abnormal retina rod cell morphology|MP:0001394,circling|MP:0005191,head tilt|MP:0008451,retina rod cell degeneration
MGI:5566827	Myo7a<sh1-13J>	MP:0000436,abnormal head movements|MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0002730,head shaking|MP:0003382,straub tail|MP:0005307,head tossing|MP:0010323,retropulsion
MGI:2448695	Myo7a<sh1-1R>	MP:0001525,impaired balance
MGI:1860092	Myo7a<sh1-6J>	MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001522,impaired swimming|MP:0001925,male infertility|MP:0001967,deafness|MP:0005307,head tossing|MP:0010323,retropulsion
MGI:3045593	Myo7a<sh1-7J>	MP:0001394,circling|MP:0001967,deafness|MP:0002730,head shaking|MP:0005191,head tilt
MGI:2182918	Myo7a<sh1-8J>	MP:0001186,pigmentation phenotype|MP:0001394,circling|MP:0001410,head bobbing|MP:0002068,abnormal parental behavior|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1857528	Myo7a<sh1-9J>	MP:0001394,circling|MP:0001967,deafness
MGI:4431921	Myo7a<tm1a(EUCOMM)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0001408,stereotypic behavior|MP:0001512,trunk curl|MP:0001523,impaired righting response|MP:0005565,increased blood urea nitrogen level|MP:0005633,increased circulating sodium level|MP:0006358,absent pinna reflex
MGI:6405407	Myo7a<tm1b(EUCOMM)Wtsi>	MP:0000032,cochlear degeneration|MP:0001399,hyperactivity|MP:0001411,spinning|MP:0001967,deafness|MP:0002857,cochlear ganglion degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004364,thin stria vascularis|MP:0004404,cochlear outer hair cell degeneration|MP:0004740,sensorineural hearing loss|MP:0005191,head tilt|MP:0006243,impaired pupillary reflex|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:5555872	Myo7b<tm1b(EUCOMM)Hmgu>	MP:0003019,increased circulating chloride level|MP:0005560,decreased circulating glucose level|MP:0005633,increased circulating sodium level
MGI:6681833	Myo9a<em1Atuf>	MP:0001393,ataxia|MP:0001891,hydrocephaly|MP:0002064,seizures|MP:0002082,postnatal lethality|MP:0002705,dilated renal tubule|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0008060,abnormal podocyte slit diaphragm morphology|MP:0008061,absent podocyte slit diaphragm|MP:0008140,podocyte foot process effacement|MP:0011293,dilated nephron|MP:0011339,abnormal glomerular mesangium morphology|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011864,abnormal podocyte adhesion|MP:0011867,decreased podocyte motility
MGI:6111331	Myo9a<tm1.2Bah>	MP:0000825,dilated lateral ventricle|MP:0000826,abnormal third ventricle morphology|MP:0000917,obstructive hydrocephaly|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0003631,nervous system phenotype|MP:0005537,abnormal cerebral aqueduct morphology|MP:0008536,enlarged third ventricle|MP:0009689,abnormal neural tube ventricular layer morphology|MP:0013228,brain ventricle stenosis
MGI:5636908	Myo9a<tm1b(EUCOMM)Wtsi>	MP:0001015,small superior cervical ganglion|MP:0003584,bifid ureter|MP:0003826,abnormal Mullerian duct morphology|MP:0003827,abnormal Wolffian duct morphology|MP:0004160,retroesophageal right subclavian artery|MP:0004613,fusion of vertebral arches|MP:0006093,arteriovenous malformation|MP:0013848,subcutaneous edema|MP:0013969,reduced sympathetic cervical ganglion size|MP:0013971,blood in lymph vessels
MGI:4867913	Myo9b<tm1.1Bah>	MP:0002169,no abnormal phenotype detected
MGI:4867915	Myo9b<tm1.2Bah>	MP:0000221,decreased leukocyte cell number|MP:0002451,abnormal macrophage physiology|MP:0003799,impaired macrophage chemotaxis
MGI:3773718	Myocd<tm1.1Msp>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5615209	Myocd<tm1(cre)Dzw>	MP:0003984,embryonic growth retardation|MP:0011092,embryonic lethality, complete penetrance|MP:0012270,cardiac edema
MGI:3849559	Myocd<tm1(cre)Jomm>	MP:0002169,no abnormal phenotype detected
MGI:3052940	Myocd<tm1Eno>	MP:0001614,abnormal blood vessel morphology|MP:0001719,absent vitelline blood vessels|MP:0001722,pale yolk sac|MP:0003984,embryonic growth retardation|MP:0004787,abnormal dorsal aorta morphology|MP:0005312,pericardial effusion|MP:0005385,cardiovascular system phenotype|MP:0005592,abnormal vascular smooth muscle morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3773717	Myocd<tm1Msp>	MP:0000260,abnormal angiogenesis|MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0001575,cyanosis|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0003139,patent ductus arteriosus|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0004090,abnormal sarcomere morphology|MP:0004566,myocardial fiber degeneration|MP:0005140,decreased cardiac muscle contractility|MP:0005312,pericardial effusion|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006267,abnormal intercalated disk morphology|MP:0008725,increased heart atrium size|MP:0008772,increased heart ventricle size|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011925,abnormal heart echocardiography feature|MP:0014730,abnormal myocardial fiber myofibril morphology|MP:0020409,abnormal cardiac thrombosis|MP:0031131,myocardial fiber disarray
MGI:2183812	Myoc<tm1.1Rjo>	MP:0002169,no abnormal phenotype detected
MGI:2183810	Myoc<tm1Rjo>	MP:0002169,no abnormal phenotype detected
MGI:3693012	Myoc<tm2.1Rjo>	MP:0005257,abnormal intraocular pressure|MP:0005391,vision/eye phenotype
MGI:3027189	Myod1<tm1.1Glh>	MP:0000733,abnormal muscle development
MGI:3804837	Myod1<tm1Ahb>	MP:0002106,abnormal muscle physiology|MP:0002108,abnormal muscle morphology|MP:0031328,delayed skeletal muscle regeneration
MGI:1857221	Myod1<tm1Jae>	MP:0000729,abnormal myogenesis|MP:0000730,increased satellite cell number|MP:0002169,no abnormal phenotype detected|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5637058	Myof<tm1b(EUCOMM)Hmgu>	MP:0000194,increased circulating calcium level|MP:0001566,increased circulating phosphate level|MP:0005553,increased circulating creatinine level|MP:0005568,increased circulating total protein level
MGI:4822406	Myof<tm1Mcn>	MP:0000729,abnormal myogenesis|MP:0001265,decreased body size|MP:0003071,decreased vascular permeability|MP:0003081,abnormal soleus morphology|MP:0009408,decreased skeletal muscle fiber density|MP:0009412,skeletal muscle fiber degeneration
MGI:3036561	Myog<tm1Sjb>	MP:0005369,muscle phenotype
MGI:1857667	Myog<tm1Whk>	MP:0000005,increased brown adipose tissue amount|MP:0000061,fragile skeleton|MP:0000150,abnormal rib morphology|MP:0000160,kyphosis|MP:0000729,abnormal myogenesis|MP:0000733,abnormal muscle development|MP:0000734,muscle hypoplasia|MP:0000761,thin diaphragm muscle|MP:0001176,abnormal lung development|MP:0001178,pulmonary hypoplasia|MP:0001404,no spontaneous movement|MP:0001491,unresponsive to tactile stimuli|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0001961,abnormal reflex|MP:0002263,abnormal laryngeal muscle morphology|MP:0004321,short sternum|MP:0004672,short ribs|MP:0004819,decreased skeletal muscle mass|MP:0005380,embryo phenotype|MP:0008277,abnormal sternum ossification|MP:0009408,decreased skeletal muscle fiber density|MP:0011087,neonatal lethality, complete penetrance|MP:0011808,abnormal myoblast differentiation|MP:0012280,abnormal sternebra size
MGI:1927620	Myog<tm1Yin>	MP:0000734,muscle hypoplasia|MP:0011087,neonatal lethality, complete penetrance
MGI:1913094	Myog<tm2Whk>	MP:0000160,kyphosis|MP:0000734,muscle hypoplasia|MP:0001785,edema|MP:0004321,short sternum|MP:0011087,neonatal lethality, complete penetrance
MGI:3618992	Myog<tm3Whk>	MP:0000761,thin diaphragm muscle|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5790669	myol	MP:0001523,impaired righting response|MP:0003157,impaired muscle relaxation
MGI:6114782	Myom2<em1(IMPC)J>	MP:0002075,abnormal coat/hair pigmentation|MP:0004222,iris synechia|MP:0010053,decreased grip strength
MGI:6377206	Myom3<em1(IMPC)Mbp>	MP:0002135,abnormal kidney morphology|MP:0002989,small kidney
MGI:7787039	Myorg<em#Zqx>	MP:0030014,calcified brain
MGI:5471224	Myorg<tm1b(KOMP)Wtsi>	MP:0005560,decreased circulating glucose level
MGI:3697714	Myot<tm1.1Moza>	MP:0002169,no abnormal phenotype detected
MGI:4436678	Myoz1<tm1a(EUCOMM)Hmgu>	MP:0000562,polydactyly|MP:0001262,decreased body weight|MP:0004651,increased thoracic vertebrae number|MP:0010100,increased cervical vertebrae number
MGI:5548708	Myoz1<tm1b(EUCOMM)Hmgu>	MP:0002997,enlarged seminal vesicle|MP:0005554,decreased circulating creatinine level|MP:0008181,increased marginal zone B cell number|MP:0008528,polycystic kidney|MP:0009476,enlarged cecum|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength
MGI:3831744	Myoz1<tm1Eno>	MP:0000749,muscle degeneration|MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0002106,abnormal muscle physiology|MP:0003082,abnormal gastrocnemius morphology|MP:0004142,abnormal muscle tone|MP:0009400,decreased skeletal muscle fiber size|MP:0009401,increased skeletal muscle fiber diameter|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009422,decreased gastrocnemius weight|MP:0012107,enhanced exercise endurance|MP:0031318,enhanced skeletal muscle regeneration
MGI:3525108	Myoz2<tm1Eno>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000759,abnormal skeletal muscle morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0003140,dilated heart atrium|MP:0004485,increased response of heart to induced stress|MP:0004565,decreased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0009400,decreased skeletal muscle fiber size|MP:0009409,abnormal skeletal muscle fiber type ratio
MGI:7378569	Myoz3<em1(IMPC)J>	MP:0001402,decreased locomotor activity
MGI:6149973	Mypn<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0010053,decreased grip strength
MGI:5910326	Mypn<tm1.1Epu>	MP:0000278,abnormal myocardial fiber morphology|MP:0000751,myopathy|MP:0001636,irregular heartbeat|MP:0002169,no abnormal phenotype detected|MP:0003105,abnormal heart atrium morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004084,abnormal cardiac muscle relaxation|MP:0004091,abnormal Z line morphology|MP:0005608,cardiac interstitial fibrosis|MP:0006267,abnormal intercalated disk morphology|MP:0010505,abnormal T wave|MP:0010519,atrioventricular block|MP:0011925,abnormal heart echocardiography feature|MP:0014730,abnormal myocardial fiber myofibril morphology
MGI:3626351	mypy	MP:0002451,abnormal macrophage physiology|MP:0020913,increased susceptibility to Riboviria infection|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:6414560	Myrf<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011962,increased cornea thickness|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3851143	Myrf<tm1Barr>	MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0000955,abnormal spinal cord morphology|MP:0001326,retina degeneration|MP:0001330,abnormal optic nerve morphology|MP:0001393,ataxia|MP:0002064,seizures|MP:0003631,nervous system phenotype|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005103,abnormal retina pigmentation|MP:0005548,retina pigment epithelium atrophy|MP:0008446,decreased retina cone cell number|MP:0008515,thin retina outer nuclear layer|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment|MP:0011085,postnatal lethality, complete penetrance|MP:0011965,decreased total retina thickness
MGI:6368190	Myrip<tm1Tiz>	MP:0001262,decreased body weight|MP:0003059,decreased insulin secretion|MP:0005215,abnormal pancreatic islet morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance
MGI:4362924	Mysm1<tm1a(KOMP)Wtsi>	MP:0000137,abnormal vertebrae morphology|MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000322,increased granulocyte number|MP:0000367,abnormal coat/ hair morphology|MP:0000373,belly spot|MP:0000377,abnormal hair follicle morphology|MP:0000384,distorted hair follicle pattern|MP:0000427,abnormal hair cycle|MP:0000556,abnormal hindlimb morphology|MP:0000572,abnormal autopod morphology|MP:0000575,increased foot pad pigmentation|MP:0000585,kinked tail|MP:0000592,short tail|MP:0000745,tremors|MP:0001216,abnormal epidermal layer morphology|MP:0001256,abnormal body length|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001512,trunk curl|MP:0001566,increased circulating phosphate level|MP:0002075,abnormal coat/hair pigmentation|MP:0002111,abnormal tail morphology|MP:0002590,increased mean corpuscular volume|MP:0002644,decreased circulating triglyceride level|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002896,abnormal bone mineralization|MP:0002968,increased circulating alkaline phosphatase level|MP:0003051,curly tail|MP:0003062,abnormal coping response|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0004924,abnormal behavior|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005179,decreased circulating cholesterol level|MP:0005505,thrombocytosis|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008211,decreased mature B cell number|MP:0008501,increased IgG2b level|MP:0011277,decreased tail pigmentation
MGI:5896989	Mysm1<tm1b(KOMP)Wtsi>	MP:0000592,short tail|MP:0001732,postnatal growth retardation|MP:0001802,arrested B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0005017,decreased B cell number|MP:0005152,pancytopenia|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008215,decreased immature B cell number|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0011182,decreased hematopoietic cell number
MGI:6741516	Myt1l<em1Jdd>	MP:0000746,weakness|MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0000913,abnormal brain development|MP:0001261,obese|MP:0001399,hyperactivity|MP:0002175,decreased brain weight|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002574,increased vertical activity|MP:0003863,decreased aggression towards mice|MP:0004263,abnormal limb posture|MP:0004811,abnormal neuron physiology|MP:0005386,behavior/neurological phenotype|MP:0005498,hyporesponsive to tactile stimuli|MP:0006253,clinodactyly|MP:0008026,abnormal brain white matter morphology|MP:0009456,impaired cued conditioning behavior|MP:0010053,decreased grip strength|MP:0011087,neonatal lethality, complete penetrance|MP:0013140,excessive vocalization|MP:0020394,decreased neuronal precursor proliferation|MP:0020507,increased dendritic spine density|MP:0020512,abnormal dendritic mushroom spine morphology|MP:0020513,abnormal dendritic stubby spine morphology|MP:0020514,abnormal dendritic thin spine morphology|MP:0021111,decreased social investigation|MP:0031391,increased locomotor activity
MGI:7328725	Myt1l<em1Mwer>	MP:0001261,obese|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001447,abnormal nest building behavior|MP:0001488,increased startle reflex|MP:0002574,increased vertical activity|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0011087,neonatal lethality, complete penetrance|MP:0011620,abnormal habituation to a new environment|MP:0013140,excessive vocalization|MP:0031391,increased locomotor activity
MGI:4842524	Myt1l<tm1a(EUCOMM)Wtsi>	MP:0010087,increased circulating fructosamine level
MGI:3765056	Myt1<tm1.1Ggu>	MP:0002279,abnormal diaphragm morphology|MP:0009195,abnormal PP cell physiology|MP:0011087,neonatal lethality, complete penetrance
MGI:4943749	Myt1<tm1(EGFP/icre)Ldh>	MP:0011085,postnatal lethality, complete penetrance
MGI:6200294	Myzap<em1(IMPC)J>	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0030610,absent teeth
MGI:6158943	Myzap<tm1Norf>	MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0005140,decreased cardiac muscle contractility|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0005402,abnormal action potential|MP:0005630,increased lung weight|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010630,abnormal cardiac muscle tissue morphology|MP:0010768,mortality/aging
MGI:6147535	Mzb1<em1(IMPC)Ccpcz>	MP:0004151,decreased circulating iron level|MP:0005564,increased hemoglobin content|MP:0005634,decreased circulating sodium level|MP:0009198,abnormal male genitalia morphology|MP:0009208,abnormal female genitalia morphology
MGI:5636601	Mzb1<tm1.1Rug>	MP:0000692,small spleen|MP:0002458,abnormal B cell number|MP:0003134,increased late pro-B cell number|MP:0008186,increased pro-B cell number|MP:0008209,decreased pre-B cell number
MGI:5636602	Mzb1<tm1.2Rug>	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008186,increased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0020154,impaired humoral immune response
MGI:2182764	Mzf1<tm1Ppp>	MP:0000168,abnormal bone marrow development|MP:0000240,extramedullary hematopoiesis|MP:0001601,abnormal myelopoiesis|MP:0002083,premature death|MP:0003331,increased hepatocellular carcinoma incidence|MP:0005397,hematopoietic system phenotype|MP:0005649,increased spleen neoplasm incidence
MGI:6490607	N4bp1<em1Vmd>	MP:0005387,immune system phenotype|MP:0008706,decreased interleukin-6 secretion
MGI:6490626	N4bp1<tm1.2Vmd>	MP:0001193,psoriasis|MP:0001222,epidermal hyperplasia|MP:0001577,anemia|MP:0001829,increased activated T cell number|MP:0001861,lung inflammation|MP:0002451,abnormal macrophage physiology|MP:0005165,increased susceptibility to injury|MP:0005534,decreased body temperature|MP:0008177,increased germinal center B cell number|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008596,increased circulating interleukin-6 level|MP:0008705,increased interleukin-6 secretion|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0013022,increased Ly6C high monocyte number
MGI:6152521	Naa10<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000639,abnormal adrenal gland morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001297,microphthalmia|MP:0001891,hydrocephaly|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002282,abnormal trachea morphology|MP:0002339,abnormal lymph node morphology|MP:0002834,decreased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0003960,increased lean body mass|MP:0004931,enlarged epididymis|MP:0005292,improved glucose tolerance|MP:0005635,decreased circulating bilirubin level|MP:0009709,hydrometra|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength
MGI:6315272	Naa10<tm1.1Yzhg>	MP:0000440,domed cranium|MP:0000827,dilated third ventricle|MP:0001262,decreased body weight|MP:0001698,decreased embryo size|MP:0001714,absent trophoblast giant cells|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0001915,intracranial hemorrhage|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0003403,absent placental labyrinth|MP:0003718,maternal effect|MP:0003787,abnormal imprinting|MP:0004921,decreased placenta weight|MP:0005389,reproductive system phenotype|MP:0008535,enlarged lateral ventricles|MP:0008877,abnormal DNA methylation|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012100,absent spongiotrophoblast layer
MGI:6315313	Naa10<tm1Jprk>	MP:0000062,increased bone mineral density|MP:0000074,abnormal neurocranium morphology|MP:0002113,abnormal skeleton development|MP:0005006,abnormal osteoblast physiology|MP:0010875,increased bone volume|MP:0011710,enhanced osteoblast differentiation|MP:0030278,thick neurocranium
MGI:7462362	Naa11<em1(IMPC)Kmpc>	MP:0001552,increased circulating triglyceride level|MP:0001925,male infertility
MGI:6151419	Naa16<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0001399,hyperactivity
MGI:7549282	Naa20<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:6156571	Naa25<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001399,hyperactivity|MP:0002060,abnormal skin morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6314217	Naa35<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0001566,increased circulating phosphate level|MP:0011100,preweaning lethality, complete penetrance
MGI:6341883	Naa38<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000538,abnormal urinary bladder morphology|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001262,decreased body weight|MP:0002339,abnormal lymph node morphology|MP:0009552,urinary bladder obstruction|MP:0009709,hydrometra|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5317907	Naa40<tm1Qwzh>	MP:0000183,decreased circulating LDL cholesterol level|MP:0001260,increased body weight|MP:0001431,abnormal eating behavior|MP:0002118,abnormal lipid homeostasis|MP:0003960,increased lean body mass|MP:0003976,decreased circulating VLDL triglyceride level|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005459,decreased percent body fat/body weight|MP:0005559,increased circulating glucose level|MP:0009356,decreased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0010360,decreased liver free fatty acids level|MP:0010379,decreased respiratory quotient|MP:0014171,increased fatty acid oxidation|MP:0031270,decreased susceptibility to age-related hepatic steatosis
MGI:6276983	Naa50<em1(IMPC)Mbp>	MP:0001785,edema|MP:0003984,embryonic growth retardation|MP:0004931,enlarged epididymis|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:4419604	Naaa<tm1a(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008810,increased circulating iron level|MP:0010073,decreased pruritus
MGI:7510099	Naalad2<em1(IMPC)J>	MP:0005566,decreased blood urea nitrogen level
MGI:7662575	Naalad2<em1Jzhan>	MP:0005376,homeostasis/metabolism phenotype
MGI:6257753	Naaladl2<em1(IMPC)Tcp>	MP:0001488,increased startle reflex|MP:0002092,abnormal eye morphology
MGI:6358624	Nab1<em1(IMPC)H>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3584131	Nab1<tm1Jmi>	MP:0002169,no abnormal phenotype detected
MGI:5548375	Nab2<tm1b(EUCOMM)Hmgu>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000598,abnormal liver morphology|MP:0001312,abnormal cornea morphology|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002574,increased vertical activity|MP:0002797,increased thigmotaxis|MP:0004924,abnormal behavior|MP:0005179,decreased circulating cholesterol level|MP:0020420,abnormal freezing behavior
MGI:3584132	Nab2<tm1Jmi>	MP:0002169,no abnormal phenotype detected
MGI:5644800	Nabp1<tm1.1Kkha>	MP:0001147,small testis|MP:0004852,decreased testis weight|MP:0005384,cellular phenotype|MP:0005397,hematopoietic system phenotype
MGI:5644720	Nabp1<tm1Kkha>	MP:0005384,cellular phenotype
MGI:5502334	Nabp2<tm1.1Kkha>	MP:0000496,abnormal small intestine morphology|MP:0001147,small testis|MP:0001258,decreased body length|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002687,oligozoospermia|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003992,increased mortality induced by ionizing radiation|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0004852,decreased testis weight|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0006362,abnormal male germ cell morphology|MP:0008280,abnormal male germ cell apoptosis|MP:0008866,chromosomal instability|MP:0009541,increased thymocyte apoptosis|MP:0013600,testis degeneration
MGI:5770469	Nabp2<tm1.1Schg>	MP:0000556,abnormal hindlimb morphology|MP:0008866,chromosomal instability|MP:0009703,decreased birth body size|MP:0010207,abnormal telomere morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:5502335	Nabp2<tm1.2Kkha>	MP:0000030,abnormal tympanic ring morphology|MP:0000111,cleft palate|MP:0000150,abnormal rib morphology|MP:0000428,abnormal craniofacial morphology|MP:0000443,abnormal snout morphology|MP:0000458,abnormal mandible morphology|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000572,abnormal autopod morphology|MP:0001176,abnormal lung development|MP:0001954,respiratory distress|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002639,micrognathia|MP:0002764,short tibia|MP:0002820,abnormal premaxilla morphology|MP:0002896,abnormal bone mineralization|MP:0003109,short femur|MP:0004340,short scapula|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004624,abnormal thoracic cage morphology|MP:0004625,abnormal rib joint morphology|MP:0004686,decreased length of long bones|MP:0005384,cellular phenotype|MP:0005430,absent fibula|MP:0006279,abnormal limb development|MP:0008148,abnormal sternocostal joint morphology|MP:0008271,abnormal bone ossification|MP:0009431,decreased fetal weight|MP:0009703,decreased birth body size|MP:0010099,abnormal thoracic cage shape|MP:0010103,small thoracic cage|MP:0010819,primary atelectasis|MP:0011087,neonatal lethality, complete penetrance|MP:0014281,hindlimb oligodactyly|MP:0014473,increased pulmonary alveolus wall thickness
MGI:5448642	Nabp2<tm1.2Nfel>	MP:0000030,abnormal tympanic ring morphology|MP:0000111,cleft palate|MP:0000164,abnormal cartilage development|MP:0000438,abnormal cranium morphology|MP:0000460,mandible hypoplasia|MP:0002823,abnormal rib development|MP:0003795,abnormal bone structure|MP:0004201,fetal growth retardation|MP:0004347,abnormal scapular spine morphology|MP:0004353,abnormal deltoid tuberosity morphology|MP:0004354,absent deltoid tuberosity|MP:0005508,abnormal skeleton morphology|MP:0006279,abnormal limb development|MP:0008866,chromosomal instability|MP:0010103,small thoracic cage|MP:0010876,decreased bone volume|MP:0011089,perinatal lethality, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis|MP:0014281,hindlimb oligodactyly
MGI:6324183	Nabp2<tm1b(KOMP)Wtsi>	MP:0000428,abnormal craniofacial morphology|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0002109,abnormal limb morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5770467	Nabp2<tm1Schg>	MP:0001658,increased mortality induced by gamma-irradiation|MP:0002083,premature death|MP:0008476,increased spleen red pulp amount|MP:0008866,chromosomal instability
MGI:4362585	Nacad<tm1(KOMP)Wtsi>	MP:0001258,decreased body length|MP:0002079,increased circulating insulin level|MP:0005560,decreased circulating glucose level|MP:0005633,increased circulating sodium level
MGI:4421140	Naca<tm1.1Star>	MP:0002896,abnormal bone mineralization|MP:0008753,abnormal osteocyte morphology|MP:0009346,decreased trabecular bone thickness|MP:0010867,abnormal bone trabecula morphology|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0010924,abnormal osteoid morphology|MP:0010927,decreased osteoid volume|MP:0010930,decreased osteoid thickness|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization|MP:0030482,increased osteocyte number
MGI:4867685	Naca<tm1Dsr>	MP:0000279,ventricular hypoplasia|MP:0000281,abnormal interventricular septum morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001787,pericardial edema|MP:0002106,abnormal muscle physiology|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002652,thin myocardium|MP:0003984,embryonic growth retardation|MP:0004819,decreased skeletal muscle mass|MP:0005244,hemopericardium|MP:0005294,abnormal heart ventricle morphology|MP:0005329,abnormal myocardium layer morphology|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0013239,impaired skeletal muscle regeneration
MGI:5605557	Naca<tm2Star>	MP:0002169,no abnormal phenotype detected
MGI:6324156	Nacc1<em1(IMPC)Hmgu>	MP:0001284,absent vibrissae|MP:0001325,abnormal retina morphology|MP:0001489,decreased startle reflex|MP:0002764,short tibia|MP:0004738,abnormal auditory brainstem response|MP:0005293,impaired glucose tolerance|MP:0008528,polycystic kidney|MP:0009709,hydrometra|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0011965,decreased total retina thickness
MGI:8172584	Nacc1<em1Mdif>	MP:0001262,decreased body weight|MP:0001407,short stride length|MP:0001447,abnormal nest building behavior|MP:0001513,limb grasping|MP:0002064,seizures|MP:0002797,increased thigmotaxis|MP:0004994,abnormal brain wave pattern|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0008489,slow postnatal weight gain|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012288,abnormal paradoxical sleep pattern|MP:0012290,abnormal slow-wave sleep pattern|MP:0012291,increased slow-wave sleep duration
MGI:5547984	Nacc1<tm1.1Jlwa>	MP:0000137,abnormal vertebrae morphology|MP:0000461,decreased presacral vertebrae number|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003345,decreased rib number|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004622,sacral vertebral fusion|MP:0009780,abnormal chondrocyte physiology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3767840	Nacc1<tm1Jabl>	MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009712,impaired conditioned place preference behavior|MP:0009754,enhanced behavioral response to cocaine
MGI:5637027	Nacc2<tm2b(EUCOMM)Wtsi>	MP:0001406,abnormal gait|MP:0001510,abnormal coat appearance|MP:0002968,increased circulating alkaline phosphatase level|MP:0013406,abnormal epidermal immune compartment
MGI:4418718	nad	MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001505,hunched posture|MP:0001511,disheveled coat|MP:0001513,limb grasping|MP:0001925,male infertility|MP:0002083,premature death|MP:0002393,abnormal bronchus-associated lymphoid tissue morphology|MP:0003225,axonal dystrophy|MP:0005376,homeostasis/metabolism phenotype|MP:0009417,skeletal muscle atrophy|MP:0009434,paraparesis
MGI:5689888	Nadk2<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system|MP:0001700,abnormal embryo turning|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4842252	Nadk2<tm1a(EUCOMM)Wtsi>	MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000609,abnormal liver physiology|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002628,hepatic steatosis|MP:0003103,liver degeneration|MP:0003333,liver fibrosis|MP:0003674,oxidative stress|MP:0003979,increased circulating carnitine level|MP:0004890,decreased energy expenditure|MP:0009355,increased liver triglyceride level|MP:0010378,increased respiratory quotient|MP:0014172,decreased fatty acid oxidation|MP:0030718,increased circulating lysine level|MP:0030721,increased lysine level
MGI:5637034	Nadk2<tm1b(EUCOMM)Wtsi>	MP:0001711,abnormal placenta morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0005031,abnormal trophoblast layer morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:6257722	Nadk<em2(IMPC)Bay>	MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5548698	Nadsyn1<tm1b(KOMP)Wtsi>	MP:0000691,enlarged spleen|MP:0001314,cornea opacity|MP:0001926,female infertility|MP:0005333,decreased heart rate|MP:0005542,cornea vascularization|MP:0005575,increased pulmonary ventilation|MP:0005576,decreased pulmonary ventilation|MP:0010053,decreased grip strength|MP:0010506,prolonged RR interval|MP:0010570,prolonged ST segment
MGI:5548785	Nae1<tm1b(EUCOMM)Wtsi>	MP:0001417,decreased exploration in new environment|MP:0001566,increased circulating phosphate level|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6159278	Nae1<tm1c(EUCOMM)Wtsi>	MP:0000267,abnormal heart development|MP:0000274,enlarged heart|MP:0001575,cyanosis|MP:0001625,cardiac hypertrophy|MP:0002206,abnormal CNS synaptic transmission|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002833,increased heart weight|MP:0003201,extremity edema|MP:0004564,increased myocardial fiber size|MP:0005329,abnormal myocardium layer morphology|MP:0005333,decreased heart rate|MP:0005386,behavior/neurological phenotype|MP:0005598,decreased heart ventricle muscle contractility|MP:0008428,abnormal spatial working memory|MP:0009936,abnormal dendritic spine morphology|MP:0010500,myocardium hypoplasia|MP:0010556,thin ventricle myocardium compact layer|MP:0011085,postnatal lethality, complete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0014365,impaired short-term object recognition memory|MP:0014367,impaired long-term object recognition memory|MP:0014518,myocardial hypertrabeculation|MP:0014519,myocardial ventricular hypertrabeculation|MP:0020508,decreased dendritic spine density|MP:0021158,decreased heart left ventricle wall thickness|MP:0031525,thin left ventricle myocardium compact layer
MGI:5816378	Naf1<em1Arman>	MP:0002169,no abnormal phenotype detected|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:4820246	Naga<tm1a(EUCOMM)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level
MGI:3604489	Nagk<Gt(OST125530)Lex>	MP:0002169,no abnormal phenotype detected
MGI:5548501	Nagk<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0013279,increased fasting circulating glucose level
MGI:1934018	Naglu<tm1Efn>	MP:0000026,abnormal inner ear morphology|MP:0000031,abnormal cochlea morphology|MP:0000034,abnormal inner ear vestibule morphology|MP:0000042,abnormal organ of Corti morphology|MP:0000043,organ of Corti degeneration|MP:0000049,abnormal middle ear morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000818,abnormal amygdala morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000830,abnormal diencephalon morphology|MP:0000848,abnormal pons morphology|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000897,abnormal midbrain morphology|MP:0001209,spontaneous skin ulceration|MP:0001263,weight loss|MP:0001270,distended abdomen|MP:0001325,abnormal retina morphology|MP:0001363,increased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001405,impaired coordination|MP:0001511,disheveled coat|MP:0001850,increased susceptibility to otitis media|MP:0002083,premature death|MP:0002446,abnormal macrophage morphology|MP:0002698,abnormal sclera morphology|MP:0002882,abnormal neuron morphology|MP:0003460,decreased fear-related response|MP:0003622,ischuria|MP:0004021,abnormal rod electrophysiology|MP:0004249,abnormal crista ampullaris morphology|MP:0004287,abnormal spiral limbus morphology|MP:0004288,abnormal spiral ligament morphology|MP:0004408,decreased cochlear hair cell number|MP:0004739,conductive hearing loss|MP:0005058,abnormal lysosome morphology|MP:0005105,abnormal middle ear ossicle morphology|MP:0005107,abnormal stapes morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005326,abnormal podocyte morphology|MP:0005551,abnormal eye electrophysiology|MP:0006021,abnormal Reissner membrane morphology|MP:0008114,abnormal Kupffer cell morphology|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment|MP:0008847,abnormal suprachiasmatic nucleus morphology|MP:0009640,abnormal renal tubule epithelium morphology|MP:0009945,abnormal accessory olfactory bulb morphology|MP:0009979,abnormal cerebellum deep nucleus morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0020467,abnormal circadian behavior|MP:0020475,delayed circadian behavior phase
MGI:4834497	Nagpa<tm1Skor>	MP:0003174,increased lysosomal enzyme secretion
MGI:3847452	Nags<tm1(KOMP)Vlcg>	MP:0000416,sparse hair|MP:0001262,decreased body weight|MP:0001386,abnormal maternal nurturing|MP:0005309,increased circulating ammonia level|MP:0005311,abnormal circulating amino acid level|MP:0010768,mortality/aging|MP:0010831,lethality, incomplete penetrance|MP:0011085,postnatal lethality, complete penetrance|MP:0020837,decreased circulating citrulline level
MGI:3620316	Naip1<tm1Aem>	MP:0008235,increased susceptibility to neuronal excitotoxicity
MGI:3604514	Naip1<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3769036	Naip5<Lgn1-s>	MP:0002412,increased susceptibility to bacterial infection
MGI:5789561	Naip5<m1Btlr>	MP:0008658,decreased interleukin-1 beta secretion
MGI:5789559	Naip5<m2Btlr>	MP:0008658,decreased interleukin-1 beta secretion
MGI:3817439	Naip5<tm1Vnce>	MP:0008658,decreased interleukin-1 beta secretion|MP:0012555,decreased cell death
MGI:5755387	Naipc<tm1.1Kmma>	MP:0004499,increased incidence of tumors by chemical induction|MP:0008539,decreased susceptibility to induced colitis|MP:0008658,decreased interleukin-1 beta secretion|MP:0010181,decreased susceptibility to weight loss|MP:0014234,decreased enterocyte apoptosis
MGI:5755386	Naipc<tm1Kmma>	MP:0002006,neoplasm|MP:0004499,increased incidence of tumors by chemical induction|MP:0008539,decreased susceptibility to induced colitis|MP:0010181,decreased susceptibility to weight loss
MGI:5800457	Nalcn<Drl>	MP:0002272,abnormal nervous system electrophysiology|MP:0005386,behavior/neurological phenotype|MP:0012288,abnormal paradoxical sleep pattern|MP:0014623,abnormal brain theta wave pattern|MP:0020467,abnormal circadian behavior
MGI:5806546	Nalcn<em1Iiis>	MP:0012288,abnormal paradoxical sleep pattern
MGI:6158472	Nalcn<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001914,hemorrhage|MP:0002135,abnormal kidney morphology|MP:0003054,spina bifida|MP:0010067,increased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance
MGI:3819820	Nalcn<tm1.1Dren>	MP:0001951,abnormal breathing pattern|MP:0001957,apnea|MP:0002272,abnormal nervous system electrophysiology|MP:0003484,abnormal channel response|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0005403,abnormal nerve conduction|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0011087,neonatal lethality, complete penetrance
MGI:5823777	Nalcn<tm1c(KOMP)Wtsi>	MP:0002272,abnormal nervous system electrophysiology|MP:0002578,impaired ability to fire action potentials|MP:0011083,lethality at weaning, complete penetrance
MGI:6153852	Nalf1<em1(IMPC)H>	MP:0001529,abnormal vocalization|MP:0004357,long tibia|MP:0010392,prolonged QRS complex duration|MP:0011100,preweaning lethality, complete penetrance
MGI:4330782	Nampt<Gt(RRR084)Byg>	MP:0000222,decreased neutrophil cell number|MP:0005166,decreased susceptibility to injury|MP:0008706,decreased interleukin-6 secretion|MP:0011100,preweaning lethality, complete penetrance
MGI:3772777	Nampt<Gt(RRT307)Byg>	MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0011092,embryonic lethality, complete penetrance
MGI:5548712	Nampt<tm1.1(KOMP)Vlcg>	MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3818627	Nampt<tm1Oleo>	MP:0001059,optic nerve atrophy|MP:0001325,abnormal retina morphology|MP:0001823,thymus hypoplasia|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0005548,retina pigment epithelium atrophy|MP:0006035,abnormal mitochondrial morphology|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0011635,abnormal mitochondrial crista morphology|MP:0011965,decreased total retina thickness
MGI:1862023	Nano	MP:0000433,microcephaly|MP:0002938,white spotting|MP:0011100,preweaning lethality, complete penetrance|MP:0030064,small face|MP:0030067,narrow face
MGI:3875053	Nanog<Gt(D042B07)Wrst>	MP:0002718,abnormal inner cell mass morphology|MP:0010380,abnormal inner cell mass apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011185,absent primitive endoderm
MGI:3874467	Nanog<Gt(D047A12)Wrst>	MP:0002718,abnormal inner cell mass morphology|MP:0010380,abnormal inner cell mass apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011185,absent primitive endoderm
MGI:2664492	Nanog<tm1Yam>	MP:0002582,disorganized extraembryonic tissue|MP:0002583,absent extraembryonic ectoderm|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011184,absent embryonic epiblast
MGI:2671008	Nanos1<tm1Ysa>	MP:0002169,no abnormal phenotype detected
MGI:6330714	Nanos2<em1(IMPC)Bay>	MP:0001925,male infertility|MP:0005565,increased blood urea nitrogen level|MP:0011239,abnormal skin coloration
MGI:2682606	Nanos2<tm1Ysa>	MP:0001925,male infertility|MP:0001929,abnormal gametogenesis|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0006362,abnormal male germ cell morphology
MGI:3768177	Nanos2<tm3Ysa>	MP:0001156,abnormal spermatogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0004901,decreased male germ cell number
MGI:2682607	Nanos3<tm1Ysa>	MP:0001116,small gonad|MP:0001127,small ovary|MP:0001925,male infertility|MP:0001926,female infertility|MP:0004806,absent germ cells|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0008392,decreased primordial germ cell number
MGI:7425849	Nanp<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6316200	Nans<em1(IMPC)Tcp>	MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6197066	Nap1l1<em1Jwji>	MP:0003690,abnormal glial cell physiology|MP:0008415,abnormal neurite morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0020394,decreased neuronal precursor proliferation
MGI:5569102	Nap1l2<tm1Ucr>	MP:0010768,mortality/aging
MGI:6273660	Nap1l5<em1(IMPC)J>	MP:0001284,absent vibrissae
MGI:7425850	Napa<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001303,abnormal lens morphology|MP:0001486,abnormal startle reflex|MP:0002060,abnormal skin morphology|MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance
MGI:1856610	Napa<hyh>	MP:0000440,domed cranium|MP:0000780,abnormal corpus callosum morphology|MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000792,abnormal cortical marginal zone morphology|MP:0000825,dilated lateral ventricle|MP:0000826,abnormal third ventricle morphology|MP:0000827,dilated third ventricle|MP:0000841,abnormal hindbrain morphology|MP:0000864,abnormal cerebellum vermis morphology|MP:0000897,abnormal midbrain morphology|MP:0001394,circling|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002200,abnormal brain ventricular system morphology|MP:0002948,abnormal neuron specification|MP:0005377,hearing/vestibular/ear phenotype|MP:0005537,abnormal cerebral aqueduct morphology|MP:0008458,abnormal cortical ventricular zone morphology|MP:0009688,abnormal spinal cord central canal morphology|MP:0010151,abnormal spinal cord ependymal layer morphology|MP:0010152,abnormal brain ependyma morphology
MGI:3036672	Napa<tm1Caw>	MP:0011091,prenatal lethality, complete penetrance
MGI:6120686	Napb<tm1b(EUCOMM)Hmgu>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0004924,abnormal behavior|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020870,decreased thigmotaxis
MGI:4879973	Napb<tm1Bros>	MP:0001393,ataxia|MP:0002064,seizures|MP:0002083,premature death|MP:0004811,abnormal neuron physiology
MGI:5296775	Napepld<tm1.2Ueda>	MP:0002118,abnormal lipid homeostasis
MGI:3695401	Napepld<tm1Crv>	MP:0002152,abnormal brain morphology
MGI:2179260	Naq1<RR>	MP:0001386,abnormal maternal nurturing
MGI:6257548	Nars1<em1(IMPC)Bay>	MP:0001728,failure of embryo implantation|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011100,preweaning lethality, complete penetrance|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:7310304	Nars1<em1Rwb>	MP:0003631,nervous system phenotype|MP:0011092,embryonic lethality, complete penetrance
MGI:7310307	Nars1<em2Rwb>	MP:0003631,nervous system phenotype|MP:0011092,embryonic lethality, complete penetrance
MGI:5790096	Nars2<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0020870,decreased thigmotaxis
MGI:3694795	Nasp<tm1Mgor>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:7585238	Nat10<em2Cya>	MP:0001973,increased thermal nociceptive threshold|MP:0005166,decreased susceptibility to injury|MP:0008469,abnormal protein level|MP:0020955,increased mechanical nociceptive threshold
MGI:5050156	Nat10<tm1a(KOMP)Wtsi>	MP:0001262,decreased body weight|MP:0011092,embryonic lethality, complete penetrance
MGI:3793317	Nat1<Rgsc1523>	MP:0001921,reduced fertility|MP:0005584,abnormal enzyme/coenzyme activity
MGI:2675637	Nat2<tm1Esim>	MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0002092,abnormal eye morphology|MP:0002169,no abnormal phenotype detected|MP:0003078,aphakia|MP:0003720,abnormal neural tube closure|MP:0004179,transmission ratio distortion|MP:0005266,abnormal metabolism
MGI:3843196	Nat3<tm1Dmg>	MP:0002169,no abnormal phenotype detected
MGI:5445781	Nat8f2<tm1.1(KOMP)Vlcg>	MP:0000702,enlarged lymph nodes|MP:0013279,increased fasting circulating glucose level
MGI:5696519	Nat8f5<b2b1702.1Clo>	MP:0000284,double outlet right ventricle|MP:0000531,right pulmonary isomerism|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0000757,herniated abdominal wall|MP:0002192,hydrops fetalis|MP:0003052,omphalocele|MP:0004133,heterotaxia|MP:0008772,increased heart ventricle size|MP:0010412,atrioventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010476,coronary fistula|MP:0010808,right-sided stomach|MP:0010975,abnormal lung lobe morphology|MP:0011666,double outlet right ventricle, ventricular defect committed to aorta|MP:0011668,double outlet right ventricle, Taussig bing type
MGI:5637037	Nat8f5<tm1b(EUCOMM)Wtsi>	MP:0000745,tremors
MGI:5771691	Nat8l<tm1.2Meck>	MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0003631,nervous system phenotype|MP:0005319,abnormal enzyme/coenzyme level|MP:0005386,behavior/neurological phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0014365,impaired short-term object recognition memory
MGI:5444021	Nat8l<tm1Atni>	MP:0001360,abnormal social investigation|MP:0001402,decreased locomotor activity|MP:0001441,increased grooming behavior|MP:0002574,increased vertical activity|MP:0003107,abnormal response to novelty|MP:0011621,abnormal habituation to a novel object
MGI:5548455	Natd1<tm1b(EUCOMM)Wtsi>	MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width
MGI:6377197	Nav1<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000774,decreased brain size|MP:0001399,hyperactivity|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002989,small kidney|MP:0005333,decreased heart rate|MP:0010053,decreased grip strength|MP:0010506,prolonged RR interval|MP:0020421,increased freezing behavior
MGI:6156559	Nav2<em1(IMPC)Tcp>	MP:0000219,increased neutrophil cell number|MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002989,small kidney|MP:0005343,increased circulating aspartate transaminase level
MGI:3054375	Nav2<Gt(OST125046)Lex>	MP:0001263,weight loss|MP:0001330,abnormal optic nerve morphology|MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0001973,increased thermal nociceptive threshold|MP:0001984,abnormal olfaction
MGI:6276948	Nav3<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0002092,abnormal eye morphology
MGI:7606177	Naxd<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity|MP:0001410,head bobbing|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6156822	Naxe<tm1.1Lfan>	MP:0003711,pathological neovascularization|MP:0005385,cardiovascular system phenotype|MP:0005601,increased angiogenesis
MGI:5692800	Naxe<tm1b(EUCOMM)Hmgu>	MP:0001489,decreased startle reflex|MP:0002874,decreased hemoglobin content|MP:0004952,increased spleen weight|MP:0010067,increased red blood cell distribution width
MGI:3529870	Nba10<NZB>	MP:0002743,glomerulonephritis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004829,increased anti-chromatin antibody level|MP:0005615,increased susceptibility to type III hypersensitivity reaction
MGI:3530768	Nba11<NZB>	MP:0002743,glomerulonephritis
MGI:3530766	Nba12<NZB>	MP:0004762,increased anti-double stranded DNA antibody level
MGI:3576908	Nba4<NZB>	MP:0002743,glomerulonephritis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004796,increased anti-histone antibody level|MP:0008502,increased IgG3 level
MGI:3529872	Nba5<NZB>	MP:0002743,glomerulonephritis|MP:0005615,increased susceptibility to type III hypersensitivity reaction
MGI:3530052	Nba8<NZB>	MP:0002743,glomerulonephritis
MGI:5548607	Nbas<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0008259,abnormal optic disk morphology|MP:0010025,decreased total body fat amount|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:6414490	Nbea<em1(IMPC)Bay>	MP:0000063,decreased bone mineral density|MP:0000111,cleft palate|MP:0001697,abnormal embryo size|MP:0003385,abnormal body wall morphology|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:4130191	Nbea<Gt(RRK418)Byg>	MP:0001404,no spontaneous movement|MP:0001491,unresponsive to tactile stimuli|MP:0001575,cyanosis|MP:0002206,abnormal CNS synaptic transmission|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004792,abnormal synaptic vesicle number|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0006320,abnormal interscapular fat pad morphology|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0009538,abnormal synapse morphology|MP:0010146,umbilical hernia|MP:0011087,neonatal lethality, complete penetrance|MP:0014379,decreased excitatory postsynaptic current frequency|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude
MGI:5583020	Nbeal2<gps>	MP:0000222,decreased neutrophil cell number|MP:0003179,thrombocytopenia|MP:0020399,enhanced megakaryocyte emperipolesis|MP:0020431,decreased platelet alpha-granule number
MGI:4461705	Nbeal2<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0000229,abnormal megakaryocyte differentiation|MP:0000691,enlarged spleen|MP:0001273,decreased metastatic potential|MP:0001846,increased inflammatory response|MP:0002417,abnormal megakaryocyte morphology|MP:0002599,increased mean platelet volume|MP:0003179,thrombocytopenia|MP:0003405,abnormal platelet shape|MP:0004720,abnormal platelet morphology|MP:0010124,decreased bone mineral content|MP:0011747,myelofibrosis|MP:0020431,decreased platelet alpha-granule number
MGI:5007262	Nbeal2<tm1Lex>	MP:0000691,enlarged spleen|MP:0001792,impaired wound healing|MP:0002417,abnormal megakaryocyte morphology|MP:0003179,thrombocytopenia|MP:0004720,abnormal platelet morphology|MP:0005164,abnormal response to injury|MP:0005606,increased bleeding time|MP:0006058,decreased cerebral infarct size|MP:0006298,abnormal platelet activation|MP:0008254,increased megakaryocyte cell number|MP:0009549,decreased platelet aggregation|MP:0012197,impaired myofibroblast differentiation|MP:0020399,enhanced megakaryocyte emperipolesis|MP:0020431,decreased platelet alpha-granule number|MP:0031120,decreased susceptibility to induced thrombosis
MGI:4452356	Nbea<Tg(GH1)240BNec>	MP:0000738,impaired muscle contractility|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001360,abnormal social investigation|MP:0001402,decreased locomotor activity|MP:0001404,no spontaneous movement|MP:0001441,increased grooming behavior|MP:0001463,abnormal spatial learning|MP:0001491,unresponsive to tactile stimuli|MP:0001575,cyanosis|MP:0002176,increased brain weight|MP:0002557,abnormal social/conspecific interaction behavior|MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype|MP:0003816,abnormal pituitary gland development|MP:0004835,abnormal miniature endplate potential|MP:0006320,abnormal interscapular fat pad morphology|MP:0009453,enhanced contextual conditioning behavior|MP:0011087,neonatal lethality, complete penetrance
MGI:2385843	Nbl1<tm1Rmh>	MP:0002169,no abnormal phenotype detected
MGI:3042574	Nbl1<tm1Saki>	MP:0001970,abnormal pain threshold
MGI:2385845	Nbl1<tm2Rmh>	MP:0002169,no abnormal phenotype detected
MGI:6771579	Nbn<em1Jpt>	MP:0010768,mortality/aging
MGI:6771580	Nbn<em2Jpt>	MP:0010768,mortality/aging
MGI:6771581	Nbn<em3Jpt>	MP:0002006,neoplasm|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0010768,mortality/aging
MGI:6771582	Nbn<em4Jpt>	MP:0002006,neoplasm|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0010768,mortality/aging
MGI:6771583	Nbn<em5Jpt>	MP:0011091,prenatal lethality, complete penetrance
MGI:6771584	Nbn<em6Jpt>	MP:0011091,prenatal lethality, complete penetrance
MGI:6771585	Nbn<em7Jpt>	MP:0011091,prenatal lethality, complete penetrance
MGI:3505757	Nbn<tm1.1Md>	MP:0011091,prenatal lethality, complete penetrance
MGI:2183796	Nbn<tm1Jpt>	MP:0002006,neoplasm|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0004028,chromosome breakage|MP:0004045,abnormal cell cycle checkpoint function|MP:0005384,cellular phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype
MGI:2156049	Nbn<tm1Nus>	MP:0001698,decreased embryo size|MP:0002006,neoplasm|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002583,absent extraembryonic ectoderm|MP:0003988,disorganized embryonic tissue|MP:0004965,inner cell mass degeneration|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011184,absent embryonic epiblast|MP:0011198,absent proamniotic cavity|MP:0012113,decreased inner cell mass proliferation
MGI:2182645	Nbn<tm1Xu>	MP:0001262,decreased body weight|MP:0001658,increased mortality induced by gamma-irradiation|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0001926,female infertility|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002024,increased T cell derived lymphoma incidence|MP:0002421,abnormal cell-mediated immunity|MP:0002777,absent ovarian follicles|MP:0003077,abnormal cell cycle|MP:0003631,nervous system phenotype|MP:0004805,absent oocytes|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0011704,decreased fibroblast proliferation|MP:0013236,ovary degeneration
MGI:2682000	Nbn<tm1Zqw>	MP:0001658,increased mortality induced by gamma-irradiation|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0003324,increased liver adenoma incidence|MP:0003496,increased thyroid adenoma incidence|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0004965,inner cell mass degeneration|MP:0005028,abnormal trophectoderm morphology|MP:0006042,increased apoptosis|MP:0008866,chromosomal instability|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009590,increased gonad tumor incidence|MP:0009591,increased liver adenocarcinoma incidence|MP:0009592,increased Leydig cell tumor incidence|MP:0010308,decreased tumor latency|MP:0010380,abnormal inner cell mass apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation|MP:0012431,increased lymphoma incidence
MGI:3771078	Nbn<tm2.1Jpt>	MP:0004228,decreased cellular sensitivity to ionizing radiation induced cell death
MGI:3578645	Nbn<tm2Zqw>	MP:0000168,abnormal bone marrow development|MP:0000221,decreased leukocyte cell number|MP:0000745,tremors|MP:0000852,small cerebellum|MP:0000853,absent cerebellar foliation|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001409,increased stereotypic behavior|MP:0001525,impaired balance|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality|MP:0002175,decreased brain weight|MP:0002182,abnormal astrocyte morphology|MP:0002690,akinesia|MP:0002875,decreased erythrocyte cell number|MP:0003492,abnormal involuntary movement|MP:0009937,abnormal neuron differentiation
MGI:3831174	Nbn<tm3Jpt>	MP:0004228,decreased cellular sensitivity to ionizing radiation induced cell death
MGI:4837426	Nbr1<tm1.1Jmos>	MP:0001876,decreased inflammatory response|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008567,decreased interferon-gamma secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion
MGI:5548384	Nbr1<tm1b(KOMP)Wtsi>	MP:0005293,impaired glucose tolerance
MGI:4819974	Nbr1<tm1Whca>	MP:0000062,increased bone mineral density|MP:0001541,abnormal osteoclast physiology|MP:0003795,abnormal bone structure|MP:0005605,increased bone mass|MP:0008158,increased diameter of femur|MP:0008160,increased diameter of humerus|MP:0008395,abnormal osteoblast differentiation|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0010929,increased osteoid thickness|MP:0013631,decreased bone trabecular spacing|MP:0020011,increased bone mineral density of femur|MP:0020039,increased bone ossification
MGI:3573888	Nbwa1<NZB>	MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004829,increased anti-chromatin antibody level
MGI:3573891	Nbwa2<NZB>	MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002743,glomerulonephritis|MP:0004801,increased susceptibility to systemic lupus erythematosus
MGI:3573892	Nbwa2<NZW>	MP:0004762,increased anti-double stranded DNA antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus
MGI:5468989	Ncald<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0000774,decreased brain size|MP:0000807,abnormal hippocampus morphology|MP:0000825,dilated lateral ventricle|MP:0000913,abnormal brain development|MP:0000920,abnormal myelination|MP:0001262,decreased body weight|MP:0001319,irregularly shaped pupil|MP:0001399,hyperactivity|MP:0001921,reduced fertility|MP:0002079,increased circulating insulin level|MP:0002175,decreased brain weight|MP:0002546,mydriasis|MP:0002702,decreased circulating free fatty acids level|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003063,increased coping response|MP:0003631,nervous system phenotype|MP:0003651,abnormal axon extension|MP:0003795,abnormal bone structure|MP:0004924,abnormal behavior|MP:0005378,growth/size/body region phenotype|MP:0005565,increased blood urea nitrogen level|MP:0005633,increased circulating sodium level|MP:0006009,abnormal neuronal migration|MP:0006243,impaired pupillary reflex|MP:0008283,small hippocampus|MP:0008535,enlarged lateral ventricles|MP:0008948,decreased neuron number|MP:0009142,decreased prepulse inhibition|MP:0010097,abnormal retina blood vessel morphology|MP:0010124,decreased bone mineral content|MP:0011396,abnormal sleep behavior|MP:0011827,impaired neuron differentiation|MP:0014812,abnormal brain physiology|MP:0020870,decreased thigmotaxis|MP:0030981,abnormal dentate gyrus subgranular zone morphology
MGI:5475137	Ncald<tm1Rsha>	MP:0006144,increased systemic arterial systolic blood pressure|MP:0011100,preweaning lethality, complete penetrance
MGI:3574595	Ncam1<tm1.1Mag>	MP:0005386,behavior/neurological phenotype
MGI:1857222	Ncam1<tm1Cgn>	MP:0000774,decreased brain size|MP:0000952,abnormal CNS glial cell morphology|MP:0001463,abnormal spatial learning|MP:0002090,abnormal vision|MP:0002741,small olfactory bulb|MP:0002983,increased retina ganglion cell number|MP:0004021,abnormal rod electrophysiology|MP:0006149,decreased visual acuity|MP:0006309,decreased retina ganglion cell number|MP:0008508,thick retina ganglion layer|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008519,thin retina outer plexiform layer|MP:0009937,abnormal neuron differentiation|MP:0011963,abnormal total retina thickness|MP:0014265,thick retina inner plexiform layer|MP:0020468,abnormal circadian behavior period|MP:0020470,shortened circadian behavior period|MP:0020473,abnormal circadian behavior phase
MGI:3665409	Ncam1<tm1Klc>	MP:0002741,small olfactory bulb|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0008267,abnormal hippocampus CA3 region morphology
MGI:2182406	Ncam1<tm1Mag>	MP:0000819,abnormal olfactory bulb morphology|MP:0000849,abnormal cerebellum morphology|MP:0001325,abnormal retina morphology|MP:0002741,small olfactory bulb|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0020470,shortened circadian behavior period
MGI:3575008	Ncam1<tm1Msch>	MP:0001473,reduced long-term potentiation|MP:0001899,absent long-term depression|MP:0005386,behavior/neurological phenotype
MGI:2182407	Ncam1<tm2Mag>	MP:0011091,prenatal lethality, complete penetrance
MGI:3529671	Ncam2<Gt(OST370191)Lex>	MP:0002169,no abnormal phenotype detected
MGI:5825282	Ncam2<tm1.1Bdrt>	MP:0003631,nervous system phenotype|MP:0009967,abnormal neuron proliferation
MGI:6120818	Ncam2<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment|MP:0002753,dilated heart left ventricle|MP:0002968,increased circulating alkaline phosphatase level|MP:0005011,increased eosinophil cell number|MP:0005140,decreased cardiac muscle contractility|MP:0009142,decreased prepulse inhibition
MGI:3663377	Ncam2<tm1Mom>	MP:0000819,abnormal olfactory bulb morphology|MP:0001983,abnormal olfactory system physiology
MGI:2182148	Ncan<tm1Ref>	MP:0002207,abnormal long-term potentiation
MGI:2182149	Ncan<tm2Ref>	MP:0002207,abnormal long-term potentiation
MGI:2182151	Ncan<tm3Ref>	MP:0002207,abnormal long-term potentiation
MGI:7384854	Ncapd2<em1Cya>	MP:0004502,decreased incidence of tumors by chemical induction|MP:0008539,decreased susceptibility to induced colitis
MGI:6357830	Ncapd3<em1(IMPC)J>	MP:0001556,increased circulating HDL cholesterol level|MP:0001566,increased circulating phosphate level|MP:0005178,increased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:3039486	Ncapg2<tm1Jdc>	MP:0001694,absent egg cylinders|MP:0010380,abnormal inner cell mass apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:3710093	Ncaph2<nes>	MP:0000433,microcephaly|MP:0000715,decreased thymocyte number|MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0001823,thymus hypoplasia|MP:0002175,decreased brain weight|MP:0002371,abnormal thymus cortex morphology|MP:0002407,abnormal double-negative T cell morphology|MP:0004046,abnormal mitosis|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008037,abnormal T cell morphology|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008826,abnormal splenic cell ratio|MP:0008827,abnormal thymus cell ratio|MP:0009543,abnormal thymus corticomedullary boundary morphology|MP:0020066,abnormal neocortex size
MGI:5703870	Ncaph2<tm1.2Hiran>	MP:0011092,embryonic lethality, complete penetrance
MGI:4433039	Ncaph2<tm1a(EUCOMM)Wtsi>	MP:0008806,increased circulating amylase level
MGI:5703876	Ncaph<tm1.2Hiran>	MP:0011092,embryonic lethality, complete penetrance
MGI:5788506	Ncbp1<em1(IMPC)J>	MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:5789874	Ncbp2<em1(IMPC)J>	MP:0001363,increased anxiety-related response|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5637019	Ncbp3<tm1b(EUCOMM)Wtsi>	MP:0000274,enlarged heart|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2678444	Ncdn<Gt(pT1Betageo)6Flo>	MP:0013454,lacrimal gland hypertrophy
MGI:4420954	Ncdn<tm1.1Mfla>	MP:0001473,reduced long-term potentiation|MP:0001475,reduced long-term depression|MP:0008911,induced hyperactivity|MP:0009142,decreased prepulse inhibition|MP:0009746,enhanced behavioral response to xenobiotic
MGI:2681104	Ncdn<tm1Afu>	MP:0000131,abnormal long bone epiphysis morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000166,abnormal chondrocyte morphology|MP:0001672,abnormal embryo development|MP:0004173,abnormal intervertebral disk morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3586335	Ncdn<tm2Afu>	MP:0000812,abnormal dentate gyrus morphology|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0002064,seizures|MP:0002182,abnormal astrocyte morphology|MP:0014746,abnormal hippocampal mossy fiber innervation pattern
MGI:4359388	Nceh1<tm1Ishi>	MP:0002451,abnormal macrophage physiology|MP:0003193,decreased cholesterol efflux|MP:0005278,abnormal cholesterol homeostasis
MGI:3629327	Nceh1<tm1Jcsd>	MP:0008875,abnormal xenobiotic pharmacokinetics
MGI:6276933	Ncf1<em1(IMPC)Mbp>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000266,abnormal heart morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001175,abnormal lung morphology|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0003604,single kidney|MP:0004924,abnormal behavior|MP:0008725,increased heart atrium size|MP:0020870,decreased thigmotaxis
MGI:7464912	Ncf1<em1Nansh>	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:2661962	Ncf1<m1J>	MP:0002451,abnormal macrophage physiology|MP:0003674,oxidative stress|MP:0005074,impaired granulocyte bactericidal activity|MP:0020947,decreased susceptibility to Orthomyxoviridae infection
MGI:3576788	Ncf1<tm1Hbd>	MP:0001175,abnormal lung morphology|MP:0001212,skin lesions|MP:0002463,abnormal neutrophil physiology|MP:0002500,granulomatous inflammation|MP:0002928,abnormal bile duct morphology|MP:0003332,liver abscess|MP:0004003,abnormal vascular endothelial cell physiology|MP:0005387,immune system phenotype
MGI:1934143	Ncf1<tm1Shl>	MP:0000260,abnormal angiogenesis|MP:0000266,abnormal heart morphology|MP:0000343,abnormal response to cardiac infarction|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0001731,abnormal postnatal growth|MP:0001845,abnormal inflammatory response|MP:0002406,increased susceptibility to infection|MP:0002500,granulomatous inflammation|MP:0002753,dilated heart left ventricle|MP:0002842,increased systemic arterial blood pressure|MP:0002972,abnormal cardiac muscle contractility|MP:0003008,enhanced long-term potentiation|MP:0003026,decreased vasoconstriction|MP:0003184,increased angiotensin I-converting enzyme activity|MP:0003313,abnormal locomotor activation|MP:0003352,increased circulating renin level|MP:0003449,abnormal intestine goblet cell morphology|MP:0004883,abnormal vascular wound healing|MP:0005025,abnormal response to infection|MP:0005088,increased acute inflammation|MP:0005595,abnormal vascular smooth muscle physiology|MP:0009456,impaired cued conditioning behavior|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:4432766	Ncf2<tm1a(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0002599,increased mean platelet volume|MP:0004974,decreased regulatory T cell number|MP:0005018,decreased T cell number|MP:0005478,decreased circulating thyroxine level|MP:0008040,decreased NK T cell number|MP:0008045,decreased NK cell number|MP:0008810,increased circulating iron level|MP:0010053,decreased grip strength|MP:0012765,decreased alpha-beta T cell number|MP:0012767,increased KLRG1-positive NK cell number
MGI:6153187	Ncf2<tm1b(EUCOMM)Wtsi>	MP:0001829,increased activated T cell number|MP:0001861,lung inflammation|MP:0002083,premature death|MP:0002359,abnormal spleen germinal center morphology|MP:0002962,increased urine protein level|MP:0003186,abnormal redox activity|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005325,abnormal renal glomerulus morphology|MP:0005399,increased susceptibility to fungal infection|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008173,increased follicular B cell number|MP:0008177,increased germinal center B cell number|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010835,increased CD4-positive, alpha-beta memory T cell number|MP:0011338,abnormal mesangial matrix morphology|MP:0011425,abnormal kidney interstitium morphology|MP:0011506,glomerular crescent|MP:0020518,renal glomerular protein deposits|MP:0020519,renal glomerular immunoglobulin deposits
MGI:5692579	Ncf4<tm1b(KOMP)Wtsi>	MP:0008806,increased circulating amylase level
MGI:3701805	Ncf4<tm1Pth>	MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3712357	Ncf4<tm2Pth>	MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology
MGI:3045607	Ncilt<C57BL/10J>	MP:0002006,neoplasm
MGI:5708180	Nck1<tm1b(EUCOMM)Wtsi>	MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005343,increased circulating aspartate transaminase level
MGI:2667151	Nck1<tm1Paw>	MP:0002169,no abnormal phenotype detected
MGI:2667153	Nck2<tm1Paw>	MP:0002169,no abnormal phenotype detected
MGI:2667154	Nck2<tm2Paw>	MP:0002169,no abnormal phenotype detected
MGI:4330168	Nckap1<Gt(RRQ139)Byg>	MP:0003091,abnormal cell migration|MP:0006042,increased apoptosis|MP:0011255,abnormal anterior visceral endoderm cell migration
MGI:3707168	Nckap1<Gt(XE068)Byg>	MP:0000267,abnormal heart development|MP:0001688,abnormal somite development|MP:0001726,abnormal allantois morphology|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0002151,abnormal neural tube morphology|MP:0003119,abnormal digestive system development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012156,rostral-caudal axis duplication
MGI:3707169	Nckap1<Gt(XE133)Byg>	MP:0000267,abnormal heart development|MP:0001688,abnormal somite development|MP:0001726,abnormal allantois morphology|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0002151,abnormal neural tube morphology|MP:0003119,abnormal digestive system development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012156,rostral-caudal axis duplication
MGI:3578145	Nckap1<khlo>	MP:0000474,abnormal foregut morphology|MP:0000929,open neural tube|MP:0001680,abnormal mesoderm development|MP:0001685,abnormal endoderm development|MP:0001701,incomplete embryo turning|MP:0001726,abnormal allantois morphology|MP:0001730,embryonic growth arrest|MP:0002230,abnormal primitive streak formation|MP:0002231,abnormal primitive streak morphology|MP:0004187,cardia bifida|MP:0008029,abnormal paraxial mesoderm morphology|MP:0009657,failure of chorioallantoic fusion|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011255,abnormal anterior visceral endoderm cell migration|MP:0011732,decreased somite size|MP:0012156,rostral-caudal axis duplication
MGI:6283866	Nckap1l<m1Btlr>	MP:0001262,decreased body weight|MP:0005017,decreased B cell number|MP:0008045,decreased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010848,decreased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0012764,increased alpha-beta T cell number|MP:0012765,decreased alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:3818728	Nckap1l<m1Iri>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000314,schistocytosis|MP:0000598,abnormal liver morphology|MP:0000604,amyloidosis|MP:0000693,spleen hyperplasia|MP:0001798,impaired macrophage phagocytosis|MP:0001823,thymus hypoplasia|MP:0001853,heart inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002367,abnormal thymus lobule morphology|MP:0002401,abnormal lymphopoiesis|MP:0002467,impaired neutrophil phagocytosis|MP:0002591,decreased mean corpuscular volume|MP:0002631,abnormal epididymis morphology|MP:0002640,reticulocytosis|MP:0002643,poikilocytosis|MP:0002722,abnormal immune system organ morphology|MP:0003141,cardiac fibrosis|MP:0004733,abnormal thoracic cavity morphology|MP:0004972,abnormal regulatory T cell number|MP:0005016,decreased lymphocyte cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0005325,abnormal renal glomerulus morphology|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008101,lymph node hypoplasia|MP:0008211,decreased mature B cell number|MP:0008354,decreased mature gamma-delta T cell number|MP:0008388,hypochromic microcytic anemia|MP:0008560,increased tumor necrosis factor secretion|MP:0008596,increased circulating interleukin-6 level|MP:0008614,increased circulating interleukin-17 level|MP:0008681,increased interleukin-17 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008720,impaired neutrophil chemotaxis|MP:0008801,abnormal erythroid progenitor cell morphology|MP:0010176,dacryocytosis|MP:0010177,acanthocytosis|MP:0031085,increased erythrocyte osmotic fragility
MGI:4442818	Nckipsd<tm1.2Toft>	MP:0000358,abnormal cell morphology|MP:0003091,abnormal cell migration|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0014698,decreased fibroblast adhesion
MGI:3846741	Nckipsd<tm1Wkso>	MP:0002882,abnormal neuron morphology|MP:0020849,abnormal actin cytoskeleton morphology
MGI:6842504	Ncl<em1Mfz>	MP:0003651,abnormal axon extension|MP:0011100,preweaning lethality, complete penetrance
MGI:7543678	Ncln<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:3664107	Ncoa1<tm1.1Hkaw>	MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0001261,obese|MP:0001940,testis hypoplasia|MP:0002780,decreased circulating testosterone level|MP:0002968,increased circulating alkaline phosphatase level|MP:0002998,abnormal bone remodeling|MP:0004992,increased bone resorption|MP:0005182,increased circulating estradiol level|MP:0005669,increased circulating leptin level|MP:0009643,abnormal urine homeostasis|MP:0010124,decreased bone mineral content|MP:0010876,decreased bone volume|MP:0020010,decreased bone mineral density of femur
MGI:5708185	Ncoa1<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0005630,increased lung weight|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content|MP:0013278,decreased fasting circulating glucose level
MGI:2183532	Ncoa1<tm1Bwo>	MP:0000628,abnormal mammary gland development|MP:0000849,abnormal cerebellum morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000877,abnormal Purkinje cell morphology|MP:0001119,abnormal female reproductive system morphology|MP:0001145,abnormal male reproductive system morphology|MP:0001147,small testis|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0002774,small prostate gland|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003845,abnormal decidualization|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005468,abnormal thyroid hormone level|MP:0005470,increased thyroxine level|MP:0005474,increased triiodothyronine level|MP:0005477,increased circulating thyroxine level|MP:0005480,increased circulating triiodothyronine level
MGI:3664106	Ncoa1<tm1Hkaw>	MP:0002169,no abnormal phenotype detected
MGI:3641219	Ncoa1<tm1Jkr>	MP:0002169,no abnormal phenotype detected
MGI:6377204	Ncoa2<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001404,no spontaneous movement|MP:0001711,abnormal placenta morphology|MP:0001725,abnormal umbilical cord morphology|MP:0002060,abnormal skin morphology|MP:0002079,increased circulating insulin level|MP:0002111,abnormal tail morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003231,abnormal placenta vasculature|MP:0003385,abnormal body wall morphology|MP:0004738,abnormal auditory brainstem response|MP:0004924,abnormal behavior|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020870,decreased thigmotaxis
MGI:2183799	Ncoa2<tm1.1Ipc>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0001728,failure of embryo implantation|MP:0001926,female infertility|MP:0003845,abnormal decidualization|MP:0005389,reproductive system phenotype
MGI:2183803	Ncoa2<tm1.2Ipc>	MP:0001146,abnormal testis morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001919,abnormal reproductive system physiology|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002160,abnormal reproductive system morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0002631,abnormal epididymis morphology|MP:0002784,abnormal Sertoli cell morphology|MP:0004852,decreased testis weight|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0006416,abnormal rete testis morphology|MP:0009231,detached acrosome
MGI:4818421	Ncoa3<tm1.1Bwo>	MP:0001260,increased body weight|MP:0001402,decreased locomotor activity|MP:0001431,abnormal eating behavior|MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002332,abnormal exercise endurance|MP:0002696,decreased circulating glucagon level|MP:0003620,oliguria|MP:0003866,abnormal defecation|MP:0003953,abnormal hormone level|MP:0004499,increased incidence of tumors by chemical induction|MP:0004702,increased circulating insulin-like growth factor I level|MP:0004893,decreased adiponectin level|MP:0005076,abnormal cell differentiation|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005534,decreased body temperature|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0008964,decreased carbon dioxide production|MP:0009355,increased liver triglyceride level|MP:0010024,increased total body fat amount|MP:0010400,increased liver glycogen level|MP:0011049,impaired adaptive thermogenesis
MGI:5692598	Ncoa3<tm1b(EUCOMM)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0002100,abnormal tooth morphology|MP:0003179,thrombocytopenia|MP:0005293,impaired glucose tolerance|MP:0005344,increased circulating bilirubin level|MP:0005561,increased mean corpuscular hemoglobin|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1931860	Ncoa3<tm1Jxu>	MP:0000003,abnormal adipose tissue morphology|MP:0000186,decreased circulating HDL cholesterol level|MP:0000218,increased leukocyte cell number|MP:0000601,small liver|MP:0000628,abnormal mammary gland development|MP:0000662,abnormal branching of the mammary ductal tree|MP:0000691,enlarged spleen|MP:0001140,abnormal vagina epithelium morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0001935,decreased litter size|MP:0001938,delayed sexual maturation|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0002356,abnormal spleen red pulp morphology|MP:0002401,abnormal lymphopoiesis|MP:0002427,disproportionate dwarf|MP:0002636,delayed vaginal opening|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003179,thrombocytopenia|MP:0003402,decreased liver weight|MP:0003699,abnormal female reproductive system physiology|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004889,increased energy expenditure|MP:0004939,abnormal B cell morphology|MP:0005013,increased lymphocyte cell number|MP:0005014,increased B cell number|MP:0005076,abnormal cell differentiation|MP:0005150,cachexia|MP:0005154,increased B cell proliferation|MP:0005179,decreased circulating cholesterol level|MP:0005181,decreased circulating estradiol level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005348,increased T cell proliferation|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0006319,abnormal epididymal fat pad morphology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008483,increased spleen germinal center size|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008596,increased circulating interleukin-6 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008658,decreased interleukin-1 beta secretion|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0008963,increased carbon dioxide production|MP:0009006,prolonged estrous cycle|MP:0009116,abnormal brown fat cell morphology|MP:0009125,decreased brown fat cell lipid droplet size|MP:0009133,decreased white fat cell size|MP:0009136,decreased brown fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009341,decreased splenocyte apoptosis|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010025,decreased total body fat amount|MP:0010179,rough coat|MP:0010378,increased respiratory quotient|MP:0011049,impaired adaptive thermogenesis|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011630,increased mitochondrial size|MP:0011708,decreased fibroblast cell migration|MP:0012106,impaired exercise endurance|MP:0012431,increased lymphoma incidence|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis|MP:0031420,decreased superovulation rate
MGI:1931861	Ncoa3<tm1Rsd>	MP:0000024,lowered ear position|MP:0000352,decreased cell proliferation|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005379,endocrine/exocrine gland phenotype|MP:0005621,abnormal cell physiology
MGI:4462057	Ncoa3<tm2.1Jxu>	MP:0002169,no abnormal phenotype detected
MGI:4462058	Ncoa3<tm2.2Jxu>	MP:0001262,decreased body weight|MP:0004701,decreased circulating insulin-like growth factor I level
MGI:5660201	Ncoa4<tm1Msnt>	MP:0008008,early cellular replicative senescence|MP:0008057,abnormal DNA replication|MP:0011704,decreased fibroblast proliferation
MGI:5637765	Ncoa5<tm1.1(KOMP)Mbp>	MP:0002833,increased heart weight|MP:0005011,increased eosinophil cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5581698	Ncoa5<tm1Hxia>	MP:0000598,abnormal liver morphology|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0002628,hepatic steatosis|MP:0002675,asthenozoospermia|MP:0002941,increased circulating alanine transaminase level|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003333,liver fibrosis|MP:0003887,increased hepatocyte apoptosis|MP:0003893,increased hepatocyte proliferation|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005416,abnormal circulating protein level|MP:0005578,teratozoospermia|MP:0009168,decreased pancreatic islet number|MP:0009172,small pancreatic islets|MP:0009230,abnormal sperm head morphology|MP:0009355,increased liver triglyceride level|MP:0009831,abnormal sperm midpiece morphology|MP:0013279,increased fasting circulating glucose level|MP:0014190,abnormal epididymis physiology|MP:0014465,abnormal sperm mitochondrial morphology|MP:0020451,decreased sperm progressive motility|MP:0031301,chronic liver inflammation
MGI:5607863	Ncoa6<em1(IMPC)J>	MP:0001325,abnormal retina morphology|MP:0010025,decreased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2448999	Ncoa6<tm1.1Jkr>	MP:0000266,abnormal heart morphology|MP:0000295,trabecula carnea hypoplasia|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000606,decreased hepatocyte number|MP:0000913,abnormal brain development|MP:0001324,abnormal eye pigmentation|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0002110,abnormal digit morphology|MP:0003057,abnormal epicardium morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0003396,abnormal embryonic hematopoiesis|MP:0003717,pallor|MP:0003887,increased hepatocyte apoptosis|MP:0003984,embryonic growth retardation|MP:0004057,thin myocardium compact layer|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004938,dilated vasculature|MP:0005031,abnormal trophoblast layer morphology|MP:0005294,abnormal heart ventricle morphology|MP:0005329,abnormal myocardium layer morphology|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0008973,decreased erythroid progenitor cell number|MP:0009887,abnormal palatal shelf fusion at midline|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0012235,abnormal liver bud morphology|MP:0031589,detached epicardium
MGI:3046462	Ncoa6<tm1Hhs>	MP:0000259,abnormal vascular development|MP:0000267,abnormal heart development|MP:0000379,decreased hair follicle number|MP:0000596,abnormal liver development|MP:0000913,abnormal brain development|MP:0001219,thick epidermis|MP:0001698,decreased embryo size|MP:0001792,impaired wound healing|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0002908,delayed wound healing|MP:0005389,reproductive system phenotype|MP:0005621,abnormal cell physiology|MP:0006372,impaired placental function|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0013191,increased sebaceous gland number|MP:0013501,increased fibroblast apoptosis|MP:0014281,hindlimb oligodactyly
MGI:2448995	Ncoa6<tm1Jkr>	MP:0000266,abnormal heart morphology|MP:0000628,abnormal mammary gland development|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001547,abnormal lipid level|MP:0001625,cardiac hypertrophy|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0004090,abnormal sarcomere morphology|MP:0004937,dilated heart|MP:0005140,decreased cardiac muscle contractility|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0006270,abnormal mammary gland growth during lactation|MP:0011629,decreased mitochondrial number|MP:0011925,abnormal heart echocardiography feature|MP:0013716,hypolactation|MP:0013782,abnormal mammary duct terminal end bud morphology
MGI:2445463	Ncoa6<tm1Jxu>	MP:0000280,thin ventricular wall|MP:0000295,trabecula carnea hypoplasia|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0002190,disorganized myocardium|MP:0002740,heart hypoplasia|MP:0003403,absent placental labyrinth|MP:0003984,embryonic growth retardation|MP:0005033,abnormal trophoblast giant cell morphology|MP:0005312,pericardial effusion|MP:0009397,increased trophoblast giant cell number|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0011531,abnormal syncytiotrophoblast morphology|MP:0014678,increased erythrophagocytosis|MP:0030989,decreased spongiotrophoblast cell number
MGI:2450859	Ncoa6<tm1Pera>	MP:0000280,thin ventricular wall|MP:0000295,trabecula carnea hypoplasia|MP:0000827,dilated third ventricle|MP:0000837,abnormal hypothalamus morphology|MP:0001711,abnormal placenta morphology|MP:0001889,delayed brain development|MP:0002190,disorganized myocardium|MP:0002652,thin myocardium|MP:0003231,abnormal placenta vasculature|MP:0003451,absent olfactory bulb|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0008948,decreased neuron number|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012099,decreased spongiotrophoblast size|MP:0020527,small thalamus
MGI:3769253	Ncoa6<tm2Jxu>	MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0002118,abnormal lipid homeostasis|MP:0002981,increased liver weight|MP:0003868,abnormal feces composition|MP:0005178,increased circulating cholesterol level|MP:0005365,abnormal bile salt homeostasis|MP:0005389,reproductive system phenotype|MP:0011969,abnormal circulating triglyceride level
MGI:4837690	Ncoa6<tm3.1Jxu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001306,small lens
MGI:4837687	Ncoa6<tm3Jxu>	MP:0001304,cataract|MP:0001306,small lens|MP:0001926,female infertility|MP:0003845,abnormal decidualization|MP:0009662,abnormal uterine receptivity|MP:0009664,abnormal luminal closure
MGI:6714028	Ncoa7<em1Pelo>	MP:0000788,abnormal cerebral cortex morphology|MP:0001363,increased anxiety-related response|MP:0003172,abnormal lysosome physiology|MP:0003631,nervous system phenotype|MP:0005058,abnormal lysosome morphology|MP:0005386,behavior/neurological phenotype|MP:0009349,increased urine pH|MP:0020358,abnormal inhibitory synapse morphology|MP:0020395,abnormal response to social novelty
MGI:5695956	Ncoa7<tm1.1(KOMP)Vlcg>	MP:0001488,increased startle reflex
MGI:5587819	Ncor1<tm1.1Anh>	MP:0001262,decreased body weight|MP:0002833,increased heart weight|MP:0003503,decreased activity of thyroid gland|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003915,increased heart left ventricle weight|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005333,decreased heart rate|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005386,behavior/neurological phenotype|MP:0005469,abnormal thyroxine level|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level|MP:0010025,decreased total body fat amount|MP:0010768,mortality/aging
MGI:5305235	Ncor1<tm1.1Ics>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000348,abnormal aerobic fitness|MP:0000759,abnormal skeletal muscle morphology|MP:0002106,abnormal muscle physiology|MP:0002628,hepatic steatosis|MP:0003081,abnormal soleus morphology|MP:0003082,abnormal gastrocnemius morphology|MP:0003948,abnormal gas homeostasis|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0009401,increased skeletal muscle fiber diameter|MP:0010225,abnormal quadriceps morphology|MP:0010379,decreased respiratory quotient|MP:0010398,decreased liver glycogen level|MP:0012107,enhanced exercise endurance|MP:0014344,abnormal skeletal muscle fiber mitochondrial morphology|MP:0014652,increased skeletal muscle fiber mitochondrial size|MP:0020523,decreased susceptibility to induced hypothermia|MP:0031391,increased locomotor activity
MGI:3821874	Ncor1<tm1Anh>	MP:0000183,decreased circulating LDL cholesterol level|MP:0005478,decreased circulating thyroxine level
MGI:3831119	Ncor1<tm1Laz>	MP:0000003,abnormal adipose tissue morphology|MP:0001262,decreased body weight|MP:0001554,increased circulating free fatty acids level|MP:0002078,abnormal glucose homeostasis|MP:0002575,increased circulating ketone body level|MP:0002891,increased insulin sensitivity|MP:0003461,abnormal response to novel object|MP:0005289,increased oxygen consumption|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008965,increased basal metabolism|MP:0009133,decreased white fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0011939,increased food intake|MP:0014368,enhanced long-term object recognition memory|MP:0020470,shortened circadian behavior period
MGI:2677822	Ncor1<tm1Rsd>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000601,small liver|MP:0000607,abnormal hepatocyte morphology|MP:0000706,small thymus|MP:0000827,dilated third ventricle|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0001785,edema|MP:0001825,arrested T cell differentiation|MP:0002596,abnormal hematocrit|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0009395,increased nucleated erythrocyte cell number|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0020527,small thalamus
MGI:6430669	Ncor2<em1(IMPC)Mbp>	MP:0000428,abnormal craniofacial morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:4329504	Ncor2<Gt(RRM275)Byg>	MP:0000008,increased white adipose tissue amount|MP:0001431,abnormal eating behavior|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003953,abnormal hormone level|MP:0004890,decreased energy expenditure|MP:0005076,abnormal cell differentiation|MP:0005290,decreased oxygen consumption|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0005670,abnormal white adipose tissue physiology|MP:0008964,decreased carbon dioxide production|MP:0009130,increased white fat cell number|MP:0009133,decreased white fat cell size|MP:0011091,prenatal lethality, complete penetrance|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5575500	Ncor2<tm1.1Ics>	MP:0005370,liver/biliary system phenotype
MGI:3829987	Ncor2<tm1Rev>	MP:0000065,abnormal bone marrow cavity morphology|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000172,abnormal bone marrow cell number|MP:0000240,extramedullary hematopoiesis|MP:0000280,thin ventricular wall|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001533,abnormal skeleton physiology|MP:0001570,abnormal circulating enzyme level|MP:0002397,abnormal bone marrow morphology|MP:0003135,increased erythroid progenitor cell number|MP:0003383,abnormal gluconeogenesis|MP:0003631,nervous system phenotype|MP:0003948,abnormal gas homeostasis|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004890,decreased energy expenditure|MP:0004892,increased adiponectin level|MP:0004984,increased osteoclast cell number|MP:0004991,decreased bone strength|MP:0005076,abnormal cell differentiation|MP:0005266,abnormal metabolism|MP:0005290,decreased oxygen consumption|MP:0005331,insulin resistance|MP:0005375,adipose tissue phenotype|MP:0005418,abnormal circulating hormone level|MP:0005422,osteosclerosis|MP:0005458,increased percent body fat/body weight|MP:0005534,decreased body temperature|MP:0005559,increased circulating glucose level|MP:0008254,increased megakaryocyte cell number|MP:0008872,abnormal physiological response to xenobiotic|MP:0008964,decreased carbon dioxide production|MP:0009288,increased epididymal fat pad weight|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0011747,myelofibrosis|MP:0031204,hindlimb paresis
MGI:3765904	Ncor2<tm1Rsd>	MP:0000267,abnormal heart development|MP:0000280,thin ventricular wall|MP:0000787,abnormal telencephalon morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0010402,ventricular septal defect|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5309015	Ncr1<noe>	MP:0002412,increased susceptibility to bacterial infection|MP:0008044,increased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010766,abnormal NK cell physiology|MP:0010839,decreased CD8-positive, alpha-beta memory T cell number|MP:0020917,decreased susceptibility to Herpesvirales infection|MP:0031025,decreased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:5308410	Ncr1<tm1.1(icre)Viv>	MP:0002169,no abnormal phenotype detected|MP:0005397,hematopoietic system phenotype|MP:0010766,abnormal NK cell physiology|MP:0031025,decreased susceptibility to Herpesvirales infection induced morbidity/mortality|MP:0031045,decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:3664443	Ncr1<tm1Oman>	MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0008045,decreased NK cell number|MP:0031046,increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:5430925	Ncr1<tm2.1Viv>	MP:0005387,immune system phenotype
MGI:8162228	Ncs1<m1Rbrc>	MP:0001417,decreased exploration in new environment|MP:0001458,abnormal object recognition memory|MP:0002757,decreased vertical activity|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0012307,impaired spatial learning
MGI:5548385	Ncs1<tm1b(EUCOMM)Hmgu>	MP:0001312,abnormal cornea morphology|MP:0001566,increased circulating phosphate level|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:5009035	Ncstn<tm1.1Akli>	MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000519,hydronephrosis|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0003587,ureter obstruction|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004809,increased hematopoietic stem cell number|MP:0008476,increased spleen red pulp amount|MP:0009333,abnormal splenocyte physiology|MP:0009550,increased urinary bladder carcinoma incidence
MGI:3796837	Ncstn<tm1.1Sud>	MP:0001212,skin lesions|MP:0001399,hyperactivity|MP:0001409,increased stereotypic behavior|MP:0001415,increased exploration in new environment|MP:0001441,increased grooming behavior|MP:0001463,abnormal spatial learning|MP:0001510,abnormal coat appearance|MP:0002183,gliosis|MP:0003203,increased neuron apoptosis|MP:0003241,loss of cortex neurons|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0004998,decreased CNS synapse formation|MP:0005386,behavior/neurological phenotype|MP:0006254,thin cerebral cortex|MP:0008143,abnormal dendrite morphology|MP:0009142,decreased prepulse inhibition|MP:0009454,impaired contextual conditioning behavior|MP:0011731,decreased myelin sheath thickness|MP:0013438,dysmyelination|MP:0014370,impaired spatial working memory
MGI:3848925	Ncstn<tm1.2Sud>	MP:0011092,embryonic lethality, complete penetrance
MGI:2675667	Ncstn<tm1Jli>	MP:0001688,abnormal somite development|MP:0011092,embryonic lethality, complete penetrance
MGI:2667524	Ncstn<tm1Pcw>	MP:0000267,abnormal heart development|MP:0000292,distended pericardium|MP:0001690,failure of somite differentiation|MP:0002151,abnormal neural tube morphology|MP:0002188,small heart|MP:0003229,abnormal vitelline vasculature morphology|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0004251,failure of heart looping|MP:0005621,abnormal cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3629090	Ncstn<tm1Rroz>	MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0003229,abnormal vitelline vasculature morphology|MP:0003400,kinked neural tube|MP:0003425,abnormal optic vesicle formation|MP:0003885,abnormal rostral-caudal body axis extension|MP:0006042,increased apoptosis|MP:0006337,abnormal first pharyngeal arch morphology|MP:0009846,abnormal neural crest morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012701,increased embryonic neuroepithelium apoptosis
MGI:4943563	Ncstn<tm1Sud>	MP:0002169,no abnormal phenotype detected
MGI:3811743	Nct1/Nct2<tm1Nbh>	MP:0002169,no abnormal phenotype detected
MGI:3811745	Nct1/Nct2<tm1Nbh>	MP:0002169,no abnormal phenotype detected
MGI:1856967	nd	MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000877,abnormal Purkinje cell morphology|MP:0001393,ataxia|MP:0001410,head bobbing|MP:0001524,impaired limb coordination|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002272,abnormal nervous system electrophysiology|MP:0002924,delayed CNS synapse formation|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004143,muscle hypertonia|MP:0005403,abnormal nerve conduction|MP:0008571,abnormal synaptic bouton morphology|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:1856630	Ndc1<sks>	MP:0000137,abnormal vertebrae morphology|MP:0000154,rib fusion|MP:0000242,impaired fertilization|MP:0000585,kinked tail|MP:0001147,small testis|MP:0001258,decreased body length|MP:0001539,decreased caudal vertebrae number|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002759,abnormal caudal vertebrae morphology|MP:0003345,decreased rib number|MP:0004620,cervical vertebral fusion|MP:0004621,lumbar vertebral fusion|MP:0004623,thoracic vertebral fusion|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis
MGI:6256533	Ndc80<em1(IMPC)J>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6449895	Ndc80<tm1Tski>	MP:0004024,aneuploidy|MP:0009761,abnormal meiotic spindle morphology|MP:0009769,abnormal meiotic spindle assembly checkpoint
MGI:3514026	Nde1<tm1Caw>	MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0002175,decreased brain weight|MP:0003241,loss of cortex neurons|MP:0009937,abnormal neuron differentiation|MP:0014553,decreased neuronal migration
MGI:3589465	Ndel1<tm1.1Shr>	MP:0004965,inner cell mass degeneration|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5635250	Ndel1<tm1b(KOMP)Wtsi>	MP:0001697,abnormal embryo size|MP:0002111,abnormal tail morphology|MP:0003984,embryonic growth retardation|MP:0005388,respiratory system phenotype|MP:0011100,preweaning lethality, complete penetrance
MGI:4421670	Ndel1<tm1Shr>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3695433	Ndfip1<Gt(RRD002)Byg>	MP:0000172,abnormal bone marrow cell number|MP:0000240,extramedullary hematopoiesis|MP:0000592,short tail|MP:0000598,abnormal liver morphology|MP:0001194,dermatitis|MP:0001829,increased activated T cell number|MP:0001846,increased inflammatory response|MP:0001861,lung inflammation|MP:0002083,premature death|MP:0002111,abnormal tail morphology|MP:0002444,abnormal T cell physiology|MP:0002928,abnormal bile duct morphology|MP:0002981,increased liver weight|MP:0004952,increased spleen weight|MP:0005150,cachexia|MP:0005348,increased T cell proliferation|MP:0005466,abnormal T-helper 2 physiology|MP:0008687,increased interleukin-2 secretion
MGI:5442611	Ndfip1<kru>	MP:0005387,immune system phenotype|MP:0008090,increased T-helper 2 cell number
MGI:5550254	Ndfip1<tm1.1Pmo>	MP:0001829,increased activated T cell number|MP:0003278,esophageal inflammation|MP:0004947,skin inflammation|MP:0005011,increased eosinophil cell number
MGI:5620967	Ndfip1<tm1.1Sest>	MP:0005637,abnormal iron homeostasis|MP:0011451,increased susceptibility to dopaminergic neuron neurotoxicity
MGI:5313245	Ndfip1<tm1Sest>	MP:0006060,increased cerebral infarct size
MGI:4436082	Ndfip2<tm1a(EUCOMM)Hmgu>	MP:0004152,abnormal circulating iron level|MP:0005397,hematopoietic system phenotype|MP:0005637,abnormal iron homeostasis|MP:0008738,abnormal liver iron level|MP:0008743,decreased liver iron level|MP:0008807,increased liver iron level|MP:0011895,abnormal circulating unsaturated transferrin level
MGI:5548666	Ndfip2<tm1b(EUCOMM)Hmgu>	MP:0000194,increased circulating calcium level|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001402,decreased locomotor activity|MP:0002135,abnormal kidney morphology|MP:0002574,increased vertical activity|MP:0002965,increased circulating serum albumin level|MP:0005633,increased circulating sodium level|MP:0010052,increased grip strength
MGI:7259868	Ndnf<em1Nou>	MP:0005165,increased susceptibility to injury|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009417,skeletal muscle atrophy
MGI:5702713	Ndnf<tm1.1(folA/cre)Hze>	MP:0002169,no abnormal phenotype detected
MGI:2653064	Ndn<tm1.1Mus>	MP:0000837,abnormal hypothalamus morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001405,impaired coordination|MP:0001412,excessive scratching|MP:0001463,abnormal spatial learning|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002272,abnormal nervous system electrophysiology|MP:0003122,maternal imprinting|MP:0003998,decreased thermal nociceptive threshold|MP:0004297,abnormal proprioceptive neuron morphology|MP:0006404,abnormal lumbar dorsal root ganglion morphology|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2653065	Ndn<tm1Alb>	MP:0002169,no abnormal phenotype detected
MGI:3586988	Ndn<tm1Ky>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0001973,increased thermal nociceptive threshold|MP:0003122,maternal imprinting
MGI:2653045	Ndn<tm1Stw>	MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002082,postnatal lethality|MP:0003122,maternal imprinting|MP:0004144,hypotonia|MP:0008770,decreased survivor rate|MP:0010768,mortality/aging
MGI:2653048	Ndn<tm2Stw>	MP:0001575,cyanosis|MP:0001943,abnormal respiration|MP:0001954,respiratory distress|MP:0002082,postnatal lethality|MP:0002321,hypoventilation|MP:0003122,maternal imprinting|MP:0003880,abnormal central pattern generator function|MP:0004144,hypotonia|MP:0005039,hypoxia|MP:0010746,abnormal pre-Botzinger complex physiology|MP:0011087,neonatal lethality, complete penetrance
MGI:4414644	Ndp<tm1Lex>	MP:0000255,blood vessel congestion|MP:0002792,abnormal retina vasculature morphology|MP:0003070,increased vascular permeability
MGI:2676199	Ndp<tm1Wbrg>	MP:0001327,decreased retina photoreceptor cell number|MP:0001328,disorganized retina layers|MP:0001967,deafness|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002855,abnormal cochlear ganglion morphology|MP:0002857,cochlear ganglion degeneration|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0004363,stria vascularis degeneration|MP:0004367,abnormal strial intermediate cell morphology|MP:0004368,abnormal stria vascularis vasculature morphology|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004487,type I spiral ligament fibrocyte degeneration|MP:0004740,sensorineural hearing loss|MP:0004748,increased susceptibility to age-related hearing loss|MP:0004758,absent strial marginal cells|MP:0005103,abnormal retina pigmentation|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0006200,vitreous body deposition|MP:0008509,disorganized retina ganglion layer|MP:0008584,photoreceptor outer segment degeneration|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4414794	Ndp<tm2Nat>	MP:0002792,abnormal retina vasculature morphology|MP:0004950,abnormal brain vasculature morphology
MGI:7366891	Ndrg1<em1Lxli>	MP:0000921,demyelination|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0002006,neoplasm|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002651,abnormal sciatic nerve morphology|MP:0005402,abnormal action potential|MP:0005404,abnormal axon morphology|MP:0008814,decreased nerve conduction velocity|MP:0011731,decreased myelin sheath thickness|MP:0031204,hindlimb paresis
MGI:5009138	Ndrg1<str>	MP:0000745,tremors|MP:0000746,weakness|MP:0000755,hindlimb paralysis|MP:0000921,demyelination|MP:0001265,decreased body size|MP:0001304,cataract|MP:0001513,limb grasping|MP:0002083,premature death|MP:0008814,decreased nerve conduction velocity|MP:0009417,skeletal muscle atrophy
MGI:3043362	Ndrg1<tm1Myta>	MP:0000746,weakness|MP:0000755,hindlimb paralysis|MP:0000921,demyelination|MP:0000958,peripheral nervous system degeneration|MP:0001265,decreased body size|MP:0001304,cataract|MP:0001513,limb grasping|MP:0002083,premature death|MP:0008814,decreased nerve conduction velocity|MP:0009417,skeletal muscle atrophy|MP:0009434,paraparesis
MGI:5692623	Ndrg1<tm2b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000745,tremors|MP:0001406,abnormal gait|MP:0001566,increased circulating phosphate level|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0010506,prolonged RR interval|MP:0013278,decreased fasting circulating glucose level
MGI:5636684	Ndrg2<tm1.1Hori>	MP:0001876,decreased inflammatory response|MP:0003204,decreased neuron apoptosis|MP:0003690,abnormal glial cell physiology|MP:0005166,decreased susceptibility to injury|MP:0008706,decreased interleukin-6 secretion|MP:0008916,abnormal astrocyte physiology|MP:0010761,abnormal microglial cell chemotaxis|MP:0012066,decreased astrocyte number
MGI:5441449	Ndrg2<tm1.1Xzg>	MP:0003047,abnormal thoracic vertebrae morphology|MP:0004616,lumbar vertebral transformation|MP:0004617,sacral vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0005380,embryo phenotype
MGI:5617965	Ndrg2<tm1Kmori>	MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0003331,increased hepatocellular carcinoma incidence|MP:0006262,increased testis tumor incidence|MP:0008714,increased lung carcinoma incidence|MP:0008770,decreased survivor rate|MP:0009153,increased pancreas tumor incidence|MP:0009277,increased brain tumor incidence|MP:0010279,increased gastrointestinal tumor incidence|MP:0010300,increased skin tumor incidence|MP:0011703,increased fibroblast proliferation
MGI:5441448	Ndrg2<tm1Xzg>	MP:0003047,abnormal thoracic vertebrae morphology|MP:0004616,lumbar vertebral transformation|MP:0004617,sacral vertebral transformation|MP:0004618,thoracic vertebral transformation
MGI:6152522	Ndrg3<em1(IMPC)Mbp>	MP:0000195,decreased circulating calcium level|MP:0000691,enlarged spleen|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002092,abnormal eye morphology|MP:0002151,abnormal neural tube morphology|MP:0003068,enlarged kidney|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6360448	Ndrg3<em1Qshi>	MP:0001922,reduced male fertility|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005169,abnormal male meiosis|MP:0010948,abnormal double-strand DNA break repair|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:3529819	Ndrg3<Gt(OST12106)Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:5637125	Ndrg4<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0005140,decreased cardiac muscle contractility|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level
MGI:5287887	Ndrg4<tm1Myta>	MP:0001463,abnormal spatial learning|MP:0002152,abnormal brain morphology|MP:0003076,increased susceptibility to ischemic brain injury|MP:0006060,increased cerebral infarct size
MGI:5491260	Ndst1<b2b2230Clo>	MP:0000024,lowered ear position|MP:0000087,absent mandible|MP:0000276,heart right ventricle hypertrophy|MP:0000519,hydronephrosis|MP:0001293,anophthalmia|MP:0001823,thymus hypoplasia|MP:0001890,anencephaly|MP:0002625,heart left ventricle hypertrophy|MP:0002633,persistent truncus arteriosus|MP:0003052,omphalocele|MP:0003675,kidney cyst|MP:0004133,heterotaxia|MP:0004157,interrupted aortic arch|MP:0004158,right aortic arch|MP:0006290,proboscis|MP:0009880,decreased mouth size|MP:0010412,atrioventricular septal defect|MP:0010466,vascular ring
MGI:3589383	Ndst1<tm1.1Grob>	MP:0000060,delayed bone ossification|MP:0000075,absent neurocranium|MP:0000087,absent mandible|MP:0000438,abnormal cranium morphology|MP:0000787,abnormal telencephalon morphology|MP:0000830,abnormal diencephalon morphology|MP:0000913,abnormal brain development|MP:0000952,abnormal CNS glial cell morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001347,absent lacrimal glands|MP:0002092,abnormal eye morphology|MP:0002199,abnormal brain commissure morphology|MP:0002659,pituitary gland hypoplasia|MP:0003078,aphakia|MP:0003232,abnormal forebrain development|MP:0003451,absent olfactory bulb|MP:0003743,abnormal facial morphology|MP:0005397,hematopoietic system phenotype|MP:0008221,abnormal hippocampal commissure morphology|MP:0008225,abnormal anterior commissure morphology|MP:0010714,iris coloboma|MP:0011089,perinatal lethality, complete penetrance|MP:0030385,decreased facial bone number|MP:0031445,midline cleft upper lip
MGI:1888706	Ndst1<tm1Ekf>	MP:0001177,atelectasis|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0004780,abnormal surfactant secretion|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3588580	Ndst1<tm1Grob>	MP:0001297,microphthalmia|MP:0001347,absent lacrimal glands|MP:0005391,vision/eye phenotype|MP:0013331,abnormal lacrimal gland development
MGI:1889939	Ndst1<tm1Hgx>	MP:0001177,atelectasis|MP:0001179,thick pulmonary interalveolar septum|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002275,abnormal type II pneumocyte morphology|MP:0004780,abnormal surfactant secretion|MP:0010890,decreased alveolar lamellar body number|MP:0011087,neonatal lethality, complete penetrance
MGI:3589211	Ndst1<tm1Je>	MP:0000259,abnormal vascular development|MP:0000761,thin diaphragm muscle|MP:0001876,decreased inflammatory response|MP:0002279,abnormal diaphragm morphology|MP:0003156,abnormal leukocyte migration|MP:0003628,abnormal leukocyte adhesion|MP:0003924,diaphragmatic hernia|MP:0005039,hypoxia|MP:0005602,decreased angiogenesis|MP:0010080,abnormal hepatocyte physiology|MP:0010912,herniated liver|MP:0011643,abnormal tendon collagen fibril morphology|MP:0012061,abnormal diaphragm central tendon morphology|MP:0012201,decreased endothelial cell proliferation|MP:0012252,abnormal septum transversum morphology|MP:0020332,impaired leukocyte tethering or rolling|MP:0030803,abnormal tendon cell morphology
MGI:1913285	Ndst2<tm1Lkj>	MP:0000336,decreased mast cell number|MP:0000359,abnormal mast cell morphology|MP:0000361,decreased mast cell protease storage|MP:0000362,decreased mast cell histamine storage|MP:0008765,decreased mast cell degranulation
MGI:1913286	Ndst2<tm1Rls>	MP:0000361,decreased mast cell protease storage|MP:0000362,decreased mast cell histamine storage|MP:0003436,decreased susceptibility to induced arthritis|MP:0005025,abnormal response to infection|MP:0005462,abnormal mast cell differentiation|MP:0008765,decreased mast cell degranulation
MGI:5571271	Ndst3<m1Anu>	MP:0002169,no abnormal phenotype detected
MGI:3806156	Ndst3<tm1.1Grob>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001364,decreased anxiety-related response|MP:0003631,nervous system phenotype|MP:0005016,decreased lymphocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:6111332	Ndst4<tm1.1Ntuy>	MP:0000488,abnormal intestinal epithelium morphology|MP:0000495,abnormal colon morphology|MP:0008885,increased enterocyte apoptosis|MP:0014221,increased colon goblet cell number
MGI:6317360	Ndufa10<tm1e.1(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0001406,abnormal gait|MP:0003795,abnormal bone structure|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:7425854	Ndufa11<em1(IMPC)Bay>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0014586,decreased egg cylinder size
MGI:7314467	Ndufa13<em1Nju>	MP:0001146,abnormal testis morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002780,decreased circulating testosterone level|MP:0003674,oxidative stress|MP:0004543,abnormal sperm physiology|MP:0004884,abnormal testis physiology|MP:0005389,reproductive system phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0011092,embryonic lethality, complete penetrance|MP:0014052,increased male germ cell apoptosis|MP:0020451,decreased sperm progressive motility
MGI:3056073	Ndufa13<tm1Xc>	MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0002718,abnormal inner cell mass morphology|MP:0005028,abnormal trophectoderm morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011633,abnormal mitochondrial shape|MP:0011635,abnormal mitochondrial crista morphology
MGI:6140203	Ndufa1<tm1.1Nay>	MP:0000876,Purkinje cell degeneration|MP:0001402,decreased locomotor activity|MP:0001661,extended life span|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002665,decreased circulating corticosterone level|MP:0003806,abnormal nucleotide metabolism|MP:0003963,abnormal corticosterone level|MP:0004151,decreased circulating iron level|MP:0004890,decreased energy expenditure|MP:0005266,abnormal metabolism|MP:0005278,abnormal cholesterol homeostasis|MP:0005281,increased fatty acids level|MP:0005290,decreased oxygen consumption|MP:0005311,abnormal circulating amino acid level|MP:0005635,decreased circulating bilirubin level|MP:0010026,decreased liver cholesterol level|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake|MP:0012230,abnormal sphingolipid level|MP:0013242,abnormal amino acid metabolism|MP:0013245,abnormal lipid metabolism|MP:0020234,decreased basal metabolism|MP:0030636,decreased taurine level
MGI:4130259	Ndufa5<Gt(RRK279)Byg>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6257716	Ndufa6<em1(IMPC)Bay>	MP:0002953,thick ventricular wall|MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6467482	Ndufa7<em1(IMPC)Bay>	MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval
MGI:4436517	Ndufa8<tm1a(EUCOMM)Hmgu>	MP:0005634,decreased circulating sodium level|MP:0010052,increased grip strength
MGI:5548563	Ndufa8<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0010097,abnormal retina blood vessel morphology|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness
MGI:5910587	Ndufa9<em1(IMPC)J>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:6476764	Ndufab1<tm1Xiwa>	MP:0000189,hypoglycemia|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002727,decreased circulating insulin level|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0010398,decreased liver glycogen level|MP:0010399,decreased skeletal muscle glycogen level|MP:0011100,preweaning lethality, complete penetrance|MP:0011636,disorganized mitochondrial cristae
MGI:5521199	Ndufaf2<tm1.1Itl>	MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport
MGI:5694352	Ndufaf2<tm1Itl>	MP:0002169,no abnormal phenotype detected
MGI:7519114	Ndufaf5<em1(IMPC)Bay>	MP:0001392,abnormal locomotor behavior|MP:0001417,decreased exploration in new environment|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4433125	Ndufaf6<tm1a(EUCOMM)Wtsi>	MP:0001260,increased body weight
MGI:4960984	Ndufaf7<Gt(430C7)Cmhd>	MP:0013292,embryonic lethality prior to organogenesis
MGI:6342902	Ndufaf8<em1(IMPC)Bay>	MP:0000266,abnormal heart morphology|MP:0001697,abnormal embryo size|MP:0003232,abnormal forebrain development|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:7662902	Ndufb3<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:7425856	Ndufb5<em1(IMPC)Bay>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001726,abnormal allantois morphology|MP:0002151,abnormal neural tube morphology|MP:0002861,abnormal tail bud morphology|MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4432457	Ndufb8<tm1a(EUCOMM)Wtsi>	MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:5637008	Ndufb9<tm1b(EUCOMM)Hmgu>	MP:0002079,increased circulating insulin level|MP:0002135,abnormal kidney morphology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:5548814	Ndufs1<tm1b(EUCOMM)Hmgu>	MP:0000194,increased circulating calcium level|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001566,increased circulating phosphate level|MP:0002644,decreased circulating triglyceride level|MP:0002699,abnormal vitreous body morphology|MP:0002757,decreased vertical activity|MP:0005553,increased circulating creatinine level|MP:0005633,increased circulating sodium level|MP:0011100,preweaning lethality, complete penetrance|MP:0011886,increased circulating lipase level
MGI:5754607	Ndufs2<em1(IMPC)Tcp>	MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4433795	Ndufs3<tm1a(EUCOMM)Wtsi>	MP:0001391,abnormal tail movements|MP:0002833,increased heart weight|MP:0002875,decreased erythrocyte cell number|MP:0003960,increased lean body mass|MP:0005571,decreased lactate dehydrogenase level
MGI:4942335	Ndufs4<fky>	MP:0000418,focal hair loss|MP:0001265,decreased body size|MP:0001394,circling|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0003979,increased circulating carnitine level|MP:0005191,head tilt|MP:0030655,increased circulating glycine level|MP:0030670,increased circulating phenylalanine level|MP:0030745,increased circulating homocitrulline level
MGI:3793713	Ndufs4<tm1.1Rpa>	MP:0000160,kyphosis|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000745,tremors|MP:0000846,abnormal medulla oblongata morphology|MP:0000876,Purkinje cell degeneration|MP:0001059,optic nerve atrophy|MP:0001258,decreased body length|MP:0001259,abnormal body weight|MP:0001265,decreased body size|MP:0001304,cataract|MP:0001344,blepharoptosis|MP:0001393,ataxia|MP:0001394,circling|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001442,decreased grooming behavior|MP:0001447,abnormal nest building behavior|MP:0001489,decreased startle reflex|MP:0001504,abnormal posture|MP:0001505,hunched posture|MP:0001512,trunk curl|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0001915,intracranial hemorrhage|MP:0001951,abnormal breathing pattern|MP:0001954,respiratory distress|MP:0001957,apnea|MP:0002001,blindness|MP:0002064,seizures|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002083,premature death|MP:0002090,abnormal vision|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0002338,abnormal pulmonary ventilation|MP:0002572,abnormal emotion/affect behavior|MP:0002654,spongiform encephalopathy|MP:0002882,abnormal neuron morphology|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0003382,straub tail|MP:0003631,nervous system phenotype|MP:0003674,oxidative stress|MP:0004142,abnormal muscle tone|MP:0004144,hypotonia|MP:0004811,abnormal neuron physiology|MP:0004950,abnormal brain vasculature morphology|MP:0005114,premature hair loss|MP:0005202,lethargy|MP:0005333,decreased heart rate|MP:0005356,positive geotaxis|MP:0005498,hyporesponsive to tactile stimuli|MP:0005507,tail dragging|MP:0005534,decreased body temperature|MP:0005551,abnormal eye electrophysiology|MP:0005574,decreased pulmonary respiratory rate|MP:0005604,hyperekplexia|MP:0005656,decreased aggression|MP:0006051,brainstem hemorrhage|MP:0008025,brain vacuoles|MP:0008918,microgliosis|MP:0009358,environmentally induced seizures|MP:0009642,abnormal blood homeostasis|MP:0009931,abnormal skin appearance|MP:0009947,abnormal olfactory bulb external plexiform layer morphology|MP:0009964,abnormal cerebellum lobule morphology|MP:0009983,abnormal cerebellum fastigial nucleus morphology|MP:0010047,axonal spheroids|MP:0010323,retropulsion|MP:0010746,abnormal pre-Botzinger complex physiology|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011635,abnormal mitochondrial crista morphology|MP:0020351,decreased vocalization
MGI:5464892	Ndufs4<tm1Capt>	MP:0005584,abnormal enzyme/coenzyme activity|MP:0010955,abnormal respiratory electron transport chain
MGI:3527173	Ndufs4<tm1Rpa>	MP:0000160,kyphosis|MP:0000414,alopecia|MP:0000745,tremors|MP:0000846,abnormal medulla oblongata morphology|MP:0001059,optic nerve atrophy|MP:0001258,decreased body length|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001304,cataract|MP:0001344,blepharoptosis|MP:0001393,ataxia|MP:0001394,circling|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001442,decreased grooming behavior|MP:0001447,abnormal nest building behavior|MP:0001489,decreased startle reflex|MP:0001504,abnormal posture|MP:0001512,trunk curl|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0001915,intracranial hemorrhage|MP:0001951,abnormal breathing pattern|MP:0001954,respiratory distress|MP:0001957,apnea|MP:0002064,seizures|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002083,premature death|MP:0002090,abnormal vision|MP:0002169,no abnormal phenotype detected|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0002338,abnormal pulmonary ventilation|MP:0002572,abnormal emotion/affect behavior|MP:0002654,spongiform encephalopathy|MP:0003354,astrocytosis|MP:0003382,straub tail|MP:0003631,nervous system phenotype|MP:0003997,tonic-clonic seizures|MP:0004142,abnormal muscle tone|MP:0004144,hypotonia|MP:0004950,abnormal brain vasculature morphology|MP:0005202,lethargy|MP:0005333,decreased heart rate|MP:0005356,positive geotaxis|MP:0005386,behavior/neurological phenotype|MP:0005498,hyporesponsive to tactile stimuli|MP:0005507,tail dragging|MP:0005534,decreased body temperature|MP:0005574,decreased pulmonary respiratory rate|MP:0005604,hyperekplexia|MP:0005656,decreased aggression|MP:0006051,brainstem hemorrhage|MP:0008025,brain vacuoles|MP:0008918,microgliosis|MP:0009358,environmentally induced seizures|MP:0009642,abnormal blood homeostasis|MP:0009947,abnormal olfactory bulb external plexiform layer morphology|MP:0009964,abnormal cerebellum lobule morphology|MP:0009983,abnormal cerebellum fastigial nucleus morphology|MP:0010323,retropulsion|MP:0010746,abnormal pre-Botzinger complex physiology|MP:0010771,integument phenotype|MP:0010955,abnormal respiratory electron transport chain|MP:0020351,decreased vocalization
MGI:7425857	Ndufs5<em1(IMPC)Bay>	MP:0002574,increased vertical activity|MP:0011100,preweaning lethality, complete penetrance
MGI:6306612	Ndufs6<em1(IMPC)Bay>	MP:0002080,prenatal lethality|MP:0011100,preweaning lethality, complete penetrance
MGI:4346527	Ndufs6<Gt(AR0138)Wtsi>	MP:0000274,enlarged heart|MP:0001263,weight loss|MP:0001544,abnormal cardiovascular system physiology|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003819,increased left ventricle diastolic pressure|MP:0003822,decreased left ventricle systolic pressure|MP:0003913,increased heart right ventricle weight|MP:0003915,increased heart left ventricle weight|MP:0004084,abnormal cardiac muscle relaxation|MP:0005281,increased fatty acids level|MP:0005598,decreased heart ventricle muscle contractility|MP:0006035,abnormal mitochondrial morphology|MP:0008772,increased heart ventricle size|MP:0010563,increased heart right ventricle size|MP:0010579,increased heart left ventricle size|MP:0010955,abnormal respiratory electron transport chain|MP:0011631,decreased mitochondrial size
MGI:5609354	Ndufs7<tm1b(EUCOMM)Hmgu>	MP:0000367,abnormal coat/ hair morphology|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001718,abnormal visceral yolk sac morphology|MP:0002110,abnormal digit morphology|MP:0002874,decreased hemoglobin content|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration|MP:0011965,decreased total retina thickness|MP:0013292,embryonic lethality prior to organogenesis
MGI:5749812	Ndufs8<em1(IMPC)J>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:5705868	Ndufv1<tm1.1(KOMP)Vlcg>	MP:0000208,decreased hematocrit|MP:0001399,hyperactivity|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6279918	Ndufv2<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:5287501	Ndufv2<Tn(sb-rtTA)2426A.SB5Ove>	MP:0006205,embryonic lethality between implantation and somite formation
MGI:7425858	Ndufv3<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:4949933	Neat1<tm1.1Shna>	MP:0000627,abnormal mammary gland morphology|MP:0000628,abnormal mammary gland development|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001262,decreased body weight|MP:0001882,abnormal lactation|MP:0003111,abnormal cell nucleus morphology|MP:0003718,maternal effect|MP:0005381,digestive/alimentary phenotype|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009506,abnormal mammary gland alveolus morphology|MP:0010174,decreased mammary gland epithelial cell proliferation|MP:0010768,mortality/aging|MP:0011940,decreased food intake
MGI:6711840	Nebl<tm1.1Epu>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0004063,dilated heart left atrium|MP:0004090,abnormal sarcomere morphology|MP:0004485,increased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0009732,ventricular premature beat|MP:0011925,abnormal heart echocardiography feature|MP:0012106,impaired exercise endurance|MP:0020419,decreased cardiac muscle relaxation
MGI:5692728	Nebl<tm1b(EUCOMM)Wtsi>	MP:0002160,abnormal reproductive system morphology
MGI:6404214	Neb<m2Anu>	MP:0001262,decreased body weight|MP:0011100,preweaning lethality, complete penetrance
MGI:5553119	Neb<tm1.1Hgra>	MP:0000747,muscle weakness|MP:0001732,postnatal growth retardation|MP:0002106,abnormal muscle physiology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0009400,decreased skeletal muscle fiber size|MP:0011085,postnatal lethality, complete penetrance
MGI:3664092	Neb<tm1(cre)Chen>	MP:0001262,decreased body weight|MP:0001436,abnormal suckling behavior|MP:0004087,abnormal muscle fiber morphology|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0005369,muscle phenotype|MP:0010025,decreased total body fat amount|MP:0011085,postnatal lethality, complete penetrance|MP:0030566,abnormal A band morphology|MP:0030567,abnormal I band morphology
MGI:3703320	Neb<tm1Slbt>	MP:0000160,kyphosis|MP:0000748,progressive muscle weakness|MP:0001344,blepharoptosis|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0004090,abnormal sarcomere morphology|MP:0005620,abnormal muscle contractility|MP:0011083,lethality at weaning, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0030568,abnormal H zone morphology
MGI:5618471	Neb<tm2.1Chen>	MP:0004145,abnormal muscle electrophysiology|MP:0005165,increased susceptibility to injury|MP:0005369,muscle phenotype
MGI:5642118	Neb<tm2Hgra>	MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002841,impaired skeletal muscle contractility|MP:0004087,abnormal muscle fiber morphology|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0009398,abnormal skeletal muscle fiber size|MP:0009405,increased skeletal muscle fiber number|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0010227,decreased quadriceps weight|MP:0010239,decreased skeletal muscle weight|MP:0012106,impaired exercise endurance|MP:0030566,abnormal A band morphology|MP:0030568,abnormal H zone morphology
MGI:4363790	Necab2<tm1a(KOMP)Wtsi>	MP:0006380,abnormal spermatid morphology
MGI:6360037	Necap1<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6360669	Necap2<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin
MGI:3814719	Nectin1<tm1Mjd>	MP:0000116,abnormal tooth development|MP:0000126,brittle teeth|MP:0001297,microphthalmia|MP:0002649,abnormal enamel rod pattern|MP:0002650,abnormal ameloblast morphology|MP:0004830,short incisors|MP:0010096,abnormal incisor color|MP:0030450,abnormal enamel mineralization|MP:0030458,abnormal tooth wear|MP:0030459,abnormal tooth attrition
MGI:3605480	Nectin1<tm1Ytk>	MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001302,eyelids open at birth|MP:0001303,abnormal lens morphology|MP:0002699,abnormal vitreous body morphology|MP:0003727,abnormal retina layer morphology|MP:0003932,abnormal molar crown morphology|MP:0005193,abnormal anterior eye segment morphology|MP:0006402,small molars|MP:0009264,failure of eyelid fusion|MP:0014165,absent ciliary process|MP:0014175,abnormal ciliary epithelium morphology|MP:0030136,abnormal lower incisor morphology|MP:0030138,abnormal lower incisor color
MGI:2183406	Nectin2<tm1Smu>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0004542,impaired acrosome reaction|MP:0004543,abnormal sperm physiology|MP:0005578,teratozoospermia|MP:0009230,abnormal sperm head morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031012,impaired sperm migration in female genital tract|MP:0031389,abnormal ectoplasmic specialization morphology
MGI:2183405	Nectin2<tm1Vrr>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0014468,disorganized sperm mitochondrial sheath
MGI:3605481	Nectin3<tm1Ytk>	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001306,small lens|MP:0001925,male infertility|MP:0002699,abnormal vitreous body morphology|MP:0003727,abnormal retina layer morphology|MP:0005193,abnormal anterior eye segment morphology|MP:0005206,abnormal aqueous humor|MP:0014165,absent ciliary process|MP:0014175,abnormal ciliary epithelium morphology|MP:0030136,abnormal lower incisor morphology|MP:0030138,abnormal lower incisor color
MGI:5752746	Nectin4<em1(IMPC)J>	MP:0001417,decreased exploration in new environment|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:8213563	Nectin4<em1Jaa>	MP:0005597,decreased susceptibility to type I hypersensitivity reaction
MGI:6257744	Nedd1<em1(IMPC)H>	MP:0000195,decreased circulating calcium level|MP:0000367,abnormal coat/ hair morphology|MP:0005011,increased eosinophil cell number|MP:0005627,increased circulating potassium level|MP:0010088,decreased circulating fructosamine level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3529811	Nedd4<Gt(OST16211)Lex>	MP:0001262,decreased body weight|MP:0002058,neonatal lethality
MGI:3829272	Nedd4<Gt(XA209)Byg>	MP:0000063,decreased bone mineral density|MP:0000107,abnormal frontal bone morphology|MP:0000111,cleft palate|MP:0000382,underdeveloped hair follicles|MP:0000428,abnormal craniofacial morphology|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0000736,delayed muscle development|MP:0001081,abnormal cranial ganglia morphology|MP:0001093,small trigeminal ganglion|MP:0001096,abnormal glossopharyngeal ganglion morphology|MP:0001100,abnormal vagus ganglion morphology|MP:0001116,small gonad|MP:0001698,decreased embryo size|MP:0001732,postnatal growth retardation|MP:0001828,abnormal T cell activation|MP:0001930,abnormal meiosis|MP:0002116,abnormal craniofacial bone morphology|MP:0002210,abnormal sex determination|MP:0002494,increased IgM level|MP:0002820,abnormal premaxilla morphology|MP:0002995,primary sex reversal|MP:0003830,abnormal testis development|MP:0004016,decreased bone mass|MP:0004109,abnormal Sertoli cell development|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0004445,small exoccipital bone|MP:0004447,small basioccipital bone|MP:0004540,small maxilla|MP:0004592,small mandible|MP:0004610,small vertebrae|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005095,decreased T cell proliferation|MP:0005652,sex reversal|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008688,decreased interleukin-2 secretion|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009431,decreased fetal weight|MP:0009674,decreased birth weight|MP:0009888,palatal shelves fail to meet at midline|MP:0011089,perinatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0012701,increased embryonic neuroepithelium apoptosis|MP:0012745,abnormal neural crest cell physiology|MP:0012755,decreased cranial neural crest cell number|MP:0012761,increased cranial neural crest cell apoptosis|MP:0020040,decreased bone ossification|MP:0030049,prominent forehead|MP:0030320,abnormal temporal bone tympanic part morphology|MP:0031443,abnormal tongue position|MP:0031458,absent palate bones
MGI:3829273	Nedd4<Gt(XB398)Byg>	MP:0002494,increased IgM level|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005095,decreased T cell proliferation|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008688,decreased interleukin-2 secretion|MP:0011089,perinatal lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:3799317	Nedd4<Gt(XB786)Byg>	MP:0011091,prenatal lethality, complete penetrance
MGI:4836397	Nedd4l<andi>	MP:0000519,hydronephrosis|MP:0001426,polydipsia|MP:0001762,polyuria|MP:0002703,abnormal renal tubule morphology|MP:0002988,decreased urine osmolality
MGI:4940977	Nedd4l<tm1.1Hkb>	MP:0001175,abnormal lung morphology|MP:0001861,lung inflammation|MP:0002282,abnormal trachea morphology|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0006050,pulmonary fibrosis|MP:0010861,increased respiratory mucosa goblet cell number|MP:0011085,postnatal lethality, complete penetrance
MGI:3846431	Nedd4l<tm1.2Blyg>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000231,hypertension|MP:0001762,polyuria|MP:0002666,increased circulating aldosterone level|MP:0003915,increased heart left ventricle weight|MP:0004217,salt-sensitive hypertension|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0005627,increased circulating potassium level|MP:0005633,increased circulating sodium level|MP:0011941,increased fluid intake|MP:0014206,decreased intestinal epithelial sodium ion transmembrane transport
MGI:5637104	Nedd4l<tm1b(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0004738,abnormal auditory brainstem response|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5546607	Nedd4l<tm1Shkr>	MP:0000219,increased neutrophil cell number|MP:0001575,cyanosis|MP:0001861,lung inflammation|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002270,abnormal pulmonary alveolus morphology|MP:0004875,increased mean systemic arterial blood pressure|MP:0005388,respiratory system phenotype|MP:0010768,mortality/aging|MP:0010819,primary atelectasis|MP:0010858,pulmonary epithelial necrosis|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3799318	Nedd4<tm1Bros>	MP:0011091,prenatal lethality, complete penetrance
MGI:5692904	Nedd4<tm2b(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0000745,tremors|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0004924,abnormal behavior|MP:0005013,increased lymphocyte cell number|MP:0005293,impaired glucose tolerance|MP:0005554,decreased circulating creatinine level|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0020870,decreased thigmotaxis
MGI:4836403	Nedd4<tm2Bros>	MP:0001914,hemorrhage|MP:0002882,abnormal neuron morphology|MP:0003631,nervous system phenotype|MP:0004201,fetal growth retardation|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008143,abnormal dendrite morphology|MP:0009538,abnormal synapse morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0014711,decreased synaptic vesicle readily releasable pool size
MGI:4836405	Nedd4<tm3.1Bros>	MP:0003631,nervous system phenotype|MP:0006254,thin cerebral cortex|MP:0008143,abnormal dendrite morphology|MP:0008540,abnormal cerebral hemisphere morphology
MGI:6269438	Nedd9<m1Btlr>	MP:0008168,decreased B-1a cell number|MP:0008170,decreased B-1b cell number|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:5912392	Nedd9<tm1.1Mcda>	MP:0008143,abnormal dendrite morphology|MP:0009938,abnormal hippocampus granule cell morphology|MP:0012307,impaired spatial learning|MP:0020335,abnormal dentate gyrus neuron dendrite morphology|MP:0020508,decreased dendritic spine density
MGI:3700233	Nedd9<tm1Miku>	MP:0000694,spleen hypoplasia|MP:0002444,abnormal T cell physiology|MP:0002458,abnormal B cell number|MP:0003156,abnormal leukocyte migration|MP:0005016,decreased lymphocyte cell number|MP:0008101,lymph node hypoplasia|MP:0008173,increased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008191,abnormal follicular B cell physiology
MGI:5445744	Nefh<tm1.1(KOMP)Vlcg>	MP:0002941,increased circulating alanine transaminase level|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:2183246	Nefh<tm1Dwc>	MP:0000937,abnormal motor neuron morphology|MP:0000965,abnormal sensory neuron morphology|MP:0003651,abnormal axon extension
MGI:2180125	Nefh<tm1Jpj>	MP:0003993,abnormal ventral spinal root morphology|MP:0005404,abnormal axon morphology
MGI:2183425	Nefh<tm1Ral>	MP:0003631,nervous system phenotype|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration
MGI:2387787	Nefh<tm2Dwc>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0009937,abnormal neuron differentiation
MGI:5749796	Nefl<tm1.1Liem>	MP:0002169,no abnormal phenotype detected
MGI:3777624	Nefl<tm1(cre/ERT)Nat>	MP:0002169,no abnormal phenotype detected
MGI:2180095	Nefl<tm1Jpj>	MP:0003993,abnormal ventral spinal root morphology|MP:0005404,abnormal axon morphology
MGI:5749799	Nefl<tm2.1Liem>	MP:0000745,tremors|MP:0000788,abnormal cerebral cortex morphology|MP:0000848,abnormal pons morphology|MP:0000849,abnormal cerebellum morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001513,limb grasping|MP:0002651,abnormal sciatic nerve morphology|MP:0008503,abnormal spinal cord grey matter morphology|MP:0014062,nervous system inclusion bodies
MGI:4415254	Nefm<tm1Dwc>	MP:0003631,nervous system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology
MGI:2180106	Nefm<tm1Jpj>	MP:0000937,abnormal motor neuron morphology|MP:0000939,decreased motor neuron number|MP:0002882,abnormal neuron morphology|MP:0003993,abnormal ventral spinal root morphology|MP:0004768,abnormal axonal transport|MP:0005404,abnormal axon morphology
MGI:5428135	Nefm<tm1Milg>	MP:0000920,abnormal myelination|MP:0003631,nervous system phenotype|MP:0003871,abnormal myelin sheath morphology|MP:0009937,abnormal neuron differentiation
MGI:2686958	Nefm<tm1Mvr>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential|MP:0005404,abnormal axon morphology|MP:0009937,abnormal neuron differentiation
MGI:2180135	Nefm<tm1Ral>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration
MGI:5447400	Negr1<m1H>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0003402,decreased liver weight|MP:0003961,decreased lean body mass|MP:0005448,abnormal energy homeostasis|MP:0009356,decreased liver triglyceride level|MP:0011940,decreased food intake
MGI:5692835	Negr1<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001399,hyperactivity|MP:0002092,abnormal eye morphology|MP:0002175,decreased brain weight|MP:0004924,abnormal behavior|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:5447397	Negr1<tm1Mkes>	MP:0001262,decreased body weight
MGI:3620011	Neil1<tm1Rsld>	MP:0000013,abnormal adipose tissue distribution|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0001209,spontaneous skin ulceration|MP:0001261,obese|MP:0001552,increased circulating triglyceride level|MP:0001924,infertility|MP:0002020,increased tumor incidence|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002933,joint inflammation|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005669,increased circulating leptin level|MP:0010024,increased total body fat amount
MGI:5752781	Neil2<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0004924,abnormal behavior|MP:0005566,decreased blood urea nitrogen level|MP:0010053,decreased grip strength|MP:0020870,decreased thigmotaxis
MGI:5804531	Neil2<tm1.1Tkhz>	MP:0000219,increased neutrophil cell number|MP:0001861,lung inflammation|MP:0003674,oxidative stress|MP:0004029,spontaneous chromosome breakage|MP:0030927,decreased telomere length
MGI:5804530	Neil2<tm1Tkhz>	MP:0002169,no abnormal phenotype detected
MGI:5306033	Neil3<tm1Bjor>	MP:0004948,abnormal neuronal precursor proliferation|MP:0004981,decreased neuronal precursor cell number|MP:0006060,increased cerebral infarct size|MP:0008058,abnormal DNA repair|MP:0009937,abnormal neuron differentiation|MP:0020449,decreased microglial cell activation
MGI:3521920	Neil3<tm1Yun>	MP:0002169,no abnormal phenotype detected
MGI:5548867	Nek10<tm1b(KOMP)Wtsi>	MP:0011239,abnormal skin coloration
MGI:5578488	Nek11<tm1b(KOMP)Wtsi>	MP:0001523,impaired righting response|MP:0004151,decreased circulating iron level|MP:0005560,decreased circulating glucose level
MGI:6257505	Nek1<em1(IMPC)Bay>	MP:0000438,abnormal cranium morphology|MP:0001258,decreased body length|MP:0001925,male infertility|MP:0002764,short tibia|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003795,abnormal bone structure|MP:0004509,abnormal pelvic girdle bone morphology|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0011952,decreased cardiac stroke volume|MP:0011965,decreased total retina thickness
MGI:1858030	Nek1<kat>	MP:0000416,sparse hair|MP:0000428,abnormal craniofacial morphology|MP:0000435,shortened head|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000522,kidney cortex cyst|MP:0000819,abnormal olfactory bulb morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0000829,dilated fourth ventricle|MP:0000917,obstructive hydrocephaly|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002741,small olfactory bulb|MP:0003657,abnormal erythrocyte osmotic lysis|MP:0003675,kidney cyst|MP:0005537,abnormal cerebral aqueduct morphology|MP:0008528,polycystic kidney|MP:0008974,proportional dwarf|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1858122	Nek1<kat-2J>	MP:0000428,abnormal craniofacial morphology|MP:0000435,shortened head|MP:0000445,short snout|MP:0000522,kidney cortex cyst|MP:0000819,abnormal olfactory bulb morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0000829,dilated fourth ventricle|MP:0000917,obstructive hydrocephaly|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001940,testis hypoplasia|MP:0002083,premature death|MP:0002643,poikilocytosis|MP:0002703,abnormal renal tubule morphology|MP:0002741,small olfactory bulb|MP:0003675,kidney cyst|MP:0005537,abnormal cerebral aqueduct morphology|MP:0005565,increased blood urea nitrogen level|MP:0008528,polycystic kidney|MP:0009703,decreased birth body size
MGI:5754994	Nek2<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0002135,abnormal kidney morphology
MGI:5619615	Nek2<tm1b(KOMP)Wtsi>	MP:0001392,abnormal locomotor behavior|MP:0002833,increased heart weight|MP:0004738,abnormal auditory brainstem response|MP:0013279,increased fasting circulating glucose level
MGI:5792084	Nek5<mpc234H>	MP:0006325,impaired hearing
MGI:5427679	Nek6<tm1Dgen>	MP:0001625,cardiac hypertrophy|MP:0002169,no abnormal phenotype detected|MP:0002833,increased heart weight|MP:0004485,increased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0005608,cardiac interstitial fibrosis|MP:0005630,increased lung weight|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4346630	Nek7<Gt(AR1081)Wtsi>	MP:0005391,vision/eye phenotype
MGI:4125203	Nek7<Gt(NPX451)Byg>	MP:0005391,vision/eye phenotype
MGI:5690178	Nek7<M1Btlr>	MP:0000754,paresis|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001876,decreased inflammatory response|MP:0001924,infertility|MP:0002451,abnormal macrophage physiology|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008658,decreased interleukin-1 beta secretion|MP:0008685,decreased interleukin-18 secretion
MGI:5635251	Nek7<tm1b(EUCOMM)Hmgu>	MP:0002959,increased urine microalbumin level|MP:0011100,preweaning lethality, complete penetrance
MGI:4999797	Nek7<tm1Mot>	MP:0001732,postnatal growth retardation|MP:0003708,binucleate|MP:0004024,aneuploidy|MP:0004025,polyploidy|MP:0004046,abnormal mitosis|MP:0005391,vision/eye phenotype|MP:0008866,chromosomal instability|MP:0009674,decreased birth weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5317588	Nek8<b2b1449Clo>	MP:0004133,heterotaxia|MP:0005388,respiratory system phenotype|MP:0010422,heart right ventricle hypoplasia
MGI:1856919	Nek8<jck>	MP:0000522,kidney cortex cyst|MP:0001386,abnormal maternal nurturing|MP:0002083,premature death|MP:0003068,enlarged kidney|MP:0003675,kidney cyst|MP:0003917,increased kidney weight|MP:0004860,dilated kidney collecting duct|MP:0005553,increased circulating creatinine level|MP:0008528,polycystic kidney|MP:0011307,kidney medulla cyst
MGI:6268750	Nek8<m1Btlr>	MP:0004875,increased mean systemic arterial blood pressure|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008537,increased susceptibility to induced colitis|MP:0010845,decreased effector memory CD4-positive, alpha-beta T cell number|MP:0010851,decreased effector memory CD8-positive, alpha-beta T cell number
MGI:5503122	Nek8<tm1Bei>	MP:0000284,double outlet right ventricle|MP:0000531,right pulmonary isomerism|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002058,neonatal lethality|MP:0009050,dilated proximal convoluted tubule|MP:0010412,atrioventricular septal defect|MP:0011249,abdominal situs inversus|MP:0011252,situs inversus totalis|MP:0011682,renal glomerulus cyst
MGI:6887930	Nek9<em1Nmz>	MP:0005367,renal/urinary system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging|MP:0011066,abnormal renal tubule epithelial cell primary cilium morphology|MP:0011408,renal tubule hypertrophy|MP:0030940,impaired autophagy
MGI:4433670	Nek9<tm1a(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0001711,abnormal placenta morphology|MP:0004259,small placenta|MP:0005031,abnormal trophoblast layer morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0008810,increased circulating iron level|MP:0009931,abnormal skin appearance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0030975,placenta hemorrhage
MGI:6156462	Nelfa<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0002060,abnormal skin morphology|MP:0002833,increased heart weight|MP:0004952,increased spleen weight|MP:0008528,polycystic kidney|MP:0010067,increased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:3846131	Nelfb<tm1.2Roli>	MP:0001730,embryonic growth arrest|MP:0004957,abnormal blastocyst morphology|MP:0004964,absent inner cell mass|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:6860664	Nelfcd<em1(IMPC)J>	MP:0001556,increased circulating HDL cholesterol level|MP:0002591,decreased mean corpuscular volume|MP:0011100,preweaning lethality, complete penetrance
MGI:4842623	Nelfe<tm1a(EUCOMM)Wtsi>	MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:6293848	Nell1<em1(IMPC)Mbp>	MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002339,abnormal lymph node morphology|MP:0002699,abnormal vitreous body morphology|MP:0002768,small adrenal glands|MP:0002989,small kidney|MP:0005562,decreased mean corpuscular hemoglobin
MGI:2449599	Nell1<l7R6-1R>	MP:0011100,preweaning lethality, complete penetrance
MGI:2449600	Nell1<l7R6-2R>	MP:0011100,preweaning lethality, complete penetrance
MGI:2449601	Nell1<l7R6-3R>	MP:0011100,preweaning lethality, complete penetrance
MGI:3689209	Nell1<l7R6-4R>	MP:0011089,perinatal lethality, complete penetrance
MGI:3689210	Nell1<l7R6-5R>	MP:0011089,perinatal lethality, complete penetrance
MGI:3626314	Nell1<l7R6-6R>	MP:0000063,decreased bone mineral density|MP:0000074,abnormal neurocranium morphology|MP:0000434,megacephaly|MP:0001953,respiratory failure|MP:0001961,abnormal reflex|MP:0002114,abnormal axial skeleton morphology|MP:0002896,abnormal bone mineralization|MP:0003048,abnormal cervical vertebrae morphology|MP:0004173,abnormal intervertebral disk morphology|MP:0004174,abnormal spine curvature|MP:0004375,enlarged frontal bone|MP:0004386,enlarged interparietal bone|MP:0004421,enlarged parietal bone|MP:0004474,enlarged nasal bone|MP:0005225,abnormal vertebrae development|MP:0005229,abnormal intervertebral disk development|MP:0011089,perinatal lethality, complete penetrance|MP:0020040,decreased bone ossification|MP:0030275,thin frontal bone|MP:0030277,thin interparietal bone|MP:0030281,thin parietal bone
MGI:3689212	Nell1<l7R6-7R>	MP:0011089,perinatal lethality, complete penetrance
MGI:3689213	Nell1<l7R6-8R>	MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2448835	Nell1<l7R6-9R>	MP:0011091,prenatal lethality, complete penetrance
MGI:6460272	Nell2<em1Osb>	MP:0001925,male infertility|MP:0002660,abnormal caput epididymis morphology|MP:0004935,epididymis degeneration|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031012,impaired sperm migration in female genital tract
MGI:3043786	Nell2<tm1Mho>	MP:0003008,enhanced long-term potentiation
MGI:6850156	Nemf<em8Cx>	MP:0000958,peripheral nervous system degeneration|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001954,respiratory distress|MP:0002229,neurodegeneration|MP:0002269,muscular atrophy|MP:0005405,axon degeneration|MP:0011100,preweaning lethality, complete penetrance
MGI:5428665	Nemf<pdft>	MP:0000958,peripheral nervous system degeneration|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0002229,neurodegeneration|MP:0002269,muscular atrophy|MP:0003224,neuron degeneration|MP:0005405,axon degeneration|MP:0008489,slow postnatal weight gain|MP:0010053,decreased grip strength|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011400,lethality, complete penetrance
MGI:5488789	Nemf<tm1b(EUCOMM)Hmgu>	MP:0002111,abnormal tail morphology|MP:0002833,increased heart weight|MP:0005179,decreased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance
MGI:5428666	Nemf<tvrm116>	MP:0000958,peripheral nervous system degeneration|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0002229,neurodegeneration|MP:0002269,muscular atrophy|MP:0003224,neuron degeneration|MP:0005405,axon degeneration|MP:0008489,slow postnatal weight gain|MP:0010053,decreased grip strength
MGI:6693344	Nemp1<em1Hmc>	MP:0001125,abnormal oocyte morphology|MP:0001577,anemia|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0003718,maternal effect|MP:0005168,abnormal female meiosis|MP:0005389,reproductive system phenotype|MP:0011121,decreased primordial ovarian follicle number
MGI:5897390	Nemp1<em1(IMPC)Mbp>	MP:0000208,decreased hematocrit|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001402,decreased locomotor activity|MP:0001926,female infertility|MP:0002092,abnormal eye morphology|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0004952,increased spleen weight|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010067,increased red blood cell distribution width
MGI:7641859	Nemp1<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6156576	Nemp2<em1(IMPC)Tcp>	MP:0000689,abnormal spleen morphology|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0009142,decreased prepulse inhibition
MGI:5559062	Nenf<tm1Mkga>	MP:0001363,increased anxiety-related response|MP:0005386,behavior/neurological phenotype|MP:0005643,decreased dopamine level|MP:0008143,abnormal dendrite morphology|MP:0010070,decreased serotonin level
MGI:3665445	Neo1<Gt(KST265)Byg>	MP:0000628,abnormal mammary gland development|MP:0001065,abnormal trigeminal nerve morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:5708202	Nepn<tm1b(KOMP)Wtsi>	MP:0002644,decreased circulating triglyceride level
MGI:5695952	Nepro<tm1.1(KOMP)Vlcg>	MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5659990	Nepro<tm1.1Tets>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5659988	Nepro<tm1Tets>	MP:0003111,abnormal cell nucleus morphology|MP:0008830,abnormal nucleolus morphology|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012129,failure of blastocyst formation
MGI:5704140	nerv	MP:0000745,tremors|MP:0001399,hyperactivity|MP:0002064,seizures
MGI:7447464	Nes<em1Pqt>	MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype
MGI:5520173	Nes<tm1b(KOMP)Wtsi>	MP:0001488,increased startle reflex|MP:0002833,increased heart weight|MP:0003019,increased circulating chloride level|MP:0005179,decreased circulating cholesterol level
MGI:3844224	Nes<tm1Dopa>	MP:0001698,decreased embryo size|MP:0004981,decreased neuronal precursor cell number|MP:0009703,decreased birth body size|MP:0009937,abnormal neuron differentiation|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011105,embryonic lethality between implantation and placentation, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5285585	Nes<tm1Nagy>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0001405,impaired coordination|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:5707255	Net1<tm1.2Jafr>	MP:0000628,abnormal mammary gland development|MP:0000662,abnormal branching of the mammary ductal tree|MP:0008904,abnormal mammary fat pad morphology|MP:0013784,abnormal mammary gland bud elongation
MGI:3799763	Neto1<tm1(KOMP)Vlcg>	MP:0002910,abnormal excitatory postsynaptic currents|MP:0003635,abnormal synaptic transmission|MP:0009244,abnormal acid-activated cation-mediated receptor currents
MGI:3836584	Neto1<tm1Mci>	MP:0001473,reduced long-term potentiation|MP:0002063,abnormal learning/memory/conditioning|MP:0002064,seizures|MP:0002910,abnormal excitatory postsynaptic currents|MP:0011274,short excitatory postsynaptic current decay time
MGI:6384608	Neto2<em1(IMPC)Hmgu>	MP:0000745,tremors|MP:0008806,increased circulating amylase level|MP:0011886,increased circulating lipase level
MGI:5141222	Neto2<tm1Mci>	MP:0003631,nervous system phenotype
MGI:3042795	Neu1<a>	MP:0001262,decreased body weight|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008114,abnormal Kupffer cell morphology
MGI:2675708	Neu1<tm1Adz>	MP:0000136,abnormal microglial cell morphology|MP:0000160,kyphosis|MP:0000162,lordosis|MP:0000240,extramedullary hematopoiesis|MP:0000243,myoclonus|MP:0000519,hydronephrosis|MP:0000539,distended urinary bladder|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000745,tremors|MP:0000820,abnormal choroid plexus morphology|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001785,edema|MP:0001786,skin edema|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002882,abnormal neuron morphology|MP:0003201,extremity edema|MP:0003622,ischuria|MP:0005058,abnormal lysosome morphology|MP:0005060,accumulation of giant lysosomes in kidney/renal tubule cells|MP:0005567,decreased circulating total protein level|MP:0006167,eyelid edema|MP:0008114,abnormal Kupffer cell morphology|MP:0009643,abnormal urine homeostasis
MGI:6887912	Neu2<em1Kyp>	MP:0001260,increased body weight|MP:0001261,obese|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002108,abnormal muscle morphology|MP:0002628,hepatic steatosis|MP:0002804,abnormal motor learning|MP:0003249,increased muscle free fatty acids level|MP:0003333,liver fibrosis|MP:0004890,decreased energy expenditure|MP:0005178,increased circulating cholesterol level|MP:0005290,decreased oxygen consumption|MP:0005448,abnormal energy homeostasis|MP:0005565,increased blood urea nitrogen level|MP:0008964,decreased carbon dioxide production|MP:0009406,decreased skeletal muscle fiber number|MP:0010359,increased liver free fatty acids level|MP:0012106,impaired exercise endurance
MGI:5446783	Neu3<tm1Yamk>	MP:0002006,neoplasm|MP:0002169,no abnormal phenotype detected|MP:0004502,decreased incidence of tumors by chemical induction
MGI:3793789	Neu4<tm1Avps>	MP:0001547,abnormal lipid level|MP:0003172,abnormal lysosome physiology|MP:0003982,increased cholesterol level|MP:0005283,increased unsaturated fatty acids level|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging|MP:0031632,increased lung cholesterol level
MGI:2153143	Neurl1a<tm1Led>	MP:0001382,abnormal nursing|MP:0001925,male infertility|MP:0002006,neoplasm|MP:0002675,asthenozoospermia|MP:0004047,abnormal milk composition|MP:0005380,embryo phenotype|MP:0005578,teratozoospermia|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0006270,abnormal mammary gland growth during lactation|MP:0006380,abnormal spermatid morphology|MP:0009234,absent sperm head|MP:0009546,absent gastric milk in neonates|MP:0009830,abnormal sperm connecting piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0013716,hypolactation|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0031410,biflagellated sperm
MGI:2152037	Neurl1a<tm1Ynj>	MP:0001460,abnormal olfactory discrimination memory|MP:0003312,abnormal locomotor coordination|MP:0003631,nervous system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype
MGI:5578489	Neurl2<tm1.1(KOMP)Vlcg>	MP:0000221,decreased leukocyte cell number|MP:0001510,abnormal coat appearance|MP:0002833,increased heart weight|MP:0004151,decreased circulating iron level|MP:0005560,decreased circulating glucose level
MGI:3043523	Neurl2<tm1Adz>	MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight
MGI:3804451	Neurl2<tm1Kong>	MP:0002169,no abnormal phenotype detected
MGI:7646922	Neurl3<em1Luda>	MP:0001654,hepatic necrosis|MP:0020913,increased susceptibility to Riboviria infection|MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality
MGI:6152523	Neurl4<em1(IMPC)Mbp>	MP:0000221,decreased leukocyte cell number|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002834,decreased heart weight|MP:0002989,small kidney|MP:0003642,absent seminal vesicle|MP:0003960,increased lean body mass|MP:0005084,abnormal gallbladder morphology|MP:0006203,eye hemorrhage|MP:0009142,decreased prepulse inhibition|MP:0009342,enlarged gallbladder|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength
MGI:6114089	Neurod1<m1Btlr>	MP:0001399,hyperactivity|MP:0005307,head tossing
MGI:5472139	Neurod1<tm1.1(Atoh7)Whk>	MP:0000849,abnormal cerebellum morphology|MP:0001006,abnormal retina cone cell morphology|MP:0001394,circling|MP:0002983,increased retina ganglion cell number|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005191,head tilt|MP:0005241,abnormal retina ganglion layer morphology|MP:0008056,abnormal retina ganglion cell morphology
MGI:3603335	Neurod1<tm1.1Kan>	MP:0003631,nervous system phenotype
MGI:2385826	Neurod1<tm1Jle>	MP:0001559,hyperglycemia|MP:0005240,abnormal amacrine cell morphology|MP:0005547,abnormal Muller cell morphology|MP:0006072,abnormal retina apoptosis|MP:0006073,abnormal retina bipolar cell morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0030005,increased retina apoptosis
MGI:3603334	Neurod1<tm1Kan>	MP:0011089,perinatal lethality, complete penetrance
MGI:2148229	Neurod1<tm1Mjts>	MP:0000436,abnormal head movements|MP:0000511,abnormal intestinal mucosa morphology|MP:0000807,abnormal hippocampus morphology|MP:0000808,abnormal hippocampus development|MP:0000812,abnormal dentate gyrus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000951,sporadic seizures|MP:0001183,overexpanded pulmonary alveolus|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001429,dehydration|MP:0001559,hyperglycemia|MP:0002064,seizures|MP:0002893,ketoaciduria|MP:0003339,decreased pancreatic beta cell number|MP:0003997,tonic-clonic seizures|MP:0004994,abnormal brain wave pattern|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0006027,impaired lung alveolus development|MP:0006382,abnormal lung epithelium morphology|MP:0008269,abnormal hippocampus CA4 region morphology|MP:0008285,abnormal hippocampus granule cell layer|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009161,pancreatic acinar cell zymogen granule accumulation|MP:0009173,absent pancreatic islets|MP:0009177,decreased pancreatic alpha cell number|MP:0009181,decreased pancreatic delta cell number|MP:0009938,abnormal hippocampus granule cell morphology|MP:0010802,abnormal intestinal enteroendocrine cell morphology|MP:0010916,decreased solitary pulmonary neuroendocrine cell number|MP:0010919,increased number of pulmonary neuroendocrine bodies|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013220,increased pancreas apoptosis
MGI:6273956	Neurod2<em1(IMPC)Hmgu>	MP:0000195,decreased circulating calcium level|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001325,abnormal retina morphology|MP:0001363,increased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001415,increased exploration in new environment|MP:0001489,decreased startle reflex|MP:0001510,abnormal coat appearance|MP:0002757,decreased vertical activity|MP:0002764,short tibia|MP:0002797,increased thigmotaxis|MP:0004924,abnormal behavior|MP:0005287,narrow eye opening|MP:0005544,cornea deposits|MP:0009142,decreased prepulse inhibition|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake|MP:0011965,decreased total retina thickness
MGI:2385828	Neurod2<tm1Tap>	MP:0000852,small cerebellum|MP:0000951,sporadic seizures|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001394,circling|MP:0001405,impaired coordination|MP:0001441,increased grooming behavior|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003997,tonic-clonic seizures
MGI:2158737	Neurod4<tm1Kag>	MP:0000852,small cerebellum|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000890,thin cerebellar molecular layer|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001422,abnormal drinking behavior|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0006097,abnormal cerebellar lobule formation|MP:0006098,absent cerebellar lobules|MP:0006099,thin cerebellar granule layer|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2159008	Neurod6<tm1Kan>	MP:0005386,behavior/neurological phenotype
MGI:2183171	Neurog1<tm1And>	MP:0001056,abnormal cranial nerve morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0001075,abnormal accessory nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001097,abnormal superior glossopharyngeal ganglion morphology|MP:0001101,abnormal superior vagus ganglion morphology|MP:0001436,abnormal suckling behavior|MP:0011087,neonatal lethality, complete penetrance|MP:0013183,absent trigeminal ganglion
MGI:5638453	Neurog2<tm1.1Meg>	MP:0000939,decreased motor neuron number|MP:0003631,nervous system phenotype|MP:0021104,abnormal ventral interneuron 2 morphology
MGI:2159009	Neurog2<tm1Fgu>	MP:0000937,abnormal motor neuron morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001034,abnormal parasympathetic ganglion morphology|MP:0001071,abnormal facial nerve morphology|MP:0001082,abnormal geniculate ganglion morphology|MP:0001084,abnormal petrosal ganglion morphology|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001436,abnormal suckling behavior|MP:0001732,postnatal growth retardation|MP:0002751,abnormal autonomic nervous system morphology|MP:0002752,abnormal somatic nervous system morphology|MP:0004263,abnormal limb posture|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0021091,abnormal dorsal interneuron morphology
MGI:5431772	Neurog2<tm1(icre/ERT2*)Ggc>	MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:2159010	Neurog2<tm2Fgu>	MP:0000783,abnormal forebrain morphology|MP:0000832,abnormal thalamus morphology|MP:0008031,decreased Cajal-Retzius cell number|MP:0009937,abnormal neuron differentiation|MP:0011089,perinatal lethality, complete penetrance
MGI:2159011	Neurog2<tm3(Ascl1)Fgu>	MP:0000934,abnormal telencephalon development|MP:0021093,abnormal dorsal interneuron 2 morphology|MP:0021094,abnormal dorsal interneuron 3 morphology|MP:0021096,abnormal dorsal interneuron 5 morphology
MGI:2673381	Neurog2<tm4Fgu>	MP:0000812,abnormal dentate gyrus morphology|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0003648,abnormal radial glial cell morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0004981,decreased neuronal precursor cell number|MP:0006009,abnormal neuronal migration|MP:0009937,abnormal neuron differentiation|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3664585	Neurog2<tm5(Neurog2)Fgu>	MP:0006009,abnormal neuronal migration|MP:0009937,abnormal neuron differentiation
MGI:3796207	Neurog3<tm1.1(cre/ERT)Ggu>	MP:0005293,impaired glucose tolerance
MGI:3505733	Neurog3<tm1.1Ggr>	MP:0002169,no abnormal phenotype detected
MGI:2651394	Neurog3<tm1(EGFP)Khk>	MP:0002691,small stomach|MP:0005210,disorganized stomach mucosa|MP:0005211,increased stomach mucosa thickness|MP:0005214,regional gastric metaplasia|MP:0005216,abnormal pancreatic alpha cell morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005218,abnormal pancreatic delta cell morphology
MGI:2159017	Neurog3<tm1Fgu>	MP:0001262,decreased body weight|MP:0001429,dehydration|MP:0001759,increased urine glucose level|MP:0005559,increased circulating glucose level|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009161,pancreatic acinar cell zymogen granule accumulation|MP:0009173,absent pancreatic islets|MP:0009174,absent pancreatic beta cells|MP:0009178,absent pancreatic alpha cells|MP:0011085,postnatal lethality, complete penetrance
MGI:3842455	Neurog3<tm1Heed>	MP:0009165,abnormal endocrine pancreas morphology
MGI:4460088	Neurog3<tm3.1Ggr>	MP:0000010,abnormal abdominal fat pad morphology|MP:0000186,decreased circulating HDL cholesterol level|MP:0000489,abnormal large intestine morphology|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002169,no abnormal phenotype detected|MP:0002644,decreased circulating triglyceride level|MP:0002791,steatorrhea|MP:0002891,increased insulin sensitivity|MP:0003016,increased circulating bicarbonate level|MP:0003449,abnormal intestine goblet cell morphology|MP:0003867,increased defecation amount|MP:0003960,increased lean body mass|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0005036,diarrhea|MP:0005179,decreased circulating cholesterol level|MP:0005215,abnormal pancreatic islet morphology|MP:0005292,improved glucose tolerance|MP:0005342,abnormal intestinal lipid absorption|MP:0005381,digestive/alimentary phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0006001,abnormal intestinal transit time|MP:0006086,decreased body mass index|MP:0008108,abnormal small intestinal villus morphology|MP:0008109,abnormal small intestinal microvillus morphology|MP:0008141,decreased small intestinal microvillus size|MP:0009172,small pancreatic islets|MP:0009674,decreased birth weight|MP:0010025,decreased total body fat amount|MP:0010157,abnormal small intestinal crypt cell proliferation|MP:0010158,abnormal intestine development|MP:0010802,abnormal intestinal enteroendocrine cell morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011984,decreased enteroendocrine cell number
MGI:5049955	nevo	MP:0012269,nuchal edema|MP:0012270,cardiac edema
MGI:6156555	Nexmif<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000692,small spleen|MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0001552,increased circulating triglyceride level|MP:0001925,male infertility|MP:0002060,abnormal skin morphology|MP:0002590,increased mean corpuscular volume|MP:0002606,increased basophil cell number|MP:0002989,small kidney|MP:0003961,decreased lean body mass|MP:0005011,increased eosinophil cell number|MP:0005561,increased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0009454,impaired contextual conditioning behavior|MP:0010024,increased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010124,decreased bone mineral content|MP:0011874,enlarged urinary bladder
MGI:4419911	Nexmif<tm1(KOMP)Wtsi>	MP:0000418,focal hair loss|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001529,abnormal vocalization|MP:0002064,seizures|MP:0002083,premature death|MP:0002206,abnormal CNS synaptic transmission|MP:0002919,enhanced paired-pulse facilitation|MP:0003107,abnormal response to novelty|MP:0004924,abnormal behavior|MP:0004998,decreased CNS synapse formation|MP:0008414,abnormal spatial reference memory|MP:0008432,abnormal long-term spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0013117,focal hair loss in thorax region|MP:0020338,abnormal hippocampal pyramidal neuron dendrite morphology|MP:0020351,decreased vocalization|MP:0020395,abnormal response to social novelty|MP:0020508,decreased dendritic spine density|MP:0020510,increased dendritic spine length|MP:0020513,abnormal dendritic stubby spine morphology|MP:0020514,abnormal dendritic thin spine morphology|MP:0031391,increased locomotor activity
MGI:6510879	Nexn<em1Chen>	MP:0000278,abnormal myocardial fiber morphology|MP:0002795,dilated cardiomyopathy|MP:0005140,decreased cardiac muscle contractility|MP:0010579,increased heart left ventricle size|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011925,abnormal heart echocardiography feature
MGI:6510878	Nexn<tm1.1Chen>	MP:0000274,enlarged heart|MP:0001262,decreased body weight|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0005140,decreased cardiac muscle contractility|MP:0005385,cardiovascular system phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0011925,abnormal heart echocardiography feature|MP:0031147,abnormal ventricular thrombosis
MGI:5780982	Nexn<tm1.1Zhh>	MP:0000266,abnormal heart morphology|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0005140,decreased cardiac muscle contractility|MP:0010579,increased heart left ventricle size|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6510877	Nexn<tm1Chen>	MP:0000278,abnormal myocardial fiber morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0004215,abnormal myocardial fiber physiology|MP:0011085,postnatal lethality, complete penetrance|MP:0011925,abnormal heart echocardiography feature|MP:0031147,abnormal ventricular thrombosis
MGI:6510889	Nexn<tm2.1Chen>	MP:0005385,cardiovascular system phenotype
MGI:2682223	Nf1<Mhdadsk9>	MP:0000575,increased foot pad pigmentation|MP:0000762,abnormal tongue morphology|MP:0001148,enlarged testis|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0004182,abnormal spermiation|MP:0005536,decreased Leydig cell number|MP:0006380,abnormal spermatid morphology|MP:0009233,enlarged sperm head|MP:0011091,prenatal lethality, complete penetrance|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014635,increased round spermatid number|MP:0020355,abnormal Sertoli cell barrier morphology|MP:0030603,increased sperm number
MGI:6153136	Nf1<tm1.1Kest>	MP:0005312,pericardial effusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4364806	Nf1<tm1a(KOMP)Wtsi>	MP:0001260,increased body weight|MP:0002942,decreased circulating alanine transaminase level|MP:0005571,decreased lactate dehydrogenase level|MP:0005632,decreased circulating aspartate transaminase level|MP:0008858,abnormal hair cycle anagen phase|MP:0011100,preweaning lethality, complete penetrance
MGI:2137365	Nf1<tm1Cbr>	MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0002006,neoplasm|MP:0002802,abnormal discrimination learning|MP:0003631,nervous system phenotype
MGI:6153138	Nf1<tm1c(KOMP)Wtsi>	MP:0000755,hindlimb paralysis|MP:0001077,abnormal spinal nerve morphology|MP:0001194,dermatitis|MP:0001263,weight loss|MP:0001429,dehydration|MP:0002752,abnormal somatic nervous system morphology|MP:0005202,lethargy|MP:0010314,increased neurofibroma incidence
MGI:6275187	Nf1<tm1d(KOMP)Wtsi>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1857444	Nf1<tm1Fcr>	MP:0000255,blood vessel congestion|MP:0000267,abnormal heart development|MP:0000285,abnormal heart valve morphology|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000434,megacephaly|MP:0000528,delayed kidney development|MP:0000597,delayed hepatic development|MP:0000600,liver hypoplasia|MP:0000603,pale liver|MP:0000736,delayed muscle development|MP:0000914,exencephaly|MP:0001009,paravertebral ganglia hyperplasia|MP:0001010,prevertebral ganglia hyperplasia|MP:0001267,enlarged chest|MP:0001297,microphthalmia|MP:0001330,abnormal optic nerve morphology|MP:0001656,focal hepatic necrosis|MP:0001785,edema|MP:0001879,abnormal lymphatic vessel morphology|MP:0002108,abnormal muscle morphology|MP:0002190,disorganized myocardium|MP:0002633,persistent truncus arteriosus|MP:0002725,abnormal vein morphology|MP:0002740,heart hypoplasia|MP:0003808,increased atrioventricular cushion size|MP:0003888,liver hemorrhage|MP:0004505,decreased renal glomerulus number|MP:0005312,pericardial effusion|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006107,abnormal fetal atrioventricular canal morphology|MP:0009460,skeletal muscle hypoplasia|MP:0009967,abnormal neuron proliferation|MP:0010278,increased glioma incidence|MP:0010334,pleural effusion|MP:0010402,ventricular septal defect|MP:0010614,abnormal mitral valve cusp morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011364,abnormal metanephros morphology|MP:0020549,increased optic chiasm size|MP:0031511,globular heart
MGI:2176057	Nf1<tm1Par>	MP:0000061,fragile skeleton|MP:0000063,decreased bone mineral density|MP:0000163,abnormal cartilage morphology|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000284,double outlet right ventricle|MP:0000322,increased granulocyte number|MP:0000547,short limbs|MP:0000633,abnormal pituitary gland morphology|MP:0000639,abnormal adrenal gland morphology|MP:0000642,enlarged adrenal glands|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000729,abnormal myogenesis|MP:0000733,abnormal muscle development|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000863,abnormal secondary somatosensory cortex morphology|MP:0000913,abnormal brain development|MP:0000952,abnormal CNS glial cell morphology|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001505,hunched posture|MP:0001511,disheveled coat|MP:0001601,abnormal myelopoiesis|MP:0001732,postnatal growth retardation|MP:0001953,respiratory failure|MP:0002006,neoplasm|MP:0002020,increased tumor incidence|MP:0002050,increased pheochromocytoma incidence|MP:0002063,abnormal learning/memory/conditioning|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002108,abnormal muscle morphology|MP:0002123,abnormal definitive hematopoiesis|MP:0002152,abnormal brain morphology|MP:0002182,abnormal astrocyte morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002652,thin myocardium|MP:0002999,abnormal bone healing|MP:0003354,astrocytosis|MP:0003491,abnormal voluntary movement|MP:0003631,nervous system phenotype|MP:0003808,increased atrioventricular cushion size|MP:0003816,abnormal pituitary gland development|MP:0003834,abnormal adrenergic chromaffin cell morphology|MP:0003953,abnormal hormone level|MP:0004057,thin myocardium compact layer|MP:0004087,abnormal muscle fiber morphology|MP:0004232,decreased muscle weight|MP:0004819,decreased skeletal muscle mass|MP:0004924,abnormal behavior|MP:0004948,abnormal neuronal precursor proliferation|MP:0004984,increased osteoclast cell number|MP:0004987,abnormal osteoblast cell number|MP:0005013,increased lymphocyte cell number|MP:0005120,decreased circulating growth hormone level|MP:0005312,pericardial effusion|MP:0005361,small pituitary gland|MP:0005385,cardiovascular system phenotype|MP:0005645,abnormal hypothalamus physiology|MP:0005646,abnormal pituitary gland physiology|MP:0006254,thin cerebral cortex|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008143,abnormal dendrite morphology|MP:0008250,abnormal myeloid leukocyte morphology|MP:0008272,abnormal endochondral bone ossification|MP:0008288,abnormal adrenal cortex morphology|MP:0008302,thin adrenal cortex|MP:0008321,small adenohypophysis|MP:0008916,abnormal astrocyte physiology|MP:0009406,decreased skeletal muscle fiber number|MP:0009419,skeletal muscle fibrosis|MP:0010160,increased oligodendrocyte number|MP:0010361,increased gangliosarcoma incidence|MP:0010362,increased ganglioneuroma incidence|MP:0010402,ventricular septal defect|MP:0010924,abnormal osteoid morphology|MP:0010929,increased osteoid thickness|MP:0010964,increased compact bone volume|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011180,abnormal hematopoietic cell number|MP:0011808,abnormal myoblast differentiation|MP:0012138,decreased forebrain size|MP:0030947,increased myoblast proliferation
MGI:1857478	Nf1<tm1Tyj>	MP:0000284,double outlet right ventricle|MP:0000292,distended pericardium|MP:0001463,abnormal spatial learning|MP:0002020,increased tumor incidence|MP:0002026,increased leukemia incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002030,increased neurofibrosarcoma incidence|MP:0002031,increased adrenal gland tumor incidence|MP:0002050,increased pheochromocytoma incidence|MP:0002192,hydrops fetalis|MP:0002423,abnormal mast cell physiology|MP:0003717,pallor|MP:0005329,abnormal myocardium layer morphology|MP:0008764,increased mast cell degranulation|MP:0009845,abnormal neural crest cell morphology|MP:0010264,increased hepatoma incidence|MP:0010363,increased fibrosarcoma incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012431,increased lymphoma incidence
MGI:6153137	Nf1<tm2.1Kest>	MP:0002169,no abnormal phenotype detected
MGI:1888776	Nf2<tm1Gth>	MP:0000116,abnormal tooth development|MP:0002006,neoplasm|MP:0002027,increased lung adenocarcinoma incidence|MP:0002030,increased neurofibrosarcoma incidence|MP:0002032,increased sarcoma incidence|MP:0002703,abnormal renal tubule morphology|MP:0003631,nervous system phenotype|MP:0003789,increased osteosarcoma incidence|MP:0004986,abnormal osteoblast morphology|MP:0010309,increased mesothelioma incidence|MP:0010313,increased osteoma incidence|MP:0010314,increased neurofibroma incidence|MP:0010347,osseous metaplasia|MP:0010364,increased fibroadenoma incidence|MP:0010384,increased renal carcinoma incidence|MP:0011092,embryonic lethality, complete penetrance
MGI:5504369	Nf2<tm1Gvn>	MP:0005404,abnormal axon morphology
MGI:1857941	Nf2<tm1Tyj>	MP:0001683,absent mesoderm|MP:0001696,failure to gastrulate|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0001711,abnormal placenta morphology|MP:0002006,neoplasm|MP:0002018,increased malignant tumor incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0002038,increased carcinoma incidence|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002582,disorganized extraembryonic tissue|MP:0002583,absent extraembryonic ectoderm|MP:0002584,small ectoplacental cone|MP:0003789,increased osteosarcoma incidence|MP:0010363,increased fibrosarcoma incidence|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0012431,increased lymphoma incidence
MGI:1926957	Nf2<tm2.1Gth>	MP:0002006,neoplasm|MP:0002027,increased lung adenocarcinoma incidence|MP:0003631,nervous system phenotype|MP:0003789,increased osteosarcoma incidence|MP:0010313,increased osteoma incidence|MP:0010363,increased fibrosarcoma incidence|MP:0011092,embryonic lethality, complete penetrance
MGI:1926955	Nf2<tm2Gth>	MP:0000111,cleft palate|MP:0000116,abnormal tooth development|MP:0000121,failure of tooth eruption|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000681,abnormal thyroid gland morphology|MP:0001077,abnormal spinal nerve morphology|MP:0001106,abnormal Schwann cell morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001394,circling|MP:0001410,head bobbing|MP:0001512,trunk curl|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0001850,increased susceptibility to otitis media|MP:0001924,infertility|MP:0002006,neoplasm|MP:0002020,increased tumor incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002030,increased neurofibrosarcoma incidence|MP:0002032,increased sarcoma incidence|MP:0002041,increased pituitary adenoma incidence|MP:0002049,increased extremity angiosarcoma incidence|MP:0002083,premature death|MP:0002703,abnormal renal tubule morphology|MP:0003053,delayed tooth eruption|MP:0003237,abnormal lens epithelium morphology|MP:0003255,bile duct proliferation|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003631,nervous system phenotype|MP:0003789,increased osteosarcoma incidence|MP:0004269,abnormal optic cup morphology|MP:0004740,sensorineural hearing loss|MP:0004839,bile duct hyperplasia|MP:0004986,abnormal osteoblast morphology|MP:0005170,cleft upper lip|MP:0005191,head tilt|MP:0005253,abnormal eye physiology|MP:0005262,coloboma|MP:0005307,head tossing|MP:0005549,retina pigment epithelium hyperplasia|MP:0008490,enlarged dorsal root ganglion|MP:0008770,decreased survivor rate|MP:0009264,failure of eyelid fusion|MP:0010297,increased hepatobiliary system tumor incidence|MP:0010310,increased Schwannoma incidence|MP:0010311,increased meningioma incidence|MP:0010313,increased osteoma incidence|MP:0010347,osseous metaplasia|MP:0010353,increased odontoma incidence|MP:0010354,increased odontosarcoma incidence|MP:0010364,increased fibroadenoma incidence|MP:0010384,increased renal carcinoma incidence|MP:0010742,increased Schwann cell number|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012534,abnormal optic fissure morphology|MP:0013611,abnormal bile duct epithelium morphology|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:5504370	Nf2<tm2Gvn>	MP:0001405,impaired coordination|MP:0001973,increased thermal nociceptive threshold|MP:0005402,abnormal action potential|MP:0005404,abnormal axon morphology
MGI:6341941	Nfam1<em1(IMPC)Ccpcz>	MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0002100,abnormal tooth morphology|MP:0009709,hydrometra
MGI:3808598	Nfasc<tm1.1Brp>	MP:0000753,paralysis|MP:0002651,abnormal sciatic nerve morphology|MP:0005404,abnormal axon morphology|MP:0008814,decreased nerve conduction velocity|MP:0008917,abnormal oligodendrocyte physiology|MP:0011085,postnatal lethality, complete penetrance
MGI:4435919	Nfasc<tm1a(EUCOMM)Hmgu>	MP:0001552,increased circulating triglyceride level
MGI:3836177	Nfasc<tm1Bhat>	MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001516,abnormal motor coordination/balance|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0004263,abnormal limb posture|MP:0005404,abnormal axon morphology|MP:0008814,decreased nerve conduction velocity|MP:0011085,postnatal lethality, complete penetrance|MP:0014329,abnormal Purkinje cell axon morphology
MGI:4837620	Nfasc<tm2Bhat>	MP:0001263,weight loss|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0010734,abnormal paranode morphology|MP:0010735,abnormal paranodal axoglial junction morphology
MGI:5522568	Nfat5<tm1.1Itl>	MP:0001879,abnormal lymphatic vessel morphology|MP:0004875,increased mean systemic arterial blood pressure|MP:0012007,abnormal chloride level
MGI:4840524	Nfat5<tm1.1Joar>	MP:0002444,abnormal T cell physiology
MGI:5635252	Nfat5<tm1b(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0003019,increased circulating chloride level|MP:0005292,improved glucose tolerance|MP:0005344,increased circulating bilirubin level|MP:0005633,increased circulating sodium level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3038988	Nfat5<tm1Rao>	MP:0001732,postnatal growth retardation|MP:0001784,abnormal fluid regulation|MP:0002135,abnormal kidney morphology|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0004194,abnormal kidney pelvis morphology|MP:0004970,kidney atrophy|MP:0009640,abnormal renal tubule epithelium morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011304,kidney papillary atrophy|MP:0011332,abnormal kidney outer medulla morphology|MP:0011368,increased kidney apoptosis|MP:0011378,abnormal kidney outer medulla inner stripe morphology|MP:0011405,tubulointerstitial nephritis
MGI:5287396	Nfat5<tm1Skc>	MP:0000280,thin ventricular wall|MP:0001544,abnormal cardiovascular system physiology|MP:0001577,anemia|MP:0001785,edema|MP:0002189,abnormal myocardial trabeculae morphology|MP:0004056,abnormal myocardium compact layer morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation
MGI:3050805	Nfat5<tm1Snh>	MP:0000694,spleen hypoplasia|MP:0001805,decreased IgG level|MP:0001823,thymus hypoplasia|MP:0002490,abnormal immunoglobulin level|MP:0005095,decreased T cell proliferation|MP:0011089,perinatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:7425862	Nfatc1<em1(IMPC)Bay>	MP:0001392,abnormal locomotor behavior|MP:0011100,preweaning lethality, complete penetrance
MGI:7639766	Nfatc1<tm1.1Fbs>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004973,increased regulatory T cell number|MP:0005387,immune system phenotype|MP:0005673,decreased susceptibility to graft versus host disease|MP:0008567,decreased interferon-gamma secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008687,increased interleukin-2 secretion
MGI:2181762	Nfatc1<tm1Glm>	MP:0000266,abnormal heart morphology|MP:0000301,decreased atrioventricular cushion size|MP:0000465,gastrointestinal hemorrhage|MP:0001544,abnormal cardiovascular system physiology|MP:0001785,edema|MP:0002128,abnormal blood circulation|MP:0002746,abnormal semilunar valve morphology|MP:0003717,pallor|MP:0005312,pericardial effusion|MP:0006049,semilunar valve regurgitation|MP:0006126,abnormal cardiac outflow tract development|MP:0010402,ventricular septal defect|MP:0010597,absent aortic valve cusps|MP:0010604,absent pulmonary valve cusps|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2181766	Nfatc1<tm1Mak>	MP:0000281,abnormal interventricular septum morphology|MP:0001577,anemia|MP:0001625,cardiac hypertrophy|MP:0001785,edema|MP:0006126,abnormal cardiac outflow tract development|MP:0010614,abnormal mitral valve cusp morphology|MP:0010622,abnormal tricuspid valve cusp morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0013241,embryo tissue necrosis|MP:0031551,abnormal mitral valve development|MP:0031552,abnormal tricuspid valve development|MP:0031553,abnormal semilunar valve development
MGI:5295237	Nfatc1<tm1Rao>	MP:0001806,decreased IgM level|MP:0002459,abnormal B cell physiology|MP:0002494,increased IgM level|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004816,abnormal class switch recombination|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0008168,decreased B-1a cell number|MP:0008193,abnormal marginal zone B cell physiology|MP:0008496,decreased IgG2a level|MP:0008498,decreased IgG3 level|MP:0008660,increased interleukin-10 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008782,increased B cell apoptosis|MP:0014469,abnormal B cell calcium ion homeostasis
MGI:3831720	Nfatc1<tm3Glm>	MP:0000067,osteopetrosis|MP:0002764,short tibia|MP:0003109,short femur|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0004595,abnormal mandibular condyloid process morphology|MP:0004686,decreased length of long bones|MP:0004791,absent lower incisors|MP:0004985,decreased osteoclast cell number|MP:0005390,skeleton phenotype|MP:0008272,abnormal endochondral bone ossification|MP:0008396,abnormal osteoclast differentiation|MP:0030083,long upper incisors|MP:0030089,short lower incisors
MGI:6336082	Nfatc2ip<em1(IMPC)Ics>	MP:0000194,increased circulating calcium level|MP:0001392,abnormal locomotor behavior|MP:0005011,increased eosinophil cell number
MGI:4437260	Nfatc2ip<tm1.1Glm>	MP:0000336,decreased mast cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005466,abnormal T-helper 2 physiology|MP:0008091,decreased T-helper 2 cell number|MP:0008246,abnormal leukocyte morphology|MP:0008567,decreased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion|MP:0008603,decreased circulating interleukin-4 level|MP:0008673,decreased interleukin-13 secretion|MP:0008697,decreased interleukin-3 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion
MGI:5563447	Nfatc2<m1Anu>	MP:0005387,immune system phenotype
MGI:2182740	Nfatc2<tm1Glm>	MP:0005382,craniofacial phenotype
MGI:2182743	Nfatc2<tm1Rao>	MP:0002423,abnormal mast cell physiology|MP:0008561,decreased tumor necrosis factor secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008700,decreased interleukin-4 secretion
MGI:2182770	Nfatc2<tm1Srf>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000708,thymus hyperplasia|MP:0000709,enlarged thymus|MP:0001790,abnormal immune system physiology|MP:0001824,abnormal thymus involution|MP:0001829,increased activated T cell number|MP:0002339,abnormal lymph node morphology|MP:0002344,abnormal lymph node B cell domain morphology|MP:0002359,abnormal spleen germinal center morphology|MP:0002444,abnormal T cell physiology|MP:0002458,abnormal B cell number|MP:0002459,abnormal B cell physiology|MP:0002461,increased immunoglobulin level|MP:0002497,increased IgE level|MP:0002722,abnormal immune system organ morphology|MP:0003945,abnormal lymphocyte physiology|MP:0005013,increased lymphocyte cell number|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0008102,lymph node hyperplasia|MP:0008499,increased IgG1 level|MP:0008567,decreased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion
MGI:3820411	Nfatc3<tm1.1Grc>	MP:0001935,decreased litter size|MP:0005387,immune system phenotype|MP:0008101,lymph node hypoplasia|MP:0008770,decreased survivor rate|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5548344	Nfatc3<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001488,increased startle reflex|MP:0011100,preweaning lethality, complete penetrance
MGI:2182778	Nfatc3<tm1Glm>	MP:0000747,muscle weakness|MP:0000759,abnormal skeletal muscle morphology|MP:0001698,decreased embryo size|MP:0001788,periorbital edema|MP:0004486,decreased response of heart to induced stress|MP:0009406,decreased skeletal muscle fiber number|MP:0009424,decreased extensor digitorum longus weight|MP:0009426,decreased soleus weight|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3820410	Nfatc3<tm1Grc>	MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0002169,no abnormal phenotype detected|MP:0005090,increased double-negative T cell number|MP:0006413,increased T cell apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008101,lymph node hypoplasia
MGI:5554925	Nfatc4<tm1.1(KOMP)Vlcg>	MP:0002833,increased heart weight|MP:0005633,increased circulating sodium level|MP:0013278,decreased fasting circulating glucose level
MGI:2388915	Nfatc4<tm1Jmk>	MP:0001625,cardiac hypertrophy|MP:0005385,cardiovascular system phenotype
MGI:7425863	Nfe2<em1(IMPC)Ccpcz>	MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000438,abnormal cranium morphology|MP:0000689,abnormal spleen morphology|MP:0001312,abnormal cornea morphology|MP:0003036,vertebral transformation|MP:0004599,abnormal vertebral arch morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5804004	Nfe2l1<tm1.1Mym>	MP:0002727,decreased circulating insulin level|MP:0005378,growth/size/body region phenotype|MP:0005560,decreased circulating glucose level|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3828165	Nfe2l1<tm1Mym>	MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level
MGI:2385936	Nfe2l1<tm1Tow>	MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0002396,abnormal hematopoietic system morphology/development|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance
MGI:2385929	Nfe2l1<tm1Ywk>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000601,small liver|MP:0000603,pale liver|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0003674,oxidative stress|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0009395,increased nucleated erythrocyte cell number|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:7426127	Nfe2l2<em1(IMPC)Ccpcz>	MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002100,abnormal tooth morphology|MP:0002339,abnormal lymph node morphology|MP:0002599,increased mean platelet volume|MP:0002608,increased hematocrit|MP:0002968,increased circulating alkaline phosphatase level|MP:0002997,enlarged seminal vesicle|MP:0003131,increased erythrocyte cell number|MP:0003402,decreased liver weight|MP:0005344,increased circulating bilirubin level|MP:0005553,increased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:5463890	Nfe2l2<tm1.1Sred>	MP:0000313,abnormal cell death|MP:0008561,decreased tumor necrosis factor secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0014600,increased susceptibility to hyperoxia-induced injury
MGI:2385925	Nfe2l2<tm1Mym>	MP:0000129,ameloblast degeneration|MP:0000189,hypoglycemia|MP:0000702,enlarged lymph nodes|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001394,circling|MP:0001770,abnormal iron level|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002083,premature death|MP:0002100,abnormal tooth morphology|MP:0002133,abnormal respiratory system physiology|MP:0002451,abnormal macrophage physiology|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002576,abnormal enamel morphology|MP:0002743,glomerulonephritis|MP:0002941,increased circulating alanine transaminase level|MP:0002962,increased urine protein level|MP:0003076,increased susceptibility to ischemic brain injury|MP:0003628,abnormal leukocyte adhesion|MP:0003674,oxidative stress|MP:0003887,increased hepatocyte apoptosis|MP:0004499,increased incidence of tumors by chemical induction|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004821,increased susceptibility to experimental autoimmune uveoretinitis|MP:0004924,abnormal behavior|MP:0004952,increased spleen weight|MP:0005018,decreased T cell number|MP:0005088,increased acute inflammation|MP:0005150,cachexia|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0005630,increased lung weight|MP:0005637,abnormal iron homeostasis|MP:0006050,pulmonary fibrosis|MP:0006060,increased cerebral infarct size|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008537,increased susceptibility to induced colitis|MP:0008553,increased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level|MP:0008807,increased liver iron level|MP:0008872,abnormal physiological response to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010096,abnormal incisor color|MP:0010301,increased stomach tumor incidence|MP:0011320,abnormal glomerular capillary morphology|MP:0011339,abnormal glomerular mesangium morphology|MP:0011427,increased mesangial cell number|MP:0011440,increased kidney cell proliferation|MP:0011471,decreased urine creatinine level|MP:0011506,glomerular crescent|MP:0031115,macrovesicular hepatic steatosis
MGI:2385960	Nfe2l2<tm1Ney>	MP:0005397,hematopoietic system phenotype
MGI:5509351	Nfe2l2<tm1Sud>	MP:0002169,no abnormal phenotype detected
MGI:2385926	Nfe2l2<tm1Ywk>	MP:0000208,decreased hematocrit|MP:0000314,schistocytosis|MP:0000609,abnormal liver physiology|MP:0000691,enlarged spleen|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001182,lung hemorrhage|MP:0001585,hemolytic anemia|MP:0001922,reduced male fertility|MP:0002118,abnormal lipid homeostasis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002463,abnormal neutrophil physiology|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002654,spongiform encephalopathy|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002944,increased lactate dehydrogenase level|MP:0003179,thrombocytopenia|MP:0003354,astrocytosis|MP:0003402,decreased liver weight|MP:0003507,abnormal ovary physiology|MP:0003656,abnormal erythrocyte physiology|MP:0003668,abnormal periodontal ligament morphology|MP:0003674,oxidative stress|MP:0003871,abnormal myelin sheath morphology|MP:0004001,decreased hepatocyte proliferation|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004852,decreased testis weight|MP:0004875,increased mean systemic arterial blood pressure|MP:0004882,enlarged lung|MP:0004929,decreased epididymis weight|MP:0004952,increased spleen weight|MP:0005165,increased susceptibility to injury|MP:0005319,abnormal enzyme/coenzyme level|MP:0005344,increased circulating bilirubin level|MP:0005367,renal/urinary system phenotype|MP:0005371,limbs/digits/tail phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0005397,hematopoietic system phenotype|MP:0005425,increased macrophage cell number|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006362,abnormal male germ cell morphology|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0008469,abnormal protein level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008737,abnormal spleen physiology|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008995,early reproductive senescence|MP:0009322,increased splenocyte apoptosis|MP:0009333,abnormal splenocyte physiology|MP:0009433,polyovular ovarian follicle|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010177,acanthocytosis|MP:0010178,increased number of Howell-Jolly bodies|MP:0010768,mortality/aging|MP:0011121,decreased primordial ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0011603,decreased glutathione peroxidase activity|MP:0012604,decreased glutathione level|MP:0012652,decreased catalase level|MP:0013129,abnormal tooth color|MP:0013501,increased fibroblast apoptosis|MP:0014052,increased male germ cell apoptosis|MP:0014433,increased cytokine level|MP:0030466,alveolar process atrophy|MP:0031324,delayed liver regeneration
MGI:3045075	Nfe2l3<tm1Vbl>	MP:0002169,no abnormal phenotype detected
MGI:6446746	Nfe2<tm1.1Hlpa>	MP:0009439,increased myeloid sarcoma incidence|MP:0020838,increased acute myeloid leukemia incidence
MGI:1857224	Nfe2<tm1Sho>	MP:0000691,enlarged spleen|MP:0001265,decreased body size|MP:0001545,abnormal hematopoietic system physiology|MP:0001577,anemia|MP:0001634,internal hemorrhage|MP:0002021,increased incidence of induced tumors|MP:0002417,abnormal megakaryocyte morphology|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0003179,thrombocytopenia|MP:0003714,absent platelets|MP:0003717,pallor|MP:0004984,increased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0008254,increased megakaryocyte cell number|MP:0008770,decreased survivor rate|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010878,increased trabecular bone volume|MP:0010961,increased compact bone mass|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0020039,increased bone ossification|MP:0020399,enhanced megakaryocyte emperipolesis|MP:0020934,increased susceptibility to Retroviridae infection
MGI:2449024	Nfia<tm1Rmg>	MP:0000519,hydronephrosis|MP:0000520,absent kidney|MP:0000745,tremors|MP:0000780,abnormal corpus callosum morphology|MP:0000807,abnormal hippocampus morphology|MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0000857,abnormal cerebellar foliation|MP:0000889,abnormal cerebellar molecular layer|MP:0001265,decreased body size|MP:0001891,hydrocephaly|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002196,absent corpus callosum|MP:0002705,dilated renal tubule|MP:0003586,dilated ureter|MP:0003634,abnormal glial cell morphology|MP:0003651,abnormal axon extension|MP:0003672,abnormal ureter development|MP:0003675,kidney cyst|MP:0003718,maternal effect|MP:0004017,duplex kidney|MP:0004098,abnormal cerebellar granule cell morphology|MP:0008221,abnormal hippocampal commissure morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011488,abnormal ureterovesical junction morphology|MP:0011493,double ureter|MP:0011495,abnormal head shape|MP:0012545,syringomyelia
MGI:2178748	Nfib<tm1Hsch>	MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001178,pulmonary hypoplasia|MP:0001302,eyelids open at birth|MP:0001575,cyanosis|MP:0001943,abnormal respiration|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0009264,failure of eyelid fusion|MP:0010825,abnormal lung saccule morphology|MP:0010826,absent lung saccules|MP:0011032,impaired branching involved in terminal bronchiole morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011143,thick lung-associated mesenchyme|MP:0011163,increased wet-to-dry lung weight ratio
MGI:3530139	Nfib<tm1Rmg>	MP:0000780,abnormal corpus callosum morphology|MP:0000808,abnormal hippocampus development|MP:0000814,absent dentate gyrus|MP:0000848,abnormal pons morphology|MP:0000853,absent cerebellar foliation|MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0002133,abnormal respiratory system physiology|MP:0002196,absent corpus callosum|MP:0003005,abnormal hippocampal fimbria morphology|MP:0003634,abnormal glial cell morphology|MP:0003792,abnormal major salivary gland morphology|MP:0003935,abnormal craniofacial development|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004200,decreased fetal size|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0008268,absent hippocampus CA3 region|MP:0009520,decreased submandibular gland size|MP:0009522,submandibular gland hypoplasia|MP:0010768,mortality/aging|MP:0010826,absent lung saccules|MP:0010827,small lung saccule|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011380,enlarged brain ventricles|MP:0013541,abnormal submandibular gland development
MGI:5052268	Nfib<tm2Rmg>	MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0002133,abnormal respiratory system physiology|MP:0004882,enlarged lung|MP:0005388,respiratory system phenotype|MP:0010825,abnormal lung saccule morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:7545651	Nfic<em1(IMPC)Ccpcz>	MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0002100,abnormal tooth morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003233,prolonged QT interval|MP:0003402,decreased liver weight|MP:0003961,decreased lean body mass|MP:0004122,abnormal sinus arrhythmia|MP:0004156,abnormal QT variability|MP:0005270,abnormal zygomatic bone morphology|MP:0005333,decreased heart rate|MP:0005385,cardiovascular system phenotype|MP:0009142,decreased prepulse inhibition|MP:0010068,decreased red blood cell distribution width|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010379,decreased respiratory quotient|MP:0010506,prolonged RR interval|MP:0010570,prolonged ST segment
MGI:2450153	Nfic<tm1Rmg>	MP:0000116,abnormal tooth development|MP:0000126,brittle teeth|MP:0001265,decreased body size|MP:0001431,abnormal eating behavior|MP:0002083,premature death|MP:0002689,abnormal molar morphology|MP:0002818,abnormal dentin morphology|MP:0003631,nervous system phenotype|MP:0004592,small mandible|MP:0004791,absent lower incisors|MP:0005389,reproductive system phenotype|MP:0011165,abnormal tooth root development|MP:0011166,absent molar root|MP:0030083,long upper incisors|MP:0030136,abnormal lower incisor morphology|MP:0030137,abnormal upper incisor morphology|MP:0030489,abnormal molar socket morphology
MGI:4360908	Nfil3<tm1.1Brad>	MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005387,immune system phenotype|MP:0008039,increased NK T cell number|MP:0008045,decreased NK cell number|MP:0008049,increased memory T cell number|MP:0008053,abnormal NK cell differentiation|MP:0008567,decreased interferon-gamma secretion
MGI:5708176	Nfil3<tm1.1(KOMP)Vlcg>	MP:0000494,abnormal cecum morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0001312,abnormal cornea morphology|MP:0001944,abnormal pancreas morphology|MP:0004952,increased spleen weight|MP:0005542,cornea vascularization|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5005060	Nfil3<tm1.1Kubo>	MP:0001262,decreased body weight|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005036,diarrhea|MP:0005381,digestive/alimentary phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0008568,abnormal interleukin secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008712,decreased interleukin-9 secretion
MGI:6460440	Nfil3<tm1.2Kubo>	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008127,decreased dendritic cell number
MGI:4361260	Nfil3<tm1Look>	MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005387,immune system phenotype|MP:0008045,decreased NK cell number|MP:0008053,abnormal NK cell differentiation|MP:0008567,decreased interferon-gamma secretion
MGI:4436769	Nfil3<tm1Pbro>	MP:0000493,rectal prolapse|MP:0000495,abnormal colon morphology|MP:0000512,intestinal ulcer|MP:0002439,abnormal plasma cell morphology|MP:0002492,decreased IgE level|MP:0002816,colitis|MP:0003009,abnormal cytokine secretion|MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype|MP:0008045,decreased NK cell number|MP:0008246,abnormal leukocyte morphology|MP:0008495,decreased IgG1 level|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008593,increased circulating interleukin-10 level|MP:0008614,increased circulating interleukin-17 level|MP:0008647,increased circulating interleukin-12b level|MP:0008660,increased interleukin-10 secretion|MP:0008669,increased interleukin-12b secretion|MP:0008681,increased interleukin-17 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0010210,abnormal circulating cytokine level|MP:0010219,increased T-helper 17 cell number|MP:0011078,increased macrophage cytokine production|MP:0013795,abnormal colon goblet cell morphology
MGI:3802571	Nfix<tm1.1Rmg>	MP:0000780,abnormal corpus callosum morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000859,abnormal somatosensory cortex morphology|MP:0001263,weight loss|MP:0001290,delayed eyelid opening|MP:0001360,abnormal social investigation|MP:0002152,abnormal brain morphology|MP:0002176,increased brain weight|MP:0002199,abnormal brain commissure morphology|MP:0002729,abnormal inner ear canal morphology|MP:0005238,increased brain size|MP:0005382,craniofacial phenotype|MP:0008221,abnormal hippocampal commissure morphology|MP:0008225,abnormal anterior commissure morphology|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008431,abnormal short-term spatial reference memory|MP:0008432,abnormal long-term spatial reference memory|MP:0008439,abnormal cortical plate morphology|MP:0008489,slow postnatal weight gain|MP:0008535,enlarged lateral ventricles|MP:0008547,abnormal neocortex morphology|MP:0012293,impaired active avoidance behavior|MP:0012307,impaired spatial learning|MP:0012473,increased cingulate cortex size|MP:0012489,abnormal retrosplenial region morphology|MP:0020067,increased neocortex size|MP:0020395,abnormal response to social novelty
MGI:3714028	Nfix<tm1Aes>	MP:0000060,delayed bone ossification|MP:0000135,decreased compact bone thickness|MP:0000141,abnormal vertebral body morphology|MP:0000160,kyphosis|MP:0000161,scoliosis|MP:0000162,lordosis|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000434,megacephaly|MP:0000440,domed cranium|MP:0000496,abnormal small intestine morphology|MP:0000780,abnormal corpus callosum morphology|MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001513,limb grasping|MP:0001891,hydrocephaly|MP:0002116,abnormal craniofacial bone morphology|MP:0002835,abnormal cranial suture morphology|MP:0002896,abnormal bone mineralization|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003419,delayed endochondral bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004173,abnormal intervertebral disk morphology|MP:0004174,abnormal spine curvature|MP:0004684,intervertebral disk degeneration|MP:0004874,abnormal timing of postnatal eyelid opening|MP:0006398,increased long bone epiphyseal plate size|MP:0009346,decreased trabecular bone thickness|MP:0010873,decreased trabecular bone mass|MP:0011084,lethality at weaning, incomplete penetrance
MGI:3802570	Nfix<tm1Rmg>	MP:0002169,no abnormal phenotype detected
MGI:2678387	Nfkb1<Gt(pT1ATGBetageo)1Ruiz>	MP:0002169,no abnormal phenotype detected
MGI:5607766	Nfkb1<M1Btlr>	MP:0001805,decreased IgG level|MP:0020154,impaired humoral immune response
MGI:6113387	Nfkb1<m2Btlr>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002492,decreased IgE level|MP:0010842,decreased central memory CD4-positive, alpha-beta T cell number|MP:0010845,decreased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6113381	Nfkb1<M3Btlr>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0002492,decreased IgE level|MP:0008537,increased susceptibility to induced colitis|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number
MGI:6200021	Nfkb1<M4Btlr>	MP:0004978,decreased B-1 B cell number
MGI:6283996	Nfkb1<M5Btlr>	MP:0002492,decreased IgE level|MP:0008168,decreased B-1a cell number|MP:0008658,decreased interleukin-1 beta secretion
MGI:6284012	Nfkb1<M6Btlr>	MP:0002492,decreased IgE level
MGI:4363738	Nfkb1<tm1a(KOMP)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0000688,lymphoid hyperplasia|MP:0001191,abnormal skin condition|MP:0001312,abnormal cornea morphology|MP:0001554,increased circulating free fatty acids level|MP:0001807,decreased IgA level|MP:0001973,increased thermal nociceptive threshold|MP:0002412,increased susceptibility to bacterial infection|MP:0002968,increased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0003998,decreased thermal nociceptive threshold|MP:0004974,decreased regulatory T cell number|MP:0005634,decreased circulating sodium level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008045,decreased NK cell number|MP:0008495,decreased IgG1 level|MP:0008805,decreased circulating amylase level|MP:0010379,decreased respiratory quotient
MGI:1857225	Nfkb1<tm1Bal>	MP:0000495,abnormal colon morphology|MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002083,premature death|MP:0002376,abnormal dendritic cell physiology|MP:0002389,abnormal Peyer's patch follicle morphology|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002392,abnormal Peyer's patch T cell area morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002452,abnormal professional antigen presenting cell physiology|MP:0002459,abnormal B cell physiology|MP:0002460,decreased immunoglobulin level|MP:0002492,decreased IgE level|MP:0002857,cochlear ganglion degeneration|MP:0003009,abnormal cytokine secretion|MP:0003303,peritoneal inflammation|MP:0003304,large intestinal inflammation|MP:0004231,abnormal calcium ion homeostasis|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004417,decreased cochlear nerve compound action potential|MP:0004597,increased susceptibility to noise-induced hearing loss|MP:0004748,increased susceptibility to age-related hearing loss|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0004816,abnormal class switch recombination|MP:0005036,diarrhea|MP:0005093,decreased B cell proliferation|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0006042,increased apoptosis|MP:0008122,decreased myeloid dendritic cell number|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0008182,decreased marginal zone B cell number|MP:0008495,decreased IgG1 level|MP:0008706,decreased interleukin-6 secretion|MP:0009481,cecum inflammation|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0031039,decreased susceptibility to Picornaviridae infection induced morbidity/mortality
MGI:2179707	Nfkb1<tm1Brv>	MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001732,postnatal growth retardation|MP:0001800,abnormal humoral immune response|MP:0001845,abnormal inflammatory response|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002083,premature death|MP:0002221,abnormal lymph organ size|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002412,increased susceptibility to bacterial infection|MP:0002461,increased immunoglobulin level|MP:0002497,increased IgE level|MP:0002875,decreased erythrocyte cell number|MP:0003009,abnormal cytokine secretion|MP:0003945,abnormal lymphocyte physiology|MP:0004985,decreased osteoclast cell number|MP:0005095,decreased T cell proliferation|MP:0005154,increased B cell proliferation|MP:0005202,lethargy|MP:0005390,skeleton phenotype|MP:0008083,decreased single-positive T cell number|MP:0008498,decreased IgG3 level|MP:0008499,increased IgG1 level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0010179,rough coat|MP:0010373,myeloid hyperplasia|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3822895	Nfkb1<tm1Sley>	MP:0002353,abnormal inguinal lymph node morphology|MP:0004974,decreased regulatory T cell number|MP:0005095,decreased T cell proliferation|MP:0008040,decreased NK T cell number|MP:0008050,decreased memory T cell number|MP:0008561,decreased tumor necrosis factor secretion|MP:0008600,decreased circulating interleukin-2 level|MP:0009622,absent inguinal lymph nodes|MP:0009624,small inguinal lymph nodes
MGI:4412046	Nfkb2<Lym1>	MP:0000067,osteopetrosis|MP:0000130,abnormal trabecular bone morphology|MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0001844,autoimmune response|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002219,decreased lymph node number|MP:0002339,abnormal lymph node morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002358,abnormal spleen periarteriolar lymphoid sheath morphology|MP:0002364,abnormal thymus size|MP:0002460,decreased immunoglobulin level|MP:0002831,absent Peyer's patches|MP:0003763,abnormal thymus physiology|MP:0004816,abnormal class switch recombination|MP:0004952,increased spleen weight|MP:0005013,increased lymphocyte cell number|MP:0005090,increased double-negative T cell number|MP:0005091,increased double-positive T cell number|MP:0005093,decreased B cell proliferation|MP:0005232,abnormal mesenteric lymph node morphology|MP:0005397,hematopoietic system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008099,abnormal plasma cell differentiation|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008189,increased transitional stage B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008211,decreased mature B cell number|MP:0008396,abnormal osteoclast differentiation|MP:0008463,abnormal peripheral lymph node morphology|MP:0008465,absent mesenteric lymph nodes|MP:0008471,abnormal spleen primary B follicle morphology|MP:0008473,abnormal spleen follicular dendritic cell network|MP:0008476,increased spleen red pulp amount|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008827,abnormal thymus cell ratio|MP:0009622,absent inguinal lymph nodes|MP:0009628,absent brachial lymph nodes|MP:0009630,absent axillary lymph nodes|MP:0009633,absent cervical lymph nodes
MGI:5640748	Nfkb2<m2Btlr>	MP:0008167,increased B-1a cell number
MGI:6305796	Nfkb2<m3Btlr>	MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0004977,increased B-1 B cell number|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0008045,decreased NK cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0010851,decreased effector memory CD8-positive, alpha-beta T cell number|MP:0013436,increased CD8-positive, naive alpha-beta T cell number
MGI:6305800	Nfkb2<M4Btlr>	MP:0005015,increased T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:6305804	Nfkb2<m5Btlr>	MP:0004977,increased B-1 B cell number
MGI:2179689	Nfkb2<tm1Brv>	MP:0000322,increased granulocyte number|MP:0000694,spleen hypoplasia|MP:0000702,enlarged lymph nodes|MP:0000717,abnormal lymphocyte cell number|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001505,hunched posture|MP:0001511,disheveled coat|MP:0001577,anemia|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002343,abnormal lymph node cortex morphology|MP:0002344,abnormal lymph node B cell domain morphology|MP:0002397,abnormal bone marrow morphology|MP:0002691,small stomach|MP:0003009,abnormal cytokine secretion|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0003944,abnormal T cell subpopulation ratio|MP:0004953,decreased spleen weight|MP:0005092,decreased double-positive T cell number|MP:0005154,increased B cell proliferation|MP:0005348,increased T cell proliferation|MP:0005449,abnormal food intake|MP:0005493,stomach epithelial hyperplasia|MP:0006387,abnormal T cell number|MP:0008475,intermingled spleen red and white pulp|MP:0008560,increased tumor necrosis factor secretion|MP:0008660,increased interleukin-10 secretion|MP:0008687,increased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0009543,abnormal thymus corticomedullary boundary morphology|MP:0010798,abnormal stomach cardiac region morphology
MGI:2675476	Nfkb2<tm1Rsch>	MP:0000696,abnormal Peyer's patch morphology|MP:0002389,abnormal Peyer's patch follicle morphology|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002392,abnormal Peyer's patch T cell area morphology|MP:0005017,decreased B cell number|MP:0006173,abnormal myeloid dendritic cell morphology|MP:0008122,decreased myeloid dendritic cell number|MP:0008127,decreased dendritic cell number|MP:0008135,small Peyer's patches|MP:0008524,increased plasmacytoid dendritic cell number
MGI:2179705	Nfkb2<tm1Sbn>	MP:0000717,abnormal lymphocyte cell number|MP:0001807,decreased IgA level|MP:0002357,abnormal spleen white pulp morphology|MP:0002362,abnormal spleen marginal zone morphology|MP:0002490,abnormal immunoglobulin level|MP:0002494,increased IgM level|MP:0004816,abnormal class switch recombination|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0008240,abnormal spleen marginal zone macrophage morphology|MP:0008241,abnormal metallophilic macrophage morphology|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008474,absent spleen germinal center|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011708,decreased fibroblast cell migration|MP:0020416,decreased fibroblast chemotaxis
MGI:2180306	Nfkb2<tm2Brv>	MP:0000689,abnormal spleen morphology|MP:0001807,decreased IgA level|MP:0002339,abnormal lymph node morphology|MP:0002494,increased IgM level|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008234,absent spleen marginal zone|MP:0008241,abnormal metallophilic macrophage morphology|MP:0008343,abnormal gamma-delta T cell morphology|MP:0008347,decreased gamma-delta T cell number|MP:0008474,absent spleen germinal center|MP:0008495,decreased IgG1 level|MP:0008498,decreased IgG3 level|MP:0008500,increased IgG2a level|MP:0008523,absent lymph node germinal center|MP:0009322,increased splenocyte apoptosis
MGI:2667230	Nfkb2<xdr>	MP:0000689,abnormal spleen morphology|MP:0004977,increased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005397,hematopoietic system phenotype|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008207,decreased B-2 B cell number|MP:0008211,decreased mature B cell number|MP:0008241,abnormal metallophilic macrophage morphology|MP:0008463,abnormal peripheral lymph node morphology|MP:0008472,abnormal spleen secondary B follicle morphology|MP:0008473,abnormal spleen follicular dendritic cell network|MP:0009926,decreased transitional stage T2 B cell number
MGI:3577710	Nfkbia<tm1.1Kbp>	MP:0000245,abnormal erythropoiesis|MP:0000321,increased bone marrow cell number|MP:0000322,increased granulocyte number|MP:0001732,postnatal growth retardation|MP:0002441,abnormal granulocyte morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:4829878	Nfkbia<tm1.1Pjc>	MP:0000714,increased thymocyte number|MP:0001828,abnormal T cell activation|MP:0001829,increased activated T cell number|MP:0001844,autoimmune response|MP:0002083,premature death|MP:0002499,chronic inflammation|MP:0002869,increased anti-insulin autoantibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005091,increased double-positive T cell number|MP:0005348,increased T cell proliferation|MP:0006387,abnormal T cell number|MP:0006413,increased T cell apoptosis|MP:0008049,increased memory T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008553,increased circulating tumor necrosis factor level|MP:0008614,increased circulating interleukin-17 level|MP:0008638,increased circulating interleukin-1 alpha level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010210,abnormal circulating cytokine level
MGI:4941306	Nfkbia<tm1.1Smiy>	MP:0001807,decreased IgA level|MP:0002144,abnormal B cell differentiation|MP:0003132,increased pre-B cell number|MP:0004974,decreased regulatory T cell number|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0008174,decreased follicular B cell number|MP:0008180,abnormal marginal zone B cell morphology|MP:0008182,decreased marginal zone B cell number|MP:0008186,increased pro-B cell number|MP:0008207,decreased B-2 B cell number|MP:0008211,decreased mature B cell number|MP:0008214,increased immature B cell number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0009926,decreased transitional stage T2 B cell number|MP:0010674,increased activation-induced B cell apoptosis|MP:0010836,decreased CD4-positive, alpha-beta memory T cell number
MGI:1858084	Nfkbia<tm1Bal>	MP:0000218,increased leukocyte cell number|MP:0001191,abnormal skin condition|MP:0001192,scaly skin|MP:0001195,flaky skin|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001265,decreased body size|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0005092,decreased double-positive T cell number|MP:0008111,abnormal granulocyte differentiation|MP:0011085,postnatal lethality, complete penetrance
MGI:3654110	Nfkbia<tm1Fey>	MP:0000692,small spleen|MP:0000715,decreased thymocyte number|MP:0001190,reddish skin|MP:0001192,scaly skin|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001800,abnormal humoral immune response|MP:0002144,abnormal B cell differentiation|MP:0002493,increased IgG level|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0003644,thymus atrophy|MP:0003853,dry skin|MP:0005076,abnormal cell differentiation|MP:0005089,decreased double-negative T cell number|MP:0005095,decreased T cell proliferation|MP:0005154,increased B cell proliferation|MP:0005621,abnormal cell physiology|MP:0008082,increased single-positive T cell number|MP:0008474,absent spleen germinal center|MP:0011085,postnatal lethality, complete penetrance
MGI:3577709	Nfkbia<tm1Kbp>	MP:0005397,hematopoietic system phenotype
MGI:3630257	Nfkbia<tm1(Nfkbib)Brv>	MP:0002169,no abnormal phenotype detected
MGI:3616190	Nfkbia<tm1Stw>	MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0001194,dermatitis|MP:0001195,flaky skin|MP:0001209,spontaneous skin ulceration|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001601,abnormal myelopoiesis|MP:0001732,postnatal growth retardation|MP:0001874,acanthosis|MP:0002451,abnormal macrophage physiology|MP:0002655,abnormal keratinocyte morphology|MP:0003853,dry skin|MP:0005425,increased macrophage cell number|MP:0008752,abnormal tumor necrosis factor level|MP:0011085,postnatal lethality, complete penetrance
MGI:5296337	Nfkbib<tm1.2Rsch>	MP:0000685,abnormal immune system morphology|MP:0001790,abnormal immune system physiology|MP:0003009,abnormal cytokine secretion|MP:0005017,decreased B cell number|MP:0005425,increased macrophage cell number|MP:0008049,increased memory T cell number|MP:0008181,increased marginal zone B cell number|MP:0008556,abnormal tumor necrosis factor secretion|MP:0008656,abnormal interleukin-1 beta secretion|MP:0008704,abnormal interleukin-6 secretion|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:4822433	Nfkbib<tm1Bal>	MP:0003436,decreased susceptibility to induced arthritis|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008597,decreased circulating interleukin-6 level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:3687303	Nfkbib<tm1Jpmz>	MP:0002169,no abnormal phenotype detected
MGI:5428994	Nfkbid<m1Btlr>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0004816,abnormal class switch recombination|MP:0004978,decreased B-1 B cell number|MP:0005093,decreased B cell proliferation|MP:0005387,immune system phenotype|MP:0008168,decreased B-1a cell number|MP:0008183,absent marginal zone B cells|MP:0008495,decreased IgG1 level|MP:0008498,decreased IgG3 level|MP:0008782,increased B cell apoptosis
MGI:4432464	Nfkbid<tm1a(EUCOMM)Wtsi>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0004816,abnormal class switch recombination|MP:0004924,abnormal behavior|MP:0005017,decreased B cell number
MGI:3777661	Nfkbid<tm1Clay>	MP:0003850,abnormal thymocyte activation|MP:0005095,decreased T cell proliferation|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion|MP:0010766,abnormal NK cell physiology
MGI:3702939	Nfkbid<tm1Ktak>	MP:0008537,increased susceptibility to induced colitis|MP:0008566,increased interferon-gamma secretion|MP:0008663,increased interleukin-12 secretion|MP:0008669,increased interleukin-12b secretion|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock
MGI:3034029	Nfkbie<tm1Syme>	MP:0002407,abnormal double-negative T cell morphology|MP:0002494,increased IgM level|MP:0005390,skeleton phenotype|MP:0008499,increased IgG1 level
MGI:5286210	Nfkbil1<tm1a(KOMP)Wtsi>	MP:0005419,decreased circulating serum albumin level|MP:0010052,increased grip strength
MGI:5501251	Nfkbiz<tm1.1Muta>	MP:0001194,dermatitis|MP:0005387,immune system phenotype|MP:0006167,eyelid edema|MP:0013452,increased lacrimal gland apoptosis
MGI:3046930	Nfkbiz<tm1Aki>	MP:0000414,alopecia|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001190,reddish skin|MP:0001194,dermatitis|MP:0001212,skin lesions|MP:0001216,abnormal epidermal layer morphology|MP:0001222,epidermal hyperplasia|MP:0001786,skin edema|MP:0001790,abnormal immune system physiology|MP:0001851,eye inflammation|MP:0001852,conjunctivitis|MP:0001862,interstitial pneumonia|MP:0002073,abnormal hair growth|MP:0002433,abnormal T-helper 1 cell morphology|MP:0002442,abnormal leukocyte physiology|MP:0002461,increased immunoglobulin level|MP:0002497,increased IgE level|MP:0002619,abnormal lymphocyte morphology|MP:0002722,abnormal immune system organ morphology|MP:0003009,abnormal cytokine secretion|MP:0004947,skin inflammation|MP:0005251,blepharitis|MP:0006167,eyelid edema|MP:0008556,abnormal tumor necrosis factor secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008828,abnormal lymph node cell ratio|MP:0008880,lacrimal gland inflammation|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012164,abnormal conjunctiva goblet cell morphology|MP:0013452,increased lacrimal gland apoptosis|MP:0013459,perioral dermatitis|MP:0013460,periocular dermatitis|MP:0013464,decreased conjunctiva goblet cell number|MP:0013478,corneal limbitis|MP:0020220,decreased tear production
MGI:3525252	Nfkbiz<tm1Mamo>	MP:0000414,alopecia|MP:0001191,abnormal skin condition|MP:0001192,scaly skin|MP:0001194,dermatitis|MP:0001200,thick skin|MP:0001209,spontaneous skin ulceration|MP:0001242,hyperkeratosis|MP:0001412,excessive scratching|MP:0001874,acanthosis|MP:0002060,abnormal skin morphology|MP:0002497,increased IgE level|MP:0003427,parakeratosis|MP:0006167,eyelid edema|MP:0011101,prenatal lethality, incomplete penetrance
MGI:7539829	Nfx1<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length
MGI:4432670	Nfxl1<tm1a(EUCOMM)Wtsi>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002764,short tibia
MGI:3027021	Nfya<tm1.1Mait>	MP:0011092,embryonic lethality, complete penetrance
MGI:1861227	Ng	MP:0000367,abnormal coat/ hair morphology|MP:0000416,sparse hair|MP:0001216,abnormal epidermal layer morphology|MP:0002060,abnormal skin morphology|MP:0002073,abnormal hair growth|MP:0002655,abnormal keratinocyte morphology|MP:0002656,abnormal keratinocyte differentiation|MP:0003815,hairless
MGI:5440446	Ngb<tm1.2Geno>	MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging|MP:0020475,delayed circadian behavior phase
MGI:5692691	Ngdn<tm1b(EUCOMM)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001303,abnormal lens morphology|MP:0005179,decreased circulating cholesterol level|MP:0009709,hydrometra|MP:0011100,preweaning lethality, complete penetrance
MGI:3578638	Ngef<tm1Meg>	MP:0003651,abnormal axon extension
MGI:5301291	Ngfr<tm1.1Vk>	MP:0001513,limb grasping|MP:0002169,no abnormal phenotype detected|MP:0002651,abnormal sciatic nerve morphology|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype
MGI:5301294	Ngfr<tm1.2Vk>	MP:0001513,limb grasping|MP:0001732,postnatal growth retardation
MGI:4432054	Ngfr<tm1a(EUCOMM)Wtsi>	MP:0002966,decreased circulating alkaline phosphatase level
MGI:5637211	Ngfr<tm1b(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001566,increased circulating phosphate level|MP:0002110,abnormal digit morphology|MP:0004924,abnormal behavior|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020870,decreased thigmotaxis
MGI:2386981	Ngfr<tm1Gdc>	MP:0001022,abnormal L5 dorsal root ganglion morphology|MP:0001107,decreased Schwann cell number|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001614,abnormal blood vessel morphology|MP:0001914,hemorrhage|MP:0002651,abnormal sciatic nerve morphology|MP:0004068,dilated dorsal aorta|MP:0011090,perinatal lethality, incomplete penetrance
MGI:1857226	Ngfr<tm1Jae>	MP:0000043,organ of Corti degeneration|MP:0000378,absent hair follicles|MP:0000578,ulcerated autopod|MP:0000764,abnormal tongue epithelium morphology|MP:0000904,abnormal superior colliculus morphology|MP:0000939,decreased motor neuron number|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001021,small L4 dorsal root ganglion|MP:0001038,abnormal cholinergic neuron morphology|MP:0001052,abnormal innervation pattern to muscle|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001463,abnormal spatial learning|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002100,abnormal tooth morphology|MP:0002108,abnormal muscle morphology|MP:0002335,decreased airway responsiveness|MP:0002689,abnormal molar morphology|MP:0002857,cochlear ganglion degeneration|MP:0002882,abnormal neuron morphology|MP:0002961,abnormal axon guidance|MP:0003038,decreased myocardial infarct size|MP:0003201,extremity edema|MP:0003202,abnormal neuron apoptosis|MP:0003204,decreased neuron apoptosis|MP:0003651,abnormal axon extension|MP:0003932,abnormal molar crown morphology|MP:0004220,abnormal peripheral nervous system regeneration|MP:0004297,abnormal proprioceptive neuron morphology|MP:0004362,cochlear hair cell degeneration|MP:0004740,sensorineural hearing loss|MP:0004748,increased susceptibility to age-related hearing loss|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004883,abnormal vascular wound healing|MP:0005253,abnormal eye physiology|MP:0005367,renal/urinary system phenotype|MP:0006070,increased retina photoreceptor cell number|MP:0006258,abnormal circumvallate papillae morphology|MP:0006260,abnormal gustatory papilla taste bud morphology|MP:0008056,abnormal retina ganglion cell morphology|MP:0008114,abnormal Kupffer cell morphology|MP:0008486,decreased muscle spindle number|MP:0008752,abnormal tumor necrosis factor level|MP:0008947,increased neuron number|MP:0008960,abnormal axon pruning|MP:0009937,abnormal neuron differentiation|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013818,abnormal oral cavity morphology
MGI:5461488	Ngf<tm1.1Blhe>	MP:0000278,abnormal myocardial fiber morphology|MP:0001785,edema|MP:0002083,premature death|MP:0002652,thin myocardium|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0003070,increased vascular permeability|MP:0003719,abnormal pericyte morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004003,abnormal vascular endothelial cell physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005329,abnormal myocardium layer morphology|MP:0006055,abnormal vascular endothelial cell morphology
MGI:1857535	Ngf<tm1Gne>	MP:0000745,tremors|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001014,absent superior cervical ganglion|MP:0001015,small superior cervical ganglion|MP:0001038,abnormal cholinergic neuron morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001290,delayed eyelid opening|MP:0001344,blepharoptosis|MP:0001406,abnormal gait|MP:0001458,abnormal object recognition memory|MP:0001732,postnatal growth retardation|MP:0001970,abnormal pain threshold|MP:0002073,abnormal hair growth|MP:0003043,hypoalgesia|MP:0003631,nervous system phenotype|MP:0006408,dorsal root ganglion hypoplasia|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012307,impaired spatial learning|MP:0014488,abnormal skin sensory neuron innervation pattern
MGI:6388456	Ngf<tm1(NGF*)Cat>	MP:0001038,abnormal cholinergic neuron morphology|MP:0001262,decreased body weight|MP:0001968,abnormal touch/nociception|MP:0001973,increased thermal nociceptive threshold|MP:0002083,premature death|MP:0002651,abnormal sciatic nerve morphology|MP:0003631,nervous system phenotype|MP:0004077,abnormal striatum morphology|MP:0005379,endocrine/exocrine gland phenotype|MP:0005386,behavior/neurological phenotype|MP:0008531,increased chemical nociceptive threshold|MP:0014488,abnormal skin sensory neuron innervation pattern
MGI:5461489	Ngf<tm2.1Blhe>	MP:0002169,no abnormal phenotype detected
MGI:5752820	Ngly1<em10Lutzy>	MP:0008762,embryonic lethality
MGI:5614022	Ngly1<em4Lutzy>	MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5752816	Ngly1<em9Lutzy>	MP:0008762,embryonic lethality
MGI:5705596	Ngly1<tm1.1Tasuz>	MP:0005621,abnormal cell physiology|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:6120689	Ngp<tm1b(KOMP)Wtsi>	MP:0001314,cornea opacity|MP:0004952,increased spleen weight
MGI:4940742	Ngrn<tm1a(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:3664915	Nhdlq10<PERA/EiJ>	MP:0000180,abnormal circulating cholesterol level
MGI:3037963	Nhdlq1<CAST/Ei>	MP:0000180,abnormal circulating cholesterol level
MGI:3037967	Nhdlq2<129S1/SvImJ>	MP:0000180,abnormal circulating cholesterol level
MGI:3041098	Nhdlq3<RIIIS/J>	MP:0002118,abnormal lipid homeostasis
MGI:3497792	Nhdlq4<129S1/SvImJ>	MP:0000180,abnormal circulating cholesterol level
MGI:3664913	Nhdlq9<DBA/2J>	MP:0000180,abnormal circulating cholesterol level
MGI:5475156	Nhej1<tm1.1Ics>	MP:0000715,decreased thymocyte number|MP:0005016,decreased lymphocyte cell number|MP:0008040,decreased NK T cell number|MP:0008754,abnormal T cell receptor V(D)J recombination|MP:0008943,increased sensitivity to induced cell death|MP:0009541,increased thymocyte apoptosis
MGI:3809930	Nhej1<tm1Fwa>	MP:0000694,spleen hypoplasia|MP:0001823,thymus hypoplasia|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002494,increased IgM level|MP:0004029,spontaneous chromosome breakage|MP:0004816,abnormal class switch recombination|MP:0008058,abnormal DNA repair|MP:0008495,decreased IgG1 level|MP:0008498,decreased IgG3 level
MGI:6402884	Nherf1<em1(IMPC)H>	MP:0000218,increased leukocyte cell number|MP:0002606,increased basophil cell number|MP:0004151,decreased circulating iron level
MGI:3526430	Nherf1<tm1Geo>	MP:0000198,decreased circulating phosphate level|MP:0000477,abnormal intestine morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0002083,premature death|MP:0003449,abnormal intestine goblet cell morphology
MGI:2386785	Nherf1<tm1Ssl>	MP:0000063,decreased bone mineral density|MP:0001392,abnormal locomotor behavior|MP:0001891,hydrocephaly|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002901,increased urine phosphate level|MP:0005389,reproductive system phenotype|MP:0008872,abnormal physiological response to xenobiotic|MP:0010124,decreased bone mineral content|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3530645	Nherf2<Gt(OST2298)Lex>	MP:0005376,homeostasis/metabolism phenotype
MGI:5511797	Nherf2<tm2a(EUCOMM)Hmgu>	MP:0000208,decreased hematocrit|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0005561,increased mean corpuscular hemoglobin
MGI:3691627	Nhil1<C57BL/6JOla>	MP:0008807,increased liver iron level
MGI:3691630	Nhil2<SWR/Ola>	MP:0008807,increased liver iron level
MGI:3691632	Nhil3<SWR/Ola>	MP:0008807,increased liver iron level
MGI:3691634	Nhil4<SWR/Ola>	MP:0008807,increased liver iron level
MGI:3691636	Nhil5<SWR/Ola>	MP:0008807,increased liver iron level
MGI:5696940	Nhlh1<tm1b(KOMP)Wtsi>	MP:0000702,enlarged lymph nodes|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2183573	Nhlh1<tm1Irk>	MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0003929,decreased heart rate variability|MP:0004156,abnormal QT variability|MP:0006277,abnormal parasympathetic nervous system physiology|MP:0009732,ventricular premature beat
MGI:6158510	Nhlh2<em1(IMPC)Mbp>	MP:0000063,decreased bone mineral density|MP:0000538,abnormal urinary bladder morphology|MP:0001925,male infertility|MP:0001926,female infertility|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0010124,decreased bone mineral content
MGI:5637212	Nhlh2<tm1b(KOMP)Mbp>	MP:0000063,decreased bone mineral density|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002059,abnormal seminal vesicle morphology|MP:0002590,increased mean corpuscular volume|MP:0002631,abnormal epididymis morphology|MP:0002637,small uterus|MP:0002941,increased circulating alanine transaminase level|MP:0003578,absent ovary|MP:0003642,absent seminal vesicle|MP:0003795,abnormal bone structure|MP:0003918,decreased kidney weight|MP:0003961,decreased lean body mass|MP:0004727,absent epididymis|MP:0004952,increased spleen weight|MP:0005278,abnormal cholesterol homeostasis|MP:0005343,increased circulating aspartate transaminase level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0006203,eye hemorrhage|MP:0006415,absent testes|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2180391	Nhlh2<tm1Irk>	MP:0001116,small gonad|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001134,absent corpus luteum|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001261,obese|MP:0001376,abnormal mating receptivity|MP:0001380,decreased male mating frequency|MP:0001433,polyphagia|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001927,abnormal estrous cycle|MP:0001935,decreased litter size|MP:0002059,abnormal seminal vesicle morphology|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002636,delayed vaginal opening|MP:0002637,small uterus|MP:0002716,small male preputial gland|MP:0002769,abnormal vas deferens morphology|MP:0002780,decreased circulating testosterone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003212,increased susceptibility to age related obesity|MP:0003491,abnormal voluntary movement|MP:0004901,decreased male germ cell number|MP:0004930,small epididymis|MP:0005159,azoospermia|MP:0005188,small penis|MP:0005189,abnormal anogenital distance|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005458,increased percent body fat/body weight|MP:0005536,decreased Leydig cell number|MP:0008995,early reproductive senescence|MP:0009011,prolonged diestrus|MP:0009014,prolonged proestrus|MP:0009018,short estrus|MP:0011014,decreased core body temperature|MP:0031287,bilateral cryptorchism|MP:0031420,decreased superovulation rate
MGI:3057284	Nhlh2<tm1Thbr>	MP:0001127,small ovary|MP:0001147,small testis|MP:0002637,small uterus|MP:0002882,abnormal neuron morphology|MP:0003212,increased susceptibility to age related obesity|MP:0005188,small penis|MP:0008947,increased neuron number|MP:0008948,decreased neuron number|MP:0011723,ectopic neuron
MGI:5524018	Nhlh2<tm2Thbr>	MP:0000008,increased white adipose tissue amount|MP:0001260,increased body weight|MP:0003631,nervous system phenotype|MP:0004905,decreased uterus weight|MP:0005181,decreased circulating estradiol level|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0008948,decreased neuron number|MP:0020411,increased abdominal adipose tissue amount
MGI:5312925	Nhlrc1<tm1.2Geno>	MP:0000243,myoclonus|MP:0001458,abnormal object recognition memory|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0004101,abnormal brain interneuron morphology|MP:0008260,abnormal autophagy|MP:0008840,abnormal spike wave discharge|MP:0008842,lipofuscinosis|MP:0014063,Lafora bodies
MGI:5312923	Nhlrc1<tm1Bmin>	MP:0002715,decreased glycogen catabolism rate|MP:0005376,homeostasis/metabolism phenotype|MP:0010400,increased liver glycogen level|MP:0010401,increased skeletal muscle glycogen level|MP:0014063,Lafora bodies
MGI:3808349	Nhlrc1<tm1(KOMP)Vlcg>	MP:0000811,hippocampal neuron degeneration|MP:0000950,abnormal seizure response to pharmacological agent|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001650,abnormal seizure response to electrical stimulation|MP:0002152,abnormal brain morphology|MP:0002182,abnormal astrocyte morphology|MP:0002183,gliosis|MP:0002882,abnormal neuron morphology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003008,enhanced long-term potentiation|MP:0003224,neuron degeneration|MP:0003634,abnormal glial cell morphology|MP:0005440,increased glycogen level|MP:0010401,increased skeletal muscle glycogen level|MP:0014063,Lafora bodies|MP:0014071,increased cardiac muscle glycogen level|MP:0014074,increased brain glycogen level|MP:0030940,impaired autophagy
MGI:4419640	Nhlrc2<tm1a(KOMP)Wtsi>	MP:0001696,failure to gastrulate|MP:0003087,absent allantois|MP:0003984,embryonic growth retardation|MP:0005030,absent amnion|MP:0005031,abnormal trophoblast layer morphology|MP:0009593,absent chorion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance
MGI:6158498	Nhlrc3<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0020421,increased freezing behavior
MGI:4362251	Nhp2<tm1a(KOMP)Wtsi>	MP:0001257,increased body length|MP:0002599,increased mean platelet volume|MP:0010025,decreased total body fat amount|MP:0010088,decreased circulating fructosamine level|MP:0011100,preweaning lethality, complete penetrance
MGI:5754996	Nhs<em1(IMPC)Tcp>	MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0010393,shortened QRS complex duration
MGI:5708170	Nhsl1<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001175,abnormal lung morphology
MGI:6257670	Nhsl2<em1(IMPC)Tcp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001200,thick skin|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002637,small uterus|MP:0011874,enlarged urinary bladder
MGI:1861111	Nhs<Xcat>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology|MP:0003236,abnormal lens capsule morphology|MP:0008841,ruptured lens capsule|MP:0010263,total cataract|MP:0011697,lens vacuoles
MGI:6341856	Niban1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0001120,abnormal uterus morphology|MP:0002060,abnormal skin morphology|MP:0004906,enlarged uterus|MP:0011496,abnormal head size
MGI:3716629	Niban1<tm1Hin>	MP:0002169,no abnormal phenotype detected
MGI:6214829	Niban2<em1(IMPC)J>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6152483	Niban3<em1(IMPC)Mbp>	MP:0000639,abnormal adrenal gland morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology
MGI:6388736	Niban3<tm1Jyw>	MP:0001807,decreased IgA level|MP:0002144,abnormal B cell differentiation|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0004816,abnormal class switch recombination|MP:0005014,increased B cell number|MP:0005154,increased B cell proliferation|MP:0008168,decreased B-1a cell number|MP:0008173,increased follicular B cell number|MP:0008188,abnormal transitional stage B cell morphology|MP:0008499,increased IgG1 level|MP:0008502,increased IgG3 level|MP:0008897,decreased IgG2c level|MP:0009925,increased transitional stage T2 B cell number|MP:0014469,abnormal B cell calcium ion homeostasis|MP:0020155,enhanced humoral immune response
MGI:7470865	Nicol1<em1Osb>	MP:0001925,male infertility|MP:0004935,epididymis degeneration|MP:0005389,reproductive system phenotype|MP:0009647,decreased fertilization frequency|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031012,impaired sperm migration in female genital tract
MGI:3803890	Nicoq1<C57BL/6J>	MP:0002553,preference for addictive substance
MGI:3803892	Nicoq2<C57BL/6J>	MP:0002553,preference for addictive substance
MGI:3803893	Nicoq3<C3H/HeJ>	MP:0002553,preference for addictive substance
MGI:3803896	Nicoq4<C57BL/6J>	MP:0002553,preference for addictive substance
MGI:2682959	Nid1<tm1Dong>	MP:0000951,sporadic seizures|MP:0001303,abnormal lens morphology|MP:0001961,abnormal reflex|MP:0002106,abnormal muscle physiology|MP:0003658,abnormal capillary morphology|MP:0004272,abnormal basement membrane morphology
MGI:2388069	Nid2<Gt(GST011)Byg>	MP:0000163,abnormal cartilage morphology|MP:0003200,calcified joint|MP:0003560,osteoarthritis|MP:0005384,cellular phenotype|MP:0006429,abnormal hyaline cartilage morphology
MGI:2447047	Nidd1k<KK-A(y)/Jcl>	MP:0001559,hyperglycemia
MGI:3036073	Nidd1n<NSY>	MP:0005293,impaired glucose tolerance
MGI:2155870	Nidd1<NON/LtHl>	MP:0002078,abnormal glucose homeostasis
MGI:2155871	Nidd1<NZO/Hl>	MP:0001260,increased body weight|MP:0002078,abnormal glucose homeostasis
MGI:2447045	Nidd2k<KK/TaJcl>	MP:0001260,increased body weight|MP:0001559,hyperglycemia|MP:0006087,increased body mass index
MGI:2389387	Nidd2n<NSY>	MP:0005293,impaired glucose tolerance
MGI:2445564	Nidd2<NON/LtHl>	MP:0000188,abnormal circulating glucose level|MP:0002078,abnormal glucose homeostasis
MGI:2447049	Nidd3k<KK/TaJcl>	MP:0002078,abnormal glucose homeostasis|MP:0006353,increased glycosylated hemoglobin level
MGI:2156477	Nidd3n<NSY>	MP:0005293,impaired glucose tolerance
MGI:2445567	Nidd3<NZO/Hl>	MP:0001260,increased body weight|MP:0002078,abnormal glucose homeostasis
MGI:2447051	Nidd4k<KK/TaJcl>	MP:0001559,hyperglycemia
MGI:3036077	Nidd4n<NSY>	MP:0005293,impaired glucose tolerance
MGI:3036082	Nidd4<TSOD>	MP:0001559,hyperglycemia
MGI:2154985	Nidd5<BALB/cA>	MP:0001262,decreased body weight|MP:0010025,decreased total body fat amount
MGI:3038865	Nidd5k<KK/TaJcl>	MP:0001559,hyperglycemia
MGI:2154986	Nidd5<TSOD>	MP:0001260,increased body weight|MP:0002727,decreased circulating insulin level|MP:0005217,abnormal pancreatic beta cell morphology
MGI:3038868	Nidd6k<PWK>	MP:0000189,hypoglycemia
MGI:2154247	Nidd6<TSOD>	MP:0001260,increased body weight
MGI:3038869	Nidd7k<KK/TaJcl>	MP:0001559,hyperglycemia
MGI:2388838	Nidds<SJL/NBom>	MP:0001559,hyperglycemia|MP:0005217,abnormal pancreatic beta cell morphology
MGI:6404513	Nifk<em1(IMPC)Mbp>	MP:0001289,persistence of hyaloid vascular system|MP:0001293,anophthalmia|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001728,failure of embryo implantation|MP:0002092,abnormal eye morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012058,abnormal morula morphology|MP:0013292,embryonic lethality prior to organogenesis
MGI:3845106	Nihlr1<CAST/EiJ>	MP:0004925,decreased susceptibility to noise-induced hearing loss
MGI:3845108	Nihls1<CAST/EiJ>	MP:0004597,increased susceptibility to noise-induced hearing loss
MGI:1861185	Nil	MP:0000477,abnormal intestine morphology|MP:0000496,abnormal small intestine morphology|MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0005342,abnormal intestinal lipid absorption|MP:0005378,growth/size/body region phenotype|MP:0011092,embryonic lethality, complete penetrance
MGI:3630157	Nilac10<A/J>	MP:0009752,enhanced behavioral response to nicotine
MGI:3630159	Nilac11<A/J>	MP:0009752,enhanced behavioral response to nicotine
MGI:3630160	Nilac11<C57BL/6J>	MP:0009752,enhanced behavioral response to nicotine
MGI:3630161	Nilac12<A/J>	MP:0009752,enhanced behavioral response to nicotine
MGI:3629994	Nilac1<A/J>	MP:0009756,impaired behavioral response to nicotine
MGI:3629995	Nilac1<C57BL/6J>	MP:0009752,enhanced behavioral response to nicotine
MGI:3629997	Nilac2<C57BL/6J>	MP:0009756,impaired behavioral response to nicotine
MGI:3629998	Nilac3<A/J>	MP:0009752,enhanced behavioral response to nicotine
MGI:3630000	Nilac4<A/J>	MP:0009752,enhanced behavioral response to nicotine
MGI:3630003	Nilac5<A/J>	MP:0009752,enhanced behavioral response to nicotine
MGI:3630149	Nilac6<A/J>	MP:0009752,enhanced behavioral response to nicotine
MGI:3630152	Nilac7<C57BL/6J>	MP:0009752,enhanced behavioral response to nicotine
MGI:3630153	Nilac8<A/J>	MP:0009752,enhanced behavioral response to nicotine
MGI:3630155	Nilac9<A/J>	MP:0009752,enhanced behavioral response to nicotine
MGI:3630156	Nilac9<C57BL/6J>	MP:0009752,enhanced behavioral response to nicotine
MGI:4362260	Ninj1<tm1a(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5519238	Ninj1<tm1b(KOMP)Wtsi>	MP:0001891,hydrocephaly|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002083,premature death|MP:0008007,abnormal cellular replicative senescence
MGI:5583960	Ninj1<tm1Gto>	MP:0001393,ataxia|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0002442,abnormal leukocyte physiology|MP:0003628,abnormal leukocyte adhesion|MP:0003799,impaired macrophage chemotaxis|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005397,hematopoietic system phenotype
MGI:7646979	Ninj2<em1Cqxu>	MP:0001263,weight loss|MP:0002079,increased circulating insulin level|MP:0003383,abnormal gluconeogenesis|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005370,liver/biliary system phenotype|MP:0005559,increased circulating glucose level|MP:0006094,increased fat cell size|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009115,abnormal fat cell morphology|MP:0009131,decreased white fat cell number|MP:0010398,decreased liver glycogen level|MP:0011167,abnormal adipose tissue development|MP:0011168,abnormal fat cell differentiation|MP:0013279,increased fasting circulating glucose level|MP:0020520,whitened brown adipose tissue morphology|MP:0031269,increased susceptibility to diet-induced hepatic steatosis|MP:0031415,increased skeletal muscle triglyceride level|MP:0031602,white adipose tissue inflammation
MGI:4451377	Ninj2<tm1a(KOMP)Wtsi>	MP:0000194,increased circulating calcium level|MP:0003960,increased lean body mass|MP:0010067,increased red blood cell distribution width|MP:0010123,increased bone mineral content
MGI:4433740	Ninl<tm2a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0013415,increased myeloid cell number in bone marrow
MGI:5606341	Nin<tm1b(EUCOMM)Hmgu>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001489,decreased startle reflex|MP:0004738,abnormal auditory brainstem response|MP:0009142,decreased prepulse inhibition
MGI:6358683	Nin<tm1c(EUCOMM)Hmgu>	MP:0001199,thin skin|MP:0001218,thin epidermis|MP:0001238,thin epidermis stratum spinosum|MP:0002060,abnormal skin morphology|MP:0002796,impaired skin barrier function|MP:0009441,delayed skin barrier formation|MP:0009598,thin epidermis stratum granulosum|MP:0009605,decreased keratohyalin granule number|MP:0009607,decreased keratohyalin granule size|MP:0009714,thin epidermis stratum basale
MGI:6358684	Nin<tm1d(EUCOMM)Hmgu>	MP:0001216,abnormal epidermal layer morphology|MP:0001218,thin epidermis|MP:0001238,thin epidermis stratum spinosum|MP:0002060,abnormal skin morphology|MP:0002655,abnormal keratinocyte morphology|MP:0002796,impaired skin barrier function|MP:0003941,abnormal skin development|MP:0005501,abnormal skin physiology|MP:0009441,delayed skin barrier formation|MP:0009598,thin epidermis stratum granulosum|MP:0009605,decreased keratohyalin granule number|MP:0009607,decreased keratohyalin granule size|MP:0009608,abnormal epidermal lamellar body morphology|MP:0009714,thin epidermis stratum basale|MP:0009760,abnormal mitotic spindle morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0030605,abnormal corneocyte morphology
MGI:5563445	Nip7<m1Anu>	MP:0008762,embryonic lethality
MGI:4363744	Nipa1<tm1a(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level
MGI:7425864	Nipal2<em1(IMPC)Ccpcz>	MP:0000208,decreased hematocrit|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0002060,abnormal skin morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002874,decreased hemoglobin content
MGI:4360699	Nipal3<tm1Pbfd>	MP:0001360,abnormal social investigation|MP:0001413,abnormal response to new environment|MP:0001806,decreased IgM level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0005575,increased pulmonary ventilation|MP:0005585,increased tidal volume|MP:0008045,decreased NK cell number|MP:0008500,increased IgG2a level|MP:0014274,decreased respiration
MGI:6159563	Nipal4<tm1Akih>	MP:0001196,shiny skin|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001242,hyperkeratosis|MP:0001263,weight loss|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0009474,thick epidermis stratum spinosum|MP:0009596,abnormal stratum corneum lipid matrix formation|MP:0009602,abnormal keratohyalin granule morphology|MP:0009604,increased keratohyalin granule number|MP:0009607,decreased keratohyalin granule size|MP:0009608,abnormal epidermal lamellar body morphology|MP:0009674,decreased birth weight|MP:0009931,abnormal skin appearance|MP:0011087,neonatal lethality, complete penetrance|MP:0011979,abnormal magnesium ion homeostasis|MP:0020116,increased sphingosine level|MP:0020117,decreased sphingosine level|MP:0020582,increased ceramide level|MP:0020583,decreased ceramide level|MP:0030605,abnormal corneocyte morphology
MGI:5644433	Nipbl<Gt(EUCE313f02)1.1Hmgu>	MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0010403,atrial septal defect
MGI:5644813	Nipbl<Gt(EUCE313f02)1.2Hmgu>	MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0002188,small heart|MP:0010405,ostium secundum atrial septal defect|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4374347	Nipbl<Gt(EUCE313f02)Hmgu>	MP:0001265,decreased body size|MP:0002188,small heart|MP:0005385,cardiovascular system phenotype|MP:0010405,ostium secundum atrial septal defect|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4332250	Nipbl<Gt(RRS564)Byg>	MP:0000074,abnormal neurocranium morphology|MP:0000104,abnormal sphenoid bone morphology|MP:0000266,abnormal heart morphology|MP:0000281,abnormal interventricular septum morphology|MP:0000432,abnormal head morphology|MP:0000433,microcephaly|MP:0000435,shortened head|MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0000849,abnormal cerebellum morphology|MP:0001262,decreased body weight|MP:0001340,abnormal eyelid morphology|MP:0001394,circling|MP:0001513,limb grasping|MP:0001716,abnormal placenta labyrinth morphology|MP:0001731,abnormal postnatal growth|MP:0001732,postnatal growth retardation|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0001845,abnormal inflammatory response|MP:0001851,eye inflammation|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002196,absent corpus callosum|MP:0002544,brachydactyly|MP:0003419,delayed endochondral bone ossification|MP:0003420,delayed intramembranous bone ossification|MP:0003649,decreased heart right ventricle size|MP:0004023,abnormal chromosome number|MP:0004055,heart atrium hypoplasia|MP:0004056,abnormal myocardium compact layer morphology|MP:0004200,decreased fetal size|MP:0004686,decreased length of long bones|MP:0004738,abnormal auditory brainstem response|MP:0004920,increased placenta weight|MP:0005076,abnormal cell differentiation|MP:0005385,cardiovascular system phenotype|MP:0006113,abnormal heart septum morphology|MP:0006411,upturned snout|MP:0008721,abnormal chemokine level|MP:0008957,abnormal placenta junctional zone morphology|MP:0008959,abnormal spongiotrophoblast cell morphology|MP:0009429,decreased embryo weight|MP:0009431,decreased fetal weight|MP:0009703,decreased birth body size|MP:0009777,abnormal behavioral response to anesthetic|MP:0010038,abnormal placenta physiology|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010499,abnormal ventricle myocardium morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0012085,midface hypoplasia|MP:0014760,impaired DNA repair|MP:0020040,decreased bone ossification|MP:0030303,small ethmoid bone
MGI:5638625	Nipbl<tm1.1Hpt>	MP:0000024,lowered ear position|MP:0000088,short mandible|MP:0000438,abnormal cranium morphology|MP:0000454,abnormal jaw morphology|MP:0000457,maxilla hypoplasia|MP:0000460,mandible hypoplasia|MP:0001302,eyelids open at birth|MP:0002169,no abnormal phenotype detected|MP:0003773,eclabion|MP:0003935,abnormal craniofacial development|MP:0004592,small mandible|MP:0006411,upturned snout|MP:0011262,abnormal pharyngeal arch mesenchyme morphology|MP:0012523,abnormal upper lip morphology|MP:0012760,decreased cranial neural crest cell proliferation|MP:0030065,face hypoplasia
MGI:5636687	Nipbl<tm1.2Hpt>	MP:0000060,delayed bone ossification|MP:0000074,abnormal neurocranium morphology|MP:0000150,abnormal rib morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0004351,short humerus|MP:0004355,short radius|MP:0005508,abnormal skeleton morphology|MP:0008277,abnormal sternum ossification|MP:0009431,decreased fetal weight|MP:0009703,decreased birth body size|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4431806	Nipsnap1<tm1a(EUCOMM)Wtsi>	MP:0002590,increased mean corpuscular volume|MP:0003313,abnormal locomotor activation
MGI:5319314	Nipsnap1<tm1Eoa>	MP:0003177,allodynia|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5637068	Nipsnap3a<tm1b(KOMP)Wtsi>	MP:0013772,increased effector memory T-helper cell number
MGI:7435701	Nipsnap3b<em1(IMPC)J>	MP:0000194,increased circulating calcium level|MP:0000221,decreased leukocyte cell number|MP:0002757,decreased vertical activity|MP:0004738,abnormal auditory brainstem response
MGI:3653501	Nisch<edsn>	MP:0000445,short snout|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001850,increased susceptibility to otitis media|MP:0001958,emphysema|MP:0005105,abnormal middle ear ossicle morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0006018,abnormal tympanic membrane morphology|MP:0006325,impaired hearing|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011142,abnormal lung-associated mesenchyme development|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5637098	Nisch<tm1b(EUCOMM)Hmgu>	MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0001402,decreased locomotor activity|MP:0001410,head bobbing|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0001566,increased circulating phosphate level|MP:0003795,abnormal bone structure|MP:0004174,abnormal spine curvature|MP:0004924,abnormal behavior|MP:0004952,increased spleen weight|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0010124,decreased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:6100940	Nisch<V33A>	MP:0001850,increased susceptibility to otitis media|MP:0006325,impaired hearing
MGI:3691199	Nit1<tm1.1Hbn>	MP:0002169,no abnormal phenotype detected|MP:0004499,increased incidence of tumors by chemical induction
MGI:3691030	Nit1<tm1Hbn>	MP:0000358,abnormal cell morphology|MP:0000662,abnormal branching of the mammary ductal tree|MP:0003207,decreased cellular sensitivity to gamma-irradiation
MGI:6276926	Nkapd1<em1(IMPC)Mbp>	MP:0001718,abnormal visceral yolk sac morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003229,abnormal vitelline vasculature morphology|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0020421,increased freezing behavior
MGI:7868146	Nkapd1<tm1.1Tak>	MP:0000221,decreased leukocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0000468,abnormal esophageal epithelium morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000601,small liver|MP:0000764,abnormal tongue epithelium morphology|MP:0001221,epidermal atrophy|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002144,abnormal B cell differentiation|MP:0002169,no abnormal phenotype detected|MP:0002416,abnormal proerythroblast morphology|MP:0003077,abnormal cell cycle|MP:0003306,small intestinal inflammation|MP:0004809,increased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0005397,hematopoietic system phenotype|MP:0006042,increased apoptosis|MP:0008973,decreased erythroid progenitor cell number|MP:0011089,perinatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011111,lethality during fetal growth through weaning, complete penetrance|MP:0011177,abnormal erythroblast number|MP:0011246,abnormal fetal liver hematopoietic progenitor cell morphology|MP:0013659,abnormal erythroid lineage cell morphology|MP:0013704,increased megakaryocyte-erythroid progenitor cell number|MP:0013707,abnormal hematopoietic precursor cell morphology|MP:0013848,subcutaneous edema|MP:0013893,decreased common lymphocyte progenitor cell number
MGI:4415546	Nkapl<tm1(KOMP)Vlcg>	MP:0001147,small testis|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:4839023	Nkap<tm1.1Viss>	MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010133,increased DN3 thymocyte number|MP:0010136,decreased DN4 thymocyte number
MGI:3714460	Nkd1<tm1Kwha>	MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0004471,short nasal bone|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype
MGI:3530367	Nkd1<tm1Tko>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001922,reduced male fertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia
MGI:3714464	Nkd2<tm1Kwha>	MP:0001935,decreased litter size|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype
MGI:5548721	Nkg7<tm1.1(KOMP)Vlcg>	MP:0002436,abnormal CD8-positive, alpha-beta cytotoxic T cell morphology|MP:0005011,increased eosinophil cell number|MP:0005397,hematopoietic system phenotype|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008087,decreased T helper 1 cell number|MP:0008247,abnormal mononuclear cell morphology|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008578,decreased circulating interferon-gamma level|MP:0010750,increased susceptibility to parasitic infection induced morbidity/mortality|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality
MGI:7425866	Nkiras1<em1(IMPC)Ccpcz>	MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0010052,increased grip strength
MGI:6284319	Nkpd1<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content
MGI:3612957	Nkrf<tm1.1Hjh>	MP:0002169,no abnormal phenotype detected
MGI:2681149	Nktcn1<C57BL/6J>	MP:0002145,abnormal T cell differentiation|MP:0008039,increased NK T cell number
MGI:2681151	Nktcn2<C57BL/6J>	MP:0008039,increased NK T cell number
MGI:2684149	Nkx1-1<tm1Tlu>	MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0010053,decreased grip strength|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2677488	Nkx2-1<tm1Jaw>	MP:0001175,abnormal lung morphology|MP:0001178,pulmonary hypoplasia|MP:0001953,respiratory failure|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0003421,abnormal thyroid gland development|MP:0004007,abnormal lung vasculature morphology|MP:0010825,abnormal lung saccule morphology|MP:0010856,dilated respiratory conducting tube|MP:0010911,abnormal pulmonary acinus morphology|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011034,impaired branching involved in respiratory bronchiole morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011145,abnormal mesenchymal cell differentiation involved in lung development
MGI:1857494	Nkx2-1<tm1Shk>	MP:0000474,abnormal foregut morphology|MP:0000783,abnormal forebrain morphology|MP:0000830,abnormal diencephalon morphology|MP:0000837,abnormal hypothalamus morphology|MP:0001176,abnormal lung development|MP:0001178,pulmonary hypoplasia|MP:0001405,impaired coordination|MP:0002264,abnormal bronchus morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002282,abnormal trachea morphology|MP:0002295,abnormal pulmonary circulation|MP:0002786,abnormal Leydig cell morphology|MP:0002951,small thyroid gland|MP:0003120,abnormal tracheal cartilage morphology|MP:0003321,tracheoesophageal fistula|MP:0003421,abnormal thyroid gland development|MP:0004551,decreased tracheal cartilage ring number|MP:0004733,abnormal thoracic cavity morphology|MP:0004852,decreased testis weight|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005314,absent thyroid gland|MP:0005315,absent pituitary gland|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0005631,decreased lung weight|MP:0006382,abnormal lung epithelium morphology|MP:0008288,abnormal adrenal cortex morphology|MP:0009431,decreased fetal weight|MP:0010812,absent type II pneumocytes|MP:0010901,abnormal pulmonary alveolar parenchyma morphology|MP:0010943,abnormal bronchus epithelium morphology|MP:0010993,decreased surfactant secretion|MP:0011028,impaired branching involved in bronchus morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0012684,abnormal pleural cavity morphology|MP:0013337,abnormal adenohypophysis development|MP:0013351,abnormal Rathke's pouch development|MP:0013352,abnormal Rathke's pouch apoptosis|MP:0014198,absent pituitary infundibular stalk|MP:0014269,decreased testes secretion|MP:0020556,abnormal ventromedial hypothalamic nucleus morphology|MP:0020558,decreased ventromedial hypothalamic nucleus size
MGI:5700385	Nkx2-1<tm2.1(flpo)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:4941951	Nkx2-1<tm2Rdl>	MP:0001175,abnormal lung morphology|MP:0001953,respiratory failure|MP:0003421,abnormal thyroid gland development|MP:0003816,abnormal pituitary gland development|MP:0005314,absent thyroid gland|MP:0005315,absent pituitary gland|MP:0011087,neonatal lethality, complete penetrance|MP:0013351,abnormal Rathke's pouch development|MP:0013490,absent infundibular recess of third ventricle
MGI:3653645	Nkx2-1<tm2Shk>	MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001923,reduced female fertility|MP:0001928,abnormal ovulation|MP:0001938,delayed sexual maturation|MP:0002951,small thyroid gland|MP:0003631,nervous system phenotype|MP:0003858,enhanced coordination|MP:0004696,abnormal thyroid follicle morphology|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005386,behavior/neurological phenotype|MP:0008995,early reproductive senescence|MP:0009006,prolonged estrous cycle|MP:0009008,delayed estrous cycle|MP:0010383,increased adenoma incidence|MP:0031391,increased locomotor activity
MGI:4941952	Nkx2-1<tm3Rdl>	MP:0001175,abnormal lung morphology|MP:0001953,respiratory failure|MP:0003421,abnormal thyroid gland development|MP:0005314,absent thyroid gland|MP:0011087,neonatal lethality, complete penetrance
MGI:1932100	Nkx2-2<tm1Jlr>	MP:0000953,abnormal oligodendrocyte morphology|MP:0001559,hyperglycemia|MP:0001732,postnatal growth retardation|MP:0002711,decreased glucagon secretion|MP:0002948,abnormal neuron specification|MP:0003059,decreased insulin secretion|MP:0003647,absent oligodendrocytes|MP:0003877,abnormal serotonergic neuron morphology|MP:0005192,increased motor neuron number|MP:0005215,abnormal pancreatic islet morphology|MP:0009174,absent pancreatic beta cells|MP:0009175,abnormal pancreatic beta cell differentiation|MP:0009177,decreased pancreatic alpha cell number|MP:0009186,decreased PP cell number|MP:0011085,postnatal lethality, complete penetrance
MGI:5297810	Nkx2-2<tm2.1Suss>	MP:0001559,hyperglycemia|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002083,premature death|MP:0003339,decreased pancreatic beta cell number|MP:0009172,small pancreatic islets|MP:0009176,increased pancreatic alpha cell number|MP:0009190,increased pancreatic epsilon cell number|MP:0009254,disorganized pancreatic islets
MGI:5302422	Nkx2-2<tm3Suss>	MP:0001732,postnatal growth retardation|MP:0001944,abnormal pancreas morphology|MP:0002082,postnatal lethality|MP:0002693,abnormal pancreas physiology|MP:0003632,abnormal nervous system morphology
MGI:5538250	Nkx2-2<tm4.1(cre/EGFP)Suss>	MP:0002169,no abnormal phenotype detected
MGI:5544082	Nkx2-2<tm5.1Suss>	MP:0001559,hyperglycemia|MP:0003339,decreased pancreatic beta cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0005559,increased circulating glucose level|MP:0009177,decreased pancreatic alpha cell number|MP:0009190,increased pancreatic epsilon cell number|MP:0011085,postnatal lethality, complete penetrance
MGI:2386680	Nkx2-3<tm1Hha>	MP:0000350,abnormal cell proliferation|MP:0000477,abnormal intestine morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000496,abnormal small intestine morphology|MP:0000689,abnormal spleen morphology|MP:0000690,absent spleen|MP:0000692,small spleen|MP:0001614,abnormal blood vessel morphology|MP:0001732,postnatal growth retardation|MP:0002358,abnormal spleen periarteriolar lymphoid sheath morphology|MP:0002363,abnormal spleen marginal sinus morphology|MP:0002389,abnormal Peyer's patch follicle morphology|MP:0002581,abnormal ileum morphology|MP:0003156,abnormal leukocyte migration|MP:0004002,abnormal jejunum morphology|MP:0004953,decreased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005150,cachexia|MP:0005232,abnormal mesenteric lymph node morphology|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0008180,abnormal marginal zone B cell morphology|MP:0008183,absent marginal zone B cells|MP:0008234,absent spleen marginal zone|MP:0008240,abnormal spleen marginal zone macrophage morphology|MP:0008241,abnormal metallophilic macrophage morphology|MP:0008471,abnormal spleen primary B follicle morphology|MP:0008475,intermingled spleen red and white pulp|MP:0008479,decreased spleen white pulp amount|MP:0008826,abnormal splenic cell ratio|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2448069	Nkx2-3<tm1Rph>	MP:0000116,abnormal tooth development|MP:0000121,failure of tooth eruption|MP:0000218,increased leukocyte cell number|MP:0000328,increased enterocyte cell number|MP:0000477,abnormal intestine morphology|MP:0000478,delayed intestine development|MP:0000496,abnormal small intestine morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000690,absent spleen|MP:0000692,small spleen|MP:0002252,abnormal oropharynx morphology|MP:0002356,abnormal spleen red pulp morphology|MP:0002358,abnormal spleen periarteriolar lymphoid sheath morphology|MP:0002378,abnormal gut-associated lymphoid tissue morphology|MP:0002644,decreased circulating triglyceride level|MP:0002791,steatorrhea|MP:0003156,abnormal leukocyte migration|MP:0003271,abnormal duodenum morphology|MP:0003289,abnormal intestinal peristalsis|MP:0003643,spleen atrophy|MP:0004002,abnormal jejunum morphology|MP:0004035,abnormal sublingual gland morphology|MP:0005036,diarrhea|MP:0005232,abnormal mesenteric lymph node morphology|MP:0006400,decreased molar number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008098,decreased plasma cell number|MP:0008108,abnormal small intestinal villus morphology|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0008234,absent spleen marginal zone|MP:0008241,abnormal metallophilic macrophage morphology|MP:0008470,abnormal spleen B cell follicle morphology|MP:0009477,small cecum|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013483,abnormal jejunum crypts of Lieberkuhn morphology|MP:0030457,abnormal molar cusp morphology
MGI:6360206	Nkx2-5<em1Dsr>	MP:0002652,thin myocardium|MP:0004067,abnormal trabecula carnea morphology|MP:0005294,abnormal heart ventricle morphology
MGI:6286225	Nkx2-5<tm1.1Burg>	MP:0000298,absent atrioventricular cushions|MP:0001698,decreased embryo size|MP:0002188,small heart|MP:0002652,thin myocardium|MP:0003896,prolonged PR interval|MP:0003984,embryonic growth retardation|MP:0004067,abnormal trabecula carnea morphology|MP:0005294,abnormal heart ventricle morphology|MP:0005312,pericardial effusion|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010405,ostium secundum atrial septal defect|MP:0010519,atrioventricular block|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012082,delayed heart development
MGI:5706642	Nkx2-5<tm1.1Gum>	MP:0000352,decreased cell proliferation|MP:0006042,increased apoptosis|MP:0009861,abnormal pyloric sphincter morphology|MP:0010780,abnormal stomach smooth muscle circular layer morphology|MP:0010805,abnormal stomach smooth muscle outer longitudinal layer morphology
MGI:6294718	Nkx2-5<tm1.1Hkas>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000282,abnormal interatrial septum morphology|MP:0000284,double outlet right ventricle|MP:0001575,cyanosis|MP:0002624,abnormal tricuspid valve morphology|MP:0003137,abnormal impulse conducting system conduction|MP:0003896,prolonged PR interval|MP:0003984,embryonic growth retardation|MP:0004114,abnormal atrioventricular node morphology|MP:0005294,abnormal heart ventricle morphology|MP:0005330,cardiomyopathy|MP:0005385,cardiovascular system phenotype|MP:0006061,right atrial isomerism|MP:0006123,tricuspid valve atresia|MP:0006141,abnormal atrioventricular node conduction|MP:0010392,prolonged QRS complex duration|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010424,double chambered heart right ventricle|MP:0010498,abnormal interventricular septum muscular part morphology|MP:0010519,atrioventricular block|MP:0010536,Ebstein's malformation of tricuspid valve|MP:0010566,abnormal left posterior bundle morphology|MP:0010622,abnormal tricuspid valve cusp morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0012624,decreased acetylcholinesterase activity
MGI:6314342	Nkx2-5<tm1.1Krc>	MP:0002624,abnormal tricuspid valve morphology|MP:0005294,abnormal heart ventricle morphology|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010622,abnormal tricuspid valve cusp morphology|MP:0010768,mortality/aging
MGI:5582820	Nkx2-5<tm1.1Pash>	MP:0002169,no abnormal phenotype detected
MGI:5606034	Nkx2-5<tm1.1Wtp>	MP:0002169,no abnormal phenotype detected
MGI:3042511	Nkx2-5<tm1Krc>	MP:0000278,abnormal myocardial fiber morphology|MP:0000284,double outlet right ventricle|MP:0001575,cyanosis|MP:0001625,cardiac hypertrophy|MP:0002081,perinatal lethality|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002192,hydrops fetalis|MP:0002633,persistent truncus arteriosus|MP:0002795,dilated cardiomyopathy|MP:0003649,decreased heart right ventricle size|MP:0003872,absent heart right ventricle|MP:0003920,abnormal heart right ventricle morphology|MP:0004117,abnormal atrioventricular bundle morphology|MP:0004123,abnormal impulse conducting system morphology|MP:0005385,cardiovascular system phenotype|MP:0005608,cardiac interstitial fibrosis|MP:0006126,abnormal cardiac outflow tract development|MP:0010422,heart right ventricle hypoplasia|MP:0010519,atrioventricular block|MP:0010533,atrioventricular node hypoplasia|MP:0010585,abnormal conotruncal ridge morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014519,myocardial ventricular hypertrabeculation
MGI:1857618	Nkx2-5<tm1Siz>	MP:0000267,abnormal heart development|MP:0000293,absent myocardial trabeculae|MP:0000298,absent atrioventricular cushions|MP:0000352,decreased cell proliferation|MP:0001577,anemia|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0001722,pale yolk sac|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003137,abnormal impulse conducting system conduction|MP:0003229,abnormal vitelline vasculature morphology|MP:0003396,abnormal embryonic hematopoiesis|MP:0003896,prolonged PR interval|MP:0003984,embryonic growth retardation|MP:0004124,abnormal Purkinje fiber morphology|MP:0004555,pharynx hypoplasia|MP:0004787,abnormal dorsal aorta morphology|MP:0005312,pericardial effusion|MP:0005598,decreased heart ventricle muscle contractility|MP:0006107,abnormal fetal atrioventricular canal morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0010392,prolonged QRS complex duration|MP:0010432,common ventricle|MP:0010519,atrioventricular block|MP:0010662,abnormal intersomitic artery morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011205,excessive folding of visceral yolk sac|MP:0012492,pharyngeal arch artery hypoplasia
MGI:1927227	Nkx2-5<tm1Wehi>	MP:0000270,abnormal heart tube morphology|MP:0000277,abnormal heart shape|MP:0000282,abnormal interatrial septum morphology|MP:0000296,absent trabeculae carneae|MP:0000298,absent atrioventricular cushions|MP:0000694,spleen hypoplasia|MP:0000729,abnormal myogenesis|MP:0001633,poor circulation|MP:0001688,abnormal somite development|MP:0001689,incomplete somite formation|MP:0001698,decreased embryo size|MP:0001785,edema|MP:0001787,pericardial edema|MP:0002190,disorganized myocardium|MP:0003228,abnormal sinus venosus morphology|MP:0003896,prolonged PR interval|MP:0003984,embryonic growth retardation|MP:0004225,patent cardiac foramen ovale|MP:0004251,failure of heart looping|MP:0005329,abnormal myocardium layer morphology|MP:0006107,abnormal fetal atrioventricular canal morphology|MP:0006117,aortic valve stenosis|MP:0006126,abnormal cardiac outflow tract development|MP:0010403,atrial septal defect|MP:0010450,atrial septal aneurysm|MP:0010484,bicuspid aortic valve|MP:0010593,thick aortic valve cusps|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0031166,abnormal aortic valve commissure morphology|MP:0031530,abnormal heart ventricle shape
MGI:5828833	Nkx2-5<tm2.1Mwc>	MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0001636,irregular heartbeat|MP:0002754,dilated heart right ventricle|MP:0003897,abnormal ST segment|MP:0003898,abnormal QRS complex|MP:0003901,abnormal PR interval|MP:0003916,decreased heart left ventricle weight|MP:0003920,abnormal heart right ventricle morphology|MP:0004062,dilated heart right atrium|MP:0004225,patent cardiac foramen ovale|MP:0004251,failure of heart looping|MP:0005598,decreased heart ventricle muscle contractility|MP:0006142,abnormal sinoatrial node conduction|MP:0010392,prolonged QRS complex duration|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010520,sinoatrial block|MP:0010533,atrioventricular node hypoplasia|MP:0010571,shortened ST segment|MP:0010754,abnormal heart left ventricle pressure|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011952,decreased cardiac stroke volume|MP:0011953,prolonged PQ interval|MP:0012515,abnormal heart apex morphology|MP:0031633,decreased heart left ventricle muscle contractility|MP:0031634,decreased heart right ventricle muscle contractility
MGI:3040604	Nkx2-5<tm2Siz>	MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0003105,abnormal heart atrium morphology|MP:0004114,abnormal atrioventricular node morphology|MP:0004123,abnormal impulse conducting system morphology|MP:0004124,abnormal Purkinje fiber morphology|MP:0006107,abnormal fetal atrioventricular canal morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0010532,absent atrioventricular node|MP:0010559,heart block|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0031530,abnormal heart ventricle shape
MGI:5828836	Nkx2-5<tm3.1Mwc>	MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0002754,dilated heart right ventricle|MP:0003920,abnormal heart right ventricle morphology|MP:0004062,dilated heart right atrium|MP:0004114,abnormal atrioventricular node morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004225,patent cardiac foramen ovale|MP:0004251,failure of heart looping|MP:0006142,abnormal sinoatrial node conduction|MP:0010392,prolonged QRS complex duration|MP:0010403,atrial septal defect|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010520,sinoatrial block|MP:0010557,dilated pulmonary artery|MP:0010571,shortened ST segment|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011953,prolonged PQ interval|MP:0012515,abnormal heart apex morphology|MP:0031634,decreased heart right ventricle muscle contractility
MGI:3655239	Nkx2-5<tm4Rph>	MP:0000267,abnormal heart development|MP:0000282,abnormal interatrial septum morphology|MP:0004063,dilated heart left atrium|MP:0004225,patent cardiac foramen ovale|MP:0005294,abnormal heart ventricle morphology|MP:0005329,abnormal myocardium layer morphology|MP:0006113,abnormal heart septum morphology|MP:0010403,atrial septal defect|MP:0010450,atrial septal aneurysm|MP:0010484,bicuspid aortic valve|MP:0021158,decreased heart left ventricle wall thickness|MP:0031633,decreased heart left ventricle muscle contractility
MGI:6741035	Nkx2-6<em1(IMPC)H>	MP:0002941,increased circulating alanine transaminase level|MP:0005627,increased circulating potassium level
MGI:2386678	Nkx2-6<tm1Siz>	MP:0002169,no abnormal phenotype detected
MGI:2655862	Nkx2-9<tm1Hha>	MP:0000937,abnormal motor neuron morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001075,abnormal accessory nerve morphology|MP:0004568,fusion of glossopharyngeal and vagus nerve|MP:0004949,absent neuronal precursor cells|MP:0005192,increased motor neuron number|MP:0010768,mortality/aging|MP:0014747,abnormal motor neuron axon guidance
MGI:3692933	Nkx2-9<tm1Jlck>	MP:0000940,abnormal motor neuron innervation pattern|MP:0001075,abnormal accessory nerve morphology|MP:0002048,increased lung adenoma incidence|MP:0004207,increased squamous cell carcinoma incidence|MP:0005488,bronchial epithelial hyperplasia|MP:0008014,increased lung tumor incidence|MP:0010942,abnormal respiratory epithelium morphology|MP:0010943,abnormal bronchus epithelium morphology
MGI:3045877	Nkx3-1<tm1.1Saa>	MP:0002009,preneoplasia
MGI:1928654	Nkx3-1<tm1Hha>	MP:0000351,increased cell proliferation|MP:0000615,abnormal palatine gland morphology|MP:0000618,small salivary gland|MP:0000619,salivary gland epithelial hyperplasia|MP:0000620,narrow salivary ducts|MP:0000623,decreased salivation|MP:0000664,small prostate gland anterior lobe|MP:0000665,decreased ductal branching in the coagulating gland|MP:0000666,decreased prostate gland duct number|MP:0001158,abnormal prostate gland morphology|MP:0001163,abnormal prostate gland anterior lobe morphology|MP:0001168,abnormal prostate gland epithelium morphology|MP:0001169,abnormal bulbourethral gland morphology|MP:0001380,decreased male mating frequency|MP:0003791,abnormal minor salivary gland morphology|MP:0005305,prostate gland anterior lobe hyperplasia|MP:0005380,embryo phenotype|MP:0009517,abnormal salivary gland duct morphology|MP:0009736,abnormal prostate gland branching morphogenesis|MP:0013736,abnormal bulbourethral gland development|MP:0013737,small bulbourethral gland|MP:0031369,prostate gland dorsolateral lobe hyperplasia
MGI:1926960	Nkx3-1<tm1Mms>	MP:0000666,decreased prostate gland duct number|MP:0000671,bulbourethral gland hypoplasia|MP:0001163,abnormal prostate gland anterior lobe morphology|MP:0001167,prostate gland epithelial hyperplasia|MP:0001168,abnormal prostate gland epithelium morphology|MP:0001380,decreased male mating frequency|MP:0002009,preneoplasia|MP:0003607,abnormal prostate gland physiology|MP:0005305,prostate gland anterior lobe hyperplasia|MP:0005389,reproductive system phenotype|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009736,abnormal prostate gland branching morphogenesis|MP:0011781,abnormal bulbourethral gland physiology|MP:0013736,abnormal bulbourethral gland development|MP:0031369,prostate gland dorsolateral lobe hyperplasia
MGI:2447385	Nkx3-1<tm1Saa>	MP:0002009,preneoplasia|MP:0009219,increased prostate intraepithelial neoplasia incidence
MGI:1928655	Nkx3-1<tm1Siz>	MP:0000613,abnormal salivary gland morphology|MP:0000615,abnormal palatine gland morphology|MP:0000616,decreased ductal branching in the palatine gland|MP:0000617,increased salivary gland mucosal cell number|MP:0000660,prostate gland lateral lobe hypoplasia|MP:0000661,small prostate gland ventral lobe|MP:0000664,small prostate gland anterior lobe|MP:0000665,decreased ductal branching in the coagulating gland|MP:0000666,decreased prostate gland duct number|MP:0001157,small seminal vesicle|MP:0001158,abnormal prostate gland morphology|MP:0001163,abnormal prostate gland anterior lobe morphology|MP:0001167,prostate gland epithelial hyperplasia|MP:0001168,abnormal prostate gland epithelium morphology
MGI:3038373	Nkx3-1<tm2Mms>	MP:0005389,reproductive system phenotype
MGI:1857926	Nkx3-2<tm1.1Tlu>	MP:0000071,axial skeleton hypoplasia|MP:0000074,abnormal neurocranium morphology|MP:0000079,abnormal basioccipital bone morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000141,abnormal vertebral body morphology|MP:0000164,abnormal cartilage development|MP:0000438,abnormal cranium morphology|MP:0000592,short tail|MP:0000690,absent spleen|MP:0001255,decreased body height|MP:0001268,barrel chest|MP:0004173,abnormal intervertebral disk morphology|MP:0004443,absent supraoccipital bone|MP:0004445,small exoccipital bone|MP:0004599,abnormal vertebral arch morphology|MP:0004607,abnormal cervical atlas morphology|MP:0004610,small vertebrae|MP:0004704,short vertebral column|MP:0004733,abnormal thoracic cavity morphology|MP:0005227,abnormal vertebral body development|MP:0005371,limbs/digits/tail phenotype|MP:0008271,abnormal bone ossification|MP:0011087,neonatal lethality, complete penetrance
MGI:1931319	Nkx3-2<tm1Bobh>	MP:0000029,abnormal malleus morphology|MP:0000030,abnormal tympanic ring morphology|MP:0000049,abnormal middle ear morphology|MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000163,abnormal cartilage morphology|MP:0000164,abnormal cartilage development|MP:0000585,kinked tail|MP:0000588,thick tail|MP:0000592,short tail|MP:0000690,absent spleen|MP:0001255,decreased body height|MP:0001706,abnormal left-right axis patterning|MP:0002114,abnormal axial skeleton morphology|MP:0002825,abnormal notochord morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003283,abnormal digestive organ placement|MP:0003934,abnormal pancreas development|MP:0004447,small basioccipital bone|MP:0004462,small basisphenoid bone|MP:0004626,vertebral compression|MP:0004652,small caudal vertebrae|MP:0004668,absent vertebral body|MP:0004683,absent intervertebral disk|MP:0005105,abnormal middle ear ossicle morphology|MP:0005226,abnormal vertebral arch development|MP:0006029,abnormal sclerotome morphology|MP:0008381,absent gonial bone|MP:0008382,gonial bone hypoplasia|MP:0010029,abnormal basicranium morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0030027,basioccipital bone hypoplasia|MP:0030084,tympanic ring hypoplasia
MGI:3848005	Nkx3-2<tm1(cre)Wez>	MP:0004703,abnormal vertebral column morphology|MP:0005508,abnormal skeleton morphology|MP:0008385,absent basisphenoid bone|MP:0009609,absent basioccipital bone
MGI:3032961	Nkx3-2<tm1Tlu>	MP:0000071,axial skeleton hypoplasia|MP:0000074,abnormal neurocranium morphology|MP:0000079,abnormal basioccipital bone morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000141,abnormal vertebral body morphology|MP:0000164,abnormal cartilage development|MP:0000438,abnormal cranium morphology|MP:0000592,short tail|MP:0000690,absent spleen|MP:0001255,decreased body height|MP:0001268,barrel chest|MP:0004173,abnormal intervertebral disk morphology|MP:0004443,absent supraoccipital bone|MP:0004445,small exoccipital bone|MP:0004599,abnormal vertebral arch morphology|MP:0004610,small vertebrae|MP:0004704,short vertebral column|MP:0004733,abnormal thoracic cavity morphology|MP:0005227,abnormal vertebral body development|MP:0005371,limbs/digits/tail phenotype|MP:0008271,abnormal bone ossification|MP:0010729,absent arcus anterior|MP:0011087,neonatal lethality, complete penetrance
MGI:2183276	Nkx3-2<tm1Tno>	MP:0000078,abnormal supraoccipital bone morphology|MP:0000080,abnormal exoccipital bone morphology|MP:0000141,abnormal vertebral body morphology|MP:0000164,abnormal cartilage development|MP:0000352,decreased cell proliferation|MP:0000462,abnormal digestive system morphology|MP:0000585,kinked tail|MP:0000690,absent spleen|MP:0001258,decreased body length|MP:0001954,respiratory distress|MP:0002114,abnormal axial skeleton morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002825,abnormal notochord morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0004461,basisphenoid bone hypoplasia|MP:0004599,abnormal vertebral arch morphology|MP:0004607,abnormal cervical atlas morphology|MP:0004608,abnormal cervical axis morphology|MP:0004659,abnormal odontoid process morphology|MP:0004667,vertebral body hypoplasia|MP:0004683,absent intervertebral disk|MP:0004711,persistence of notochord tissue|MP:0005225,abnormal vertebrae development|MP:0006029,abnormal sclerotome morphology|MP:0009917,abnormal hyoid bone body morphology|MP:0010731,absent ventral tubercle of atlas|MP:0011087,neonatal lethality, complete penetrance|MP:0030027,basioccipital bone hypoplasia
MGI:5300900	Nkx3-2<tm3.1(cre)Tlu>	MP:0002169,no abnormal phenotype detected
MGI:5300901	Nkx3-2<tm4.1(cre)Tlu>	MP:0002169,no abnormal phenotype detected
MGI:2386119	Nkx6-1<tm1Jlr>	MP:0000939,decreased motor neuron number|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002948,abnormal neuron specification|MP:0003059,decreased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0009172,small pancreatic islets|MP:0011087,neonatal lethality, complete penetrance|MP:0021103,abnormal ventral interneuron 1 morphology|MP:0021104,abnormal ventral interneuron 2 morphology
MGI:4412372	Nkx6-2<tm1(cre/ERT2)Fsh>	MP:0010768,mortality/aging
MGI:2651850	Nkx6-2<tm1Ercs>	MP:0002169,no abnormal phenotype detected
MGI:3522433	Nkx6-2<tm1Gow>	MP:0000920,abnormal myelination|MP:0001330,abnormal optic nerve morphology|MP:0001405,impaired coordination|MP:0005403,abnormal nerve conduction|MP:0005405,axon degeneration
MGI:2182286	Nkx6-2<tm1Qiu>	MP:0002169,no abnormal phenotype detected
MGI:3795186	Nkx6-3<tm1Shiv>	MP:0004137,abnormal gastric surface mucous cell morphology|MP:0004139,abnormal gastric parietal cell morphology|MP:0004732,decreased circulating gastrin level|MP:0008006,increased stomach pH|MP:0010803,abnormal stomach enteroendocrine cell morphology
MGI:2671871	Nle1<l11Jus1>	MP:0001694,absent egg cylinders|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2671874	Nle1<l11Jus4>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5476692	Nle1<rs13468707-C>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5553358	Nle1<tm1.2Cota>	MP:0001672,abnormal embryo development|MP:0003694,failure of blastocyst to hatch from the zona pellucida
MGI:3624778	Nle1<tm1Cba>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0010380,abnormal inner cell mass apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6400993	Nlgn1<em1Taku>	MP:0001360,abnormal social investigation|MP:0003631,nervous system phenotype|MP:0003863,decreased aggression towards mice|MP:0005386,behavior/neurological phenotype|MP:0008414,abnormal spatial reference memory|MP:0012307,impaired spatial learning
MGI:5754559	Nlgn1<tm1.1Sud>	MP:0003631,nervous system phenotype|MP:0011270,decreased excitatory postsynaptic current amplitude
MGI:3687638	Nlgn1<tm1Bros>	MP:0002206,abnormal CNS synaptic transmission
MGI:5509357	Nlgn1<tm1Sud>	MP:0002169,no abnormal phenotype detected
MGI:6158645	Nlgn2<tm1.1Gchn>	MP:0001489,decreased startle reflex|MP:0001745,increased circulating corticosterone level|MP:0002572,abnormal emotion/affect behavior|MP:0002797,increased thigmotaxis|MP:0008428,abnormal spatial working memory|MP:0008911,induced hyperactivity|MP:0009142,decreased prepulse inhibition|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0009454,impaired contextual conditioning behavior|MP:0012006,abnormal hippocampus physiology|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude|MP:0020422,decreased freezing behavior|MP:0020551,abnormal postsynaptic density morphology
MGI:5567078	Nlgn2<tm1.1Sud>	MP:0001361,social withdrawal|MP:0001364,decreased anxiety-related response|MP:0002206,abnormal CNS synaptic transmission|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0009538,abnormal synapse morphology|MP:0011269,increased excitatory postsynaptic current amplitude|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude
MGI:6156147	Nlgn3<em1(IMPC)Rbrc>	MP:0000062,increased bone mineral density|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0003313,abnormal locomotor activation|MP:0005011,increased eosinophil cell number|MP:0008820,abnormal blood uric acid level
MGI:4867464	Nlgn3<tm1.1Htz>	MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001489,decreased startle reflex|MP:0001516,abnormal motor coordination/balance|MP:0001732,postnatal growth retardation|MP:0002063,abnormal learning/memory/conditioning|MP:0002757,decreased vertical activity|MP:0002797,increased thigmotaxis|MP:0002862,abnormal righting response|MP:0002865,increased growth rate|MP:0003631,nervous system phenotype|MP:0003858,enhanced coordination|MP:0020351,decreased vocalization
MGI:3687640	Nlgn3<tm1Bros>	MP:0000774,decreased brain size|MP:0001360,abnormal social investigation|MP:0001415,increased exploration in new environment|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008544,impaired olfaction|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0020351,decreased vocalization|MP:0031391,increased locomotor activity
MGI:5439278	Nlgn3<tm1Rhn>	MP:0001516,abnormal motor coordination/balance|MP:0001899,absent long-term depression|MP:0001900,impaired synaptic plasticity|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004997,increased CNS synapse formation|MP:0011269,increased excitatory postsynaptic current amplitude
MGI:3758949	Nlgn3<tm1Sud>	MP:0001360,abnormal social investigation|MP:0001409,increased stereotypic behavior|MP:0001463,abnormal spatial learning|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0012314,enhanced learning|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0031391,increased locomotor activity
MGI:3758960	Nlgn3<tm2.1Sud>	MP:0001408,stereotypic behavior|MP:0001409,increased stereotypic behavior|MP:0002169,no abnormal phenotype detected|MP:0002574,increased vertical activity|MP:0012314,enhanced learning|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0031391,increased locomotor activity
MGI:4940407	Nlgn3<tm3.1Sud>	MP:0002886,abnormal glutamate-mediated receptor currents|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0011003,reduced AMPA-mediated synaptic currents
MGI:5649372	Nlgn3<tm4.1Sud>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0012314,enhanced learning|MP:0031391,increased locomotor activity
MGI:3775814	Nlgn4l<Gt(XST093)Byg>	MP:0000774,decreased brain size|MP:0001360,abnormal social investigation|MP:0003863,decreased aggression towards mice|MP:0020351,decreased vocalization
MGI:4130034	Nlk<Gt(RRJ297)Byg>	MP:0001405,impaired coordination
MGI:5550140	Nlk<tm1.1Ecan>	MP:0002169,no abnormal phenotype detected
MGI:2177606	Nlk<tm1Tbo>	MP:0000168,abnormal bone marrow development|MP:0000333,decreased bone marrow cell number|MP:0000694,spleen hypoplasia|MP:0000715,decreased thymocyte number|MP:0001393,ataxia|MP:0001602,impaired myelopoiesis|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002217,small lymph nodes|MP:0002722,abnormal immune system organ morphology|MP:0005016,decreased lymphocyte cell number|MP:0005092,decreased double-positive T cell number|MP:0008045,decreased NK cell number|MP:0008208,decreased pro-B cell number|MP:0008347,decreased gamma-delta T cell number|MP:0011091,prenatal lethality, complete penetrance
MGI:5790640	Nlk<tm2b(KOMP)Wtsi>	MP:0001488,increased startle reflex|MP:0002968,increased circulating alkaline phosphatase level|MP:0004738,abnormal auditory brainstem response|MP:0011100,preweaning lethality, complete penetrance
MGI:4125183	Nln<Gt(NPX481)Byg>	MP:0001262,decreased body weight|MP:0002891,increased insulin sensitivity|MP:0003383,abnormal gluconeogenesis|MP:0005292,improved glucose tolerance|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0010954,abnormal cellular respiration|MP:0012106,impaired exercise endurance
MGI:5439971	Nlrc3<tm1Bhk>	MP:0000220,increased monocyte cell number|MP:0001262,decreased body weight|MP:0005534,decreased body temperature|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008596,increased circulating interleukin-6 level|MP:0008735,increased susceptibility to endotoxin shock
MGI:6508701	Nlrc4<em1Vnce>	MP:0001876,decreased inflammatory response|MP:0005389,reproductive system phenotype|MP:0005571,decreased lactate dehydrogenase level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010768,mortality/aging
MGI:6508702	Nlrc4<em2Vnce>	MP:0001876,decreased inflammatory response|MP:0005389,reproductive system phenotype|MP:0005571,decreased lactate dehydrogenase level|MP:0010768,mortality/aging
MGI:6508703	Nlrc4<em3Vnce>	MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:5695007	Nlrc4<m1Btlr>	MP:0008658,decreased interleukin-1 beta secretion
MGI:3722152	Nlrc4<tm1Gln>	MP:0005387,immune system phenotype
MGI:5446022	Nlrc4<tm1Gne>	MP:0005387,immune system phenotype
MGI:3664623	Nlrc4<tm1Nnz>	MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology
MGI:3046934	Nlrc4<tm1Vmd>	MP:0000313,abnormal cell death|MP:0003009,abnormal cytokine secretion|MP:0005025,abnormal response to infection|MP:0008658,decreased interleukin-1 beta secretion
MGI:5426421	Nlrc5<tm1.1Ggaur>	MP:0000691,enlarged spleen|MP:0002444,abnormal T cell physiology|MP:0005387,immune system phenotype|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:4939792	Nlrc5<tm1Aki>	MP:0005387,immune system phenotype
MGI:5445207	Nlrc5<tm1Itl>	MP:0005387,immune system phenotype|MP:0008565,decreased interferon-beta secretion|MP:0008706,decreased interleukin-6 secretion
MGI:5085851	Nlrp10<tm1Seis>	MP:0002376,abnormal dendritic cell physiology|MP:0002420,abnormal adaptive immunity|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005387,immune system phenotype|MP:0005466,abnormal T-helper 2 physiology|MP:0008127,decreased dendritic cell number|MP:0008495,decreased IgG1 level|MP:0008567,decreased interferon-gamma secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:4836357	Nlrp12<tm1Jpyt>	MP:0000222,decreased neutrophil cell number|MP:0003156,abnormal leukocyte migration|MP:0005387,immune system phenotype|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008720,impaired neutrophil chemotaxis
MGI:5305143	Nlrp12<tm1Tdk>	MP:0000691,enlarged spleen|MP:0001846,increased inflammatory response|MP:0004499,increased incidence of tumors by chemical induction|MP:0008537,increased susceptibility to induced colitis|MP:0008713,abnormal cytokine level|MP:0008721,abnormal chemokine level
MGI:7442772	Nlrp14<em1Gfan>	MP:0003718,maternal effect
MGI:7425868	Nlrp14<em1(IMPC)Bay>	MP:0001926,female infertility
MGI:6276972	Nlrp1a<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology
MGI:6200049	Nlrp1a<m1Btlr>	MP:0001262,decreased body weight|MP:0002497,increased IgE level|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008045,decreased NK cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0008170,decreased B-1b cell number|MP:0008207,decreased B-2 B cell number|MP:0008560,increased tumor necrosis factor secretion|MP:0010848,decreased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0011080,increased macrophage apoptosis
MGI:6200053	Nlrp1a<m2Btlr>	MP:0000189,hypoglycemia|MP:0000219,increased neutrophil cell number|MP:0005017,decreased B cell number|MP:0008045,decreased NK cell number|MP:0008126,increased dendritic cell number|MP:0008658,decreased interleukin-1 beta secretion|MP:0011080,increased macrophage apoptosis
MGI:5471965	Nlrp1a<Neut1>	MP:0000219,increased neutrophil cell number|MP:0000691,enlarged spleen|MP:0001846,increased inflammatory response|MP:0001856,myocarditis|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001869,pancreas inflammation|MP:0002083,premature death|MP:0003884,decreased macrophage cell number|MP:0005016,decreased lymphocyte cell number|MP:0005389,reproductive system phenotype|MP:0011078,increased macrophage cytokine production|MP:0031110,meningitis
MGI:5449888	Nlrp1b<tm1Bhk>	MP:0002451,abnormal macrophage physiology|MP:0005166,decreased susceptibility to injury|MP:0005571,decreased lactate dehydrogenase level|MP:0008655,decreased interleukin-1 alpha secretion|MP:0008658,decreased interleukin-1 beta secretion
MGI:7642231	Nlrp2<em1Kzt>	MP:0005389,reproductive system phenotype
MGI:6343489	Nlrp2<tm1.2Itl>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0003718,maternal effect|MP:0005384,cellular phenotype|MP:0005387,immune system phenotype|MP:0009781,abnormal preimplantation embryo development|MP:0012128,abnormal blastocyst formation
MGI:4880891	Nlrp2<tm1a(KOMP)Wtsi>	MP:0001125,abnormal oocyte morphology|MP:0001131,abnormal ovarian follicle morphology|MP:0003718,maternal effect|MP:0005389,reproductive system phenotype|MP:0008868,abnormal granulosa cell morphology|MP:0009647,decreased fertilization frequency|MP:0031239,increased atretic ovarian follicle number|MP:0031381,decreased secondary ovarian follicle number
MGI:5756073	Nlrp2<tm1b(KOMP)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0011960,abnormal eye anterior chamber depth|MP:0011964,increased total retina thickness
MGI:7545524	Nlrp3<em1Taoli>	MP:0008658,decreased interleukin-1 beta secretion
MGI:5789569	Nlrp3<M10Btlr>	MP:0008658,decreased interleukin-1 beta secretion
MGI:6114093	Nlrp3<M11Btlr>	MP:0008658,decreased interleukin-1 beta secretion
MGI:6284017	Nlrp3<m12Btlr>	MP:0008658,decreased interleukin-1 beta secretion
MGI:4442850	Nlrp3<m1Btlr>	MP:0008658,decreased interleukin-1 beta secretion
MGI:4835549	Nlrp3<m2Btlr>	MP:0008656,abnormal interleukin-1 beta secretion
MGI:4835554	Nlrp3<m3Btlr>	MP:0008656,abnormal interleukin-1 beta secretion
MGI:4999611	Nlrp3<m4Btlr>	MP:0008658,decreased interleukin-1 beta secretion
MGI:5466146	Nlrp3<m5Btlr>	MP:0008658,decreased interleukin-1 beta secretion
MGI:5607728	Nlrp3<M6Btlr>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0008658,decreased interleukin-1 beta secretion
MGI:5607730	Nlrp3<M7Btlr>	MP:0008658,decreased interleukin-1 beta secretion|MP:0011072,abnormal macrophage cytokine production
MGI:5613597	Nlrp3<M8Btlr>	MP:0008658,decreased interleukin-1 beta secretion
MGI:5632190	Nlrp3<M9Btlr>	MP:0008658,decreased interleukin-1 beta secretion
MGI:5465108	Nlrp3<tm1Bhk>	MP:0000598,abnormal liver morphology|MP:0001663,abnormal digestive system physiology|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0003674,oxidative stress|MP:0004890,decreased energy expenditure|MP:0005387,immune system phenotype|MP:0005571,decreased lactate dehydrogenase level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0008658,decreased interleukin-1 beta secretion|MP:0009355,increased liver triglyceride level|MP:0010377,abnormal gut flora balance|MP:0013245,abnormal lipid metabolism|MP:0014142,increased body fat mass|MP:0031602,white adipose tissue inflammation
MGI:3686871	Nlrp3<tm1Flv>	MP:0002451,abnormal macrophage physiology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008539,decreased susceptibility to induced colitis|MP:0008636,decreased circulating interleukin-18 level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008658,decreased interleukin-1 beta secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:3850011	Nlrp3<tm1Hhf>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000477,abnormal intestine morphology|MP:0001190,reddish skin|MP:0001192,scaly skin|MP:0001846,increased inflammatory response|MP:0002135,abnormal kidney morphology|MP:0002376,abnormal dendritic cell physiology|MP:0002451,abnormal macrophage physiology|MP:0002455,abnormal dendritic cell antigen presentation|MP:0003815,hairless|MP:0005505,thrombocytosis|MP:0008489,slow postnatal weight gain|MP:0008553,increased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level|MP:0008635,increased circulating interleukin-18 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0010209,abnormal circulating chemokine level|MP:0010210,abnormal circulating cytokine level|MP:0011085,postnatal lethality, complete penetrance
MGI:3721141	Nlrp3<tm1Tsc>	MP:0008658,decreased interleukin-1 beta secretion
MGI:3622094	Nlrp3<tm1Vmd>	MP:0003009,abnormal cytokine secretion|MP:0005025,abnormal response to infection|MP:0005387,immune system phenotype|MP:0008636,decreased circulating interleukin-18 level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008658,decreased interleukin-1 beta secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:3850069	Nlrp3<tm1Wstr>	MP:0000218,increased leukocyte cell number|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001194,dermatitis|MP:0001732,postnatal growth retardation|MP:0001829,increased activated T cell number|MP:0001921,reduced fertility|MP:0002339,abnormal lymph node morphology|MP:0002356,abnormal spleen red pulp morphology|MP:0002376,abnormal dendritic cell physiology|MP:0002451,abnormal macrophage physiology|MP:0002499,chronic inflammation|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008073,abnormal CD4-positive, alpha-beta T cell number|MP:0008086,increased T-helper 1 cell number|MP:0008489,slow postnatal weight gain|MP:0008657,increased interleukin-1 beta secretion|MP:0008681,increased interleukin-17 secretion|MP:0008684,increased interleukin-18 secretion|MP:0008770,decreased survivor rate|MP:0009278,abnormal bone marrow cell physiology
MGI:3850013	Nlrp3<tm2Hhf>	MP:0002376,abnormal dendritic cell physiology|MP:0002451,abnormal macrophage physiology|MP:0011089,perinatal lethality, complete penetrance
MGI:5517707	Nlrp3<tm3.1Hhf>	MP:0000063,decreased bone mineral density|MP:0000065,abnormal bone marrow cavity morphology|MP:0000130,abnormal trabecular bone morphology|MP:0000131,abnormal long bone epiphysis morphology|MP:0000135,decreased compact bone thickness|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000167,decreased chondrocyte number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0000352,decreased cell proliferation|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0001846,increased inflammatory response|MP:0002113,abnormal skeleton development|MP:0002875,decreased erythrocyte cell number|MP:0002933,joint inflammation|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0004016,decreased bone mass|MP:0004984,increased osteoclast cell number|MP:0004992,increased bone resorption|MP:0005013,increased lymphocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0005190,osteomyelitis|MP:0005387,immune system phenotype|MP:0005505,thrombocytosis|MP:0006397,disorganized long bone epiphyseal plate|MP:0008396,abnormal osteoclast differentiation|MP:0008553,increased circulating tumor necrosis factor level|MP:0008566,increased interferon-gamma secretion|MP:0008596,increased circulating interleukin-6 level|MP:0008602,increased circulating interleukin-4 level|MP:0008608,increased circulating interleukin-13 level|MP:0008623,increased circulating interleukin-3 level|MP:0008627,decreased circulating interleukin-5 level|MP:0008629,increased circulating interleukin-9 level|MP:0008635,increased circulating interleukin-18 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008648,decreased circulating interleukin-12b level|MP:0008657,increased interleukin-1 beta secretion|MP:0009278,abnormal bone marrow cell physiology|MP:0009346,decreased trabecular bone thickness|MP:0009780,abnormal chondrocyte physiology|MP:0010209,abnormal circulating chemokine level|MP:0010869,decreased bone trabecula number|MP:0010873,decreased trabecular bone mass|MP:0010968,decreased compact bone area|MP:0011085,postnatal lethality, complete penetrance|MP:0030825,decreased femur size|MP:0031110,meningitis
MGI:5308094	Nlrp3<tm3Hhf>	MP:0002169,no abnormal phenotype detected
MGI:6393576	Nlrp4f<em1Lil>	MP:0001125,abnormal oocyte morphology|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0003718,maternal effect|MP:0005389,reproductive system phenotype
MGI:2178449	Nlrp5<tm1Zbt>	MP:0001926,female infertility|MP:0003718,maternal effect|MP:0020850,abnormal microtubule cytoskeleton morphology
MGI:5085850	Nlrp6<tm1Flv>	MP:0000218,increased leukocyte cell number|MP:0002495,increased IgA level|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005014,increased B cell number|MP:0005036,diarrhea|MP:0008136,enlarged Peyer's patches|MP:0008537,increased susceptibility to induced colitis|MP:0008636,decreased circulating interleukin-18 level|MP:0008685,decreased interleukin-18 secretion|MP:0008896,increased IgG2c level|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010377,abnormal gut flora balance|MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality
MGI:5140329	Nlrp6<tm1Macha>	MP:0000511,abnormal intestinal mucosa morphology|MP:0000512,intestinal ulcer|MP:0001505,hunched posture|MP:0001792,impaired wound healing|MP:0003288,intestinal edema|MP:0003293,rectal hemorrhage|MP:0004499,increased incidence of tumors by chemical induction|MP:0008537,increased susceptibility to induced colitis|MP:0008883,abnormal enterocyte proliferation|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010155,abnormal intestine physiology|MP:0010180,increased susceptibility to weight loss|MP:0010279,increased gastrointestinal tumor incidence|MP:0013956,decreased colon length
MGI:5752293	Nlrp6<tm1Opaz>	MP:0001364,decreased anxiety-related response|MP:0002062,abnormal associative learning|MP:0002988,decreased urine osmolality|MP:0005386,behavior/neurological phenotype|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0011431,increased urine flow rate|MP:0012306,enhanced spatial learning|MP:0012307,impaired spatial learning
MGI:5910440	Nlrp9b<em1Flv>	MP:0005036,diarrhea|MP:0006043,decreased apoptosis|MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality
MGI:5637166	Nlrp9b<tm1b(KOMP)Wtsi>	MP:0000274,enlarged heart|MP:0000691,enlarged spleen|MP:0001147,small testis
MGI:6276838	Nlrx1<em1(IMPC)Mbp>	MP:0000692,small spleen|MP:0001325,abnormal retina morphology
MGI:5141085	Nlrx1<tm1Jpyt>	MP:0001262,decreased body weight|MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology|MP:0008564,increased interferon-beta secretion|MP:0008596,increased circulating interleukin-6 level|MP:0008657,increased interleukin-1 beta secretion|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:3038126	nm3	MP:0001388,abnormal stationary movement|MP:0002082,postnatal lethality|MP:0003631,nervous system phenotype|MP:0005156,bradykinesia|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005424,jerky movement|MP:0005643,decreased dopamine level
MGI:1889328	nma	MP:0000746,weakness|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001525,impaired balance|MP:0002083,premature death|MP:0003314,dysmetria|MP:0003631,nervous system phenotype|MP:0005369,muscle phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005560,decreased circulating glucose level|MP:0009434,paraparesis
MGI:2387767	Nmbr<tm1Hoh>	MP:0001386,abnormal maternal nurturing|MP:0001777,abnormal body temperature homeostasis
MGI:6110562	Nmb<tm1Zfc>	MP:0001440,abnormal grooming behavior|MP:0005386,behavior/neurological phenotype
MGI:3628812	Nme1<tm1Jyd>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0001262,decreased body weight|MP:0001882,abnormal lactation|MP:0002184,abnormal innervation|MP:0003718,maternal effect|MP:0005517,impaired liver regeneration|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012431,increased lymphoma incidence
MGI:4122609	Nme2<Gt(69C10)Cmhd>	MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008688,decreased interleukin-2 secretion
MGI:5582447	Nme2<tm1.1(KOMP)Vlcg>	MP:0000470,abnormal stomach morphology|MP:0000598,abnormal liver morphology|MP:0001120,abnormal uterus morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0004906,enlarged uterus
MGI:8264618	Nme3<em1Zefc>	MP:0000160,kyphosis|MP:0001393,ataxia|MP:0031252,abnormal physiological response to hypoxia
MGI:5429195	Nme5<tm1Lex>	MP:0000440,domed cranium|MP:0001155,arrest of spermatogenesis|MP:0001866,nasal inflammation|MP:0001891,hydrocephaly|MP:0001917,intraventricular hemorrhage|MP:0005159,azoospermia|MP:0005378,growth/size/body region phenotype|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0008893,detached sperm flagellum|MP:0010752,impaired mucociliary clearance|MP:0030113,maxillary sinus inflammation
MGI:5565612	Nme6<tm1.1(KOMP)Vlcg>	MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4151115	Nme7<Gt(OST31116)Lex>	MP:0000440,domed cranium|MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0001891,hydrocephaly|MP:0002766,situs inversus|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0011055,abnormal respiratory motile cilium physiology
MGI:5692842	Nme7<tm2b(EUCOMM)Hmgu>	MP:0005560,decreased circulating glucose level|MP:0005567,decreased circulating total protein level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5550546	Nme8<tm1.1Arte>	MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:2678015	nmf110	MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001489,decreased startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2678255	nmf111	MP:0000745,tremors|MP:0001265,decreased body size
MGI:2663969	nmf118	MP:0000745,tremors|MP:0000749,muscle degeneration|MP:0001265,decreased body size|MP:0002857,cochlear ganglion degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004738,abnormal auditory brainstem response|MP:0010053,decreased grip strength
MGI:2681979	nmf127	MP:0001393,ataxia
MGI:2683168	Nmf128	MP:0001316,cornea scarring|MP:0002699,abnormal vitreous body morphology|MP:0012671,retina spots
MGI:3053683	nmf131	MP:0001289,persistence of hyaloid vascular system|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001316,cornea scarring|MP:0003381,vitreal fibroplasia|MP:0012671,retina spots
MGI:2663830	nmf148	MP:0001265,decreased body size|MP:0001393,ataxia
MGI:2651834	Nmf15	MP:0001260,increased body weight|MP:0001261,obese|MP:0001944,abnormal pancreas morphology|MP:0002628,hepatic steatosis|MP:0009171,enlarged pancreatic islets
MGI:3579048	nmf161	MP:0000743,muscle spasm|MP:0000921,demyelination
MGI:3032516	nmf172	MP:0001394,circling|MP:0001967,deafness|MP:0004738,abnormal auditory brainstem response
MGI:3511215	Nmf191	MP:0001325,abnormal retina morphology
MGI:3574832	nmf195	MP:0001325,abnormal retina morphology
MGI:2686758	nmf206	MP:0000745,tremors
MGI:2680537	Nmf220	MP:0000745,tremors
MGI:3586973	nmf242	MP:0000743,muscle spasm|MP:0001393,ataxia
MGI:3611322	nmf246	MP:0001326,retina degeneration
MGI:3621648	nmf253	MP:0001426,polydipsia
MGI:3611686	nmf268	MP:0012671,retina spots
MGI:2429921	Nmf31	MP:0000243,myoclonus|MP:0001954,respiratory distress|MP:0002193,minimal clonic seizures|MP:0003631,nervous system phenotype|MP:0011085,postnatal lethality, complete penetrance
MGI:3531433	nmf313	MP:0000745,tremors|MP:0001393,ataxia|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0001525,impaired balance
MGI:3612845	nmf347	MP:0000743,muscle spasm|MP:0000745,tremors|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001410,head bobbing
MGI:3606096	nmf356	MP:0000436,abnormal head movements|MP:0000743,muscle spasm|MP:0000745,tremors|MP:0000747,muscle weakness|MP:0001513,limb grasping|MP:0003103,liver degeneration|MP:0003644,thymus atrophy|MP:0005424,jerky movement|MP:0005491,pancreatic islet hyperplasia
MGI:3624125	nmf370	MP:0001395,bidirectional circling|MP:0001504,abnormal posture|MP:0001849,ear inflammation|MP:0002730,head shaking|MP:0005377,hearing/vestibular/ear phenotype|MP:0010323,retropulsion
MGI:3612864	nmf391	MP:0000243,myoclonus|MP:0000745,tremors|MP:0000747,muscle weakness|MP:0000752,dystrophic muscle|MP:0001265,decreased body size|MP:0001849,ear inflammation
MGI:2429915	nmf4	MP:0000692,small spleen|MP:0000745,tremors|MP:0005191,head tilt|MP:0013585,thymus cortex atrophy
MGI:3621487	nmf418	MP:0000743,muscle spasm|MP:0000747,muscle weakness|MP:0000849,abnormal cerebellum morphology|MP:0001513,limb grasping|MP:0005369,muscle phenotype|MP:0005371,limbs/digits/tail phenotype|MP:0005386,behavior/neurological phenotype
MGI:3603001	nmf419	MP:0000745,tremors|MP:0000958,peripheral nervous system degeneration|MP:0001513,limb grasping|MP:0005386,behavior/neurological phenotype|MP:0009434,paraparesis
MGI:3641334	nmf445	MP:0005191,head tilt
MGI:2651825	nmf62	MP:0001406,abnormal gait|MP:0010053,decreased grip strength
MGI:2651889	nmf63	MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0002272,abnormal nervous system electrophysiology|MP:0002690,akinesia|MP:0004994,abnormal brain wave pattern
MGI:2651829	nmf65	MP:0001406,abnormal gait|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0005150,cachexia|MP:0010053,decreased grip strength
MGI:2651831	nmf67	MP:0000747,muscle weakness|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001325,abnormal retina morphology|MP:0001328,disorganized retina layers|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0008025,brain vacuoles|MP:0008027,abnormal spinal cord white matter morphology
MGI:2661772	nmf88	MP:0001650,abnormal seizure response to electrical stimulation
MGI:6764595	Nmi<em1Hhl>	MP:0002942,decreased circulating alanine transaminase level|MP:0005632,decreased circulating aspartate transaminase level|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008597,decreased circulating interleukin-6 level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:6402447	Nmi<tm1.1Geno>	MP:0001272,increased metastatic potential|MP:0001884,mammary gland alveolar hyperplasia|MP:0001885,mammary gland duct hyperplasia|MP:0004499,increased incidence of tumors by chemical induction|MP:0005379,endocrine/exocrine gland phenotype|MP:0009504,abnormal mammary gland epithelium morphology|MP:0013782,abnormal mammary duct terminal end bud morphology
MGI:5903758	Nmnat1<imh>	MP:0002792,abnormal retina vasculature morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005548,retina pigment epithelium atrophy|MP:0006243,impaired pupillary reflex|MP:0008450,retina photoreceptor degeneration|MP:0008511,thin retina inner nuclear layer|MP:0008512,disorganized retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008580,photoreceptor inner segment degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0010768,mortality/aging|MP:0011965,decreased total retina thickness|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:5450825	Nmnat1<tm1.2Lcon>	MP:0003631,nervous system phenotype|MP:0011091,prenatal lethality, complete penetrance
MGI:4431754	Nmnat1<tm1a(EUCOMM)Wtsi>	MP:0002590,increased mean corpuscular volume|MP:0002896,abnormal bone mineralization|MP:0003795,abnormal bone structure
MGI:6156360	Nmnat1<tm1c(EUCOMM)Wtsi>	MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008587,short photoreceptor outer segment|MP:0011965,decreased total retina thickness
MGI:6272869	Nmnat1<tm1d(EUCOMM)Wtsi>	MP:0011092,embryonic lethality, complete penetrance
MGI:6272867	Nmnat1<tm1Ruch>	MP:0002169,no abnormal phenotype detected
MGI:5902788	Nmnat1<tvrm113>	MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0002792,abnormal retina vasculature morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005548,retina pigment epithelium atrophy|MP:0008450,retina photoreceptor degeneration|MP:0010768,mortality/aging|MP:0011965,decreased total retina thickness|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:6276887	Nmnat2<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001297,microphthalmia|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0002339,abnormal lymph node morphology|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:5543590	Nmnat2<Gt(EUCE0262a08)1.1Hmgu>	MP:0005405,axon degeneration
MGI:4371844	Nmnat2<Gt(EUCE0262a08)Hmgu>	MP:0000539,distended urinary bladder|MP:0000753,paralysis|MP:0000778,abnormal nervous system tract morphology|MP:0001177,atelectasis|MP:0001332,abnormal optic nerve innervation|MP:0001334,absent optic tract|MP:0001505,hunched posture|MP:0001953,respiratory failure|MP:0002184,abnormal innervation|MP:0003491,abnormal voluntary movement|MP:0003624,anuria|MP:0003651,abnormal axon extension|MP:0004232,decreased muscle weight|MP:0004819,decreased skeletal muscle mass|MP:0008415,abnormal neurite morphology|MP:0008492,dorsal root ganglion degeneration|MP:0010057,abnormal olfactory bulb outer nerve layer morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0012251,abnormal diaphragm development|MP:0012484,decreased corticospinal tract size
MGI:5473270	Nmnat2<Tn(sb-Tyr)2172.P9KK4BOve>	MP:0000527,abnormal kidney development|MP:0000537,abnormal urethra morphology|MP:0000539,distended urinary bladder|MP:0000753,paralysis|MP:0000909,abnormal facial motor nucleus morphology|MP:0000939,decreased motor neuron number|MP:0000958,peripheral nervous system degeneration|MP:0000964,small dorsal root ganglion|MP:0000966,decreased sensory neuron number|MP:0001177,atelectasis|MP:0001270,distended abdomen|MP:0001505,hunched posture|MP:0001948,vesicoureteral reflux|MP:0001953,respiratory failure|MP:0002882,abnormal neuron morphology|MP:0004819,decreased skeletal muscle mass|MP:0005405,axon degeneration|MP:0009431,decreased fetal weight|MP:0011087,neonatal lethality, complete penetrance|MP:0012251,abnormal diaphragm development
MGI:5638788	Nmnat3<Gt(3020)Tgen>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000256,echinocytosis|MP:0000691,enlarged spleen|MP:0001585,hemolytic anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002640,reticulocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0003656,abnormal erythrocyte physiology|MP:0004952,increased spleen weight|MP:0005319,abnormal enzyme/coenzyme level|MP:0008476,increased spleen red pulp amount|MP:0008809,increased spleen iron level|MP:0008973,decreased erythroid progenitor cell number|MP:0010035,increased erythrocyte clearance|MP:0010177,acanthocytosis
MGI:5695916	Nmral1<tm1.1(KOMP)Vlcg>	MP:0001314,cornea opacity|MP:0001399,hyperactivity|MP:0005576,decreased pulmonary ventilation|MP:0010378,increased respiratory quotient|MP:0012125,decreased bronchoconstrictive response
MGI:5471953	Nmrk2<tm1.1(KOMP)Vlcg>	MP:0001566,increased circulating phosphate level|MP:0005633,increased circulating sodium level
MGI:4842902	Nmrk2<tm1(KOMP)Vlcg>	MP:0003631,nervous system phenotype
MGI:3586313	Nmt1<Gt(XE400)Byg>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5696555	Nmt1<tm1.1Poru>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0008083,decreased single-positive T cell number
MGI:5696557	Nmt2<tm1.1Poru>	MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0008083,decreased single-positive T cell number
MGI:5692594	Nmt2<tm2b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0002968,increased circulating alkaline phosphatase level
MGI:5548449	Nmur1<tm1.1(KOMP)Vlcg>	MP:0005566,decreased blood urea nitrogen level
MGI:4358246	Nmur1<tm1Doma>	MP:0005376,homeostasis/metabolism phenotype
MGI:3795273	Nmur1<tm1Lex>	MP:0003638,abnormal response/metabolism to endogenous compounds
MGI:3722111	Nmur1<tm1Rtor>	MP:0005386,behavior/neurological phenotype
MGI:3822773	Nmur1<tm1Sjab>	MP:0002169,no abnormal phenotype detected
MGI:3701426	Nmur2<m1Hzg>	MP:0001442,decreased grooming behavior|MP:0001970,abnormal pain threshold|MP:0001973,increased thermal nociceptive threshold|MP:0003631,nervous system phenotype|MP:0005449,abnormal food intake|MP:0011957,decreased compensatory feeding amount
MGI:4359163	Nmur2<tm1.1Eege>	MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005455,increased susceptibility to weight gain|MP:0005658,increased susceptibility to diet-induced obesity|MP:0010024,increased total body fat amount
MGI:4358245	Nmur2<tm1Dgen>	MP:0001262,decreased body weight|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003961,decreased lean body mass|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008489,slow postnatal weight gain|MP:0010025,decreased total body fat amount|MP:0011940,decreased food intake
MGI:3722114	Nmur2<tm1Rtor>	MP:0001973,increased thermal nociceptive threshold|MP:0008531,increased chemical nociceptive threshold
MGI:3056512	Nmu<tm1Mko>	MP:0001261,obese|MP:0001402,decreased locomotor activity|MP:0001433,polyphagia|MP:0001554,increased circulating free fatty acids level|MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0002665,decreased circulating corticosterone level|MP:0005178,increased circulating cholesterol level|MP:0005290,decreased oxygen consumption|MP:0005317,increased triglyceride level|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0011049,impaired adaptive thermogenesis|MP:0020467,abnormal circadian behavior
MGI:3822775	Nmu<tm1Sjab>	MP:0008597,decreased circulating interleukin-6 level
MGI:6152524	Nnat<em1(IMPC)Mbp>	MP:0000274,enlarged heart|MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology|MP:0003795,abnormal bone structure|MP:0010124,decreased bone mineral content
MGI:6356534	Nnat<tm1.1Geno>	MP:0003059,decreased insulin secretion|MP:0003122,maternal imprinting|MP:0005293,impaired glucose tolerance|MP:0013279,increased fasting circulating glucose level
MGI:6455186	Nnat<tm1.2Geno>	MP:0002079,increased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003122,maternal imprinting|MP:0005215,abnormal pancreatic islet morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype
MGI:5007264	Nnat<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:3036086	Nnc1<C3H/HeJ>	MP:0002983,increased retina ganglion cell number
MGI:3036085	Nnc1<DBA/2J>	MP:0002983,increased retina ganglion cell number
MGI:6152525	Nnmt<em1(IMPC)Mbp>	MP:0000691,enlarged spleen|MP:0001126,abnormal ovary morphology|MP:0001944,abnormal pancreas morphology|MP:0002060,abnormal skin morphology|MP:0004832,enlarged ovary
MGI:3626282	Nnt<C57BL/6J>	MP:0002665,decreased circulating corticosterone level|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0008291,abnormal adrenocortical cell morphology|MP:0014285,disorganized adrenal gland zona fasciculata
MGI:6257492	Nnt<em1(IMPC)H>	MP:0001406,abnormal gait|MP:0005178,increased circulating cholesterol level|MP:0005559,increased circulating glucose level
MGI:3625823	Nnt<G745D>	MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005621,abnormal cell physiology
MGI:3625821	Nnt<N68K>	MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005621,abnormal cell physiology
MGI:2667674	Noa	MP:0000377,abnormal hair follicle morphology|MP:0001209,spontaneous skin ulceration|MP:0001230,epidermal desquamation|MP:0001242,hyperkeratosis|MP:0001245,thick dermal layer|MP:0001278,kinked vibrissae|MP:0001280,loss of vibrissae|MP:0001412,excessive scratching|MP:0002073,abnormal hair growth|MP:0002098,abnormal vibrissa morphology|MP:0002497,increased IgE level|MP:0003815,hairless|MP:0009004,progressive hair loss|MP:0009474,thick epidermis stratum spinosum|MP:0009599,thick epidermis stratum granulosum|MP:0031395,cutaneous mastocytosis
MGI:5293450	Noa1<tm1Tze>	MP:0003984,embryonic growth retardation|MP:0005031,abnormal trophoblast layer morphology|MP:0005621,abnormal cell physiology|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006043,decreased apoptosis|MP:0008944,decreased sensitivity to induced cell death|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011635,abnormal mitochondrial crista morphology|MP:0013241,embryo tissue necrosis|MP:0013505,decreased embryonic tissue cell apoptosis
MGI:3513472	Noan1<C57BL/6>	MP:0001981,increased chemically-elicited antinociception
MGI:3513480	Noan2<C57BL/6>	MP:0001981,increased chemically-elicited antinociception
MGI:6423083	nob10	MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008450,retina photoreceptor degeneration|MP:0011965,decreased total retina thickness|MP:0012029,abnormal electroretinogram waveform feature|MP:0012144,decreased b-wave amplitude|MP:0012671,retina spots
MGI:5605743	Nobox<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001697,abnormal embryo size|MP:0002059,abnormal seminal vesicle morphology|MP:0003984,embryonic growth retardation|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:3053093	Nobox<tm1Rajk>	MP:0001125,abnormal oocyte morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001926,female infertility|MP:0002016,ovary cyst|MP:0004805,absent oocytes|MP:0004833,ovary atrophy|MP:0005431,decreased oocyte number|MP:0008871,abnormal ovarian follicle number|MP:0009093,oocyte degeneration|MP:0031382,absent secondary ovarian follicles
MGI:2446833	Nobq2<NZO/HlBom>	MP:0002079,increased circulating insulin level
MGI:5662104	Noc2l<tm1.1Arte>	MP:0000694,spleen hypoplasia|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0001823,thymus hypoplasia|MP:0001824,abnormal thymus involution|MP:0001825,arrested T cell differentiation|MP:0003077,abnormal cell cycle|MP:0004939,abnormal B cell morphology|MP:0005092,decreased double-positive T cell number|MP:0005094,abnormal T cell proliferation|MP:0008037,abnormal T cell morphology|MP:0008070,absent T cells|MP:0008083,decreased single-positive T cell number|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008827,abnormal thymus cell ratio|MP:0009541,increased thymocyte apoptosis|MP:0010134,decreased DN3 thymocyte number|MP:0010136,decreased DN4 thymocyte number|MP:0012765,decreased alpha-beta T cell number
MGI:5574094	Noc3l<tm1Maim>	MP:0001730,embryonic growth arrest|MP:0002663,absent blastocoele|MP:0003706,abnormal cell nucleus count|MP:0011092,embryonic lethality, complete penetrance
MGI:6356390	Noc4l<em1(IMPC)J>	MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6362739	Noc4l<tm1.1Nju>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:2661857	Nociq1<C57BL/6J>	MP:0002735,abnormal chemical nociception|MP:0002736,abnormal nociception after inflammation
MGI:2661860	Nociq2<C57BL/6J>	MP:0002735,abnormal chemical nociception|MP:0002736,abnormal nociception after inflammation
MGI:2686733	Noct<tm1Bjc>	MP:0002310,decreased susceptibility to hepatic steatosis|MP:0002891,increased insulin sensitivity|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity
MGI:4820590	Nod1<tm1Bert>	MP:0005387,immune system phenotype
MGI:2674231	Nod1<tm1Inoh>	MP:0001790,abnormal immune system physiology|MP:0002451,abnormal macrophage physiology|MP:0003009,abnormal cytokine secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion
MGI:6277024	Nod2<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001146,abnormal testis morphology|MP:0001944,abnormal pancreas morphology|MP:0002339,abnormal lymph node morphology|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:4437257	Nod2<tm1Daph>	MP:0002451,abnormal macrophage physiology|MP:0008260,abnormal autophagy
MGI:3529594	Nod2<tm1Flv>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0001793,abnormal susceptibility to infection|MP:0001798,impaired macrophage phagocytosis|MP:0001805,decreased IgG level|MP:0002451,abnormal macrophage physiology|MP:0002467,impaired neutrophil phagocytosis|MP:0003436,decreased susceptibility to induced arthritis|MP:0005025,abnormal response to infection|MP:0005465,abnormal T-helper 1 physiology|MP:0008553,increased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008599,increased circulating interleukin-2 level|MP:0008706,decreased interleukin-6 secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:3722087	Nod2<tm1Jhgt>	MP:0000685,abnormal immune system morphology|MP:0000696,abnormal Peyer's patch morphology|MP:0001790,abnormal immune system physiology|MP:0002344,abnormal lymph node B cell domain morphology|MP:0005025,abnormal response to infection|MP:0005090,increased double-negative T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008132,increased Peyer's patch number|MP:0008136,enlarged Peyer's patches|MP:0008537,increased susceptibility to induced colitis|MP:0008713,abnormal cytokine level|MP:0008750,abnormal interferon level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level
MGI:3530578	Nod2<tm1Mka>	MP:0001263,weight loss|MP:0002446,abnormal macrophage morphology|MP:0008537,increased susceptibility to induced colitis|MP:0008657,increased interleukin-1 beta secretion|MP:0008713,abnormal cytokine level|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:2680581	Nod2<tm1Pmu>	MP:0002451,abnormal macrophage physiology|MP:0008734,decreased susceptibility to endotoxin shock
MGI:3622092	Nod2<tm1Vmd>	MP:0003009,abnormal cytokine secretion
MGI:1856970	Nodal<TgR(MPSVNeo)413.dRob>	MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0001693,failure of primitive streak formation|MP:0001698,decreased embryo size|MP:0001710,absent amniotic folds|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002584,small ectoplacental cone|MP:0003087,absent allantois|MP:0003403,absent placental labyrinth|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0005030,absent amnion|MP:0006323,abnormal extraembryonic mesoderm development|MP:0006386,absent somites|MP:0009397,increased trophoblast giant cell number|MP:0010736,abnormal extraembryonic ectoderm morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011203,abnormal parietal yolk sac morphology|MP:0011206,absent visceral yolk sac|MP:0012724,absent head fold
MGI:3664774	Nodal<tm1.1Dbc>	MP:0001730,embryonic growth arrest|MP:0002230,abnormal primitive streak formation|MP:0009266,abnormal mesendoderm development|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3574979	Nodal<tm1.1Hmd>	MP:0002169,no abnormal phenotype detected
MGI:5462059	Nodal<tm1.1Ysa>	MP:0006362,abnormal male germ cell morphology
MGI:6120819	Nodal<tm1b(EUCOMM)Wtsi>	MP:0001402,decreased locomotor activity|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005542,cornea vascularization|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2654943	Nodal<tm1Hmd>	MP:0000508,right-sided isomerism|MP:0000531,right pulmonary isomerism|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000694,spleen hypoplasia|MP:0001706,abnormal left-right axis patterning|MP:0001730,embryonic growth arrest|MP:0003119,abnormal digestive system development|MP:0004110,transposition of great arteries|MP:0006061,right atrial isomerism|MP:0006065,abnormal heart position or orientation|MP:0010807,abnormal stomach position or orientation|MP:0011089,perinatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:2158730	Nodal<tm1Mku>	MP:0000269,abnormal heart looping|MP:0002169,no abnormal phenotype detected
MGI:2180793	Nodal<tm1Rob>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0011091,prenatal lethality, complete penetrance
MGI:2181583	Nodal<tm2Rob>	MP:0000269,abnormal heart looping|MP:0000508,right-sided isomerism|MP:0000531,right pulmonary isomerism|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002844,aortic hypertrophy|MP:0005380,embryo phenotype|MP:0006065,abnormal heart position or orientation|MP:0009266,abnormal mesendoderm development|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012157,rostral body truncation|MP:0012515,abnormal heart apex morphology
MGI:2388004	Nodal<tm3Rob>	MP:0002169,no abnormal phenotype detected
MGI:2668418	Nodal<tm4Rob>	MP:0000267,abnormal heart development|MP:0003935,abnormal craniofacial development|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3521719	Nodal<tm6Rob>	MP:0002169,no abnormal phenotype detected
MGI:6341872	Nog<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000443,abnormal snout morphology|MP:0001614,abnormal blood vessel morphology|MP:0001691,abnormal somite shape|MP:0001700,abnormal embryo turning|MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001785,edema|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0002989,small kidney|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0003425,abnormal optic vesicle formation|MP:0003720,abnormal neural tube closure|MP:0003795,abnormal bone structure|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:4941468	Nog<tm1.1Rmh>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000163,abnormal cartilage morphology|MP:0000164,abnormal cartilage development|MP:0002113,abnormal skeleton development
MGI:1862000	Nog<tm1Amc>	MP:0000029,abnormal malleus morphology|MP:0000031,abnormal cochlea morphology|MP:0000049,abnormal middle ear morphology|MP:0000077,abnormal interparietal bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000109,abnormal parietal bone morphology|MP:0000150,abnormal rib morphology|MP:0000160,kyphosis|MP:0000428,abnormal craniofacial morphology|MP:0000432,abnormal head morphology|MP:0000474,abnormal foregut morphology|MP:0000537,abnormal urethra morphology|MP:0000547,short limbs|MP:0000585,kinked tail|MP:0000830,abnormal diencephalon morphology|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0000929,open neural tube|MP:0000930,wavy neural tube|MP:0000955,abnormal spinal cord morphology|MP:0001145,abnormal male reproductive system morphology|MP:0001158,abnormal prostate gland morphology|MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001286,abnormal eye development|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001785,edema|MP:0002081,perinatal lethality|MP:0002108,abnormal muscle morphology|MP:0002109,abnormal limb morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002151,abnormal neural tube morphology|MP:0002286,cryptorchism|MP:0002632,vestigial tail|MP:0002770,absent bulbourethral gland|MP:0002825,abnormal notochord morphology|MP:0002896,abnormal bone mineralization|MP:0003125,abnormal septation of the cloaca|MP:0003130,anal atresia|MP:0003148,decreased cochlea coiling|MP:0003160,abnormal esophagus development|MP:0003190,fused synovial joints|MP:0003276,esophageal atresia|MP:0003321,tracheoesophageal fistula|MP:0003400,kinked neural tube|MP:0003456,absent tail|MP:0003704,abnormal hair follicle development|MP:0003720,abnormal neural tube closure|MP:0003740,fusion of middle ear ossicles|MP:0003816,abnormal pituitary gland development|MP:0003938,abnormal ear development|MP:0003942,abnormal urinary system development|MP:0004087,abnormal muscle fiber morphology|MP:0004200,decreased fetal size|MP:0004395,increased cochlear inner hair cell number|MP:0004401,increased cochlear outer hair cell number|MP:0004575,small limb buds|MP:0004599,abnormal vertebral arch morphology|MP:0004603,absent vertebral arch|MP:0004739,conductive hearing loss|MP:0005105,abnormal middle ear ossicle morphology|MP:0005106,abnormal incus morphology|MP:0005107,abnormal stapes morphology|MP:0005269,abnormal occipital bone morphology|MP:0005297,spina bifida occulta|MP:0005315,absent pituitary gland|MP:0005377,hearing/vestibular/ear phenotype|MP:0005508,abnormal skeleton morphology|MP:0005646,abnormal pituitary gland physiology|MP:0005650,abnormal limb bud morphology|MP:0005657,abnormal neural plate morphology|MP:0006042,increased apoptosis|MP:0006325,impaired hearing|MP:0008023,abnormal styloid process morphology|MP:0008320,absent adenohypophysis|MP:0008530,abnormal rostral-caudal patterning of the somites|MP:0008817,hematoma|MP:0009570,abnormal right lung morphology|MP:0009735,abnormal prostate gland development|MP:0010029,abnormal basicranium morphology|MP:0010103,small thoracic cage|MP:0010116,abnormal primitive urogenital sinus morphology|MP:0010884,esophagus stenosis|MP:0011089,perinatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011361,pelvic kidney|MP:0011732,decreased somite size|MP:0011759,absent Rathke's pouch|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013351,abnormal Rathke's pouch development|MP:0013352,abnormal Rathke's pouch apoptosis|MP:0014198,absent pituitary infundibular stalk|MP:0030066,short face|MP:0031362,decreased prostate gland ventral lobe weight
MGI:6342900	Nol10<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6276885	Nol3<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0001126,abnormal ovary morphology|MP:0001304,cataract|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0004832,enlarged ovary
MGI:5470099	Nol3<tm1.1Rnkt>	MP:0000352,decreased cell proliferation|MP:0003547,abnormal pulmonary pressure|MP:0004007,abnormal lung vasculature morphology|MP:0005166,decreased susceptibility to injury|MP:0006042,increased apoptosis
MGI:3711185	Nol3<tm1Rvh>	MP:0002753,dilated heart left ventricle|MP:0003037,increased myocardial infarct size|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0005385,cardiovascular system phenotype|MP:0005598,decreased heart ventricle muscle contractility|MP:0005629,abnormal lung weight
MGI:6284324	Nol4<em1(IMPC)J>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0020870,decreased thigmotaxis
MGI:5574602	Nol8<tm1b(EUCOMM)Hmgu>	MP:0001488,increased startle reflex|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:6121485	Nol9<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0005553,increased circulating creatinine level|MP:0005566,decreased blood urea nitrogen level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5692702	Nolc1<tm1b(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0001488,increased startle reflex
MGI:4841092	Nom1<tm1a(KOMP)Wtsi>	MP:0008858,abnormal hair cycle anagen phase
MGI:6361225	Nono<em1(IMPC)Bay>	MP:0001417,decreased exploration in new environment
MGI:3895540	Nono<Gt(E086B07)Wrst>	MP:0001695,abnormal gastrulation
MGI:3895669	Nono<Gt(E089G04)Wrst>	MP:0002169,no abnormal phenotype detected
MGI:4348955	Nono<Gt(P030B07)Wrst>	MP:0001695,abnormal gastrulation
MGI:3866756	Nono<Gt(YHA266)Byg>	MP:0000428,abnormal craniofacial morphology|MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0001792,impaired wound healing|MP:0002188,small heart|MP:0002834,decreased heart weight|MP:0003077,abnormal cell cycle|MP:0003402,decreased liver weight|MP:0003821,decreased left ventricle diastolic pressure|MP:0003918,decreased kidney weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005608,cardiac interstitial fibrosis|MP:0008009,delayed cellular replicative senescence|MP:0008770,decreased survivor rate|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011703,increased fibroblast proliferation|MP:0011708,decreased fibroblast cell migration|MP:0020470,shortened circadian behavior period
MGI:5750473	Nop10<tm1.1(KOMP)Vlcg>	MP:0002968,increased circulating alkaline phosphatase level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5752216	Nop2<Gt1Gaj>	MP:0011091,prenatal lethality, complete penetrance
MGI:5906161	Nop53<tm1Asuz>	MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0020438,decreased papilloma incidence
MGI:5906164	Nop53<tm2.1Asuz>	MP:0000715,decreased thymocyte number
MGI:7262675	Norad<em1Cyang>	MP:0000160,kyphosis|MP:0003786,premature aging|MP:0004684,intervertebral disk degeneration|MP:0005165,increased susceptibility to injury|MP:0006392,abnormal nucleus pulposus morphology
MGI:5548603	Nos1ap<tm1b(KOMP)Wtsi>	MP:0000538,abnormal urinary bladder morphology|MP:0000745,tremors|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0002574,increased vertical activity|MP:0002833,increased heart weight|MP:0002942,decreased circulating alanine transaminase level|MP:0008259,abnormal optic disk morphology|MP:0009142,decreased prepulse inhibition|MP:0010097,abnormal retina blood vessel morphology|MP:0010124,decreased bone mineral content
MGI:6358783	Nos1ap<tm1Tsso>	MP:0001636,irregular heartbeat|MP:0003233,prolonged QT interval|MP:0003674,oxidative stress|MP:0005140,decreased cardiac muscle contractility|MP:0005385,cardiovascular system phenotype|MP:0005402,abnormal action potential|MP:0006110,ventricular fibrillation|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010392,prolonged QRS complex duration
MGI:4941223	Nos1<tm1.1(cre/ERT2)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:5301174	Nos1<tm1(cre)Mgmj>	MP:0002169,no abnormal phenotype detected
MGI:3584262	Nos1<tm1Enik>	MP:0009937,abnormal neuron differentiation
MGI:1857227	Nos1<tm1Plh>	MP:0000062,increased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000937,abnormal motor neuron morphology|MP:0001262,decreased body weight|MP:0001354,increased aggression towards male mice|MP:0001363,increased anxiety-related response|MP:0001423,abnormal liquid preference|MP:0001441,increased grooming behavior|MP:0001463,abnormal spatial learning|MP:0001501,abnormal sleep pattern|MP:0001525,impaired balance|MP:0001544,abnormal cardiovascular system physiology|MP:0001552,increased circulating triglyceride level|MP:0001629,abnormal heart rate|MP:0001664,abnormal digestion|MP:0001876,decreased inflammatory response|MP:0001899,absent long-term depression|MP:0001951,abnormal breathing pattern|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002113,abnormal skeleton development|MP:0002152,abnormal brain morphology|MP:0002207,abnormal long-term potentiation|MP:0002463,abnormal neutrophil physiology|MP:0002625,heart left ventricle hypertrophy|MP:0002626,increased heart rate|MP:0002703,abnormal renal tubule morphology|MP:0002834,decreased heart weight|MP:0002841,impaired skeletal muscle contractility|MP:0003023,decreased coronary flow rate|MP:0003063,increased coping response|MP:0003285,gastric hypertrophy|MP:0003307,pyloric stenosis|MP:0003355,decreased ovulation rate|MP:0003434,decreased susceptibility to induced choroidal neovascularization|MP:0003545,increased alcohol consumption|MP:0003628,abnormal leukocyte adhesion|MP:0003631,nervous system phenotype|MP:0003633,abnormal nervous system physiology|MP:0003646,increased muscle fatigability|MP:0003718,maternal effect|MP:0003858,enhanced coordination|MP:0003862,decreased aggression towards male mice|MP:0003883,enlarged stomach|MP:0004036,abnormal muscle relaxation|MP:0004084,abnormal cardiac muscle relaxation|MP:0004220,abnormal peripheral nervous system regeneration|MP:0004484,abnormal response of heart to induced stress|MP:0004495,decreased synaptic glutamate release|MP:0004545,enlarged esophagus|MP:0004876,decreased mean systemic arterial blood pressure|MP:0004883,abnormal vascular wound healing|MP:0004893,decreased adiponectin level|MP:0004994,abnormal brain wave pattern|MP:0005140,decreased cardiac muscle contractility|MP:0005166,decreased susceptibility to injury|MP:0005167,abnormal blood-brain barrier function|MP:0005288,abnormal oxygen consumption|MP:0005289,increased oxygen consumption|MP:0005322,abnormal serotonin level|MP:0005331,insulin resistance|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0005573,increased pulmonary respiratory rate|MP:0005575,increased pulmonary ventilation|MP:0005585,increased tidal volume|MP:0005600,increased heart ventricle muscle contractility|MP:0006036,abnormal mitochondrial physiology|MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0008143,abnormal dendrite morphology|MP:0008236,decreased susceptibility to neuronal excitotoxicity|MP:0008396,abnormal osteoclast differentiation|MP:0008770,decreased survivor rate|MP:0008779,abnormal maternal behavior|MP:0008872,abnormal physiological response to xenobiotic|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008962,abnormal carbon dioxide production|MP:0009347,increased trabecular bone thickness|MP:0009349,increased urine pH|MP:0009357,abnormal seizure response to inducing agent|MP:0009748,abnormal behavioral response to addictive substance|MP:0009749,enhanced behavioral response to addictive substance|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0009854,impaired gastric peristalsis|MP:0010107,abnormal renal reabsorption|MP:0010108,abnormal renal water reabsorption|MP:0010123,increased bone mineral content|MP:0010154,abnormal gastroesophageal sphincter physiology|MP:0010239,decreased skeletal muscle weight|MP:0010654,slow Wallerian degeneration|MP:0010781,pyloric sphincter hypertrophy|MP:0010782,stomach smooth muscle circular layer hypertrophy|MP:0010783,abnormal stomach wall morphology|MP:0010878,increased trabecular bone volume|MP:0011462,increased urine bicarbonate level|MP:0011882,enlarged duodenum|MP:0011988,increased mating frequency|MP:0012551,metabolic acidosis|MP:0020333,enhanced leukocyte tethering or rolling|MP:0020844,abnormal pulmonary respiratory rate response|MP:0031182,abnormal cerebral blood flow rate|MP:0031330,delayed peripheral nervous system regeneration|MP:0031420,decreased superovulation rate
MGI:3621899	Nos1<tm2Plh>	MP:0001262,decreased body weight|MP:0001380,decreased male mating frequency|MP:0001751,increased circulating luteinizing hormone level|MP:0001752,abnormal hypothalamus secretion|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002680,decreased corpora lutea number|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003307,pyloric stenosis|MP:0003883,enlarged stomach|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight
MGI:6257530	Nos2<em1(IMPC)Bay>	MP:0011960,abnormal eye anterior chamber depth|MP:0020870,decreased thigmotaxis
MGI:1857228	Nos2<tm1Lau>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000266,abnormal heart morphology|MP:0000685,abnormal immune system morphology|MP:0000780,abnormal corpus callosum morphology|MP:0001146,abnormal testis morphology|MP:0001431,abnormal eating behavior|MP:0001501,abnormal sleep pattern|MP:0001783,decreased white adipose tissue amount|MP:0001845,abnormal inflammatory response|MP:0001876,decreased inflammatory response|MP:0001929,abnormal gametogenesis|MP:0002078,abnormal glucose homeostasis|MP:0002133,abnormal respiratory system physiology|MP:0002160,abnormal reproductive system morphology|MP:0002166,abnormal tumor susceptibility|MP:0002412,increased susceptibility to bacterial infection|MP:0002420,abnormal adaptive immunity|MP:0002551,abnormal blood coagulation|MP:0002724,enhanced wound healing|MP:0002865,increased growth rate|MP:0002891,increased insulin sensitivity|MP:0002896,abnormal bone mineralization|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002942,decreased circulating alanine transaminase level|MP:0003194,abnormal frequency of paradoxical sleep|MP:0003434,decreased susceptibility to induced choroidal neovascularization|MP:0003710,abnormal physiological neovascularization|MP:0003795,abnormal bone structure|MP:0003823,increased left ventricle developed pressure|MP:0003992,increased mortality induced by ionizing radiation|MP:0004389,abnormal respiratory bronchiole morphology|MP:0004782,abnormal surfactant physiology|MP:0004851,increased testis weight|MP:0004947,skin inflammation|MP:0004982,abnormal osteoclast morphology|MP:0004994,abnormal brain wave pattern|MP:0005166,decreased susceptibility to injury|MP:0005169,abnormal male meiosis|MP:0005292,improved glucose tolerance|MP:0005294,abnormal heart ventricle morphology|MP:0005319,abnormal enzyme/coenzyme level|MP:0005329,abnormal myocardium layer morphology|MP:0005348,increased T cell proliferation|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0005410,abnormal fertilization|MP:0005464,abnormal platelet physiology|MP:0005553,increased circulating creatinine level|MP:0005610,increased circulating antidiuretic hormone level|MP:0005632,decreased circulating aspartate transaminase level|MP:0005668,decreased circulating leptin level|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006308,enlarged seminiferous tubules|MP:0008082,increased single-positive T cell number|MP:0008539,decreased susceptibility to induced colitis|MP:0009349,increased urine pH|MP:0009623,enlarged inguinal lymph nodes|MP:0009642,abnormal blood homeostasis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009808,decreased oligodendrocyte number|MP:0010768,mortality/aging|MP:0011939,increased food intake|MP:0020478,abnormal circadian sleep/wake cycle|MP:0030013,enhanced central nervous system regeneration|MP:0030603,increased sperm number
MGI:2158787	Nos2<tm1Liew>	MP:0001876,decreased inflammatory response|MP:0005027,increased susceptibility to parasitic infection|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0005465,abnormal T-helper 1 physiology|MP:0008566,increased interferon-gamma secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:2158791	Nos2<tm1Mrl>	MP:0000130,abnormal trabecular bone morphology|MP:0000188,abnormal circulating glucose level|MP:0000199,abnormal circulating serum albumin level|MP:0000505,decreased digestive secretion|MP:0001120,abnormal uterus morphology|MP:0001260,increased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0001552,increased circulating triglyceride level|MP:0001664,abnormal digestion|MP:0001764,abnormal homeostasis|MP:0001790,abnormal immune system physiology|MP:0001846,increased inflammatory response|MP:0001869,pancreas inflammation|MP:0001881,abnormal mammary gland physiology|MP:0001935,decreased litter size|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002127,abnormal cardiovascular system morphology|MP:0002128,abnormal blood circulation|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002602,abnormal eosinophil cell number|MP:0002699,abnormal vitreous body morphology|MP:0002733,abnormal thermal nociception|MP:0002842,increased systemic arterial blood pressure|MP:0002865,increased growth rate|MP:0002891,increased insulin sensitivity|MP:0002908,delayed wound healing|MP:0002999,abnormal bone healing|MP:0003037,increased myocardial infarct size|MP:0003177,allodynia|MP:0003224,neuron degeneration|MP:0003333,liver fibrosis|MP:0003631,nervous system phenotype|MP:0003930,abnormal tooth hard tissue morphology|MP:0003953,abnormal hormone level|MP:0003966,abnormal adrenocorticotropin level|MP:0003995,abnormal uterine artery morphology|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0004220,abnormal peripheral nervous system regeneration|MP:0004751,increased length of allograft survival|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004875,increased mean systemic arterial blood pressure|MP:0004893,decreased adiponectin level|MP:0004982,abnormal osteoclast morphology|MP:0004985,decreased osteoclast cell number|MP:0004993,decreased bone resorption|MP:0005012,decreased eosinophil cell number|MP:0005025,abnormal response to infection|MP:0005124,increased circulating prolactin level|MP:0005178,increased circulating cholesterol level|MP:0005183,abnormal circulating estradiol level|MP:0005292,improved glucose tolerance|MP:0005294,abnormal heart ventricle morphology|MP:0005316,abnormal response to tactile stimuli|MP:0005338,atherosclerotic lesions|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0005553,increased circulating creatinine level|MP:0005582,increased renin activity|MP:0006058,decreased cerebral infarct size|MP:0006144,increased systemic arterial systolic blood pressure|MP:0006271,abnormal involution of the mammary gland|MP:0008396,abnormal osteoclast differentiation|MP:0008500,increased IgG2a level|MP:0008566,increased interferon-gamma secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008770,decreased survivor rate|MP:0009011,prolonged diestrus|MP:0009548,abnormal platelet aggregation|MP:0009642,abnormal blood homeostasis|MP:0009660,abnormal induced retina neovascularization|MP:0010755,abnormal heart right ventricle pressure|MP:0010875,increased bone volume|MP:0010961,increased compact bone mass|MP:0011564,decreased urine prostaglandin level|MP:0011939,increased food intake|MP:0013717,hyperlactation|MP:0020011,increased bone mineral density of femur|MP:0031330,delayed peripheral nervous system regeneration
MGI:6276977	Nos3<em1(IMPC)Mbp>	MP:0000198,decreased circulating phosphate level|MP:0000219,increased neutrophil cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002606,increased basophil cell number|MP:0002631,abnormal epididymis morphology|MP:0002833,increased heart weight|MP:0002989,small kidney|MP:0004931,enlarged epididymis|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005565,increased blood urea nitrogen level|MP:0013278,decreased fasting circulating glucose level
MGI:5691955	Nos3<m1Btlr>	MP:0008537,increased susceptibility to induced colitis|MP:0010180,increased susceptibility to weight loss
MGI:6284778	Nos3<M2Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:5438593	Nos3<tm1.1Taka>	MP:0002169,no abnormal phenotype detected
MGI:5438595	Nos3<tm1.2Taka>	MP:0001552,increased circulating triglyceride level|MP:0003918,decreased kidney weight|MP:0004875,increased mean systemic arterial blood pressure|MP:0005325,abnormal renal glomerulus morphology|MP:0005333,decreased heart rate|MP:0005559,increased circulating glucose level|MP:0006144,increased systemic arterial systolic blood pressure
MGI:2159003	Nos3<tm1Gdk>	MP:0000231,hypertension|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001463,abnormal spatial learning|MP:0001905,abnormal dopamine level|MP:0002063,abnormal learning/memory/conditioning|MP:0003025,increased vasoconstriction|MP:0005322,abnormal serotonin level|MP:0005333,decreased heart rate|MP:0014368,enhanced long-term object recognition memory
MGI:2150145	Nos3<tm1Plh>	MP:0000008,increased white adipose tissue amount|MP:0000063,decreased bone mineral density|MP:0000188,abnormal circulating glucose level|MP:0000230,abnormal systemic arterial blood pressure|MP:0000231,hypertension|MP:0000233,abnormal blood flow velocity|MP:0000249,abnormal blood vessel physiology|MP:0000559,abnormal femur morphology|MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0000812,abnormal dentate gyrus morphology|MP:0001125,abnormal oocyte morphology|MP:0001127,small ovary|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001378,abnormal ejaculation|MP:0001379,abnormal penile erection|MP:0001552,increased circulating triglyceride level|MP:0001613,abnormal vasodilation|MP:0001923,reduced female fertility|MP:0001931,abnormal oogenesis|MP:0001935,decreased litter size|MP:0002062,abnormal associative learning|MP:0002083,premature death|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0002625,heart left ventricle hypertrophy|MP:0002626,increased heart rate|MP:0002628,hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0002842,increased systemic arterial blood pressure|MP:0002882,abnormal neuron morphology|MP:0002896,abnormal bone mineralization|MP:0003023,decreased coronary flow rate|MP:0003025,increased vasoconstriction|MP:0003033,abnormal pulmonary vascular resistance|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003355,decreased ovulation rate|MP:0003507,abnormal ovary physiology|MP:0003547,abnormal pulmonary pressure|MP:0003548,pulmonary hypertension|MP:0003628,abnormal leukocyte adhesion|MP:0003631,nervous system phenotype|MP:0003633,abnormal nervous system physiology|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003718,maternal effect|MP:0003921,abnormal heart left ventricle morphology|MP:0003990,decreased neurotransmitter release|MP:0004003,abnormal vascular endothelial cell physiology|MP:0004007,abnormal lung vasculature morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004875,increased mean systemic arterial blood pressure|MP:0004877,abnormal systemic vascular resistance|MP:0004883,abnormal vascular wound healing|MP:0004893,decreased adiponectin level|MP:0004948,abnormal neuronal precursor proliferation|MP:0005006,abnormal osteoblast physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005168,abnormal female meiosis|MP:0005182,increased circulating estradiol level|MP:0005186,increased circulating progesterone level|MP:0005253,abnormal eye physiology|MP:0005325,abnormal renal glomerulus morphology|MP:0005331,insulin resistance|MP:0005333,decreased heart rate|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0005452,abnormal adipose tissue amount|MP:0005560,decreased circulating glucose level|MP:0005591,decreased vasodilation|MP:0005599,increased cardiac muscle contractility|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0008770,decreased survivor rate|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009006,prolonged estrous cycle|MP:0009007,short estrous cycle|MP:0009011,prolonged diestrus|MP:0009345,abnormal trabecular bone thickness|MP:0009357,abnormal seizure response to inducing agent|MP:0009648,abnormal superovulation|MP:0009660,abnormal induced retina neovascularization|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0009815,decreased prostaglandin level|MP:0010755,abnormal heart right ventricle pressure|MP:0012737,abnormal primary polar body morphology|MP:0020333,enhanced leukocyte tethering or rolling|MP:0031182,abnormal cerebral blood flow rate|MP:0031420,decreased superovulation rate
MGI:1857229	Nos3<tm1Unc>	MP:0000062,increased bone mineral density|MP:0000063,decreased bone mineral density|MP:0000230,abnormal systemic arterial blood pressure|MP:0000231,hypertension|MP:0000260,abnormal angiogenesis|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000281,abnormal interventricular septum morphology|MP:0000484,abnormal pulmonary artery morphology|MP:0000521,abnormal kidney cortex morphology|MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001175,abnormal lung morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001182,lung hemorrhage|MP:0001262,decreased body weight|MP:0001541,abnormal osteoclast physiology|MP:0001544,abnormal cardiovascular system physiology|MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001575,cyanosis|MP:0001613,abnormal vasodilation|MP:0001625,cardiac hypertrophy|MP:0001729,impaired embryo implantation|MP:0001846,increased inflammatory response|MP:0001859,kidney inflammation|MP:0001954,respiratory distress|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002127,abnormal cardiovascular system morphology|MP:0002135,abnormal kidney morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002626,increased heart rate|MP:0002680,decreased corpora lutea number|MP:0002705,dilated renal tubule|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0002842,increased systemic arterial blood pressure|MP:0002871,albuminuria|MP:0003025,increased vasoconstriction|MP:0003071,decreased vascular permeability|MP:0003186,abnormal redox activity|MP:0003215,renal interstitial fibrosis|MP:0003227,abnormal vascular branching morphogenesis|MP:0003352,increased circulating renin level|MP:0003355,decreased ovulation rate|MP:0003446,renal hypoplasia|MP:0003606,kidney failure|MP:0003670,dilated renal glomerular capsule|MP:0003820,increased left ventricle systolic pressure|MP:0004007,abnormal lung vasculature morphology|MP:0004148,increased compact bone thickness|MP:0004153,increased renal tubule apoptosis|MP:0004154,renal tubular necrosis|MP:0004201,fetal growth retardation|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004780,abnormal surfactant secretion|MP:0004857,abnormal heart weight|MP:0004875,increased mean systemic arterial blood pressure|MP:0005006,abnormal osteoblast physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005167,abnormal blood-brain barrier function|MP:0005178,increased circulating cholesterol level|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005331,insulin resistance|MP:0005333,decreased heart rate|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005416,abnormal circulating protein level|MP:0005534,decreased body temperature|MP:0005565,increased blood urea nitrogen level|MP:0005590,increased vasodilation|MP:0005591,decreased vasodilation|MP:0005600,increased heart ventricle muscle contractility|MP:0006057,decreased vascular endothelial cell number|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008725,increased heart atrium size|MP:0008772,increased heart ventricle size|MP:0008823,abnormal interventricular septum membranous part morphology|MP:0008869,anovulation|MP:0009640,abnormal renal tubule epithelium morphology|MP:0009641,kidney degeneration|MP:0009642,abnormal blood homeostasis|MP:0009647,decreased fertilization frequency|MP:0009661,abnormal pregnancy|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010018,pulmonary vascular congestion|MP:0010090,increased circulating creatine kinase level|MP:0010402,ventricular septal defect|MP:0010405,ostium secundum atrial septal defect|MP:0010420,muscular ventricular septal defect|MP:0010484,bicuspid aortic valve|MP:0010563,increased heart right ventricle size|MP:0010579,increased heart left ventricle size|MP:0010755,abnormal heart right ventricle pressure|MP:0010814,absent alveolar lamellar bodies|MP:0010894,pulmonary alveolar edema|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011294,renal glomerulus hypertrophy|MP:0011353,expanded mesangial matrix|MP:0011368,increased kidney apoptosis|MP:0011377,renal glomerulus fibrosis|MP:0011392,increased fetal cardiomyocyte apoptosis|MP:0011402,renal cast|MP:0011427,increased mesangial cell number|MP:0011430,mesangiolysis|MP:0011441,decreased kidney cell proliferation|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011508,abnormal glomerular capillary thrombosis|MP:0011561,renal glomerulus lipidosis|MP:0014316,decreased heart left ventricle posterior wall thickness|MP:0030984,increased circulating osteocalcin level|MP:0031274,increased susceptibility to induced aneurysm formation
MGI:2657240	Nos3<tm1Weo>	MP:0000242,impaired fertilization|MP:0000547,short limbs|MP:0000564,syndactyly|MP:0002109,abnormal limb morphology|MP:0002161,abnormal fertility/fecundity|MP:0004084,abnormal cardiac muscle relaxation|MP:0005389,reproductive system phenotype|MP:0008976,delayed female fertility|MP:0008995,early reproductive senescence|MP:0009648,abnormal superovulation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031420,decreased superovulation rate
MGI:5499171	Nos3<tm2.1Plh>	MP:0000005,increased brown adipose tissue amount|MP:0000182,increased circulating LDL cholesterol level|MP:0001554,increased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002981,increased liver weight|MP:0004875,increased mean systemic arterial blood pressure|MP:0004893,decreased adiponectin level|MP:0005331,insulin resistance|MP:0005455,increased susceptibility to weight gain|MP:0005591,decreased vasodilation|MP:0005669,increased circulating leptin level|MP:0009118,increased white fat cell size|MP:0009292,increased inguinal fat pad weight|MP:0009304,increased retroperitoneal fat pad weight
MGI:5499172	Nos3<tm3.1Plh>	MP:0002079,increased circulating insulin level|MP:0005292,improved glucose tolerance|MP:0005559,increased circulating glucose level|MP:0009133,decreased white fat cell size
MGI:7425873	Nosip<em1(IMPC)Tcp>	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0002792,abnormal retina vasculature morphology|MP:0005505,thrombocytosis|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:4201195	Nosip<Gt(OST138992)Lex>	MP:0000108,midline facial cleft|MP:0000428,abnormal craniofacial morphology|MP:0000825,dilated lateral ventricle|MP:0000914,exencephaly|MP:0000934,abnormal telencephalon development|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0003451,absent olfactory bulb|MP:0003755,abnormal palate morphology|MP:0004276,abnormal medial ganglionic eminence morphology|MP:0004277,abnormal lateral ganglionic eminence morphology|MP:0005157,holoprosencephaly|MP:0005163,cyclopia|MP:0005262,coloboma|MP:0006197,ocular hypotelorism|MP:0006290,proboscis|MP:0008385,absent basisphenoid bone|MP:0008536,enlarged third ventricle|MP:0009429,decreased embryo weight|MP:0009431,decreased fetal weight|MP:0009890,cleft secondary palate|MP:0010059,olfactory bulb hypoplasia|MP:0011089,perinatal lethality, complete penetrance|MP:0012683,absent telencephalon|MP:0030095,abnormal midface morphology|MP:0030191,narrow snout|MP:0030268,agnathia|MP:0030558,absent nasopharynx
MGI:5444009	Nostrin<tm1.1Oess>	MP:0002792,abnormal retina vasculature morphology|MP:0003544,abnormal vascular endothelial cell migration|MP:0005602,decreased angiogenesis|MP:0009660,abnormal induced retina neovascularization|MP:0020316,decreased vascular endothelial cell proliferation
MGI:5444008	Nostrin<tm1Oess>	MP:0003544,abnormal vascular endothelial cell migration|MP:0020316,decreased vascular endothelial cell proliferation
MGI:5004944	Notch1<sot>	MP:0000259,abnormal vascular development|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001698,decreased embryo size|MP:0003861,abnormal nervous system development|MP:0006346,small pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5304912	Notch1<tm1.1(cre/ERT2)Sat>	MP:0002169,no abnormal phenotype detected|MP:0008762,embryonic lethality
MGI:1933835	Notch1<tm1Agt>	MP:0000260,abnormal angiogenesis|MP:0000371,diluted coat color|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001262,decreased body weight|MP:0001688,abnormal somite development|MP:0001701,incomplete embryo turning|MP:0001730,embryonic growth arrest|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0001914,hemorrhage|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002169,no abnormal phenotype detected|MP:0002652,thin myocardium|MP:0003227,abnormal vascular branching morphogenesis|MP:0003984,embryonic growth retardation|MP:0004057,thin myocardium compact layer|MP:0004076,abnormal vitelline vascular remodeling|MP:0004784,abnormal anterior cardinal vein morphology|MP:0004939,abnormal B cell morphology|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005244,hemopericardium|MP:0005312,pericardial effusion|MP:0005397,hematopoietic system phenotype|MP:0006042,increased apoptosis|MP:0006207,embryonic lethality during organogenesis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0008083,decreased single-positive T cell number|MP:0008214,increased immature B cell number|MP:0008758,abnormal T cell receptor beta chain V(D)J recombination|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0008827,abnormal thymus cell ratio|MP:0009328,delayed heart looping|MP:0010500,myocardium hypoplasia|MP:0010551,abnormal coronary vessel morphology|MP:0010561,absent coronary vessels|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012253,abnormal intersomitic vessel morphology|MP:0012509,neural tube degeneration
MGI:5692906	Notch1<tm1b(EUCOMM)Hmgu>	MP:0000137,abnormal vertebrae morphology|MP:0001488,increased startle reflex|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:1857230	Notch1<tm1Con>	MP:0000292,distended pericardium|MP:0000295,trabecula carnea hypoplasia|MP:0000313,abnormal cell death|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002190,disorganized myocardium|MP:0002792,abnormal retina vasculature morphology|MP:0003400,kinked neural tube|MP:0003794,delayed somite formation|MP:0004712,notochord degeneration|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005222,abnormal somite size|MP:0005224,abnormal left-right axis symmetry of the somites|MP:0005329,abnormal myocardium layer morphology|MP:0005385,cardiovascular system phenotype|MP:0010593,thick aortic valve cusps|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0031124,aortic valve inflammation|MP:0031518,calcified aortic valve cusp
MGI:1857877	Notch1<tm1Grid>	MP:0001719,absent vitelline blood vessels|MP:0001722,pale yolk sac|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0004401,increased cochlear outer hair cell number|MP:0004787,abnormal dorsal aorta morphology|MP:0005602,decreased angiogenesis|MP:0010097,abnormal retina blood vessel morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3665446	Notch1<tm1Pst>	MP:0002085,abnormal embryonic tissue morphology|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1913189	Notch1<tm1Rko>	MP:0000292,distended pericardium|MP:0001688,abnormal somite development|MP:0001719,absent vitelline blood vessels|MP:0001730,embryonic growth arrest|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011092,embryonic lethality, complete penetrance
MGI:5431503	Notch1<tm2.1Rko>	MP:0000137,abnormal vertebrae morphology
MGI:3043290	Notch1<tm2Agt>	MP:0002191,abnormal artery morphology|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3774549	Notch1<tm2Pst>	MP:0000715,decreased thymocyte number|MP:0001732,postnatal growth retardation|MP:0002145,abnormal T cell differentiation|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0005389,reproductive system phenotype|MP:0006413,increased T cell apoptosis
MGI:3044585	Notch1<tm2Rko>	MP:0000240,extramedullary hematopoiesis|MP:0000377,abnormal hair follicle morphology|MP:0000387,disorganized inner root sheath cells|MP:0000410,waved hair|MP:0000414,alopecia|MP:0000417,short hair|MP:0000598,abnormal liver morphology|MP:0000602,dilated liver sinusoidal space|MP:0000603,pale liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001312,abnormal cornea morphology|MP:0001337,dry eyes|MP:0001648,abnormal apoptosis|MP:0002073,abnormal hair growth|MP:0002083,premature death|MP:0002947,increased hemangioma incidence|MP:0003229,abnormal vitelline vasculature morphology|MP:0003809,abnormal hair shaft morphology|MP:0005382,craniofacial phenotype|MP:0005435,hemoperitoneum|MP:0005542,cornea vascularization|MP:0005544,cornea deposits|MP:0005601,increased angiogenesis|MP:0008947,increased neuron number|MP:0008986,abnormal liver parenchyma morphology|MP:0008987,abnormal liver lobule morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012246,abnormal hepatic cord morphology|MP:0012725,small sebaceous gland|MP:0013464,decreased conjunctiva goblet cell number|MP:0014148,lacrimal gland degeneration|MP:0014154,Meibomian gland degeneration|MP:0031301,chronic liver inflammation
MGI:3514150	Notch1<tm3(cre)Rko>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5009237	Notch1<tm5(cre/ERT2)Rko>	MP:0006207,embryonic lethality during organogenesis
MGI:3777790	Notch2<Gt(AG0498)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:4360085	Notch2<Gt(betageo)1Byg>	MP:0008182,decreased marginal zone B cell number
MGI:5304913	Notch2<tm1.1(cre/ERT2)Sat>	MP:0002169,no abnormal phenotype detected|MP:0008762,embryonic lethality
MGI:5803717	Notch2<tm1.1Ecan>	MP:0000063,decreased bone mineral density|MP:0000135,decreased compact bone thickness|MP:0001262,decreased body weight|MP:0003109,short femur|MP:0003797,abnormal compact bone morphology|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0004992,increased bone resorption|MP:0008396,abnormal osteoclast differentiation|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0010879,decreased trabecular bone volume|MP:0010933,decreased trabecular bone connectivity density|MP:0010968,decreased compact bone area|MP:0011089,perinatal lethality, complete penetrance|MP:0020080,increased bone mineralization
MGI:2663710	Notch2<tm1.1Hhi>	MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005027,increased susceptibility to parasitic infection|MP:0005078,abnormal cytotoxic T cell physiology|MP:0008182,decreased marginal zone B cell number
MGI:6766469	Notch2<tm1.1Hhtg>	MP:0000063,decreased bone mineral density|MP:0000141,abnormal vertebral body morphology|MP:0002083,premature death|MP:0002764,short tibia|MP:0003109,short femur|MP:0004706,short vertebral body|MP:0004984,increased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0004992,increased bone resorption|MP:0005367,renal/urinary system phenotype|MP:0005451,abnormal body composition|MP:0005508,abnormal skeleton morphology|MP:0008152,decreased diameter of femur|MP:0008396,abnormal osteoclast differentiation|MP:0008596,increased circulating interleukin-6 level|MP:0008705,increased interleukin-6 secretion|MP:0008751,abnormal interleukin level|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0013624,decreased femur compact bone thickness|MP:0020010,decreased bone mineral density of femur|MP:0020039,increased bone ossification|MP:0031074,increased circulating type I collagen C-terminal telopeptide level
MGI:3621957	Notch2<tm1Bmc>	MP:0002169,no abnormal phenotype detected
MGI:3695412	Notch2<tm1Frad>	MP:0000371,diluted coat color|MP:0001186,pigmentation phenotype|MP:0002144,abnormal B cell differentiation|MP:0005397,hematopoietic system phenotype|MP:0008183,absent marginal zone B cells
MGI:1933205	Notch2<tm1Grid>	MP:0000521,abnormal kidney cortex morphology|MP:0001297,microphthalmia|MP:0001786,skin edema|MP:0001914,hemorrhage|MP:0002092,abnormal eye morphology|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002740,heart hypoplasia|MP:0002929,abnormal bile duct development|MP:0002989,small kidney|MP:0003446,renal hypoplasia|MP:0003984,embryonic growth retardation|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005312,pericardial effusion|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0006032,abnormal ureteric bud morphology|MP:0010451,kidney microaneurysm|MP:0010711,persistent hyperplastic primary vitreous|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011368,increased kidney apoptosis|MP:0011429,absent mesangial cell|MP:0011441,decreased kidney cell proliferation|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0012537,abnormal hyaloid artery morphology
MGI:3522155	Notch2<tm1Rko>	MP:0002169,no abnormal phenotype detected
MGI:1857783	Notch2<tm1Yha>	MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0002362,abnormal spleen marginal zone morphology|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0004560,abnormal chorionic plate morphology|MP:0004978,decreased B-1 B cell number|MP:0008182,decreased marginal zone B cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:6157622	Notch2<tm2.1Ecan>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000559,abnormal femur morphology|MP:0003797,abnormal compact bone morphology|MP:0004984,increased osteoclast cell number|MP:0005390,skeleton phenotype|MP:0009346,decreased trabecular bone thickness|MP:0010867,abnormal bone trabecula morphology|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0010933,decreased trabecular bone connectivity density|MP:0010965,decreased compact bone volume|MP:0010968,decreased compact bone area|MP:0013630,increased bone trabecular spacing|MP:0020137,decreased bone mineralization
MGI:6157623	Notch2<tm2.2Ecan>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000559,abnormal femur morphology|MP:0003109,short femur|MP:0003797,abnormal compact bone morphology|MP:0009346,decreased trabecular bone thickness|MP:0010867,abnormal bone trabecula morphology|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0010933,decreased trabecular bone connectivity density|MP:0010965,decreased compact bone volume|MP:0013630,increased bone trabecular spacing
MGI:3617327	Notch2<tm2Grid>	MP:0001544,abnormal cardiovascular system physiology|MP:0001787,pericardial edema|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2663711	Notch2<tm2Hhi>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3617329	Notch2<tm3.1Grid>	MP:0001544,abnormal cardiovascular system physiology|MP:0001787,pericardial edema|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5523517	Notch2<tm3.1Rko>	MP:0005367,renal/urinary system phenotype
MGI:3617328	Notch2<tm3Grid>	MP:0000527,abnormal kidney development|MP:0000530,abnormal kidney vasculature morphology|MP:0000533,kidney hemorrhage|MP:0000538,abnormal urinary bladder morphology|MP:0000965,abnormal sensory neuron morphology|MP:0001126,abnormal ovary morphology|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002703,abnormal renal tubule morphology|MP:0002989,small kidney|MP:0003077,abnormal cell cycle|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration|MP:0003231,abnormal placenta vasculature|MP:0003446,renal hypoplasia|MP:0003606,kidney failure|MP:0003633,abnormal nervous system physiology|MP:0004193,abnormal kidney papilla morphology|MP:0004194,abnormal kidney pelvis morphology|MP:0004754,abnormal kidney collecting duct morphology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004834,ovary hemorrhage|MP:0004980,increased neuronal precursor cell number|MP:0005325,abnormal renal glomerulus morphology|MP:0005361,small pituitary gland|MP:0005384,cellular phenotype|MP:0006042,increased apoptosis|MP:0008137,absent podocytes|MP:0008789,abnormal olfactory epithelium morphology|MP:0009444,ovarian follicular cyst|MP:0009661,abnormal pregnancy|MP:0011087,neonatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6400222	Notch3<em1Ecan>	MP:0000063,decreased bone mineral density|MP:0000135,decreased compact bone thickness|MP:0001262,decreased body weight|MP:0002896,abnormal bone mineralization|MP:0004984,increased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0005386,behavior/neurological phenotype|MP:0008396,abnormal osteoclast differentiation|MP:0010867,abnormal bone trabecula morphology|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0010879,decreased trabecular bone volume|MP:0010933,decreased trabecular bone connectivity density|MP:0020039,increased bone ossification|MP:0030438,increased osteoblast proliferation|MP:0030482,increased osteocyte number
MGI:3522153	Notch3<Gt(PST033)Byg>	MP:0003076,increased susceptibility to ischemic brain injury|MP:0003631,nervous system phenotype|MP:0005385,cardiovascular system phenotype|MP:0006060,increased cerebral infarct size|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:4418503	Notch3<hpbk>	MP:0000160,kyphosis|MP:0000751,myopathy|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002083,premature death|MP:0003554,phimosis|MP:0005150,cachexia|MP:0006325,impaired hearing|MP:0009417,skeletal muscle atrophy|MP:0009661,abnormal pregnancy|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5304914	Notch3<tm1.1(cre/ERT2)Sat>	MP:0002169,no abnormal phenotype detected
MGI:5462093	Notch3<tm1.1Dwr>	MP:0000754,paresis|MP:0001393,ataxia|MP:0001417,decreased exploration in new environment|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002183,gliosis|MP:0002191,abnormal artery morphology|MP:0005385,cardiovascular system phenotype|MP:0021002,brain lesion|MP:0031168,abnormal brain thrombosis
MGI:5695981	Notch3<tm1.1(KOMP)Vlcg>	MP:0000219,increased neutrophil cell number|MP:0002135,abnormal kidney morphology|MP:0002833,increased heart weight|MP:0003068,enlarged kidney|MP:0003402,decreased liver weight|MP:0003917,increased kidney weight|MP:0004952,increased spleen weight|MP:0005292,improved glucose tolerance|MP:0009142,decreased prepulse inhibition|MP:0010067,increased red blood cell distribution width
MGI:2687010	Notch3<tm1Grid>	MP:0000262,poor arterial differentiation|MP:0002128,abnormal blood circulation|MP:0002169,no abnormal phenotype detected|MP:0002191,abnormal artery morphology|MP:0003719,abnormal pericyte morphology|MP:0005532,abnormal vascular resistance|MP:0005592,abnormal vascular smooth muscle morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:3578622	Notch3<tm1Khan>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number
MGI:3528497	Notch3<tm1Ul>	MP:0002169,no abnormal phenotype detected|MP:0005385,cardiovascular system phenotype
MGI:5304916	Notch4<tm1.1(cre/ERT2)Sat>	MP:0002169,no abnormal phenotype detected
MGI:1929139	Notch4<tm1Grid>	MP:0002169,no abnormal phenotype detected|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:4842905	Notch4<tm1(KOMP)Vlcg>	MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0010768,mortality/aging
MGI:1857063	Noto<tc>	MP:0000137,abnormal vertebrae morphology|MP:0000592,short tail|MP:0000755,hindlimb paralysis|MP:0000925,abnormal floor plate morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001539,decreased caudal vertebrae number|MP:0001614,abnormal blood vessel morphology|MP:0001688,abnormal somite development|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0004612,fusion of vertebral bodies|MP:0004645,decreased vertebrae number|MP:0004647,decreased lumbar vertebrae number|MP:0004714,truncated notochord|MP:0006029,abnormal sclerotome morphology
MGI:5294811	Noto<tm1.1(cre)Csgn>	MP:0005380,embryo phenotype|MP:0005390,skeleton phenotype
MGI:4366167	Noto<tm1(cre/ERT2)Hssk>	MP:0000592,short tail|MP:0002111,abnormal tail morphology|MP:0003051,curly tail|MP:0003456,absent tail
MGI:3053092	Noto<tm1Gos>	MP:0000592,short tail|MP:0002082,postnatal lethality|MP:0004066,abnormal primitive node morphology|MP:0004131,abnormal motile primary cilium morphology|MP:0004645,decreased vertebrae number|MP:0004714,truncated notochord|MP:0011998,decreased embryonic cilium length|MP:0012027,abnormal embryonic cilium location or orientation|MP:0012093,absent nodal flow
MGI:5317920	Noto<tm2.1(Foxj1)Gos>	MP:0000585,kinked tail|MP:0000592,short tail|MP:0001706,abnormal left-right axis patterning|MP:0004066,abnormal primitive node morphology|MP:0004131,abnormal motile primary cilium morphology|MP:0008933,abnormal motile primary cilium physiology|MP:0012027,abnormal embryonic cilium location or orientation
MGI:6200803	Notum<em150Sinn>	MP:0000527,abnormal kidney development|MP:0002081,perinatal lethality|MP:0002264,abnormal bronchus morphology|MP:0002282,abnormal trachea morphology|MP:0002284,abnormal tracheal smooth muscle morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0004551,decreased tracheal cartilage ring number|MP:0010883,trachea stenosis|MP:0013496,abnormal trachea development
MGI:6156499	Notum<em1(IMPC)Tcp>	MP:0000692,small spleen|MP:0001120,abnormal uterus morphology|MP:0001127,small ovary|MP:0001293,anophthalmia|MP:0001417,decreased exploration in new environment|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002637,small uterus|MP:0005278,abnormal cholesterol homeostasis|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4214308	Notum<Gt(OST172035)Lex>	MP:0000062,increased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0002499,chronic inflammation|MP:0002689,abnormal molar morphology|MP:0002818,abnormal dentin morphology|MP:0003604,single kidney|MP:0003668,abnormal periodontal ligament morphology|MP:0003917,increased kidney weight|MP:0003933,abnormal cementum morphology|MP:0003960,increased lean body mass|MP:0003961,decreased lean body mass|MP:0004148,increased compact bone thickness|MP:0004149,increased bone strength|MP:0005390,skeleton phenotype|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013251,dental pulp necrosis|MP:0013623,increased femur compact bone thickness|MP:0014143,decreased body fat mass|MP:0030101,carious teeth|MP:0030132,periodontium inflammation|MP:0030453,abnormal odontoblast morphology|MP:0030463,apical tooth abscess|MP:0030494,abnormal molar root morphology|MP:0030542,abnormal dentin development
MGI:2386947	Nova1<tm1Rbd>	MP:0000745,tremors|MP:0000746,weakness|MP:0000955,abnormal spinal cord morphology|MP:0001516,abnormal motor coordination/balance|MP:0003203,increased neuron apoptosis|MP:0004200,decreased fetal size|MP:0011085,postnatal lethality, complete penetrance
MGI:3526014	Nova2<tm1Rbd>	MP:0002207,abnormal long-term potentiation|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0011085,postnatal lethality, complete penetrance
MGI:5486319	Nox1<tm1.1Anrt>	MP:0002816,colitis|MP:0003186,abnormal redox activity|MP:0005023,abnormal wound healing
MGI:3695407	Nox1<tm1Cyn>	MP:0001613,abnormal vasodilation|MP:0001792,impaired wound healing|MP:0002843,decreased systemic arterial blood pressure|MP:0003009,abnormal cytokine secretion|MP:0003186,abnormal redox activity|MP:0011805,decreased cell migration
MGI:3616995	Nox1<tm1Kkr>	MP:0000249,abnormal blood vessel physiology|MP:0000272,abnormal aorta morphology|MP:0005319,abnormal enzyme/coenzyme level|MP:0006264,decreased systemic arterial systolic blood pressure
MGI:1856606	Nox3<het>	MP:0001262,decreased body weight|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001522,impaired swimming|MP:0002862,abnormal righting response|MP:0002978,absent otoliths|MP:0004813,absent linear vestibular evoked potential|MP:0004845,absent vestibuloocular reflex|MP:0005191,head tilt|MP:0005377,hearing/vestibular/ear phenotype|MP:0005449,abnormal food intake|MP:0010025,decreased total body fat amount|MP:0011020,abnormal circadian temperature homeostasis|MP:0020467,abnormal circadian behavior
MGI:1857794	Nox3<het-2J>	MP:0001522,impaired swimming|MP:0002978,absent otoliths|MP:0005191,head tilt
MGI:2179106	Nox3<het-3J>	MP:0001405,impaired coordination|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0002978,absent otoliths|MP:0002980,abnormal postural reflex|MP:0005191,head tilt
MGI:3511429	Nox3<het-4J>	MP:0001394,circling|MP:0005191,head tilt|MP:0005377,hearing/vestibular/ear phenotype
MGI:4834516	Nox3<het-5J>	MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001443,poor grooming|MP:0001522,impaired swimming|MP:0002978,absent otoliths|MP:0005191,head tilt|MP:0005424,jerky movement
MGI:3034162	Nox3<het-R542>	MP:0001405,impaired coordination|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0002978,absent otoliths|MP:0002980,abnormal postural reflex|MP:0005191,head tilt
MGI:3034161	Nox3<het-R96>	MP:0001405,impaired coordination|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0002978,absent otoliths|MP:0002980,abnormal postural reflex|MP:0005191,head tilt
MGI:6276965	Nox4<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology|MP:0005553,increased circulating creatinine level
MGI:4838549	Nox4<tm1.1Ams>	MP:0001625,cardiac hypertrophy|MP:0002136,abnormal kidney physiology|MP:0004485,increased response of heart to induced stress|MP:0004937,dilated heart|MP:0005608,cardiac interstitial fibrosis
MGI:4881785	Nox4<tm1.1Hwsc>	MP:0003204,decreased neuron apoptosis|MP:0003674,oxidative stress|MP:0005385,cardiovascular system phenotype|MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0031385,enhanced blood-brain barrier function
MGI:4830885	Nox4<tm1.1Jusa>	MP:0002625,heart left ventricle hypertrophy|MP:0003223,decreased cardiomyocyte apoptosis|MP:0003674,oxidative stress|MP:0004486,decreased response of heart to induced stress|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006036,abnormal mitochondrial physiology|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5502326	Nox4<tm1Kkr>	MP:0001175,abnormal lung morphology|MP:0003674,oxidative stress|MP:0006043,decreased apoptosis|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010181,decreased susceptibility to weight loss
MGI:5620884	Nox4<tm1Syb>	MP:0003186,abnormal redox activity|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0008561,decreased tumor necrosis factor secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0011371,decreased kidney apoptosis|MP:0011372,decreased renal tubule apoptosis
MGI:7425874	Noxa1<em1(IMPC)Ccpcz>	MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001529,abnormal vocalization|MP:0004924,abnormal behavior|MP:0010053,decreased grip strength
MGI:4457198	Noxa1<tm1.2Brg>	MP:0002169,no abnormal phenotype detected
MGI:4457196	Noxa1<tm1Brg>	MP:0002169,no abnormal phenotype detected
MGI:2675672	Noxo1<hslt>	MP:0001394,circling|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0001526,abnormal placing response|MP:0002978,absent otoliths|MP:0005191,head tilt
MGI:6276857	Npas2<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000702,enlarged lymph nodes|MP:0001297,microphthalmia|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0003068,enlarged kidney|MP:0005016,decreased lymphocyte cell number|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2180392	Npas2<tm1Slm>	MP:0000233,abnormal blood flow velocity|MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0001501,abnormal sleep pattern|MP:0001596,hypotension|MP:0002063,abnormal learning/memory/conditioning|MP:0003194,abnormal frequency of paradoxical sleep|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005164,abnormal response to injury|MP:0005333,decreased heart rate|MP:0005416,abnormal circulating protein level|MP:0005661,decreased circulating adrenaline level|MP:0005664,decreased circulating noradrenaline level|MP:0014624,abnormal brain delta wave pattern|MP:0014639,decreased sleep duration
MGI:6120711	Npas3<tm1b(KOMP)Wtsi>	MP:0001404,no spontaneous movement|MP:0001488,increased startle reflex|MP:0001491,unresponsive to tactile stimuli|MP:0011100,preweaning lethality, complete penetrance
MGI:3605473	Npas3<tm1Ewb>	MP:0000780,abnormal corpus callosum morphology|MP:0000807,abnormal hippocampus morphology|MP:0000857,abnormal cerebellar foliation|MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001415,increased exploration in new environment|MP:0001447,abnormal nest building behavior|MP:0001486,abnormal startle reflex|MP:0001513,limb grasping|MP:0001961,abnormal reflex|MP:0003107,abnormal response to novelty|MP:0003461,abnormal response to novel object|MP:0004167,abnormal cingulate gyrus morphology|MP:0008534,enlarged fourth ventricle|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0009745,abnormal behavioral response to xenobiotic|MP:0012489,abnormal retrosplenial region morphology|MP:0031442,enlarged cerebral aqueduct
MGI:3852356	Npas3<tm1Mesu>	MP:0001183,overexpanded pulmonary alveolus|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0001958,emphysema|MP:0004007,abnormal lung vasculature morphology|MP:0006027,impaired lung alveolus development|MP:0010856,dilated respiratory conducting tube|MP:0010901,abnormal pulmonary alveolar parenchyma morphology|MP:0010935,increased airway resistance|MP:0011012,bronchiectasis|MP:0011026,impaired branching involved in trachea morphogenesis|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3054783	Npas3<tm1Slm>	MP:0001265,decreased body size|MP:0001360,abnormal social investigation|MP:0001386,abnormal maternal nurturing|MP:0001399,hyperactivity|MP:0001407,short stride length|MP:0001408,stereotypic behavior
MGI:3828099	Npas4<tm1Meg>	MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0002064,seizures|MP:0002083,premature death|MP:0003631,nervous system phenotype
MGI:3835590	Npas4<tm1Ooe>	MP:0000243,myoclonus|MP:0002083,premature death|MP:0002183,gliosis|MP:0002882,abnormal neuron morphology|MP:0003224,neuron degeneration|MP:0004924,abnormal behavior|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:3828100	Npas4<tm2Meg>	MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004753,abnormal miniature excitatory postsynaptic currents
MGI:6390882	Npat<Mpv20>	MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012111,failure of morula compaction
MGI:5636907	Npat<tm1b(EUCOMM)Wtsi>	MP:0000154,rib fusion|MP:0000282,abnormal interatrial septum morphology|MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000639,abnormal adrenal gland morphology|MP:0001015,small superior cervical ganglion|MP:0001146,abnormal testis morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0004201,fetal growth retardation|MP:0004613,fusion of vertebral arches|MP:0005296,abnormal humerus morphology|MP:0008923,thoracoschisis|MP:0010418,perimembraneous ventricular septal defect|MP:0011100,preweaning lethality, complete penetrance|MP:0011493,double ureter|MP:0013815,abnormal digastric muscle morphology|MP:0013848,subcutaneous edema|MP:0013877,abnormal ductus venosus valve morphology|MP:0013943,abnormal ureter topology|MP:0013966,abnormal infrahyoid muscle morphology|MP:0013968,multiple persisting craniopharyngeal ducts|MP:0013969,reduced sympathetic cervical ganglion size|MP:0013971,blood in lymph vessels|MP:0013977,symmetric azygos veins|MP:0013996,abnormal vertebral artery origin|MP:0014001,abnormal vertebral artery topology|MP:0014023,abnormal intestine placement|MP:0014087,retrolental blood|MP:0020500,persistent trigeminal artery
MGI:3584339	Npb<tm1Ywa>	MP:0001260,increased body weight|MP:0005407,hyperalgesia
MGI:3522352	Npbwr1<tm1Rck>	MP:0000599,enlarged liver|MP:0001392,abnormal locomotor behavior|MP:0001433,polyphagia|MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0003212,increased susceptibility to age related obesity|MP:0005290,decreased oxygen consumption|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level
MGI:4842197	Npc1l1<tm1a(EUCOMM)Hmgu>	MP:0002645,abnormal intestinal cholesterol absorption|MP:0002647,decreased intestinal cholesterol absorption|MP:0005179,decreased circulating cholesterol level
MGI:3043784	Npc1l1<tm1Swa>	MP:0002647,decreased intestinal cholesterol absorption|MP:0010026,decreased liver cholesterol level
MGI:3579462	Npc1l1<tm1Yaio>	MP:0000181,abnormal circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000187,abnormal triglyceride level|MP:0002118,abnormal lipid homeostasis|MP:0002323,decreased susceptibility to hyperlipidemia|MP:0002647,decreased intestinal cholesterol absorption|MP:0005085,abnormal gallbladder physiology|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005342,abnormal intestinal lipid absorption|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:1857409	Npc1<m1N>	MP:0000242,impaired fertilization|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0000691,enlarged spleen|MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0000788,abnormal cerebral cortex morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000848,abnormal pons morphology|MP:0000852,small cerebellum|MP:0000867,abnormal cerebellum anterior vermis morphology|MP:0000869,abnormal cerebellum posterior vermis morphology|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0000952,abnormal CNS glial cell morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001119,abnormal female reproductive system morphology|MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001131,abnormal ovarian follicle morphology|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001175,abnormal lung morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001312,abnormal cornea morphology|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001458,abnormal object recognition memory|MP:0001488,increased startle reflex|MP:0001547,abnormal lipid level|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001866,nasal inflammation|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002133,abnormal respiratory system physiology|MP:0002175,decreased brain weight|MP:0002229,neurodegeneration|MP:0002275,abnormal type II pneumocyte morphology|MP:0002446,abnormal macrophage morphology|MP:0002628,hepatic steatosis|MP:0002687,oligozoospermia|MP:0002882,abnormal neuron morphology|MP:0002981,increased liver weight|MP:0003172,abnormal lysosome physiology|MP:0003191,abnormal cellular cholesterol metabolism|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0003982,increased cholesterol level|MP:0004007,abnormal lung vasculature morphology|MP:0004163,abnormal adenohypophysis morphology|MP:0004543,abnormal sperm physiology|MP:0004777,abnormal phospholipid level|MP:0004778,increased macrophage derived foam cell number|MP:0004781,abnormal surfactant composition|MP:0004856,decreased ovary weight|MP:0004894,uterus atrophy|MP:0005121,decreased circulating prolactin level|MP:0005138,decreased prolactin level|MP:0005178,increased circulating cholesterol level|MP:0005236,abnormal olfactory nerve morphology|MP:0005319,abnormal enzyme/coenzyme level|MP:0005499,abnormal olfactory system morphology|MP:0005544,cornea deposits|MP:0005578,teratozoospermia|MP:0005630,increased lung weight|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0008245,abnormal alveolar macrophage morphology|MP:0008257,thin myometrium|MP:0008258,thin endometrium|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0008332,decreased lactotroph cell number|MP:0008365,adenohypophysis hypoplasia|MP:0008544,impaired olfaction|MP:0008545,absent sperm flagellum|MP:0008547,abnormal neocortex morphology|MP:0008570,lipidosis|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008789,abnormal olfactory epithelium morphology|MP:0008868,abnormal granulosa cell morphology|MP:0008869,anovulation|MP:0008918,microgliosis|MP:0009009,absent estrous cycle|MP:0009081,thin uterus|MP:0009096,decreased endometrial gland number|MP:0009142,decreased prepulse inhibition|MP:0009230,abnormal sperm head morphology|MP:0009234,absent sperm head|MP:0009287,decreased abdominal fat pad weight|MP:0009359,endometrium atrophy|MP:0009363,abnormal tertiary ovarian follicle morphology|MP:0009823,abnormal sphingomyelin level|MP:0009841,foam cell reticulosis|MP:0010026,decreased liver cholesterol level|MP:0010027,increased liver cholesterol level|MP:0010053,decreased grip strength|MP:0010161,decreased brain cholesterol level|MP:0010162,increased brain cholesterol level|MP:0010762,abnormal microglial cell activation|MP:0010813,abnormal alveolar lamellar body morphology|MP:0010815,enlarged alveolar lamellar bodies|MP:0010831,lethality, incomplete penetrance|MP:0010998,pulmonary alveolar proteinosis|MP:0011129,decreased tertiary ovarian follicle number|MP:0011633,abnormal mitochondrial shape|MP:0011635,abnormal mitochondrial crista morphology|MP:0011637,abnormal mitochondrial matrix morphology|MP:0011743,abnormal Golgi apparatus morphology|MP:0011940,decreased food intake|MP:0012232,abnormal ceramide level|MP:0013203,abnormal primary cilium morphology|MP:0014270,decreased ovary secretion|MP:0014329,abnormal Purkinje cell axon morphology|MP:0014330,abnormal Purkinje cell focal axonal swelling|MP:0014460,increased lipid level|MP:0020448,increased microglial cell activation|MP:0020582,increased ceramide level|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031381,decreased secondary ovarian follicle number|MP:0031420,decreased superovulation rate|MP:0031561,increased ganglioside level|MP:0031632,increased lung cholesterol level
MGI:2686741	Npc1<nmf164>	MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000876,Purkinje cell degeneration|MP:0001263,weight loss|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001488,increased startle reflex|MP:0001547,abnormal lipid level|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0003191,abnormal cellular cholesterol metabolism|MP:0004778,increased macrophage derived foam cell number|MP:0008916,abnormal astrocyte physiology|MP:0009142,decreased prepulse inhibition|MP:0009589,sphingomyelinosis|MP:0010026,decreased liver cholesterol level|MP:0010027,increased liver cholesterol level|MP:0010053,decreased grip strength|MP:0010162,increased brain cholesterol level|MP:0010831,lethality, incomplete penetrance|MP:0020448,increased microglial cell activation
MGI:1857051	Npc1<spm>	MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0000880,decreased Purkinje cell number|MP:0001263,weight loss|MP:0001393,ataxia|MP:0002083,premature death|MP:0003947,abnormal cholesterol level|MP:0004778,increased macrophage derived foam cell number|MP:0009587,abnormal plasma membrane sphingolipid content|MP:0009588,increased plasma membrane sphingolipid content|MP:0009589,sphingomyelinosis|MP:0010027,increased liver cholesterol level
MGI:5641735	Npc1<tm1.1Dso>	MP:0000607,abnormal hepatocyte morphology|MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002446,abnormal macrophage morphology|MP:0003354,astrocytosis|MP:0004778,increased macrophage derived foam cell number|MP:0005278,abnormal cholesterol homeostasis|MP:0005425,increased macrophage cell number|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008918,microgliosis|MP:0009589,sphingomyelinosis|MP:0010027,increased liver cholesterol level|MP:0010047,axonal spheroids|MP:0010162,increased brain cholesterol level|MP:0010762,abnormal microglial cell activation|MP:0012230,abnormal sphingolipid level|MP:0014460,increased lipid level|MP:0020448,increased microglial cell activation|MP:0020582,increased ceramide level|MP:0031561,increased ganglioside level
MGI:4431253	Npc1<tm1.2Apl>	MP:0001263,weight loss|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death
MGI:5636924	Npc1<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5293759	Npc1<tm1Mbjg>	MP:0000745,tremors|MP:0000880,decreased Purkinje cell number|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001393,ataxia|MP:0001547,abnormal lipid level|MP:0002083,premature death|MP:0003982,increased cholesterol level|MP:0009841,foam cell reticulosis|MP:0010027,increased liver cholesterol level
MGI:6315233	Npc1<tm1Tacf>	MP:0000598,abnormal liver morphology|MP:0000602,dilated liver sinusoidal space|MP:0000745,tremors|MP:0000877,abnormal Purkinje cell morphology|MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001458,abnormal object recognition memory|MP:0002083,premature death|MP:0003043,hypoalgesia|MP:0003461,abnormal response to novel object|MP:0008489,slow postnatal weight gain|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0010027,increased liver cholesterol level|MP:0010052,increased grip strength|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012315,impaired learning|MP:0020582,increased ceramide level|MP:0031391,increased locomotor activity
MGI:6315236	Npc1<tm2Tacf>	MP:0011101,prenatal lethality, incomplete penetrance
MGI:3587940	Npc2<Gt(LST105)Byg>	MP:0000685,abnormal immune system morphology|MP:0001790,abnormal immune system physiology
MGI:5513806	Npc2<tm1e.1(EUCOMM)Wtsi>	MP:0002768,small adrenal glands|MP:0005627,increased circulating potassium level
MGI:3044774	Npc2<tm1Plob>	MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0000880,decreased Purkinje cell number|MP:0001175,abnormal lung morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001392,abnormal locomotor behavior|MP:0001393,ataxia|MP:0001547,abnormal lipid level|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002275,abnormal type II pneumocyte morphology|MP:0002444,abnormal T cell physiology|MP:0004007,abnormal lung vasculature morphology|MP:0004777,abnormal phospholipid level|MP:0004781,abnormal surfactant composition|MP:0005058,abnormal lysosome morphology|MP:0005630,increased lung weight|MP:0008045,decreased NK cell number|MP:0008245,abnormal alveolar macrophage morphology|MP:0008570,lipidosis|MP:0010027,increased liver cholesterol level|MP:0010766,abnormal NK cell physiology|MP:0010889,small alveolar lamellar bodies|MP:0010891,increased alveolar lamellar body number|MP:0010998,pulmonary alveolar proteinosis|MP:0031632,increased lung cholesterol level
MGI:6361116	Npcd<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0002644,decreased circulating triglyceride level|MP:0005632,decreased circulating aspartate transaminase level
MGI:3512311	Npdc1<tm1Ce>	MP:0002169,no abnormal phenotype detected
MGI:6276869	Npepps<em1(IMPC)Hmgu>	MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0002100,abnormal tooth morphology|MP:0002757,decreased vertical activity|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content|MP:0011965,decreased total retina thickness|MP:0030610,absent teeth
MGI:2673210	Npepps<goku>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001363,increased anxiety-related response|MP:0001380,decreased male mating frequency|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001973,increased thermal nociceptive threshold|MP:0002216,abnormal seminiferous tubule morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002773,decreased circulating luteinizing hormone level|MP:0002780,decreased circulating testosterone level|MP:0002784,abnormal Sertoli cell morphology|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0002797,increased thigmotaxis|MP:0005121,decreased circulating prolactin level|MP:0014636,decreased elongated spermatid number
MGI:3774016	Npepps<tm1Klr>	MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0005387,immune system phenotype|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5646536	Npffr1<tm1Lex>	MP:0001746,abnormal pituitary secretion|MP:0001751,increased circulating luteinizing hormone level|MP:0001934,increased litter size|MP:0005131,increased follicle stimulating hormone level|MP:0005132,decreased luteinizing hormone level|MP:0005133,increased luteinizing hormone level|MP:0005389,reproductive system phenotype|MP:0008947,increased neuron number|MP:0010180,increased susceptibility to weight loss
MGI:6313711	Npffr2<tm1.1Hhzg>	MP:0000008,increased white adipose tissue amount|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001783,decreased white adipose tissue amount|MP:0001934,increased litter size|MP:0002079,increased circulating insulin level|MP:0003109,short femur|MP:0003631,nervous system phenotype|MP:0004148,increased compact bone thickness|MP:0004889,increased energy expenditure|MP:0004890,decreased energy expenditure|MP:0005386,behavior/neurological phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0009288,increased epididymal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009298,increased mesenteric fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0009347,increased trabecular bone thickness|MP:0010379,decreased respiratory quotient|MP:0010868,increased bone trabecula number|MP:0010872,increased trabecular bone mass|MP:0010964,increased compact bone volume|MP:0011019,abnormal adaptive thermogenesis|MP:0011699,abnormal brown adipose tissue thermogenesis|MP:0011940,decreased food intake
MGI:6163806	Npffr2<tm1.2Ics>	MP:0003884,decreased macrophage cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0011075,abnormal macrophage activation involved in immune response|MP:0011986,decreased macrophage proliferation
MGI:5634708	Npff<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity
MGI:7280685	Nphp1<em1Lisu>	MP:0001156,abnormal spermatogenesis|MP:0001326,retina degeneration|MP:0002135,abnormal kidney morphology|MP:0002703,abnormal renal tubule morphology|MP:0003985,renal fibrosis|MP:0004901,decreased male germ cell number|MP:0005264,glomerulosclerosis|MP:0005371,limbs/digits/tail phenotype|MP:0005385,cardiovascular system phenotype|MP:0005553,increased circulating creatinine level|MP:0008512,disorganized retina inner nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008519,thin retina outer plexiform layer|MP:0008580,photoreceptor inner segment degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0011308,kidney corticomedullary cyst|MP:0011408,renal tubule hypertrophy|MP:0013305,isosthenuria|MP:0031358,decreased urine output
MGI:8166954	Nphp1<em1Ssau>	MP:0002705,dilated renal tubule|MP:0004021,abnormal rod electrophysiology|MP:0008450,retina photoreceptor degeneration|MP:0012143,decreased a-wave amplitude|MP:0020382,increased kidney epithelial cell primary cilium length
MGI:3813273	Nphp1<tm1.1Hung>	MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0004182,abnormal spermiation|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005367,renal/urinary system phenotype|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0014686,premature spermiation
MGI:5695906	Nphp1<tm1.1(KOMP)Vlcg>	MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001417,decreased exploration in new environment|MP:0001925,male infertility|MP:0002060,abnormal skin morphology|MP:0004906,enlarged uterus|MP:0009709,hydrometra
MGI:4437792	Nphp1<tm1Jgg>	MP:0001326,retina degeneration|MP:0008515,thin retina outer nuclear layer
MGI:6273809	Nphp3<em1(IMPC)J>	MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1856987	Nphp3<pcy>	MP:0000120,malocclusion|MP:0000122,premature tooth eruption|MP:0000745,tremors|MP:0001270,distended abdomen|MP:0001577,anemia|MP:0001859,kidney inflammation|MP:0002083,premature death|MP:0002703,abnormal renal tubule morphology|MP:0002828,abnormal renal glomerular capsule morphology|MP:0003068,enlarged kidney|MP:0003215,renal interstitial fibrosis|MP:0003670,dilated renal glomerular capsule|MP:0003675,kidney cyst|MP:0003917,increased kidney weight|MP:0004777,abnormal phospholipid level|MP:0004860,dilated kidney collecting duct|MP:0005178,increased circulating cholesterol level|MP:0005202,lethargy|MP:0005278,abnormal cholesterol homeostasis|MP:0005565,increased blood urea nitrogen level|MP:0006084,abnormal circulating phospholipid level|MP:0008528,polycystic kidney|MP:0009051,dilated distal convoluted tubule|MP:0010478,intracranial aneurysm
MGI:3847130	Nphp3<pol>	MP:0000914,exencephaly|MP:0001859,kidney inflammation|MP:0002082,postnatal lethality|MP:0003068,enlarged kidney|MP:0003985,renal fibrosis|MP:0005565,increased blood urea nitrogen level|MP:0008528,polycystic kidney
MGI:3809285	Nphp3<tm1Cbe>	MP:0000266,abnormal heart morphology|MP:0001700,abnormal embryo turning|MP:0001706,abnormal left-right axis patterning|MP:0011091,prenatal lethality, complete penetrance
MGI:6361236	Nphp4<em1(IMPC)Bay>	MP:0001925,male infertility
MGI:3032515	Nphp4<nmf192>	MP:0000242,impaired fertilization|MP:0001325,abnormal retina morphology|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0005103,abnormal retina pigmentation|MP:0005367,renal/urinary system phenotype|MP:0005389,reproductive system phenotype|MP:0006072,abnormal retina apoptosis|MP:0008450,retina photoreceptor degeneration|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008519,thin retina outer plexiform layer|MP:0008587,short photoreceptor outer segment|MP:0010097,abnormal retina blood vessel morphology|MP:0012671,retina spots
MGI:2678400	Nphs1<Gt(pT1Betageo)1Ruiz>	MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0002962,increased urine protein level|MP:0003670,dilated renal glomerular capsule|MP:0005325,abnormal renal glomerulus morphology|MP:0008059,abnormal podocyte foot process morphology|MP:0008061,absent podocyte slit diaphragm|MP:0008062,abnormal podocyte slit junction morphology|MP:0008139,fused podocyte foot processes|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011353,expanded mesangial matrix|MP:0011377,renal glomerulus fibrosis
MGI:6356793	Nphs1<tm1.1Tbh>	MP:0002962,increased urine protein level|MP:0008059,abnormal podocyte foot process morphology|MP:0008060,abnormal podocyte slit diaphragm morphology|MP:0010107,abnormal renal reabsorption|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5661391	Nphs1<tm1Afrn>	MP:0002169,no abnormal phenotype detected
MGI:2386182	Nphs1<tm1Ktry>	MP:0000522,kidney cortex cyst|MP:0001785,edema|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0003068,enlarged kidney|MP:0003631,nervous system phenotype|MP:0003917,increased kidney weight|MP:0008059,abnormal podocyte foot process morphology|MP:0008061,absent podocyte slit diaphragm|MP:0008140,podocyte foot process effacement|MP:0009050,dilated proximal convoluted tubule|MP:0009051,dilated distal convoluted tubule|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011307,kidney medulla cyst|MP:0011427,increased mesangial cell number|MP:0011501,increased glomerular capsule space
MGI:2386960	Nphs1<tm1Rkl>	MP:0002705,dilated renal tubule|MP:0002962,increased urine protein level|MP:0008061,absent podocyte slit diaphragm|MP:0011085,postnatal lethality, complete penetrance|MP:0011501,increased glomerular capsule space
MGI:3028629	Nphs2<tm1Antc>	MP:0000521,abnormal kidney cortex morphology|MP:0000523,cortical renal glomerulopathies|MP:0000533,kidney hemorrhage|MP:0001265,decreased body size|MP:0002828,abnormal renal glomerular capsule morphology|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0003606,kidney failure|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005367,renal/urinary system phenotype|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008059,abnormal podocyte foot process morphology|MP:0008061,absent podocyte slit diaphragm|MP:0008140,podocyte foot process effacement|MP:0009050,dilated proximal convoluted tubule|MP:0009640,abnormal renal tubule epithelium morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011294,renal glomerulus hypertrophy|MP:0011309,abnormal kidney arterial blood vessel morphology|MP:0011320,abnormal glomerular capillary morphology|MP:0011321,abnormal peritubular capillary morphology|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011353,expanded mesangial matrix|MP:0011402,renal cast|MP:0011430,mesangiolysis|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011506,glomerular crescent|MP:0011868,podocyte microvillus transformation|MP:0011871,podocyte hypertrophy
MGI:4360671	Nphs2<tm2.1Antc>	MP:0000533,kidney hemorrhage|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002871,albuminuria|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005264,glomerulosclerosis|MP:0005326,abnormal podocyte morphology|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008061,absent podocyte slit diaphragm|MP:0008140,podocyte foot process effacement|MP:0009050,dilated proximal convoluted tubule|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011320,abnormal glomerular capillary morphology|MP:0011353,expanded mesangial matrix|MP:0011402,renal cast|MP:0011430,mesangiolysis|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011454,abnormal glomerular endothelium fenestra morphology|MP:0011509,dilated glomerular capillary
MGI:7567785	Npl<em1Avps>	MP:0000747,muscle weakness|MP:0002908,delayed wound healing|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0009400,decreased skeletal muscle fiber size|MP:0009643,abnormal urine homeostasis|MP:0010954,abnormal cellular respiration|MP:0010959,abnormal oxidative phosphorylation|MP:0011628,increased mitochondrial number|MP:0012106,impaired exercise endurance
MGI:7567786	Npl<em2Avps>	MP:0000747,muscle weakness|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0009643,abnormal urine homeostasis|MP:0010954,abnormal cellular respiration|MP:0010959,abnormal oxidative phosphorylation|MP:0011628,increased mitochondrial number
MGI:3530042	Npl<Gt(OST15553)Lex>	MP:0005178,increased circulating cholesterol level|MP:0005380,embryo phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype
MGI:4432939	Nploc4<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:3529824	Npm1<Gt(OST331547)Lex>	MP:0004809,increased hematopoietic stem cell number|MP:0005397,hematopoietic system phenotype|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011087,neonatal lethality, complete penetrance|MP:0011092,embryonic lethality, complete penetrance
MGI:3604210	Npm1<Gt(VICTR37)704Lex>	MP:0000350,abnormal cell proliferation|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0001730,embryonic growth arrest|MP:0005380,embryo phenotype|MP:0006042,increased apoptosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013501,increased fibroblast apoptosis
MGI:5004857	Npm1<tm1Gsva>	MP:0000218,increased leukocyte cell number|MP:0000322,increased granulocyte number|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0002590,increased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002981,increased liver weight|MP:0004049,increased acute promyelocytic leukemia incidence|MP:0004952,increased spleen weight|MP:0005017,decreased B cell number|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:5478640	Npm1<tm1Hft>	MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000322,increased granulocyte number|MP:0000691,enlarged spleen|MP:0002006,neoplasm|MP:0002398,abnormal bone marrow cell morphology/development|MP:0004809,increased hematopoietic stem cell number|MP:0004952,increased spleen weight|MP:0005397,hematopoietic system phenotype|MP:0005505,thrombocytosis|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008111,abnormal granulocyte differentiation|MP:0008470,abnormal spleen B cell follicle morphology|MP:0010373,myeloid hyperplasia|MP:0011092,embryonic lethality, complete penetrance
MGI:3604807	Npm1<tm1Ppp>	MP:0000228,abnormal thrombopoiesis|MP:0000321,increased bone marrow cell number|MP:0000350,abnormal cell proliferation|MP:0001293,anophthalmia|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0001719,absent vitelline blood vessels|MP:0002152,abnormal brain morphology|MP:0002416,abnormal proerythroblast morphology|MP:0002417,abnormal megakaryocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002642,anisocytosis|MP:0003077,abnormal cell cycle|MP:0003396,abnormal embryonic hematopoiesis|MP:0003717,pallor|MP:0004028,chromosome breakage|MP:0004259,small placenta|MP:0008941,reticulocytopenia|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011204,abnormal visceral yolk sac blood island morphology|MP:0011704,decreased fibroblast proliferation|MP:0011877,absent liver|MP:0012136,absent forebrain|MP:0013504,increased embryonic tissue cell apoptosis
MGI:6285874	Npm1<tm1Trow>	MP:0004810,decreased hematopoietic stem cell number|MP:0009278,abnormal bone marrow cell physiology|MP:0013660,abnormal bone marrow hematopoietic cell morphology|MP:0013696,increased granulocyte monocyte progenitor cell number
MGI:3604808	Npm1<tm2Ppp>	MP:0001286,abnormal eye development|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0003396,abnormal embryonic hematopoiesis|MP:0003717,pallor|MP:0004028,chromosome breakage|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:2182141	Npm2<tm1Zuk>	MP:0001125,abnormal oocyte morphology|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002085,abnormal embryonic tissue morphology
MGI:5577271	Npm3<tm1.1(KOMP)Vlcg>	MP:0001303,abnormal lens morphology|MP:0005560,decreased circulating glucose level|MP:0011396,abnormal sleep behavior
MGI:6825765	Npnt<em1Zhwe>	MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0003722,absent ureter|MP:0011089,perinatal lethality, complete penetrance
MGI:3715213	Npnt<tm1.1Lfr>	MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003604,single kidney|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005367,renal/urinary system phenotype
MGI:1857231	Nppa<tm1Unc>	MP:0000208,decreased hematocrit|MP:0000230,abnormal systemic arterial blood pressure|MP:0000231,hypertension|MP:0000274,enlarged heart|MP:0000276,heart right ventricle hypertrophy|MP:0001544,abnormal cardiovascular system physiology|MP:0002625,heart left ventricle hypertrophy|MP:0002626,increased heart rate|MP:0002833,increased heart weight|MP:0003393,decreased cardiac output|MP:0003548,pulmonary hypertension|MP:0004217,salt-sensitive hypertension|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005532,abnormal vascular resistance|MP:0005581,abnormal renin activity|MP:0005592,abnormal vascular smooth muscle morphology|MP:0005662,increased circulating adrenaline level|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0008776,increased right ventricle peak pressure|MP:0010109,abnormal renal sodium reabsorption|MP:0010755,abnormal heart right ventricle pressure
MGI:7366919	Nppb<em1Vmc>	MP:0005385,cardiovascular system phenotype
MGI:7366920	Nppb<em2Vmc>	MP:0005385,cardiovascular system phenotype
MGI:2386215	Nppb<tm1Yog>	MP:0000278,abnormal myocardial fiber morphology|MP:0003141,cardiac fibrosis|MP:0005294,abnormal heart ventricle morphology|MP:0014731,disorganized myocardial fiber myofibrils
MGI:2388899	Nppc<lbab>	MP:0000547,short limbs|MP:0000592,short tail|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001147,small testis|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002427,disproportionate dwarf|MP:0002764,short tibia|MP:0002765,short fibula|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004686,decreased length of long bones|MP:0005168,abnormal female meiosis|MP:0005389,reproductive system phenotype|MP:0006396,decreased long bone epiphyseal plate size|MP:0006397,disorganized long bone epiphyseal plate|MP:0008272,abnormal endochondral bone ossification|MP:0009346,decreased trabecular bone thickness|MP:0010876,decreased bone volume|MP:0011085,postnatal lethality, complete penetrance
MGI:4365461	Nppc<tm1.1Fgr>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0001255,decreased body height|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004811,abnormal neuron physiology|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:2182456	Nppc<tm1Yog>	MP:0000163,abnormal cartilage morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002427,disproportionate dwarf|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0006394,abnormal vertebral epiphyseal plate morphology|MP:0006396,decreased long bone epiphyseal plate size|MP:0008525,decreased cranium height|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5750455	Npr1<tm1.1Kkan>	MP:0001272,increased metastatic potential|MP:0001625,cardiac hypertrophy|MP:0002842,increased systemic arterial blood pressure|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5516490	Npr1<tm1.1Rsha>	MP:0001625,cardiac hypertrophy|MP:0002666,increased circulating aldosterone level|MP:0002833,increased heart weight|MP:0004875,increased mean systemic arterial blood pressure|MP:0006144,increased systemic arterial systolic blood pressure
MGI:2178776	Npr1<tm1Gar>	MP:0000230,abnormal systemic arterial blood pressure|MP:0001613,abnormal vasodilation|MP:0002192,hydrops fetalis|MP:0002842,increased systemic arterial blood pressure|MP:0003038,decreased myocardial infarct size|MP:0004216,salt-resistant hypertension|MP:0005522,increased circulating atrial natriuretic factor|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008720,impaired neutrophil chemotaxis|MP:0010768,mortality/aging
MGI:2386604	Npr1<tm1Kuhn>	MP:0000230,abnormal systemic arterial blood pressure|MP:0001596,hypotension|MP:0001613,abnormal vasodilation|MP:0001625,cardiac hypertrophy|MP:0004084,abnormal cardiac muscle relaxation|MP:0004564,increased myocardial fiber size|MP:0005522,increased circulating atrial natriuretic factor|MP:0005608,cardiac interstitial fibrosis|MP:0006138,congestive heart failure|MP:0006264,decreased systemic arterial systolic blood pressure
MGI:2158387	Npr1<tm1Mae>	MP:0000231,hypertension|MP:0000274,enlarged heart|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002295,abnormal pulmonary circulation|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002780,decreased circulating testosterone level|MP:0002842,increased systemic arterial blood pressure|MP:0003353,decreased circulating renin level|MP:0004044,aortic dissection|MP:0004216,salt-resistant hypertension|MP:0005329,abnormal myocardium layer morphology|MP:0005522,increased circulating atrial natriuretic factor|MP:0005608,cardiac interstitial fibrosis|MP:0005647,abnormal sex gland physiology|MP:0006085,myocardium necrosis|MP:0006138,congestive heart failure|MP:0010768,mortality/aging|MP:0031080,pulmonary embolism
MGI:2158630	Npr1<tm1(Npr1)Unc>	MP:0002781,increased circulating testosterone level|MP:0002843,decreased systemic arterial blood pressure|MP:0005647,abnormal sex gland physiology
MGI:1856702	Npr2<cn>	MP:0000097,short maxilla|MP:0000120,malocclusion|MP:0000166,abnormal chondrocyte morphology|MP:0000428,abnormal craniofacial morphology|MP:0000440,domed cranium|MP:0000547,short limbs|MP:0000588,thick tail|MP:0000592,short tail|MP:0000692,small spleen|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001259,abnormal body weight|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0001575,cyanosis|MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0002128,abnormal blood circulation|MP:0002233,abnormal nose morphology|MP:0002544,brachydactyly|MP:0002764,short tibia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004340,short scapula|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004595,abnormal mandibular condyloid process morphology|MP:0004686,decreased length of long bones|MP:0004704,short vertebral column|MP:0006396,decreased long bone epiphyseal plate size|MP:0008526,decreased cranium width|MP:0009677,abnormal spinal cord dorsal column morphology|MP:0010029,abnormal basicranium morphology|MP:0010867,abnormal bone trabecula morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011862,decreased cranium length
MGI:2152891	Npr2<cn-2J>	MP:0003109,short femur|MP:0004673,splayed ribs|MP:0005168,abnormal female meiosis|MP:0005390,skeleton phenotype|MP:0006397,disorganized long bone epiphyseal plate|MP:0008158,increased diameter of femur|MP:0030245,round head
MGI:3583746	Npr2<cn-3J>	MP:0000445,short snout|MP:0000592,short tail|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002427,disproportionate dwarf|MP:0008736,micromelia
MGI:6276971	Npr2<em1(IMPC)H>	MP:0000432,abnormal head morphology|MP:0000443,abnormal snout morphology|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000745,tremors|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0001512,trunk curl|MP:0001513,limb grasping|MP:0002111,abnormal tail morphology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0009456,impaired cued conditioning behavior|MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011496,abnormal head size|MP:0011999,abnormal tail length|MP:0020421,increased freezing behavior
MGI:4358115	Npr2<pwe>	MP:0000120,malocclusion|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000440,domed cranium|MP:0000445,short snout|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0002427,disproportionate dwarf|MP:0002636,delayed vaginal opening|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004351,short humerus|MP:0004607,abnormal cervical atlas morphology|MP:0008272,abnormal endochondral bone ossification|MP:0008770,decreased survivor rate|MP:0010768,mortality/aging
MGI:3774275	Npr2<slw>	MP:0000440,domed cranium|MP:0000592,short tail|MP:0001258,decreased body length|MP:0001663,abnormal digestive system physiology|MP:0002427,disproportionate dwarf|MP:0002657,chondrodystrophy|MP:0003157,impaired muscle relaxation|MP:0004386,enlarged interparietal bone|MP:0004421,enlarged parietal bone|MP:0004444,small supraoccipital bone|MP:0004470,small nasal bone|MP:0008272,abnormal endochondral bone ossification|MP:0009247,meteorism|MP:0009854,impaired gastric peristalsis|MP:0009861,abnormal pyloric sphincter morphology|MP:0010155,abnormal intestine physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:5567993	Npr2<tm1Fgr>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0001265,decreased body size
MGI:3522129	Npr2<tm1Gar>	MP:0000120,malocclusion|MP:0000438,abnormal cranium morphology|MP:0001120,abnormal uterus morphology|MP:0001127,small ovary|MP:0001134,absent corpus luteum|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0001926,female infertility|MP:0002083,premature death|MP:0002113,abnormal skeleton development|MP:0002637,small uterus|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0004831,long incisors|MP:0005385,cardiovascular system phenotype|MP:0006396,decreased long bone epiphyseal plate size|MP:0008257,thin myometrium|MP:0008258,thin endometrium|MP:0009009,absent estrous cycle|MP:0009088,thin uterine horn|MP:0030082,long lower incisors|MP:0030083,long upper incisors
MGI:6269452	Npr3<kylb>	MP:0000137,abnormal vertebrae morphology|MP:0000160,kyphosis|MP:0001257,increased body length|MP:0002968,increased circulating alkaline phosphatase level|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003795,abnormal bone structure|MP:0004695,increased length of long bones|MP:0004705,elongated vertebral body|MP:0006394,abnormal vertebral epiphyseal plate morphology|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:1857837	Npr3<lgj>	MP:0000003,abnormal adipose tissue morphology|MP:0000010,abnormal abdominal fat pad morphology|MP:0000013,abnormal adipose tissue distribution|MP:0000137,abnormal vertebrae morphology|MP:0000585,kinked tail|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0004624,abnormal thoracic cage morphology|MP:0005382,craniofacial phenotype|MP:0006296,arachnodactyly
MGI:1857835	Npr3<lgj-2J>	MP:0000003,abnormal adipose tissue morphology|MP:0000010,abnormal abdominal fat pad morphology|MP:0000013,abnormal adipose tissue distribution|MP:0000137,abnormal vertebrae morphology|MP:0000160,kyphosis|MP:0000585,kinked tail|MP:0002083,premature death|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0004624,abnormal thoracic cage morphology|MP:0005382,craniofacial phenotype|MP:0006296,arachnodactyly
MGI:3773670	Npr3<lgj-3J>	MP:0000160,kyphosis|MP:0000585,kinked tail|MP:0002110,abnormal digit morphology|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0004703,abnormal vertebral column morphology|MP:0006253,clinodactyly|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3799700	Npr3<lgj-4J>	MP:0000160,kyphosis|MP:0000585,kinked tail|MP:0001257,increased body length|MP:0002759,abnormal caudal vertebrae morphology|MP:0004695,increased length of long bones|MP:0005391,vision/eye phenotype|MP:0006296,arachnodactyly
MGI:3777586	Npr3<m1Btlr>	MP:0000160,kyphosis|MP:0001257,increased body length|MP:0002758,long tail|MP:0008771,elongated vertebral column
MGI:5620887	Npr3<skm1>	MP:0000160,kyphosis|MP:0000585,kinked tail|MP:0001257,increased body length|MP:0002113,abnormal skeleton development|MP:0004619,caudal vertebral fusion|MP:0006296,arachnodactyly|MP:0008833,caudal hemivertebra|MP:0013138,thin body
MGI:1857836	Npr3<stri>	MP:0000010,abnormal abdominal fat pad morphology|MP:0000013,abnormal adipose tissue distribution|MP:0000137,abnormal vertebrae morphology|MP:0000160,kyphosis|MP:0000554,abnormal carpal bone morphology|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0002115,abnormal limb bone morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0003419,delayed endochondral bone ossification|MP:0004651,increased thoracic vertebrae number|MP:0004685,calcified intervertebral disk|MP:0005225,abnormal vertebrae development|MP:0005229,abnormal intervertebral disk development|MP:0005306,abnormal phalanx morphology|MP:0006392,abnormal nucleus pulposus morphology|MP:0006393,absent nucleus pulposus|MP:0006394,abnormal vertebral epiphyseal plate morphology
MGI:5605844	Npr3<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001566,increased circulating phosphate level
MGI:2158355	Npr3<tm1Unc>	MP:0000060,delayed bone ossification|MP:0000440,domed cranium|MP:0001257,increased body length|MP:0001262,decreased body weight|MP:0001426,polydipsia|MP:0001429,dehydration|MP:0001505,hunched posture|MP:0001596,hypotension|MP:0001762,polyuria|MP:0001921,reduced fertility|MP:0002113,abnormal skeleton development|MP:0002608,increased hematocrit|MP:0002758,long tail|MP:0002968,increased circulating alkaline phosphatase level|MP:0002988,decreased urine osmolality|MP:0002998,abnormal bone remodeling|MP:0003131,increased erythrocyte cell number|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004641,elongated metatarsal bones|MP:0004695,increased length of long bones|MP:0004705,elongated vertebral body|MP:0004982,abnormal osteoclast morphology|MP:0004988,increased osteoblast cell number|MP:0005564,increased hemoglobin content|MP:0006320,abnormal interscapular fat pad morphology|MP:0009125,decreased brown fat cell lipid droplet size|MP:0009133,decreased white fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009295,decreased interscapular fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0009642,abnormal blood homeostasis|MP:0010103,small thoracic cage|MP:0010128,hypovolemia|MP:0010867,abnormal bone trabecula morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011476,abnormal urine nucleotide level
MGI:5792912	Nprl2<tm1.2Bpt>	MP:0000245,abnormal erythropoiesis|MP:0000603,pale liver|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001606,impaired hematopoiesis|MP:0001698,decreased embryo size|MP:0005397,hematopoietic system phenotype|MP:0008973,decreased erythroid progenitor cell number|MP:0013242,abnormal amino acid metabolism|MP:0014399,decreased hematopoietic precursor cell number
MGI:5426855	Nprl3<tm1.1Drhi>	MP:0000111,cleft palate|MP:0000267,abnormal heart development|MP:0000273,overriding aortic valve|MP:0000274,enlarged heart|MP:0000279,ventricular hypoplasia|MP:0000284,double outlet right ventricle|MP:0000484,abnormal pulmonary artery morphology|MP:0001785,edema|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0002450,abnormal lymph organ development|MP:0003385,abnormal body wall morphology|MP:0003717,pallor|MP:0004113,abnormal aortic arch morphology|MP:0004157,interrupted aortic arch|MP:0004158,right aortic arch|MP:0004200,decreased fetal size|MP:0005294,abnormal heart ventricle morphology|MP:0008022,dilated heart ventricle|MP:0010146,umbilical hernia|MP:0010402,ventricular septal defect|MP:0010426,abnormal heart and great artery attachment|MP:0010439,abnormal hepatic vein morphology|MP:0010499,abnormal ventricle myocardium morphology|MP:0010556,thin ventricle myocardium compact layer|MP:0010912,herniated liver|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012269,nuchal edema|MP:0014519,myocardial ventricular hypertrabeculation
MGI:7284431	Npsr1<em1Yfu>	MP:0009453,enhanced contextual conditioning behavior|MP:0012288,abnormal paradoxical sleep pattern|MP:0012289,abnormal non-rapid eye movement sleep pattern|MP:0020477,abnormal locomotor circadian rhythm|MP:0020478,abnormal circadian sleep/wake cycle
MGI:7284434	Npsr1<em2Yfu>	MP:0005386,behavior/neurological phenotype
MGI:3832372	Npsr1<tm1Bhk>	MP:0005387,immune system phenotype|MP:0008872,abnormal physiological response to xenobiotic|MP:0010936,decreased airway resistance
MGI:5612826	Npsr1<tm1b(KOMP)Wtsi>	MP:0005011,increased eosinophil cell number
MGI:7547096	Nps<tm1.1Rkr>	MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0003631,nervous system phenotype|MP:0004000,impaired passive avoidance behavior
MGI:5911043	Nptn<pitch>	MP:0001512,trunk curl|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0004402,decreased cochlear outer hair cell number|MP:0004433,abnormal cochlear inner hair cell physiology|MP:0004562,abnormal inner hair cell synaptic ribbon morphology|MP:0005191,head tilt|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5775785	Nptn<tm1.2Mtg>	MP:0002206,abnormal CNS synaptic transmission|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004998,decreased CNS synapse formation|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0009936,abnormal dendritic spine morphology|MP:0014384,increased miniature inhibitory postsynaptic current amplitude
MGI:5548382	Nptn<tm1b(EUCOMM)Hmgu>	MP:0000745,tremors|MP:0001322,abnormal iris morphology|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001486,abnormal startle reflex|MP:0001513,limb grasping|MP:0001566,increased circulating phosphate level|MP:0002102,abnormal ear morphology|MP:0002590,increased mean corpuscular volume|MP:0002833,increased heart weight|MP:0004738,abnormal auditory brainstem response|MP:0004924,abnormal behavior|MP:0005178,increased circulating cholesterol level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0008810,increased circulating iron level|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:5911041	Nptn<Y219X>	MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3628746	Nptx1<tm1Mspn>	MP:0002184,abnormal innervation|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:3765981	Nptx2<tm1Awj>	MP:0002802,abnormal discrimination learning
MGI:3628749	Nptx2<tm1Mspn>	MP:0002184,abnormal innervation
MGI:3628751	Nptxr<tm1Mspn>	MP:0002184,abnormal innervation
MGI:7622046	Npvf<tm1.1Ubu>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001973,increased thermal nociceptive threshold|MP:0005386,behavior/neurological phenotype|MP:0031392,hypoactivity
MGI:5307897	Npy1r<tm1.1Ceva>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001745,increased circulating corticosterone level|MP:0005668,decreased circulating leptin level|MP:0008489,slow postnatal weight gain|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008907,decreased total fat pad weight|MP:0009289,decreased epididymal fat pad weight
MGI:3053796	Npy1r<tm1.1Wpg>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001353,increased aggression towards mice|MP:0001399,hyperactivity|MP:0001790,abnormal immune system physiology|MP:0001819,abnormal immune cell physiology|MP:0001828,abnormal T cell activation|MP:0001845,abnormal inflammatory response|MP:0001934,increased litter size|MP:0002451,abnormal macrophage physiology|MP:0002452,abnormal professional antigen presenting cell physiology|MP:0002461,increased immunoglobulin level|MP:0002490,abnormal immunoglobulin level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002722,abnormal immune system organ morphology|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004279,abnormal rostral migratory stream morphology|MP:0004981,decreased neuronal precursor cell number|MP:0005017,decreased B cell number|MP:0005465,abnormal T-helper 1 physiology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0006387,abnormal T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0008182,decreased marginal zone B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008211,decreased mature B cell number|MP:0008496,decreased IgG2a level|MP:0008501,increased IgG2b level|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008567,decreased interferon-gamma secretion|MP:0008618,decreased circulating interleukin-12 level|MP:0008826,abnormal splenic cell ratio|MP:0008828,abnormal lymph node cell ratio|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0009937,abnormal neuron differentiation
MGI:2158689	Npy1r<tm1Aka>	MP:0001261,obese|MP:0001431,abnormal eating behavior
MGI:2158702	Npy1r<tm1Mnak>	MP:0001260,increased body weight|MP:0002079,increased circulating insulin level|MP:0004890,decreased energy expenditure|MP:0005293,impaired glucose tolerance|MP:0005386,behavior/neurological phenotype|MP:0009285,increased gonadal fat pad weight|MP:0009304,increased retroperitoneal fat pad weight
MGI:2158704	Npy1r<tm1Pern>	MP:0002862,abnormal righting response
MGI:2158699	Npy1r<tm1Tped>	MP:0000250,abnormal vasoconstriction|MP:0001007,abnormal sympathetic system morphology|MP:0001261,obese|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001544,abnormal cardiovascular system physiology|MP:0001554,increased circulating free fatty acids level|MP:0001559,hyperglycemia|MP:0001745,increased circulating corticosterone level|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0003545,increased alcohol consumption|MP:0005290,decreased oxygen consumption|MP:0005333,decreased heart rate|MP:0005386,behavior/neurological phenotype|MP:0005437,abnormal glycogen level|MP:0005450,abnormal energy expenditure|MP:0005458,increased percent body fat/body weight|MP:0005608,cardiac interstitial fibrosis|MP:0005669,increased circulating leptin level|MP:0009288,increased epididymal fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0009755,impaired behavioral response to alcohol|MP:0010024,increased total body fat amount|MP:0010768,mortality/aging|MP:0011940,decreased food intake|MP:0011957,decreased compensatory feeding amount|MP:0030016,increased adipocyte glucose uptake
MGI:3053795	Npy1r<tm1Wpg>	MP:0000062,increased bone mineral density|MP:0002169,no abnormal phenotype detected|MP:0004149,increased bone strength|MP:0005006,abnormal osteoblast physiology|MP:0008158,increased diameter of femur|MP:0008271,abnormal bone ossification|MP:0009347,increased trabecular bone thickness|MP:0010123,increased bone mineral content|MP:0010868,increased bone trabecula number
MGI:6287375	Npy2r<em1(IMPC)H>	MP:0000691,enlarged spleen|MP:0001392,abnormal locomotor behavior|MP:0004952,increased spleen weight
MGI:2447398	Npy2r<tm1.1Hhz>	MP:0000130,abnormal trabecular bone morphology|MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001431,abnormal eating behavior|MP:0001463,abnormal spatial learning|MP:0001783,decreased white adipose tissue amount|MP:0002665,decreased circulating corticosterone level|MP:0002727,decreased circulating insulin level|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004279,abnormal rostral migratory stream morphology|MP:0004702,increased circulating insulin-like growth factor I level|MP:0004981,decreased neuronal precursor cell number|MP:0004985,decreased osteoclast cell number|MP:0005137,increased growth hormone level|MP:0005449,abnormal food intake|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0009347,increased trabecular bone thickness|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011385,abnormal testosterone level|MP:0011941,increased fluid intake|MP:0014367,impaired long-term object recognition memory|MP:0014567,increased circulating pancreatic peptide level
MGI:2447395	Npy2r<tm1Hhz>	MP:0000130,abnormal trabecular bone morphology|MP:0001262,decreased body weight|MP:0001560,abnormal circulating insulin level|MP:0001745,increased circulating corticosterone level|MP:0002078,abnormal glucose homeostasis|MP:0003313,abnormal locomotor activation|MP:0004985,decreased osteoclast cell number|MP:0005289,increased oxygen consumption|MP:0005367,renal/urinary system phenotype|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005418,abnormal circulating hormone level|MP:0005449,abnormal food intake|MP:0005455,increased susceptibility to weight gain|MP:0005534,decreased body temperature|MP:0009347,increased trabecular bone thickness|MP:0009355,increased liver triglyceride level|MP:0010878,increased trabecular bone volume|MP:0014142,increased body fat mass|MP:0014145,increased white adipose tissue mass|MP:0014146,decreased white adipose tissue mass|MP:0014567,increased circulating pancreatic peptide level|MP:0020039,increased bone ossification|MP:0020080,increased bone mineralization
MGI:2654580	Npy2r<tm1Pern>	MP:0001260,increased body weight|MP:0001402,decreased locomotor activity|MP:0001433,polyphagia|MP:0002570,alcohol aversion|MP:0002862,abnormal righting response|MP:0004890,decreased energy expenditure|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008908,increased total fat pad weight|MP:0011021,abnormal circadian regulation of heart rate|MP:0011941,increased fluid intake|MP:0014441,decreased response to leptin|MP:0014638,increased sleep duration
MGI:2183929	Npy4r<tm1.1Hhz>	MP:0001262,decreased body weight|MP:0001353,increased aggression towards mice|MP:0001431,abnormal eating behavior|MP:0001783,decreased white adipose tissue amount|MP:0004989,decreased osteoblast cell number|MP:0005334,abnormal fat pad morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005449,abnormal food intake|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0011941,increased fluid intake|MP:0014567,increased circulating pancreatic peptide level
MGI:2183928	Npy4r<tm1Hhz>	MP:0002169,no abnormal phenotype detected
MGI:5429060	Npy4r<tm1Lex>	MP:0005375,adipose tissue phenotype
MGI:6741037	Npy5r<em1(IMPC)H>	MP:0001402,decreased locomotor activity|MP:0001556,increased circulating HDL cholesterol level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount
MGI:2158688	Npy5r<tm1Aka>	MP:0001261,obese|MP:0005658,increased susceptibility to diet-induced obesity|MP:0011940,decreased food intake
MGI:2654579	Npy5r<tm1Pern>	MP:0005386,behavior/neurological phenotype
MGI:3028279	Npy5r<tm1Rpa>	MP:0001259,abnormal body weight|MP:0001261,obese|MP:0001433,polyphagia|MP:0001745,increased circulating corticosterone level|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005669,increased circulating leptin level|MP:0009304,increased retroperitoneal fat pad weight|MP:0010024,increased total body fat amount
MGI:5427680	Npy6r<tm1Dgen>	MP:0001516,abnormal motor coordination/balance
MGI:5588329	Npy6r<tm1Hhzg>	MP:0000005,increased brown adipose tissue amount|MP:0000008,increased white adipose tissue amount|MP:0000010,abnormal abdominal fat pad morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001399,hyperactivity|MP:0001780,decreased brown adipose tissue amount|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0002981,increased liver weight|MP:0003212,increased susceptibility to age related obesity|MP:0003867,increased defecation amount|MP:0003961,decreased lean body mass|MP:0004700,abnormal circulating insulin-like growth factor I level|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004889,increased energy expenditure|MP:0005292,improved glucose tolerance|MP:0005293,impaired glucose tolerance|MP:0005345,abnormal circulating corticosterone level|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005449,abnormal food intake|MP:0005450,abnormal energy expenditure|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0009288,increased epididymal fat pad weight|MP:0009289,decreased epididymal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0010024,increased total body fat amount|MP:0010025,decreased total body fat amount|MP:0010378,increased respiratory quotient|MP:0010379,decreased respiratory quotient|MP:0011939,increased food intake|MP:0011940,decreased food intake|MP:0012311,decreased defecation amount
MGI:3811718	Npy<tm1(cre)Tkar>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002757,decreased vertical activity|MP:0003867,increased defecation amount
MGI:5750089	Npy<tm1(cre)Zman>	MP:0002169,no abnormal phenotype detected
MGI:2182113	Npy<tm1Rpa>	MP:0000951,sporadic seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0005376,homeostasis/metabolism phenotype
MGI:3527174	Npy<tm2Rpa>	MP:0001262,decreased body weight|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0005378,growth/size/body region phenotype|MP:0008907,decreased total fat pad weight
MGI:2388490	Nqo1<tm1Akj>	MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0002712,increased circulating glucagon level|MP:0003186,abnormal redox activity|MP:0003383,abnormal gluconeogenesis|MP:0003806,abnormal nucleotide metabolism|MP:0005317,increased triglyceride level|MP:0005331,insulin resistance|MP:0005560,decreased circulating glucose level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008853,decreased abdominal adipose tissue amount|MP:0010300,increased skin tumor incidence
MGI:4353051	Nqo1<tm1Msho>	MP:0005621,abnormal cell physiology
MGI:2447336	Nqo2<tm1Akj>	MP:0000322,increased granulocyte number|MP:0002401,abnormal lymphopoiesis|MP:0005505,thrombocytosis|MP:0005584,abnormal enzyme/coenzyme activity|MP:0010300,increased skin tumor incidence
MGI:3512531	Nqo2<tm1Bout>	MP:0001463,abnormal spatial learning|MP:0002804,abnormal motor learning|MP:0008428,abnormal spatial working memory|MP:0014368,enhanced long-term object recognition memory
MGI:1856971	nr	MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0001265,decreased body size|MP:0001325,abnormal retina morphology|MP:0001392,abnormal locomotor behavior|MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0001921,reduced fertility|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0003313,abnormal locomotor activation|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0006035,abnormal mitochondrial morphology|MP:0008450,retina photoreceptor degeneration|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0014330,abnormal Purkinje cell focal axonal swelling|MP:0014331,abnormal Purkinje cell mitochondrial morphology
MGI:6153726	Nr0b1<em2(IMPC)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0002160,abnormal reproductive system morphology|MP:0002965,increased circulating serum albumin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005564,increased hemoglobin content|MP:0008810,increased circulating iron level|MP:0010092,increased circulating magnesium level|MP:0010123,increased bone mineral content
MGI:2159321	Nr0b1<tm1.1Lja>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002118,abnormal lipid homeostasis|MP:0002786,abnormal Leydig cell morphology|MP:0004109,abnormal Sertoli cell development|MP:0004728,abnormal efferent ductules of testis morphology|MP:0004806,absent germ cells|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005379,endocrine/exocrine gland phenotype|MP:0006262,increased testis tumor incidence|MP:0006417,rete testis obstruction|MP:0006418,abnormal testis cord formation|MP:0006419,disorganized testis cords|MP:0006420,abnormal peritubular myoid cell morphology|MP:0006421,decreased number of peritubular myoid cells|MP:0006427,ectopic Leydig cells|MP:0006428,ectopic Sertoli cells|MP:0008297,retention of the adrenal gland x-zone|MP:0009257,dilated seminiferous tubule|MP:0009433,polyovular ovarian follicle|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0013603,abnormal fetal Leydig cell differentiation|MP:0031407,increased Sertoli cell proliferation
MGI:2159305	Nr0b1<tm1Lja>	MP:0002211,abnormal primary sex determination|MP:0002995,primary sex reversal|MP:0002996,ovotestis
MGI:3700157	Nr0b2<tm1.1Auw>	MP:0001147,small testis|MP:0002781,increased circulating testosterone level|MP:0003378,early sexual maturation|MP:0004852,decreased testis weight|MP:0004884,abnormal testis physiology|MP:0004928,increased epididymis weight
MGI:3847927	Nr0b2<tm1.1Mjev>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005376,homeostasis/metabolism phenotype
MGI:3700156	Nr0b2<tm1Auw>	MP:0002169,no abnormal phenotype detected
MGI:2671111	Nr0b2<tm1Ddm>	MP:0004774,abnormal bile salt level|MP:0004789,increased bile salt level|MP:0005179,decreased circulating cholesterol level|MP:0005365,abnormal bile salt homeostasis|MP:0009355,increased liver triglyceride level|MP:0010180,increased susceptibility to weight loss
MGI:3847926	Nr0b2<tm1Mjev>	MP:0000183,decreased circulating LDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:3607116	Nr0b2<tm1Rus>	MP:0000609,abnormal liver physiology|MP:0002118,abnormal lipid homeostasis|MP:0002646,increased intestinal cholesterol absorption|MP:0002941,increased circulating alanine transaminase level|MP:0004774,abnormal bile salt level|MP:0005343,increased circulating aspartate transaminase level|MP:0005365,abnormal bile salt homeostasis
MGI:7526547	Nr1d1<em1Bwu>	MP:0005381,digestive/alimentary phenotype
MGI:5548823	Nr1d1<tm1.1(KOMP)Vlcg>	MP:0000745,tremors|MP:0001491,unresponsive to tactile stimuli|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5426700	Nr1d1<tm1.2Rev>	MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020470,shortened circadian behavior period
MGI:3847528	Nr1d1<tm1(KOMP)Vlcg>	MP:0000274,enlarged heart|MP:0001399,hyperactivity|MP:0002092,abnormal eye morphology|MP:0003393,decreased cardiac output|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0008045,decreased NK cell number|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0011959,abnormal eye posterior chamber depth|MP:0011960,abnormal eye anterior chamber depth|MP:0011965,decreased total retina thickness|MP:0020870,decreased thigmotaxis
MGI:2671157	Nr1d1<tm1Schb>	MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0001935,decreased litter size|MP:0005365,abnormal bile salt homeostasis|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level|MP:0020470,shortened circadian behavior period|MP:0020474,advanced circadian behavior phase
MGI:2449852	Nr1d1<tm1Ven>	MP:0000849,abnormal cerebellum morphology|MP:0000854,abnormal cerebellum development|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001262,decreased body weight|MP:0001923,reduced female fertility|MP:0004098,abnormal cerebellar granule cell morphology|MP:0005289,increased oxygen consumption|MP:0005533,increased body temperature|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008579,abnormal Purkinje cell differentiation|MP:0009399,increased skeletal muscle fiber size|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0011016,increased core body temperature|MP:0011020,abnormal circadian temperature homeostasis|MP:0020523,decreased susceptibility to induced hypothermia|MP:0030016,increased adipocyte glucose uptake
MGI:6158470	Nr1d2<em1(IMPC)Mbp>	MP:0002941,increased circulating alanine transaminase level
MGI:5752902	Nr1d2<tm1.1Pbrc>	MP:0001363,increased anxiety-related response|MP:0009747,impaired behavioral response to xenobiotic
MGI:5426701	Nr1d2<tm1.2Rev>	MP:0002169,no abnormal phenotype detected
MGI:5427681	Nr1d2<tm1Dgen>	MP:0000266,abnormal heart morphology|MP:0002169,no abnormal phenotype detected|MP:0010404,ostium primum atrial septal defect|MP:0010412,atrioventricular septal defect|MP:0010419,inlet ventricular septal defect|MP:0010607,common atrioventricular valve|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2653342	Nr1h2<tm1.1Gstr>	MP:0000953,abnormal oligodendrocyte morphology|MP:0001175,abnormal lung morphology|MP:0001325,abnormal retina morphology|MP:0001330,abnormal optic nerve morphology|MP:0001547,abnormal lipid level|MP:0002784,abnormal Sertoli cell morphology|MP:0003191,abnormal cellular cholesterol metabolism|MP:0003329,amyloid beta deposits|MP:0005389,reproductive system phenotype|MP:0006219,optic nerve degeneration|MP:0006303,abnormal retina nerve fiber layer morphology|MP:0006309,decreased retina ganglion cell number|MP:0008056,abnormal retina ganglion cell morphology|MP:0009808,decreased oligodendrocyte number|MP:0020448,increased microglial cell activation
MGI:4946260	Nr1h2<tm1.1Nph>	MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0003191,abnormal cellular cholesterol metabolism|MP:0005278,abnormal cholesterol homeostasis|MP:0005438,abnormal glycogen homeostasis|MP:0030021,increased muscle cell glucose uptake
MGI:4437128	Nr1h2<tm1Dgen>	MP:0001533,abnormal skeleton physiology
MGI:3041856	Nr1h2<tm1Djm>	MP:0000740,impaired smooth muscle contractility|MP:0000755,hindlimb paralysis|MP:0001218,thin epidermis|MP:0002412,increased susceptibility to bacterial infection|MP:0002685,abnormal spermatogonia proliferation|MP:0002784,abnormal Sertoli cell morphology|MP:0002907,abnormal parturition|MP:0008028,pregnancy-related premature death|MP:0008256,abnormal myometrium morphology|MP:0009671,abnormal uterus physiology|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:2653319	Nr1h2<tm1Gstr>	MP:0002169,no abnormal phenotype detected
MGI:5426973	Nr1h3<tm1.1Djm>	MP:0002118,abnormal lipid homeostasis|MP:0002981,increased liver weight|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010027,increased liver cholesterol level
MGI:2653344	Nr1h3<tm1.1Gstr>	MP:0000182,increased circulating LDL cholesterol level|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0002941,increased circulating alanine transaminase level|MP:0003191,abnormal cellular cholesterol metabolism|MP:0005388,respiratory system phenotype|MP:0010027,increased liver cholesterol level
MGI:5695902	Nr1h3<tm1.1(KOMP)Vlcg>	MP:0002135,abnormal kidney morphology|MP:0002941,increased circulating alanine transaminase level
MGI:4946259	Nr1h3<tm1.1Nph>	MP:0005376,homeostasis/metabolism phenotype
MGI:3664445	Nr1h3<tm1Dgen>	MP:0002118,abnormal lipid homeostasis|MP:0002139,abnormal hepatobiliary system physiology|MP:0005278,abnormal cholesterol homeostasis
MGI:2181380	Nr1h3<tm1Djm>	MP:0000182,increased circulating LDL cholesterol level|MP:0000603,pale liver|MP:0001846,increased inflammatory response|MP:0002412,increased susceptibility to bacterial infection|MP:0002628,hepatic steatosis|MP:0002679,abnormal corpus luteum morphology|MP:0002773,decreased circulating luteinizing hormone level|MP:0002780,decreased circulating testosterone level|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003070,increased vascular permeability|MP:0003103,liver degeneration|MP:0003507,abnormal ovary physiology|MP:0004832,enlarged ovary|MP:0004834,ovary hemorrhage|MP:0005178,increased circulating cholesterol level|MP:0005182,increased circulating estradiol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005365,abnormal bile salt homeostasis|MP:0005376,homeostasis/metabolism phenotype|MP:0009648,abnormal superovulation|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010027,increased liver cholesterol level|MP:0014052,increased male germ cell apoptosis|MP:0014604,hemorrhagic ovary cyst|MP:0031063,increased erythrocyte sedimentation rate
MGI:2653320	Nr1h3<tm1Gstr>	MP:0002169,no abnormal phenotype detected
MGI:4415263	Nr1h3<tm1Wexi>	MP:0002628,hepatic steatosis|MP:0008734,decreased susceptibility to endotoxin shock
MGI:3774280	Nr1h4<tm1.1Gonz>	MP:0001552,increased circulating triglyceride level|MP:0004789,increased bile salt level|MP:0005178,increased circulating cholesterol level|MP:0005365,abnormal bile salt homeostasis
MGI:5521510	Nr1h4<tm1.1Mbj>	MP:0000063,decreased bone mineral density|MP:0000609,abnormal liver physiology|MP:0000611,jaundice|MP:0001262,decreased body weight|MP:0001860,liver inflammation|MP:0002628,hepatic steatosis|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003103,liver degeneration|MP:0004789,increased bile salt level|MP:0004889,increased energy expenditure|MP:0004952,increased spleen weight|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005344,increased circulating bilirubin level|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005560,decreased circulating glucose level|MP:0008988,abnormal liver perisinusoidal space morphology|MP:0008989,abnormal liver sinusoid morphology|MP:0009133,decreased white fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009295,decreased interscapular fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0009342,enlarged gallbladder|MP:0009355,increased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010771,integument phenotype|MP:0011939,increased food intake|MP:0011941,increased fluid intake|MP:0031236,increased cecum weight
MGI:4437614	Nr1h4<tm1.2Auw>	MP:0000607,abnormal hepatocyte morphology|MP:0003887,increased hepatocyte apoptosis|MP:0003893,increased hepatocyte proliferation|MP:0004789,increased bile salt level
MGI:2137330	Nr1h4<tm1Gonz>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0001656,focal hepatic necrosis|MP:0001860,liver inflammation|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003887,increased hepatocyte apoptosis|MP:0003893,increased hepatocyte proliferation|MP:0003980,increased circulating phospholipid level|MP:0004773,abnormal bile composition|MP:0004774,abnormal bile salt level|MP:0004789,increased bile salt level|MP:0005150,cachexia|MP:0005178,increased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005365,abnormal bile salt homeostasis|MP:0005376,homeostasis/metabolism phenotype|MP:0005534,decreased body temperature|MP:0008019,increased liver tumor incidence|MP:0009355,increased liver triglyceride level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010027,increased liver cholesterol level|MP:0010182,decreased susceptibility to weight gain
MGI:2679472	Nr1h4<tm1Kok>	MP:0004772,abnormal bile secretion|MP:0004773,abnormal bile composition|MP:0004789,increased bile salt level|MP:0005365,abnormal bile salt homeostasis|MP:0009642,abnormal blood homeostasis
MGI:5693976	Nr1i2<tm1.1(NR1I2)Kann>	MP:0005266,abnormal metabolism
MGI:3790844	Nr1i2<tm1(NR1I2)Arte>	MP:0005370,liver/biliary system phenotype|MP:0005389,reproductive system phenotype|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010768,mortality/aging
MGI:2386087	Nr1i2<tm1Rev>	MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3609633	Nr1i2<tm1Sakl>	MP:0004001,decreased hepatocyte proliferation|MP:0008872,abnormal physiological response to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009747,impaired behavioral response to xenobiotic|MP:0014782,increased liver enzyme/coenzyme level|MP:0014783,decreased liver enzyme/coenzyme level
MGI:3790846	Nr1i2<tm3Arte>	MP:0005370,liver/biliary system phenotype|MP:0005389,reproductive system phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010768,mortality/aging
MGI:3815105	Nr1i3<tm1.1Arte>	MP:0005370,liver/biliary system phenotype|MP:0005389,reproductive system phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010768,mortality/aging
MGI:2657124	Nr1i3<tm1Ddm>	MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005559,increased circulating glucose level|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3044371	Nr1i3<tm1Dgen>	MP:0005376,homeostasis/metabolism phenotype|MP:0005469,abnormal thyroxine level|MP:0005472,abnormal triiodothyronine level|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010180,increased susceptibility to weight loss|MP:0010951,abnormal lipid oxidation
MGI:3815103	Nr1i3<tm1(NR1I3)Arte>	MP:0005370,liver/biliary system phenotype|MP:0005389,reproductive system phenotype|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0010768,mortality/aging
MGI:2675740	Nr2c1<tm1Chc>	MP:0001588,abnormal hemoglobin|MP:0002169,no abnormal phenotype detected
MGI:4941026	Nr2c2<tm1Amj>	MP:0000183,decreased circulating LDL cholesterol level|MP:0001262,decreased body weight|MP:0001431,abnormal eating behavior|MP:0001876,decreased inflammatory response|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0002942,decreased circulating alanine transaminase level|MP:0003948,abnormal gas homeostasis|MP:0004889,increased energy expenditure|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005448,abnormal energy homeostasis|MP:0005560,decreased circulating glucose level|MP:0005632,decreased circulating aspartate transaminase level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005670,abnormal white adipose tissue physiology|MP:0008963,increased carbon dioxide production|MP:0009133,decreased white fat cell size|MP:0009287,decreased abdominal fat pad weight|MP:0009289,decreased epididymal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0009642,abnormal blood homeostasis|MP:0010378,increased respiratory quotient|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0014143,decreased body fat mass|MP:0014169,decreased brown adipose tissue mass|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis|MP:0031270,decreased susceptibility to age-related hepatic steatosis
MGI:5517362	Nr2c2<tm1Bbm>	MP:0001265,decreased body size|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001968,abnormal touch/nociception|MP:0001973,increased thermal nociceptive threshold|MP:0002734,abnormal mechanical nociception|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology|MP:0005386,behavior/neurological phenotype|MP:0008319,abnormal sympathetic afferent fiber morphology|MP:0008531,increased chemical nociceptive threshold|MP:0008948,decreased neuron number|MP:0010073,decreased pruritus|MP:0010771,integument phenotype
MGI:6120712	Nr2c2<tm1b(EUCOMM)Wtsi>	MP:0005293,impaired glucose tolerance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3050563	Nr2c2<tm1Chc>	MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001154,seminiferous tubule degeneration|MP:0001265,decreased body size|MP:0001588,abnormal hemoglobin|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001927,abnormal estrous cycle|MP:0001928,abnormal ovulation|MP:0001935,decreased litter size|MP:0002636,delayed vaginal opening|MP:0002637,small uterus|MP:0002679,abnormal corpus luteum morphology|MP:0002680,decreased corpora lutea number|MP:0002682,decreased mature ovarian follicle number|MP:0002687,oligozoospermia|MP:0003507,abnormal ovary physiology|MP:0004852,decreased testis weight|MP:0005181,decreased circulating estradiol level|MP:0005185,decreased circulating progesterone level|MP:0008261,arrest of male meiosis|MP:0008983,small vagina|MP:0009006,prolonged estrous cycle|MP:0009011,prolonged diestrus|MP:0009015,short proestrus|MP:0009018,short estrus|MP:0009209,abnormal internal female genitalia morphology|MP:0013508,increased granulosa cell apoptosis|MP:0020550,multinucleated giant male germ cells|MP:0031239,increased atretic ovarian follicle number|MP:0031420,decreased superovulation rate
MGI:2176490	Nr2e1<frc>	MP:0000774,decreased brain size|MP:0000784,forebrain hypoplasia|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0001330,abnormal optic nerve morphology|MP:0001353,increased aggression towards mice|MP:0001357,increased aggression towards humans|MP:0001382,abnormal nursing|MP:0001417,decreased exploration in new environment|MP:0001891,hydrocephaly|MP:0001923,reduced female fertility|MP:0002061,abnormal aggression-related behavior|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002199,abnormal brain commissure morphology|MP:0002741,small olfactory bulb|MP:0002792,abnormal retina vasculature morphology|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003734,abnormal retina inner plexiform layer morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0005241,abnormal retina ganglion layer morphology|MP:0005551,abnormal eye electrophysiology|MP:0006303,abnormal retina nerve fiber layer morphology|MP:0008056,abnormal retina ganglion cell morphology|MP:0008489,slow postnatal weight gain|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008540,abnormal cerebral hemisphere morphology|MP:0010025,decreased total body fat amount|MP:0011380,enlarged brain ventricles
MGI:2151350	Nr2e1<tm1Gsc>	MP:0000774,decreased brain size|MP:0000812,abnormal dentate gyrus morphology|MP:0000818,abnormal amygdala morphology|MP:0001386,abnormal maternal nurturing|MP:0002063,abnormal learning/memory/conditioning|MP:0002741,small olfactory bulb|MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0004166,abnormal limbic system morphology|MP:0005267,abnormal olfactory cortex morphology|MP:0005655,increased aggression|MP:0006300,abnormal entorhinal cortex morphology|MP:0008226,decreased anterior commissure size|MP:0008457,abnormal cortical intermediate zone morphology|MP:0008489,slow postnatal weight gain|MP:0020537,decreased subiculum size
MGI:3777019	Nr2e1<tm1Rev>	MP:0000812,abnormal dentate gyrus morphology|MP:0001463,abnormal spatial learning|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0008431,abnormal short-term spatial reference memory|MP:0009937,abnormal neuron differentiation
MGI:2176560	Nr2e1<tm1Rtyu>	MP:0000818,abnormal amygdala morphology|MP:0000934,abnormal telencephalon development|MP:0001325,abnormal retina morphology|MP:0001330,abnormal optic nerve morphology|MP:0002001,blindness|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0004171,abnormal pallium development|MP:0004268,abnormal optic stalk morphology|MP:0004277,abnormal lateral ganglionic eminence morphology|MP:0005241,abnormal retina ganglion layer morphology|MP:0005551,abnormal eye electrophysiology|MP:0006219,optic nerve degeneration|MP:0008509,disorganized retina ganglion layer|MP:0008512,disorganized retina inner nuclear layer|MP:0008516,disorganized retina outer nuclear layer|MP:0008585,absent photoreceptor outer segment|MP:0009450,abnormal axon fasciculation|MP:0020388,decreased radial glial cell number|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:3764730	Nr2e1<tm2Gsc>	MP:0000774,decreased brain size|MP:0000825,dilated lateral ventricle|MP:0001353,increased aggression towards mice|MP:0001364,decreased anxiety-related response|MP:0001732,postnatal growth retardation|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0008283,small hippocampus
MGI:1859180	Nr2e3<rd7>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001006,abnormal retina cone cell morphology|MP:0001326,retina degeneration|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008516,disorganized retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008587,short photoreceptor outer segment|MP:0030005,increased retina apoptosis
MGI:3805457	Nr2e3<tm1Dgen>	MP:0003731,abnormal retina outer nuclear layer morphology
MGI:8253349	Nr2f1<em1Cpsc>	MP:0000781,decreased corpus callosum size|MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001415,increased exploration in new environment|MP:0001529,abnormal vocalization|MP:0003312,abnormal locomotor coordination|MP:0003491,abnormal voluntary movement|MP:0008283,small hippocampus|MP:0008535,enlarged lateral ventricles|MP:0012293,impaired active avoidance behavior|MP:0012312,impaired avoidance learning behavior|MP:0014416,decreased social novelty preference|MP:0020351,decreased vocalization
MGI:8253350	Nr2f1<em1Ics>	MP:0000781,decreased corpus callosum size|MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001415,increased exploration in new environment|MP:0001529,abnormal vocalization|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003312,abnormal locomotor coordination|MP:0003491,abnormal voluntary movement|MP:0008283,small hippocampus|MP:0008535,enlarged lateral ventricles|MP:0012312,impaired avoidance learning behavior|MP:0020351,decreased vocalization|MP:0021110,increased social investigation
MGI:5635253	Nr2f1<tm1.1(KOMP)Mbp>	MP:0001289,persistence of hyaloid vascular system|MP:0003984,embryonic growth retardation|MP:0004738,abnormal auditory brainstem response|MP:0011100,preweaning lethality, complete penetrance
MGI:3521756	Nr2f1<tm1Mist>	MP:0000780,abnormal corpus callosum morphology|MP:0000781,decreased corpus callosum size|MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0001529,abnormal vocalization|MP:0002199,abnormal brain commissure morphology|MP:0002882,abnormal neuron morphology|MP:0002961,abnormal axon guidance|MP:0003312,abnormal locomotor coordination|MP:0004167,abnormal cingulate gyrus morphology|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0008221,abnormal hippocampal commissure morphology|MP:0008225,abnormal anterior commissure morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0020351,decreased vocalization
MGI:2385930	Nr2f1<tm1Mjts>	MP:0000788,abnormal cerebral cortex morphology|MP:0000862,absent barrels in primary somatosensory cortex|MP:0001096,abnormal glossopharyngeal ganglion morphology|MP:0001262,decreased body weight|MP:0001437,no swallowing reflex|MP:0001473,reduced long-term potentiation|MP:0001489,decreased startle reflex|MP:0001523,impaired righting response|MP:0001898,abnormal long-term depression|MP:0001900,impaired synaptic plasticity|MP:0001963,abnormal hearing physiology|MP:0002961,abnormal axon guidance|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0003631,nervous system phenotype|MP:0004102,abnormal dorsal striatum morphology|MP:0004144,hypotonia|MP:0004395,increased cochlear inner hair cell number|MP:0004401,increased cochlear outer hair cell number|MP:0004407,increased cochlear hair cell number|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004492,abnormal orientation of inner hair cell stereociliary bundles|MP:0004589,abnormal cochlear hair cell development|MP:0004840,increased Deiters cell number|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0006325,impaired hearing|MP:0008304,abnormal organ of Corti supporting cell differentiation|MP:0008307,short scala media|MP:0010053,decreased grip strength|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012318,slow extinction of fear memory|MP:0020068,increased neocortex volume|MP:0020083,decreased hippocampus volume
MGI:5523158	Nr2f1<tm2.1Mist>	MP:0000788,abnormal cerebral cortex morphology|MP:0000860,abnormal primary somatosensory cortex morphology|MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0003989,abnormal barrel cortex morphology
MGI:4439069	Nr2f1<tm2.1Mjts>	MP:0005391,vision/eye phenotype
MGI:2385933	Nr2f2<tm1Tsa>	MP:0000270,abnormal heart tube morphology|MP:0000296,absent trabeculae carneae|MP:0001126,abnormal ovary morphology|MP:0001265,decreased body size|MP:0001689,incomplete somite formation|MP:0001732,postnatal growth retardation|MP:0001914,hemorrhage|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002636,delayed vaginal opening|MP:0002725,abnormal vein morphology|MP:0004784,abnormal anterior cardinal vein morphology|MP:0004785,abnormal posterior cardinal vein morphology|MP:0005185,decreased circulating progesterone level|MP:0005380,embryo phenotype|MP:0005602,decreased angiogenesis|MP:0009009,absent estrous cycle|MP:0009011,prolonged diestrus|MP:0009020,prolonged metestrus|MP:0009021,absent estrus|MP:0009085,abnormal uterine horn morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3578106	Nr2f2<tm1Vco>	MP:0001547,abnormal lipid level|MP:0001552,increased circulating triglyceride level|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0003058,increased insulin secretion|MP:0003059,decreased insulin secretion|MP:0005282,decreased fatty acids level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005560,decreased circulating glucose level|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance
MGI:3579117	Nr2f2<tm2.1Tsa>	MP:0000470,abnormal stomach morphology|MP:0000471,abnormal stomach epithelium morphology|MP:0000473,abnormal stomach glandular epithelium morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001614,abnormal blood vessel morphology|MP:0001712,abnormal placenta development|MP:0001729,impaired embryo implantation|MP:0001785,edema|MP:0001914,hemorrhage|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0002691,small stomach|MP:0002725,abnormal vein morphology|MP:0003119,abnormal digestive system development|MP:0003403,absent placental labyrinth|MP:0004014,abnormal uterine environment|MP:0004139,abnormal gastric parietal cell morphology|MP:0004256,abnormal maternal decidual layer morphology|MP:0005391,vision/eye phenotype|MP:0008256,abnormal myometrium morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009089,short uterine horn|MP:0009397,increased trophoblast giant cell number|MP:0010198,decreased lymphatic vessel endothelial cell number|MP:0010780,abnormal stomach smooth muscle circular layer morphology|MP:0010785,abnormal stomach pyloric region morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0013575,abnormal forestomach-glandular stomach junction morphology|MP:0013576,small forestomach|MP:0030989,decreased spongiotrophoblast cell number|MP:0031137,vaginal hemorrhage|MP:0031434,increased miscarriage rate
MGI:6153804	Nr2f6<em1(IMPC)H>	MP:0003795,abnormal bone structure|MP:0010124,decreased bone mineral content
MGI:3574037	Nr2f6<tm1Ge>	MP:0002733,abnormal thermal nociception|MP:0002736,abnormal nociception after inflammation|MP:0005447,abnormal synaptic norepinephrine release|MP:0020467,abnormal circadian behavior|MP:0020470,shortened circadian behavior period|MP:0020477,abnormal locomotor circadian rhythm
MGI:3817754	Nr3c1<Gt(ESKN92)Hgs>	MP:0000639,abnormal adrenal gland morphology|MP:0000642,enlarged adrenal glands|MP:0001745,increased circulating corticosterone level|MP:0002666,increased circulating aldosterone level|MP:0005345,abnormal circulating corticosterone level|MP:0005367,renal/urinary system phenotype|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005582,increased renin activity|MP:0006144,increased systemic arterial systolic blood pressure|MP:0006375,increased circulating angiotensinogen level|MP:0008293,abnormal adrenal gland zona glomerulosa morphology|MP:0008294,abnormal adrenal gland zona fasciculata morphology|MP:0009355,increased liver triglyceride level|MP:0011085,postnatal lethality, complete penetrance
MGI:5526027	Nr3c1<tm1.1Jaci>	MP:0000274,enlarged heart|MP:0001175,abnormal lung morphology|MP:0001625,cardiac hypertrophy|MP:0001633,poor circulation|MP:0001853,heart inflammation|MP:0001855,abnormal atrial thrombosis|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0003141,cardiac fibrosis|MP:0003711,pathological neovascularization|MP:0003915,increased heart left ventricle weight|MP:0004215,abnormal myocardial fiber physiology|MP:0004231,abnormal calcium ion homeostasis|MP:0004564,increased myocardial fiber size|MP:0004733,abnormal thoracic cavity morphology|MP:0005385,cardiovascular system phenotype|MP:0006138,congestive heart failure|MP:0011925,abnormal heart echocardiography feature|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5447468	Nr3c1<tm1.1Jda>	MP:0001800,abnormal humoral immune response|MP:0001823,thymus hypoplasia|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0009542,decreased thymocyte apoptosis
MGI:5306342	Nr3c1<tm1.1Mvc>	MP:0001262,decreased body weight|MP:0001745,increased circulating corticosterone level|MP:0001748,increased circulating adrenocorticotropin level|MP:0005645,abnormal hypothalamus physiology|MP:0011400,lethality, complete penetrance
MGI:3842978	Nr3c1<tm1Dage>	MP:0002664,decreased circulating adrenocorticotropin level|MP:0002665,decreased circulating corticosterone level|MP:0002768,small adrenal glands|MP:0002780,decreased circulating testosterone level|MP:0003884,decreased macrophage cell number|MP:0004875,increased mean systemic arterial blood pressure|MP:0005017,decreased B cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008302,thin adrenal cortex|MP:0008872,abnormal physiological response to xenobiotic|MP:0014287,decreased adrenal gland zona fasciculata size
MGI:1857745	Nr3c1<tm1Gsc>	MP:0000609,abnormal liver physiology|MP:0000639,abnormal adrenal gland morphology|MP:0000642,enlarged adrenal glands|MP:0000643,absent adrenal medulla|MP:0000645,absent adrenergic chromaffin cells|MP:0000646,enlarged adrenocortical cells|MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001179,thick pulmonary interalveolar septum|MP:0001575,cyanosis|MP:0001742,absent circulating adrenaline|MP:0001745,increased circulating corticosterone level|MP:0001748,increased circulating adrenocorticotropin level|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0002324,abnormal alveolocapillary membrane morphology|MP:0003115,abnormal respiratory system development|MP:0004202,pulmonary hyperplasia|MP:0004780,abnormal surfactant secretion|MP:0005630,increased lung weight|MP:0005664,decreased circulating noradrenaline level|MP:0006027,impaired lung alveolus development|MP:0008288,abnormal adrenal cortex morphology|MP:0008292,enlarged adrenocortical cell nuclei|MP:0008295,abnormal adrenal gland zona reticularis morphology|MP:0008504,abnormal adrenal chromaffin cell morphology|MP:0008770,decreased survivor rate|MP:0010810,increased type II pneumocyte number|MP:0010816,decreased type I pneumocyte number|MP:0011031,abnormal branching involved in terminal bronchiole morphogenesis|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0012574,decreased noradrenaline level|MP:0014286,increased adrenal gland zona fasciculata size|MP:0030762,decreased adrenaline level
MGI:2651864	Nr3c1<tm1Ljm>	MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001179,thick pulmonary interalveolar septum|MP:0001953,respiratory failure|MP:0009258,abnormal thymocyte apoptosis|MP:0011087,neonatal lethality, complete penetrance
MGI:1931328	Nr3c1<tm2.1Gsc>	MP:0001742,absent circulating adrenaline|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005006,abnormal osteoblast physiology|MP:0005167,abnormal blood-brain barrier function|MP:0005390,skeleton phenotype|MP:0005664,decreased circulating noradrenaline level|MP:0006414,decreased T cell apoptosis|MP:0008395,abnormal osteoblast differentiation|MP:0008504,abnormal adrenal chromaffin cell morphology|MP:0008973,decreased erythroid progenitor cell number|MP:0011087,neonatal lethality, complete penetrance
MGI:4456461	Nr3c1<tm2.1Ljm>	MP:0003075,abnormal response to CNS ischemic injury|MP:0003631,nervous system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0008236,decreased susceptibility to neuronal excitotoxicity|MP:0008657,increased interleukin-1 beta secretion|MP:0008704,abnormal interleukin-6 secretion|MP:0012441,abnormal monocyte cell number
MGI:1931327	Nr3c1<tm2Gsc>	MP:0000013,abnormal adipose tissue distribution|MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0001257,increased body length|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001364,decreased anxiety-related response|MP:0001745,increased circulating corticosterone level|MP:0001753,hypersecretion of corticotropin-releasing hormone|MP:0002065,abnormal fear/anxiety-related behavior|MP:0002272,abnormal nervous system electrophysiology|MP:0002664,decreased circulating adrenocorticotropin level|MP:0003367,increased circulating glucocorticoid level|MP:0003631,nervous system phenotype|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005129,increased adrenocorticotropin level|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005390,skeleton phenotype|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0006414,decreased T cell apoptosis|MP:0008271,abnormal bone ossification|MP:0008395,abnormal osteoblast differentiation|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009506,abnormal mammary gland alveolus morphology|MP:0009748,abnormal behavioral response to addictive substance|MP:0010119,abnormal bone mineral density|MP:0010869,decreased bone trabecula number|MP:0013630,increased bone trabecular spacing
MGI:3575536	Nr3c1<tm2Ljm>	MP:0000494,abnormal cecum morphology|MP:0001402,decreased locomotor activity|MP:0001745,increased circulating corticosterone level|MP:0001899,absent long-term depression|MP:0002573,behavioral despair|MP:0008735,increased susceptibility to endotoxin shock|MP:0008750,abnormal interferon level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0009481,cecum inflammation|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:1931329	Nr3c1<tm3Gsc>	MP:0001745,increased circulating corticosterone level|MP:0005006,abnormal osteoblast physiology|MP:0005390,skeleton phenotype|MP:0008973,decreased erythroid progenitor cell number
MGI:3577992	Nr3c1<tm3Ljm>	MP:0002169,no abnormal phenotype detected
MGI:5691956	Nr3c2<m1Btlr>	MP:0001262,decreased body weight
MGI:5474998	Nr3c2<tm1.1Ics>	MP:0000250,abnormal vasoconstriction|MP:0001613,abnormal vasodilation|MP:0002834,decreased heart weight|MP:0003025,increased vasoconstriction|MP:0003026,decreased vasoconstriction|MP:0003186,abnormal redox activity|MP:0004142,abnormal muscle tone|MP:0005367,renal/urinary system phenotype|MP:0005385,cardiovascular system phenotype|MP:0005590,increased vasodilation|MP:0006264,decreased systemic arterial systolic blood pressure
MGI:2441654	Nr3c2<tm1Gsc>	MP:0001263,weight loss|MP:0001429,dehydration|MP:0001765,abnormal ion homeostasis|MP:0002608,increased hematocrit|MP:0002666,increased circulating aldosterone level|MP:0002829,abnormal juxtaglomerular apparatus morphology|MP:0003352,increased circulating renin level|MP:0005325,abnormal renal glomerulus morphology|MP:0005367,renal/urinary system phenotype|MP:0005582,increased renin activity|MP:0005627,increased circulating potassium level|MP:0005634,decreased circulating sodium level|MP:0006316,increased urine sodium level|MP:0010109,abnormal renal sodium reabsorption|MP:0010128,hypovolemia|MP:0011085,postnatal lethality, complete penetrance|MP:0011299,abnormal macula densa morphology|MP:0011300,abnormal juxtaglomerular cell morphology|MP:0011302,abnormal extraglomerular mesangial cell morphology|MP:0011442,abnormal renal sodium ion transport|MP:0031232,increased circulating angiotensin II level
MGI:3613053	Nr3c2<tm1Krst>	MP:0004753,abnormal miniature excitatory postsynaptic currents
MGI:3613035	Nr3c2<tm2.1Gsc>	MP:0002082,postnatal lethality
MGI:3613034	Nr3c2<tm2Gsc>	MP:0001463,abnormal spatial learning|MP:0001762,polyuria|MP:0002666,increased circulating aldosterone level|MP:0003461,abnormal response to novel object|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0006316,increased urine sodium level|MP:0008428,abnormal spatial working memory|MP:0014746,abnormal hippocampal mossy fiber innervation pattern
MGI:5570322	Nr4a1<m1Anu>	MP:0002169,no abnormal phenotype detected
MGI:2182325	Nr4a1<tm1Jmi>	MP:0001619,abnormal vascular permeability|MP:0003721,increased tumor growth/size|MP:0005154,increased B cell proliferation|MP:0005379,endocrine/exocrine gland phenotype|MP:0005387,immune system phenotype|MP:0008735,increased susceptibility to endotoxin shock|MP:0008783,decreased B cell apoptosis|MP:0009671,abnormal uterus physiology|MP:0013026,decreased Ly6C low monocyte number
MGI:5546594	Nr4a1<tm1Pcn>	MP:0005154,increased B cell proliferation|MP:0005387,immune system phenotype
MGI:4437024	Nr4a2<tm1.1Pcn>	MP:0001265,decreased body size|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001409,increased stereotypic behavior|MP:0002690,akinesia|MP:0002757,decreased vertical activity|MP:0003224,neuron degeneration|MP:0003243,abnormal dopaminergic neuron morphology|MP:0003631,nervous system phenotype|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004941,abnormal regulatory T cell morphology|MP:0004946,abnormal regulatory T cell physiology|MP:0004974,decreased regulatory T cell number|MP:0005387,immune system phenotype|MP:0005643,decreased dopamine level|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008086,increased T-helper 1 cell number|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008537,increased susceptibility to induced colitis|MP:0010069,increased serotonin level|MP:0010180,increased susceptibility to weight loss|MP:0010221,abnormal T-helper 17 cell differentiation|MP:0011083,lethality at weaning, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011448,decreased dopaminergic neuron number
MGI:2429971	Nr4a2<tm1Niko>	MP:0001429,dehydration|MP:0003244,loss of dopaminergic neurons|MP:0003631,nervous system phenotype|MP:0005643,decreased dopamine level|MP:0011087,neonatal lethality, complete penetrance
MGI:3043985	Nr4a2<tm1Omc>	MP:0000836,abnormal substantia nigra morphology|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001436,abnormal suckling behavior|MP:0003313,abnormal locomotor activation|MP:0003864,abnormal midbrain development|MP:0005643,decreased dopamine level|MP:0006100,abnormal tegmentum morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0012503,increased midbrain apoptosis|MP:0012574,decreased noradrenaline level
MGI:2157566	Nr4a2<tm1Tpe>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001436,abnormal suckling behavior|MP:0001523,impaired righting response|MP:0001905,abnormal dopamine level|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002573,behavioral despair|MP:0003244,loss of dopaminergic neurons|MP:0003861,abnormal nervous system development|MP:0003964,abnormal noradrenaline level|MP:0004000,impaired passive avoidance behavior|MP:0005322,abnormal serotonin level|MP:0005643,decreased dopamine level|MP:0009746,enhanced behavioral response to xenobiotic|MP:0009749,enhanced behavioral response to addictive substance|MP:0011087,neonatal lethality, complete penetrance|MP:0031391,increased locomotor activity
MGI:3037444	Nr4a3<tm1Omc>	MP:0000046,abnormal sulcus ampullaris morphology|MP:0000808,abnormal hippocampus development|MP:0001395,bidirectional circling|MP:0001399,hyperactivity|MP:0001525,impaired balance|MP:0002428,abnormal semicircular canal morphology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002961,abnormal axon guidance|MP:0003203,increased neuron apoptosis|MP:0003240,loss of hippocampal neurons|MP:0003651,abnormal axon extension|MP:0003997,tonic-clonic seizures|MP:0004742,abnormal vestibular system physiology|MP:0006011,abnormal endolymphatic duct morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0009971,decreased hippocampus pyramidal cell number
MGI:3043761	Nr4a3<tm1Wnt>	MP:0001695,abnormal gastrulation|MP:0002085,abnormal embryonic tissue morphology|MP:0002174,abnormal gastrulation movements|MP:0003984,embryonic growth retardation|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6355954	Nr5a1<em1Kemi>	MP:0001116,small gonad|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001939,secondary sex reversal|MP:0002768,small adrenal glands|MP:0005313,absent adrenal gland|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging|MP:0011085,postnatal lethality, complete penetrance
MGI:5292676	Nr5a1<tm1.1Hain>	MP:0001146,abnormal testis morphology|MP:0001152,increased Leydig cell number|MP:0001154,seminiferous tubule degeneration|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002687,oligozoospermia|MP:0002768,small adrenal glands|MP:0003830,abnormal testis development|MP:0003963,abnormal corticosterone level|MP:0004852,decreased testis weight|MP:0008297,retention of the adrenal gland x-zone|MP:0010768,mortality/aging|MP:0011384,abnormal progesterone level|MP:0011385,abnormal testosterone level|MP:0011415,abnormal aldosterone level
MGI:1857712	Nr5a1<tm1Enl>	MP:0000633,abnormal pituitary gland morphology|MP:0000837,abnormal hypothalamus morphology|MP:0001939,secondary sex reversal|MP:0002211,abnormal primary sex determination|MP:0002212,abnormal secondary sex determination|MP:0003578,absent ovary|MP:0005313,absent adrenal gland|MP:0005644,agonadal|MP:0006415,absent testes|MP:0008335,decreased gonadotroph cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0014629,hypothalamus hypoplasia|MP:0020558,decreased ventromedial hypothalamic nucleus size
MGI:1931426	Nr5a1<tm1Jmi>	MP:0001939,secondary sex reversal|MP:0002211,abnormal primary sex determination|MP:0003578,absent ovary|MP:0005313,absent adrenal gland|MP:0005644,agonadal|MP:0006415,absent testes|MP:0011085,postnatal lethality, complete penetrance
MGI:1857391	Nr5a1<tm1Klp>	MP:0001939,secondary sex reversal|MP:0002083,premature death|MP:0002184,abnormal innervation|MP:0002211,abnormal primary sex determination|MP:0003578,absent ovary|MP:0005313,absent adrenal gland|MP:0005644,agonadal|MP:0006415,absent testes|MP:0009937,abnormal neuron differentiation|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011411,abnormal gonadal ridge morphology|MP:0020556,abnormal ventromedial hypothalamic nucleus morphology
MGI:5472122	Nr5a1<tm2.1Hain>	MP:0002169,no abnormal phenotype detected
MGI:2180092	Nr5a1<tm2.1Klp>	MP:0005313,absent adrenal gland|MP:0005644,agonadal|MP:0011089,perinatal lethality, complete penetrance
MGI:2180013	Nr5a1<tm2Klp>	MP:0000653,abnormal sex gland morphology|MP:0001116,small gonad|MP:0001121,uterus hypoplasia|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002169,no abnormal phenotype detected|MP:0002566,abnormal sexual interaction|MP:0002773,decreased circulating luteinizing hormone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003379,absent sexual maturation|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0005147,prostate gland hypoplasia|MP:0005148,seminal vesicle hypoplasia|MP:0005536,decreased Leydig cell number|MP:0008293,abnormal adrenal gland zona glomerulosa morphology
MGI:3652587	Nr5a1<tm3Klp>	MP:0001262,decreased body weight|MP:0002160,abnormal reproductive system morphology|MP:0003578,absent ovary|MP:0005313,absent adrenal gland|MP:0005644,agonadal|MP:0006415,absent testes|MP:0011085,postnatal lethality, complete penetrance
MGI:3053912	Nr5a2<tm1Auw>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000495,abnormal colon morphology|MP:0001652,colonic necrosis|MP:0001785,edema|MP:0002780,decreased circulating testosterone level|MP:0004910,decreased seminal vesicle weight|MP:0004929,decreased epididymis weight|MP:0008537,increased susceptibility to induced colitis|MP:0011091,prenatal lethality, complete penetrance
MGI:3050234	Nr5a2<tm1Bel>	MP:0001674,abnormal germ layer development|MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0001923,reduced female fertility|MP:0004774,abnormal bile salt level|MP:0004904,increased uterus weight|MP:0005179,decreased circulating cholesterol level|MP:0005185,decreased circulating progesterone level|MP:0005389,reproductive system phenotype|MP:0009661,abnormal pregnancy|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011199,abnormal amniotic cavity morphology|MP:0012142,absent amniotic cavity
MGI:3528835	Nr5a2<tm1Lex>	MP:0001672,abnormal embryo development|MP:0001675,abnormal ectoderm development|MP:0001698,decreased embryo size|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011197,abnormal proamniotic cavity morphology
MGI:3795276	Nr5a2<tm1Sakl>	MP:0004773,abnormal bile composition|MP:0005179,decreased circulating cholesterol level|MP:0005381,digestive/alimentary phenotype|MP:0005632,decreased circulating aspartate transaminase level
MGI:3720193	Nr5a2<tm1Sjns>	MP:0001652,colonic necrosis|MP:0003868,abnormal feces composition|MP:0004774,abnormal bile salt level|MP:0005342,abnormal intestinal lipid absorption|MP:0008537,increased susceptibility to induced colitis|MP:0014476,abnormal feces lipid level|MP:0014478,increased feces bile salt level
MGI:5607404	Nr5a2<tm3.1Sjns>	MP:0005365,abnormal bile salt homeostasis
MGI:3848981	Nr6a1<Gt(RRA042)Byg>	MP:0001672,abnormal embryo development|MP:0011092,embryonic lethality, complete penetrance
MGI:5561560	Nr6a1<tm1b(EUCOMM)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0000288,abnormal pericardium morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0001672,abnormal embryo development|MP:0001691,abnormal somite shape|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001718,abnormal visceral yolk sac morphology|MP:0001722,pale yolk sac|MP:0001726,abnormal allantois morphology|MP:0002151,abnormal neural tube morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0002861,abnormal tail bud morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003232,abnormal forebrain development|MP:0003425,abnormal optic vesicle formation|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5510737	Nr6a1<tm1c(EUCOMM)Wtsi>	MP:0005389,reproductive system phenotype
MGI:2385846	Nr6a1<tm1Coo>	MP:0000292,distended pericardium|MP:0000913,abnormal brain development|MP:0001056,abnormal cranial nerve morphology|MP:0001061,abnormal oculomotor nerve morphology|MP:0001063,abnormal trochlear nerve morphology|MP:0001672,abnormal embryo development|MP:0001689,incomplete somite formation|MP:0001726,abnormal allantois morphology|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002231,abnormal primitive streak morphology|MP:0002836,abnormal chorion morphology|MP:0003384,abnormal ventral body wall morphology|MP:0003720,abnormal neural tube closure|MP:0004073,caudal body truncation|MP:0004174,abnormal spine curvature|MP:0004180,failure of initiation of embryo turning|MP:0004556,enlarged allantois|MP:0008786,abnormal hindgut morphology|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012544,abnormal caudal neuropore morphology
MGI:5532717	Nr6a1<tm1d(EUCOMM)Wtsi>	MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0009768,impaired somite development|MP:0011092,embryonic lethality, complete penetrance
MGI:2448158	Nr6a1<tm2Coo>	MP:0000292,distended pericardium|MP:0000928,incomplete rostral neuropore closure|MP:0001689,incomplete somite formation|MP:0001726,abnormal allantois morphology|MP:0002084,abnormal developmental patterning|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002231,abnormal primitive streak morphology|MP:0002836,abnormal chorion morphology|MP:0002861,abnormal tail bud morphology|MP:0004180,failure of initiation of embryo turning|MP:0004556,enlarged allantois|MP:0009657,failure of chorioallantoic fusion|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0012086,absent hindgut
MGI:2674000	Nr6a1<tm3Coo>	MP:0001125,abnormal oocyte morphology|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002780,decreased circulating testosterone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0005181,decreased circulating estradiol level|MP:0005185,decreased circulating progesterone level|MP:0005376,homeostasis/metabolism phenotype|MP:0009006,prolonged estrous cycle|MP:0009010,abnormal diestrus|MP:0009011,prolonged diestrus|MP:0009433,polyovular ovarian follicle
MGI:5888871	Nradd<tm1.2Pabk>	MP:0002169,no abnormal phenotype detected
MGI:5788510	Nrap<em1(IMPC)J>	MP:0001363,increased anxiety-related response
MGI:5438570	Nrarp<tm1Grid>	MP:0000154,rib fusion|MP:0000963,fused dorsal root ganglion|MP:0001077,abnormal spinal nerve morphology|MP:0001732,postnatal growth retardation|MP:0004609,vertebral fusion|MP:0004612,fusion of vertebral bodies|MP:0004619,caudal vertebral fusion|MP:0004621,lumbar vertebral fusion|MP:0004622,sacral vertebral fusion|MP:0004623,thoracic vertebral fusion|MP:0005223,abnormal dorsal-ventral polarity of the somites|MP:0005382,craniofacial phenotype|MP:0005397,hematopoietic system phenotype
MGI:3833551	Nrarp<tm1Vlcg>	MP:0000364,abnormal vascular regression|MP:0001923,reduced female fertility|MP:0002792,abnormal retina vasculature morphology|MP:0005602,decreased angiogenesis|MP:0009660,abnormal induced retina neovascularization|MP:0020316,decreased vascular endothelial cell proliferation
MGI:5317888	Nrarp<tm1Ybes>	MP:0000137,abnormal vertebrae morphology|MP:0000154,rib fusion|MP:0000585,kinked tail|MP:0001539,decreased caudal vertebrae number|MP:0001689,incomplete somite formation|MP:0004647,decreased lumbar vertebrae number|MP:0012670,prolonged somite segmentation clock period
MGI:5447943	Nras<tm1.1Emfu>	MP:0000217,abnormal leukocyte cell number|MP:0000223,decreased monocyte cell number|MP:0000322,increased granulocyte number|MP:0000603,pale liver|MP:0000703,abnormal thymus morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001732,postnatal growth retardation|MP:0004953,decreased spleen weight|MP:0005015,increased T cell number|MP:0008111,abnormal granulocyte differentiation|MP:0011100,preweaning lethality, complete penetrance
MGI:5785045	Nras<tm1b(EUCOMM)Hmgu>	MP:0001556,increased circulating HDL cholesterol level|MP:0002764,short tibia|MP:0005559,increased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance
MGI:3794957	Nras<tm1Mok>	MP:0002169,no abnormal phenotype detected|MP:0012080,chylous ascites
MGI:2385944	Nras<tm1Rak>	MP:0002169,no abnormal phenotype detected
MGI:3775824	Nras<tm1Tyj>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000280,thin ventricular wall|MP:0000284,double outlet right ventricle|MP:0000438,abnormal cranium morphology|MP:0000601,small liver|MP:0000691,enlarged spleen|MP:0000745,tremors|MP:0001188,hyperpigmentation|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0001654,hepatic necrosis|MP:0002006,neoplasm|MP:0002060,abnormal skin morphology|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002192,hydrops fetalis|MP:0002652,thin myocardium|MP:0002738,hyperresponsive to tactile stimuli|MP:0002877,abnormal melanocyte morphology|MP:0003135,increased erythroid progenitor cell number|MP:0003717,pallor|MP:0004200,decreased fetal size|MP:0004809,increased hematopoietic stem cell number|MP:0004924,abnormal behavior|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0006128,pulmonary valve stenosis|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009391,abnormal leptomeninges pigmentation|MP:0010275,increased melanoma incidence|MP:0010336,increased acute lymphoblastic leukemia incidence|MP:0010373,myeloid hyperplasia|MP:0010402,ventricular septal defect|MP:0010556,thin ventricle myocardium compact layer|MP:0010741,abnormal melanocyte proliferation|MP:0010768,mortality/aging|MP:0011091,prenatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011246,abnormal fetal liver hematopoietic progenitor cell morphology|MP:0014518,myocardial hypertrabeculation|MP:0031555,abnormal pulmonary valve development
MGI:5142507	Nras<tm1Zhng>	MP:0002006,neoplasm
MGI:5502421	Nras<tm3Emfu>	MP:0002169,no abnormal phenotype detected
MGI:5502423	Nras<tm4Emfu>	MP:0002169,no abnormal phenotype detected
MGI:3923820	Nrbf2<Gt(Ayu21-W143)Imeg>	MP:0000598,abnormal liver morphology|MP:0001656,focal hepatic necrosis|MP:0003887,increased hepatocyte apoptosis|MP:0008943,increased sensitivity to induced cell death|MP:0010768,mortality/aging|MP:0030939,abnormal autophagosome formation|MP:0030940,impaired autophagy
MGI:5427569	Nrbp1<tm1.1Dja>	MP:0000477,abnormal intestine morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000598,abnormal liver morphology|MP:0002020,increased tumor incidence|MP:0002026,increased leukemia incidence|MP:0003288,intestinal edema|MP:0003449,abnormal intestine goblet cell morphology|MP:0008714,increased lung carcinoma incidence|MP:0008883,abnormal enterocyte proliferation|MP:0009511,distended stomach|MP:0010279,increased gastrointestinal tumor incidence|MP:0010802,abnormal intestinal enteroendocrine cell morphology|MP:0012431,increased lymphoma incidence|MP:0014077,ectopic Paneth cells|MP:0014237,decreased tumor-free survival time
MGI:5427570	Nrbp1<tm1.2Dja>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5637124	Nrbp1<tm3b(EUCOMM)Wtsi>	MP:0001711,abnormal placenta morphology|MP:0002836,abnormal chorion morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010052,increased grip strength|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:4361555	Nrcam<20884>	MP:0003631,nervous system phenotype|MP:0008814,decreased nerve conduction velocity|MP:0010053,decreased grip strength
MGI:5444298	Nrcam<m1J>	MP:0000920,abnormal myelination|MP:0001405,impaired coordination|MP:0003631,nervous system phenotype|MP:0008814,decreased nerve conduction velocity|MP:0010559,heart block|MP:0010732,abnormal node of Ranvier morphology
MGI:2179756	Nrcam<tm1Fgr>	MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0002579,disorganized secondary lens fibers|MP:0010254,nuclear cataract
MGI:2387976	Nrcam<tm1Gmt>	MP:0000852,small cerebellum|MP:0001360,abnormal social investigation|MP:0001463,abnormal spatial learning|MP:0002063,abnormal learning/memory/conditioning|MP:0002757,decreased vertical activity|MP:0002804,abnormal motor learning|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0005404,abnormal axon morphology|MP:0008415,abnormal neurite morphology|MP:0009142,decreased prepulse inhibition
MGI:5488665	Nrcam<tm2e.1(KOMP)Wtsi>	MP:0000947,convulsive seizures|MP:0001513,limb grasping|MP:0013279,increased fasting circulating glucose level
MGI:4415719	Nrdc<tm1Eiin>	MP:0000788,abnormal cerebral cortex morphology|MP:0000920,abnormal myelination|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002175,decreased brain weight|MP:0002651,abnormal sciatic nerve morphology|MP:0003871,abnormal myelin sheath morphology|MP:0005404,abnormal axon morphology|MP:0006254,thin cerebral cortex|MP:0008428,abnormal spatial working memory|MP:0008535,enlarged lateral ventricles|MP:0009674,decreased birth weight|MP:0010053,decreased grip strength|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4843855	Nrde2<tm2a(KOMP)Wtsi>	MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:4353245	Nrep<tm1Wcw>	MP:0001440,abnormal grooming behavior|MP:0001460,abnormal olfactory discrimination memory|MP:0001463,abnormal spatial learning|MP:0001516,abnormal motor coordination/balance|MP:0001522,impaired swimming|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002969,impaired social transmission of food preference|MP:0009454,impaired contextual conditioning behavior
MGI:6272010	Nrf1<tm1c(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0002984,retina hypoplasia|MP:0003651,abnormal axon extension|MP:0003727,abnormal retina layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006069,abnormal retina neuronal layer morphology|MP:0006071,abnormal retina progenitor cell morphology|MP:0006309,decreased retina ganglion cell number|MP:0008446,decreased retina cone cell number|MP:0008451,retina rod cell degeneration|MP:0008453,decreased retina rod cell number|MP:0008507,thin retina ganglion layer|MP:0008510,absent retina ganglion layer|MP:0008515,thin retina outer nuclear layer|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment|MP:0011628,increased mitochondrial number|MP:0011631,decreased mitochondrial size|MP:0011965,decreased total retina thickness
MGI:2385947	Nrf1<tm1Rcs>	MP:0000352,decreased cell proliferation|MP:0006035,abnormal mitochondrial morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5285952	Nrg1<m1Yzcm>	MP:0001322,abnormal iris morphology|MP:0002546,mydriasis|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1928489	Nrg1<tm1Cbm>	MP:0000274,enlarged heart|MP:0000291,enlarged pericardium|MP:0000295,trabecula carnea hypoplasia|MP:0000299,failure of atrioventricular cushion closure|MP:0000920,abnormal myelination|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001056,abnormal cranial nerve morphology|MP:0001066,absent trigeminal nerve|MP:0001081,abnormal cranial ganglia morphology|MP:0001085,small petrosal ganglion|MP:0001088,small nodose ganglion|MP:0001101,abnormal superior vagus ganglion morphology|MP:0001263,weight loss|MP:0001544,abnormal cardiovascular system physiology|MP:0001636,irregular heartbeat|MP:0002834,decreased heart weight|MP:0002950,abnormal neural crest cell migration|MP:0003647,absent oligodendrocytes|MP:0004075,decreased Schwann cell precursor number|MP:0005294,abnormal heart ventricle morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005403,abnormal nerve conduction|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014119,abnormal mandibular nerve innervation pattern|MP:0020388,decreased radial glial cell number|MP:0031633,decreased heart left ventricle muscle contractility
MGI:2448075	Nrg1<tm1Fej>	MP:0001106,abnormal Schwann cell morphology|MP:0003631,nervous system phenotype|MP:0006269,abnormal mammary gland growth during pregnancy
MGI:1928825	Nrg1<tm1Gne>	MP:0000274,enlarged heart|MP:0000280,thin ventricular wall|MP:0000296,absent trabeculae carneae|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0001067,absent mandibular nerve|MP:0001076,abnormal hypoglossal nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001084,abnormal petrosal ganglion morphology|MP:0001088,small nodose ganglion|MP:0001399,hyperactivity|MP:0001633,poor circulation|MP:0001636,irregular heartbeat|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003008,enhanced long-term potentiation|MP:0003312,abnormal locomotor coordination|MP:0003993,abnormal ventral spinal root morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1928491	Nrg1<tm1Leth>	MP:0000295,trabecula carnea hypoplasia|MP:0000297,abnormal atrioventricular cushion morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001068,abnormal mandibular nerve branching|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001730,embryonic growth arrest|MP:0002913,abnormal PNS synaptic transmission|MP:0002914,abnormal endplate potential|MP:0003393,decreased cardiac output|MP:0003631,nervous system phenotype|MP:0004835,abnormal miniature endplate potential|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0008022,dilated heart ventricle|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3604407	Nrg1<tm1Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:1928831	Nrg1<tm1Lwr>	MP:0000761,thin diaphragm muscle|MP:0000920,abnormal myelination|MP:0000939,decreased motor neuron number|MP:0000940,abnormal motor neuron innervation pattern|MP:0000964,small dorsal root ganglion|MP:0000966,decreased sensory neuron number|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001056,abnormal cranial nerve morphology|MP:0001077,abnormal spinal nerve morphology|MP:0001078,abnormal phrenic nerve morphology|MP:0001080,defasiculated phrenic nerve|MP:0001081,abnormal cranial ganglia morphology|MP:0001107,decreased Schwann cell number|MP:0001108,absent Schwann cells|MP:0001404,no spontaneous movement|MP:0001491,unresponsive to tactile stimuli|MP:0001506,limp posture|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002280,abnormal intercostal muscle morphology|MP:0005369,muscle phenotype|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0011087,neonatal lethality, complete penetrance
MGI:5292107	Nrg1<tm1Sabe>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0003698,abnormal male reproductive system physiology|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0008280,abnormal male germ cell apoptosis
MGI:1928830	Nrg1<tm1Zhou>	MP:0000295,trabecula carnea hypoplasia|MP:0001065,abnormal trigeminal nerve morphology|MP:0001068,abnormal mandibular nerve branching|MP:0001081,abnormal cranial ganglia morphology|MP:0001085,small petrosal ganglion|MP:0001088,small nodose ganglion|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001636,irregular heartbeat|MP:0005333,decreased heart rate|MP:0005385,cardiovascular system phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1928490	Nrg1<tm2Cbm>	MP:0000274,enlarged heart|MP:0000291,enlarged pericardium|MP:0000295,trabecula carnea hypoplasia|MP:0000299,failure of atrioventricular cushion closure|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001056,abnormal cranial nerve morphology|MP:0001066,absent trigeminal nerve|MP:0001081,abnormal cranial ganglia morphology|MP:0001085,small petrosal ganglion|MP:0001088,small nodose ganglion|MP:0001101,abnormal superior vagus ganglion morphology|MP:0001107,decreased Schwann cell number|MP:0001636,irregular heartbeat|MP:0002950,abnormal neural crest cell migration|MP:0003631,nervous system phenotype|MP:0004075,decreased Schwann cell precursor number|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014119,abnormal mandibular nerve innervation pattern
MGI:2448078	Nrg1<tm2Zhou>	MP:0000266,abnormal heart morphology|MP:0001399,hyperactivity|MP:0003088,abnormal prepulse inhibition|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2447761	Nrg1<tm3Cbm>	MP:0001405,impaired coordination|MP:0004069,abnormal muscle spindle morphology|MP:0008486,decreased muscle spindle number
MGI:5524248	Nrg1<tm4.1Cbm>	MP:0008486,decreased muscle spindle number
MGI:3055488	Nrg2<tm1Bus>	MP:0001262,decreased body weight|MP:0001935,decreased litter size|MP:0002082,postnatal lethality
MGI:1889610	Nrg3<ska>	MP:0000628,abnormal mammary gland development|MP:0000629,absent mammary gland|MP:0009720,abnormal mammary gland pattern|MP:0009721,increased mammary gland number|MP:0009722,abnormal nipple development|MP:0009723,increased nipple number|MP:0009724,ectopic nipples|MP:0009741,ectopic mammary gland
MGI:6277991	Nrg3<tm1.1Plet>	MP:0001415,increased exploration in new environment|MP:0002635,reduced sensorimotor gating|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0009142,decreased prepulse inhibition|MP:0009456,impaired cued conditioning behavior
MGI:3530094	Nrg4<Gt(OST98495)Lex>	MP:0002169,no abnormal phenotype detected
MGI:6386306	Nrgn<em1(IMPC)H>	MP:0001392,abnormal locomotor behavior|MP:0002965,increased circulating serum albumin level|MP:0008805,decreased circulating amylase level
MGI:1927195	Nrgn<tm1Kph>	MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001900,impaired synaptic plasticity|MP:0002207,abnormal long-term potentiation
MGI:3628817	Nrgn<tm1Sut>	MP:0001898,abnormal long-term depression|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002923,increased post-tetanic potentiation|MP:0003008,enhanced long-term potentiation
MGI:2657149	Nrip1<tm1Mpk>	MP:0000496,abnormal small intestine morphology|MP:0001125,abnormal oocyte morphology|MP:0001265,decreased body size|MP:0001926,female infertility|MP:0001928,abnormal ovulation|MP:0002161,abnormal fertility/fecundity|MP:0004843,abnormal Paneth cell morphology|MP:0005164,abnormal response to injury|MP:0005379,endocrine/exocrine gland phenotype|MP:0008869,anovulation|MP:0008883,abnormal enterocyte proliferation|MP:0008885,increased enterocyte apoptosis|MP:0009648,abnormal superovulation|MP:0031420,decreased superovulation rate|MP:0031422,failure of superovulation
MGI:5292103	Nrk<tm1Mkom>	MP:0004260,enlarged placenta|MP:0004514,dystocia|MP:0004920,increased placenta weight|MP:0008028,pregnancy-related premature death|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012098,increased spongiotrophoblast size
MGI:5490568	Nrl<tm1.1Jcco>	MP:0001004,abnormal retina photoreceptor morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology
MGI:5285194	Nrl<tm1.1(Thrb)Df>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0005253,abnormal eye physiology|MP:0008445,increased retina cone cell number|MP:0008454,absent retina rod cells|MP:0008587,short photoreceptor outer segment
MGI:2152376	Nrl<tm1Asw>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001006,abnormal retina cone cell morphology|MP:0001325,abnormal retina morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005253,abnormal eye physiology|MP:0008444,retina cone cell degeneration|MP:0008445,increased retina cone cell number|MP:0008450,retina photoreceptor degeneration|MP:0012029,abnormal electroretinogram waveform feature|MP:0014645,decreased optokinetic reflex
MGI:5490567	Nrl<tm1Jcco>	MP:0001004,abnormal retina photoreceptor morphology|MP:0003631,nervous system phenotype|MP:0004021,abnormal rod electrophysiology|MP:0005253,abnormal eye physiology
MGI:4145374	Nrn1l<Gt(OST22693)Lex>	MP:0002169,no abnormal phenotype detected
MGI:5554940	Nrn1l<tm1.1(KOMP)Vlcg>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005560,decreased circulating glucose level
MGI:5307918	Nrn1<tm1.2Ndiv>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001463,abnormal spatial learning|MP:0002924,delayed CNS synapse formation|MP:0002946,delayed axon extension|MP:0003631,nervous system phenotype|MP:0003861,abnormal nervous system development|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004996,abnormal CNS synapse formation|MP:0008143,abnormal dendrite morphology|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0009538,abnormal synapse morphology|MP:0020551,abnormal postsynaptic density morphology
MGI:5288597	Nrp1<tm1.1Cruh>	MP:0005385,cardiovascular system phenotype|MP:0010098,abnormal retina blood vessel pattern
MGI:5588167	Nrp1<tm1.1Izac>	MP:0001265,decreased body size|MP:0002083,premature death|MP:0002792,abnormal retina vasculature morphology|MP:0003447,decreased tumor growth/size|MP:0003814,vascular smooth muscle hypoplasia|MP:0004111,abnormal coronary artery morphology|MP:0004950,abnormal brain vasculature morphology|MP:0005602,decreased angiogenesis|MP:0009660,abnormal induced retina neovascularization|MP:0010097,abnormal retina blood vessel morphology|MP:0010551,abnormal coronary vessel morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5793069	Nrp1<tm1b(EUCOMM)Hmgu>	MP:0004738,abnormal auditory brainstem response|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:3512099	Nrp1<tm1Ddg>	MP:0000780,abnormal corpus callosum morphology|MP:0000807,abnormal hippocampus morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001056,abnormal cranial nerve morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0001072,abnormal vestibulocochlear nerve morphology|MP:0001077,abnormal spinal nerve morphology|MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality|MP:0002376,abnormal dendritic cell physiology|MP:0002444,abnormal T cell physiology|MP:0003140,dilated heart atrium|MP:0005391,vision/eye phenotype|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0014748,abnormal sensory neuron axon guidance
MGI:1857853	Nrp1<tm1Hfu>	MP:0000259,abnormal vascular development|MP:0000484,abnormal pulmonary artery morphology|MP:0000909,abnormal facial motor nucleus morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0001071,abnormal facial nerve morphology|MP:0001077,abnormal spinal nerve morphology|MP:0001723,disorganized yolk sac vascular plexus|MP:0002633,persistent truncus arteriosus|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0002961,abnormal axon guidance|MP:0003631,nervous system phenotype|MP:0004110,transposition of great arteries|MP:0004158,right aortic arch|MP:0004159,double aortic arch|MP:0004787,abnormal dorsal aorta morphology|MP:0005602,decreased angiogenesis|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0006355,abnormal sixth pharyngeal arch artery morphology|MP:0006356,abnormal third pharyngeal arch artery morphology|MP:0010355,abnormal first pharyngeal arch artery morphology|MP:0010356,abnormal second pharyngeal arch artery morphology|MP:0010464,abnormal aortic arch and aortic arch branch attachment|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014554,delayed neuronal migration
MGI:3512103	Nrp1<tm2.1Ddg>	MP:0001065,abnormal trigeminal nerve morphology|MP:0001077,abnormal spinal nerve morphology
MGI:3512101	Nrp1<tm2Ddg>	MP:0002127,abnormal cardiovascular system morphology|MP:0002633,persistent truncus arteriosus|MP:0010402,ventricular septal defect|MP:0010551,abnormal coronary vessel morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:1927804	Nrp2<Gt(GST039)Byg>	MP:0001061,abnormal oculomotor nerve morphology|MP:0001064,absent trochlear nerve|MP:0001065,abnormal trigeminal nerve morphology|MP:0003631,nervous system phenotype|MP:0004082,abnormal habenula morphology|MP:0008225,abnormal anterior commissure morphology|MP:0009677,abnormal spinal cord dorsal column morphology|MP:0010860,abnormal anterior commissure pars posterior morphology|MP:0014746,abnormal hippocampal mossy fiber innervation pattern
MGI:3712239	Nrp2<Gt(pMS-1)1Hmy>	MP:0001265,decreased body size|MP:0002184,abnormal innervation|MP:0003631,nervous system phenotype|MP:0011090,perinatal lethality, incomplete penetrance
MGI:2183904	Nrp2<tm1.2Mom>	MP:0000243,myoclonus|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001732,postnatal growth retardation|MP:0001879,abnormal lymphatic vessel morphology|MP:0001891,hydrocephaly|MP:0001921,reduced fertility|MP:0002064,seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002961,abnormal axon guidance|MP:0004106,lymphatic vessel hyperplasia|MP:0004859,abnormal synaptic plasticity|MP:0008143,abnormal dendrite morphology|MP:0009358,environmentally induced seizures|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009936,abnormal dendritic spine morphology|MP:0009939,abnormal hippocampus neuron morphology|MP:0010197,abnormal lymphatic vessel endothelial cell morphology|MP:0010368,abnormal lymphatic system physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011678,abnormal vomeronasal sensory neuron physiology|MP:0011679,abnormal vomeronasal sensory neuron morphology|MP:0012014,abnormal olfactory neuron innervation pattern|MP:0014812,abnormal brain physiology
MGI:2137037	Nrp2<tm1Ddg>	MP:0000352,decreased cell proliferation|MP:0005391,vision/eye phenotype|MP:0008778,abnormal lymphangiogenesis
MGI:2183238	Nrp2<tm1Mkl>	MP:0003861,abnormal nervous system development|MP:0005380,embryo phenotype|MP:0006009,abnormal neuronal migration|MP:0010768,mortality/aging
MGI:5007223	Nrros<tm1Lex>	MP:0002409,decreased susceptibility to infection|MP:0003674,oxidative stress|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:6144005	Nrros<tm1Wouy>	MP:0003674,oxidative stress|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0009858,abnormal cellular extravasation
MGI:5614593	Nrsn1<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0004924,abnormal behavior|MP:0009142,decreased prepulse inhibition|MP:0013279,increased fasting circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:6336125	Nrsn2<em1(IMPC)Kmpc>	MP:0000194,increased circulating calcium level|MP:0000598,abnormal liver morphology|MP:0002339,abnormal lymph node morphology|MP:0008821,increased blood uric acid level|MP:0010067,increased red blood cell distribution width
MGI:2448936	Nrtn<tm1Jmi>	MP:0000740,impaired smooth muscle contractility|MP:0001037,abnormal parasympathetic neuron morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001168,abnormal prostate gland epithelium morphology|MP:0001313,increased incidence of corneal inflammation|MP:0001337,dry eyes|MP:0001344,blepharoptosis|MP:0001348,abnormal lacrimal gland physiology|MP:0001993,abnormal blinking|MP:0002092,abnormal eye morphology|MP:0003290,intestinal hypoperistalsis|MP:0004990,abnormal ciliary ganglion morphology|MP:0005253,abnormal eye physiology|MP:0005445,abnormal neurotransmitter secretion|MP:0006000,abnormal cornea epithelium morphology|MP:0006162,thick eyelids|MP:0006198,enophthalmos|MP:0008313,abnormal parasympathetic postganglionic fiber morphology|MP:0008315,abnormal otic ganglion morphology|MP:0012164,abnormal conjunctiva goblet cell morphology|MP:0013466,keratoconjunctivitis sicca|MP:0014149,abnormal lacrimal gland innervation pattern|MP:0020220,decreased tear production|MP:0020854,increased cornea epithelium thickness
MGI:5636923	Nrxn1<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000745,tremors|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0005016,decreased lymphocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0005574,decreased pulmonary respiratory rate|MP:0008806,increased circulating amylase level|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010067,increased red blood cell distribution width|MP:0013278,decreased fasting circulating glucose level
MGI:3042794	Nrxn1<tm1Sud>	MP:0001441,increased grooming behavior|MP:0001447,abnormal nest building behavior|MP:0002804,abnormal motor learning|MP:0002910,abnormal excitatory postsynaptic currents|MP:0004495,decreased synaptic glutamate release|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005386,behavior/neurological phenotype|MP:0009142,decreased prepulse inhibition|MP:0014812,abnormal brain physiology
MGI:3797417	Nrxn1<tm2Sud>	MP:0002169,no abnormal phenotype detected
MGI:5468258	Nrxn1<tm3Sud>	MP:0002169,no abnormal phenotype detected
MGI:5605040	Nrxn1<tm5Sud>	MP:0002169,no abnormal phenotype detected
MGI:6149205	Nrxn2<em1(IMPC)H>	MP:0000274,enlarged heart|MP:0000745,tremors|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001512,trunk curl|MP:0001552,increased circulating triglyceride level|MP:0003960,increased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0005565,increased blood urea nitrogen level|MP:0005568,increased circulating total protein level
MGI:3042719	Nrxn2<tm1Sud>	MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0002574,increased vertical activity|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype
MGI:3797418	Nrxn2<tm2Sud>	MP:0002169,no abnormal phenotype detected
MGI:3820412	Nrxn2<tm3Sud>	MP:0001262,decreased body weight|MP:0002082,postnatal lethality|MP:0002945,abnormal inhibitory postsynaptic currents
MGI:5605009	Nrxn2<tm4Sud>	MP:0002169,no abnormal phenotype detected
MGI:3042720	Nrxn3<tm1Sud>	MP:0011086,postnatal lethality, incomplete penetrance
MGI:3797484	Nrxn3<tm2Sud>	MP:0002169,no abnormal phenotype detected
MGI:4946102	Nrxn3<tm4.1Sud>	MP:0001473,reduced long-term potentiation|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0009538,abnormal synapse morphology|MP:0020551,abnormal postsynaptic density morphology
MGI:6276940	Nsa2<em1(IMPC)Mbp>	MP:0001785,edema|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:2667262	Nsd1<tm1.1Pcn>	MP:0001683,absent mesoderm|MP:0002084,abnormal developmental patterning|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002174,abnormal gastrulation movements|MP:0002231,abnormal primitive streak morphology|MP:0003085,abnormal egg cylinder morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0009266,abnormal mesendoderm development|MP:0009331,absent primitive node|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3851507	Nsd2<tm1Ykan>	MP:0000111,cleft palate|MP:0000120,malocclusion|MP:0000282,abnormal interatrial septum morphology|MP:0001732,postnatal growth retardation|MP:0004200,decreased fetal size|MP:0008277,abnormal sternum ossification|MP:0008278,failure of sternum ossification|MP:0010403,atrial septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:7643542	Nsd3<tm1.1Caox>	MP:0011079,decreased macrophage cytokine production|MP:0020913,increased susceptibility to Riboviria infection|MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality
MGI:5637114	Nsd3<tm1b(EUCOMM)Hmgu>	MP:0000443,abnormal snout morphology|MP:0000692,small spleen|MP:0000745,tremors|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0001512,trunk curl|MP:0002968,increased circulating alkaline phosphatase level|MP:0010024,increased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1857776	Nsdhl<Bpa-1H>	MP:0000367,abnormal coat/ hair morphology|MP:0000372,irregular coat pigmentation|MP:0000414,alopecia|MP:0000547,short limbs|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001304,cataract|MP:0001386,abnormal maternal nurturing|MP:0001511,disheveled coat|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0002111,abnormal tail morphology|MP:0002544,brachydactyly|MP:0002772,brachypodia|MP:0003417,premature endochondral bone ossification|MP:0003717,pallor|MP:0003809,abnormal hair shaft morphology|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004259,small placenta|MP:0006253,clinodactyly|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011523,thin placenta labyrinth|MP:0011527,disorganized placental labyrinth
MGI:1857777	Nsdhl<Bpa-3H>	MP:0000372,irregular coat pigmentation|MP:0000418,focal hair loss|MP:0001191,abnormal skin condition|MP:0001242,hyperkeratosis|MP:0004703,abnormal vertebral column morphology|MP:0005508,abnormal skeleton morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:3587827	Nsdhl<Bpa-4H>	MP:0000414,alopecia|MP:0004703,abnormal vertebral column morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:1857778	Nsdhl<Bpa-5H>	MP:0000372,irregular coat pigmentation|MP:0000418,focal hair loss|MP:0001242,hyperkeratosis|MP:0001265,decreased body size|MP:0004704,short vertebral column|MP:0005508,abnormal skeleton morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:1857779	Nsdhl<Bpa-6H>	MP:0000372,irregular coat pigmentation|MP:0000418,focal hair loss|MP:0001242,hyperkeratosis|MP:0005508,abnormal skeleton morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:3587790	Nsdhl<Bpa-7H>	MP:0000414,alopecia|MP:0001191,abnormal skin condition|MP:0001242,hyperkeratosis|MP:0002080,prenatal lethality
MGI:1862021	Nsdhl<Bpa-8H>	MP:0000372,irregular coat pigmentation|MP:0000414,alopecia|MP:0000783,abnormal forebrain morphology|MP:0001191,abnormal skin condition|MP:0001242,hyperkeratosis|MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0001722,pale yolk sac|MP:0001914,hemorrhage|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004259,small placenta|MP:0005312,pericardial effusion|MP:0011091,prenatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011523,thin placenta labyrinth|MP:0011527,disorganized placental labyrinth
MGI:1857780	Nsdhl<Str-1H>	MP:0000160,kyphosis|MP:0000372,irregular coat pigmentation|MP:0000397,abnormal guard hair morphology|MP:0000405,abnormal auchene hair morphology|MP:0000417,short hair|MP:0000674,abnormal sweat gland morphology|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0001722,pale yolk sac|MP:0001914,hemorrhage|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004259,small placenta|MP:0005312,pericardial effusion|MP:0010768,mortality/aging|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011523,thin placenta labyrinth|MP:0011527,disorganized placental labyrinth
MGI:1857781	Nsdhl<Str-1Or>	MP:0000367,abnormal coat/ hair morphology|MP:0000372,irregular coat pigmentation|MP:0002940,variable body spotting|MP:0004259,small placenta|MP:0011091,prenatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1857782	Nsdhl<Str-2H>	MP:0000372,irregular coat pigmentation|MP:0002940,variable body spotting|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5581334	Nsdhl<tm1.1Hrm>	MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000852,small cerebellum|MP:0000873,thin external granule cell layer|MP:0001242,hyperkeratosis|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001732,postnatal growth retardation|MP:0002073,abnormal hair growth|MP:0002083,premature death|MP:0004098,abnormal cerebellar granule cell morphology|MP:0005508,abnormal skeleton morphology|MP:0008283,small hippocampus|MP:0008415,abnormal neurite morphology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008924,decreased cerebellar granule cell number|MP:0009938,abnormal hippocampus granule cell morphology|MP:0009939,abnormal hippocampus neuron morphology|MP:0010387,abnormal Bergmann glial cell morphology|MP:0012204,abnormal neuronal stem cell physiology
MGI:2671808	nse1	MP:0001340,abnormal eyelid morphology
MGI:2671809	nse2	MP:0001297,microphthalmia
MGI:5446014	Nsf<tm1b(KOMP)Mbp>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001325,abnormal retina morphology|MP:0005560,decreased circulating glucose level|MP:0005564,increased hemoglobin content|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0020870,decreased thigmotaxis
MGI:7531287	Nsf<tm1Himat>	MP:0001363,increased anxiety-related response|MP:0001475,reduced long-term depression|MP:0002574,increased vertical activity|MP:0011092,embryonic lethality, complete penetrance|MP:0020351,decreased vocalization|MP:0020551,abnormal postsynaptic density morphology|MP:0021111,decreased social investigation
MGI:5695882	Nsg1<tm1.1(KOMP)Vlcg>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0002599,increased mean platelet volume|MP:0002606,increased basophil cell number|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0006203,eye hemorrhage
MGI:7425879	Nsg2<em1(IMPC)Kmpc>	MP:0001399,hyperactivity|MP:0002965,increased circulating serum albumin level|MP:0009455,enhanced cued conditioning behavior
MGI:3580577	Nsila10<A/J>	MP:0001364,decreased anxiety-related response
MGI:3580560	Nsila1<C57BL/6J>	MP:0001364,decreased anxiety-related response
MGI:3580562	Nsila2<C57BL/6J>	MP:0001364,decreased anxiety-related response
MGI:3580563	Nsila3<A/J>	MP:0001364,decreased anxiety-related response
MGI:3580566	Nsila4<C57BL/6J>	MP:0001364,decreased anxiety-related response
MGI:3580568	Nsila5<C57BL/6J>	MP:0001364,decreased anxiety-related response
MGI:3580570	Nsila6<C57BL/6J>	MP:0001364,decreased anxiety-related response
MGI:3580571	Nsila7<A/J>	MP:0001364,decreased anxiety-related response
MGI:3580573	Nsila8<A/J>	MP:0001364,decreased anxiety-related response
MGI:3580575	Nsila9<A/J>	MP:0001364,decreased anxiety-related response
MGI:3580576	Nsila9<C57BL/6J>	MP:0001364,decreased anxiety-related response
MGI:6317375	Nsl1<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0000221,decreased leukocyte cell number|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0012129,failure of blastocyst formation|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:2386083	Nsmaf<tm1Mkr>	MP:0002444,abnormal T cell physiology|MP:0002796,impaired skin barrier function|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008734,decreased susceptibility to endotoxin shock
MGI:6153567	Nsmce1<em1(IMPC)Wtsi>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001120,abnormal uterus morphology|MP:0001325,abnormal retina morphology|MP:0001552,increased circulating triglyceride level|MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0005568,increased circulating total protein level|MP:0009709,hydrometra|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6257714	Nsmce2<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001718,abnormal visceral yolk sac morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4331032	Nsmce2<Gt(AA0032)Wtsi>	MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0003111,abnormal cell nucleus morphology|MP:0003701,elevated level of mitotic sister chromatid exchange|MP:0003702,abnormal chromosome morphology|MP:0003707,increased cell nucleus count|MP:0003902,abnormal cell mass|MP:0004046,abnormal mitosis|MP:0006204,embryonic lethality before implantation|MP:0008019,increased liver tumor incidence|MP:0009153,increased pancreas tumor incidence|MP:0009321,increased histiocytic sarcoma incidence|MP:0010291,increased cardiovascular system tumor incidence|MP:0012431,increased lymphoma incidence|MP:0031678,increased micronucleus incidence
MGI:5906663	Nsmce2<tm1.1Ofc>	MP:0002169,no abnormal phenotype detected
MGI:5906664	Nsmce2<tm2.1Ofc>	MP:0000488,abnormal intestinal epithelium morphology|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0002095,abnormal skin pigmentation|MP:0003701,elevated level of mitotic sister chromatid exchange|MP:0003763,abnormal thymus physiology|MP:0003786,premature aging|MP:0004046,abnormal mitosis|MP:0009567,mitotic nondisjunction|MP:0010025,decreased total body fat amount|MP:0031678,increased micronucleus incidence
MGI:6358416	Nsmf<tm1.2Mrkr>	MP:0000807,abnormal hippocampus morphology|MP:0001458,abnormal object recognition memory|MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002184,abnormal innervation|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003867,increased defecation amount|MP:0004077,abnormal striatum morphology|MP:0005181,decreased circulating estradiol level|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0005394,taste/olfaction phenotype|MP:0008143,abnormal dendrite morphology|MP:0009012,short diestrus|MP:0009020,prolonged metestrus|MP:0009454,impaired contextual conditioning behavior|MP:0009538,abnormal synapse morphology|MP:0011125,decreased primary ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0020508,decreased dendritic spine density|MP:0031381,decreased secondary ovarian follicle number|MP:0031391,increased locomotor activity
MGI:4363881	Nsmf<tm1a(KOMP)Wtsi>	MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0001938,delayed sexual maturation|MP:0002636,delayed vaginal opening|MP:0003631,nervous system phenotype|MP:0004856,decreased ovary weight|MP:0004905,decreased uterus weight|MP:0005389,reproductive system phenotype|MP:0005561,increased mean corpuscular hemoglobin|MP:0008335,decreased gonadotroph cell number
MGI:7490174	Nsrp1<em1(IMPC)Mbp>	MP:0000198,decreased circulating phosphate level|MP:0001325,abnormal retina morphology|MP:0002060,abnormal skin morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3923407	Nsrp1<Gt(Ayu21-T93)Imeg>	MP:0011092,embryonic lethality, complete penetrance
MGI:6759471	Nsrp1<tm1.1Cdj>	MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0006387,abnormal T cell number|MP:0006413,increased T cell apoptosis|MP:0008049,increased memory T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010768,mortality/aging
MGI:2176548	Nss1<NOD/ShiLtJ>	MP:0001870,salivary gland inflammation
MGI:3873208	Nsun2<Gt(D014D11)Wrst>	MP:0000414,alopecia|MP:0000427,abnormal hair cycle|MP:0001265,decreased body size|MP:0001925,male infertility|MP:0008858,abnormal hair cycle anagen phase
MGI:4432654	Nsun2<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000150,abnormal rib morphology|MP:0000160,kyphosis|MP:0000162,lordosis|MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000427,abnormal hair cycle|MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0000609,abnormal liver physiology|MP:0000783,abnormal forebrain morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001015,small superior cervical ganglion|MP:0001146,abnormal testis morphology|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001312,abnormal cornea morphology|MP:0001349,excessive tearing|MP:0001399,hyperactivity|MP:0001510,abnormal coat appearance|MP:0001511,disheveled coat|MP:0001925,male infertility|MP:0002100,abnormal tooth morphology|MP:0002161,abnormal fertility/fecundity|MP:0002368,abnormal thymus capsule morphology|MP:0002591,decreased mean corpuscular volume|MP:0002687,oligozoospermia|MP:0002702,decreased circulating free fatty acids level|MP:0002932,abnormal joint morphology|MP:0003131,increased erythrocyte cell number|MP:0003442,decreased circulating glycerol level|MP:0003686,abnormal eye muscle morphology|MP:0003961,decreased lean body mass|MP:0004160,retroesophageal right subclavian artery|MP:0004174,abnormal spine curvature|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0004353,abnormal deltoid tuberosity morphology|MP:0004463,basisphenoid bone foramen|MP:0004613,fusion of vertebral arches|MP:0004666,absent stapedial artery|MP:0004686,decreased length of long bones|MP:0004889,increased energy expenditure|MP:0004890,decreased energy expenditure|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005296,abnormal humerus morphology|MP:0005459,decreased percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008805,decreased circulating amylase level|MP:0008858,abnormal hair cycle anagen phase|MP:0008861,abnormal hair shedding|MP:0008923,thoracoschisis|MP:0008963,increased carbon dioxide production|MP:0009770,abnormal optic chiasm morphology|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0010831,lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011655,abnormal systemic artery morphology|MP:0013600,testis degeneration|MP:0013826,absent hypoglossal canal|MP:0013834,thin hypoglossal nerve|MP:0013835,absent hypoglossal nerve|MP:0013836,abnormal hypoglossal nerve topology|MP:0013840,absent segment of posterior cerebral artery|MP:0013842,ductus venosus stenosis|MP:0013848,subcutaneous edema|MP:0013875,increased trigeminal neuroma incidence|MP:0013876,absent ductus venosus valve|MP:0013877,abnormal ductus venosus valve morphology|MP:0013928,thin motoric part of trigeminal nerve|MP:0013948,intraembryonal intestine elongation|MP:0013967,abnormal infrahyoid muscle connection|MP:0013969,reduced sympathetic cervical ganglion size|MP:0013992,persistent dorsal ophthalmic artery|MP:0013995,abnormal external carotid artery origin|MP:0014001,abnormal vertebral artery topology|MP:0020500,persistent trigeminal artery
MGI:5310947	Nsun2<tm1c(EUCOMM)Wtsi>	MP:0008858,abnormal hair cycle anagen phase
MGI:7718594	Nsun3<tm1.1Tomik>	MP:0000274,enlarged heart|MP:0001544,abnormal cardiovascular system physiology|MP:0002833,increased heart weight|MP:0005599,increased cardiac muscle contractility|MP:0006036,abnormal mitochondrial physiology|MP:0011925,abnormal heart echocardiography feature|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:7718595	Nsun3<tm1.2Tomik>	MP:0001698,decreased embryo size|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5618266	Nsun4<tm1.2Arte>	MP:0002083,premature death|MP:0002833,increased heart weight|MP:0003984,embryonic growth retardation|MP:0006036,abnormal mitochondrial physiology|MP:0010959,abnormal oxidative phosphorylation|MP:0011092,embryonic lethality, complete penetrance|MP:0030937,increased mitochondrial DNA content
MGI:6294475	Nsun5<em1Lgch>	MP:0000812,abnormal dentate gyrus morphology|MP:0001473,reduced long-term potentiation|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0008428,abnormal spatial working memory|MP:0012307,impaired spatial learning
MGI:5635257	Nsun5<tm2b(EUCOMM)Wtsi>	MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0001402,decreased locomotor activity|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0003179,thrombocytopenia|MP:0004924,abnormal behavior|MP:0004953,decreased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0006243,impaired pupillary reflex|MP:0010392,prolonged QRS complex duration|MP:0013279,increased fasting circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:4435545	Nsun6<tm1a(EUCOMM)Hmgu>	MP:0002169,no abnormal phenotype detected
MGI:3720682	Nsun7<Ste5Jcs1>	MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002674,abnormal sperm motility|MP:0002675,asthenozoospermia|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology
MGI:2154485	Nsv1<C57BL/6J>	MP:0002418,increased susceptibility to viral infection
MGI:1857804	nt	MP:0000822,abnormal brain ventricle morphology|MP:0000926,absent floor plate|MP:0000929,open neural tube|MP:0001689,incomplete somite formation|MP:0001691,abnormal somite shape|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0002621,delayed neural tube closure|MP:0002824,abnormal chorioallantoic fusion|MP:0002861,abnormal tail bud morphology|MP:0004252,abnormal direction of heart looping|MP:0004712,notochord degeneration|MP:0005312,pericardial effusion|MP:0006346,small pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011732,decreased somite size|MP:0012062,small tail bud|MP:0030249,small frontonasal prominence
MGI:6368538	Nt5c1a<tm1.1Mhrd>	MP:0003806,abnormal nucleotide metabolism
MGI:7641911	Nt5c1b<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5635258	Nt5c1b<tm1b(KOMP)Wtsi>	MP:0005293,impaired glucose tolerance|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:6273967	Nt5c2<em1(IMPC)Hmgu>	MP:0000598,abnormal liver morphology|MP:0001489,decreased startle reflex|MP:0002135,abnormal kidney morphology
MGI:6147342	Nt5c2<tm1.1Aafo>	MP:0009278,abnormal bone marrow cell physiology
MGI:6368539	Nt5c2<tm1.1Mhrd>	MP:0002169,no abnormal phenotype detected
MGI:6432324	Nt5c3<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000702,enlarged lymph nodes|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002590,increased mean corpuscular volume|MP:0010067,increased red blood cell distribution width
MGI:5649018	Nt5dc1<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0001363,increased anxiety-related response|MP:0001486,abnormal startle reflex|MP:0002075,abnormal coat/hair pigmentation|MP:0005560,decreased circulating glucose level
MGI:5902345	Nt5dc2<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0000572,abnormal autopod morphology|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002110,abnormal digit morphology|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0010053,decreased grip strength
MGI:5901849	Nt5dc3<em1(IMPC)J>	MP:0013278,decreased fasting circulating glucose level
MGI:6449045	Nt5e<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001304,cataract|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0009552,urinary bladder obstruction
MGI:4363980	Nt5el<tm1a(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:3054787	Nt5e<tm1Jgsc>	MP:0002968,increased circulating alkaline phosphatase level|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005529,abnormal renal vascular resistance
MGI:3609975	Nt5e<tm1Jsc>	MP:0003023,decreased coronary flow rate|MP:0005464,abnormal platelet physiology|MP:0005607,decreased bleeding time|MP:0031121,increased susceptibility to induced thrombosis
MGI:3522017	Nt5e<tm1Lft>	MP:0000343,abnormal response to cardiac infarction|MP:0001357,increased aggression towards humans|MP:0001785,edema|MP:0003037,increased myocardial infarct size|MP:0003070,increased vascular permeability|MP:0003195,calcinosis|MP:0003196,calcified skin|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005202,lethargy|MP:0030533,abnormal snout skin morphology
MGI:2449464	Ntan1<tm1Avar>	MP:0001363,increased anxiety-related response|MP:0001413,abnormal response to new environment|MP:0001463,abnormal spatial learning|MP:0002083,premature death|MP:0002444,abnormal T cell physiology|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002798,abnormal active avoidance behavior|MP:0005088,increased acute inflammation|MP:0005156,bradykinesia|MP:0008432,abnormal long-term spatial reference memory|MP:0008770,decreased survivor rate|MP:0009335,decreased splenocyte proliferation
MGI:5240806	Ntaq1<Gt(IST14542A4)Tigm>	MP:0004924,abnormal behavior
MGI:5749452	Ntaq1<tm1.1(KOMP)Vlcg>	MP:0000218,increased leukocyte cell number|MP:0002591,decreased mean corpuscular volume|MP:0002941,increased circulating alanine transaminase level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0006243,impaired pupillary reflex|MP:0010053,decreased grip strength
MGI:5559188	Ntf3<tm1.1Eafx>	MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0001732,postnatal growth retardation
MGI:2152961	Ntf3<tm1(Bdnf)Tes>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0000965,abnormal sensory neuron morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001504,abnormal posture|MP:0001516,abnormal motor coordination/balance|MP:0002184,abnormal innervation|MP:0003631,nervous system phenotype|MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0008467,absent proprioceptive neurons|MP:0008468,absent muscle spindles|MP:0008948,decreased neuron number
MGI:2653300	Ntf3<tm1Esm>	MP:0000778,abnormal nervous system tract morphology|MP:0002090,abnormal vision|MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0004998,decreased CNS synapse formation
MGI:1857232	Ntf3<tm1Jae>	MP:0000907,small mesencephalic trigeminal nucleus|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000964,small dorsal root ganglion|MP:0000966,decreased sensory neuron number|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001000,absent golgi tendon organ|MP:0001015,small superior cervical ganglion|MP:0001017,abnormal stellate ganglion morphology|MP:0001052,abnormal innervation pattern to muscle|MP:0001088,small nodose ganglion|MP:0001093,small trigeminal ganglion|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001524,impaired limb coordination|MP:0001544,abnormal cardiovascular system physiology|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002108,abnormal muscle morphology|MP:0003964,abnormal noradrenaline level|MP:0004297,abnormal proprioceptive neuron morphology|MP:0005333,decreased heart rate|MP:0008467,absent proprioceptive neurons|MP:0008468,absent muscle spindles|MP:0011085,postnatal lethality, complete penetrance
MGI:1933843	Ntf3<tm1Lfr>	MP:0000907,small mesencephalic trigeminal nucleus|MP:0000939,decreased motor neuron number|MP:0000964,small dorsal root ganglion|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001015,small superior cervical ganglion|MP:0001024,small L5 dorsal root ganglion|MP:0001081,abnormal cranial ganglia morphology|MP:0001083,small geniculate ganglion|MP:0001093,small trigeminal ganglion|MP:0001402,decreased locomotor activity|MP:0001527,athetotic walking movements|MP:0003637,cochlear ganglion hypoplasia|MP:0004069,abnormal muscle spindle morphology|MP:0004263,abnormal limb posture|MP:0005449,abnormal food intake|MP:0008468,absent muscle spindles|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2388319	Ntf3<tm1Mpin>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0000973,abnormal cutaneous/subcutaneous mechanoreceptor morphology|MP:0000985,abnormal Merkel's receptor morphology|MP:0001393,ataxia|MP:0003631,nervous system phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:1933844	Ntf3<tm1Par>	MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000273,overriding aortic valve|MP:0000274,enlarged heart|MP:0000285,abnormal heart valve morphology|MP:0000956,decreased spinal cord size|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000964,small dorsal root ganglion|MP:0000966,decreased sensory neuron number|MP:0001015,small superior cervical ganglion|MP:0001021,small L4 dorsal root ganglion|MP:0001024,small L5 dorsal root ganglion|MP:0001083,small geniculate ganglion|MP:0001085,small petrosal ganglion|MP:0001088,small nodose ganglion|MP:0001093,small trigeminal ganglion|MP:0001262,decreased body weight|MP:0001504,abnormal posture|MP:0001614,abnormal blood vessel morphology|MP:0001625,cardiac hypertrophy|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002127,abnormal cardiovascular system morphology|MP:0002633,persistent truncus arteriosus|MP:0002726,abnormal pulmonary vein morphology|MP:0002745,abnormal atrioventricular valve morphology|MP:0002746,abnormal semilunar valve morphology|MP:0002752,abnormal somatic nervous system morphology|MP:0002754,dilated heart right ventricle|MP:0002976,vascular smooth muscle hypotrophy|MP:0003140,dilated heart atrium|MP:0003228,abnormal sinus venosus morphology|MP:0003279,aneurysm|MP:0003828,pulmonary edema|MP:0003986,small cochlear ganglion|MP:0004297,abnormal proprioceptive neuron morphology|MP:0005294,abnormal heart ventricle morphology|MP:0005333,decreased heart rate|MP:0006128,pulmonary valve stenosis|MP:0010224,abnormal heart ventricle outflow tract morphology|MP:0010405,ostium secundum atrial septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010440,anomalous pulmonary venous connection|MP:0010449,heart right ventricle outflow tract stenosis|MP:0010501,atrium myocardium hypoplasia|MP:0010557,dilated pulmonary artery|MP:0010558,sinus venosus hypoplasia|MP:0010563,increased heart right ventricle size|MP:0010576,premature closure of the ductus arteriosus|MP:0010578,abnormal heart left ventricle size|MP:0010581,abnormal atrium myocardial trabeculae morphology|MP:0010593,thick aortic valve cusps|MP:0010605,thick pulmonary valve cusps|MP:0010617,thick mitral valve cusps|MP:0010909,pulmonary alveolar hemorrhage|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:2180062	Ntf3<tm1Tojo>	MP:0000960,abnormal sensory ganglion morphology|MP:0000964,small dorsal root ganglion|MP:0001093,small trigeminal ganglion|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001436,abnormal suckling behavior|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0002269,muscular atrophy|MP:0003631,nervous system phenotype|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020863,abnormal suckling reflex
MGI:1861706	Ntf3<tm2Jae>	MP:0000857,abnormal cerebellar foliation|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001431,abnormal eating behavior|MP:0001504,abnormal posture|MP:0002169,no abnormal phenotype detected|MP:0002272,abnormal nervous system electrophysiology|MP:0003631,nervous system phenotype
MGI:5548954	Ntf5<tm1b(EUCOMM)Hmgu>	MP:0000745,tremors|MP:0001289,persistence of hyaloid vascular system|MP:0001392,abnormal locomotor behavior|MP:0001556,increased circulating HDL cholesterol level|MP:0001926,female infertility|MP:0002591,decreased mean corpuscular volume|MP:0003233,prolonged QT interval|MP:0005178,increased circulating cholesterol level|MP:0005568,increased circulating total protein level|MP:0010392,prolonged QRS complex duration
MGI:1930044	Ntf5<tm1Gdy>	MP:0000966,decreased sensory neuron number|MP:0001085,small petrosal ganglion|MP:0001088,small nodose ganglion
MGI:1857233	Ntf5<tm1Jae>	MP:0000427,abnormal hair cycle|MP:0000966,decreased sensory neuron number|MP:0001021,small L4 dorsal root ganglion|MP:0001083,small geniculate ganglion|MP:0001085,small petrosal ganglion|MP:0001088,small nodose ganglion|MP:0001200,thick skin|MP:0003204,decreased neuron apoptosis|MP:0003987,small vestibular ganglion
MGI:1933845	Ntf5<tm1Par>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001052,abnormal innervation pattern to muscle|MP:0001405,impaired coordination|MP:0003631,nervous system phenotype|MP:0009937,abnormal neuron differentiation
MGI:6430670	Nthl1<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001304,cataract|MP:0002699,abnormal vitreous body morphology
MGI:2446391	Nthl1<tm1Tbor>	MP:0002006,neoplasm|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0008058,abnormal DNA repair
MGI:2183467	Nthl1<tm1Yas>	MP:0014760,impaired DNA repair
MGI:6200272	Ntmt1<m1Btlr>	MP:0001262,decreased body weight
MGI:4880414	Ntmt1<tm1(NCOM)Mfgc>	MP:0000160,kyphosis|MP:0000598,abnormal liver morphology|MP:0001127,small ovary|MP:0001134,absent corpus luteum|MP:0001218,thin epidermis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001926,female infertility|MP:0002016,ovary cyst|MP:0002083,premature death|MP:0003103,liver degeneration|MP:0003674,oxidative stress|MP:0003786,premature aging|MP:0005114,premature hair loss|MP:0005389,reproductive system phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0008869,anovulation|MP:0009932,skin fibrosis|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014273,abnormal skin vasculature morphology
MGI:6469750	Ntm<tm1.1Pagr>	MP:0005385,cardiovascular system phenotype
MGI:5007266	Ntm<tm1Lex>	MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0012293,impaired active avoidance behavior|MP:0030586,impaired behavioral response to amphetamine
MGI:2137018	Ntn1<Gt(IRESBetageo)1Pgr>	MP:0002199,abnormal brain commissure morphology|MP:0002859,abnormal inner ear canal fusion|MP:0003161,absent lateral semicircular canal|MP:0003163,absent posterior semicircular canal|MP:0009546,absent gastric milk in neonates|MP:0011089,perinatal lethality, complete penetrance
MGI:1927548	Ntn1<Gt(ST629)Byg>	MP:0000628,abnormal mammary gland development|MP:0002196,absent corpus callosum|MP:0002199,abnormal brain commissure morphology|MP:0002862,abnormal righting response|MP:0002878,abnormal corticospinal tract morphology|MP:0003312,abnormal locomotor coordination|MP:0003631,nervous system phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0008223,absent hippocampal commissure|MP:0008225,abnormal anterior commissure morphology|MP:0009546,absent gastric milk in neonates|MP:0009677,abnormal spinal cord dorsal column morphology|MP:0009681,abnormal pyramidal decussation morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0020560,abnormal pontine nuclei morphology
MGI:5888901	Ntn1<tm1.2Good>	MP:0005262,coloboma|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009890,cleft secondary palate
MGI:5752968	Ntn1<tm1.2Tek>	MP:0002961,abnormal axon guidance|MP:0003994,abnormal dorsal spinal root morphology|MP:0009688,abnormal spinal cord central canal morphology|MP:0009695,abnormal spinal cord ventral commissure morphology|MP:0010151,abnormal spinal cord ependymal layer morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0014748,abnormal sensory neuron axon guidance
MGI:4456545	Ntn3<tm1(KOMP)Mbp>	MP:0003177,allodynia|MP:0003631,nervous system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging|MP:0014488,abnormal skin sensory neuron innervation pattern|MP:0020954,decreased mechanical nociceptive threshold
MGI:5548502	Ntn4<tm1b(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0000689,abnormal spleen morphology|MP:0003179,thrombocytopenia
MGI:5490629	Ntn4<tm1Wjbr>	MP:0000351,increased cell proliferation|MP:0002792,abnormal retina vasculature morphology|MP:0005253,abnormal eye physiology|MP:0005391,vision/eye phenotype|MP:0008056,abnormal retina ganglion cell morphology|MP:0009450,abnormal axon fasciculation
MGI:5701693	Ntn5<tm1.1Rwb>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0011723,ectopic neuron
MGI:3757573	Ntng1<tm1Ito>	MP:0003631,nervous system phenotype|MP:0010768,mortality/aging
MGI:3757587	Ntng2<tm1Ito>	MP:0010768,mortality/aging
MGI:3848334	Ntng2<tm1Lex>	MP:0005377,hearing/vestibular/ear phenotype|MP:0006359,absent startle reflex|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:7544953	Ntrk1<em1Krvl>	MP:0001008,abnormal sympathetic ganglion morphology|MP:0001320,small pupil|MP:0001344,blepharoptosis|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0003651,abnormal axon extension|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:5621022	Ntrk1<tm1.1Azmo>	MP:0000966,decreased sensory neuron number|MP:0002735,abnormal chemical nociception|MP:0002736,abnormal nociception after inflammation|MP:0003631,nervous system phenotype|MP:0003663,abnormal thermosensation|MP:0005386,behavior/neurological phenotype|MP:0008415,abnormal neurite morphology|MP:0014488,abnormal skin sensory neuron innervation pattern
MGI:5620208	Ntrk1<tm1.1Jcar>	MP:0010055,abnormal sensory neuron physiology|MP:0010768,mortality/aging
MGI:8233844	Ntrk1<tm1.1(NTRK1*)Cat>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0001364,decreased anxiety-related response|MP:0001973,increased thermal nociceptive threshold|MP:0003043,hypoalgesia|MP:0008489,slow postnatal weight gain|MP:0008531,increased chemical nociceptive threshold|MP:0011085,postnatal lethality, complete penetrance|MP:0013370,anhidrosis|MP:0014370,impaired spatial working memory|MP:0014416,decreased social novelty preference|MP:0014488,abnormal skin sensory neuron innervation pattern|MP:0020955,increased mechanical nociceptive threshold|MP:0021111,decreased social investigation
MGI:2678328	Ntrk1<tm1Apat>	MP:0000966,decreased sensory neuron number
MGI:1888374	Ntrk1<tm1Bbd>	MP:0000421,mottled coat|MP:0000578,ulcerated autopod|MP:0000964,small dorsal root ganglion|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001015,small superior cervical ganglion|MP:0001038,abnormal cholinergic neuron morphology|MP:0001093,small trigeminal ganglion|MP:0001212,skin lesions|MP:0001265,decreased body size|MP:0001314,cornea opacity|MP:0001344,blepharoptosis|MP:0001490,abnormal vibrissae reflex|MP:0001491,unresponsive to tactile stimuli|MP:0001973,increased thermal nociceptive threshold|MP:0002003,miotic pupil|MP:0002083,premature death|MP:0002110,abnormal digit morphology|MP:0004183,abnormal sympathetic nervous system physiology|MP:0005377,hearing/vestibular/ear phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5637213	Ntrk1<tm1b(EUCOMM)Wtsi>	MP:0002606,increased basophil cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:3583733	Ntrk1<tm1Ddg>	MP:0002169,no abnormal phenotype detected
MGI:1933963	Ntrk1<tm1Par>	MP:0000964,small dorsal root ganglion|MP:0000966,decreased sensory neuron number
MGI:3505767	Ntrk1<tm1Tes>	MP:0002423,abnormal mast cell physiology|MP:0002461,increased immunoglobulin level|MP:0002494,increased IgM level|MP:0004977,increased B-1 B cell number|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level
MGI:5319087	Ntrk1<tm2.1Lfr>	MP:0002184,abnormal innervation|MP:0003461,abnormal response to novel object|MP:0004924,abnormal behavior|MP:0009456,impaired cued conditioning behavior
MGI:8233845	Ntrk1<tm2.1(NTRK1)Cat>	MP:0005386,behavior/neurological phenotype
MGI:5588369	Ntrk1<tm2.1Tes>	MP:0002736,abnormal nociception after inflammation|MP:0003631,nervous system phenotype|MP:0003663,abnormal thermosensation|MP:0003998,decreased thermal nociceptive threshold|MP:0004811,abnormal neuron physiology
MGI:3052071	Ntrk1<tm2(Ntrk3)Apat>	MP:0000966,decreased sensory neuron number|MP:0001970,abnormal pain threshold|MP:0002083,premature death|MP:0004297,abnormal proprioceptive neuron morphology|MP:0008485,increased muscle spindle number
MGI:2667686	Ntrk2<tm1.1Lfr>	MP:0004220,abnormal peripheral nervous system regeneration
MGI:3640817	Ntrk2<tm1.1Tes>	MP:0000818,abnormal amygdala morphology|MP:0002797,increased thigmotaxis|MP:0008143,abnormal dendrite morphology|MP:0014491,abnormal mammary gland sensory innervation pattern
MGI:1857814	Ntrk2<tm1Bbd>	MP:0000854,abnormal cerebellum development|MP:0000910,small facial motor nucleus|MP:0000939,decreased motor neuron number|MP:0000964,small dorsal root ganglion|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001021,small L4 dorsal root ganglion|MP:0001083,small geniculate ganglion|MP:0001085,small petrosal ganglion|MP:0001088,small nodose ganglion|MP:0001093,small trigeminal ganglion|MP:0001435,absent suckling reflex|MP:0001437,no swallowing reflex|MP:0001490,abnormal vibrissae reflex|MP:0002752,abnormal somatic nervous system morphology|MP:0002855,abnormal cochlear ganglion morphology|MP:0002856,abnormal vestibular ganglion morphology|MP:0003986,small cochlear ganglion|MP:0003987,small vestibular ganglion|MP:0003989,abnormal barrel cortex morphology|MP:0004333,abnormal utricular macula morphology|MP:0004409,abnormal crista ampullaris neuroepithelium morphology|MP:0004718,abnormal vestibular nerve morphology|MP:0004747,abnormal cochlear OHC afferent innervation pattern|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014490,abnormal inner ear vestibular sensory neuron innervation pattern
MGI:5637214	Ntrk2<tm1b(EUCOMM)Wtsi>	MP:0000150,abnormal rib morphology|MP:0001556,increased circulating HDL cholesterol level|MP:0003960,increased lean body mass|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4947984	Ntrk2<tm1Bxu>	MP:0002183,gliosis|MP:0002184,abnormal innervation|MP:0002229,neurodegeneration|MP:0003243,abnormal dopaminergic neuron morphology|MP:0010768,mortality/aging|MP:0011448,decreased dopaminergic neuron number|MP:0011451,increased susceptibility to dopaminergic neuron neurotoxicity
MGI:3583735	Ntrk2<tm1Ddg>	MP:0002169,no abnormal phenotype detected|MP:0014491,abnormal mammary gland sensory innervation pattern
MGI:3050229	Ntrk2<tm1Jom>	MP:0001500,decreased kindling response|MP:0003631,nervous system phenotype
MGI:1930163	Ntrk2<tm1Kln>	MP:0000034,abnormal inner ear vestibule morphology|MP:0000959,abnormal somatic sensory system morphology|MP:0000966,decreased sensory neuron number|MP:0000968,abnormal sensory neuron innervation pattern|MP:0000980,absent hair-down neurons|MP:0001072,abnormal vestibulocochlear nerve morphology|MP:0001088,small nodose ganglion|MP:0001399,hyperactivity|MP:0003987,small vestibular ganglion|MP:0004718,abnormal vestibular nerve morphology|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0009538,abnormal synapse morphology|MP:0014490,abnormal inner ear vestibular sensory neuron innervation pattern
MGI:3612277	Ntrk2<tm1Lfp>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0001083,small geniculate ganglion|MP:0001085,small petrosal ganglion|MP:0001088,small nodose ganglion|MP:0001093,small trigeminal ganglion|MP:0002752,abnormal somatic nervous system morphology|MP:0003986,small cochlear ganglion|MP:0003987,small vestibular ganglion|MP:0003989,abnormal barrel cortex morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:2384391	Ntrk2<tm1Lfr>	MP:0000805,abnormal visual cortex morphology|MP:0000859,abnormal somatosensory cortex morphology|MP:0002882,abnormal neuron morphology|MP:0006309,decreased retina ganglion cell number|MP:0008056,abnormal retina ganglion cell morphology|MP:0008143,abnormal dendrite morphology|MP:0008948,decreased neuron number
MGI:3774320	Ntrk2<tm1Mini>	MP:0000598,abnormal liver morphology|MP:0001748,increased circulating adrenocorticotropin level|MP:0001900,impaired synaptic plasticity|MP:0002079,increased circulating insulin level|MP:0002207,abnormal long-term potentiation|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003212,increased susceptibility to age related obesity|MP:0005386,behavior/neurological phenotype|MP:0005669,increased circulating leptin level|MP:0008299,adrenal cortical hyperplasia|MP:0009286,increased abdominal fat pad weight|MP:0014286,increased adrenal gland zona fasciculata size
MGI:3039928	Ntrk2<tm1Rohr>	MP:0001129,impaired ovarian folliculogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001330,abnormal optic nerve morphology|MP:0001340,abnormal eyelid morphology|MP:0001523,impaired righting response|MP:0001951,abnormal breathing pattern|MP:0002090,abnormal vision|MP:0002638,abnormal pupillary reflex|MP:0002664,decreased circulating adrenocorticotropin level|MP:0002665,decreased circulating corticosterone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003357,impaired granulosa cell differentiation|MP:0004021,abnormal rod electrophysiology|MP:0005345,abnormal circulating corticosterone level|MP:0008106,decreased amacrine cell number|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0009772,abnormal retina development|MP:0011085,postnatal lethality, complete penetrance|MP:0031018,decreased granulosa cell proliferation|MP:0031381,decreased secondary ovarian follicle number
MGI:5490140	Ntrk2<tm2.1Ddg>	MP:0010769,abnormal survival|MP:0011087,neonatal lethality, complete penetrance|MP:0014491,abnormal mammary gland sensory innervation pattern
MGI:4840323	Ntrk2<tm2.1Mini>	MP:0000788,abnormal cerebral cortex morphology|MP:0001732,postnatal growth retardation|MP:0003354,astrocytosis|MP:0004427,abnormal vestibular labyrinth morphology|MP:0006009,abnormal neuronal migration|MP:0009450,abnormal axon fasciculation|MP:0009937,abnormal neuron differentiation|MP:0011085,postnatal lethality, complete penetrance
MGI:5476922	Ntrk2<tm2.1Tes>	MP:0001473,reduced long-term potentiation|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0003651,abnormal axon extension|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory
MGI:1933974	Ntrk2<tm2Kln>	MP:0000013,abnormal adipose tissue distribution|MP:0000788,abnormal cerebral cortex morphology|MP:0000805,abnormal visual cortex morphology|MP:0000859,abnormal somatosensory cortex morphology|MP:0000921,demyelination|MP:0001260,increased body weight|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001547,abnormal lipid level|MP:0001732,postnatal growth retardation|MP:0001900,impaired synaptic plasticity|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002169,no abnormal phenotype detected|MP:0002207,abnormal long-term potentiation|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0003212,increased susceptibility to age related obesity|MP:0003631,nervous system phenotype|MP:0003871,abnormal myelin sheath morphology|MP:0005293,impaired glucose tolerance|MP:0005345,abnormal circulating corticosterone level|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005455,increased susceptibility to weight gain|MP:0005669,increased circulating leptin level|MP:0006009,abnormal neuronal migration|MP:0008299,adrenal cortical hyperplasia|MP:0008439,abnormal cortical plate morphology|MP:0008911,induced hyperactivity|MP:0009285,increased gonadal fat pad weight|MP:0009286,increased abdominal fat pad weight|MP:0009450,abnormal axon fasciculation|MP:0009754,enhanced behavioral response to cocaine|MP:0009937,abnormal neuron differentiation|MP:0010024,increased total body fat amount|MP:0011987,abnormal GABAergic neuron physiology|MP:0014286,increased adrenal gland zona fasciculata size|MP:0020467,abnormal circadian behavior|MP:0031391,increased locomotor activity
MGI:5532831	Ntrk2<tm2Lfp>	MP:0000160,kyphosis|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0006396,decreased long bone epiphyseal plate size|MP:0009703,decreased birth body size|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3716645	Ntrk2<tm2Lfr>	MP:0008056,abnormal retina ganglion cell morphology|MP:0008143,abnormal dendrite morphology
MGI:5616440	Ntrk2<tm3.1(cre/ERT2)Ddg>	MP:0010769,abnormal survival
MGI:5617004	Ntrk2<tm4.1Ddg>	MP:0014491,abnormal mammary gland sensory innervation pattern
MGI:4950053	Ntrk3<tm1.1Tes>	MP:0005391,vision/eye phenotype|MP:0008067,retina ganglion cell degeneration
MGI:1888375	Ntrk3<tm1Bbd>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001524,impaired limb coordination|MP:0001527,athetotic walking movements|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0003986,small cochlear ganglion|MP:0003987,small vestibular ganglion|MP:0004746,abnormal cochlear IHC afferent innervation pattern|MP:0005386,behavior/neurological phenotype|MP:0006404,abnormal lumbar dorsal root ganglion morphology
MGI:3583736	Ntrk3<tm1Ddg>	MP:0002169,no abnormal phenotype detected
MGI:2656335	Ntrk3<tm1Kln>	MP:0000966,decreased sensory neuron number|MP:0004716,abnormal cochlear nerve morphology
MGI:1933975	Ntrk3<tm1Par>	MP:0000274,enlarged heart|MP:0000285,abnormal heart valve morphology|MP:0000286,abnormal mitral valve morphology|MP:0000966,decreased sensory neuron number|MP:0001024,small L5 dorsal root ganglion|MP:0001081,abnormal cranial ganglia morphology|MP:0001085,small petrosal ganglion|MP:0001088,small nodose ganglion|MP:0001093,small trigeminal ganglion|MP:0001182,lung hemorrhage|MP:0002624,abnormal tricuspid valve morphology|MP:0002726,abnormal pulmonary vein morphology|MP:0002747,abnormal aortic valve morphology|MP:0002754,dilated heart right ventricle|MP:0003986,small cochlear ganglion|MP:0003987,small vestibular ganglion|MP:0004297,abnormal proprioceptive neuron morphology|MP:0006113,abnormal heart septum morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0006128,pulmonary valve stenosis|MP:0010402,ventricular septal defect|MP:0010405,ostium secundum atrial septal defect|MP:0010454,abnormal truncus arteriosus septation|MP:0011085,postnatal lethality, complete penetrance|MP:0031511,globular heart|MP:0031529,pulmonary valve hyperplasia|MP:0031563,pulmonary valve hypertrophy
MGI:5707201	Ntrk3<tm2.1Ddg>	MP:0011087,neonatal lethality, complete penetrance
MGI:5707203	Ntrk3<tm3.1(cre/ERT2)Ddg>	MP:0011087,neonatal lethality, complete penetrance
MGI:5575489	n-TRtct5<m1J>	MP:0000950,abnormal seizure response to pharmacological agent|MP:0001650,abnormal seizure response to electrical stimulation|MP:0003635,abnormal synaptic transmission|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004807,abnormal paired-pulse inhibition|MP:0021081,abnormal ribosomal stalling
MGI:6510875	n-TRtct5<tm1.1Slac>	MP:0000950,abnormal seizure response to pharmacological agent|MP:0001650,abnormal seizure response to electrical stimulation|MP:0002206,abnormal CNS synaptic transmission|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004807,abnormal paired-pulse inhibition|MP:0014382,increased miniature inhibitory postsynaptic current frequency
MGI:6510888	n-TRtct5<tm2.1Slac>	MP:0000950,abnormal seizure response to pharmacological agent|MP:0002206,abnormal CNS synaptic transmission|MP:0004807,abnormal paired-pulse inhibition|MP:0005402,abnormal action potential|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0014382,increased miniature inhibitory postsynaptic current frequency|MP:0014384,increased miniature inhibitory postsynaptic current amplitude
MGI:3604581	Ntsr1<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:2389321	Ntsr1<tm1Fer>	MP:0000008,increased white adipose tissue amount|MP:0001260,increased body weight|MP:0001433,polyphagia|MP:0001905,abnormal dopamine level|MP:0005386,behavior/neurological phenotype|MP:0005533,increased body temperature
MGI:3029204	Ntsr1<tm1Hmno>	MP:0002169,no abnormal phenotype detected
MGI:4418203	Ntsr1<tm1Pang>	MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0003088,abnormal prepulse inhibition
MGI:3761722	Ntsr1<tm2Dgen>	MP:0001405,impaired coordination|MP:0001982,decreased chemically-elicited antinociception|MP:0003290,intestinal hypoperistalsis|MP:0005534,decreased body temperature
MGI:4418470	Ntsr1<tm2Pang>	MP:0001777,abnormal body temperature homeostasis|MP:0002574,increased vertical activity|MP:0002733,abnormal thermal nociception
MGI:4459069	Ntsr2<tm1Dafe>	MP:0001406,abnormal gait|MP:0001489,decreased startle reflex|MP:0009141,increased prepulse inhibition
MGI:3029205	Ntsr2<tm1Hmno>	MP:0001973,increased thermal nociceptive threshold
MGI:3044928	Ntsr2<tm1Mfsc>	MP:0003631,nervous system phenotype
MGI:5296932	Nts<tm1(cre)Mgmj>	MP:0001262,decreased body weight|MP:0010025,decreased total body fat amount
MGI:2446607	Nts<tm1Dob>	MP:0008872,abnormal physiological response to xenobiotic
MGI:2655313	n-TUtca2<tm1.1Dhat>	MP:0011091,prenatal lethality, complete penetrance
MGI:2653318	n-TUtca2<tm1Dhat>	MP:0000060,delayed bone ossification|MP:0000074,abnormal neurocranium morphology|MP:0000107,abnormal frontal bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000163,abnormal cartilage morphology|MP:0000433,microcephaly|MP:0000438,abnormal cranium morphology|MP:0000445,short snout|MP:0000454,abnormal jaw morphology|MP:0000547,short limbs|MP:0000592,short tail|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001533,abnormal skeleton physiology|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002109,abnormal limb morphology|MP:0002896,abnormal bone mineralization|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003935,abnormal craniofacial development|MP:0004686,decreased length of long bones|MP:0005352,small cranium|MP:0005379,endocrine/exocrine gland phenotype|MP:0005508,abnormal skeleton morphology|MP:0006398,increased long bone epiphyseal plate size|MP:0010883,trachea stenosis|MP:0013753,tracheomalacia|MP:0030262,frontal bossing|MP:0030297,outer ear hypoplasia
MGI:2181883	n-TUtca2<tm1Mmt>	MP:0002169,no abnormal phenotype detected|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3577028	n-TUtca2<tm1Mym>	MP:0001698,decreased embryo size|MP:0002084,abnormal developmental patterning|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:5428915	Nuak1<tm1Esu>	MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005369,muscle phenotype|MP:0005560,decreased circulating glucose level|MP:0010401,increased skeletal muscle glycogen level|MP:0031617,abnormal skeletal muscle cell glucose uptake
MGI:3770654	Nuak1<tm1Sia>	MP:0000757,herniated abdominal wall|MP:0003052,omphalocele|MP:0003631,nervous system phenotype|MP:0011089,perinatal lethality, complete penetrance
MGI:3809459	Nuak2<tm1Esu>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000914,exencephaly|MP:0001260,increased body weight|MP:0001552,increased circulating triglyceride level|MP:0002404,increased intestinal adenoma incidence|MP:0002702,decreased circulating free fatty acids level|MP:0005559,increased circulating glucose level|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5431630	Nuak2<tm1Sia>	MP:0000914,exencephaly
MGI:5766751	Nub1<tm1b(EUCOMM)Hmgu>	MP:0000266,abnormal heart morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0004151,decreased circulating iron level|MP:0005387,immune system phenotype|MP:0005627,increased circulating potassium level|MP:0008040,decreased NK T cell number|MP:0008045,decreased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008259,abnormal optic disk morphology|MP:0008725,increased heart atrium size|MP:0010097,abnormal retina blood vessel morphology|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013510,decreased CD4-negative NK T cell number|MP:0013513,decreased memory-marker CD4-negative NK T cell number|MP:0013649,decreased CD11b-high dendritic cell number|MP:0013678,decreased Ly6C-positive NK T cell number|MP:0013679,increased Ly6C-positive NK T cell number|MP:0013691,decreased CD5-positive Ly6C-positive T cell number|MP:0013772,increased effector memory T-helper cell number|MP:0020421,increased freezing behavior
MGI:5463617	Nubp1<m1Nisw>	MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001178,pulmonary hypoplasia|MP:0001304,cataract|MP:0001953,respiratory failure|MP:0002110,abnormal digit morphology|MP:0006382,abnormal lung epithelium morphology|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011087,neonatal lethality, complete penetrance
MGI:6450510	Nubp2<dor>	MP:0000087,absent mandible|MP:0000108,midline facial cleft|MP:0000450,absent snout|MP:0000565,oligodactyly|MP:0001286,abnormal eye development|MP:0002152,abnormal brain morphology|MP:0003984,embryonic growth retardation|MP:0004201,fetal growth retardation|MP:0006280,abnormal digit development|MP:0006337,abnormal first pharyngeal arch morphology|MP:0008736,micromelia|MP:0008817,hematoma|MP:0009902,abnormal lateral nasal prominence morphology|MP:0009903,abnormal medial nasal prominence morphology|MP:0009908,protruding tongue|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0012260,encephalomeningocele|MP:0030095,abnormal midface morphology|MP:0030249,small frontonasal prominence|MP:0030342,small maxillary prominence|MP:0030344,absent maxillary prominence|MP:0030346,small mandibular prominence
MGI:5613638	Nubp2<tm1b(EUCOMM)Hmgu>	MP:0002764,short tibia|MP:0010087,increased circulating fructosamine level|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness
MGI:7449244	Nubpl<em1Vkim>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5548675	Nubpl<tm1b(KOMP)Wtsi>	MP:0001711,abnormal placenta morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:1860214	Nuca	MP:0001304,cataract|MP:0001924,infertility|MP:0001935,decreased litter size|MP:0010254,nuclear cataract|MP:0010261,sutural cataract
MGI:6152526	Nucb1<em1(IMPC)Mbp>	MP:0000063,decreased bone mineral density|MP:0000266,abnormal heart morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001402,decreased locomotor activity|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002188,small heart|MP:0002339,abnormal lymph node morphology|MP:0002834,decreased heart weight|MP:0003179,thrombocytopenia|MP:0004924,abnormal behavior|MP:0008528,polycystic kidney|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:3604493	Nucb2<Gt(OST287865)Lex>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005333,decreased heart rate
MGI:7310446	Nucb2<tm1.1Vdix>	MP:0002078,abnormal glucose homeostasis|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005378,growth/size/body region phenotype
MGI:7310447	Nucb2<tm1.2Vdix>	MP:0001554,increased circulating free fatty acids level|MP:0002078,abnormal glucose homeostasis|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0008560,increased tumor necrosis factor secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0020102,increased hepatic glucose production
MGI:6294929	Nucks1<tm1.2Vter>	MP:0001260,increased body weight|MP:0001402,decreased locomotor activity|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0004890,decreased energy expenditure|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005380,embryo phenotype|MP:0005559,increased circulating glucose level|MP:0005573,increased pulmonary respiratory rate|MP:0005669,increased circulating leptin level|MP:0009302,increased renal fat pad weight|MP:0010024,increased total body fat amount|MP:0011939,increased food intake|MP:0020234,decreased basal metabolism|MP:0030968,decreased circulating adiponectin level
MGI:6120767	Nucks1<tm1b(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0000470,abnormal stomach morphology|MP:0000702,enlarged lymph nodes|MP:0001289,persistence of hyaloid vascular system|MP:0002092,abnormal eye morphology|MP:0002098,abnormal vibrissa morphology|MP:0002135,abnormal kidney morphology|MP:0002644,decreased circulating triglyceride level|MP:0003020,decreased circulating chloride level|MP:0004002,abnormal jejunum morphology|MP:0005553,increased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6342901	Nudcd2<em1(IMPC)Bay>	MP:0002080,prenatal lethality|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6153752	Nudcd3<em1(IMPC)Wtsi>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001823,thymus hypoplasia|MP:0001924,infertility|MP:0002079,increased circulating insulin level|MP:0002145,abnormal T cell differentiation|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002494,increased IgM level|MP:0002497,increased IgE level|MP:0003132,increased pre-B cell number|MP:0005090,increased double-negative T cell number|MP:0005091,increased double-positive T cell number|MP:0005553,increased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0008040,decreased NK T cell number|MP:0008049,increased memory T cell number|MP:0008501,increased IgG2b level|MP:0008754,abnormal T cell receptor V(D)J recombination|MP:0008761,abnormal immunoglobulin light chain V-J recombination|MP:0010067,increased red blood cell distribution width|MP:0010133,increased DN3 thymocyte number|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5296095	Nudc<tm1a(KOMP)Mbp>	MP:0002169,no abnormal phenotype detected
MGI:7618456	Nudc<tm1c(KOMP)Mbp>	MP:0001005,abnormal retina rod cell morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0008451,retina rod cell degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0011965,decreased total retina thickness|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0012148,decreased a-wave implicit time|MP:0020448,increased microglial cell activation|MP:0020813,abnormal photoreceptor outer segment disc membrane morphology|MP:0030005,increased retina apoptosis
MGI:6361148	Nudt10<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6382616	Nudt12<em1Embrp>	MP:0005266,abnormal metabolism
MGI:5692678	Nudt13<tm2b(EUCOMM)Hmgu>	MP:0010097,abnormal retina blood vessel morphology|MP:0011965,decreased total retina thickness|MP:0013279,increased fasting circulating glucose level
MGI:7595847	Nudt15<em1Maska>	MP:0000222,decreased neutrophil cell number|MP:0000333,decreased bone marrow cell number|MP:0002083,premature death|MP:0004810,decreased hematopoietic stem cell number|MP:0005152,pancytopenia|MP:0005378,growth/size/body region phenotype|MP:0014399,decreased hematopoietic precursor cell number
MGI:7343888	Nudt16l1<em1(IMPC)J>	MP:0002942,decreased circulating alanine transaminase level|MP:0005632,decreased circulating aspartate transaminase level
MGI:5569079	Nudt19<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0002060,abnormal skin morphology|MP:0002599,increased mean platelet volume|MP:0005574,decreased pulmonary respiratory rate
MGI:2387695	Nudt1<tm1Tts>	MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0005386,behavior/neurological phenotype|MP:0005621,abnormal cell physiology|MP:0008019,increased liver tumor incidence|MP:0010301,increased stomach tumor incidence
MGI:6257720	Nudt21<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6385854	Nudt21<tm1.1Ejwpj>	MP:0005088,increased acute inflammation|MP:0005165,increased susceptibility to injury|MP:0006050,pulmonary fibrosis|MP:0020253,increased collagen level
MGI:4432760	Nudt2<tm1a(EUCOMM)Wtsi>	MP:0005387,immune system phenotype|MP:0009278,abnormal bone marrow cell physiology|MP:0020414,abnormal fibroblast physiology
MGI:6120720	Nudt5<tm1b(EUCOMM)Hmgu>	MP:0003733,abnormal retina inner nuclear layer morphology|MP:0011959,abnormal eye posterior chamber depth|MP:0011965,decreased total retina thickness
MGI:6285596	Nudt6<em1(IMPC)Bay>	MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount
MGI:6369729	Nudt7<em1Ejj>	MP:0003560,osteoarthritis|MP:0003724,increased susceptibility to induced arthritis|MP:0009780,abnormal chondrocyte physiology|MP:0014101,decreased chondrocyte proliferation|MP:0014103,increased chondrocyte apoptosis|MP:0020847,abnormal peroxisome physiology
MGI:7413115	Nufip1<em1Cya>	MP:0002006,neoplasm|MP:0003447,decreased tumor growth/size
MGI:6152527	Nufip1<em1(IMPC)Mbp>	MP:0009455,enhanced cued conditioning behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation|MP:0020421,increased freezing behavior
MGI:6258455	Nufip2<em1(IMPC)J>	MP:0001488,increased startle reflex|MP:0001697,abnormal embryo size|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003720,abnormal neural tube closure|MP:0005562,decreased mean corpuscular hemoglobin|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:6399900	Nuggc<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0000759,abnormal skeletal muscle morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002110,abnormal digit morphology
MGI:5449547	Nuggc<tm1Diaz>	MP:0004815,abnormal somatic hypermutation frequency|MP:0005387,immune system phenotype
MGI:3838102	Numa1<tm1.1Dwc>	MP:0003631,nervous system phenotype|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0009760,abnormal mitotic spindle morphology|MP:0010768,mortality/aging|MP:0011705,absent fibroblast proliferation
MGI:3838103	Numa1<tm1.2Dwc>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3838104	Numa1<tm1Dwc>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2429686	Numbl<tm1Wmz>	MP:0001923,reduced female fertility|MP:0002169,no abnormal phenotype detected
MGI:1932086	Numb<tm1.1Ynj>	MP:0000929,open neural tube|MP:0000936,small embryonic telencephalon|MP:0001698,decreased embryo size|MP:0003232,abnormal forebrain development|MP:0009937,abnormal neuron differentiation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013241,embryo tissue necrosis
MGI:2388023	Numb<tm1.1Zili>	MP:0000266,abnormal heart morphology|MP:0000364,abnormal vascular regression|MP:0000929,open neural tube|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001787,pericardial edema|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0004180,failure of initiation of embryo turning|MP:0004188,delayed embryo turning|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0006108,abnormal hindbrain development|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009937,abnormal neuron differentiation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011523,thin placenta labyrinth
MGI:1932085	Numb<tm1Ynj>	MP:0002169,no abnormal phenotype detected
MGI:2388022	Numb<tm1Zili>	MP:0000852,small cerebellum|MP:0000854,abnormal cerebellum development|MP:0000864,abnormal cerebellum vermis morphology|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000880,decreased Purkinje cell number|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000890,thin cerebellar molecular layer|MP:0001393,ataxia|MP:0002645,abnormal intestinal cholesterol absorption|MP:0005179,decreased circulating cholesterol level|MP:0006097,abnormal cerebellar lobule formation|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6149753	Nup107<em1Rajk>	MP:0001923,reduced female fertility|MP:0005389,reproductive system phenotype
MGI:3799269	Nup133<Gt(RRK090)Byg>	MP:0001672,abnormal embryo development|MP:0003632,abnormal nervous system morphology
MGI:3578539	Nup133<mermaid>	MP:0000914,exencephaly|MP:0001258,decreased body length|MP:0001688,abnormal somite development|MP:0001730,embryonic growth arrest|MP:0001787,pericardial edema|MP:0002151,abnormal neural tube morphology|MP:0002231,abnormal primitive streak morphology|MP:0003400,kinked neural tube|MP:0003861,abnormal nervous system development|MP:0003984,embryonic growth retardation|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012183,decreased paraxial mesoderm size
MGI:6324152	Nup133<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6158658	Nup153<em1(IMPC)J>	MP:0001284,absent vibrissae|MP:0001399,hyperactivity|MP:0001529,abnormal vocalization|MP:0002834,decreased heart weight|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6276986	Nup155<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001728,failure of embryo implantation|MP:0002339,abnormal lymph node morphology|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0005565,increased blood urea nitrogen level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:3840086	Nup155<Gt(RRD107)Byg>	MP:0003137,abnormal impulse conducting system conduction|MP:0005385,cardiovascular system phenotype|MP:0005402,abnormal action potential|MP:0008543,atrial fibrillation|MP:0010504,abnormal RR interval|MP:0010510,absent P wave|MP:0011092,embryonic lethality, complete penetrance
MGI:6719493	Nup160<tm1Mdan>	MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011903,decreased hematopoietic stem cell proliferation
MGI:6209645	Nup205<em1(IMPC)J>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0003961,decreased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0010024,increased total body fat amount|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:6449026	Nup210<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001304,cataract|MP:0002699,abnormal vitreous body morphology
MGI:6268316	Nup210<enuI476T>	MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0012762,abnormal alpha-beta T cell morphology
MGI:3045544	Nup210l<Tg(Gt(ROSA)26Sor-EGFP)130910Eps>	MP:0001154,seminiferous tubule degeneration|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008898,abnormal acrosome morphology|MP:0009831,abnormal sperm midpiece morphology
MGI:6830911	Nup210<tm1.1Mdan>	MP:0000221,decreased leukocyte cell number|MP:0001828,abnormal T cell activation|MP:0002619,abnormal lymphocyte morphology|MP:0005397,hematopoietic system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008073,abnormal CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0013772,increased effector memory T-helper cell number
MGI:6501962	Nup210<tm1b(EUCOMM)Hmgu>	MP:0005018,decreased T cell number|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008086,increased T-helper 1 cell number|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0012765,decreased alpha-beta T cell number
MGI:6830910	Nup210<tm1Mdan>	MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology
MGI:2441651	Nup214<tm1Gcg>	MP:0004963,abnormal blastocoele morphology|MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:6154324	Nup35<m1Apb>	MP:0001045,abnormal enteric ganglia morphology|MP:0002083,premature death|MP:0002446,abnormal macrophage morphology|MP:0002731,megacolon|MP:0005367,renal/urinary system phenotype|MP:0005369,muscle phenotype|MP:0005370,liver/biliary system phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008802,abnormal intestinal smooth muscle morphology|MP:0009536,abnormal interstitial cell of Cajal morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0014033,abnormal submucosal gland morphology|MP:0014221,increased colon goblet cell number|MP:0014231,intestinal mucus accumulation
MGI:6160168	Nup35<tm1b(EUCOMM)Wtsi>	MP:0009476,enlarged cecum|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:5708217	Nup37<tm1.1(KOMP)Vlcg>	MP:0000572,abnormal autopod morphology|MP:0001303,abnormal lens morphology|MP:0002574,increased vertical activity|MP:0003960,increased lean body mass
MGI:2386173	Nup50<tm1Clur>	MP:0000914,exencephaly|MP:0001698,decreased embryo size|MP:0003400,kinked neural tube|MP:0011089,perinatal lethality, complete penetrance
MGI:7425881	Nup54<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0002582,disorganized extraembryonic tissue|MP:0003984,embryonic growth retardation|MP:0004924,abnormal behavior|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0014586,decreased egg cylinder size|MP:0020870,decreased thigmotaxis
MGI:7330226	Nup62cl<em1(IMPC)J>	MP:0000198,decreased circulating phosphate level|MP:0000218,increased leukocyte cell number|MP:0001314,cornea opacity|MP:0005632,decreased circulating aspartate transaminase level|MP:0005635,decreased circulating bilirubin level
MGI:5286652	Nup62<Tg(Tyr)2397E-1a2Ove>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5692631	Nup62<tm1b(KOMP)Wtsi>	MP:0003733,abnormal retina inner nuclear layer morphology|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness
MGI:6451077	Nup85<tm1.1Yter>	MP:0003447,decreased tumor growth/size|MP:0003884,decreased macrophage cell number|MP:0013023,decreased Ly6C high monocyte number|MP:0013026,decreased Ly6C low monocyte number
MGI:4944384	Nup85<tm1a(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6430664	Nup93<em1(IMPC)Mbp>	MP:0001714,absent trophoblast giant cells|MP:0001727,abnormal embryo implantation|MP:0002792,abnormal retina vasculature morphology|MP:0004964,absent inner cell mass|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6437047	Nup98<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:3653729	Nup98<tm1Bmaf>	MP:0001805,decreased IgG level|MP:0001839,abnormal level of surface class I molecules|MP:0005017,decreased B cell number|MP:0005040,abnormal MHC II cell surface expression on macrophages|MP:0005042,abnormal level of surface class II molecules|MP:0005095,decreased T cell proliferation|MP:0005348,increased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008495,decreased IgG1 level
MGI:3759762	Nup98<tm1Jvd>	MP:0001672,abnormal embryo development|MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0011089,perinatal lethality, complete penetrance
MGI:3784016	Nupr1<tm1Jlio>	MP:0000313,abnormal cell death|MP:0001938,delayed sexual maturation|MP:0002679,abnormal corpus luteum morphology|MP:0003077,abnormal cell cycle|MP:0005131,increased follicle stimulating hormone level|MP:0005132,decreased luteinizing hormone level|MP:0005133,increased luteinizing hormone level|MP:0005159,azoospermia|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0011703,increased fibroblast proliferation
MGI:2671725	nur1	MP:0000745,tremors|MP:0001399,hyperactivity|MP:0008912,nervous
MGI:2671738	nur10	MP:0000745,tremors|MP:0001399,hyperactivity
MGI:2671783	nur11	MP:0000160,kyphosis|MP:0001406,abnormal gait
MGI:2671786	nur13	MP:0001393,ataxia
MGI:2671788	nur15	MP:0000371,diluted coat color|MP:0002880,opisthotonus|MP:0011085,postnatal lethality, complete penetrance
MGI:2671789	nur16	MP:0000371,diluted coat color|MP:0002880,opisthotonus|MP:0011085,postnatal lethality, complete penetrance
MGI:2671792	nur18	MP:0000938,motor neuron degeneration
MGI:2671793	nur19	MP:0001388,abnormal stationary movement|MP:0001393,ataxia
MGI:2671727	nur2	MP:0001399,hyperactivity
MGI:2671794	nur20	MP:0000745,tremors
MGI:2671795	nur21	MP:0005191,head tilt|MP:0005377,hearing/vestibular/ear phenotype
MGI:2671796	nur22	MP:0000436,abnormal head movements|MP:0001265,decreased body size|MP:0006325,impaired hearing
MGI:2671797	nur23	MP:0000746,weakness|MP:0005202,lethargy
MGI:2671799	nur24	MP:0001394,circling
MGI:2671800	nur25	MP:0001394,circling|MP:0001410,head bobbing
MGI:2671801	nur26	MP:0001394,circling|MP:0005307,head tossing
MGI:2671802	nur27	MP:0001394,circling|MP:0005307,head tossing
MGI:2671803	nur28	MP:0005307,head tossing
MGI:2671805	nur29	MP:0001394,circling|MP:0005307,head tossing
MGI:2671729	nur3	MP:0000428,abnormal craniofacial morphology|MP:0001399,hyperactivity
MGI:2671806	nur30	MP:0001265,decreased body size|MP:0004924,abnormal behavior|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2671807	nur31	MP:0001265,decreased body size|MP:0004924,abnormal behavior
MGI:3038764	nur33	MP:0000243,myoclonus|MP:0000747,muscle weakness
MGI:3038766	nur34	MP:0001393,ataxia
MGI:3038767	Nur35	MP:0001394,circling
MGI:3038768	Nur36	MP:0001394,circling
MGI:3038769	Nur37	MP:0001391,abnormal tail movements|MP:0002064,seizures
MGI:3038770	nur38	MP:0000745,tremors
MGI:3038771	nur39	MP:0001406,abnormal gait|MP:0001525,impaired balance
MGI:2671730	nur4	MP:0000745,tremors
MGI:3038773	nur40	MP:0001406,abnormal gait
MGI:3038774	nur41	MP:0001406,abnormal gait|MP:0005307,head tossing
MGI:3038775	nur42	MP:0001388,abnormal stationary movement|MP:0001406,abnormal gait|MP:0005307,head tossing
MGI:3038776	nur43	MP:0001406,abnormal gait
MGI:3038778	nur44	MP:0001388,abnormal stationary movement|MP:0001406,abnormal gait
MGI:3038781	nur45	MP:0001406,abnormal gait
MGI:3038782	nur46	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002083,premature death
MGI:3038784	nur47	MP:0000585,kinked tail|MP:0000745,tremors|MP:0001394,circling|MP:0005191,head tilt
MGI:3038785	nur48	MP:0001406,abnormal gait|MP:0001524,impaired limb coordination
MGI:3038787	nur49	MP:0001406,abnormal gait|MP:0001524,impaired limb coordination
MGI:3038789	nur50	MP:0000745,tremors|MP:0001406,abnormal gait
MGI:3038790	nur51	MP:0001394,circling|MP:0005307,head tossing
MGI:3038791	nur52	MP:0001393,ataxia|MP:0001525,impaired balance
MGI:3038793	nur53	MP:0001265,decreased body size|MP:0001524,impaired limb coordination
MGI:3038796	nur54	MP:0001524,impaired limb coordination|MP:0001525,impaired balance
MGI:3038797	nur55	MP:0001406,abnormal gait|MP:0001524,impaired limb coordination
MGI:3038799	nur56	MP:0001524,impaired limb coordination
MGI:3038800	nur57	MP:0005191,head tilt|MP:0005307,head tossing
MGI:3038801	nur58	MP:0005307,head tossing
MGI:3038802	nur59	MP:0001394,circling|MP:0005307,head tossing
MGI:2671732	nur6	MP:0001265,decreased body size|MP:0001399,hyperactivity
MGI:3041801	nur60	MP:0000745,tremors|MP:0005307,head tossing
MGI:3041802	nur61	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001513,limb grasping|MP:0001524,impaired limb coordination
MGI:3041803	nur62	MP:0000745,tremors|MP:0001524,impaired limb coordination
MGI:3043666	nur63	MP:0000745,tremors|MP:0001265,decreased body size
MGI:3043667	nur64	MP:0001524,impaired limb coordination
MGI:3043668	nur65	MP:0001394,circling
MGI:3043669	nur66	MP:0001394,circling
MGI:3046759	Nur67	MP:0001524,impaired limb coordination
MGI:3046762	nur68	MP:0000745,tremors|MP:0001406,abnormal gait|MP:0001525,impaired balance
MGI:3046765	nur69	MP:0000745,tremors|MP:0001406,abnormal gait|MP:0001525,impaired balance
MGI:3046769	nur70	MP:0000745,tremors
MGI:3577488	nur71	MP:0000745,tremors|MP:0001265,decreased body size
MGI:3577489	nur72	MP:0000745,tremors
MGI:3577490	nur73	MP:0001406,abnormal gait
MGI:3577491	nur74	MP:0001394,circling|MP:0005307,head tossing
MGI:3577492	nur75	MP:0001406,abnormal gait
MGI:3577495	nur76	MP:0001406,abnormal gait|MP:0001504,abnormal posture
MGI:3577496	nur77	MP:0000745,tremors
MGI:2671734	nur8	MP:0001399,hyperactivity|MP:0002064,seizures
MGI:2671735	nur9	MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001967,deafness
MGI:5911854	Nus1<tm1.1Qrm>	MP:0000180,abnormal circulating cholesterol level|MP:0000259,abnormal vascular development|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001698,decreased embryo size|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0003229,abnormal vitelline vasculature morphology|MP:0004950,abnormal brain vasculature morphology|MP:0009355,increased liver triglyceride level|MP:0010026,decreased liver cholesterol level|MP:0010359,increased liver free fatty acids level|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5620527	Nus1<tm1.1Wcsa>	MP:0011092,embryonic lethality, complete penetrance
MGI:6361026	Nus1<tm1.2Qrm>	MP:0000259,abnormal vascular development|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5620526	Nus1<tm1Wcsa>	MP:0000259,abnormal vascular development|MP:0001698,decreased embryo size|MP:0001914,hemorrhage|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0004003,abnormal vascular endothelial cell physiology|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011131,abnormal lung endothelial cell physiology|MP:0011140,decreased lung endothelial cell proliferation|MP:0011141,increased lung endothelial cell apoptosis|MP:0011205,excessive folding of visceral yolk sac|MP:0011523,thin placenta labyrinth|MP:0012201,decreased endothelial cell proliferation|MP:0013848,subcutaneous edema|MP:0014134,abnormal embryo morphology|MP:0020321,increased vascular endothelial cell apoptosis|MP:0020517,abnormal visceral yolk sac physiology|MP:0020830,abnormal jugular lymph sac morphology
MGI:4833676	Nusap1<tm1.1Gcm>	MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0002718,abnormal inner cell mass morphology|MP:0003988,disorganized embryonic tissue|MP:0004046,abnormal mitosis|MP:0004760,increased mitotic index|MP:0009760,abnormal mitotic spindle morphology|MP:0010380,abnormal inner cell mass apoptosis|MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:5548558	Nutf2<tm1b(KOMP)Mbp>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0005333,decreased heart rate|MP:0011100,preweaning lethality, complete penetrance
MGI:5812926	Nutm1<tm1b(KOMP)Wtsi>	MP:0001925,male infertility|MP:0003960,increased lean body mass|MP:0005419,decreased circulating serum albumin level|MP:0005561,increased mean corpuscular hemoglobin|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width
MGI:6695078	Nutm1<tm1Ger>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0005159,azoospermia
MGI:5637173	Nutm2<tm2b(EUCOMM)Wtsi>	MP:0001925,male infertility
MGI:1856972	nv	MP:0000026,abnormal inner ear morphology|MP:0000037,abnormal lateral semicircular canal morphology|MP:0001262,decreased body weight|MP:0001353,increased aggression towards mice|MP:0001395,bidirectional circling|MP:0001399,hyperactivity|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002428,abnormal semicircular canal morphology|MP:0002730,head shaking|MP:0003161,absent lateral semicircular canal|MP:0004249,abnormal crista ampullaris morphology|MP:0004924,abnormal behavior
MGI:3531155	Nwa2<NZW/LacJ>	MP:0004771,increased anti-single stranded DNA antibody level|MP:0004796,increased anti-histone antibody level
MGI:8203529	Nwd1<em2.1Sisa>	MP:0000218,increased leukocyte cell number|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002628,hepatic steatosis|MP:0003333,liver fibrosis|MP:0008114,abnormal Kupffer cell morphology|MP:0009355,increased liver triglyceride level|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010027,increased liver cholesterol level|MP:0011101,prenatal lethality, incomplete penetrance|MP:0014363,increased pyroptosis|MP:0020354,increased endoplasmic reticulum stress
MGI:6341878	Nwd2<em1(IMPC)Ccpcz>	MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0002059,abnormal seminal vesicle morphology|MP:0002997,enlarged seminal vesicle|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:2680965	Nxf1<Mvb1>	MP:0010768,mortality/aging
MGI:3848439	Nxf2<tm1.2Jw>	MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0002685,abnormal spermatogonia proliferation|MP:0002687,oligozoospermia|MP:0004218,meiotic nondisjunction during M1 phase|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0008280,abnormal male germ cell apoptosis|MP:0008995,early reproductive senescence|MP:0014617,decreased spermatogonia number
MGI:4950382	Nxf3<tm1.1Jw>	MP:0005389,reproductive system phenotype
MGI:4950383	Nxf3<tm1.2Jw>	MP:0005389,reproductive system phenotype
MGI:5649077	Nxf7<tm1.1Froy>	MP:0005386,behavior/neurological phenotype|MP:0012307,impaired spatial learning
MGI:6257797	Nxn<em1(IMPC)Bay>	MP:0001491,unresponsive to tactile stimuli|MP:0001697,abnormal embryo size|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003743,abnormal facial morphology|MP:0008797,facial cleft|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0011496,abnormal head size
MGI:5620177	Nxn<em1(IMPC)J>	MP:0000111,cleft palate|MP:0001697,abnormal embryo size|MP:0003743,abnormal facial morphology|MP:0005344,increased circulating bilirubin level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008797,facial cleft|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:6158480	Nxn<em1(IMPC)Mbp>	MP:0001258,decreased body length|MP:0001914,hemorrhage|MP:0003054,spina bifida|MP:0011100,preweaning lethality, complete penetrance
MGI:2671884	Nxn<l11Jus13>	MP:0011089,perinatal lethality, complete penetrance
MGI:5432155	Nxnl1<tm1.2Tlev>	MP:0002090,abnormal vision|MP:0002118,abnormal lipid homeostasis|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005253,abnormal eye physiology|MP:0008446,decreased retina cone cell number|MP:0008515,thin retina outer nuclear layer|MP:0008918,microgliosis
MGI:7425882	Nxnl2<em1(IMPC)Ccpcz>	MP:0000367,abnormal coat/ hair morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0000759,abnormal skeletal muscle morphology|MP:0003961,decreased lean body mass|MP:0005599,increased cardiac muscle contractility
MGI:5426260	Nxnl2<tm1.2Tlev>	MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0008446,decreased retina cone cell number|MP:0008544,impaired olfaction|MP:0008587,short photoreceptor outer segment
MGI:4432925	Nxn<tm1a(EUCOMM)Wtsi>	MP:0001293,anophthalmia|MP:0001319,irregularly shaped pupil|MP:0005140,decreased cardiac muscle contractility|MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5548389	Nxn<tm1b(EUCOMM)Wtsi>	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0000602,dilated liver sinusoidal space|MP:0000627,abnormal mammary gland morphology|MP:0001340,abnormal eyelid morphology|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001404,no spontaneous movement|MP:0001417,decreased exploration in new environment|MP:0001491,unresponsive to tactile stimuli|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0001697,abnormal embryo size|MP:0002110,abnormal digit morphology|MP:0002764,short tibia|MP:0002768,small adrenal glands|MP:0002968,increased circulating alkaline phosphatase level|MP:0003743,abnormal facial morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0004666,absent stapedial artery|MP:0008259,abnormal optic disk morphology|MP:0008797,facial cleft|MP:0010418,perimembraneous ventricular septal defect|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0010912,herniated liver|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0011496,abnormal head size|MP:0013916,decreased intestine length|MP:0013986,abnormal vitelline vein topology|MP:0020420,abnormal freezing behavior
MGI:4881787	Nxn<tm1Hmik>	MP:0000157,abnormal sternum morphology|MP:0002633,persistent truncus arteriosus|MP:0004200,decreased fetal size|MP:0004377,small frontal bone|MP:0004678,split xiphoid process|MP:0004988,increased osteoblast cell number|MP:0005621,abnormal cell physiology|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0011089,perinatal lethality, complete penetrance
MGI:4433447	Nxpe5<tm1a(EUCOMM)Wtsi>	MP:0002875,decreased erythrocyte cell number
MGI:2445315	Nxph1<tm1Sud>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0005378,growth/size/body region phenotype|MP:0010768,mortality/aging
MGI:3706428	Nxph3<tm1.1Mami>	MP:0001392,abnormal locomotor behavior|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001488,increased startle reflex|MP:0003631,nervous system phenotype|MP:0005389,reproductive system phenotype
MGI:3705089	Nxph3<tm1Mami>	MP:0002169,no abnormal phenotype detected
MGI:5007268	Nxph4<tm1Lex>	MP:0002644,decreased circulating triglyceride level|MP:0011741,increased urine nitrite level
MGI:6188299	Nxt2<em1Qsh>	MP:0005389,reproductive system phenotype
MGI:2448764	Ny	MP:0009004,progressive hair loss
MGI:6414480	Nyap1<em1(IMPC)Bay>	MP:0001399,hyperactivity
MGI:6158517	Nynrin<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology
MGI:2177945	Nyx<nob>	MP:0002090,abnormal vision|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0010749,absent visual evoked potential
MGI:5284928	Oaf<tm1a(EUCOMM)Wtsi>	MP:0003960,increased lean body mass
MGI:3850108	oar	MP:0001406,abnormal gait|MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype
MGI:5644469	Oard1<em1(IMPC)J>	MP:0009142,decreased prepulse inhibition
MGI:6152739	Oard1<em1(IMPC)Wtsi>	MP:0006358,absent pinna reflex
MGI:1857802	Oas1b<Flv-mr>	MP:0020944,decreased susceptibility to Flaviviridae infection
MGI:1857800	Oas1b<Flv-r>	MP:0020944,decreased susceptibility to Flaviviridae infection
MGI:2181524	Oas1b<Flv-s>	MP:0020943,increased susceptibility to Flaviviridae infection
MGI:5285411	Oas1b<tm1.1Brin>	MP:0020944,decreased susceptibility to Flaviviridae infection
MGI:6358068	Oas1c<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001293,anophthalmia|MP:0002092,abnormal eye morphology|MP:0002100,abnormal tooth morphology|MP:0010574,dilated aorta
MGI:3581976	Oas1d<tm1Zuk>	MP:0001131,abnormal ovarian follicle morphology|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002680,decreased corpora lutea number|MP:0003718,maternal effect|MP:0031420,decreased superovulation rate
MGI:5569082	Oas1g<tm1b(KOMP)Wtsi>	MP:0005559,increased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance
MGI:7641813	Oas1h<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6154625	Oas2<M1Apb>	MP:0001881,abnormal mammary gland physiology|MP:0005379,endocrine/exocrine gland phenotype|MP:0006042,increased apoptosis|MP:0006270,abnormal mammary gland growth during lactation|MP:0009506,abnormal mammary gland alveolus morphology|MP:0010174,decreased mammary gland epithelial cell proliferation|MP:0010249,lactation failure|MP:0013716,hypolactation
MGI:5700045	Oasl1<tm1b(EUCOMM)Hmgu>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5498949	Oasl1<tm1Yjk>	MP:0008548,abnormal circulating interferon level|MP:0020938,decreased susceptibility to Picornaviridae infection|MP:0031039,decreased susceptibility to Picornaviridae infection induced morbidity/mortality
MGI:4431962	Oasl2<tm1a(EUCOMM)Wtsi>	MP:0005560,decreased circulating glucose level
MGI:1857018	Oat<rhg>	MP:0000377,abnormal hair follicle morphology|MP:0000420,ruffled hair|MP:0000424,retarded hair growth|MP:0001265,decreased body size|MP:0001304,cataract|MP:0002075,abnormal coat/hair pigmentation|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005377,hearing/vestibular/ear phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005478,decreased circulating thyroxine level|MP:0005548,retina pigment epithelium atrophy|MP:0008587,short photoreceptor outer segment|MP:0008805,decreased circulating amylase level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0030650,increased circulating ornithine level
MGI:2150441	Oat<tm1Dva>	MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0001327,decreased retina photoreceptor cell number|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005202,lethargy|MP:0005309,increased circulating ammonia level|MP:0005311,abnormal circulating amino acid level|MP:0005551,abnormal eye electrophysiology|MP:0008515,thin retina outer nuclear layer|MP:0008581,disorganized photoreceptor inner segment|MP:0008582,short photoreceptor inner segment|MP:0008585,absent photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0011087,neonatal lethality, complete penetrance|MP:0011765,oroticaciduria|MP:0020837,decreased circulating citrulline level|MP:0030650,increased circulating ornithine level|MP:0030651,decreased circulating ornithine level|MP:0030662,decreased circulating arginine level|MP:0030671,decreased circulating phenylalanine level
MGI:5763465	Oaz2<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0002590,increased mean corpuscular volume|MP:0005567,decreased circulating total protein level|MP:0010053,decreased grip strength
MGI:4462794	Oaz3<tm1Htan>	MP:0001925,male infertility|MP:0004542,impaired acrosome reaction|MP:0008893,detached sperm flagellum
MGI:3721926	Obox6<tm1Hung>	MP:0002169,no abnormal phenotype detected
MGI:5692815	Obp2a<tm1b(EUCOMM)Wtsi>	MP:0002075,abnormal coat/hair pigmentation|MP:0005178,increased circulating cholesterol level
MGI:6336126	Obp2b<em1(IMPC)Kmpc>	MP:0000367,abnormal coat/ hair morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0003068,enlarged kidney|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020421,increased freezing behavior
MGI:2154915	Obq10<NZO/HlLt>	MP:0000008,increased white adipose tissue amount
MGI:2156025	Obq11<NZO/HlLt>	MP:0000008,increased white adipose tissue amount
MGI:2156027	Obq12<NZO/HlLt>	MP:0000008,increased white adipose tissue amount
MGI:2156430	Obq13<NZO/HlLt>	MP:0000008,increased white adipose tissue amount
MGI:2156432	Obq14<NZO/HlLt>	MP:0000008,increased white adipose tissue amount
MGI:2156688	Obq15<NZO/HlLt>	MP:0000008,increased white adipose tissue amount
MGI:3497808	Obq16<129S1/SvImJ>	MP:0005458,increased percent body fat/body weight|MP:0006087,increased body mass index
MGI:3497812	Obq17<129S1/SvImJ>	MP:0005458,increased percent body fat/body weight|MP:0006087,increased body mass index
MGI:3497815	Obq19<C57BL/6J>	MP:0006087,increased body mass index
MGI:2156845	Obq1<EL/SuzSeyFrkJ>	MP:0000008,increased white adipose tissue amount
MGI:3614889	Obq20<NZB/BlNJ>	MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight
MGI:2154250	Obq2<129T2/SvEmsJ>	MP:0000008,increased white adipose tissue amount
MGI:3614948	Obq21<NZB/BlNJ>	MP:0009304,increased retroperitoneal fat pad weight
MGI:3614954	Obq22<NZB/BlNJ>	MP:0009285,increased gonadal fat pad weight|MP:0009304,increased retroperitoneal fat pad weight
MGI:2429748	Obq36<SM/J>	MP:0000008,increased white adipose tissue amount
MGI:2155173	Obq3<AKR/J>	MP:0002089,abnormal postnatal growth/weight/body size
MGI:2429751	Obq4<C57L/J>	MP:0009292,increased inguinal fat pad weight
MGI:2157358	Obq5<KK/HlLt>	MP:0000008,increased white adipose tissue amount
MGI:2157362	Obq6<KK/HlLt>	MP:0010024,increased total body fat amount
MGI:2154252	Obq7<NZO/HlLt>	MP:0000008,increased white adipose tissue amount
MGI:2154255	Obq8<NZO/HlLt>	MP:0000008,increased white adipose tissue amount
MGI:2154257	Obq9<NZO/HlLt>	MP:0000008,increased white adipose tissue amount
MGI:3845221	Obrq13<A/J>	MP:0002310,decreased susceptibility to hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0005179,decreased circulating cholesterol level|MP:0005331,insulin resistance|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity
MGI:3845224	Obrq14<A/J>	MP:0002628,hepatic steatosis|MP:0005178,increased circulating cholesterol level|MP:0005331,insulin resistance|MP:0005658,increased susceptibility to diet-induced obesity
MGI:3845226	Obrq15<A/J>	MP:0001554,increased circulating free fatty acids level|MP:0005659,decreased susceptibility to diet-induced obesity
MGI:3845234	Obrq16<A/J>	MP:0009356,decreased liver triglyceride level
MGI:3845236	Obrq17<A/J>	MP:0002644,decreased circulating triglyceride level
MGI:6757165	Obscn<tm1.1Geno>	MP:0002626,increased heart rate|MP:0003141,cardiac fibrosis|MP:0004215,abnormal myocardial fiber physiology|MP:0004485,increased response of heart to induced stress|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0031635,increased heart left ventricle muscle contractility
MGI:4361272	Obscn<tm1Chen>	MP:0000751,myopathy|MP:0002106,abnormal muscle physiology|MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0004121,abnormal sarcolemma morphology|MP:0005369,muscle phenotype|MP:0009401,increased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:6450042	Obsl1<tm1.1Slan>	MP:0005369,muscle phenotype|MP:0009401,increased skeletal muscle fiber diameter|MP:0009423,increased extensor digitorum longus weight|MP:0010768,mortality/aging
MGI:6450045	Obsl1<tm1.2Slan>	MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:3525657	Obsty1<LG/J>	MP:0001260,increased body weight|MP:0002758,long tail|MP:0003917,increased kidney weight|MP:0008908,increased total fat pad weight|MP:0009298,increased mesenteric fat pad weight|MP:0009302,increased renal fat pad weight|MP:0009304,increased retroperitoneal fat pad weight
MGI:3525676	Obsty2<SM/J>	MP:0009302,increased renal fat pad weight
MGI:3525677	Obsty3<LG/J>	MP:0001260,increased body weight|MP:0002833,increased heart weight|MP:0008908,increased total fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009298,increased mesenteric fat pad weight|MP:0009302,increased renal fat pad weight
MGI:3525694	Obsty4<LG/J>	MP:0008908,increased total fat pad weight
MGI:3525700	Obsty5<SM/J>	MP:0005178,increased circulating cholesterol level|MP:0005669,increased circulating leptin level|MP:0008908,increased total fat pad weight|MP:0009298,increased mesenteric fat pad weight
MGI:3614850	Obwq1<NZB/BlNJ>	MP:0001260,increased body weight|MP:0009298,increased mesenteric fat pad weight
MGI:3614852	Obwq2<NZB/BlNJ>	MP:0001260,increased body weight|MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight
MGI:3614856	Obwq3<SM/J>	MP:0001260,increased body weight|MP:0009292,increased inguinal fat pad weight|MP:0009304,increased retroperitoneal fat pad weight
MGI:3614861	Obwq4<NZB/BlNJ>	MP:0001260,increased body weight|MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009298,increased mesenteric fat pad weight|MP:0009304,increased retroperitoneal fat pad weight
MGI:3614864	Obwq5<NZB/BlNJ>	MP:0001260,increased body weight|MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009298,increased mesenteric fat pad weight|MP:0009304,increased retroperitoneal fat pad weight
MGI:3606973	Oc90<df1D8R>	MP:0002169,no abnormal phenotype detected
MGI:3606974	Oc90<df1H5R>	MP:0002169,no abnormal phenotype detected
MGI:3715290	Oc90<tm1Ywl>	MP:0002894,abnormal otolith morphology|MP:0003143,enlarged otoliths|MP:0003144,decreased otolith number|MP:0003149,abnormal tectorial membrane morphology|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology
MGI:1856114	Oca2<p>	MP:0005172,decreased eye pigmentation
MGI:1857923	Oca2<p-103G>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001324,abnormal eye pigmentation|MP:0001925,male infertility|MP:0002083,premature death|MP:0005409,darkened coat color|MP:0008912,nervous
MGI:1857917	Oca2<p-116G>	MP:0000111,cleft palate|MP:0008480,absent eye pigmentation|MP:0011085,postnatal lethality, complete penetrance
MGI:1857920	Oca2<p-12DTR>	MP:0000371,diluted coat color|MP:0000745,tremors|MP:0001265,decreased body size|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002083,premature death|MP:0003492,abnormal involuntary movement|MP:0011100,preweaning lethality, complete penetrance
MGI:1857919	Oca2<p-12R250M>	MP:0011086,postnatal lethality, incomplete penetrance
MGI:1857916	Oca2<p-132G>	MP:0002080,prenatal lethality
MGI:1857885	Oca2<p-15J>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation
MGI:1857918	Oca2<p-17FATWb>	MP:0002082,postnatal lethality
MGI:3612248	Oca2<p-18CoS>	MP:0011086,postnatal lethality, incomplete penetrance
MGI:4999725	Oca2<p-18J>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation
MGI:3043517	Oca2<p-23DFiOD>	MP:0011091,prenatal lethality, complete penetrance
MGI:1856126	Oca2<p-25H>	MP:0000371,diluted coat color|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001384,abnormal pup retrieval|MP:0001386,abnormal maternal nurturing|MP:0001405,impaired coordination|MP:0001935,decreased litter size|MP:0001940,testis hypoplasia|MP:0004901,decreased male germ cell number|MP:0005172,decreased eye pigmentation|MP:0005379,endocrine/exocrine gland phenotype|MP:0005390,skeleton phenotype|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0008912,nervous|MP:0009230,abnormal sperm head morphology|MP:0009233,enlarged sperm head|MP:0020550,multinucleated giant male germ cells
MGI:3783461	Oca2<p-2Btlr>	MP:0000371,diluted coat color|MP:0006159,ocular albinism
MGI:3043520	Oca2<p-30PUb>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857924	Oca2<p-39DSD>	MP:0011086,postnatal lethality, incomplete penetrance
MGI:3783463	Oca2<p-3Btlr>	MP:0000371,diluted coat color|MP:0002412,increased susceptibility to bacterial infection|MP:0006159,ocular albinism|MP:0010766,abnormal NK cell physiology
MGI:1857914	Oca2<p-46DfiOD>	MP:0002081,perinatal lethality
MGI:1857921	Oca2<p-48PB>	MP:0002081,perinatal lethality
MGI:3783466	Oca2<p-4Btlr>	MP:0000371,diluted coat color|MP:0002412,increased susceptibility to bacterial infection|MP:0005387,immune system phenotype|MP:0006159,ocular albinism
MGI:2673989	Oca2<p-4THO-II>	MP:0000111,cleft palate|MP:0002058,neonatal lethality
MGI:5301923	Oca2<p-55H>	MP:0011091,prenatal lethality, complete penetrance
MGI:5578028	Oca2<p-5Btlr>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation
MGI:5301924	Oca2<p-61H>	MP:0002169,no abnormal phenotype detected
MGI:5301925	Oca2<p-65H>	MP:0001324,abnormal eye pigmentation
MGI:5301926	Oca2<p-66H>	MP:0002075,abnormal coat/hair pigmentation
MGI:5607162	Oca2<p-6Btlr>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation
MGI:1856125	Oca2<p-6H>	MP:0000371,diluted coat color|MP:0001124,abnormal gametes|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001324,abnormal eye pigmentation|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001924,infertility|MP:0001925,male infertility|MP:0001929,abnormal gametogenesis|MP:0001931,abnormal oogenesis|MP:0001932,abnormal spermiogenesis|MP:0001940,testis hypoplasia|MP:0004901,decreased male germ cell number|MP:0005172,decreased eye pigmentation|MP:0005390,skeleton phenotype|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0008912,nervous|MP:0009230,abnormal sperm head morphology|MP:0009233,enlarged sperm head|MP:0020550,multinucleated giant male germ cells
MGI:5301927	Oca2<p-78H>	MP:0002169,no abnormal phenotype detected
MGI:6114099	Oca2<p-7Btlr>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation
MGI:1857915	Oca2<p-7FR60Lb>	MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3612257	Oca2<p-7R>	MP:0001324,abnormal eye pigmentation|MP:0005409,darkened coat color
MGI:5301928	Oca2<p-80H>	MP:0000371,diluted coat color|MP:0002075,abnormal coat/hair pigmentation
MGI:3798909	Oca2<p-80K>	MP:0011091,prenatal lethality, complete penetrance
MGI:1856310	Oca2<p-81H>	MP:0002080,prenatal lethality|MP:0005172,decreased eye pigmentation
MGI:1856311	Oca2<p-82H>	MP:0002080,prenatal lethality
MGI:5301930	Oca2<p-85H>	MP:0000371,diluted coat color|MP:0002075,abnormal coat/hair pigmentation
MGI:1856314	Oca2<p-87H>	MP:0002080,prenatal lethality
MGI:6197816	Oca2<p-8Btlr>	MP:0000371,diluted coat color|MP:0008537,increased susceptibility to induced colitis
MGI:3798907	Oca2<p-8FDFoD>	MP:0011091,prenatal lethality, complete penetrance
MGI:5301933	Oca2<p-92H>	MP:0002075,abnormal coat/hair pigmentation
MGI:5301934	Oca2<p-93H>	MP:0011091,prenatal lethality, complete penetrance
MGI:5301935	Oca2<p-95H>	MP:0002169,no abnormal phenotype detected
MGI:5301936	Oca2<p-96H>	MP:0002080,prenatal lethality
MGI:5301937	Oca2<p-97H>	MP:0002169,no abnormal phenotype detected
MGI:5301938	Oca2<p-98H>	MP:0011400,lethality, complete penetrance
MGI:5301939	Oca2<p-99H>	MP:0011400,lethality, complete penetrance
MGI:1857922	Oca2<p-9DTW>	MP:0011086,postnatal lethality, incomplete penetrance
MGI:3512102	Oca2<p-9J>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation
MGI:1856115	Oca2<p-bs>	MP:0000371,diluted coat color|MP:0001265,decreased body size|MP:0001516,abnormal motor coordination/balance|MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002161,abnormal fertility/fecundity|MP:0005424,jerky movement
MGI:3783453	Oca2<p-Btlr>	MP:0000371,diluted coat color|MP:0005387,immune system phenotype|MP:0006159,ocular albinism
MGI:1857334	Oca2<p-cas>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0002075,abnormal coat/hair pigmentation|MP:0003136,yellow coat color
MGI:1856116	Oca2<p-cp>	MP:0000111,cleft palate|MP:0000371,diluted coat color|MP:0001732,postnatal growth retardation|MP:0005172,decreased eye pigmentation|MP:0005424,jerky movement|MP:0011090,perinatal lethality, incomplete penetrance
MGI:1856117	Oca2<p-d>	MP:0000371,diluted coat color|MP:0002075,abnormal coat/hair pigmentation|MP:0005172,decreased eye pigmentation|MP:0005389,reproductive system phenotype
MGI:1856118	Oca2<p-dn>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation|MP:0005386,behavior/neurological phenotype
MGI:1856127	Oca2<p-J>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation
MGI:1856122	Oca2<p-s>	MP:0001265,decreased body size|MP:0001386,abnormal maternal nurturing|MP:0001516,abnormal motor coordination/balance|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002083,premature death|MP:0005172,decreased eye pigmentation|MP:0005578,teratozoospermia
MGI:1856123	Oca2<p-un>	MP:0000371,diluted coat color|MP:0000421,mottled coat|MP:0001324,abnormal eye pigmentation|MP:0002075,abnormal coat/hair pigmentation|MP:0010389,mosaic coat color
MGI:2152524	Oca2<p-un+2J>	MP:0001186,pigmentation phenotype|MP:0001324,abnormal eye pigmentation|MP:0003171,phenotypic reversion|MP:0005172,decreased eye pigmentation|MP:0005366,variegated coat color
MGI:2152525	Oca2<p-un+3J>	MP:0001186,pigmentation phenotype|MP:0001324,abnormal eye pigmentation|MP:0003171,phenotypic reversion|MP:0005172,decreased eye pigmentation|MP:0005366,variegated coat color
MGI:2152526	Oca2<p-un+4J>	MP:0001186,pigmentation phenotype|MP:0003171,phenotypic reversion
MGI:2152527	Oca2<p-un+5J>	MP:0001186,pigmentation phenotype|MP:0003171,phenotypic reversion
MGI:2152528	Oca2<p-un+6J>	MP:0001186,pigmentation phenotype|MP:0003171,phenotypic reversion
MGI:2152523	Oca2<p-un+J>	MP:0001186,pigmentation phenotype|MP:0001324,abnormal eye pigmentation|MP:0003171,phenotypic reversion|MP:0005172,decreased eye pigmentation|MP:0005366,variegated coat color
MGI:1856124	Oca2<p-x>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0011279,decreased ear pigmentation
MGI:1856974	ocd	MP:0000131,abnormal long bone epiphysis morphology|MP:0000428,abnormal craniofacial morphology|MP:0000440,domed cranium|MP:0000588,thick tail|MP:0000592,short tail|MP:0001265,decreased body size|MP:0001925,male infertility|MP:0002111,abnormal tail morphology|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004686,decreased length of long bones|MP:0008525,decreased cranium height|MP:0008909,supination
MGI:1857321	Och	MP:0000371,diluted coat color|MP:0001265,decreased body size|MP:0001516,abnormal motor coordination/balance|MP:0005376,homeostasis/metabolism phenotype|MP:0011084,lethality at weaning, incomplete penetrance
MGI:6403863	Ociad1<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0001566,increased circulating phosphate level|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level
MGI:6367551	Ociad1<tm1.1Msin>	MP:0000160,kyphosis|MP:0000172,abnormal bone marrow cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000321,increased bone marrow cell number|MP:0000322,increased granulocyte number|MP:0000333,decreased bone marrow cell number|MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0001658,increased mortality induced by gamma-irradiation|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0003131,increased erythrocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005425,increased macrophage cell number|MP:0006043,decreased apoptosis|MP:0008483,increased spleen germinal center size|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011181,increased hematopoietic cell number|MP:0011898,abnormal platelet cell number|MP:0011902,increased hematopoietic stem cell proliferation|MP:0012734,abnormal response to radiation|MP:0013415,increased myeloid cell number in bone marrow|MP:0013696,increased granulocyte monocyte progenitor cell number|MP:0013893,decreased common lymphocyte progenitor cell number
MGI:6367550	Ociad1<tm1Msin>	MP:0004809,increased hematopoietic stem cell number|MP:0011181,increased hematopoietic cell number
MGI:6362817	Ociad2<em1(IMPC)Tcp>	MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005343,increased circulating aspartate transaminase level
MGI:3640976	Ocln<Gt(ROSA)39Tshi>	MP:0000130,abnormal trabecular bone morphology|MP:0001873,stomach inflammation|MP:0004139,abnormal gastric parietal cell morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0009517,abnormal salivary gland duct morphology|MP:0010779,abnormal stomach muscularis externa morphology|MP:0010792,abnormal stomach mucosa morphology
MGI:3582233	Ocln<tm1Sts>	MP:0000473,abnormal stomach glandular epithelium morphology|MP:0000559,abnormal femur morphology|MP:0000613,abnormal salivary gland morphology|MP:0000849,abnormal cerebellum morphology|MP:0001382,abnormal nursing|MP:0001732,postnatal growth retardation|MP:0001873,stomach inflammation|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0006007,abnormal basal ganglion morphology
MGI:3641043	Ocln<tm1Tshi>	MP:0000130,abnormal trabecular bone morphology|MP:0001873,stomach inflammation|MP:0002108,abnormal muscle morphology|MP:0004139,abnormal gastric parietal cell morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0009517,abnormal salivary gland duct morphology|MP:0010779,abnormal stomach muscularis externa morphology|MP:0010792,abnormal stomach mucosa morphology
MGI:3582579	Ocln<tm2Sts>	MP:0000473,abnormal stomach glandular epithelium morphology|MP:0000559,abnormal femur morphology|MP:0000849,abnormal cerebellum morphology|MP:0001382,abnormal nursing|MP:0001732,postnatal growth retardation|MP:0001873,stomach inflammation|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0004139,abnormal gastric parietal cell morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0005211,increased stomach mucosa thickness|MP:0005376,homeostasis/metabolism phenotype|MP:0006007,abnormal basal ganglion morphology|MP:0009517,abnormal salivary gland duct morphology
MGI:4366443	Ocm<tm1.1Ddsi>	MP:0001967,deafness|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004586,pillar cell degeneration|MP:0004736,abnormal distortion product otoacoustic emission|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0011968,decreased threshold for auditory brainstem response
MGI:4432497	Ocm<tm1e(EUCOMM)Wtsi>	MP:0006358,absent pinna reflex
MGI:2159611	Ocrl<tm1Nbm>	MP:0002169,no abnormal phenotype detected
MGI:2159678	Ocrl<tm2Nbm>	MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0010768,mortality/aging
MGI:4458541	Ocstamp<tm2a(KOMP)Wtsi>	MP:0004982,abnormal osteoclast morphology|MP:0005390,skeleton phenotype
MGI:5447727	Ocstamp<tm2b(KOMP)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005560,decreased circulating glucose level
MGI:3851741	oda	MP:0000371,diluted coat color|MP:0009379,abnormal foot pigmentation|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:5692838	Odad1<tm2b(EUCOMM)Wtsi>	MP:0001364,decreased anxiety-related response|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5437099	Odad2<b2b227.1Clo>	MP:0000284,double outlet right ventricle|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0000694,spleen hypoplasia|MP:0001943,abnormal respiration|MP:0004133,heterotaxia|MP:0004880,lung cyst|MP:0005330,cardiomyopathy|MP:0010402,ventricular septal defect|MP:0010808,right-sided stomach|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia
MGI:5311373	Odad2<b2b643Clo>	MP:0000249,abnormal blood vessel physiology|MP:0000644,dextrocardia|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0005294,abnormal heart ventricle morphology|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011250,abdominal situs ambiguus|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia|MP:0011666,double outlet right ventricle, ventricular defect committed to aorta|MP:0011683,dual inferior vena cava
MGI:6277027	Odad2<em1(IMPC)Mbp>	MP:0000692,small spleen|MP:0001925,male infertility|MP:0002989,small kidney
MGI:5445347	Odad3<b2b1885Clo>	MP:0000639,abnormal adrenal gland morphology|MP:0000644,dextrocardia|MP:0000694,spleen hypoplasia|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011252,situs inversus totalis|MP:0011649,immotile respiratory cilia
MGI:5548687	Odad3<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000440,domed cranium|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000690,absent spleen|MP:0000691,enlarged spleen|MP:0000849,abnormal cerebellum morphology|MP:0001732,postnatal growth retardation|MP:0001893,non-obstructive hydrocephaly|MP:0001915,intracranial hemorrhage|MP:0002766,situs inversus|MP:0003795,abnormal bone structure|MP:0005159,azoospermia|MP:0005293,impaired glucose tolerance|MP:0006254,thin cerebral cortex|MP:0008535,enlarged lateral ventricles|MP:0010152,abnormal brain ependyma morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011252,situs inversus totalis|MP:0011253,situs inversus with levocardia|MP:0012139,increased forebrain size
MGI:6360701	Odad3<tm1c(EUCOMM)Hmgu>	MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia
MGI:6110171	Odad4<em#Omra>	MP:0000644,dextrocardia|MP:0001265,decreased body size|MP:0001891,hydrocephaly|MP:0004133,heterotaxia|MP:0010752,impaired mucociliary clearance|MP:0010854,lung situs inversus|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012093,absent nodal flow
MGI:7425884	Odaph<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002060,abnormal skin morphology|MP:0002100,abnormal tooth morphology|MP:0002110,abnormal digit morphology|MP:0002968,increased circulating alkaline phosphatase level
MGI:6781218	Odaph<tm1Cya>	MP:0000458,abnormal mandible morphology|MP:0002648,delaminated enamel|MP:0002649,abnormal enamel rod pattern|MP:0002650,abnormal ameloblast morphology|MP:0030450,abnormal enamel mineralization
MGI:5602832	Odc1<tm1b(EUCOMM)Hmgu>	MP:0002833,increased heart weight|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2387837	Odc1<tm1Jlc>	MP:0002169,no abnormal phenotype detected|MP:0010380,abnormal inner cell mass apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5692908	Odf1<tm1b(EUCOMM)Hmgu>	MP:0001566,increased circulating phosphate level|MP:0001925,male infertility|MP:0008810,increased circulating iron level
MGI:5319183	Odf1<tm1Shf>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004542,impaired acrosome reaction|MP:0005389,reproductive system phenotype|MP:0008893,detached sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology
MGI:3689998	Odf2<Gt(RRO072)Byg>	MP:0004179,transmission ratio distortion|MP:0005389,reproductive system phenotype|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4128382	Odf2<Gt(XL169)Byg>	MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0004179,transmission ratio distortion|MP:0008892,abnormal sperm flagellum morphology|MP:0009237,kinked sperm flagellum|MP:0009831,abnormal sperm midpiece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0031356,abnormal outer dense fiber morphology
MGI:6277011	Odf2l<em1(IMPC)Mbp>	MP:0002135,abnormal kidney morphology|MP:0002989,small kidney
MGI:5313543	Odf2<tm1.2Sats>	MP:0001925,male infertility
MGI:7331638	Odf4<em1Ktos>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0008892,abnormal sperm flagellum morphology|MP:0009243,hairpin sperm flagellum|MP:0013286,abnormal sperm capacitation
MGI:5708240	Odf4<tm1.1(KOMP)Vlcg>	MP:0000274,enlarged heart|MP:0000538,abnormal urinary bladder morphology|MP:0001925,male infertility
MGI:3033745	Odsm1<A/J>	MP:0001939,secondary sex reversal
MGI:3033744	Odsm1<FVB/N>	MP:0001939,secondary sex reversal
MGI:2447988	Ods<Tg(Dct-Tyr)1220Ove>	MP:0001286,abnormal eye development|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001939,secondary sex reversal|MP:0002075,abnormal coat/hair pigmentation|MP:0002995,primary sex reversal
MGI:3052442	Ods<tm1Ceb>	MP:0002169,no abnormal phenotype detected
MGI:1856975	oe	MP:0001286,abnormal eye development|MP:0001297,microphthalmia|MP:0001302,eyelids open at birth|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001340,abnormal eyelid morphology|MP:0002092,abnormal eye morphology|MP:0003153,early eyelid opening|MP:0005545,abnormal lens development|MP:0021107,retina fold
MGI:1856976	oed	MP:0000180,abnormal circulating cholesterol level|MP:0000183,decreased circulating LDL cholesterol level|MP:0000184,abnormal circulating HDL cholesterol level|MP:0000218,increased leukocyte cell number|MP:0000322,increased granulocyte number|MP:0001191,abnormal skin condition|MP:0001196,shiny skin|MP:0001764,abnormal homeostasis|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002058,neonatal lethality|MP:0002118,abnormal lipid homeostasis|MP:0003089,decreased skin tensile strength|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005282,decreased fatty acids level|MP:0005318,decreased triglyceride level|MP:0008817,hematoma
MGI:1856977	oel	MP:0000111,cleft palate|MP:0011089,perinatal lethality, complete penetrance
MGI:3044645	Ofact<129P2/OlaHsd>	MP:0001402,decreased locomotor activity
MGI:5752778	Ofcc1<em1(IMPC)J>	MP:0000556,abnormal hindlimb morphology|MP:0001486,abnormal startle reflex|MP:0001566,increased circulating phosphate level|MP:0003179,thrombocytopenia|MP:0010053,decreased grip strength|MP:0020870,decreased thigmotaxis
MGI:5693944	Ofcc1<tm1.2Tohn>	MP:0001570,abnormal circulating enzyme level|MP:0005382,craniofacial phenotype|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype
MGI:3620081	Ofd1<tm1Bfra>	MP:0004355,short radius|MP:0011261,abnormal limb mesenchyme morphology
MGI:4882077	Ofd1<tm2.1Bfra>	MP:0000111,cleft palate|MP:0000150,abnormal rib morphology|MP:0000157,abnormal sternum morphology|MP:0000270,abnormal heart tube morphology|MP:0000292,distended pericardium|MP:0000547,short limbs|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000926,absent floor plate|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001706,abnormal left-right axis patterning|MP:0002082,postnatal lethality|MP:0002152,abnormal brain morphology|MP:0002764,short tibia|MP:0002765,short fibula|MP:0002896,abnormal bone mineralization|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003641,small lung|MP:0004214,abnormal long bone diaphysis morphology|MP:0004252,abnormal direction of heart looping|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004686,decreased length of long bones|MP:0005296,abnormal humerus morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0005371,limbs/digits/tail phenotype|MP:0005380,embryo phenotype|MP:0006279,abnormal limb development|MP:0006396,decreased long bone epiphyseal plate size|MP:0008525,decreased cranium height|MP:0009743,preaxial polydactyly|MP:0009780,abnormal chondrocyte physiology|MP:0009937,abnormal neuron differentiation|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011261,abnormal limb mesenchyme morphology|MP:0011682,renal glomerulus cyst
MGI:3883869	Oga<Gt(YTC085)Byg>	MP:0001177,atelectasis|MP:0001953,respiratory failure|MP:0004024,aneuploidy|MP:0004046,abnormal mitosis|MP:0008008,early cellular replicative senescence|MP:0008866,chromosomal instability|MP:0009431,decreased fetal weight|MP:0009674,decreased birth weight|MP:0010865,prenatal growth retardation|MP:0011089,perinatal lethality, complete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0013289,abnormal mitotic cytokinesis
MGI:6257829	Ogdhl<em1(IMPC)Bay>	MP:0001925,male infertility|MP:0001926,female infertility
MGI:4939737	Ogdh<tm1e(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0002169,no abnormal phenotype detected|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013971,blood in lymph vessels
MGI:4362420	Ogfod1<tm1a(KOMP)Wtsi>	MP:0000559,abnormal femur morphology|MP:0001191,abnormal skin condition|MP:0004151,decreased circulating iron level
MGI:5607136	Ogfod1<tm1d(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5548515	Ogfod3<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0001512,trunk curl|MP:0009142,decreased prepulse inhibition
MGI:7865460	Ogfrl1<em1Uek>	MP:0002169,no abnormal phenotype detected
MGI:7865456	Ogfrl1<tm1.2Itl>	MP:0002169,no abnormal phenotype detected
MGI:2386943	Ogg1<tm1Tld>	MP:0002169,no abnormal phenotype detected
MGI:2386212	Ogg1<tm1Tno>	MP:0005370,liver/biliary system phenotype|MP:0005621,abnormal cell physiology|MP:0008058,abnormal DNA repair
MGI:2653014	Ogg1<tm1Yun>	MP:0001402,decreased locomotor activity|MP:0002048,increased lung adenoma incidence|MP:0002229,neurodegeneration|MP:0002757,decreased vertical activity|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0008714,increased lung carcinoma incidence|MP:0008918,microgliosis
MGI:5616354	Ogn<tm1b(KOMP)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0001399,hyperactivity|MP:0010506,prolonged RR interval|MP:0013279,increased fasting circulating glucose level
MGI:2664973	Ogn<tm1Eta>	MP:0001312,abnormal cornea morphology|MP:0005275,abnormal skin tensile strength|MP:0008438,abnormal cutaneous collagen fibril morphology
MGI:5427433	Ogn<tm1Hds>	MP:0003966,abnormal adrenocorticotropin level
MGI:7714705	Ogt<em1Dvaa>	MP:0000433,microcephaly|MP:0000438,abnormal cranium morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001764,abnormal homeostasis|MP:0002175,decreased brain weight|MP:0003960,increased lean body mass|MP:0005352,small cranium|MP:0005389,reproductive system phenotype|MP:0005560,decreased circulating glucose level|MP:0009108,increased pancreas weight|MP:0010768,mortality/aging|MP:0011862,decreased cranium length|MP:0014143,decreased body fat mass
MGI:3855487	Ogt<Gt(BGA526)Byg>	MP:0002169,no abnormal phenotype detected
MGI:2387867	Ogt<tm1Gwh>	MP:0000313,abnormal cell death|MP:0000352,decreased cell proliferation|MP:0000715,decreased thymocyte number|MP:0001392,abnormal locomotor behavior|MP:0001436,abnormal suckling behavior|MP:0001926,female infertility|MP:0002169,no abnormal phenotype detected|MP:0004200,decreased fetal size|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0006413,increased T cell apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1856978	oh	MP:0000788,abnormal cerebral cortex morphology|MP:0000917,obstructive hydrocephaly|MP:0001262,decreased body weight|MP:0002082,postnatal lethality|MP:0002958,cerebral aqueductal stenosis|MP:0003131,increased erythrocyte cell number|MP:0005425,increased macrophage cell number|MP:0008026,abnormal brain white matter morphology
MGI:7424872	Oip5os1<em1Shx>	MP:0002169,no abnormal phenotype detected
MGI:6295970	Oip5os1<tm1.2Dpbl>	MP:0002169,no abnormal phenotype detected
MGI:5315854	Oit3<tm1Zgh>	MP:0001762,polyuria|MP:0008822,decreased blood uric acid level|MP:0011424,decreased urine uric acid level
MGI:6257712	Ola1<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0004258,abnormal placenta size|MP:0011100,preweaning lethality, complete penetrance
MGI:4275736	Ola1<Gt(OST312288)Lex>	MP:0000597,delayed hepatic development|MP:0001176,abnormal lung development|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001575,cyanosis|MP:0001698,decreased embryo size|MP:0001954,respiratory distress|MP:0002123,abnormal definitive hematopoiesis|MP:0003984,embryonic growth retardation|MP:0005389,reproductive system phenotype|MP:0009431,decreased fetal weight|MP:0009703,decreased birth body size|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5898257	Ola1<tm1.2Zshi>	MP:0002058,neonatal lethality
MGI:7720263	Olah<em1Kedk>	MP:0000240,extramedullary hematopoiesis|MP:0000537,abnormal urethra morphology|MP:0000693,spleen hyperplasia|MP:0001547,abnormal lipid level|MP:0002446,abnormal macrophage morphology|MP:0002451,abnormal macrophage physiology|MP:0005282,decreased fatty acids level|MP:0011485,abnormal urethra urothelium morphology|MP:0020947,decreased susceptibility to Orthomyxoviridae infection|MP:0031045,decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:5548738	Olah<tm1b(KOMP)Wtsi>	MP:0002590,increased mean corpuscular volume|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:3702618	Olfm1<tm1.1Lex>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0001134,absent corpus luteum|MP:0001262,decreased body weight|MP:0001728,failure of embryo implantation|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0001938,delayed sexual maturation|MP:0002566,abnormal sexual interaction|MP:0002636,delayed vaginal opening|MP:0003355,decreased ovulation rate|MP:0006058,decreased cerebral infarct size|MP:0008544,impaired olfaction|MP:0009649,delayed embryo implantation|MP:0009674,decreased birth weight|MP:0009945,abnormal accessory olfactory bulb morphology|MP:0014592,decreased gonadotropin-releasing hormone neuron number|MP:0030982,abnormal copulatory plug deposition|MP:0030983,failure of copulatory plug deposition|MP:0031420,decreased superovulation rate
MGI:5706836	Olfm2<tm1.1Sit>	MP:0001330,abnormal optic nerve morphology|MP:0001362,abnormal anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002757,decreased vertical activity|MP:0005378,growth/size/body region phenotype|MP:0005391,vision/eye phenotype|MP:0010748,abnormal visual evoked potential|MP:0010768,mortality/aging
MGI:4461923	Olfm4<tm1Gpro>	MP:0001873,stomach inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0005381,digestive/alimentary phenotype|MP:0005397,hematopoietic system phenotype|MP:0008617,increased circulating interleukin-12 level|MP:0008623,increased circulating interleukin-3 level|MP:0008713,abnormal cytokine level|MP:0010377,abnormal gut flora balance
MGI:5805245	Olfm4<tm2.1(EGFP/cre/ERT2)Cle>	MP:0005381,digestive/alimentary phenotype|MP:0014201,abnormal intestinal epithelium physiology
MGI:5644713	Olfml2b<em1(IMPC)J>	MP:0010053,decreased grip strength
MGI:3612393	Olfml3<tm1Mike>	MP:0002169,no abnormal phenotype detected
MGI:6336105	Olig1<em2(IMPC)Ics>	MP:0000198,decreased circulating phosphate level|MP:0001399,hyperactivity
MGI:2179311	Olig1<tm1(cre)Rth>	MP:0000849,abnormal cerebellum morphology|MP:0000953,abnormal oligodendrocyte morphology|MP:0003631,nervous system phenotype|MP:0004101,abnormal brain interneuron morphology|MP:0009808,decreased oligodendrocyte number|MP:0009941,abnormal olfactory bulb interneuron morphology|MP:0009969,abnormal cerebral cortex pyramidal cell morphology
MGI:5629414	Olig1<tm1Wdr>	MP:0000953,abnormal oligodendrocyte morphology
MGI:2183410	Olig2<tm1(cre/Esr1*)Htak>	MP:0000939,decreased motor neuron number|MP:0000954,decreased oligodendrocyte progenitor number|MP:0000955,abnormal spinal cord morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000965,abnormal sensory neuron morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001438,aphagia|MP:0001504,abnormal posture|MP:0001961,abnormal reflex|MP:0003631,nervous system phenotype|MP:0004144,hypotonia|MP:0004297,abnormal proprioceptive neuron morphology|MP:0005076,abnormal cell differentiation|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0006009,abnormal neuronal migration|MP:0011087,neonatal lethality, complete penetrance
MGI:3614399	Olig2<tm1Qrlu>	MP:0000745,tremors|MP:0000780,abnormal corpus callosum morphology|MP:0000920,abnormal myelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0001513,limb grasping
MGI:2179312	Olig2<tm1Rth>	MP:0000939,decreased motor neuron number|MP:0000954,decreased oligodendrocyte progenitor number|MP:0001404,no spontaneous movement|MP:0001951,abnormal breathing pattern|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0021104,abnormal ventral interneuron 2 morphology
MGI:3828309	Olig3<tm1Qiu>	MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0003684,abnormal inferior olivary complex morphology|MP:0004279,abnormal rostral migratory stream morphology|MP:0009937,abnormal neuron differentiation|MP:0011087,neonatal lethality, complete penetrance
MGI:3573868	Olig3<tm1Tre>	MP:0002948,abnormal neuron specification|MP:0006009,abnormal neuronal migration|MP:0009937,abnormal neuron differentiation
MGI:3528911	Olr1<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:3772336	Olr1<tm1Meht>	MP:0003038,decreased myocardial infarct size|MP:0004037,increased muscle relaxation|MP:0004484,abnormal response of heart to induced stress|MP:0005341,decreased susceptibility to atherosclerosis|MP:0005376,homeostasis/metabolism phenotype|MP:0008593,increased circulating interleukin-10 level
MGI:1856620	olt	MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000424,retarded hair growth|MP:0001156,abnormal spermatogenesis|MP:0001216,abnormal epidermal layer morphology|MP:0001925,male infertility|MP:0001929,abnormal gametogenesis|MP:0002073,abnormal hair growth|MP:0002160,abnormal reproductive system morphology|MP:0003704,abnormal hair follicle development|MP:0003809,abnormal hair shaft morphology|MP:0003811,abnormal hair cortex morphology|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0008279,arrest of spermiogenesis|MP:0008859,abnormal hair cycle catagen phase|MP:0010771,integument phenotype|MP:0014633,decreased spermatid number
MGI:1861473	Om	MP:0001672,abnormal embryo development|MP:0001923,reduced female fertility|MP:0003718,maternal effect|MP:0004179,transmission ratio distortion|MP:0005031,abnormal trophoblast layer morphology|MP:0005168,abnormal female meiosis|MP:0011104,embryonic lethality before implantation, incomplete penetrance
MGI:5426689	Oma1<tm1Otin>	MP:0001260,increased body weight|MP:0001552,increased circulating triglyceride level|MP:0002078,abnormal glucose homeostasis|MP:0002500,granulomatous inflammation|MP:0002628,hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0002941,increased circulating alanine transaminase level|MP:0003948,abnormal gas homeostasis|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005534,decreased body temperature|MP:0005621,abnormal cell physiology|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0006035,abnormal mitochondrial morphology|MP:0008403,decreased cellular sensitivity to alkylating agent induced cell death|MP:0008903,abnormal mesenteric fat pad morphology|MP:0008964,decreased carbon dioxide production|MP:0009118,increased white fat cell size|MP:0009285,increased gonadal fat pad weight|MP:0009642,abnormal blood homeostasis|MP:0011020,abnormal circadian temperature homeostasis|MP:0011630,increased mitochondrial size|MP:0011639,decreased mitochondrial DNA content|MP:0011699,abnormal brown adipose tissue thermogenesis|MP:0014174,decreased fatty acid beta-oxidation|MP:0014398,abnormal fat cell mitochondrial morphology|MP:0020234,decreased basal metabolism
MGI:3604408	Omd<tm1Lex>	MP:0009456,impaired cued conditioning behavior
MGI:4399087	Omg<tm1.2Bzh>	MP:0002169,no abnormal phenotype detected
MGI:4399088	Omg<tm1.3Bzh>	MP:0002169,no abnormal phenotype detected
MGI:3821628	Omg<tm1Shmi>	MP:0005164,abnormal response to injury|MP:0005376,homeostasis/metabolism phenotype
MGI:5285648	Omp<tm1.1(COP4*/EYFP)Tboz>	MP:0002169,no abnormal phenotype detected
MGI:2387862	Omp<tm1Flm>	MP:0001983,abnormal olfactory system physiology|MP:0002741,small olfactory bulb|MP:0005584,abnormal enzyme/coenzyme activity
MGI:3526029	Onecut1<tm1.1Mga>	MP:0001869,pancreas inflammation|MP:0001914,hemorrhage|MP:0001944,abnormal pancreas morphology|MP:0002078,abnormal glucose homeostasis|MP:0002693,abnormal pancreas physiology|MP:0003334,pancreas fibrosis|MP:0003336,pancreas cyst|MP:0003339,decreased pancreatic beta cell number|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005391,vision/eye phenotype|MP:0005559,increased circulating glucose level|MP:0008515,thin retina outer nuclear layer|MP:0008516,disorganized retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008519,thin retina outer plexiform layer|MP:0009143,abnormal pancreatic duct morphology|MP:0009144,dilated pancreatic duct|MP:0009145,abnormal pancreatic acinus morphology|MP:0009149,decreased pancreatic acinar cell number|MP:0009164,exocrine pancreas atrophy|MP:0009173,absent pancreatic islets|MP:0009177,decreased pancreatic alpha cell number|MP:0011934,abnormal branching involved in pancreas development|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0013221,pancreatic acinar-to-ductal metaplasia|MP:0014092,abnormal pancreatic primary cilium morphology|MP:0014094,decreased pancreatic primary cilium number|MP:0014108,calcified pancreas
MGI:2179340	Onecut1<tm1Flem>	MP:0000611,jaundice|MP:0001732,postnatal growth retardation|MP:0001944,abnormal pancreas morphology|MP:0002696,decreased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0002929,abnormal bile duct development|MP:0003250,absent gallbladder|MP:0003266,biliary cyst|MP:0003339,decreased pancreatic beta cell number|MP:0003934,abnormal pancreas development|MP:0004201,fetal growth retardation|MP:0005083,abnormal biliary tract morphology|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0005560,decreased circulating glucose level|MP:0009111,pancreas hypoplasia|MP:0009174,absent pancreatic beta cells|MP:0009177,decreased pancreatic alpha cell number|MP:0009178,absent pancreatic alpha cells|MP:0009181,decreased pancreatic delta cell number|MP:0009254,disorganized pancreatic islets|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011932,abnormal endocrine pancreas development|MP:0012242,abnormal hepatoblast differentiation
MGI:3588425	Onecut2<tm1Flem>	MP:0000598,abnormal liver morphology|MP:0002929,abnormal bile duct development|MP:0005379,endocrine/exocrine gland phenotype
MGI:3711023	Onecut3<tm1Jqmn>	MP:0005379,endocrine/exocrine gland phenotype
MGI:3812181	Ooep<Gt(139A2)Cmhd>	MP:0001672,abnormal embryo development|MP:0001926,female infertility|MP:0003718,maternal effect|MP:0005389,reproductive system phenotype|MP:0020850,abnormal microtubule cytoskeleton morphology
MGI:4941977	Ooep<tm1Miya>	MP:0001926,female infertility|MP:0003718,maternal effect|MP:0005389,reproductive system phenotype
MGI:6438243	Oosp1<tm1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6438185	Oosp2<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6438186	Oosp3<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6384604	Opa1<em1(IMPC)Bay>	MP:0000266,abnormal heart morphology|MP:0001691,abnormal somite shape|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001718,abnormal visceral yolk sac morphology|MP:0002151,abnormal neural tube morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3578528	Opa1<lilr3>	MP:0000428,abnormal craniofacial morphology|MP:0000914,exencephaly|MP:0001691,abnormal somite shape|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001914,hemorrhage|MP:0002884,abnormal pharyngeal arch morphology|MP:0003984,embryonic growth retardation|MP:0005221,abnormal rostral-caudal axis patterning|MP:0006035,abnormal mitochondrial morphology|MP:0009901,abnormal frontonasal prominence morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011732,decreased somite size
MGI:4412032	Opa1<M1Bewi>	MP:0000745,tremors|MP:0001330,abnormal optic nerve morphology|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001785,edema|MP:0002183,gliosis|MP:0003213,decreased susceptibility to age related obesity|MP:0003984,embryonic growth retardation|MP:0005369,muscle phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0006303,abnormal retina nerve fiber layer morphology|MP:0006309,decreased retina ganglion cell number|MP:0008259,abnormal optic disk morphology|MP:0008513,thin retina inner plexiform layer|MP:0010025,decreased total body fat amount|MP:0011092,embryonic lethality, complete penetrance
MGI:3711758	Opa1<Q285X>	MP:0001330,abnormal optic nerve morphology|MP:0001413,abnormal response to new environment|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0002090,abnormal vision|MP:0003232,abnormal forebrain development|MP:0003984,embryonic growth retardation|MP:0005389,reproductive system phenotype|MP:0005551,abnormal eye electrophysiology|MP:0006035,abnormal mitochondrial morphology|MP:0010748,abnormal visual evoked potential|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6117138	Opa1<tm1.1Geno>	MP:0000823,abnormal lateral ventricle morphology|MP:0000825,dilated lateral ventricle|MP:0000829,dilated fourth ventricle|MP:0000849,abnormal cerebellum morphology|MP:0000921,demyelination|MP:0001330,abnormal optic nerve morphology|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001967,deafness|MP:0002090,abnormal vision|MP:0002651,abnormal sciatic nerve morphology|MP:0002834,decreased heart weight|MP:0004087,abnormal muscle fiber morphology|MP:0004090,abnormal sarcomere morphology|MP:0005405,axon degeneration|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0008056,abnormal retina ganglion cell morphology|MP:0008067,retina ganglion cell degeneration|MP:0008260,abnormal autophagy|MP:0010061,increased creatine level|MP:0010630,abnormal cardiac muscle tissue morphology|MP:0010748,abnormal visual evoked potential|MP:0011092,embryonic lethality, complete penetrance|MP:0011628,increased mitochondrial number|MP:0011629,decreased mitochondrial number|MP:0011630,increased mitochondrial size|MP:0011633,abnormal mitochondrial shape|MP:0011636,disorganized mitochondrial cristae|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014046,abnormal mitophagy|MP:0014185,cerebellum atrophy|MP:0014386,decreased muscle fiber mitochondrial DNA content
MGI:5317789	Opa1<tm1.2Hise>	MP:0011092,embryonic lethality, complete penetrance
MGI:5605402	Opa1<tm1Lsc>	MP:0006036,abnormal mitochondrial physiology|MP:0011635,abnormal mitochondrial crista morphology
MGI:5312669	Opa3<m1Votr>	MP:0000005,increased brown adipose tissue amount|MP:0000010,abnormal abdominal fat pad morphology|MP:0000445,short snout|MP:0000598,abnormal liver morphology|MP:0000745,tremors|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001330,abnormal optic nerve morphology|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001429,dehydration|MP:0001492,abnormal pilomotor reflex|MP:0001505,hunched posture|MP:0001732,postnatal growth retardation|MP:0001783,decreased white adipose tissue amount|MP:0002083,premature death|MP:0002090,abnormal vision|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0002970,abnormal white adipose tissue morphology|MP:0002971,abnormal brown adipose tissue morphology|MP:0002981,increased liver weight|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003727,abnormal retina layer morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004777,abnormal phospholipid level|MP:0005405,axon degeneration|MP:0005608,cardiac interstitial fibrosis|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006303,abnormal retina nerve fiber layer morphology|MP:0006309,decreased retina ganglion cell number|MP:0006395,abnormal epiphyseal plate morphology|MP:0008507,thin retina ganglion layer|MP:0008513,thin retina inner plexiform layer|MP:0008515,thin retina outer nuclear layer|MP:0009269,decreased fat cell size|MP:0009355,increased liver triglyceride level|MP:0009642,abnormal blood homeostasis|MP:0009703,decreased birth body size|MP:0010025,decreased total body fat amount|MP:0010398,decreased liver glycogen level|MP:0010499,abnormal ventricle myocardium morphology|MP:0010725,thin interventricular septum|MP:0011015,decreased body surface temperature|MP:0011110,preweaning lethality, incomplete penetrance|MP:0031115,macrovesicular hepatic steatosis
MGI:6322964	Opalin<tm1Tfr>	MP:0001415,increased exploration in new environment|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype
MGI:6469751	Opcml<tm1.1Pagr>	MP:0005385,cardiovascular system phenotype
MGI:3576034	opey	MP:0001302,eyelids open at birth
MGI:3757609	Ophn1<tm1Bill>	MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0001891,hydrocephaly|MP:0002061,abnormal aggression-related behavior|MP:0002083,premature death|MP:0002797,increased thigmotaxis|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003107,abnormal response to novelty|MP:0003863,decreased aggression towards mice|MP:0004924,abnormal behavior|MP:0005238,increased brain size|MP:0006254,thin cerebral cortex|MP:0008143,abnormal dendrite morphology
MGI:3757642	Ophn1<tm2Bill>	MP:0008143,abnormal dendrite morphology
MGI:3720821	Ophn1<Wtgr>	MP:0000402,abnormal zigzag hair morphology|MP:0000410,waved hair|MP:0001265,decreased body size|MP:0001274,curly vibrissae|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0010231,transverse fur striping|MP:0010768,mortality/aging|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5548658	Oplah<tm1b(KOMP)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001488,increased startle reflex|MP:0005333,decreased heart rate|MP:0010068,decreased red blood cell distribution width|MP:0011897,decreased circulating unsaturated transferrin level
MGI:5006763	Opn1mw<tm1a(EUCOMM)Wtsi>	MP:0001325,abnormal retina morphology|MP:0012144,decreased b-wave amplitude
MGI:2678763	Opn1mw<tm1(OPN1LW)Nat>	MP:0002090,abnormal vision
MGI:5431113	Opn1sw<tm1.1Pugh>	MP:0004022,abnormal cone electrophysiology|MP:0005391,vision/eye phenotype
MGI:5431111	Opn1sw<tm1Pugh>	MP:0005391,vision/eye phenotype|MP:0008586,disorganized photoreceptor outer segment
MGI:6152532	Opn3<em1(IMPC)Mbp>	MP:0000221,decreased leukocyte cell number|MP:0002092,abnormal eye morphology|MP:0002606,increased basophil cell number
MGI:6456885	Opn3<em2Lan>	MP:0011014,decreased core body temperature|MP:0011049,impaired adaptive thermogenesis
MGI:5897190	Opn3<tm2b(EUCOMM)Wtsi>	MP:0001764,abnormal homeostasis|MP:0004890,decreased energy expenditure|MP:0005290,decreased oxygen consumption|MP:0005666,abnormal adipose tissue physiology|MP:0008963,increased carbon dioxide production|MP:0009132,abnormal white fat cell size|MP:0011014,decreased core body temperature|MP:0011049,impaired adaptive thermogenesis|MP:0011940,decreased food intake|MP:0011942,decreased fluid intake|MP:0020325,abnormal beige fat cell morphology
MGI:6449231	Opn3<tm2c(EUCOMM)Wtsi>	MP:0005375,adipose tissue phenotype|MP:0005666,abnormal adipose tissue physiology|MP:0009132,abnormal white fat cell size|MP:0011014,decreased core body temperature|MP:0011049,impaired adaptive thermogenesis|MP:0011973,abnormal circulating glycerol level|MP:0020325,abnormal beige fat cell morphology
MGI:5520169	Opn4<tm1.1Yau>	MP:0002169,no abnormal phenotype detected
MGI:2449696	Opn4<tm1Ruby>	MP:0020473,abnormal circadian behavior phase
MGI:2449695	Opn4<tm1Skay>	MP:0001999,photosensitivity|MP:0002638,abnormal pupillary reflex|MP:0008056,abnormal retina ganglion cell morphology|MP:0020470,shortened circadian behavior period|MP:0020473,abnormal circadian behavior phase
MGI:3790239	Opn4<tm4(DTA)Saha>	MP:0006156,abnormal visual pursuit|MP:0006243,impaired pupillary reflex|MP:0008056,abnormal retina ganglion cell morphology|MP:0008847,abnormal suprachiasmatic nucleus morphology|MP:0020469,prolonged circadian behavior period|MP:0020473,abnormal circadian behavior phase|MP:0020476,abnormal circardian behavior entrainment|MP:0020477,abnormal locomotor circadian rhythm
MGI:5706751	Opn5<tm1.1Yau>	MP:0020476,abnormal circardian behavior entrainment
MGI:7748787	Opr1	MP:0001330,abnormal optic nerve morphology|MP:0005195,abnormal posterior eye segment morphology|MP:0005497,optic nerve cupping
MGI:7779612	opr2	MP:0001330,abnormal optic nerve morphology|MP:0005195,abnormal posterior eye segment morphology|MP:0005497,optic nerve cupping
MGI:7780159	Opr3	MP:0001330,abnormal optic nerve morphology|MP:0005195,abnormal posterior eye segment morphology|MP:0005497,optic nerve cupping
MGI:5562342	Oprd1<tm1.1Cgrf>	MP:0002736,abnormal nociception after inflammation|MP:0005386,behavior/neurological phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5562352	Oprd1<tm1.2Cgrf>	MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3604473	Oprd1<tm1Dgen>	MP:0002906,increased susceptibility to pharmacologically induced seizures
MGI:2387891	Oprd1<tm1Jep>	MP:0001980,abnormal chemically-elicited antinociception|MP:0005386,behavior/neurological phenotype|MP:0009748,abnormal behavioral response to addictive substance
MGI:2387013	Oprd1<tm1Kff>	MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0003064,decreased coping response
MGI:5636741	Oprk1<tm1.1Waca>	MP:0001364,decreased anxiety-related response|MP:0005386,behavior/neurological phenotype|MP:0009754,enhanced behavioral response to cocaine
MGI:5636742	Oprk1<tm1.2Waca>	MP:0001982,decreased chemically-elicited antinociception|MP:0005386,behavior/neurological phenotype
MGI:4413460	Oprk1<tm1Jep>	MP:0001462,abnormal avoidance learning behavior|MP:0001980,abnormal chemically-elicited antinociception|MP:0001982,decreased chemically-elicited antinociception|MP:0003313,abnormal locomotor activation|MP:0009778,impaired behavioral response to anesthetic|MP:0010149,abnormal synaptic dopamine release
MGI:2387031	Oprk1<tm1Kff>	MP:0000623,decreased salivation|MP:0001392,abnormal locomotor behavior|MP:0001934,increased litter size|MP:0001970,abnormal pain threshold|MP:0009757,impaired behavioral response to morphine
MGI:5823257	Oprk1<tm2.1Kff>	MP:0002062,abnormal associative learning|MP:0010149,abnormal synaptic dopamine release
MGI:6336208	Oprl1<em1(IMPC)Mbp>	MP:0000601,small liver|MP:0000691,enlarged spleen|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002599,increased mean platelet volume|MP:0002699,abnormal vitreous body morphology|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010067,increased red blood cell distribution width
MGI:3604471	Oprl1<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:2181784	Oprl1<tm1Hta>	MP:0001413,abnormal response to new environment|MP:0001463,abnormal spatial learning|MP:0001906,increased dopamine level|MP:0001968,abnormal touch/nociception|MP:0001982,decreased chemically-elicited antinociception|MP:0002063,abnormal learning/memory/conditioning|MP:0002734,abnormal mechanical nociception|MP:0002735,abnormal chemical nociception|MP:0002799,abnormal passive avoidance behavior|MP:0003008,enhanced long-term potentiation|MP:0003998,decreased thermal nociceptive threshold|MP:0004597,increased susceptibility to noise-induced hearing loss|MP:0009757,impaired behavioral response to morphine
MGI:6388520	Oprm1<IAP>	MP:0003998,decreased thermal nociceptive threshold|MP:0009757,impaired behavioral response to morphine
MGI:5561219	Oprm1<tm1.1Cgrf>	MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0009748,abnormal behavioral response to addictive substance|MP:0010771,integument phenotype
MGI:5586574	Oprm1<tm1.1Jbwa>	MP:0009749,enhanced behavioral response to addictive substance
MGI:5561220	Oprm1<tm1.2Cgrf>	MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3820121	Oprm1<tm1Jabl>	MP:0001982,decreased chemically-elicited antinociception|MP:0003998,decreased thermal nociceptive threshold|MP:0009712,impaired conditioned place preference behavior|MP:0009757,impaired behavioral response to morphine
MGI:2179052	Oprm1<tm1Jep>	MP:0001260,increased body weight|MP:0002079,increased circulating insulin level|MP:0002578,impaired ability to fire action potentials|MP:0002803,abnormal operant conditioning behavior|MP:0003058,increased insulin secretion|MP:0003959,abnormal lean body mass|MP:0005292,improved glucose tolerance|MP:0005458,increased percent body fat/body weight|MP:0008911,induced hyperactivity|MP:0009108,increased pancreas weight|MP:0009171,enlarged pancreatic islets|MP:0009749,enhanced behavioral response to addictive substance|MP:0009757,impaired behavioral response to morphine|MP:0009778,impaired behavioral response to anesthetic|MP:0009779,enhanced behavioral response to anesthetic|MP:0010024,increased total body fat amount
MGI:3773695	Oprm1<tm1Jlw>	MP:0001981,increased chemically-elicited antinociception|MP:0009748,abnormal behavioral response to addictive substance
MGI:2159000	Oprm1<tm1Kff>	MP:0001360,abnormal social investigation|MP:0001402,decreased locomotor activity|MP:0001970,abnormal pain threshold|MP:0003063,increased coping response|MP:0009757,impaired behavioral response to morphine|MP:0009776,decreased behavioral withdrawal response|MP:0009778,impaired behavioral response to anesthetic
MGI:4948248	Oprm1<tm1Lex>	MP:0001973,increased thermal nociceptive threshold|MP:0001982,decreased chemically-elicited antinociception|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009757,impaired behavioral response to morphine
MGI:2388673	Oprm1<tm1Loh>	MP:0000188,abnormal circulating glucose level|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001982,decreased chemically-elicited antinociception|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003633,abnormal nervous system physiology|MP:0009754,enhanced behavioral response to cocaine|MP:0009757,impaired behavioral response to morphine|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:2159002	Oprm1<tm1Lyu>	MP:0001402,decreased locomotor activity|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0001982,decreased chemically-elicited antinociception|MP:0002574,increased vertical activity|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0003135,increased erythroid progenitor cell number|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0009278,abnormal bone marrow cell physiology|MP:0009336,increased splenocyte proliferation|MP:0009757,impaired behavioral response to morphine|MP:0030982,abnormal copulatory plug deposition|MP:0031436,decreased copulatory plug deposition|MP:0031628,abnormal intromission|MP:0031650,decreased mounting behavior
MGI:5000465	Oprm1<tm1Shlz>	MP:0001980,abnormal chemically-elicited antinociception|MP:0001981,increased chemically-elicited antinociception|MP:0009753,enhanced behavioral response to morphine
MGI:2159001	Oprm1<tm1Uhl>	MP:0001970,abnormal pain threshold|MP:0003998,decreased thermal nociceptive threshold|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009713,enhanced conditioned place preference behavior|MP:0009757,impaired behavioral response to morphine|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:3840671	Oprm1<tm1Yxp>	MP:0001982,decreased chemically-elicited antinociception|MP:0006001,abnormal intestinal transit time
MGI:2651420	Oprm1<tm2.1Loh>	MP:0001968,abnormal touch/nociception
MGI:2651421	Oprm1<tm2Loh>	MP:0002169,no abnormal phenotype detected
MGI:5462239	Optc<tm1.1Pnb>	MP:0009660,abnormal induced retina neovascularization
MGI:7278809	Optn<em1Hyua>	MP:0001405,impaired coordination|MP:0002090,abnormal vision|MP:0004768,abnormal axonal transport|MP:0005253,abnormal eye physiology|MP:0005391,vision/eye phenotype|MP:0005405,axon degeneration|MP:0008067,retina ganglion cell degeneration|MP:0008507,thin retina ganglion layer|MP:0010748,abnormal visual evoked potential|MP:0011275,abnormal behavioral response to light|MP:0011965,decreased total retina thickness|MP:0030005,increased retina apoptosis|MP:0030940,impaired autophagy
MGI:5574310	Optn<tm1.2Jda>	MP:0005387,immune system phenotype|MP:0010768,mortality/aging|MP:0011102,embryonic lethality, incomplete penetrance
MGI:4432769	Optn<tm1a(EUCOMM)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0004129,abnormal respiratory quotient|MP:0005179,decreased circulating cholesterol level|MP:0005628,decreased circulating potassium level
MGI:3693376	Or10a2<tm1Mom>	MP:0012014,abnormal olfactory neuron innervation pattern
MGI:2179510	Or10a4<tm1Mom>	MP:0012014,abnormal olfactory neuron innervation pattern
MGI:3623580	Or10a4<tm1Rax>	MP:0012014,abnormal olfactory neuron innervation pattern
MGI:3623581	Or10a4<tm2(Or10a5)Rax>	MP:0012014,abnormal olfactory neuron innervation pattern
MGI:2179504	Or10a4<tm2(Or7a40)Mom>	MP:0002739,abnormal olfactory bulb development
MGI:3045156	Or10a4<tm3Mom>	MP:0000819,abnormal olfactory bulb morphology|MP:0012014,abnormal olfactory neuron innervation pattern
MGI:3623582	Or10a4<tm3(Or8a1)Rax>	MP:0012014,abnormal olfactory neuron innervation pattern
MGI:3045157	Or10a4<tm4Mom>	MP:0000819,abnormal olfactory bulb morphology|MP:0012014,abnormal olfactory neuron innervation pattern
MGI:3623583	Or10a4<tm4(Or6b9)Rax>	MP:0012014,abnormal olfactory neuron innervation pattern
MGI:3693374	Or10a5<tm1Mom>	MP:0012014,abnormal olfactory neuron innervation pattern
MGI:3693375	Or10a5<tm2Mom>	MP:0003631,nervous system phenotype
MGI:6342605	Or10ad1c<tm1.1Hsak>	MP:0020852,abnormal olfactory behavior
MGI:8187417	Or10p1<em1Wanyg>	MP:0000609,abnormal liver physiology|MP:0001764,abnormal homeostasis|MP:0001777,abnormal body temperature homeostasis|MP:0002891,increased insulin sensitivity|MP:0003458,decreased circulating ketone body level|MP:0005266,abnormal metabolism|MP:0005376,homeostasis/metabolism phenotype|MP:0013278,decreased fasting circulating glucose level|MP:0014812,abnormal brain physiology|MP:0020223,increased alertness|MP:0030973,impaired gluconeogenesis|MP:0031391,increased locomotor activity
MGI:3722363	Or11h4<tm1Mom>	MP:0005394,taste/olfaction phenotype
MGI:6887709	Or12d17<em1Cya>	MP:0001783,decreased white adipose tissue amount|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003058,increased insulin secretion|MP:0003402,decreased liver weight|MP:0004889,increased energy expenditure|MP:0005292,improved glucose tolerance|MP:0005386,behavior/neurological phenotype|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0009133,decreased white fat cell size|MP:0010378,increased respiratory quotient|MP:0013278,decreased fasting circulating glucose level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:6152529	Or1e1c<em1(IMPC)Mbp>	MP:0000494,abnormal cecum morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0004832,enlarged ovary|MP:0005632,decreased circulating aspartate transaminase level|MP:0005635,decreased circulating bilirubin level|MP:0009476,enlarged cecum
MGI:6152530	Or1e21<em1(IMPC)Mbp>	MP:0000538,abnormal urinary bladder morphology|MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001175,abnormal lung morphology|MP:0002092,abnormal eye morphology
MGI:6152531	Or1e32<em1(IMPC)Mbp>	MP:0000494,abnormal cecum morphology|MP:0000639,abnormal adrenal gland morphology|MP:0000702,enlarged lymph nodes|MP:0001293,anophthalmia|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0005278,abnormal cholesterol homeostasis|MP:0009476,enlarged cecum
MGI:3722372	Or2b4<tm1Mom>	MP:0002169,no abnormal phenotype detected
MGI:3722373	Or2b4<tm2Mom>	MP:0011677,abnormal olfactory sensory neuron physiology
MGI:3722374	Or2b4<tm3Mom>	MP:0001003,abnormal olfactory receptor morphology|MP:0006092,abnormal olfactory sensory neuron morphology
MGI:3722376	Or2b4<tm4Mom>	MP:0001003,abnormal olfactory receptor morphology|MP:0006092,abnormal olfactory sensory neuron morphology
MGI:3722381	Or2b4<tm5(cre)Mom>	MP:0001003,abnormal olfactory receptor morphology|MP:0006092,abnormal olfactory sensory neuron morphology
MGI:7281119	Or2l13b<em1Scjc>	MP:0004720,abnormal platelet morphology|MP:0005164,abnormal response to injury|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006298,abnormal platelet activation
MGI:6356784	Or2y1g<tm1.1Itl>	MP:0001759,increased urine glucose level|MP:0005292,improved glucose tolerance
MGI:6361024	Or4m1<em1Tshu>	MP:0000188,abnormal circulating glucose level|MP:0001262,decreased body weight|MP:0001922,reduced male fertility|MP:0002078,abnormal glucose homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002675,asthenozoospermia|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0004543,abnormal sperm physiology|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0009289,decreased epididymal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0009647,decreased fertilization frequency|MP:0010025,decreased total body fat amount|MP:0010026,decreased liver cholesterol level|MP:0011940,decreased food intake|MP:0013278,decreased fasting circulating glucose level|MP:0020103,decreased hepatic glucose production|MP:0020451,decreased sperm progressive motility
MGI:7616972	Or51e1<tm1Jplu>	MP:0000230,abnormal systemic arterial blood pressure|MP:0003025,increased vasoconstriction|MP:0003026,decreased vasoconstriction|MP:0004875,increased mean systemic arterial blood pressure|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005397,hematopoietic system phenotype|MP:0005583,decreased renin activity|MP:0005590,increased vasodilation|MP:0005595,abnormal vascular smooth muscle physiology|MP:0006263,decreased systemic arterial diastolic blood pressure|MP:0031391,increased locomotor activity
MGI:3722382	Or51e2<tm1Mom>	MP:0002739,abnormal olfactory bulb development|MP:0003438,abnormal carotid body physiology|MP:0005572,abnormal pulmonary respiratory rate
MGI:7662976	Or51e2<tm3.1Mom>	MP:0020843,abnormal type I cell of carotid body physiology
MGI:7310250	Or52s19<em1Beal>	MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:3722366	Or55b10<tm3(Or8a1b)Mom>	MP:0002169,no abnormal phenotype detected
MGI:3722369	Or55b10<tm4Mom>	MP:0002739,abnormal olfactory bulb development
MGI:7608095	Or55b4<em1Lsj>	MP:0005378,growth/size/body region phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:6316640	Or5an6<tm2.1(tauEGFP)Hsak>	MP:0020852,abnormal olfactory behavior
MGI:6511030	Or5ar1<tm1Hsak>	MP:0020421,increased freezing behavior
MGI:6511032	Or5ar1<tm2Hsak>	MP:0020422,decreased freezing behavior
MGI:7425886	Or5b112<em1(IMPC)Hmgu>	MP:0013279,increased fasting circulating glucose level
MGI:5469474	Or8a1b<tm1.1(COP4*/EYFP)Tboz>	MP:0002169,no abnormal phenotype detected
MGI:3719814	Or8a1b<tm11(Or55b10)Mom>	MP:0002169,no abnormal phenotype detected
MGI:3047226	Or8a1b<tm2Mom>	MP:0001984,abnormal olfaction|MP:0002184,abnormal innervation|MP:0002739,abnormal olfactory bulb development|MP:0002882,abnormal neuron morphology
MGI:3047161	Or8a1<tm12(Or10j5)Mom>	MP:0003631,nervous system phenotype
MGI:3047217	Or8a1<tm13(Olr226)Mom>	MP:0003631,nervous system phenotype
MGI:3047219	Or8a1<tm14(Adrb2)Mom>	MP:0003631,nervous system phenotype
MGI:3047221	Or8a1<tm15(Vmn1r49)Mom>	MP:0002739,abnormal olfactory bulb development
MGI:3047222	Or8a1<tm16(Or8a1b/Or1f19)Mom>	MP:0002739,abnormal olfactory bulb development|MP:0003651,abnormal axon extension
MGI:3047223	Or8a1<tm17Mom>	MP:0002739,abnormal olfactory bulb development|MP:0002882,abnormal neuron morphology|MP:0003651,abnormal axon extension
MGI:3047224	Or8a1<tm18Mom>	MP:0002184,abnormal innervation|MP:0002739,abnormal olfactory bulb development|MP:0002882,abnormal neuron morphology
MGI:3047225	Or8a1<tm19Mom>	MP:0003631,nervous system phenotype
MGI:3047227	Or8a1<tm20Mom>	MP:0002739,abnormal olfactory bulb development|MP:0002882,abnormal neuron morphology|MP:0003651,abnormal axon extension
MGI:3047229	Or8a1<tm21Mom>	MP:0002739,abnormal olfactory bulb development|MP:0003651,abnormal axon extension
MGI:3047231	Or8a1<tm23Mom>	MP:0002739,abnormal olfactory bulb development
MGI:3051336	Or8a1<tm26Mom>	MP:0000819,abnormal olfactory bulb morphology|MP:0000968,abnormal sensory neuron innervation pattern
MGI:3693508	Or8a1<tm29Mom>	MP:0000819,abnormal olfactory bulb morphology|MP:0006092,abnormal olfactory sensory neuron morphology
MGI:3696075	Or8a1<tm30Mom>	MP:0000819,abnormal olfactory bulb morphology
MGI:3696076	Or8a1<tm31Mom>	MP:0000819,abnormal olfactory bulb morphology
MGI:3696077	Or8a1<tm32Mom>	MP:0000819,abnormal olfactory bulb morphology
MGI:3722388	Or8a1<tm35(Adrb2)Mom>	MP:0001003,abnormal olfactory receptor morphology|MP:0002739,abnormal olfactory bulb development
MGI:5489810	Or8a1<tm37(Or10j5*,Gnas*)Mom>	MP:0001003,abnormal olfactory receptor morphology|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0008544,impaired olfaction|MP:0020348,decreased olfactory sensory neuron number
MGI:5489815	Or8a1<tm38Mom>	MP:0001003,abnormal olfactory receptor morphology|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0009941,abnormal olfactory bulb interneuron morphology|MP:0020348,decreased olfactory sensory neuron number
MGI:5784884	Or8a1<tm39(Gnas*)Mom>	MP:0001003,abnormal olfactory receptor morphology|MP:0020348,decreased olfactory sensory neuron number
MGI:5788006	Or8a1<tm40(Gnas*)Mom>	MP:0000819,abnormal olfactory bulb morphology
MGI:5616561	Or8a1<tm41(Drd1)Mom>	MP:0006092,abnormal olfactory sensory neuron morphology|MP:0020348,decreased olfactory sensory neuron number
MGI:5661034	Or8a1<tm42(Mc4r)Mom>	MP:0006092,abnormal olfactory sensory neuron morphology|MP:0020348,decreased olfactory sensory neuron number
MGI:6152528	Or8h8<em1(IMPC)Mbp>	MP:0002092,abnormal eye morphology
MGI:6277053	Or9g4<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001556,increased circulating HDL cholesterol level|MP:0001944,abnormal pancreas morphology|MP:0002060,abnormal skin morphology|MP:0002188,small heart|MP:0002339,abnormal lymph node morphology|MP:0002965,increased circulating serum albumin level|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0005178,increased circulating cholesterol level|MP:0005568,increased circulating total protein level
MGI:8273507	Orai1<em1Dirr>	MP:0000195,decreased circulating calcium level|MP:0000738,impaired muscle contractility|MP:0000747,muscle weakness|MP:0001385,pup cannibalization|MP:0002106,abnormal muscle physiology|MP:0003157,impaired muscle relaxation|MP:0003358,abnormal hypaxial muscle morphology|MP:0003646,increased muscle fatigability|MP:0003674,oxidative stress|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0011092,embryonic lethality, complete penetrance|MP:0012106,impaired exercise endurance|MP:0012322,decreased total tissue mass|MP:0014342,abnormal muscle fiber mitochondrial morphology|MP:0014389,decreased skeletal muscle fiber mitochondrial DNA content
MGI:8246889	Orai1<em1Ics>	MP:0000160,kyphosis|MP:0000195,decreased circulating calcium level|MP:0000240,extramedullary hematopoiesis|MP:0000738,impaired muscle contractility|MP:0001258,decreased body length|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003179,thrombocytopenia|MP:0003646,increased muscle fatigability|MP:0004952,increased spleen weight|MP:0009412,skeletal muscle fiber degeneration|MP:0009413,skeletal muscle fiber atrophy|MP:0020280,increased creatine kinase level
MGI:8273508	Orai1<em2Dirr>	MP:0002169,no abnormal phenotype detected
MGI:3772453	Orai1<Gt(XL922)Byg>	MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002423,abnormal mast cell physiology|MP:0002662,abnormal cauda epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0004231,abnormal calcium ion homeostasis|MP:0004811,abnormal neuron physiology|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0006379,abnormal spermatocyte morphology|MP:0006380,abnormal spermatid morphology|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion|MP:0009230,abnormal sperm head morphology|MP:0009257,dilated seminiferous tubule|MP:0009817,decreased leukotriene level|MP:0010768,mortality/aging|MP:0011632,dilated mitochondrion|MP:0011743,abnormal Golgi apparatus morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014636,decreased elongated spermatid number|MP:0020355,abnormal Sertoli cell barrier morphology|MP:0020362,abnormal male germ cell physiology|MP:0020451,decreased sperm progressive motility|MP:0020550,multinucleated giant male germ cells|MP:0031389,abnormal ectoplasmic specialization morphology
MGI:5637538	Orai1<tm1.1Hjm>	MP:0002444,abnormal T cell physiology
MGI:5700370	Orai1<tm1b(EUCOMM)Hmgu>	MP:0001491,unresponsive to tactile stimuli|MP:0001697,abnormal embryo size|MP:0004122,abnormal sinus arrhythmia|MP:0011100,preweaning lethality, complete penetrance
MGI:3832514	Orai1<tm1Fesk>	MP:0004867,decreased platelet calcium level|MP:0006298,abnormal platelet activation|MP:0011087,neonatal lethality, complete penetrance
MGI:3810487	Orai1<tm1Rao>	MP:0000414,alopecia|MP:0001199,thin skin|MP:0001262,decreased body weight|MP:0001282,short vibrissae|MP:0001828,abnormal T cell activation|MP:0002421,abnormal cell-mediated immunity|MP:0002423,abnormal mast cell physiology|MP:0003009,abnormal cytokine secretion|MP:0003850,abnormal thymocyte activation|MP:0005251,blepharitis|MP:0005621,abnormal cell physiology|MP:0008217,abnormal B cell activation|MP:0008567,decreased interferon-gamma secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008770,decreased survivor rate|MP:0011089,perinatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6119518	Orai1<tm1Smua>	MP:0002459,abnormal B cell physiology|MP:0004231,abnormal calcium ion homeostasis|MP:0005387,immune system phenotype|MP:0008217,abnormal B cell activation
MGI:6358679	Orai2<tm1.1Itl>	MP:0005596,increased susceptibility to type I hypersensitivity reaction
MGI:5908178	Orai2<tm1.1(KOMP)Vlcg>	MP:0002444,abnormal T cell physiology|MP:0002451,abnormal macrophage physiology
MGI:6358680	Orai2<tm1.2Itl>	MP:0002423,abnormal mast cell physiology|MP:0008764,increased mast cell degranulation|MP:0010768,mortality/aging
MGI:7625689	Orai3<em1.1Treb>	MP:0005387,immune system phenotype|MP:0008217,abnormal B cell activation
MGI:6257666	Orai3<em1(IMPC)Bay>	MP:0003731,abnormal retina outer nuclear layer morphology
MGI:6355393	Orc1<tm1.1Gle>	MP:0000496,abnormal small intestine morphology|MP:0000606,decreased hepatocyte number|MP:0002169,no abnormal phenotype detected|MP:0003893,increased hepatocyte proliferation|MP:0004025,polyploidy|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0005370,liver/biliary system phenotype|MP:0005384,cellular phenotype|MP:0008057,abnormal DNA replication|MP:0008108,abnormal small intestinal villus morphology|MP:0008800,increased small intestinal crypt cell apoptosis|MP:0010157,abnormal small intestinal crypt cell proliferation|MP:0011705,absent fibroblast proliferation|MP:0014082,decreased small intestinal villus height|MP:0020427,increased hepatocyte karyomegaly|MP:0021085,increased DNA replication|MP:0021086,decreased DNA replication
MGI:6355394	Orc1<tm1.2Gle>	MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:4847686	Orc1<tm1a(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5515783	Orc1<tm1b(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6284488	Orc2<em1(IMPC)J>	MP:0001513,limb grasping|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:4947979	Orc3<tm1.1Zhua>	MP:0003631,nervous system phenotype|MP:0003648,abnormal radial glial cell morphology|MP:0020388,decreased radial glial cell number|MP:0020394,decreased neuronal precursor proliferation
MGI:4433411	Orc3<tm1a(EUCOMM)Wtsi>	MP:0004509,abnormal pelvic girdle bone morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:7314200	Orc4<tm1c(EUCOMM)Wtsi>	MP:0001125,abnormal oocyte morphology|MP:0001926,female infertility|MP:0005168,abnormal female meiosis|MP:0012736,abnormal polar body morphology
MGI:5638892	Orc6<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system|MP:0001399,hyperactivity|MP:0001730,embryonic growth arrest|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0005554,decreased circulating creatinine level|MP:0006243,impaired pupillary reflex|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012058,abnormal morula morphology|MP:0012129,failure of blastocyst formation|MP:0013292,embryonic lethality prior to organogenesis
MGI:2154297	Orch4<BALB/cByJ>	MP:0001875,testis inflammation
MGI:2154295	Orch4<DBA/2J>	MP:0001876,decreased inflammatory response
MGI:2154300	Orch5<BALB/cByJ>	MP:0001875,testis inflammation
MGI:2154299	Orch5<DBA/2J>	MP:0001876,decreased inflammatory response
MGI:3042434	Orgwq1<M16i>	MP:0002834,decreased heart weight|MP:0003918,decreased kidney weight|MP:0004952,increased spleen weight
MGI:3042436	Orgwq2<M16i>	MP:0004952,increased spleen weight
MGI:3042438	Orgwq3<M16i>	MP:0002981,increased liver weight
MGI:3042440	Orgwq4<M16i>	MP:0002833,increased heart weight|MP:0002981,increased liver weight
MGI:3042442	Orgwq5<M16i>	MP:0002834,decreased heart weight|MP:0003918,decreased kidney weight
MGI:3042444	Orgwq6<M16i>	MP:0004952,increased spleen weight
MGI:3042446	Orgwq7<M16i>	MP:0002981,increased liver weight|MP:0003917,increased kidney weight|MP:0004952,increased spleen weight
MGI:3042448	Orgwq8<M16i>	MP:0002981,increased liver weight|MP:0003917,increased kidney weight|MP:0004952,increased spleen weight
MGI:3042450	Orgwq9<M16i>	MP:0002833,increased heart weight|MP:0003917,increased kidney weight
MGI:2157493	Oriq1<C57BL/6J>	MP:0005389,reproductive system phenotype
MGI:2155158	Oriq2<C57BL/6J>	MP:0005389,reproductive system phenotype
MGI:2156624	Oriq3<C57BL/6J>	MP:0005389,reproductive system phenotype
MGI:2446905	Oriq4<C57BL/6J>	MP:0005389,reproductive system phenotype
MGI:2157951	Oriq5<C57BL/6J>	MP:0005389,reproductive system phenotype
MGI:6357675	Orm1<tm1Smoc>	MP:0004145,abnormal muscle electrophysiology|MP:0012106,impaired exercise endurance
MGI:7607189	Orm2<em1Bcgen>	MP:0000182,increased circulating LDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0001860,liver inflammation|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003333,liver fibrosis|MP:0005343,increased circulating aspartate transaminase level|MP:0005375,adipose tissue phenotype|MP:0009355,increased liver triglyceride level
MGI:3808483	Orm2<tm1(KOMP)Vlcg>	MP:0001859,kidney inflammation|MP:0003985,renal fibrosis
MGI:7647342	Ormdl1<em1Pdra>	MP:0005387,immune system phenotype
MGI:7427586	Ormdl2<em1Pdra>	MP:0005387,immune system phenotype
MGI:7427587	Ormdl3<em1Pdra>	MP:0002423,abnormal mast cell physiology|MP:0002531,abnormal type I hypersensitivity reaction|MP:0008764,increased mast cell degranulation|MP:0020116,increased sphingosine level|MP:0020582,increased ceramide level
MGI:6369059	Ormdl3<em1Quli>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0008826,abnormal splenic cell ratio
MGI:3512229	Orq1<M16i>	MP:0031411,increased ovulation rate
MGI:3512243	Orq2<M16i>	MP:0031411,increased ovulation rate
MGI:3512231	Orq3<M16i>	MP:0031411,increased ovulation rate
MGI:1857646	Os	MP:0000554,abnormal carpal bone morphology|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002080,prenatal lethality|MP:0002085,abnormal embryonic tissue morphology|MP:0002135,abnormal kidney morphology|MP:0002743,glomerulonephritis|MP:0002956,decreased compensatory renal growth|MP:0003881,abnormal nephron morphology|MP:0003918,decreased kidney weight|MP:0004046,abnormal mitosis|MP:0004083,polysyndactyly|MP:0004505,decreased renal glomerulus number|MP:0004576,abnormal embryonic autopod plate morphology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004760,increased mitotic index|MP:0005104,abnormal tarsal bone morphology|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005565,increased blood urea nitrogen level|MP:0005650,abnormal limb bud morphology|MP:0008915,fused carpal bones|MP:0008919,fused tarsal bones|MP:0009727,abnormal navicular morphology|MP:0009728,abnormal calcaneum morphology|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011261,abnormal limb mesenchyme morphology|MP:0011353,expanded mesangial matrix|MP:0011408,renal tubule hypertrophy|MP:0011431,increased urine flow rate|MP:0011757,abnormal kidney collecting duct principal cell morphology
MGI:4939774	Os9<tm1a(EUCOMM)Wtsi>	MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0002100,abnormal tooth morphology|MP:0004609,vertebral fusion
MGI:5613891	Osbp2<tm1Arai>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008280,abnormal male germ cell apoptosis|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009833,absent sperm mitochondrial sheath|MP:0009852,increased Sertoli cell phagocytosis
MGI:6369352	Osbp<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000702,enlarged lymph nodes|MP:0001714,absent trophoblast giant cells|MP:0001727,abnormal embryo implantation|MP:0002060,abnormal skin morphology|MP:0004964,absent inner cell mass|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5790203	Osbpl10<em1(IMPC)J>	MP:0001304,cataract
MGI:5692785	Osbpl11<tm1b(EUCOMM)Hmgu>	MP:0002644,decreased circulating triglyceride level|MP:0005292,improved glucose tolerance|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:7425889	Osbpl1a<em1(IMPC)Bay>	MP:0001513,limb grasping
MGI:7331342	Osbpl2<em1Cya>	MP:0000031,abnormal cochlea morphology|MP:0002622,abnormal cochlear hair cell morphology|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0004300,abnormal organ of Corti supporting cell morphology|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0006288,small otic capsule|MP:0006325,impaired hearing|MP:0011061,abnormal inner hair cell kinocilium morphology|MP:0011062,abnormal outer hair cell kinocilium morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013203,abnormal primary cilium morphology|MP:0014406,increased or absent distortion product otoacoustic emission threshold|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:4842360	Osbpl3<tm1a(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:7738855	Osbpl3<tm1c(EUCOMM)Wtsi>	MP:0002006,neoplasm|MP:0004499,increased incidence of tumors by chemical induction|MP:0010308,decreased tumor latency|MP:0010639,abnormal tumor pathology
MGI:7256900	Osbpl6<em1(IMPC)Tcp>	MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin
MGI:6399913	Osbpl8<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001489,decreased startle reflex|MP:0002092,abnormal eye morphology|MP:0004738,abnormal auditory brainstem response|MP:0009142,decreased prepulse inhibition|MP:0010067,increased red blood cell distribution width|MP:0020870,decreased thigmotaxis
MGI:3871235	Osbpl8<Gt(DD0748)Wtsi>	MP:0001552,increased circulating triglyceride level|MP:0003980,increased circulating phospholipid level|MP:0005178,increased circulating cholesterol level|MP:0010332,abnormal circulating apolipoprotein level|MP:0010333,abnormal circulating apolipoprotein E level
MGI:5692798	Oscar<tm1b(KOMP)Wtsi>	MP:0010052,increased grip strength
MGI:5301430	Oscar<tm1Ywc>	MP:0008396,abnormal osteoclast differentiation
MGI:5692692	Oscp1<tm1b(EUCOMM)Hmgu>	MP:0002059,abnormal seminal vesicle morphology|MP:0002608,increased hematocrit
MGI:6279914	Oser1<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6257500	Osgep<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:2680723	Osmr<tm1Mtan>	MP:0000208,decreased hematocrit|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001577,anemia|MP:0001846,increased inflammatory response|MP:0002079,increased circulating insulin level|MP:0002123,abnormal definitive hematopoiesis|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002628,hepatic steatosis|MP:0002875,decreased erythrocyte cell number|MP:0002981,increased liver weight|MP:0003179,thrombocytopenia|MP:0003645,increased pancreatic beta cell number|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005397,hematopoietic system phenotype|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008255,decreased megakaryocyte cell number|MP:0008553,increased circulating tumor necrosis factor level|MP:0008593,increased circulating interleukin-10 level|MP:0008801,abnormal erythroid progenitor cell morphology|MP:0009288,increased epididymal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0010398,decreased liver glycogen level|MP:0010934,increased subcutaneous adipose tissue amount|MP:0011939,increased food intake|MP:0031602,white adipose tissue inflammation
MGI:5474774	Osm<tm1b(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0002590,increased mean corpuscular volume|MP:0002702,decreased circulating free fatty acids level|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0005560,decreased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0010123,increased bone mineral content
MGI:3574987	Osm<tm1Ymo>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0003043,hypoalgesia
MGI:3827104	Osr1<tm1(EGFP/cre/ERT2)Amc>	MP:0002169,no abnormal phenotype detected
MGI:3613748	Osr1<tm1Jian>	MP:0000281,abnormal interventricular septum morphology|MP:0000282,abnormal interatrial septum morphology|MP:0000527,abnormal kidney development|MP:0001175,abnormal lung morphology|MP:0001719,absent vitelline blood vessels|MP:0002128,abnormal blood circulation|MP:0002192,hydrops fetalis|MP:0002725,abnormal vein morphology|MP:0003140,dilated heart atrium|MP:0003578,absent ovary|MP:0003827,abnormal Wolffian duct morphology|MP:0005313,absent adrenal gland|MP:0005644,agonadal|MP:0006107,abnormal fetal atrioventricular canal morphology|MP:0006415,absent testes|MP:0008487,abnormal mesonephros morphology|MP:0009075,rudimentary Wolffian ducts|MP:0010406,common atrium|MP:0010978,absent ureteric bud|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0010986,abnormal mesonephric mesenchyme morphology|MP:0010987,abnormal nephrogenic mesenchyme morphogenesis|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011366,absent metanephros|MP:0011368,increased kidney apoptosis|MP:0011386,increased metanephric mesenchyme apoptosis|MP:0011387,absent metanephric mesenchyme|MP:0011412,gonadal ridge hypoplasia|MP:0031587,abnormal pericardium development
MGI:5003112	Osr1<tm2.1Jian>	MP:0001730,embryonic growth arrest|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002127,abnormal cardiovascular system morphology|MP:0002160,abnormal reproductive system morphology|MP:0003057,abnormal epicardium morphology|MP:0010769,abnormal survival|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013164,abnormal forelimb bud morphology
MGI:5004961	Osr1<tm2.2Jian>	MP:0002169,no abnormal phenotype detected
MGI:5003109	Osr1<tm2Jian>	MP:0005390,skeleton phenotype
MGI:3033240	Osr2<tm1Jian>	MP:0000030,abnormal tympanic ring morphology|MP:0000116,abnormal tooth development|MP:0001286,abnormal eye development|MP:0001302,eyelids open at birth|MP:0002058,neonatal lethality|MP:0003190,fused synovial joints|MP:0004033,supernumerary teeth|MP:0006020,decreased tympanic ring size|MP:0009264,failure of eyelid fusion|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0021166,delayed palatal shelf elevation|MP:0021210,bilateral cleft palate|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0030136,abnormal lower incisor morphology
MGI:4441462	Osr2<tm1Pzg>	MP:0002169,no abnormal phenotype detected|MP:0011087,neonatal lethality, complete penetrance
MGI:3768549	Osr2<tm2(cre)Jian>	MP:0002169,no abnormal phenotype detected
MGI:3849032	Osr2<tm3(Osr1)Jian>	MP:0001286,abnormal eye development|MP:0001302,eyelids open at birth|MP:0005377,hearing/vestibular/ear phenotype|MP:0005382,craniofacial phenotype|MP:0009263,abnormal eyelid fusion
MGI:3849034	Osr2<tm4(Osr2*)Jian>	MP:0001302,eyelids open at birth|MP:0005377,hearing/vestibular/ear phenotype|MP:0005382,craniofacial phenotype
MGI:3689329	Ostes	MP:0000745,tremors|MP:0000752,dystrophic muscle|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002269,muscular atrophy
MGI:5811626	Ostf1<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0001488,increased startle reflex|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:4880102	Ostf1<tm1(NCOM)Cmhd>	MP:0000130,abnormal trabecular bone morphology|MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype|MP:0013615,increased volumetric bone mineral density|MP:0020011,increased bone mineral density of femur
MGI:1856885	Ostm1<gl>	MP:0000064,failure of bone resorption|MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000445,short snout|MP:0001290,delayed eyelid opening|MP:0001406,abnormal gait|MP:0001851,eye inflammation|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0002113,abnormal skeleton development|MP:0003932,abnormal molar crown morphology|MP:0005150,cachexia|MP:0005358,abnormal incisor morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0008274,failure of bone ossification|MP:0008733,abnormal hair shaft melanin granule distribution|MP:0030089,short lower incisors|MP:0030236,abnormal mental foramen morphology|MP:0030451,abnormal dentin mineralization|MP:0030494,abnormal molar root morphology
MGI:5512861	Ostm1<om>	MP:0000063,decreased bone mineral density|MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000130,abnormal trabecular bone morphology|MP:0000150,abnormal rib morphology|MP:0000183,decreased circulating LDL cholesterol level|MP:0000455,abnormal maxilla morphology|MP:0000559,abnormal femur morphology|MP:0001265,decreased body size|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0002644,decreased circulating triglyceride level|MP:0002689,abnormal molar morphology|MP:0002874,decreased hemoglobin content|MP:0002968,increased circulating alkaline phosphatase level|MP:0003109,short femur|MP:0003723,abnormal long bone morphology|MP:0003797,abnormal compact bone morphology|MP:0003961,decreased lean body mass|MP:0004353,abnormal deltoid tuberosity morphology|MP:0004830,short incisors|MP:0005358,abnormal incisor morphology|MP:0010025,decreased total body fat amount|MP:0011084,lethality at weaning, incomplete penetrance|MP:0030302,abnormal maxillary zygomatic process morphology
MGI:5908915	Ostn<tm1.1Geno>	MP:0005290,decreased oxygen consumption|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0011631,decreased mitochondrial size|MP:0012106,impaired exercise endurance
MGI:6156601	Otc<em1(IMPC)Tcp>	MP:0000709,enlarged thymus|MP:0001552,increased circulating triglyceride level|MP:0002941,increased circulating alanine transaminase level
MGI:1856178	Otc<spf>	MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000418,focal hair loss|MP:0000422,delayed hair appearance|MP:0000436,abnormal head movements|MP:0000598,abnormal liver morphology|MP:0000745,tremors|MP:0000774,decreased brain size|MP:0001038,abnormal cholinergic neuron morphology|MP:0001146,abnormal testis morphology|MP:0001211,wrinkled skin|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001431,abnormal eating behavior|MP:0001442,decreased grooming behavior|MP:0001510,abnormal coat appearance|MP:0001777,abnormal body temperature homeostasis|MP:0001923,reduced female fertility|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0003415,priapism|MP:0003806,abnormal nucleotide metabolism|MP:0003997,tonic-clonic seizures|MP:0004000,impaired passive avoidance behavior|MP:0005266,abnormal metabolism|MP:0005309,increased circulating ammonia level|MP:0005311,abnormal circulating amino acid level|MP:0005332,abnormal amino acid level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008143,abnormal dendrite morphology|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0011380,enlarged brain ventricles|MP:0011396,abnormal sleep behavior|MP:0011588,decreased ornithine carbamoyltransferase activity|MP:0011626,orotic acid urinary bladder stones|MP:0011765,oroticaciduria|MP:0020837,decreased circulating citrulline level|MP:0030648,decreased ornithine level|MP:0030651,decreased circulating ornithine level|MP:0030662,decreased circulating arginine level|MP:0030706,increased glutamine level|MP:0030709,increased circulating glutamine level
MGI:1856179	Otc<spf-ash>	MP:0000416,sparse hair|MP:0000599,enlarged liver|MP:0001211,wrinkled skin|MP:0001265,decreased body size|MP:0001463,abnormal spatial learning|MP:0001764,abnormal homeostasis|MP:0002981,increased liver weight|MP:0005027,increased susceptibility to parasitic infection|MP:0005309,increased circulating ammonia level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006036,abnormal mitochondrial physiology|MP:0008414,abnormal spatial reference memory|MP:0008428,abnormal spatial working memory|MP:0008469,abnormal protein level|MP:0008735,increased susceptibility to endotoxin shock|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011588,decreased ornithine carbamoyltransferase activity|MP:0011765,oroticaciduria
MGI:1856372	Otc<spf-J>	MP:0000416,sparse hair|MP:0000418,focal hair loss|MP:0001265,decreased body size|MP:0002075,abnormal coat/hair pigmentation|MP:0005311,abnormal circulating amino acid level|MP:0005332,abnormal amino acid level|MP:0009642,abnormal blood homeostasis
MGI:5548754	Otoa<tm1.1(KOMP)Vlcg>	MP:0001488,increased startle reflex|MP:0004738,abnormal auditory brainstem response|MP:0005562,decreased mean corpuscular hemoglobin|MP:0009142,decreased prepulse inhibition
MGI:5469411	Otoa<tm1Gpr>	MP:0003149,abnormal tectorial membrane morphology|MP:0003150,detached tectorial membrane|MP:0004415,abnormal cochlear nerve compound action potential|MP:0005377,hearing/vestibular/ear phenotype|MP:0006325,impaired hearing|MP:0013962,absent Hensen stripe
MGI:3712927	Otof<deaf5Jcs>	MP:0001967,deafness|MP:0002918,abnormal paired-pulse facilitation|MP:0003635,abnormal synaptic transmission|MP:0004716,abnormal cochlear nerve morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0006335,abnormal hearing electrophysiology|MP:0006358,absent pinna reflex|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012486,decreased cochlear VIII nucleus size
MGI:3708344	Otof<pga>	MP:0001489,decreased startle reflex|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4950055	Otof<tm1.1Erei>	MP:0003631,nervous system phenotype|MP:0004433,abnormal cochlear inner hair cell physiology|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3640614	Otof<tm1Ugds>	MP:0001967,deafness|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004433,abnormal cochlear inner hair cell physiology|MP:0004562,abnormal inner hair cell synaptic ribbon morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6342258	Otog<em1(IMPC)J>	MP:0002098,abnormal vibrissa morphology|MP:0004738,abnormal auditory brainstem response|MP:0005343,increased circulating aspartate transaminase level|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5755623	Otogl<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001284,absent vibrissae|MP:0001399,hyperactivity|MP:0001486,abnormal startle reflex|MP:0001529,abnormal vocalization|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0004738,abnormal auditory brainstem response|MP:0020870,decreased thigmotaxis
MGI:2181633	Otog<tm1Prs>	MP:0000031,abnormal cochlea morphology|MP:0001394,circling|MP:0001504,abnormal posture|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0002428,abnormal semicircular canal morphology|MP:0003145,detached otolithic membrane|MP:0003149,abnormal tectorial membrane morphology|MP:0004249,abnormal crista ampullaris morphology|MP:0005191,head tilt|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology|MP:0006325,impaired hearing|MP:0006358,absent pinna reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856640	Otog<twt>	MP:0001394,circling|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001485,abnormal pinna reflex|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0001526,abnormal placing response|MP:0001921,reduced fertility|MP:0002895,abnormal otolithic membrane morphology|MP:0003145,detached otolithic membrane|MP:0003878,abnormal ear physiology|MP:0004249,abnormal crista ampullaris morphology|MP:0005191,head tilt|MP:0006325,impaired hearing|MP:0006359,absent startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3852110	Otog<twt-2J>	MP:0001394,circling|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0002894,abnormal otolith morphology|MP:0005191,head tilt|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3852126	Otog<twt-3J>	MP:0001394,circling|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0002894,abnormal otolith morphology|MP:0005191,head tilt|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4421285	Otog<twt-4J>	MP:0001522,impaired swimming|MP:0001967,deafness|MP:0002894,abnormal otolith morphology|MP:0005191,head tilt|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4421286	Otog<twt-5J>	MP:0001522,impaired swimming|MP:0001967,deafness|MP:0002894,abnormal otolith morphology|MP:0005191,head tilt|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5883222	Otog<vbd>	MP:0001394,circling|MP:0001485,abnormal pinna reflex|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0004249,abnormal crista ampullaris morphology|MP:0004330,abnormal vestibular saccular macula morphology|MP:0004517,decreased vestibular hair cell stereocilia number|MP:0005191,head tilt|MP:0006328,nonsyndromic hearing impairment
MGI:6158513	Otol1<em1(IMPC)Mbp>	MP:0001120,abnormal uterus morphology|MP:0009709,hydrometra
MGI:6388391	Otop1<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001262,decreased body weight|MP:0005343,increased circulating aspartate transaminase level
MGI:4881519	Otop1<ied>	MP:0001405,impaired coordination|MP:0001504,abnormal posture|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0002757,decreased vertical activity|MP:0002978,absent otoliths|MP:0005191,head tilt|MP:0005377,hearing/vestibular/ear phenotype
MGI:2655558	Otop1<mlh>	MP:0001522,impaired swimming|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002978,absent otoliths|MP:0005191,head tilt
MGI:1856638	Otop1<tlt>	MP:0001504,abnormal posture|MP:0001522,impaired swimming|MP:0002856,abnormal vestibular ganglion morphology|MP:0002978,absent otoliths|MP:0004813,absent linear vestibular evoked potential|MP:0005191,head tilt|MP:0005377,hearing/vestibular/ear phenotype
MGI:4950042	Otop1<tm1Dor>	MP:0001522,impaired swimming|MP:0002978,absent otoliths|MP:0004742,abnormal vestibular system physiology|MP:0005377,hearing/vestibular/ear phenotype
MGI:3530083	Otos<tm1Cham>	MP:0000031,abnormal cochlea morphology|MP:0001967,deafness|MP:0004294,abnormal type II spiral ligament fibrocytes|MP:0004296,abnormal type IV spiral ligament fibrocytes|MP:0004414,decreased cochlear microphonics|MP:0004417,decreased cochlear nerve compound action potential
MGI:6355465	Otp<M1H>	MP:0000008,increased white adipose tissue amount|MP:0000063,decreased bone mineral density|MP:0001257,increased body length|MP:0001261,obese|MP:0001262,decreased body weight|MP:0002079,increased circulating insulin level|MP:0003960,increased lean body mass|MP:0004889,increased energy expenditure|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005334,abnormal fat pad morphology|MP:0005448,abnormal energy homeostasis|MP:0005669,increased circulating leptin level|MP:0011100,preweaning lethality, complete penetrance|MP:0011939,increased food intake|MP:0014142,increased body fat mass
MGI:2180541	Otp<tm1Asim>	MP:0001261,obese|MP:0003243,abnormal dopaminergic neuron morphology|MP:0003960,increased lean body mass|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005669,increased circulating leptin level|MP:0014142,increased body fat mass
MGI:6314266	Otp<tm1b(EUCOMM)Wtsi>	MP:0008810,increased circulating iron level|MP:0011100,preweaning lethality, complete penetrance
MGI:2387865	Otp<tm1Tlu>	MP:0000774,decreased brain size|MP:0000826,abnormal third ventricle morphology|MP:0000830,abnormal diencephalon morphology|MP:0000837,abnormal hypothalamus morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0004164,abnormal neurohypophysis morphology|MP:0005645,abnormal hypothalamus physiology|MP:0008845,abnormal paraventricular hypothalamic nucleus morphology|MP:0008846,abnormal supraoptic nucleus morphology|MP:0009229,abnormal neurohypophysis median eminence morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:2156627	Ots1<LT/Sv>	MP:0002016,ovary cyst
MGI:6730110	Otub1<tm1Ama>	MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5692787	Otub1<tm1b(EUCOMM)Hmgu>	MP:0000438,abnormal cranium morphology|MP:0001175,abnormal lung morphology|MP:0001417,decreased exploration in new environment|MP:0006065,abnormal heart position or orientation|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011962,increased cornea thickness
MGI:6377208	Otub1<tm1c(EUCOMM)Hmgu>	MP:0000691,enlarged spleen|MP:0002461,increased immunoglobulin level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004978,decreased B-1 B cell number|MP:0005014,increased B cell number|MP:0005018,decreased T cell number|MP:0005350,increased susceptibility to autoimmune disorder|MP:0008172,abnormal follicular B cell morphology|MP:0008181,increased marginal zone B cell number|MP:0008206,increased B-2 B cell number|MP:0008210,increased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008217,abnormal B cell activation|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008596,increased circulating interleukin-6 level
MGI:7640053	Otub2<tm1.1Gpt>	MP:0004499,increased incidence of tumors by chemical induction
MGI:7303765	Otud1<em2Gpt>	MP:0002419,abnormal innate immunity|MP:0008575,increased circulating interferon-beta level|MP:0008735,increased susceptibility to endotoxin shock|MP:0020914,decreased susceptibility to Riboviria infection|MP:0020917,decreased susceptibility to Herpesvirales infection
MGI:6467362	Otud3<em1Nju>	MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0008564,increased interferon-beta secretion|MP:0008722,abnormal chemokine secretion|MP:0010768,mortality/aging|MP:0020914,decreased susceptibility to Riboviria infection|MP:0031023,decreased susceptibility to Riboviria infection induced morbidity/mortality
MGI:6120694	Otud4<tm1b(EUCOMM)Hmgu>	MP:0001697,abnormal embryo size|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4123470	Otud5<Gt(A021B07)Wrst>	MP:0001700,abnormal embryo turning|MP:0002084,abnormal developmental patterning
MGI:5752247	Otud5<tm1Vmd>	MP:0000715,decreased thymocyte number|MP:0001858,intestinal inflammation|MP:0004974,decreased regulatory T cell number|MP:0005387,immune system phenotype|MP:0008614,increased circulating interleukin-17 level|MP:0008681,increased interleukin-17 secretion|MP:0008711,increased interleukin-9 secretion|MP:0009057,increased interleukin-21 secretion|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010221,abnormal T-helper 17 cell differentiation
MGI:7594029	Otud6a<em1Smoc>	MP:0002419,abnormal innate immunity|MP:0020914,decreased susceptibility to Riboviria infection|MP:0020917,decreased susceptibility to Herpesvirales infection
MGI:4951157	Otud6a<tm1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001556,increased circulating HDL cholesterol level|MP:0002606,increased basophil cell number|MP:0005011,increased eosinophil cell number|MP:0005178,increased circulating cholesterol level
MGI:5637064	Otud6b<tm1b(EUCOMM)Wtsi>	MP:0002606,increased basophil cell number|MP:0004200,decreased fetal size|MP:0010402,ventricular septal defect|MP:0011089,perinatal lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6108137	Otud7a<em1Cpsc>	MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001489,decreased startle reflex|MP:0001529,abnormal vocalization|MP:0003053,delayed tooth eruption|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008840,abnormal spike wave discharge|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0020508,decreased dendritic spine density|MP:0021165,behavioral developmental delay
MGI:6257769	Otud7a<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5637162	Otud7b<tm1b(EUCOMM)Wtsi>	MP:0004613,fusion of vertebral arches|MP:0010420,muscular ventricular septal defect|MP:0011100,preweaning lethality, complete penetrance
MGI:5494636	Otud7b<tm1Dgen>	MP:0000688,lymphoid hyperplasia|MP:0001262,decreased body weight|MP:0002411,decreased susceptibility to bacterial infection|MP:0002495,increased IgA level|MP:0005014,increased B cell number|MP:0005154,increased B cell proliferation|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0010675,decreased activation-induced B cell apoptosis
MGI:4839147	Otud7b<tm1(NCOM)Cmhd>	MP:0001262,decreased body weight|MP:0002462,abnormal granulocyte physiology|MP:0005179,decreased circulating cholesterol level
MGI:7256497	Otulin<em1Gvl>	MP:0011091,prenatal lethality, complete penetrance
MGI:6257734	Otulin<em1(IMPC)Bay>	MP:0000689,abnormal spleen morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:4830117	Otulin<m3Sapc>	MP:0000433,microcephaly|MP:0001071,abnormal facial nerve morphology|MP:0001072,abnormal vestibulocochlear nerve morphology|MP:0001614,abnormal blood vessel morphology|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002639,micrognathia|MP:0003544,abnormal vascular endothelial cell migration|MP:0004950,abnormal brain vasculature morphology|MP:0006346,small pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012730,abnormal internal carotid artery morphology
MGI:5521504	Otulin<m8Sapc>	MP:0006346,small pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012730,abnormal internal carotid artery morphology
MGI:6449230	Otulin<tm1c(EUCOMM)Hmgu>	MP:0001194,dermatitis|MP:0001209,spontaneous skin ulceration|MP:0001212,skin lesions|MP:0001222,epidermal hyperplasia|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0003414,epidermal cyst|MP:0005380,embryo phenotype|MP:0009704,increased skin squamous cell carcinoma incidence|MP:0009793,sebaceous gland hypertrophy|MP:0011006,abnormal epidermal stem cell proliferation|MP:0011007,abnormal epidermal stem cell apoptosis
MGI:1856925	Otx1<jv>	MP:0001394,circling|MP:0002730,head shaking|MP:0003161,absent lateral semicircular canal|MP:0005377,hearing/vestibular/ear phenotype|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology
MGI:2136272	Otx1<tm1Asim>	MP:0000026,abnormal inner ear morphology|MP:0000036,absent semicircular canals|MP:0000774,decreased brain size|MP:0000777,increased inferior colliculus size|MP:0000788,abnormal cerebral cortex morphology|MP:0000897,abnormal midbrain morphology|MP:0000905,increased superior colliculus size|MP:0000934,abnormal telencephalon development|MP:0000947,convulsive seizures|MP:0000948,nonconvulsive seizures|MP:0001127,small ovary|MP:0001130,abnormal ovarian folliculogenesis|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001262,decreased body weight|MP:0001322,abnormal iris morphology|MP:0001347,absent lacrimal glands|MP:0001732,postnatal growth retardation|MP:0001746,abnormal pituitary secretion|MP:0002064,seizures|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002216,abnormal seminiferous tubule morphology|MP:0002683,delayed fertility|MP:0002780,decreased circulating testosterone level|MP:0003161,absent lateral semicircular canal|MP:0008881,absent Harderian gland|MP:0014165,absent ciliary process|MP:0020531,increased cerebellar foliation
MGI:2153198	Otx1<tm1Sia>	MP:0000163,abnormal cartilage morphology|MP:0000438,abnormal cranium morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000826,abnormal third ventricle morphology|MP:0000906,abnormal trigeminal V mesencephalic nucleus morphology|MP:0001303,abnormal lens morphology|MP:0001329,retina hyperplasia|MP:0001347,absent lacrimal glands|MP:0003632,abnormal nervous system morphology|MP:0004457,abnormal orbitosphenoid bone morphology|MP:0005205,abnormal eye anterior chamber morphology|MP:0008283,small hippocampus|MP:0009247,meteorism|MP:0011087,neonatal lethality, complete penetrance|MP:0011962,increased cornea thickness
MGI:2153199	Otx1<tm2(otd)Asim>	MP:0000774,decreased brain size|MP:0000857,abnormal cerebellar foliation|MP:0000897,abnormal midbrain morphology|MP:0000934,abnormal telencephalon development|MP:0001322,abnormal iris morphology|MP:0001347,absent lacrimal glands|MP:0002092,abnormal eye morphology|MP:0002175,decreased brain weight|MP:0002892,decreased superior colliculus size|MP:0003161,absent lateral semicircular canal|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008881,absent Harderian gland|MP:0009038,decreased inferior colliculus size|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2153200	Otx1<tm3(OTX2)Asim>	MP:0000026,abnormal inner ear morphology|MP:0000774,decreased brain size|MP:0000857,abnormal cerebellar foliation|MP:0000934,abnormal telencephalon development|MP:0001347,absent lacrimal glands|MP:0002175,decreased brain weight|MP:0003161,absent lateral semicircular canal|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008881,absent Harderian gland|MP:0010768,mortality/aging|MP:0012089,decreased midbrain size|MP:0014165,absent ciliary process
MGI:2445568	Otx2m1<CBA>	MP:0000087,absent mandible|MP:0000088,short mandible
MGI:2445571	Otx2m2<C57BL/6>	MP:0000087,absent mandible
MGI:4365829	Otx2<tm10Asim>	MP:0000432,abnormal head morphology|MP:0000783,abnormal forebrain morphology|MP:0001672,abnormal embryo development
MGI:5608496	Otx2<tm10Sia>	MP:0000783,abnormal forebrain morphology|MP:0004261,abnormal embryonic neuroepithelium morphology
MGI:4365830	Otx2<tm11Asim>	MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005391,vision/eye phenotype|MP:0006068,abnormal retina horizontal cell morphology|MP:0006073,abnormal retina bipolar cell morphology|MP:0006149,decreased visual acuity|MP:0008446,decreased retina cone cell number|MP:0008511,thin retina inner nuclear layer|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3695699	Otx2<tm1.1Tlam>	MP:0000458,abnormal mandible morphology|MP:0000776,abnormal inferior colliculus morphology|MP:0000897,abnormal midbrain morphology|MP:0001265,decreased body size|MP:0001286,abnormal eye development|MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality|MP:0003232,abnormal forebrain development|MP:0003244,loss of dopaminergic neurons|MP:0009038,decreased inferior colliculus size
MGI:5573195	Otx2<tm12.1Asim>	MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0001327,decreased retina photoreceptor cell number|MP:0001330,abnormal optic nerve morphology|MP:0003631,nervous system phenotype|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005391,vision/eye phenotype|MP:0006068,abnormal retina horizontal cell morphology|MP:0006073,abnormal retina bipolar cell morphology|MP:0006149,decreased visual acuity|MP:0006309,decreased retina ganglion cell number|MP:0008446,decreased retina cone cell number|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0010768,mortality/aging
MGI:3695700	Otx2<tm1.2Tlam>	MP:0012135,embryonic-extraembryonic boundary constriction
MGI:3609983	Otx2<tm1(Dkk1)Imat>	MP:0005221,abnormal rostral-caudal axis patterning
MGI:2153202	Otx2<tm1(OTX1)Asim>	MP:0003232,abnormal forebrain development|MP:0003864,abnormal midbrain development|MP:0003935,abnormal craniofacial development|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0006337,abnormal first pharyngeal arch morphology|MP:0009579,acephaly|MP:0010940,abnormal maxillary prominence morphology|MP:0011259,abnormal cephalic neural fold morphology|MP:0012157,rostral body truncation|MP:0030324,abnormal anterior head development
MGI:1857510	Otx2<tm1Pas>	MP:0001680,abnormal mesoderm development|MP:0001688,abnormal somite development|MP:0001691,abnormal somite shape|MP:0001698,decreased embryo size|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002151,abnormal neural tube morphology|MP:0002188,small heart|MP:0002773,decreased circulating luteinizing hormone level|MP:0003874,absent pharyngeal arches|MP:0003984,embryonic growth retardation|MP:0004066,abnormal primitive node morphology|MP:0004852,decreased testis weight|MP:0005029,abnormal amnion morphology|MP:0006108,abnormal hindbrain development|MP:0006293,absent nasal placodes|MP:0006294,absent optic vesicle|MP:0008325,abnormal gonadotroph morphology|MP:0008335,decreased gonadotroph cell number|MP:0011091,prenatal lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012087,absent midbrain|MP:0012136,absent forebrain|MP:0012157,rostral body truncation
MGI:1857543	Otx2<tm1Sia>	MP:0000029,abnormal malleus morphology|MP:0000087,absent mandible|MP:0000106,abnormal basisphenoid bone morphology|MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0000445,short snout|MP:0000458,abnormal mandible morphology|MP:0000776,abnormal inferior colliculus morphology|MP:0000826,abnormal third ventricle morphology|MP:0000841,abnormal hindbrain morphology|MP:0000906,abnormal trigeminal V mesencephalic nucleus morphology|MP:0000913,abnormal brain development|MP:0001061,abnormal oculomotor nerve morphology|MP:0001063,abnormal trochlear nerve morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001299,abnormal eye distance/ position|MP:0001340,abnormal eyelid morphology|MP:0001695,abnormal gastrulation|MP:0001730,embryonic growth arrest|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0002237,abnormal nasal cavity morphology|MP:0002239,abnormal nasal septum morphology|MP:0002243,abnormal vomeronasal organ morphology|MP:0002639,micrognathia|MP:0002698,abnormal sclera morphology|MP:0003078,aphakia|MP:0003235,abnormal alisphenoid bone morphology|MP:0003451,absent olfactory bulb|MP:0003727,abnormal retina layer morphology|MP:0003755,abnormal palate morphology|MP:0004163,abnormal adenohypophysis morphology|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004448,abnormal presphenoid bone morphology|MP:0004453,abnormal pterygoid bone morphology|MP:0004463,basisphenoid bone foramen|MP:0004726,abnormal nasal capsule morphology|MP:0004872,absent nasal septum|MP:0004912,absent mandibular coronoid process|MP:0004990,abnormal ciliary ganglion morphology|MP:0005106,abnormal incus morphology|MP:0005193,abnormal anterior eye segment morphology|MP:0005247,abnormal extraocular muscle morphology|MP:0005261,aniridia|MP:0005352,small cranium|MP:0005549,retina pigment epithelium hyperplasia|MP:0005587,abnormal Meckel's cartilage morphology|MP:0008384,absent nasal capsule|MP:0008789,abnormal olfactory epithelium morphology|MP:0008934,absent choroid plexus|MP:0009266,abnormal mesendoderm development|MP:0009579,acephaly|MP:0009905,absent tongue|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011388,absent heart|MP:0012083,absent foregut|MP:0012087,absent midbrain|MP:0012132,abnormal midbrain-hindbrain boundary morphology|MP:0012136,absent forebrain|MP:0012157,rostral body truncation|MP:0012247,absent cornea|MP:0012516,absent metencephalon|MP:0012703,decreased embryonic neuroepithelium thickness|MP:0013595,absent vomeronasal organ|MP:0014061,ethmocephaly|MP:0030102,absent orbitosphenoid bone|MP:0030320,abnormal temporal bone tympanic part morphology|MP:0030324,abnormal anterior head development|MP:0030558,absent nasopharynx
MGI:1857502	Otx2<tm1Sla>	MP:0000913,abnormal brain development|MP:0000929,open neural tube|MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0001684,abnormal axial mesoderm morphology|MP:0001691,abnormal somite shape|MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0001726,abnormal allantois morphology|MP:0002084,abnormal developmental patterning|MP:0002151,abnormal neural tube morphology|MP:0002230,abnormal primitive streak formation|MP:0002825,abnormal notochord morphology|MP:0003984,embryonic growth retardation|MP:0005221,abnormal rostral-caudal axis patterning|MP:0009768,impaired somite development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011733,fused somites|MP:0012087,absent midbrain|MP:0012135,embryonic-extraembryonic boundary constriction|MP:0012136,absent forebrain|MP:0012157,rostral body truncation|MP:0012276,absent prechordal mesoderm|MP:0012516,absent metencephalon|MP:0012685,abnormal primitive streak elongation|MP:0020515,abnormal visceral yolk sac endoderm morphology|MP:0020516,abnormal visceral yolk sac mesenchyme morphology
MGI:3612403	Otx2<tm2.1Imat>	MP:0005221,abnormal rostral-caudal axis patterning|MP:0009579,acephaly
MGI:2150146	Otx2<tm2Asim>	MP:0000433,microcephaly|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001890,anencephaly|MP:0001921,reduced fertility|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003232,abnormal forebrain development|MP:0003864,abnormal midbrain development|MP:0012089,decreased midbrain size|MP:0012138,decreased forebrain size
MGI:2153203	Otx2<tm2(Otx1)Sia>	MP:0000458,abnormal mandible morphology|MP:0000913,abnormal brain development|MP:0001293,anophthalmia|MP:0002092,abnormal eye morphology|MP:0003232,abnormal forebrain development|MP:0003451,absent olfactory bulb|MP:0003864,abnormal midbrain development|MP:0004539,absent maxilla|MP:0004592,small mandible|MP:0005315,absent pituitary gland|MP:0005380,embryo phenotype|MP:0005382,craniofacial phenotype|MP:0009578,otocephaly|MP:0011087,neonatal lethality, complete penetrance
MGI:2157061	Otx2<tm3(Emx2)Sia>	MP:0009637,abnormal pretectal region morphology
MGI:2157778	Otx2<tm3(otd)Asim>	MP:0000432,abnormal head morphology|MP:0000914,exencephaly|MP:0003232,abnormal forebrain development|MP:0004096,abnormal midbrain-hindbrain boundary development|MP:0009579,acephaly
MGI:3774322	Otx2<tm3Tlam>	MP:0000830,abnormal diencephalon morphology|MP:0000897,abnormal midbrain morphology|MP:0000913,abnormal brain development|MP:0003743,abnormal facial morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2178753	Otx2<tm4.1Sia>	MP:0002169,no abnormal phenotype detected
MGI:2178755	Otx2<tm4.2Sia>	MP:0002169,no abnormal phenotype detected
MGI:2157779	Otx2<tm4(otd)Asim>	MP:0001265,decreased body size|MP:0006337,abnormal first pharyngeal arch morphology|MP:0009579,acephaly|MP:0010940,abnormal maxillary prominence morphology
MGI:2178747	Otx2<tm4Sia>	MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:2157780	Otx2<tm5(OTX2)Asim>	MP:0000432,abnormal head morphology|MP:0003232,abnormal forebrain development|MP:0003864,abnormal midbrain development|MP:0009579,acephaly
MGI:3046839	Otx2<tm5Sia>	MP:0003631,nervous system phenotype
MGI:3046840	Otx2<tm6Sia>	MP:0003631,nervous system phenotype
MGI:3042842	Otx2<tm7(OTX1)Asim>	MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype
MGI:3046841	Otx2<tm7Sia>	MP:0003631,nervous system phenotype|MP:0005380,embryo phenotype
MGI:4867634	Otx2<tm8.2Sia>	MP:0000788,abnormal cerebral cortex morphology|MP:0000913,abnormal brain development
MGI:4365827	Otx2<tm8Asim>	MP:0002169,no abnormal phenotype detected|MP:0005389,reproductive system phenotype
MGI:4365828	Otx2<tm9Asim>	MP:0000428,abnormal craniofacial morphology|MP:0000914,exencephaly|MP:0003232,abnormal forebrain development|MP:0003864,abnormal midbrain development|MP:0009579,acephaly
MGI:5608495	Otx2<tm9Sia>	MP:0000783,abnormal forebrain morphology|MP:0004261,abnormal embryonic neuroepithelium morphology
MGI:6460276	Ovch2<em1Osb>	MP:0001925,male infertility|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031012,impaired sperm migration in female genital tract
MGI:5635260	Ovch2<tm1b(KOMP)Mbp>	MP:0001925,male infertility
MGI:2677401	Ovgp1<tm1Yar>	MP:0005389,reproductive system phenotype
MGI:5507829	Ovol1<tm1b(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0002075,abnormal coat/hair pigmentation|MP:0002098,abnormal vibrissa morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia
MGI:1926599	Ovol1<tm1Efu>	MP:0000398,splitting of guard hairs|MP:0000400,abnormal awl hair morphology|MP:0000405,abnormal auchene hair morphology|MP:0000420,ruffled hair|MP:0000522,kidney cortex cyst|MP:0001123,dilated uterus|MP:0001136,dilated uterine cervix|MP:0001143,constricted vagina orifice|MP:0001144,vagina atresia|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001191,abnormal skin condition|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002135,abnormal kidney morphology|MP:0002796,impaired skin barrier function|MP:0003675,kidney cyst|MP:0003809,abnormal hair shaft morphology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0004970,kidney atrophy|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3777011	Ovol2<tm1Sito>	MP:0000260,abnormal angiogenesis|MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0000293,absent myocardial trabeculae|MP:0000929,open neural tube|MP:0001622,abnormal vasculogenesis|MP:0001698,decreased embryo size|MP:0001719,absent vitelline blood vessels|MP:0001914,hemorrhage|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002128,abnormal blood circulation|MP:0002188,small heart|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0003874,absent pharyngeal arches|MP:0003974,abnormal endocardium morphology|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0005294,abnormal heart ventricle morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012254,absent intersomitic vessels|MP:0012510,abnormal aortic sac morphology
MGI:3522498	Ovol2<tm1Xdai>	MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0000270,abnormal heart tube morphology|MP:0000474,abnormal foregut morphology|MP:0000928,incomplete rostral neuropore closure|MP:0001700,abnormal embryo turning|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0002825,abnormal notochord morphology|MP:0003054,spina bifida|MP:0003119,abnormal digestive system development|MP:0003232,abnormal forebrain development|MP:0004187,cardia bifida|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004387,abnormal prechordal plate morphology|MP:0006305,abnormal optic eminence morphology|MP:0006346,small pharyngeal arch|MP:0008786,abnormal hindgut morphology|MP:0010432,common ventricle|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011259,abnormal cephalic neural fold morphology|MP:0011260,abnormal head mesenchyme morphology|MP:0012155,abnormal optic pit morphology|MP:0012532,abnormal surface ectoderm morphology|MP:0012702,increased embryonic neuroepithelium thickness|MP:0012706,decreased embryonic neuroepithelial cell proliferation|MP:0012744,increased neural crest cell apoptosis|MP:0012746,abnormal neural crest cell delamination|MP:0030061,absent otic pit
MGI:6257623	Oxa1l<em1(IMPC)Bay>	MP:0002953,thick ventricular wall|MP:0003043,hypoalgesia|MP:0010579,increased heart left ventricle size|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4364940	Oxct1<tm1a(KOMP)Wtsi>	MP:0000189,hypoglycemia|MP:0002106,abnormal muscle physiology|MP:0002575,increased circulating ketone body level|MP:0003031,acidosis|MP:0008260,abnormal autophagy|MP:0011088,neonatal lethality, incomplete penetrance|MP:0013404,decreased circulating lactate level|MP:0014814,increased brain glucose metabolism
MGI:3812671	Oxgr1<tm1(KOMP)Vlcg>	MP:0001790,abnormal immune system physiology|MP:0003016,increased circulating bicarbonate level|MP:0003020,decreased circulating chloride level|MP:0009350,decreased urine pH
MGI:4330699	Oxr1<Gt(RRR195)Byg>	MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging
MGI:4461745	Oxr1<tm1a(EUCOMM)Wtsi>	MP:0001258,decreased body length|MP:0001393,ataxia|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0003179,thrombocytopenia|MP:0003203,increased neuron apoptosis
MGI:4126436	Oxsr1<Gt(XH180)Byg>	MP:0011092,embryonic lethality, complete penetrance
MGI:5462099	Oxsr1<tm1.1Arte>	MP:0002376,abnormal dendritic cell physiology|MP:0005461,abnormal dendritic cell morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5297491	Oxsr1<tm1.1Ssy>	MP:0001596,hypotension|MP:0002136,abnormal kidney physiology|MP:0002988,decreased urine osmolality|MP:0005441,increased urine calcium level|MP:0005619,increased urine potassium level|MP:0005628,decreased circulating potassium level|MP:0006316,increased urine sodium level
MGI:5297492	Oxsr1<tm1.2Ssy>	MP:0001596,hypotension
MGI:3608706	Oxtr<tm1.1Knis>	MP:0001353,increased aggression towards mice|MP:0001360,abnormal social investigation|MP:0001384,abnormal pup retrieval|MP:0001386,abnormal maternal nurturing|MP:0009326,absent maternal crouching|MP:0010249,lactation failure|MP:0020351,decreased vocalization|MP:0031391,increased locomotor activity
MGI:5766256	Oxtr<tm1.1(KOMP)Vlcg>	MP:0000182,increased circulating LDL cholesterol level
MGI:3800791	Oxtr<tm1.1Wsy>	MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0002169,no abnormal phenotype detected|MP:0005379,endocrine/exocrine gland phenotype
MGI:3800792	Oxtr<tm1.2Wsy>	MP:0001360,abnormal social investigation|MP:0001935,decreased litter size|MP:0003838,abnormal milk ejection|MP:0005369,muscle phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010771,integument phenotype
MGI:5543243	Oxtr<tm1Knis>	MP:0001360,abnormal social investigation|MP:0001469,abnormal contextual conditioning behavior|MP:0002063,abnormal learning/memory/conditioning|MP:0005386,behavior/neurological phenotype
MGI:3800795	Oxtr<tm1Wsy>	MP:0002152,abnormal brain morphology|MP:0003631,nervous system phenotype
MGI:2663036	Oxt<tm1Ljm>	MP:0005389,reproductive system phenotype
MGI:1857234	Oxt<tm1Wsy>	MP:0001362,abnormal anxiety-related response|MP:0001422,abnormal drinking behavior|MP:0001432,abnormal food preference|MP:0001442,decreased grooming behavior|MP:0001544,abnormal cardiovascular system physiology|MP:0001596,hypotension|MP:0001882,abnormal lactation|MP:0003866,abnormal defecation|MP:0004184,abnormal baroreceptor physiology|MP:0005367,renal/urinary system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005656,decreased aggression|MP:0006270,abnormal mammary gland growth during lactation|MP:0011957,decreased compensatory feeding amount|MP:0013718,galactostasis|MP:0020467,abnormal circadian behavior
MGI:2386203	Oxt<tm1Zuk>	MP:0001353,increased aggression towards mice|MP:0001360,abnormal social investigation|MP:0001382,abnormal nursing|MP:0001460,abnormal olfactory discrimination memory|MP:0002557,abnormal social/conspecific interaction behavior|MP:0003838,abnormal milk ejection
MGI:3771290	Oxt<tm2Ljm>	MP:0002907,abnormal parturition|MP:0008028,pregnancy-related premature death|MP:0020467,abnormal circadian behavior
MGI:3771291	Oxt<tm3Ljm>	MP:0002907,abnormal parturition|MP:0008028,pregnancy-related premature death|MP:0020467,abnormal circadian behavior
MGI:4439298	p23-ST1	MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001454,abnormal cued conditioning behavior|MP:0001762,polyuria|MP:0001893,non-obstructive hydrocephaly|MP:0003280,urinary incontinence|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0005238,increased brain size|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008918,microgliosis|MP:0008948,decreased neuron number|MP:0011380,enlarged brain ventricles|MP:0011535,increased urination frequency
MGI:2181608	P2rx1<tm1Chn>	MP:0000231,hypertension|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002769,abnormal vas deferens morphology|MP:0005159,azoospermia
MGI:6306613	P2rx2<em1(IMPC)H>	MP:0001402,decreased locomotor activity|MP:0005560,decreased circulating glucose level
MGI:6886215	P2rx2<em1Xzl>	MP:0001405,impaired coordination|MP:0003806,abnormal nucleotide metabolism|MP:0003998,decreased thermal nociceptive threshold|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004562,abnormal inner hair cell synaptic ribbon morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0010771,integument phenotype|MP:0011806,decreased dermal fibroblast proliferation|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6279891	P2rx2<tm1b(EUCOMM)Hmgu>	MP:0001147,small testis|MP:0001417,decreased exploration in new environment
MGI:2687349	P2rx2<tm1Ckn>	MP:0003438,abnormal carotid body physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005576,decreased pulmonary ventilation
MGI:1934019	P2rx3<tm1Ckn>	MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype
MGI:2385840	P2rx3<tm1Jwo>	MP:0001968,abnormal touch/nociception|MP:0001973,increased thermal nociceptive threshold|MP:0002735,abnormal chemical nociception|MP:0003463,abnormal single cell response
MGI:3612982	P2rx4<tm1Ando>	MP:0000249,abnormal blood vessel physiology|MP:0001613,abnormal vasodilation|MP:0002463,abnormal neutrophil physiology|MP:0003957,abnormal nitric oxide homeostasis|MP:0004003,abnormal vascular endothelial cell physiology|MP:0004875,increased mean systemic arterial blood pressure|MP:0005381,digestive/alimentary phenotype|MP:0011742,decreased urine nitrite level|MP:0012729,abnormal common carotid artery morphology
MGI:5548440	P2rx4<tm1b(EUCOMM)Wtsi>	MP:0002591,decreased mean corpuscular volume|MP:0005298,abnormal clavicle morphology
MGI:3834163	P2rx4<tm1Dgen>	MP:0002451,abnormal macrophage physiology
MGI:3665297	P2rx4<tm1Rass>	MP:0001473,reduced long-term potentiation
MGI:5692770	P2rx5<tm1b(EUCOMM)Hmgu>	MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5430769	P2rx5<tm1Lex>	MP:0001415,increased exploration in new environment|MP:0008044,increased NK cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0009456,impaired cued conditioning behavior
MGI:5427682	P2rx6<tm1Dgen>	MP:0001973,increased thermal nociceptive threshold|MP:0002887,decreased susceptibility to pharmacologically induced seizures
MGI:3042190	P2rx7<rs48804829-T>	MP:0000313,abnormal cell death|MP:0001648,abnormal apoptosis
MGI:4432150	P2rx7<tm1a(EUCOMM)Wtsi>	MP:0003442,decreased circulating glycerol level
MGI:5548444	P2rx7<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract
MGI:2386080	P2rx7<tm1Gab>	MP:0000313,abnormal cell death|MP:0001262,decreased body weight|MP:0001533,abnormal skeleton physiology|MP:0002113,abnormal skeleton development|MP:0002423,abnormal mast cell physiology|MP:0004984,increased osteoclast cell number|MP:0005377,hearing/vestibular/ear phenotype|MP:0008150,decreased diameter of long bones|MP:0008152,decreased diameter of femur|MP:0008156,decreased diameter of tibia|MP:0008658,decreased interleukin-1 beta secretion|MP:0008704,abnormal interleukin-6 secretion
MGI:3606250	P2rx7<tm1Ipch>	MP:0001845,abnormal inflammatory response|MP:0001970,abnormal pain threshold|MP:0002451,abnormal macrophage physiology|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype
MGI:3529296	P2rx7<tm1Lex>	MP:0002451,abnormal macrophage physiology|MP:0003063,increased coping response|MP:0005386,behavior/neurological phenotype|MP:0011958,increased compensatory feeding amount
MGI:2445936	P2ry12<tm1Cjf>	MP:0005606,increased bleeding time|MP:0009549,decreased platelet aggregation
MGI:5427683	P2ry12<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:2674084	P2ry12<tm1Pcon>	MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0009549,decreased platelet aggregation|MP:0031120,decreased susceptibility to induced thrombosis
MGI:5569058	P2ry13<tm1.1(KOMP)Vlcg>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:4946289	P2ry13<tm1Dgen>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0003442,decreased circulating glycerol level|MP:0005179,decreased circulating cholesterol level|MP:0005282,decreased fatty acids level|MP:0005559,increased circulating glucose level|MP:0010967,increased compact bone area|MP:0014480,increased feces cholesterol level
MGI:4839758	P2ry13<tm1Loma>	MP:0004772,abnormal bile secretion|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010026,decreased liver cholesterol level|MP:0010080,abnormal hepatocyte physiology|MP:0031683,abnormal cholesterol transport
MGI:5749947	P2ry14<em1(IMPC)H>	MP:0002941,increased circulating alanine transaminase level|MP:0004357,long tibia|MP:0005343,increased circulating aspartate transaminase level|MP:0010024,increased total body fat amount|MP:0013278,decreased fasting circulating glucose level
MGI:5707037	P2ry14<tm1.1Shbg>	MP:0002335,decreased airway responsiveness|MP:0002626,increased heart rate|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0004875,increased mean systemic arterial blood pressure|MP:0004952,increased spleen weight|MP:0005293,impaired glucose tolerance|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0009854,impaired gastric peristalsis|MP:0010182,decreased susceptibility to weight gain|MP:0010895,increased lung compliance
MGI:3849078	P2ry14<tm1Gbtm>	MP:0002106,abnormal muscle physiology
MGI:3623115	P2ry1<tm1Bhk>	MP:0003422,abnormal thrombolysis|MP:0005606,increased bleeding time|MP:0009549,decreased platelet aggregation
MGI:2181709	P2ry1<tm1Gac>	MP:0005606,increased bleeding time|MP:0009549,decreased platelet aggregation|MP:0031120,decreased susceptibility to induced thrombosis
MGI:3613160	P2ry2<tm1Bhk>	MP:0001765,abnormal ion homeostasis|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003651,abnormal axon extension|MP:0009937,abnormal neuron differentiation
MGI:5792951	P2ry2<tm1c(EUCOMM)Hmgu>	MP:0005591,decreased vasodilation|MP:0012045,increased susceptibility to hypertension
MGI:3612162	P2ry4<tm1Brob>	MP:0000501,abnormal digestive secretion|MP:0011090,perinatal lethality, incomplete penetrance
MGI:4941863	P2ry6<tm1.1Brob>	MP:0002451,abnormal macrophage physiology|MP:0003026,decreased vasoconstriction|MP:0005591,decreased vasodilation
MGI:5304911	P2ry6<tm1Jabo>	MP:0000219,increased neutrophil cell number|MP:0001861,lung inflammation|MP:0002281,abnormal respiratory mucosa goblet cell morphology|MP:0002492,decreased IgE level|MP:0005011,increased eosinophil cell number|MP:0005348,increased T cell proliferation|MP:0006414,decreased T cell apoptosis|MP:0008566,increased interferon-gamma secretion|MP:0008672,increased interleukin-13 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion
MGI:5532323	P3h1<tm1.1Brle>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010873,decreased trabecular bone mass|MP:0010879,decreased trabecular bone volume|MP:0011642,abnormal bone collagen fibril morphology
MGI:5708192	P3h1<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000759,abnormal skeletal muscle morphology|MP:0001199,thin skin|MP:0001258,decreased body length|MP:0001402,decreased locomotor activity|MP:0002060,abnormal skin morphology|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0010506,prolonged RR interval|MP:0012000,abnormal limb position
MGI:4830452	P3h1<tm1Dgen>	MP:0000060,delayed bone ossification|MP:0000063,decreased bone mineral density|MP:0000069,kyphoscoliosis|MP:0000130,abnormal trabecular bone morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000559,abnormal femur morphology|MP:0001199,thin skin|MP:0001243,abnormal dermal layer morphology|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002427,disproportionate dwarf|MP:0003109,short femur|MP:0004686,decreased length of long bones|MP:0005503,abnormal tendon morphology|MP:0009826,abnormal dermis reticular layer collagen network|MP:0010025,decreased total body fat amount
MGI:6257567	P3h2<em1(IMPC)H>	MP:0000443,abnormal snout morphology|MP:0001402,decreased locomotor activity|MP:0005627,increased circulating potassium level|MP:0010088,decreased circulating fructosamine level
MGI:5792811	P3h2<tm1d(KOMP)Wtsi>	MP:0005253,abnormal eye physiology|MP:0005390,skeleton phenotype
MGI:5585628	P3h2<tm1Hpb>	MP:0005048,abnormal thrombosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:5548424	P3h3<tm1.1(KOMP)Vlcg>	MP:0000198,decreased circulating phosphate level|MP:0002590,increased mean corpuscular volume
MGI:4399383	P3h3<tm1(KOMP)Vlcg>	MP:0003089,decreased skin tensile strength|MP:0005378,growth/size/body region phenotype|MP:0008438,abnormal cutaneous collagen fibril morphology
MGI:5905852	P3h4<tm1.2Rmr>	MP:0000135,decreased compact bone thickness|MP:0002108,abnormal muscle morphology|MP:0003089,decreased skin tensile strength|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0010879,decreased trabecular bone volume|MP:0010933,decreased trabecular bone connectivity density|MP:0011642,abnormal bone collagen fibril morphology
MGI:3706369	P4ha1<tm1Jomy>	MP:0001698,decreased embryo size|MP:0003044,impaired basement membrane formation|MP:0003658,abnormal capillary morphology|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011261,abnormal limb mesenchyme morphology
MGI:6306463	P4ha3<em1(IMPC)J>	MP:0001510,abnormal coat appearance|MP:0005333,decreased heart rate
MGI:5504624	P4hb<tm1.1Geno>	MP:0005397,hematopoietic system phenotype|MP:0005606,increased bleeding time|MP:0009446,abnormal platelet dense granule physiology|MP:0009549,decreased platelet aggregation|MP:0031120,decreased susceptibility to induced thrombosis
MGI:5692909	P4hb<tm1b(KOMP)Wtsi>	MP:0003984,embryonic growth retardation|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5583029	P4htm<tm1Jomy>	MP:0002092,abnormal eye morphology|MP:0002962,increased urine protein level
MGI:4220888	Pa2g4<Gt(OST186047)Lex>	MP:0000352,decreased cell proliferation|MP:0000585,kinked tail|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001935,decreased litter size|MP:0008008,early cellular replicative senescence
MGI:4433339	Pa2g4<tm1a(EUCOMM)Wtsi>	MP:0002590,increased mean corpuscular volume
MGI:2387307	Paam1<MRL/MpJ>	MP:0005350,increased susceptibility to autoimmune disorder
MGI:2387310	Paam2<MRL/MpJ>	MP:0005350,increased susceptibility to autoimmune disorder
MGI:7494133	Pabir1<em1.1Yhua>	MP:0001262,decreased body weight|MP:0002834,decreased heart weight|MP:0005140,decreased cardiac muscle contractility|MP:0011925,abnormal heart echocardiography feature|MP:0011952,decreased cardiac stroke volume
MGI:7494165	Pabir1<em2Yhua>	MP:0001672,abnormal embryo development|MP:0001688,abnormal somite development|MP:0001700,abnormal embryo turning|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002652,thin myocardium|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0005312,pericardial effusion|MP:0010493,abnormal atrium myocardium morphology|MP:0010499,abnormal ventricle myocardium morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011259,abnormal cephalic neural fold morphology|MP:0012501,abnormal pericardial cavity morphology
MGI:6341835	Pabir2<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000470,abnormal stomach morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001148,enlarged testis|MP:0001399,hyperactivity|MP:0002060,abnormal skin morphology|MP:0002100,abnormal tooth morphology|MP:0002110,abnormal digit morphology|MP:0002188,small heart|MP:0002339,abnormal lymph node morphology|MP:0002691,small stomach|MP:0013129,abnormal tooth color
MGI:3857650	Pabir2<Gt(AZ0548)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5437740	Pabpc1l<tm1.1Esel>	MP:0000242,impaired fertilization|MP:0001125,abnormal oocyte morphology|MP:0001131,abnormal ovarian follicle morphology|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0003355,decreased ovulation rate|MP:0005431,decreased oocyte number|MP:0005621,abnormal cell physiology|MP:0009433,polyovular ovarian follicle|MP:0011701,decreased cumulus expansion|MP:0014445,abnormal spindle assembly in female meiosis|MP:0031383,increased secondary ovarian follicle number
MGI:4431852	Pabpc1l<tm1a(EUCOMM)Wtsi>	MP:0001926,female infertility|MP:0005561,increased mean corpuscular hemoglobin
MGI:6867024	Pabpc2<tm1Tba>	MP:0002169,no abnormal phenotype detected
MGI:4364054	Pabpc4<tm1a(KOMP)Wtsi>	MP:0002833,increased heart weight|MP:0004174,abnormal spine curvature|MP:0005179,decreased circulating cholesterol level
MGI:6423066	Pabpc5<em1(IMPC)Mbp>	MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology
MGI:7666422	Pabpc6<em1Sikas>	MP:0002169,no abnormal phenotype detected
MGI:6509577	Pabpn1l<em1Hyfn>	MP:0001125,abnormal oocyte morphology|MP:0001926,female infertility|MP:0003718,maternal effect|MP:0005389,reproductive system phenotype
MGI:4842589	Pabpn1l<tm1a(EUCOMM)Wtsi>	MP:0001926,female infertility
MGI:6110860	Pabpn1<tm1.2Gpvl>	MP:0001513,limb grasping|MP:0002080,prenatal lethality|MP:0003806,abnormal nucleotide metabolism|MP:0006036,abnormal mitochondrial physiology|MP:0009401,increased skeletal muscle fiber diameter|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009417,skeletal muscle atrophy|MP:0009461,skeletal muscle hypertrophy|MP:0010959,abnormal oxidative phosphorylation
MGI:6110864	Pabpn1<tm2.2Gpvl>	MP:0002080,prenatal lethality|MP:0003806,abnormal nucleotide metabolism|MP:0005369,muscle phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0009401,increased skeletal muscle fiber diameter|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009417,skeletal muscle atrophy|MP:0009461,skeletal muscle hypertrophy|MP:0010959,abnormal oxidative phosphorylation
MGI:2156395	Pabr1<129X1/SvJ>	MP:0005416,abnormal circulating protein level
MGI:2156396	Pabr1<C57BL/6J>	MP:0005416,abnormal circulating protein level
MGI:2155712	Pabr2<129X1/SvJ>	MP:0005416,abnormal circulating protein level
MGI:2155713	Pabr2<C57BL/6J>	MP:0005416,abnormal circulating protein level
MGI:5004973	pac	MP:0001092,abnormal trigeminal ganglion morphology|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0003861,abnormal nervous system development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012494,dilated pharyngeal arch artery
MGI:6356325	Pacc1<em1.1Zzq>	MP:0004811,abnormal neuron physiology|MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0008944,decreased sensitivity to induced cell death
MGI:5755130	Pacrg<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001556,increased circulating HDL cholesterol level|MP:0001925,male infertility|MP:0002075,abnormal coat/hair pigmentation
MGI:6257514	Pacs1<em1(IMPC)Hmgu>	MP:0002059,abnormal seminal vesicle morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:4313108	Pacs2<Gt(OST426086)Lex>	MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0006043,decreased apoptosis
MGI:4435377	Pacs2<tm1a(EUCOMM)Hmgu>	MP:0002764,short tibia|MP:0004924,abnormal behavior|MP:0010053,decreased grip strength
MGI:6402889	Pacsin1<em1(IMPC)H>	MP:0002941,increased circulating alanine transaminase level
MGI:4265743	Pacsin1<Gt(OST287788)Lex>	MP:0005387,immune system phenotype|MP:0008563,decreased interferon-alpha secretion|MP:0008574,decreased circulating interferon-alpha level|MP:0008769,abnormal plasmacytoid dendritic cell physiology
MGI:5660311	Pacsin1<tm1.1Bqu>	MP:0001262,decreased body weight|MP:0001921,reduced fertility|MP:0002272,abnormal nervous system electrophysiology|MP:0002917,decreased synaptic depression|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0003997,tonic-clonic seizures|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004769,abnormal synaptic vesicle morphology|MP:0004770,abnormal synaptic vesicle recycling|MP:0004792,abnormal synaptic vesicle number|MP:0008546,abnormal vesicle-mediated transport|MP:0009538,abnormal synapse morphology|MP:0010768,mortality/aging|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0020082,increased hippocampus volume
MGI:6360215	Pacsin2<tm1.1Cgn>	MP:0003137,abnormal impulse conducting system conduction|MP:0005385,cardiovascular system phenotype|MP:0005402,abnormal action potential|MP:0011390,abnormal fetal cardiomyocyte physiology|MP:0012106,impaired exercise endurance
MGI:5569946	Pacsin2<tm1b(EUCOMM)Hmgu>	MP:0000208,decreased hematocrit|MP:0001759,increased urine glucose level|MP:0002591,decreased mean corpuscular volume|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0003960,increased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005505,thrombocytosis|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0013279,increased fasting circulating glucose level
MGI:8161188	Pacsin3<tm1.2Bqu>	MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003950,abnormal plasma membrane morphology|MP:0004510,myositis|MP:0005369,muscle phenotype|MP:0005385,cardiovascular system phenotype|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0009401,increased skeletal muscle fiber diameter|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009412,skeletal muscle fiber degeneration|MP:0009414,skeletal muscle fiber necrosis|MP:0011390,abnormal fetal cardiomyocyte physiology
MGI:1856983	pad	MP:0000150,abnormal rib morphology|MP:0000435,shortened head|MP:0000477,abnormal intestine morphology|MP:0000547,short limbs|MP:0002657,chondrodystrophy|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004540,small maxilla|MP:0004592,small mandible|MP:0004703,abnormal vertebral column morphology|MP:0006395,abnormal epiphyseal plate morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0021208,median cleft palate|MP:0030267,decreased basicranium angle
MGI:6305190	Padi1<em1(IMPC)J>	MP:0001566,increased circulating phosphate level|MP:0010053,decreased grip strength
MGI:5548442	Padi2<tm1b(KOMP)Wtsi>	MP:0002941,increased circulating alanine transaminase level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3528933	Padi2<tm1Lex>	MP:0001844,autoimmune response|MP:0002423,abnormal mast cell physiology
MGI:4362791	Padi3<tm1a(KOMP)Wtsi>	MP:0000367,abnormal coat/ hair morphology|MP:0002098,abnormal vibrissa morphology|MP:0002832,coarse hair|MP:0003809,abnormal hair shaft morphology|MP:0010179,rough coat
MGI:5793070	Padi3<tm1b(KOMP)Wtsi>	MP:0001556,increased circulating HDL cholesterol level|MP:0003961,decreased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0010024,increased total body fat amount
MGI:6276970	Padi4<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001552,increased circulating triglyceride level|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002590,increased mean corpuscular volume|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0005179,decreased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0005561,increased mean corpuscular hemoglobin
MGI:5285854	Padi4<tm1.1Kmow>	MP:0002463,abnormal neutrophil physiology|MP:0005387,immune system phenotype|MP:0010181,decreased susceptibility to weight loss|MP:0020947,decreased susceptibility to Orthomyxoviridae infection
MGI:5056532	Padi4<tm1.1Ywan>	MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0002467,impaired neutrophil phagocytosis|MP:0010831,lethality, incomplete penetrance
MGI:5695766	Padi4<tm1.2Kmow>	MP:0002169,no abnormal phenotype detected
MGI:5056529	Padi4<tm1Ywan>	MP:0002169,no abnormal phenotype detected
MGI:3806009	Padi6<tm1.1Jgo>	MP:0001125,abnormal oocyte morphology|MP:0001672,abnormal embryo development|MP:0001926,female infertility|MP:0003406,failure of zygotic cell division|MP:0005389,reproductive system phenotype
MGI:5582442	Padi6<tm1b(KOMP)Wtsi>	MP:0001926,female infertility|MP:0005630,increased lung weight
MGI:3708454	pado	MP:0001489,decreased startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856622	Paf	MP:0001510,abnormal coat appearance|MP:0001929,abnormal gametogenesis|MP:0001930,abnormal meiosis|MP:0002073,abnormal hair growth|MP:0004218,meiotic nondisjunction during M1 phase
MGI:5775649	Paf1<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2683481	Pafah1b1<Gt(IRESBetageo)1Hha>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002208,abnormal germ cell morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0005159,azoospermia|MP:0006378,abnormal spermatogonia morphology|MP:0006380,abnormal spermatid morphology|MP:0008279,arrest of spermiogenesis|MP:0008898,abnormal acrosome morphology|MP:0014686,premature spermiation
MGI:2384054	Pafah1b1<tm1Awb>	MP:0000790,abnormal stratification in cerebral cortex|MP:0000807,abnormal hippocampus morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001513,limb grasping|MP:0001889,delayed brain development|MP:0003203,increased neuron apoptosis|MP:0006009,abnormal neuronal migration|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008547,abnormal neocortex morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011093,embryonic lethality at implantation, complete penetrance|MP:0011380,enlarged brain ventricles
MGI:2387783	Pafah1b1<tm1Or>	MP:0000934,abnormal telencephalon development|MP:0001889,delayed brain development|MP:0003648,abnormal radial glial cell morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2384063	Pafah1b1<tm2.2Awb>	MP:0000790,abnormal stratification in cerebral cortex|MP:0000807,abnormal hippocampus morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011380,enlarged brain ventricles
MGI:2384060	Pafah1b1<tm2Awb>	MP:0000807,abnormal hippocampus morphology
MGI:2665020	Pafah1b2<Gt(Betageo)1Cla>	MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005380,embryo phenotype|MP:0006379,abnormal spermatocyte morphology|MP:0006380,abnormal spermatid morphology|MP:0020550,multinucleated giant male germ cells
MGI:2655809	Pafah1b2<tm1Arai>	MP:0004852,decreased testis weight
MGI:2655810	Pafah1b3<tm1Arai>	MP:0002169,no abnormal phenotype detected
MGI:2665018	Pafah1b3<tm1Cla>	MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype
MGI:3772686	Pafah2<tm1Arai>	MP:0001654,hepatic necrosis|MP:0002941,increased circulating alanine transaminase level|MP:0008412,increased cellular sensitivity to oxidative stress
MGI:4441057	Pag1<tm1.1Tara>	MP:0005387,immune system phenotype
MGI:3604217	Pag1<tm1Kplm>	MP:0000714,increased thymocyte number
MGI:5301868	Pag1<tm1Sbln>	MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging
MGI:4441056	Pag1<tm1Tara>	MP:0005387,immune system phenotype
MGI:5629850	Pagr1a<tm1Kaig>	MP:0001689,incomplete somite formation|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0001730,embryonic growth arrest|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002836,abnormal chorion morphology|MP:0003232,abnormal forebrain development|MP:0003794,delayed somite formation|MP:0003885,abnormal rostral-caudal body axis extension|MP:0003891,increased allantois apoptosis|MP:0003984,embryonic growth retardation|MP:0004180,failure of initiation of embryo turning|MP:0004559,small allantois|MP:0005029,abnormal amnion morphology|MP:0010736,abnormal extraembryonic ectoderm morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011199,abnormal amniotic cavity morphology|MP:0011200,abnormal extraembryonic coelom morphology|MP:0012701,increased embryonic neuroepithelium apoptosis|MP:0020515,abnormal visceral yolk sac endoderm morphology|MP:0020517,abnormal visceral yolk sac physiology
MGI:6156602	Pah<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000692,small spleen|MP:0001297,microphthalmia|MP:0001312,abnormal cornea morphology|MP:0001417,decreased exploration in new environment|MP:0001926,female infertility|MP:0002075,abnormal coat/hair pigmentation|MP:0002768,small adrenal glands
MGI:6715267	Pah<em1Skym>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000371,diluted coat color|MP:0000780,abnormal corpus callosum morphology|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001312,abnormal cornea morphology|MP:0001447,abnormal nest building behavior|MP:0002152,abnormal brain morphology|MP:0002175,decreased brain weight|MP:0002204,abnormal synaptic neurotransmitter level|MP:0005179,decreased circulating cholesterol level|MP:0005332,abnormal amino acid level|MP:0008732,reduced hair shaft melanin granule number|MP:0010070,decreased serotonin level|MP:0012574,decreased noradrenaline level|MP:0013438,dysmyelination|MP:0013724,decreased circulating tyrosine level|MP:0020875,decreased nervous system dopamine level|MP:0030670,increased circulating phenylalanine level|MP:0030697,increased phenylalanine level
MGI:1857271	Pah<enu1>	MP:0001935,decreased litter size|MP:0005311,abnormal circulating amino acid level|MP:0005386,behavior/neurological phenotype
MGI:1857272	Pah<enu2>	MP:0000433,microcephaly|MP:0000788,abnormal cerebral cortex morphology|MP:0001460,abnormal olfactory discrimination memory|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0001935,decreased litter size|MP:0002063,abnormal learning/memory/conditioning|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005408,hypopigmentation|MP:0009643,abnormal urine homeostasis|MP:0010070,decreased serotonin level|MP:0020446,increased NAD(P)H oxidase activity|MP:0030670,increased circulating phenylalanine level|MP:0030697,increased phenylalanine level
MGI:1857273	Pah<enu3>	MP:0000433,microcephaly|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0001935,decreased litter size|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005408,hypopigmentation|MP:0009643,abnormal urine homeostasis|MP:0030670,increased circulating phenylalanine level
MGI:4361841	Pah<m1Btlr>	MP:0000371,diluted coat color|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001496,audiogenic seizures|MP:0009358,environmentally induced seizures
MGI:6152730	Paics<em1(IMPC)Mbp>	MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:3582724	Pain2<C3H/HeN>	MP:0001968,abnormal touch/nociception|MP:0003177,allodynia
MGI:6414533	Paip1<em1(IMPC)Tcp>	MP:0000208,decreased hematocrit|MP:0000702,enlarged lymph nodes|MP:0001925,male infertility|MP:0002591,decreased mean corpuscular volume|MP:0005419,decreased circulating serum albumin level|MP:0005505,thrombocytosis|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010067,increased red blood cell distribution width
MGI:4837192	Paip2b<tm1.2Nso>	MP:0005389,reproductive system phenotype
MGI:4837189	Paip2<tm1.2Nso>	MP:0001925,male infertility|MP:0002662,abnormal cauda epididymis morphology|MP:0005389,reproductive system phenotype
MGI:7284811	Pak1<em1Yuwa>	MP:0020438,decreased papilloma incidence
MGI:7284812	Pak1<em2Yuwa>	MP:0002006,neoplasm
MGI:6156479	Pak1ip1<em1(IMPC)Tcp>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5548169	Pak1ip1<mray>	MP:0000352,decreased cell proliferation|MP:0000455,abnormal maxilla morphology|MP:0000822,abnormal brain ventricle morphology|MP:0001786,skin edema|MP:0003935,abnormal craniofacial development|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0004235,abnormal masseter muscle morphology|MP:0008797,facial cleft|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012091,increased midbrain size|MP:0012138,decreased forebrain size|MP:0012263,decreased hindbrain size|MP:0030095,abnormal midface morphology|MP:0030197,small nasal septum
MGI:5470058	Pak1<tm1.1Xwg>	MP:0001625,cardiac hypertrophy|MP:0002169,no abnormal phenotype detected|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0003828,pulmonary edema|MP:0004485,increased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0006138,congestive heart failure
MGI:5636968	Pak1<tm1b(EUCOMM)Hmgu>	MP:0001552,increased circulating triglyceride level|MP:0005565,increased blood urea nitrogen level|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:3834675	Pak1<tm1Cher>	MP:0002423,abnormal mast cell physiology|MP:0005397,hematopoietic system phenotype|MP:0008765,decreased mast cell degranulation
MGI:5694233	Pak1<tm1Zpj>	MP:0001473,reduced long-term potentiation|MP:0003631,nervous system phenotype
MGI:6153805	Pak2<em1(IMPC)H>	MP:0002590,increased mean corpuscular volume|MP:0005561,increased mean corpuscular hemoglobin|MP:0008806,increased circulating amylase level|MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:1861800	Pak2<Gt(OST104058)Lex>	MP:0001360,abnormal social investigation|MP:0001361,social withdrawal|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001473,reduced long-term potentiation|MP:0002912,abnormal excitatory postsynaptic potential|MP:0005386,behavior/neurological phenotype|MP:0006009,abnormal neuronal migration|MP:0020395,abnormal response to social novelty|MP:0020508,decreased dendritic spine density|MP:0020551,abnormal postsynaptic density morphology|MP:0020849,abnormal actin cytoskeleton morphology
MGI:5494659	Pak2<tm1.1Cher>	MP:0010763,abnormal hematopoietic stem cell physiology
MGI:5006978	Pak2<tm1.1Rjak>	MP:0000313,abnormal cell death|MP:0011703,increased fibroblast proliferation
MGI:5427684	Pak2<tm1Dgen>	MP:0011100,preweaning lethality, complete penetrance
MGI:5006977	Pak2<tm1Rjak>	MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0009768,impaired somite development|MP:0011100,preweaning lethality, complete penetrance
MGI:6466590	Pak3<tm1.1Rpo>	MP:0002063,abnormal learning/memory/conditioning|MP:0004811,abnormal neuron physiology|MP:0008432,abnormal long-term spatial reference memory|MP:0009937,abnormal neuron differentiation|MP:0020335,abnormal dentate gyrus neuron dendrite morphology
MGI:3584167	Pak3<tm1Zpj>	MP:0001473,reduced long-term potentiation|MP:0002805,abnormal conditioned taste aversion behavior
MGI:2679635	Pak4<tm1Amin>	MP:0000280,thin ventricular wall|MP:0000352,decreased cell proliferation|MP:0000937,abnormal motor neuron morphology|MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001722,pale yolk sac|MP:0002151,abnormal neural tube morphology|MP:0002152,abnormal brain morphology|MP:0002652,thin myocardium|MP:0003231,abnormal placenta vasculature|MP:0003566,abnormal cell adhesion|MP:0003651,abnormal axon extension|MP:0003717,pallor|MP:0003861,abnormal nervous system development|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004266,pale placenta|MP:0004937,dilated heart|MP:0006009,abnormal neuronal migration|MP:0006042,increased apoptosis|MP:0009937,abnormal neuron differentiation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012703,decreased embryonic neuroepithelium thickness|MP:0021101,abnormal ventral interneuron morphology
MGI:6158512	Pak5<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001513,limb grasping|MP:0002339,abnormal lymph node morphology|MP:0002574,increased vertical activity
MGI:2679653	Pak5<tm1Amin>	MP:0002798,abnormal active avoidance behavior|MP:0003631,nervous system phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:6257785	Pak6<em1(IMPC)Bay>	MP:0000195,decreased circulating calcium level|MP:0002644,decreased circulating triglyceride level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration
MGI:3821622	Pak6<tm1Amin>	MP:0002169,no abnormal phenotype detected
MGI:7618327	Pakap<tm1.1Div>	MP:0000343,abnormal response to cardiac infarction|MP:0003037,increased myocardial infarct size|MP:0004485,increased response of heart to induced stress|MP:0031217,increased susceptibility to myocardial ischemic injury
MGI:5004957	pal	MP:0000259,abnormal vascular development|MP:0001096,abnormal glossopharyngeal ganglion morphology|MP:0001100,abnormal vagus ganglion morphology|MP:0001698,decreased embryo size|MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0003861,abnormal nervous system development|MP:0009806,abnormal otic vesicle morphology|MP:0009937,abnormal neuron differentiation|MP:0010642,absent third pharyngeal arch|MP:0010643,absent fourth pharyngeal arch|MP:0010939,abnormal mandibular prominence morphology|MP:0010940,abnormal maxillary prominence morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012493,absent pharyngeal arch arteries|MP:0012494,dilated pharyngeal arch artery|MP:0012756,impaired cranial neural crest cell differentiation|MP:0013183,absent trigeminal ganglion
MGI:3801303	Palb2<Gt(CG0691)Wtsi>	MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0002825,abnormal notochord morphology|MP:0002861,abnormal tail bud morphology|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0005030,absent amnion|MP:0006386,absent somites|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011105,embryonic lethality between implantation and placentation, incomplete penetrance|MP:0012113,decreased inner cell mass proliferation
MGI:5495825	Palb2<tm1.1Dli>	MP:0005380,embryo phenotype
MGI:5471393	Palb2<tm1.1(KOMP)Vlcg>	MP:0002079,increased circulating insulin level|MP:0002702,decreased circulating free fatty acids level|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5495930	Palb2<tm1.2Dli>	MP:0000914,exencephaly|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0003229,abnormal vitelline vasculature morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:6156342	Pald1<em1(IMPC)Kmpc>	MP:0002092,abnormal eye morphology|MP:0005293,impaired glucose tolerance|MP:0009455,enhanced cued conditioning behavior|MP:0020421,increased freezing behavior
MGI:5317962	Pald1<tm1Vlcg>	MP:0001183,overexpanded pulmonary alveolus|MP:0001942,abnormal lung volume|MP:0001958,emphysema|MP:0002309,abnormal vital capacity|MP:0002311,abnormal inspiratory capacity|MP:0006057,decreased vascular endothelial cell number|MP:0010895,increased lung compliance|MP:0010936,decreased airway resistance|MP:0010937,increased total lung capacity|MP:0011139,increased lung endothelial cell proliferation|MP:0011141,increased lung endothelial cell apoptosis
MGI:3623949	Palld<tm1Zgwg>	MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011708,decreased fibroblast cell migration|MP:0014698,decreased fibroblast adhesion
MGI:6161257	Palm3<tm1b(EUCOMM)Wtsi>	MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0009142,decreased prepulse inhibition
MGI:6158662	Palmd<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0010053,decreased grip strength
MGI:6477926	Palmd<tm1.2Kili>	MP:0004003,abnormal vascular endothelial cell physiology
MGI:6153569	Palm<em1(IMPC)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0005293,impaired glucose tolerance
MGI:6883588	Palm<tm1.2Kili>	MP:0002169,no abnormal phenotype detected
MGI:4459078	Pals1<tm1Caw>	MP:0000350,abnormal cell proliferation|MP:0000352,decreased cell proliferation|MP:0000788,abnormal cerebral cortex morphology|MP:0001004,abnormal retina photoreceptor morphology|MP:0001005,abnormal retina rod cell morphology|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001401,jumpy|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0001511,disheveled coat|MP:0001526,abnormal placing response|MP:0002152,abnormal brain morphology|MP:0002169,no abnormal phenotype detected|MP:0003203,increased neuron apoptosis|MP:0003241,loss of cortex neurons|MP:0003354,astrocytosis|MP:0003424,premature neuronal precursor differentiation|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003734,abnormal retina inner plexiform layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004924,abnormal behavior|MP:0004948,abnormal neuronal precursor proliferation|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005424,jerky movement|MP:0005551,abnormal eye electrophysiology|MP:0006254,thin cerebral cortex|MP:0008067,retina ganglion cell degeneration|MP:0008283,small hippocampus|MP:0008450,retina photoreceptor degeneration|MP:0008507,thin retina ganglion layer|MP:0008509,disorganized retina ganglion layer|MP:0008513,thin retina inner plexiform layer|MP:0008515,thin retina outer nuclear layer|MP:0008516,disorganized retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008582,short photoreceptor inner segment|MP:0008583,absent photoreceptor inner segment|MP:0008585,absent photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0008918,microgliosis|MP:0010053,decreased grip strength|MP:0010236,abnormal retina outer limiting membrane morphology|MP:0010768,mortality/aging|MP:0021107,retina fold|MP:0030005,increased retina apoptosis|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:6156145	Pals2<em1(IMPC)Rbrc>	MP:0000470,abnormal stomach morphology|MP:0000689,abnormal spleen morphology|MP:0001258,decreased body length|MP:0002764,short tibia|MP:0003795,abnormal bone structure|MP:0004613,fusion of vertebral arches|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5637011	Pam16<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:7425892	Pamr1<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0001402,decreased locomotor activity|MP:0002591,decreased mean corpuscular volume|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010896,decreased lung compliance|MP:0010935,increased airway resistance|MP:0011044,increased lung elastance|MP:0011047,increased lung tissue damping
MGI:3610996	Pam<tm1Jep>	MP:0001785,edema|MP:0002191,abnormal artery morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0005293,impaired glucose tolerance|MP:0010024,increased total body fat amount|MP:0010943,abnormal bronchus epithelium morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012303,umbilical vein stenosis
MGI:5563441	Pan2<m1Anu>	MP:0008762,embryonic lethality
MGI:5605785	Pan2<tm1b(KOMP)Wtsi>	MP:0002833,increased heart weight|MP:0005011,increased eosinophil cell number
MGI:6367973	Pan3<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000702,enlarged lymph nodes|MP:0002060,abnormal skin morphology|MP:0005562,decreased mean corpuscular hemoglobin|MP:0009476,enlarged cecum|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6423827	Pank1<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001402,decreased locomotor activity
MGI:4462018	Pank1<tm1.1Suja>	MP:0000187,abnormal triglyceride level|MP:0000609,abnormal liver physiology|MP:0001260,increased body weight|MP:0001433,polyphagia|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0003383,abnormal gluconeogenesis|MP:0005332,abnormal amino acid level|MP:0005560,decreased circulating glucose level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009355,increased liver triglyceride level|MP:0009356,decreased liver triglyceride level|MP:0009642,abnormal blood homeostasis|MP:0014172,decreased fatty acid oxidation
MGI:7425893	Pank2<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001417,decreased exploration in new environment|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002110,abnormal digit morphology|MP:0005387,immune system phenotype|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0011971,increased circulating lactate dehydrogenase level|MP:0020421,increased freezing behavior
MGI:5446719	Pank2<tm1.1Suja>	MP:0001147,small testis|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0011100,preweaning lethality, complete penetrance
MGI:3514020	Pank2<tm1Jgt>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002638,abnormal pupillary reflex|MP:0003631,nervous system phenotype|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005159,azoospermia|MP:0005386,behavior/neurological phenotype|MP:0008455,abnormal retina rod cell inner segment morphology|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:5637135	Pank3<tm1b(KOMP)Mbp>	MP:0000219,increased neutrophil cell number|MP:0001402,decreased locomotor activity|MP:0002875,decreased erythrocyte cell number|MP:0004357,long tibia|MP:0005016,decreased lymphocyte cell number|MP:0010088,decreased circulating fructosamine level
MGI:6336127	Pank4<em1(IMPC)Kmpc>	MP:0000598,abnormal liver morphology|MP:0001399,hyperactivity
MGI:6508538	Pank4<em1Nju>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology|MP:0003237,abnormal lens epithelium morphology|MP:0008794,increased lens epithelium apoptosis
MGI:5563530	Pantr1<tm1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:5563531	Pantr2<tm1Vlcg>	MP:0000861,disorganized barrel cortex|MP:0001262,decreased body weight|MP:0003989,abnormal barrel cortex morphology|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0008947,increased neuron number|MP:0008948,decreased neuron number|MP:0020069,decreased neocortex size
MGI:5297171	Panx1<tm1.1Fama>	MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0004811,abnormal neuron physiology|MP:0005377,hearing/vestibular/ear phenotype
MGI:5487761	Panx1<tm1.1Vshe>	MP:0002983,increased retina ganglion cell number|MP:0003204,decreased neuron apoptosis|MP:0005164,abnormal response to injury
MGI:5013648	Panx1<tm1.2Vmd>	MP:0002444,abnormal T cell physiology|MP:0005387,immune system phenotype
MGI:4363250	Panx1<tm1a(KOMP)Wtsi>	MP:0002133,abnormal respiratory system physiology|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0004811,abnormal neuron physiology|MP:0005621,abnormal cell physiology
MGI:5696900	Panx1<tm1b(KOMP)Wtsi>	MP:0004924,abnormal behavior|MP:0005419,decreased circulating serum albumin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0020870,decreased thigmotaxis
MGI:5487760	Panx1<tm1Vshe>	MP:0002983,increased retina ganglion cell number|MP:0003204,decreased neuron apoptosis|MP:0005164,abnormal response to injury
MGI:5310802	Panx2<tm1.1Mony>	MP:0006059,decreased susceptibility to ischemic brain injury
MGI:5548503	Panx2<tm1b(KOMP)Wtsi>	MP:0001102,small superior vagus ganglion|MP:0004906,enlarged uterus|MP:0004952,increased spleen weight|MP:0009142,decreased prepulse inhibition|MP:0009709,hydrometra
MGI:5548608	Panx3<tm1b(KOMP)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5788523	Panx3<tm1c(KOMP)Wtsi>	MP:0003436,decreased susceptibility to induced arthritis|MP:0013304,osteophytes
MGI:5788524	Panx3<tm1d(KOMP)Wtsi>	MP:0001935,decreased litter size|MP:0003436,decreased susceptibility to induced arthritis|MP:0005390,skeleton phenotype
MGI:5548591	Paox<tm1.1(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0002792,abnormal retina vasculature morphology|MP:0003179,thrombocytopenia|MP:0005343,increased circulating aspartate transaminase level|MP:0010097,abnormal retina blood vessel morphology|MP:0013278,decreased fasting circulating glucose level
MGI:2445581	Papg1<BALB/cJ>	MP:0002020,increased tumor incidence
MGI:6314387	Papola<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0001697,abnormal embryo size|MP:0003961,decreased lean body mass|MP:0005343,increased circulating aspartate transaminase level|MP:0011100,preweaning lethality, complete penetrance
MGI:5696917	Papolb<tm1.1(KOMP)Vlcg>	MP:0000538,abnormal urinary bladder morphology|MP:0001120,abnormal uterus morphology|MP:0001925,male infertility|MP:0004906,enlarged uterus
MGI:2447177	Papolb<tm1Tba>	MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0014052,increased male germ cell apoptosis
MGI:6303601	Papolg<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001402,decreased locomotor activity|MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5789593	Pappa2<M1Btlr>	MP:0001262,decreased body weight
MGI:5789591	Pappa2<M2Btlr>	MP:0001262,decreased body weight
MGI:6113589	Pappa2<m3Btlr>	MP:0001262,decreased body weight
MGI:6283598	Pappa2<M4Btlr>	MP:0001262,decreased body weight
MGI:6283613	Pappa2<M5Btlr>	MP:0001262,decreased body weight
MGI:5504500	Pappa2<tm1.1Jkcs>	MP:0000088,short mandible|MP:0000458,abnormal mandible morphology|MP:0000592,short tail|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002764,short tibia|MP:0003109,short femur|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004509,abnormal pelvic girdle bone morphology|MP:0009674,decreased birth weight|MP:0010114,abnormal coccyx morphology|MP:0011862,decreased cranium length
MGI:5142320	Pappa2<tm1Lex>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002176,increased brain weight|MP:0002833,increased heart weight|MP:0002981,increased liver weight|MP:0004952,increased spleen weight|MP:0005389,reproductive system phenotype
MGI:6286271	Pappa<m1Btlr>	MP:0000063,decreased bone mineral density|MP:0001262,decreased body weight|MP:0002764,short tibia|MP:0003961,decreased lean body mass|MP:0004692,small pubis|MP:0010124,decreased bone mineral content|MP:0020010,decreased bone mineral density of femur
MGI:6286275	Pappa<M2Btlr>	MP:0001262,decreased body weight
MGI:6286281	Pappa<m3Btlr>	MP:0001262,decreased body weight
MGI:6305839	Pappa<m4Btlr>	MP:0001262,decreased body weight
MGI:3037868	Pappa<tm1Cac>	MP:0000060,delayed bone ossification|MP:0001127,small ovary|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0004856,decreased ovary weight|MP:0005181,decreased circulating estradiol level|MP:0005182,increased circulating estradiol level|MP:0005185,decreased circulating progesterone level|MP:0005319,abnormal enzyme/coenzyme level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008974,proportional dwarf|MP:0009703,decreased birth body size|MP:0031420,decreased superovulation rate
MGI:5523410	Pappa<tm1Lex>	MP:0002169,no abnormal phenotype detected|MP:0004883,abnormal vascular wound healing
MGI:6360034	Papss1<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:1856688	Papss2<bm>	MP:0000111,cleft palate|MP:0000120,malocclusion|MP:0000130,abnormal trabecular bone morphology|MP:0000164,abnormal cartilage development|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000166,abnormal chondrocyte morphology|MP:0000440,domed cranium|MP:0000462,abnormal digestive system morphology|MP:0000588,thick tail|MP:0000592,short tail|MP:0001258,decreased body length|MP:0001259,abnormal body weight|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002111,abnormal tail morphology|MP:0002113,abnormal skeleton development|MP:0002427,disproportionate dwarf|MP:0002657,chondrodystrophy|MP:0002993,autoimmune arthritis|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004686,decreased length of long bones|MP:0005606,increased bleeding time|MP:0006396,decreased long bone epiphyseal plate size|MP:0008271,abnormal bone ossification|MP:0008272,abnormal endochondral bone ossification|MP:0008525,decreased cranium height|MP:0009780,abnormal chondrocyte physiology
MGI:6437039	Papss2<em1(IMPC)Bay>	MP:0002109,abnormal limb morphology|MP:0003743,abnormal facial morphology|MP:0009908,protruding tongue|MP:0011100,preweaning lethality, complete penetrance
MGI:3757569	Paqr3<tm1Ychn>	MP:0001219,thick epidermis|MP:0002038,increased carcinoma incidence|MP:0002051,increased skin papilloma incidence|MP:0003721,increased tumor growth/size|MP:0004499,increased incidence of tumors by chemical induction|MP:0009583,increased keratinocyte proliferation
MGI:7425895	Paqr5<em1(IMPC)Ccpcz>	MP:0000194,increased circulating calcium level|MP:0001304,cataract|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003917,increased kidney weight
MGI:5548574	Paqr6<tm1b(KOMP)Wtsi>	MP:0000194,increased circulating calcium level|MP:0001488,increased startle reflex
MGI:6158497	Paqr8<em1(IMPC)Mbp>	MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis
MGI:6394097	Paqr9<em1Jddl>	MP:0010182,decreased susceptibility to weight gain
MGI:3036742	Par1<M. spretus>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:2445574	Par2<BALB/c>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:3586643	Par2<BALB/cByJJcl>	MP:0002048,increased lung adenoma incidence
MGI:2158300	Par3<SM/J>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:2445579	Par5<BALB/cJ>	MP:0010267,decreased lung tumor incidence
MGI:5588280	Pard3b<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001399,hyperactivity|MP:0005599,increased cardiac muscle contractility|MP:0010097,abnormal retina blood vessel morphology
MGI:3838017	Pard3<tm1.1Shoh>	MP:0000267,abnormal heart development|MP:0000279,ventricular hypoplasia|MP:0000592,short tail|MP:0000934,abnormal telencephalon development|MP:0001785,edema|MP:0003984,embryonic growth retardation|MP:0004055,heart atrium hypoplasia|MP:0008725,increased heart atrium size|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5637107	Pard3<tm1b(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0002607,decreased basophil cell number|MP:0008259,abnormal optic disk morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:3838016	Pard3<tm1Shoh>	MP:0001272,increased metastatic potential|MP:0002006,neoplasm|MP:0002877,abnormal melanocyte morphology|MP:0003447,decreased tumor growth/size|MP:0003721,increased tumor growth/size|MP:0004381,abnormal hair follicle melanocyte morphology|MP:0004499,increased incidence of tumors by chemical induction|MP:0004502,decreased incidence of tumors by chemical induction|MP:0009388,abnormal epidermal melanocyte morphology|MP:0009828,increased tumor latency|MP:0010308,decreased tumor latency|MP:0012022,increased melanocyte number
MGI:5632530	Pard6a<tm1.1(KOMP)Vlcg>	MP:0005293,impaired glucose tolerance
MGI:3526553	Parg<tm1Tmd>	MP:0000352,decreased cell proliferation|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0006042,increased apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3052740	Parg<tm1Zqw>	MP:0001658,increased mortality induced by gamma-irradiation|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005559,increased circulating glucose level|MP:0008553,increased circulating tumor necrosis factor level|MP:0008735,increased susceptibility to endotoxin shock|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:5587048	Parg<tm2b(KOMP)Mbp>	MP:0000221,decreased leukocyte cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6336217	Park7<em1(IMPC)H>	MP:0000063,decreased bone mineral density|MP:0000432,abnormal head morphology|MP:0001556,increased circulating HDL cholesterol level|MP:0002965,increased circulating serum albumin level
MGI:3587946	Park7<Gt(XE726)Byg>	MP:0001516,abnormal motor coordination/balance|MP:0001905,abnormal dopamine level|MP:0011451,increased susceptibility to dopaminergic neuron neurotoxicity
MGI:3522482	Park7<tm1Cai>	MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0002804,abnormal motor learning|MP:0010053,decreased grip strength
MGI:3576227	Park7<tm1Dsp>	MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003224,neuron degeneration|MP:0003244,loss of dopaminergic neurons|MP:0003661,abnormal locus ceruleus morphology|MP:0004077,abnormal striatum morphology|MP:0008872,abnormal physiological response to xenobiotic|MP:0009745,abnormal behavioral response to xenobiotic|MP:0010053,decreased grip strength|MP:0013219,abnormal substantia nigra pars compacta morphology
MGI:3579140	Park7<tm1Shn>	MP:0001388,abnormal stationary movement|MP:0001405,impaired coordination|MP:0001899,absent long-term depression|MP:0002757,decreased vertical activity|MP:0003313,abnormal locomotor activation|MP:0003444,abnormal neurotransmitter uptake|MP:0003631,nervous system phenotype|MP:0005156,bradykinesia|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential
MGI:3514165	Park7<tm1Tmd>	MP:0003631,nervous system phenotype|MP:0010954,abnormal cellular respiration|MP:0010958,abnormal tricarboxylic acid cycle
MGI:3586448	Park7<tm1Xz>	MP:0001402,decreased locomotor activity|MP:0001524,impaired limb coordination|MP:0001906,increased dopamine level|MP:0002757,decreased vertical activity
MGI:3693645	Parl<tm1.1Bdes>	MP:0000160,kyphosis|MP:0000754,paresis|MP:0001145,abnormal male reproductive system morphology|MP:0001147,small testis|MP:0001505,hunched posture|MP:0001622,abnormal vasculogenesis|MP:0001634,internal hemorrhage|MP:0001732,postnatal growth retardation|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0002269,muscular atrophy|MP:0002286,cryptorchism|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0003491,abnormal voluntary movement|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0004014,abnormal uterine environment|MP:0004819,decreased skeletal muscle mass|MP:0004930,small epididymis|MP:0004939,abnormal B cell morphology|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005092,decreased double-positive T cell number|MP:0005150,cachexia|MP:0005403,abnormal nerve conduction|MP:0005621,abnormal cell physiology|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006051,brainstem hemorrhage|MP:0006054,spinal hemorrhage|MP:0006413,increased T cell apoptosis|MP:0008918,microgliosis|MP:0009402,decreased skeletal muscle fiber diameter|MP:0010955,abnormal respiratory electron transport chain|MP:0011635,abnormal mitochondrial crista morphology|MP:0013806,encephalopathy|MP:0014180,abnormal thymus apoptosis|MP:0014812,abnormal brain physiology
MGI:4435986	Parl<tm1a(EUCOMM)Hmgu>	MP:0002590,increased mean corpuscular volume
MGI:3526574	Parl<tm1Bdes>	MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0002269,muscular atrophy|MP:0003103,liver degeneration|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0010768,mortality/aging|MP:0014180,abnormal thymus apoptosis
MGI:6404379	Parn<em1Ins>	MP:0011092,embryonic lethality, complete penetrance
MGI:6404380	Parn<em2Ins>	MP:0011092,embryonic lethality, complete penetrance
MGI:5548742	Parp11<tm1.1(KOMP)Vlcg>	MP:0005344,increased circulating bilirubin level
MGI:4415414	Parp11<tm1(KOMP)Vlcg>	MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009647,decreased fertilization frequency
MGI:5548746	Parp12<tm1.1(KOMP)Vlcg>	MP:0000219,increased neutrophil cell number|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001926,female infertility|MP:0002599,increased mean platelet volume|MP:0002606,increased basophil cell number|MP:0005573,increased pulmonary respiratory rate|MP:0005576,decreased pulmonary ventilation|MP:0012125,decreased bronchoconstrictive response
MGI:4310014	Parp14<Gt(OST415485)Lex>	MP:0001807,decreased IgA level|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0005093,decreased B cell proliferation|MP:0005154,increased B cell proliferation|MP:0008173,increased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008782,increased B cell apoptosis
MGI:7425896	Parp1<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001120,abnormal uterus morphology|MP:0001157,small seminal vesicle|MP:0001297,microphthalmia|MP:0002059,abnormal seminal vesicle morphology|MP:0002092,abnormal eye morphology|MP:0013279,increased fasting circulating glucose level
MGI:5692622	Parp1<tm1b(EUCOMM)Hmgu>	MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005387,immune system phenotype|MP:0008045,decreased NK cell number|MP:0009141,increased prepulse inhibition|MP:0010053,decreased grip strength|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:1857765	Parp1<tm1Hsmm>	MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:1857861	Parp1<tm1Jmdm>	MP:0001262,decreased body weight|MP:0001658,increased mortality induced by gamma-irradiation|MP:0001845,abnormal inflammatory response|MP:0001935,decreased litter size|MP:0003156,abnormal leukocyte migration|MP:0003701,elevated level of mitotic sister chromatid exchange|MP:0003992,increased mortality induced by ionizing radiation|MP:0004030,induced chromosome breakage|MP:0004045,abnormal cell cycle checkpoint function|MP:0004925,decreased susceptibility to noise-induced hearing loss|MP:0005387,immune system phenotype|MP:0006042,increased apoptosis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011101,prenatal lethality, incomplete penetrance|MP:0014760,impaired DNA repair
MGI:1857862	Parp1<tm1Zqw>	MP:0000352,decreased cell proliferation|MP:0001214,skin hyperplasia|MP:0001876,decreased inflammatory response|MP:0002724,enhanced wound healing|MP:0003204,decreased neuron apoptosis|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003691,abnormal microglial cell physiology|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0005166,decreased susceptibility to injury|MP:0005387,immune system phenotype|MP:0005527,increased renal glomerular filtration rate|MP:0005554,decreased circulating creatinine level|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0011372,decreased renal tubule apoptosis|MP:0011452,decreased susceptibility to dopaminergic neuron neurotoxicity
MGI:3497740	Parp1<tm2Zqw>	MP:0001845,abnormal inflammatory response|MP:0001876,decreased inflammatory response|MP:0002451,abnormal macrophage physiology|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008734,decreased susceptibility to endotoxin shock
MGI:2663016	Parp2<tm1Jmdm>	MP:0001658,increased mortality induced by gamma-irradiation|MP:0002006,neoplasm|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0003701,elevated level of mitotic sister chromatid exchange|MP:0004030,induced chromosome breakage|MP:0004045,abnormal cell cycle checkpoint function|MP:0005384,cellular phenotype|MP:0014760,impaired DNA repair
MGI:4948941	Parp3<tm1.2Ics>	MP:0010768,mortality/aging
MGI:6362804	Parp4<em1(IMPC)Mbp>	MP:0001417,decreased exploration in new environment|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0002989,small kidney|MP:0005178,increased circulating cholesterol level
MGI:3046826	Parp4<tm1Leah>	MP:0002169,no abnormal phenotype detected
MGI:6865766	Parp6<em1Msco>	MP:0001175,abnormal lung morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001401,jumpy|MP:0001575,cyanosis|MP:0001925,male infertility|MP:0003631,nervous system phenotype|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5494979	Parp8<tm1.1(KOMP)Wtsi>	MP:0001417,decreased exploration in new environment|MP:0002833,increased heart weight|MP:0003064,decreased coping response
MGI:6721053	Parp9<tm1.2Arte>	MP:0005025,abnormal response to infection|MP:0008548,abnormal circulating interferon level|MP:0008555,abnormal interferon secretion
MGI:7425898	Parva<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001126,abnormal ovary morphology|MP:0002100,abnormal tooth morphology|MP:0002339,abnormal lymph node morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:4368017	Parva<tm1Ref>	MP:0000267,abnormal heart development|MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0001914,hemorrhage|MP:0002127,abnormal cardiovascular system morphology|MP:0002633,persistent truncus arteriosus|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0003279,aneurysm|MP:0003719,abnormal pericyte morphology|MP:0003984,embryonic growth retardation|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0004938,dilated vasculature|MP:0005312,pericardial effusion|MP:0005592,abnormal vascular smooth muscle morphology|MP:0005601,increased angiogenesis|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011738,anasarca|MP:0031613,fetal cardiomyocyte disarray
MGI:4431642	Parvb<tm1a(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0000063,decreased bone mineral density|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0002896,abnormal bone mineralization|MP:0004151,decreased circulating iron level|MP:0005018,decreased T cell number|MP:0005179,decreased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0005567,decreased circulating total protein level|MP:0008045,decreased NK cell number|MP:0008211,decreased mature B cell number
MGI:3835446	Parvb<tm1Ref>	MP:0002169,no abnormal phenotype detected
MGI:3621813	Parvg<tm1Ref>	MP:0002169,no abnormal phenotype detected
MGI:2156573	Pas14<A/J>	MP:0002048,increased lung adenoma incidence|MP:0010267,decreased lung tumor incidence
MGI:2156631	Pas17<M. spretus>	MP:0010267,decreased lung tumor incidence
MGI:3036102	Pas19<A/J>	MP:0002048,increased lung adenoma incidence
MGI:2156544	Pas1c<BALB/cOlaHsd>	MP:0002048,increased lung adenoma incidence|MP:0004499,increased incidence of tumors by chemical induction
MGI:3036738	Pas5b<A/JOlaHsd>	MP:0002048,increased lung adenoma incidence|MP:0004499,increased incidence of tumors by chemical induction
MGI:2445575	Pas7<A/JOlaHsd>	MP:0002048,increased lung adenoma incidence|MP:0004499,increased incidence of tumors by chemical induction
MGI:2154304	Pas8<A/JOlaHsd>	MP:0002048,increased lung adenoma incidence|MP:0004499,increased incidence of tumors by chemical induction
MGI:2155667	Pas9<A/JOlaHsd>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:2155668	Pas9<BALB/cOlaHsd>	MP:0002021,increased incidence of induced tumors|MP:0002048,increased lung adenoma incidence
MGI:2677908	Pask<tm1Weng>	MP:0002078,abnormal glucose homeostasis|MP:0002106,abnormal muscle physiology|MP:0002338,abnormal pulmonary ventilation|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0004129,abnormal respiratory quotient|MP:0005266,abnormal metabolism|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005379,endocrine/exocrine gland phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0014812,abnormal brain physiology|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:6361096	Pate1<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6361098	Pate2<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5548876	Pate2<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart
MGI:5614597	Pate4<tm1.1(KOMP)Mbp>	MP:0001399,hyperactivity|MP:0002833,increased heart weight|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0013279,increased fasting circulating glucose level
MGI:4456499	Pate4<tm1(KOMP)Mbp>	MP:0002169,no abnormal phenotype detected
MGI:6324666	Pate4<tm1Osb>	MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002673,abnormal sperm number|MP:0005389,reproductive system phenotype|MP:0030982,abnormal copulatory plug deposition
MGI:5763464	Patj<em1(IMPC)J>	MP:0001486,abnormal startle reflex|MP:0005343,increased circulating aspartate transaminase level
MGI:5574606	Patl1<tm1b(EUCOMM)Wtsi>	MP:0001491,unresponsive to tactile stimuli|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:6200023	Patl2<tm1b(EUCOMM)Hmgu>	MP:0000242,impaired fertilization|MP:0001125,abnormal oocyte morphology|MP:0001923,reduced female fertility|MP:0001931,abnormal oogenesis|MP:0001935,decreased litter size|MP:0005168,abnormal female meiosis|MP:0005389,reproductive system phenotype|MP:0009761,abnormal meiotic spindle morphology|MP:0010767,abnormal female meiosis I arrest|MP:0011120,increased primordial ovarian follicle number|MP:0014447,impaired spindle assembly in female meiosis|MP:0031014,polyspermy
MGI:5695909	Patz1<tm1.1(KOMP)Vlcg>	MP:0011100,preweaning lethality, complete penetrance
MGI:4454313	Patz1<tm1.1Welm>	MP:0000715,decreased thymocyte number|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002080,prenatal lethality|MP:0003944,abnormal T cell subpopulation ratio|MP:0009339,decreased splenocyte number|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5572819	Patz1<tm1.2Welm>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype|MP:0005462,abnormal mast cell differentiation|MP:0008706,decreased interleukin-6 secretion
MGI:3795851	Patz1<tm1Pchi>	MP:0000774,decreased brain size|MP:0000820,abnormal choroid plexus morphology|MP:0000830,abnormal diencephalon morphology|MP:0000841,abnormal hindbrain morphology|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002152,abnormal brain morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0002685,abnormal spermatogonia proliferation|MP:0003077,abnormal cell cycle|MP:0004110,transposition of great arteries|MP:0004200,decreased fetal size|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0006126,abnormal cardiac outflow tract development|MP:0008008,early cellular replicative senescence|MP:0009869,abnormal descending aorta morphology|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011380,enlarged brain ventricles|MP:0011703,increased fibroblast proliferation|MP:0011704,decreased fibroblast proliferation
MGI:8213455	Paupar<tm1.1Suss>	MP:0002078,abnormal glucose homeostasis|MP:0002696,decreased circulating glucagon level|MP:0002710,increased glucagon secretion|MP:0002711,decreased glucagon secretion|MP:0005216,abnormal pancreatic alpha cell morphology|MP:0009113,increased pancreatic beta cell mass|MP:0009176,increased pancreatic alpha cell number|MP:0013278,decreased fasting circulating glucose level|MP:0030588,decreased pancreatic alpha cell mass
MGI:3624677	Pawr<tm1.1Yshi>	MP:0002169,no abnormal phenotype detected
MGI:5692789	Pawr<tm1b(EUCOMM)Wtsi>	MP:0001402,decreased locomotor activity|MP:0005554,decreased circulating creatinine level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2678021	Pawr<tm1Jmos>	MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0005013,increased lymphocyte cell number|MP:0005154,increased B cell proliferation|MP:0005348,increased T cell proliferation|MP:0005466,abnormal T-helper 2 physiology|MP:0008944,decreased sensitivity to induced cell death
MGI:3692443	Pawr<tm1Lht>	MP:0002573,behavioral despair|MP:0005386,behavior/neurological phenotype
MGI:4888634	Pawr<tm1Rang>	MP:0002169,no abnormal phenotype detected
MGI:3624675	Pawr<tm1Yshi>	MP:0002169,no abnormal phenotype detected
MGI:7565345	Pax1dt<em1Rmh>	MP:0002169,no abnormal phenotype detected
MGI:5688488	Pax1<m1Btlr>	MP:0000585,kinked tail
MGI:5502388	Pax1<tm1.1Tlu>	MP:0002169,no abnormal phenotype detected
MGI:1857560	Pax1<tm1Neu>	MP:0000137,abnormal vertebrae morphology|MP:0000141,abnormal vertebral body morphology|MP:0000149,abnormal scapula morphology|MP:0000157,abnormal sternum morphology|MP:0000161,scoliosis|MP:0000585,kinked tail|MP:0002759,abnormal caudal vertebrae morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0004346,absent acromion|MP:0004607,abnormal cervical atlas morphology|MP:0004608,abnormal cervical axis morphology|MP:0004625,abnormal rib joint morphology|MP:0004658,abnormal ventral tubercle of atlas morphology|MP:0004683,absent intervertebral disk|MP:0004703,abnormal vertebral column morphology|MP:0010082,sternebra fusion|MP:0010701,fusion of atlas and odontoid process
MGI:4358156	Pax1<tm1(sb-pLHED)Jtak>	MP:0002169,no abnormal phenotype detected
MGI:5502389	Pax1<tm2.1Tlu>	MP:0000352,decreased cell proliferation|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001265,decreased body size
MGI:1857741	Pax1<tm2Neu>	MP:0000141,abnormal vertebral body morphology|MP:0000150,abnormal rib morphology|MP:0004670,small vertebral body|MP:0005508,abnormal skeleton morphology
MGI:1856222	Pax1<un>	MP:0000137,abnormal vertebrae morphology|MP:0000149,abnormal scapula morphology|MP:0000160,kyphosis|MP:0000585,kinked tail|MP:0000592,short tail|MP:0002111,abnormal tail morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0004346,absent acromion|MP:0004625,abnormal rib joint morphology|MP:0004652,small caudal vertebrae|MP:0005225,abnormal vertebrae development|MP:0005229,abnormal intervertebral disk development|MP:0030833,small acromion
MGI:1856223	Pax1<un-ex>	MP:0000137,abnormal vertebrae morphology|MP:0000139,absent vertebral transverse processes|MP:0000161,scoliosis|MP:0000454,abnormal jaw morphology|MP:0000564,syndactyly|MP:0000585,kinked tail|MP:0002111,abnormal tail morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0004083,polysyndactyly|MP:0004604,abnormal vertebral pedicle morphology|MP:0004624,abnormal thoracic cage morphology|MP:0004625,abnormal rib joint morphology|MP:0004626,vertebral compression|MP:0004668,absent vertebral body|MP:0004683,absent intervertebral disk|MP:0004687,split vertebrae|MP:0004703,abnormal vertebral column morphology|MP:0008149,abnormal costovertebral joint morphology
MGI:3603176	Pax1<un-i>	MP:0000137,abnormal vertebrae morphology|MP:0000149,abnormal scapula morphology|MP:0000161,scoliosis|MP:0000585,kinked tail|MP:0000715,decreased thymocyte number|MP:0000737,abnormal myotome development|MP:0001392,abnormal locomotor behavior|MP:0002759,abnormal caudal vertebrae morphology|MP:0002825,abnormal notochord morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003795,abnormal bone structure|MP:0004173,abnormal intervertebral disk morphology|MP:0004346,absent acromion|MP:0004347,abnormal scapular spine morphology|MP:0004353,abnormal deltoid tuberosity morphology|MP:0004607,abnormal cervical atlas morphology|MP:0004658,abnormal ventral tubercle of atlas morphology|MP:0004667,vertebral body hypoplasia|MP:0004683,absent intervertebral disk|MP:0005089,decreased double-negative T cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005225,abnormal vertebrae development|MP:0005226,abnormal vertebral arch development|MP:0005296,abnormal humerus morphology|MP:0006295,absent sclerotome|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010082,sternebra fusion|MP:0010701,fusion of atlas and odontoid process|MP:0013176,abnormal tail position or orientation
MGI:1856225	Pax1<Un-s>	MP:0000137,abnormal vertebrae morphology|MP:0000141,abnormal vertebral body morphology|MP:0000592,short tail|MP:0002111,abnormal tail morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0004173,abnormal intervertebral disk morphology|MP:0004625,abnormal rib joint morphology|MP:0004668,absent vertebral body|MP:0004683,absent intervertebral disk|MP:0008149,abnormal costovertebral joint morphology|MP:0011400,lethality, complete penetrance|MP:0013179,wavy tail
MGI:1857114	Pax2<1Neu>	MP:0000026,abnormal inner ear morphology|MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000534,abnormal ureter morphology|MP:0000536,hydroureter|MP:0000820,abnormal choroid plexus morphology|MP:0000850,absent cerebellum|MP:0000897,abnormal midbrain morphology|MP:0000899,abnormal corpora quadrigemina morphology|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0001330,abnormal optic nerve morphology|MP:0001948,vesicoureteral reflux|MP:0002621,delayed neural tube closure|MP:0002792,abnormal retina vasculature morphology|MP:0002989,small kidney|MP:0003446,renal hypoplasia|MP:0003584,bifid ureter|MP:0003586,dilated ureter|MP:0003604,single kidney|MP:0003626,kidney medulla hypoplasia|MP:0003672,abnormal ureter development|MP:0003675,kidney cyst|MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0003727,abnormal retina layer morphology|MP:0004017,duplex kidney|MP:0004268,abnormal optic stalk morphology|MP:0004369,absent utricle|MP:0004505,decreased renal glomerulus number|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005379,endocrine/exocrine gland phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0006012,dilated endolymphatic duct|MP:0006032,abnormal ureteric bud morphology|MP:0006069,abnormal retina neuronal layer morphology|MP:0006303,abnormal retina nerve fiber layer morphology|MP:0006309,decreased retina ganglion cell number|MP:0008259,abnormal optic disk morphology|MP:0008507,thin retina ganglion layer|MP:0009113,increased pancreatic beta cell mass|MP:0009167,increased pancreatic islet number|MP:0009262,absent semicircular canal ampulla|MP:0010980,ectopic ureteric bud|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011238,abnormal inner ear development|MP:0011290,decreased nephron number|MP:0011334,abnormal nephrogenic zone morphology|MP:0011368,increased kidney apoptosis|MP:0011493,double ureter|MP:0012133,absent midbrain-hindbrain boundary
MGI:4442602	Pax2<M1Bpb>	MP:0000519,hydronephrosis|MP:0000527,abnormal kidney development|MP:0000536,hydroureter|MP:0001286,abnormal eye development|MP:0001325,abnormal retina morphology|MP:0001330,abnormal optic nerve morphology|MP:0002703,abnormal renal tubule morphology|MP:0003446,renal hypoplasia|MP:0003631,nervous system phenotype|MP:0003675,kidney cyst|MP:0005201,abnormal retina pigment epithelium morphology|MP:0008259,abnormal optic disk morphology|MP:0009846,abnormal neural crest morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0010098,abnormal retina blood vessel pattern|MP:0011089,perinatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012132,abnormal midbrain-hindbrain boundary morphology|MP:0012533,uveal coloboma|MP:0012536,delayed optic fissure closure
MGI:1934620	Pax2<Opdc>	MP:0001330,abnormal optic nerve morphology|MP:0002092,abnormal eye morphology|MP:0010716,optic disk coloboma
MGI:5427892	Pax2<tm1.1Gdr>	MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000914,exencephaly|MP:0011087,neonatal lethality, complete penetrance
MGI:2657223	Pax2<tm1Cjt>	MP:0000026,abnormal inner ear morphology|MP:0000520,absent kidney|MP:0003146,absent cochlear ganglion|MP:0003147,absent cochlea|MP:0003722,absent ureter
MGI:5427893	Pax2<tm1Gdr>	MP:0003446,renal hypoplasia|MP:0011290,decreased nephron number|MP:0011307,kidney medulla cyst|MP:0011382,abnormal kidney lobule morphology|MP:0011493,double ureter
MGI:1858000	Pax2<tm1Mbu>	MP:0000026,abnormal inner ear morphology|MP:0000520,absent kidney|MP:0000850,absent cerebellum|MP:0000897,abnormal midbrain morphology|MP:0000913,abnormal brain development|MP:0001325,abnormal retina morphology|MP:0002199,abnormal brain commissure morphology|MP:0003146,absent cochlear ganglion|MP:0003147,absent cochlea|MP:0003535,absent vagina|MP:0003557,absent vas deferens|MP:0003558,absent uterus|MP:0003575,absent oviduct|MP:0003642,absent seminal vesicle|MP:0003722,absent ureter|MP:0004315,absent vestibular saccule|MP:0004425,abnormal otolith organ morphology|MP:0004727,absent epididymis|MP:0005103,abnormal retina pigmentation|MP:0006106,absent tectum|MP:0006426,Mullerian duct degeneration|MP:0009074,Wolffian duct degeneration|MP:0011089,perinatal lethality, complete penetrance|MP:0012133,absent midbrain-hindbrain boundary|MP:0012535,abnormal optic fissure closure
MGI:1857673	Pax2<tm1Pgr>	MP:0000026,abnormal inner ear morphology|MP:0000031,abnormal cochlea morphology|MP:0000034,abnormal inner ear vestibule morphology|MP:0000042,abnormal organ of Corti morphology|MP:0000044,absent organ of Corti|MP:0000048,abnormal stria vascularis morphology|MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000830,abnormal diencephalon morphology|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0001146,abnormal testis morphology|MP:0001286,abnormal eye development|MP:0001330,abnormal optic nerve morphology|MP:0001332,abnormal optic nerve innervation|MP:0002152,abnormal brain morphology|MP:0002428,abnormal semicircular canal morphology|MP:0002989,small kidney|MP:0003146,absent cochlear ganglion|MP:0003147,absent cochlea|MP:0003148,decreased cochlea coiling|MP:0003169,abnormal scala media morphology|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0003446,renal hypoplasia|MP:0003535,absent vagina|MP:0003557,absent vas deferens|MP:0003575,absent oviduct|MP:0003642,absent seminal vesicle|MP:0003651,abnormal axon extension|MP:0003720,abnormal neural tube closure|MP:0003722,absent ureter|MP:0003987,small vestibular ganglion|MP:0004195,abnormal kidney calyx morphology|MP:0004267,abnormal optic tract morphology|MP:0004268,abnormal optic stalk morphology|MP:0004315,absent vestibular saccule|MP:0004330,abnormal vestibular saccular macula morphology|MP:0004505,decreased renal glomerulus number|MP:0004717,absent cochlear nerve|MP:0004727,absent epididymis|MP:0004729,absent efferent ductules of testis|MP:0004922,abnormal common crus morphology|MP:0005103,abnormal retina pigmentation|MP:0005262,coloboma|MP:0005377,hearing/vestibular/ear phenotype|MP:0006011,abnormal endolymphatic duct morphology|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology|MP:0006426,Mullerian duct degeneration|MP:0008065,short endolymphatic duct|MP:0008066,small endolymphatic duct|MP:0008307,short scala media|MP:0008487,abnormal mesonephros morphology|MP:0008488,abnormal semicircular canal ampulla morphology|MP:0009074,Wolffian duct degeneration|MP:0009075,rudimentary Wolffian ducts|MP:0009076,rudimentary Mullerian ducts|MP:0009215,absent uterine horn|MP:0009771,absent optic chiasm|MP:0010118,abnormal intermediate mesoderm morphology|MP:0010717,optic nerve coloboma|MP:0010978,absent ureteric bud|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0010986,abnormal mesonephric mesenchyme morphology|MP:0011290,decreased nephron number|MP:0011360,kidney cortex hypoplasia|MP:0011366,absent metanephros|MP:0012535,abnormal optic fissure closure
MGI:1926937	Pax2<tm2(Pax5)Mbu>	MP:0000527,abnormal kidney development|MP:0001325,abnormal retina morphology|MP:0002989,small kidney|MP:0003446,renal hypoplasia|MP:0003606,kidney failure|MP:0003631,nervous system phenotype|MP:0005367,renal/urinary system phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0011089,perinatal lethality, complete penetrance|MP:0011368,increased kidney apoptosis
MGI:5640771	Pax3<M1Btlr>	MP:0002940,variable body spotting
MGI:5789596	Pax3<m2Btlr>	MP:0002940,variable body spotting
MGI:5662101	Pax3<Rwa>	MP:0000373,belly spot|MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0008237,abnormal ventral coat pigmentation|MP:0008762,embryonic lethality|MP:0009933,abnormal tail hair pigmentation|MP:0009934,abnormal hind foot hair pigmentation|MP:0010231,transverse fur striping|MP:0014134,abnormal embryo morphology
MGI:1856173	Pax3<Sp>	MP:0000373,belly spot|MP:0000585,kinked tail|MP:0000729,abnormal myogenesis|MP:0000822,abnormal brain ventricle morphology|MP:0000929,open neural tube|MP:0000936,small embryonic telencephalon|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001189,absent skin pigmentation|MP:0002111,abnormal tail morphology|MP:0002151,abnormal neural tube morphology|MP:0002428,abnormal semicircular canal morphology|MP:0002938,white spotting|MP:0003054,spina bifida|MP:0003090,abnormal muscle precursor cell migration|MP:0003148,decreased cochlea coiling|MP:0003864,abnormal midbrain development|MP:0004206,abnormal dermomyotome development|MP:0004289,abnormal bony labyrinth|MP:0004760,increased mitotic index|MP:0005171,absent coat pigmentation|MP:0005377,hearing/vestibular/ear phenotype|MP:0006011,abnormal endolymphatic duct morphology|MP:0006030,abnormal otic vesicle development|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology|MP:0008065,short endolymphatic duct|MP:0011089,perinatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012547,spina bifida cystica|MP:0012701,increased embryonic neuroepithelium apoptosis|MP:0030535,abnormal hypoglossal cord morphology
MGI:4818483	Pax3<Sp-10J>	MP:0000373,belly spot|MP:0002938,white spotting|MP:0003051,curly tail|MP:0005391,vision/eye phenotype|MP:0011091,prenatal lethality, complete penetrance
MGI:1856292	Pax3<Sp-1H>	MP:0000284,double outlet right ventricle|MP:0000681,abnormal thyroid gland morphology|MP:0000703,abnormal thymus morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0000929,open neural tube|MP:0000955,abnormal spinal cord morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0002633,persistent truncus arteriosus|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0002951,small thyroid gland|MP:0004160,retroesophageal right subclavian artery|MP:0004914,absent ultimobranchial body|MP:0005314,absent thyroid gland|MP:0006355,abnormal sixth pharyngeal arch artery morphology|MP:0010572,persistent right dorsal aorta|MP:0010589,common truncal valve|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012729,abnormal common carotid artery morphology
MGI:5523956	Pax3<Sp-1Wli>	MP:0000373,belly spot|MP:0000914,exencephaly|MP:0002151,abnormal neural tube morphology|MP:0002938,white spotting|MP:0003054,spina bifida|MP:0011091,prenatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5490564	Pax3<Sp-1Xzg>	MP:0000373,belly spot|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0002109,abnormal limb morphology|MP:0002938,white spotting|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0005408,hypopigmentation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011277,decreased tail pigmentation
MGI:1856293	Pax3<Sp-2H>	MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0000729,abnormal myogenesis|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0002151,abnormal neural tube morphology|MP:0002633,persistent truncus arteriosus|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0003054,spina bifida|MP:0003090,abnormal muscle precursor cell migration|MP:0004206,abnormal dermomyotome development|MP:0004215,abnormal myocardial fiber physiology|MP:0004838,abnormal neural fold elevation formation|MP:0010402,ventricular septal defect|MP:0011091,prenatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0031633,decreased heart left ventricle muscle contractility
MGI:1856296	Pax3<Sp-2J>	MP:0000373,belly spot|MP:0002939,head spot|MP:0011091,prenatal lethality, complete penetrance
MGI:1856297	Pax3<Sp-3J>	MP:0000373,belly spot
MGI:1856294	Pax3<Sp-4H>	MP:0000373,belly spot|MP:0001696,failure to gastrulate|MP:0002940,variable body spotting|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1858094	Pax3<Sp-5H>	MP:0001265,decreased body size|MP:0002938,white spotting|MP:0003631,nervous system phenotype|MP:0011102,embryonic lethality, incomplete penetrance
MGI:1858125	Pax3<Sp-6H>	MP:0001265,decreased body size|MP:0002938,white spotting
MGI:3043030	Pax3<Sp-7H>	MP:0000373,belly spot|MP:0000841,abnormal hindbrain morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002621,delayed neural tube closure|MP:0002950,abnormal neural crest cell migration
MGI:1856174	Pax3<Sp-d>	MP:0000373,belly spot|MP:0000914,exencephaly|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000962,disorganized dorsal root ganglion|MP:0002151,abnormal neural tube morphology|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0009245,caudal rachischisis|MP:0011089,perinatal lethality, complete penetrance
MGI:1856295	Pax3<Sp-J>	MP:0000373,belly spot
MGI:2385685	Pax3<tm1.1Sjc>	MP:0002169,no abnormal phenotype detected
MGI:2385687	Pax3<tm1.2Sjc>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2687297	Pax3<tm1Buck>	MP:0000373,belly spot|MP:0000729,abnormal myogenesis|MP:0000733,abnormal muscle development|MP:0000737,abnormal myotome development|MP:0000914,exencephaly|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001688,abnormal somite development|MP:0002151,abnormal neural tube morphology|MP:0002950,abnormal neural crest cell migration|MP:0003054,spina bifida|MP:0003090,abnormal muscle precursor cell migration|MP:0004206,abnormal dermomyotome development|MP:0011091,prenatal lethality, complete penetrance|MP:0013720,abnormal mammary line morphology|MP:0013721,abnormal mammary placode morphology
MGI:3573783	Pax3<tm1(cre)Joe>	MP:0000556,abnormal hindlimb morphology|MP:0000761,thin diaphragm muscle|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0002151,abnormal neural tube morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0012251,abnormal diaphragm development
MGI:2388378	Pax3<tm1(FOXO1A)Gcg>	MP:0000280,thin ventricular wall|MP:0000281,abnormal interventricular septum morphology|MP:0000759,abnormal skeletal muscle morphology|MP:0000914,exencephaly|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002006,neoplasm|MP:0002151,abnormal neural tube morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002367,abnormal thymus lobule morphology|MP:0003007,ectopic thymus|MP:0003054,spina bifida|MP:0004136,abnormal tongue muscle morphology|MP:0005385,cardiovascular system phenotype|MP:0006062,abnormal vena cava morphology|MP:0006138,congestive heart failure|MP:0010420,muscular ventricular septal defect|MP:0010628,patent tricuspid valve|MP:0010649,dilated pulmonary trunk|MP:0010724,thick interventricular septum|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012251,abnormal diaphragm development
MGI:3487369	Pax3<tm1Mrc>	MP:0000090,absent premaxilla|MP:0000102,abnormal nasal bone morphology|MP:0000154,rib fusion|MP:0000157,abnormal sternum morphology|MP:0000457,maxilla hypoplasia|MP:0000734,muscle hypoplasia|MP:0000761,thin diaphragm muscle|MP:0000783,abnormal forebrain morphology|MP:0000784,forebrain hypoplasia|MP:0000788,abnormal cerebral cortex morphology|MP:0000898,midbrain hyperplasia|MP:0000914,exencephaly|MP:0000919,cranioschisis|MP:0000964,small dorsal root ganglion|MP:0001262,decreased body weight|MP:0001293,anophthalmia|MP:0001732,postnatal growth retardation|MP:0002006,neoplasm|MP:0002036,increased rhabdomyosarcoma incidence|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002233,abnormal nose morphology|MP:0002820,abnormal premaxilla morphology|MP:0003052,omphalocele|MP:0003359,hypaxial muscle hypoplasia|MP:0003451,absent olfactory bulb|MP:0003833,decreased satellite cell number|MP:0004376,absent frontal bone|MP:0004383,absent interparietal bone|MP:0004419,absent parietal bone|MP:0004477,turbinate hypoplasia|MP:0004609,vertebral fusion|MP:0004819,decreased skeletal muscle mass|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009407,increased skeletal muscle fiber density|MP:0012169,optic placode degeneration|MP:0030056,lacrimal bone hypoplasia
MGI:4442463	Pax3<tm2.1Joe>	MP:0002169,no abnormal phenotype detected
MGI:2687299	Pax3<tm2.1(PAX3/FOXO1A)Buck>	MP:0000154,rib fusion|MP:0000729,abnormal myogenesis|MP:0000733,abnormal muscle development|MP:0000759,abnormal skeletal muscle morphology|MP:0001688,abnormal somite development|MP:0002280,abnormal intercostal muscle morphology|MP:0003939,abnormal myotome morphology|MP:0004206,abnormal dermomyotome development|MP:0011089,perinatal lethality, complete penetrance|MP:0012728,abnormal somite border morphology
MGI:4442462	Pax3<tm2Joe>	MP:0000373,belly spot|MP:0000914,exencephaly|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002169,no abnormal phenotype detected|MP:0002633,persistent truncus arteriosus|MP:0003054,spina bifida|MP:0003359,hypaxial muscle hypoplasia|MP:0005385,cardiovascular system phenotype|MP:0006126,abnormal cardiac outflow tract development|MP:0006284,absent hypaxial muscle|MP:0009703,decreased birth body size|MP:0011087,neonatal lethality, complete penetrance|MP:0011091,prenatal lethality, complete penetrance
MGI:2687304	Pax3<tm2(PAX3/FOXO1A)Buck>	MP:0000373,belly spot
MGI:3047632	Pax3<tm3.1(Pax7)Buck>	MP:0000352,decreased cell proliferation|MP:0000729,abnormal myogenesis|MP:0000733,abnormal muscle development|MP:0003090,abnormal muscle precursor cell migration|MP:0003631,nervous system phenotype|MP:0005380,embryo phenotype|MP:0010771,integument phenotype|MP:0011089,perinatal lethality, complete penetrance|MP:0012251,abnormal diaphragm development
MGI:3047631	Pax3<tm3(Pax7)Buck>	MP:0000733,abnormal muscle development|MP:0002950,abnormal neural crest cell migration|MP:0003054,spina bifida|MP:0008460,absent dorsal root ganglion|MP:0010016,variable depigmentation
MGI:3690080	Pax3<tm5.1Buck>	MP:0000729,abnormal myogenesis|MP:0003054,spina bifida|MP:0004206,abnormal dermomyotome development|MP:0011089,perinatal lethality, complete penetrance
MGI:3687384	Pax3<tm5Buck>	MP:0000373,belly spot
MGI:5291822	Pax3<tm6.1(Pax8)Buck>	MP:0000373,belly spot|MP:0000733,abnormal muscle development|MP:0000737,abnormal myotome development|MP:0000914,exencephaly|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001688,abnormal somite development|MP:0002151,abnormal neural tube morphology|MP:0002950,abnormal neural crest cell migration|MP:0003054,spina bifida|MP:0003090,abnormal muscle precursor cell migration|MP:0004206,abnormal dermomyotome development|MP:0004846,absent skeletal muscle|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5291823	Pax3<tm6.2Buck>	MP:0000914,exencephaly
MGI:5291649	Pax3<tm6(Pax8)Buck>	MP:0000373,belly spot|MP:0000733,abnormal muscle development|MP:0000737,abnormal myotome development|MP:0000929,open neural tube|MP:0002950,abnormal neural crest cell migration|MP:0004846,absent skeletal muscle|MP:0008460,absent dorsal root ganglion
MGI:5466350	Pax4<tm1.1Aman>	MP:0002169,no abnormal phenotype detected
MGI:5548955	Pax4<tm1b(EUCOMM)Hmgu>	MP:0000745,tremors|MP:0002968,increased circulating alkaline phosphatase level|MP:0005568,increased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance
MGI:3772207	Pax4<tm1(cre/ERT2)Sosa>	MP:0001265,decreased body size|MP:0001944,abnormal pancreas morphology|MP:0009174,absent pancreatic beta cells|MP:0009182,absent pancreatic delta cells|MP:0011085,postnatal lethality, complete penetrance
MGI:2182122	Pax4<tm1Pgr>	MP:0001944,abnormal pancreas morphology|MP:0002694,abnormal pancreas secretion|MP:0003339,decreased pancreatic beta cell number|MP:0005215,abnormal pancreatic islet morphology|MP:0005379,endocrine/exocrine gland phenotype|MP:0009174,absent pancreatic beta cells|MP:0009182,absent pancreatic delta cells|MP:0011085,postnatal lethality, complete penetrance
MGI:5632194	Pax5<m1Btlr>	MP:0000220,increased monocyte cell number|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005425,increased macrophage cell number|MP:0008082,increased single-positive T cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0020154,impaired humoral immune response
MGI:6113401	Pax5<m2Btlr>	MP:0004977,increased B-1 B cell number|MP:0008170,decreased B-1b cell number
MGI:6113407	Pax5<m3Btlr>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010838,increased CD8-positive, alpha-beta memory T cell number
MGI:6199943	Pax5<m4Btlr>	MP:0002491,decreased IgD level
MGI:6199947	Pax5<M5Btlr>	MP:0002491,decreased IgD level
MGI:5692910	Pax5<tm1b(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0001399,hyperactivity|MP:0001552,increased circulating triglyceride level|MP:0004738,abnormal auditory brainstem response|MP:0005293,impaired glucose tolerance|MP:0005387,immune system phenotype|MP:0008806,increased circulating amylase level|MP:0011100,preweaning lethality, complete penetrance|MP:0011886,increased circulating lipase level|MP:0013520,increased CD4-positive NK T cell number|MP:0013523,increased memory-marker CD4-positive NK T cell number
MGI:1926938	Pax5<tm1Mbu>	MP:0000849,abnormal cerebellum morphology|MP:0000857,abnormal cerebellar foliation|MP:0000864,abnormal cerebellum vermis morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0001802,arrested B cell differentiation|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0002401,abnormal lymphopoiesis|MP:0002459,abnormal B cell physiology|MP:0002460,decreased immunoglobulin level|MP:0004978,decreased B-1 B cell number|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005020,abnormal late pro-B cell|MP:0005377,hearing/vestibular/ear phenotype|MP:0005434,absent late pro-B cells|MP:0006097,abnormal cerebellar lobule formation|MP:0006108,abnormal hindbrain development|MP:0008205,absent B-2 B cells|MP:0008212,absent mature B cells|MP:0008215,decreased immature B cell number|MP:0008760,abnormal immunoglobulin heavy chain V(D)J recombination|MP:0009038,decreased inferior colliculus size|MP:0011083,lethality at weaning, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014471,enhanced B cell migration|MP:0014696,decreased cell adhesion
MGI:4879988	Pax5<tm3.1Mbu>	MP:0001732,postnatal growth retardation|MP:0001802,arrested B cell differentiation|MP:0011083,lethality at weaning, complete penetrance
MGI:2386577	Pax5<tm3Mbu>	MP:0000440,domed cranium|MP:0000788,abnormal cerebral cortex morphology|MP:0000825,dilated lateral ventricle|MP:0001363,increased anxiety-related response|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0031391,increased locomotor activity
MGI:3830360	Pax5<tm4(CD2*)Mbu>	MP:0005387,immune system phenotype
MGI:3830361	Pax5<tm5Mbu>	MP:0005387,immune system phenotype
MGI:4941325	Pax5<tm6.1Mbu>	MP:0005387,immune system phenotype
MGI:2156820	Pax6<10Neu>	MP:0000428,abnormal craniofacial morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001317,abnormal pupil morphology
MGI:1856585	Pax6<132-14Neu>	MP:0001292,abnormal lens vesicle development|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001307,fused cornea and lens|MP:0001312,abnormal cornea morphology|MP:0002699,abnormal vitreous body morphology|MP:0005205,abnormal eye anterior chamber morphology|MP:0005262,coloboma|MP:0005300,abnormal cornea stroma morphology|MP:0005301,abnormal cornea endothelium morphology|MP:0010259,anterior polar cataract
MGI:2680557	Pax6<1Jrt>	MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001314,cornea opacity|MP:0001322,abnormal iris morphology|MP:0005241,abnormal retina ganglion layer morphology|MP:0011481,anterior iris synechia
MGI:2156812	Pax6<2Neu>	MP:0000428,abnormal craniofacial morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001317,abnormal pupil morphology|MP:0010259,anterior polar cataract|MP:0011481,anterior iris synechia
MGI:2156742	Pax6<3Neu>	MP:0000428,abnormal craniofacial morphology|MP:0000783,abnormal forebrain morphology|MP:0000785,telencephalon hypoplasia|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001307,fused cornea and lens|MP:0001314,cornea opacity|MP:0001319,irregularly shaped pupil|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0008458,abnormal cortical ventricular zone morphology|MP:0009859,eye opacity|MP:0010259,anterior polar cataract|MP:0011481,anterior iris synechia
MGI:2156741	Pax6<4Neu>	MP:0000787,abnormal telencephalon morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001319,irregularly shaped pupil|MP:0001322,abnormal iris morphology|MP:0003935,abnormal craniofacial development|MP:0009902,abnormal lateral nasal prominence morphology|MP:0009903,abnormal medial nasal prominence morphology|MP:0010259,anterior polar cataract|MP:0011085,postnatal lethality, complete penetrance|MP:0011481,anterior iris synechia
MGI:2156817	Pax6<5Neu>	MP:0000428,abnormal craniofacial morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001317,abnormal pupil morphology|MP:0010259,anterior polar cataract|MP:0011481,anterior iris synechia
MGI:2156818	Pax6<6Neu>	MP:0000428,abnormal craniofacial morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001317,abnormal pupil morphology|MP:0010259,anterior polar cataract|MP:0011481,anterior iris synechia
MGI:2156738	Pax6<7Neu>	MP:0000428,abnormal craniofacial morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001319,irregularly shaped pupil|MP:0001322,abnormal iris morphology|MP:0010259,anterior polar cataract|MP:0011481,anterior iris synechia
MGI:2156819	Pax6<8Neu>	MP:0000428,abnormal craniofacial morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001317,abnormal pupil morphology
MGI:2156821	Pax6<9Neu>	MP:0000428,abnormal craniofacial morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001317,abnormal pupil morphology
MGI:3611067	Pax6<ADD4802>	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001307,fused cornea and lens|MP:0001314,cornea opacity
MGI:5511011	Pax6<Aey80>	MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001306,small lens|MP:0002001,blindness|MP:0002092,abnormal eye morphology|MP:0002697,abnormal eye size|MP:0005391,vision/eye phenotype|MP:0010713,corneal-lenticular stalk|MP:0011089,perinatal lethality, complete penetrance
MGI:1931308	Pax6<Coop>	MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001314,cornea opacity|MP:0001322,abnormal iris morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0013791,absent external nares
MGI:6277040	Pax6<em1(IMPC)Mbp>	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001258,decreased body length|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001314,cornea opacity|MP:0001399,hyperactivity|MP:0001711,abnormal placenta morphology|MP:0002092,abnormal eye morphology|MP:0002152,abnormal brain morphology|MP:0003231,abnormal placenta vasculature|MP:0005542,cornea vascularization|MP:0008797,facial cleft|MP:0011100,preweaning lethality, complete penetrance
MGI:1934622	Pax6<Leca1>	MP:0001297,microphthalmia|MP:0001307,fused cornea and lens|MP:0002092,abnormal eye morphology
MGI:1934621	Pax6<Leca2>	MP:0001297,microphthalmia|MP:0001307,fused cornea and lens|MP:0002092,abnormal eye morphology
MGI:1934632	Pax6<Leca3>	MP:0001297,microphthalmia|MP:0001307,fused cornea and lens|MP:0002092,abnormal eye morphology
MGI:1934618	Pax6<Leca4>	MP:0001297,microphthalmia|MP:0001307,fused cornea and lens|MP:0002092,abnormal eye morphology
MGI:3837670	Pax6<m1Lsli>	MP:0001944,abnormal pancreas morphology|MP:0003953,abnormal hormone level|MP:0005128,decreased adrenocorticotropin level|MP:0005293,impaired glucose tolerance
MGI:3529954	Pax6<Mhdaaey11>	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001314,cornea opacity|MP:0010713,corneal-lenticular stalk
MGI:3521718	Pax6<Mhdaaey18>	MP:0000934,abnormal telencephalon development|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001314,cornea opacity|MP:0003232,abnormal forebrain development|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0008441,thin cortical plate|MP:0009937,abnormal neuron differentiation|MP:0010713,corneal-lenticular stalk|MP:0011087,neonatal lethality, complete penetrance
MGI:6865677	Pax6os1<em1Rttr>	MP:0002169,no abnormal phenotype detected
MGI:3798888	Pax6<Rgsc123>	MP:0001297,microphthalmia|MP:0031345,developmental cataract
MGI:3798478	Pax6<Rgsc20>	MP:0001297,microphthalmia|MP:0031345,developmental cataract
MGI:3799162	Pax6<Rgsc242>	MP:0001297,microphthalmia|MP:0031345,developmental cataract
MGI:1856155	Pax6<Sey>	MP:0000102,abnormal nasal bone morphology|MP:0000445,short snout|MP:0000788,abnormal cerebral cortex morphology|MP:0000830,abnormal diencephalon morphology|MP:0000849,abnormal cerebellum morphology|MP:0000864,abnormal cerebellum vermis morphology|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000885,ectopic Purkinje cell|MP:0000913,abnormal brain development|MP:0000934,abnormal telencephalon development|MP:0001265,decreased body size|MP:0001292,abnormal lens vesicle development|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001306,small lens|MP:0001312,abnormal cornea morphology|MP:0001325,abnormal retina morphology|MP:0001330,abnormal optic nerve morphology|MP:0001953,respiratory failure|MP:0002116,abnormal craniofacial bone morphology|MP:0002233,abnormal nose morphology|MP:0002237,abnormal nasal cavity morphology|MP:0002840,abnormal lens fiber morphology|MP:0003078,aphakia|MP:0003115,abnormal respiratory system development|MP:0003232,abnormal forebrain development|MP:0003237,abnormal lens epithelium morphology|MP:0003425,abnormal optic vesicle formation|MP:0003451,absent olfactory bulb|MP:0003635,abnormal synaptic transmission|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004221,abnormal iridocorneal angle|MP:0004269,abnormal optic cup morphology|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004726,abnormal nasal capsule morphology|MP:0005172,decreased eye pigmentation|MP:0005193,abnormal anterior eye segment morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005205,abnormal eye anterior chamber morphology|MP:0005301,abnormal cornea endothelium morphology|MP:0005382,craniofacial phenotype|MP:0005542,cornea vascularization|MP:0005545,abnormal lens development|MP:0006000,abnormal cornea epithelium morphology|MP:0006254,thin cerebral cortex|MP:0006293,absent nasal placodes|MP:0008441,thin cortical plate|MP:0009265,delayed eyelid fusion|MP:0009637,abnormal pretectal region morphology|MP:0009725,absent lens vesicle|MP:0009937,abnormal neuron differentiation|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011481,anterior iris synechia|MP:0020527,small thalamus|MP:0021103,abnormal ventral interneuron 1 morphology|MP:0021107,retina fold|MP:0030060,absent nasal pit
MGI:1934365	Pax6<Sey-2H>	MP:0000914,exencephaly|MP:0002938,white spotting|MP:0009703,decreased birth body size|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance
MGI:1934366	Pax6<Sey-3H>	MP:0002938,white spotting|MP:0009703,decreased birth body size|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:4430205	Pax6<Sey-4H>	MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0002404,increased intestinal adenoma incidence|MP:0004761,increased susceptibility to induced pancreatitis|MP:0010292,increased alimentary system tumor incidence|MP:0010301,increased stomach tumor incidence
MGI:1856157	Pax6<Sey-Dey>	MP:0000373,belly spot|MP:0000914,exencephaly|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001306,small lens|MP:0001307,fused cornea and lens|MP:0002006,neoplasm|MP:0004200,decreased fetal size|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005261,aniridia|MP:0005262,coloboma|MP:0005300,abnormal cornea stroma morphology|MP:0005367,renal/urinary system phenotype|MP:0005408,hypopigmentation|MP:0005545,abnormal lens development|MP:0006000,abnormal cornea epithelium morphology|MP:0006226,iris hypoplasia|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0020855,decreased cornea epithelium thickness|MP:0021107,retina fold
MGI:1856156	Pax6<Sey-H>	MP:0000018,small ears|MP:0000024,lowered ear position|MP:0000373,belly spot|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001923,reduced female fertility|MP:0005262,coloboma|MP:0011092,embryonic lethality, complete penetrance
MGI:1856158	Pax6<Sey-Neu>	MP:0000783,abnormal forebrain morphology|MP:0000849,abnormal cerebellum morphology|MP:0000864,abnormal cerebellum vermis morphology|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000885,ectopic Purkinje cell|MP:0001286,abnormal eye development|MP:0001288,abnormal lens induction|MP:0001292,abnormal lens vesicle development|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001312,abnormal cornea morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002199,abnormal brain commissure morphology|MP:0003093,abnormal cornea anterior stroma morphology|MP:0003425,abnormal optic vesicle formation|MP:0003793,abnormal submandibular gland morphology|MP:0003953,abnormal hormone level|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004171,abnormal pallium development|MP:0004726,abnormal nasal capsule morphology|MP:0005120,decreased circulating growth hormone level|MP:0005205,abnormal eye anterior chamber morphology|MP:0005236,abnormal olfactory nerve morphology|MP:0005300,abnormal cornea stroma morphology|MP:0005542,cornea vascularization|MP:0005545,abnormal lens development|MP:0006000,abnormal cornea epithelium morphology|MP:0006226,iris hypoplasia|MP:0008521,abnormal Bowman membrane morphology|MP:0008789,abnormal olfactory epithelium morphology|MP:0009174,absent pancreatic beta cells|MP:0009178,absent pancreatic alpha cells|MP:0009522,submandibular gland hypoplasia|MP:0011087,neonatal lethality, complete penetrance|MP:0011481,anterior iris synechia|MP:0011932,abnormal endocrine pancreas development|MP:0014707,increased corneal pannus formation|MP:0020855,decreased cornea epithelium thickness
MGI:4354123	Pax6<tm1.1Ued>	MP:0000787,abnormal telencephalon morphology|MP:0002092,abnormal eye morphology|MP:0003743,abnormal facial morphology
MGI:5317866	Pax6<tm1.1Xzh>	MP:0001346,abnormal lacrimal gland morphology|MP:0005391,vision/eye phenotype
MGI:5567084	Pax6<tm1.1Zkoz>	MP:0000352,decreased cell proliferation|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0002984,retina hypoplasia|MP:0003077,abnormal cell cycle|MP:0003727,abnormal retina layer morphology|MP:0004045,abnormal cell cycle checkpoint function|MP:0004046,abnormal mitosis|MP:0004269,abnormal optic cup morphology|MP:0005253,abnormal eye physiology|MP:0005391,vision/eye phenotype|MP:0006071,abnormal retina progenitor cell morphology|MP:0006095,absent amacrine cells|MP:0009772,abnormal retina development|MP:0011965,decreased total retina thickness|MP:0030005,increased retina apoptosis
MGI:5317867	Pax6<tm1.2Xzh>	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0002840,abnormal lens fiber morphology|MP:0005262,coloboma|MP:0010713,corneal-lenticular stalk
MGI:2674289	Pax6<tm1Gfs>	MP:0001303,abnormal lens morphology|MP:0001317,abnormal pupil morphology|MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0002546,mydriasis|MP:0003237,abnormal lens epithelium morphology|MP:0003631,nervous system phenotype|MP:0005261,aniridia|MP:0005300,abnormal cornea stroma morphology|MP:0006226,iris hypoplasia
MGI:2449854	Pax6<tm1Lan>	MP:0001292,abnormal lens vesicle development|MP:0001303,abnormal lens morphology|MP:0002840,abnormal lens fiber morphology|MP:0003237,abnormal lens epithelium morphology|MP:0012168,abnormal optic placode morphology
MGI:1934347	Pax6<tm1Pgr>	MP:0001293,anophthalmia|MP:0001307,fused cornea and lens|MP:0002206,abnormal CNS synaptic transmission|MP:0003451,absent olfactory bulb|MP:0004221,abnormal iridocorneal angle|MP:0004811,abnormal neuron physiology|MP:0009178,absent pancreatic alpha cells|MP:0009254,disorganized pancreatic islets|MP:0010709,absent eye anterior chamber|MP:0011087,neonatal lethality, complete penetrance|MP:0011481,anterior iris synechia|MP:0021101,abnormal ventral interneuron morphology|MP:0021102,abnormal ventral interneuron 0 morphology|MP:0021103,abnormal ventral interneuron 1 morphology|MP:0021105,abnormal ventral interneuron 3 morphology
MGI:4354122	Pax6<tm1Ued>	MP:0000934,abnormal telencephalon development|MP:0002169,no abnormal phenotype detected|MP:0008128,abnormal brain internal capsule morphology
MGI:5512912	Pax6<tm2.1(Pax6_i5a,Pax2)Xzh>	MP:0000934,abnormal telencephalon development|MP:0001286,abnormal eye development|MP:0004948,abnormal neuronal precursor proliferation|MP:0008439,abnormal cortical plate morphology|MP:0009772,abnormal retina development|MP:0010713,corneal-lenticular stalk
MGI:5512910	Pax6<tm2(Pax6_i5a,Pax2)Xzh>	MP:0000934,abnormal telencephalon development|MP:0001286,abnormal eye development|MP:0004948,abnormal neuronal precursor proliferation|MP:0005391,vision/eye phenotype|MP:0008441,thin cortical plate|MP:0009772,abnormal retina development
MGI:1934348	Pax6<tm2Pgr>	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001306,small lens|MP:0001307,fused cornea and lens|MP:0001319,irregularly shaped pupil|MP:0001322,abnormal iris morphology|MP:0001330,abnormal optic nerve morphology|MP:0001559,hyperglycemia|MP:0001732,postnatal growth retardation|MP:0002546,mydriasis|MP:0002575,increased circulating ketone body level|MP:0002699,abnormal vitreous body morphology|MP:0002700,increased opacity of vitreous body|MP:0002727,decreased circulating insulin level|MP:0002840,abnormal lens fiber morphology|MP:0002984,retina hypoplasia|MP:0003237,abnormal lens epithelium morphology|MP:0003339,decreased pancreatic beta cell number|MP:0003687,abnormal intraocular muscle morphology|MP:0004221,abnormal iridocorneal angle|MP:0004224,absent trabecular meshwork|MP:0004226,absent Schlemm's canal|MP:0005193,abnormal anterior eye segment morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005208,abnormal iris stroma morphology|MP:0005258,ocular hypertension|MP:0005300,abnormal cornea stroma morphology|MP:0005391,vision/eye phenotype|MP:0005545,abnormal lens development|MP:0006219,optic nerve degeneration|MP:0006221,optic nerve hypoplasia|MP:0006226,iris hypoplasia|MP:0006243,impaired pupillary reflex|MP:0008794,increased lens epithelium apoptosis|MP:0009177,decreased pancreatic alpha cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0011481,anterior iris synechia|MP:0011962,increased cornea thickness|MP:0013742,absent ciliary body
MGI:5308728	Pax7<tm1.1(HBEGF,-EYFP)Mal>	MP:0000750,abnormal muscle regeneration|MP:0002083,premature death|MP:0003833,decreased satellite cell number|MP:0004510,myositis|MP:0004819,decreased skeletal muscle mass|MP:0005369,muscle phenotype|MP:0009703,decreased birth body size|MP:0013239,impaired skeletal muscle regeneration
MGI:5505636	Pax7<tm1.1(KOMP)Vlcg>	MP:0002644,decreased circulating triglyceride level|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5441709	Pax7<tm1.1(rtTA)Sjl>	MP:0001265,decreased body size|MP:0005150,cachexia|MP:0010239,decreased skeletal muscle weight|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5548068	Pax7<tm1.1Thbr>	MP:0000750,abnormal muscle regeneration|MP:0000759,abnormal skeletal muscle morphology|MP:0001265,decreased body size|MP:0002108,abnormal muscle morphology|MP:0003833,decreased satellite cell number|MP:0003852,skeletal muscle necrosis|MP:0005369,muscle phenotype|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009406,decreased skeletal muscle fiber number|MP:0009410,abnormal skeletal muscle satellite cell proliferation|MP:0009419,skeletal muscle fibrosis|MP:0010240,decreased skeletal muscle size|MP:0013239,impaired skeletal muscle regeneration
MGI:4353152	Pax7<tm1.2Fan>	MP:0009419,skeletal muscle fibrosis|MP:0013239,impaired skeletal muscle regeneration
MGI:4436914	Pax7<tm1(cre/Esr1*)Cklr>	MP:0002169,no abnormal phenotype detected
MGI:3497712	Pax7<tm1(cre)Mrc>	MP:0002169,no abnormal phenotype detected
MGI:1857831	Pax7<tm1Pgr>	MP:0000097,short maxilla|MP:0000448,pointed snout|MP:0000747,muscle weakness|MP:0000750,abnormal muscle regeneration|MP:0000761,thin diaphragm muscle|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0003631,nervous system phenotype|MP:0004726,abnormal nasal capsule morphology|MP:0005369,muscle phenotype|MP:0005380,embryo phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005384,cellular phenotype|MP:0008052,abnormal serous gland morphology|MP:0009402,decreased skeletal muscle fiber diameter|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3047633	Pax7<tm2Pgr>	MP:0000097,short maxilla|MP:0000448,pointed snout|MP:0000496,abnormal small intestine morphology|MP:0000750,abnormal muscle regeneration|MP:0001732,postnatal growth retardation|MP:0003833,decreased satellite cell number|MP:0004726,abnormal nasal capsule morphology|MP:0008052,abnormal serous gland morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2445461	Pax8<tm1(cre)Mbu>	MP:0001732,postnatal growth retardation|MP:0005314,absent thyroid gland|MP:0011083,lethality at weaning, complete penetrance
MGI:2156985	Pax8<tm1Pgr>	MP:0000018,small ears|MP:0000042,abnormal organ of Corti morphology|MP:0000049,abnormal middle ear morphology|MP:0000060,delayed bone ossification|MP:0000135,decreased compact bone thickness|MP:0000547,short limbs|MP:0000681,abnormal thyroid gland morphology|MP:0001121,uterus hypoplasia|MP:0001136,dilated uterine cervix|MP:0001144,vagina atresia|MP:0001155,arrest of spermatogenesis|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001967,deafness|MP:0002083,premature death|MP:0002177,abnormal outer ear morphology|MP:0002622,abnormal cochlear hair cell morphology|MP:0002660,abnormal caput epididymis morphology|MP:0002661,abnormal corpus epididymis morphology|MP:0002951,small thyroid gland|MP:0002998,abnormal bone remodeling|MP:0003205,testicular atrophy|MP:0003419,delayed endochondral bone ossification|MP:0003421,abnormal thyroid gland development|MP:0003572,abnormal uterus development|MP:0003825,abnormal pillar cell morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0004163,abnormal adenohypophysis morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004433,abnormal cochlear inner hair cell physiology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004562,abnormal inner hair cell synaptic ribbon morphology|MP:0004591,enlarged tectorial membrane|MP:0004633,abnormal cochlear IHC efferent innervation pattern|MP:0004660,absent thyroid follicular cells|MP:0004662,abnormal thyroid diverticulum morphology|MP:0004664,delayed inner ear development|MP:0004665,abnormal stapedial artery morphology|MP:0004666,absent stapedial artery|MP:0004727,absent epididymis|MP:0004729,absent efferent ductules of testis|MP:0004852,decreased testis weight|MP:0004930,small epididymis|MP:0004933,abnormal epididymis epithelium morphology|MP:0005105,abnormal middle ear ossicle morphology|MP:0005107,abnormal stapes morphology|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005135,increased thyroid-stimulating hormone level|MP:0005402,abnormal action potential|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level|MP:0005579,absent outer ear|MP:0006033,abnormal external auditory canal morphology|MP:0006395,abnormal epiphyseal plate morphology|MP:0008257,thin myometrium|MP:0008329,decreased somatotroph cell number|MP:0008332,decreased lactotroph cell number|MP:0008337,increased thyrotroph cell number|MP:0009069,dilated oviduct|MP:0009215,absent uterine horn|MP:0009224,absent endometrium|MP:0010867,abnormal bone trabecula morphology|MP:0010876,decreased bone volume|MP:0011060,abnormal kinocilium morphology|MP:0011083,lethality at weaning, complete penetrance|MP:0011085,postnatal lethality, complete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013624,decreased femur compact bone thickness|MP:0020010,decreased bone mineral density of femur|MP:0020137,decreased bone mineralization|MP:0021184,decreased bone mineral density of humerus|MP:0030160,abnormal auditory bulla morphology|MP:0030407,abnormal stapes crus morpholgy|MP:0030411,decreased round window size|MP:0030412,absent round window|MP:0031285,external auditory canal stenosis
MGI:5299327	Pax8<tm1Rdl>	MP:0000054,delayed ear emergence|MP:0000681,abnormal thyroid gland morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001290,delayed eyelid opening|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002951,small thyroid gland|MP:0003503,decreased activity of thyroid gland|MP:0004696,abnormal thyroid follicle morphology|MP:0004697,abnormal thyroid follicular cell morphology|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005478,decreased circulating thyroxine level|MP:0006042,increased apoptosis
MGI:3723638	Pax9<tm1.1Hpt>	MP:0000090,absent premaxilla|MP:0000094,absent alveolar process|MP:0000118,arrest of tooth development|MP:0000562,polydactyly|MP:0000680,absent parathyroid glands|MP:0001438,aphagia|MP:0002169,no abnormal phenotype detected|MP:0002367,abnormal thymus lobule morphology|MP:0004537,abnormal palatine bone horizontal plate morphology|MP:0004538,abnormal maxillary shelf morphology|MP:0004912,absent mandibular coronoid process|MP:0009886,failure of palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance|MP:0030084,tympanic ring hypoplasia|MP:0030610,absent teeth
MGI:5013428	Pax9<tm1.1(Osr2)Jian>	MP:0000118,arrest of tooth development|MP:0000458,abnormal mandible morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0004592,small mandible|MP:0004912,absent mandibular coronoid process|MP:0006020,decreased tympanic ring size|MP:0009743,preaxial polydactyly|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance|MP:0031460,abnormal palatal shelf morphology
MGI:5013429	Pax9<tm1.2(Osr2)Jian>	MP:0005382,craniofacial phenotype
MGI:5013431	Pax9<tm1.3(Osr2)Jian>	MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:3612401	Pax9<tm1Hpt>	MP:0000116,abnormal tooth development|MP:0000121,failure of tooth eruption|MP:0002100,abnormal tooth morphology|MP:0002689,abnormal molar morphology|MP:0002818,abnormal dentin morphology|MP:0004791,absent lower incisors|MP:0005379,endocrine/exocrine gland phenotype|MP:0006400,decreased molar number|MP:0030459,abnormal tooth attrition|MP:0030608,decreased tooth number
MGI:5013430	Pax9<tm1(Osr2)Jian>	MP:0030136,abnormal lower incisor morphology
MGI:1857887	Pax9<tm1Rbal>	MP:0000094,absent alveolar process|MP:0000111,cleft palate|MP:0000118,arrest of tooth development|MP:0000125,absent incisors|MP:0000284,double outlet right ventricle|MP:0000430,absent maxillary shelf|MP:0000431,absent palatine bone horizontal plate|MP:0000438,abnormal cranium morphology|MP:0000458,abnormal mandible morphology|MP:0000562,polydactyly|MP:0000680,absent parathyroid glands|MP:0000705,athymia|MP:0001270,distended abdomen|MP:0001823,thymus hypoplasia|MP:0001954,respiratory distress|MP:0002058,neonatal lethality|MP:0002256,abnormal laryngeal cartilage morphology|MP:0002260,abnormal thyroid cartilage morphology|MP:0003007,ectopic thymus|MP:0003056,abnormal hyoid bone morphology|MP:0003931,absent molars|MP:0004083,polysyndactyly|MP:0004113,abnormal aortic arch morphology|MP:0004157,interrupted aortic arch|MP:0004452,abnormal pterygoid process morphology|MP:0004552,fused tracheal cartilage rings|MP:0004912,absent mandibular coronoid process|MP:0004914,absent ultimobranchial body|MP:0004915,abnormal Reichert's cartilage morphology|MP:0004916,absent Reichert cartilage|MP:0005503,abnormal tendon morphology|MP:0006020,decreased tympanic ring size|MP:0006031,abnormal pharyngeal pouch morphology|MP:0006279,abnormal limb development|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0006356,abnormal third pharyngeal arch artery morphology|MP:0009743,preaxial polydactyly|MP:0009843,decreased neural crest cell number|MP:0009885,abnormal palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0009913,abnormal hyoid bone greater horn morphology|MP:0009914,abnormal hyoid bone lesser horn morphology|MP:0010355,abnormal first pharyngeal arch artery morphology|MP:0010356,abnormal second pharyngeal arch artery morphology|MP:0010402,ventricular septal defect|MP:0010465,aberrant origin of the right subclavian artery|MP:0011087,neonatal lethality, complete penetrance|MP:0012729,abnormal common carotid artery morphology|MP:0021207,abnormal autopod muscle morphology|MP:0030335,absent third pharyngeal arch artery|MP:0030336,third pharyngeal arch artery hypoplasia|MP:0030340,absent fourth pharyngeal arch artery|MP:0030341,fourth pharyngeal arch artery hypoplasia|MP:0030610,absent teeth|MP:0030870,abnormal superior horn of thyroid cartilage morphology|MP:0030871,abnormal inferior horn of thyroid cartilage morphology|MP:0031460,abnormal palatal shelf morphology
MGI:6827438	Paxbp1<tm1.1Nju>	MP:0011092,embryonic lethality, complete penetrance
MGI:3814327	Paxip1<L5Jcs36>	MP:0000263,absent organized vascular network|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001726,abnormal allantois morphology|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0004251,failure of heart looping|MP:0009657,failure of chorioallantoic fusion|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3814326	Paxip1<L5Jcs4>	MP:0000292,distended pericardium|MP:0001622,abnormal vasculogenesis|MP:0001698,decreased embryo size|MP:0001715,placental labyrinth hypoplasia|MP:0001722,pale yolk sac|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0010241,abnormal aortic arch development|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2653321	Paxip1<tm1Gdr>	MP:0000267,abnormal heart development|MP:0000352,decreased cell proliferation|MP:0001689,incomplete somite formation|MP:0001698,decreased embryo size|MP:0001726,abnormal allantois morphology|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0003988,disorganized embryonic tissue|MP:0004046,abnormal mitosis|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0005030,absent amnion|MP:0011092,embryonic lethality, complete penetrance|MP:0012113,decreased inner cell mass proliferation|MP:0013504,increased embryonic tissue cell apoptosis|MP:0014586,decreased egg cylinder size|MP:0014760,impaired DNA repair|MP:0021086,decreased DNA replication
MGI:3767658	Paxip1<tm2Gdr>	MP:0002169,no abnormal phenotype detected|MP:0011087,neonatal lethality, complete penetrance
MGI:6152605	Paxx<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0002339,abnormal lymph node morphology|MP:0020421,increased freezing behavior
MGI:5822837	Paxx<em1Spj>	MP:0001658,increased mortality induced by gamma-irradiation|MP:0002006,neoplasm|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005384,cellular phenotype|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008174,decreased follicular B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008210,increased mature B cell number|MP:0009339,decreased splenocyte number
MGI:3625691	Pbat1<BXSB/Slc>	MP:0003179,thrombocytopenia|MP:0003725,increased autoantibody level
MGI:3625693	Pbat2<BXSB/Slc>	MP:0003179,thrombocytopenia|MP:0003725,increased autoantibody level
MGI:2447019	Pbbcp1<C57BL/6J>	MP:0005014,increased B cell number
MGI:3027144	Pbd1<SAMP2>	MP:0004148,increased compact bone thickness
MGI:3027145	Pbd1<SAMP6>	MP:0000135,decreased compact bone thickness
MGI:2389308	Pbd2<SAMP2>	MP:0000062,increased bone mineral density|MP:0004148,increased compact bone thickness
MGI:2389313	Pbd2<SAMP6>	MP:0000063,decreased bone mineral density|MP:0000135,decreased compact bone thickness
MGI:2680470	pbdl	MP:0002731,megacolon|MP:0002940,variable body spotting
MGI:3698212	Pbft3<CASA/Rk>	MP:0005458,increased percent body fat/body weight
MGI:6771577	Pbk<em1Sdgl>	MP:0005389,reproductive system phenotype
MGI:6771578	Pbk<em2Sdgl>	MP:0005389,reproductive system phenotype
MGI:5293435	Pbk<tm1Zgdo>	MP:0001219,thick epidermis|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0002060,abnormal skin morphology|MP:0008560,increased tumor necrosis factor secretion|MP:0008705,increased interleukin-6 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0009932,skin fibrosis
MGI:6257556	Pbld1<em1(IMPC)Bay>	MP:0000195,decreased circulating calcium level
MGI:5696905	Pbld2<tm1.1(KOMP)Vlcg>	MP:0001120,abnormal uterus morphology|MP:0004906,enlarged uterus
MGI:3699867	Pbrbc1<CBA/HOla>	MP:0003131,increased erythrocyte cell number
MGI:3699871	Pbrbc2<A/J>	MP:0003131,increased erythrocyte cell number
MGI:3699874	Pbrbc3<C57BL/6J>	MP:0003131,increased erythrocyte cell number
MGI:3699869	Pbrbc4<C57BL/6J>	MP:0003131,increased erythrocyte cell number
MGI:2447055	Pbrgcsf2<DBA/2J>	MP:0002123,abnormal definitive hematopoiesis
MGI:5548674	Pbrm1<tm1b(EUCOMM)Wtsi>	MP:0001406,abnormal gait|MP:0002135,abnormal kidney morphology|MP:0002599,increased mean platelet volume|MP:0005554,decreased circulating creatinine level|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:3526660	Pbrm1<tm1Rtj>	MP:0000279,ventricular hypoplasia|MP:0000281,abnormal interventricular septum morphology|MP:0000601,small liver|MP:0001716,abnormal placenta labyrinth morphology|MP:0003641,small lung|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5810066	Pbrm1<tm1Zhwa>	MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008660,increased interleukin-10 secretion|MP:0008699,increased interleukin-4 secretion
MGI:5662440	Pbsn<em1(IMPC)J>	MP:0001303,abnormal lens morphology|MP:0002574,increased vertical activity
MGI:2154308	Pbw1<C57BL/6J>	MP:0009776,decreased behavioral withdrawal response
MGI:2154307	Pbw1<DBA/2J>	MP:0009775,increased behavioral withdrawal response
MGI:2386562	Pbw2<C57BL/6J>	MP:0009776,decreased behavioral withdrawal response
MGI:2386561	Pbw2<DBA/2J>	MP:0009775,increased behavioral withdrawal response
MGI:3580126	Pbw3<DBA/1J>	MP:0009775,increased behavioral withdrawal response
MGI:3717775	Pbwg1.1<M. m. castaneus>	MP:0001260,increased body weight
MGI:3717777	Pbwg1.2<M. m. castaneus>	MP:0005455,increased susceptibility to weight gain
MGI:3717779	Pbwg1.3<M. m. castaneus>	MP:0001257,increased body length
MGI:3717781	Pbwg1.4<M. m. castaneus>	MP:0002758,long tail
MGI:3609404	Pbwg14<M. m. castaneus>	MP:0001262,decreased body weight
MGI:3717782	Pbwg1.5<C57BL/6J>	MP:0009285,increased gonadal fat pad weight
MGI:3609407	Pbwg15<M. m. castaneus>	MP:0001262,decreased body weight
MGI:3717784	Pbwg1.6<C57BL/6J>	MP:0005336,abnormal inguinal fat pad morphology
MGI:3609410	Pbwg16<M. m. castaneus>	MP:0001262,decreased body weight
MGI:3717786	Pbwg1.7<C57BL/6J>	MP:0009304,increased retroperitoneal fat pad weight
MGI:3609412	Pbwg17<M. m. castaneus>	MP:0001262,decreased body weight
MGI:3717788	Pbwg1.8<C57BL/6J>	MP:0008908,increased total fat pad weight
MGI:3609414	Pbwg18<M. m. castaneus>	MP:0001262,decreased body weight
MGI:3717791	Pbwg1.9<M. m. castaneus>	MP:0004952,increased spleen weight
MGI:3609416	Pbwg19<M. m. castaneus>	MP:0001260,increased body weight
MGI:2154943	Pbwg1<M. m. castaneus>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation
MGI:3609418	Pbwg20<M. m. castaneus>	MP:0001262,decreased body weight
MGI:3609485	Pbwg21<M. m. castaneus>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation
MGI:3609487	Pbwg22<M. m. castaneus>	MP:0001262,decreased body weight
MGI:3038168	Pbwg2<M. m. castaneus>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation
MGI:3038170	Pbwg3<M. m. castaneus>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation
MGI:3038172	Pbwg4<M. m. castaneus>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation
MGI:3038174	Pbwg5<M. m. castaneus>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation
MGI:2157311	Pbwg6<M. m. castaneus>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation
MGI:3038178	Pbwg7<M. m. castaneus>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation
MGI:3038182	Pbwg9<M. m. castaneus>	MP:0005455,increased susceptibility to weight gain
MGI:2154311	Pbwm<DBA/2J>	MP:0009775,increased behavioral withdrawal response
MGI:6883575	Pbx1<em1Dunw>	MP:0000600,liver hypoplasia|MP:0000640,adrenal gland hypoplasia|MP:0000694,spleen hypoplasia|MP:0000774,decreased brain size|MP:0001178,pulmonary hypoplasia|MP:0001302,eyelids open at birth|MP:0001505,hunched posture|MP:0001823,thymus hypoplasia|MP:0002211,abnormal primary sex determination|MP:0002633,persistent truncus arteriosus|MP:0003007,ectopic thymus|MP:0003276,esophageal atresia|MP:0009890,cleft secondary palate|MP:0010146,umbilical hernia|MP:0010402,ventricular septal defect|MP:0010788,stomach hypoplasia|MP:0010807,abnormal stomach position or orientation|MP:0011361,pelvic kidney|MP:0012491,larynx stenosis|MP:0013497,trachea occlusion|MP:0013848,subcutaneous edema
MGI:3770151	Pbx1<tm1.1Febe>	MP:0001505,hunched posture|MP:0001622,abnormal vasculogenesis|MP:0001786,skin edema|MP:0002088,abnormal embryonic growth/weight/body size|MP:0002109,abnormal limb morphology|MP:0002768,small adrenal glands|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003717,pallor|MP:0014287,decreased adrenal gland zona fasciculata size
MGI:5426974	Pbx1<tm1.1Koss>	MP:0000689,abnormal spleen morphology|MP:0000694,spleen hypoplasia
MGI:5305253	Pbx1<tm1Koss>	MP:0000689,abnormal spleen morphology|MP:0000694,spleen hypoplasia|MP:0011263,abnormal spleen mesenchyme morphology
MGI:2155612	Pbx1<tm1Mlc>	MP:0000029,abnormal malleus morphology|MP:0000149,abnormal scapula morphology|MP:0000208,decreased hematocrit|MP:0000239,absent common myeloid progenitor cells|MP:0000521,abnormal kidney cortex morphology|MP:0000528,delayed kidney development|MP:0000600,liver hypoplasia|MP:0000690,absent spleen|MP:0001178,pulmonary hypoplasia|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0001705,abnormal proximal-distal axis patterning|MP:0001785,edema|MP:0001786,skin edema|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002088,abnormal embryonic growth/weight/body size|MP:0002114,abnormal axial skeleton morphology|MP:0002115,abnormal limb bone morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002177,abnormal outer ear morphology|MP:0002594,low mean erythrocyte cell number|MP:0002891,increased insulin sensitivity|MP:0002989,small kidney|MP:0003007,ectopic thymus|MP:0003014,abnormal kidney medulla morphology|MP:0003059,decreased insulin secretion|MP:0003446,renal hypoplasia|MP:0003600,ectopic kidney|MP:0003604,single kidney|MP:0003717,pallor|MP:0003924,diaphragmatic hernia|MP:0004204,absent stapes|MP:0004505,decreased renal glomerulus number|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005105,abnormal middle ear ossicle morphology|MP:0005215,abnormal pancreatic islet morphology|MP:0005224,abnormal left-right axis symmetry of the somites|MP:0005293,impaired glucose tolerance|MP:0005298,abnormal clavicle morphology|MP:0005313,absent adrenal gland|MP:0005492,exocrine pancreas hypoplasia|MP:0005650,abnormal limb bud morphology|MP:0005651,abnormal gonad rudiment morphology|MP:0006338,abnormal second pharyngeal arch morphology|MP:0008023,abnormal styloid process morphology|MP:0009173,absent pancreatic islets|MP:0009883,palatal shelf hypoplasia|MP:0009914,abnormal hyoid bone lesser horn morphology|MP:0010788,stomach hypoplasia|MP:0010982,abnormal ureteric bud elongation|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0010987,abnormal nephrogenic mesenchyme morphogenesis|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011290,decreased nephron number|MP:0011334,abnormal nephrogenic zone morphology|MP:0011364,abnormal metanephros morphology|MP:0014101,decreased chondrocyte proliferation|MP:0014107,premature chondrocyte differentiation|MP:0030190,small snout|MP:0030297,outer ear hypoplasia|MP:0030323,short styloid process|MP:0030465,absent oval window
MGI:3783739	Pbx1<tm2Mlc>	MP:0002169,no abnormal phenotype detected
MGI:3047327	Pbx2<tm1Mlc>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype|MP:0005390,skeleton phenotype|MP:0005397,hematopoietic system phenotype
MGI:3773270	Pbx3<tm1.1Og>	MP:0001575,cyanosis|MP:0011087,neonatal lethality, complete penetrance
MGI:4433160	Pbx3<tm1a(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0000063,decreased bone mineral density|MP:0001413,abnormal response to new environment|MP:0003960,increased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:5548956	Pbx3<tm1b(EUCOMM)Wtsi>	MP:0002100,abnormal tooth morphology|MP:0003578,absent ovary|MP:0005344,increased circulating bilirubin level|MP:0005566,decreased blood urea nitrogen level|MP:0010025,decreased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:3510441	Pbx3<tm1Mlc>	MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002321,hypoventilation|MP:0005423,abnormal somatic nervous system physiology|MP:0011087,neonatal lethality, complete penetrance
MGI:3773271	Pbx3<tm1Og>	MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001488,increased startle reflex|MP:0001513,limb grasping|MP:0002863,improved righting response|MP:0002882,abnormal neuron morphology|MP:0003312,abnormal locomotor coordination|MP:0003998,decreased thermal nociceptive threshold|MP:0004263,abnormal limb posture|MP:0004924,abnormal behavior|MP:0005156,bradykinesia|MP:0005498,hyporesponsive to tactile stimuli|MP:0006282,abnormal spinal cord dorsal horn morphology|MP:0008948,decreased neuron number|MP:0009937,abnormal neuron differentiation
MGI:7738768	Pbx4<em2Hncs>	MP:0000164,abnormal cartilage development|MP:0000219,increased neutrophil cell number|MP:0000414,alopecia|MP:0000556,abnormal hindlimb morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002566,abnormal sexual interaction|MP:0002757,decreased vertical activity|MP:0002874,decreased hemoglobin content|MP:0003109,short femur|MP:0005016,decreased lymphocyte cell number|MP:0005306,abnormal phalanx morphology|MP:0005353,abnormal patella morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0006279,abnormal limb development|MP:0008941,reticulocytopenia|MP:0010053,decreased grip strength|MP:0010225,abnormal quadriceps morphology|MP:0011286,decreased circulating erythropoietin level|MP:0014320,abnormal autopod rotation|MP:0014322,short hindlimb|MP:0020010,decreased bone mineral density of femur|MP:0030835,abnormal ankle joint morphology|MP:0030837,abnormal knee joint morphology
MGI:7738769	Pbx4<em3Hncs>	MP:0005389,reproductive system phenotype
MGI:7738771	Pbx4<em4Hncs>	MP:0005389,reproductive system phenotype
MGI:6363078	Pbxip1<em1Smoc>	MP:0002764,short tibia|MP:0003109,short femur|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004708,short lumbar vertebrae|MP:0008974,proportional dwarf
MGI:6363079	Pbxip1<tm1Cya>	MP:0002764,short tibia|MP:0003109,short femur|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003560,osteoarthritis|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004708,short lumbar vertebrae|MP:0005166,decreased susceptibility to injury|MP:0008974,proportional dwarf
MGI:1856985	pc	MP:0000111,cleft palate|MP:0000164,abnormal cartilage development|MP:0000438,abnormal cranium morphology|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0002058,neonatal lethality|MP:0002100,abnormal tooth morphology|MP:0002110,abnormal digit morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002427,disproportionate dwarf|MP:0004790,absent upper incisors|MP:0008526,decreased cranium width|MP:0030090,short upper incisors
MGI:5751702	Pcare<tm1Kpal>	MP:0001326,retina degeneration|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005103,abnormal retina pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0008444,retina cone cell degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0009392,retina gliosis|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0014059,abnormal photoreceptor connecting cilium morphology|MP:0020448,increased microglial cell activation
MGI:3688844	pcat<1R>	MP:0031345,developmental cataract
MGI:2384425	Pcbd1<tm1Grc>	MP:0000373,belly spot|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0002079,increased circulating insulin level|MP:0002893,ketoaciduria|MP:0005293,impaired glucose tolerance|MP:0005408,hypopigmentation|MP:0030670,increased circulating phenylalanine level
MGI:5908909	Pcbp1<em2Salr>	MP:0001262,decreased body weight|MP:0005397,hematopoietic system phenotype|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:5908912	Pcbp2<tm1.1Salr>	MP:0002169,no abnormal phenotype detected
MGI:5908914	Pcbp2<tm1.2Salr>	MP:0001262,decreased body weight|MP:0001914,hemorrhage|MP:0011085,postnatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011176,abnormal erythroblast morphology|MP:0011898,abnormal platelet cell number|MP:0013848,subcutaneous edema
MGI:3891773	Pcbp4<Gt(D136D11)Wrst>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002023,increased B cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0008009,delayed cellular replicative senescence|MP:0010294,increased kidney tumor incidence|MP:0011703,increased fibroblast proliferation
MGI:7425899	Pcca<em1(IMPC)Hmgu>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:2180816	Pcca<tm1Tmiy>	MP:0001388,abnormal stationary movement|MP:0001429,dehydration|MP:0001756,abnormal urination|MP:0002628,hepatic steatosis|MP:0002893,ketoaciduria|MP:0003853,dry skin|MP:0004860,dilated kidney collecting duct|MP:0009546,absent gastric milk in neonates|MP:0010398,decreased liver glycogen level|MP:0011085,postnatal lethality, complete penetrance|MP:0011402,renal cast
MGI:5708203	Pccb<tm1.1(KOMP)Vlcg>	MP:0000428,abnormal craniofacial morphology|MP:0001297,microphthalmia|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002135,abnormal kidney morphology|MP:0003054,spina bifida|MP:0008528,polycystic kidney|MP:0011100,preweaning lethality, complete penetrance
MGI:3603789	Pcd4ts1<DBA/2>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology
MGI:2673497	Pcd4ts2<BALB/c>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology
MGI:2673503	Pcd4ts3<BALB/c>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology
MGI:2673483	Pcd8ts1<C57BL/6>	MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:6473472	Pcdh10<tm1bNarl>	MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0010124,decreased bone mineral content
MGI:3764488	Pcdh10<tm1Lex>	MP:0000787,abnormal telencephalon morphology|MP:0001265,decreased body size|MP:0002152,abnormal brain morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:7425900	Pcdh12<em2(IMPC)J>	MP:0001303,abnormal lens morphology
MGI:3512625	Pcdh12<tm1Hub>	MP:0002169,no abnormal phenotype detected
MGI:1856467	Pcdh15<av>	MP:0000042,abnormal organ of Corti morphology|MP:0001386,abnormal maternal nurturing|MP:0001967,deafness|MP:0002169,no abnormal phenotype detected|MP:0002622,abnormal cochlear hair cell morphology|MP:0002855,abnormal cochlear ganglion morphology|MP:0003151,absent tunnel of Corti
MGI:1856396	Pcdh15<av-2J>	MP:0001393,ataxia|MP:0001394,circling|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0002622,abnormal cochlear hair cell morphology|MP:0003825,abnormal pillar cell morphology|MP:0004300,abnormal organ of Corti supporting cell morphology|MP:0004303,abnormal Hensen cell morphology|MP:0004362,cochlear hair cell degeneration|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004524,short cochlear hair cell stereocilia|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004742,abnormal vestibular system physiology|MP:0004813,absent linear vestibular evoked potential|MP:0005377,hearing/vestibular/ear phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856394	Pcdh15<av-3J>	MP:0001394,circling|MP:0001522,impaired swimming|MP:0001961,abnormal reflex|MP:0002622,abnormal cochlear hair cell morphology|MP:0002644,decreased circulating triglyceride level|MP:0002894,abnormal otolith morphology|MP:0002895,abnormal otolithic membrane morphology|MP:0003144,decreased otolith number|MP:0003949,abnormal circulating lipid level|MP:0004324,vestibular hair cell degeneration|MP:0004329,vestibular saccular degeneration|MP:0004331,vestibular saccular macula degeneration|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0004524,short cochlear hair cell stereocilia|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004577,abnormal cochlear hair cell inter-stereocilial links morphology|MP:0004578,abnormal cochlear hair bundle tip links morphology|MP:0004742,abnormal vestibular system physiology|MP:0004813,absent linear vestibular evoked potential|MP:0005179,decreased circulating cholesterol level|MP:0005377,hearing/vestibular/ear phenotype|MP:0006089,abnormal vestibular saccule morphology|MP:0011039,abnormal vestibuloocular dark reflex|MP:0011040,abnormal vestibuloocular light reflex|MP:0011061,abnormal inner hair cell kinocilium morphology|MP:0011062,abnormal outer hair cell kinocilium morphology|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2183469	Pcdh15<av-5J>	MP:0000042,abnormal organ of Corti morphology|MP:0000043,organ of Corti degeneration|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0001732,postnatal growth retardation|MP:0001967,deafness|MP:0002857,cochlear ganglion degeneration|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0004021,abnormal rod electrophysiology|MP:0004362,cochlear hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0005191,head tilt|MP:0005307,head tossing|MP:0005551,abnormal eye electrophysiology|MP:0006359,absent startle reflex|MP:0011064,abnormal vestibular hair cell kinocilium morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:3505691	Pcdh15<av-6J>	MP:0000043,organ of Corti degeneration|MP:0001265,decreased body size|MP:0001395,bidirectional circling|MP:0001406,abnormal gait|MP:0001967,deafness|MP:0002622,abnormal cochlear hair cell morphology|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0003637,cochlear ganglion hypoplasia|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0005307,head tossing|MP:0005377,hearing/vestibular/ear phenotype|MP:0006359,absent startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1855958	Pcdh15<av-J>	MP:0001394,circling|MP:0001522,impaired swimming|MP:0002622,abnormal cochlear hair cell morphology|MP:0003825,abnormal pillar cell morphology|MP:0004300,abnormal organ of Corti supporting cell morphology|MP:0004303,abnormal Hensen cell morphology|MP:0004362,cochlear hair cell degeneration|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004492,abnormal orientation of inner hair cell stereociliary bundles|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004524,short cochlear hair cell stereocilia|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004813,absent linear vestibular evoked potential|MP:0005377,hearing/vestibular/ear phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2448714	Pcdh15<av-Jfb>	MP:0001394,circling|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005307,head tossing|MP:0005551,abnormal eye electrophysiology|MP:0012029,abnormal electroretinogram waveform feature
MGI:2151877	Pcdh15<av-Tg2742Rpw>	MP:0000043,organ of Corti degeneration|MP:0001394,circling|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0002894,abnormal otolith morphology|MP:0002895,abnormal otolithic membrane morphology|MP:0003143,enlarged otoliths|MP:0003144,decreased otolith number|MP:0004324,vestibular hair cell degeneration|MP:0004329,vestibular saccular degeneration|MP:0004331,vestibular saccular macula degeneration|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004813,absent linear vestibular evoked potential|MP:0005376,homeostasis/metabolism phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0006089,abnormal vestibular saccule morphology|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6153753	Pcdh15<em1(IMPC)Wtsi>	MP:0010123,increased bone mineral content
MGI:7564294	Pcdh15<em1Zma>	MP:0001394,circling|MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0001516,abnormal motor coordination/balance|MP:0001764,abnormal homeostasis|MP:0001967,deafness|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0004362,cochlear hair cell degeneration|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0005391,vision/eye phenotype|MP:0008515,thin retina outer nuclear layer|MP:0031122,areflexia
MGI:3814568	Pcdh15<m1Btlr>	MP:0001394,circling|MP:0001399,hyperactivity
MGI:5497993	Pcdh15<m2Btlr>	MP:0001399,hyperactivity|MP:0005323,dystonia|MP:0010323,retropulsion
MGI:5527537	Pcdh15<m3Btlr>	MP:0001394,circling|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001410,head bobbing
MGI:5806326	Pcdh15<m4Btlr>	MP:0001394,circling|MP:0005191,head tilt
MGI:6114106	Pcdh15<m5Btlr>	MP:0001393,ataxia|MP:0001394,circling|MP:0001399,hyperactivity
MGI:5704141	Pcdh15<roda>	MP:0001394,circling|MP:0001410,head bobbing|MP:0001525,impaired balance|MP:0001967,deafness|MP:0004362,cochlear hair cell degeneration|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004533,fused inner hair cell stereocilia|MP:0004534,decreased inner hair cell stereocilia number|MP:0030962,abnormal inner hair cell kinocilium location or orientation
MGI:5697804	Pcdh15<tm1.1Mll>	MP:0005377,hearing/vestibular/ear phenotype
MGI:5566900	Pcdh15<tm1.1Ugds>	MP:0001967,deafness|MP:0004415,abnormal cochlear nerve compound action potential|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0004531,short outer hair cell stereocilia|MP:0004534,decreased inner hair cell stereocilia number|MP:0004536,short inner hair cell stereocilia|MP:0004578,abnormal cochlear hair bundle tip links morphology|MP:0004738,abnormal auditory brainstem response|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5697806	Pcdh15<tm2.1Mll>	MP:0001967,deafness|MP:0004362,cochlear hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004529,decreased outer hair cell stereocilia number|MP:0004737,absent distortion product otoacoustic emissions|MP:0005386,behavior/neurological phenotype|MP:0011064,abnormal vestibular hair cell kinocilium morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0030961,abnormal outer hair cell kinocilium location or orientation|MP:0030962,abnormal inner hair cell kinocilium location or orientation
MGI:5697809	Pcdh15<tm3.1Mll>	MP:0005377,hearing/vestibular/ear phenotype
MGI:5520081	Pcdh17<tm1.1Sia>	MP:0002917,decreased synaptic depression|MP:0003063,increased coping response|MP:0003631,nervous system phenotype|MP:0004792,abnormal synaptic vesicle number|MP:0004807,abnormal paired-pulse inhibition|MP:0005386,behavior/neurological phenotype
MGI:5548631	Pcdh18<tm1.1(KOMP)Vlcg>	MP:0000564,syndactyly|MP:0001289,persistence of hyaloid vascular system|MP:0001314,cornea opacity|MP:0001399,hyperactivity|MP:0002764,short tibia|MP:0003900,shortened QT interval|MP:0003960,increased lean body mass|MP:0004924,abnormal behavior|MP:0010025,decreased total body fat amount|MP:0010571,shortened ST segment|MP:0020870,decreased thigmotaxis
MGI:6117336	Pcdh19<tm1Tac>	MP:0003631,nervous system phenotype|MP:0004994,abnormal brain wave pattern|MP:0005386,behavior/neurological phenotype|MP:0006009,abnormal neuronal migration
MGI:6153572	Pcdh1<em1(IMPC)Wtsi>	MP:0002073,abnormal hair growth
MGI:5755156	Pcdh20<em1(IMPC)H>	MP:0001364,decreased anxiety-related response|MP:0001410,head bobbing|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:6489541	Pcdh7<em1Ywc>	MP:0004985,decreased osteoclast cell number|MP:0005390,skeleton phenotype|MP:0009347,increased trabecular bone thickness|MP:0010872,increased trabecular bone mass|MP:0010878,increased trabecular bone volume|MP:0013631,decreased bone trabecular spacing
MGI:6257472	Pcdh8<em1(IMPC)H>	MP:0005293,impaired glucose tolerance
MGI:3630287	Pcdh8<tm1Emdr>	MP:0002169,no abnormal phenotype detected
MGI:5621140	Pcdh9<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001566,increased circulating phosphate level|MP:0002574,increased vertical activity|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5825237	Pcdh9<tm1Mjhk>	MP:0001405,impaired coordination|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0006254,thin cerebral cortex|MP:0008143,abnormal dendrite morphology|MP:0008948,decreased neuron number|MP:0009142,decreased prepulse inhibition|MP:0014367,impaired long-term object recognition memory|MP:0020396,abnormal social recognition|MP:0021019,increased dendritic spine number|MP:0031391,increased locomotor activity
MGI:3719154	Pcdha1<tm1Mrc>	MP:0002169,no abnormal phenotype detected
MGI:6266829	Pcdha2<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000702,enlarged lymph nodes|MP:0001417,decreased exploration in new environment
MGI:5906282	Pcdha9<b2b635.1Clo>	MP:0001625,cardiac hypertrophy|MP:0010463,aorta stenosis|MP:0010484,bicuspid aortic valve|MP:0010541,aorta hypoplasia
MGI:8162198	Pcdha9<em1Zhxu>	MP:0000160,kyphosis|MP:0000938,motor neuron degeneration|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001263,weight loss|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001524,impaired limb coordination|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0002651,abnormal sciatic nerve morphology|MP:0003354,astrocytosis|MP:0004145,abnormal muscle electrophysiology|MP:0008571,abnormal synaptic bouton morphology|MP:0010053,decreased grip strength|MP:0011975,neuronal cytoplasmic inclusions|MP:0031202,hemiplegia
MGI:8162200	Pcdha9<em2Zhxu>	MP:0000160,kyphosis|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001263,weight loss|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001524,impaired limb coordination|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0008571,abnormal synaptic bouton morphology|MP:0010053,decreased grip strength|MP:0031202,hemiplegia
MGI:3719165	Pcdhac1<tm1Mrc>	MP:0002169,no abnormal phenotype detected
MGI:3719171	Pcdhac2<tm1Mrc>	MP:0002169,no abnormal phenotype detected
MGI:4421020	Pcdha<tm10Tyag>	MP:0005389,reproductive system phenotype
MGI:3719178	Pcdha<tm1.1Mrc>	MP:0002169,no abnormal phenotype detected
MGI:4421021	Pcdha<tm11Tyag>	MP:0005389,reproductive system phenotype
MGI:3719183	Pcdha<tm2Mrc>	MP:0002169,no abnormal phenotype detected
MGI:3797610	Pcdha<tm3Tyag>	MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000832,abnormal thalamus morphology|MP:0000836,abnormal substantia nigra morphology|MP:0001212,skin lesions|MP:0001262,decreased body weight|MP:0001441,increased grooming behavior|MP:0003631,nervous system phenotype|MP:0003877,abnormal serotonergic neuron morphology|MP:0004081,abnormal globus pallidus morphology|MP:0004102,abnormal dorsal striatum morphology|MP:0004165,abnormal lateral geniculate nucleus morphology|MP:0004167,abnormal cingulate gyrus morphology|MP:0006300,abnormal entorhinal cortex morphology|MP:0008930,abnormal medial geniculate nucleus morphology|MP:0010069,increased serotonin level|MP:0012448,abnormal primary motor cortex morphology
MGI:3829038	Pcdha<tm4.1Tyag>	MP:0005386,behavior/neurological phenotype
MGI:3829037	Pcdha<tm4Tyag>	MP:0001469,abnormal contextual conditioning behavior|MP:0003631,nervous system phenotype|MP:0005322,abnormal serotonin level|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory
MGI:4356090	Pcdha<tm5.1Tyag>	MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0001212,skin lesions|MP:0001262,decreased body weight|MP:0001441,increased grooming behavior|MP:0003877,abnormal serotonergic neuron morphology|MP:0005322,abnormal serotonin level
MGI:3829039	Pcdha<tm5Tyag>	MP:0001469,abnormal contextual conditioning behavior|MP:0005322,abnormal serotonin level|MP:0008428,abnormal spatial working memory
MGI:4421018	Pcdha<tm8Tyag>	MP:0005389,reproductive system phenotype
MGI:4421019	Pcdha<tm9Tyag>	MP:0005389,reproductive system phenotype
MGI:6385279	Pcdhb10<em1(IMPC)Tcp>	MP:0002092,abnormal eye morphology|MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin
MGI:6257657	Pcdhb13<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000186,decreased circulating HDL cholesterol level|MP:0000702,enlarged lymph nodes|MP:0001258,decreased body length|MP:0002607,decreased basophil cell number|MP:0005179,decreased circulating cholesterol level|MP:0011874,enlarged urinary bladder
MGI:5635261	Pcdhb22<tm1.1(KOMP)Vlcg>	MP:0000208,decreased hematocrit|MP:0001513,limb grasping|MP:0002875,decreased erythrocyte cell number
MGI:6342494	Pcdhb9<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response|MP:0010052,increased grip strength|MP:0010097,abnormal retina blood vessel morphology|MP:0010392,prolonged QRS complex duration
MGI:3719174	Pcdhga1<tm1Mrc>	MP:0002169,no abnormal phenotype detected
MGI:6120529	Pcdhgb1<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior
MGI:6336214	Pcdhgb2<em1(IMPC)Hmgu>	MP:0011886,increased circulating lipase level
MGI:6336215	Pcdhgc3<em1(IMPC)Hmgu>	MP:0002753,dilated heart left ventricle
MGI:6285828	Pcdhg<em35Rwb>	MP:0002169,no abnormal phenotype detected
MGI:6284353	Pcdhg<em41Rwb>	MP:0000745,tremors|MP:0000955,abnormal spinal cord morphology|MP:0000956,decreased spinal cord size|MP:0001505,hunched posture|MP:0001523,impaired righting response|MP:0004100,abnormal spinal cord interneuron morphology|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0008918,microgliosis|MP:0011087,neonatal lethality, complete penetrance|MP:0013182,increased spinal cord apoptosis
MGI:6285780	Pcdhg<em5Rwb>	MP:0000745,tremors|MP:0000955,abnormal spinal cord morphology|MP:0000956,decreased spinal cord size|MP:0001505,hunched posture|MP:0001523,impaired righting response|MP:0003354,astrocytosis|MP:0004100,abnormal spinal cord interneuron morphology|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0008503,abnormal spinal cord grey matter morphology|MP:0008918,microgliosis|MP:0011087,neonatal lethality, complete penetrance|MP:0013182,increased spinal cord apoptosis
MGI:6285783	Pcdhg<em8Rwb>	MP:0002169,no abnormal phenotype detected
MGI:5504502	Pcdhg<tm1.1Sch>	MP:0011089,perinatal lethality, complete penetrance
MGI:5440844	Pcdhg<tm1.1Tman>	MP:0000745,tremors|MP:0001505,hunched posture|MP:0001961,abnormal reflex|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0003491,abnormal voluntary movement|MP:0004143,muscle hypertonia|MP:0008918,microgliosis|MP:0010146,umbilical hernia|MP:0011087,neonatal lethality, complete penetrance
MGI:5504505	Pcdhg<tm1.2Sch>	MP:0002739,abnormal olfactory bulb development|MP:0003631,nervous system phenotype|MP:0008143,abnormal dendrite morphology|MP:0021018,decreased dendritic spine number
MGI:5504501	Pcdhg<tm1Sch>	MP:0011089,perinatal lethality, complete penetrance
MGI:3623601	Pcdhg<tm1Xzw>	MP:0002169,no abnormal phenotype detected
MGI:5440845	Pcdhg<tm2.1Tman>	MP:0002169,no abnormal phenotype detected
MGI:3821851	Pcdhg<tm2.1Xzw>	MP:0000955,abnormal spinal cord morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3821773	Pcdhg<tm2Xzw>	MP:0005391,vision/eye phenotype|MP:0005547,abnormal Muller cell morphology|MP:0005551,abnormal eye electrophysiology|MP:0006073,abnormal retina bipolar cell morphology|MP:0006309,decreased retina ganglion cell number|MP:0008106,decreased amacrine cell number|MP:0008511,thin retina inner nuclear layer|MP:0008513,thin retina inner plexiform layer|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0030005,increased retina apoptosis
MGI:3821852	Pcdhg<tm3.1Xzw>	MP:0000955,abnormal spinal cord morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3821850	Pcdhg<tm3Xzw>	MP:0001325,abnormal retina morphology|MP:0008511,thin retina inner nuclear layer|MP:0008513,thin retina inner plexiform layer|MP:0011965,decreased total retina thickness
MGI:6470899	Pcgf1<tm1.1Hko>	MP:0000495,abnormal colon morphology|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002581,abnormal ileum morphology|MP:0003868,abnormal feces composition|MP:0004002,abnormal jejunum morphology|MP:0006001,abnormal intestinal transit time|MP:0008770,decreased survivor rate|MP:0008947,increased neuron number|MP:0008948,decreased neuron number|MP:0014484,decreased feces water content
MGI:5620906	Pcgf1<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0001303,abnormal lens morphology|MP:0001399,hyperactivity|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0002574,increased vertical activity|MP:0002884,abnormal pharyngeal arch morphology|MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5548974	Pcgf2<tm1b(KOMP)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0003049,abnormal lumbar vertebrae morphology|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:1857633	Pcgf2<tm1Hko>	MP:0000078,abnormal supraoccipital bone morphology|MP:0000080,abnormal exoccipital bone morphology|MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000715,decreased thymocyte number|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002114,abnormal axial skeleton morphology|MP:0003036,vertebral transformation|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004617,sacral vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004659,abnormal odontoid process morphology|MP:0005016,decreased lymphocyte cell number|MP:0005269,abnormal occipital bone morphology|MP:0005466,abnormal T-helper 2 physiology|MP:0008148,abnormal sternocostal joint morphology|MP:0008277,abnormal sternum ossification|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5559317	Pcgf2<tm2.1Hko>	MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype
MGI:6257509	Pcgf3<em1(IMPC)Bay>	MP:0000111,cleft palate|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0001297,microphthalmia|MP:0001399,hyperactivity|MP:0001697,abnormal embryo size|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0003743,abnormal facial morphology|MP:0008797,facial cleft|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:5287257	Pcgf3<TgTn(sb-cHS4,Tyr)2349AOve>	MP:0000690,absent spleen
MGI:6117847	Pcgf5<tm1.1Aiwa>	MP:0005397,hematopoietic system phenotype
MGI:6357174	Pcgf6<tm1.2Hko>	MP:0000154,rib fusion|MP:0000480,increased rib number|MP:0001712,abnormal placenta development|MP:0001713,decreased trophoblast giant cell number|MP:0001715,placental labyrinth hypoplasia|MP:0001716,abnormal placenta labyrinth morphology|MP:0002399,abnormal pluripotent precursor cell morphology|MP:0003984,embryonic growth retardation|MP:0004259,small placenta|MP:0004615,cervical vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0005221,abnormal rostral-caudal axis patterning|MP:0008148,abnormal sternocostal joint morphology|MP:0009781,abnormal preimplantation embryo development|MP:0009879,abnormal arcus anterior morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012398,decreased nucleated erythrocyte cell number|MP:0030989,decreased spongiotrophoblast cell number
MGI:7425902	Pcid2<em1(IMPC)Ccpcz>	MP:0002092,abnormal eye morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:6388554	Pcid2<tm1.1Imku>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4843141	Pcid2<tm1Imku>	MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008211,decreased mature B cell number|MP:0008470,abnormal spleen B cell follicle morphology
MGI:6452630	Pcif1<em1Embrp>	MP:0001262,decreased body weight
MGI:6358070	Pcif1<em1(IMPC)Bay>	MP:0001258,decreased body length|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0008259,abnormal optic disk morphology|MP:0010025,decreased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011960,abnormal eye anterior chamber depth|MP:0020870,decreased thigmotaxis
MGI:6452631	Pcif1<em2Embrp>	MP:0002169,no abnormal phenotype detected
MGI:2182394	Pck1<tm1.1Lre>	MP:0001559,hyperglycemia|MP:0001783,decreased white adipose tissue amount|MP:0002644,decreased circulating triglyceride level|MP:0003458,decreased circulating ketone body level|MP:0005376,homeostasis/metabolism phenotype|MP:0005670,abnormal white adipose tissue physiology|MP:0008853,decreased abdominal adipose tissue amount|MP:0009116,abnormal brown fat cell morphology|MP:0009117,abnormal white fat cell morphology|MP:0009122,decreased white fat cell lipid droplet size|MP:0009128,decreased brown fat cell number|MP:0009133,decreased white fat cell size|MP:0009136,decreased brown fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0011174,lipodystrophy
MGI:2449283	Pck1<tm1.1Mgn>	MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002169,no abnormal phenotype detected|MP:0002981,increased liver weight|MP:0009355,increased liver triglyceride level|MP:0010398,decreased liver glycogen level
MGI:2449284	Pck1<tm1.2Mgn>	MP:0000189,hypoglycemia|MP:0000603,pale liver|MP:0001265,decreased body size|MP:0003717,pallor|MP:0005202,lethargy|MP:0009546,absent gastric milk in neonates|MP:0010398,decreased liver glycogen level|MP:0011085,postnatal lethality, complete penetrance
MGI:2449282	Pck1<tm1Mgn>	MP:0000599,enlarged liver
MGI:3514160	Pck1<tm1Rwh>	MP:0000598,abnormal liver morphology|MP:0001552,increased circulating triglyceride level|MP:0001731,abnormal postnatal growth|MP:0002575,increased circulating ketone body level|MP:0002628,hepatic steatosis|MP:0003949,abnormal circulating lipid level|MP:0005309,increased circulating ammonia level|MP:0005311,abnormal circulating amino acid level|MP:0005459,decreased percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0010398,decreased liver glycogen level|MP:0011085,postnatal lethality, complete penetrance|MP:0013405,increased circulating lactate level
MGI:6257433	Pck2<em1(IMPC)Tcp>	MP:0000470,abnormal stomach morphology|MP:0000702,enlarged lymph nodes|MP:0002060,abnormal skin morphology|MP:0002644,decreased circulating triglyceride level|MP:0004930,small epididymis
MGI:5302414	Pclaf<tm1.1Lkd>	MP:0000221,decreased leukocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0000694,spleen hypoplasia|MP:0001545,abnormal hematopoietic system physiology|MP:0001823,thymus hypoplasia|MP:0003674,oxidative stress|MP:0004810,decreased hematopoietic stem cell number|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008813,decreased common myeloid progenitor cell number|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:4461695	Pclaf<tm1a(EUCOMM)Wtsi>	MP:0004974,decreased regulatory T cell number|MP:0005018,decreased T cell number|MP:0005293,impaired glucose tolerance|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0008126,increased dendritic cell number|MP:0008127,decreased dendritic cell number|MP:0008186,increased pro-B cell number|MP:0013430,increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0013649,decreased CD11b-high dendritic cell number|MP:0013651,increased CD11b-low dendritic cell number|MP:0013666,decreased immature NK cell number|MP:0013673,increased mature NK cell number
MGI:5775083	Pclo<tm1.1Mver>	MP:0002206,abnormal CNS synaptic transmission|MP:0002916,increased synaptic depression|MP:0005386,behavior/neurological phenotype|MP:0008921,increased neurotransmitter release|MP:0011269,increased excitatory postsynaptic current amplitude
MGI:3699630	Pclo<tm1Sud>	MP:0002169,no abnormal phenotype detected
MGI:3785835	Pclo<tm2Sud>	MP:0002169,no abnormal phenotype detected
MGI:3783987	Pclo<tm3.1Sud>	MP:0002169,no abnormal phenotype detected
MGI:4442914	Pclo<tm3.2Sud>	MP:0001265,decreased body size|MP:0002083,premature death|MP:0002916,increased synaptic depression|MP:0003631,nervous system phenotype|MP:0004792,abnormal synaptic vesicle number|MP:0008770,decreased survivor rate
MGI:4442915	Pclo<tm3.3Sud>	MP:0002169,no abnormal phenotype detected
MGI:6156455	Pcm1<em1(IMPC)Tcp>	MP:0000438,abnormal cranium morphology|MP:0000692,small spleen|MP:0001258,decreased body length|MP:0001488,increased startle reflex|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0003961,decreased lean body mass|MP:0004953,decreased spleen weight|MP:0005293,impaired glucose tolerance|MP:0009142,decreased prepulse inhibition|MP:0010392,prolonged QRS complex duration|MP:0010506,prolonged RR interval
MGI:6164632	Pcm1<tm1Asaw>	MP:0000774,decreased brain size|MP:0002757,decreased vertical activity|MP:0005386,behavior/neurological phenotype|MP:0020396,abnormal social recognition
MGI:2384152	Pcmt1<tm1Scl>	MP:0001732,postnatal growth retardation|MP:0001764,abnormal homeostasis|MP:0002083,premature death|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003997,tonic-clonic seizures|MP:0005621,abnormal cell physiology
MGI:2384158	Pcmt1<tm1Shs>	MP:0000160,kyphosis|MP:0000198,decreased circulating phosphate level|MP:0000243,myoclonus|MP:0000692,small spleen|MP:0000947,convulsive seizures|MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0001732,postnatal growth retardation|MP:0001745,increased circulating corticosterone level|MP:0001953,respiratory failure|MP:0002083,premature death|MP:0002176,increased brain weight|MP:0002272,abnormal nervous system electrophysiology|MP:0002666,increased circulating aldosterone level|MP:0003996,clonic seizures|MP:0003997,tonic-clonic seizures|MP:0004994,abnormal brain wave pattern|MP:0005179,decreased circulating cholesterol level|MP:0005238,increased brain size|MP:0005404,abnormal axon morphology|MP:0005565,increased blood urea nitrogen level|MP:0005621,abnormal cell physiology|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0010091,decreased circulating creatine kinase level|MP:0011891,decreased circulating ferritin level|MP:0011972,decreased circulating lactate dehydrogenase level
MGI:3817295	Pcna<tm1.1Mdsc>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5478543	Pcna<tm1.1Scwh>	MP:0001262,decreased body weight|MP:0003960,increased lean body mass|MP:0005459,decreased percent body fat/body weight|MP:0009131,decreased white fat cell number|MP:0010182,decreased susceptibility to weight gain|MP:0011167,abnormal adipose tissue development
MGI:3761720	Pcna<tm1Jcbs>	MP:0001924,infertility|MP:0004806,absent germ cells|MP:0004815,abnormal somatic hypermutation frequency|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:6158500	Pcnp<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0001700,abnormal embryo turning|MP:0002060,abnormal skin morphology|MP:0002151,abnormal neural tube morphology|MP:0002631,abnormal epididymis morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003232,abnormal forebrain development|MP:0003425,abnormal optic vesicle formation|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0004931,enlarged epididymis|MP:0009806,abnormal otic vesicle morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6377198	Pcnt<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001258,decreased body length|MP:0001289,persistence of hyaloid vascular system|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:4340776	Pcnt<Gt(RRU388)Byg>	MP:0000111,cleft palate|MP:0000259,abnormal vascular development|MP:0000266,abnormal heart morphology|MP:0000273,overriding aortic valve|MP:0000433,microcephaly|MP:0000522,kidney cortex cyst|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000774,decreased brain size|MP:0000807,abnormal hippocampus morphology|MP:0000913,abnormal brain development|MP:0001177,atelectasis|MP:0001178,pulmonary hypoplasia|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002192,hydrops fetalis|MP:0003675,kidney cyst|MP:0003935,abnormal craniofacial development|MP:0004017,duplex kidney|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0006045,mitral valve regurgitation|MP:0006047,aortic valve regurgitation|MP:0006113,abnormal heart septum morphology|MP:0006138,congestive heart failure|MP:0006254,thin cerebral cortex|MP:0008441,thin cortical plate|MP:0008458,abnormal cortical ventricular zone morphology|MP:0008772,increased heart ventricle size|MP:0009760,abnormal mitotic spindle morphology|MP:0009937,abnormal neuron differentiation|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010412,atrioventricular septal defect|MP:0010865,prenatal growth retardation|MP:0010993,decreased surfactant secretion|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0011495,abnormal head shape|MP:0011682,renal glomerulus cyst|MP:0012285,misaligned sternebrae
MGI:3799303	Pcnt<m239Asp>	MP:0000562,polydactyly|MP:0000788,abnormal cerebral cortex morphology|MP:0000951,sporadic seizures|MP:0002083,premature death
MGI:3799305	Pcnt<m275Asp>	MP:0000562,polydactyly|MP:0000788,abnormal cerebral cortex morphology|MP:0000951,sporadic seizures|MP:0002081,perinatal lethality|MP:0002083,premature death
MGI:5752758	Pcnx2<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001304,cataract|MP:0005568,increased circulating total protein level|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:6305217	Pcnx4<em1(IMPC)J>	MP:0001523,impaired righting response|MP:0004738,abnormal auditory brainstem response
MGI:3722112	Pcolce2<tm1Ccb>	MP:0002169,no abnormal phenotype detected
MGI:3612407	Pcolce<tm1Dgr>	MP:0000130,abnormal trabecular bone morphology|MP:0000559,abnormal femur morphology|MP:0001533,abnormal skeleton physiology|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0003797,abnormal compact bone morphology|MP:0004148,increased compact bone thickness|MP:0005503,abnormal tendon morphology|MP:0010768,mortality/aging|MP:0010967,increased compact bone area
MGI:1856986	pcp	MP:0000111,cleft palate|MP:0000562,polydactyly|MP:0002081,perinatal lethality
MGI:3579782	Pcp2<tm1Bhk>	MP:0002169,no abnormal phenotype detected
MGI:3578623	Pcp2<tm1(cre)Nobs>	MP:0002169,no abnormal phenotype detected
MGI:3579785	Pcp2<tm1Jim>	MP:0002169,no abnormal phenotype detected
MGI:6120730	Pcp4l1<tm1b(KOMP)Wtsi>	MP:0001402,decreased locomotor activity|MP:0002792,abnormal retina vasculature morphology|MP:0004738,abnormal auditory brainstem response
MGI:5086270	Pcp4<tm1.1Jim>	MP:0002804,abnormal motor learning|MP:0003631,nervous system phenotype|MP:0004859,abnormal synaptic plasticity|MP:0005386,behavior/neurological phenotype
MGI:6113653	Pcp4<tm1.1Kzy>	MP:0000823,abnormal lateral ventricle morphology
MGI:2159381	Pcpila1<C57BL/6J>	MP:0009749,enhanced behavioral response to addictive substance
MGI:2159383	Pcpila2<C57BL/6J>	MP:0009749,enhanced behavioral response to addictive substance
MGI:2159385	Pcpila3<C57BL/6J>	MP:0009749,enhanced behavioral response to addictive substance
MGI:1861456	Pcs1	MP:0001297,microphthalmia|MP:0001314,cornea opacity|MP:0001322,abnormal iris morphology|MP:0010259,anterior polar cataract
MGI:7279192	Pcsk1<em2Irli>	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002693,abnormal pancreas physiology|MP:0003449,abnormal intestine goblet cell morphology|MP:0005128,decreased adrenocorticotropin level|MP:0005215,abnormal pancreatic islet morphology|MP:0005560,decreased circulating glucose level|MP:0005646,abnormal pituitary gland physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011984,decreased enteroendocrine cell number
MGI:5792086	Pcsk1<mpc242H>	MP:0001261,obese|MP:0005036,diarrhea|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance
MGI:3629669	Pcsk1<N222D>	MP:0000008,increased white adipose tissue amount|MP:0001260,increased body weight|MP:0001261,obese|MP:0001433,polyphagia|MP:0001921,reduced fertility|MP:0004818,increased skeletal muscle mass|MP:0004819,decreased skeletal muscle mass|MP:0004852,decreased testis weight|MP:0005266,abnormal metabolism|MP:0005336,abnormal inguinal fat pad morphology|MP:0005669,increased circulating leptin level
MGI:4459814	Pcsk1n<tm1Jep>	MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0002757,decreased vertical activity|MP:0003313,abnormal locomotor activation|MP:0003908,decreased stereotypic behavior
MGI:5548957	Pcsk1<tm1b(EUCOMM)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0001402,decreased locomotor activity|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020420,abnormal freezing behavior
MGI:2384741	Pcsk1<tm1Dfs>	MP:0000189,hypoglycemia|MP:0000691,enlarged spleen|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001665,chronic diarrhea|MP:0002357,abnormal spleen white pulp morphology|MP:0002362,abnormal spleen marginal zone morphology|MP:0002696,decreased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0003953,abnormal hormone level|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005013,increased lymphocyte cell number|MP:0005018,decreased T cell number|MP:0005120,decreased circulating growth hormone level|MP:0005128,decreased adrenocorticotropin level|MP:0005291,abnormal glucose tolerance|MP:0008040,decreased NK T cell number|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008200,decreased follicular dendritic cell number|MP:0008244,abnormal peritoneal macrophage morphology|MP:0008475,intermingled spleen red and white pulp|MP:0008553,increased circulating tumor necrosis factor level|MP:0008577,increased circulating interferon-gamma level|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008617,increased circulating interleukin-12 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008657,increased interleukin-1 beta secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3714927	Pcsk1<tm1Mbi>	MP:0004179,transmission ratio distortion|MP:0005376,homeostasis/metabolism phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0008489,slow postnatal weight gain|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:6316118	Pcsk2<em1(IMPC)H>	MP:0000367,abnormal coat/ hair morphology|MP:0001392,abnormal locomotor behavior|MP:0001513,limb grasping|MP:0001556,increased circulating HDL cholesterol level|MP:0002590,increased mean corpuscular volume|MP:0002941,increased circulating alanine transaminase level|MP:0005178,increased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0008806,increased circulating amylase level|MP:0008810,increased circulating iron level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1857445	Pcsk2<tm1Dfs>	MP:0001923,reduced female fertility|MP:0001973,increased thermal nociceptive threshold|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002164,abnormal gland physiology|MP:0002696,decreased circulating glucagon level|MP:0002705,dilated renal tubule|MP:0002711,decreased glucagon secretion|MP:0002727,decreased circulating insulin level|MP:0002842,increased systemic arterial blood pressure|MP:0003059,decreased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0003365,increased glucagonoma incidence|MP:0003430,increased pancreatic islet cell adenoma incidence|MP:0003972,decreased pituitary hormone level|MP:0004270,analgesia|MP:0005215,abnormal pancreatic islet morphology|MP:0005216,abnormal pancreatic alpha cell morphology|MP:0005292,improved glucose tolerance|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0005498,hyporesponsive to tactile stimuli|MP:0005560,decreased circulating glucose level|MP:0008953,abnormal pancreatic somatostatin secretion|MP:0009151,increased pancreatic ductal adenocarcinoma incidence|MP:0009153,increased pancreas tumor incidence|MP:0009171,enlarged pancreatic islets|MP:0009175,abnormal pancreatic beta cell differentiation|MP:0009176,increased pancreatic alpha cell number|MP:0009179,abnormal pancreatic alpha cell differentiation|MP:0009180,increased pancreatic delta cell number|MP:0010768,mortality/aging|MP:0014109,increased pancreatic alpha cell proliferation|MP:0030589,increased pancreatic alpha cell mass
MGI:5498354	Pcsk4<tm1b(KOMP)Wtsi>	MP:0002833,increased heart weight|MP:0005633,increased circulating sodium level
MGI:2665512	Pcsk4<tm1Mbi>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0004179,transmission ratio distortion|MP:0004543,abnormal sperm physiology|MP:0009230,abnormal sperm head morphology|MP:0009282,decreased hyperactivated sperm motility|MP:0013286,abnormal sperm capacitation|MP:0013287,abnormal acrosome reaction|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031354,abnormal acrosome assembly|MP:0031355,abnormal proacrosomal vesicle fusion
MGI:5430343	Pcsk5<b2b1549Clo>	MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0004133,heterotaxia|MP:0010413,complete atrioventricular septal defect|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011649,immotile respiratory cilia|MP:0011665,d-loop transposition of the great arteries|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:5313702	Pcsk5<b2b585Clo>	MP:0000284,double outlet right ventricle|MP:0000480,increased rib number|MP:0000520,absent kidney|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0002109,abnormal limb morphology|MP:0002633,persistent truncus arteriosus|MP:0003130,anal atresia|MP:0003321,tracheoesophageal fistula|MP:0003456,absent tail|MP:0004159,double aortic arch
MGI:3612544	Pcsk5<tm1.1Prat>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5474776	Pcsk5<tm1b(KOMP)Mbp>	MP:0000111,cleft palate|MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0001399,hyperactivity|MP:0001697,abnormal embryo size|MP:0001914,hemorrhage|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0002833,increased heart weight|MP:0003385,abnormal body wall morphology|MP:0003720,abnormal neural tube closure|MP:0003743,abnormal facial morphology|MP:0003960,increased lean body mass|MP:0003984,embryonic growth retardation|MP:0005179,decreased circulating cholesterol level|MP:0005650,abnormal limb bud morphology|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:3789184	Pcsk5<tm2.1Prat>	MP:0011092,embryonic lethality, complete penetrance
MGI:3795786	Pcsk5<vcc>	MP:0000266,abnormal heart morphology|MP:0000284,double outlet right ventricle|MP:0000480,increased rib number|MP:0000492,abnormal rectum morphology|MP:0000520,absent kidney|MP:0000538,abnormal urinary bladder morphology|MP:0000550,abnormal forelimb morphology|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0000572,abnormal autopod morphology|MP:0000644,dextrocardia|MP:0000706,small thymus|MP:0000955,abnormal spinal cord morphology|MP:0001178,pulmonary hypoplasia|MP:0002367,abnormal thymus lobule morphology|MP:0002633,persistent truncus arteriosus|MP:0003052,omphalocele|MP:0003139,patent ductus arteriosus|MP:0003321,tracheoesophageal fistula|MP:0003456,absent tail|MP:0003641,small lung|MP:0003755,abnormal palate morphology|MP:0004158,right aortic arch|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004651,increased thoracic vertebrae number|MP:0004653,absent caudal vertebrae|MP:0004656,absent sacral vertebrae|MP:0004694,absent patella|MP:0004703,abnormal vertebral column morphology|MP:0005430,absent fibula|MP:0008999,absent anus|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010466,vascular ring|MP:0011872,absent xiphoid process|MP:0014322,short hindlimb
MGI:6358003	Pcsk6<em1(IMPC)J>	MP:0001314,cornea opacity
MGI:2181754	Pcsk6<tm1Rob>	MP:0000284,double outlet right ventricle|MP:0000644,dextrocardia|MP:0001126,abnormal ovary morphology|MP:0001293,anophthalmia|MP:0001706,abnormal left-right axis patterning|MP:0001927,abnormal estrous cycle|MP:0002016,ovary cyst|MP:0002633,persistent truncus arteriosus|MP:0002777,absent ovarian follicles|MP:0003178,left pulmonary isomerism|MP:0003632,abnormal nervous system morphology|MP:0003699,abnormal female reproductive system physiology|MP:0004252,abnormal direction of heart looping|MP:0005163,cyclopia|MP:0008000,increased ovary tumor incidence|MP:0008384,absent nasal capsule|MP:0008995,early reproductive senescence|MP:0010287,increased reproductive system tumor incidence|MP:0010308,decreased tumor latency|MP:0010335,fused first pharyngeal arch|MP:0010402,ventricular septal defect|MP:0010406,common atrium|MP:0010432,common ventricle|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012084,truncated foregut|MP:0013906,absent embryonic telencephalon|MP:0014604,hemorrhagic ovary cyst|MP:0030268,agnathia
MGI:5428017	Pcsk7<tm1Rob>	MP:0005376,homeostasis/metabolism phenotype|MP:0010768,mortality/aging
MGI:7431378	Pcsk9<em1(IMPC)Ccpcz>	MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0013763,increased T-helper cell number
MGI:5516591	Pcsk9<m1Bms>	MP:0000183,decreased circulating LDL cholesterol level|MP:0004789,increased bile salt level
MGI:4943284	Pcsk9<tm1.1Prat>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:4943496	Pcsk9<tm1.2Prat>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0002658,abnormal liver regeneration|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005517,impaired liver regeneration
MGI:3577021	Pcsk9<tm1Jdh>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:5637110	Pcsk9<tm2b(EUCOMM)Hmgu>	MP:0000186,decreased circulating HDL cholesterol level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005179,decreased circulating cholesterol level|MP:0008806,increased circulating amylase level|MP:0011886,increased circulating lipase level
MGI:3608872	Pctm<BALB/cAnPt>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:3691424	Pctp<R120H>	MP:0002118,abnormal lipid homeostasis
MGI:2673156	Pctp<tm1Bor>	MP:0002169,no abnormal phenotype detected|MP:0002451,abnormal macrophage physiology|MP:0002830,gallstones|MP:0003982,increased cholesterol level|MP:0003983,decreased cholesterol level|MP:0004772,abnormal bile secretion|MP:0004773,abnormal bile composition|MP:0004774,abnormal bile salt level|MP:0004777,abnormal phospholipid level|MP:0005085,abnormal gallbladder physiology|MP:0008991,abnormal bile canaliculus morphology|MP:0011080,increased macrophage apoptosis
MGI:3036108	Pctr2<DBA/2N>	MP:0002052,decreased tumor incidence
MGI:3608869	Pcts<BALB/cAnPt>	MP:0004499,increased incidence of tumors by chemical induction|MP:0010286,increased plasmacytoma incidence
MGI:5548959	Pcx<tm1b(EUCOMM)Wtsi>	MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content|MP:0010379,decreased respiratory quotient|MP:0011100,preweaning lethality, complete penetrance
MGI:6382162	Pcx<tm1c(EUCOMM)Wtsi>	MP:0000189,hypoglycemia|MP:0000609,abnormal liver physiology|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002575,increased circulating ketone body level|MP:0002628,hepatic steatosis|MP:0003564,abnormal insulin secretion|MP:0003839,abnormal insulin clearance|MP:0003917,increased kidney weight|MP:0005292,improved glucose tolerance|MP:0005378,growth/size/body region phenotype|MP:0005560,decreased circulating glucose level|MP:0006036,abnormal mitochondrial physiology|MP:0009355,increased liver triglyceride level|MP:0010180,increased susceptibility to weight loss|MP:0010953,abnormal fatty acid oxidation|MP:0013242,abnormal amino acid metabolism|MP:0013278,decreased fasting circulating glucose level|MP:0013405,increased circulating lactate level|MP:0030973,impaired gluconeogenesis
MGI:5788765	Pcyox1l<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001489,decreased startle reflex|MP:0002574,increased vertical activity|MP:0002834,decreased heart weight|MP:0003795,abnormal bone structure|MP:0003928,increased heart rate variability|MP:0003961,decreased lean body mass|MP:0004122,abnormal sinus arrhythmia|MP:0004738,abnormal auditory brainstem response|MP:0005385,cardiovascular system phenotype|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:2449567	Pcyox1<tm1Sgy>	MP:0002169,no abnormal phenotype detected
MGI:3526522	Pcyt1a<tm1.1Irt>	MP:0001728,failure of embryo implantation|MP:0001730,embryonic growth arrest|MP:0002663,absent blastocoele|MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3027956	Pcyt1a<tm1Irt>	MP:0001177,atelectasis|MP:0001575,cyanosis|MP:0001819,abnormal immune cell physiology|MP:0001954,respiratory distress|MP:0002275,abnormal type II pneumocyte morphology|MP:0002451,abnormal macrophage physiology|MP:0004007,abnormal lung vasculature morphology|MP:0004780,abnormal surfactant secretion|MP:0004781,abnormal surfactant composition|MP:0005317,increased triglyceride level|MP:0010018,pulmonary vascular congestion|MP:0010811,decreased type II pneumocyte number|MP:0010825,abnormal lung saccule morphology|MP:0010890,decreased alveolar lamellar body number|MP:0010902,abnormal pulmonary alveolar sac morphology|MP:0011018,pulmonary hyaline membrane formation|MP:0011087,neonatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014473,increased pulmonary alveolus wall thickness
MGI:3045401	Pcyt1b<tm1Mkar>	MP:0001126,abnormal ovary morphology|MP:0001128,ovary hyperplasia|MP:0001134,absent corpus luteum|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0002020,increased tumor incidence|MP:0002777,absent ovarian follicles|MP:0003205,testicular atrophy
MGI:4415290	Pcyt2<tm1.1Suja>	MP:0000603,pale liver|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level
MGI:3711450	Pcyt2<tm1Mbak>	MP:0002118,abnormal lipid homeostasis|MP:0005389,reproductive system phenotype|MP:0011092,embryonic lethality, complete penetrance
MGI:2665086	Pcyts1<BALB/c>	MP:0010286,increased plasmacytoma incidence
MGI:2665088	Pcyts2<BALB/c>	MP:0010286,increased plasmacytoma incidence
MGI:2665090	Pcyts3<BALB/c>	MP:0010286,increased plasmacytoma incidence
MGI:2665092	Pcyts4<BALB/c>	MP:0010286,increased plasmacytoma incidence
MGI:2665095	Pcyts5<BALB/c>	MP:0010286,increased plasmacytoma incidence
MGI:2665097	Pcyts6<C57BL/6J>	MP:0010286,increased plasmacytoma incidence
MGI:6695800	Pdap1<em1Rkuhn>	MP:0002459,abnormal B cell physiology|MP:0004815,abnormal somatic hypermutation frequency|MP:0004816,abnormal class switch recombination|MP:0006036,abnormal mitochondrial physiology|MP:0008178,decreased germinal center B cell number|MP:0008211,decreased mature B cell number|MP:0008782,increased B cell apoptosis
MGI:5052184	Pdcd10<tm1.1Kwhi>	MP:0001730,embryonic growth arrest|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:5002631	Pdcd10<tm1.1Wami>	MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0001622,abnormal vasculogenesis|MP:0001698,decreased embryo size|MP:0002652,thin myocardium|MP:0003717,pallor|MP:0010503,myocardial trabeculae hypoplasia|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance
MGI:5297592	Pdcd10<tm1Arte>	MP:0002792,abnormal retina vasculature morphology|MP:0004950,abnormal brain vasculature morphology
MGI:5052183	Pdcd10<tm1Kwhi>	MP:0002169,no abnormal phenotype detected|MP:0002652,thin myocardium|MP:0004783,abnormal cardinal vein morphology|MP:0005385,cardiovascular system phenotype|MP:0009382,abnormal cardiac jelly morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5002630	Pdcd10<tm1Wami>	MP:0000260,abnormal angiogenesis|MP:0000291,enlarged pericardium|MP:0000433,microcephaly|MP:0001262,decreased body weight|MP:0001394,circling|MP:0001406,abnormal gait|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002463,abnormal neutrophil physiology|MP:0002652,thin myocardium|MP:0002947,increased hemangioma incidence|MP:0003227,abnormal vascular branching morphogenesis|MP:0003229,abnormal vitelline vasculature morphology|MP:0003354,astrocytosis|MP:0003544,abnormal vascular endothelial cell migration|MP:0003631,nervous system phenotype|MP:0003717,pallor|MP:0003974,abnormal endocardium morphology|MP:0004068,dilated dorsal aorta|MP:0004076,abnormal vitelline vascular remodeling|MP:0004154,renal tubular necrosis|MP:0004783,abnormal cardinal vein morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0004938,dilated vasculature|MP:0004950,abnormal brain vasculature morphology|MP:0005065,abnormal neutrophil morphology|MP:0005238,increased brain size|MP:0005329,abnormal myocardium layer morphology|MP:0005385,cardiovascular system phenotype|MP:0005553,increased circulating creatinine level|MP:0009577,abnormal developmental vascular remodeling|MP:0010503,myocardial trabeculae hypoplasia|MP:0010768,mortality/aging|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012253,abnormal intersomitic vessel morphology|MP:0012676,dilated brain ventricle
MGI:3762772	Pdcd1lg2<tm1.1Lex>	MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3582552	Pdcd1lg2<tm1Dmp>	MP:0002455,abnormal dendritic cell antigen presentation|MP:0003009,abnormal cytokine secretion|MP:0003721,increased tumor growth/size|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005095,decreased T cell proliferation|MP:0008496,decreased IgG2a level|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3688152	Pdcd1lg2<tm1Shr>	MP:0002494,increased IgM level|MP:0005027,increased susceptibility to parasitic infection|MP:0008500,increased IgG2a level
MGI:3720327	Pdcd1lg2<tm2Shr>	MP:0002376,abnormal dendritic cell physiology|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion
MGI:3720328	Pdcd1lg2<tm3Shr>	MP:0001559,hyperglycemia|MP:0004031,insulitis|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008102,lymph node hyperplasia
MGI:5449635	Pdcd1<tm1.1Liux>	MP:0000352,decreased cell proliferation|MP:0003447,decreased tumor growth/size|MP:0004974,decreased regulatory T cell number|MP:0006042,increased apoptosis|MP:0008086,increased T-helper 1 cell number|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:4397682	Pdcd1<tm1.1Shr>	MP:0002983,increased retina ganglion cell number|MP:0004973,increased regulatory T cell number|MP:0004978,decreased B-1 B cell number
MGI:2386184	Pdcd1<tm1Hon>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001544,abnormal cardiovascular system physiology|MP:0001601,abnormal myelopoiesis|MP:0001627,abnormal cardiac output|MP:0001654,hepatic necrosis|MP:0001828,abnormal T cell activation|MP:0001846,increased inflammatory response|MP:0002083,premature death|MP:0002490,abnormal immunoglobulin level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002743,glomerulonephritis|MP:0002750,exophthalmos|MP:0002972,abnormal cardiac muscle contractility|MP:0002993,autoimmune arthritis|MP:0003141,cardiac fibrosis|MP:0003725,increased autoantibody level|MP:0004977,increased B-1 B cell number|MP:0005013,increased lymphocyte cell number|MP:0005014,increased B cell number|MP:0005154,increased B cell proliferation|MP:0005460,abnormal leukopoiesis|MP:0005671,abnormal response to transplant|MP:0008022,dilated heart ventricle|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level|MP:0008566,increased interferon-gamma secretion|MP:0009148,pancreas necrosis|MP:0010857,pulmonary necrosis|MP:0021160,decreased heart right ventricle wall thickness
MGI:3762771	Pdcd1<tm1Llc>	MP:0003009,abnormal cytokine secretion|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:6718514	Pdcd2l<em1Marp>	MP:0011091,prenatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5636894	Pdcd2<tm1b(EUCOMM)Wtsi>	MP:0001340,abnormal eyelid morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5609169	Pdcd2<tm1c(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:4867683	Pdcd2<tm1Jcs>	MP:0001730,embryonic growth arrest|MP:0002718,abnormal inner cell mass morphology|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0003984,embryonic growth retardation|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4418524	Pdcd4<tm1.1Tosc>	MP:0002014,increased papilloma incidence
MGI:3707444	Pdcd4<tm1Yhcn>	MP:0002009,preneoplasia|MP:0002016,ovary cyst|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0003009,abnormal cytokine secretion|MP:0003675,kidney cyst|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0009737,prostate gland cyst
MGI:6257536	Pdcd6ip<em1(IMPC)Hmgu>	MP:0000702,enlarged lymph nodes|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001415,increased exploration in new environment|MP:0004924,abnormal behavior|MP:0005333,decreased heart rate|MP:0005565,increased blood urea nitrogen level|MP:0010052,increased grip strength|MP:0010067,increased red blood cell distribution width|MP:0011940,decreased food intake|MP:0020870,decreased thigmotaxis
MGI:6152606	Pdcd6ip<em1(IMPC)Mbp>	MP:0000470,abnormal stomach morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000774,decreased brain size|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001175,abnormal lung morphology|MP:0001200,thick skin|MP:0001258,decreased body length|MP:0001297,microphthalmia|MP:0001556,increased circulating HDL cholesterol level|MP:0001891,hydrocephaly|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002175,decreased brain weight|MP:0002339,abnormal lymph node morphology|MP:0002834,decreased heart weight|MP:0002989,small kidney|MP:0003883,enlarged stomach|MP:0005565,increased blood urea nitrogen level|MP:0005635,decreased circulating bilirubin level|MP:0008528,polycystic kidney
MGI:5824749	Pdcd6ip<tm1.2Adz>	MP:0000440,domed cranium|MP:0000774,decreased brain size|MP:0000820,abnormal choroid plexus morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001891,hydrocephaly|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0003354,astrocytosis|MP:0006254,thin cerebral cortex|MP:0008283,small hippocampus|MP:0008535,enlarged lateral ventricles|MP:0010152,abnormal brain ependyma morphology|MP:0011056,abnormal brain ependyma motile cilium morphology|MP:0011069,abnormal brain ependyma motile cilium physiology|MP:0013907,abnormal cerebrospinal fluid flow|MP:0030963,abnormal brain ependyma motile cilium location or orientation
MGI:2180799	Pdcd6<tm1Hua>	MP:0002169,no abnormal phenotype detected
MGI:6423840	Pdcd7<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001148,enlarged testis|MP:0001157,small seminal vesicle|MP:0001289,persistence of hyaloid vascular system|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001711,abnormal placenta morphology|MP:0001714,absent trophoblast giant cells|MP:0001727,abnormal embryo implantation|MP:0002626,increased heart rate|MP:0002699,abnormal vitreous body morphology|MP:0004964,absent inner cell mass|MP:0005419,decreased circulating serum albumin level|MP:0010067,increased red blood cell distribution width|MP:0010507,shortened RR interval|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:7546801	Pdcl2<em1Osb>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002686,globozoospermia|MP:0008839,absent acrosome|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0020869,immotile sperm|MP:0031354,abnormal acrosome assembly
MGI:5516193	Pdcl<tm1.1Bmw>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001999,photosensitivity|MP:0003011,delayed dark adaptation|MP:0005253,abnormal eye physiology|MP:0006149,decreased visual acuity|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0012029,abnormal electroretinogram waveform feature|MP:0014336,short retina rod cell outer segment
MGI:4417957	Pdc<tm1Luhe>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000231,hypertension|MP:0001544,abnormal cardiovascular system physiology|MP:0002127,abnormal cardiovascular system morphology|MP:0002546,mydriasis|MP:0002626,increased heart rate|MP:0002975,vascular smooth muscle hypertrophy|MP:0003025,increased vasoconstriction|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005333,decreased heart rate|MP:0005402,abnormal action potential|MP:0005591,decreased vasodilation|MP:0005600,increased heart ventricle muscle contractility|MP:0005665,increased circulating noradrenaline level|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0008772,increased heart ventricle size|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0011478,abnormal urine catecholamine level
MGI:3042204	Pdc<tm1Vya>	MP:0005253,abnormal eye physiology
MGI:6399881	Pde10a<em1(IMPC)H>	MP:0001402,decreased locomotor activity|MP:0002590,increased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0008810,increased circulating iron level
MGI:5823061	Pde10a<tm1.1Njbr>	MP:0001405,impaired coordination|MP:0001516,abnormal motor coordination/balance|MP:0001525,impaired balance|MP:0002757,decreased vertical activity|MP:0005156,bradykinesia
MGI:5610034	Pde10a<tm1Dgen>	MP:0005402,abnormal action potential|MP:0006299,abnormal latent inhibition of conditioning behavior|MP:0012317,impaired conditioning behavior
MGI:3663426	Pde10a<tm1Pfi>	MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001462,abnormal avoidance learning behavior|MP:0005584,abnormal enzyme/coenzyme activity
MGI:5568702	Pde10a<tm1Smsh>	MP:0000188,abnormal circulating glucose level|MP:0001262,decreased body weight|MP:0001560,abnormal circulating insulin level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0002942,decreased circulating alanine transaminase level|MP:0003961,decreased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008907,decreased total fat pad weight|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake
MGI:3794648	Pde10a<tm1(tTA)Yoko>	MP:0001360,abnormal social investigation
MGI:6276934	Pde11a<em1(IMPC)Mbp>	MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0002574,increased vertical activity|MP:0009709,hydrometra
MGI:4462264	Pde11a<tm1Dgen>	MP:0001360,abnormal social investigation|MP:0008535,enlarged lateral ventricles|MP:0009746,enhanced behavioral response to xenobiotic|MP:0031391,increased locomotor activity
MGI:5548813	Pde12<tm1b(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6343412	Pde1a<em1Cjwa>	MP:0000522,kidney cortex cyst|MP:0002136,abnormal kidney physiology|MP:0002843,decreased systemic arterial blood pressure|MP:0003068,enlarged kidney|MP:0003675,kidney cyst|MP:0005389,reproductive system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0011307,kidney medulla cyst|MP:0011925,abnormal heart echocardiography feature|MP:0031635,increased heart left ventricle muscle contractility
MGI:6153806	Pde1a<em1(IMPC)H>	MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0002644,decreased circulating triglyceride level|MP:0003960,increased lean body mass|MP:0005566,decreased blood urea nitrogen level|MP:0010025,decreased total body fat amount
MGI:6343413	Pde1a<em2Cjwa>	MP:0000522,kidney cortex cyst|MP:0002136,abnormal kidney physiology|MP:0002843,decreased systemic arterial blood pressure|MP:0003068,enlarged kidney|MP:0003675,kidney cyst|MP:0005389,reproductive system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0011307,kidney medulla cyst|MP:0011925,abnormal heart echocardiography feature|MP:0031635,increased heart left ventricle muscle contractility
MGI:5614713	Pde1b<tm1b(EUCOMM)Wtsi>	MP:0001399,hyperactivity|MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:2676625	Pde1b<tm1Cvv>	MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001463,abnormal spatial learning
MGI:3604470	Pde1b<tm1Dgen>	MP:0003063,increased coping response
MGI:7425903	Pde1c<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3851438	Pde1c<tm1.1Hazh>	MP:0001983,abnormal olfactory system physiology|MP:0009562,abnormal odor adaptation
MGI:6257817	Pde2a<em1(IMPC)H>	MP:0000219,increased neutrophil cell number|MP:0002644,decreased circulating triglyceride level|MP:0002833,increased heart weight|MP:0005344,increased circulating bilirubin level|MP:0011100,preweaning lethality, complete penetrance
MGI:5427685	Pde2a<tm1Dgen>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:4367746	Pde2a<tm1Dtst>	MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5427686	Pde3a<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3046786	Pde3a<tm1Vman>	MP:0001926,female infertility|MP:0005168,abnormal female meiosis
MGI:5692612	Pde3b<tm1b(KOMP)Wtsi>	MP:0004357,long tibia
MGI:3696665	Pde3b<tm1Yhc>	MP:0001260,increased body weight|MP:0001554,increased circulating free fatty acids level|MP:0002075,abnormal coat/hair pigmentation|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0003058,increased insulin secretion|MP:0003441,increased glycerol level|MP:0003443,increased circulating glycerol level|MP:0005281,increased fatty acids level|MP:0005317,increased triglyceride level|MP:0005331,insulin resistance|MP:0005418,abnormal circulating hormone level|MP:0005459,decreased percent body fat/body weight|MP:0008034,enhanced lipolysis|MP:0009115,abnormal fat cell morphology|MP:0009283,decreased gonadal fat pad weight|MP:0014782,increased liver enzyme/coenzyme level|MP:0030969,increased circulating adiponectin level
MGI:3851439	Pde4a<tm1.1Hazh>	MP:0003631,nervous system phenotype
MGI:3525068	Pde4a<tm1Mct>	MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype
MGI:5648042	Pde4b<enu1H>	MP:0001364,decreased anxiety-related response|MP:0001415,increased exploration in new environment|MP:0001458,abnormal object recognition memory|MP:0002063,abnormal learning/memory/conditioning|MP:0002206,abnormal CNS synaptic transmission|MP:0002574,increased vertical activity|MP:0002917,decreased synaptic depression|MP:0002923,increased post-tetanic potentiation|MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype|MP:0009456,impaired cued conditioning behavior|MP:0009937,abnormal neuron differentiation|MP:0012314,enhanced learning|MP:0014369,enhanced spatial working memory|MP:0020507,increased dendritic spine density
MGI:5427687	Pde4b<tm1Dgen>	MP:0000955,abnormal spinal cord morphology|MP:0008025,brain vacuoles
MGI:2181444	Pde4b<tm1Mct>	MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008561,decreased tumor necrosis factor secretion|MP:0008719,impaired neutrophil recruitment|MP:0008720,impaired neutrophil chemotaxis|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:5585589	Pde4c<tm1.1(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0001489,decreased startle reflex|MP:0005386,behavior/neurological phenotype|MP:0010053,decreased grip strength
MGI:5637006	Pde4dip<tm1b(KOMP)Wtsi>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005564,increased hemoglobin content|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011960,abnormal eye anterior chamber depth|MP:0011962,increased cornea thickness|MP:0011965,decreased total retina thickness
MGI:5613970	Pde4dip<tm1Mhda>	MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0010831,lethality, incomplete penetrance
MGI:2451168	Pde4d<tm1Mct>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0005387,immune system phenotype|MP:0005599,increased cardiac muscle contractility|MP:0008719,impaired neutrophil recruitment|MP:0008720,impaired neutrophil chemotaxis|MP:0008752,abnormal tumor necrosis factor level|MP:0009777,abnormal behavioral response to anesthetic|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031420,decreased superovulation rate
MGI:2451182	Pde4d<tm2Mct>	MP:0011086,postnatal lethality, incomplete penetrance
MGI:6362807	Pde5a<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001258,decreased body length|MP:0002759,abnormal caudal vertebrae morphology
MGI:6368794	Pde5a<em1Laj>	MP:0002169,no abnormal phenotype detected
MGI:5896441	Pde6a<em1(IMPC)Mbp>	MP:0001566,increased circulating phosphate level|MP:0002092,abnormal eye morphology
MGI:6152607	Pde6a<em2(IMPC)Mbp>	MP:0000367,abnormal coat/ hair morphology
MGI:3611307	Pde6a<nmf282>	MP:0001326,retina degeneration|MP:0001327,decreased retina photoreceptor cell number|MP:0002864,abnormal ocular fundus morphology|MP:0008025,brain vacuoles|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008582,short photoreceptor inner segment|MP:0008585,absent photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0012029,abnormal electroretinogram waveform feature|MP:0012671,retina spots
MGI:3828520	Pde6a<nmf363>	MP:0001327,decreased retina photoreceptor cell number|MP:0005551,abnormal eye electrophysiology|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment
MGI:4867884	Pde6a<tvrm58>	MP:0001326,retina degeneration|MP:0002864,abnormal ocular fundus morphology|MP:0008515,thin retina outer nuclear layer
MGI:2178311	Pde6b<atrd1>	MP:0002001,blindness|MP:0006149,decreased visual acuity|MP:0008259,abnormal optic disk morphology|MP:0008515,thin retina outer nuclear layer|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:2178315	Pde6b<atrd2>	MP:0001325,abnormal retina morphology|MP:0002001,blindness|MP:0002864,abnormal ocular fundus morphology|MP:0006149,decreased visual acuity|MP:0008259,abnormal optic disk morphology|MP:0008515,thin retina outer nuclear layer|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:2178316	Pde6b<atrd3>	MP:0001326,retina degeneration|MP:0006149,decreased visual acuity|MP:0008259,abnormal optic disk morphology|MP:0008515,thin retina outer nuclear layer
MGI:1856373	Pde6b<rd1>	MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0002001,blindness|MP:0002864,abnormal ocular fundus morphology|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005253,abnormal eye physiology|MP:0005391,vision/eye phenotype|MP:0005547,abnormal Muller cell morphology|MP:0006149,decreased visual acuity|MP:0006243,impaired pupillary reflex|MP:0006303,abnormal retina nerve fiber layer morphology|MP:0008259,abnormal optic disk morphology|MP:0008454,absent retina rod cells|MP:0008507,thin retina ganglion layer|MP:0008513,thin retina inner plexiform layer|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008519,thin retina outer plexiform layer|MP:0008585,absent photoreceptor outer segment|MP:0010097,abnormal retina blood vessel morphology|MP:0011965,decreased total retina thickness|MP:0031139,abnormal retina artery morphology
MGI:2388259	Pde6b<rd10>	MP:0001005,abnormal retina rod cell morphology|MP:0002792,abnormal retina vasculature morphology|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology|MP:0008451,retina rod cell degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:2178317	Pde6b<rd1-1H>	MP:0001326,retina degeneration
MGI:2178318	Pde6b<rd1-2H>	MP:0001326,retina degeneration
MGI:2665102	Pde6b<rd1-2J>	MP:0001326,retina degeneration|MP:0002792,abnormal retina vasculature morphology|MP:0005551,abnormal eye electrophysiology
MGI:2178319	Pde6b<rd1-3H>	MP:0001326,retina degeneration
MGI:2178320	Pde6b<rd1-4H>	MP:0001326,retina degeneration
MGI:5708282	Pde6b<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity
MGI:2657247	Pde6c<cpfl1>	MP:0003733,abnormal retina inner nuclear layer morphology|MP:0004022,abnormal cone electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008446,decreased retina cone cell number
MGI:6198326	Pde6d<m1Btlr>	MP:0001262,decreased body weight
MGI:3712059	Pde6d<tm1.1Wbae>	MP:0001005,abnormal retina rod cell morphology|MP:0001262,decreased body weight|MP:0001326,retina degeneration|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0008446,decreased retina cone cell number|MP:0008515,thin retina outer nuclear layer|MP:0014336,short retina rod cell outer segment
MGI:3712058	Pde6d<tm1Wbae>	MP:0002169,no abnormal phenotype detected
MGI:2677504	Pde6g<tm1Goff>	MP:0001327,decreased retina photoreceptor cell number|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0005551,abnormal eye electrophysiology|MP:0008584,photoreceptor outer segment degeneration|MP:0008586,disorganized photoreceptor outer segment
MGI:5702758	Pde6h<tm1.1Bewi>	MP:0005391,vision/eye phenotype
MGI:2684009	Pde7a<Gt(Betageo-puro)1Yang>	MP:0001800,abnormal humoral immune response
MGI:6152608	Pde7b<em1(IMPC)Mbp>	MP:0005565,increased blood urea nitrogen level
MGI:7261163	Pde7b<tm1Pfi>	MP:0005387,immune system phenotype
MGI:5694167	Pde8a<tm1b(EUCOMM)Hmgu>	MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount
MGI:3699271	Pde8a<tm1Dgen>	MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003998,decreased thermal nociceptive threshold|MP:0005584,abnormal enzyme/coenzyme activity|MP:0011385,abnormal testosterone level
MGI:5526098	Pde8b<tm1Dgen>	MP:0002664,decreased circulating adrenocorticotropin level|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0011549,increased urine corticosterone level
MGI:5697082	Pde9a<tm1Pfi>	MP:0004486,decreased response of heart to induced stress
MGI:1926817	Pdgfa<tm1Cbet>	MP:0000276,heart right ventricle hypertrophy|MP:0000496,abnormal small intestine morphology|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001175,abnormal lung morphology|MP:0001177,atelectasis|MP:0001182,lung hemorrhage|MP:0001184,absent pulmonary alveoli|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001953,respiratory failure|MP:0001958,emphysema|MP:0002083,premature death|MP:0002631,abnormal epididymis morphology|MP:0002953,thick ventricular wall|MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0004735,enlarged thoracic cavity|MP:0004933,abnormal epididymis epithelium morphology|MP:0006027,impaired lung alveolus development|MP:0010822,pneumothorax|MP:0010900,abnormal pulmonary interalveolar septum morphology|MP:0010901,abnormal pulmonary alveolar parenchyma morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0014079,decreased small intestinal villus number
MGI:5548172	Pdgfa<tm2Cbet>	MP:0005388,respiratory system phenotype|MP:0010768,mortality/aging
MGI:1933334	Pdgfb<tm1Cbet>	MP:0000208,decreased hematocrit|MP:0000274,enlarged heart|MP:0000538,abnormal urinary bladder morphology|MP:0000601,small liver|MP:0001614,abnormal blood vessel morphology|MP:0001786,skin edema|MP:0001914,hemorrhage|MP:0001953,respiratory failure|MP:0002135,abnormal kidney morphology|MP:0002191,abnormal artery morphology|MP:0002590,increased mean corpuscular volume|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002811,macrocytic anemia|MP:0002874,decreased hemoglobin content|MP:0002989,small kidney|MP:0003179,thrombocytopenia|MP:0003231,abnormal placenta vasculature|MP:0003634,abnormal glial cell morphology|MP:0003658,abnormal capillary morphology|MP:0003719,abnormal pericyte morphology|MP:0003920,abnormal heart right ventricle morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0005096,erythroblastosis|MP:0005325,abnormal renal glomerulus morphology|MP:0006055,abnormal vascular endothelial cell morphology|MP:0006056,increased vascular endothelial cell number|MP:0006138,congestive heart failure|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009865,abnormal aorta smooth muscle morphology|MP:0010451,kidney microaneurysm|MP:0010551,abnormal coronary vessel morphology|MP:0010574,dilated aorta|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011428,decreased mesangial cell number|MP:0011429,absent mesangial cell
MGI:2670574	Pdgfb<tm3.1Cbet>	MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0001614,abnormal blood vessel morphology|MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0002092,abnormal eye morphology|MP:0002182,abnormal astrocyte morphology|MP:0002183,gliosis|MP:0002792,abnormal retina vasculature morphology|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0003658,abnormal capillary morphology|MP:0003719,abnormal pericyte morphology|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005264,glomerulosclerosis|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006069,abnormal retina neuronal layer morphology|MP:0006186,retina fibrosis|MP:0011339,abnormal glomerular mesangium morphology|MP:0011353,expanded mesangial matrix|MP:0011428,decreased mesangial cell number|MP:0011509,dilated glomerular capillary|MP:0020329,decreased capillary density|MP:0031384,impaired blood-brain barrier function
MGI:3530825	Pdgfc<Gt(OST91573)Lex>	MP:0005103,abnormal retina pigmentation
MGI:3768438	Pdgfc<tm1.1Hdin>	MP:0001208,blistering|MP:0002239,abnormal nasal septum morphology|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate
MGI:6160167	Pdgfc<tm1b(EUCOMM)Hmgu>	MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0002059,abnormal seminal vesicle morphology|MP:0002135,abnormal kidney morphology|MP:0005333,decreased heart rate|MP:0005553,increased circulating creatinine level|MP:0010067,increased red blood cell distribution width|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011951,increased cardiac stroke volume|MP:0013886,increased CD4-negative, CD25-positive NK T cell number
MGI:3768436	Pdgfc<tm1Hdin>	MP:0002169,no abnormal phenotype detected
MGI:3510799	Pdgfc<tm1Nagy>	MP:0001208,blistering|MP:0001785,edema|MP:0005297,spina bifida occulta|MP:0009883,palatal shelf hypoplasia|MP:0009886,failure of palatal shelf elevation|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009890,cleft secondary palate|MP:0009891,abnormal palate bone morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014079,decreased small intestinal villus number|MP:0030203,short nasal septum
MGI:6341877	Pdgfd<em1(IMPC)Ccpcz>	MP:0000538,abnormal urinary bladder morphology|MP:0002135,abnormal kidney morphology|MP:0005628,decreased circulating potassium level
MGI:6343510	Pdgfd<tm1Ueks>	MP:0000194,increased circulating calcium level|MP:0001260,increased body weight|MP:0001935,decreased litter size|MP:0003020,decreased circulating chloride level|MP:0003719,abnormal pericyte morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005385,cardiovascular system phenotype|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure
MGI:6389062	Pdgfra<em1(IMPC)Ccpcz>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0003068,enlarged kidney|MP:0003917,increased kidney weight|MP:0004924,abnormal behavior|MP:0008039,increased NK T cell number|MP:0010935,increased airway resistance|MP:0011100,preweaning lethality, complete penetrance|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0013520,increased CD4-positive NK T cell number|MP:0013523,increased memory-marker CD4-positive NK T cell number
MGI:2663635	Pdgfra<tm10(Pdgfra/tor)Sor>	MP:0000108,midline facial cleft|MP:0000111,cleft palate|MP:0000158,absent sternum|MP:0000929,open neural tube|MP:0002192,hydrops fetalis|MP:0003054,spina bifida|MP:0004625,abnormal rib joint morphology|MP:0005385,cardiovascular system phenotype|MP:0006113,abnormal heart septum morphology|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5475226	Pdgfra<tm1.1(cre/Esr1*)Nshk>	MP:0005397,hematopoietic system phenotype
MGI:5644346	Pdgfra<tm1.1(EGFP/cre/ERT2)Hyma>	MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype
MGI:2663656	Pdgfra<tm11(EGFP)Sor>	MP:0001712,abnormal placenta development|MP:0002080,prenatal lethality|MP:0003231,abnormal placenta vasculature
MGI:3838514	Pdgfra<tm12.1Sor>	MP:0000150,abnormal rib morphology|MP:0000157,abnormal sternum morphology|MP:0000351,increased cell proliferation|MP:0000470,abnormal stomach morphology|MP:0000534,abnormal ureter morphology|MP:0001176,abnormal lung development|MP:0001699,increased embryo size|MP:0001785,edema|MP:0002722,abnormal immune system organ morphology|MP:0003587,ureter obstruction|MP:0003672,abnormal ureter development|MP:0004194,abnormal kidney pelvis morphology|MP:0004199,increased fetal size|MP:0004202,pulmonary hyperplasia|MP:0004546,esophagus hyperplasia|MP:0006301,abnormal mesenchyme morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011147,increased mesenchymal cell proliferation involved in lung development|MP:0011426,abnormal ureter smooth muscle morphology|MP:0011703,increased fibroblast proliferation|MP:0012279,wide sternum|MP:0020417,increased fibroblast chemotaxis
MGI:3838504	Pdgfra<tm12Sor>	MP:0000494,abnormal cecum morphology|MP:0000496,abnormal small intestine morphology|MP:0001198,tight skin|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0003141,cardiac fibrosis|MP:0003215,renal interstitial fibrosis|MP:0003851,skeletal muscle interstitial fibrosis|MP:0005264,glomerulosclerosis|MP:0006050,pulmonary fibrosis|MP:0008011,intestine polyps|MP:0011294,renal glomerulus hypertrophy|MP:0011377,renal glomerulus fibrosis|MP:0011748,intestinal fibrosis
MGI:3838516	Pdgfra<tm13.1Sor>	MP:0000470,abnormal stomach morphology|MP:0000519,hydronephrosis|MP:0000534,abnormal ureter morphology|MP:0003586,dilated ureter|MP:0003587,ureter obstruction|MP:0004194,abnormal kidney pelvis morphology|MP:0004546,esophagus hyperplasia|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011426,abnormal ureter smooth muscle morphology|MP:0011703,increased fibroblast proliferation
MGI:3838510	Pdgfra<tm13Sor>	MP:0001198,tight skin|MP:0003141,cardiac fibrosis|MP:0003851,skeletal muscle interstitial fibrosis|MP:0005264,glomerulosclerosis|MP:0008011,intestine polyps|MP:0011294,renal glomerulus hypertrophy|MP:0011748,intestinal fibrosis
MGI:1926714	Pdgfra<tm1Sor>	MP:0000102,abnormal nasal bone morphology|MP:0000105,impaired ossification of basisphenoid bone|MP:0000107,abnormal frontal bone morphology|MP:0000108,midline facial cleft|MP:0000109,abnormal parietal bone morphology|MP:0000149,abnormal scapula morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000157,abnormal sternum morphology|MP:0000737,abnormal myotome development|MP:0000757,herniated abdominal wall|MP:0000924,absent roof plate|MP:0000928,incomplete rostral neuropore closure|MP:0000930,wavy neural tube|MP:0001186,pigmentation phenotype|MP:0001218,thin epidermis|MP:0001690,failure of somite differentiation|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001785,edema|MP:0001786,skin edema|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0002990,short ureter|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003054,spina bifida|MP:0003229,abnormal vitelline vasculature morphology|MP:0003939,abnormal myotome morphology|MP:0003984,embryonic growth retardation|MP:0004174,abnormal spine curvature|MP:0004467,absent zygomatic bone|MP:0006042,increased apoptosis|MP:0008856,fetal bleb|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012754,abnormal cranial neural crest cell morphology|MP:0030834,acromion hypoplasia
MGI:1926728	Pdgfra<tm2Sor>	MP:0000102,abnormal nasal bone morphology|MP:0000105,impaired ossification of basisphenoid bone|MP:0000107,abnormal frontal bone morphology|MP:0000108,midline facial cleft|MP:0000109,abnormal parietal bone morphology|MP:0000149,abnormal scapula morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000157,abnormal sternum morphology|MP:0000737,abnormal myotome development|MP:0000757,herniated abdominal wall|MP:0000924,absent roof plate|MP:0000928,incomplete rostral neuropore closure|MP:0000930,wavy neural tube|MP:0001178,pulmonary hypoplasia|MP:0001186,pigmentation phenotype|MP:0001218,thin epidermis|MP:0001690,failure of somite differentiation|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001785,edema|MP:0001786,skin edema|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003054,spina bifida|MP:0003105,abnormal heart atrium morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003924,diaphragmatic hernia|MP:0003939,abnormal myotome morphology|MP:0003984,embryonic growth retardation|MP:0004174,abnormal spine curvature|MP:0004467,absent zygomatic bone|MP:0006042,increased apoptosis|MP:0008856,fetal bleb|MP:0010402,ventricular septal defect|MP:0010440,anomalous pulmonary venous connection|MP:0010441,total anomalous pulmonary venous connection|MP:0010528,pulmonary vein hypoplasia|MP:0010548,abnormal dorsal mesocardium morphology|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011683,dual inferior vena cava|MP:0012251,abnormal diaphragm development|MP:0012754,abnormal cranial neural crest cell morphology|MP:0014808,abnormal pleuroperitoneal fold morphology|MP:0030834,acromion hypoplasia
MGI:2135541	Pdgfra<tm3Sor>	MP:0002169,no abnormal phenotype detected
MGI:2656146	Pdgfra<tm5Sor>	MP:0000157,abnormal sternum morphology|MP:0000920,abnormal myelination|MP:0001265,decreased body size|MP:0001953,respiratory failure|MP:0001958,emphysema|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003054,spina bifida|MP:0004508,abnormal pectoral girdle bone morphology|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2656147	Pdgfra<tm6Sor>	MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0002064,seizures|MP:0002083,premature death|MP:0003312,abnormal locomotor coordination|MP:0005382,craniofacial phenotype|MP:0005390,skeleton phenotype
MGI:2449440	Pdgfra<tm8Sor>	MP:0000102,abnormal nasal bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000108,midline facial cleft|MP:0000445,short snout|MP:0000706,small thymus|MP:0001121,uterus hypoplasia|MP:0001127,small ovary|MP:0001131,abnormal ovarian follicle morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001622,abnormal vasculogenesis|MP:0001914,hemorrhage|MP:0002082,postnatal lethality|MP:0002113,abnormal skeleton development|MP:0002633,persistent truncus arteriosus|MP:0002683,delayed fertility|MP:0002687,oligozoospermia|MP:0004160,retroesophageal right subclavian artery|MP:0004726,abnormal nasal capsule morphology|MP:0005181,decreased circulating estradiol level|MP:0005389,reproductive system phenotype|MP:0005536,decreased Leydig cell number|MP:0006379,abnormal spermatocyte morphology|MP:0006418,abnormal testis cord formation|MP:0008525,decreased cranium height|MP:0008869,anovulation|MP:0009370,decreased theca cell number|MP:0009901,abnormal frontonasal prominence morphology|MP:0010402,ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010441,total anomalous pulmonary venous connection|MP:0010548,abnormal dorsal mesocardium morphology|MP:0011385,abnormal testosterone level|MP:0011683,dual inferior vena cava|MP:0012082,delayed heart development
MGI:2663633	Pdgfra<tm9(Pdgfra/Fgfr1)Sor>	MP:0000111,cleft palate|MP:0000154,rib fusion|MP:0000562,polydactyly|MP:0000929,open neural tube|MP:0003054,spina bifida|MP:0004260,enlarged placenta|MP:0004506,abnormal pubis morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0014166,ectopic cranial bone
MGI:5618619	Pdgfrb<b2b2903Clo>	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0000484,abnormal pulmonary artery morphology|MP:0001823,thymus hypoplasia|MP:0002639,micrognathia|MP:0004158,right aortic arch|MP:0006253,clinodactyly|MP:0008816,petechiae|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010466,vascular ring|MP:0010488,abnormal left subclavian artery morphology
MGI:5617727	Pdgfrb<redeye>	MP:0002792,abnormal retina vasculature morphology|MP:0003070,increased vascular permeability|MP:0003719,abnormal pericyte morphology|MP:0004272,abnormal basement membrane morphology|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005391,vision/eye phenotype|MP:0006203,eye hemorrhage|MP:0006309,decreased retina ganglion cell number|MP:0008067,retina ganglion cell degeneration|MP:0010097,abnormal retina blood vessel morphology|MP:0010098,abnormal retina blood vessel pattern|MP:0014179,abnormal blood-retina barrier function|MP:0030005,increased retina apoptosis
MGI:2682393	Pdgfrb<tm10Sor>	MP:0000533,kidney hemorrhage|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0002081,perinatal lethality|MP:0002192,hydrops fetalis|MP:0011514,skin hemorrhage
MGI:3526812	Pdgfrb<tm11Sor>	MP:0005389,reproductive system phenotype
MGI:5140889	Pdgfrb<tm12(Pdgfrb)Sor>	MP:0002169,no abnormal phenotype detected
MGI:5140888	Pdgfrb<tm13(Pdgfrb)Sor>	MP:0001732,postnatal growth retardation|MP:0010996,increased aorta wall thickness|MP:0011085,postnatal lethality, complete penetrance
MGI:5140883	Pdgfrb<tm14(Pdgfrb)Sor>	MP:0000003,abnormal adipose tissue morphology|MP:0000272,abnormal aorta morphology|MP:0001732,postnatal growth retardation|MP:0002169,no abnormal phenotype detected|MP:0002792,abnormal retina vasculature morphology|MP:0002970,abnormal white adipose tissue morphology|MP:0003658,abnormal capillary morphology|MP:0003719,abnormal pericyte morphology|MP:0004113,abnormal aortic arch morphology|MP:0004950,abnormal brain vasculature morphology|MP:0005336,abnormal inguinal fat pad morphology|MP:0005375,adipose tissue phenotype|MP:0005378,growth/size/body region phenotype|MP:0005489,vascular smooth muscle hyperplasia|MP:0008903,abnormal mesenteric fat pad morphology|MP:0009130,increased white fat cell number|MP:0009867,abnormal ascending aorta morphology|MP:0009869,abnormal descending aorta morphology|MP:0009870,abnormal abdominal aorta morphology|MP:0009873,abnormal aorta tunica media morphology|MP:0010468,abnormal thoracic aorta morphology|MP:0010574,dilated aorta|MP:0010768,mortality/aging|MP:0010996,increased aorta wall thickness|MP:0011085,postnatal lethality, complete penetrance|MP:0011156,abnormal hypodermis fat layer morphology|MP:0011169,abnormal white fat cell differentation|MP:0031510,increased vascular smooth muscle cell proliferation
MGI:5692911	Pdgfrb<tm1b(EUCOMM)Hmgu>	MP:0000274,enlarged heart|MP:0001552,increased circulating triglyceride level|MP:0002059,abnormal seminal vesicle morphology|MP:0010088,decreased circulating fructosamine level|MP:0011100,preweaning lethality, complete penetrance
MGI:3715030	Pdgfrb<tm1Mdt>	MP:0010418,perimembraneous ventricular septal defect
MGI:3641430	Pdgfrb<tm1Msas>	MP:0000352,decreased cell proliferation|MP:0001360,abnormal social investigation|MP:0001792,impaired wound healing|MP:0002272,abnormal nervous system electrophysiology|MP:0002635,reduced sensorimotor gating|MP:0005164,abnormal response to injury|MP:0006042,increased apoptosis|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0008948,decreased neuron number|MP:0009142,decreased prepulse inhibition
MGI:3511432	Pdgfrb<tm1Rheu>	MP:0003396,abnormal embryonic hematopoiesis|MP:0011706,abnormal fibroblast migration|MP:0013502,decreased fibroblast apoptosis
MGI:2135508	Pdgfrb<tm1Sor>	MP:0000260,abnormal angiogenesis|MP:0000314,schistocytosis|MP:0000533,kidney hemorrhage|MP:0001577,anemia|MP:0001614,abnormal blood vessel morphology|MP:0001914,hemorrhage|MP:0002192,hydrops fetalis|MP:0002447,abnormal erythrocyte morphology|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0003179,thrombocytopenia|MP:0003231,abnormal placenta vasculature|MP:0003717,pallor|MP:0003719,abnormal pericyte morphology|MP:0004125,abnormal venule morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0005097,polychromatophilia|MP:0005602,decreased angiogenesis|MP:0006055,abnormal vascular endothelial cell morphology|MP:0006056,increased vascular endothelial cell number|MP:0008137,absent podocytes|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009395,increased nucleated erythrocyte cell number|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011359,decreased glomerular capillary number|MP:0011429,absent mesangial cell|MP:0011437,glomerulus hemorrhage|MP:0011515,purpura
MGI:3641437	Pdgfrb<tm2Msas>	MP:0005164,abnormal response to injury
MGI:2135519	Pdgfrb<tm2Sor>	MP:0000314,schistocytosis|MP:0000533,kidney hemorrhage|MP:0001577,anemia|MP:0001914,hemorrhage|MP:0002192,hydrops fetalis|MP:0002447,abnormal erythrocyte morphology|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0003179,thrombocytopenia|MP:0003717,pallor|MP:0004125,abnormal venule morphology|MP:0005097,polychromatophilia|MP:0008137,absent podocytes|MP:0009395,increased nucleated erythrocyte cell number|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011359,decreased glomerular capillary number|MP:0011429,absent mesangial cell|MP:0011437,glomerulus hemorrhage|MP:0011515,purpura
MGI:2135532	Pdgfrb<tm3Sor>	MP:0003719,abnormal pericyte morphology
MGI:2135533	Pdgfrb<tm4Sor>	MP:0002136,abnormal kidney physiology|MP:0003719,abnormal pericyte morphology|MP:0005327,abnormal mesangial cell morphology|MP:0005385,cardiovascular system phenotype|MP:0011441,decreased kidney cell proliferation|MP:0011704,decreased fibroblast proliferation
MGI:2135534	Pdgfrb<tm5Sor>	MP:0000274,enlarged heart|MP:0005165,increased susceptibility to injury|MP:0011508,abnormal glomerular capillary thrombosis
MGI:2682372	Pdgfrb<tm7Sor>	MP:0001614,abnormal blood vessel morphology|MP:0003719,abnormal pericyte morphology
MGI:2682376	Pdgfrb<tm8Sor>	MP:0000530,abnormal kidney vasculature morphology|MP:0001614,abnormal blood vessel morphology|MP:0003719,abnormal pericyte morphology|MP:0005325,abnormal renal glomerulus morphology
MGI:2682377	Pdgfrb<tm9Sor>	MP:0000530,abnormal kidney vasculature morphology|MP:0001614,abnormal blood vessel morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003719,abnormal pericyte morphology|MP:0003727,abnormal retina layer morphology
MGI:5755394	Pdgfrl<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0005564,increased hemoglobin content
MGI:2386704	Pdha1<tm1.1Ptl>	MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0011092,embryonic lethality, complete penetrance
MGI:2386703	Pdha1<tm1Ptl>	MP:0000781,decreased corpus callosum size|MP:0000832,abnormal thalamus morphology|MP:0000852,small cerebellum|MP:0000880,decreased Purkinje cell number|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001125,abnormal oocyte morphology|MP:0001260,increased body weight|MP:0001926,female infertility|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002625,heart left ventricle hypertrophy|MP:0002833,increased heart weight|MP:0003921,abnormal heart left ventricle morphology|MP:0004079,abnormal putamen morphology|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005168,abnormal female meiosis|MP:0005237,abnormal olfactory tract morphology|MP:0008026,abnormal brain white matter morphology|MP:0008547,abnormal neocortex morphology|MP:0008931,abnormal paraventricular thalamic nucleus morphology|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0009976,abnormal cerebellar peduncle morphology|MP:0009979,abnormal cerebellum deep nucleus morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012736,abnormal polar body morphology|MP:0014447,impaired spindle assembly in female meiosis|MP:0020554,decreased stria medullaris size
MGI:6257440	Pdha2<em1(IMPC)Bay>	MP:0000689,abnormal spleen morphology
MGI:6257416	Pdhb<em1(IMPC)Bay>	MP:0001691,abnormal somite shape|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0002151,abnormal neural tube morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003232,abnormal forebrain development|MP:0003984,embryonic growth retardation|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5613640	Pdhx<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness
MGI:6399889	Pdia3<em1(IMPC)Hmgu>	MP:0000367,abnormal coat/ hair morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:4456212	Pdia3<Gt(RST003)Byg>	MP:0001698,decreased embryo size|MP:0005621,abnormal cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4128251	Pdia3<Gt(RST613)Byg>	MP:0000130,abnormal trabecular bone morphology|MP:0010868,increased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0010968,decreased compact bone area|MP:0011091,prenatal lethality, complete penetrance
MGI:3664743	Pdia3<tm1.1Gjh>	MP:0011091,prenatal lethality, complete penetrance
MGI:3664742	Pdia3<tm1Gjh>	MP:0002459,abnormal B cell physiology
MGI:5636896	Pdia4<tm1b(EUCOMM)Wtsi>	MP:0005343,increased circulating aspartate transaminase level|MP:0005397,hematopoietic system phenotype|MP:0005606,increased bleeding time|MP:0009448,decreased platelet ATP level|MP:0009549,decreased platelet aggregation|MP:0010090,increased circulating creatine kinase level
MGI:6456065	Pdia6<em1Btlr>	MP:0011100,preweaning lethality, complete penetrance
MGI:6456064	Pdia6<m1Btlr>	MP:0001262,decreased body weight|MP:0005387,immune system phenotype
MGI:5605786	Pdia6<tm1b(EUCOMM)Hmgu>	MP:0000702,enlarged lymph nodes|MP:0001406,abnormal gait|MP:0003961,decreased lean body mass|MP:0005355,enlarged thyroid gland|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0013519,decreased CD4-positive NK T cell number
MGI:6152611	Pdik1l<em1(IMPC)Mbp>	MP:0000208,decreased hematocrit|MP:0000274,enlarged heart|MP:0000367,abnormal coat/ hair morphology|MP:0000538,abnormal urinary bladder morphology|MP:0000598,abnormal liver morphology|MP:0000639,abnormal adrenal gland morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001200,thick skin|MP:0001293,anophthalmia|MP:0001510,abnormal coat appearance|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002631,abnormal epididymis morphology|MP:0002875,decreased erythrocyte cell number|MP:0004931,enlarged epididymis|MP:0004952,increased spleen weight|MP:0010067,increased red blood cell distribution width
MGI:5316367	Pdilt<tm1Osb>	MP:0001925,male infertility|MP:0004543,abnormal sperm physiology|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0031012,impaired sperm migration in female genital tract
MGI:5695937	Pdk1<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis
MGI:4436144	Pdk1<tm1a(EUCOMM)Hmgu>	MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype|MP:0010768,mortality/aging
MGI:6711986	Pdk1<tm1b(EUCOMM)Hmgu>	MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype|MP:0010768,mortality/aging
MGI:6276955	Pdk2<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001297,microphthalmia|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002339,abnormal lymph node morphology|MP:0003068,enlarged kidney
MGI:3521813	Pdk2<tm1Rhar>	MP:0002841,impaired skeletal muscle contractility
MGI:3521806	Pdk4<tm1Rhar>	MP:0001554,increased circulating free fatty acids level|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002575,increased circulating ketone body level|MP:0003439,abnormal glycerol level|MP:0005292,improved glucose tolerance|MP:0005311,abnormal circulating amino acid level|MP:0005560,decreased circulating glucose level|MP:0009642,abnormal blood homeostasis|MP:0010398,decreased liver glycogen level|MP:0013404,decreased circulating lactate level|MP:0030674,decreased circulating alanine level|MP:0030970,ketosis
MGI:5307906	Pdk4<tm1Tok>	MP:0000130,abnormal trabecular bone morphology|MP:0004982,abnormal osteoclast morphology|MP:0004983,abnormal osteoclast cell number|MP:0008396,abnormal osteoclast differentiation|MP:0009345,abnormal trabecular bone thickness|MP:0010874,abnormal bone volume|MP:0010877,abnormal trabecular bone volume
MGI:4045825	Pdlim1<Gt(IST12013D3)Tigm>	MP:0005048,abnormal thrombosis|MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology|MP:0009586,increased platelet aggregation
MGI:4124892	Pdlim1<Gt(XC262)Byg>	MP:0002599,increased mean platelet volume|MP:0005048,abnormal thrombosis|MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology|MP:0009446,abnormal platelet dense granule physiology|MP:0009586,increased platelet aggregation
MGI:3623895	Pdlim2<tm1Gru>	MP:0002412,increased susceptibility to bacterial infection|MP:0005465,abnormal T-helper 1 physiology|MP:0008566,increased interferon-gamma secretion
MGI:2385940	Pdlim3<tm1Dsb>	MP:0002169,no abnormal phenotype detected
MGI:2388199	Pdlim3<tm1Krc>	MP:0000295,trabecula carnea hypoplasia|MP:0001785,edema|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0003393,decreased cardiac output|MP:0003920,abnormal heart right ventricle morphology|MP:0006065,abnormal heart position or orientation|MP:0010428,abnormal heart right ventricle outflow tract morphology|MP:0010725,thin interventricular septum|MP:0011101,prenatal lethality, incomplete penetrance|MP:0021160,decreased heart right ventricle wall thickness|MP:0031634,decreased heart right ventricle muscle contractility
MGI:7425904	Pdlim4<em1(IMPC)Ics>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001944,abnormal pancreas morphology|MP:0002764,short tibia|MP:0002797,increased thigmotaxis|MP:0004924,abnormal behavior|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level
MGI:4126899	Pdlim5<Gt(XH199)Byg>	MP:0001402,decreased locomotor activity|MP:0002573,behavioral despair|MP:0003088,abnormal prepulse inhibition|MP:0005386,behavior/neurological phenotype|MP:0008770,decreased survivor rate|MP:0009750,impaired behavioral response to addictive substance
MGI:5284898	Pdlim5<tm1.1Chen>	MP:0000266,abnormal heart morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0002972,abnormal cardiac muscle contractility|MP:0003822,decreased left ventricle systolic pressure|MP:0004091,abnormal Z line morphology|MP:0005389,reproductive system phenotype|MP:0010579,increased heart left ventricle size|MP:0010695,abnormal blood pressure regulation|MP:0010768,mortality/aging
MGI:5284897	Pdlim5<tm1Chen>	MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0031633,decreased heart left ventricle muscle contractility
MGI:6293849	Pdlim7<em1(IMPC)Mbp>	MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology|MP:0002599,increased mean platelet volume|MP:0002699,abnormal vitreous body morphology
MGI:4319956	Pdlim7<Gt(OST445990)Lex>	MP:0000220,increased monocyte cell number|MP:0000286,abnormal mitral valve morphology|MP:0001262,decreased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0002624,abnormal tricuspid valve morphology|MP:0002745,abnormal atrioventricular valve morphology|MP:0003140,dilated heart atrium|MP:0004938,dilated vasculature|MP:0005013,increased lymphocyte cell number|MP:0005048,abnormal thrombosis|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005607,decreased bleeding time|MP:0010018,pulmonary vascular congestion|MP:0010613,abnormal mitral valve annulus morphology|MP:0010621,abnormal tricuspid valve annulus morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0020409,abnormal cardiac thrombosis
MGI:6152612	Pdp1<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001926,female infertility|MP:0002699,abnormal vitreous body morphology|MP:0002833,increased heart weight|MP:0005292,improved glucose tolerance|MP:0010053,decreased grip strength
MGI:6755467	Pdp2<em1(IMPC)J>	MP:0001304,cataract
MGI:3530735	Pdpk1<Gt(OST82857)Lex>	MP:0011091,prenatal lethality, complete penetrance
MGI:4838167	Pdpk1<tm1.1Daca>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2677461	Pdpk1<tm1.1Mlw>	MP:0000266,abnormal heart morphology|MP:0000276,heart right ventricle hypertrophy|MP:0000278,abnormal myocardial fiber morphology|MP:0000280,thin ventricular wall|MP:0001262,decreased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0002083,premature death|MP:0002127,abnormal cardiovascular system morphology|MP:0002169,no abnormal phenotype detected|MP:0002188,small heart|MP:0002795,dilated cardiomyopathy|MP:0003920,abnormal heart right ventricle morphology|MP:0004091,abnormal Z line morphology|MP:0004565,decreased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005294,abnormal heart ventricle morphology|MP:0008725,increased heart atrium size|MP:0010500,myocardium hypoplasia
MGI:2677462	Pdpk1<tm1.2Mlw>	MP:0001293,anophthalmia|MP:0001685,abnormal endoderm development|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001726,abnormal allantois morphology|MP:0002085,abnormal embryonic tissue morphology|MP:0003874,absent pharyngeal arches|MP:0003885,abnormal rostral-caudal body axis extension|MP:0004559,small allantois|MP:0006386,absent somites|MP:0008460,absent dorsal root ganglion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011259,abnormal cephalic neural fold morphology|MP:0011388,absent heart|MP:0012081,absent heart tube|MP:0012136,absent forebrain|MP:0012176,abnormal head development|MP:0012182,abnormal presomitic mesoderm morphology|MP:0012745,abnormal neural crest cell physiology
MGI:3608995	Pdpk1<tm1Bcol>	MP:0000088,short mandible|MP:0000428,abnormal craniofacial morphology|MP:0000550,abnormal forelimb morphology|MP:0001324,abnormal eye pigmentation|MP:0001698,decreased embryo size|MP:0011089,perinatal lethality, complete penetrance
MGI:3795190	Pdpk1<tm1Dral>	MP:0000692,small spleen|MP:0000774,decreased brain size|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0002079,increased circulating insulin level|MP:0002706,abnormal kidney size|MP:0004247,small pancreas|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005491,pancreatic islet hyperplasia|MP:0009169,pancreatic islet hypoplasia|MP:0014287,decreased adrenal gland zona fasciculata size
MGI:3043781	Pdpk1<tm1Ejm>	MP:0000783,abnormal forebrain morphology|MP:0000913,abnormal brain development|MP:0001622,abnormal vasculogenesis|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0002086,abnormal extraembryonic tissue morphology|MP:0006337,abnormal first pharyngeal arch morphology|MP:0008460,absent dorsal root ganglion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012138,decreased forebrain size
MGI:3790718	Pdpk1<tm1Jcbr>	MP:0001260,increased body weight|MP:0001433,polyphagia|MP:0002078,abnormal glucose homeostasis|MP:0002665,decreased circulating corticosterone level|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0005292,improved glucose tolerance|MP:0005559,increased circulating glucose level|MP:0005560,decreased circulating glucose level|MP:0005667,abnormal circulating leptin level|MP:0008324,abnormal melanotroph morphology|MP:0008341,decreased corticotroph cell number|MP:0009283,decreased gonadal fat pad weight
MGI:3628819	Pdpk1<tm1Maka>	MP:0000189,hypoglycemia|MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0001926,female infertility|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002665,decreased circulating corticosterone level|MP:0002693,abnormal pancreas physiology|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003718,maternal effect|MP:0004811,abnormal neuron physiology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0008130,abnormal pituitary intermediate lobe morphology|MP:0009172,small pancreatic islets|MP:0010024,increased total body fat amount|MP:0011939,increased food intake|MP:0013344,increased pituitary gland apoptosis|MP:0013346,increased melanotroph apoptosis|MP:0013347,increased corticotroph apoptosis|MP:0014441,decreased response to leptin
MGI:2677460	Pdpk1<tm1Mlw>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002145,abnormal T cell differentiation|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005018,decreased T cell number|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008036,abnormal NK T cell morphology|MP:0008040,decreased NK T cell number|MP:0008041,absent NK T cells|MP:0009703,decreased birth body size|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3043785	Pdpk1<tm2Ejm>	MP:0000913,abnormal brain development|MP:0002084,abnormal developmental patterning|MP:0003631,nervous system phenotype|MP:0003984,embryonic growth retardation|MP:0005380,embryo phenotype|MP:0005385,cardiovascular system phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012138,decreased forebrain size
MGI:3775822	Pdpn<tm1Acgg>	MP:0000267,abnormal heart development|MP:0000281,abnormal interventricular septum morphology|MP:0000301,decreased atrioventricular cushion size|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002652,thin myocardium|MP:0004056,abnormal myocardium compact layer morphology|MP:0004111,abnormal coronary artery morphology|MP:0005329,abnormal myocardium layer morphology|MP:0010426,abnormal heart and great artery attachment|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0031589,detached epicardium
MGI:5548337	Pdpn<tm1b(EUCOMM)Wtsi>	MP:0000194,increased circulating calcium level|MP:0001284,absent vibrissae|MP:0005178,increased circulating cholesterol level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3641576	Pdpn<tm1Bwd>	MP:0001953,respiratory failure|MP:0005390,skeleton phenotype|MP:0009432,increased fetal weight|MP:0011087,neonatal lethality, complete penetrance
MGI:4820841	Pdpn<tm1(cre)Mlkn>	MP:0001879,abnormal lymphatic vessel morphology|MP:0003288,intestinal edema|MP:0005376,homeostasis/metabolism phenotype
MGI:2657021	Pdpn<tm1Mcws>	MP:0001175,abnormal lung morphology|MP:0001177,atelectasis|MP:0001179,thick pulmonary interalveolar septum|MP:0001575,cyanosis|MP:0001879,abnormal lymphatic vessel morphology|MP:0001953,respiratory failure|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002274,abnormal type I pneumocyte morphology|MP:0003390,lymphedema|MP:0003659,abnormal lymph circulation|MP:0004038,lymphangiectasis|MP:0004197,abnormal fetal growth/weight/body size|MP:0005202,lethargy|MP:0009931,abnormal skin appearance|MP:0011087,neonatal lethality, complete penetrance
MGI:5552845	Pdpn<tm2.1Mlkn>	MP:0001614,abnormal blood vessel morphology|MP:0001914,hemorrhage|MP:0002339,abnormal lymph node morphology|MP:0003070,increased vascular permeability|MP:0008464,absent peripheral lymph nodes|MP:0008778,abnormal lymphangiogenesis|MP:0031051,lymph node hemorrhage
MGI:6120785	Pdpr<tm1b(EUCOMM)Wtsi>	MP:0001402,decreased locomotor activity|MP:0002608,increased hematocrit|MP:0005278,abnormal cholesterol homeostasis|MP:0005292,improved glucose tolerance|MP:0005554,decreased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0012361,decreased large unstained cell number|MP:0013279,increased fasting circulating glucose level
MGI:3847257	Pds5a<Gt(RRM243)Byg>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000157,abnormal sternum morphology|MP:0000266,abnormal heart morphology|MP:0000284,double outlet right ventricle|MP:0000520,absent kidney|MP:0001044,abnormal enteric nervous system morphology|MP:0001954,respiratory distress|MP:0003446,renal hypoplasia|MP:0003604,single kidney|MP:0003631,nervous system phenotype|MP:0004505,decreased renal glomerulus number|MP:0004607,abnormal cervical atlas morphology|MP:0004615,cervical vertebral transformation|MP:0004620,cervical vertebral fusion|MP:0005389,reproductive system phenotype|MP:0008148,abnormal sternocostal joint morphology|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0011087,neonatal lethality, complete penetrance
MGI:5563475	Pds5a<tm1.1Alos>	MP:0000379,decreased hair follicle number|MP:0001780,decreased brown adipose tissue amount|MP:0002060,abnormal skin morphology|MP:0003419,delayed endochondral bone ossification|MP:0004046,abnormal mitosis|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0008276,failure of intramembranous bone ossification|MP:0009267,abnormal cerebellum fissure morphology|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3850477	Pds5b<Tg(Wap-ERBB2)229Wzw>	MP:0002169,no abnormal phenotype detected
MGI:5563482	Pds5b<tm1.2Alos>	MP:0000352,decreased cell proliferation|MP:0001780,decreased brown adipose tissue amount|MP:0003111,abnormal cell nucleus morphology|MP:0003702,abnormal chromosome morphology|MP:0003708,binucleate|MP:0004024,aneuploidy|MP:0004046,abnormal mitosis|MP:0011101,prenatal lethality, incomplete penetrance|MP:0031678,increased micronucleus incidence
MGI:3722688	Pds5b<tm1Jmi>	MP:0000060,delayed bone ossification|MP:0000088,short mandible|MP:0000154,rib fusion|MP:0000266,abnormal heart morphology|MP:0000433,microcephaly|MP:0000445,short snout|MP:0000547,short limbs|MP:0001011,abnormal superior cervical ganglion morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002114,abnormal axial skeleton morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002209,decreased germ cell number|MP:0003056,abnormal hyoid bone morphology|MP:0003345,decreased rib number|MP:0003717,pallor|MP:0003723,abnormal long bone morphology|MP:0003743,abnormal facial morphology|MP:0004201,fetal growth retardation|MP:0004321,short sternum|MP:0004340,short scapula|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004901,decreased male germ cell number|MP:0005225,abnormal vertebrae development|MP:0008277,abnormal sternum ossification|MP:0008312,abnormal sympathetic postganglionic fiber morphology|MP:0009703,decreased birth body size|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0009891,abnormal palate bone morphology|MP:0010402,ventricular septal defect|MP:0010405,ostium secundum atrial septal defect|MP:0010413,complete atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0030168,thin upper lip|MP:0030243,abnormal chin morphology|MP:0030244,short chin
MGI:6152613	Pdss1<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000639,abnormal adrenal gland morphology|MP:0001126,abnormal ovary morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0004832,enlarged ovary|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:1856927	Pdss2<kd>	MP:0000751,myopathy|MP:0001263,weight loss|MP:0001426,polydipsia|MP:0001505,hunched posture|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0002871,albuminuria|MP:0003215,renal interstitial fibrosis|MP:0003674,oxidative stress|MP:0003675,kidney cyst|MP:0004969,pale kidney|MP:0004970,kidney atrophy|MP:0005264,glomerulosclerosis|MP:0005319,abnormal enzyme/coenzyme level|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0006035,abnormal mitochondrial morphology|MP:0008140,podocyte foot process effacement|MP:0010954,abnormal cellular respiration|MP:0010955,abnormal respiratory electron transport chain|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011346,renal tubule atrophy|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011402,renal cast|MP:0011405,tubulointerstitial nephritis|MP:0011413,colorless urine|MP:0011498,abnormal glomerular capsule parietal layer morphology|MP:0011534,granular kidney|MP:0011639,decreased mitochondrial DNA content|MP:0014388,decreased hepatocyte mitochondrial DNA content|MP:0030937,increased mitochondrial DNA content
MGI:3797369	Pdss2<tm1.1Dalg>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5304520	Pdss2<tm1.2Jdhu>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5692707	Pdss2<tm1b(EUCOMM)Hmgu>	MP:0001304,cataract|MP:0001364,decreased anxiety-related response|MP:0002100,abnormal tooth morphology|MP:0003179,thrombocytopenia|MP:0004609,vertebral fusion|MP:0005344,increased circulating bilirubin level|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0020870,decreased thigmotaxis
MGI:3797368	Pdss2<tm1Dalg>	MP:0000180,abnormal circulating cholesterol level|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002871,albuminuria|MP:0005178,increased circulating cholesterol level|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005448,abnormal energy homeostasis|MP:0010955,abnormal respiratory electron transport chain|MP:0010957,abnormal aerobic respiration|MP:0011405,tubulointerstitial nephritis|MP:0014046,abnormal mitophagy
MGI:1856988	pdw	MP:0001265,decreased body size|MP:0005390,skeleton phenotype|MP:0008770,decreased survivor rate|MP:0008974,proportional dwarf|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4359453	Pdx1<tm1.1Stof>	MP:0001559,hyperglycemia|MP:0002727,decreased circulating insulin level|MP:0003934,abnormal pancreas development|MP:0005218,abnormal pancreatic delta cell morphology|MP:0005293,impaired glucose tolerance|MP:0005379,endocrine/exocrine gland phenotype|MP:0009111,pancreas hypoplasia|MP:0009114,decreased pancreatic beta cell mass|MP:0009169,pancreatic islet hypoplasia|MP:0009184,abnormal PP cell morphology|MP:0009189,abnormal pancreatic epsilon cell morphology|MP:0011911,abnormal pancreatic endocrine progenitor cell physiology|MP:0030588,decreased pancreatic alpha cell mass
MGI:5587047	Pdx1<tm1b(EUCOMM)Wtsi>	MP:0005293,impaired glucose tolerance|MP:0011100,preweaning lethality, complete penetrance
MGI:2181360	Pdx1<tm1Cvw>	MP:0000416,sparse hair|MP:0000470,abnormal stomach morphology|MP:0000474,abnormal foregut morphology|MP:0000496,abnormal small intestine morphology|MP:0000596,abnormal liver development|MP:0001199,thin skin|MP:0001262,decreased body weight|MP:0001429,dehydration|MP:0001732,postnatal growth retardation|MP:0002929,abnormal bile duct development|MP:0003059,decreased insulin secretion|MP:0003271,abnormal duodenum morphology|MP:0003339,decreased pancreatic beta cell number|MP:0003562,abnormal pancreatic beta cell physiology|MP:0003655,absent pancreas|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005379,endocrine/exocrine gland phenotype|MP:0005559,increased circulating glucose level|MP:0009143,abnormal pancreatic duct morphology|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009170,abnormal pancreatic islet size|MP:0009172,small pancreatic islets|MP:0009175,abnormal pancreatic beta cell differentiation|MP:0009254,disorganized pancreatic islets|MP:0009861,abnormal pyloric sphincter morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0012520,absent Brunner's glands|MP:0014117,increased pancreatic beta cell apoptosis
MGI:3688420	Pdx1<tm1Egs>	MP:0002169,no abnormal phenotype detected
MGI:3603310	Pdx1<tm1Heed>	MP:0001759,increased urine glucose level|MP:0003339,decreased pancreatic beta cell number|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005215,abnormal pancreatic islet morphology|MP:0005559,increased circulating glucose level|MP:0009176,increased pancreatic alpha cell number|MP:0009254,disorganized pancreatic islets
MGI:2388676	Pdx1<tm1Macd>	MP:0005293,impaired glucose tolerance|MP:0005370,liver/biliary system phenotype
MGI:2152755	Pdx1<tm1Ted>	MP:0000497,abnormal small intestine placement|MP:0001265,decreased body size|MP:0001869,pancreas inflammation|MP:0003059,decreased insulin secretion|MP:0003655,absent pancreas|MP:0003934,abnormal pancreas development|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005370,liver/biliary system phenotype|MP:0005387,immune system phenotype|MP:0005559,increased circulating glucose level|MP:0009114,decreased pancreatic beta cell mass|MP:0009168,decreased pancreatic islet number|MP:0009172,small pancreatic islets|MP:0009488,abnormal pancreatic islet cell apoptosis|MP:0011085,postnatal lethality, complete penetrance|MP:0014116,abnormal pancreatic beta cell apoptosis
MGI:2181362	Pdx1<tm2Cvw>	MP:0000416,sparse hair|MP:0000470,abnormal stomach morphology|MP:0000474,abnormal foregut morphology|MP:0000477,abnormal intestine morphology|MP:0000496,abnormal small intestine morphology|MP:0000596,abnormal liver development|MP:0001199,thin skin|MP:0001262,decreased body weight|MP:0001429,dehydration|MP:0001732,postnatal growth retardation|MP:0002710,increased glucagon secretion|MP:0002929,abnormal bile duct development|MP:0003059,decreased insulin secretion|MP:0003271,abnormal duodenum morphology|MP:0003562,abnormal pancreatic beta cell physiology|MP:0003655,absent pancreas|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0009143,abnormal pancreatic duct morphology|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009175,abnormal pancreatic beta cell differentiation|MP:0009511,distended stomach|MP:0009861,abnormal pyloric sphincter morphology|MP:0010785,abnormal stomach pyloric region morphology|MP:0010803,abnormal stomach enteroendocrine cell morphology|MP:0010958,abnormal tricarboxylic acid cycle|MP:0011085,postnatal lethality, complete penetrance|MP:0014125,decreased amylin secretion
MGI:3702893	Pdx1<tm3Cvw>	MP:0002727,decreased circulating insulin level|MP:0003934,abnormal pancreas development|MP:0004141,abnormal enteroendocrine cell morphology|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0009176,increased pancreatic alpha cell number|MP:0009185,increased PP cell number|MP:0009254,disorganized pancreatic islets|MP:0011085,postnatal lethality, complete penetrance
MGI:3702084	Pdx1<tm4Cvw>	MP:0002169,no abnormal phenotype detected
MGI:6257615	Pdxdc1<em1(IMPC)Tcp>	MP:0001120,abnormal uterus morphology|MP:0001157,small seminal vesicle|MP:0001258,decreased body length|MP:0002060,abnormal skin morphology|MP:0020422,decreased freezing behavior
MGI:4441874	Pdxk<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6357839	Pdxp<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0001399,hyperactivity|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0010124,decreased bone mineral content
MGI:6367624	Pdxp<tm1.1Ango>	MP:0010052,increased grip strength|MP:0010053,decreased grip strength
MGI:6367625	Pdxp<tm1.2Ango>	MP:0000747,muscle weakness|MP:0001363,increased anxiety-related response|MP:0002572,abnormal emotion/affect behavior|MP:0002797,increased thigmotaxis|MP:0005332,abnormal amino acid level|MP:0005389,reproductive system phenotype|MP:0005400,abnormal vitamin level|MP:0008414,abnormal spatial reference memory|MP:0010053,decreased grip strength|MP:0010768,mortality/aging|MP:0012306,enhanced spatial learning|MP:0030642,decreased methionine level|MP:0030659,decreased glycine level|MP:0030691,increased serine level|MP:0030698,decreased phenylalanine level|MP:0030700,increased threonine level|MP:0030707,decreased glutamine level|MP:0030732,increased gamma-aminobutyric acid level|MP:0031640,increased alanine level
MGI:6148321	Pdyn<em1(IMPC)Rbrc>	MP:0003179,thrombocytopenia|MP:0004152,abnormal circulating iron level
MGI:3715202	Pdyn<tm1(cre)Czer>	MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001431,abnormal eating behavior|MP:0001745,increased circulating corticosterone level|MP:0001764,abnormal homeostasis|MP:0001783,decreased white adipose tissue amount|MP:0002696,decreased circulating glucagon level|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003867,increased defecation amount|MP:0003961,decreased lean body mass|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004101,abnormal brain interneuron morphology|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005478,decreased circulating thyroxine level|MP:0005534,decreased body temperature|MP:0005560,decreased circulating glucose level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008853,decreased abdominal adipose tissue amount|MP:0010123,increased bone mineral content|MP:0010379,decreased respiratory quotient
MGI:2176368	Pdyn<tm1Ute>	MP:0001362,abnormal anxiety-related response|MP:0001364,decreased anxiety-related response|MP:0001968,abnormal touch/nociception|MP:0002733,abnormal thermal nociception|MP:0005316,abnormal response to tactile stimuli|MP:0009712,impaired conditioned place preference behavior
MGI:3719377	Pdyn<tm1Zim>	MP:0001982,decreased chemically-elicited antinociception|MP:0009712,impaired conditioned place preference behavior
MGI:4130736	Pdzd2<Gt(S3-7A1)Sor>	MP:0002079,increased circulating insulin level|MP:0003058,increased insulin secretion|MP:0003631,nervous system phenotype|MP:0005292,improved glucose tolerance|MP:0005386,behavior/neurological phenotype|MP:0005560,decreased circulating glucose level
MGI:4974441	Pdzd2<Gt(S7-9G1)Sor>	MP:0002079,increased circulating insulin level|MP:0003058,increased insulin secretion|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level
MGI:4329459	Pdzd4<Gt(RRO278)Byg>	MP:0002169,no abnormal phenotype detected
MGI:5792094	Pdzd7<mpc265H>	MP:0001967,deafness
MGI:4433578	Pdzd7<tm1a(EUCOMM)Wtsi>	MP:0001967,deafness|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004414,decreased cochlear microphonics|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0004736,abnormal distortion product otoacoustic emission|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0030961,abnormal outer hair cell kinocilium location or orientation
MGI:5708255	Pdzd8<tm1b(EUCOMM)Wtsi>	MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001473,reduced long-term potentiation|MP:0001552,increased circulating triglyceride level|MP:0001566,increased circulating phosphate level|MP:0001732,postnatal growth retardation|MP:0002098,abnormal vibrissa morphology|MP:0002599,increased mean platelet volume|MP:0002764,short tibia|MP:0002892,decreased superior colliculus size|MP:0002920,decreased paired-pulse facilitation|MP:0004081,abnormal globus pallidus morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0005565,increased blood urea nitrogen level|MP:0008282,enlarged hippocampus|MP:0008432,abnormal long-term spatial reference memory|MP:0008806,increased circulating amylase level|MP:0008914,enlarged cerebellum|MP:0009849,increased vertical stereotypic behavior|MP:0010025,decreased total body fat amount|MP:0010058,enlarged olfactory bulb|MP:0010067,increased red blood cell distribution width|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012362,increased large unstained cell number|MP:0012489,abnormal retrosplenial region morphology|MP:0020527,small thalamus
MGI:3588076	Pdzk1<tm1Dls>	MP:0000598,abnormal liver morphology|MP:0005416,abnormal circulating protein level
MGI:2450706	Pdzk1<tm1Oko>	MP:0005178,increased circulating cholesterol level
MGI:5692756	Pdzk1<tm2b(EUCOMM)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0000562,polydactyly|MP:0000783,abnormal forebrain morphology|MP:0001556,increased circulating HDL cholesterol level|MP:0001879,abnormal lymphatic vessel morphology|MP:0003686,abnormal eye muscle morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0003827,abnormal Wolffian duct morphology|MP:0004613,fusion of vertebral arches|MP:0005178,increased circulating cholesterol level|MP:0010404,ostium primum atrial septal defect|MP:0010412,atrioventricular septal defect|MP:0010440,anomalous pulmonary venous connection|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013840,absent segment of posterior cerebral artery|MP:0013848,subcutaneous edema|MP:0013859,abnormal vitelline vein connection|MP:0013967,abnormal infrahyoid muscle connection|MP:0013970,absent connection between subcutaneous lymph vessels and lymph sac|MP:0013971,blood in lymph vessels|MP:0013977,symmetric azygos veins|MP:0013981,double lumen aortic arch|MP:0014001,abnormal vertebral artery topology
MGI:7510089	Pdzph1<em1(IMPC)Ccpcz>	MP:0000538,abnormal urinary bladder morphology|MP:0002135,abnormal kidney morphology|MP:0002606,increased basophil cell number|MP:0003917,increased kidney weight|MP:0008528,polycystic kidney|MP:0011874,enlarged urinary bladder
MGI:5825050	Pdzrn3<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5708414	Pdzrn3<tm1.1Ysa>	MP:0001711,abnormal placenta morphology|MP:0001723,disorganized yolk sac vascular plexus|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003631,nervous system phenotype|MP:0003984,embryonic growth retardation|MP:0004950,abnormal brain vasculature morphology|MP:0005380,embryo phenotype|MP:0006207,embryonic lethality during organogenesis|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0010664,abnormal vitelline artery morphology|MP:0011521,decreased placental labyrinth size
MGI:2671817	Pea1	MP:0002100,abnormal tooth morphology
MGI:2677021	Pea15a<tm1Chne>	MP:0001262,decreased body weight|MP:0002182,abnormal astrocyte morphology|MP:0003631,nervous system phenotype|MP:0014052,increased male germ cell apoptosis
MGI:6306478	Peak1<em1(IMPC)J>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0001488,increased startle reflex|MP:0003179,thrombocytopenia|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005419,decreased circulating serum albumin level|MP:0005566,decreased blood urea nitrogen level|MP:0005567,decreased circulating total protein level
MGI:6361446	Peak1<tm1.1Klem>	MP:0005602,decreased angiogenesis
MGI:6361447	Peak1<tm1.2Itl>	MP:0000120,malocclusion|MP:0005397,hematopoietic system phenotype|MP:0005602,decreased angiogenesis|MP:0010097,abnormal retina blood vessel morphology|MP:0010144,abnormal tumor vascularization
MGI:4363617	Pear1<tm1a(KOMP)Wtsi>	MP:0005376,homeostasis/metabolism phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0009549,decreased platelet aggregation
MGI:5755025	Pebp1<em1(IMPC)Tcp>	MP:0000063,decreased bone mineral density|MP:0000266,abnormal heart morphology|MP:0000598,abnormal liver morphology|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0001126,abnormal ovary morphology|MP:0001417,decreased exploration in new environment|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002631,abnormal epididymis morphology|MP:0002989,small kidney|MP:0005012,decreased eosinophil cell number|MP:0005084,abnormal gallbladder morphology
MGI:3722117	Pebp1<Gt(AQ0005)Wtsi>	MP:0001984,abnormal olfaction
MGI:6450937	Pebp1<tm1.1Norm>	MP:0003476,decreased summary potential intensity|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0011150,abnormal hippocampus stratum oriens morphology
MGI:1888376	Pecam1<Gt(OST16303)Lex>	MP:0001613,abnormal vasodilation|MP:0003957,abnormal nitric oxide homeostasis|MP:0005591,decreased vasodilation
MGI:2677448	Pecam1<tm1Mak>	MP:0000532,kidney vascular congestion|MP:0001175,abnormal lung morphology|MP:0001860,liver inflammation|MP:0002442,abnormal leukocyte physiology|MP:0002933,joint inflammation|MP:0003009,abnormal cytokine secretion|MP:0003070,increased vascular permeability|MP:0003724,increased susceptibility to induced arthritis|MP:0003828,pulmonary edema|MP:0006027,impaired lung alveolus development|MP:0008566,increased interferon-gamma secretion|MP:0010018,pulmonary vascular congestion|MP:0010019,liver vascular congestion|MP:0010020,spleen vascular congestion|MP:0010902,abnormal pulmonary alveolar sac morphology|MP:0011134,decreased lung endothelial cell migration|MP:0011433,glomerular capillary congestion|MP:0014473,increased pulmonary alveolus wall thickness
MGI:5320611	Pedc	MP:0002075,abnormal coat/hair pigmentation|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011279,decreased ear pigmentation
MGI:5499207	Pedm105	MP:0001566,increased circulating phosphate level
MGI:5499202	Pedm14	MP:0001559,hyperglycemia
MGI:5499197	Pedm15	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001362,abnormal anxiety-related response
MGI:5499198	Pedm25	MP:0000745,tremors|MP:0004924,abnormal behavior
MGI:5499200	Pedm29	MP:0001362,abnormal anxiety-related response|MP:0001399,hyperactivity
MGI:5499196	Pedm32	MP:0002871,albuminuria
MGI:5499204	Pedm35	MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level
MGI:5499199	Pedm36	MP:0001402,decreased locomotor activity|MP:0001513,limb grasping|MP:0002075,abnormal coat/hair pigmentation|MP:0010323,retropulsion
MGI:5499201	Pedm41	MP:0000547,short limbs|MP:0001265,decreased body size|MP:0002110,abnormal digit morphology
MGI:5499203	Pedm42	MP:0002671,belted
MGI:5499206	Pedm52	MP:0002109,abnormal limb morphology|MP:0003051,curly tail|MP:0003054,spina bifida
MGI:5499205	Pedm83	MP:0002546,mydriasis|MP:0003743,abnormal facial morphology|MP:0006211,small orbits|MP:0010030,abnormal orbit morphology
MGI:4363077	Peds1<tm1a(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0000208,decreased hematocrit|MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0002590,increased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003961,decreased lean body mass|MP:0005376,homeostasis/metabolism phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006358,absent pinna reflex|MP:0010088,decreased circulating fructosamine level|MP:0010096,abnormal incisor color|MP:0012216,decreased plasmalogen level|MP:0012218,decreased brain plasmalogen level|MP:0012220,abnormal ether lipid level
MGI:3620548	Peg10<tm1Fuis>	MP:0003122,maternal imprinting|MP:0003403,absent placental labyrinth|MP:0003984,embryonic growth retardation|MP:0004259,small placenta|MP:0008959,abnormal spongiotrophoblast cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3530465	Peg12<tm1Brn>	MP:0002169,no abnormal phenotype detected
MGI:5426383	Peg3<tm1.1Jkim>	MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0003787,abnormal imprinting|MP:0005384,cellular phenotype|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4435596	Peg3<tm1a(EUCOMM)Hmgu>	MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0005431,decreased oocyte number|MP:0009546,absent gastric milk in neonates|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3589260	Peg3<tm1Masu>	MP:0000837,abnormal hypothalamus morphology|MP:0001262,decreased body weight|MP:0001384,abnormal pup retrieval|MP:0003122,maternal imprinting|MP:0003631,nervous system phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0009326,absent maternal crouching
MGI:5467250	Peli1<tm1.1Arte>	MP:0000613,abnormal salivary gland morphology|MP:0000688,lymphoid hyperplasia|MP:0000702,enlarged lymph nodes|MP:0003009,abnormal cytokine secretion|MP:0005387,immune system phenotype|MP:0008463,abnormal peripheral lymph node morphology|MP:0008561,decreased tumor necrosis factor secretion|MP:0008563,decreased interferon-alpha secretion|MP:0008565,decreased interferon-beta secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0010831,lethality, incomplete penetrance
MGI:5548537	Peli1<tm1b(EUCOMM)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001258,decreased body length|MP:0002175,decreased brain weight|MP:0003960,increased lean body mass|MP:0004952,increased spleen weight|MP:0005292,improved glucose tolerance
MGI:4361448	Peli1<tm1Tigm>	MP:0005093,decreased B cell proliferation|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008576,decreased circulating interferon-beta level|MP:0008597,decreased circulating interleukin-6 level|MP:0008648,decreased circulating interleukin-12b level|MP:0008664,decreased interleukin-12 secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008782,increased B cell apoptosis|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:6401217	Peli2<tm1.1Arte>	MP:0003009,abnormal cytokine secretion|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008658,decreased interleukin-1 beta secretion|MP:0008685,decreased interleukin-18 secretion|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010210,abnormal circulating cytokine level|MP:0011080,increased macrophage apoptosis
MGI:5441750	Peli3<tm1.1Arte>	MP:0002376,abnormal dendritic cell physiology|MP:0005621,abnormal cell physiology|MP:0011072,abnormal macrophage cytokine production|MP:0020938,decreased susceptibility to Picornaviridae infection|MP:0031039,decreased susceptibility to Picornaviridae infection induced morbidity/mortality
MGI:4840811	Peli3<tm1a(KOMP)Mbp>	MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:5637764	Peli3<tm1b(KOMP)Mbp>	MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis
MGI:6718612	Pelo<tm1.1Slac>	MP:0000849,abnormal cerebellum morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2450933	Pelo<tm1Imad>	MP:0001674,abnormal germ layer development|MP:0001698,decreased embryo size|MP:0001724,abnormal extraembryonic endoderm formation|MP:0001730,embryonic growth arrest|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003984,embryonic growth retardation|MP:0004024,aneuploidy|MP:0004025,polyploidy|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011209,absent extraembryonic coelom|MP:0012114,absent inner cell mass proliferation
MGI:6718611	Pelo<tm1Slac>	MP:0000851,cerebellum hypoplasia|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000880,decreased Purkinje cell number|MP:0002892,decreased superior colliculus size|MP:0003203,increased neuron apoptosis|MP:0003246,loss of GABAergic neurons|MP:0003631,nervous system phenotype|MP:0004101,abnormal brain interneuron morphology|MP:0008924,decreased cerebellar granule cell number|MP:0009038,decreased inferior colliculus size|MP:0009960,abnormal cerebellum anterior lobe morphology|MP:0020393,increased neuronal precursor proliferation
MGI:5705245	Pelo<tm2Imad>	MP:0011092,embryonic lethality, complete penetrance
MGI:1857394	Pemt<tm1J>	MP:0000180,abnormal circulating cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0001547,abnormal lipid level|MP:0002628,hepatic steatosis|MP:0005179,decreased circulating cholesterol level|MP:0012334,decreased circulating homocysteine level
MGI:2136456	Penk-rs<tm1Pig>	MP:0001353,increased aggression towards mice|MP:0001357,increased aggression towards humans|MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001861,lung inflammation|MP:0001968,abnormal touch/nociception|MP:0001982,decreased chemically-elicited antinociception|MP:0002062,abnormal associative learning|MP:0002572,abnormal emotion/affect behavior|MP:0002735,abnormal chemical nociception|MP:0002797,increased thigmotaxis|MP:0003998,decreased thermal nociceptive threshold|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005466,abnormal T-helper 2 physiology|MP:0008091,decreased T-helper 2 cell number|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009756,impaired behavioral response to nicotine|MP:0009776,decreased behavioral withdrawal response
MGI:2388020	Penk<tm1Dwp>	MP:0001363,increased anxiety-related response|MP:0001454,abnormal cued conditioning behavior|MP:0002908,delayed wound healing|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3628668	Penk<tm1Jep>	MP:0001980,abnormal chemically-elicited antinociception|MP:0009748,abnormal behavioral response to addictive substance
MGI:4454042	Penk<tm1(KOMP)Mbp>	MP:0001258,decreased body length|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0003795,abnormal bone structure|MP:0006415,absent testes|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5607585	Penk<tm2(cre)Hze>	MP:0002169,no abnormal phenotype detected
MGI:4819769	Pepc<m1Lws>	MP:0002169,no abnormal phenotype detected
MGI:4819770	Pepc<m2Lws>	MP:0002169,no abnormal phenotype detected
MGI:4819771	Pepc<m3Lws>	MP:0002169,no abnormal phenotype detected
MGI:4819773	Pepc<m4Lws>	MP:0002169,no abnormal phenotype detected
MGI:4819774	Pepc<m5Lws>	MP:0002169,no abnormal phenotype detected
MGI:2683249	Pepd<dal>	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0000372,irregular coat pigmentation|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001265,decreased body size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002780,decreased circulating testosterone level|MP:0002953,thick ventricular wall|MP:0003808,increased atrioventricular cushion size|MP:0003984,embryonic growth retardation|MP:0005409,darkened coat color|MP:0005431,decreased oocyte number|MP:0006113,abnormal heart septum morphology|MP:0008025,brain vacuoles|MP:0009643,abnormal urine homeostasis|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010630,abnormal cardiac muscle tissue morphology|MP:0010633,myocardium hypertrophy|MP:0010724,thick interventricular septum|MP:0010770,preweaning lethality|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011416,abnormal testis interstitial tissue morphology|MP:0011640,abnormal aorta collagen fibril morphology|MP:0012076,abnormal agouti pigmentation|MP:0020254,decreased collagen level|MP:0031131,myocardial fiber disarray|MP:0031609,increased fetal cardiomyocyte size
MGI:4363495	Pepd<tm1a(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0001312,abnormal cornea morphology|MP:0001325,abnormal retina morphology|MP:0002079,increased circulating insulin level|MP:0002932,abnormal joint morphology|MP:0003795,abnormal bone structure|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008215,decreased immature B cell number|MP:0009923,decreased transitional stage T1 B cell number|MP:0010124,decreased bone mineral content|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013427,increased memory-marker NK cell number|MP:0013430,increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0013514,increased memory-marker CD4-negative NK T cell number|MP:0013678,decreased Ly6C-positive NK T cell number|MP:0013772,increased effector memory T-helper cell number
MGI:6120820	Pepd<tm1b(KOMP)Wtsi>	MP:0000702,enlarged lymph nodes|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0002691,small stomach|MP:0002757,decreased vertical activity|MP:0002764,short tibia|MP:0002797,increased thigmotaxis|MP:0004924,abnormal behavior|MP:0005333,decreased heart rate|MP:0005343,increased circulating aspartate transaminase level|MP:0008168,decreased B-1a cell number|MP:0008174,decreased follicular B cell number|MP:0008259,abnormal optic disk morphology|MP:0010052,increased grip strength|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0010506,prolonged RR interval|MP:0011896,increased circulating unsaturated transferrin level|MP:0013691,decreased CD5-positive Ly6C-positive T cell number
MGI:3522305	Per1<Hftm>	MP:0020470,shortened circadian behavior period
MGI:2182834	Per1<tm1Brd>	MP:0001259,abnormal body weight|MP:0001262,decreased body weight|MP:0001432,abnormal food preference|MP:0001729,impaired embryo implantation|MP:0001923,reduced female fertility|MP:0001927,abnormal estrous cycle|MP:0001935,decreased litter size|MP:0004988,increased osteoblast cell number|MP:0005449,abnormal food intake|MP:0005605,increased bone mass|MP:0008961,abnormal basal metabolism|MP:0008995,early reproductive senescence|MP:0009009,absent estrous cycle|MP:0009661,abnormal pregnancy
MGI:2182831	Per1<tm1Drw>	MP:0001501,abnormal sleep pattern|MP:0002063,abnormal learning/memory/conditioning|MP:0002574,increased vertical activity|MP:0005643,decreased dopamine level|MP:0010698,abnormal impulsive behavior control|MP:0014624,abnormal brain delta wave pattern|MP:0020469,prolonged circadian behavior period|MP:0020472,arrhythmic circadian behavior persistence|MP:0020478,abnormal circadian sleep/wake cycle|MP:0031391,increased locomotor activity
MGI:2182634	Per1<tm1Saco>	MP:0020470,shortened circadian behavior period|MP:0020473,abnormal circadian behavior phase|MP:0020476,abnormal circardian behavior entrainment
MGI:5805980	Per2<M1Btlr>	MP:0004994,abnormal brain wave pattern|MP:0020467,abnormal circadian behavior|MP:0020470,shortened circadian behavior period|MP:0020475,delayed circadian behavior phase
MGI:4436072	Per2<tm1a(EUCOMM)Hmgu>	MP:0002075,abnormal coat/hair pigmentation|MP:0002896,abnormal bone mineralization|MP:0002968,increased circulating alkaline phosphatase level
MGI:1934020	Per2<tm1Brd>	MP:0000619,salivary gland epithelial hyperplasia|MP:0001259,abnormal body weight|MP:0001260,increased body weight|MP:0001385,pup cannibalization|MP:0001432,abnormal food preference|MP:0001658,increased mortality induced by gamma-irradiation|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002717,abnormal male preputial gland morphology|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0003631,nervous system phenotype|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0005386,behavior/neurological phenotype|MP:0005449,abnormal food intake|MP:0008779,abnormal maternal behavior|MP:0008961,abnormal basal metabolism|MP:0008995,early reproductive senescence|MP:0009006,prolonged estrous cycle|MP:0009009,absent estrous cycle|MP:0009661,abnormal pregnancy|MP:0009713,enhanced conditioned place preference behavior|MP:0009754,enhanced behavioral response to cocaine|MP:0010875,increased bone volume|MP:0012431,increased lymphoma incidence|MP:0020039,increased bone ossification|MP:0020470,shortened circadian behavior period|MP:0020472,arrhythmic circadian behavior persistence|MP:0020477,abnormal locomotor circadian rhythm|MP:0020478,abnormal circadian sleep/wake cycle
MGI:2388602	Per2<tm1Ccl>	MP:0000619,salivary gland epithelial hyperplasia|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0010318,increased salivary gland tumor incidence|MP:0020470,shortened circadian behavior period|MP:0020472,arrhythmic circadian behavior persistence
MGI:2182832	Per2<tm1Drw>	MP:0001325,abnormal retina morphology|MP:0001501,abnormal sleep pattern|MP:0001614,abnormal blood vessel morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002792,abnormal retina vasculature morphology|MP:0003632,abnormal nervous system morphology|MP:0004809,increased hematopoietic stem cell number|MP:0005292,improved glucose tolerance|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011020,abnormal circadian temperature homeostasis|MP:0011903,decreased hematopoietic stem cell proliferation|MP:0020472,arrhythmic circadian behavior persistence
MGI:3040876	Per2<tm1Jt>	MP:0002169,no abnormal phenotype detected
MGI:2385797	Per3<tm1Drw>	MP:0001501,abnormal sleep pattern|MP:0002573,behavioral despair|MP:0014624,abnormal brain delta wave pattern|MP:0020470,shortened circadian behavior period
MGI:6384664	Percc1<em1Lap>	MP:0001262,decreased body weight|MP:0003868,abnormal feces composition
MGI:6384662	Percc1<tm1.1Lap>	MP:0000470,abnormal stomach morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0003868,abnormal feces composition|MP:0008770,decreased survivor rate|MP:0010377,abnormal gut flora balance
MGI:5705623	Perl<tm1Vlcg>	MP:0001262,decreased body weight|MP:0011086,postnatal lethality, incomplete penetrance
MGI:7447455	Perm1<em1Jswn>	MP:0005140,decreased cardiac muscle contractility
MGI:2683069	Perp<tm1Att>	MP:0003204,decreased neuron apoptosis|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0009542,decreased thymocyte apoptosis|MP:0011085,postnatal lethality, complete penetrance
MGI:4882063	Perp<tm2Att>	MP:0004947,skin inflammation|MP:0009581,decreased keratinocyte apoptosis|MP:0009704,increased skin squamous cell carcinoma incidence|MP:0010308,decreased tumor latency
MGI:5637005	Pes1<tm1b(EUCOMM)Wtsi>	MP:0000443,abnormal snout morphology|MP:0002599,increased mean platelet volume|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0010088,decreased circulating fructosamine level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2445464	Pes1<tm1Sad>	MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0005380,embryo phenotype|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5638060	Pex10<m1Nisw>	MP:0000755,hindlimb paralysis|MP:0000756,forelimb paralysis|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001107,decreased Schwann cell number|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002914,abnormal endplate potential|MP:0003651,abnormal axon extension|MP:0005281,increased fatty acids level|MP:0005365,abnormal bile salt homeostasis|MP:0005404,abnormal axon morphology|MP:0009450,abnormal axon fasciculation|MP:0011090,perinatal lethality, incomplete penetrance|MP:0012216,decreased plasmalogen level|MP:0031494,abnormal prenatal movement
MGI:5487452	Pex11a<tm1Itl>	MP:0000358,abnormal cell morphology|MP:0000607,abnormal hepatocyte morphology|MP:0001260,increased body weight|MP:0001261,obese|MP:0001554,increased circulating free fatty acids level|MP:0002575,increased circulating ketone body level|MP:0002628,hepatic steatosis|MP:0005376,homeostasis/metabolism phenotype|MP:0009355,increased liver triglyceride level|MP:0011969,abnormal circulating triglyceride level
MGI:2445440	Pex11a<tm1Sjg>	MP:0014010,abnormal peroxisome morphology|MP:0014341,abnormal hepatocyte mitochondrial morphology
MGI:2181008	Pex11b<tm1Sjg>	MP:0000074,abnormal neurocranium morphology|MP:0000597,delayed hepatic development|MP:0000788,abnormal cerebral cortex morphology|MP:0000849,abnormal cerebellum morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001436,abnormal suckling behavior|MP:0003203,increased neuron apoptosis|MP:0003674,oxidative stress|MP:0005376,homeostasis/metabolism phenotype|MP:0005382,craniofacial phenotype|MP:0008547,abnormal neocortex morphology|MP:0009937,abnormal neuron differentiation|MP:0010398,decreased liver glycogen level|MP:0011087,neonatal lethality, complete penetrance|MP:0011628,increased mitochondrial number|MP:0014010,abnormal peroxisome morphology|MP:0020847,abnormal peroxisome physiology
MGI:2384515	Pex13<tm1.1Crne>	MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0001438,aphagia|MP:0001954,respiratory distress|MP:0003224,neuron degeneration|MP:0003674,oxidative stress|MP:0004144,hypotonia|MP:0005156,bradykinesia|MP:0005325,abnormal renal glomerulus morphology|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006254,thin cerebral cortex|MP:0008059,abnormal podocyte foot process morphology|MP:0008291,abnormal adrenocortical cell morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011635,abnormal mitochondrial crista morphology|MP:0014010,abnormal peroxisome morphology|MP:0020847,abnormal peroxisome physiology|MP:0031115,macrovesicular hepatic steatosis
MGI:6257786	Pex14<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:2678453	Pex14<Gt(pT1Betageo)1Ruiz>	MP:0011091,prenatal lethality, complete penetrance
MGI:6438234	Pex16<tm1c(EUCOMM)Hmgu>	MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0006036,abnormal mitochondrial physiology|MP:0009118,increased white fat cell size|MP:0009124,increased brown fat cell lipid droplet size|MP:0009285,increased gonadal fat pad weight|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010024,increased total body fat amount|MP:0011049,impaired adaptive thermogenesis|MP:0014396,decreased fat cell mitochondrial DNA content|MP:0020520,whitened brown adipose tissue morphology
MGI:7425905	Pex19<em1(IMPC)Bay>	MP:0001297,microphthalmia|MP:0001417,decreased exploration in new environment|MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance|MP:0011959,abnormal eye posterior chamber depth|MP:0011962,increased cornea thickness
MGI:6390206	Pex1<tm1.1Hrw>	MP:0000519,hydronephrosis|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000610,cholestasis|MP:0000746,weakness|MP:0001265,decreased body size|MP:0001559,hyperglycemia|MP:0001654,hepatic necrosis|MP:0001732,postnatal growth retardation|MP:0001860,liver inflammation|MP:0003255,bile duct proliferation|MP:0003324,increased liver adenoma incidence|MP:0003333,liver fibrosis|MP:0004777,abnormal phospholipid level|MP:0005280,abnormal fatty acids level|MP:0005365,abnormal bile salt homeostasis|MP:0005389,reproductive system phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0008770,decreased survivor rate|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0010140,phlebitis|MP:0010398,decreased liver glycogen level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0011632,dilated mitochondrion|MP:0011635,abnormal mitochondrial crista morphology|MP:0014010,abnormal peroxisome morphology|MP:0031158,abnormal venous thrombosis
MGI:5570186	Pex1<tm1.1Sjms>	MP:0000610,cholestasis|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0003255,bile duct proliferation|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005281,increased fatty acids level|MP:0005282,decreased fatty acids level|MP:0005284,increased saturated fatty acids level|MP:0005342,abnormal intestinal lipid absorption|MP:0005365,abnormal bile salt homeostasis|MP:0006084,abnormal circulating phospholipid level|MP:0008444,retina cone cell degeneration|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0031116,microvesicular hepatic steatosis
MGI:7857121	Pex1<tm1e.1(EUCOMM)Hmgu>	MP:0000598,abnormal liver morphology|MP:0002753,dilated heart left ventricle|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0011100,preweaning lethality, complete penetrance
MGI:5548637	Pex26<tm1.1(KOMP)Vlcg>	MP:0000691,enlarged spleen|MP:0011100,preweaning lethality, complete penetrance
MGI:2180128	Pex2<tm1Plf>	MP:0000063,decreased bone mineral density|MP:0000074,abnormal neurocranium morphology|MP:0000077,abnormal interparietal bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000186,decreased circulating HDL cholesterol level|MP:0000433,microcephaly|MP:0000436,abnormal head movements|MP:0000598,abnormal liver morphology|MP:0000609,abnormal liver physiology|MP:0000610,cholestasis|MP:0000774,decreased brain size|MP:0000790,abnormal stratification in cerebral cortex|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001438,aphagia|MP:0001512,trunk curl|MP:0001513,limb grasping|MP:0001525,impaired balance|MP:0001553,abnormal circulating free fatty acids level|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002136,abnormal kidney physiology|MP:0002628,hepatic steatosis|MP:0003420,delayed intramembranous bone ossification|MP:0003983,decreased cholesterol level|MP:0004773,abnormal bile composition|MP:0005179,decreased circulating cholesterol level|MP:0005386,behavior/neurological phenotype|MP:0008026,abnormal brain white matter morphology|MP:0008288,abnormal adrenal cortex morphology|MP:0009429,decreased embryo weight|MP:0010026,decreased liver cholesterol level|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0020137,decreased bone mineralization
MGI:6276884	Pex39<em1(IMPC)Mbp>	MP:0001404,no spontaneous movement
MGI:4431895	Pex3<tm1a(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000647,abnormal sebaceous gland morphology|MP:0001262,decreased body weight|MP:0001312,abnormal cornea morphology|MP:0001539,decreased caudal vertebrae number|MP:0002092,abnormal eye morphology|MP:0002111,abnormal tail morphology|MP:0002697,abnormal eye size|MP:0002942,decreased circulating alanine transaminase level|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005567,decreased circulating total protein level|MP:0005632,decreased circulating aspartate transaminase level|MP:0009759,abnormal hair follicle bulge morphology|MP:0010025,decreased total body fat amount|MP:0010087,increased circulating fructosamine level|MP:0010088,decreased circulating fructosamine level|MP:0010101,increased sacral vertebrae number|MP:0012725,small sebaceous gland
MGI:5139912	Pex5l<tm1.1Chet>	MP:0001447,abnormal nest building behavior|MP:0001489,decreased startle reflex|MP:0002804,abnormal motor learning|MP:0003360,abnormal depression-related behavior|MP:0004811,abnormal neuron physiology
MGI:3808533	Pex5l<tm1(KOMP)Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:2154454	Pex5<tm1Baes>	MP:0000478,delayed intestine development|MP:0000528,delayed kidney development|MP:0000598,abnormal liver morphology|MP:0000747,muscle weakness|MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0001889,delayed brain development|MP:0001954,respiratory distress|MP:0002135,abnormal kidney morphology|MP:0003984,embryonic growth retardation|MP:0011085,postnatal lethality, complete penetrance
MGI:2384516	Pex5<tm1Pec>	MP:0000160,kyphosis|MP:0000358,abnormal cell morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000920,abnormal myelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0001146,abnormal testis morphology|MP:0001154,seminiferous tubule degeneration|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001731,abnormal postnatal growth|MP:0001845,abnormal inflammatory response|MP:0001925,male infertility|MP:0001951,abnormal breathing pattern|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002183,gliosis|MP:0002216,abnormal seminiferous tubule morphology|MP:0003634,abnormal glial cell morphology|MP:0004852,decreased testis weight|MP:0005058,abnormal lysosome morphology|MP:0005141,liver hyperplasia|MP:0005365,abnormal bile salt homeostasis|MP:0005370,liver/biliary system phenotype|MP:0005404,abnormal axon morphology|MP:0008019,increased liver tumor incidence|MP:0008026,abnormal brain white matter morphology|MP:0008489,slow postnatal weight gain|MP:0008918,microgliosis|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009642,abnormal blood homeostasis|MP:0010952,abnormal fatty acid beta-oxidation|MP:0010955,abnormal respiratory electron transport chain|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011633,abnormal mitochondrial shape|MP:0011634,abnormal mitochondrial inner membrane morphology|MP:0011635,abnormal mitochondrial crista morphology|MP:0013405,increased circulating lactate level|MP:0031204,hindlimb paresis
MGI:6414534	Pex6<em1(IMPC)Bay>	MP:0001297,microphthalmia|MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance
MGI:6358627	Pex6<em1(IMPC)Tcp>	MP:0001297,microphthalmia|MP:0001312,abnormal cornea morphology|MP:0001322,abnormal iris morphology|MP:0001697,abnormal embryo size|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0006243,impaired pupillary reflex|MP:0011100,preweaning lethality, complete penetrance
MGI:4443125	Pex7<tm1Nbra>	MP:0000060,delayed bone ossification|MP:0000266,abnormal heart morphology|MP:0000599,enlarged liver|MP:0000639,abnormal adrenal gland morphology|MP:0000807,abnormal hippocampus morphology|MP:0000921,demyelination|MP:0000955,abnormal spinal cord morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001860,liver inflammation|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002628,hepatic steatosis|MP:0002840,abnormal lens fiber morphology|MP:0003103,liver degeneration|MP:0003236,abnormal lens capsule morphology|MP:0005281,increased fatty acids level|MP:0005282,decreased fatty acids level|MP:0005286,decreased saturated fatty acids level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005621,abnormal cell physiology|MP:0008489,slow postnatal weight gain|MP:0008570,lipidosis|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss
MGI:3052739	Pex7<tm1Rjaw>	MP:0000164,abnormal cartilage development|MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0001304,cataract|MP:0001431,abnormal eating behavior|MP:0001547,abnormal lipid level|MP:0001924,infertility|MP:0002427,disproportionate dwarf|MP:0003205,testicular atrophy|MP:0004982,abnormal osteoclast morphology|MP:0005281,increased fatty acids level|MP:0005323,dystonia|MP:0006009,abnormal neuronal migration|MP:0011088,neonatal lethality, incomplete penetrance|MP:0020137,decreased bone mineralization
MGI:1856990	pf	MP:0000378,absent hair follicles|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001241,absent epidermis stratum corneum|MP:0001243,abnormal dermal layer morphology|MP:0002058,neonatal lethality|MP:0002060,abnormal skin morphology|MP:0002111,abnormal tail morphology
MGI:3525230	Pf4<tm1Mako>	MP:0005505,thrombocytosis|MP:0031120,decreased susceptibility to induced thrombosis
MGI:6314199	Pfas<em1(IMPC)J>	MP:0000443,abnormal snout morphology|MP:0000579,abnormal nail morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002644,decreased circulating triglyceride level|MP:0005632,decreased circulating aspartate transaminase level|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3717451	Pfas<Sofa>	MP:0000373,belly spot|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0001262,decreased body weight|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001300,ocular hypertelorism|MP:0002092,abnormal eye morphology|MP:0003961,decreased lean body mass|MP:0005175,non-pigmented tail tip|MP:0006411,upturned snout|MP:0008818,abnormal interfrontal bone morphology|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011862,decreased cranium length|MP:0030444,premature cranial synchondrosis closure|MP:0030466,alveolar process atrophy
MGI:5476717	Pfas<Sofa-2J>	MP:0000373,belly spot|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0003961,decreased lean body mass|MP:0005175,non-pigmented tail tip|MP:0006086,decreased body mass index|MP:0008188,abnormal transitional stage B cell morphology|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011862,decreased cranium length|MP:0030444,premature cranial synchondrosis closure|MP:0030466,alveolar process atrophy
MGI:5514227	Pfas<Sofa-3J>	MP:0000373,belly spot|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0003961,decreased lean body mass|MP:0005175,non-pigmented tail tip|MP:0005459,decreased percent body fat/body weight|MP:0008818,abnormal interfrontal bone morphology|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011862,decreased cranium length|MP:0030444,premature cranial synchondrosis closure|MP:0030466,alveolar process atrophy
MGI:5514246	Pfas<Sofa-4J>	MP:0000373,belly spot|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0003961,decreased lean body mass|MP:0005175,non-pigmented tail tip|MP:0005459,decreased percent body fat/body weight|MP:0006086,decreased body mass index|MP:0008818,abnormal interfrontal bone morphology|MP:0010025,decreased total body fat amount|MP:0011862,decreased cranium length|MP:0030444,premature cranial synchondrosis closure|MP:0030466,alveolar process atrophy
MGI:5514248	Pfas<Sofa-5J>	MP:0000097,short maxilla|MP:0000373,belly spot|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0005175,non-pigmented tail tip|MP:0008525,decreased cranium height|MP:0008818,abnormal interfrontal bone morphology|MP:0010124,decreased bone mineral content|MP:0011862,decreased cranium length|MP:0030444,premature cranial synchondrosis closure|MP:0030466,alveolar process atrophy
MGI:5691529	Pfas<Sofa-6J>	MP:0000373,belly spot|MP:0000445,short snout|MP:0005175,non-pigmented tail tip
MGI:5287493	Pfas<Tg(Tyr)2307COve>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6195846	Pfdn1<em1(IMPC)J>	MP:0000111,cleft palate|MP:0001392,abnormal locomotor behavior|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0001697,abnormal embryo size|MP:0001914,hemorrhage|MP:0002111,abnormal tail morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:3800373	Pfdn1<Gt(GTR1.3)1Rul>	MP:0000333,decreased bone marrow cell number|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0000703,abnormal thymus morphology|MP:0000780,abnormal corpus callosum morphology|MP:0000781,decreased corpus callosum size|MP:0000849,abnormal cerebellum morphology|MP:0001263,weight loss|MP:0001405,impaired coordination|MP:0001823,thymus hypoplasia|MP:0001828,abnormal T cell activation|MP:0001872,sinus inflammation|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0002199,abnormal brain commissure morphology|MP:0002356,abnormal spleen red pulp morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002875,decreased erythrocyte cell number|MP:0004939,abnormal B cell morphology|MP:0004956,decreased thymus weight|MP:0004978,decreased B-1 B cell number|MP:0005065,abnormal neutrophil morphology|MP:0008026,abnormal brain white matter morphology|MP:0008207,decreased B-2 B cell number|MP:0008209,decreased pre-B cell number|MP:0008217,abnormal B cell activation|MP:0008489,slow postnatal weight gain|MP:0008826,abnormal splenic cell ratio|MP:0008827,abnormal thymus cell ratio|MP:0009703,decreased birth body size
MGI:6342903	Pfdn2<em1(IMPC)Bay>	MP:0003795,abnormal bone structure|MP:0011100,preweaning lethality, complete penetrance
MGI:5287019	Pfdn2<TgTn(sb-cHS4,Tyr)2321E-3Ove>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4867864	Pfdn5<nmf5a>	MP:0000820,abnormal choroid plexus morphology|MP:0000827,dilated third ventricle|MP:0000852,small cerebellum|MP:0000880,decreased Purkinje cell number|MP:0001004,abnormal retina photoreceptor morphology|MP:0001147,small testis|MP:0001325,abnormal retina morphology|MP:0001393,ataxia|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002687,oligozoospermia|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0005389,reproductive system phenotype|MP:0005551,abnormal eye electrophysiology|MP:0006072,abnormal retina apoptosis|MP:0008028,pregnancy-related premature death|MP:0008450,retina photoreceptor degeneration|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008582,short photoreceptor inner segment|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0008995,early reproductive senescence|MP:0009325,necrospermia|MP:0010236,abnormal retina outer limiting membrane morphology|MP:0011056,abnormal brain ependyma motile cilium morphology|MP:0014812,abnormal brain physiology|MP:0030966,decreased brain ependyma motile cilium number
MGI:5692755	Pfdn5<tm1b(EUCOMM)Wtsi>	MP:0000428,abnormal craniofacial morphology|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0002080,prenatal lethality|MP:0002111,abnormal tail morphology|MP:0003961,decreased lean body mass|MP:0003984,embryonic growth retardation|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration
MGI:5581419	Pfdn6<tm1.1(KOMP)Vlcg>	MP:0001523,impaired righting response|MP:0002590,increased mean corpuscular volume|MP:0005560,decreased circulating glucose level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6470720	Pfkfb2<tm1.2Dap>	MP:0002989,small kidney|MP:0003985,renal fibrosis|MP:0005566,decreased blood urea nitrogen level|MP:0031003,increased kidney glycogen level
MGI:5605741	Pfkfb2<tm1b(KOMP)Wtsi>	MP:0000222,decreased neutrophil cell number|MP:0000280,thin ventricular wall|MP:0001325,abnormal retina morphology|MP:0002606,increased basophil cell number|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0013279,increased fasting circulating glucose level
MGI:6470752	Pfkfb3<tm1.1Pec>	MP:0000259,abnormal vascular development|MP:0001764,abnormal homeostasis|MP:0002446,abnormal macrophage morphology|MP:0002451,abnormal macrophage physiology|MP:0002715,decreased glycogen catabolism rate|MP:0003658,abnormal capillary morphology|MP:0003852,skeletal muscle necrosis|MP:0004043,abnormal pH regulation|MP:0005039,hypoxia|MP:0005384,cellular phenotype|MP:0006057,decreased vascular endothelial cell number|MP:0009402,decreased skeletal muscle fiber diameter|MP:0013243,abnormal carbohydrate metabolism|MP:0013404,decreased circulating lactate level|MP:0031126,gangrene
MGI:5692802	Pfkfb3<tm1b(EUCOMM)Wtsi>	MP:0003795,abnormal bone structure
MGI:3576782	Pfkfb3<tm1Jche>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5548881	Pfkfb4<tm1b(KOMP)Wtsi>	MP:0001529,abnormal vocalization|MP:0001926,female infertility|MP:0006203,eye hemorrhage
MGI:4432814	Pfkl<tm1a(EUCOMM)Wtsi>	MP:0003413,hair follicle degeneration|MP:0008859,abnormal hair cycle catagen phase|MP:0011100,preweaning lethality, complete penetrance
MGI:6386304	Pfkm<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001157,small seminal vesicle|MP:0001258,decreased body length|MP:0001304,cataract|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002699,abnormal vitreous body morphology|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount
MGI:3759504	Pfkm<GT(OST56064)Lex>	MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level
MGI:4356541	Pfkm<tm1Fbos>	MP:0000208,decreased hematocrit|MP:0000260,abnormal angiogenesis|MP:0000274,enlarged heart|MP:0000691,enlarged spleen|MP:0001625,cardiac hypertrophy|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002625,heart left ventricle hypertrophy|MP:0002640,reticulocytosis|MP:0002833,increased heart weight|MP:0002944,increased lactate dehydrogenase level|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004809,increased hematopoietic stem cell number|MP:0004952,increased spleen weight|MP:0005039,hypoxia|MP:0005344,increased circulating bilirubin level|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009412,skeletal muscle fiber degeneration|MP:0009414,skeletal muscle fiber necrosis|MP:0010401,increased skeletal muscle glycogen level|MP:0011084,lethality at weaning, incomplete penetrance|MP:0012106,impaired exercise endurance|MP:0013404,decreased circulating lactate level|MP:0014071,increased cardiac muscle glycogen level|MP:0031085,increased erythrocyte osmotic fragility|MP:0031318,enhanced skeletal muscle regeneration
MGI:4433191	Pfn1<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0001307,fused cornea and lens|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0005292,improved glucose tolerance|MP:0008806,increased circulating amylase level|MP:0010025,decreased total body fat amount|MP:0010088,decreased circulating fructosamine level|MP:0010092,increased circulating magnesium level|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:7482601	Pfn1<tm1Fgi>	MP:0000358,abnormal cell morphology|MP:0003707,increased cell nucleus count|MP:0003708,binucleate|MP:0013289,abnormal mitotic cytokinesis|MP:0031678,increased micronucleus incidence
MGI:5470084	Pfn1<tm1Foxp>	MP:0002169,no abnormal phenotype detected|MP:0002908,delayed wound healing|MP:0003544,abnormal vascular endothelial cell migration|MP:0004883,abnormal vascular wound healing|MP:0005602,decreased angiogenesis
MGI:3843221	Pfn1<tm1Ref>	MP:0000069,kyphoscoliosis|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000746,weakness|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002113,abnormal skeleton development|MP:0003109,short femur|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004351,short humerus|MP:0004686,decreased length of long bones|MP:0008770,decreased survivor rate|MP:0009780,abnormal chondrocyte physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014105,abnormal chondrocyte differentiation
MGI:2183296	Pfn1<tm1Wit>	MP:0011090,perinatal lethality, incomplete penetrance|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5568700	Pfn1<tm2.1(GFP/ACTB)Wit>	MP:0011400,lethality, complete penetrance
MGI:3715145	Pfn2<tm1Wit>	MP:0001415,increased exploration in new environment|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002920,decreased paired-pulse facilitation|MP:0003461,abnormal response to novel object|MP:0004077,abnormal striatum morphology|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004792,abnormal synaptic vesicle number|MP:0005621,abnormal cell physiology
MGI:6384215	Pfn3<em1Hsc>	MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0004542,impaired acrosome reaction|MP:0005389,reproductive system phenotype|MP:0008469,abnormal protein level|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009325,necrospermia|MP:0009830,abnormal sperm connecting piece morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0011743,abnormal Golgi apparatus morphology|MP:0014465,abnormal sperm mitochondrial morphology|MP:0020451,decreased sperm progressive motility|MP:0030940,impaired autophagy|MP:0030949,abnormal Golgi vesicle transport|MP:0031354,abnormal acrosome assembly|MP:0031355,abnormal proacrosomal vesicle fusion|MP:0031374,abnormal manchette assembly
MGI:6384216	Pfn3<em2Hsc>	MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0004542,impaired acrosome reaction|MP:0005389,reproductive system phenotype|MP:0008469,abnormal protein level|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009325,necrospermia|MP:0009830,abnormal sperm connecting piece morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0011743,abnormal Golgi apparatus morphology|MP:0014465,abnormal sperm mitochondrial morphology|MP:0020451,decreased sperm progressive motility|MP:0030940,impaired autophagy|MP:0030949,abnormal Golgi vesicle transport|MP:0031354,abnormal acrosome assembly|MP:0031355,abnormal proacrosomal vesicle fusion|MP:0031374,abnormal manchette assembly
MGI:6384217	Pfn3<em3Hsc>	MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0004542,impaired acrosome reaction|MP:0005389,reproductive system phenotype|MP:0008469,abnormal protein level|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009325,necrospermia|MP:0009830,abnormal sperm connecting piece morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0011743,abnormal Golgi apparatus morphology|MP:0014465,abnormal sperm mitochondrial morphology|MP:0020451,decreased sperm progressive motility|MP:0030940,impaired autophagy|MP:0030949,abnormal Golgi vesicle transport|MP:0031354,abnormal acrosome assembly|MP:0031355,abnormal proacrosomal vesicle fusion|MP:0031374,abnormal manchette assembly
MGI:6718278	Pfn4<em1Hsc>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0004542,impaired acrosome reaction|MP:0004884,abnormal testis physiology|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009235,small sperm head|MP:0009238,coiled sperm flagellum|MP:0009325,necrospermia|MP:0009376,abnormal manchette morphology|MP:0009830,abnormal sperm connecting piece morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0011743,abnormal Golgi apparatus morphology|MP:0020451,decreased sperm progressive motility|MP:0030940,impaired autophagy|MP:0030949,abnormal Golgi vesicle transport|MP:0031354,abnormal acrosome assembly|MP:0031355,abnormal proacrosomal vesicle fusion|MP:0031374,abnormal manchette assembly|MP:0031388,absent manchette
MGI:6718279	Pfn4<em2Hsc>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0004542,impaired acrosome reaction|MP:0004884,abnormal testis physiology|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009235,small sperm head|MP:0009238,coiled sperm flagellum|MP:0009325,necrospermia|MP:0009376,abnormal manchette morphology|MP:0009830,abnormal sperm connecting piece morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0011743,abnormal Golgi apparatus morphology|MP:0020451,decreased sperm progressive motility|MP:0030940,impaired autophagy|MP:0030949,abnormal Golgi vesicle transport|MP:0031354,abnormal acrosome assembly|MP:0031355,abnormal proacrosomal vesicle fusion|MP:0031374,abnormal manchette assembly|MP:0031388,absent manchette
MGI:5548626	Pfn4<tm1b(KOMP)Wtsi>	MP:0002111,abnormal tail morphology|MP:0005573,increased pulmonary respiratory rate|MP:0005576,decreased pulmonary ventilation|MP:0012125,decreased bronchoconstrictive response
MGI:2176997	pfz	MP:0000414,alopecia
MGI:6473536	Pgam1<tm1.1Hiko>	MP:0003806,abnormal nucleotide metabolism|MP:0004043,abnormal pH regulation|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005087,decreased acute inflammation|MP:0005266,abnormal metabolism|MP:0005290,decreased oxygen consumption|MP:0005397,hematopoietic system phenotype|MP:0008040,decreased NK T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008091,decreased T-helper 2 cell number|MP:0008688,decreased interleukin-2 secretion|MP:0010220,decreased T-helper 17 cell number|MP:0013762,abnormal effector T cell number
MGI:6730298	Pgam1<tm2.2Hiko>	MP:0011092,embryonic lethality, complete penetrance
MGI:7425906	Pgam2<em1(IMPC)Bay>	MP:0010053,decreased grip strength
MGI:4432458	Pgam5<tm1a(EUCOMM)Wtsi>	MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001516,abnormal motor coordination/balance|MP:0002690,akinesia|MP:0002757,decreased vertical activity|MP:0003224,neuron degeneration|MP:0003244,loss of dopaminergic neurons|MP:0003674,oxidative stress|MP:0005156,bradykinesia|MP:0005376,homeostasis/metabolism phenotype|MP:0005643,decreased dopamine level|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0011635,abnormal mitochondrial crista morphology
MGI:5548621	Pgam5<tm1b(EUCOMM)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001417,decreased exploration in new environment|MP:0002590,increased mean corpuscular volume|MP:0002764,short tibia|MP:0002875,decreased erythrocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005567,decreased circulating total protein level|MP:0011965,decreased total retina thickness
MGI:5882559	Pgam5<tm1c(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5882561	Pgam5<tm1d(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002083,premature death|MP:0003186,abnormal redox activity|MP:0005384,cellular phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0008656,abnormal interleukin-1 beta secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008770,decreased survivor rate|MP:0011075,abnormal macrophage activation involved in immune response|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011633,abnormal mitochondrial shape
MGI:2656407	Pgame1<1Neu>	MP:0002169,no abnormal phenotype detected
MGI:2656425	Pgame2<1Neu>	MP:0002169,no abnormal phenotype detected|MP:0011100,preweaning lethality, complete penetrance
MGI:6360661	Pgap1<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:4461887	Pgap1<m1Nisw>	MP:0000077,abnormal interparietal bone morphology|MP:0000438,abnormal cranium morphology|MP:0000784,forebrain hypoplasia|MP:0002092,abnormal eye morphology|MP:0003232,abnormal forebrain development|MP:0004200,decreased fetal size|MP:0005157,holoprosencephaly|MP:0005269,abnormal occipital bone morphology|MP:0008533,abnormal anterior visceral endoderm morphology|MP:0008926,abnormal anterior definitive endoderm morphology|MP:0009609,absent basioccipital bone|MP:0010126,abnormal distal visceral endoderm morphology|MP:0011255,abnormal anterior visceral endoderm cell migration|MP:0030464,abnormal cranial cartilage morphology
MGI:1856621	Pgap1<oto>	MP:0000087,absent mandible|MP:0000157,abnormal sternum morphology|MP:0000433,microcephaly|MP:0000438,abnormal cranium morphology|MP:0000480,increased rib number|MP:0000783,abnormal forebrain morphology|MP:0000787,abnormal telencephalon morphology|MP:0000830,abnormal diencephalon morphology|MP:0000913,abnormal brain development|MP:0000934,abnormal telencephalon development|MP:0000936,small embryonic telencephalon|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001924,infertility|MP:0002092,abnormal eye morphology|MP:0002151,abnormal neural tube morphology|MP:0002177,abnormal outer ear morphology|MP:0002252,abnormal oropharynx morphology|MP:0002639,micrognathia|MP:0003036,vertebral transformation|MP:0003743,abnormal facial morphology|MP:0004541,absent auditory tube|MP:0004592,small mandible|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0005163,cyclopia|MP:0006197,ocular hypotelorism|MP:0006290,proboscis|MP:0008770,decreased survivor rate|MP:0009578,otocephaly|MP:0009903,abnormal medial nasal prominence morphology|MP:0010335,fused first pharyngeal arch|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011759,absent Rathke's pouch|MP:0012084,truncated foregut|MP:0030043,small forehead|MP:0030067,narrow face
MGI:4355040	Pgap1<tm1Asp>	MP:0000783,abnormal forebrain morphology|MP:0000936,small embryonic telencephalon
MGI:6323435	Pgap1<tm1Osb>	MP:0000242,impaired fertilization|MP:0000788,abnormal cerebral cortex morphology|MP:0000934,abnormal telencephalon development|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0002152,abnormal brain morphology|MP:0003451,absent olfactory bulb|MP:0004539,absent maxilla|MP:0004592,small mandible|MP:0009546,absent gastric milk in neonates|MP:0009578,otocephaly|MP:0011090,perinatal lethality, incomplete penetrance|MP:0012176,abnormal head development|MP:0013817,absent nasal cavity|MP:0030071,abnormal face shape|MP:0030382,absent paranasal sinus|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031012,impaired sperm migration in female genital tract
MGI:5056366	Pgap2<clpex>	MP:0000111,cleft palate|MP:0000914,exencephaly|MP:0005170,cleft upper lip|MP:0012174,flat head
MGI:5637131	Pgap2<tm1b(EUCOMM)Wtsi>	MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:5538630	Pgap3<tm1.1Ymra>	MP:0000585,kinked tail|MP:0000753,paralysis|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0001798,impaired macrophage phagocytosis|MP:0002111,abnormal tail morphology|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008037,abnormal T cell morphology|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008481,increased spleen germinal center number|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011294,renal glomerulus hypertrophy|MP:0011496,abnormal head size
MGI:5538656	Pgap3<tm1Ymra>	MP:0005387,immune system phenotype
MGI:6471949	Pgap4<em1Osbir>	MP:0000150,abnormal rib morphology|MP:0000194,increased circulating calcium level|MP:0001402,decreased locomotor activity|MP:0002764,short tibia|MP:0002968,increased circulating alkaline phosphatase level|MP:0003048,abnormal cervical vertebrae morphology|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0003795,abnormal bone structure|MP:0004658,abnormal ventral tubercle of atlas morphology|MP:0005364,increased susceptibility to prion infection|MP:0005458,increased percent body fat/body weight|MP:0008271,abnormal bone ossification|MP:0009454,impaired contextual conditioning behavior|MP:0009787,increased susceptibility to infection induced morbidity/mortality|MP:0010099,abnormal thoracic cage shape|MP:0010124,decreased bone mineral content|MP:0011919,abnormal R wave|MP:0013670,increased Ly6C-positive immature NK cell number|MP:0014142,increased body fat mass|MP:0020137,decreased bone mineralization
MGI:7425907	Pgap6<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001404,no spontaneous movement|MP:0001925,male infertility|MP:0002060,abnormal skin morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6147693	Pgap6<tm1Osb>	MP:0001730,embryonic growth arrest|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011102,embryonic lethality, incomplete penetrance
MGI:5755026	Pgbd1<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000266,abnormal heart morphology|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001147,small testis|MP:0001293,anophthalmia|MP:0001944,abnormal pancreas morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002637,small uterus|MP:0002768,small adrenal glands|MP:0004958,enlarged prostate gland|MP:0011874,enlarged urinary bladder
MGI:6156565	Pgbd5<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0001293,anophthalmia|MP:0001399,hyperactivity|MP:0002941,increased circulating alanine transaminase level|MP:0003068,enlarged kidney|MP:0005293,impaired glucose tolerance|MP:0009454,impaired contextual conditioning behavior|MP:0009516,enlarged salivary gland|MP:0010024,increased total body fat amount|MP:0010052,increased grip strength
MGI:7334717	Pgbd5<tm1.2Aken>	MP:0003631,nervous system phenotype
MGI:7543060	Pgc<em1Hcz>	MP:0000473,abnormal stomach glandular epithelium morphology|MP:0002083,premature death|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002966,decreased circulating alkaline phosphatase level|MP:0004502,decreased incidence of tumors by chemical induction
MGI:7426124	Pgc<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0009142,decreased prepulse inhibition
MGI:7425474	Pgcka1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001556,increased circulating HDL cholesterol level
MGI:2389315	Pgct1<129S1/SvImJ>	MP:0006262,increased testis tumor incidence
MGI:6718292	Pgd<tm1.1Pse>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001265,decreased body size|MP:0001849,ear inflammation|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002496,increased IgD level|MP:0002497,increased IgE level|MP:0003447,decreased tumor growth/size|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004946,abnormal regulatory T cell physiology|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005015,increased T cell number|MP:0005251,blepharitis|MP:0005440,increased glycogen level|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008500,increased IgG2a level|MP:0008502,increased IgG3 level|MP:0008566,increased interferon-gamma secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008602,increased circulating interleukin-4 level|MP:0008614,increased circulating interleukin-17 level|MP:0008626,increased circulating interleukin-5 level|MP:0010183,abnormal CD4-positive helper T cell morphology|MP:0012762,abnormal alpha-beta T cell morphology
MGI:4431737	Pgd<tm1a(EUCOMM)Wtsi>	MP:0002896,abnormal bone mineralization
MGI:7425908	Pgf<em1(IMPC)Ccpcz>	MP:0002792,abnormal retina vasculature morphology|MP:0008045,decreased NK cell number
MGI:2183459	Pgf<tm1Pec>	MP:0000003,abnormal adipose tissue morphology|MP:0000260,abnormal angiogenesis|MP:0001619,abnormal vascular permeability|MP:0002908,delayed wound healing|MP:0003447,decreased tumor growth/size|MP:0004921,decreased placenta weight|MP:0005388,respiratory system phenotype|MP:0005542,cornea vascularization|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009269,decreased fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0009674,decreased birth weight|MP:0010025,decreased total body fat amount|MP:0010182,decreased susceptibility to weight gain
MGI:3713757	Pggt1b<tm1.1Mbrg>	MP:0000358,abnormal cell morphology|MP:0003091,abnormal cell migration
MGI:3713756	Pggt1b<tm1Mbrg>	MP:0000382,underdeveloped hair follicles|MP:0009584,decreased keratinocyte proliferation|MP:0011087,neonatal lethality, complete penetrance|MP:0011705,absent fibroblast proliferation
MGI:2157154	Pgia10<BALB/cCrl>	MP:0001846,increased inflammatory response|MP:0003725,increased autoantibody level
MGI:2157156	Pgia11<BALB/cCrl>	MP:0003725,increased autoantibody level
MGI:2157158	Pgia12<BALB/cCrl>	MP:0001846,increased inflammatory response
MGI:2155748	Pgia13<C3H/HeJCr>	MP:0003724,increased susceptibility to induced arthritis
MGI:3036112	Pgia14<C3H/HeJCr>	MP:0003724,increased susceptibility to induced arthritis
MGI:2389317	Pgia15<C3H/HeJCr>	MP:0003724,increased susceptibility to induced arthritis
MGI:2156060	Pgia16<C3H/HeJCr>	MP:0005350,increased susceptibility to autoimmune disorder
MGI:2675321	Pgia26<BALB/cCrl>	MP:0001846,increased inflammatory response
MGI:2675320	Pgia26<DBA/2Crl>	MP:0001845,abnormal inflammatory response
MGI:2154923	Pgia2<BALB/cCrl>	MP:0003725,increased autoantibody level
MGI:2156701	Pgia3<DBA/2Crl>	MP:0001846,increased inflammatory response|MP:0003725,increased autoantibody level
MGI:2157012	Pgia4<BALB/cCrl>	MP:0003725,increased autoantibody level
MGI:2157141	Pgia5<BALB/cCrl>	MP:0001846,increased inflammatory response
MGI:2157144	Pgia6<BALB/cCrl>	MP:0003725,increased autoantibody level
MGI:2157146	Pgia7<BALB/cCrl>	MP:0003725,increased autoantibody level
MGI:3803903	Pgia8<DBA/2>	MP:0003436,decreased susceptibility to induced arthritis|MP:0008560,increased tumor necrosis factor secretion|MP:0008706,decreased interleukin-6 secretion
MGI:2157150	Pgia8<DBA/2Crl>	MP:0001846,increased inflammatory response
MGI:2157152	Pgia9<BALB/cCrl>	MP:0001846,increased inflammatory response
MGI:3803908	Pgia9<DBA/2>	MP:0003436,decreased susceptibility to induced arthritis|MP:0008560,increased tumor necrosis factor secretion|MP:0008705,increased interleukin-6 secretion
MGI:3622199	Pgis1<DBA/2>	MP:0003724,increased susceptibility to induced arthritis
MGI:3622200	Pgis2<BALB/c>	MP:0003724,increased susceptibility to induced arthritis
MGI:4421784	Pgk2<tm1Dao>	MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0005389,reproductive system phenotype|MP:0020451,decreased sperm progressive motility
MGI:6257442	Pgls<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:2661914	Pglt	MP:0003051,curly tail
MGI:4949894	Pglyrp1<tm1.1Lky>	MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology
MGI:2670590	Pglyrp1<tm1Rdz>	MP:0000465,gastrointestinal hemorrhage|MP:0000488,abnormal intestinal epithelium morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000512,intestinal ulcer|MP:0001263,weight loss|MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0003449,abnormal intestine goblet cell morphology|MP:0003724,increased susceptibility to induced arthritis|MP:0005074,impaired granulocyte bactericidal activity|MP:0008537,increased susceptibility to induced colitis|MP:0008705,increased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010377,abnormal gut flora balance
MGI:4452065	Pglyrp2<tm1Lky>	MP:0002451,abnormal macrophage physiology|MP:0008597,decreased circulating interleukin-6 level|MP:0008752,abnormal tumor necrosis factor level|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:5297105	Pglyrp2<tm1Rdz>	MP:0000465,gastrointestinal hemorrhage|MP:0000488,abnormal intestinal epithelium morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000512,intestinal ulcer|MP:0001263,weight loss|MP:0003436,decreased susceptibility to induced arthritis|MP:0003449,abnormal intestine goblet cell morphology|MP:0008537,increased susceptibility to induced colitis|MP:0008705,increased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010209,abnormal circulating chemokine level|MP:0010377,abnormal gut flora balance
MGI:7425909	Pglyrp3<em1(IMPC)Ccpcz>	MP:0001262,decreased body weight|MP:0003233,prolonged QT interval|MP:0004156,abnormal QT variability|MP:0005333,decreased heart rate|MP:0005385,cardiovascular system phenotype|MP:0010506,prolonged RR interval
MGI:5297106	Pglyrp3<tm1Rdz>	MP:0000465,gastrointestinal hemorrhage|MP:0000488,abnormal intestinal epithelium morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000512,intestinal ulcer|MP:0001263,weight loss|MP:0003449,abnormal intestine goblet cell morphology|MP:0005387,immune system phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0008705,increased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010377,abnormal gut flora balance
MGI:6389073	Pglyrp4<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0000709,enlarged thymus|MP:0002110,abnormal digit morphology|MP:0002339,abnormal lymph node morphology
MGI:5297107	Pglyrp4<tm1Rdz>	MP:0000465,gastrointestinal hemorrhage|MP:0000488,abnormal intestinal epithelium morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000512,intestinal ulcer|MP:0001263,weight loss|MP:0003449,abnormal intestine goblet cell morphology|MP:0005387,immune system phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0008705,increased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010377,abnormal gut flora balance
MGI:6157346	Pgm1<em1(IMPC)J>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000367,abnormal coat/ hair morphology|MP:0001510,abnormal coat appearance|MP:0001529,abnormal vocalization|MP:0001697,abnormal embryo size|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0002151,abnormal neural tube morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003984,embryonic growth retardation|MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014134,abnormal embryo morphology
MGI:7428455	Pgm1<em1Laik>	MP:0011092,embryonic lethality, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5316476	Pgm2<b-m1Ehs>	MP:0002169,no abnormal phenotype detected
MGI:5305322	Pgm2<m1H>	MP:0002169,no abnormal phenotype detected
MGI:5305326	Pgm2<m2H>	MP:0002169,no abnormal phenotype detected
MGI:5305329	Pgm2<m3H>	MP:0002169,no abnormal phenotype detected
MGI:5305330	Pgm2<m4H>	MP:0002169,no abnormal phenotype detected
MGI:3758654	Pgm2<n>	MP:0002169,no abnormal phenotype detected
MGI:6388357	Pgm3<em1(IMPC)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:3758644	Pgm3<Gt(W037B08)Wrst>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3758645	Pgm3<mld1>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000228,abnormal thrombopoiesis|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000333,decreased bone marrow cell number|MP:0000613,abnormal salivary gland morphology|MP:0001156,abnormal spermatogenesis|MP:0001577,anemia|MP:0001925,male infertility|MP:0001944,abnormal pancreas morphology|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0003868,abnormal feces composition|MP:0004952,increased spleen weight|MP:0005017,decreased B cell number|MP:0008175,absent follicular B cells|MP:0008186,increased pro-B cell number|MP:0008476,increased spleen red pulp amount|MP:0009145,abnormal pancreatic acinus morphology
MGI:3708381	pgo	MP:0001394,circling|MP:0001489,decreased startle reflex|MP:0001522,impaired swimming|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:7330093	Pgpep1<em1(IMPC)J>	MP:0000194,increased circulating calcium level|MP:0001488,increased startle reflex|MP:0009142,decreased prepulse inhibition
MGI:6150835	Pgp<tm1.1Ango>	MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0010768,mortality/aging
MGI:6150833	Pgp<tm1.2Ango>	MP:0000266,abnormal heart morphology|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0001914,hemorrhage|MP:0003984,embryonic growth retardation|MP:0004188,delayed embryo turning|MP:0004259,small placenta|MP:0005621,abnormal cell physiology|MP:0011092,embryonic lethality, complete penetrance|MP:0011702,abnormal fibroblast proliferation
MGI:6272833	Pgrmc1<em1Ejho>	MP:0001554,increased circulating free fatty acids level|MP:0001860,liver inflammation|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002941,increased circulating alanine transaminase level|MP:0003333,liver fibrosis|MP:0009121,increased white fat cell lipid droplet size|MP:0009355,increased liver triglyceride level
MGI:5775088	Pgrmc1<tm1.1Jjp>	MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0003631,nervous system phenotype|MP:0005394,taste/olfaction phenotype
MGI:6118911	Pgrmc2<tm1.1Jjp>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0004896,abnormal endometrium morphology|MP:0005185,decreased circulating progesterone level|MP:0008876,decreased uterine NK cell number|MP:0008995,early reproductive senescence|MP:0009082,uterus cyst|MP:0009094,abnormal endometrial gland morphology|MP:0009251,enlarged endometrial glands|MP:0013401,increased endometrial gland number
MGI:5487679	Pgr<tm1.1(cre)Shah>	MP:0002169,no abnormal phenotype detected
MGI:3689426	Pgr<tm1.1Mlia>	MP:0001619,abnormal vascular permeability|MP:0001729,impaired embryo implantation|MP:0002169,no abnormal phenotype detected|MP:0009671,abnormal uterus physiology
MGI:3689427	Pgr<tm1.2Mlia>	MP:0001926,female infertility|MP:0003572,abnormal uterus development|MP:0009671,abnormal uterus physiology|MP:0031422,failure of superovulation
MGI:1857933	Pgr<tm1Bwo>	MP:0000130,abnormal trabecular bone morphology|MP:0000558,abnormal tibia morphology|MP:0000628,abnormal mammary gland development|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001120,abnormal uterus morphology|MP:0001123,dilated uterus|MP:0001134,absent corpus luteum|MP:0001376,abnormal mating receptivity|MP:0001881,abnormal mammary gland physiology|MP:0001926,female infertility|MP:0002053,decreased incidence of induced tumors|MP:0002079,increased circulating insulin level|MP:0002676,uterus hyperplasia|MP:0002773,decreased circulating luteinizing hormone level|MP:0003058,increased insulin secretion|MP:0003356,impaired luteinization|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003645,increased pancreatic beta cell number|MP:0003845,abnormal decidualization|MP:0003967,abnormal follicle stimulating hormone level|MP:0004148,increased compact bone thickness|MP:0004883,abnormal vascular wound healing|MP:0004982,abnormal osteoclast morphology|MP:0005124,increased circulating prolactin level|MP:0005292,improved glucose tolerance|MP:0005296,abnormal humerus morphology|MP:0005489,vascular smooth muscle hyperplasia|MP:0005491,pancreatic islet hyperplasia|MP:0005560,decreased circulating glucose level|MP:0005605,increased bone mass|MP:0008271,abnormal bone ossification|MP:0008870,increased mature ovarian follicle number|MP:0009080,uterus inflammation|MP:0009251,enlarged endometrial glands|MP:0009347,increased trabecular bone thickness|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009506,abnormal mammary gland alveolus morphology|MP:0009671,abnormal uterus physiology|MP:0010174,decreased mammary gland epithelial cell proliferation|MP:0011819,increased pancreatic beta cell proliferation|MP:0031422,failure of superovulation
MGI:3032652	Pgr<tm1Lyd>	MP:0000628,abnormal mammary gland development|MP:0001119,abnormal female reproductive system morphology|MP:0001134,absent corpus luteum|MP:0001919,abnormal reproductive system physiology|MP:0001926,female infertility|MP:0001928,abnormal ovulation|MP:0002169,no abnormal phenotype detected|MP:0002566,abnormal sexual interaction|MP:0002676,uterus hyperplasia|MP:0003009,abnormal cytokine secretion
MGI:2183208	Pgr<tm1Omc>	MP:0001926,female infertility|MP:0002676,uterus hyperplasia|MP:0003845,abnormal decidualization|MP:0004014,abnormal uterine environment|MP:0005379,endocrine/exocrine gland phenotype|MP:0031420,decreased superovulation rate
MGI:2674932	Pgr<tm2Omc>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0001882,abnormal lactation|MP:0005389,reproductive system phenotype|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009506,abnormal mammary gland alveolus morphology
MGI:5487681	Pgr<tm2Shah>	MP:0002169,no abnormal phenotype detected
MGI:3768562	Pgr<tm3(rtTA2S*M2)Lyd>	MP:0001119,abnormal female reproductive system morphology|MP:0001926,female infertility|MP:0002566,abnormal sexual interaction
MGI:4439306	Pgr<tm4.2Lyd>	MP:0001881,abnormal mammary gland physiology|MP:0009671,abnormal uterus physiology|MP:0031422,failure of superovulation
MGI:5637078	Pgs1<tm1b(EUCOMM)Hmgu>	MP:0001566,increased circulating phosphate level|MP:0011100,preweaning lethality, complete penetrance
MGI:1888789	pgtr	MP:0001394,circling|MP:0001732,postnatal growth retardation|MP:0002566,abnormal sexual interaction|MP:0003051,curly tail
MGI:1857106	Ph	MP:0000373,belly spot|MP:0002940,variable body spotting
MGI:1889550	Ph<3H>	MP:0000108,midline facial cleft|MP:0002081,perinatal lethality|MP:0002940,variable body spotting
MGI:6152614	Phactr1<em1(IMPC)Mbp>	MP:0000221,decreased leukocyte cell number|MP:0000367,abnormal coat/ hair morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002942,decreased circulating alanine transaminase level|MP:0005632,decreased circulating aspartate transaminase level|MP:0010123,increased bone mineral content
MGI:6324157	Phactr4<em1(IMPC)Hmgu>	MP:0004156,abnormal QT variability|MP:0011100,preweaning lethality, complete penetrance
MGI:3720739	Phactr4<Gt(RRA075)Byg>	MP:0001672,abnormal embryo development
MGI:3720740	Phactr4<humdy>	MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0000930,wavy neural tube|MP:0001325,abnormal retina morphology|MP:0002151,abnormal neural tube morphology|MP:0003077,abnormal cell cycle|MP:0003885,abnormal rostral-caudal body axis extension|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005262,coloboma|MP:0006069,abnormal retina neuronal layer morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:7425910	Phb1<em1(IMPC)H>	MP:0001552,increased circulating triglyceride level|MP:0005565,increased blood urea nitrogen level|MP:0010068,decreased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance|MP:0012362,increased large unstained cell number
MGI:3771852	Phb1<Gt(BGB069)Byg>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3529854	Phb1<Gt(OST368818)Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:3771851	Phb1<Gt(XT0035)Wtsi>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5051969	Phb1<tm1.1Bwo>	MP:0001120,abnormal uterus morphology|MP:0001926,female infertility|MP:0004896,abnormal endometrium morphology|MP:0004902,abnormal uterus size|MP:0004905,decreased uterus weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0009088,thin uterine horn|MP:0009091,endometrium hypoplasia
MGI:5051970	Phb1<tm1.2Bwo>	MP:0011092,embryonic lethality, complete penetrance
MGI:5051968	Phb1<tm1Bwo>	MP:0001265,decreased body size|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3775183	Phb2<tm1.1Tlan>	MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:3574361	Phb2<tm1Katz>	MP:0001120,abnormal uterus morphology|MP:0001933,abnormal litter size|MP:0004904,increased uterus weight|MP:0005455,increased susceptibility to weight gain|MP:0011092,embryonic lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3775179	Phb2<tm1Tlan>	MP:0006035,abnormal mitochondrial morphology|MP:0008943,increased sensitivity to induced cell death|MP:0011704,decreased fibroblast proliferation
MGI:5299189	Phb2<tm2.1Katz>	MP:0000627,abnormal mammary gland morphology|MP:0001382,abnormal nursing|MP:0004047,abnormal milk composition|MP:0005389,reproductive system phenotype|MP:0006270,abnormal mammary gland growth during lactation|MP:0006271,abnormal involution of the mammary gland|MP:0009503,abnormal mammary gland duct morphology|MP:0009506,abnormal mammary gland alveolus morphology|MP:0014126,increased mammary gland apoptosis
MGI:1857629	Phc1<tm1Os>	MP:0000104,abnormal sphenoid bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000157,abnormal sternum morphology|MP:0000240,extramedullary hematopoiesis|MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0000273,overriding aortic valve|MP:0000276,heart right ventricle hypertrophy|MP:0000280,thin ventricular wall|MP:0001265,decreased body size|MP:0001606,impaired hematopoiesis|MP:0002144,abnormal B cell differentiation|MP:0002746,abnormal semilunar valve morphology|MP:0002925,abnormal cardiovascular development|MP:0003494,parathyroid hypoplasia|MP:0004269,abnormal optic cup morphology|MP:0004441,small occipital bone|MP:0004448,abnormal presphenoid bone morphology|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004620,cervical vertebral fusion|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight|MP:0005269,abnormal occipital bone morphology|MP:0006117,aortic valve stenosis|MP:0006126,abnormal cardiac outflow tract development|MP:0006128,pulmonary valve stenosis|MP:0008022,dilated heart ventricle|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0010402,ventricular septal defect|MP:0010428,abnormal heart right ventricle outflow tract morphology|MP:0010458,pulmonary trunk hypoplasia|MP:0010568,abnormal bulbus cordis morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0013545,cleft hard palate|MP:0021210,bilateral cleft palate
MGI:3586989	Phc2<tm1Hko>	MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000157,abnormal sternum morphology|MP:0000480,increased rib number|MP:0002114,abnormal axial skeleton morphology|MP:0003036,vertebral transformation|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004620,cervical vertebral fusion|MP:0005387,immune system phenotype|MP:0008008,early cellular replicative senescence|MP:0008146,asymmetric sternocostal joints|MP:0010701,fusion of atlas and odontoid process|MP:0010702,split cervical atlas|MP:0010703,split cervical axis|MP:0011704,decreased fibroblast proliferation
MGI:5559318	Phc2<tm2.1Hko>	MP:0000480,increased rib number|MP:0003036,vertebral transformation|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004620,cervical vertebral fusion
MGI:5559319	Phc2<tm3.1Hko>	MP:0000480,increased rib number|MP:0003036,vertebral transformation|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004620,cervical vertebral fusion
MGI:5708239	Phc3<tm2b(KOMP)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level
MGI:3525315	Phdlc1<CASA/RkJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3525316	Phdlc2<C57BL/6J>	MP:0001556,increased circulating HDL cholesterol level
MGI:1889551	Ph<e>	MP:0002075,abnormal coat/hair pigmentation|MP:0008797,facial cleft|MP:0011102,embryonic lethality, incomplete penetrance
MGI:5435304	Phex<Hpr>	MP:0000063,decreased bone mineral density|MP:0000137,abnormal vertebrae morphology|MP:0000198,decreased circulating phosphate level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003109,short femur|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0004686,decreased length of long bones|MP:0008158,increased diameter of femur
MGI:1857312	Phex<Hyp>	MP:0000063,decreased bone mineral density|MP:0000088,short mandible|MP:0000091,short premaxilla|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000592,short tail|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001666,abnormal intestinal absorption|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002759,abnormal caudal vertebrae morphology|MP:0002764,short tibia|MP:0002765,short fibula|MP:0002835,abnormal cranial suture morphology|MP:0002896,abnormal bone mineralization|MP:0002901,increased urine phosphate level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003109,short femur|MP:0003116,rickets|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003718,maternal effect|MP:0004380,short frontal bone|MP:0004471,short nasal bone|MP:0004652,small caudal vertebrae|MP:0004686,decreased length of long bones|MP:0005353,abnormal patella morphology|MP:0005384,cellular phenotype|MP:0005628,decreased circulating potassium level|MP:0006397,disorganized long bone epiphyseal plate|MP:0006431,abnormal fibrocartilage morphology|MP:0008151,increased diameter of long bones|MP:0008525,decreased cranium height|MP:0009445,osteomalacia|MP:0009780,abnormal chondrocyte physiology|MP:0010110,abnormal renal phosphate reabsorption|MP:0011221,decreased intestinal calcium absorption|MP:0011228,abnormal vitamin D level|MP:0011447,abnormal renal glucose reabsorption|MP:0011476,abnormal urine nucleotide level|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013942,enthesitis|MP:0014322,short hindlimb|MP:0020137,decreased bone mineralization|MP:0030484,abnormal osteocyte lacuna morphology|MP:0030485,abnormal osteocyte lacunocanalicular system morphology
MGI:2181653	Phex<Hyp-2J>	MP:0000063,decreased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0000592,short tail|MP:0001262,decreased body weight|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002116,abnormal craniofacial bone morphology|MP:0002764,short tibia|MP:0002765,short fibula|MP:0003109,short femur|MP:0003167,abnormal scala tympani morphology|MP:0004686,decreased length of long bones|MP:0005352,small cranium|MP:0005353,abnormal patella morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005628,decreased circulating potassium level|MP:0006397,disorganized long bone epiphyseal plate|MP:0008151,increased diameter of long bones|MP:0014322,short hindlimb
MGI:2388890	Phex<Hyp-Duk>	MP:0000031,abnormal cochlea morphology|MP:0000039,abnormal otic capsule morphology|MP:0000043,organ of Corti degeneration|MP:0000063,decreased bone mineral density|MP:0000097,short maxilla|MP:0000195,decreased circulating calcium level|MP:0000438,abnormal cranium morphology|MP:0000592,short tail|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001394,circling|MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0001732,postnatal growth retardation|MP:0001849,ear inflammation|MP:0001850,increased susceptibility to otitis media|MP:0002115,abnormal limb bone morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002764,short tibia|MP:0002765,short fibula|MP:0002857,cochlear ganglion degeneration|MP:0003109,short femur|MP:0003167,abnormal scala tympani morphology|MP:0004686,decreased length of long bones|MP:0004699,unilateral deafness|MP:0005272,abnormal temporal bone morphology|MP:0005352,small cranium|MP:0005353,abnormal patella morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0005628,decreased circulating potassium level|MP:0006025,distended Reissner membrane|MP:0006089,abnormal vestibular saccule morphology|MP:0006325,impaired hearing|MP:0006397,disorganized long bone epiphyseal plate|MP:0008151,increased diameter of long bones|MP:0010025,decreased total body fat amount|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014322,short hindlimb
MGI:5489940	Phex<m1Jrt>	MP:0000063,decreased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002932,abnormal joint morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003797,abnormal compact bone morphology|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004610,small vertebrae|MP:0004686,decreased length of long bones|MP:0005390,skeleton phenotype|MP:0006398,increased long bone epiphyseal plate size|MP:0008152,decreased diameter of femur|MP:0009445,osteomalacia|MP:0010124,decreased bone mineral content|MP:0010924,abnormal osteoid morphology|MP:0011505,camptomelia
MGI:5424918	Phex<Mhdabap012>	MP:0000198,decreased circulating phosphate level|MP:0001394,circling|MP:0002968,increased circulating alkaline phosphatase level|MP:0014322,short hindlimb
MGI:5424921	Phex<Mhdabap024>	MP:0000063,decreased bone mineral density|MP:0000198,decreased circulating phosphate level|MP:0001265,decreased body size|MP:0001394,circling|MP:0002901,increased urine phosphate level|MP:0002904,increased circulating parathyroid hormone level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0002986,decreased urine calcium level|MP:0003432,increased activity of parathyroid|MP:0003620,oliguria|MP:0003797,abnormal compact bone morphology|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005385,cardiovascular system phenotype|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0009642,abnormal blood homeostasis|MP:0011470,increased urine creatinine level|MP:0012336,decreased vitamin D level|MP:0031060,decreased circulating C-reactive protein level
MGI:3797014	Phex<Pug>	MP:0000063,decreased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000592,short tail|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0002427,disproportionate dwarf|MP:0002896,abnormal bone mineralization|MP:0005508,abnormal skeleton morphology|MP:0006281,abnormal tail development|MP:0006397,disorganized long bone epiphyseal plate|MP:0010878,increased trabecular bone volume|MP:0014104,decreased chondrocyte apoptosis|MP:0014322,short hindlimb|MP:0021186,decreased bone mineral density of vertebrae
MGI:2429767	Phex<Ska1>	MP:0000063,decreased bone mineral density|MP:0000133,abnormal long bone metaphysis morphology|MP:0000135,decreased compact bone thickness|MP:0000150,abnormal rib morphology|MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000556,abnormal hindlimb morphology|MP:0001406,abnormal gait|MP:0001541,abnormal osteoclast physiology|MP:0002759,abnormal caudal vertebrae morphology|MP:0002764,short tibia|MP:0002765,short fibula|MP:0002896,abnormal bone mineralization|MP:0002968,increased circulating alkaline phosphatase level|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003116,rickets|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0004338,small clavicle|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004993,decreased bone resorption|MP:0005508,abnormal skeleton morphology|MP:0009445,osteomalacia|MP:0009877,exostosis|MP:0011504,abnormal limb long bone morphology|MP:0014322,short hindlimb|MP:0020010,decreased bone mineral density of femur|MP:0030828,abnormal obturator foramen morphology|MP:0030830,abnormal acetabulum morphology|MP:0030876,abnormal costochondral joint morphology
MGI:3775078	Phex<tm1.1Mkd>	MP:0000198,decreased circulating phosphate level|MP:0003109,short femur|MP:0004686,decreased length of long bones|MP:0009445,osteomalacia|MP:0010110,abnormal renal phosphate reabsorption|MP:0030484,abnormal osteocyte lacuna morphology|MP:0030485,abnormal osteocyte lacunocanalicular system morphology
MGI:3775079	Phex<tm1.2Mkd>	MP:0000198,decreased circulating phosphate level|MP:0003109,short femur|MP:0004686,decreased length of long bones|MP:0009445,osteomalacia|MP:0010110,abnormal renal phosphate reabsorption|MP:0030484,abnormal osteocyte lacuna morphology|MP:0030485,abnormal osteocyte lacunocanalicular system morphology
MGI:5439538	Phf10<tm1.1Grc>	MP:0002169,no abnormal phenotype detected
MGI:6276833	Phf10<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:6257484	Phf11c<em1(IMPC)Tcp>	MP:0001399,hyperactivity
MGI:5689881	Phf11d<m1H>	MP:0001845,abnormal inflammatory response|MP:0005388,respiratory system phenotype|MP:0005397,hematopoietic system phenotype
MGI:4122549	Phf13<Gt(XA022)Byg>	MP:0001145,abnormal male reproductive system morphology|MP:0003698,abnormal male reproductive system physiology|MP:0010769,abnormal survival
MGI:3836461	Phf13<Gt(XB691)Byg>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0003205,testicular atrophy|MP:0004852,decreased testis weight|MP:0008280,abnormal male germ cell apoptosis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:6277016	Phf14<em1(IMPC)Hmgu>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0002757,decreased vertical activity|MP:0002966,decreased circulating alkaline phosphatase level|MP:0011100,preweaning lethality, complete penetrance
MGI:5426539	Phf14<tm1Take>	MP:0000351,increased cell proliferation|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0008277,abnormal sternum ossification|MP:0010903,abnormal pulmonary alveolus wall morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011703,increased fibroblast proliferation
MGI:5695927	Phf19<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0010379,decreased respiratory quotient
MGI:6827412	Phf19<tm1.1Ldc>	MP:0000333,decreased bone marrow cell number|MP:0000480,increased rib number|MP:0000691,enlarged spleen|MP:0001606,impaired hematopoiesis|MP:0003036,vertebral transformation|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011181,increased hematopoietic cell number|MP:0011182,decreased hematopoietic cell number|MP:0011902,increased hematopoietic stem cell proliferation
MGI:4129686	Phf20<Gt(XN131)Byg>	MP:0000060,delayed bone ossification|MP:0000061,fragile skeleton|MP:0000333,decreased bone marrow cell number|MP:0000692,small spleen|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0002396,abnormal hematopoietic system morphology/development|MP:0004200,decreased fetal size|MP:0004647,decreased lumbar vertebrae number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008475,intermingled spleen red and white pulp|MP:0010025,decreased total body fat amount|MP:0011088,neonatal lethality, incomplete penetrance
MGI:6273283	Phf20l1<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000702,enlarged lymph nodes|MP:0001258,decreased body length|MP:0001325,abnormal retina morphology|MP:0002152,abnormal brain morphology|MP:0002590,increased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002764,short tibia|MP:0002833,increased heart weight|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0004952,increased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0005561,increased mean corpuscular hemoglobin|MP:0010025,decreased total body fat amount|MP:0020421,increased freezing behavior
MGI:4432264	Phf20<tm1a(EUCOMM)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3629054	Phf21a<tm1Tba>	MP:0001436,abnormal suckling behavior|MP:0011087,neonatal lethality, complete penetrance
MGI:7335174	Phf21b<em1Mlwg>	MP:0001473,reduced long-term potentiation|MP:0005386,behavior/neurological phenotype|MP:0006254,thin cerebral cortex|MP:0008415,abnormal neurite morphology|MP:0008948,decreased neuron number|MP:0012066,decreased astrocyte number|MP:0020514,abnormal dendritic thin spine morphology|MP:0021112,impaired social recognition
MGI:5706936	Phf24<tm1.2(HBEGF)Azmo>	MP:0002734,abnormal mechanical nociception|MP:0002735,abnormal chemical nociception|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5496656	Phf2<tm1.1Yima>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002176,increased brain weight|MP:0005376,homeostasis/metabolism phenotype|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009131,decreased white fat cell number|MP:0009133,decreased white fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0009289,decreased epididymal fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0010025,decreased total body fat amount|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011167,abnormal adipose tissue development
MGI:5496657	Phf2<tm1.2Yima>	MP:0011167,abnormal adipose tissue development
MGI:5287021	Phf5a<TgTn(sb-cHS4,Tyr)2323COve>	MP:0006205,embryonic lethality between implantation and somite formation
MGI:7611699	Phf5a<tm1.1Oux>	MP:0000692,small spleen|MP:0002459,abnormal B cell physiology|MP:0005017,decreased B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008760,abnormal immunoglobulin heavy chain V(D)J recombination|MP:0008766,abnormal B cell receptor editing|MP:0011815,increased pre-pro B cell number|MP:0014403,decreased early pro-B cell number|MP:0014404,decreased late pro-B cell number
MGI:6280442	Phf6<em1Azbi>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001417,decreased exploration in new environment|MP:0001458,abnormal object recognition memory|MP:0001489,decreased startle reflex|MP:0002757,decreased vertical activity|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003466,decreased single cell response threshold|MP:0003468,increased single cell response intensity|MP:0004811,abnormal neuron physiology|MP:0005402,abnormal action potential|MP:0009454,impaired contextual conditioning behavior|MP:0020396,abnormal social recognition
MGI:7280677	Phf6<em1Wencc>	MP:0000218,increased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000321,increased bone marrow cell number|MP:0000333,decreased bone marrow cell number|MP:0000691,enlarged spleen|MP:0002417,abnormal megakaryocyte morphology|MP:0003179,thrombocytopenia|MP:0004809,increased hematopoietic stem cell number|MP:0004810,decreased hematopoietic stem cell number|MP:0005014,increased B cell number|MP:0005016,decreased lymphocyte cell number|MP:0005089,decreased double-negative T cell number|MP:0005387,immune system phenotype|MP:0005390,skeleton phenotype|MP:0005397,hematopoietic system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008186,increased pro-B cell number|MP:0008254,increased megakaryocyte cell number|MP:0008826,abnormal splenic cell ratio|MP:0008827,abnormal thymus cell ratio|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0011902,increased hematopoietic stem cell proliferation|MP:0013697,decreased granulocyte monocyte progenitor cell number|MP:0013762,abnormal effector T cell number
MGI:6280443	Phf6<em2Azbi>	MP:0011089,perinatal lethality, complete penetrance
MGI:6507034	Phf6<tm1.1Avo>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001545,abnormal hematopoietic system physiology|MP:0002026,increased leukemia incidence|MP:0002145,abnormal T cell differentiation|MP:0004809,increased hematopoietic stem cell number|MP:0004810,decreased hematopoietic stem cell number|MP:0008524,increased plasmacytoid dendritic cell number|MP:0008573,increased circulating interferon-alpha level|MP:0010132,decreased DN2 thymocyte number|MP:0011902,increased hematopoietic stem cell proliferation|MP:0013707,abnormal hematopoietic precursor cell morphology|MP:0013892,increased common lymphocyte progenitor cell number|MP:0014400,increased hematopoietic precursor cell number
MGI:6507035	Phf6<tm1.2Avo>	MP:0000008,increased white adipose tissue amount|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002026,increased leukemia incidence|MP:0003961,decreased lean body mass|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005120,decreased circulating growth hormone level|MP:0005128,decreased adrenocorticotropin level|MP:0005136,decreased growth hormone level|MP:0005138,decreased prolactin level|MP:0005361,small pituitary gland|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011089,perinatal lethality, complete penetrance
MGI:5548606	Phf6<tm1b(EUCOMM)Wtsi>	MP:0004738,abnormal auditory brainstem response|MP:0011100,preweaning lethality, complete penetrance
MGI:6153574	Phf7<em1(IMPC)Wtsi>	MP:0001925,male infertility
MGI:6423316	Phf7<tm1b(EUCOMM)Hmgu>	MP:0001925,male infertility|MP:0011972,decreased circulating lactate dehydrogenase level
MGI:6690457	Phf7<tm1c(EUCOMM)Hmgu>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009233,enlarged sperm head|MP:0009647,decreased fertilization frequency
MGI:6153728	Phf8<em2(IMPC)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0002875,decreased erythrocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0005561,increased mean corpuscular hemoglobin
MGI:6370001	Phf8<tm1.1Cdcn>	MP:0001473,reduced long-term potentiation|MP:0003635,abnormal synaptic transmission|MP:0004000,impaired passive avoidance behavior|MP:0005382,craniofacial phenotype|MP:0008414,abnormal spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0012307,impaired spatial learning|MP:0031391,increased locomotor activity
MGI:6094243	Phf8<tm1.1Hoch>	MP:0000352,decreased cell proliferation|MP:0001364,decreased anxiety-related response|MP:0003063,increased coping response|MP:0004077,abnormal striatum morphology|MP:0005378,growth/size/body region phenotype|MP:0005382,craniofacial phenotype|MP:0020870,decreased thigmotaxis
MGI:7432909	Phf8<tm1dIcs>	MP:0000219,increased neutrophil cell number|MP:0001556,increased circulating HDL cholesterol level|MP:0002941,increased circulating alanine transaminase level|MP:0003921,abnormal heart left ventricle morphology|MP:0005016,decreased lymphocyte cell number|MP:0005292,improved glucose tolerance|MP:0011960,abnormal eye anterior chamber depth
MGI:3769591	Phgdh<tm1.1Shfu>	MP:0000571,interdigital webbing|MP:0000774,decreased brain size|MP:0000784,forebrain hypoplasia|MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0000850,absent cerebellum|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0001698,decreased embryo size|MP:0003451,absent olfactory bulb|MP:0003861,abnormal nervous system development|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0008535,enlarged lateral ventricles|MP:0009937,abnormal neuron differentiation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4881750	Phgdh<tm1.2Shfu>	MP:0000433,microcephaly|MP:0000784,forebrain hypoplasia|MP:0002175,decreased brain weight|MP:0030655,increased circulating glycine level|MP:0030659,decreased glycine level|MP:0030664,increased arginine level|MP:0030665,decreased arginine level|MP:0030685,decreased cystathionine level|MP:0030692,decreased serine level|MP:0030697,increased phenylalanine level|MP:0030698,decreased phenylalanine level|MP:0030701,decreased threonine level|MP:0030706,increased glutamine level|MP:0030737,decreased glutamic acid level
MGI:6120719	Phgdh<tm1b(KOMP)Wtsi>	MP:0000841,abnormal hindbrain morphology|MP:0001297,microphthalmia|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001404,no spontaneous movement|MP:0001491,unresponsive to tactile stimuli|MP:0001614,abnormal blood vessel morphology|MP:0001672,abnormal embryo development|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001718,abnormal visceral yolk sac morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002080,prenatal lethality|MP:0002092,abnormal eye morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0010379,decreased respiratory quotient|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0011496,abnormal head size|MP:0011940,decreased food intake|MP:0011942,decreased fluid intake
MGI:6156509	Phip<em1(IMPC)Tcp>	MP:0000438,abnormal cranium morphology|MP:0001399,hyperactivity|MP:0001697,abnormal embryo size|MP:0001891,hydrocephaly|MP:0002637,small uterus|MP:0005343,increased circulating aspartate transaminase level|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder
MGI:6153577	Phip<em1(IMPC)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0001258,decreased body length|MP:0003020,decreased circulating chloride level
MGI:4129907	Phip<Gt(RRJ571)Byg>	MP:0000189,hypoglycemia|MP:0000607,abnormal hepatocyte morphology|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002891,increased insulin sensitivity|MP:0004565,decreased myocardial fiber size|MP:0005621,abnormal cell physiology|MP:0006382,abnormal lung epithelium morphology|MP:0010025,decreased total body fat amount|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6156433	Phka1<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000692,small spleen|MP:0001120,abnormal uterus morphology|MP:0002060,abnormal skin morphology
MGI:4821260	Phka1<I/FnLn>	MP:0010401,increased skeletal muscle glycogen level
MGI:5901846	Phkb<em1(IMPC)J>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0001303,abnormal lens morphology|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001552,increased circulating triglyceride level|MP:0002075,abnormal coat/hair pigmentation|MP:0002575,increased circulating ketone body level|MP:0002715,decreased glycogen catabolism rate|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0002981,increased liver weight|MP:0003961,decreased lean body mass|MP:0005343,increased circulating aspartate transaminase level|MP:0005560,decreased circulating glucose level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008821,increased blood uric acid level|MP:0009356,decreased liver triglyceride level|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010400,increased liver glycogen level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013245,abnormal lipid metabolism|MP:0013278,decreased fasting circulating glucose level|MP:0030974,enhanced gluconeogenesis
MGI:6857718	Phkg1<tm1.1(KOMP)Vlcg>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001258,decreased body length|MP:0001304,cataract|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney
MGI:5629316	Phkg2<tm1.1(KOMP)Vlcg>	MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0005564,increased hemoglobin content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3664205	Phl1<101/H>	MP:0004767,increased cochlear nerve compound action potential
MGI:3664208	Phl2<101/H>	MP:0004767,increased cochlear nerve compound action potential
MGI:2182815	Phlda1<tm1Ywc>	MP:0005387,immune system phenotype
MGI:2181542	Phlda2<tm1Bty>	MP:0003123,paternal imprinting|MP:0004920,increased placenta weight|MP:0012098,increased spongiotrophoblast size|MP:0012108,increased trophoblast glycogen cell number
MGI:2181543	Phlda2<tm2Bty>	MP:0003123,paternal imprinting|MP:0004920,increased placenta weight|MP:0009431,decreased fetal weight|MP:0012098,increased spongiotrophoblast size|MP:0012108,increased trophoblast glycogen cell number
MGI:2181548	Phlda3<tm1Bty>	MP:0005380,embryo phenotype
MGI:6093475	Phldb1<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001402,decreased locomotor activity|MP:0001529,abnormal vocalization|MP:0003179,thrombocytopenia|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:6149207	Phldb2<em1(IMPC)H>	MP:0001333,absent optic nerve|MP:0001488,increased startle reflex|MP:0002606,increased basophil cell number
MGI:6364613	Phldb2<tm1Msat>	MP:0001473,reduced long-term potentiation|MP:0005386,behavior/neurological phenotype|MP:0008414,abnormal spatial reference memory|MP:0009936,abnormal dendritic spine morphology
MGI:6257557	Phlpp1<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity|MP:0002792,abnormal retina vasculature morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003961,decreased lean body mass
MGI:4421807	Phlpp1<tm1.1Saco>	MP:0005381,digestive/alimentary phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0020473,abnormal circadian behavior phase|MP:0020475,delayed circadian behavior phase
MGI:6315515	Phlpp2<em1(IMPC)H>	MP:0001488,increased startle reflex
MGI:5795604	Phlpp2<tm1d(EUCOMM)Hmgu>	MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype
MGI:5049904	Phospho1<m1Jlm>	MP:0000061,fragile skeleton|MP:0000062,increased bone mineral density|MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000150,abnormal rib morphology|MP:0000161,scoliosis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001566,increased circulating phosphate level|MP:0001732,postnatal growth retardation|MP:0002764,short tibia|MP:0003109,short femur|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0003797,abnormal compact bone morphology|MP:0004358,bowed tibia|MP:0004361,bowed ulna|MP:0004371,bowed femur|MP:0004372,bowed fibula|MP:0004373,bowed humerus|MP:0004374,bowed radius|MP:0005298,abnormal clavicle morphology|MP:0005508,abnormal skeleton morphology|MP:0008274,failure of bone ossification|MP:0009445,osteomalacia|MP:0009780,abnormal chondrocyte physiology|MP:0010868,increased bone trabecula number|MP:0011940,decreased food intake|MP:0011942,decreased fluid intake|MP:0020010,decreased bone mineral density of femur|MP:0021184,decreased bone mineral density of humerus
MGI:2157906	Phospq1<SM/J>	MP:0001547,abnormal lipid level
MGI:3531321	Phox2a/Inppl1<tm1Ssch>	MP:0000189,hypoglycemia|MP:0001262,decreased body weight|MP:0001575,cyanosis|MP:0001732,postnatal growth retardation|MP:0001954,respiratory distress|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003383,abnormal gluconeogenesis|MP:0005202,lethargy|MP:0005292,improved glucose tolerance|MP:0005438,abnormal glycogen homeostasis|MP:0011085,postnatal lethality, complete penetrance
MGI:3531322	Phox2a/Inppl1<tm1Ssch>	MP:0000189,hypoglycemia|MP:0001262,decreased body weight|MP:0001575,cyanosis|MP:0001732,postnatal growth retardation|MP:0001954,respiratory distress|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003383,abnormal gluconeogenesis|MP:0005202,lethargy|MP:0005292,improved glucose tolerance|MP:0005438,abnormal glycogen homeostasis|MP:0011085,postnatal lethality, complete penetrance
MGI:2180355	Phox2a<tm1.1Sgu>	MP:0000939,decreased motor neuron number|MP:0001015,small superior cervical ganglion|MP:0001034,abnormal parasympathetic ganglion morphology|MP:0001036,small submandibular ganglion|MP:0001071,abnormal facial nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001083,small geniculate ganglion|MP:0001085,small petrosal ganglion|MP:0001088,small nodose ganglion|MP:0001093,small trigeminal ganglion|MP:0001943,abnormal respiration|MP:0002751,abnormal autonomic nervous system morphology|MP:0003661,abnormal locus ceruleus morphology|MP:0005574,decreased pulmonary respiratory rate|MP:0008314,abnormal pterygopalatine ganglion morphology|MP:0008315,abnormal otic ganglion morphology|MP:0008947,increased neuron number|MP:0009937,abnormal neuron differentiation
MGI:2180328	Phox2a<tm1Jbr>	MP:0001015,small superior cervical ganglion|MP:0001034,abnormal parasympathetic ganglion morphology|MP:0001035,abnormal submandibular ganglion morphology|MP:0001036,small submandibular ganglion|MP:0001071,abnormal facial nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001083,small geniculate ganglion|MP:0001085,small petrosal ganglion|MP:0001088,small nodose ganglion|MP:0002751,abnormal autonomic nervous system morphology|MP:0003661,abnormal locus ceruleus morphology|MP:0005573,increased pulmonary respiratory rate|MP:0005575,increased pulmonary ventilation|MP:0005585,increased tidal volume|MP:0008314,abnormal pterygopalatine ganglion morphology|MP:0008315,abnormal otic ganglion morphology|MP:0010105,abnormal sublingual ganglion morphology
MGI:3521825	Phox2a<tm1(Phox2b)Mist>	MP:0001061,abnormal oculomotor nerve morphology|MP:0001063,abnormal trochlear nerve morphology|MP:0003631,nervous system phenotype|MP:0010768,mortality/aging
MGI:4438118	Phox2a<tm2.1Jbr>	MP:0003631,nervous system phenotype
MGI:1934628	Phox2b<Dilp1>	MP:0002082,postnatal lethality|MP:0002092,abnormal eye morphology|MP:0002546,mydriasis|MP:0004990,abnormal ciliary ganglion morphology|MP:0006243,impaired pupillary reflex|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7657398	Phox2b<em3(cre)Heno>	MP:0001732,postnatal growth retardation
MGI:5451081	Phox2b<tm1.1Heno>	MP:0000910,small facial motor nucleus|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001100,abnormal vagus ganglion morphology|MP:0001575,cyanosis|MP:0002327,abnormal respiratory function|MP:0003634,abnormal glial cell morphology|MP:0004811,abnormal neuron physiology|MP:0004948,abnormal neuronal precursor proliferation|MP:0004981,decreased neuronal precursor cell number|MP:0011087,neonatal lethality, complete penetrance|MP:0011406,abnormal retrotrapezoid nucleus morphology|MP:0011827,impaired neuron differentiation|MP:0013002,decreased enteric neural crest cell number|MP:0013005,decreased enteric neural crest cell proliferation|MP:0013006,abnormal enteric neural crest cell migration
MGI:1926861	Phox2b<tm1Jbr>	MP:0000255,blood vessel congestion|MP:0000846,abnormal medulla oblongata morphology|MP:0000937,abnormal motor neuron morphology|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001034,abnormal parasympathetic ganglion morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001056,abnormal cranial nerve morphology|MP:0001066,absent trigeminal nerve|MP:0001074,abnormal vagus nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001082,abnormal geniculate ganglion morphology|MP:0001084,abnormal petrosal ganglion morphology|MP:0001087,abnormal nodose ganglion morphology|MP:0001096,abnormal glossopharyngeal ganglion morphology|MP:0001100,abnormal vagus ganglion morphology|MP:0002338,abnormal pulmonary ventilation|MP:0002546,mydriasis|MP:0002751,abnormal autonomic nervous system morphology|MP:0003437,abnormal carotid body morphology|MP:0003661,abnormal locus ceruleus morphology|MP:0003964,abnormal noradrenaline level|MP:0004186,abnormal area postrema morphology|MP:0004561,absent facial nerve|MP:0004990,abnormal ciliary ganglion morphology|MP:0005576,decreased pulmonary ventilation|MP:0006243,impaired pupillary reflex|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3521828	Phox2b<tm1(Phox2a)Mist>	MP:0000910,small facial motor nucleus|MP:0000937,abnormal motor neuron morphology|MP:0001034,abnormal parasympathetic ganglion morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001093,small trigeminal ganglion|MP:0001100,abnormal vagus ganglion morphology|MP:0002127,abnormal cardiovascular system morphology|MP:0003632,abnormal nervous system morphology|MP:0003661,abnormal locus ceruleus morphology|MP:0003964,abnormal noradrenaline level|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5575410	Phox2b<tm1Rth>	MP:0000906,abnormal trigeminal V mesencephalic nucleus morphology|MP:0001071,abnormal facial nerve morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001436,abnormal suckling behavior|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002184,abnormal innervation|MP:0002272,abnormal nervous system electrophysiology|MP:0002882,abnormal neuron morphology|MP:0003631,nervous system phenotype|MP:0003661,abnormal locus ceruleus morphology|MP:0005574,decreased pulmonary respiratory rate|MP:0011089,perinatal lethality, complete penetrance|MP:0011406,abnormal retrotrapezoid nucleus morphology
MGI:5451082	Phox2b<tm2.1Heno>	MP:0001008,abnormal sympathetic ganglion morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001575,cyanosis|MP:0002327,abnormal respiratory function|MP:0003634,abnormal glial cell morphology|MP:0004811,abnormal neuron physiology|MP:0004948,abnormal neuronal precursor proliferation|MP:0004981,decreased neuronal precursor cell number|MP:0011087,neonatal lethality, complete penetrance|MP:0011406,abnormal retrotrapezoid nucleus morphology|MP:0011827,impaired neuron differentiation|MP:0013002,decreased enteric neural crest cell number|MP:0013005,decreased enteric neural crest cell proliferation|MP:0013006,abnormal enteric neural crest cell migration
MGI:3773691	Phox2b<tm2Jbr>	MP:0001575,cyanosis|MP:0001942,abnormal lung volume|MP:0001943,abnormal respiration|MP:0001951,abnormal breathing pattern|MP:0001953,respiratory failure|MP:0001957,apnea|MP:0002321,hypoventilation|MP:0004101,abnormal brain interneuron morphology|MP:0004811,abnormal neuron physiology|MP:0011087,neonatal lethality, complete penetrance
MGI:4418265	Phox2b<tm3.1Jbr>	MP:0000937,abnormal motor neuron morphology|MP:0001034,abnormal parasympathetic ganglion morphology|MP:0001086,absent petrosal ganglion|MP:0001265,decreased body size|MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0003632,abnormal nervous system morphology|MP:0004811,abnormal neuron physiology|MP:0008314,abnormal pterygopalatine ganglion morphology|MP:0009937,abnormal neuron differentiation|MP:0011085,postnatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4418298	Phox2b<tm4Jbr>	MP:0001943,abnormal respiration|MP:0002327,abnormal respiratory function|MP:0003029,alkalemia|MP:0005576,decreased pulmonary ventilation|MP:0006276,abnormal autonomic nervous system physiology|MP:0010768,mortality/aging|MP:0011087,neonatal lethality, complete penetrance|MP:0011406,abnormal retrotrapezoid nucleus morphology
MGI:6401823	Phpt1<tm1.1Eys>	MP:0002079,increased circulating insulin level|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0005560,decreased circulating glucose level
MGI:5695929	Phpt1<tm1.1(KOMP)Vlcg>	MP:0005573,increased pulmonary respiratory rate|MP:0005576,decreased pulmonary ventilation
MGI:6156548	Phrf1<em1(IMPC)Tcp>	MP:0000266,abnormal heart morphology|MP:0000613,abnormal salivary gland morphology|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001258,decreased body length|MP:0001552,increased circulating triglyceride level|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002637,small uterus|MP:0003795,abnormal bone structure|MP:0009516,enlarged salivary gland
MGI:7549295	Phrf1<em1Mscha>	MP:0001363,increased anxiety-related response|MP:0001900,impaired synaptic plasticity|MP:0002797,increased thigmotaxis|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0008428,abnormal spatial working memory|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0012307,impaired spatial learning
MGI:2154106	Phrtq1<MH>	MP:0002834,decreased heart weight
MGI:5548431	Phtf1<tm1b(KOMP)Wtsi>	MP:0001944,abnormal pancreas morphology|MP:0002060,abnormal skin morphology
MGI:6726306	Phyhipl<em1Tsdk>	MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000889,abnormal cerebellar molecular layer|MP:0000890,thin cerebellar molecular layer|MP:0001405,impaired coordination|MP:0002804,abnormal motor learning|MP:0003894,abnormal Purkinje cell innervation|MP:0004998,decreased CNS synapse formation|MP:0014327,decreased Purkinje cell size
MGI:5605835	Phyh<tm1b(EUCOMM)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0009142,decreased prepulse inhibition
MGI:3822777	Phyh<tm1Safe>	MP:0000880,decreased Purkinje cell number|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001512,trunk curl|MP:0001783,decreased white adipose tissue amount|MP:0001860,liver inflammation|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002941,increased circulating alanine transaminase level|MP:0003103,liver degeneration|MP:0003633,abnormal nervous system physiology|MP:0003949,abnormal circulating lipid level|MP:0005179,decreased circulating cholesterol level|MP:0005402,abnormal action potential|MP:0008570,lipidosis|MP:0008806,increased circulating amylase level|MP:0008814,decreased nerve conduction velocity|MP:0008916,abnormal astrocyte physiology|MP:0009642,abnormal blood homeostasis|MP:0014617,decreased spermatogonia number|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis
MGI:4431628	Phykpl<tm1a(EUCOMM)Wtsi>	MP:0001325,abnormal retina morphology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005554,decreased circulating creatinine level
MGI:6449040	Pi16<em1(IMPC)Mbp>	MP:0000062,increased bone mineral density|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0005344,increased circulating bilirubin level
MGI:4267708	Pi16<Gt(OST292194)Lex>	MP:0002344,abnormal lymph node B cell domain morphology|MP:0002359,abnormal spleen germinal center morphology|MP:0002397,abnormal bone marrow morphology|MP:0004973,increased regulatory T cell number
MGI:6114785	Pi16<tm1.2Engl>	MP:0001764,abnormal homeostasis|MP:0001790,abnormal immune system physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype
MGI:4345401	Pi4k2a<Gt(AK0094)Wtsi>	MP:0000745,tremors|MP:0000746,weakness|MP:0000880,decreased Purkinje cell number|MP:0001263,weight loss|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002183,gliosis|MP:0003280,urinary incontinence|MP:0003354,astrocytosis|MP:0005343,increased circulating aspartate transaminase level|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology
MGI:7660787	Pi4ka<em1Jgg>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:6200379	Pi4ka<m1Btlr>	MP:0008561,decreased tumor necrosis factor secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0011081,decreased macrophage apoptosis|MP:0012556,increased cell death
MGI:6286120	Pi4ka<m2Btlr>	MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0012764,increased alpha-beta T cell number
MGI:5008156	Pi4ka<tm1.1Arte>	MP:0000462,abnormal digestive system morphology|MP:0000477,abnormal intestine morphology|MP:0000494,abnormal cecum morphology|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0003271,abnormal duodenum morphology|MP:0004139,abnormal gastric parietal cell morphology|MP:0009511,distended stomach|MP:0010792,abnormal stomach mucosa morphology
MGI:5478563	Pi4ka<tm1.2Pdc>	MP:0011092,embryonic lethality, complete penetrance
MGI:5696927	Pi4ka<tm1b(EUCOMM)Wtsi>	MP:0000220,increased monocyte cell number|MP:0001513,limb grasping|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5008158	Pi4ka<tm2.1Arte>	MP:0000462,abnormal digestive system morphology|MP:0000489,abnormal large intestine morphology|MP:0000689,abnormal spleen morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001491,unresponsive to tactile stimuli|MP:0001505,hunched posture|MP:0001510,abnormal coat appearance|MP:0001664,abnormal digestion|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005036,diarrhea|MP:0008108,abnormal small intestinal villus morphology
MGI:6696050	Pi4kb<tm1.1Tbal>	MP:0001106,abnormal Schwann cell morphology|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002651,abnormal sciatic nerve morphology|MP:0008814,decreased nerve conduction velocity|MP:0010732,abnormal node of Ranvier morphology|MP:0012051,spasticity|MP:0020456,decreased myelin sheath amount
MGI:6363553	Pianp<em1Bet>	MP:0002910,abnormal excitatory postsynaptic currents|MP:0002918,abnormal paired-pulse facilitation|MP:0003631,nervous system phenotype|MP:0009142,decreased prepulse inhibition|MP:0030735,abnormal glutamic acid level
MGI:6363552	Pianp<tm1d(KOMP)Wtsi>	MP:0000788,abnormal cerebral cortex morphology|MP:0000880,decreased Purkinje cell number|MP:0000890,thin cerebellar molecular layer|MP:0001361,social withdrawal|MP:0001363,increased anxiety-related response|MP:0001441,increased grooming behavior|MP:0002572,abnormal emotion/affect behavior|MP:0003063,increased coping response|MP:0003203,increased neuron apoptosis|MP:0003424,premature neuronal precursor differentiation|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0003858,enhanced coordination|MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype|MP:0006099,thin cerebellar granule layer|MP:0010052,increased grip strength|MP:0012460,decreased dentate gyrus size|MP:0020395,abnormal response to social novelty|MP:0030585,enhanced behavioral response to amphetamine
MGI:3052227	Pias1<tm1Kes>	MP:0001265,decreased body size|MP:0008735,increased susceptibility to endotoxin shock|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0011090,perinatal lethality, incomplete penetrance|MP:0031023,decreased susceptibility to Riboviria infection induced morbidity/mortality
MGI:2678428	Pias2<Gt(pT1Betageo)1Ruiz>	MP:0001146,abnormal testis morphology|MP:0001153,small seminiferous tubules|MP:0002160,abnormal reproductive system morphology|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004884,abnormal testis physiology|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0006042,increased apoptosis
MGI:4419892	Pias2<tm1a(KOMP)Wtsi>	MP:0001258,decreased body length|MP:0001325,abnormal retina morphology|MP:0002079,increased circulating insulin level|MP:0002110,abnormal digit morphology|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:7662566	Pias3<em1Cya>	MP:0031273,decreased susceptibility to induced aneurysm formation
MGI:3046514	Pias4<tm1Hwu>	MP:0002082,postnatal lethality|MP:0002169,no abnormal phenotype detected
MGI:3512663	Pias4<tm1Rug>	MP:0001601,abnormal myelopoiesis|MP:0011090,perinatal lethality, incomplete penetrance
MGI:7798750	Pibf1<m1Bei>	MP:0005170,cleft upper lip
MGI:5505638	Pibf1<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001787,pericardial edema|MP:0002151,abnormal neural tube morphology|MP:0002833,increased heart weight|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0004132,absent embryonic cilia|MP:0005344,increased circulating bilirubin level|MP:0011100,preweaning lethality, complete penetrance|MP:0011396,abnormal sleep behavior|MP:0013203,abnormal primary cilium morphology|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:1857817	Picalm<fit1-3452SB>	MP:0001265,decreased body size|MP:0001577,anemia
MGI:1857818	Picalm<fit1-4226SB>	MP:0001265,decreased body size|MP:0001577,anemia
MGI:1857819	Picalm<fit1-4397SB>	MP:0001265,decreased body size|MP:0001577,anemia
MGI:1857815	Picalm<fit1-494SB>	MP:0001265,decreased body size|MP:0001577,anemia
MGI:1857816	Picalm<fit1-764SB>	MP:0001265,decreased body size|MP:0001577,anemia
MGI:5636370	Picalm<tm1.1Tmae>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000371,diluted coat color|MP:0000691,enlarged spleen|MP:0001606,impaired hematopoiesis|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002810,microcytic anemia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005637,abnormal iron homeostasis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008388,hypochromic microcytic anemia|MP:0008810,increased circulating iron level|MP:0010067,increased red blood cell distribution width|MP:0011178,increased erythroblast number|MP:0011179,decreased erythroblast number|MP:0011285,increased circulating erythropoietin level
MGI:5640747	Picalm<tm1.2Tmae>	MP:0000245,abnormal erythropoiesis|MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0002810,microcytic anemia|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011178,increased erythroblast number|MP:0011179,decreased erythroblast number|MP:0011246,abnormal fetal liver hematopoietic progenitor cell morphology
MGI:5430167	Picalm<tm1Towa>	MP:0000245,abnormal erythropoiesis|MP:0000333,decreased bone marrow cell number|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002144,abnormal B cell differentiation|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003656,abnormal erythrocyte physiology|MP:0004201,fetal growth retardation|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005621,abnormal cell physiology|MP:0005637,abnormal iron homeostasis|MP:0005639,hemosiderosis|MP:0008388,hypochromic microcytic anemia|MP:0008973,decreased erythroid progenitor cell number|MP:0009429,decreased embryo weight|MP:0010080,abnormal hepatocyte physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011400,lethality, complete penetrance|MP:0014263,decreased spleen B cell follicle number
MGI:3584144	Pick1<tm1Rlh>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001899,absent long-term depression|MP:0001900,impaired synaptic plasticity|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005578,teratozoospermia|MP:0008898,abnormal acrosome morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0014052,increased male germ cell apoptosis
MGI:2157199	Pid2<CAST/Ei>	MP:0003633,abnormal nervous system physiology
MGI:3847893	Pidd1<tm1.1Anvi>	MP:0002169,no abnormal phenotype detected
MGI:4133392	Pierce1<Gt(OST3440)Lex>	MP:0000266,abnormal heart morphology|MP:0000286,abnormal mitral valve morphology|MP:0000531,right pulmonary isomerism|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0000689,abnormal spleen morphology|MP:0001706,abnormal left-right axis patterning|MP:0002135,abnormal kidney morphology|MP:0002633,persistent truncus arteriosus|MP:0002740,heart hypoplasia|MP:0003140,dilated heart atrium|MP:0003178,left pulmonary isomerism|MP:0003921,abnormal heart left ventricle morphology|MP:0004066,abnormal primitive node morphology|MP:0004133,heterotaxia|MP:0008987,abnormal liver lobule morphology|MP:0010117,abnormal lateral plate mesoderm morphology|MP:0010402,ventricular septal defect|MP:0010808,right-sided stomach|MP:0010853,abnormal lung position or orientation|MP:0010975,abnormal lung lobe morphology|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011252,situs inversus totalis|MP:0020494,left sided inferior vena cava
MGI:5637039	Pierce1<tm2b(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected|MP:0002766,situs inversus|MP:0002767,situs ambiguus|MP:0008933,abnormal motile primary cilium physiology|MP:0010052,increased grip strength|MP:0010420,muscular ventricular septal defect|MP:0010595,abnormal aortic valve cusp morphology|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011252,situs inversus totalis|MP:0013840,absent segment of posterior cerebral artery|MP:0013847,retropleural edema|MP:0013971,blood in lymph vessels|MP:0014001,abnormal vertebral artery topology|MP:0014021,heterochrony
MGI:6283399	Pierce2<em1(IMPC)H>	MP:0000194,increased circulating calcium level|MP:0003900,shortened QT interval|MP:0008933,abnormal motile primary cilium physiology|MP:0010392,prolonged QRS complex duration
MGI:8275336	Piezo1<em1Bxiao>	MP:0004875,increased mean systemic arterial blood pressure|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0006144,increased systemic arterial systolic blood pressure|MP:0012106,impaired exercise endurance
MGI:8215377	Piezo1<em1Dbee>	MP:0000208,decreased hematocrit|MP:0002640,reticulocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003656,abnormal erythrocyte physiology|MP:0004952,increased spleen weight|MP:0008850,increased hemoglobin concentration distribution width|MP:0010067,increased red blood cell distribution width|MP:0010074,stomatocytosis|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011893,increased circulating transferrin level|MP:0031084,decreased erythrocyte osmotic fragility
MGI:4126380	Piezo1<Gt(RST343)Byg>	MP:0000263,absent organized vascular network|MP:0001723,disorganized yolk sac vascular plexus|MP:0002169,no abnormal phenotype detected|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0005312,pericardial effusion|MP:0005385,cardiovascular system phenotype|MP:0009577,abnormal developmental vascular remodeling|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012253,abnormal intersomitic vessel morphology
MGI:4451539	Piezo1<tm1a(KOMP)Wtsi>	MP:0001723,disorganized yolk sac vascular plexus|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004003,abnormal vascular endothelial cell physiology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006055,abnormal vascular endothelial cell morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5582446	Piezo1<tm1b(KOMP)Wtsi>	MP:0000538,abnormal urinary bladder morphology|MP:0001402,decreased locomotor activity|MP:0001697,abnormal embryo size|MP:0001722,pale yolk sac|MP:0002941,increased circulating alanine transaminase level|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0005650,abnormal limb bud morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5823989	Piezo1<tm1c(KOMP)Wtsi>	MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation
MGI:5766345	Piezo1<tm2.1Apat>	MP:0000208,decreased hematocrit|MP:0000248,macrocytosis|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0004231,abnormal calcium ion homeostasis|MP:0005561,increased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008826,abnormal splenic cell ratio|MP:0008998,decreased blood osmolality|MP:0010067,increased red blood cell distribution width|MP:0012384,abnormal erythrocyte ion transport|MP:0012664,decreased circulating haptoglobin level|MP:0014606,dark spleen|MP:0031085,increased erythrocyte osmotic fragility
MGI:6195008	Piezo2<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:6294748	Piezo2<em2(IMPC)J>	MP:0001552,increased circulating triglyceride level|MP:0001697,abnormal embryo size|MP:0002574,increased vertical activity|MP:0011100,preweaning lethality, complete penetrance
MGI:3699312	Pif1<tm1Leah>	MP:0002169,no abnormal phenotype detected|MP:0030928,increased telomere length
MGI:2386158	Piga<tm1.1Tak>	MP:0000164,abnormal cartilage development|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0005382,craniofacial phenotype|MP:0011091,prenatal lethality, complete penetrance
MGI:2386121	Piga<tm1Bsl>	MP:0000111,cleft palate|MP:0000746,weakness|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001436,abnormal suckling behavior|MP:0002023,increased B cell derived lymphoma incidence|MP:0002123,abnormal definitive hematopoiesis|MP:0002447,abnormal erythrocyte morphology|MP:0002640,reticulocytosis|MP:0002947,increased hemangioma incidence|MP:0003656,abnormal erythrocyte physiology|MP:0003743,abnormal facial morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0031085,increased erythrocyte osmotic fragility
MGI:2386120	Piga<tm1Tak>	MP:0000111,cleft palate|MP:0000242,impaired fertilization|MP:0001124,abnormal gametes|MP:0001192,scaly skin|MP:0001211,wrinkled skin|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001429,dehydration|MP:0001828,abnormal T cell activation|MP:0001874,acanthosis|MP:0001926,female infertility|MP:0002116,abnormal craniofacial bone morphology|MP:0002444,abnormal T cell physiology|MP:0002796,impaired skin barrier function|MP:0005170,cleft upper lip|MP:0005332,abnormal amino acid level|MP:0008037,abnormal T cell morphology|MP:0009608,abnormal epidermal lamellar body morphology|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0031010,failure of sperm-egg fusion
MGI:3652879	Piga<tm2Tak>	MP:0003950,abnormal plasma membrane morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:7615156	Pigb<em1(IMPC)Bay>	MP:0001529,abnormal vocalization
MGI:5629300	Pigc<em1(IMPC)J>	MP:0002590,increased mean corpuscular volume|MP:0005293,impaired glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:5013736	Pigf<tm1a(KOMP)Wtsi>	MP:0001711,abnormal placenta morphology|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:7549283	Pigg<em1(IMPC)Bay>	MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0005675,small gallbladder
MGI:5445921	Pigh<tm1.1(KOMP)Vlcg>	MP:0000186,decreased circulating HDL cholesterol level|MP:0005633,increased circulating sodium level|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6257417	Pigk<em1(IMPC)Bay>	MP:0001415,increased exploration in new environment|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7511851	Pigk<em1Linwu>	MP:0011092,embryonic lethality, complete penetrance
MGI:7511852	Pigk<em2Linwu>	MP:0011092,embryonic lethality, complete penetrance
MGI:5637168	Pigl<tm1b(KOMP)Wtsi>	MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0002098,abnormal vibrissa morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5695915	Pigm<tm1.1(KOMP)Vlcg>	MP:0002135,abnormal kidney morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6377205	Pign<em1(IMPC)Mbp>	MP:0000428,abnormal craniofacial morphology|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000914,exencephaly|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001293,anophthalmia|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0001614,abnormal blood vessel morphology|MP:0001785,edema|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0003984,embryonic growth retardation|MP:0008797,facial cleft|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape
MGI:4460999	Pign<m1Nisw>	MP:0000077,abnormal interparietal bone morphology|MP:0000078,abnormal supraoccipital bone morphology|MP:0000438,abnormal cranium morphology|MP:0000784,forebrain hypoplasia|MP:0001297,microphthalmia|MP:0001695,abnormal gastrulation|MP:0002092,abnormal eye morphology|MP:0003109,short femur|MP:0003232,abnormal forebrain development|MP:0004200,decreased fetal size|MP:0004384,small interparietal bone|MP:0005157,holoprosencephaly|MP:0005262,coloboma|MP:0005269,abnormal occipital bone morphology|MP:0006290,proboscis|MP:0008533,abnormal anterior visceral endoderm morphology|MP:0008926,abnormal anterior definitive endoderm morphology|MP:0010126,abnormal distal visceral endoderm morphology|MP:0011255,abnormal anterior visceral endoderm cell migration|MP:0012090,midbrain hypoplasia|MP:0030464,abnormal cranial cartilage morphology
MGI:5692643	Pigo<tm1b(EUCOMM)Wtsi>	MP:0003928,increased heart rate variability|MP:0005385,cardiovascular system phenotype|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6148224	Pigq<tm2b(EUCOMM)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0000288,abnormal pericardium morphology|MP:0001614,abnormal blood vessel morphology|MP:0001672,abnormal embryo development|MP:0001691,abnormal somite shape|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001706,abnormal left-right axis patterning|MP:0001718,abnormal visceral yolk sac morphology|MP:0001722,pale yolk sac|MP:0001726,abnormal allantois morphology|MP:0001785,edema|MP:0002151,abnormal neural tube morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0002861,abnormal tail bud morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0003425,abnormal optic vesicle formation|MP:0003717,pallor|MP:0003720,abnormal neural tube closure|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0005650,abnormal limb bud morphology|MP:0006108,abnormal hindbrain development|MP:0009806,abnormal otic vesicle morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011960,abnormal eye anterior chamber depth|MP:0011965,decreased total retina thickness|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2651657	Pigr<tm1Fejo>	MP:0000501,abnormal digestive secretion|MP:0001764,abnormal homeostasis|MP:0001807,decreased IgA level|MP:0002490,abnormal immunoglobulin level|MP:0002493,increased IgG level|MP:0002495,increased IgA level|MP:0005027,increased susceptibility to parasitic infection|MP:0005389,reproductive system phenotype|MP:0010155,abnormal intestine physiology|MP:0010223,abnormal immunoglobulin transcytosis
MGI:2445730	Pigr<tm1Ohw>	MP:0001807,decreased IgA level|MP:0002412,increased susceptibility to bacterial infection|MP:0002493,increased IgG level|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0003945,abnormal lymphocyte physiology|MP:0008401,abnormal CD8 positive, alpha-beta intraepithelial T cell morphology|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008895,abnormal intraepithelial T cell number
MGI:2651659	Pigr<tm1Rast>	MP:0000477,abnormal intestine morphology|MP:0000716,abnormal immune system cell morphology|MP:0001807,decreased IgA level|MP:0002490,abnormal immunoglobulin level|MP:0002493,increased IgG level|MP:0002495,increased IgA level|MP:0010223,abnormal immunoglobulin transcytosis
MGI:5007288	Pigt<tm1Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:5548887	Pigu<tm1b(EUCOMM)Hmgu>	MP:0001891,hydrocephaly|MP:0011100,preweaning lethality, complete penetrance
MGI:5645357	Pigv<b2b2859Clo>	MP:0000111,cleft palate|MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000519,hydronephrosis|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001823,thymus hypoplasia|MP:0002639,micrognathia|MP:0003675,kidney cyst|MP:0004158,right aortic arch|MP:0010402,ventricular septal defect|MP:0010466,vascular ring|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:7425911	Pigx<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:7638748	Pigyl<em1(IMPC)Mbp>	MP:0011100,preweaning lethality, complete penetrance
MGI:6393546	Pigz<em1(IMPC)J>	MP:0005559,increased circulating glucose level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5429067	Pik3ap1<m1Btlr>	MP:0001802,arrested B cell differentiation|MP:0001806,decreased IgM level|MP:0005387,immune system phenotype
MGI:6114668	Pik3ap1<m2Btlr>	MP:0002494,increased IgM level|MP:0008168,decreased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0020154,impaired humoral immune response
MGI:6283640	Pik3ap1<M3Btlr>	MP:0004978,decreased B-1 B cell number
MGI:5793073	Pik3ap1<tm1b(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0005278,abnormal cholesterol homeostasis
MGI:2178861	Pik3ap1<tm1Kuro>	MP:0000694,spleen hypoplasia|MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0002460,decreased immunoglobulin level|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0008174,decreased follicular B cell number|MP:0008203,absent B-1a cells|MP:0008209,decreased pre-B cell number|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:3529840	Pik3c2a<Gt(OST288105)Lex>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001566,increased circulating phosphate level|MP:0001732,postnatal growth retardation|MP:0001762,polyuria|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002599,increased mean platelet volume|MP:0002743,glomerulonephritis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002962,increased urine protein level|MP:0002968,increased circulating alkaline phosphatase level|MP:0002989,small kidney|MP:0003606,kidney failure|MP:0003961,decreased lean body mass|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004969,pale kidney|MP:0005014,increased B cell number|MP:0005178,increased circulating cholesterol level|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005387,immune system phenotype|MP:0005505,thrombocytosis|MP:0005553,increased circulating creatinine level|MP:0005558,decreased creatinine clearance|MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level|MP:0005635,decreased circulating bilirubin level|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008140,podocyte foot process effacement|MP:0009642,abnormal blood homeostasis|MP:0010025,decreased total body fat amount|MP:0011353,expanded mesangial matrix
MGI:5513807	Pik3c2a<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0000702,enlarged lymph nodes|MP:0001402,decreased locomotor activity|MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0005016,decreased lymphocyte cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5779550	Pik3c2a<tm1Bvan>	MP:0000228,abnormal thrombopoiesis|MP:0002417,abnormal megakaryocyte morphology|MP:0002608,increased hematocrit|MP:0003405,abnormal platelet shape|MP:0003950,abnormal plasma membrane morphology|MP:0004720,abnormal platelet morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005464,abnormal platelet physiology|MP:0009549,decreased platelet aggregation|MP:0011091,prenatal lethality, complete penetrance|MP:0014060,abnormal platelet alpha-granule morphology|MP:0020431,decreased platelet alpha-granule number|MP:0031120,decreased susceptibility to induced thrombosis
MGI:3611683	Pik3c2b<tm1.1Pkha>	MP:0010771,integument phenotype
MGI:5779504	Pik3c2g<tm1Ehi>	MP:0001260,increased body weight|MP:0001552,increased circulating triglyceride level|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0003402,decreased liver weight|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005370,liver/biliary system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0006094,increased fat cell size|MP:0009288,increased epididymal fat pad weight|MP:0010398,decreased liver glycogen level
MGI:4941351	Pik3c3<tm1.1Fawa>	MP:0000352,decreased cell proliferation|MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0003886,abnormal embryonic epiblast morphology|MP:0003984,embryonic growth retardation|MP:0003988,disorganized embryonic tissue|MP:0005384,cellular phenotype|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology
MGI:5427838	Pik3c3<tm1.1Flv>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0003674,oxidative stress|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005016,decreased lymphocyte cell number|MP:0005387,immune system phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006387,abnormal T cell number|MP:0006413,increased T cell apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008260,abnormal autophagy
MGI:4433098	Pik3c3<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0005632,decreased circulating aspartate transaminase level|MP:0010053,decreased grip strength
MGI:5316387	Pik3c3<tm1c(EUCOMM)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000352,decreased cell proliferation|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0002833,increased heart weight|MP:0003915,increased heart left ventricle weight|MP:0003921,abnormal heart left ventricle morphology|MP:0005140,decreased cardiac muscle contractility|MP:0006138,congestive heart failure|MP:0008260,abnormal autophagy|MP:0010398,decreased liver glycogen level|MP:0020851,abnormal vacuole morphology
MGI:4459941	Pik3c3<tm1Fawa>	MP:0000755,hindlimb paralysis|MP:0000965,abnormal sensory neuron morphology|MP:0000966,decreased sensory neuron number|MP:0001405,impaired coordination|MP:0001504,abnormal posture|MP:0002169,no abnormal phenotype detected|MP:0002229,neurodegeneration|MP:0003203,increased neuron apoptosis|MP:0004297,abnormal proprioceptive neuron morphology|MP:0005405,axon degeneration|MP:0011085,postnatal lethality, complete penetrance
MGI:5529808	Pik3c3<tm1Tssk>	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001306,small lens|MP:0002840,abnormal lens fiber morphology|MP:0030940,impaired autophagy
MGI:3691485	Pik3ca<tm1.1Jjz>	MP:0005621,abnormal cell physiology
MGI:4845856	Pik3ca<tm1.1Rzl>	MP:0001260,increased body weight|MP:0001925,male infertility|MP:0001938,delayed sexual maturation|MP:0002773,decreased circulating luteinizing hormone level|MP:0002781,increased circulating testosterone level|MP:0002834,decreased heart weight|MP:0002953,thick ventricular wall|MP:0003953,abnormal hormone level|MP:0004215,abnormal myocardial fiber physiology|MP:0004852,decreased testis weight|MP:0004884,abnormal testis physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005189,abnormal anogenital distance|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005669,increased circulating leptin level|MP:0005670,abnormal white adipose tissue physiology|MP:0008940,delayed balanopreputial separation|MP:0009819,abnormal circulating androgen level|MP:0010024,increased total body fat amount|MP:0010579,increased heart left ventricle size
MGI:5427579	Pik3ca<tm1.1Waph>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0001126,abnormal ovary morphology|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0003789,increased osteosarcoma incidence|MP:0006422,increased mammary adenoacanthoma incidence|MP:0009503,abnormal mammary gland duct morphology|MP:0009504,abnormal mammary gland epithelium morphology|MP:0010173,increased mammary gland epithelial cell proliferation|MP:0010299,increased mammary gland tumor incidence|MP:0010364,increased fibroadenoma incidence|MP:0011703,increased fibroblast proliferation|MP:0013502,decreased fibroblast apoptosis|MP:0013778,abnormal mammary gland myoepithelium morphology|MP:0013782,abnormal mammary duct terminal end bud morphology|MP:0014057,abnormal mammary gland stroma morphology
MGI:3628805	Pik3ca<tm1Bvan>	MP:0000259,abnormal vascular development|MP:0000260,abnormal angiogenesis|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001433,polyphagia|MP:0001634,internal hemorrhage|MP:0001730,embryonic growth arrest|MP:0001732,postnatal growth retardation|MP:0002079,increased circulating insulin level|MP:0002792,abnormal retina vasculature morphology|MP:0003645,increased pancreatic beta cell number|MP:0003961,decreased lean body mass|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004201,fetal growth retardation|MP:0004787,abnormal dorsal aorta morphology|MP:0004819,decreased skeletal muscle mass|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012253,abnormal intersomitic vessel morphology|MP:0012732,abnormal perineural vascular plexus morphology
MGI:5438138	Pik3ca<tm1Gilb>	MP:0002006,neoplasm
MGI:5469577	Pik3ca<tm1Gne>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0002006,neoplasm|MP:0010299,increased mammary gland tumor incidence|MP:0010768,mortality/aging
MGI:3716068	Pik3ca<tm1Jdo>	MP:0001262,decreased body weight|MP:0001879,abnormal lymphatic vessel morphology|MP:0004502,decreased incidence of tumors by chemical induction|MP:0008778,abnormal lymphangiogenesis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012080,chylous ascites
MGI:3691486	Pik3ca<tm1Jjz>	MP:0005621,abnormal cell physiology|MP:0008444,retina cone cell degeneration|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0012144,decreased b-wave amplitude
MGI:2180704	Pik3ca<tm1Nbm>	MP:0000255,blood vessel congestion|MP:0000352,decreased cell proliferation|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0001914,hemorrhage|MP:0003229,abnormal vitelline vasculature morphology|MP:0003974,abnormal endocardium morphology|MP:0004784,abnormal anterior cardinal vein morphology|MP:0004950,abnormal brain vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3795787	Pik3ca<tm3Bvan>	MP:0000259,abnormal vascular development|MP:0004076,abnormal vitelline vascular remodeling|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3604500	Pik3cb<Gt(OST147188)Lex>	MP:0005333,decreased heart rate|MP:0011100,preweaning lethality, complete penetrance
MGI:3795850	Pik3cb<tm1.1Bvan>	MP:0011102,embryonic lethality, incomplete penetrance
MGI:4358053	Pik3cb<tm1.1Ehi>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001698,decreased embryo size|MP:0001732,postnatal growth retardation|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001922,reduced male fertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002644,decreased circulating triglyceride level|MP:0002685,abnormal spermatogonia proliferation|MP:0002687,oligozoospermia|MP:0003058,increased insulin secretion|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005179,decreased circulating cholesterol level|MP:0005331,insulin resistance|MP:0005389,reproductive system phenotype|MP:0005464,abnormal platelet physiology|MP:0005491,pancreatic islet hyperplasia|MP:0005559,increased circulating glucose level|MP:0009549,decreased platelet aggregation|MP:0009703,decreased birth body size|MP:0010398,decreased liver glycogen level|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011416,abnormal testis interstitial tissue morphology|MP:0011704,decreased fibroblast proliferation|MP:0013601,increased testis apoptosis|MP:0014617,decreased spermatogonia number|MP:0030973,impaired gluconeogenesis
MGI:5646522	Pik3cb<tm1.1Jdo>	MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0005630,increased lung weight|MP:0006050,pulmonary fibrosis|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0011102,embryonic lethality, incomplete penetrance
MGI:4845857	Pik3cb<tm1.1Rzl>	MP:0002834,decreased heart weight|MP:0005385,cardiovascular system phenotype
MGI:4434375	Pik3cb<tm1a(EUCOMM)Wtsi>	MP:0004647,decreased lumbar vertebrae number|MP:0005554,decreased circulating creatinine level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content
MGI:3795849	Pik3cb<tm1Bvan>	MP:0005385,cardiovascular system phenotype|MP:0009549,decreased platelet aggregation
MGI:3805847	Pik3cb<tm1Jjz>	MP:0002006,neoplasm|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005621,abnormal cell physiology|MP:0005669,increased circulating leptin level|MP:0011704,decreased fibroblast proliferation
MGI:2180703	Pik3cb<tm1Nbm>	MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance
MGI:8213491	Pik3cd<em1.1Pls>	MP:0000221,decreased leukocyte cell number|MP:0000496,abnormal small intestine morphology|MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000696,abnormal Peyer's patch morphology|MP:0000702,enlarged lymph nodes|MP:0001175,abnormal lung morphology|MP:0001829,increased activated T cell number|MP:0002144,abnormal B cell differentiation|MP:0002378,abnormal gut-associated lymphoid tissue morphology|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002419,abnormal innate immunity|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004816,abnormal class switch recombination|MP:0005000,abnormal immune tolerance|MP:0005013,increased lymphocyte cell number|MP:0005154,increased B cell proliferation|MP:0005232,abnormal mesenteric lymph node morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008097,increased plasma cell number|MP:0008102,lymph node hyperplasia|MP:0008167,increased B-1a cell number|MP:0008174,decreased follicular B cell number|MP:0008177,increased germinal center B cell number|MP:0008181,increased marginal zone B cell number|MP:0008185,decreased naive B cell number|MP:0008189,increased transitional stage B cell number|MP:0008191,abnormal follicular B cell physiology|MP:0008522,abnormal lymph node germinal center morphology|MP:0008783,decreased B cell apoptosis|MP:0009922,increased transitional stage T1 B cell number|MP:0010186,increased T follicular helper cell number|MP:0010377,abnormal gut flora balance|MP:0013940,abnormal plasmablast number|MP:0020002,increased response to antigen|MP:0020154,impaired humoral immune response|MP:0020175,abnormal IgG1 level|MP:0020193,increased lymphocyte activation involved in immune response
MGI:3530101	Pik3cd<Gt(OST451938)Lex>	MP:0000218,increased leukocyte cell number|MP:0005013,increased lymphocyte cell number|MP:0008495,decreased IgG1 level
MGI:5582742	Pik3cd<m1Btlr>	MP:0001800,abnormal humoral immune response
MGI:5806440	Pik3cd<m2Btlr>	MP:0001606,impaired hematopoiesis|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002497,increased IgE level|MP:0004978,decreased B-1 B cell number|MP:0008168,decreased B-1a cell number|MP:0008573,increased circulating interferon-alpha level|MP:0020001,decreased response to antigen|MP:0020002,increased response to antigen|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:2385596	Pik3cd<tm1.1Bvan>	MP:0000219,increased neutrophil cell number|MP:0000488,abnormal intestinal epithelium morphology|MP:0000491,crypts of Lieberkuhn abscesses|MP:0000511,abnormal intestinal mucosa morphology|MP:0000694,spleen hypoplasia|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0001858,intestinal inflammation|MP:0002144,abnormal B cell differentiation|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002460,decreased immunoglobulin level|MP:0004978,decreased B-1 B cell number|MP:0005385,cardiovascular system phenotype|MP:0008474,absent spleen germinal center|MP:0009548,abnormal platelet aggregation
MGI:2446574	Pik3cd<tm1Jni>	MP:0000692,small spleen|MP:0001800,abnormal humoral immune response|MP:0002217,small lymph nodes|MP:0002460,decreased immunoglobulin level|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0005387,immune system phenotype|MP:0008202,absent B-1 B cells|MP:0008211,decreased mature B cell number|MP:0008474,absent spleen germinal center|MP:0014469,abnormal B cell calcium ion homeostasis
MGI:2388047	Pik3cd<tm1Tnr>	MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0001876,decreased inflammatory response|MP:0002459,abnormal B cell physiology|MP:0003436,decreased susceptibility to induced arthritis|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0008182,decreased marginal zone B cell number|MP:0008207,decreased B-2 B cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0009548,abnormal platelet aggregation
MGI:4850049	Pik3cd<tm2.1Tnr>	MP:0001800,abnormal humoral immune response|MP:0002420,abnormal adaptive immunity|MP:0002497,increased IgE level|MP:0005018,decreased T cell number|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008178,decreased germinal center B cell number|MP:0008482,decreased spleen germinal center number|MP:0008484,decreased spleen germinal center size|MP:0008495,decreased IgG1 level|MP:0010187,decreased T follicular helper cell number
MGI:4432229	Pik3cg<tm1a(EUCOMM)Wtsi>	MP:0002942,decreased circulating alanine transaminase level
MGI:1858011	Pik3cg<tm1Dwu>	MP:0001263,weight loss|MP:0002460,decreased immunoglobulin level|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004867,decreased platelet calcium level|MP:0005025,abnormal response to infection|MP:0005387,immune system phenotype|MP:0005464,abnormal platelet physiology|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008720,impaired neutrophil chemotaxis|MP:0009549,decreased platelet aggregation|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0020928,increased susceptibility to Poxviridae infection|MP:0031120,decreased susceptibility to induced thrombosis
MGI:3051886	Pik3cg<tm1Ehi>	MP:0000278,abnormal myocardial fiber morphology|MP:0003799,impaired macrophage chemotaxis|MP:0005294,abnormal heart ventricle morphology|MP:0008719,impaired neutrophil recruitment|MP:0009549,decreased platelet aggregation
MGI:3840088	Pik3cg<tm1Lste>	MP:0002463,abnormal neutrophil physiology|MP:0008719,impaired neutrophil recruitment|MP:0008720,impaired neutrophil chemotaxis
MGI:1858013	Pik3cg<tm1Pngr>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000715,decreased thymocyte number|MP:0001819,abnormal immune cell physiology|MP:0001823,thymus hypoplasia|MP:0001828,abnormal T cell activation|MP:0001876,decreased inflammatory response|MP:0002123,abnormal definitive hematopoiesis|MP:0002145,abnormal T cell differentiation|MP:0002444,abnormal T cell physiology|MP:0002463,abnormal neutrophil physiology|MP:0003436,decreased susceptibility to induced arthritis|MP:0004084,abnormal cardiac muscle relaxation|MP:0005011,increased eosinophil cell number|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005095,decreased T cell proliferation|MP:0005466,abnormal T-helper 2 physiology|MP:0005599,increased cardiac muscle contractility|MP:0008053,abnormal NK cell differentiation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008719,impaired neutrophil recruitment|MP:0008720,impaired neutrophil chemotaxis
MGI:1858012	Pik3cg<tm1Wym>	MP:0000219,increased neutrophil cell number|MP:0002412,increased susceptibility to bacterial infection|MP:0002442,abnormal leukocyte physiology|MP:0002463,abnormal neutrophil physiology|MP:0003799,impaired macrophage chemotaxis|MP:0005599,increased cardiac muscle contractility|MP:0008719,impaired neutrophil recruitment|MP:0008720,impaired neutrophil chemotaxis
MGI:3722941	Pik3cg<tm2Ehi>	MP:0000218,increased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0001212,skin lesions|MP:0001845,abnormal inflammatory response|MP:0002451,abnormal macrophage physiology|MP:0003799,impaired macrophage chemotaxis|MP:0003884,decreased macrophage cell number|MP:0008560,increased tumor necrosis factor secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008705,increased interleukin-6 secretion|MP:0008720,impaired neutrophil chemotaxis
MGI:5563439	Pik3ip1<m1Anu>	MP:0005387,immune system phenotype
MGI:6113575	Pik3r1<m1Btlr>	MP:0005017,decreased B cell number|MP:0008168,decreased B-1a cell number|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010838,increased CD8-positive, alpha-beta memory T cell number
MGI:6113585	Pik3r1<M2Btlr>	MP:0004978,decreased B-1 B cell number|MP:0008040,decreased NK T cell number|MP:0008168,decreased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0008170,decreased B-1b cell number|MP:0008207,decreased B-2 B cell number
MGI:6286124	Pik3r1<m3Btlr>	MP:0008169,increased B-1b cell number
MGI:6153554	Pik3r1<tm1.1Geno>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0004702,increased circulating insulin-like growth factor I level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005491,pancreatic islet hyperplasia|MP:0006319,abnormal epididymal fat pad morphology|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009133,decreased white fat cell size|MP:0011092,embryonic lethality, complete penetrance|MP:0011174,lipodystrophy|MP:0030017,decreased adipocyte glucose uptake
MGI:2149438	Pik3r1<tm1Dfr>	MP:0000189,hypoglycemia|MP:0001654,hepatic necrosis|MP:0001802,arrested B cell differentiation|MP:0002078,abnormal glucose homeostasis|MP:0002144,abnormal B cell differentiation|MP:0002727,decreased circulating insulin level|MP:0002837,dystrophic cardiac calcinosis|MP:0002971,abnormal brown adipose tissue morphology|MP:0005093,decreased B cell proliferation|MP:0005292,improved glucose tolerance|MP:0008186,increased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0009399,increased skeletal muscle fiber size|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012080,chylous ascites
MGI:3028729	Pik3r1<tm1Khn>	MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005318,decreased triglyceride level|MP:0005334,abnormal fat pad morphology|MP:0005378,growth/size/body region phenotype|MP:0009115,abnormal fat cell morphology
MGI:3607981	Pik3r1<tm1Lca>	MP:0001006,abnormal retina cone cell morphology|MP:0002169,no abnormal phenotype detected|MP:0008444,retina cone cell degeneration|MP:0009538,abnormal synapse morphology|MP:0012144,decreased b-wave amplitude|MP:0020359,abnormal ribbon synapse morphology
MGI:2149414	Pik3r1<tm1Tka>	MP:0000189,hypoglycemia|MP:0001800,abnormal humoral immune response|MP:0002083,premature death|MP:0002412,increased susceptibility to bacterial infection|MP:0002459,abnormal B cell physiology|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0005560,decreased circulating glucose level|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0030016,increased adipocyte glucose uptake|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:4818438	Pik3r1<tm2Dfr>	MP:0000189,hypoglycemia|MP:0000245,abnormal erythropoiesis|MP:0001654,hepatic necrosis|MP:0002144,abnormal B cell differentiation|MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0009399,increased skeletal muscle fiber size|MP:0011089,perinatal lethality, complete penetrance|MP:0012080,chylous ascites
MGI:7529483	Pik3r2<em1Gldn>	MP:0000789,thickened cerebral cortex|MP:0002176,increased brain weight|MP:0003631,nervous system phenotype|MP:0005238,increased brain size|MP:0005389,reproductive system phenotype|MP:0005603,neuron hypertrophy|MP:0012676,dilated brain ventricle|MP:0014693,abnormal cell nucleus size
MGI:4363631	Pik3r2<tm1e(KOMP)Wtsi>	MP:0001262,decreased body weight|MP:0005554,decreased circulating creatinine level
MGI:2159732	Pik3r2<tm1Lca>	MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005560,decreased circulating glucose level
MGI:6324670	Pik3r4<mbe>	MP:0005621,abnormal cell physiology|MP:0006009,abnormal neuronal migration|MP:0008260,abnormal autophagy|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008428,abnormal spatial working memory|MP:0010011,ectopic hippocampus pyramidal cells|MP:0011150,abnormal hippocampus stratum oriens morphology|MP:0020338,abnormal hippocampal pyramidal neuron dendrite morphology
MGI:5499157	Pik3r4<tm1.1Mpnd>	MP:0000747,muscle weakness|MP:0000751,myopathy|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0002169,no abnormal phenotype detected|MP:0004121,abnormal sarcolemma morphology|MP:0004510,myositis|MP:0006009,abnormal neuronal migration|MP:0006254,thin cerebral cortex|MP:0008260,abnormal autophagy|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009414,skeletal muscle fiber necrosis|MP:0009415,skeletal muscle degeneration|MP:0010090,increased circulating creatine kinase level|MP:0010401,increased skeletal muscle glycogen level
MGI:5499158	Pik3r4<tm1.2Mpnd>	MP:0011092,embryonic lethality, complete penetrance
MGI:3840090	Pik3r5<tm1Lste>	MP:0000219,increased neutrophil cell number|MP:0008719,impaired neutrophil recruitment|MP:0008720,impaired neutrophil chemotaxis
MGI:5829800	Pik3r6<tm1.1Lste>	MP:0000219,increased neutrophil cell number|MP:0000334,decreased granulocyte number|MP:0002463,abnormal neutrophil physiology|MP:0005016,decreased lymphocyte cell number|MP:0005387,immune system phenotype
MGI:3853063	Pikfyve<Gt(AT0926)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000689,abnormal spleen morphology|MP:0000694,spleen hypoplasia|MP:0000703,abnormal thymus morphology|MP:0000848,abnormal pons morphology|MP:0000897,abnormal midbrain morphology|MP:0000955,abnormal spinal cord morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001262,decreased body weight|MP:0001392,abnormal locomotor behavior|MP:0001547,abnormal lipid level|MP:0001823,thymus hypoplasia|MP:0002152,abnormal brain morphology|MP:0002175,decreased brain weight|MP:0002188,small heart|MP:0002703,abnormal renal tubule morphology|MP:0002754,dilated heart right ventricle|MP:0002882,abnormal neuron morphology|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0005277,abnormal brainstem morphology|MP:0006064,abnormal superior vena cava morphology|MP:0008025,brain vacuoles|MP:0008727,increased heart right atrium size|MP:0009641,kidney degeneration|MP:0009703,decreased birth body size|MP:0009979,abnormal cerebellum deep nucleus morphology|MP:0010018,pulmonary vascular congestion|MP:0010493,abnormal atrium myocardium morphology|MP:0010499,abnormal ventricle myocardium morphology|MP:0010899,abnormal pulmonary alveolar system morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:4949700	Pikfyve<tm1.1Ashi>	MP:0001260,increased body weight|MP:0001552,increased circulating triglyceride level|MP:0002079,increased circulating insulin level|MP:0002169,no abnormal phenotype detected|MP:0002834,decreased heart weight|MP:0003212,increased susceptibility to age related obesity|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0006094,increased fat cell size|MP:0009285,increased gonadal fat pad weight|MP:0009302,increased renal fat pad weight|MP:0010024,increased total body fat amount|MP:0021086,decreased DNA replication|MP:0030016,increased adipocyte glucose uptake|MP:0030022,decreased muscle cell glucose uptake
MGI:4949709	Pikfyve<tm1.2Ashi>	MP:0000358,abnormal cell morphology|MP:0002663,absent blastocoele|MP:0002718,abnormal inner cell mass morphology|MP:0004957,abnormal blastocyst morphology|MP:0004963,abnormal blastocoele morphology|MP:0005028,abnormal trophectoderm morphology|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance
MGI:6156635	Pikfyve<tm1b(EUCOMM)Hmgu>	MP:0004974,decreased regulatory T cell number|MP:0005011,increased eosinophil cell number|MP:0005387,immune system phenotype|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008245,abnormal alveolar macrophage morphology|MP:0008672,increased interleukin-13 secretion|MP:0008699,increased interleukin-4 secretion|MP:0014226,abnormal alveolar macrophage physiology|MP:0014229,decreased alveolar macrophage number
MGI:5474980	Pikfyve<tm1Tssk>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0012028,abnormal visceral endoderm physiology
MGI:5474981	Pikfyve<tm2.1Tssk>	MP:0000371,diluted coat color|MP:0000479,abnormal enterocyte morphology|MP:0001262,decreased body weight|MP:0001505,hunched posture|MP:0001511,disheveled coat|MP:0001570,abnormal circulating enzyme level|MP:0001858,intestinal inflammation|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0002702,decreased circulating free fatty acids level|MP:0003292,melena|MP:0004381,abnormal hair follicle melanocyte morphology|MP:0005036,diarrhea|MP:0005202,lethargy|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0008109,abnormal small intestinal microvillus morphology|MP:0008141,decreased small intestinal microvillus size|MP:0008732,reduced hair shaft melanin granule number|MP:0010831,lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011748,intestinal fibrosis|MP:0030914,abnormal endosome to melanosome transport|MP:0030915,abnormal melanosome maturation
MGI:8242351	Pilra<em1Asw>	MP:0005391,vision/eye phenotype
MGI:5469884	Pilra<tm1Osb>	MP:0000219,increased neutrophil cell number|MP:0002463,abnormal neutrophil physiology|MP:0002941,increased circulating alanine transaminase level|MP:0003628,abnormal leukocyte adhesion|MP:0003888,liver hemorrhage|MP:0005565,increased blood urea nitrogen level|MP:0008735,increased susceptibility to endotoxin shock|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010080,abnormal hepatocyte physiology|MP:0011971,increased circulating lactate dehydrogenase level|MP:0012246,abnormal hepatic cord morphology
MGI:4437413	Pilrb1<tm1Pgh>	MP:0002411,decreased susceptibility to bacterial infection|MP:0003009,abnormal cytokine secretion|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008597,decreased circulating interleukin-6 level|MP:0008617,increased circulating interleukin-12 level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008658,decreased interleukin-1 beta secretion|MP:0008660,increased interleukin-10 secretion|MP:0008663,increased interleukin-12 secretion|MP:0008713,abnormal cytokine level|MP:0008721,abnormal chemokine level|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:5491066	Pim1<tm1Mjn>	MP:0002169,no abnormal phenotype detected
MGI:2182396	Pim1<tm1Pwl>	MP:0000245,abnormal erythropoiesis|MP:0001588,abnormal hemoglobin|MP:0002423,abnormal mast cell physiology|MP:0002591,decreased mean corpuscular volume
MGI:4847572	Pim2<tm1.1Lex>	MP:0008706,decreased interleukin-6 secretion
MGI:3050662	Pim2<tm1Brn>	MP:0005095,decreased T cell proliferation
MGI:3050663	Pim3<tm1Brn>	MP:0002169,no abnormal phenotype detected
MGI:2177943	Pin1<tm1Tuc>	MP:0001154,seminiferous tubule degeneration|MP:0001262,decreased body weight|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0003329,amyloid beta deposits|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0008392,decreased primordial germ cell number|MP:0008871,abnormal ovarian follicle number|MP:0030934,decreased primordial germ cell proliferation|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:5436308	Pink1<tm1.1Wrst>	MP:0001360,abnormal social investigation|MP:0001406,abnormal gait|MP:0001984,abnormal olfaction|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002184,abnormal innervation|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0009948,abnormal olfactory bulb glomerular layer morphology
MGI:3850370	Pink1<tm1Aub>	MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001661,extended life span|MP:0003631,nervous system phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0005643,decreased dopamine level|MP:0006036,abnormal mitochondrial physiology|MP:0010954,abnormal cellular respiration|MP:0010955,abnormal respiratory electron transport chain|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport
MGI:5637036	Pink1<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0008935,decreased mean platelet volume|MP:0010124,decreased bone mineral content
MGI:4941901	Pink1<tm1Hbu>	MP:0005643,decreased dopamine level|MP:0006036,abnormal mitochondrial physiology|MP:0008657,increased interleukin-1 beta secretion|MP:0008660,increased interleukin-10 secretion|MP:0008663,increased interleukin-12 secretion
MGI:5142502	Pink1<tm1Hlw>	MP:0003243,abnormal dopaminergic neuron morphology|MP:0003674,oxidative stress|MP:0004811,abnormal neuron physiology|MP:0008943,increased sensitivity to induced cell death
MGI:3847806	Pink1<tm1Lex>	MP:0000788,abnormal cerebral cortex morphology|MP:0002272,abnormal nervous system electrophysiology|MP:0003203,increased neuron apoptosis|MP:0004811,abnormal neuron physiology|MP:0005058,abnormal lysosome morphology|MP:0010954,abnormal cellular respiration|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport
MGI:3716083	Pink1<tm1Shn>	MP:0001473,reduced long-term potentiation|MP:0001475,reduced long-term depression|MP:0003633,abnormal nervous system physiology|MP:0005643,decreased dopamine level
MGI:5319215	Pink1<tm1Vbae>	MP:0003674,oxidative stress|MP:0005384,cellular phenotype|MP:0005621,abnormal cell physiology|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology
MGI:7639784	Pinlyp<em1Liax>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6194721	Pinlyp<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:5013947	Pinx1<tm1.1Kplu>	MP:0001214,skin hyperplasia|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002038,increased carcinoma incidence|MP:0003667,increased hemangiosarcoma incidence|MP:0003717,pallor|MP:0004086,absent heartbeat|MP:0008014,increased lung tumor incidence|MP:0008019,increased liver tumor incidence|MP:0008866,chromosomal instability|MP:0009321,increased histiocytic sarcoma incidence|MP:0010279,increased gastrointestinal tumor incidence|MP:0010299,increased mammary gland tumor incidence|MP:0010344,increased hibernoma incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012431,increased lymphoma incidence|MP:0013538,increased Harderian gland adenoma incidence|MP:0030928,increased telomere length
MGI:5568930	Pip4k2a<tm1.2Lca>	MP:0002169,no abnormal phenotype detected
MGI:3046749	Pip4k2b<Gt(Betageo)1Lca>	MP:0000063,decreased bone mineral density|MP:0001262,decreased body weight|MP:0001560,abnormal circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003109,short femur|MP:0004601,abnormal vertebral spinous process morphology|MP:0010025,decreased total body fat amount|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5428995	Pip4k2b<Gt(OST341064)Lex>	MP:0005459,decreased percent body fat/body weight
MGI:5629320	Pip4k2c<tm1b(KOMP)Wtsi>	MP:0000603,pale liver|MP:0001399,hyperactivity|MP:0001828,abnormal T cell activation|MP:0001846,increased inflammatory response|MP:0001858,intestinal inflammation|MP:0001859,kidney inflammation|MP:0001861,lung inflammation|MP:0001870,salivary gland inflammation|MP:0002499,chronic inflammation|MP:0004738,abnormal auditory brainstem response|MP:0004974,decreased regulatory T cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005348,increased T cell proliferation|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005416,abnormal circulating protein level|MP:0005566,decreased blood urea nitrogen level|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008502,increased IgG3 level|MP:0008566,increased interferon-gamma secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008593,increased circulating interleukin-10 level|MP:0008599,increased circulating interleukin-2 level|MP:0008602,increased circulating interleukin-4 level|MP:0008617,increased circulating interleukin-12 level|MP:0008647,increased circulating interleukin-12b level|MP:0008681,increased interleukin-17 secretion|MP:0010209,abnormal circulating chemokine level|MP:0013279,increased fasting circulating glucose level|MP:0013763,increased T-helper cell number|MP:0031301,chronic liver inflammation
MGI:6152709	Pip4p1<em1(IMPC)Ccpcz>	MP:0001260,increased body weight|MP:0001399,hyperactivity|MP:0013886,increased CD4-negative, CD25-positive NK T cell number
MGI:4419980	Pip4p1<tm1(KOMP)Wtsi>	MP:0001730,embryonic growth arrest|MP:0005621,abnormal cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3530752	Pip5k1a<Gt(OST43713)Lex>	MP:0002169,no abnormal phenotype detected
MGI:3773719	Pip5k1a<Gt(XE248)Byg>	MP:0005397,hematopoietic system phenotype
MGI:5430936	Pip5k1a<tm1.1Tba>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0009647,decreased fertilization frequency|MP:0009831,abnormal sperm midpiece morphology|MP:0010831,lethality, incomplete penetrance
MGI:3577649	Pip5k1b<tm1Tssk>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0002423,abnormal mast cell physiology|MP:0005397,hematopoietic system phenotype|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0009647,decreased fertilization frequency
MGI:3773720	Pip5k1c<Gt(XD096)Byg>	MP:0000281,abnormal interventricular septum morphology|MP:0000292,distended pericardium|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0000955,abnormal spinal cord morphology|MP:0001698,decreased embryo size|MP:0002417,abnormal megakaryocyte morphology|MP:0003920,abnormal heart right ventricle morphology|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004783,abnormal cardinal vein morphology|MP:0005312,pericardial effusion|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014553,decreased neuronal migration
MGI:5509207	Pip5k1c<tm1.1Ref>	MP:0005384,cellular phenotype
MGI:4838023	Pip5k1c<tm1.2Ref>	MP:0001489,decreased startle reflex|MP:0004770,abnormal synaptic vesicle recycling|MP:0005621,abnormal cell physiology|MP:0010768,mortality/aging
MGI:5509059	Pip5k1c<tm1b(KOMP)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0001785,edema|MP:0002968,increased circulating alkaline phosphatase level|MP:0011100,preweaning lethality, complete penetrance
MGI:5496873	Pip5k1c<tm1Csab>	MP:0005464,abnormal platelet physiology
MGI:3054978	Pip5k1c<tm1Pdc>	MP:0001392,abnormal locomotor behavior|MP:0001900,impaired synaptic plasticity|MP:0002206,abnormal CNS synaptic transmission|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0002916,increased synaptic depression|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0009546,absent gastric milk in neonates|MP:0011087,neonatal lethality, complete penetrance
MGI:5509203	Pip5k1c<tm2.1Ref>	MP:0004770,abnormal synaptic vesicle recycling|MP:0005621,abnormal cell physiology|MP:0009546,absent gastric milk in neonates|MP:0010771,integument phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:5509205	Pip5k1c<tm2.2Ref>	MP:0002169,no abnormal phenotype detected|MP:0005384,cellular phenotype
MGI:5496877	Pip5k1c<tm2Csab>	MP:0005464,abnormal platelet physiology|MP:0009548,abnormal platelet aggregation
MGI:7377679	Pip<em1(IMPC)Mbp>	MP:0002941,increased circulating alanine transaminase level
MGI:5513809	Pipox<tm1b(EUCOMM)Wtsi>	MP:0001402,decreased locomotor activity|MP:0010393,shortened QRS complex duration
MGI:5516489	Pip<tm1Myal>	MP:0000351,increased cell proliferation|MP:0000511,abnormal intestinal mucosa morphology|MP:0000709,enlarged thymus|MP:0002742,enlarged submandibular lymph nodes|MP:0002816,colitis|MP:0006042,increased apoptosis|MP:0009381,abnormal prostate gland dorsolateral lobe morphology|MP:0009543,abnormal thymus corticomedullary boundary morphology|MP:0010138,arteritis|MP:0013590,enlarged thymus medulla
MGI:6694115	Pirb<em1Fgla>	MP:0004752,decreased length of allograft survival
MGI:3664198	Pirb<tm1Stz>	MP:0000805,abnormal visual cortex morphology|MP:0003631,nervous system phenotype
MGI:2180757	Pirb<tm1Ttk>	MP:0000716,abnormal immune system cell morphology|MP:0002442,abnormal leukocyte physiology|MP:0002444,abnormal T cell physiology|MP:0004977,increased B-1 B cell number|MP:0005154,increased B cell proliferation|MP:0005466,abnormal T-helper 2 physiology|MP:0008115,abnormal dendritic cell differentiation|MP:0008217,abnormal B cell activation
MGI:3857267	Pir<Gt(AW0646)Wtsi>	MP:0003984,embryonic growth retardation
MGI:6281572	Pirnac1<em1Arte>	MP:0002169,no abnormal phenotype detected
MGI:3834636	Pirt<tm1Xzd>	MP:0001973,increased thermal nociceptive threshold|MP:0008531,increased chemical nociceptive threshold|MP:0009253,abnormal sympathetic neuron physiology
MGI:3713337	Pis1<A/J>	MP:0002906,increased susceptibility to pharmacologically induced seizures
MGI:3713339	Pis2<A/J>	MP:0002906,increased susceptibility to pharmacologically induced seizures
MGI:3510427	pisa	MP:0001394,circling|MP:0001504,abnormal posture|MP:0005377,hearing/vestibular/ear phenotype
MGI:3612417	Pisd<Gt1(Betageo)Jev>	MP:0001674,abnormal germ layer development|MP:0001698,decreased embryo size|MP:0002086,abnormal extraembryonic tissue morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006035,abnormal mitochondrial morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013241,embryo tissue necrosis
MGI:6416148	Pithd1<em1Osb>	MP:0000242,impaired fertilization|MP:0002675,asthenozoospermia|MP:0005379,endocrine/exocrine gland phenotype|MP:0005578,teratozoospermia|MP:0031408,multi-headed sperm
MGI:6416147	Pithd1<tm1Ohi>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0004884,abnormal testis physiology|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0031408,multi-headed sperm
MGI:2154482	Pitm1<C57BL/FaDk>	MP:0005363,decreased susceptibility to prion infection
MGI:2155692	Pitm2<C57BL/FaDk>	MP:0005363,decreased susceptibility to prion infection
MGI:2156998	Pitm3<C57BL/FaDk>	MP:0005363,decreased susceptibility to prion infection
MGI:2429531	Pitm4<C57BL/FaDk>	MP:0005363,decreased susceptibility to prion infection
MGI:7425913	Pitpna<em2(IMPC)Rbrc>	MP:0000137,abnormal vertebrae morphology|MP:0004599,abnormal vertebral arch morphology
MGI:2676301	Pitpna<Gt(OST1152)Lex>	MP:0000010,abnormal abdominal fat pad morphology|MP:0000189,hypoglycemia|MP:0000479,abnormal enterocyte morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000745,tremors|MP:0000849,abnormal cerebellum morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0000921,demyelination|MP:0000955,abnormal spinal cord morphology|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001648,abnormal apoptosis|MP:0001732,postnatal growth retardation|MP:0001745,increased circulating corticosterone level|MP:0002064,seizures|MP:0002082,postnatal lethality|MP:0002229,neurodegeneration|MP:0002644,decreased circulating triglyceride level|MP:0002696,decreased circulating glucagon level|MP:0002715,decreased glycogen catabolism rate|MP:0002727,decreased circulating insulin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005215,abnormal pancreatic islet morphology|MP:0005277,abnormal brainstem morphology|MP:0005336,abnormal inguinal fat pad morphology|MP:0005342,abnormal intestinal lipid absorption|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0008027,abnormal spinal cord white matter morphology|MP:0009168,decreased pancreatic islet number|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011231,abnormal vitamin E level|MP:0031116,microvesicular hepatic steatosis
MGI:2676298	Pitpna<tm1Vab>	MP:0000010,abnormal abdominal fat pad morphology|MP:0000189,hypoglycemia|MP:0000479,abnormal enterocyte morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000745,tremors|MP:0000849,abnormal cerebellum morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0000921,demyelination|MP:0000955,abnormal spinal cord morphology|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001671,abnormal vitamin absorption|MP:0001732,postnatal growth retardation|MP:0001745,increased circulating corticosterone level|MP:0002064,seizures|MP:0002229,neurodegeneration|MP:0002644,decreased circulating triglyceride level|MP:0002696,decreased circulating glucagon level|MP:0002715,decreased glycogen catabolism rate|MP:0002727,decreased circulating insulin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005215,abnormal pancreatic islet morphology|MP:0005277,abnormal brainstem morphology|MP:0005336,abnormal inguinal fat pad morphology|MP:0005342,abnormal intestinal lipid absorption|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0008027,abnormal spinal cord white matter morphology|MP:0009168,decreased pancreatic islet number|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012261,increased hindbrain apoptosis|MP:0031116,microvesicular hepatic steatosis
MGI:1856642	Pitpna<vb>	MP:0000745,tremors|MP:0000849,abnormal cerebellum morphology|MP:0000955,abnormal spinal cord morphology|MP:0001516,abnormal motor coordination/balance|MP:0002083,premature death|MP:0002882,abnormal neuron morphology|MP:0002883,chromatolysis|MP:0003224,neuron degeneration|MP:0011400,lethality, complete penetrance
MGI:3582490	Pitpnb<tm1Vab>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6336129	Pitpnc1<em1(IMPC)Kmpc>	MP:0000062,increased bone mineral density|MP:0000182,increased circulating LDL cholesterol level|MP:0001399,hyperactivity|MP:0002965,increased circulating serum albumin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0005568,increased circulating total protein level|MP:0010090,increased circulating creatine kinase level
MGI:4431584	Pitpnm1<tm1a(EUCOMM)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0000221,decreased leukocyte cell number|MP:0004738,abnormal auditory brainstem response|MP:0005179,decreased circulating cholesterol level|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0005561,increased mean corpuscular hemoglobin|MP:0005628,decreased circulating potassium level
MGI:2679326	Pitpnm2<tm1Tili>	MP:0002169,no abnormal phenotype detected
MGI:6384593	Pitpnm3<em1(IMPC)Bay>	MP:0003795,abnormal bone structure|MP:0010123,increased bone mineral content
MGI:5085349	Pitrm1<tm1a(KOMP)Wtsi>	MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0001711,abnormal placenta morphology|MP:0002183,gliosis|MP:0002757,decreased vertical activity|MP:0002836,abnormal chorion morphology|MP:0003224,neuron degeneration|MP:0003329,amyloid beta deposits|MP:0005031,abnormal trophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0005290,decreased oxygen consumption|MP:0005356,positive geotaxis|MP:0005621,abnormal cell physiology|MP:0006036,abnormal mitochondrial physiology|MP:0008964,decreased carbon dioxide production|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0020234,decreased basal metabolism
MGI:6140217	Pitx1<em1(IMPC)Wtsi>	MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0000572,abnormal autopod morphology|MP:0000579,abnormal nail morphology|MP:0001312,abnormal cornea morphology|MP:0002110,abnormal digit morphology|MP:0002932,abnormal joint morphology|MP:0003036,vertebral transformation|MP:0004083,polysyndactyly|MP:0008730,fused phalanges|MP:0011100,preweaning lethality, complete penetrance
MGI:1857659	Pitx1<tm1Jdr>	MP:0000163,abnormal cartilage morphology|MP:0000556,abnormal hindlimb morphology|MP:0000558,abnormal tibia morphology|MP:0002187,abnormal fibula morphology|MP:0002639,micrognathia|MP:0002764,short tibia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004575,small limb buds|MP:0004688,absent ilium|MP:0004689,small ischium|MP:0004692,small pubis|MP:0004694,absent patella|MP:0005105,abnormal middle ear ossicle morphology|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006020,decreased tympanic ring size|MP:0008381,absent gonial bone|MP:0009886,failure of palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0009910,bifurcated tongue|MP:0011089,perinatal lethality, complete penetrance|MP:0014281,hindlimb oligodactyly|MP:0014322,short hindlimb|MP:0030859,absent sesamoid bone of gastrocnemius
MGI:1934200	Pitx1<tm1Rsd>	MP:0000088,short mandible|MP:0000111,cleft palate|MP:0000556,abnormal hindlimb morphology|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0000576,clubfoot|MP:0000633,abnormal pituitary gland morphology|MP:0000734,muscle hypoplasia|MP:0001731,abnormal postnatal growth|MP:0002187,abnormal fibula morphology|MP:0002191,abnormal artery morphology|MP:0002544,brachydactyly|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004592,small mandible|MP:0004694,absent patella|MP:0005104,abnormal tarsal bone morphology|MP:0005452,abnormal adipose tissue amount|MP:0008335,decreased gonadotroph cell number|MP:0008338,decreased thyrotroph cell number|MP:0009524,absent submandibular gland|MP:0010876,decreased bone volume|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0014322,short hindlimb|MP:0020301,short tongue
MGI:6275111	Pitx2<egl1>	MP:0001296,macrophthalmia|MP:0001314,cornea opacity|MP:0003727,abnormal retina layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005102,abnormal iris pigmentation|MP:0005258,ocular hypertension|MP:0005497,optic nerve cupping|MP:0005551,abnormal eye electrophysiology|MP:0009829,enlarged eye anterior chamber|MP:0011481,anterior iris synechia|MP:0011965,decreased total retina thickness|MP:0012144,decreased b-wave amplitude
MGI:5308807	Pitx2<tm1.1Dmm>	MP:0000266,abnormal heart morphology|MP:0001672,abnormal embryo development|MP:0001700,abnormal embryo turning
MGI:4880738	Pitx2<tm1.1Mbf>	MP:0009490,abnormal heart left atrium auricular region morphology|MP:0010422,heart right ventricle hypoplasia
MGI:5760000	Pitx2<tm1b(EUCOMM)Wtsi>	MP:0000274,enlarged heart|MP:0001147,small testis|MP:0001314,cornea opacity|MP:0001319,irregularly shaped pupil|MP:0002080,prenatal lethality|MP:0002100,abnormal tooth morphology|MP:0008259,abnormal optic disk morphology|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:3767234	Pitx2<tm1Hmd>	MP:0000272,abnormal aorta morphology|MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000299,failure of atrioventricular cushion closure|MP:0000531,right pulmonary isomerism|MP:0000644,dextrocardia|MP:0000692,small spleen|MP:0001706,abnormal left-right axis patterning|MP:0001944,abnormal pancreas morphology|MP:0003271,abnormal duodenum morphology|MP:0004110,transposition of great arteries|MP:0004113,abnormal aortic arch morphology|MP:0006061,right atrial isomerism|MP:0006062,abnormal vena cava morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0006355,abnormal sixth pharyngeal arch artery morphology|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010412,atrioventricular septal defect|MP:0010607,common atrioventricular valve|MP:0010668,abnormal hepatic portal vein morphology|MP:0011569,abnormal azygos vein morphology
MGI:2136268	Pitx2<tm1Jfm>	MP:0000111,cleft palate|MP:0000118,arrest of tooth development|MP:0000282,abnormal interatrial septum morphology|MP:0000284,double outlet right ventricle|MP:0000299,failure of atrioventricular cushion closure|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0000531,right pulmonary isomerism|MP:0000644,dextrocardia|MP:0000694,spleen hypoplasia|MP:0001312,abnormal cornea morphology|MP:0001319,irregularly shaped pupil|MP:0001636,irregular heartbeat|MP:0001701,incomplete embryo turning|MP:0003052,omphalocele|MP:0003105,abnormal heart atrium morphology|MP:0003119,abnormal digestive system development|MP:0004283,absent cornea endothelium|MP:0005381,digestive/alimentary phenotype|MP:0006061,right atrial isomerism|MP:0006064,abnormal superior vena cava morphology|MP:0006107,abnormal fetal atrioventricular canal morphology|MP:0006241,abnormal placement of pupils|MP:0008543,atrial fibrillation|MP:0010392,prolonged QRS complex duration|MP:0010437,absent coronary sinus|MP:0010440,anomalous pulmonary venous connection|MP:0010454,abnormal truncus arteriosus septation|MP:0010607,common atrioventricular valve|MP:0010709,absent eye anterior chamber|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011667,double outlet right ventricle with atrioventricular septal defect|MP:0030026,small Meckel's cartilage|MP:0030171,absent extraocular muscles
MGI:1857880	Pitx2<tm1Kki>	MP:0000267,abnormal heart development|MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000531,right pulmonary isomerism|MP:0001312,abnormal cornea morphology|MP:0001680,abnormal mesoderm development|MP:0002823,abnormal rib development|MP:0003119,abnormal digestive system development|MP:0003384,abnormal ventral body wall morphology|MP:0004624,abnormal thoracic cage morphology|MP:0004673,splayed ribs|MP:0006107,abnormal fetal atrioventricular canal morphology|MP:0006198,enophthalmos|MP:0008726,increased heart left atrium size|MP:0010406,common atrium|MP:0010422,heart right ventricle hypoplasia|MP:0010426,abnormal heart and great artery attachment|MP:0010607,common atrioventricular valve|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0030171,absent extraocular muscles
MGI:2384494	Pitx2<tm1Rsd>	MP:0000118,arrest of tooth development|MP:0000162,lordosis|MP:0000279,ventricular hypoplasia|MP:0000458,abnormal mandible morphology|MP:0000531,right pulmonary isomerism|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0000689,abnormal spleen morphology|MP:0001303,abnormal lens morphology|MP:0001701,incomplete embryo turning|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002659,pituitary gland hypoplasia|MP:0003384,abnormal ventral body wall morphology|MP:0003816,abnormal pituitary gland development|MP:0005247,abnormal extraocular muscle morphology|MP:0010406,common atrium|MP:0010807,abnormal stomach position or orientation|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012273,axial mesoderm hypoplasia|MP:0030038,abnormal periorbital region morphology|MP:0030039,abnormal facial muscle morphology|MP:0030579,thoracoabdominoschisis
MGI:1857844	Pitx2<tm1Sac>	MP:0000120,malocclusion|MP:0000281,abnormal interventricular septum morphology|MP:0000531,right pulmonary isomerism|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001317,abnormal pupil morphology|MP:0003686,abnormal eye muscle morphology|MP:0004163,abnormal adenohypophysis morphology|MP:0005130,decreased follicle stimulating hormone level|MP:0005132,decreased luteinizing hormone level|MP:0005379,endocrine/exocrine gland phenotype|MP:0006065,abnormal heart position or orientation|MP:0006240,anisocoria|MP:0006241,abnormal placement of pupils|MP:0008329,decreased somatotroph cell number|MP:0008336,absent gonadotrophs|MP:0008338,decreased thyrotroph cell number|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0030541,misaligned incisors
MGI:2136271	Pitx2<tm2.1Jfm>	MP:0000111,cleft palate|MP:0000477,abnormal intestine morphology|MP:0000531,right pulmonary isomerism|MP:0002092,abnormal eye morphology|MP:0003119,abnormal digestive system development|MP:0005382,craniofacial phenotype|MP:0005385,cardiovascular system phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1857846	Pitx2<tm2Sac>	MP:0000120,malocclusion|MP:0000274,enlarged heart|MP:0000281,abnormal interventricular septum morphology|MP:0000531,right pulmonary isomerism|MP:0000914,exencephaly|MP:0001265,decreased body size|MP:0001286,abnormal eye development|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001317,abnormal pupil morphology|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0002745,abnormal atrioventricular valve morphology|MP:0003105,abnormal heart atrium morphology|MP:0003384,abnormal ventral body wall morphology|MP:0003818,abnormal eye muscle development|MP:0005545,abnormal lens development|MP:0006062,abnormal vena cava morphology|MP:0006065,abnormal heart position or orientation|MP:0006240,anisocoria|MP:0006241,abnormal placement of pupils|MP:0008365,adenohypophysis hypoplasia|MP:0009937,abnormal neuron differentiation|MP:0010406,common atrium|MP:0011092,embryonic lethality, complete penetrance|MP:0012535,abnormal optic fissure closure|MP:0012536,delayed optic fissure closure|MP:0013337,abnormal adenohypophysis development|MP:0013351,abnormal Rathke's pouch development|MP:0013352,abnormal Rathke's pouch apoptosis|MP:0020854,increased cornea epithelium thickness|MP:0030541,misaligned incisors
MGI:2445428	Pitx2<tm3.1Jfm>	MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000531,right pulmonary isomerism|MP:0000692,small spleen|MP:0001575,cyanosis|MP:0001706,abnormal left-right axis patterning|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0002725,abnormal vein morphology|MP:0002766,situs inversus|MP:0004158,right aortic arch|MP:0004159,double aortic arch|MP:0005380,embryo phenotype|MP:0005382,craniofacial phenotype|MP:0010402,ventricular septal defect|MP:0010440,anomalous pulmonary venous connection|MP:0011087,neonatal lethality, complete penetrance
MGI:2445425	Pitx2<tm3Jfm>	MP:0002169,no abnormal phenotype detected
MGI:2445429	Pitx2<tm4(cre)Jfm>	MP:0002576,abnormal enamel morphology
MGI:1856667	Pitx3<ak>	MP:0000897,abnormal midbrain morphology|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001299,abnormal eye distance/ position|MP:0001325,abnormal retina morphology|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001921,reduced fertility|MP:0002757,decreased vertical activity|MP:0002864,abnormal ocular fundus morphology|MP:0003244,loss of dopaminergic neurons|MP:0004102,abnormal dorsal striatum morphology|MP:0005102,abnormal iris pigmentation|MP:0005193,abnormal anterior eye segment morphology|MP:0005195,abnormal posterior eye segment morphology|MP:0005545,abnormal lens development|MP:0005643,decreased dopamine level|MP:0012101,acoria|MP:0013219,abnormal substantia nigra pars compacta morphology|MP:0013453,enlarged lacrimal gland|MP:0020543,decreased substantia nigra size|MP:0021107,retina fold|MP:0031391,increased locomotor activity
MGI:4429408	Pitx3<eyl>	MP:0000221,decreased leukocyte cell number|MP:0000322,increased granulocyte number|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001307,fused cornea and lens|MP:0001325,abnormal retina morphology|MP:0001328,disorganized retina layers|MP:0001363,increased anxiety-related response|MP:0001364,decreased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001566,increased circulating phosphate level|MP:0001806,decreased IgM level|MP:0001943,abnormal respiration|MP:0002327,abnormal respiratory function|MP:0002490,abnormal immunoglobulin level|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002738,hyperresponsive to tactile stimuli|MP:0002968,increased circulating alkaline phosphatase level|MP:0003078,aphakia|MP:0003179,thrombocytopenia|MP:0003960,increased lean body mass|MP:0003998,decreased thermal nociceptive threshold|MP:0004016,decreased bone mass|MP:0004151,decreased circulating iron level|MP:0004889,increased energy expenditure|MP:0005176,eyelids fail to open|MP:0005179,decreased circulating cholesterol level|MP:0005449,abnormal food intake|MP:0005533,increased body temperature|MP:0005573,increased pulmonary respiratory rate|MP:0005586,decreased tidal volume|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008498,decreased IgG3 level|MP:0008532,decreased chemical nociceptive threshold|MP:0008805,decreased circulating amylase level|MP:0008821,increased blood uric acid level|MP:0008822,decreased blood uric acid level|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0011448,decreased dopaminergic neuron number|MP:0011962,increased cornea thickness|MP:0021107,retina fold
MGI:3716548	Pitx3<tm1.1Jdr>	MP:0002092,abnormal eye morphology|MP:0003244,loss of dopaminergic neurons
MGI:5488783	Pitx3<tm1.1(KOMP)Vlcg>	MP:0001293,anophthalmia|MP:0001399,hyperactivity|MP:0001516,abnormal motor coordination/balance|MP:0002626,increased heart rate|MP:0002702,decreased circulating free fatty acids level|MP:0002757,decreased vertical activity|MP:0002804,abnormal motor learning|MP:0003063,increased coping response|MP:0005560,decreased circulating glucose level|MP:0010052,increased grip strength|MP:0010571,shortened ST segment|MP:0011396,abnormal sleep behavior|MP:0013279,increased fasting circulating glucose level
MGI:3573869	Pitx3<tm1Mli>	MP:0003203,increased neuron apoptosis|MP:0003244,loss of dopaminergic neurons|MP:0008947,increased neuron number
MGI:3783311	Pitx3<tm2Mli>	MP:0003631,nervous system phenotype
MGI:5316870	Piwil1<tm1.1Embrp>	MP:0001925,male infertility|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology
MGI:5316871	Piwil1<tm1.2Embrp>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0031620,abnormal chromatoid body morphology
MGI:2182488	Piwil1<tm1Hfl>	MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0006362,abnormal male germ cell morphology|MP:0008261,arrest of male meiosis
MGI:5320635	Piwil2<tm1.1Doca>	MP:0001925,male infertility|MP:0003205,testicular atrophy|MP:0005621,abnormal cell physiology|MP:0008261,arrest of male meiosis|MP:0008280,abnormal male germ cell apoptosis|MP:0008877,abnormal DNA methylation
MGI:3029596	Piwil2<tm1Nkn>	MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:5521292	Piwil2<tm2.1Doca>	MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005621,abnormal cell physiology|MP:0008280,abnormal male germ cell apoptosis
MGI:5521293	Piwil2<tm2.2Doca>	MP:0005621,abnormal cell physiology|MP:0006378,abnormal spermatogonia morphology|MP:0006379,abnormal spermatocyte morphology
MGI:5320636	Piwil4<tm1.1Doca>	MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype
MGI:3712153	Piwil4<tm1Ghan>	MP:0001147,small testis|MP:0001922,reduced male fertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0004901,decreased male germ cell number|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis
MGI:5320638	Piwil4<tm2.1Doca>	MP:0004852,decreased testis weight
MGI:3778927	piza	MP:0000940,abnormal motor neuron innervation pattern
MGI:6152616	Pja1<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0001126,abnormal ovary morphology|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001402,decreased locomotor activity|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0004832,enlarged ovary
MGI:5762626	Pja1<m1Yah>	MP:0002169,no abnormal phenotype detected
MGI:7610503	Pja2<tm1.2Afel>	MP:0000519,hydronephrosis|MP:0000530,abnormal kidney vasculature morphology|MP:0001262,decreased body weight|MP:0001785,edema|MP:0001859,kidney inflammation|MP:0002705,dilated renal tubule|MP:0011320,abnormal glomerular capillary morphology|MP:0011338,abnormal mesangial matrix morphology|MP:0011363,renal glomerulus atrophy|MP:0011423,kidney cortex atrophy|MP:0011427,increased mesangial cell number|MP:0011501,increased glomerular capsule space|MP:0014361,increased necroptotic process
MGI:5572033	Pja2<tm1b(EUCOMM)Wtsi>	MP:0000689,abnormal spleen morphology|MP:0002060,abnormal skin morphology
MGI:7427802	Pjvk<em1Chchw>	MP:0001394,circling|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0002857,cochlear ganglion degeneration|MP:0004298,vestibular ganglion degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004414,decreased cochlear microphonics|MP:0004529,decreased outer hair cell stereocilia number|MP:0005191,head tilt|MP:0006325,impaired hearing|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014407,decreased distortion product otoacoustic emission threshold|MP:0014740,increased auditory brainstem response wave peak latency|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:6379292	Pjvk<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0001489,decreased startle reflex|MP:0004738,abnormal auditory brainstem response|MP:0009142,decreased prepulse inhibition
MGI:3708376	Pjvk<sti>	MP:0001394,circling|MP:0001489,decreased startle reflex|MP:0001522,impaired swimming|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3654320	Pjvk<tm1Ugds>	MP:0003631,nervous system phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:1856993	pk	MP:0000652,enlarged sebaceous gland|MP:0001284,absent vibrissae|MP:0001510,abnormal coat appearance|MP:0002060,abnormal skin morphology|MP:0002073,abnormal hair growth|MP:0003809,abnormal hair shaft morphology|MP:0009931,abnormal skin appearance
MGI:5752521	Pk27053	MP:0020244,increased pyruvate kinase activity
MGI:2155322	Pkcal<A/J>	MP:0005584,abnormal enzyme/coenzyme activity
MGI:5438059	Pkd1<b2b1585Clo>	MP:0000276,heart right ventricle hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia|MP:0008528,polycystic kidney
MGI:4948351	Pkd1l1<rks>	MP:0000531,right pulmonary isomerism|MP:0000644,dextrocardia|MP:0001706,abnormal left-right axis patterning|MP:0001730,embryonic growth arrest|MP:0001785,edema|MP:0003984,embryonic growth retardation|MP:0004190,abnormal direction of embryo turning|MP:0005367,renal/urinary system phenotype|MP:0005380,embryo phenotype|MP:0010808,right-sided stomach|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4949891	Pkd1l1<tm1Lex>	MP:0002766,situs inversus|MP:0003631,nervous system phenotype|MP:0005380,embryo phenotype|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:7641816	Pkd1l2<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5548849	Pkd1l2<tm1b(KOMP)Mbp>	MP:0001303,abnormal lens morphology|MP:0001926,female infertility
MGI:4837113	Pkd1l3<tm1.1Abek>	MP:0003631,nervous system phenotype|MP:0005394,taste/olfaction phenotype
MGI:3784517	Pkd1l3<tm1Sul>	MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype
MGI:2152894	Pkd1<m1Bei>	MP:0001785,edema|MP:0003068,enlarged kidney|MP:0003450,enlarged pancreas|MP:0003675,kidney cyst
MGI:3846084	Pkd1<tm1.1Bol>	MP:0002169,no abnormal phenotype detected
MGI:3521724	Pkd1<tm1.1Djmp>	MP:0002169,no abnormal phenotype detected|MP:0003675,kidney cyst
MGI:5470234	Pkd1<tm1.1Fqi>	MP:0001263,weight loss|MP:0001270,distended abdomen|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002705,dilated renal tubule|MP:0003068,enlarged kidney|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008528,polycystic kidney|MP:0009495,abnormal common bile duct morphology
MGI:5476822	Pkd1<tm1.1Pcha>	MP:0003068,enlarged kidney|MP:0003602,increased renal hamartoma incidence|MP:0003917,increased kidney weight|MP:0003985,renal fibrosis|MP:0004754,abnormal kidney collecting duct morphology|MP:0005565,increased blood urea nitrogen level|MP:0008528,polycystic kidney|MP:0009050,dilated proximal convoluted tubule
MGI:3846085	Pkd1<tm1.2Bol>	MP:0011091,prenatal lethality, complete penetrance
MGI:3771608	Pkd1<tm1.2Djmp>	MP:0011091,prenatal lethality, complete penetrance|MP:0011440,increased kidney cell proliferation
MGI:3714781	Pkd1<tm1Bdgz>	MP:0001786,skin edema|MP:0002705,dilated renal tubule|MP:0003327,liver cyst|MP:0003336,pancreas cyst|MP:0003675,kidney cyst|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5637215	Pkd1<tm1b(EUCOMM)Hmgu>	MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0000757,herniated abdominal wall|MP:0002875,decreased erythrocyte cell number|MP:0002966,decreased circulating alkaline phosphatase level|MP:0004174,abnormal spine curvature|MP:0005567,decreased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance
MGI:3521583	Pkd1<tm1Djmp>	MP:0001262,decreased body weight|MP:0001270,distended abdomen|MP:0001732,postnatal growth retardation|MP:0001859,kidney inflammation|MP:0002083,premature death|MP:0003215,renal interstitial fibrosis|MP:0003253,dilated bile duct|MP:0003266,biliary cyst|MP:0003336,pancreas cyst|MP:0003675,kidney cyst|MP:0004044,aortic dissection|MP:0006278,aortic aneurysm
MGI:5470240	Pkd1<tm1Fqi>	MP:0011091,prenatal lethality, complete penetrance
MGI:3612339	Pkd1<tm1Ggg>	MP:0001711,abnormal placenta morphology|MP:0001712,abnormal placenta development|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003231,abnormal placenta vasculature|MP:0003336,pancreas cyst|MP:0003675,kidney cyst|MP:0004020,polyhydramnios|MP:0011091,prenatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012172,abnormal amniotic fluid composition
MGI:4437121	Pkd1<tm1Gztn>	MP:0002136,abnormal kidney physiology|MP:0008528,polycystic kidney
MGI:3612536	Pkd1<tm1Hung>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0001732,postnatal growth retardation|MP:0001924,infertility|MP:0002083,premature death|MP:0002113,abnormal skeleton development|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003215,renal interstitial fibrosis|MP:0003336,pancreas cyst|MP:0003675,kidney cyst|MP:0005370,liver/biliary system phenotype|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0005565,increased blood urea nitrogen level
MGI:1857562	Pkd1<tm1Jzh>	MP:0000522,kidney cortex cyst|MP:0000608,dissociated hepatocytes|MP:0001178,pulmonary hypoplasia|MP:0001270,distended abdomen|MP:0001786,skin edema|MP:0001859,kidney inflammation|MP:0001954,respiratory distress|MP:0002192,hydrops fetalis|MP:0002260,abnormal thyroid cartilage morphology|MP:0002427,disproportionate dwarf|MP:0002657,chondrodystrophy|MP:0002705,dilated renal tubule|MP:0002896,abnormal bone mineralization|MP:0002928,abnormal bile duct morphology|MP:0003068,enlarged kidney|MP:0003215,renal interstitial fibrosis|MP:0003254,bile duct inflammation|MP:0003325,decreased liver function|MP:0003327,liver cyst|MP:0003334,pancreas fibrosis|MP:0003336,pancreas cyst|MP:0003338,pancreas lipomatosis|MP:0003641,small lung|MP:0003675,kidney cyst|MP:0004020,polyhydramnios|MP:0004967,abnormal kidney epithelium morphology|MP:0005220,abnormal exocrine pancreas morphology|MP:0005297,spina bifida occulta|MP:0005328,abnormal circulating creatinine level|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005385,cardiovascular system phenotype|MP:0005397,hematopoietic system phenotype|MP:0009050,dilated proximal convoluted tubule|MP:0009144,dilated pancreatic duct|MP:0009145,abnormal pancreatic acinus morphology|MP:0009164,exocrine pancreas atrophy|MP:0009168,decreased pancreatic islet number|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011307,kidney medulla cyst|MP:0011744,abnormal kidney epithelial cell primary cilium physiology
MGI:2183523	Pkd1<tm1Maa>	MP:0001614,abnormal blood vessel morphology|MP:0001786,skin edema|MP:0001914,hemorrhage|MP:0002192,hydrops fetalis|MP:0003336,pancreas cyst|MP:0003675,kidney cyst|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2152589	Pkd1<tm1Rsa>	MP:0000137,abnormal vertebrae morphology|MP:0000164,abnormal cartilage development|MP:0000284,double outlet right ventricle|MP:0000299,failure of atrioventricular cushion closure|MP:0000552,abnormal radius morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002116,abnormal craniofacial bone morphology|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002652,thin myocardium|MP:0003327,liver cyst|MP:0003675,kidney cyst|MP:0004174,abnormal spine curvature|MP:0004686,decreased length of long bones|MP:0005108,abnormal ulna morphology|MP:0005244,hemopericardium|MP:0005587,abnormal Meckel's cartilage morphology|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010585,abnormal conotruncal ridge morphology|MP:0010607,common atrioventricular valve|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2183431	Pkd1<tm1Shh>	MP:0000284,double outlet right ventricle|MP:0001786,skin edema|MP:0003675,kidney cyst|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3793793	Pkd1<tm1Som>	MP:0001698,decreased embryo size|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003336,pancreas cyst|MP:0003675,kidney cyst|MP:0003717,pallor|MP:0005385,cardiovascular system phenotype|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4366012	Pkd1<tm2.1Bol>	MP:0002169,no abnormal phenotype detected
MGI:3617325	Pkd1<tm2.1Ggg>	MP:0001784,abnormal fluid regulation|MP:0001914,hemorrhage|MP:0003336,pancreas cyst|MP:0003675,kidney cyst|MP:0011091,prenatal lethality, complete penetrance
MGI:3793792	Pkd1<tm2.1Som>	MP:0006207,embryonic lethality during organogenesis
MGI:4366013	Pkd1<tm2.2Bol>	MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0001785,edema|MP:0001891,hydrocephaly|MP:0001914,hemorrhage|MP:0003675,kidney cyst|MP:0004950,abnormal brain vasculature morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3612341	Pkd1<tm2Ggg>	MP:0000063,decreased bone mineral density|MP:0000135,decreased compact bone thickness|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002397,abnormal bone marrow morphology|MP:0002904,increased circulating parathyroid hormone level|MP:0003068,enlarged kidney|MP:0003109,short femur|MP:0003327,liver cyst|MP:0003336,pancreas cyst|MP:0003675,kidney cyst|MP:0003917,increased kidney weight|MP:0003985,renal fibrosis|MP:0005220,abnormal exocrine pancreas morphology|MP:0005367,renal/urinary system phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005565,increased blood urea nitrogen level|MP:0006357,abnormal circulating mineral level|MP:0008395,abnormal osteoblast differentiation|MP:0008528,polycystic kidney|MP:0010879,decreased trabecular bone volume|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011167,abnormal adipose tissue development|MP:0011368,increased kidney apoptosis|MP:0011440,increased kidney cell proliferation|MP:0011711,impaired osteoblast differentiation|MP:0020137,decreased bone mineralization|MP:0030438,increased osteoblast proliferation
MGI:2182840	Pkd1<tm2Jzh>	MP:0000065,abnormal bone marrow cavity morphology|MP:0001785,edema|MP:0001786,skin edema|MP:0002113,abnormal skeleton development|MP:0002192,hydrops fetalis|MP:0002260,abnormal thyroid cartilage morphology|MP:0002427,disproportionate dwarf|MP:0002657,chondrodystrophy|MP:0002896,abnormal bone mineralization|MP:0003327,liver cyst|MP:0003336,pancreas cyst|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003420,delayed intramembranous bone ossification|MP:0003675,kidney cyst|MP:0004020,polyhydramnios|MP:0004686,decreased length of long bones|MP:0005297,spina bifida occulta|MP:0008528,polycystic kidney|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5697038	Pkd1<tm2Pcha>	MP:0011400,lethality, complete penetrance
MGI:3793791	Pkd1<tm2Som>	MP:0001566,increased circulating phosphate level|MP:0002135,abnormal kidney morphology|MP:0003606,kidney failure|MP:0003675,kidney cyst|MP:0003917,increased kidney weight|MP:0005178,increased circulating cholesterol level|MP:0005553,increased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0008528,polycystic kidney|MP:0011085,postnatal lethality, complete penetrance|MP:0011440,increased kidney cell proliferation
MGI:4366014	Pkd1<tm3.1Bol>	MP:0002169,no abnormal phenotype detected
MGI:3811234	Pkd1<tm3.1Jzh>	MP:0001785,edema|MP:0004020,polyhydramnios|MP:0008528,polycystic kidney|MP:0011087,neonatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4366015	Pkd1<tm3.2Bol>	MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0001785,edema|MP:0001891,hydrocephaly|MP:0001914,hemorrhage|MP:0003675,kidney cyst|MP:0004950,abnormal brain vasculature morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3811233	Pkd1<tm3Jzh>	MP:0000060,delayed bone ossification|MP:0000088,short mandible|MP:0000091,short premaxilla|MP:0000097,short maxilla|MP:0000103,nasal bone hypoplasia|MP:0000104,abnormal sphenoid bone morphology|MP:0000120,malocclusion|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000457,maxilla hypoplasia|MP:0002083,premature death|MP:0002116,abnormal craniofacial bone morphology|MP:0003420,delayed intramembranous bone ossification|MP:0003797,abnormal compact bone morphology|MP:0004153,increased renal tubule apoptosis|MP:0004380,short frontal bone|MP:0004451,short presphenoid bone|MP:0004471,short nasal bone|MP:0006322,abnormal perichondrium morphology|MP:0008489,slow postnatal weight gain|MP:0008528,polycystic kidney|MP:0010029,abnormal basicranium morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0014101,decreased chondrocyte proliferation|MP:0030444,premature cranial synchondrosis closure|MP:0030445,abnormal sphenooccipital synchondrosis|MP:0030446,premature sphenooccipital synchondrosis closure|MP:0030447,abnormal presphenoid synchondrosis|MP:0030448,premature presphenoid synchondrosis closure
MGI:5008611	Pkd2l1<tm1.1Yuni>	MP:0001985,abnormal gustatory system physiology|MP:0003477,abnormal nerve fiber response
MGI:5548488	Pkd2l2<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level|MP:0010087,increased circulating fructosamine level|MP:0013278,decreased fasting circulating glucose level
MGI:3604592	Pkd2l2<tm1Dgen>	MP:0001415,increased exploration in new environment|MP:0031391,increased locomotor activity
MGI:3640799	Pkd2<lrm4>	MP:0000531,right pulmonary isomerism|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0001706,abnormal left-right axis patterning|MP:0001785,edema|MP:0002766,situs inversus|MP:0003178,left pulmonary isomerism|MP:0004190,abnormal direction of embryo turning|MP:0005380,embryo phenotype|MP:0010807,abnormal stomach position or orientation|MP:0010808,right-sided stomach|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5690203	Pkd2<m1Btlr>	MP:0001270,distended abdomen|MP:0002135,abnormal kidney morphology|MP:0008528,polycystic kidney
MGI:6201745	Pkd2<tm1.1Gwu>	MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003327,liver cyst|MP:0003336,pancreas cyst|MP:0003606,kidney failure|MP:0003675,kidney cyst|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0011440,increased kidney cell proliferation
MGI:4843126	Pkd2<tm1.1Tjwt>	MP:0001914,hemorrhage|MP:0002169,no abnormal phenotype detected|MP:0003231,abnormal placenta vasculature|MP:0004020,polyhydramnios|MP:0005376,homeostasis/metabolism phenotype|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4843127	Pkd2<tm1.2Tjwt>	MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2676373	Pkd2<tm1Dwo>	MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0000522,kidney cortex cyst|MP:0000596,abnormal liver development|MP:0000690,absent spleen|MP:0001176,abnormal lung development|MP:0001706,abnormal left-right axis patterning|MP:0001914,hemorrhage|MP:0001944,abnormal pancreas morphology|MP:0002192,hydrops fetalis|MP:0002766,situs inversus|MP:0002767,situs ambiguus|MP:0003336,pancreas cyst|MP:0003675,kidney cyst|MP:0004190,abnormal direction of embryo turning|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3826433	Pkd2<tm1Gwu>	MP:0000598,abnormal liver morphology|MP:0001732,postnatal growth retardation|MP:0002705,dilated renal tubule|MP:0003253,dilated bile duct|MP:0003327,liver cyst|MP:0003336,pancreas cyst|MP:0003675,kidney cyst|MP:0009050,dilated proximal convoluted tubule|MP:0009144,dilated pancreatic duct|MP:0010439,abnormal hepatic vein morphology|MP:0010768,mortality/aging|MP:0011331,abnormal papillary duct morphology|MP:0011501,increased glomerular capsule space
MGI:5496378	Pkd2<tm1Sia>	MP:0004066,abnormal primitive node morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:1860840	Pkd2<tm1Som>	MP:0000522,kidney cortex cyst|MP:0003327,liver cyst|MP:0003675,kidney cyst|MP:0011307,kidney medulla cyst
MGI:4843125	Pkd2<tm1Tjwt>	MP:0011086,postnatal lethality, incomplete penetrance
MGI:1860866	Pkd2<tm2Som>	MP:0000522,kidney cortex cyst|MP:0001914,hemorrhage|MP:0002083,premature death|MP:0002192,hydrops fetalis|MP:0003327,liver cyst|MP:0003336,pancreas cyst|MP:0003675,kidney cyst|MP:0004020,polyhydramnios|MP:0004066,abnormal primitive node morphology|MP:0005312,pericardial effusion|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010412,atrioventricular septal defect|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012172,abnormal amniotic fluid composition
MGI:5430797	Pkd2<tm3Som>	MP:0002083,premature death|MP:0003068,enlarged kidney|MP:0004860,dilated kidney collecting duct|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008528,polycystic kidney|MP:0009760,abnormal mitotic spindle morphology|MP:0011440,increased kidney cell proliferation
MGI:6277065	Pkdcc<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000288,abnormal pericardium morphology|MP:0000428,abnormal craniofacial morphology|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001404,no spontaneous movement|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0002989,small kidney|MP:0003231,abnormal placenta vasculature|MP:0003743,abnormal facial morphology|MP:0003984,embryonic growth retardation|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape
MGI:4438609	Pkdcc<tm1.1Mask>	MP:0000060,delayed bone ossification|MP:0000097,short maxilla|MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0000547,short limbs|MP:0001175,abnormal lung morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002109,abnormal limb morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003723,abnormal long bone morphology|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004540,small maxilla|MP:0004726,abnormal nasal capsule morphology|MP:0006027,impaired lung alveolus development|MP:0008160,increased diameter of humerus|MP:0008161,increased diameter of radius|MP:0008163,increased diameter of ulna|MP:0009546,absent gastric milk in neonates|MP:0009703,decreased birth body size|MP:0009885,abnormal palatal shelf elevation|MP:0011087,neonatal lethality, complete penetrance|MP:0014106,delayed chondrocyte differentiation
MGI:5523590	Pkdcc<tm1.2Azun>	MP:0000164,abnormal cartilage development|MP:0001953,respiratory failure|MP:0002764,short tibia|MP:0003419,delayed endochondral bone ossification|MP:0004351,short humerus|MP:0004686,decreased length of long bones|MP:0009703,decreased birth body size|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance
MGI:5014347	Pkdcc<tm1Belo>	MP:0000547,short limbs|MP:0000556,abnormal hindlimb morphology|MP:0002764,short tibia|MP:0002896,abnormal bone mineralization|MP:0004355,short radius|MP:0004359,short ulna|MP:0009703,decreased birth body size
MGI:3814573	Pkdcc<tm1Hssk>	MP:0000157,abnormal sternum morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000455,abnormal maxilla morphology|MP:0000477,abnormal intestine morphology|MP:0000547,short limbs|MP:0001575,cyanosis|MP:0002169,no abnormal phenotype detected|MP:0002759,abnormal caudal vertebrae morphology|MP:0002896,abnormal bone mineralization|MP:0003048,abnormal cervical vertebrae morphology|MP:0004358,bowed tibia|MP:0004463,basisphenoid bone foramen|MP:0004607,abnormal cervical atlas morphology|MP:0004608,abnormal cervical axis morphology|MP:0004686,decreased length of long bones|MP:0005249,abnormal palatine bone morphology|MP:0005380,embryo phenotype|MP:0005576,decreased pulmonary ventilation|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance|MP:0021208,median cleft palate
MGI:3799312	Pkdrej<tm1Dgen>	MP:0003666,impaired sperm capacitation|MP:0005389,reproductive system phenotype
MGI:6194908	Pkdrej<tm1Osb>	MP:0002169,no abnormal phenotype detected
MGI:7568836	Pkhd1<cyli>	MP:0000599,enlarged liver|MP:0002929,abnormal bile duct development|MP:0003253,dilated bile duct|MP:0003266,biliary cyst|MP:0003327,liver cyst|MP:0005083,abnormal biliary tract morphology|MP:0005367,renal/urinary system phenotype|MP:0013611,abnormal bile duct epithelium morphology|MP:0014233,bile duct epithelium hyperplasia
MGI:6388657	Pkhd1<em1Mrug>	MP:0000521,abnormal kidney cortex morphology|MP:0002135,abnormal kidney morphology|MP:0003253,dilated bile duct|MP:0003255,bile duct proliferation|MP:0003266,biliary cyst|MP:0003327,liver cyst|MP:0003333,liver fibrosis|MP:0009050,dilated proximal convoluted tubule
MGI:6149161	Pkhd1l1<em1(IMPC)H>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0010067,increased red blood cell distribution width
MGI:6369356	Pkhd1l1<tm2c(EUCOMM)Hmgu>	MP:0003149,abnormal tectorial membrane morphology|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0004736,abnormal distortion product otoacoustic emission|MP:0006325,impaired hearing|MP:0011091,prenatal lethality, complete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3759215	Pkhd1<tm1.1Ggg>	MP:0001732,postnatal growth retardation|MP:0001953,respiratory failure|MP:0002705,dilated renal tubule|MP:0002929,abnormal bile duct development|MP:0003068,enlarged kidney|MP:0003254,bile duct inflammation|MP:0003266,biliary cyst|MP:0003327,liver cyst|MP:0003333,liver fibrosis|MP:0003336,pancreas cyst|MP:0003675,kidney cyst|MP:0004839,bile duct hyperplasia|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3814174	Pkhd1<tm1Cjwa>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0003253,dilated bile duct|MP:0003255,bile duct proliferation|MP:0003327,liver cyst|MP:0003333,liver fibrosis|MP:0003336,pancreas cyst|MP:0003675,kidney cyst|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0009050,dilated proximal convoluted tubule|MP:0009143,abnormal pancreatic duct morphology|MP:0009144,dilated pancreatic duct|MP:0011352,proximal convoluted tubule brush border loss|MP:0012238,abnormal cholangiocyte primary cilium morphology
MGI:3759214	Pkhd1<tm1Ggg>	MP:0002169,no abnormal phenotype detected
MGI:3826780	Pkhd1<tm1Gwu>	MP:0000598,abnormal liver morphology|MP:0001654,hepatic necrosis|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002705,dilated renal tubule|MP:0003300,gastrointestinal ulcer|MP:0003327,liver cyst|MP:0003333,liver fibrosis|MP:0003336,pancreas cyst|MP:0003675,kidney cyst|MP:0003946,renal necrosis|MP:0003985,renal fibrosis|MP:0004153,increased renal tubule apoptosis|MP:0009050,dilated proximal convoluted tubule|MP:0009144,dilated pancreatic duct|MP:0011066,abnormal renal tubule epithelial cell primary cilium morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011331,abnormal papillary duct morphology|MP:0011359,decreased glomerular capillary number|MP:0011427,increased mesangial cell number|MP:0011441,decreased kidney cell proliferation|MP:0011501,increased glomerular capsule space
MGI:3664756	Pkhd1<tm1Rbu>	MP:0000596,abnormal liver development|MP:0002928,abnormal bile duct morphology|MP:0002929,abnormal bile duct development|MP:0003327,liver cyst|MP:0003333,liver fibrosis|MP:0005367,renal/urinary system phenotype|MP:0005389,reproductive system phenotype
MGI:3774015	Pkhd1<tm1Som>	MP:0000691,enlarged spleen|MP:0002138,abnormal hepatobiliary system morphology|MP:0003255,bile duct proliferation|MP:0003266,biliary cyst|MP:0003327,liver cyst|MP:0003333,liver fibrosis|MP:0003334,pancreas fibrosis|MP:0003336,pancreas cyst|MP:0004967,abnormal kidney epithelium morphology|MP:0005367,renal/urinary system phenotype|MP:0005384,cellular phenotype|MP:0009144,dilated pancreatic duct|MP:0009760,abnormal mitotic spindle morphology
MGI:5430994	Pkhd1<tm1Sswi>	MP:0002705,dilated renal tubule|MP:0003215,renal interstitial fibrosis|MP:0003253,dilated bile duct|MP:0003333,liver fibrosis|MP:0003336,pancreas cyst|MP:0003675,kidney cyst|MP:0005084,abnormal gallbladder morphology|MP:0009497,abnormal intrahepatic bile duct morphology|MP:0009498,abnormal extrahepatic bile duct morphology|MP:0009501,abnormal hepatic duct morphology|MP:0011682,renal glomerulus cyst
MGI:5438325	Pkhd1<tm2.1Cjwa>	MP:0002169,no abnormal phenotype detected
MGI:5438324	Pkhd1<tm2Cjwa>	MP:0002981,increased liver weight|MP:0003327,liver cyst|MP:0003333,liver fibrosis|MP:0003675,kidney cyst|MP:0003917,increased kidney weight|MP:0005379,endocrine/exocrine gland phenotype|MP:0009050,dilated proximal convoluted tubule
MGI:8221217	Pkhd1<tm2Ggg>	MP:0000120,malocclusion|MP:0001314,cornea opacity|MP:0001922,reduced male fertility|MP:0002697,abnormal eye size|MP:0002929,abnormal bile duct development|MP:0003068,enlarged kidney|MP:0003253,dilated bile duct|MP:0003327,liver cyst|MP:0005367,renal/urinary system phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0008737,abnormal spleen physiology|MP:0009825,cornea ulcer|MP:0011210,abnormal temporomandibular joint morphology|MP:0012236,abnormal cholangiocyte morphology|MP:0030541,misaligned incisors
MGI:5616352	Pkia<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0002764,short tibia|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0011965,decreased total retina thickness|MP:0020870,decreased thigmotaxis
MGI:2158639	Pkia<tm1Idz>	MP:0002169,no abnormal phenotype detected
MGI:2158356	Pkib<tm1Idz>	MP:0002169,no abnormal phenotype detected
MGI:5636975	Pkig<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001319,irregularly shaped pupil|MP:0001325,abnormal retina morphology|MP:0001488,increased startle reflex|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005565,increased blood urea nitrogen level|MP:0010097,abnormal retina blood vessel morphology|MP:0011965,decreased total retina thickness
MGI:3027066	Pklr<char4>	MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001585,hemolytic anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002640,reticulocytosis|MP:0002874,decreased hemoglobin content|MP:0005026,decreased susceptibility to parasitic infection|MP:0010035,increased erythrocyte clearance|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality
MGI:7572604	Pklr<em1Appsc>	MP:0005266,abnormal metabolism|MP:0005286,decreased saturated fatty acids level|MP:0009823,abnormal sphingomyelin level|MP:0020583,decreased ceramide level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:4820881	Pklr<M1Neu>	MP:0002169,no abnormal phenotype detected
MGI:1856522	Pklr<slc>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001585,hemolytic anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0005026,decreased susceptibility to parasitic infection|MP:0005344,increased circulating bilirubin level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005639,hemosiderosis|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0009395,increased nucleated erythrocyte cell number|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010035,increased erythrocyte clearance|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality|MP:0011178,increased erythroblast number|MP:0031085,increased erythrocyte osmotic fragility
MGI:6414486	Pkm<em1(IMPC)Bay>	MP:0001693,failure of primitive streak formation|MP:0001694,absent egg cylinders|MP:0001696,failure to gastrulate|MP:0001697,abnormal embryo size|MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold
MGI:4455158	Pkm<r>	MP:0011091,prenatal lethality, complete penetrance|MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:5547750	Pkm<tm1.1Mgvh>	MP:0002169,no abnormal phenotype detected
MGI:5925317	Pkmyt1<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0000603,pale liver|MP:0000783,abnormal forebrain morphology|MP:0001529,abnormal vocalization|MP:0003717,pallor|MP:0003720,abnormal neural tube closure|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5911979	Pkn1<tm1Ajmc>	MP:0001544,abnormal cardiovascular system physiology|MP:0003037,increased myocardial infarct size|MP:0003822,decreased left ventricle systolic pressure|MP:0003824,decreased left ventricle developed pressure|MP:0004231,abnormal calcium ion homeostasis|MP:0005140,decreased cardiac muscle contractility|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging|MP:0011925,abnormal heart echocardiography feature|MP:0020419,decreased cardiac muscle relaxation
MGI:5636911	Pkn1<tm1b(KOMP)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005564,increased hemoglobin content|MP:0010024,increased total body fat amount|MP:0010068,decreased red blood cell distribution width|MP:0012361,decreased large unstained cell number|MP:0013278,decreased fasting circulating glucose level
MGI:5475202	Pkn1<tm1Kik>	MP:0002494,increased IgM level|MP:0002743,glomerulonephritis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004815,abnormal somatic hypermutation frequency|MP:0005154,increased B cell proliferation|MP:0005387,immune system phenotype|MP:0008177,increased germinal center B cell number|MP:0008192,abnormal germinal center B cell physiology|MP:0008483,increased spleen germinal center size|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0009338,increased splenocyte number|MP:0010675,decreased activation-induced B cell apoptosis|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011427,increased mesangial cell number|MP:0020519,renal glomerular immunoglobulin deposits
MGI:4363870	Pkn2<tm1a(KOMP)Wtsi>	MP:0000259,abnormal vascular development|MP:0000929,open neural tube|MP:0001688,abnormal somite development|MP:0001700,abnormal embryo turning|MP:0001719,absent vitelline blood vessels|MP:0001723,disorganized yolk sac vascular plexus|MP:0001787,pericardial edema|MP:0002084,abnormal developmental patterning|MP:0002151,abnormal neural tube morphology|MP:0002950,abnormal neural crest cell migration|MP:0003229,abnormal vitelline vasculature morphology|MP:0003874,absent pharyngeal arches|MP:0003885,abnormal rostral-caudal body axis extension|MP:0004837,abnormal neural fold formation|MP:0006301,abnormal mesenchyme morphology|MP:0008784,craniorachischisis|MP:0009328,delayed heart looping|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011702,abnormal fibroblast proliferation|MP:0012176,abnormal head development|MP:0013925,abnormal vascular plexus formation|MP:0014138,abnormal germ layer morphology
MGI:5613636	Pkn2<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0005179,decreased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0005567,decreased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance|MP:0011897,decreased circulating unsaturated transferrin level
MGI:5911965	Pkn2<tm1c(KOMP)Wtsi>	MP:0000259,abnormal vascular development|MP:0001183,overexpanded pulmonary alveolus|MP:0001625,cardiac hypertrophy|MP:0001700,abnormal embryo turning|MP:0001914,hemorrhage|MP:0002169,no abnormal phenotype detected|MP:0003874,absent pharyngeal arches|MP:0004046,abnormal mitosis|MP:0004759,decreased mitotic index|MP:0006050,pulmonary fibrosis|MP:0006301,abnormal mesenchyme morphology|MP:0010831,lethality, incomplete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0013504,increased embryonic tissue cell apoptosis|MP:0014134,abnormal embryo morphology|MP:0014141,abnormal mesoderm morphology
MGI:5614598	Pkn3<tm1.1(KOMP)Vlcg>	MP:0010052,increased grip strength|MP:0013278,decreased fasting circulating glucose level
MGI:5688854	Pkn3<tm1.1Mrl>	MP:0005397,hematopoietic system phenotype
MGI:5688856	Pkn3<tm1.2Mrl>	MP:0002169,no abnormal phenotype detected
MGI:5911981	Pkn3<tm1Ajmc>	MP:0002169,no abnormal phenotype detected
MGI:3530910	Pknox1<Gt(OST71835)Lex>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000596,abnormal liver development|MP:0001262,decreased body weight|MP:0001286,abnormal eye development|MP:0001306,small lens|MP:0001577,anemia|MP:0001785,edema|MP:0001823,thymus hypoplasia|MP:0001914,hemorrhage|MP:0002092,abnormal eye morphology|MP:0002429,abnormal blood cell morphology/development|MP:0003717,pallor|MP:0004196,abnormal prenatal growth/weight/body size|MP:0004200,decreased fetal size|MP:0005090,increased double-negative T cell number|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005459,decreased percent body fat/body weight|MP:0005602,decreased angiogenesis|MP:0006069,abnormal retina neuronal layer morphology|MP:0006413,increased T cell apoptosis|MP:0008083,decreased single-positive T cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0009395,increased nucleated erythrocyte cell number|MP:0009703,decreased birth body size|MP:0011089,perinatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:6116700	Pknox1<tm1.1Rygo>	MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0002685,abnormal spermatogonia proliferation|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0006378,abnormal spermatogonia morphology|MP:0013601,increased testis apoptosis|MP:0014052,increased male germ cell apoptosis
MGI:5317868	Pknox1<tm1.1Xzh>	MP:0002169,no abnormal phenotype detected|MP:0005391,vision/eye phenotype
MGI:5317869	Pknox1<tm1.2Xzh>	MP:0011092,embryonic lethality, complete penetrance
MGI:4839363	Pknox1<tm1Fbla>	MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002399,abnormal pluripotent precursor cell morphology|MP:0003984,embryonic growth retardation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0012159,absent anterior visceral endoderm
MGI:4459452	Pknox1<tm1Ngc>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5469880	Pknox1<tm2.1Fbla>	MP:0008186,increased pro-B cell number|MP:0008209,decreased pre-B cell number
MGI:6341886	Pknox2<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen
MGI:7868152	Pknox2<em1Lff>	MP:0004562,abnormal inner hair cell synaptic ribbon morphology|MP:0005386,behavior/neurological phenotype|MP:0006335,abnormal hearing electrophysiology|MP:0011968,decreased threshold for auditory brainstem response|MP:0014407,decreased distortion product otoacoustic emission threshold|MP:0020359,abnormal ribbon synapse morphology|MP:0031672,increased auditory brainstem response wave amplitude
MGI:5823266	Pkp1<tm2d(KOMP)Wtsi>	MP:0001199,thin skin|MP:0001212,skin lesions|MP:0001233,abnormal epidermis suprabasal layer morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001263,weight loss|MP:0001284,absent vibrissae|MP:0001429,dehydration|MP:0002655,abnormal keratinocyte morphology|MP:0002796,impaired skin barrier function|MP:0003089,decreased skin tensile strength|MP:0003453,abnormal keratinocyte physiology|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009584,decreased keratinocyte proliferation|MP:0009598,thin epidermis stratum granulosum|MP:0009674,decreased birth weight|MP:0011087,neonatal lethality, complete penetrance|MP:0014696,decreased cell adhesion|MP:0030605,abnormal corneocyte morphology
MGI:3487374	Pkp2<tm1Wbm>	MP:0000266,abnormal heart morphology|MP:0000295,trabecula carnea hypoplasia|MP:0001633,poor circulation|MP:0001785,edema|MP:0001787,pericardial edema|MP:0002128,abnormal blood circulation|MP:0003105,abnormal heart atrium morphology|MP:0005244,hemopericardium|MP:0005329,abnormal myocardium layer morphology|MP:0005435,hemoperitoneum|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0020378,abnormal cell cytoskeleton morphology
MGI:3798862	Pkp3<tm1.1Fvr>	MP:0000382,underdeveloped hair follicles|MP:0000383,abnormal hair follicle orientation|MP:0000400,abnormal awl hair morphology|MP:0000402,abnormal zigzag hair morphology|MP:0000405,abnormal auchene hair morphology|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000420,ruffled hair|MP:0000424,retarded hair growth|MP:0000702,enlarged lymph nodes|MP:0001190,reddish skin|MP:0001194,dermatitis|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001510,abnormal coat appearance|MP:0001511,disheveled coat|MP:0001874,acanthosis|MP:0003427,parakeratosis|MP:0003810,abnormal hair cuticle|MP:0003812,abnormal hair medulla|MP:0003846,matted coat|MP:0003848,brittle hair|MP:0005150,cachexia|MP:0008768,abnormal hair medulla air spaces|MP:0009580,increased keratinocyte apoptosis|MP:0009583,increased keratinocyte proliferation|MP:0010234,abnormal vibrissa follicle morphology|MP:0010685,abnormal hair follicle inner root sheath morphology|MP:0011195,increased hair follicle apoptosis
MGI:3798859	Pkp3<tm1Fvr>	MP:0002169,no abnormal phenotype detected
MGI:2678397	Pkp4<Gt(pT1Betageo)1Ruiz>	MP:0002169,no abnormal phenotype detected
MGI:5581414	Pkp4<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0001523,impaired righting response|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0004151,decreased circulating iron level|MP:0010124,decreased bone mineral content|MP:0011396,abnormal sleep behavior
MGI:1856994	pl	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0004142,abnormal muscle tone|MP:0009434,paraparesis|MP:0011085,postnatal lethality, complete penetrance|MP:0011091,prenatal lethality, complete penetrance
MGI:7482743	Pla1a<em1Appsc>	MP:0000599,enlarged liver|MP:0001265,decreased body size|MP:0003436,decreased susceptibility to induced arthritis|MP:0005013,increased lymphocyte cell number|MP:0008751,abnormal interleukin level|MP:0012573,decreased susceptibility to chemically induced skin inflammation
MGI:7435735	Pla1a<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number
MGI:3512106	Pla2g10<Gt712Lex>	MP:0001876,decreased inflammatory response|MP:0002492,decreased IgE level|MP:0005012,decreased eosinophil cell number|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008751,abnormal interleukin level|MP:0009811,abnormal prostaglandin level
MGI:4435080	Pla2g10<tm1a(EUCOMM)Hmgu>	MP:0001260,increased body weight
MGI:5548469	Pla2g10<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0010053,decreased grip strength
MGI:4836546	Pla2g10<tm1Itl>	MP:0001744,hypersecretion of corticosterone|MP:0001745,increased circulating corticosterone level
MGI:4412409	Pla2g10<tm1Kiku>	MP:0000222,decreased neutrophil cell number|MP:0002463,abnormal neutrophil physiology|MP:0002972,abnormal cardiac muscle contractility|MP:0003038,decreased myocardial infarct size|MP:0003698,abnormal male reproductive system physiology|MP:0004484,abnormal response of heart to induced stress|MP:0005387,immune system phenotype|MP:0008720,impaired neutrophil chemotaxis
MGI:2680455	Pla2g12b<hlb218>	MP:0000186,decreased circulating HDL cholesterol level|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level
MGI:5791984	Pla2g12b<mpc96H>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level
MGI:3665283	Pla2g15<tm1.1Jash>	MP:0000266,abnormal heart morphology|MP:0000689,abnormal spleen morphology|MP:0002135,abnormal kidney morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002446,abnormal macrophage morphology|MP:0002451,abnormal macrophage physiology|MP:0002628,hepatic steatosis|MP:0004778,increased macrophage derived foam cell number|MP:0004952,increased spleen weight|MP:0005389,reproductive system phenotype|MP:0005425,increased macrophage cell number
MGI:3665282	Pla2g15<tm1Jash>	MP:0002169,no abnormal phenotype detected
MGI:3576269	Pla2g15<tm1Ytan>	MP:0000180,abnormal circulating cholesterol level|MP:0005341,decreased susceptibility to atherosclerosis
MGI:2445572	Pla2g1b<tm1Dyh>	MP:0000188,abnormal circulating glucose level|MP:0001262,decreased body weight|MP:0001783,decreased white adipose tissue amount|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0005292,improved glucose tolerance|MP:0005342,abnormal intestinal lipid absorption|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005668,decreased circulating leptin level|MP:0009289,decreased epididymal fat pad weight|MP:0009307,decreased uterine fat pad weight
MGI:5816875	Pla2g2c<tm1b(EUCOMM)Wtsi>	MP:0001925,male infertility
MGI:5621139	Pla2g2d<tm1.1(KOMP)Vlcg>	MP:0000221,decreased leukocyte cell number|MP:0001399,hyperactivity|MP:0011436,decreased urine magnesium level
MGI:5517549	Pla2g2d<tm1.1Mhg>	MP:0002118,abnormal lipid homeostasis|MP:0002376,abnormal dendritic cell physiology|MP:0002435,abnormal effector T cell morphology|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005285,decreased unsaturated fatty acids level|MP:0005387,immune system phenotype|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008126,increased dendritic cell number|MP:0008561,decreased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008706,decreased interleukin-6 secretion|MP:0020349,abnormal dendritic cell migration|MP:0020950,decreased susceptibility to Coronaviridae infection|MP:0031047,decreased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:5636980	Pla2g2e<tm1b(EUCOMM)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level|MP:0010067,increased red blood cell distribution width|MP:0011951,increased cardiac stroke volume|MP:0013279,increased fasting circulating glucose level
MGI:5517550	Pla2g2e<tm1Mhg>	MP:0005387,immune system phenotype
MGI:6367951	Pla2g2f<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0002599,increased mean platelet volume|MP:0010052,increased grip strength
MGI:5517551	Pla2g2f<tm1Mhg>	MP:0005387,immune system phenotype
MGI:4461174	Pla2g3<tm1Murm>	MP:0000359,abnormal mast cell morphology|MP:0001785,edema|MP:0001849,ear inflammation|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002660,abnormal caput epididymis morphology|MP:0002686,globozoospermia|MP:0003698,abnormal male reproductive system physiology|MP:0004543,abnormal sperm physiology|MP:0004777,abnormal phospholipid level|MP:0005462,abnormal mast cell differentiation|MP:0005535,abnormal body temperature|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0008765,decreased mast cell degranulation|MP:0008898,abnormal acrosome morphology|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009280,decreased activated sperm motility|MP:0009647,decreased fertilization frequency|MP:0009781,abnormal preimplantation embryo development|MP:0009838,abnormal sperm axoneme morphology|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0014467,increased sperm mitochondrial size|MP:0014468,disorganized sperm mitochondrial sheath|MP:0020451,decreased sperm progressive motility|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031352,absent sperm axonemal central pair|MP:0031356,abnormal outer dense fiber morphology|MP:0031410,biflagellated sperm
MGI:2181427	Pla2g4a<tm1Jvb>	MP:0000274,enlarged heart|MP:0001262,decreased body weight|MP:0001625,cardiac hypertrophy|MP:0001906,increased dopamine level|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002833,increased heart weight|MP:0002872,polycythemia|MP:0002988,decreased urine osmolality|MP:0003033,abnormal pulmonary vascular resistance|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003718,maternal effect|MP:0003915,increased heart left ventricle weight|MP:0003920,abnormal heart right ventricle morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004485,increased response of heart to induced stress|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004564,increased myocardial fiber size|MP:0005164,abnormal response to injury|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005462,abnormal mast cell differentiation|MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0008764,increased mast cell degranulation|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008997,increased blood osmolality|MP:0009401,increased skeletal muscle fiber diameter|MP:0011452,decreased susceptibility to dopaminergic neuron neurotoxicity
MGI:2385582	Pla2g4a<tm1Tksh>	MP:0001935,decreased litter size|MP:0002451,abnormal macrophage physiology|MP:0002703,abnormal renal tubule morphology|MP:0004031,insulitis|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005293,impaired glucose tolerance|MP:0005378,growth/size/body region phenotype|MP:0005387,immune system phenotype|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008713,abnormal cytokine level|MP:0010936,decreased airway resistance|MP:0012010,parturition failure
MGI:5696922	Pla2g4b<tm1b(EUCOMM)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0002833,increased heart weight
MGI:7444531	Pla2g4e<em1Murm>	MP:0001222,epidermal hyperplasia|MP:0001547,abnormal lipid level|MP:0002060,abnormal skin morphology|MP:0012572,increased susceptibility to chemically induced skin inflammation
MGI:5613650	Pla2g4e<tm2b(EUCOMM)Hmgu>	MP:0000195,decreased circulating calcium level|MP:0001510,abnormal coat appearance|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005567,decreased circulating total protein level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010052,increased grip strength
MGI:6356868	Pla2g4f<tm1.1Itl>	MP:0005384,cellular phenotype
MGI:4435081	Pla2g4f<tm1a(EUCOMM)Hmgu>	MP:0005633,increased circulating sodium level
MGI:6388359	Pla2g5<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001488,increased startle reflex|MP:0002339,abnormal lymph node morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0004122,abnormal sinus arrhythmia|MP:0005011,increased eosinophil cell number|MP:0005385,cardiovascular system phenotype|MP:0010506,prolonged RR interval
MGI:5431474	Pla2g5<tm1.1Kiku>	MP:0000343,abnormal response to cardiac infarction|MP:0002972,abnormal cardiac muscle contractility|MP:0003038,decreased myocardial infarct size|MP:0003221,abnormal cardiomyocyte apoptosis|MP:0004215,abnormal myocardial fiber physiology|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3042209	Pla2g5<tm1Jarm>	MP:0001798,impaired macrophage phagocytosis|MP:0002451,abnormal macrophage physiology|MP:0005087,decreased acute inflammation|MP:0005387,immune system phenotype
MGI:8187927	Pla2g6<em1Susz>	MP:0002136,abnormal kidney physiology|MP:0002705,dilated renal tubule|MP:0005165,increased susceptibility to injury|MP:0005565,increased blood urea nitrogen level|MP:0006036,abnormal mitochondrial physiology
MGI:4412026	Pla2g6<m1J>	MP:0000745,tremors|MP:0001263,weight loss|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0008916,abnormal astrocyte physiology|MP:0010053,decreased grip strength
MGI:4361203	Pla2g6<m1Sein>	MP:0000755,hindlimb paralysis|MP:0000955,abnormal spinal cord morphology|MP:0001263,weight loss|MP:0001393,ataxia|MP:0001516,abnormal motor coordination/balance|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002229,neurodegeneration|MP:0002269,muscular atrophy|MP:0003225,axonal dystrophy|MP:0003632,abnormal nervous system morphology|MP:0005092,decreased double-positive T cell number|MP:0005277,abnormal brainstem morphology|MP:0005404,abnormal axon morphology|MP:0008026,abnormal brain white matter morphology|MP:0008916,abnormal astrocyte physiology|MP:0009417,skeletal muscle atrophy|MP:0010053,decreased grip strength
MGI:6849808	Pla2g6<tm1.1Hlw>	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002757,decreased vertical activity|MP:0003224,neuron degeneration|MP:0003674,oxidative stress|MP:0005156,bradykinesia|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0008571,abnormal synaptic bouton morphology|MP:0011631,decreased mitochondrial size|MP:0011635,abnormal mitochondrial crista morphology|MP:0013219,abnormal substantia nigra pars compacta morphology|MP:0014046,abnormal mitophagy|MP:0014065,Lewy bodies|MP:0020354,increased endoplasmic reticulum stress
MGI:6209669	Pla2g6<tm1a(EUCOMM)Wtsi>	MP:0001925,male infertility
MGI:3777373	Pla2g6<tm1Tsu>	MP:0000160,kyphosis|MP:0001263,weight loss|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001524,impaired limb coordination|MP:0001922,reduced male fertility|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0002651,abnormal sciatic nerve morphology|MP:0003225,axonal dystrophy|MP:0003871,abnormal myelin sheath morphology|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0006035,abnormal mitochondrial morphology|MP:0008503,abnormal spinal cord grey matter morphology|MP:0008571,abnormal synaptic bouton morphology|MP:0010047,axonal spheroids|MP:0011635,abnormal mitochondrial crista morphology|MP:0020378,abnormal cell cytoskeleton morphology
MGI:3055154	Pla2g6<tm1Turk>	MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001415,increased exploration in new environment|MP:0001516,abnormal motor coordination/balance|MP:0001524,impaired limb coordination|MP:0001922,reduced male fertility|MP:0002229,neurodegeneration|MP:0002675,asthenozoospermia|MP:0003312,abnormal locomotor coordination
MGI:5523997	Pla2g6<tm1Zyao>	MP:0001925,male infertility|MP:0002001,blindness|MP:0003982,increased cholesterol level|MP:0010331,abnormal apolipoprotein level
MGI:5662431	Pla2g7<em1(IMPC)J>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005344,increased circulating bilirubin level|MP:0005566,decreased blood urea nitrogen level
MGI:5707934	Pla2g7<tm1.1Mcap>	MP:0002412,increased susceptibility to bacterial infection|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:3686614	Pla2r1<tm1Itoh>	MP:0002020,increased tumor incidence|MP:0008734,decreased susceptibility to endotoxin shock
MGI:6336130	Plaa<em1(IMPC)Kmpc>	MP:0011100,preweaning lethality, complete penetrance
MGI:5828117	Plaa<em1Pmi>	MP:0000160,kyphosis|MP:0000745,tremors|MP:0000746,weakness|MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0000852,small cerebellum|MP:0000877,abnormal Purkinje cell morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0002183,gliosis|MP:0002913,abnormal PNS synaptic transmission|MP:0003852,skeletal muscle necrosis|MP:0004835,abnormal miniature endplate potential|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008770,decreased survivor rate|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009413,skeletal muscle fiber atrophy|MP:0009434,paraparesis|MP:0010008,abnormal Purkinje cell migration|MP:0010053,decreased grip strength|MP:0010768,mortality/aging|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude
MGI:7868153	Plaat1<em1Ueda>	MP:0000181,abnormal circulating LDL cholesterol level|MP:0000188,abnormal circulating glucose level|MP:0001553,abnormal circulating free fatty acids level|MP:0001573,abnormal circulating alanine transaminase level|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0004777,abnormal phospholipid level|MP:0005179,decreased circulating cholesterol level|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0006084,abnormal circulating phospholipid level|MP:0008804,abnormal circulating amylase level|MP:0009356,decreased liver triglyceride level|MP:0009422,decreased gastrocnemius weight|MP:0010239,decreased skeletal muscle weight|MP:0010952,abnormal fatty acid beta-oxidation|MP:0013138,thin body|MP:0014146,decreased white adipose tissue mass|MP:0014605,dark liver|MP:0020868,decreased lipogenesis|MP:0030969,increased circulating adiponectin level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:6156556	Plaat3<em1(IMPC)Tcp>	MP:0000689,abnormal spleen morphology|MP:0002833,increased heart weight|MP:0005293,impaired glucose tolerance|MP:0005561,increased mean corpuscular hemoglobin
MGI:7868154	Plaat3<em1Ueda>	MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0002079,increased circulating insulin level|MP:0002981,increased liver weight|MP:0005331,insulin resistance|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009133,decreased white fat cell size|MP:0009422,decreased gastrocnemius weight|MP:0010239,decreased skeletal muscle weight|MP:0013138,thin body|MP:0014146,decreased white adipose tissue mass|MP:0030968,decreased circulating adiponectin level|MP:0031269,increased susceptibility to diet-induced hepatic steatosis|MP:0031602,white adipose tissue inflammation
MGI:5882500	Plaat3<tm1.1Hsul>	MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002941,increased circulating alanine transaminase level|MP:0003926,decreased cellular glucose uptake|MP:0003960,increased lean body mass|MP:0005289,increased oxygen consumption|MP:0005318,decreased triglyceride level|MP:0005331,insulin resistance|MP:0005375,adipose tissue phenotype|MP:0005438,abnormal glycogen homeostasis|MP:0005559,increased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008034,enhanced lipolysis|MP:0009133,decreased white fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009303,decreased renal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0010182,decreased susceptibility to weight gain|MP:0012634,decreased phospholipase A2 level|MP:0013245,abnormal lipid metabolism|MP:0013279,increased fasting circulating glucose level|MP:0014171,increased fatty acid oxidation|MP:0030968,decreased circulating adiponectin level
MGI:6156474	Plaat5<em1(IMPC)Tcp>	MP:0001417,decreased exploration in new environment|MP:0005011,increased eosinophil cell number|MP:0009453,enhanced contextual conditioning behavior
MGI:4880046	Plaa<tm1(NCOM)Cmhd>	MP:0008546,abnormal vesicle-mediated transport|MP:0011091,prenatal lethality, complete penetrance
MGI:3808477	Plac1<tm1(KOMP)Vlcg>	MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0003123,paternal imprinting|MP:0004260,enlarged placenta|MP:0004920,increased placenta weight|MP:0008957,abnormal placenta junctional zone morphology|MP:0009397,increased trophoblast giant cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012098,increased spongiotrophoblast size
MGI:5637155	Plac8<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001510,abnormal coat appearance|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology
MGI:3834141	Plac8<tm1Bhk>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0001260,increased body weight|MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0003070,increased vascular permeability|MP:0005534,decreased body temperature|MP:0009124,increased brown fat cell lipid droplet size|MP:0009137,decreased brown fat lipid droplet number|MP:0011049,impaired adaptive thermogenesis|MP:0014142,increased body fat mass|MP:0020520,whitened brown adipose tissue morphology
MGI:5637163	Plac9<tm1b(EUCOMM)Hmgu>	MP:0000222,decreased neutrophil cell number|MP:0001556,increased circulating HDL cholesterol level|MP:0002591,decreased mean corpuscular volume|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010068,decreased red blood cell distribution width|MP:0010087,increased circulating fructosamine level|MP:0010124,decreased bone mineral content|MP:0013278,decreased fasting circulating glucose level
MGI:6273963	Plag1<em1(IMPC)Hmgu>	MP:0000432,abnormal head morphology|MP:0000443,abnormal snout morphology|MP:0001258,decreased body length|MP:0001489,decreased startle reflex|MP:0002764,short tibia|MP:0003795,abnormal bone structure|MP:0004738,abnormal auditory brainstem response|MP:0005343,increased circulating aspartate transaminase level|MP:0010052,increased grip strength|MP:0010067,increased red blood cell distribution width|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:3580633	Plag1<tm1Wjmv>	MP:0001290,delayed eyelid opening|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002059,abnormal seminal vesicle morphology|MP:0004910,decreased seminal vesicle weight|MP:0009429,decreased embryo weight|MP:0013319,seminal vesicle atrophy|MP:0031362,decreased prostate gland ventral lobe weight
MGI:4218514	Plagl1<Gt(OST181461)Lex>	MP:0000266,abnormal heart morphology|MP:0001211,wrinkled skin|MP:0002080,prenatal lethality|MP:0002082,postnatal lethality|MP:0003051,curly tail|MP:0003123,paternal imprinting|MP:0003720,abnormal neural tube closure|MP:0008770,decreased survivor rate|MP:0009674,decreased birth weight|MP:0010403,atrial septal defect|MP:0010420,muscular ventricular septal defect|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3693683	Plagl1<tm1Jour>	MP:0001177,atelectasis|MP:0001211,wrinkled skin|MP:0001954,respiratory distress|MP:0002082,postnatal lethality|MP:0002759,abnormal caudal vertebrae morphology|MP:0002834,decreased heart weight|MP:0003051,curly tail|MP:0003122,maternal imprinting|MP:0005109,abnormal talus morphology|MP:0005306,abnormal phalanx morphology|MP:0008271,abnormal bone ossification|MP:0009431,decreased fetal weight|MP:0009674,decreased birth weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3771822	Plagl2<tm1Wjmv>	MP:0000477,abnormal intestine morphology|MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0005178,increased circulating cholesterol level|MP:0005342,abnormal intestinal lipid absorption|MP:0008489,slow postnatal weight gain|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3703627	Plast1a<CASA/Rk>	MP:0000180,abnormal circulating cholesterol level|MP:0002647,decreased intestinal cholesterol absorption|MP:0003192,increased cholesterol efflux
MGI:3703629	Plast1b<CASA/Rk>	MP:0000180,abnormal circulating cholesterol level|MP:0002647,decreased intestinal cholesterol absorption|MP:0003192,increased cholesterol efflux
MGI:3703768	Plast1<C57BL/6J>	MP:0000180,abnormal circulating cholesterol level
MGI:3703770	Plast2a<C57BL/6J>	MP:0000180,abnormal circulating cholesterol level
MGI:3703772	Plast2b<C57BL/6J>	MP:0000180,abnormal circulating cholesterol level
MGI:7388290	Platr4<em#Dlsp>	MP:0000285,abnormal heart valve morphology|MP:0001614,abnormal blood vessel morphology|MP:0002083,premature death|MP:0002625,heart left ventricle hypertrophy|MP:0003141,cardiac fibrosis|MP:0003393,decreased cardiac output|MP:0005140,decreased cardiac muscle contractility|MP:0005329,abnormal myocardium layer morphology|MP:0005333,decreased heart rate|MP:0006431,abnormal fibrocartilage morphology|MP:0011925,abnormal heart echocardiography feature
MGI:5582448	Plat<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis
MGI:1857288	Plat<tm1Mlg>	MP:0001364,decreased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0001745,increased circulating corticosterone level|MP:0001899,absent long-term depression|MP:0001900,impaired synaptic plasticity|MP:0001916,intracerebral hemorrhage|MP:0002625,heart left ventricle hypertrophy|MP:0002757,decreased vertical activity|MP:0002798,abnormal active avoidance behavior|MP:0002804,abnormal motor learning|MP:0002935,chronic joint inflammation|MP:0002936,joint swelling|MP:0002993,autoimmune arthritis|MP:0003075,abnormal response to CNS ischemic injury|MP:0003423,reduced thrombolysis|MP:0003426,pulmonary interstitial fibrosis|MP:0003434,decreased susceptibility to induced choroidal neovascularization|MP:0003455,decreased susceptibility to induced retina damage|MP:0003691,abnormal microglial cell physiology|MP:0005369,muscle phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005425,increased macrophage cell number|MP:0005598,decreased heart ventricle muscle contractility|MP:0005602,decreased angiogenesis|MP:0005608,cardiac interstitial fibrosis|MP:0005643,decreased dopamine level|MP:0006058,decreased cerebral infarct size|MP:0008713,abnormal cytokine level|MP:0009712,impaired conditioned place preference behavior|MP:0009757,impaired behavioral response to morphine|MP:0010211,abnormal acute phase protein level|MP:0010768,mortality/aging|MP:0010909,pulmonary alveolar hemorrhage|MP:0020948,abnormal susceptibility to Coronaviridae infection|MP:0030006,decreased retina apoptosis|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality|MP:0031121,increased susceptibility to induced thrombosis
MGI:6149208	Plaur<em1(IMPC)H>	MP:0000208,decreased hematocrit|MP:0002875,decreased erythrocyte cell number|MP:0009142,decreased prepulse inhibition
MGI:1857290	Plaur<tm1Jld>	MP:0001846,increased inflammatory response|MP:0001860,liver inflammation|MP:0002451,abnormal macrophage physiology|MP:0002499,chronic inflammation|MP:0003333,liver fibrosis|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005602,decreased angiogenesis|MP:0013498,trachea inflammation
MGI:1934210	Plaur<tm1Mlg>	MP:0000243,myoclonus|MP:0000788,abnormal cerebral cortex morphology|MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology|MP:0002467,impaired neutrophil phagocytosis|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003241,loss of cortex neurons|MP:0003246,loss of GABAergic neurons|MP:0004101,abnormal brain interneuron morphology|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005397,hematopoietic system phenotype|MP:0008713,abnormal cytokine level|MP:0014551,impaired neuronal migration
MGI:4836576	Plau<tm1.1Bug>	MP:0001860,liver inflammation|MP:0002499,chronic inflammation|MP:0003333,liver fibrosis|MP:0005376,homeostasis/metabolism phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0013498,trachea inflammation
MGI:5754608	Plau<tm1b(EUCOMM)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0001417,decreased exploration in new environment|MP:0010053,decreased grip strength
MGI:1857289	Plau<tm1Mlg>	MP:0000492,abnormal rectum morphology|MP:0000493,rectal prolapse|MP:0000751,myopathy|MP:0001273,decreased metastatic potential|MP:0001340,abnormal eyelid morphology|MP:0001846,increased inflammatory response|MP:0001860,liver inflammation|MP:0001876,decreased inflammatory response|MP:0002083,premature death|MP:0002282,abnormal trachea morphology|MP:0002421,abnormal cell-mediated immunity|MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology|MP:0002467,impaired neutrophil phagocytosis|MP:0002499,chronic inflammation|MP:0003315,abnormal perineum morphology|MP:0003333,liver fibrosis|MP:0003423,reduced thrombolysis|MP:0003426,pulmonary interstitial fibrosis|MP:0003434,decreased susceptibility to induced choroidal neovascularization|MP:0003435,herniated seminal vesicle|MP:0003436,decreased susceptibility to induced arthritis|MP:0003447,decreased tumor growth/size|MP:0003448,abnormal tumor morphology|MP:0003631,nervous system phenotype|MP:0003799,impaired macrophage chemotaxis|MP:0004486,decreased response of heart to induced stress|MP:0005013,increased lymphocyte cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005048,abnormal thrombosis|MP:0005074,impaired granulocyte bactericidal activity|MP:0005095,decreased T cell proliferation|MP:0005150,cachexia|MP:0005164,abnormal response to injury|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005399,increased susceptibility to fungal infection|MP:0005416,abnormal circulating protein level|MP:0005608,cardiac interstitial fibrosis|MP:0008713,abnormal cytokine level|MP:0010025,decreased total body fat amount|MP:0010211,abnormal acute phase protein level|MP:0010398,decreased liver glycogen level|MP:0010768,mortality/aging|MP:0013239,impaired skeletal muscle regeneration|MP:0013498,trachea inflammation|MP:0013499,trachea fibrosis|MP:0030530,abnormal outer ear skin morphology|MP:0030531,abnormal facial skin morphology|MP:0031121,increased susceptibility to induced thrombosis|MP:0031635,increased heart left ventricle muscle contractility
MGI:5496403	Play1	MP:0020473,abnormal circadian behavior phase
MGI:5496404	Play16	MP:0020476,abnormal circardian behavior entrainment
MGI:5496405	Play19	MP:0020476,abnormal circardian behavior entrainment
MGI:3606337	Play22	MP:0001402,decreased locomotor activity
MGI:3606328	Play24	MP:0020470,shortened circadian behavior period
MGI:5496406	Play31	MP:0001402,decreased locomotor activity
MGI:5496407	Play32	MP:0001402,decreased locomotor activity
MGI:3606335	Play36	MP:0020475,delayed circadian behavior phase
MGI:5496408	Play40	MP:0020476,abnormal circardian behavior entrainment
MGI:3606329	Play41	MP:0020469,prolonged circadian behavior period
MGI:5496409	Play42	MP:0020473,abnormal circadian behavior phase
MGI:5496410	Play44	MP:0020476,abnormal circardian behavior entrainment
MGI:3606334	Play46	MP:0020474,advanced circadian behavior phase
MGI:5496412	Play47	MP:0020476,abnormal circardian behavior entrainment
MGI:3606330	Play48	MP:0020470,shortened circadian behavior period
MGI:3606338	Play50	MP:0001402,decreased locomotor activity
MGI:3606332	Play57	MP:0020470,shortened circadian behavior period
MGI:5141718	Play63	MP:0001402,decreased locomotor activity
MGI:5495814	Play65	MP:0020468,abnormal circadian behavior period
MGI:5495815	Play72	MP:0001402,decreased locomotor activity
MGI:5495933	Play78	MP:0020476,abnormal circardian behavior entrainment
MGI:5496397	Play79	MP:0020476,abnormal circardian behavior entrainment
MGI:5496398	Play81	MP:0020470,shortened circadian behavior period|MP:0020476,abnormal circardian behavior entrainment
MGI:5496401	Play82	MP:0001402,decreased locomotor activity
MGI:6295415	Plb1<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount
MGI:3784271	Plbcq1<M16i>	MP:0001260,increased body weight|MP:0002981,increased liver weight|MP:0003960,increased lean body mass
MGI:3784280	Plbcq2<M16i>	MP:0005334,abnormal fat pad morphology|MP:0005458,increased percent body fat/body weight|MP:0005459,decreased percent body fat/body weight
MGI:3784282	Plbcq3<M16i>	MP:0001260,increased body weight|MP:0003960,increased lean body mass
MGI:3784284	Plbcq4<M16i>	MP:0001260,increased body weight
MGI:3784286	Plbcq5<M16i>	MP:0005334,abnormal fat pad morphology|MP:0005458,increased percent body fat/body weight|MP:0005459,decreased percent body fat/body weight
MGI:3784287	Plbcq6<FVB/NJ>	MP:0010269,decreased mammary gland tumor incidence
MGI:3784288	Plbcq6<M16i>	MP:0001260,increased body weight|MP:0003402,decreased liver weight|MP:0010299,increased mammary gland tumor incidence
MGI:3784290	Plbcq7<M16i>	MP:0001260,increased body weight|MP:0002981,increased liver weight|MP:0003960,increased lean body mass
MGI:3784292	Plbcq8<M16i>	MP:0001260,increased body weight|MP:0003960,increased lean body mass|MP:0005458,increased percent body fat/body weight
MGI:3784294	Plbcq9<M16i>	MP:0001260,increased body weight
MGI:4362953	Plbd1<tm1a(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:6356392	Plbd2<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0005562,decreased mean corpuscular hemoglobin
MGI:6276999	Plcb1<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001126,abnormal ovary morphology|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002699,abnormal vitreous body morphology|MP:0003068,enlarged kidney
MGI:3613593	Plcb1<Tg(LGB)56Mbal>	MP:0000160,kyphosis|MP:0000439,enlarged cranium|MP:0000441,increased cranium width|MP:0000771,abnormal brain size|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002082,postnatal lethality|MP:0002427,disproportionate dwarf|MP:0003723,abnormal long bone morphology|MP:0003917,increased kidney weight|MP:0004851,increased testis weight
MGI:2652485	Plcb1<tm1Hssh>	MP:0000947,convulsive seizures|MP:0001265,decreased body size|MP:0001399,hyperactivity|MP:0001463,abnormal spatial learning|MP:0001489,decreased startle reflex|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003240,loss of hippocampal neurons|MP:0009142,decreased prepulse inhibition|MP:0011084,lethality at weaning, incomplete penetrance
MGI:5548374	Plcb2<tm1b(KOMP)Wtsi>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001402,decreased locomotor activity|MP:0001529,abnormal vocalization|MP:0001925,male infertility|MP:0005576,decreased pulmonary ventilation
MGI:2653348	Plcb2<tm1Dwu>	MP:0001985,abnormal gustatory system physiology|MP:0001986,abnormal taste sensitivity|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002409,decreased susceptibility to infection|MP:0002410,decreased susceptibility to viral infection|MP:0002411,decreased susceptibility to bacterial infection|MP:0002442,abnormal leukocyte physiology|MP:0004209,abnormal sweet taste sensitivity|MP:0004210,abnormal bitter taste sensitivity|MP:0011678,abnormal vomeronasal sensory neuron physiology
MGI:2680661	Plcb3<tm1Dwu>	MP:0001209,spontaneous skin ulceration|MP:0004231,abnormal calcium ion homeostasis|MP:0004270,analgesia
MGI:2445310	Plcb3<tm1Sko>	MP:0002086,abnormal extraembryonic tissue morphology|MP:0002663,absent blastocoele|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5630063	Plcb4<tm1b(EUCOMM)Wtsi>	MP:0001120,abnormal uterus morphology|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0002574,increased vertical activity|MP:0003960,increased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005084,abnormal gallbladder morphology|MP:0009342,enlarged gallbladder|MP:0009709,hydrometra|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2183374	Plcb4<tm1Dwu>	MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0002090,abnormal vision|MP:0003312,abnormal locomotor coordination|MP:0003894,abnormal Purkinje cell innervation|MP:0004021,abnormal rod electrophysiology
MGI:2652541	Plcb4<tm1Hssh>	MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0003635,abnormal synaptic transmission|MP:0005369,muscle phenotype|MP:0005390,skeleton phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2654917	Plcb4<tm1Tyo>	MP:0001475,reduced long-term depression|MP:0003633,abnormal nervous system physiology
MGI:5546649	Plcd1<tm1.1Kfu>	MP:0000322,increased granulocyte number|MP:0002875,decreased erythrocyte cell number|MP:0005017,decreased B cell number|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008039,increased NK T cell number|MP:0008614,increased circulating interleukin-17 level|MP:0008681,increased interleukin-17 secretion|MP:0009623,enlarged inguinal lymph nodes
MGI:2667234	Plcd1<tm1Tta>	MP:0000218,increased leukocyte cell number|MP:0000322,increased granulocyte number|MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001233,abnormal epidermis suprabasal layer morphology|MP:0001265,decreased body size|MP:0002656,abnormal keratinocyte differentiation|MP:0002875,decreased erythrocyte cell number|MP:0003414,epidermal cyst|MP:0005017,decreased B cell number|MP:0005397,hematopoietic system phenotype|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008111,abnormal granulocyte differentiation|MP:0008614,increased circulating interleukin-17 level|MP:0008681,increased interleukin-17 secretion|MP:0009623,enlarged inguinal lymph nodes|MP:0009631,enlarged axillary lymph nodes|MP:0010300,increased skin tumor incidence|MP:0013378,increased sebocyte number
MGI:2155167	Plcd4<tm1Kfu>	MP:0001925,male infertility|MP:0004542,impaired acrosome reaction|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype
MGI:5692570	Plcd4<tm2b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment
MGI:6276910	Plce1<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0002060,abnormal skin morphology|MP:0002833,increased heart weight|MP:0005016,decreased lymphocyte cell number|MP:0010392,prolonged QRS complex duration
MGI:3697316	Plce1<tm1Avsm>	MP:0004215,abnormal myocardial fiber physiology|MP:0004231,abnormal calcium ion homeostasis|MP:0004485,increased response of heart to induced stress|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3525208	Plce1<tm1Tkat>	MP:0000274,enlarged heart|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005140,decreased cardiac muscle contractility|MP:0005598,decreased heart ventricle muscle contractility|MP:0006047,aortic valve regurgitation|MP:0006048,pulmonary valve regurgitation|MP:0006117,aortic valve stenosis|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010484,bicuspid aortic valve|MP:0010594,thick aortic valve|MP:0010601,thick pulmonary valve|MP:0031166,abnormal aortic valve commissure morphology|MP:0031553,abnormal semilunar valve development
MGI:5514168	Plce1<tm2Avsm>	MP:0004486,decreased response of heart to induced stress
MGI:2388141	Plcg1<tm1Gcrp>	MP:0001730,embryonic growth arrest|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2155982	Plcg1<tm1Ine>	MP:0003396,abnormal embryonic hematopoiesis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2388142	Plcg1<tm2Gcrp>	MP:0001622,abnormal vasculogenesis|MP:0001721,absent visceral yolk sac blood islands|MP:0001730,embryonic growth arrest|MP:0002416,abnormal proerythroblast morphology|MP:0003396,abnormal embryonic hematopoiesis|MP:0003542,abnormal vascular endothelial cell development|MP:0003984,embryonic growth retardation|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3833399	Plcg2<al>	MP:0001634,internal hemorrhage|MP:0001879,abnormal lymphatic vessel morphology|MP:0002083,premature death|MP:0012080,chylous ascites
MGI:4840229	Plcg2<Ali14>	MP:0000574,abnormal foot pad morphology|MP:0001845,abnormal inflammatory response
MGI:3577720	Plcg2<Ali5>	MP:0001194,dermatitis|MP:0002459,abnormal B cell physiology|MP:0002499,chronic inflammation|MP:0002743,glomerulonephritis|MP:0003560,osteoarthritis|MP:0005387,immune system phenotype|MP:0008190,decreased transitional stage B cell number|MP:0008207,decreased B-2 B cell number|MP:0008211,decreased mature B cell number
MGI:6316314	Plcg2<em1Msasn>	MP:0001798,impaired macrophage phagocytosis|MP:0020879,abnormal calcium level|MP:0030951,abnormal endocytosis
MGI:4838296	Plcg2<m1Btlr>	MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0005387,immune system phenotype
MGI:5619131	Plcg2<M2Btlr>	MP:0008561,decreased tumor necrosis factor secretion
MGI:6199511	Plcg2<M3Btlr>	MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0008168,decreased B-1a cell number
MGI:6286285	Plcg2<m4Btlr>	MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:3773674	Plcg2<tm1.1Kuro>	MP:0000693,spleen hyperplasia|MP:0002144,abnormal B cell differentiation|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0008186,increased pro-B cell number|MP:0008567,decreased interferon-gamma secretion|MP:0010766,abnormal NK cell physiology
MGI:3833397	Plcg2<tm1Ichi>	MP:0001634,internal hemorrhage|MP:0001879,abnormal lymphatic vessel morphology|MP:0002083,premature death|MP:0012080,chylous ascites
MGI:2386100	Plcg2<tm1Jni>	MP:0000130,abnormal trabecular bone morphology|MP:0001802,arrested B cell differentiation|MP:0002144,abnormal B cell differentiation|MP:0002376,abnormal dendritic cell physiology|MP:0002459,abnormal B cell physiology|MP:0003132,increased pre-B cell number|MP:0003436,decreased susceptibility to induced arthritis|MP:0004985,decreased osteoclast cell number|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005093,decreased B cell proliferation|MP:0005154,increased B cell proliferation|MP:0005461,abnormal dendritic cell morphology|MP:0008174,decreased follicular B cell number|MP:0008186,increased pro-B cell number|MP:0008211,decreased mature B cell number|MP:0008396,abnormal osteoclast differentiation|MP:0008567,decreased interferon-gamma secretion|MP:0008782,increased B cell apoptosis|MP:0009347,increased trabecular bone thickness|MP:0009549,decreased platelet aggregation|MP:0009925,increased transitional stage T2 B cell number|MP:0010740,abnormal dendritic cell chemotaxis|MP:0010878,increased trabecular bone volume|MP:0014469,abnormal B cell calcium ion homeostasis|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:2449276	Plcg2<tm1Kuro>	MP:0001800,abnormal humoral immune response|MP:0005093,decreased B cell proliferation|MP:0005387,immune system phenotype|MP:0008167,increased B-1a cell number|MP:0008186,increased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008214,increased immature B cell number
MGI:4440833	Plch2<tm1Kfu>	MP:0002169,no abnormal phenotype detected
MGI:5607951	Plcl1<tm1.1Matk>	MP:0001222,epidermal hyperplasia|MP:0003721,increased tumor growth/size|MP:0004499,increased incidence of tumors by chemical induction|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010768,mortality/aging
MGI:3526123	Plcl1<tm1Mh>	MP:0001516,abnormal motor coordination/balance|MP:0002064,seizures|MP:0002272,abnormal nervous system electrophysiology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0009747,impaired behavioral response to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:5607952	Plcl1<tm2.1Matk>	MP:0004499,increased incidence of tumors by chemical induction
MGI:2679632	Plcl2<tm1Tta>	MP:0002420,abnormal adaptive immunity|MP:0002494,increased IgM level|MP:0004231,abnormal calcium ion homeostasis|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005154,increased B cell proliferation|MP:0008168,decreased B-1a cell number|MP:0008211,decreased mature B cell number|MP:0014469,abnormal B cell calcium ion homeostasis
MGI:5749950	Plcz1<em1(IMPC)H>	MP:0001406,abnormal gait|MP:0004151,decreased circulating iron level|MP:0008935,decreased mean platelet volume|MP:0013279,increased fasting circulating glucose level
MGI:5766302	Plcz1<em1Jparr>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0005389,reproductive system phenotype|MP:0031013,abnormal egg activation|MP:0031014,polyspermy
MGI:5766360	Plcz1<em2Jparr>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0005389,reproductive system phenotype|MP:0031013,abnormal egg activation|MP:0031014,polyspermy
MGI:5556064	Pld1<tm1.1Gdp>	MP:0005376,homeostasis/metabolism phenotype|MP:0008260,abnormal autophagy
MGI:5468471	Pld1<tm1.1Mafr>	MP:0001273,decreased metastatic potential|MP:0002169,no abnormal phenotype detected|MP:0003447,decreased tumor growth/size|MP:0005464,abnormal platelet physiology|MP:0005602,decreased angiogenesis|MP:0010144,abnormal tumor vascularization
MGI:5708179	Pld1<tm1b(KOMP)Wtsi>	MP:0002833,increased heart weight
MGI:5575654	Pld1<tm3Mafr>	MP:0002599,increased mean platelet volume|MP:0005166,decreased susceptibility to injury|MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0006298,abnormal platelet activation|MP:0009549,decreased platelet aggregation|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:4880012	Pld2<tm1.1Gdp>	MP:0001547,abnormal lipid level|MP:0002006,neoplasm|MP:0003638,abnormal response/metabolism to endogenous compounds
MGI:5317803	Pld2<tm1.1Mjow>	MP:0002463,abnormal neutrophil physiology
MGI:3847515	Pld2<tm1(KOMP)Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:5468333	Pld2<tm1Yaka>	MP:0002169,no abnormal phenotype detected
MGI:6451776	Pld3<em1Nemz>	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008705,increased interleukin-6 secretion
MGI:4842606	Pld3<tm1e(EUCOMM)Wtsi>	MP:0003179,thrombocytopenia|MP:0005562,decreased mean corpuscular hemoglobin
MGI:6423843	Pld4<em1(IMPC)Mbp>	MP:0000195,decreased circulating calcium level|MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001314,cornea opacity|MP:0004952,increased spleen weight|MP:0005013,increased lymphocyte cell number|MP:0006203,eye hemorrhage
MGI:5791986	Pld4<mpc96H>	MP:0001265,decreased body size
MGI:4431064	Pld4<thss>	MP:0000416,sparse hair|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002490,abnormal immunoglobulin level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005425,increased macrophage cell number|MP:0008097,increased plasma cell number|MP:0008102,lymph node hyperplasia|MP:0008181,increased marginal zone B cell number|MP:0008481,increased spleen germinal center number|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level|MP:0008524,increased plasmacytoid dendritic cell number|MP:0010768,mortality/aging|MP:0012762,abnormal alpha-beta T cell morphology|MP:0020519,renal glomerular immunoglobulin deposits
MGI:6451772	Pld4<tm1.1Nemz>	MP:0005397,hematopoietic system phenotype|MP:0008244,abnormal peritoneal macrophage morphology
MGI:6451773	Pld4<tm1.2Nemz>	MP:0000217,abnormal leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000691,enlarged spleen|MP:0003179,thrombocytopenia|MP:0004978,decreased B-1 B cell number|MP:0005387,immune system phenotype|MP:0008040,decreased NK T cell number|MP:0008181,increased marginal zone B cell number|MP:0008244,abnormal peritoneal macrophage morphology|MP:0008577,increased circulating interferon-gamma level|MP:0010768,mortality/aging|MP:0031220,increased circulating CXCL10 level
MGI:4363433	Pld5<tm1a(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5548802	Pld5<tm1b(KOMP)Wtsi>	MP:0001556,increased circulating HDL cholesterol level|MP:0003961,decreased lean body mass|MP:0004599,abnormal vertebral arch morphology|MP:0008935,decreased mean platelet volume|MP:0010068,decreased red blood cell distribution width
MGI:4946932	Pld6<tm1.1Hsas>	MP:0001147,small testis|MP:0001925,male infertility|MP:0004884,abnormal testis physiology|MP:0005159,azoospermia|MP:0006362,abnormal male germ cell morphology|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0008280,abnormal male germ cell apoptosis|MP:0008878,abnormal DNA methylation during gametogenesis|MP:0014633,decreased spermatid number
MGI:4946513	Pld6<tm1.1Mafr>	MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0003698,abnormal male reproductive system physiology|MP:0006035,abnormal mitochondrial morphology|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis
MGI:4397697	Pldi<tm1.2Ploen>	MP:0002675,asthenozoospermia|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype
MGI:3795548	Pldmq1<FVB/NJ>	MP:0001272,increased metastatic potential|MP:0010269,decreased mammary gland tumor incidence|MP:0010299,increased mammary gland tumor incidence
MGI:3795558	Pldmq2<FVB/NJ>	MP:0001272,increased metastatic potential
MGI:3795559	Pldmq2<M16i>	MP:0001272,increased metastatic potential
MGI:3795560	Pldmq3<FVB/NJ>	MP:0001272,increased metastatic potential|MP:0010299,increased mammary gland tumor incidence
MGI:3795562	Pldmq4<FVB/NJ>	MP:0010299,increased mammary gland tumor incidence
MGI:3795564	Pldmq5<FVB/NJ>	MP:0010299,increased mammary gland tumor incidence
MGI:1856995	ple	MP:0001265,decreased body size|MP:0001921,reduced fertility|MP:0002082,postnatal lethality|MP:0008770,decreased survivor rate|MP:0011087,neonatal lethality, complete penetrance
MGI:6414547	Plec<em1(IMPC)Bay>	MP:0001785,edema|MP:0011100,preweaning lethality, complete penetrance
MGI:2678403	Plec<Gt(U3Betageo)1Ruiz>	MP:0011091,prenatal lethality, complete penetrance
MGI:4414773	Plec/Parp10<tm1.1Gwi>	MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0008814,decreased nerve conduction velocity
MGI:4414775	Plec/Parp10<tm1.1Gwi>	MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0008814,decreased nerve conduction velocity
MGI:2181791	Plec<tm1Gwi>	MP:0000278,abnormal myocardial fiber morphology|MP:0000749,muscle degeneration|MP:0000751,myopathy|MP:0001208,blistering|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001232,absent epidermis stratum basale|MP:0001243,abnormal dermal layer morphology|MP:0001262,decreased body weight|MP:0001914,hemorrhage|MP:0002655,abnormal keratinocyte morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0006267,abnormal intercalated disk morphology|MP:0009827,skin detachment|MP:0011085,postnatal lethality, complete penetrance
MGI:2181792	Plec<tm2Gwi>	MP:0000278,abnormal myocardial fiber morphology|MP:0000749,muscle degeneration|MP:0000751,myopathy|MP:0001208,blistering|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001232,absent epidermis stratum basale|MP:0001243,abnormal dermal layer morphology|MP:0001262,decreased body weight|MP:0001914,hemorrhage|MP:0002655,abnormal keratinocyte morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0006267,abnormal intercalated disk morphology|MP:0009827,skin detachment|MP:0011085,postnatal lethality, complete penetrance
MGI:3613062	Plec<tm3Gwi>	MP:0000358,abnormal cell morphology|MP:0001792,impaired wound healing|MP:0002444,abnormal T cell physiology|MP:0003799,impaired macrophage chemotaxis|MP:0005023,abnormal wound healing|MP:0005369,muscle phenotype|MP:0010771,integument phenotype|MP:0011708,decreased fibroblast cell migration|MP:0020416,decreased fibroblast chemotaxis
MGI:3721885	Plec<tm4Gwi>	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0001191,abnormal skin condition|MP:0001208,blistering|MP:0001212,skin lesions|MP:0001265,decreased body size|MP:0001436,abnormal suckling behavior|MP:0001732,postnatal growth retardation|MP:0002169,no abnormal phenotype detected|MP:0002796,impaired skin barrier function|MP:0003081,abnormal soleus morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004121,abnormal sarcolemma morphology|MP:0004819,decreased skeletal muscle mass|MP:0005369,muscle phenotype|MP:0005385,cardiovascular system phenotype|MP:0008770,decreased survivor rate|MP:0009399,increased skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009406,decreased skeletal muscle fiber number|MP:0009413,skeletal muscle fiber atrophy|MP:0009414,skeletal muscle fiber necrosis|MP:0011085,postnatal lethality, complete penetrance|MP:0012106,impaired exercise endurance|MP:0014342,abnormal muscle fiber mitochondrial morphology
MGI:3799314	Plec<tm5Gwi>	MP:0003084,abnormal skeletal muscle fiber morphology|MP:0009399,increased skeletal muscle fiber size|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009414,skeletal muscle fiber necrosis|MP:0010957,abnormal aerobic respiration
MGI:3799315	Plec<tm6Gwi>	MP:0005369,muscle phenotype
MGI:5311563	Plec<tm7.1Gwi>	MP:0001212,skin lesions|MP:0002655,abnormal keratinocyte morphology|MP:0003453,abnormal keratinocyte physiology|MP:0009473,abnormal skin exfoliation|MP:0011160,dermal-epidermal separation
MGI:6274931	Plek2<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0002060,abnormal skin morphology
MGI:6162244	Plek2<tm1Pji>	MP:0000229,abnormal megakaryocyte differentiation|MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0005076,abnormal cell differentiation|MP:0008111,abnormal granulocyte differentiation|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0011178,increased erythroblast number|MP:0011913,abnormal reticulocyte cell number
MGI:3526857	Plekha1<Gt(ROSA)82Sor>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001260,increased body weight|MP:0001925,male infertility|MP:0002082,postnatal lethality|MP:0002780,decreased circulating testosterone level|MP:0005536,decreased Leydig cell number|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006379,abnormal spermatocyte morphology|MP:0006418,abnormal testis cord formation
MGI:4941745	Plekha1<tm1.1Arte>	MP:0002169,no abnormal phenotype detected
MGI:6256795	Plekha1<tm1b(EUCOMM)Hmgu>	MP:0000062,increased bone mineral density|MP:0000194,increased circulating calcium level|MP:0001147,small testis|MP:0002092,abnormal eye morphology|MP:0010123,increased bone mineral content|MP:0011896,increased circulating unsaturated transferrin level
MGI:4941747	Plekha2<tm1.1Arte>	MP:0002169,no abnormal phenotype detected
MGI:5634757	Plekha3<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0010053,decreased grip strength|MP:0011396,abnormal sleep behavior
MGI:6414535	Plekha5<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001488,increased startle reflex|MP:0002060,abnormal skin morphology|MP:0004952,increased spleen weight|MP:0005287,narrow eye opening|MP:0005542,cornea vascularization|MP:0005562,decreased mean corpuscular hemoglobin|MP:0006241,abnormal placement of pupils|MP:0011874,enlarged urinary bladder
MGI:2450300	Plekha5<Tg(AMH-cre)1Flor>	MP:0002784,abnormal Sertoli cell morphology|MP:0003674,oxidative stress|MP:0005389,reproductive system phenotype|MP:0008280,abnormal male germ cell apoptosis|MP:0020847,abnormal peroxisome physiology
MGI:8244804	Plekha7<em1Citi>	MP:0005381,digestive/alimentary phenotype
MGI:5907899	Plekha7<tm1.1Janc>	MP:0002411,decreased susceptibility to bacterial infection|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:5569074	Plekha8<tm1b(KOMP)Wtsi>	MP:0002135,abnormal kidney morphology|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0008528,polycystic kidney
MGI:3057317	Plekhb1<tm1Dva>	MP:0002169,no abnormal phenotype detected
MGI:6153580	Plekhf1<em1(IMPC)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6343232	Plekhf1<tm1.1Caox>	MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0003009,abnormal cytokine secretion|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008576,decreased circulating interferon-beta level|MP:0008597,decreased circulating interleukin-6 level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0030951,abnormal endocytosis
MGI:6336059	Plekhf2<em1(IMPC)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001489,decreased startle reflex|MP:0002591,decreased mean corpuscular volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0002989,small kidney|MP:0004738,abnormal auditory brainstem response|MP:0005179,decreased circulating cholesterol level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010067,increased red blood cell distribution width|MP:0011896,increased circulating unsaturated transferrin level|MP:0011965,decreased total retina thickness
MGI:4431598	Plekhg1<tm1a(EUCOMM)Wtsi>	MP:0010087,increased circulating fructosamine level
MGI:6356394	Plekhg2<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0001566,increased circulating phosphate level
MGI:5548798	Plekhg3<tm1b(EUCOMM)Hmgu>	MP:0011960,abnormal eye anterior chamber depth
MGI:4414815	Plekhg5<tm1.1Jbar>	MP:0000260,abnormal angiogenesis|MP:0000530,abnormal kidney vasculature morphology|MP:0003410,abnormal artery development|MP:0005602,decreased angiogenesis|MP:0010551,abnormal coronary vessel morphology
MGI:5484788	Plekhg5<tm1Jbar>	MP:0001614,abnormal blood vessel morphology|MP:0001785,edema|MP:0002796,impaired skin barrier function|MP:0003070,increased vascular permeability|MP:0003921,abnormal heart left ventricle morphology|MP:0005598,decreased heart ventricle muscle contractility|MP:0006055,abnormal vascular endothelial cell morphology
MGI:6120775	Plekhh1<tm1.1(KOMP)Mbp>	MP:0011886,increased circulating lipase level
MGI:3529341	Plekhm1<Gt(OST201689)Lex>	MP:0002169,no abnormal phenotype detected
MGI:5806231	Plekhm1<tm1.1Hzhao>	MP:0001541,abnormal osteoclast physiology|MP:0003173,decreased lysosomal enzyme secretion|MP:0004982,abnormal osteoclast morphology|MP:0004989,decreased osteoblast cell number|MP:0004993,decreased bone resorption|MP:0005058,abnormal lysosome morphology|MP:0010868,increased bone trabecula number|MP:0010872,increased trabecular bone mass|MP:0010878,increased trabecular bone volume|MP:0013631,decreased bone trabecular spacing|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization
MGI:5888869	Plekhm1<tm1.2Hzhao>	MP:0001541,abnormal osteoclast physiology|MP:0003173,decreased lysosomal enzyme secretion|MP:0004982,abnormal osteoclast morphology|MP:0004989,decreased osteoblast cell number|MP:0004993,decreased bone resorption|MP:0005058,abnormal lysosome morphology|MP:0010868,increased bone trabecula number|MP:0010872,increased trabecular bone mass|MP:0010878,increased trabecular bone volume|MP:0013631,decreased bone trabecular spacing|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization
MGI:5513810	Plekhm1<tm1b(EUCOMM)Hmgu>	MP:0000062,increased bone mineral density|MP:0000137,abnormal vertebrae morphology|MP:0002764,short tibia|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0008259,abnormal optic disk morphology|MP:0008528,polycystic kidney|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:4432896	Plekhm2<tm1a(EUCOMM)Wtsi>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0001262,decreased body weight|MP:0002411,decreased susceptibility to bacterial infection|MP:0002874,decreased hemoglobin content|MP:0002968,increased circulating alkaline phosphatase level|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:6356363	Plekhn1<tm1.1Hkon>	MP:0001260,increased body weight|MP:0001261,obese|MP:0001433,polyphagia|MP:0002981,increased liver weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005669,increased circulating leptin level|MP:0009288,increased epididymal fat pad weight|MP:0011698,abnormal brown adipose tissue physiology|MP:0011939,increased food intake|MP:0020414,abnormal fibroblast physiology
MGI:3835921	Plekho1<tm1Fhe>	MP:0002113,abnormal skeleton development|MP:0005006,abnormal osteoblast physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005605,increased bone mass
MGI:6363012	Plekho2<em1Lzhn>	MP:0003884,decreased macrophage cell number|MP:0005387,immune system phenotype|MP:0011080,increased macrophage apoptosis
MGI:3845059	Plek<tm1Csab>	MP:0003179,thrombocytopenia|MP:0006298,abnormal platelet activation|MP:0009549,decreased platelet aggregation
MGI:5311637	ples	MP:0011279,decreased ear pigmentation
MGI:6147556	Plet1<em1(IMPC)Wtsi>	MP:0002079,increased circulating insulin level|MP:0005634,decreased circulating sodium level
MGI:6369063	Plet1<em1Yhh>	MP:0001792,impaired wound healing|MP:0002166,abnormal tumor susceptibility|MP:0010155,abnormal intestine physiology
MGI:6714310	Plet1<tm1Cupe>	MP:0008108,abnormal small intestinal villus morphology|MP:0008125,abnormal dendritic cell number|MP:0008126,increased dendritic cell number|MP:0020349,abnormal dendritic cell migration
MGI:3815498	Plgr1<BALB/cJ>	MP:0002411,decreased susceptibility to bacterial infection
MGI:6384265	Plgrkt<tm1Lmls>	MP:0001194,dermatitis|MP:0001262,decreased body weight|MP:0002451,abnormal macrophage physiology|MP:0003718,maternal effect|MP:0003799,impaired macrophage chemotaxis|MP:0013716,hypolactation|MP:0020212,impaired leukocyte migration
MGI:5571896	Plg<tm1.1Fjc>	MP:0000492,abnormal rectum morphology|MP:0000493,rectal prolapse|MP:0000702,enlarged lymph nodes|MP:0001732,postnatal growth retardation|MP:0003333,liver fibrosis|MP:0012331,increased circulating fibrinogen level
MGI:2158761	Plg<tm1Dco>	MP:0000492,abnormal rectum morphology|MP:0000493,rectal prolapse|MP:0000702,enlarged lymph nodes|MP:0001262,decreased body weight|MP:0001845,abnormal inflammatory response|MP:0001923,reduced female fertility|MP:0002083,premature death|MP:0002551,abnormal blood coagulation|MP:0003068,enlarged kidney|MP:0003282,gastric ulcer|MP:0003333,liver fibrosis|MP:0003434,decreased susceptibility to induced choroidal neovascularization|MP:0006050,pulmonary fibrosis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010211,abnormal acute phase protein level|MP:0012331,increased circulating fibrinogen level
MGI:1857291	Plg<tm1Jld>	MP:0000470,abnormal stomach morphology|MP:0000492,abnormal rectum morphology|MP:0000493,rectal prolapse|MP:0000495,abnormal colon morphology|MP:0000512,intestinal ulcer|MP:0000598,abnormal liver morphology|MP:0000628,abnormal mammary gland development|MP:0001139,abnormal vagina morphology|MP:0001175,abnormal lung morphology|MP:0001259,abnormal body weight|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001310,abnormal conjunctiva morphology|MP:0001312,abnormal cornea morphology|MP:0001654,hepatic necrosis|MP:0001792,impaired wound healing|MP:0001851,eye inflammation|MP:0001852,conjunctivitis|MP:0001882,abnormal lactation|MP:0001923,reduced female fertility|MP:0002083,premature death|MP:0002249,abnormal larynx morphology|MP:0002282,abnormal trachea morphology|MP:0002816,colitis|MP:0003273,duodenal ulcer|MP:0003282,gastric ulcer|MP:0003300,gastrointestinal ulcer|MP:0003305,proctitis|MP:0003447,decreased tumor growth/size|MP:0003633,abnormal nervous system physiology|MP:0003691,abnormal microglial cell physiology|MP:0003893,increased hepatocyte proliferation|MP:0004481,abnormal conjunctival epithelium morphology|MP:0004547,esophageal ulcer|MP:0005035,perianal ulcer|MP:0005048,abnormal thrombosis|MP:0005150,cachexia|MP:0005300,abnormal cornea stroma morphology|MP:0005385,cardiovascular system phenotype|MP:0005542,cornea vascularization|MP:0005602,decreased angiogenesis|MP:0006000,abnormal cornea epithelium morphology|MP:0006137,venoocclusion|MP:0006164,ectropion|MP:0006203,eye hemorrhage|MP:0006270,abnormal mammary gland growth during lactation|MP:0006271,abnormal involution of the mammary gland|MP:0008236,decreased susceptibility to neuronal excitotoxicity|MP:0009507,abnormal mammary gland connective tissue morphology|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010249,lactation failure|MP:0011507,abnormal kidney thrombosis|MP:0012194,decreased keratinocyte migration|MP:0020856,absent cornea epithelium
MGI:3710993	Plin1<tm1Asg>	MP:0001553,abnormal circulating free fatty acids level|MP:0001780,decreased brown adipose tissue amount|MP:0002971,abnormal brown adipose tissue morphology|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0008034,enhanced lipolysis|MP:0011698,abnormal brown adipose tissue physiology|MP:0014146,decreased white adipose tissue mass
MGI:2176249	Plin1<tm1Cdl>	MP:0000598,abnormal liver morphology|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0003960,increased lean body mass|MP:0005289,increased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005334,abnormal fat pad morphology|MP:0005378,growth/size/body region phenotype|MP:0005669,increased circulating leptin level|MP:0008032,abnormal lipolysis|MP:0008033,impaired lipolysis|MP:0008034,enhanced lipolysis|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008907,decreased total fat pad weight|MP:0009137,decreased brown fat lipid droplet number|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009301,decreased parametrial fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0010025,decreased total body fat amount
MGI:2176248	Plin1<tm1Chan>	MP:0001553,abnormal circulating free fatty acids level|MP:0003439,abnormal glycerol level|MP:0003457,abnormal circulating ketone body level|MP:0003960,increased lean body mass|MP:0005289,increased oxygen consumption|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008034,enhanced lipolysis|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008907,decreased total fat pad weight|MP:0009125,decreased brown fat cell lipid droplet size|MP:0009133,decreased white fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009295,decreased interscapular fat pad weight|MP:0009421,increased gastrocnemius weight|MP:0009642,abnormal blood homeostasis|MP:0010025,decreased total body fat amount|MP:0011049,impaired adaptive thermogenesis|MP:0011939,increased food intake
MGI:5429062	Plin1<tm2Lex>	MP:0005459,decreased percent body fat/body weight
MGI:3529131	Plin2<Gt(OST170322)Lex>	MP:0001925,male infertility
MGI:5502311	Plin2<tm1.1Asg>	MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001876,decreased inflammatory response|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0005376,homeostasis/metabolism phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005666,abnormal adipose tissue physiology|MP:0005668,decreased circulating leptin level|MP:0008779,abnormal maternal behavior|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009117,abnormal white fat cell morphology|MP:0009269,decreased fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0011940,decreased food intake|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3617784	Plin2<tm1Chan>	MP:0002310,decreased susceptibility to hepatic steatosis|MP:0002991,abnormal sebaceous gland physiology|MP:0004047,abnormal milk composition|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0009356,decreased liver triglyceride level|MP:0012725,small sebaceous gland|MP:0013193,sebaceous gland hypoplasia|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3820655	Plin2<tm1Itl>	MP:0003011,delayed dark adaptation|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology|MP:0011233,abnormal vitamin A metabolism
MGI:6158435	Plin3<tm1.1Jbki>	MP:0002118,abnormal lipid homeostasis|MP:0004889,increased energy expenditure|MP:0005266,abnormal metabolism|MP:0005289,increased oxygen consumption|MP:0005336,abnormal inguinal fat pad morphology|MP:0005378,growth/size/body region phenotype|MP:0005533,increased body temperature|MP:0005670,abnormal white adipose tissue physiology|MP:0006036,abnormal mitochondrial physiology|MP:0008034,enhanced lipolysis|MP:0009116,abnormal brown fat cell morphology|MP:0009117,abnormal white fat cell morphology|MP:0009125,decreased brown fat cell lipid droplet size|MP:0014171,increased fatty acid oxidation|MP:0020426,abnormal beige fat cell physiology|MP:0020523,decreased susceptibility to induced hypothermia
MGI:5548711	Plin4<tm1.1(KOMP)Wtsi>	MP:0000598,abnormal liver morphology|MP:0001258,decreased body length|MP:0004738,abnormal auditory brainstem response|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:5502545	Plin4<tm1Vlcg>	MP:0005375,adipose tissue phenotype|MP:0005385,cardiovascular system phenotype|MP:0031417,decreased cardiac muscle triglyceride level
MGI:4363886	Plin5<tm1e(KOMP)Wtsi>	MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005331,insulin resistance|MP:0008034,enhanced lipolysis|MP:0009823,abnormal sphingomyelin level|MP:0010378,increased respiratory quotient|MP:0010399,decreased skeletal muscle glycogen level|MP:0012232,abnormal ceramide level|MP:0013243,abnormal carbohydrate metabolism|MP:0014171,increased fatty acid oxidation|MP:0014172,decreased fatty acid oxidation|MP:0030017,decreased adipocyte glucose uptake|MP:0031414,decreased skeletal muscle triglyceride level|MP:0031417,decreased cardiac muscle triglyceride level
MGI:6758997	Plin5<tm1Macl>	MP:0000266,abnormal heart morphology|MP:0000343,abnormal response to cardiac infarction|MP:0001544,abnormal cardiovascular system physiology|MP:0004485,increased response of heart to induced stress|MP:0005140,decreased cardiac muscle contractility|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0014172,decreased fatty acid oxidation|MP:0030018,increased cardiac muscle cell glucose uptake|MP:0031417,decreased cardiac muscle triglyceride level
MGI:5440666	Plin5<tm1Tosu>	MP:0001399,hyperactivity|MP:0001547,abnormal lipid level|MP:0001554,increased circulating free fatty acids level|MP:0003674,oxidative stress|MP:0005140,decreased cardiac muscle contractility|MP:0005282,decreased fatty acids level|MP:0005289,increased oxygen consumption|MP:0005294,abnormal heart ventricle morphology|MP:0005318,decreased triglyceride level|MP:0009355,increased liver triglyceride level|MP:0009356,decreased liver triglyceride level|MP:0010359,increased liver free fatty acids level|MP:0010360,decreased liver free fatty acids level|MP:0014171,increased fatty acid oxidation|MP:0031417,decreased cardiac muscle triglyceride level
MGI:3822515	Plk1<Gt(RRR358)Byg>	MP:0001730,embryonic growth arrest|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0003077,abnormal cell cycle|MP:0004024,aneuploidy|MP:0004207,increased squamous cell carcinoma incidence|MP:0008714,increased lung carcinoma incidence|MP:0009760,abnormal mitotic spindle morphology|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012431,increased lymphoma incidence
MGI:5548960	Plk1<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3840104	Plk2<tm1Elan>	MP:0011100,preweaning lethality, complete penetrance
MGI:2678106	Plk2<tm1Rle>	MP:0000060,delayed bone ossification|MP:0001265,decreased body size|MP:0001302,eyelids open at birth|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0003077,abnormal cell cycle|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004921,decreased placenta weight|MP:0009431,decreased fetal weight
MGI:3796743	Plk3<tm1Dai>	MP:0002020,increased tumor incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002035,increased leiomyosarcoma incidence|MP:0003448,abnormal tumor morphology|MP:0003721,increased tumor growth/size|MP:0008014,increased lung tumor incidence|MP:0008019,increased liver tumor incidence
MGI:5438531	Plk3<tm1Elan>	MP:0010768,mortality/aging|MP:0011400,lethality, complete penetrance
MGI:4456133	Plk3<tm1Pjs>	MP:0002006,neoplasm|MP:0003077,abnormal cell cycle|MP:0004025,polyploidy|MP:0004045,abnormal cell cycle checkpoint function
MGI:4127391	Plk4<Gt(XK603)Byg>	MP:0001147,small testis|MP:0005389,reproductive system phenotype|MP:0011092,embryonic lethality, complete penetrance
MGI:5296670	Plk4<m1Lja>	MP:0001147,small testis|MP:0001750,increased circulating follicle stimulating hormone level|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0011092,embryonic lethality, complete penetrance
MGI:2387766	Plk4<tm1Jwd>	MP:0001648,abnormal apoptosis|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002151,abnormal neural tube morphology|MP:0004046,abnormal mitosis|MP:0006386,absent somites|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3847500	Pllp<tm1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001304,cataract|MP:0001402,decreased locomotor activity|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002965,increased circulating serum albumin level|MP:0002989,small kidney|MP:0005178,increased circulating cholesterol level
MGI:2158357	Pln<tm1Egk>	MP:0002833,increased heart weight|MP:0004084,abnormal cardiac muscle relaxation|MP:0004215,abnormal myocardial fiber physiology|MP:0005599,increased cardiac muscle contractility|MP:0008543,atrial fibrillation|MP:0010754,abnormal heart left ventricle pressure
MGI:5605846	Plod1<tm1b(EUCOMM)Hmgu>	MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength
MGI:3712146	Plod1<tm1Soin>	MP:0000753,paralysis|MP:0001914,hemorrhage|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0004044,aortic dissection|MP:0004144,hypotonia|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0009865,abnormal aorta smooth muscle morphology|MP:0009866,abnormal aorta wall morphology
MGI:5903134	Plod2<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001392,abnormal locomotor behavior|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001697,abnormal embryo size|MP:0002075,abnormal coat/hair pigmentation|MP:0002080,prenatal lethality|MP:0011100,preweaning lethality, complete penetrance
MGI:6460419	Plod2<em1Kaat>	MP:0000280,thin ventricular wall|MP:0001698,decreased embryo size|MP:0005294,abnormal heart ventricle morphology|MP:0006042,increased apoptosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0020354,increased endoplasmic reticulum stress
MGI:7798735	Plod2<tm1.1Krako>	MP:0004174,abnormal spine curvature|MP:0004200,decreased fetal size|MP:0005353,abnormal patella morphology|MP:0005390,skeleton phenotype|MP:0005503,abnormal tendon morphology|MP:0009431,decreased fetal weight|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0030798,joint contracture|MP:0030800,abnormal patellar ligament morphology
MGI:5629312	Plod3<tm1.1(KOMP)Wtsi>	MP:0000288,abnormal pericardium morphology|MP:0000538,abnormal urinary bladder morphology|MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0004738,abnormal auditory brainstem response|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3620600	Plod3<tm1Rmyl>	MP:0002151,abnormal neural tube morphology|MP:0003044,impaired basement membrane formation|MP:0003954,abnormal Reichert's membrane morphology|MP:0003984,embryonic growth retardation|MP:0005590,increased vasodilation|MP:0006055,abnormal vascular endothelial cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3497741	Plod3<tm1Soin>	MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0009781,abnormal preimplantation embryo development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014239,abnormal intracellular organelle morphology
MGI:3620603	Plod3<tm2.1Rmyl>	MP:0001175,abnormal lung morphology|MP:0001216,abnormal epidermal layer morphology|MP:0003044,impaired basement membrane formation|MP:0008438,abnormal cutaneous collagen fibril morphology
MGI:3620601	Plod3<tm2Rmyl>	MP:0001208,blistering|MP:0001915,intracranial hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0003044,impaired basement membrane formation|MP:0003954,abnormal Reichert's membrane morphology|MP:0003984,embryonic growth retardation|MP:0005590,increased vasodilation|MP:0006055,abnormal vascular endothelial cell morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:6194326	Plod3<ugli>	MP:0000111,cleft palate|MP:0000914,exencephaly|MP:0002092,abnormal eye morphology|MP:0005508,abnormal skeleton morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1856065	Plp1<jp>	MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0001262,decreased body weight|MP:0001290,delayed eyelid opening|MP:0001402,decreased locomotor activity|MP:0001486,abnormal startle reflex|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002182,abnormal astrocyte morphology|MP:0003354,astrocytosis|MP:0003871,abnormal myelin sheath morphology|MP:0003997,tonic-clonic seizures|MP:0008026,abnormal brain white matter morphology|MP:0008916,abnormal astrocyte physiology|MP:0009358,environmentally induced seizures|MP:0009434,paraparesis|MP:0009808,decreased oligodendrocyte number|MP:0020351,decreased vocalization
MGI:1856375	Plp1<jp-4J>	MP:0000745,tremors|MP:0000921,demyelination|MP:0000952,abnormal CNS glial cell morphology|MP:0002064,seizures|MP:0003354,astrocytosis|MP:0009808,decreased oligodendrocyte number|MP:0011083,lethality at weaning, complete penetrance
MGI:5810210	Plp1<jp-6J>	MP:0000745,tremors|MP:0002083,premature death|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia
MGI:1856066	Plp1<jp-msd>	MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001262,decreased body weight|MP:0002064,seizures|MP:0002083,premature death|MP:0006042,increased apoptosis|MP:0011085,postnatal lethality, complete penetrance
MGI:1856067	Plp1<jp-rsh>	MP:0000136,abnormal microglial cell morphology|MP:0000745,tremors|MP:0000913,abnormal brain development|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002064,seizures|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology|MP:0003312,abnormal locomotor coordination|MP:0003354,astrocytosis|MP:0003634,abnormal glial cell morphology|MP:0003871,abnormal myelin sheath morphology|MP:0004768,abnormal axonal transport|MP:0004777,abnormal phospholipid level|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0006042,increased apoptosis|MP:0010160,increased oligodendrocyte number|MP:0013438,dysmyelination|MP:0020938,decreased susceptibility to Picornaviridae infection
MGI:5476996	Plp1<tm1.1Blyg>	MP:0003631,nervous system phenotype
MGI:4835263	Plp1<tm1.1Gow>	MP:0000849,abnormal cerebellum morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001405,impaired coordination|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0005405,axon degeneration|MP:0009978,abnormal cerebellum white matter morphology|MP:0010047,axonal spheroids
MGI:6115637	Plp1<tm1c(EUCOMM)Wtsi>	MP:0003005,abnormal hippocampal fimbria morphology|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0005015,increased T cell number|MP:0008918,microgliosis|MP:0010047,axonal spheroids
MGI:3828298	Plp1<tm1Frca>	MP:0000921,demyelination|MP:0001405,impaired coordination|MP:0003871,abnormal myelin sheath morphology|MP:0005386,behavior/neurological phenotype|MP:0005405,axon degeneration
MGI:4835262	Plp1<tm1Gow>	MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001405,impaired coordination|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0005405,axon degeneration|MP:0009978,abnormal cerebellum white matter morphology|MP:0010047,axonal spheroids
MGI:1857446	Plp1<tm1Kan>	MP:0000136,abnormal microglial cell morphology|MP:0000160,kyphosis|MP:0000755,hindlimb paralysis|MP:0000921,demyelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0003005,abnormal hippocampal fimbria morphology|MP:0003312,abnormal locomotor coordination|MP:0003354,astrocytosis|MP:0003871,abnormal myelin sheath morphology|MP:0003983,decreased cholesterol level|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0008918,microgliosis|MP:0009434,paraparesis|MP:0010047,axonal spheroids|MP:0012674,tomacula|MP:0013438,dysmyelination
MGI:2384125	Plp1<tm1Wst>	MP:0000920,abnormal myelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0003871,abnormal myelin sheath morphology|MP:0005403,abnormal nerve conduction|MP:0005404,abnormal axon morphology|MP:0010047,axonal spheroids
MGI:2384127	Plp1<tm2Wst>	MP:0000920,abnormal myelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0005403,abnormal nerve conduction
MGI:3617313	Plp1<tm3Wst>	MP:0000920,abnormal myelination|MP:0001330,abnormal optic nerve morphology|MP:0003871,abnormal myelin sheath morphology
MGI:5707490	Plp2<tm1Dva>	MP:0003076,increased susceptibility to ischemic brain injury|MP:0003203,increased neuron apoptosis|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0013501,increased fibroblast apoptosis|MP:0020354,increased endoplasmic reticulum stress|MP:0030949,abnormal Golgi vesicle transport
MGI:7594045	Plpbp<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3849483	Plpp1<Gt(RRD231)Byg>	MP:0005389,reproductive system phenotype|MP:0009642,abnormal blood homeostasis
MGI:2182608	Plpp2<tm1Grid>	MP:0002169,no abnormal phenotype detected
MGI:5548553	Plpp3<tm1b(EUCOMM)Hmgu>	MP:0005553,increased circulating creatinine level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2674217	Plpp3<tm1Stw>	MP:0001622,abnormal vasculogenesis|MP:0001695,abnormal gastrulation|MP:0001700,abnormal embryo turning|MP:0001719,absent vitelline blood vessels|MP:0001722,pale yolk sac|MP:0001723,disorganized yolk sac vascular plexus|MP:0001726,abnormal allantois morphology|MP:0001914,hemorrhage|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002151,abnormal neural tube morphology|MP:0002231,abnormal primitive streak morphology|MP:0002825,abnormal notochord morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004066,abnormal primitive node morphology|MP:0004076,abnormal vitelline vascular remodeling|MP:0004777,abnormal phospholipid level|MP:0005221,abnormal rostral-caudal axis patterning|MP:0008533,abnormal anterior visceral endoderm morphology|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012135,embryonic-extraembryonic boundary constriction|MP:0012156,rostral-caudal axis duplication|MP:0012157,rostral body truncation|MP:0012173,short rostral-caudal axis|MP:0012181,increased somite number|MP:0012274,increased axial mesoderm size
MGI:3723646	Plpp3<tm2Stw>	MP:0000929,open neural tube|MP:0001695,abnormal gastrulation|MP:0001726,abnormal allantois morphology|MP:0002080,prenatal lethality|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0009657,failure of chorioallantoic fusion
MGI:3723634	Plpp3<tm3.1Stw>	MP:0001700,abnormal embryo turning|MP:0001726,abnormal allantois morphology|MP:0001914,hemorrhage|MP:0003229,abnormal vitelline vasculature morphology|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0004556,enlarged allantois|MP:0009657,failure of chorioallantoic fusion|MP:0011091,prenatal lethality, complete penetrance|MP:0011256,abnormal neural fold morphology
MGI:3723633	Plpp3<tm3Stw>	MP:0002169,no abnormal phenotype detected
MGI:7425917	Plpp4<em1(IMPC)Hmgu>	MP:0005560,decreased circulating glucose level
MGI:4453994	Plpp5<tm1(KOMP)Mbp>	MP:0002169,no abnormal phenotype detected
MGI:5692731	Plpp6<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0002599,increased mean platelet volume
MGI:7427352	Plpp6<tm1Bdl>	MP:0001547,abnormal lipid level|MP:0002376,abnormal dendritic cell physiology|MP:0002492,decreased IgE level|MP:0003983,decreased cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0008126,increased dendritic cell number|MP:0008127,decreased dendritic cell number|MP:0008524,increased plasmacytoid dendritic cell number|MP:0010539,decreased level of surface class II molecules|MP:0020868,decreased lipogenesis|MP:0031470,abnormal macropinocytosis
MGI:6507762	Plpp7<em1Eno>	MP:0000189,hypoglycemia|MP:0000747,muscle weakness|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0002106,abnormal muscle physiology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003111,abnormal cell nucleus morphology|MP:0003631,nervous system phenotype|MP:0003702,abnormal chromosome morphology|MP:0004090,abnormal sarcomere morphology|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005384,cellular phenotype|MP:0005385,cardiovascular system phenotype|MP:0009402,decreased skeletal muscle fiber diameter|MP:0010630,abnormal cardiac muscle tissue morphology|MP:0010768,mortality/aging|MP:0011100,preweaning lethality, complete penetrance
MGI:4431223	Plppr4<tm1Roni>	MP:0001262,decreased body weight|MP:0002064,seizures|MP:0002175,decreased brain weight|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0003997,tonic-clonic seizures|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014812,abnormal brain physiology
MGI:4431224	Plppr4<tm2.1Roni>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0011269,increased excitatory postsynaptic current amplitude|MP:0014375,increased miniature excitatory postsynaptic current frequency
MGI:7425918	Plppr5<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000538,abnormal urinary bladder morphology|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001293,anophthalmia|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002311,abnormal inspiratory capacity|MP:0002339,abnormal lymph node morphology|MP:0003019,increased circulating chloride level|MP:0003795,abnormal bone structure|MP:0003917,increased kidney weight|MP:0010895,increased lung compliance|MP:0011045,decreased lung elastance|MP:0011625,cystolithiasis
MGI:7310260	Plppr5<em2Gpt>	MP:0001260,increased body weight|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001441,increased grooming behavior|MP:0001513,limb grasping|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003461,abnormal response to novel object|MP:0004000,impaired passive avoidance behavior|MP:0005356,positive geotaxis|MP:0006060,increased cerebral infarct size|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010182,decreased susceptibility to weight gain|MP:0020870,decreased thigmotaxis
MGI:3848230	Plrg1<tm1Jcbr>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3848231	Plrg1<tm2Jcbr>	MP:0000280,thin ventricular wall|MP:0000352,decreased cell proliferation|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0003077,abnormal cell cycle|MP:0003203,increased neuron apoptosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0004937,dilated heart|MP:0005294,abnormal heart ventricle morphology|MP:0005598,decreased heart ventricle muscle contractility|MP:0011085,postnatal lethality, complete penetrance
MGI:5609592	Pls1<tm1Fri>	MP:0000488,abnormal intestinal epithelium morphology|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0004525,thin cochlear hair cell stereocilia|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004528,fused outer hair cell stereocilia|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004534,decreased inner hair cell stereocilia number|MP:0004536,short inner hair cell stereocilia|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0006325,impaired hearing|MP:0008141,decreased small intestinal microvillus size|MP:0008537,increased susceptibility to induced colitis|MP:0008885,increased enterocyte apoptosis|MP:0010155,abnormal intestine physiology|MP:0010768,mortality/aging|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013298,increased susceptibility to colitis induced morbidity/mortality
MGI:6302819	Pls3<em1Bult>	MP:0000062,increased bone mineral density|MP:0000757,herniated abdominal wall|MP:0000761,thin diaphragm muscle|MP:0002279,abnormal diaphragm morphology|MP:0003257,abnormal abdominal wall morphology|MP:0003385,abnormal body wall morphology|MP:0003924,diaphragmatic hernia|MP:0005376,homeostasis/metabolism phenotype|MP:0005388,respiratory system phenotype|MP:0010770,preweaning lethality|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012251,abnormal diaphragm development|MP:0013857,abnormal abdominal muscle morphology
MGI:6513056	Pls3<em2Bult>	MP:0000063,decreased bone mineral density
MGI:4451991	Pls3<tm1a(EUCOMM)Wtsi>	MP:0001552,increased circulating triglyceride level|MP:0001566,increased circulating phosphate level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005561,increased mean corpuscular hemoglobin|MP:0010052,increased grip strength
MGI:6266858	Pls3<tm1d(EUCOMM)Wtsi>	MP:0000066,osteoporosis|MP:0001533,abnormal skeleton physiology|MP:0004991,decreased bone strength|MP:0004992,increased bone resorption|MP:0005390,skeleton phenotype|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0010968,decreased compact bone area|MP:0013624,decreased femur compact bone thickness|MP:0013630,increased bone trabecular spacing|MP:0013639,decreased bone stiffness
MGI:6830916	Plscr1l1<em1Kzt>	MP:0005389,reproductive system phenotype
MGI:5548929	Plscr1<tm1b(EUCOMM)Hmgu>	MP:0001488,increased startle reflex|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0010393,shortened QRS complex duration|MP:0011965,decreased total retina thickness
MGI:2180949	Plscr1<tm1Lex>	MP:0000222,decreased neutrophil cell number|MP:0000334,decreased granulocyte number|MP:0001601,abnormal myelopoiesis|MP:0002415,abnormal neutrophil differentiation|MP:0005334,abnormal fat pad morphology|MP:0006094,increased fat cell size|MP:0008111,abnormal granulocyte differentiation
MGI:3053448	Plscr3<tm1Sims>	MP:0000010,abnormal abdominal fat pad morphology|MP:0000180,abnormal circulating cholesterol level|MP:0001261,obese|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005669,increased circulating leptin level|MP:0009118,increased white fat cell size|MP:0030968,decreased circulating adiponectin level
MGI:6360696	Plscr5<em1(IMPC)J>	MP:0001489,decreased startle reflex|MP:0004738,abnormal auditory brainstem response
MGI:8220012	Plscr5<em1Wagq>	MP:0004404,cochlear outer hair cell degeneration|MP:0004432,abnormal cochlear hair cell physiology|MP:0004529,decreased outer hair cell stereocilia number|MP:0004534,decreased inner hair cell stereocilia number|MP:0005377,hearing/vestibular/ear phenotype|MP:0006325,impaired hearing|MP:0014406,increased or absent distortion product otoacoustic emission threshold|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:1857881	plt	MP:0000217,abnormal leukocyte cell number|MP:0001346,abnormal lacrimal gland morphology|MP:0001790,abnormal immune system physiology|MP:0001828,abnormal T cell activation|MP:0001846,increased inflammatory response|MP:0001870,salivary gland inflammation|MP:0002163,abnormal gland morphology|MP:0002347,abnormal lymph node T cell domain morphology|MP:0002356,abnormal spleen red pulp morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002371,abnormal thymus cortex morphology|MP:0002722,abnormal immune system organ morphology|MP:0003156,abnormal leukocyte migration|MP:0003452,abnormal parotid gland morphology|MP:0003793,abnormal submandibular gland morphology|MP:0004751,increased length of allograft survival|MP:0005015,increased T cell number|MP:0005018,decreased T cell number|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005387,immune system phenotype|MP:0008049,increased memory T cell number|MP:0008083,decreased single-positive T cell number|MP:0008101,lymph node hypoplasia|MP:0008135,small Peyer's patches|MP:0008463,abnormal peripheral lymph node morphology|MP:0008872,abnormal physiological response to xenobiotic|MP:0008879,submandibular gland inflammation|MP:0008880,lacrimal gland inflammation|MP:0013367,parotid gland inflammation|MP:0013588,small thymus medulla
MGI:5436094	Plt001	MP:0005505,thrombocytosis
MGI:5436096	plt005	MP:0005505,thrombocytosis|MP:0010831,lethality, incomplete penetrance
MGI:5436097	plt008	MP:0003179,thrombocytopenia
MGI:5436098	plt009	MP:0005505,thrombocytosis
MGI:5436071	Plt18	MP:0003179,thrombocytopenia
MGI:5436072	Plt21	MP:0003179,thrombocytopenia
MGI:3512147	Pltct1<QSi5/Ianm>	MP:0003179,thrombocytopenia
MGI:3512149	Pltct2<QSi5/Ianm>	MP:0005505,thrombocytosis
MGI:2684253	Pltiq1<NZB/BlNJ>	MP:0005584,abnormal enzyme/coenzyme activity
MGI:2677964	plto	MP:0000371,diluted coat color
MGI:2684222	Pltpq1<NZB/BlNJ>	MP:0005584,abnormal enzyme/coenzyme activity
MGI:2684236	Pltpq3<NZB/BlNJ>	MP:0005584,abnormal enzyme/coenzyme activity
MGI:2684245	Pltpq4<SM/J>	MP:0005584,abnormal enzyme/coenzyme activity
MGI:2176342	Pltp<tm1Jia>	MP:0000180,abnormal circulating cholesterol level|MP:0000182,increased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000242,impaired fertilization|MP:0001312,abnormal cornea morphology|MP:0001337,dry eyes|MP:0001922,reduced male fertility|MP:0002660,abnormal caput epididymis morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0002675,asthenozoospermia|MP:0004543,abnormal sperm physiology|MP:0004777,abnormal phospholipid level|MP:0005145,increased circulating VLDL cholesterol level|MP:0005300,abnormal cornea stroma morphology|MP:0005389,reproductive system phenotype|MP:0006000,abnormal cornea epithelium morphology|MP:0011231,abnormal vitamin E level|MP:0020854,increased cornea epithelium thickness|MP:0020859,disorganized cornea epithelium|MP:0031432,cornea perforation
MGI:5825236	Pltp<tm2.1Jia>	MP:0000186,decreased circulating HDL cholesterol level|MP:0002644,decreased circulating triglyceride level|MP:0003191,abnormal cellular cholesterol metabolism|MP:0003981,decreased circulating phospholipid level|MP:0005179,decreased circulating cholesterol level|MP:0020126,decreased circulating HDL phospholipid level|MP:0020129,decreased circulating non-HDL phospholipid level|MP:0020151,abnormal circulating non-HDL cholesterol level
MGI:3609355	Pltq1<SM/J>	MP:0005505,thrombocytosis
MGI:3609361	Pltq2<NZW/LacJ>	MP:0005505,thrombocytosis
MGI:3609366	Pltq3<NZW/LacJ>	MP:0005505,thrombocytosis
MGI:5473517	Plvap<tm1.1Rvst>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001270,distended abdomen|MP:0001552,increased circulating triglyceride level|MP:0001732,postnatal growth retardation|MP:0001783,decreased white adipose tissue amount|MP:0003070,increased vascular permeability|MP:0003658,abnormal capillary morphology|MP:0003949,abnormal circulating lipid level|MP:0004247,small pancreas|MP:0005178,increased circulating cholesterol level|MP:0005324,ascites|MP:0005385,cardiovascular system phenotype|MP:0005567,decreased circulating total protein level|MP:0010768,mortality/aging|MP:0010831,lethality, incomplete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:5473518	Plvap<tm1.2Rvst>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0000585,kinked tail|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001270,distended abdomen|MP:0001547,abnormal lipid level|MP:0001552,increased circulating triglyceride level|MP:0001732,postnatal growth retardation|MP:0001785,edema|MP:0003070,increased vascular permeability|MP:0003180,abnormal pulmonary endothelial cell surface|MP:0003288,intestinal edema|MP:0003658,abnormal capillary morphology|MP:0003692,xanthoma|MP:0004247,small pancreas|MP:0005178,increased circulating cholesterol level|MP:0005324,ascites|MP:0005367,renal/urinary system phenotype|MP:0005416,abnormal circulating protein level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0006055,abnormal vascular endothelial cell morphology|MP:0008853,decreased abdominal adipose tissue amount|MP:0009283,decreased gonadal fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0009699,hyperchylomicronemia|MP:0010155,abnormal intestine physiology|MP:0010831,lethality, incomplete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011310,abnormal kidney capillary morphology|MP:0011860,abnormal peritubular capillary endothelium morphology
MGI:4434827	Plvap<tm1e(EUCOMM)Hmgu>	MP:0000280,thin ventricular wall|MP:0000585,kinked tail|MP:0000692,small spleen|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001785,edema|MP:0001786,skin edema|MP:0001914,hemorrhage|MP:0001944,abnormal pancreas morphology|MP:0002083,premature death|MP:0002447,abnormal erythrocyte morphology|MP:0002989,small kidney|MP:0003658,abnormal capillary morphology|MP:0003717,pallor|MP:0004247,small pancreas|MP:0004969,pale kidney|MP:0005385,cardiovascular system phenotype|MP:0009395,increased nucleated erythrocyte cell number|MP:0010402,ventricular septal defect|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4941938	Plxdc2<tm1.1Mitc>	MP:0003631,nervous system phenotype
MGI:3641211	Plxna1<tm1Kik>	MP:0002376,abnormal dendritic cell physiology|MP:0003723,abnormal long bone morphology|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0010872,increased trabecular bone mass
MGI:3831874	Plxna1<tm1Tmj>	MP:0000953,abnormal oligodendrocyte morphology|MP:0001879,abnormal lymphatic vessel morphology|MP:0003631,nervous system phenotype|MP:0004297,abnormal proprioceptive neuron morphology|MP:0005391,vision/eye phenotype|MP:0010197,abnormal lymphatic vessel endothelial cell morphology
MGI:3831875	Plxna1<tm2Tmj>	MP:0000953,abnormal oligodendrocyte morphology|MP:0004297,abnormal proprioceptive neuron morphology
MGI:3793765	Plxna2<nmf454>	MP:0000889,abnormal cerebellar molecular layer|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0002762,ectopic cerebellar granule cells|MP:0014553,decreased neuronal migration
MGI:4432861	Plxna2<tm1a(EUCOMM)Wtsi>	MP:0005561,increased mean corpuscular hemoglobin
MGI:3793763	Plxna2<tm1Hfu>	MP:0001879,abnormal lymphatic vessel morphology|MP:0002762,ectopic cerebellar granule cells|MP:0003734,abnormal retina inner plexiform layer morphology|MP:0004811,abnormal neuron physiology|MP:0005240,abnormal amacrine cell morphology|MP:0005391,vision/eye phenotype|MP:0008143,abnormal dendrite morphology|MP:0014553,decreased neuronal migration|MP:0014744,abnormal hippocampal mossy fiber suprapyramidal bundle morphology|MP:0014746,abnormal hippocampal mossy fiber innervation pattern
MGI:2386961	Plxna3<tm1Matl>	MP:0000807,abnormal hippocampus morphology|MP:0000815,abnormal Ammon gyrus morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0002961,abnormal axon guidance|MP:0005391,vision/eye phenotype|MP:0008960,abnormal axon pruning|MP:0014745,abnormal hippocampal mossy fiber infrapyramidal bundle morphology
MGI:6449055	Plxna4<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001258,decreased body length|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002699,abnormal vitreous body morphology|MP:0005278,abnormal cholesterol homeostasis|MP:0006243,impaired pupillary reflex|MP:0008259,abnormal optic disk morphology
MGI:3578655	Plxna4<tm1Hfu>	MP:0000861,disorganized barrel cortex|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001056,abnormal cranial nerve morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0001071,abnormal facial nerve morphology|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001077,abnormal spinal nerve morphology|MP:0002961,abnormal axon guidance|MP:0008225,abnormal anterior commissure morphology|MP:0008312,abnormal sympathetic postganglionic fiber morphology|MP:0009937,abnormal neuron differentiation|MP:0010859,abnormal anterior commissure pars anterior morphology|MP:0010860,abnormal anterior commissure pars posterior morphology|MP:0014746,abnormal hippocampal mossy fiber innervation pattern
MGI:3579185	Plxna4<tm1Matl>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0001065,abnormal trigeminal nerve morphology|MP:0002961,abnormal axon guidance|MP:0005240,abnormal amacrine cell morphology|MP:0008056,abnormal retina ganglion cell morphology|MP:0008226,decreased anterior commissure size|MP:0008415,abnormal neurite morphology|MP:0014748,abnormal sensory neuron axon guidance
MGI:3790773	Plxnb1<tm1.1Ltam>	MP:0002169,no abnormal phenotype detected|MP:0003068,enlarged kidney|MP:0010981,abnormal branching involved in ureteric bud morphogenesis
MGI:3765917	Plxnb1<tm1Matl>	MP:0003631,nervous system phenotype
MGI:3722359	Plxnb1<tm1Mom>	MP:0005391,vision/eye phenotype
MGI:3713703	Plxnb1<tm1Rkun>	MP:0003068,enlarged kidney|MP:0003631,nervous system phenotype|MP:0010981,abnormal branching involved in ureteric bud morphogenesis|MP:0011364,abnormal metanephros morphology
MGI:4849926	Plxnb2<m597804Hubr>	MP:0000914,exencephaly|MP:0002151,abnormal neural tube morphology
MGI:5807117	Plxnb2<tm1.1Rkun>	MP:0004041,increased susceptibility to kidney reperfusion injury|MP:0009640,abnormal renal tubule epithelium morphology
MGI:4433461	Plxnb2<tm1a(EUCOMM)Wtsi>	MP:0000373,belly spot|MP:0001260,increased body weight|MP:0001756,abnormal urination|MP:0002075,abnormal coat/hair pigmentation
MGI:3620317	Plxnb2<tm1Matl>	MP:0000373,belly spot|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000885,ectopic Purkinje cell|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0002762,ectopic cerebellar granule cells|MP:0002989,small kidney|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0003446,renal hypoplasia|MP:0003648,abnormal radial glial cell morphology|MP:0004017,duplex kidney|MP:0004097,abnormal cerebellar cortex morphology|MP:0004279,abnormal rostral migratory stream morphology|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0009941,abnormal olfactory bulb interneuron morphology|MP:0009942,abnormal olfactory bulb granule cell morphology|MP:0009943,abnormal olfactory bulb periglomerular cell morphology|MP:0009946,abnormal olfactory bulb layer morphology|MP:0009950,abnormal olfactory bulb internal plexiform layer morphology|MP:0009951,abnormal olfactory bulb mitral cell layer morphology|MP:0009977,abnormal cerebellar granule cell migration|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011493,double ureter|MP:0011760,abnormal ureteric bud tip morphology|MP:0011803,double kidney pelvis|MP:0012707,incomplete caudal neuropore closure|MP:0020394,decreased neuronal precursor proliferation|MP:0030956,abnormal neuronal precursor cell migration
MGI:3713706	Plxnb2<tm1Rkun>	MP:0000820,abnormal choroid plexus morphology|MP:0000822,abnormal brain ventricle morphology|MP:0000830,abnormal diencephalon morphology|MP:0000853,absent cerebellar foliation|MP:0000857,abnormal cerebellar foliation|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0002152,abnormal brain morphology|MP:0002739,abnormal olfactory bulb development|MP:0003054,spina bifida|MP:0004077,abnormal striatum morphology|MP:0004098,abnormal cerebellar granule cell morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011380,enlarged brain ventricles
MGI:4419514	Plxnb3<tm1a(KOMP)Wtsi>	MP:0001510,abnormal coat appearance
MGI:3722360	Plxnb3<tm1Mom>	MP:0005391,vision/eye phenotype
MGI:6293850	Plxnc1<em1(IMPC)Mbp>	MP:0000194,increased circulating calcium level|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001325,abnormal retina morphology|MP:0001556,increased circulating HDL cholesterol level|MP:0002135,abnormal kidney morphology|MP:0002574,increased vertical activity|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0005178,increased circulating cholesterol level|MP:0005568,increased circulating total protein level
MGI:2683882	Plxnc1<tm1Alk>	MP:0002169,no abnormal phenotype detected|MP:0002882,abnormal neuron morphology|MP:0005391,vision/eye phenotype|MP:0006009,abnormal neuronal migration
MGI:5476170	Plxnd1<b2b1863Clo>	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0000520,absent kidney|MP:0001823,thymus hypoplasia|MP:0004158,right aortic arch|MP:0010412,atrioventricular septal defect|MP:0011662,persistent truncus arteriosus type ii|MP:0011683,dual inferior vena cava
MGI:5648017	Plxnd1<b2b3150Clo>	MP:0000111,cleft palate|MP:0000445,short snout|MP:0000520,absent kidney|MP:0001823,thymus hypoplasia|MP:0002633,persistent truncus arteriosus|MP:0002639,micrognathia|MP:0004158,right aortic arch|MP:0010402,ventricular septal defect|MP:0010406,common atrium|MP:0010412,atrioventricular septal defect|MP:0010466,vascular ring|MP:0010488,abnormal left subclavian artery morphology
MGI:5316780	Plxnd1<b2b553Clo>	MP:0000284,double outlet right ventricle|MP:0000520,absent kidney|MP:0002633,persistent truncus arteriosus|MP:0004158,right aortic arch|MP:0006063,abnormal inferior vena cava morphology|MP:0010413,complete atrioventricular septal defect|MP:0011661,persistent truncus arteriosus type i|MP:0011662,persistent truncus arteriosus type ii|MP:0011681,atrium cyst|MP:0011682,renal glomerulus cyst|MP:0011683,dual inferior vena cava
MGI:7425339	Plxnd1<em1Zho>	MP:0001177,atelectasis|MP:0002276,abnormal lung interstitium morphology|MP:0002633,persistent truncus arteriosus|MP:0002652,thin myocardium|MP:0002724,enhanced wound healing|MP:0002726,abnormal pulmonary vein morphology|MP:0003544,abnormal vascular endothelial cell migration|MP:0004007,abnormal lung vasculature morphology|MP:0004200,decreased fetal size|MP:0005601,increased angiogenesis|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010499,abnormal ventricle myocardium morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013975,abnormal coronary sinus connection|MP:0020330,increased capillary density|MP:0031152,subcutaneous hemorrhage
MGI:3848812	Plxnd1<tm1.1Tmj>	MP:0000141,abnormal vertebral body morphology|MP:0000154,rib fusion|MP:0000272,abnormal aorta morphology|MP:0000592,short tail|MP:0001255,decreased body height|MP:0001575,cyanosis|MP:0001614,abnormal blood vessel morphology|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0002633,persistent truncus arteriosus|MP:0002792,abnormal retina vasculature morphology|MP:0003105,abnormal heart atrium morphology|MP:0003140,dilated heart atrium|MP:0003544,abnormal vascular endothelial cell migration|MP:0004158,right aortic arch|MP:0004612,fusion of vertebral bodies|MP:0005329,abnormal myocardium layer morphology|MP:0005385,cardiovascular system phenotype|MP:0005391,vision/eye phenotype|MP:0005602,decreased angiogenesis|MP:0010402,ventricular septal defect|MP:0010454,abnormal truncus arteriosus septation|MP:0010551,abnormal coronary vessel morphology|MP:0010768,mortality/aging|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012253,abnormal intersomitic vessel morphology|MP:0031589,detached epicardium
MGI:5544786	Plxnd1<tm1.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:3527997	Plxnd1<tm1Ddg>	MP:0012253,abnormal intersomitic vessel morphology
MGI:3050678	Plxnd1<tm1Joe>	MP:0000141,abnormal vertebral body morphology|MP:0001575,cyanosis|MP:0002191,abnormal artery morphology|MP:0002633,persistent truncus arteriosus|MP:0003105,abnormal heart atrium morphology|MP:0003544,abnormal vascular endothelial cell migration|MP:0004158,right aortic arch|MP:0004612,fusion of vertebral bodies|MP:0005592,abnormal vascular smooth muscle morphology|MP:0005601,increased angiogenesis|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0006355,abnormal sixth pharyngeal arch artery morphology|MP:0008725,increased heart atrium size|MP:0010465,aberrant origin of the right subclavian artery|MP:0010472,abnormal ascending aorta and coronary artery attachment|MP:0010488,abnormal left subclavian artery morphology|MP:0010565,absent fetal ductus arteriosus|MP:0011087,neonatal lethality, complete penetrance|MP:0012253,abnormal intersomitic vessel morphology
MGI:3052203	Plyid<HIGA/Nsc>	MP:0001800,abnormal humoral immune response|MP:0002495,increased IgA level
MGI:6162684	Pm20d1<em1Brsp>	MP:0001982,decreased chemically-elicited antinociception|MP:0002736,abnormal nociception after inflammation|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0011019,abnormal adaptive thermogenesis|MP:0013245,abnormal lipid metabolism
MGI:6750923	Pm20d1<em1(IMPC)H>	MP:0001552,increased circulating triglyceride level|MP:0001566,increased circulating phosphate level|MP:0002608,increased hematocrit
MGI:1856996	pma	MP:0000576,clubfoot|MP:0000749,muscle degeneration|MP:0000751,myopathy|MP:0001052,abnormal innervation pattern to muscle|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0002269,muscular atrophy|MP:0003632,abnormal nervous system morphology|MP:0004087,abnormal muscle fiber morphology|MP:0008069,abnormal joint mobility
MGI:2681649	Pmaip1<tm1Ast>	MP:0003631,nervous system phenotype|MP:0005068,abnormal NK cell morphology|MP:0005387,immune system phenotype|MP:0008944,decreased sensitivity to induced cell death
MGI:2678372	Pmaip1<tm1Ttg>	MP:0002006,neoplasm|MP:0003010,decreased mortality induced by ionizing radiation|MP:0004587,decreased cellular sensitivity to X-ray irradiation|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008944,decreased sensitivity to induced cell death
MGI:5692912	Pmch<tm1.1(KOMP)Vlcg>	MP:0000274,enlarged heart|MP:0002135,abnormal kidney morphology|MP:0010123,increased bone mineral content
MGI:2445313	Pmch<tm1Emf>	MP:0001262,decreased body weight|MP:0005289,increased oxygen consumption|MP:0005318,decreased triglyceride level|MP:0005668,decreased circulating leptin level|MP:0010180,increased susceptibility to weight loss|MP:0011940,decreased food intake
MGI:1857040	Pmel<si>	MP:0000372,irregular coat pigmentation|MP:0001186,pigmentation phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0008732,reduced hair shaft melanin granule number
MGI:5294792	Pmel<tm1.1Sson>	MP:0000371,diluted coat color|MP:0005075,abnormal melanosome morphology|MP:0009933,abnormal tail hair pigmentation|MP:0010192,abnormal retina melanin granule morphology|MP:0010193,abnormal choroid melanin granule morphology
MGI:5637220	Pmel<tm1b(EUCOMM)Wtsi>	MP:0001488,increased startle reflex|MP:0005344,increased circulating bilirubin level|MP:0010025,decreased total body fat amount
MGI:7491928	Pmepa1<em1Akt>	MP:0001541,abnormal osteoclast physiology|MP:0004985,decreased osteoclast cell number|MP:0004993,decreased bone resorption|MP:0008396,abnormal osteoclast differentiation|MP:0010875,increased bone volume
MGI:5614705	Pmepa1<tm2b(EUCOMM)Hmgu>	MP:0000195,decreased circulating calcium level|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0011965,decreased total retina thickness
MGI:6259647	Pmfbp1<em1Wli>	MP:0001925,male infertility|MP:0005389,reproductive system phenotype|MP:0009234,absent sperm head|MP:0009830,abnormal sperm connecting piece morphology|MP:0009838,abnormal sperm axoneme morphology
MGI:6681928	Pmfbp1<em#Jfw>	MP:0001925,male infertility|MP:0009234,absent sperm head|MP:0009838,abnormal sperm axoneme morphology|MP:0014468,disorganized sperm mitochondrial sheath
MGI:5429746	Pmis2<tm1Osb>	MP:0001925,male infertility|MP:0003698,abnormal male reproductive system physiology|MP:0005386,behavior/neurological phenotype|MP:0009647,decreased fertilization frequency|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031012,impaired sperm migration in female genital tract
MGI:6195046	Pml<tm1.1Ews>	MP:0002006,neoplasm|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0003701,elevated level of mitotic sister chromatid exchange|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0004809,increased hematopoietic stem cell number|MP:0008886,abnormal PML bodies|MP:0014764,impaired double-strand DNA break repair
MGI:5014059	Pml<tm1(PML/RARA)Ley>	MP:0000691,enlarged spleen|MP:0002026,increased leukemia incidence|MP:0002169,no abnormal phenotype detected|MP:0004810,decreased hematopoietic stem cell number|MP:0005397,hematopoietic system phenotype|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011091,prenatal lethality, complete penetrance
MGI:2429949	Pml<tm1Ppp>	MP:0000221,decreased leukocyte cell number|MP:0000334,decreased granulocyte number|MP:0000716,abnormal immune system cell morphology|MP:0001601,abnormal myelopoiesis|MP:0002020,increased tumor incidence|MP:0002412,increased susceptibility to bacterial infection|MP:0004809,increased hematopoietic stem cell number|MP:0005621,abnormal cell physiology|MP:0011703,increased fibroblast proliferation|MP:0012431,increased lymphoma incidence|MP:0014764,impaired double-strand DNA break repair
MGI:3663169	Pmm1<tm1Gmat>	MP:0002169,no abnormal phenotype detected
MGI:5311936	Pmm2<tm1.1Cknr>	MP:0002169,no abnormal phenotype detected
MGI:5811780	Pmm2<tm1.1Jins>	MP:0011101,prenatal lethality, incomplete penetrance
MGI:5605770	Pmm2<tm1b(EUCOMM)Hmgu>	MP:0000702,enlarged lymph nodes|MP:0005565,increased blood urea nitrogen level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3663170	Pmm2<tm1Cthl>	MP:0003718,maternal effect|MP:0011092,embryonic lethality, complete penetrance
MGI:5311938	Pmm2<tm2.1Cknr>	MP:0011092,embryonic lethality, complete penetrance
MGI:5811781	Pmm2<tm2.1Jins>	MP:0011091,prenatal lethality, complete penetrance
MGI:5427467	Pmp22<M1247Lja>	MP:0000745,tremors
MGI:5425012	Pmp22<Mhdatre002>	MP:0000745,tremors|MP:0002968,increased circulating alkaline phosphatase level
MGI:3614822	Pmp22<tm1Lnot>	MP:0000745,tremors|MP:0000747,muscle weakness|MP:0000755,hindlimb paralysis|MP:0000921,demyelination|MP:0001106,abnormal Schwann cell morphology|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002566,abnormal sexual interaction|MP:0002882,abnormal neuron morphology|MP:0003871,abnormal myelin sheath morphology|MP:0005404,abnormal axon morphology
MGI:2447704	Pmp22<tm1Ueli>	MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000920,abnormal myelination|MP:0000947,convulsive seizures|MP:0001106,abnormal Schwann cell morphology|MP:0001516,abnormal motor coordination/balance|MP:0003871,abnormal myelin sheath morphology|MP:0005402,abnormal action potential|MP:0005404,abnormal axon morphology|MP:0008814,decreased nerve conduction velocity|MP:0011904,abnormal Schwann cell physiology|MP:0011906,increased Schwann cell proliferation
MGI:1856216	Pmp22<Tr>	MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000756,forelimb paralysis|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0000947,convulsive seizures|MP:0001106,abnormal Schwann cell morphology|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0002064,seizures|MP:0010768,mortality/aging|MP:0011083,lethality at weaning, complete penetrance
MGI:1862010	Pmp22<Tr-1H>	MP:0000745,tremors|MP:0000921,demyelination|MP:0001106,abnormal Schwann cell morphology|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0005405,axon degeneration|MP:0010053,decreased grip strength
MGI:1862011	Pmp22<Tr-2H>	MP:0000745,tremors|MP:0000921,demyelination|MP:0001106,abnormal Schwann cell morphology|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0005405,axon degeneration|MP:0010053,decreased grip strength
MGI:5515890	Pmp22<Tr-2J>	MP:0000745,tremors|MP:0000921,demyelination|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001922,reduced male fertility|MP:0001967,deafness|MP:0005371,limbs/digits/tail phenotype|MP:0005391,vision/eye phenotype|MP:0006325,impaired hearing|MP:0010768,mortality/aging|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012051,spasticity
MGI:2388488	Pmp22<Tr-3H>	MP:0000745,tremors|MP:0000921,demyelination|MP:0001106,abnormal Schwann cell morphology|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0005405,axon degeneration|MP:0010053,decreased grip strength
MGI:1856217	Pmp22<Tr-J>	MP:0000745,tremors|MP:0000749,muscle degeneration|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001106,abnormal Schwann cell morphology|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0002082,postnatal lethality|MP:0005402,abnormal action potential|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0005621,abnormal cell physiology|MP:0008260,abnormal autophagy|MP:0008770,decreased survivor rate|MP:0010742,increased Schwann cell number|MP:0011731,decreased myelin sheath thickness|MP:0013438,dysmyelination
MGI:1856420	Pmp22<Tr-Ncnp>	MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001106,abnormal Schwann cell morphology|MP:0001406,abnormal gait
MGI:5803681	Pmp2<tm1.1(KOMP)Vlcg>	MP:0002118,abnormal lipid homeostasis|MP:0005386,behavior/neurological phenotype|MP:0008814,decreased nerve conduction velocity
MGI:6149992	Pmpca<em1(IMPC)J>	MP:0000194,increased circulating calcium level|MP:0001284,absent vibrissae|MP:0001529,abnormal vocalization|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5286662	Pmpcb<Tg(Tyr)2364D-3a1Ove>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:5587049	Pmpcb<tm1b(EUCOMM)Hmgu>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:1857948	Pms1<tm1Lisk>	MP:0002006,neoplasm
MGI:6764550	Pms2<tm1.1Sks>	MP:0005389,reproductive system phenotype
MGI:4819008	Pms2<tm1.1Wed>	MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002947,increased hemangioma incidence|MP:0003324,increased liver adenoma incidence|MP:0004816,abnormal class switch recombination|MP:0005389,reproductive system phenotype|MP:0008058,abnormal DNA repair|MP:0009308,increased adenocarcinoma incidence|MP:0012431,increased lymphoma incidence|MP:0014766,impaired mismatch repair
MGI:1857947	Pms2<tm1Lisk>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002023,increased B cell derived lymphoma incidence|MP:0002032,increased sarcoma incidence|MP:0002038,increased carcinoma incidence|MP:0002083,premature death|MP:0002216,abnormal seminiferous tubule morphology|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0004499,increased incidence of tumors by chemical induction|MP:0004816,abnormal class switch recombination|MP:0004901,decreased male germ cell number|MP:0005169,abnormal male meiosis|MP:0005578,teratozoospermia|MP:0005621,abnormal cell physiology|MP:0008058,abnormal DNA repair|MP:0008866,chromosomal instability|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009797,abnormal mismatch repair|MP:0012431,increased lymphoma incidence|MP:0014766,impaired mismatch repair
MGI:5538273	Pms2<tm2(cre)Lisk>	MP:0002083,premature death
MGI:1856998	pn	MP:0000088,short mandible|MP:0000109,abnormal parietal bone morphology|MP:0000157,abnormal sternum morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000346,broad head|MP:0000435,shortened head|MP:0000443,abnormal snout morphology|MP:0000458,abnormal mandible morphology|MP:0001211,wrinkled skin|MP:0001262,decreased body weight|MP:0001386,abnormal maternal nurturing|MP:0001919,abnormal reproductive system physiology|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002116,abnormal craniofacial bone morphology|MP:0002161,abnormal fertility/fecundity|MP:0002907,abnormal parturition|MP:0003743,abnormal facial morphology|MP:0003956,abnormal body size|MP:0004379,wide frontal bone|MP:0004380,short frontal bone|MP:0004726,abnormal nasal capsule morphology|MP:0008779,abnormal maternal behavior|MP:0030049,prominent forehead
MGI:1856999	pnc	MP:0002079,increased circulating insulin level|MP:0002082,postnatal lethality|MP:0005324,ascites|MP:0008770,decreased survivor rate
MGI:5548467	Pnck<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0005574,decreased pulmonary respiratory rate|MP:0005576,decreased pulmonary ventilation|MP:0005586,decreased tidal volume|MP:0010123,increased bone mineral content
MGI:3525308	Pnhdlc1<C57BL/6J>	MP:0000180,abnormal circulating cholesterol level
MGI:3525310	Pnhdlc2<C57BL/6J>	MP:0000180,abnormal circulating cholesterol level
MGI:3525313	Pnhdlc3<CASA/RkJ>	MP:0000180,abnormal circulating cholesterol level
MGI:7431379	Pnisr<em1(IMPC)Ccpcz>	MP:0000438,abnormal cranium morphology|MP:0001399,hyperactivity|MP:0002060,abnormal skin morphology|MP:0003961,decreased lean body mass|MP:0011100,preweaning lethality, complete penetrance
MGI:5006973	Pnkd<tm1Ljp>	MP:0001905,abnormal dopamine level|MP:0005386,behavior/neurological phenotype
MGI:7425920	Pnkp<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003604,single kidney|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5795744	Pnkp<tm1.1Pmc>	MP:0000352,decreased cell proliferation|MP:0000774,decreased brain size|MP:0000920,abnormal myelination|MP:0001265,decreased body size|MP:0001915,intracranial hemorrhage|MP:0004097,abnormal cerebellar cortex morphology|MP:0004101,abnormal brain interneuron morphology|MP:0008058,abnormal DNA repair|MP:0008948,decreased neuron number|MP:0009808,decreased oligodendrocyte number|MP:0011085,postnatal lethality, complete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0014178,increased brain apoptosis|MP:0014764,impaired double-strand DNA break repair|MP:0014768,impaired single-strand DNA break repair
MGI:5795742	Pnkp<tm1Pmc>	MP:0000352,decreased cell proliferation|MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000852,small cerebellum|MP:0004097,abnormal cerebellar cortex morphology|MP:0014178,increased brain apoptosis|MP:0014760,impaired DNA repair|MP:0014764,impaired double-strand DNA break repair|MP:0014768,impaired single-strand DNA break repair
MGI:5795746	Pnkp<tm2.1Pmc>	MP:0011092,embryonic lethality, complete penetrance
MGI:6266820	Pnldc1<em1(IMPC)Bay>	MP:0001312,abnormal cornea morphology|MP:0001925,male infertility|MP:0011962,increased cornea thickness
MGI:6159916	Pnldc1<em1Nkn>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0005378,growth/size/body region phenotype|MP:0008877,abnormal DNA methylation|MP:0010768,mortality/aging
MGI:6159928	Pnldc1<em2Nkn>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0008877,abnormal DNA methylation
MGI:6356882	Pnliprp1<tm1Smoc>	MP:0001260,increased body weight|MP:0001261,obese|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005378,growth/size/body region phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005658,increased susceptibility to diet-induced obesity|MP:0009118,increased white fat cell size|MP:0010934,increased subcutaneous adipose tissue amount|MP:0014142,increased body fat mass|MP:0020411,increased abdominal adipose tissue amount
MGI:1857970	Pnliprp2<tm1Gru>	MP:0001732,postnatal growth retardation|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005342,abnormal intestinal lipid absorption
MGI:2681122	Pnlip<tm1Dyh>	MP:0002647,decreased intestinal cholesterol absorption|MP:0002727,decreased circulating insulin level|MP:0003402,decreased liver weight|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005331,insulin resistance|MP:0005342,abnormal intestinal lipid absorption|MP:0005365,abnormal bile salt homeostasis|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0014480,increased feces cholesterol level
MGI:6156151	Pnma3<em1(IMPC)Rbrc>	MP:0008820,abnormal blood uric acid level
MGI:7539665	Pnma8b<em1(IMPC)Tcp>	MP:0000222,decreased neutrophil cell number|MP:0001289,persistence of hyaloid vascular system|MP:0002092,abnormal eye morphology|MP:0002792,abnormal retina vasculature morphology|MP:0005013,increased lymphocyte cell number|MP:0009142,decreased prepulse inhibition|MP:0010097,abnormal retina blood vessel morphology
MGI:5523412	Pnmt<tm1.1(KOMP)Vlcg>	MP:0001303,abnormal lens morphology|MP:0005292,improved glucose tolerance|MP:0005633,increased circulating sodium level
MGI:3510456	Pnmt<tm1(cre)Sne>	MP:0012575,increased noradrenaline level|MP:0030762,decreased adrenaline level
MGI:3810658	Pnmt<tm1(cre)Xbao>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000231,hypertension|MP:0002953,thick ventricular wall|MP:0005376,homeostasis/metabolism phenotype|MP:0005406,abnormal heart size|MP:0012575,increased noradrenaline level
MGI:5449442	Pnmt<tm2.1Sne>	MP:0002169,no abnormal phenotype detected
MGI:5695886	Pnn<tm1.1(KOMP)Vlcg>	MP:0010378,increased respiratory quotient|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4455342	Pnn<tm1.2Sps>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4455340	Pnn<tm1Sps>	MP:0000111,cleft palate|MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000284,double outlet right ventricle|MP:0000379,decreased hair follicle number|MP:0001243,abnormal dermal layer morphology|MP:0001244,thin dermal layer|MP:0001780,decreased brown adipose tissue amount|MP:0001785,edema|MP:0002633,persistent truncus arteriosus|MP:0003984,embryonic growth retardation|MP:0004110,transposition of great arteries|MP:0004616,lumbar vertebral transformation|MP:0006126,abnormal cardiac outflow tract development|MP:0010402,ventricular septal defect|MP:0010771,integument phenotype|MP:0011089,perinatal lethality, complete penetrance
MGI:5465466	Pno1<tm1Jwu>	MP:0001730,embryonic growth arrest|MP:0005387,immune system phenotype|MP:0011092,embryonic lethality, complete penetrance
MGI:2679470	Pnoc<tm1Jep>	MP:0009746,enhanced behavioral response to xenobiotic
MGI:2181778	Pnoc<tm1Rkr>	MP:0002734,abnormal mechanical nociception
MGI:7520368	Pnp2<em1Smoc>	MP:0005387,immune system phenotype
MGI:5468722	Pnp<bata>	MP:0005093,decreased B cell proliferation|MP:0008182,decreased marginal zone B cell number|MP:0010186,increased T follicular helper cell number
MGI:3777967	Pnp<e>	MP:0001823,thymus hypoplasia|MP:0002442,abnormal leukocyte physiology|MP:0011476,abnormal urine nucleotide level|MP:0011597,decreased purine-nucleoside phosphorylase activity
MGI:3777968	Pnp<f>	MP:0000217,abnormal leukocyte cell number|MP:0001823,thymus hypoplasia|MP:0002442,abnormal leukocyte physiology|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0011476,abnormal urine nucleotide level|MP:0011597,decreased purine-nucleoside phosphorylase activity
MGI:3777975	Pnp<g>	MP:0000217,abnormal leukocyte cell number|MP:0001823,thymus hypoplasia|MP:0002442,abnormal leukocyte physiology|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011597,decreased purine-nucleoside phosphorylase activity
MGI:3777976	Pnp<h>	MP:0011597,decreased purine-nucleoside phosphorylase activity
MGI:3777978	Pnp<i>	MP:0011597,decreased purine-nucleoside phosphorylase activity
MGI:5904454	Pnpla1<tm1.1Fpwr>	MP:0001190,reddish skin|MP:0001196,shiny skin|MP:0001211,wrinkled skin|MP:0001216,abnormal epidermal layer morphology|MP:0001242,hyperkeratosis|MP:0001402,decreased locomotor activity|MP:0001698,decreased embryo size|MP:0001874,acanthosis|MP:0002060,abnormal skin morphology|MP:0002796,impaired skin barrier function|MP:0003853,dry skin|MP:0003941,abnormal skin development|MP:0009429,decreased embryo weight|MP:0009546,absent gastric milk in neonates|MP:0009597,impaired stratum corneum desquamation|MP:0011087,neonatal lethality, complete penetrance|MP:0012232,abnormal ceramide level|MP:0013177,abnormal tail tip morphology
MGI:5906480	Pnpla1<tm1.1Murm>	MP:0001230,epidermal desquamation|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0002796,impaired skin barrier function|MP:0011085,postnatal lethality, complete penetrance|MP:0012232,abnormal ceramide level
MGI:5085354	Pnpla1<tm1a(KOMP)Wtsi>	MP:0001196,shiny skin|MP:0001198,tight skin|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001874,acanthosis|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002796,impaired skin barrier function|MP:0003773,eclabion|MP:0005282,decreased fatty acids level|MP:0009546,absent gastric milk in neonates|MP:0009596,abnormal stratum corneum lipid matrix formation|MP:0009597,impaired stratum corneum desquamation|MP:0009605,decreased keratohyalin granule number|MP:0009607,decreased keratohyalin granule size|MP:0009674,decreased birth weight|MP:0009823,abnormal sphingomyelin level|MP:0010358,abnormal free fatty acids level|MP:0011087,neonatal lethality, complete penetrance|MP:0012232,abnormal ceramide level
MGI:5548905	Pnpla1<tm1b(KOMP)Wtsi>	MP:0001257,increased body length|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5906479	Pnpla1<tm1Murm>	MP:0001196,shiny skin|MP:0001198,tight skin|MP:0001222,epidermal hyperplasia|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0002796,impaired skin barrier function|MP:0003982,increased cholesterol level|MP:0005317,increased triglyceride level|MP:0009602,abnormal keratohyalin granule morphology|MP:0009605,decreased keratohyalin granule number|MP:0009608,abnormal epidermal lamellar body morphology|MP:0010358,abnormal free fatty acids level|MP:0011087,neonatal lethality, complete penetrance|MP:0012232,abnormal ceramide level|MP:0013177,abnormal tail tip morphology
MGI:5296237	Pnpla2<tm1.1Hsul>	MP:0000005,increased brown adipose tissue amount|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0002971,abnormal brown adipose tissue morphology|MP:0005288,abnormal oxygen consumption|MP:0005290,decreased oxygen consumption|MP:0005455,increased susceptibility to weight gain|MP:0005560,decreased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005666,abnormal adipose tissue physiology|MP:0008033,impaired lipolysis|MP:0008908,increased total fat pad weight|MP:0009118,increased white fat cell size|MP:0009119,increased brown fat cell size|MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009302,increased renal fat pad weight|MP:0011049,impaired adaptive thermogenesis|MP:0014172,decreased fatty acid oxidation|MP:0030017,decreased adipocyte glucose uptake
MGI:5294351	Pnpla2<tm1Eek>	MP:0001547,abnormal lipid level|MP:0002833,increased heart weight|MP:0005281,increased fatty acids level|MP:0031415,increased skeletal muscle triglyceride level|MP:0031418,increased cardiac muscle triglyceride level
MGI:5427437	Pnpla2<tm1Gam>	MP:0000607,abnormal hepatocyte morphology|MP:0001554,increased circulating free fatty acids level|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0009355,increased liver triglyceride level|MP:0012236,abnormal cholangiocyte morphology|MP:0014172,decreased fatty acid oxidation|MP:0020234,decreased basal metabolism|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis
MGI:3629035	Pnpla2<tm1Rze>	MP:0000005,increased brown adipose tissue amount|MP:0000008,increased white adipose tissue amount|MP:0000186,decreased circulating HDL cholesterol level|MP:0000188,abnormal circulating glucose level|MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0001260,increased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0001560,abnormal circulating insulin level|MP:0001625,cardiac hypertrophy|MP:0001764,abnormal homeostasis|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002127,abnormal cardiovascular system morphology|MP:0002626,increased heart rate|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002833,increased heart weight|MP:0002891,increased insulin sensitivity|MP:0002970,abnormal white adipose tissue morphology|MP:0002971,abnormal brown adipose tissue morphology|MP:0003141,cardiac fibrosis|MP:0003221,abnormal cardiomyocyte apoptosis|MP:0003915,increased heart left ventricle weight|MP:0003948,abnormal gas homeostasis|MP:0003976,decreased circulating VLDL triglyceride level|MP:0004129,abnormal respiratory quotient|MP:0004215,abnormal myocardial fiber physiology|MP:0005266,abnormal metabolism|MP:0005281,increased fatty acids level|MP:0005290,decreased oxygen consumption|MP:0005291,abnormal glucose tolerance|MP:0005292,improved glucose tolerance|MP:0005294,abnormal heart ventricle morphology|MP:0005317,increased triglyceride level|MP:0005329,abnormal myocardium layer morphology|MP:0005418,abnormal circulating hormone level|MP:0005560,decreased circulating glucose level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005598,decreased heart ventricle muscle contractility|MP:0005669,increased circulating leptin level|MP:0006087,increased body mass index|MP:0006138,congestive heart failure|MP:0008033,impaired lipolysis|MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009294,increased interscapular fat pad weight|MP:0009355,increased liver triglyceride level|MP:0010018,pulmonary vascular congestion|MP:0010378,increased respiratory quotient|MP:0010724,thick interventricular septum|MP:0010771,integument phenotype|MP:0011049,impaired adaptive thermogenesis|MP:0012270,cardiac edema|MP:0014071,increased cardiac muscle glycogen level|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0031418,increased cardiac muscle triglyceride level|MP:0031633,decreased heart left ventricle muscle contractility
MGI:6197539	Pnpla3<tm1.1Hobb>	MP:0002628,hepatic steatosis|MP:0005281,increased fatty acids level|MP:0005376,homeostasis/metabolism phenotype|MP:0009115,abnormal fat cell morphology|MP:0009355,increased liver triglyceride level
MGI:4939497	Pnpla3<tm1Eek>	MP:0005376,homeostasis/metabolism phenotype
MGI:6197540	Pnpla3<tm2.1Hobb>	MP:0002628,hepatic steatosis|MP:0009115,abnormal fat cell morphology|MP:0009355,increased liver triglyceride level
MGI:6276944	Pnpla5<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen
MGI:2655812	Pnpla6<tm1Blw>	MP:0001399,hyperactivity|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002574,increased vertical activity|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0005386,behavior/neurological phenotype|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0031391,increased locomotor activity
MGI:3028797	Pnpla6<tm1Mos>	MP:0000291,enlarged pericardium|MP:0001622,abnormal vasculogenesis|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001712,abnormal placenta development|MP:0001713,decreased trophoblast giant cell number|MP:0001718,abnormal visceral yolk sac morphology|MP:0001915,intracranial hemorrhage|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002584,small ectoplacental cone|MP:0002836,abnormal chorion morphology|MP:0003403,absent placental labyrinth|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004068,dilated dorsal aorta|MP:0004560,abnormal chorionic plate morphology|MP:0004938,dilated vasculature|MP:0005033,abnormal trophoblast giant cell morphology|MP:0005657,abnormal neural plate morphology|MP:0006042,increased apoptosis|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009656,delayed chorioallantoic fusion|MP:0009658,increased placenta apoptosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3040330	Pnpla6<tm1Mvc>	MP:0000807,abnormal hippocampus morphology|MP:0000832,abnormal thalamus morphology|MP:0000880,decreased Purkinje cell number|MP:0001262,decreased body weight|MP:0001516,abnormal motor coordination/balance|MP:0002229,neurodegeneration|MP:0002878,abnormal corticospinal tract morphology|MP:0002882,abnormal neuron morphology|MP:0003491,abnormal voluntary movement|MP:0004777,abnormal phospholipid level|MP:0005404,abnormal axon morphology|MP:0009683,abnormal lateral corticospinal tract morphology
MGI:7439459	Pnpla7<tm1.1Murm>	MP:0030753,decreased choline level
MGI:7439460	Pnpla7<tm1.2Murm>	MP:0000160,kyphosis|MP:0001263,weight loss|MP:0001399,hyperactivity|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002575,increased circulating ketone body level|MP:0002727,decreased circulating insulin level|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005289,increased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005452,abnormal adipose tissue amount|MP:0005478,decreased circulating thyroxine level|MP:0005534,decreased body temperature|MP:0005560,decreased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009356,decreased liver triglyceride level|MP:0010379,decreased respiratory quotient|MP:0010400,increased liver glycogen level|MP:0011939,increased food intake|MP:0011969,abnormal circulating triglyceride level|MP:0020521,browned white adipose tissue morphology|MP:0030753,decreased choline level|MP:0030968,decreased circulating adiponectin level
MGI:3769265	Pnpla8<tm1Rigr>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002644,decreased circulating triglyceride level|MP:0005534,decreased body temperature|MP:0005560,decreased circulating glucose level|MP:0006036,abnormal mitochondrial physiology|MP:0008489,slow postnatal weight gain|MP:0009356,decreased liver triglyceride level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010957,abnormal aerobic respiration|MP:0011049,impaired adaptive thermogenesis|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012106,impaired exercise endurance|MP:0030753,decreased choline level
MGI:6199970	Pnp<M1Btlr>	MP:0002494,increased IgM level|MP:0020154,impaired humoral immune response
MGI:6199974	Pnp<m2Btlr>	MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008168,decreased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0008207,decreased B-2 B cell number|MP:0010838,increased CD8-positive, alpha-beta memory T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:4882056	Pnpt1<tm1.1Teit>	MP:0006036,abnormal mitochondrial physiology|MP:0008762,embryonic lethality
MGI:4364657	Pnpt1<tm1a(KOMP)Wtsi>	MP:0000150,abnormal rib morphology|MP:0002590,increased mean corpuscular volume|MP:0005298,abnormal clavicle morphology|MP:0005561,increased mean corpuscular hemoglobin
MGI:4882055	Pnpt1<tm1Teit>	MP:0002169,no abnormal phenotype detected|MP:0006036,abnormal mitochondrial physiology|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011635,abnormal mitochondrial crista morphology
MGI:2386195	Pnp<tm1Cmr>	MP:0001601,abnormal myelopoiesis|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0003132,increased pre-B cell number|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006036,abnormal mitochondrial physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0009541,increased thymocyte apoptosis|MP:0011477,abnormal urine nucleoside level|MP:0011597,decreased purine-nucleoside phosphorylase activity|MP:0014760,impaired DNA repair
MGI:3771820	Pnrc2<tm1Shch>	MP:0001262,decreased body weight|MP:0001431,abnormal eating behavior|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005334,abnormal fat pad morphology|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0009115,abnormal fat cell morphology|MP:0009283,decreased gonadal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0010180,increased susceptibility to weight loss|MP:0020523,decreased susceptibility to induced hypothermia|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:1861167	Po	MP:0000562,polydactyly
MGI:3775523	Poats1<C57BL/6JCrl>	MP:0002031,increased adrenal gland tumor incidence
MGI:2135614	Poc1a<cha>	MP:0001116,small gonad|MP:0001155,arrest of spermatogenesis|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002427,disproportionate dwarf|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004686,decreased length of long bones|MP:0004708,short lumbar vertebrae|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0006396,decreased long bone epiphyseal plate size|MP:0011100,preweaning lethality, complete penetrance
MGI:5630068	Poc1a<tm1.1(KOMP)Mbp>	MP:0001925,male infertility|MP:0001926,female infertility|MP:0002959,increased urine microalbumin level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:7528727	Poc1b<em1Xjzha>	MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009239,short sperm flagellum|MP:0009831,abnormal sperm midpiece morphology|MP:0009837,abnormal sperm end piece morphology|MP:0014636,decreased elongated spermatid number|MP:0020869,immotile sperm|MP:0031352,absent sperm axonemal central pair|MP:0031356,abnormal outer dense fiber morphology
MGI:6324185	Poc1b<tm1b(KOMP)Wtsi>	MP:0001944,abnormal pancreas morphology
MGI:5755027	Poc5<em1(IMPC)Tcp>	MP:0001126,abnormal ovary morphology|MP:0001147,small testis|MP:0001417,decreased exploration in new environment|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5605822	Podn<tm1b(KOMP)Wtsi>	MP:0001319,irregularly shaped pupil|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011960,abnormal eye anterior chamber depth
MGI:5569957	Podxl2<tm1.1(KOMP)Vlcg>	MP:0000219,increased neutrophil cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002135,abnormal kidney morphology
MGI:4842467	Podxl2<tm1a(EUCOMM)Wtsi>	MP:0005367,renal/urinary system phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:6153807	Podxl<em1(IMPC)H>	MP:0001325,abnormal retina morphology|MP:0002874,decreased hemoglobin content|MP:0010067,increased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance
MGI:2182833	Podxl<tm1Kmn>	MP:0002192,hydrops fetalis|MP:0002842,increased systemic arterial blood pressure|MP:0003052,omphalocele|MP:0003624,anuria|MP:0008061,absent podocyte slit diaphragm|MP:0008138,absent podocyte foot process|MP:0011087,neonatal lethality, complete penetrance
MGI:4442892	Podxl<tm1Parl>	MP:0002169,no abnormal phenotype detected|MP:0003658,abnormal capillary morphology|MP:0004181,abnormal carotid artery morphology|MP:0011380,enlarged brain ventricles
MGI:5694686	Podxl<tm2Kmn>	MP:0001175,abnormal lung morphology|MP:0001183,overexpanded pulmonary alveolus|MP:0001942,abnormal lung volume|MP:0002169,no abnormal phenotype detected|MP:0003070,increased vascular permeability|MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0010935,increased airway resistance|MP:0011136,increased lung endothelial cell adhesion|MP:0011137,decreased lung endothelial cell adhesion|MP:0011641,abnormal pulmonary collagen fibril morphology
MGI:6423826	Pof1b<em1(IMPC)Mbp>	MP:0000194,increased circulating calcium level|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney
MGI:5008640	Pof1b<tm1Toni>	MP:0002169,no abnormal phenotype detected
MGI:3719000	Pofut1<cax>	MP:0000154,rib fusion|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001258,decreased body length|MP:0001688,abnormal somite development|MP:0004606,absent vertebral spinous process|MP:0004610,small vertebrae|MP:0004703,abnormal vertebral column morphology|MP:0005222,abnormal somite size|MP:0005223,abnormal dorsal-ventral polarity of the somites|MP:0005380,embryo phenotype|MP:0008832,hemivertebra
MGI:3808705	Pofut1<tm1.1Ysa>	MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0001614,abnormal blood vessel morphology|MP:0001688,abnormal somite development|MP:0002151,abnormal neural tube morphology|MP:0003984,embryonic growth retardation|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2662305	Pofut1<tm1Pst>	MP:0000267,abnormal heart development|MP:0000292,distended pericardium|MP:0001622,abnormal vasculogenesis|MP:0001691,abnormal somite shape|MP:0001719,absent vitelline blood vessels|MP:0002740,heart hypoplasia|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0004251,failure of heart looping|MP:0005222,abnormal somite size|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011733,fused somites|MP:0012254,absent intersomitic vessels
MGI:3808704	Pofut1<tm1Ysa>	MP:0000267,abnormal heart development|MP:0000297,abnormal atrioventricular cushion morphology|MP:0006207,embryonic lethality during organogenesis|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0010503,myocardial trabeculae hypoplasia
MGI:3617318	Pofut1<tm2Pst>	MP:0001242,hyperkeratosis|MP:0003414,epidermal cyst|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0006269,abnormal mammary gland growth during pregnancy
MGI:3604508	Pofut2<Gt(OST231463)Lex>	MP:0011092,embryonic lethality, complete penetrance
MGI:4127173	Pofut2<Gt(RST434)Byg>	MP:0001672,abnormal embryo development|MP:0001675,abnormal ectoderm development|MP:0002582,disorganized extraembryonic tissue|MP:0003543,abnormal vascular endothelial cell differentiation|MP:0003886,abnormal embryonic epiblast morphology|MP:0003954,abnormal Reichert's membrane morphology|MP:0003988,disorganized embryonic tissue|MP:0004229,abnormal embryonic erythropoiesis|MP:0008533,abnormal anterior visceral endoderm morphology|MP:0008872,abnormal physiological response to xenobiotic|MP:0009331,absent primitive node|MP:0010736,abnormal extraembryonic ectoderm morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5812116	Pofut2<tm2.2Bch>	MP:0001683,absent mesoderm|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002582,disorganized extraembryonic tissue|MP:0003988,disorganized embryonic tissue|MP:0008533,abnormal anterior visceral endoderm morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0014134,abnormal embryo morphology
MGI:5812115	Pofut2<tm2Bch>	MP:0008762,embryonic lethality
MGI:6257495	Poglut1<em1(IMPC)Bay>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3942939	Poglut1<Gt(IST10323G11)Tigm>	MP:0000259,abnormal vascular development|MP:0000267,abnormal heart development|MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0002084,abnormal developmental patterning|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004180,failure of initiation of embryo turning|MP:0004187,cardia bifida|MP:0004787,abnormal dorsal aorta morphology|MP:0004837,abnormal neural fold formation|MP:0005657,abnormal neural plate morphology|MP:0006386,absent somites|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012254,absent intersomitic vessels|MP:0012498,abnormal cardiogenic plate morphology
MGI:2137554	Poglut1<wsnp>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0005657,abnormal neural plate morphology|MP:0006386,absent somites|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0012183,decreased paraxial mesoderm size|MP:0012272,decreased axial mesoderm size
MGI:7465080	Poglut2<tm2d(EUCOMM)Hmgu>	MP:0002169,no abnormal phenotype detected
MGI:7465087	Poglut3<tm1.3Rsh>	MP:0002169,no abnormal phenotype detected
MGI:2148487	pogo	MP:0000864,abnormal cerebellum vermis morphology|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001504,abnormal posture|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0030737,decreased glutamic acid level
MGI:7615290	Pogz<em1Tnkw>	MP:0000774,decreased brain size|MP:0000859,abnormal somatosensory cortex morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001441,increased grooming behavior|MP:0001529,abnormal vocalization|MP:0002062,abnormal associative learning|MP:0002175,decreased brain weight|MP:0003461,abnormal response to novel object|MP:0004924,abnormal behavior|MP:0005369,muscle phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005380,embryo phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005386,behavior/neurological phenotype|MP:0005388,respiratory system phenotype|MP:0005390,skeleton phenotype|MP:0005391,vision/eye phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0009703,decreased birth body size|MP:0010402,ventricular septal defect|MP:0011091,prenatal lethality, complete penetrance|MP:0011275,abnormal behavioral response to light|MP:0012138,decreased forebrain size|MP:0014378,increased excitatory postsynaptic current frequency|MP:0020395,abnormal response to social novelty|MP:0020507,increased dendritic spine density|MP:0020870,decreased thigmotaxis
MGI:6360952	Pogz<tm1.2Jrk>	MP:0000600,liver hypoplasia|MP:0001577,anemia|MP:0004200,decreased fetal size|MP:0011100,preweaning lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3877914	Pola1<Gt(CSG241)Byg>	MP:0002169,no abnormal phenotype detected
MGI:5614599	Pola2<tm1b(KOMP)Mbp>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5427084	Polb<tm1.1Jbsw>	MP:0000352,decreased cell proliferation|MP:0001194,dermatitis|MP:0001265,decreased body size|MP:0001870,salivary gland inflammation|MP:0002359,abnormal spleen germinal center morphology|MP:0002493,increased IgG level|MP:0002743,glomerulonephritis|MP:0003077,abnormal cell cycle|MP:0003203,increased neuron apoptosis|MP:0003865,lymph node inflammation|MP:0003887,increased hepatocyte apoptosis|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004815,abnormal somatic hypermutation frequency|MP:0008090,increased T-helper 2 cell number|MP:0008177,increased germinal center B cell number|MP:0008481,increased spleen germinal center number|MP:0008542,enlarged cervical lymph nodes|MP:0008760,abnormal immunoglobulin heavy chain V(D)J recombination|MP:0008866,chromosomal instability|MP:0008943,increased sensitivity to induced cell death|MP:0009322,increased splenocyte apoptosis|MP:0009516,enlarged salivary gland|MP:0009674,decreased birth weight|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011368,increased kidney apoptosis|MP:0011704,decreased fibroblast proliferation|MP:0013504,increased embryonic tissue cell apoptosis|MP:0014762,impaired base-excision repair
MGI:2386536	Polb<tm1.1Rsky>	MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4950969	Polb<tm1a(KOMP)Wtsi>	MP:0000282,abnormal interatrial septum morphology|MP:0000640,adrenal gland hypoplasia|MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000841,abnormal hindbrain morphology|MP:0001015,small superior cervical ganglion|MP:0001100,abnormal vagus ganglion morphology|MP:0001102,small superior vagus ganglion|MP:0001247,dermal cyst|MP:0002599,increased mean platelet volume|MP:0002951,small thyroid gland|MP:0003048,abnormal cervical vertebrae morphology|MP:0003686,abnormal eye muscle morphology|MP:0003960,increased lean body mass|MP:0004252,abnormal direction of heart looping|MP:0004269,abnormal optic cup morphology|MP:0004607,abnormal cervical atlas morphology|MP:0004613,fusion of vertebral arches|MP:0004666,absent stapedial artery|MP:0006203,eye hemorrhage|MP:0006408,dorsal root ganglion hypoplasia|MP:0008128,abnormal brain internal capsule morphology|MP:0008491,dorsal root ganglion hyperplasia|MP:0008922,abnormal cervical rib|MP:0010025,decreased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0013827,thin oculomotor nerve|MP:0013828,thin facial nerve|MP:0013829,thin splanchnic nerve|MP:0013834,thin hypoglossal nerve|MP:0013836,abnormal hypoglossal nerve topology|MP:0013841,abnormal lymphatic vessel topology|MP:0013848,subcutaneous edema|MP:0013851,abnormal Wolffian duct topology|MP:0013859,abnormal vitelline vein connection|MP:0013875,increased trigeminal neuroma incidence|MP:0013928,thin motoric part of trigeminal nerve|MP:0013952,retroesophageal left subclavian artery|MP:0013969,reduced sympathetic cervical ganglion size|MP:0013982,inverse situs of great intrathoracic arteries|MP:0014001,abnormal vertebral artery topology|MP:0014002,absent extracranial vertebral artery segment|MP:0014017,abnormal Wolffian duct connection|MP:0020500,persistent trigeminal artery
MGI:2386539	Polb<tm1Koy>	MP:0001177,atelectasis|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0001961,abnormal reflex|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003203,increased neuron apoptosis|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0006254,thin cerebral cortex|MP:0009937,abnormal neuron differentiation|MP:0011087,neonatal lethality, complete penetrance
MGI:2386535	Polb<tm1Rsky>	MP:0005387,immune system phenotype
MGI:4458032	Pold1<tm1.1Bdp>	MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0002404,increased intestinal adenoma incidence|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0008014,increased lung tumor incidence|MP:0010300,increased skin tumor incidence|MP:0012431,increased lymphoma incidence
MGI:3833575	Pold1<tm1.1Uchi>	MP:0000709,enlarged thymus|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0005380,embryo phenotype
MGI:2447628	Pold1<tm1Bdp>	MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0004207,increased squamous cell carcinoma incidence|MP:0010300,increased skin tumor incidence|MP:0012431,increased lymphoma incidence
MGI:3769033	Pold1<tm1Loeb>	MP:0002083,premature death|MP:0005330,cardiomyopathy|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3833573	Pold1<tm1Uchi>	MP:0004965,inner cell mass degeneration|MP:0005031,abnormal trophoblast layer morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:3769034	Pold1<tm2Loeb>	MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:7467225	Pold1<tyrn>	MP:0000352,decreased cell proliferation|MP:0001698,decreased embryo size|MP:0001726,abnormal allantois morphology|MP:0002085,abnormal embryonic tissue morphology|MP:0005380,embryo phenotype|MP:0012685,abnormal primitive streak elongation|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5635267	Pold2<tm1.1(KOMP)Vlcg>	MP:0001728,failure of embryo implantation|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0009687,empty decidua capsularis|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6195840	Pold3<em1Linl>	MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001694,absent egg cylinders|MP:0004029,spontaneous chromosome breakage|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0008261,arrest of male meiosis|MP:0008932,abnormal embryonic tissue physiology|MP:0010039,abnormal trophoblast giant cell proliferation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012113,decreased inner cell mass proliferation|MP:0014052,increased male germ cell apoptosis|MP:0014764,impaired double-strand DNA break repair|MP:0030927,decreased telomere length
MGI:5637026	Pold3<tm1b(EUCOMM)Wtsi>	MP:0002079,increased circulating insulin level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6259891	Pold4<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0000221,decreased leukocyte cell number
MGI:7423649	Pold4<em1Zzho>	MP:0001661,extended life span|MP:0010266,decreased liver tumor incidence
MGI:4044390	Poldip2<Gt(IST12080D9)Tigm>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000250,abnormal vasoconstriction|MP:0000272,abnormal aorta morphology|MP:0001265,decreased body size|MP:0001613,abnormal vasodilation|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009862,abnormal aorta elastic tissue morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6448070	Poldip2<tm1.1Kkgg>	MP:0010768,mortality/aging
MGI:6448071	Poldip2<tm1.2Kkgg>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:7425921	Poldip3<em1(IMPC)Bay>	MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011962,increased cornea thickness
MGI:6152617	Pole2<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001147,small testis|MP:0001297,microphthalmia|MP:0001700,abnormal embryo turning|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002151,abnormal neural tube morphology|MP:0002188,small heart|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0005293,impaired glucose tolerance|MP:0009141,increased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6273618	Pole3<em1(IMPC)J>	MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:6490633	Pole3<em1Tbo>	MP:0000715,decreased thymocyte number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005380,embryo phenotype|MP:0009339,decreased splenocyte number|MP:0010768,mortality/aging
MGI:6490634	Pole3<em2Tbo>	MP:0000715,decreased thymocyte number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005380,embryo phenotype|MP:0009339,decreased splenocyte number|MP:0010768,mortality/aging
MGI:6490635	Pole3<em3Tbo>	MP:0000692,small spleen|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0003077,abnormal cell cycle|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005092,decreased double-positive T cell number|MP:0005380,embryo phenotype|MP:0008209,decreased pre-B cell number|MP:0008215,decreased immature B cell number|MP:0008347,decreased gamma-delta T cell number|MP:0009339,decreased splenocyte number|MP:0009541,increased thymocyte apoptosis|MP:0010133,increased DN3 thymocyte number|MP:0010136,decreased DN4 thymocyte number|MP:0010768,mortality/aging|MP:0014180,abnormal thymus apoptosis
MGI:6490636	Pole3<em4Tbo>	MP:0000715,decreased thymocyte number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005380,embryo phenotype|MP:0008209,decreased pre-B cell number|MP:0008215,decreased immature B cell number|MP:0009339,decreased splenocyte number|MP:0009541,increased thymocyte apoptosis|MP:0010133,increased DN3 thymocyte number|MP:0010136,decreased DN4 thymocyte number|MP:0010768,mortality/aging|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014180,abnormal thymus apoptosis
MGI:4415417	Pole3<tm1(KOMP)Vlcg>	MP:0000060,delayed bone ossification|MP:0000592,short tail|MP:0000913,abnormal brain development|MP:0004200,decreased fetal size|MP:0004609,vertebral fusion|MP:0010133,increased DN3 thymocyte number|MP:0010136,decreased DN4 thymocyte number|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5085645	Pole4<tm1(KOMP)Vlcg>	MP:0000088,short mandible|MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000322,increased granulocyte number|MP:0000373,belly spot|MP:0000428,abnormal craniofacial morphology|MP:0000585,kinked tail|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000705,athymia|MP:0000828,abnormal fourth ventricle morphology|MP:0000852,small cerebellum|MP:0000923,abnormal roof plate morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001577,anemia|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001732,postnatal growth retardation|MP:0001802,arrested B cell differentiation|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002024,increased T cell derived lymphoma incidence|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002175,decreased brain weight|MP:0002764,short tibia|MP:0003051,curly tail|MP:0003077,abnormal cell cycle|MP:0004030,induced chromosome breakage|MP:0004200,decreased fetal size|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004619,caudal vertebral fusion|MP:0004809,increased hematopoietic stem cell number|MP:0004810,decreased hematopoietic stem cell number|MP:0004901,decreased male germ cell number|MP:0004953,decreased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005090,increased double-negative T cell number|MP:0005232,abnormal mesenteric lymph node morphology|MP:0005505,thrombocytosis|MP:0008057,abnormal DNA replication|MP:0008083,decreased single-positive T cell number|MP:0008409,increased cellular sensitivity to hydroxyurea induced cell death|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008866,chromosomal instability|MP:0009429,decreased embryo weight|MP:0009431,decreased fetal weight|MP:0009719,reduced cerebellar foliation|MP:0010250,absent thymus cortex|MP:0010865,prenatal growth retardation|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0012431,increased lymphoma incidence|MP:0012504,increased forebrain apoptosis|MP:0013504,increased embryonic tissue cell apoptosis|MP:0030049,prominent forehead
MGI:5287491	Pole<Tg(Tyr)2300A-1b1b1Ove>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:4366913	Pole<tm1.1Bdp>	MP:0000691,enlarged spleen|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0002404,increased intestinal adenoma incidence|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0008014,increased lung tumor incidence|MP:0009309,increased small intestine adenocarcinoma incidence|MP:0009314,increased colon adenocarcinoma incidence|MP:0009321,increased histiocytic sarcoma incidence|MP:0010383,increased adenoma incidence|MP:0012431,increased lymphoma incidence
MGI:6355913	Polg2<M1Rvt>	MP:0003197,nephrocalcinosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005391,vision/eye phenotype
MGI:5470227	Polg2<tm1.1Wcc>	MP:0004180,failure of initiation of embryo turning|MP:0006035,abnormal mitochondrial morphology|MP:0010955,abnormal respiratory electron transport chain|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011636,disorganized mitochondrial cristae|MP:0011639,decreased mitochondrial DNA content
MGI:4432134	Polg2<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5470226	Polg2<tm1Wcc>	MP:0002169,no abnormal phenotype detected
MGI:3046825	Polg<tm1.1Lrsn>	MP:0000066,osteoporosis|MP:0000160,kyphosis|MP:0000278,abnormal myocardial fiber morphology|MP:0000414,alopecia|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001263,weight loss|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002083,premature death|MP:0002687,oligozoospermia|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0005159,azoospermia|MP:0008389,hypochromic macrocytic anemia|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0010025,decreased total body fat amount|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011630,increased mitochondrial size
MGI:8207427	Polg<tm1.1Suom>	MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001654,hepatic necrosis|MP:0001847,brain inflammation|MP:0001860,liver inflammation|MP:0003245,abnormal GABAergic neuron morphology|MP:0003806,abnormal nucleotide metabolism|MP:0006036,abnormal mitochondrial physiology|MP:0008576,decreased circulating interferon-beta level|MP:0008578,decreased circulating interferon-gamma level|MP:0008596,increased circulating interleukin-6 level|MP:0014361,increased necroptotic process|MP:0014387,decreased neuron mitochondrial DNA content|MP:0014388,decreased hepatocyte mitochondrial DNA content|MP:0020943,increased susceptibility to Flaviviridae infection
MGI:3584444	Polg<tm1.2Lrsn>	MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:5502688	Polg<tm1Jiha>	MP:0000160,kyphosis|MP:0002021,increased incidence of induced tumors|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0003674,oxidative stress|MP:0005560,decreased circulating glucose level|MP:0009278,abnormal bone marrow cell physiology|MP:0010768,mortality/aging|MP:0010771,integument phenotype|MP:0010959,abnormal oxidative phosphorylation|MP:0013405,increased circulating lactate level
MGI:3583920	Polg<tm1Prol>	MP:0000066,osteoporosis|MP:0000160,kyphosis|MP:0000248,macrocytosis|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000715,decreased thymocyte number|MP:0001263,weight loss|MP:0001824,abnormal thymus involution|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0002401,abnormal lymphopoiesis|MP:0002590,increased mean corpuscular volume|MP:0002811,macrocytic anemia|MP:0002857,cochlear ganglion degeneration|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003205,testicular atrophy|MP:0003786,premature aging|MP:0004362,cochlear hair cell degeneration|MP:0004363,stria vascularis degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004748,increased susceptibility to age-related hearing loss|MP:0004819,decreased skeletal muscle mass|MP:0005016,decreased lymphocyte cell number|MP:0005092,decreased double-positive T cell number|MP:0005114,premature hair loss|MP:0006036,abnormal mitochondrial physiology|MP:0006042,increased apoptosis|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0011178,increased erythroblast number|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013659,abnormal erythroid lineage cell morphology
MGI:3614412	Polh<tm1.1Rak>	MP:0000015,abnormal ear pigmentation|MP:0001203,increased sensitivity to skin irradiation|MP:0004207,increased squamous cell carcinoma incidence|MP:0004501,increased incidence of tumors by UV-induction|MP:0010300,increased skin tumor incidence
MGI:3577345	Polh<tm1Crey>	MP:0002459,abnormal B cell physiology
MGI:3583930	Polh<tm1Fmh>	MP:0002459,abnormal B cell physiology
MGI:3691063	Polh<tm2Fmh>	MP:0001202,skin photosensitivity|MP:0004501,increased incidence of tumors by UV-induction
MGI:3055735	Poli<d>	MP:0002006,neoplasm
MGI:5582769	Poli<tm1.1Lgh>	MP:0002006,neoplasm|MP:0004499,increased incidence of tumors by chemical induction
MGI:5636979	Poli<tm1b(EUCOMM)Hmgu>	MP:0010506,prolonged RR interval
MGI:2445458	Polk<tm1.1Rsky>	MP:0005387,immune system phenotype|MP:0008058,abnormal DNA repair|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death
MGI:3615272	Polk<tm1Hohm>	MP:0005387,immune system phenotype
MGI:2179232	Poll<tm1Crey>	MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0008760,abnormal immunoglobulin heavy chain V(D)J recombination|MP:0014762,impaired base-excision repair
MGI:6286309	Polm<m1Btlr>	MP:0005017,decreased B cell number
MGI:6286313	Polm<m2Btlr>	MP:0002619,abnormal lymphocyte morphology|MP:0005017,decreased B cell number
MGI:3629201	Polm<tm1Abnd>	MP:0002458,abnormal B cell number
MGI:2179233	Polm<tm1Crey>	MP:0000696,abnormal Peyer's patch morphology|MP:0002223,lymphoid hypoplasia|MP:0005017,decreased B cell number|MP:0005153,abnormal B cell proliferation|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0008761,abnormal immunoglobulin light chain V-J recombination
MGI:5903479	Poln<em1Rwd>	MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:5903480	Poln<em2Rwd>	MP:0005389,reproductive system phenotype
MGI:5903477	Poln<tm1.2Rwd>	MP:0001930,abnormal meiosis|MP:0002169,no abnormal phenotype detected
MGI:2656007	Polq<chaos1>	MP:0004028,chromosome breakage
MGI:6276888	Polq<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0010052,increased grip strength
MGI:3610670	Polq<tm1Jcs>	MP:0004815,abnormal somatic hypermutation frequency
MGI:3604448	Polq<tm1Jow>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002459,abnormal B cell physiology|MP:0002460,decreased immunoglobulin level|MP:0004815,abnormal somatic hypermutation frequency|MP:0008495,decreased IgG1 level
MGI:3693648	Polq<tm2Jow>	MP:0004815,abnormal somatic hypermutation frequency
MGI:7526140	Polr1a<em1Knwea>	MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:7526142	Polr1a<em2Knwea>	MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype
MGI:7526145	Polr1a<em3Knwea>	MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype
MGI:5299805	Polr1a<tm1a(EUCOMM)Hmgu>	MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:5810733	Polr1a<tm1b(EUCOMM)Hmgu>	MP:0001730,embryonic growth arrest|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012129,failure of blastocyst formation
MGI:7526217	Polr1a<tm1d(EUCOMM)Hmgu>	MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6156451	Polr1b<em1(IMPC)Tcp>	MP:0000598,abnormal liver morphology|MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0001200,thick skin|MP:0002100,abnormal tooth morphology|MP:0003068,enlarged kidney|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:3774130	Polr1b<Gt(Ayu8019)Imeg>	MP:0002663,absent blastocoele|MP:0004964,absent inner cell mass|MP:0008830,abnormal nucleolus morphology|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5901842	Polr1c<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001284,absent vibrissae|MP:0001304,cataract|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002075,abnormal coat/hair pigmentation|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5904258	Polr1d<em1(IMPC)J>	MP:0001728,failure of embryo implantation|MP:0001730,embryonic growth arrest|MP:0002663,absent blastocoele|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0003984,embryonic growth retardation|MP:0005028,abnormal trophectoderm morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012129,failure of blastocyst formation|MP:0013241,embryo tissue necrosis|MP:0013292,embryonic lethality prior to organogenesis|MP:0013504,increased embryonic tissue cell apoptosis
MGI:4362193	Polr1e<tm1a(KOMP)Wtsi>	MP:0001262,decreased body weight|MP:0003345,decreased rib number|MP:0004647,decreased lumbar vertebrae number|MP:0004924,abnormal behavior|MP:0010101,increased sacral vertebrae number
MGI:5692700	Polr1g<tm1b(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3641214	Polr2a<tm1Cdn>	MP:0002169,no abnormal phenotype detected
MGI:5287203	Polr2a<tm1Og>	MP:0011091,prenatal lethality, complete penetrance
MGI:3641215	Polr2a<tm2Cdn>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0004200,decreased fetal size|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5560335	Polr2a<Tn(pb-CAG-GCaMP5g,-tdTomato)Tvrd>	MP:0002169,no abnormal phenotype detected
MGI:5578722	Polr2a<Tn(pb-CAG-GCaMP5g)Tvrd>	MP:0002169,no abnormal phenotype detected
MGI:6266826	Polr2b<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity|MP:0001728,failure of embryo implantation|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012058,abnormal morula morphology
MGI:7840179	Polr2f<tm1e(EUCOMM)Wtsi>	MP:0005293,impaired glucose tolerance
MGI:6378226	Polr2g<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5498773	Polr2h<tm1.1(KOMP)Wtsi>	MP:0001554,increased circulating free fatty acids level|MP:0004151,decreased circulating iron level|MP:0005634,decreased circulating sodium level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:7447412	Polr2j<em1(IMPC)Bay>	MP:0001728,failure of embryo implantation|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012058,abnormal morula morphology
MGI:6258608	Polr2l<em1(IMPC)J>	MP:0001284,absent vibrissae|MP:0001399,hyperactivity|MP:0011100,preweaning lethality, complete penetrance
MGI:6503875	Polr2m<tm1.1Rgr>	MP:0002644,decreased circulating triglyceride level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005370,liver/biliary system phenotype|MP:0010080,abnormal hepatocyte physiology|MP:0020427,increased hepatocyte karyomegaly
MGI:6503889	Polr2m<tm1.2Rgr>	MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance
MGI:5755039	Polr3a<em2(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0002599,increased mean platelet volume|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6214817	Polr3a<Gt(LG04)Osb>	MP:0011092,embryonic lethality, complete penetrance
MGI:6209826	Polr3a<tm1.1Bebr>	MP:0001406,abnormal gait|MP:0003631,nervous system phenotype
MGI:8187814	Polr3a<tm1.1Iwil>	MP:0011092,embryonic lethality, complete penetrance
MGI:8187813	Polr3a<tm1Iwil>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001442,decreased grooming behavior|MP:0001458,abnormal object recognition memory|MP:0001489,decreased startle reflex|MP:0001973,increased thermal nociceptive threshold|MP:0002229,neurodegeneration|MP:0002572,abnormal emotion/affect behavior|MP:0002757,decreased vertical activity|MP:0005376,homeostasis/metabolism phenotype|MP:0008026,abnormal brain white matter morphology|MP:0008414,abnormal spatial reference memory|MP:0008489,slow postnatal weight gain|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008853,decreased abdominal adipose tissue amount|MP:0008917,abnormal oligodendrocyte physiology|MP:0009164,exocrine pancreas atrophy|MP:0009808,decreased oligodendrocyte number|MP:0011731,decreased myelin sheath thickness|MP:0013438,dysmyelination|MP:0020448,increased microglial cell activation|MP:0031496,motor developmental delay
MGI:6257593	Polr3b<em7(IMPC)Tcp>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6257695	Polr3d<em1(IMPC)Tcp>	MP:0002060,abnormal skin morphology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005278,abnormal cholesterol homeostasis|MP:0008935,decreased mean platelet volume|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013292,embryonic lethality prior to organogenesis
MGI:4431549	Polr3f<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6384605	Polr3gl<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6455458	Polr3gl<tm1Rgr>	MP:0000851,cerebellum hypoplasia|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0011085,postnatal lethality, complete penetrance
MGI:4441807	Polr3g<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6455435	Polr3g<tm1Rgr>	MP:0001730,embryonic growth arrest|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:6696391	Polr3h<em1Cfe>	MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6696392	Polr3h<em2Cfe>	MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0001938,delayed sexual maturation|MP:0005378,growth/size/body region phenotype|MP:0008940,delayed balanopreputial separation|MP:0009008,delayed estrous cycle|MP:0011125,decreased primary ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number
MGI:6277039	Polrmt<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001404,no spontaneous movement|MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology|MP:0002339,abnormal lymph node morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6147647	Polrmt<tm1.1Arte>	MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003929,decreased heart rate variability|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology
MGI:6147646	Polrmt<tm1.2Arte>	MP:0013292,embryonic lethality prior to organogenesis
MGI:7430792	Pom121l2<em1(IMPC)J>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:5694180	Pom121<tm1b(EUCOMM)Wtsi>	MP:0001510,abnormal coat appearance|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness|MP:0013292,embryonic lethality prior to organogenesis
MGI:6148322	Pomc<em1(IMPC)Rbrc>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0005293,impaired glucose tolerance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6282893	Pomc<tm1.1Kgm>	MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001433,polyphagia|MP:0005290,decreased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0014142,increased body fat mass
MGI:1857481	Pomc<tm1Low>	MP:0001260,increased body weight|MP:0001261,obese|MP:0001353,increased aggression towards mice|MP:0001425,abnormal alcohol consumption|MP:0001433,polyphagia|MP:0001745,increased circulating corticosterone level|MP:0001968,abnormal touch/nociception|MP:0002041,increased pituitary adenoma incidence|MP:0002079,increased circulating insulin level|MP:0002629,hyperactivity elicited by ethanol administration|MP:0002664,decreased circulating adrenocorticotropin level|MP:0002665,decreased circulating corticosterone level|MP:0002768,small adrenal glands|MP:0002803,abnormal operant conditioning behavior|MP:0003545,increased alcohol consumption|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004811,abnormal neuron physiology|MP:0004924,abnormal behavior|MP:0005128,decreased adrenocorticotropin level|MP:0005293,impaired glucose tolerance|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008560,increased tumor necrosis factor secretion|MP:0008596,increased circulating interleukin-6 level|MP:0008705,increased interleukin-6 secretion|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009302,increased renal fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0009336,increased splenocyte proliferation|MP:0009712,impaired conditioned place preference behavior|MP:0009748,abnormal behavioral response to addictive substance|MP:0010024,increased total body fat amount|MP:0011090,perinatal lethality, incomplete penetrance|MP:0014285,disorganized adrenal gland zona fasciculata|MP:0014287,decreased adrenal gland zona fasciculata size|MP:0030770,increased urine adrenaline level
MGI:3040514	Pomc<tm1Sora>	MP:0000371,diluted coat color|MP:0001261,obese|MP:0001433,polyphagia|MP:0002665,decreased circulating corticosterone level|MP:0005290,decreased oxygen consumption|MP:0005478,decreased circulating thyroxine level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0010771,integument phenotype|MP:0014441,decreased response to leptin
MGI:2687084	Pomc<tm2Ute>	MP:0000371,diluted coat color|MP:0001257,increased body length|MP:0001261,obese|MP:0001906,increased dopamine level|MP:0002664,decreased circulating adrenocorticotropin level|MP:0002665,decreased circulating corticosterone level|MP:0002667,decreased circulating aldosterone level|MP:0003136,yellow coat color|MP:0005313,absent adrenal gland|MP:0005378,growth/size/body region phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005661,decreased circulating adrenaline level|MP:0005669,increased circulating leptin level|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011939,increased food intake
MGI:3623521	Pomgnt1<Gt(OST179231)Lex>	MP:0000752,dystrophic muscle|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000825,dilated lateral ventricle|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0001265,decreased body size|MP:0001330,abnormal optic nerve morphology|MP:0001513,limb grasping|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0003044,impaired basement membrane formation|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003727,abnormal retina layer morphology|MP:0004136,abnormal tongue muscle morphology|MP:0004272,abnormal basement membrane morphology|MP:0005385,cardiovascular system phenotype|MP:0005551,abnormal eye electrophysiology|MP:0006254,thin cerebral cortex|MP:0006309,decreased retina ganglion cell number|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010235,abnormal retina inner limiting membrane morphology
MGI:5052171	Pomgnt1<tm1.1Cfg>	MP:0000776,abnormal inferior colliculus morphology|MP:0000825,dilated lateral ventricle|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000904,abnormal superior colliculus morphology|MP:0001891,hydrocephaly|MP:0003648,abnormal radial glial cell morphology|MP:0005623,abnormal meninges morphology|MP:0008030,abnormal Cajal-Retzius cell morphology|MP:0008547,abnormal neocortex morphology|MP:0009026,abnormal brain pia mater morphology|MP:0009959,abnormal cerebellar hemisphere morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5007295	Pomgnt1<tm1Lex>	MP:0000913,abnormal brain development|MP:0001326,retina degeneration|MP:0005560,decreased circulating glucose level|MP:0010098,abnormal retina blood vessel pattern|MP:0010452,retina microaneurysm
MGI:3832592	Pomgnt1<tm1Stk>	MP:0000750,abnormal muscle regeneration|MP:0000752,dystrophic muscle|MP:0001265,decreased body size|MP:0002106,abnormal muscle physiology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009400,decreased skeletal muscle fiber size|MP:0009406,decreased skeletal muscle fiber number|MP:0009410,abnormal skeletal muscle satellite cell proliferation|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5617746	Pomgnt2<tm1Kkat>	MP:0000788,abnormal cerebral cortex morphology|MP:0004200,decreased fetal size|MP:0004273,abnormal basal lamina morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006009,abnormal neuronal migration|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0011087,neonatal lethality, complete penetrance|MP:0020391,radial glial endfoot detachment
MGI:7425922	Pomk<em1(IMPC)Hmgu>	MP:0000062,increased bone mineral density|MP:0001489,decreased startle reflex|MP:0002135,abnormal kidney morphology|MP:0004952,increased spleen weight|MP:0011100,preweaning lethality, complete penetrance
MGI:4247868	Pomk<Gt(OST243203)Lex>	MP:0000745,tremors|MP:0000812,abnormal dentate gyrus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000857,abnormal cerebellar foliation|MP:0000885,ectopic Purkinje cell|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002635,reduced sensorimotor gating|MP:0002762,ectopic cerebellar granule cells|MP:0004097,abnormal cerebellar cortex morphology|MP:0006009,abnormal neuronal migration|MP:0008531,increased chemical nociceptive threshold|MP:0009142,decreased prepulse inhibition|MP:0009456,impaired cued conditioning behavior|MP:0009956,abnormal cerebellar layer morphology|MP:0009977,abnormal cerebellar granule cell migration|MP:0010008,abnormal Purkinje cell migration|MP:0010053,decreased grip strength|MP:0011495,abnormal head shape
MGI:3529694	Pomt1<Gt(OST194127)Lex>	MP:0000219,increased neutrophil cell number|MP:0001805,decreased IgG level|MP:0005590,increased vasodilation|MP:0011100,preweaning lethality, complete penetrance
MGI:6197751	Pomt1<tm1c(EUCOMM)Hmgu>	MP:0002090,abnormal vision|MP:0002184,abnormal innervation|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0005404,abnormal axon morphology|MP:0006073,abnormal retina bipolar cell morphology|MP:0008143,abnormal dendrite morphology|MP:0008515,thin retina outer nuclear layer|MP:0008519,thin retina outer plexiform layer|MP:0008571,abnormal synaptic bouton morphology|MP:0012144,decreased b-wave amplitude|MP:0012150,increased b-wave implicit time|MP:0014645,decreased optokinetic reflex|MP:0020359,abnormal ribbon synapse morphology
MGI:3497739	Pomt1<tm1Jec>	MP:0001730,embryonic growth arrest|MP:0003954,abnormal Reichert's membrane morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5302103	Pomt2<tm1.1Hhu>	MP:0000783,abnormal forebrain morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000813,abnormal hippocampus layer morphology|MP:0000815,abnormal Ammon gyrus morphology|MP:0000849,abnormal cerebellum morphology|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0003648,abnormal radial glial cell morphology|MP:0004272,abnormal basement membrane morphology|MP:0008030,abnormal Cajal-Retzius cell morphology|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0008547,abnormal neocortex morphology|MP:0009977,abnormal cerebellar granule cell migration
MGI:5302226	Pomt2<tm1.2Hhu>	MP:0001698,decreased embryo size|MP:0003954,abnormal Reichert's membrane morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5563037	Pomt2<tm1Sstr>	MP:0001730,embryonic growth arrest|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012129,failure of blastocyst formation|MP:0014696,decreased cell adhesion
MGI:2148702	Pon1<tm1Lus>	MP:0000182,increased circulating LDL cholesterol level|MP:0003674,oxidative stress|MP:0005145,increased circulating VLDL cholesterol level|MP:0005339,increased susceptibility to atherosclerosis|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:3695400	Pon2<Gt(XE661)Byg>	MP:0000183,decreased circulating LDL cholesterol level|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0003674,oxidative stress|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005339,increased susceptibility to atherosclerosis|MP:0005416,abnormal circulating protein level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0010760,abnormal macrophage chemotaxis
MGI:5804643	Pon2<tm1b(EUCOMM)Hmgu>	MP:0005178,increased circulating cholesterol level
MGI:6188494	Pon3<tm1b(KOMP)Wtsi>	MP:0001552,increased circulating triglyceride level
MGI:5825222	Pon3<tm1Dmsh>	MP:0000182,increased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000611,jaundice|MP:0001260,increased body weight|MP:0001547,abnormal lipid level|MP:0001552,increased circulating triglyceride level|MP:0001860,liver inflammation|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002830,gallstones|MP:0002941,increased circulating alanine transaminase level|MP:0003674,oxidative stress|MP:0003887,increased hepatocyte apoptosis|MP:0004773,abnormal bile composition|MP:0004789,increased bile salt level|MP:0005178,increased circulating cholesterol level|MP:0005290,decreased oxygen consumption|MP:0005339,increased susceptibility to atherosclerosis|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005365,abnormal bile salt homeostasis|MP:0005658,increased susceptibility to diet-induced obesity|MP:0008469,abnormal protein level|MP:0009118,increased white fat cell size|MP:0009121,increased white fat cell lipid droplet size|MP:0009285,increased gonadal fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010027,increased liver cholesterol level|MP:0010768,mortality/aging|MP:0010934,increased subcutaneous adipose tissue amount|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0012338,decreased bile salt level|MP:0014172,decreased fatty acid oxidation
MGI:5544271	Pon3<tm1Lus>	MP:0003674,oxidative stress|MP:0012604,decreased glutathione level
MGI:5425686	Pon3<tm1Tigm>	MP:0004921,decreased placenta weight|MP:0009431,decreased fetal weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3040786	Poo	MP:0001928,abnormal ovulation|MP:0001930,abnormal meiosis
MGI:6414467	Pop1<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:5700023	Pop4<em1Mvw>	MP:0002169,no abnormal phenotype detected|MP:0011091,prenatal lethality, complete penetrance
MGI:4944520	Pop4<tm1a(EUCOMM)Wtsi>	MP:0006358,absent pinna reflex|MP:0011100,preweaning lethality, complete penetrance
MGI:6403854	Pop5<em1(IMPC)J>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012111,failure of morula compaction|MP:0012129,failure of blastocyst formation|MP:0013292,embryonic lethality prior to organogenesis
MGI:6305126	Pop7<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5583059	Popdc1<tm1.1(KOMP)Vlcg>	MP:0001402,decreased locomotor activity|MP:0001529,abnormal vocalization|MP:0002060,abnormal skin morphology|MP:0005292,improved glucose tolerance|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2385915	Popdc1<tm1Tbd>	MP:0004115,abnormal sinoatrial node morphology|MP:0004484,abnormal response of heart to induced stress|MP:0005385,cardiovascular system phenotype|MP:0006142,abnormal sinoatrial node conduction|MP:0010637,sinus bradycardia|MP:0031328,delayed skeletal muscle regeneration
MGI:3773727	Popdc2<tm1Tbd>	MP:0004115,abnormal sinoatrial node morphology|MP:0004484,abnormal response of heart to induced stress|MP:0006142,abnormal sinoatrial node conduction|MP:0008489,slow postnatal weight gain|MP:0010637,sinus bradycardia
MGI:3511872	Popoa<LT/SvKau>	MP:0001928,abnormal ovulation|MP:0005168,abnormal female meiosis
MGI:3877648	Porcn<Gt(CSD256)Byg>	MP:0000414,alopecia|MP:0000519,hydronephrosis|MP:0001212,skin lesions|MP:0001218,thin epidermis|MP:0001247,dermal cyst|MP:0001924,infertility|MP:0002080,prenatal lethality|MP:0002085,abnormal embryonic tissue morphology|MP:0002110,abnormal digit morphology|MP:0002213,true hermaphroditism|MP:0002769,abnormal vas deferens morphology|MP:0003384,abnormal ventral body wall morphology|MP:0008730,fused phalanges
MGI:5523157	Porcn<tm1.1Jrt>	MP:0001672,abnormal embryo development|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001725,abnormal umbilical cord morphology|MP:0001726,abnormal allantois morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0005030,absent amnion|MP:0005380,embryo phenotype|MP:0009593,absent chorion|MP:0010768,mortality/aging|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4429133	Porcn<tm1.1Lcm>	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0000547,short limbs|MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0000572,abnormal autopod morphology|MP:0000592,short tail|MP:0001243,abnormal dermal layer morphology|MP:0001244,thin dermal layer|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001680,abnormal mesoderm development|MP:0002060,abnormal skin morphology|MP:0002111,abnormal tail morphology|MP:0002169,no abnormal phenotype detected|MP:0003052,omphalocele|MP:0003704,abnormal hair follicle development|MP:0003815,hairless|MP:0003935,abnormal craniofacial development|MP:0004073,caudal body truncation|MP:0004323,sternum hypoplasia|MP:0004360,absent ulna|MP:0005103,abnormal retina pigmentation|MP:0005193,abnormal anterior eye segment morphology|MP:0005262,coloboma|MP:0005543,decreased cornea thickness|MP:0006226,iris hypoplasia|MP:0009264,failure of eyelid fusion|MP:0010771,integument phenotype|MP:0011089,perinatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012132,abnormal midbrain-hindbrain boundary morphology|MP:0014291,decreased autopod size|MP:0031445,midline cleft upper lip
MGI:5435556	Porcn<tm1.1Vdv>	MP:0000414,alopecia|MP:0000547,short limbs|MP:0000564,syndactyly|MP:0000929,open neural tube|MP:0001199,thin skin|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002073,abnormal hair growth|MP:0002100,abnormal tooth morphology|MP:0002544,brachydactyly|MP:0003384,abnormal ventral body wall morphology|MP:0003704,abnormal hair follicle development|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0004686,decreased length of long bones|MP:0011091,prenatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011156,abnormal hypodermis fat layer morphology
MGI:6368150	Porcn<tm1.2Lcm>	MP:0000428,abnormal craniofacial morphology|MP:0000564,syndactyly|MP:0000592,short tail|MP:0002109,abnormal limb morphology|MP:0003051,curly tail|MP:0004073,caudal body truncation|MP:0005103,abnormal retina pigmentation|MP:0005262,coloboma|MP:0009264,failure of eyelid fusion|MP:0012132,abnormal midbrain-hindbrain boundary morphology|MP:0014280,forelimb oligodactyly
MGI:5435557	Porcn<tm1.2Vdv>	MP:0002073,abnormal hair growth|MP:0011092,embryonic lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:5435555	Porcn<tm1Vdv>	MP:0000519,hydronephrosis|MP:0000565,oligodactyly|MP:0001147,small testis|MP:0002544,brachydactyly|MP:0002759,abnormal caudal vertebrae morphology|MP:0008730,fused phalanges|MP:0009085,abnormal uterine horn morphology
MGI:2159651	Por<tm1Cbk>	MP:0000296,absent trabeculae carneae|MP:0000592,short tail|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0001672,abnormal embryo development|MP:0001787,pericardial edema|MP:0001915,intracranial hemorrhage|MP:0002085,abnormal embryonic tissue morphology|MP:0002092,abnormal eye morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003566,abnormal cell adhesion|MP:0003935,abnormal craniofacial development|MP:0003984,embryonic growth retardation|MP:0004838,abnormal neural fold elevation formation|MP:0005294,abnormal heart ventricle morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005391,vision/eye phenotype|MP:0006042,increased apoptosis|MP:0006126,abnormal cardiac outflow tract development|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012501,abnormal pericardial cavity morphology|MP:0012531,delayed limb development
MGI:2668450	Por<tm1Ding>	MP:0000598,abnormal liver morphology|MP:0000603,pale liver|MP:0001654,hepatic necrosis|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0005179,decreased circulating cholesterol level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009746,enhanced behavioral response to xenobiotic
MGI:2656919	Por<tm1Wolf>	MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002644,decreased circulating triglyceride level|MP:0002941,increased circulating alanine transaminase level|MP:0004774,abnormal bile salt level|MP:0005179,decreased circulating cholesterol level|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0012691,abnormal acetaminophen metabolism|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis
MGI:3703087	Por<tm2Ding>	MP:0001262,decreased body weight|MP:0001923,reduced female fertility|MP:0002628,hepatic steatosis|MP:0002781,increased circulating testosterone level|MP:0002834,decreased heart weight|MP:0003918,decreased kidney weight|MP:0005179,decreased circulating cholesterol level|MP:0005185,decreased circulating progesterone level|MP:0005319,abnormal enzyme/coenzyme level|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4457492	Por<tm3Ding>	MP:0001262,decreased body weight|MP:0001926,female infertility|MP:0002781,increased circulating testosterone level|MP:0002834,decreased heart weight|MP:0003918,decreased kidney weight|MP:0005179,decreased circulating cholesterol level|MP:0005186,increased circulating progesterone level|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005631,decreased lung weight|MP:0009779,enhanced behavioral response to anesthetic|MP:0010768,mortality/aging|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6304299	Postn<m1Btlr>	MP:0001262,decreased body weight
MGI:5520181	Postn<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0001523,impaired righting response|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0005505,thrombocytosis|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content|MP:0010124,decreased bone mineral content|MP:0011396,abnormal sleep behavior|MP:0020870,decreased thigmotaxis
MGI:3819350	Postn<tm1Jmol>	MP:0000343,abnormal response to cardiac infarction|MP:0001262,decreased body weight|MP:0002188,small heart|MP:0005166,decreased susceptibility to injury|MP:0005376,homeostasis/metabolism phenotype|MP:0014698,decreased fibroblast adhesion
MGI:3621456	Postn<tm1Kudo>	MP:0000119,abnormal tooth eruption|MP:0000343,abnormal response to cardiac infarction|MP:0002576,abnormal enamel morphology|MP:0002650,abnormal ameloblast morphology|MP:0002818,abnormal dentin morphology|MP:0003668,abnormal periodontal ligament morphology|MP:0003721,increased tumor growth/size|MP:0003930,abnormal tooth hard tissue morphology|MP:0005385,cardiovascular system phenotype|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3611751	Postn<tm1Sjc>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000150,abnormal rib morphology|MP:0000285,abnormal heart valve morphology|MP:0000458,abnormal mandible morphology|MP:0001127,small ovary|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0002576,abnormal enamel morphology|MP:0002637,small uterus|MP:0002650,abnormal ameloblast morphology|MP:0002764,short tibia|MP:0002818,abnormal dentin morphology|MP:0003109,short femur|MP:0003668,abnormal periodontal ligament morphology|MP:0003699,abnormal female reproductive system physiology|MP:0003723,abnormal long bone morphology|MP:0003930,abnormal tooth hard tissue morphology|MP:0004189,abnormal alveolar process morphology|MP:0004343,small scapula|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004672,short ribs|MP:0004674,thin ribs|MP:0004984,increased osteoclast cell number|MP:0005352,small cranium|MP:0005358,abnormal incisor morphology|MP:0005369,muscle phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0006395,abnormal epiphyseal plate morphology|MP:0008271,abnormal bone ossification|MP:0009009,absent estrous cycle|MP:0009070,small oviduct|MP:0010879,decreased trabecular bone volume|MP:0010965,decreased compact bone volume|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020010,decreased bone mineral density of femur|MP:0030132,periodontium inflammation|MP:0030451,abnormal dentin mineralization|MP:0030494,abnormal molar root morphology|MP:0030524,abnormal tooth root resorption
MGI:3665328	Pot1a<Gt(RRA096)Byg>	MP:0004964,absent inner cell mass|MP:0011091,prenatal lethality, complete penetrance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3665307	Pot1a<tm1.1Schg>	MP:0000352,decreased cell proliferation
MGI:3665329	Pot1a<tm1Tdl>	MP:0011091,prenatal lethality, complete penetrance
MGI:5287258	Pot1b<TgTn(sb-cHS4,Tyr)2325D-8c1aOve>	MP:0002399,abnormal pluripotent precursor cell morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3831881	Pot1b<tm1.1Schg>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000579,abnormal nail morphology|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001188,hyperpigmentation|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001922,reduced male fertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0004901,decreased male germ cell number|MP:0014052,increased male germ cell apoptosis
MGI:3665333	Pot1b<tm1Tdl>	MP:0002169,no abnormal phenotype detected
MGI:1856024	Pou1f1<dw>	MP:0000048,abnormal stria vascularis morphology|MP:0001265,decreased body size|MP:0001661,extended life span|MP:0001924,infertility|MP:0001967,deafness|MP:0003149,abnormal tectorial membrane morphology|MP:0003825,abnormal pillar cell morphology|MP:0003879,abnormal hair cell physiology|MP:0004163,abnormal adenohypophysis morphology|MP:0004367,abnormal strial intermediate cell morphology|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004411,decreased endocochlear potential|MP:0004413,absent cochlear microphonics|MP:0004466,short cochlear outer hair cells|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004737,absent distortion product otoacoustic emissions|MP:0005017,decreased B cell number|MP:0005121,decreased circulating prolactin level|MP:0005136,decreased growth hormone level|MP:0005138,decreased prolactin level|MP:0008330,absent somatotrophs|MP:0008333,absent lactotrophs|MP:0008338,decreased thyrotroph cell number|MP:0008365,adenohypophysis hypoplasia|MP:0008974,proportional dwarf|MP:0013344,increased pituitary gland apoptosis|MP:0013808,abnormal tunnel of Corti morphology|MP:0013961,abnormal Hensen stripe morphology|MP:0014091,abnormal tectorial membrane striated-sheet matrix morphology|MP:0020849,abnormal actin cytoskeleton morphology|MP:0030494,abnormal molar root morphology
MGI:1856025	Pou1f1<dw-J>	MP:0000812,abnormal dentate gyrus morphology|MP:0000854,abnormal cerebellum development|MP:0000857,abnormal cerebellar foliation|MP:0000886,abnormal cerebellar granule layer morphology|MP:0002762,ectopic cerebellar granule cells|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0009971,decreased hippocampus pyramidal cell number
MGI:6285599	Pou1f1<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:8240788	Pou1f1<em1Snar>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002664,decreased circulating adrenocorticotropin level|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005121,decreased circulating prolactin level|MP:0005478,decreased circulating thyroxine level|MP:0008330,absent somatotrophs|MP:0008770,decreased survivor rate|MP:0008938,decreased pituitary gland weight
MGI:5708168	Pou2af1<tm1b(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0004953,decreased spleen weight|MP:0005016,decreased lymphocyte cell number
MGI:2386101	Pou2af1<tm1Pjln>	MP:0000694,spleen hypoplasia|MP:0001807,decreased IgA level|MP:0002144,abnormal B cell differentiation|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008474,absent spleen germinal center|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008567,decreased interferon-gamma secretion|MP:0008672,increased interleukin-13 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008782,increased B cell apoptosis
MGI:2388055	Pou2af1<tm1Pmt>	MP:0002460,decreased immunoglobulin level
MGI:1931863	Pou2af1<tm1Rgr>	MP:0001262,decreased body weight|MP:0001802,arrested B cell differentiation|MP:0001805,decreased IgG level|MP:0001807,decreased IgA level|MP:0002144,abnormal B cell differentiation|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002403,abnormal pre-B cell morphology|MP:0002460,decreased immunoglobulin level|MP:0002492,decreased IgE level|MP:0002494,increased IgM level|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0005154,increased B cell proliferation|MP:0008474,absent spleen germinal center|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008523,absent lymph node germinal center
MGI:7490316	Pou2af2<em1Crva>	MP:0000488,abnormal intestinal epithelium morphology|MP:0000537,abnormal urethra morphology|MP:0000764,abnormal tongue epithelium morphology|MP:0002282,abnormal trachea morphology|MP:0008789,abnormal olfactory epithelium morphology|MP:0009492,abnormal gallbladder epithelium morphology|MP:0010768,mortality/aging|MP:0010942,abnormal respiratory epithelium morphology|MP:0014353,abnormal gastrointestinal brush cell morphology|MP:0014354,abnormal respiratory tract brush cell morphology
MGI:5766180	Pou2af3<tm1b(NCOM)Mfgc>	MP:0000063,decreased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0001489,decreased startle reflex|MP:0001566,increased circulating phosphate level|MP:0001925,male infertility|MP:0002764,short tibia|MP:0002968,increased circulating alkaline phosphatase level|MP:0003928,increased heart rate variability|MP:0005016,decreased lymphocyte cell number|MP:0005565,increased blood urea nitrogen level|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content|MP:0013278,decreased fasting circulating glucose level
MGI:4838111	Pou2f1<tm1Cav>	MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001717,absent ectoplacental cone|MP:0001730,embryonic growth arrest|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0008533,abnormal anterior visceral endoderm morphology|MP:0010736,abnormal extraembryonic ectoderm morphology|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:3028868	Pou2f1<tm1Shrp>	MP:0000245,abnormal erythropoiesis|MP:0000601,small liver|MP:0001306,small lens|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0003717,pallor|MP:0005391,vision/eye phenotype|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3028896	Pou2f2<tm1Bal>	MP:0001429,dehydration|MP:0001436,abnormal suckling behavior|MP:0001575,cyanosis|MP:0001802,arrested B cell differentiation|MP:0001806,decreased IgM level|MP:0002460,decreased immunoglobulin level|MP:0005017,decreased B cell number|MP:0005202,lethargy|MP:0005388,respiratory system phenotype|MP:0008211,decreased mature B cell number|MP:0008495,decreased IgG1 level|MP:0011087,neonatal lethality, complete penetrance
MGI:3037094	Pou2f2<tm1Lmc>	MP:0001802,arrested B cell differentiation|MP:0002460,decreased immunoglobulin level|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0011087,neonatal lethality, complete penetrance
MGI:5695872	Pou2f3<tm1.1(KOMP)Vlcg>	MP:0000274,enlarged heart
MGI:5140071	Pou2f3<tm1Abek>	MP:0001423,abnormal liquid preference|MP:0004209,abnormal sweet taste sensitivity|MP:0004210,abnormal bitter taste sensitivity|MP:0004213,abnormal umami taste sensitivity|MP:0006260,abnormal gustatory papilla taste bud morphology
MGI:2450109	Pou2f3<tm1Rsd>	MP:0002656,abnormal keratinocyte differentiation|MP:0010771,integument phenotype
MGI:1857995	Pou3f1<tm1Mejr>	MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0001265,decreased body size|MP:0002651,abnormal sciatic nerve morphology|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3574356	Pou3f1<tm1(Pou3f3)1Weg>	MP:0002169,no abnormal phenotype detected
MGI:1857994	Pou3f1<tm1Rsd>	MP:0000920,abnormal myelination|MP:0001078,abnormal phrenic nerve morphology|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002651,abnormal sciatic nerve morphology|MP:0005237,abnormal olfactory tract morphology|MP:0010771,integument phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2387953	Pou3f1<tm2.1Mejr>	MP:0000920,abnormal myelination|MP:0005388,respiratory system phenotype|MP:0010768,mortality/aging
MGI:4359591	Pou3f2<tm1Mejr>	MP:0003631,nervous system phenotype
MGI:1857996	Pou3f2<tm1Rsd>	MP:0000633,abnormal pituitary gland morphology|MP:0000837,abnormal hypothalamus morphology|MP:0001195,flaky skin|MP:0001242,hyperkeratosis|MP:0001265,decreased body size|MP:0001780,decreased brown adipose tissue amount|MP:0003631,nervous system phenotype|MP:0004164,abnormal neurohypophysis morphology|MP:0005379,endocrine/exocrine gland phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0013340,abnormal pituicyte morphology
MGI:2429695	Pou3f2<tm1Tno>	MP:0000837,abnormal hypothalamus morphology|MP:0001732,postnatal growth retardation|MP:0002628,hepatic steatosis|MP:0002971,abnormal brown adipose tissue morphology|MP:0004164,abnormal neurohypophysis morphology|MP:0004979,abnormal neuronal precursor cell number|MP:0008843,absent subcutaneous adipose tissue|MP:0011085,postnatal lethality, complete penetrance|MP:0014629,hypothalamus hypoplasia
MGI:2660725	Pou3f3<tm1Rmc>	MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0004467,absent zygomatic bone|MP:0004755,abnormal loop of Henle morphology|MP:0004899,absent temporal bone squamous part|MP:0005107,abnormal stapes morphology|MP:0008023,abnormal styloid process morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0030111,absent temporomandibular joint|MP:0030394,abnormal incus short process morphology
MGI:2673387	Pou3f3<tm1Tno>	MP:0000528,delayed kidney development|MP:0002703,abnormal renal tubule morphology|MP:0003606,kidney failure|MP:0003620,oliguria|MP:0003918,decreased kidney weight|MP:0004757,abnormal distal convoluted tubule morphology|MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level|MP:0011087,neonatal lethality, complete penetrance|MP:0011345,truncated loop of Henle|MP:0011368,increased kidney apoptosis|MP:0011441,decreased kidney cell proliferation
MGI:3712282	Pou3f3<urehr2>	MP:0002989,small kidney|MP:0003918,decreased kidney weight|MP:0005367,renal/urinary system phenotype|MP:0005553,increased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0006317,decreased urine sodium level
MGI:2179137	Pou3f4<del-J>	MP:0001394,circling|MP:0001410,head bobbing|MP:0004813,absent linear vestibular evoked potential|MP:0006325,impaired hearing
MGI:4887839	Pou3f4<sdl>	MP:0000048,abnormal stria vascularis morphology|MP:0001394,circling|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0003148,decreased cochlea coiling|MP:0004404,cochlear outer hair cell degeneration|MP:0004742,abnormal vestibular system physiology|MP:0005307,head tossing|MP:0005377,hearing/vestibular/ear phenotype|MP:0005627,increased circulating potassium level|MP:0006325,impaired hearing|MP:0006359,absent startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856631	Pou3f4<Slf>	MP:0001485,abnormal pinna reflex|MP:0002730,head shaking|MP:0003069,abnormal superior semicircular canal morphology|MP:0004292,abnormal spiral ligament fibrocyte morphology
MGI:1857990	Pou3f4<tm1Cren>	MP:0000031,abnormal cochlea morphology|MP:0000037,abnormal lateral semicircular canal morphology|MP:0001282,short vibrissae|MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0001485,abnormal pinna reflex|MP:0001967,deafness|MP:0003069,abnormal superior semicircular canal morphology|MP:0003148,decreased cochlea coiling|MP:0003167,abnormal scala tympani morphology|MP:0004286,abnormal internal auditory canal morphology|MP:0004287,abnormal spiral limbus morphology|MP:0004289,abnormal bony labyrinth|MP:0004290,abnormal stapes footplate morphology|MP:0004292,abnormal spiral ligament fibrocyte morphology|MP:0004411,decreased endocochlear potential|MP:0004479,abnormal oval window morphology|MP:0004739,conductive hearing loss|MP:0004740,sensorineural hearing loss|MP:0004862,small scala tympani|MP:0005107,abnormal stapes morphology|MP:0005272,abnormal temporal bone morphology|MP:0006012,dilated endolymphatic duct|MP:0006021,abnormal Reissner membrane morphology|MP:0006025,distended Reissner membrane|MP:0009822,abnormal subarcuate fossa morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0030407,abnormal stapes crus morpholgy
MGI:1857991	Pou3f4<tm1Tno>	MP:0000031,abnormal cochlea morphology|MP:0001967,deafness|MP:0004292,abnormal spiral ligament fibrocyte morphology|MP:0004293,abnormal type I spiral ligament fibrocytes|MP:0004294,abnormal type II spiral ligament fibrocytes|MP:0004411,decreased endocochlear potential|MP:0005386,behavior/neurological phenotype|MP:0006023,detached Reissner membrane|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5629682	Pou4f1<tm1.1(cre)Tcba>	MP:0002169,no abnormal phenotype detected
MGI:5607137	Pou4f1<tm1.1Gan>	MP:0005391,vision/eye phenotype
MGI:3611849	Pou4f1<tm1Dsl>	MP:0001092,abnormal trigeminal ganglion morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:2387665	Pou4f1<tm1Nat>	MP:0000840,abnormal epithalamus morphology|MP:0000846,abnormal medulla oblongata morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001083,small geniculate ganglion|MP:0001093,small trigeminal ganglion|MP:0001435,absent suckling reflex|MP:0001523,impaired righting response|MP:0002856,abnormal vestibular ganglion morphology|MP:0003637,cochlear ganglion hypoplasia|MP:0009546,absent gastric milk in neonates|MP:0011087,neonatal lethality, complete penetrance|MP:0012267,abnormal red nucleus morphology
MGI:3512302	Pou4f1<tm1Rsd>	MP:0000841,abnormal hindbrain morphology|MP:0000964,small dorsal root ganglion|MP:0001093,small trigeminal ganglion|MP:0001388,abnormal stationary movement|MP:0001438,aphagia|MP:0001523,impaired righting response|MP:0003637,cochlear ganglion hypoplasia|MP:0003684,abnormal inferior olivary complex morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0012268,absent red nucleus
MGI:3611851	Pou4f1<tm2Dsl>	MP:0000961,abnormal dorsal root ganglion morphology
MGI:5629683	Pou4f2<tm1.1(cre)Tcba>	MP:0002169,no abnormal phenotype detected
MGI:4353890	Pou4f2<tm1.1Xmu>	MP:0002169,no abnormal phenotype detected
MGI:2176272	Pou4f2<tm1Nat>	MP:0002984,retina hypoplasia|MP:0004811,abnormal neuron physiology|MP:0005551,abnormal eye electrophysiology|MP:0006156,abnormal visual pursuit|MP:0006221,optic nerve hypoplasia|MP:0006243,impaired pupillary reflex|MP:0006309,decreased retina ganglion cell number|MP:0008507,thin retina ganglion layer|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0020470,shortened circadian behavior period|MP:0020476,abnormal circardian behavior entrainment
MGI:3582493	Pou4f2<tm1Rsd>	MP:0000904,abnormal superior colliculus morphology|MP:0008067,retina ganglion cell degeneration
MGI:5607138	Pou4f2<tm2.1Gan>	MP:0005391,vision/eye phenotype
MGI:3842365	Pou4f2<tm2.1Nat>	MP:0002184,abnormal innervation|MP:0008847,abnormal suprachiasmatic nucleus morphology
MGI:2429633	Pou4f2<tm3Whk>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0001325,abnormal retina morphology|MP:0001330,abnormal optic nerve morphology|MP:0006303,abnormal retina nerve fiber layer morphology|MP:0006309,decreased retina ganglion cell number|MP:0008056,abnormal retina ganglion cell morphology|MP:0008105,increased amacrine cell number|MP:0008507,thin retina ganglion layer
MGI:3838536	Pou4f2<tm4(DTA)Whk>	MP:0001059,optic nerve atrophy|MP:0001325,abnormal retina morphology|MP:0001330,abnormal optic nerve morphology|MP:0002090,abnormal vision|MP:0002183,gliosis|MP:0002184,abnormal innervation|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology|MP:0006219,optic nerve degeneration|MP:0006243,impaired pupillary reflex|MP:0006309,decreased retina ganglion cell number|MP:0008259,abnormal optic disk morphology|MP:0008507,thin retina ganglion layer|MP:0009639,abnormal olivary pretectal nucleus morphology|MP:0011965,decreased total retina thickness|MP:0020468,abnormal circadian behavior period
MGI:1857795	Pou4f3<ddl>	MP:0001265,decreased body size|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001967,deafness|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004586,pillar cell degeneration|MP:0005307,head tossing|MP:0006358,absent pinna reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6693366	Pou4f3<em1(cre/ERT2)Yss>	MP:0004362,cochlear hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0006325,impaired hearing|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014406,increased or absent distortion product otoacoustic emission threshold|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:5467563	Pou4f3<tm1.1(HBEGF)Jsto>	MP:0001263,weight loss|MP:0001394,circling|MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002623,abnormal vestibular hair cell morphology|MP:0004328,decreased vestibular hair cell number|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004742,abnormal vestibular system physiology|MP:0006090,abnormal utricle morphology
MGI:5902780	Pou4f3<tm1.1(HBEGF)Rubel>	MP:0001967,deafness|MP:0002855,abnormal cochlear ganglion morphology|MP:0002857,cochlear ganglion degeneration|MP:0003986,small cochlear ganglion|MP:0004397,absent cochlear inner hair cells|MP:0004403,absent cochlear outer hair cells|MP:0004739,conductive hearing loss|MP:0004740,sensorineural hearing loss|MP:0004741,mixed hearing loss
MGI:3849065	Pou4f3<tm1.1Nat>	MP:0002169,no abnormal phenotype detected
MGI:2176270	Pou4f3<tm1Rsd>	MP:0000031,abnormal cochlea morphology|MP:0000042,abnormal organ of Corti morphology|MP:0000043,organ of Corti degeneration|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001516,abnormal motor coordination/balance|MP:0001777,abnormal body temperature homeostasis|MP:0001967,deafness|MP:0002855,abnormal cochlear ganglion morphology|MP:0002857,cochlear ganglion degeneration|MP:0003151,absent tunnel of Corti|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0004298,vestibular ganglion degeneration|MP:0004301,absent organ of Corti supporting cells|MP:0004306,small Rosenthal canal|MP:0004308,abnormal basilar membrane morphology|MP:0004325,absent vestibular hair cells|MP:0004363,stria vascularis degeneration|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004405,absent cochlear hair cells|MP:0004465,degeneration of organ of Corti supporting cells|MP:0004518,absent vestibular hair cell stereocilia|MP:0004526,absent cochlear hair cell stereocilia|MP:0004530,absent outer hair cell stereocilia|MP:0004535,absent inner hair cell stereocilia|MP:0004589,abnormal cochlear hair cell development|MP:0005377,hearing/vestibular/ear phenotype|MP:0006276,abnormal autonomic nervous system physiology|MP:0008304,abnormal organ of Corti supporting cell differentiation|MP:0010015,abnormal cuticular plate morphology|MP:0011020,abnormal circadian temperature homeostasis|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:8220018	Pou4f3<tm1Wagq>	MP:0004362,cochlear hair cell degeneration|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004402,decreased cochlear outer hair cell number|MP:0004404,cochlear outer hair cell degeneration|MP:0004529,decreased outer hair cell stereocilia number|MP:0004533,fused inner hair cell stereocilia|MP:0004597,increased susceptibility to noise-induced hearing loss|MP:0005377,hearing/vestibular/ear phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0006090,abnormal utricle morphology|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014406,increased or absent distortion product otoacoustic emission threshold|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:2429629	Pou4f3<tm1Whk>	MP:0000034,abnormal inner ear vestibule morphology|MP:0004742,abnormal vestibular system physiology
MGI:1857425	Pou4f3<tm1Xia>	MP:0000042,abnormal organ of Corti morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001394,circling|MP:0001489,decreased startle reflex|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0001921,reduced fertility|MP:0001967,deafness|MP:0002857,cochlear ganglion degeneration|MP:0003152,abnormal pillar cell differentiation|MP:0003987,small vestibular ganglion|MP:0004298,vestibular ganglion degeneration|MP:0004301,absent organ of Corti supporting cells|MP:0004302,abnormal Deiters cell morphology|MP:0004312,absent pillar cells|MP:0004324,vestibular hair cell degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004398,cochlear inner hair cell degeneration|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004409,abnormal crista ampullaris neuroepithelium morphology|MP:0004518,absent vestibular hair cell stereocilia|MP:0004526,absent cochlear hair cell stereocilia|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004535,absent inner hair cell stereocilia|MP:0004586,pillar cell degeneration|MP:0004588,abnormal vestibular hair cell development|MP:0004589,abnormal cochlear hair cell development|MP:0004590,absent Deiters cells|MP:0005450,abnormal energy expenditure|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5049897	Pou5f1<tm1.1(cre/Esr1*)Yseg>	MP:0002169,no abnormal phenotype detected
MGI:1933381	Pou5f1<tm1Cgre>	MP:0004964,absent inner cell mass|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5504452	Pou5f1<tm1Grc>	MP:0011091,prenatal lethality, complete penetrance
MGI:3771368	Pou5f1<tm1Jae>	MP:0002169,no abnormal phenotype detected
MGI:5610123	Pou5f1<tm1Jnic>	MP:0002718,abnormal inner cell mass morphology|MP:0011183,abnormal primitive endoderm morphology
MGI:3578312	Pou5f1<tm1Scho>	MP:0003631,nervous system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005386,behavior/neurological phenotype|MP:0005397,hematopoietic system phenotype|MP:0010771,integument phenotype
MGI:3772191	Pou5f1<tm2Jae>	MP:0002169,no abnormal phenotype detected
MGI:2661927	Pou5f2<tm1Rsd>	MP:0001922,reduced male fertility|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype
MGI:3826835	Pou6f2<tm1Nat>	MP:0002169,no abnormal phenotype detected
MGI:3522301	powder	MP:0000371,diluted coat color
MGI:6693655	Pp2d1<em1Zuk>	MP:0002169,no abnormal phenotype detected
MGI:8275795	Ppa1<em1Cya>	MP:0000013,abnormal adipose tissue distribution|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002079,increased circulating insulin level|MP:0002970,abnormal white adipose tissue morphology|MP:0002981,increased liver weight|MP:0003249,increased muscle free fatty acids level|MP:0003961,decreased lean body mass|MP:0004890,decreased energy expenditure|MP:0005281,increased fatty acids level|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005317,increased triglyceride level|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008964,decreased carbon dioxide production|MP:0009132,abnormal white fat cell size|MP:0009133,decreased white fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0010359,increased liver free fatty acids level|MP:0010379,decreased respiratory quotient|MP:0011400,lethality, complete penetrance|MP:0011629,decreased mitochondrial number|MP:0011631,decreased mitochondrial size|MP:0014142,increased body fat mass|MP:0014396,decreased fat cell mitochondrial DNA content|MP:0014398,abnormal fat cell mitochondrial morphology|MP:0030968,decreased circulating adiponectin level|MP:0031269,increased susceptibility to diet-induced hepatic steatosis|MP:0031415,increased skeletal muscle triglyceride level
MGI:6381444	Ppa2<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6810185	Ppara<em1Tyrb>	MP:0001363,increased anxiety-related response|MP:0009142,decreased prepulse inhibition|MP:0009936,abnormal dendritic spine morphology|MP:0020508,decreased dendritic spine density
MGI:5636895	Ppara<tm1b(EUCOMM)Wtsi>	MP:0001510,abnormal coat appearance|MP:0011239,abnormal skin coloration
MGI:1857774	Ppara<tm1Gonz>	MP:0000184,abnormal circulating HDL cholesterol level|MP:0000188,abnormal circulating glucose level|MP:0000189,hypoglycemia|MP:0000278,abnormal myocardial fiber morphology|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0001216,abnormal epidermal layer morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001260,increased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001560,abnormal circulating insulin level|MP:0001596,hypotension|MP:0001853,heart inflammation|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002656,abnormal keratinocyte differentiation|MP:0002891,increased insulin sensitivity|MP:0002908,delayed wound healing|MP:0003141,cardiac fibrosis|MP:0003457,abnormal circulating ketone body level|MP:0004215,abnormal myocardial fiber physiology|MP:0004566,myocardial fiber degeneration|MP:0005178,increased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005329,abnormal myocardium layer morphology|MP:0005330,cardiomyopathy|MP:0005331,insulin resistance|MP:0005367,renal/urinary system phenotype|MP:0005560,decreased circulating glucose level|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0005658,increased susceptibility to diet-induced obesity|MP:0006055,abnormal vascular endothelial cell morphology|MP:0006085,myocardium necrosis|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0009285,increased gonadal fat pad weight|MP:0009598,thin epidermis stratum granulosum|MP:0009605,decreased keratohyalin granule number|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010398,decreased liver glycogen level|MP:0010771,integument phenotype|MP:0011049,impaired adaptive thermogenesis|MP:0014172,decreased fatty acid oxidation|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0030021,increased muscle cell glucose uptake|MP:0031415,increased skeletal muscle triglyceride level
MGI:2386684	Ppard<tm1.1Rev>	MP:0000003,abnormal adipose tissue morphology|MP:0001712,abnormal placenta development|MP:0003984,embryonic growth retardation|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009115,abnormal fat cell morphology|MP:0009287,decreased abdominal fat pad weight|MP:0009295,decreased interscapular fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011521,decreased placental labyrinth size
MGI:3604590	Ppard<tm1Dgen>	MP:0000825,dilated lateral ventricle|MP:0003998,decreased thermal nociceptive threshold|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3623147	Ppard<tm1Dsvg>	MP:0000063,decreased bone mineral density|MP:0000747,muscle weakness|MP:0001712,abnormal placenta development|MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0003061,decreased aerobic running capacity|MP:0003797,abnormal compact bone morphology|MP:0003961,decreased lean body mass|MP:0003984,embryonic growth retardation|MP:0004819,decreased skeletal muscle mass|MP:0004984,increased osteoclast cell number|MP:0004991,decreased bone strength|MP:0004992,increased bone resorption|MP:0005293,impaired glucose tolerance|MP:0005416,abnormal circulating protein level|MP:0008271,abnormal bone ossification|MP:0010876,decreased bone volume|MP:0010963,abnormal compact bone volume|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011711,impaired osteoblast differentiation|MP:0012735,abnormal response to exercise|MP:0013639,decreased bone stiffness|MP:0013646,decreased energy dissipated prior to femur fracture|MP:0020010,decreased bone mineral density of femur|MP:0030009,increased bone marrow adipose tissue amount
MGI:1889516	Ppard<tm1Jps>	MP:0000774,decreased brain size|MP:0000920,abnormal myelination|MP:0001222,epidermal hyperplasia|MP:0001265,decreased body size|MP:0001547,abnormal lipid level|MP:0001552,increased circulating triglyceride level|MP:0002020,increased tumor incidence|MP:0002051,increased skin papilloma incidence|MP:0002080,prenatal lethality|MP:0002152,abnormal brain morphology|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0004200,decreased fetal size|MP:0004499,increased incidence of tumors by chemical induction|MP:0004947,skin inflammation|MP:0005145,increased circulating VLDL cholesterol level|MP:0005281,increased fatty acids level|MP:0005335,abnormal gonadal fat pad morphology|MP:0005450,abnormal energy expenditure|MP:0008011,intestine polyps|MP:0009356,decreased liver triglyceride level|MP:0010024,increased total body fat amount|MP:0010026,decreased liver cholesterol level|MP:0010300,increased skin tumor incidence|MP:0013383,increased sebaceous gland adenoma incidence
MGI:3629067	Ppard<tm1Mtz>	MP:0001191,abnormal skin condition|MP:0001216,abnormal epidermal layer morphology|MP:0002060,abnormal skin morphology|MP:0002655,abnormal keratinocyte morphology|MP:0003983,decreased cholesterol level
MGI:5576390	Ppard<tm1(PPARD)Bsls>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000189,hypoglycemia|MP:0005179,decreased circulating cholesterol level|MP:0005376,homeostasis/metabolism phenotype
MGI:2386683	Ppard<tm1Rev>	MP:0005375,adipose tissue phenotype
MGI:3575004	Ppard<tm1Wwah>	MP:0000382,underdeveloped hair follicles|MP:0001199,thin skin|MP:0001219,thick epidermis|MP:0002908,delayed wound healing|MP:0003704,abnormal hair follicle development|MP:0004126,thin hypodermis|MP:0009580,increased keratinocyte apoptosis|MP:0009583,increased keratinocyte proliferation|MP:0009584,decreased keratinocyte proliferation|MP:0011101,prenatal lethality, incomplete penetrance|MP:0030576,abnormal keratinocyte adhesion|MP:0030583,abnormal hair follicle peg morphology
MGI:5318332	Ppard<tm1Yjj>	MP:0001240,abnormal epidermis stratum corneum morphology|MP:0009596,abnormal stratum corneum lipid matrix formation
MGI:3616172	Ppard<tm2Rev>	MP:0002086,abnormal extraembryonic tissue morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:6285589	Ppargc1a<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:4950745	Ppargc1a<tm1.1Amos>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0003721,increased tumor growth/size|MP:0004499,increased incidence of tumors by chemical induction|MP:0008108,abnormal small intestinal villus morphology
MGI:5319541	Ppargc1a<tm1.1Javi>	MP:0001262,decreased body weight|MP:0003402,decreased liver weight|MP:0005375,adipose tissue phenotype|MP:0009116,abnormal brown fat cell morphology|MP:0009133,decreased white fat cell size|MP:0009136,decreased brown fat cell size|MP:0010025,decreased total body fat amount
MGI:5882330	Ppargc1a<tm1Aztc>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002727,decreased circulating insulin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0003917,increased kidney weight|MP:0003961,decreased lean body mass|MP:0004955,increased thymus weight|MP:0005179,decreased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0009305,decreased retroperitoneal fat pad weight|MP:0010124,decreased bone mineral content|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake|MP:0013307,increased adrenal gland weight|MP:0014143,decreased body fat mass
MGI:3511352	Ppargc1a<tm1Brsp>	MP:0000189,hypoglycemia|MP:0000243,myoclonus|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0001513,limb grasping|MP:0001846,increased inflammatory response|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002183,gliosis|MP:0002654,spongiform encephalopathy|MP:0002727,decreased circulating insulin level|MP:0002833,increased heart weight|MP:0002882,abnormal neuron morphology|MP:0002891,increased insulin sensitivity|MP:0002971,abnormal brown adipose tissue morphology|MP:0003383,abnormal gluconeogenesis|MP:0003674,oxidative stress|MP:0004485,increased response of heart to induced stress|MP:0005150,cachexia|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005323,dystonia|MP:0005387,immune system phenotype|MP:0005630,increased lung weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0006036,abnormal mitochondrial physiology|MP:0006138,congestive heart failure|MP:0006237,abnormal choroid vasculature morphology|MP:0006238,abnormal choriocapillaris morphology|MP:0008450,retina photoreceptor degeneration|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment|MP:0008705,increased interleukin-6 secretion|MP:0008834,abnormal melanosome transport|MP:0008842,lipofuscinosis|MP:0009356,decreased liver triglyceride level|MP:0009710,anhedonia|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010954,abnormal cellular respiration|MP:0011049,impaired adaptive thermogenesis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011639,decreased mitochondrial DNA content|MP:0020038,retina macular degeneration|MP:0030940,impaired autophagy
MGI:3522468	Ppargc1a<tm1Dpk>	MP:0000609,abnormal liver physiology|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000836,abnormal substantia nigra morphology|MP:0000849,abnormal cerebellum morphology|MP:0001259,abnormal body weight|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002128,abnormal blood circulation|MP:0002229,neurodegeneration|MP:0002628,hepatic steatosis|MP:0002797,increased thigmotaxis|MP:0002834,decreased heart weight|MP:0002891,increased insulin sensitivity|MP:0002899,fatigue|MP:0002971,abnormal brown adipose tissue morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003393,decreased cardiac output|MP:0003646,increased muscle fatigability|MP:0005156,bradykinesia|MP:0005277,abnormal brainstem morphology|MP:0005290,decreased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005318,decreased triglyceride level|MP:0005333,decreased heart rate|MP:0005455,increased susceptibility to weight gain|MP:0005458,increased percent body fat/body weight|MP:0006007,abnormal basal ganglion morphology|MP:0009115,abnormal fat cell morphology|MP:0009422,decreased gastrocnemius weight|MP:0009426,decreased soleus weight|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010239,decreased skeletal muscle weight|MP:0010954,abnormal cellular respiration|MP:0011049,impaired adaptive thermogenesis|MP:0020875,decreased nervous system dopamine level|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5576884	Ppargc1a<tm2.1Brsp>	MP:0002727,decreased circulating insulin level|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005378,growth/size/body region phenotype|MP:0005458,increased percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0005643,decreased dopamine level|MP:0005670,abnormal white adipose tissue physiology|MP:0006036,abnormal mitochondrial physiology|MP:0010379,decreased respiratory quotient|MP:0011448,decreased dopaminergic neuron number|MP:0013894,abnormal behavioral response to amphetamine|MP:0014396,decreased fat cell mitochondrial DNA content|MP:0014398,abnormal fat cell mitochondrial morphology
MGI:3693963	Ppargc1a<tm2Brsp>	MP:0001925,male infertility|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005559,increased circulating glucose level|MP:0005621,abnormal cell physiology|MP:0008596,increased circulating interleukin-6 level|MP:0009642,abnormal blood homeostasis
MGI:3757705	Ppargc1b<tm1.1Avp>	MP:0001262,decreased body weight|MP:0001783,decreased white adipose tissue amount|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002970,abnormal white adipose tissue morphology|MP:0002981,increased liver weight|MP:0005179,decreased circulating cholesterol level|MP:0005266,abnormal metabolism|MP:0005290,decreased oxygen consumption|MP:0005333,decreased heart rate|MP:0009118,increased white fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014344,abnormal skeletal muscle fiber mitochondrial morphology
MGI:3802519	Ppargc1b<tm1.1Dpk>	MP:0002082,postnatal lethality|MP:0002106,abnormal muscle physiology|MP:0002971,abnormal brown adipose tissue morphology|MP:0005318,decreased triglyceride level|MP:0005369,muscle phenotype|MP:0005375,adipose tissue phenotype|MP:0005385,cardiovascular system phenotype|MP:0008770,decreased survivor rate|MP:0009115,abnormal fat cell morphology|MP:0011049,impaired adaptive thermogenesis|MP:0012106,impaired exercise endurance
MGI:5638648	Ppargc1b<tm1.1Javi>	MP:0000005,increased brown adipose tissue amount|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0009116,abnormal brown fat cell morphology|MP:0009124,increased brown fat cell lipid droplet size|MP:0009137,decreased brown fat lipid droplet number|MP:0010955,abnormal respiratory electron transport chain|MP:0010958,abnormal tricarboxylic acid cycle|MP:0010959,abnormal oxidative phosphorylation
MGI:3706314	Ppargc1b<tm1.1Rev>	MP:0001402,decreased locomotor activity|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002981,increased liver weight|MP:0005376,homeostasis/metabolism phenotype|MP:0009355,increased liver triglyceride level|MP:0011049,impaired adaptive thermogenesis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031115,macrovesicular hepatic steatosis
MGI:4461888	Ppargc1b<tm1.2Rev>	MP:0004993,decreased bone resorption|MP:0008396,abnormal osteoclast differentiation
MGI:3771174	Ppargc1b<tm1Lowl>	MP:0005331,insulin resistance|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0009355,increased liver triglyceride level
MGI:6199499	Pparg<m1Btlr>	MP:0001262,decreased body weight
MGI:2683413	Pparg<tm1.1Auw>	MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001661,extended life span|MP:0002644,decreased circulating triglyceride level|MP:0002891,increased insulin sensitivity|MP:0003795,abnormal bone structure|MP:0005076,abnormal cell differentiation|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0006086,decreased body mass index|MP:0008907,decreased total fat pad weight|MP:0011020,abnormal circadian temperature homeostasis|MP:0011941,increased fluid intake|MP:0030016,increased adipocyte glucose uptake
MGI:2384321	Pparg<tm1.1Gonz>	MP:0001259,abnormal body weight|MP:0001599,abnormal blood volume|MP:0001625,cardiac hypertrophy|MP:0001798,impaired macrophage phagocytosis|MP:0002135,abnormal kidney morphology|MP:0002451,abnormal macrophage physiology|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002596,abnormal hematocrit|MP:0002743,glomerulonephritis|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0003068,enlarged kidney|MP:0003725,increased autoantibody level|MP:0003881,abnormal nephron morphology|MP:0003917,increased kidney weight|MP:0004564,increased myocardial fiber size|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005325,abnormal renal glomerulus morphology|MP:0005333,decreased heart rate|MP:0005346,abnormal circulating aldosterone level|MP:0005491,pancreatic islet hyperplasia|MP:0006274,abnormal urine sodium level|MP:0008059,abnormal podocyte foot process morphology|MP:0008139,fused podocyte foot processes|MP:0008244,abnormal peritoneal macrophage morphology|MP:0008872,abnormal physiological response to xenobiotic|MP:0010064,increased circulating creatine level|MP:0011075,abnormal macrophage activation involved in immune response|MP:0011294,renal glomerulus hypertrophy|MP:0011353,expanded mesangial matrix|MP:0011369,increased renal glomerulus apoptosis|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011427,increased mesangial cell number|MP:0011442,abnormal renal sodium ion transport
MGI:2385456	Pparg<tm1.1Mgn>	MP:0002169,no abnormal phenotype detected
MGI:3041450	Pparg<tm1.1Mtz>	MP:0001712,abnormal placenta development|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4412008	Pparg<tm1.1Unc>	MP:0002843,decreased systemic arterial blood pressure|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype
MGI:4818655	Pparg<tm1.2Auw>	MP:0002083,premature death
MGI:2385457	Pparg<tm1.2Mgn>	MP:0011091,prenatal lethality, complete penetrance
MGI:3041451	Pparg<tm1.2Mtz>	MP:0001780,decreased brown adipose tissue amount|MP:0002060,abnormal skin morphology|MP:0002169,no abnormal phenotype detected|MP:0002655,abnormal keratinocyte morphology|MP:0005459,decreased percent body fat/body weight|MP:0005666,abnormal adipose tissue physiology|MP:0009116,abnormal brown fat cell morphology|MP:0009117,abnormal white fat cell morphology|MP:0009124,increased brown fat cell lipid droplet size|MP:0009289,decreased epididymal fat pad weight
MGI:2683406	Pparg<tm1Auw>	MP:0000599,enlarged liver|MP:0001262,decreased body weight|MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001573,abnormal circulating alanine transaminase level|MP:0001732,postnatal growth retardation|MP:0002078,abnormal glucose homeostasis|MP:0002971,abnormal brown adipose tissue morphology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005343,increased circulating aspartate transaminase level|MP:0005534,decreased body temperature|MP:0009355,increased liver triglyceride level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011174,lipodystrophy|MP:0014146,decreased white adipose tissue mass|MP:0014169,decreased brown adipose tissue mass|MP:0031115,macrovesicular hepatic steatosis
MGI:3694813	Pparg<tm1Avp>	MP:0000013,abnormal adipose tissue distribution|MP:0000187,abnormal triglyceride level|MP:0001552,increased circulating triglyceride level|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0011100,preweaning lethality, complete penetrance|MP:0011168,abnormal fat cell differentiation|MP:0030968,decreased circulating adiponectin level
MGI:5637216	Pparg<tm1b(KOMP)Wtsi>	MP:0001406,abnormal gait|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2384211	Pparg<tm1Gonz>	MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0005389,reproductive system phenotype|MP:0006269,abnormal mammary gland growth during pregnancy
MGI:3794857	Pparg<tm1Laz>	MP:0002078,abnormal glucose homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005668,decreased circulating leptin level|MP:0009269,decreased fat cell size|MP:0030969,increased circulating adiponectin level
MGI:3580102	Pparg<tm1Lja>	MP:0000231,hypertension|MP:0001262,decreased body weight|MP:0001554,increased circulating free fatty acids level|MP:0001698,decreased embryo size|MP:0002079,increased circulating insulin level|MP:0005331,insulin resistance|MP:0006319,abnormal epididymal fat pad morphology|MP:0009116,abnormal brown fat cell morphology|MP:0009133,decreased white fat cell size|MP:0009355,increased liver triglyceride level|MP:0011092,embryonic lethality, complete penetrance|MP:0011174,lipodystrophy|MP:0014143,decreased body fat mass|MP:0030968,decreased circulating adiponectin level|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:3050095	Pparg<tm1Mae>	MP:0000013,abnormal adipose tissue distribution|MP:0000231,hypertension|MP:0005292,improved glucose tolerance|MP:0005335,abnormal gonadal fat pad morphology|MP:0005336,abnormal inguinal fat pad morphology|MP:0009115,abnormal fat cell morphology|MP:0009165,abnormal endocrine pancreas morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:2149838	Pparg<tm1Rev>	MP:0000280,thin ventricular wall|MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0002078,abnormal glucose homeostasis|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002652,thin myocardium|MP:0002891,increased insulin sensitivity|MP:0004560,abnormal chorionic plate morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0010556,thin ventricle myocardium compact layer|MP:0010725,thin interventricular septum|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012126,abnormal placenta hemotrichorial membrane morphology|MP:0031607,abnormal fetal cardiomyocyte mitochondrial morphology
MGI:2429766	Pparg<tm1Tka>	MP:0000168,abnormal bone marrow development|MP:0000267,abnormal heart development|MP:0001715,placental labyrinth hypoplasia|MP:0001716,abnormal placenta labyrinth morphology|MP:0001780,decreased brown adipose tissue amount|MP:0001800,abnormal humoral immune response|MP:0002397,abnormal bone marrow morphology|MP:0002459,abnormal B cell physiology|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002652,thin myocardium|MP:0002727,decreased circulating insulin level|MP:0002792,abnormal retina vasculature morphology|MP:0002891,increased insulin sensitivity|MP:0003724,increased susceptibility to induced arthritis|MP:0003984,embryonic growth retardation|MP:0004499,increased incidence of tumors by chemical induction|MP:0004988,increased osteoblast cell number|MP:0005076,abnormal cell differentiation|MP:0005154,increased B cell proliferation|MP:0005164,abnormal response to injury|MP:0005387,immune system phenotype|MP:0005390,skeleton phenotype|MP:0005533,increased body temperature|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0008271,abnormal bone ossification|MP:0008395,abnormal osteoblast differentiation|MP:0008541,leukostasis|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009115,abnormal fat cell morphology|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010025,decreased total body fat amount|MP:0010872,increased trabecular bone mass|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011940,decreased food intake|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3055128	Pparg<tm1Uls>	MP:0001732,postnatal growth retardation|MP:0010025,decreased total body fat amount|MP:0011091,prenatal lethality, complete penetrance
MGI:3575005	Pparg<tm1Wwah>	MP:0002080,prenatal lethality|MP:0005387,immune system phenotype
MGI:3050813	Pparg<tm1Yec>	MP:0001262,decreased body weight|MP:0001783,decreased white adipose tissue amount|MP:0002970,abnormal white adipose tissue morphology|MP:0002971,abnormal brown adipose tissue morphology|MP:0005331,insulin resistance|MP:0005370,liver/biliary system phenotype|MP:0005668,decreased circulating leptin level|MP:0005670,abnormal white adipose tissue physiology|MP:0009125,decreased brown fat cell lipid droplet size|MP:0009131,decreased white fat cell number|MP:0009133,decreased white fat cell size|MP:0009137,decreased brown fat lipid droplet number|MP:0009283,decreased gonadal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0030968,decreased circulating adiponectin level
MGI:3711168	Pparg<tm2Avp>	MP:0000013,abnormal adipose tissue distribution|MP:0002078,abnormal glucose homeostasis|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005389,reproductive system phenotype|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0005670,abnormal white adipose tissue physiology|MP:0006094,increased fat cell size|MP:0010025,decreased total body fat amount|MP:0030968,decreased circulating adiponectin level
MGI:2651605	Pparg<tm2Rev>	MP:0000062,increased bone mineral density|MP:0000065,abnormal bone marrow cavity morphology|MP:0000130,abnormal trabecular bone morphology|MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000276,heart right ventricle hypertrophy|MP:0000333,decreased bone marrow cell number|MP:0000377,abnormal hair follicle morphology|MP:0000427,abnormal hair cycle|MP:0000484,abnormal pulmonary artery morphology|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000649,sebaceous gland atrophy|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001190,reddish skin|MP:0001195,flaky skin|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001412,excessive scratching|MP:0001510,abnormal coat appearance|MP:0001613,abnormal vasodilation|MP:0001732,postnatal growth retardation|MP:0001780,decreased brown adipose tissue amount|MP:0001781,abnormal white adipose tissue amount|MP:0001935,decreased litter size|MP:0002060,abnormal skin morphology|MP:0002079,increased circulating insulin level|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002628,hepatic steatosis|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0002971,abnormal brown adipose tissue morphology|MP:0003157,impaired muscle relaxation|MP:0003631,nervous system phenotype|MP:0003795,abnormal bone structure|MP:0003846,matted coat|MP:0004003,abnormal vascular endothelial cell physiology|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004811,abnormal neuron physiology|MP:0004875,increased mean systemic arterial blood pressure|MP:0004947,skin inflammation|MP:0004982,abnormal osteoclast morphology|MP:0004985,decreased osteoclast cell number|MP:0005114,premature hair loss|MP:0005133,increased luteinizing hormone level|MP:0005317,increased triglyceride level|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0006080,brain ischemia|MP:0006320,abnormal interscapular fat pad morphology|MP:0008396,abnormal osteoclast differentiation|MP:0008489,slow postnatal weight gain|MP:0008858,abnormal hair cycle anagen phase|MP:0008861,abnormal hair shedding|MP:0009004,progressive hair loss|MP:0009010,abnormal diestrus|MP:0009118,increased white fat cell size|MP:0009119,increased brown fat cell size|MP:0009128,decreased brown fat cell number|MP:0009135,abnormal brown fat cell size|MP:0009295,decreased interscapular fat pad weight|MP:0009332,abnormal splenocyte morphology|MP:0009338,increased splenocyte number|MP:0009347,increased trabecular bone thickness|MP:0009506,abnormal mammary gland alveolus morphology|MP:0009535,abnormal skin sebaceous gland morphology|MP:0009931,abnormal skin appearance|MP:0009932,skin fibrosis|MP:0010221,abnormal T-helper 17 cell differentiation|MP:0010678,abnormal skin adnexa morphology|MP:0010758,increased right ventricle systolic pressure|MP:0010867,abnormal bone trabecula morphology|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume|MP:0010878,increased trabecular bone volume|MP:0013242,abnormal amino acid metabolism|MP:0030923,abnormal hair follicle ostium morphology
MGI:3511358	Pparg<tm2(tTA)Yba>	MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001559,hyperglycemia|MP:0001921,reduced fertility|MP:0002079,increased circulating insulin level|MP:0002970,abnormal white adipose tissue morphology|MP:0002971,abnormal brown adipose tissue morphology|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0008843,absent subcutaneous adipose tissue|MP:0009110,pancreas hyperplasia|MP:0009117,abnormal white fat cell morphology|MP:0009119,increased brown fat cell size|MP:0009132,abnormal white fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0009294,increased interscapular fat pad weight
MGI:3511359	Pparg<tm3(tTA)Yba>	MP:0000599,enlarged liver|MP:0001552,increased circulating triglyceride level|MP:0002079,increased circulating insulin level|MP:0002971,abnormal brown adipose tissue morphology|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009116,abnormal brown fat cell morphology|MP:0009119,increased brown fat cell size|MP:0009283,decreased gonadal fat pad weight
MGI:6442550	Ppat<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001312,abnormal cornea morphology|MP:0001325,abnormal retina morphology|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5692644	Ppbp<tm1.1(KOMP)Vlcg>	MP:0000219,increased neutrophil cell number|MP:0004952,increased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0005568,increased circulating total protein level
MGI:3797508	Ppbp<tm1(KOMP)Vlcg>	MP:0002442,abnormal leukocyte physiology|MP:0003156,abnormal leukocyte migration|MP:0005164,abnormal response to injury|MP:0005387,immune system phenotype
MGI:4830871	Ppcd1	MP:0001296,macrophthalmia|MP:0001303,abnormal lens morphology|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001316,cornea scarring|MP:0002697,abnormal eye size|MP:0004221,abnormal iridocorneal angle|MP:0005203,abnormal trabecular meshwork morphology|MP:0005391,vision/eye phenotype|MP:0005542,cornea vascularization|MP:0005543,decreased cornea thickness|MP:0006249,phthisis bulbi|MP:0009825,cornea ulcer|MP:0009829,enlarged eye anterior chamber|MP:0011100,preweaning lethality, complete penetrance|MP:0011481,anterior iris synechia|MP:0011482,posterior iris synechia
MGI:5582431	Ppdpf<tm1.1(KOMP)Mbp>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6739867	Ppdpf<tm1Nju>	MP:0001260,increased body weight|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0009355,increased liver triglyceride level|MP:0020867,increased lipogenesis|MP:0031269,increased susceptibility to diet-induced hepatic steatosis
MGI:2182810	Ppef1<tm1Nat>	MP:0002169,no abnormal phenotype detected
MGI:2182812	Ppef2<tm1Nat>	MP:0002169,no abnormal phenotype detected|MP:0005391,vision/eye phenotype
MGI:6188059	Ppfia1<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0001697,abnormal embryo size|MP:0002075,abnormal coat/hair pigmentation|MP:0011100,preweaning lethality, complete penetrance
MGI:5692833	Ppfia2<tm1b(EUCOMM)Hmgu>	MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0002792,abnormal retina vasculature morphology|MP:0008259,abnormal optic disk morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:6109981	Ppfia3<em1(IMPC)J>	MP:0001319,irregularly shaped pupil|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001529,abnormal vocalization|MP:0002574,increased vertical activity
MGI:6356372	Ppfia3<em1Pska>	MP:0002206,abnormal CNS synaptic transmission|MP:0008571,abnormal synaptic bouton morphology|MP:0009538,abnormal synapse morphology|MP:0020551,abnormal postsynaptic density morphology|MP:0030950,abnormal synaptic vesicle exocytosis|MP:0031391,increased locomotor activity
MGI:6257682	Ppfia4<em1(IMPC)Bay>	MP:0001417,decreased exploration in new environment|MP:0001523,impaired righting response|MP:0004924,abnormal behavior|MP:0011962,increased cornea thickness
MGI:7518993	Ppfibp1<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6156597	Ppfibp2<em1(IMPC)Tcp>	MP:0000470,abnormal stomach morphology|MP:0000702,enlarged lymph nodes|MP:0001200,thick skin|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001529,abnormal vocalization|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0010053,decreased grip strength|MP:0011874,enlarged urinary bladder
MGI:3587189	Pphln1<Gt(A043F08)Wrst>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6449018	Ppia<em1(IMPC)Mbp>	MP:0000443,abnormal snout morphology|MP:0000495,abnormal colon morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001258,decreased body length|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002599,increased mean platelet volume|MP:0002699,abnormal vitreous body morphology|MP:0002731,megacolon|MP:0002834,decreased heart weight|MP:0002875,decreased erythrocyte cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0002989,small kidney|MP:0004738,abnormal auditory brainstem response|MP:0004952,increased spleen weight|MP:0005561,increased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0010067,increased red blood cell distribution width
MGI:3505553	Ppia<tm1Lubn>	MP:0000693,spleen hyperplasia|MP:0001846,increased inflammatory response|MP:0001853,heart inflammation|MP:0001860,liver inflammation|MP:0001869,pancreas inflammation|MP:0002461,increased immunoglobulin level|MP:0002497,increased IgE level|MP:0005015,increased T cell number|MP:0005251,blepharitis|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008499,increased IgG1 level|MP:0008602,increased circulating interleukin-4 level|MP:0008687,increased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4125284	Ppib<Gt(RST139)Byg>	MP:0000061,fragile skeleton|MP:0000066,osteoporosis|MP:0000074,abnormal neurocranium morphology|MP:0000160,kyphosis|MP:0000547,short limbs|MP:0000559,abnormal femur morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002764,short tibia|MP:0003109,short femur|MP:0004624,abnormal thoracic cage morphology|MP:0004991,decreased bone strength|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013618,decreased areal bone mineral density|MP:0013620,increased internal diameter of femur|MP:0013624,decreased femur compact bone thickness|MP:0013626,decreased femur yield load|MP:0013633,decreased femur maximal load|MP:0013638,decreased femur stiffness|MP:0020010,decreased bone mineral density of femur|MP:0020137,decreased bone mineralization|MP:0021182,decreased femoral compact bone area|MP:0021186,decreased bone mineral density of vertebrae
MGI:4462803	Ppib<tm1.1Rjb>	MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000160,kyphosis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002083,premature death|MP:0003089,decreased skin tensile strength|MP:0005421,loose skin|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0010879,decreased trabecular bone volume|MP:0013630,increased bone trabecular spacing|MP:0020254,decreased collagen level
MGI:6886012	Ppic<em1Igc>	MP:0005397,hematopoietic system phenotype|MP:0008045,decreased NK cell number|MP:0009922,increased transitional stage T1 B cell number|MP:0009925,increased transitional stage T2 B cell number
MGI:6388386	Ppie<em1(IMPC)Tcp>	MP:0001417,decreased exploration in new environment|MP:0003019,increased circulating chloride level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005567,decreased circulating total protein level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7779593	Ppif<em1Cask>	MP:0006036,abnormal mitochondrial physiology|MP:0031217,increased susceptibility to myocardial ischemic injury
MGI:3603458	Ppif<tm1.1Mmos>	MP:0003631,nervous system phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0006058,decreased cerebral infarct size
MGI:3577093	Ppif<tm1Jmol>	MP:0003038,decreased myocardial infarct size|MP:0006036,abnormal mitochondrial physiology
MGI:3586298	Ppif<tm1Maf>	MP:0006036,abnormal mitochondrial physiology
MGI:3577023	Ppif<tm1Tsu>	MP:0003038,decreased myocardial infarct size|MP:0006036,abnormal mitochondrial physiology|MP:0008407,decreased cellular sensitivity to hydrogen peroxide|MP:0008944,decreased sensitivity to induced cell death
MGI:6306944	Ppig<em1(IMPC)J>	MP:0010053,decreased grip strength
MGI:6293839	Ppil1<em1(IMPC)Mbp>	MP:0000692,small spleen|MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0005553,increased circulating creatinine level|MP:0008528,polycystic kidney|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6509458	Ppil1<em2Jgg>	MP:0011092,embryonic lethality, complete penetrance
MGI:6509459	Ppil1<em3Jgg>	MP:0000433,microcephaly|MP:0000784,forebrain hypoplasia|MP:0000788,abnormal cerebral cortex morphology|MP:0003203,increased neuron apoptosis|MP:0003241,loss of cortex neurons|MP:0006254,thin cerebral cortex|MP:0011087,neonatal lethality, complete penetrance|MP:0012559,decreased forebrain volume|MP:0020602,decreased cerebral cortex average cell area
MGI:6509462	Ppil1<em4Jgg>	MP:0000433,microcephaly|MP:0003203,increased neuron apoptosis|MP:0003241,loss of cortex neurons|MP:0006254,thin cerebral cortex|MP:0011089,perinatal lethality, complete penetrance
MGI:6509463	Ppil1<em5Jgg>	MP:0003631,nervous system phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:5637044	Ppil3<tm1b(EUCOMM)Wtsi>	MP:0001554,increased circulating free fatty acids level|MP:0001556,increased circulating HDL cholesterol level|MP:0003795,abnormal bone structure|MP:0005178,increased circulating cholesterol level|MP:0006358,absent pinna reflex
MGI:7425924	Ppil6<em1(IMPC)Hmgu>	MP:0001399,hyperactivity|MP:0001891,hydrocephaly|MP:0002599,increased mean platelet volume|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:7840356	Ppip5k2<em1Yul>	MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001316,cornea scarring|MP:0005300,abnormal cornea stroma morphology|MP:0005542,cornea vascularization|MP:0005543,decreased cornea thickness|MP:0020854,increased cornea epithelium thickness
MGI:7840357	Ppip5k2<em2Yul>	MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001316,cornea scarring|MP:0005300,abnormal cornea stroma morphology|MP:0005542,cornea vascularization|MP:0005543,decreased cornea thickness|MP:0020854,increased cornea epithelium thickness
MGI:4433621	Ppip5k2<tm1a(EUCOMM)Wtsi>	MP:0004404,cochlear outer hair cell degeneration|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:5635268	Ppip5k2<tm1b(EUCOMM)Wtsi>	MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001316,cornea scarring|MP:0005300,abnormal cornea stroma morphology|MP:0005542,cornea vascularization|MP:0005543,decreased cornea thickness|MP:0010053,decreased grip strength|MP:0020854,increased cornea epithelium thickness
MGI:3050592	Ppl<tm1Aho>	MP:0002169,no abnormal phenotype detected
MGI:5696881	Ppl<tm1b(KOMP)Wtsi>	MP:0000702,enlarged lymph nodes|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002989,small kidney
MGI:5304773	Ppm1a<tm1.1Xya>	MP:0002908,delayed wound healing|MP:0005023,abnormal wound healing|MP:0012194,decreased keratinocyte migration
MGI:5616245	Ppm1a<tm1.2Lavi>	MP:0001792,impaired wound healing|MP:0003711,pathological neovascularization|MP:0005088,increased acute inflammation|MP:0005601,increased angiogenesis
MGI:5637227	Ppm1a<tm1b(EUCOMM)Hmgu>	MP:0001513,limb grasping|MP:0002764,short tibia|MP:0003795,abnormal bone structure|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content|MP:0013278,decreased fasting circulating glucose level
MGI:5304768	Ppm1a<tm1Xya>	MP:0002908,delayed wound healing|MP:0005023,abnormal wound healing|MP:0012194,decreased keratinocyte migration
MGI:3857220	Ppm1b<Gt(AW0406)Wtsi>	MP:0000313,abnormal cell death|MP:0005389,reproductive system phenotype|MP:0010769,abnormal survival
MGI:3712852	Ppm1b<tm1.1Tamu>	MP:0002085,abnormal embryonic tissue morphology|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2179128	Ppm1d<tm1Lad>	MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000706,small thymus|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001212,skin lesions|MP:0001265,decreased body size|MP:0001925,male infertility|MP:0002083,premature death|MP:0002499,chronic inflammation|MP:0002631,abnormal epididymis morphology|MP:0002687,oligozoospermia|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005293,impaired glucose tolerance|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010373,myeloid hyperplasia|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011820,decreased pancreatic beta cell proliferation|MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:3604597	Ppm1f<tm1Dgen>	MP:0001973,increased thermal nociceptive threshold|MP:0011100,preweaning lethality, complete penetrance|MP:0031391,increased locomotor activity
MGI:3604466	Ppm1g<tm1Dgen>	MP:0009142,decreased prepulse inhibition|MP:0011090,perinatal lethality, incomplete penetrance
MGI:6794071	Ppm1h<tm1Tac>	MP:0004101,abnormal brain interneuron morphology
MGI:3850971	Ppm1k<tm1Yiwa>	MP:0003674,oxidative stress|MP:0005311,abnormal circulating amino acid level|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3785735	Ppm1l<tm1Dgen>	MP:0001260,increased body weight|MP:0002702,decreased circulating free fatty acids level|MP:0002842,increased systemic arterial blood pressure|MP:0005292,improved glucose tolerance|MP:0005559,increased circulating glucose level|MP:0010024,increased total body fat amount
MGI:6117305	Ppm1l<tm1Tkoba>	MP:0000781,decreased corpus callosum size|MP:0000783,abnormal forebrain morphology|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001524,impaired limb coordination|MP:0004102,abnormal dorsal striatum morphology|MP:0008225,abnormal anterior commissure morphology|MP:0008226,decreased anterior commissure size|MP:0008535,enlarged lateral ventricles|MP:0008770,decreased survivor rate|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011731,decreased myelin sheath thickness|MP:0012468,decreased striatum size|MP:0013438,dysmyelination
MGI:5638564	Ppm1m<tm2b(EUCOMM)Hmgu>	MP:0012361,decreased large unstained cell number
MGI:6276865	Ppm1n<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0004906,enlarged uterus|MP:0010052,increased grip strength
MGI:6156152	Ppme1<em1(IMPC)Rbrc>	MP:0000598,abnormal liver morphology|MP:0001552,increased circulating triglyceride level|MP:0011100,preweaning lethality, complete penetrance
MGI:3804708	Ppme1<tm1Crv>	MP:0001436,abnormal suckling behavior|MP:0001951,abnormal breathing pattern|MP:0005584,abnormal enzyme/coenzyme activity|MP:0011087,neonatal lethality, complete penetrance
MGI:6303599	Ppox<em1(IMPC)J>	MP:0000267,abnormal heart development|MP:0000928,incomplete rostral neuropore closure|MP:0001566,increased circulating phosphate level|MP:0001697,abnormal embryo size|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001726,abnormal allantois morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0002941,increased circulating alanine transaminase level|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0004180,failure of initiation of embryo turning|MP:0004738,abnormal auditory brainstem response|MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0012099,decreased spongiotrophoblast size|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014134,abnormal embryo morphology
MGI:5697201	Ppox<tm1.1Had>	MP:0003868,abnormal feces composition|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009643,abnormal urine homeostasis
MGI:5696597	Ppox<tm1Had>	MP:0003868,abnormal feces composition|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009643,abnormal urine homeostasis|MP:0011091,prenatal lethality, complete penetrance
MGI:3530126	Ppp1cb<Gt(OST319712)Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:6140218	Ppp1cc<em1(IMPC)Wtsi>	MP:0001925,male infertility|MP:0005561,increased mean corpuscular hemoglobin
MGI:5605736	Ppp1cc<tm1b(EUCOMM)Wtsi>	MP:0001402,decreased locomotor activity
MGI:3528932	Ppp1cc<tm1Lex>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0009237,kinked sperm flagellum|MP:0009832,abnormal sperm mitochondrial sheath morphology
MGI:2182577	Ppp1cc<tm1Var>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0004543,abnormal sperm physiology|MP:0004901,decreased male germ cell number|MP:0005169,abnormal male meiosis|MP:0008279,arrest of spermiogenesis|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009236,pinhead sperm|MP:0009781,abnormal preimplantation embryo development|MP:0009831,abnormal sperm midpiece morphology|MP:0009833,absent sperm mitochondrial sheath|MP:0009836,abnormal sperm principal piece morphology|MP:0009839,multiflagellated sperm|MP:0014468,disorganized sperm mitochondrial sheath|MP:0014636,decreased elongated spermatid number|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0031356,abnormal outer dense fiber morphology
MGI:5286653	Ppp1r10<Tg(Tyr)2393B-3bOve>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:7548994	Ppp1r11<em1(IMPC)J>	MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:5755518	Ppp1r12a<em1Sfsh>	MP:0000249,abnormal blood vessel physiology
MGI:3586994	Ppp1r12a<tm1Mito>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5559675	Ppp1r12a<tm1Mzhu>	MP:0000477,abnormal intestine morphology|MP:0000496,abnormal small intestine morphology|MP:0000767,abnormal smooth muscle morphology|MP:0001270,distended abdomen|MP:0002083,premature death|MP:0002581,abnormal ileum morphology|MP:0003290,intestinal hypoperistalsis|MP:0003306,small intestinal inflammation|MP:0003622,ischuria|MP:0003883,enlarged stomach|MP:0004002,abnormal jejunum morphology|MP:0004145,abnormal muscle electrophysiology|MP:0005381,digestive/alimentary phenotype|MP:0005620,abnormal muscle contractility|MP:0006144,increased systemic arterial systolic blood pressure|MP:0009483,enlarged ileum|MP:0009536,abnormal interstitial cell of Cajal morphology|MP:0011874,enlarged urinary bladder|MP:0011882,enlarged duodenum
MGI:7621836	Ppp1r12b<em1Chana>	MP:0000278,abnormal myocardial fiber morphology|MP:0004486,decreased response of heart to induced stress|MP:0005385,cardiovascular system phenotype
MGI:6259156	Ppp1r12b<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001260,increased body weight|MP:0001284,absent vibrissae|MP:0001544,abnormal cardiovascular system physiology|MP:0002834,decreased heart weight|MP:0005599,increased cardiac muscle contractility|MP:0010580,decreased heart left ventricle size
MGI:3052747	Ppp1r13b<Gt(22A6)Cmhd>	MP:0002169,no abnormal phenotype detected
MGI:3794784	Ppp1r13b<tm1Suda>	MP:0001786,skin edema|MP:0001879,abnormal lymphatic vessel morphology|MP:0003659,abnormal lymph circulation|MP:0005385,cardiovascular system phenotype|MP:0008489,slow postnatal weight gain
MGI:5295045	Ppp1r13l<tm1.1Xlu>	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0000358,abnormal cell morphology|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0002083,premature death|MP:0002190,disorganized myocardium|MP:0002754,dilated heart right ventricle|MP:0002952,ventricular cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0003393,decreased cardiac output|MP:0005329,abnormal myocardium layer morphology|MP:0005598,decreased heart ventricle muscle contractility|MP:0006267,abnormal intercalated disk morphology|MP:0008008,early cellular replicative senescence|MP:0008022,dilated heart ventricle|MP:0008950,ventricular tachycardia|MP:0009416,cardiac muscle degeneration|MP:0009584,decreased keratinocyte proliferation|MP:0009732,ventricular premature beat|MP:0011704,decreased fibroblast proliferation|MP:0011925,abnormal heart echocardiography feature|MP:0011952,decreased cardiac stroke volume|MP:0020409,abnormal cardiac thrombosis|MP:0021160,decreased heart right ventricle wall thickness
MGI:5295044	Ppp1r13l<tm1Xlu>	MP:0002656,abnormal keratinocyte differentiation|MP:0003077,abnormal cell cycle|MP:0008008,early cellular replicative senescence|MP:0011704,decreased fibroblast proliferation
MGI:3575541	Ppp1r13l<wa3>	MP:0000410,waved hair|MP:0001262,decreased body weight|MP:0001302,eyelids open at birth|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0005140,decreased cardiac muscle contractility|MP:0006085,myocardium necrosis|MP:0008028,pregnancy-related premature death|MP:0009351,thin hair shaft|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031157,abnormal arterial thrombosis
MGI:3813487	Ppp1r13l<wa3-J>	MP:0000410,waved hair|MP:0000416,sparse hair|MP:0001302,eyelids open at birth|MP:0001853,heart inflammation|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0002001,blindness|MP:0002795,dilated cardiomyopathy|MP:0005330,cardiomyopathy|MP:0006138,congestive heart failure
MGI:5449625	Ppp1r13l<woe2>	MP:0000266,abnormal heart morphology|MP:0000281,abnormal interventricular septum morphology|MP:0000410,waved hair|MP:0001242,hyperkeratosis|MP:0001297,microphthalmia|MP:0001302,eyelids open at birth|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0001340,abnormal eyelid morphology|MP:0002083,premature death|MP:0003078,aphakia|MP:0005329,abnormal myocardium layer morphology|MP:0005542,cornea vascularization|MP:0006236,absent Meibomian glands|MP:0009264,failure of eyelid fusion|MP:0011481,anterior iris synechia|MP:0013744,abnormal conjunctival sac morphology
MGI:6487902	Ppp1r14a<em1Gpt>	MP:0003026,decreased vasoconstriction|MP:0006264,decreased systemic arterial systolic blood pressure
MGI:6487903	Ppp1r14a<em2Gpt>	MP:0006264,decreased systemic arterial systolic blood pressure
MGI:4450989	Ppp1r14c<tm1Uhl>	MP:0001981,increased chemically-elicited antinociception|MP:0005386,behavior/neurological phenotype|MP:0009711,abnormal conditioned place preference behavior|MP:0009748,abnormal behavioral response to addictive substance|MP:0009753,enhanced behavioral response to morphine|MP:0011101,prenatal lethality, incomplete penetrance|MP:0020949,increased susceptibility to Coronaviridae infection
MGI:5605788	Ppp1r14d<tm1b(KOMP)Wtsi>	MP:0002753,dilated heart left ventricle|MP:0010068,decreased red blood cell distribution width
MGI:7526520	Ppp1r15a<em2(IMPC)H>	MP:0002941,increased circulating alanine transaminase level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010067,increased red blood cell distribution width
MGI:3621811	Ppp1r15a<tm1.1Ajf>	MP:0000245,abnormal erythropoiesis|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002641,anisopoikilocytosis|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0004952,increased spleen weight|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008826,abnormal splenic cell ratio|MP:0010175,leptocytosis|MP:0010177,acanthocytosis|MP:0010178,increased number of Howell-Jolly bodies|MP:0031084,decreased erythrocyte osmotic fragility
MGI:2652765	Ppp1r15a<tm1Dron>	MP:0005621,abnormal cell physiology
MGI:3641226	Ppp1r15a<tm1Kii>	MP:0002169,no abnormal phenotype detected|MP:0005621,abnormal cell physiology
MGI:3833920	Ppp1r15b<tm1Dron>	MP:0000208,decreased hematocrit|MP:0000256,echinocytosis|MP:0000598,abnormal liver morphology|MP:0001436,abnormal suckling behavior|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0009703,decreased birth body size|MP:0011087,neonatal lethality, complete penetrance
MGI:3722113	Ppp1r16b<tm1Ccb>	MP:0002169,no abnormal phenotype detected
MGI:6361229	Ppp1r17<em1(IMPC)H>	MP:0000219,increased neutrophil cell number
MGI:3577713	Ppp1r17<tm1Nkz>	MP:0005391,vision/eye phenotype
MGI:7388240	Ppp1r18<em1Mgin>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0002444,abnormal T cell physiology|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005387,immune system phenotype|MP:0020212,impaired leukocyte migration
MGI:7388241	Ppp1r18<em2Mgin>	MP:0005387,immune system phenotype
MGI:7388242	Ppp1r18<em3Mgin>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0002444,abnormal T cell physiology|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005387,immune system phenotype|MP:0020212,impaired leukocyte migration
MGI:2180759	Ppp1r1a<tm1Pba>	MP:0001473,reduced long-term potentiation|MP:0005386,behavior/neurological phenotype
MGI:2183150	Ppp1r1b<tm1Aaf>	MP:0001425,abnormal alcohol consumption|MP:0002629,hyperactivity elicited by ethanol administration|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009712,impaired conditioned place preference behavior|MP:0009750,impaired behavioral response to addictive substance|MP:0009754,enhanced behavioral response to cocaine|MP:0009758,impaired behavioral response to cocaine
MGI:3620646	Ppp1r1b<tm1Pggd>	MP:0008872,abnormal physiological response to xenobiotic|MP:0009750,impaired behavioral response to addictive substance|MP:0009758,impaired behavioral response to cocaine
MGI:3620647	Ppp1r1b<tm2Pggd>	MP:0005386,behavior/neurological phenotype|MP:0009750,impaired behavioral response to addictive substance
MGI:3620653	Ppp1r1b<tm3Pggd>	MP:0008872,abnormal physiological response to xenobiotic|MP:0009750,impaired behavioral response to addictive substance|MP:0009758,impaired behavioral response to cocaine
MGI:3799291	Ppp1r1b<tm4Pggd>	MP:0004924,abnormal behavior|MP:0005386,behavior/neurological phenotype|MP:0009712,impaired conditioned place preference behavior|MP:0009757,impaired behavioral response to morphine|MP:0009758,impaired behavioral response to cocaine
MGI:4830458	Ppp1r1b<tm5.1Pggd>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001473,reduced long-term potentiation|MP:0009747,impaired behavioral response to xenobiotic|MP:0009754,enhanced behavioral response to cocaine|MP:0009758,impaired behavioral response to cocaine
MGI:6257617	Ppp1r21<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:5603572	Ppp1r26<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0005633,increased circulating sodium level
MGI:4223448	Ppp1r2<Gt(OST190571)Lex>	MP:0003461,abnormal response to novel object|MP:0005386,behavior/neurological phenotype|MP:0009453,enhanced contextual conditioning behavior|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5588283	Ppp1r35<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0000291,enlarged pericardium|MP:0000292,distended pericardium|MP:0000926,absent floor plate|MP:0000929,open neural tube|MP:0001303,abnormal lens morphology|MP:0001697,abnormal embryo size|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001730,embryonic growth arrest|MP:0001914,hemorrhage|MP:0002825,abnormal notochord morphology|MP:0002861,abnormal tail bud morphology|MP:0003020,decreased circulating chloride level|MP:0003077,abnormal cell cycle|MP:0003232,abnormal forebrain development|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0004132,absent embryonic cilia|MP:0004180,failure of initiation of embryo turning|MP:0005560,decreased circulating glucose level|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012505,increased neural tube apoptosis|MP:0013214,decreased embryonic neuroepithelium primary cilium number|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0030538,abnormal notochordal plate morphology
MGI:7424871	Ppp1r36dn<em1Shx>	MP:0002169,no abnormal phenotype detected
MGI:2653989	Ppp1r3a<tm1Adpr>	MP:0005584,abnormal enzyme/coenzyme activity|MP:0010399,decreased skeletal muscle glycogen level
MGI:2653915	Ppp1r3a<tm1Ptwc>	MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001261,obese|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005455,increased susceptibility to weight gain|MP:0005584,abnormal enzyme/coenzyme activity|MP:0010024,increased total body fat amount|MP:0010399,decreased skeletal muscle glycogen level|MP:0020411,increased abdominal adipose tissue amount|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:3785748	Ppp1r3a<tm2Adpr>	MP:0005438,abnormal glycogen homeostasis|MP:0010399,decreased skeletal muscle glycogen level
MGI:4431078	Ppp1r3b<tm1.1Arte>	MP:0001262,decreased body weight|MP:0002644,decreased circulating triglyceride level|MP:0004179,transmission ratio distortion|MP:0005202,lethargy|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005560,decreased circulating glucose level
MGI:5906221	Ppp1r3c<tm1Adpr>	MP:0002078,abnormal glucose homeostasis|MP:0002891,increased insulin sensitivity|MP:0004889,increased energy expenditure|MP:0005376,homeostasis/metabolism phenotype|MP:0005438,abnormal glycogen homeostasis|MP:0010768,mortality/aging|MP:0030021,increased muscle cell glucose uptake
MGI:2662307	Ppp1r3c<tm1Ars>	MP:0001552,increased circulating triglyceride level|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002833,increased heart weight|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005438,abnormal glycogen homeostasis|MP:0005439,decreased glycogen level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005669,increased circulating leptin level|MP:0010398,decreased liver glycogen level|MP:0010399,decreased skeletal muscle glycogen level|MP:0011091,prenatal lethality, complete penetrance|MP:0014072,decreased cardiac muscle glycogen level|MP:0030994,decreased adipose tissue glycogen level|MP:0031415,increased skeletal muscle triglyceride level|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:6367634	Ppp1r3g<tm1Nju>	MP:0002078,abnormal glucose homeostasis|MP:0002891,increased insulin sensitivity|MP:0003960,increased lean body mass|MP:0005289,increased oxygen consumption|MP:0005386,behavior/neurological phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008963,increased carbon dioxide production|MP:0008965,increased basal metabolism|MP:0009289,decreased epididymal fat pad weight|MP:0010398,decreased liver glycogen level|MP:0011939,increased food intake|MP:0014143,decreased body fat mass|MP:0030994,decreased adipose tissue glycogen level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:7641912	Ppp1r42<em1Osb>	MP:0005389,reproductive system phenotype
MGI:4364817	Ppp1r42<tm1a(KOMP)Wtsi>	MP:0004609,vertebral fusion
MGI:3050545	Ppp1r8<tm1Ave>	MP:0001674,abnormal germ layer development|MP:0001675,abnormal ectoderm development|MP:0001683,absent mesoderm|MP:0001698,decreased embryo size|MP:0001717,absent ectoplacental cone|MP:0002084,abnormal developmental patterning|MP:0002086,abnormal extraembryonic tissue morphology|MP:0010736,abnormal extraembryonic ectoderm morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011197,abnormal proamniotic cavity morphology|MP:0011198,absent proamniotic cavity|MP:0011208,small proamniotic cavity
MGI:4397456	Ppp1r9a<tm1Pggd>	MP:0001473,reduced long-term potentiation|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004811,abnormal neuron physiology|MP:0009754,enhanced behavioral response to cocaine|MP:0014378,increased excitatory postsynaptic current frequency
MGI:5445920	Ppp1r9b<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002574,increased vertical activity|MP:0002941,increased circulating alanine transaminase level|MP:0003063,increased coping response|MP:0003795,abnormal bone structure|MP:0005343,increased circulating aspartate transaminase level|MP:0011396,abnormal sleep behavior
MGI:2389199	Ppp1r9b<tm1Jfe>	MP:0000774,decreased brain size|MP:0000807,abnormal hippocampus morphology|MP:0000813,abnormal hippocampus layer morphology|MP:0001262,decreased body weight|MP:0001475,reduced long-term depression|MP:0001899,absent long-term depression|MP:0002805,abnormal conditioned taste aversion behavior|MP:0002882,abnormal neuron morphology|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0004811,abnormal neuron physiology|MP:0008236,decreased susceptibility to neuronal excitotoxicity|MP:0008283,small hippocampus|MP:0009754,enhanced behavioral response to cocaine
MGI:5755278	Ppp2ca<tm1.1Jmli>	MP:0002169,no abnormal phenotype detected
MGI:4950915	Ppp2ca<tm1.1Nju>	MP:0000245,abnormal erythropoiesis|MP:0000598,abnormal liver morphology|MP:0000603,pale liver|MP:0001577,anemia|MP:0002169,no abnormal phenotype detected|MP:0003656,abnormal erythrocyte physiology|MP:0003717,pallor|MP:0004809,increased hematopoietic stem cell number|MP:0005385,cardiovascular system phenotype|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011243,decreased fetal derived definitive erythrocyte cell number
MGI:5320588	Ppp2ca<tm1.2Nju>	MP:0001672,abnormal embryo development|MP:0001683,absent mesoderm|MP:0001698,decreased embryo size|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3613579	Ppp2ca<tm1Gotz>	MP:0001683,absent mesoderm|MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0005380,embryo phenotype|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5320589	Ppp2cb<tm1.1Nju>	MP:0002169,no abnormal phenotype detected
MGI:5692604	Ppp2cb<tm1b(EUCOMM)Hmgu>	MP:0011110,preweaning lethality, incomplete penetrance|MP:0011962,increased cornea thickness|MP:0011965,decreased total retina thickness
MGI:5287362	Ppp2r1a<tm1.2Wltr>	MP:0004499,increased incidence of tumors by chemical induction|MP:0008014,increased lung tumor incidence|MP:0011092,embryonic lethality, complete penetrance
MGI:5287375	Ppp2r1a<tm2.1Wltr>	MP:0002169,no abnormal phenotype detected|MP:0004499,increased incidence of tumors by chemical induction|MP:0008014,increased lung tumor incidence
MGI:5287370	Ppp2r1a<tm3.1Wltr>	MP:0002169,no abnormal phenotype detected
MGI:7788353	Ppp2r1b<tm1.2Yxy>	MP:0001147,small testis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:5694177	Ppp2r1b<tm1b(EUCOMM)Wtsi>	MP:0001925,male infertility|MP:0002100,abnormal tooth morphology|MP:0002606,increased basophil cell number|MP:0005011,increased eosinophil cell number|MP:0013279,increased fasting circulating glucose level
MGI:6149954	Ppp2r2a<igt10>	MP:0002079,increased circulating insulin level|MP:0005331,insulin resistance|MP:0009113,increased pancreatic beta cell mass
MGI:5694176	Ppp2r2a<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:4364039	Ppp2r2b<tm1a(KOMP)Wtsi>	MP:0002591,decreased mean corpuscular volume|MP:0003179,thrombocytopenia|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005628,decreased circulating potassium level
MGI:5513812	Ppp2r2b<tm1b(KOMP)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0003929,decreased heart rate variability|MP:0013279,increased fasting circulating glucose level
MGI:6731086	Ppp2r2d<em1Gct>	MP:0004946,abnormal regulatory T cell physiology|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008687,increased interleukin-2 secretion|MP:0010768,mortality/aging
MGI:6276994	Ppp2r2d<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology
MGI:4819992	Ppp2r3a<tm1(KOMP)Mbp>	MP:0002968,increased circulating alkaline phosphatase level|MP:0010053,decreased grip strength
MGI:6403697	Ppp2r3c<em1(IMPC)H>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3759678	Ppp2r3c<tm1Imku>	MP:0000692,small spleen|MP:0001800,abnormal humoral immune response|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0008168,decreased B-1a cell number|MP:0008174,decreased follicular B cell number|MP:0008186,increased pro-B cell number|MP:0008189,increased transitional stage B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008217,abnormal B cell activation|MP:0008484,decreased spleen germinal center size
MGI:6276896	Ppp2r5a<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology
MGI:4119929	Ppp2r5a<Gt(IST13127C10)Tigm>	MP:0000240,extramedullary hematopoiesis|MP:0000414,alopecia|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001212,skin lesions|MP:0001222,epidermal hyperplasia|MP:0004971,dermal hyperplasia|MP:0005380,embryo phenotype|MP:0008466,enlarged mesenteric lymph nodes|MP:0009794,sebaceous gland hyperplasia|MP:0010308,decreased tumor latency|MP:0012110,increased hair follicle number
MGI:8161229	Ppp2r5b<em1Bmc>	MP:0002169,no abnormal phenotype detected
MGI:8161231	Ppp2r5b<em2Bmc>	MP:0002169,no abnormal phenotype detected
MGI:6277066	Ppp2r5c<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001319,irregularly shaped pupil|MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0002339,abnormal lymph node morphology|MP:0002590,increased mean corpuscular volume|MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0003900,shortened QT interval|MP:0003961,decreased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0006241,abnormal placement of pupils|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010571,shortened ST segment|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4331551	Ppp2r5c<Gt(XP0444)Wtsi>	MP:0000281,abnormal interventricular septum morphology|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0002169,no abnormal phenotype detected|MP:0002652,thin myocardium|MP:0003717,pallor|MP:0004091,abnormal Z line morphology|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010402,ventricular septal defect|MP:0010725,thin interventricular septum|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011392,increased fetal cardiomyocyte apoptosis|MP:0031611,decreased fetal cardiomyocyte number
MGI:8161233	Ppp2r5d<em1Bmc>	MP:0002169,no abnormal phenotype detected
MGI:8161234	Ppp2r5d<em2Bmc>	MP:0002169,no abnormal phenotype detected
MGI:4128952	Ppp2r5d<Gt(RRG285)Byg>	MP:0002082,postnatal lethality|MP:0009142,decreased prepulse inhibition
MGI:4340650	Ppp2r5d<Gt(RRT114)Byg>	MP:0005380,embryo phenotype
MGI:4950873	Ppp2r5d<tm1Vjan>	MP:0001405,impaired coordination|MP:0003998,decreased thermal nociceptive threshold|MP:0004924,abnormal behavior
MGI:8161235	Ppp2r5e<em1Bmc>	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation
MGI:8161237	Ppp2r5e<em2Bmc>	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation
MGI:3878135	Ppp2r5e<Gt(YHD256)Byg>	MP:0001732,postnatal growth retardation
MGI:2150749	Ppp3ca<tm1Jse>	MP:0000195,decreased circulating calcium level|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0002987,abnormal urine osmolality|MP:0002988,decreased urine osmolality|MP:0005095,decreased T cell proliferation|MP:0005553,increased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0009401,increased skeletal muscle fiber diameter|MP:0009406,decreased skeletal muscle fiber number|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0011471,decreased urine creatinine level
MGI:7425926	Ppp3cb<em1(IMPC)Ccpcz>	MP:0002135,abnormal kidney morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0005387,immune system phenotype|MP:0008040,decreased NK T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013519,decreased CD4-positive NK T cell number|MP:0013522,decreased memory-marker CD4-positive NK T cell number|MP:0013764,decreased T-helper cell number|MP:0013772,increased effector memory T-helper cell number
MGI:5806304	Ppp3cb<M1Btlr>	MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0010766,abnormal NK cell physiology|MP:0011822,increased CD8-positive, alpha-beta memory T cell proliferation
MGI:5806307	Ppp3cb<m2Btlr>	MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0010766,abnormal NK cell physiology|MP:0011822,increased CD8-positive, alpha-beta memory T cell proliferation|MP:0020001,decreased response to antigen
MGI:6113566	Ppp3cb<M3Btlr>	MP:0010839,decreased CD8-positive, alpha-beta memory T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6113605	Ppp3cb<M4Btlr>	MP:0010839,decreased CD8-positive, alpha-beta memory T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number
MGI:6286021	Ppp3cb<m5Btlr>	MP:0008037,abnormal T cell morphology|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:6286032	Ppp3cb<M6Btlr>	MP:0002619,abnormal lymphocyte morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0012765,decreased alpha-beta T cell number
MGI:2181294	Ppp3cb<tm1Jmk>	MP:0001262,decreased body weight|MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0002188,small heart|MP:0003009,abnormal cytokine secretion|MP:0004486,decreased response of heart to induced stress|MP:0004956,decreased thymus weight|MP:0005018,decreased T cell number|MP:0005095,decreased T cell proliferation|MP:0005166,decreased susceptibility to injury|MP:0005385,cardiovascular system phenotype|MP:0008083,decreased single-positive T cell number|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009405,increased skeletal muscle fiber number|MP:0009409,abnormal skeletal muscle fiber type ratio
MGI:5788175	Ppp3cc<tm1.1Osb>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0005389,reproductive system phenotype|MP:0009282,decreased hyperactivated sperm motility|MP:0009831,abnormal sperm midpiece morphology
MGI:5692566	Ppp3cc<tm1b(EUCOMM)Hmgu>	MP:0001925,male infertility|MP:0008935,decreased mean platelet volume
MGI:6490502	Ppp3r1<tm1.1Jhon>	MP:0000278,abnormal myocardial fiber morphology|MP:0000280,thin ventricular wall|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0003222,increased cardiomyocyte apoptosis|MP:0005608,cardiac interstitial fibrosis|MP:0006138,congestive heart failure|MP:0010563,increased heart right ventricle size|MP:0010579,increased heart left ventricle size|MP:0011925,abnormal heart echocardiography feature|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3043986	Ppp3r1<tm1Grc>	MP:0000260,abnormal angiogenesis|MP:0000292,distended pericardium|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001719,absent vitelline blood vessels|MP:0001723,disorganized yolk sac vascular plexus|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2156983	Ppp3r1<tm1Stl>	MP:0001265,decreased body size|MP:0001361,social withdrawal|MP:0001399,hyperactivity|MP:0001447,abnormal nest building behavior|MP:0001475,reduced long-term depression|MP:0002063,abnormal learning/memory/conditioning|MP:0002083,premature death|MP:0002574,increased vertical activity|MP:0002635,reduced sensorimotor gating|MP:0006299,abnormal latent inhibition of conditioning behavior|MP:0008428,abnormal spatial working memory
MGI:3044031	Ppp3r1<tm2.1Grc>	MP:0000260,abnormal angiogenesis|MP:0000266,abnormal heart morphology|MP:0000292,distended pericardium|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0001723,disorganized yolk sac vascular plexus|MP:0002086,abnormal extraembryonic tissue morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3044022	Ppp3r1<tm2Grc>	MP:0000267,abnormal heart development|MP:0000352,decreased cell proliferation|MP:0000519,hydronephrosis|MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0002705,dilated renal tubule|MP:0003215,renal interstitial fibrosis|MP:0003542,abnormal vascular endothelial cell development|MP:0003606,kidney failure|MP:0003672,abnormal ureter development|MP:0004194,abnormal kidney pelvis morphology|MP:0004970,kidney atrophy|MP:0005385,cardiovascular system phenotype|MP:0005565,increased blood urea nitrogen level|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011305,dilated kidney calyx|MP:0011480,impaired ureteric peristalsis|MP:0011491,ureteropelvic junction obstruction
MGI:5788176	Ppp3r2<em1Osb>	MP:0001925,male infertility|MP:0009282,decreased hyperactivated sperm motility|MP:0009831,abnormal sperm midpiece morphology
MGI:5548369	Ppp3r2<tm1.1(KOMP)Vlcg>	MP:0001925,male infertility|MP:0010067,increased red blood cell distribution width
MGI:6336089	Ppp4c<em1(IMPC)Ics>	MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0001469,abnormal contextual conditioning behavior|MP:0002833,increased heart weight|MP:0004102,abnormal dorsal striatum morphology|MP:0005344,increased circulating bilirubin level|MP:0008226,decreased anterior commissure size|MP:0012453,decreased retrosplenial granular cortex size|MP:0012474,decreased cingulate cortex size|MP:0012478,decreased secondary somatosensory cortex size
MGI:7280773	Ppp4c<em1Qys>	MP:0000242,impaired fertilization|MP:0001147,small testis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0006379,abnormal spermatocyte morphology|MP:0008279,arrest of spermiogenesis|MP:0009237,kinked sperm flagellum|MP:0009647,decreased fertilization frequency|MP:0009831,abnormal sperm midpiece morphology|MP:0014052,increased male germ cell apoptosis|MP:0020451,decreased sperm progressive motility|MP:0030978,impaired binding of sperm to zona pellucida
MGI:3794743	Ppp4c<tm1.1Htn>	MP:0003077,abnormal cell cycle|MP:0020850,abnormal microtubule cytoskeleton morphology
MGI:3794751	Ppp4c<tm1.2Htn>	MP:0004965,inner cell mass degeneration|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3794733	Ppp4c<tm1Htn>	MP:0011091,prenatal lethality, complete penetrance
MGI:3697685	Ppp4c<tm1Tht>	MP:0001828,abnormal T cell activation|MP:0002145,abnormal T cell differentiation|MP:0004919,abnormal positive T cell selection|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number
MGI:3699355	Ppp4c<tm2Tht>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6148323	Ppp4r1<em1(IMPC)Rbrc>	MP:0000062,increased bone mineral density|MP:0001925,male infertility|MP:0005505,thrombocytosis|MP:0010123,increased bone mineral content
MGI:5548882	Ppp4r2<tm2b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002135,abnormal kidney morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:7312039	Ppp4r3a<em1Qili>	MP:0001363,increased anxiety-related response|MP:0002573,behavioral despair|MP:0002797,increased thigmotaxis|MP:0003990,decreased neurotransmitter release|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005386,behavior/neurological phenotype|MP:0020379,abnormal sucrose solution preference|MP:0020508,decreased dendritic spine density
MGI:6120774	Ppp4r3b<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0001126,abnormal ovary morphology|MP:0001406,abnormal gait|MP:0002135,abnormal kidney morphology|MP:0004906,enlarged uterus|MP:0005293,impaired glucose tolerance|MP:0011964,increased total retina thickness
MGI:3715027	Ppp5c<Gt(XG029)Byg>	MP:0004045,abnormal cell cycle checkpoint function
MGI:5301885	Ppp5c<tm1.2Rhon>	MP:0000358,abnormal cell morphology|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001935,decreased litter size|MP:0002169,no abnormal phenotype detected|MP:0003566,abnormal cell adhesion|MP:0010831,lethality, incomplete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:4431812	Ppp5c<tm1a(EUCOMM)Wtsi>	MP:0000150,abnormal rib morphology|MP:0000186,decreased circulating HDL cholesterol level|MP:0000688,lymphoid hyperplasia|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002075,abnormal coat/hair pigmentation|MP:0002644,decreased circulating triglyceride level|MP:0003036,vertebral transformation|MP:0003345,decreased rib number|MP:0003795,abnormal bone structure|MP:0004609,vertebral fusion|MP:0004614,caudal vertebral transformation|MP:0004619,caudal vertebral fusion|MP:0004620,cervical vertebral fusion|MP:0004647,decreased lumbar vertebrae number|MP:0004648,decreased thoracic vertebrae number|MP:0004677,truncated ribs|MP:0004924,abnormal behavior|MP:0005015,increased T cell number|MP:0005179,decreased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010379,decreased respiratory quotient|MP:0012431,increased lymphoma incidence
MGI:3528936	Ppp5c<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:5775139	Ppp6c<tm1.1Shma>	MP:0001672,abnormal embryo development|MP:0011092,embryonic lethality, complete penetrance
MGI:5548551	Ppp6c<tm1b(EUCOMM)Hmgu>	MP:0001392,abnormal locomotor behavior|MP:0001529,abnormal vocalization|MP:0002590,increased mean corpuscular volume|MP:0002764,short tibia|MP:0004738,abnormal auditory brainstem response|MP:0005566,decreased blood urea nitrogen level|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:5775125	Ppp6c<tm1Shma>	MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0004499,increased incidence of tumors by chemical induction|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0012572,increased susceptibility to chemically induced skin inflammation
MGI:7577005	Ppp6r1<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0002757,decreased vertical activity
MGI:5614602	Ppp6r2<tm1.1(KOMP)Vlcg>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5426425	Pprc1<tm1Gning>	MP:0001674,abnormal germ layer development|MP:0003695,delayed blastocyst hatching from the zona pellucida|MP:0003988,disorganized embryonic tissue|MP:0004965,inner cell mass degeneration|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5585301	Ppt1<tm1.1Dprc>	MP:0001260,increased body weight|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0001516,abnormal motor coordination/balance|MP:0003354,astrocytosis|MP:0008842,lipofuscinosis|MP:0010762,abnormal microglial cell activation
MGI:3527191	Ppt1<tm1Aj>	MP:0000243,myoclonus|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000755,hindlimb paralysis|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0001513,limb grasping|MP:0001847,brain inflammation|MP:0002001,blindness|MP:0002064,seizures|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002175,decreased brain weight|MP:0002229,neurodegeneration|MP:0003241,loss of cortex neurons|MP:0003246,loss of GABAergic neurons|MP:0005326,abnormal podocyte morphology|MP:0006069,abnormal retina neuronal layer morphology|MP:0012506,brain atrophy
MGI:2176390	Ppt1<tm1Hof>	MP:0000243,myoclonus|MP:0000755,hindlimb paralysis|MP:0000774,decreased brain size|MP:0000805,abnormal visual cortex morphology|MP:0000811,hippocampal neuron degeneration|MP:0000876,Purkinje cell degeneration|MP:0001327,decreased retina photoreceptor cell number|MP:0001406,abnormal gait|MP:0001442,decreased grooming behavior|MP:0001847,brain inflammation|MP:0002061,abnormal aggression-related behavior|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002175,decreased brain weight|MP:0002229,neurodegeneration|MP:0003354,astrocytosis|MP:0005424,jerky movement|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0006075,abnormal retina cone bipolar cell morphology|MP:0006187,retina deposits|MP:0006254,thin cerebral cortex|MP:0008067,retina ganglion cell degeneration|MP:0008446,decreased retina cone cell number|MP:0008450,retina photoreceptor degeneration|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008713,abnormal cytokine level|MP:0008918,microgliosis|MP:0009392,retina gliosis|MP:0011965,decreased total retina thickness|MP:0012506,brain atrophy|MP:0030278,thick neurocranium
MGI:2176405	Ppt2<tm1Hof>	MP:0000240,extramedullary hematopoiesis|MP:0000540,abnormal urinary bladder urothelium morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000743,muscle spasm|MP:0000788,abnormal cerebral cortex morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001393,ataxia|MP:0001513,limb grasping|MP:0001944,abnormal pancreas morphology|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002175,decreased brain weight|MP:0002398,abnormal bone marrow cell morphology/development|MP:0003203,increased neuron apoptosis|MP:0003450,enlarged pancreas|MP:0003892,abnormal gastric gland morphology|MP:0004952,increased spleen weight|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005220,abnormal exocrine pancreas morphology|MP:0005397,hematopoietic system phenotype|MP:0005424,jerky movement|MP:0005425,increased macrophage cell number|MP:0008842,lipofuscinosis|MP:0009160,abnormal pancreatic acinar cell zymogen granule morphology|MP:0009978,abnormal cerebellum white matter morphology|MP:0010797,abnormal pyloric gastric gland morphology|MP:0011416,abnormal testis interstitial tissue morphology|MP:0014263,decreased spleen B cell follicle number
MGI:5636995	Ppt2<tm2b(KOMP)Wtsi>	MP:0005565,increased blood urea nitrogen level
MGI:6094244	Pptc7<em1Pagd>	MP:0000189,hypoglycemia|MP:0000266,abnormal heart morphology|MP:0000598,abnormal liver morphology|MP:0002078,abnormal glucose homeostasis|MP:0003458,decreased circulating ketone body level|MP:0006036,abnormal mitochondrial physiology|MP:0009431,decreased fetal weight|MP:0009674,decreased birth weight|MP:0011087,neonatal lethality, complete penetrance|MP:0013405,increased circulating lactate level|MP:0014341,abnormal hepatocyte mitochondrial morphology|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0020423,abnormal mitochondrial biogenesis
MGI:6143811	Pptc7<em2Pagd>	MP:0000189,hypoglycemia|MP:0000266,abnormal heart morphology|MP:0000598,abnormal liver morphology|MP:0002078,abnormal glucose homeostasis|MP:0003458,decreased circulating ketone body level|MP:0006036,abnormal mitochondrial physiology|MP:0009431,decreased fetal weight|MP:0009674,decreased birth weight|MP:0011087,neonatal lethality, complete penetrance|MP:0013405,increased circulating lactate level|MP:0014341,abnormal hepatocyte mitochondrial morphology|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0020423,abnormal mitochondrial biogenesis
MGI:5609359	Pptc7<tm1b(EUCOMM)Hmgu>	MP:0001491,unresponsive to tactile stimuli|MP:0001510,abnormal coat appearance|MP:0001697,abnormal embryo size|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5695979	Ppy<tm1b(KOMP)Wtsi>	MP:0001488,increased startle reflex|MP:0002079,increased circulating insulin level|MP:0010088,decreased circulating fructosamine level
MGI:3771719	Ppy<tm1Mws>	MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype
MGI:6341881	Pqbp1<em1(IMPC)Tcp>	MP:0001697,abnormal embryo size
MGI:7797303	Pqbp1<em1Jhhan>	MP:0000433,microcephaly|MP:0001262,decreased body weight|MP:0002175,decreased brain weight|MP:0003631,nervous system phenotype|MP:0004979,abnormal neuronal precursor cell number|MP:0004981,decreased neuronal precursor cell number|MP:0006254,thin cerebral cortex
MGI:6467464	Pqbp1<tm1.1Hiok>	MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000812,abnormal dentate gyrus morphology|MP:0001525,impaired balance|MP:0002175,decreased brain weight|MP:0002882,abnormal neuron morphology|MP:0003077,abnormal cell cycle|MP:0003631,nervous system phenotype|MP:0004045,abnormal cell cycle checkpoint function|MP:0004046,abnormal mitosis|MP:0006254,thin cerebral cortex|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0009456,impaired cued conditioning behavior|MP:0012203,abnormal neuronal stem cell morphology
MGI:1857006	pr	MP:0000034,abnormal inner ear vestibule morphology|MP:0000035,abnormal membranous labyrinth morphology|MP:0000041,absent endolymphatic duct|MP:0000592,short tail|MP:0000854,abnormal cerebellum development|MP:0002111,abnormal tail morphology|MP:0002230,abnormal primitive streak formation|MP:0002632,vestigial tail|MP:0002759,abnormal caudal vertebrae morphology|MP:0004652,small caudal vertebrae|MP:0005272,abnormal temporal bone morphology|MP:0006011,abnormal endolymphatic duct morphology|MP:0006013,absent endolymphatic sac|MP:0006281,abnormal tail development|MP:0008913,weaving|MP:0009821,abnormal vestibular aqueduct morphology|MP:0030842,absent subarcuate fossa
MGI:4311398	Pradc1<Gt(OST419896)Lex>	MP:0005559,increased circulating glucose level
MGI:5754594	Prag1<em2(IMPC)Tcp>	MP:0009142,decreased prepulse inhibition|MP:0013278,decreased fasting circulating glucose level
MGI:4944311	Prag1<tm1a(KOMP)Mbp>	MP:0011092,embryonic lethality, complete penetrance
MGI:5637181	Pram1<tm1b(EUCOMM)Wtsi>	MP:0002833,increased heart weight
MGI:3579812	Pram1<tm1Gak>	MP:0002463,abnormal neutrophil physiology
MGI:6277026	Pramel12<em1(IMPC)Mbp>	MP:0000470,abnormal stomach morphology|MP:0000494,abnormal cecum morphology|MP:0000538,abnormal urinary bladder morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001925,male infertility|MP:0001944,abnormal pancreas morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003271,abnormal duodenum morphology|MP:0004002,abnormal jejunum morphology
MGI:6724472	Pramel13<em1Dean>	MP:0001147,small testis|MP:0001925,male infertility|MP:0005389,reproductive system phenotype
MGI:7425927	Pramel13<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001304,cataract|MP:0001925,male infertility|MP:0002060,abnormal skin morphology|MP:0002699,abnormal vitreous body morphology
MGI:6724473	Pramel13<em2Dean>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002685,abnormal spermatogonia proliferation|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0014052,increased male germ cell apoptosis
MGI:7788862	Pramel15<em1Bzhu>	MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0008877,abnormal DNA methylation
MGI:7788863	Pramel15<em2Bzhu>	MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0008877,abnormal DNA methylation
MGI:5548898	Pramel17<tm1b(KOMP)Wtsi>	MP:0000274,enlarged heart|MP:0002111,abnormal tail morphology|MP:0003917,increased kidney weight|MP:0004738,abnormal auditory brainstem response
MGI:6156469	Pramel1<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001417,decreased exploration in new environment|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002941,increased circulating alanine transaminase level|MP:0003068,enlarged kidney|MP:0011874,enlarged urinary bladder
MGI:7855636	Pramel1<em1Liuw>	MP:0001147,small testis|MP:0001148,enlarged testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001934,increased litter size|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002685,abnormal spermatogonia proliferation|MP:0002687,oligozoospermia|MP:0004884,abnormal testis physiology|MP:0004901,decreased male germ cell number|MP:0006308,enlarged seminiferous tubules|MP:0006362,abnormal male germ cell morphology|MP:0006378,abnormal spermatogonia morphology|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014052,increased male germ cell apoptosis|MP:0014617,decreased spermatogonia number|MP:0030603,increased sperm number|MP:0031475,decreased male germ cell apoptosis
MGI:7855637	Pramel1<em2Liuw>	MP:0001147,small testis|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:5637189	Pramel31<tm2b(KOMP)Wtsi>	MP:0008806,increased circulating amylase level
MGI:7641814	Pramel34<em1Kzt>	MP:0005389,reproductive system phenotype
MGI:7641815	Pramel47<em1Kzt>	MP:0005389,reproductive system phenotype
MGI:6449711	Pramex1<tm1c(KOMP)Wtsi>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0006379,abnormal spermatocyte morphology|MP:0006428,ectopic Sertoli cells|MP:0013601,increased testis apoptosis|MP:0014052,increased male germ cell apoptosis
MGI:5007296	Prap1<tm1Lex>	MP:0001800,abnormal humoral immune response|MP:0001846,increased inflammatory response|MP:0002461,increased immunoglobulin level|MP:0003077,abnormal cell cycle|MP:0003992,increased mortality induced by ionizing radiation|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0008599,increased circulating interleukin-2 level|MP:0008602,increased circulating interleukin-4 level|MP:0008617,increased circulating interleukin-12 level|MP:0008669,increased interleukin-12b secretion|MP:0008882,abnormal enterocyte physiology|MP:0008885,increased enterocyte apoptosis|MP:0010377,abnormal gut flora balance|MP:0012734,abnormal response to radiation
MGI:5563437	Prc1<m1Anu>	MP:0008762,embryonic lethality
MGI:5613643	Prc1<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:6367736	Prcd<tm1Vya>	MP:0003729,abnormal photoreceptor outer segment morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005391,vision/eye phenotype|MP:0008451,retina rod cell degeneration|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0008515,thin retina outer nuclear layer|MP:0020448,increased microglial cell activation|MP:0020813,abnormal photoreceptor outer segment disc membrane morphology|MP:0020814,abnormal photoreceptor outer segment diameter
MGI:7505540	Prcp<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology
MGI:4123993	Prcp<Gt(KST302)Byg>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0006086,decreased body mass index|MP:0008907,decreased total fat pad weight|MP:0009283,decreased gonadal fat pad weight|MP:0009291,decreased femoral fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0011940,decreased food intake
MGI:5574612	Prdm10<tm1b(EUCOMM)Hmgu>	MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5645487	Prdm11<tm1.1Ahl>	MP:0000222,decreased neutrophil cell number|MP:0001800,abnormal humoral immune response|MP:0005014,increased B cell number|MP:0005621,abnormal cell physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion|MP:0013707,abnormal hematopoietic precursor cell morphology|MP:0020464,decreased megakaryocyte progenitor cell number|MP:0020466,increased megakaryocyte progenitor cell proliferation
MGI:6386418	Prdm12<tm1.1Ejbd>	MP:0000966,decreased sensory neuron number|MP:0001093,small trigeminal ganglion|MP:0001097,abnormal superior glossopharyngeal ganglion morphology|MP:0003203,increased neuron apoptosis
MGI:6386384	Prdm12<tm1Ejbd>	MP:0000964,small dorsal root ganglion|MP:0000966,decreased sensory neuron number|MP:0001093,small trigeminal ganglion|MP:0001097,abnormal superior glossopharyngeal ganglion morphology|MP:0003203,increased neuron apoptosis|MP:0008415,abnormal neurite morphology|MP:0008948,decreased neuron number|MP:0011087,neonatal lethality, complete penetrance
MGI:5605825	Prdm12<tm2b(EUCOMM)Hmgu>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001697,abnormal embryo size|MP:0005178,increased circulating cholesterol level|MP:0010393,shortened QRS complex duration|MP:0011100,preweaning lethality, complete penetrance
MGI:6156585	Prdm13<em1(IMPC)Tcp>	MP:0000689,abnormal spleen morphology|MP:0004952,increased spleen weight|MP:0005344,increased circulating bilirubin level
MGI:5752205	Prdm13<tm1.1Tfur>	MP:0003734,abnormal retina inner plexiform layer morphology|MP:0008106,decreased amacrine cell number|MP:0014642,increased optokinetic reflex
MGI:5752207	Prdm13<tm1.2Tfur>	MP:0003734,abnormal retina inner plexiform layer morphology|MP:0008106,decreased amacrine cell number|MP:0008511,thin retina inner nuclear layer|MP:0008513,thin retina inner plexiform layer|MP:0011831,abnormal visual contrast sensitivity|MP:0014642,increased optokinetic reflex
MGI:6257498	Prdm14<em1(IMPC)Bay>	MP:0000063,decreased bone mineral density|MP:0001510,abnormal coat appearance|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011960,abnormal eye anterior chamber depth
MGI:4441656	Prdm14<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001399,hyperactivity|MP:0001925,male infertility|MP:0002764,short tibia|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010379,decreased respiratory quotient|MP:0013772,increased effector memory T-helper cell number
MGI:5755614	Prdm14<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000150,abnormal rib morphology|MP:0001925,male infertility|MP:0001926,female infertility|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:4441771	Prdm14<tm1e(EUCOMM)Wtsi>	MP:0008391,abnormal primordial germ cell morphology
MGI:3805889	Prdm14<tm1Sait>	MP:0001925,male infertility|MP:0001926,female infertility|MP:0004806,absent germ cells|MP:0008391,abnormal primordial germ cell morphology|MP:0008392,decreased primordial germ cell number
MGI:4432795	Prdm15<tm1a(EUCOMM)Wtsi>	MP:0001698,decreased embryo size|MP:0002092,abnormal eye morphology|MP:0002152,abnormal brain morphology|MP:0002169,no abnormal phenotype detected|MP:0003232,abnormal forebrain development|MP:0003984,embryonic growth retardation|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004276,abnormal medial ganglionic eminence morphology|MP:0004277,abnormal lateral ganglionic eminence morphology|MP:0005157,holoprosencephaly|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011091,prenatal lethality, complete penetrance|MP:0011205,excessive folding of visceral yolk sac|MP:0012157,rostral body truncation|MP:0020515,abnormal visceral yolk sac endoderm morphology|MP:0030324,abnormal anterior head development
MGI:5548716	Prdm15<tm1b(EUCOMM)Wtsi>	MP:0002953,thick ventricular wall|MP:0010579,increased heart left ventricle size|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6153140	Prdm15<tm1c(EUCOMM)Wtsi>	MP:0001698,decreased embryo size|MP:0002152,abnormal brain morphology|MP:0002169,no abnormal phenotype detected|MP:0011091,prenatal lethality, complete penetrance
MGI:3576024	Prdm16<csp1>	MP:0000097,short maxilla|MP:0000102,abnormal nasal bone morphology|MP:0000266,abnormal heart morphology|MP:0000279,ventricular hypoplasia|MP:0000443,abnormal snout morphology|MP:0000445,short snout|MP:0000458,abnormal mandible morphology|MP:0000460,mandible hypoplasia|MP:0000762,abnormal tongue morphology|MP:0000820,abnormal choroid plexus morphology|MP:0001175,abnormal lung morphology|MP:0001178,pulmonary hypoplasia|MP:0001270,distended abdomen|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002639,micrognathia|MP:0003416,premature bone ossification|MP:0003641,small lung|MP:0004035,abnormal sublingual gland morphology|MP:0004471,short nasal bone|MP:0004592,small mandible|MP:0005294,abnormal heart ventricle morphology|MP:0009522,submandibular gland hypoplasia|MP:0009525,abnormal submandibular duct morphology|MP:0009527,abnormal sublingual duct morphology|MP:0009885,abnormal palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance|MP:0011615,submucous cleft palate|MP:0013933,short Meckel's cartilage|MP:0021107,retina fold|MP:0030191,narrow snout|MP:0030248,narrow maxilla|MP:0031443,abnormal tongue position
MGI:3531188	Prdm16<Gt(OST67423)Lex>	MP:0000218,increased leukocyte cell number|MP:0000266,abnormal heart morphology|MP:0000279,ventricular hypoplasia|MP:0000448,pointed snout|MP:0000762,abnormal tongue morphology|MP:0009890,cleft secondary palate|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0031443,abnormal tongue position
MGI:5564782	Prdm16<tm1.1Brsp>	MP:0000003,abnormal adipose tissue morphology|MP:0000013,abnormal adipose tissue distribution|MP:0000267,abnormal heart development|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0002079,increased circulating insulin level|MP:0002169,no abnormal phenotype detected|MP:0002628,hepatic steatosis|MP:0002753,dilated heart left ventricle|MP:0002971,abnormal brown adipose tissue morphology|MP:0003961,decreased lean body mass|MP:0005140,decreased cardiac muscle contractility|MP:0005288,abnormal oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005330,cardiomyopathy|MP:0005331,insulin resistance|MP:0005385,cardiovascular system phenotype|MP:0005425,increased macrophage cell number|MP:0005455,increased susceptibility to weight gain|MP:0005666,abnormal adipose tissue physiology|MP:0006094,increased fat cell size|MP:0006320,abnormal interscapular fat pad morphology|MP:0009124,increased brown fat cell lipid droplet size|MP:0009137,decreased brown fat lipid droplet number|MP:0009294,increased interscapular fat pad weight|MP:0009355,increased liver triglyceride level|MP:0010024,increased total body fat amount|MP:0010378,increased respiratory quotient|MP:0010579,increased heart left ventricle size|MP:0010725,thin interventricular septum|MP:0010934,increased subcutaneous adipose tissue amount|MP:0010954,abnormal cellular respiration|MP:0011049,impaired adaptive thermogenesis|MP:0011085,postnatal lethality, complete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0011629,decreased mitochondrial number|MP:0011699,abnormal brown adipose tissue thermogenesis|MP:0011925,abnormal heart echocardiography feature|MP:0012515,abnormal heart apex morphology|MP:0014143,decreased body fat mass|MP:0014396,decreased fat cell mitochondrial DNA content|MP:0020520,whitened brown adipose tissue morphology|MP:0030017,decreased adipocyte glucose uptake|MP:0031525,thin left ventricle myocardium compact layer
MGI:5446157	Prdm1<b2b1765Clo>	MP:0000284,double outlet right ventricle|MP:0002747,abnormal aortic valve morphology|MP:0004158,right aortic arch|MP:0010412,atrioventricular septal defect|MP:0010466,vascular ring|MP:0010488,abnormal left subclavian artery morphology
MGI:6279910	Prdm1<em1(IMPC)Bay>	MP:0000266,abnormal heart morphology|MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3605622	Prdm1<tm1.1Clme>	MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0001914,hemorrhage|MP:0002884,abnormal pharyngeal arch morphology|MP:0004206,abnormal dermomyotome development|MP:0004787,abnormal dorsal aorta morphology|MP:0006345,absent second pharyngeal arch|MP:0008392,decreased primordial germ cell number|MP:0010642,absent third pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011262,abnormal pharyngeal arch mesenchyme morphology
MGI:4366868	Prdm1<tm1.1Liz>	MP:0008100,absent plasma cells|MP:0009333,abnormal splenocyte physiology
MGI:3605621	Prdm1<tm1Clme>	MP:0001790,abnormal immune system physiology|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001859,kidney inflammation|MP:0002135,abnormal kidney morphology|MP:0002144,abnormal B cell differentiation|MP:0002439,abnormal plasma cell morphology|MP:0002460,decreased immunoglobulin level|MP:0002461,increased immunoglobulin level|MP:0002493,increased IgG level|MP:0002962,increased urine protein level|MP:0003725,increased autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005327,abnormal mesangial cell morphology|MP:0005379,endocrine/exocrine gland phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008093,abnormal memory B cell number|MP:0008098,decreased plasma cell number|MP:0008099,abnormal plasma cell differentiation|MP:0008177,increased germinal center B cell number|MP:0008192,abnormal germinal center B cell physiology|MP:0008481,increased spleen germinal center number|MP:0008483,increased spleen germinal center size|MP:0008705,increased interleukin-6 secretion|MP:0009338,increased splenocyte number|MP:0010186,increased T follicular helper cell number|MP:0010188,abnormal T follicular helper cell differentiation
MGI:3586884	Prdm1<tm1Masu>	MP:0002982,abnormal primordial germ cell migration|MP:0008392,decreased primordial germ cell number
MGI:3510704	Prdm1<tm1Nutt>	MP:0011091,prenatal lethality, complete penetrance
MGI:3605482	Prdm1<tm1Rob>	MP:0000737,abnormal myotome development|MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0001914,hemorrhage|MP:0002884,abnormal pharyngeal arch morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0006339,abnormal third pharyngeal arch morphology|MP:0006345,absent second pharyngeal arch|MP:0008392,decreased primordial germ cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011262,abnormal pharyngeal arch mesenchyme morphology
MGI:4366869	Prdm1<tm2.1Liz>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype
MGI:4355900	Prdm1<tm2.1Nutt>	MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:3605483	Prdm1<tm2Rob>	MP:0000737,abnormal myotome development|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0001713,decreased trophoblast giant cell number|MP:0001716,abnormal placenta labyrinth morphology|MP:0001914,hemorrhage|MP:0002884,abnormal pharyngeal arch morphology|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0004898,uterine hemorrhage|MP:0006339,abnormal third pharyngeal arch morphology|MP:0006345,absent second pharyngeal arch|MP:0008392,decreased primordial germ cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011262,abnormal pharyngeal arch mesenchyme morphology
MGI:5491215	Prdm1<tm3.1Liz>	MP:0001672,abnormal embryo development|MP:0001711,abnormal placenta morphology|MP:0003984,embryonic growth retardation|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5491216	Prdm1<tm4.1Liz>	MP:0002169,no abnormal phenotype detected
MGI:2388354	Prdm2<tm1Shg>	MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002041,increased pituitary adenoma incidence|MP:0002083,premature death|MP:0003667,increased hemangiosarcoma incidence|MP:0012431,increased lymphoma incidence
MGI:5548625	Prdm4<tm1b(EUCOMM)Hmgu>	MP:0000690,absent spleen|MP:0001297,microphthalmia|MP:0001312,abnormal cornea morphology|MP:0001322,abnormal iris morphology|MP:0001406,abnormal gait|MP:0002764,short tibia|MP:0002953,thick ventricular wall|MP:0003921,abnormal heart left ventricle morphology|MP:0003960,increased lean body mass|MP:0005293,impaired glucose tolerance|MP:0005599,increased cardiac muscle contractility|MP:0008806,increased circulating amylase level|MP:0010025,decreased total body fat amount|MP:0011874,enlarged urinary bladder
MGI:5547613	Prdm4<tm1b(EUCOMM)Liz>	MP:0002169,no abnormal phenotype detected
MGI:5547614	Prdm4<tm2.1Liz>	MP:0002169,no abnormal phenotype detected
MGI:6156485	Prdm5<em1(IMPC)Tcp>	MP:0001147,small testis|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0004738,abnormal auditory brainstem response|MP:0005633,increased circulating sodium level|MP:0008259,abnormal optic disk morphology
MGI:3853086	Prdm5<Gt(AV0702)Wtsi>	MP:0000060,delayed bone ossification|MP:0003795,abnormal bone structure|MP:0004986,abnormal osteoblast morphology|MP:0010124,decreased bone mineral content|MP:0010876,decreased bone volume|MP:0010879,decreased trabecular bone volume|MP:0010965,decreased compact bone volume|MP:0011642,abnormal bone collagen fibril morphology|MP:0020010,decreased bone mineral density of femur
MGI:5576800	Prdm6<tm1.2Jrld>	MP:0000260,abnormal angiogenesis|MP:0001785,edema|MP:0002652,thin myocardium|MP:0003229,abnormal vitelline vasculature morphology|MP:0003717,pallor|MP:0005385,cardiovascular system phenotype|MP:0011091,prenatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:6153584	Prdm8<em1(IMPC)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002100,abnormal tooth morphology|MP:0002188,small heart|MP:0002311,abnormal inspiratory capacity|MP:0002626,increased heart rate|MP:0002764,short tibia|MP:0003921,abnormal heart left ventricle morphology|MP:0004906,enlarged uterus|MP:0005293,impaired glucose tolerance|MP:0005633,increased circulating sodium level|MP:0010935,increased airway resistance|MP:0020421,increased freezing behavior
MGI:5315763	Prdm8<tm1Mci>	MP:0001212,skin lesions|MP:0001412,excessive scratching|MP:0001516,abnormal motor coordination/balance|MP:0002196,absent corpus callosum|MP:0003631,nervous system phenotype|MP:0008223,absent hippocampal commissure|MP:0014747,abnormal motor neuron axon guidance
MGI:6489980	Prdm9<em2Kpgn>	MP:0001127,small ovary|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005168,abnormal female meiosis|MP:0005431,decreased oocyte number|MP:0008261,arrest of male meiosis|MP:0008878,abnormal DNA methylation during gametogenesis|MP:0008966,abnormal chiasmata formation|MP:0009451,abnormal chromosomal synapsis
MGI:6506065	Prdm9<em3Kpgn>	MP:0005384,cellular phenotype
MGI:5306140	Prdm9<M1045Lja>	MP:0001147,small testis|MP:0001932,abnormal spermiogenesis|MP:0002208,abnormal germ cell morphology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0014636,decreased elongated spermatid number
MGI:3512904	Prdm9<repro7>	MP:0001127,small ovary|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002777,absent ovarian follicles|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis
MGI:5699103	Prdm9<tm1.1Kpgn>	MP:0001930,abnormal meiosis
MGI:3623909	Prdm9<tm1Ymat>	MP:0001130,abnormal ovarian folliculogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001929,abnormal gametogenesis|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0005431,decreased oocyte number|MP:0008261,arrest of male meiosis|MP:0008966,abnormal chiasmata formation|MP:0009451,abnormal chromosomal synapsis|MP:0010767,abnormal female meiosis I arrest|MP:0010948,abnormal double-strand DNA break repair|MP:0014764,impaired double-strand DNA break repair
MGI:2158330	Prdt1<CAST/EiJH>	MP:0005363,decreased susceptibility to prion infection
MGI:2158331	Prdt1<NZW/OlaHsd>	MP:0005364,increased susceptibility to prion infection
MGI:2158332	Prdt2<CAST/EiJH>	MP:0003633,abnormal nervous system physiology
MGI:2158333	Prdt2<NZW/OlaHsd>	MP:0003633,abnormal nervous system physiology
MGI:2158334	Prdt3<CAST/EiJH>	MP:0005363,decreased susceptibility to prion infection
MGI:2158335	Prdt3<NZW/OlaHsd>	MP:0005364,increased susceptibility to prion infection
MGI:2158336	Prdt4<CAST/EiJH>	MP:0003633,abnormal nervous system physiology
MGI:2158337	Prdt4<NZW/OlaHsd>	MP:0003633,abnormal nervous system physiology
MGI:8266888	Prdx1<em1Xixie>	MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:4819263	Prdx1<flro>	MP:0002447,abnormal erythrocyte morphology|MP:0002619,abnormal lymphocyte morphology
MGI:3611932	Prdx1<Gt(OST422296)Lex>	MP:0003186,abnormal redox activity
MGI:2670538	Prdx1<tm1Rave>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000352,decreased cell proliferation|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001585,hemolytic anemia|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002018,increased malignant tumor incidence|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0002038,increased carcinoma incidence|MP:0002083,premature death|MP:0002447,abnormal erythrocyte morphology|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0003077,abnormal cell cycle|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003430,increased pancreatic islet cell adenoma incidence|MP:0003448,abnormal tumor morphology|MP:0003667,increased hemangiosarcoma incidence|MP:0003789,increased osteosarcoma incidence|MP:0004952,increased spleen weight|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005097,polychromatophilia|MP:0008038,abnormal NK T cell number|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0008850,increased hemoglobin concentration distribution width|MP:0009321,increased histiocytic sarcoma incidence|MP:0010363,increased fibrosarcoma incidence|MP:0010383,increased adenoma incidence|MP:0011971,increased circulating lactate dehydrogenase level|MP:0012431,increased lymphoma incidence|MP:0012664,decreased circulating haptoglobin level|MP:0014237,decreased tumor-free survival time
MGI:6458773	Prdx1<tm1Yu>	MP:0001199,thin skin|MP:0004502,decreased incidence of tumors by chemical induction|MP:0009580,increased keratinocyte apoptosis
MGI:2668456	Prdx2<tm1Yu>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000256,echinocytosis|MP:0000314,schistocytosis|MP:0000691,enlarged spleen|MP:0001585,hemolytic anemia|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002416,abnormal proerythroblast morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002640,reticulocytosis|MP:0002812,spherocytosis|MP:0002874,decreased hemoglobin content|MP:0004952,increased spleen weight|MP:0005639,hemosiderosis|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0008476,increased spleen red pulp amount|MP:0011171,increased number of Heinz bodies
MGI:3700138	Prdx3<Gt(Betageo-puro)711Lex>	MP:0001262,decreased body weight|MP:0001861,lung inflammation|MP:0005621,abnormal cell physiology
MGI:5749424	Prdx3<tm1Hjha>	MP:0000008,increased white adipose tissue amount|MP:0001260,increased body weight|MP:0002079,increased circulating insulin level|MP:0002644,decreased circulating triglyceride level|MP:0003186,abnormal redox activity|MP:0003674,oxidative stress|MP:0004893,decreased adiponectin level|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005416,abnormal circulating protein level|MP:0005670,abnormal white adipose tissue physiology|MP:0006036,abnormal mitochondrial physiology|MP:0006319,abnormal epididymal fat pad morphology|MP:0008902,abnormal renal fat pad morphology|MP:0009118,increased white fat cell size|MP:0011169,abnormal white fat cell differentation|MP:0013245,abnormal lipid metabolism|MP:0013279,increased fasting circulating glucose level|MP:0014142,increased body fat mass|MP:0014172,decreased fatty acid oxidation|MP:0030968,decreased circulating adiponectin level
MGI:3848347	Prdx4<tm1.1Jufu>	MP:0002687,oligozoospermia|MP:0003205,testicular atrophy|MP:0003674,oxidative stress|MP:0004852,decreased testis weight|MP:0014052,increased male germ cell apoptosis
MGI:6719042	Prdx5<tm1.1(KOMP)Vlcg>	MP:0003186,abnormal redox activity|MP:0003674,oxidative stress|MP:0003957,abnormal nitric oxide homeostasis|MP:0005290,decreased oxygen consumption|MP:0005387,immune system phenotype|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008647,increased circulating interleukin-12b level|MP:0008669,increased interleukin-12b secretion|MP:0008705,increased interleukin-6 secretion|MP:0010954,abnormal cellular respiration|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport
MGI:6458912	Prdx5<tm1Dsle>	MP:0001260,increased body weight|MP:0002079,increased circulating insulin level|MP:0002981,increased liver weight|MP:0003674,oxidative stress|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005336,abnormal inguinal fat pad morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0006319,abnormal epididymal fat pad morphology|MP:0009355,increased liver triglyceride level|MP:0031269,increased susceptibility to diet-induced hepatic steatosis
MGI:2683326	Prdx6<tm1Abf>	MP:0002169,no abnormal phenotype detected
MGI:4431891	Prdx6<tm1a(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:2668338	Prdx6<tm1Pgn>	MP:0000523,cortical renal glomerulopathies|MP:0000533,kidney hemorrhage|MP:0001182,lung hemorrhage|MP:0002128,abnormal blood circulation|MP:0002132,abnormal respiratory system morphology|MP:0002135,abnormal kidney morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002271,abnormal pulmonary alveolar duct morphology|MP:0002551,abnormal blood coagulation|MP:0002703,abnormal renal tubule morphology|MP:0003674,oxidative stress|MP:0003888,liver hemorrhage|MP:0009640,abnormal renal tubule epithelium morphology|MP:0010857,pulmonary necrosis|MP:0010858,pulmonary epithelial necrosis|MP:0010894,pulmonary alveolar edema|MP:0010909,pulmonary alveolar hemorrhage|MP:0011402,renal cast|MP:0031158,abnormal venous thrombosis|MP:0031161,abnormal kidney venous thrombosis
MGI:5817017	Prdx6<tm2Abf>	MP:0004777,abnormal phospholipid level|MP:0004782,abnormal surfactant physiology
MGI:6382785	Preb<em1(IMPC)J>	MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3640543	Pregq1<C57BL/10SnSg>	MP:0002161,abnormal fertility/fecundity
MGI:3640545	Pregq2<C57BL/10SnSg>	MP:0002161,abnormal fertility/fecundity
MGI:3640547	Pregq3<C57BL/10SnSg>	MP:0002161,abnormal fertility/fecundity
MGI:5437508	Prelid1<tm1Hmva>	MP:0002169,no abnormal phenotype detected
MGI:5637093	Prelid2<tm1b(EUCOMM)Wtsi>	MP:0000274,enlarged heart|MP:0003960,increased lean body mass
MGI:5548757	Prelp<tm1.1(KOMP)Vlcg>	MP:0000194,increased circulating calcium level|MP:0001258,decreased body length|MP:0005344,increased circulating bilirubin level
MGI:4329536	Prep<Gt(RRM213)Byg>	MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0002981,increased liver weight|MP:0003917,increased kidney weight|MP:0003918,decreased kidney weight|MP:0004952,increased spleen weight|MP:0005458,increased percent body fat/body weight|MP:0005669,increased circulating leptin level|MP:0006086,decreased body mass index|MP:0006087,increased body mass index|MP:0010025,decreased total body fat amount
MGI:6285592	Prepl<em1(IMPC)H>	MP:0001333,absent optic nerve|MP:0001406,abnormal gait|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5629515	Prepl<tm1.2Sagh>	MP:0000746,weakness|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001523,impaired righting response|MP:0001732,postnatal growth retardation|MP:0004144,hypotonia|MP:0008489,slow postnatal weight gain
MGI:5471425	Prep<tm1b(KOMP)Wtsi>	MP:0002702,decreased circulating free fatty acids level|MP:0005627,increased circulating potassium level|MP:0005633,increased circulating sodium level|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0020870,decreased thigmotaxis
MGI:5427690	Prep<tm1Dgen>	MP:0001488,increased startle reflex|MP:0009142,decreased prepulse inhibition
MGI:3716869	Prex1<tm1Dwu>	MP:0008720,impaired neutrophil chemotaxis
MGI:3716859	Prex1<tm1Hcew>	MP:0000219,increased neutrophil cell number|MP:0000601,small liver|MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001441,increased grooming behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0001475,reduced long-term depression|MP:0002063,abnormal learning/memory/conditioning|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype|MP:0008719,impaired neutrophil recruitment|MP:0008720,impaired neutrophil chemotaxis|MP:0012307,impaired spatial learning|MP:0020351,decreased vocalization
MGI:6257467	Prex2<em1(IMPC)Bay>	MP:0000280,thin ventricular wall
MGI:3856561	Prex2<Gt(AH0440)Wtsi>	MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level
MGI:3783295	Prex2<Gt(RRD186)Byg>	MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0001488,increased startle reflex|MP:0001513,limb grasping|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:5607639	Prf1<m1Btlr>	MP:0020916,increased susceptibility to Herpesvirales infection|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:5708283	Prf1<tm1.1(KOMP)Vlcg>	MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:2158403	Prf1<tm1Clrk>	MP:0001829,increased activated T cell number|MP:0003009,abnormal cytokine secretion|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005387,immune system phenotype|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0020913,increased susceptibility to Riboviria infection
MGI:3829709	Prf1<tm1Geno>	MP:0002169,no abnormal phenotype detected
MGI:1857235	Prf1<tm1Sdz>	MP:0000188,abnormal circulating glucose level|MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000333,decreased bone marrow cell number|MP:0000420,ruffled hair|MP:0000921,demyelination|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001505,hunched posture|MP:0001552,increased circulating triglyceride level|MP:0001777,abnormal body temperature homeostasis|MP:0001828,abnormal T cell activation|MP:0001845,abnormal inflammatory response|MP:0001847,brain inflammation|MP:0001860,liver inflammation|MP:0002021,increased incidence of induced tumors|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002339,abnormal lymph node morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002406,increased susceptibility to infection|MP:0002412,increased susceptibility to bacterial infection|MP:0002442,abnormal leukocyte physiology|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0003339,decreased pancreatic beta cell number|MP:0003448,abnormal tumor morphology|MP:0003699,abnormal female reproductive system physiology|MP:0003865,lymph node inflammation|MP:0003945,abnormal lymphocyte physiology|MP:0004031,insulitis|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0004924,abnormal behavior|MP:0005027,increased susceptibility to parasitic infection|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005152,pancytopenia|MP:0005202,lethargy|MP:0005343,increased circulating aspartate transaminase level|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005534,decreased body temperature|MP:0005580,periinsulitis|MP:0006082,CNS inflammation|MP:0008476,increased spleen red pulp amount|MP:0008553,increased circulating tumor necrosis factor level|MP:0008567,decreased interferon-gamma secretion|MP:0008573,increased circulating interferon-alpha level|MP:0008577,increased circulating interferon-gamma level|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008635,increased circulating interleukin-18 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008660,increased interleukin-10 secretion|MP:0008791,decreased NK cell degranulation|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009022,abnormal brain meninges morphology|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009791,increased susceptibility to viral infection induced morbidity/mortality|MP:0009828,increased tumor latency|MP:0010210,abnormal circulating cytokine level|MP:0010308,decreased tumor latency|MP:0010766,abnormal NK cell physiology|MP:0011075,abnormal macrophage activation involved in immune response|MP:0011971,increased circulating lactate dehydrogenase level|MP:0012330,decreased circulating fibrinogen level|MP:0012431,increased lymphoma incidence|MP:0020913,increased susceptibility to Riboviria infection|MP:0020937,increased susceptibility to Picornaviridae infection|MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality|MP:0031052,lymph node necrosis
MGI:2158418	Prf1<tm1Tsc>	MP:0002411,decreased susceptibility to bacterial infection|MP:0002942,decreased circulating alanine transaminase level|MP:0003721,increased tumor growth/size|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0006414,decreased T cell apoptosis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010766,abnormal NK cell physiology
MGI:6120685	Prg2<tm1b(EUCOMM)Hmgu>	MP:0001510,abnormal coat appearance|MP:0010378,increased respiratory quotient|MP:0011959,abnormal eye posterior chamber depth
MGI:3027719	Prg2<tm1Nal>	MP:0001845,abnormal inflammatory response|MP:0002405,respiratory system inflammation|MP:0005061,abnormal eosinophil morphology
MGI:5605767	Prg3<tm1.1(KOMP)Vlcg>	MP:0002060,abnormal skin morphology
MGI:6341884	Prg4<em1(IMPC)Ccpcz>	MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002591,decreased mean corpuscular volume|MP:0002932,abnormal joint morphology|MP:0005292,improved glucose tolerance|MP:0005627,increased circulating potassium level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010053,decreased grip strength
MGI:5490969	Prg4<tm1(GFP/cre/ERT2)Abl>	MP:0000167,decreased chondrocyte number|MP:0002932,abnormal joint morphology|MP:0010768,mortality/aging
MGI:3513195	Prg4<tm1Mawa>	MP:0001406,abnormal gait|MP:0002932,abnormal joint morphology|MP:0002936,joint swelling|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003200,calcified joint|MP:0003807,camptodactyly|MP:0005385,cardiovascular system phenotype|MP:0006433,abnormal articular cartilage morphology
MGI:5581510	Prg4<tm2Mawa>	MP:0005508,abnormal skeleton morphology
MGI:5297388	Prickle1<b2b019Clo>	MP:0000111,cleft palate|MP:0000433,microcephaly|MP:0002639,micrognathia|MP:0010418,perimembraneous ventricular septal defect|MP:0011666,double outlet right ventricle, ventricular defect committed to aorta
MGI:6885945	Prickle1<em1Yzou>	MP:0001360,abnormal social investigation|MP:0001458,abnormal object recognition memory|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0008414,abnormal spatial reference memory|MP:0020357,abnormal excitatory synapse morphology
MGI:4941928	Prickle1<m1Ingm>	MP:0001650,abnormal seizure response to electrical stimulation|MP:0010768,mortality/aging
MGI:4941929	Prickle1<m2Ingm>	MP:0000445,short snout|MP:0001650,abnormal seizure response to electrical stimulation|MP:0009652,abnormal palatal rugae morphology|MP:0009655,abnormal secondary palate development|MP:0009886,failure of palatal shelf elevation|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0009897,decreased maxillary shelf size|MP:0011091,prenatal lethality, complete penetrance|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0031460,abnormal palatal shelf morphology|MP:0031462,decreased palatal shelf size
MGI:5645931	Prickle1<tm1.2Asw>	MP:0000088,short mandible|MP:0000091,short premaxilla|MP:0000111,cleft palate|MP:0000166,abnormal chondrocyte morphology|MP:0000377,abnormal hair follicle morphology|MP:0000383,abnormal hair follicle orientation|MP:0000445,short snout|MP:0000547,short limbs|MP:0000592,short tail|MP:0000778,abnormal nervous system tract morphology|MP:0000807,abnormal hippocampus morphology|MP:0001265,decreased body size|MP:0001302,eyelids open at birth|MP:0002084,abnormal developmental patterning|MP:0002110,abnormal digit morphology|MP:0002135,abnormal kidney morphology|MP:0002184,abnormal innervation|MP:0002233,abnormal nose morphology|MP:0002621,delayed neural tube closure|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0003419,delayed endochondral bone ossification|MP:0003675,kidney cyst|MP:0004077,abnormal striatum morphology|MP:0004110,transposition of great arteries|MP:0004471,short nasal bone|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004524,short cochlear hair cell stereocilia|MP:0004686,decreased length of long bones|MP:0004754,abnormal kidney collecting duct morphology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005306,abnormal phalanx morphology|MP:0006032,abnormal ureteric bud morphology|MP:0008151,increased diameter of long bones|MP:0008535,enlarged lateral ventricles|MP:0008727,increased heart right atrium size|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0009909,bifid tongue|MP:0010403,atrial septal defect|MP:0011085,postnatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012285,misaligned sternebrae|MP:0013179,wavy tail|MP:0014321,short forelimb|MP:0014730,abnormal myocardial fiber myofibril morphology|MP:0020301,short tongue|MP:0031131,myocardial fiber disarray
MGI:5645933	Prickle1<tm1.3Asw>	MP:0011085,postnatal lethality, complete penetrance
MGI:5645929	Prickle1<tm1Asw>	MP:0000445,short snout|MP:0000447,flattened snout|MP:0001258,decreased body length|MP:0001300,ocular hypertelorism|MP:0001340,abnormal eyelid morphology|MP:0002544,brachydactyly|MP:0004686,decreased length of long bones|MP:0005225,abnormal vertebrae development|MP:0013895,abnormal eyelid cilium morphology|MP:0030049,prominent forehead|MP:0030475,fused lower incisors
MGI:4356107	Prickle1<tm1Nue>	MP:0001650,abnormal seizure response to electrical stimulation|MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001724,abnormal extraembryonic endoderm formation|MP:0001730,embryonic growth arrest|MP:0003886,abnormal embryonic epiblast morphology|MP:0004759,decreased mitotic index|MP:0009760,abnormal mitotic spindle morphology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011255,abnormal anterior visceral endoderm cell migration|MP:0013504,increased embryonic tissue cell apoptosis
MGI:4941925	Prickle2<tm1Nue>	MP:0001650,abnormal seizure response to electrical stimulation|MP:0002906,increased susceptibility to pharmacologically induced seizures
MGI:6502853	Prickle3<em1Mxg>	MP:0001325,abnormal retina morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0006035,abnormal mitochondrial morphology|MP:0008067,retina ganglion cell degeneration|MP:0010097,abnormal retina blood vessel morphology|MP:0020339,abnormal retina ganglion cell dendrite morphology|MP:0031141,increased retina vascular tortuosity
MGI:5911622	Prim1<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0011100,preweaning lethality, complete penetrance|MP:0011185,absent primitive endoderm|MP:0012102,absent trophectoderm|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:3841111	Prima1<tm1Vebe>	MP:0005388,respiratory system phenotype|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:5905761	Primpol<em1Nki>	MP:0004815,abnormal somatic hypermutation frequency|MP:0005387,immune system phenotype
MGI:4268998	Primpol<Gt(OST296220)Lex>	MP:0002169,no abnormal phenotype detected
MGI:5575391	Primpol<tm1.2Ado>	MP:0004046,abnormal mitosis
MGI:5548900	Primpol<tm1b(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0001325,abnormal retina morphology|MP:0001925,male infertility
MGI:3029359	Prkaa1<tm1Sbj>	MP:0000208,decreased hematocrit|MP:0001129,impaired ovarian folliculogenesis|MP:0001585,hemolytic anemia|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002594,low mean erythrocyte cell number|MP:0002640,reticulocytosis|MP:0002680,decreased corpora lutea number|MP:0002682,decreased mature ovarian follicle number|MP:0003357,impaired granulosa cell differentiation|MP:0003657,abnormal erythrocyte osmotic lysis|MP:0003953,abnormal hormone level|MP:0004952,increased spleen weight|MP:0005319,abnormal enzyme/coenzyme level|MP:0005418,abnormal circulating hormone level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0009006,prolonged estrous cycle|MP:0010067,increased red blood cell distribution width|MP:0011124,increased primary ovarian follicle number|MP:0011128,increased tertiary ovarian follicle number|MP:0011385,abnormal testosterone level|MP:0014514,increased circulating anti-Mullerian hormone level|MP:0021106,abnormal secondary ovarian follicle morphology|MP:0031239,increased atretic ovarian follicle number|MP:0031383,increased secondary ovarian follicle number|MP:0031420,decreased superovulation rate|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:8276809	Prkaa2<em1Smz>	MP:0001524,impaired limb coordination|MP:0003203,increased neuron apoptosis|MP:0003461,abnormal response to novel object|MP:0005386,behavior/neurological phenotype|MP:0012307,impaired spatial learning|MP:0020379,abnormal sucrose solution preference
MGI:4836201	Prkaa2<tm1.1Sjm>	MP:0003548,pulmonary hypertension
MGI:2448467	Prkaa2<tm1.1Vio>	MP:0001554,increased circulating free fatty acids level|MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0004183,abnormal sympathetic nervous system physiology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005438,abnormal glycogen homeostasis|MP:0005668,decreased circulating leptin level|MP:0010399,decreased skeletal muscle glycogen level|MP:0011478,abnormal urine catecholamine level|MP:0031618,decreased skeletal muscle cell glucose uptake|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:5636958	Prkaa2<tm1b(EUCOMM)Hmgu>	MP:0000691,enlarged spleen|MP:0001417,decreased exploration in new environment|MP:0002941,increased circulating alanine transaminase level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0008935,decreased mean platelet volume|MP:0010088,decreased circulating fructosamine level|MP:0010090,increased circulating creatine kinase level|MP:0013278,decreased fasting circulating glucose level
MGI:2448466	Prkaa2<tm1Vio>	MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0003383,abnormal gluconeogenesis|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology|MP:0005266,abnormal metabolism|MP:0005281,increased fatty acids level|MP:0005293,impaired glucose tolerance|MP:0005317,increased triglyceride level|MP:0005376,homeostasis/metabolism phenotype|MP:0005458,increased percent body fat/body weight|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0009746,enhanced behavioral response to xenobiotic|MP:0011958,increased compensatory feeding amount|MP:0030969,increased circulating adiponectin level
MGI:6257561	Prkab1<em1(IMPC)Bay>	MP:0004952,increased spleen weight
MGI:5642073	Prkab1<em1(IMPC)J>	MP:0002591,decreased mean corpuscular volume|MP:0005293,impaired glucose tolerance|MP:0005562,decreased mean corpuscular hemoglobin|MP:0013278,decreased fasting circulating glucose level
MGI:3838355	Prkab1<Gt(RRR454)Byg>	MP:0000745,tremors|MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000888,absent cerebellar granule layer|MP:0000920,abnormal myelination|MP:0001262,decreased body weight|MP:0001330,abnormal optic nerve morphology|MP:0001393,ataxia|MP:0002064,seizures|MP:0002182,abnormal astrocyte morphology|MP:0003240,loss of hippocampal neurons|MP:0003354,astrocytosis|MP:0004948,abnormal neuronal precursor proliferation|MP:0005404,abnormal axon morphology|MP:0006221,optic nerve hypoplasia|MP:0008025,brain vacuoles|MP:0008143,abnormal dendrite morphology|MP:0008489,slow postnatal weight gain|MP:0008924,decreased cerebellar granule cell number|MP:0008948,decreased neuron number|MP:0009808,decreased oligodendrocyte number|MP:0009937,abnormal neuron differentiation|MP:0011085,postnatal lethality, complete penetrance|MP:0014185,cerebellum atrophy
MGI:4362414	Prkab1<tm1a(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0002169,no abnormal phenotype detected|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005344,increased circulating bilirubin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0006063,abnormal inferior vena cava morphology|MP:0010093,decreased circulating magnesium level|MP:0013873,abnormal ductus venosus morphology
MGI:5501071	Prkab1<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000198,decreased circulating phosphate level|MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000256,echinocytosis|MP:0000274,enlarged heart|MP:0000314,schistocytosis|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001262,decreased body weight|MP:0001293,anophthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001404,no spontaneous movement|MP:0001585,hemolytic anemia|MP:0002135,abnormal kidney morphology|MP:0002397,abnormal bone marrow morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002626,increased heart rate|MP:0002631,abnormal epididymis morphology|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002792,abnormal retina vasculature morphology|MP:0002810,microcytic anemia|MP:0002813,microcytosis|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003020,decreased circulating chloride level|MP:0003068,enlarged kidney|MP:0003135,increased erythroid progenitor cell number|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003918,decreased kidney weight|MP:0004151,decreased circulating iron level|MP:0004931,enlarged epididymis|MP:0004952,increased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005344,increased circulating bilirubin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0006353,increased glycosylated hemoglobin level|MP:0006358,absent pinna reflex|MP:0008476,increased spleen red pulp amount|MP:0008805,decreased circulating amylase level|MP:0008809,increased spleen iron level|MP:0009454,impaired contextual conditioning behavior|MP:0010053,decreased grip strength|MP:0010067,increased red blood cell distribution width|MP:0010074,stomatocytosis|MP:0010097,abnormal retina blood vessel morphology|MP:0010124,decreased bone mineral content|MP:0010177,acanthocytosis|MP:0010507,shortened RR interval|MP:0010895,increased lung compliance|MP:0011045,decreased lung elastance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011178,increased erythroblast number|MP:0011285,increased circulating erythropoietin level|MP:0011890,increased circulating ferritin level|MP:0011913,abnormal reticulocyte cell number|MP:0011965,decreased total retina thickness|MP:0013279,increased fasting circulating glucose level|MP:0013418,increased memory-marker gamma-delta T cell number|MP:0013514,increased memory-marker CD4-negative NK T cell number|MP:0013675,decreased Ly6C-positive mature NK cell number|MP:0020420,abnormal freezing behavior|MP:0031084,decreased erythrocyte osmotic fragility
MGI:4439277	Prkab1<tm1Eihl>	MP:0001262,decreased body weight|MP:0001547,abnormal lipid level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008597,decreased circulating interleukin-6 level|MP:0009289,decreased epididymal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0010080,abnormal hepatocyte physiology|MP:0011940,decreased food intake|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:4345788	Prkab2<Gt(AL0483)Wtsi>	MP:0001552,increased circulating triglyceride level|MP:0002079,increased circulating insulin level|MP:0002715,decreased glycogen catabolism rate|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005560,decreased circulating glucose level|MP:0010024,increased total body fat amount|MP:0010399,decreased skeletal muscle glycogen level|MP:0012106,impaired exercise endurance|MP:0030022,decreased muscle cell glucose uptake
MGI:4868754	Prkab2<tm1.1Grst>	MP:0000747,muscle weakness|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0005331,insulin resistance|MP:0005658,increased susceptibility to diet-induced obesity|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009400,decreased skeletal muscle fiber size|MP:0010398,decreased liver glycogen level|MP:0010399,decreased skeletal muscle glycogen level|MP:0012106,impaired exercise endurance|MP:0030021,increased muscle cell glucose uptake|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:5636959	Prkab2<tm1b(EUCOMM)Hmgu>	MP:0005011,increased eosinophil cell number|MP:0008935,decreased mean platelet volume|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5293372	Prkab2<tm1Grst>	MP:0012106,impaired exercise endurance
MGI:2181021	Prkaca<tm1Gsm>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0002113,abnormal skeleton development|MP:0002675,asthenozoospermia|MP:0002963,decreased urine protein level|MP:0005389,reproductive system phenotype|MP:0009346,decreased trabecular bone thickness|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3054825	Prkaca<tm2Gsm>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002675,asthenozoospermia
MGI:3610390	Prkaca<tm3Gsm>	MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001552,increased circulating triglyceride level|MP:0001732,postnatal growth retardation|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0005375,adipose tissue phenotype|MP:0005438,abnormal glycogen homeostasis|MP:0005559,increased circulating glucose level|MP:0010398,decreased liver glycogen level
MGI:4821830	Prkaca<tm4.1Gsm>	MP:0002674,abnormal sperm motility
MGI:6315510	Prkacb<em1(IMPC)H>	MP:0002941,increased circulating alanine transaminase level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2180946	Prkacb<tm1Gsm>	MP:0001473,reduced long-term potentiation|MP:0001899,absent long-term depression|MP:0002917,decreased synaptic depression
MGI:2651519	Prkacb<tm2Gsm>	MP:0001454,abnormal cued conditioning behavior|MP:0003633,abnormal nervous system physiology|MP:0005386,behavior/neurological phenotype
MGI:4880680	Prkag1<tm1.2Mfor>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000248,macrocytosis|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001585,hemolytic anemia|MP:0001770,abnormal iron level|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003656,abnormal erythrocyte physiology|MP:0005344,increased circulating bilirubin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008114,abnormal Kupffer cell morphology|MP:0008476,increased spleen red pulp amount|MP:0008807,increased liver iron level|MP:0008809,increased spleen iron level|MP:0009568,abnormal red blood cell deformability|MP:0010035,increased erythrocyte clearance|MP:0010067,increased red blood cell distribution width
MGI:5829423	Prkag2<em1(IMPC)J>	MP:0001417,decreased exploration in new environment|MP:0010052,increased grip strength|MP:0020870,decreased thigmotaxis
MGI:5907189	Prkag2<tm1.1Geno>	MP:0001433,polyphagia|MP:0001845,abnormal inflammatory response|MP:0002626,increased heart rate|MP:0002628,hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0003212,increased susceptibility to age related obesity|MP:0003562,abnormal pancreatic beta cell physiology|MP:0004115,abnormal sinoatrial node morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005333,decreased heart rate|MP:0006142,abnormal sinoatrial node conduction|MP:0009118,increased white fat cell size|MP:0010637,sinus bradycardia|MP:0014071,increased cardiac muscle glycogen level|MP:0014142,increased body fat mass|MP:0031602,white adipose tissue inflammation
MGI:6435147	Prkag2<tm2.1Mrl>	MP:0001625,cardiac hypertrophy|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002891,increased insulin sensitivity|MP:0004122,abnormal sinus arrhythmia|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005333,decreased heart rate|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009732,ventricular premature beat|MP:0010401,increased skeletal muscle glycogen level|MP:0010507,shortened RR interval|MP:0010511,shortened PR interval|MP:0011954,shortened PQ interval|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:6435148	Prkag2<tm3.1Mrl>	MP:0001625,cardiac hypertrophy|MP:0001859,kidney inflammation|MP:0002135,abnormal kidney morphology|MP:0002575,increased circulating ketone body level|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002703,abnormal renal tubule morphology|MP:0002891,increased insulin sensitivity|MP:0002962,increased urine protein level|MP:0003675,kidney cyst|MP:0004122,abnormal sinus arrhythmia|MP:0004193,abnormal kidney papilla morphology|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005333,decreased heart rate|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009732,ventricular premature beat|MP:0010401,increased skeletal muscle glycogen level|MP:0010507,shortened RR interval|MP:0010511,shortened PR interval|MP:0010999,proteinosis|MP:0011368,increased kidney apoptosis|MP:0011940,decreased food intake|MP:0011954,shortened PQ interval|MP:0014071,increased cardiac muscle glycogen level|MP:0020153,abnormal urine albumin level|MP:0031003,increased kidney glycogen level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3055131	Prkag3<tm1Sson>	MP:0002078,abnormal glucose homeostasis|MP:0010399,decreased skeletal muscle glycogen level
MGI:6682077	Prkar1a<tm1.1Geno>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000428,abnormal craniofacial morphology|MP:0000445,short snout|MP:0000547,short limbs|MP:0000592,short tail|MP:0001258,decreased body length|MP:0001732,postnatal growth retardation|MP:0001926,female infertility|MP:0002113,abnormal skeleton development|MP:0002116,abnormal craniofacial bone morphology|MP:0002544,brachydactyly|MP:0002657,chondrodystrophy|MP:0002904,increased circulating parathyroid hormone level|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004214,abnormal long bone diaphysis morphology|MP:0004686,decreased length of long bones|MP:0009643,abnormal urine homeostasis|MP:0010876,decreased bone volume|MP:0011091,prenatal lethality, complete penetrance
MGI:3580100	Prkar1a<tm1.1Lsk>	MP:0000063,decreased bone mineral density|MP:0001924,infertility|MP:0002020,increased tumor incidence|MP:0002896,abnormal bone mineralization|MP:0003789,increased osteosarcoma incidence|MP:0010280,increased skeletal tumor incidence|MP:0010310,increased Schwannoma incidence|MP:0010316,increased thyroid tumor incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3512112	Prkar1a<tm1.2Lsk>	MP:0000681,abnormal thyroid gland morphology|MP:0002998,abnormal bone remodeling|MP:0003502,increased activity of thyroid gland|MP:0005123,increased circulating growth hormone level|MP:0005134,decreased thyroid-stimulating hormone level|MP:0005355,enlarged thyroid gland|MP:0005470,increased thyroxine level|MP:0008018,increased facial tumor incidence|MP:0010280,increased skeletal tumor incidence|MP:0010310,increased Schwannoma incidence|MP:0010320,increased pituitary gland tumor incidence|MP:0010346,increased thyroid carcinoma incidence|MP:0011087,neonatal lethality, complete penetrance
MGI:2183602	Prkar1a<tm1Gsm>	MP:0000358,abnormal cell morphology|MP:0000474,abnormal foregut morphology|MP:0001186,pigmentation phenotype|MP:0001691,abnormal somite shape|MP:0001697,abnormal embryo size|MP:0001698,decreased embryo size|MP:0001922,reduced male fertility|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002231,abnormal primitive streak morphology|MP:0002724,enhanced wound healing|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003667,increased hemangiosarcoma incidence|MP:0003929,decreased heart rate variability|MP:0003984,embryonic growth retardation|MP:0004180,failure of initiation of embryo turning|MP:0010363,increased fibrosarcoma incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011205,excessive folding of visceral yolk sac|MP:0011732,decreased somite size|MP:0012081,absent heart tube|MP:0012183,decreased paraxial mesoderm size|MP:0012272,decreased axial mesoderm size|MP:0012498,abnormal cardiogenic plate morphology
MGI:4456236	Prkar1a<tm1Lsk>	MP:0000013,abnormal adipose tissue distribution|MP:0001745,increased circulating corticosterone level|MP:0002169,no abnormal phenotype detected|MP:0002909,abnormal adrenal gland physiology|MP:0008288,abnormal adrenal cortex morphology|MP:0008293,abnormal adrenal gland zona glomerulosa morphology|MP:0008297,retention of the adrenal gland x-zone|MP:0008299,adrenal cortical hyperplasia|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0013579,increased adrenal gland apoptosis|MP:0014285,disorganized adrenal gland zona fasciculata|MP:0014287,decreased adrenal gland zona fasciculata size
MGI:3845256	Prkar1a<tm2Gsm>	MP:0000445,short snout|MP:0000496,abnormal small intestine morphology|MP:0001262,decreased body weight|MP:0001270,distended abdomen|MP:0001337,dry eyes|MP:0001344,blepharoptosis|MP:0001783,decreased white adipose tissue amount|MP:0002083,premature death|MP:0002233,abnormal nose morphology|MP:0002269,muscular atrophy|MP:0003270,intestinal obstruction|MP:0003290,intestinal hypoperistalsis|MP:0004816,abnormal class switch recombination|MP:0005381,digestive/alimentary phenotype|MP:0005382,craniofacial phenotype|MP:0006002,abnormal small intestinal transit time|MP:0011881,distended duodenum
MGI:2158640	Prkar1b<tm1Gsm>	MP:0001473,reduced long-term potentiation|MP:0001475,reduced long-term depression|MP:0001876,decreased inflammatory response|MP:0001973,increased thermal nociceptive threshold|MP:0002736,abnormal nociception after inflammation|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:2158358	Prkar2a<tm1Gsm>	MP:0002169,no abnormal phenotype detected
MGI:2158642	Prkar2b<tm1Gsm>	MP:0000183,decreased circulating LDL cholesterol level|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001433,polyphagia|MP:0001783,decreased white adipose tissue amount|MP:0002727,decreased circulating insulin level|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005318,decreased triglyceride level|MP:0005376,homeostasis/metabolism phenotype|MP:0005449,abnormal food intake|MP:0005450,abnormal energy expenditure|MP:0005533,increased body temperature|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0009356,decreased liver triglyceride level|MP:0009749,enhanced behavioral response to addictive substance|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3773428	Prkar2b<tm2Gsm>	MP:0001433,polyphagia|MP:0005459,decreased percent body fat/body weight|MP:0005668,decreased circulating leptin level|MP:0031391,increased locomotor activity
MGI:5515221	Prkar2b<tm3Gsm>	MP:0000183,decreased circulating LDL cholesterol level|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001783,decreased white adipose tissue amount|MP:0002310,decreased susceptibility to hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0004889,increased energy expenditure|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005318,decreased triglyceride level|MP:0005449,abnormal food intake|MP:0005450,abnormal energy expenditure|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0009356,decreased liver triglyceride level|MP:0010024,increased total body fat amount|MP:0010378,increased respiratory quotient
MGI:3603307	Prkca<tm1Cda>	MP:0001222,epidermal hyperplasia|MP:0002051,increased skin papilloma incidence
MGI:2679305	Prkca<tm1Far>	MP:0003631,nervous system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0030016,increased adipocyte glucose uptake|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:3037088	Prkca<tm1Jmk>	MP:0002972,abnormal cardiac muscle contractility|MP:0004486,decreased response of heart to induced stress|MP:0005329,abnormal myocardium layer morphology|MP:0005385,cardiovascular system phenotype
MGI:4835545	Prkcb<M1Btlr>	MP:0001806,decreased IgM level|MP:0005387,immune system phenotype
MGI:5615710	Prkcb<M2Btlr>	MP:0001806,decreased IgM level|MP:0020001,decreased response to antigen|MP:0020154,impaired humoral immune response
MGI:5615714	Prkcb<M3Btlr>	MP:0001806,decreased IgM level|MP:0020001,decreased response to antigen|MP:0020154,impaired humoral immune response
MGI:6305123	Prkcb<M4Btlr>	MP:0004978,decreased B-1 B cell number|MP:0005015,increased T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:6305128	Prkcb<M5Btlr>	MP:0001806,decreased IgM level|MP:0020154,impaired humoral immune response
MGI:6305150	Prkcb<M6Btlr>	MP:0004978,decreased B-1 B cell number
MGI:4819152	Prkcb<tilc>	MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0005093,decreased B cell proliferation|MP:0005387,immune system phenotype|MP:0008168,decreased B-1a cell number|MP:0008498,decreased IgG3 level
MGI:2183193	Prkcb<tm1Tara>	MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0003631,nervous system phenotype|MP:0004883,abnormal vascular wound healing|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0008168,decreased B-1a cell number|MP:0008498,decreased IgG3 level
MGI:6199962	Prkcd<M1Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:6199966	Prkcd<m2Btlr>	MP:0002494,increased IgM level|MP:0008044,increased NK cell number|MP:0008537,increased susceptibility to induced colitis|MP:0020155,enhanced humoral immune response
MGI:5699182	Prkcd<tm1.1Chou>	MP:0002463,abnormal neutrophil physiology
MGI:5086282	Prkcd<tm1.1Khn>	MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance
MGI:2179710	Prkcd<tm1Kin>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001262,decreased body weight|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002490,abnormal immunoglobulin level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002743,glomerulonephritis|MP:0003059,decreased insulin secretion|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0004829,increased anti-chromatin antibody level|MP:0005014,increased B cell number|MP:0005088,increased acute inflammation|MP:0005154,increased B cell proliferation|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0008099,abnormal plasma cell differentiation|MP:0008173,increased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008189,increased transitional stage B cell number|MP:0008271,abnormal bone ossification|MP:0008395,abnormal osteoblast differentiation|MP:0008481,increased spleen germinal center number|MP:0008499,increased IgG1 level|MP:0008522,abnormal lymph node germinal center morphology|MP:0008705,increased interleukin-6 secretion|MP:0020519,renal glomerular immunoglobulin deposits
MGI:3046799	Prkcd<tm1Msg>	MP:0000222,decreased neutrophil cell number|MP:0002463,abnormal neutrophil physiology|MP:0003075,abnormal response to CNS ischemic injury
MGI:2385756	Prkcd<tm1Qxu>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001262,decreased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0002083,premature death|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002891,increased insulin sensitivity|MP:0003131,increased erythrocyte cell number|MP:0003991,arteriosclerosis|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005014,increased B cell number|MP:0005292,improved glucose tolerance|MP:0005387,immune system phenotype|MP:0005489,vascular smooth muscle hyperplasia|MP:0005671,abnormal response to transplant|MP:0008499,increased IgG1 level|MP:0008782,increased B cell apoptosis|MP:0009356,decreased liver triglyceride level
MGI:6269444	Prkce<m1Btlr>	MP:0008045,decreased NK cell number|MP:0008127,decreased dendritic cell number
MGI:3524969	Prkce<tm1Bai>	MP:0005387,immune system phenotype
MGI:3609215	Prkce<tm1Bsca>	MP:0001120,abnormal uterus morphology|MP:0001123,dilated uterus|MP:0001265,decreased body size|MP:0001923,reduced female fertility|MP:0002412,increased susceptibility to bacterial infection|MP:0003037,increased myocardial infarct size|MP:0005095,decreased T cell proliferation|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0010025,decreased total body fat amount|MP:0011077,decreased macrophage nitric oxide production|MP:0011081,decreased macrophage apoptosis
MGI:2680163	Prkce<tm1Ltg>	MP:0008561,decreased tumor necrosis factor secretion
MGI:6865661	Prkcg<em1Jpka>	MP:0000889,abnormal cerebellar molecular layer|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0002184,abnormal innervation|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:3603180	Prkcg<tm1(cre)Zfc>	MP:0002169,no abnormal phenotype detected
MGI:1857237	Prkcg<tm1Stl>	MP:0001364,decreased anxiety-related response|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0001876,decreased inflammatory response|MP:0001970,abnormal pain threshold|MP:0001987,alcohol preference|MP:0002736,abnormal nociception after inflammation|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype|MP:0009751,enhanced behavioral response to alcohol|MP:0009755,impaired behavioral response to alcohol|MP:0010698,abnormal impulsive behavior control
MGI:5431008	Prkch<tm1.2Gasc>	MP:0000702,enlarged lymph nodes|MP:0001823,thymus hypoplasia|MP:0002339,abnormal lymph node morphology|MP:0002351,abnormal cervical lymph node morphology|MP:0002435,abnormal effector T cell morphology|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0005231,abnormal brachial lymph node morphology|MP:0008049,increased memory T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008542,enlarged cervical lymph nodes|MP:0009623,enlarged inguinal lymph nodes|MP:0009631,enlarged axillary lymph nodes|MP:0010130,decreased DN1 thymic pro-T cell number|MP:0010136,decreased DN4 thymocyte number
MGI:5694739	Prkch<tm1b(EUCOMM)Hmgu>	MP:0003960,increased lean body mass|MP:0010053,decreased grip strength
MGI:2663731	Prkch<tm1Cda>	MP:0001222,epidermal hyperplasia|MP:0001262,decreased body weight|MP:0001792,impaired wound healing|MP:0002051,increased skin papilloma incidence|MP:0002908,delayed wound healing|MP:0003671,abnormal eyelid aperture|MP:0004499,increased incidence of tumors by chemical induction|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5520927	Prkci<tm1.1Rfar>	MP:0000270,abnormal heart tube morphology|MP:0000358,abnormal cell morphology|MP:0001680,abnormal mesoderm development|MP:0001705,abnormal proximal-distal axis patterning|MP:0003087,absent allantois|MP:0003984,embryonic growth retardation|MP:0004559,small allantois|MP:0005221,abnormal rostral-caudal axis patterning|MP:0006386,absent somites|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011190,thick embryonic epiblast|MP:0011257,abnormal head fold morphology|MP:0012081,absent heart tube|MP:0012104,small amniotic cavity
MGI:3054940	Prkci<tm1Hed>	MP:0000358,abnormal cell morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:3526850	Prkci<tm1Kido>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001318,pupil opacity|MP:0001320,small pupil|MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0001891,hydrocephaly|MP:0002579,disorganized secondary lens fibers|MP:0002694,abnormal pancreas secretion|MP:0003237,abnormal lens epithelium morphology|MP:0005193,abnormal anterior eye segment morphology|MP:0005199,abnormal iris pigment epithelium|MP:0005293,impaired glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0008583,absent photoreceptor inner segment|MP:0008585,absent photoreceptor outer segment
MGI:5520924	Prkci<tm1Ltg>	MP:0000270,abnormal heart tube morphology|MP:0001705,abnormal proximal-distal axis patterning|MP:0003087,absent allantois|MP:0003984,embryonic growth retardation|MP:0004559,small allantois|MP:0005221,abnormal rostral-caudal axis patterning|MP:0006386,absent somites|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011190,thick embryonic epiblast|MP:0011257,abnormal head fold morphology|MP:0012081,absent heart tube|MP:0012104,small amniotic cavity
MGI:3720810	Prkci<tm1Rfar>	MP:0000182,increased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001260,increased body weight|MP:0001261,obese|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001732,postnatal growth retardation|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0002705,dilated renal tubule|MP:0002962,increased urine protein level|MP:0003606,kidney failure|MP:0003949,abnormal circulating lipid level|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005178,increased circulating cholesterol level|MP:0005264,glomerulosclerosis|MP:0005293,impaired glucose tolerance|MP:0005326,abnormal podocyte morphology|MP:0005331,insulin resistance|MP:0005491,pancreatic islet hyperplasia|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0008060,abnormal podocyte slit diaphragm morphology|MP:0008062,abnormal podocyte slit junction morphology|MP:0008140,podocyte foot process effacement|MP:0011402,renal cast|MP:0011939,increased food intake|MP:0030017,decreased adipocyte glucose uptake|MP:0030020,decreased cardiac muscle cell glucose uptake|MP:0030022,decreased muscle cell glucose uptake|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:5520925	Prkci<tm2.1(Prkcz)Ltg>	MP:0003984,embryonic growth retardation|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011111,lethality during fetal growth through weaning, complete penetrance
MGI:6114110	Prkcq<m1Btlr>	MP:0001805,decreased IgG level|MP:0020154,impaired humoral immune response
MGI:6114114	Prkcq<m2Btlr>	MP:0001805,decreased IgG level|MP:0020154,impaired humoral immune response
MGI:5639127	Prkcq<rpea1>	MP:0001006,abnormal retina cone cell morphology|MP:0002864,abnormal ocular fundus morphology|MP:0003099,retina detachment|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0005103,abnormal retina pigmentation|MP:0005548,retina pigment epithelium atrophy|MP:0005551,abnormal eye electrophysiology|MP:0006237,abnormal choroid vasculature morphology|MP:0008449,abnormal retina cone cell outer segment morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0020442,serous retina detachment
MGI:2664377	Prkcq<tm1.1Bai>	MP:0002444,abnormal T cell physiology|MP:0005095,decreased T cell proliferation|MP:0008688,decreased interleukin-2 secretion
MGI:5695978	Prkcq<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001925,male infertility
MGI:2664379	Prkcq<tm1Litt>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0001326,retina degeneration|MP:0001828,abnormal T cell activation|MP:0002078,abnormal glucose homeostasis|MP:0002335,decreased airway responsiveness|MP:0002435,abnormal effector T cell morphology|MP:0002864,abnormal ocular fundus morphology|MP:0002891,increased insulin sensitivity|MP:0002914,abnormal endplate potential|MP:0003099,retina detachment|MP:0003861,abnormal nervous system development|MP:0004130,abnormal muscle cell glucose uptake|MP:0004185,abnormal adipocyte glucose uptake|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004919,abnormal positive T cell selection|MP:0005025,abnormal response to infection|MP:0005095,decreased T cell proliferation|MP:0005172,decreased eye pigmentation|MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005464,abnormal platelet physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0006298,abnormal platelet activation|MP:0006413,increased T cell apoptosis|MP:0006414,decreased T cell apoptosis|MP:0008040,decreased NK T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008567,decreased interferon-gamma secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009335,decreased splenocyte proliferation|MP:0009446,abnormal platelet dense granule physiology|MP:0009586,increased platelet aggregation|MP:0010130,decreased DN1 thymic pro-T cell number
MGI:5705869	Prkcsh<tm1.1(KOMP)Vlcg>	MP:0001486,abnormal startle reflex|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5442302	Prkcsh<tm1.1Som>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5442170	Prkcsh<tm1Som>	MP:0002083,premature death|MP:0003327,liver cyst|MP:0003675,kidney cyst|MP:0004860,dilated kidney collecting duct|MP:0011344,abnormal loop of Henle ascending limb thick segment morphology
MGI:5485241	Prkcz<tm1.1Msg>	MP:0001364,decreased anxiety-related response|MP:0005386,behavior/neurological phenotype
MGI:5485243	Prkcz<tm1.1Rlh>	MP:0003631,nervous system phenotype
MGI:5485244	Prkcz<tm1.2Rlh>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:4433718	Prkcz<tm1a(EUCOMM)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0002075,abnormal coat/hair pigmentation|MP:0002877,abnormal melanocyte morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005343,increased circulating aspartate transaminase level|MP:0008810,increased circulating iron level
MGI:2183160	Prkcz<tm1Jmos>	MP:0000696,abnormal Peyer's patch morphology|MP:0002362,abnormal spleen marginal zone morphology|MP:0002389,abnormal Peyer's patch follicle morphology|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0008135,small Peyer's patches|MP:0014348,decreased spleen B cell follicle size
MGI:6153770	Prkd1<em2(IMPC)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0002079,increased circulating insulin level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:4867731	Prkd1<tm1.1Daca>	MP:0011090,perinatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3778382	Prkd1<tm1.1Eno>	MP:0011102,embryonic lethality, incomplete penetrance
MGI:3778381	Prkd1<tm1Eno>	MP:0001629,abnormal heart rate|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003921,abnormal heart left ventricle morphology|MP:0005599,increased cardiac muscle contractility
MGI:6257638	Prkd2<em1(IMPC)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001489,decreased startle reflex|MP:0002152,abnormal brain morphology|MP:0002941,increased circulating alanine transaminase level|MP:0009142,decreased prepulse inhibition|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake
MGI:4129995	Prkd2<Gt(RRJ380)Byg>	MP:0005387,immune system phenotype
MGI:4867730	Prkd2<tm1.1Daca>	MP:0001806,decreased IgM level|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008495,decreased IgG1 level|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion
MGI:5805706	Prkd2<tm1.1Shoy>	MP:0005387,immune system phenotype
MGI:3530140	Prkd3<Gt(OST191038)Lex>	MP:0000130,abnormal trabecular bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000559,abnormal femur morphology
MGI:6472607	Prkd3<tm1b(EUCOMM)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0010097,abnormal retina blood vessel morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:5009121	Prkdc<berty>	MP:0008070,absent T cells|MP:0008071,absent B cells
MGI:3574427	Prkdc<dxnph>	MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002135,abnormal kidney morphology|MP:0002962,increased urine protein level|MP:0005264,glomerulosclerosis|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:6257656	Prkdc<em2(IMPC)Ics>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0001566,increased circulating phosphate level|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:4820716	Prkdc<hanky>	MP:0000321,increased bone marrow cell number|MP:0001860,liver inflammation|MP:0001862,interstitial pneumonia|MP:0002816,colitis|MP:0005016,decreased lymphocyte cell number|MP:0005036,diarrhea|MP:0008097,increased plasma cell number|MP:0008102,lymph node hyperplasia|MP:0008466,enlarged mesenteric lymph nodes|MP:0009481,cecum inflammation|MP:0010373,myeloid hyperplasia
MGI:6114645	Prkdc<M10Btlr>	MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:6114652	Prkdc<M11Btlr>	MP:0002494,increased IgM level|MP:0020155,enhanced humoral immune response
MGI:6198357	Prkdc<m12Btlr>	MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008040,decreased NK T cell number|MP:0008044,increased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6285188	Prkdc<m13Btlr>	MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number
MGI:6285200	Prkdc<m14Btlr>	MP:0001260,increased body weight|MP:0008076,abnormal CD4-positive T cell differentiation
MGI:6285210	Prkdc<M15Btlr>	MP:0004978,decreased B-1 B cell number
MGI:6285484	Prkdc<M16Btlr>	MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation
MGI:6285488	Prkdc<m17Btlr>	MP:0008524,increased plasmacytoid dendritic cell number
MGI:6304295	Prkdc<m18Btlr>	MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0004978,decreased B-1 B cell number|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0012765,decreased alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6304458	Prkdc<m19Btlr>	MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008044,increased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:5563438	Prkdc<m1Anu>	MP:0002619,abnormal lymphocyte morphology
MGI:5299140	Prkdc<m1Btlr>	MP:0001790,abnormal immune system physiology|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0004816,abnormal class switch recombination|MP:0005017,decreased B cell number
MGI:5532715	Prkdc<m2Btlr>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002459,abnormal B cell physiology|MP:0005017,decreased B cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:5688503	Prkdc<m3Btlr>	MP:0001805,decreased IgG level|MP:0020154,impaired humoral immune response
MGI:6114123	Prkdc<m4Btlr>	MP:0000219,increased neutrophil cell number|MP:0005017,decreased B cell number|MP:0008169,increased B-1b cell number
MGI:6114130	Prkdc<m5Btlr>	MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0012764,increased alpha-beta T cell number
MGI:6114136	Prkdc<m6Btlr>	MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0012764,increased alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6114147	Prkdc<m7Btlr>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number
MGI:6114155	Prkdc<M8Btlr>	MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008524,increased plasmacytoid dendritic cell number
MGI:6114639	Prkdc<M9Btlr>	MP:0005014,increased B cell number|MP:0008168,decreased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0010845,decreased effector memory CD4-positive, alpha-beta T cell number
MGI:1857113	Prkdc<scid>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000238,absent pre-B cells|MP:0000322,increased granulocyte number|MP:0000333,decreased bone marrow cell number|MP:0000488,abnormal intestinal epithelium morphology|MP:0000687,small lymphoid organs|MP:0000694,spleen hypoplasia|MP:0000696,abnormal Peyer's patch morphology|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001841,decreased level of surface class I molecules|MP:0001870,salivary gland inflammation|MP:0001873,stomach inflammation|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0002223,lymphoid hypoplasia|MP:0002339,abnormal lymph node morphology|MP:0002344,abnormal lymph node B cell domain morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002367,abnormal thymus lobule morphology|MP:0002460,decreased immunoglobulin level|MP:0002471,abnormal complement pathway|MP:0002473,impaired complement classical pathway|MP:0002590,increased mean corpuscular volume|MP:0002831,absent Peyer's patches|MP:0002875,decreased erythrocyte cell number|MP:0002879,increased cellular sensitivity to X-ray irradiation induced cell death|MP:0004751,increased length of allograft survival|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005042,abnormal level of surface class II molecules|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005425,increased macrophage cell number|MP:0005559,increased circulating glucose level|MP:0005671,abnormal response to transplant|MP:0008044,increased NK cell number|MP:0008045,decreased NK cell number|MP:0008071,absent B cells|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008101,lymph node hypoplasia|MP:0008135,small Peyer's patches|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0009543,abnormal thymus corticomedullary boundary morphology|MP:0010250,absent thymus cortex|MP:0010766,abnormal NK cell physiology|MP:0014130,thymus cyst
MGI:3620758	Prkdc<Tg(INS-PDE2)5-1Lmb>	MP:0000703,abnormal thymus morphology|MP:0001658,increased mortality induced by gamma-irradiation|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death
MGI:4950416	Prkdc<tm1.1Bpcc>	MP:0000221,decreased leukocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0000334,decreased granulocyte number|MP:0000687,small lymphoid organs|MP:0001188,hyperpigmentation|MP:0001802,arrested B cell differentiation|MP:0002083,premature death|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0003717,pallor|MP:0003884,decreased macrophage cell number|MP:0003992,increased mortality induced by ionizing radiation|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0004810,decreased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005152,pancytopenia|MP:0008058,abnormal DNA repair|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008211,decreased mature B cell number|MP:0008347,decreased gamma-delta T cell number|MP:0008402,increased cellular sensitivity to alkylating agent induced cell death|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008489,slow postnatal weight gain|MP:0008755,abnormal immunoglobulin V(D)J recombination|MP:0008800,increased small intestinal crypt cell apoptosis|MP:0008943,increased sensitivity to induced cell death|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2667593	Prkdc<tm1Fwa>	MP:0000238,absent pre-B cells|MP:0000715,decreased thymocyte number|MP:0001802,arrested B cell differentiation|MP:0001825,arrested T cell differentiation|MP:0003631,nervous system phenotype|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0005092,decreased double-positive T cell number|MP:0008754,abnormal T cell receptor V(D)J recombination|MP:0008758,abnormal T cell receptor beta chain V(D)J recombination|MP:0009339,decreased splenocyte number
MGI:1857934	Prkdc<tm1Gcl>	MP:0000495,abnormal colon morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000706,small thymus|MP:0001802,arrested B cell differentiation|MP:0001823,thymus hypoplasia|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002009,preneoplasia|MP:0002024,increased T cell derived lymphoma incidence|MP:0002217,small lymph nodes|MP:0002339,abnormal lymph node morphology|MP:0002831,absent Peyer's patches|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005384,cellular phenotype|MP:0008011,intestine polyps|MP:0008135,small Peyer's patches|MP:0008212,absent mature B cells|MP:0008758,abnormal T cell receptor beta chain V(D)J recombination|MP:0008759,abnormal T cell receptor delta chain V(D)J recombination|MP:0008760,abnormal immunoglobulin heavy chain V(D)J recombination|MP:0009542,decreased thymocyte apoptosis|MP:0013741,absent thymus corticomedullary boundary
MGI:2383951	Prkdc<tm1Get>	MP:0000694,spleen hypoplasia|MP:0001802,arrested B cell differentiation|MP:0001806,decreased IgM level|MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002217,small lymph nodes|MP:0005090,increased double-negative T cell number|MP:0005091,increased double-positive T cell number|MP:0006387,abnormal T cell number|MP:0008044,increased NK cell number|MP:0008083,decreased single-positive T cell number|MP:0008479,decreased spleen white pulp amount|MP:0008756,abnormal T cell receptor alpha chain V-J recombination|MP:0008758,abnormal T cell receptor beta chain V(D)J recombination|MP:0008759,abnormal T cell receptor delta chain V(D)J recombination|MP:0008760,abnormal immunoglobulin heavy chain V(D)J recombination|MP:0008761,abnormal immunoglobulin light chain V-J recombination|MP:0009543,abnormal thymus corticomedullary boundary morphology
MGI:5313455	Prkg1<tm1.1Arte>	MP:0002842,increased systemic arterial blood pressure|MP:0003393,decreased cardiac output|MP:0004875,increased mean systemic arterial blood pressure|MP:0005591,decreased vasodilation|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure
MGI:5496128	Prkg1<tm1.1Pfe>	MP:0011167,abnormal adipose tissue development
MGI:5692576	Prkg1<tm1b(KOMP)Wtsi>	MP:0000274,enlarged heart|MP:0000691,enlarged spleen|MP:0001488,increased startle reflex|MP:0003271,abnormal duodenum morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2181586	Prkg1<tm1Hfm>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000231,hypertension|MP:0000477,abnormal intestine morphology|MP:0000740,impaired smooth muscle contractility|MP:0001379,abnormal penile erection|MP:0001780,decreased brown adipose tissue amount|MP:0001922,reduced male fertility|MP:0003157,impaired muscle relaxation|MP:0003289,abnormal intestinal peristalsis|MP:0003307,pyloric stenosis|MP:0004084,abnormal cardiac muscle relaxation|MP:0004875,increased mean systemic arterial blood pressure|MP:0005318,decreased triglyceride level|MP:0005595,abnormal vascular smooth muscle physiology|MP:0006001,abnormal intestinal transit time|MP:0009125,decreased brown fat cell lipid droplet size|MP:0010781,pyloric sphincter hypertrophy|MP:0010786,stomach fundus hypertrophy|MP:0011015,decreased body surface temperature|MP:0011167,abnormal adipose tissue development|MP:0011699,abnormal brown adipose tissue thermogenesis|MP:0014396,decreased fat cell mitochondrial DNA content
MGI:3789972	Prkg1<tm1Meme>	MP:0000249,abnormal blood vessel physiology|MP:0002842,increased systemic arterial blood pressure|MP:0004216,salt-resistant hypertension|MP:0004875,increased mean systemic arterial blood pressure|MP:0005367,renal/urinary system phenotype|MP:0005591,decreased vasodilation|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure
MGI:2668650	Prkg1<tm1Naw>	MP:0002083,premature death|MP:0002972,abnormal cardiac muscle contractility
MGI:2668653	Prkg1<tm2.1Naw>	MP:0000208,decreased hematocrit|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002083,premature death|MP:0002447,abnormal erythrocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002875,decreased erythrocyte cell number|MP:0004875,increased mean systemic arterial blood pressure|MP:0005418,abnormal circulating hormone level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005595,abnormal vascular smooth muscle physiology|MP:0006001,abnormal intestinal transit time|MP:0010035,increased erythrocyte clearance|MP:0010067,increased red blood cell distribution width
MGI:2668652	Prkg1<tm2Naw>	MP:0001898,abnormal long-term depression|MP:0002169,no abnormal phenotype detected|MP:0002972,abnormal cardiac muscle contractility|MP:0003289,abnormal intestinal peristalsis|MP:0006001,abnormal intestinal transit time|MP:0011082,abnormal gastrointestinal motility
MGI:5287505	Prkg1<Tn(sb-rtTA)2497B.SB2Ove>	MP:0011085,postnatal lethality, complete penetrance
MGI:2449704	Prkg2<tm1Pfe>	MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000438,abnormal cranium morphology|MP:0000505,decreased digestive secretion|MP:0000547,short limbs|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002427,disproportionate dwarf|MP:0002764,short tibia|MP:0003109,short femur|MP:0004351,short humerus|MP:0004359,short ulna|MP:0004610,small vertebrae|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0008271,abnormal bone ossification
MGI:3764690	Prkn<tm1Ccs>	MP:0000952,abnormal CNS glial cell morphology|MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0001905,abnormal dopamine level|MP:0002797,increased thigmotaxis|MP:0002882,abnormal neuron morphology|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0008025,brain vacuoles|MP:0009747,impaired behavioral response to xenobiotic
MGI:2678247	Prkn<tm1Roo>	MP:0000160,kyphosis|MP:0000414,alopecia|MP:0000811,hippocampal neuron degeneration|MP:0001262,decreased body weight|MP:0001388,abnormal stationary movement|MP:0001391,abnormal tail movements|MP:0001407,short stride length|MP:0001417,decreased exploration in new environment|MP:0001504,abnormal posture|MP:0001906,increased dopamine level|MP:0002083,premature death|MP:0002327,abnormal respiratory function|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration|MP:0003244,loss of dopaminergic neurons|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0003635,abnormal synaptic transmission|MP:0004250,tau protein deposits|MP:0005369,muscle phenotype|MP:0011014,decreased core body temperature|MP:0020543,decreased substantia nigra size
MGI:3055212	Prkn<tm1Rpa>	MP:0003631,nervous system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype
MGI:2681404	Prkn<tm1Shn>	MP:0000343,abnormal response to cardiac infarction|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001906,increased dopamine level|MP:0002272,abnormal nervous system electrophysiology|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0008260,abnormal autophagy|MP:0008943,increased sensitivity to induced cell death|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011631,decreased mitochondrial size|MP:0014046,abnormal mitophagy
MGI:3050230	Prkn<tm1Tmd>	MP:0001489,decreased startle reflex|MP:0003661,abnormal locus ceruleus morphology|MP:0012574,decreased noradrenaline level
MGI:3698054	Prkn<tm1Ykt>	MP:0001262,decreased body weight|MP:0001906,increased dopamine level|MP:0013219,abnormal substantia nigra pars compacta morphology
MGI:4949289	Prkn<tm2Tmd>	MP:0011448,decreased dopaminergic neuron number
MGI:6257728	Prkra<em1(IMPC)H>	MP:0001925,male infertility|MP:0002102,abnormal ear morphology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0005565,increased blood urea nitrogen level|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0020421,increased freezing behavior
MGI:4442387	Prkra<lear>	MP:0000018,small ears|MP:0001265,decreased body size|MP:0001921,reduced fertility|MP:0006325,impaired hearing
MGI:4442398	Prkra<lear-2J>	MP:0000018,small ears|MP:0001265,decreased body size|MP:0001921,reduced fertility|MP:0006325,impaired hearing
MGI:5461152	Prkra<lear-3J>	MP:0000018,small ears|MP:0001265,decreased body size|MP:0001924,infertility|MP:0005391,vision/eye phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5430998	Prkra<rep>	MP:0000018,small ears|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001926,female infertility|MP:0004471,short nasal bone|MP:0030258,small mandibular condyloid process|MP:0030261,abnormal temporal bone zygomatic process morphology|MP:0030283,small mandibular coronoid process
MGI:3626341	Prkra<tm1Gcs>	MP:0000018,small ears|MP:0000049,abnormal middle ear morphology|MP:0000074,abnormal neurocranium morphology|MP:0000445,short snout|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002177,abnormal outer ear morphology|MP:0004384,small interparietal bone|MP:0004477,turbinate hypoplasia|MP:0005105,abnormal middle ear ossicle morphology|MP:0006033,abnormal external auditory canal morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0030029,wide cranial sutures|MP:0030188,round snout|MP:0030258,small mandibular condyloid process
MGI:3809637	Prkra<tm1Wsmay>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5689895	Prkx<em1(IMPC)J>	MP:0001486,abnormal startle reflex|MP:0005293,impaired glucose tolerance
MGI:3808306	Prl3c1<tm1(KOMP)Vlcg>	MP:0001148,enlarged testis|MP:0001152,increased Leydig cell number|MP:0001260,increased body weight|MP:0001751,increased circulating luteinizing hormone level|MP:0001923,reduced female fertility|MP:0002059,abnormal seminal vesicle morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0002669,abnormal scrotum morphology|MP:0002781,increased circulating testosterone level|MP:0002997,enlarged seminal vesicle|MP:0004851,increased testis weight|MP:0004884,abnormal testis physiology|MP:0004909,increased seminal vesicle weight|MP:0005646,abnormal pituitary gland physiology|MP:0013604,abnormal adult Leydig cell differentiation|MP:0030603,increased sperm number
MGI:7425929	Prl3d1<em1(IMPC)Bay>	MP:0001399,hyperactivity|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3513079	Prl4a1<tm1Soar>	MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001712,abnormal placenta development|MP:0001926,female infertility|MP:0005032,abnormal ectoplacental cone morphology|MP:0005033,abnormal trophoblast giant cell morphology
MGI:5692736	Prl7b1<tm1.1(KOMP)Vlcg>	MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level
MGI:3800059	Prl7b1<tm1(KOMP)Vlcg>	MP:0003231,abnormal placenta vasculature|MP:0003718,maternal effect|MP:0005389,reproductive system phenotype|MP:0009432,increased fetal weight
MGI:6156603	Prl7d1<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0009142,decreased prepulse inhibition
MGI:6470966	Prl7d1<em1Liga>	MP:0001711,abnormal placenta morphology|MP:0001935,decreased litter size|MP:0003718,maternal effect|MP:0004921,decreased placenta weight|MP:0008957,abnormal placenta junctional zone morphology|MP:0009394,increased uterine NK cell number|MP:0010768,mortality/aging|MP:0012108,increased trophoblast glycogen cell number|MP:0012726,abnormal uterine spiral artery morphology
MGI:3513194	Prl8a2<tm1Soar>	MP:0001126,abnormal ovary morphology|MP:0001712,abnormal placenta development|MP:0001914,hemorrhage|MP:0003845,abnormal decidualization|MP:0005031,abnormal trophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0005164,abnormal response to injury
MGI:3044896	Prlhr<tm1Askr>	MP:0001432,abnormal food preference|MP:0002079,increased circulating insulin level|MP:0005331,insulin resistance|MP:0005455,increased susceptibility to weight gain
MGI:3764478	Prlhr<tm1Dgen>	MP:0000182,increased circulating LDL cholesterol level|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001556,increased circulating HDL cholesterol level|MP:0001745,increased circulating corticosterone level|MP:0003982,increased cholesterol level|MP:0005458,increased percent body fat/body weight|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0010024,increased total body fat amount|MP:0011940,decreased food intake
MGI:3611903	Prlhr<tm1Map>	MP:0001973,increased thermal nociceptive threshold|MP:0001981,increased chemically-elicited antinociception|MP:0002665,decreased circulating corticosterone level|MP:0002734,abnormal mechanical nociception|MP:0009713,enhanced conditioned place preference behavior|MP:0009776,decreased behavioral withdrawal response
MGI:3832409	Prlh<tm1Taon>	MP:0000005,increased brown adipose tissue amount|MP:0000008,increased white adipose tissue amount|MP:0001260,increased body weight|MP:0001261,obese|MP:0001552,increased circulating triglyceride level|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0006276,abnormal autonomic nervous system physiology|MP:0009355,increased liver triglyceride level|MP:0011939,increased food intake|MP:0011958,increased compensatory feeding amount
MGI:5634278	Prlh<tm2Smln>	MP:0001260,increased body weight|MP:0001261,obese|MP:0001559,hyperglycemia|MP:0001777,abnormal body temperature homeostasis|MP:0002079,increased circulating insulin level|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0009288,increased epididymal fat pad weight|MP:0010024,increased total body fat amount|MP:0010934,increased subcutaneous adipose tissue amount|MP:0011014,decreased core body temperature|MP:0011939,increased food intake
MGI:6400798	Prlr<tm1.1Skkm>	MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:1888377	Prlr<tm1Cnp>	MP:0000060,delayed bone ossification|MP:0000063,decreased bone mineral density|MP:0000367,abnormal coat/ hair morphology|MP:0000427,abnormal hair cycle|MP:0000628,abnormal mammary gland development|MP:0000681,abnormal thyroid gland morphology|MP:0001168,abnormal prostate gland epithelium morphology|MP:0001262,decreased body weight|MP:0001346,abnormal lacrimal gland morphology|MP:0001384,abnormal pup retrieval|MP:0001386,abnormal maternal nurturing|MP:0001562,abnormal circulating calcium level|MP:0001882,abnormal lactation|MP:0001919,abnormal reproductive system physiology|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0002832,coarse hair|MP:0002896,abnormal bone mineralization|MP:0002904,increased circulating parathyroid hormone level|MP:0003059,decreased insulin secretion|MP:0003355,decreased ovulation rate|MP:0003845,abnormal decidualization|MP:0004014,abnormal uterine environment|MP:0004015,abnormal oviduct environment|MP:0004016,decreased bone mass|MP:0004909,increased seminal vesicle weight|MP:0005124,increased circulating prolactin level|MP:0005181,decreased circulating estradiol level|MP:0005185,decreased circulating progesterone level|MP:0005215,abnormal pancreatic islet morphology|MP:0005248,abnormal Harderian gland morphology|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0005394,taste/olfaction phenotype|MP:0005471,decreased thyroxine level|MP:0005534,decreased body temperature|MP:0005668,decreased circulating leptin level|MP:0008271,abnormal bone ossification|MP:0008489,slow postnatal weight gain|MP:0008779,abnormal maternal behavior|MP:0009114,decreased pancreatic beta cell mass|MP:0009172,small pancreatic islets|MP:0009287,decreased abdominal fat pad weight|MP:0009967,abnormal neuron proliferation|MP:0010346,increased thyroid carcinoma incidence|MP:0011125,decreased primary ovarian follicle number|MP:0011988,increased mating frequency|MP:0013476,abnormal Harderian gland porphyrin secretion|MP:0031364,increased prostate gland ventral lobe weight
MGI:1934021	Prl<tm1Hmn>	MP:0000627,abnormal mammary gland morphology|MP:0000628,abnormal mammary gland development|MP:0000633,abnormal pituitary gland morphology|MP:0000635,pituitary gland hyperplasia|MP:0000636,enlarged pituitary gland|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001728,failure of embryo implantation|MP:0001746,abnormal pituitary secretion|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0002041,increased pituitary adenoma incidence|MP:0002773,decreased circulating luteinizing hormone level|MP:0003371,decreased circulating estrogen level|MP:0003402,decreased liver weight|MP:0004910,decreased seminal vesicle weight|MP:0005121,decreased circulating prolactin level|MP:0005130,decreased follicle stimulating hormone level|MP:0005132,decreased luteinizing hormone level|MP:0005138,decreased prolactin level|MP:0005181,decreased circulating estradiol level|MP:0005379,endocrine/exocrine gland phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005643,decreased dopamine level|MP:0008325,abnormal gonadotroph morphology|MP:0008332,decreased lactotroph cell number|MP:0008939,increased pituitary gland weight|MP:0009006,prolonged estrous cycle|MP:0009007,short estrous cycle|MP:0009014,prolonged proestrus|MP:0009017,prolonged estrus|MP:0013336,pituitary gland hypertrophy|MP:0031362,decreased prostate gland ventral lobe weight
MGI:3039794	Prm1<tm1Eddy>	MP:0001924,infertility|MP:0005410,abnormal fertilization|MP:0005578,teratozoospermia|MP:0020869,immotile sperm
MGI:5760133	Prm2<em1Hsc>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0003674,oxidative stress|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009235,small sperm head|MP:0009325,necrospermia|MP:0009831,abnormal sperm midpiece morphology|MP:0014803,abnormal flagellar waveform|MP:0020869,immotile sperm
MGI:5770554	Prm2<em2Hsc>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0003674,oxidative stress|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009235,small sperm head|MP:0009325,necrospermia|MP:0009831,abnormal sperm midpiece morphology|MP:0014803,abnormal flagellar waveform|MP:0020869,immotile sperm
MGI:3039800	Prm2<tm1Eddy>	MP:0001924,infertility|MP:0005410,abnormal fertilization|MP:0005578,teratozoospermia|MP:0020869,immotile sperm
MGI:3815297	Prm3<tm1Grz>	MP:0002674,abnormal sperm motility|MP:0005389,reproductive system phenotype
MGI:2448365	Prmt1<Gt(U3BetaGeo)7.4.2Rul>	MP:0001710,absent amniotic folds|MP:0001730,embryonic growth arrest|MP:0003085,abnormal egg cylinder morphology|MP:0009687,empty decidua capsularis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011198,absent proamniotic cavity|MP:0011207,absent ectoplacental cavity|MP:0014586,decreased egg cylinder size
MGI:3848227	Prmt1<tm1.1Rchd>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4432476	Prmt1<tm1a(EUCOMM)Wtsi>	MP:0005553,increased circulating creatinine level|MP:0011100,preweaning lethality, complete penetrance
MGI:7327647	Prmt1<tm1Hkim>	MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:3848226	Prmt1<tm1Rchd>	MP:0000088,short mandible|MP:0000091,short premaxilla|MP:0000097,short maxilla|MP:0000107,abnormal frontal bone morphology|MP:0000431,absent palatine bone horizontal plate|MP:0000433,microcephaly|MP:0000435,shortened head|MP:0002116,abnormal craniofacial bone morphology|MP:0002820,abnormal premaxilla morphology|MP:0003935,abnormal craniofacial development|MP:0004189,abnormal alveolar process morphology|MP:0004377,small frontal bone|MP:0004380,short frontal bone|MP:0004538,abnormal maxillary shelf morphology|MP:0004540,small maxilla|MP:0004592,small mandible|MP:0004830,short incisors|MP:0004870,small premaxilla|MP:0005249,abnormal palatine bone morphology|MP:0009546,absent gastric milk in neonates|MP:0009888,palatal shelves fail to meet at midline|MP:0009907,decreased tongue size|MP:0011087,neonatal lethality, complete penetrance|MP:0020301,short tongue|MP:0021166,delayed palatal shelf elevation|MP:0021213,complete cleft palate|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0030089,short lower incisors|MP:0030090,short upper incisors|MP:0030431,wide metopic suture
MGI:4433170	Prmt2<tm1a(EUCOMM)Wtsi>	MP:0010101,increased sacral vertebrae number
MGI:3663741	Prmt2<tm1Enbl>	MP:0003077,abnormal cell cycle|MP:0004883,abnormal vascular wound healing
MGI:3716216	Prmt3<Gt(XC265)Byg>	MP:0001698,decreased embryo size
MGI:4433008	Prmt3<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001304,cataract|MP:0001312,abnormal cornea morphology|MP:0001313,increased incidence of corneal inflammation|MP:0001314,cornea opacity|MP:0001891,hydrocephaly|MP:0005015,increased T cell number|MP:0005287,narrow eye opening|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008770,decreased survivor rate|MP:0010101,increased sacral vertebrae number|MP:0010124,decreased bone mineral content|MP:0010379,decreased respiratory quotient|MP:0010831,lethality, incomplete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011156,abnormal hypodermis fat layer morphology
MGI:4124631	Prmt5<Gt(RRA014)Byg>	MP:0011092,embryonic lethality, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:5546597	Prmt5<tm2c(EUCOMM)Wtsi>	MP:0000137,abnormal vertebrae morphology|MP:0000161,scoliosis|MP:0000166,abnormal chondrocyte morphology|MP:0000745,tremors|MP:0000774,decreased brain size|MP:0000823,abnormal lateral ventricle morphology|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0001265,decreased body size|MP:0001525,impaired balance|MP:0001698,decreased embryo size|MP:0002175,decreased brain weight|MP:0002690,akinesia|MP:0003203,increased neuron apoptosis|MP:0003419,delayed endochondral bone ossification|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004173,abnormal intervertebral disk morphology|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004610,small vertebrae|MP:0004948,abnormal neuronal precursor proliferation|MP:0005227,abnormal vertebral body development|MP:0005229,abnormal intervertebral disk development|MP:0005390,skeleton phenotype|MP:0006254,thin cerebral cortex|MP:0008272,abnormal endochondral bone ossification|MP:0008439,abnormal cortical plate morphology|MP:0008535,enlarged lateral ventricles|MP:0010879,decreased trabecular bone volume|MP:0011085,postnatal lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0014561,decreased cortical ventricular zone cell density|MP:0020137,decreased bone mineralization
MGI:5508653	Prmt6<tm1.2Rchd>	MP:0003077,abnormal cell cycle|MP:0008008,early cellular replicative senescence|MP:0011704,decreased fibroblast proliferation
MGI:6281577	Prmt7<tm1.1Rchd>	MP:0002106,abnormal muscle physiology|MP:0005164,abnormal response to injury|MP:0008008,early cellular replicative senescence|MP:0013239,impaired skeletal muscle regeneration
MGI:6281578	Prmt7<tm1.2Rchd>	MP:0001262,decreased body weight|MP:0002106,abnormal muscle physiology|MP:0003833,decreased satellite cell number|MP:0005164,abnormal response to injury|MP:0008008,early cellular replicative senescence|MP:0009288,increased epididymal fat pad weight|MP:0009674,decreased birth weight|MP:0010239,decreased skeletal muscle weight|MP:0011808,abnormal myoblast differentiation|MP:0013239,impaired skeletal muscle regeneration
MGI:4431677	Prmt7<tm1a(EUCOMM)Wtsi>	MP:0000150,abnormal rib morphology|MP:0001260,increased body weight|MP:0002747,abnormal aortic valve morphology|MP:0002875,decreased erythrocyte cell number|MP:0003961,decreased lean body mass|MP:0004160,retroesophageal right subclavian artery|MP:0005084,abnormal gallbladder morphology|MP:0005244,hemopericardium|MP:0006063,abnormal inferior vena cava morphology|MP:0008922,abnormal cervical rib|MP:0008923,thoracoschisis|MP:0009820,abnormal liver vasculature morphology|MP:0010490,abnormal inferior vena cava valve morphology|MP:0011513,abnormal vertebral artery morphology|MP:0011683,dual inferior vena cava|MP:0013836,abnormal hypoglossal nerve topology|MP:0013840,absent segment of posterior cerebral artery|MP:0013848,subcutaneous edema|MP:0013859,abnormal vitelline vein connection|MP:0013875,increased trigeminal neuroma incidence|MP:0013877,abnormal ductus venosus valve morphology|MP:0013878,abnormal ductus venosus valve topology|MP:0013936,abnormal thymus topology|MP:0013971,blood in lymph vessels|MP:0013975,abnormal coronary sinus connection|MP:0013986,abnormal vitelline vein topology|MP:0014018,embryo tumor|MP:0014021,heterochrony
MGI:5806495	Prmt8<tm1d(EUCOMM)Wtsi>	MP:0000849,abnormal cerebellum morphology|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001413,abnormal response to new environment|MP:0001513,limb grasping|MP:0003990,decreased neurotransmitter release|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:8166514	Prmt9<em1.1Sqiu>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0011086,postnatal lethality, incomplete penetrance
MGI:7336180	Prmt9<em1Cya>	MP:0002410,decreased susceptibility to viral infection|MP:0008564,increased interferon-beta secretion|MP:0008575,increased circulating interferon-beta level
MGI:6104244	Prmt9<em1(IMPC)J>	MP:0001304,cataract|MP:0002590,increased mean corpuscular volume|MP:0004738,abnormal auditory brainstem response|MP:0005292,improved glucose tolerance|MP:0005561,increased mean corpuscular hemoglobin|MP:0010052,increased grip strength
MGI:8166513	Prmt9<em1Sqiu>	MP:0001473,reduced long-term potentiation|MP:0001475,reduced long-term depression|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0002912,abnormal excitatory postsynaptic potential|MP:0004998,decreased CNS synapse formation|MP:0008432,abnormal long-term spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0012307,impaired spatial learning|MP:0014379,decreased excitatory postsynaptic current frequency|MP:0020357,abnormal excitatory synapse morphology|MP:0020508,decreased dendritic spine density|MP:0021088,impaired spatial memory extinction
MGI:3047561	Prnd<tm1Aag>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009243,hairpin sperm flagellum|MP:0030976,impaired sperm penetration of zona pellucida
MGI:3047060	Prnd<tm1Dwm>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0004542,impaired acrosome reaction
MGI:3045029	Prnp<a>	MP:0005364,increased susceptibility to prion infection
MGI:3045031	Prnp<b>	MP:0005363,decreased susceptibility to prion infection
MGI:3045033	Prnp<c>	MP:0005363,decreased susceptibility to prion infection
MGI:7860792	Prnp<em1.1(Prnp)Jwat>	MP:0003631,nervous system phenotype
MGI:7860793	Prnp<em2.1(Prnp*D178N)Jwat>	MP:0000160,kyphosis|MP:0001194,dermatitis|MP:0001263,weight loss|MP:0001393,ataxia|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002654,spongiform encephalopathy|MP:0003354,astrocytosis|MP:0003632,abnormal nervous system morphology|MP:0008025,brain vacuoles|MP:0008469,abnormal protein level
MGI:7860794	Prnp<em3.1(Prnp*E200K)Jwat>	MP:0000160,kyphosis|MP:0001194,dermatitis|MP:0001263,weight loss|MP:0001393,ataxia|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002654,spongiform encephalopathy|MP:0003354,astrocytosis|MP:0003632,abnormal nervous system morphology|MP:0008025,brain vacuoles|MP:0008469,abnormal protein level
MGI:3047634	Prnp/Prnd<tm1Aag>	MP:0001925,male infertility|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005578,teratozoospermia
MGI:3047635	Prnp/Prnd<tm1Aag>	MP:0001925,male infertility|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005578,teratozoospermia
MGI:3047062	Prnp/Prnd<tm1Dwm>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0004542,impaired acrosome reaction
MGI:3047064	Prnp/Prnd<tm1Dwm>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0004542,impaired acrosome reaction
MGI:3619122	Prnp<tm1Canc>	MP:0002169,no abnormal phenotype detected
MGI:1888773	Prnp<tm1Cwe>	MP:0001473,reduced long-term potentiation|MP:0002206,abnormal CNS synaptic transmission|MP:0002911,abnormal inhibitory postsynaptic potential|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0005386,behavior/neurological phenotype|MP:0011215,decreased brain copper level
MGI:1934274	Prnp<tm1Edin>	MP:0020187,abnormal susceptibility to prion infection
MGI:3054245	Prnp<tm1Ito>	MP:0000745,tremors|MP:0001393,ataxia
MGI:4412098	Prnp<tm1Lnq>	MP:0003631,nervous system phenotype|MP:0005363,decreased susceptibility to prion infection
MGI:1934272	Prnp<tm1Miy>	MP:0000876,Purkinje cell degeneration|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0005363,decreased susceptibility to prion infection
MGI:2681980	Prnp<tm1(PRNP)Tkit>	MP:0005363,decreased susceptibility to prion infection|MP:0005364,increased susceptibility to prion infection
MGI:1934273	Prnp<tm1Rcm>	MP:0020187,abnormal susceptibility to prion infection
MGI:3052798	Prnp<tm1Tuzi>	MP:0005363,decreased susceptibility to prion infection|MP:0005387,immune system phenotype
MGI:5606060	Prnp<tm1Wsj>	MP:0005386,behavior/neurological phenotype
MGI:2682338	Prnp<tm2.1Cwe>	MP:0000745,tremors|MP:0000849,abnormal cerebellum morphology|MP:0000880,decreased Purkinje cell number|MP:0000890,thin cerebellar molecular layer|MP:0001393,ataxia|MP:0002106,abnormal muscle physiology|MP:0002183,gliosis
MGI:3619124	Prnp<tm2Canc>	MP:0002169,no abnormal phenotype detected
MGI:2682347	Prnp<tm2Cwe>	MP:0002169,no abnormal phenotype detected
MGI:2387688	Prnp<tm2Edin>	MP:0004948,abnormal neuronal precursor proliferation|MP:0009937,abnormal neuron differentiation
MGI:4412099	Prnp<tm2Lnq>	MP:0000788,abnormal cerebral cortex morphology|MP:0000832,abnormal thalamus morphology|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001501,abnormal sleep pattern|MP:0001777,abnormal body temperature homeostasis|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0002757,decreased vertical activity|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration|MP:0003632,abnormal nervous system morphology|MP:0004924,abnormal behavior|MP:0005387,immune system phenotype|MP:0008025,brain vacuoles|MP:0008026,abnormal brain white matter morphology|MP:0008948,decreased neuron number|MP:0009967,abnormal neuron proliferation|MP:0011380,enlarged brain ventricles|MP:0014185,cerebellum atrophy|MP:0014638,increased sleep duration
MGI:3762784	Prnp<tm2(PRNP*129M)Tkit>	MP:0005363,decreased susceptibility to prion infection|MP:0005364,increased susceptibility to prion infection
MGI:2682351	Prnp<tm2Rcm>	MP:0001393,ataxia
MGI:3052799	Prnp<tm2Tuzi>	MP:0005363,decreased susceptibility to prion infection|MP:0005387,immune system phenotype
MGI:3619125	Prnp<tm3Canc>	MP:0002169,no abnormal phenotype detected
MGI:5546407	Prnp<tm3Lnq>	MP:0000807,abnormal hippocampus morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0002654,spongiform encephalopathy|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0003491,abnormal voluntary movement|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0009967,abnormal neuron proliferation
MGI:3762785	Prnp<tm3(PRNP*129V)Tkit>	MP:0000689,abnormal spleen morphology|MP:0002152,abnormal brain morphology|MP:0005363,decreased susceptibility to prion infection|MP:0005364,increased susceptibility to prion infection
MGI:3762786	Prnp<tm4(PRNP)Tkit>	MP:0005364,increased susceptibility to prion infection
MGI:3762867	Prnp<tm5(PRNP*)TKit>	MP:0005387,immune system phenotype
MGI:3042575	Prnr1<RIII/FaDk>	MP:0005363,decreased susceptibility to prion infection
MGI:3042578	Prnr2<C57BL/FaDk>	MP:0005363,decreased susceptibility to prion infection
MGI:6402744	Prob1<em1(IMPC)J>	MP:0010024,increased total body fat amount
MGI:5703644	Procr<tm1.1(cre/ERT2)Yaz>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5775084	Procr<tm1.1Pcl>	MP:0000240,extramedullary hematopoiesis|MP:0000333,decreased bone marrow cell number|MP:0000691,enlarged spleen|MP:0003179,thrombocytopenia|MP:0004952,increased spleen weight|MP:0005397,hematopoietic system phenotype|MP:0005416,abnormal circulating protein level|MP:0008476,increased spleen red pulp amount|MP:0008596,increased circulating interleukin-6 level|MP:0008735,increased susceptibility to endotoxin shock|MP:0009338,increased splenocyte number|MP:0010768,mortality/aging|MP:0013776,bone marrow failure|MP:0031121,increased susceptibility to induced thrombosis
MGI:2445432	Procr<tm1Cte>	MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002551,abnormal blood coagulation|MP:0003179,thrombocytopenia|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0020407,abnormal placental thrombosis
MGI:3033747	Procr<tm1Fjc>	MP:0002169,no abnormal phenotype detected
MGI:3702857	Procr<tm2Cte>	MP:0002396,abnormal hematopoietic system morphology/development|MP:0003179,thrombocytopenia|MP:0012330,decreased circulating fibrinogen level|MP:0031059,increased circulating C-reactive protein level
MGI:3831362	Procr<tm3Cte>	MP:0011091,prenatal lethality, complete penetrance
MGI:2183063	Proc<tm1Fjc>	MP:0001436,abnormal suckling behavior|MP:0001656,focal hepatic necrosis|MP:0001860,liver inflammation|MP:0001915,intracranial hemorrhage|MP:0002419,abnormal innate immunity|MP:0002551,abnormal blood coagulation|MP:0003103,liver degeneration|MP:0003333,liver fibrosis|MP:0009275,bruising|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0020409,abnormal cardiac thrombosis|MP:0031167,abnormal lung thrombosis|MP:0031168,abnormal brain thrombosis
MGI:6472936	Prodh2<em1Jkni>	MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005386,behavior/neurological phenotype|MP:0006272,abnormal urine organic anion level|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009643,abnormal urine homeostasis|MP:0030681,increased circulating hydroxyproline level|MP:0030682,hydroxyprolinuria
MGI:2446517	Prodh<m1Kara>	MP:0001262,decreased body weight|MP:0001488,increased startle reflex|MP:0003631,nervous system phenotype|MP:0020237,increased proline level|MP:0030667,increased circulating proline level|MP:0030733,decreased gamma-aminobutyric acid level|MP:0030737,decreased glutamic acid level|MP:0030743,decreased aspartic acid level
MGI:5548961	Prodh<tm1b(KOMP)Wtsi>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002764,short tibia
MGI:3582623	Prok2<tm1Qyz>	MP:0000819,abnormal olfactory bulb morphology|MP:0002741,small olfactory bulb|MP:0004279,abnormal rostral migratory stream morphology
MGI:3848169	Prokr1<tm1.1Cagn>	MP:0000266,abnormal heart morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging|MP:0020329,decreased capillary density
MGI:5448534	Prokr1<tm1.1(KOMP)Vlcg>	MP:0001325,abnormal retina morphology
MGI:3623446	Prokr1<tm1Api>	MP:0002169,no abnormal phenotype detected
MGI:3653379	Prokr1<tm1Lex>	MP:0001973,increased thermal nociceptive threshold|MP:0002733,abnormal thermal nociception|MP:0002736,abnormal nociception after inflammation|MP:0003043,hypoalgesia|MP:0005498,hyporesponsive to tactile stimuli|MP:0005534,decreased body temperature|MP:0008531,increased chemical nociceptive threshold|MP:0011947,abnormal fluid intake
MGI:3623447	Prokr2<tm1Api>	MP:0000627,abnormal mammary gland morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0001119,abnormal female reproductive system morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001134,absent corpus luteum|MP:0001145,abnormal male reproductive system morphology|MP:0001153,small seminiferous tubules|MP:0002216,abnormal seminiferous tubule morphology|MP:0002739,abnormal olfactory bulb development|MP:0002741,small olfactory bulb|MP:0002780,decreased circulating testosterone level|MP:0002882,abnormal neuron morphology|MP:0003205,testicular atrophy|MP:0003651,abnormal axon extension|MP:0004833,ovary atrophy|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0004894,uterus atrophy|MP:0004895,vagina atrophy|MP:0005130,decreased follicle stimulating hormone level|MP:0005159,azoospermia|MP:0005536,decreased Leydig cell number|MP:0005645,abnormal hypothalamus physiology|MP:0008261,arrest of male meiosis|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3701804	Prokr2<tm1Brd>	MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0005534,decreased body temperature|MP:0010768,mortality/aging|MP:0011020,abnormal circadian temperature homeostasis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020472,arrhythmic circadian behavior persistence|MP:0020473,abnormal circadian behavior phase
MGI:5605699	Prom1<rd19>	MP:0001324,abnormal eye pigmentation|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008450,retina photoreceptor degeneration|MP:0010097,abnormal retina blood vessel morphology|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0014658,absent a-wave|MP:0020439,absent b-wave
MGI:4360366	Prom1<tm1.1(DTA)Toko>	MP:0001262,decreased body weight|MP:0001327,decreased retina photoreceptor cell number|MP:0001393,ataxia|MP:0002169,no abnormal phenotype detected|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008450,retina photoreceptor degeneration|MP:0008511,thin retina inner nuclear layer|MP:0008513,thin retina inner plexiform layer|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008519,thin retina outer plexiform layer|MP:0008580,photoreceptor inner segment degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0014178,increased brain apoptosis|MP:0020816,decreased photoreceptor outer segment number
MGI:3830624	Prom1<tm1(cre/ERT2)Gilb>	MP:0002169,no abnormal phenotype detected
MGI:3838534	Prom1<tm1Pec>	MP:0001005,abnormal retina rod cell morphology|MP:0001006,abnormal retina cone cell morphology|MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005103,abnormal retina pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0008449,abnormal retina cone cell outer segment morphology|MP:0008450,retina photoreceptor degeneration|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0008518,retina outer nuclear layer degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0014333,short retina cone cell outer segment
MGI:5443933	Prom2<tm1.1(KOMP)Vlcg>	MP:0000195,decreased circulating calcium level|MP:0000579,abnormal nail morphology|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0002941,increased circulating alanine transaminase level|MP:0004151,decreased circulating iron level|MP:0005343,increased circulating aspartate transaminase level|MP:0005564,increased hemoglobin content|MP:0005627,increased circulating potassium level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010053,decreased grip strength|MP:0011396,abnormal sleep behavior
MGI:5007297	Prom2<tm1Lex>	MP:0000208,decreased hematocrit|MP:0001577,anemia|MP:0002875,decreased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin
MGI:1856842	Prop1<df>	MP:0000633,abnormal pituitary gland morphology|MP:0001127,small ovary|MP:0001131,abnormal ovarian follicle morphology|MP:0001134,absent corpus luteum|MP:0001265,decreased body size|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002083,premature death|MP:0002659,pituitary gland hypoplasia|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0002951,small thyroid gland|MP:0003816,abnormal pituitary gland development|MP:0005119,decreased circulating thyroid-stimulating hormone level|MP:0005120,decreased circulating growth hormone level|MP:0005121,decreased circulating prolactin level|MP:0005130,decreased follicle stimulating hormone level|MP:0005132,decreased luteinizing hormone level|MP:0005379,endocrine/exocrine gland phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008321,small adenohypophysis|MP:0008330,absent somatotrophs|MP:0008338,decreased thyrotroph cell number|MP:0008868,abnormal granulosa cell morphology|MP:0008974,proportional dwarf|MP:0011120,increased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0011130,absent tertiary ovarian follicles|MP:0031381,decreased secondary ovarian follicle number
MGI:3690463	Prop1<tm1Rsd>	MP:0013337,abnormal adenohypophysis development
MGI:3521736	Prop1<tm1Sac>	MP:0000633,abnormal pituitary gland morphology|MP:0001116,small gonad|MP:0001177,atelectasis|MP:0001575,cyanosis|MP:0001745,increased circulating corticosterone level|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002133,abnormal respiratory system physiology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002659,pituitary gland hypoplasia|MP:0002951,small thyroid gland|MP:0003348,hypopituitarism|MP:0004164,abnormal neurohypophysis morphology|MP:0004780,abnormal surfactant secretion|MP:0005202,lethargy|MP:0008365,adenohypophysis hypoplasia|MP:0008974,proportional dwarf|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:6281697	Prorp<tm1.1Afi>	MP:0002083,premature death|MP:0002833,increased heart weight|MP:0005330,cardiomyopathy|MP:0006036,abnormal mitochondrial physiology|MP:0006085,myocardium necrosis|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport
MGI:6281700	Prorp<tm1.2Afi>	MP:0001672,abnormal embryo development|MP:0011092,embryonic lethality, complete penetrance
MGI:4359168	Pros1<tm1.1Ansc>	MP:0000606,decreased hepatocyte number|MP:0001654,hepatic necrosis|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0003179,thrombocytopenia|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003717,pallor|MP:0005048,abnormal thrombosis|MP:0008254,increased megakaryocyte cell number|MP:0009275,bruising|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011089,perinatal lethality, complete penetrance|MP:0031121,increased susceptibility to induced thrombosis
MGI:5499100	Pros1<tm1.2Grl>	MP:0000255,blood vessel congestion|MP:0001614,abnormal blood vessel morphology|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0002551,abnormal blood coagulation|MP:0003070,increased vascular permeability|MP:0003229,abnormal vitelline vasculature morphology|MP:0003814,vascular smooth muscle hypoplasia|MP:0004950,abnormal brain vasculature morphology|MP:0005048,abnormal thrombosis|MP:0005607,decreased bleeding time|MP:0008547,abnormal neocortex morphology|MP:0010022,brain vascular congestion|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011380,enlarged brain ventricles
MGI:5499097	Pros1<tm1Grl>	MP:0002169,no abnormal phenotype detected|MP:0003070,increased vascular permeability|MP:0005048,abnormal thrombosis|MP:0005385,cardiovascular system phenotype|MP:0010768,mortality/aging
MGI:6388362	Proser2<em1(IMPC)Ccpcz>	MP:0000280,thin ventricular wall|MP:0000538,abnormal urinary bladder morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001489,decreased startle reflex|MP:0002059,abnormal seminal vesicle morphology|MP:0002339,abnormal lymph node morphology|MP:0003020,decreased circulating chloride level|MP:0011625,cystolithiasis
MGI:5438824	Prox1<tm1.1Fuma>	MP:0000812,abnormal dentate gyrus morphology|MP:0008269,abnormal hippocampus CA4 region morphology|MP:0009938,abnormal hippocampus granule cell morphology
MGI:2386336	Prox1<tm1Gco>	MP:0000477,abnormal intestine morphology|MP:0000596,abnormal liver development|MP:0000601,small liver|MP:0001286,abnormal eye development|MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001436,abnormal suckling behavior|MP:0001575,cyanosis|MP:0001785,edema|MP:0001846,increased inflammatory response|MP:0001879,abnormal lymphatic vessel morphology|MP:0001954,respiratory distress|MP:0002079,increased circulating insulin level|MP:0002450,abnormal lymph organ development|MP:0002628,hepatic steatosis|MP:0002712,increased circulating glucagon level|MP:0002941,increased circulating alanine transaminase level|MP:0003212,increased susceptibility to age related obesity|MP:0003659,abnormal lymph circulation|MP:0003660,chylothorax|MP:0004001,decreased hepatocyte proliferation|MP:0004247,small pancreas|MP:0005385,cardiovascular system phenotype|MP:0005425,increased macrophage cell number|MP:0005545,abnormal lens development|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0008107,absent retina horizontal cells|MP:0008908,increased total fat pad weight|MP:0009159,increased pancreatic acinar cell number|MP:0009165,abnormal endocrine pancreas morphology|MP:0009355,increased liver triglyceride level|MP:0010024,increased total body fat amount|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011964,increased total retina thickness
MGI:3609548	Prox1<tm2Gco>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000281,abnormal interventricular septum morphology|MP:0000477,abnormal intestine morphology|MP:0000759,abnormal skeletal muscle morphology|MP:0001785,edema|MP:0001855,abnormal atrial thrombosis|MP:0001879,abnormal lymphatic vessel morphology|MP:0002083,premature death|MP:0002652,thin myocardium|MP:0002795,dilated cardiomyopathy|MP:0003212,increased susceptibility to age related obesity|MP:0003659,abnormal lymph circulation|MP:0003660,chylothorax|MP:0004937,dilated heart|MP:0005598,decreased heart ventricle muscle contractility|MP:0010416,interventricular septum membranous part aneurysm|MP:0010498,abnormal interventricular septum muscular part morphology|MP:0010626,thick tricuspid valve cusps|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014731,disorganized myocardial fiber myofibrils|MP:0020409,abnormal cardiac thrombosis|MP:0031147,abnormal ventricular thrombosis
MGI:3759501	Prox1<tm3(cre/ERT2)Gco>	MP:0002169,no abnormal phenotype detected
MGI:4441290	Prox1<tm4.1Gco>	MP:0001785,edema|MP:0005385,cardiovascular system phenotype|MP:0010198,decreased lymphatic vessel endothelial cell number
MGI:4441289	Prox1<tm5(GFP/cre)Gco>	MP:0008770,decreased survivor rate
MGI:6257723	Prox2<em1(IMPC)Hmgu>	MP:0009476,enlarged cecum
MGI:4835278	Prox2<tm1Aoh>	MP:0002169,no abnormal phenotype detected
MGI:1931524	Proz<tm1Gjb>	MP:0002169,no abnormal phenotype detected|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0031121,increased susceptibility to induced thrombosis
MGI:5695914	Prpf18<tm1.1(KOMP)Vlcg>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3711357	Prpf19<tm1Glri>	MP:0000352,decreased cell proliferation|MP:0002169,no abnormal phenotype detected|MP:0010380,abnormal inner cell mass apoptosis|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:4438621	Prpf31<tm1.1Bha>	MP:0001326,retina degeneration|MP:0005201,abnormal retina pigment epithelium morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:4432954	Prpf31<tm1a(EUCOMM)Wtsi>	MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:4438620	Prpf31<tm1Bha>	MP:0005391,vision/eye phenotype|MP:0011092,embryonic lethality, complete penetrance
MGI:5695913	Prpf38b<tm1.1(KOMP)Vlcg>	MP:0011100,preweaning lethality, complete penetrance
MGI:7256913	Prpf39<em1(IMPC)Tcp>	MP:0000208,decreased hematocrit|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002092,abnormal eye morphology|MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:4329457	Prpf3<Gt(RRO284)Byg>	MP:0005391,vision/eye phenotype|MP:0011092,embryonic lethality, complete penetrance
MGI:4950562	Prpf3<tm1.1Eap>	MP:0001326,retina degeneration|MP:0004021,abnormal rod electrophysiology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005391,vision/eye phenotype
MGI:5637050	Prpf3<tm1b(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5818299	Prpf40a<em1(IMPC)J>	MP:0001304,cataract|MP:0001488,increased startle reflex|MP:0002574,increased vertical activity|MP:0002590,increased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5779705	Prpf4b<em1(IMPC)J>	MP:0001728,failure of embryo implantation|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0003984,embryonic growth retardation|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012129,failure of blastocyst formation|MP:0013292,embryonic lethality prior to organogenesis
MGI:5447745	Prpf6<tm1.1(KOMP)Vlcg>	MP:0000195,decreased circulating calcium level|MP:0001399,hyperactivity|MP:0001523,impaired righting response|MP:0004924,abnormal behavior|MP:0005560,decreased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0020870,decreased thigmotaxis
MGI:6257811	Prpf8<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:4950563	Prpf8<tm1.1Eap>	MP:0001326,retina degeneration|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005391,vision/eye phenotype
MGI:7593949	Prph2<em1Sal>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001326,retina degeneration|MP:0001851,eye inflammation|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0006149,decreased visual acuity|MP:0008448,abnormal retina cone cell inner segment morphology|MP:0008449,abnormal retina cone cell outer segment morphology|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008581,disorganized photoreceptor inner segment|MP:0008582,short photoreceptor inner segment|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0009392,retina gliosis|MP:0009538,abnormal synapse morphology|MP:0011965,decreased total retina thickness|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0020448,increased microglial cell activation|MP:0020724,thick retina inner nuclear layer|MP:0020813,abnormal photoreceptor outer segment disc membrane morphology
MGI:3038638	Prph2<Nmf193>	MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008516,disorganized retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008585,absent photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0012671,retina spots|MP:0030005,increased retina apoptosis|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:1856523	Prph2<Rd2>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001006,abnormal retina cone cell morphology|MP:0001286,abnormal eye development|MP:0001325,abnormal retina morphology|MP:0002446,abnormal macrophage morphology|MP:0002864,abnormal ocular fundus morphology|MP:0003727,abnormal retina layer morphology|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005547,abnormal Muller cell morphology|MP:0005551,abnormal eye electrophysiology|MP:0006069,abnormal retina neuronal layer morphology|MP:0008445,increased retina cone cell number|MP:0008447,absent retina cone cells|MP:0008450,retina photoreceptor degeneration|MP:0008454,absent retina rod cells|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008519,thin retina outer plexiform layer|MP:0008585,absent photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0008852,retina neovascularization|MP:0009772,abnormal retina development|MP:0011965,decreased total retina thickness|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0014658,absent a-wave|MP:0020813,abnormal photoreceptor outer segment disc membrane morphology|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:6367794	Prph2<tm1.1Itl>	MP:0002864,abnormal ocular fundus morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008450,retina photoreceptor degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0008587,short photoreceptor outer segment|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0020813,abnormal photoreceptor outer segment disc membrane morphology
MGI:2182621	Prph2<tm1Nmc>	MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005551,abnormal eye electrophysiology|MP:0008453,decreased retina rod cell number|MP:0008515,thin retina outer nuclear layer|MP:0008585,absent photoreceptor outer segment|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0030005,increased retina apoptosis|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:6492300	Prph2<tm4.1Itl>	MP:0002792,abnormal retina vasculature morphology|MP:0002864,abnormal ocular fundus morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008587,short photoreceptor outer segment|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0020813,abnormal photoreceptor outer segment disc membrane morphology
MGI:2180052	Prph<tm1Jpj>	MP:0000965,abnormal sensory neuron morphology|MP:0003631,nervous system phenotype|MP:0005404,abnormal axon morphology
MGI:6509043	Prps1l1<em1Wyan>	MP:0005389,reproductive system phenotype
MGI:5548962	Prps1<tm1b(EUCOMM)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005568,increased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance
MGI:4362501	Prps2<tm1a(KOMP)Wtsi>	MP:0002459,abnormal B cell physiology|MP:0005397,hematopoietic system phenotype
MGI:4432556	Prpsap2<tm1a(EUCOMM)Wtsi>	MP:0002764,short tibia
MGI:5548795	Prr15l<tm1.1(KOMP)Vlcg>	MP:0001529,abnormal vocalization|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:7543712	Prr16<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0002834,decreased heart weight|MP:0010124,decreased bone mineral content
MGI:6455144	Prr19<em1Atot>	MP:0001925,male infertility|MP:0001926,female infertility|MP:0001930,abnormal meiosis|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005431,decreased oocyte number|MP:0005578,teratozoospermia|MP:0011751,abnormal X-Y chromosome synapsis during male meiosis|MP:0014052,increased male germ cell apoptosis|MP:0014764,impaired double-strand DNA break repair
MGI:6455145	Prr19<em2Atot>	MP:0001930,abnormal meiosis|MP:0014764,impaired double-strand DNA break repair
MGI:5692727	Prr27<tm1b(KOMP)Wtsi>	MP:0000218,increased leukocyte cell number
MGI:7408180	Prr30<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number
MGI:5638569	Prr35<tm1b(KOMP)Wtsi>	MP:0003733,abnormal retina inner nuclear layer morphology|MP:0011965,decreased total retina thickness
MGI:6258434	Prr5<em1(IMPC)J>	MP:0001513,limb grasping|MP:0001556,increased circulating HDL cholesterol level|MP:0003961,decreased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0010024,increased total body fat amount
MGI:4399196	Prr7<tm1(KOMP)Vlcg>	MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:6152618	Prr9<em1(IMPC)Mbp>	MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation
MGI:6724325	Prrc2a<tm1Fcw>	MP:0000780,abnormal corpus callosum morphology|MP:0000913,abnormal brain development|MP:0000954,decreased oligodendrocyte progenitor number|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002176,increased brain weight|MP:0003631,nervous system phenotype|MP:0008535,enlarged lateral ventricles|MP:0008814,decreased nerve conduction velocity|MP:0008916,abnormal astrocyte physiology|MP:0009808,decreased oligodendrocyte number|MP:0010053,decreased grip strength|MP:0012066,decreased astrocyte number|MP:0012307,impaired spatial learning|MP:0013438,dysmyelination
MGI:4461729	Prrc2b<tm1a(EUCOMM)Wtsi>	MP:0000602,dilated liver sinusoidal space|MP:0000681,abnormal thyroid gland morphology|MP:0000759,abnormal skeletal muscle morphology|MP:0000783,abnormal forebrain morphology|MP:0001914,hemorrhage|MP:0002092,abnormal eye morphology|MP:0003686,abnormal eye muscle morphology|MP:0004158,right aortic arch|MP:0004269,abnormal optic cup morphology|MP:0004613,fusion of vertebral arches|MP:0004846,absent skeletal muscle|MP:0004938,dilated vasculature|MP:0006093,arteriovenous malformation|MP:0006203,eye hemorrhage|MP:0010418,perimembraneous ventricular septal defect|MP:0010572,persistent right dorsal aorta|MP:0010602,abnormal pulmonary valve cusp morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011697,lens vacuoles|MP:0013826,absent hypoglossal canal|MP:0013835,absent hypoglossal nerve|MP:0013836,abnormal hypoglossal nerve topology|MP:0013840,absent segment of posterior cerebral artery|MP:0013847,retropleural edema|MP:0013917,persistent right 6th pharyngeal arch artery|MP:0013953,left sided brachiocephalic trunk|MP:0013986,abnormal vitelline vein topology|MP:0020500,persistent trigeminal artery
MGI:6143826	Prrc2c<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001399,hyperactivity|MP:0001529,abnormal vocalization|MP:0001697,abnormal embryo size|MP:0002151,abnormal neural tube morphology|MP:0003720,abnormal neural tube closure|MP:0004738,abnormal auditory brainstem response|MP:0011100,preweaning lethality, complete penetrance
MGI:5548709	Prrg2<tm1b(EUCOMM)Wtsi>	MP:0000194,increased circulating calcium level|MP:0008810,increased circulating iron level
MGI:7377680	Prrg4<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001157,small seminal vesicle|MP:0002059,abnormal seminal vesicle morphology
MGI:3812714	Prrt1<tm1(KOMP)Vlcg>	MP:0001415,increased exploration in new environment|MP:0001458,abnormal object recognition memory|MP:0001473,reduced long-term potentiation|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005386,behavior/neurological phenotype|MP:0012307,impaired spatial learning
MGI:4362325	Prrt2<tm1a(KOMP)Wtsi>	MP:0001401,jumpy|MP:0001441,increased grooming behavior|MP:0001496,audiogenic seizures|MP:0001525,impaired balance|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004859,abnormal synaptic plasticity|MP:0005386,behavior/neurological phenotype|MP:0005424,jerky movement|MP:0006254,thin cerebral cortex|MP:0008806,increased circulating amylase level|MP:0008911,induced hyperactivity|MP:0010323,retropulsion|MP:0020357,abnormal excitatory synapse morphology|MP:0020358,abnormal inhibitory synapse morphology
MGI:6120738	Prrt2<tm1b(KOMP)Wtsi>	MP:0001454,abnormal cued conditioning behavior|MP:0001489,decreased startle reflex|MP:0002764,short tibia|MP:0002966,decreased circulating alkaline phosphatase level
MGI:6502626	Prrt2<tm1d(KOMP)Wtsi>	MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001523,impaired righting response|MP:0002910,abnormal excitatory postsynaptic currents|MP:0005323,dystonia|MP:0009538,abnormal synapse morphology|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0031391,increased locomotor activity
MGI:3773688	Prrx1<tm1Bhr>	MP:0000130,abnormal trabecular bone morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000548,long limbs|MP:0003409,decreased width of hypertrophic chondrocyte zone
MGI:1857531	Prrx1<tm1Jfm>	MP:0000547,short limbs|MP:0001178,pulmonary hypoplasia|MP:0001265,decreased body size|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0004007,abnormal lung vasculature morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:1857640	Prrx1<tm1Tex>	MP:0000024,lowered ear position|MP:0000029,abnormal malleus morphology|MP:0000060,delayed bone ossification|MP:0000137,abnormal vertebrae morphology|MP:0000163,abnormal cartilage morphology|MP:0000430,absent maxillary shelf|MP:0000431,absent palatine bone horizontal plate|MP:0000433,microcephaly|MP:0000448,pointed snout|MP:0000458,abnormal mandible morphology|MP:0000460,mandible hypoplasia|MP:0000486,abnormal pulmonary trunk morphology|MP:0000558,abnormal tibia morphology|MP:0001270,distended abdomen|MP:0001438,aphagia|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002191,abnormal artery morphology|MP:0002764,short tibia|MP:0002765,short fibula|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003054,spina bifida|MP:0003073,abnormal metacarpal bone morphology|MP:0003138,absent tympanic ring|MP:0003723,abnormal long bone morphology|MP:0003855,abnormal forelimb zeugopod morphology|MP:0003857,abnormal hindlimb zeugopod morphology|MP:0004113,abnormal aortic arch morphology|MP:0004355,short radius|MP:0004358,bowed tibia|MP:0004359,short ulna|MP:0004374,bowed radius|MP:0004443,absent supraoccipital bone|MP:0004455,pterygoid bone hypoplasia|MP:0004458,absent alisphenoid bone|MP:0004460,alisphenoid bone hypoplasia|MP:0004467,absent zygomatic bone|MP:0004899,absent temporal bone squamous part|MP:0005105,abnormal middle ear ossicle morphology|MP:0005106,abnormal incus morphology|MP:0005107,abnormal stapes morphology|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006288,small otic capsule|MP:0008374,abnormal malleus manubrium morphology|MP:0008375,short malleus manubrium|MP:0008381,absent gonial bone|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009890,cleft secondary palate|MP:0009898,maxillary shelf hypoplasia|MP:0009918,abnormal stylohyoid ligament morphology|MP:0010324,abnormal malleus processus brevis morphology|MP:0010564,abnormal fetal ductus arteriosus morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0030108,abnormal incudostapedial joint morphology|MP:0030111,absent temporomandibular joint|MP:0030406,absent stapes obturator foramen|MP:0030407,abnormal stapes crus morpholgy
MGI:3773689	Prrx1<tm2Bhr>	MP:0005371,limbs/digits/tail phenotype
MGI:1857641	Prrx2<tm1Hubr>	MP:0002169,no abnormal phenotype detected
MGI:1857684	Prrx2<tm1Mjk>	MP:0002169,no abnormal phenotype detected
MGI:6341914	Prss12<em1(IMPC)Ccpcz>	MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001262,decreased body weight|MP:0002092,abnormal eye morphology|MP:0010463,aorta stenosis|MP:0011971,increased circulating lactate dehydrogenase level
MGI:3604467	Prss12<tm1Dgen>	MP:0001402,decreased locomotor activity|MP:0002797,increased thigmotaxis
MGI:4456117	Prss12<tm1Mits>	MP:0001360,abnormal social investigation|MP:0004811,abnormal neuron physiology|MP:0020508,decreased dendritic spine density
MGI:3843929	Prss16<tm1.1Mal>	MP:0002371,abnormal thymus cortex morphology|MP:0008195,abnormal professional antigen presenting cell morphology
MGI:3514011	Prss16<tm1Cbo>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype
MGI:5692918	Prss1<tm1.1(KOMP)Vlcg>	MP:0000274,enlarged heart
MGI:6341900	Prss21<em1(IMPC)Ccpcz>	MP:0000160,kyphosis|MP:0000162,lordosis|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001404,no spontaneous movement|MP:0004174,abnormal spine curvature|MP:0009709,hydrometra|MP:0011100,preweaning lethality, complete penetrance
MGI:4397679	Prss21<tm1Anta>	MP:0000242,impaired fertilization|MP:0001156,abnormal spermatogenesis|MP:0002687,oligozoospermia|MP:0004543,abnormal sperm physiology|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0008893,detached sperm flagellum|MP:0009230,abnormal sperm head morphology|MP:0009238,coiled sperm flagellum|MP:0009243,hairpin sperm flagellum|MP:0009647,decreased fertilization frequency|MP:0020451,decreased sperm progressive motility
MGI:3829187	Prss21<tm1Tba>	MP:0000242,impaired fertilization|MP:0004542,impaired acrosome reaction|MP:0030976,impaired sperm penetration of zona pellucida|MP:0030978,impaired binding of sperm to zona pellucida
MGI:3531182	Prss27<Gt(OST34330)Lex>	MP:0002169,no abnormal phenotype detected
MGI:5766137	Prss27<tm1.1(NCOM)Mfgc>	MP:0000223,decreased monocyte cell number
MGI:6724044	Prss28<em1Dhap>	MP:0005389,reproductive system phenotype
MGI:6724045	Prss29<em1Dhap>	MP:0005389,reproductive system phenotype
MGI:5705866	Prss2<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0000198,decreased circulating phosphate level|MP:0001402,decreased locomotor activity|MP:0001415,increased exploration in new environment|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002075,abnormal coat/hair pigmentation|MP:0010124,decreased bone mineral content
MGI:6341862	Prss33<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0002060,abnormal skin morphology|MP:0004906,enlarged uterus
MGI:6343399	Prss34<tm1.1Hkar>	MP:0001876,decreased inflammatory response|MP:0003071,decreased vascular permeability|MP:0005384,cellular phenotype|MP:0005387,immune system phenotype
MGI:6341954	Prss35<em1(IMPC)Ccpcz>	MP:0000160,kyphosis|MP:0000162,lordosis|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001147,small testis|MP:0002060,abnormal skin morphology|MP:0003019,increased circulating chloride level|MP:0005293,impaired glucose tolerance|MP:0009709,hydrometra
MGI:5007299	Prss35<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:5774444	Prss36<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response
MGI:5520954	Prss37<tm1Zgwg>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0005389,reproductive system phenotype|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031012,impaired sperm migration in female genital tract
MGI:6307777	Prss3b<tm1.1Satom>	MP:0001265,decreased body size|MP:0001944,abnormal pancreas morphology|MP:0002083,premature death|MP:0003340,acute pancreas inflammation|MP:0003341,chronic pancreas inflammation|MP:0004247,small pancreas|MP:0005376,homeostasis/metabolism phenotype|MP:0008805,decreased circulating amylase level|MP:0009108,increased pancreas weight|MP:0009109,decreased pancreas weight|MP:0009149,decreased pancreatic acinar cell number|MP:0009171,enlarged pancreatic islets|MP:0013295,pancreas atrophy
MGI:5548539	Prss3b<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0002792,abnormal retina vasculature morphology|MP:0002942,decreased circulating alanine transaminase level|MP:0009142,decreased prepulse inhibition
MGI:6307817	Prss3b<tm2.1Satom>	MP:0005379,endocrine/exocrine gland phenotype
MGI:6361142	Prss44<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6257688	Prss45<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6361143	Prss46<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6341895	Prss47<em1(IMPC)Ccpcz>	MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002100,abnormal tooth morphology|MP:0002339,abnormal lymph node morphology|MP:0009709,hydrometra|MP:0013129,abnormal tooth color
MGI:6367954	Prss48<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001157,small seminal vesicle|MP:0002059,abnormal seminal vesicle morphology|MP:0002092,abnormal eye morphology|MP:0002110,abnormal digit morphology|MP:0002135,abnormal kidney morphology|MP:0003961,decreased lean body mass|MP:0004599,abnormal vertebral arch morphology|MP:0005599,increased cardiac muscle contractility|MP:0010379,decreased respiratory quotient
MGI:6711590	Prss50<em1Cajj>	MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002675,asthenozoospermia|MP:0005376,homeostasis/metabolism phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008545,absent sperm flagellum|MP:0009282,decreased hyperactivated sperm motility|MP:0009833,absent sperm mitochondrial sheath|MP:0009834,abnormal sperm annulus morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0009839,multiflagellated sperm|MP:0020451,decreased sperm progressive motility|MP:0020869,immotile sperm|MP:0031408,multi-headed sperm
MGI:4455807	Prss50<tm1a(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0002896,abnormal bone mineralization|MP:0005018,decreased T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:6454670	Prss51<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6140219	Prss53<em1(IMPC)Wtsi>	MP:0002098,abnormal vibrissa morphology
MGI:6147557	Prss53<em2(IMPC)Wtsi>	MP:0002073,abnormal hair growth|MP:0006358,absent pinna reflex
MGI:6153264	Prss53<em3(IMPC)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0001257,increased body length|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0005567,decreased circulating total protein level
MGI:6361141	Prss54<em1Bcm>	MP:0005389,reproductive system phenotype
MGI:6341879	Prss54<em1(IMPC)Ccpcz>	MP:0000160,kyphosis|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001489,decreased startle reflex|MP:0002060,abnormal skin morphology|MP:0004174,abnormal spine curvature|MP:0005568,increased circulating total protein level|MP:0008040,decreased NK T cell number|MP:0013519,decreased CD4-positive NK T cell number|MP:0013522,decreased memory-marker CD4-positive NK T cell number
MGI:7427434	Prss54<tm1Zgwg>	MP:0001922,reduced male fertility|MP:0005389,reproductive system phenotype|MP:0008898,abnormal acrosome morphology|MP:0030976,impaired sperm penetration of zona pellucida
MGI:7294425	Prss55<em1Huizh>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009238,coiled sperm flagellum|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011635,abnormal mitochondrial crista morphology|MP:0020451,decreased sperm progressive motility|MP:0031356,abnormal outer dense fiber morphology
MGI:6341944	Prss55<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001417,decreased exploration in new environment|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002997,enlarged seminal vesicle|MP:0005333,decreased heart rate
MGI:6454671	Prss55<em1Osb>	MP:0001922,reduced male fertility|MP:0009647,decreased fertilization frequency
MGI:6188297	Prss55<em1Qsh>	MP:0005389,reproductive system phenotype
MGI:6357155	Prss55<tm1Zgwg>	MP:0001925,male infertility|MP:0005389,reproductive system phenotype|MP:0009647,decreased fertilization frequency|MP:0030977,impaired sperm-egg recognition|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031012,impaired sperm migration in female genital tract
MGI:5616626	Prss56<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number
MGI:6157340	Prss56<em2(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0006153,hypermetropia|MP:0010081,posterior microphthalmia|MP:0011959,abnormal eye posterior chamber depth|MP:0011964,increased total retina thickness|MP:0014657,decreased cornea curvature|MP:0021107,retina fold
MGI:5444189	Prss56<glcr4>	MP:0001059,optic nerve atrophy|MP:0001303,abnormal lens morphology|MP:0002092,abnormal eye morphology|MP:0002697,abnormal eye size|MP:0002698,abnormal sclera morphology|MP:0004221,abnormal iridocorneal angle|MP:0004223,hypoplastic trabecular meshwork|MP:0005098,abnormal optic choroid morphology|MP:0005253,abnormal eye physiology|MP:0005258,ocular hypertension|MP:0006153,hypermetropia|MP:0008067,retina ganglion cell degeneration|MP:0009829,enlarged eye anterior chamber|MP:0010081,posterior microphthalmia|MP:0011959,abnormal eye posterior chamber depth|MP:0011964,increased total retina thickness|MP:0014657,decreased cornea curvature|MP:0021107,retina fold
MGI:6341906	Prss57<em1(IMPC)Ccpcz>	MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0008040,decreased NK T cell number|MP:0009141,increased prepulse inhibition|MP:0009709,hydrometra|MP:0011047,increased lung tissue damping
MGI:6513231	Prss57<tm1.1Gne>	MP:0000359,abnormal mast cell morphology|MP:0000362,decreased mast cell histamine storage|MP:0002423,abnormal mast cell physiology|MP:0003071,decreased vascular permeability|MP:0010070,decreased serotonin level|MP:0030756,decreased histamine level
MGI:5007300	Prss57<tm1Lex>	MP:0002423,abnormal mast cell physiology
MGI:6717357	Prss58<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6514738	Prss59<em1Fcw>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0031012,impaired sperm migration in female genital tract
MGI:6446228	Prss8<em1Bug>	MP:0000416,sparse hair|MP:0001274,curly vibrissae|MP:0001278,kinked vibrissae|MP:0008218,delayed emergence of vibrissae|MP:0010768,mortality/aging|MP:0010771,integument phenotype
MGI:1856875	Prss8<fr>	MP:0000416,sparse hair|MP:0000417,short hair|MP:0001274,curly vibrissae|MP:0001510,abnormal coat appearance|MP:0001511,disheveled coat|MP:0002073,abnormal hair growth|MP:0002098,abnormal vibrissa morphology|MP:0003809,abnormal hair shaft morphology|MP:0003812,abnormal hair medulla|MP:0010179,rough coat
MGI:3930527	Prss8<Gt(IST10122F12)Tigm>	MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001429,dehydration|MP:0002796,impaired skin barrier function|MP:0011085,postnatal lethality, complete penetrance
MGI:5588579	Prss8<tm1.1Bug>	MP:0000416,sparse hair|MP:0001262,decreased body weight|MP:0001274,curly vibrissae|MP:0001278,kinked vibrissae|MP:0001282,short vibrissae|MP:0001284,absent vibrissae|MP:0002796,impaired skin barrier function|MP:0002908,delayed wound healing|MP:0010768,mortality/aging
MGI:2384523	Prss8<tm1.2Hum>	MP:0002169,no abnormal phenotype detected
MGI:5646004	Prss8<tm1b(EUCOMM)Hmgu>	MP:0001304,cataract|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:7443118	Prssly<em1Fjw>	MP:0005389,reproductive system phenotype
MGI:7444010	Prssly<em2Fjw>	MP:0005389,reproductive system phenotype
MGI:7425931	Prtg<em1(IMPC)Bay>	MP:0000111,cleft palate|MP:0011100,preweaning lethality, complete penetrance
MGI:6781728	Prtg<tm1.1Mjfn>	MP:0000106,abnormal basisphenoid bone morphology|MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0001732,postnatal growth retardation|MP:0003631,nervous system phenotype|MP:0004872,absent nasal septum|MP:0005249,abnormal palatine bone morphology|MP:0009546,absent gastric milk in neonates|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012761,increased cranial neural crest cell apoptosis|MP:0020137,decreased bone mineralization|MP:0030203,short nasal septum|MP:0030206,thin nasal septum
MGI:2449079	prtm	MP:0020470,shortened circadian behavior period
MGI:5705568	Prtn3<tm1.1Hrlu>	MP:0000219,increased neutrophil cell number|MP:0002463,abnormal neutrophil physiology|MP:0006043,decreased apoptosis
MGI:2671839	pru1	MP:0002871,albuminuria
MGI:2671840	pru2	MP:0002871,albuminuria
MGI:5286667	Prune1<Tg(Tyr)2391A-1a3Ove>	MP:0001672,abnormal embryo development
MGI:5695935	Prune1<tm1.1(KOMP)Vlcg>	MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6367583	Prune2<em1Tkgw>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008544,impaired olfaction
MGI:7425932	Prx<em1(IMPC)Rbrc>	MP:0001402,decreased locomotor activity
MGI:4951256	Prxl2a<tm1(KOMP)Vlcg>	MP:0002079,increased circulating insulin level|MP:0004892,increased adiponectin level|MP:0005378,growth/size/body region phenotype|MP:0006319,abnormal epididymal fat pad morphology|MP:0020254,decreased collagen level|MP:0020354,increased endoplasmic reticulum stress|MP:0030968,decreased circulating adiponectin level|MP:0031602,white adipose tissue inflammation
MGI:6728799	Prxl2b<tm1.2Ksak>	MP:0001547,abnormal lipid level|MP:0005258,ocular hypertension
MGI:5779678	Prxl2b<tm1b(EUCOMM)Hmgu>	MP:0010067,increased red blood cell distribution width
MGI:2450150	Prx<tm1Brp>	MP:0000920,abnormal myelination|MP:0001106,abnormal Schwann cell morphology|MP:0001263,weight loss|MP:0001406,abnormal gait|MP:0001438,aphagia|MP:0001513,limb grasping|MP:0001968,abnormal touch/nociception|MP:0002272,abnormal nervous system electrophysiology|MP:0002314,abnormal respiratory mechanics|MP:0003998,decreased thermal nociceptive threshold|MP:0005402,abnormal action potential|MP:0005403,abnormal nerve conduction|MP:0005498,hyporesponsive to tactile stimuli|MP:0008814,decreased nerve conduction velocity|MP:0010738,abnormal internode morphology
MGI:5509222	Prx<tm2.1Brp>	MP:0000344,absent Cajal-Retzius cell|MP:0000920,abnormal myelination|MP:0001106,abnormal Schwann cell morphology|MP:0001405,impaired coordination|MP:0005386,behavior/neurological phenotype|MP:0005403,abnormal nerve conduction|MP:0008814,decreased nerve conduction velocity|MP:0010738,abnormal internode morphology|MP:0010742,increased Schwann cell number|MP:0010771,integument phenotype
MGI:1861471	Ps	MP:0000579,abnormal nail morphology|MP:0001262,decreased body weight|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0001785,edema|MP:0001786,skin edema|MP:0002081,perinatal lethality|MP:0002543,brachyphalangia|MP:0003072,abnormal metatarsal bone morphology|MP:0003201,extremity edema|MP:0004083,polysyndactyly|MP:0004576,abnormal embryonic autopod plate morphology|MP:0005306,abnormal phalanx morphology|MP:0009049,abnormal hallux morphology|MP:0009874,abnormal interdigital cell death|MP:0009875,absent interdigital cell death
MGI:6268779	Psap<m1Btlr>	MP:0001393,ataxia
MGI:3711720	Psap<tm1Ggb>	MP:0000160,kyphosis|MP:0000755,hindlimb paralysis|MP:0000783,abnormal forebrain morphology|MP:0000787,abnormal telencephalon morphology|MP:0000876,Purkinje cell degeneration|MP:0000920,abnormal myelination|MP:0001263,weight loss|MP:0001393,ataxia|MP:0001547,abnormal lipid level|MP:0001919,abnormal reproductive system physiology|MP:0002083,premature death|MP:0003224,neuron degeneration|MP:0003382,straub tail|MP:0003631,nervous system phenotype|MP:0003691,abnormal microglial cell physiology|MP:0004191,neuronal intranuclear inclusions|MP:0004924,abnormal behavior|MP:0005367,renal/urinary system phenotype|MP:0005405,axon degeneration|MP:0014606,dark spleen
MGI:3521746	Psap<tm1Juma>	MP:0000519,hydronephrosis|MP:0000521,abnormal kidney cortex morphology|MP:0000852,small cerebellum|MP:0000876,Purkinje cell degeneration|MP:0000920,abnormal myelination|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001426,polydipsia|MP:0001516,abnormal motor coordination/balance|MP:0001762,polyuria|MP:0002083,premature death|MP:0002703,abnormal renal tubule morphology|MP:0003691,abnormal microglial cell physiology|MP:0005277,abnormal brainstem morphology
MGI:3576780	Psap<tm1Mhor>	MP:0002169,no abnormal phenotype detected
MGI:1888378	Psap<tm1Suz>	MP:0000031,abnormal cochlea morphology|MP:0000042,abnormal organ of Corti morphology|MP:0000436,abnormal head movements|MP:0000607,abnormal hepatocyte morphology|MP:0000745,tremors|MP:0000748,progressive muscle weakness|MP:0000755,hindlimb paralysis|MP:0000820,abnormal choroid plexus morphology|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001106,abnormal Schwann cell morphology|MP:0001158,abnormal prostate gland morphology|MP:0001168,abnormal prostate gland epithelium morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001547,abnormal lipid level|MP:0001967,deafness|MP:0002059,abnormal seminal vesicle morphology|MP:0002064,seizures|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0002118,abnormal lipid homeostasis|MP:0002182,abnormal astrocyte morphology|MP:0002269,muscular atrophy|MP:0002446,abnormal macrophage morphology|MP:0002631,abnormal epididymis morphology|MP:0002703,abnormal renal tubule morphology|MP:0002730,head shaking|MP:0002826,tonic seizures|MP:0002882,abnormal neuron morphology|MP:0002989,small kidney|MP:0003354,astrocytosis|MP:0003402,decreased liver weight|MP:0003632,abnormal nervous system morphology|MP:0003918,decreased kidney weight|MP:0004087,abnormal muscle fiber morphology|MP:0004302,abnormal Deiters cell morphology|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004632,abnormal cochlear OHC efferent innervation pattern|MP:0004633,abnormal cochlear IHC efferent innervation pattern|MP:0004740,sensorineural hearing loss|MP:0004746,abnormal cochlear IHC afferent innervation pattern|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0004910,decreased seminal vesicle weight|MP:0004929,decreased epididymis weight|MP:0004953,decreased spleen weight|MP:0004962,decreased prostate gland weight|MP:0005180,abnormal circulating testosterone level|MP:0005300,abnormal cornea stroma morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005405,axon degeneration|MP:0005449,abnormal food intake|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006055,abnormal vascular endothelial cell morphology|MP:0008026,abnormal brain white matter morphology|MP:0008489,slow postnatal weight gain|MP:0009434,paraparesis|MP:0010047,axonal spheroids|MP:0011083,lethality at weaning, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014409,decreased distortion product otoacoustic emission amplitude|MP:0020261,increased beta-galactosidase level
MGI:6444205	Psap<tm2.1Juma>	MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003354,astrocytosis|MP:0004098,abnormal cerebellar granule cell morphology|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006055,abnormal vascular endothelial cell morphology|MP:0008924,decreased cerebellar granule cell number|MP:0010047,axonal spheroids|MP:0014062,nervous system inclusion bodies
MGI:3802531	Psap<tm2Ggb>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001525,impaired balance|MP:0001859,kidney inflammation|MP:0002083,premature death|MP:0002133,abnormal respiratory system physiology|MP:0002136,abnormal kidney physiology|MP:0003631,nervous system phenotype|MP:0003633,abnormal nervous system physiology|MP:0004811,abnormal neuron physiology|MP:0005386,behavior/neurological phenotype|MP:0006082,CNS inflammation|MP:0008918,microgliosis|MP:0009643,abnormal urine homeostasis
MGI:2183897	Psap<tm2Suz>	MP:0000598,abnormal liver morphology|MP:0000747,muscle weakness|MP:0000755,hindlimb paralysis|MP:0000849,abnormal cerebellum morphology|MP:0000921,demyelination|MP:0000955,abnormal spinal cord morphology|MP:0001106,abnormal Schwann cell morphology|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001547,abnormal lipid level|MP:0002064,seizures|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0002446,abnormal macrophage morphology|MP:0002809,increased spinal cord size|MP:0003289,abnormal intestinal peristalsis|MP:0003492,abnormal involuntary movement|MP:0003632,abnormal nervous system morphology|MP:0003871,abnormal myelin sheath morphology|MP:0003993,abnormal ventral spinal root morphology|MP:0004191,neuronal intranuclear inclusions|MP:0005277,abnormal brainstem morphology|MP:0005302,neurogenic bladder|MP:0005376,homeostasis/metabolism phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006082,CNS inflammation|MP:0008026,abnormal brain white matter morphology|MP:0008918,microgliosis|MP:0011617,abnormal habituation|MP:0030941,enhanced autophagy
MGI:4418521	Psap<tm3.1Ggb>	MP:0000755,hindlimb paralysis|MP:0000852,small cerebellum|MP:0000880,decreased Purkinje cell number|MP:0000921,demyelination|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001364,decreased anxiety-related response|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001473,reduced long-term potentiation|MP:0001513,limb grasping|MP:0001524,impaired limb coordination|MP:0002184,abnormal innervation|MP:0002574,increased vertical activity|MP:0003354,astrocytosis|MP:0005404,abnormal axon morphology|MP:0008285,abnormal hippocampus granule cell layer|MP:0009434,paraparesis|MP:0010047,axonal spheroids
MGI:5510529	Psap<tm4.1Ggb>	MP:0000598,abnormal liver morphology|MP:0000745,tremors|MP:0001263,weight loss|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002882,abnormal neuron morphology|MP:0003329,amyloid beta deposits|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0004757,abnormal distal convoluted tubule morphology|MP:0006055,abnormal vascular endothelial cell morphology|MP:0008918,microgliosis|MP:0011617,abnormal habituation|MP:0030941,enhanced autophagy
MGI:4363603	Psat1<tm1a(KOMP)Wtsi>	MP:0000428,abnormal craniofacial morphology|MP:0000914,exencephaly|MP:0001260,increased body weight|MP:0004201,fetal growth retardation|MP:0005566,decreased blood urea nitrogen level|MP:0011100,preweaning lethality, complete penetrance
MGI:5605790	Psca<tm1b(EUCOMM)Hmgu>	MP:0000689,abnormal spleen morphology|MP:0011239,abnormal skin coloration
MGI:3784994	Psca<tm1Witt>	MP:0002169,no abnormal phenotype detected
MGI:3617623	Pscr1<DBA/2>	MP:0002411,decreased susceptibility to bacterial infection
MGI:3617625	Pscr2<DBA/2>	MP:0002411,decreased susceptibility to bacterial infection
MGI:3617627	Pscr3<DBA/2>	MP:0002411,decreased susceptibility to bacterial infection
MGI:6358601	Psd2<em1Sakag>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0020360,abnormal asymmetric synapse morphology
MGI:6281095	Psd3<em1(IMPC)H>	MP:0000062,increased bone mineral density|MP:0000745,tremors|MP:0001402,decreased locomotor activity|MP:0003394,increased cardiac output|MP:0005567,decreased circulating total protein level|MP:0009456,impaired cued conditioning behavior|MP:0010123,increased bone mineral content|MP:0010392,prolonged QRS complex duration|MP:0011951,increased cardiac stroke volume|MP:0020421,increased freezing behavior
MGI:5749456	Psd4<tm1.1(KOMP)Vlcg>	MP:0010053,decreased grip strength
MGI:6152619	Psd<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0002092,abnormal eye morphology
MGI:4837239	psds1l	MP:0000416,sparse hair|MP:0000418,focal hair loss|MP:0002075,abnormal coat/hair pigmentation
MGI:5515627	Psen1<tm1.1(KOMP)Vlcg>	MP:0001491,unresponsive to tactile stimuli|MP:0001575,cyanosis|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5439663	Psen1<tm1.1Ruvi>	MP:0001126,abnormal ovary morphology|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001926,female infertility|MP:0005389,reproductive system phenotype
MGI:5292236	Psen1<tm1.1Tcs>	MP:0000592,short tail|MP:0001914,hemorrhage|MP:0004200,decreased fetal size|MP:0006279,abnormal limb development|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2149116	Psen1<tm1Bdes>	MP:0000074,abnormal neurocranium morphology|MP:0000592,short tail|MP:0000788,abnormal cerebral cortex morphology|MP:0000792,abnormal cortical marginal zone morphology|MP:0001916,intracerebral hemorrhage|MP:0003052,omphalocele|MP:0003385,abnormal body wall morphology|MP:0003843,abnormal sagittal suture morphology|MP:0004201,fetal growth retardation|MP:0004950,abnormal brain vasculature morphology|MP:0005623,abnormal meninges morphology|MP:0008031,decreased Cajal-Retzius cell number|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0014552,enhanced neuronal migration
MGI:3608968	Psen1<tm1Dgf>	MP:0003631,nervous system phenotype
MGI:1932738	Psen1<tm1Hko>	MP:0000140,absent vertebral pedicles|MP:0000141,abnormal vertebral body morphology|MP:0000150,abnormal rib morphology|MP:0000259,abnormal vascular development|MP:0000260,abnormal angiogenesis|MP:0000592,short tail|MP:0001614,abnormal blood vessel morphology|MP:0001786,skin edema|MP:0001916,intracerebral hemorrhage|MP:0003658,abnormal capillary morphology|MP:0004073,caudal body truncation|MP:0004605,abnormal vertebral lamina morphology|MP:0004703,abnormal vertebral column morphology|MP:0004950,abnormal brain vasculature morphology|MP:0005412,vascular stenosis|MP:0005590,increased vasodilation|MP:0006029,abnormal sclerotome morphology|MP:0006055,abnormal vascular endothelial cell morphology|MP:0008530,abnormal rostral-caudal patterning of the somites|MP:0011087,neonatal lethality, complete penetrance|MP:0014273,abnormal skin vasculature morphology|MP:0020329,decreased capillary density
MGI:2155978	Psen1<tm1Jzt>	MP:0000352,decreased cell proliferation|MP:0000812,abnormal dentate gyrus morphology|MP:0001469,abnormal contextual conditioning behavior|MP:0002169,no abnormal phenotype detected
MGI:3510457	Psen1<tm1Lpr>	MP:0005178,increased circulating cholesterol level
MGI:1930937	Psen1<tm1Mpm>	MP:0002229,neurodegeneration|MP:0005386,behavior/neurological phenotype|MP:0008235,increased susceptibility to neuronal excitotoxicity
MGI:1930934	Psen1<tm1Pcw>	MP:0000079,abnormal basioccipital bone morphology|MP:0000592,short tail|MP:0000963,fused dorsal root ganglion|MP:0001690,failure of somite differentiation|MP:0001691,abnormal somite shape|MP:0001698,decreased embryo size|MP:0001915,intracranial hemorrhage|MP:0001917,intraventricular hemorrhage|MP:0002114,abnormal axial skeleton morphology|MP:0002823,abnormal rib development|MP:0004200,decreased fetal size|MP:0005225,abnormal vertebrae development|MP:0006029,abnormal sclerotome morphology|MP:0006054,spinal hemorrhage|MP:0008530,abnormal rostral-caudal patterning of the somites|MP:0011089,perinatal lethality, complete penetrance
MGI:2155771	Psen1<tm1Psgh>	MP:0002114,abnormal axial skeleton morphology
MGI:1857974	Psen1<tm1Shn>	MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000157,abnormal sternum morphology|MP:0000556,abnormal hindlimb morphology|MP:0000585,kinked tail|MP:0000592,short tail|MP:0000788,abnormal cerebral cortex morphology|MP:0000808,abnormal hippocampus development|MP:0000812,abnormal dentate gyrus morphology|MP:0000825,dilated lateral ventricle|MP:0000826,abnormal third ventricle morphology|MP:0000830,abnormal diencephalon morphology|MP:0000936,small embryonic telencephalon|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001648,abnormal apoptosis|MP:0001915,intracranial hemorrhage|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002114,abnormal axial skeleton morphology|MP:0002152,abnormal brain morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003051,curly tail|MP:0003224,neuron degeneration|MP:0003345,decreased rib number|MP:0004174,abnormal spine curvature|MP:0004277,abnormal lateral ganglionic eminence morphology|MP:0004321,short sternum|MP:0004609,vertebral fusion|MP:0004620,cervical vertebral fusion|MP:0004621,lumbar vertebral fusion|MP:0004622,sacral vertebral fusion|MP:0004981,decreased neuronal precursor cell number|MP:0005421,loose skin|MP:0008149,abnormal costovertebral joint morphology|MP:0008271,abnormal bone ossification|MP:0008441,thin cortical plate|MP:0008530,abnormal rostral-caudal patterning of the somites|MP:0009937,abnormal neuron differentiation|MP:0011087,neonatal lethality, complete penetrance|MP:0012173,short rostral-caudal axis|MP:0021008,temporal lobe atrophy|MP:0030286,occipital bone hypoplasia
MGI:3051523	Psen1<tm1Shs>	MP:0000140,absent vertebral pedicles|MP:0000141,abnormal vertebral body morphology|MP:0000150,abnormal rib morphology|MP:0000284,double outlet right ventricle|MP:0000592,short tail|MP:0000790,abnormal stratification in cerebral cortex|MP:0001698,decreased embryo size|MP:0001915,intracranial hemorrhage|MP:0003052,omphalocele|MP:0003424,premature neuronal precursor differentiation|MP:0004605,abnormal vertebral lamina morphology|MP:0004624,abnormal thoracic cage morphology|MP:0004703,abnormal vertebral column morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0004980,increased neuronal precursor cell number|MP:0005223,abnormal dorsal-ventral polarity of the somites|MP:0006029,abnormal sclerotome morphology|MP:0009937,abnormal neuron differentiation|MP:0010402,ventricular septal defect|MP:0010459,supravalvar pulmonary trunk stenosis|MP:0011091,prenatal lethality, complete penetrance|MP:0014552,enhanced neuronal migration
MGI:3583662	Psen1<tm1Tak>	MP:0001463,abnormal spatial learning|MP:0001488,increased startle reflex|MP:0002152,abnormal brain morphology|MP:0003214,neurofibrillary tangles|MP:0004250,tau protein deposits|MP:0010052,increased grip strength
MGI:2684616	Psen1<tm1Vln>	MP:0002169,no abnormal phenotype detected|MP:0002207,abnormal long-term potentiation|MP:0003329,amyloid beta deposits|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:2449306	Psen1<tm2.1Shn>	MP:0003631,nervous system phenotype|MP:0005371,limbs/digits/tail phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005382,craniofacial phenotype|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0005390,skeleton phenotype|MP:0010768,mortality/aging|MP:0010771,integument phenotype
MGI:2446469	Psen1<tm2Psgh>	MP:0000137,abnormal vertebrae morphology|MP:0000141,abnormal vertebral body morphology|MP:0000585,kinked tail|MP:0000592,short tail|MP:0000755,hindlimb paralysis|MP:0000783,abnormal forebrain morphology|MP:0000955,abnormal spinal cord morphology|MP:0001265,decreased body size|MP:0001915,intracranial hemorrhage|MP:0002083,premature death|MP:0002114,abnormal axial skeleton morphology|MP:0003631,nervous system phenotype|MP:0004605,abnormal vertebral lamina morphology|MP:0004703,abnormal vertebral column morphology|MP:0006054,spinal hemorrhage|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2449304	Psen1<tm2Shn>	MP:0001463,abnormal spatial learning|MP:0003329,amyloid beta deposits|MP:0003631,nervous system phenotype|MP:0008432,abnormal long-term spatial reference memory
MGI:5427478	Psen1<tm3.1Shn>	MP:0003631,nervous system phenotype
MGI:5751732	Psen1<tm4.1Shn>	MP:0000585,kinked tail|MP:0000592,short tail|MP:0004277,abnormal lateral ganglionic eminence morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0012173,short rostral-caudal axis|MP:0014558,decreased cortical ventricular zone thickness
MGI:5751734	Psen1<tm5.1Shn>	MP:0000585,kinked tail|MP:0000592,short tail|MP:0004277,abnormal lateral ganglionic eminence morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0012173,short rostral-caudal axis|MP:0014558,decreased cortical ventricular zone thickness
MGI:6442543	Psen2<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001325,abnormal retina morphology|MP:0001891,hydrocephaly|MP:0002059,abnormal seminal vesicle morphology|MP:0002110,abnormal digit morphology|MP:0002152,abnormal brain morphology|MP:0005561,increased mean corpuscular hemoglobin
MGI:2149117	Psen2<tm1Bdes>	MP:0001182,lung hemorrhage|MP:0003631,nervous system phenotype|MP:0005371,limbs/digits/tail phenotype|MP:0006050,pulmonary fibrosis|MP:0011141,increased lung endothelial cell apoptosis|MP:0014473,increased pulmonary alveolus wall thickness|MP:0030002,increased lung apoptosis
MGI:1930939	Psen2<tm1Ber>	MP:0002169,no abnormal phenotype detected
MGI:2664242	Psen2<tm1Haa>	MP:0002169,no abnormal phenotype detected
MGI:3529036	Psenen<tm1Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:5703082	Psg16<tm1b(KOMP)Mbp>	MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010052,increased grip strength
MGI:6153590	Psg20<em1(IMPC)Wtsi>	MP:0005179,decreased circulating cholesterol level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6153592	Psg22<em1(IMPC)Wtsi>	MP:0013279,increased fasting circulating glucose level
MGI:3032931	Psg23<ltr>	MP:0002169,no abnormal phenotype detected
MGI:6153593	Psg25<em1(IMPC)Wtsi>	MP:0003020,decreased circulating chloride level|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level
MGI:6153594	Psg26<em1(IMPC)Wtsi>	MP:0002075,abnormal coat/hair pigmentation
MGI:6153595	Psg27<em1(IMPC)Wtsi>	MP:0002079,increased circulating insulin level
MGI:6367581	Psip1<em1(IMPC)J>	MP:0003984,embryonic growth retardation|MP:0005554,decreased circulating creatinine level|MP:0011100,preweaning lethality, complete penetrance
MGI:3664569	Psip1<Gt(betageo)1Hgs>	MP:0000010,abnormal abdominal fat pad morphology|MP:0000074,abnormal neurocranium morphology|MP:0000102,abnormal nasal bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000155,asymmetric rib joints|MP:0000346,broad head|MP:0000435,shortened head|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000454,abnormal jaw morphology|MP:0001147,small testis|MP:0001402,decreased locomotor activity|MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0001922,reduced male fertility|MP:0002114,abnormal axial skeleton morphology|MP:0002757,decreased vertical activity|MP:0002823,abnormal rib development|MP:0003036,vertebral transformation|MP:0003048,abnormal cervical vertebrae morphology|MP:0003345,decreased rib number|MP:0003643,spleen atrophy|MP:0004174,abnormal spine curvature|MP:0004321,short sternum|MP:0004384,small interparietal bone|MP:0004444,small supraoccipital bone|MP:0004445,small exoccipital bone|MP:0004471,short nasal bone|MP:0004472,broad nasal bone|MP:0004607,abnormal cervical atlas morphology|MP:0004608,abnormal cervical axis morphology|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004647,decreased lumbar vertebrae number|MP:0005251,blepharitis|MP:0005391,vision/eye phenotype|MP:0008901,absent epididymal fat pad|MP:0009546,absent gastric milk in neonates|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0030066,short face|MP:0030069,broad face|MP:0030288,broad occipital bone|MP:0030289,flat occipital bone
MGI:5294949	Psip1<tm1Eng>	MP:0002169,no abnormal phenotype detected|MP:0005621,abnormal cell physiology
MGI:5311390	Pskh1<b2b1230Clo>	MP:0000284,double outlet right ventricle|MP:0010853,abnormal lung position or orientation|MP:0011252,situs inversus totalis
MGI:5792080	Pskh1<mpc232H>	MP:0000527,abnormal kidney development
MGI:5645992	Pskh1<tm1b(EUCOMM)Wtsi>	MP:0001785,edema|MP:0001914,hemorrhage|MP:0002833,increased heart weight|MP:0005292,improved glucose tolerance|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:2157475	Psl1<DBA/2>	MP:0010300,increased skin tumor incidence
MGI:2664124	Psl2<DBA/2>	MP:0010300,increased skin tumor incidence
MGI:2664125	Psl3<C57BL/6>	MP:0010300,increased skin tumor incidence
MGI:2664128	Psl4<DBA/2>	MP:0010300,increased skin tumor incidence
MGI:6414482	Psma5<em1(IMPC)Bay>	MP:0011959,abnormal eye posterior chamber depth
MGI:6725089	Psma5<m1Btlr>	MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0004703,abnormal vertebral column morphology
MGI:6257761	Psma8<em1(IMPC)Tcp>	MP:0000220,increased monocyte cell number|MP:0000706,small thymus|MP:0001147,small testis|MP:0001925,male infertility|MP:0001944,abnormal pancreas morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0003068,enlarged kidney|MP:0004930,small epididymis|MP:0011874,enlarged urinary bladder
MGI:6364865	Psma8<em1Yuc>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0004543,abnormal sperm physiology|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0014633,decreased spermatid number
MGI:3723600	Psmb10<tm1Mgro>	MP:0002436,abnormal CD8-positive, alpha-beta cytotoxic T cell morphology|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005095,decreased T cell proliferation|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:6154286	Psmb10<Tub6>	MP:0000221,decreased leukocyte cell number|MP:0000322,increased granulocyte number|MP:0000414,alopecia|MP:0000705,athymia|MP:0001242,hyperkeratosis|MP:0001265,decreased body size|MP:0001828,abnormal T cell activation|MP:0001846,increased inflammatory response|MP:0002083,premature death|MP:0002460,decreased immunoglobulin level|MP:0004947,skin inflammation|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005046,absent spleen white pulp|MP:0008024,absent lymph nodes|MP:0008045,decreased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008477,decreased spleen red pulp amount|MP:0008553,increased circulating tumor necrosis factor level|MP:0008567,decreased interferon-gamma secretion|MP:0008591,increased circulating interleukin-1 level|MP:0008596,increased circulating interleukin-6 level|MP:0008843,absent subcutaneous adipose tissue|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:7425933	Psmb11<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000495,abnormal colon morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002060,abnormal skin morphology|MP:0002110,abnormal digit morphology|MP:0002581,abnormal ileum morphology|MP:0003917,increased kidney weight|MP:0008039,increased NK T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013520,increased CD4-positive NK T cell number|MP:0013523,increased memory-marker CD4-positive NK T cell number|MP:0013763,increased T-helper cell number|MP:0013771,decreased effector memory T-helper cell number|MP:0013772,increased effector memory T-helper cell number
MGI:5514401	Psmb11<tm1(Psmb8)Khog>	MP:0002145,abnormal T cell differentiation|MP:0005005,abnormal self tolerance|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005348,increased T cell proliferation|MP:0008050,decreased memory T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008754,abnormal T cell receptor V(D)J recombination
MGI:3716870	Psmb11<tm1Smta>	MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3055222	Psmb8<tm1Hjf>	MP:0001838,defective intracellular transport of class I molecules|MP:0001841,decreased level of surface class I molecules|MP:0002166,abnormal tumor susceptibility|MP:0002455,abnormal dendritic cell antigen presentation
MGI:2152729	Psmb9<tm1Stl>	MP:0001790,abnormal immune system physiology|MP:0002035,increased leiomyosarcoma incidence|MP:0002436,abnormal CD8-positive, alpha-beta cytotoxic T cell morphology|MP:0003331,increased hepatocellular carcinoma incidence|MP:0008014,increased lung tumor incidence|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:3809771	Psmc1<tm1.1Maye>	MP:0011091,prenatal lethality, complete penetrance
MGI:3809769	Psmc1<tm1Maye>	MP:0001265,decreased body size|MP:0001431,abnormal eating behavior|MP:0001463,abnormal spatial learning|MP:0001732,postnatal growth retardation|MP:0002065,abnormal fear/anxiety-related behavior|MP:0002083,premature death|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration|MP:0003241,loss of cortex neurons|MP:0003964,abnormal noradrenaline level|MP:0005643,decreased dopamine level|MP:0006254,thin cerebral cortex|MP:0008493,alpha-synuclein inclusion body|MP:0011085,postnatal lethality, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0012508,forebrain atrophy
MGI:5692582	Psmc2<tm1b(EUCOMM)Hmgu>	MP:0001406,abnormal gait|MP:0005344,increased circulating bilirubin level|MP:0005567,decreased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance
MGI:3628799	Psmc3ip<tm1Rdco>	MP:0001117,absent gametes|MP:0001924,infertility|MP:0001930,abnormal meiosis|MP:0001940,testis hypoplasia|MP:0002777,absent ovarian follicles|MP:0003582,abnormal ovary development|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis
MGI:2180548	Psmc3<tm1Aki>	MP:0001728,failure of embryo implantation|MP:0001730,embryonic growth arrest|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2180553	Psmc4<tm1Aki>	MP:0001728,failure of embryo implantation|MP:0001730,embryonic growth arrest|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:6155608	Psmc5<tm1.1Itl>	MP:0009758,impaired behavioral response to cocaine|MP:0011624,abnormal sensitization to xenobiotic
MGI:5635269	Psmc6<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0020870,decreased thigmotaxis
MGI:7643431	Psmd11<tm1.1Qit>	MP:0006042,increased apoptosis
MGI:7643432	Psmd11<tm1.2Qit>	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6188002	Psmd13<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6161408	Psmd2<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3762160	Psmd4<tm1Smta>	MP:0001695,abnormal gastrulation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:3762171	Psmd4<tm2.1Smta>	MP:0001732,postnatal growth retardation|MP:0003984,embryonic growth retardation|MP:0004180,failure of initiation of embryo turning|MP:0011092,embryonic lethality, complete penetrance
MGI:3762169	Psmd4<tm2Smta>	MP:0000609,abnormal liver physiology|MP:0002169,no abnormal phenotype detected
MGI:5692666	Psmd5<tm1b(EUCOMM)Wtsi>	MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level
MGI:6187994	Psmd6<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:2673434	Psmd7<Mov34>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2388600	Psme1/Psme2<tm1Tchi>	MP:0002166,abnormal tumor susceptibility
MGI:2388601	Psme1/Psme2<tm1Tchi>	MP:0002166,abnormal tumor susceptibility
MGI:5548393	Psme1<tm1.1(KOMP)Vlcg>	MP:0002135,abnormal kidney morphology
MGI:2386980	Psme2<tm1Yya>	MP:0001837,defective assembly of class I molecules|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005079,decreased cytotoxic T cell cytolysis
MGI:3038704	Psme3<tm1Jjm>	MP:0001732,postnatal growth retardation|MP:0004045,abnormal cell cycle checkpoint function|MP:0005092,decreased double-positive T cell number|MP:0005399,increased susceptibility to fungal infection|MP:0011704,decreased fibroblast proliferation
MGI:3038739	Psme3<tm1Tchi>	MP:0000352,decreased cell proliferation|MP:0001732,postnatal growth retardation
MGI:5437081	Psme4<b2b1508Clo>	MP:0000531,right pulmonary isomerism|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0001823,thymus hypoplasia|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0006123,tricuspid valve atresia|MP:0010412,atrioventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011665,d-loop transposition of the great arteries|MP:0011668,double outlet right ventricle, Taussig bing type|MP:0011683,dual inferior vena cava
MGI:3623144	Psme4<tm1Slek>	MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0005578,teratozoospermia|MP:0006362,abnormal male germ cell morphology|MP:0006379,abnormal spermatocyte morphology|MP:0006380,abnormal spermatid morphology|MP:0020550,multinucleated giant male germ cells
MGI:5521286	Psme4<tm1Tchi>	MP:0001922,reduced male fertility|MP:0006380,abnormal spermatid morphology|MP:0014052,increased male germ cell apoptosis
MGI:6835661	Psmf1<em1Hs>	MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0011089,perinatal lethality, complete penetrance
MGI:4436459	Psmf1<tm1a(EUCOMM)Hmgu>	MP:0001914,hemorrhage|MP:0004200,decreased fetal size|MP:0006208,lethality throughout fetal growth and development
MGI:5577264	Psmf1<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:6835662	Psmf1<tm1c(EUCOMM)Hmgu>	MP:0000160,kyphosis|MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000876,Purkinje cell degeneration|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002269,muscular atrophy|MP:0003354,astrocytosis|MP:0004142,abnormal muscle tone|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0008571,abnormal synaptic bouton morphology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008918,microgliosis|MP:0009979,abnormal cerebellum deep nucleus morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0012051,spasticity|MP:0014329,abnormal Purkinje cell axon morphology|MP:0014330,abnormal Purkinje cell focal axonal swelling
MGI:4820728	Psmg1<tm1.1Smta>	MP:0000607,abnormal hepatocyte morphology|MP:0000745,tremors|MP:0000849,abnormal cerebellum morphology|MP:0000854,abnormal cerebellum development|MP:0001393,ataxia|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0002169,no abnormal phenotype detected|MP:0006254,thin cerebral cortex|MP:0008283,small hippocampus|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008989,abnormal liver sinusoid morphology|MP:0010080,abnormal hepatocyte physiology|MP:0010768,mortality/aging|MP:0011085,postnatal lethality, complete penetrance|MP:0012246,abnormal hepatic cord morphology|MP:0012460,decreased dentate gyrus size|MP:0013551,decreased cerebellar granule cell precursor proliferation
MGI:4820730	Psmg1<tm1.2Smta>	MP:0001672,abnormal embryo development|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6120723	Psmg1<tm1b(KOMP)Wtsi>	MP:0001314,cornea opacity|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001718,abnormal visceral yolk sac morphology|MP:0002151,abnormal neural tube morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7425934	Psors1c2<em1(IMPC)Hmgu>	MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6277043	Pspc1<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0001925,male infertility|MP:0002797,increased thigmotaxis
MGI:4330222	Pspc1<Gt(RRS358)Byg>	MP:0005386,behavior/neurological phenotype
MGI:5548963	Psph<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0000428,abnormal craniofacial morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001697,abnormal embryo size|MP:0001722,pale yolk sac|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0002644,decreased circulating triglyceride level|MP:0002768,small adrenal glands|MP:0003179,thrombocytopenia|MP:0003717,pallor|MP:0003928,increased heart rate variability|MP:0004266,pale placenta|MP:0005385,cardiovascular system phenotype|MP:0011100,preweaning lethality, complete penetrance
MGI:4950198	Psph<tm1a(EUCOMM)Hmgu>	MP:0000104,abnormal sphenoid bone morphology|MP:0000141,abnormal vertebral body morphology|MP:0000154,rib fusion|MP:0000282,abnormal interatrial septum morphology|MP:0000284,double outlet right ventricle|MP:0000480,increased rib number|MP:0000559,abnormal femur morphology|MP:0000565,oligodactyly|MP:0000613,abnormal salivary gland morphology|MP:0000614,absent salivary gland|MP:0000618,small salivary gland|MP:0000632,abnormal pineal gland morphology|MP:0000681,abnormal thyroid gland morphology|MP:0000694,spleen hypoplasia|MP:0000703,abnormal thymus morphology|MP:0000705,athymia|MP:0000783,abnormal forebrain morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000841,abnormal hindbrain morphology|MP:0000897,abnormal midbrain morphology|MP:0001015,small superior cervical ganglion|MP:0001064,absent trochlear nerve|MP:0001303,abnormal lens morphology|MP:0001711,abnormal placenta morphology|MP:0002015,epithelioid cyst|MP:0002177,abnormal outer ear morphology|MP:0002199,abnormal brain commissure morphology|MP:0002237,abnormal nasal cavity morphology|MP:0002239,abnormal nasal septum morphology|MP:0002243,abnormal vomeronasal organ morphology|MP:0002249,abnormal larynx morphology|MP:0002428,abnormal semicircular canal morphology|MP:0002633,persistent truncus arteriosus|MP:0002858,abnormal posterior semicircular canal morphology|MP:0002928,abnormal bile duct morphology|MP:0002989,small kidney|MP:0003078,aphakia|MP:0003262,intestinal/bowel diverticulum|MP:0003387,aorta coarctation|MP:0003451,absent olfactory bulb|MP:0003686,abnormal eye muscle morphology|MP:0003827,abnormal Wolffian duct morphology|MP:0003984,embryonic growth retardation|MP:0004163,abnormal adenohypophysis morphology|MP:0004164,abnormal neurohypophysis morphology|MP:0004201,fetal growth retardation|MP:0004259,small placenta|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004539,absent maxilla|MP:0004612,fusion of vertebral bodies|MP:0004613,fusion of vertebral arches|MP:0004666,absent stapedial artery|MP:0005031,abnormal trophoblast layer morphology|MP:0005105,abnormal middle ear ossicle morphology|MP:0005157,holoprosencephaly|MP:0005236,abnormal olfactory nerve morphology|MP:0006033,abnormal external auditory canal morphology|MP:0006063,abnormal inferior vena cava morphology|MP:0006254,thin cerebral cortex|MP:0008128,abnormal brain internal capsule morphology|MP:0008129,absent brain internal capsule|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0008923,thoracoschisis|MP:0009688,abnormal spinal cord central canal morphology|MP:0009707,absent external auditory canal|MP:0009771,absent optic chiasm|MP:0009904,tongue hypoplasia|MP:0009905,absent tongue|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010912,herniated liver|MP:0011100,preweaning lethality, complete penetrance|MP:0012303,umbilical vein stenosis|MP:0013247,placenta necrosis|MP:0013362,absent pineal gland|MP:0013595,absent vomeronasal organ|MP:0013818,abnormal oral cavity morphology|MP:0013833,absent olfactory nerve|MP:0013835,absent hypoglossal nerve|MP:0013836,abnormal hypoglossal nerve topology|MP:0013840,absent segment of posterior cerebral artery|MP:0013848,subcutaneous edema|MP:0013849,absent abducens nerve|MP:0013850,absent posterior commissure|MP:0013855,absent celiac artery|MP:0013859,abnormal vitelline vein connection|MP:0013875,increased trigeminal neuroma incidence|MP:0013878,abnormal ductus venosus valve topology|MP:0013926,absent neurohypophysis|MP:0013927,abnormal facial nerve topology|MP:0013929,absent eye muscles|MP:0013932,fragmented Meckel's cartilage|MP:0013933,short Meckel's cartilage|MP:0013935,basal brain tissue herniation|MP:0013936,abnormal thymus topology|MP:0013948,intraembryonal intestine elongation|MP:0013950,abnormal dorsal root ganglion topology|MP:0013967,abnormal infrahyoid muscle connection|MP:0013970,absent connection between subcutaneous lymph vessels and lymph sac|MP:0013971,blood in lymph vessels|MP:0013980,abnormal pulmonary artery origin|MP:0013988,absent portal vein segment|MP:0013994,abnormal parasellar internal carotid artery branch morphology|MP:0013996,abnormal vertebral artery origin|MP:0014009,anastomosis between middle cerebral arteries|MP:0014019,embryo cyst|MP:0014021,heterochrony|MP:0014022,abnormal duodenum topology|MP:0020500,persistent trigeminal artery|MP:0030975,placenta hemorrhage
MGI:2183393	Pspn<tm1Bjh>	MP:0003076,increased susceptibility to ischemic brain injury|MP:0006060,increased cerebral infarct size
MGI:2449571	psrt<1R>	MP:0001265,decreased body size|MP:0002064,seizures|MP:0011083,lethality at weaning, complete penetrance
MGI:2449572	psrt<2R>	MP:0001265,decreased body size|MP:0002064,seizures|MP:0011083,lethality at weaning, complete penetrance
MGI:1861179	Pst	MP:0000539,distended urinary bladder|MP:0000562,polydactyly|MP:0000572,abnormal autopod morphology|MP:0000592,short tail|MP:0003050,abnormal sacral vertebrae morphology|MP:0006280,abnormal digit development|MP:0011089,perinatal lethality, complete penetrance
MGI:3699727	Pstc6<MRL/MpJ>	MP:0000559,abnormal femur morphology
MGI:7615157	Pstk<em1(IMPC)Bay>	MP:0001410,head bobbing|MP:0011100,preweaning lethality, complete penetrance
MGI:6341846	Pstpip1<em1(IMPC)Ccpcz>	MP:0000162,lordosis|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002135,abnormal kidney morphology|MP:0003917,increased kidney weight|MP:0004952,increased spleen weight|MP:0005568,increased circulating total protein level|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0013763,increased T-helper cell number
MGI:5496137	Pstpip1<tm1.1Dtg>	MP:0005387,immune system phenotype
MGI:4361584	Pstpip1<tm1Spg>	MP:0000716,abnormal immune system cell morphology|MP:0002444,abnormal T cell physiology
MGI:1856595	Pstpip2<cmo>	MP:0000240,extramedullary hematopoiesis|MP:0000572,abnormal autopod morphology|MP:0000580,deformed nails|MP:0000585,kinked tail|MP:0000691,enlarged spleen|MP:0001849,ear inflammation|MP:0002177,abnormal outer ear morphology|MP:0002339,abnormal lymph node morphology|MP:0002499,chronic inflammation|MP:0005190,osteomyelitis|MP:0010768,mortality/aging|MP:0030422,abnormal outer ear cartilage morphology
MGI:5755044	Pstpip2<em1(IMPC)Tcp>	MP:0000063,decreased bone mineral density|MP:0000137,abnormal vertebrae morphology|MP:0000598,abnormal liver morphology|MP:0000702,enlarged lymph nodes|MP:0001417,decreased exploration in new environment|MP:0002059,abnormal seminal vesicle morphology|MP:0002110,abnormal digit morphology|MP:0002111,abnormal tail morphology|MP:0002875,decreased erythrocyte cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0005292,improved glucose tolerance|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength
MGI:3760548	Pstpip2<Lupo>	MP:0000019,thick ears|MP:0000316,cellular necrosis|MP:0001190,reddish skin|MP:0001192,scaly skin|MP:0001209,spontaneous skin ulceration|MP:0001242,hyperkeratosis|MP:0001874,acanthosis|MP:0002493,increased IgG level|MP:0002497,increased IgE level|MP:0003009,abnormal cytokine secretion|MP:0003725,increased autoantibody level|MP:0004947,skin inflammation|MP:0005306,abnormal phalanx morphology|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level
MGI:5491057	Pstpip2<m1Bcs>	MP:0000136,abnormal microglial cell morphology|MP:0000316,cellular necrosis|MP:0000572,abnormal autopod morphology|MP:0000573,increased hindlimb autopod size|MP:0001402,decreased locomotor activity|MP:0001442,decreased grooming behavior|MP:0001533,abnormal skeleton physiology|MP:0001844,autoimmune response|MP:0001845,abnormal inflammatory response|MP:0001849,ear inflammation|MP:0001968,abnormal touch/nociception|MP:0002734,abnormal mechanical nociception|MP:0002757,decreased vertical activity|MP:0003998,decreased thermal nociceptive threshold|MP:0004947,skin inflammation|MP:0005386,behavior/neurological phenotype|MP:0008254,increased megakaryocyte cell number
MGI:1861192	Pt	MP:0000585,kinked tail|MP:0000592,short tail|MP:0001265,decreased body size|MP:0001539,decreased caudal vertebrae number|MP:0002759,abnormal caudal vertebrae morphology|MP:0002825,abnormal notochord morphology|MP:0004682,small intervertebral disk|MP:0004710,small notochord|MP:0006392,abnormal nucleus pulposus morphology|MP:0008770,decreased survivor rate|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013177,abnormal tail tip morphology
MGI:3522330	pta	MP:0000024,lowered ear position|MP:0000088,short mandible|MP:0000091,short premaxilla|MP:0000097,short maxilla|MP:0000440,domed cranium|MP:0000447,flattened snout|MP:0000547,short limbs|MP:0001823,thymus hypoplasia|MP:0002081,perinatal lethality|MP:0002633,persistent truncus arteriosus|MP:0002639,micrognathia|MP:0002745,abnormal atrioventricular valve morphology|MP:0004375,enlarged frontal bone|MP:0004471,short nasal bone|MP:0006049,semilunar valve regurgitation|MP:0010404,ostium primum atrial septal defect|MP:0010413,complete atrioventricular septal defect
MGI:5697309	Ptafr<tm1b(KOMP)Wtsi>	MP:0004738,abnormal auditory brainstem response
MGI:3612592	Ptafr<tm1Eit>	MP:0004003,abnormal vascular endothelial cell physiology|MP:0005167,abnormal blood-brain barrier function
MGI:3036770	Ptafr<tm1Tksh>	MP:0001876,decreased inflammatory response|MP:0002411,decreased susceptibility to bacterial infection|MP:0003631,nervous system phenotype|MP:0005027,increased susceptibility to parasitic infection|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0005596,increased susceptibility to type I hypersensitivity reaction
MGI:4868473	Ptbp1<tm1Msol>	MP:0000352,decreased cell proliferation|MP:0001685,abnormal endoderm development|MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0002663,absent blastocoele|MP:0003954,abnormal Reichert's membrane morphology|MP:0003984,embryonic growth retardation|MP:0005032,abnormal ectoplacental cone morphology|MP:0006042,increased apoptosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5585398	Ptbp1<tm1Nobu>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6388381	Ptbp2<em1(IMPC)Hmgu>	MP:0002098,abnormal vibrissa morphology|MP:0002100,abnormal tooth morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:4124189	Ptbp2<Gt(NPX210)Byg>	MP:0002058,neonatal lethality|MP:0003424,premature neuronal precursor differentiation|MP:0004981,decreased neuronal precursor cell number|MP:0008458,abnormal cortical ventricular zone morphology|MP:0009937,abnormal neuron differentiation
MGI:5607602	Ptbp2<tm1.1Dblk>	MP:0001265,decreased body size|MP:0001575,cyanosis|MP:0001732,postnatal growth retardation|MP:0002196,absent corpus callosum|MP:0002199,abnormal brain commissure morphology|MP:0002229,neurodegeneration|MP:0003224,neuron degeneration|MP:0005237,abnormal olfactory tract morphology|MP:0006254,thin cerebral cortex|MP:0008026,abnormal brain white matter morphology|MP:0008128,abnormal brain internal capsule morphology|MP:0008283,small hippocampus|MP:0008489,slow postnatal weight gain|MP:0008535,enlarged lateral ventricles|MP:0009946,abnormal olfactory bulb layer morphology|MP:0009954,abnormal mitral cell morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011087,neonatal lethality, complete penetrance
MGI:5431214	Ptbp2<tm1.1Rbd>	MP:0003424,premature neuronal precursor differentiation|MP:0004981,decreased neuronal precursor cell number|MP:0008458,abnormal cortical ventricular zone morphology|MP:0009937,abnormal neuron differentiation|MP:0011087,neonatal lethality, complete penetrance
MGI:5608588	Ptbp2<tm1.2Dblk>	MP:0000753,paralysis|MP:0001953,respiratory failure|MP:0002229,neurodegeneration|MP:0011087,neonatal lethality, complete penetrance
MGI:4951221	Ptcd1<tm1(KOMP)Vlcg>	MP:0001261,obese|MP:0001552,increased circulating triglyceride level|MP:0001625,cardiac hypertrophy|MP:0002628,hepatic steatosis|MP:0002953,thick ventricular wall|MP:0003333,liver fibrosis|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005599,increased cardiac muscle contractility|MP:0005669,increased circulating leptin level|MP:0006036,abnormal mitochondrial physiology|MP:0010580,decreased heart left ventricle size|MP:0010724,thick interventricular septum|MP:0010959,abnormal oxidative phosphorylation|MP:0011092,embryonic lethality, complete penetrance|MP:0011635,abnormal mitochondrial crista morphology|MP:0014341,abnormal hepatocyte mitochondrial morphology
MGI:3830811	Ptcd2<Gt(RRF537)Byg>	MP:0000280,thin ventricular wall|MP:0000598,abnormal liver morphology|MP:0002135,abnormal kidney morphology|MP:0002703,abnormal renal tubule morphology|MP:0003068,enlarged kidney|MP:0004121,abnormal sarcolemma morphology|MP:0004566,myocardial fiber degeneration|MP:0005294,abnormal heart ventricle morphology|MP:0006035,abnormal mitochondrial morphology|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:5705874	Ptcd3<tm1.1(KOMP)Vlcg>	MP:0000186,decreased circulating HDL cholesterol level|MP:0005561,increased mean corpuscular hemoglobin|MP:0006243,impaired pupillary reflex|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5544595	Ptch1<dl>	MP:0000077,abnormal interparietal bone morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000109,abnormal parietal bone morphology|MP:0000157,abnormal sternum morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000432,abnormal head morphology|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0001264,increased body size|MP:0003841,abnormal lambdoid suture morphology|MP:0004342,scapular bone foramen|MP:0004449,absent presphenoid bone|MP:0004460,alisphenoid bone hypoplasia|MP:0004462,small basisphenoid bone|MP:0008146,asymmetric sternocostal joints|MP:0008273,abnormal intramembranous bone ossification|MP:0008785,abnormal sternum manubrium morphology|MP:0009743,preaxial polydactyly|MP:0009882,absent palatal shelf|MP:0009883,palatal shelf hypoplasia|MP:0009890,cleft secondary palate|MP:0010029,abnormal basicranium morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0030284,short mandibular coronoid process
MGI:1856954	Ptch1<mes>	MP:0000160,kyphosis|MP:0000373,belly spot|MP:0000435,shortened head|MP:0000562,polydactyly|MP:0000574,abnormal foot pad morphology|MP:0000585,kinked tail|MP:0000588,thick tail|MP:0000592,short tail|MP:0001156,abnormal spermatogenesis|MP:0001157,small seminal vesicle|MP:0001300,ocular hypertelorism|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002286,cryptorchism|MP:0002576,abnormal enamel morphology|MP:0002716,small male preputial gland|MP:0003460,decreased fear-related response|MP:0004733,abnormal thoracic cavity morphology|MP:0004971,dermal hyperplasia|MP:0005503,abnormal tendon morphology|MP:0005508,abnormal skeleton morphology|MP:0030137,abnormal upper incisor morphology
MGI:2675358	Ptch1<tm1.1Bjw>	MP:0000428,abnormal craniofacial morphology|MP:0000929,open neural tube|MP:0000934,abnormal telencephalon development|MP:0001730,embryonic growth arrest|MP:0002080,prenatal lethality|MP:0012136,absent forebrain
MGI:5447563	Ptch1<tm1.1Hahn>	MP:0000929,open neural tube|MP:0002020,increased tumor incidence|MP:0002036,increased rhabdomyosarcoma incidence|MP:0002083,premature death|MP:0006283,increased medulloblastoma incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2675356	Ptch1<tm1Bjw>	MP:0000849,abnormal cerebellum morphology|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0001212,skin lesions|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0001924,infertility|MP:0002020,increased tumor incidence|MP:0002080,prenatal lethality|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0003675,kidney cyst|MP:0004194,abnormal kidney pelvis morphology|MP:0004208,increased basal cell carcinoma incidence|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004754,abnormal kidney collecting duct morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0004980,increased neuronal precursor cell number|MP:0006283,increased medulloblastoma incidence|MP:0008914,enlarged cerebellum|MP:0012525,abnormal rhombic lip morphology
MGI:4453152	Ptch1<tm1Cklr>	MP:0001393,ataxia|MP:0002006,neoplasm|MP:0006283,increased medulloblastoma incidence
MGI:3764517	Ptch1<tm1Hahn>	MP:0000219,increased neutrophil cell number|MP:0001823,thymus hypoplasia|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002367,abnormal thymus lobule morphology|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002407,abnormal double-negative T cell morphology|MP:0003414,epidermal cyst|MP:0003447,decreased tumor growth/size|MP:0003580,increased fibroma incidence|MP:0004208,increased basal cell carcinoma incidence|MP:0005014,increased B cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008082,increased single-positive T cell number|MP:0008190,decreased transitional stage B cell number|MP:0008209,decreased pre-B cell number|MP:0008210,increased mature B cell number|MP:0008215,decreased immature B cell number
MGI:3609560	Ptch1<tm1Kmmt>	MP:0030220,mandibular cyst
MGI:1857447	Ptch1<tm1Mps>	MP:0000267,abnormal heart development|MP:0000418,focal hair loss|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000889,abnormal cerebellar molecular layer|MP:0000929,open neural tube|MP:0001264,increased body size|MP:0002020,increased tumor incidence|MP:0002036,increased rhabdomyosarcoma incidence|MP:0002083,premature death|MP:0003667,increased hemangiosarcoma incidence|MP:0004208,increased basal cell carcinoma incidence|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0004501,increased incidence of tumors by UV-induction|MP:0006283,increased medulloblastoma incidence|MP:0008784,craniorachischisis|MP:0010279,increased gastrointestinal tumor incidence|MP:0010300,increased skin tumor incidence|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012431,increased lymphoma incidence|MP:0013292,embryonic lethality prior to organogenesis|MP:0014237,decreased tumor-free survival time
MGI:3687452	Ptch1<tm1Yy>	MP:0002006,neoplasm|MP:0002083,premature death|MP:0008271,abnormal bone ossification|MP:0010768,mortality/aging|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1857935	Ptch1<tm1Zim>	MP:0000150,abnormal rib morphology|MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0001247,dermal cyst|MP:0001264,increased body size|MP:0002036,increased rhabdomyosarcoma incidence|MP:0003345,decreased rib number|MP:0003720,abnormal neural tube closure|MP:0003992,increased mortality induced by ionizing radiation|MP:0004199,increased fetal size|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0006283,increased medulloblastoma incidence|MP:0009743,preaxial polydactyly|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0030220,mandibular cyst
MGI:2655210	Ptch1<tm2Mps>	MP:0001924,infertility
MGI:5004953	Ptch1<wig>	MP:0000259,abnormal vascular development|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001081,abnormal cranial ganglia morphology|MP:0001082,abnormal geniculate ganglion morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001096,abnormal glossopharyngeal ganglion morphology|MP:0001699,increased embryo size|MP:0003632,abnormal nervous system morphology|MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0004310,small otic vesicle|MP:0005657,abnormal neural plate morphology|MP:0006292,abnormal nasal placode morphology|MP:0006294,absent optic vesicle|MP:0006344,small second pharyngeal arch|MP:0008784,craniorachischisis|MP:0009937,abnormal neuron differentiation|MP:0010642,absent third pharyngeal arch|MP:0010643,absent fourth pharyngeal arch|MP:0010939,abnormal mandibular prominence morphology|MP:0010940,abnormal maxillary prominence morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3604587	Ptch2<tm1Dgen>	MP:0000172,abnormal bone marrow cell number|MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002874,decreased hemoglobin content
MGI:3656034	Ptch2<tm1Hui>	MP:0000414,alopecia|MP:0001209,spontaneous skin ulceration|MP:0001212,skin lesions|MP:0001222,epidermal hyperplasia|MP:0001243,abnormal dermal layer morphology|MP:0003631,nervous system phenotype|MP:0004971,dermal hyperplasia|MP:0005389,reproductive system phenotype
MGI:3665289	Ptch2<tm1Pmc>	MP:0002169,no abnormal phenotype detected
MGI:5788664	Ptch2<tm3b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0011874,enlarged urinary bladder|MP:0013279,increased fasting circulating glucose level
MGI:5763006	Ptchd1<tm1b(KOMP)IcsOrl>	MP:0000063,decreased bone mineral density|MP:0000689,abnormal spleen morphology|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0001529,abnormal vocalization|MP:0002574,increased vertical activity|MP:0002875,decreased erythrocyte cell number|MP:0003960,increased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005553,increased circulating creatinine level|MP:0005655,increased aggression
MGI:5792576	Ptchd1<tm2.1Gfng>	MP:0001399,hyperactivity|MP:0005386,behavior/neurological phenotype|MP:0009436,fragmentation of sleep/wake states|MP:0014114,abnormal cognition
MGI:5792687	Ptchd1<tm2.2Gfng>	MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001501,abnormal sleep pattern|MP:0003463,abnormal single cell response|MP:0003631,nervous system phenotype|MP:0004144,hypotonia|MP:0005386,behavior/neurological phenotype|MP:0005655,increased aggression|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0012312,impaired avoidance learning behavior|MP:0014114,abnormal cognition
MGI:6152621	Ptchd3<em1(IMPC)Mbp>	MP:0001293,anophthalmia|MP:0002092,abnormal eye morphology
MGI:4451466	Ptchd3<tm1a(KOMP)Wtsi>	MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:6388379	Ptchd4<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0002060,abnormal skin morphology|MP:0002110,abnormal digit morphology|MP:0011044,increased lung elastance
MGI:4843449	Ptcra<tm1.1Shoy>	MP:0000715,decreased thymocyte number|MP:0005015,increased T cell number|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0008346,increased gamma-delta T cell number|MP:0010133,increased DN3 thymocyte number
MGI:3526158	Ptcra<tm1Bjf>	MP:0002145,abnormal T cell differentiation|MP:0005089,decreased double-negative T cell number|MP:0008083,decreased single-positive T cell number
MGI:3696089	Ptcra<tm1(icre)Hjf>	MP:0000715,decreased thymocyte number|MP:0005092,decreased double-positive T cell number|MP:0010136,decreased DN4 thymocyte number
MGI:3051255	Ptcra<tm1Vbo>	MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0002408,abnormal double-positive T cell morphology|MP:0005090,increased double-negative T cell number|MP:0010133,increased DN3 thymocyte number|MP:0010136,decreased DN4 thymocyte number
MGI:1856624	ptd	MP:0000111,cleft palate|MP:0000562,polydactyly|MP:0002111,abnormal tail morphology|MP:0010769,abnormal survival|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:5548417	Ptdss1<tm1b(EUCOMM)Hmgu>	MP:0000194,increased circulating calcium level|MP:0009141,increased prepulse inhibition|MP:0012361,decreased large unstained cell number
MGI:3798813	Ptdss1<tm1Jev>	MP:0003631,nervous system phenotype|MP:0004777,abnormal phospholipid level|MP:0010768,mortality/aging
MGI:2447151	Ptdss2<Gt(KST314)Byg>	MP:0001146,abnormal testis morphology|MP:0001152,increased Leydig cell number|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001925,male infertility|MP:0003205,testicular atrophy|MP:0004852,decreased testis weight
MGI:3578141	Pten<m1un>	MP:0001701,incomplete embryo turning|MP:0001730,embryonic growth arrest|MP:0004187,cardia bifida|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4442330	Pten<tm1.1Gle>	MP:0001695,abnormal gastrulation|MP:0002024,increased T cell derived lymphoma incidence|MP:0002031,increased adrenal gland tumor incidence|MP:0002085,abnormal embryonic tissue morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0009092,endometrium hyperplasia|MP:0010299,increased mammary gland tumor incidence|MP:0010301,increased stomach tumor incidence|MP:0010316,increased thyroid tumor incidence|MP:0010357,increased prostate gland tumor incidence|MP:0011092,embryonic lethality, complete penetrance|MP:0012431,increased lymphoma incidence
MGI:3653378	Pten<tm1.1Hwu>	MP:0000688,lymphoid hyperplasia|MP:0000819,abnormal olfactory bulb morphology|MP:0000858,abnormal metastatic potential|MP:0000929,open neural tube|MP:0000930,wavy neural tube|MP:0001120,abnormal uterus morphology|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002019,abnormal tumor incidence|MP:0002947,increased hemangioma incidence|MP:0003496,increased thyroid adenoma incidence|MP:0004950,abnormal brain vasculature morphology|MP:0010357,increased prostate gland tumor incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012431,increased lymphoma incidence|MP:0031587,abnormal pericardium development
MGI:5796481	Pten<tm1.1Jaes>	MP:0002206,abnormal CNS synaptic transmission|MP:0002915,abnormal synaptic depression
MGI:2183285	Pten<tm1.1Mro>	MP:0001272,increased metastatic potential|MP:0001672,abnormal embryo development|MP:0002020,increased tumor incidence|MP:0002050,increased pheochromocytoma incidence|MP:0008762,embryonic lethality
MGI:4366755	Pten<tm1.1Mwst>	MP:0004697,abnormal thyroid follicular cell morphology|MP:0010299,increased mammary gland tumor incidence
MGI:6730304	Pten<tm1.1Yxy>	MP:0001473,reduced long-term potentiation|MP:0002739,abnormal olfactory bulb development|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0003037,increased myocardial infarct size|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0008544,impaired olfaction|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009951,abnormal olfactory bulb mitral cell layer morphology|MP:0010954,abnormal cellular respiration|MP:0011636,disorganized mitochondrial cristae|MP:0012307,impaired spatial learning|MP:0012319,fast extinction of fear memory|MP:0014046,abnormal mitophagy|MP:0014395,increased myocardial fiber mitochondrial DNA content|MP:0030736,increased glutamic acid level|MP:0030951,abnormal endocytosis|MP:0031217,increased susceptibility to myocardial ischemic injury
MGI:4442327	Pten<tm1.2Mwst>	MP:0001695,abnormal gastrulation|MP:0002024,increased T cell derived lymphoma incidence|MP:0002031,increased adrenal gland tumor incidence|MP:0002085,abnormal embryonic tissue morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0006422,increased mammary adenoacanthoma incidence|MP:0009092,endometrium hyperplasia|MP:0009223,increased uterus carcinoma incidence|MP:0010279,increased gastrointestinal tumor incidence|MP:0010299,increased mammary gland tumor incidence|MP:0010301,increased stomach tumor incidence|MP:0010316,increased thyroid tumor incidence|MP:0010357,increased prostate gland tumor incidence|MP:0011092,embryonic lethality, complete penetrance|MP:0012431,increased lymphoma incidence
MGI:5509194	Pten<tm1Engc>	MP:0000351,increased cell proliferation|MP:0000434,megacephaly|MP:0001265,decreased body size|MP:0001360,abnormal social investigation|MP:0001525,impaired balance|MP:0002176,increased brain weight|MP:0003354,astrocytosis|MP:0003691,abnormal microglial cell physiology|MP:0005238,increased brain size|MP:0005621,abnormal cell physiology|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008914,enlarged cerebellum|MP:0009938,abnormal hippocampus granule cell morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0010160,increased oligodendrocyte number|MP:0012065,increased astrocyte number
MGI:2156086	Pten<tm1Hwu>	MP:0000189,hypoglycemia|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000259,abnormal vascular development|MP:0000322,increased granulocyte number|MP:0000333,decreased bone marrow cell number|MP:0000343,abnormal response to cardiac infarction|MP:0000381,enlarged hair follicles|MP:0000434,megacephaly|MP:0000477,abnormal intestine morphology|MP:0000496,abnormal small intestine morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000516,abnormal renal/urinary system morphology|MP:0000519,hydronephrosis|MP:0000534,abnormal ureter morphology|MP:0000540,abnormal urinary bladder urothelium morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000613,abnormal salivary gland morphology|MP:0000630,mammary gland hyperplasia|MP:0000659,prostate gland hyperplasia|MP:0000662,abnormal branching of the mammary ductal tree|MP:0000681,abnormal thyroid gland morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0000780,abnormal corpus callosum morphology|MP:0000813,abnormal hippocampus layer morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000849,abnormal cerebellum morphology|MP:0000853,absent cerebellar foliation|MP:0000854,abnormal cerebellum development|MP:0000857,abnormal cerebellar foliation|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000885,ectopic Purkinje cell|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000897,abnormal midbrain morphology|MP:0000953,abnormal oligodendrocyte morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001106,abnormal Schwann cell morphology|MP:0001125,abnormal oocyte morphology|MP:0001130,abnormal ovarian folliculogenesis|MP:0001131,abnormal ovarian follicle morphology|MP:0001133,impaired luteal cell differentiation|MP:0001158,abnormal prostate gland morphology|MP:0001167,prostate gland epithelial hyperplasia|MP:0001168,abnormal prostate gland epithelium morphology|MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001188,hyperpigmentation|MP:0001195,flaky skin|MP:0001200,thick skin|MP:0001211,wrinkled skin|MP:0001212,skin lesions|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001260,increased body weight|MP:0001272,increased metastatic potential|MP:0001302,eyelids open at birth|MP:0001304,cataract|MP:0001330,abnormal optic nerve morphology|MP:0001505,hunched posture|MP:0001575,cyanosis|MP:0001577,anemia|MP:0001664,abnormal digestion|MP:0001716,abnormal placenta labyrinth morphology|MP:0001732,postnatal growth retardation|MP:0001756,abnormal urination|MP:0001805,decreased IgG level|MP:0001861,lung inflammation|MP:0001874,acanthosis|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001885,mammary gland duct hyperplasia|MP:0001906,increased dopamine level|MP:0001914,hemorrhage|MP:0001921,reduced fertility|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0001935,decreased litter size|MP:0001954,respiratory distress|MP:0001984,abnormal olfaction|MP:0002006,neoplasm|MP:0002014,increased papilloma incidence|MP:0002018,increased malignant tumor incidence|MP:0002019,abnormal tumor incidence|MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002038,increased carcinoma incidence|MP:0002051,increased skin papilloma incidence|MP:0002052,decreased tumor incidence|MP:0002059,abnormal seminal vesicle morphology|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002152,abnormal brain morphology|MP:0002160,abnormal reproductive system morphology|MP:0002169,no abnormal phenotype detected|MP:0002176,increased brain weight|MP:0002411,decreased susceptibility to bacterial infection|MP:0002412,increased susceptibility to bacterial infection|MP:0002429,abnormal blood cell morphology/development|MP:0002439,abnormal plasma cell morphology|MP:0002459,abnormal B cell physiology|MP:0002463,abnormal neutrophil physiology|MP:0002494,increased IgM level|MP:0002628,hepatic steatosis|MP:0002651,abnormal sciatic nerve morphology|MP:0002676,uterus hyperplasia|MP:0002679,abnormal corpus luteum morphology|MP:0002681,increased corpora lutea number|MP:0002693,abnormal pancreas physiology|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002731,megacolon|MP:0002763,ectopic Bergmann glia cells|MP:0002769,abnormal vas deferens morphology|MP:0002891,increased insulin sensitivity|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003038,decreased myocardial infarct size|MP:0003058,increased insulin secretion|MP:0003075,abnormal response to CNS ischemic injury|MP:0003231,abnormal placenta vasculature|MP:0003243,abnormal dopaminergic neuron morphology|MP:0003271,abnormal duodenum morphology|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003449,abnormal intestine goblet cell morphology|MP:0003462,abnormal response to novel odor|MP:0003496,increased thyroid adenoma incidence|MP:0003498,thyroid gland hyperplasia|MP:0003507,abnormal ovary physiology|MP:0003607,abnormal prostate gland physiology|MP:0003608,prostate gland inflammation|MP:0003645,increased pancreatic beta cell number|MP:0003674,oxidative stress|MP:0003809,abnormal hair shaft morphology|MP:0003828,pulmonary edema|MP:0003871,abnormal myelin sheath morphology|MP:0003887,increased hepatocyte apoptosis|MP:0003893,increased hepatocyte proliferation|MP:0004002,abnormal jejunum morphology|MP:0004007,abnormal lung vasculature morphology|MP:0004049,increased acute promyelocytic leukemia incidence|MP:0004077,abnormal striatum morphology|MP:0004087,abnormal muscle fiber morphology|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004202,pulmonary hyperplasia|MP:0004207,increased squamous cell carcinoma incidence|MP:0004256,abnormal maternal decidual layer morphology|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004499,increased incidence of tumors by chemical induction|MP:0004696,abnormal thyroid follicle morphology|MP:0004768,abnormal axonal transport|MP:0004811,abnormal neuron physiology|MP:0004816,abnormal class switch recombination|MP:0004832,enlarged ovary|MP:0004839,bile duct hyperplasia|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0004843,abnormal Paneth cell morphology|MP:0004848,abnormal liver size|MP:0004868,increased endometrial carcinoma incidence|MP:0004896,abnormal endometrium morphology|MP:0004904,increased uterus weight|MP:0004905,decreased uterus weight|MP:0004933,abnormal epididymis epithelium morphology|MP:0004944,abnormal B cell negative selection|MP:0004948,abnormal neuronal precursor proliferation|MP:0004952,increased spleen weight|MP:0004958,enlarged prostate gland|MP:0004961,increased prostate gland weight|MP:0004977,increased B-1 B cell number|MP:0004980,increased neuronal precursor cell number|MP:0005014,increased B cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005031,abnormal trophoblast layer morphology|MP:0005131,increased follicle stimulating hormone level|MP:0005133,increased luteinizing hormone level|MP:0005135,increased thyroid-stimulating hormone level|MP:0005154,increased B cell proliferation|MP:0005166,decreased susceptibility to injury|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005220,abnormal exocrine pancreas morphology|MP:0005238,increased brain size|MP:0005277,abnormal brainstem morphology|MP:0005280,abnormal fatty acids level|MP:0005292,improved glucose tolerance|MP:0005305,prostate gland anterior lobe hyperplasia|MP:0005355,enlarged thyroid gland|MP:0005367,renal/urinary system phenotype|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0005402,abnormal action potential|MP:0005405,axon degeneration|MP:0005425,increased macrophage cell number|MP:0005470,increased thyroxine level|MP:0005471,decreased thyroxine level|MP:0005488,bronchial epithelial hyperplasia|MP:0005490,increased club cell number|MP:0005491,pancreatic islet hyperplasia|MP:0005502,abnormal renal/urinary system physiology|MP:0005505,thrombocytosis|MP:0005560,decreased circulating glucose level|MP:0005603,neuron hypertrophy|MP:0005607,decreased bleeding time|MP:0005668,decreased circulating leptin level|MP:0006078,abnormal nipple morphology|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0006271,abnormal involution of the mammary gland|MP:0006298,abnormal platelet activation|MP:0006382,abnormal lung epithelium morphology|MP:0008011,intestine polyps|MP:0008019,increased liver tumor incidence|MP:0008026,abnormal brain white matter morphology|MP:0008033,impaired lipolysis|MP:0008108,abnormal small intestinal villus morphology|MP:0008143,abnormal dendrite morphology|MP:0008181,increased marginal zone B cell number|MP:0008245,abnormal alveolar macrophage morphology|MP:0008256,abnormal myometrium morphology|MP:0008413,decreased cellular sensitivity to oxidative stress|MP:0008458,abnormal cortical ventricular zone morphology|MP:0008482,decreased spleen germinal center number|MP:0008489,slow postnatal weight gain|MP:0008688,decreased interleukin-2 secretion|MP:0008713,abnormal cytokine level|MP:0008719,impaired neutrophil recruitment|MP:0008770,decreased survivor rate|MP:0008782,increased B cell apoptosis|MP:0008814,decreased nerve conduction velocity|MP:0008876,decreased uterine NK cell number|MP:0008914,enlarged cerebellum|MP:0009092,endometrium hyperplasia|MP:0009113,increased pancreatic beta cell mass|MP:0009145,abnormal pancreatic acinus morphology|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009151,increased pancreatic ductal adenocarcinoma incidence|MP:0009152,increased pancreatic intraepithelial neoplasia incidence|MP:0009159,increased pancreatic acinar cell number|MP:0009167,increased pancreatic islet number|MP:0009171,enlarged pancreatic islets|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0009314,increased colon adenocarcinoma incidence|MP:0009355,increased liver triglyceride level|MP:0009361,abnormal primordial ovarian follicle morphology|MP:0009469,increased skin hamartoma incidence|MP:0009480,distended cecum|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009505,abnormal mammary gland lobule morphology|MP:0009550,increased urinary bladder carcinoma incidence|MP:0009586,increased platelet aggregation|MP:0009612,thick epidermis suprabasal layer|MP:0009661,abnormal pregnancy|MP:0009671,abnormal uterus physiology|MP:0009704,increased skin squamous cell carcinoma incidence|MP:0009738,enlarged prostate gland anterior lobe|MP:0009745,abnormal behavioral response to xenobiotic|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0009937,abnormal neuron differentiation|MP:0010025,decreased total body fat amount|MP:0010050,hypermyelination|MP:0010157,abnormal small intestinal crypt cell proliferation|MP:0010171,abnormal centroacinar cell of Langerhans morphology|MP:0010234,abnormal vibrissa follicle morphology|MP:0010279,increased gastrointestinal tumor incidence|MP:0010299,increased mammary gland tumor incidence|MP:0010300,increased skin tumor incidence|MP:0010315,increased cholangiocarcinoma incidence|MP:0010316,increased thyroid tumor incidence|MP:0010336,increased acute lymphoblastic leukemia incidence|MP:0010357,increased prostate gland tumor incidence|MP:0010364,increased fibroadenoma incidence|MP:0010384,increased renal carcinoma incidence|MP:0010387,abnormal Bergmann glial cell morphology|MP:0010388,abnormal Bergmann glial cell differentiation|MP:0010400,increased liver glycogen level|MP:0010760,abnormal macrophage chemotaxis|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0010768,mortality/aging|MP:0010802,abnormal intestinal enteroendocrine cell morphology|MP:0010910,bronchiolar epithelial hyperplasia|MP:0010915,increased solitary pulmonary neuroendocrine cell number|MP:0010942,abnormal respiratory epithelium morphology|MP:0011083,lethality at weaning, complete penetrance|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011121,decreased primordial ovarian follicle number|MP:0011122,absent primordial ovarian follicles|MP:0011139,increased lung endothelial cell proliferation|MP:0011142,abnormal lung-associated mesenchyme development|MP:0011237,decreased blood oxygen capacity|MP:0011403,pyelonephritis|MP:0011789,increased urethra carcinoma incidence|MP:0011819,increased pancreatic beta cell proliferation|MP:0012411,increased granulosa cell tumor incidence|MP:0012674,tomacula|MP:0013218,abnormal substantia nigra pars reticulata morphology|MP:0013219,abnormal substantia nigra pars compacta morphology|MP:0013399,endometrium fibrosis|MP:0014049,increased T cell acute lymphoblastic leukemia incidence|MP:0014081,branched small intestinal villi|MP:0014237,decreased tumor-free survival time|MP:0014574,decreased circulating resistin level|MP:0014648,abnormal response to nerve crush injury|MP:0031016,decreased granulosa cell apoptosis|MP:0031019,increased granulosa cell proliferation|MP:0031020,premature ovarian failure|MP:0031115,macrovesicular hepatic steatosis|MP:0031318,enhanced skeletal muscle regeneration|MP:0031421,increased superovulation rate|MP:0031423,abnormal luteolysis|MP:0031424,enhanced female fertility
MGI:1857937	Pten<tm1Mak>	MP:0000913,abnormal brain development|MP:0000929,open neural tube|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001726,abnormal allantois morphology|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002031,increased adrenal gland tumor incidence|MP:0002038,increased carcinoma incidence|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0003269,colon polyps|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0003988,disorganized embryonic tissue|MP:0004180,failure of initiation of embryo turning|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0004556,enlarged allantois|MP:0004868,increased endometrial carcinoma incidence|MP:0008136,enlarged Peyer's patches|MP:0009092,endometrium hyperplasia|MP:0009657,failure of chorioallantoic fusion|MP:0010299,increased mammary gland tumor incidence|MP:0010306,increased hamartoma incidence|MP:0010357,increased prostate gland tumor incidence|MP:0010364,increased fibroadenoma incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012431,increased lymphoma incidence
MGI:2183284	Pten<tm1Mro>	MP:0000659,prostate gland hyperplasia|MP:0000849,abnormal cerebellum morphology|MP:0000853,absent cerebellar foliation|MP:0000854,abnormal cerebellum development|MP:0000864,abnormal cerebellum vermis morphology|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000885,ectopic Purkinje cell|MP:0000889,abnormal cerebellar molecular layer|MP:0001167,prostate gland epithelial hyperplasia|MP:0001168,abnormal prostate gland epithelium morphology|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001525,impaired balance|MP:0002006,neoplasm|MP:0004961,increased prostate gland weight|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008914,enlarged cerebellum|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0010357,increased prostate gland tumor incidence|MP:0014551,impaired neuronal migration
MGI:1857936	Pten<tm1Ppp>	MP:0002018,increased malignant tumor incidence|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3831201	Pten<tm1Rdp>	MP:0001186,pigmentation phenotype
MGI:2151804	Pten<tm1Rps>	MP:0000434,megacephaly|MP:0000681,abnormal thyroid gland morphology|MP:0000691,enlarged spleen|MP:0000709,enlarged thymus|MP:0001168,abnormal prostate gland epithelium morphology|MP:0001360,abnormal social investigation|MP:0001409,increased stereotypic behavior|MP:0002020,increased tumor incidence|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002176,increased brain weight|MP:0002344,abnormal lymph node B cell domain morphology|MP:0002627,increased teratoma incidence|MP:0003324,increased liver adenoma incidence|MP:0003862,decreased aggression towards male mice|MP:0003988,disorganized embryonic tissue|MP:0004924,abnormal behavior|MP:0008011,intestine polyps|MP:0008102,lymph node hyperplasia|MP:0009092,endometrium hyperplasia|MP:0009142,decreased prepulse inhibition|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0010346,increased thyroid carcinoma incidence|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012431,increased lymphoma incidence
MGI:4442331	Pten<tm2.1Gle>	MP:0001695,abnormal gastrulation|MP:0002024,increased T cell derived lymphoma incidence|MP:0002031,increased adrenal gland tumor incidence|MP:0002085,abnormal embryonic tissue morphology|MP:0004697,abnormal thyroid follicular cell morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0006422,increased mammary adenoacanthoma incidence|MP:0009092,endometrium hyperplasia|MP:0010299,increased mammary gland tumor incidence|MP:0010316,increased thyroid tumor incidence|MP:0010357,increased prostate gland tumor incidence|MP:0011092,embryonic lethality, complete penetrance|MP:0012431,increased lymphoma incidence
MGI:2679886	Pten<tm2.1Ppp>	MP:0000659,prostate gland hyperplasia|MP:0001065,abnormal trigeminal nerve morphology|MP:0001158,abnormal prostate gland morphology|MP:0001167,prostate gland epithelial hyperplasia|MP:0001168,abnormal prostate gland epithelium morphology|MP:0001186,pigmentation phenotype|MP:0002030,increased neurofibrosarcoma incidence|MP:0002083,premature death|MP:0002651,abnormal sciatic nerve morphology|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003496,increased thyroid adenoma incidence|MP:0003498,thyroid gland hyperplasia|MP:0003632,abnormal nervous system morphology|MP:0003635,abnormal synaptic transmission|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004958,enlarged prostate gland|MP:0005134,decreased thyroid-stimulating hormone level|MP:0005470,increased thyroxine level|MP:0008143,abnormal dendrite morphology|MP:0008177,increased germinal center B cell number|MP:0008499,increased IgG1 level|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0010186,increased T follicular helper cell number|MP:0010346,increased thyroid carcinoma incidence|MP:0010357,increased prostate gland tumor incidence|MP:0014373,increased miniature excitatory postsynaptic current amplitude|MP:0014375,increased miniature excitatory postsynaptic current frequency|MP:0020507,increased dendritic spine density
MGI:3653409	Pten<tm2Hwu>	MP:0002019,abnormal tumor incidence
MGI:2182005	Pten<tm2Mak>	MP:0000062,increased bone mineral density|MP:0000065,abnormal bone marrow cavity morphology|MP:0000131,abnormal long bone epiphysis morphology|MP:0000160,kyphosis|MP:0000163,abnormal cartilage morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000166,abnormal chondrocyte morphology|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000420,ruffled hair|MP:0000434,megacephaly|MP:0000519,hydronephrosis|MP:0000540,abnormal urinary bladder urothelium morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0000755,hindlimb paralysis|MP:0000789,thickened cerebral cortex|MP:0000807,abnormal hippocampus morphology|MP:0000811,hippocampal neuron degeneration|MP:0000812,abnormal dentate gyrus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000857,abnormal cerebellar foliation|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000889,abnormal cerebellar molecular layer|MP:0000951,sporadic seizures|MP:0001176,abnormal lung development|MP:0001222,epidermal hyperplasia|MP:0001257,increased body length|MP:0001265,decreased body size|MP:0001272,increased metastatic potential|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001386,abnormal maternal nurturing|MP:0001393,ataxia|MP:0001409,increased stereotypic behavior|MP:0001447,abnormal nest building behavior|MP:0001488,increased startle reflex|MP:0001575,cyanosis|MP:0001625,cardiac hypertrophy|MP:0001860,liver inflammation|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001891,hydrocephaly|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002006,neoplasm|MP:0002027,increased lung adenocarcinoma incidence|MP:0002064,seizures|MP:0002083,premature death|MP:0002166,abnormal tumor susceptibility|MP:0002176,increased brain weight|MP:0002183,gliosis|MP:0002184,abnormal innervation|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0002274,abnormal type I pneumocyte morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002324,abnormal alveolocapillary membrane morphology|MP:0002566,abnormal sexual interaction|MP:0002628,hepatic steatosis|MP:0002635,reduced sensorimotor gating|MP:0002727,decreased circulating insulin level|MP:0002758,long tail|MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0002762,ectopic cerebellar granule cells|MP:0002797,increased thigmotaxis|MP:0002891,increased insulin sensitivity|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0002981,increased liver weight|MP:0003191,abnormal cellular cholesterol metabolism|MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003333,liver fibrosis|MP:0003630,abnormal urothelium morphology|MP:0003633,abnormal nervous system physiology|MP:0003674,oxidative stress|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0003869,ectopic cartilage|MP:0003893,increased hepatocyte proliferation|MP:0003921,abnormal heart left ventricle morphology|MP:0003997,tonic-clonic seizures|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004202,pulmonary hyperplasia|MP:0004499,increased incidence of tumors by chemical induction|MP:0004564,increased myocardial fiber size|MP:0004754,abnormal kidney collecting duct morphology|MP:0004792,abnormal synaptic vesicle number|MP:0004924,abnormal behavior|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005039,hypoxia|MP:0005140,decreased cardiac muscle contractility|MP:0005202,lethargy|MP:0005238,increased brain size|MP:0005284,increased saturated fatty acids level|MP:0005325,abnormal renal glomerulus morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0005367,renal/urinary system phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005603,neuron hypertrophy|MP:0006099,thin cerebellar granule layer|MP:0006395,abnormal epiphyseal plate morphology|MP:0008143,abnormal dendrite morphology|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008717,increased lung squamous cell carcinoma incidence|MP:0008770,decreased survivor rate|MP:0008840,abnormal spike wave discharge|MP:0008916,abnormal astrocyte physiology|MP:0008989,abnormal liver sinusoid morphology|MP:0009092,endometrium hyperplasia|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0009355,increased liver triglyceride level|MP:0009538,abnormal synapse morphology|MP:0009551,increased urinary bladder transitional cell carcinoma incidence|MP:0009971,decreased hippocampus pyramidal cell number|MP:0010027,increased liver cholesterol level|MP:0010080,abnormal hepatocyte physiology|MP:0010299,increased mammary gland tumor incidence|MP:0010306,increased hamartoma incidence|MP:0010357,increased prostate gland tumor incidence|MP:0010367,increased spindle cell carcinoma incidence|MP:0010688,hair follicle outer root sheath hyperplasia|MP:0010825,abnormal lung saccule morphology|MP:0010827,small lung saccule|MP:0010829,increased bronchioalveolar stem cell number|MP:0010890,decreased alveolar lamellar body number|MP:0010910,bronchiolar epithelial hyperplasia|MP:0010980,ectopic ureteric bud|MP:0010993,decreased surfactant secretion|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011147,increased mesenchymal cell proliferation involved in lung development|MP:0011320,abnormal glomerular capillary morphology|MP:0011723,ectopic neuron|MP:0012043,increased myoepithelioma incidence|MP:0012307,impaired spatial learning|MP:0012431,increased lymphoma incidence|MP:0012459,increased dentate gyrus size|MP:0012550,respiratory acidosis|MP:0012570,increased mammary gland tumor incidence in breeding females|MP:0013278,decreased fasting circulating glucose level|MP:0014038,increased hepatocyte number|MP:0014045,Mallory bodies|MP:0020507,increased dendritic spine density|MP:0031116,microvesicular hepatic steatosis|MP:0031391,increased locomotor activity
MGI:7425935	Pter<em1(IMPC)Bay>	MP:0010124,decreased bone mineral content
MGI:2387812	Ptf1a<tm1.1(cre)Cvw>	MP:0001286,abnormal eye development|MP:0001325,abnormal retina morphology|MP:0002983,increased retina ganglion cell number|MP:0003655,absent pancreas|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0006095,absent amacrine cells|MP:0008107,absent retina horizontal cells|MP:0008508,thick retina ganglion layer|MP:0008514,absent retina inner plexiform layer|MP:0011087,neonatal lethality, complete penetrance
MGI:2152066	Ptf1a<tm1Pkwe>	MP:0000189,hypoglycemia|MP:0000689,abnormal spleen morphology|MP:0000850,absent cerebellum|MP:0000854,abnormal cerebellum development|MP:0001262,decreased body weight|MP:0001575,cyanosis|MP:0003655,absent pancreas|MP:0009177,decreased pancreatic alpha cell number|MP:0011087,neonatal lethality, complete penetrance
MGI:3691484	Ptf1a<tm2.1Mgn>	MP:0002983,increased retina ganglion cell number
MGI:3771319	Ptf1a<tm2Macd>	MP:0000852,small cerebellum|MP:0000886,abnormal cerebellar granule layer morphology|MP:0002151,abnormal neural tube morphology|MP:0003246,loss of GABAergic neurons|MP:0003247,abnormal glutaminergic neuron morphology|MP:0003655,absent pancreas|MP:0003934,abnormal pancreas development|MP:0004981,decreased neuronal precursor cell number|MP:0006282,abnormal spinal cord dorsal horn morphology|MP:0009937,abnormal neuron differentiation|MP:0011087,neonatal lethality, complete penetrance
MGI:3623476	Ptgdr2<tm1Byl>	MP:0003009,abnormal cytokine secretion|MP:0005011,increased eosinophil cell number
MGI:5473331	Ptgdr2<tm1Dgen>	MP:0005385,cardiovascular system phenotype
MGI:3773068	Ptgdr2<tm1Tasa>	MP:0001785,edema|MP:0001845,abnormal inflammatory response|MP:0001876,decreased inflammatory response|MP:0002492,decreased IgE level|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008721,abnormal chemokine level|MP:0008723,impaired eosinophil recruitment|MP:0009815,decreased prostaglandin level
MGI:5473328	Ptgdr<tm1Dgen>	MP:0005590,increased vasodilation|MP:0005591,decreased vasodilation
MGI:2386956	Ptgdr<tm1Sna>	MP:0000362,decreased mast cell histamine storage|MP:0001619,abnormal vascular permeability|MP:0001847,brain inflammation|MP:0002405,respiratory system inflammation|MP:0002423,abnormal mast cell physiology|MP:0002654,spongiform encephalopathy|MP:0004973,increased regulatory T cell number|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0008020,abnormal dermal mast cell morphology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008657,increased interleukin-1 beta secretion|MP:0008765,decreased mast cell degranulation|MP:0011075,abnormal macrophage activation involved in immune response|MP:0020449,decreased microglial cell activation|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:3581526	Ptgds<tm1Mfg>	MP:0005387,immune system phenotype
MGI:2657199	Ptgds<tm1Ohy>	MP:0000362,decreased mast cell histamine storage|MP:0001785,edema|MP:0001970,abnormal pain threshold|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0008020,abnormal dermal mast cell morphology|MP:0008765,decreased mast cell degranulation|MP:0010771,integument phenotype
MGI:3700011	Ptger1<tm1Crjk>	MP:0002988,decreased urine osmolality|MP:0003953,abnormal hormone level
MGI:3604468	Ptger1<tm1Dgen>	MP:0001402,decreased locomotor activity
MGI:2387971	Ptger1<tm1Jdm>	MP:0002626,increased heart rate|MP:0002736,abnormal nociception after inflammation|MP:0002843,decreased systemic arterial blood pressure|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005582,increased renin activity|MP:0008531,increased chemical nociceptive threshold|MP:0010768,mortality/aging
MGI:3764892	Ptger1<tm1Matb>	MP:0001625,cardiac hypertrophy|MP:0003620,oliguria|MP:0004875,increased mean systemic arterial blood pressure|MP:0004876,decreased mean systemic arterial blood pressure|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006317,decreased urine sodium level|MP:0011940,decreased food intake|MP:0011942,decreased fluid intake
MGI:2137762	Ptger1<tm1Sna>	MP:0001260,increased body weight|MP:0001354,increased aggression towards male mice|MP:0001360,abnormal social investigation|MP:0001488,increased startle reflex|MP:0001906,increased dopamine level|MP:0001970,abnormal pain threshold|MP:0002339,abnormal lymph node morphology|MP:0002351,abnormal cervical lymph node morphology|MP:0002664,decreased circulating adrenocorticotropin level|MP:0003313,abnormal locomotor activation|MP:0003447,decreased tumor growth/size|MP:0003829,impaired febrile response|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005025,abnormal response to infection|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005407,hyperalgesia|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0005643,decreased dopamine level|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008559,abnormal interferon-gamma secretion|MP:0008872,abnormal physiological response to xenobiotic|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010698,abnormal impulsive behavior control|MP:0010768,mortality/aging
MGI:5559328	Ptger2<tm1.1Kand>	MP:0003691,abnormal microglial cell physiology|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5708285	Ptger2<tm1.1(KOMP)Vlcg>	MP:0001925,male infertility|MP:0001926,female infertility
MGI:2179967	Ptger2<tm1Brey>	MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001562,abnormal circulating calcium level|MP:0001613,abnormal vasodilation|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002334,abnormal airway responsiveness|MP:0002842,increased systemic arterial blood pressure|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003025,increased vasoconstriction|MP:0003447,decreased tumor growth/size|MP:0003691,abnormal microglial cell physiology|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005025,abnormal response to infection|MP:0005164,abnormal response to injury|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0006060,increased cerebral infarct size|MP:0014812,abnormal brain physiology|MP:0031420,decreased superovulation rate
MGI:2181616	Ptger2<tm1Rsz>	MP:0008396,abnormal osteoclast differentiation
MGI:2651880	Ptger2<tm1Sna>	MP:0000242,impaired fertilization|MP:0001125,abnormal oocyte morphology|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002680,decreased corpora lutea number|MP:0003355,decreased ovulation rate|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0009373,abnormal cumulus expansion|MP:0009374,absent cumulus expansion|MP:0010768,mortality/aging
MGI:2181614	Ptger2<tm2Bhk>	MP:0000242,impaired fertilization|MP:0001596,hypotension|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0005367,renal/urinary system phenotype|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005581,abnormal renin activity
MGI:2157796	Ptger3<tm1Cof>	MP:0002987,abnormal urine osmolality|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005525,increased renal plasma flow rate|MP:0005530,decreased renal vascular resistance|MP:0005590,increased vasodilation|MP:0010768,mortality/aging|MP:0031120,decreased susceptibility to induced thrombosis
MGI:3764893	Ptger3<tm1Csml>	MP:0003829,impaired febrile response|MP:0005376,homeostasis/metabolism phenotype|MP:0011049,impaired adaptive thermogenesis
MGI:2137759	Ptger3<tm1Sna>	MP:0001777,abnormal body temperature homeostasis|MP:0001785,edema|MP:0001970,abnormal pain threshold|MP:0002664,decreased circulating adrenocorticotropin level|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003829,impaired febrile response|MP:0005025,abnormal response to infection|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008872,abnormal physiological response to xenobiotic|MP:0010768,mortality/aging
MGI:3052967	Ptger4<tm1.1Matb>	MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0001853,heart inflammation|MP:0002169,no abnormal phenotype detected|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0005140,decreased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0010630,abnormal cardiac muscle tissue morphology|MP:0011925,abnormal heart echocardiography feature|MP:0014316,decreased heart left ventricle posterior wall thickness
MGI:3665234	Ptger4<tm1.2Matb>	MP:0002081,perinatal lethality|MP:0003139,patent ductus arteriosus|MP:0004231,abnormal calcium ion homeostasis
MGI:2137850	Ptger4<tm1Bhk>	MP:0000364,abnormal vascular regression|MP:0001175,abnormal lung morphology|MP:0001182,lung hemorrhage|MP:0002451,abnormal macrophage physiology|MP:0003035,decreased pulmonary vascular resistance|MP:0003139,patent ductus arteriosus|MP:0003436,decreased susceptibility to induced arthritis|MP:0003561,rheumatoid arthritis|MP:0003658,abnormal capillary morphology|MP:0003828,pulmonary edema|MP:0004038,lymphangiectasis|MP:0005387,immune system phenotype|MP:0005630,increased lung weight|MP:0008595,abnormal circulating interleukin-6 level|MP:0008713,abnormal cytokine level|MP:0009811,abnormal prostaglandin level|MP:0010018,pulmonary vascular congestion|MP:0010019,liver vascular congestion|MP:0010214,abnormal circulating serum amyloid protein level|MP:0010768,mortality/aging|MP:0010909,pulmonary alveolar hemorrhage|MP:0011085,postnatal lethality, complete penetrance|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis|MP:0031129,left-to-right shunt
MGI:3052800	Ptger4<tm1Matb>	MP:0002058,neonatal lethality|MP:0003139,patent ductus arteriosus
MGI:2137851	Ptger4<tm1Sna>	MP:0001541,abnormal osteoclast physiology|MP:0001828,abnormal T cell activation|MP:0002009,preneoplasia|MP:0002082,postnatal lethality|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002753,dilated heart left ventricle|MP:0003139,patent ductus arteriosus|MP:0003717,pallor|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005095,decreased T cell proliferation|MP:0005202,lethargy|MP:0005362,abnormal Langerhans cell physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0006138,congestive heart failure|MP:0008396,abnormal osteoclast differentiation|MP:0008567,decreased interferon-gamma secretion|MP:0008770,decreased survivor rate|MP:0010018,pulmonary vascular congestion|MP:0010557,dilated pulmonary artery
MGI:4432215	Ptges2<tm1a(EUCOMM)Wtsi>	MP:0005561,increased mean corpuscular hemoglobin
MGI:3620552	Ptges2<tm1Bhk>	MP:0005376,homeostasis/metabolism phenotype
MGI:5517548	Ptges2<tm1Kymm>	MP:0001785,edema|MP:0005596,increased susceptibility to type I hypersensitivity reaction
MGI:3701300	Ptges3<Gt(RST271)Byg>	MP:0001177,atelectasis|MP:0001196,shiny skin|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001951,abnormal breathing pattern|MP:0002796,impaired skin barrier function|MP:0003641,small lung|MP:0004780,abnormal surfactant secretion|MP:0005202,lethargy|MP:0006027,impaired lung alveolus development|MP:0009931,abnormal skin appearance|MP:0010811,decreased type II pneumocyte number|MP:0010887,pale lung|MP:0011087,neonatal lethality, complete penetrance
MGI:3701321	Ptges3<Gt(W069F07)Wrst>	MP:0001177,atelectasis|MP:0001196,shiny skin|MP:0001951,abnormal breathing pattern|MP:0002796,impaired skin barrier function|MP:0003641,small lung|MP:0004780,abnormal surfactant secretion|MP:0005202,lethargy|MP:0006027,impaired lung alveolus development|MP:0009931,abnormal skin appearance|MP:0010811,decreased type II pneumocyte number|MP:0010887,pale lung|MP:0011087,neonatal lethality, complete penetrance
MGI:3759309	Ptges3<tm1Nkt>	MP:0001177,atelectasis|MP:0001216,abnormal epidermal layer morphology|MP:0001218,thin epidermis|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001243,abnormal dermal layer morphology|MP:0001262,decreased body weight|MP:0001954,respiratory distress|MP:0004201,fetal growth retardation|MP:0009815,decreased prostaglandin level|MP:0011089,perinatal lethality, complete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:5570356	Ptges<tm1.1Gaf>	MP:0000218,increased leukocyte cell number|MP:0002442,abnormal leukocyte physiology|MP:0004883,abnormal vascular wound healing|MP:0005385,cardiovascular system phenotype|MP:0009814,increased prostaglandin level|MP:0009815,decreased prostaglandin level
MGI:3051640	Ptges<tm1Aki>	MP:0001785,edema|MP:0001845,abnormal inflammatory response|MP:0002499,chronic inflammation|MP:0003799,impaired macrophage chemotaxis|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0009811,abnormal prostaglandin level|MP:0009817,decreased leukotriene level
MGI:3045658	Ptges<tm1Lpa>	MP:0001876,decreased inflammatory response|MP:0001970,abnormal pain threshold|MP:0009815,decreased prostaglandin level
MGI:7514735	Ptgfrn<em1(IMPC)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0001402,decreased locomotor activity
MGI:4316955	Ptgfrn<Gt(OST437383)Lex>	MP:0003360,abnormal depression-related behavior
MGI:2179271	Ptgfr<tm1Sna>	MP:0001919,abnormal reproductive system physiology|MP:0002783,abnormal ovary secretion|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0012010,parturition failure
MGI:2137832	Ptgir<tm1Sna>	MP:0000249,abnormal blood vessel physiology|MP:0001544,abnormal cardiovascular system physiology|MP:0002006,neoplasm|MP:0002551,abnormal blood coagulation|MP:0005087,decreased acute inflammation|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005413,vascular restenosis|MP:0006298,abnormal platelet activation|MP:0008531,increased chemical nociceptive threshold|MP:0009815,decreased prostaglandin level|MP:0009818,abnormal thromboxane level|MP:0010768,mortality/aging|MP:0011101,prenatal lethality, incomplete penetrance|MP:0031121,increased susceptibility to induced thrombosis
MGI:6277047	Ptgis<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002339,abnormal lymph node morphology|MP:0002591,decreased mean corpuscular volume|MP:0002833,increased heart weight|MP:0002989,small kidney|MP:0003918,decreased kidney weight|MP:0005238,increased brain size|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008528,polycystic kidney|MP:0010067,increased red blood cell distribution width
MGI:3610729	Ptgis<tm1Tada>	MP:0000532,kidney vascular congestion|MP:0002135,abnormal kidney morphology|MP:0002703,abnormal renal tubule morphology|MP:0002842,increased systemic arterial blood pressure|MP:0003670,dilated renal glomerular capsule|MP:0003675,kidney cyst|MP:0003946,renal necrosis|MP:0003985,renal fibrosis|MP:0004970,kidney atrophy|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0009814,increased prostaglandin level|MP:0009815,decreased prostaglandin level|MP:0009818,abnormal thromboxane level|MP:0009866,abnormal aorta wall morphology|MP:0009871,abnormal aorta tunica adventitia morphology|MP:0009873,abnormal aorta tunica media morphology|MP:0010468,abnormal thoracic aorta morphology|MP:0011423,kidney cortex atrophy
MGI:5548534	Ptgr1<tm1b(EUCOMM)Wtsi>	MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:7510090	Ptgr2<em1(IMPC)Bay>	MP:0001486,abnormal startle reflex
MGI:7425936	Ptgs1<em1(IMPC)Mbp>	MP:0000494,abnormal cecum morphology|MP:0004738,abnormal auditory brainstem response|MP:0009476,enlarged cecum
MGI:3576237	Ptgs1<tm1Fun>	MP:0001876,decreased inflammatory response|MP:0005389,reproductive system phenotype|MP:0005606,increased bleeding time|MP:0009549,decreased platelet aggregation|MP:0009818,abnormal thromboxane level|MP:0011564,decreased urine prostaglandin level|MP:0031120,decreased susceptibility to induced thrombosis
MGI:1857238	Ptgs1<tm1Unc>	MP:0000233,abnormal blood flow velocity|MP:0000505,decreased digestive secretion|MP:0000691,enlarged spleen|MP:0001422,abnormal drinking behavior|MP:0001876,decreased inflammatory response|MP:0001973,increased thermal nociceptive threshold|MP:0002006,neoplasm|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002135,abnormal kidney morphology|MP:0002551,abnormal blood coagulation|MP:0002656,abnormal keratinocyte differentiation|MP:0002679,abnormal corpus luteum morphology|MP:0002736,abnormal nociception after inflammation|MP:0002907,abnormal parturition|MP:0003177,allodynia|MP:0003436,decreased susceptibility to induced arthritis|MP:0003631,nervous system phenotype|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003718,maternal effect|MP:0004014,abnormal uterine environment|MP:0004144,hypotonia|MP:0004484,abnormal response of heart to induced stress|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0004875,increased mean systemic arterial blood pressure|MP:0005023,abnormal wound healing|MP:0005165,increased susceptibility to injury|MP:0005186,increased circulating progesterone level|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype|MP:0005527,increased renal glomerular filtration rate|MP:0005531,increased renal vascular resistance|MP:0008004,abnormal stomach pH|MP:0008537,increased susceptibility to induced colitis|MP:0008735,increased susceptibility to endotoxin shock|MP:0008800,increased small intestinal crypt cell apoptosis|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009549,decreased platelet aggregation|MP:0009643,abnormal urine homeostasis|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0009814,increased prostaglandin level|MP:0009815,decreased prostaglandin level|MP:0011021,abnormal circadian regulation of heart rate|MP:0011022,abnormal circadian regulation of systemic arterial blood pressure|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011564,decreased urine prostaglandin level|MP:0012008,delayed parturition|MP:0012124,increased bronchoconstrictive response|MP:0031180,decreased brain blood flow rate
MGI:5565173	Ptgs2os2<tm1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:7314907	Ptgs2os<tm1Scrp>	MP:0000222,decreased neutrophil cell number|MP:0008564,increased interferon-beta secretion|MP:0008597,decreased circulating interleukin-6 level|MP:0008721,abnormal chemokine level|MP:0031247,decreased CCL3 level|MP:0031250,decreased circulating CCL3 level
MGI:3629677	Ptgs2<tm1.1Fun>	MP:0000521,abnormal kidney cortex morphology|MP:0001859,kidney inflammation|MP:0001923,reduced female fertility|MP:0002989,small kidney|MP:0004505,decreased renal glomerulus number|MP:0004969,pale kidney|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005565,increased blood urea nitrogen level|MP:0009815,decreased prostaglandin level
MGI:4420987	Ptgs2<tm1.1Wls>	MP:0003829,impaired febrile response|MP:0005367,renal/urinary system phenotype|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0008735,increased susceptibility to endotoxin shock|MP:0011563,increased urine prostaglandin level
MGI:3628614	Ptgs2<tm1Fun>	MP:0002551,abnormal blood coagulation|MP:0003422,abnormal thrombolysis|MP:0005464,abnormal platelet physiology|MP:0006144,increased systemic arterial systolic blood pressure|MP:0009815,decreased prostaglandin level|MP:0011564,decreased urine prostaglandin level|MP:0031120,decreased susceptibility to induced thrombosis
MGI:3844713	Ptgs2<tm1Gaf>	MP:0001263,weight loss|MP:0002753,dilated heart left ventricle|MP:0004564,increased myocardial fiber size|MP:0005333,decreased heart rate|MP:0008950,ventricular tachycardia|MP:0012106,impaired exercise endurance|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3623499	Ptgs2<tm1Hahe>	MP:0002169,no abnormal phenotype detected
MGI:1857239	Ptgs2<tm1Jed>	MP:0000242,impaired fertilization|MP:0000521,abnormal kidney cortex morphology|MP:0000522,kidney cortex cyst|MP:0000523,cortical renal glomerulopathies|MP:0000527,abnormal kidney development|MP:0001127,small ovary|MP:0001134,absent corpus luteum|MP:0001728,failure of embryo implantation|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002833,increased heart weight|MP:0002989,small kidney|MP:0003071,decreased vascular permeability|MP:0003139,patent ductus arteriosus|MP:0003141,cardiac fibrosis|MP:0003215,renal interstitial fibrosis|MP:0003303,peritoneal inflammation|MP:0003355,decreased ovulation rate|MP:0003426,pulmonary interstitial fibrosis|MP:0003606,kidney failure|MP:0003626,kidney medulla hypoplasia|MP:0003675,kidney cyst|MP:0003845,abnormal decidualization|MP:0003918,decreased kidney weight|MP:0004754,abnormal kidney collecting duct morphology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004969,pale kidney|MP:0005025,abnormal response to infection|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005528,decreased renal glomerular filtration rate|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008004,abnormal stomach pH|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009641,kidney degeneration|MP:0009815,decreased prostaglandin level|MP:0010985,abnormal kidney mesenchyme morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011294,renal glomerulus hypertrophy|MP:0011308,kidney corticomedullary cyst|MP:0011346,renal tubule atrophy|MP:0011352,proximal convoluted tubule brush border loss|MP:0011376,abnormal kidney corticomedullary boundary morphology|MP:0011377,renal glomerulus fibrosis|MP:0011403,pyelonephritis|MP:0011408,renal tubule hypertrophy|MP:0011423,kidney cortex atrophy|MP:0011682,renal glomerulus cyst|MP:0012737,abnormal primary polar body morphology|MP:0031420,decreased superovulation rate
MGI:2158457	Ptgs2<tm1Unc>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000495,abnormal colon morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000521,abnormal kidney cortex morphology|MP:0000522,kidney cortex cyst|MP:0000527,abnormal kidney development|MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0001260,increased body weight|MP:0001263,weight loss|MP:0001422,abnormal drinking behavior|MP:0001577,anemia|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001919,abnormal reproductive system physiology|MP:0001926,female infertility|MP:0001973,increased thermal nociceptive threshold|MP:0002021,increased incidence of induced tumors|MP:0002079,increased circulating insulin level|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002135,abnormal kidney morphology|MP:0002451,abnormal macrophage physiology|MP:0002494,increased IgM level|MP:0002656,abnormal keratinocyte differentiation|MP:0002679,abnormal corpus luteum morphology|MP:0002705,dilated renal tubule|MP:0002736,abnormal nociception after inflammation|MP:0002833,increased heart weight|MP:0002842,increased systemic arterial blood pressure|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0002989,small kidney|MP:0002999,abnormal bone healing|MP:0003075,abnormal response to CNS ischemic injury|MP:0003139,patent ductus arteriosus|MP:0003177,allodynia|MP:0003197,nephrocalcinosis|MP:0003215,renal interstitial fibrosis|MP:0003288,intestinal edema|MP:0003303,peritoneal inflammation|MP:0003357,impaired granulosa cell differentiation|MP:0003436,decreased susceptibility to induced arthritis|MP:0003606,kidney failure|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003675,kidney cyst|MP:0003829,impaired febrile response|MP:0003918,decreased kidney weight|MP:0003997,tonic-clonic seizures|MP:0004155,decreased susceptibility to induced pancreatitis|MP:0004193,abnormal kidney papilla morphology|MP:0004484,abnormal response of heart to induced stress|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004505,decreased renal glomerulus number|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004816,abnormal class switch recombination|MP:0004867,decreased platelet calcium level|MP:0004969,pale kidney|MP:0005023,abnormal wound healing|MP:0005025,abnormal response to infection|MP:0005048,abnormal thrombosis|MP:0005164,abnormal response to injury|MP:0005166,decreased susceptibility to injury|MP:0005232,abnormal mesenteric lymph node morphology|MP:0005264,glomerulosclerosis|MP:0005319,abnormal enzyme/coenzyme level|MP:0005325,abnormal renal glomerulus morphology|MP:0005367,renal/urinary system phenotype|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005528,decreased renal glomerular filtration rate|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005571,decreased lactate dehydrogenase level|MP:0005656,decreased aggression|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005666,abnormal adipose tissue physiology|MP:0005669,increased circulating leptin level|MP:0006058,decreased cerebral infarct size|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0006238,abnormal choriocapillaris morphology|MP:0008095,abnormal memory B cell differentiation|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0008236,decreased susceptibility to neuronal excitotoxicity|MP:0008272,abnormal endochondral bone ossification|MP:0008396,abnormal osteoclast differentiation|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008498,decreased IgG3 level|MP:0008531,increased chemical nociceptive threshold|MP:0008537,increased susceptibility to induced colitis|MP:0008560,increased tumor necrosis factor secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008770,decreased survivor rate|MP:0008907,decreased total fat pad weight|MP:0009148,pancreas necrosis|MP:0009373,abnormal cumulus expansion|MP:0009641,kidney degeneration|MP:0009660,abnormal induced retina neovascularization|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0009814,increased prostaglandin level|MP:0009815,decreased prostaglandin level|MP:0010768,mortality/aging|MP:0010985,abnormal kidney mesenchyme morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011290,decreased nephron number|MP:0011294,renal glomerulus hypertrophy|MP:0011334,abnormal nephrogenic zone morphology|MP:0011346,renal tubule atrophy|MP:0011352,proximal convoluted tubule brush border loss|MP:0011377,renal glomerulus fibrosis|MP:0011383,abnormal kidney capsule morphology|MP:0011402,renal cast|MP:0011405,tubulointerstitial nephritis|MP:0011408,renal tubule hypertrophy|MP:0011423,kidney cortex atrophy|MP:0011534,granular kidney|MP:0011682,renal glomerulus cyst|MP:0013239,impaired skeletal muscle regeneration|MP:0031420,decreased superovulation rate|MP:0031422,failure of superovulation
MGI:3837433	Ptgs2<tm1Wlf>	MP:0002735,abnormal chemical nociception|MP:0002736,abnormal nociception after inflammation|MP:0005376,homeostasis/metabolism phenotype
MGI:3699107	Ptgs2<tm2.1(Ptgs1)Fun>	MP:0001859,kidney inflammation|MP:0001935,decreased litter size|MP:0002161,abnormal fertility/fecundity|MP:0002451,abnormal macrophage physiology|MP:0003071,decreased vascular permeability|MP:0003303,peritoneal inflammation|MP:0005325,abnormal renal glomerulus morphology|MP:0005565,increased blood urea nitrogen level|MP:0011564,decreased urine prostaglandin level
MGI:3701117	Ptgs2<tm2(Ptgs1)Fun>	MP:0002451,abnormal macrophage physiology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3846762	Ptgs2<tm3Fun>	MP:0002703,abnormal renal tubule morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0005367,renal/urinary system phenotype|MP:0005385,cardiovascular system phenotype|MP:0005565,increased blood urea nitrogen level|MP:0009586,increased platelet aggregation|MP:0009643,abnormal urine homeostasis|MP:0031121,increased susceptibility to induced thrombosis
MGI:3687642	Pth1r<tm1Abas>	MP:0000194,increased circulating calcium level|MP:0001565,abnormal circulating phosphate level|MP:0002905,decreased circulating parathyroid hormone level|MP:0005006,abnormal osteoblast physiology|MP:0009642,abnormal blood homeostasis
MGI:5014612	Pth1r<tm1a(EUCOMM)Hmgu>	MP:0000703,abnormal thymus morphology|MP:0001303,abnormal lens morphology|MP:0001711,abnormal placenta morphology|MP:0002152,abnormal brain morphology|MP:0002947,increased hemangioma incidence|MP:0003253,dilated bile duct|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content|MP:0010200,enlarged lymphatic vessel|MP:0010490,abnormal inferior vena cava valve morphology|MP:0010912,herniated liver|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness|MP:0013840,absent segment of posterior cerebral artery|MP:0013846,retropharyngeal edema|MP:0013864,enlarged paraumbilical vein|MP:0013876,absent ductus venosus valve|MP:0013877,abnormal ductus venosus valve morphology|MP:0013963,jugular vein stenosis|MP:0013971,blood in lymph vessels|MP:0014000,anastomosis between internal carotid artery and basilar artery|MP:0014001,abnormal vertebral artery topology|MP:0030975,placenta hemorrhage
MGI:2154519	Pth1r<tm1Hmk>	MP:0000074,abnormal neurocranium morphology|MP:0000088,short mandible|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000547,short limbs|MP:0001177,atelectasis|MP:0001698,decreased embryo size|MP:0001953,respiratory failure|MP:0002896,abnormal bone mineralization|MP:0003641,small lung|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003984,embryonic growth retardation|MP:0004053,abnormal synchondrosis|MP:0004200,decreased fetal size|MP:0004686,decreased length of long bones|MP:0005388,respiratory system phenotype|MP:0006429,abnormal hyaline cartilage morphology|MP:0009908,protruding tongue|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0030094,foramen magnum stenosis
MGI:2183512	Pth1r<tm2Hmk>	MP:0000130,abnormal trabecular bone morphology|MP:0000157,abnormal sternum morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000167,decreased chondrocyte number|MP:0002657,chondrodystrophy|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0005390,skeleton phenotype|MP:0006396,decreased long bone epiphyseal plate size|MP:0020010,decreased bone mineral density of femur|MP:0021186,decreased bone mineral density of vertebrae
MGI:2183514	Pth1r<tm3Hmk>	MP:0003055,abnormal long bone epiphyseal plate morphology
MGI:3628795	Pth1r<tm4Hmk>	MP:0002113,abnormal skeleton development
MGI:6330764	Pth2r<tm1.1Tbu>	MP:0001392,abnormal locomotor behavior|MP:0001442,decreased grooming behavior|MP:0003360,abnormal depression-related behavior|MP:0004924,abnormal behavior|MP:0005386,behavior/neurological phenotype|MP:0011014,decreased core body temperature|MP:0020477,abnormal locomotor circadian rhythm
MGI:4364506	Pth2r<tm2a(KOMP)Wtsi>	MP:0002833,increased heart weight
MGI:3807987	Pth2<tm1Vlcg>	MP:0001119,abnormal female reproductive system morphology|MP:0001127,small ovary|MP:0001145,abnormal male reproductive system morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001930,abnormal meiosis|MP:0002160,abnormal reproductive system morphology|MP:0002777,absent ovarian follicles|MP:0004852,decreased testis weight|MP:0004910,decreased seminal vesicle weight|MP:0014633,decreased spermatid number
MGI:2387462	Pthlh<tm1Ack>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0004982,abnormal osteoclast morphology|MP:0004985,decreased osteoclast cell number|MP:0004986,abnormal osteoblast morphology|MP:0004989,decreased osteoblast cell number|MP:0008271,abnormal bone ossification
MGI:4880897	Pthlh<tm1a(KOMP)Wtsi>	MP:0000432,abnormal head morphology|MP:0000438,abnormal cranium morphology|MP:0000602,dilated liver sinusoidal space|MP:0000783,abnormal forebrain morphology|MP:0002169,no abnormal phenotype detected|MP:0004950,abnormal brain vasculature morphology|MP:0005565,increased blood urea nitrogen level|MP:0006063,abnormal inferior vena cava morphology|MP:0008922,abnormal cervical rib|MP:0011100,preweaning lethality, complete penetrance|MP:0013877,abnormal ductus venosus valve morphology|MP:0014018,embryo tumor
MGI:3829430	Pthlh<tm1Broa>	MP:0002657,chondrodystrophy|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004672,short ribs
MGI:2388593	Pthlh<tm1Fbe>	MP:0000088,short mandible|MP:0000121,failure of tooth eruption|MP:0000130,abnormal trabecular bone morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000458,abnormal mandible morphology|MP:0000547,short limbs|MP:0001562,abnormal circulating calcium level|MP:0002114,abnormal axial skeleton morphology|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0004231,abnormal calcium ion homeostasis|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004672,short ribs|MP:0004986,abnormal osteoblast morphology|MP:0005298,abnormal clavicle morphology|MP:0006396,decreased long bone epiphyseal plate size|MP:0009908,protruding tongue|MP:0011087,neonatal lethality, complete penetrance
MGI:2154515	Pthlh<tm1Hmk>	MP:0000088,short mandible|MP:0000130,abnormal trabecular bone morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000141,abnormal vertebral body morphology|MP:0000150,abnormal rib morphology|MP:0000164,abnormal cartilage development|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000547,short limbs|MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002276,abnormal lung interstitium morphology|MP:0002427,disproportionate dwarf|MP:0002657,chondrodystrophy|MP:0002764,short tibia|MP:0002896,abnormal bone mineralization|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003112,enlarged parathyroid gland|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003416,premature bone ossification|MP:0003417,premature endochondral bone ossification|MP:0003641,small lung|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0004148,increased compact bone thickness|MP:0004321,short sternum|MP:0004672,short ribs|MP:0004673,splayed ribs|MP:0004686,decreased length of long bones|MP:0004734,small thoracic cavity|MP:0004982,abnormal osteoclast morphology|MP:0004985,decreased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0004989,decreased osteoblast cell number|MP:0006396,decreased long bone epiphyseal plate size|MP:0008151,increased diameter of long bones|MP:0008271,abnormal bone ossification|MP:0008277,abnormal sternum ossification|MP:0008395,abnormal osteoblast differentiation|MP:0009908,protruding tongue|MP:0010099,abnormal thoracic cage shape|MP:0010817,absent type I pneumocytes|MP:0010825,abnormal lung saccule morphology|MP:0010827,small lung saccule|MP:0010867,abnormal bone trabecula morphology|MP:0010890,decreased alveolar lamellar body number|MP:0010898,abnormal pulmonary alveolus epithelium morphology|MP:0010993,decreased surfactant secretion|MP:0011089,perinatal lethality, complete penetrance|MP:0011143,thick lung-associated mesenchyme|MP:0011145,abnormal mesenchymal cell differentiation involved in lung development|MP:0014103,increased chondrocyte apoptosis|MP:0030441,increased osteoblast apoptosis|MP:0030479,increased osteocyte apoptosis
MGI:3826465	Pthlh<tm2Ack>	MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000130,abnormal trabecular bone morphology|MP:0000160,kyphosis|MP:0000167,decreased chondrocyte number|MP:0000352,decreased cell proliferation|MP:0000774,decreased brain size|MP:0001218,thin epidermis|MP:0001242,hyperkeratosis|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001614,abnormal blood vessel morphology|MP:0001732,postnatal growth retardation|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003786,premature aging|MP:0004985,decreased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0005150,cachexia|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype|MP:0005560,decreased circulating glucose level|MP:0006042,increased apoptosis|MP:0006396,decreased long bone epiphyseal plate size|MP:0008260,abnormal autophagy|MP:0010025,decreased total body fat amount|MP:0011085,postnatal lethality, complete penetrance|MP:0014101,decreased chondrocyte proliferation
MGI:4849407	Pth<tm1a(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0001325,abnormal retina morphology
MGI:2665181	Pth<tm1Dgo>	MP:0000130,abnormal trabecular bone morphology|MP:0000164,abnormal cartilage development|MP:0000260,abnormal angiogenesis|MP:0000438,abnormal cranium morphology|MP:0002113,abnormal skeleton development|MP:0002896,abnormal bone mineralization|MP:0003112,enlarged parathyroid gland|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003795,abnormal bone structure|MP:0004148,increased compact bone thickness|MP:0004634,short metacarpal bones|MP:0004635,short metatarsal bones|MP:0004670,small vertebral body|MP:0004686,decreased length of long bones|MP:0004982,abnormal osteoclast morphology|MP:0004985,decreased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0030441,increased osteoblast apoptosis|MP:0030479,increased osteocyte apoptosis
MGI:7511566	Ptk2b<em1Yank>	MP:0001934,increased litter size|MP:0002678,increased follicle recruitment|MP:0005389,reproductive system phenotype
MGI:7511568	Ptk2b<em2Yank>	MP:0005389,reproductive system phenotype
MGI:3811004	Ptk2b<tm1Okig>	MP:0003544,abnormal vascular endothelial cell migration|MP:0003710,abnormal physiological neovascularization|MP:0004231,abnormal calcium ion homeostasis|MP:0005591,decreased vasodilation
MGI:3583796	Ptk2b<tm1Schl>	MP:0002451,abnormal macrophage physiology|MP:0003799,impaired macrophage chemotaxis|MP:0005087,decreased acute inflammation
MGI:3583806	Ptk2<tm1.1Guan>	MP:0001614,abnormal blood vessel morphology|MP:0001625,cardiac hypertrophy|MP:0001698,decreased embryo size|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002190,disorganized myocardium|MP:0002753,dilated heart left ventricle|MP:0003070,increased vascular permeability|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0004564,increased myocardial fiber size|MP:0004938,dilated vasculature|MP:0005329,abnormal myocardium layer morphology|MP:0005608,cardiac interstitial fibrosis|MP:0006042,increased apoptosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011523,thin placenta labyrinth
MGI:4837147	Ptk2<tm1.1Itl>	MP:0000259,abnormal vascular development|MP:0000266,abnormal heart morphology|MP:0000432,abnormal head morphology|MP:0001914,hemorrhage|MP:0003229,abnormal vitelline vasculature morphology|MP:0004076,abnormal vitelline vascular remodeling|MP:0004086,absent heartbeat|MP:0004556,enlarged allantois|MP:0005621,abnormal cell physiology|MP:0006386,absent somites|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011706,abnormal fibroblast migration
MGI:3821611	Ptk2<tm1.1Jtpa>	MP:0005369,muscle phenotype|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:3583807	Ptk2<tm1.2Guan>	MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3521998	Ptk2<tm1Gwm>	MP:0003447,decreased tumor growth/size|MP:0004502,decreased incidence of tumors by chemical induction|MP:0009580,increased keratinocyte apoptosis|MP:0012194,decreased keratinocyte migration
MGI:4437305	Ptk2<tm1Heen>	MP:0000267,abnormal heart development|MP:0000596,abnormal liver development|MP:0000597,delayed hepatic development|MP:0001176,abnormal lung development|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001723,disorganized yolk sac vascular plexus|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003229,abnormal vitelline vasculature morphology|MP:0003888,liver hemorrhage|MP:0003984,embryonic growth retardation|MP:0005389,reproductive system phenotype|MP:0006279,abnormal limb development|MP:0008770,decreased survivor rate|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0011708,decreased fibroblast cell migration|MP:0012082,delayed heart development
MGI:1857596	Ptk2<tm1Imeg>	MP:0000259,abnormal vascular development|MP:0000267,abnormal heart development|MP:0000272,abnormal aorta morphology|MP:0000358,abnormal cell morphology|MP:0000474,abnormal foregut morphology|MP:0001614,abnormal blood vessel morphology|MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001719,absent vitelline blood vessels|MP:0001726,abnormal allantois morphology|MP:0001914,hemorrhage|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002128,abnormal blood circulation|MP:0002825,abnormal notochord morphology|MP:0003091,abnormal cell migration|MP:0003542,abnormal vascular endothelial cell development|MP:0003974,abnormal endocardium morphology|MP:0004180,failure of initiation of embryo turning|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0005029,abnormal amnion morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0009657,failure of chorioallantoic fusion|MP:0010547,abnormal mesocardium morphology|MP:0010656,thick myocardium|MP:0010664,abnormal vitelline artery morphology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011201,abnormal visceral yolk sac cavity morphology|MP:0011257,abnormal head fold morphology|MP:0011260,abnormal head mesenchyme morphology|MP:0012104,small amniotic cavity|MP:0012131,small visceral yolk sac
MGI:4837152	Ptk2<tm1Itl>	MP:0001265,decreased body size|MP:0011091,prenatal lethality, complete penetrance
MGI:2684666	Ptk2<tm1Lfr>	MP:0000364,abnormal vascular regression|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001723,disorganized yolk sac vascular plexus|MP:0001914,hemorrhage|MP:0003229,abnormal vitelline vasculature morphology|MP:0003658,abnormal capillary morphology|MP:0005602,decreased angiogenesis|MP:0006055,abnormal vascular endothelial cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3777585	Ptk2<tm1Mmsh>	MP:0002184,abnormal innervation|MP:0002763,ectopic Bergmann glia cells|MP:0003894,abnormal Purkinje cell innervation|MP:0009719,reduced cerebellar foliation
MGI:4820570	Ptk2<tm2.1Guan>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5485069	Ptk2<tm3.1Guan>	MP:0002169,no abnormal phenotype detected
MGI:3662667	Ptk6<tm1Aty>	MP:0000496,abnormal small intestine morphology|MP:0002581,abnormal ileum morphology|MP:0004002,abnormal jejunum morphology
MGI:5708289	Ptk6<tm1b(EUCOMM)Wtsi>	MP:0000538,abnormal urinary bladder morphology
MGI:5552948	Ptk7<b2b2445Clo>	MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0000914,exencephaly|MP:0002639,micrognathia|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003052,omphalocele|MP:0003054,spina bifida|MP:0003456,absent tail|MP:0003675,kidney cyst|MP:0009743,preaxial polydactyly|MP:0010402,ventricular septal defect
MGI:3640803	Ptk7<chz>	MP:0000137,abnormal vertebrae morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000266,abnormal heart morphology|MP:0000284,double outlet right ventricle|MP:0000956,decreased spinal cord size|MP:0001095,enlarged trigeminal ganglion|MP:0001096,abnormal glossopharyngeal ganglion morphology|MP:0001100,abnormal vagus ganglion morphology|MP:0001672,abnormal embryo development|MP:0001701,incomplete embryo turning|MP:0003052,omphalocele|MP:0003400,kinked neural tube|MP:0003671,abnormal eyelid aperture|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0008784,craniorachischisis|MP:0009743,preaxial polydactyly|MP:0009744,postaxial polydactyly|MP:0009845,abnormal neural crest cell morphology|MP:0010402,ventricular septal defect|MP:0010557,dilated pulmonary artery|MP:0010975,abnormal lung lobe morphology|MP:0010976,small lung lobe|MP:0011143,thick lung-associated mesenchyme
MGI:3046905	Ptk7<Gt(Betageo)1Matl>	MP:0000562,polydactyly|MP:0001691,abnormal somite shape|MP:0002989,small kidney|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004395,increased cochlear inner hair cell number|MP:0004401,increased cochlear outer hair cell number|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004492,abnormal orientation of inner hair cell stereociliary bundles|MP:0008784,craniorachischisis|MP:0011089,perinatal lethality, complete penetrance|MP:0012675,enlarged floor plate|MP:0030961,abnormal outer hair cell kinocilium location or orientation
MGI:6120747	Ptk7<tm1b(EUCOMM)Hmgu>	MP:0000428,abnormal craniofacial morphology|MP:0000757,herniated abdominal wall|MP:0001697,abnormal embryo size|MP:0004174,abnormal spine curvature|MP:0011100,preweaning lethality, complete penetrance
MGI:6121068	Ptma<tm1.1Got>	MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001473,reduced long-term potentiation|MP:0002063,abnormal learning/memory/conditioning|MP:0002799,abnormal passive avoidance behavior|MP:0002912,abnormal excitatory postsynaptic potential|MP:0005386,behavior/neurological phenotype|MP:0005534,decreased body temperature|MP:0009456,impaired cued conditioning behavior|MP:0009937,abnormal neuron differentiation|MP:0009939,abnormal hippocampus neuron morphology|MP:0009967,abnormal neuron proliferation|MP:0011092,embryonic lethality, complete penetrance|MP:0012307,impaired spatial learning
MGI:5548964	Ptma<tm1.1(KOMP)Vlcg>	MP:0001289,persistence of hyaloid vascular system|MP:0001314,cornea opacity|MP:0011100,preweaning lethality, complete penetrance
MGI:8275781	Ptms<em1Caid>	MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0004924,abnormal behavior|MP:0010053,decreased grip strength|MP:0012307,impaired spatial learning|MP:0012506,brain atrophy
MGI:5515315	Ptms<tm1.1(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0001566,increased circulating phosphate level|MP:0004924,abnormal behavior|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011436,decreased urine magnesium level|MP:0020870,decreased thigmotaxis
MGI:2183157	Ptn<tm1Rau>	MP:0002919,enhanced paired-pulse facilitation|MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype
MGI:3053747	Ptn<tm1Tmu>	MP:0001570,abnormal circulating enzyme level|MP:0001963,abnormal hearing physiology|MP:0003402,decreased liver weight|MP:0003799,impaired macrophage chemotaxis|MP:0003884,decreased macrophage cell number|MP:0008719,impaired neutrophil recruitment
MGI:3583634	Ptnu1<FGS/Kist>	MP:0002962,increased urine protein level
MGI:3583636	Ptnu2<FGS/Kist>	MP:0002962,increased urine protein level
MGI:6414559	Ptov1<em1(IMPC)Bay>	MP:0000111,cleft palate|MP:0000562,polydactyly|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003385,abnormal body wall morphology|MP:0003743,abnormal facial morphology|MP:0008797,facial cleft|MP:0011100,preweaning lethality, complete penetrance
MGI:5755068	Ptp4a1<em2(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000266,abnormal heart morphology|MP:0000692,small spleen|MP:0001120,abnormal uterus morphology|MP:0001297,microphthalmia|MP:0002060,abnormal skin morphology|MP:0002764,short tibia|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0002989,small kidney|MP:0003795,abnormal bone structure|MP:0010097,abnormal retina blood vessel morphology|MP:0010124,decreased bone mineral content|MP:0011874,enlarged urinary bladder
MGI:3870365	Ptp4a1<Gt(CC0606)Wtsi>	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6156454	Ptp4a2<em1(IMPC)Tcp>	MP:0000470,abnormal stomach morphology|MP:0000702,enlarged lymph nodes|MP:0001147,small testis|MP:0001200,thick skin|MP:0001258,decreased body length|MP:0002060,abnormal skin morphology|MP:0002591,decreased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002764,short tibia|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0010052,increased grip strength|MP:0010393,shortened QRS complex duration
MGI:4346477	Ptp4a2<Gt(AQ0673)Wtsi>	MP:0000352,decreased cell proliferation|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0002687,oligozoospermia|MP:0003205,testicular atrophy|MP:0004256,abnormal maternal decidual layer morphology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0004921,decreased placenta weight|MP:0004953,decreased spleen weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0008489,slow postnatal weight gain|MP:0009431,decreased fetal weight|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011521,decreased placental labyrinth size|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0012099,decreased spongiotrophoblast size|MP:0012109,decreased trophoblast glycogen cell number|MP:0014052,increased male germ cell apoptosis|MP:0020362,abnormal male germ cell physiology
MGI:6277020	Ptp4a3<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001297,microphthalmia|MP:0001399,hyperactivity|MP:0002092,abnormal eye morphology|MP:0004924,abnormal behavior|MP:0009709,hydrometra|MP:0020870,decreased thigmotaxis
MGI:5473867	Ptp4a3<tm1.1Geh>	MP:0001262,decreased body weight|MP:0003447,decreased tumor growth/size|MP:0004502,decreased incidence of tumors by chemical induction|MP:0006086,decreased body mass index|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5514244	Ptp4a3<tm1.2Xhan>	MP:0005376,homeostasis/metabolism phenotype|MP:0005560,decreased circulating glucose level
MGI:5695946	Ptpdc1<tm1.1(KOMP)Vlcg>	MP:0001566,increased circulating phosphate level|MP:0010124,decreased bone mineral content
MGI:3528492	Ptpdc1<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:5291923	Ptpmt1<tm1.1Jedi>	MP:0000352,decreased cell proliferation|MP:0005621,abnormal cell physiology|MP:0006035,abnormal mitochondrial morphology|MP:0010957,abnormal aerobic respiration
MGI:5548522	Ptpmt1<tm1.1(KOMP)Vlcg>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5291922	Ptpmt1<tm1.2Jedi>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:5300821	Ptpmt1<tm1Ckq>	MP:0003984,embryonic growth retardation|MP:0003988,disorganized embryonic tissue|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5300822	Ptpmt1<tm2.1Ckq>	MP:0000333,decreased bone marrow cell number|MP:0000692,small spleen|MP:0000706,small thymus|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0002083,premature death|MP:0004809,increased hematopoietic stem cell number|MP:0005152,pancytopenia|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008813,decreased common myeloid progenitor cell number|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0010957,abnormal aerobic respiration|MP:0011085,postnatal lethality, complete penetrance
MGI:5639081	Ptpn11<tm1.1Ics>	MP:0000274,enlarged heart|MP:0000691,enlarged spleen|MP:0001300,ocular hypertelorism|MP:0001547,abnormal lipid level|MP:0001625,cardiac hypertrophy|MP:0001732,postnatal growth retardation|MP:0001780,decreased brown adipose tissue amount|MP:0002625,heart left ventricle hypertrophy|MP:0002727,decreased circulating insulin level|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002843,decreased systemic arterial blood pressure|MP:0002891,increased insulin sensitivity|MP:0002942,decreased circulating alanine transaminase level|MP:0003441,increased glycerol level|MP:0003960,increased lean body mass|MP:0004889,increased energy expenditure|MP:0005140,decreased cardiac muscle contractility|MP:0005292,improved glucose tolerance|MP:0005333,decreased heart rate|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0006094,increased fat cell size|MP:0006113,abnormal heart septum morphology|MP:0006319,abnormal epididymal fat pad morphology|MP:0008034,enhanced lipolysis|MP:0008489,slow postnatal weight gain|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009131,decreased white fat cell number|MP:0009356,decreased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0010031,abnormal cranium size|MP:0011168,abnormal fat cell differentiation|MP:0011862,decreased cranium length|MP:0011952,decreased cardiac stroke volume|MP:0013243,abnormal carbohydrate metabolism|MP:0014316,decreased heart left ventricle posterior wall thickness|MP:0030016,increased adipocyte glucose uptake|MP:0030968,decreased circulating adiponectin level|MP:0031414,decreased skeletal muscle triglyceride level
MGI:3852440	Ptpn11<tm1.1Rbns>	MP:0000018,small ears|MP:0000073,absent craniofacial bones|MP:0000087,absent mandible|MP:0000102,abnormal nasal bone morphology|MP:0000433,microcephaly|MP:0000458,abnormal mandible morphology|MP:0000762,abnormal tongue morphology|MP:0001299,abnormal eye distance/ position|MP:0002169,no abnormal phenotype detected|MP:0002251,abnormal nasopharynx morphology|MP:0002633,persistent truncus arteriosus|MP:0002639,micrognathia|MP:0004200,decreased fetal size|MP:0008384,absent nasal capsule|MP:0010402,ventricular septal defect|MP:0010464,abnormal aortic arch and aortic arch branch attachment|MP:0010589,common truncal valve|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0030190,small snout|MP:0031449,abnormal nasal cartilage morphology
MGI:4365539	Ptpn11<tm1.1Wbm>	MP:0000428,abnormal craniofacial morphology|MP:0000920,abnormal myelination|MP:0000939,decreased motor neuron number|MP:0000966,decreased sensory neuron number|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001107,decreased Schwann cell number|MP:0001109,absent Schwann cell precursors|MP:0002877,abnormal melanocyte morphology|MP:0003651,abnormal axon extension|MP:0004075,decreased Schwann cell precursor number|MP:0008814,decreased nerve conduction velocity|MP:0009450,abnormal axon fasciculation|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011904,abnormal Schwann cell physiology|MP:0013002,decreased enteric neural crest cell number
MGI:3050284	Ptpn11<tm1Bgn>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000284,double outlet right ventricle|MP:0000351,increased cell proliferation|MP:0000447,flattened snout|MP:0000601,small liver|MP:0000691,enlarged spleen|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001654,hepatic necrosis|MP:0001914,hemorrhage|MP:0002192,hydrops fetalis|MP:0002652,thin myocardium|MP:0003223,decreased cardiomyocyte apoptosis|MP:0004057,thin myocardium compact layer|MP:0005013,increased lymphocyte cell number|MP:0005312,pericardial effusion|MP:0005352,small cranium|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0010373,myeloid hyperplasia|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010412,atrioventricular septal defect|MP:0010618,enlarged mitral valve|MP:0010768,mortality/aging|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0030166,increased inner canthal distance|MP:0030189,broad snout
MGI:5295460	Ptpn11<tm1Ckq>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000270,abnormal heart tube morphology|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001802,arrested B cell differentiation|MP:0002023,increased B cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002398,abnormal bone marrow cell morphology/development|MP:0003935,abnormal craniofacial development|MP:0003984,embryonic growth retardation|MP:0004024,aneuploidy|MP:0004049,increased acute promyelocytic leukemia incidence|MP:0004809,increased hematopoietic stem cell number|MP:0004810,decreased hematopoietic stem cell number|MP:0004952,increased spleen weight|MP:0005387,immune system phenotype|MP:0008813,decreased common myeloid progenitor cell number|MP:0008866,chromosomal instability|MP:0009320,increased lymphoblastic lymphoma incidence|MP:0010336,increased acute lymphoblastic leukemia incidence|MP:0010373,myeloid hyperplasia|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3522021	Ptpn11<tm1Gsf>	MP:0000005,increased brown adipose tissue amount|MP:0000008,increased white adipose tissue amount|MP:0000069,kyphoscoliosis|MP:0000160,kyphosis|MP:0000161,scoliosis|MP:0000162,lordosis|MP:0000189,hypoglycemia|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0001059,optic nerve atrophy|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001257,increased body length|MP:0001261,obese|MP:0001263,weight loss|MP:0001326,retina degeneration|MP:0001347,absent lacrimal glands|MP:0001406,abnormal gait|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0001654,hepatic necrosis|MP:0001656,focal hepatic necrosis|MP:0001744,hypersecretion of corticosterone|MP:0001745,increased circulating corticosterone level|MP:0001860,liver inflammation|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0002795,dilated cardiomyopathy|MP:0002941,increased circulating alanine transaminase level|MP:0003324,increased liver adenoma incidence|MP:0003333,liver fibrosis|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003869,ectopic cartilage|MP:0003893,increased hepatocyte proliferation|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0004174,abnormal spine curvature|MP:0004499,increased incidence of tumors by chemical induction|MP:0004564,increased myocardial fiber size|MP:0004703,abnormal vertebral column morphology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005088,increased acute inflammation|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005123,increased circulating growth hormone level|MP:0005141,liver hyperplasia|MP:0005159,azoospermia|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005343,increased circulating aspartate transaminase level|MP:0005390,skeleton phenotype|MP:0005418,abnormal circulating hormone level|MP:0005455,increased susceptibility to weight gain|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level|MP:0005534,decreased body temperature|MP:0005669,increased circulating leptin level|MP:0006138,congestive heart failure|MP:0006378,abnormal spermatogonia morphology|MP:0006379,abnormal spermatocyte morphology|MP:0006394,abnormal vertebral epiphyseal plate morphology|MP:0008067,retina ganglion cell degeneration|MP:0008507,thin retina ganglion layer|MP:0008511,thin retina inner nuclear layer|MP:0008513,thin retina inner plexiform layer|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008596,increased circulating interleukin-6 level|MP:0008772,increased heart ventricle size|MP:0008986,abnormal liver parenchyma morphology|MP:0009355,increased liver triglyceride level|MP:0009877,exostosis|MP:0010400,increased liver glycogen level|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0011925,abnormal heart echocardiography feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0013331,abnormal lacrimal gland development|MP:0014052,increased male germ cell apoptosis|MP:0020346,abnormal myocardial fiber calcium currents|MP:0020355,abnormal Sertoli cell barrier morphology|MP:0020356,abnormal Sertoli cell barrier function|MP:0030020,decreased cardiac muscle cell glucose uptake|MP:0031415,increased skeletal muscle triglyceride level|MP:0031418,increased cardiac muscle triglyceride level|MP:0031618,decreased skeletal muscle cell glucose uptake|MP:0031633,decreased heart left ventricle muscle contractility
MGI:2176524	Ptpn11<tm1Paw>	MP:0000267,abnormal heart development|MP:0000313,abnormal cell death|MP:0000352,decreased cell proliferation|MP:0000929,open neural tube|MP:0001684,abnormal axial mesoderm morphology|MP:0001689,incomplete somite formation|MP:0001695,abnormal gastrulation|MP:0001718,abnormal visceral yolk sac morphology|MP:0001726,abnormal allantois morphology|MP:0001730,embryonic growth arrest|MP:0002151,abnormal neural tube morphology|MP:0002825,abnormal notochord morphology|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0004025,polyploidy|MP:0004073,caudal body truncation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004180,failure of initiation of embryo turning|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2176526	Ptpn11<tm1Rbn>	MP:0001935,decreased litter size|MP:0002169,no abnormal phenotype detected|MP:0011092,embryonic lethality, complete penetrance
MGI:3690333	Ptpn11<tm1Yan>	MP:0009400,decreased skeletal muscle fiber size|MP:0009406,decreased skeletal muscle fiber number
MGI:3621004	Ptpn11<tm2Bgn>	MP:0003988,disorganized embryonic tissue|MP:0004965,inner cell mass degeneration|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4868451	Ptpn11<tm3Bgn>	MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level
MGI:5004658	Ptpn11<tm4.2Bgn>	MP:0000042,abnormal organ of Corti morphology|MP:0000274,enlarged heart|MP:0000281,abnormal interventricular septum morphology|MP:0001265,decreased body size|MP:0001299,abnormal eye distance/ position|MP:0001300,ocular hypertelorism|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002160,abnormal reproductive system morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0003109,short femur|MP:0003141,cardiac fibrosis|MP:0003743,abnormal facial morphology|MP:0004134,abnormal chest morphology|MP:0004564,increased myocardial fiber size|MP:0005385,cardiovascular system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005598,decreased heart ventricle muscle contractility|MP:0010031,abnormal cranium size|MP:0010724,thick interventricular septum|MP:0012514,pectus excavatum|MP:0030034,depressed nasal bridge|MP:0031277,pectus carinatum
MGI:3512153	Ptpn11<tm5Bgn>	MP:0001685,abnormal endoderm development|MP:0001729,impaired embryo implantation|MP:0004957,abnormal blastocyst morphology|MP:0005028,abnormal trophectoderm morphology|MP:0011103,embryonic lethality at implantation, incomplete penetrance|MP:0012117,decreased trophectoderm cell proliferation
MGI:3840248	Ptpn11<tm6Bgn>	MP:0000172,abnormal bone marrow cell number|MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000266,abnormal heart morphology|MP:0000284,double outlet right ventricle|MP:0000322,increased granulocyte number|MP:0000333,decreased bone marrow cell number|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001417,decreased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0001577,anemia|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002652,thin myocardium|MP:0003808,increased atrioventricular cushion size|MP:0003958,heart valve hyperplasia|MP:0004810,decreased hematopoietic stem cell number|MP:0005385,cardiovascular system phenotype|MP:0005460,abnormal leukopoiesis|MP:0008475,intermingled spleen red and white pulp|MP:0008525,decreased cranium height|MP:0008762,embryonic lethality|MP:0008813,decreased common myeloid progenitor cell number|MP:0008826,abnormal splenic cell ratio|MP:0008989,abnormal liver sinusoid morphology|MP:0009456,impaired cued conditioning behavior|MP:0009939,abnormal hippocampus neuron morphology|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0011100,preweaning lethality, complete penetrance|MP:0013697,decreased granulocyte monocyte progenitor cell number|MP:0030166,increased inner canthal distance
MGI:3840251	Ptpn11<tm7Bgn>	MP:0000284,double outlet right ventricle|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002652,thin myocardium|MP:0003808,increased atrioventricular cushion size|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008525,decreased cranium height|MP:0008770,decreased survivor rate|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0030166,increased inner canthal distance
MGI:5766164	Ptpn12<tm1b(NCOM)Mfgc>	MP:0000288,abnormal pericardium morphology|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3707593	Ptpn12<tm1Mtr>	MP:0000267,abnormal heart development|MP:0000596,abnormal liver development|MP:0001672,abnormal embryo development|MP:0001688,abnormal somite development|MP:0003227,abnormal vascular branching morphogenesis|MP:0003229,abnormal vitelline vasculature morphology|MP:0003400,kinked neural tube|MP:0003885,abnormal rostral-caudal body axis extension|MP:0003984,embryonic growth retardation|MP:0004180,failure of initiation of embryo turning|MP:0006057,decreased vascular endothelial cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012252,abnormal septum transversum morphology|MP:0012509,neural tube degeneration
MGI:4830749	Ptpn12<tm1Vei>	MP:0002444,abnormal T cell physiology|MP:0003009,abnormal cytokine secretion|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005095,decreased T cell proliferation
MGI:3700029	Ptpn13<tm1Gru>	MP:0002411,decreased susceptibility to bacterial infection|MP:0003009,abnormal cytokine secretion|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005621,abnormal cell physiology
MGI:3054733	Ptpn13<tm1Wjh>	MP:0001261,obese|MP:0002184,abnormal innervation|MP:0003634,abnormal glial cell morphology|MP:0005404,abnormal axon morphology|MP:0008056,abnormal retina ganglion cell morphology|MP:0008090,increased T-helper 2 cell number
MGI:4330561	Ptpn14<Gt(RRR484)Byg>	MP:0001262,decreased body weight|MP:0001731,abnormal postnatal growth|MP:0001788,periorbital edema|MP:0003390,lymphedema|MP:0004106,lymphatic vessel hyperplasia|MP:0005382,craniofacial phenotype
MGI:5695871	Ptpn14<tm1.1(KOMP)Vlcg>	MP:0000274,enlarged heart|MP:0001120,abnormal uterus morphology|MP:0001925,male infertility|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003604,single kidney|MP:0003960,increased lean body mass|MP:0004906,enlarged uterus|MP:0009709,hydrometra|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6403887	Ptpn18<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0002875,decreased erythrocyte cell number|MP:0005333,decreased heart rate|MP:0005635,decreased circulating bilirubin level|MP:0006241,abnormal placement of pupils|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4300169	Ptpn1<Gt(OST378842)Lex>	MP:0005459,decreased percent body fat/body weight
MGI:5319223	Ptpn1<tm1.1Kry>	MP:0005376,homeostasis/metabolism phenotype
MGI:2384135	Ptpn1<tm1Bbk>	MP:0000683,decreased percent water in carcass|MP:0001262,decreased body weight|MP:0001783,decreased white adipose tissue amount|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005292,improved glucose tolerance|MP:0005334,abnormal fat pad morphology|MP:0005379,endocrine/exocrine gland phenotype|MP:0005449,abnormal food intake|MP:0005450,abnormal energy expenditure|MP:0005451,abnormal body composition|MP:0005459,decreased percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008965,increased basal metabolism|MP:0009115,abnormal fat cell morphology|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009295,decreased interscapular fat pad weight|MP:0011016,increased core body temperature
MGI:2176520	Ptpn1<tm1Bpk>	MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005318,decreased triglyceride level|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity
MGI:3663370	Ptpn1<tm2Bbk>	MP:0000063,decreased bone mineral density|MP:0001262,decreased body weight|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003953,abnormal hormone level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005318,decreased triglyceride level|MP:0005334,abnormal fat pad morphology|MP:0005378,growth/size/body region phenotype|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0005669,increased circulating leptin level|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake|MP:0014440,increased response to leptin|MP:0030969,increased circulating adiponectin level
MGI:7294472	Ptpn20<em1Mmsk>	MP:0001893,non-obstructive hydrocephaly|MP:0003631,nervous system phenotype|MP:0011380,enlarged brain ventricles|MP:0021024,abnormal cerebrospinal fluid physiology
MGI:5632524	Ptpn20<tm1b(KOMP)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001513,limb grasping|MP:0003019,increased circulating chloride level
MGI:5516594	Ptpn22<tm1.1Draw>	MP:0000613,abnormal salivary gland morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000703,abnormal thymus morphology|MP:0000708,thymus hyperplasia|MP:0001175,abnormal lung morphology|MP:0001844,autoimmune response|MP:0001846,increased inflammatory response|MP:0001864,vascular inflammation|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002444,abnormal T cell physiology|MP:0002458,abnormal B cell number|MP:0002459,abnormal B cell physiology|MP:0002494,increased IgM level|MP:0002497,increased IgE level|MP:0002743,glomerulonephritis|MP:0002869,increased anti-insulin autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004939,abnormal B cell morphology|MP:0004973,increased regulatory T cell number|MP:0005014,increased B cell number|MP:0005091,increased double-positive T cell number|MP:0005154,increased B cell proliferation|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0006387,abnormal T cell number|MP:0008037,abnormal T cell morphology|MP:0008174,decreased follicular B cell number|MP:0008177,increased germinal center B cell number|MP:0008211,decreased mature B cell number|MP:0008217,abnormal B cell activation|MP:0008483,increased spleen germinal center size|MP:0008499,increased IgG1 level|MP:0008502,increased IgG3 level|MP:0008687,increased interleukin-2 secretion|MP:0008783,decreased B cell apoptosis|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009922,increased transitional stage T1 B cell number|MP:0010835,increased CD4-positive, alpha-beta memory T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number
MGI:5294241	Ptpn22<tm1.1Kas>	MP:0000691,enlarged spleen|MP:0000709,enlarged thymus|MP:0002376,abnormal dendritic cell physiology|MP:0002494,increased IgM level|MP:0005015,increased T cell number|MP:0005154,increased B cell proliferation|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008126,increased dendritic cell number|MP:0008481,increased spleen germinal center number|MP:0008483,increased spleen germinal center size|MP:0008500,increased IgG2a level|MP:0008502,increased IgG3 level|MP:0008663,increased interleukin-12 secretion
MGI:3043469	Ptpn22<tm1Achn>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002444,abnormal T cell physiology|MP:0002497,increased IgE level|MP:0005014,increased B cell number|MP:0008173,increased follicular B cell number|MP:0008481,increased spleen germinal center number|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level
MGI:3043477	Ptpn22<tm2Achn>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001828,abnormal T cell activation|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002408,abnormal double-positive T cell morphology|MP:0002444,abnormal T cell physiology|MP:0002497,increased IgE level|MP:0003850,abnormal thymocyte activation|MP:0003944,abnormal T cell subpopulation ratio|MP:0005014,increased B cell number|MP:0008049,increased memory T cell number|MP:0008173,increased follicular B cell number|MP:0008481,increased spleen germinal center number|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level
MGI:3870117	Ptpn23<Gt(YHB130)Byg>	MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5567111	Ptpn23<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0001556,increased circulating HDL cholesterol level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0011100,preweaning lethality, complete penetrance
MGI:5319222	Ptpn2<tm1.1Kry>	MP:0001541,abnormal osteoclast physiology|MP:0002891,increased insulin sensitivity|MP:0004889,increased energy expenditure|MP:0004992,increased bone resorption|MP:0005289,increased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0008396,abnormal osteoclast differentiation|MP:0008963,increased carbon dioxide production|MP:0030984,increased circulating osteocalcin level
MGI:5304815	Ptpn2<tm1.1Ttig>	MP:0000063,decreased bone mineral density|MP:0000333,decreased bone marrow cell number|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001431,abnormal eating behavior|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004889,increased energy expenditure|MP:0004892,increased adiponectin level|MP:0005120,decreased circulating growth hormone level|MP:0005289,increased oxygen consumption|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0014440,increased response to leptin
MGI:4441737	Ptpn2<tm1a(EUCOMM)Wtsi>	MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content
MGI:3044910	Ptpn2<tm1Mtr>	MP:0000062,increased bone mineral density|MP:0000172,abnormal bone marrow cell number|MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000333,decreased bone marrow cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0000715,decreased thymocyte number|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001492,abnormal pilomotor reflex|MP:0001505,hunched posture|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0001824,abnormal thymus involution|MP:0001845,abnormal inflammatory response|MP:0001846,increased inflammatory response|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0002339,abnormal lymph node morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002458,abnormal B cell number|MP:0002875,decreased erythrocyte cell number|MP:0003109,short femur|MP:0003132,increased pre-B cell number|MP:0003644,thymus atrophy|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0003944,abnormal T cell subpopulation ratio|MP:0003961,decreased lean body mass|MP:0004918,abnormal negative T cell selection|MP:0004919,abnormal positive T cell selection|MP:0004978,decreased B-1 B cell number|MP:0005014,increased B cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005036,diarrhea|MP:0005092,decreased double-positive T cell number|MP:0005287,narrow eye opening|MP:0005390,skeleton phenotype|MP:0005397,hematopoietic system phenotype|MP:0005425,increased macrophage cell number|MP:0005508,abnormal skeleton morphology|MP:0006399,abnormal long bone epiphyseal ossification zone morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0008102,lymph node hyperplasia|MP:0008152,decreased diameter of femur|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008210,increased mature B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008476,increased spleen red pulp amount|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008663,increased interleukin-12 secretion|MP:0008973,decreased erythroid progenitor cell number|MP:0009338,increased splenocyte number|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010867,abnormal bone trabecula morphology|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011722,abnormal ossification involved in bone maturation
MGI:5436249	Ptpn2<tm2.1Ttig>	MP:0000062,increased bone mineral density|MP:0000172,abnormal bone marrow cell number|MP:0000333,decreased bone marrow cell number|MP:0000702,enlarged lymph nodes|MP:0000715,decreased thymocyte number|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0002875,decreased erythrocyte cell number|MP:0003644,thymus atrophy|MP:0003944,abnormal T cell subpopulation ratio|MP:0003961,decreased lean body mass|MP:0004918,abnormal negative T cell selection|MP:0004919,abnormal positive T cell selection|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005092,decreased double-positive T cell number|MP:0005390,skeleton phenotype|MP:0005397,hematopoietic system phenotype|MP:0005508,abnormal skeleton morphology|MP:0006396,decreased long bone epiphyseal plate size|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content
MGI:3830860	Ptpn3<Gt(RRR012)Byg>	MP:0002169,no abnormal phenotype detected
MGI:3830863	Ptpn3<Gt(RRS555)Byg>	MP:0002169,no abnormal phenotype detected
MGI:3830864	Ptpn3<tm1Pdk>	MP:0002169,no abnormal phenotype detected
MGI:3769232	Ptpn3<tm1Rhvh>	MP:0001264,increased body size|MP:0010123,increased bone mineral content
MGI:3830997	Ptpn4<Gt(OST146128)Lex>	MP:0005387,immune system phenotype
MGI:3809671	Ptpn4<tm1.1Oers>	MP:0005387,immune system phenotype
MGI:3764684	Ptpn4<tm1Tya>	MP:0001405,impaired coordination|MP:0001475,reduced long-term depression|MP:0002807,abnormal eye blink conditioning behavior|MP:0003631,nervous system phenotype
MGI:5617143	Ptpn5<tm1b(KOMP)Wtsi>	MP:0002833,increased heart weight
MGI:3835526	Ptpn5<tm1Pjlo>	MP:0003631,nervous system phenotype
MGI:5805709	Ptpn6<em1.1Shoy>	MP:0000715,decreased thymocyte number
MGI:4939486	Ptpn6<m1Amgn>	MP:0000063,decreased bone mineral density|MP:0001193,psoriasis|MP:0004016,decreased bone mass|MP:0008614,increased circulating interleukin-17 level|MP:0010124,decreased bone mineral content
MGI:5563436	Ptpn6<m1Anu>	MP:0001806,decreased IgM level
MGI:3717648	Ptpn6<m1Btlr>	MP:0000219,increased neutrophil cell number|MP:0000578,ulcerated autopod|MP:0000691,enlarged spleen|MP:0001846,increased inflammatory response|MP:0001861,lung inflammation|MP:0001870,salivary gland inflammation|MP:0002411,decreased susceptibility to bacterial infection|MP:0002494,increased IgM level|MP:0003135,increased erythroid progenitor cell number|MP:0004829,increased anti-chromatin antibody level|MP:0008211,decreased mature B cell number|MP:0008250,abnormal myeloid leukocyte morphology|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0010771,integument phenotype
MGI:4999612	Ptpn6<m2Btlr>	MP:0001212,skin lesions|MP:0001265,decreased body size
MGI:5789594	Ptpn6<m3Btlr>	MP:0004977,increased B-1 B cell number|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005017,decreased B cell number|MP:0005425,increased macrophage cell number|MP:0008126,increased dendritic cell number|MP:0008167,increased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0008207,decreased B-2 B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number
MGI:6199040	Ptpn6<m4Btlr>	MP:0004977,increased B-1 B cell number|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010838,increased CD8-positive, alpha-beta memory T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6199169	Ptpn6<M5Btlr>	MP:0001806,decreased IgM level|MP:0002491,decreased IgD level|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6285167	Ptpn6<m6Btlr>	MP:0002145,abnormal T cell differentiation|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation
MGI:6285172	Ptpn6<m7Btlr>	MP:0002145,abnormal T cell differentiation
MGI:1856073	Ptpn6<me>	MP:0000136,abnormal microglial cell morphology|MP:0000217,abnormal leukocyte cell number|MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0000418,focal hair loss|MP:0000549,decreased limb number|MP:0000691,enlarged spleen|MP:0000696,abnormal Peyer's patch morphology|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0000716,abnormal immune system cell morphology|MP:0000774,decreased brain size|MP:0000783,abnormal forebrain morphology|MP:0000808,abnormal hippocampus development|MP:0000920,abnormal myelination|MP:0000934,abnormal telencephalon development|MP:0000952,abnormal CNS glial cell morphology|MP:0001175,abnormal lung morphology|MP:0001191,abnormal skin condition|MP:0001212,skin lesions|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001800,abnormal humoral immune response|MP:0001844,autoimmune response|MP:0001861,lung inflammation|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002095,abnormal skin pigmentation|MP:0002182,abnormal astrocyte morphology|MP:0002441,abnormal granulocyte morphology|MP:0002461,increased immunoglobulin level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0003077,abnormal cell cycle|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0003632,abnormal nervous system morphology|MP:0003644,thymus atrophy|MP:0003725,increased autoantibody level|MP:0004045,abnormal cell cycle checkpoint function|MP:0006043,decreased apoptosis|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008948,decreased neuron number|MP:0009336,increased splenocyte proliferation|MP:0010899,abnormal pulmonary alveolar system morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020448,increased microglial cell activation
MGI:1856501	Ptpn6<me-2J>	MP:0000418,focal hair loss|MP:0001212,skin lesions|MP:0001510,abnormal coat appearance|MP:0002082,postnatal lethality|MP:0002095,abnormal skin pigmentation
MGI:4947257	Ptpn6<me-B2>	MP:0000219,increased neutrophil cell number|MP:0000706,small thymus|MP:0001862,interstitial pneumonia|MP:0001926,female infertility|MP:0002083,premature death|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0003201,extremity edema|MP:0004833,ovary atrophy|MP:0004947,skin inflammation|MP:0005389,reproductive system phenotype|MP:0008577,increased circulating interferon-gamma level|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0009278,abnormal bone marrow cell physiology|MP:0010209,abnormal circulating chemokine level|MP:0011130,absent tertiary ovarian follicles|MP:0031234,increased circulating serum amyloid protein level
MGI:1856074	Ptpn6<me-v>	MP:0000418,focal hair loss|MP:0000704,abnormal thymus development|MP:0001189,absent skin pigmentation|MP:0001191,abnormal skin condition|MP:0001209,spontaneous skin ulceration|MP:0001265,decreased body size|MP:0001325,abnormal retina morphology|MP:0001327,decreased retina photoreceptor cell number|MP:0001845,abnormal inflammatory response|MP:0001862,interstitial pneumonia|MP:0002083,premature death|MP:0002439,abnormal plasma cell morphology|MP:0002444,abnormal T cell physiology|MP:0002490,abnormal immunoglobulin level|MP:0002499,chronic inflammation|MP:0003561,rheumatoid arthritis|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0005017,decreased B cell number|MP:0005391,vision/eye phenotype|MP:0008097,increased plasma cell number|MP:0008211,decreased mature B cell number|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:3719625	Ptpn6<tm1Rsky>	MP:0000217,abnormal leukocyte cell number|MP:0000322,increased granulocyte number|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001790,abnormal immune system physiology|MP:0001800,abnormal humoral immune response|MP:0002221,abnormal lymph organ size|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005093,decreased B cell proliferation|MP:0005425,increased macrophage cell number|MP:0008097,increased plasma cell number|MP:0008167,increased B-1a cell number|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number
MGI:2178956	Ptpn7<tm1Bwz>	MP:0002169,no abnormal phenotype detected|MP:0005397,hematopoietic system phenotype
MGI:3700988	Ptpn9<tm1Dny>	MP:0000074,abnormal neurocranium morphology|MP:0000440,domed cranium|MP:0000745,tremors|MP:0000754,paresis|MP:0000774,decreased brain size|MP:0000914,exencephaly|MP:0001265,decreased body size|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0002100,abnormal tooth morphology|MP:0002145,abnormal T cell differentiation|MP:0002151,abnormal neural tube morphology|MP:0003984,embryonic growth retardation|MP:0004214,abnormal long bone diaphysis morphology|MP:0005095,decreased T cell proliferation|MP:0005464,abnormal platelet physiology|MP:0008026,abnormal brain white matter morphology|MP:0008535,enlarged lateral ventricles|MP:0009549,decreased platelet aggregation|MP:0009929,meningomyelocele|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012260,encephalomeningocele|MP:0013241,embryo tissue necrosis
MGI:5812936	Ptpra<tm1b(EUCOMM)Hmgu>	MP:0001488,increased startle reflex|MP:0005561,increased mean corpuscular hemoglobin|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength
MGI:6682153	Ptpra<tm1c(EUCOMM)Hmgu>	MP:0005166,decreased susceptibility to injury|MP:0005376,homeostasis/metabolism phenotype
MGI:2445612	Ptpra<tm1Cjp>	MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001463,abnormal spatial learning|MP:0002757,decreased vertical activity|MP:0005376,homeostasis/metabolism phenotype|MP:0009969,abnormal cerebral cortex pyramidal cell morphology
MGI:2675252	Ptpra<tm1Sap>	MP:0002068,abnormal parental behavior|MP:0002089,abnormal postnatal growth/weight/body size|MP:0003566,abnormal cell adhesion|MP:0005621,abnormal cell physiology
MGI:4849921	Ptprb<m594684Hubr>	MP:0012270,cardiac edema
MGI:3760508	Ptprb<tm1Dgen>	MP:0000263,absent organized vascular network|MP:0000270,abnormal heart tube morphology|MP:0000291,enlarged pericardium|MP:0001614,abnormal blood vessel morphology|MP:0001701,incomplete embryo turning|MP:0001722,pale yolk sac|MP:0001726,abnormal allantois morphology|MP:0002189,abnormal myocardial trabeculae morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012253,abnormal intersomitic vessel morphology|MP:0012254,absent intersomitic vessels
MGI:3763454	Ptprb<tm1Gdy>	MP:0000274,enlarged heart|MP:0000364,abnormal vascular regression|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0001730,embryonic growth arrest|MP:0004076,abnormal vitelline vascular remodeling|MP:0004783,abnormal cardinal vein morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3047383	Ptprcap<tm1Svn>	MP:0000688,lymphoid hyperplasia|MP:0000702,enlarged lymph nodes
MGI:1888379	Ptprcap<tm1Tho>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype
MGI:2448362	Ptprcap<tm1Tkda>	MP:0005078,abnormal cytotoxic T cell physiology|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype
MGI:3611894	Ptprc<loc>	MP:0001825,arrested T cell differentiation|MP:0002408,abnormal double-positive T cell morphology|MP:0002458,abnormal B cell number|MP:0003850,abnormal thymocyte activation|MP:0004917,abnormal T cell selection|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0008037,abnormal T cell morphology|MP:0008048,abnormal memory T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:4441612	Ptprc<ltng>	MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:6285772	Ptprc<M10Btlr>	MP:0002492,decreased IgE level|MP:0008170,decreased B-1b cell number
MGI:6305154	Ptprc<M11Btlr>	MP:0002144,abnormal B cell differentiation|MP:0004977,increased B-1 B cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation
MGI:6305858	Ptprc<m12Btlr>	MP:0004977,increased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010845,decreased effector memory CD4-positive, alpha-beta T cell number|MP:0010848,decreased central memory CD8 positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:4355241	Ptprc<m1Btlr>	MP:0008070,absent T cells
MGI:5613813	Ptprc<m1Smv>	MP:0000716,abnormal immune system cell morphology|MP:0001790,abnormal immune system physiology|MP:0005090,increased double-negative T cell number|MP:0006082,CNS inflammation|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0010133,increased DN3 thymocyte number|MP:0010136,decreased DN4 thymocyte number|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:5609786	Ptprc<m2Btlr>	MP:0000219,increased neutrophil cell number|MP:0001800,abnormal humoral immune response|MP:0004977,increased B-1 B cell number|MP:0008050,decreased memory T cell number|MP:0008082,increased single-positive T cell number|MP:0008083,decreased single-positive T cell number|MP:0008126,increased dendritic cell number|MP:0008168,decreased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0008207,decreased B-2 B cell number|MP:0008211,decreased mature B cell number|MP:0008729,decreased memory B cell number|MP:0010836,decreased CD4-positive, alpha-beta memory T cell number|MP:0010839,decreased CD8-positive, alpha-beta memory T cell number
MGI:6113595	Ptprc<m3Btlr>	MP:0005017,decreased B cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008168,decreased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0008207,decreased B-2 B cell number
MGI:6199046	Ptprc<m4Btlr>	MP:0004977,increased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6199958	Ptprc<M5Btlr>	MP:0012764,increased alpha-beta T cell number
MGI:6200077	Ptprc<M6Btlr>	MP:0004977,increased B-1 B cell number|MP:0008168,decreased B-1a cell number|MP:0008170,decreased B-1b cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6268383	Ptprc<m7Btlr>	MP:0004977,increased B-1 B cell number|MP:0005017,decreased B cell number|MP:0008040,decreased NK T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0012765,decreased alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6268389	Ptprc<M8Btlr>	MP:0004977,increased B-1 B cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number
MGI:6285650	Ptprc<M9Btlr>	MP:0002144,abnormal B cell differentiation|MP:0002619,abnormal lymphocyte morphology|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005017,decreased B cell number|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0008045,decreased NK cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number
MGI:5694925	Ptprc<nim>	MP:0000221,decreased leukocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number
MGI:4819248	Ptprc<rain>	MP:0008246,abnormal leukocyte morphology
MGI:4819159	Ptprc<strm>	MP:0005017,decreased B cell number|MP:0005018,decreased T cell number
MGI:1857277	Ptprc<tm1Holm>	MP:0000693,spleen hyperplasia|MP:0000715,decreased thymocyte number|MP:0002145,abnormal T cell differentiation|MP:0002401,abnormal lymphopoiesis|MP:0002458,abnormal B cell number|MP:0005018,decreased T cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:2181288	Ptprc<tm1Mak>	MP:0000133,abnormal long bone metaphysis morphology|MP:0000715,decreased thymocyte number|MP:0000920,abnormal myelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0001541,abnormal osteoclast physiology|MP:0001825,arrested T cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002398,abnormal bone marrow cell morphology/development|MP:0003944,abnormal T cell subpopulation ratio|MP:0004982,abnormal osteoclast morphology|MP:0005018,decreased T cell number|MP:0005025,abnormal response to infection|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005090,increased double-negative T cell number|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0006413,increased T cell apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008351,decreased gamma-delta intraepithelial T cell number|MP:0008400,abnormal CD4-positive, alpha-beta intraepithelial T cell morphology|MP:0008765,decreased mast cell degranulation|MP:0008894,abnormal intraepithelial T cell morphology|MP:0008895,abnormal intraepithelial T cell number|MP:0009808,decreased oligodendrocyte number|MP:0010766,abnormal NK cell physiology
MGI:3579087	Ptprc<tm1Tyb>	MP:0000691,enlarged spleen|MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0002169,no abnormal phenotype detected|MP:0002444,abnormal T cell physiology|MP:0003009,abnormal cytokine secretion|MP:0004919,abnormal positive T cell selection|MP:0005036,diarrhea|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008044,increased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008722,abnormal chemokine secretion|MP:0010766,abnormal NK cell physiology|MP:0010768,mortality/aging|MP:0011084,lethality at weaning, incomplete penetrance
MGI:3027340	Ptprc<tm1Weis>	MP:0000217,abnormal leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001664,abnormal digestion|MP:0001828,abnormal T cell activation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002083,premature death|MP:0002408,abnormal double-positive T cell morphology|MP:0002495,increased IgA level|MP:0002722,abnormal immune system organ morphology|MP:0002743,glomerulonephritis|MP:0002962,increased urine protein level|MP:0003606,kidney failure|MP:0003620,oliguria|MP:0003850,abnormal thymocyte activation|MP:0003944,abnormal T cell subpopulation ratio|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005387,immune system phenotype|MP:0008049,increased memory T cell number|MP:0008097,increased plasma cell number|MP:0008102,lymph node hyperplasia|MP:0008111,abnormal granulocyte differentiation|MP:0008174,decreased follicular B cell number|MP:0008189,increased transitional stage B cell number|MP:0008191,abnormal follicular B cell physiology|MP:0008217,abnormal B cell activation|MP:0008476,increased spleen red pulp amount|MP:0008478,increased spleen white pulp amount|MP:0008500,increased IgG2a level|MP:0008524,increased plasmacytoid dendritic cell number
MGI:2158795	Ptprd<tm1Yiw>	MP:0001262,decreased body weight|MP:0001431,abnormal eating behavior|MP:0001463,abnormal spatial learning|MP:0001522,impaired swimming|MP:0002083,premature death|MP:0002919,enhanced paired-pulse facilitation|MP:0003008,enhanced long-term potentiation
MGI:4458607	Ptprd<tm2a(KOMP)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0003960,increased lean body mass|MP:0005292,improved glucose tolerance|MP:0008810,increased circulating iron level|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2385777	Ptpre<tm1Ael>	MP:0000921,demyelination|MP:0001541,abnormal osteoclast physiology|MP:0003484,abnormal channel response|MP:0004357,long tibia|MP:0008396,abnormal osteoclast differentiation|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0031073,decreased circulating type I collagen C-terminal telopeptide level
MGI:2156205	Ptprf<Gt(ST534)Byg>	MP:0000351,increased cell proliferation|MP:0005076,abnormal cell differentiation|MP:0009937,abnormal neuron differentiation
MGI:2158762	Ptprf<tm1Wjh>	MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001447,abnormal nest building behavior|MP:0001463,abnormal spatial learning|MP:0003838,abnormal milk ejection|MP:0004220,abnormal peripheral nervous system regeneration|MP:0005387,immune system phenotype|MP:0006271,abnormal involution of the mammary gland|MP:0008056,abnormal retina ganglion cell morphology|MP:0009506,abnormal mammary gland alveolus morphology|MP:0030012,impaired central nervous system regeneration|MP:0031330,delayed peripheral nervous system regeneration
MGI:4202506	Ptprg<Gt(OST142086)Lex>	MP:0001399,hyperactivity|MP:0003360,abnormal depression-related behavior
MGI:5464886	Ptprg<tm1.1Lex>	MP:0003360,abnormal depression-related behavior|MP:0005386,behavior/neurological phenotype
MGI:3663183	Ptprg<tm1Shar>	MP:0001405,impaired coordination|MP:0001454,abnormal cued conditioning behavior|MP:0001489,decreased startle reflex|MP:0002065,abnormal fear/anxiety-related behavior|MP:0002738,hyperresponsive to tactile stimuli|MP:0005386,behavior/neurological phenotype
MGI:3839028	Ptprh<tm1.1Mato>	MP:0005381,digestive/alimentary phenotype
MGI:2155181	Ptprj<Scc1-r>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:2155183	Ptprj<Scc1-s>	MP:0002020,increased tumor incidence
MGI:3774766	Ptprj<tm1.2Weis>	MP:0001924,infertility|MP:0002144,abnormal B cell differentiation|MP:0008181,increased marginal zone B cell number|MP:0008206,increased B-2 B cell number|MP:0008826,abnormal splenic cell ratio
MGI:3664243	Ptprj<tm1Fus>	MP:0002006,neoplasm|MP:0002169,no abnormal phenotype detected
MGI:2653313	Ptprj<tm1Taka>	MP:0000259,abnormal vascular development|MP:0000264,failure of vascular branching|MP:0000267,abnormal heart development|MP:0000292,distended pericardium|MP:0000298,absent atrioventricular cushions|MP:0000433,microcephaly|MP:0001698,decreased embryo size|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002652,thin myocardium|MP:0003227,abnormal vascular branching morphogenesis|MP:0003229,abnormal vitelline vasculature morphology|MP:0003719,abnormal pericyte morphology|MP:0003814,vascular smooth muscle hypoplasia|MP:0003974,abnormal endocardium morphology|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004787,abnormal dorsal aorta morphology|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006055,abnormal vascular endothelial cell morphology|MP:0006056,increased vascular endothelial cell number|MP:0009328,delayed heart looping|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012253,abnormal intersomitic vessel morphology|MP:0012501,abnormal pericardial cavity morphology
MGI:8261383	Ptprk<em1Gne>	MP:0001304,cataract|MP:0004499,increased incidence of tumors by chemical induction|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0010180,increased susceptibility to weight loss
MGI:5827691	Ptprk<em1(IMPC)J>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0002075,abnormal coat/hair pigmentation
MGI:6156153	Ptprm<em1(IMPC)Rbrc>	MP:0000188,abnormal circulating glucose level|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0010090,increased circulating creatine kinase level
MGI:3575002	Ptprm<tm1Mfbg>	MP:0005591,decreased vasodilation
MGI:3051779	Ptprn2<tm1Aln>	MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype
MGI:3625093	Ptprn<tm1Aln>	MP:0004031,insulitis|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005293,impaired glucose tolerance
MGI:3604600	Ptpro<tm1Dgen>	MP:0002906,increased susceptibility to pharmacologically induced seizures
MGI:5494167	Ptpro<tm1Shs>	MP:0002169,no abnormal phenotype detected
MGI:2687220	Ptpro<tm1Wig>	MP:0001544,abnormal cardiovascular system physiology|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005528,decreased renal glomerular filtration rate|MP:0008059,abnormal podocyte foot process morphology
MGI:5792035	Ptprq<mpc205H>	MP:0004748,increased susceptibility to age-related hearing loss
MGI:2679315	Ptprq<tm1Bow>	MP:0000043,organ of Corti degeneration|MP:0001967,deafness|MP:0004362,cochlear hair cell degeneration|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0004492,abnormal orientation of inner hair cell stereociliary bundles|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004531,short outer hair cell stereocilia|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004533,fused inner hair cell stereocilia|MP:0004534,decreased inner hair cell stereocilia number|MP:0004585,absent vestibular hair bundle shaft connectors|MP:0006358,absent pinna reflex
MGI:2679316	Ptprq<tm2Bow>	MP:0000043,organ of Corti degeneration|MP:0001967,deafness|MP:0004362,cochlear hair cell degeneration|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0004492,abnormal orientation of inner hair cell stereociliary bundles|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004531,short outer hair cell stereocilia|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004533,fused inner hair cell stereocilia|MP:0004534,decreased inner hair cell stereocilia number|MP:0004585,absent vestibular hair bundle shaft connectors|MP:0006358,absent pinna reflex
MGI:3710117	Ptprr<tm1Wjh>	MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0003631,nervous system phenotype|MP:0010053,decreased grip strength
MGI:5605845	Ptprs<tm1b(KOMP)Mbp>	MP:0002599,increased mean platelet volume|MP:0011100,preweaning lethality, complete penetrance
MGI:2158734	Ptprs<tm1Dro>	MP:0001732,postnatal growth retardation|MP:0005150,cachexia|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2158757	Ptprs<tm1Mtr>	MP:0000774,decreased brain size|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002741,small olfactory bulb|MP:0003651,abnormal axon extension|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004811,abnormal neuron physiology|MP:0005361,small pituitary gland|MP:0008544,impaired olfaction|MP:0009009,absent estrous cycle|MP:0009021,absent estrus|MP:0011088,neonatal lethality, incomplete penetrance|MP:0030013,enhanced central nervous system regeneration
MGI:6690611	Ptprt<m1Rgsc>	MP:0002573,behavioral despair|MP:0003008,enhanced long-term potentiation|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0011827,impaired neuron differentiation|MP:0020357,abnormal excitatory synapse morphology|MP:0020358,abnormal inhibitory synapse morphology|MP:0030707,decreased glutamine level|MP:0030733,decreased gamma-aminobutyric acid level
MGI:4437410	Ptprt<tm1Sata>	MP:0002044,increased colon adenoma incidence|MP:0002573,behavioral despair|MP:0003008,enhanced long-term potentiation|MP:0004499,increased incidence of tumors by chemical induction|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0011827,impaired neuron differentiation|MP:0012207,decreased neuronal stem cell self-renewal|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0030733,decreased gamma-aminobutyric acid level
MGI:5608701	Ptpru<tm1.1(KOMP)Vlcg>	MP:0001289,persistence of hyaloid vascular system|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0011396,abnormal sleep behavior
MGI:3039948	Ptprv<tm1Asmi>	MP:0001148,enlarged testis|MP:0001152,increased Leydig cell number|MP:0002079,increased circulating insulin level|MP:0002169,no abnormal phenotype detected|MP:0002781,increased circulating testosterone level|MP:0004851,increased testis weight|MP:0004909,increased seminal vesicle weight|MP:0004928,increased epididymis weight|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008280,abnormal male germ cell apoptosis|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0011819,increased pancreatic beta cell proliferation|MP:0030603,increased sperm number
MGI:5513815	Ptprv<tm1b(NCOM)Mfgc>	MP:0005628,decreased circulating potassium level|MP:0009142,decreased prepulse inhibition
MGI:3762914	Ptprv<tm1Kry>	MP:0000189,hypoglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002781,increased circulating testosterone level|MP:0002891,increased insulin sensitivity|MP:0003058,increased insulin secretion|MP:0004889,increased energy expenditure|MP:0004909,increased seminal vesicle weight|MP:0004928,increased epididymis weight|MP:0005215,abnormal pancreatic islet morphology|MP:0005292,improved glucose tolerance|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0005560,decreased circulating glucose level|MP:0006094,increased fat cell size|MP:0009113,increased pancreatic beta cell mass|MP:0009167,increased pancreatic islet number|MP:0009283,decreased gonadal fat pad weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011819,increased pancreatic beta cell proliferation|MP:0014342,abnormal muscle fiber mitochondrial morphology|MP:0030016,increased adipocyte glucose uptake|MP:0030021,increased muscle cell glucose uptake|MP:0030603,increased sperm number|MP:0030969,increased circulating adiponectin level
MGI:6414542	Ptprz1<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001199,thin skin|MP:0001293,anophthalmia|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology
MGI:2678757	Ptprz1<tm1Mno>	MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0002169,no abnormal phenotype detected|MP:0002411,decreased susceptibility to bacterial infection|MP:0003008,enhanced long-term potentiation
MGI:2386268	Ptprz1<tm1Schl>	MP:0000920,abnormal myelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0003789,increased osteosarcoma incidence|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis
MGI:3845016	Ptprz1<tm1Vlcg>	MP:0001405,impaired coordination|MP:0001973,increased thermal nociceptive threshold|MP:0002736,abnormal nociception after inflammation|MP:0003043,hypoalgesia|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory
MGI:3775076	Ptrh2<tm1.1Eruo>	MP:0000222,decreased neutrophil cell number|MP:0000528,delayed kidney development|MP:0000748,progressive muscle weakness|MP:0000751,myopathy|MP:0000752,dystrophic muscle|MP:0001393,ataxia|MP:0001523,impaired righting response|MP:0004121,abnormal sarcolemma morphology|MP:0004248,abnormal epaxial muscle morphology|MP:0005150,cachexia|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009415,skeletal muscle degeneration|MP:0009420,skeletal muscle endomysial fibrosis|MP:0011085,postnatal lethality, complete penetrance|MP:0013502,decreased fibroblast apoptosis|MP:0020309,increased creatine kinase activity|MP:0030798,joint contracture
MGI:3775073	Ptrh2<tm1Eruo>	MP:0002169,no abnormal phenotype detected
MGI:6154658	Pts<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0012362,increased large unstained cell number
MGI:2669870	Pts<tm1Ich>	MP:0001732,postnatal growth retardation|MP:0003633,abnormal nervous system physiology|MP:0005320,abnormal biopterin level|MP:0005321,abnormal neopterin level|MP:0005333,decreased heart rate|MP:0005643,decreased dopamine level|MP:0010070,decreased serotonin level|MP:0011085,postnatal lethality, complete penetrance|MP:0012574,decreased noradrenaline level|MP:0030697,increased phenylalanine level
MGI:2669828	Pts<tm1Thny>	MP:0000371,diluted coat color|MP:0000414,alopecia|MP:0000622,increased salivation|MP:0000745,tremors|MP:0001402,decreased locomotor activity|MP:0001437,no swallowing reflex|MP:0001732,postnatal growth retardation|MP:0001905,abnormal dopamine level|MP:0001937,abnormal sexual maturation|MP:0002083,premature death|MP:0005311,abnormal circulating amino acid level|MP:0005320,abnormal biopterin level|MP:0005321,abnormal neopterin level|MP:0005322,abnormal serotonin level|MP:0005323,dystonia|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:6194654	Pttg1ip2<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6149209	Pttg1ip<em1(IMPC)H>	MP:0000062,increased bone mineral density|MP:0002968,increased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0005565,increased blood urea nitrogen level|MP:0010024,increased total body fat amount|MP:0010123,increased bone mineral content
MGI:3624203	Pttg1<tm1.2Kna>	MP:0001921,reduced fertility
MGI:5696897	Pttg1<tm1b(EUCOMM)Wtsi>	MP:0000692,small spleen|MP:0001147,small testis|MP:0001552,increased circulating triglyceride level|MP:0002059,abnormal seminal vesicle morphology|MP:0002989,small kidney|MP:0005553,increased circulating creatinine level|MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3711120	Pttg1<tm1Pzg>	MP:0000352,decreased cell proliferation|MP:0004045,abnormal cell cycle checkpoint function|MP:0010768,mortality/aging
MGI:2157014	Pttg1<tm1Sme>	MP:0000708,thymus hyperplasia|MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0001762,polyuria|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002460,decreased immunoglobulin level|MP:0002722,abnormal immune system organ morphology|MP:0002727,decreased circulating insulin level|MP:0003179,thrombocytopenia|MP:0004852,decreased testis weight|MP:0004953,decreased spleen weight|MP:0005015,increased T cell number|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005606,increased bleeding time|MP:0006319,abnormal epididymal fat pad morphology|MP:0009114,decreased pancreatic beta cell mass|MP:0011820,decreased pancreatic beta cell proliferation|MP:0011939,increased food intake
MGI:2675283	Ptx3<tm1Mant>	MP:0000242,impaired fertilization|MP:0001798,impaired macrophage phagocytosis|MP:0001861,lung inflammation|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0002376,abnormal dendritic cell physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002452,abnormal professional antigen presenting cell physiology|MP:0005389,reproductive system phenotype|MP:0005399,increased susceptibility to fungal infection|MP:0005465,abnormal T-helper 1 physiology|MP:0009372,abnormal cumulus oophorus morphology|MP:0009374,absent cumulus expansion
MGI:2670952	Ptx3<tm1Zuk>	MP:0000242,impaired fertilization|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0009372,abnormal cumulus oophorus morphology|MP:0009374,absent cumulus expansion|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031420,decreased superovulation rate
MGI:7537143	Ptx4<em1(IMPC)J>	MP:0001402,decreased locomotor activity
MGI:3811899	Pubt1<C57BL/6J>	MP:0002636,delayed vaginal opening
MGI:5749450	Pudp<tm1.1(KOMP)Vlcg>	MP:0001304,cataract|MP:0013279,increased fasting circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:6414530	Puf60<em1(IMPC)Bay>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:7487995	Puf60<tm1.1Kmtsu>	MP:0001672,abnormal embryo development|MP:0011092,embryonic lethality, complete penetrance|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:6382402	Pum1<em1(IMPC)Mbp>	MP:0002060,abnormal skin morphology|MP:0009142,decreased prepulse inhibition
MGI:4126030	Pum1<Gt(XE002)Byg>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5316377	Pum1<tm1.2Hfl>	MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001922,reduced male fertility|MP:0001940,testis hypoplasia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype|MP:0014052,increased male germ cell apoptosis
MGI:3719788	Pum2<Gt(XE772)Byg>	MP:0001154,seminiferous tubule degeneration|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype
MGI:5605806	Pum2<tm1b(KOMP)Wtsi>	MP:0001488,increased startle reflex|MP:0002599,increased mean platelet volume|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:7481935	Pum3<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:5305287	Pura<tm1Herm>	MP:0000745,tremors|MP:0000746,weakness|MP:0000812,abnormal dentate gyrus morphology|MP:0000880,decreased Purkinje cell number|MP:0001263,weight loss|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0002176,increased brain weight|MP:0005238,increased brain size|MP:0005404,abnormal axon morphology|MP:0008924,decreased cerebellar granule cell number|MP:0009967,abnormal neuron proliferation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011149,abnormal hippocampus stratum lacunosum morphology
MGI:2677937	Pura<tm1Kkh>	MP:0000352,decreased cell proliferation|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000745,tremors|MP:0000778,abnormal nervous system tract morphology|MP:0000807,abnormal hippocampus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000851,cerebellum hypoplasia|MP:0000854,abnormal cerebellum development|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000880,decreased Purkinje cell number|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001391,abnormal tail movements|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002083,premature death|MP:0004097,abnormal cerebellar cortex morphology|MP:0004953,decreased spleen weight|MP:0004998,decreased CNS synapse formation|MP:0008026,abnormal brain white matter morphology|MP:0008489,slow postnatal weight gain|MP:0008941,reticulocytopenia|MP:0008948,decreased neuron number|MP:0010897,abnormal bronchiole epithelium morphology|MP:0014327,decreased Purkinje cell size|MP:0020394,decreased neuronal precursor proliferation|MP:0021086,decreased DNA replication
MGI:5701724	Pus10<tm1b(EUCOMM)Hmgu>	MP:0002968,increased circulating alkaline phosphatase level
MGI:6158647	Pus1<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0001529,abnormal vocalization|MP:0001566,increased circulating phosphate level|MP:0002075,abnormal coat/hair pigmentation|MP:0005344,increased circulating bilirubin level|MP:0010053,decreased grip strength
MGI:5811315	Pus1<tm1.1Mdf>	MP:0002106,abnormal muscle physiology|MP:0004819,decreased skeletal muscle mass|MP:0008489,slow postnatal weight gain|MP:0009400,decreased skeletal muscle fiber size|MP:0011631,decreased mitochondrial size|MP:0012106,impaired exercise endurance
MGI:6306465	Pus7<em1(IMPC)J>	MP:0004258,abnormal placenta size|MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance
MGI:1856625	Pv	MP:0000026,abnormal inner ear morphology|MP:0000036,absent semicircular canals|MP:0000037,abnormal lateral semicircular canal morphology|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001967,deafness|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002428,abnormal semicircular canal morphology|MP:0002858,abnormal posterior semicircular canal morphology|MP:0003161,absent lateral semicircular canal|MP:0003162,decreased lateral semicircular canal size|MP:0003165,absent superior semicircular canal|MP:0003166,decreased superior semicircular canal size
MGI:4421793	Pvalb<tm1.1(cre)Aibs>	MP:0002169,no abnormal phenotype detected
MGI:4365738	Pvalb<tm1(cre/ERT2)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:2652272	Pvalb<tm1Swal>	MP:0005620,abnormal muscle contractility|MP:0006035,abnormal mitochondrial morphology|MP:0014331,abnormal Purkinje cell mitochondrial morphology
MGI:5700403	Pvalb<tm2(cre/ERT2)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:5461318	Pvalb<tm3.1(dre)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5501499	Pvalb<tm5.1(cre/folA)Hze>	MP:0002169,no abnormal phenotype detected
MGI:6153598	Pvr<em1(IMPC)Wtsi>	MP:0002079,increased circulating insulin level|MP:0005358,abnormal incisor morphology
MGI:6276850	Pvrig<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology
MGI:7287678	Pvrig<tm1.2Sgng>	MP:0002444,abnormal T cell physiology|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology
MGI:3719436	Pvr<tm1Gbn>	MP:0001805,decreased IgG level|MP:0001807,decreased IgA level|MP:0005025,abnormal response to infection|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level
MGI:3829366	Pvr<tm1Hfuk>	MP:0004502,decreased incidence of tumors by chemical induction|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3055801	pvt	MP:0000048,abnormal stria vascularis morphology|MP:0001394,circling|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0002428,abnormal semicircular canal morphology|MP:0002622,abnormal cochlear hair cell morphology|MP:0004363,stria vascularis degeneration|MP:0006024,collapsed Reissner membrane|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3042934	Pwatq1<L6>	MP:0000683,decreased percent water in carcass
MGI:5825368	pwhl	MP:0001395,bidirectional circling|MP:0001522,impaired swimming|MP:0004742,abnormal vestibular system physiology|MP:0005377,hearing/vestibular/ear phenotype
MGI:1889626	pwk	MP:0000372,irregular coat pigmentation
MGI:4441688	Pwp1<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6385154	Pwwp2b<em1(IMPC)J>	MP:0005293,impaired glucose tolerance
MGI:6867219	Pwwp2b<tm1.1Bcgen>	MP:0000598,abnormal liver morphology|MP:0002891,increased insulin sensitivity|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005574,decreased pulmonary respiratory rate|MP:0008965,increased basal metabolism|MP:0009122,decreased white fat cell lipid droplet size|MP:0009125,decreased brown fat cell lipid droplet size|MP:0009293,decreased inguinal fat pad weight|MP:0010182,decreased susceptibility to weight gain|MP:0011019,abnormal adaptive thermogenesis|MP:0014143,decreased body fat mass|MP:0020520,whitened brown adipose tissue morphology
MGI:6156480	Pwwp3a<em1(IMPC)Tcp>	MP:0000706,small thymus|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005505,thrombocytosis|MP:0005565,increased blood urea nitrogen level
MGI:5637020	Pxdc1<tm1e.1(KOMP)Wtsi>	MP:0010067,increased red blood cell distribution width
MGI:5829376	Pxdn<em1(IMPC)J>	MP:0001293,anophthalmia|MP:0001314,cornea opacity|MP:0001399,hyperactivity|MP:0002075,abnormal coat/hair pigmentation|MP:0002574,increased vertical activity|MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020870,decreased thigmotaxis
MGI:5584201	Pxdn<mhdakta048>	MP:0000352,decreased cell proliferation|MP:0000373,belly spot|MP:0000585,kinked tail|MP:0001297,microphthalmia|MP:0001306,small lens|MP:0001307,fused cornea and lens|MP:0001314,cornea opacity|MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0001330,abnormal optic nerve morphology|MP:0001851,eye inflammation|MP:0002579,disorganized secondary lens fibers|MP:0002840,abnormal lens fiber morphology|MP:0003237,abnormal lens epithelium morphology|MP:0004221,abnormal iridocorneal angle|MP:0005193,abnormal anterior eye segment morphology|MP:0005205,abnormal eye anterior chamber morphology|MP:0005299,abnormal eye posterior chamber morphology|MP:0005300,abnormal cornea stroma morphology|MP:0005545,abnormal lens development|MP:0006200,vitreous body deposition|MP:0006221,optic nerve hypoplasia|MP:0006226,iris hypoplasia|MP:0006309,decreased retina ganglion cell number|MP:0008841,ruptured lens capsule|MP:0009392,retina gliosis|MP:0009742,increased cornea stroma thickness|MP:0010235,abnormal retina inner limiting membrane morphology|MP:0010709,absent eye anterior chamber|MP:0010713,corneal-lenticular stalk|MP:0013258,abnormal extracellular matrix morphology|MP:0013743,ciliary body hypoplasia|MP:0020855,decreased cornea epithelium thickness|MP:0021107,retina fold|MP:0031212,decreased eye anterior chamber depth
MGI:6385270	Pxk<em1(IMPC)Tcp>	MP:0002060,abnormal skin morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010024,increased total body fat amount|MP:0010123,increased bone mineral content
MGI:3844254	Pxmp2<tm1Jkh>	MP:0000609,abnormal liver physiology|MP:0001119,abnormal female reproductive system morphology|MP:0005266,abnormal metabolism|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0008821,increased blood uric acid level|MP:0009643,abnormal urine homeostasis|MP:0013716,hypolactation
MGI:7258107	Pxmp4<em1Jwjk>	MP:0001764,abnormal homeostasis|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype
MGI:2158458	Pxn<tm1Smth>	MP:0000267,abnormal heart development|MP:0000474,abnormal foregut morphology|MP:0000932,absent notochord|MP:0001698,decreased embryo size|MP:0001726,abnormal allantois morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0005029,abnormal amnion morphology|MP:0005223,abnormal dorsal-ventral polarity of the somites|MP:0005384,cellular phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012499,absent cardiogenic plate
MGI:4362699	Pxylp1<tm1a(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0003961,decreased lean body mass|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010124,decreased bone mineral content
MGI:1857010	py	MP:0000562,polydactyly|MP:0002110,abnormal digit morphology|MP:0009743,preaxial polydactyly
MGI:5467340	Pycard<tm1Ayaz>	MP:0002006,neoplasm|MP:0004502,decreased incidence of tumors by chemical induction|MP:0008561,decreased tumor necrosis factor secretion|MP:0008655,decreased interleukin-1 alpha secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008706,decreased interleukin-6 secretion
MGI:3686870	Pycard<tm1Flv>	MP:0002451,abnormal macrophage physiology|MP:0002495,increased IgA level|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008045,decreased NK cell number|MP:0008136,enlarged Peyer's patches|MP:0008537,increased susceptibility to induced colitis|MP:0008636,decreased circulating interleukin-18 level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008655,decreased interleukin-1 alpha secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008896,increased IgG2c level|MP:0010377,abnormal gut flora balance|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:3771030	Pycard<tm1Nnz>	MP:0008658,decreased interleukin-1 beta secretion|MP:0008685,decreased interleukin-18 secretion
MGI:3590154	Pycard<tm1Tno>	MP:0008567,decreased interferon-gamma secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008685,decreased interleukin-18 secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:3046932	Pycard<tm1Vmd>	MP:0001876,decreased inflammatory response|MP:0002006,neoplasm|MP:0002451,abnormal macrophage physiology|MP:0005025,abnormal response to infection|MP:0008560,increased tumor necrosis factor secretion|MP:0008564,increased interferon-beta secretion|MP:0008636,decreased circulating interleukin-18 level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008655,decreased interleukin-1 alpha secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008685,decreased interleukin-18 secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:7624490	Pycr1<em1Zhob>	MP:0003038,decreased myocardial infarct size|MP:0031216,decreased susceptibility to myocardial ischemic injury
MGI:5507839	Pycr1<tm1.1(KOMP)Vlcg>	MP:0002702,decreased circulating free fatty acids level
MGI:4881190	Pycr1<tm1(KOMP)Vlcg>	MP:0002644,decreased circulating triglyceride level|MP:0005293,impaired glucose tolerance|MP:0005390,skeleton phenotype|MP:0010771,integument phenotype
MGI:5502703	Pycr2<m1J>	MP:0000160,kyphosis|MP:0000186,decreased circulating HDL cholesterol level|MP:0000221,decreased leukocyte cell number|MP:0001199,thin skin|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002607,decreased basophil cell number|MP:0002644,decreased circulating triglyceride level|MP:0003631,nervous system phenotype|MP:0005016,decreased lymphocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0005404,abnormal axon morphology|MP:0005565,increased blood urea nitrogen level|MP:0005628,decreased circulating potassium level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011561,renal glomerulus lipidosis|MP:0011730,increased myelin sheath thickness|MP:0013138,thin body|MP:0030740,decreased circulating glutamic acid level
MGI:6470408	Pycr2<tm1.1Brre>	MP:0000160,kyphosis|MP:0000781,decreased corpus callosum size|MP:0000811,hippocampal neuron degeneration|MP:0000953,abnormal oligodendrocyte morphology|MP:0001263,weight loss|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001525,impaired balance|MP:0002083,premature death|MP:0002882,abnormal neuron morphology|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration|MP:0003225,axonal dystrophy|MP:0005332,abnormal amino acid level|MP:0006086,decreased body mass index|MP:0010047,axonal spheroids|MP:0010205,abnormal oligodendrocyte apoptosis|MP:0011827,impaired neuron differentiation
MGI:4842705	Pycr2<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000223,decreased monocyte cell number|MP:0001512,trunk curl|MP:0001513,limb grasping|MP:0005561,increased mean corpuscular hemoglobin|MP:0006358,absent pinna reflex|MP:0013026,decreased Ly6C low monocyte number|MP:0013279,increased fasting circulating glucose level
MGI:6383391	Pycr3<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response
MGI:4362669	Pygl<tm1a(KOMP)Wtsi>	MP:0000189,hypoglycemia|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0001764,abnormal homeostasis|MP:0001860,liver inflammation|MP:0002575,increased circulating ketone body level|MP:0002644,decreased circulating triglyceride level|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003333,liver fibrosis|MP:0005179,decreased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008989,abnormal liver sinusoid morphology|MP:0009820,abnormal liver vasculature morphology|MP:0010400,increased liver glycogen level|MP:0013278,decreased fasting circulating glucose level|MP:0020103,decreased hepatic glucose production
MGI:6363565	Pygm<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0001402,decreased locomotor activity|MP:0002968,increased circulating alkaline phosphatase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5696972	Pygm<tm1.1Adru>	MP:0003061,decreased aerobic running capacity|MP:0006034,myoglobinuria|MP:0009403,increased variability of skeletal muscle fiber size|MP:0010053,decreased grip strength|MP:0010401,increased skeletal muscle glycogen level|MP:0020280,increased creatine kinase level
MGI:5518424	Pygo1<tm1.1Kba>	MP:0010768,mortality/aging
MGI:3711231	Pygo1<tm1Ssp>	MP:0002169,no abnormal phenotype detected
MGI:5518423	Pygo2<tm1.1Kba>	MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:3711233	Pygo2<tm1.1Ssp>	MP:0000527,abnormal kidney development|MP:0001288,abnormal lens induction|MP:0001297,microphthalmia|MP:0001306,small lens|MP:0003078,aphakia|MP:0003237,abnormal lens epithelium morphology|MP:0004200,decreased fetal size|MP:0004269,abnormal optic cup morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012168,abnormal optic placode morphology|MP:0030242,small optic pit
MGI:3712856	Pygo2<tm1.2Ssp>	MP:0000111,cleft palate|MP:0000914,exencephaly|MP:0002135,abnormal kidney morphology|MP:0003078,aphakia|MP:0003672,abnormal ureter development|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0011087,neonatal lethality, complete penetrance
MGI:3711739	Pygo2<tm1.2Xdai>	MP:0000440,domed cranium|MP:0000496,abnormal small intestine morphology|MP:0000914,exencephaly|MP:0001176,abnormal lung development|MP:0001290,delayed eyelid opening|MP:0001297,microphthalmia|MP:0001306,small lens|MP:0001312,abnormal cornea morphology|MP:0001325,abnormal retina morphology|MP:0002840,abnormal lens fiber morphology|MP:0003078,aphakia|MP:0003237,abnormal lens epithelium morphology|MP:0003704,abnormal hair follicle development|MP:0005238,increased brain size|MP:0005545,abnormal lens development|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0010174,decreased mammary gland epithelial cell proliferation|MP:0011089,perinatal lethality, complete penetrance
MGI:5636261	Pygo2<tm1b(EUCOMM)Wtsi>	MP:0000428,abnormal craniofacial morphology|MP:0000841,abnormal hindbrain morphology|MP:0000897,abnormal midbrain morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002092,abnormal eye morphology|MP:0002109,abnormal limb morphology|MP:0002135,abnormal kidney morphology|MP:0003720,abnormal neural tube closure|MP:0011100,preweaning lethality, complete penetrance
MGI:3055100	Pymr<NC/JicJcl>	MP:0005027,increased susceptibility to parasitic infection
MGI:5563211	Pyroxd1<tm1b(KOMP)Wtsi>	MP:0000470,abnormal stomach morphology|MP:0000745,tremors|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3771165	Pyy<tm1.1Batt>	MP:0000013,abnormal adipose tissue distribution|MP:0001261,obese|MP:0001433,polyphagia|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005669,increased circulating leptin level|MP:0010024,increased total body fat amount
MGI:3580424	Pyy<tm1Able>	MP:0002169,no abnormal phenotype detected
MGI:3771166	Pyy<tm1Batt>	MP:0002169,no abnormal phenotype detected
MGI:3664105	Pyy<tm1(cre)Hhzg>	MP:0000008,increased white adipose tissue amount|MP:0000062,increased bone mineral density|MP:0001259,abnormal body weight|MP:0001260,increased body weight|MP:0002079,increased circulating insulin level|MP:0002781,increased circulating testosterone level|MP:0002896,abnormal bone mineralization|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003212,increased susceptibility to age related obesity|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0004702,increased circulating insulin-like growth factor I level|MP:0005293,impaired glucose tolerance|MP:0005386,behavior/neurological phenotype|MP:0005645,abnormal hypothalamus physiology|MP:0009285,increased gonadal fat pad weight|MP:0010024,increased total body fat amount|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0010878,increased trabecular bone volume|MP:0021191,increased bone mineral density of lumbar vertebrae
MGI:3771716	Pyy<tm1Mws>	MP:0000063,decreased bone mineral density|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003961,decreased lean body mass|MP:0004016,decreased bone mass|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005455,increased susceptibility to weight gain|MP:0005458,increased percent body fat/body weight|MP:0010124,decreased bone mineral content
MGI:3529167	Pzp2<tm1Lex>	MP:0000062,increased bone mineral density|MP:0001402,decreased locomotor activity|MP:0005333,decreased heart rate
MGI:2180117	Pzp2<tm1Vln>	MP:0000341,abnormal bile color|MP:0000599,enlarged liver|MP:0001402,decreased locomotor activity|MP:0001511,disheveled coat|MP:0001654,hepatic necrosis|MP:0001860,liver inflammation|MP:0001869,pancreas inflammation|MP:0002006,neoplasm|MP:0002169,no abnormal phenotype detected|MP:0002628,hepatic steatosis|MP:0002830,gallstones|MP:0003009,abnormal cytokine secretion|MP:0003829,impaired febrile response|MP:0003849,greasy coat|MP:0004761,increased susceptibility to induced pancreatitis|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005388,respiratory system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008713,abnormal cytokine level|MP:0008806,increased circulating amylase level|MP:0009145,abnormal pancreatic acinus morphology|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010182,decreased susceptibility to weight gain|MP:0011886,increased circulating lipase level
MGI:1861449	Q	MP:0000585,kinked tail|MP:0000745,tremors|MP:0001405,impaired coordination|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011105,embryonic lethality between implantation and placentation, incomplete penetrance|MP:0030930,decreased digit pigmentation
MGI:7425939	Qars1<em1(IMPC)Mbp>	MP:0000759,abnormal skeletal muscle morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001293,anophthalmia|MP:0001325,abnormal retina morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002152,abnormal brain morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3580348	qbal	MP:0000414,alopecia
MGI:3612520	Qbis1<C57BLKS/J>	MP:0001260,increased body weight|MP:0008908,increased total fat pad weight
MGI:3612523	Qbis2<DBA/2Jcl>	MP:0001260,increased body weight|MP:0008908,increased total fat pad weight
MGI:3612525	Qbis3<DBA/2Jcl>	MP:0001260,increased body weight
MGI:3612527	Qbis4<DBA/2Jcl>	MP:0001260,increased body weight
MGI:1889620	Qd	MP:0000585,kinked tail|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3529090	Qdpr<tm1Lex>	MP:0001764,abnormal homeostasis|MP:0003674,oxidative stress|MP:0005321,abnormal neopterin level|MP:0010831,lethality, incomplete penetrance|MP:0012335,increased circulating homocysteine level
MGI:3037830	Qki<e5>	MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0000920,abnormal myelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0001393,ataxia|MP:0002064,seizures|MP:0002083,premature death|MP:0008026,abnormal brain white matter morphology
MGI:3575120	Qki<qk-2J>	MP:0000745,tremors|MP:0003871,abnormal myelin sheath morphology|MP:0004077,abnormal striatum morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1857100	Qki<qk-k2>	MP:0000260,abnormal angiogenesis|MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0000274,enlarged heart|MP:0001622,abnormal vasculogenesis|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0003229,abnormal vitelline vasculature morphology|MP:0003631,nervous system phenotype|MP:0003861,abnormal nervous system development|MP:0003984,embryonic growth retardation|MP:0005312,pericardial effusion|MP:0005385,cardiovascular system phenotype|MP:0005657,abnormal neural plate morphology|MP:0006057,decreased vascular endothelial cell number|MP:0006281,abnormal tail development|MP:0006386,absent somites|MP:0008533,abnormal anterior visceral endoderm morphology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1857101	Qki<qk-kt1>	MP:0000267,abnormal heart development|MP:0005221,abnormal rostral-caudal axis patterning|MP:0008530,abnormal rostral-caudal patterning of the somites|MP:0011092,embryonic lethality, complete penetrance|MP:0011257,abnormal head fold morphology
MGI:1856538	Qki<qk-l1>	MP:0000260,abnormal angiogenesis|MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0005312,pericardial effusion|MP:0006281,abnormal tail development|MP:0008533,abnormal anterior visceral endoderm morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5637515	Qki<qk-shk>	MP:0000745,tremors|MP:0000921,demyelination|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0002826,tonic seizures|MP:0005386,behavior/neurological phenotype|MP:0010734,abnormal paranode morphology|MP:0011731,decreased myelin sheath thickness
MGI:1856539	Qki<qk-v>	MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0000920,abnormal myelination|MP:0001156,abnormal spermatogenesis|MP:0001388,abnormal stationary movement|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001441,increased grooming behavior|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002064,seizures|MP:0002687,oligozoospermia|MP:0002826,tonic seizures|MP:0003461,abnormal response to novel object|MP:0004814,reduced linear vestibular evoked potential|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009325,necrospermia|MP:0009434,paraparesis
MGI:3033861	Qki<tm1Imeg>	MP:0000266,abnormal heart morphology|MP:0000929,open neural tube|MP:0000930,wavy neural tube|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0002151,abnormal neural tube morphology|MP:0002396,abnormal hematopoietic system morphology/development|MP:0003229,abnormal vitelline vasculature morphology|MP:0005312,pericardial effusion|MP:0005329,abnormal myocardium layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7442900	Qpctl<tm1.1Gne>	MP:0000220,increased monocyte cell number|MP:0000223,decreased monocyte cell number|MP:0003447,decreased tumor growth/size
MGI:7442902	Qpct<tm1.1Gne>	MP:0005387,immune system phenotype
MGI:4941596	Qpct<tm1.2Tbay>	MP:0005386,behavior/neurological phenotype
MGI:6723745	Qprt<Gt(OST337946)Lex>	MP:0002446,abnormal macrophage morphology|MP:0002451,abnormal macrophage physiology|MP:0006035,abnormal mitochondrial morphology|MP:0008713,abnormal cytokine level|MP:0010959,abnormal oxidative phosphorylation
MGI:8209546	Qprt<tm1Kshib>	MP:0000781,decreased corpus callosum size|MP:0001262,decreased body weight|MP:0004019,abnormal vitamin homeostasis|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008026,abnormal brain white matter morphology|MP:0008802,abnormal intestinal smooth muscle morphology|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0011940,decreased food intake|MP:0012462,decreased brain internal capsule size
MGI:7788184	Qrfpr<em1Smln>	MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005376,homeostasis/metabolism phenotype
MGI:7788186	Qrfprl<tm1.1Smln>	MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005376,homeostasis/metabolism phenotype
MGI:3830475	Qrfpr<tm1Lex>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000160,kyphosis|MP:0003049,abnormal lumbar vertebrae morphology|MP:0004173,abnormal intervertebral disk morphology|MP:0005225,abnormal vertebrae development|MP:0005390,skeleton phenotype|MP:0006392,abnormal nucleus pulposus morphology
MGI:6163999	Qrfp<tm1Stak>	MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002757,decreased vertical activity|MP:0003064,decreased coping response|MP:0005668,decreased circulating leptin level|MP:0011940,decreased food intake|MP:0012289,abnormal non-rapid eye movement sleep pattern|MP:0014143,decreased body fat mass|MP:0020478,abnormal circadian sleep/wake cycle
MGI:5554436	Qrich1<b2b2404Clo>	MP:0000111,cleft palate|MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0001823,thymus hypoplasia|MP:0004056,abnormal myocardium compact layer morphology|MP:0008528,polycystic kidney|MP:0010402,ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0011667,double outlet right ventricle with atrioventricular septal defect
MGI:7785048	Qrich1<em1Nki>	MP:0002169,no abnormal phenotype detected
MGI:7785050	Qrich1<em2Nki>	MP:0005562,decreased mean corpuscular hemoglobin|MP:0011091,prenatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011523,thin placenta labyrinth|MP:0012701,increased embryonic neuroepithelium apoptosis
MGI:7785052	Qrich1<em3Nki>	MP:0005562,decreased mean corpuscular hemoglobin|MP:0011091,prenatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011523,thin placenta labyrinth|MP:0012701,increased embryonic neuroepithelium apoptosis
MGI:6356346	Qrich2<em1Xdz>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004929,decreased epididymis weight|MP:0004930,small epididymis|MP:0005389,reproductive system phenotype|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009831,abnormal sperm midpiece morphology|MP:0009836,abnormal sperm principal piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0020451,decreased sperm progressive motility|MP:0031356,abnormal outer dense fiber morphology
MGI:6306906	Qrsl1<em1(IMPC)J>	MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:5615575	Qsox1<b2b2673Clo>	MP:0000111,cleft palate|MP:0000445,short snout|MP:0000562,polydactyly|MP:0000694,spleen hypoplasia|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002633,persistent truncus arteriosus|MP:0002639,micrognathia|MP:0003321,tracheoesophageal fistula|MP:0009743,preaxial polydactyly|MP:0010412,atrioventricular septal defect|MP:0010466,vascular ring|MP:0010488,abnormal left subclavian artery morphology
MGI:6156344	Qsox1<em1(IMPC)Kmpc>	MP:0002075,abnormal coat/hair pigmentation|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0011239,abnormal skin coloration|MP:0011971,increased circulating lactate dehydrogenase level|MP:0013278,decreased fasting circulating glucose level
MGI:6336131	Qsox2<em1(IMPC)Kmpc>	MP:0005568,increased circulating total protein level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0013279,increased fasting circulating glucose level
MGI:4974232	Qtrt1<Gt(S12-11A1)Sor>	MP:0005621,abnormal cell physiology|MP:0013724,decreased circulating tyrosine level
MGI:5499208	Quaver	MP:0000745,tremors|MP:0001260,increased body weight
MGI:2176543	Qui<C57BL/6J>	MP:0001986,abnormal taste sensitivity|MP:0002850,saccharin preference
MGI:5554211	qvyr	MP:0000745,tremors|MP:0001265,decreased body size|MP:0002083,premature death|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5617141	R3hcc1l<tm1b(KOMP)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin
MGI:5692840	R3hdm1<tm1b(EUCOMM)Wtsi>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology
MGI:6385112	R3hdml<tm1Mita>	MP:0000733,abnormal muscle development|MP:0001262,decreased body weight|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004090,abnormal sarcomere morphology|MP:0004093,diffuse Z line|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009410,abnormal skeletal muscle satellite cell proliferation|MP:0010225,abnormal quadriceps morphology|MP:0010239,decreased skeletal muscle weight|MP:0013239,impaired skeletal muscle regeneration
MGI:5907845	Rab10<em1(IMPC)J>	MP:0001488,increased startle reflex|MP:0002591,decreased mean corpuscular volume|MP:0004222,iris synechia|MP:0004738,abnormal auditory brainstem response|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6281610	Rab10<tm1c(KOMP)Wtsi>	MP:0002079,increased circulating insulin level|MP:0005331,insulin resistance|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0020102,increased hepatic glucose production|MP:0030017,decreased adipocyte glucose uptake
MGI:6197683	Rab10<tm1Tax>	MP:0000352,decreased cell proliferation|MP:0001674,abnormal germ layer development|MP:0001693,failure of primitive streak formation|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002086,abnormal extraembryonic tissue morphology|MP:0010736,abnormal extraembryonic ectoderm morphology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011207,absent ectoplacental cavity|MP:0011209,absent extraembryonic coelom|MP:0012142,absent amniotic cavity|MP:0014693,abnormal cell nucleus size|MP:0020851,abnormal vacuole morphology
MGI:5608786	Rab11a<tm1.1Ngao>	MP:0000477,abnormal intestine morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0001265,decreased body size|MP:0001663,abnormal digestive system physiology|MP:0001858,intestinal inflammation|MP:0002083,premature death|MP:0002404,increased intestinal adenoma incidence|MP:0003009,abnormal cytokine secretion|MP:0003449,abnormal intestine goblet cell morphology|MP:0004499,increased incidence of tumors by chemical induction|MP:0008108,abnormal small intestinal villus morphology|MP:0008142,decreased small intestinal villus size|MP:0008657,increased interleukin-1 beta secretion|MP:0008705,increased interleukin-6 secretion|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010155,abnormal intestine physiology|MP:0010156,abnormal small intestinal crypt cell physiology|MP:0010157,abnormal small intestinal crypt cell proliferation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013956,decreased colon length|MP:0014433,increased cytokine level
MGI:5629313	Rab11a<tm1b(KOMP)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0005292,improved glucose tolerance|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:5790204	Rab11b<em1(IMPC)J>	MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:6257821	Rab11fip1<em1(IMPC)Bay>	MP:0013279,increased fasting circulating glucose level
MGI:6450140	Rab11fip2<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0005564,increased hemoglobin content
MGI:5755639	Rab11fip3<em1(IMPC)J>	MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0002574,increased vertical activity|MP:0004738,abnormal auditory brainstem response|MP:0004924,abnormal behavior|MP:0005292,improved glucose tolerance|MP:0020870,decreased thigmotaxis
MGI:5644714	Rab11fip4<em1(IMPC)J>	MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001489,decreased startle reflex|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:5620907	Rab11fip5<tm1.1(KOMP)Vlcg>	MP:0005560,decreased circulating glucose level|MP:0010053,decreased grip strength
MGI:5468257	Rab11fip5<tm1Sud>	MP:0002169,no abnormal phenotype detected
MGI:6151445	Rab13<tm1.1Ktg>	MP:0000692,small spleen|MP:0002223,lymphoid hypoplasia|MP:0002444,abnormal T cell physiology|MP:0003628,abnormal leukocyte adhesion|MP:0005016,decreased lymphocyte cell number|MP:0005378,growth/size/body region phenotype|MP:0005387,immune system phenotype|MP:0009624,small inguinal lymph nodes|MP:0010768,mortality/aging|MP:0020212,impaired leukocyte migration|MP:0031207,decreased lymphocyte chemotaxis
MGI:7621850	Rab14<em2Cya>	MP:0011092,embryonic lethality, complete penetrance
MGI:4363640	Rab15<tm1a(KOMP)Wtsi>	MP:0001513,limb grasping|MP:0002727,decreased circulating insulin level
MGI:4369232	Rab18<Gt(EUCE0233a03)Hmgu>	MP:0000746,weakness|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001286,abnormal eye development|MP:0001317,abnormal pupil morphology|MP:0001513,limb grasping|MP:0002003,miotic pupil|MP:0002638,abnormal pupillary reflex|MP:0002651,abnormal sciatic nerve morphology|MP:0003632,abnormal nervous system morphology|MP:0009121,increased white fat cell lipid droplet size|MP:0010254,nuclear cataract|MP:0011090,perinatal lethality, incomplete penetrance|MP:0020378,abnormal cell cytoskeleton morphology
MGI:5698701	Rab18<m1Hongc>	MP:0000780,abnormal corpus callosum morphology|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001973,increased thermal nociceptive threshold|MP:0003994,abnormal dorsal spinal root morphology|MP:0005405,axon degeneration|MP:0005498,hyporesponsive to tactile stimuli|MP:0006219,optic nerve degeneration
MGI:5548343	Rab19<tm1b(EUCOMM)Hmgu>	MP:0000195,decreased circulating calcium level|MP:0001289,persistence of hyaloid vascular system|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001469,abnormal contextual conditioning behavior|MP:0002833,increased heart weight|MP:0005011,increased eosinophil cell number|MP:0011962,increased cornea thickness|MP:0012361,decreased large unstained cell number
MGI:4125357	Rab1a<Gt(XB498)Byg>	MP:0002169,no abnormal phenotype detected|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6281094	Rab1a<tm1b(KOMP)Wtsi>	MP:0002098,abnormal vibrissa morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:3530156	Rab1b<Gt(OST191074)Lex>	MP:0002169,no abnormal phenotype detected
MGI:5294223	Rab20<tm1a(EUCOMM)Hmgu>	MP:0002451,abnormal macrophage physiology
MGI:5520178	Rab20<tm1b(EUCOMM)Hmgu>	MP:0005633,increased circulating sodium level
MGI:5638577	Rab21<tm1b(KOMP)Wtsi>	MP:0001711,abnormal placenta morphology|MP:0002836,abnormal chorion morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:1856980	Rab23<opb>	MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0000955,abnormal spinal cord morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001288,abnormal lens induction|MP:0001292,abnormal lens vesicle development|MP:0001293,anophthalmia|MP:0002114,abnormal axial skeleton morphology|MP:0002151,abnormal neural tube morphology|MP:0002728,absent tibia|MP:0003054,spina bifida|MP:0003720,abnormal neural tube closure|MP:0003855,abnormal forelimb zeugopod morphology|MP:0003857,abnormal hindlimb zeugopod morphology|MP:0004269,abnormal optic cup morphology|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0005104,abnormal tarsal bone morphology|MP:0005226,abnormal vertebral arch development|MP:0005297,spina bifida occulta|MP:0006069,abnormal retina neuronal layer morphology|MP:0006279,abnormal limb development|MP:0009688,abnormal spinal cord central canal morphology|MP:0009689,abnormal neural tube ventricular layer morphology|MP:0009827,skin detachment
MGI:2137533	Rab23<opb2>	MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0000955,abnormal spinal cord morphology|MP:0002092,abnormal eye morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012707,incomplete caudal neuropore closure
MGI:8249197	Rab23<tm1.1Elkg>	MP:0000166,abnormal chondrocyte morphology|MP:0000428,abnormal craniofacial morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000849,abnormal cerebellum morphology|MP:0001261,obese|MP:0001293,anophthalmia|MP:0002092,abnormal eye morphology|MP:0002151,abnormal neural tube morphology|MP:0002152,abnormal brain morphology|MP:0004083,polysyndactyly|MP:0004201,fetal growth retardation|MP:0006254,thin cerebral cortex|MP:0009964,abnormal cerebellum lobule morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0012526,abnormal upper rhombic lip morphology|MP:0013203,abnormal primary cilium morphology
MGI:5695135	Rab23<tm1b(EUCOMM)Wtsi>	MP:0002599,increased mean platelet volume|MP:0002941,increased circulating alanine transaminase level|MP:0003961,decreased lean body mass|MP:0005343,increased circulating aspartate transaminase level|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:5474977	Rab24<tm1.1(KOMP)Wtsi>	MP:0001258,decreased body length|MP:0001307,fused cornea and lens|MP:0001510,abnormal coat appearance|MP:0002833,increased heart weight|MP:0003795,abnormal bone structure|MP:0010124,decreased bone mineral content
MGI:4440861	Rab25<tm1Jrgo>	MP:0000466,esophageal epithelium hyperplasia|MP:0001140,abnormal vagina epithelium morphology|MP:0003276,esophageal atresia
MGI:6719236	Rab26<em1Guwa>	MP:0005165,increased susceptibility to injury|MP:0008735,increased susceptibility to endotoxin shock|MP:0020344,abnormal susceptibility to injury induced morbidity/mortality
MGI:6399914	Rab26<em1(IMPC)H>	MP:0001392,abnormal locomotor behavior
MGI:7424866	Rab26os<em1Shx>	MP:0002169,no abnormal phenotype detected
MGI:1856656	Rab27a<ash>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000371,diluted coat color|MP:0001263,weight loss|MP:0001505,hunched posture|MP:0002075,abnormal coat/hair pigmentation|MP:0002095,abnormal skin pigmentation|MP:0002875,decreased erythrocyte cell number|MP:0002877,abnormal melanocyte morphology|MP:0003179,thrombocytopenia|MP:0003798,abnormal Harderian gland pigmentation|MP:0004721,abnormal platelet dense granule morphology|MP:0004725,decreased platelet serotonin level|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005152,pancytopenia|MP:0005202,lethargy|MP:0005343,increased circulating aspartate transaminase level|MP:0005387,immune system phenotype|MP:0005391,vision/eye phenotype|MP:0005534,decreased body temperature|MP:0005606,increased bleeding time|MP:0008546,abnormal vesicle-mediated transport|MP:0008553,increased circulating tumor necrosis factor level|MP:0008577,increased circulating interferon-gamma level|MP:0008596,increased circulating interleukin-6 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008790,abnormal NK cell degranulation|MP:0008791,decreased NK cell degranulation|MP:0008834,abnormal melanosome transport|MP:0009446,abnormal platelet dense granule physiology|MP:0009448,decreased platelet ATP level|MP:0009549,decreased platelet aggregation|MP:0009557,decreased platelet ADP level|MP:0010771,integument phenotype|MP:0011971,increased circulating lactate dehydrogenase level|MP:0020432,decreased platelet dense granule number|MP:0020913,increased susceptibility to Riboviria infection
MGI:2388568	Rab27a<ash-N>	MP:0000371,diluted coat color|MP:0002075,abnormal coat/hair pigmentation|MP:0005384,cellular phenotype
MGI:3689096	Rab27a<cct>	MP:0002463,abnormal neutrophil physiology|MP:0005387,immune system phenotype|MP:0005408,hypopigmentation
MGI:6361224	Rab27a<em1(IMPC)Bay>	MP:0001513,limb grasping|MP:0002075,abnormal coat/hair pigmentation
MGI:5563433	Rab27a<m1Anu>	MP:0002075,abnormal coat/hair pigmentation
MGI:5640752	Rab27a<m2Btlr>	MP:0000371,diluted coat color
MGI:5775010	Rab27a<m3Btlr>	MP:0000371,diluted coat color
MGI:3706986	Rab27b<tm1.2Seab>	MP:0002551,abnormal blood coagulation|MP:0004725,decreased platelet serotonin level|MP:0009446,abnormal platelet dense granule physiology|MP:0009549,decreased platelet aggregation|MP:0020432,decreased platelet dense granule number
MGI:5502310	Rab27b<tm1b(KOMP)Wtsi>	MP:0011396,abnormal sleep behavior
MGI:3834149	Rab27b<tm1Tiz>	MP:0002169,no abnormal phenotype detected
MGI:6195850	Rab28<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001529,abnormal vocalization|MP:0001552,increased circulating triglyceride level|MP:0002075,abnormal coat/hair pigmentation|MP:0002834,decreased heart weight|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005567,decreased circulating total protein level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:6360453	Rab28<tm1d(EUCOMM)Hmgu>	MP:0001006,abnormal retina cone cell morphology|MP:0005103,abnormal retina pigmentation|MP:0008444,retina cone cell degeneration|MP:0008449,abnormal retina cone cell outer segment morphology|MP:0008587,short photoreceptor outer segment|MP:0011997,abnormal retina outer nuclear layer thickness|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0014332,long retina cone cell outer segment|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:6360451	Rab28<tm1d(EUCOMM)Wtsi>	MP:0001006,abnormal retina cone cell morphology|MP:0005103,abnormal retina pigmentation|MP:0008444,retina cone cell degeneration|MP:0008449,abnormal retina cone cell outer segment morphology|MP:0008587,short photoreceptor outer segment|MP:0011997,abnormal retina outer nuclear layer thickness|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0014332,long retina cone cell outer segment|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:6825753	Rab29<tm1b(EUCOMM)Wtsi>	MP:0005060,accumulation of giant lysosomes in kidney/renal tubule cells|MP:0008546,abnormal vesicle-mediated transport|MP:0030949,abnormal Golgi vesicle transport
MGI:6157330	Rab2a<em2(IMPC)Tcp>	MP:0001697,abnormal embryo size|MP:0002060,abnormal skin morphology|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0004952,increased spleen weight|MP:0005561,increased mean corpuscular hemoglobin|MP:0010067,increased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance
MGI:8210472	Rab30<em1.1Mwol>	MP:0002644,decreased circulating triglyceride level
MGI:8210453	Rab30<em1Mwol>	MP:0001260,increased body weight|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005559,increased circulating glucose level
MGI:6294099	Rab31<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:5692679	Rab32<tm1b(KOMP)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0003917,increased kidney weight|MP:0009709,hydrometra|MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6393526	Rab32<tm1c(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0002412,increased susceptibility to bacterial infection|MP:0003009,abnormal cytokine secretion|MP:0005397,hematopoietic system phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0013298,increased susceptibility to colitis induced morbidity/mortality|MP:0013956,decreased colon length
MGI:6369353	Rab33a<em1(IMPC)H>	MP:0002965,increased circulating serum albumin level
MGI:6324683	Rab33b<em1(IMPC)J>	MP:0003896,prolonged PR interval|MP:0005179,decreased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level
MGI:7516354	Rab33b<em1Rmr>	MP:0000559,abnormal femur morphology|MP:0001262,decreased body weight|MP:0004148,increased compact bone thickness|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0004993,decreased bone resorption|MP:0008396,abnormal osteoclast differentiation|MP:0009347,increased trabecular bone thickness|MP:0013615,increased volumetric bone mineral density|MP:0013623,increased femur compact bone thickness|MP:0013625,increased femur yield load|MP:0013637,increased femur stiffness|MP:0021191,increased bone mineral density of lumbar vertebrae
MGI:5520180	Rab34<tm1b(EUCOMM)Hmgu>	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0001293,anophthalmia|MP:0001785,edema|MP:0002109,abnormal limb morphology|MP:0002833,increased heart weight|MP:0003385,abnormal body wall morphology|MP:0003743,abnormal facial morphology|MP:0005650,abnormal limb bud morphology|MP:0008797,facial cleft|MP:0011100,preweaning lethality, complete penetrance
MGI:6467522	Rab35<tm1.1Vha>	MP:0010768,mortality/aging|MP:0011731,decreased myelin sheath thickness|MP:0012674,tomacula|MP:0020434,increased astrocyte size
MGI:5548685	Rab35<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0011100,preweaning lethality, complete penetrance
MGI:5507834	Rab36<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000432,abnormal head morphology|MP:0002833,increased heart weight|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005419,decreased circulating serum albumin level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005566,decreased blood urea nitrogen level
MGI:7447468	Rab37<tm1Hsliu>	MP:0001559,hyperglycemia|MP:0003059,decreased insulin secretion
MGI:1856819	Rab38<cht>	MP:0001324,abnormal eye pigmentation|MP:0001942,abnormal lung volume|MP:0002075,abnormal coat/hair pigmentation|MP:0002095,abnormal skin pigmentation|MP:0002275,abnormal type II pneumocyte morphology|MP:0004382,abnormal hair follicle melanogenesis|MP:0004780,abnormal surfactant secretion|MP:0005075,abnormal melanosome morphology|MP:0005102,abnormal iris pigmentation|MP:0005172,decreased eye pigmentation|MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0010815,enlarged alveolar lamellar bodies|MP:0010856,dilated respiratory conducting tube|MP:0010891,increased alveolar lamellar body number|MP:0010895,increased lung compliance|MP:0010903,abnormal pulmonary alveolus wall morphology|MP:0010908,dilated pulmonary alveolar duct|MP:0010911,abnormal pulmonary acinus morphology
MGI:5430811	Rab38<em1Rkuhn>	MP:0002075,abnormal coat/hair pigmentation
MGI:5544452	Rab38<em4Rkuhn>	MP:0002075,abnormal coat/hair pigmentation
MGI:5497994	Rab38<m1Btlr>	MP:0000371,diluted coat color
MGI:6491324	Rab38<tm1.1Ics>	MP:0000371,diluted coat color|MP:0001179,thick pulmonary interalveolar septum|MP:0010815,enlarged alveolar lamellar bodies|MP:0010911,abnormal pulmonary acinus morphology
MGI:6156477	Rab39b<em1(IMPC)Tcp>	MP:0000470,abnormal stomach morphology|MP:0000598,abnormal liver morphology|MP:0000745,tremors|MP:0001127,small ovary|MP:0002060,abnormal skin morphology|MP:0002834,decreased heart weight|MP:0004738,abnormal auditory brainstem response|MP:0004953,decreased spleen weight|MP:0005343,increased circulating aspartate transaminase level|MP:0009709,hydrometra|MP:0011874,enlarged urinary bladder|MP:0013278,decreased fasting circulating glucose level|MP:0020420,abnormal freezing behavior
MGI:6695910	Rab39b<em1Jfch>	MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0002176,increased brain weight|MP:0002804,abnormal motor learning|MP:0005238,increased brain size|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging|MP:0020395,abnormal response to social novelty|MP:0020593,increased cerebral cortex cell number
MGI:7547217	Rab39b<tm1Pdad>	MP:0008428,abnormal spatial working memory|MP:0009456,impaired cued conditioning behavior|MP:0009936,abnormal dendritic spine morphology|MP:0020507,increased dendritic spine density|MP:0021111,decreased social investigation
MGI:2388806	Rab3a<Ebd>	MP:0020470,shortened circadian behavior period
MGI:1857240	Rab3a<tm1Sud>	MP:0002916,increased synaptic depression|MP:0020470,shortened circadian behavior period
MGI:3615355	Rab3b<tm1Sud>	MP:0002169,no abnormal phenotype detected
MGI:5635270	Rab3c<tm1b(EUCOMM)Wtsi>	MP:0001516,abnormal motor coordination/balance|MP:0003131,increased erythrocyte cell number
MGI:3615356	Rab3c<tm1Sud>	MP:0002169,no abnormal phenotype detected
MGI:2669989	Rab3d<tm1Rja>	MP:0002169,no abnormal phenotype detected
MGI:6294152	Rab3gap1<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001417,decreased exploration in new environment|MP:0002968,increased circulating alkaline phosphatase level|MP:0005562,decreased mean corpuscular hemoglobin
MGI:3654149	Rab3gap1<tm1Tkss>	MP:0002910,abnormal excitatory postsynaptic currents|MP:0002919,enhanced paired-pulse facilitation|MP:0005445,abnormal neurotransmitter secretion
MGI:5629315	Rab3gap2<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000208,decreased hematocrit|MP:0000443,abnormal snout morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0001399,hyperactivity|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0005287,narrow eye opening|MP:0005333,decreased heart rate|MP:0005344,increased circulating bilirubin level|MP:0008259,abnormal optic disk morphology|MP:0010506,prolonged RR interval
MGI:7367264	Rab3il1<em1(IMPC)J>	MP:0001284,absent vibrissae|MP:0001488,increased startle reflex|MP:0002591,decreased mean corpuscular volume|MP:0003131,increased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin
MGI:3047686	Rab3ip<Gt(pPAT)1Sia>	MP:0002169,no abnormal phenotype detected
MGI:5500804	Rab3ip<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0001417,decreased exploration in new environment|MP:0002590,increased mean corpuscular volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0005561,increased mean corpuscular hemoglobin|MP:0010124,decreased bone mineral content
MGI:5790205	Rab40b<em1(IMPC)J>	MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:5521537	Rab40c<tm1b(KOMP)Wtsi>	MP:0002080,prenatal lethality|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005633,increased circulating sodium level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5494988	Rab43<tm1.1(KOMP)Vlcg>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005561,increased mean corpuscular hemoglobin
MGI:5807220	Rab43<tm1.2Kmm>	MP:0002455,abnormal dendritic cell antigen presentation
MGI:6695900	Rab44<em1Rbrc>	MP:0002423,abnormal mast cell physiology|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0020523,decreased susceptibility to induced hypothermia|MP:0030759,decreased circulating histamine level
MGI:5636897	Rab4a<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0005333,decreased heart rate|MP:0005554,decreased circulating creatinine level|MP:0010506,prolonged RR interval
MGI:5795836	Rab4b<em1(IMPC)J>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005553,increased circulating creatinine level
MGI:5475013	Rab5a<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001325,abnormal retina morphology|MP:0002591,decreased mean corpuscular volume|MP:0002833,increased heart weight|MP:0003131,increased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005627,increased circulating potassium level|MP:0005633,increased circulating sodium level|MP:0010053,decreased grip strength|MP:0011396,abnormal sleep behavior
MGI:5817196	Rab5b<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0002574,increased vertical activity
MGI:4432624	Rab5c<tm1a(EUCOMM)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005179,decreased circulating cholesterol level|MP:0005568,increased circulating total protein level|MP:0010087,increased circulating fructosamine level|MP:0011100,preweaning lethality, complete penetrance
MGI:5912015	Rab6a<tm1.2Ics>	MP:0003886,abnormal embryonic epiblast morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0014134,abnormal embryo morphology
MGI:5755647	Rab6b<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0004924,abnormal behavior|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0020870,decreased thigmotaxis
MGI:3529990	Rab6b<Gt(OST68543)Lex>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0004924,abnormal behavior|MP:0005387,immune system phenotype|MP:0010025,decreased total body fat amount
MGI:6888140	Rab7b<tm1Ciphe>	MP:0005058,abnormal lysosome morphology|MP:0020349,abnormal dendritic cell migration
MGI:7387060	Rab7<em2Rwb>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0003172,abnormal lysosome physiology|MP:0005058,abnormal lysosome morphology|MP:0006036,abnormal mitochondrial physiology|MP:0014345,abnormal neuron mitochondrial morphology|MP:0020954,decreased mechanical nociceptive threshold
MGI:5469733	Rab7<tm1.1Ale>	MP:0002169,no abnormal phenotype detected|MP:0002444,abnormal T cell physiology|MP:0003674,oxidative stress|MP:0003944,abnormal T cell subpopulation ratio|MP:0005018,decreased T cell number|MP:0005095,decreased T cell proliferation|MP:0008037,abnormal T cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008260,abnormal autophagy|MP:0011630,increased mitochondrial size
MGI:5779674	Rab7<tm1.2Ale>	MP:0008762,embryonic lethality|MP:0010831,lethality, incomplete penetrance
MGI:5437841	Rab7<tm1.2Ywd>	MP:0001696,failure to gastrulate|MP:0011186,abnormal visceral endoderm morphology|MP:0012685,abnormal primitive streak elongation
MGI:5905648	Rab8a<em1(IMPC)J>	MP:0003961,decreased lean body mass|MP:0010052,increased grip strength
MGI:3719352	Rab8a<tm1.1Aha>	MP:0002083,premature death
MGI:3719354	Rab8a<tm1.2Aha>	MP:0000496,abnormal small intestine morphology|MP:0001666,abnormal intestinal absorption|MP:0002083,premature death|MP:0005036,diarrhea|MP:0005060,accumulation of giant lysosomes in kidney/renal tubule cells|MP:0005150,cachexia|MP:0008141,decreased small intestinal microvillus size
MGI:3719350	Rab8a<tm1Aha>	MP:0000496,abnormal small intestine morphology|MP:0001666,abnormal intestinal absorption|MP:0002083,premature death|MP:0005036,diarrhea|MP:0005060,accumulation of giant lysosomes in kidney/renal tubule cells|MP:0005150,cachexia|MP:0008141,decreased small intestinal microvillus size
MGI:5578141	Rab8b<tm1.2Aha>	MP:0002169,no abnormal phenotype detected
MGI:4337269	Rab9<Gt(W255D06)Wrst>	MP:0002169,no abnormal phenotype detected
MGI:5635277	Rabac1<tm1.1(KOMP)Vlcg>	MP:0001303,abnormal lens morphology|MP:0011396,abnormal sleep behavior
MGI:7408531	Rabep2<em1Dmar>	MP:0006060,increased cerebral infarct size
MGI:3530043	Rabgap1l<Gt(PT1-ATG)1Ber>	MP:0002169,no abnormal phenotype detected
MGI:6120783	Rabgap1<tm1b(EUCOMM)Hmgu>	MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0001147,small testis|MP:0001289,persistence of hyaloid vascular system|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001891,hydrocephaly|MP:0002764,short tibia|MP:0002792,abnormal retina vasculature morphology|MP:0005292,improved glucose tolerance|MP:0005567,decreased circulating total protein level|MP:0008259,abnormal optic disk morphology|MP:0008528,polycystic kidney|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0010097,abnormal retina blood vessel morphology|MP:0011874,enlarged urinary bladder|MP:0011886,increased circulating lipase level|MP:0011965,decreased total retina thickness|MP:0013436,increased CD8-positive, naive alpha-beta T cell number|MP:0013771,decreased effector memory T-helper cell number
MGI:3051384	Rabgef1<tm1Glli>	MP:0000359,abnormal mast cell morphology|MP:0001216,abnormal epidermal layer morphology|MP:0001222,epidermal hyperplasia|MP:0001243,abnormal dermal layer morphology|MP:0001845,abnormal inflammatory response|MP:0002497,increased IgE level|MP:0002499,chronic inflammation|MP:0002655,abnormal keratinocyte morphology|MP:0008560,increased tumor necrosis factor secretion|MP:0008705,increased interleukin-6 secretion|MP:0011086,postnatal lethality, incomplete penetrance|MP:0030758,increased circulating histamine level|MP:0031395,cutaneous mastocytosis
MGI:3051238	Rabgef1<tm2Glli>	MP:0008560,increased tumor necrosis factor secretion|MP:0008705,increased interleukin-6 secretion|MP:0011087,neonatal lethality, complete penetrance
MGI:1856886	Rabggta<gm>	MP:0000229,abnormal megakaryocyte differentiation|MP:0000371,diluted coat color|MP:0001186,pigmentation phenotype|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0002599,increased mean platelet volume|MP:0003179,thrombocytopenia|MP:0004725,decreased platelet serotonin level|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005606,increased bleeding time|MP:0014060,abnormal platelet alpha-granule morphology|MP:0020432,decreased platelet dense granule number|MP:0031165,increased circulating von Willebrand factor level
MGI:5766259	Rabggta<tm1.1(KOMP)Vlcg>	MP:0000222,decreased neutrophil cell number|MP:0005564,increased hemoglobin content
MGI:5469381	Rabl2<mot>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0009239,short sperm flagellum
MGI:5548568	Rabl2<tm1.1(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000572,abnormal autopod morphology|MP:0000579,abnormal nail morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001488,increased startle reflex|MP:0001926,female infertility|MP:0002079,increased circulating insulin level|MP:0002110,abnormal digit morphology|MP:0002175,decreased brain weight|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0006203,eye hemorrhage|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:6441477	Rabl3<em1Btlr>	MP:0011092,embryonic lethality, complete penetrance
MGI:6441472	Rabl3<xm>	MP:0006387,abnormal T cell number|MP:0008037,abnormal T cell morphology
MGI:5548811	Rabl6<tm1b(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0003960,increased lean body mass|MP:0010123,increased bone mineral content
MGI:6276963	Rac1<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001399,hyperactivity|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0002989,small kidney|MP:0003131,increased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2663669	Rac1<tm1.1Djk>	MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:3665172	Rac1<tm1Brak>	MP:0000367,abnormal coat/ hair morphology|MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000652,enlarged sebaceous gland|MP:0001191,abnormal skin condition|MP:0002095,abnormal skin pigmentation|MP:0003453,abnormal keratinocyte physiology|MP:0003809,abnormal hair shaft morphology|MP:0005389,reproductive system phenotype|MP:0005501,abnormal skin physiology
MGI:2663662	Rac1<tm1Djk>	MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000273,overriding aortic valve|MP:0000281,abnormal interventricular septum morphology|MP:0000284,double outlet right ventricle|MP:0000295,trabecula carnea hypoplasia|MP:0000377,abnormal hair follicle morphology|MP:0000427,abnormal hair cycle|MP:0000652,enlarged sebaceous gland|MP:0001213,abnormal skin cell number|MP:0001216,abnormal epidermal layer morphology|MP:0001231,abnormal epidermis stratum basale morphology|MP:0003453,abnormal keratinocyte physiology|MP:0003566,abnormal cell adhesion|MP:0003920,abnormal heart right ventricle morphology|MP:0004032,abnormal interventricular groove morphology|MP:0004056,abnormal myocardium compact layer morphology|MP:0004057,thin myocardium compact layer|MP:0004067,abnormal trabecula carnea morphology|MP:0006042,increased apoptosis|MP:0006126,abnormal cardiac outflow tract development|MP:0006298,abnormal platelet activation|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0009549,decreased platelet aggregation|MP:0009759,abnormal hair follicle bulge morphology|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010499,abnormal ventricle myocardium morphology|MP:0010556,thin ventricle myocardium compact layer|MP:0010682,abnormal hair follicle infundibulum morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0012515,abnormal heart apex morphology|MP:0013377,abnormal sebocyte number|MP:0030919,absent hair follicle bulb|MP:0031526,thin right ventricle myocardium compact layer
MGI:1857700	Rac1<tm1Jms>	MP:0001674,abnormal germ layer development|MP:0001683,absent mesoderm|MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0003885,abnormal rostral-caudal body axis extension|MP:0003886,abnormal embryonic epiblast morphology|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0006042,increased apoptosis|MP:0006386,absent somites|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011190,thick embryonic epiblast
MGI:2684419	Rac1<tm1Tyb>	MP:0005387,immune system phenotype
MGI:2684421	Rac1<tm2Tyb>	MP:0001730,embryonic growth arrest|MP:0002230,abnormal primitive streak formation|MP:0011092,embryonic lethality, complete penetrance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011255,abnormal anterior visceral endoderm cell migration|MP:0012135,embryonic-extraembryonic boundary constriction
MGI:6158519	Rac2<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology
MGI:6473850	Rac2<em1Shl>	MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0003674,oxidative stress|MP:0005016,decreased lymphocyte cell number|MP:0005018,decreased T cell number|MP:0005065,abnormal neutrophil morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0012765,decreased alpha-beta T cell number
MGI:5640784	Rac2<m1Btlr>	MP:0001806,decreased IgM level|MP:0020154,impaired humoral immune response
MGI:5775009	Rac2<M2Btlr>	MP:0004978,decreased B-1 B cell number|MP:0008168,decreased B-1a cell number|MP:0008169,increased B-1b cell number
MGI:5806333	Rac2<m3Btlr>	MP:0000219,increased neutrophil cell number|MP:0001606,impaired hematopoiesis|MP:0001806,decreased IgM level|MP:0004977,increased B-1 B cell number|MP:0005017,decreased B cell number|MP:0008168,decreased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0020001,decreased response to antigen
MGI:6114684	Rac2<M4Btlr>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002492,decreased IgE level|MP:0002494,increased IgM level|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005078,abnormal cytotoxic T cell physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0012764,increased alpha-beta T cell number|MP:0012765,decreased alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0020154,impaired humoral immune response
MGI:6114713	Rac2<M5Btlr>	MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008168,decreased B-1a cell number|MP:0008169,increased B-1b cell number
MGI:1857701	Rac2<tm1Mddw>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0002908,delayed wound healing|MP:0005023,abnormal wound healing|MP:0005095,decreased T cell proliferation|MP:0005602,decreased angiogenesis|MP:0008111,abnormal granulocyte differentiation|MP:0008720,impaired neutrophil chemotaxis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0020316,decreased vascular endothelial cell proliferation
MGI:3512107	Rac3<tm1Hkp>	MP:0005397,hematopoietic system phenotype
MGI:3581887	Rac3<tm1Idc>	MP:0001407,short stride length|MP:0001973,increased thermal nociceptive threshold|MP:0002804,abnormal motor learning|MP:0003631,nervous system phenotype
MGI:2674133	Racgap1<Gt(pSABetageo)11Huy>	MP:0003406,failure of zygotic cell division|MP:0004957,abnormal blastocyst morphology|MP:0004964,absent inner cell mass|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3803293	Racgap1<tm1Mahi>	MP:0000333,decreased bone marrow cell number|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001601,abnormal myelopoiesis|MP:0001925,male infertility|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002144,abnormal B cell differentiation|MP:0002216,abnormal seminiferous tubule morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002685,abnormal spermatogonia proliferation|MP:0002784,abnormal Sertoli cell morphology|MP:0004852,decreased testis weight|MP:0004884,abnormal testis physiology|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0006378,abnormal spermatogonia morphology|MP:0008190,decreased transitional stage B cell number|MP:0008208,decreased pro-B cell number|MP:0014617,decreased spermatogonia number|MP:0020550,multinucleated giant male germ cells
MGI:5660834	Rack1<tm1Sbif>	MP:0000373,belly spot|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001672,abnormal embryo development|MP:0001694,absent egg cylinders|MP:0001732,postnatal growth retardation|MP:0005175,non-pigmented tail tip|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011277,decreased tail pigmentation|MP:0011568,decreased foot pigmentation|MP:0013272,abnormal translation
MGI:3056344	Rad17<tm1Maas>	MP:0000266,abnormal heart morphology|MP:0000598,abnormal liver morphology|MP:0001689,incomplete somite formation|MP:0001914,hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4433190	Rad18<tm1a(EUCOMM)Wtsi>	MP:0000367,abnormal coat/ hair morphology|MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0002074,abnormal hair texture|MP:0002590,increased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008866,chromosomal instability|MP:0008963,increased carbon dioxide production|MP:0010025,decreased total body fat amount|MP:0010679,abnormal arrector pilli muscle morphology
MGI:3835812	Rad18<tm1Stat>	MP:0001154,seminiferous tubule degeneration|MP:0001922,reduced male fertility|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0006378,abnormal spermatogonia morphology
MGI:4941376	Rad1<tm1.1Jcbs>	MP:0005387,immune system phenotype
MGI:5605756	Rad1<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001303,abnormal lens morphology|MP:0001700,abnormal embryo turning|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0003795,abnormal bone structure|MP:0004151,decreased circulating iron level|MP:0005344,increased circulating bilirubin level|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5292341	Rad21l<tm1Amp>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002682,decreased mature ovarian follicle number|MP:0004833,ovary atrophy|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0005431,decreased oocyte number|MP:0008261,arrest of male meiosis|MP:0008280,abnormal male germ cell apoptosis|MP:0009452,abnormal synaptonemal complex|MP:0010207,abnormal telomere morphology|MP:0010948,abnormal double-strand DNA break repair|MP:0011122,absent primordial ovarian follicles|MP:0013607,ovary fibrosis
MGI:5448653	Rad21l<tm1b(KOMP)Wtsi>	MP:0001925,male infertility|MP:0003020,decreased circulating chloride level|MP:0005384,cellular phenotype|MP:0005560,decreased circulating glucose level
MGI:5615691	Rad21l<tm1Yow>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001930,abnormal meiosis|MP:0002777,absent ovarian follicles|MP:0004805,absent oocytes|MP:0004852,decreased testis weight|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis|MP:0009451,abnormal chromosomal synapsis|MP:0009452,abnormal synaptonemal complex
MGI:4840469	Rad21<tm1.1Kktk>	MP:0001922,reduced male fertility|MP:0005168,abnormal female meiosis|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5293824	Rad21<tm1.1Mmk>	MP:0002145,abnormal T cell differentiation|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0005092,decreased double-positive T cell number|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:4840471	Rad21<tm2.1Kktk>	MP:0011101,prenatal lethality, incomplete penetrance
MGI:3797600	Rad23a<tm1(HBB)Laat>	MP:0002169,no abnormal phenotype detected
MGI:2668469	Rad23a<tm1Jhjh>	MP:0002169,no abnormal phenotype detected
MGI:3797601	Rad23a<tm2(HBB)Laat>	MP:0002169,no abnormal phenotype detected
MGI:2179121	Rad23b<tm1Gvh>	MP:0000493,rectal prolapse|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001199,thin skin|MP:0001302,eyelids open at birth|MP:0001349,excessive tearing|MP:0001394,circling|MP:0001412,excessive scratching|MP:0001622,abnormal vasculogenesis|MP:0001711,abnormal placenta morphology|MP:0001852,conjunctivitis|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0002574,increased vertical activity|MP:0002784,abnormal Sertoli cell morphology|MP:0003868,abnormal feces composition|MP:0004201,fetal growth retardation|MP:0005031,abnormal trophoblast layer morphology|MP:0005034,abnormal anus morphology|MP:0005170,cleft upper lip|MP:0005251,blepharitis|MP:0006167,eyelid edema|MP:0009703,decreased birth body size|MP:0009859,eye opacity|MP:0009890,cleft secondary palate|MP:0010025,decreased total body fat amount|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3527268	Rad50<tm1Flv>	MP:0005466,abnormal T-helper 2 physiology|MP:0008673,decreased interleukin-13 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion
MGI:2387852	Rad50<tm1Jpt>	MP:0000352,decreased cell proliferation|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002084,abnormal developmental patterning|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4837633	Rad50<tm2.1Flv>	MP:0008673,decreased interleukin-13 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion
MGI:4837634	Rad50<tm2.2Flv>	MP:0011091,prenatal lethality, complete penetrance
MGI:2387857	Rad50<tm2Jpt>	MP:0000175,absent bone marrow cell|MP:0000689,abnormal spleen morphology|MP:0000693,spleen hyperplasia|MP:0000703,abnormal thymus morphology|MP:0000716,abnormal immune system cell morphology|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0002024,increased T cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002722,abnormal immune system organ morphology|MP:0003134,increased late pro-B cell number|MP:0003179,thrombocytopenia|MP:0003884,decreased macrophage cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0005152,pancytopenia|MP:0005425,increased macrophage cell number|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008215,decreased immature B cell number|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012431,increased lymphoma incidence
MGI:5514423	Rad50<tm3.1Flv>	MP:0008673,decreased interleukin-13 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion
MGI:5514424	Rad50<tm4.1Flv>	MP:0008672,increased interleukin-13 secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion|MP:0008703,decreased interleukin-5 secretion
MGI:5614069	Rad50<tm4.1Jpt>	MP:0000575,increased foot pad pigmentation|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001606,impaired hematopoiesis|MP:0001891,hydrocephaly|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001929,abnormal gametogenesis|MP:0001935,decreased litter size|MP:0002161,abnormal fertility/fecundity|MP:0002216,abnormal seminiferous tubule morphology|MP:0002673,abnormal sperm number|MP:0003205,testicular atrophy|MP:0003324,increased liver adenoma incidence|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004833,ovary atrophy|MP:0008019,increased liver tumor incidence|MP:0010054,increased hepatoblastoma incidence|MP:0011276,increased tail pigmentation|MP:0030926,increased skin pigmentation
MGI:5614068	Rad50<tm4Jpt>	MP:0001891,hydrocephaly|MP:0003324,increased liver adenoma incidence|MP:0008019,increased liver tumor incidence
MGI:5614071	Rad50<tm5Jpt>	MP:0011091,prenatal lethality, complete penetrance
MGI:5635282	Rad51ap1<tm1.1(KOMP)Vlcg>	MP:0001289,persistence of hyaloid vascular system|MP:0001489,decreased startle reflex|MP:0005560,decreased circulating glucose level
MGI:6888019	Rad51ap2<em1Qsh>	MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0011751,abnormal X-Y chromosome synapsis during male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:6888020	Rad51ap2<em2Qsh>	MP:0011751,abnormal X-Y chromosome synapsis during male meiosis
MGI:3621480	Rad51b<tm1Kmic>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4461202	Rad51c<tm1.1Bcg>	MP:0001698,decreased embryo size|MP:0011092,embryonic lethality, complete penetrance
MGI:3707425	Rad51c<tm1.1Sks>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4461206	Rad51c<tm1Bcg>	MP:0011100,preweaning lethality, complete penetrance
MGI:3707422	Rad51c<tm1Sks>	MP:0004852,decreased testis weight
MGI:2386281	Rad51d<tm1Jcs>	MP:0001700,abnormal embryo turning|MP:0001787,pericardial edema|MP:0002084,abnormal developmental patterning|MP:0002151,abnormal neural tube morphology|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0005650,abnormal limb bud morphology|MP:0008405,decreased cellular sensitivity to methylmethanesulfonate induced cell death|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7310230	Rad51<tm1Csha>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002776,increased Sertoli cell number|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005169,abnormal male meiosis|MP:0006379,abnormal spermatocyte morphology|MP:0014052,increased male germ cell apoptosis|MP:0014619,absent spermatogonia|MP:0014764,impaired double-strand DNA break repair
MGI:1857587	Rad51<tm1Hst>	MP:0000352,decreased cell proliferation|MP:0001683,absent mesoderm|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002085,abnormal embryonic tissue morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011191,increased embryonic epiblast cell apoptosis|MP:0012114,absent inner cell mass proliferation|MP:0012142,absent amniotic cavity
MGI:2179218	Rad51<tm1Tkm>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2383953	Rad52<tm1Aps>	MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype
MGI:3617695	Rad54b<tm1Roka>	MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:6414504	Rad54l2<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0001713,decreased trophoblast giant cell number|MP:0001727,abnormal embryo implantation|MP:0002060,abnormal skin morphology|MP:0005505,thrombocytosis|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:3712952	Rad54l2<Gt(A016E03)Oaj>	MP:0000352,decreased cell proliferation|MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0002151,abnormal neural tube morphology|MP:0003984,embryonic growth retardation|MP:0006042,increased apoptosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0012505,increased neural tube apoptosis|MP:0012706,decreased embryonic neuroepithelial cell proliferation|MP:0013501,increased fibroblast apoptosis
MGI:5819211	Rad54l<em1Murr>	MP:0012121,sclerocornea
MGI:2183934	Rad54l<tm1Jhjh>	MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002123,abnormal definitive hematopoiesis|MP:0003702,abnormal chromosome morphology|MP:0005387,immune system phenotype|MP:0005621,abnormal cell physiology|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:5636951	Rad9a<tm1.1(KOMP)Wtsi>	MP:0000266,abnormal heart morphology|MP:0001614,abnormal blood vessel morphology|MP:0001672,abnormal embryo development|MP:0001691,abnormal somite shape|MP:0001697,abnormal embryo size|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001718,abnormal visceral yolk sac morphology|MP:0001722,pale yolk sac|MP:0002085,abnormal embryonic tissue morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0002884,abnormal pharyngeal arch morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0003717,pallor|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0004251,failure of heart looping|MP:0006108,abnormal hindbrain development|MP:0008762,embryonic lethality|MP:0011100,preweaning lethality, complete penetrance|MP:0011256,abnormal neural fold morphology|MP:0011960,abnormal eye anterior chamber depth|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3052710	Rad9a<tm1Lieb>	MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3809875	Rad9a<tm2Lieb>	MP:0002051,increased skin papilloma incidence|MP:0002095,abnormal skin pigmentation|MP:0003077,abnormal cell cycle|MP:0006042,increased apoptosis|MP:0010948,abnormal double-strand DNA break repair
MGI:3526236	Rad9b<tm1Lieb>	MP:0000929,open neural tube|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0003232,abnormal forebrain development|MP:0003984,embryonic growth retardation|MP:0005384,cellular phenotype|MP:0008008,early cellular replicative senescence|MP:0008943,increased sensitivity to induced cell death|MP:0009768,impaired somite development|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5755070	Radil<em1(IMPC)Tcp>	MP:0000689,abnormal spleen morphology|MP:0001417,decreased exploration in new environment
MGI:2159709	Radpf1<C57BL/6J>	MP:0006050,pulmonary fibrosis
MGI:2664770	Radpf2<C57BL/6J>	MP:0006050,pulmonary fibrosis
MGI:2664773	Radpf3<C3H/Kam>	MP:0006050,pulmonary fibrosis
MGI:2664776	Radpf4<C57BL/6J>	MP:0006050,pulmonary fibrosis
MGI:3717170	Radsvq1<C57BL/6JNrs>	MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death
MGI:3619246	Rae1<tm1Jvd>	MP:0004024,aneuploidy|MP:0004045,abnormal cell cycle checkpoint function|MP:0004046,abnormal mitosis|MP:0004499,increased incidence of tumors by chemical induction|MP:0004965,inner cell mass degeneration|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5287038	Raf1<TgTn(sb-cHS4,Tyr)2526AOve>	MP:0006207,embryonic lethality during organogenesis
MGI:5003364	Raf1<tm1.1Bgn>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000441,increased cranium width|MP:0000447,flattened snout|MP:0000691,enlarged spleen|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001300,ocular hypertelorism|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0003141,cardiac fibrosis|MP:0003394,increased cardiac output|MP:0003743,abnormal facial morphology|MP:0003820,increased left ventricle systolic pressure|MP:0003921,abnormal heart left ventricle morphology|MP:0004485,increased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005385,cardiovascular system phenotype|MP:0005599,increased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008525,decreased cranium height|MP:0008727,increased heart right atrium size|MP:0008772,increased heart ventricle size|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010579,increased heart left ventricle size|MP:0010724,thick interventricular septum|MP:0010754,abnormal heart left ventricle pressure|MP:0011951,increased cardiac stroke volume
MGI:2388026	Raf1<tm1Bacc>	MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004259,small placenta|MP:0004921,decreased placenta weight|MP:0006042,increased apoptosis|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0008943,increased sensitivity to induced cell death|MP:0008944,decreased sensitivity to induced cell death|MP:0008989,abnormal liver sinusoid morphology|MP:0009429,decreased embryo weight|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012099,decreased spongiotrophoblast size|MP:0012244,increased hepatoblast apoptosis|MP:0013501,increased fibroblast apoptosis
MGI:5548965	Raf1<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0011100,preweaning lethality, complete penetrance
MGI:3040971	Raf1<tm1Ulb>	MP:0000600,liver hypoplasia|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0001622,abnormal vasculogenesis|MP:0001648,abnormal apoptosis|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0001719,absent vitelline blood vessels|MP:0001730,embryonic growth arrest|MP:0001914,hemorrhage|MP:0002080,prenatal lethality
MGI:2429683	Raf1<tm1Zim>	MP:0000292,distended pericardium|MP:0000380,small hair follicles|MP:0000382,underdeveloped hair follicles|MP:0001216,abnormal epidermal layer morphology|MP:0001218,thin epidermis|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001243,abnormal dermal layer morphology|MP:0001244,thin dermal layer|MP:0001302,eyelids open at birth|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0001730,embryonic growth arrest|MP:0001953,respiratory failure|MP:0002151,abnormal neural tube morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003641,small lung|MP:0003984,embryonic growth retardation|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009431,decreased fetal weight|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0021107,retina fold
MGI:5445964	Raf1<tm2.1Ara>	MP:0000274,enlarged heart|MP:0000420,ruffled hair|MP:0000745,tremors|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001505,hunched posture|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0003394,increased cardiac output|MP:0003921,abnormal heart left ventricle morphology|MP:0004564,increased myocardial fiber size|MP:0005397,hematopoietic system phenotype|MP:0005599,increased cardiac muscle contractility|MP:0008526,decreased cranium width|MP:0010031,abnormal cranium size|MP:0011951,increased cardiac stroke volume
MGI:3497907	Raf1<tm2Bacc>	MP:0000274,enlarged heart|MP:0002169,no abnormal phenotype detected|MP:0002652,thin myocardium|MP:0002753,dilated heart left ventricle|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0005140,decreased cardiac muscle contractility|MP:0006042,increased apoptosis|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3040973	Raf1<tm2Ulb>	MP:0002169,no abnormal phenotype detected
MGI:3817448	Raf1<tm3Ulb>	MP:0000352,decreased cell proliferation|MP:0003984,embryonic growth retardation|MP:0008943,increased sensitivity to induced cell death|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3606902	Rafar2<C57BL/6NClr>	MP:0000550,abnormal forelimb morphology
MGI:3580539	Rafar<C57BL/6NClr>	MP:0000550,abnormal forelimb morphology
MGI:4819232	Rag1<coln>	MP:0008070,absent T cells|MP:0008071,absent B cells
MGI:7428606	Rag1<em2Mvw>	MP:0001802,arrested B cell differentiation|MP:0001825,arrested T cell differentiation|MP:0008070,absent T cells|MP:0008071,absent B cells
MGI:7612089	Rag1<em3Mvw>	MP:0001802,arrested B cell differentiation|MP:0001825,arrested T cell differentiation|MP:0008070,absent T cells|MP:0008071,absent B cells
MGI:5563427	Rag1<m1Anu>	MP:0005016,decreased lymphocyte cell number
MGI:3851764	Rag1<m1Btlr>	MP:0005434,absent late pro-B cells|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:5429068	Rag1<m2Btlr>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0004816,abnormal class switch recombination|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number
MGI:6286258	Rag1<m3Btlr>	MP:0010847,increased central memory CD8 positive, alpha-beta T cell number
MGI:6283875	Rag1<m4Btlr>	MP:0002145,abnormal T cell differentiation|MP:0005017,decreased B cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0012764,increased alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:3720344	Rag1/Rag2<tm1Mnz>	MP:0002407,abnormal double-negative T cell morphology|MP:0002408,abnormal double-positive T cell morphology|MP:0005018,decreased T cell number|MP:0008037,abnormal T cell morphology
MGI:3720345	Rag1/Rag2<tm1Mnz>	MP:0002407,abnormal double-negative T cell morphology|MP:0002408,abnormal double-positive T cell morphology|MP:0005018,decreased T cell number|MP:0008037,abnormal T cell morphology
MGI:4414763	Rag1<tm1.1Sadu>	MP:0001802,arrested B cell differentiation|MP:0005387,immune system phenotype
MGI:3584018	Rag1<tm1(cre)Thr>	MP:0000726,absent lymphocyte|MP:0002401,abnormal lymphopoiesis
MGI:2681693	Rag1<tm1Fwa>	MP:0001823,thymus hypoplasia|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0005017,decreased B cell number|MP:0005090,increased double-negative T cell number
MGI:2388344	Rag1<tm1(GFP)Imku>	MP:0008755,abnormal immunoglobulin V(D)J recombination
MGI:3840831	Rag1<tm1Jsek>	MP:0001802,arrested B cell differentiation|MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002401,abnormal lymphopoiesis|MP:0002490,abnormal immunoglobulin level|MP:0004029,spontaneous chromosome breakage|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008186,increased pro-B cell number|MP:0008212,absent mature B cells|MP:0008213,absent immature B cells|MP:0008347,decreased gamma-delta T cell number|MP:0008754,abnormal T cell receptor V(D)J recombination|MP:0008758,abnormal T cell receptor beta chain V(D)J recombination|MP:0008760,abnormal immunoglobulin heavy chain V(D)J recombination
MGI:1857241	Rag1<tm1Mom>	MP:0000222,decreased neutrophil cell number|MP:0000322,increased granulocyte number|MP:0000694,spleen hypoplasia|MP:0000706,small thymus|MP:0001192,scaly skin|MP:0001194,dermatitis|MP:0001200,thick skin|MP:0001222,epidermal hyperplasia|MP:0001246,mixed cellular infiltration to dermis|MP:0001325,abnormal retina morphology|MP:0001364,decreased anxiety-related response|MP:0001806,decreased IgM level|MP:0001823,thymus hypoplasia|MP:0001844,autoimmune response|MP:0001849,ear inflammation|MP:0001879,abnormal lymphatic vessel morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0002095,abnormal skin pigmentation|MP:0002132,abnormal respiratory system morphology|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002353,abnormal inguinal lymph node morphology|MP:0002407,abnormal double-negative T cell morphology|MP:0002460,decreased immunoglobulin level|MP:0002998,abnormal bone remodeling|MP:0003071,decreased vascular permeability|MP:0003631,nervous system phenotype|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005025,abnormal response to infection|MP:0005042,abnormal level of surface class II molecules|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype|MP:0005425,increased macrophage cell number|MP:0008037,abnormal T cell morphology|MP:0008044,increased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008211,decreased mature B cell number|MP:0008212,absent mature B cells|MP:0008214,increased immature B cell number|MP:0008539,decreased susceptibility to induced colitis|MP:0008754,abnormal T cell receptor V(D)J recombination|MP:0008755,abnormal immunoglobulin V(D)J recombination|MP:0009544,abnormal thymus epithelium morphology|MP:0009967,abnormal neuron proliferation|MP:0012563,increased tumor incidence following infection
MGI:5524145	Rag2<m1Btlr>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0005017,decreased B cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:2654909	Rag2<tm1.1Cgn>	MP:0001802,arrested B cell differentiation|MP:0001825,arrested T cell differentiation
MGI:4941315	Rag2<tm1.1Desi>	MP:0008755,abnormal immunoglobulin V(D)J recombination
MGI:5002798	Rag2<tm1.1Mss>	MP:0002006,neoplasm|MP:0002401,abnormal lymphopoiesis|MP:0002403,abnormal pre-B cell morphology|MP:0008209,decreased pre-B cell number|MP:0010133,increased DN3 thymocyte number
MGI:3713766	Rag2<tm1Avla>	MP:0000414,alopecia|MP:0000462,abnormal digestive system morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000716,abnormal immune system cell morphology|MP:0001802,arrested B cell differentiation|MP:0001805,decreased IgG level|MP:0001807,decreased IgA level|MP:0001825,arrested T cell differentiation|MP:0002217,small lymph nodes|MP:0002339,abnormal lymph node morphology|MP:0002459,abnormal B cell physiology|MP:0002722,abnormal immune system organ morphology|MP:0002816,colitis|MP:0002831,absent Peyer's patches|MP:0003454,erythroderma|MP:0003945,abnormal lymphocyte physiology|MP:0005016,decreased lymphocyte cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0005150,cachexia|MP:0008040,decreased NK T cell number|MP:0008479,decreased spleen white pulp amount|MP:0009540,absent Hassall's corpuscle|MP:0009624,small inguinal lymph nodes|MP:0030011,small cervical lymph nodes
MGI:2654906	Rag2<tm1Cgn>	MP:0002169,no abnormal phenotype detected
MGI:1858556	Rag2<tm1Fwa>	MP:0000322,increased granulocyte number|MP:0000488,abnormal intestinal epithelium morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000689,abnormal spleen morphology|MP:0000694,spleen hypoplasia|MP:0000715,decreased thymocyte number|MP:0001265,decreased body size|MP:0001802,arrested B cell differentiation|MP:0001806,decreased IgM level|MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0001861,lung inflammation|MP:0002406,increased susceptibility to infection|MP:0002412,increased susceptibility to bacterial infection|MP:0002435,abnormal effector T cell morphology|MP:0002451,abnormal macrophage physiology|MP:0002816,colitis|MP:0003080,increased natural killer cell mediated cytotoxicity|MP:0004939,abnormal B cell morphology|MP:0005026,decreased susceptibility to parasitic infection|MP:0005089,decreased double-negative T cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005425,increased macrophage cell number|MP:0005465,abnormal T-helper 1 physiology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0005671,abnormal response to transplant|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008101,lymph node hypoplasia|MP:0008212,absent mature B cells|MP:0008555,abnormal interferon secretion|MP:0008722,abnormal chemokine secretion|MP:0008754,abnormal T cell receptor V(D)J recombination|MP:0008755,abnormal immunoglobulin V(D)J recombination|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0010792,abnormal stomach mucosa morphology
MGI:3700748	Rag2<tm1Libo>	MP:0000223,decreased monocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0002144,abnormal B cell differentiation|MP:0002459,abnormal B cell physiology|MP:0005017,decreased B cell number|MP:0008209,decreased pre-B cell number
MGI:2450735	Rag2<tm1Mao>	MP:0000716,abnormal immune system cell morphology|MP:0001802,arrested B cell differentiation|MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0002458,abnormal B cell number|MP:0005089,decreased double-negative T cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008214,increased immature B cell number|MP:0008215,decreased immature B cell number|MP:0008356,abnormal gamma-delta T cell differentiation
MGI:3687306	Rag2<tm1Tgi>	MP:0000696,abnormal Peyer's patch morphology|MP:0000715,decreased thymocyte number|MP:0001802,arrested B cell differentiation|MP:0001825,arrested T cell differentiation|MP:0005017,decreased B cell number|MP:0005092,decreased double-positive T cell number
MGI:3623131	Rag2<tm2Fwa>	MP:0002169,no abnormal phenotype detected
MGI:5755138	Rai14<em1(IMPC)J>	MP:0001575,cyanosis|MP:0001785,edema|MP:0002590,increased mean corpuscular volume|MP:0003385,abnormal body wall morphology|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3526160	Rai1<tm1Jrl>	MP:0000008,increased white adipose tissue amount|MP:0000102,abnormal nasal bone morphology|MP:0000120,malocclusion|MP:0000160,kyphosis|MP:0000413,polyphalangy|MP:0000443,abnormal snout morphology|MP:0000445,short snout|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001405,impaired coordination|MP:0001433,polyphagia|MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0001745,increased circulating corticosterone level|MP:0002064,seizures|MP:0002114,abnormal axial skeleton morphology|MP:0002260,abnormal thyroid cartilage morphology|MP:0002574,increased vertical activity|MP:0002823,abnormal rib development|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003997,tonic-clonic seizures|MP:0004471,short nasal bone|MP:0004472,broad nasal bone|MP:0004994,abnormal brain wave pattern|MP:0005226,abnormal vertebral arch development|MP:0005669,increased circulating leptin level|MP:0008770,decreased survivor rate|MP:0010701,fusion of atlas and odontoid process|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011939,increased food intake|MP:0014124,increased amylin secretion|MP:0020411,increased abdominal adipose tissue amount|MP:0020467,abnormal circadian behavior|MP:0030189,broad snout
MGI:5816464	Rai1<tm2.1Luo>	MP:0000160,kyphosis|MP:0000182,increased circulating LDL cholesterol level|MP:0001260,increased body weight|MP:0001261,obese|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001433,polyphagia|MP:0001513,limb grasping|MP:0001556,increased circulating HDL cholesterol level|MP:0002062,abnormal associative learning|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0003960,increased lean body mass|MP:0003982,increased cholesterol level|MP:0005145,increased circulating VLDL cholesterol level|MP:0005317,increased triglyceride level|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory|MP:0008908,increased total fat pad weight|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0014142,increased body fat mass
MGI:5817606	Rai1<tm2.2Luo>	MP:0001405,impaired coordination
MGI:6257758	Rai2<em1(IMPC)Bay>	MP:0002764,short tibia|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010579,increased heart left ventricle size|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3871305	Rala<Gt(DD1113)Wtsi>	MP:0000914,exencephaly
MGI:5505277	Rala<tm1.1Cjm>	MP:0000914,exencephaly|MP:0005384,cellular phenotype|MP:0011100,preweaning lethality, complete penetrance
MGI:5505279	Rala<tm1.2Cjm>	MP:0002006,neoplasm|MP:0010768,mortality/aging
MGI:4451975	Rala<tm1a(EUCOMM)Wtsi>	MP:0000026,abnormal inner ear morphology|MP:0000534,abnormal ureter morphology|MP:0000783,abnormal forebrain morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000826,abnormal third ventricle morphology|MP:0000841,abnormal hindbrain morphology|MP:0000914,exencephaly|MP:0001015,small superior cervical ganglion|MP:0001303,abnormal lens morphology|MP:0001917,intraventricular hemorrhage|MP:0002152,abnormal brain morphology|MP:0002947,increased hemangioma incidence|MP:0003686,abnormal eye muscle morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0003827,abnormal Wolffian duct morphology|MP:0004160,retroesophageal right subclavian artery|MP:0004268,abnormal optic stalk morphology|MP:0004613,fusion of vertebral arches|MP:0005262,coloboma|MP:0005296,abnormal humerus morphology|MP:0006054,spinal hemorrhage|MP:0009493,abnormal cystic duct morphology|MP:0009688,abnormal spinal cord central canal morphology|MP:0010420,muscular ventricular septal defect|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011380,enlarged brain ventricles|MP:0011513,abnormal vertebral artery morphology|MP:0013840,absent segment of posterior cerebral artery|MP:0013873,abnormal ductus venosus morphology|MP:0013877,abnormal ductus venosus valve morphology|MP:0013968,multiple persisting craniopharyngeal ducts|MP:0013969,reduced sympathetic cervical ganglion size|MP:0013971,blood in lymph vessels|MP:0013986,abnormal vitelline vein topology|MP:0014000,anastomosis between internal carotid artery and basilar artery|MP:0014001,abnormal vertebral artery topology|MP:0014019,embryo cyst|MP:0014087,retrolental blood
MGI:3530809	Ralbp1<Gt(OST359995)Lex>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0003043,hypoalgesia|MP:0003674,oxidative stress|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:4125518	Ralbp1<Gt(RRC077)Byg>	MP:0001475,reduced long-term depression|MP:0003631,nervous system phenotype
MGI:5505278	Ralb<tm1.1Cjm>	MP:0002169,no abnormal phenotype detected
MGI:5505280	Ralb<tm1.2Cjm>	MP:0010768,mortality/aging
MGI:4433898	Ralb<tm1a(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0004599,abnormal vertebral arch morphology
MGI:6147545	Ralgapa1<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0011100,preweaning lethality, complete penetrance
MGI:6456667	Ralgapa1<tm1.1Schen>	MP:0001260,increased body weight|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002079,increased circulating insulin level|MP:0002106,abnormal muscle physiology|MP:0005178,increased circulating cholesterol level|MP:0005331,insulin resistance|MP:0006094,increased fat cell size|MP:0009355,increased liver triglyceride level|MP:0010024,increased total body fat amount|MP:0010027,increased liver cholesterol level|MP:0013279,increased fasting circulating glucose level|MP:0030022,decreased muscle cell glucose uptake
MGI:6456655	Ralgapa1<tm2c(KOMP)Wtsi>	MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0005178,increased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0030021,increased muscle cell glucose uptake
MGI:5469375	Ralgapa2<tm1Hhor>	MP:0004499,increased incidence of tumors by chemical induction|MP:0010289,increased urinary system tumor incidence
MGI:4363602	Ralgapb<tm1a(KOMP)Wtsi>	MP:0005628,decreased circulating potassium level|MP:0011100,preweaning lethality, complete penetrance
MGI:3574574	Ralgds<tm1Cjm>	MP:0003447,decreased tumor growth/size|MP:0004502,decreased incidence of tumors by chemical induction
MGI:6188291	Ralgps1<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0003179,thrombocytopenia|MP:0005343,increased circulating aspartate transaminase level
MGI:5755074	Raly<em2(IMPC)Tcp>	MP:0001175,abnormal lung morphology|MP:0001552,increased circulating triglyceride level|MP:0001944,abnormal pancreas morphology|MP:0002764,short tibia
MGI:3838882	Raly<Gt(RST374)Byg>	MP:0002006,neoplasm|MP:0002169,no abnormal phenotype detected
MGI:7328450	Ramac<em1(IMPC)J>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0002582,disorganized extraembryonic tissue|MP:0003984,embryonic growth retardation|MP:0010052,increased grip strength|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0014586,decreased egg cylinder size
MGI:3655652	Raml1<C57BL/6J>	MP:0002879,increased cellular sensitivity to X-ray irradiation induced cell death
MGI:3722397	Ramls1<CBA/H>	MP:0004500,increased incidence of tumors by ionizing radiation induction
MGI:3761144	Ramp1<tm1.1Tsuj>	MP:0003009,abnormal cytokine secretion|MP:0005591,decreased vasodilation|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008553,increased circulating tumor necrosis factor level|MP:0008577,increased circulating interferon-gamma level|MP:0008596,increased circulating interleukin-6 level|MP:0008722,abnormal chemokine secretion
MGI:5636992	Ramp1<tm1b(EUCOMM)Wtsi>	MP:0002606,increased basophil cell number|MP:0010053,decreased grip strength|MP:0010068,decreased red blood cell distribution width
MGI:3773019	Ramp2<tm1.1Tash>	MP:0000598,abnormal liver morphology|MP:0001622,abnormal vasculogenesis|MP:0001634,internal hemorrhage|MP:0001785,edema|MP:0002191,abnormal artery morphology|MP:0003070,increased vascular permeability|MP:0003230,abnormal umbilical artery morphology|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003888,liver hemorrhage|MP:0005312,pericardial effusion|MP:0005602,decreased angiogenesis|MP:0006144,increased systemic arterial systolic blood pressure|MP:0010664,abnormal vitelline artery morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011514,skin hemorrhage|MP:0031384,impaired blood-brain barrier function
MGI:3718497	Ramp2<tm1Kmca>	MP:0001785,edema|MP:0001879,abnormal lymphatic vessel morphology|MP:0001935,decreased litter size|MP:0002188,small heart|MP:0002450,abnormal lymph organ development|MP:0003390,lymphedema|MP:0003920,abnormal heart right ventricle morphology|MP:0009865,abnormal aorta smooth muscle morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3718499	Ramp3<tm1Kmca>	MP:0001262,decreased body weight
MGI:3852712	Ranbp10<Gt(RRZ226)Byg>	MP:0000229,abnormal megakaryocyte differentiation|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0003405,abnormal platelet shape|MP:0005397,hematopoietic system phenotype|MP:0005606,increased bleeding time|MP:0009446,abnormal platelet dense granule physiology|MP:0009549,decreased platelet aggregation
MGI:5708223	Ranbp10<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0005559,increased circulating glucose level
MGI:6156506	Ranbp17<em1(IMPC)Tcp>	MP:0000470,abnormal stomach morphology|MP:0000691,enlarged spleen|MP:0001293,anophthalmia|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology
MGI:6314348	Ranbp1<Gt(S17-6E1)1.1Sor>	MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000787,abnormal telencephalon morphology|MP:0000914,exencephaly|MP:0001297,microphthalmia|MP:0001299,abnormal eye distance/ position|MP:0001698,decreased embryo size|MP:0002741,small olfactory bulb|MP:0002884,abnormal pharyngeal arch morphology|MP:0003077,abnormal cell cycle|MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0005262,coloboma|MP:0006254,thin cerebral cortex|MP:0006337,abnormal first pharyngeal arch morphology|MP:0006338,abnormal second pharyngeal arch morphology|MP:0008441,thin cortical plate|MP:0008457,abnormal cortical intermediate zone morphology|MP:0008948,decreased neuron number|MP:0009937,abnormal neuron differentiation|MP:0011111,lethality during fetal growth through weaning, complete penetrance|MP:0014134,abnormal embryo morphology
MGI:5696936	Ranbp1<tm1b(KOMP)Wtsi>	MP:0000428,abnormal craniofacial morphology|MP:0000783,abnormal forebrain morphology|MP:0000841,abnormal hindbrain morphology|MP:0000897,abnormal midbrain morphology|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0003720,abnormal neural tube closure|MP:0004258,abnormal placenta size|MP:0011100,preweaning lethality, complete penetrance
MGI:4946608	Ranbp1<tm1Yyo>	MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0008280,abnormal male germ cell apoptosis
MGI:3693886	Ranbp2<Gt(pGT0pfs)630Wcs>	MP:0003631,nervous system phenotype|MP:0004021,abnormal rod electrophysiology|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0011091,prenatal lethality, complete penetrance|MP:0014812,abnormal brain physiology
MGI:3800899	Ranbp2<tm1.1Jvd>	MP:0004024,aneuploidy|MP:0011092,embryonic lethality, complete penetrance
MGI:5583083	Ranbp2<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002631,abnormal epididymis morphology|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0004931,enlarged epididymis|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012058,abnormal morula morphology|MP:0012129,failure of blastocyst formation|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3800898	Ranbp2<tm1Jvd>	MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003701,elevated level of mitotic sister chromatid exchange|MP:0004024,aneuploidy|MP:0004046,abnormal mitosis|MP:0004499,increased incidence of tumors by chemical induction|MP:0008714,increased lung carcinoma incidence|MP:0010308,decreased tumor latency
MGI:3867519	Ranbp9<Gt(RHA056)Byg>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001265,decreased body size|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002016,ovary cyst|MP:0002216,abnormal seminiferous tubule morphology|MP:0002685,abnormal spermatogonia proliferation|MP:0003699,abnormal female reproductive system physiology|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0005431,decreased oocyte number|MP:0006362,abnormal male germ cell morphology|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0008871,abnormal ovarian follicle number|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011125,decreased primary ovarian follicle number|MP:0014052,increased male germ cell apoptosis|MP:0014617,decreased spermatogonia number|MP:0014633,decreased spermatid number
MGI:5702969	Ranbp9<tm1.1Wyan>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0008770,decreased survivor rate|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014052,increased male germ cell apoptosis
MGI:5702963	Ranbp9<tm1Wyan>	MP:0001147,small testis|MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0004930,small epididymis|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009238,coiled sperm flagellum|MP:0009248,small caput epididymis|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014052,increased male germ cell apoptosis|MP:0020451,decreased sperm progressive motility
MGI:3702086	Rangap1<Gt(U3neo)1B6Rul>	MP:0001672,abnormal embryo development|MP:0001680,abnormal mesoderm development|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0003886,abnormal embryonic epiblast morphology|MP:0005032,abnormal ectoplacental cone morphology|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0011200,abnormal extraembryonic coelom morphology|MP:0011207,absent ectoplacental cavity|MP:0011208,small proamniotic cavity
MGI:7386934	Rangrf<tm1.1Tke>	MP:0001544,abnormal cardiovascular system physiology|MP:0003141,cardiac fibrosis|MP:0004090,abnormal sarcomere morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005294,abnormal heart ventricle morphology|MP:0006036,abnormal mitochondrial physiology|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010392,prolonged QRS complex duration|MP:0010519,atrioventricular block|MP:0010630,abnormal cardiac muscle tissue morphology|MP:0011628,increased mitochondrial number|MP:0011630,increased mitochondrial size|MP:0011636,disorganized mitochondrial cristae|MP:0011703,increased fibroblast proliferation|MP:0011925,abnormal heart echocardiography feature|MP:0014730,abnormal myocardial fiber myofibril morphology|MP:0020414,abnormal fibroblast physiology|MP:0020423,abnormal mitochondrial biogenesis|MP:0030567,abnormal I band morphology
MGI:3813936	Rap1a<tm1Laaq>	MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology|MP:0003156,abnormal leukocyte migration|MP:0005387,immune system phenotype|MP:0005602,decreased angiogenesis|MP:0011092,embryonic lethality, complete penetrance
MGI:3830343	Rap1a<tm1Tze>	MP:0003628,abnormal leukocyte adhesion|MP:0005095,decreased T cell proliferation|MP:0008688,decreased interleukin-2 secretion
MGI:3573929	Rap1b<tm1Gwht>	MP:0001265,decreased body size|MP:0001914,hemorrhage|MP:0001935,decreased litter size|MP:0005606,increased bleeding time|MP:0009549,decreased platelet aggregation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0031120,decreased susceptibility to induced thrombosis
MGI:5563432	Rap1gap2<m1Anu>	MP:0005387,immune system phenotype
MGI:6120805	Rap1gap2<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0001566,increased circulating phosphate level|MP:0002833,increased heart weight|MP:0004738,abnormal auditory brainstem response|MP:0005655,increased aggression
MGI:6153810	Rap1gap<em1(IMPC)H>	MP:0000219,increased neutrophil cell number|MP:0004952,increased spleen weight|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0008806,increased circulating amylase level|MP:0010067,increased red blood cell distribution width
MGI:3613572	Rap1gds1<tm1Ytk>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0000746,weakness|MP:0000846,abnormal medulla oblongata morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001575,cyanosis|MP:0001785,edema|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002981,increased liver weight|MP:0003105,abnormal heart atrium morphology|MP:0003222,increased cardiomyocyte apoptosis|MP:0003653,decreased skin turgor|MP:0005294,abnormal heart ventricle morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005630,increased lung weight|MP:0006113,abnormal heart septum morphology|MP:0009541,increased thymocyte apoptosis|MP:0010018,pulmonary vascular congestion|MP:0010019,liver vascular congestion|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013182,increased spinal cord apoptosis
MGI:5588282	Rap2b<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001510,abnormal coat appearance|MP:0001516,abnormal motor coordination/balance|MP:0004151,decreased circulating iron level|MP:0004924,abnormal behavior|MP:0005560,decreased circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:2445403	Rapgef1<Gt(pGT1.8geo)5Pgr>	MP:0001785,edema|MP:0001914,hemorrhage|MP:0003632,abnormal nervous system morphology|MP:0003814,vascular smooth muscle hypoplasia|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004950,abnormal brain vasculature morphology|MP:0005592,abnormal vascular smooth muscle morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011708,decreased fibroblast cell migration|MP:0014698,decreased fibroblast adhesion
MGI:5635284	Rapgef1<tm1b(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:2675465	Rapgef1<tm1Mats>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6279906	Rapgef2<em1(IMPC)H>	MP:0001325,abnormal retina morphology|MP:0001417,decreased exploration in new environment|MP:0005344,increased circulating bilirubin level|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4839105	Rapgef2<tm1.1Hous>	MP:0000259,abnormal vascular development|MP:0000603,pale liver|MP:0002123,abnormal definitive hematopoiesis|MP:0003717,pallor|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008973,decreased erythroid progenitor cell number|MP:0009703,decreased birth body size|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3760243	Rapgef2<tm1.1Tkat>	MP:0000259,abnormal vascular development|MP:0000930,wavy neural tube|MP:0001622,abnormal vasculogenesis|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001719,absent vitelline blood vessels|MP:0001722,pale yolk sac|MP:0001730,embryonic growth arrest|MP:0001890,anencephaly|MP:0002875,decreased erythrocyte cell number|MP:0003054,spina bifida|MP:0004188,delayed embryo turning|MP:0004259,small placenta|MP:0004556,enlarged allantois|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011204,abnormal visceral yolk sac blood island morphology
MGI:4839129	Rapgef2<tm1.2Hous>	MP:0000215,absent erythrocytes|MP:0000245,abnormal erythropoiesis|MP:0000259,abnormal vascular development|MP:0000267,abnormal heart development|MP:0000352,decreased cell proliferation|MP:0000596,abnormal liver development|MP:0000913,abnormal brain development|MP:0001201,translucent skin|MP:0001698,decreased embryo size|MP:0001719,absent vitelline blood vessels|MP:0003091,abnormal cell migration|MP:0003119,abnormal digestive system development|MP:0003396,abnormal embryonic hematopoiesis|MP:0003566,abnormal cell adhesion|MP:0004810,decreased hematopoietic stem cell number|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5559594	Rapgef3<tm1.1Chen>	MP:0001262,decreased body weight|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0008489,slow postnatal weight gain|MP:0009133,decreased white fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0010025,decreased total body fat amount|MP:0011167,abnormal adipose tissue development|MP:0011940,decreased food intake
MGI:5318394	Rapgef3<tm1.1Geno>	MP:0003631,nervous system phenotype
MGI:5571846	Rapgef3<tm1.2Chen>	MP:0005385,cardiovascular system phenotype
MGI:5574090	Rapgef3<tm1Fsel>	MP:0005397,hematopoietic system phenotype
MGI:5532318	Rapgef3<tm1Skc>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001260,increased body weight|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0004031,insulitis|MP:0005179,decreased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005491,pancreatic islet hyperplasia|MP:0005566,decreased blood urea nitrogen level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0009171,enlarged pancreatic islets|MP:0009176,increased pancreatic alpha cell number|MP:0010378,increased respiratory quotient
MGI:4947366	Rapgef3<tm1Utak>	MP:0003204,decreased neuron apoptosis
MGI:6313355	Rapgef4<em1(IMPC)H>	MP:0000195,decreased circulating calcium level|MP:0003179,thrombocytopenia|MP:0010067,increased red blood cell distribution width|MP:0013278,decreased fasting circulating glucose level
MGI:4321519	Rapgef4<Gt(OST450264)Lex>	MP:0004231,abnormal calcium ion homeostasis
MGI:3767602	Rapgef4<tm1.1Sse>	MP:0003564,abnormal insulin secretion
MGI:5571845	Rapgef4<tm1.2Chen>	MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0005385,cardiovascular system phenotype|MP:0008950,ventricular tachycardia
MGI:6153844	Rapgef5<em1(IMPC)H>	MP:0001147,small testis
MGI:3760543	Rapgef6<tm1.1Tkat>	MP:0000691,enlarged spleen|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0003205,testicular atrophy|MP:0005376,homeostasis/metabolism phenotype|MP:0009230,abnormal sperm head morphology|MP:0014696,decreased cell adhesion
MGI:4362680	Rapgefl1<tm1a(KOMP)Wtsi>	MP:0001973,increased thermal nociceptive threshold
MGI:5575553	Raph1<tm1.1Makr>	MP:0000373,belly spot|MP:0001265,decreased body size|MP:0001924,infertility|MP:0009546,absent gastric milk in neonates|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011707,impaired fibroblast cell migration|MP:0012023,decreased melanocyte number
MGI:5818712	Raph1<tm1.2Fbg>	MP:0000492,abnormal rectum morphology|MP:0000493,rectal prolapse|MP:0000495,abnormal colon morphology|MP:0001846,increased inflammatory response|MP:0002038,increased carcinoma incidence|MP:0002412,increased susceptibility to bacterial infection|MP:0003288,intestinal edema|MP:0003304,large intestinal inflammation|MP:0008713,abnormal cytokine level|MP:0013663,increased myeloid cell number
MGI:5637089	Raph1<tm1b(EUCOMM)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:2157471	Rapop1<BALB/cHeA>	MP:0001648,abnormal apoptosis
MGI:2157468	Rapop2<BALB/cHeA>	MP:0001648,abnormal apoptosis
MGI:2157469	Rapop2<STS/A>	MP:0001648,abnormal apoptosis
MGI:2155516	Rapop3<BALB/cHeA>	MP:0001648,abnormal apoptosis
MGI:2157486	Rapop4<C3H/Kam>	MP:0001648,abnormal apoptosis
MGI:6389103	Rapsn<em1Gan>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0001575,cyanosis|MP:0004835,abnormal miniature endplate potential|MP:0008571,abnormal synaptic bouton morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:5637222	Rapsn<tm1b(EUCOMM)Wtsi>	MP:0001556,increased circulating HDL cholesterol level|MP:0011100,preweaning lethality, complete penetrance
MGI:2148091	Rapsn<tm1Jrs>	MP:0000747,muscle weakness|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001055,failure of neuromuscular synapse postsynaptic differentiation|MP:0001954,respiratory distress|MP:0011089,perinatal lethality, complete penetrance
MGI:5608510	Rara<tm1.1Ybe>	MP:0002401,abnormal lymphopoiesis
MGI:1857622	Rara<tm1Ipc>	MP:0000571,interdigital webbing|MP:0001146,abnormal testis morphology|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002083,premature death|MP:0002258,abnormal cricoid cartilage morphology|MP:0002260,abnormal thyroid cartilage morphology|MP:0002687,oligozoospermia|MP:0003036,vertebral transformation|MP:0003048,abnormal cervical vertebrae morphology|MP:0003056,abnormal hyoid bone morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0003235,abnormal alisphenoid bone morphology|MP:0004423,abnormal temporal bone squamous part morphology|MP:0004608,abnormal cervical axis morphology|MP:0004613,fusion of vertebral arches|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004620,cervical vertebral fusion|MP:0005106,abnormal incus morphology|MP:0005287,narrow eye opening|MP:0005508,abnormal skeleton morphology|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008280,abnormal male germ cell apoptosis|MP:0010701,fusion of atlas and odontoid process|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2158687	Rara<tm1Rev>	MP:0002169,no abnormal phenotype detected
MGI:1857867	Rara<tm2Ipc>	MP:0002169,no abnormal phenotype detected
MGI:2386107	Rara<tm3.1Ipc>	MP:0001146,abnormal testis morphology|MP:0001925,male infertility
MGI:6336132	Rarb<em1(IMPC)Kmpc>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0005287,narrow eye opening|MP:0010025,decreased total body fat amount
MGI:1857623	Rarb<tm1Ipc>	MP:0002169,no abnormal phenotype detected|MP:0010711,persistent hyperplastic primary vitreous
MGI:1857851	Rarb<tm1Mma>	MP:0000079,abnormal basioccipital bone morphology|MP:0001176,abnormal lung development|MP:0001262,decreased body weight|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0001732,postnatal growth retardation|MP:0003036,vertebral transformation|MP:0003631,nervous system phenotype|MP:0004599,abnormal vertebral arch morphology|MP:0004613,fusion of vertebral arches|MP:0004615,cervical vertebral transformation|MP:0005287,narrow eye opening|MP:0005371,limbs/digits/tail phenotype|MP:0005508,abnormal skeleton morphology|MP:0006200,vitreous body deposition|MP:0010701,fusion of atlas and odontoid process|MP:0010702,split cervical atlas|MP:0010703,split cervical axis|MP:0010705,absent metoptic pillar|MP:0010711,persistent hyperplastic primary vitreous|MP:0010728,fusion of atlas and occipital bones|MP:0010902,abnormal pulmonary alveolar sac morphology|MP:0010995,abnormal lung alveolus development|MP:0021107,retina fold
MGI:2158691	Rarb<tm1Vgi>	MP:0001176,abnormal lung development|MP:0001262,decreased body weight|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001899,absent long-term depression|MP:0002271,abnormal pulmonary alveolar duct morphology|MP:0002327,abnormal respiratory function|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003182,decreased pulmonary endothelial cell surface|MP:0006027,impaired lung alveolus development|MP:0010899,abnormal pulmonary alveolar system morphology|MP:0010902,abnormal pulmonary alveolar sac morphology
MGI:2386109	Rarb<tm2.1Ipc>	MP:0010711,persistent hyperplastic primary vitreous
MGI:2681395	Rarg<tm1Blt>	MP:0001262,decreased body weight|MP:0001922,reduced male fertility|MP:0002083,premature death|MP:0004552,fused tracheal cartilage rings|MP:0005248,abnormal Harderian gland morphology|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0013321,squamous metaplasia of seminal vesicles|MP:0013322,squamous metaplasia of prostate gland
MGI:1931079	Rarg<tm1Ipc>	MP:0000079,abnormal basioccipital bone morphology|MP:0000154,rib fusion|MP:0001158,abnormal prostate gland morphology|MP:0001196,shiny skin|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001262,decreased body weight|MP:0001340,abnormal eyelid morphology|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0002083,premature death|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0002258,abnormal cricoid cartilage morphology|MP:0002655,abnormal keratinocyte morphology|MP:0002796,impaired skin barrier function|MP:0003036,vertebral transformation|MP:0003048,abnormal cervical vertebrae morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0003639,abnormal response to vitamins|MP:0004552,fused tracheal cartilage rings|MP:0004601,abnormal vertebral spinous process morphology|MP:0004607,abnormal cervical atlas morphology|MP:0004608,abnormal cervical axis morphology|MP:0004613,fusion of vertebral arches|MP:0004615,cervical vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0005248,abnormal Harderian gland morphology|MP:0005287,narrow eye opening|MP:0005508,abnormal skeleton morphology|MP:0008770,decreased survivor rate|MP:0009608,abnormal epidermal lamellar body morphology|MP:0010701,fusion of atlas and odontoid process|MP:0010702,split cervical atlas|MP:0010703,split cervical axis|MP:0010705,absent metoptic pillar|MP:0010728,fusion of atlas and occipital bones|MP:0013319,seminal vesicle atrophy|MP:0013321,squamous metaplasia of seminal vesicles|MP:0013322,squamous metaplasia of prostate gland
MGI:1932114	Rarg<tm2Ipc>	MP:0002169,no abnormal phenotype detected
MGI:2386112	Rarg<tm3.1Ipc>	MP:0001925,male infertility|MP:0013321,squamous metaplasia of seminal vesicles|MP:0013322,squamous metaplasia of prostate gland
MGI:2386111	Rarg<tm3Ipc>	MP:0001196,shiny skin|MP:0001216,abnormal epidermal layer morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0002060,abnormal skin morphology|MP:0002655,abnormal keratinocyte morphology|MP:0002796,impaired skin barrier function
MGI:2445724	Rarg<tm4Ipc>	MP:0001732,postnatal growth retardation|MP:0002258,abnormal cricoid cartilage morphology|MP:0003048,abnormal cervical vertebrae morphology
MGI:7311668	Rarres1<tm1.2Mhl>	MP:0000240,extramedullary hematopoiesis|MP:0002144,abnormal B cell differentiation|MP:0002459,abnormal B cell physiology|MP:0005154,increased B cell proliferation|MP:0005621,abnormal cell physiology|MP:0008099,abnormal plasma cell differentiation|MP:0008217,abnormal B cell activation|MP:0008482,decreased spleen germinal center number|MP:0008783,decreased B cell apoptosis|MP:0009317,increased follicular lymphoma incidence
MGI:7311664	Rarres1<tm1d(KOMP)Wtsi>	MP:0009317,increased follicular lymphoma incidence|MP:0011087,neonatal lethality, complete penetrance
MGI:5550146	Rarres2<tm1Yktk>	MP:0002702,decreased circulating free fatty acids level|MP:0003059,decreased insulin secretion|MP:0003383,abnormal gluconeogenesis|MP:0003884,decreased macrophage cell number|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005559,increased circulating glucose level|MP:0030021,increased muscle cell glucose uptake
MGI:4432394	Rars1<tm1a(EUCOMM)Wtsi>	MP:0001973,increased thermal nociceptive threshold
MGI:4432770	Rars2<tm1a(EUCOMM)Wtsi>	MP:0001556,increased circulating HDL cholesterol level|MP:0004924,abnormal behavior
MGI:1857011	ras	MP:0004994,abnormal brain wave pattern|MP:0005386,behavior/neurological phenotype
MGI:5609364	Rasa1<tm1b(EUCOMM)Hmgu>	MP:0000198,decreased circulating phosphate level|MP:0002792,abnormal retina vasculature morphology|MP:0002833,increased heart weight|MP:0003179,thrombocytopenia|MP:0004924,abnormal behavior|MP:0005560,decreased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:1857417	Rasa1<tm1Paw>	MP:0000313,abnormal cell death|MP:0001689,incomplete somite formation|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0006337,abnormal first pharyngeal arch morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011205,excessive folding of visceral yolk sac
MGI:5446031	Rasa1<tm1Wid>	MP:0001544,abnormal cardiovascular system physiology|MP:0003222,increased cardiomyocyte apoptosis|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008537,increased susceptibility to induced colitis|MP:0008885,increased enterocyte apoptosis|MP:0008943,increased sensitivity to induced cell death|MP:0013956,decreased colon length
MGI:5661985	Rasa1<tm2.1Pdk>	MP:0000292,distended pericardium|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0003229,abnormal vitelline vasculature morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0010662,abnormal intersomitic artery morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011205,excessive folding of visceral yolk sac
MGI:3575140	Rasa3<hlb381>	MP:0000221,decreased leukocyte cell number|MP:0000691,enlarged spleen|MP:0002599,increased mean platelet volume|MP:0002640,reticulocytosis|MP:0003179,thrombocytopenia|MP:0004952,increased spleen weight|MP:0005464,abnormal platelet physiology|MP:0008254,increased megakaryocyte cell number|MP:0010768,mortality/aging
MGI:1857029	Rasa3<scat>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000229,abnormal megakaryocyte differentiation|MP:0000245,abnormal erythropoiesis|MP:0000333,decreased bone marrow cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001548,hyperlipidemia|MP:0001577,anemia|MP:0001634,internal hemorrhage|MP:0002083,premature death|MP:0002417,abnormal megakaryocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0003674,oxidative stress|MP:0003717,pallor|MP:0003718,maternal effect|MP:0004045,abnormal cell cycle checkpoint function|MP:0004952,increased spleen weight|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005097,polychromatophilia|MP:0005344,increased circulating bilirubin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0006043,decreased apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008254,increased megakaryocyte cell number|MP:0008476,increased spleen red pulp amount|MP:0008816,petechiae|MP:0008850,increased hemoglobin concentration distribution width|MP:0009246,pale spleen|MP:0009275,bruising|MP:0009661,abnormal pregnancy|MP:0009703,decreased birth body size|MP:0010067,increased red blood cell distribution width|MP:0010163,hemolysis|MP:0011092,embryonic lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011176,abnormal erythroblast morphology
MGI:6509614	Rasa3<tm1.1Llp>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000245,abnormal erythropoiesis|MP:0001577,anemia|MP:0001914,hemorrhage|MP:0002590,increased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0003396,abnormal embryonic hematopoiesis|MP:0004952,increased spleen weight|MP:0005152,pancytopenia|MP:0005344,increased circulating bilirubin level|MP:0005397,hematopoietic system phenotype|MP:0010067,increased red blood cell distribution width|MP:0010163,hemolysis|MP:0011971,increased circulating lactate dehydrogenase level|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0013704,increased megakaryocyte-erythroid progenitor cell number|MP:0013776,bone marrow failure
MGI:5469322	Rasa3<tm1a(KOMP)J>	MP:0000603,pale liver|MP:0001914,hemorrhage|MP:0003717,pallor|MP:0011092,embryonic lethality, complete penetrance
MGI:5502307	Rasa3<tm1b(KOMP)J>	MP:0000783,abnormal forebrain morphology|MP:0000897,abnormal midbrain morphology|MP:0001417,decreased exploration in new environment|MP:0001914,hemorrhage|MP:0002833,increased heart weight|MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance|MP:0011396,abnormal sleep behavior|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:3710014	Rasa3<tm1Shiw>	MP:0001672,abnormal embryo development|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003542,abnormal vascular endothelial cell development|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3589205	Rasa4<tm1Ywh>	MP:0001798,impaired macrophage phagocytosis|MP:0002412,increased susceptibility to bacterial infection
MGI:4364597	Rasal1<tm1a(KOMP)Wtsi>	MP:0003215,renal interstitial fibrosis
MGI:4960535	Rasal2<Gt(463C12)Cmhd>	MP:0002083,premature death|MP:0010308,decreased tumor latency
MGI:4939768	Rasal2<tm1a(EUCOMM)Wtsi>	MP:0001510,abnormal coat appearance|MP:0002073,abnormal hair growth|MP:0006358,absent pinna reflex
MGI:5776708	Rasal3<tm1.1Fuj>	MP:0000322,increased granulocyte number|MP:0002942,decreased circulating alanine transaminase level|MP:0005166,decreased susceptibility to injury|MP:0005632,decreased circulating aspartate transaminase level|MP:0008040,decreased NK T cell number|MP:0008567,decreased interferon-gamma secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0008603,decreased circulating interleukin-4 level|MP:0008700,decreased interleukin-4 secretion
MGI:6120796	Rasal3<tm1b(EUCOMM)Hmgu>	MP:0001258,decreased body length|MP:0001552,increased circulating triglyceride level|MP:0002764,short tibia|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0005554,decreased circulating creatinine level|MP:0011960,abnormal eye anterior chamber depth
MGI:5695889	Rasd1<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart
MGI:5502750	Rasd1<tm1.1Snyd>	MP:0005637,abnormal iron homeostasis|MP:0008236,decreased susceptibility to neuronal excitotoxicity
MGI:3054834	Rasd1<tm1Pngr>	MP:0020470,shortened circadian behavior period|MP:0020474,advanced circadian behavior phase|MP:0020476,abnormal circardian behavior entrainment
MGI:3050759	Rasd2<tm1Rdl>	MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002066,abnormal motor capabilities/coordination/movement
MGI:6830921	Rasef<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5903207	Rasgef1a<em1(IMPC)J>	MP:0002574,increased vertical activity
MGI:6200233	Rasgef1b<em1(IMPC)J>	MP:0004924,abnormal behavior|MP:0009142,decreased prepulse inhibition|MP:0020870,decreased thigmotaxis
MGI:2670335	Rasgrf1<enu1H>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0003122,maternal imprinting
MGI:2670337	Rasgrf1<enu2H>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0003122,maternal imprinting
MGI:6473478	Rasgrf1<tm1bNarl>	MP:0001399,hyperactivity|MP:0003960,increased lean body mass
MGI:2667231	Rasgrf1<tm1Esn>	MP:0001262,decreased body weight|MP:0002727,decreased circulating insulin level|MP:0003339,decreased pancreatic beta cell number|MP:0005293,impaired glucose tolerance|MP:0008034,enhanced lipolysis|MP:0009172,small pancreatic islets|MP:0010025,decreased total body fat amount
MGI:2157015	Rasgrf1<tm1Kln>	MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002798,abnormal active avoidance behavior|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008432,abnormal long-term spatial reference memory|MP:0009454,impaired contextual conditioning behavior
MGI:2388130	Rasgrf1<tm1Pds>	MP:0003787,abnormal imprinting
MGI:3045890	Rasgrf1<tm1Sva>	MP:0001262,decreased body weight|MP:0001463,abnormal spatial learning|MP:0002802,abnormal discrimination learning|MP:0002969,impaired social transmission of food preference
MGI:2157017	Rasgrf1<tm1Toc>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001746,abnormal pituitary secretion|MP:0003122,maternal imprinting|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005136,decreased growth hormone level
MGI:3611766	Rasgrf1<tm2Pds>	MP:0003787,abnormal imprinting|MP:0008877,abnormal DNA methylation
MGI:2679659	Rasgrf1<tm3.1Pds>	MP:0003123,paternal imprinting|MP:0003787,abnormal imprinting
MGI:3611767	Rasgrf1<tm4.1Pds>	MP:0002169,no abnormal phenotype detected|MP:0003787,abnormal imprinting|MP:0005384,cellular phenotype|MP:0005621,abnormal cell physiology
MGI:5501498	Rasgrf2<tm1(cre/folA)Hze>	MP:0002169,no abnormal phenotype detected
MGI:2183211	Rasgrf2<tm1Esn>	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0008561,decreased tumor necrosis factor secretion|MP:0008688,decreased interleukin-2 secretion
MGI:2675033	Rasgrp1<lag>	MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology|MP:0002444,abnormal T cell physiology|MP:0002493,increased IgG level|MP:0002743,glomerulonephritis|MP:0002828,abnormal renal glomerular capsule morphology|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004919,abnormal positive T cell selection|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005095,decreased T cell proliferation|MP:0005325,abnormal renal glomerulus morphology
MGI:4838027	Rasgrp1<m1Anu>	MP:0001844,autoimmune response|MP:0002145,abnormal T cell differentiation|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005387,immune system phenotype|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number
MGI:6200006	Rasgrp1<m1Btlr>	MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0008044,increased NK cell number|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010838,increased CD8-positive, alpha-beta memory T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:5563430	Rasgrp1<m2Anu>	MP:0005387,immune system phenotype
MGI:6200009	Rasgrp1<m2Btlr>	MP:0005018,decreased T cell number|MP:0008044,increased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6200346	Rasgrp1<m3Btlr>	MP:0000219,increased neutrophil cell number|MP:0002494,increased IgM level|MP:0005014,increased B cell number|MP:0005018,decreased T cell number|MP:0008044,increased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0008169,increased B-1b cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6268413	Rasgrp1<M4Btlr>	MP:0008037,abnormal T cell morphology
MGI:6286073	Rasgrp1<m5Btlr>	MP:0008044,increased NK cell number
MGI:5694744	Rasgrp1<tm1.1Wz>	MP:0000691,enlarged spleen|MP:0000716,abnormal immune system cell morphology|MP:0001790,abnormal immune system physiology|MP:0002145,abnormal T cell differentiation|MP:0002490,abnormal immunoglobulin level|MP:0002497,increased IgE level|MP:0002722,abnormal immune system organ morphology|MP:0003725,increased autoantibody level|MP:0004952,increased spleen weight|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008082,increased single-positive T cell number|MP:0008083,decreased single-positive T cell number|MP:0008499,increased IgG1 level|MP:0010835,increased CD4-positive, alpha-beta memory T cell number
MGI:2386261	Rasgrp1<tm1Jstn>	MP:0000691,enlarged spleen|MP:0000715,decreased thymocyte number|MP:0001800,abnormal humoral immune response|MP:0002408,abnormal double-positive T cell morphology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002461,increased immunoglobulin level|MP:0005017,decreased B cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008097,increased plasma cell number
MGI:3055135	Rasgrp2<tm1Amg>	MP:0002463,abnormal neutrophil physiology|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0008719,impaired neutrophil recruitment|MP:0009549,decreased platelet aggregation
MGI:6153600	Rasgrp3<em1(IMPC)Wtsi>	MP:0001120,abnormal uterus morphology|MP:0002092,abnormal eye morphology|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008935,decreased mean platelet volume|MP:0013436,increased CD8-positive, naive alpha-beta T cell number|MP:0013772,increased effector memory T-helper cell number
MGI:3525522	Rasgrp3<Gt(Pt1-ATG)1Vb>	MP:0002169,no abnormal phenotype detected
MGI:3625862	Rasgrp3<tm1Jstn>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0005017,decreased B cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level
MGI:5432887	Rasgrp4<tm1a(KOMP)Lste>	MP:0002463,abnormal neutrophil physiology|MP:0008720,impaired neutrophil chemotaxis
MGI:5432899	Rasgrp4<tm1(cre)Rls>	MP:0003436,decreased susceptibility to induced arthritis|MP:0008539,decreased susceptibility to induced colitis
MGI:5432886	Rasgrp4<tm1d(KOMP)Lste>	MP:0002463,abnormal neutrophil physiology|MP:0008720,impaired neutrophil chemotaxis
MGI:4841072	Rasgrp4<tm2a(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0002599,increased mean platelet volume
MGI:5056095	Rasip1<tm1.1Oncl>	MP:0000259,abnormal vascular development|MP:0001726,abnormal allantois morphology|MP:0001785,edema|MP:0002925,abnormal cardiovascular development|MP:0003229,abnormal vitelline vasculature morphology|MP:0003542,abnormal vascular endothelial cell development|MP:0003543,abnormal vascular endothelial cell differentiation|MP:0003974,abnormal endocardium morphology|MP:0003984,embryonic growth retardation|MP:0004787,abnormal dorsal aorta morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5543662	Rasip1<tm1.1Wye>	MP:0001698,decreased embryo size|MP:0001785,edema|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0003717,pallor|MP:0004068,dilated dorsal aorta|MP:0004076,abnormal vitelline vascular remodeling|MP:0004787,abnormal dorsal aorta morphology|MP:0006055,abnormal vascular endothelial cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5437949	Rasl10b<tm1Eno>	MP:0000358,abnormal cell morphology|MP:0008546,abnormal vesicle-mediated transport
MGI:6740202	Rassf10<em1(IMPC)J>	MP:0020870,decreased thigmotaxis
MGI:3604204	Rassf1<tm1.1Brd>	MP:0002169,no abnormal phenotype detected|MP:0004486,decreased response of heart to induced stress
MGI:3604205	Rassf1<tm1.2Brd>	MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0003141,cardiac fibrosis|MP:0003992,increased mortality induced by ionizing radiation|MP:0004485,increased response of heart to induced stress|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0005387,immune system phenotype|MP:0005621,abnormal cell physiology|MP:0010383,increased adenoma incidence|MP:0012431,increased lymphoma incidence
MGI:3528065	Rassf1<tm1Gpp>	MP:0002023,increased B cell derived lymphoma incidence|MP:0002048,increased lung adenoma incidence|MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0005379,endocrine/exocrine gland phenotype|MP:0008019,increased liver tumor incidence|MP:0010040,abnormal oval cell morphology
MGI:5314787	Rassf2<tm1Dlim>	MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000130,abnormal trabecular bone morphology|MP:0000221,decreased leukocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0000694,spleen hypoplasia|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0002083,premature death|MP:0002356,abnormal spleen red pulp morphology|MP:0002875,decreased erythrocyte cell number|MP:0002896,abnormal bone mineralization|MP:0003333,liver fibrosis|MP:0004016,decreased bone mass|MP:0004810,decreased hematopoietic stem cell number|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight|MP:0004985,decreased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008250,abnormal myeloid leukocyte morphology|MP:0008395,abnormal osteoblast differentiation|MP:0008396,abnormal osteoclast differentiation|MP:0008813,decreased common myeloid progenitor cell number|MP:0009346,decreased trabecular bone thickness|MP:0009544,abnormal thymus epithelium morphology|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume
MGI:3054868	Rassf5<tm1Kina>	MP:0000691,enlarged spleen|MP:0000694,spleen hypoplasia|MP:0000702,enlarged lymph nodes|MP:0000715,decreased thymocyte number|MP:0002023,increased B cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002144,abnormal B cell differentiation|MP:0002223,lymphoid hypoplasia|MP:0002343,abnormal lymph node cortex morphology|MP:0002356,abnormal spleen red pulp morphology|MP:0002375,abnormal thymus medulla morphology|MP:0002376,abnormal dendritic cell physiology|MP:0002493,increased IgG level|MP:0002743,glomerulonephritis|MP:0002962,increased urine protein level|MP:0003156,abnormal leukocyte migration|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003945,abnormal lymphocyte physiology|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005154,increased B cell proliferation|MP:0005348,increased T cell proliferation|MP:0008049,increased memory T cell number|MP:0008097,increased plasma cell number|MP:0008827,abnormal thymus cell ratio|MP:0008828,abnormal lymph node cell ratio|MP:0009543,abnormal thymus corticomedullary boundary morphology
MGI:4868223	Rassf5<tm1Sblee>	MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0013502,decreased fibroblast apoptosis
MGI:5695922	Rassf8<tm1.1(KOMP)Vlcg>	MP:0000367,abnormal coat/ hair morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4999600	Rassf9<Tg(PDLIM7*)2Cml>	MP:0000414,alopecia|MP:0000427,abnormal hair cycle|MP:0001183,overexpanded pulmonary alveolus|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001245,thick dermal layer|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0003786,premature aging|MP:0003809,abnormal hair shaft morphology|MP:0004971,dermal hyperplasia|MP:0005501,abnormal skin physiology|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008858,abnormal hair cycle anagen phase|MP:0009583,increased keratinocyte proliferation|MP:0010680,abnormal skin adnexa physiology|MP:0010825,abnormal lung saccule morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6414545	Raver1<em1(IMPC)Hmgu>	MP:0003795,abnormal bone structure|MP:0004952,increased spleen weight
MGI:3802576	Raver1<tm1Hha>	MP:0001473,reduced long-term potentiation|MP:0001475,reduced long-term depression|MP:0005384,cellular phenotype
MGI:6294074	Raver2<em1(IMPC)J>	MP:0000198,decreased circulating phosphate level|MP:0010053,decreased grip strength
MGI:1856862	Rax<ey1>	MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001306,small lens|MP:0001330,abnormal optic nerve morphology|MP:0002092,abnormal eye morphology|MP:0004269,abnormal optic cup morphology|MP:0005545,abnormal lens development|MP:0008847,abnormal suprachiasmatic nucleus morphology|MP:0020476,abnormal circardian behavior entrainment
MGI:3576778	Rax<tm1.1Lwd>	MP:0001293,anophthalmia|MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0005382,craniofacial phenotype
MGI:5494255	Rax<tm1.1(rTA,tetO-cre)Lan>	MP:0001265,decreased body size|MP:0001293,anophthalmia|MP:0001297,microphthalmia
MGI:5302230	Rax<tm1.1Tfur>	MP:0002984,retina hypoplasia
MGI:3576779	Rax<tm1.2Lwd>	MP:0000111,cleft palate|MP:0001286,abnormal eye development|MP:0001293,anophthalmia|MP:0002081,perinatal lethality|MP:0002621,delayed neural tube closure|MP:0030241,absent optic pit
MGI:3576777	Rax<tm1Lwd>	MP:0001286,abnormal eye development|MP:0001293,anophthalmia|MP:0002081,perinatal lethality|MP:0002621,delayed neural tube closure|MP:0030241,absent optic pit
MGI:2152531	Rax<tm1Mjam>	MP:0000111,cleft palate|MP:0000783,abnormal forebrain morphology|MP:0000837,abnormal hypothalamus morphology|MP:0001286,abnormal eye development|MP:0001293,anophthalmia|MP:0002081,perinatal lethality|MP:0002621,delayed neural tube closure|MP:0003755,abnormal palate morphology|MP:0004269,abnormal optic cup morphology|MP:0006294,absent optic vesicle|MP:0011255,abnormal anterior visceral endoderm cell migration|MP:0012089,decreased midbrain size|MP:0012136,absent forebrain|MP:0030241,absent optic pit
MGI:2683726	Raz	MP:0000149,abnormal scapula morphology|MP:0000266,abnormal heart morphology|MP:0002092,abnormal eye morphology|MP:0002152,abnormal brain morphology|MP:0004342,scapular bone foramen|MP:0006279,abnormal limb development|MP:0009743,preaxial polydactyly|MP:0011087,neonatal lethality, complete penetrance
MGI:3531161	Rb(12.Ts17<16>65Dn)2Cje	MP:0000807,abnormal hippocampus morphology|MP:0001265,decreased body size|MP:0002272,abnormal nervous system electrophysiology|MP:0002882,abnormal neuron morphology|MP:0003203,increased neuron apoptosis|MP:0003240,loss of hippocampal neurons|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype
MGI:6277004	Rb1cc1<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0001297,microphthalmia|MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:3526069	Rb1cc1<tm1.1Guan>	MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0000245,abnormal erythropoiesis|MP:0000479,abnormal enterocyte morphology|MP:0000598,abnormal liver morphology|MP:0000603,pale liver|MP:0001328,disorganized retina layers|MP:0001575,cyanosis|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002169,no abnormal phenotype detected|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0005103,abnormal retina pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005391,vision/eye phenotype|MP:0005548,retina pigment epithelium atrophy|MP:0006035,abnormal mitochondrial morphology|MP:0008260,abnormal autophagy|MP:0008515,thin retina outer nuclear layer|MP:0008516,disorganized retina outer nuclear layer|MP:0008842,lipofuscinosis|MP:0008918,microgliosis|MP:0010067,increased red blood cell distribution width|MP:0010813,abnormal alveolar lamellar body morphology|MP:0010889,small alveolar lamellar bodies|MP:0010890,decreased alveolar lamellar body number|MP:0011085,postnatal lethality, complete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011178,increased erythroblast number|MP:0011902,increased hematopoietic stem cell proliferation|MP:0012144,decreased b-wave amplitude|MP:0030940,impaired autophagy|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:3690328	Rb1cc1<tm1.2Guan>	MP:0000266,abnormal heart morphology|MP:0000280,thin ventricular wall|MP:0000598,abnormal liver morphology|MP:0000606,decreased hepatocyte number|MP:0000607,abnormal hepatocyte morphology|MP:0000608,dissociated hepatocytes|MP:0001785,edema|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002652,thin myocardium|MP:0002753,dilated heart left ventricle|MP:0003103,liver degeneration|MP:0003717,pallor|MP:0003887,increased hepatocyte apoptosis|MP:0003888,liver hemorrhage|MP:0003904,decreased cell mass|MP:0004056,abnormal myocardium compact layer morphology|MP:0004067,abnormal trabecula carnea morphology|MP:0005294,abnormal heart ventricle morphology|MP:0005329,abnormal myocardium layer morphology|MP:0006138,congestive heart failure|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0013501,increased fibroblast apoptosis
MGI:3624440	Rb1<tm1.1Gfk>	MP:0002877,abnormal melanocyte morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:2445439	Rb1<tm1.1Jyjw>	MP:0001492,abnormal pilomotor reflex|MP:0002006,neoplasm|MP:0005202,lethargy|MP:0006043,decreased apoptosis|MP:0006072,abnormal retina apoptosis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0011101,prenatal lethality, incomplete penetrance|MP:0030006,decreased retina apoptosis
MGI:3624441	Rb1<tm1.2Gfk>	MP:0002020,increased tumor incidence|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014237,decreased tumor-free survival time
MGI:1857339	Rb1<tm1Brd>	MP:0000160,kyphosis|MP:0000350,abnormal cell proliferation|MP:0000601,small liver|MP:0000602,dilated liver sinusoidal space|MP:0000606,decreased hepatocyte number|MP:0000631,abnormal neuroendocrine gland morphology|MP:0000774,decreased brain size|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000964,small dorsal root ganglion|MP:0001261,obese|MP:0001272,increased metastatic potential|MP:0001614,abnormal blood vessel morphology|MP:0001672,abnormal embryo development|MP:0001785,edema|MP:0002006,neoplasm|MP:0002041,increased pituitary adenoma incidence|MP:0002050,increased pheochromocytoma incidence|MP:0002152,abnormal brain morphology|MP:0002447,abnormal erythrocyte morphology|MP:0003203,increased neuron apoptosis|MP:0004200,decreased fetal size|MP:0005150,cachexia|MP:0005391,vision/eye phenotype|MP:0006087,increased body mass index|MP:0008534,enlarged fourth ventricle|MP:0009277,increased brain tumor incidence|MP:0009395,increased nucleated erythrocyte cell number|MP:0010345,increased thyroid C-cell carcinoma incidence|MP:0010350,increased pituitary adenohypophysis tumor incidence|MP:0010351,increased pituitary melanotroph tumor incidence|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:1931015	Rb1<tm1Brn>	MP:0002041,increased pituitary adenoma incidence|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0008130,abnormal pituitary intermediate lobe morphology|MP:0008371,pituitary intermediate lobe hyperplasia|MP:0014237,decreased tumor-free survival time
MGI:3617652	Rb1<tm1Dwg>	MP:0000245,abnormal erythropoiesis|MP:0000826,abnormal third ventricle morphology|MP:0000828,abnormal fourth ventricle morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0002446,abnormal macrophage morphology|MP:0002840,abnormal lens fiber morphology|MP:0003077,abnormal cell cycle|MP:0003717,pallor|MP:0004045,abnormal cell cycle checkpoint function|MP:0004265,abnormal placental transport|MP:0008796,increased lens fiber apoptosis|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011703,increased fibroblast proliferation
MGI:3624796	Rb1<tm1Fad>	MP:0000630,mammary gland hyperplasia|MP:0001885,mammary gland duct hyperplasia|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003702,abnormal chromosome morphology|MP:0003838,abnormal milk ejection|MP:0004024,aneuploidy|MP:0004046,abnormal mitosis
MGI:2445438	Rb1<tm1Jyjw>	MP:0001492,abnormal pilomotor reflex|MP:0005202,lethargy|MP:0006043,decreased apoptosis|MP:0006072,abnormal retina apoptosis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0011101,prenatal lethality, incomplete penetrance|MP:0030006,decreased retina apoptosis
MGI:1857340	Rb1<tm1Mlh>	MP:0000245,abnormal erythropoiesis|MP:0000602,dilated liver sinusoidal space|MP:0000606,decreased hepatocyte number|MP:0000798,abnormal frontal lobe morphology|MP:0000829,dilated fourth ventricle|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001601,abnormal myelopoiesis|MP:0001722,pale yolk sac|MP:0002006,neoplasm|MP:0002123,abnormal definitive hematopoiesis|MP:0002229,neurodegeneration|MP:0002447,abnormal erythrocyte morphology|MP:0002840,abnormal lens fiber morphology|MP:0002875,decreased erythrocyte cell number|MP:0003984,embryonic growth retardation|MP:0005391,vision/eye phenotype|MP:0006042,increased apoptosis|MP:0008254,increased megakaryocyte cell number|MP:0010351,increased pituitary melanotroph tumor incidence|MP:0011092,embryonic lethality, complete penetrance|MP:0030047,flat forehead
MGI:1857242	Rb1<tm1Tyj>	MP:0000163,abnormal cartilage morphology|MP:0000245,abnormal erythropoiesis|MP:0000351,increased cell proliferation|MP:0000598,abnormal liver morphology|MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0000826,abnormal third ventricle morphology|MP:0000828,abnormal fourth ventricle morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001272,increased metastatic potential|MP:0001505,hunched posture|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0001786,skin edema|MP:0001787,pericardial edema|MP:0002006,neoplasm|MP:0002050,increased pheochromocytoma incidence|MP:0002083,premature death|MP:0002447,abnormal erythrocyte morphology|MP:0002594,low mean erythrocyte cell number|MP:0002840,abnormal lens fiber morphology|MP:0003077,abnormal cell cycle|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0003717,pallor|MP:0004045,abnormal cell cycle checkpoint function|MP:0004265,abnormal placental transport|MP:0005039,hypoxia|MP:0005076,abnormal cell differentiation|MP:0005150,cachexia|MP:0005391,vision/eye phenotype|MP:0005545,abnormal lens development|MP:0006042,increased apoptosis|MP:0008014,increased lung tumor incidence|MP:0008113,abnormal macrophage differentiation|MP:0008796,increased lens fiber apoptosis|MP:0009395,increased nucleated erythrocyte cell number|MP:0009937,abnormal neuron differentiation|MP:0010316,increased thyroid tumor incidence|MP:0010320,increased pituitary gland tumor incidence|MP:0010345,increased thyroid C-cell carcinoma incidence|MP:0010350,increased pituitary adenohypophysis tumor incidence|MP:0010351,increased pituitary melanotroph tumor incidence|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011703,increased fibroblast proliferation
MGI:4415315	Rb1<tm2.1Brn>	MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4439301	Rb1<tm2.1Dwg>	MP:0002169,no abnormal phenotype detected
MGI:5614046	Rb1<tm2.1Fad>	MP:0001885,mammary gland duct hyperplasia|MP:0001954,respiratory distress|MP:0002006,neoplasm|MP:0003631,nervous system phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005384,cellular phenotype|MP:0009417,skeletal muscle atrophy|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4354271	Rb1<tm2.1Jyjw>	MP:0000630,mammary gland hyperplasia|MP:0001885,mammary gland duct hyperplasia|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003838,abnormal milk ejection
MGI:1931018	Rb1<tm2Brn>	MP:0000042,abnormal organ of Corti morphology|MP:0000864,abnormal cerebellum vermis morphology|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000873,thin external granule cell layer|MP:0000877,abnormal Purkinje cell morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001394,circling|MP:0001522,impaired swimming|MP:0001963,abnormal hearing physiology|MP:0001967,deafness|MP:0002006,neoplasm|MP:0002038,increased carcinoma incidence|MP:0002081,perinatal lethality|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002622,abnormal cochlear hair cell morphology|MP:0002623,abnormal vestibular hair cell morphology|MP:0002970,abnormal white adipose tissue morphology|MP:0003203,increased neuron apoptosis|MP:0003354,astrocytosis|MP:0004097,abnormal cerebellar cortex morphology|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004101,abnormal brain interneuron morphology|MP:0004324,vestibular hair cell degeneration|MP:0004327,increased vestibular hair cell number|MP:0004362,cochlear hair cell degeneration|MP:0004395,increased cochlear inner hair cell number|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004401,increased cochlear outer hair cell number|MP:0004404,cochlear outer hair cell degeneration|MP:0004407,increased cochlear hair cell number|MP:0004742,abnormal vestibular system physiology|MP:0004840,increased Deiters cell number|MP:0004948,abnormal neuronal precursor proliferation|MP:0005388,respiratory system phenotype|MP:0005391,vision/eye phenotype|MP:0008306,abnormal organ of Corti supporting cell proliferation|MP:0008883,abnormal enterocyte proliferation|MP:0010320,increased pituitary gland tumor incidence|MP:0010350,increased pituitary adenohypophysis tumor incidence|MP:0010351,increased pituitary melanotroph tumor incidence
MGI:1857341	Rb1<tm2Mlh>	MP:0000245,abnormal erythropoiesis|MP:0000602,dilated liver sinusoidal space|MP:0000606,decreased hepatocyte number|MP:0000798,abnormal frontal lobe morphology|MP:0000829,dilated fourth ventricle|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001601,abnormal myelopoiesis|MP:0001722,pale yolk sac|MP:0002006,neoplasm|MP:0002123,abnormal definitive hematopoiesis|MP:0002229,neurodegeneration|MP:0002447,abnormal erythrocyte morphology|MP:0002840,abnormal lens fiber morphology|MP:0002875,decreased erythrocyte cell number|MP:0003984,embryonic growth retardation|MP:0005391,vision/eye phenotype|MP:0006042,increased apoptosis|MP:0008254,increased megakaryocyte cell number|MP:0010351,increased pituitary melanotroph tumor incidence|MP:0011092,embryonic lethality, complete penetrance|MP:0030047,flat forehead
MGI:5638883	Rb1<tm3Fad>	MP:0012431,increased lymphoma incidence|MP:0014237,decreased tumor-free survival time
MGI:2450162	Rb1<tm3Tyj>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001222,epidermal hyperplasia|MP:0001233,abnormal epidermis suprabasal layer morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001325,abnormal retina morphology|MP:0001327,decreased retina photoreceptor cell number|MP:0001925,male infertility|MP:0002006,neoplasm|MP:0002161,abnormal fertility/fecundity|MP:0002183,gliosis|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003734,abnormal retina inner plexiform layer morphology|MP:0004025,polyploidy|MP:0004179,transmission ratio distortion|MP:0004852,decreased testis weight|MP:0005241,abnormal retina ganglion layer morphology|MP:0006096,absent retina bipolar cells|MP:0006309,decreased retina ganglion cell number|MP:0008511,thin retina inner nuclear layer|MP:0008512,disorganized retina inner nuclear layer|MP:0008513,thin retina inner plexiform layer|MP:0008515,thin retina outer nuclear layer|MP:0010320,increased pituitary gland tumor incidence|MP:0014237,decreased tumor-free survival time|MP:0030005,increased retina apoptosis
MGI:3708456	rba	MP:0001394,circling|MP:0001489,decreased startle reflex|MP:0001522,impaired swimming|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6152622	Rbbp4<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001325,abnormal retina morphology|MP:0001728,failure of embryo implantation|MP:0001914,hemorrhage|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002718,abnormal inner cell mass morphology|MP:0003054,spina bifida|MP:0003068,enlarged kidney|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0003886,abnormal embryonic epiblast morphology|MP:0005028,abnormal trophectoderm morphology|MP:0005084,abnormal gallbladder morphology|MP:0005384,cellular phenotype|MP:0005621,abnormal cell physiology|MP:0010123,increased bone mineral content|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011183,abnormal primitive endoderm morphology|MP:0012128,abnormal blastocyst formation|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3711066	Rbbp6<tm1Xya>	MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0006042,increased apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4349000	Rbbp7<Gt(Q017B06)Wrst>	MP:0001700,abnormal embryo turning|MP:0002084,abnormal developmental patterning
MGI:4455962	Rbbp7<tm1a(EUCOMM)Wtsi>	MP:0000455,abnormal maxilla morphology|MP:0002100,abnormal tooth morphology
MGI:6268411	Rbbp8nl<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system
MGI:3577029	Rbbp8<tm1Whl>	MP:0001694,absent egg cylinders|MP:0001730,embryonic growth arrest|MP:0003077,abnormal cell cycle|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012431,increased lymphoma incidence|MP:0014237,decreased tumor-free survival time
MGI:5494401	Rbbp8<tm2.1Thl>	MP:0002006,neoplasm|MP:0005384,cellular phenotype|MP:0010768,mortality/aging
MGI:5494423	Rbbp8<tm2Thl>	MP:0002006,neoplasm
MGI:6120709	Rbck1<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity
MGI:5000222	Rbck1<tm1Kiwa>	MP:0003887,increased hepatocyte apoptosis
MGI:3622228	Rbcq1<SM/J>	MP:0003131,increased erythrocyte cell number
MGI:3622230	Rbcq2<SM/J>	MP:0003131,increased erythrocyte cell number
MGI:3622232	Rbcq3<SM/J>	MP:0003131,increased erythrocyte cell number
MGI:3622235	Rbcq4<C57BLKS/J>	MP:0003131,increased erythrocyte cell number
MGI:4838179	Rbfox1<tm1.1Dblk>	MP:0001265,decreased body size|MP:0001921,reduced fertility|MP:0002064,seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0003997,tonic-clonic seizures|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0020508,decreased dendritic spine density
MGI:5695122	Rbfox1<tm1b(KOMP)Wtsi>	MP:0002764,short tibia|MP:0011100,preweaning lethality, complete penetrance
MGI:4838182	Rbfox2<tm1.1Dblk>	MP:0000074,abnormal neurocranium morphology|MP:0000102,abnormal nasal bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000428,abnormal craniofacial morphology|MP:0000431,absent palatine bone horizontal plate|MP:0000852,small cerebellum|MP:0000879,increased Purkinje cell number|MP:0000885,ectopic Purkinje cell|MP:0000890,thin cerebellar molecular layer|MP:0001061,abnormal oculomotor nerve morphology|MP:0001063,abnormal trochlear nerve morphology|MP:0001076,abnormal hypoglossal nerve morphology|MP:0001177,atelectasis|MP:0001244,thin dermal layer|MP:0001262,decreased body weight|MP:0001504,abnormal posture|MP:0001891,hydrocephaly|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002114,abnormal axial skeleton morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0003203,increased neuron apoptosis|MP:0003313,abnormal locomotor activation|MP:0003885,abnormal rostral-caudal body axis extension|MP:0004174,abnormal spine curvature|MP:0004592,small mandible|MP:0004612,fusion of vertebral bodies|MP:0004734,small thoracic cavity|MP:0004811,abnormal neuron physiology|MP:0004869,frontal bone hypoplasia|MP:0005369,muscle phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0010008,abnormal Purkinje cell migration|MP:0010831,lethality, incomplete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0013551,decreased cerebellar granule cell precursor proliferation|MP:0013848,subcutaneous edema|MP:0014167,ectopic bone|MP:0020040,decreased bone ossification|MP:0021215,abnormal palatal mesenchymal cell proliferation
MGI:4434907	Rbfox3<tm1a(EUCOMM)Hmgu>	MP:0001364,decreased anxiety-related response|MP:0001458,abnormal object recognition memory|MP:0001475,reduced long-term depression|MP:0001900,impaired synaptic plasticity|MP:0002175,decreased brain weight|MP:0002206,abnormal CNS synaptic transmission|MP:0002733,abnormal thermal nociception|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002920,decreased paired-pulse facilitation|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003631,nervous system phenotype|MP:0004981,decreased neuronal precursor cell number|MP:0005386,behavior/neurological phenotype|MP:0008026,abnormal brain white matter morphology|MP:0008921,increased neurotransmitter release|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0009937,abnormal neuron differentiation|MP:0009938,abnormal hippocampus granule cell morphology|MP:0009939,abnormal hippocampus neuron morphology|MP:0010053,decreased grip strength|MP:0012006,abnormal hippocampus physiology|MP:0012307,impaired spatial learning|MP:0014382,increased miniature inhibitory postsynaptic current frequency|MP:0020335,abnormal dentate gyrus neuron dendrite morphology|MP:0020357,abnormal excitatory synapse morphology|MP:0020394,decreased neuronal precursor proliferation|MP:0020507,increased dendritic spine density|MP:0031391,increased locomotor activity
MGI:6356625	Rbks<tm1d(EUCOMM)Wtsi>	MP:0003291,interstinal hyperperistalsis|MP:0005381,digestive/alimentary phenotype|MP:0010155,abnormal intestine physiology|MP:0011082,abnormal gastrointestinal motility
MGI:5614063	Rbl1<tm1.1Fad>	MP:0005384,cellular phenotype
MGI:5692547	Rbl1<tm1b(EUCOMM)Hmgu>	MP:0002135,abnormal kidney morphology|MP:0005292,improved glucose tolerance|MP:0010393,shortened QRS complex duration|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2385659	Rbl1<tm1Htr>	MP:0001286,abnormal eye development|MP:0001325,abnormal retina morphology|MP:0001330,abnormal optic nerve morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003734,abnormal retina inner plexiform layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005240,abnormal amacrine cell morphology|MP:0006073,abnormal retina bipolar cell morphology|MP:0006309,decreased retina ganglion cell number|MP:0008453,decreased retina rod cell number|MP:0008515,thin retina outer nuclear layer
MGI:1857798	Rbl1<tm1Mru>	MP:0000240,extramedullary hematopoiesis|MP:0000321,increased bone marrow cell number|MP:0000351,increased cell proliferation|MP:0001209,spontaneous skin ulceration|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001783,decreased white adipose tissue amount|MP:0001845,abnormal inflammatory response|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002123,abnormal definitive hematopoiesis|MP:0002356,abnormal spleen red pulp morphology|MP:0002628,hepatic steatosis|MP:0002970,abnormal white adipose tissue morphology|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0004980,increased neuronal precursor cell number|MP:0005289,increased oxygen consumption|MP:0005459,decreased percent body fat/body weight|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008907,decreased total fat pad weight|MP:0009133,decreased white fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009295,decreased interscapular fat pad weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011703,increased fibroblast proliferation
MGI:1857448	Rbl1<tm1Tyj>	MP:0002169,no abnormal phenotype detected|MP:0005384,cellular phenotype|MP:0008151,increased diameter of long bones|MP:0010771,integument phenotype
MGI:4818640	Rbl1<tm3.1Jsag>	MP:0011703,increased fibroblast proliferation
MGI:5646005	Rbl2<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1857500	Rbl2<tm1Mru>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000350,abnormal cell proliferation|MP:0000737,abnormal myotome development|MP:0000925,abnormal floor plate morphology|MP:0000926,absent floor plate|MP:0000932,absent notochord|MP:0001689,incomplete somite formation|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0002169,no abnormal phenotype detected|MP:0002652,thin myocardium|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0004180,failure of initiation of embryo turning|MP:0004251,failure of heart looping|MP:0005369,muscle phenotype|MP:0005371,limbs/digits/tail phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0005385,cardiovascular system phenotype|MP:0006042,increased apoptosis|MP:0009937,abnormal neuron differentiation|MP:0010768,mortality/aging|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013168,absent hindlimb buds
MGI:1857449	Rbl2<tm1Tyj>	MP:0002169,no abnormal phenotype detected|MP:0005384,cellular phenotype|MP:0010771,integument phenotype
MGI:6276949	Rbm10<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney
MGI:4340523	Rbm10<Gt(W081D04)Wrst>	MP:0002169,no abnormal phenotype detected
MGI:5296372	Rbm12<m1Tc>	MP:0000929,open neural tube|MP:0003632,abnormal nervous system morphology|MP:0003984,embryonic growth retardation
MGI:6455488	Rbm14<em1Wli>	MP:0001696,failure to gastrulate|MP:0002231,abnormal primitive streak morphology|MP:0003077,abnormal cell cycle|MP:0003087,absent allantois|MP:0003886,abnormal embryonic epiblast morphology|MP:0005030,absent amnion|MP:0006042,increased apoptosis|MP:0006323,abnormal extraembryonic mesoderm development|MP:0009593,absent chorion|MP:0011092,embryonic lethality, complete penetrance|MP:0011186,abnormal visceral endoderm morphology
MGI:4362139	Rbm14<tm1a(KOMP)Wtsi>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3706995	Rbm15<tm1.1Dgg>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3849068	Rbm15<tm1.1(MAL)Dgg>	MP:0000240,extramedullary hematopoiesis|MP:0002026,increased leukemia incidence|MP:0004809,increased hematopoietic stem cell number|MP:0006410,abnormal common myeloid progenitor cell morphology
MGI:4357897	Rbm15<tm1Swm>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000229,abnormal megakaryocyte differentiation|MP:0002123,abnormal definitive hematopoiesis|MP:0002874,decreased hemoglobin content|MP:0004809,increased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0008254,increased megakaryocyte cell number|MP:0008476,increased spleen red pulp amount
MGI:3843656	Rbm19<Gt(XC768)Byg>	MP:0001730,embryonic growth arrest|MP:0003111,abnormal cell nucleus morphology|MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012111,failure of morula compaction
MGI:6437154	Rbm20<em1Hide>	MP:0000274,enlarged heart|MP:0000280,thin ventricular wall|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0003233,prolonged QT interval|MP:0003896,prolonged PR interval|MP:0004071,prolonged P wave|MP:0005140,decreased cardiac muscle contractility|MP:0006110,ventricular fibrillation|MP:0008543,atrial fibrillation|MP:0008950,ventricular tachycardia|MP:0010392,prolonged QRS complex duration|MP:0011919,abnormal R wave|MP:0011925,abnormal heart echocardiography feature|MP:0031302,syncope
MGI:6293845	Rbm20<em1(IMPC)Mbp>	MP:0000277,abnormal heart shape|MP:0000692,small spleen|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001333,absent optic nerve|MP:0001552,increased circulating triglyceride level|MP:0002699,abnormal vitreous body morphology
MGI:7276163	Rbm20<em2Wguo>	MP:0000266,abnormal heart morphology|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0008725,increased heart atrium size|MP:0011925,abnormal heart echocardiography feature|MP:0021158,decreased heart left ventricle wall thickness
MGI:6437214	Rbm20<em3Hide>	MP:0003233,prolonged QT interval|MP:0005140,decreased cardiac muscle contractility|MP:0008543,atrial fibrillation|MP:0011925,abnormal heart echocardiography feature
MGI:7266849	Rbm20<em3Wguo>	MP:0000266,abnormal heart morphology|MP:0002083,premature death|MP:0002652,thin myocardium|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003105,abnormal heart atrium morphology|MP:0003901,abnormal PR interval|MP:0004009,abnormal diastolic filling velocity|MP:0004070,abnormal P wave|MP:0004085,abnormal heartbeat|MP:0004090,abnormal sarcomere morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0008725,increased heart atrium size|MP:0010504,abnormal RR interval|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5551818	Rbm20<tm1Hgra>	MP:0000278,abnormal myocardial fiber morphology|MP:0003141,cardiac fibrosis|MP:0003921,abnormal heart left ventricle morphology|MP:0004090,abnormal sarcomere morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005385,cardiovascular system phenotype|MP:0011952,decreased cardiac stroke volume
MGI:5564779	Rbm20<tm2.1Hgra>	MP:0000278,abnormal myocardial fiber morphology|MP:0002332,abnormal exercise endurance|MP:0003921,abnormal heart left ventricle morphology
MGI:6152623	Rbm22<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001914,hemorrhage|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0002631,abnormal epididymis morphology|MP:0002833,increased heart weight|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0003054,spina bifida|MP:0003271,abnormal duodenum morphology|MP:0004931,enlarged epididymis|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5750474	Rbm22<tm1.1(KOMP)Vlcg>	MP:0000062,increased bone mineral density|MP:0001489,decreased startle reflex|MP:0003960,increased lean body mass|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6149956	Rbm24<tm1.1Xch>	MP:0000299,failure of atrioventricular cushion closure|MP:0000300,thin atrioventricular cushion|MP:0003984,embryonic growth retardation|MP:0010503,myocardial trabeculae hypoplasia|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:7408183	Rbm24<tm1.1Xixu>	MP:0001263,weight loss|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0004094,abnormal M line morphology|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011925,abnormal heart echocardiography feature|MP:0031392,hypoactivity|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5784893	Rbm25<em1(IMPC)J>	MP:0001293,anophthalmia|MP:0001304,cataract|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5630069	Rbm26<tm1b(KOMP)Mbp>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:7612606	Rbm28<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:5637065	Rbm33<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5692588	Rbm34<tm1b(EUCOMM)Hmgu>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5688508	Rbm38<tm1.1Xch>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000333,decreased bone marrow cell number|MP:0000691,enlarged spleen|MP:0001209,spontaneous skin ulceration|MP:0001263,weight loss|MP:0001577,anemia|MP:0001658,increased mortality induced by gamma-irradiation|MP:0002020,increased tumor incidence|MP:0002447,abnormal erythrocyte morphology|MP:0002874,decreased hemoglobin content|MP:0003667,increased hemangiosarcoma incidence|MP:0003786,premature aging|MP:0008254,increased megakaryocyte cell number|MP:0008478,increased spleen white pulp amount|MP:0009283,decreased gonadal fat pad weight|MP:0010025,decreased total body fat amount|MP:0010264,increased hepatoma incidence|MP:0012431,increased lymphoma incidence|MP:0014237,decreased tumor-free survival time|MP:0031253,lordokyphosis
MGI:6403708	Rbm39<em1(IMPC)Hmgu>	MP:0002753,dilated heart left ventricle|MP:0005140,decreased cardiac muscle contractility|MP:0013278,decreased fasting circulating glucose level
MGI:2679203	Rbm39<Gt(U3Betageo)1Ruiz>	MP:0011091,prenatal lethality, complete penetrance
MGI:3869024	Rbm3<Gt(PST7787)Mfgc>	MP:0002084,abnormal developmental patterning|MP:0006386,absent somites
MGI:5569944	Rbm3<tm1.1(KOMP)Vlcg>	MP:0000598,abnormal liver morphology
MGI:5285686	Rbm3<tm1Ttg>	MP:0003077,abnormal cell cycle|MP:0005387,immune system phenotype|MP:0011704,decreased fibroblast proliferation
MGI:3872331	Rbm41<Gt(W007A05)Wrst>	MP:0002169,no abnormal phenotype detected
MGI:8161451	Rbm43<em1Brsp>	MP:0001876,decreased inflammatory response|MP:0002419,abnormal innate immunity|MP:0004889,increased energy expenditure|MP:0005292,improved glucose tolerance|MP:0005375,adipose tissue phenotype|MP:0005378,growth/size/body region phenotype|MP:0005670,abnormal white adipose tissue physiology|MP:0008469,abnormal protein level|MP:0010954,abnormal cellular respiration|MP:0010959,abnormal oxidative phosphorylation|MP:0011167,abnormal adipose tissue development|MP:0013245,abnormal lipid metabolism|MP:0013272,abnormal translation|MP:0014397,increased fat cell mitochondrial DNA content|MP:0014398,abnormal fat cell mitochondrial morphology
MGI:4949229	Rbm44<tm1.1Zuk>	MP:0001934,increased litter size|MP:0030603,increased sperm number|MP:0031425,enhanced male fertility
MGI:6400536	Rbm45<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0000562,polydactyly|MP:0001293,anophthalmia|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002111,abnormal tail morphology|MP:0003385,abnormal body wall morphology|MP:0003743,abnormal facial morphology|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape
MGI:7356597	Rbm46<em1Rpc>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001924,infertility|MP:0004805,absent oocytes|MP:0004852,decreased testis weight
MGI:7356598	Rbm46<em2Rpc>	MP:0002169,no abnormal phenotype detected
MGI:7356604	Rbm46<em3Rpc>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0004852,decreased testis weight
MGI:3888581	Rbm47<Gt(D027B04)Wrst>	MP:0001265,decreased body size|MP:0002169,no abnormal phenotype detected|MP:0005621,abnormal cell physiology|MP:0008770,decreased survivor rate|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6357918	Rbm48<em1(IMPC)J>	MP:0001404,no spontaneous movement|MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance
MGI:5603573	Rbm4b<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001759,increased urine glucose level|MP:0002574,increased vertical activity|MP:0005344,increased circulating bilirubin level|MP:0011396,abnormal sleep behavior
MGI:5467988	Rbm4b<tm1Wtarn>	MP:0001559,hyperglycemia|MP:0005293,impaired glucose tolerance|MP:0009172,small pancreatic islets
MGI:4435180	Rbm4<tm1a(EUCOMM)Hmgu>	MP:0008497,decreased IgG2b level
MGI:5467987	Rbm4<tm1Wtarn>	MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0009172,small pancreatic islets|MP:0010147,abnormal endocrine pancreas physiology
MGI:5563424	Rbm5<sda>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0003205,testicular atrophy|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005388,respiratory system phenotype|MP:0006380,abnormal spermatid morphology|MP:0008279,arrest of spermiogenesis|MP:0008280,abnormal male germ cell apoptosis|MP:0014052,increased male germ cell apoptosis
MGI:6104257	Rbm6<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001488,increased startle reflex|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0010053,decreased grip strength|MP:0013278,decreased fasting circulating glucose level
MGI:6456581	Rbm7<em1Aki>	MP:0000223,decreased monocyte cell number|MP:0003333,liver fibrosis|MP:0003985,renal fibrosis|MP:0005166,decreased susceptibility to injury|MP:0006050,pulmonary fibrosis
MGI:5644432	Rbm8a<tm1Dlsi>	MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000934,abnormal telencephalon development|MP:0003203,increased neuron apoptosis|MP:0003424,premature neuronal precursor differentiation|MP:0003648,abnormal radial glial cell morphology|MP:0004981,decreased neuronal precursor cell number|MP:0006254,thin cerebral cortex|MP:0008947,increased neuron number|MP:0008948,decreased neuron number|MP:0011724,ectopic cortical neuron|MP:0011827,impaired neuron differentiation|MP:0012504,increased forebrain apoptosis|MP:0013227,small brain ventricles|MP:0020069,decreased neocortex size|MP:0020388,decreased radial glial cell number|MP:0020392,abnormal radial glial cell apoptosis|MP:0020393,increased neuronal precursor proliferation
MGI:5636998	Rbms1<tm1b(EUCOMM)Wtsi>	MP:0000274,enlarged heart|MP:0000367,abnormal coat/ hair morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0011100,preweaning lethality, complete penetrance
MGI:2384095	Rbms1<tm1Hiro>	MP:0001698,decreased embryo size|MP:0002637,small uterus|MP:0003984,embryonic growth retardation|MP:0005185,decreased circulating progesterone level|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:6355368	Rbmxl2<tm1.2Dell>	MP:0001147,small testis|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0005621,abnormal cell physiology|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis|MP:0014633,decreased spermatid number|MP:0014634,decreased round spermatid number|MP:0014636,decreased elongated spermatid number
MGI:4363716	Rbmx<tm2a(KOMP)Wtsi>	MP:0002079,increased circulating insulin level
MGI:5558151	Rbmx<tm2b(KOMP)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003019,increased circulating chloride level|MP:0003917,increased kidney weight|MP:0010052,increased grip strength
MGI:2181412	Rbp1<tm1Ipc>	MP:0000219,increased neutrophil cell number|MP:0000322,increased granulocyte number|MP:0000598,abnormal liver morphology|MP:0000609,abnormal liver physiology|MP:0001153,small seminiferous tubules|MP:0001325,abnormal retina morphology|MP:0001732,postnatal growth retardation|MP:0002216,abnormal seminiferous tubule morphology|MP:0003011,delayed dark adaptation|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005253,abnormal eye physiology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005444,abnormal retinol metabolism|MP:0005551,abnormal eye electrophysiology|MP:0011234,abnormal retinol level|MP:0011750,abnormal seminiferous tubule epithelium morphology
MGI:5637217	Rbp1<tm2b(EUCOMM)Hmgu>	MP:0010053,decreased grip strength|MP:0013278,decreased fasting circulating glucose level
MGI:2672086	Rbp2<tm1Eli>	MP:0001671,abnormal vitamin absorption|MP:0003718,maternal effect|MP:0011234,abnormal retinol level
MGI:2183368	Rbp3<tm1Gil>	MP:0003729,abnormal photoreceptor outer segment morphology|MP:0005551,abnormal eye electrophysiology|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment
MGI:5548967	Rbp4<tm1.1(KOMP)Vlcg>	MP:0001289,persistence of hyaloid vascular system|MP:0005561,increased mean corpuscular hemoglobin|MP:0006203,eye hemorrhage
MGI:3625605	Rbp4<tm1.1Mma>	MP:0001146,abnormal testis morphology|MP:0001156,abnormal spermatogenesis|MP:0001929,abnormal gametogenesis|MP:0003698,abnormal male reproductive system physiology|MP:0005400,abnormal vitamin level|MP:0006380,abnormal spermatid morphology|MP:0011234,abnormal retinol level|MP:0014684,impaired spermiation
MGI:2445721	Rbp4<tm1Gott>	MP:0000285,abnormal heart valve morphology|MP:0000295,trabecula carnea hypoplasia|MP:0001325,abnormal retina morphology|MP:0002090,abnormal vision|MP:0003567,abnormal fetal cardiomyocyte proliferation|MP:0004056,abnormal myocardium compact layer morphology|MP:0005551,abnormal eye electrophysiology|MP:0011234,abnormal retinol level
MGI:3625604	Rbp4<tm1Mma>	MP:0002169,no abnormal phenotype detected
MGI:6196354	Rbp4<tm2Zhel>	MP:0001325,abnormal retina morphology|MP:0002864,abnormal ocular fundus morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0008507,thin retina ganglion layer|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008587,short photoreceptor outer segment|MP:0011234,abnormal retinol level|MP:0011965,decreased total retina thickness|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0012147,increased a-wave implicit time|MP:0012150,increased b-wave implicit time
MGI:3590573	Rbp7<tm1Vgl>	MP:0011232,abnormal vitamin A level
MGI:5636933	Rbpjl<tm1b(KOMP)Wtsi>	MP:0001402,decreased locomotor activity|MP:0001410,head bobbing|MP:0008806,increased circulating amylase level
MGI:2387866	Rbpjl<tm1Hon>	MP:0002169,no abnormal phenotype detected
MGI:3807508	Rbpj<tm1.1Hon>	MP:0002792,abnormal retina vasculature morphology
MGI:3809244	Rbpj<tm1.1Rsch>	MP:0011091,prenatal lethality, complete penetrance
MGI:5606039	Rbpj<tm1.1Wtp>	MP:0002169,no abnormal phenotype detected
MGI:5614604	Rbpj<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000186,decreased circulating HDL cholesterol level|MP:0001488,increased startle reflex|MP:0005292,improved glucose tolerance|MP:0005344,increased circulating bilirubin level|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3583755	Rbpj<tm1Hon>	MP:0000220,increased monocyte cell number|MP:0000267,abnormal heart development|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000371,diluted coat color|MP:0000488,abnormal intestinal epithelium morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0000729,abnormal myogenesis|MP:0001186,pigmentation phenotype|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001280,loss of vibrissae|MP:0001404,no spontaneous movement|MP:0001436,abnormal suckling behavior|MP:0001790,abnormal immune system physiology|MP:0001825,arrested T cell differentiation|MP:0001953,respiratory failure|MP:0002144,abnormal B cell differentiation|MP:0002151,abnormal neural tube morphology|MP:0002279,abnormal diaphragm morphology|MP:0002280,abnormal intercostal muscle morphology|MP:0002401,abnormal lymphopoiesis|MP:0002412,increased susceptibility to bacterial infection|MP:0003009,abnormal cytokine secretion|MP:0003246,loss of GABAergic neurons|MP:0003247,abnormal glutaminergic neuron morphology|MP:0003359,hypaxial muscle hypoplasia|MP:0003414,epidermal cyst|MP:0003447,decreased tumor growth/size|MP:0003449,abnormal intestine goblet cell morphology|MP:0003833,decreased satellite cell number|MP:0003845,abnormal decidualization|MP:0004248,abnormal epaxial muscle morphology|MP:0004381,abnormal hair follicle melanocyte morphology|MP:0004382,abnormal hair follicle melanogenesis|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004946,abnormal regulatory T cell physiology|MP:0004981,decreased neuronal precursor cell number|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005076,abnormal cell differentiation|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005114,premature hair loss|MP:0005171,absent coat pigmentation|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0005390,skeleton phenotype|MP:0005425,increased macrophage cell number|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0008082,increased single-positive T cell number|MP:0008083,decreased single-positive T cell number|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008127,decreased dendritic cell number|MP:0008137,absent podocytes|MP:0008173,increased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008200,decreased follicular dendritic cell number|MP:0008502,increased IgG3 level|MP:0008524,increased plasmacytoid dendritic cell number|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0009338,increased splenocyte number|MP:0009408,decreased skeletal muscle fiber density|MP:0009783,abnormal melanoblast morphology|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0009937,abnormal neuron differentiation|MP:0010183,abnormal CD4-positive helper T cell morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0012023,decreased melanocyte number|MP:0021095,abnormal dorsal interneuron 4 morphology
MGI:1857411	Rbpj<tm1Kyo>	MP:0000295,trabecula carnea hypoplasia|MP:0000364,abnormal vascular regression|MP:0001614,abnormal blood vessel morphology|MP:0001800,abnormal humoral immune response|MP:0002190,disorganized myocardium|MP:0002747,abnormal aortic valve morphology|MP:0003141,cardiac fibrosis|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004784,abnormal anterior cardinal vein morphology|MP:0004786,abnormal common cardinal vein morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0005025,abnormal response to infection|MP:0005140,decreased cardiac muscle contractility|MP:0005329,abnormal myocardium layer morphology|MP:0006093,arteriovenous malformation|MP:0008700,decreased interleukin-4 secretion|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0010593,thick aortic valve cusps|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0011925,abnormal heart echocardiography feature|MP:0012099,decreased spongiotrophoblast size|MP:0031124,aortic valve inflammation|MP:0031518,calcified aortic valve cusp
MGI:3809241	Rbpj<tm1Rsch>	MP:0001664,abnormal digestion|MP:0001732,postnatal growth retardation|MP:0001944,abnormal pancreas morphology|MP:0003934,abnormal pancreas development|MP:0004247,small pancreas|MP:0009149,decreased pancreatic acinar cell number|MP:0009168,decreased pancreatic islet number|MP:0009176,increased pancreatic alpha cell number|MP:0009179,abnormal pancreatic alpha cell differentiation|MP:0009254,disorganized pancreatic islets|MP:0011085,postnatal lethality, complete penetrance
MGI:5755482	Rbpms2<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0000579,abnormal nail morphology|MP:0001303,abnormal lens morphology|MP:0001926,female infertility|MP:0002075,abnormal coat/hair pigmentation|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:8226419	Rbpms2<tm1.1Thbr>	MP:0010768,mortality/aging
MGI:7287467	Rbpms<em1Eno>	MP:0000284,double outlet right ventricle|MP:0001575,cyanosis|MP:0003139,patent ductus arteriosus|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0005386,behavior/neurological phenotype|MP:0005388,respiratory system phenotype|MP:0010402,ventricular septal defect|MP:0010556,thin ventricle myocardium compact layer|MP:0010725,thin interventricular septum|MP:0010909,pulmonary alveolar hemorrhage|MP:0011085,postnatal lethality, complete penetrance|MP:0014519,myocardial ventricular hypertrabeculation|MP:0031611,decreased fetal cardiomyocyte number
MGI:6257465	Rbpms<em1(IMPC)H>	MP:0002968,increased circulating alkaline phosphatase level|MP:0011100,preweaning lethality, complete penetrance
MGI:3864173	Rbpms<Gt(AS0009)Wtsi>	MP:0000477,abnormal intestine morphology|MP:0002083,premature death|MP:0008725,increased heart atrium size|MP:0008802,abnormal intestinal smooth muscle morphology|MP:0014724,increased binucleate cardiomyocyte number|MP:0014727,premature cardiomyocyte maturation
MGI:8226420	Rbpms<tm1.1Thbr>	MP:0000278,abnormal myocardial fiber morphology|MP:0000692,small spleen|MP:0002083,premature death|MP:0002188,small heart|MP:0009511,distended stomach|MP:0010768,mortality/aging|MP:0011881,distended duodenum|MP:0014727,premature cardiomyocyte maturation
MGI:4441653	Rbsn<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:3842436	Rbx1<Gt(XB674)Byg>	MP:0000352,decreased cell proliferation|MP:0001698,decreased embryo size|MP:0003077,abnormal cell cycle|MP:0009781,abnormal preimplantation embryo development|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3870403	Rc3h1<Gt(CC0753)Wtsi>	MP:0001858,intestinal inflammation|MP:0009482,ileum inflammation|MP:0031301,chronic liver inflammation
MGI:5789557	Rc3h1<m1Btlr>	MP:0001262,decreased body weight|MP:0003051,curly tail
MGI:3581675	Rc3h1<san>	MP:0000491,crypts of Lieberkuhn abscesses|MP:0000512,intestinal ulcer|MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0001654,hepatic necrosis|MP:0001829,increased activated T cell number|MP:0001860,liver inflammation|MP:0002024,increased T cell derived lymphoma incidence|MP:0002145,abnormal T cell differentiation|MP:0002339,abnormal lymph node morphology|MP:0002435,abnormal effector T cell morphology|MP:0002493,increased IgG level|MP:0002500,granulomatous inflammation|MP:0002743,glomerulonephritis|MP:0002816,colitis|MP:0003179,thrombocytopenia|MP:0003306,small intestinal inflammation|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0004952,increased spleen weight|MP:0005348,increased T cell proliferation|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008108,abnormal small intestinal villus morphology|MP:0008522,abnormal lymph node germinal center morphology|MP:0008553,increased circulating tumor necrosis factor level|MP:0008895,abnormal intraepithelial T cell number|MP:0009481,cecum inflammation|MP:0009482,ileum inflammation|MP:0010186,increased T follicular helper cell number|MP:0010189,abnormal T follicular helper cell physiology|MP:0031301,chronic liver inflammation
MGI:5301575	Rc3h1<tm1.1Mass>	MP:0000333,decreased bone marrow cell number|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0001807,decreased IgA level|MP:0002144,abnormal B cell differentiation|MP:0002435,abnormal effector T cell morphology|MP:0004952,increased spleen weight|MP:0004973,increased regulatory T cell number|MP:0005011,increased eosinophil cell number|MP:0005014,increased B cell number|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0005425,increased macrophage cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008192,abnormal germinal center B cell physiology|MP:0008215,decreased immature B cell number|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008495,decreased IgG1 level|MP:0008498,decreased IgG3 level|MP:0008501,increased IgG2b level|MP:0009338,increased splenocyte number
MGI:5508923	Rc3h1<tm1.2Cgv>	MP:0001176,abnormal lung development|MP:0003720,abnormal neural tube closure|MP:0011089,perinatal lethality, complete penetrance
MGI:5301574	Rc3h1<tm1.2Mass>	MP:0000691,enlarged spleen|MP:0000704,abnormal thymus development|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002435,abnormal effector T cell morphology|MP:0003051,curly tail|MP:0004703,abnormal vertebral column morphology|MP:0004952,increased spleen weight|MP:0005387,immune system phenotype|MP:0010819,primary atelectasis|MP:0011087,neonatal lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5508928	Rc3h2<tm1.2Cgv>	MP:0005387,immune system phenotype|MP:0008560,increased tumor necrosis factor secretion|MP:0011078,increased macrophage cytokine production
MGI:4364357	Rc3h2<tm1a(KOMP)Wtsi>	MP:0001176,abnormal lung development|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0003631,nervous system phenotype|MP:0005371,limbs/digits/tail phenotype|MP:0005387,immune system phenotype|MP:0010995,abnormal lung alveolus development|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5509140	Rc3h2<tm1c(KOMP)Wtsi>	MP:0005387,immune system phenotype
MGI:5790056	Rcan1<tm1b(KOMP)Wtsi>	MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount
MGI:3783735	Rcan1<tm1Emar>	MP:0001739,abnormal adrenal gland secretion|MP:0003674,oxidative stress
MGI:2450144	Rcan1<tm1Eno>	MP:0000266,abnormal heart morphology|MP:0002834,decreased heart weight|MP:0004486,decreased response of heart to induced stress
MGI:2674908	Rcan1<tm1Fmc>	MP:0005095,decreased T cell proliferation|MP:0005416,abnormal circulating protein level|MP:0005465,abnormal T-helper 1 physiology|MP:0006412,abnormal T cell apoptosis|MP:0008496,decreased IgG2a level|MP:0008567,decreased interferon-gamma secretion|MP:0008735,increased susceptibility to endotoxin shock
MGI:3641540	Rcan1<tm1Jmol>	MP:0000343,abnormal response to cardiac infarction|MP:0001262,decreased body weight|MP:0001921,reduced fertility|MP:0002833,increased heart weight|MP:0004486,decreased response of heart to induced stress|MP:0005329,abnormal myocardium layer morphology
MGI:4941349	Rcan2<tm1Ypt>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001732,postnatal growth retardation|MP:0002764,short tibia|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0005292,improved glucose tolerance|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009289,decreased epididymal fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0011940,decreased food intake|MP:0011957,decreased compensatory feeding amount|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:6314562	Rcan3<em1(IMPC)J>	MP:0010393,shortened QRS complex duration
MGI:6431098	Rcbtb2<tm1.1Xyw>	MP:0000691,enlarged spleen|MP:0002020,increased tumor incidence|MP:0008019,increased liver tumor incidence|MP:0008466,enlarged mesenteric lymph nodes|MP:0009278,abnormal bone marrow cell physiology|MP:0009321,increased histiocytic sarcoma incidence|MP:0009333,abnormal splenocyte physiology|MP:0010279,increased gastrointestinal tumor incidence|MP:0012431,increased lymphoma incidence
MGI:6342905	Rcc1<em1(IMPC)Tcp>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6392239	Rcc1l<m1Dgr>	MP:0013292,embryonic lethality prior to organogenesis
MGI:4435393	Rcc1l<tm1a(EUCOMM)Hmgu>	MP:0008495,decreased IgG1 level
MGI:5692719	Rcc2<tm1b(EUCOMM)Wtsi>	MP:0001325,abnormal retina morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002591,decreased mean corpuscular volume|MP:0002833,increased heart weight|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0008259,abnormal optic disk morphology
MGI:5609358	Rccd1<tm1.1(KOMP)Wtsi>	MP:0001406,abnormal gait|MP:0004357,long tibia
MGI:1857763	Rce1<tm1Kim>	MP:0001265,decreased body size|MP:0011085,postnatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:2447870	Rce1<tm2Kim>	MP:0005370,liver/biliary system phenotype
MGI:5293227	Rchy1<tm1.1Raz>	MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death
MGI:5613634	Rcn1<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002699,abnormal vitreous body morphology|MP:0002764,short tibia|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0005566,decreased blood urea nitrogen level|MP:0010097,abnormal retina blood vessel morphology
MGI:6369411	Rcn2<tm1b(KOMP)Wtsi>	MP:0000249,abnormal blood vessel physiology|MP:0002626,increased heart rate|MP:0002843,decreased systemic arterial blood pressure|MP:0005367,renal/urinary system phenotype|MP:0012046,decreased susceptibility to hypertension
MGI:5692599	Rcn3<tm1b(EUCOMM)Hmgu>	MP:0001785,edema|MP:0009908,protruding tongue|MP:0011100,preweaning lethality, complete penetrance
MGI:6356297	Rcn3<tm1Rzm>	MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0004777,abnormal phospholipid level|MP:0004781,abnormal surfactant composition|MP:0006027,impaired lung alveolus development|MP:0010890,decreased alveolar lamellar body number|MP:0010898,abnormal pulmonary alveolus epithelium morphology|MP:0010903,abnormal pulmonary alveolus wall morphology|MP:0010993,decreased surfactant secretion|MP:0011087,neonatal lethality, complete penetrance|MP:0031006,increased lung glycogen level
MGI:5581612	Rcor1<tm2.1Gman>	MP:0002169,no abnormal phenotype detected
MGI:5581675	Rcor1<tm2.2Gman>	MP:0004229,abnormal embryonic erythropoiesis|MP:0008973,decreased erythroid progenitor cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:5806455	Rcor2<tm1c(EUCOMM)Wtsi>	MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0003077,abnormal cell cycle|MP:0004811,abnormal neuron physiology|MP:0004981,decreased neuronal precursor cell number|MP:0006254,thin cerebral cortex|MP:0009974,decreased cerebral cortex pyramidal cell number|MP:0020394,decreased neuronal precursor proliferation
MGI:6317336	Rcor3<em1(IMPC)J>	MP:0001489,decreased startle reflex|MP:0002590,increased mean corpuscular volume|MP:0004738,abnormal auditory brainstem response
MGI:3584102	Rcvrn<tm1Clma>	MP:0005253,abnormal eye physiology|MP:0005551,abnormal eye electrophysiology
MGI:3045621	rd13	MP:0008515,thin retina outer nuclear layer
MGI:4867488	rd14	MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0001406,abnormal gait|MP:0005551,abnormal eye electrophysiology|MP:0012671,retina spots
MGI:5906381	rd21	MP:0001326,retina degeneration|MP:0002792,abnormal retina vasculature morphology|MP:0003099,retina detachment|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0010749,absent visual evoked potential
MGI:7638770	rd22	MP:0001005,abnormal retina rod cell morphology|MP:0001006,abnormal retina cone cell morphology|MP:0001326,retina degeneration|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005253,abnormal eye physiology|MP:0005389,reproductive system phenotype|MP:0005551,abnormal eye electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008451,retina rod cell degeneration|MP:0008455,abnormal retina rod cell inner segment morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:7643884	rd24	MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0012029,abnormal electroretinogram waveform feature|MP:0012144,decreased b-wave amplitude|MP:0014658,absent a-wave
MGI:7660543	rd25	MP:0001326,retina degeneration|MP:0004021,abnormal rod electrophysiology|MP:0008451,retina rod cell degeneration
MGI:7662983	rd26	MP:0001326,retina degeneration|MP:0005551,abnormal eye electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0010749,absent visual evoked potential
MGI:6257739	Rd3<em1(IMPC)Bay>	MP:0001325,abnormal retina morphology|MP:0002608,increased hematocrit|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011959,abnormal eye posterior chamber depth|MP:0011960,abnormal eye anterior chamber depth|MP:0011965,decreased total retina thickness
MGI:1857014	Rd3<rd3>	MP:0003728,abnormal retina photoreceptor layer morphology|MP:0005551,abnormal eye electrophysiology|MP:0008450,retina photoreceptor degeneration|MP:0008454,absent retina rod cells|MP:0008515,thin retina outer nuclear layer
MGI:3055794	rda	MP:0000043,organ of Corti degeneration|MP:0001394,circling|MP:0001967,deafness|MP:0002857,cochlear ganglion degeneration|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0004530,absent outer hair cell stereocilia|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004533,fused inner hair cell stereocilia|MP:0005377,hearing/vestibular/ear phenotype|MP:0006359,absent startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3799307	Rdh10<m366Asp>	MP:0000428,abnormal craniofacial morphology|MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0002092,abnormal eye morphology|MP:0002109,abnormal limb morphology|MP:0003631,nervous system phenotype|MP:0006254,thin cerebral cortex
MGI:5294926	Rdh10<tm1.1Ics>	MP:0000267,abnormal heart development|MP:0000270,abnormal heart tube morphology|MP:0000470,abnormal stomach morphology|MP:0000477,abnormal intestine morphology|MP:0000564,syndactyly|MP:0000600,liver hypoplasia|MP:0001181,absent lungs|MP:0001286,abnormal eye development|MP:0001306,small lens|MP:0001394,circling|MP:0001544,abnormal cardiovascular system physiology|MP:0001672,abnormal embryo development|MP:0001680,abnormal mesoderm development|MP:0001701,incomplete embryo turning|MP:0002109,abnormal limb morphology|MP:0002544,brachydactyly|MP:0002633,persistent truncus arteriosus|MP:0002884,abnormal pharyngeal arch morphology|MP:0003446,renal hypoplasia|MP:0003935,abnormal craniofacial development|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0004310,small otic vesicle|MP:0005380,embryo phenotype|MP:0006108,abnormal hindbrain development|MP:0008797,facial cleft|MP:0009111,pancreas hypoplasia|MP:0009806,abnormal otic vesicle morphology|MP:0010707,decreased ventral retina size|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011111,lethality during fetal growth through weaning, complete penetrance|MP:0013166,small forelimb buds|MP:0013241,embryo tissue necrosis
MGI:4362599	Rdh10<tm1a(KOMP)Wtsi>	MP:0000270,abnormal heart tube morphology|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0003874,absent pharyngeal arches|MP:0003885,abnormal rostral-caudal body axis extension|MP:0003984,embryonic growth retardation|MP:0004251,failure of heart looping|MP:0004310,small otic vesicle|MP:0011732,decreased somite size
MGI:5429723	Rdh10<tm1c(KOMP)Wtsi>	MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0003698,abnormal male reproductive system physiology|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype|MP:0006378,abnormal spermatogonia morphology|MP:0008261,arrest of male meiosis|MP:0031464,abnormal spontaneous fetal mouth movement
MGI:5429724	Rdh10<tm1d(KOMP)Wtsi>	MP:0000270,abnormal heart tube morphology|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001730,embryonic growth arrest|MP:0003984,embryonic growth retardation|MP:0004251,failure of heart looping|MP:0004310,small otic vesicle|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011233,abnormal vitamin A metabolism|MP:0011732,decreased somite size
MGI:5294925	Rdh10<tm1Ics>	MP:0002169,no abnormal phenotype detected
MGI:5294929	Rdh10<tm2Ics>	MP:0000267,abnormal heart development|MP:0000270,abnormal heart tube morphology|MP:0000470,abnormal stomach morphology|MP:0000477,abnormal intestine morphology|MP:0000564,syndactyly|MP:0000600,liver hypoplasia|MP:0001181,absent lungs|MP:0001286,abnormal eye development|MP:0001306,small lens|MP:0001394,circling|MP:0001544,abnormal cardiovascular system physiology|MP:0001672,abnormal embryo development|MP:0001680,abnormal mesoderm development|MP:0001701,incomplete embryo turning|MP:0002109,abnormal limb morphology|MP:0002544,brachydactyly|MP:0002633,persistent truncus arteriosus|MP:0002884,abnormal pharyngeal arch morphology|MP:0003446,renal hypoplasia|MP:0003935,abnormal craniofacial development|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0004310,small otic vesicle|MP:0005380,embryo phenotype|MP:0006108,abnormal hindbrain development|MP:0008797,facial cleft|MP:0009111,pancreas hypoplasia|MP:0009806,abnormal otic vesicle morphology|MP:0010707,decreased ventral retina size|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011111,lethality during fetal growth through weaning, complete penetrance|MP:0013166,small forelimb buds|MP:0013241,embryo tissue necrosis
MGI:4437845	Rdh10<trex>	MP:0000108,midline facial cleft|MP:0000269,abnormal heart looping|MP:0000428,abnormal craniofacial morphology|MP:0000550,abnormal forelimb morphology|MP:0000553,absent radius|MP:0000601,small liver|MP:0001081,abnormal cranial ganglia morphology|MP:0001082,abnormal geniculate ganglion morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001096,abnormal glossopharyngeal ganglion morphology|MP:0001100,abnormal vagus ganglion morphology|MP:0001116,small gonad|MP:0001176,abnormal lung development|MP:0001178,pulmonary hypoplasia|MP:0001286,abnormal eye development|MP:0001306,small lens|MP:0001325,abnormal retina morphology|MP:0001914,hemorrhage|MP:0002691,small stomach|MP:0002884,abnormal pharyngeal arch morphology|MP:0003425,abnormal optic vesicle formation|MP:0003655,absent pancreas|MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0003874,absent pharyngeal arches|MP:0003936,abnormal reproductive system development|MP:0004310,small otic vesicle|MP:0004787,abnormal dorsal aorta morphology|MP:0004872,absent nasal septum|MP:0005380,embryo phenotype|MP:0006030,abnormal otic vesicle development|MP:0006126,abnormal cardiac outflow tract development|MP:0006280,abnormal digit development|MP:0006292,abnormal nasal placode morphology|MP:0006339,abnormal third pharyngeal arch morphology|MP:0006340,abnormal fourth pharyngeal arch morphology|MP:0006347,abnormal sixth pharyngeal arch morphology|MP:0008797,facial cleft|MP:0008986,abnormal liver parenchyma morphology|MP:0009705,abnormal midgut morphology|MP:0009806,abnormal otic vesicle morphology|MP:0009901,abnormal frontonasal prominence morphology|MP:0009902,abnormal lateral nasal prominence morphology|MP:0009903,abnormal medial nasal prominence morphology|MP:0010356,abnormal second pharyngeal arch artery morphology|MP:0010642,absent third pharyngeal arch|MP:0010643,absent fourth pharyngeal arch|MP:0010644,absent sixth pharyngeal arch|MP:0010907,absent lung buds|MP:0010940,abnormal maxillary prominence morphology|MP:0011026,impaired branching involved in trachea morphogenesis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011233,abnormal vitamin A metabolism|MP:0011364,abnormal metanephros morphology|MP:0012247,absent cornea|MP:0012270,cardiac edema|MP:0013164,abnormal forelimb bud morphology|MP:0013166,small forelimb buds|MP:0013817,absent nasal cavity|MP:0014291,decreased autopod size|MP:0020350,fused pharyngeal arches|MP:0030250,frontonasal prominence hypoplasia|MP:0030334,absent sixth pharyngeal arch artery|MP:0030335,absent third pharyngeal arch artery
MGI:3586379	Rdh11<tm1Akjc>	MP:0003011,delayed dark adaptation
MGI:3526658	Rdh11<tm1Tsyk>	MP:0003011,delayed dark adaptation|MP:0005389,reproductive system phenotype
MGI:3700208	Rdh12<tm1.1Cahb>	MP:0006069,abnormal retina neuronal layer morphology
MGI:3696994	Rdh12<tm1Kpal>	MP:0003011,delayed dark adaptation|MP:0005253,abnormal eye physiology|MP:0005551,abnormal eye electrophysiology|MP:0006069,abnormal retina neuronal layer morphology|MP:0006072,abnormal retina apoptosis|MP:0014336,short retina rod cell outer segment
MGI:5007302	Rdh13<tm1Lex>	MP:0003312,abnormal locomotor coordination
MGI:5467544	Rdh13<tm1Xuxn>	MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0005165,increased susceptibility to injury|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration
MGI:4362960	Rdh16<tm1a(KOMP)Wtsi>	MP:0005627,increased circulating potassium level
MGI:3804065	Rdh1<tm1.1Jln>	MP:0000683,decreased percent water in carcass|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0002981,increased liver weight|MP:0003917,increased kidney weight|MP:0005380,embryo phenotype|MP:0005458,increased percent body fat/body weight|MP:0008908,increased total fat pad weight|MP:0011234,abnormal retinol level
MGI:2388375	Rdh5<tm1Drie>	MP:0003011,delayed dark adaptation
MGI:2446073	Rdh5<tm1Wsb>	MP:0003011,delayed dark adaptation|MP:0005551,abnormal eye electrophysiology
MGI:6362645	Rdh7<tm1c(KOMP)Wtsi>	MP:0002411,decreased susceptibility to bacterial infection|MP:0005016,decreased lymphocyte cell number|MP:0005387,immune system phenotype
MGI:3586327	Rdh8<tm1Kpal>	MP:0003011,delayed dark adaptation
MGI:3711415	Rdh9<tm1Jln>	MP:0002169,no abnormal phenotype detected
MGI:5694059	Rdns	MP:0000097,short maxilla|MP:0000120,malocclusion|MP:0000440,domed cranium|MP:0000454,abnormal jaw morphology|MP:0001850,increased susceptibility to otitis media|MP:0001935,decreased litter size|MP:0006325,impaired hearing|MP:0011862,decreased cranium length|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012175,flat face|MP:0013614,abnormal areal bone mineral density|MP:0030066,short face|MP:0030166,increased inner canthal distance
MGI:3689100	rdp	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation
MGI:7541197	Rdur<em1Jiche>	MP:0002418,increased susceptibility to viral infection|MP:0008591,increased circulating interleukin-1 level|MP:0008596,increased circulating interleukin-6 level|MP:0009791,increased susceptibility to viral infection induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss
MGI:5445756	Rdx<tm1.1(KOMP)Vlcg>	MP:0005561,increased mean corpuscular hemoglobin|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2671151	Rdx<tm1Sts>	MP:0000043,organ of Corti degeneration|MP:0000598,abnormal liver morphology|MP:0001967,deafness|MP:0002968,increased circulating alkaline phosphatase level|MP:0004362,cochlear hair cell degeneration|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004528,fused outer hair cell stereocilia|MP:0004531,short outer hair cell stereocilia|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004533,fused inner hair cell stereocilia|MP:0004536,short inner hair cell stereocilia|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0006358,absent pinna reflex|MP:0009642,abnormal blood homeostasis|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856541	Re<3J>	MP:0000410,waved hair|MP:0001274,curly vibrissae
MGI:1856542	Re<4J>	MP:0000410,waved hair
MGI:1856140	Re<5J>	MP:0000410,waved hair
MGI:2680119	Rear1<C57BL/6J>	MP:0002574,increased vertical activity
MGI:2680121	Rear2<C57BL/6J>	MP:0002574,increased vertical activity
MGI:6284008	Rec114<tm1.2(KOMP)Wtsi>	MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001156,abnormal spermatogenesis|MP:0001930,abnormal meiosis|MP:0001931,abnormal oogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0004852,decreased testis weight|MP:0009451,abnormal chromosomal synapsis|MP:0009452,abnormal synaptonemal complex|MP:0011121,decreased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number|MP:0031381,decreased secondary ovarian follicle number
MGI:4419253	Rec114<tm1(KOMP)Wtsi>	MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001930,abnormal meiosis|MP:0001931,abnormal oogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0006379,abnormal spermatocyte morphology|MP:0009451,abnormal chromosomal synapsis|MP:0009452,abnormal synaptonemal complex|MP:0011121,decreased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number|MP:0014764,impaired double-strand DNA break repair|MP:0031381,decreased secondary ovarian follicle number
MGI:3512754	Rec8<mei8>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001924,infertility|MP:0002777,absent ovarian follicles|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis|MP:0009451,abnormal chromosomal synapsis|MP:0009452,abnormal synaptonemal complex
MGI:4840466	Rec8<tm1.1Kktk>	MP:0005168,abnormal female meiosis
MGI:5694668	Rec8<tm1b(KOMP)Wtsi>	MP:0001556,increased circulating HDL cholesterol level|MP:0001925,male infertility|MP:0005169,abnormal male meiosis|MP:0005178,increased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010024,increased total body fat amount|MP:0010948,abnormal double-strand DNA break repair
MGI:3583574	Rec8<tm1Mjm>	MP:0001119,abnormal female reproductive system morphology|MP:0001126,abnormal ovary morphology|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001929,abnormal gametogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002777,absent ovarian follicles|MP:0004200,decreased fetal size|MP:0004805,absent oocytes|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0008261,arrest of male meiosis|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5646527	Rec9	MP:0000373,belly spot|MP:0010053,decreased grip strength
MGI:5646525	Recb13	MP:0002151,abnormal neural tube morphology
MGI:3623517	Reck<tm1Ito>	MP:0000260,abnormal angiogenesis|MP:0001614,abnormal blood vessel morphology|MP:0001634,internal hemorrhage|MP:0001698,decreased embryo size|MP:0001914,hemorrhage|MP:0004076,abnormal vitelline vascular remodeling|MP:0004273,abnormal basal lamina morphology|MP:0004938,dilated vasculature|MP:0006055,abnormal vascular endothelial cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:8275291	Recql4<tm1.1Brle>	MP:0000137,abnormal vertebrae morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000561,adactyly|MP:0001732,postnatal growth retardation|MP:0002109,abnormal limb morphology|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004624,abnormal thoracic cage morphology|MP:0006279,abnormal limb development|MP:0008271,abnormal bone ossification|MP:0009780,abnormal chondrocyte physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0014101,decreased chondrocyte proliferation|MP:0014103,increased chondrocyte apoptosis|MP:0014321,short forelimb|MP:0014322,short hindlimb|MP:0030350,premature coronal suture closure|MP:0030358,premature squamoparietal suture closure
MGI:5548719	Recql4<tm1.1(KOMP)Vlcg>	MP:0000367,abnormal coat/ hair morphology|MP:0001258,decreased body length|MP:0005655,increased aggression|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2677314	Recql4<tm1Abe>	MP:0000128,growth retardation of molars|MP:0000133,abnormal long bone metaphysis morphology|MP:0000414,alopecia|MP:0000496,abnormal small intestine morphology|MP:0000706,small thymus|MP:0001212,skin lesions|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0005171,absent coat pigmentation|MP:0005359,growth retardation of incisors|MP:0005391,vision/eye phenotype|MP:0008479,decreased spleen white pulp amount|MP:0009543,abnormal thymus corticomedullary boundary morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2679155	Recql4<tm1Furu>	MP:0005033,abnormal trophoblast giant cell morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0012113,decreased inner cell mass proliferation
MGI:3045113	Recql4<tm1Glu>	MP:0000111,cleft palate|MP:0000413,polyphalangy|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002115,abnormal limb bone morphology|MP:0004028,chromosome breakage|MP:0005174,abnormal tail pigmentation|MP:0009743,preaxial polydactyly|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012431,increased lymphoma incidence|MP:0014321,short forelimb
MGI:3577100	Recql5<tm1.1Glu>	MP:0003701,elevated level of mitotic sister chromatid exchange
MGI:3701259	Recql<tm1Pjb>	MP:0003701,elevated level of mitotic sister chromatid exchange|MP:0003702,abnormal chromosome morphology|MP:0004024,aneuploidy|MP:0004029,spontaneous chromosome breakage|MP:0011704,decreased fibroblast proliferation
MGI:6444609	Redrum<em1Jgkm>	MP:0002169,no abnormal phenotype detected
MGI:6116844	Reep1<Gt(OST398247)Lex>	MP:0000788,abnormal cerebral cortex morphology|MP:0000921,demyelination|MP:0000937,abnormal motor neuron morphology|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0002272,abnormal nervous system electrophysiology|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0005179,decreased circulating cholesterol level|MP:0005404,abnormal axon morphology|MP:0008853,decreased abdominal adipose tissue amount|MP:0009115,abnormal fat cell morphology|MP:0009122,decreased white fat cell lipid droplet size|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0010025,decreased total body fat amount|MP:0011168,abnormal fat cell differentiation|MP:0011174,lipodystrophy|MP:0012051,spasticity|MP:0020211,slow movement|MP:0030736,increased glutamic acid level
MGI:5558070	Reep1<tm1.1Cahb>	MP:0000160,kyphosis|MP:0000937,abnormal motor neuron morphology|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0005405,axon degeneration
MGI:7465002	Reep3<em1(IMPC)Tcp>	MP:0000221,decreased leukocyte cell number|MP:0002792,abnormal retina vasculature morphology|MP:0005016,decreased lymphocyte cell number|MP:0010097,abnormal retina blood vessel morphology
MGI:4269334	Reep5<Gt(OST296938)Lex>	MP:0002169,no abnormal phenotype detected
MGI:6118044	Reep6<em1Ruch>	MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0008450,retina photoreceptor degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0008580,photoreceptor inner segment degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:6120531	Reep6<em2Ruch>	MP:0001005,abnormal retina rod cell morphology|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004542,impaired acrosome reaction|MP:0005578,teratozoospermia|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008584,photoreceptor outer segment degeneration|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0020354,increased endoplasmic reticulum stress|MP:0020813,abnormal photoreceptor outer segment disc membrane morphology
MGI:2446480	Reg1<tm1Okam>	MP:0002693,abnormal pancreas physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype
MGI:5548968	Reg2<tm1.1(KOMP)Vlcg>	MP:0004738,abnormal auditory brainstem response
MGI:3812476	Reg2<tm1Lchr>	MP:0001076,abnormal hypoglossal nerve morphology|MP:0001436,abnormal suckling behavior|MP:0003631,nervous system phenotype|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004001,decreased hepatocyte proliferation|MP:0005165,increased susceptibility to injury|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0031324,delayed liver regeneration
MGI:7425941	Reg3b<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0005344,increased circulating bilirubin level
MGI:5007303	Reg3b<tm1Lex>	MP:0005293,impaired glucose tolerance
MGI:5636985	Reg3d<tm1b(EUCOMM)Wtsi>	MP:0003960,increased lean body mass
MGI:5295366	Reg3g<tm1.1Lvh>	MP:0002495,increased IgA level|MP:0003868,abnormal feces composition|MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype|MP:0008086,increased T-helper 1 cell number|MP:0010155,abnormal intestine physiology|MP:0010377,abnormal gut flora balance
MGI:4363444	Reg3g<tm1a(KOMP)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:3794987	Rela<tm1.1Gho>	MP:0001286,abnormal eye development|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002109,abnormal limb morphology|MP:0011102,embryonic lethality, incomplete penetrance
MGI:3794988	Rela<tm1.2Gho>	MP:0003887,increased hepatocyte apoptosis|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3775205	Rela<tm1Asba>	MP:0000488,abnormal intestinal epithelium morphology|MP:0000496,abnormal small intestine morphology|MP:0002083,premature death|MP:0002731,megacolon|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0005036,diarrhea|MP:0008108,abnormal small intestinal villus morphology|MP:0008489,slow postnatal weight gain|MP:0008537,increased susceptibility to induced colitis|MP:0008770,decreased survivor rate|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0031319,impaired intestine regeneration
MGI:1857270	Rela<tm1Bal>	MP:0000313,abnormal cell death|MP:0001065,abnormal trigeminal nerve morphology|MP:0001634,internal hemorrhage|MP:0003103,liver degeneration|MP:0003203,increased neuron apoptosis|MP:0003887,increased hepatocyte apoptosis|MP:0004811,abnormal neuron physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0008182,decreased marginal zone B cell number|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3803795	Rela<tm1Mpa>	MP:0008735,increased susceptibility to endotoxin shock
MGI:3713697	Rela<tm1Rsch>	MP:0001861,lung inflammation|MP:0001869,pancreas inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005387,immune system phenotype|MP:0008343,abnormal gamma-delta T cell morphology|MP:0008682,decreased interleukin-17 secretion|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:5568757	Rela<tm1Ukl>	MP:0002169,no abnormal phenotype detected
MGI:1860444	Rela<tm1Yuo>	MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000729,abnormal myogenesis|MP:0001807,decreased IgA level|MP:0003945,abnormal lymphocyte physiology|MP:0005092,decreased double-positive T cell number|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0008495,decreased IgG1 level|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4830882	Rela<tm2.1Gho>	MP:0000219,increased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000266,abnormal heart morphology|MP:0000380,small hair follicles|MP:0000384,distorted hair follicle pattern|MP:0000495,abnormal colon morphology|MP:0000600,liver hypoplasia|MP:0000689,abnormal spleen morphology|MP:0001220,epidermal necrosis|MP:0001222,epidermal hyperplasia|MP:0001265,decreased body size|MP:0001654,hepatic necrosis|MP:0001732,postnatal growth retardation|MP:0001846,increased inflammatory response|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001862,interstitial pneumonia|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0003333,liver fibrosis|MP:0003795,abnormal bone structure|MP:0004510,myositis|MP:0009932,skin fibrosis
MGI:3846176	Rela<tm2.1Mpa>	MP:0002169,no abnormal phenotype detected
MGI:5002714	Relb<shep>	MP:0000589,thin tail|MP:0000603,pale liver|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001860,liver inflammation|MP:0003046,liver cirrhosis|MP:0003325,decreased liver function|MP:0003326,liver failure|MP:0005416,abnormal circulating protein level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0008805,decreased circulating amylase level|MP:0011083,lethality at weaning, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2179544	Relb<Tg(H2-K1/GH1)106Bri>	MP:0000322,increased granulocyte number|MP:0000420,ruffled hair|MP:0000603,pale liver|MP:0000691,enlarged spleen|MP:0000696,abnormal Peyer's patch morphology|MP:0001175,abnormal lung morphology|MP:0001242,hyperkeratosis|MP:0001265,decreased body size|MP:0001786,skin edema|MP:0001835,abnormal antigen presentation|MP:0001846,increased inflammatory response|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002083,premature death|MP:0002339,abnormal lymph node morphology|MP:0002743,glomerulonephritis|MP:0002831,absent Peyer's patches|MP:0003333,liver fibrosis|MP:0004947,skin inflammation|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005095,decreased T cell proliferation|MP:0005150,cachexia|MP:0005425,increased macrophage cell number|MP:0008024,absent lymph nodes|MP:0008040,decreased NK T cell number|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0008209,decreased pre-B cell number|MP:0008603,decreased circulating interleukin-4 level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013587,absent thymus medulla
MGI:5441212	Relb<tm1.1Fwei>	MP:0002412,increased susceptibility to bacterial infection|MP:0005387,immune system phenotype|MP:0008343,abnormal gamma-delta T cell morphology|MP:0008682,decreased interleukin-17 secretion
MGI:2179545	Relb<tm1Brv>	MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000321,increased bone marrow cell number|MP:0000414,alopecia|MP:0000604,amyloidosis|MP:0000693,spleen hyperplasia|MP:0001190,reddish skin|MP:0001192,scaly skin|MP:0001194,dermatitis|MP:0001200,thick skin|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001224,abnormal keratinocyte apoptosis|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001245,thick dermal layer|MP:0001246,mixed cellular infiltration to dermis|MP:0001270,distended abdomen|MP:0001505,hunched posture|MP:0001511,disheveled coat|MP:0001790,abnormal immune system physiology|MP:0001800,abnormal humoral immune response|MP:0001823,thymus hypoplasia|MP:0001858,intestinal inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001868,ovary inflammation|MP:0001870,salivary gland inflammation|MP:0001873,stomach inflammation|MP:0001874,acanthosis|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002138,abnormal hepatobiliary system morphology|MP:0002339,abnormal lymph node morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002416,abnormal proerythroblast morphology|MP:0002421,abnormal cell-mediated immunity|MP:0002451,abnormal macrophage physiology|MP:0002467,impaired neutrophil phagocytosis|MP:0002490,abnormal immunoglobulin level|MP:0002494,increased IgM level|MP:0002497,increased IgE level|MP:0002722,abnormal immune system organ morphology|MP:0002928,abnormal bile duct morphology|MP:0003333,liver fibrosis|MP:0003453,abnormal keratinocyte physiology|MP:0003596,epididymis inflammation|MP:0003644,thymus atrophy|MP:0003711,pathological neovascularization|MP:0004510,myositis|MP:0004952,increased spleen weight|MP:0005011,increased eosinophil cell number|MP:0005018,decreased T cell number|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005093,decreased B cell proliferation|MP:0005232,abnormal mesenteric lymph node morphology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0006050,pulmonary fibrosis|MP:0008127,decreased dendritic cell number|MP:0008343,abnormal gamma-delta T cell morphology|MP:0008476,increased spleen red pulp amount|MP:0008479,decreased spleen white pulp amount|MP:0008713,abnormal cytokine level|MP:0008750,abnormal interferon level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0009583,increased keratinocyte proliferation|MP:0010373,myeloid hyperplasia|MP:0010861,increased respiratory mucosa goblet cell number|MP:0010909,pulmonary alveolar hemorrhage|MP:0020913,increased susceptibility to Riboviria infection
MGI:6143833	Relch<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0001529,abnormal vocalization|MP:0002574,increased vertical activity|MP:0002590,increased mean corpuscular volume|MP:0004738,abnormal auditory brainstem response|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:6273812	Rell1<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0004738,abnormal auditory brainstem response|MP:0009142,decreased prepulse inhibition
MGI:5806335	Rel<M1Btlr>	MP:0001606,impaired hematopoiesis|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002492,decreased IgE level|MP:0004978,decreased B-1 B cell number|MP:0005015,increased T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0020001,decreased response to antigen
MGI:6285776	Rel<M2Btlr>	MP:0002145,abnormal T cell differentiation|MP:0004978,decreased B-1 B cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0010842,decreased central memory CD4-positive, alpha-beta T cell number|MP:0010845,decreased effector memory CD4-positive, alpha-beta T cell number|MP:0012765,decreased alpha-beta T cell number
MGI:6285867	Rel<m3Btlr>	MP:0001806,decreased IgM level|MP:0020154,impaired humoral immune response
MGI:6276929	Reln<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001404,no spontaneous movement|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5563426	Reln<m1Anu>	MP:0001265,decreased body size|MP:0001405,impaired coordination
MGI:1856398	Reln<rl>	MP:0000745,tremors|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000792,abnormal cortical marginal zone morphology|MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000876,Purkinje cell degeneration|MP:0000880,decreased Purkinje cell number|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001360,abnormal social investigation|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001511,disheveled coat|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0001924,infertility|MP:0001925,male infertility|MP:0002083,premature death|MP:0002566,abnormal sexual interaction|MP:0003088,abnormal prepulse inhibition|MP:0003631,nervous system phenotype|MP:0003651,abnormal axon extension|MP:0004103,abnormal ventral striatum morphology|MP:0005036,diarrhea|MP:0005267,abnormal olfactory cortex morphology|MP:0005386,behavior/neurological phenotype|MP:0006009,abnormal neuronal migration|MP:0006300,abnormal entorhinal cortex morphology|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008265,abnormal hippocampus CA2 region morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008431,abnormal short-term spatial reference memory|MP:0008489,slow postnatal weight gain|MP:0009937,abnormal neuron differentiation|MP:0011083,lethality at weaning, complete penetrance|MP:0011448,decreased dopaminergic neuron number
MGI:1856543	Reln<rl-2J>	MP:0003733,abnormal retina inner nuclear layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0006074,abnormal retina rod bipolar cell morphology
MGI:3051628	Reln<rl-4J>	MP:0000790,abnormal stratification in cerebral cortex|MP:0000813,abnormal hippocampus layer morphology|MP:0000852,small cerebellum|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0004097,abnormal cerebellar cortex morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3579800	Reln<rl-5J>	MP:0000790,abnormal stratification in cerebral cortex|MP:0000792,abnormal cortical marginal zone morphology|MP:0000813,abnormal hippocampus layer morphology|MP:0000852,small cerebellum|MP:0000884,delaminated Purkinje cell layer|MP:0000887,delaminated cerebellar granule layer|MP:0001393,ataxia
MGI:3611331	Reln<rl-6J>	MP:0000743,muscle spasm|MP:0000745,tremors|MP:0000790,abnormal stratification in cerebral cortex|MP:0000852,small cerebellum|MP:0000854,abnormal cerebellum development
MGI:3757710	Reln<rl-7J>	MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000807,abnormal hippocampus morphology|MP:0000852,small cerebellum|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0002083,premature death
MGI:3814321	Reln<rl-8J>	MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000852,small cerebellum|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001523,impaired righting response|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0004097,abnormal cerebellar cortex morphology
MGI:1856418	Reln<rl-Alb>	MP:0000745,tremors|MP:0000852,small cerebellum|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000885,ectopic Purkinje cell|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0008770,decreased survivor rate
MGI:1857345	Reln<rl-Alb2>	MP:0000745,tremors|MP:0001523,impaired righting response
MGI:2156492	Reln<rl-od>	MP:0000745,tremors|MP:0000790,abnormal stratification in cerebral cortex|MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001516,abnormal motor coordination/balance|MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality
MGI:1856416	Reln<rl-Orl>	MP:0000819,abnormal olfactory bulb morphology|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004279,abnormal rostral migratory stream morphology|MP:0009949,abnormal olfactory bulb granule cell layer morphology
MGI:1856417	Reln<rl-tg>	MP:0000745,tremors|MP:0000852,small cerebellum|MP:0000853,absent cerebellar foliation|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0004097,abnormal cerebellar cortex morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008285,abnormal hippocampus granule cell layer
MGI:5774964	Reln<tm1.1Mhat>	MP:0000788,abnormal cerebral cortex morphology|MP:0000792,abnormal cortical marginal zone morphology|MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008263,abnormal hippocampus CA1 region morphology
MGI:6369620	Relt<em1Jpsi>	MP:0002576,abnormal enamel morphology|MP:0030450,abnormal enamel mineralization
MGI:5637218	Rel<tm1b(EUCOMM)Wtsi>	MP:0000223,decreased monocyte cell number|MP:0000745,tremors|MP:0001284,absent vibrissae|MP:0005293,impaired glucose tolerance
MGI:3639342	Rel<tm1Brv>	MP:0000240,extramedullary hematopoiesis|MP:0000333,decreased bone marrow cell number|MP:0000470,abnormal stomach morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001175,abnormal lung morphology|MP:0001194,dermatitis|MP:0001805,decreased IgG level|MP:0002083,premature death|MP:0002412,increased susceptibility to bacterial infection|MP:0002442,abnormal leukocyte physiology|MP:0002444,abnormal T cell physiology|MP:0002446,abnormal macrophage morphology|MP:0002451,abnormal macrophage physiology|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0003799,impaired macrophage chemotaxis|MP:0005508,abnormal skeleton morphology|MP:0008482,decreased spleen germinal center number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008500,increased IgG2a level|MP:0008826,abnormal splenic cell ratio|MP:0014347,increased spleen B cell follicle size
MGI:2179622	Rel<tm1Grd>	MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0002451,abnormal macrophage physiology|MP:0003009,abnormal cytokine secretion|MP:0005026,decreased susceptibility to parasitic infection|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:2180672	Rel<tm1Hcl>	MP:0002376,abnormal dendritic cell physiology|MP:0002451,abnormal macrophage physiology|MP:0002452,abnormal professional antigen presenting cell physiology|MP:0002492,decreased IgE level|MP:0003009,abnormal cytokine secretion|MP:0003077,abnormal cell cycle|MP:0003203,increased neuron apoptosis|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005011,increased eosinophil cell number|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0006043,decreased apoptosis|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008093,abnormal memory B cell number|MP:0021086,decreased DNA replication
MGI:5568752	Rel<tm1Ukl>	MP:0002169,no abnormal phenotype detected
MGI:6400520	Relt<tm1Hlee>	MP:0002166,abnormal tumor susceptibility|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008037,abnormal T cell morphology
MGI:6760672	Rem1<tm1Jsat>	MP:0005385,cardiovascular system phenotype|MP:0020346,abnormal myocardial fiber calcium currents
MGI:5294188	Rem2<tm1a(EUCOMM)Hmgu>	MP:0000805,abnormal visual cortex morphology|MP:0001389,abnormal eye movement|MP:0001935,decreased litter size|MP:0002206,abnormal CNS synaptic transmission|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004998,decreased CNS synapse formation|MP:0005389,reproductive system phenotype|MP:0005402,abnormal action potential|MP:0008770,decreased survivor rate|MP:0010768,mortality/aging|MP:0014382,increased miniature inhibitory postsynaptic current frequency|MP:0020506,abnormal dendritic spine density
MGI:6192081	Rem2<tm1c(EUCOMM)Hmgu>	MP:0000805,abnormal visual cortex morphology|MP:0002206,abnormal CNS synaptic transmission|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005391,vision/eye phenotype|MP:0005402,abnormal action potential
MGI:4939805	Ren1<tm1.1Sig>	MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0010768,mortality/aging
MGI:4939806	Ren1<tm1.2Sig>	MP:0000208,decreased hematocrit|MP:0001762,polyuria|MP:0002666,increased circulating aldosterone level|MP:0002988,decreased urine osmolality|MP:0003026,decreased vasoconstriction|MP:0004184,abnormal baroreceptor physiology|MP:0004876,decreased mean systemic arterial blood pressure|MP:0004970,kidney atrophy|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0011085,postnatal lethality, complete penetrance
MGI:2136642	Ren1<tm1Afu>	MP:0000519,hydronephrosis|MP:0001426,polydipsia|MP:0001762,polyuria|MP:0002184,abnormal innervation|MP:0002829,abnormal juxtaglomerular apparatus morphology|MP:0002843,decreased systemic arterial blood pressure|MP:0003353,decreased circulating renin level|MP:0004970,kidney atrophy|MP:0005385,cardiovascular system phenotype|MP:0005489,vascular smooth muscle hyperplasia|MP:0006263,decreased systemic arterial diastolic blood pressure|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0009642,abnormal blood homeostasis|MP:0011085,postnatal lethality, complete penetrance|MP:0011299,abnormal macula densa morphology|MP:0011300,abnormal juxtaglomerular cell morphology
MGI:3699140	Ren1<tm1Bjm>	MP:0001392,abnormal locomotor behavior|MP:0001596,hypotension|MP:0002626,increased heart rate|MP:0003631,nervous system phenotype|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005385,cardiovascular system phenotype|MP:0005528,decreased renal glomerular filtration rate|MP:0005553,increased circulating creatinine level|MP:0006263,decreased systemic arterial diastolic blood pressure|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0011299,abnormal macula densa morphology
MGI:2386989	Ren1<tm1Gom>	MP:0002843,decreased systemic arterial blood pressure|MP:0003353,decreased circulating renin level|MP:0011300,abnormal juxtaglomerular cell morphology
MGI:2385802	Ren1<tm1Mgfs>	MP:0002843,decreased systemic arterial blood pressure|MP:0003353,decreased circulating renin level|MP:0009642,abnormal blood homeostasis|MP:0011299,abnormal macula densa morphology|MP:0011300,abnormal juxtaglomerular cell morphology
MGI:3653266	Ren1<tm1Tkh>	MP:0000519,hydronephrosis|MP:0001262,decreased body weight|MP:0001429,dehydration|MP:0001762,polyuria|MP:0001859,kidney inflammation|MP:0002169,no abnormal phenotype detected|MP:0002843,decreased systemic arterial blood pressure|MP:0002988,decreased urine osmolality|MP:0002989,small kidney|MP:0003215,renal interstitial fibrosis|MP:0003353,decreased circulating renin level|MP:0005264,glomerulosclerosis|MP:0005389,reproductive system phenotype|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0009643,abnormal urine homeostasis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011304,kidney papillary atrophy|MP:0011312,abnormal kidney afferent arteriole morphology|MP:0011316,abnormal kidney interlobular artery morphology|MP:0011422,kidney medulla atrophy|MP:0011534,granular kidney|MP:0011565,kidney papillary hypoplasia|MP:0012551,metabolic acidosis|MP:0031231,decreased circulating angiotensin II level
MGI:3527932	Ren1<tm3Gom>	MP:0000521,abnormal kidney cortex morphology|MP:0002705,dilated renal tubule|MP:0002843,decreased systemic arterial blood pressure|MP:0002989,small kidney|MP:0003014,abnormal kidney medulla morphology|MP:0003215,renal interstitial fibrosis|MP:0003353,decreased circulating renin level|MP:0003918,decreased kidney weight|MP:0004970,kidney atrophy|MP:0005325,abnormal renal glomerulus morphology|MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level|MP:0011294,renal glomerulus hypertrophy|MP:0011300,abnormal juxtaglomerular cell morphology|MP:0011346,renal tubule atrophy|MP:0011352,proximal convoluted tubule brush border loss|MP:0011363,renal glomerulus atrophy|MP:0011377,renal glomerulus fibrosis|MP:0011423,kidney cortex atrophy|MP:0011534,granular kidney
MGI:2385805	Ren2<tm1Mgfs>	MP:0002169,no abnormal phenotype detected
MGI:2386397	Renbp<tm1Csch>	MP:0005376,homeostasis/metabolism phenotype|MP:0009643,abnormal urine homeostasis
MGI:2156439	Rencd<CAST/EiJ>	MP:0003675,kidney cyst
MGI:2447058	Rends<PL/J>	MP:0002136,abnormal kidney physiology
MGI:2389224	Renf1<129X1/SvJ>	MP:0003606,kidney failure
MGI:2429592	Renf2<129X1/SvJ>	MP:0003606,kidney failure
MGI:5755079	Rep15<em1(IMPC)Tcp>	MP:0000062,increased bone mineral density|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:2670758	Reph8<1R>	MP:0005409,darkened coat color
MGI:3512931	repro10	MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia
MGI:3052834	repro13	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype
MGI:3512909	repro14	MP:0001127,small ovary|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002777,absent ovarian follicles|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005431,decreased oocyte number|MP:0008261,arrest of male meiosis
MGI:3512934	repro15	MP:0001146,abnormal testis morphology|MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0002686,globozoospermia
MGI:3512935	repro16	MP:0001146,abnormal testis morphology|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia
MGI:3512936	repro17	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0009239,short sperm flagellum
MGI:3512910	repro19	MP:0001751,increased circulating luteinizing hormone level|MP:0001922,reduced male fertility|MP:0002674,abnormal sperm motility|MP:0002687,oligozoospermia|MP:0002781,increased circulating testosterone level|MP:0004852,decreased testis weight|MP:0004910,decreased seminal vesicle weight|MP:0005578,teratozoospermia
MGI:3512896	repro2	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009234,absent sperm head|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0020869,immotile sperm|MP:0030590,abnormal sperm fibrous sheath morphology
MGI:3512937	repro20	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0008545,absent sperm flagellum|MP:0009239,short sperm flagellum
MGI:3512939	repro21	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0008545,absent sperm flagellum|MP:0014636,decreased elongated spermatid number|MP:0020869,immotile sperm
MGI:3512945	repro24	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype
MGI:3512946	repro25	MP:0001926,female infertility|MP:0005389,reproductive system phenotype
MGI:3512948	repro26	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0006380,abnormal spermatid morphology|MP:0008545,absent sperm flagellum
MGI:3590191	repro28	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0004910,decreased seminal vesicle weight|MP:0008545,absent sperm flagellum|MP:0009237,kinked sperm flagellum
MGI:3590190	repro3	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009239,short sperm flagellum|MP:0009833,absent sperm mitochondrial sheath|MP:0020869,immotile sperm
MGI:3692894	repro30	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0004910,decreased seminal vesicle weight|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis
MGI:3590193	repro31	MP:0001672,abnormal embryo development|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002673,abnormal sperm number|MP:0002674,abnormal sperm motility|MP:0004910,decreased seminal vesicle weight|MP:0005389,reproductive system phenotype|MP:0006362,abnormal male germ cell morphology|MP:0006380,abnormal spermatid morphology
MGI:3590194	repro33	MP:0001925,male infertility|MP:0002673,abnormal sperm number|MP:0002674,abnormal sperm motility|MP:0004910,decreased seminal vesicle weight|MP:0005389,reproductive system phenotype|MP:0006362,abnormal male germ cell morphology
MGI:3708998	repro36	MP:0001127,small ovary|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002777,absent ovarian follicles|MP:0004852,decreased testis weight|MP:0004910,decreased seminal vesicle weight|MP:0005159,azoospermia|MP:0005431,decreased oocyte number|MP:0008261,arrest of male meiosis
MGI:3708995	repro46	MP:0001127,small ovary|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0004852,decreased testis weight|MP:0004910,decreased seminal vesicle weight|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0014604,hemorrhagic ovary cyst
MGI:3692921	repro47	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0004910,decreased seminal vesicle weight|MP:0005578,teratozoospermia
MGI:3692898	repro48	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0004910,decreased seminal vesicle weight
MGI:3692917	repro49	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0004910,decreased seminal vesicle weight|MP:0005578,teratozoospermia
MGI:3692913	repro50	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0004910,decreased seminal vesicle weight|MP:0005578,teratozoospermia|MP:0009230,abnormal sperm head morphology|MP:0009239,short sperm flagellum|MP:0020869,immotile sperm
MGI:3692909	repro51	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004910,decreased seminal vesicle weight|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia
MGI:3692906	repro52	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004910,decreased seminal vesicle weight
MGI:3692902	repro53	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004910,decreased seminal vesicle weight|MP:0005389,reproductive system phenotype
MGI:3692889	repro54	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004910,decreased seminal vesicle weight|MP:0005578,teratozoospermia
MGI:5812581	Reps2<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0001304,cataract
MGI:4329578	Rer1<Gt(RRN159)Byg>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0009402,decreased skeletal muscle fiber diameter
MGI:5708209	Rer1<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0003795,abnormal bone structure|MP:0004924,abnormal behavior|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0020870,decreased thigmotaxis
MGI:3577419	Rere<eyes3>	MP:0000520,absent kidney|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0030191,narrow snout
MGI:2687216	Rere<Gt(PTO26)1Byg>	MP:0005380,embryo phenotype|MP:0011091,prenatal lethality, complete penetrance
MGI:2687072	Rere<om>	MP:0000928,incomplete rostral neuropore closure|MP:0000934,abnormal telencephalon development|MP:0001688,abnormal somite development|MP:0001691,abnormal somite shape|MP:0002085,abnormal embryonic tissue morphology|MP:0003425,abnormal optic vesicle formation|MP:0004251,failure of heart looping|MP:0005222,abnormal somite size|MP:0006341,small first pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6416530	Rere<tm1Dsco>	MP:0000111,cleft palate|MP:0009888,palatal shelves fail to meet at midline|MP:0011089,perinatal lethality, complete penetrance|MP:0021166,delayed palatal shelf elevation|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0031462,decreased palatal shelf size
MGI:6305159	Rergl<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001284,absent vibrissae|MP:0001402,decreased locomotor activity
MGI:1856141	Re<Ri>	MP:0000410,waved hair|MP:0001274,curly vibrissae
MGI:6140116	Resf1<em1(IMPC)Mbp>	MP:0001404,no spontaneous movement|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002092,abnormal eye morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5443932	Resp18<tm1.1(KOMP)Vlcg>	MP:0001325,abnormal retina morphology|MP:0001556,increased circulating HDL cholesterol level|MP:0002702,decreased circulating free fatty acids level|MP:0002833,increased heart weight|MP:0005633,increased circulating sodium level
MGI:4949626	Resp18<tm1Mlit>	MP:0011091,prenatal lethality, complete penetrance
MGI:6378685	Rest<tm1.1Bban>	MP:0001967,deafness|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5141103	Rest<tm1.1Jhsi>	MP:0009937,abnormal neuron differentiation|MP:0011092,embryonic lethality, complete penetrance
MGI:4867679	Rest<tm1.1Whk>	MP:0002983,increased retina ganglion cell number|MP:0005241,abnormal retina ganglion layer morphology|MP:0006071,abnormal retina progenitor cell morphology|MP:0008508,thick retina ganglion layer|MP:0014265,thick retina inner plexiform layer
MGI:4437069	Rest<tm1.1Yasu>	MP:0000373,belly spot|MP:0001186,pigmentation phenotype|MP:0002939,head spot|MP:0003631,nervous system phenotype|MP:0009783,abnormal melanoblast morphology|MP:0010768,mortality/aging|MP:0011087,neonatal lethality, complete penetrance
MGI:6378686	Rest<tm1.2Bban>	MP:0001525,impaired balance|MP:0001967,deafness|MP:0003631,nervous system phenotype|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0006090,abnormal utricle morphology|MP:0011060,abnormal kinocilium morphology|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3640355	Rest<tm1And>	MP:0000936,small embryonic telencephalon|MP:0001688,abnormal somite development|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5052049	Rest<tm1Mlit>	MP:0003203,increased neuron apoptosis
MGI:5450873	Rest<tm1Ymat>	MP:0000783,abnormal forebrain morphology|MP:0004203,abnormal cranial flexure morphology|MP:0008392,decreased primordial germ cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0030935,increased primordial germ cell apoptosis
MGI:5692555	Rest<tm2b(EUCOMM)Wtsi>	MP:0004738,abnormal auditory brainstem response|MP:0008935,decreased mean platelet volume|MP:0011100,preweaning lethality, complete penetrance
MGI:3832583	Retnla<tm1Mer>	MP:0002451,abnormal macrophage physiology|MP:0002497,increased IgE level|MP:0005292,improved glucose tolerance|MP:0005466,abnormal T-helper 2 physiology|MP:0005668,decreased circulating leptin level|MP:0008499,increased IgG1 level|MP:0008539,decreased susceptibility to induced colitis|MP:0008660,increased interleukin-10 secretion|MP:0008672,increased interleukin-13 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0008723,impaired eosinophil recruitment
MGI:3690334	Retnlb<tm1Gdw>	MP:0001876,decreased inflammatory response|MP:0005166,decreased susceptibility to injury|MP:0008539,decreased susceptibility to induced colitis|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:5007306	Retnlb<tm1Lex>	MP:0000219,increased neutrophil cell number|MP:0000495,abnormal colon morphology|MP:0000599,enlarged liver|MP:0001260,increased body weight|MP:0001860,liver inflammation|MP:0004499,increased incidence of tumors by chemical induction|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005293,impaired glucose tolerance|MP:0005378,growth/size/body region phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008597,decreased circulating interleukin-6 level|MP:0008608,increased circulating interleukin-13 level|MP:0009298,increased mesenteric fat pad weight|MP:0031602,white adipose tissue inflammation
MGI:3818561	Retnlb<tm1Mer>	MP:0000488,abnormal intestinal epithelium morphology|MP:0001663,abnormal digestive system physiology|MP:0005026,decreased susceptibility to parasitic infection|MP:0008496,decreased IgG2a level|MP:0008499,increased IgG1 level|MP:0008537,increased susceptibility to induced colitis|MP:0008539,decreased susceptibility to induced colitis|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion
MGI:5909238	Retnlg<em1(IMPC)J>	MP:0002941,increased circulating alanine transaminase level|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:3043419	Retn<tm1Laz>	MP:0005292,improved glucose tolerance|MP:0005375,adipose tissue phenotype|MP:0005560,decreased circulating glucose level|MP:0009356,decreased liver triglyceride level
MGI:6304302	Retreg1<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001417,decreased exploration in new environment
MGI:5774849	Retreg1<tm1.1Cahb>	MP:0000965,abnormal sensory neuron morphology|MP:0001973,increased thermal nociceptive threshold|MP:0003224,neuron degeneration
MGI:6147536	Retreg2<em2(IMPC)Ccpcz>	MP:0000218,increased leukocyte cell number|MP:0000266,abnormal heart morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001325,abnormal retina morphology|MP:0005013,increased lymphocyte cell number|MP:0020421,increased freezing behavior
MGI:4433416	Retreg3<tm2a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0002874,decreased hemoglobin content
MGI:5548555	Retreg3<tm2b(EUCOMM)Wtsi>	MP:0001325,abnormal retina morphology|MP:0001552,increased circulating triglyceride level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0005343,increased circulating aspartate transaminase level|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0008806,increased circulating amylase level|MP:0009142,decreased prepulse inhibition
MGI:5708113	Retsat<tm1Kpal>	MP:0000010,abnormal abdominal fat pad morphology|MP:0005336,abnormal inguinal fat pad morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005458,increased percent body fat/body weight|MP:0011167,abnormal adipose tissue development|MP:0011233,abnormal vitamin A metabolism
MGI:3614436	Ret<tm10(RET)Jmi>	MP:0005367,renal/urinary system phenotype
MGI:4413351	Ret<tm1.1Ddg>	MP:0002882,abnormal neuron morphology
MGI:3662902	Ret<tm1.1Kln>	MP:0001052,abnormal innervation pattern to muscle
MGI:4440475	Ret<tm1.1Pern>	MP:0000909,abnormal facial motor nucleus morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0002169,no abnormal phenotype detected|MP:0004281,abnormal hypoglossal nucleus morphology|MP:0005367,renal/urinary system phenotype
MGI:3614441	Ret<tm11(RET)Jmi>	MP:0000519,hydronephrosis|MP:0000527,abnormal kidney development|MP:0000534,abnormal ureter morphology|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002286,cryptorchism|MP:0003446,renal hypoplasia|MP:0003585,large ureter|MP:0003586,dilated ureter|MP:0003587,ureter obstruction|MP:0003588,ureter stenosis|MP:0003600,ectopic kidney|MP:0003613,abnormal kidney medulla development|MP:0003631,nervous system phenotype|MP:0003675,kidney cyst|MP:0004505,decreased renal glomerulus number|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0004970,kidney atrophy|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0006032,abnormal ureteric bud morphology|MP:0009857,absent kidney cortex|MP:0010980,ectopic ureteric bud|MP:0011368,increased kidney apoptosis|MP:0011438,absent kidney medulla|MP:0011727,ectopic ovary
MGI:5544788	Ret<tm1.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:4440476	Ret<tm1.2Pern>	MP:0000527,abnormal kidney development|MP:0001053,abnormal neuromuscular synapse morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:3614442	Ret<tm12(RET)Jmi>	MP:0000939,decreased motor neuron number|MP:0000940,abnormal motor neuron innervation pattern|MP:0002269,muscular atrophy|MP:0003358,abnormal hypaxial muscle morphology|MP:0003586,dilated ureter|MP:0004069,abnormal muscle spindle morphology
MGI:3691588	Ret<tm13.1Jmi>	MP:0000520,absent kidney|MP:0001046,abnormal enteric neuron morphology|MP:0001048,absent enteric neurons|MP:0003631,nervous system phenotype
MGI:3774316	Ret<tm14(Gfra1)Jmi>	MP:0002169,no abnormal phenotype detected
MGI:2136894	Ret<tm1Cos>	MP:0000520,absent kidney|MP:0000534,abnormal ureter morphology|MP:0001014,absent superior cervical ganglion|MP:0001017,abnormal stellate ganglion morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001048,absent enteric neurons|MP:0001176,abnormal lung development|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0002989,small kidney|MP:0003290,intestinal hypoperistalsis|MP:0003604,single kidney|MP:0003670,dilated renal glomerular capsule|MP:0003672,abnormal ureter development|MP:0003685,abnormal cardiac ganglion morphology|MP:0003722,absent ureter|MP:0004505,decreased renal glomerulus number|MP:0004754,abnormal kidney collecting duct morphology|MP:0005379,endocrine/exocrine gland phenotype|MP:0005385,cardiovascular system phenotype|MP:0005445,abnormal neurotransmitter secretion|MP:0008313,abnormal parasympathetic postganglionic fiber morphology|MP:0008487,abnormal mesonephros morphology|MP:0010981,abnormal branching involved in ureteric bud morphogenesis|MP:0010982,abnormal ureteric bud elongation|MP:0010983,abnormal ureteric bud invasion|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0010985,abnormal kidney mesenchyme morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011386,increased metanephric mesenchyme apoptosis|MP:0011407,absent nephrogenic zone|MP:0011797,blind ureter|MP:0012171,oligohydramnios|MP:0013006,abnormal enteric neural crest cell migration
MGI:3626295	Ret<tm1Cti>	MP:0000489,abnormal large intestine morphology|MP:0000496,abnormal small intestine morphology|MP:0000520,absent kidney|MP:0000538,abnormal urinary bladder morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001048,absent enteric neurons|MP:0011087,neonatal lethality, complete penetrance
MGI:4413350	Ret<tm1Ddg>	MP:0000746,weakness|MP:0000964,small dorsal root ganglion|MP:0001048,absent enteric neurons|MP:0001270,distended abdomen|MP:0002882,abnormal neuron morphology|MP:0002926,aganglionic megacolon|MP:0004002,abnormal jejunum morphology|MP:0009483,enlarged ileum|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3819163	Ret<tm1Giro>	MP:0000520,absent kidney|MP:0000681,abnormal thyroid gland morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0003496,increased thyroid adenoma incidence|MP:0003631,nervous system phenotype|MP:0008299,adrenal cortical hyperplasia|MP:0009937,abnormal neuron differentiation|MP:0011087,neonatal lethality, complete penetrance
MGI:3777553	Ret<tm1Heno>	MP:0000939,decreased motor neuron number|MP:0000940,abnormal motor neuron innervation pattern|MP:0003082,abnormal gastrocnemius morphology|MP:0003358,abnormal hypaxial muscle morphology|MP:0004069,abnormal muscle spindle morphology
MGI:2449909	Ret<tm1Jmi>	MP:0000351,increased cell proliferation|MP:0000520,absent kidney|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001015,small superior cervical ganglion|MP:0001025,abnormal sympathetic neuron morphology|MP:0001048,absent enteric neurons|MP:0002184,abnormal innervation|MP:0003203,increased neuron apoptosis|MP:0003793,abnormal submandibular gland morphology|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0008312,abnormal sympathetic postganglionic fiber morphology|MP:0008316,abnormal prevertebral ganglion morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3662623	Ret<tm1Kln>	MP:0000576,clubfoot|MP:0001052,abnormal innervation pattern to muscle|MP:0003244,loss of dopaminergic neurons|MP:0010149,abnormal synaptic dopamine release
MGI:3055332	Ret<tm1Mat>	MP:0000495,abnormal colon morphology|MP:0000496,abnormal small intestine morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001270,distended abdomen|MP:0001732,postnatal growth retardation|MP:0003675,kidney cyst|MP:0003918,decreased kidney weight|MP:0006032,abnormal ureteric bud morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:2387445	Ret<tm1(RET)Vpa>	MP:0002169,no abnormal phenotype detected
MGI:2136896	Ret<tm2.1Cos>	MP:0000639,abnormal adrenal gland morphology|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001925,male infertility|MP:0002050,increased pheochromocytoma incidence|MP:0003498,thyroid gland hyperplasia|MP:0005387,immune system phenotype|MP:0008289,abnormal adrenal medulla morphology|MP:0008298,adrenergic chromaffin cell hyperplasia|MP:0010362,increased ganglioneuroma incidence
MGI:3777556	Ret<tm2.1Heno>	MP:0000520,absent kidney|MP:0000939,decreased motor neuron number|MP:0000940,abnormal motor neuron innervation pattern|MP:0001044,abnormal enteric nervous system morphology|MP:0002269,muscular atrophy|MP:0003082,abnormal gastrocnemius morphology|MP:0003203,increased neuron apoptosis|MP:0003358,abnormal hypaxial muscle morphology|MP:0004069,abnormal muscle spindle morphology
MGI:2136895	Ret<tm2Cos>	MP:0000520,absent kidney|MP:0003289,abnormal intestinal peristalsis|MP:0011087,neonatal lethality, complete penetrance
MGI:4437245	Ret<tm2(cre/ERT2)Ddg>	MP:0002169,no abnormal phenotype detected
MGI:3777555	Ret<tm2(RET)Heno>	MP:0000939,decreased motor neuron number|MP:0000940,abnormal motor neuron innervation pattern|MP:0003631,nervous system phenotype
MGI:3057332	Ret<tm2(RET)Jmi>	MP:0000519,hydronephrosis|MP:0003586,dilated ureter|MP:0003631,nervous system phenotype
MGI:2387446	Ret<tm2(RET)Vpa>	MP:0001045,abnormal enteric ganglia morphology|MP:0001732,postnatal growth retardation|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003446,renal hypoplasia|MP:0003675,kidney cyst|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013003,absent enteric neural crest cell|MP:0013006,abnormal enteric neural crest cell migration
MGI:4459031	Ret<tm3.1(Bcl2l1)Heno>	MP:0003204,decreased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0005381,digestive/alimentary phenotype
MGI:3057333	Ret<tm3.1(RET)Jmi>	MP:0000495,abnormal colon morphology|MP:0000527,abnormal kidney development|MP:0001044,abnormal enteric nervous system morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0002083,premature death|MP:0003446,renal hypoplasia|MP:0003675,kidney cyst|MP:0004505,decreased renal glomerulus number|MP:0008314,abnormal pterygopalatine ganglion morphology|MP:0009485,distended ileum|MP:0011402,renal cast
MGI:3693325	Ret<tm3Cos>	MP:0000495,abnormal colon morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001048,absent enteric neurons|MP:0005584,abnormal enzyme/coenzyme activity|MP:0013001,abnormal enteric neural crest cell morphology|MP:0013006,abnormal enteric neural crest cell migration
MGI:3487229	Ret<tm3(RET)Jmi>	MP:0002169,no abnormal phenotype detected
MGI:3607929	Ret<tm3(RET)Vpa>	MP:0001045,abnormal enteric ganglia morphology|MP:0002058,neonatal lethality|MP:0002135,abnormal kidney morphology|MP:0003289,abnormal intestinal peristalsis|MP:0003446,renal hypoplasia|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0013003,absent enteric neural crest cell
MGI:3614429	Ret<tm4(RET)Jmi>	MP:0000519,hydronephrosis|MP:0003586,dilated ureter
MGI:3607930	Ret<tm4(RET)Vpa>	MP:0002169,no abnormal phenotype detected
MGI:3614430	Ret<tm5(RET)Jmi>	MP:0002169,no abnormal phenotype detected
MGI:3607931	Ret<tm5(RET)Vpa>	MP:0001045,abnormal enteric ganglia morphology|MP:0002989,small kidney|MP:0003675,kidney cyst|MP:0004505,decreased renal glomerulus number
MGI:3614431	Ret<tm6(RET)Jmi>	MP:0002169,no abnormal phenotype detected
MGI:3614432	Ret<tm7(RET)Jmi>	MP:0003585,large ureter
MGI:3614433	Ret<tm8(RET)Jmi>	MP:0000534,abnormal ureter morphology|MP:0002135,abnormal kidney morphology|MP:0002769,abnormal vas deferens morphology|MP:0003446,renal hypoplasia|MP:0003585,large ureter|MP:0003586,dilated ureter|MP:0003675,kidney cyst|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0006032,abnormal ureteric bud morphology|MP:0010980,ectopic ureteric bud|MP:0011410,ectopic testis|MP:0011727,ectopic ovary
MGI:3614435	Ret<tm9(RET)Jmi>	MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0002135,abnormal kidney morphology|MP:0003604,single kidney|MP:0003675,kidney cyst|MP:0004505,decreased renal glomerulus number|MP:0011407,absent nephrogenic zone
MGI:4355740	Rev1<tm1.1Jow>	MP:0004815,abnormal somatic hypermutation frequency|MP:0005387,immune system phenotype
MGI:3701945	Rev1<tm1Ndew>	MP:0001262,decreased body weight|MP:0002223,lymphoid hypoplasia|MP:0004815,abnormal somatic hypermutation frequency|MP:0005387,immune system phenotype|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3850228	Rev1<tm2Ndew>	MP:0002169,no abnormal phenotype detected
MGI:5442607	Rev3l<tm1.1Kunk>	MP:0004815,abnormal somatic hypermutation frequency|MP:0005387,immune system phenotype
MGI:5605987	Rev3l<tm1b(EUCOMM)Hmgu>	MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0002591,decreased mean corpuscular volume|MP:0005554,decreased circulating creatinine level|MP:0005566,decreased blood urea nitrogen level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance
MGI:2386305	Rev3l<tm1Esp>	MP:0002085,abnormal embryonic tissue morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2178815	Rev3l<tm1Kaji>	MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:2386282	Rev3l<tm1Msn>	MP:0001698,decreased embryo size|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2183197	Rev3l<tm1Ndew>	MP:0002085,abnormal embryonic tissue morphology|MP:0004029,spontaneous chromosome breakage|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2386322	Rev3l<tm1Rwd>	MP:0001689,incomplete somite formation|MP:0001691,abnormal somite shape|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0001787,pericardial edema|MP:0002085,abnormal embryonic tissue morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003935,abnormal craniofacial development|MP:0003984,embryonic growth retardation|MP:0004188,delayed embryo turning|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0006301,abnormal mesenchyme morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012509,neural tube degeneration|MP:0012556,increased cell death
MGI:6105940	Rex1bd<em1(IMPC)J>	MP:0002075,abnormal coat/hair pigmentation|MP:0011953,prolonged PQ interval
MGI:6414770	Rexo1<em1(IMPC)J>	MP:0000266,abnormal heart morphology|MP:0000603,pale liver|MP:0000783,abnormal forebrain morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001697,abnormal embryo size|MP:0001914,hemorrhage|MP:0002111,abnormal tail morphology|MP:0003385,abnormal body wall morphology|MP:0003743,abnormal facial morphology|MP:0003984,embryonic growth retardation|MP:0005650,abnormal limb bud morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape
MGI:6695997	Rexo2<tm1.1Arte>	MP:0002169,no abnormal phenotype detected
MGI:6695998	Rexo2<tm1.2Arte>	MP:0000267,abnormal heart development|MP:0001698,decreased embryo size|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:5636999	Rexo2<tm1b(EUCOMM)Wtsi>	MP:0000222,decreased neutrophil cell number|MP:0001556,increased circulating HDL cholesterol level|MP:0002965,increased circulating serum albumin level|MP:0005013,increased lymphocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0011100,preweaning lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:5911539	Rexo5<em1Embrp>	MP:0005389,reproductive system phenotype
MGI:1861224	Rf	MP:0000141,abnormal vertebral body morphology|MP:0000154,rib fusion|MP:0000585,kinked tail|MP:0000914,exencephaly|MP:0001926,female infertility|MP:0002085,abnormal embryonic tissue morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002632,vestigial tail|MP:0002823,abnormal rib development|MP:0003456,absent tail|MP:0003984,embryonic growth retardation|MP:0004599,abnormal vertebral arch morphology|MP:0004612,fusion of vertebral bodies|MP:0004613,fusion of vertebral arches|MP:0004703,abnormal vertebral column morphology|MP:0005657,abnormal neural plate morphology|MP:0006386,absent somites|MP:0008832,hemivertebra|MP:0009703,decreased birth body size|MP:0011089,perinatal lethality, complete penetrance|MP:0011999,abnormal tail length
MGI:5495286	Rfc1<tm1b(KOMP)Mbp>	MP:0001556,increased circulating HDL cholesterol level|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0002702,decreased circulating free fatty acids level|MP:0003984,embryonic growth retardation|MP:0005178,increased circulating cholesterol level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5755480	Rfc2<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6382783	Rfc5<em1(IMPC)J>	MP:0000198,decreased circulating phosphate level|MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6341904	Rffl<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000277,abnormal heart shape|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus
MGI:3846097	Rffl<tm1Cota>	MP:0002169,no abnormal phenotype detected
MGI:6449039	Rfk<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001289,persistence of hyaloid vascular system|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003604,single kidney|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:4356069	Rfk<tm1.1Jcbr>	MP:0011077,decreased macrophage nitric oxide production
MGI:4356070	Rfk<tm1.2Jcbr>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5618543	Rflna<tm1Tfur>	MP:0002169,no abnormal phenotype detected
MGI:3528231	Rflnb<tm1Sia>	MP:0002169,no abnormal phenotype detected
MGI:2182609	Rfng<tm1Grid>	MP:0002169,no abnormal phenotype detected
MGI:3662622	Rfng<tm2.1Tfv>	MP:0002169,no abnormal phenotype detected
MGI:3662621	Rfng<tm2Tfv>	MP:0000088,short mandible|MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0009886,failure of palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0011089,perinatal lethality, complete penetrance
MGI:5692864	Rft1<tm1b(KOMP)Wtsi>	MP:0000220,increased monocyte cell number|MP:0002590,increased mean corpuscular volume|MP:0002606,increased basophil cell number|MP:0002875,decreased erythrocyte cell number|MP:0004357,long tibia|MP:0005016,decreased lymphocyte cell number|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3850829	Rftn1<tm1Ayos>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008496,decreased IgG2a level|MP:0008567,decreased interferon-gamma secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0009339,decreased splenocyte number
MGI:6093702	Rfwd3<tm1.1Dtch>	MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002083,premature death|MP:0002687,oligozoospermia|MP:0003205,testicular atrophy|MP:0004833,ovary atrophy|MP:0014040,increased cellular sensitivity to DNA damaging agent induced cell death
MGI:4329124	Rfx1<Gt(RRO347)Byg>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5907528	Rfx1<tm1.1Wrth>	MP:0005377,hearing/vestibular/ear phenotype
MGI:3966900	Rfx2<Gt(IST10638H11)Tigm>	MP:0001152,increased Leydig cell number|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0006380,abnormal spermatid morphology|MP:0013598,Leydig cell hypertrophy|MP:0020550,multinucleated giant male germ cells
MGI:5792884	Rfx2<tm1.1Wrth>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002662,abnormal cauda epididymis morphology|MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0008279,arrest of spermiogenesis|MP:0008898,abnormal acrosome morphology|MP:0009231,detached acrosome|MP:0009377,ectopic manchette|MP:0009838,abnormal sperm axoneme morphology|MP:0011743,abnormal Golgi apparatus morphology|MP:0020550,multinucleated giant male germ cells|MP:0031354,abnormal acrosome assembly|MP:0031389,abnormal ectoplasmic specialization morphology
MGI:5792885	Rfx2<tm1.2Wrth>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002662,abnormal cauda epididymis morphology|MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0008279,arrest of spermiogenesis|MP:0008898,abnormal acrosome morphology|MP:0009231,detached acrosome|MP:0009377,ectopic manchette|MP:0009838,abnormal sperm axoneme morphology|MP:0011743,abnormal Golgi apparatus morphology|MP:0020550,multinucleated giant male germ cells|MP:0031354,abnormal acrosome assembly|MP:0031389,abnormal ectoplasmic specialization morphology
MGI:7312142	Rfx2<tm1Hncs>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0002083,premature death|MP:0002631,abnormal epididymis morphology|MP:0005159,azoospermia|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0008279,arrest of spermiogenesis|MP:0008898,abnormal acrosome morphology|MP:0009376,abnormal manchette morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0014052,increased male germ cell apoptosis|MP:0014634,decreased round spermatid number|MP:0014636,decreased elongated spermatid number|MP:0020550,multinucleated giant male germ cells
MGI:5560494	Rfx3<b2b1213Clo>	MP:0004133,heterotaxia|MP:0005330,cardiomyopathy|MP:0010402,ventricular septal defect
MGI:3045792	Rfx3<tm1.1Wrth>	MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0001706,abnormal left-right axis patterning|MP:0001732,postnatal growth retardation|MP:0002766,situs inversus|MP:0004131,abnormal motile primary cilium morphology|MP:0004190,abnormal direction of embryo turning|MP:0004252,abnormal direction of heart looping|MP:0009703,decreased birth body size|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3045791	Rfx3<tm1Wrth>	MP:0002169,no abnormal phenotype detected
MGI:3045794	Rfx3<tm2.1Wrth>	MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0001706,abnormal left-right axis patterning|MP:0001732,postnatal growth retardation|MP:0002766,situs inversus|MP:0004131,abnormal motile primary cilium morphology|MP:0004190,abnormal direction of embryo turning|MP:0004252,abnormal direction of heart looping|MP:0009703,decreased birth body size|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3045793	Rfx3<tm2Wrth>	MP:0002169,no abnormal phenotype detected|MP:0005377,hearing/vestibular/ear phenotype
MGI:3799278	Rfx4<m269Asp>	MP:0000787,abnormal telencephalon morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000841,abnormal hindbrain morphology|MP:0000925,abnormal floor plate morphology|MP:0000927,small floor plate|MP:0000937,abnormal motor neuron morphology|MP:0000955,abnormal spinal cord morphology|MP:0011056,abnormal brain ependyma motile cilium morphology|MP:0011058,abnormal spinal cord motile cilium morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3851404	Rfx4<Tg(Myh6-CYP2J2)Tr5Dcz>	MP:0000343,abnormal response to cardiac infarction|MP:0000913,abnormal brain development|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002958,cerebral aqueductal stenosis|MP:0006007,abnormal basal ganglion morphology|MP:0009717,absent subcommissural organ|MP:0011089,perinatal lethality, complete penetrance|MP:0014402,abnormal Reissner's fiber morphology
MGI:2386501	Rfx5<tm1.1Ifo>	MP:0001806,decreased IgM level|MP:0002371,abnormal thymus cortex morphology|MP:0002453,abnormal B lymphocyte antigen presentation|MP:0005040,abnormal MHC II cell surface expression on macrophages|MP:0005042,abnormal level of surface class II molecules|MP:0005461,abnormal dendritic cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0008114,abnormal Kupffer cell morphology|MP:0008495,decreased IgG1 level
MGI:2386499	Rfx5<tm1Ifo>	MP:0005387,immune system phenotype
MGI:4429702	Rfx6<tm1.1(EGFP/cre)Mger>	MP:0001270,distended abdomen|MP:0001438,aphagia|MP:0002082,postnatal lethality|MP:0003270,intestinal obstruction|MP:0004247,small pancreas
MGI:5582441	Rfx6<tm1.1(KOMP)Vlcg>	MP:0005293,impaired glucose tolerance|MP:0011100,preweaning lethality, complete penetrance
MGI:6513141	Rfx7<tm1.1Ggaur>	MP:0000692,small spleen|MP:0002418,increased susceptibility to viral infection|MP:0005068,abnormal NK cell morphology|MP:0008045,decreased NK cell number|MP:0010766,abnormal NK cell physiology
MGI:6513142	Rfx7<tm1.2Ggaur>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5637140	Rfx7<tm2b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:5811625	Rfx8<tm1b(EUCOMM)Hmgu>	MP:0001925,male infertility|MP:0001926,female infertility
MGI:5614696	Rfxank<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0002968,increased circulating alkaline phosphatase level
MGI:6342848	Rfxap<em1(IMPC)J>	MP:0001314,cornea opacity|MP:0001399,hyperactivity|MP:0004738,abnormal auditory brainstem response|MP:0005287,narrow eye opening|MP:0005542,cornea vascularization|MP:0005560,decreased circulating glucose level|MP:0012121,sclerocornea
MGI:1857016	rg	MP:0000026,abnormal inner ear morphology|MP:0000035,abnormal membranous labyrinth morphology|MP:0000370,head blaze|MP:0000373,belly spot|MP:0000585,kinked tail|MP:0001395,bidirectional circling|MP:0001399,hyperactivity|MP:0001408,stereotypic behavior|MP:0002111,abnormal tail morphology|MP:0002428,abnormal semicircular canal morphology|MP:0002938,white spotting|MP:0004331,vestibular saccular macula degeneration|MP:0005424,jerky movement|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5569044	Rgcc<tm1.1(KOMP)Wtsi>	MP:0001944,abnormal pancreas morphology|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis
MGI:6367994	Rgcc<tm1Hrus>	MP:0005348,increased T cell proliferation|MP:0008687,increased interleukin-2 secretion|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4362711	Rgcc<tm1(KOMP)Wtsi>	MP:0001262,decreased body weight|MP:0003229,abnormal vitelline vasculature morphology|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0004259,small placenta|MP:0004921,decreased placenta weight|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009431,decreased fetal weight|MP:0009674,decreased birth weight|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011521,decreased placental labyrinth size
MGI:3823251	Rgcs1<BALB/cByJ>	MP:0006309,decreased retina ganglion cell number
MGI:6277056	Rgl1<em1(IMPC)Mbp>	MP:0000111,cleft palate|MP:0000219,increased neutrophil cell number|MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001488,increased startle reflex|MP:0001700,abnormal embryo turning|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002109,abnormal limb morphology|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0002339,abnormal lymph node morphology|MP:0002591,decreased mean corpuscular volume|MP:0002833,increased heart weight|MP:0003068,enlarged kidney|MP:0003231,abnormal placenta vasculature|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0006108,abnormal hindbrain development|MP:0009142,decreased prepulse inhibition|MP:0009709,hydrometra|MP:0011100,preweaning lethality, complete penetrance
MGI:6149210	Rgl3<em1(IMPC)H>	MP:0000195,decreased circulating calcium level|MP:0001406,abnormal gait|MP:0002966,decreased circulating alkaline phosphatase level
MGI:3029714	Rgma<tm1Arbr>	MP:0000438,abnormal cranium morphology|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0001672,abnormal embryo development|MP:0003631,nervous system phenotype|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4939680	Rgmb<tm1Hlin>	MP:0011085,postnatal lethality, complete penetrance
MGI:2670511	Rgn<tm1Aish>	MP:0000063,decreased bone mineral density|MP:0000414,alopecia|MP:0000427,abnormal hair cycle|MP:0000607,abnormal hepatocyte morphology|MP:0001244,thin dermal layer|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001406,abnormal gait|MP:0001958,emphysema|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002628,hepatic steatosis|MP:0002655,abnormal keratinocyte morphology|MP:0002857,cochlear ganglion degeneration|MP:0003674,oxidative stress|MP:0003887,increased hepatocyte apoptosis|MP:0004777,abnormal phospholipid level|MP:0005311,abnormal circulating amino acid level|MP:0005332,abnormal amino acid level|MP:0005459,decreased percent body fat/body weight|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0009355,increased liver triglyceride level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009820,abnormal liver vasculature morphology|MP:0010027,increased liver cholesterol level|MP:0010252,anterior subcapsular cataract|MP:0010911,abnormal pulmonary acinus morphology|MP:0011229,abnormal vitamin C level|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014341,abnormal hepatocyte mitochondrial morphology|MP:0030679,decreased hydroxyproline level|MP:0030827,femur fracture|MP:0030884,rachitic rosary
MGI:5474777	Rgp1<tm1.1(KOMP)Vlcg>	MP:0000195,decreased circulating calcium level|MP:0000955,abnormal spinal cord morphology|MP:0004924,abnormal behavior|MP:0005179,decreased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0020870,decreased thigmotaxis
MGI:2181447	Rgr<tm1Hkf>	MP:0005253,abnormal eye physiology|MP:0005551,abnormal eye electrophysiology
MGI:3530289	Rgs10<Gt(OST24334)Lex>	MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level
MGI:3717931	Rgs10<tm1Ypl>	MP:0000062,increased bone mineral density|MP:0000547,short limbs|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003723,abnormal long bone morphology|MP:0004985,decreased osteoclast cell number|MP:0006395,abnormal epiphyseal plate morphology|MP:0008396,abnormal osteoclast differentiation|MP:0011085,postnatal lethality, complete penetrance
MGI:3528953	Rgs11<tm1Lex>	MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology
MGI:5490960	Rgs12<tm1.1Syy>	MP:0000065,abnormal bone marrow cavity morphology|MP:0000067,osteopetrosis|MP:0000130,abnormal trabecular bone morphology|MP:0004985,decreased osteoclast cell number|MP:0005605,increased bone mass|MP:0009347,increased trabecular bone thickness|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume
MGI:5490961	Rgs12<tm1Syy>	MP:0002169,no abnormal phenotype detected
MGI:5514157	Rgs13<tm1.1Jhk>	MP:0000689,abnormal spleen morphology|MP:0001800,abnormal humoral immune response|MP:0002144,abnormal B cell differentiation|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0005014,increased B cell number|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0008177,increased germinal center B cell number|MP:0008481,increased spleen germinal center number|MP:0008483,increased spleen germinal center size|MP:0008499,increased IgG1 level|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level|MP:0008896,increased IgG2c level
MGI:3771964	Rgs13<tm1Drue>	MP:0002423,abnormal mast cell physiology|MP:0005596,increased susceptibility to type I hypersensitivity reaction
MGI:3528963	Rgs14<tm1Lex>	MP:0001463,abnormal spatial learning|MP:0003008,enhanced long-term potentiation|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology|MP:0004859,abnormal synaptic plasticity|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype|MP:0005391,vision/eye phenotype|MP:0005397,hematopoietic system phenotype|MP:0005402,abnormal action potential|MP:0010771,integument phenotype|MP:0014368,enhanced long-term object recognition memory
MGI:3514019	Rgs14<tm1Pngr>	MP:0003406,failure of zygotic cell division|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5442790	Rgs16<tm1.1Drue>	MP:0002500,granulomatous inflammation|MP:0005027,increased susceptibility to parasitic infection|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0006050,pulmonary fibrosis|MP:0008660,increased interleukin-10 secretion|MP:0008672,increased interleukin-13 secretion|MP:0008702,increased interleukin-5 secretion
MGI:5546629	Rgs16<tm1Sia>	MP:0020469,prolonged circadian behavior period
MGI:5004805	Rgs16<tm1Tmw>	MP:0002575,increased circulating ketone body level|MP:0014171,increased fatty acid oxidation
MGI:7574257	Rgs17<em1(IMPC)J>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5307901	Rgs18<m1H>	MP:0005607,decreased bleeding time|MP:0009586,increased platelet aggregation|MP:0009676,abnormal hemostasis|MP:0031121,increased susceptibility to induced thrombosis
MGI:5751583	Rgs18<tm1.1Ics>	MP:0000229,abnormal megakaryocyte differentiation|MP:0001488,increased startle reflex|MP:0002398,abnormal bone marrow cell morphology/development|MP:0003179,thrombocytopenia|MP:0003631,nervous system phenotype|MP:0003998,decreased thermal nociceptive threshold|MP:0005386,behavior/neurological phenotype|MP:0008255,decreased megakaryocyte cell number|MP:0009586,increased platelet aggregation
MGI:3044786	Rgs1<tm1Jhk>	MP:0002359,abnormal spleen germinal center morphology|MP:0002376,abnormal dendritic cell physiology|MP:0002461,increased immunoglobulin level|MP:0008098,decreased plasma cell number|MP:0008135,small Peyer's patches|MP:0008181,increased marginal zone B cell number|MP:0014469,abnormal B cell calcium ion homeostasis|MP:0014471,enhanced B cell migration
MGI:6357987	Rgs21<tm1.2Dski>	MP:0001985,abnormal gustatory system physiology|MP:0001986,abnormal taste sensitivity|MP:0004209,abnormal sweet taste sensitivity|MP:0004210,abnormal bitter taste sensitivity|MP:0004212,abnormal salty taste sensitivity|MP:0004213,abnormal umami taste sensitivity|MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype
MGI:6153812	Rgs2<em1(IMPC)H>	MP:0000691,enlarged spleen|MP:0001314,cornea opacity|MP:0002100,abnormal tooth morphology|MP:0005553,increased circulating creatinine level|MP:0013278,decreased fasting circulating glucose level|MP:0020421,increased freezing behavior
MGI:5426401	Rgs2<tm1.1Kjb>	MP:0004875,increased mean systemic arterial blood pressure|MP:0005385,cardiovascular system phenotype|MP:0005591,decreased vasodilation
MGI:3604465	Rgs2<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:2388144	Rgs2<tm1Pngr>	MP:0000249,abnormal blood vessel physiology|MP:0000530,abnormal kidney vasculature morphology|MP:0001363,increased anxiety-related response|MP:0002272,abnormal nervous system electrophysiology|MP:0002842,increased systemic arterial blood pressure|MP:0002844,aortic hypertrophy|MP:0003025,increased vasoconstriction|MP:0003631,nervous system phenotype|MP:0005094,abnormal T cell proliferation|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005397,hematopoietic system phenotype|MP:0005591,decreased vasodilation|MP:0005656,decreased aggression|MP:0008263,abnormal hippocampus CA1 region morphology
MGI:5572935	Rgs3<tm1Ndul>	MP:0001861,lung inflammation|MP:0002339,abnormal lymph node morphology|MP:0005014,increased B cell number|MP:0005387,immune system phenotype|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:6302752	Rgs4<em1(IMPC)H>	MP:0002590,increased mean corpuscular volume|MP:0004952,increased spleen weight|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number
MGI:5476691	Rgs4<tm1.1Amus>	MP:0005526,decreased renal plasma flow rate|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:3580388	Rgs4<tm1.1Jbr>	MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001968,abnormal touch/nociception|MP:0003631,nervous system phenotype|MP:0009757,impaired behavioral response to morphine|MP:0009776,decreased behavioral withdrawal response|MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance
MGI:4456099	Rgs4<tm1.1Jlr>	MP:0002169,no abnormal phenotype detected
MGI:3604580	Rgs4<tm1Dgen>	MP:0001399,hyperactivity|MP:0001556,increased circulating HDL cholesterol level|MP:0002574,increased vertical activity|MP:0003863,decreased aggression towards mice|MP:0005178,increased circulating cholesterol level|MP:0005386,behavior/neurological phenotype|MP:0009712,impaired conditioned place preference behavior|MP:0010024,increased total body fat amount
MGI:5605686	Rgs4<tm1Sdlk>	MP:0002703,abnormal renal tubule morphology|MP:0005553,increased circulating creatinine level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010760,abnormal macrophage chemotaxis
MGI:3796067	Rgs5<tm1.1Rgan>	MP:0002169,no abnormal phenotype detected
MGI:3785528	Rgs5<tm1Cbet>	MP:0002626,increased heart rate|MP:0004876,decreased mean systemic arterial blood pressure|MP:0006263,decreased systemic arterial diastolic blood pressure|MP:0006264,decreased systemic arterial systolic blood pressure
MGI:3604464	Rgs5<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3784984	Rgs5<tm1Jhk>	MP:0000272,abnormal aorta morphology|MP:0001596,hypotension|MP:0005016,decreased lymphocyte cell number|MP:0008489,slow postnatal weight gain|MP:0010025,decreased total body fat amount
MGI:5301342	Rgs6<tm1Lex>	MP:0003137,abnormal impulse conducting system conduction|MP:0005333,decreased heart rate|MP:0006142,abnormal sinoatrial node conduction
MGI:3773065	Rgs7bp<tm1Itl>	MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:5427707	Rgs7<tm1.1Kama>	MP:0005391,vision/eye phenotype
MGI:5426905	Rgs7<tm1Cjch>	MP:0001265,decreased body size|MP:0001290,delayed eyelid opening|MP:0005389,reproductive system phenotype|MP:0005551,abnormal eye electrophysiology|MP:0008489,slow postnatal weight gain|MP:0010768,mortality/aging
MGI:3528964	Rgs7<tm1Lex>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0004021,abnormal rod electrophysiology|MP:0005293,impaired glucose tolerance
MGI:6306620	Rgs8<em1(IMPC)H>	MP:0001399,hyperactivity
MGI:5566702	Rgs8<tm1.1Atai>	MP:0003631,nervous system phenotype|MP:0005389,reproductive system phenotype
MGI:3028628	Rgs9bp<tm1Hels>	MP:0005253,abnormal eye physiology|MP:0005391,vision/eye phenotype
MGI:7425944	Rgs9<em1(IMPC)Ccpcz>	MP:0000218,increased leukocyte cell number|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0001399,hyperactivity|MP:0001552,increased circulating triglyceride level|MP:0002792,abnormal retina vasculature morphology|MP:0002981,increased liver weight|MP:0003036,vertebral transformation|MP:0003961,decreased lean body mass|MP:0004599,abnormal vertebral arch morphology|MP:0005013,increased lymphocyte cell number|MP:0008935,decreased mean platelet volume|MP:0010090,increased circulating creatine kinase level|MP:0011047,increased lung tissue damping|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2386798	Rgs9<tm1Citb>	MP:0004021,abnormal rod electrophysiology|MP:0005253,abnormal eye physiology|MP:0005391,vision/eye phenotype
MGI:3813589	Rgsc1002	MP:0001399,hyperactivity|MP:0004000,impaired passive avoidance behavior
MGI:3813599	Rgsc1015	MP:0006359,absent startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3798849	Rgsc103	MP:0000574,abnormal foot pad morphology
MGI:3813612	Rgsc1033	MP:0002041,increased pituitary adenoma incidence|MP:0010346,increased thyroid carcinoma incidence
MGI:3808123	Rgsc1039	MP:0000574,abnormal foot pad morphology
MGI:3811077	Rgsc1045	MP:0002463,abnormal neutrophil physiology
MGI:3813618	Rgsc1049	MP:0004207,increased squamous cell carcinoma incidence
MGI:3813623	Rgsc1050	MP:0010384,increased renal carcinoma incidence
MGI:3811088	Rgsc1051	MP:0001596,hypotension
MGI:3808782	Rgsc1056	MP:0002792,abnormal retina vasculature morphology
MGI:3813824	Rgsc1085	MP:0001150,enlarged scrotum|MP:0001190,reddish skin
MGI:3809030	Rgsc1088	MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin
MGI:3809279	Rgsc1091	MP:0005175,non-pigmented tail tip
MGI:3813833	Rgsc1120	MP:0001596,hypotension
MGI:3813845	Rgsc1130	MP:0001274,curly vibrissae
MGI:3811769	Rgsc114	MP:0006325,impaired hearing|MP:0006359,absent startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3809287	Rgsc1142	MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin
MGI:3813865	Rgsc1152	MP:0000436,abnormal head movements|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001399,hyperactivity|MP:0006325,impaired hearing
MGI:3814080	Rgsc1158	MP:0001596,hypotension
MGI:3809294	Rgsc1159	MP:0001297,microphthalmia|MP:0001314,cornea opacity
MGI:3798872	Rgsc116	MP:0000413,polyphalangy|MP:0000574,abnormal foot pad morphology|MP:0009743,preaxial polydactyly
MGI:3798878	Rgsc117	MP:0000373,belly spot|MP:0000440,domed cranium
MGI:3809309	Rgsc1175	MP:0000371,diluted coat color|MP:0002875,decreased erythrocyte cell number|MP:0005561,increased mean corpuscular hemoglobin
MGI:3814085	Rgsc1177	MP:0002591,decreased mean corpuscular volume
MGI:3809394	Rgsc1196	MP:0002966,decreased circulating alkaline phosphatase level
MGI:3798438	Rgsc12	MP:0000159,abnormal xiphoid process morphology
MGI:3815139	Rgsc1243	MP:0001393,ataxia
MGI:3808788	Rgsc1246	MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0002938,white spotting|MP:0008237,abnormal ventral coat pigmentation
MGI:3808795	Rgsc1256	MP:0000564,syndactyly
MGI:3815145	Rgsc1324	MP:0002050,increased pheochromocytoma incidence
MGI:3815150	Rgsc1328	MP:0002050,increased pheochromocytoma incidence
MGI:3808800	Rgsc1350	MP:0000585,kinked tail
MGI:3811094	Rgsc1354	MP:0002463,abnormal neutrophil physiology
MGI:3815155	Rgsc1358	MP:0001260,increased body weight
MGI:3815161	Rgsc1361	MP:0001260,increased body weight|MP:0005559,increased circulating glucose level
MGI:3811749	Rgsc1371	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001314,cornea opacity|MP:0010096,abnormal incisor color
MGI:3798447	Rgsc14	MP:0000218,increased leukocyte cell number|MP:0005013,increased lymphocyte cell number
MGI:3811828	Rgsc141	MP:0000585,kinked tail
MGI:3811838	Rgsc142	MP:0002024,increased T cell derived lymphoma incidence|MP:0002026,increased leukemia incidence
MGI:3815166	Rgsc1453	MP:0000410,waved hair|MP:0000414,alopecia
MGI:3809407	Rgsc1460	MP:0010096,abnormal incisor color
MGI:3809417	Rgsc1461	MP:0000373,belly spot|MP:0000574,abnormal foot pad morphology|MP:0009743,preaxial polydactyly
MGI:3811754	Rgsc1465	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001314,cornea opacity
MGI:3815171	Rgsc1471	MP:0003179,thrombocytopenia
MGI:3809422	Rgsc1472	MP:0008805,decreased circulating amylase level
MGI:3809427	Rgsc1473	MP:0005358,abnormal incisor morphology|MP:0010096,abnormal incisor color
MGI:3815177	Rgsc1475	MP:0001274,curly vibrissae
MGI:3815555	Rgsc1479	MP:0001393,ataxia
MGI:3809441	Rgsc1490	MP:0005358,abnormal incisor morphology|MP:0010096,abnormal incisor color
MGI:3815550	Rgsc1497	MP:0001399,hyperactivity
MGI:3798455	Rgsc15	MP:0000218,increased leukocyte cell number|MP:0005013,increased lymphocyte cell number
MGI:3798215	Rgsc150	MP:0000575,increased foot pad pigmentation
MGI:3811099	Rgsc1501	MP:0005571,decreased lactate dehydrogenase level
MGI:3811105	Rgsc1513	MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0008237,abnormal ventral coat pigmentation
MGI:3809516	Rgsc1520	MP:0000373,belly spot|MP:0005175,non-pigmented tail tip|MP:0030930,decreased digit pigmentation
MGI:3809528	Rgsc1532	MP:0000435,shortened head
MGI:3815560	Rgsc1543	MP:0001399,hyperactivity
MGI:3810684	Rgsc1545	MP:0000373,belly spot
MGI:3815565	Rgsc1547	MP:0001850,increased susceptibility to otitis media|MP:0004738,abnormal auditory brainstem response|MP:0006325,impaired hearing|MP:0006359,absent startle reflex
MGI:3815570	Rgsc1553	MP:0000414,alopecia
MGI:3810692	Rgsc1554	MP:0000373,belly spot
MGI:3817239	Rgsc1556	MP:0001399,hyperactivity
MGI:3811240	Rgsc1566	MP:0002966,decreased circulating alkaline phosphatase level
MGI:3810699	Rgsc1571	MP:0000585,kinked tail
MGI:3817246	Rgsc1583	MP:0000410,waved hair|MP:0001304,cataract
MGI:3798900	Rgsc159	MP:0001513,limb grasping
MGI:3817256	Rgsc1590	MP:0000574,abnormal foot pad morphology|MP:0000585,kinked tail|MP:0003051,curly tail
MGI:3798463	Rgsc16	MP:0002875,decreased erythrocyte cell number|MP:0010067,increased red blood cell distribution width
MGI:3811843	Rgsc160	MP:0001559,hyperglycemia
MGI:3817263	Rgsc1605	MP:0002591,decreased mean corpuscular volume|MP:0003131,increased erythrocyte cell number
MGI:3811256	Rgsc1655	MP:0001394,circling
MGI:3811277	Rgsc1658	MP:0000371,diluted coat color|MP:0002075,abnormal coat/hair pigmentation
MGI:3817281	Rgsc1662	MP:0008822,decreased blood uric acid level
MGI:3817287	Rgsc1663	MP:0005565,increased blood urea nitrogen level
MGI:3817292	Rgsc1666	MP:0008822,decreased blood uric acid level
MGI:3817298	Rgsc1670	MP:0001399,hyperactivity|MP:0020467,abnormal circadian behavior
MGI:3817303	Rgsc1677	MP:0005262,coloboma
MGI:3811759	Rgsc1679	MP:0000435,shortened head
MGI:3811764	Rgsc1682	MP:0000435,shortened head
MGI:3811389	Rgsc1683	MP:0000585,kinked tail
MGI:3817308	Rgsc1686	MP:0005561,increased mean corpuscular hemoglobin
MGI:3817602	Rgsc1688	MP:0002966,decreased circulating alkaline phosphatase level
MGI:3817614	Rgsc1699	MP:0001399,hyperactivity
MGI:3798472	Rgsc17	MP:0000221,decreased leukocyte cell number|MP:0005016,decreased lymphocyte cell number
MGI:3817650	Rgsc1700	MP:0003179,thrombocytopenia
MGI:3817655	Rgsc1701	MP:0003179,thrombocytopenia
MGI:3811394	Rgsc1707	MP:0000435,shortened head
MGI:3817660	Rgsc1716	MP:0005505,thrombocytosis
MGI:3798972	Rgsc172	MP:0005565,increased blood urea nitrogen level|MP:0008806,increased circulating amylase level
MGI:3817665	Rgsc1733	MP:0001405,impaired coordination|MP:0001513,limb grasping
MGI:3817938	Rgsc1740	MP:0006349,decreased circulating copper level
MGI:3811399	Rgsc1742	MP:0000373,belly spot
MGI:3817943	Rgsc1747	MP:0001402,decreased locomotor activity|MP:0020467,abnormal circadian behavior
MGI:3817948	Rgsc1752	MP:0001326,retina degeneration
MGI:3817956	Rgsc1755	MP:0002792,abnormal retina vasculature morphology|MP:0005103,abnormal retina pigmentation
MGI:3818753	Rgsc1769	MP:0001399,hyperactivity
MGI:3819695	Rgsc1770	MP:0001362,abnormal anxiety-related response|MP:0003313,abnormal locomotor activation|MP:0031391,increased locomotor activity
MGI:3818842	Rgsc1771	MP:0001488,increased startle reflex
MGI:3818859	Rgsc1798	MP:0001399,hyperactivity
MGI:3818867	Rgsc1809	MP:0001304,cataract
MGI:3818878	rgsc1816	MP:0000410,waved hair|MP:0001274,curly vibrissae
MGI:3818902	rgsc1820	MP:0005171,absent coat pigmentation|MP:0008480,absent eye pigmentation
MGI:3798192	Rgsc183	MP:0000575,increased foot pad pigmentation
MGI:3818930	Rgsc1843	MP:0002940,variable body spotting
MGI:3818945	Rgsc1851	MP:0001552,increased circulating triglyceride level
MGI:3818966	Rgsc1854	MP:0000018,small ears
MGI:3818971	Rgsc1855	MP:0000373,belly spot
MGI:3818976	rgsc1887	MP:0010179,rough coat
MGI:3811848	Rgsc190	MP:0004738,abnormal auditory brainstem response|MP:0006325,impaired hearing|MP:0006359,absent startle reflex
MGI:3818982	rgsc1904	MP:0000371,diluted coat color
MGI:3798412	Rgsc194	MP:0000575,increased foot pad pigmentation
MGI:3798983	Rgsc197	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:3798208	Rgsc207	MP:0000575,increased foot pad pigmentation
MGI:3798988	Rgsc212	MP:0008812,abnormal rostrocaudal coat patterning
MGI:3798993	Rgsc216	MP:0002764,short tibia|MP:0002765,short fibula|MP:0003109,short femur|MP:0014322,short hindlimb
MGI:3799132	Rgsc225	MP:0006358,absent pinna reflex|MP:0006359,absent startle reflex
MGI:3798484	Rgsc23	MP:0001399,hyperactivity|MP:0001410,head bobbing
MGI:3799156	Rgsc241	MP:0000585,kinked tail
MGI:3798490	Rgsc25	MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level
MGI:3811860	Rgsc252	MP:0000018,small ears|MP:0004738,abnormal auditory brainstem response|MP:0006325,impaired hearing|MP:0006359,absent startle reflex
MGI:3799167	Rgsc257	MP:0002075,abnormal coat/hair pigmentation
MGI:3799172	Rgsc258	MP:0001297,microphthalmia|MP:0001304,cataract
MGI:3799179	Rgsc263	MP:0002966,decreased circulating alkaline phosphatase level
MGI:3811865	Rgsc264	MP:0002968,increased circulating alkaline phosphatase level
MGI:3799184	Rgsc268	MP:0010096,abnormal incisor color
MGI:3799189	Rgsc269	MP:0000373,belly spot|MP:0005175,non-pigmented tail tip|MP:0030930,decreased digit pigmentation
MGI:3799205	Rgsc273	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:3799211	Rgsc278	MP:0002642,anisocytosis|MP:0008850,increased hemoglobin concentration distribution width
MGI:3799218	Rgsc279	MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number
MGI:3800202	Rgsc288	MP:0000421,mottled coat
MGI:3800209	Rgsc300	MP:0001297,microphthalmia
MGI:3808805	Rgsc301	MP:0000585,kinked tail|MP:0001297,microphthalmia
MGI:3808810	Rgsc318	MP:0000745,tremors
MGI:3800219	Rgsc320	MP:0005175,non-pigmented tail tip
MGI:3800225	Rgsc333	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005567,decreased circulating total protein level
MGI:3800387	Rgsc344	MP:0002875,decreased erythrocyte cell number|MP:0005561,increased mean corpuscular hemoglobin
MGI:3811873	Rgsc350	MP:0002642,anisocytosis
MGI:3800412	Rgsc357	MP:0003815,hairless
MGI:3800419	Rgsc362	MP:0000562,polydactyly
MGI:3811881	Rgsc366a	MP:0000585,kinked tail
MGI:3800427	Rgsc370	MP:0008805,decreased circulating amylase level
MGI:3800439	Rgsc372	MP:0000575,increased foot pad pigmentation
MGI:3800444	Rgsc375	MP:0002642,anisocytosis
MGI:3812031	Rgsc376	MP:0004738,abnormal auditory brainstem response|MP:0006325,impaired hearing|MP:0006359,absent startle reflex
MGI:3800453	Rgsc386	MP:0001399,hyperactivity
MGI:3800479	Rgsc387	MP:0000585,kinked tail
MGI:3810704	Rgsc391	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:3800489	Rgsc393	MP:0002642,anisocytosis|MP:0008850,increased hemoglobin concentration distribution width
MGI:3800672	Rgsc394	MP:0005175,non-pigmented tail tip|MP:0030930,decreased digit pigmentation
MGI:3798421	Rgsc396	MP:0000562,polydactyly|MP:0001891,hydrocephaly|MP:0002939,head spot|MP:0004083,polysyndactyly
MGI:3800681	Rgsc398	MP:0005175,non-pigmented tail tip|MP:0030930,decreased digit pigmentation
MGI:3808140	Rgsc400	MP:0001304,cataract
MGI:3800686	Rgsc411	MP:0002642,anisocytosis
MGI:3801042	Rgsc431	MP:0000585,kinked tail|MP:0000588,thick tail|MP:0000592,short tail|MP:0002111,abnormal tail morphology|MP:0003456,absent tail
MGI:3812038	Rgsc433	MP:0000231,hypertension
MGI:3808148	Rgsc435	MP:0001304,cataract
MGI:3801072	Rgsc441	MP:0001511,disheveled coat
MGI:3801086	Rgsc444	MP:0005174,abnormal tail pigmentation
MGI:3801092	Rgsc448	MP:0010096,abnormal incisor color
MGI:3798178	Rgsc45	MP:0000575,increased foot pad pigmentation|MP:0001219,thick epidermis
MGI:3801329	Rgsc453	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:3805912	Rgsc460	MP:0002642,anisocytosis
MGI:3812051	Rgsc461	MP:0002642,anisocytosis
MGI:3805925	Rgsc466	MP:0008822,decreased blood uric acid level
MGI:3812062	Rgsc469	MP:0006359,absent startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3806026	Rgsc471	MP:0002642,anisocytosis
MGI:3806038	Rgsc473	MP:0000585,kinked tail
MGI:3810709	Rgsc477	MP:0006350,increased circulating copper level
MGI:3806045	Rgsc484	MP:0002966,decreased circulating alkaline phosphatase level
MGI:3806053	Rgsc485	MP:0002591,decreased mean corpuscular volume|MP:0002642,anisocytosis
MGI:3806058	Rgsc486	MP:0002642,anisocytosis|MP:0008850,increased hemoglobin concentration distribution width
MGI:3806081	Rgsc493	MP:0000585,kinked tail
MGI:3808815	Rgsc496	MP:0010179,rough coat
MGI:3806094	Rgsc498	MP:0004615,cervical vertebral transformation
MGI:3798426	Rgsc5	MP:0003109,short femur|MP:0030302,abnormal maxillary zygomatic process morphology
MGI:3806112	Rgsc510	MP:0005175,non-pigmented tail tip|MP:0030930,decreased digit pigmentation
MGI:3812075	Rgsc513	MP:0004738,abnormal auditory brainstem response|MP:0006325,impaired hearing|MP:0006359,absent startle reflex
MGI:3806121	Rgsc515	MP:0000575,increased foot pad pigmentation
MGI:3806126	Rgsc522	MP:0008805,decreased circulating amylase level
MGI:3812080	Rgsc524	MP:0001489,decreased startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3806131	Rgsc525	MP:0005175,non-pigmented tail tip
MGI:3806335	Rgsc526	MP:0000575,increased foot pad pigmentation
MGI:3806349	Rgsc528	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:3806358	Rgsc530	MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin
MGI:3806447	Rgsc538	MP:0002591,decreased mean corpuscular volume|MP:0002642,anisocytosis|MP:0005562,decreased mean corpuscular hemoglobin
MGI:3806482	Rgsc545	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:3806493	Rgsc546	MP:0002642,anisocytosis|MP:0005562,decreased mean corpuscular hemoglobin
MGI:3806498	Rgsc547	MP:0002075,abnormal coat/hair pigmentation
MGI:3806506	Rgsc548	MP:0002591,decreased mean corpuscular volume|MP:0002642,anisocytosis
MGI:3812086	Rgsc558	MP:0006359,absent startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3808160	Rgsc566	MP:0000108,midline facial cleft|MP:0000435,shortened head
MGI:3812100	Rgsc569	MP:0001596,hypotension
MGI:3812121	Rgsc570	MP:0000231,hypertension|MP:0014280,forelimb oligodactyly
MGI:3806514	Rgsc576	MP:0000074,abnormal neurocranium morphology|MP:0004615,cervical vertebral transformation|MP:0008525,decreased cranium height
MGI:3798625	Rgsc58	MP:0000372,irregular coat pigmentation
MGI:3808823	Rgsc597	MP:0001265,decreased body size
MGI:3806519	Rgsc602	MP:0000585,kinked tail
MGI:3808828	Rgsc612	MP:0000745,tremors|MP:0001393,ataxia
MGI:3806638	Rgsc615	MP:0010096,abnormal incisor color
MGI:3812127	Rgsc624	MP:0000231,hypertension
MGI:3812135	Rgsc627	MP:0002968,increased circulating alkaline phosphatase level|MP:0005344,increased circulating bilirubin level|MP:0006350,increased circulating copper level
MGI:3806645	Rgsc629	MP:0008805,decreased circulating amylase level
MGI:3798652	Rgsc63	MP:0000575,increased foot pad pigmentation
MGI:3806799	Rgsc630	MP:0002642,anisocytosis
MGI:3812145	Rgsc639	MP:0004738,abnormal auditory brainstem response|MP:0006325,impaired hearing|MP:0006359,absent startle reflex
MGI:3812213	Rgsc649	MP:0003179,thrombocytopenia
MGI:3812221	Rgsc651	MP:0000745,tremors|MP:0001393,ataxia
MGI:3812304	Rgsc654	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001393,ataxia
MGI:3808898	Rgsc657	MP:0001297,microphthalmia|MP:0001314,cornea opacity
MGI:3806804	Rgsc662	MP:0005175,non-pigmented tail tip|MP:0030930,decreased digit pigmentation
MGI:3806811	Rgsc663	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:3812322	Rgsc665	MP:0000231,hypertension
MGI:3806820	Rgsc668	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:3806834	Rgsc669	MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0005561,increased mean corpuscular hemoglobin
MGI:3810716	Rgsc670	MP:0006359,absent startle reflex
MGI:3812328	Rgsc676	MP:0001596,hypotension
MGI:3806989	Rgsc677	MP:0004617,sacral vertebral transformation
MGI:3812336	Rgsc679	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3812349	Rgsc682	MP:0004207,increased squamous cell carcinoma incidence
MGI:3812361	Rgsc709	MP:0001596,hypotension
MGI:3798657	Rgsc71	MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0008237,abnormal ventral coat pigmentation
MGI:3806999	Rgsc710	MP:0002875,decreased erythrocyte cell number|MP:0005561,increased mean corpuscular hemoglobin
MGI:3807006	Rgsc713	MP:0000373,belly spot|MP:0005175,non-pigmented tail tip|MP:0030930,decreased digit pigmentation
MGI:3807012	Rgsc715	MP:0000575,increased foot pad pigmentation
MGI:3812371	Rgsc718	MP:0000745,tremors|MP:0001393,ataxia
MGI:3810721	Rgsc719	MP:0002591,decreased mean corpuscular volume|MP:0002642,anisocytosis|MP:0008850,increased hemoglobin concentration distribution width
MGI:3798668	Rgsc73	MP:0000947,convulsive seizures|MP:0001399,hyperactivity|MP:0001505,hunched posture|MP:0001525,impaired balance
MGI:3807017	Rgsc733	MP:0000186,decreased circulating HDL cholesterol level
MGI:3807025	Rgsc736	MP:0005175,non-pigmented tail tip
MGI:3808172	Rgsc745	MP:0003815,hairless
MGI:3807030	Rgsc747	MP:0002642,anisocytosis
MGI:3807035	Rgsc755	MP:0005175,non-pigmented tail tip|MP:0030930,decreased digit pigmentation
MGI:3807043	Rgsc756	MP:0000438,abnormal cranium morphology|MP:0004617,sacral vertebral transformation
MGI:3810726	Rgsc758	MP:0002591,decreased mean corpuscular volume|MP:0002642,anisocytosis
MGI:3808177	Rgsc767	MP:0000371,diluted coat color|MP:0005175,non-pigmented tail tip|MP:0030930,decreased digit pigmentation
MGI:3808747	Rgsc776	MP:0004615,cervical vertebral transformation
MGI:3808909	Rgsc779	MP:0000371,diluted coat color
MGI:3808986	Rgsc780	MP:0000371,diluted coat color
MGI:3812377	Rgsc785	MP:0004738,abnormal auditory brainstem response|MP:0006325,impaired hearing|MP:0006359,absent startle reflex
MGI:3812389	Rgsc786	MP:0001402,decreased locomotor activity
MGI:3811029	Rgsc788	MP:0005377,hearing/vestibular/ear phenotype|MP:0006325,impaired hearing|MP:0006359,absent startle reflex
MGI:3812394	Rgsc793	MP:0000231,hypertension
MGI:3812400	Rgsc796	MP:0000371,diluted coat color|MP:0001485,abnormal pinna reflex|MP:0003998,decreased thermal nociceptive threshold
MGI:3808991	Rgsc798	MP:0002075,abnormal coat/hair pigmentation
MGI:3798687	Rgsc80	MP:0000371,diluted coat color
MGI:3807056	Rgsc803	MP:0000373,belly spot|MP:0005175,non-pigmented tail tip|MP:0008525,decreased cranium height
MGI:3807068	Rgsc811	MP:0000585,kinked tail
MGI:3812530	Rgsc814	MP:0004207,increased squamous cell carcinoma incidence
MGI:3807236	Rgsc825	MP:0004617,sacral vertebral transformation
MGI:3812557	Rgsc832	MP:0002968,increased circulating alkaline phosphatase level
MGI:3807957	Rgsc833	MP:0002966,decreased circulating alkaline phosphatase level
MGI:3808995	Rgsc834	MP:0001297,microphthalmia|MP:0001314,cornea opacity
MGI:3808753	Rgsc836	MP:0003815,hairless|MP:0003853,dry skin
MGI:3811046	Rgsc844	MP:0002463,abnormal neutrophil physiology
MGI:3807964	Rgsc846	MP:0002966,decreased circulating alkaline phosphatase level
MGI:3807248	Rgsc848	MP:0004617,sacral vertebral transformation
MGI:3812564	Rgsc850	MP:0004738,abnormal auditory brainstem response|MP:0006325,impaired hearing|MP:0006359,absent startle reflex
MGI:3812571	Rgsc851	MP:0000410,waved hair|MP:0001274,curly vibrissae
MGI:3812576	Rgsc852	MP:0004738,abnormal auditory brainstem response|MP:0006325,impaired hearing|MP:0006359,absent startle reflex
MGI:3807972	Rgsc855	MP:0000186,decreased circulating HDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:3807258	Rgsc859	MP:0002591,decreased mean corpuscular volume|MP:0002642,anisocytosis|MP:0003131,increased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008850,increased hemoglobin concentration distribution width
MGI:3812581	Rgsc861	MP:0002875,decreased erythrocyte cell number
MGI:3807939	Rgsc881	MP:0000585,kinked tail
MGI:3807947	Rgsc890	MP:0000562,polydactyly
MGI:3808028	Rgsc900	MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin
MGI:3813528	Rgsc901	MP:0004738,abnormal auditory brainstem response|MP:0006325,impaired hearing|MP:0006359,absent startle reflex
MGI:3811570	Rgsc906	MP:0000435,shortened head|MP:0004615,cervical vertebral transformation|MP:0004617,sacral vertebral transformation
MGI:3808034	Rgsc916	MP:0008822,decreased blood uric acid level
MGI:3808039	Rgsc919	MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002642,anisocytosis|MP:0003131,increased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008850,increased hemoglobin concentration distribution width
MGI:3813533	Rgsc920	MP:0004738,abnormal auditory brainstem response|MP:0006325,impaired hearing|MP:0006359,absent startle reflex
MGI:3813540	Rgsc921	MP:0002864,abnormal ocular fundus morphology
MGI:3808045	Rgsc930	MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002642,anisocytosis|MP:0005562,decreased mean corpuscular hemoglobin
MGI:3813548	Rgsc933	MP:0002875,decreased erythrocyte cell number
MGI:3809002	Rgsc934	MP:0001399,hyperactivity
MGI:3798827	Rgsc95	MP:0006358,absent pinna reflex|MP:0006359,absent startle reflex
MGI:3809007	Rgsc955	MP:0004615,cervical vertebral transformation
MGI:3813558	Rgsc961	MP:0000410,waved hair|MP:0001274,curly vibrissae
MGI:3809015	Rgsc967	MP:0001265,decreased body size
MGI:3813564	Rgsc970	MP:0001596,hypotension
MGI:3813570	Rgsc974	MP:0001399,hyperactivity
MGI:3811742	Rgsc975	MP:0001304,cataract
MGI:3809020	Rgsc976	MP:0001297,microphthalmia|MP:0001314,cornea opacity
MGI:3813583	Rgsc977	MP:0000410,waved hair|MP:0001274,curly vibrissae
MGI:3809025	Rgsc987	MP:0004615,cervical vertebral transformation
MGI:3808770	Rgsc990	MP:0000569,abnormal digit pigmentation|MP:0005175,non-pigmented tail tip
MGI:3808775	Rgsc992	MP:0002792,abnormal retina vasculature morphology
MGI:3811056	Rgsc995	MP:0001596,hypotension
MGI:3617638	Rgv1<C57BL/6>	MP:0002026,increased leukemia incidence|MP:0002053,decreased incidence of induced tumors
MGI:1857017	rh	MP:0000154,rib fusion|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001265,decreased body size|MP:0001688,abnormal somite development|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0004608,abnormal cervical axis morphology|MP:0004621,lumbar vertebral fusion|MP:0004623,thoracic vertebral fusion|MP:0004646,decreased cervical vertebrae number|MP:0008920,absent cervical axis|MP:0008922,abnormal cervical rib
MGI:7425945	Rhag<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002339,abnormal lymph node morphology|MP:0005178,increased circulating cholesterol level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005568,increased circulating total protein level
MGI:5318589	Rhag<tm1Goo>	MP:0003656,abnormal erythrocyte physiology|MP:0008810,increased circulating iron level|MP:0009642,abnormal blood homeostasis
MGI:5442518	Rhbdd1<tm1.1Mfm>	MP:0008469,abnormal protein level|MP:0008560,increased tumor necrosis factor secretion|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0020354,increased endoplasmic reticulum stress|MP:0031265,increased susceptibility to hepatic steatosis
MGI:5516031	Rhbdd3<tm1Caox>	MP:0001654,hepatic necrosis|MP:0001860,liver inflammation|MP:0002376,abnormal dendritic cell physiology|MP:0002941,increased circulating alanine transaminase level|MP:0003080,increased natural killer cell mediated cytotoxicity|MP:0005343,increased circulating aspartate transaminase level|MP:0005387,immune system phenotype|MP:0008044,increased NK cell number|MP:0008566,increased interferon-gamma secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008596,increased circulating interleukin-6 level|MP:0008705,increased interleukin-6 secretion|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:6446985	Rhbdf1<em1Mvw>	MP:0002169,no abnormal phenotype detected
MGI:5306771	Rhbdf1/Hba<tm1.1(RHBDF1/HBA)Ajhs>	MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002874,decreased hemoglobin content|MP:0005562,decreased mean corpuscular hemoglobin
MGI:5309139	Rhbdf1/Hba<tm1.1(RHBDF1/HBA)Ajhs>	MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002874,decreased hemoglobin content|MP:0005562,decreased mean corpuscular hemoglobin
MGI:5306770	Rhbdf1/Hba<tm1(RHBDF1/HBA)Ajhs>	MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5306773	Rhbdf1/Hba<tm1(RHBDF1/HBA)Ajhs>	MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5309142	Rhbdf1/Hba<tm2.1Ajhs>	MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0005562,decreased mean corpuscular hemoglobin
MGI:5309144	Rhbdf1/Hba<tm2.1Ajhs>	MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0005562,decreased mean corpuscular hemoglobin
MGI:5309140	Rhbdf1/Hba<tm2Ajhs>	MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0002591,decreased mean corpuscular volume|MP:0002641,anisopoikilocytosis|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0003717,pallor|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5309141	Rhbdf1/Hba<tm2Ajhs>	MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0002591,decreased mean corpuscular volume|MP:0002641,anisopoikilocytosis|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0003717,pallor|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5614607	Rhbdf1<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5551620	Rhbdf1<tm1.1Mfm>	MP:0000266,abnormal heart morphology|MP:0000333,decreased bone marrow cell number|MP:0000692,small spleen|MP:0000706,small thymus|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001783,decreased white adipose tissue amount|MP:0001916,intracerebral hemorrhage|MP:0002083,premature death|MP:0005397,hematopoietic system phenotype|MP:0008489,slow postnatal weight gain|MP:0009145,abnormal pancreatic acinus morphology|MP:0009154,pancreatic acinar hypoplasia|MP:0009162,absent pancreatic acinar cell zymogen granule|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011945,increased eating frequency|MP:0020409,abnormal cardiac thrombosis
MGI:5792831	Rhbdf1<tm1b(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:2653121	Rhbdf2<cub>	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000652,enlarged sebaceous gland|MP:0001214,skin hyperplasia|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0002724,enhanced wound healing|MP:0003453,abnormal keratinocyte physiology|MP:0003809,abnormal hair shaft morphology|MP:0009273,abnormal hair shaft melanin granule shape|MP:0010685,abnormal hair follicle inner root sheath morphology|MP:0020414,abnormal fibroblast physiology|MP:0031602,white adipose tissue inflammation
MGI:6153755	Rhbdf2<em1(IMPC)Wtsi>	MP:0001510,abnormal coat appearance|MP:0002073,abnormal hair growth|MP:0002098,abnormal vibrissa morphology|MP:0005561,increased mean corpuscular hemoglobin|MP:0010092,increased circulating magnesium level
MGI:6119764	Rhbdf2<em2Mvw>	MP:0000377,abnormal hair follicle morphology|MP:0000652,enlarged sebaceous gland|MP:0001214,skin hyperplasia|MP:0001242,hyperkeratosis|MP:0002073,abnormal hair growth|MP:0002724,enhanced wound healing|MP:0003453,abnormal keratinocyte physiology
MGI:5437475	Rhbdf2<m1Btlr>	MP:0008561,decreased tumor necrosis factor secretion
MGI:5583871	Rhbdf2<M2Btlr>	MP:0001790,abnormal immune system physiology
MGI:5632144	Rhbdf2<M3Btlr>	MP:0001790,abnormal immune system physiology
MGI:5309177	Rhbdf2<tm1.1Mfm>	MP:0000574,abnormal foot pad morphology|MP:0001218,thin epidermis|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion
MGI:4362881	Rhbdf2<tm1a(KOMP)Wtsi>	MP:0008561,decreased tumor necrosis factor secretion
MGI:5309136	Rhbdf2<tm1Mak>	MP:0000609,abnormal liver physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002442,abnormal leukocyte physiology|MP:0002459,abnormal B cell physiology|MP:0002723,abnormal immune serum protein physiology|MP:0003691,abnormal microglial cell physiology|MP:0005385,cardiovascular system phenotype|MP:0005390,skeleton phenotype|MP:0005391,vision/eye phenotype|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0009786,decreased susceptibility to infection induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:2387311	Rhbdf2<Uncv>	MP:0000416,sparse hair|MP:0000652,enlarged sebaceous gland|MP:0001935,decreased litter size|MP:0003815,hairless|MP:0005159,azoospermia|MP:0008489,slow postnatal weight gain
MGI:5548786	Rhbdl1<tm1.1(KOMP)Vlcg>	MP:0002060,abnormal skin morphology|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5572036	Rhbdl2<tm1b(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0001759,increased urine glucose level|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number
MGI:5548774	Rhbdl3<tm1b(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6273949	Rhbg<em1(IMPC)Hmgu>	MP:0002942,decreased circulating alanine transaminase level|MP:0004151,decreased circulating iron level
MGI:5477809	Rhbg<tm1.1Idw>	MP:0005376,homeostasis/metabolism phenotype|MP:0011736,decreased urine ammonia level
MGI:3608962	Rhbg<tm1Rc>	MP:0002169,no abnormal phenotype detected
MGI:3818662	Rhcg<tm1Ibmm>	MP:0000525,renal tubular acidosis|MP:0001262,decreased body weight|MP:0001922,reduced male fertility|MP:0002631,abnormal epididymis morphology|MP:0003031,acidosis|MP:0005628,decreased circulating potassium level|MP:0009349,increased urine pH|MP:0011736,decreased urine ammonia level
MGI:5496356	Rhcg<tm1Tigm>	MP:0003014,abnormal kidney medulla morphology|MP:0003031,acidosis|MP:0004754,abnormal kidney collecting duct morphology|MP:0009349,increased urine pH|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011736,decreased urine ammonia level
MGI:4431572	Rhd<tm1a(EUCOMM)Wtsi>	MP:0001191,abnormal skin condition|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:5318588	Rhd<tm1Goo>	MP:0003656,abnormal erythrocyte physiology|MP:0008810,increased circulating iron level
MGI:4939475	Rhebl1<tm1.1Pfw>	MP:0002169,no abnormal phenotype detected
MGI:5502740	Rheb<tm1.1Otsu>	MP:0002169,no abnormal phenotype detected|MP:0002834,decreased heart weight|MP:0003921,abnormal heart left ventricle morphology|MP:0004090,abnormal sarcomere morphology|MP:0004565,decreased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0010725,thin interventricular septum|MP:0011085,postnatal lethality, complete penetrance
MGI:4939473	Rheb<tm1.1Pfw>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4949062	Rheb<tm1.1Yelg>	MP:0000267,abnormal heart development|MP:0000280,thin ventricular wall|MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0005244,hemopericardium|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0013241,embryo tissue necrosis|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3850507	Rheb<tm1Pfw>	MP:0000913,abnormal brain development|MP:0000921,demyelination|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0003871,abnormal myelin sheath morphology|MP:0004852,decreased testis weight|MP:0004929,decreased epididymis weight|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0006254,thin cerebral cortex|MP:0009808,decreased oligodendrocyte number
MGI:7594046	Rhno1<em1(IMPC)Bay>	MP:0001529,abnormal vocalization
MGI:6401218	Rhoa<tm1.1Tpal>	MP:0004973,increased regulatory T cell number|MP:0005348,increased T cell proliferation|MP:0010186,increased T follicular helper cell number
MGI:5548162	Rhoa<tm1Csab>	MP:0002169,no abnormal phenotype detected|MP:0002599,increased mean platelet volume|MP:0003179,thrombocytopenia
MGI:4950374	Rhoa<tm1Jrel>	MP:0003424,premature neuronal precursor differentiation|MP:0003631,nervous system phenotype|MP:0004948,abnormal neuronal precursor proliferation|MP:0009689,abnormal neural tube ventricular layer morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0013182,increased spinal cord apoptosis
MGI:5004976	Rhoa<tm1Yuyo>	MP:0000897,abnormal midbrain morphology|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0002152,abnormal brain morphology|MP:0003864,abnormal midbrain development|MP:0004980,increased neuronal precursor cell number|MP:0009967,abnormal neuron proliferation|MP:0012091,increased midbrain size
MGI:6147537	Rhobtb1<em2(IMPC)Ccpcz>	MP:0000681,abnormal thyroid gland morphology|MP:0001402,decreased locomotor activity|MP:0001552,increased circulating triglyceride level|MP:0004924,abnormal behavior|MP:0005355,enlarged thyroid gland|MP:0013679,increased Ly6C-positive NK T cell number|MP:0020870,decreased thigmotaxis
MGI:4362349	Rhobtb3<tm1a(KOMP)Wtsi>	MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0002100,abnormal tooth morphology|MP:0002590,increased mean corpuscular volume|MP:0002834,decreased heart weight|MP:0002932,abnormal joint morphology|MP:0003918,decreased kidney weight|MP:0003961,decreased lean body mass|MP:0004852,decreased testis weight|MP:0004953,decreased spleen weight|MP:0005353,abnormal patella morphology|MP:0005381,digestive/alimentary phenotype|MP:0008770,decreased survivor rate|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2387429	Rhob<tm1Gcp>	MP:0000259,abnormal vascular development|MP:0001265,decreased body size|MP:0002021,increased incidence of induced tumors|MP:0002792,abnormal retina vasculature morphology|MP:0003566,abnormal cell adhesion|MP:0004499,increased incidence of tumors by chemical induction|MP:0005376,homeostasis/metabolism phenotype|MP:0005621,abnormal cell physiology|MP:0011708,decreased fibroblast cell migration
MGI:3589206	Rhoc<tm1Mak>	MP:0000358,abnormal cell morphology|MP:0005387,immune system phenotype
MGI:6690835	Rhof<tm1.2Dash>	MP:0002362,abnormal spleen marginal zone morphology|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005387,immune system phenotype|MP:0008182,decreased marginal zone B cell number|MP:0010768,mortality/aging
MGI:5496692	Rhof<tm1.2Tac>	MP:0003179,thrombocytopenia|MP:0005397,hematopoietic system phenotype
MGI:3029009	Rhog<tm1Tnr>	MP:0002442,abnormal leukocyte physiology|MP:0002461,increased immunoglobulin level|MP:0003631,nervous system phenotype|MP:0005154,increased B cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005466,abnormal T-helper 2 physiology
MGI:5692733	Rhoh<tm1b(EUCOMM)Hmgu>	MP:0000221,decreased leukocyte cell number|MP:0011239,abnormal skin coloration
MGI:3826431	Rhoh<tm1Brak>	MP:0000694,spleen hypoplasia|MP:0000717,abnormal lymphocyte cell number|MP:0001823,thymus hypoplasia|MP:0002407,abnormal double-negative T cell morphology|MP:0002722,abnormal immune system organ morphology|MP:0005015,increased T cell number|MP:0005018,decreased T cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005094,abnormal T cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005348,increased T cell proliferation|MP:0006414,decreased T cell apoptosis|MP:0008039,increased NK T cell number|MP:0008044,increased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0008346,increased gamma-delta T cell number|MP:0008826,abnormal splenic cell ratio
MGI:3687310	Rhoh<tm1Daw>	MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number
MGI:3830828	Rhoh<tm1Hasu>	MP:0002423,abnormal mast cell physiology|MP:0005387,immune system phenotype|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0008765,decreased mast cell degranulation
MGI:5608668	Rhoj<tm1.1Auem>	MP:0001634,internal hemorrhage|MP:0003447,decreased tumor growth/size|MP:0003448,abnormal tumor morphology|MP:0010144,abnormal tumor vascularization
MGI:5608669	Rhoj<tm1.2Auem>	MP:0001273,decreased metastatic potential|MP:0001634,internal hemorrhage|MP:0003447,decreased tumor growth/size|MP:0003448,abnormal tumor morphology|MP:0005385,cardiovascular system phenotype|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0010144,abnormal tumor vascularization
MGI:4365246	Rhoj<tm1a(KOMP)Wtsi>	MP:0002792,abnormal retina vasculature morphology
MGI:2449080	Rho<Noerg1>	MP:0001326,retina degeneration|MP:0001999,photosensitivity|MP:0005551,abnormal eye electrophysiology
MGI:6152625	Rhoq<em1(IMPC)Mbp>	MP:0001402,decreased locomotor activity|MP:0001415,increased exploration in new environment
MGI:7492305	Rhoq<tm1b(EUCOMM)Hmgu>	MP:0003631,nervous system phenotype|MP:0003651,abnormal axon extension|MP:0004220,abnormal peripheral nervous system regeneration|MP:0005404,abnormal axon morphology|MP:0008415,abnormal neurite morphology|MP:0020850,abnormal microtubule cytoskeleton morphology|MP:0030012,impaired central nervous system regeneration
MGI:7492304	Rhoq<tm1c(EUCOMM)Hmgu>	MP:0004220,abnormal peripheral nervous system regeneration
MGI:4367268	Rho<R3>	MP:0001006,abnormal retina cone cell morphology|MP:0001326,retina degeneration|MP:0002792,abnormal retina vasculature morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005103,abnormal retina pigmentation|MP:0005551,abnormal eye electrophysiology|MP:0008518,retina outer nuclear layer degeneration|MP:0008585,absent photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0030005,increased retina apoptosis
MGI:5619347	Rhot1<tm1.1Jmsu>	MP:0000160,kyphosis|MP:0001391,abnormal tail movements|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0005277,abnormal brainstem morphology|MP:0008489,slow postnatal weight gain|MP:0012051,spasticity
MGI:5619348	Rhot1<tm1.2Jmsu>	MP:0000939,decreased motor neuron number|MP:0001078,abnormal phrenic nerve morphology|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002184,abnormal innervation|MP:0005277,abnormal brainstem morphology|MP:0005385,cardiovascular system phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0011087,neonatal lethality, complete penetrance
MGI:4432006	Rhot1<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5906207	Rhot1<tm1c(EUCOMM)Wtsi>	MP:0000774,decreased brain size|MP:0002229,neurodegeneration|MP:0003354,astrocytosis|MP:0004768,abnormal axonal transport|MP:0006254,thin cerebral cortex|MP:0008143,abnormal dendrite morphology|MP:0008283,small hippocampus|MP:0008948,decreased neuron number|MP:0011380,enlarged brain ventricles
MGI:5906208	Rhot1<tm1d(EUCOMM)Wtsi>	MP:0001575,cyanosis|MP:0002882,abnormal neuron morphology|MP:0004768,abnormal axonal transport|MP:0008143,abnormal dendrite morphology|MP:0008415,abnormal neurite morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0014345,abnormal neuron mitochondrial morphology
MGI:4419477	Rhot2<tm1(KOMP)Wtsi>	MP:0001262,decreased body weight|MP:0002169,no abnormal phenotype detected|MP:0003961,decreased lean body mass|MP:0004151,decreased circulating iron level|MP:0010124,decreased bone mineral content
MGI:5566834	Rho<tm1.1Eye>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001325,abnormal retina morphology|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:4947230	Rho<tm1.1Kpal>	MP:0001327,decreased retina photoreceptor cell number|MP:0003727,abnormal retina layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008451,retina rod cell degeneration|MP:0008453,decreased retina rod cell number|MP:0008515,thin retina outer nuclear layer|MP:0008586,disorganized photoreceptor outer segment|MP:0014336,short retina rod cell outer segment
MGI:5550062	Rho<tm1.1(RHO*)Akgr>	MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0008585,absent photoreceptor outer segment|MP:0030005,increased retina apoptosis
MGI:8221592	Rho<tm1.1(RHO*/TagRFP-T)Twe>	MP:0001326,retina degeneration|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008451,retina rod cell degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0012029,abnormal electroretinogram waveform feature|MP:0012033,abnormal ERG implicit time|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0020813,abnormal photoreceptor outer segment disc membrane morphology|MP:0030005,increased retina apoptosis
MGI:3055163	Rho<tm1(EDNRB)Fji>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0008450,retina photoreceptor degeneration|MP:0008456,abnormal retina rod cell outer segment morphology
MGI:2680822	Rho<tm1Jlem>	MP:0001286,abnormal eye development|MP:0001328,disorganized retina layers|MP:0002090,abnormal vision|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008585,absent photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0014658,absent a-wave|MP:0020439,absent b-wave|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:2181812	Rho<tm1Phm>	MP:0001004,abnormal retina photoreceptor morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0008515,thin retina outer nuclear layer|MP:0008585,absent photoreceptor outer segment|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:5474849	Rho<tm2.1Kpal>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001325,abnormal retina morphology|MP:0001327,decreased retina photoreceptor cell number|MP:0002864,abnormal ocular fundus morphology|MP:0003099,retina detachment|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005391,vision/eye phenotype|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008586,disorganized photoreceptor outer segment|MP:0008918,microgliosis
MGI:3590580	Rho<tm2Jlem>	MP:0001326,retina degeneration|MP:0008453,decreased retina rod cell number|MP:0008515,thin retina outer nuclear layer|MP:0014336,short retina rod cell outer segment
MGI:3046186	Rho<tm2(RHO/GFP)Jhw>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001326,retina degeneration|MP:0003727,abnormal retina layer morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer
MGI:3046187	Rho<tm3(RHO/GFP)Jhw>	MP:0001326,retina degeneration
MGI:5490865	Rho<tm4.1(RHO*/EGFP)Jhw>	MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0004021,abnormal rod electrophysiology|MP:0005391,vision/eye phenotype|MP:0008450,retina photoreceptor degeneration
MGI:3845396	Rho<Tvrm1>	MP:0001999,photosensitivity|MP:0003011,delayed dark adaptation|MP:0008450,retina photoreceptor degeneration|MP:0011234,abnormal retinol level
MGI:5609882	Rho<Tvrm144>	MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008519,thin retina outer plexiform layer
MGI:5810761	Rho<Tvrm334>	MP:0004021,abnormal rod electrophysiology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0008450,retina photoreceptor degeneration|MP:0011965,decreased total retina thickness
MGI:3845397	Rho<Tvrm4>	MP:0001999,photosensitivity|MP:0003011,delayed dark adaptation|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0008450,retina photoreceptor degeneration|MP:0008516,disorganized retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008581,disorganized photoreceptor inner segment|MP:0008586,disorganized photoreceptor outer segment|MP:0011234,abnormal retinol level|MP:0030005,increased retina apoptosis
MGI:4363423	Rhou<tm1a(KOMP)Wtsi>	MP:0002590,increased mean corpuscular volume|MP:0005565,increased blood urea nitrogen level
MGI:5902138	Rhox13<tm1.2Chge>	MP:0002161,abnormal fertility/fecundity|MP:0002687,oligozoospermia|MP:0004901,decreased male germ cell number|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014052,increased male germ cell apoptosis
MGI:2447572	Rhox5<tm1Clm>	MP:0002169,no abnormal phenotype detected
MGI:2182786	Rhox9<tm1Dean>	MP:0002169,no abnormal phenotype detected
MGI:5763218	Rhox<tm1.1Wilk>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype
MGI:5582426	Rhpn1<tm1b(KOMP)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001399,hyperactivity|MP:0001556,increased circulating HDL cholesterol level|MP:0002135,abnormal kidney morphology|MP:0002599,increased mean platelet volume|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level
MGI:6316664	Rhpn1<tm1Ktry>	MP:0002871,albuminuria|MP:0003068,enlarged kidney|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0008059,abnormal podocyte foot process morphology|MP:0008060,abnormal podocyte slit diaphragm morphology|MP:0008140,podocyte foot process effacement|MP:0011339,abnormal glomerular mesangium morphology|MP:0011402,renal cast|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011483,renal glomerular synechia|MP:0011868,podocyte microvillus transformation
MGI:3577068	Rhpn2<tm1Ssch>	MP:0002169,no abnormal phenotype detected
MGI:2156406	Rhs1<C57BL/6>	MP:0020917,decreased susceptibility to Herpesvirales infection
MGI:4435468	Ric1<tm1a(EUCOMM)Hmgu>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0001262,decreased body weight|MP:0002590,increased mean corpuscular volume|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002896,abnormal bone mineralization|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0005017,decreased B cell number|MP:0008211,decreased mature B cell number|MP:0010052,increased grip strength
MGI:5467414	Ric8a<tm1.1Zhua>	MP:0000849,abnormal cerebellum morphology|MP:0000854,abnormal cerebellum development|MP:0000857,abnormal cerebellar foliation|MP:0000885,ectopic Purkinje cell|MP:0001393,ataxia|MP:0002762,ectopic cerebellar granule cells|MP:0004272,abnormal basement membrane morphology|MP:0008914,enlarged cerebellum|MP:0009268,absent cerebellum fissure|MP:0009964,abnormal cerebellum lobule morphology|MP:0009977,abnormal cerebellar granule cell migration|MP:0010387,abnormal Bergmann glial cell morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3608888	Ric8a<tm1Aks>	MP:0001363,increased anxiety-related response|MP:0001463,abnormal spatial learning|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5616363	Ric8a<tm1b(KOMP)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0006243,impaired pupillary reflex|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5548860	Ric8b<tm1b(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0001314,cornea opacity|MP:0002606,increased basophil cell number|MP:0005013,increased lymphocyte cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:5692848	Ric8b<tm1c(EUCOMM)Hmgu>	MP:0002741,small olfactory bulb|MP:0003203,increased neuron apoptosis|MP:0005386,behavior/neurological phenotype|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0008544,impaired olfaction|MP:0008770,decreased survivor rate|MP:0009948,abnormal olfactory bulb glomerular layer morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011677,abnormal olfactory sensory neuron physiology|MP:0012020,abnormal olfactory epithelium physiology|MP:0020348,decreased olfactory sensory neuron number
MGI:3775093	Rictor<Gt(RRR347)Byg>	MP:0001711,abnormal placenta morphology|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011524,thick placenta labyrinth
MGI:5448837	Rictor<tm1.1Klg>	MP:0001823,thymus hypoplasia|MP:0002407,abnormal double-negative T cell morphology|MP:0004956,decreased thymus weight|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008083,decreased single-positive T cell number|MP:0010130,decreased DN1 thymic pro-T cell number|MP:0010132,decreased DN2 thymocyte number|MP:0010134,decreased DN3 thymocyte number|MP:0010136,decreased DN4 thymocyte number
MGI:3703321	Rictor<tm1.1Mgn>	MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005293,impaired glucose tolerance|MP:0009114,decreased pancreatic beta cell mass|MP:0011820,decreased pancreatic beta cell proliferation
MGI:3850086	Rictor<tm1.1Mnh>	MP:0001257,increased body length|MP:0002079,increased circulating insulin level|MP:0002833,increased heart weight|MP:0002981,increased liver weight|MP:0003917,increased kidney weight|MP:0003960,increased lean body mass|MP:0004702,increased circulating insulin-like growth factor I level|MP:0004893,decreased adiponectin level|MP:0004952,increased spleen weight|MP:0005178,increased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005331,insulin resistance|MP:0005455,increased susceptibility to weight gain|MP:0009108,increased pancreas weight|MP:0009171,enlarged pancreatic islets|MP:0009288,increased epididymal fat pad weight|MP:0010123,increased bone mineral content|MP:0031115,macrovesicular hepatic steatosis
MGI:3703322	Rictor<tm1.2Mgn>	MP:0000352,decreased cell proliferation|MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3703325	Rictor<tm1.3Mgn>	MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3526066	Rictor<tm1Mgn>	MP:0001716,abnormal placenta labyrinth morphology|MP:0002192,hydrops fetalis|MP:0004259,small placenta|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3829768	Rictor<tm1Rueg>	MP:0001260,increased body weight|MP:0005369,muscle phenotype|MP:0010768,mortality/aging
MGI:5002935	Rida<tm1a(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0004151,decreased circulating iron level|MP:0006358,absent pinna reflex
MGI:4335499	Rif1<Gt(A045A01)Wrst>	MP:0000352,decreased cell proliferation|MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0004046,abnormal mitosis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4331936	Rif1<Gt(XT0278)Wtsi>	MP:0001805,decreased IgG level|MP:0001807,decreased IgA level|MP:0002412,increased susceptibility to bacterial infection|MP:0003984,embryonic growth retardation|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype|MP:0008058,abnormal DNA repair|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0010948,abnormal double-strand DNA break repair|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5515365	Rif1<MommeD18>	MP:0012167,abnormal epigenetic regulation of gene expression
MGI:4417933	Rif1<tm1.1Sbcb>	MP:0000352,decreased cell proliferation
MGI:4417935	Rif1<tm2Sbcb>	MP:0011092,embryonic lethality, complete penetrance
MGI:5439959	Rif1<tm3.1Sbcd>	MP:0002169,no abnormal phenotype detected
MGI:6164046	Rigi<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation
MGI:6276945	Rigi<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0005293,impaired glucose tolerance
MGI:3589395	Rigi<tm1Aki>	MP:0002376,abnormal dendritic cell physiology|MP:0003103,liver degeneration|MP:0005621,abnormal cell physiology|MP:0008750,abnormal interferon level|MP:0008770,decreased survivor rate|MP:0011085,postnatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0031044,increased susceptibility to Flaviviridae infection induced morbidity/mortality
MGI:3809597	Rigi<tm1Zgwg>	MP:0000240,extramedullary hematopoiesis|MP:0000322,increased granulocyte number|MP:0000691,enlarged spleen|MP:0001263,weight loss|MP:0001829,increased activated T cell number|MP:0002144,abnormal B cell differentiation|MP:0002441,abnormal granulocyte morphology|MP:0002462,abnormal granulocyte physiology|MP:0002816,colitis|MP:0005018,decreased T cell number|MP:0005387,immune system phenotype|MP:0005481,increased chronic myelocytic leukemia incidence|MP:0008049,increased memory T cell number|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0008537,increased susceptibility to induced colitis
MGI:2156784	Rigs1<HLG>	MP:0000757,herniated abdominal wall
MGI:5635167	Riiad1<tm1b(KOMP)Wtsi>	MP:0001284,absent vibrissae|MP:0001513,limb grasping|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3581270	Ril1<A/J>	MP:0002026,increased leukemia incidence|MP:0004503,decreased incidence of tumors by ionizing radiation induction
MGI:3581273	Ril2<C57BL/10ScSn>	MP:0002026,increased leukemia incidence|MP:0004503,decreased incidence of tumors by ionizing radiation induction
MGI:3581275	Ril3<C57BL/10ScSn>	MP:0002026,increased leukemia incidence|MP:0004503,decreased incidence of tumors by ionizing radiation induction
MGI:3611363	Ril4<BALB/c>	MP:0002026,increased leukemia incidence
MGI:5548660	Rilpl1<tm1b(EUCOMM)Hmgu>	MP:0001488,increased startle reflex|MP:0013279,increased fasting circulating glucose level
MGI:5468953	Rilpl2<tm1b(KOMP)Wtsi>	MP:0002833,increased heart weight|MP:0005179,decreased circulating cholesterol level|MP:0013279,increased fasting circulating glucose level
MGI:6116836	Rimbp2<tm1.2Geno>	MP:0002206,abnormal CNS synaptic transmission|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002919,enhanced paired-pulse facilitation|MP:0003631,nervous system phenotype|MP:0004807,abnormal paired-pulse inhibition|MP:0004859,abnormal synaptic plasticity|MP:0005389,reproductive system phenotype|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0014254,increased paired-pulse ratio
MGI:5509348	Rimbp2<tm1Sud>	MP:0002169,no abnormal phenotype detected
MGI:3830663	Rimbp3<tm1Gxu>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0008893,detached sperm flagellum|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009237,kinked sperm flagellum|MP:0009377,ectopic manchette
MGI:7432669	Rimkla<tm1.1Meck>	MP:0001402,decreased locomotor activity|MP:0005391,vision/eye phenotype|MP:0014365,impaired short-term object recognition memory
MGI:6693818	Rimklb<em1Matak>	MP:0000242,impaired fertilization|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0009230,abnormal sperm head morphology
MGI:5474780	Rimklb<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001925,male infertility|MP:0002833,increased heart weight|MP:0005561,increased mean corpuscular hemoglobin|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content|MP:0011396,abnormal sleep behavior
MGI:5692784	Rimoc1<tm1b(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005533,increased body temperature|MP:0010097,abnormal retina blood vessel morphology|MP:0011965,decreased total retina thickness
MGI:2178099	Rims1<tm1Sud>	MP:0000861,disorganized barrel cortex|MP:0001386,abnormal maternal nurturing|MP:0001473,reduced long-term potentiation|MP:0001898,abnormal long-term depression|MP:0001900,impaired synaptic plasticity|MP:0002206,abnormal CNS synaptic transmission|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002918,abnormal paired-pulse facilitation|MP:0002919,enhanced paired-pulse facilitation|MP:0002920,decreased paired-pulse facilitation|MP:0002921,abnormal post-tetanic potentiation|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004807,abnormal paired-pulse inhibition
MGI:3693318	Rims1<tm2Sud>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:3830681	Rims1<tm3.1Sud>	MP:0001900,impaired synaptic plasticity|MP:0002082,postnatal lethality|MP:0002919,enhanced paired-pulse facilitation|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004807,abnormal paired-pulse inhibition|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3822548	Rims1<tm3Sud>	MP:0002945,abnormal inhibitory postsynaptic currents
MGI:3706333	Rims2<tm1.1Schc>	MP:0001265,decreased body size|MP:0001386,abnormal maternal nurturing|MP:0002083,premature death|MP:0003631,nervous system phenotype
MGI:3762950	Rims2<tm1.2Schc>	MP:0002169,no abnormal phenotype detected
MGI:4838195	Rims2<tm1Sse>	MP:0001265,decreased body size|MP:0002712,increased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005120,decreased circulating growth hormone level|MP:0005293,impaired glucose tolerance|MP:0005491,pancreatic islet hyperplasia|MP:0005559,increased circulating glucose level|MP:0005560,decreased circulating glucose level|MP:0005661,decreased circulating adrenaline level|MP:0009176,increased pancreatic alpha cell number
MGI:4451369	Rims3<tm1a(KOMP)Wtsi>	MP:0005377,hearing/vestibular/ear phenotype
MGI:5548815	Rims3<tm1b(KOMP)Wtsi>	MP:0002797,increased thigmotaxis
MGI:6114721	Rims4<m1Btlr>	MP:0001262,decreased body weight
MGI:6114733	Rims4<m2Btlr>	MP:0001262,decreased body weight
MGI:2451226	Rin1<tm1Colc>	MP:0001454,abnormal cued conditioning behavior|MP:0002805,abnormal conditioned taste aversion behavior|MP:0003008,enhanced long-term potentiation|MP:0005386,behavior/neurological phenotype
MGI:7425947	Rin2<em1(IMPC)Bay>	MP:0001417,decreased exploration in new environment
MGI:5608689	Rin3<tm1.1(KOMP)Vlcg>	MP:0000130,abnormal trabecular bone morphology|MP:0000195,decreased circulating calcium level|MP:0003020,decreased circulating chloride level|MP:0004151,decreased circulating iron level|MP:0004982,abnormal osteoclast morphology|MP:0004993,decreased bone resorption|MP:0005006,abnormal osteoblast physiology|MP:0005378,growth/size/body region phenotype|MP:0005560,decreased circulating glucose level|MP:0010868,increased bone trabecula number|MP:0010872,increased trabecular bone mass|MP:0010878,increased trabecular bone volume|MP:0011436,decreased urine magnesium level|MP:0013279,increased fasting circulating glucose level|MP:0013621,decreased internal diameter of femur|MP:0013631,decreased bone trabecular spacing|MP:0020039,increased bone ossification
MGI:1926913	Ring1<tm1Mvi>	MP:0000137,abnormal vertebrae morphology|MP:0000480,increased rib number|MP:0003036,vertebral transformation|MP:0004607,abnormal cervical atlas morphology|MP:0004608,abnormal cervical axis morphology
MGI:7623983	Rinl<tm1.1Boun>	MP:0000691,enlarged spleen|MP:0005014,increased B cell number|MP:0005387,immune system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008177,increased germinal center B cell number|MP:0009338,increased splenocyte number|MP:0010186,increased T follicular helper cell number|MP:0020912,abnormal susceptibility to Riboviria infection
MGI:5447050	Rint1<tm1b(KOMP)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0002702,decreased circulating free fatty acids level|MP:0005344,increased circulating bilirubin level|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0005567,decreased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3716054	Rint1<tm1Whl>	MP:0001672,abnormal embryo development|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002014,increased papilloma incidence|MP:0002020,increased tumor incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002041,increased pituitary adenoma incidence|MP:0002083,premature death|MP:0002947,increased hemangioma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003570,increased uterus leiomyoma incidence|MP:0008000,increased ovary tumor incidence|MP:0009687,empty decidua capsularis|MP:0009704,increased skin squamous cell carcinoma incidence|MP:0010299,increased mammary gland tumor incidence|MP:0010309,increased mesothelioma incidence|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012431,increased lymphoma incidence|MP:0013488,increased keratoacanthoma incidence|MP:0013751,increased cystadenoma incidence
MGI:5911955	Riok1<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:5605779	Riok2<tm1b(KOMP)Wtsi>	MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6712634	Riok2<tm1c(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0000220,increased monocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000245,abnormal erythropoiesis|MP:0000685,abnormal immune system morphology|MP:0001545,abnormal hematopoietic system physiology|MP:0001577,anemia|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004809,increased hematopoietic stem cell number|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008039,increased NK T cell number|MP:0008568,abnormal interleukin secretion|MP:0008588,abnormal circulating interleukin level|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008973,decreased erythroid progenitor cell number|MP:0009278,abnormal bone marrow cell physiology|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011091,prenatal lethality, complete penetrance|MP:0013663,increased myeloid cell number|MP:0013696,increased granulocyte monocyte progenitor cell number
MGI:7377682	Riok3<em1(IMPC)Mbp>	MP:0001289,persistence of hyaloid vascular system|MP:0001293,anophthalmia|MP:0001925,male infertility|MP:0002092,abnormal eye morphology|MP:0002574,increased vertical activity|MP:0002792,abnormal retina vasculature morphology
MGI:5762848	Riox1<tm1Qch>	MP:0000062,increased bone mineral density|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003795,abnormal bone structure|MP:0004148,increased compact bone thickness|MP:0004985,decreased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0005378,growth/size/body region phenotype|MP:0005605,increased bone mass|MP:0008271,abnormal bone ossification|MP:0008272,abnormal endochondral bone ossification|MP:0008273,abnormal intramembranous bone ossification|MP:0009673,increased birth weight|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume|MP:0011710,enhanced osteoblast differentiation|MP:0030278,thick neurocranium
MGI:5526952	Riox2<tm1Mtsun>	MP:0000222,decreased neutrophil cell number|MP:0001876,decreased inflammatory response|MP:0002335,decreased airway responsiveness|MP:0002490,abnormal immunoglobulin level|MP:0003884,decreased macrophage cell number|MP:0005012,decreased eosinophil cell number|MP:0008551,abnormal circulating interferon-gamma level|MP:0008601,abnormal circulating interleukin-4 level|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5614600	Ripk1<tm1.1Vmd>	MP:0000477,abnormal intestine morphology|MP:0000495,abnormal colon morphology|MP:0002058,neonatal lethality|MP:0009541,increased thymocyte apoptosis|MP:0011698,abnormal brown adipose tissue physiology|MP:0012556,increased cell death
MGI:5614572	Ripk1<tm1Geno>	MP:0005535,abnormal body temperature|MP:0008944,decreased sensitivity to induced cell death|MP:0010768,mortality/aging
MGI:2179109	Ripk1<tm1Led>	MP:0000217,abnormal leukocyte cell number|MP:0000703,abnormal thymus morphology|MP:0000715,decreased thymocyte number|MP:0001243,abnormal dermal layer morphology|MP:0001262,decreased body weight|MP:0001785,edema|MP:0002339,abnormal lymph node morphology|MP:0002722,abnormal immune system organ morphology|MP:0002971,abnormal brown adipose tissue morphology|MP:0003865,lymph node inflammation|MP:0008476,increased spleen red pulp amount|MP:0011085,postnatal lethality, complete penetrance|MP:0031052,lymph node necrosis
MGI:3622328	Ripk2<tm1Cfl>	MP:0002451,abnormal macrophage physiology
MGI:2660793	Ripk2<tm1Flv>	MP:0002451,abnormal macrophage physiology|MP:0003009,abnormal cytokine secretion|MP:0005095,decreased T cell proliferation|MP:0005465,abnormal T-helper 1 physiology|MP:0008561,decreased tumor necrosis factor secretion|MP:0008706,decreased interleukin-6 secretion|MP:0012564,decreased tumor incidence following infection
MGI:2446070	Ripk2<tm1Ghc>	MP:0002406,increased susceptibility to infection|MP:0005095,decreased T cell proliferation|MP:0008496,decreased IgG2a level|MP:0008567,decreased interferon-gamma secretion
MGI:3622329	Ripk2<tm2Cfl>	MP:0005387,immune system phenotype
MGI:5705237	Ripk3<m1Btlr>	MP:0002169,no abnormal phenotype detected
MGI:5583070	Ripk3<tm1.1(KOMP)Wtsi>	MP:0001284,absent vibrissae|MP:0002135,abnormal kidney morphology
MGI:5614565	Ripk3<tm1Arte>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0001263,weight loss|MP:0001858,intestinal inflammation|MP:0002619,abnormal lymphocyte morphology|MP:0003288,intestinal edema|MP:0003644,thymus atrophy|MP:0005036,diarrhea|MP:0010155,abnormal intestine physiology|MP:0010768,mortality/aging|MP:0014080,fused small intestinal villi|MP:0014083,blunted small intestinal villi
MGI:3028853	Ripk3<tm1Vmd>	MP:0001876,decreased inflammatory response|MP:0005387,immune system phenotype|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010768,mortality/aging
MGI:4431195	Ripk3<tm1Xidw>	MP:0004155,decreased susceptibility to induced pancreatitis|MP:0008944,decreased sensitivity to induced cell death|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:5614606	Ripk3<tm2Vmd>	MP:0003229,abnormal vitelline vasculature morphology|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4442055	Ripk4<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight
MGI:2387011	Ripk4<tm1Pmh>	MP:0000111,cleft palate|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000571,interdigital webbing|MP:0000592,short tail|MP:0001200,thick skin|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001233,abnormal epidermis suprabasal layer morphology|MP:0001241,absent epidermis stratum corneum|MP:0001284,absent vibrissae|MP:0002098,abnormal vibrissa morphology|MP:0002111,abnormal tail morphology|MP:0002233,abnormal nose morphology|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0003130,anal atresia|MP:0003276,esophageal atresia|MP:0003427,parakeratosis|MP:0005382,craniofacial phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0009576,oral atresia|MP:0009655,abnormal secondary palate development|MP:0009884,palatal shelf fusion with tongue or mandible|MP:0009886,failure of palatal shelf elevation|MP:0009931,abnormal skin appearance|MP:0011089,perinatal lethality, complete penetrance|MP:0011771,abnormal genital tubercle morphology|MP:0013530,abnormal periderm morphology|MP:0013531,abnormal periderm development|MP:0014322,short hindlimb|MP:0020849,abnormal actin cytoskeleton morphology
MGI:5085529	Ripor2<tm1(KOMP)Vlcg>	MP:0001967,deafness|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004525,thin cochlear hair cell stereocilia|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004534,decreased inner hair cell stereocilia number|MP:0004737,absent distortion product otoacoustic emissions|MP:0005377,hearing/vestibular/ear phenotype|MP:0006325,impaired hearing|MP:0031674,long inner hair cell stereocilia
MGI:4459309	Ripply1<tm1.1Sjt>	MP:0003048,abnormal cervical vertebrae morphology
MGI:3758856	Ripply2<tm1.1Ysa>	MP:0000137,abnormal vertebrae morphology|MP:0000140,absent vertebral pedicles|MP:0000152,absent proximal rib|MP:0000592,short tail|MP:0001258,decreased body length|MP:0001690,failure of somite differentiation|MP:0003939,abnormal myotome morphology|MP:0004604,abnormal vertebral pedicle morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3764703	Ripply2<tm1Asas>	MP:0000137,abnormal vertebrae morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000592,short tail|MP:0001689,incomplete somite formation|MP:0001953,respiratory failure|MP:0003345,decreased rib number|MP:0004073,caudal body truncation|MP:0004604,abnormal vertebral pedicle morphology|MP:0004734,small thoracic cavity|MP:0005390,skeleton phenotype|MP:0008530,abnormal rostral-caudal patterning of the somites|MP:0011087,neonatal lethality, complete penetrance
MGI:4433779	Ripply3<tm1a(EUCOMM)Wtsi>	MP:0005561,increased mean corpuscular hemoglobin
MGI:4880754	Ripply3<tm1Sjt>	MP:0000272,abnormal aorta morphology|MP:0000364,abnormal vascular regression|MP:0000678,abnormal parathyroid gland morphology|MP:0000704,abnormal thymus development|MP:0000706,small thymus|MP:0001575,cyanosis|MP:0002191,abnormal artery morphology|MP:0002950,abnormal neural crest cell migration|MP:0003007,ectopic thymus|MP:0003395,abnormal subclavian artery morphology|MP:0003955,abnormal ultimobranchial body morphology|MP:0004157,interrupted aortic arch|MP:0006031,abnormal pharyngeal pouch morphology|MP:0006339,abnormal third pharyngeal arch morphology|MP:0006340,abnormal fourth pharyngeal arch morphology|MP:0006346,small pharyngeal arch|MP:0009113,increased pancreatic beta cell mass|MP:0010356,abnormal second pharyngeal arch artery morphology|MP:0010395,abnormal pharyngeal arch development|MP:0010402,ventricular septal defect|MP:0010564,abnormal fetal ductus arteriosus morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011819,increased pancreatic beta cell proliferation|MP:0030335,absent third pharyngeal arch artery|MP:0030340,absent fourth pharyngeal arch artery|MP:0030589,increased pancreatic alpha cell mass
MGI:6293852	Rit1<em1(IMPC)Mbp>	MP:0001293,anophthalmia|MP:0002135,abnormal kidney morphology|MP:0002599,increased mean platelet volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0003068,enlarged kidney|MP:0005343,increased circulating aspartate transaminase level|MP:0010067,increased red blood cell distribution width
MGI:6342637	Rit1<tm1.1Tumg>	MP:0000266,abnormal heart morphology|MP:0000445,short snout|MP:0000493,rectal prolapse|MP:0000691,enlarged spleen|MP:0001255,decreased body height|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0001577,anemia|MP:0001914,hemorrhage|MP:0001923,reduced female fertility|MP:0002080,prenatal lethality|MP:0002083,premature death|MP:0002192,hydrops fetalis|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0003141,cardiac fibrosis|MP:0005343,increased circulating aspartate transaminase level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0011925,abnormal heart echocardiography feature|MP:0030245,round head
MGI:5317831	Rit1<tm1Dand>	MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death
MGI:3662926	Rky	MP:0001394,circling|MP:0001410,head bobbing|MP:0001522,impaired swimming|MP:0002092,abnormal eye morphology|MP:0005377,hearing/vestibular/ear phenotype
MGI:5548969	Rlbp1<tm1b(EUCOMM)Hmgu>	MP:0002100,abnormal tooth morphology|MP:0003960,increased lean body mass
MGI:2181491	Rlbp1<tm1Jsa>	MP:0001326,retina degeneration|MP:0001327,decreased retina photoreceptor cell number|MP:0002075,abnormal coat/hair pigmentation|MP:0003011,delayed dark adaptation|MP:0005253,abnormal eye physiology
MGI:3821599	Rlf<MommeD8>	MP:0001265,decreased body size|MP:0002082,postnatal lethality
MGI:6156154	Rlim<em1(IMPC)Rbrc>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002339,abnormal lymph node morphology|MP:0002591,decreased mean corpuscular volume|MP:0004613,fusion of vertebral arches|MP:0005562,decreased mean corpuscular hemoglobin
MGI:3863846	Rlim<Gt(AD0035)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:4838153	Rlim<tm1.1Inba>	MP:0010768,mortality/aging
MGI:4838154	Rlim<tm1.2Inba>	MP:0002169,no abnormal phenotype detected
MGI:2668458	Rln1<tm1Wint>	MP:0001145,abnormal male reproductive system morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001157,small seminal vesicle|MP:0001158,abnormal prostate gland morphology|MP:0001168,abnormal prostate gland epithelium morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001436,abnormal suckling behavior|MP:0001922,reduced male fertility|MP:0001938,delayed sexual maturation|MP:0002058,neonatal lethality|MP:0002216,abnormal seminiferous tubule morphology|MP:0002631,abnormal epididymis morphology|MP:0002687,oligozoospermia|MP:0002774,small prostate gland|MP:0004514,dystocia|MP:0004930,small epididymis|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0006042,increased apoptosis|MP:0006078,abnormal nipple morphology|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0006270,abnormal mammary gland growth during lactation|MP:0006271,abnormal involution of the mammary gland|MP:0008997,increased blood osmolality|MP:0009503,abnormal mammary gland duct morphology|MP:0009546,absent gastric milk in neonates|MP:0009575,abnormal pubic symphysis morphology|MP:0009735,abnormal prostate gland development|MP:0013713,decreased nipple size
MGI:4456517	Rln3<tm1(KOMP)Mbp>	MP:0002075,abnormal coat/hair pigmentation|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0008810,increased circulating iron level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5295187	Rln3<tm1Lex>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001360,abnormal social investigation|MP:0001402,decreased locomotor activity|MP:0002573,behavioral despair|MP:0002727,decreased circulating insulin level|MP:0004892,increased adiponectin level|MP:0005386,behavior/neurological phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009299,decreased mesenteric fat pad weight|MP:0010025,decreased total body fat amount
MGI:5293802	Rln3<tm1Mast>	MP:0001364,decreased anxiety-related response|MP:0001488,increased startle reflex|MP:0004807,abnormal paired-pulse inhibition
MGI:3798960	Rmcf<r>	MP:0020935,decreased susceptibility to Retroviridae infection
MGI:3798962	Rmcf<s>	MP:0020934,increased susceptibility to Retroviridae infection
MGI:4227269	Rmdn3<Gt(OST197572)Lex>	MP:0002169,no abnormal phenotype detected
MGI:4819201	Rmdn3<tm1a(KOMP)Wtsi>	MP:0000877,abnormal Purkinje cell morphology
MGI:4936755	Rmi1<Gt(pUHachi)0283Imeg>	MP:0001262,decreased body weight|MP:0005291,abnormal glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009283,decreased gonadal fat pad weight|MP:0011092,embryonic lethality, complete penetrance|MP:0011940,decreased food intake
MGI:5755131	Rmnd5b<em1(IMPC)J>	MP:0010053,decreased grip strength
MGI:3613793	Rmp1<DBA/2J>	MP:0020928,increased susceptibility to Poxviridae infection
MGI:3614837	Rmp2<DBA/2J>	MP:0020928,increased susceptibility to Poxviridae infection
MGI:3614839	Rmp3<DBA/2J>	MP:0020928,increased susceptibility to Poxviridae infection
MGI:3617640	Rmp4<C57BL/6NCr>	MP:0020929,decreased susceptibility to Poxviridae infection
MGI:3614843	Rmp5<C57BL/6NCr>	MP:0020929,decreased susceptibility to Poxviridae infection
MGI:3614845	Rmp6<C57BL/6NCr>	MP:0020929,decreased susceptibility to Poxviridae infection
MGI:7564552	Rmrp<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000689,abnormal spleen morphology|MP:0001556,increased circulating HDL cholesterol level|MP:0002060,abnormal skin morphology|MP:0002188,small heart|MP:0005178,increased circulating cholesterol level|MP:0011100,preweaning lethality, complete penetrance
MGI:5297721	Rmrp<tm1.1Whah>	MP:0002169,no abnormal phenotype detected|MP:0011092,embryonic lethality, complete penetrance
MGI:5297708	Rmrp<tm1Whah>	MP:0002169,no abnormal phenotype detected|MP:0011092,embryonic lethality, complete penetrance
MGI:1856626	rmy	MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death
MGI:1856142	Rn	MP:0000372,irregular coat pigmentation|MP:0005376,homeostasis/metabolism phenotype
MGI:7581007	Rn4.5s<tm1.1Shna>	MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014134,abnormal embryo morphology
MGI:7386923	Rn7sk<tm1.2Mfrye>	MP:0010771,integument phenotype|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4435923	Rnase10<tm1a(EUCOMM)Hmgu>	MP:0001402,decreased locomotor activity|MP:0004924,abnormal behavior
MGI:6276978	Rnase11<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002989,small kidney|MP:0003918,decreased kidney weight|MP:0005013,increased lymphocyte cell number|MP:0009552,urinary bladder obstruction|MP:0020421,increased freezing behavior
MGI:6276895	Rnase12<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology
MGI:6276876	Rnase13<em1(IMPC)Mbp>	MP:0000470,abnormal stomach morphology|MP:0002060,abnormal skin morphology|MP:0003883,enlarged stomach|MP:0011875,absent stomach
MGI:6361109	Rnase13<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5755080	Rnase1<em5(IMPC)Tcp>	MP:0002060,abnormal skin morphology|MP:0009142,decreased prepulse inhibition
MGI:6456551	Rnase1<tm1.2Rtrs>	MP:0001260,increased body weight|MP:0002551,abnormal blood coagulation|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009642,abnormal blood homeostasis
MGI:7868142	Rnase2a<tm1.1Anjm>	MP:0000222,decreased neutrophil cell number|MP:0002133,abnormal respiratory system physiology|MP:0002415,abnormal neutrophil differentiation|MP:0003884,decreased macrophage cell number|MP:0008719,impaired neutrophil recruitment|MP:0013697,decreased granulocyte monocyte progenitor cell number
MGI:7562150	Rnase4<em1(IMPC)J>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:7735214	Rnase4<em1Zpxu>	MP:0003868,abnormal feces composition|MP:0004843,abnormal Paneth cell morphology|MP:0005381,digestive/alimentary phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0010377,abnormal gut flora balance
MGI:7735216	Rnase4<em2Zpxu>	MP:0005381,digestive/alimentary phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0010377,abnormal gut flora balance
MGI:6281927	Rnase6<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000220,increased monocyte cell number|MP:0000470,abnormal stomach morphology|MP:0001126,abnormal ovary morphology
MGI:5637811	Rnase9<tm1.1Xen>	MP:0002169,no abnormal phenotype detected|MP:0002674,abnormal sperm motility|MP:0003666,impaired sperm capacitation|MP:0005389,reproductive system phenotype
MGI:2655784	Rnaseh1<tm1Crh>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0006035,abnormal mitochondrial morphology|MP:0010955,abnormal respiratory electron transport chain|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011630,increased mitochondrial size|MP:0011636,disorganized mitochondrial cristae|MP:0011639,decreased mitochondrial DNA content|MP:0013504,increased embryonic tissue cell apoptosis
MGI:6402027	Rnaseh2a<em1(IMPC)Tcp>	MP:0000220,increased monocyte cell number|MP:0001126,abnormal ovary morphology|MP:0001488,increased startle reflex|MP:0002591,decreased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0004952,increased spleen weight|MP:0005505,thrombocytosis|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6147721	Rnaseh2a<tm1Crh>	MP:0001698,decreased embryo size|MP:0002419,abnormal innate immunity|MP:0003631,nervous system phenotype|MP:0004200,decreased fetal size|MP:0011089,perinatal lethality, complete penetrance|MP:0020914,decreased susceptibility to Riboviria infection
MGI:7279261	Rnaseh2b<em1Anu>	MP:0011092,embryonic lethality, complete penetrance
MGI:4432164	Rnaseh2b<tm1a(EUCOMM)Wtsi>	MP:0000352,decreased cell proliferation|MP:0000600,liver hypoplasia|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001785,edema|MP:0001823,thymus hypoplasia|MP:0001914,hemorrhage|MP:0003984,embryonic growth retardation|MP:0009703,decreased birth body size|MP:0010770,preweaning lethality|MP:0011089,perinatal lethality, complete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:5911393	Rnaseh2b<tm1c(EUCOMM)Wtsi>	MP:0005093,decreased B cell proliferation|MP:0005387,immune system phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5431529	Rnaseh2b<tm1Hgu>	MP:0000358,abnormal cell morphology|MP:0001698,decreased embryo size|MP:0001726,abnormal allantois morphology|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0009768,impaired somite development|MP:0010770,preweaning lethality
MGI:4364620	Rnaseh2c<tm1(KOMP)Wtsi>	MP:0004509,abnormal pelvic girdle bone morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5911394	Rnaseh2c<tm1Roer>	MP:0001698,decreased embryo size|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5636901	Rnasek<tm1b(EUCOMM)Wtsi>	MP:0002941,increased circulating alanine transaminase level|MP:0011100,preweaning lethality, complete penetrance
MGI:2182763	Rnasel<tm1Slvm>	MP:0000703,abnormal thymus morphology|MP:0000708,thymus hyperplasia|MP:0000709,enlarged thymus|MP:0006414,decreased T cell apoptosis|MP:0020937,increased susceptibility to Picornaviridae infection
MGI:5637192	Rnaset2b<tm1b(EUCOMM)Hmgu>	MP:0000691,enlarged spleen|MP:0003068,enlarged kidney|MP:0005293,impaired glucose tolerance|MP:0010052,increased grip strength
MGI:6152627	Rnd2<em1(IMPC)Mbp>	MP:0000538,abnormal urinary bladder morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001257,increased body length|MP:0001293,anophthalmia|MP:0001944,abnormal pancreas morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0010506,prolonged RR interval|MP:0011874,enlarged urinary bladder
MGI:7647328	Rnd2<tm1.1Fgu>	MP:0001363,increased anxiety-related response|MP:0003203,increased neuron apoptosis|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential|MP:0009939,abnormal hippocampus neuron morphology|MP:0009977,abnormal cerebellar granule cell migration|MP:0021090,abnormal dendrite arborization pattern
MGI:7645342	Rnd2<tm1.1Jya>	MP:0000920,abnormal myelination|MP:0011730,increased myelin sheath thickness|MP:0011731,decreased myelin sheath thickness
MGI:4072882	Rnd3<Gt(IST12405G10)Tigm>	MP:0000440,domed cranium|MP:0000827,dilated third ventricle|MP:0001891,hydrocephaly|MP:0002200,abnormal brain ventricular system morphology|MP:0002958,cerebral aqueductal stenosis|MP:0005537,abnormal cerebral aqueduct morphology|MP:0008535,enlarged lateral ventricles|MP:0010152,abnormal brain ependyma morphology
MGI:3530138	Rnd3<Gt(OST364657)Lex>	MP:0000939,decreased motor neuron number|MP:0000947,convulsive seizures|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001077,abnormal spinal nerve morphology|MP:0001263,weight loss|MP:0001290,delayed eyelid opening|MP:0001392,abnormal locomotor behavior|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001485,abnormal pinna reflex|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001526,abnormal placing response|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002651,abnormal sciatic nerve morphology|MP:0003083,abnormal tibialis anterior morphology|MP:0003358,abnormal hypaxial muscle morphology|MP:0003938,abnormal ear development|MP:0004263,abnormal limb posture|MP:0005356,positive geotaxis|MP:0008489,slow postnatal weight gain|MP:0009703,decreased birth body size|MP:0010053,decreased grip strength|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020865,delayed suckling reflex loss|MP:0021165,behavioral developmental delay
MGI:5637075	Rnd3<tm1b(EUCOMM)Hmgu>	MP:0000274,enlarged heart|MP:0008528,polycystic kidney|MP:0010053,decreased grip strength|MP:0012362,increased large unstained cell number
MGI:4410507	Rnf103<tm1.1Thg>	MP:0001363,increased anxiety-related response|MP:0001405,impaired coordination|MP:0001489,decreased startle reflex|MP:0009141,increased prepulse inhibition|MP:0009453,enhanced contextual conditioning behavior
MGI:6257818	Rnf10<em1(IMPC)Bay>	MP:0002574,increased vertical activity|MP:0009142,decreased prepulse inhibition|MP:0010097,abnormal retina blood vessel morphology|MP:0011965,decreased total retina thickness
MGI:5644522	Rnf10<em1(IMPC)J>	MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0001513,limb grasping|MP:0002574,increased vertical activity|MP:0002591,decreased mean corpuscular volume|MP:0003795,abnormal bone structure|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010123,increased bone mineral content
MGI:6158466	Rnf10<em1(IMPC)Mbp>	MP:0001293,anophthalmia|MP:0001489,decreased startle reflex|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002175,decreased brain weight|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005559,increased circulating glucose level
MGI:4362564	Rnf10<tm1a(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:5548492	Rnf10<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000186,decreased circulating HDL cholesterol level|MP:0000220,increased monocyte cell number|MP:0000274,enlarged heart|MP:0000558,abnormal tibia morphology|MP:0000689,abnormal spleen morphology|MP:0000947,convulsive seizures|MP:0001258,decreased body length|MP:0001363,increased anxiety-related response|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0002574,increased vertical activity|MP:0002591,decreased mean corpuscular volume|MP:0002644,decreased circulating triglyceride level|MP:0002757,decreased vertical activity|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003900,shortened QT interval|MP:0003960,increased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0004924,abnormal behavior|MP:0005016,decreased lymphocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005567,decreased circulating total protein level|MP:0005633,increased circulating sodium level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0006358,absent pinna reflex|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010053,decreased grip strength|MP:0010067,increased red blood cell distribution width|MP:0010123,increased bone mineral content|MP:0010571,shortened ST segment|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness|MP:0012362,increased large unstained cell number|MP:0013278,decreased fasting circulating glucose level|MP:0020420,abnormal freezing behavior|MP:0020870,decreased thigmotaxis
MGI:7865128	Rnf111<em1Fzh>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0005431,decreased oocyte number|MP:0011121,decreased primordial ovarian follicle number
MGI:7865129	Rnf111<em2Fzh>	MP:0001125,abnormal oocyte morphology|MP:0001698,decreased embryo size|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002085,abnormal embryonic tissue morphology|MP:0005431,decreased oocyte number|MP:0011121,decreased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance|MP:0031381,decreased secondary ovarian follicle number|MP:0031420,decreased superovulation rate
MGI:2680166	Rnf111<Gt(Betageo)1Vep>	MP:0000913,abnormal brain development|MP:0001730,embryonic growth arrest|MP:0002151,abnormal neural tube morphology|MP:0004180,failure of initiation of embryo turning|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5617261	Rnf112<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0002574,increased vertical activity
MGI:3812654	Rnf112<tm1(KOMP)Vlcg>	MP:0000774,decreased brain size|MP:0001919,abnormal reproductive system physiology|MP:0002920,decreased paired-pulse facilitation|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0021018,decreased dendritic spine number
MGI:6257832	Rnf113a1<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology
MGI:6153605	Rnf114<em1(IMPC)Wtsi>	MP:0002599,increased mean platelet volume
MGI:6761767	Rnf114<em1Nju>	MP:0001926,female infertility|MP:0003718,maternal effect|MP:0005389,reproductive system phenotype|MP:0005431,decreased oocyte number
MGI:6690637	Rnf115<em1Gpt>	MP:0002410,decreased susceptibility to viral infection|MP:0008564,increased interferon-beta secretion|MP:0008575,increased circulating interferon-beta level|MP:0009790,decreased susceptibility to viral infection induced morbidity/mortality|MP:0009791,increased susceptibility to viral infection induced morbidity/mortality
MGI:6153813	Rnf115<em1(IMPC)H>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0004952,increased spleen weight|MP:0005560,decreased circulating glucose level
MGI:5609353	Rnf121<tm1b(EUCOMM)Hmgu>	MP:0013293,embryonic lethality prior to tooth bud stage
MGI:7647313	Rnf122<em1Caox>	MP:0005387,immune system phenotype|MP:0008560,increased tumor necrosis factor secretion|MP:0008562,increased interferon-alpha secretion|MP:0008564,increased interferon-beta secretion|MP:0008573,increased circulating interferon-alpha level|MP:0008575,increased circulating interferon-beta level|MP:0008596,increased circulating interleukin-6 level|MP:0008705,increased interleukin-6 secretion|MP:0031023,decreased susceptibility to Riboviria infection induced morbidity/mortality
MGI:6164028	Rnf123<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0002591,decreased mean corpuscular volume|MP:0004738,abnormal auditory brainstem response|MP:0005292,improved glucose tolerance|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0013279,increased fasting circulating glucose level
MGI:7619960	Rnf123<em1Nmea>	MP:0002591,decreased mean corpuscular volume|MP:0005026,decreased susceptibility to parasitic infection|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality
MGI:7619961	Rnf123<em2Nmea>	MP:0002591,decreased mean corpuscular volume|MP:0005026,decreased susceptibility to parasitic infection|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality
MGI:4881004	Rnf125<tm1a(EUCOMM)Hmgu>	MP:0005344,increased circulating bilirubin level
MGI:6838377	Rnf126<em1(IMPC)J>	MP:0005632,decreased circulating aspartate transaminase level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7614508	Rnf126<tm1.1Bcgen>	MP:0003992,increased mortality induced by ionizing radiation|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0011101,prenatal lethality, incomplete penetrance
MGI:7614507	Rnf126<tm1Bcgen>	MP:0012734,abnormal response to radiation
MGI:7354910	Rnf128<em1Tvg>	MP:0012564,decreased tumor incidence following infection
MGI:4365554	Rnf128<tm1.1Flv>	MP:0005348,increased T cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008566,increased interferon-gamma secretion|MP:0008599,increased circulating interleukin-2 level|MP:0008749,abnormal peripheral T cell anergy
MGI:6274923	Rnf128<tm1.1(KOMP)Vlcg>	MP:0000538,abnormal urinary bladder morphology|MP:0011874,enlarged urinary bladder|MP:0013772,increased effector memory T-helper cell number
MGI:6164139	Rnf128<tm1.2Cmse>	MP:0002451,abnormal macrophage physiology|MP:0005376,homeostasis/metabolism phenotype
MGI:4459531	Rnf128<tm1Cdon>	MP:0000691,enlarged spleen|MP:0001861,lung inflammation|MP:0002494,increased IgM level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004946,abnormal regulatory T cell physiology|MP:0005000,abnormal immune tolerance|MP:0005348,increased T cell proliferation|MP:0006082,CNS inflammation|MP:0008466,enlarged mesenteric lymph nodes|MP:0008499,increased IgG1 level|MP:0008566,increased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008681,increased interleukin-17 secretion|MP:0008687,increased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0009057,increased interleukin-21 secretion|MP:0009336,increased splenocyte proliferation
MGI:4432601	Rnf130<tm1a(EUCOMM)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005376,homeostasis/metabolism phenotype|MP:0008469,abnormal protein level|MP:0011101,prenatal lethality, incomplete penetrance
MGI:7378666	Rnf133<em1Zuk>	MP:0001922,reduced male fertility|MP:0002674,abnormal sperm motility|MP:0002675,asthenozoospermia|MP:0005578,teratozoospermia|MP:0009230,abnormal sperm head morphology|MP:0009237,kinked sperm flagellum|MP:0009243,hairpin sperm flagellum|MP:0009282,decreased hyperactivated sperm motility|MP:0020451,decreased sperm progressive motility
MGI:6156488	Rnf135<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000470,abnormal stomach morphology|MP:0000702,enlarged lymph nodes|MP:0001127,small ovary|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002637,small uterus|MP:0010053,decreased grip strength
MGI:6834806	Rnf138<tm1.1Lwan>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0002687,oligozoospermia|MP:0003205,testicular atrophy|MP:0004852,decreased testis weight|MP:0006378,abnormal spermatogonia morphology|MP:0006379,abnormal spermatocyte morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0013601,increased testis apoptosis
MGI:4419541	Rnf139<tm1(KOMP)Wtsi>	MP:0001860,liver inflammation|MP:0003333,liver fibrosis|MP:0003887,increased hepatocyte apoptosis
MGI:5608781	Rnf13<tm1.1(KOMP)Vlcg>	MP:0000556,abnormal hindlimb morphology|MP:0005561,increased mean corpuscular hemoglobin|MP:0011396,abnormal sleep behavior|MP:0012000,abnormal limb position
MGI:7594042	Rnf13<tm1.1Xgao>	MP:0001363,increased anxiety-related response|MP:0001463,abnormal spatial learning|MP:0008571,abnormal synaptic bouton morphology|MP:0014370,impaired spatial working memory|MP:0020357,abnormal excitatory synapse morphology
MGI:5499169	Rnf141<tm1Szzh>	MP:0001935,decreased litter size|MP:0005389,reproductive system phenotype
MGI:5755081	Rnf144a<em1(IMPC)Tcp>	MP:0000470,abnormal stomach morphology|MP:0003020,decreased circulating chloride level
MGI:7621645	Rnf144a<em1Smoc>	MP:0002419,abnormal innate immunity|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:7586259	Rnf144b<em1Cya>	MP:0020914,decreased susceptibility to Riboviria infection|MP:0020938,decreased susceptibility to Picornaviridae infection|MP:0031039,decreased susceptibility to Picornaviridae infection induced morbidity/mortality
MGI:5574609	Rnf144b<tm1b(EUCOMM)Hmgu>	MP:0000194,increased circulating calcium level|MP:0001529,abnormal vocalization|MP:0005178,increased circulating cholesterol level
MGI:6153606	Rnf145<em1(IMPC)Wtsi>	MP:0008806,increased circulating amylase level
MGI:6150887	Rnf146<tm1.1Rtpl>	MP:0000063,decreased bone mineral density|MP:0000085,large anterior fontanelle|MP:0000135,decreased compact bone thickness|MP:0000150,abnormal rib morphology|MP:0001552,increased circulating triglyceride level|MP:0001954,respiratory distress|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003797,abnormal compact bone morphology|MP:0004189,abnormal alveolar process morphology|MP:0004337,clavicle hypoplasia|MP:0004984,increased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0005293,impaired glucose tolerance|MP:0005390,skeleton phenotype|MP:0005559,increased circulating glucose level|MP:0008272,abnormal endochondral bone ossification|MP:0008273,abnormal intramembranous bone ossification|MP:0008396,abnormal osteoclast differentiation|MP:0008553,increased circulating tumor necrosis factor level|MP:0009168,decreased pancreatic islet number|MP:0009172,small pancreatic islets|MP:0010024,increased total body fat amount|MP:0010869,decreased bone trabecula number|MP:0010873,decreased trabecular bone mass|MP:0010879,decreased trabecular bone volume|MP:0010965,decreased compact bone volume|MP:0011087,neonatal lethality, complete penetrance|MP:0011504,abnormal limb long bone morphology|MP:0011711,impaired osteoblast differentiation|MP:0013630,increased bone trabecular spacing|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization|MP:0030009,increased bone marrow adipose tissue amount|MP:0030387,large posterior fontanelle|MP:0030439,decreased osteoblast proliferation|MP:0030471,abnormal ameloblast differentiation|MP:0030985,decreased circulating osteocalcin level
MGI:6341955	Rnf148<em1(IMPC)Ccpcz>	MP:0000160,kyphosis|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0002286,cryptorchism|MP:0003019,increased circulating chloride level|MP:0004174,abnormal spine curvature|MP:0004924,abnormal behavior|MP:0005419,decreased circulating serum albumin level|MP:0020870,decreased thigmotaxis
MGI:7378667	Rnf148<em1Zuk>	MP:0005389,reproductive system phenotype
MGI:7643433	Rnf149<em1Staa>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000351,increased cell proliferation|MP:0005013,increased lymphocyte cell number|MP:0020414,abnormal fibroblast physiology
MGI:6341897	Rnf14<em1(IMPC)Ccpcz>	MP:0000162,lordosis|MP:0001556,increased circulating HDL cholesterol level|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002834,decreased heart weight
MGI:7378668	Rnf151<em1Zuk>	MP:0005389,reproductive system phenotype
MGI:7627054	Rnf152<em1Pwa>	MP:0020414,abnormal fibroblast physiology
MGI:5252664	Rnf157<Gt(IST14744E5)Tigm>	MP:0002169,no abnormal phenotype detected
MGI:5637139	Rnf157<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0008806,increased circulating amylase level
MGI:6838385	Rnf166<em1(IMPC)J>	MP:0000198,decreased circulating phosphate level|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0010506,prolonged RR interval
MGI:6153814	Rnf168<em1(IMPC)H>	MP:0000443,abnormal snout morphology|MP:0001314,cornea opacity|MP:0002075,abnormal coat/hair pigmentation|MP:0002941,increased circulating alanine transaminase level|MP:0005287,narrow eye opening|MP:0010052,increased grip strength|MP:0010090,increased circulating creatine kinase level
MGI:4970574	Rnf168<Gt(156B6)Cmhd>	MP:0001147,small testis|MP:0001805,decreased IgG level|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002006,neoplasm|MP:0002786,abnormal Leydig cell morphology|MP:0003205,testicular atrophy|MP:0004045,abnormal cell cycle checkpoint function|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0004816,abnormal class switch recombination|MP:0004901,decreased male germ cell number|MP:0005090,increased double-negative T cell number|MP:0005387,immune system phenotype|MP:0006362,abnormal male germ cell morphology|MP:0008347,decreased gamma-delta T cell number|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008498,decreased IgG3 level|MP:0008759,abnormal T cell receptor delta chain V(D)J recombination|MP:0008866,chromosomal instability|MP:0010133,increased DN3 thymocyte number
MGI:4962718	Rnf168<Gt(405F11)Cmhd>	MP:0001147,small testis|MP:0001805,decreased IgG level|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002006,neoplasm|MP:0002786,abnormal Leydig cell morphology|MP:0003205,testicular atrophy|MP:0004045,abnormal cell cycle checkpoint function|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0004816,abnormal class switch recombination|MP:0004901,decreased male germ cell number|MP:0005090,increased double-negative T cell number|MP:0005387,immune system phenotype|MP:0006362,abnormal male germ cell morphology|MP:0008347,decreased gamma-delta T cell number|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008498,decreased IgG3 level|MP:0008759,abnormal T cell receptor delta chain V(D)J recombination|MP:0008866,chromosomal instability|MP:0010133,increased DN3 thymocyte number
MGI:6433991	Rnf168<tm2b(EUCOMM)Hmgu>	MP:0000208,decreased hematocrit|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000432,abnormal head morphology|MP:0000438,abnormal cranium morphology|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001262,decreased body weight|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001307,fused cornea and lens|MP:0001312,abnormal cornea morphology|MP:0001566,increased circulating phosphate level|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002599,increased mean platelet volume|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0004174,abnormal spine curvature|MP:0004609,vertebral fusion|MP:0005011,increased eosinophil cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005561,increased mean corpuscular hemoglobin|MP:0010052,increased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0011971,increased circulating lactate dehydrogenase level
MGI:4452734	Rnf169<tm1a(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000220,increased monocyte cell number|MP:0002702,decreased circulating free fatty acids level|MP:0002896,abnormal bone mineralization
MGI:5907138	Rnf170<Gt(OST104375)Lex>	MP:0001406,abnormal gait|MP:0001524,impaired limb coordination|MP:0001973,increased thermal nociceptive threshold|MP:0002106,abnormal muscle physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0010053,decreased grip strength
MGI:7450912	Rnf17<em1Shnk>	MP:0005169,abnormal male meiosis
MGI:3526166	Rnf17<tm1Jw>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0005159,azoospermia
MGI:6360732	Rnf180<em1(IMPC)J>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0002590,increased mean corpuscular volume|MP:0005278,abnormal cholesterol homeostasis|MP:0005566,decreased blood urea nitrogen level|MP:0005567,decreased circulating total protein level
MGI:5903887	Rnf180<tm1.1Jaru>	MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0002797,increased thigmotaxis|MP:0003063,increased coping response|MP:0003661,abnormal locus ceruleus morphology|MP:0004000,impaired passive avoidance behavior|MP:0005584,abnormal enzyme/coenzyme activity|MP:0010070,decreased serotonin level|MP:0012574,decreased noradrenaline level
MGI:6343557	Rnf186<em1Ktak>	MP:0008537,increased susceptibility to induced colitis|MP:0008885,increased enterocyte apoptosis|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010155,abnormal intestine physiology|MP:0013298,increased susceptibility to colitis induced morbidity/mortality|MP:0020354,increased endoplasmic reticulum stress
MGI:6343556	Rnf186<tm1Ktak>	MP:0000488,abnormal intestinal epithelium morphology|MP:0005381,digestive/alimentary phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0008885,increased enterocyte apoptosis|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010155,abnormal intestine physiology|MP:0013298,increased susceptibility to colitis induced morbidity/mortality|MP:0020354,increased endoplasmic reticulum stress
MGI:6849819	Rnf187<em1(IMPC)J>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001488,increased startle reflex|MP:0005565,increased blood urea nitrogen level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3530036	Rnf19a<Gt(OST244733)Lex>	MP:0001399,hyperactivity|MP:0003008,enhanced long-term potentiation|MP:0003861,abnormal nervous system development|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0009938,abnormal hippocampus granule cell morphology|MP:0009967,abnormal neuron proliferation
MGI:6341934	Rnf19b<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001314,cornea opacity|MP:0001325,abnormal retina morphology|MP:0001404,no spontaneous movement|MP:0003179,thrombocytopenia|MP:0005011,increased eosinophil cell number|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4436863	Rnf19b<tm1Jkorn>	MP:0001272,increased metastatic potential|MP:0003721,increased tumor growth/size|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0008567,decreased interferon-gamma secretion
MGI:6341956	Rnf208<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001262,decreased body weight|MP:0002339,abnormal lymph node morphology|MP:0002941,increased circulating alanine transaminase level|MP:0005011,increased eosinophil cell number|MP:0005084,abnormal gallbladder morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0009342,enlarged gallbladder|MP:0010052,increased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0011047,increased lung tissue damping
MGI:4129198	Rnf20<Gt(RRJ249)Byg>	MP:0000691,enlarged spleen|MP:0002442,abnormal leukocyte physiology|MP:0002444,abnormal T cell physiology|MP:0003674,oxidative stress|MP:0003957,abnormal nitric oxide homeostasis|MP:0004499,increased incidence of tumors by chemical induction|MP:0004952,increased spleen weight|MP:0008537,increased susceptibility to induced colitis|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0009310,increased large intestine adenocarcinoma incidence|MP:0009314,increased colon adenocarcinoma incidence|MP:0010155,abnormal intestine physiology|MP:0010180,increased susceptibility to weight loss|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0013663,increased myeloid cell number|MP:0013956,decreased colon length
MGI:5605801	Rnf20<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation|MP:0020870,decreased thigmotaxis
MGI:3708256	Rnf212<repro57>	MP:0001925,male infertility|MP:0002208,abnormal germ cell morphology|MP:0004852,decreased testis weight|MP:0004910,decreased seminal vesicle weight|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis
MGI:5438282	Rnf212<tm1Nhtr>	MP:0005169,abnormal male meiosis
MGI:8253058	Rnf213<em1Takag>	MP:0001175,abnormal lung morphology|MP:0001386,abnormal maternal nurturing|MP:0001953,respiratory failure|MP:0002276,abnormal lung interstitium morphology|MP:0003641,small lung|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005425,increased macrophage cell number|MP:0010911,abnormal pulmonary acinus morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0014473,increased pulmonary alveolus wall thickness
MGI:5510405	Rnf213<tm1.1Akoi>	MP:0001262,decreased body weight|MP:0003059,decreased insulin secretion|MP:0005376,homeostasis/metabolism phenotype|MP:0005560,decreased circulating glucose level
MGI:5708305	Rnf213<tm1.1Kure>	MP:0003710,abnormal physiological neovascularization|MP:0005166,decreased susceptibility to injury
MGI:5752774	Rnf213<tm1.1Mfuji>	MP:0002169,no abnormal phenotype detected
MGI:6160287	Rnf214<em1(IMPC)J>	MP:0000194,increased circulating calcium level|MP:0001399,hyperactivity|MP:0001529,abnormal vocalization|MP:0001566,increased circulating phosphate level|MP:0005562,decreased mean corpuscular hemoglobin
MGI:7294478	Rnf216<em1Lijd>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002662,abnormal cauda epididymis morphology|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004884,abnormal testis physiology|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:5605760	Rnf216<tm1b(EUCOMM)Wtsi>	MP:0000220,increased monocyte cell number|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002631,abnormal epididymis morphology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005016,decreased lymphocyte cell number|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0006379,abnormal spermatocyte morphology|MP:0013279,increased fasting circulating glucose level|MP:0014052,increased male germ cell apoptosis|MP:0014636,decreased elongated spermatid number
MGI:6357892	Rnf217<em1(IMPC)J>	MP:0001523,impaired righting response
MGI:7428715	Rnf217<tm1.1Fudi>	MP:0005637,abnormal iron homeostasis|MP:0008808,decreased spleen iron level|MP:0008810,increased circulating iron level
MGI:6451114	Rnf220<em1.1Kust>	MP:0000753,paralysis|MP:0002083,premature death|MP:0003491,abnormal voluntary movement
MGI:6393918	Rnf220<em1Chek>	MP:0000939,decreased motor neuron number|MP:0021101,abnormal ventral interneuron morphology|MP:0021102,abnormal ventral interneuron 0 morphology|MP:0021103,abnormal ventral interneuron 1 morphology|MP:0021104,abnormal ventral interneuron 2 morphology|MP:0021105,abnormal ventral interneuron 3 morphology
MGI:6414503	Rnf220<em1(IMPC)Bay>	MP:0002574,increased vertical activity|MP:0011100,preweaning lethality, complete penetrance
MGI:6451111	Rnf220<em1Kust>	MP:0000939,decreased motor neuron number|MP:0002151,abnormal neural tube morphology|MP:0005390,skeleton phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:6341957	Rnf223<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001325,abnormal retina morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0003604,single kidney
MGI:5825334	Rnf24<em1(IMPC)J>	MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number
MGI:5569948	Rnf25<tm1.1(KOMP)Vlcg>	MP:0001303,abnormal lens morphology|MP:0001402,decreased locomotor activity|MP:0001523,impaired righting response|MP:0001556,increased circulating HDL cholesterol level|MP:0002590,increased mean corpuscular volume|MP:0003020,decreased circulating chloride level|MP:0005178,increased circulating cholesterol level|MP:0005633,increased circulating sodium level
MGI:2447529	Rnf2<tm1Hko>	MP:0004615,cervical vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0008277,abnormal sternum ossification
MGI:3772186	Rnf2<tm1Mvi>	MP:0000223,decreased monocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0002144,abnormal B cell differentiation|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002875,decreased erythrocyte cell number|MP:0005017,decreased B cell number|MP:0005505,thrombocytosis|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0009937,abnormal neuron differentiation
MGI:2653961	Rnf2<tm1Mvl>	MP:0001680,abnormal mesoderm development|MP:0001696,failure to gastrulate|MP:0001730,embryonic growth arrest|MP:0003886,abnormal embryonic epiblast morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3790776	Rnf2<tm3Hko>	MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype
MGI:5550368	Rnf31<tm1.1Kiwa>	MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0004940,abnormal B-1 B cell morphology|MP:0005387,immune system phenotype|MP:0008168,decreased B-1a cell number|MP:0008170,decreased B-1b cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:5550376	Rnf31<tm1.2Kiwa>	MP:0011092,embryonic lethality, complete penetrance
MGI:5638568	Rnf31<tm1b(KOMP)Wtsi>	MP:0001257,increased body length|MP:0001697,abnormal embryo size|MP:0002833,increased heart weight|MP:0003984,embryonic growth retardation|MP:0006108,abnormal hindbrain development|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:4942113	Rnf34<tm1a(EUCOMM)Hmgu>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001175,abnormal lung morphology|MP:0001293,anophthalmia|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0004882,enlarged lung|MP:0005292,improved glucose tolerance|MP:0005333,decreased heart rate|MP:0011239,abnormal skin coloration
MGI:5569953	Rnf38<tm1b(KOMP)Wtsi>	MP:0001491,unresponsive to tactile stimuli|MP:0010097,abnormal retina blood vessel morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:8210419	Rnf39<em1Zwei>	MP:0008564,increased interferon-beta secretion|MP:0008705,increased interleukin-6 secretion|MP:0020914,decreased susceptibility to Riboviria infection|MP:0031023,decreased susceptibility to Riboviria infection induced morbidity/mortality
MGI:6158667	Rnf40<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6781798	Rnf40<tm1.1Sajo>	MP:0004149,increased bone strength|MP:0008539,decreased susceptibility to induced colitis
MGI:6257577	Rnf41<em1(IMPC)Bay>	MP:0001488,increased startle reflex|MP:0001925,male infertility|MP:0002953,thick ventricular wall
MGI:5287504	Rnf41<TgTn(sb-rtTA,Tyr)2435COve>	MP:0001925,male infertility
MGI:6442534	Rnf43<em1(IMPC)Tcp>	MP:0000691,enlarged spleen|MP:0001402,decreased locomotor activity|MP:0002060,abnormal skin morphology|MP:0002590,increased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0002764,short tibia|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0005627,increased circulating potassium level|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount
MGI:6403353	Rnf43<em1Mage>	MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype|MP:0010768,mortality/aging|MP:0010783,abnormal stomach wall morphology|MP:0010792,abnormal stomach mucosa morphology|MP:0013578,abnormal stomach glandular region morphology
MGI:6403354	Rnf43<em2Mage>	MP:0001873,stomach inflammation|MP:0002814,hyperchromasia|MP:0003111,abnormal cell nucleus morphology|MP:0005213,gastric metaplasia|MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype|MP:0008566,increased interferon-gamma secretion|MP:0010768,mortality/aging|MP:0010783,abnormal stomach wall morphology|MP:0010792,abnormal stomach mucosa morphology|MP:0013578,abnormal stomach glandular region morphology
MGI:6257833	Rnf44<em1(IMPC)Bay>	MP:0001417,decreased exploration in new environment|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0011965,decreased total retina thickness
MGI:6341902	Rnf4<em1(IMPC)Ccpcz>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001404,no spontaneous movement|MP:0001552,increased circulating triglyceride level|MP:0001697,abnormal embryo size|MP:0005568,increased circulating total protein level|MP:0008935,decreased mean platelet volume|MP:0011100,preweaning lethality, complete penetrance
MGI:4829855	Rnf4<Gt(ROSABetageo)1Gel>	MP:0001544,abnormal cardiovascular system physiology|MP:0008877,abnormal DNA methylation|MP:0010402,ventricular septal defect|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:6361211	Rnf5<tm1.1(KOMP)Vlcg>	MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001404,no spontaneous movement|MP:0002060,abnormal skin morphology|MP:0005084,abnormal gallbladder morphology|MP:0009342,enlarged gallbladder|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020421,increased freezing behavior
MGI:3775796	Rnf5<tm1Zron>	MP:0000750,abnormal muscle regeneration
MGI:4125996	Rnf7<Gt(XE423)Byg>	MP:0000352,decreased cell proliferation|MP:0001787,pericardial edema|MP:0003077,abnormal cell cycle|MP:0003229,abnormal vitelline vasculature morphology|MP:0003674,oxidative stress|MP:0003984,embryonic growth retardation|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0005076,abnormal cell differentiation|MP:0005602,decreased angiogenesis|MP:0006042,increased apoptosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011204,abnormal visceral yolk sac blood island morphology|MP:0013182,increased spinal cord apoptosis|MP:0013504,increased embryonic tissue cell apoptosis
MGI:4432053	Rnf7<tm1a(EUCOMM)Wtsi>	MP:0002644,decreased circulating triglyceride level|MP:0003019,increased circulating chloride level|MP:0003020,decreased circulating chloride level|MP:0005316,abnormal response to tactile stimuli
MGI:5545787	Rnf7<tm1c(EUCOMM)Wtsi>	MP:0000852,small cerebellum|MP:0000884,delaminated Purkinje cell layer|MP:0000885,ectopic Purkinje cell|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0002169,no abnormal phenotype detected|MP:0006009,abnormal neuronal migration|MP:0009956,abnormal cerebellar layer morphology|MP:0011380,enlarged brain ventricles|MP:0013551,decreased cerebellar granule cell precursor proliferation
MGI:4346727	Rnf8<Gt(AS0574)Wtsi>	MP:0000333,decreased bone marrow cell number|MP:0000715,decreased thymocyte number|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001658,increased mortality induced by gamma-irradiation|MP:0001732,postnatal growth retardation|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002006,neoplasm|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002024,increased T cell derived lymphoma incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002687,oligozoospermia|MP:0004029,spontaneous chromosome breakage|MP:0004030,induced chromosome breakage|MP:0004816,abnormal class switch recombination|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005159,azoospermia|MP:0006379,abnormal spermatocyte morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008215,decreased immature B cell number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0009339,decreased splenocyte number|MP:0009541,increased thymocyte apoptosis|MP:0010300,increased skin tumor incidence|MP:0011704,decreased fibroblast proliferation|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0012431,increased lymphoma incidence|MP:0014617,decreased spermatogonia number
MGI:3800229	Rnf8<Gt(RRR260)Byg>	MP:0000333,decreased bone marrow cell number|MP:0000715,decreased thymocyte number|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001658,increased mortality induced by gamma-irradiation|MP:0001732,postnatal growth retardation|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001925,male infertility|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002024,increased T cell derived lymphoma incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002687,oligozoospermia|MP:0004029,spontaneous chromosome breakage|MP:0004030,induced chromosome breakage|MP:0004816,abnormal class switch recombination|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005159,azoospermia|MP:0006379,abnormal spermatocyte morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008215,decreased immature B cell number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0009339,decreased splenocyte number|MP:0009541,increased thymocyte apoptosis|MP:0010300,increased skin tumor incidence|MP:0011704,decreased fibroblast proliferation|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0012431,increased lymphoma incidence|MP:0014617,decreased spermatogonia number
MGI:1856143	Rn<fkl>	MP:0000372,irregular coat pigmentation
MGI:6341832	Rnft1<em1(IMPC)Ccpcz>	MP:0000627,abnormal mammary gland morphology|MP:0002135,abnormal kidney morphology|MP:0003917,increased kidney weight
MGI:5616364	Rnft2<tm1b(EUCOMM)Hmgu>	MP:0000689,abnormal spleen morphology|MP:0011960,abnormal eye anterior chamber depth|MP:0011965,decreased total retina thickness
MGI:6162065	Rnh1<tm1Rall>	MP:0000245,abnormal erythropoiesis|MP:0001577,anemia|MP:0001722,pale yolk sac|MP:0003984,embryonic growth retardation|MP:0004229,abnormal embryonic erythropoiesis|MP:0004230,abnormal embryonic erythrocyte morphology|MP:0008801,abnormal erythroid progenitor cell morphology|MP:0008973,decreased erythroid progenitor cell number|MP:0011092,embryonic lethality, complete penetrance|MP:0011176,abnormal erythroblast morphology|MP:0011204,abnormal visceral yolk sac blood island morphology|MP:0013272,abnormal translation
MGI:4366017	Rnl11	MP:0002871,albuminuria
MGI:4441351	Rnl20	MP:0002871,albuminuria
MGI:4843948	Rnl23	MP:0005565,increased blood urea nitrogen level
MGI:4366018	Rnl25	MP:0005565,increased blood urea nitrogen level
MGI:3797736	Rnl27	MP:0005565,increased blood urea nitrogen level
MGI:4441352	Rnl29	MP:0005565,increased blood urea nitrogen level
MGI:4843954	Rnl32	MP:0005565,increased blood urea nitrogen level
MGI:4441353	Rnl43	MP:0005565,increased blood urea nitrogen level
MGI:6120734	Rnls<tm1b(EUCOMM)Wtsi>	MP:0010097,abnormal retina blood vessel morphology
MGI:5433853	Rnls<tm1Gvd>	MP:0001544,abnormal cardiovascular system physiology|MP:0001906,increased dopamine level|MP:0002625,heart left ventricle hypertrophy|MP:0002626,increased heart rate|MP:0002842,increased systemic arterial blood pressure|MP:0003037,increased myocardial infarct size|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005662,increased circulating adrenaline level|MP:0005665,increased circulating noradrenaline level|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure
MGI:5617142	Rnmt<tm1b(KOMP)Mbp>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6153815	Rnpc3<em1(IMPC)H>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:4433222	Rnpc3<tm1a(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:6276236	Rnpc3<tm1b(EUCOMM)Wtsi>	MP:0001730,embryonic growth arrest|MP:0002169,no abnormal phenotype detected|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:6269405	Rnpc3<tm1c(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0000223,decreased monocyte cell number|MP:0000462,abnormal digestive system morphology|MP:0000469,abnormal esophageal squamous epithelium morphology|MP:0000473,abnormal stomach glandular epithelium morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000649,sebaceous gland atrophy|MP:0001221,epidermal atrophy|MP:0001263,weight loss|MP:0001505,hunched posture|MP:0001511,disheveled coat|MP:0001577,anemia|MP:0002060,abnormal skin morphology|MP:0002169,no abnormal phenotype detected|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0003278,esophageal inflammation|MP:0003306,small intestinal inflammation|MP:0003644,thymus atrophy|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0004956,decreased thymus weight|MP:0005016,decreased lymphocyte cell number|MP:0008800,increased small intestinal crypt cell apoptosis|MP:0008883,abnormal enterocyte proliferation|MP:0010157,abnormal small intestinal crypt cell proliferation|MP:0013139,moribund|MP:0013585,thymus cortex atrophy|MP:0013586,thymus medulla atrophy|MP:0014082,decreased small intestinal villus height
MGI:6406455	Rnpep<em1(IMPC)J>	MP:0005562,decreased mean corpuscular hemoglobin
MGI:6277041	Rnpepl1<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001304,cataract|MP:0002339,abnormal lymph node morphology|MP:0002574,increased vertical activity
MGI:7425950	Rnps1<em1(IMPC)Hmgu>	MP:0001312,abnormal cornea morphology|MP:0001319,irregularly shaped pupil|MP:0001322,abnormal iris morphology|MP:0001488,increased startle reflex|MP:0002792,abnormal retina vasculature morphology|MP:0002941,increased circulating alanine transaminase level|MP:0005561,increased mean corpuscular hemoglobin|MP:0008259,abnormal optic disk morphology
MGI:6393645	Rnu11<tm1.1Rank>	MP:0000433,microcephaly|MP:0000809,absent hippocampus|MP:0004171,abnormal pallium development|MP:0004981,decreased neuronal precursor cell number|MP:0008948,decreased neuron number|MP:0011092,embryonic lethality, complete penetrance|MP:0012556,increased cell death|MP:0020388,decreased radial glial cell number
MGI:3054730	Rnu2-8<nmf291>	MP:0000745,tremors|MP:0000748,progressive muscle weakness|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0003224,neuron degeneration|MP:0004098,abnormal cerebellar granule cell morphology|MP:0008924,decreased cerebellar granule cell number
MGI:7709114	rnv6	MP:0008852,retina neovascularization
MGI:7716845	rnv7	MP:0008852,retina neovascularization
MGI:7730770	rnv8	MP:0005546,choroidal neovascularization|MP:0008852,retina neovascularization
MGI:7735175	rnv9	MP:0008852,retina neovascularization
MGI:1857019	ro	MP:0001279,wavy vibrissae|MP:0001510,abnormal coat appearance|MP:0002075,abnormal coat/hair pigmentation|MP:0003809,abnormal hair shaft morphology|MP:0003812,abnormal hair medulla|MP:0003846,matted coat|MP:0003849,greasy coat|MP:0008767,abnormal hair medullary septa cells|MP:0008768,abnormal hair medulla air spaces
MGI:2670227	Ro60<tm1Woln>	MP:0001202,skin photosensitivity|MP:0002083,premature death|MP:0002494,increased IgM level|MP:0002743,glomerulonephritis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004796,increased anti-histone antibody level|MP:0004829,increased anti-chromatin antibody level|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008500,increased IgG2a level|MP:0010771,integument phenotype
MGI:5496051	Robo1<b2b872Clo>	MP:0000111,cleft palate|MP:0000266,abnormal heart morphology|MP:0000276,heart right ventricle hypertrophy|MP:0000284,double outlet right ventricle|MP:0000428,abnormal craniofacial morphology|MP:0000445,short snout|MP:0000519,hydronephrosis|MP:0000536,hydroureter|MP:0000653,abnormal sex gland morphology|MP:0002135,abnormal kidney morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002639,micrognathia|MP:0008528,polycystic kidney|MP:0010402,ventricular septal defect|MP:0010405,ostium secundum atrial septal defect|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect
MGI:6276925	Robo1<em1(IMPC)Mbp>	MP:0001402,decreased locomotor activity|MP:0001404,no spontaneous movement|MP:0001711,abnormal placenta morphology|MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020870,decreased thigmotaxis
MGI:3641236	Robo1<tm1.1Ljr>	MP:0000780,abnormal corpus callosum morphology|MP:0000781,decreased corpus callosum size|MP:0002199,abnormal brain commissure morphology|MP:0002961,abnormal axon guidance|MP:0003651,abnormal axon extension|MP:0008221,abnormal hippocampal commissure morphology|MP:0008222,decreased hippocampal commissure size|MP:0011089,perinatal lethality, complete penetrance|MP:0014552,enhanced neuronal migration
MGI:3043142	Robo1<tm1Matl>	MP:0005237,abnormal olfactory tract morphology|MP:0009503,abnormal mammary gland duct morphology|MP:0009678,abnormal spinal cord lateral column morphology|MP:0010173,increased mammary gland epithelial cell proliferation|MP:0014751,abnormal commissural neuron axon guidance
MGI:2654881	Robo1<tm1Phr>	MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001179,thick pulmonary interalveolar septum|MP:0001438,aphagia|MP:0001953,respiratory failure|MP:0002027,increased lung adenocarcinoma incidence|MP:0002038,increased carcinoma incidence|MP:0002264,abnormal bronchus morphology|MP:0002267,abnormal bronchiole morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0005488,bronchial epithelial hyperplasia|MP:0010900,abnormal pulmonary interalveolar septum morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012431,increased lymphoma incidence
MGI:3772898	Robo1<tm1Wian>	MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0008415,abnormal neurite morphology|MP:0010418,perimembraneous ventricular septal defect
MGI:6276992	Robo2<em1(IMPC)Mbp>	MP:0001614,abnormal blood vessel morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0003068,enlarged kidney|MP:0009709,hydrometra|MP:0011100,preweaning lethality, complete penetrance
MGI:3759448	Robo2<tm1.1Rilm>	MP:0000516,abnormal renal/urinary system morphology|MP:0002135,abnormal kidney morphology|MP:0002990,short ureter|MP:0003585,large ureter|MP:0003586,dilated ureter|MP:0003675,kidney cyst|MP:0004101,abnormal brain interneuron morphology|MP:0008415,abnormal neurite morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance
MGI:3043127	Robo2<tm1Mrt>	MP:0000534,abnormal ureter morphology|MP:0002184,abnormal innervation|MP:0005237,abnormal olfactory tract morphology|MP:0009678,abnormal spinal cord lateral column morphology|MP:0009976,abnormal cerebellar peduncle morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0014751,abnormal commissural neuron axon guidance
MGI:3759447	Robo2<tm1Rilm>	MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002169,no abnormal phenotype detected|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:6741097	Robo3<em1(IMPC)H>	MP:0001325,abnormal retina morphology|MP:0002833,increased heart weight|MP:0005344,increased circulating bilirubin level|MP:0011100,preweaning lethality, complete penetrance
MGI:5294930	Robo3<m1J>	MP:0001393,ataxia|MP:0001525,impaired balance|MP:0010768,mortality/aging
MGI:4441335	Robo3<tm1.1Ache>	MP:0000846,abnormal medulla oblongata morphology|MP:0000848,abnormal pons morphology|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001516,abnormal motor coordination/balance|MP:0001961,abnormal reflex|MP:0002184,abnormal innervation|MP:0002199,abnormal brain commissure morphology|MP:0004738,abnormal auditory brainstem response|MP:0010745,abnormal pre-Botzinger complex morphology|MP:0010746,abnormal pre-Botzinger complex physiology|MP:0011042,abnormal horizontal vestibuloocular reflex|MP:0011087,neonatal lethality, complete penetrance|MP:0014647,decreased horizontal optokinetic reflex
MGI:3043150	Robo3<tm1Matl>	MP:0000848,abnormal pons morphology|MP:0000925,abnormal floor plate morphology|MP:0001575,cyanosis|MP:0001951,abnormal breathing pattern|MP:0002199,abnormal brain commissure morphology|MP:0010746,abnormal pre-Botzinger complex physiology|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0014751,abnormal commissural neuron axon guidance|MP:0021092,abnormal dorsal interneuron 1 morphology
MGI:6324190	Robo4<tm1.1(KOMP)Vlcg>	MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5523987	Robo4<tm1.1Xby>	MP:0000934,abnormal telencephalon development|MP:0003631,nervous system phenotype
MGI:3785556	Robo4<tm1Kzh>	MP:0000259,abnormal vascular development|MP:0000260,abnormal angiogenesis|MP:0001619,abnormal vascular permeability|MP:0002279,abnormal diaphragm morphology|MP:0002796,impaired skin barrier function|MP:0003711,pathological neovascularization|MP:0005292,improved glucose tolerance|MP:0005378,growth/size/body region phenotype|MP:0005560,decreased circulating glucose level|MP:0005590,increased vasodilation|MP:0005601,increased angiogenesis|MP:0005602,decreased angiogenesis|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0011132,abnormal lung endothelial cell migration|MP:0012107,enhanced exercise endurance|MP:0013278,decreased fasting circulating glucose level
MGI:5543630	Rock1<tm1.1Itl>	MP:0001260,increased body weight|MP:0001261,obese|MP:0001402,decreased locomotor activity|MP:0002079,increased circulating insulin level|MP:0002272,abnormal nervous system electrophysiology|MP:0005331,insulin resistance|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype|MP:0005669,increased circulating leptin level|MP:0008260,abnormal autophagy|MP:0009288,increased epididymal fat pad weight|MP:0009298,increased mesenteric fat pad weight|MP:0009302,increased renal fat pad weight|MP:0010024,increased total body fat amount|MP:0011939,increased food intake
MGI:5556290	Rock1<tm1.2Itl>	MP:0008260,abnormal autophagy
MGI:5766167	Rock1<tm1b(NCOM)Mfgc>	MP:0001785,edema|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3521801	Rock1<tm1Leiw>	MP:0001544,abnormal cardiovascular system physiology|MP:0002626,increased heart rate|MP:0011103,embryonic lethality at implantation, incomplete penetrance
MGI:5431098	Rock1<tm1Lex>	MP:0002083,premature death|MP:0005260,ocular hypotension|MP:0005391,vision/eye phenotype|MP:0010831,lethality, incomplete penetrance
MGI:3665285	Rock1<tm1Liao>	MP:0002133,abnormal respiratory system physiology|MP:0003156,abnormal leukocyte migration|MP:0003628,abnormal leukocyte adhesion|MP:0003799,impaired macrophage chemotaxis|MP:0004003,abnormal vascular endothelial cell physiology|MP:0004883,abnormal vascular wound healing|MP:0005592,abnormal vascular smooth muscle morphology|MP:0008719,impaired neutrophil recruitment
MGI:3578223	Rock1<tm1Sna>	MP:0001302,eyelids open at birth|MP:0001340,abnormal eyelid morphology|MP:0002655,abnormal keratinocyte morphology|MP:0003052,omphalocele|MP:0005251,blepharitis|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5431873	Rock2<Gt(OST440776)Lex>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001326,retina degeneration|MP:0005260,ocular hypotension|MP:0008852,retina neovascularization|MP:0010831,lethality, incomplete penetrance|MP:0031212,decreased eye anterior chamber depth
MGI:5702750	Rock2<tm1.1Itl>	MP:0003009,abnormal cytokine secretion|MP:0005595,abnormal vascular smooth muscle physiology|MP:0011092,embryonic lethality, complete penetrance|MP:0012046,decreased susceptibility to hypertension|MP:0031509,decreased vascular smooth muscle cell proliferation
MGI:3793462	Rock2<tm1.1Liao>	MP:0005385,cardiovascular system phenotype
MGI:2668391	Rock2<tm1Sna>	MP:0001265,decreased body size|MP:0001711,abnormal placenta morphology|MP:0001914,hemorrhage|MP:0002083,premature death|MP:0002086,abnormal extraembryonic tissue morphology|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5692187	Rock2<tm1Zpj>	MP:0000180,abnormal circulating cholesterol level|MP:0001473,reduced long-term potentiation|MP:0001544,abnormal cardiovascular system physiology|MP:0002127,abnormal cardiovascular system morphology|MP:0002702,decreased circulating free fatty acids level|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002920,decreased paired-pulse facilitation|MP:0003631,nervous system phenotype|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009538,abnormal synapse morphology|MP:0020510,increased dendritic spine length|MP:0020849,abnormal actin cytoskeleton morphology
MGI:5488746	Rock2<tm2Liao>	MP:0000266,abnormal heart morphology|MP:0005385,cardiovascular system phenotype|MP:0005406,abnormal heart size
MGI:7574508	Rogdi<tm1.2Ics>	MP:0000195,decreased circulating calcium level|MP:0000812,abnormal dentate gyrus morphology|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000890,thin cerebellar molecular layer|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001458,abnormal object recognition memory|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002576,abnormal enamel morphology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002968,increased circulating alkaline phosphatase level|MP:0003461,abnormal response to novel object|MP:0004422,small temporal bone|MP:0004441,small occipital bone|MP:0004470,small nasal bone|MP:0004540,small maxilla|MP:0004870,small premaxilla|MP:0006099,thin cerebellar granule layer|MP:0008006,increased stomach pH|MP:0009511,distended stomach|MP:0010004,abnormal paramedian lobule morphology|MP:0010005,abnormal lobule simplex morphology|MP:0010053,decreased grip strength|MP:0010096,abnormal incisor color|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012446,thin hippocampus stratum oriens|MP:0030262,frontal bossing|MP:0030265,parietal bossing|MP:0030450,abnormal enamel mineralization|MP:0030544,abnormal enamel development|MP:0031391,increased locomotor activity
MGI:1857020	rol	MP:0031084,decreased erythrocyte osmotic fragility
MGI:3814074	Rom1<Rgsc1156>	MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0002864,abnormal ocular fundus morphology|MP:0005551,abnormal eye electrophysiology|MP:0008515,thin retina outer nuclear layer|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0010097,abnormal retina blood vessel morphology
MGI:2181662	Rom1<tm1Mci>	MP:0001325,abnormal retina morphology|MP:0004021,abnormal rod electrophysiology|MP:0008451,retina rod cell degeneration|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0008515,thin retina outer nuclear layer
MGI:6156345	Romo1<em1(IMPC)Kmpc>	MP:0001399,hyperactivity|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001722,pale yolk sac|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0005568,increased circulating total protein level|MP:0010090,increased circulating creatine kinase level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:8211164	Romo1<tm1.1Xiwa>	MP:0011091,prenatal lethality, complete penetrance
MGI:8210928	Romo1<tm1Xiwa>	MP:0005290,decreased oxygen consumption|MP:0006036,abnormal mitochondrial physiology
MGI:4144733	Ropn1<Gt(OST21705)Lex>	MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0005388,respiratory system phenotype
MGI:4143866	Ropn1l<Gt(OST20298)Lex>	MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0011055,abnormal respiratory motile cilium physiology
MGI:5548780	Ropn1l<tm1b(EUCOMM)Wtsi>	MP:0000160,kyphosis|MP:0000443,abnormal snout morphology|MP:0002100,abnormal tooth morphology|MP:0004174,abnormal spine curvature|MP:0010053,decreased grip strength
MGI:7425951	Ror1<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001404,no spontaneous movement|MP:0002989,small kidney|MP:0009141,increased prepulse inhibition|MP:0009709,hydrometra|MP:0011100,preweaning lethality, complete penetrance
MGI:5315484	Ror1<tm1.2Meg>	MP:0000914,exencephaly
MGI:2183224	Ror1<tm1Ymi>	MP:0000031,abnormal cochlea morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0001967,deafness|MP:0002133,abnormal respiratory system physiology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002622,abnormal cochlear hair cell morphology|MP:0003148,decreased cochlea coiling|MP:0009450,abnormal axon fasciculation|MP:0009538,abnormal synapse morphology|MP:0009642,abnormal blood homeostasis|MP:0011087,neonatal lethality, complete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014409,decreased distortion product otoacoustic emission amplitude|MP:0020359,abnormal ribbon synapse morphology
MGI:6423831	Ror2<em1(IMPC)Mbp>	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0001711,abnormal placenta morphology|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:5315486	Ror2<tm1.2Meg>	MP:0000547,short limbs|MP:0003743,abnormal facial morphology|MP:0004073,caudal body truncation
MGI:3793279	Ror2<tm1Anec>	MP:0000088,short mandible|MP:0000102,abnormal nasal bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000154,rib fusion|MP:0000164,abnormal cartilage development|MP:0000445,short snout|MP:0000585,kinked tail|MP:0001153,small seminiferous tubules|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001349,excessive tearing|MP:0001922,reduced male fertility|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0002543,brachyphalangia|MP:0002544,brachydactyly|MP:0002687,oligozoospermia|MP:0002759,abnormal caudal vertebrae morphology|MP:0002896,abnormal bone mineralization|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003419,delayed endochondral bone ossification|MP:0003960,increased lean body mass|MP:0004173,abnormal intervertebral disk morphology|MP:0004471,short nasal bone|MP:0004472,broad nasal bone|MP:0004619,caudal vertebral fusion|MP:0004634,short metacarpal bones|MP:0004667,vertebral body hypoplasia|MP:0004852,decreased testis weight|MP:0005306,abnormal phalanx morphology|MP:0005371,limbs/digits/tail phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0006165,entropion|MP:0006212,large orbits|MP:0006279,abnormal limb development|MP:0006280,abnormal digit development|MP:0010025,decreased total body fat amount|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume
MGI:2386954	Ror2<tm1Gdy>	MP:0000111,cleft palate|MP:0000137,abnormal vertebrae morphology|MP:0000154,rib fusion|MP:0000445,short snout|MP:0000547,short limbs|MP:0000552,abnormal radius morphology|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0000592,short tail|MP:0002111,abnormal tail morphology|MP:0002113,abnormal skeleton development|MP:0002187,abnormal fibula morphology|MP:0002544,brachydactyly|MP:0002759,abnormal caudal vertebrae morphology|MP:0002764,short tibia|MP:0002765,short fibula|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003723,abnormal long bone morphology|MP:0003856,abnormal hindlimb stylopod morphology|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004471,short nasal bone|MP:0004652,small caudal vertebrae|MP:0004703,abnormal vertebral column morphology|MP:0004708,short lumbar vertebrae|MP:0005108,abnormal ulna morphology|MP:0005296,abnormal humerus morphology|MP:0005306,abnormal phalanx morphology|MP:0006279,abnormal limb development|MP:0006280,abnormal digit development|MP:0008272,abnormal endochondral bone ossification|MP:0011089,perinatal lethality, complete penetrance
MGI:2183225	Ror2<tm1Ymi>	MP:0000029,abnormal malleus morphology|MP:0000042,abnormal organ of Corti morphology|MP:0000060,delayed bone ossification|MP:0000088,short mandible|MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000163,abnormal cartilage morphology|MP:0000164,abnormal cartilage development|MP:0000438,abnormal cranium morphology|MP:0000441,increased cranium width|MP:0000454,abnormal jaw morphology|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0000562,polydactyly|MP:0000572,abnormal autopod morphology|MP:0000592,short tail|MP:0001300,ocular hypertelorism|MP:0001575,cyanosis|MP:0001688,abnormal somite development|MP:0001691,abnormal somite shape|MP:0001698,decreased embryo size|MP:0001954,respiratory distress|MP:0002109,abnormal limb morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002543,brachyphalangia|MP:0002544,brachydactyly|MP:0002622,abnormal cochlear hair cell morphology|MP:0002982,abnormal primordial germ cell migration|MP:0003050,abnormal sacral vertebrae morphology|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003854,abnormal forelimb stylopod morphology|MP:0003855,abnormal forelimb zeugopod morphology|MP:0003856,abnormal hindlimb stylopod morphology|MP:0003857,abnormal hindlimb zeugopod morphology|MP:0003935,abnormal craniofacial development|MP:0004110,transposition of great arteries|MP:0004355,short radius|MP:0004359,short ulna|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004595,abnormal mandibular condyloid process morphology|MP:0004596,abnormal mandibular angle morphology|MP:0004622,sacral vertebral fusion|MP:0004634,short metacarpal bones|MP:0004657,small sacral vertebrae|MP:0004686,decreased length of long bones|MP:0004726,abnormal nasal capsule morphology|MP:0005105,abnormal middle ear ossicle morphology|MP:0005222,abnormal somite size|MP:0005225,abnormal vertebrae development|MP:0005587,abnormal Meckel's cartilage morphology|MP:0008392,decreased primordial germ cell number|MP:0009642,abnormal blood homeostasis|MP:0009886,failure of palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0010418,perimembraneous ventricular septal defect|MP:0011087,neonatal lethality, complete penetrance|MP:0011772,genital tubercle hypoplasia|MP:0012062,small tail bud|MP:0012085,midface hypoplasia|MP:0013933,short Meckel's cartilage|MP:0014106,delayed chondrocyte differentiation|MP:0030321,abnormal tegmen tympani morphology
MGI:3719410	Ror2<Tn(pb-ZG-s)1.1Mrc>	MP:0000547,short limbs|MP:0000592,short tail|MP:0005508,abnormal skeleton morphology|MP:0009703,decreased birth body size
MGI:5305088	Ror2<Y324C>	MP:0001919,abnormal reproductive system physiology|MP:0002081,perinatal lethality|MP:0002982,abnormal primordial germ cell migration|MP:0006281,abnormal tail development|MP:0008392,decreased primordial germ cell number|MP:0008786,abnormal hindgut morphology|MP:0009768,impaired somite development|MP:0030935,increased primordial germ cell apoptosis
MGI:1857035	Rora<sg>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000250,abnormal vasoconstriction|MP:0000745,tremors|MP:0000819,abnormal olfactory bulb morphology|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000857,abnormal cerebellar foliation|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000884,delaminated Purkinje cell layer|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0000890,thin cerebellar molecular layer|MP:0001265,decreased body size|MP:0001386,abnormal maternal nurturing|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001463,abnormal spatial learning|MP:0001513,limb grasping|MP:0001613,abnormal vasodilation|MP:0001790,abnormal immune system physiology|MP:0001861,lung inflammation|MP:0001923,reduced female fertility|MP:0001927,abnormal estrous cycle|MP:0001984,abnormal olfaction|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002118,abnormal lipid homeostasis|MP:0002152,abnormal brain morphology|MP:0002161,abnormal fertility/fecundity|MP:0002277,abnormal respiratory mucosa morphology|MP:0002333,abnormal lung compliance|MP:0002451,abnormal macrophage physiology|MP:0002497,increased IgE level|MP:0002566,abnormal sexual interaction|MP:0002722,abnormal immune system organ morphology|MP:0002741,small olfactory bulb|MP:0002804,abnormal motor learning|MP:0003126,abnormal external female genitalia morphology|MP:0003633,abnormal nervous system physiology|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0003684,abnormal inferior olivary complex morphology|MP:0003699,abnormal female reproductive system physiology|MP:0003953,abnormal hormone level|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004263,abnormal limb posture|MP:0004494,abnormal synaptic glutamate release|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005179,decreased circulating cholesterol level|MP:0005338,atherosclerotic lesions|MP:0005339,increased susceptibility to atherosclerosis|MP:0005387,immune system phenotype|MP:0005394,taste/olfaction phenotype|MP:0005601,increased angiogenesis|MP:0006099,thin cerebellar granule layer|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008579,abnormal Purkinje cell differentiation|MP:0008651,increased interleukin-1 secretion|MP:0008924,decreased cerebellar granule cell number|MP:0009008,delayed estrous cycle|MP:0009017,prolonged estrus|MP:0009020,prolonged metestrus|MP:0009942,abnormal olfactory bulb granule cell morphology|MP:0009946,abnormal olfactory bulb layer morphology|MP:0009947,abnormal olfactory bulb external plexiform layer morphology|MP:0009948,abnormal olfactory bulb glomerular layer morphology|MP:0009949,abnormal olfactory bulb granule cell layer morphology|MP:0009950,abnormal olfactory bulb internal plexiform layer morphology|MP:0009951,abnormal olfactory bulb mitral cell layer morphology|MP:0009956,abnormal cerebellar layer morphology|MP:0009979,abnormal cerebellum deep nucleus morphology|MP:0010053,decreased grip strength|MP:0010057,abnormal olfactory bulb outer nerve layer morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012490,abnormal cochlear VIII nucleus morphology|MP:0012575,increased noradrenaline level|MP:0014327,decreased Purkinje cell size|MP:0030636,decreased taurine level|MP:0030733,decreased gamma-aminobutyric acid level|MP:0030743,decreased aspartic acid level
MGI:3054679	Rora<sg-3J>	MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0001265,decreased body size|MP:0001523,impaired righting response|MP:0001524,impaired limb coordination|MP:0001525,impaired balance
MGI:5548347	Rora<tm1b(EUCOMM)Wtsi>	MP:0001489,decreased startle reflex|MP:0002968,increased circulating alkaline phosphatase level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6256736	Rora<tm1c(EUCOMM)Wtsi>	MP:0008245,abnormal alveolar macrophage morphology|MP:0008719,impaired neutrophil recruitment
MGI:1926597	Rora<tm1Mba>	MP:0000408,absent duvet hair|MP:0000416,sparse hair|MP:0000424,retarded hair growth|MP:0000852,small cerebellum|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000876,Purkinje cell degeneration|MP:0000880,decreased Purkinje cell number|MP:0000885,ectopic Purkinje cell|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002804,abnormal motor learning|MP:0002910,abnormal excitatory postsynaptic currents|MP:0006099,thin cerebellar granule layer|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0009958,absent cerebellar granule cells|MP:0010053,decreased grip strength|MP:0011084,lethality at weaning, incomplete penetrance
MGI:1933211	Rora<tm1Vgi>	MP:0000745,tremors|MP:0000852,small cerebellum|MP:0000880,decreased Purkinje cell number|MP:0000885,ectopic Purkinje cell|MP:0001525,impaired balance|MP:0011085,postnatal lethality, complete penetrance
MGI:2670437	Rora<tmgc26>	MP:0000755,hindlimb paralysis|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0000885,ectopic Purkinje cell|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000888,absent cerebellar granule layer|MP:0000889,abnormal cerebellar molecular layer|MP:0000890,thin cerebellar molecular layer|MP:0001393,ataxia|MP:0002762,ectopic cerebellar granule cells|MP:0003648,abnormal radial glial cell morphology|MP:0004101,abnormal brain interneuron morphology|MP:0008924,decreased cerebellar granule cell number|MP:0009719,reduced cerebellar foliation|MP:0009967,abnormal neuron proliferation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013551,decreased cerebellar granule cell precursor proliferation|MP:0014327,decreased Purkinje cell size
MGI:3846436	Rorb<hstp>	MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002882,abnormal neuron morphology|MP:0005241,abnormal retina ganglion layer morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology|MP:0008450,retina photoreceptor degeneration|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:7495931	Rorb<hstp-2J>	MP:0001328,disorganized retina layers|MP:0001406,abnormal gait|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0008448,abnormal retina cone cell inner segment morphology|MP:0008449,abnormal retina cone cell outer segment morphology|MP:0008581,disorganized photoreceptor inner segment|MP:0008586,disorganized photoreceptor outer segment
MGI:7495932	Rorb<hstp-3J>	MP:0001406,abnormal gait|MP:0005391,vision/eye phenotype
MGI:7496018	Rorb<hstp-4J>	MP:0001406,abnormal gait|MP:0005391,vision/eye phenotype
MGI:3835752	Rorb<m1Btlr>	MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001925,male infertility
MGI:5640755	Rorb<m2Btlr>	MP:0001524,impaired limb coordination
MGI:6114739	Rorb<m3Btlr>	MP:0001406,abnormal gait|MP:0001524,impaired limb coordination
MGI:5507855	Rorb<tm1.1(cre)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5548298	Rorb<tm1.1Df>	MP:0001406,abnormal gait|MP:0002983,increased retina ganglion cell number|MP:0003734,abnormal retina inner plexiform layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005391,vision/eye phenotype|MP:0006095,absent amacrine cells|MP:0008056,abnormal retina ganglion cell morphology|MP:0008107,absent retina horizontal cells|MP:0008445,increased retina cone cell number|MP:0008453,decreased retina rod cell number|MP:0008511,thin retina inner nuclear layer|MP:0008520,disorganized retina outer plexiform layer|MP:0009772,abnormal retina development
MGI:2158692	Rorb<tm1Mba>	MP:0001265,decreased body size|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0001328,disorganized retina layers|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0002063,abnormal learning/memory/conditioning|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002566,abnormal sexual interaction|MP:0003631,nervous system phenotype|MP:0003734,abnormal retina inner plexiform layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005253,abnormal eye physiology|MP:0005386,behavior/neurological phenotype|MP:0005656,decreased aggression|MP:0006095,absent amacrine cells|MP:0008107,absent retina horizontal cells|MP:0008445,increased retina cone cell number|MP:0008454,absent retina rod cells|MP:0008520,disorganized retina outer plexiform layer|MP:0008583,absent photoreceptor inner segment|MP:0008585,absent photoreceptor outer segment
MGI:5905301	Rorb<tm2.1Df>	MP:0001006,abnormal retina cone cell morphology|MP:0005391,vision/eye phenotype|MP:0008445,increased retina cone cell number|MP:0008453,decreased retina rod cell number
MGI:5523975	Rorc<m1Btlr>	MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:5615712	Rorc<m2Btlr>	MP:0001806,decreased IgM level|MP:0020001,decreased response to antigen|MP:0020154,impaired humoral immune response
MGI:5789592	Rorc<m3Btlr>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008167,increased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0008207,decreased B-2 B cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0020001,decreased response to antigen|MP:0020154,impaired humoral immune response
MGI:6095621	Rorc<tm1.1Zsun>	MP:0002831,absent Peyer's patches|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0009624,small inguinal lymph nodes|MP:0010221,abnormal T-helper 17 cell differentiation
MGI:2386114	Rorc<tm1Amj>	MP:0000691,enlarged spleen|MP:0001823,thymus hypoplasia|MP:0002444,abnormal T cell physiology|MP:0002450,abnormal lymph organ development|MP:0002831,absent Peyer's patches|MP:0004956,decreased thymus weight|MP:0005018,decreased T cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0006413,increased T cell apoptosis|MP:0008024,absent lymph nodes|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008751,abnormal interleukin level|MP:0008826,abnormal splenic cell ratio
MGI:2384142	Rorc<tm1Litt>	MP:0000495,abnormal colon morphology|MP:0000715,decreased thymocyte number|MP:0001263,weight loss|MP:0001652,colonic necrosis|MP:0002145,abnormal T cell differentiation|MP:0002412,increased susceptibility to bacterial infection|MP:0002816,colitis|MP:0003077,abnormal cell cycle|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005092,decreased double-positive T cell number|MP:0008024,absent lymph nodes|MP:0008037,abnormal T cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0009541,increased thymocyte apoptosis|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010221,abnormal T-helper 17 cell differentiation
MGI:3026635	Rorc<tm2Litt>	MP:0002378,abnormal gut-associated lymphoid tissue morphology|MP:0002450,abnormal lymph organ development|MP:0002831,absent Peyer's patches|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008024,absent lymph nodes|MP:0008045,decreased NK cell number|MP:0008400,abnormal CD4-positive, alpha-beta intraepithelial T cell morphology|MP:0008401,abnormal CD8 positive, alpha-beta intraepithelial T cell morphology|MP:0009541,increased thymocyte apoptosis
MGI:6460274	Ros1<em1Osb>	MP:0001925,male infertility|MP:0004935,epididymis degeneration|MP:0030978,impaired binding of sperm to zona pellucida
MGI:5500177	Ros1<tm1.1Char>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0004933,abnormal epididymis epithelium morphology|MP:0009243,hairpin sperm flagellum|MP:0020451,decreased sperm progressive motility
MGI:2450566	Ros1<tm1Cbm>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002631,abnormal epididymis morphology|MP:0002660,abnormal caput epididymis morphology|MP:0002675,asthenozoospermia|MP:0004933,abnormal epididymis epithelium morphology|MP:0005389,reproductive system phenotype|MP:0009243,hairpin sperm flagellum|MP:0009248,small caput epididymis|MP:0031012,impaired sperm migration in female genital tract
MGI:2450662	Ros1<tm2Cbm>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002631,abnormal epididymis morphology|MP:0002660,abnormal caput epididymis morphology|MP:0004933,abnormal epididymis epithelium morphology|MP:0005389,reproductive system phenotype|MP:0009248,small caput epididymis|MP:0031012,impaired sperm migration in female genital tract
MGI:3716487	Rosq1<DBA/1J>	MP:0002463,abnormal neutrophil physiology
MGI:4354082	Rp1l1<tm1Jnz>	MP:0001325,abnormal retina morphology|MP:0001327,decreased retina photoreceptor cell number|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008451,retina rod cell degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment
MGI:5604910	Rp1<m1Jdun>	MP:0001004,abnormal retina photoreceptor morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008581,disorganized photoreceptor inner segment|MP:0008582,short photoreceptor inner segment|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:3652902	Rp1<tm1Eap>	MP:0001004,abnormal retina photoreceptor morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008515,thin retina outer nuclear layer|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:2179129	Rp1<tm1Jnz>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001327,decreased retina photoreceptor cell number|MP:0002864,abnormal ocular fundus morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0005253,abnormal eye physiology|MP:0008444,retina cone cell degeneration
MGI:5463924	Rp1<tm2.1Eap>	MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0006069,abnormal retina neuronal layer morphology|MP:0008515,thin retina outer nuclear layer
MGI:4867393	Rp1<tvrm64>	MP:0002792,abnormal retina vasculature morphology|MP:0002864,abnormal ocular fundus morphology|MP:0005391,vision/eye phenotype|MP:0008450,retina photoreceptor degeneration|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment
MGI:4874654	Rp2<Gt(EUCJ0183f04)Hmgu>	MP:0002090,abnormal vision|MP:0005253,abnormal eye physiology|MP:0012029,abnormal electroretinogram waveform feature|MP:0012031,abnormal b-wave amplitude|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:5613810	Rp2<tm1.1Asw>	MP:0005391,vision/eye phenotype
MGI:5619358	Rp2<tm1.2Asw>	MP:0001004,abnormal retina photoreceptor morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005391,vision/eye phenotype|MP:0008446,decreased retina cone cell number|MP:0008515,thin retina outer nuclear layer|MP:0008586,disorganized photoreceptor outer segment|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:5708236	Rp9<tm1b(EUCOMM)Wtsi>	MP:0001120,abnormal uterus morphology|MP:0001258,decreased body length|MP:0002941,increased circulating alanine transaminase level|MP:0009142,decreased prepulse inhibition|MP:0009709,hydrometra
MGI:5446173	Rpa1<tm1b(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0002590,increased mean corpuscular volume|MP:0002702,decreased circulating free fatty acids level|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3582609	Rpa1<tm1Wed>	MP:0000352,decreased cell proliferation|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0004028,chromosome breakage|MP:0005013,increased lymphocyte cell number|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012431,increased lymphoma incidence
MGI:5911998	Rpain<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response|MP:0005028,abnormal trophectoderm morphology|MP:0010053,decreased grip strength|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6158491	Rpap3<em1(IMPC)Mbp>	MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7310425	Rpap3<tm1c(KOMP)Wtsi>	MP:0000479,abnormal enterocyte morphology|MP:0000496,abnormal small intestine morphology|MP:0001263,weight loss|MP:0002169,no abnormal phenotype detected|MP:0003306,small intestinal inflammation|MP:0013792,abnormal small intestine goblet cell morphology|MP:0013958,decreased small intestine length|MP:0014201,abnormal intestinal epithelium physiology
MGI:3702572	Rpe65<450L>	MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration
MGI:2680347	Rpe65<450M>	MP:0005253,abnormal eye physiology
MGI:2388240	Rpe65<rd12>	MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0008515,thin retina outer nuclear layer|MP:0012671,retina spots|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:7614412	Rpe65<rd12-2J>	MP:0001326,retina degeneration|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0012143,decreased a-wave amplitude|MP:0012149,decreased b-wave implicit time|MP:0012671,retina spots
MGI:4436481	Rpe65<tm1a(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0001317,abnormal pupil morphology|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001513,limb grasping
MGI:3771723	Rpe65<tm1Lrcb>	MP:0003011,delayed dark adaptation|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0008518,retina outer nuclear layer degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0011233,abnormal vitamin A metabolism
MGI:2181399	Rpe65<tm1Tmr>	MP:0001326,retina degeneration|MP:0004021,abnormal rod electrophysiology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005253,abnormal eye physiology|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0011233,abnormal vitamin A metabolism|MP:0012671,retina spots
MGI:4867394	Rpe65<tvrm148>	MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005103,abnormal retina pigmentation|MP:0008450,retina photoreceptor degeneration|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment|MP:0012671,retina spots
MGI:6152628	Rpe<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002188,small heart|MP:0003068,enlarged kidney|MP:0004906,enlarged uterus|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:4432510	Rpgrip1l<tm1a(EUCOMM)Wtsi>	MP:0000026,abnormal inner ear morphology|MP:0000079,abnormal basioccipital bone morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0000111,cleft palate|MP:0000141,abnormal vertebral body morphology|MP:0000150,abnormal rib morphology|MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000455,abnormal maxilla morphology|MP:0000562,polydactyly|MP:0000602,dilated liver sinusoidal space|MP:0000632,abnormal pineal gland morphology|MP:0000690,absent spleen|MP:0000694,spleen hypoplasia|MP:0000783,abnormal forebrain morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000841,abnormal hindbrain morphology|MP:0000897,abnormal midbrain morphology|MP:0000964,small dorsal root ganglion|MP:0001014,absent superior cervical ganglion|MP:0001015,small superior cervical ganglion|MP:0001062,absent oculomotor nerve|MP:0001075,abnormal accessory nerve morphology|MP:0001146,abnormal testis morphology|MP:0001293,anophthalmia|MP:0001711,abnormal placenta morphology|MP:0002237,abnormal nasal cavity morphology|MP:0002239,abnormal nasal septum morphology|MP:0003056,abnormal hyoid bone morphology|MP:0003178,left pulmonary isomerism|MP:0003327,liver cyst|MP:0003451,absent olfactory bulb|MP:0003584,bifid ureter|MP:0003686,abnormal eye muscle morphology|MP:0003755,abnormal palate morphology|MP:0003888,liver hemorrhage|MP:0004110,transposition of great arteries|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0004181,abnormal carotid artery morphology|MP:0004259,small placenta|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004613,fusion of vertebral arches|MP:0004668,absent vertebral body|MP:0004950,abnormal brain vasculature morphology|MP:0005157,holoprosencephaly|MP:0005170,cleft upper lip|MP:0005358,abnormal incisor morphology|MP:0006065,abnormal heart position or orientation|MP:0008129,absent brain internal capsule|MP:0008320,absent adenohypophysis|MP:0008461,left atrial isomerism|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0008923,thoracoschisis|MP:0009526,absent sublingual gland|MP:0009570,abnormal right lung morphology|MP:0009771,absent optic chiasm|MP:0009907,decreased tongue size|MP:0010403,atrial septal defect|MP:0010406,common atrium|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010427,double outlet left ventricle|MP:0010431,atrial situs inversus|MP:0010440,anomalous pulmonary venous connection|MP:0010490,abnormal inferior vena cava valve morphology|MP:0010572,persistent right dorsal aorta|MP:0011100,preweaning lethality, complete penetrance|MP:0011250,abdominal situs ambiguus|MP:0012730,abnormal internal carotid artery morphology|MP:0013186,abnormal basilar artery morphology|MP:0013247,placenta necrosis|MP:0013828,thin facial nerve|MP:0013830,abnormal intrathoracic topology of vagus nerve|MP:0013834,thin hypoglossal nerve|MP:0013835,absent hypoglossal nerve|MP:0013836,abnormal hypoglossal nerve topology|MP:0013840,absent segment of posterior cerebral artery|MP:0013848,subcutaneous edema|MP:0013852,abnormal Mullerian duct topology|MP:0013853,abnormal hepatic portal vein formation|MP:0013858,abnormal azygos vein topology|MP:0013859,abnormal vitelline vein connection|MP:0013861,abnormal pancreas topology|MP:0013867,abnormal ventral pancreas morphology|MP:0013876,absent ductus venosus valve|MP:0013878,abnormal ductus venosus valve topology|MP:0013914,absent intracranial segment of vertebral artery|MP:0013917,persistent right 6th pharyngeal arch artery|MP:0013928,thin motoric part of trigeminal nerve|MP:0013952,retroesophageal left subclavian artery|MP:0013970,absent connection between subcutaneous lymph vessels and lymph sac|MP:0013975,abnormal coronary sinus connection|MP:0013977,symmetric azygos veins|MP:0013979,abnormal subclavian artery origin|MP:0013982,inverse situs of great intrathoracic arteries|MP:0013985,abnormal umbilical vein topology|MP:0013987,absent intrahepatic inferior vena cava segment|MP:0013996,abnormal vertebral artery origin|MP:0013997,abnormal internal carotid artery topology|MP:0013998,absent canalicular internal carotid artery segment|MP:0013999,absent parasellar internal carotid artery|MP:0014000,anastomosis between internal carotid artery and basilar artery|MP:0014012,abnormal cranial blood vasculature morphology|MP:0014021,heterochrony|MP:0014023,abnormal intestine placement|MP:0020485,abnormal inferior vena cava topology|MP:0030975,placenta hemorrhage
MGI:3716208	Rpgrip1l<tm1Urt>	MP:0000291,enlarged pericardium|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0000460,mandible hypoplasia|MP:0000644,dextrocardia|MP:0000781,decreased corpus callosum size|MP:0000783,abnormal forebrain morphology|MP:0000851,cerebellum hypoplasia|MP:0000914,exencephaly|MP:0000926,absent floor plate|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001706,abnormal left-right axis patterning|MP:0002151,abnormal neural tube morphology|MP:0002196,absent corpus callosum|MP:0002741,small olfactory bulb|MP:0002929,abnormal bile duct development|MP:0003178,left pulmonary isomerism|MP:0003333,liver fibrosis|MP:0003451,absent olfactory bulb|MP:0004133,heterotaxia|MP:0004574,broad limb buds|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005170,cleft upper lip|MP:0005274,abnormal viscerocranium morphology|MP:0005650,abnormal limb bud morphology|MP:0009743,preaxial polydactyly|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011759,absent Rathke's pouch|MP:0012676,dilated brain ventricle|MP:0013349,small Rathke's pouch
MGI:5792096	Rpgrip1<mpc269H>	MP:0001326,retina degeneration
MGI:3511348	Rpgrip1<nmf247>	MP:0003381,vitreal fibroplasia|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008582,short photoreceptor inner segment|MP:0008585,absent photoreceptor outer segment|MP:0012671,retina spots
MGI:2655714	Rpgrip1<tm1Tili>	MP:0001326,retina degeneration|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008450,retina photoreceptor degeneration
MGI:5810760	Rpgrip1<tvrm111>	MP:0008586,disorganized photoreceptor outer segment|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:3511481	Rpgr<Rd9>	MP:0001006,abnormal retina cone cell morphology|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0002792,abnormal retina vasculature morphology|MP:0002864,abnormal ocular fundus morphology|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0004022,abnormal cone electrophysiology|MP:0004175,telangiectasia|MP:0005103,abnormal retina pigmentation|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:5610131	Rpgr<tm1.1Sgj>	MP:0001326,retina degeneration|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008515,thin retina outer nuclear layer
MGI:2386674	Rpgr<tm1Tili>	MP:0001006,abnormal retina cone cell morphology|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0002864,abnormal ocular fundus morphology|MP:0005253,abnormal eye physiology|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment
MGI:4458091	Rpgr<tm1Wbrg>	MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005391,vision/eye phenotype|MP:0008446,decreased retina cone cell number|MP:0008515,thin retina outer nuclear layer
MGI:3051976	Rph3al<tm1Sse>	MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0009161,pancreatic acinar cell zymogen granule accumulation
MGI:2179730	Rph3a<tm1Sud>	MP:0002169,no abnormal phenotype detected
MGI:4364474	Rpia<tm1a(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0003442,decreased circulating glycerol level|MP:0011100,preweaning lethality, complete penetrance
MGI:7385085	Rpl10a<em1Mbar>	MP:0011092,embryonic lethality, complete penetrance
MGI:7385086	Rpl10a<em2Mbar>	MP:0000163,abnormal cartilage morphology|MP:0000552,abnormal radius morphology|MP:0000565,oligodactyly|MP:0001614,abnormal blood vessel morphology|MP:0001691,abnormal somite shape|MP:0001785,edema|MP:0002152,abnormal brain morphology|MP:0004073,caudal body truncation|MP:0004609,vertebral fusion|MP:0004624,abnormal thoracic cage morphology|MP:0005229,abnormal intervertebral disk development|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0012173,short rostral-caudal axis
MGI:7385087	Rpl10a<tm1c(EUCOMM)Hmgu>	MP:0005380,embryo phenotype
MGI:7385088	Rpl10a<tm1d(EUCOMM)Hmgu>	MP:0011092,embryonic lethality, complete penetrance
MGI:6865773	Rpl10l<em1Qsh>	MP:0001925,male infertility|MP:0001940,testis hypoplasia|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:6865774	Rpl10l<em2Qsh>	MP:0001940,testis hypoplasia
MGI:6510292	Rpl11<tm1.1Srn>	MP:0000245,abnormal erythropoiesis|MP:0000248,macrocytosis|MP:0000477,abnormal intestine morphology|MP:0001577,anemia|MP:0001658,increased mortality induced by gamma-irradiation|MP:0002083,premature death|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002416,abnormal proerythroblast morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0008807,increased liver iron level|MP:0011091,prenatal lethality, complete penetrance|MP:0011179,decreased erythroblast number
MGI:6152629	Rpl12<em1(IMPC)Mbp>	MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001157,small seminal vesicle|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0003068,enlarged kidney|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5816858	Rpl13a<tm1.1Jesc>	MP:0000188,abnormal circulating glucose level|MP:0003058,increased insulin secretion|MP:0003186,abnormal redox activity|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0010959,abnormal oxidative phosphorylation
MGI:5502322	Rpl13a<tm1.1Mazu>	MP:0001175,abnormal lung morphology|MP:0001402,decreased locomotor activity|MP:0002083,premature death|MP:0005343,increased circulating aspartate transaminase level|MP:0005426,tachypnea|MP:0005565,increased blood urea nitrogen level|MP:0008553,increased circulating tumor necrosis factor level|MP:0008713,abnormal cytokine level|MP:0010760,abnormal macrophage chemotaxis
MGI:3804429	Rpl22<Gt(GST000137)Lex>	MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002743,glomerulonephritis|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0006387,abnormal T cell number|MP:0006413,increased T cell apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3870024	Rpl22<Gt(YHB332)Byg>	MP:0000704,abnormal thymus development|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005378,growth/size/body region phenotype
MGI:6121072	Rpl22l1<tm1.1Psam>	MP:0001672,abnormal embryo development|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4355967	Rpl22<tm1.1Psam>	MP:0002169,no abnormal phenotype detected
MGI:4355968	Rpl22<tm1.2Psam>	MP:0002169,no abnormal phenotype detected
MGI:1856685	Rpl24<Bst>	MP:0000373,belly spot|MP:0000562,polydactyly|MP:0000585,kinked tail|MP:0000592,short tail|MP:0000914,exencephaly|MP:0001059,optic nerve atrophy|MP:0001262,decreased body weight|MP:0001286,abnormal eye development|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001330,abnormal optic nerve morphology|MP:0001333,absent optic nerve|MP:0001539,decreased caudal vertebrae number|MP:0001698,decreased embryo size|MP:0002110,abnormal digit morphology|MP:0002697,abnormal eye size|MP:0002938,white spotting|MP:0002984,retina hypoplasia|MP:0003077,abnormal cell cycle|MP:0003099,retina detachment|MP:0003711,pathological neovascularization|MP:0003727,abnormal retina layer morphology|MP:0003734,abnormal retina inner plexiform layer morphology|MP:0004269,abnormal optic cup morphology|MP:0004619,caudal vertebral fusion|MP:0004650,increased lumbar vertebrae number|MP:0005241,abnormal retina ganglion layer morphology|MP:0005621,abnormal cell physiology|MP:0006069,abnormal retina neuronal layer morphology|MP:0006071,abnormal retina progenitor cell morphology|MP:0006221,optic nerve hypoplasia|MP:0006243,impaired pupillary reflex|MP:0006309,decreased retina ganglion cell number|MP:0008507,thin retina ganglion layer|MP:0008511,thin retina inner nuclear layer|MP:0008512,disorganized retina inner nuclear layer|MP:0008516,disorganized retina outer nuclear layer|MP:0008852,retina neovascularization|MP:0010717,optic nerve coloboma|MP:0011091,prenatal lethality, complete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0012536,delayed optic fissure closure|MP:0021107,retina fold
MGI:8255293	Rpl26<em1Yuehu>	MP:0001260,increased body weight|MP:0001552,increased circulating triglyceride level|MP:0005178,increased circulating cholesterol level|MP:0005370,liver/biliary system phenotype|MP:0010087,increased circulating fructosamine level|MP:0014242,abnormal ribosome biogenesis|MP:0031269,increased susceptibility to diet-induced hepatic steatosis
MGI:5140351	Rpl27a<Sfa>	MP:0000221,decreased leukocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0000575,increased foot pad pigmentation|MP:0000692,small spleen|MP:0000706,small thymus|MP:0000852,small cerebellum|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000873,thin external granule cell layer|MP:0000877,abnormal Purkinje cell morphology|MP:0000885,ectopic Purkinje cell|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001188,hyperpigmentation|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001577,anemia|MP:0001658,increased mortality induced by gamma-irradiation|MP:0001732,postnatal growth retardation|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0004810,decreased hematopoietic stem cell number|MP:0005152,pancytopenia|MP:0008924,decreased cerebellar granule cell number|MP:0009278,abnormal bone marrow cell physiology|MP:0009388,abnormal epidermal melanocyte morphology|MP:0009956,abnormal cerebellar layer morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011182,decreased hematopoietic cell number|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation|MP:0011902,increased hematopoietic stem cell proliferation
MGI:3696667	Rpl29<tm1Udel>	MP:0000060,delayed bone ossification|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001938,delayed sexual maturation|MP:0003077,abnormal cell cycle|MP:0003984,embryonic growth retardation|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:3696668	Rpl29<tm2Udel>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4948266	Rpl31<Dts>	MP:0000585,kinked tail|MP:0000592,short tail|MP:0001146,abnormal testis morphology|MP:0001891,hydrocephaly
MGI:5755291	Rpl31<Dts-2J>	MP:0000585,kinked tail|MP:0000592,short tail
MGI:5692914	Rpl32<tm1b(EUCOMM)Hmgu>	MP:0010067,increased red blood cell distribution width
MGI:2447994	Rpl38<Rbt>	MP:0000150,abnormal rib morphology|MP:0000438,abnormal cranium morphology|MP:0000480,increased rib number|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0003036,vertebral transformation|MP:0003048,abnormal cervical vertebrae morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004600,abnormal vertebral transverse process morphology|MP:0004601,abnormal vertebral spinous process morphology|MP:0004604,abnormal vertebral pedicle morphology|MP:0004605,abnormal vertebral lamina morphology|MP:0004607,abnormal cervical atlas morphology|MP:0004614,caudal vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004617,sacral vertebral transformation|MP:0004620,cervical vertebral fusion|MP:0008146,asymmetric sternocostal joints|MP:0010768,mortality/aging|MP:0011091,prenatal lethality, complete penetrance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1861228	Rpl38<Ts>	MP:0000049,abnormal middle ear morphology|MP:0000102,abnormal nasal bone morphology|MP:0000154,rib fusion|MP:0000267,abnormal heart development|MP:0000372,irregular coat pigmentation|MP:0000373,belly spot|MP:0000441,increased cranium width|MP:0000445,short snout|MP:0000480,increased rib number|MP:0000550,abnormal forelimb morphology|MP:0000562,polydactyly|MP:0000565,oligodactyly|MP:0000572,abnormal autopod morphology|MP:0000585,kinked tail|MP:0000592,short tail|MP:0000819,abnormal olfactory bulb morphology|MP:0000928,incomplete rostral neuropore closure|MP:0000930,wavy neural tube|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001539,decreased caudal vertebrae number|MP:0001566,increased circulating phosphate level|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0001850,increased susceptibility to otitis media|MP:0001890,anencephaly|MP:0001921,reduced fertility|MP:0001963,abnormal hearing physiology|MP:0002110,abnormal digit morphology|MP:0002151,abnormal neural tube morphology|MP:0002237,abnormal nasal cavity morphology|MP:0002663,absent blastocoele|MP:0002764,short tibia|MP:0002825,abnormal notochord morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0003051,curly tail|MP:0003052,omphalocele|MP:0003054,spina bifida|MP:0003072,abnormal metatarsal bone morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0003109,short femur|MP:0003208,abnormal neuromere morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0003330,abnormal auditory tube morphology|MP:0003456,absent tail|MP:0003984,embryonic growth retardation|MP:0004229,abnormal embryonic erythropoiesis|MP:0004322,abnormal sternebra morphology|MP:0004351,short humerus|MP:0004355,short radius|MP:0004479,abnormal oval window morphology|MP:0004480,abnormal round window morphology|MP:0004609,vertebral fusion|MP:0004619,caudal vertebral fusion|MP:0004651,increased thoracic vertebrae number|MP:0004652,small caudal vertebrae|MP:0004653,absent caudal vertebrae|MP:0004686,decreased length of long bones|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004739,conductive hearing loss|MP:0004957,abnormal blastocyst morphology|MP:0004963,abnormal blastocoele morphology|MP:0005225,abnormal vertebrae development|MP:0005296,abnormal humerus morphology|MP:0005397,hematopoietic system phenotype|MP:0008525,decreased cranium height|MP:0008830,abnormal nucleolus morphology|MP:0009781,abnormal preimplantation embryo development|MP:0010082,sternebra fusion|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011103,embryonic lethality at implantation, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012284,increased sternebra number
MGI:1859977	Rpl38<Tss>	MP:0000111,cleft palate|MP:0000562,polydactyly|MP:0000565,oligodactyly|MP:0000585,kinked tail|MP:0000592,short tail|MP:0000757,herniated abdominal wall|MP:0000914,exencephaly|MP:0002111,abnormal tail morphology|MP:0003051,curly tail|MP:0005170,cleft upper lip|MP:0011092,embryonic lethality, complete penetrance
MGI:6857773	Rpl39l<em1Hqi>	MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0002685,abnormal spermatogonia proliferation|MP:0002687,oligozoospermia|MP:0003674,oxidative stress|MP:0004543,abnormal sperm physiology|MP:0004852,decreased testis weight|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0013601,increased testis apoptosis|MP:0014617,decreased spermatogonia number|MP:0020362,abnormal male germ cell physiology
MGI:7471434	Rpl3<em1Kei>	MP:0011091,prenatal lethality, complete penetrance
MGI:7434982	Rpl3l<em1Jmol>	MP:0002188,small heart|MP:0002834,decreased heart weight|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype
MGI:7471435	Rpl3l<em1Kei>	MP:0002972,abnormal cardiac muscle contractility|MP:0005378,growth/size/body region phenotype|MP:0011925,abnormal heart echocardiography feature
MGI:3046775	Rpl5<Skax23-Jus>	MP:0000284,double outlet right ventricle|MP:0000585,kinked tail|MP:0000600,liver hypoplasia|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002416,abnormal proerythroblast morphology|MP:0002811,macrocytic anemia|MP:0002874,decreased hemoglobin content|MP:0003051,curly tail|MP:0003109,short femur|MP:0003179,thrombocytopenia|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004201,fetal growth retardation|MP:0005152,pancytopenia|MP:0005382,craniofacial phenotype|MP:0009703,decreased birth body size|MP:0010114,abnormal coccyx morphology|MP:0010402,ventricular septal defect|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011862,decreased cranium length
MGI:6363222	Rpl5<tm1Itl>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5692656	Rpl7l1<tm2b(EUCOMM)Hmgu>	MP:0000367,abnormal coat/ hair morphology|MP:0001510,abnormal coat appearance|MP:0011100,preweaning lethality, complete penetrance|MP:0011960,abnormal eye anterior chamber depth|MP:0013292,embryonic lethality prior to organogenesis
MGI:3045767	Rplag<FVB/NJ>	MP:0005464,abnormal platelet physiology
MGI:4432779	Rpn2<tm1a(EUCOMM)Wtsi>	MP:0001554,increased circulating free fatty acids level|MP:0003442,decreased circulating glycerol level|MP:0003443,increased circulating glycerol level|MP:0011100,preweaning lethality, complete penetrance
MGI:4435125	Rprd1b<tm1a(EUCOMM)Hmgu>	MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:6818638	Rprd1b<tm1Tshu>	MP:0001262,decreased body weight|MP:0001792,impaired wound healing|MP:0003119,abnormal digestive system development|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005381,digestive/alimentary phenotype|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013298,increased susceptibility to colitis induced morbidity/mortality|MP:0013486,decreased Paneth cell number|MP:0013792,abnormal small intestine goblet cell morphology|MP:0013793,abnormal large intestine goblet cell morphology|MP:0031319,impaired intestine regeneration
MGI:6189568	Rprd2<em1(IMPC)J>	MP:0000266,abnormal heart morphology|MP:0000928,incomplete rostral neuropore closure|MP:0001392,abnormal locomotor behavior|MP:0001701,incomplete embryo turning|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002824,abnormal chorioallantoic fusion|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0004180,failure of initiation of embryo turning|MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011199,abnormal amniotic cavity morphology|MP:0011495,abnormal head shape|MP:0012099,decreased spongiotrophoblast size|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:8260983	Rprm<em2Gpt>	MP:0003010,decreased mortality induced by ionizing radiation|MP:0004503,decreased incidence of tumors by ionizing radiation induction|MP:0010181,decreased susceptibility to weight loss
MGI:7521935	Rps12<em1.1Nbakr>	MP:0000221,decreased leukocyte cell number|MP:0000245,abnormal erythropoiesis|MP:0000333,decreased bone marrow cell number|MP:0000575,increased foot pad pigmentation|MP:0000585,kinked tail|MP:0001262,decreased body weight|MP:0001698,decreased embryo size|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0004810,decreased hematopoietic stem cell number|MP:0004953,decreased spleen weight|MP:0005152,pancytopenia|MP:0008028,pregnancy-related premature death|MP:0008973,decreased erythroid progenitor cell number|MP:0009429,decreased embryo weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011176,abnormal erythroblast morphology|MP:0011179,decreased erythroblast number|MP:0011901,abnormal hematopoietic stem cell proliferation
MGI:6152630	Rps12<em1(IMPC)Mbp>	MP:0011100,preweaning lethality, complete penetrance
MGI:6388411	Rps12<em1Nbakr>	MP:0004810,decreased hematopoietic stem cell number|MP:0005152,pancytopenia
MGI:3047792	Rps12-ps1/Xist<tm1.1Nbd>	MP:0005384,cellular phenotype
MGI:3047793	Rps12-ps1/Xist<tm1.1Nbd>	MP:0005384,cellular phenotype
MGI:3047790	Rps12-ps1/Xist<tm1Nbd>	MP:0005384,cellular phenotype
MGI:3047791	Rps12-ps1/Xist<tm1Nbd>	MP:0005384,cellular phenotype
MGI:6147818	Rps14<tm1.1Ble>	MP:0000691,enlarged spleen|MP:0001606,impaired hematopoiesis|MP:0002397,abnormal bone marrow morphology|MP:0002417,abnormal megakaryocyte morphology|MP:0003077,abnormal cell cycle|MP:0003405,abnormal platelet shape|MP:0005397,hematopoietic system phenotype|MP:0005505,thrombocytosis|MP:0006042,increased apoptosis|MP:0008801,abnormal erythroid progenitor cell morphology|MP:0009278,abnormal bone marrow cell physiology|MP:0013272,abnormal translation|MP:0030927,decreased telomere length
MGI:4410386	Rps18<GT(RNA1)Whk>	MP:0002169,no abnormal phenotype detected
MGI:5617789	Rps19bp1<tm1.1(KOMP)Wtsi>	MP:0000689,abnormal spleen morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration|MP:0013292,embryonic lethality prior to organogenesis
MGI:2682230	Rps19<Mhdadsk3>	MP:0000373,belly spot|MP:0000575,increased foot pad pigmentation|MP:0001262,decreased body weight|MP:0002095,abnormal skin pigmentation|MP:0002875,decreased erythrocyte cell number|MP:0006042,increased apoptosis|MP:0008941,reticulocytopenia|MP:0009387,abnormal epidermal pigmentation|MP:0009388,abnormal epidermal melanocyte morphology|MP:0009674,decreased birth weight|MP:0009783,abnormal melanoblast morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation|MP:0012022,increased melanocyte number
MGI:3043595	Rps19<tm1Dahl>	MP:0005397,hematopoietic system phenotype|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:6257676	Rps20<em1(IMPC)Bay>	MP:0001417,decreased exploration in new environment|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2681787	Rps20<Mhdadsk4>	MP:0000575,increased foot pad pigmentation|MP:0002095,abnormal skin pigmentation|MP:0009387,abnormal epidermal pigmentation|MP:0009388,abnormal epidermal melanocyte morphology|MP:0009783,abnormal melanoblast morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation|MP:0012022,increased melanocyte number
MGI:6761756	Rps21<em1Utr>	MP:0000373,belly spot|MP:0000585,kinked tail|MP:0001265,decreased body size|MP:0001922,reduced male fertility|MP:0002083,premature death|MP:0009934,abnormal hind foot hair pigmentation
MGI:6761757	Rps21<em2Utr>	MP:0002081,perinatal lethality
MGI:6361943	Rps23rg1<em1Ywuz>	MP:0001402,decreased locomotor activity|MP:0001473,reduced long-term potentiation|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003461,abnormal response to novel object|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004924,abnormal behavior|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0012307,impaired spatial learning|MP:0020551,abnormal postsynaptic density morphology
MGI:6363221	Rps24<tm1Itl>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6467469	Rps26<tm1.1Jzc>	MP:0001125,abnormal oocyte morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001130,abnormal ovarian folliculogenesis|MP:0001926,female infertility|MP:0004805,absent oocytes|MP:0008871,abnormal ovarian follicle number|MP:0031020,premature ovarian failure
MGI:5692633	Rps26<tm2b(EUCOMM)Hmgu>	MP:0001488,increased startle reflex|MP:0005343,increased circulating aspartate transaminase level
MGI:7425952	Rps27<em1(IMPC)Bay>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0002582,disorganized extraembryonic tissue|MP:0003984,embryonic growth retardation|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0014586,decreased egg cylinder size
MGI:7703428	Rps27<em1Mbar>	MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:7703430	Rps27<em2(Rps27l)Mbar>	MP:0002169,no abnormal phenotype detected
MGI:7703397	Rps27l<em1Mbar>	MP:0011100,preweaning lethality, complete penetrance
MGI:7703398	Rps27l<em2(Rps27)Mbar>	MP:0002169,no abnormal phenotype detected
MGI:4022789	Rps27l<Gt(IST11658B7)Tigm>	MP:0000333,decreased bone marrow cell number|MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0000694,spleen hypoplasia|MP:0000711,thymus cortex hypoplasia|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001823,thymus hypoplasia|MP:0002083,premature death|MP:0004810,decreased hematopoietic stem cell number|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight|MP:0008813,decreased common myeloid progenitor cell number|MP:0009541,increased thymocyte apoptosis|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4410387	Rps28<GT(RNA2)Whk>	MP:0002169,no abnormal phenotype detected
MGI:4410388	Rps28<GT(RNA3)Whk>	MP:0002169,no abnormal phenotype detected
MGI:6883670	Rps2<tm1.1Geno>	MP:0000746,weakness|MP:0001262,decreased body weight|MP:0003674,oxidative stress|MP:0005386,behavior/neurological phenotype|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0011100,preweaning lethality, complete penetrance
MGI:5792822	Rps6ka1<em1(IMPC)J>	MP:0001304,cataract|MP:0001489,decreased startle reflex
MGI:5544762	Rps6ka2<tm1.1Mskf>	MP:0000278,abnormal myocardial fiber morphology|MP:0004486,decreased response of heart to induced stress|MP:0005294,abnormal heart ventricle morphology|MP:0005385,cardiovascular system phenotype
MGI:3042586	Rps6ka3<tm1.1Kry>	MP:0000063,decreased bone mineral density|MP:0001469,abnormal contextual conditioning behavior|MP:0002062,abnormal associative learning|MP:0002100,abnormal tooth morphology|MP:0002206,abnormal CNS synaptic transmission|MP:0002689,abnormal molar morphology|MP:0002896,abnormal bone mineralization|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0003723,abnormal long bone morphology|MP:0003932,abnormal molar crown morphology|MP:0004016,decreased bone mass|MP:0004033,supernumerary teeth|MP:0004377,small frontal bone|MP:0004380,short frontal bone|MP:0004384,small interparietal bone|MP:0004418,small parietal bone|MP:0004610,small vertebrae|MP:0004686,decreased length of long bones|MP:0005006,abnormal osteoblast physiology|MP:0005367,renal/urinary system phenotype|MP:0005369,muscle phenotype|MP:0005370,liver/biliary system phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0005394,taste/olfaction phenotype|MP:0005397,hematopoietic system phenotype|MP:0008271,abnormal bone ossification|MP:0009538,abnormal synapse morphology|MP:0009936,abnormal dendritic spine morphology|MP:0010771,integument phenotype|MP:0010869,decreased bone trabecula number|MP:0011003,reduced AMPA-mediated synaptic currents|MP:0011165,abnormal tooth root development|MP:0011274,short excitatory postsynaptic current decay time|MP:0011862,decreased cranium length|MP:0020551,abnormal postsynaptic density morphology|MP:0030029,wide cranial sutures|MP:0030388,large fontanelles|MP:0030536,abnormal diastema morphology
MGI:2387473	Rps6ka3<tm1Ljg>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001783,decreased white adipose tissue amount|MP:0001924,infertility|MP:0002063,abnormal learning/memory/conditioning|MP:0002079,increased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0010399,decreased skeletal muscle glycogen level
MGI:5467986	Rps6ka5<tm1.1Arte>	MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0009936,abnormal dendritic spine morphology
MGI:3574760	Rps6ka5<tm1Jsca>	MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0009713,enhanced conditioned place preference behavior|MP:0009758,impaired behavioral response to cocaine|MP:0011380,enlarged brain ventricles
MGI:4330363	Rps6ka6<Gt(RRS057)Byg>	MP:0000267,abnormal heart development|MP:0000433,microcephaly|MP:0001695,abnormal gastrulation|MP:0002230,abnormal primitive streak formation|MP:0002231,abnormal primitive streak morphology|MP:0004073,caudal body truncation|MP:0004180,failure of initiation of embryo turning|MP:0009331,absent primitive node|MP:0009657,failure of chorioallantoic fusion|MP:0012082,delayed heart development
MGI:2387472	Rps6kb1<tm1Gtho>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001559,hyperglycemia|MP:0001698,decreased embryo size|MP:0001732,postnatal growth retardation|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0009114,decreased pancreatic beta cell mass|MP:0009172,small pancreatic islets|MP:0009402,decreased skeletal muscle fiber diameter
MGI:3511860	Rps6kb1<tm1Nte>	MP:0000750,abnormal muscle regeneration|MP:0001265,decreased body size|MP:0001661,extended life span|MP:0003083,abnormal tibialis anterior morphology|MP:0005289,increased oxygen consumption|MP:0008963,increased carbon dioxide production|MP:0009289,decreased epididymal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009295,decreased interscapular fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0010239,decreased skeletal muscle weight
MGI:3771299	Rps6kb2<tm1Gtho>	MP:0002169,no abnormal phenotype detected
MGI:5617793	Rps6kc1<tm1b(EUCOMM)Wtsi>	MP:0001258,decreased body length|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005419,decreased circulating serum albumin level|MP:0009142,decreased prepulse inhibition|MP:0011960,abnormal eye anterior chamber depth|MP:0011965,decreased total retina thickness
MGI:5614610	Rps6kl1<tm1.1(KOMP)Vlcg>	MP:0004151,decreased circulating iron level|MP:0005560,decreased circulating glucose level|MP:0005633,increased circulating sodium level
MGI:2387471	Rps6<tm1Gtho>	MP:0000358,abnormal cell morphology|MP:0000575,increased foot pad pigmentation|MP:0003077,abnormal cell cycle|MP:0005409,darkened coat color|MP:0005517,impaired liver regeneration|MP:0009385,abnormal dermal pigmentation|MP:0009387,abnormal epidermal pigmentation|MP:0011276,increased tail pigmentation|MP:0011277,decreased tail pigmentation|MP:0011278,increased ear pigmentation|MP:0011627,decreased skin pigmentation|MP:0020221,reduced foot pad pigmentation
MGI:3603166	Rps6<tm1Om>	MP:0000358,abnormal cell morphology|MP:0000607,abnormal hepatocyte morphology|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0003077,abnormal cell cycle|MP:0005215,abnormal pancreatic islet morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0005621,abnormal cell physiology
MGI:3043039	Rps7<Mtu>	MP:0000373,belly spot|MP:0000585,kinked tail|MP:0000841,abnormal hindbrain morphology|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002590,increased mean corpuscular volume|MP:0003051,curly tail|MP:0004599,abnormal vertebral arch morphology|MP:0004645,decreased vertebrae number|MP:0006254,thin cerebral cortex|MP:0008428,abnormal spatial working memory|MP:0009843,decreased neural crest cell number|MP:0011380,enlarged brain ventricles
MGI:5500069	Rps7<Zma>	MP:0000245,abnormal erythropoiesis|MP:0000373,belly spot|MP:0000480,increased rib number|MP:0000585,kinked tail|MP:0000788,abnormal cerebral cortex morphology|MP:0001297,microphthalmia|MP:0001539,decreased caudal vertebrae number|MP:0002081,perinatal lethality|MP:0002083,premature death|MP:0003203,increased neuron apoptosis|MP:0003984,embryonic growth retardation|MP:0004322,abnormal sternebra morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004600,abnormal vertebral transverse process morphology|MP:0004609,vertebral fusion|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0006254,thin cerebral cortex|MP:0008146,asymmetric sternocostal joints|MP:0008271,abnormal bone ossification|MP:0008283,small hippocampus|MP:0009783,abnormal melanoblast morphology|MP:0010768,mortality/aging|MP:0011380,enlarged brain ventricles|MP:0012533,uveal coloboma|MP:0012536,delayed optic fissure closure
MGI:7384901	Rps9<tm1.1Geno>	MP:0000160,kyphosis|MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000414,alopecia|MP:0000746,weakness|MP:0001304,cataract|MP:0001522,impaired swimming|MP:0001577,anemia|MP:0002083,premature death|MP:0003587,ureter obstruction|MP:0003674,oxidative stress|MP:0003786,premature aging|MP:0003961,decreased lean body mass|MP:0005386,behavior/neurological phenotype|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009295,decreased interscapular fat pad weight|MP:0010951,abnormal lipid oxidation|MP:0014143,decreased body fat mass|MP:0031392,hypoactivity
MGI:3803603	Rpsa<tm1Ells>	MP:0003935,abnormal craniofacial development|MP:0004201,fetal growth retardation|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3039664	Rpsa<tp1>	MP:0001636,irregular heartbeat|MP:0005648,heart right ventricle degeneration
MGI:4879103	Rptor<tm1.1Dmsa>	MP:0000601,small liver|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0001154,seminiferous tubule degeneration|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002575,increased circulating ketone body level|MP:0003830,abnormal testis development|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0004929,decreased epididymis weight|MP:0005159,azoospermia|MP:0005250,decreased Sertoli cell number|MP:0006420,abnormal peritubular myoid cell morphology|MP:0006428,ectopic Sertoli cells|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0013600,testis degeneration|MP:0013601,increased testis apoptosis|MP:0014633,decreased spermatid number|MP:0014634,decreased round spermatid number|MP:0014636,decreased elongated spermatid number|MP:0020355,abnormal Sertoli cell barrier morphology|MP:0020362,abnormal male germ cell physiology|MP:0020378,abnormal cell cytoskeleton morphology
MGI:3829706	Rptor<tm1.1Rueg>	MP:0005076,abnormal cell differentiation|MP:0011092,embryonic lethality, complete penetrance
MGI:5441589	Rptor<tm1Ahir>	MP:0008126,increased dendritic cell number|MP:0008537,increased susceptibility to induced colitis|MP:0010180,increased susceptibility to weight loss|MP:0013956,decreased colon length
MGI:3529138	Rptor<tm1Lex>	MP:0005033,abnormal trophoblast giant cell morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012113,decreased inner cell mass proliferation
MGI:3829770	Rptor<tm1Rueg>	MP:0000160,kyphosis|MP:0000752,dystrophic muscle|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001780,decreased brown adipose tissue amount|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002108,abnormal muscle morphology|MP:0002727,decreased circulating insulin level|MP:0003851,skeletal muscle interstitial fibrosis|MP:0003960,increased lean body mass|MP:0004130,abnormal muscle cell glucose uptake|MP:0004232,decreased muscle weight|MP:0004893,decreased adiponectin level|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008907,decreased total fat pad weight|MP:0009131,decreased white fat cell number|MP:0009133,decreased white fat cell size|MP:0009356,decreased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0010401,increased skeletal muscle glycogen level|MP:0012106,impaired exercise endurance
MGI:5548643	Rptor<tm2b(EUCOMM)Wtsi>	MP:0004122,abnormal sinus arrhythmia|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6150871	Rpusd2<tm1b(KOMP)Wtsi>	MP:0003733,abnormal retina inner nuclear layer morphology|MP:0004952,increased spleen weight
MGI:6360038	Rpusd3<em1(IMPC)Bay>	MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3698404	Rr100<tm2.1Welm>	MP:0002145,abnormal T cell differentiation|MP:0003944,abnormal T cell subpopulation ratio|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3687192	Rr100<tm2Welm>	MP:0002169,no abnormal phenotype detected
MGI:3664645	Rr101<tm2Kio>	MP:0005387,immune system phenotype
MGI:4830690	Rr103<tm3.1Sia>	MP:0004171,abnormal pallium development
MGI:5285264	Rr104<tm1.1Mym>	MP:0002169,no abnormal phenotype detected
MGI:5285265	Rr104<tm1.2Mym>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000603,pale liver|MP:0000609,abnormal liver physiology|MP:0001577,anemia|MP:0003717,pallor|MP:0010768,mortality/aging|MP:0011243,decreased fetal derived definitive erythrocyte cell number
MGI:3052219	Rr105<tm1Bas>	MP:0002169,no abnormal phenotype detected
MGI:4880752	Rr10<tm1.1Kubo>	MP:0005387,immune system phenotype
MGI:7367576	Rr115<em1Bobh>	MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:4948508	Rr117<tm1.1Dje>	MP:0003631,nervous system phenotype
MGI:5463979	Rr123<tm1.1Vbo>	MP:0004941,abnormal regulatory T cell morphology|MP:0004973,increased regulatory T cell number|MP:0005387,immune system phenotype
MGI:7431269	Rr124128<tm1.1Jfer>	MP:0001559,hyperglycemia|MP:0002727,decreased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005378,growth/size/body region phenotype
MGI:7431276	Rr124128<tm1.2Jfer>	MP:0002727,decreased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005378,growth/size/body region phenotype
MGI:1860836	Rr128<tm1Masu>	MP:0001260,increased body weight|MP:0001262,decreased body weight
MGI:3617970	Rr129<tm4Msb>	MP:0005384,cellular phenotype
MGI:2653307	Rr133<tm1Eno>	MP:0000030,abnormal tympanic ring morphology|MP:0000088,short mandible|MP:0000430,absent maxillary shelf|MP:0000458,abnormal mandible morphology|MP:0000460,mandible hypoplasia|MP:0001436,abnormal suckling behavior|MP:0002116,abnormal craniofacial bone morphology|MP:0004136,abnormal tongue muscle morphology|MP:0004448,abnormal presphenoid bone morphology|MP:0004453,abnormal pterygoid bone morphology|MP:0004592,small mandible|MP:0004596,abnormal mandibular angle morphology|MP:0005105,abnormal middle ear ossicle morphology|MP:0005385,cardiovascular system phenotype|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006020,decreased tympanic ring size|MP:0008374,abnormal malleus manubrium morphology|MP:0008382,gonial bone hypoplasia|MP:0009655,abnormal secondary palate development|MP:0009886,failure of palatal shelf elevation|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009890,cleft secondary palate|MP:0009914,abnormal hyoid bone lesser horn morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0013933,short Meckel's cartilage
MGI:7413089	Rr1367<em1Cya>	MP:0005390,skeleton phenotype|MP:0030258,small mandibular condyloid process
MGI:5140090	Rr13<tm3Mom>	MP:0005499,abnormal olfactory system morphology
MGI:2675412	Rr142<tm1.1Rud>	MP:0001513,limb grasping|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation
MGI:2675411	Rr142<tm1Rud>	MP:0000150,abnormal rib morphology|MP:0000480,increased rib number|MP:0001265,decreased body size|MP:0001513,limb grasping|MP:0003036,vertebral transformation|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0012284,increased sternebra number
MGI:6201366	Rr143<tm1.1Sson>	MP:0001260,increased body weight|MP:0002833,increased heart weight|MP:0003398,increased skeletal muscle size|MP:0003917,increased kidney weight|MP:0003960,increased lean body mass
MGI:3604300	Rr148<tm1.1Fwa>	MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0001802,arrested B cell differentiation|MP:0002144,abnormal B cell differentiation|MP:0005387,immune system phenotype|MP:0008215,decreased immature B cell number
MGI:3796983	Rr148<tm1Anbo>	MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008760,abnormal immunoglobulin heavy chain V(D)J recombination
MGI:3604299	Rr148<tm1Fwa>	MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0001802,arrested B cell differentiation|MP:0002831,absent Peyer's patches|MP:0005022,abnormal immature B cell morphology|MP:0005387,immune system phenotype|MP:0008071,absent B cells
MGI:3796984	Rr148<tm2Anbo>	MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008760,abnormal immunoglobulin heavy chain V(D)J recombination
MGI:3590151	Rr149356<tm1.1Pf>	MP:0000703,abnormal thymus morphology|MP:0000715,decreased thymocyte number|MP:0001825,arrested T cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002371,abnormal thymus cortex morphology|MP:0002375,abnormal thymus medulla morphology|MP:0005018,decreased T cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008083,decreased single-positive T cell number|MP:0008101,lymph node hypoplasia|MP:0008346,increased gamma-delta T cell number
MGI:3802614	Rr149356<tm1Abnd>	MP:0000703,abnormal thymus morphology|MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0005018,decreased T cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008083,decreased single-positive T cell number|MP:0008346,increased gamma-delta T cell number
MGI:3620665	Rr149356<tm1Che>	MP:0002006,neoplasm|MP:0002407,abnormal double-negative T cell morphology|MP:0002408,abnormal double-positive T cell morphology
MGI:5049943	Rr14<tm1.1Bulg>	MP:0008469,abnormal protein level
MGI:3045811	Rr152<tm2Cog>	MP:0001805,decreased IgG level|MP:0003132,increased pre-B cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:3522204	Rr152<tm3.1Cog>	MP:0001805,decreased IgG level|MP:0001807,decreased IgA level|MP:0002460,decreased immunoglobulin level|MP:0002492,decreased IgE level|MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:3522200	Rr152<tm3Cog>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002460,decreased immunoglobulin level|MP:0002492,decreased IgE level|MP:0004816,abnormal class switch recombination|MP:0004939,abnormal B cell morphology|MP:0005387,immune system phenotype|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:4836663	Rr152<tm5.1Cog>	MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002492,decreased IgE level|MP:0004815,abnormal somatic hypermutation frequency|MP:0004816,abnormal class switch recombination|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:4456430	Rr155<tm1.1Erpi>	MP:0002490,abnormal immunoglobulin level|MP:0005387,immune system phenotype|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level
MGI:4838169	Rr156<tm6.1Cog>	MP:0000333,decreased bone marrow cell number|MP:0001806,decreased IgM level|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:4838168	Rr156<tm6Cog>	MP:0000333,decreased bone marrow cell number|MP:0001806,decreased IgM level|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:2179291	Rr158<tm1Cgn>	MP:0000694,spleen hypoplasia|MP:0002144,abnormal B cell differentiation|MP:0008210,increased mature B cell number|MP:0008211,decreased mature B cell number
MGI:3757685	Rr158<tm1(Igh)Xu>	MP:0000685,abnormal immune system morphology|MP:0003132,increased pre-B cell number|MP:0005017,decreased B cell number|MP:0008215,decreased immature B cell number
MGI:2179292	Rr158<tm2Cgn>	MP:0002144,abnormal B cell differentiation
MGI:3758449	Rr158<tm2Xu>	MP:0005017,decreased B cell number
MGI:3687498	Rr159<tm1.1Fwa>	MP:0002144,abnormal B cell differentiation|MP:0005017,decreased B cell number
MGI:3687497	Rr159<tm1Fwa>	MP:0002144,abnormal B cell differentiation|MP:0005014,increased B cell number|MP:0005017,decreased B cell number
MGI:3790771	Rr160<tm1Wtg>	MP:0002490,abnormal immunoglobulin level|MP:0004815,abnormal somatic hypermutation frequency|MP:0008171,abnormal mature B cell morphology|MP:0008174,decreased follicular B cell number|MP:0008189,increased transitional stage B cell number
MGI:4887406	Rr161<tm2.2Wtg>	MP:0002144,abnormal B cell differentiation|MP:0003132,increased pre-B cell number|MP:0005017,decreased B cell number|MP:0008208,decreased pro-B cell number|MP:0008755,abnormal immunoglobulin V(D)J recombination|MP:0008877,abnormal DNA methylation
MGI:5009316	Rr162<tm3.1Wtg>	MP:0005387,immune system phenotype|MP:0008755,abnormal immunoglobulin V(D)J recombination
MGI:3653474	Rr163<tm1Lfdn>	MP:0001790,abnormal immune system physiology|MP:0005387,immune system phenotype
MGI:5474643	Rr166<tm4.1Wtg>	MP:0002144,abnormal B cell differentiation|MP:0002403,abnormal pre-B cell morphology|MP:0002459,abnormal B cell physiology|MP:0002490,abnormal immunoglobulin level|MP:0008761,abnormal immunoglobulin light chain V-J recombination
MGI:3512141	Rr169<tm2Rao>	MP:0005027,increased susceptibility to parasitic infection|MP:0008088,abnormal T-helper 1 cell differentiation
MGI:5311639	Rr16<Tn(sb-Tyr)1HCeb>	MP:0000111,cleft palate|MP:0001288,abnormal lens induction|MP:0001293,anophthalmia|MP:0011088,neonatal lethality, incomplete penetrance
MGI:7439372	Rr170<tm1.1Iku>	MP:0005018,decreased T cell number|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0006413,increased T cell apoptosis
MGI:5304851	Rr175<tm1.1Mema>	MP:0011085,postnatal lethality, complete penetrance
MGI:5313386	Rr17<tm1.1Cdon>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005387,immune system phenotype|MP:0008681,increased interleukin-17 secretion|MP:0008682,decreased interleukin-17 secretion
MGI:5908022	Rr198<em1Takas>	MP:0005384,cellular phenotype|MP:0012167,abnormal epigenetic regulation of gene expression
MGI:5908024	Rr199<em1Takas>	MP:0005384,cellular phenotype|MP:0012167,abnormal epigenetic regulation of gene expression
MGI:5433040	Rr19<tm1.1Nses>	MP:0002878,abnormal corticospinal tract morphology
MGI:4421023	Rr1<tm1Hgc>	MP:0002169,no abnormal phenotype detected
MGI:5908025	Rr200<em1Takas>	MP:0005384,cellular phenotype|MP:0012167,abnormal epigenetic regulation of gene expression
MGI:5441845	Rr20<tm1.1Vlcg>	MP:0000130,abnormal trabecular bone morphology|MP:0002896,abnormal bone mineralization|MP:0004986,abnormal osteoblast morphology|MP:0005390,skeleton phenotype|MP:0005605,increased bone mass|MP:0008271,abnormal bone ossification|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0010932,increased trabecular bone connectivity density
MGI:5463413	Rr21<tm1.1Jta>	MP:0002169,no abnormal phenotype detected
MGI:7432343	Rr229173<em1Fena>	MP:0020470,shortened circadian behavior period
MGI:5470292	Rr23<tm1Axvi>	MP:0000074,abnormal neurocranium morphology|MP:0000438,abnormal cranium morphology|MP:0003758,narrow palate|MP:0030066,short face|MP:0030420,short basicranium
MGI:5466176	Rr249<tm1.1Ebres>	MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003070,increased vascular permeability|MP:0004810,decreased hematopoietic stem cell number|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0009489,abnormal blood vessel endothelium morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5470293	Rr24<tm1Axvi>	MP:0000438,abnormal cranium morphology
MGI:3760155	Rr250409<tm1Lky>	MP:0002492,decreased IgE level|MP:0005025,abnormal response to infection|MP:0005026,decreased susceptibility to parasitic infection|MP:0008673,decreased interleukin-13 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion
MGI:6363029	Rr250<em1Ebres>	MP:0000208,decreased hematocrit|MP:0001606,impaired hematopoiesis|MP:0002875,decreased erythrocyte cell number|MP:0003402,decreased liver weight|MP:0004810,decreased hematopoietic stem cell number|MP:0005397,hematopoietic system phenotype|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008973,decreased erythroid progenitor cell number|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:5605695	Rr251<tm2.1Ebres>	MP:0002169,no abnormal phenotype detected
MGI:7331606	Rr253<em1Kmm>	MP:0000219,increased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000694,spleen hypoplasia|MP:0004816,abnormal class switch recombination|MP:0005013,increased lymphocyte cell number|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005380,embryo phenotype|MP:0005397,hematopoietic system phenotype|MP:0008044,increased NK cell number|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0008126,increased dendritic cell number|MP:0008244,abnormal peritoneal macrophage morphology|MP:0008470,abnormal spleen B cell follicle morphology|MP:0009791,increased susceptibility to viral infection induced morbidity/mortality|MP:0013672,decreased mature NK cell number|MP:0013762,abnormal effector T cell number|MP:0014263,decreased spleen B cell follicle number|MP:0014348,decreased spleen B cell follicle size
MGI:7448464	Rr253<em3Kmm>	MP:0008127,decreased dendritic cell number
MGI:7448465	Rr253<em4Kmm>	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:7448466	Rr253<em5Kmm>	MP:0008126,increased dendritic cell number|MP:0008127,decreased dendritic cell number
MGI:7448467	Rr253<em6Kmm>	MP:0000223,decreased monocyte cell number|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005466,abnormal T-helper 2 physiology|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0008126,increased dendritic cell number|MP:0008127,decreased dendritic cell number|MP:0010750,increased susceptibility to parasitic infection induced morbidity/mortality|MP:0013697,decreased granulocyte monocyte progenitor cell number
MGI:7443204	Rr258107<em1Issa>	MP:0005391,vision/eye phenotype
MGI:5470294	Rr25<tm1Axvi>	MP:0000074,abnormal neurocranium morphology|MP:0000438,abnormal cranium morphology|MP:0030070,long face|MP:0030420,short basicranium
MGI:7333232	Rr265<em1Maros>	MP:0000572,abnormal autopod morphology|MP:0000574,abnormal foot pad morphology|MP:0002115,abnormal limb bone morphology|MP:0005306,abnormal phalanx morphology|MP:0005380,embryo phenotype|MP:0006279,abnormal limb development|MP:0009005,abnormal sesamoid bone of gastrocnemius morphology|MP:0010771,integument phenotype
MGI:7338992	Rr266<em1Hino>	MP:0005376,homeostasis/metabolism phenotype
MGI:7338993	Rr268<em1Hino>	MP:0005376,homeostasis/metabolism phenotype
MGI:5486166	Rr26<tm1Svok>	MP:0005390,skeleton phenotype
MGI:7339168	Rr270<em1Mgn>	MP:0005380,embryo phenotype|MP:0010768,mortality/aging|MP:0020495,abnormal embryonic lymph sac morphology
MGI:7339169	Rr271<em1Mgn>	MP:0001698,decreased embryo size|MP:0003988,disorganized embryonic tissue|MP:0005380,embryo phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7443202	Rr272<em1Issa>	MP:0005384,cellular phenotype|MP:0005391,vision/eye phenotype|MP:0005547,abnormal Muller cell morphology|MP:0006096,absent retina bipolar cells|MP:0006148,binocular blindness|MP:0008445,increased retina cone cell number|MP:0008452,increased retina rod cell number|MP:0008511,thin retina inner nuclear layer|MP:0008513,thin retina inner plexiform layer|MP:0008517,thick retina outer nuclear layer|MP:0011965,decreased total retina thickness|MP:0012029,abnormal electroretinogram waveform feature|MP:0020439,absent b-wave
MGI:6469562	Rr272<em1Mad>	MP:0003631,nervous system phenotype|MP:0005391,vision/eye phenotype|MP:0006096,absent retina bipolar cells
MGI:7341373	Rr272<em2Mad>	MP:0001297,microphthalmia|MP:0006149,decreased visual acuity
MGI:7443203	Rr273<em1Issa>	MP:0000352,decreased cell proliferation|MP:0001297,microphthalmia|MP:0005391,vision/eye phenotype|MP:0005549,retina pigment epithelium hyperplasia
MGI:7341363	Rr273<em1Mad>	MP:0001297,microphthalmia|MP:0002984,retina hypoplasia|MP:0006149,decreased visual acuity
MGI:7341364	Rr274<em1Mad>	MP:0002092,abnormal eye morphology|MP:0002984,retina hypoplasia|MP:0006149,decreased visual acuity
MGI:7341438	Rr274<em2Mad>	MP:0002092,abnormal eye morphology
MGI:7341436	Rr274<em3Mad>	MP:0002092,abnormal eye morphology
MGI:7341437	Rr274<em4Mad>	MP:0002092,abnormal eye morphology
MGI:2388608	Rr275254<tm2.1Dhr>	MP:0008356,abnormal gamma-delta T cell differentiation|MP:0008757,abnormal T cell receptor gamma chain V-J recombination
MGI:2388607	Rr275254<tm2Dhr>	MP:0008356,abnormal gamma-delta T cell differentiation|MP:0008757,abnormal T cell receptor gamma chain V-J recombination
MGI:7341365	Rr275<em1Mad>	MP:0002092,abnormal eye morphology
MGI:7341366	Rr276<em1Mad>	MP:0006096,absent retina bipolar cells|MP:0006149,decreased visual acuity
MGI:7341596	Rr277<em1Flc>	MP:0000280,thin ventricular wall|MP:0005294,abnormal heart ventricle morphology|MP:0010556,thin ventricle myocardium compact layer|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0021159,increased heart right ventricle wall thickness|MP:0030564,thick myocardium compact layer
MGI:7341598	Rr278<em1Flc>	MP:0005294,abnormal heart ventricle morphology|MP:0005380,embryo phenotype|MP:0021159,increased heart right ventricle wall thickness|MP:0030564,thick myocardium compact layer
MGI:2655219	Rr27<tm1.1Kpfe>	MP:0008877,abnormal DNA methylation
MGI:6753234	Rr27<tm1.1Mnn>	MP:0003787,abnormal imprinting|MP:0009429,decreased embryo weight|MP:0009703,decreased birth body size|MP:0010768,mortality/aging
MGI:1930816	Rr27<tm1.1Msb>	MP:0001262,decreased body weight|MP:0001264,increased body size|MP:0003787,abnormal imprinting
MGI:2655218	Rr27<tm1Kpfe>	MP:0003787,abnormal imprinting|MP:0004256,abnormal maternal decidual layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0008957,abnormal placenta junctional zone morphology|MP:0011521,decreased placental labyrinth size|MP:0031431,increased spongiotrophoblast cell number
MGI:3046753	Rr27<tm1Pes>	MP:0000562,polydactyly|MP:0003123,paternal imprinting|MP:0004920,increased placenta weight|MP:0009432,increased fetal weight
MGI:2653959	Rr27<tm1Rohl>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0003787,abnormal imprinting|MP:0005455,increased susceptibility to weight gain
MGI:2451308	Rr27<tm1Tilg>	MP:0001260,increased body weight|MP:0003787,abnormal imprinting
MGI:3050788	Rr27<tm1Wrk>	MP:0002169,no abnormal phenotype detected
MGI:5486345	Rr27<tm2.1Pes>	MP:0005384,cellular phenotype
MGI:3617783	Rr27<tm2Msb>	MP:0003123,paternal imprinting
MGI:3045724	Rr27<tm2Rohl>	MP:0002169,no abnormal phenotype detected
MGI:2683633	Rr27<tm2Tilg>	MP:0005384,cellular phenotype
MGI:3051218	Rr27<tm2Wrk>	MP:0002169,no abnormal phenotype detected
MGI:3617969	Rr27<tm3Msb>	MP:0003787,abnormal imprinting
MGI:3617971	Rr27<tm4Msb>	MP:0003787,abnormal imprinting|MP:0004920,increased placenta weight|MP:0009430,increased embryo weight
MGI:5140188	Rr27<tm5.1Msb>	MP:0003787,abnormal imprinting|MP:0005378,growth/size/body region phenotype
MGI:5140189	Rr27<tm6.1Msb>	MP:0003787,abnormal imprinting|MP:0005378,growth/size/body region phenotype
MGI:5575358	Rr27<tm7.1Msb>	MP:0009673,increased birth weight|MP:0009906,increased tongue size
MGI:2388606	Rr282726<tm1Dhr>	MP:0008356,abnormal gamma-delta T cell differentiation|MP:0008757,abnormal T cell receptor gamma chain V-J recombination
MGI:7383032	Rr282729<tm1.1Iku>	MP:0008347,decreased gamma-delta T cell number|MP:0008757,abnormal T cell receptor gamma chain V-J recombination
MGI:7346397	Rr284<em1Zllr>	MP:0005371,limbs/digits/tail phenotype
MGI:7346400	Rr287<em1Zllr>	MP:0005371,limbs/digits/tail phenotype
MGI:3701074	Rr28<tm1Msb>	MP:0005384,cellular phenotype
MGI:1930789	Rr28<tm1Tilg>	MP:0001262,decreased body weight|MP:0009674,decreased birth weight
MGI:7356587	Rr291<tm1.1Mekk>	MP:0003245,abnormal GABAergic neuron morphology|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0009456,impaired cued conditioning behavior|MP:0010768,mortality/aging
MGI:7356589	Rr291<tm2.1Mekk>	MP:0003245,abnormal GABAergic neuron morphology|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:7356588	Rr293<tm1.1Mekk>	MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:7356640	Rr295<em1Hzo>	MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0003631,nervous system phenotype|MP:0003863,decreased aggression towards mice|MP:0005386,behavior/neurological phenotype|MP:0020395,abnormal response to social novelty|MP:0031391,increased locomotor activity
MGI:7356641	Rr296<em1Hzo>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0031392,hypoactivity
MGI:3722842	Rr299391<tm1.1Fwa>	MP:0000715,decreased thymocyte number|MP:0005018,decreased T cell number
MGI:3851923	Rr29<Dz>	MP:0000562,polydactyly|MP:0002109,abnormal limb morphology|MP:0002764,short tibia|MP:0002765,short fibula|MP:0004358,bowed tibia|MP:0004372,bowed fibula|MP:0005371,limbs/digits/tail phenotype|MP:0005430,absent fibula|MP:0008985,hemimelia
MGI:1860897	Rr29<Hx>	MP:0000558,abnormal tibia morphology|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0002110,abnormal digit morphology|MP:0002764,short tibia|MP:0003072,abnormal metatarsal bone morphology|MP:0004355,short radius|MP:0004640,decreased metatarsal bone number|MP:0005104,abnormal tarsal bone morphology|MP:0005109,abnormal talus morphology|MP:0005230,ectrodactyly|MP:0005606,increased bleeding time|MP:0008985,hemimelia|MP:0009743,preaxial polydactyly|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012528,abnormal zone of polarizing activity morphology|MP:0013545,cleft hard palate
MGI:3051414	Rr29<Hxl3>	MP:0000558,abnormal tibia morphology|MP:0000562,polydactyly
MGI:3714299	Rr29<rgsc1116>	MP:0000562,polydactyly
MGI:3714300	Rr29<rgsc1117>	MP:0005371,limbs/digits/tail phenotype
MGI:3714302	Rr29<rgsc1192>	MP:0005371,limbs/digits/tail phenotype
MGI:5613147	Rr29<tm1.1Bobh>	MP:0000565,oligodactyly|MP:0003072,abnormal metatarsal bone morphology|MP:0003857,abnormal hindlimb zeugopod morphology|MP:0004642,fused metatarsal bones|MP:0005104,abnormal tarsal bone morphology|MP:0008919,fused tarsal bones|MP:0014321,short forelimb
MGI:5613146	Rr29<tm1Bobh>	MP:0002109,abnormal limb morphology
MGI:5613151	Rr29<tm3.1Bobh>	MP:0005371,limbs/digits/tail phenotype
MGI:5613150	Rr29<tm3Bobh>	MP:0002109,abnormal limb morphology
MGI:4421031	Rr2<tm1Hgc>	MP:0003604,single kidney|MP:0005565,increased blood urea nitrogen level
MGI:7367219	Rr303<em1Vave>	MP:0001636,irregular heartbeat|MP:0003928,increased heart rate variability|MP:0004115,abnormal sinoatrial node morphology|MP:0005333,decreased heart rate|MP:0005380,embryo phenotype|MP:0005385,cardiovascular system phenotype|MP:0010637,sinus bradycardia
MGI:7367486	Rr304<em1Drf>	MP:0005380,embryo phenotype|MP:0005394,taste/olfaction phenotype
MGI:7367487	Rr305<em1Drf>	MP:0001475,reduced long-term depression|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0008544,impaired olfaction
MGI:2654436	Rr308<tm1.1Fwa>	MP:0002145,abnormal T cell differentiation|MP:0008756,abnormal T cell receptor alpha chain V-J recombination
MGI:2654435	Rr308<tm1Fwa>	MP:0002145,abnormal T cell differentiation|MP:0008756,abnormal T cell receptor alpha chain V-J recombination
MGI:2654481	Rr308<tm2Fwa>	MP:0002145,abnormal T cell differentiation
MGI:7380441	Rr314<em1Vmc>	MP:0003928,increased heart rate variability|MP:0005333,decreased heart rate|MP:0006142,abnormal sinoatrial node conduction
MGI:3762391	Rr320<tm1.1Fier>	MP:0005397,hematopoietic system phenotype
MGI:2386946	Rr320<tm1.1Mkg>	MP:0000603,pale liver|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001722,pale yolk sac|MP:0008770,decreased survivor rate|MP:0011100,preweaning lethality, complete penetrance
MGI:2662827	Rr320<tm1Ley>	MP:0000208,decreased hematocrit|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2445412	Rr320<tm2.1Mkg>	MP:0002169,no abnormal phenotype detected
MGI:2445411	Rr320<tm2Mkg>	MP:0000245,abnormal erythropoiesis|MP:0000274,enlarged heart|MP:0001577,anemia|MP:0002641,anisopoikilocytosis|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3525615	Rr320<tm3.1Mkg>	MP:0005397,hematopoietic system phenotype
MGI:7407248	Rr327<em1Mgn>	MP:0003058,increased insulin secretion
MGI:5588381	Rr32<tm1.1Weav>	MP:0005387,immune system phenotype|MP:0008567,decreased interferon-gamma secretion
MGI:7852297	Rr337<em1Rnis>	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype
MGI:7413214	Rr338<em1Jeng>	MP:0002145,abnormal T cell differentiation|MP:0006387,abnormal T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:7428576	Rr344<em1Jfer>	MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0002711,decreased glucagon secretion|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0008953,abnormal pancreatic somatostatin secretion|MP:0009111,pancreas hypoplasia|MP:0009114,decreased pancreatic beta cell mass|MP:0009144,dilated pancreatic duct|MP:0011934,abnormal branching involved in pancreas development|MP:0011935,abnormal pancreatic bud formation|MP:0030588,decreased pancreatic alpha cell mass
MGI:7431475	Rr347<em1Prdns>	MP:0000266,abnormal heart morphology|MP:0001891,hydrocephaly|MP:0002135,abnormal kidney morphology|MP:0003631,nervous system phenotype|MP:0003884,decreased macrophage cell number|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005382,craniofacial phenotype|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype|MP:0005391,vision/eye phenotype|MP:0008118,absent Langerhans cell|MP:0009216,abnormal peritoneum morphology|MP:0010771,integument phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0011982,decreased microglial cell number|MP:0013025,increased Ly6C low monocyte number
MGI:2445400	Rr349<tm1.1Wgw>	MP:0000245,abnormal erythropoiesis|MP:0001588,abnormal hemoglobin|MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin
MGI:2445391	Rr349<tm1Wgw>	MP:0000596,abnormal liver development|MP:0001577,anemia|MP:0001588,abnormal hemoglobin|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002874,decreased hemoglobin content|MP:0003717,pallor|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5616932	Rr34<tm1.1Lap>	MP:0000278,abnormal myocardial fiber morphology|MP:0001262,decreased body weight|MP:0005140,decreased cardiac muscle contractility|MP:0031131,myocardial fiber disarray
MGI:5616933	Rr35<tm1.1Lap>	MP:0000278,abnormal myocardial fiber morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005378,growth/size/body region phenotype|MP:0031131,myocardial fiber disarray
MGI:7448757	Rr364729<em1Almk>	MP:0001364,decreased anxiety-related response|MP:0001432,abnormal food preference|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0012042,low alcohol preference
MGI:7435285	Rr364<tm1.1Aak>	MP:0004816,abnormal class switch recombination|MP:0008498,decreased IgG3 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level
MGI:5617037	Rr36<tm1.1Krum>	MP:0002169,no abnormal phenotype detected
MGI:7439129	Rr381<em1Kap>	MP:0000727,absent CD8-positive, alpha-beta T cells
MGI:7439127	Rr381<em2Kap>	MP:0005397,hematopoietic system phenotype
MGI:7439137	Rr381<em3Kap>	MP:0005397,hematopoietic system phenotype
MGI:7439138	Rr381<em4Kap>	MP:0000727,absent CD8-positive, alpha-beta T cells
MGI:7439139	Rr381<em5Kap>	MP:0000727,absent CD8-positive, alpha-beta T cells
MGI:3774005	Rr381<tm1.1Tani>	MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3663313	Rr383<tm1Caob>	MP:0002113,abnormal skeleton development|MP:0002169,no abnormal phenotype detected|MP:0004985,decreased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0004993,decreased bone resorption|MP:0005376,homeostasis/metabolism phenotype|MP:0005605,increased bone mass|MP:0010868,increased bone trabecula number|MP:0010872,increased trabecular bone mass|MP:0010932,increased trabecular bone connectivity density|MP:0013631,decreased bone trabecular spacing|MP:0013644,increased vertebra maximal load
MGI:7439579	Rr386<em1Pdi>	MP:0005387,immune system phenotype
MGI:7440065	Rr387<em1Zyliu>	MP:0000854,abnormal cerebellum development|MP:0001525,impaired balance|MP:0002083,premature death|MP:0005377,hearing/vestibular/ear phenotype
MGI:7440074	Rr388<em1Jdai>	MP:0003631,nervous system phenotype|MP:0004396,decreased cochlear inner hair cell number|MP:0004402,decreased cochlear outer hair cell number|MP:0005380,embryo phenotype|MP:0010768,mortality/aging|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5750934	Rr38<tm1.2Aafo>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0003763,abnormal thymus physiology|MP:0004956,decreased thymus weight|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0010133,increased DN3 thymocyte number
MGI:7444371	Rr394<em1Bhao>	MP:0000715,decreased thymocyte number|MP:0005397,hematopoietic system phenotype|MP:0008756,abnormal T cell receptor alpha chain V-J recombination|MP:0010133,increased DN3 thymocyte number
MGI:7444372	Rr395<em1Bhao>	MP:0000715,decreased thymocyte number|MP:0005092,decreased double-positive T cell number|MP:0005397,hematopoietic system phenotype|MP:0009541,increased thymocyte apoptosis|MP:0010135,increased DN4 thymocyte number
MGI:5829195	Rr39<em1Ched>	MP:0003721,increased tumor growth/size|MP:0005387,immune system phenotype|MP:0013026,decreased Ly6C low monocyte number
MGI:4421035	Rr3<tm1Hgc>	MP:0002169,no abnormal phenotype detected
MGI:7447461	Rr400<em1Pqt>	MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype
MGI:7448545	Rr401<em1Yushi>	MP:0001127,small ovary|MP:0001130,abnormal ovarian folliculogenesis|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002680,decreased corpora lutea number|MP:0002687,oligozoospermia|MP:0002786,abnormal Leydig cell morphology|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003631,nervous system phenotype|MP:0003642,absent seminal vesicle|MP:0005188,small penis|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0012225,decreased sterol level|MP:0020824,abnormal testis tissue architecture
MGI:7489686	Rr426<em1Axvi>	MP:0005388,respiratory system phenotype
MGI:6117321	Rr45<tm1.1Tshir>	MP:0000079,abnormal basioccipital bone morphology|MP:0000104,abnormal sphenoid bone morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0000111,cleft palate|MP:0000762,abnormal tongue morphology|MP:0002234,abnormal pharynx morphology|MP:0002257,abnormal arytenoid cartilage morphology|MP:0002260,abnormal thyroid cartilage morphology|MP:0003056,abnormal hyoid bone morphology|MP:0009247,meteorism|MP:0009546,absent gastric milk in neonates|MP:0010371,abnormal epiglottis morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0030291,short soft palate
MGI:7579304	Rr468<tm1.1Df>	MP:0004022,abnormal cone electrophysiology|MP:0012144,decreased b-wave amplitude
MGI:7579305	Rr468<tm2.1Df>	MP:0004022,abnormal cone electrophysiology|MP:0012144,decreased b-wave amplitude
MGI:7579306	Rr468<tm3.1Df>	MP:0005391,vision/eye phenotype
MGI:7489586	Rr49<em1Axvi>	MP:0011092,embryonic lethality, complete penetrance
MGI:4421037	Rr4<tm1Hgc>	MP:0002169,no abnormal phenotype detected
MGI:7707802	Rr504<em1Takas>	MP:0001939,secondary sex reversal
MGI:7707822	Rr504<em2Takas>	MP:0002687,oligozoospermia|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype
MGI:7707823	Rr504<em3Takas>	MP:0004851,increased testis weight|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0011416,abnormal testis interstitial tissue morphology
MGI:7787033	Rr504<em4Takas>	MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005189,abnormal anogenital distance|MP:0005380,embryo phenotype
MGI:7787037	Rr504<em5Takas>	MP:0001939,secondary sex reversal
MGI:7709764	Rr510<em1Mwil>	MP:0000137,abnormal vertebrae morphology|MP:0001525,impaired balance|MP:0003314,dysmetria|MP:0004263,abnormal limb posture|MP:0005386,behavior/neurological phenotype|MP:0020167,abnormal vertical activity
MGI:7489587	Rr51<em1Axvi>	MP:0001178,pulmonary hypoplasia|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7489590	Rr53<em1Axvi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:7489588	Rr54<em1Axvi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:7489591	Rr55<em1Axvi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:7852299	Rr592<em2Rnis>	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype
MGI:7852482	Rr593<em1Emta>	MP:0000274,enlarged heart|MP:0002753,dilated heart left ventricle|MP:0004090,abnormal sarcomere morphology|MP:0010633,myocardium hypertrophy|MP:0031633,decreased heart left ventricle muscle contractility
MGI:7853984	Rr596<tm1.1Low>	MP:0001257,increased body length|MP:0001261,obese|MP:0001433,polyphagia|MP:0001552,increased circulating triglyceride level|MP:0002981,increased liver weight|MP:0005178,increased circulating cholesterol level|MP:0010024,increased total body fat amount|MP:0013279,increased fasting circulating glucose level
MGI:7855976	Rr597<em1Yagk>	MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0013458,decreased eccrine gland number
MGI:5578654	Rr609<m1H>	MP:0000063,decreased bone mineral density|MP:0000194,increased circulating calcium level|MP:0000589,thin tail|MP:0000607,abnormal hepatocyte morphology|MP:0001199,thin skin|MP:0001260,increased body weight|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001426,polydipsia|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0001745,increased circulating corticosterone level|MP:0001759,increased urine glucose level|MP:0001762,polyuria|MP:0001764,abnormal homeostasis|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002397,abnormal bone marrow morphology|MP:0002712,increased circulating glucagon level|MP:0002905,decreased circulating parathyroid hormone level|MP:0002941,increased circulating alanine transaminase level|MP:0002962,increased urine protein level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0003963,abnormal corticosterone level|MP:0004989,decreased osteoblast cell number|MP:0005114,premature hair loss|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005343,increased circulating aspartate transaminase level|MP:0005376,homeostasis/metabolism phenotype|MP:0005441,increased urine calcium level|MP:0005553,increased circulating creatinine level|MP:0005568,increased circulating total protein level|MP:0005669,increased circulating leptin level|MP:0008821,increased blood uric acid level|MP:0009115,abnormal fat cell morphology|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0010024,increased total body fat amount|MP:0011549,increased urine corticosterone level|MP:0013307,increased adrenal gland weight|MP:0014286,increased adrenal gland zona fasciculata size|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization|MP:0030985,decreased circulating osteocalcin level
MGI:8186509	Rr695522<em1Vmc>	MP:0001636,irregular heartbeat|MP:0003137,abnormal impulse conducting system conduction|MP:0003896,prolonged PR interval|MP:0003928,increased heart rate variability|MP:0004070,abnormal P wave|MP:0005333,decreased heart rate
MGI:8186510	Rr695523<em1Vmc>	MP:0001636,irregular heartbeat|MP:0003137,abnormal impulse conducting system conduction|MP:0003928,increased heart rate variability|MP:0004070,abnormal P wave|MP:0005333,decreased heart rate
MGI:5500170	Rr695562<tm1.1Glh>	MP:0002169,no abnormal phenotype detected
MGI:5500171	Rr695562<tm1Glh>	MP:0002169,no abnormal phenotype detected
MGI:8237986	Rr695571<tm1Dlsi>	MP:0003631,nervous system phenotype|MP:0003648,abnormal radial glial cell morphology|MP:0008547,abnormal neocortex morphology|MP:0014812,abnormal brain physiology|MP:0020067,increased neocortex size|MP:0020069,decreased neocortex size|MP:0020389,increased radial glial cell number
MGI:8262913	Rr695606<em2Plm>	MP:0001923,reduced female fertility|MP:0009006,prolonged estrous cycle
MGI:3617404	Rr70<tm1Alb>	MP:0003121,genetic imprinting|MP:0003787,abnormal imprinting|MP:0008877,abnormal DNA methylation
MGI:6438145	Rr76<em1Ona>	MP:0002169,no abnormal phenotype detected
MGI:7580428	Rr79<em2Rtew>	MP:0001828,abnormal T cell activation|MP:0002444,abnormal T cell physiology|MP:0003944,abnormal T cell subpopulation ratio
MGI:4837102	Rr7<tm1.1Kio>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0005387,immune system phenotype
MGI:4837105	Rr7<tm2.1Kio>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0005387,immune system phenotype
MGI:5305062	Rr7<tm3.1Kio>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0005387,immune system phenotype
MGI:5305068	Rr7<tm4.1Kio>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology
MGI:5305069	Rr7<tm5.1Kio>	MP:0005387,immune system phenotype
MGI:6720282	Rr80<em1Jwsk>	MP:0000458,abnormal mandible morphology
MGI:6762177	Rr83<tm1Stlo>	MP:0001003,abnormal olfactory receptor morphology
MGI:4413473	Rr92<tm1.1Brts>	MP:0010768,mortality/aging
MGI:4452050	Rr94<tm3.1Litt>	MP:0002145,abnormal T cell differentiation|MP:0003944,abnormal T cell subpopulation ratio|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:4452053	Rr94<tm3.2Litt>	MP:0002145,abnormal T cell differentiation|MP:0002408,abnormal double-positive T cell morphology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0003944,abnormal T cell subpopulation ratio|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:7439589	Rr95<em1Pdi>	MP:0005387,immune system phenotype
MGI:3774142	Rr96<tm1.1Yzo>	MP:0002145,abnormal T cell differentiation|MP:0005091,increased double-positive T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number
MGI:3774141	Rr96<tm1Yzo>	MP:0002145,abnormal T cell differentiation|MP:0002169,no abnormal phenotype detected|MP:0005091,increased double-positive T cell number
MGI:2446611	Rr96<tm2Litt>	MP:0005010,abnormal CD8-positive, alpha beta T cell morphology
MGI:3761127	Rr97<tm3Welm>	MP:0002145,abnormal T cell differentiation|MP:0002408,abnormal double-positive T cell morphology|MP:0005461,abnormal dendritic cell morphology|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008349,abnormal gamma-delta intraepithelial T cell morphology
MGI:3698402	Rr98<tm1Welm>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype
MGI:3584476	Rr99<tm1Litt>	MP:0005010,abnormal CD8-positive, alpha beta T cell morphology
MGI:4880765	Rr9<tm1.1Kubo>	MP:0005387,immune system phenotype|MP:0008673,decreased interleukin-13 secretion
MGI:5502315	Rrad<tm1.1(KOMP)Vlcg>	MP:0002626,increased heart rate|MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005627,increased circulating potassium level|MP:0010507,shortened RR interval|MP:0010571,shortened ST segment
MGI:3827009	Rrad<tm1Yec>	MP:0002833,increased heart weight|MP:0002972,abnormal cardiac muscle contractility|MP:0005385,cardiovascular system phenotype
MGI:5499905	Rraga<tm1.1Dmsa>	MP:0000189,hypoglycemia|MP:0003383,abnormal gluconeogenesis|MP:0005311,abnormal circulating amino acid level|MP:0005376,homeostasis/metabolism phenotype|MP:0005438,abnormal glycogen homeostasis|MP:0008260,abnormal autophagy|MP:0009674,decreased birth weight|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011087,neonatal lethality, complete penetrance
MGI:5638547	Rraga<tm1Dmsa>	MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5638549	Rraga<tm2.1Dmsa>	MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5638548	Rraga<tm2Dmsa>	MP:0000220,increased monocyte cell number|MP:0000691,enlarged spleen|MP:0001263,weight loss|MP:0002083,premature death|MP:0002891,increased insulin sensitivity|MP:0005017,decreased B cell number|MP:0005560,decreased circulating glucose level|MP:0006042,increased apoptosis|MP:0010373,myeloid hyperplasia|MP:0012431,increased lymphoma incidence|MP:0020444,abnormal intestine apoptosis
MGI:5638551	Rragb<tm1.1Dmsa>	MP:0002169,no abnormal phenotype detected
MGI:6874615	Rragc<em1Efe>	MP:0001806,decreased IgM level|MP:0002459,abnormal B cell physiology|MP:0004816,abnormal class switch recombination|MP:0005093,decreased B cell proliferation|MP:0005378,growth/size/body region phenotype|MP:0005397,hematopoietic system phenotype|MP:0008098,decreased plasma cell number|MP:0008178,decreased germinal center B cell number|MP:0008217,abnormal B cell activation|MP:0008484,decreased spleen germinal center size|MP:0008495,decreased IgG1 level|MP:0010080,abnormal hepatocyte physiology|MP:0010768,mortality/aging|MP:0011100,preweaning lethality, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0020154,impaired humoral immune response|MP:0020414,abnormal fibroblast physiology
MGI:6414528	Rras2<em1(IMPC)Ccpcz>	MP:0000538,abnormal urinary bladder morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001262,decreased body weight|MP:0002135,abnormal kidney morphology|MP:0008044,increased NK cell number|MP:0009709,hydrometra
MGI:4294133	Rras2<Gt(OST361011)Lex>	MP:0000694,spleen hypoplasia|MP:0002459,abnormal B cell physiology|MP:0003718,maternal effect|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004953,decreased spleen weight|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005093,decreased B cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008050,decreased memory T cell number|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008217,abnormal B cell activation|MP:0008522,abnormal lymph node germinal center morphology|MP:0014348,decreased spleen B cell follicle size
MGI:4160490	Rras2<Gt(OST47398)Lex>	MP:0001264,increased body size|MP:0001326,retina degeneration|MP:0002792,abnormal retina vasculature morphology|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0008515,thin retina outer nuclear layer|MP:0010024,increased total body fat amount
MGI:6144259	Rras<em1(IMPC)H>	MP:0000195,decreased circulating calcium level|MP:0001552,increased circulating triglyceride level|MP:0002965,increased circulating serum albumin level|MP:0010052,increased grip strength|MP:0013278,decreased fasting circulating glucose level
MGI:3530792	Rras<Gt(OST24882)Lex>	MP:0003710,abnormal physiological neovascularization|MP:0004883,abnormal vascular wound healing|MP:0005017,decreased B cell number|MP:0006135,artery stenosis|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010144,abnormal tumor vascularization
MGI:5314105	Rras<tm1Itl>	MP:0002376,abnormal dendritic cell physiology|MP:0003721,increased tumor growth/size|MP:0005387,immune system phenotype|MP:0005461,abnormal dendritic cell morphology
MGI:6283589	Rrbp1<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001304,cataract|MP:0002591,decreased mean corpuscular volume|MP:0003960,increased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005419,decreased circulating serum albumin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005567,decreased circulating total protein level|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7339258	Rreb1<em1Tcp>	MP:0000351,increased cell proliferation|MP:0000445,short snout|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001300,ocular hypertelorism|MP:0001625,cardiac hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0002834,decreased heart weight|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance|MP:0030166,increased inner canthal distance|MP:0030189,broad snout
MGI:5817430	Rreb1<Sao>	MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0001393,ataxia
MGI:5816878	Rreb1<tm1b(EUCOMM)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003960,increased lean body mass|MP:0005419,decreased circulating serum albumin level|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width
MGI:6368179	Rrh<tm1Ght>	MP:0005253,abnormal eye physiology
MGI:5766147	Rrm1<tm1.1(NCOM)Mfgc>	MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5776729	Rrm1<tm1.1Ofc>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:6489292	Rrm2b<em1Mem>	MP:0001263,weight loss|MP:0002083,premature death|MP:0004969,pale kidney
MGI:6489298	Rrm2b<em2Mem>	MP:0001263,weight loss|MP:0002083,premature death|MP:0004969,pale kidney
MGI:3529827	Rrm2b<Gt(OST85254)Lex>	MP:0000208,decreased hematocrit|MP:0000523,cortical renal glomerulopathies|MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0001566,increased circulating phosphate level|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002828,abnormal renal glomerular capsule morphology|MP:0002874,decreased hemoglobin content|MP:0002962,increased urine protein level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003068,enlarged kidney|MP:0003606,kidney failure|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0003797,abnormal compact bone morphology|MP:0003961,decreased lean body mass|MP:0004153,increased renal tubule apoptosis|MP:0004154,renal tubular necrosis|MP:0004969,pale kidney|MP:0005178,increased circulating cholesterol level|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005505,thrombocytosis|MP:0005553,increased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0008140,podocyte foot process effacement|MP:0008489,slow postnatal weight gain|MP:0009640,abnormal renal tubule epithelium morphology|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0010025,decreased total body fat amount|MP:0011320,abnormal glomerular capillary morphology|MP:0011339,abnormal glomerular mesangium morphology|MP:0011346,renal tubule atrophy|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011352,proximal convoluted tubule brush border loss|MP:0011359,decreased glomerular capillary number|MP:0011368,increased kidney apoptosis|MP:0011377,renal glomerulus fibrosis|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011440,increased kidney cell proliferation|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011454,abnormal glomerular endothelium fenestra morphology|MP:0011498,abnormal glomerular capsule parietal layer morphology|MP:0011501,increased glomerular capsule space|MP:0011871,podocyte hypertrophy
MGI:2672883	Rrm2b<tm1Ynak>	MP:0000598,abnormal liver morphology|MP:0000711,thymus cortex hypoplasia|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002136,abnormal kidney physiology|MP:0002651,abnormal sciatic nerve morphology|MP:0002705,dilated renal tubule|MP:0002962,increased urine protein level|MP:0003141,cardiac fibrosis|MP:0003606,kidney failure|MP:0003793,abnormal submandibular gland morphology|MP:0004111,abnormal coronary artery morphology|MP:0005232,abnormal mesenteric lymph node morphology|MP:0005264,glomerulosclerosis|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008479,decreased spleen white pulp amount|MP:0009417,skeletal muscle atrophy|MP:0011368,increased kidney apoptosis
MGI:5548970	Rrm2<tm1b(KOMP)Wtsi>	MP:0001566,increased circulating phosphate level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3584035	Rrn3<tm1.1Igt>	MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002229,neurodegeneration|MP:0003244,loss of dopaminergic neurons|MP:0003674,oxidative stress|MP:0005384,cellular phenotype|MP:0005424,jerky movement|MP:0005621,abnormal cell physiology|MP:0005643,decreased dopamine level|MP:0006035,abnormal mitochondrial morphology|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0008489,slow postnatal weight gain|MP:0008830,abnormal nucleolus morphology
MGI:3584037	Rrn3<tm1.2Igt>	MP:0001689,incomplete somite formation|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0002151,abnormal neural tube morphology|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012505,increased neural tube apoptosis
MGI:2680115	Rrodp1<C57BL/6J>	MP:0003312,abnormal locomotor coordination
MGI:2680116	Rrodp2<129S6/SvEvTac>	MP:0003312,abnormal locomotor coordination
MGI:5790642	Rrp1b<tm2b(EUCOMM)Hmgu>	MP:0002699,abnormal vitreous body morphology
MGI:6257632	Rrp1<em1(IMPC)Bay>	MP:0005534,decreased body temperature|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5581417	Rrp8<tm1.1(KOMP)Vlcg>	MP:0001697,abnormal embryo size|MP:0002941,increased circulating alanine transaminase level|MP:0003019,increased circulating chloride level|MP:0003064,decreased coping response|MP:0003984,embryonic growth retardation|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:5749453	Rrs1<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3617827	Rrsv<A/WySnJ>	MP:0002021,increased incidence of induced tumors|MP:0002032,increased sarcoma incidence
MGI:3617826	Rrsv<CBA/J>	MP:0002021,increased incidence of induced tumors|MP:0002032,increased sarcoma incidence
MGI:3617828	Rrsv<SW>	MP:0002053,decreased incidence of induced tumors
MGI:1857022	rs	MP:0000370,head blaze|MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0002075,abnormal coat/hair pigmentation|MP:0002938,white spotting|MP:0002939,head spot|MP:0008237,abnormal ventral coat pigmentation
MGI:6383470	Rs1<em1Fegu>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001325,abnormal retina morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0005551,abnormal eye electrophysiology|MP:0006069,abnormal retina neuronal layer morphology|MP:0008512,disorganized retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008516,disorganized retina outer nuclear layer|MP:0008520,disorganized retina outer plexiform layer|MP:0008580,photoreceptor inner segment degeneration|MP:0008582,short photoreceptor inner segment|MP:0012144,decreased b-wave amplitude|MP:0020816,decreased photoreceptor outer segment number
MGI:6404913	Rs1<tm1.1Rom>	MP:0001006,abnormal retina cone cell morphology|MP:0001325,abnormal retina morphology|MP:0002182,abnormal astrocyte morphology|MP:0002184,abnormal innervation|MP:0003727,abnormal retina layer morphology|MP:0004811,abnormal neuron physiology|MP:0005547,abnormal Muller cell morphology|MP:0005551,abnormal eye electrophysiology|MP:0008515,thin retina outer nuclear layer|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0014333,short retina cone cell outer segment
MGI:3056058	Rs1<tm1Sie>	MP:0001325,abnormal retina morphology|MP:0001328,disorganized retina layers|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0005551,abnormal eye electrophysiology|MP:0006069,abnormal retina neuronal layer morphology|MP:0008512,disorganized retina inner nuclear layer|MP:0008516,disorganized retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008520,disorganized retina outer plexiform layer|MP:0008581,disorganized photoreceptor inner segment|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:2179757	Rs1<tm1Web>	MP:0001325,abnormal retina morphology|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0004022,abnormal cone electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0008446,decreased retina cone cell number|MP:0008512,disorganized retina inner nuclear layer|MP:0008516,disorganized retina outer nuclear layer|MP:0008585,absent photoreceptor outer segment
MGI:6404921	Rs1<tm2.1Rom>	MP:0001006,abnormal retina cone cell morphology|MP:0001325,abnormal retina morphology|MP:0002182,abnormal astrocyte morphology|MP:0002184,abnormal innervation|MP:0003727,abnormal retina layer morphology|MP:0004811,abnormal neuron physiology|MP:0005391,vision/eye phenotype|MP:0005547,abnormal Muller cell morphology|MP:0005551,abnormal eye electrophysiology|MP:0008515,thin retina outer nuclear layer|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0014333,short retina cone cell outer segment
MGI:6404929	Rs1<tm3.1Rom>	MP:0001006,abnormal retina cone cell morphology|MP:0001325,abnormal retina morphology|MP:0002182,abnormal astrocyte morphology|MP:0002184,abnormal innervation|MP:0003727,abnormal retina layer morphology|MP:0004811,abnormal neuron physiology|MP:0005391,vision/eye phenotype|MP:0005547,abnormal Muller cell morphology|MP:0005551,abnormal eye electrophysiology|MP:0008515,thin retina outer nuclear layer|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0014333,short retina cone cell outer segment
MGI:2448640	Rs1<tmgc1>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001328,disorganized retina layers|MP:0002864,abnormal ocular fundus morphology|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005240,abnormal amacrine cell morphology|MP:0005551,abnormal eye electrophysiology|MP:0006069,abnormal retina neuronal layer morphology
MGI:1857886	rs<2J>	MP:0000370,head blaze|MP:0000371,diluted coat color|MP:0000373,belly spot
MGI:5548890	Rsad1<tm1.1(KOMP)Vlcg>	MP:0000702,enlarged lymph nodes|MP:0000706,small thymus|MP:0001120,abnormal uterus morphology|MP:0002768,small adrenal glands|MP:0005566,decreased blood urea nitrogen level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6153816	Rsad2<em1(IMPC)H>	MP:0001402,decreased locomotor activity|MP:0001566,increased circulating phosphate level|MP:0002965,increased circulating serum albumin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0004924,abnormal behavior|MP:0005553,increased circulating creatinine level|MP:0005627,increased circulating potassium level|MP:0011951,increased cardiac stroke volume|MP:0020870,decreased thigmotaxis
MGI:4943550	Rsad2<tm1Aki>	MP:0008563,decreased interferon-alpha secretion|MP:0008565,decreased interferon-beta secretion|MP:0008574,decreased circulating interferon-alpha level
MGI:3844545	Rsad2<tm1Kchc>	MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008495,decreased IgG1 level|MP:0008566,increased interferon-gamma secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion
MGI:5548833	Rsbn1<tm1b(EUCOMM)Wtsi>	MP:0001392,abnormal locomotor behavior|MP:0002059,abnormal seminal vesicle morphology|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:3526519	Rsc1a1<tm1Koep>	MP:0000676,abnormal body water content|MP:0001260,increased body weight|MP:0001261,obese|MP:0001264,increased body size|MP:0005178,increased circulating cholesterol level|MP:0005448,abnormal energy homeostasis|MP:0005449,abnormal food intake|MP:0005458,increased percent body fat/body weight|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0013758,increased intestinal glucose absorption
MGI:5605823	Rsf1<tm1b(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0001697,abnormal embryo size|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:6270386	Rsf1<tm1c(EUCOMM)Wtsi>	MP:0003204,decreased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0010948,abnormal double-strand DNA break repair
MGI:1856889	rs<grc>	MP:0002075,abnormal coat/hair pigmentation
MGI:3044189	rsl	MP:0005389,reproductive system phenotype
MGI:3525236	rslk	MP:0000370,head blaze|MP:0000371,diluted coat color|MP:0000373,belly spot
MGI:3616701	rslk<2J>	MP:0000371,diluted coat color|MP:0002938,white spotting
MGI:1857023	rsm1	MP:0002421,abnormal cell-mediated immunity
MGI:3688847	rsnd<1R>	MP:0000564,syndactyly|MP:0001525,impaired balance
MGI:2177012	rsph	MP:0001925,male infertility|MP:0002686,globozoospermia
MGI:3807704	Rsph1<tm1Htan>	MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0002160,abnormal reproductive system morphology|MP:0002687,oligozoospermia|MP:0003698,abnormal male reproductive system physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009852,increased Sertoli cell phagocytosis
MGI:5696930	Rsph3b<tm1b(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6241356	Rsph6a<em1Osb>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0009230,abnormal sperm head morphology|MP:0009239,short sperm flagellum|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0020869,immotile sperm|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0031375,abnormal manchette disassembly
MGI:6241362	Rsph6a<em2Osb>	MP:0009230,abnormal sperm head morphology|MP:0009239,short sperm flagellum|MP:0020869,immotile sperm
MGI:6466630	Rsph9<em1Jwji>	MP:0000434,megacephaly|MP:0000439,enlarged cranium|MP:0000440,domed cranium|MP:0000747,muscle weakness|MP:0000807,abnormal hippocampus morphology|MP:0000837,abnormal hypothalamus morphology|MP:0000920,abnormal myelination|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001872,sinus inflammation|MP:0001891,hydrocephaly|MP:0002572,abnormal emotion/affect behavior|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0004950,abnormal brain vasculature morphology|MP:0005202,lethargy|MP:0005238,increased brain size|MP:0005378,growth/size/body region phenotype|MP:0006254,thin cerebral cortex|MP:0008535,enlarged lateral ventricles|MP:0008770,decreased survivor rate|MP:0008918,microgliosis|MP:0010152,abnormal brain ependyma morphology|MP:0010160,increased oligodendrocyte number|MP:0011056,abnormal brain ependyma motile cilium morphology|MP:0011069,abnormal brain ependyma motile cilium physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011380,enlarged brain ventricles|MP:0013907,abnormal cerebrospinal fluid flow|MP:0020448,increased microglial cell activation
MGI:5695930	Rsph9<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0002797,increased thigmotaxis|MP:0004924,abnormal behavior|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5583071	Rspo1<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001926,female infertility|MP:0002098,abnormal vibrissa morphology|MP:0002135,abnormal kidney morphology|MP:0002175,decreased brain weight|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content
MGI:3784965	Rspo1<tm1.1Ktom>	MP:0001923,reduced female fertility|MP:0002682,decreased mature ovarian follicle number|MP:0002783,abnormal ovary secretion|MP:0002787,pseudohermaphroditism|MP:0003582,abnormal ovary development|MP:0005431,decreased oocyte number
MGI:3784976	Rspo1<tm1Mcch>	MP:0001931,abnormal oogenesis|MP:0002208,abnormal germ cell morphology|MP:0002787,pseudohermaphroditism|MP:0003582,abnormal ovary development|MP:0005168,abnormal female meiosis|MP:0005431,decreased oocyte number|MP:0011121,decreased primordial ovarian follicle number
MGI:5766760	Rspo1<tm2b(KOMP)Wtsi>	MP:0002699,abnormal vitreous body morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003961,decreased lean body mass|MP:0005013,increased lymphocyte cell number|MP:0005553,increased circulating creatinine level|MP:0011960,abnormal eye anterior chamber depth|MP:0011965,decreased total retina thickness
MGI:3045965	Rspo2<ftls>	MP:0000527,abnormal kidney development|MP:0000528,delayed kidney development|MP:0000550,abnormal forelimb morphology|MP:0000553,absent radius|MP:0000556,abnormal hindlimb morphology|MP:0000572,abnormal autopod morphology|MP:0001923,reduced female fertility|MP:0002016,ovary cyst|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0002728,absent tibia|MP:0002764,short tibia|MP:0003355,decreased ovulation rate|MP:0003604,single kidney|MP:0005306,abnormal phalanx morphology|MP:0005430,absent fibula|MP:0008494,absence of all nails|MP:0009890,cleft secondary palate|MP:0011089,perinatal lethality, complete penetrance|MP:0014320,abnormal autopod rotation|MP:0014322,short hindlimb
MGI:3783769	Rspo2<tm1Hoka>	MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000572,abnormal autopod morphology|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0002110,abnormal digit morphology|MP:0003855,abnormal forelimb zeugopod morphology|MP:0005306,abnormal phalanx morphology|MP:0005430,absent fibula|MP:0006279,abnormal limb development|MP:0011089,perinatal lethality, complete penetrance
MGI:3762378	Rspo2<tm1Nuv>	MP:0000088,short mandible|MP:0000111,cleft palate|MP:0000116,abnormal tooth development|MP:0000520,absent kidney|MP:0000564,syndactyly|MP:0001178,pulmonary hypoplasia|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0001923,reduced female fertility|MP:0002543,brachyphalangia|MP:0002765,short fibula|MP:0003119,abnormal digestive system development|MP:0004007,abnormal lung vasculature morphology|MP:0004538,abnormal maxillary shelf morphology|MP:0004540,small maxilla|MP:0004592,small mandible|MP:0004596,abnormal mandibular angle morphology|MP:0004635,short metatarsal bones|MP:0004912,absent mandibular coronoid process|MP:0005306,abnormal phalanx morphology|MP:0005359,growth retardation of incisors|MP:0006020,decreased tympanic ring size|MP:0006279,abnormal limb development|MP:0008271,abnormal bone ossification|MP:0008494,absence of all nails|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009890,cleft secondary palate|MP:0009907,decreased tongue size|MP:0011089,perinatal lethality, complete penetrance|MP:0011262,abnormal pharyngeal arch mesenchyme morphology|MP:0013933,short Meckel's cartilage|MP:0021166,delayed palatal shelf elevation|MP:0030258,small mandibular condyloid process|MP:0030302,abnormal maxillary zygomatic process morphology
MGI:3839444	Rspo2<tm1Suda>	MP:0000455,abnormal maxilla morphology|MP:0000572,abnormal autopod morphology|MP:0000579,abnormal nail morphology|MP:0001175,abnormal lung morphology|MP:0001178,pulmonary hypoplasia|MP:0001182,lung hemorrhage|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002256,abnormal laryngeal cartilage morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0004423,abnormal temporal bone squamous part morphology|MP:0004912,absent mandibular coronoid process|MP:0005170,cleft upper lip|MP:0005270,abnormal zygomatic bone morphology|MP:0009437,arytenoid and cricoid cartilage fusion|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0009895,decreased palatine bone horizontal plate size|MP:0009898,maxillary shelf hypoplasia|MP:0011087,neonatal lethality, complete penetrance|MP:0014281,hindlimb oligodactyly
MGI:5609537	Rspo3<tm1.1Arte>	MP:0000260,abnormal angiogenesis|MP:0001711,abnormal placenta morphology|MP:0001722,pale yolk sac|MP:0001730,embryonic growth arrest|MP:0001914,hemorrhage|MP:0003229,abnormal vitelline vasculature morphology
MGI:5443941	Rspo3<tm1.1Jcob>	MP:0002169,no abnormal phenotype detected
MGI:5443965	Rspo3<tm1.2Jcob>	MP:0000291,enlarged pericardium|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0001730,embryonic growth arrest|MP:0001914,hemorrhage|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5643687	Rspo3<tm1Arte>	MP:0000255,blood vessel congestion|MP:0000284,double outlet right ventricle|MP:0001787,pericardial edema|MP:0002652,thin myocardium|MP:0003649,decreased heart right ventricle size|MP:0003920,abnormal heart right ventricle morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3695687	Rspo3<tm1Okam>	MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0001730,embryonic growth arrest|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:4364711	Rspo4<tm1a(KOMP)Wtsi>	MP:0013279,increased fasting circulating glucose level
MGI:6285608	Rsrc2<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:6294909	Rsu1<em1(IMPC)J>	MP:0001697,abnormal embryo size|MP:0003717,pallor|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:3665216	Rsxr<129S1/Sv>	MP:0005652,sex reversal
MGI:3665215	Rsxr<C57BL/6J>	MP:0005652,sex reversal
MGI:6356819	Rtbdn<tm1.1Itl>	MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0006069,abnormal retina neuronal layer morphology|MP:0008446,decreased retina cone cell number|MP:0008450,retina photoreceptor degeneration|MP:0008453,decreased retina rod cell number|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:4433926	Rtbdn<tm1a(EUCOMM)Wtsi>	MP:0001325,abnormal retina morphology|MP:0002073,abnormal hair growth|MP:0005292,improved glucose tolerance|MP:0005505,thrombocytosis
MGI:4841792	Rtca<tm1a(EUCOMM)Hmgu>	MP:0003631,nervous system phenotype|MP:0011101,prenatal lethality, incomplete penetrance|MP:0030013,enhanced central nervous system regeneration
MGI:5688394	Rtcb<tm1c(KOMP)Wtsi>	MP:0001806,decreased IgM level|MP:0002439,abnormal plasma cell morphology|MP:0002458,abnormal B cell number|MP:0002459,abnormal B cell physiology
MGI:7444023	Rtcb<tm1Hyfn>	MP:0001127,small ovary|MP:0001926,female infertility|MP:0002777,absent ovarian follicles|MP:0011129,decreased tertiary ovarian follicle number|MP:0031381,decreased secondary ovarian follicle number
MGI:3772371	Rtel1<tm1.1Hdin>	MP:0001711,abnormal placenta morphology|MP:0002151,abnormal neural tube morphology|MP:0004556,enlarged allantois|MP:0005312,pericardial effusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3772370	Rtel1<tm1Hdin>	MP:0002169,no abnormal phenotype detected|MP:0021086,decreased DNA replication
MGI:3052235	Rtel1<tm1Pml>	MP:0000737,abnormal myotome development|MP:0000928,incomplete rostral neuropore closure|MP:0001698,decreased embryo size|MP:0001713,decreased trophoblast giant cell number|MP:0002151,abnormal neural tube morphology|MP:0002584,small ectoplacental cone|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0004206,abnormal dermomyotome development|MP:0004559,small allantois|MP:0005076,abnormal cell differentiation|MP:0005244,hemopericardium|MP:0005294,abnormal heart ventricle morphology|MP:0008817,hematoma|MP:0009657,failure of chorioallantoic fusion|MP:0009845,abnormal neural crest cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011259,abnormal cephalic neural fold morphology|MP:0012675,enlarged floor plate|MP:0030539,abnormal head paraxial mesoderm morphology
MGI:5559530	Rtel1<tm2.1Hdin>	MP:0004046,abnormal mitosis|MP:0005384,cellular phenotype|MP:0005621,abnormal cell physiology|MP:0008008,early cellular replicative senescence|MP:0010207,abnormal telomere morphology|MP:0021086,decreased DNA replication
MGI:5505465	Rtel1<tm2.1Pml>	MP:0002169,no abnormal phenotype detected
MGI:5559531	Rtel1<tm3.1Hdin>	MP:0005384,cellular phenotype
MGI:4363925	Rtf1<tm1a(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:7511793	Rtf1<tm1c(KOMP)Wtsi>	MP:0000280,thin ventricular wall|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0005598,decreased heart ventricle muscle contractility|MP:0006138,congestive heart failure|MP:0006267,abnormal intercalated disk morphology|MP:0008022,dilated heart ventricle|MP:0011925,abnormal heart echocardiography feature|MP:0021158,decreased heart left ventricle wall thickness|MP:0021160,decreased heart right ventricle wall thickness|MP:0031131,myocardial fiber disarray|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4365094	Rtf2<tm1a(KOMP)Wtsi>	MP:0014257,embryonic lethality prior to tooth bud stage, complete penetrance
MGI:7852633	Rtf2<tm1d(KOMP)Wtsi>	MP:0011091,prenatal lethality, complete penetrance
MGI:3525129	Rthyd1<NOD/MrkTac>	MP:0005002,abnormal T cell clonal deletion
MGI:3525130	Rthyd2<B10.Br/SgSnJ>	MP:0005002,abnormal T cell clonal deletion
MGI:3525132	Rthyd3<B10.Br/SgSnJ>	MP:0005002,abnormal T cell clonal deletion
MGI:3525137	Rthyd5<NOD/MrkTac>	MP:0005002,abnormal T cell clonal deletion
MGI:5825309	Rtl10<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation
MGI:3776873	Rtl1<tm1Fuis>	MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0004201,fetal growth retardation|MP:0004258,abnormal placenta size|MP:0004260,enlarged placenta|MP:0004272,abnormal basement membrane morphology|MP:0004920,increased placenta weight|MP:0004921,decreased placenta weight|MP:0005031,abnormal trophoblast layer morphology|MP:0006372,impaired placental function|MP:0008770,decreased survivor rate|MP:0011087,neonatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:6152631	Rtl3<em1(IMPC)Mbp>	MP:0005655,increased aggression|MP:0020421,increased freezing behavior
MGI:5789261	Rtl4<tm1.1Fuis>	MP:0001357,increased aggression towards humans|MP:0001399,hyperactivity|MP:0001413,abnormal response to new environment|MP:0004924,abnormal behavior|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0008911,induced hyperactivity|MP:0010768,mortality/aging|MP:0012574,decreased noradrenaline level|MP:0014114,abnormal cognition|MP:0014370,impaired spatial working memory
MGI:6152725	Rtl5<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0020421,increased freezing behavior
MGI:7378511	Rtl5<tm1.1Tmki>	MP:0005387,immune system phenotype
MGI:7571418	Rtl9<em2Tmki>	MP:0002419,abnormal innate immunity
MGI:6277151	Rtn1<tm1Yanr>	MP:0002169,no abnormal phenotype detected
MGI:3528884	Rtn2<tm1Lex>	MP:0000188,abnormal circulating glucose level|MP:0005369,muscle phenotype|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:5691761	Rtn3<tm1Yanr>	MP:0002135,abnormal kidney morphology|MP:0002703,abnormal renal tubule morphology|MP:0002959,increased urine microalbumin level|MP:0003985,renal fibrosis|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0006035,abnormal mitochondrial morphology|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011425,abnormal kidney interstitium morphology
MGI:6279927	Rtn4<em1(IMPC)Hmgu>	MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0002599,increased mean platelet volume|MP:0004738,abnormal auditory brainstem response|MP:0009142,decreased prepulse inhibition|MP:0010124,decreased bone mineral content|MP:0011964,increased total retina thickness
MGI:3783322	Rtn4<Gt715Lex>	MP:0003651,abnormal axon extension
MGI:2661228	Rtn4<Gt(OST45048)Lex>	MP:0003631,nervous system phenotype|MP:0030013,enhanced central nervous system regeneration
MGI:5705876	Rtn4ip1<tm1.1(KOMP)Vlcg>	MP:0011100,preweaning lethality, complete penetrance
MGI:3530246	Rtn4rl1<Gt(OST188035)Lex>	MP:0000607,abnormal hepatocyte morphology|MP:0002628,hepatic steatosis|MP:0002928,abnormal bile duct morphology
MGI:6449051	Rtn4rl2<em1(IMPC)Mbp>	MP:0000774,decreased brain size|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001304,cataract|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002699,abnormal vitreous body morphology|MP:0003068,enlarged kidney|MP:0004738,abnormal auditory brainstem response|MP:0010067,increased red blood cell distribution width
MGI:3806672	Rtn4rl2<tm1.1Pado>	MP:0003631,nervous system phenotype
MGI:3604410	Rtn4rl2<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:4867902	Rtn4rl2<tm1Svk>	MP:0003631,nervous system phenotype
MGI:5292066	Rtn4rl2<tm1Yanr>	MP:0002169,no abnormal phenotype detected
MGI:5293442	Rtn4r<rgsc1836>	MP:0001463,abnormal spatial learning|MP:0002557,abnormal social/conspecific interaction behavior|MP:0005386,behavior/neurological phenotype
MGI:3806671	Rtn4r<tm1.1Pado>	MP:0003651,abnormal axon extension
MGI:3774128	Rtn4r<tm1Gogo>	MP:0001402,decreased locomotor activity|MP:0002757,decreased vertical activity|MP:0005386,behavior/neurological phenotype
MGI:3530480	Rtn4r<tm1Matl>	MP:0003075,abnormal response to CNS ischemic injury|MP:0003631,nervous system phenotype
MGI:3514018	Rtn4r<tm1Stmr>	MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0030013,enhanced central nervous system regeneration
MGI:5510952	Rtn4r<tm2.2Stmr>	MP:0004858,abnormal nervous system regeneration
MGI:2661136	Rtn4<tm1Matl>	MP:0003633,abnormal nervous system physiology
MGI:3623522	Rtn4<tm1Schw>	MP:0030013,enhanced central nervous system regeneration
MGI:2661216	Rtn4<tm2.1Matl>	MP:0008762,embryonic lethality
MGI:2661167	Rtn4<tm2Matl>	MP:0003631,nervous system phenotype|MP:0011092,embryonic lethality, complete penetrance
MGI:2661204	Rtn4<tm3.1Matl>	MP:0002169,no abnormal phenotype detected|MP:0003407,abnormal central nervous system regeneration
MGI:2661203	Rtn4<tm3Matl>	MP:0002169,no abnormal phenotype detected
MGI:5141446	Rtp1<tm1.1Hmat>	MP:0001924,infertility|MP:0002739,abnormal olfactory bulb development
MGI:5141449	Rtp2<tm1Hmat>	MP:0001924,infertility
MGI:6470099	Rtp4<em#Xzs>	MP:0002410,decreased susceptibility to viral infection|MP:0005026,decreased susceptibility to parasitic infection|MP:0005378,growth/size/body region phenotype|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality|MP:0010768,mortality/aging
MGI:6729665	Rtp4<tm1b(EUCOMM)Hmgu>	MP:0000367,abnormal coat/ hair morphology|MP:0000598,abnormal liver morphology|MP:0001399,hyperactivity|MP:0002599,increased mean platelet volume|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5585725	Rtraf<tm1b(EUCOMM)Hmgu>	MP:0000745,tremors|MP:0001417,decreased exploration in new environment|MP:0005011,increased eosinophil cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6156434	Rttn<em1(IMPC)Tcp>	MP:0000470,abnormal stomach morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0001697,abnormal embryo size|MP:0002060,abnormal skin morphology|MP:0002188,small heart|MP:0003984,embryonic growth retardation|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:2674124	Rttn<Gt(pGT1.8geo)7Pgr>	MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0002151,abnormal neural tube morphology|MP:0004180,failure of initiation of embryo turning|MP:0004252,abnormal direction of heart looping|MP:0004712,notochord degeneration|MP:0005312,pericardial effusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5287032	Rttn<TgTn(sb-cHS4,Tyr)2514A-1bOve>	MP:0001672,abnormal embryo development
MGI:3829722	Rtwq1<PWK/PhJ>	MP:0004852,decreased testis weight
MGI:3829724	Rtwq2<PWK/PhJ>	MP:0004852,decreased testis weight
MGI:6196512	Rubcn<em1Dgre>	MP:0002451,abnormal macrophage physiology|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0010768,mortality/aging
MGI:6356294	Rubcnl<em1Qsun>	MP:0000609,abnormal liver physiology|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0003333,liver fibrosis|MP:0003458,decreased circulating ketone body level|MP:0009355,increased liver triglyceride level|MP:0010400,increased liver glycogen level|MP:0030940,impaired autophagy
MGI:6400429	Rubie<em1Bbr>	MP:0001394,circling
MGI:5568608	Rubie<SWR-J>	MP:0000037,abnormal lateral semicircular canal morphology|MP:0001395,bidirectional circling|MP:0001399,hyperactivity|MP:0011238,abnormal inner ear development
MGI:6283651	Rufy1<em1(IMPC)J>	MP:0003961,decreased lean body mass
MGI:6358745	Rufy1<em1Lagbu>	MP:0005386,behavior/neurological phenotype
MGI:4434385	Rufy2<tm1a(EUCOMM)Wtsi>	MP:0005293,impaired glucose tolerance
MGI:6111136	Rufy3<tm1.1Migar>	MP:0001575,cyanosis|MP:0002882,abnormal neuron morphology|MP:0005404,abnormal axon morphology|MP:0008415,abnormal neurite morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0020581,abnormal neuron polarity
MGI:5581413	Rufy3<tm1b(EUCOMM)Hmgu>	MP:0000470,abnormal stomach morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:6276899	Rufy4<em1(IMPC)Mbp>	MP:0001417,decreased exploration in new environment|MP:0002797,increased thigmotaxis|MP:0020421,increased freezing behavior
MGI:4441618	Rundc1<tm1a(EUCOMM)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0011100,preweaning lethality, complete penetrance
MGI:5548750	Rundc1<tm1b(EUCOMM)Wtsi>	MP:0000150,abnormal rib morphology|MP:0000602,dilated liver sinusoidal space|MP:0002092,abnormal eye morphology|MP:0002947,increased hemangioma incidence|MP:0003686,abnormal eye muscle morphology|MP:0004613,fusion of vertebral arches|MP:0006221,optic nerve hypoplasia|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5609349	Rundc3a<tm1b(EUCOMM)Wtsi>	MP:0001399,hyperactivity|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0011965,decreased total retina thickness|MP:0020870,decreased thigmotaxis
MGI:7425954	Rundc3b<em1(IMPC)Bay>	MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0011960,abnormal eye anterior chamber depth
MGI:6201257	Runx1t1<tm1b(EUCOMM)Hmgu>	MP:0001552,increased circulating triglyceride level|MP:0011100,preweaning lethality, complete penetrance
MGI:2671472	Runx1t1<tm1Buch>	MP:0002169,no abnormal phenotype detected
MGI:2183012	Runx1t1<tm1Fc>	MP:0000477,abnormal intestine morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000492,abnormal rectum morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0002083,premature death|MP:0003052,omphalocele|MP:0003271,abnormal duodenum morphology|MP:0003293,rectal hemorrhage|MP:0003717,pallor|MP:0008108,abnormal small intestinal villus morphology|MP:0009546,absent gastric milk in neonates|MP:0009706,absent midgut|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4417838	Runx1<tm1.1Glac>	MP:0005380,embryo phenotype|MP:0005397,hematopoietic system phenotype|MP:0010768,mortality/aging
MGI:4437264	Runx1<tm1.1Gss>	MP:0000603,pale liver|MP:0001914,hemorrhage|MP:0002123,abnormal definitive hematopoiesis|MP:0004810,decreased hematopoietic stem cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3625886	Runx1<tm1.1Medv>	MP:0002169,no abnormal phenotype detected
MGI:4835663	Runx1<tm1.1(RUNX1*)Homy>	MP:0000603,pale liver|MP:0001606,impaired hematopoiesis|MP:0001786,skin edema|MP:0001914,hemorrhage|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0003279,aneurysm|MP:0003719,abnormal pericyte morphology|MP:0004938,dilated vasculature|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008973,decreased erythroid progenitor cell number|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011182,decreased hematopoietic cell number
MGI:4440931	Runx1<tm1.1Stkd>	MP:0000157,abnormal sternum morphology|MP:0000159,abnormal xiphoid process morphology|MP:0002113,abnormal skeleton development|MP:0002896,abnormal bone mineralization|MP:0005390,skeleton phenotype
MGI:2671464	Runx1<tm1Buch>	MP:0002169,no abnormal phenotype detected
MGI:3711451	Runx1<tm1(cre/Esr1*)Ims>	MP:0002058,neonatal lethality|MP:0005397,hematopoietic system phenotype
MGI:2387293	Runx1<tm1Dez>	MP:0001606,impaired hematopoiesis|MP:0001914,hemorrhage|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1857580	Runx1<tm1Dow>	MP:0000603,pale liver|MP:0001634,internal hemorrhage|MP:0001917,intraventricular hemorrhage|MP:0002169,no abnormal phenotype detected|MP:0003396,abnormal embryonic hematopoiesis|MP:0005244,hemopericardium|MP:0005435,hemoperitoneum|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3777250	Runx1<tm1Itan>	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:3625885	Runx1<tm1Medv>	MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0001914,hemorrhage|MP:0002058,neonatal lethality|MP:0002396,abnormal hematopoietic system morphology/development|MP:0003717,pallor|MP:0005397,hematopoietic system phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011180,abnormal hematopoietic cell number
MGI:3701004	Runx1<tm1(RUNX1/EVI1)Kmit>	MP:0001601,abnormal myelopoiesis|MP:0001917,intraventricular hemorrhage|MP:0002417,abnormal megakaryocyte morphology|MP:0002875,decreased erythrocyte cell number|MP:0003396,abnormal embryonic hematopoiesis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3621479	Runx1<tm1(RUNX1)Gcg>	MP:0001272,increased metastatic potential|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0002024,increased T cell derived lymphoma incidence|MP:0002145,abnormal T cell differentiation|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008111,abnormal granulocyte differentiation
MGI:1934197	Runx1<tm1Sata>	MP:0000245,abnormal erythropoiesis|MP:0000260,abnormal angiogenesis|MP:0001634,internal hemorrhage|MP:0001917,intraventricular hemorrhage|MP:0002123,abnormal definitive hematopoiesis|MP:0003227,abnormal vascular branching morphogenesis|MP:0003279,aneurysm|MP:0004076,abnormal vitelline vascular remodeling|MP:0005244,hemopericardium|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1857568	Runx1<tm1Spe>	MP:0000245,abnormal erythropoiesis|MP:0001602,impaired myelopoiesis|MP:0001606,impaired hematopoiesis|MP:0001634,internal hemorrhage|MP:0001914,hemorrhage|MP:0002006,neoplasm|MP:0002024,increased T cell derived lymphoma incidence|MP:0003396,abnormal embryonic hematopoiesis|MP:0005244,hemopericardium|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0009395,increased nucleated erythrocyte cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013241,embryo tissue necrosis
MGI:2447630	Runx1<tm1Tani>	MP:0000715,decreased thymocyte number|MP:0001825,arrested T cell differentiation|MP:0002408,abnormal double-positive T cell morphology|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation
MGI:3029984	Runx1<tm1Toku>	MP:0000706,small thymus|MP:0001823,thymus hypoplasia|MP:0003944,abnormal T cell subpopulation ratio|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3760788	Runx1<tm1Yg>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001265,decreased body size|MP:0001823,thymus hypoplasia|MP:0002123,abnormal definitive hematopoiesis|MP:0002145,abnormal T cell differentiation|MP:0002367,abnormal thymus lobule morphology|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002398,abnormal bone marrow cell morphology/development|MP:0004787,abnormal dorsal aorta morphology|MP:0005018,decreased T cell number|MP:0005091,increased double-positive T cell number|MP:0005460,abnormal leukopoiesis|MP:0008083,decreased single-positive T cell number|MP:0008489,slow postnatal weight gain|MP:0009541,increased thymocyte apoptosis|MP:0009543,abnormal thymus corticomedullary boundary morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0014130,thymus cyst
MGI:5316015	Runx1<tm2.1(cre/Esr1*)Ims>	MP:0001577,anemia|MP:0001914,hemorrhage|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5613812	Runx1<tm2.1Gss>	MP:0000208,decreased hematocrit|MP:0000220,increased monocyte cell number|MP:0000229,abnormal megakaryocyte differentiation|MP:0000245,abnormal erythropoiesis|MP:0000322,increased granulocyte number|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002123,abnormal definitive hematopoiesis|MP:0002357,abnormal spleen white pulp morphology|MP:0002417,abnormal megakaryocyte morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0003131,increased erythrocyte cell number|MP:0005397,hematopoietic system phenotype|MP:0005425,increased macrophage cell number|MP:0005505,thrombocytosis|MP:0005564,increased hemoglobin content|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008186,increased pro-B cell number|MP:0008210,increased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008246,abnormal leukocyte morphology|MP:0008801,abnormal erythroid progenitor cell morphology|MP:0010067,increased red blood cell distribution width|MP:0010373,myeloid hyperplasia|MP:0010768,mortality/aging|MP:0011816,decreased pre-pro B cell number
MGI:4835664	Runx1<tm2.1(Runx1/Mecom)Homy>	MP:0002169,no abnormal phenotype detected
MGI:3798051	Runx1<tm2Buch>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000324,increased mast cell number|MP:0000701,abnormal lymph node size|MP:0001602,impaired myelopoiesis|MP:0002024,increased T cell derived lymphoma incidence|MP:0002169,no abnormal phenotype detected|MP:0002367,abnormal thymus lobule morphology|MP:0002417,abnormal megakaryocyte morphology|MP:0002722,abnormal immune system organ morphology|MP:0003179,thrombocytopenia|MP:0004809,increased hematopoietic stem cell number|MP:0004952,increased spleen weight|MP:0004956,decreased thymus weight|MP:0005016,decreased lymphocyte cell number|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008135,small Peyer's patches|MP:0008211,decreased mature B cell number|MP:0008246,abnormal leukocyte morphology|MP:0008255,decreased megakaryocyte cell number|MP:0008476,increased spleen red pulp amount|MP:0008479,decreased spleen white pulp amount|MP:0010178,increased number of Howell-Jolly bodies|MP:0012431,increased lymphoma incidence
MGI:2387300	Runx1<tm2Dow>	MP:0000603,pale liver|MP:0001917,intraventricular hemorrhage|MP:0003396,abnormal embryonic hematopoiesis|MP:0005244,hemopericardium|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3777251	Runx1<tm2Itan>	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:3029983	Runx1<tm2(Runx1)Toku>	MP:0003944,abnormal T cell subpopulation ratio
MGI:4358510	Runx1<tm3.1Spe>	MP:0002169,no abnormal phenotype detected
MGI:2387301	Runx1<tm3Dow>	MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002032,increased sarcoma incidence|MP:0002396,abnormal hematopoietic system morphology/development|MP:0004049,increased acute promyelocytic leukemia incidence|MP:0005397,hematopoietic system phenotype|MP:0005621,abnormal cell physiology|MP:0014237,decreased tumor-free survival time
MGI:4458865	Runx1<tm3Itan>	MP:0000221,decreased leukocyte cell number|MP:0000696,abnormal Peyer's patch morphology|MP:0000715,decreased thymocyte number|MP:0002340,abnormal axillary lymph node morphology|MP:0002353,abnormal inguinal lymph node morphology|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002450,abnormal lymph organ development|MP:0003179,thrombocytopenia|MP:0004787,abnormal dorsal aorta morphology|MP:0004809,increased hematopoietic stem cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0010768,mortality/aging
MGI:3581528	Runx1<tm3(Runx3)Toku>	MP:0000221,decreased leukocyte cell number|MP:0000692,small spleen|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001823,thymus hypoplasia|MP:0002375,abnormal thymus medulla morphology|MP:0005016,decreased lymphocyte cell number|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3043614	Runx1<tm3Spe>	MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0000402,abnormal zigzag hair morphology|MP:0000404,decreased curvature of zigzag hairs|MP:0000406,increased curvature of auchene hairs|MP:0000603,pale liver|MP:0000715,decreased thymocyte number|MP:0000966,decreased sensory neuron number|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001510,abnormal coat appearance|MP:0001577,anemia|MP:0001634,internal hemorrhage|MP:0001825,arrested T cell differentiation|MP:0002169,no abnormal phenotype detected|MP:0002414,abnormal myeloblast morphology/development|MP:0003043,hypoalgesia|MP:0003179,thrombocytopenia|MP:0004499,increased incidence of tumors by chemical induction|MP:0004720,abnormal platelet morphology|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004809,increased hematopoietic stem cell number|MP:0004810,decreased hematopoietic stem cell number|MP:0004952,increased spleen weight|MP:0004956,decreased thymus weight|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005089,decreased double-negative T cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005386,behavior/neurological phenotype|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0009253,abnormal sympathetic neuron physiology|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3040872	Runx1<tm4Dow>	MP:0002169,no abnormal phenotype detected
MGI:3581529	Runx1<tm4(Runx2)Toku>	MP:0000221,decreased leukocyte cell number
MGI:3707165	Runx1<tm4Spe>	MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0001732,postnatal growth retardation|MP:0003179,thrombocytopenia|MP:0003396,abnormal embryonic hematopoiesis|MP:0005016,decreased lymphocyte cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3707170	Runx1<tm5Spe>	MP:0001917,intraventricular hemorrhage|MP:0003396,abnormal embryonic hematopoiesis|MP:0005244,hemopericardium|MP:0005435,hemoperitoneum|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3707171	Runx1<tm6Spe>	MP:0001917,intraventricular hemorrhage|MP:0003396,abnormal embryonic hematopoiesis|MP:0005244,hemopericardium|MP:0005435,hemoperitoneum|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3707172	Runx1<tm7Spe>	MP:0001917,intraventricular hemorrhage|MP:0003396,abnormal embryonic hematopoiesis|MP:0005244,hemopericardium|MP:0005435,hemoperitoneum|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3707173	Runx1<tm8Spe>	MP:0001732,postnatal growth retardation|MP:0001861,lung inflammation|MP:0003396,abnormal embryonic hematopoiesis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0011085,postnatal lethality, complete penetrance
MGI:6402897	Runx2<em1(IMPC)Rbrc>	MP:0000137,abnormal vertebrae morphology|MP:0000438,abnormal cranium morphology|MP:0003795,abnormal bone structure|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004599,abnormal vertebral arch morphology|MP:0005270,abnormal zygomatic bone morphology|MP:0005296,abnormal humerus morphology|MP:0005298,abnormal clavicle morphology|MP:0010124,decreased bone mineral content
MGI:5750985	Runx2<tm1.1Hkiy>	MP:0010768,mortality/aging
MGI:3829608	Runx2<tm1.1Jals>	MP:0005390,skeleton phenotype
MGI:5570536	Runx2<tm1.1Yyon>	MP:0000060,delayed bone ossification|MP:0001954,respiratory distress|MP:0003419,delayed endochondral bone ossification|MP:0005390,skeleton phenotype|MP:0010768,mortality/aging|MP:0011087,neonatal lethality, complete penetrance
MGI:2183833	Runx2<tm1Gss>	MP:0000074,abnormal neurocranium morphology|MP:0000164,abnormal cartilage development|MP:0000259,abnormal vascular development|MP:0001262,decreased body weight|MP:0002116,abnormal craniofacial bone morphology|MP:0002896,abnormal bone mineralization|MP:0004339,absent clavicle|MP:0005390,skeleton phenotype|MP:0006279,abnormal limb development|MP:0008271,abnormal bone ossification|MP:0008489,slow postnatal weight gain|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5750983	Runx2<tm1Hkiy>	MP:0000060,delayed bone ossification|MP:0000074,abnormal neurocranium morphology|MP:0002113,abnormal skeleton development|MP:0003056,abnormal hyoid bone morphology|MP:0003419,delayed endochondral bone ossification|MP:0003420,delayed intramembranous bone ossification|MP:0004016,decreased bone mass|MP:0004338,small clavicle|MP:0004339,absent clavicle|MP:0004440,absent occipital bone|MP:0005306,abnormal phalanx morphology|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0011087,neonatal lethality, complete penetrance|MP:0011711,impaired osteoblast differentiation|MP:0013616,decreased volumetric bone mineral density|MP:0013630,increased bone trabecular spacing|MP:0020010,decreased bone mineral density of femur|MP:0030371,delayed sagittal suture closure
MGI:3829607	Runx2<tm1Jals>	MP:0000074,abnormal neurocranium morphology|MP:0000130,abnormal trabecular bone morphology|MP:0002113,abnormal skeleton development|MP:0002835,abnormal cranial suture morphology|MP:0004337,clavicle hypoplasia|MP:0004462,small basisphenoid bone|MP:0005298,abnormal clavicle morphology|MP:0005390,skeleton phenotype|MP:0008271,abnormal bone ossification|MP:0008395,abnormal osteoblast differentiation|MP:0010768,mortality/aging|MP:0030029,wide cranial sutures|MP:0030438,increased osteoblast proliferation
MGI:5582325	Runx2<tm1Javed>	MP:0000138,absent vertebrae|MP:0001953,respiratory failure|MP:0002115,abnormal limb bone morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003072,abnormal metatarsal bone morphology|MP:0003074,absent metacarpal bones|MP:0004341,absent scapula|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004672,short ribs|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0011087,neonatal lethality, complete penetrance
MGI:2176466	Runx2<tm1Kish>	MP:0000065,abnormal bone marrow cavity morphology|MP:0000074,abnormal neurocranium morphology|MP:0000077,abnormal interparietal bone morphology|MP:0000078,abnormal supraoccipital bone morphology|MP:0000103,nasal bone hypoplasia|MP:0000109,abnormal parietal bone morphology|MP:0000164,abnormal cartilage development|MP:0000166,abnormal chondrocyte morphology|MP:0000240,extramedullary hematopoiesis|MP:0000322,increased granulocyte number|MP:0000547,short limbs|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0000681,abnormal thyroid gland morphology|MP:0000691,enlarged spleen|MP:0000709,enlarged thymus|MP:0000715,decreased thymocyte number|MP:0001243,abnormal dermal layer morphology|MP:0001262,decreased body weight|MP:0001575,cyanosis|MP:0001577,anemia|MP:0001953,respiratory failure|MP:0002113,abnormal skeleton development|MP:0002123,abnormal definitive hematopoiesis|MP:0002427,disproportionate dwarf|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003503,decreased activity of thyroid gland|MP:0003631,nervous system phenotype|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004337,clavicle hypoplasia|MP:0004696,abnormal thyroid follicle morphology|MP:0005017,decreased B cell number|MP:0005135,increased thyroid-stimulating hormone level|MP:0005369,muscle phenotype|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype|MP:0005471,decreased thyroxine level|MP:0005473,decreased triiodothyronine level|MP:0005478,decreased circulating thyroxine level|MP:0006399,abnormal long bone epiphyseal ossification zone morphology|MP:0008156,decreased diameter of tibia|MP:0008271,abnormal bone ossification|MP:0008395,abnormal osteoblast differentiation|MP:0008396,abnormal osteoclast differentiation|MP:0008826,abnormal splenic cell ratio|MP:0009395,increased nucleated erythrocyte cell number|MP:0011049,impaired adaptive thermogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0030393,delayed fontanelle closure
MGI:3043791	Runx2<tm1Ldq>	MP:0000060,delayed bone ossification|MP:0000085,large anterior fontanelle|MP:0000102,abnormal nasal bone morphology|MP:0000130,abnormal trabecular bone morphology|MP:0000131,abnormal long bone epiphysis morphology|MP:0000135,decreased compact bone thickness|MP:0000150,abnormal rib morphology|MP:0000438,abnormal cranium morphology|MP:0000558,abnormal tibia morphology|MP:0002083,premature death|MP:0003056,abnormal hyoid bone morphology|MP:0004440,absent occipital bone|MP:0004686,decreased length of long bones|MP:0004900,absent zygomatic arch|MP:0005298,abnormal clavicle morphology|MP:0005306,abnormal phalanx morphology|MP:0005508,abnormal skeleton morphology|MP:0008271,abnormal bone ossification|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2176465	Runx2<tm1Mjo>	MP:0000084,abnormal fontanelle morphology|MP:0000116,abnormal tooth development|MP:0000118,arrest of tooth development|MP:0000128,growth retardation of molars|MP:0000159,abnormal xiphoid process morphology|MP:0000163,abnormal cartilage morphology|MP:0000164,abnormal cartilage development|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000166,abnormal chondrocyte morphology|MP:0000175,absent bone marrow cell|MP:0000382,underdeveloped hair follicles|MP:0000438,abnormal cranium morphology|MP:0000552,abnormal radius morphology|MP:0001218,thin epidermis|MP:0001233,abnormal epidermis suprabasal layer morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001302,eyelids open at birth|MP:0001942,abnormal lung volume|MP:0001953,respiratory failure|MP:0002060,abnormal skin morphology|MP:0002113,abnormal skeleton development|MP:0002233,abnormal nose morphology|MP:0002576,abnormal enamel morphology|MP:0002689,abnormal molar morphology|MP:0002818,abnormal dentin morphology|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003056,abnormal hyoid bone morphology|MP:0003419,delayed endochondral bone ossification|MP:0003420,delayed intramembranous bone ossification|MP:0004337,clavicle hypoplasia|MP:0004354,absent deltoid tuberosity|MP:0004385,interparietal bone hypoplasia|MP:0004420,parietal bone hypoplasia|MP:0004690,ischium hypoplasia|MP:0004693,pubis hypoplasia|MP:0004989,decreased osteoblast cell number|MP:0005108,abnormal ulna morphology|MP:0005296,abnormal humerus morphology|MP:0005298,abnormal clavicle morphology|MP:0005358,abnormal incisor morphology|MP:0005359,growth retardation of incisors|MP:0005602,decreased angiogenesis|MP:0006402,small molars|MP:0008271,abnormal bone ossification|MP:0008395,abnormal osteoblast differentiation|MP:0009395,increased nucleated erythrocyte cell number|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0009899,hyoid bone hypoplasia|MP:0010018,pulmonary vascular congestion|MP:0010864,abnormal enamel knot morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0030029,wide cranial sutures|MP:0030079,small incisors|MP:0030498,abnormal dental lamina morphology|MP:0030507,abnormal dental papilla morphology|MP:0030521,abnormal cervical loop morphology
MGI:5635287	Runx3<tm1b(KOMP)Wtsi>	MP:0001392,abnormal locomotor behavior|MP:0011100,preweaning lethality, complete penetrance
MGI:3761811	Runx3<tm1Itan>	MP:0001861,lung inflammation|MP:0002495,increased IgA level|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation
MGI:3818488	Runx3<tm1Litt>	MP:0002408,abnormal double-positive T cell morphology|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation
MGI:2183399	Runx3<tm1Yg>	MP:0000060,delayed bone ossification|MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000160,kyphosis|MP:0000161,scoliosis|MP:0000162,lordosis|MP:0000402,abnormal zigzag hair morphology|MP:0000405,abnormal auchene hair morphology|MP:0000416,sparse hair|MP:0000438,abnormal cranium morphology|MP:0000489,abnormal large intestine morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000494,abnormal cecum morphology|MP:0000495,abnormal colon morphology|MP:0000956,decreased spinal cord size|MP:0000964,small dorsal root ganglion|MP:0000965,abnormal sensory neuron morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001431,abnormal eating behavior|MP:0001504,abnormal posture|MP:0001663,abnormal digestive system physiology|MP:0001845,abnormal inflammatory response|MP:0001858,intestinal inflammation|MP:0001861,lung inflammation|MP:0001873,stomach inflammation|MP:0001952,increased airway responsiveness|MP:0002082,postnatal lethality|MP:0002113,abnormal skeleton development|MP:0002133,abnormal respiratory system physiology|MP:0002272,abnormal nervous system electrophysiology|MP:0002376,abnormal dendritic cell physiology|MP:0002497,increased IgE level|MP:0002816,colitis|MP:0002896,abnormal bone mineralization|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003109,short femur|MP:0003306,small intestinal inflammation|MP:0003994,abnormal dorsal spinal root morphology|MP:0004016,decreased bone mass|MP:0004139,abnormal gastric parietal cell morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0004142,abnormal muscle tone|MP:0004351,short humerus|MP:0004686,decreased length of long bones|MP:0004989,decreased osteoblast cell number|MP:0004991,decreased bone strength|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005232,abnormal mesenteric lymph node morphology|MP:0005298,abnormal clavicle morphology|MP:0005390,skeleton phenotype|MP:0005461,abnormal dendritic cell morphology|MP:0005508,abnormal skeleton morphology|MP:0006282,abnormal spinal cord dorsal horn morphology|MP:0006382,abnormal lung epithelium morphology|MP:0008115,abnormal dendritic cell differentiation|MP:0008118,absent Langerhans cell|MP:0008126,increased dendritic cell number|MP:0008152,decreased diameter of femur|MP:0008273,abnormal intramembranous bone ossification|MP:0008468,absent muscle spindles|MP:0008713,abnormal cytokine level|MP:0008750,abnormal interferon level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0009346,decreased trabecular bone thickness|MP:0009400,decreased skeletal muscle fiber size|MP:0009677,abnormal spinal cord dorsal column morphology|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010792,abnormal stomach mucosa morphology|MP:0010876,decreased bone volume|MP:0010879,decreased trabecular bone volume|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013639,decreased bone stiffness|MP:0020010,decreased bone mineral density of femur|MP:0030315,small neurocranium|MP:0030439,decreased osteoblast proliferation
MGI:2179229	Runx3<tm1Yito>	MP:0000471,abnormal stomach epithelium morphology|MP:0005211,increased stomach mucosa thickness|MP:0005560,decreased circulating glucose level|MP:0010799,stomach mucosa hyperplasia|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3641439	Runx3<tm2Yg>	MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005386,behavior/neurological phenotype|MP:0008115,abnormal dendritic cell differentiation
MGI:5689489	Runx3<tm3.1Yg>	MP:0000063,decreased bone mineral density|MP:0001255,decreased body height|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001663,abnormal digestive system physiology|MP:0001790,abnormal immune system physiology|MP:0001858,intestinal inflammation|MP:0003109,short femur|MP:0004924,abnormal behavior|MP:0008118,absent Langerhans cell|MP:0010124,decreased bone mineral content|MP:0010968,decreased compact bone area
MGI:5689483	Runx3<tm3Yg>	MP:0000161,scoliosis|MP:0001255,decreased body height|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0004297,abnormal proprioceptive neuron morphology|MP:0005390,skeleton phenotype|MP:0006086,decreased body mass index|MP:0008152,decreased diameter of femur|MP:0008467,absent proprioceptive neurons|MP:0008770,decreased survivor rate|MP:0010124,decreased bone mineral content|MP:0021182,decreased femoral compact bone area
MGI:5755133	Rusc1<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system|MP:0002591,decreased mean corpuscular volume|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content
MGI:6188969	Rusc2<em1(IMPC)J>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5638544	Ruvbl1<tm1.1Oxbk>	MP:0000333,decreased bone marrow cell number|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0005152,pancytopenia|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011695,absent hematopoietic stem cells|MP:0013776,bone marrow failure
MGI:5638545	Ruvbl1<tm1.2Oxbk>	MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012113,decreased inner cell mass proliferation|MP:0012128,abnormal blastocyst formation
MGI:4432034	Ruvbl1<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight
MGI:7425955	Ruvbl2<em1(IMPC)Bay>	MP:0001727,abnormal embryo implantation|MP:0002718,abnormal inner cell mass morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:5428996	Ruvbl2<M1Btlr>	MP:0000373,belly spot|MP:0000714,increased thymocyte number|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0004816,abnormal class switch recombination|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008495,decreased IgG1 level|MP:0011400,lethality, complete penetrance
MGI:3611350	Rv2<BALB/cJ>	MP:0002026,increased leukemia incidence
MGI:3611355	Rv3<C57BL/6J>	MP:0002026,increased leukemia incidence
MGI:3611356	Rv3<CBA/Lac>	MP:0002026,increased leukemia incidence
MGI:3611360	Rvil1<CE/J>	MP:0002026,increased leukemia incidence
MGI:1934625	Rvm	MP:0002792,abnormal retina vasculature morphology|MP:0005262,coloboma
MGI:1857317	Rw	MP:0002938,white spotting|MP:0002940,variable body spotting|MP:0011091,prenatal lethality, complete penetrance
MGI:5637013	Rwdd1<tm1b(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0001552,increased circulating triglyceride level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0003795,abnormal bone structure|MP:0004974,decreased regulatory T cell number|MP:0005344,increased circulating bilirubin level|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0013418,increased memory-marker gamma-delta T cell number|MP:0013675,decreased Ly6C-positive mature NK cell number
MGI:6361969	Rwdd2a<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0000221,decreased leukocyte cell number|MP:0003961,decreased lean body mass|MP:0005343,increased circulating aspartate transaminase level|MP:0010124,decreased bone mineral content
MGI:5548630	Rwdd3<tm1b(KOMP)Wtsi>	MP:0010053,decreased grip strength|MP:0010570,prolonged ST segment|MP:0011100,preweaning lethality, complete penetrance
MGI:3054831	Rxfp1<tm1Aia>	MP:0001882,abnormal lactation|MP:0002907,abnormal parturition|MP:0006050,pulmonary fibrosis|MP:0009722,abnormal nipple development|MP:0013713,decreased nipple size
MGI:3028654	Rxfp1<tm1Jgo>	MP:0001119,abnormal female reproductive system morphology|MP:0001145,abnormal male reproductive system morphology|MP:0001156,abnormal spermatogenesis|MP:0001921,reduced fertility|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002907,abnormal parturition|MP:0004852,decreased testis weight|MP:0004929,decreased epididymis weight|MP:0005159,azoospermia|MP:0005397,hematopoietic system phenotype|MP:0013713,decreased nipple size
MGI:4840457	Rxfp2<m1Lja>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0002286,cryptorchism|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number
MGI:4433327	Rxfp2<tm1a(EUCOMM)Wtsi>	MP:0000220,increased monocyte cell number|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0002286,cryptorchism|MP:0002492,decreased IgE level|MP:0004924,abnormal behavior
MGI:2388129	Rxfp2<tm1Aia>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002286,cryptorchism|MP:0003673,abnormal inguinal canal morphology|MP:0005149,abnormal gubernaculum morphology|MP:0005159,azoospermia|MP:0031287,bilateral cryptorchism
MGI:5548762	Rxfp2<tm1b(EUCOMM)Wtsi>	MP:0000194,increased circulating calcium level|MP:0000598,abnormal liver morphology|MP:0001147,small testis|MP:0001925,male infertility|MP:0002608,increased hematocrit|MP:0002968,increased circulating alkaline phosphatase level|MP:0003131,increased erythrocyte cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005564,increased hemoglobin content|MP:0005573,increased pulmonary respiratory rate|MP:0005633,increased circulating sodium level|MP:0008259,abnormal optic disk morphology|MP:0009552,urinary bladder obstruction|MP:0011886,increased circulating lipase level
MGI:5473310	Rxfp2<tm1c(EUCOMM)Wtsi>	MP:0005389,reproductive system phenotype
MGI:6257608	Rxfp3<em1(IMPC)Bay>	MP:0002953,thick ventricular wall|MP:0010579,increased heart left ventricle size
MGI:5697049	Rxfp3<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology
MGI:5688755	Rxfp3<tm1Dgen>	MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype
MGI:5581468	Rxfp4<tm1.1(KOMP)Vlcg>	MP:0000221,decreased leukocyte cell number|MP:0003179,thrombocytopenia|MP:0011436,decreased urine magnesium level
MGI:5637423	Rxfp4<tm1Sora>	MP:0001262,decreased body weight|MP:0001432,abnormal food preference|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005449,abnormal food intake|MP:0009283,decreased gonadal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0010025,decreased total body fat amount|MP:0011957,decreased compensatory feeding amount
MGI:3612274	Rxra<pke>	MP:0000160,kyphosis|MP:0000371,diluted coat color|MP:0000414,alopecia|MP:0001247,dermal cyst|MP:0001314,cornea opacity|MP:0002376,abnormal dendritic cell physiology|MP:0002434,abnormal T-helper 2 cell morphology|MP:0004946,abnormal regulatory T cell physiology
MGI:2385921	Rxra<tm1.1Krc>	MP:0006138,congestive heart failure|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3839151	Rxra<tm1.1Pcn>	MP:0001340,abnormal eyelid morphology|MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0002864,abnormal ocular fundus morphology|MP:0004200,decreased fetal size|MP:0005300,abnormal cornea stroma morphology|MP:0008259,abnormal optic disk morphology|MP:0008881,absent Harderian gland|MP:0010584,abnormal conotruncus septation|MP:0010640,ventricular myocardium compact layer hypoplasia|MP:0010706,ventral rotation of lens|MP:0010707,decreased ventral retina size|MP:0010710,absent sclera|MP:0010711,persistent hyperplastic primary vitreous|MP:0010720,absent sublingual duct|MP:0011089,perinatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:1857511	Rxra<tm1Ipc>	MP:0000279,ventricular hypoplasia|MP:0001191,abnormal skin condition|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0002060,abnormal skin morphology|MP:0002655,abnormal keratinocyte morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2385918	Rxra<tm1Krc>	MP:0001167,prostate gland epithelial hyperplasia|MP:0001798,impaired macrophage phagocytosis|MP:0002135,abnormal kidney morphology|MP:0002169,no abnormal phenotype detected|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002743,glomerulonephritis|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0003068,enlarged kidney|MP:0003607,abnormal prostate gland physiology|MP:0003725,increased autoantibody level|MP:0003881,abnormal nephron morphology|MP:0003917,increased kidney weight|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005325,abnormal renal glomerulus morphology|MP:0008059,abnormal podocyte foot process morphology|MP:0008139,fused podocyte foot processes|MP:0008244,abnormal peritoneal macrophage morphology|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009736,abnormal prostate gland branching morphogenesis|MP:0010064,increased circulating creatine level|MP:0011075,abnormal macrophage activation involved in immune response|MP:0011294,renal glomerulus hypertrophy|MP:0011353,expanded mesangial matrix|MP:0011369,increased renal glomerulus apoptosis|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011427,increased mesangial cell number
MGI:1857672	Rxra<tm1Rev>	MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000279,ventricular hypoplasia|MP:0000280,thin ventricular wall|MP:0000281,abnormal interventricular septum morphology|MP:0000284,double outlet right ventricle|MP:0000286,abnormal mitral valve morphology|MP:0000288,abnormal pericardium morphology|MP:0000295,trabecula carnea hypoplasia|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000299,failure of atrioventricular cushion closure|MP:0000597,delayed hepatic development|MP:0000601,small liver|MP:0001201,translucent skin|MP:0001786,skin edema|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002624,abnormal tricuspid valve morphology|MP:0002633,persistent truncus arteriosus|MP:0002745,abnormal atrioventricular valve morphology|MP:0002754,dilated heart right ventricle|MP:0003393,decreased cardiac output|MP:0003923,abnormal heart left atrium morphology|MP:0004001,decreased hepatocyte proliferation|MP:0004056,abnormal myocardium compact layer morphology|MP:0004058,abnormal ventricle papillary muscle morphology|MP:0004062,dilated heart right atrium|MP:0005294,abnormal heart ventricle morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005333,decreased heart rate|MP:0006119,mitral valve atresia|MP:0006122,mitral valve stenosis|MP:0006138,congestive heart failure|MP:0010413,complete atrioventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010454,abnormal truncus arteriosus septation|MP:0010455,aortopulmonary window|MP:0010457,pulmonary artery stenosis|MP:0010519,atrioventricular block|MP:0010559,heart block|MP:0010585,abnormal conotruncal ridge morphology|MP:0010640,ventricular myocardium compact layer hypoplasia|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012501,abnormal pericardial cavity morphology|MP:0021158,decreased heart left ventricle wall thickness|MP:0021160,decreased heart right ventricle wall thickness|MP:0031530,abnormal heart ventricle shape|MP:0031633,decreased heart left ventricle muscle contractility
MGI:2136274	Rxra<tm2Ipc>	MP:0002080,prenatal lethality|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002092,abnormal eye morphology|MP:0002127,abnormal cardiovascular system morphology|MP:0002258,abnormal cricoid cartilage morphology
MGI:2136273	Rxra<tm3Ipc>	MP:0002089,abnormal postnatal growth/weight/body size|MP:0002092,abnormal eye morphology|MP:0002110,abnormal digit morphology|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0002127,abnormal cardiovascular system morphology|MP:0005386,behavior/neurological phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2153829	Rxra<tm4.1Ipc>	MP:0001286,abnormal eye development|MP:0001622,abnormal vasculogenesis|MP:0001785,edema|MP:0003717,pallor|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2153828	Rxra<tm4Ipc>	MP:0001196,shiny skin|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001327,decreased retina photoreceptor cell number|MP:0002655,abnormal keratinocyte morphology|MP:0003011,delayed dark adaptation|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005103,abnormal retina pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005548,retina pigment epithelium atrophy|MP:0008586,disorganized photoreceptor outer segment|MP:0008587,short photoreceptor outer segment
MGI:1857822	Rxrb<tm1Ipc>	MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002209,decreased germ cell number|MP:0002216,abnormal seminiferous tubule morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0008839,absent acrosome|MP:0008898,abnormal acrosome morphology|MP:0009231,detached acrosome|MP:0009238,coiled sperm flagellum|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3606210	Rxrb<tm1Mma>	MP:0002784,abnormal Sertoli cell morphology|MP:0003193,decreased cholesterol efflux|MP:0005389,reproductive system phenotype
MGI:3611570	Rxrb<tm1Pcn>	MP:0002169,no abnormal phenotype detected
MGI:2385928	Rxrg<tm1Ipc>	MP:0002169,no abnormal phenotype detected
MGI:2183715	Rxrg<tm1Ysa>	MP:0002083,premature death|MP:0002822,catalepsy|MP:0004037,increased muscle relaxation|MP:0004077,abnormal striatum morphology
MGI:2183717	Rxrg<tm2Ysa>	MP:0004077,abnormal striatum morphology|MP:0010768,mortality/aging
MGI:5905666	Rxylt1<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001399,hyperactivity|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002075,abnormal coat/hair pigmentation|MP:0010052,increased grip strength|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:6414519	Rybp<em1(IMPC)Bay>	MP:0001392,abnormal locomotor behavior|MP:0001417,decreased exploration in new environment|MP:0002966,decreased circulating alkaline phosphatase level|MP:0011100,preweaning lethality, complete penetrance
MGI:3790768	Rybp<tm1Nisa>	MP:0000914,exencephaly|MP:0001059,optic nerve atrophy|MP:0001329,retina hyperplasia|MP:0001714,absent trophoblast giant cells|MP:0001729,impaired embryo implantation|MP:0002621,delayed neural tube closure|MP:0003232,abnormal forebrain development|MP:0003864,abnormal midbrain development|MP:0003886,abnormal embryonic epiblast morphology|MP:0003984,embryonic growth retardation|MP:0005262,coloboma|MP:0010706,ventral rotation of lens|MP:0010715,retina coloboma|MP:0010717,optic nerve coloboma|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011193,embryonic epiblast cell degeneration|MP:0012102,absent trophectoderm
MGI:6449021	Ryk<em1(IMPC)Mbp>	MP:0000111,cleft palate|MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000428,abnormal craniofacial morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0005013,increased lymphocyte cell number|MP:0006203,eye hemorrhage|MP:0011100,preweaning lethality, complete penetrance
MGI:2667542	Ryk<tm1Stac>	MP:0000074,abnormal neurocranium morphology|MP:0000088,short mandible|MP:0000433,microcephaly|MP:0000445,short snout|MP:0000455,abnormal maxilla morphology|MP:0000547,short limbs|MP:0000556,abnormal hindlimb morphology|MP:0001297,microphthalmia|MP:0001406,abnormal gait|MP:0001575,cyanosis|MP:0001732,postnatal growth retardation|MP:0002765,short fibula|MP:0004359,short ulna|MP:0004471,short nasal bone|MP:0005150,cachexia|MP:0009890,cleft secondary palate|MP:0009906,increased tongue size|MP:0011088,neonatal lethality, incomplete penetrance|MP:0030095,abnormal midface morphology|MP:0030315,small neurocranium
MGI:7258399	Ryr1<em1Tmur>	MP:0001777,abnormal body temperature homeostasis|MP:0002106,abnormal muscle physiology|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0020214,increased susceptibility to malignant hyperthermia
MGI:7339039	Ryr1<em1Zor>	MP:0000747,muscle weakness|MP:0001402,decreased locomotor activity|MP:0004231,abnormal calcium ion homeostasis|MP:0005369,muscle phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005391,vision/eye phenotype|MP:0009411,abnormal skeletal muscle fiber triad morphology|MP:0009412,skeletal muscle fiber degeneration
MGI:7339045	Ryr1<em2Zor>	MP:0005369,muscle phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005391,vision/eye phenotype
MGI:2152892	Ryr1<m1Bei>	MP:0000759,abnormal skeletal muscle morphology|MP:0001258,decreased body length|MP:0001260,increased body weight|MP:0004674,thin ribs
MGI:4887400	Ryr1<m1Nisw>	MP:0000747,muscle weakness|MP:0000751,myopathy|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0005627,increased circulating potassium level|MP:0006036,abnormal mitochondrial physiology|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010053,decreased grip strength|MP:0011633,abnormal mitochondrial shape|MP:0011978,abnormal potassium ion homeostasis
MGI:4418317	Ryr1<tm1.1Dhm>	MP:0000005,increased brown adipose tissue amount|MP:0000060,delayed bone ossification|MP:0000160,kyphosis|MP:0000382,underdeveloped hair follicles|MP:0000440,domed cranium|MP:0000733,abnormal muscle development|MP:0000738,impaired muscle contractility|MP:0000747,muscle weakness|MP:0000751,myopathy|MP:0000753,paralysis|MP:0000755,hindlimb paralysis|MP:0001191,abnormal skin condition|MP:0001198,tight skin|MP:0001201,translucent skin|MP:0001243,abnormal dermal layer morphology|MP:0001262,decreased body weight|MP:0001392,abnormal locomotor behavior|MP:0001491,unresponsive to tactile stimuli|MP:0001504,abnormal posture|MP:0001575,cyanosis|MP:0001786,skin edema|MP:0001954,respiratory distress|MP:0002106,abnormal muscle physiology|MP:0002279,abnormal diaphragm morphology|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004032,abnormal interventricular groove morphology|MP:0004087,abnormal muscle fiber morphology|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0004111,abnormal coronary artery morphology|MP:0004201,fetal growth retardation|MP:0004819,decreased skeletal muscle mass|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009415,skeletal muscle degeneration|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0009890,cleft secondary palate|MP:0010025,decreased total body fat amount|MP:0010099,abnormal thoracic cage shape|MP:0010404,ostium primum atrial septal defect|MP:0010405,ostium secundum atrial septal defect|MP:0011087,neonatal lethality, complete penetrance|MP:0012082,delayed heart development
MGI:5314364	Ryr1<tm1.1Inp>	MP:0002106,abnormal muscle physiology|MP:0003030,acidemia|MP:0003081,abnormal soleus morphology|MP:0003157,impaired muscle relaxation|MP:0008872,abnormal physiological response to xenobiotic|MP:0011016,increased core body temperature|MP:0020214,increased susceptibility to malignant hyperthermia
MGI:5293352	Ryr1<tm1.1Itl>	MP:0000759,abnormal skeletal muscle morphology|MP:0002106,abnormal muscle physiology|MP:0005620,abnormal muscle contractility
MGI:5484746	Ryr1<tm1.1Msnr>	MP:0004145,abnormal muscle electrophysiology|MP:0005620,abnormal muscle contractility|MP:0009045,muscle tetany|MP:0009046,muscle twitch
MGI:4887253	Ryr1<tm1Alle>	MP:0005621,abnormal cell physiology
MGI:5700047	Ryr1<tm1b(EUCOMM)Hmgu>	MP:0004952,increased spleen weight|MP:0011100,preweaning lethality, complete penetrance
MGI:3619253	Ryr1<tm1Slh>	MP:0000150,abnormal rib morphology|MP:0000160,kyphosis|MP:0000759,abnormal skeletal muscle morphology|MP:0001777,abnormal body temperature homeostasis|MP:0001785,edema|MP:0002106,abnormal muscle physiology|MP:0003052,omphalocele|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0005620,abnormal muscle contractility|MP:0005627,increased circulating potassium level|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009746,enhanced behavioral response to xenobiotic|MP:0010099,abnormal thoracic cage shape|MP:0011089,perinatal lethality, complete penetrance|MP:0012514,pectus excavatum
MGI:2152826	Ryr1<tm1Tno>	MP:0001404,no spontaneous movement|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002109,abnormal limb morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004174,abnormal spine curvature|MP:0009400,decreased skeletal muscle fiber size|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009406,decreased skeletal muscle fiber number|MP:0011087,neonatal lethality, complete penetrance
MGI:4887389	Ryr1<tm2.1Alle>	MP:0002318,hypercapnia|MP:0003030,acidemia|MP:0004231,abnormal calcium ion homeostasis|MP:0005573,increased pulmonary respiratory rate|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0020214,increased susceptibility to malignant hyperthermia
MGI:5544310	Ryr1<tm2.1Itl>	MP:0002106,abnormal muscle physiology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0005369,muscle phenotype|MP:0010053,decreased grip strength
MGI:6515829	Ryr1<tm3.1Alle>	MP:0001777,abnormal body temperature homeostasis|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0020214,increased susceptibility to malignant hyperthermia
MGI:6682022	Ryr2<em1Swch>	MP:0001636,irregular heartbeat|MP:0004215,abnormal myocardial fiber physiology|MP:0004486,decreased response of heart to induced stress|MP:0005333,decreased heart rate|MP:0005402,abnormal action potential|MP:0011091,prenatal lethality, complete penetrance|MP:0011925,abnormal heart echocardiography feature|MP:0020346,abnormal myocardial fiber calcium currents|MP:0020347,abnormal myocardial fiber sodium currents
MGI:6268706	Ryr2<M1Btlr>	MP:0002626,increased heart rate
MGI:6268710	Ryr2<m2Btlr>	MP:0005333,decreased heart rate
MGI:6268714	Ryr2<m3Btlr>	MP:0005333,decreased heart rate
MGI:5432111	Ryr2<tm1.1Clhh>	MP:0001636,irregular heartbeat|MP:0004215,abnormal myocardial fiber physiology|MP:0008950,ventricular tachycardia
MGI:5749278	Ryr2<tm1.1Hnis>	MP:0002220,large lymphoid organs|MP:0002357,abnormal spleen white pulp morphology|MP:0003631,nervous system phenotype|MP:0004952,increased spleen weight|MP:0004955,increased thymus weight|MP:0005232,abnormal mesenteric lymph node morphology|MP:0005367,renal/urinary system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0008466,enlarged mesenteric lymph nodes|MP:0009559,thymus cortex hyperplasia
MGI:3640298	Ryr2<tm1.1Hta>	MP:0002189,abnormal myocardial trabeculae morphology|MP:0002190,disorganized myocardium|MP:0003057,abnormal epicardium morphology|MP:0003984,embryonic growth retardation|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011390,abnormal fetal cardiomyocyte physiology|MP:0031607,abnormal fetal cardiomyocyte mitochondrial morphology|MP:0031614,fetal cardiomyocyte vacuoles
MGI:4442645	Ryr2<tm1.1Maya>	MP:0004215,abnormal myocardial fiber physiology|MP:0005386,behavior/neurological phenotype|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008950,ventricular tachycardia
MGI:3713774	Ryr2<tm1.1Msnr>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001262,decreased body weight|MP:0002625,heart left ventricle hypertrophy|MP:0003141,cardiac fibrosis|MP:0005333,decreased heart rate|MP:0005598,decreased heart ventricle muscle contractility|MP:0010725,thin interventricular septum|MP:0011085,postnatal lethality, complete penetrance|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5285537	Ryr2<tm1.1Swch>	MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008950,ventricular tachycardia
MGI:4359589	Ryr2<tm1.1Wex>	MP:0004484,abnormal response of heart to induced stress|MP:0004485,increased response of heart to induced stress|MP:0005385,cardiovascular system phenotype|MP:0008950,ventricular tachycardia
MGI:3619529	Ryr2<tm1Amks>	MP:0000343,abnormal response to cardiac infarction
MGI:5637225	Ryr2<tm1b(KOMP)Wtsi>	MP:0001488,increased startle reflex|MP:0011100,preweaning lethality, complete penetrance
MGI:3818448	Ryr2<tm1Hhv>	MP:0000278,abnormal myocardial fiber morphology|MP:0005385,cardiovascular system phenotype
MGI:3640297	Ryr2<tm1Hta>	MP:0002169,no abnormal phenotype detected
MGI:5576915	Ryr2<tm1Krbr>	MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002626,increased heart rate|MP:0003393,decreased cardiac output|MP:0004122,abnormal sinus arrhythmia|MP:0005202,lethargy|MP:0005330,cardiomyopathy|MP:0005333,decreased heart rate|MP:0006138,congestive heart failure|MP:0010505,abnormal T wave|MP:0010519,atrioventricular block|MP:0010637,sinus bradycardia
MGI:3641338	Ryr2<tm1Sgp>	MP:0001636,irregular heartbeat|MP:0005385,cardiovascular system phenotype|MP:0006110,ventricular fibrillation|MP:0008950,ventricular tachycardia
MGI:3665257	Ryr2<tm1Slh>	MP:0001636,irregular heartbeat|MP:0002272,abnormal nervous system electrophysiology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003412,abnormal afterhyperpolarization|MP:0004215,abnormal myocardial fiber physiology|MP:0004484,abnormal response of heart to induced stress|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004994,abnormal brain wave pattern|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0005333,decreased heart rate|MP:0006110,ventricular fibrillation|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010519,atrioventricular block|MP:0014253,decreased paired-pulse ratio|MP:0014623,abnormal brain theta wave pattern|MP:0031634,decreased heart right ventricle muscle contractility
MGI:5432932	Ryr2<tm2.1Maya>	MP:0004215,abnormal myocardial fiber physiology|MP:0005385,cardiovascular system phenotype|MP:0008950,ventricular tachycardia
MGI:5518958	Ryr2<tm2.1Msnr>	MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0003920,abnormal heart right ventricle morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0005385,cardiovascular system phenotype|MP:0010724,thick interventricular septum
MGI:5605476	Ryr2<tm2.1Swch>	MP:0001544,abnormal cardiovascular system physiology|MP:0002972,abnormal cardiac muscle contractility|MP:0004215,abnormal myocardial fiber physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5571850	Ryr2<tm2.1Wex>	MP:0000278,abnormal myocardial fiber morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004086,absent heartbeat|MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0004485,increased response of heart to induced stress|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0005385,cardiovascular system phenotype|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3802940	Ryr2<tm2Amks>	MP:0000278,abnormal myocardial fiber morphology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003631,nervous system phenotype|MP:0003997,tonic-clonic seizures|MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0004201,fetal growth retardation|MP:0004215,abnormal myocardial fiber physiology|MP:0004485,increased response of heart to induced stress|MP:0004994,abnormal brain wave pattern|MP:0008543,atrial fibrillation|MP:0008770,decreased survivor rate|MP:0008950,ventricular tachycardia|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5583980	Ryr2<tm2Hhv>	MP:0001544,abnormal cardiovascular system physiology|MP:0001636,irregular heartbeat|MP:0004215,abnormal myocardial fiber physiology|MP:0009732,ventricular premature beat|MP:0011092,embryonic lethality, complete penetrance
MGI:5582510	Ryr2<tm3.1Amks>	MP:0000278,abnormal myocardial fiber morphology|MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0008543,atrial fibrillation
MGI:5750602	Ryr2<tm3.1Hhv>	MP:0004215,abnormal myocardial fiber physiology|MP:0005333,decreased heart rate|MP:0006110,ventricular fibrillation|MP:0011091,prenatal lethality, complete penetrance
MGI:5606046	Ryr2<tm3.1Swch>	MP:0004215,abnormal myocardial fiber physiology|MP:0011092,embryonic lethality, complete penetrance
MGI:5582511	Ryr2<tm4.1Amks>	MP:0000278,abnormal myocardial fiber morphology|MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0008543,atrial fibrillation
MGI:3575753	Ryr3<tm1Jms>	MP:0001463,abnormal spatial learning|MP:0001899,absent long-term depression|MP:0003008,enhanced long-term potentiation
MGI:2429752	Ryr3<tm1Tno>	MP:0001399,hyperactivity|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0004000,impaired passive avoidance behavior|MP:0031391,increased locomotor activity
MGI:2181794	Ryr3<tm1Vso>	MP:0000738,impaired muscle contractility|MP:0005620,abnormal muscle contractility
MGI:2429753	Ryr3<tm2Tno>	MP:0001399,hyperactivity|MP:0031391,increased locomotor activity
MGI:3665443	S100a10<tm1Jwo>	MP:0001970,abnormal pain threshold|MP:0003177,allodynia|MP:0003469,decreased single cell response intensity
MGI:3775204	S100a10<tm1Pggd>	MP:0002797,increased thigmotaxis|MP:0003360,abnormal depression-related behavior|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005322,abnormal serotonin level|MP:0009747,impaired behavioral response to xenobiotic
MGI:2681771	S100a11<tm1Wen>	MP:0002673,abnormal sperm number
MGI:5513816	S100a14<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7398436	S100a16<em1.1Gpt>	MP:0002942,decreased circulating alanine transaminase level|MP:0003333,liver fibrosis|MP:0005166,decreased susceptibility to injury|MP:0005632,decreased circulating aspartate transaminase level
MGI:6283645	S100a16<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0001697,abnormal embryo size|MP:0001711,abnormal placenta morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7425956	S100a1<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001148,enlarged testis|MP:0001293,anophthalmia|MP:0001304,cataract|MP:0002092,abnormal eye morphology|MP:0002699,abnormal vitreous body morphology|MP:0004738,abnormal auditory brainstem response
MGI:3530817	S100a1<Gt(OST24588)Lex>	MP:0002169,no abnormal phenotype detected
MGI:3530818	S100a1<Gt(OST28275)Lex>	MP:0001364,decreased anxiety-related response|MP:0001415,increased exploration in new environment|MP:0002572,abnormal emotion/affect behavior|MP:0003461,abnormal response to novel object
MGI:2446086	S100a1<tm1Jhh>	MP:0003034,increased pulmonary vascular resistance|MP:0003548,pulmonary hypertension|MP:0003820,increased left ventricle systolic pressure|MP:0003913,increased heart right ventricle weight|MP:0003957,abnormal nitric oxide homeostasis|MP:0004007,abnormal lung vasculature morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005591,decreased vasodilation|MP:0010758,increased right ventricle systolic pressure|MP:0011131,abnormal lung endothelial cell physiology|MP:0011141,increased lung endothelial cell apoptosis
MGI:3775945	S100a1<tm1Mfs>	MP:0002106,abnormal muscle physiology
MGI:7425957	S100a3<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0001304,cataract|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney
MGI:5317430	S100a4<tm1.1Abres>	MP:0002465,abnormal eosinophil physiology|MP:0003799,impaired macrophage chemotaxis
MGI:3043753	S100a4<tm1Amba>	MP:0001648,abnormal apoptosis|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002020,increased tumor incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0008714,increased lung carcinoma incidence|MP:0010363,increased fibrosarcoma incidence|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012431,increased lymphoma incidence
MGI:2665826	S100a4<tm1Egn>	MP:0002169,no abnormal phenotype detected
MGI:5605391	S100a5<tm1.1Mom>	MP:0002169,no abnormal phenotype detected
MGI:5692619	S100a6<tm1b(KOMP)Wtsi>	MP:0002574,increased vertical activity|MP:0010378,increased respiratory quotient|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5296777	S100a8<tm1Hogg>	MP:0011092,embryonic lethality, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance
MGI:2179780	S100a8<tm1Hume>	MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0005380,embryo phenotype|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:2654353	S100a9<tm1Hogg>	MP:0002463,abnormal neutrophil physiology|MP:0005065,abnormal neutrophil morphology|MP:0005387,immune system phenotype
MGI:2450165	S100a9<tm1Nck>	MP:0005398,decreased susceptibility to fungal infection|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0009858,abnormal cellular extravasation
MGI:4432844	S100b<tm1a(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected|MP:0010092,increased circulating magnesium level
MGI:2386179	S100b<tm1Daoh>	MP:0003177,allodynia
MGI:2451049	S100b<tm1Ito>	MP:0002169,no abnormal phenotype detected
MGI:3665167	S100g<del1>	MP:0002169,no abnormal phenotype detected
MGI:3795783	S100g<tm1Ebje>	MP:0002169,no abnormal phenotype detected
MGI:5295051	S1pr1<tm1.1Cys>	MP:0002459,abnormal B cell physiology|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype
MGI:4822471	S1pr1<tm1.1Thla>	MP:0003156,abnormal leukocyte migration|MP:0003945,abnormal lymphocyte physiology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5295050	S1pr1<tm1Cys>	MP:0002459,abnormal B cell physiology|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype
MGI:4939069	S1pr1<tm1Jch>	MP:0000921,demyelination|MP:0003354,astrocytosis|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005387,immune system phenotype|MP:0005404,abnormal axon morphology
MGI:2158346	S1pr1<tm1Rlp>	MP:0000272,abnormal aorta morphology|MP:0000291,enlarged pericardium|MP:0000783,abnormal forebrain morphology|MP:0000787,abnormal telencephalon morphology|MP:0000830,abnormal diencephalon morphology|MP:0001614,abnormal blood vessel morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001785,edema|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0002109,abnormal limb morphology|MP:0002191,abnormal artery morphology|MP:0003203,increased neuron apoptosis|MP:0003227,abnormal vascular branching morphogenesis|MP:0003719,abnormal pericyte morphology|MP:0003814,vascular smooth muscle hypoplasia|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006055,abnormal vascular endothelial cell morphology|MP:0008045,decreased NK cell number|MP:0008053,abnormal NK cell differentiation|MP:0009864,abnormal aorta endothelium morphology|MP:0009865,abnormal aorta smooth muscle morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011707,impaired fibroblast cell migration|MP:0020321,increased vascular endothelial cell apoptosis
MGI:2681911	S1pr1<tm2Rlp>	MP:0002169,no abnormal phenotype detected
MGI:5423977	S1pr2<stdf>	MP:0000042,abnormal organ of Corti morphology|MP:0004363,stria vascularis degeneration|MP:0004366,abnormal strial marginal cell morphology|MP:0004368,abnormal stria vascularis vasculature morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004411,decreased endocochlear potential|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5605543	S1pr2<tm1.1Toka>	MP:0002083,premature death
MGI:2180817	S1pr2<tm1Ajml>	MP:0000043,organ of Corti degeneration|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0002023,increased B cell derived lymphoma incidence|MP:0002064,seizures|MP:0002083,premature death|MP:0002206,abnormal CNS synaptic transmission|MP:0002272,abnormal nervous system electrophysiology|MP:0002362,abnormal spleen marginal zone morphology|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003144,decreased otolith number|MP:0003149,abnormal tectorial membrane morphology|MP:0003997,tonic-clonic seizures|MP:0004305,abnormal Rosenthal canal morphology|MP:0004329,vestibular saccular degeneration|MP:0004364,thin stria vascularis|MP:0004404,cochlear outer hair cell degeneration|MP:0004742,abnormal vestibular system physiology|MP:0004897,otosclerosis|MP:0005015,increased T cell number|MP:0005191,head tilt|MP:0005402,abnormal action potential|MP:0006023,detached Reissner membrane|MP:0008014,increased lung tumor incidence|MP:0008177,increased germinal center B cell number|MP:0008308,small scala media|MP:0008481,increased spleen germinal center number|MP:0008483,increased spleen germinal center size|MP:0011269,increased excitatory postsynaptic current amplitude|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014378,increased excitatory postsynaptic current frequency|MP:0014625,abnormal ictal brain wave pattern
MGI:2183402	S1pr2<tm1Jch>	MP:0001935,decreased litter size|MP:0006359,absent startle reflex
MGI:3620009	S1pr2<tm1Rlp>	MP:0000043,organ of Corti degeneration|MP:0000048,abnormal stria vascularis morphology|MP:0001967,deafness|MP:0002359,abnormal spleen germinal center morphology|MP:0002857,cochlear ganglion degeneration|MP:0003143,enlarged otoliths|MP:0003144,decreased otolith number|MP:0004362,cochlear hair cell degeneration|MP:0004365,abnormal strial basal cell morphology|MP:0004366,abnormal strial marginal cell morphology|MP:0004367,abnormal strial intermediate cell morphology|MP:0004368,abnormal stria vascularis vasculature morphology|MP:0004427,abnormal vestibular labyrinth morphology|MP:0004737,absent distortion product otoacoustic emissions|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005154,increased B cell proliferation|MP:0005191,head tilt|MP:0005385,cardiovascular system phenotype|MP:0008177,increased germinal center B cell number|MP:0008783,decreased B cell apoptosis|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4881823	S1pr2<tm1Ytak>	MP:0002064,seizures|MP:0003448,abnormal tumor morphology|MP:0003721,increased tumor growth/size|MP:0005601,increased angiogenesis|MP:0010144,abnormal tumor vascularization|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011133,increased lung endothelial cell migration
MGI:4881825	S1pr2<tm2Ytak>	MP:0003631,nervous system phenotype
MGI:5701466	S1pr3<tm1.1Hrose>	MP:0002169,no abnormal phenotype detected
MGI:5636967	S1pr3<tm1b(EUCOMM)Wtsi>	MP:0001325,abnormal retina morphology|MP:0001925,male infertility|MP:0001926,female infertility|MP:0010097,abnormal retina blood vessel morphology|MP:0011239,abnormal skin coloration
MGI:2182637	S1pr3<tm1Jch>	MP:0001935,decreased litter size|MP:0005377,hearing/vestibular/ear phenotype|MP:0005621,abnormal cell physiology|MP:0008466,enlarged mesenteric lymph nodes|MP:0008713,abnormal cytokine level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:3620010	S1pr3<tm1Rlp>	MP:0002459,abnormal B cell physiology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005385,cardiovascular system phenotype
MGI:3604550	S1pr4<tm1Dgen>	MP:0009142,decreased prepulse inhibition|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5301363	S1pr4<tm1Lipp>	MP:0000228,abnormal thrombopoiesis|MP:0002417,abnormal megakaryocyte morphology|MP:0005397,hematopoietic system phenotype
MGI:5301364	S1pr4<tm2Lipp>	MP:0005397,hematopoietic system phenotype
MGI:3577728	S1pr5<tm1Club>	MP:0005068,abnormal NK cell morphology|MP:0008045,decreased NK cell number|MP:0008917,abnormal oligodendrocyte physiology|MP:0010766,abnormal NK cell physiology
MGI:4368002	S1pr5<tm1Jch>	MP:0008053,abnormal NK cell differentiation
MGI:6154052	S2bpcox16<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005566,decreased blood urea nitrogen level
MGI:3578535	s2ga	MP:0001730,embryonic growth arrest|MP:0002086,abnormal extraembryonic tissue morphology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:2449591	Saa3<l7R3-1R>	MP:0011100,preweaning lethality, complete penetrance
MGI:2449592	Saa3<l7R3-2R>	MP:0011100,preweaning lethality, complete penetrance
MGI:5569083	Saa3<tm1.1(KOMP)Vlcg>	MP:0002941,increased circulating alanine transaminase level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4452947	Saa3<tm1(KOMP)Vlcg>	MP:0000183,decreased circulating LDL cholesterol level|MP:0002644,decreased circulating triglyceride level|MP:0003402,decreased liver weight|MP:0005179,decreased circulating cholesterol level|MP:0005376,homeostasis/metabolism phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009118,increased white fat cell size|MP:0031233,decreased circulating serum amyloid protein level
MGI:7763990	Saa<em1.1Hiras>	MP:0001273,decreased metastatic potential|MP:0005389,reproductive system phenotype|MP:0010639,abnormal tumor pathology|MP:0010768,mortality/aging
MGI:3831538	Sac3d1<tm1Hnaka>	MP:0000693,spleen hyperplasia|MP:0000708,thymus hyperplasia|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002423,abnormal mast cell physiology|MP:0002459,abnormal B cell physiology|MP:0003135,increased erythroid progenitor cell number|MP:0005348,increased T cell proliferation|MP:0006410,abnormal common myeloid progenitor cell morphology
MGI:5704142	Sacc	MP:0002730,head shaking|MP:0005307,head tossing|MP:0005377,hearing/vestibular/ear phenotype
MGI:4125191	Sacm1l<Gt(NPX473)Byg>	MP:0001672,abnormal embryo development|MP:0011091,prenatal lethality, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:5605807	Sacm1l<tm1b(KOMP)Wtsi>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001399,hyperactivity|MP:0002631,abnormal epididymis morphology|MP:0004924,abnormal behavior|MP:0004931,enlarged epididymis|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0020870,decreased thigmotaxis
MGI:6156435	Sacs<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000689,abnormal spleen morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002590,increased mean corpuscular volume|MP:0002637,small uterus|MP:0011100,preweaning lethality, complete penetrance
MGI:5702397	Sacs<tm1(NCOM)Mfgc>	MP:0000876,Purkinje cell degeneration|MP:0006036,abnormal mitochondrial physiology|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:6316982	Sacs<tm2Bebr>	MP:0000745,tremors|MP:0000747,muscle weakness|MP:0000876,Purkinje cell degeneration|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001525,impaired balance|MP:0003082,abnormal gastrocnemius morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0005405,axon degeneration|MP:0008143,abnormal dendrite morphology|MP:0009422,decreased gastrocnemius weight|MP:0009426,decreased soleus weight|MP:0010053,decreased grip strength|MP:0014329,abnormal Purkinje cell axon morphology
MGI:6860670	Sae1<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:6161399	Safb2<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002574,increased vertical activity|MP:0003795,abnormal bone structure|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5695073	Safb2<tm1So>	MP:0002776,increased Sertoli cell number|MP:0004851,increased testis weight
MGI:3577076	Safb<tm1So>	MP:0000245,abnormal erythropoiesis|MP:0000598,abnormal liver morphology|MP:0001119,abnormal female reproductive system morphology|MP:0001145,abnormal male reproductive system morphology|MP:0001152,increased Leydig cell number|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001157,small seminal vesicle|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001380,decreased male mating frequency|MP:0001575,cyanosis|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001929,abnormal gametogenesis|MP:0001935,decreased litter size|MP:0002161,abnormal fertility/fecundity|MP:0002780,decreased circulating testosterone level|MP:0003700,abnormal oviduct transport|MP:0004200,decreased fetal size|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004833,ovary atrophy|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005181,decreased circulating estradiol level|MP:0005647,abnormal sex gland physiology|MP:0009064,oviduct atrophy|MP:0009070,small oviduct|MP:0009546,absent gastric milk in neonates|MP:0010103,small thoracic cage|MP:0010995,abnormal lung alveolus development|MP:0011087,neonatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011121,decreased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number|MP:0013318,abnormal branching involved in seminal vesicle morphogenesis|MP:0014052,increased male germ cell apoptosis
MGI:1862016	Sagg	MP:0005421,loose skin
MGI:4433619	Sag<tm1a(EUCOMM)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0003960,increased lean body mass|MP:0004222,iris synechia|MP:0010025,decreased total body fat amount|MP:0010088,decreased circulating fructosamine level
MGI:2388373	Sag<tm1Jnc>	MP:0004021,abnormal rod electrophysiology|MP:0005391,vision/eye phenotype|MP:0008456,abnormal retina rod cell outer segment morphology
MGI:4462422	Sall1<tm1.1Mrau>	MP:0000554,abnormal carpal bone morphology
MGI:2677452	Sall1<tm1Mrau>	MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0000554,abnormal carpal bone morphology|MP:0000555,absent carpal bone|MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0000914,exencephaly|MP:0001967,deafness|MP:0002083,premature death|MP:0002705,dilated renal tubule|MP:0002989,small kidney|MP:0003130,anal atresia|MP:0003270,intestinal obstruction|MP:0003446,renal hypoplasia|MP:0003675,kidney cyst|MP:0004637,metacarpal bone hypoplasia|MP:0004639,fused metacarpal bones|MP:0004739,conductive hearing loss|MP:0011091,prenatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0030862,absent triquetrum
MGI:2388379	Sall1<tm1Ryn>	MP:0000520,absent kidney|MP:0000521,abnormal kidney cortex morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0001436,abnormal suckling behavior|MP:0002989,small kidney|MP:0003604,single kidney|MP:0003675,kidney cyst|MP:0003722,absent ureter|MP:0004154,renal tubular necrosis|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005371,limbs/digits/tail phenotype|MP:0010983,abnormal ureteric bud invasion|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0010985,abnormal kidney mesenchyme morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011363,renal glomerulus atrophy|MP:0011386,increased metanephric mesenchyme apoptosis
MGI:2388380	Sall1<tm2Ryn>	MP:0000520,absent kidney|MP:0000521,abnormal kidney cortex morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0001436,abnormal suckling behavior|MP:0002989,small kidney|MP:0003604,single kidney|MP:0003675,kidney cyst|MP:0003722,absent ureter|MP:0004154,renal tubular necrosis|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005371,limbs/digits/tail phenotype|MP:0010983,abnormal ureteric bud invasion|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011363,renal glomerulus atrophy|MP:0011386,increased metanephric mesenchyme apoptosis
MGI:3603818	Sall1<tm3Ryn>	MP:0000520,absent kidney|MP:0002135,abnormal kidney morphology
MGI:4443121	Sall1<tm4.1Ryn>	MP:0002135,abnormal kidney morphology|MP:0002169,no abnormal phenotype detected|MP:0002703,abnormal renal tubule morphology|MP:0002989,small kidney|MP:0011087,neonatal lethality, complete penetrance
MGI:4454454	Sall1<tm4.2Ryn>	MP:0000520,absent kidney|MP:0002135,abnormal kidney morphology
MGI:3828110	Sall2<tm1Jkoh>	MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0003631,nervous system phenotype|MP:0011090,perinatal lethality, incomplete penetrance
MGI:2448237	Sall2<tm1Ryn>	MP:0002169,no abnormal phenotype detected
MGI:6714005	Sall3<tm1.1(KOMP)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001148,enlarged testis|MP:0001399,hyperactivity|MP:0001404,no spontaneous movement|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology|MP:0005599,increased cardiac muscle contractility|MP:0011100,preweaning lethality, complete penetrance
MGI:3052730	Sall3<tm1Apm>	MP:0000746,weakness|MP:0000762,abnormal tongue morphology|MP:0000959,abnormal somatic sensory system morphology|MP:0001056,abnormal cranial nerve morphology|MP:0001076,abnormal hypoglossal nerve morphology|MP:0001429,dehydration|MP:0001436,abnormal suckling behavior|MP:0001523,impaired righting response|MP:0003154,abnormal soft palate morphology|MP:0010371,abnormal epiglottis morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3688849	Sall4<Gt(RRC044)Byg>	MP:0001730,embryonic growth arrest|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3613746	Sall4<Gt(W097E01)Flo>	MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0003885,abnormal rostral-caudal body axis extension|MP:0003886,abnormal embryonic epiblast morphology|MP:0009266,abnormal mesendoderm development|MP:0009331,absent primitive node|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011189,small embryonic epiblast
MGI:3587949	Sall4<Gt(XE027)Byg>	MP:0000267,abnormal heart development|MP:0000554,abnormal carpal bone morphology|MP:0001730,embryonic growth arrest|MP:0002110,abnormal digit morphology|MP:0002190,disorganized myocardium|MP:0002652,thin myocardium|MP:0004032,abnormal interventricular groove morphology|MP:0004638,elongated metacarpal bones|MP:0005306,abnormal phalanx morphology|MP:0006207,embryonic lethality during organogenesis|MP:0010420,muscular ventricular septal defect|MP:0010432,common ventricle|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0013167,abnormal hindlimb bud morphology
MGI:3715468	Sall4<tm1Bili>	MP:0002083,premature death|MP:0011091,prenatal lethality, complete penetrance
MGI:3698290	Sall4<tm1Brd>	MP:0000049,abnormal middle ear morphology|MP:0000102,abnormal nasal bone morphology|MP:0000914,exencephaly|MP:0001048,absent enteric neurons|MP:0001485,abnormal pinna reflex|MP:0001849,ear inflammation|MP:0001850,increased susceptibility to otitis media|MP:0002082,postnatal lethality|MP:0002116,abnormal craniofacial bone morphology|MP:0003129,persistent cloaca|MP:0003130,anal atresia|MP:0003315,abnormal perineum morphology|MP:0003446,renal hypoplasia|MP:0003604,single kidney|MP:0004739,conductive hearing loss|MP:0006325,impaired hearing|MP:0006358,absent pinna reflex|MP:0009098,anovaginal fistula|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0030410,middle ear effusion|MP:0030862,absent triquetrum
MGI:3699175	Sall4<tm1Ryn>	MP:0000492,abnormal rectum morphology|MP:0000585,kinked tail|MP:0000914,exencephaly|MP:0002083,premature death|MP:0002731,megacolon|MP:0003886,abnormal embryonic epiblast morphology|MP:0005034,abnormal anus morphology|MP:0005371,limbs/digits/tail phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0010402,ventricular septal defect|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012113,decreased inner cell mass proliferation
MGI:3692447	Sall4<tm1Tre>	MP:0001714,absent trophoblast giant cells|MP:0002085,abnormal embryonic tissue morphology|MP:0002718,abnormal inner cell mass morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4438383	Sall4<tm1Yam>	MP:0000352,decreased cell proliferation|MP:0000492,abnormal rectum morphology|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001694,absent egg cylinders|MP:0002083,premature death|MP:0003695,delayed blastocyst hatching from the zona pellucida|MP:0005621,abnormal cell physiology|MP:0009053,abnormal anal canal morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011183,abnormal primitive endoderm morphology|MP:0012113,decreased inner cell mass proliferation
MGI:3693080	Sall4<tm2.1Tre>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3699176	Sall4<tm2Ryn>	MP:0000492,abnormal rectum morphology|MP:0000585,kinked tail|MP:0000914,exencephaly|MP:0002083,premature death|MP:0002085,abnormal embryonic tissue morphology|MP:0002718,abnormal inner cell mass morphology|MP:0002731,megacolon|MP:0005034,abnormal anus morphology|MP:0010402,ventricular septal defect|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3514278	Salpa1<MRL/MpJ>	MP:0011584,increased alkaline phosphatase activity
MGI:3514280	Salpa2<MRL/MpJ>	MP:0011584,increased alkaline phosphatase activity
MGI:3613004	Salpa3<DBA/2J>	MP:0011584,increased alkaline phosphatase activity
MGI:3708380	salr	MP:0001489,decreased startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6121489	Samd11<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0020870,decreased thigmotaxis
MGI:7520290	Samd11<em1Tfur>	MP:0002169,no abnormal phenotype detected
MGI:7451188	Samd1<tm1Pfi>	MP:0000074,abnormal neurocranium morphology|MP:0000186,decreased circulating HDL cholesterol level|MP:0000259,abnormal vascular development|MP:0000267,abnormal heart development|MP:0000596,abnormal liver development|MP:0000914,exencephaly|MP:0001176,abnormal lung development|MP:0001262,decreased body weight|MP:0001560,abnormal circulating insulin level|MP:0001633,poor circulation|MP:0001672,abnormal embryo development|MP:0001722,pale yolk sac|MP:0001745,increased circulating corticosterone level|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002267,abnormal bronchiole morphology|MP:0002666,increased circulating aldosterone level|MP:0002875,decreased erythrocyte cell number|MP:0003416,premature bone ossification|MP:0003717,pallor|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0004266,pale placenta|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005291,abnormal glucose tolerance|MP:0005452,abnormal adipose tissue amount|MP:0009415,skeletal muscle degeneration|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011111,lethality during fetal growth through weaning, complete penetrance|MP:0011206,absent visceral yolk sac|MP:0012301,absent umbilical cord blood vessels|MP:0031232,increased circulating angiotensin II level
MGI:6293846	Samd3<em1(IMPC)H>	MP:0005565,increased blood urea nitrogen level
MGI:7260138	Samd3<tm1.1(HBEGF)Wfkr>	MP:0005387,immune system phenotype|MP:0008045,decreased NK cell number|MP:0008050,decreased memory T cell number|MP:0008053,abnormal NK cell differentiation|MP:0010839,decreased CD8-positive, alpha-beta memory T cell number
MGI:5547989	Samd4<m1Btlr>	MP:0000160,kyphosis|MP:0000182,increased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000734,muscle hypoplasia|MP:0000751,myopathy|MP:0000759,abnormal skeletal muscle morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0004087,abnormal muscle fiber morphology|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005375,adipose tissue phenotype|MP:0005390,skeleton phenotype|MP:0005451,abnormal body composition|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0006086,decreased body mass index|MP:0008963,increased carbon dioxide production|MP:0009117,abnormal white fat cell morphology|MP:0009133,decreased white fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010025,decreased total body fat amount|MP:0010399,decreased skeletal muscle glycogen level|MP:0010934,increased subcutaneous adipose tissue amount
MGI:3624556	Samd4<sunk>	MP:0000135,decreased compact bone thickness|MP:0000160,kyphosis|MP:0001406,abnormal gait
MGI:6370355	Samd7<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0001392,abnormal locomotor behavior
MGI:6150316	Samd7<tm1Tfur>	MP:0001325,abnormal retina morphology|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0010768,mortality/aging|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:5707954	Samd8<tm1.1Kwi>	MP:0003631,nervous system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0012232,abnormal ceramide level
MGI:5749225	Samd8<tm1Jia>	MP:0005319,abnormal enzyme/coenzyme level|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype
MGI:5707965	Samd8<tm2.2Kwi>	MP:0012232,abnormal ceramide level
MGI:5548452	Samd9l<tm1.1(KOMP)Wtsi>	MP:0000194,increased circulating calcium level|MP:0001529,abnormal vocalization|MP:0001566,increased circulating phosphate level
MGI:5304359	Samd9l<tm1Homy>	MP:0000218,increased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000245,abnormal erythropoiesis|MP:0000321,increased bone marrow cell number|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002417,abnormal megakaryocyte morphology|MP:0002641,anisopoikilocytosis|MP:0005065,abnormal neutrophil morphology|MP:0005097,polychromatophilia|MP:0005376,homeostasis/metabolism phenotype|MP:0010178,increased number of Howell-Jolly bodies|MP:0011176,abnormal erythroblast morphology|MP:0012563,increased tumor incidence following infection|MP:0020934,increased susceptibility to Retroviridae infection|MP:0030025,giant platelets
MGI:5543254	Samhd1<tm1.1Crs>	MP:0010768,mortality/aging
MGI:5543255	Samhd1<tm1.2Crs>	MP:0020934,increased susceptibility to Retroviridae infection
MGI:4431751	Samhd1<tm1a(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5551758	Samhd1<tm1d(EUCOMM)Wtsi>	MP:0005025,abnormal response to infection|MP:0005387,immune system phenotype|MP:0005621,abnormal cell physiology
MGI:5543256	Samhd1<tm2.1Crs>	MP:0010768,mortality/aging
MGI:5543257	Samhd1<tm2.2Crs>	MP:0020934,increased susceptibility to Retroviridae infection
MGI:6414489	Samm50<em1(IMPC)Hmgu>	MP:0001523,impaired righting response|MP:0002100,abnormal tooth morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:4437672	Samsn1<tm1Xyw>	MP:0002376,abnormal dendritic cell physiology|MP:0002494,increased IgM level|MP:0005154,increased B cell proliferation|MP:0005348,increased T cell proliferation|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0008167,increased B-1a cell number|MP:0008502,increased IgG3 level|MP:0008577,increased circulating interferon-gamma level|MP:0008663,increased interleukin-12 secretion|MP:0008699,increased interleukin-4 secretion
MGI:7662920	Sanbr<em1(IMPC)Mbp>	MP:0001925,male infertility
MGI:5425004	SAP003	MP:0002968,increased circulating alkaline phosphatase level
MGI:5425005	SAP004	MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level
MGI:5425006	SAP006	MP:0002968,increased circulating alkaline phosphatase level
MGI:5425008	SAP008	MP:0002968,increased circulating alkaline phosphatase level
MGI:5906284	Sap130<b2b635.2Clo>	MP:0010446,heart left ventricle hypoplasia|MP:0010463,aorta stenosis|MP:0031523,mitral valve hypoplasia
MGI:5141821	Sap130<tm1a(KOMP)Mbp>	MP:0000221,decreased leukocyte cell number|MP:0011093,embryonic lethality at implantation, complete penetrance|MP:0011939,increased food intake
MGI:5300459	Sap130<Tn(sb-Tyr)1799B.CA9Ove>	MP:0002169,no abnormal phenotype detected
MGI:5911231	Sap18<em1(IMPC)J>	MP:0002574,increased vertical activity|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5286682	Sap30bp<Tg(Tyr)2375C-1Ove>	MP:0001577,anemia
MGI:6388615	Sap30<em1(IMPC)J>	MP:0002590,increased mean corpuscular volume|MP:0005559,increased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5617792	Sapcd1<tm1.1(KOMP)Vlcg>	MP:0000062,increased bone mineral density
MGI:3513254	Sapcd2<tm1Sia>	MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype
MGI:1861667	sar	MP:0003631,nervous system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0030644,increased circulating methionine level|MP:0030655,increased circulating glycine level|MP:0031637,methioninuria
MGI:7331421	Sar1b<em1Emle>	MP:0000186,decreased circulating HDL cholesterol level|MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0005342,abnormal intestinal lipid absorption|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0013245,abnormal lipid metabolism|MP:0020151,abnormal circulating non-HDL cholesterol level|MP:0020868,decreased lipogenesis
MGI:7331422	Sar1b<em2Emle>	MP:0000186,decreased circulating HDL cholesterol level|MP:0002644,decreased circulating triglyceride level|MP:0002791,steatorrhea|MP:0005179,decreased circulating cholesterol level|MP:0005342,abnormal intestinal lipid absorption|MP:0010027,increased liver cholesterol level|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0013245,abnormal lipid metabolism|MP:0020151,abnormal circulating non-HDL cholesterol level|MP:0020868,decreased lipogenesis
MGI:4432515	Sar1b<tm1a(EUCOMM)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001191,abnormal skin condition|MP:0001554,increased circulating free fatty acids level|MP:0002702,decreased circulating free fatty acids level|MP:0002942,decreased circulating alanine transaminase level|MP:0005179,decreased circulating cholesterol level|MP:0005561,increased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance
MGI:7509470	Saraf<tm1c(KOMP)Wtsi>	MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001264,increased body size|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001745,increased circulating corticosterone level|MP:0001780,decreased brown adipose tissue amount|MP:0003212,increased susceptibility to age related obesity|MP:0003503,decreased activity of thyroid gland|MP:0003960,increased lean body mass|MP:0003961,decreased lean body mass|MP:0004231,abnormal calcium ion homeostasis|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005370,liver/biliary system phenotype|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005458,increased percent body fat/body weight|MP:0005459,decreased percent body fat/body weight|MP:0008965,increased basal metabolism|MP:0009118,increased white fat cell size|MP:0010080,abnormal hepatocyte physiology|MP:0010954,abnormal cellular respiration|MP:0011704,decreased fibroblast proliferation|MP:0012006,abnormal hippocampus physiology|MP:0020234,decreased basal metabolism|MP:0020394,decreased neuronal precursor proliferation|MP:0020411,increased abdominal adipose tissue amount|MP:0020520,whitened brown adipose tissue morphology|MP:0031271,increased susceptibility to age-related hepatic steatosis|MP:0031391,increased locomotor activity
MGI:6515833	Sardh<em1Tzq>	MP:0000807,abnormal hippocampus morphology|MP:0001262,decreased body weight|MP:0001902,reduced NMDA-mediated synaptic currents|MP:0008428,abnormal spatial working memory
MGI:5507721	Sarm1<tm1.1Diam>	MP:0003203,increased neuron apoptosis|MP:0003204,decreased neuron apoptosis|MP:0003633,abnormal nervous system physiology|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008552,abnormal circulating tumor necrosis factor level|MP:0020449,decreased microglial cell activation|MP:0020943,increased susceptibility to Flaviviridae infection|MP:0031044,increased susceptibility to Flaviviridae infection induced morbidity/mortality
MGI:3765956	Sarm1<tm1Aidi>	MP:0005387,immune system phenotype|MP:0006043,decreased apoptosis
MGI:5548511	Sarnp<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001488,increased startle reflex|MP:0002699,abnormal vitreous body morphology|MP:0005561,increased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness
MGI:5751876	Sars1<tm1.1(KOMP)Vlcg>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0005102,abnormal iris pigmentation|MP:0005292,improved glucose tolerance|MP:0010053,decreased grip strength|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012058,abnormal morula morphology|MP:0012129,failure of blastocyst formation|MP:0013292,embryonic lethality prior to organogenesis
MGI:5705870	Sart1<tm1.1(KOMP)Vlcg>	MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0020870,decreased thigmotaxis
MGI:7425960	Sart3<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0001727,abnormal embryo implantation|MP:0003984,embryonic growth retardation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:5052106	Sart3<tm1.1Hbro>	MP:0002123,abnormal definitive hematopoiesis|MP:0004810,decreased hematopoietic stem cell number|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008973,decreased erythroid progenitor cell number
MGI:6257607	Sash1<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0002792,abnormal retina vasculature morphology|MP:0003984,embryonic growth retardation|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:3716944	Sash3<tm1Hlz>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001845,abnormal inflammatory response|MP:0002223,lymphoid hypoplasia|MP:0002459,abnormal B cell physiology|MP:0002722,abnormal immune system organ morphology|MP:0004751,increased length of allograft survival|MP:0004939,abnormal B cell morphology|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0008037,abnormal T cell morphology|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008133,decreased Peyer's patch number|MP:0008182,decreased marginal zone B cell number|MP:0008193,abnormal marginal zone B cell physiology|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion
MGI:8242359	Sass6<em1Baz>	MP:0001700,abnormal embryo turning|MP:0001730,embryonic growth arrest|MP:0004046,abnormal mitosis|MP:0009768,impaired somite development|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance|MP:0031682,abnormal centriole morphology
MGI:7425961	Sass6<em1(IMPC)Bay>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0000288,abnormal pericardium morphology|MP:0001691,abnormal somite shape|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001722,pale yolk sac|MP:0001785,edema|MP:0002151,abnormal neural tube morphology|MP:0002861,abnormal tail bud morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0003425,abnormal optic vesicle formation|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:8242360	Sass6<em2Baz>	MP:0001700,abnormal embryo turning|MP:0001730,embryonic growth arrest|MP:0009768,impaired somite development|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance|MP:0031682,abnormal centriole morphology
MGI:3521903	Sat1<tm1Alh>	MP:0000609,abnormal liver physiology|MP:0001923,reduced female fertility|MP:0002169,no abnormal phenotype detected|MP:0005455,increased susceptibility to weight gain|MP:0005458,increased percent body fat/body weight|MP:0005669,increased circulating leptin level|MP:0005670,abnormal white adipose tissue physiology|MP:0008908,increased total fat pad weight|MP:0010957,abnormal aerobic respiration
MGI:7311696	Satb1<em1Zfa>	MP:0002083,premature death|MP:0013893,decreased common lymphocyte progenitor cell number
MGI:5563413	Satb1<m1Anu>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology
MGI:4436287	Satb1<tm1a(EUCOMM)Hmgu>	MP:0001732,postnatal growth retardation|MP:0003631,nervous system phenotype|MP:0004101,abnormal brain interneuron morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:5548358	Satb1<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002699,abnormal vitreous body morphology|MP:0003795,abnormal bone structure|MP:0004738,abnormal auditory brainstem response|MP:0005343,increased circulating aspartate transaminase level|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2386676	Satb1<tm1Kos>	MP:0000692,small spleen|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001265,decreased body size|MP:0001290,delayed eyelid opening|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0001825,arrested T cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002217,small lymph nodes|MP:0005094,abnormal T cell proliferation|MP:0011085,postnatal lethality, complete penetrance
MGI:5702862	Satb1<tm2Kos>	MP:0000623,decreased salivation|MP:0001859,kidney inflammation|MP:0001869,pancreas inflammation|MP:0001870,salivary gland inflammation|MP:0002083,premature death|MP:0002962,increased urine protein level|MP:0003725,increased autoantibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004975,absent regulatory T cells|MP:0005325,abnormal renal glomerulus morphology|MP:0005350,increased susceptibility to autoimmune disorder|MP:0013583,salivary gland degeneration
MGI:5755082	Satb2<em3(IMPC)Tcp>	MP:0000428,abnormal craniofacial morphology|MP:0001325,abnormal retina morphology|MP:0002590,increased mean corpuscular volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0011100,preweaning lethality, complete penetrance
MGI:5424899	Satb2<Mhdabap002>	MP:0000063,decreased bone mineral density|MP:0000126,brittle teeth|MP:0000130,abnormal trabecular bone morphology|MP:0000194,increased circulating calcium level|MP:0000454,abnormal jaw morphology|MP:0002968,increased circulating alkaline phosphatase level
MGI:5548857	Satb2<tm1b(KOMP)Wtsi>	MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:3695425	Satb2<tm1(cre)Vit>	MP:0000111,cleft palate|MP:0000125,absent incisors|MP:0000433,microcephaly|MP:0000445,short snout|MP:0000454,abnormal jaw morphology|MP:0000547,short limbs|MP:0002081,perinatal lethality|MP:0002639,micrognathia|MP:0002689,abnormal molar morphology|MP:0003056,abnormal hyoid bone morphology|MP:0004726,abnormal nasal capsule morphology|MP:0004871,premaxilla hypoplasia|MP:0005358,abnormal incisor morphology|MP:0008862,asymmetric snout|MP:0009524,absent submandibular gland|MP:0009880,decreased mouth size|MP:0009907,decreased tongue size|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3692768	Satb2<tm1Rug>	MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000102,abnormal nasal bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000130,abnormal trabecular bone morphology|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0002639,micrognathia|MP:0002820,abnormal premaxilla morphology|MP:0002896,abnormal bone mineralization|MP:0003056,abnormal hyoid bone morphology|MP:0003755,abnormal palate morphology|MP:0003795,abnormal bone structure|MP:0004791,absent lower incisors|MP:0005170,cleft upper lip|MP:0005272,abnormal temporal bone morphology|MP:0006337,abnormal first pharyngeal arch morphology|MP:0008271,abnormal bone ossification|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0009907,decreased tongue size|MP:0009914,abnormal hyoid bone lesser horn morphology|MP:0009917,abnormal hyoid bone body morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011711,impaired osteoblast differentiation|MP:0014322,short hindlimb|MP:0020301,short tongue|MP:0030868,absent thyroid cartilage
MGI:4838640	Sav1<tm1.1Dupa>	MP:0003269,colon polyps|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0008883,abnormal enterocyte proliferation
MGI:5784888	Sav1<tm1.1Gpp>	MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0004839,bile duct hyperplasia|MP:0008019,increased liver tumor incidence|MP:0010040,abnormal oval cell morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:4430538	Sav1<tm1.1Rjo>	MP:0002038,increased carcinoma incidence|MP:0002981,increased liver weight|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003893,increased hepatocyte proliferation|MP:0008019,increased liver tumor incidence
MGI:3790763	Sav1<tm1Dlim>	MP:0000328,increased enterocyte cell number|MP:0000382,underdeveloped hair follicles|MP:0000479,abnormal enterocyte morphology|MP:0001176,abnormal lung development|MP:0001222,epidermal hyperplasia|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001235,disorganized suprabasal layer|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001329,retina hyperplasia|MP:0002083,premature death|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0003427,parakeratosis|MP:0003449,abnormal intestine goblet cell morphology|MP:0003789,increased osteosarcoma incidence|MP:0004201,fetal growth retardation|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0008000,increased ovary tumor incidence|MP:0008019,increased liver tumor incidence|MP:0008108,abnormal small intestinal villus morphology|MP:0008109,abnormal small intestinal microvillus morphology|MP:0008770,decreased survivor rate|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0008883,abnormal enterocyte proliferation|MP:0010264,increased hepatoma incidence|MP:0010802,abnormal intestinal enteroendocrine cell morphology|MP:0010945,lung epithelium hyperplasia|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012431,increased lymphoma incidence
MGI:4457496	Sav1<tm2.1Dlim>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0002981,increased liver weight|MP:0003331,increased hepatocellular carcinoma incidence|MP:0005370,liver/biliary system phenotype|MP:0008992,abnormal portal lobule morphology|MP:0010040,abnormal oval cell morphology|MP:0010042,abnormal oval cell physiology|MP:0010264,increased hepatoma incidence
MGI:6693656	Saxo1<em1Zuk>	MP:0002169,no abnormal phenotype detected
MGI:6120754	Saxo1<tm1b(EUCOMM)Hmgu>	MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0002699,abnormal vitreous body morphology|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number
MGI:7641913	Saxo4<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5582432	Saxo4<tm1b(KOMP)Wtsi>	MP:0002075,abnormal coat/hair pigmentation
MGI:5548667	Saxo5<tm3b(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:7378848	Saysd1<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0005278,abnormal cholesterol homeostasis|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7580962	Saysd1<em1Yogo>	MP:0002169,no abnormal phenotype detected|MP:0002687,oligozoospermia
MGI:1857027	sb	MP:0000069,kyphoscoliosis|MP:0000154,rib fusion|MP:0000162,lordosis|MP:0000592,short tail|MP:0001258,decreased body length|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0003048,abnormal cervical vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0003345,decreased rib number|MP:0004174,abnormal spine curvature|MP:0004648,decreased thoracic vertebrae number|MP:0004703,abnormal vertebral column morphology|MP:0005508,abnormal skeleton morphology|MP:0006281,abnormal tail development|MP:0008770,decreased survivor rate|MP:0010099,abnormal thoracic cage shape|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5646532	SB2/1	MP:0006325,impaired hearing
MGI:2679584	Sbc	MP:0020467,abnormal circadian behavior
MGI:7484403	Sbds<em1(SBDS*)Dbau>	MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0014242,abnormal ribosome biogenesis
MGI:5007535	Sbds<tm1.1Aljw>	MP:0011092,embryonic lethality, complete penetrance
MGI:4452398	Sbds<tm1Dats>	MP:0000221,decreased leukocyte cell number|MP:0001606,impaired hematopoiesis|MP:0002127,abnormal cardiovascular system morphology|MP:0002397,abnormal bone marrow morphology|MP:0002417,abnormal megakaryocyte morphology|MP:0003795,abnormal bone structure|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005065,abnormal neutrophil morphology|MP:0008250,abnormal myeloid leukocyte morphology
MGI:3664792	Sbds<tm1Jrom>	MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011198,absent proamniotic cavity|MP:0012114,absent inner cell mass proliferation
MGI:5446042	Sbds<tm2.1Jrom>	MP:0005380,embryo phenotype
MGI:6860354	Sbf1<em1Frobi>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001925,male infertility|MP:0002651,abnormal sciatic nerve morphology|MP:0005386,behavior/neurological phenotype|MP:0020452,abnormal axon radial sorting
MGI:6491422	Sbf1<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000774,decreased brain size|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001258,decreased body length|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001925,male infertility|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002175,decreased brain weight|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003068,enlarged kidney|MP:0004924,abnormal behavior|MP:0005016,decreased lymphocyte cell number|MP:0009142,decreased prepulse inhibition|MP:0009552,urinary bladder obstruction|MP:0010052,increased grip strength|MP:0010067,increased red blood cell distribution width|MP:0010123,increased bone mineral content|MP:0013278,decreased fasting circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:2449174	Sbf1<tm1Mlc>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0005159,azoospermia|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014633,decreased spermatid number|MP:0014634,decreased round spermatid number|MP:0014636,decreased elongated spermatid number
MGI:7541409	Sbf2<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3783290	Sbf2<Gt(RRF511)Byg>	MP:0001504,abnormal posture|MP:0003871,abnormal myelin sheath morphology|MP:0005403,abnormal nerve conduction
MGI:3776016	Sbf2<Gt(XH212)Byg>	MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0003224,neuron degeneration|MP:0003871,abnormal myelin sheath morphology|MP:0005389,reproductive system phenotype|MP:0005402,abnormal action potential|MP:0005404,abnormal axon morphology
MGI:5692766	Sbk1<tm1b(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0001510,abnormal coat appearance|MP:0005419,decreased circulating serum albumin level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration|MP:0011960,abnormal eye anterior chamber depth|MP:0011965,decreased total retina thickness
MGI:6257813	Sbk2<em1(IMPC)Bay>	MP:0005419,decreased circulating serum albumin level
MGI:2662979	Sbmd1<AKR/J>	MP:0000062,increased bone mineral density
MGI:2662982	Sbmd2<SAMR1>	MP:0000062,increased bone mineral density
MGI:2662985	Sbmd3<SAMP6>	MP:0000062,increased bone mineral density
MGI:2662987	Sbmd4<SAMP6>	MP:0000062,increased bone mineral density
MGI:3710668	Sbmd5<AKR/J>	MP:0000062,increased bone mineral density
MGI:6267489	Sbno1<tm1.1Hssk>	MP:0000352,decreased cell proliferation|MP:0001730,embryonic growth arrest|MP:0002663,absent blastocoele|MP:0006042,increased apoptosis|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:6120781	Sbno1<tm1b(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0001510,abnormal coat appearance|MP:0002075,abnormal coat/hair pigmentation|MP:0010067,increased red blood cell distribution width|MP:0010087,increased circulating fructosamine level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5551983	Sbno2<tm1.1Aki>	MP:0000067,osteopetrosis|MP:0001262,decreased body weight|MP:0001541,abnormal osteoclast physiology|MP:0002113,abnormal skeleton development|MP:0002896,abnormal bone mineralization|MP:0004982,abnormal osteoclast morphology|MP:0005369,muscle phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005605,increased bone mass|MP:0008271,abnormal bone ossification|MP:0009347,increased trabecular bone thickness|MP:0010867,abnormal bone trabecula morphology|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011711,impaired osteoblast differentiation
MGI:3758823	sbse	MP:0000018,small ears|MP:0000063,decreased bone mineral density|MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000440,domed cranium|MP:0000445,short snout|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001891,hydrocephaly|MP:0001935,decreased litter size|MP:0004748,increased susceptibility to age-related hearing loss|MP:0005352,small cranium|MP:0005379,endocrine/exocrine gland phenotype|MP:0005391,vision/eye phenotype|MP:0005459,decreased percent body fat/body weight|MP:0008525,decreased cranium height|MP:0010124,decreased bone mineral content|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6500980	Sbsn<em1Ham>	MP:0001240,abnormal epidermis stratum corneum morphology|MP:0002796,impaired skin barrier function|MP:0005387,immune system phenotype|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008700,decreased interleukin-4 secretion|MP:0009642,abnormal blood homeostasis
MGI:6341905	Sbsn<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0002932,abnormal joint morphology|MP:0005627,increased circulating potassium level|MP:0005634,decreased circulating sodium level|MP:0008725,increased heart atrium size|MP:0010090,increased circulating creatine kinase level
MGI:6147538	Sbspon<em1(IMPC)Ccpcz>	MP:0000627,abnormal mammary gland morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:2154315	Sbw1<NZB/BlScr>	MP:0000691,enlarged spleen
MGI:2155971	Sbw2<NZB/BlScr>	MP:0000691,enlarged spleen
MGI:1857028	sc	MP:0000074,abnormal neurocranium morphology|MP:0000157,abnormal sternum morphology|MP:0000454,abnormal jaw morphology|MP:0000464,increased presacral vertebrae number|MP:0001265,decreased body size|MP:0001921,reduced fertility|MP:0002100,abnormal tooth morphology|MP:0002111,abnormal tail morphology|MP:0002114,abnormal axial skeleton morphology|MP:0004321,short sternum|MP:0005225,abnormal vertebrae development|MP:0005227,abnormal vertebral body development|MP:0008148,abnormal sternocostal joint morphology|MP:0010831,lethality, incomplete penetrance|MP:0012279,wide sternum
MGI:5648222	Sc5d<b2b3462Clo>	MP:0000520,absent kidney|MP:0000564,syndactyly|MP:0002109,abnormal limb morphology|MP:0002639,micrognathia|MP:0010422,heart right ventricle hypoplasia
MGI:4458024	Sc5d<N224K>	MP:0000547,short limbs|MP:0000564,syndactyly|MP:0002109,abnormal limb morphology|MP:0003051,curly tail|MP:0011089,perinatal lethality, complete penetrance
MGI:2668464	Sc5d<tm1Fdp>	MP:0000074,abnormal neurocranium morphology|MP:0000111,cleft palate|MP:0000460,mandible hypoplasia|MP:0000547,short limbs|MP:0000562,polydactyly|MP:0000572,abnormal autopod morphology|MP:0000585,kinked tail|MP:0001177,atelectasis|MP:0001786,skin edema|MP:0002639,micrognathia|MP:0002971,abnormal brown adipose tissue morphology|MP:0002981,increased liver weight|MP:0003983,decreased cholesterol level|MP:0004201,fetal growth retardation|MP:0004358,bowed tibia|MP:0004361,bowed ulna|MP:0004374,bowed radius|MP:0004385,interparietal bone hypoplasia|MP:0004674,thin ribs|MP:0005059,lysosomal protein accumulation|MP:0005278,abnormal cholesterol homeostasis|MP:0005306,abnormal phalanx morphology|MP:0006279,abnormal limb development|MP:0009160,abnormal pancreatic acinar cell zymogen granule morphology|MP:0009674,decreased birth weight|MP:0010161,decreased brain cholesterol level|MP:0010398,decreased liver glycogen level|MP:0011089,perinatal lethality, complete penetrance|MP:0030252,narrow frontonasal prominence|MP:0030256,abnormal mandibular dental arch morphology
MGI:6152741	Scaf11<em1(IMPC)Wtsi>	MP:0003036,vertebral transformation|MP:0003795,abnormal bone structure|MP:0010124,decreased bone mineral content
MGI:7481978	Scaf8<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0002834,decreased heart weight|MP:0011100,preweaning lethality, complete penetrance
MGI:5898410	Scai<tm1b(EUCOMM)Hmgu>	MP:0001129,impaired ovarian folliculogenesis|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0003992,increased mortality induced by ionizing radiation|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0005384,cellular phenotype|MP:0005387,immune system phenotype|MP:0008261,arrest of male meiosis|MP:0011125,decreased primary ovarian follicle number|MP:0014764,impaired double-strand DNA break repair
MGI:2445741	Scamp1<tm1Sud>	MP:0002169,no abnormal phenotype detected|MP:0005621,abnormal cell physiology
MGI:5752771	Scamp2<em1(IMPC)J>	MP:0001304,cataract|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0004738,abnormal auditory brainstem response|MP:0005568,increased circulating total protein level|MP:0010053,decreased grip strength|MP:0012121,sclerocornea|MP:0013278,decreased fasting circulating glucose level
MGI:5585591	Scamp5<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001489,decreased startle reflex|MP:0002941,increased circulating alanine transaminase level|MP:0002959,increased urine microalbumin level|MP:0003960,increased lean body mass|MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0011396,abnormal sleep behavior|MP:0020870,decreased thigmotaxis
MGI:6441508	Scamp5<tm1Smoc>	MP:0001496,audiogenic seizures|MP:0002064,seizures|MP:0002083,premature death|MP:0004145,abnormal muscle electrophysiology|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004994,abnormal brain wave pattern|MP:0011269,increased excitatory postsynaptic current amplitude
MGI:7425962	Scand1<em1(IMPC)H>	MP:0001399,hyperactivity|MP:0005553,increased circulating creatinine level|MP:0010068,decreased red blood cell distribution width
MGI:4455688	Scaper<tm1a(EUCOMM)Hmgu>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0011121,decreased primordial ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0031239,increased atretic ovarian follicle number
MGI:5792557	Scaper<tm1b(EUCOMM)Hmgu>	MP:0001925,male infertility|MP:0005566,decreased blood urea nitrogen level|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5286697	Scap<Tg(Tyr)2391B-1bOve>	MP:0001265,decreased body size
MGI:2148743	Scap<tm1Mbjg>	MP:0002118,abnormal lipid homeostasis|MP:0002702,decreased circulating free fatty acids level|MP:0005278,abnormal cholesterol homeostasis|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level
MGI:5510759	Scara5<tm1Ktry>	MP:0001146,abnormal testis morphology|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001862,interstitial pneumonia|MP:0001922,reduced male fertility|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004947,skin inflammation|MP:0009646,urinary bladder inflammation|MP:0020386,adipose tissue inflammation
MGI:3513434	Scarb1<Chohd1>	MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3839755	Scarb1<Hdlq1-129S1/SvImJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:2387157	Scarb1<Hdlq1-NZB/BlNJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3575158	Scarb1<Hlb398>	MP:0000609,abnormal liver physiology|MP:0001547,abnormal lipid level|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0003980,increased circulating phospholipid level|MP:0005178,increased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005389,reproductive system phenotype
MGI:3690317	Scarb1<tm1.1Thh>	MP:0001556,increased circulating HDL cholesterol level|MP:0001926,female infertility|MP:0005178,increased circulating cholesterol level|MP:0005339,increased susceptibility to atherosclerosis|MP:0008596,increased circulating interleukin-6 level
MGI:5548930	Scarb1<tm1b(EUCOMM)Wtsi>	MP:0000274,enlarged heart|MP:0000691,enlarged spleen|MP:0002757,decreased vertical activity|MP:0002833,increased heart weight|MP:0004122,abnormal sinus arrhythmia|MP:0004952,increased spleen weight|MP:0005178,increased circulating cholesterol level|MP:0005333,decreased heart rate|MP:0005385,cardiovascular system phenotype|MP:0010506,prolonged RR interval|MP:0010570,prolonged ST segment|MP:0011953,prolonged PQ interval
MGI:1928989	Scarb1<tm1Dhu>	MP:0000184,abnormal circulating HDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0002118,abnormal lipid homeostasis|MP:0005178,increased circulating cholesterol level
MGI:1888384	Scarb1<tm1Kri>	MP:0000180,abnormal circulating cholesterol level|MP:0000242,impaired fertilization|MP:0000248,macrocytosis|MP:0001125,abnormal oocyte morphology|MP:0001577,anemia|MP:0001926,female infertility|MP:0002085,abnormal embryonic tissue morphology|MP:0002118,abnormal lipid homeostasis|MP:0002447,abnormal erythrocyte morphology|MP:0002643,poikilocytosis|MP:0002909,abnormal adrenal gland physiology|MP:0003191,abnormal cellular cholesterol metabolism|MP:0003406,failure of zygotic cell division|MP:0003947,abnormal cholesterol level|MP:0003982,increased cholesterol level|MP:0004883,abnormal vascular wound healing|MP:0005168,abnormal female meiosis|MP:0005178,increased circulating cholesterol level|MP:0009093,oocyte degeneration|MP:0011088,neonatal lethality, incomplete penetrance|MP:0031013,abnormal egg activation
MGI:3690316	Scarb1<tm1Thh>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005339,increased susceptibility to atherosclerosis|MP:0008596,increased circulating interleukin-6 level
MGI:5755083	Scarb2<em2(IMPC)Tcp>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000702,enlarged lymph nodes|MP:0002591,decreased mean corpuscular volume|MP:0003068,enlarged kidney|MP:0003928,increased heart rate variability|MP:0003960,increased lean body mass|MP:0004122,abnormal sinus arrhythmia|MP:0004156,abnormal QT variability|MP:0005013,increased lymphocyte cell number|MP:0005385,cardiovascular system phenotype|MP:0005505,thrombocytosis|MP:0005565,increased blood urea nitrogen level|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2654430	Scarb2<tm1Psa>	MP:0000048,abnormal stria vascularis morphology|MP:0000519,hydronephrosis|MP:0000534,abnormal ureter morphology|MP:0000745,tremors|MP:0000753,paralysis|MP:0000921,demyelination|MP:0001078,abnormal phrenic nerve morphology|MP:0001106,abnormal Schwann cell morphology|MP:0001262,decreased body weight|MP:0001270,distended abdomen|MP:0001426,polydipsia|MP:0001513,limb grasping|MP:0001762,polyuria|MP:0001967,deafness|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0002857,cochlear ganglion degeneration|MP:0002871,albuminuria|MP:0002882,abnormal neuron morphology|MP:0002895,abnormal otolithic membrane morphology|MP:0002978,absent otoliths|MP:0002988,decreased urine osmolality|MP:0003354,astrocytosis|MP:0003630,abnormal urothelium morphology|MP:0003632,abnormal nervous system morphology|MP:0003870,decreased urine glucose level|MP:0004363,stria vascularis degeneration|MP:0004366,abnormal strial marginal cell morphology|MP:0004368,abnormal stria vascularis vasculature morphology|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004410,absent endocochlear potential|MP:0004411,decreased endocochlear potential|MP:0004438,abnormal vestibular hair cell physiology|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004738,abnormal auditory brainstem response|MP:0004740,sensorineural hearing loss|MP:0004924,abnormal behavior|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006359,absent startle reflex|MP:0008918,microgliosis|MP:0011305,dilated kidney calyx|MP:0011418,leukocyturia|MP:0011426,abnormal ureter smooth muscle morphology|MP:0011487,abnormal ureteropelvic junction morphology|MP:0011491,ureteropelvic junction obstruction
MGI:3052974	Scarf1<tm1Ishi>	MP:0002169,no abnormal phenotype detected
MGI:5562868	Scarf1<tm1Tkms>	MP:0000414,alopecia|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001280,loss of vibrissae|MP:0001798,impaired macrophage phagocytosis|MP:0002376,abnormal dendritic cell physiology|MP:0002459,abnormal B cell physiology|MP:0002493,increased IgG level|MP:0002743,glomerulonephritis|MP:0002962,increased urine protein level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004796,increased anti-histone antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004947,skin inflammation|MP:0005013,increased lymphocyte cell number|MP:0005014,increased B cell number|MP:0005161,hematuria|MP:0005384,cellular phenotype|MP:0005387,immune system phenotype|MP:0005565,increased blood urea nitrogen level|MP:0005621,abnormal cell physiology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008483,increased spleen germinal center size|MP:0010186,increased T follicular helper cell number|MP:0010768,mortality/aging|MP:0011420,pyuria|MP:0020519,renal glomerular immunoglobulin deposits
MGI:5548490	Scarf2<tm1.1(KOMP)Vlcg>	MP:0004357,long tibia
MGI:7425964	Scart1<em1(IMPC)Bay>	MP:0001392,abnormal locomotor behavior
MGI:5548819	Scart2<tm1b(KOMP)Wtsi>	MP:0002111,abnormal tail morphology|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis
MGI:1857030	scb	MP:0000367,abnormal coat/ hair morphology|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001191,abnormal skin condition|MP:0001192,scaly skin|MP:0001510,abnormal coat appearance|MP:0002073,abnormal hair growth|MP:0002111,abnormal tail morphology|MP:0003701,elevated level of mitotic sister chromatid exchange|MP:0003702,abnormal chromosome morphology|MP:0005390,skeleton phenotype
MGI:3577062	Scc11<BALB/cHeA>	MP:0002020,increased tumor incidence
MGI:2155185	Scc2<STS/A>	MP:0002020,increased tumor incidence
MGI:2157958	Scc6<STS/A>	MP:0002044,increased colon adenoma incidence
MGI:2157035	Scc8<STS/A>	MP:0002044,increased colon adenoma incidence
MGI:2157956	Scc9<STS/A>	MP:0002044,increased colon adenoma incidence
MGI:6112025	Sccpdh<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0001925,male infertility|MP:0010393,shortened QRS complex duration
MGI:1858028	Scd1<ab>	MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000414,alopecia|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0001732,postnatal growth retardation|MP:0001919,abnormal reproductive system physiology|MP:0001923,reduced female fertility|MP:0001927,abnormal estrous cycle|MP:0002001,blindness|MP:0002060,abnormal skin morphology|MP:0002073,abnormal hair growth|MP:0003704,abnormal hair follicle development|MP:0005266,abnormal metabolism|MP:0005501,abnormal skin physiology|MP:0008418,abnormal cutaneous elastic fiber morphology|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0009011,prolonged diestrus|MP:0010685,abnormal hair follicle inner root sheath morphology|MP:0013193,sebaceous gland hypoplasia|MP:0013787,photophobia|MP:0030570,abnormal piliary canal morphology
MGI:1858029	Scd1<ab-2J>	MP:0000377,abnormal hair follicle morphology|MP:0000381,enlarged hair follicles|MP:0000416,sparse hair|MP:0000427,abnormal hair cycle|MP:0001192,scaly skin|MP:0001195,flaky skin|MP:0001219,thick epidermis|MP:0001245,thick dermal layer|MP:0001505,hunched posture|MP:0001547,abnormal lipid level|MP:0001762,polyuria|MP:0001874,acanthosis|MP:0002060,abnormal skin morphology|MP:0002500,granulomatous inflammation|MP:0002796,impaired skin barrier function|MP:0003427,parakeratosis|MP:0003809,abnormal hair shaft morphology|MP:0003846,matted coat|MP:0003853,dry skin|MP:0009675,orthokeratosis|MP:0010681,abnormal hair follicle bulb morphology|MP:0010685,abnormal hair follicle inner root sheath morphology|MP:0011941,increased fluid intake|MP:0012725,small sebaceous gland|MP:0013193,sebaceous gland hypoplasia|MP:0013375,abnormal sebocyte morphology|MP:0013382,small perianal sebaceous gland|MP:0013388,small Meibomian gland
MGI:1855952	Scd1<ab-J>	MP:0000416,sparse hair|MP:0001192,scaly skin|MP:0001195,flaky skin|MP:0001242,hyperkeratosis|MP:0001245,thick dermal layer|MP:0001505,hunched posture|MP:0002060,abnormal skin morphology|MP:0003846,matted coat|MP:0003853,dry skin|MP:0010771,integument phenotype
MGI:2653202	Scd1<ab-Xyk>	MP:0000377,abnormal hair follicle morphology|MP:0000384,distorted hair follicle pattern|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000417,short hair|MP:0001191,abnormal skin condition|MP:0001195,flaky skin|MP:0001211,wrinkled skin|MP:0001219,thick epidermis|MP:0002060,abnormal skin morphology|MP:0002073,abnormal hair growth|MP:0003089,decreased skin tensile strength|MP:0003853,dry skin|MP:0005176,eyelids fail to open|MP:0009535,abnormal skin sebaceous gland morphology|MP:0010684,abnormal hair follicle outer root sheath morphology|MP:0010685,abnormal hair follicle inner root sheath morphology|MP:0013193,sebaceous gland hypoplasia|MP:0013375,abnormal sebocyte morphology
MGI:3620028	Scd1<flk>	MP:0000414,alopecia|MP:0000649,sebaceous gland atrophy|MP:0001192,scaly skin|MP:0001195,flaky skin|MP:0001209,spontaneous skin ulceration|MP:0002412,increased susceptibility to bacterial infection|MP:0002992,abnormal sebaceous lipid secretion
MGI:4184323	Scd1<Gt(OST102902)Lex>	MP:0005459,decreased percent body fat/body weight
MGI:2388371	Scd1<tm1Ntam>	MP:0000649,sebaceous gland atrophy|MP:0001345,Meibomian gland atrophy|MP:0001431,abnormal eating behavior|MP:0001433,polyphagia|MP:0001783,decreased white adipose tissue amount|MP:0002078,abnormal glucose homeostasis|MP:0002575,increased circulating ketone body level|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003710,abnormal physiological neovascularization|MP:0005278,abnormal cholesterol homeostasis|MP:0005284,increased saturated fatty acids level|MP:0005285,decreased unsaturated fatty acids level|MP:0005287,narrow eye opening|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005602,decreased angiogenesis|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009004,progressive hair loss|MP:0009356,decreased liver triglyceride level|MP:0013245,abnormal lipid metabolism|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3773308	Scd1<tm2Ntam>	MP:0000379,decreased hair follicle number|MP:0000609,abnormal liver physiology|MP:0001783,decreased white adipose tissue amount|MP:0002118,abnormal lipid homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0003383,abnormal gluconeogenesis|MP:0003413,hair follicle degeneration|MP:0003809,abnormal hair shaft morphology|MP:0003976,decreased circulating VLDL triglyceride level|MP:0005178,increased circulating cholesterol level|MP:0005334,abnormal fat pad morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009283,decreased gonadal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0009545,abnormal dermis papillary layer morphology|MP:0010398,decreased liver glycogen level|MP:0010686,abnormal hair follicle matrix region morphology|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:4888575	Scd2<swty>	MP:0000416,sparse hair|MP:0001923,reduced female fertility|MP:0003849,greasy coat|MP:0005251,blepharitis|MP:0009794,sebaceous gland hyperplasia
MGI:3603451	Scd2<tm1Myz>	MP:0000609,abnormal liver physiology|MP:0001191,abnormal skin condition|MP:0001242,hyperkeratosis|MP:0001265,decreased body size|MP:0001429,dehydration|MP:0002644,decreased circulating triglyceride level|MP:0002796,impaired skin barrier function|MP:0003051,curly tail|MP:0005282,decreased fatty acids level|MP:0005501,abnormal skin physiology|MP:0009356,decreased liver triglyceride level|MP:0009608,abnormal epidermal lamellar body morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:7738724	Scd4<tm1.1Ntam>	MP:0003710,abnormal physiological neovascularization|MP:0013245,abnormal lipid metabolism|MP:0020447,decreased NAD(P)H oxidase activity
MGI:7425965	Scel<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002110,abnormal digit morphology|MP:0005633,increased circulating sodium level
MGI:3044133	Scel<tm1Hba>	MP:0002169,no abnormal phenotype detected
MGI:6383384	Scfd1<em1(IMPC)Tcp>	MP:0001728,failure of embryo implantation|MP:0002060,abnormal skin morphology|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0004964,absent inner cell mass|MP:0005028,abnormal trophectoderm morphology|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6293920	Scfd2<em1(IMPC)J>	MP:0002968,increased circulating alkaline phosphatase level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3043106	Scfpq1<L6>	MP:0000013,abnormal adipose tissue distribution
MGI:3042956	Scfq1<L6>	MP:0008844,decreased subcutaneous adipose tissue amount
MGI:3043136	Scfq2<L6>	MP:0005334,abnormal fat pad morphology
MGI:3043123	Scfq3<L6>	MP:0008844,decreased subcutaneous adipose tissue amount
MGI:3043151	Scfq4<L6>	MP:0008844,decreased subcutaneous adipose tissue amount
MGI:6845088	Scg2<em1Meg>	MP:0004811,abnormal neuron physiology
MGI:5907855	Scg3<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0002574,increased vertical activity
MGI:1888380	Scg3<Gt(VICTR20)13Lex>	MP:0002693,abnormal pancreas physiology|MP:0002727,decreased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005646,abnormal pituitary gland physiology|MP:0005658,increased susceptibility to diet-induced obesity|MP:0010768,mortality/aging
MGI:5702924	Scg3<m1Mhda>	MP:0002169,no abnormal phenotype detected
MGI:7425966	Scg5<em1(IMPC)Mbp>	MP:0000220,increased monocyte cell number|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:2159289	Scg5<tm1Led>	MP:0000013,abnormal adipose tissue distribution|MP:0000189,hypoglycemia|MP:0000192,abnormal mineral level|MP:0000274,enlarged heart|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000599,enlarged liver|MP:0000639,abnormal adrenal gland morphology|MP:0000947,convulsive seizures|MP:0001199,thin skin|MP:0001242,hyperkeratosis|MP:0001244,thin dermal layer|MP:0001265,decreased body size|MP:0001433,polyphagia|MP:0001560,abnormal circulating insulin level|MP:0001654,hepatic necrosis|MP:0001745,increased circulating corticosterone level|MP:0001914,hemorrhage|MP:0001943,abnormal respiration|MP:0001954,respiratory distress|MP:0002073,abnormal hair growth|MP:0002078,abnormal glucose homeostasis|MP:0002127,abnormal cardiovascular system morphology|MP:0002163,abnormal gland morphology|MP:0002286,cryptorchism|MP:0002628,hepatic steatosis|MP:0002696,decreased circulating glucagon level|MP:0002837,dystrophic cardiac calcinosis|MP:0003643,spleen atrophy|MP:0003717,pallor|MP:0005129,increased adrenocorticotropin level|MP:0005215,abnormal pancreatic islet morphology|MP:0005243,hemothorax|MP:0005491,pancreatic islet hyperplasia|MP:0005534,decreased body temperature|MP:0008299,adrenal cortical hyperplasia|MP:0008321,small adenohypophysis|MP:0009113,increased pancreatic beta cell mass|MP:0009275,bruising|MP:0009276,ecchymosis|MP:0010093,decreased circulating magnesium level|MP:0010400,increased liver glycogen level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013405,increased circulating lactate level
MGI:3797250	Scgb1a1<tm1.1(cre)Fjd>	MP:0002169,no abnormal phenotype detected
MGI:2386295	Scgb1a1<tm1Abm>	MP:0000195,decreased circulating calcium level|MP:0000523,cortical renal glomerulopathies|MP:0001263,weight loss|MP:0002132,abnormal respiratory system morphology|MP:0002135,abnormal kidney morphology|MP:0002495,increased IgA level|MP:0002962,increased urine protein level|MP:0005150,cachexia|MP:0005161,hematuria|MP:0005325,abnormal renal glomerulus morphology|MP:0009148,pancreas necrosis|MP:0009642,abnormal blood homeostasis|MP:0011566,abnormal complement protein level
MGI:2684333	Scgb1a1<tm1Brst>	MP:0002277,abnormal respiratory mucosa morphology|MP:0005388,respiratory system phenotype|MP:0008875,abnormal xenobiotic pharmacokinetics
MGI:3849566	Scgb1a1<tm1(cre/ERT)Blh>	MP:0002169,no abnormal phenotype detected
MGI:3797249	Scgb1a1<tm1(cre)Fjd>	MP:0002169,no abnormal phenotype detected
MGI:5763057	Scgb1c1<em1(IMPC)J>	MP:0010053,decreased grip strength
MGI:6500967	Scgb3a1<tm1.1Shk>	MP:0005388,respiratory system phenotype|MP:0011053,decreased respiratory motile cilia number
MGI:6196554	Scgb3a2<tm1.1Shk>	MP:0005166,decreased susceptibility to injury|MP:0005376,homeostasis/metabolism phenotype|MP:0005388,respiratory system phenotype|MP:0011053,decreased respiratory motile cilia number
MGI:6711490	Scgn<em1Ezb>	MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005397,hematopoietic system phenotype|MP:0010768,mortality/aging|MP:0013298,increased susceptibility to colitis induced morbidity/mortality
MGI:6711491	Scgn<em2Ezb>	MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype|MP:0010768,mortality/aging|MP:0013298,increased susceptibility to colitis induced morbidity/mortality
MGI:1857031	sch	MP:0000416,sparse hair|MP:0001510,abnormal coat appearance|MP:0002073,abnormal hair growth|MP:0003815,hairless|MP:0010771,integument phenotype
MGI:3526869	Schip1<Gt(ROSA)77Sor>	MP:0000091,short premaxilla|MP:0000097,short maxilla|MP:0000157,abnormal sternum morphology|MP:0000445,short snout|MP:0000480,increased rib number|MP:0002082,postnatal lethality|MP:0004471,short nasal bone|MP:0005508,abnormal skeleton morphology|MP:0008146,asymmetric sternocostal joints|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009895,decreased palatine bone horizontal plate size|MP:0011708,decreased fibroblast cell migration|MP:0030189,broad snout|MP:0030383,small presphenoid bone
MGI:5007004	Scimp<tm1Lex>	MP:0001260,increased body weight|MP:0001577,anemia|MP:0005178,increased circulating cholesterol level
MGI:6152632	Scin<em1(IMPC)Mbp>	MP:0002092,abnormal eye morphology
MGI:5758940	Scin<tm1Glog>	MP:0001541,abnormal osteoclast physiology|MP:0004982,abnormal osteoclast morphology|MP:0005166,decreased susceptibility to injury|MP:0008396,abnormal osteoclast differentiation
MGI:3611371	Scl2<C57BL/6J>	MP:0005027,increased susceptibility to parasitic infection
MGI:6156476	Sclt1<em1(IMPC)Tcp>	MP:0000562,polydactyly|MP:0001552,increased circulating triglyceride level|MP:0002092,abnormal eye morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3612989	Sclt1<Tg(CAG-sb10)1Dla>	MP:0000111,cleft palate|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003985,renal fibrosis|MP:0005150,cachexia|MP:0005378,growth/size/body region phenotype|MP:0005565,increased blood urea nitrogen level|MP:0008489,slow postnatal weight gain|MP:0008528,polycystic kidney|MP:0009743,preaxial polydactyly|MP:0011307,kidney medulla cyst|MP:0013916,decreased intestine length
MGI:4362224	Scly<tm1a(KOMP)Wtsi>	MP:0001463,abnormal spatial learning|MP:0005386,behavior/neurological phenotype
MGI:6324158	Scmh1<tm1e.1(EUCOMM)Hmgu>	MP:0000280,thin ventricular wall|MP:0000598,abnormal liver morphology|MP:0009476,enlarged cecum
MGI:3706668	Scmh1<tm1Hko>	MP:0000480,increased rib number|MP:0001146,abnormal testis morphology|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0003036,vertebral transformation|MP:0004615,cervical vertebral transformation|MP:0004620,cervical vertebral fusion|MP:0005159,azoospermia|MP:0008008,early cellular replicative senescence|MP:0008148,abnormal sternocostal joint morphology|MP:0008261,arrest of male meiosis|MP:0020550,multinucleated giant male germ cells
MGI:5475146	Scmh1<tm1Yota>	MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004809,increased hematopoietic stem cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype|MP:0010373,myeloid hyperplasia|MP:0011246,abnormal fetal liver hematopoietic progenitor cell morphology
MGI:6362616	Scml1<tm1.2Atot>	MP:0002169,no abnormal phenotype detected|MP:0005389,reproductive system phenotype|MP:0006379,abnormal spermatocyte morphology
MGI:6266819	Scml2<em1(IMPC)Rbrc>	MP:0001146,abnormal testis morphology|MP:0001147,small testis
MGI:5690091	Scml2<em1Shnk>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0005159,azoospermia|MP:0014052,increased male germ cell apoptosis|MP:0020550,multinucleated giant male germ cells
MGI:5690097	Scml2<em2Shnk>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0005159,azoospermia|MP:0014052,increased male germ cell apoptosis|MP:0020550,multinucleated giant male germ cells
MGI:6324242	Scml4<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0005559,increased circulating glucose level
MGI:3794859	Scn10a<Psm>	MP:0001391,abnormal tail movements|MP:0001504,abnormal posture|MP:0001523,impaired righting response|MP:0001957,apnea|MP:0002272,abnormal nervous system electrophysiology|MP:0002822,catalepsy|MP:0003463,abnormal single cell response|MP:0003998,decreased thermal nociceptive threshold|MP:0004994,abnormal brain wave pattern|MP:0005386,behavior/neurological phenotype|MP:0010504,abnormal RR interval|MP:0010637,sinus bradycardia
MGI:2180183	Scn10a<tm1Jwo>	MP:0002733,abnormal thermal nociception|MP:0002734,abnormal mechanical nociception|MP:0003043,hypoalgesia
MGI:4430300	Scn10a<tm1Lex>	MP:0001970,abnormal pain threshold|MP:0002578,impaired ability to fire action potentials|MP:0005402,abnormal action potential|MP:0005407,hyperalgesia
MGI:8214715	Scn11a<em1.1Frbo>	MP:0004811,abnormal neuron physiology|MP:0010072,increased pruritus
MGI:6392908	Scn11a<em1Akoi>	MP:0002272,abnormal nervous system electrophysiology|MP:0002733,abnormal thermal nociception|MP:0003998,decreased thermal nociceptive threshold|MP:0005402,abnormal action potential
MGI:6266832	Scn11a<em1(IMPC)H>	MP:0003961,decreased lean body mass
MGI:6415024	Scn11a<em2Akoi>	MP:0002272,abnormal nervous system electrophysiology|MP:0005402,abnormal action potential
MGI:6415027	Scn11a<em3Akoi>	MP:0002272,abnormal nervous system electrophysiology|MP:0005402,abnormal action potential
MGI:5558025	Scn11a<tm1.1Ikth>	MP:0001212,skin lesions|MP:0002272,abnormal nervous system electrophysiology|MP:0002736,abnormal nociception after inflammation|MP:0003412,abnormal afterhyperpolarization|MP:0003484,abnormal channel response|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005402,abnormal action potential|MP:0010771,integument phenotype
MGI:3604572	Scn11a<tm1Dgen>	MP:0002736,abnormal nociception after inflammation
MGI:5608917	Scn11a<tm1Gsk>	MP:0003463,abnormal single cell response
MGI:3528983	Scn11a<tm1Lex>	MP:0001970,abnormal pain threshold|MP:0002734,abnormal mechanical nociception|MP:0002736,abnormal nociception after inflammation
MGI:3818305	Scn11a<tm1Mdba>	MP:0002272,abnormal nervous system electrophysiology|MP:0005402,abnormal action potential
MGI:8214713	Scn11a<tm1(tetO)Frbo>	MP:0002272,abnormal nervous system electrophysiology|MP:0004811,abnormal neuron physiology|MP:0005402,abnormal action potential|MP:0010073,decreased pruritus
MGI:3695487	Scn11a<tm1Wlf>	MP:0002736,abnormal nociception after inflammation|MP:0003463,abnormal single cell response
MGI:7437626	Scn1a<em1Anord>	MP:0001399,hyperactivity|MP:0001732,postnatal growth retardation|MP:0002058,neonatal lethality|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003461,abnormal response to novel object|MP:0005369,muscle phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory|MP:0008840,abnormal spike wave discharge|MP:0009358,environmentally induced seizures|MP:0009703,decreased birth body size|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4458373	Scn1a<tm1.1Aesc>	MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0002064,seizures|MP:0002194,maximal tonic hindlimb extension seizures|MP:0002578,impaired ability to fire action potentials|MP:0002826,tonic seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003631,nervous system phenotype|MP:0003996,clonic seizures|MP:0003997,tonic-clonic seizures|MP:0004008,abnormal GABA-mediated receptor currents|MP:0008840,abnormal spike wave discharge|MP:0009358,environmentally induced seizures|MP:0011085,postnatal lethality, complete penetrance
MGI:5521534	Scn1a<tm1.1Kzy>	MP:0000947,convulsive seizures|MP:0001544,abnormal cardiovascular system physiology|MP:0001636,irregular heartbeat|MP:0001957,apnea|MP:0002064,seizures|MP:0002083,premature death|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003233,prolonged QT interval|MP:0004215,abnormal myocardial fiber physiology|MP:0005333,decreased heart rate|MP:0006110,ventricular fibrillation|MP:0009358,environmentally induced seizures|MP:0009732,ventricular premature beat|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010504,abnormal RR interval|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010636,bundle branch block
MGI:5699848	Scn1a<tm1.1Swl>	MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0003635,abnormal synaptic transmission|MP:0003997,tonic-clonic seizures|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008143,abnormal dendrite morphology|MP:0009358,environmentally induced seizures|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0009936,abnormal dendritic spine morphology|MP:0009938,abnormal hippocampus granule cell morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0014253,decreased paired-pulse ratio
MGI:5510417	Scn1a<tm1Kea>	MP:0002064,seizures|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected
MGI:3713733	Scn1a<tm1Kzy>	MP:0000774,decreased brain size|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001406,abnormal gait|MP:0002064,seizures|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002826,tonic seizures|MP:0003492,abnormal involuntary movement|MP:0003997,tonic-clonic seizures|MP:0005424,jerky movement|MP:0011085,postnatal lethality, complete penetrance
MGI:3665322	Scn1a<tm1Wac>	MP:0000745,tremors|MP:0000947,convulsive seizures|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001393,ataxia|MP:0001394,circling|MP:0001410,head bobbing|MP:0001441,increased grooming behavior|MP:0001447,abnormal nest building behavior|MP:0001504,abnormal posture|MP:0001523,impaired righting response|MP:0001921,reduced fertility|MP:0002064,seizures|MP:0002083,premature death|MP:0002272,abnormal nervous system electrophysiology|MP:0002690,akinesia|MP:0002797,increased thigmotaxis|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002980,abnormal postural reflex|MP:0003462,abnormal response to novel odor|MP:0003996,clonic seizures|MP:0003997,tonic-clonic seizures|MP:0004994,abnormal brain wave pattern|MP:0005402,abnormal action potential|MP:0008432,abnormal long-term spatial reference memory|MP:0008840,abnormal spike wave discharge|MP:0009454,impaired contextual conditioning behavior|MP:0011085,postnatal lethality, complete penetrance|MP:0011622,abnormal habituation to a novel odor|MP:0012307,impaired spatial learning|MP:0020395,abnormal response to social novelty|MP:0020852,abnormal olfactory behavior|MP:0031391,increased locomotor activity
MGI:5523787	Scn1a<tm2.1Kzy>	MP:0000889,abnormal cerebellar molecular layer|MP:0000947,convulsive seizures|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0005386,behavior/neurological phenotype|MP:0008547,abnormal neocortex morphology|MP:0009939,abnormal hippocampus neuron morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0014626,abnormal postictal brain wave pattern
MGI:5447489	Scn1a<tm2.1Wac>	MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001394,circling|MP:0002064,seizures|MP:0002083,premature death|MP:0002797,increased thigmotaxis|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003996,clonic seizures|MP:0003997,tonic-clonic seizures|MP:0009358,environmentally induced seizures|MP:0009454,impaired contextual conditioning behavior|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014378,increased excitatory postsynaptic current frequency|MP:0031391,increased locomotor activity
MGI:5523788	Scn1a<tm2.2Kzy>	MP:0000947,convulsive seizures|MP:0001263,weight loss|MP:0001393,ataxia|MP:0002083,premature death|MP:0011085,postnatal lethality, complete penetrance
MGI:6153817	Scn1b<em1(IMPC)H>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:4829975	Scn1b<tm1.1Bion>	MP:0000745,tremors|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002083,premature death|MP:0002272,abnormal nervous system electrophysiology|MP:0003997,tonic-clonic seizures|MP:0004994,abnormal brain wave pattern|MP:0005402,abnormal action potential|MP:0009358,environmentally induced seizures
MGI:3043422	Scn1b<tm1Isom>	MP:0001330,abnormal optic nerve morphology|MP:0001393,ataxia|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0003631,nervous system phenotype|MP:0003632,abnormal nervous system morphology|MP:0005402,abnormal action potential|MP:0005404,abnormal axon morphology|MP:0011083,lethality at weaning, complete penetrance
MGI:3768514	Scn1b<tm2.1Isom>	MP:0001393,ataxia|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0011085,postnatal lethality, complete penetrance
MGI:3768513	Scn1b<tm2Isom>	MP:0002169,no abnormal phenotype detected
MGI:6781911	Scn2a<em1Gsp>	MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0002206,abnormal CNS synaptic transmission|MP:0003484,abnormal channel response|MP:0005402,abnormal action potential|MP:0011089,perinatal lethality, complete penetrance|MP:0014379,decreased excitatory postsynaptic current frequency|MP:0020395,abnormal response to social novelty|MP:0031391,increased locomotor activity
MGI:2180186	Scn2a<tm1Mml>	MP:0001263,weight loss|MP:0001575,cyanosis|MP:0001588,abnormal hemoglobin|MP:0001954,respiratory distress|MP:0002272,abnormal nervous system electrophysiology|MP:0005039,hypoxia|MP:0005277,abnormal brainstem morphology|MP:0009546,absent gastric milk in neonates|MP:0011085,postnatal lethality, complete penetrance
MGI:6257529	Scn2b<em1(IMPC)Bay>	MP:0010579,increased heart left ventricle size
MGI:2451362	Scn2b<tm1Isom>	MP:0002272,abnormal nervous system electrophysiology|MP:0002906,increased susceptibility to pharmacologically induced seizures
MGI:5007314	Scn2b<tm1Lex>	MP:0005293,impaired glucose tolerance
MGI:3604522	Scn3a<Gt(OST52130)Lex>	MP:0001265,decreased body size|MP:0005202,lethargy|MP:0005292,improved glucose tolerance|MP:0011100,preweaning lethality, complete penetrance
MGI:5505505	Scn3a<tm1.1Jwo>	MP:0002169,no abnormal phenotype detected|MP:0005386,behavior/neurological phenotype
MGI:5505523	Scn3a<tm1.2Jwo>	MP:0002169,no abnormal phenotype detected
MGI:4363292	Scn3b<tm1a(KOMP)Wtsi>	MP:0003795,abnormal bone structure|MP:0004510,myositis|MP:0004609,vertebral fusion|MP:0011157,abnormal hypodermis muscle layer morphology
MGI:5294639	Scn3b<tm1Clhh>	MP:0001636,irregular heartbeat|MP:0004215,abnormal myocardial fiber physiology|MP:0010508,abnormal heart electrocardiography waveform feature
MGI:5308659	Scn4a<m1Aaa>	MP:0001405,impaired coordination|MP:0001515,abnormal grip strength|MP:0001942,abnormal lung volume|MP:0001954,respiratory distress|MP:0002106,abnormal muscle physiology|MP:0002108,abnormal muscle morphology|MP:0002690,akinesia|MP:0002841,impaired skeletal muscle contractility|MP:0003157,impaired muscle relaxation|MP:0003646,increased muscle fatigability|MP:0004087,abnormal muscle fiber morphology|MP:0004145,abnormal muscle electrophysiology|MP:0004889,increased energy expenditure|MP:0005292,improved glucose tolerance|MP:0005369,muscle phenotype|MP:0005668,decreased circulating leptin level|MP:0008489,slow postnatal weight gain|MP:0009046,muscle twitch|MP:0009399,increased skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010768,mortality/aging|MP:0011089,perinatal lethality, complete penetrance
MGI:5301528	Scn4a<tm1.1Cann>	MP:0000747,muscle weakness|MP:0004087,abnormal muscle fiber morphology|MP:0005620,abnormal muscle contractility
MGI:4366146	Scn4a<tm1.1Ljh>	MP:0000747,muscle weakness|MP:0000751,myopathy|MP:0001262,decreased body weight|MP:0001513,limb grasping|MP:0002106,abnormal muscle physiology|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003157,impaired muscle relaxation|MP:0003646,increased muscle fatigability|MP:0004037,increased muscle relaxation|MP:0008770,decreased survivor rate|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009417,skeletal muscle atrophy|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3763891	Scn4a<tm1Ljh>	MP:0000747,muscle weakness|MP:0000751,myopathy|MP:0001262,decreased body weight|MP:0001513,limb grasping|MP:0002106,abnormal muscle physiology|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003157,impaired muscle relaxation|MP:0003646,increased muscle fatigability|MP:0004037,increased muscle relaxation|MP:0008770,decreased survivor rate|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009417,skeletal muscle atrophy|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5548971	Scn4a<tm2b(KOMP)Wtsi>	MP:0002966,decreased circulating alkaline phosphatase level|MP:0008806,increased circulating amylase level|MP:0008935,decreased mean platelet volume|MP:0011100,preweaning lethality, complete penetrance
MGI:6153611	Scn4b<em1(IMPC)Wtsi>	MP:0000745,tremors|MP:0001406,abnormal gait
MGI:6155711	Scn4b<tm1.2Geh>	MP:0001475,reduced long-term depression|MP:0003466,decreased single cell response threshold|MP:0005402,abnormal action potential|MP:0030586,impaired behavioral response to amphetamine
MGI:6415727	Scn5a<em1Coop>	MP:0001636,irregular heartbeat|MP:0003137,abnormal impulse conducting system conduction|MP:0003896,prolonged PR interval|MP:0003899,abnormal QT interval|MP:0005333,decreased heart rate|MP:0006142,abnormal sinoatrial node conduction|MP:0008950,ventricular tachycardia|MP:0010392,prolonged QRS complex duration|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010519,atrioventricular block|MP:0010637,sinus bradycardia
MGI:6415584	Scn5a<tm1.1Iba>	MP:0000266,abnormal heart morphology|MP:0001262,decreased body weight|MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0003105,abnormal heart atrium morphology|MP:0003141,cardiac fibrosis|MP:0003233,prolonged QT interval|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0005402,abnormal action potential|MP:0005630,increased lung weight|MP:0006110,ventricular fibrillation|MP:0006138,congestive heart failure|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0010019,liver vascular congestion|MP:0010392,prolonged QRS complex duration|MP:0010519,atrioventricular block|MP:0011925,abnormal heart echocardiography feature|MP:0020347,abnormal myocardial fiber sodium currents
MGI:2179753	Scn5a<tm1Agrc>	MP:0001629,abnormal heart rate|MP:0001698,decreased embryo size|MP:0002972,abnormal cardiac muscle contractility|MP:0003137,abnormal impulse conducting system conduction|MP:0003141,cardiac fibrosis|MP:0003233,prolonged QT interval|MP:0003896,prolonged PR interval|MP:0004067,abnormal trabecula carnea morphology|MP:0004071,prolonged P wave|MP:0004215,abnormal myocardial fiber physiology|MP:0004567,decreased myocardial fiber number|MP:0005294,abnormal heart ventricle morphology|MP:0005333,decreased heart rate|MP:0008950,ventricular tachycardia|MP:0010392,prolonged QRS complex duration|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3769902	Scn5a<tm1Care>	MP:0003137,abnormal impulse conducting system conduction|MP:0003233,prolonged QT interval|MP:0004215,abnormal myocardial fiber physiology|MP:0005333,decreased heart rate|MP:0006142,abnormal sinoatrial node conduction|MP:0010392,prolonged QRS complex duration|MP:0010768,mortality/aging|MP:0011091,prenatal lethality, complete penetrance|MP:0011953,prolonged PQ interval
MGI:3765977	Scn5a<tm1Clhh>	MP:0001636,irregular heartbeat|MP:0001698,decreased embryo size|MP:0002064,seizures|MP:0003137,abnormal impulse conducting system conduction|MP:0003233,prolonged QT interval|MP:0003896,prolonged PR interval|MP:0004215,abnormal myocardial fiber physiology|MP:0006141,abnormal atrioventricular node conduction|MP:0006142,abnormal sinoatrial node conduction|MP:0008950,ventricular tachycardia|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010392,prolonged QRS complex duration|MP:0010519,atrioventricular block|MP:0010637,sinus bradycardia|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0013241,embryo tissue necrosis
MGI:2388158	Scn5a<tm1Pec>	MP:0001544,abnormal cardiovascular system physiology|MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0003137,abnormal impulse conducting system conduction|MP:0003233,prolonged QT interval|MP:0005333,decreased heart rate|MP:0010505,abnormal T wave|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3691483	Scn5a<tm1(SCN5A)Rdn>	MP:0002169,no abnormal phenotype detected
MGI:5705587	Scn5a<tm2.1Care>	MP:0003137,abnormal impulse conducting system conduction|MP:0003896,prolonged PR interval|MP:0004071,prolonged P wave|MP:0004116,abnormal atrioventricular bundle conduction|MP:0004215,abnormal myocardial fiber physiology|MP:0005385,cardiovascular system phenotype|MP:0010392,prolonged QRS complex duration|MP:0010768,mortality/aging
MGI:5430150	Scn5a<tm2.1(SCN5A)Rdn>	MP:0003900,shortened QT interval|MP:0004215,abnormal myocardial fiber physiology|MP:0005385,cardiovascular system phenotype|MP:0010393,shortened QRS complex duration|MP:0010511,shortened PR interval
MGI:5445892	Scn5a<tm3(SCN5A*)Rdn>	MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003896,prolonged PR interval|MP:0004071,prolonged P wave|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0006142,abnormal sinoatrial node conduction|MP:0008022,dilated heart ventricle|MP:0008543,atrial fibrillation|MP:0008950,ventricular tachycardia|MP:0010392,prolonged QRS complex duration|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010519,atrioventricular block
MGI:5445934	Scn5a<tm4(SCN5A)Rdn>	MP:0005385,cardiovascular system phenotype
MGI:2387958	Scn7a<tm1Mno>	MP:0001986,abnormal taste sensitivity
MGI:2183462	Scn8a<4J>	MP:0000755,hindlimb paralysis|MP:0001265,decreased body size|MP:0002083,premature death
MGI:2183472	Scn8a<5J>	MP:0000755,hindlimb paralysis|MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology|MP:0008924,decreased cerebellar granule cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0011380,enlarged brain ventricles
MGI:2429911	Scn8a<6J>	MP:0000755,hindlimb paralysis|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0003631,nervous system phenotype
MGI:3612949	Scn8a<7J>	MP:0000243,myoclonus|MP:0000751,myopathy|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000958,peripheral nervous system degeneration|MP:0001393,ataxia|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0003993,abnormal ventral spinal root morphology|MP:0005307,head tossing|MP:0009400,decreased skeletal muscle fiber size
MGI:3806790	Scn8a<8J>	MP:0001265,decreased body size|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0008840,abnormal spike wave discharge
MGI:3838627	Scn8a<9J>	MP:0000745,tremors|MP:0000747,muscle weakness|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0004811,abnormal neuron physiology|MP:0005323,dystonia|MP:0008814,decreased nerve conduction velocity|MP:0010053,decreased grip strength
MGI:3827095	Scn8a<Clth>	MP:0000745,tremors|MP:0000852,small cerebellum|MP:0000880,decreased Purkinje cell number|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001405,impaired coordination|MP:0001485,abnormal pinna reflex|MP:0001489,decreased startle reflex|MP:0001492,abnormal pilomotor reflex|MP:0001505,hunched posture|MP:0001961,abnormal reflex|MP:0004924,abnormal behavior|MP:0005377,hearing/vestibular/ear phenotype|MP:0006325,impaired hearing|MP:0006358,absent pinna reflex|MP:0009779,enhanced behavioral response to anesthetic|MP:0010768,mortality/aging|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2429654	Scn8a<dmu>	MP:0000749,muscle degeneration|MP:0000752,dystrophic muscle|MP:0000755,hindlimb paralysis|MP:0001262,decreased body weight|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0003631,nervous system phenotype|MP:0003852,skeletal muscle necrosis|MP:0004566,myocardial fiber degeneration|MP:0005294,abnormal heart ventricle morphology|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology|MP:0006113,abnormal heart septum morphology|MP:0010492,abnormal atrium endocardium morphology
MGI:6433992	Scn8a<em1(IMPC)Bay>	MP:0004952,increased spleen weight|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5578212	Scn8a<em1Mm>	MP:0002064,seizures|MP:0002083,premature death|MP:0004924,abnormal behavior
MGI:5506774	Scn8a<m10J>	MP:0000745,tremors|MP:0000753,paralysis|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0008814,decreased nerve conduction velocity|MP:0011085,postnatal lethality, complete penetrance
MGI:5771986	Scn8a<m11J>	MP:0000753,paralysis|MP:0000755,hindlimb paralysis|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0003157,impaired muscle relaxation|MP:0011085,postnatal lethality, complete penetrance
MGI:3809770	Scn8a<M1Btlr>	MP:0000745,tremors|MP:0001406,abnormal gait
MGI:5527541	Scn8a<m2Btlr>	MP:0000755,hindlimb paralysis
MGI:5607160	Scn8a<m3Btlr>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001393,ataxia
MGI:1856078	Scn8a<med>	MP:0000748,progressive muscle weakness|MP:0000755,hindlimb paralysis|MP:0000921,demyelination|MP:0001053,abnormal neuromuscular synapse morphology|MP:0002082,postnatal lethality|MP:0002106,abnormal muscle physiology|MP:0002269,muscular atrophy|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0002914,abnormal endplate potential|MP:0004142,abnormal muscle tone|MP:0004835,abnormal miniature endplate potential|MP:0005402,abnormal action potential|MP:0005403,abnormal nerve conduction|MP:0005551,abnormal eye electrophysiology|MP:0008840,abnormal spike wave discharge|MP:0009434,paraparesis
MGI:1856079	Scn8a<med-J>	MP:0000745,tremors|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0005323,dystonia|MP:0010768,mortality/aging
MGI:1856080	Scn8a<med-jo>	MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0001524,impaired limb coordination|MP:0002272,abnormal nervous system electrophysiology|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0003631,nervous system phenotype|MP:0005369,muscle phenotype|MP:0008840,abnormal spike wave discharge
MGI:3045039	Scn8a<med-jo2J>	MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0001406,abnormal gait|MP:0002687,oligozoospermia|MP:0004709,cervical vertebrae degeneration|MP:0005405,axon degeneration|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856414	Scn8a<med-TgA4Bs>	MP:0000755,hindlimb paralysis|MP:0001262,decreased body weight|MP:0001513,limb grasping|MP:0001525,impaired balance|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0003631,nervous system phenotype|MP:0005551,abnormal eye electrophysiology
MGI:2671787	Scn8a<nur14>	MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0001393,ataxia|MP:0002083,premature death|MP:0011085,postnatal lethality, complete penetrance
MGI:3043395	Scn8a<tm1Mm>	MP:0000755,hindlimb paralysis|MP:0001393,ataxia|MP:0002083,premature death
MGI:8266439	Scn9a<em1Ics>	MP:0001968,abnormal touch/nociception|MP:0003998,decreased thermal nociceptive threshold|MP:0020954,decreased mechanical nociceptive threshold
MGI:7466218	Scn9a<em1Wlf>	MP:0002272,abnormal nervous system electrophysiology|MP:0003468,increased single cell response intensity|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential
MGI:3053098	Scn9a<tm1.1Jwo>	MP:0011087,neonatal lethality, complete penetrance
MGI:4367789	Scn9a<tm1.1Naas>	MP:0001499,abnormal kindling response|MP:0001650,abnormal seizure response to electrical stimulation|MP:0002193,minimal clonic seizures
MGI:5544791	Scn9a<tm1.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:3604573	Scn9a<tm1Dgen>	MP:0000516,abnormal renal/urinary system morphology|MP:0001194,dermatitis|MP:0001265,decreased body size|MP:0001973,increased thermal nociceptive threshold|MP:0002734,abnormal mechanical nociception|MP:0002736,abnormal nociception after inflammation|MP:0003043,hypoalgesia|MP:0003635,abnormal synaptic transmission|MP:0004512,anosmia|MP:0005402,abnormal action potential|MP:0008531,increased chemical nociceptive threshold|MP:0009141,increased prepulse inhibition|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance
MGI:3053097	Scn9a<tm1Jwo>	MP:0001970,abnormal pain threshold|MP:0001973,increased thermal nociceptive threshold|MP:0002736,abnormal nociception after inflammation
MGI:3818057	Scnm1<m1R>	MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:3818043	Scnm1<tm1.1Mm>	MP:0002169,no abnormal phenotype detected|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:2384527	Scnn1a<tm1.1Hum>	MP:0002169,no abnormal phenotype detected|MP:0011417,abnormal renal transport
MGI:2384529	Scnn1a<tm1.2Hum>	MP:0011100,preweaning lethality, complete penetrance
MGI:2384526	Scnn1a<tm1Hum>	MP:0002169,no abnormal phenotype detected
MGI:2158700	Scnn1a<tm1Rss>	MP:0001402,decreased locomotor activity|MP:0001431,abnormal eating behavior|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0011087,neonatal lethality, complete penetrance
MGI:3832670	Scnn1b<tm1.1Hum>	MP:0002169,no abnormal phenotype detected
MGI:2448620	Scnn1b<tm1.1Ipt>	MP:0001625,cardiac hypertrophy|MP:0001663,abnormal digestive system physiology|MP:0002135,abnormal kidney morphology|MP:0002667,decreased circulating aldosterone level|MP:0003028,alkalosis|MP:0004119,hypokalemia|MP:0004217,salt-sensitive hypertension|MP:0006144,increased systemic arterial systolic blood pressure|MP:0010127,hypervolemia
MGI:3832671	Scnn1b<tm1.2Hum>	MP:0011085,postnatal lethality, complete penetrance
MGI:5548351	Scnn1b<tm1b(EUCOMM)Hmgu>	MP:0004509,abnormal pelvic girdle bone morphology|MP:0010087,increased circulating fructosamine level|MP:0011100,preweaning lethality, complete penetrance
MGI:2179831	Scnn1b<tm1Ipt>	MP:0002169,no abnormal phenotype detected
MGI:2179819	Scnn1b<tm1Wsh>	MP:0001262,decreased body weight|MP:0002666,increased circulating aldosterone level|MP:0003019,increased circulating chloride level|MP:0005388,respiratory system phenotype|MP:0005627,increased circulating potassium level|MP:0005634,decreased circulating sodium level|MP:0009643,abnormal urine homeostasis|MP:0011087,neonatal lethality, complete penetrance
MGI:3832674	Scnn1g<tm1.1Hum>	MP:0002169,no abnormal phenotype detected
MGI:3663382	Scnn1g<tm1Bhk>	MP:0001263,weight loss|MP:0003620,oliguria|MP:0003717,pallor|MP:0005202,lethargy|MP:0005618,decreased urine potassium level|MP:0005627,increased circulating potassium level|MP:0005634,decreased circulating sodium level|MP:0006316,increased urine sodium level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011163,increased wet-to-dry lung weight ratio|MP:0011462,increased urine bicarbonate level|MP:0014182,decreased respiratory epithelial sodium ion transmembrane transport|MP:0014206,decreased intestinal epithelial sodium ion transmembrane transport
MGI:5758867	Sco1<tm1c(KOMP)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0000598,abnormal liver morphology|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0003067,decreased liver copper level|MP:0003643,spleen atrophy|MP:0005397,hematopoietic system phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0008479,decreased spleen white pulp amount|MP:0008807,increased liver iron level|MP:0008809,increased spleen iron level|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0010244,decreased kidney copper level|MP:0011628,increased mitochondrial number
MGI:4413584	Sco2<tm1.1Easc>	MP:0002085,abnormal embryonic tissue morphology|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:4413585	Sco2<tm2.1Easc>	MP:0000747,muscle weakness|MP:0003952,abnormal copper level|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport
MGI:6376211	Scoc<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance
MGI:2661432	Scon1<C57BL/6ByJ>	MP:0001986,abnormal taste sensitivity
MGI:2661434	Scon2<C57BL/6ByJ>	MP:0001986,abnormal taste sensitivity
MGI:6361172	Scp2d1<em1Osb>	MP:0005389,reproductive system phenotype
MGI:3762148	Scp2<tm1Fsch>	MP:0000607,abnormal hepatocyte morphology
MGI:3722944	Scp2<tm1Kier>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000606,decreased hepatocyte number|MP:0001547,abnormal lipid level|MP:0001860,liver inflammation|MP:0002644,decreased circulating triglyceride level|MP:0003961,decreased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0005281,increased fatty acids level|MP:0009356,decreased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0010180,increased susceptibility to weight loss
MGI:1857809	Scp2<tm1Usee>	MP:0000180,abnormal circulating cholesterol level|MP:0000182,increased circulating LDL cholesterol level|MP:0001547,abnormal lipid level|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0002702,decreased circulating free fatty acids level|MP:0004772,abnormal bile secretion|MP:0004774,abnormal bile salt level|MP:0005145,increased circulating VLDL cholesterol level|MP:0005281,increased fatty acids level|MP:0005378,growth/size/body region phenotype|MP:0005449,abnormal food intake|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level
MGI:3843010	Scpep1<Gt(RST426)Byg>	MP:0002169,no abnormal phenotype detected
MGI:4437862	Scpep1<tm1Jomm>	MP:0004883,abnormal vascular wound healing
MGI:3578852	Scpro10<DBA/2J>	MP:0002123,abnormal definitive hematopoiesis
MGI:3578855	Scpro11<C57BL/6J>	MP:0002123,abnormal definitive hematopoiesis
MGI:2156754	Scpro1<DBA/2>	MP:0002123,abnormal definitive hematopoiesis|MP:0010768,mortality/aging
MGI:2157984	Scpro2<DBA/2>	MP:0002123,abnormal definitive hematopoiesis|MP:0010768,mortality/aging
MGI:3578841	Scpro4<C57BL/6J>	MP:0002123,abnormal definitive hematopoiesis
MGI:3578843	Scpro5<C57BL/6J>	MP:0002123,abnormal definitive hematopoiesis
MGI:3578842	Scpro5<DBA/2J>	MP:0002123,abnormal definitive hematopoiesis
MGI:3578845	Scpro6<C57BL/6J>	MP:0002123,abnormal definitive hematopoiesis
MGI:3578844	Scpro6<DBA/2J>	MP:0002123,abnormal definitive hematopoiesis
MGI:3578846	Scpro7<DBA/2J>	MP:0002123,abnormal definitive hematopoiesis
MGI:3578848	Scpro8<DBA/2J>	MP:0002123,abnormal definitive hematopoiesis
MGI:3578850	Scpro9<DBA/2J>	MP:0002123,abnormal definitive hematopoiesis
MGI:2671868	scpt	MP:0003201,extremity edema
MGI:1861470	Scr	MP:0000410,waved hair|MP:0000411,shiny fur|MP:0000706,small thymus|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001279,wavy vibrissae|MP:0001510,abnormal coat appearance|MP:0001511,disheveled coat
MGI:1889322	Scrib<Crc>	MP:0000585,kinked tail|MP:0000757,herniated abdominal wall|MP:0000823,abnormal lateral ventricle morphology|MP:0000929,open neural tube|MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001332,abnormal optic nerve innervation|MP:0001341,absent eyelids|MP:0001698,decreased embryo size|MP:0003051,curly tail|MP:0003232,abnormal forebrain development|MP:0003631,nervous system phenotype|MP:0004188,delayed embryo turning|MP:0004200,decreased fetal size|MP:0005241,abnormal retina ganglion layer morphology|MP:0008784,craniorachischisis|MP:0009429,decreased embryo weight|MP:0009770,abnormal optic chiasm morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011964,increased total retina thickness|MP:0012260,encephalomeningocele|MP:0012679,absent third ventricle
MGI:5056373	Scrib<crn2>	MP:0000031,abnormal cochlea morphology|MP:0000585,kinked tail|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles
MGI:4440642	Scrib<m51206BHubr>	MP:0000042,abnormal organ of Corti morphology|MP:0000757,herniated abdominal wall|MP:0003641,small lung|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0008784,craniorachischisis|MP:0010975,abnormal lung lobe morphology
MGI:3799272	Scrib<m90Asp>	MP:0000788,abnormal cerebral cortex morphology|MP:0000929,open neural tube|MP:0004261,abnormal embryonic neuroepithelium morphology
MGI:5559569	Scrib<tm1.1Cj>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001306,small lens|MP:0003237,abnormal lens epithelium morphology|MP:0006000,abnormal cornea epithelium morphology|MP:0013765,iris hyperplasia
MGI:5449166	Scrib<tm1.1Geno>	MP:0005367,renal/urinary system phenotype
MGI:5299425	Scrib<tm1.1Phum>	MP:0000659,prostate gland hyperplasia|MP:0003607,abnormal prostate gland physiology|MP:0009219,increased prostate intraepithelial neoplasia incidence
MGI:5449168	Scrib<tm1.2Geno>	MP:0005367,renal/urinary system phenotype|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5299427	Scrib<tm1.2Phum>	MP:0000659,prostate gland hyperplasia|MP:0000757,herniated abdominal wall|MP:0001302,eyelids open at birth|MP:0001944,abnormal pancreas morphology|MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0003051,curly tail|MP:0003607,abnormal prostate gland physiology|MP:0003936,abnormal reproductive system development|MP:0004961,increased prostate gland weight|MP:0005651,abnormal gonad rudiment morphology|MP:0008716,increased lung non-small cell carcinoma incidence|MP:0008784,craniorachischisis|MP:0011089,perinatal lethality, complete penetrance
MGI:5766176	Scrib<tm1b(NCOM)Mfgc>	MP:0000288,abnormal pericardium morphology|MP:0000428,abnormal craniofacial morphology|MP:0000841,abnormal hindbrain morphology|MP:0000897,abnormal midbrain morphology|MP:0001325,abnormal retina morphology|MP:0001406,abnormal gait|MP:0001552,increased circulating triglyceride level|MP:0001697,abnormal embryo size|MP:0001722,pale yolk sac|MP:0002092,abnormal eye morphology|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0011100,preweaning lethality, complete penetrance
MGI:7331507	Scrn1<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response|MP:0005635,decreased circulating bilirubin level
MGI:7334890	Scrn1<em1Mkob>	MP:0005389,reproductive system phenotype
MGI:5912018	Scrn3<em1(IMPC)J>	MP:0001304,cataract
MGI:5615951	scrny	MP:0001265,decreased body size|MP:0004087,abnormal muscle fiber morphology|MP:0008569,lethality at weaning|MP:0011083,lethality at weaning, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013138,thin body
MGI:5517547	Scs	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000592,short tail|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0004173,abnormal intervertebral disk morphology|MP:0004609,vertebral fusion|MP:0004626,vertebral compression|MP:0004683,absent intervertebral disk|MP:0004703,abnormal vertebral column morphology|MP:0004704,short vertebral column|MP:0005377,hearing/vestibular/ear phenotype|MP:0009079,prolapsed intervertebral disk
MGI:3711348	Sctr<tm1Bkcc>	MP:0000521,abnormal kidney cortex morphology|MP:0001422,abnormal drinking behavior|MP:0001426,polydipsia|MP:0001762,polyuria|MP:0001859,kidney inflammation|MP:0002988,decreased urine osmolality|MP:0003009,abnormal cytokine secretion|MP:0003014,abnormal kidney medulla morphology|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004860,dilated kidney collecting duct|MP:0005264,glomerulosclerosis|MP:0005425,increased macrophage cell number|MP:0005559,increased circulating glucose level|MP:0005609,abnormal circulating antidiuretic hormone level|MP:0005618,decreased urine potassium level|MP:0006317,decreased urine sodium level|MP:0011353,expanded mesangial matrix|MP:0011467,decreased urine urea nitrogen level|MP:0011471,decreased urine creatinine level|MP:0011501,increased glomerular capsule space
MGI:5774826	Sctr<tm1Brd>	MP:0001405,impaired coordination|MP:0001473,reduced long-term potentiation|MP:0002206,abnormal CNS synaptic transmission|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002912,abnormal excitatory postsynaptic potential|MP:0009936,abnormal dendritic spine morphology|MP:0012307,impaired spatial learning|MP:0020338,abnormal hippocampal pyramidal neuron dendrite morphology|MP:0020396,abnormal social recognition|MP:0031391,increased locomotor activity
MGI:4847670	Sct<tm1.1Bkcc>	MP:0001422,abnormal drinking behavior|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005609,abnormal circulating antidiuretic hormone level
MGI:3815315	Sct<tm1Inis>	MP:0001473,reduced long-term potentiation|MP:0002920,decreased paired-pulse facilitation|MP:0002922,decreased post-tetanic potentiation|MP:0003631,nervous system phenotype
MGI:6156156	Scube1<em1(IMPC)Rbrc>	MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002152,abnormal brain morphology
MGI:3796593	Scube1<tm1Rbya>	MP:0000075,absent neurocranium|MP:0000783,abnormal forebrain morphology|MP:0000830,abnormal diencephalon morphology|MP:0000846,abnormal medulla oblongata morphology|MP:0000914,exencephaly|MP:0001081,abnormal cranial ganglia morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0002152,abnormal brain morphology|MP:0002856,abnormal vestibular ganglion morphology|MP:0003104,acrania|MP:0003720,abnormal neural tube closure|MP:0004377,small frontal bone|MP:0004383,absent interparietal bone|MP:0004418,small parietal bone|MP:0004443,absent supraoccipital bone|MP:0004459,small alisphenoid bone|MP:0011087,neonatal lethality, complete penetrance|MP:0012686,everted embryonic neuroepithelium|MP:0012702,increased embryonic neuroepithelium thickness|MP:0012705,increased embryonic neuroepithelial cell proliferation|MP:0030121,small temporal bone squamous part
MGI:5705524	Scube1<tm2.1Rbya>	MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005606,increased bleeding time|MP:0009549,decreased platelet aggregation|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0031120,decreased susceptibility to induced thrombosis
MGI:5698367	Scube2<tm1.1Rbya>	MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0001255,decreased body height|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002113,abnormal skeleton development|MP:0002764,short tibia|MP:0003109,short femur|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004989,decreased osteoblast cell number|MP:0008271,abnormal bone ossification|MP:0008272,abnormal endochondral bone ossification|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0013616,decreased volumetric bone mineral density|MP:0014101,decreased chondrocyte proliferation|MP:0014105,abnormal chondrocyte differentiation
MGI:5698363	Scube2<tm1Rbya>	MP:0002113,abnormal skeleton development
MGI:6725086	Scube3<m1Btlr>	MP:0000160,kyphosis|MP:0000585,kinked tail|MP:0004703,abnormal vertebral column morphology
MGI:5817460	Scube3<m1Mhda>	MP:0000026,abnormal inner ear morphology|MP:0000029,abnormal malleus morphology|MP:0000049,abnormal middle ear morphology|MP:0000063,decreased bone mineral density|MP:0000154,rib fusion|MP:0000194,increased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000281,abnormal interventricular septum morphology|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001265,decreased body size|MP:0001362,abnormal anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001504,abnormal posture|MP:0001762,polyuria|MP:0002110,abnormal digit morphology|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002757,decreased vertical activity|MP:0002963,decreased urine protein level|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003072,abnormal metatarsal bone morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0003109,short femur|MP:0003442,decreased circulating glycerol level|MP:0003870,decreased urine glucose level|MP:0003916,decreased heart left ventricle weight|MP:0003961,decreased lean body mass|MP:0004508,abnormal pectoral girdle bone morphology|MP:0004604,abnormal vertebral pedicle morphology|MP:0004739,conductive hearing loss|MP:0004992,increased bone resorption|MP:0005104,abnormal tarsal bone morphology|MP:0005105,abnormal middle ear ossicle morphology|MP:0005179,decreased circulating cholesterol level|MP:0005272,abnormal temporal bone morphology|MP:0005292,improved glucose tolerance|MP:0005419,decreased circulating serum albumin level|MP:0005449,abnormal food intake|MP:0005451,abnormal body composition|MP:0005540,decreased urine albumin level|MP:0005553,increased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0005574,decreased pulmonary respiratory rate|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005627,increased circulating potassium level|MP:0008271,abnormal bone ossification|MP:0008730,fused phalanges|MP:0008821,increased blood uric acid level|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0010325,abnormal malleus head morphology|MP:0010392,prolonged QRS complex duration|MP:0011424,decreased urine uric acid level|MP:0011471,decreased urine creatinine level|MP:0011584,increased alkaline phosphatase activity|MP:0011941,increased fluid intake|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013285,abnormal renal filtration|MP:0014143,decreased body fat mass|MP:0014316,decreased heart left ventricle posterior wall thickness|MP:0030106,small incus|MP:0030123,small middle ear ossicles
MGI:4939493	Scube3<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:4415473	Scube3<tm1(KOMP)Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:5548335	Scx<tm1.1(KOMP)Vlcg>	MP:0001297,microphthalmia|MP:0001785,edema|MP:0011100,preweaning lethality, complete penetrance
MGI:3716564	Scx<tm1.1Stzr>	MP:0001391,abnormal tail movements|MP:0001523,impaired righting response|MP:0002111,abnormal tail morphology|MP:0003097,abnormal tendon stiffness|MP:0004354,absent deltoid tuberosity|MP:0005503,abnormal tendon morphology
MGI:3716563	Scx<tm1Stzr>	MP:0002169,no abnormal phenotype detected
MGI:6303927	Scyl1<m1Btlr>	MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination
MGI:1856952	Scyl1<mdf>	MP:0000745,tremors|MP:0000750,abnormal muscle regeneration|MP:0000755,hindlimb paralysis|MP:0000849,abnormal cerebellum morphology|MP:0000864,abnormal cerebellum vermis morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000938,motor neuron degeneration|MP:0000958,peripheral nervous system degeneration|MP:0001052,abnormal innervation pattern to muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001265,decreased body size|MP:0001330,abnormal optic nerve morphology|MP:0001388,abnormal stationary movement|MP:0001391,abnormal tail movements|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0001921,reduced fertility|MP:0002184,abnormal innervation|MP:0002269,muscular atrophy|MP:0002752,abnormal somatic nervous system morphology|MP:0003492,abnormal involuntary movement|MP:0003633,abnormal nervous system physiology|MP:0003871,abnormal myelin sheath morphology|MP:0004145,abnormal muscle electrophysiology|MP:0004220,abnormal peripheral nervous system regeneration|MP:0004243,abnormal motor nerve collateral sprouting|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004819,decreased skeletal muscle mass|MP:0005404,abnormal axon morphology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0009414,skeletal muscle fiber necrosis|MP:0010053,decreased grip strength
MGI:5469960	Scyl1<tm1.1Spel>	MP:0000745,tremors|MP:0000752,dystrophic muscle|MP:0000753,paralysis|MP:0000755,hindlimb paralysis|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002183,gliosis|MP:0002269,muscular atrophy|MP:0002651,abnormal sciatic nerve morphology|MP:0003312,abnormal locomotor coordination|MP:0003354,astrocytosis|MP:0004509,abnormal pelvic girdle bone morphology|MP:0008918,microgliosis|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009417,skeletal muscle atrophy|MP:0010053,decreased grip strength
MGI:5469959	Scyl1<tm1Spel>	MP:0000939,decreased motor neuron number|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003312,abnormal locomotor coordination|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0004565,decreased myocardial fiber size|MP:0005369,muscle phenotype|MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype|MP:0008918,microgliosis|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010053,decreased grip strength
MGI:5752500	Scyl2<tm1.1Spel>	MP:0000745,tremors|MP:0000774,decreased brain size|MP:0000811,hippocampal neuron degeneration|MP:0001262,decreased body weight|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0002169,no abnormal phenotype detected|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003203,increased neuron apoptosis|MP:0003354,astrocytosis|MP:0003360,abnormal depression-related behavior|MP:0003415,priapism|MP:0004924,abnormal behavior|MP:0008283,small hippocampus|MP:0008918,microgliosis|MP:0009971,decreased hippocampus pyramidal cell number|MP:0010053,decreased grip strength|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012460,decreased dentate gyrus size
MGI:5752502	Scyl2<tm1.2Spel>	MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0004924,abnormal behavior|MP:0005382,craniofacial phenotype|MP:0009546,absent gastric milk in neonates|MP:0011088,neonatal lethality, incomplete penetrance
MGI:6188894	Scyl3<tm1.1Spel>	MP:0003084,abnormal skeletal muscle fiber morphology|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype
MGI:6367945	Sdc1<em1(IMPC)H>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005553,increased circulating creatinine level
MGI:1934652	Sdc1<tm1Cma>	MP:0000350,abnormal cell proliferation|MP:0001846,increased inflammatory response|MP:0002411,decreased susceptibility to bacterial infection|MP:0002908,delayed wound healing|MP:0005027,increased susceptibility to parasitic infection|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0008495,decreased IgG1 level|MP:0008661,decreased interleukin-10 secretion|MP:0008673,decreased interleukin-13 secretion|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0020861,abnormal cornea wound healing
MGI:5548470	Sdc2<tm1b(KOMP)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001552,increased circulating triglyceride level|MP:0002075,abnormal coat/hair pigmentation|MP:0003393,decreased cardiac output|MP:0010068,decreased red blood cell distribution width|MP:0010463,aorta stenosis|MP:0011965,decreased total retina thickness
MGI:6364846	Sdc2<tm1c(KOMP)Wtsi>	MP:0002792,abnormal retina vasculature morphology|MP:0005166,decreased susceptibility to injury|MP:0005602,decreased angiogenesis|MP:0012201,decreased endothelial cell proliferation|MP:0020316,decreased vascular endothelial cell proliferation
MGI:6364847	Sdc2<tm1d(KOMP)Wtsi>	MP:0002792,abnormal retina vasculature morphology|MP:0002908,delayed wound healing|MP:0004003,abnormal vascular endothelial cell physiology|MP:0005602,decreased angiogenesis|MP:0020316,decreased vascular endothelial cell proliferation
MGI:6153756	Sdc3<em1(IMPC)Wtsi>	MP:0002073,abnormal hair growth|MP:0010124,decreased bone mineral content
MGI:2388360	Sdc3<tm1Rau>	MP:0001433,polyphagia|MP:0002727,decreased circulating insulin level|MP:0005292,improved glucose tolerance|MP:0005449,abnormal food intake|MP:0005450,abnormal energy expenditure|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0006086,decreased body mass index
MGI:2386199	Sdc4<tm1Goe>	MP:0001792,impaired wound healing|MP:0002908,delayed wound healing|MP:0005602,decreased angiogenesis|MP:0011708,decreased fibroblast cell migration
MGI:2386875	Sdc4<tm1Tmu>	MP:0002705,dilated renal tubule|MP:0003566,abnormal cell adhesion|MP:0005385,cardiovascular system phenotype|MP:0005565,increased blood urea nitrogen level|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009641,kidney degeneration|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011333,abnormal kidney inner medulla morphology
MGI:5692630	Sdc4<tm2b(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0002546,mydriasis|MP:0005016,decreased lymphocyte cell number|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0008935,decreased mean platelet volume|MP:0010067,increased red blood cell distribution width|MP:0010097,abnormal retina blood vessel morphology
MGI:6712409	Sdcbp<tm1.1Zimmy>	MP:0002169,no abnormal phenotype detected
MGI:7336099	Sdccag8<em1Lji>	MP:0000522,kidney cortex cyst|MP:0001004,abnormal retina photoreceptor morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0002135,abnormal kidney morphology|MP:0002962,increased urine protein level|MP:0003068,enlarged kidney|MP:0003985,renal fibrosis|MP:0008444,retina cone cell degeneration|MP:0008449,abnormal retina cone cell outer segment morphology|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008528,polycystic kidney|MP:0008587,short photoreceptor outer segment|MP:0009743,preaxial polydactyly|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011308,kidney corticomedullary cyst|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0013203,abnormal primary cilium morphology|MP:0014059,abnormal photoreceptor connecting cilium morphology|MP:0020384,absent kidney epithelial cell primary cilium|MP:0030005,increased retina apoptosis
MGI:7336100	Sdccag8<em2Lji>	MP:0000522,kidney cortex cyst|MP:0001004,abnormal retina photoreceptor morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0002135,abnormal kidney morphology|MP:0002962,increased urine protein level|MP:0003068,enlarged kidney|MP:0003985,renal fibrosis|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment|MP:0009743,preaxial polydactyly|MP:0011065,abnormal kidney epithelial cell primary cilium morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0013203,abnormal primary cilium morphology|MP:0014059,abnormal photoreceptor connecting cilium morphology|MP:0020383,decreased kidney epithelial cell primary cilium length|MP:0030005,increased retina apoptosis
MGI:4156902	Sdccag8<Gt(OST40418)Lex>	MP:0000522,kidney cortex cyst|MP:0001004,abnormal retina photoreceptor morphology|MP:0001326,retina degeneration|MP:0002001,blindness|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0003068,enlarged kidney|MP:0003215,renal interstitial fibrosis|MP:0003675,kidney cyst|MP:0005367,renal/urinary system phenotype|MP:0005384,cellular phenotype|MP:0008057,abnormal DNA replication|MP:0008446,decreased retina cone cell number|MP:0008450,retina photoreceptor degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0008580,photoreceptor inner segment degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0011308,kidney corticomedullary cyst|MP:0011376,abnormal kidney corticomedullary boundary morphology|MP:0011682,renal glomerulus cyst|MP:0012029,abnormal electroretinogram waveform feature
MGI:4458830	Sdccag8<tm1e(EUCOMM)Wtsi>	MP:0000111,cleft palate|MP:0000562,polydactyly|MP:0000820,abnormal choroid plexus morphology|MP:0006009,abnormal neuronal migration|MP:0008535,enlarged lateral ventricles|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013205,abnormal nonmotile primary cilium morphology
MGI:5766773	Sdf2l1<em1(IMPC)J>	MP:0010053,decreased grip strength
MGI:5904343	Sdhaf2<em1(IMPC)J>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:6257675	Sdhaf3<em1(IMPC)Bay>	MP:0010123,increased bone mineral content
MGI:7596072	Sdhaf4<em1Bcgen>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0002972,abnormal cardiac muscle contractility|MP:0003141,cardiac fibrosis|MP:0006036,abnormal mitochondrial physiology|MP:0008022,dilated heart ventricle|MP:0010656,thick myocardium|MP:0010958,abnormal tricarboxylic acid cycle|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014390,decreased myocardial fiber mitochondrial DNA content|MP:0014730,abnormal myocardial fiber myofibril morphology|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5498775	Sdha<tm2b(KOMP)Wtsi>	MP:0001554,increased circulating free fatty acids level|MP:0004924,abnormal behavior|MP:0005560,decreased circulating glucose level|MP:0005633,increased circulating sodium level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0020870,decreased thigmotaxis
MGI:5521531	Sdhb<tm1.1Ics>	MP:0002169,no abnormal phenotype detected
MGI:5521532	Sdhb<tm1.2Ics>	MP:0011092,embryonic lethality, complete penetrance
MGI:5548548	Sdhb<tm1b(EUCOMM)Hmgu>	MP:0000222,decreased neutrophil cell number|MP:0001402,decreased locomotor activity|MP:0002135,abnormal kidney morphology|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:7282124	Sdhb<tm1c(EUCOMM)Hmgu>	MP:0001559,hyperglycemia|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0009114,decreased pancreatic beta cell mass|MP:0010147,abnormal endocrine pancreas physiology|MP:0010954,abnormal cellular respiration|MP:0010955,abnormal respiratory electron transport chain|MP:0013279,increased fasting circulating glucose level
MGI:4433079	Sdhc<tm1a(EUCOMM)Wtsi>	MP:0010123,increased bone mineral content|MP:0010124,decreased bone mineral content
MGI:5694171	Sdhc<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5805498	Sdhc<tm1c(EUCOMM)Wtsi>	MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002006,neoplasm|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002727,decreased circulating insulin level|MP:0002757,decreased vertical activity|MP:0004890,decreased energy expenditure|MP:0005560,decreased circulating glucose level|MP:0009642,abnormal blood homeostasis|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0010958,abnormal tricarboxylic acid cycle|MP:0012552,lactic acidosis|MP:0014142,increased body fat mass
MGI:3526521	Sdhd<tm1Jlob>	MP:0001730,embryonic growth arrest|MP:0002006,neoplasm|MP:0003438,abnormal carotid body physiology|MP:0010955,abnormal respiratory electron transport chain|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0020840,abnormal type I cell of carotid body morphology|MP:0020843,abnormal type I cell of carotid body physiology
MGI:4418212	Sdhd<tm1Jpb>	MP:0002169,no abnormal phenotype detected|MP:0011092,embryonic lethality, complete penetrance
MGI:6336133	Sdk1<em1(IMPC)Kmpc>	MP:0001399,hyperactivity|MP:0003896,prolonged PR interval
MGI:5698883	Sdk2<tm1.1(cre/ERT2)Jrs>	MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology
MGI:6400337	Sdr16c6<tm1d(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5817201	Sdr42e1<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001312,abnormal cornea morphology
MGI:7505542	Sdr9c7<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0003984,embryonic growth retardation|MP:0008935,decreased mean platelet volume|MP:0011100,preweaning lethality, complete penetrance
MGI:6469363	Sdr9c7<em1Maak>	MP:0001222,epidermal hyperplasia|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0002796,impaired skin barrier function|MP:0003853,dry skin|MP:0009594,abnormal corneocyte envelope morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:5548781	Sdsl<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0002941,increased circulating alanine transaminase level|MP:0003795,abnormal bone structure
MGI:1857032	sea	MP:0000371,diluted coat color|MP:0005376,homeostasis/metabolism phenotype
MGI:1857033	seb	MP:0000418,focal hair loss|MP:0000427,abnormal hair cycle|MP:0001127,small ovary|MP:0001194,dermatitis|MP:0001242,hyperkeratosis|MP:0001732,postnatal growth retardation|MP:0001874,acanthosis|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002052,decreased tumor incidence|MP:0003427,parakeratosis|MP:0003815,hairless|MP:0003849,greasy coat|MP:0003865,lymph node inflammation|MP:0004889,increased energy expenditure|MP:0004894,uterus atrophy|MP:0004947,skin inflammation|MP:0005114,premature hair loss|MP:0005534,decreased body temperature|MP:0008102,lymph node hyperplasia|MP:0009793,sebaceous gland hypertrophy|MP:0010025,decreased total body fat amount|MP:0010179,rough coat|MP:0010300,increased skin tumor incidence|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5689890	Sebox<em1(IMPC)J>	MP:0013279,increased fasting circulating glucose level
MGI:3708903	Sebox<tm1Clc>	MP:0005391,vision/eye phenotype
MGI:5696903	Sec11c<tm1b(EUCOMM)Wtsi>	MP:0001402,decreased locomotor activity
MGI:6279926	Sec13<em1(IMPC)Hmgu>	MP:0010580,decreased heart left ventricle size|MP:0011100,preweaning lethality, complete penetrance
MGI:5812905	Sec14l1<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0002968,increased circulating alkaline phosphatase level|MP:0010052,increased grip strength
MGI:3771069	Sec14l2<tm1Arai>	MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:6279922	Sec14l5<em1(IMPC)Bay>	MP:0011962,increased cornea thickness
MGI:6342891	Sec16a<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:7292204	Sec16a<em1Smoc>	MP:0004761,increased susceptibility to induced pancreatitis|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009147,abnormal pancreatic acinar cell physiology|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0014098,decreased pancreatic amylase secretion
MGI:4365061	Sec16b<tm1a(KOMP)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001260,increased body weight|MP:0005179,decreased circulating cholesterol level
MGI:7314700	Sec1<em1Cya>	MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:4842255	Sec1<tm1a(EUCOMM)Wtsi>	MP:0002833,increased heart weight
MGI:4433526	Sec22b<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6115369	Sec22b<tm1c(EUCOMM)Wtsi>	MP:0005387,immune system phenotype
MGI:4128052	Sec23a<Gt(RRE297)Byg>	MP:0000164,abnormal cartilage development|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0000934,abnormal telencephalon development|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0001915,intracranial hemorrhage|MP:0002152,abnormal brain morphology|MP:0004264,abnormal extraembryonic tissue physiology|MP:0005029,abnormal amnion morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012681,collapsed brain ventricles|MP:0012706,decreased embryonic neuroepithelial cell proliferation|MP:0013227,small brain ventricles|MP:0020252,abnormal collagen level|MP:0020354,increased endoplasmic reticulum stress|MP:0020413,increased amnion apoptosis
MGI:4362215	Sec23a<tm1a(KOMP)Wtsi>	MP:0010025,decreased total body fat amount
MGI:4345347	Sec23b<Gt(AD0407)Wtsi>	MP:0000473,abnormal stomach glandular epithelium morphology|MP:0000477,abnormal intestine morphology|MP:0000613,abnormal salivary gland morphology|MP:0001436,abnormal suckling behavior|MP:0001869,pancreas inflammation|MP:0001944,abnormal pancreas morphology|MP:0003339,decreased pancreatic beta cell number|MP:0003449,abnormal intestine goblet cell morphology|MP:0003793,abnormal submandibular gland morphology|MP:0004035,abnormal sublingual gland morphology|MP:0004247,small pancreas|MP:0004843,abnormal Paneth cell morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0005560,decreased circulating glucose level|MP:0006042,increased apoptosis|MP:0009145,abnormal pancreatic acinus morphology|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009149,decreased pancreatic acinar cell number|MP:0009154,pancreatic acinar hypoplasia|MP:0009162,absent pancreatic acinar cell zymogen granule|MP:0009165,abnormal endocrine pancreas morphology|MP:0009168,decreased pancreatic islet number|MP:0009177,decreased pancreatic alpha cell number|MP:0009674,decreased birth weight|MP:0010148,abnormal exocrine pancreas physiology|MP:0011087,neonatal lethality, complete penetrance|MP:0011932,abnormal endocrine pancreas development|MP:0013568,gastric gland degeneration|MP:0013581,nasal gland degeneration|MP:0013583,salivary gland degeneration|MP:0013584,pancreas degeneration
MGI:4432981	Sec23b<tm1a(EUCOMM)Wtsi>	MP:0011087,neonatal lethality, complete penetrance|MP:0013568,gastric gland degeneration|MP:0013581,nasal gland degeneration|MP:0013583,salivary gland degeneration|MP:0013584,pancreas degeneration
MGI:5433325	Sec23b<tm1b(EUCOMM)Wtsi>	MP:0011087,neonatal lethality, complete penetrance|MP:0013568,gastric gland degeneration|MP:0013581,nasal gland degeneration|MP:0013583,salivary gland degeneration|MP:0013584,pancreas degeneration
MGI:5583845	Sec23b<tm1d(EUCOMM)Wtsi>	MP:0005397,hematopoietic system phenotype
MGI:5085903	Sec23ip<tm1.1Katn>	MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0002686,globozoospermia|MP:0009232,abnormal sperm nucleus morphology|MP:0009647,decreased fertilization frequency|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0014636,decreased elongated spermatid number|MP:0031354,abnormal acrosome assembly
MGI:4362779	Sec24a<tm1a(KOMP)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0002702,decreased circulating free fatty acids level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005179,decreased circulating cholesterol level|MP:0005565,increased blood urea nitrogen level|MP:0010025,decreased total body fat amount
MGI:6414557	Sec24b<em1(IMPC)Tcp>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000914,exencephaly|MP:0001697,abnormal embryo size|MP:0002092,abnormal eye morphology|MP:0002111,abnormal tail morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape
MGI:4440621	Sec24b<krb>	MP:0000031,abnormal cochlea morphology|MP:0000042,abnormal organ of Corti morphology|MP:0000279,ventricular hypoplasia|MP:0000757,herniated abdominal wall|MP:0001718,abnormal visceral yolk sac morphology|MP:0003641,small lung|MP:0003720,abnormal neural tube closure|MP:0004110,transposition of great arteries|MP:0004160,retroesophageal right subclavian artery|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0006126,abnormal cardiac outflow tract development|MP:0008784,craniorachischisis|MP:0010975,abnormal lung lobe morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5505528	Sec24b<m11Bei>	MP:0002151,abnormal neural tube morphology
MGI:4440619	Sec24b<Y613X>	MP:0000929,open neural tube|MP:0001697,abnormal embryo size|MP:0003052,omphalocele|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004492,abnormal orientation of inner hair cell stereociliary bundles|MP:0008784,craniorachischisis|MP:0009264,failure of eyelid fusion|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4431706	Sec24c<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5501469	Sec24c<tm1c(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0011100,preweaning lethality, complete penetrance
MGI:5501471	Sec24c<tm1d(EUCOMM)Wtsi>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:6156157	Sec24d<em1(IMPC)Rbrc>	MP:0000470,abnormal stomach morphology|MP:0000598,abnormal liver morphology|MP:0005293,impaired glucose tolerance|MP:0011100,preweaning lethality, complete penetrance
MGI:4330860	Sec24d<Gt(RRR785)Byg>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4340594	Sec24d<Gt(RRT226)Byg>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5582296	Sec24d<tm1c(EUCOMM)Hmgu>	MP:0002169,no abnormal phenotype detected
MGI:6343337	Sec31a<em1H>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:6355926	Sec31a<em3(IMPC)H>	MP:0001392,abnormal locomotor behavior|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005343,increased circulating aspartate transaminase level|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6360914	Sec31b<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level
MGI:4830998	Sec61a1<m1Gek>	MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0001265,decreased body size|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002628,hepatic steatosis|MP:0002712,increased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0003046,liver cirrhosis|MP:0003339,decreased pancreatic beta cell number|MP:0003562,abnormal pancreatic beta cell physiology|MP:0003887,increased hepatocyte apoptosis|MP:0003893,increased hepatocyte proliferation|MP:0003961,decreased lean body mass|MP:0004819,decreased skeletal muscle mass|MP:0005178,increased circulating cholesterol level|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005218,abnormal pancreatic delta cell morphology|MP:0005293,impaired glucose tolerance|MP:0009176,increased pancreatic alpha cell number|MP:0009180,increased pancreatic delta cell number|MP:0010025,decreased total body fat amount|MP:0014117,increased pancreatic beta cell apoptosis
MGI:6294092	Sec61a2<em1(IMPC)J>	MP:0001488,increased startle reflex|MP:0001566,increased circulating phosphate level|MP:0010053,decreased grip strength
MGI:6152633	Sec61b<em1(IMPC)Mbp>	MP:0001126,abnormal ovary morphology|MP:0001399,hyperactivity|MP:0002079,increased circulating insulin level
MGI:7311993	Sec61g<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011100,preweaning lethality, complete penetrance|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6188014	Sec62<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5442304	Sec63<tm1.1Som>	MP:0011092,embryonic lethality, complete penetrance
MGI:5692793	Sec63<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000219,increased neutrophil cell number|MP:0001284,absent vibrissae|MP:0002098,abnormal vibrissa morphology|MP:0002941,increased circulating alanine transaminase level|MP:0005016,decreased lymphocyte cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5442171	Sec63<tm1Som>	MP:0002083,premature death|MP:0003327,liver cyst|MP:0003675,kidney cyst|MP:0004860,dilated kidney collecting duct|MP:0005565,increased blood urea nitrogen level|MP:0011344,abnormal loop of Henle ascending limb thick segment morphology
MGI:3717856	Secia1<DBA/1J>	MP:0003724,increased susceptibility to induced arthritis
MGI:3717858	Secia2<DBA/1J>	MP:0003724,increased susceptibility to induced arthritis
MGI:3717861	Secia3<FVB/NJ>	MP:0003724,increased susceptibility to induced arthritis
MGI:3717862	Secia4<DBA/1J>	MP:0003724,increased susceptibility to induced arthritis
MGI:3717864	Secia5<DBA/1J>	MP:0003724,increased susceptibility to induced arthritis
MGI:3717866	Secia6<DBA/1J>	MP:0003724,increased susceptibility to induced arthritis
MGI:3717869	Secia7<FVB/NJ>	MP:0003724,increased susceptibility to induced arthritis
MGI:3717871	Secia8<FVB/NJ>	MP:0003724,increased susceptibility to induced arthritis
MGI:6259589	Secisbp2l<em1(IMPC)J>	MP:0000062,increased bone mineral density|MP:0000556,abnormal hindlimb morphology|MP:0001488,increased startle reflex|MP:0002626,increased heart rate|MP:0003960,increased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005178,increased circulating cholesterol level|MP:0005632,decreased circulating aspartate transaminase level|MP:0005655,increased aggression|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content
MGI:7734969	Secisbp2l<tm1.1Qiu>	MP:0000745,tremors|MP:0005470,increased thyroxine level|MP:0005473,decreased triiodothyronine level|MP:0009808,decreased oligodendrocyte number|MP:0011731,decreased myelin sheath thickness|MP:0014318,abnormal oligodendrocyte differentiation
MGI:6323602	Secisbp2<tm1.2Amdu>	MP:0011091,prenatal lethality, complete penetrance
MGI:4433050	Secisbp2<tm1a(EUCOMM)Wtsi>	MP:0001730,embryonic growth arrest|MP:0001775,abnormal selenium level|MP:0003984,embryonic growth retardation|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0008044,increased NK cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0011105,embryonic lethality between implantation and placentation, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5583885	Secisbp2<tm1c(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0001325,abnormal retina morphology|MP:0005370,liver/biliary system phenotype
MGI:5583886	Secisbp2<tm1d(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6852564	Sectm1a<em1Gcfa>	MP:0001853,heart inflammation|MP:0002451,abnormal macrophage physiology|MP:0005140,decreased cardiac muscle contractility|MP:0008553,increased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008735,increased susceptibility to endotoxin shock|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level
MGI:5320610	Segd	MP:0000414,alopecia|MP:0001211,wrinkled skin|MP:0001265,decreased body size|MP:0009703,decreased birth body size|MP:0009931,abnormal skin appearance|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:6712818	Seh1l<tm1.1Lzha>	MP:0011091,prenatal lethality, complete penetrance
MGI:4453708	Seh1l<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6712817	Seh1l<tm1Lzha>	MP:0000745,tremors|MP:0000913,abnormal brain development|MP:0000920,abnormal myelination|MP:0001393,ataxia|MP:0002064,seizures|MP:0005076,abnormal cell differentiation|MP:0009808,decreased oligodendrocyte number|MP:0011085,postnatal lethality, complete penetrance|MP:0013438,dysmyelination
MGI:5829466	Sel1l3<em1(IMPC)J>	MP:0002075,abnormal coat/hair pigmentation|MP:0002941,increased circulating alanine transaminase level|MP:0010052,increased grip strength
MGI:3864670	Sel1l<Gt(CA0017)Wtsi>	MP:0001944,abnormal pancreas morphology|MP:0003934,abnormal pancreas development|MP:0004001,decreased hepatocyte proliferation|MP:0009175,abnormal pancreatic beta cell differentiation|MP:0009179,abnormal pancreatic alpha cell differentiation|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0020354,increased endoplasmic reticulum stress
MGI:5576558	Sel1l<tm1c(KOMP)Wtsi>	MP:0000358,abnormal cell morphology|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002791,steatorrhea|MP:0005220,abnormal exocrine pancreas morphology|MP:0005342,abnormal intestinal lipid absorption|MP:0005534,decreased body temperature|MP:0009147,abnormal pancreatic acinar cell physiology|MP:0009164,exocrine pancreas atrophy|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011939,increased food intake|MP:0012556,increased cell death|MP:0013139,moribund|MP:0013220,increased pancreas apoptosis
MGI:4364219	Sel1l<tm1e(KOMP)Wtsi>	MP:0004609,vertebral fusion|MP:0011100,preweaning lethality, complete penetrance
MGI:5548951	Selenbp1<tm1b(KOMP)Wtsi>	MP:0000198,decreased circulating phosphate level|MP:0002079,increased circulating insulin level|MP:0002590,increased mean corpuscular volume|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005419,decreased circulating serum albumin level|MP:0005554,decreased circulating creatinine level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0009642,abnormal blood homeostasis
MGI:5521488	Selenbp1<tm1Hyama>	MP:0002176,increased brain weight|MP:0002682,decreased mature ovarian follicle number|MP:0002965,increased circulating serum albumin level|MP:0003402,decreased liver weight|MP:0004953,decreased spleen weight|MP:0004955,increased thymus weight|MP:0005376,homeostasis/metabolism phenotype
MGI:5293082	Selenof<tm1Vgla>	MP:0000609,abnormal liver physiology|MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology|MP:0003674,oxidative stress|MP:0005384,cellular phenotype|MP:0010254,nuclear cataract|MP:0011697,lens vacuoles
MGI:6695989	Selenoi<em1.1Prh>	MP:0011089,perinatal lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:4941878	Selenok<tm1.2Itl>	MP:0002444,abnormal T cell physiology|MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology|MP:0005095,decreased T cell proliferation|MP:0008561,decreased tumor necrosis factor secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008720,impaired neutrophil chemotaxis|MP:0010209,abnormal circulating chemokine level|MP:0020943,increased susceptibility to Flaviviridae infection|MP:0031044,increased susceptibility to Flaviviridae infection induced morbidity/mortality
MGI:4431818	Selenok<tm1a(EUCOMM)Wtsi>	MP:0003961,decreased lean body mass|MP:0008935,decreased mean platelet volume|MP:0010024,increased total body fat amount|MP:0010093,decreased circulating magnesium level
MGI:5548722	Selenok<tm1b(EUCOMM)Wtsi>	MP:0004174,abnormal spine curvature|MP:0004599,abnormal vertebral arch morphology|MP:0004738,abnormal auditory brainstem response
MGI:3812975	Selenom<tm1(KOMP)Vlcg>	MP:0001260,increased body weight|MP:0001261,obese|MP:0001402,decreased locomotor activity|MP:0002665,decreased circulating corticosterone level|MP:0003631,nervous system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005455,increased susceptibility to weight gain|MP:0005669,increased circulating leptin level|MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight
MGI:5297977	Selenon<tm1.1Mred>	MP:0002169,no abnormal phenotype detected
MGI:4946396	Selenon<tm1.2Mred>	MP:0000160,kyphosis|MP:0000750,abnormal muscle regeneration|MP:0000759,abnormal skeletal muscle morphology|MP:0002106,abnormal muscle physiology|MP:0003833,decreased satellite cell number|MP:0004819,decreased skeletal muscle mass|MP:0009400,decreased skeletal muscle fiber size|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009417,skeletal muscle atrophy|MP:0009422,decreased gastrocnemius weight|MP:0009424,decreased extensor digitorum longus weight|MP:0009426,decreased soleus weight|MP:0009428,decreased tibialis anterior weight|MP:0010182,decreased susceptibility to weight gain|MP:0010227,decreased quadriceps weight
MGI:4363081	Selenon<tm1a(KOMP)Wtsi>	MP:0004609,vertebral fusion
MGI:5510170	Selenon<tm1Begg>	MP:0000759,abnormal skeletal muscle morphology|MP:0001176,abnormal lung development|MP:0001402,decreased locomotor activity|MP:0001942,abnormal lung volume|MP:0002133,abnormal respiratory system physiology|MP:0002757,decreased vertical activity|MP:0006042,increased apoptosis|MP:0009461,skeletal muscle hypertrophy|MP:0010895,increased lung compliance|MP:0010902,abnormal pulmonary alveolar sac morphology|MP:0011045,decreased lung elastance|MP:0012107,enhanced exercise endurance
MGI:2652747	Selenop<tm1Kohr>	MP:0000592,short tail|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0002083,premature death
MGI:2656912	Selenop<tm1Rfb>	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0001442,decreased grooming behavior|MP:0001463,abnormal spatial learning|MP:0001775,abnormal selenium level|MP:0001922,reduced male fertility|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002068,abnormal parental behavior|MP:0002083,premature death|MP:0002757,decreased vertical activity|MP:0003325,decreased liver function|MP:0003887,increased hepatocyte apoptosis|MP:0005027,increased susceptibility to parasitic infection|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010053,decreased grip strength|MP:0010180,increased susceptibility to weight loss|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3785490	Selenop<tm2Rfb>	MP:0000745,tremors|MP:0001399,hyperactivity|MP:0001523,impaired righting response|MP:0001775,abnormal selenium level|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0008770,decreased survivor rate|MP:0008892,abnormal sperm flagellum morphology|MP:0009243,hairpin sperm flagellum|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009831,abnormal sperm midpiece morphology|MP:0014464,decreased sperm mitochondrial sheath size
MGI:5466366	Selenop<tm3.1Rfb>	MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001775,abnormal selenium level|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0011770,increased urine selenium level
MGI:6257874	Selenos<tm1.1Sfa>	MP:0000747,muscle weakness|MP:0001402,decreased locomotor activity|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype
MGI:6449044	Selenot<em1(IMPC)Mbp>	MP:0000774,decreased brain size|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001258,decreased body length|MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0002060,abnormal skin morphology|MP:0002152,abnormal brain morphology|MP:0003795,abnormal bone structure|MP:0005333,decreased heart rate|MP:0009141,increased prepulse inhibition|MP:0010506,prolonged RR interval
MGI:5544732	Selenot<tm1.1Ics>	MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005559,increased circulating glucose level|MP:0009167,increased pancreatic islet number|MP:0009172,small pancreatic islets
MGI:6194705	Selenov<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:7578798	Selenov<em1Xgl>	MP:0001260,increased body weight|MP:0001654,hepatic necrosis|MP:0002687,oligozoospermia|MP:0002941,increased circulating alanine transaminase level|MP:0003674,oxidative stress|MP:0003887,increased hepatocyte apoptosis|MP:0004129,abnormal respiratory quotient|MP:0004890,decreased energy expenditure|MP:0005178,increased circulating cholesterol level|MP:0005290,decreased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005669,increased circulating leptin level|MP:0005670,abnormal white adipose tissue physiology|MP:0008033,impaired lipolysis|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0008597,decreased circulating interleukin-6 level|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008964,decreased carbon dioxide production|MP:0009118,increased white fat cell size|MP:0009121,increased white fat cell lipid droplet size|MP:0009288,increased epididymal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009298,increased mesenteric fat pad weight|MP:0009302,increased renal fat pad weight|MP:0010954,abnormal cellular respiration|MP:0011014,decreased core body temperature|MP:0011015,decreased body surface temperature|MP:0011698,abnormal brown adipose tissue physiology|MP:0011699,abnormal brown adipose tissue thermogenesis|MP:0012604,decreased glutathione level|MP:0012659,decreased superoxide dismutase level|MP:0014142,increased body fat mass|MP:0014170,increased brown adipose tissue mass|MP:0014495,increased circulating chemokine level|MP:0020354,increased endoplasmic reticulum stress|MP:0020520,whitened brown adipose tissue morphology|MP:0020867,increased lipogenesis
MGI:5538611	Selenow<em#Hwl>	MP:0000062,increased bone mineral density|MP:0001260,increased body weight|MP:0004985,decreased osteoclast cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005605,increased bone mass|MP:0008396,abnormal osteoclast differentiation|MP:0009347,increased trabecular bone thickness|MP:0010878,increased trabecular bone volume|MP:0013631,decreased bone trabecular spacing
MGI:6845150	Selenow<tm1c(EUCOMM)Wtsi>	MP:0005605,increased bone mass|MP:0008396,abnormal osteoclast differentiation|MP:0020040,decreased bone ossification
MGI:2445563	Sele<tm1Alb>	MP:0000219,increased neutrophil cell number|MP:0000689,abnormal spleen morphology|MP:0000745,tremors|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001411,spinning|MP:0001492,abnormal pilomotor reflex|MP:0001851,eye inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0005191,head tilt
MGI:3665314	Sele<tm1Dmil>	MP:0003628,abnormal leukocyte adhesion
MGI:2180868	Sele<tm1Roml>	MP:0002169,no abnormal phenotype detected|MP:0002444,abnormal T cell physiology
MGI:3839963	Sele<tm2Hyn>	MP:0000324,increased mast cell number|MP:0000336,decreased mast cell number|MP:0002169,no abnormal phenotype detected|MP:0002534,abnormal type IV hypersensitivity reaction|MP:0008719,impaired neutrophil recruitment|MP:0020333,enhanced leukocyte tethering or rolling
MGI:5615716	Sell<m1Btlr>	MP:0008083,decreased single-positive T cell number
MGI:5775035	Sell<m2Btlr>	MP:0008083,decreased single-positive T cell number|MP:0020001,decreased response to antigen
MGI:6403119	Sell<tm1.1Rpmc>	MP:0001846,increased inflammatory response|MP:0002462,abnormal granulocyte physiology|MP:0002463,abnormal neutrophil physiology|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0010768,mortality/aging|MP:0031121,increased susceptibility to induced thrombosis
MGI:2656258	Sell<tm1Alb>	MP:0000240,extramedullary hematopoiesis|MP:0008475,intermingled spleen red and white pulp|MP:0010771,integument phenotype
MGI:5692915	Sell<tm1b(EUCOMM)Hmgu>	MP:0004952,increased spleen weight
MGI:3039283	Sell<tm1Flv>	MP:0001830,decreased activated T cell number|MP:0001869,pancreas inflammation|MP:0002534,abnormal type IV hypersensitivity reaction|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005351,decreased susceptibility to autoimmune disorder|MP:0005387,immune system phenotype
MGI:3663167	Sell<tm1Pest>	MP:0000691,enlarged spleen|MP:0002148,abnormal hypersensitivity reaction|MP:0002376,abnormal dendritic cell physiology|MP:0002421,abnormal cell-mediated immunity|MP:0003156,abnormal leukocyte migration|MP:0003628,abnormal leukocyte adhesion|MP:0005095,decreased T cell proliferation|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0008101,lymph node hypoplasia|MP:0008826,abnormal splenic cell ratio|MP:0009636,small popliteal lymph nodes|MP:0020332,impaired leukocyte tethering or rolling
MGI:1927795	Sell<tm1Tft>	MP:0000220,increased monocyte cell number|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0003156,abnormal leukocyte migration|MP:0003721,increased tumor growth/size|MP:0004946,abnormal regulatory T cell physiology|MP:0004972,abnormal regulatory T cell number|MP:0008101,lymph node hypoplasia|MP:0009858,abnormal cellular extravasation|MP:0020332,impaired leukocyte tethering or rolling
MGI:3820622	Sell<tm2.1Tft>	MP:0000693,spleen hyperplasia|MP:0002463,abnormal neutrophil physiology|MP:0005416,abnormal circulating protein level
MGI:3839975	Sell<tm2Hyn>	MP:0000223,decreased monocyte cell number|MP:0001273,decreased metastatic potential|MP:0002052,decreased tumor incidence|MP:0005370,liver/biliary system phenotype|MP:0005387,immune system phenotype|MP:0008719,impaired neutrophil recruitment|MP:0020332,impaired leukocyte tethering or rolling
MGI:3820621	Sell<tm2Tft>	MP:0000693,spleen hyperplasia|MP:0008101,lymph node hypoplasia
MGI:3820623	Sell<tm3Tft>	MP:0005416,abnormal circulating protein level
MGI:2176571	Selplg<tm1Fur>	MP:0000219,increased neutrophil cell number|MP:0005011,increased eosinophil cell number|MP:0008720,impaired neutrophil chemotaxis|MP:0020332,impaired leukocyte tethering or rolling
MGI:2180375	Selplg<tm1Rpmc>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0003628,abnormal leukocyte adhesion|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005387,immune system phenotype|MP:0005606,increased bleeding time|MP:0008722,abnormal chemokine secretion|MP:0020332,impaired leukocyte tethering or rolling
MGI:3809664	Selplg<tm2Rpmc>	MP:0005606,increased bleeding time|MP:0020332,impaired leukocyte tethering or rolling
MGI:5776224	Selp<tm1.1Rpmc>	MP:0020332,impaired leukocyte tethering or rolling
MGI:1857244	Selp<tm1Bay>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000336,decreased mast cell number|MP:0000689,abnormal spleen morphology|MP:0000745,tremors|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001411,spinning|MP:0001492,abnormal pilomotor reflex|MP:0001654,hepatic necrosis|MP:0001851,eye inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0002444,abnormal T cell physiology|MP:0002493,increased IgG level|MP:0003009,abnormal cytokine secretion|MP:0003156,abnormal leukocyte migration|MP:0003627,abnormal leukocyte tethering or rolling|MP:0003724,increased susceptibility to induced arthritis|MP:0005191,head tilt|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction
MGI:1857245	Selp<tm1Hyn>	MP:0000219,increased neutrophil cell number|MP:0003799,impaired macrophage chemotaxis|MP:0005011,increased eosinophil cell number|MP:0005606,increased bleeding time|MP:0008719,impaired neutrophil recruitment|MP:0008723,impaired eosinophil recruitment|MP:0011514,skin hemorrhage|MP:0020332,impaired leukocyte tethering or rolling
MGI:2445316	Selp<tm2Hyn>	MP:0001914,hemorrhage|MP:0002551,abnormal blood coagulation|MP:0006055,abnormal vascular endothelial cell morphology|MP:0008719,impaired neutrophil recruitment|MP:0009642,abnormal blood homeostasis|MP:0020332,impaired leukocyte tethering or rolling
MGI:4455203	Sema3a<m808Ddg>	MP:0009450,abnormal axon fasciculation|MP:0009798,abnormal ophthalmic nerve morphology
MGI:2158944	Sema3a<tm1.1Tyag>	MP:0000819,abnormal olfactory bulb morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001077,abnormal spinal nerve morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002376,abnormal dendritic cell physiology|MP:0002444,abnormal T cell physiology|MP:0002741,small olfactory bulb|MP:0008317,abnormal paravertebral ganglion morphology
MGI:2449920	Sema3a<tm1Mcf>	MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000157,abnormal sternum morphology|MP:0000276,heart right ventricle hypertrophy|MP:0000746,weakness|MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001265,decreased body size|MP:0001504,abnormal posture|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0004062,dilated heart right atrium|MP:0004620,cervical vertebral fusion|MP:0004678,split xiphoid process|MP:0005388,respiratory system phenotype|MP:0006254,thin cerebral cortex|MP:0008146,asymmetric sternocostal joints|MP:0008770,decreased survivor rate|MP:0009937,abnormal neuron differentiation|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0010981,abnormal branching involved in ureteric bud morphogenesis|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011940,decreased food intake
MGI:3576463	Sema3b<tm1.1Brd>	MP:0002169,no abnormal phenotype detected
MGI:3576464	Sema3b<tm1.2Brd>	MP:0002169,no abnormal phenotype detected
MGI:3617382	Sema3b<tm1Cast>	MP:0008228,increased anterior commissure size
MGI:3522218	Sema3c<L605P>	MP:0000284,double outlet right ventricle|MP:0000285,abnormal heart valve morphology|MP:0002633,persistent truncus arteriosus|MP:0004157,interrupted aortic arch|MP:0004181,abnormal carotid artery morphology|MP:0005408,hypopigmentation|MP:0006049,semilunar valve regurgitation|MP:0009389,abnormal extracutaneous pigmentation|MP:0011090,perinatal lethality, incomplete penetrance
MGI:2150759	Sema3c<tm1.1Jra>	MP:0000284,double outlet right ventricle|MP:0002633,persistent truncus arteriosus|MP:0002950,abnormal neural crest cell migration|MP:0003631,nervous system phenotype|MP:0004157,interrupted aortic arch|MP:0010418,perimembraneous ventricular septal defect|MP:0010589,common truncal valve|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011659,interrupted aortic arch, type b|MP:0012729,abnormal common carotid artery morphology|MP:0031517,interrupted aortic arch, type c
MGI:5520920	Sema3d<tm1.1Joe>	MP:0002726,abnormal pulmonary vein morphology|MP:0005385,cardiovascular system phenotype|MP:0008727,increased heart right atrium size|MP:0008772,increased heart ventricle size|MP:0010403,atrial septal defect|MP:0031129,left-to-right shunt
MGI:5548498	Sema3d<tm1b(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5317896	Sema3d<tm2.1(GFP/cre)Joe>	MP:0002925,abnormal cardiovascular development
MGI:6367960	Sema3e<em1(IMPC)H>	MP:0000198,decreased circulating phosphate level|MP:0001289,persistence of hyaloid vascular system|MP:0001319,irregularly shaped pupil|MP:0001325,abnormal retina morphology|MP:0001392,abnormal locomotor behavior|MP:0006241,abnormal placement of pupils|MP:0006243,impaired pupillary reflex|MP:0010097,abnormal retina blood vessel morphology
MGI:3529998	Sema3e<Gt(OST204387)Lex>	MP:0012539,Bergmeister's papilla
MGI:3848810	Sema3e<tm1(cre/ERT2)Arbr>	MP:0000937,abnormal motor neuron morphology|MP:0000940,abnormal motor neuron innervation pattern|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:3527995	Sema3e<tm1Ddg>	MP:0001325,abnormal retina morphology|MP:0001688,abnormal somite development|MP:0002792,abnormal retina vasculature morphology|MP:0012253,abnormal intersomitic vessel morphology
MGI:2670662	Sema3f<tm1.1Ddg>	MP:0000778,abnormal nervous system tract morphology|MP:0000808,abnormal hippocampus development|MP:0002184,abnormal innervation|MP:0008225,abnormal anterior commissure morphology|MP:0009450,abnormal axon fasciculation
MGI:2670663	Sema3f<tm1.2Ddg>	MP:0000778,abnormal nervous system tract morphology|MP:0000808,abnormal hippocampus development|MP:0001061,abnormal oculomotor nerve morphology|MP:0001064,absent trochlear nerve|MP:0001265,decreased body size|MP:0001879,abnormal lymphatic vessel morphology|MP:0002184,abnormal innervation|MP:0002961,abnormal axon guidance|MP:0004082,abnormal habenula morphology|MP:0008225,abnormal anterior commissure morphology|MP:0009450,abnormal axon fasciculation|MP:0010197,abnormal lymphatic vessel endothelial cell morphology|MP:0010368,abnormal lymphatic system physiology
MGI:3790328	Sema3f<tm1Atai>	MP:0003861,abnormal nervous system development|MP:0006009,abnormal neuronal migration
MGI:5636922	Sema3f<tm1b(EUCOMM)Hmgu>	MP:0000579,abnormal nail morphology|MP:0000745,tremors|MP:0001304,cataract|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0001513,limb grasping|MP:0004222,iris synechia|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0008810,increased circulating iron level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5320500	Sema3g<tm1Aug>	MP:0002169,no abnormal phenotype detected
MGI:3797882	Sema3g<tm1(KOMP)Vlcg>	MP:0001879,abnormal lymphatic vessel morphology
MGI:3052925	Sema4a<Gt(OST393408)Lex>	MP:0001326,retina degeneration|MP:0001327,decreased retina photoreceptor cell number|MP:0002092,abnormal eye morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0005172,decreased eye pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005253,abnormal eye physiology|MP:0005551,abnormal eye electrophysiology|MP:0008449,abnormal retina cone cell outer segment morphology|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0008511,thin retina inner nuclear layer|MP:0008513,thin retina inner plexiform layer|MP:0008515,thin retina outer nuclear layer
MGI:5548200	Sema4a<tm1.1Akum>	MP:0005391,vision/eye phenotype
MGI:5807134	Sema4a<tm1b(EUCOMM)Wtsi>	MP:0005367,renal/urinary system phenotype
MGI:3575087	Sema4a<tm1Kik>	MP:0001326,retina degeneration|MP:0002455,abnormal dendritic cell antigen presentation|MP:0003009,abnormal cytokine secretion|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008585,absent photoreceptor outer segment|MP:0030005,increased retina apoptosis
MGI:5548202	Sema4a<tm2.1Akum>	MP:0005391,vision/eye phenotype
MGI:5548203	Sema4a<tm3.1Akum>	MP:0001326,retina degeneration|MP:0001327,decreased retina photoreceptor cell number|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0008585,absent photoreceptor outer segment|MP:0030005,increased retina apoptosis
MGI:5548205	Sema4a<tm4.1Akum>	MP:0005391,vision/eye phenotype
MGI:4125445	Sema4b<Gt(RST235)Byg>	MP:0003631,nervous system phenotype|MP:0005367,renal/urinary system phenotype
MGI:4941169	Sema4b<tm1Akum>	MP:0001790,abnormal immune system physiology|MP:0002497,increased IgE level|MP:0008499,increased IgG1 level
MGI:6268787	Sema4c<m1Btlr>	MP:0000373,belly spot
MGI:4840317	Sema4c<tm1Matl>	MP:0000373,belly spot|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000914,exencephaly|MP:0002762,ectopic cerebellar granule cells|MP:0005367,renal/urinary system phenotype|MP:0009964,abnormal cerebellum lobule morphology|MP:0009977,abnormal cerebellar granule cell migration|MP:0011087,neonatal lethality, complete penetrance
MGI:5636915	Sema4d<tm1b(EUCOMM)Wtsi>	MP:0000274,enlarged heart|MP:0000691,enlarged spleen|MP:0001304,cataract|MP:0002968,increased circulating alkaline phosphatase level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:3027762	Sema4d<tm1Kik>	MP:0002490,abnormal immunoglobulin level|MP:0003631,nervous system phenotype|MP:0004940,abnormal B-1 B cell morphology|MP:0005014,increased B cell number|MP:0005018,decreased T cell number|MP:0005093,decreased B cell proliferation|MP:0005367,renal/urinary system phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008168,decreased B-1a cell number|MP:0008484,decreased spleen germinal center size
MGI:7447135	Sema4f<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0000221,decreased leukocyte cell number|MP:0010124,decreased bone mineral content
MGI:4840318	Sema4g<tm1Kik>	MP:0002169,no abnormal phenotype detected|MP:0005367,renal/urinary system phenotype
MGI:5284881	Sema5a<tm1.2Alk>	MP:0010768,mortality/aging
MGI:3577050	Sema5a<tm1Awp>	MP:0001614,abnormal blood vessel morphology|MP:0003227,abnormal vascular branching morphogenesis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3604576	Sema5a<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:5284883	Sema5b<tm1.2Alk>	MP:0008056,abnormal retina ganglion cell morphology|MP:0008143,abnormal dendrite morphology|MP:0008415,abnormal neurite morphology
MGI:4432860	Sema5b<tm1a(EUCOMM)Wtsi>	MP:0005018,decreased T cell number
MGI:2156202	Sema6a<Gt(KST069)Byg>	MP:0000783,abnormal forebrain morphology|MP:0003463,abnormal single cell response|MP:0003631,nervous system phenotype|MP:0003734,abnormal retina inner plexiform layer morphology|MP:0005240,abnormal amacrine cell morphology|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0008056,abnormal retina ganglion cell morphology|MP:0008143,abnormal dendrite morphology|MP:0008415,abnormal neurite morphology|MP:0014746,abnormal hippocampal mossy fiber innervation pattern
MGI:4461232	Sema6b<tm1Hfu>	MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0014744,abnormal hippocampal mossy fiber suprapyramidal bundle morphology|MP:0014745,abnormal hippocampal mossy fiber infrapyramidal bundle morphology|MP:0014746,abnormal hippocampal mossy fiber innervation pattern
MGI:6423845	Sema6c<em1(IMPC)Mbp>	MP:0000494,abnormal cecum morphology|MP:0000601,small liver|MP:0009476,enlarged cecum
MGI:3604574	Sema6c<tm1Dgen>	MP:0003998,decreased thermal nociceptive threshold
MGI:4461964	Sema6c<tm1Matl>	MP:0005387,immune system phenotype
MGI:6358299	Sema6d<tm1.1Jiao>	MP:0000297,abnormal atrioventricular cushion morphology|MP:0008825,abnormal cardiac epithelial to mesenchymal transition
MGI:4461971	Sema6d<tm1Kik>	MP:0005387,immune system phenotype
MGI:2683867	Sema7a<tm1Alk>	MP:0003651,abnormal axon extension|MP:0005237,abnormal olfactory tract morphology
MGI:5548489	Semg1<tm1.1(KOMP)Vlcg>	MP:0001529,abnormal vocalization|MP:0005575,increased pulmonary ventilation
MGI:5607932	Semg1<tm1Kemi>	MP:0001922,reduced male fertility|MP:0002674,abnormal sperm motility|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0013288,premature acrosome reaction|MP:0030983,failure of copulatory plug deposition
MGI:5607933	Semg1<tm2Kemi>	MP:0001922,reduced male fertility|MP:0002674,abnormal sperm motility|MP:0003698,abnormal male reproductive system physiology|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0013288,premature acrosome reaction
MGI:6362814	Senp1<em1(IMPC)H>	MP:0005565,increased blood urea nitrogen level|MP:0011100,preweaning lethality, complete penetrance
MGI:4235933	Senp1<Gt(OST215108)Lex>	MP:0003858,enhanced coordination|MP:0011091,prenatal lethality, complete penetrance
MGI:3818522	Senp1<Gt(XG001)Byg>	MP:0000245,abnormal erythropoiesis|MP:0000601,small liver|MP:0001577,anemia|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0004200,decreased fetal size|MP:0005397,hematopoietic system phenotype|MP:0008973,decreased erythroid progenitor cell number|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3582213	Senp1<m1Mku>	MP:0000313,abnormal cell death|MP:0002080,prenatal lethality|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5882691	Senp1<tm1.1Eyeh>	MP:0002578,impaired ability to fire action potentials|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005293,impaired glucose tolerance|MP:0005378,growth/size/body region phenotype
MGI:4353110	Senp1<tm1.1Wami>	MP:0000245,abnormal erythropoiesis|MP:0000259,abnormal vascular development|MP:0000601,small liver|MP:0000603,pale liver|MP:0000609,abnormal liver physiology|MP:0001577,anemia|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003402,decreased liver weight|MP:0005563,abnormal hemoglobin content|MP:0008111,abnormal granulocyte differentiation|MP:0008112,abnormal monocyte differentiation|MP:0008973,decreased erythroid progenitor cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4353109	Senp1<tm1Wami>	MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0001856,myocarditis|MP:0001869,pancreas inflammation|MP:0002575,increased circulating ketone body level|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0002869,increased anti-insulin autoantibody level|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005179,decreased circulating cholesterol level|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0008553,increased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008713,abnormal cytokine level|MP:0008721,abnormal chemokine level|MP:0008907,decreased total fat pad weight|MP:0009115,abnormal fat cell morphology|MP:0009269,decreased fat cell size|MP:0009488,abnormal pancreatic islet cell apoptosis|MP:0010210,abnormal circulating cytokine level|MP:0011941,increased fluid intake|MP:0014117,increased pancreatic beta cell apoptosis|MP:0031059,increased circulating C-reactive protein level
MGI:3818535	Senp2<Gt(AN0727)Wtsi>	MP:0000267,abnormal heart development|MP:0000297,abnormal atrioventricular cushion morphology|MP:0002652,thin myocardium|MP:0005312,pericardial effusion|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3531129	Senp2<Gt(OST66117)Lex>	MP:0005560,decreased circulating glucose level|MP:0011091,prenatal lethality, complete penetrance
MGI:5706833	Senp2<tm1.1Eyeh>	MP:0003631,nervous system phenotype|MP:0010768,mortality/aging
MGI:5706831	Senp2<tm1Eyeh>	MP:0000947,convulsive seizures|MP:0001496,audiogenic seizures|MP:0002083,premature death|MP:0002272,abnormal nervous system electrophysiology|MP:0004811,abnormal neuron physiology|MP:0004994,abnormal brain wave pattern|MP:0010519,atrioventricular block|MP:0010637,sinus bradycardia|MP:0014620,abnormal interictal brain wave pattern
MGI:3832730	Senp2<tm1Whsu>	MP:0001714,absent trophoblast giant cells|MP:0004259,small placenta|MP:0005031,abnormal trophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012099,decreased spongiotrophoblast size
MGI:4839175	Senp3<tm1(NCOM)Cmhd>	MP:0002965,increased circulating serum albumin level|MP:0004924,abnormal behavior
MGI:3531135	Senp6<Gt(OST66115)Lex>	MP:0011091,prenatal lethality, complete penetrance
MGI:5604100	Senp7<tm1b(EUCOMM)Hmgu>	MP:0001488,increased startle reflex|MP:0002075,abnormal coat/hair pigmentation
MGI:6189533	Sephs1<tm1.1Dhat>	MP:0005584,abnormal enzyme/coenzyme activity|MP:0008743,decreased liver iron level|MP:0030599,decreased liver manganese level
MGI:6189534	Sephs1<tm1.2Dhat>	MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0005029,abnormal amnion morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6158505	Sephs2<em1(IMPC)Mbp>	MP:0001404,no spontaneous movement|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6356808	Sepsecs<em1(IMPC)Tcp>	MP:0000194,increased circulating calcium level|MP:0001200,thick skin|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0002582,disorganized extraembryonic tissue|MP:0003984,embryonic growth retardation|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:7367126	Sepsecs<tm1.1Usch>	MP:0001575,cyanosis|MP:0001943,abnormal respiration|MP:0005574,decreased pulmonary respiratory rate|MP:0009546,absent gastric milk in neonates|MP:0009674,decreased birth weight|MP:0011089,perinatal lethality, complete penetrance
MGI:7366908	Sepsecs<tm1Usch>	MP:0001730,embryonic growth arrest|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:5014599	Septin10<tm1a(KOMP)Wtsi>	MP:0001925,male infertility|MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6257588	Septin11<em1(IMPC)Tcp>	MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:4124477	Septin11<Gt(KST319)Byg>	MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7280674	Septin12<em1Lych>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0009234,absent sperm head|MP:0009237,kinked sperm flagellum|MP:0009647,decreased fertilization frequency|MP:0009830,abnormal sperm connecting piece morphology|MP:0031013,abnormal egg activation|MP:0031354,abnormal acrosome assembly
MGI:3843373	Septin12<tm1.1Plk>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0008280,abnormal male germ cell apoptosis|MP:0008545,absent sperm flagellum|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009237,kinked sperm flagellum|MP:0011750,abnormal seminiferous tubule epithelium morphology
MGI:6363499	Septin12<tm3Plk>	MP:0002675,asthenozoospermia|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009237,kinked sperm flagellum|MP:0009834,abnormal sperm annulus morphology
MGI:7517009	Septin14<em1.1Plk>	MP:0002797,increased thigmotaxis|MP:0003999,enhanced passive avoidance behavior|MP:0009456,impaired cued conditioning behavior|MP:0012206,increased neuronal stem cell self-renewal
MGI:6435662	Septin14<em1(IMPC)Tcp>	MP:0000208,decreased hematocrit|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002591,decreased mean corpuscular volume|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:7435545	Septin2<em1(IMPC)Tcp>	MP:0000220,increased monocyte cell number|MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002792,abnormal retina vasculature morphology|MP:0009142,decreased prepulse inhibition|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:7520266	Septin2<tm1c(EUCOMM)Wtsi>	MP:0002651,abnormal sciatic nerve morphology|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:3623138	Septin3<Gt(2-86)Stmn>	MP:0002169,no abnormal phenotype detected
MGI:5766750	Septin3<tm1b(KOMP)Wtsi>	MP:0000198,decreased circulating phosphate level|MP:0001392,abnormal locomotor behavior|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3715203	Septin3<tm1Keng>	MP:0003631,nervous system phenotype
MGI:3822551	Septin3<tm1Wtr>	MP:0003631,nervous system phenotype
MGI:3574368	Septin4<tm1Hs>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0003666,impaired sperm capacitation|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0009237,kinked sperm flagellum|MP:0009242,thin sperm flagellum|MP:0009243,hairpin sperm flagellum|MP:0009835,absent sperm annulus|MP:0009836,abnormal sperm principal piece morphology|MP:0014465,abnormal sperm mitochondrial morphology|MP:0020869,immotile sperm|MP:0030590,abnormal sperm fibrous sheath morphology
MGI:3574373	Septin4<tm1Ksh>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0004543,abnormal sperm physiology|MP:0009237,kinked sperm flagellum|MP:0009835,absent sperm annulus|MP:0030590,abnormal sperm fibrous sheath morphology
MGI:5571344	Septin5<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000692,small spleen|MP:0001258,decreased body length|MP:0002764,short tibia|MP:0003179,thrombocytopenia|MP:0003795,abnormal bone structure|MP:0005292,improved glucose tolerance|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3640090	Septin5<tm1Bld>	MP:0003631,nervous system phenotype|MP:0005385,cardiovascular system phenotype
MGI:2669970	Septin5<tm1Wtr>	MP:0001364,decreased anxiety-related response|MP:0001463,abnormal spatial learning|MP:0001488,increased startle reflex|MP:0002557,abnormal social/conspecific interaction behavior|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology|MP:0009141,increased prepulse inhibition|MP:0009586,increased platelet aggregation
MGI:5708193	Septin6<tm1.1(KOMP)Vlcg>	MP:0002968,increased circulating alkaline phosphatase level
MGI:3611071	Septin6<tm1Nosa>	MP:0002169,no abnormal phenotype detected
MGI:5660261	Septin7<tm1.1Mgl>	MP:0011092,embryonic lethality, complete penetrance
MGI:5559527	Septin7<tm1Ksh>	MP:0005404,abnormal axon morphology|MP:0008143,abnormal dendrite morphology
MGI:5660259	Septin7<tm1Mgl>	MP:0003077,abnormal cell cycle|MP:0003707,increased cell nucleus count|MP:0003903,increased cell mass|MP:0005384,cellular phenotype|MP:0005387,immune system phenotype|MP:0011704,decreased fibroblast proliferation|MP:0013289,abnormal mitotic cytokinesis
MGI:4433986	Septin8<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0002591,decreased mean corpuscular volume|MP:0003313,abnormal locomotor activation
MGI:5806071	Septin8<tm1c(EUCOMM)Wtsi>	MP:0000921,demyelination|MP:0003631,nervous system phenotype|MP:0008814,decreased nerve conduction velocity|MP:0012674,tomacula
MGI:5806073	Septin8<tm1d(EUCOMM)Wtsi>	MP:0003631,nervous system phenotype|MP:0008814,decreased nerve conduction velocity|MP:0012674,tomacula
MGI:5544188	Septin9<tm1Emfu>	MP:0006042,increased apoptosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5544189	Septin9<tm2.1Emfu>	MP:0002145,abnormal T cell differentiation|MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0004974,decreased regulatory T cell number|MP:0005018,decreased T cell number|MP:0005090,increased double-negative T cell number|MP:0005095,decreased T cell proliferation|MP:0005386,behavior/neurological phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0010133,increased DN3 thymocyte number|MP:0010136,decreased DN4 thymocyte number|MP:0010836,decreased CD4-positive, alpha-beta memory T cell number|MP:0010838,increased CD8-positive, alpha-beta memory T cell number|MP:0010839,decreased CD8-positive, alpha-beta memory T cell number
MGI:5544191	Septin9<tm2.2Emfu>	MP:0006042,increased apoptosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7316653	Serac1<em1Bcgen>	MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000747,muscle weakness|MP:0004087,abnormal muscle fiber morphology|MP:0005179,decreased circulating cholesterol level|MP:0005330,cardiomyopathy|MP:0005389,reproductive system phenotype|MP:0006007,abnormal basal ganglion morphology|MP:0006037,abnormal mitochondrial fission|MP:0006325,impaired hearing|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0010028,aciduria|MP:0010053,decreased grip strength|MP:0010400,increased liver glycogen level|MP:0010954,abnormal cellular respiration|MP:0010959,abnormal oxidative phosphorylation|MP:0011628,increased mitochondrial number|MP:0011631,decreased mitochondrial size|MP:0011639,decreased mitochondrial DNA content|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013806,encephalopathy|MP:0014388,decreased hepatocyte mitochondrial DNA content|MP:0014389,decreased skeletal muscle fiber mitochondrial DNA content|MP:0021002,brain lesion|MP:0021158,decreased heart left ventricle wall thickness
MGI:6156583	Serac1<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001126,abnormal ovary morphology|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002757,decreased vertical activity|MP:0009453,enhanced contextual conditioning behavior|MP:0020420,abnormal freezing behavior|MP:0020421,increased freezing behavior
MGI:4436313	Serf1<tm1a(EUCOMM)Hmgu>	MP:0001556,increased circulating HDL cholesterol level|MP:0002833,increased heart weight|MP:0005018,decreased T cell number|MP:0005178,increased circulating cholesterol level|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:6120704	Serf2<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:3580368	serg1	MP:0005551,abnormal eye electrophysiology
MGI:3580374	serg2	MP:0005551,abnormal eye electrophysiology
MGI:3580380	serg3	MP:0005551,abnormal eye electrophysiology
MGI:3580387	serg4	MP:0005551,abnormal eye electrophysiology
MGI:4323314	Serinc1<Gt(OST454985)Lex>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0003961,decreased lean body mass
MGI:5702669	Serinc1<Tn(sb-lacZ,GFP)1.7Tcb>	MP:0005376,homeostasis/metabolism phenotype
MGI:6283534	Serinc2<em1(IMPC)J>	MP:0001513,limb grasping|MP:0005293,impaired glucose tolerance
MGI:4363849	Serinc3<tm1a(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0004738,abnormal auditory brainstem response|MP:0010093,decreased circulating magnesium level|MP:0010124,decreased bone mineral content
MGI:6456580	Serinc3<tm1b(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:6456568	Serinc5<em1Spst>	MP:0005387,immune system phenotype
MGI:3652355	Serp1<tm1Hori>	MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002727,decreased circulating insulin level|MP:0002768,small adrenal glands|MP:0002951,small thyroid gland|MP:0004016,decreased bone mass|MP:0005120,decreased circulating growth hormone level|MP:0005293,impaired glucose tolerance|MP:0005361,small pituitary gland|MP:0008321,small adenohypophysis|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5790709	Serp2<em1(IMPC)J>	MP:0010053,decreased grip strength
MGI:3795215	Serpina10<tm1Gjb>	MP:0008770,decreased survivor rate|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0031121,increased susceptibility to induced thrombosis
MGI:5568548	Serpina12<tm1Jwada>	MP:0000182,increased circulating LDL cholesterol level|MP:0001260,increased body weight|MP:0002981,increased liver weight|MP:0005178,increased circulating cholesterol level|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0009115,abnormal fat cell morphology|MP:0009288,increased epididymal fat pad weight|MP:0009355,increased liver triglyceride level
MGI:5566806	Serpina1a<tm1Amgh>	MP:0002169,no abnormal phenotype detected|MP:0011092,embryonic lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:3512411	Serpina1b<tm1Jti>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6358561	Serpina1<em1Chmu>	MP:0001958,emphysema
MGI:6358589	Serpina1<em2Chmu>	MP:0001958,emphysema
MGI:6358590	Serpina1<em3Chmu>	MP:0001958,emphysema
MGI:6358591	Serpina1<em#Chmu>	MP:0001183,overexpanded pulmonary alveolus|MP:0001942,abnormal lung volume|MP:0001958,emphysema|MP:0002311,abnormal inspiratory capacity|MP:0002405,respiratory system inflammation|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008735,increased susceptibility to endotoxin shock|MP:0010895,increased lung compliance|MP:0010908,dilated pulmonary alveolar duct|MP:0011045,decreased lung elastance
MGI:5649012	Serpina1f<em1(IMPC)J>	MP:0001303,abnormal lens morphology|MP:0005568,increased circulating total protein level
MGI:7292227	Serpina3c<em1Smoc>	MP:0001552,increased circulating triglyceride level|MP:0004890,decreased energy expenditure|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005670,abnormal white adipose tissue physiology|MP:0008469,abnormal protein level|MP:0008964,decreased carbon dioxide production|MP:0009118,increased white fat cell size|MP:0009288,increased epididymal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0030017,decreased adipocyte glucose uptake|MP:0031600,increased white adipose tissue apoptosis|MP:0031602,white adipose tissue inflammation
MGI:5450829	Serpina3g<tm1.1Arp>	MP:0005025,abnormal response to infection|MP:0005095,decreased T cell proliferation|MP:0010833,abnormal memory T cell morphology|MP:0010839,decreased CD8-positive, alpha-beta memory T cell number
MGI:6363554	Serpina3i<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0004738,abnormal auditory brainstem response|MP:0010052,increased grip strength
MGI:6107619	Serpina3k<em1(IMPC)J>	MP:0003186,abnormal redox activity|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0005554,decreased circulating creatinine level|MP:0005566,decreased blood urea nitrogen level|MP:0006043,decreased apoptosis|MP:0010768,mortality/aging|MP:0031252,abnormal physiological response to hypoxia
MGI:5635504	Serpina3n<tm1.2Lbrl>	MP:0002738,hyperresponsive to tactile stimuli|MP:0003177,allodynia|MP:0005164,abnormal response to injury
MGI:6276941	Serpina5<em1(IMPC)Mbp>	MP:0001925,male infertility|MP:0002135,abnormal kidney morphology|MP:0002590,increased mean corpuscular volume|MP:0003068,enlarged kidney
MGI:2445835	Serpina5<tm1Gei>	MP:0001145,abnormal male reproductive system morphology|MP:0001925,male infertility|MP:0001929,abnormal gametogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002675,asthenozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0004933,abnormal epididymis epithelium morphology|MP:0005410,abnormal fertilization|MP:0005578,teratozoospermia
MGI:4833641	Serpina6<tm1.1Mmp>	MP:0002573,behavioral despair|MP:0005345,abnormal circulating corticosterone level|MP:0005386,behavior/neurological phenotype|MP:0009758,impaired behavioral response to cocaine
MGI:3664470	Serpina6<tm1Tew>	MP:0001402,decreased locomotor activity|MP:0005129,increased adrenocorticotropin level|MP:0005345,abnormal circulating corticosterone level|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0008713,abnormal cytokine level|MP:0008735,increased susceptibility to endotoxin shock|MP:0010210,abnormal circulating cytokine level
MGI:6152724	Serpinb10<em1(IMPC)Mbp>	MP:0000195,decreased circulating calcium level|MP:0000266,abnormal heart morphology|MP:0000277,abnormal heart shape|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001175,abnormal lung morphology|MP:0001325,abnormal retina morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002644,decreased circulating triglyceride level|MP:0004952,increased spleen weight
MGI:5692711	Serpinb12<tm1b(KOMP)Wtsi>	MP:0001410,head bobbing|MP:0002764,short tibia
MGI:3761627	Serpinb1a<tm1.1Cben>	MP:0000222,decreased neutrophil cell number|MP:0001861,lung inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0004782,abnormal surfactant physiology|MP:0005044,sepsis|MP:0006042,increased apoptosis|MP:0008560,increased tumor necrosis factor secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008720,impaired neutrophil chemotaxis|MP:0008722,abnormal chemokine secretion|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010210,abnormal circulating cytokine level
MGI:5706979	Serpinb2<tm1b(EUCOMM)Wtsi>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005553,increased circulating creatinine level|MP:0010124,decreased bone mineral content
MGI:1931532	Serpinb2<tm1Dgi>	MP:0000217,abnormal leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0003179,thrombocytopenia|MP:0005016,decreased lymphocyte cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype
MGI:4837545	Serpinb2<tm2Dgi>	MP:0000217,abnormal leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0003179,thrombocytopenia|MP:0005016,decreased lymphocyte cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype
MGI:5447741	Serpinb3a<tm1Gsil>	MP:0002335,decreased airway responsiveness|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0010862,decreased respiratory mucosa goblet cell number
MGI:6156590	Serpinb3d<em1(IMPC)Tcp>	MP:0002059,abnormal seminal vesicle morphology
MGI:5484764	Serpinb5<tm1.1Pib>	MP:0002169,no abnormal phenotype detected
MGI:5575897	Serpinb5<tm1b(KOMP)Wtsi>	MP:0001523,impaired righting response|MP:0005178,increased circulating cholesterol level|MP:0011396,abnormal sleep behavior
MGI:3040188	Serpinb5<tm1Zha>	MP:0000352,decreased cell proliferation|MP:0001675,abnormal ectoderm development|MP:0001685,abnormal endoderm development|MP:0001696,failure to gastrulate|MP:0002663,absent blastocoele|MP:0002718,abnormal inner cell mass morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011193,embryonic epiblast cell degeneration|MP:0012113,decreased inner cell mass proliferation|MP:0012114,absent inner cell mass proliferation|MP:0014696,decreased cell adhesion
MGI:2673997	Serpinb6a<tm1.1Pib>	MP:0002169,no abnormal phenotype detected
MGI:7354909	Serpinb9b<em#Tvg>	MP:0012564,decreased tumor incidence following infection
MGI:5785013	Serpinb9c<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response
MGI:7425969	Serpinb9<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0001314,cornea opacity|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0003795,abnormal bone structure|MP:0010935,increased airway resistance|MP:0013771,decreased effector memory T-helper cell number
MGI:5140012	Serpinb9<tm1.1Pib>	MP:0000685,abnormal immune system morphology|MP:0001790,abnormal immune system physiology|MP:0002455,abnormal dendritic cell antigen presentation|MP:0005387,immune system phenotype|MP:0012191,decreased cytotoxic T cell apoptosis
MGI:3687210	Serpinb9<tm1Arp>	MP:0002436,abnormal CD8-positive, alpha-beta cytotoxic T cell morphology|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005319,abnormal enzyme/coenzyme level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006042,increased apoptosis|MP:0020913,increased susceptibility to Riboviria infection
MGI:3530285	Serpinc1<Gt(OST17473)Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:3692385	Serpinc1<tm1Dwr>	MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0001325,abnormal retina morphology|MP:0001654,hepatic necrosis|MP:0001855,abnormal atrial thrombosis|MP:0001860,liver inflammation|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0002551,abnormal blood coagulation|MP:0002658,abnormal liver regeneration|MP:0002698,abnormal sclera morphology|MP:0003328,portal hypertension|MP:0003415,priapism|MP:0003727,abnormal retina layer morphology|MP:0005048,abnormal thrombosis|MP:0005098,abnormal optic choroid morphology|MP:0005187,abnormal penis morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0006137,venoocclusion|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0020407,abnormal placental thrombosis|MP:0020409,abnormal cardiac thrombosis|MP:0031115,macrovesicular hepatic steatosis|MP:0031432,cornea perforation
MGI:2178128	Serpinc1<tm1Sai>	MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0003103,liver degeneration|MP:0004566,myocardial fiber degeneration|MP:0005048,abnormal thrombosis|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0031121,increased susceptibility to induced thrombosis
MGI:3713783	Serpind1<tm1Moto>	MP:0004883,abnormal vascular wound healing|MP:0005397,hematopoietic system phenotype|MP:0005489,vascular smooth muscle hyperplasia|MP:0009548,abnormal platelet aggregation|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0031121,increased susceptibility to induced thrombosis
MGI:2179102	Serpind1<tm1Toll>	MP:0031121,increased susceptibility to induced thrombosis
MGI:6257653	Serpine1<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000702,enlarged lymph nodes
MGI:5763484	Serpine1<tm1.1Vlp>	MP:0008734,decreased susceptibility to endotoxin shock|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:1857287	Serpine1<tm1Mlg>	MP:0000322,increased granulocyte number|MP:0001175,abnormal lung morphology|MP:0001182,lung hemorrhage|MP:0001259,abnormal body weight|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001559,hyperglycemia|MP:0001853,heart inflammation|MP:0002006,neoplasm|MP:0002128,abnormal blood circulation|MP:0002135,abnormal kidney morphology|MP:0002405,respiratory system inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0002498,abnormal acute inflammation|MP:0002724,enhanced wound healing|MP:0002743,glomerulonephritis|MP:0002962,increased urine protein level|MP:0003141,cardiac fibrosis|MP:0003333,liver fibrosis|MP:0005088,increased acute inflammation|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005325,abnormal renal glomerulus morphology|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005450,abnormal energy expenditure|MP:0005533,increased body temperature|MP:0005565,increased blood urea nitrogen level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005601,increased angiogenesis|MP:0005602,decreased angiogenesis|MP:0006319,abnormal epididymal fat pad morphology|MP:0008597,decreased circulating interleukin-6 level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008751,abnormal interleukin level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009356,decreased liver triglyceride level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0011506,glomerular crescent|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality|MP:0031414,decreased skeletal muscle triglyceride level
MGI:2387774	Serpine2<tm1Dmn>	MP:0000351,increased cell proliferation|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001107,decreased Schwann cell number|MP:0001473,reduced long-term potentiation|MP:0001909,reduced NMDA receptor mediated synaptic activity in barrel cortex|MP:0001922,reduced male fertility|MP:0002059,abnormal seminal vesicle morphology|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002182,abnormal astrocyte morphology|MP:0002651,abnormal sciatic nerve morphology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003607,abnormal prostate gland physiology|MP:0005389,reproductive system phenotype|MP:0010211,abnormal acute phase protein level|MP:0013320,dilated seminal vesicle|MP:0013899,abnormal seminal vesicle epithelium morphology|MP:0013903,abnormal seminal vesicle fluid composition|MP:0014648,abnormal response to nerve crush injury|MP:0031330,delayed peripheral nervous system regeneration|MP:0031435,abnormal copulatory plug biosynthesis
MGI:7378851	Serpine3<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response
MGI:2664515	Serpinf1<tm1Craw>	MP:0001158,abnormal prostate gland morphology|MP:0001167,prostate gland epithelial hyperplasia|MP:0001944,abnormal pancreas morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002896,abnormal bone mineralization|MP:0003337,exocrine pancreas hyperplasia|MP:0003450,enlarged pancreas|MP:0004991,decreased bone strength|MP:0005103,abnormal retina pigmentation|MP:0005220,abnormal exocrine pancreas morphology|MP:0005601,increased angiogenesis|MP:0006309,decreased retina ganglion cell number|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0010929,increased osteoid thickness
MGI:5573270	Serpinf1<tm1e.1(KOMP)Wtsi>	MP:0000689,abnormal spleen morphology|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:3821612	Serpinf1<tm1Sjwi>	MP:0000260,abnormal angiogenesis|MP:0002792,abnormal retina vasculature morphology|MP:0005391,vision/eye phenotype
MGI:2181226	Serpinf2<tm1Hrl>	MP:0002551,abnormal blood coagulation|MP:0003422,abnormal thrombolysis|MP:0006058,decreased cerebral infarct size
MGI:6430663	Serping1<em1(IMPC)Mbp>	MP:0000774,decreased brain size|MP:0001304,cataract|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002699,abnormal vitreous body morphology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0002989,small kidney
MGI:3046287	Serping1<Gt1Aed>	MP:0003070,increased vascular permeability
MGI:2385994	Serpinh1<tm1Kzn>	MP:0001688,abnormal somite development|MP:0002085,abnormal embryonic tissue morphology|MP:0002621,delayed neural tube closure|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5505265	Serpinh1<tm2Kzn>	MP:0000060,delayed bone ossification|MP:0000111,cleft palate|MP:0000160,kyphosis|MP:0000166,abnormal chondrocyte morphology|MP:0000445,short snout|MP:0001914,hemorrhage|MP:0001954,respiratory distress|MP:0002109,abnormal limb morphology|MP:0002113,abnormal skeleton development|MP:0002132,abnormal respiratory system morphology|MP:0002657,chondrodystrophy|MP:0002764,short tibia|MP:0002765,short fibula|MP:0002823,abnormal rib development|MP:0003109,short femur|MP:0003419,delayed endochondral bone ossification|MP:0003723,abnormal long bone morphology|MP:0004174,abnormal spine curvature|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004599,abnormal vertebral arch morphology|MP:0004624,abnormal thoracic cage morphology|MP:0004711,persistence of notochord tissue|MP:0005245,hemarthrosis|MP:0005296,abnormal humerus morphology|MP:0005306,abnormal phalanx morphology|MP:0005390,skeleton phenotype|MP:0008271,abnormal bone ossification|MP:0009674,decreased birth weight|MP:0010988,abnormal bronchial cartilage morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0013945,abnormal elbow joint morphology
MGI:2668495	Serpini1<tm1Dpw>	MP:0001362,abnormal anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003107,abnormal response to novelty
MGI:3521922	Serpini2<pq>	MP:0000333,decreased bone marrow cell number|MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0002403,abnormal pre-B cell morphology|MP:0003335,exocrine pancreatic insufficiency|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005432,abnormal pro-B cell morphology|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008215,decreased immature B cell number|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009160,abnormal pancreatic acinar cell zymogen granule morphology
MGI:4437094	Sertad1<tm1Srn>	MP:0002006,neoplasm|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0005384,cellular phenotype|MP:0009114,decreased pancreatic beta cell mass|MP:0009168,decreased pancreatic islet number|MP:0010768,mortality/aging
MGI:3530582	Sertad2<Gt(OST98734)Lex>	MP:0001262,decreased body weight|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002451,abnormal macrophage physiology|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0003953,abnormal hormone level|MP:0003960,increased lean body mass|MP:0004892,increased adiponectin level|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005418,abnormal circulating hormone level|MP:0005459,decreased percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008034,enhanced lipolysis|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009127,increased brown fat cell number|MP:0009133,decreased white fat cell size|MP:0009136,decreased brown fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0011016,increased core body temperature|MP:0011704,decreased fibroblast proliferation|MP:0014169,decreased brown adipose tissue mass|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:6502863	Sertad3<em1Bcgen>	MP:0005378,growth/size/body region phenotype|MP:0010768,mortality/aging|MP:0031046,increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:6156557	Sertad3<em1(IMPC)Tcp>	MP:0001258,decreased body length|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment
MGI:8261512	Sertm2<em1Jnch>	MP:0000940,abnormal motor neuron innervation pattern|MP:0001405,impaired coordination
MGI:2668905	Ses1a<C57BL/6J>	MP:0002411,decreased susceptibility to bacterial infection
MGI:3588695	Ses1b<C57BL/6J>	MP:0002411,decreased susceptibility to bacterial infection
MGI:2668907	Ses2<C57BL/6J>	MP:0002411,decreased susceptibility to bacterial infection
MGI:2668908	Ses3<C57BL/6J>	MP:0002411,decreased susceptibility to bacterial infection
MGI:5306501	Sesn1<tm1a(EUCOMM)Wtsi>	MP:0000691,enlarged spleen|MP:0002461,increased immunoglobulin level|MP:0004816,abnormal class switch recombination|MP:0005017,decreased B cell number|MP:0005348,increased T cell proliferation|MP:0008039,increased NK T cell number|MP:0008082,increased single-positive T cell number|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion|MP:0009338,increased splenocyte number|MP:0013663,increased myeloid cell number|MP:0013762,abnormal effector T cell number
MGI:5635289	Sesn1<tm1b(EUCOMM)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0002590,increased mean corpuscular volume|MP:0005561,increased mean corpuscular hemoglobin|MP:0005655,increased aggression|MP:0008259,abnormal optic disk morphology
MGI:3587950	Sesn2<Gt(RRJ141)Byg>	MP:0003383,abnormal gluconeogenesis|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005378,growth/size/body region phenotype|MP:0008260,abnormal autophagy|MP:0009355,increased liver triglyceride level|MP:0011629,decreased mitochondrial number|MP:0014388,decreased hepatocyte mitochondrial DNA content|MP:0030017,decreased adipocyte glucose uptake|MP:0031115,macrovesicular hepatic steatosis
MGI:4333988	Sesn2<Gt(W077E06)Wrst>	MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0011807,decreased lung fibroblast proliferation|MP:0013501,increased fibroblast apoptosis
MGI:4432370	Sesn3<tm1a(EUCOMM)Wtsi>	MP:0003019,increased circulating chloride level|MP:0005633,increased circulating sodium level
MGI:5520962	Sestd1<tm1.1Bnrc>	MP:0000495,abnormal colon morphology|MP:0000519,hydronephrosis|MP:0000592,short tail|MP:0001672,abnormal embryo development|MP:0002151,abnormal neural tube morphology|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0008999,absent anus|MP:0009252,absent urinary bladder|MP:0011087,neonatal lethality, complete penetrance|MP:0011771,abnormal genital tubercle morphology
MGI:5548727	Setbp1<tm1b(EUCOMM)Wtsi>	MP:0001529,abnormal vocalization|MP:0005179,decreased circulating cholesterol level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7378548	Setd1a<em1Yzhg>	MP:0002635,reduced sensorimotor gating|MP:0009142,decreased prepulse inhibition|MP:0009710,anhedonia|MP:0020379,abnormal sucrose solution preference|MP:0020421,increased freezing behavior|MP:0020508,decreased dendritic spine density|MP:0021090,abnormal dendrite arborization pattern|MP:0030950,abnormal synaptic vesicle exocytosis
MGI:5568939	Setd1a<tm1.1Afst>	MP:0005389,reproductive system phenotype
MGI:5568941	Setd1a<tm1.2Afst>	MP:0001696,failure to gastrulate|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4432882	Setd1a<tm1a(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000221,decreased leukocyte cell number|MP:0002942,decreased circulating alanine transaminase level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003345,decreased rib number|MP:0005179,decreased circulating cholesterol level|MP:0010025,decreased total body fat amount
MGI:5568936	Setd1a<tm1Afst>	MP:0001696,failure to gastrulate|MP:0005384,cellular phenotype|MP:0005621,abnormal cell physiology|MP:0008877,abnormal DNA methylation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5568943	Setd1b<tm1.1Afst>	MP:0003984,embryonic growth retardation|MP:0005384,cellular phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5568945	Setd1b<tm1.3Afst>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5766174	Setd2<tm1b(NCOM)Mfgc>	MP:0001417,decreased exploration in new environment|MP:0002764,short tibia|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0010392,prolonged QRS complex duration
MGI:5925367	Setd2<tm1c(NCOM)Mfgc>	MP:0002006,neoplasm|MP:0005397,hematopoietic system phenotype|MP:0008346,increased gamma-delta T cell number
MGI:4437211	Setd2<tm1Zhch>	MP:0000255,blood vessel congestion|MP:0000784,forebrain hypoplasia|MP:0000929,open neural tube|MP:0001614,abnormal blood vessel morphology|MP:0001701,incomplete embryo turning|MP:0001716,abnormal placenta labyrinth morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001785,edema|MP:0003229,abnormal vitelline vasculature morphology|MP:0003873,pharyngeal arch hypoplasia|MP:0003984,embryonic growth retardation|MP:0005312,pericardial effusion|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012176,abnormal head development|MP:0020516,abnormal visceral yolk sac mesenchyme morphology
MGI:5766145	Setd3<tm1.1(NCOM)Mfgc>	MP:0000062,increased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0001147,small testis|MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0001935,decreased litter size|MP:0001944,abnormal pancreas morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002764,short tibia|MP:0003900,shortened QT interval|MP:0004514,dystocia|MP:0004609,vertebral fusion|MP:0005013,increased lymphocyte cell number|MP:0005369,muscle phenotype|MP:0008877,abnormal DNA methylation|MP:0009142,decreased prepulse inhibition|MP:0009709,hydrometra|MP:0010123,increased bone mineral content|MP:0011805,decreased cell migration|MP:0020422,decreased freezing behavior|MP:0020914,decreased susceptibility to Riboviria infection
MGI:4364212	Setd4<tm1a(KOMP)Wtsi>	MP:0005343,increased circulating aspartate transaminase level|MP:0013278,decreased fasting circulating glucose level
MGI:6715241	Setd4<tm1b(KOMP)Wtsi>	MP:0011079,decreased macrophage cytokine production
MGI:6505434	Setd4<tm1c(KOMP)Wtsi>	MP:0001272,increased metastatic potential|MP:0003010,decreased mortality induced by ionizing radiation|MP:0003447,decreased tumor growth/size|MP:0006043,decreased apoptosis|MP:0009828,increased tumor latency|MP:0010639,abnormal tumor pathology
MGI:5509467	Setd5<tm1.1Mgn>	MP:0000259,abnormal vascular development|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0001723,disorganized yolk sac vascular plexus|MP:0001914,hemorrhage|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002861,abnormal tail bud morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0005312,pericardial effusion|MP:0005329,abnormal myocardium layer morphology|MP:0005397,hematopoietic system phenotype|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis|MP:0013925,abnormal vascular plexus formation
MGI:4432631	Setd5<tm1a(EUCOMM)Wtsi>	MP:0000220,increased monocyte cell number|MP:0000284,double outlet right ventricle|MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0000455,abnormal maxilla morphology|MP:0000602,dilated liver sinusoidal space|MP:0000632,abnormal pineal gland morphology|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0000783,abnormal forebrain morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000841,abnormal hindbrain morphology|MP:0001015,small superior cervical ganglion|MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002100,abnormal tooth morphology|MP:0002633,persistent truncus arteriosus|MP:0002836,abnormal chorion morphology|MP:0002951,small thyroid gland|MP:0002989,small kidney|MP:0003686,abnormal eye muscle morphology|MP:0004158,right aortic arch|MP:0004201,fetal growth retardation|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0004609,vertebral fusion|MP:0004613,fusion of vertebral arches|MP:0004738,abnormal auditory brainstem response|MP:0004973,increased regulatory T cell number|MP:0005031,abnormal trophoblast layer morphology|MP:0005358,abnormal incisor morphology|MP:0005560,decreased circulating glucose level|MP:0006064,abnormal superior vena cava morphology|MP:0006358,absent pinna reflex|MP:0008922,abnormal cervical rib|MP:0010053,decreased grip strength|MP:0010200,enlarged lymphatic vessel|MP:0010403,atrial septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010433,double inlet heart left ventricle|MP:0010436,abnormal coronary sinus morphology|MP:0010484,bicuspid aortic valve|MP:0010572,persistent right dorsal aorta|MP:0010595,abnormal aortic valve cusp morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011683,dual inferior vena cava|MP:0013809,absent pectinate muscle|MP:0013810,absent brachiocephalic trunk|MP:0013812,enlarged orbital veins|MP:0013813,dilated hepatic portal vein|MP:0013814,abnormal hepatic portal vein connection|MP:0013836,abnormal hypoglossal nerve topology|MP:0013840,absent segment of posterior cerebral artery|MP:0013842,ductus venosus stenosis|MP:0013848,subcutaneous edema|MP:0013859,abnormal vitelline vein connection|MP:0013864,enlarged paraumbilical vein|MP:0013874,abnormal ductus venosus topology|MP:0013876,absent ductus venosus valve|MP:0013878,abnormal ductus venosus valve topology|MP:0013948,intraembryonal intestine elongation|MP:0013969,reduced sympathetic cervical ganglion size|MP:0013971,blood in lymph vessels|MP:0013977,symmetric azygos veins|MP:0013986,abnormal vitelline vein topology|MP:0014000,anastomosis between internal carotid artery and basilar artery|MP:0014001,abnormal vertebral artery topology
MGI:7438258	Setd5<tm1c(EUCOMM)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000273,overriding aortic valve|MP:0000277,abnormal heart shape|MP:0000284,double outlet right ventricle|MP:0001698,decreased embryo size|MP:0001914,hemorrhage|MP:0003105,abnormal heart atrium morphology|MP:0003140,dilated heart atrium|MP:0004032,abnormal interventricular groove morphology|MP:0004937,dilated heart|MP:0005312,pericardial effusion|MP:0005385,cardiovascular system phenotype|MP:0006126,abnormal cardiac outflow tract development|MP:0008022,dilated heart ventricle|MP:0010406,common atrium|MP:0010418,perimembraneous ventricular septal defect|MP:0010422,heart right ventricle hypoplasia|MP:0010432,common ventricle|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5446143	Setd6<tm1.1(KOMP)Mbp>	MP:0001399,hyperactivity|MP:0001926,female infertility|MP:0002591,decreased mean corpuscular volume|MP:0002941,increased circulating alanine transaminase level|MP:0003131,increased erythrocyte cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005627,increased circulating potassium level|MP:0012121,sclerocornea
MGI:5828599	Setd7<tm1.1Ital>	MP:0001175,abnormal lung morphology|MP:0002333,abnormal lung compliance|MP:0005166,decreased susceptibility to injury|MP:0008469,abnormal protein level|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0013258,abnormal extracellular matrix morphology
MGI:3796607	Setd7<tm1Frga>	MP:0004045,abnormal cell cycle checkpoint function|MP:0008737,abnormal spleen physiology|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008944,decreased sensitivity to induced cell death|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5440719	Setdb1<tm1.1Yshk>	MP:0000116,abnormal tooth development|MP:0000788,abnormal cerebral cortex morphology|MP:0000934,abnormal telencephalon development|MP:0002182,abnormal astrocyte morphology|MP:0003203,increased neuron apoptosis|MP:0003241,loss of cortex neurons|MP:0003861,abnormal nervous system development|MP:0004948,abnormal neuronal precursor proliferation|MP:0004981,decreased neuronal precursor cell number|MP:0008439,abnormal cortical plate morphology|MP:0008947,increased neuron number|MP:0008948,decreased neuron number|MP:0009655,abnormal secondary palate development|MP:0009890,cleft secondary palate|MP:0009904,tongue hypoplasia|MP:0009937,abnormal neuron differentiation|MP:0011085,postnatal lethality, complete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0021166,delayed palatal shelf elevation|MP:0021215,abnormal palatal mesenchymal cell proliferation
MGI:4432424	Setdb1<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:3040431	Setdb1<tm1Enl>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012113,decreased inner cell mass proliferation
MGI:4462266	Setdb1<tm2.1Enl>	MP:0002169,no abnormal phenotype detected
MGI:4462267	Setdb1<tm2.2Enl>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:4364322	Setdb2<tm1a(KOMP)Wtsi>	MP:0001406,abnormal gait|MP:0003179,thrombocytopenia|MP:0010052,increased grip strength
MGI:5751798	Setdb2<tm1Desr>	MP:0000219,increased neutrophil cell number|MP:0002412,increased susceptibility to bacterial infection|MP:0005025,abnormal response to infection
MGI:4432061	Setmar<tm1a(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0003442,decreased circulating glycerol level|MP:0009141,increased prepulse inhibition
MGI:6357923	Set<tm1.1Wgu>	MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012270,cardiac edema
MGI:6881752	Setx<tm1.1Als>	MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0004811,abnormal neuron physiology|MP:0008235,increased susceptibility to neuronal excitotoxicity
MGI:5697060	Setx<tm1.1Mfl>	MP:0001147,small testis|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002686,globozoospermia|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014052,increased male germ cell apoptosis|MP:0014764,impaired double-strand DNA break repair
MGI:5584409	Setx<tm1b(EUCOMM)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0001147,small testis|MP:0001925,male infertility|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005292,improved glucose tolerance|MP:0008044,increased NK cell number|MP:0011965,decreased total retina thickness
MGI:3624558	sevr	MP:0000745,tremors|MP:0001265,decreased body size|MP:0002083,premature death|MP:0003644,thymus atrophy|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5285738	Sez6l2<tm1a(EUCOMM)Hmgu>	MP:0003631,nervous system phenotype
MGI:3665419	Sez6l2<tm1Hta>	MP:0002169,no abnormal phenotype detected
MGI:5637106	Sez6l<tm1b(EUCOMM)Hmgu>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0002797,increased thigmotaxis|MP:0002968,increased circulating alkaline phosphatase level|MP:0004924,abnormal behavior|MP:0005419,decreased circulating serum albumin level|MP:0010379,decreased respiratory quotient
MGI:3665420	Sez6l<tm1Hta>	MP:0001405,impaired coordination
MGI:3777582	Sez6<tm1.1Sest>	MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001522,impaired swimming|MP:0002206,abnormal CNS synaptic transmission|MP:0002757,decreased vertical activity|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002912,abnormal excitatory postsynaptic potential|MP:0008143,abnormal dendrite morphology|MP:0008415,abnormal neurite morphology
MGI:3665421	Sez6<tm1Hta>	MP:0002169,no abnormal phenotype detected
MGI:3818622	Sf1<Gt(pU17)1Teya>	MP:0003448,abnormal tumor morphology|MP:0004499,increased incidence of tumors by chemical induction|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:4124998	Sf1<Gt(XD130)Byg>	MP:0006262,increased testis tumor incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5287499	Sf3a1<TgTn(sb-rtTA,Tyr)2495AOve>	MP:0006204,embryonic lethality before implantation
MGI:5818977	Sf3b1<tm1.1Mdf>	MP:0000245,abnormal erythropoiesis|MP:0000248,macrocytosis|MP:0001601,abnormal myelopoiesis|MP:0001606,impaired hematopoiesis|MP:0002083,premature death|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0004809,increased hematopoietic stem cell number|MP:0008389,hypochromic macrocytic anemia|MP:0008801,abnormal erythroid progenitor cell morphology|MP:0011285,increased circulating erythropoietin level|MP:0013697,decreased granulocyte monocyte progenitor cell number
MGI:3574428	Sf3b1<tm1Hko>	MP:0000240,extramedullary hematopoiesis|MP:0001921,reduced fertility|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002590,increased mean corpuscular volume|MP:0002811,macrocytic anemia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0005505,thrombocytosis|MP:0008476,increased spleen red pulp amount|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0031392,hypoactivity
MGI:8166512	Sf3b2<em1Sqiu>	MP:0001473,reduced long-term potentiation|MP:0002912,abnormal excitatory postsynaptic potential|MP:0008432,abnormal long-term spatial reference memory|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012307,impaired spatial learning|MP:0021088,impaired spatial memory extinction
MGI:6159653	Sf3b3<em1(IMPC)J>	MP:0001312,abnormal cornea morphology|MP:0001399,hyperactivity|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0020870,decreased thigmotaxis
MGI:6393980	Sf3b4<em1Mce>	MP:0000074,abnormal neurocranium morphology|MP:0000109,abnormal parietal bone morphology|MP:0000480,increased rib number|MP:0001265,decreased body size|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004647,decreased lumbar vertebrae number|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012138,decreased forebrain size|MP:0012174,flat head|MP:0020394,decreased neuronal precursor proliferation
MGI:2679580	Sfl	MP:0020474,advanced circadian behavior phase
MGI:6414478	Sfmbt1<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6152634	Sfmbt2<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000598,abnormal liver morphology|MP:0000702,enlarged lymph nodes|MP:0001297,microphthalmia|MP:0001700,abnormal embryo turning|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0002339,abnormal lymph node morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003068,enlarged kidney|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation|MP:0020421,increased freezing behavior
MGI:1861121	Sfn<Er>	MP:0000018,small ears|MP:0000160,kyphosis|MP:0000379,decreased hair follicle number|MP:0000384,distorted hair follicle pattern|MP:0000416,sparse hair|MP:0000432,abnormal head morphology|MP:0000433,microcephaly|MP:0000445,short snout|MP:0000447,flattened snout|MP:0000454,abnormal jaw morphology|MP:0000458,abnormal mandible morphology|MP:0000547,short limbs|MP:0000552,abnormal radius morphology|MP:0000564,syndactyly|MP:0000585,kinked tail|MP:0000592,short tail|MP:0000598,abnormal liver morphology|MP:0000762,abnormal tongue morphology|MP:0001196,shiny skin|MP:0001199,thin skin|MP:0001216,abnormal epidermal layer morphology|MP:0001218,thin epidermis|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001241,absent epidermis stratum corneum|MP:0001297,microphthalmia|MP:0001340,abnormal eyelid morphology|MP:0001539,decreased caudal vertebrae number|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0001732,postnatal growth retardation|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002051,increased skin papilloma incidence|MP:0002111,abnormal tail morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002234,abnormal pharynx morphology|MP:0002237,abnormal nasal cavity morphology|MP:0002251,abnormal nasopharynx morphology|MP:0002543,brachyphalangia|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0003130,anal atresia|MP:0003315,abnormal perineum morphology|MP:0003671,abnormal eyelid aperture|MP:0003775,thin lip|MP:0003935,abnormal craniofacial development|MP:0004174,abnormal spine curvature|MP:0004207,increased squamous cell carcinoma incidence|MP:0004575,small limb buds|MP:0004576,abnormal embryonic autopod plate morphology|MP:0005114,premature hair loss|MP:0005155,herniated intestine|MP:0005306,abnormal phalanx morphology|MP:0005382,craniofacial phenotype|MP:0005650,abnormal limb bud morphology|MP:0006033,abnormal external auditory canal morphology|MP:0006279,abnormal limb development|MP:0009263,abnormal eyelid fusion|MP:0009553,fused lips|MP:0009560,absent epidermis stratum granulosum|MP:0009576,oral atresia|MP:0009884,palatal shelf fusion with tongue or mandible|MP:0009890,cleft secondary palate|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0012175,flat face|MP:0013789,small external nares|MP:0013818,abnormal oral cavity morphology|MP:0021208,median cleft palate|MP:0030179,abnormal oral epithelium morphology
MGI:4888527	Sfn<tm1Mak>	MP:0000689,abnormal spleen morphology|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0005017,decreased B cell number|MP:0005154,increased B cell proliferation|MP:0005387,immune system phenotype|MP:0008168,decreased B-1a cell number|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008234,absent spleen marginal zone|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008782,increased B cell apoptosis|MP:0020913,increased susceptibility to Riboviria infection|MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality
MGI:4452136	Sfn<tm1Mul>	MP:0000351,increased cell proliferation|MP:0003566,abnormal cell adhesion|MP:0009503,abnormal mammary gland duct morphology|MP:0009504,abnormal mammary gland epithelium morphology
MGI:3844331	Sfp1<M. m. castaneus>	MP:0020470,shortened circadian behavior period
MGI:3844332	Sfp2<M. m. castaneus>	MP:0020470,shortened circadian behavior period
MGI:3844333	Sfp3<M. m. castaneus>	MP:0020470,shortened circadian behavior period
MGI:3844334	Sfp4<M. m. castaneus>	MP:0020470,shortened circadian behavior period
MGI:3858266	Sfpq<Gt(BC0256)Wtsi>	MP:0011400,lethality, complete penetrance|MP:0020476,abnormal circardian behavior entrainment
MGI:6360736	Sfpq<tm1.1Takea>	MP:0000788,abnormal cerebral cortex morphology|MP:0000832,abnormal thalamus morphology|MP:0001297,microphthalmia|MP:0002082,postnatal lethality|MP:0002152,abnormal brain morphology|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0006254,thin cerebral cortex|MP:0008536,enlarged third ventricle|MP:0020527,small thalamus
MGI:6360737	Sfpq<tm1.2Takea>	MP:0013292,embryonic lethality prior to organogenesis
MGI:4847863	Sfpq<tm1a(EUCOMM)Wtsi>	MP:0000443,abnormal snout morphology|MP:0008805,decreased circulating amylase level
MGI:6152635	Sfr1<em1(IMPC)Mbp>	MP:0000443,abnormal snout morphology|MP:0001691,abnormal somite shape|MP:0001697,abnormal embryo size|MP:0002151,abnormal neural tube morphology|MP:0003984,embryonic growth retardation|MP:0005343,increased circulating aspartate transaminase level|MP:0011100,preweaning lethality, complete penetrance
MGI:3045799	Sfrp1<tm1Bsk>	MP:0000130,abnormal trabecular bone morphology|MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0001566,increased circulating phosphate level|MP:0002175,decreased brain weight|MP:0002833,increased heart weight|MP:0005016,decreased lymphocyte cell number|MP:0010025,decreased total body fat amount
MGI:3796251	Sfrp1<tm1Jrbn>	MP:0001158,abnormal prostate gland morphology|MP:0009736,abnormal prostate gland branching morphogenesis
MGI:3056485	Sfrp2<C50F>	MP:0005389,reproductive system phenotype
MGI:5431901	Sfrp2<tm1.1Brle>	MP:0000564,syndactyly|MP:0002544,brachydactyly|MP:0002772,brachypodia|MP:0003419,delayed endochondral bone ossification|MP:0004214,abnormal long bone diaphysis morphology|MP:0004355,short radius|MP:0004359,short ulna|MP:0004634,short metacarpal bones|MP:0004635,short metatarsal bones|MP:0004686,decreased length of long bones|MP:0005389,reproductive system phenotype|MP:0009780,abnormal chondrocyte physiology
MGI:3621117	Sfrp2<tm1Aksh>	MP:0000564,syndactyly
MGI:3810257	Sfrp2<tm1Ktas>	MP:0000564,syndactyly|MP:0000585,kinked tail|MP:0002759,abnormal caudal vertebrae morphology|MP:0004083,polysyndactyly|MP:0005371,limbs/digits/tail phenotype|MP:0006280,abnormal digit development|MP:0006394,abnormal vertebral epiphyseal plate morphology|MP:0009874,abnormal interdigital cell death
MGI:3803335	Sfrp2<tm1Nat>	MP:0002169,no abnormal phenotype detected
MGI:3664776	Sfrp2<tm1Sato>	MP:0004484,abnormal response of heart to induced stress|MP:0005599,increased cardiac muscle contractility|MP:0009937,abnormal neuron differentiation
MGI:5052054	Sfrp4<tm1.1Blan>	MP:0000133,abnormal long bone metaphysis morphology|MP:0000135,decreased compact bone thickness|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002896,abnormal bone mineralization|MP:0002998,abnormal bone remodeling|MP:0004984,increased osteoclast cell number|MP:0004991,decreased bone strength|MP:0004992,increased bone resorption|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0008151,increased diameter of long bones|MP:0008271,abnormal bone ossification|MP:0010878,increased trabecular bone volume|MP:0013624,decreased femur compact bone thickness|MP:0020039,increased bone ossification
MGI:6509974	Sfrp4<tm1.1Boer>	MP:0001130,abnormal ovarian folliculogenesis|MP:0001934,increased litter size|MP:0005389,reproductive system phenotype|MP:0008870,increased mature ovarian follicle number
MGI:5790103	Sfrp4<tm1.1Lex>	MP:0000133,abnormal long bone metaphysis morphology|MP:0000135,decreased compact bone thickness|MP:0002896,abnormal bone mineralization|MP:0002998,abnormal bone remodeling|MP:0004984,increased osteoclast cell number|MP:0004991,decreased bone strength|MP:0004992,increased bone resorption|MP:0008151,increased diameter of long bones|MP:0008271,abnormal bone ossification|MP:0010878,increased trabecular bone volume|MP:0013624,decreased femur compact bone thickness|MP:0020039,increased bone ossification
MGI:6115786	Sfrp4<tm1Maki>	MP:0000135,decreased compact bone thickness|MP:0010868,increased bone trabecula number|MP:0010872,increased trabecular bone mass|MP:0010932,increased trabecular bone connectivity density|MP:0010962,decreased compact bone mass|MP:0012072,decreased susceptibility to osteoporosis|MP:0013631,decreased bone trabecular spacing
MGI:3056483	Sfrp5<Q27stop>	MP:0005389,reproductive system phenotype
MGI:3696766	Sfrp5<tm1Shwl>	MP:0002169,no abnormal phenotype detected
MGI:6258594	Sfswap<em1(IMPC)J>	MP:0002941,increased circulating alanine transaminase level|MP:0005333,decreased heart rate|MP:0010053,decreased grip strength|MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5287267	Sfswap<Tg(Tyr)2267BOve>	MP:0000026,abnormal inner ear morphology|MP:0003491,abnormal voluntary movement
MGI:2677859	Sftpa1<tm1Haw>	MP:0001845,abnormal inflammatory response|MP:0002133,abnormal respiratory system physiology|MP:0004782,abnormal surfactant physiology|MP:0008713,abnormal cytokine level|MP:0008750,abnormal interferon level|MP:0008751,abnormal interleukin level|MP:0010895,increased lung compliance|MP:0010901,abnormal pulmonary alveolar parenchyma morphology|MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:2183737	Sftpa1<tm1Kor>	MP:0001861,lung inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0004777,abnormal phospholipid level|MP:0004782,abnormal surfactant physiology|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0011085,postnatal lethality, complete penetrance
MGI:2677852	Sftpb<tm1Jaw>	MP:0001177,atelectasis|MP:0001385,pup cannibalization|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002118,abnormal lipid homeostasis|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0004780,abnormal surfactant secretion|MP:0004781,abnormal surfactant composition|MP:0004782,abnormal surfactant physiology|MP:0010814,absent alveolar lamellar bodies|MP:0010896,decreased lung compliance|MP:0010938,decreased total lung capacity|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014600,increased susceptibility to hyperoxia-induced injury
MGI:2387813	Sftpc<tm1Swg>	MP:0001175,abnormal lung morphology|MP:0001183,overexpanded pulmonary alveolus|MP:0001263,weight loss|MP:0001443,poor grooming|MP:0001852,conjunctivitis|MP:0001958,emphysema|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0002276,abnormal lung interstitium morphology|MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0004007,abnormal lung vasculature morphology|MP:0004782,abnormal surfactant physiology|MP:0005388,respiratory system phenotype|MP:0008995,early reproductive senescence|MP:0010810,increased type II pneumocyte number|MP:0010891,increased alveolar lamellar body number|MP:0010900,abnormal pulmonary interalveolar septum morphology|MP:0010935,increased airway resistance|MP:0010943,abnormal bronchus epithelium morphology|MP:0010950,abnormal lung hysteresivity
MGI:1931531	Sftpd<tm1Haw>	MP:0001175,abnormal lung morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001183,overexpanded pulmonary alveolus|MP:0001958,emphysema|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002451,abnormal macrophage physiology|MP:0004780,abnormal surfactant secretion|MP:0004782,abnormal surfactant physiology|MP:0005278,abnormal cholesterol homeostasis|MP:0008245,abnormal alveolar macrophage morphology|MP:0010768,mortality/aging|MP:0010810,increased type II pneumocyte number|MP:0010815,enlarged alveolar lamellar bodies|MP:0010898,abnormal pulmonary alveolus epithelium morphology
MGI:1931530	Sftpd<tm1Jhf>	MP:0000219,increased neutrophil cell number|MP:0001175,abnormal lung morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001183,overexpanded pulmonary alveolus|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001861,lung inflammation|MP:0001942,abnormal lung volume|MP:0001958,emphysema|MP:0002118,abnormal lipid homeostasis|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002446,abnormal macrophage morphology|MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology|MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0004780,abnormal surfactant secretion|MP:0004781,abnormal surfactant composition|MP:0005425,increased macrophage cell number|MP:0006050,pulmonary fibrosis|MP:0008245,abnormal alveolar macrophage morphology|MP:0008713,abnormal cytokine level|MP:0008721,abnormal chemokine level|MP:0010768,mortality/aging|MP:0020946,increased susceptibility to Orthomyxoviridae infection
MGI:5660778	Sfxn1<tm1b(EUCOMM)Wtsi>	MP:0005505,thrombocytosis|MP:0010053,decreased grip strength|MP:0013279,increased fasting circulating glucose level
MGI:5548735	Sfxn3<tm1b(KOMP)Wtsi>	MP:0002079,increased circulating insulin level|MP:0005384,cellular phenotype
MGI:5632531	Sfxn4<tm1b(KOMP)Wtsi>	MP:0000221,decreased leukocyte cell number
MGI:5642356	Sfxn5<tm1b(EUCOMM)Hmgu>	MP:0010052,increased grip strength|MP:0013278,decreased fasting circulating glucose level
MGI:2656910	Sgca<tm1Eeng>	MP:0002841,impaired skeletal muscle contractility
MGI:3784951	Sgca<tm1Isrd>	MP:0005369,muscle phenotype
MGI:1934922	Sgca<tm1Kcam>	MP:0000752,dystrophic muscle|MP:0001853,heart inflammation|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003141,cardiac fibrosis|MP:0003199,calcified muscle|MP:0004087,abnormal muscle fiber morphology|MP:0004121,abnormal sarcolemma morphology|MP:0005330,cardiomyopathy|MP:0005369,muscle phenotype|MP:0005620,abnormal muscle contractility|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009423,increased extensor digitorum longus weight|MP:0009425,increased soleus weight|MP:0010090,increased circulating creatine kinase level|MP:0010106,abnormal circulating pyruvate kinase level|MP:0010632,cardiac muscle necrosis
MGI:3772335	Sgca<tm2.1Kcam>	MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype
MGI:3772334	Sgca<tm2Kcam>	MP:0000752,dystrophic muscle|MP:0000759,abnormal skeletal muscle morphology|MP:0002106,abnormal muscle physiology|MP:0003199,calcified muscle|MP:0003397,increased muscle weight|MP:0004087,abnormal muscle fiber morphology|MP:0004121,abnormal sarcolemma morphology|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005574,decreased pulmonary respiratory rate|MP:0005620,abnormal muscle contractility|MP:0009419,skeletal muscle fibrosis|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level
MGI:6119737	Sgcb<em1Isrd>	MP:0002169,no abnormal phenotype detected
MGI:2153048	Sgcb<tm1Kcam>	MP:0000752,dystrophic muscle|MP:0001614,abnormal blood vessel morphology|MP:0002108,abnormal muscle morphology|MP:0002269,muscular atrophy|MP:0003141,cardiac fibrosis|MP:0003199,calcified muscle|MP:0003279,aneurysm|MP:0004121,abnormal sarcolemma morphology|MP:0005330,cardiomyopathy|MP:0005412,vascular stenosis|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006085,myocardium necrosis
MGI:2154611	Sgcb<tm1Oza>	MP:0000752,dystrophic muscle|MP:0000759,abnormal skeletal muscle morphology|MP:0001260,increased body weight|MP:0001264,increased body size|MP:0003141,cardiac fibrosis|MP:0004510,myositis|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009412,skeletal muscle fiber degeneration|MP:0009414,skeletal muscle fiber necrosis|MP:0009421,increased gastrocnemius weight|MP:0009427,increased tibialis anterior weight
MGI:2154694	Sgcd<tm1Kcam>	MP:0000266,abnormal heart morphology|MP:0000752,dystrophic muscle|MP:0001544,abnormal cardiovascular system physiology|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002837,dystrophic cardiac calcinosis|MP:0003024,coronary artery stenosis|MP:0003141,cardiac fibrosis|MP:0003852,skeletal muscle necrosis|MP:0005330,cardiomyopathy|MP:0006085,myocardium necrosis|MP:0008022,dilated heart ventricle|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010394,decreased QRS amplitude
MGI:2180193	Sgcd<tm1Mcn>	MP:0000749,muscle degeneration|MP:0000752,dystrophic muscle|MP:0000759,abnormal skeletal muscle morphology|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002795,dilated cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0005574,decreased pulmonary respiratory rate|MP:0005620,abnormal muscle contractility|MP:0009416,cardiac muscle degeneration|MP:0009419,skeletal muscle fibrosis|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0010632,cardiac muscle necrosis|MP:0011749,perivascular fibrosis
MGI:5792156	Sgcd<tm1Ojml>	MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003061,decreased aerobic running capacity|MP:0011091,prenatal lethality, complete penetrance|MP:0012735,abnormal response to exercise
MGI:6283402	Sgce<em1(IMPC)H>	MP:0001392,abnormal locomotor behavior|MP:0005011,increased eosinophil cell number
MGI:4971042	Sgce<Gt(148G1)Cmhd>	MP:0001265,decreased body size|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0004924,abnormal behavior|MP:0005386,behavior/neurological phenotype|MP:0012575,increased noradrenaline level
MGI:5308936	Sgce<tm1.1Yql>	MP:0002804,abnormal motor learning|MP:0003631,nervous system phenotype|MP:0003908,decreased stereotypic behavior|MP:0005386,behavior/neurological phenotype
MGI:3604206	Sgce<tm1.2Yql>	MP:0000243,myoclonus|MP:0000877,abnormal Purkinje cell morphology|MP:0001405,impaired coordination|MP:0001525,impaired balance|MP:0003122,maternal imprinting
MGI:5296936	Sgce<tm1Vinni>	MP:0005385,cardiovascular system phenotype
MGI:2154693	Sgcg<tm1Mcn>	MP:0000752,dystrophic muscle|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0002279,abnormal diaphragm morphology|MP:0002834,decreased heart weight|MP:0002953,thick ventricular wall|MP:0005294,abnormal heart ventricle morphology|MP:0005369,muscle phenotype|MP:0005386,behavior/neurological phenotype|MP:0010090,increased circulating creatine kinase level|MP:0012059,thick diaphragm muscle|MP:0031192,coronary artery spasm
MGI:3609567	Sgcg<tm1Oza>	MP:0000748,progressive muscle weakness|MP:0000749,muscle degeneration|MP:0000750,abnormal muscle regeneration|MP:0000752,dystrophic muscle|MP:0002083,premature death|MP:0002279,abnormal diaphragm morphology|MP:0003083,abnormal tibialis anterior morphology|MP:0003141,cardiac fibrosis|MP:0003851,skeletal muscle interstitial fibrosis|MP:0003852,skeletal muscle necrosis|MP:0004818,increased skeletal muscle mass|MP:0006085,myocardium necrosis|MP:0009399,increased skeletal muscle fiber size|MP:0009461,skeletal muscle hypertrophy|MP:0010090,increased circulating creatine kinase level
MGI:4434904	Sgf29<tm1a(EUCOMM)Hmgu>	MP:0000745,tremors|MP:0005560,decreased circulating glucose level
MGI:2679588	Sgh	MP:0001402,decreased locomotor activity
MGI:5548629	Sgip1<tm1b(EUCOMM)Hmgu>	MP:0000579,abnormal nail morphology|MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0002110,abnormal digit morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011886,increased circulating lipase level
MGI:3846797	Sgk1<tm1.2Palm>	MP:0002666,increased circulating aldosterone level|MP:0005619,increased urine potassium level|MP:0006316,increased urine sodium level
MGI:2445418	Sgk1<tm1Kuhl>	MP:0002666,increased circulating aldosterone level|MP:0005528,decreased renal glomerular filtration rate|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0011442,abnormal renal sodium ion transport|MP:0012046,decreased susceptibility to hypertension
MGI:1856038	Sgk3<fz>	MP:0000367,abnormal coat/ hair morphology|MP:0000377,abnormal hair follicle morphology|MP:0000410,waved hair|MP:0001216,abnormal epidermal layer morphology|MP:0001279,wavy vibrissae|MP:0002074,abnormal hair texture|MP:0003813,abnormal hair follicle dermal papilla morphology|MP:0030920,small hair follicle bulb|MP:0030925,early exit from anagen phase
MGI:1856040	Sgk3<fz-2J>	MP:0000410,waved hair|MP:0001279,wavy vibrissae|MP:0001510,abnormal coat appearance|MP:0002098,abnormal vibrissa morphology
MGI:1856500	Sgk3<fz-4J>	MP:0000410,waved hair|MP:0001279,wavy vibrissae|MP:0001510,abnormal coat appearance|MP:0002098,abnormal vibrissa morphology
MGI:1856039	Sgk3<fz-fy>	MP:0000367,abnormal coat/ hair morphology|MP:0000416,sparse hair|MP:0001211,wrinkled skin|MP:0001274,curly vibrissae
MGI:3032837	Sgk3<fz-ica>	MP:0000377,abnormal hair follicle morphology|MP:0000380,small hair follicles|MP:0000392,accelerated hair follicle regression|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000427,abnormal hair cycle|MP:0001219,thick epidermis|MP:0001274,curly vibrissae|MP:0001845,abnormal inflammatory response|MP:0003704,abnormal hair follicle development|MP:0003809,abnormal hair shaft morphology|MP:0003810,abnormal hair cuticle|MP:0003812,abnormal hair medulla|MP:0008860,abnormal hair cycle telogen phase|MP:0009351,thin hair shaft
MGI:3712860	Sgk3<fz-Mdf>	MP:0000410,waved hair|MP:0000416,sparse hair|MP:0001279,wavy vibrissae
MGI:4421790	Sgk3<m1Btlr>	MP:0000410,waved hair
MGI:3524987	Sgk3<tm1Dpea>	MP:0000383,abnormal hair follicle orientation|MP:0000389,disorganized outer root sheath cells|MP:0000410,waved hair|MP:0000416,sparse hair|MP:0001274,curly vibrissae|MP:0001731,abnormal postnatal growth|MP:0002073,abnormal hair growth|MP:0003704,abnormal hair follicle development|MP:0003809,abnormal hair shaft morphology|MP:0003867,increased defecation amount|MP:0003868,abnormal feces composition|MP:0005376,homeostasis/metabolism phenotype|MP:0010685,abnormal hair follicle inner root sheath morphology|MP:0011939,increased food intake|MP:0011978,abnormal potassium ion homeostasis|MP:0013278,decreased fasting circulating glucose level|MP:0013759,decreased intestinal glucose absorption
MGI:3603415	Sgk3<tm1Okad>	MP:0000392,accelerated hair follicle regression|MP:0000416,sparse hair|MP:0000417,short hair|MP:0000427,abnormal hair cycle|MP:0001278,kinked vibrissae|MP:0002073,abnormal hair growth|MP:0003809,abnormal hair shaft morphology|MP:0003810,abnormal hair cuticle|MP:0003812,abnormal hair medulla|MP:0003813,abnormal hair follicle dermal papilla morphology|MP:0009351,thin hair shaft|MP:0010686,abnormal hair follicle matrix region morphology|MP:0011195,increased hair follicle apoptosis|MP:0030575,decreased hair follicle cell proliferation|MP:0030920,small hair follicle bulb
MGI:3588656	Sgk3<ypc>	MP:0000377,abnormal hair follicle morphology|MP:0000383,abnormal hair follicle orientation|MP:0000417,short hair|MP:0001279,wavy vibrissae|MP:0001510,abnormal coat appearance|MP:0003704,abnormal hair follicle development|MP:0003809,abnormal hair shaft morphology|MP:0003812,abnormal hair medulla|MP:0003813,abnormal hair follicle dermal papilla morphology|MP:0010686,abnormal hair follicle matrix region morphology|MP:0010690,thick hair follicle outer root sheath|MP:0010693,thin hair follicle inner root sheath|MP:0030920,small hair follicle bulb
MGI:1861633	sgl	MP:0000414,alopecia|MP:0000427,abnormal hair cycle|MP:0001191,abnormal skin condition|MP:0001195,flaky skin|MP:0001852,conjunctivitis|MP:0002073,abnormal hair growth|MP:0002075,abnormal coat/hair pigmentation|MP:0002339,abnormal lymph node morphology|MP:0003809,abnormal hair shaft morphology
MGI:3918301	Sgms1<Gt(E201D11)Wrst>	MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001547,abnormal lipid level|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0003402,decreased liver weight|MP:0004901,decreased male germ cell number|MP:0005285,decreased unsaturated fatty acids level|MP:0006380,abnormal spermatid morphology|MP:0008545,absent sperm flagellum|MP:0008839,absent acrosome|MP:0009823,abnormal sphingomyelin level|MP:0012216,decreased plasmalogen level|MP:0012230,abnormal sphingolipid level|MP:0012232,abnormal ceramide level|MP:0013601,increased testis apoptosis|MP:0020355,abnormal Sertoli cell barrier morphology|MP:0020356,abnormal Sertoli cell barrier function
MGI:4950245	Sgms1<tm1a(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0001925,male infertility|MP:0002599,increased mean platelet volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0003960,increased lean body mass|MP:0005553,increased circulating creatinine level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010092,increased circulating magnesium level
MGI:5662506	Sgms1<tm1Jia>	MP:0003009,abnormal cytokine secretion|MP:0005376,homeostasis/metabolism phenotype|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008597,decreased circulating interleukin-6 level|MP:0008706,decreased interleukin-6 secretion|MP:0008713,abnormal cytokine level|MP:0009823,abnormal sphingomyelin level|MP:0012232,abnormal ceramide level
MGI:4939657	Sgms1<tm1Kenw>	MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0001783,decreased white adipose tissue amount|MP:0002083,premature death|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0003674,oxidative stress|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance
MGI:4818459	Sgms2<tm1Jia>	MP:0001547,abnormal lipid level|MP:0002446,abnormal macrophage morphology|MP:0002451,abnormal macrophage physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005416,abnormal circulating protein level|MP:0005621,abnormal cell physiology|MP:0009823,abnormal sphingomyelin level|MP:0010080,abnormal hepatocyte physiology|MP:0010163,hemolysis|MP:0012232,abnormal ceramide level
MGI:5292035	Sgms2<tm1Kenw>	MP:0000188,abnormal circulating glucose level|MP:0001554,increased circulating free fatty acids level|MP:0002644,decreased circulating triglyceride level|MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005621,abnormal cell physiology|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009289,decreased epididymal fat pad weight|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5543407	Sgo1<Gt(neo-btk)1Dai>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0002080,prenatal lethality|MP:0004024,aneuploidy|MP:0004025,polyploidy|MP:0008866,chromosomal instability|MP:0008943,increased sensitivity to induced cell death|MP:0012436,increased colon tumor incidence
MGI:4433385	Sgo1<tm1a(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0004647,decreased lumbar vertebrae number|MP:0004924,abnormal behavior|MP:0005179,decreased circulating cholesterol level|MP:0010101,increased sacral vertebrae number
MGI:3809644	Sgo2a<Gt(D025B05)Wrst>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001929,abnormal gametogenesis|MP:0002687,oligozoospermia|MP:0005168,abnormal female meiosis|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0008261,arrest of male meiosis|MP:0014636,decreased elongated spermatid number
MGI:3621939	Sgp1<DBA/2>	MP:0005416,abnormal circulating protein level
MGI:3621943	Sgp2<129>	MP:0005416,abnormal circulating protein level
MGI:3529875	Sgp5<NZB>	MP:0002723,abnormal immune serum protein physiology|MP:0002743,glomerulonephritis|MP:0005615,increased susceptibility to type III hypersensitivity reaction
MGI:3833931	Sgpl1<Gt(OST58278)Lex>	MP:0000130,abnormal trabecular bone morphology|MP:0000220,increased monocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0000322,increased granulocyte number|MP:0000496,abnormal small intestine morphology|MP:0000694,spleen hypoplasia|MP:0000711,thymus cortex hypoplasia|MP:0001179,thick pulmonary interalveolar septum|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002223,lymphoid hypoplasia|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002339,abnormal lymph node morphology|MP:0002358,abnormal spleen periarteriolar lymphoid sheath morphology|MP:0002397,abnormal bone marrow morphology|MP:0002401,abnormal lymphopoiesis|MP:0003630,abnormal urothelium morphology|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008101,lymph node hypoplasia|MP:0008209,decreased pre-B cell number|MP:0013591,thymus medulla hyperplasia
MGI:3526851	Sgpl1<Gt(ROSA)78Sor>	MP:0000074,abnormal neurocranium morphology|MP:0000107,abnormal frontal bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000157,abnormal sternum morphology|MP:0000208,decreased hematocrit|MP:0000767,abnormal smooth muscle morphology|MP:0001121,uterus hypoplasia|MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001134,absent corpus luteum|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0001614,abnormal blood vessel morphology|MP:0001732,postnatal growth retardation|MP:0001790,abnormal immune system physiology|MP:0001859,kidney inflammation|MP:0001914,hemorrhage|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002136,abnormal kidney physiology|MP:0002444,abnormal T cell physiology|MP:0002640,reticulocytosis|MP:0002780,decreased circulating testosterone level|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002989,small kidney|MP:0003091,abnormal cell migration|MP:0003156,abnormal leukocyte migration|MP:0004599,abnormal vertebral arch morphology|MP:0004969,pale kidney|MP:0005016,decreased lymphocyte cell number|MP:0005097,polychromatophilia|MP:0005181,decreased circulating estradiol level|MP:0005325,abnormal renal glomerulus morphology|MP:0005419,decreased circulating serum albumin level|MP:0005508,abnormal skeleton morphology|MP:0005536,decreased Leydig cell number|MP:0005565,increased blood urea nitrogen level|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006379,abnormal spermatocyte morphology|MP:0006418,abnormal testis cord formation|MP:0008061,absent podocyte slit diaphragm|MP:0008140,podocyte foot process effacement|MP:0008146,asymmetric sternocostal joints|MP:0008869,anovulation|MP:0009370,decreased theca cell number|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009895,decreased palatine bone horizontal plate size|MP:0011129,decreased tertiary ovarian follicle number|MP:0011385,abnormal testosterone level|MP:0011708,decreased fibroblast cell migration|MP:0014633,decreased spermatid number|MP:0020550,multinucleated giant male germ cells|MP:0030383,small presphenoid bone
MGI:5695887	Sgpl1<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0011100,preweaning lethality, complete penetrance
MGI:5514381	Sgpl1<tm1.1Npa>	MP:0000694,spleen hypoplasia|MP:0000714,increased thymocyte number|MP:0002118,abnormal lipid homeostasis|MP:0002339,abnormal lymph node morphology|MP:0002534,abnormal type IV hypersensitivity reaction|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004972,abnormal regulatory T cell number|MP:0005378,growth/size/body region phenotype|MP:0008083,decreased single-positive T cell number|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0010768,mortality/aging
MGI:5514382	Sgpl1<tm1.2Npa>	MP:0000694,spleen hypoplasia|MP:0001731,abnormal postnatal growth|MP:0002082,postnatal lethality|MP:0002118,abnormal lipid homeostasis
MGI:5440317	Sgpl1<tm1a(KOMP)Saba>	MP:0002169,no abnormal phenotype detected
MGI:3833933	Sgpl1<tm1(SGPL1)Lex>	MP:0000516,abnormal renal/urinary system morphology|MP:0002339,abnormal lymph node morphology|MP:0002367,abnormal thymus lobule morphology|MP:0002722,abnormal immune system organ morphology|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number
MGI:3808500	Sgpp1<tm1(KOMP)Vlcg>	MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001265,decreased body size|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0005501,abnormal skin physiology|MP:0009474,thick epidermis stratum spinosum|MP:0009583,increased keratinocyte proliferation|MP:0009599,thick epidermis stratum granulosum|MP:0009715,thick epidermis stratum basale|MP:0009931,abnormal skin appearance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012232,abnormal ceramide level
MGI:5823275	Sgpp2<tm1Rlp>	MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0009114,decreased pancreatic beta cell mass|MP:0009172,small pancreatic islets|MP:0010771,integument phenotype|MP:0011820,decreased pancreatic beta cell proliferation|MP:0012232,abnormal ceramide level|MP:0020354,increased endoplasmic reticulum stress
MGI:5755086	Sgsh<em3(IMPC)Tcp>	MP:0000062,increased bone mineral density|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0002764,short tibia|MP:0002968,increased circulating alkaline phosphatase level|MP:0005505,thrombocytosis|MP:0005565,increased blood urea nitrogen level|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:2151181	Sgsh<mps3a>	MP:0000137,abnormal vertebrae morphology|MP:0000266,abnormal heart morphology|MP:0000285,abnormal heart valve morphology|MP:0000358,abnormal cell morphology|MP:0000519,hydronephrosis|MP:0000539,distended urinary bladder|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001314,cornea opacity|MP:0001394,circling|MP:0001511,disheveled coat|MP:0002074,abnormal hair texture|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002703,abnormal renal tubule morphology|MP:0003631,nervous system phenotype|MP:0005058,abnormal lysosome morphology|MP:0005329,abnormal myocardium layer morphology|MP:0030278,thick neurocranium
MGI:5636905	Sgsm1<tm1b(EUCOMM)Wtsi>	MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008810,increased circulating iron level|MP:0010067,increased red blood cell distribution width
MGI:7425970	Sgsm3<em1(IMPC)Bay>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity
MGI:5788683	Sgta<tm1.1Drmcr>	MP:0000477,abnormal intestine morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002176,increased brain weight|MP:0002691,small stomach|MP:0002717,abnormal male preputial gland morphology|MP:0002833,increased heart weight|MP:0003599,large penis|MP:0003830,abnormal testis development|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0010831,lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5515781	Sgta<tm1b(KOMP)Mbp>	MP:0000208,decreased hematocrit|MP:0001258,decreased body length|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0005343,increased circulating aspartate transaminase level
MGI:6152637	Sgtb<em1(IMPC)Mbp>	MP:0001120,abnormal uterus morphology
MGI:3721685	Sh1<SEG/Pas>	MP:0005578,teratozoospermia
MGI:6336093	Sh2b1<em1(IMPC)Ics>	MP:0005293,impaired glucose tolerance
MGI:2662436	Sh2b1<tm1Ayos>	MP:0001125,abnormal oocyte morphology|MP:0001130,abnormal ovarian folliculogenesis|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001940,testis hypoplasia|MP:0002631,abnormal epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0003355,decreased ovulation rate|MP:0003572,abnormal uterus development|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0005158,ovary hypoplasia|MP:0005379,endocrine/exocrine gland phenotype|MP:0005387,immune system phenotype|MP:0005536,decreased Leydig cell number|MP:0008974,proportional dwarf|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011130,absent tertiary ovarian follicles|MP:0031383,increased secondary ovarian follicle number|MP:0031420,decreased superovulation rate
MGI:3055487	Sh2b1<tm1Lr>	MP:0001265,decreased body size|MP:0001559,hyperglycemia|MP:0001921,reduced fertility|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005491,pancreatic islet hyperplasia
MGI:5568997	Sh2b1<tm2.1Lr>	MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005559,increased circulating glucose level|MP:0009114,decreased pancreatic beta cell mass|MP:0009172,small pancreatic islets|MP:0011819,increased pancreatic beta cell proliferation
MGI:2680256	Sh2b2<tm1Yeb>	MP:0002144,abnormal B cell differentiation|MP:0002727,decreased circulating insulin level|MP:0004977,increased B-1 B cell number|MP:0008502,increased IgG3 level
MGI:7863632	Sh2b3<em1Cgv>	MP:0000218,increased leukocyte cell number|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0001829,increased activated T cell number|MP:0002145,abnormal T cell differentiation|MP:0002362,abnormal spleen marginal zone morphology|MP:0002458,abnormal B cell number|MP:0003132,increased pre-B cell number|MP:0005013,increased lymphocyte cell number|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005090,increased double-negative T cell number|MP:0005350,increased susceptibility to autoimmune disorder|MP:0008189,increased transitional stage B cell number|MP:0008211,decreased mature B cell number|MP:0008217,abnormal B cell activation|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number
MGI:7863633	Sh2b3<em2Cgv>	MP:0000218,increased leukocyte cell number|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0001829,increased activated T cell number|MP:0002145,abnormal T cell differentiation|MP:0002362,abnormal spleen marginal zone morphology|MP:0005013,increased lymphocyte cell number|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0008189,increased transitional stage B cell number|MP:0008211,decreased mature B cell number|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number
MGI:7863634	Sh2b3<em3Cgv>	MP:0000218,increased leukocyte cell number|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0002362,abnormal spleen marginal zone morphology|MP:0005013,increased lymphocyte cell number|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0008189,increased transitional stage B cell number
MGI:2383957	Sh2b3<tm1Paw>	MP:0000217,abnormal leukocyte cell number|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000321,increased bone marrow cell number|MP:0000322,increased granulocyte number|MP:0000351,increased cell proliferation|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0001577,anemia|MP:0002417,abnormal megakaryocyte morphology|MP:0003135,increased erythroid progenitor cell number|MP:0005013,increased lymphocyte cell number|MP:0005014,increased B cell number|MP:0005017,decreased B cell number|MP:0005505,thrombocytosis|MP:0008111,abnormal granulocyte differentiation|MP:0008112,abnormal monocyte differentiation|MP:0008254,increased megakaryocyte cell number|MP:0010373,myeloid hyperplasia|MP:0011746,spleen fibrosis
MGI:2180088	Sh2b3<tm1Rmp>	MP:0004808,abnormal hematopoietic stem cell morphology
MGI:3576262	Sh2d1a<tm1Cpt>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002490,abnormal immunoglobulin level|MP:0002492,decreased IgE level|MP:0003009,abnormal cytokine secretion|MP:0005014,increased B cell number|MP:0005026,decreased susceptibility to parasitic infection|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0008040,decreased NK T cell number|MP:0008041,absent NK T cells|MP:0008042,abnormal NK T cell physiology|MP:0008176,abnormal germinal center B cell morphology|MP:0008178,decreased germinal center B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008192,abnormal germinal center B cell physiology|MP:0008482,decreased spleen germinal center number|MP:0008495,decreased IgG1 level|MP:0008500,increased IgG2a level|MP:0020913,increased susceptibility to Riboviria infection
MGI:3575311	Sh2d1a<tm1Lyin>	MP:0001790,abnormal immune system physiology|MP:0001805,decreased IgG level|MP:0002460,decreased immunoglobulin level|MP:0002492,decreased IgE level|MP:0002499,chronic inflammation|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:2388241	Sh2d1a<tm1Pls>	MP:0000717,abnormal lymphocyte cell number|MP:0001805,decreased IgG level|MP:0002406,increased susceptibility to infection|MP:0002433,abnormal T-helper 1 cell morphology|MP:0002434,abnormal T-helper 2 cell morphology|MP:0002492,decreased IgE level|MP:0005026,decreased susceptibility to parasitic infection|MP:0005027,increased susceptibility to parasitic infection|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008036,abnormal NK T cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008567,decreased interferon-gamma secretion|MP:0009058,decreased interleukin-21 secretion|MP:0010084,abnormal long lived plasma cell morphology|MP:0010766,abnormal NK cell physiology|MP:0020913,increased susceptibility to Riboviria infection
MGI:3512182	Sh2d1a<tm1Vei>	MP:0002492,decreased IgE level|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008051,abnormal memory T cell physiology|MP:0008567,decreased interferon-gamma secretion|MP:0010766,abnormal NK cell physiology
MGI:5444609	Sh2d1a<tm2.1Cpt>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0005387,immune system phenotype|MP:0008192,abnormal germinal center B cell physiology
MGI:3775432	Sh2d1a<tm2.1Vei>	MP:0001806,decreased IgM level|MP:0002492,decreased IgE level|MP:0008040,decreased NK T cell number|MP:0008178,decreased germinal center B cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:3774546	Sh2d1a<tm2Vei>	MP:0001806,decreased IgM level|MP:0002492,decreased IgE level|MP:0005387,immune system phenotype|MP:0008040,decreased NK T cell number|MP:0008178,decreased germinal center B cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:4840395	Sh2d1b1/Sh2d1b2<tm1.1Cpt>	MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0008567,decreased interferon-gamma secretion
MGI:4840396	Sh2d1b1/Sh2d1b2<tm1.1Cpt>	MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0008567,decreased interferon-gamma secretion
MGI:4840390	Sh2d1b1<tm1.1Cpt>	MP:0005070,impaired natural killer cell mediated cytotoxicity
MGI:3641174	Sh2d1b1<tm1Vei>	MP:0003080,increased natural killer cell mediated cytotoxicity|MP:0008566,increased interferon-gamma secretion
MGI:5438032	Sh2d1b1<tm3Vei>	MP:0010766,abnormal NK cell physiology
MGI:4840393	Sh2d1b2<tm1.1Cpt>	MP:0005070,impaired natural killer cell mediated cytotoxicity
MGI:3641175	Sh2d1b2<tm1Vei>	MP:0003080,increased natural killer cell mediated cytotoxicity|MP:0005070,impaired natural killer cell mediated cytotoxicity
MGI:2676915	Sh2d2a<tm1Jbs>	MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion
MGI:4838039	Sh2d3c<tm1.1Ebp>	MP:0000965,abnormal sensory neuron morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001147,small testis|MP:0003651,abnormal axon extension|MP:0005236,abnormal olfactory nerve morphology|MP:0006042,increased apoptosis|MP:0009546,absent gastric milk in neonates|MP:0009946,abnormal olfactory bulb layer morphology|MP:0009948,abnormal olfactory bulb glomerular layer morphology|MP:0009951,abnormal olfactory bulb mitral cell layer morphology|MP:0010059,olfactory bulb hypoplasia|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014592,decreased gonadotropin-releasing hormone neuron number
MGI:4461024	Sh2d3c<tm1Lex>	MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0002459,abnormal B cell physiology|MP:0003156,abnormal leukocyte migration|MP:0008182,decreased marginal zone B cell number|MP:0008193,abnormal marginal zone B cell physiology|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008706,decreased interleukin-6 secretion
MGI:3809252	Sh2d4a<tm1.1Pdk>	MP:0002169,no abnormal phenotype detected
MGI:4432348	Sh2d5<tm1a(EUCOMM)Wtsi>	MP:0004599,abnormal vertebral arch morphology|MP:0005554,decreased circulating creatinine level
MGI:5630073	Sh2d7<tm2b(KOMP)Mbp>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3721687	Sh2<SEG/Pas>	MP:0005578,teratozoospermia
MGI:5637071	Sh3bgrl3<tm2b(EUCOMM)Wtsi>	MP:0013406,abnormal epidermal immune compartment
MGI:5701634	Sh3bp2<tm1.1Ics>	MP:0000220,increased monocyte cell number|MP:0000702,enlarged lymph nodes|MP:0001846,increased inflammatory response|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0005508,abnormal skeleton morphology|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008596,increased circulating interleukin-6 level|MP:0008617,increased circulating interleukin-12 level|MP:0010210,abnormal circulating cytokine level|MP:0013123,head/neck swellings
MGI:3698401	Sh3bp2<tm1Bjro>	MP:0000063,decreased bone mineral density|MP:0000074,abnormal neurocranium morphology|MP:0000454,abnormal jaw morphology|MP:0000702,enlarged lymph nodes|MP:0001194,dermatitis|MP:0001533,abnormal skeleton physiology|MP:0001541,abnormal osteoclast physiology|MP:0001846,increased inflammatory response|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001873,stomach inflammation|MP:0002083,premature death|MP:0002116,abnormal craniofacial bone morphology|MP:0002451,abnormal macrophage physiology|MP:0002458,abnormal B cell number|MP:0002722,abnormal immune system organ morphology|MP:0002933,joint inflammation|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0003797,abnormal compact bone morphology|MP:0004510,myositis|MP:0004984,increased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0005190,osteomyelitis|MP:0005251,blepharitis|MP:0005387,immune system phenotype|MP:0008271,abnormal bone ossification|MP:0008396,abnormal osteoclast differentiation|MP:0008476,increased spleen red pulp amount|MP:0008553,increased circulating tumor necrosis factor level|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0014450,increased circulating enzyme level|MP:0030466,alveolar process atrophy|MP:0030987,spinal cord inflammation
MGI:5548461	Sh3bp2<tm1b(KOMP)Wtsi>	MP:0002764,short tibia|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level
MGI:6150886	Sh3bp2<tm1c(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0003797,abnormal compact bone morphology|MP:0004148,increased compact bone thickness|MP:0005605,increased bone mass|MP:0009347,increased trabecular bone thickness|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume
MGI:3664088	Sh3bp2<tm1Geha>	MP:0002458,abnormal B cell number|MP:0002459,abnormal B cell physiology|MP:0003132,increased pre-B cell number|MP:0005093,decreased B cell proliferation|MP:0005387,immune system phenotype
MGI:3711412	Sh3bp2<tm1Rtpl>	MP:0001798,impaired macrophage phagocytosis|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002362,abnormal spleen marginal zone morphology|MP:0002451,abnormal macrophage physiology|MP:0002458,abnormal B cell number|MP:0002460,decreased immunoglobulin level|MP:0004978,decreased B-1 B cell number|MP:0005093,decreased B cell proliferation|MP:0008181,increased marginal zone B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008193,abnormal marginal zone B cell physiology|MP:0008208,decreased pro-B cell number|MP:0008495,decreased IgG1 level|MP:0008498,decreased IgG3 level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008704,abnormal interleukin-6 secretion|MP:0008782,increased B cell apoptosis|MP:0010210,abnormal circulating cytokine level
MGI:4433523	Sh3bp4<tm1a(EUCOMM)Wtsi>	MP:0005344,increased circulating bilirubin level
MGI:5775777	Sh3d19<em1(IMPC)J>	MP:0010053,decreased grip strength
MGI:7641914	Sh3d21<em1Kzt>	MP:0005389,reproductive system phenotype
MGI:5468725	Sh3gl1<tm1Pdc>	MP:0002169,no abnormal phenotype detected
MGI:5513818	Sh3gl2<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001417,decreased exploration in new environment|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:5468726	Sh3gl2<tm1Pdc>	MP:0002169,no abnormal phenotype detected
MGI:5468729	Sh3gl3<tm1.2Itl>	MP:0002169,no abnormal phenotype detected
MGI:3608890	Sh3glb1<tm1Hgw>	MP:0013502,decreased fibroblast apoptosis
MGI:4240757	Sh3glb2<Gt(OST224737)Lex>	MP:0004043,abnormal pH regulation|MP:0005025,abnormal response to infection|MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0010768,mortality/aging|MP:0030940,impaired autophagy|MP:0030951,abnormal endocytosis
MGI:4818424	Sh3kbp1<tm1Ivdi>	MP:0001415,increased exploration in new environment|MP:0001906,increased dopamine level|MP:0003960,increased lean body mass|MP:0004077,abnormal striatum morphology|MP:0005449,abnormal food intake|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009745,abnormal behavioral response to xenobiotic|MP:0031391,increased locomotor activity
MGI:5296768	Sh3kbp1<tm1Kuro>	MP:0000717,abnormal lymphocyte cell number|MP:0001800,abnormal humoral immune response|MP:0002459,abnormal B cell physiology|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0008168,decreased B-1a cell number|MP:0008174,decreased follicular B cell number|MP:0008215,decreased immature B cell number|MP:0009926,decreased transitional stage T2 B cell number|MP:0010228,decreased transitional stage T3 B cell number
MGI:4319893	Sh3pxd2a<Gt(OST445753)Lex>	MP:0002083,premature death|MP:0004678,split xiphoid process|MP:0009546,absent gastric milk in neonates|MP:0009890,cleft secondary palate|MP:0010768,mortality/aging|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5636944	Sh3pxd2a<tm1b(EUCOMM)Wtsi>	MP:0000079,abnormal basioccipital bone morphology|MP:0000141,abnormal vertebral body morphology|MP:0000282,abnormal interatrial septum morphology|MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000445,short snout|MP:0000598,abnormal liver morphology|MP:0000600,liver hypoplasia|MP:0000602,dilated liver sinusoidal space|MP:0000632,abnormal pineal gland morphology|MP:0000783,abnormal forebrain morphology|MP:0000963,fused dorsal root ganglion|MP:0001015,small superior cervical ganglion|MP:0001146,abnormal testis morphology|MP:0001879,abnormal lymphatic vessel morphology|MP:0002108,abnormal muscle morphology|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002191,abnormal artery morphology|MP:0002237,abnormal nasal cavity morphology|MP:0002239,abnormal nasal septum morphology|MP:0002243,abnormal vomeronasal organ morphology|MP:0002249,abnormal larynx morphology|MP:0002633,persistent truncus arteriosus|MP:0002746,abnormal semilunar valve morphology|MP:0002951,small thyroid gland|MP:0002968,increased circulating alkaline phosphatase level|MP:0003253,dilated bile duct|MP:0003584,bifid ureter|MP:0003617,urinary bladder hypoplasia|MP:0003686,abnormal eye muscle morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0003924,diaphragmatic hernia|MP:0004110,transposition of great arteries|MP:0004163,abnormal adenohypophysis morphology|MP:0004201,fetal growth retardation|MP:0004269,abnormal optic cup morphology|MP:0004463,basisphenoid bone foramen|MP:0004599,abnormal vertebral arch morphology|MP:0004613,fusion of vertebral arches|MP:0004666,absent stapedial artery|MP:0005269,abnormal occipital bone morphology|MP:0006063,abnormal inferior vena cava morphology|MP:0006065,abnormal heart position or orientation|MP:0008386,absent styloid process|MP:0008534,enlarged fourth ventricle|MP:0008536,enlarged third ventricle|MP:0008922,abnormal cervical rib|MP:0008923,thoracoschisis|MP:0009526,absent sublingual gland|MP:0009570,abnormal right lung morphology|MP:0009820,abnormal liver vasculature morphology|MP:0009917,abnormal hyoid bone body morphology|MP:0010403,atrial septal defect|MP:0010404,ostium primum atrial septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010433,double inlet heart left ventricle|MP:0010439,abnormal hepatic vein morphology|MP:0010484,bicuspid aortic valve|MP:0010496,abnormal pectinate muscle morphology|MP:0010527,bicuspid pulmonary valve|MP:0010530,cerebral arteriovenous malformation|MP:0010572,persistent right dorsal aorta|MP:0010595,abnormal aortic valve cusp morphology|MP:0010602,abnormal pulmonary valve cusp morphology|MP:0010728,fusion of atlas and occipital bones|MP:0010853,abnormal lung position or orientation|MP:0010912,herniated liver|MP:0011100,preweaning lethality, complete penetrance|MP:0011361,pelvic kidney|MP:0011493,double ureter|MP:0011667,double outlet right ventricle with atrioventricular septal defect|MP:0011683,dual inferior vena cava|MP:0013186,abnormal basilar artery morphology|MP:0013818,abnormal oral cavity morphology|MP:0013826,absent hypoglossal canal|MP:0013835,absent hypoglossal nerve|MP:0013836,abnormal hypoglossal nerve topology|MP:0013840,absent segment of posterior cerebral artery|MP:0013845,abnormal eye muscle topology|MP:0013846,retropharyngeal edema|MP:0013847,retropleural edema|MP:0013848,subcutaneous edema|MP:0013852,abnormal Mullerian duct topology|MP:0013855,absent celiac artery|MP:0013871,abnormal stapedial artery topology|MP:0013876,absent ductus venosus valve|MP:0013878,abnormal ductus venosus valve topology|MP:0013917,persistent right 6th pharyngeal arch artery|MP:0013923,small prevertebral sympathetic ganglia|MP:0013925,abnormal vascular plexus formation|MP:0013930,abnormal digastric muscle connection|MP:0013931,abnormal olfactory bulb position|MP:0013932,fragmented Meckel's cartilage|MP:0013936,abnormal thymus topology|MP:0013949,fusion of axis and occipital bones|MP:0013965,abnormally deep median sulcus of tongue|MP:0013967,abnormal infrahyoid muscle connection|MP:0013969,reduced sympathetic cervical ganglion size|MP:0013970,absent connection between subcutaneous lymph vessels and lymph sac|MP:0013971,blood in lymph vessels|MP:0013976,abnormal left vena cava superior connection|MP:0013977,symmetric azygos veins|MP:0013982,inverse situs of great intrathoracic arteries|MP:0013986,abnormal vitelline vein topology|MP:0013996,abnormal vertebral artery origin|MP:0013998,absent canalicular internal carotid artery segment|MP:0013999,absent parasellar internal carotid artery|MP:0014011,abnormal ovary tissue architecture|MP:0014017,abnormal Wolffian duct connection|MP:0014019,embryo cyst|MP:0014021,heterochrony|MP:0020301,short tongue|MP:0020500,persistent trigeminal artery
MGI:4439499	Sh3pxd2b<Gt(GST_1527_E5)Lex>	MP:0000074,abnormal neurocranium morphology|MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000159,abnormal xiphoid process morphology|MP:0000160,kyphosis|MP:0000162,lordosis|MP:0000277,abnormal heart shape|MP:0000286,abnormal mitral valve morphology|MP:0000428,abnormal craniofacial morphology|MP:0001265,decreased body size|MP:0001300,ocular hypertelorism|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality|MP:0002100,abnormal tooth morphology|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002639,micrognathia|MP:0003843,abnormal sagittal suture morphology|MP:0004471,short nasal bone|MP:0005258,ocular hypertension|MP:0005294,abnormal heart ventricle morphology|MP:0005333,decreased heart rate|MP:0006120,mitral valve prolapse|MP:0006249,phthisis bulbi|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008853,decreased abdominal adipose tissue amount|MP:0010029,abnormal basicranium morphology|MP:0010725,thin interventricular septum|MP:0011962,increased cornea thickness|MP:0030030,Wormian bones|MP:0030852,abnormal ilium wing morphology|MP:0030853,abnormal iliac crest morphology|MP:0031500,increased cornea size
MGI:3689328	Sh3pxd2b<nee>	MP:0000049,abnormal middle ear morphology|MP:0000063,decreased bone mineral density|MP:0000440,domed cranium|MP:0000445,short snout|MP:0001059,optic nerve atrophy|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001304,cataract|MP:0001314,cornea opacity|MP:0001319,irregularly shaped pupil|MP:0001325,abnormal retina morphology|MP:0001731,abnormal postnatal growth|MP:0001783,decreased white adipose tissue amount|MP:0001850,increased susceptibility to otitis media|MP:0001851,eye inflammation|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002113,abnormal skeleton development|MP:0002183,gliosis|MP:0002750,exophthalmos|MP:0004221,abnormal iridocorneal angle|MP:0004224,absent trabecular meshwork|MP:0004226,absent Schlemm's canal|MP:0005205,abnormal eye anterior chamber morphology|MP:0005206,abnormal aqueous humor|MP:0005258,ocular hypertension|MP:0005497,optic nerve cupping|MP:0005542,cornea vascularization|MP:0005543,decreased cornea thickness|MP:0006219,optic nerve degeneration|MP:0006303,abnormal retina nerve fiber layer morphology|MP:0008067,retina ganglion cell degeneration|MP:0008525,decreased cranium height|MP:0008974,proportional dwarf|MP:0009829,enlarged eye anterior chamber|MP:0010253,posterior subcapsular cataract|MP:0011481,anterior iris synechia|MP:0011965,decreased total retina thickness|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013732,mature cataract|MP:0030932,hypopyon|MP:0030933,hyphema|MP:0031213,increased eye anterior chamber depth
MGI:5800300	Sh3pxd2b<tm1.1Arte>	MP:0000085,large anterior fontanelle|MP:0000160,kyphosis|MP:0000428,abnormal craniofacial morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001924,infertility|MP:0002113,abnormal skeleton development|MP:0002750,exophthalmos|MP:0002764,short tibia|MP:0003109,short femur|MP:0004686,decreased length of long bones|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009283,decreased gonadal fat pad weight|MP:0009303,decreased renal fat pad weight|MP:0011167,abnormal adipose tissue development|MP:0011174,lipodystrophy|MP:0014143,decreased body fat mass
MGI:7312050	Sh3rf1<em1Bcgen>	MP:0001262,decreased body weight|MP:0001409,increased stereotypic behavior|MP:0001447,abnormal nest building behavior|MP:0001473,reduced long-term potentiation|MP:0005394,taste/olfaction phenotype|MP:0008414,abnormal spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0012307,impaired spatial learning|MP:0020351,decreased vocalization|MP:0020508,decreased dendritic spine density|MP:0020511,decreased dendritic spine length|MP:0021111,decreased social investigation|MP:0031392,hypoactivity
MGI:6108885	Sh3rf1<em1(IMPC)J>	MP:0001417,decreased exploration in new environment|MP:0008259,abnormal optic disk morphology
MGI:6279851	Sh3rf2<tm1Zhxu>	MP:0000807,abnormal hippocampus morphology|MP:0001360,abnormal social investigation|MP:0001399,hyperactivity|MP:0001409,increased stereotypic behavior|MP:0001447,abnormal nest building behavior|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002272,abnormal nervous system electrophysiology|MP:0002574,increased vertical activity|MP:0003412,abnormal afterhyperpolarization|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0009936,abnormal dendritic spine morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0020338,abnormal hippocampal pyramidal neuron dendrite morphology|MP:0020351,decreased vocalization|MP:0020395,abnormal response to social novelty|MP:0020507,increased dendritic spine density
MGI:6258587	Sh3rf3<em1(IMPC)J>	MP:0002965,increased circulating serum albumin level
MGI:3721707	Sh3<SEG/Pas>	MP:0005578,teratozoospermia
MGI:5812928	Sh3tc1<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0002644,decreased circulating triglyceride level|MP:0002699,abnormal vitreous body morphology|MP:0003233,prolonged QT interval|MP:0005140,decreased cardiac muscle contractility|MP:0005344,increased circulating bilirubin level|MP:0010053,decreased grip strength|MP:0010570,prolonged ST segment
MGI:5444299	Sh3tc2<m1J>	MP:0000745,tremors|MP:0000921,demyelination|MP:0001106,abnormal Schwann cell morphology|MP:0003631,nervous system phenotype|MP:0008814,decreased nerve conduction velocity|MP:0010053,decreased grip strength|MP:0010559,heart block|MP:0011731,decreased myelin sheath thickness
MGI:4367025	Sh3tc2<tm1.1Rchr>	MP:0000920,abnormal myelination|MP:0001513,limb grasping|MP:0002229,neurodegeneration|MP:0005390,skeleton phenotype|MP:0005404,abnormal axon morphology|MP:0008814,decreased nerve conduction velocity|MP:0010732,abnormal node of Ranvier morphology
MGI:5447051	Sh3tc2<tm1b(KOMP)Wtsi>	MP:0005560,decreased circulating glucose level
MGI:7507206	Sh3yl1<em1(IMPC)Mbp>	MP:0000220,increased monocyte cell number|MP:0001297,microphthalmia|MP:0001399,hyperactivity|MP:0002092,abnormal eye morphology
MGI:6489952	Sh3yl1<tm1Syb>	MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0005384,cellular phenotype|MP:0008561,decreased tumor necrosis factor secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0011371,decreased kidney apoptosis|MP:0011372,decreased renal tubule apoptosis
MGI:3721709	Sh4<SEG/Pas>	MP:0005578,teratozoospermia
MGI:1856629	Sha	MP:0000416,sparse hair|MP:0000427,abnormal hair cycle|MP:0001274,curly vibrissae|MP:0001279,wavy vibrissae|MP:0001283,sparse vibrissae|MP:0001510,abnormal coat appearance|MP:0001731,abnormal postnatal growth|MP:0001732,postnatal growth retardation|MP:0002073,abnormal hair growth|MP:0002083,premature death|MP:0003811,abnormal hair cortex morphology|MP:0003812,abnormal hair medulla|MP:0003849,greasy coat|MP:0008767,abnormal hair medullary septa cells|MP:0008768,abnormal hair medulla air spaces|MP:0009351,thin hair shaft
MGI:3767298	Shali1<129X1/SvJ>	MP:0003674,oxidative stress
MGI:3767301	Shali2<C57BL/6J>	MP:0003674,oxidative stress
MGI:3767305	Shali4<C57BL/6J>	MP:0003674,oxidative stress
MGI:3767307	Shali5<C57BL/6J>	MP:0003674,oxidative stress
MGI:6313356	Shank1<em1(IMPC)Mbp>	MP:0000367,abnormal coat/ hair morphology|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000745,tremors|MP:0001126,abnormal ovary morphology|MP:0001304,cataract|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0002060,abnormal skin morphology|MP:0002699,abnormal vitreous body morphology|MP:0004832,enlarged ovary|MP:0005084,abnormal gallbladder morphology|MP:0009342,enlarged gallbladder|MP:0010052,increased grip strength
MGI:3762757	Shank1<tm1Shng>	MP:0001363,increased anxiety-related response|MP:0001386,abnormal maternal nurturing|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001921,reduced fertility|MP:0002206,abnormal CNS synaptic transmission|MP:0003631,nervous system phenotype|MP:0004996,abnormal CNS synapse formation|MP:0008414,abnormal spatial reference memory|MP:0008428,abnormal spatial working memory|MP:0008432,abnormal long-term spatial reference memory|MP:0009940,abnormal hippocampus pyramidal cell morphology
MGI:6156159	Shank2<em2(IMPC)Rbrc>	MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001513,limb grasping|MP:0002797,increased thigmotaxis|MP:0002875,decreased erythrocyte cell number|MP:0003795,abnormal bone structure|MP:0004924,abnormal behavior|MP:0010123,increased bone mineral content
MGI:5816912	Shank2<tm1.1Bcgen>	MP:0001363,increased anxiety-related response|MP:0001405,impaired coordination|MP:0001409,increased stereotypic behavior|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0020357,abnormal excitatory synapse morphology
MGI:5435698	Shank2<tm1.1Tmb>	MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001529,abnormal vocalization|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002566,abnormal sexual interaction|MP:0002863,improved righting response|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003008,enhanced long-term potentiation|MP:0003107,abnormal response to novelty|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0009936,abnormal dendritic spine morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031391,increased locomotor activity
MGI:5437479	Shank2<tm1Mgle>	MP:0000889,abnormal cerebellar molecular layer|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001384,abnormal pup retrieval|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001441,increased grooming behavior|MP:0001447,abnormal nest building behavior|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001475,reduced long-term depression|MP:0002063,abnormal learning/memory/conditioning|MP:0003491,abnormal voluntary movement|MP:0003631,nervous system phenotype|MP:0003633,abnormal nervous system physiology|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005386,behavior/neurological phenotype|MP:0020351,decreased vocalization|MP:0020357,abnormal excitatory synapse morphology|MP:0031391,increased locomotor activity
MGI:6259433	Shank3<em1Hzo>	MP:0002557,abnormal social/conspecific interaction behavior|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0011000,abnormal allogrooming behavior|MP:0020351,decreased vocalization|MP:0020508,decreased dendritic spine density
MGI:6153820	Shank3<em1(IMPC)H>	MP:0000195,decreased circulating calcium level
MGI:6379002	Shank3<tm1.1Cya>	MP:0001363,increased anxiety-related response|MP:0001441,increased grooming behavior|MP:0001529,abnormal vocalization|MP:0002272,abnormal nervous system electrophysiology|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0003908,decreased stereotypic behavior|MP:0004811,abnormal neuron physiology|MP:0004994,abnormal brain wave pattern|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging|MP:0014382,increased miniature inhibitory postsynaptic current frequency|MP:0014621,abnormal brain alpha wave pattern|MP:0014623,abnormal brain theta wave pattern|MP:0014624,abnormal brain delta wave pattern
MGI:5435700	Shank3<tm1.1Geno>	MP:0001212,skin lesions|MP:0003107,abnormal response to novelty|MP:0003461,abnormal response to novel object
MGI:5085999	Shank3<tm1.1Pfw>	MP:0001262,decreased body weight|MP:0001353,increased aggression towards mice|MP:0001360,abnormal social investigation|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0001441,increased grooming behavior|MP:0001473,reduced long-term potentiation|MP:0001489,decreased startle reflex|MP:0001516,abnormal motor coordination/balance|MP:0001529,abnormal vocalization|MP:0001898,abnormal long-term depression|MP:0001902,reduced NMDA-mediated synaptic currents|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002917,decreased synaptic depression|MP:0003107,abnormal response to novelty|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0003998,decreased thermal nociceptive threshold|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005386,behavior/neurological phenotype|MP:0008414,abnormal spatial reference memory|MP:0008911,induced hyperactivity|MP:0012013,abnormal innate avoidance response|MP:0012307,impaired spatial learning|MP:0013787,photophobia
MGI:5285394	Shank3<tm1.2Bux>	MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001473,reduced long-term potentiation|MP:0002574,increased vertical activity|MP:0002757,decreased vertical activity|MP:0002797,increased thigmotaxis|MP:0002806,abnormal conditioned emotional response|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003461,abnormal response to novel object|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004811,abnormal neuron physiology|MP:0005386,behavior/neurological phenotype|MP:0005498,hyporesponsive to tactile stimuli|MP:0010053,decreased grip strength|MP:0010831,lethality, incomplete penetrance|MP:0014253,decreased paired-pulse ratio|MP:0020351,decreased vocalization|MP:0031391,increased locomotor activity
MGI:5788281	Shank3<tm1Cmpl>	MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0001898,abnormal long-term depression|MP:0001900,impaired synaptic plasticity|MP:0002206,abnormal CNS synaptic transmission|MP:0002804,abnormal motor learning|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002922,decreased post-tetanic potentiation|MP:0003461,abnormal response to novel object|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0012307,impaired spatial learning
MGI:5792941	Shank3<tm1d(KOMP)Mbp>	MP:0002206,abnormal CNS synaptic transmission|MP:0002574,increased vertical activity|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003107,abnormal response to novelty|MP:0005386,behavior/neurological phenotype|MP:0012307,impaired spatial learning|MP:0014381,abnormal miniature inhibitory postsynaptic current frequency
MGI:4949735	Shank3<tm1Gfng>	MP:0005386,behavior/neurological phenotype|MP:0010771,integument phenotype
MGI:5056336	Shank3<tm1Yhj>	MP:0001260,increased body weight|MP:0001360,abnormal social investigation|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001458,abnormal object recognition memory|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001523,impaired righting response|MP:0001529,abnormal vocalization|MP:0001900,impaired synaptic plasticity|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002757,decreased vertical activity|MP:0002801,abnormal long-term object recognition memory|MP:0002804,abnormal motor learning|MP:0002922,decreased post-tetanic potentiation|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype|MP:0009936,abnormal dendritic spine morphology
MGI:6162240	Shank3<tm2.1Bux>	MP:0000746,weakness|MP:0001363,increased anxiety-related response|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001441,increased grooming behavior|MP:0001447,abnormal nest building behavior|MP:0001489,decreased startle reflex|MP:0001732,postnatal growth retardation|MP:0001961,abnormal reflex|MP:0002083,premature death|MP:0002566,abnormal sexual interaction|MP:0002757,decreased vertical activity|MP:0002862,abnormal righting response|MP:0003313,abnormal locomotor activation|MP:0003459,increased fear-related response|MP:0003461,abnormal response to novel object|MP:0009142,decreased prepulse inhibition|MP:0009454,impaired contextual conditioning behavior|MP:0009455,enhanced cued conditioning behavior|MP:0010540,long stride length|MP:0010698,abnormal impulsive behavior control|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011622,abnormal habituation to a novel odor|MP:0012307,impaired spatial learning|MP:0020351,decreased vocalization|MP:0020864,premature suckling reflex loss
MGI:5800311	Shank3<tm2.2Yhj>	MP:0000572,abnormal autopod morphology|MP:0000833,thalamus hyperplasia|MP:0001212,skin lesions|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001413,abnormal response to new environment|MP:0001441,increased grooming behavior|MP:0001475,reduced long-term depression|MP:0001488,increased startle reflex|MP:0002199,abnormal brain commissure morphology|MP:0002272,abnormal nervous system electrophysiology|MP:0002557,abnormal social/conspecific interaction behavior|MP:0003463,abnormal single cell response|MP:0003631,nervous system phenotype|MP:0003938,abnormal ear development|MP:0004924,abnormal behavior|MP:0006007,abnormal basal ganglion morphology|MP:0008026,abnormal brain white matter morphology|MP:0008128,abnormal brain internal capsule morphology|MP:0008232,abnormal cingulum morphology|MP:0008283,small hippocampus|MP:0009453,enhanced contextual conditioning behavior|MP:0009538,abnormal synapse morphology|MP:0009562,abnormal odor adaptation|MP:0009694,abnormal spinal cord commissure morphology|MP:0009936,abnormal dendritic spine morphology|MP:0009944,abnormal olfactory lobe morphology|MP:0009976,abnormal cerebellar peduncle morphology|MP:0012307,impaired spatial learning|MP:0012315,impaired learning|MP:0012480,decreased amygdala size|MP:0014379,decreased excitatory postsynaptic current frequency|MP:0020351,decreased vocalization
MGI:6437927	Shank3<tm2Cmpl>	MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001441,increased grooming behavior|MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002757,decreased vertical activity|MP:0002804,abnormal motor learning|MP:0003635,abnormal synaptic transmission|MP:0008414,abnormal spatial reference memory|MP:0012307,impaired spatial learning|MP:0020395,abnormal response to social novelty|MP:0020396,abnormal social recognition
MGI:4949738	Shank3<tm2Gfng>	MP:0001212,skin lesions|MP:0001361,social withdrawal|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001441,increased grooming behavior|MP:0002063,abnormal learning/memory/conditioning|MP:0002757,decreased vertical activity|MP:0004077,abnormal striatum morphology|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005386,behavior/neurological phenotype|MP:0008462,abnormal medium spiny neuron morphology|MP:0009358,environmentally induced seizures|MP:0012296,impaired discrimination learning|MP:0020512,abnormal dendritic mushroom spine morphology|MP:0020514,abnormal dendritic thin spine morphology|MP:0020551,abnormal postsynaptic density morphology
MGI:5775620	Shank3<tm3.1Gfng>	MP:0001353,increased aggression towards mice|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0001441,increased grooming behavior|MP:0001486,abnormal startle reflex|MP:0001902,reduced NMDA-mediated synaptic currents|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002804,abnormal motor learning|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004807,abnormal paired-pulse inhibition|MP:0009936,abnormal dendritic spine morphology|MP:0011000,abnormal allogrooming behavior|MP:0011270,decreased excitatory postsynaptic current amplitude
MGI:6438113	Shank3<tm3.2Cmpl>	MP:0001360,abnormal social investigation|MP:0001441,increased grooming behavior|MP:0001458,abnormal object recognition memory|MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002797,increased thigmotaxis|MP:0003635,abnormal synaptic transmission|MP:0005386,behavior/neurological phenotype|MP:0012307,impaired spatial learning|MP:0013140,excessive vocalization
MGI:5775645	Shank3<tm4.1Gfng>	MP:0001353,increased aggression towards mice|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0001441,increased grooming behavior|MP:0001486,abnormal startle reflex|MP:0001902,reduced NMDA-mediated synaptic currents|MP:0002804,abnormal motor learning|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004807,abnormal paired-pulse inhibition|MP:0009936,abnormal dendritic spine morphology|MP:0011270,decreased excitatory postsynaptic current amplitude
MGI:5775650	Shank3<tm5.1Gfng>	MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0001441,increased grooming behavior|MP:0002757,decreased vertical activity|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008462,abnormal medium spiny neuron morphology|MP:0009936,abnormal dendritic spine morphology|MP:0011270,decreased excitatory postsynaptic current amplitude
MGI:3526253	Shar	MP:0000377,abnormal hair follicle morphology|MP:0000411,shiny fur|MP:0003849,greasy coat|MP:0010179,rough coat|MP:0011091,prenatal lethality, complete penetrance
MGI:1856699	Sharpin<cpdm>	MP:0000240,extramedullary hematopoiesis|MP:0000260,abnormal angiogenesis|MP:0000321,increased bone marrow cell number|MP:0000376,folliculitis|MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000468,abnormal esophageal epithelium morphology|MP:0000471,abnormal stomach epithelium morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000765,abnormal tongue squamous epithelium morphology|MP:0000997,abnormal synovial joint capsule morphology|MP:0001190,reddish skin|MP:0001192,scaly skin|MP:0001194,dermatitis|MP:0001212,skin lesions|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0001246,mixed cellular infiltration to dermis|MP:0001263,weight loss|MP:0001510,abnormal coat appearance|MP:0001732,postnatal growth retardation|MP:0001786,skin edema|MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001807,decreased IgA level|MP:0001861,lung inflammation|MP:0001873,stomach inflammation|MP:0001874,acanthosis|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0002220,large lymphoid organs|MP:0002276,abnormal lung interstitium morphology|MP:0002339,abnormal lymph node morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002460,decreased immunoglobulin level|MP:0002492,decreased IgE level|MP:0002494,increased IgM level|MP:0002722,abnormal immune system organ morphology|MP:0002831,absent Peyer's patches|MP:0002933,joint inflammation|MP:0003278,esophageal inflammation|MP:0003427,parakeratosis|MP:0003809,abnormal hair shaft morphology|MP:0003865,lymph node inflammation|MP:0004947,skin inflammation|MP:0005011,increased eosinophil cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005114,premature hair loss|MP:0005232,abnormal mesenteric lymph node morphology|MP:0006162,thick eyelids|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008234,absent spleen marginal zone|MP:0008463,abnormal peripheral lymph node morphology|MP:0008474,absent spleen germinal center|MP:0009580,increased keratinocyte apoptosis|MP:0009583,increased keratinocyte proliferation|MP:0009715,thick epidermis stratum basale|MP:0010072,increased pruritus|MP:0014349,absent spleen B cell follicles|MP:0031395,cutaneous mastocytosis
MGI:2386682	Sharpin<cpdm-Dem>	MP:0001194,dermatitis|MP:0002722,abnormal immune system organ morphology|MP:0004947,skin inflammation
MGI:3721903	Shb<tm1.1Miwe>	MP:0000929,open neural tube|MP:0001672,abnormal embryo development|MP:0001914,hemorrhage|MP:0004179,transmission ratio distortion|MP:0006281,abnormal tail development|MP:0011091,prenatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5440310	Shby	MP:0000416,sparse hair|MP:0001211,wrinkled skin|MP:0001265,decreased body size|MP:0001274,curly vibrissae|MP:0001282,short vibrissae|MP:0002060,abnormal skin morphology|MP:0002073,abnormal hair growth|MP:0002098,abnormal vibrissa morphology
MGI:5440312	Shby<2H>	MP:0000367,abnormal coat/ hair morphology|MP:0000416,sparse hair|MP:0000417,short hair|MP:0001211,wrinkled skin|MP:0001265,decreased body size|MP:0001274,curly vibrissae|MP:0002073,abnormal hair growth|MP:0010179,rough coat
MGI:3528975	Shc1<tm1Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:2384189	Shc1<tm1Paw>	MP:0000291,enlarged pericardium|MP:0000295,trabecula carnea hypoplasia|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000358,abnormal cell morphology|MP:0001614,abnormal blood vessel morphology|MP:0001722,pale yolk sac|MP:0002652,thin myocardium|MP:0002725,abnormal vein morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003814,vascular smooth muscle hypoplasia|MP:0003921,abnormal heart left ventricle morphology|MP:0004181,abnormal carotid artery morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005592,abnormal vascular smooth muscle morphology|MP:0005602,decreased angiogenesis|MP:0005621,abnormal cell physiology|MP:0006055,abnormal vascular endothelial cell morphology|MP:0010021,heart vascular congestion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0020319,decreased vascular endothelial cell adhesion|MP:0020849,abnormal actin cytoskeleton morphology|MP:0021158,decreased heart left ventricle wall thickness|MP:0030992,atrioventricular cushion hypoplasia
MGI:2159438	Shc1<tm1Pgp>	MP:0001661,extended life span|MP:0003674,oxidative stress|MP:0005338,atherosclerotic lesions|MP:0005341,decreased susceptibility to atherosclerosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005590,increased vasodilation|MP:0008407,decreased cellular sensitivity to hydrogen peroxide|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008413,decreased cellular sensitivity to oxidative stress
MGI:2384183	Shc1<tm1Ravi>	MP:0000774,decreased brain size|MP:0001262,decreased body weight|MP:0001823,thymus hypoplasia|MP:0002407,abnormal double-negative T cell morphology|MP:0005092,decreased double-positive T cell number|MP:0008083,decreased single-positive T cell number
MGI:3716775	Shc1<tm2Paw>	MP:0002169,no abnormal phenotype detected
MGI:3716777	Shc1<tm3Paw>	MP:0011101,prenatal lethality, incomplete penetrance
MGI:3716778	Shc1<tm4Paw>	MP:0001393,ataxia|MP:0001544,abnormal cardiovascular system physiology|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002912,abnormal excitatory postsynaptic potential|MP:0004069,abnormal muscle spindle morphology|MP:0005403,abnormal nerve conduction|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3716779	Shc1<tm5Paw>	MP:0002169,no abnormal phenotype detected
MGI:3716780	Shc1<tm6Paw>	MP:0011101,prenatal lethality, incomplete penetrance
MGI:3716781	Shc1<tm7Paw>	MP:0000937,abnormal motor neuron morphology|MP:0001393,ataxia|MP:0001524,impaired limb coordination|MP:0002080,prenatal lethality|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003312,abnormal locomotor coordination|MP:0004069,abnormal muscle spindle morphology|MP:0005403,abnormal nerve conduction
MGI:3716783	Shc1<tm9Paw>	MP:0001393,ataxia|MP:0001524,impaired limb coordination|MP:0002169,no abnormal phenotype detected|MP:0003312,abnormal locomotor coordination|MP:0008486,decreased muscle spindle number
MGI:1933344	Shc2<tm1Paw>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0000964,small dorsal root ganglion|MP:0000965,abnormal sensory neuron morphology|MP:0000969,abnormal nociceptor morphology
MGI:1933356	Shc3<tm1Paw>	MP:0003631,nervous system phenotype
MGI:6294105	Shc4<em1(IMPC)J>	MP:0010052,increased grip strength
MGI:4364718	Shcbp1l<tm1a(KOMP)Wtsi>	MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0009761,abnormal meiotic spindle morphology|MP:0014052,increased male germ cell apoptosis
MGI:5582589	Shcbp1<tm1c(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005387,immune system phenotype
MGI:5582592	Shcbp1<tm1d(EUCOMM)Wtsi>	MP:0003884,decreased macrophage cell number|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:5692819	Shfl<tm1.1(KOMP)Mbp>	MP:0000494,abnormal cecum morphology|MP:0004931,enlarged epididymis|MP:0005344,increased circulating bilirubin level
MGI:1861186	Shh<Dsh>	MP:0000074,abnormal neurocranium morphology|MP:0000107,abnormal frontal bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000163,abnormal cartilage morphology|MP:0000164,abnormal cartilage development|MP:0000433,microcephaly|MP:0000438,abnormal cranium morphology|MP:0000453,absent mouth|MP:0000455,abnormal maxilla morphology|MP:0000547,short limbs|MP:0000556,abnormal hindlimb morphology|MP:0000564,syndactyly|MP:0001293,anophthalmia|MP:0001697,abnormal embryo size|MP:0001698,decreased embryo size|MP:0002102,abnormal ear morphology|MP:0002543,brachyphalangia|MP:0002544,brachydactyly|MP:0002932,abnormal joint morphology|MP:0003189,fused joints|MP:0004442,occipital bone foramen|MP:0004620,cervical vertebral fusion|MP:0004634,short metacarpal bones|MP:0005163,cyclopia|MP:0005306,abnormal phalanx morphology|MP:0009204,absent external male genitalia|MP:0009211,absent external female genitalia|MP:0010701,fusion of atlas and odontoid process|MP:0011087,neonatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0014101,decreased chondrocyte proliferation|MP:0014105,abnormal chondrocyte differentiation|MP:0030277,thin interparietal bone
MGI:3851472	Shh<tm1.1Rseg>	MP:0000851,cerebellum hypoplasia|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0002175,decreased brain weight|MP:0002741,small olfactory bulb|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0005380,embryo phenotype
MGI:5440762	Shh<tm1Ahk>	MP:0000755,hindlimb paralysis|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001906,increased dopamine level|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0003244,loss of dopaminergic neurons|MP:0005643,decreased dopamine level|MP:0008947,increased neuron number|MP:0008948,decreased neuron number|MP:0010149,abnormal synaptic dopamine release
MGI:1934261	Shh<tm1Amc>	MP:0000137,abnormal vertebrae morphology|MP:0000377,abnormal hair follicle morphology|MP:0000378,absent hair follicles|MP:0000383,abnormal hair follicle orientation|MP:0000388,absent hair follicle inner root sheath|MP:0000414,alopecia|MP:0000462,abnormal digestive system morphology|MP:0000467,abnormal esophagus morphology|MP:0000473,abnormal stomach glandular epithelium morphology|MP:0000495,abnormal colon morphology|MP:0000496,abnormal small intestine morphology|MP:0000767,abnormal smooth muscle morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001176,abnormal lung development|MP:0001178,pulmonary hypoplasia|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001243,abnormal dermal layer morphology|MP:0002234,abnormal pharynx morphology|MP:0002264,abnormal bronchus morphology|MP:0002284,abnormal tracheal smooth muscle morphology|MP:0002691,small stomach|MP:0003120,abnormal tracheal cartilage morphology|MP:0003130,anal atresia|MP:0003271,abnormal duodenum morphology|MP:0003283,abnormal digestive organ placement|MP:0003321,tracheoesophageal fistula|MP:0003704,abnormal hair follicle development|MP:0003793,abnormal submandibular gland morphology|MP:0003809,abnormal hair shaft morphology|MP:0004007,abnormal lung vasculature morphology|MP:0004200,decreased fetal size|MP:0004553,absent tracheal cartilage rings|MP:0004712,notochord degeneration|MP:0005157,holoprosencephaly|MP:0005213,gastric metaplasia|MP:0005493,stomach epithelial hyperplasia|MP:0006261,annular pancreas|MP:0009545,abnormal dermis papillary layer morphology|MP:0009584,decreased keratinocyte proliferation|MP:0010825,abnormal lung saccule morphology|MP:0011011,impaired lung lobe morphogenesis|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011028,impaired branching involved in bronchus morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5637219	Shh<tm1b(EUCOMM)Wtsi>	MP:0001556,increased circulating HDL cholesterol level|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:1857796	Shh<tm1Chg>	MP:0000033,absent scala media|MP:0000041,absent endolymphatic duct|MP:0000138,absent vertebrae|MP:0000266,abnormal heart morphology|MP:0000428,abnormal craniofacial morphology|MP:0000474,abnormal foregut morphology|MP:0000547,short limbs|MP:0000551,absent forelimb|MP:0000557,absent hindlimb|MP:0000561,adactyly|MP:0000572,abnormal autopod morphology|MP:0000774,decreased brain size|MP:0000783,abnormal forebrain morphology|MP:0000787,abnormal telencephalon morphology|MP:0000926,absent floor plate|MP:0000932,absent notochord|MP:0000937,abnormal motor neuron morphology|MP:0000939,decreased motor neuron number|MP:0000956,decreased spinal cord size|MP:0001175,abnormal lung morphology|MP:0001691,abnormal somite shape|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0002109,abnormal limb morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0002728,absent tibia|MP:0002858,abnormal posterior semicircular canal morphology|MP:0002898,absent cartilage|MP:0003069,abnormal superior semicircular canal morphology|MP:0003161,absent lateral semicircular canal|MP:0003345,decreased rib number|MP:0003425,abnormal optic vesicle formation|MP:0003723,abnormal long bone morphology|MP:0003855,abnormal forelimb zeugopod morphology|MP:0003857,abnormal hindlimb zeugopod morphology|MP:0003984,embryonic growth retardation|MP:0004100,abnormal spinal cord interneuron morphology|MP:0004201,fetal growth retardation|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0004313,absent vestibulocochlear ganglion|MP:0004315,absent vestibular saccule|MP:0004369,absent utricle|MP:0004712,notochord degeneration|MP:0005157,holoprosencephaly|MP:0005163,cyclopia|MP:0005296,abnormal humerus morphology|MP:0005430,absent fibula|MP:0006030,abnormal otic vesicle development|MP:0006042,increased apoptosis|MP:0006279,abnormal limb development|MP:0006306,abnormal nasal pit morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011732,decreased somite size|MP:0012089,decreased midbrain size|MP:0012517,absent diencephalon
MGI:5294343	Shh<tm1(cre/ERT2)Tshim>	MP:0002169,no abnormal phenotype detected
MGI:3053959	Shh<tm1(EGFP/cre)Cjt>	MP:0000484,abnormal pulmonary artery morphology|MP:0000596,abnormal liver development|MP:0001622,abnormal vasculogenesis|MP:0002115,abnormal limb bone morphology|MP:0003923,abnormal heart left atrium morphology|MP:0004391,abnormal respiratory conducting tube morphology|MP:0005592,abnormal vascular smooth muscle morphology|MP:0005675,small gallbladder|MP:0009493,abnormal cystic duct morphology|MP:0009579,acephaly|MP:0010493,abnormal atrium myocardium morphology|MP:0010646,absent pulmonary vein|MP:0031021,abnormal gallbladder smooth muscle morphology
MGI:3051902	Shh<tm1Ptch>	MP:0000565,oligodactyly|MP:0000939,decreased motor neuron number|MP:0001698,decreased embryo size|MP:0005157,holoprosencephaly|MP:0011087,neonatal lethality, complete penetrance|MP:0021104,abnormal ventral interneuron 2 morphology|MP:0021105,abnormal ventral interneuron 3 morphology
MGI:1934268	Shh<tm2Amc>	MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000939,decreased motor neuron number|MP:0001175,abnormal lung morphology|MP:0001178,pulmonary hypoplasia|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002151,abnormal neural tube morphology|MP:0002264,abnormal bronchus morphology|MP:0002282,abnormal trachea morphology|MP:0002908,delayed wound healing|MP:0003120,abnormal tracheal cartilage morphology|MP:0003631,nervous system phenotype|MP:0003710,abnormal physiological neovascularization|MP:0004101,abnormal brain interneuron morphology|MP:0004137,abnormal gastric surface mucous cell morphology|MP:0004276,abnormal medial ganglionic eminence morphology|MP:0004551,decreased tracheal cartilage ring number|MP:0004880,lung cyst|MP:0005163,cyclopia|MP:0005381,digestive/alimentary phenotype|MP:0008004,abnormal stomach pH|MP:0009684,abnormal spinal cord lateral motor column morphology|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011085,postnatal lethality, complete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0020530,disorganized thalamus
MGI:3628824	Shh<tm2Chg>	MP:0000074,abnormal neurocranium morphology|MP:0000562,polydactyly|MP:0000780,abnormal corpus callosum morphology|MP:0000787,abnormal telencephalon morphology|MP:0000808,abnormal hippocampus development|MP:0000820,abnormal choroid plexus morphology|MP:0000934,abnormal telencephalon development|MP:0003451,absent olfactory bulb|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004276,abnormal medial ganglionic eminence morphology|MP:0004277,abnormal lateral ganglionic eminence morphology|MP:0004538,abnormal maxillary shelf morphology|MP:0005157,holoprosencephaly|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0012091,increased midbrain size|MP:0012139,increased forebrain size
MGI:3759540	Shh<tm3(cre)Chg>	MP:0000428,abnormal craniofacial morphology|MP:0000462,abnormal digestive system morphology|MP:0001672,abnormal embryo development|MP:0002081,perinatal lethality|MP:0002092,abnormal eye morphology|MP:0002127,abnormal cardiovascular system morphology|MP:0002132,abnormal respiratory system morphology|MP:0003632,abnormal nervous system morphology|MP:0004196,abnormal prenatal growth/weight/body size|MP:0005508,abnormal skeleton morphology|MP:0005621,abnormal cell physiology
MGI:3775846	Shh<tm6Amc>	MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3715222	Shisa2<tm1Sia>	MP:0000837,abnormal hypothalamus morphology|MP:0001732,postnatal growth retardation|MP:0008974,proportional dwarf|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3715223	Shisa3<tm1Sia>	MP:0002169,no abnormal phenotype detected
MGI:5637763	Shisa4<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:3715224	Shisa4<tm1Sia>	MP:0002169,no abnormal phenotype detected
MGI:3715226	Shisa5<tm1Sia>	MP:0002169,no abnormal phenotype detected
MGI:6156591	Shisa6<em1(IMPC)Tcp>	MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0001258,decreased body length|MP:0002059,abnormal seminal vesicle morphology|MP:0002833,increased heart weight|MP:0005016,decreased lymphocyte cell number|MP:0009198,abnormal male genitalia morphology
MGI:6355919	Shisa6<em1Syos>	MP:0005378,growth/size/body region phenotype|MP:0010768,mortality/aging
MGI:5789901	Shisa7<em1(IMPC)J>	MP:0000745,tremors|MP:0001304,cataract|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002574,increased vertical activity|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount
MGI:6154949	Shisa7<tm1.2Sasp>	MP:0001473,reduced long-term potentiation|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0011003,reduced AMPA-mediated synaptic currents|MP:0011272,short excitatory postsynaptic current rise time|MP:0011274,short excitatory postsynaptic current decay time|MP:0012319,fast extinction of fear memory
MGI:6257819	Shisa9<em1(IMPC)H>	MP:0001399,hyperactivity|MP:0009142,decreased prepulse inhibition
MGI:6109966	Shisa9<tm1Mony>	MP:0002917,decreased synaptic depression|MP:0002919,enhanced paired-pulse facilitation|MP:0004859,abnormal synaptic plasticity|MP:0005402,abnormal action potential|MP:0011003,reduced AMPA-mediated synaptic currents|MP:0011267,abnormal excitatory postsynaptic current amplitude
MGI:6341918	Shisal1<em1(IMPC)Ccpcz>	MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0003917,increased kidney weight|MP:0005084,abnormal gallbladder morphology|MP:0009342,enlarged gallbladder|MP:0010097,abnormal retina blood vessel morphology|MP:0013279,increased fasting circulating glucose level
MGI:7413928	Shkbp1<em1(IMPC)J>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:6140112	Shld1<em1(IMPC)Mbp>	MP:0000274,enlarged heart|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0002339,abnormal lymph node morphology|MP:0004906,enlarged uterus
MGI:6257464	Shld1<em1(IMPC)Wtsi>	MP:0001552,increased circulating triglyceride level|MP:0005561,increased mean corpuscular hemoglobin|MP:0010067,increased red blood cell distribution width
MGI:6719506	Shld1<em1Nus>	MP:0004816,abnormal class switch recombination|MP:0010768,mortality/aging
MGI:4344587	Shmt1<Gt(AD0236)Wtsi>	MP:0010768,mortality/aging
MGI:3821697	Shmt1<tm1.1Stov>	MP:0000609,abnormal liver physiology
MGI:5692916	Shmt1<tm1b(KOMP)Wtsi>	MP:0002599,increased mean platelet volume|MP:0008806,increased circulating amylase level
MGI:3821629	Shmt1<tm1Stov>	MP:0030625,increased circulating cysteine level|MP:0030688,decreased circulating cystathionine level
MGI:6257517	Shmt2<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0002080,prenatal lethality|MP:0003717,pallor|MP:0004258,abnormal placenta size|MP:0004952,increased spleen weight|MP:0011100,preweaning lethality, complete penetrance
MGI:6150909	Shmt2<em1Jiha>	MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0010955,abnormal respiratory electron transport chain|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:3047738	Shmu	MP:0000373,belly spot|MP:0000585,kinked tail|MP:0001680,abnormal mesoderm development|MP:0001698,decreased embryo size|MP:0002075,abnormal coat/hair pigmentation|MP:0002939,head spot
MGI:1857038	shmy	MP:0001290,delayed eyelid opening|MP:0001406,abnormal gait|MP:0001925,male infertility|MP:0003225,axonal dystrophy
MGI:3045706	shmy<2J>	MP:0000745,tremors|MP:0001393,ataxia|MP:0003225,axonal dystrophy
MGI:3045705	shmy<3J>	MP:0000745,tremors|MP:0001393,ataxia|MP:0003225,axonal dystrophy|MP:0003631,nervous system phenotype
MGI:1857039	sho	MP:0000085,large anterior fontanelle|MP:0000098,abnormal vomer bone morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000428,abnormal craniofacial morphology|MP:0000435,shortened head|MP:0000438,abnormal cranium morphology|MP:0000458,abnormal mandible morphology|MP:0000477,abnormal intestine morphology|MP:0000496,abnormal small intestine morphology|MP:0000706,small thymus|MP:0000762,abnormal tongue morphology|MP:0001119,abnormal female reproductive system morphology|MP:0001575,cyanosis|MP:0001698,decreased embryo size|MP:0002111,abnormal tail morphology|MP:0002233,abnormal nose morphology|MP:0003574,abnormal oviduct morphology|MP:0003723,abnormal long bone morphology|MP:0004377,small frontal bone|MP:0004470,small nasal bone|MP:0004540,small maxilla|MP:0004592,small mandible|MP:0004686,decreased length of long bones|MP:0004870,small premaxilla|MP:0005406,abnormal heart size|MP:0008818,abnormal interfrontal bone morphology|MP:0009886,failure of palatal shelf elevation|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009890,cleft secondary palate|MP:0009891,abnormal palate bone morphology|MP:0009907,decreased tongue size|MP:0010082,sternebra fusion|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011727,ectopic ovary|MP:0013788,external nares atresia|MP:0021208,median cleft palate|MP:0030383,small presphenoid bone|MP:0031443,abnormal tongue position
MGI:4367837	Sho2	MP:0000435,shortened head
MGI:6160875	Shoc1<tm1Rjpz>	MP:0011092,embryonic lethality, complete penetrance
MGI:6160879	Shoc1<tm2Rjpz>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0008966,abnormal chiasmata formation|MP:0009451,abnormal chromosomal synapsis|MP:0014052,increased male germ cell apoptosis
MGI:4459449	Shoc2<tm1.1Mhan>	MP:0002169,no abnormal phenotype detected
MGI:4459450	Shoc2<tm1.2Mhan>	MP:0011092,embryonic lethality, complete penetrance
MGI:6257539	Shox2<em1(IMPC)Bay>	MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:3628798	Shox2<tm1.1Ddu>	MP:0005371,limbs/digits/tail phenotype
MGI:3794658	Shox2<tm1Acgg>	MP:0000267,abnormal heart development|MP:0001787,pericardial edema|MP:0003228,abnormal sinus venosus morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3626291	Shox2<tm1Ddu>	MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0031542,sinoatrial node hypoplasia
MGI:3605739	Shox2<tm1Ypc>	MP:0000266,abnormal heart morphology|MP:0001614,abnormal blood vessel morphology|MP:0009655,abnormal secondary palate development|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009890,cleft secondary palate|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0021214,anterior cleft palate|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0031460,abnormal palatal shelf morphology|MP:0031542,sinoatrial node hypoplasia
MGI:5009258	Shox2<tm2.1(SHOX_a)Ypc>	MP:0005385,cardiovascular system phenotype|MP:0008489,slow postnatal weight gain|MP:0011086,postnatal lethality, incomplete penetrance|MP:0030330,abnormal temporomandibular joint disk morphology
MGI:5009257	Shox2<tm2(SHOX_a)Ypc>	MP:0001636,irregular heartbeat|MP:0005333,decreased heart rate|MP:0005382,craniofacial phenotype|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0011085,postnatal lethality, complete penetrance
MGI:5504510	Shox2<tm4.1Ypc>	MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:6152640	Shpk<em1(IMPC)Mbp>	MP:0005266,abnormal metabolism|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0009643,abnormal urine homeostasis
MGI:7705855	Shpk<em1Scher>	MP:0005266,abnormal metabolism|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0009643,abnormal urine homeostasis
MGI:6156437	Shprh<em1(IMPC)Tcp>	MP:0000709,enlarged thymus|MP:0002060,abnormal skin morphology|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:6152641	Shroom2<em1(IMPC)Mbp>	MP:0001325,abnormal retina morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002968,increased circulating alkaline phosphatase level
MGI:6285605	Shroom3<em1(IMPC)Bay>	MP:0000914,exencephaly|MP:0001297,microphthalmia|MP:0002111,abnormal tail morphology|MP:0003054,spina bifida|MP:0003385,abnormal body wall morphology|MP:0003743,abnormal facial morphology|MP:0008797,facial cleft|MP:0009908,protruding tongue|MP:0011100,preweaning lethality, complete penetrance
MGI:1889778	Shroom3<Gt(ROSA53)Sor>	MP:0000075,absent neurocranium|MP:0000108,midline facial cleft|MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000284,double outlet right ventricle|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0000930,wavy neural tube|MP:0001672,abnormal embryo development|MP:0005155,herniated intestine|MP:0006126,abnormal cardiac outflow tract development|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0010402,ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010433,double inlet heart left ventricle|MP:0010585,abnormal conotruncal ridge morphology|MP:0010912,herniated liver|MP:0011089,perinatal lethality, complete penetrance|MP:0011394,increased fetal cardiomyocyte proliferation|MP:0020414,abnormal fibroblast physiology|MP:0021158,decreased heart left ventricle wall thickness|MP:0031525,thin left ventricle myocardium compact layer
MGI:4943186	Shroom3<m1Nisw>	MP:0000914,exencephaly|MP:0003385,abnormal body wall morphology|MP:0008797,facial cleft|MP:0011089,perinatal lethality, complete penetrance
MGI:5766139	Shroom4<tm1.1(NCOM)Mfgc>	MP:0001314,cornea opacity
MGI:5320604	Shsm	MP:0001265,decreased body size|MP:0005424,jerky movement|MP:0009703,decreased birth body size
MGI:3812137	shsn	MP:0000063,decreased bone mineral density|MP:0000445,short snout|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0005459,decreased percent body fat/body weight|MP:0010124,decreased bone mineral content
MGI:3603623	Shtm	MP:0020470,shortened circadian behavior period
MGI:5912122	Shtn1<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0003961,decreased lean body mass
MGI:6358574	Shtn1<tm1Nngk>	MP:0000780,abnormal corpus callosum morphology|MP:0000781,decreased corpus callosum size|MP:0000783,abnormal forebrain morphology|MP:0008222,decreased hippocampal commissure size|MP:0008225,abnormal anterior commissure morphology|MP:0008226,decreased anterior commissure size|MP:0008547,abnormal neocortex morphology|MP:0009450,abnormal axon fasciculation|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3613763	Shtrm	MP:0020470,shortened circadian behavior period
MGI:3830710	Siae<tm1.2Avrk>	MP:0005387,immune system phenotype
MGI:4842607	Siae<tm1a(EUCOMM)Wtsi>	MP:0005387,immune system phenotype
MGI:2157074	Siafq1<DBA/2>	MP:0002067,abnormal sensory capabilities/reflexes/nociception
MGI:2183245	Siah1a<tm1Ddlb>	MP:0000601,small liver|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001919,abnormal reproductive system physiology|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002083,premature death|MP:0002216,abnormal seminiferous tubule morphology|MP:0005159,azoospermia|MP:0005384,cellular phenotype|MP:0008261,arrest of male meiosis|MP:0011750,abnormal seminiferous tubule epithelium morphology
MGI:3761096	Siah1b<tm1Ddlb>	MP:0005384,cellular phenotype
MGI:2683932	Siah2<tm1Ddlb>	MP:0002397,abnormal bone marrow morphology|MP:0005384,cellular phenotype
MGI:2384716	Sials<MRL/MpJ>	MP:0001870,salivary gland inflammation
MGI:1862005	Sic	MP:0001265,decreased body size
MGI:3706137	Sicd1<C57BL/6J>	MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003240,loss of hippocampal neurons
MGI:3706138	Sicd1<FVB/NJ>	MP:0003240,loss of hippocampal neurons
MGI:3775638	Sicd4<DBA/2J>	MP:0003240,loss of hippocampal neurons
MGI:5695953	Sidt1<tm1.1(KOMP)Vlcg>	MP:0000598,abnormal liver morphology|MP:0002339,abnormal lymph node morphology
MGI:6153615	Sidt2<em1(IMPC)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0003442,decreased circulating glycerol level|MP:0004151,decreased circulating iron level|MP:0005179,decreased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005505,thrombocytosis|MP:0005567,decreased circulating total protein level|MP:0008806,increased circulating amylase level
MGI:5532825	Sidt2<tm1.1Hzha>	MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001552,increased circulating triglyceride level|MP:0001654,hepatic necrosis|MP:0001860,liver inflammation|MP:0002628,hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0002941,increased circulating alanine transaminase level|MP:0003333,liver fibrosis|MP:0003564,abnormal insulin secretion|MP:0003645,increased pancreatic beta cell number|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005376,homeostasis/metabolism phenotype|MP:0005559,increased circulating glucose level|MP:0009355,increased liver triglyceride level|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0010359,increased liver free fatty acids level|MP:0020354,increased endoplasmic reticulum stress
MGI:5532827	Sidt2<tm1Hzha>	MP:0002169,no abnormal phenotype detected
MGI:1861182	Sig	MP:0000031,abnormal cochlea morphology|MP:0000035,abnormal membranous labyrinth morphology|MP:0000041,absent endolymphatic duct|MP:0000564,syndactyly|MP:0000572,abnormal autopod morphology|MP:0001302,eyelids open at birth|MP:0001891,hydrocephaly|MP:0002102,abnormal ear morphology|MP:0004249,abnormal crista ampullaris morphology|MP:0004333,abnormal utricular macula morphology|MP:0004426,abnormal cochlear labyrinth morphology|MP:0006013,absent endolymphatic sac|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology|MP:0006148,binocular blindness|MP:0011089,perinatal lethality, complete penetrance
MGI:2675236	Sigirr<tm1Lix>	MP:0001846,increased inflammatory response|MP:0008722,abnormal chemokine secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0009334,abnormal splenocyte proliferation
MGI:3038878	Sigirr<tm1Mant>	MP:0002376,abnormal dendritic cell physiology|MP:0005387,immune system phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0008568,abnormal interleukin secretion|MP:0008705,increased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion
MGI:5478584	Siglec15<tm1Yohi>	MP:0000062,increased bone mineral density|MP:0000067,osteopetrosis|MP:0004989,decreased osteoblast cell number|MP:0004993,decreased bone resorption|MP:0005006,abnormal osteoblast physiology|MP:0005390,skeleton phenotype|MP:0008271,abnormal bone ossification|MP:0008396,abnormal osteoclast differentiation|MP:0009643,abnormal urine homeostasis|MP:0010123,increased bone mineral content|MP:0010868,increased bone trabecula number|MP:0010872,increased trabecular bone mass|MP:0010878,increased trabecular bone volume|MP:0010967,increased compact bone area|MP:0013617,increased areal bone mineral density|MP:0020011,increased bone mineral density of femur|MP:0030984,increased circulating osteocalcin level
MGI:5708288	Siglec1<tm1.1(KOMP)Vlcg>	MP:0003917,increased kidney weight|MP:0005630,increased lung weight
MGI:3617694	Siglec1<tm1Croc>	MP:0001798,impaired macrophage phagocytosis|MP:0001806,decreased IgM level|MP:0002412,increased susceptibility to bacterial infection|MP:0002458,abnormal B cell number|MP:0003944,abnormal T cell subpopulation ratio|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008597,decreased circulating interleukin-6 level|MP:0008661,decreased interleukin-10 secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008706,decreased interleukin-6 secretion
MGI:5447769	Siglec1<tm2.1Croc>	MP:0001798,impaired macrophage phagocytosis|MP:0002411,decreased susceptibility to bacterial infection|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008597,decreased circulating interleukin-6 level
MGI:6195824	Siglece<tm1.1(SIGLEC16)Avrk>	MP:0002411,decreased susceptibility to bacterial infection|MP:0008596,increased circulating interleukin-6 level|MP:0008617,increased circulating interleukin-12 level|MP:0008713,abnormal cytokine level
MGI:5490543	Siglece<tm1Arte>	MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology
MGI:5490544	Siglece<tm1Croc>	MP:0002451,abnormal macrophage physiology|MP:0002463,abnormal neutrophil physiology
MGI:5543479	Siglecf<tm1.2Avrk>	MP:0001861,lung inflammation|MP:0002443,abnormal eosinophil differentiation|MP:0002465,abnormal eosinophil physiology|MP:0005011,increased eosinophil cell number|MP:0005387,immune system phenotype
MGI:6200062	Siglecg<M1Btlr>	MP:0004977,increased B-1 B cell number
MGI:6200066	Siglecg<m2Btlr>	MP:0004977,increased B-1 B cell number|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010839,decreased CD8-positive, alpha-beta memory T cell number
MGI:6200072	Siglecg<M3Btlr>	MP:0001806,decreased IgM level|MP:0004977,increased B-1 B cell number|MP:0008167,increased B-1a cell number|MP:0008207,decreased B-2 B cell number
MGI:6283644	Siglecg<M4Btlr>	MP:0004977,increased B-1 B cell number
MGI:6283658	Siglecg<M5Btlr>	MP:0008167,increased B-1a cell number
MGI:3718495	Siglecg<tm1Lnit>	MP:0001844,autoimmune response|MP:0002494,increased IgM level|MP:0004977,increased B-1 B cell number|MP:0008099,abnormal plasma cell differentiation|MP:0008167,increased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0008496,decreased IgG2a level
MGI:3771358	Siglecg<tm1Yliu>	MP:0002494,increased IgM level|MP:0003132,increased pre-B cell number|MP:0008167,increased B-1a cell number
MGI:5052173	Siglech<tm1.1Cfg>	MP:0002216,abnormal seminiferous tubule morphology|MP:0002703,abnormal renal tubule morphology|MP:0003205,testicular atrophy|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0005565,increased blood urea nitrogen level
MGI:5308226	Siglech<tm1.1Ksat>	MP:0002455,abnormal dendritic cell antigen presentation|MP:0004941,abnormal regulatory T cell morphology|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0008573,increased circulating interferon-alpha level|MP:0008574,decreased circulating interferon-alpha level|MP:0008647,increased circulating interleukin-12b level|MP:0008648,decreased circulating interleukin-12b level|MP:0008769,abnormal plasmacytoid dendritic cell physiology|MP:0009786,decreased susceptibility to infection induced morbidity/mortality|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0010210,abnormal circulating cytokine level|MP:0010219,increased T-helper 17 cell number|MP:0010220,decreased T-helper 17 cell number
MGI:6194871	Siglecl2<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:3529055	Sigmar1<Gt(OST422756)Lex>	MP:0001405,impaired coordination|MP:0001516,abnormal motor coordination/balance|MP:0002573,behavioral despair|MP:0005386,behavior/neurological phenotype
MGI:6120698	Sigmar1<tm1.1(KOMP)Wtsi>	MP:0001399,hyperactivity
MGI:3044771	Sigmar1<tm1Lmon>	MP:0001402,decreased locomotor activity
MGI:5648546	Sik1<tm1.1Berd>	MP:0001262,decreased body weight|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003383,abnormal gluconeogenesis|MP:0005292,improved glucose tolerance|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:5548353	Sik1<tm1.1(KOMP)Vlcg>	MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0003917,increased kidney weight|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:5648836	Sik1<tm1.2Berd>	MP:0001262,decreased body weight|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005376,homeostasis/metabolism phenotype|MP:0005560,decreased circulating glucose level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6158471	Sik2<em1(IMPC)Mbp>	MP:0000274,enlarged heart
MGI:5609867	Sik2<tm1Htake>	MP:0005409,darkened coat color
MGI:5762866	Sik2<tm1Lex>	MP:0001552,increased circulating triglyceride level|MP:0001846,increased inflammatory response|MP:0002079,increased circulating insulin level|MP:0004890,decreased energy expenditure|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0008034,enhanced lipolysis|MP:0009118,increased white fat cell size|MP:0010379,decreased respiratory quotient|MP:0011168,abnormal fat cell differentiation|MP:0011940,decreased food intake|MP:0014172,decreased fatty acid oxidation|MP:0030017,decreased adipocyte glucose uptake|MP:0030022,decreased muscle cell glucose uptake|MP:0030968,decreased circulating adiponectin level|MP:0031391,increased locomotor activity
MGI:5806543	Sik3<em1Iiis>	MP:0014638,increased sleep duration
MGI:5800458	Sik3<Slp>	MP:0005386,behavior/neurological phenotype|MP:0012288,abnormal paradoxical sleep pattern|MP:0012289,abnormal non-rapid eye movement sleep pattern|MP:0014624,abnormal brain delta wave pattern|MP:0014638,increased sleep duration|MP:0020478,abnormal circadian sleep/wake cycle
MGI:5806542	Sik3<tm1.1Iiis>	MP:0014638,increased sleep duration
MGI:5085429	Sik3<tm1a(EUCOMM)Hmgu>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000160,kyphosis|MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0000208,decreased hematocrit|MP:0000322,increased granulocyte number|MP:0000438,abnormal cranium morphology|MP:0000552,abnormal radius morphology|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0001312,abnormal cornea morphology|MP:0001325,abnormal retina morphology|MP:0001926,female infertility|MP:0002075,abnormal coat/hair pigmentation|MP:0002111,abnormal tail morphology|MP:0002187,abnormal fibula morphology|MP:0002599,increased mean platelet volume|MP:0002875,decreased erythrocyte cell number|MP:0002932,abnormal joint morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0004174,abnormal spine curvature|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004974,decreased regulatory T cell number|MP:0005011,increased eosinophil cell number|MP:0005018,decreased T cell number|MP:0005108,abnormal ulna morphology|MP:0005179,decreased circulating cholesterol level|MP:0005270,abnormal zygomatic bone morphology|MP:0005292,improved glucose tolerance|MP:0005296,abnormal humerus morphology|MP:0005344,increased circulating bilirubin level|MP:0005560,decreased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005566,decreased blood urea nitrogen level|MP:0005628,decreased circulating potassium level|MP:0005633,increased circulating sodium level|MP:0008040,decreased NK T cell number|MP:0008044,increased NK cell number|MP:0008045,decreased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008173,increased follicular B cell number|MP:0008178,decreased germinal center B cell number|MP:0008347,decreased gamma-delta T cell number|MP:0008524,increased plasmacytoid dendritic cell number|MP:0008806,increased circulating amylase level|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level|MP:0010099,abnormal thoracic cage shape|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0012765,decreased alpha-beta T cell number|MP:0012768,decreased KLRG1-positive NK cell number|MP:0013154,increased KLRG1+ CD8 alpha-beta T cell number|MP:0013418,increased memory-marker gamma-delta T cell number|MP:0013420,decreased CD5-positive gamma-delta T cell number|MP:0013427,increased memory-marker NK cell number|MP:0013433,increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0013436,increased CD8-positive, naive alpha-beta T cell number|MP:0013511,increased CD4-negative NK T cell number|MP:0013513,decreased memory-marker CD4-negative NK T cell number|MP:0013517,increased KLRG1-positive CD4-negative NK T cell number|MP:0013519,decreased CD4-positive NK T cell number|MP:0013522,decreased memory-marker CD4-positive NK T cell number|MP:0013675,decreased Ly6C-positive mature NK cell number|MP:0013679,increased Ly6C-positive NK T cell number|MP:0013683,decreased early germinal center B cell number|MP:0013764,decreased T-helper cell number|MP:0013771,decreased effector memory T-helper cell number|MP:0013772,increased effector memory T-helper cell number|MP:0013774,decreased KLRG1-positive T-helper cell number|MP:0013775,increased KLRG1-positive T-helper cell number
MGI:5317918	Sik3<tm1Htake>	MP:0000109,abnormal parietal bone morphology|MP:0000161,scoliosis|MP:0000163,abnormal cartilage morphology|MP:0000167,decreased chondrocyte number|MP:0000186,decreased circulating HDL cholesterol level|MP:0000341,abnormal bile color|MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000610,cholestasis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001431,abnormal eating behavior|MP:0001552,increased circulating triglyceride level|MP:0001764,abnormal homeostasis|MP:0001780,decreased brown adipose tissue amount|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0002896,abnormal bone mineralization|MP:0002941,increased circulating alanine transaminase level|MP:0002942,decreased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003116,rickets|MP:0003402,decreased liver weight|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003420,delayed intramembranous bone ossification|MP:0003795,abnormal bone structure|MP:0003918,decreased kidney weight|MP:0003947,abnormal cholesterol level|MP:0003976,decreased circulating VLDL triglyceride level|MP:0004321,short sternum|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004672,short ribs|MP:0004686,decreased length of long bones|MP:0004703,abnormal vertebral column morphology|MP:0004773,abnormal bile composition|MP:0004789,increased bile salt level|MP:0004892,increased adiponectin level|MP:0005084,abnormal gallbladder morphology|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005344,increased circulating bilirubin level|MP:0005415,intrahepatic cholestasis|MP:0005416,abnormal circulating protein level|MP:0005418,abnormal circulating hormone level|MP:0005448,abnormal energy homeostasis|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0006398,increased long bone epiphyseal plate size|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009109,decreased pancreas weight|MP:0009269,decreased fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0009303,decreased renal fat pad weight|MP:0009342,enlarged gallbladder|MP:0009356,decreased liver triglyceride level|MP:0009492,abnormal gallbladder epithelium morphology|MP:0010026,decreased liver cholesterol level|MP:0010027,increased liver cholesterol level|MP:0010378,increased respiratory quotient|MP:0010743,delayed cranial suture closure|MP:0011016,increased core body temperature|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011168,abnormal fat cell differentiation|MP:0011234,abnormal retinol level|MP:0011504,abnormal limb long bone morphology|MP:0014682,increased polyploid hepatocyte number|MP:0030388,large fontanelles|MP:0030884,rachitic rosary|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:7796137	Sike1<em1Cya>	MP:0000609,abnormal liver physiology|MP:0003674,oxidative stress|MP:0004875,increased mean systemic arterial blood pressure|MP:0005165,increased susceptibility to injury|MP:0005319,abnormal enzyme/coenzyme level|MP:0005378,growth/size/body region phenotype|MP:0008752,abnormal tumor necrosis factor level|MP:0014433,increased cytokine level|MP:0014435,increased interferon level|MP:0014437,increased interleukin level
MGI:3603007	Sil1<Gt(RST462)Byg>	MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0001393,ataxia|MP:0001504,abnormal posture
MGI:3055918	Sil1<wz>	MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0001393,ataxia|MP:0002081,perinatal lethality
MGI:6511794	Silc1<em1Uli>	MP:0003651,abnormal axon extension|MP:0005164,abnormal response to injury
MGI:3812149	Sim1<Rgsc646>	MP:0001261,obese|MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level|MP:0002079,increased circulating insulin level|MP:0005331,insulin resistance|MP:0006353,increased glycosylated hemoglobin level
MGI:3526899	Sim1<tm1.1Az>	MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001261,obese|MP:0001433,polyphagia|MP:0002079,increased circulating insulin level|MP:0005448,abnormal energy homeostasis|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0010024,increased total body fat amount
MGI:3758479	Sim1<tm1.2Az>	MP:0002169,no abnormal phenotype detected
MGI:2180390	Sim1<tm1Fan>	MP:0000005,increased brown adipose tissue amount|MP:0000008,increased white adipose tissue amount|MP:0000778,abnormal nervous system tract morphology|MP:0000830,abnormal diencephalon morphology|MP:0001257,increased body length|MP:0001433,polyphagia|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002659,pituitary gland hypoplasia|MP:0002970,abnormal white adipose tissue morphology|MP:0002971,abnormal brown adipose tissue morphology|MP:0005455,increased susceptibility to weight gain|MP:0008845,abnormal paraventricular hypothalamic nucleus morphology|MP:0008846,abnormal supraoptic nucleus morphology|MP:0009468,absent magnocellular neurosecretory cells|MP:0011087,neonatal lethality, complete penetrance|MP:0013340,abnormal pituicyte morphology
MGI:3612969	Sim1<tm1Jlmd>	MP:0000778,abnormal nervous system tract morphology|MP:0000837,abnormal hypothalamus morphology|MP:0002058,neonatal lethality|MP:0003631,nervous system phenotype|MP:0006009,abnormal neuronal migration|MP:0006043,decreased apoptosis
MGI:2384488	Sim2<tm1Shmb>	MP:0000116,abnormal tooth development|MP:0001954,respiratory distress|MP:0002251,abnormal nasopharynx morphology|MP:0003755,abnormal palate morphology|MP:0003760,decreased palatal length|MP:0004452,abnormal pterygoid process morphology|MP:0009247,meteorism|MP:0009883,palatal shelf hypoplasia|MP:0009890,cleft secondary palate|MP:0009908,protruding tongue|MP:0010994,aerophagia|MP:0011085,postnatal lethality, complete penetrance|MP:0014429,increased hyaluronic acid level
MGI:4822565	sims	MP:0000120,malocclusion|MP:0000745,tremors|MP:0001265,decreased body size|MP:0001496,audiogenic seizures|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002637,small uterus|MP:0003936,abnormal reproductive system development|MP:0005238,increased brain size|MP:0009358,environmentally induced seizures|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3583656	Sin3a<tm1.1Rdp>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3583655	Sin3a<tm1Rdp>	MP:0002169,no abnormal phenotype detected
MGI:4410334	Sin3b<tm1.1Rdp>	MP:0002169,no abnormal phenotype detected
MGI:4410336	Sin3b<tm1.2Rdp>	MP:0000334,decreased granulocyte number|MP:0000603,pale liver|MP:0002447,abnormal erythrocyte morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002896,abnormal bone mineralization|MP:0003135,increased erythroid progenitor cell number|MP:0004045,abnormal cell cycle checkpoint function|MP:0004201,fetal growth retardation|MP:0008111,abnormal granulocyte differentiation|MP:0009395,increased nucleated erythrocyte cell number|MP:0009431,decreased fetal weight|MP:0010178,increased number of Howell-Jolly bodies|MP:0011087,neonatal lethality, complete penetrance
MGI:6341898	Sinhcaf<em1(IMPC)Ccpcz>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001404,no spontaneous movement|MP:0001697,abnormal embryo size|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0005565,increased blood urea nitrogen level|MP:0011100,preweaning lethality, complete penetrance
MGI:6474233	Sinhcaf<tm1.2Hmd>	MP:0000267,abnormal heart development|MP:0000284,double outlet right ventricle|MP:0000601,small liver|MP:0000694,spleen hypoplasia|MP:0002151,abnormal neural tube morphology|MP:0002188,small heart|MP:0003119,abnormal digestive system development|MP:0003984,embryonic growth retardation|MP:0004110,transposition of great arteries|MP:0006126,abnormal cardiac outflow tract development|MP:0010402,ventricular septal defect|MP:0010422,heart right ventricle hypoplasia|MP:0011011,impaired lung lobe morphogenesis|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012252,abnormal septum transversum morphology
MGI:6474234	Sinhcaf<tm1Hmd>	MP:0001672,abnormal embryo development|MP:0003119,abnormal digestive system development
MGI:5603576	Sipa1l1<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002574,increased vertical activity|MP:0004924,abnormal behavior|MP:0010053,decreased grip strength
MGI:7621907	Sipa1l1<tm1Taki>	MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0002574,increased vertical activity|MP:0002797,increased thigmotaxis|MP:0002807,abnormal eye blink conditioning behavior|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0009745,abnormal behavioral response to xenobiotic|MP:0009746,enhanced behavioral response to xenobiotic|MP:0009747,impaired behavioral response to xenobiotic|MP:0010768,mortality/aging|MP:0012307,impaired spatial learning|MP:0021111,decreased social investigation
MGI:6441768	Sipa1l2<tm1Mrkr>	MP:0001473,reduced long-term potentiation|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008432,abnormal long-term spatial reference memory
MGI:4392730	Sipa1l3<Gt(EUCE0020a11)Hmgu>	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001306,small lens|MP:0002840,abnormal lens fiber morphology|MP:0003237,abnormal lens epithelium morphology|MP:0011482,posterior iris synechia
MGI:5767328	Sipa1<tm1b(EUCOMM)Hmgu>	MP:0001410,head bobbing
MGI:3575291	Sipa1<tm1Nm>	MP:0000218,increased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000321,increased bone marrow cell number|MP:0000322,increased granulocyte number|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0001577,anemia|MP:0002123,abnormal definitive hematopoiesis|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002875,decreased erythrocyte cell number|MP:0004809,increased hematopoietic stem cell number|MP:0005152,pancytopenia|MP:0005481,increased chronic myelocytic leukemia incidence
MGI:5614693	Sirpa<tm1b(EUCOMM)Hmgu>	MP:0000691,enlarged spleen|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004952,increased spleen weight|MP:0005293,impaired glucose tolerance|MP:0005566,decreased blood urea nitrogen level|MP:0009142,decreased prepulse inhibition
MGI:2388979	Sirpa<tm1Nog>	MP:0001262,decreased body weight|MP:0002451,abnormal macrophage physiology|MP:0002573,behavioral despair|MP:0002628,hepatic steatosis|MP:0003179,thrombocytopenia|MP:0005018,decreased T cell number|MP:0005362,abnormal Langerhans cell physiology|MP:0008254,increased megakaryocyte cell number
MGI:5558020	Sirpa<tm1Umri>	MP:0001473,reduced long-term potentiation|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002919,enhanced paired-pulse facilitation|MP:0004769,abnormal synaptic vesicle morphology|MP:0004792,abnormal synaptic vesicle number|MP:0009538,abnormal synapse morphology
MGI:6153617	Sirpb1a<em1(IMPC)Wtsi>	MP:0002941,increased circulating alanine transaminase level
MGI:6158514	Sirpd<em1(IMPC)Mbp>	MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney
MGI:3812143	Sirt1<tm1.1Cxd>	MP:0000313,abnormal cell death|MP:0000432,abnormal head morphology|MP:0000914,exencephaly|MP:0001698,decreased embryo size|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0003702,abnormal chromosome morphology|MP:0004024,aneuploidy|MP:0004045,abnormal cell cycle checkpoint function|MP:0004760,increased mitotic index|MP:0008057,abnormal DNA replication|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008770,decreased survivor rate|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0013168,absent hindlimb buds|MP:0014760,impaired DNA repair
MGI:5544792	Sirt1<tm1.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:3713747	Sirt1<tm1.1Ygu>	MP:0000627,abnormal mammary gland morphology|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality|MP:0005389,reproductive system phenotype|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0013716,hypolactation
MGI:5305225	Sirt1<tm1.2Cxd>	MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002628,hepatic steatosis|MP:0009355,increased liver triglyceride level
MGI:5548731	Sirt1<tm1b(EUCOMM)Wtsi>	MP:0000149,abnormal scapula morphology|MP:0000443,abnormal snout morphology|MP:0000455,abnormal maxilla morphology|MP:0001322,abnormal iris morphology|MP:0002100,abnormal tooth morphology|MP:0002606,increased basophil cell number|MP:0004122,abnormal sinus arrhythmia|MP:0004509,abnormal pelvic girdle bone morphology|MP:0005287,narrow eye opening|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2677354	Sirt1<tm1Fwa>	MP:0000267,abnormal heart development|MP:0000914,exencephaly|MP:0001004,abnormal retina photoreceptor morphology|MP:0001265,decreased body size|MP:0001286,abnormal eye development|MP:0001297,microphthalmia|MP:0001698,decreased embryo size|MP:0002092,abnormal eye morphology|MP:0002687,oligozoospermia|MP:0002745,abnormal atrioventricular valve morphology|MP:0003727,abnormal retina layer morphology|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0005387,immune system phenotype|MP:0008512,disorganized retina inner nuclear layer|MP:0008516,disorganized retina outer nuclear layer|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:2448246	Sirt1<tm1Mcby>	MP:0000276,heart right ventricle hypertrophy|MP:0000445,short snout|MP:0000613,abnormal salivary gland morphology|MP:0001127,small ovary|MP:0001134,absent corpus luteum|MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001340,abnormal eyelid morphology|MP:0001346,abnormal lacrimal gland morphology|MP:0001382,abnormal nursing|MP:0001402,decreased locomotor activity|MP:0001426,polydipsia|MP:0001433,polyphagia|MP:0001698,decreased embryo size|MP:0001732,postnatal growth retardation|MP:0001861,lung inflammation|MP:0001862,interstitial pneumonia|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0002081,perinatal lethality|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002216,abnormal seminiferous tubule morphology|MP:0002461,increased immunoglobulin level|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0002743,glomerulonephritis|MP:0002773,decreased circulating luteinizing hormone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0002988,decreased urine osmolality|MP:0003058,increased insulin secretion|MP:0003725,increased autoantibody level|MP:0003828,pulmonary edema|MP:0004109,abnormal Sertoli cell development|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004852,decreased testis weight|MP:0005176,eyelids fail to open|MP:0005202,lethargy|MP:0005289,increased oxygen consumption|MP:0005291,abnormal glucose tolerance|MP:0005325,abnormal renal glomerulus morphology|MP:0005336,abnormal inguinal fat pad morphology|MP:0005389,reproductive system phenotype|MP:0005478,decreased circulating thyroxine level|MP:0005536,decreased Leydig cell number|MP:0005578,teratozoospermia|MP:0006197,ocular hypotelorism|MP:0006280,abnormal digit development|MP:0006379,abnormal spermatocyte morphology|MP:0006380,abnormal spermatid morphology|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008261,arrest of male meiosis|MP:0008489,slow postnatal weight gain|MP:0008869,anovulation|MP:0008892,abnormal sperm flagellum morphology|MP:0009009,absent estrous cycle|MP:0009081,thin uterus|MP:0009164,exocrine pancreas atrophy|MP:0009652,abnormal palatal rugae morphology|MP:0010946,hyperpnea|MP:0010954,abnormal cellular respiration|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011543,increased urine antidiuretic hormone level|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0013604,abnormal adult Leydig cell differentiation|MP:0014052,increased male germ cell apoptosis|MP:0014269,decreased testes secretion|MP:0014633,decreased spermatid number|MP:0020519,renal glomerular immunoglobulin deposits|MP:0020550,multinucleated giant male germ cells|MP:0020869,immotile sperm
MGI:3764971	Sirt1<tm1Ygu>	MP:0002169,no abnormal phenotype detected
MGI:2677369	Sirt1<tm2.1Fwa>	MP:0001265,decreased body size|MP:0002092,abnormal eye morphology|MP:0010768,mortality/aging|MP:0012298,hypoactivity in response to feed restriction
MGI:5306956	Sirt1<tm2.1Mcby>	MP:0000274,enlarged heart|MP:0000428,abnormal craniofacial morphology|MP:0000445,short snout|MP:0000613,abnormal salivary gland morphology|MP:0000691,enlarged spleen|MP:0001156,abnormal spermatogenesis|MP:0001265,decreased body size|MP:0001340,abnormal eyelid morphology|MP:0001346,abnormal lacrimal gland morphology|MP:0001783,decreased white adipose tissue amount|MP:0001925,male infertility|MP:0002078,abnormal glucose homeostasis|MP:0002081,perinatal lethality|MP:0002687,oligozoospermia|MP:0002727,decreased circulating insulin level|MP:0003450,enlarged pancreas|MP:0005238,increased brain size|MP:0005289,increased oxygen consumption|MP:0005291,abnormal glucose tolerance|MP:0005450,abnormal energy expenditure|MP:0010379,decreased respiratory quotient|MP:0010946,hyperpnea|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011939,increased food intake|MP:0020869,immotile sperm
MGI:2677357	Sirt1<tm2Fwa>	MP:0002092,abnormal eye morphology|MP:0010403,atrial septal defect
MGI:5903422	Sirt1<tm3.1Mcby>	MP:0000445,short snout|MP:0000613,abnormal salivary gland morphology|MP:0001346,abnormal lacrimal gland morphology|MP:0001922,reduced male fertility|MP:0006197,ocular hypotelorism
MGI:4359275	Sirt1<tm3Fwa>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005120,decreased circulating growth hormone level|MP:0005124,increased circulating prolactin level|MP:0005293,impaired glucose tolerance|MP:0005361,small pituitary gland|MP:0005418,abnormal circulating hormone level|MP:0005560,decreased circulating glucose level|MP:0005646,abnormal pituitary gland physiology|MP:0008938,decreased pituitary gland weight
MGI:5295483	Sirt2<tm1.1Auw>	MP:0000920,abnormal myelination|MP:0002169,no abnormal phenotype detected|MP:0005386,behavior/neurological phenotype|MP:0008814,decreased nerve conduction velocity|MP:0014648,abnormal response to nerve crush injury
MGI:5297582	Sirt2<tm1.1Cxd>	MP:0000630,mammary gland hyperplasia|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0004024,aneuploidy|MP:0004046,abnormal mitosis|MP:0008009,delayed cellular replicative senescence|MP:0008014,increased lung tumor incidence|MP:0009153,increased pancreas tumor incidence|MP:0010279,increased gastrointestinal tumor incidence|MP:0010299,increased mammary gland tumor incidence|MP:0010301,increased stomach tumor incidence|MP:0010357,increased prostate gland tumor incidence|MP:0011704,decreased fibroblast proliferation
MGI:4441346	Sirt2<tm1.1Fwa>	MP:0001648,abnormal apoptosis|MP:0002166,abnormal tumor susceptibility|MP:0003077,abnormal cell cycle|MP:0003702,abnormal chromosome morphology|MP:0004046,abnormal mitosis|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:4431586	Sirt2<tm1a(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0001399,hyperactivity|MP:0002169,no abnormal phenotype detected|MP:0005178,increased circulating cholesterol level
MGI:5467245	Sirt2<tm1Gdon>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:3529767	Sirt3<Gt(OST341297)Lex>	MP:0006144,increased systemic arterial systolic blood pressure
MGI:5556075	Sirt3<tm1.1Auw>	MP:0005376,homeostasis/metabolism phenotype
MGI:3822536	Sirt3<tm1.1Cxd>	MP:0005621,abnormal cell physiology|MP:0010768,mortality/aging|MP:0010954,abnormal cellular respiration
MGI:3769234	Sirt3<tm1.1Fwa>	MP:0000182,increased circulating LDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0001860,liver inflammation|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0002169,no abnormal phenotype detected|MP:0003333,liver fibrosis|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005290,decreased oxygen consumption|MP:0005331,insulin resistance|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005658,increased susceptibility to diet-induced obesity|MP:0008553,increased circulating tumor necrosis factor level|MP:0008577,increased circulating interferon-gamma level|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008617,increased circulating interleukin-12 level|MP:0008713,abnormal cytokine level|MP:0008964,decreased carbon dioxide production|MP:0009355,increased liver triglyceride level|MP:0010024,increased total body fat amount|MP:0010027,increased liver cholesterol level|MP:0031115,macrovesicular hepatic steatosis
MGI:5548701	Sirt3<tm1b(EUCOMM)Wtsi>	MP:0001406,abnormal gait|MP:0002941,increased circulating alanine transaminase level|MP:0004609,vertebral fusion|MP:0010090,increased circulating creatine kinase level
MGI:5548655	Sirt4<tm1b(EUCOMM)Hmgu>	MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0002965,increased circulating serum albumin level|MP:0005568,increased circulating total protein level|MP:0010087,increased circulating fructosamine level
MGI:3769237	Sirt4<tm1Fwa>	MP:0002169,no abnormal phenotype detected
MGI:5297911	Sirt5<tm1.1Ics>	MP:0001764,abnormal homeostasis
MGI:3769236	Sirt5<tm1Fwa>	MP:0002169,no abnormal phenotype detected
MGI:4847905	Sirt6<tm1.1Cxd>	MP:0000598,abnormal liver morphology|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0005559,increased circulating glucose level
MGI:4432093	Sirt6<tm1a(EUCOMM)Wtsi>	MP:0005178,increased circulating cholesterol level|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:3686893	Sirt6<tm1Fwa>	MP:0000063,decreased bone mineral density|MP:0000221,decreased leukocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0000352,decreased cell proliferation|MP:0000694,spleen hypoplasia|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001316,cornea scarring|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0002401,abnormal lymphopoiesis|MP:0002727,decreased circulating insulin level|MP:0002816,colitis|MP:0004029,spontaneous chromosome breakage|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005092,decreased double-positive T cell number|MP:0005293,impaired glucose tolerance|MP:0005300,abnormal cornea stroma morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005542,cornea vascularization|MP:0005560,decreased circulating glucose level|MP:0008402,increased cellular sensitivity to alkylating agent induced cell death|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0011083,lethality at weaning, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011962,increased cornea thickness|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0020860,abnormal cornea physiology|MP:0031253,lordokyphosis|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:4867399	Sirt6<tm2.1Cxd>	MP:0000063,decreased bone mineral density|MP:0000120,malocclusion|MP:0000189,hypoglycemia|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001382,abnormal nursing|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003786,premature aging|MP:0005287,narrow eye opening|MP:0005560,decreased circulating glucose level|MP:0008008,early cellular replicative senescence|MP:0008737,abnormal spleen physiology|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0010025,decreased total body fat amount|MP:0031253,lordokyphosis
MGI:4867398	Sirt6<tm2.2Cxd>	MP:0000063,decreased bone mineral density|MP:0000120,malocclusion|MP:0000189,hypoglycemia|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001382,abnormal nursing|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003786,premature aging|MP:0005287,narrow eye opening|MP:0005560,decreased circulating glucose level|MP:0008008,early cellular replicative senescence|MP:0008737,abnormal spleen physiology|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0010025,decreased total body fat amount|MP:0031253,lordokyphosis
MGI:3842304	Sirt7<tm1Evbo>	MP:0000160,kyphosis|MP:0000322,increased granulocyte number|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0003786,premature aging|MP:0004564,increased myocardial fiber size|MP:0005164,abnormal response to injury|MP:0005330,cardiomyopathy|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0008663,increased interleukin-12 secretion|MP:0008672,increased interleukin-13 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008713,abnormal cytokine level|MP:0008842,lipofuscinosis|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008943,increased sensitivity to induced cell death
MGI:4441347	Sirt7<tm1Fwa>	MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0001860,liver inflammation|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0003976,decreased circulating VLDL triglyceride level|MP:0005425,increased macrophage cell number|MP:0009289,decreased epididymal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0011939,increased food intake
MGI:6151414	Sis<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0005281,increased fatty acids level|MP:0005459,decreased percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0009356,decreased liver triglyceride level|MP:0010182,decreased susceptibility to weight gain|MP:0012347,low sweet preference
MGI:3588572	Sit1<tm1Lsmn>	MP:0000708,thymus hyperplasia|MP:0000717,abnormal lymphocyte cell number|MP:0002145,abnormal T cell differentiation|MP:0003009,abnormal cytokine secretion|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005091,increased double-positive T cell number|MP:0005348,increased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008101,lymph node hypoplasia|MP:0008353,increased mature gamma-delta T cell number|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion
MGI:5659562	Siva1<tm1.1Att>	MP:0002169,no abnormal phenotype detected
MGI:5659850	Siva1<tm1.2Att>	MP:0008762,embryonic lethality
MGI:5605765	Siva1<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0013279,increased fasting circulating glucose level
MGI:3849082	Six1<Cwe>	MP:0000031,abnormal cochlea morphology|MP:0000034,abnormal inner ear vestibule morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001394,circling|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002729,abnormal inner ear canal morphology|MP:0002730,head shaking|MP:0003161,absent lateral semicircular canal|MP:0003446,renal hypoplasia|MP:0004249,abnormal crista ampullaris morphology|MP:0004317,small vestibular saccule|MP:0004318,absent incus|MP:0004336,small utricle|MP:0004395,increased cochlear inner hair cell number|MP:0004396,decreased cochlear inner hair cell number|MP:0004922,abnormal common crus morphology|MP:0006030,abnormal otic vesicle development|MP:0006286,inner ear hypoplasia|MP:0006358,absent pinna reflex
MGI:6276906	Six1<em1(IMPC)Mbp>	MP:0000195,decreased circulating calcium level|MP:0000221,decreased leukocyte cell number|MP:0000274,enlarged heart|MP:0000428,abnormal craniofacial morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0001120,abnormal uterus morphology|MP:0001325,abnormal retina morphology|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0005333,decreased heart rate|MP:0009142,decreased prepulse inhibition|MP:0009476,enlarged cecum|MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance
MGI:3612276	Six1<tm1Kwk>	MP:0000026,abnormal inner ear morphology|MP:0000029,abnormal malleus morphology|MP:0000049,abnormal middle ear morphology|MP:0000520,absent kidney|MP:0000705,athymia|MP:0001302,eyelids open at birth|MP:0001957,apnea|MP:0002135,abnormal kidney morphology|MP:0002233,abnormal nose morphology|MP:0002235,abnormal external nares morphology|MP:0002237,abnormal nasal cavity morphology|MP:0002428,abnormal semicircular canal morphology|MP:0002639,micrognathia|MP:0002989,small kidney|MP:0002990,short ureter|MP:0003147,absent cochlea|MP:0004204,absent stapes|MP:0004313,absent vestibulocochlear ganglion|MP:0004314,absent inner ear vestibule|MP:0004819,decreased skeletal muscle mass|MP:0005106,abnormal incus morphology|MP:0005156,bradykinesia|MP:0006011,abnormal endolymphatic duct morphology|MP:0006012,dilated endolymphatic duct|MP:0006030,abnormal otic vesicle development|MP:0009520,decreased submandibular gland size|MP:0011089,perinatal lethality, complete penetrance|MP:0013127,epistaxis|MP:0013300,abnormal submandibular gland physiology|MP:0013541,abnormal submandibular gland development|MP:0013595,absent vomeronasal organ|MP:0014155,absent olfactory epithelium
MGI:2655195	Six1<tm1Mair>	MP:0000026,abnormal inner ear morphology|MP:0000031,abnormal cochlea morphology|MP:0000033,absent scala media|MP:0000036,absent semicircular canals|MP:0000049,abnormal middle ear morphology|MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000102,abnormal nasal bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000150,abnormal rib morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000159,abnormal xiphoid process morphology|MP:0000520,absent kidney|MP:0000705,athymia|MP:0000729,abnormal myogenesis|MP:0000734,muscle hypoplasia|MP:0000759,abnormal skeletal muscle morphology|MP:0000761,thin diaphragm muscle|MP:0001071,abnormal facial nerve morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002233,abnormal nose morphology|MP:0002237,abnormal nasal cavity morphology|MP:0002280,abnormal intercostal muscle morphology|MP:0002639,micrognathia|MP:0002925,abnormal cardiovascular development|MP:0003108,short zygomatic bone|MP:0003148,decreased cochlea coiling|MP:0003358,abnormal hypaxial muscle morphology|MP:0004087,abnormal muscle fiber morphology|MP:0004248,abnormal epaxial muscle morphology|MP:0004620,cervical vertebral fusion|MP:0004666,absent stapedial artery|MP:0004699,unilateral deafness|MP:0004739,conductive hearing loss|MP:0004819,decreased skeletal muscle mass|MP:0004873,absent turbinates|MP:0005107,abnormal stapes morphology|MP:0005499,abnormal olfactory system morphology|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006018,abnormal tympanic membrane morphology|MP:0006089,abnormal vestibular saccule morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0006288,small otic capsule|MP:0008023,abnormal styloid process morphology|MP:0008064,decreased otic epithelial cell proliferation|MP:0008065,short endolymphatic duct|MP:0008148,abnormal sternocostal joint morphology|MP:0008277,abnormal sternum ossification|MP:0008429,absent parotid gland|MP:0008430,short temporal bone squamous part|MP:0008789,abnormal olfactory epithelium morphology|MP:0009520,decreased submandibular gland size|MP:0009907,decreased tongue size|MP:0009913,abnormal hyoid bone greater horn morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011366,absent metanephros|MP:0011883,absent diaphragm|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012729,abnormal common carotid artery morphology|MP:0012754,abnormal cranial neural crest cell morphology|MP:0013331,abnormal lacrimal gland development|MP:0030095,abnormal midface morphology|MP:0030210,abnormal genioglossus muscle morphology|MP:0030313,abnormal face development
MGI:5316866	Six1<tm1Px>	MP:0002622,abnormal cochlear hair cell morphology
MGI:2682355	Six1<tm1Rsd>	MP:0000036,absent semicircular canals|MP:0000154,rib fusion|MP:0000352,decreased cell proliferation|MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0002233,abnormal nose morphology|MP:0002989,small kidney|MP:0003090,abnormal muscle precursor cell migration|MP:0003358,abnormal hypaxial muscle morphology|MP:0004624,abnormal thoracic cage morphology|MP:0006042,increased apoptosis|MP:0006285,absent inner ear|MP:0008321,small adenohypophysis
MGI:5449750	Six1<tm2.1Mair>	MP:0000750,abnormal muscle regeneration|MP:0002106,abnormal muscle physiology|MP:0005369,muscle phenotype|MP:0009419,skeletal muscle fibrosis
MGI:5449829	Six1<tm2.2Mair>	MP:0000729,abnormal myogenesis
MGI:3689891	Six1<tm2Kwk>	MP:0001092,abnormal trigeminal ganglion morphology|MP:0003203,increased neuron apoptosis|MP:0003633,abnormal nervous system physiology
MGI:3691857	Six2<tm1Gco>	MP:0000521,abnormal kidney cortex morphology|MP:0000527,abnormal kidney development|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003446,renal hypoplasia|MP:0003881,abnormal nephron morphology|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011289,abnormal nephron number
MGI:3845218	Six2<tm1(tTA,tetO-EGFP/cre)Amc>	MP:0002169,no abnormal phenotype detected|MP:0011087,neonatal lethality, complete penetrance
MGI:3845219	Six2<tm2(cre/ERT2)Amc>	MP:0002169,no abnormal phenotype detected|MP:0011087,neonatal lethality, complete penetrance
MGI:3845222	Six2<tm3(EGFP/cre/ERT2)Amc>	MP:0000111,cleft palate|MP:0000440,domed cranium|MP:0000445,short snout|MP:0002169,no abnormal phenotype detected|MP:0009888,palatal shelves fail to meet at midline|MP:0011087,neonatal lethality, complete penetrance|MP:0021166,delayed palatal shelf elevation|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0021217,abnormal palatal shelf bone ossification
MGI:2450901	Six3<tm1Gco>	MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0001293,anophthalmia|MP:0002151,abnormal neural tube morphology|MP:0003232,abnormal forebrain development|MP:0005221,abnormal rostral-caudal axis patterning|MP:0006293,absent nasal placodes|MP:0006294,absent optic vesicle|MP:0011089,perinatal lethality, complete penetrance|MP:0012091,increased midbrain size|MP:0012138,decreased forebrain size|MP:0013906,absent embryonic telencephalon|MP:0030241,absent optic pit
MGI:3693322	Six3<tm2.1Gco>	MP:0003232,abnormal forebrain development|MP:0012138,decreased forebrain size
MGI:3814869	Six3<tm3Gco>	MP:0005157,holoprosencephaly
MGI:3814875	Six3<tm4(cre/ERT2)Gco>	MP:0005157,holoprosencephaly
MGI:2388027	Six4<tm1Kwk>	MP:0002169,no abnormal phenotype detected
MGI:2148689	Six5<tm1Rdd>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001304,cataract|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0005159,azoospermia|MP:0005250,decreased Sertoli cell number|MP:0006380,abnormal spermatid morphology|MP:0010254,nuclear cataract
MGI:2148692	Six5<tm1Tap>	MP:0001304,cataract|MP:0005369,muscle phenotype
MGI:3613016	Six6<tm1Rsd>	MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001325,abnormal retina morphology|MP:0001333,absent optic nerve|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002659,pituitary gland hypoplasia|MP:0002680,decreased corpora lutea number|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0002984,retina hypoplasia|MP:0004856,decreased ovary weight|MP:0004910,decreased seminal vesicle weight|MP:0005241,abnormal retina ganglion layer morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005404,abnormal axon morphology|MP:0008469,abnormal protein level|MP:0008869,anovulation|MP:0008948,decreased neuron number|MP:0009006,prolonged estrous cycle|MP:0009015,short proestrus|MP:0009017,prolonged estrus|MP:0009047,short metestrus|MP:0009444,ovarian follicular cyst|MP:0014589,abnormal gonadotropin-releasing hormone neuron morphology|MP:0014592,decreased gonadotropin-releasing hormone neuron number|MP:0031436,decreased copulatory plug deposition
MGI:1861235	Sk	MP:0000416,sparse hair|MP:0001192,scaly skin|MP:0002083,premature death
MGI:7425971	Ska1<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0002060,abnormal skin morphology|MP:0003795,abnormal bone structure|MP:0011100,preweaning lethality, complete penetrance|MP:0013129,abnormal tooth color
MGI:5503136	Ska2<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0001556,increased circulating HDL cholesterol level|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0005344,increased circulating bilirubin level|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:3783261	Skap1<Gt713Lex>	MP:0001790,abnormal immune system physiology|MP:0002444,abnormal T cell physiology|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion
MGI:4353991	Skap2<Gt(VICTR20)21Lex>	MP:0001363,increased anxiety-related response|MP:0001806,decreased IgM level|MP:0002063,abnormal learning/memory/conditioning|MP:0002376,abnormal dendritic cell physiology|MP:0002455,abnormal dendritic cell antigen presentation|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005093,decreased B cell proliferation|MP:0008217,abnormal B cell activation|MP:0008496,decreased IgG2a level|MP:0009748,abnormal behavioral response to addictive substance|MP:0012319,fast extinction of fear memory
MGI:5645965	Skap2<tm1Momo>	MP:0010768,mortality/aging|MP:0011091,prenatal lethality, complete penetrance
MGI:2671812	skax1	MP:0000154,rib fusion|MP:0000585,kinked tail|MP:0000592,short tail|MP:0002114,abnormal axial skeleton morphology|MP:0004609,vertebral fusion|MP:0005307,head tossing
MGI:3038819	Skax11	MP:0002100,abnormal tooth morphology
MGI:3038820	Skax12	MP:0001399,hyperactivity|MP:0013176,abnormal tail position or orientation|MP:0013179,wavy tail
MGI:3038821	Skax13	MP:0000592,short tail
MGI:3038823	Skax14	MP:0002151,abnormal neural tube morphology|MP:0003054,spina bifida
MGI:3038824	skax15	MP:0002114,abnormal axial skeleton morphology
MGI:3038825	skax16	MP:0002114,abnormal axial skeleton morphology
MGI:3038828	Skax18	MP:0000564,syndactyly
MGI:3038829	Skax19	MP:0000564,syndactyly
MGI:2671813	skax2	MP:0003051,curly tail
MGI:3038830	skax20	MP:0000585,kinked tail
MGI:3038832	skax21	MP:0000585,kinked tail
MGI:3046772	skax22	MP:0000564,syndactyly
MGI:3046778	skax24	MP:0000585,kinked tail|MP:0003051,curly tail
MGI:3577509	skax25	MP:0000585,kinked tail
MGI:3577511	skax27	MP:0000585,kinked tail
MGI:3577512	skax28	MP:0000585,kinked tail
MGI:3577513	skax29	MP:0000585,kinked tail
MGI:2671814	skax3	MP:0000585,kinked tail|MP:0003051,curly tail
MGI:3577514	skax30	MP:0000592,short tail|MP:0001258,decreased body length|MP:0003051,curly tail
MGI:2671815	skax4	MP:0000585,kinked tail|MP:0001265,decreased body size
MGI:2671816	skax5	MP:0000585,kinked tail
MGI:3038806	skax6	MP:0000585,kinked tail
MGI:3038814	Skax7	MP:0000373,belly spot|MP:0000562,polydactyly|MP:0002110,abnormal digit morphology
MGI:3038815	Skax8	MP:0000564,syndactyly
MGI:3038817	Skax9	MP:0000564,syndactyly
MGI:2671724	skc1	MP:0003849,greasy coat
MGI:2671849	skc10	MP:0000371,diluted coat color|MP:0003172,abnormal lysosome physiology|MP:0005266,abnormal metabolism
MGI:2671850	skc12	MP:0000371,diluted coat color|MP:0003172,abnormal lysosome physiology|MP:0005266,abnormal metabolism
MGI:2671852	skc14	MP:0000371,diluted coat color
MGI:2671853	skc15	MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:2671854	skc16	MP:0002075,abnormal coat/hair pigmentation|MP:0005382,craniofacial phenotype
MGI:2671855	skc17	MP:0002075,abnormal coat/hair pigmentation
MGI:2671856	skc18	MP:0001265,decreased body size|MP:0002075,abnormal coat/hair pigmentation
MGI:2671857	skc19	MP:0000371,diluted coat color
MGI:3038892	Skc2	MP:0001511,disheveled coat
MGI:2671858	skc21	MP:0000371,diluted coat color
MGI:2671860	skc22	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation
MGI:2671861	skc23	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation
MGI:2671862	skc28	MP:0002075,abnormal coat/hair pigmentation
MGI:2671863	skc29	MP:0002075,abnormal coat/hair pigmentation
MGI:2671844	skc3	MP:0000576,clubfoot|MP:0003189,fused joints|MP:0005176,eyelids fail to open
MGI:2671864	skc30	MP:0000313,abnormal cell death|MP:0002075,abnormal coat/hair pigmentation|MP:0002877,abnormal melanocyte morphology
MGI:2671865	skc31	MP:0000313,abnormal cell death|MP:0002075,abnormal coat/hair pigmentation|MP:0002877,abnormal melanocyte morphology
MGI:3038896	Skc36	MP:0000421,mottled coat
MGI:3038910	skc37	MP:0000367,abnormal coat/ hair morphology|MP:0001764,abnormal homeostasis|MP:0005058,abnormal lysosome morphology
MGI:3038911	skc38	MP:0000367,abnormal coat/ hair morphology|MP:0001764,abnormal homeostasis|MP:0005058,abnormal lysosome morphology
MGI:3038912	Skc39	MP:0000575,increased foot pad pigmentation
MGI:3038913	skc40	MP:0002074,abnormal hair texture
MGI:3038914	Skc41	MP:0001188,hyperpigmentation
MGI:3038915	Skc42	MP:0000373,belly spot
MGI:3038916	Skc43	MP:0000373,belly spot|MP:0011277,decreased tail pigmentation
MGI:3038917	skc44	MP:0002671,belted|MP:0002940,variable body spotting
MGI:3038920	Skc45	MP:0005409,darkened coat color
MGI:3577517	skc46	MP:0000410,waved hair
MGI:2671846	skc6	MP:0000371,diluted coat color|MP:0002881,long hair|MP:0003172,abnormal lysosome physiology|MP:0005266,abnormal metabolism
MGI:2671847	skc8	MP:0002881,long hair
MGI:2671848	skc9	MP:0000371,diluted coat color|MP:0003172,abnormal lysosome physiology|MP:0005266,abnormal metabolism
MGI:2449146	skhr	MP:0000424,retarded hair growth
MGI:5287020	Skic2<TgTn(sb-cHS4,Tyr)2320G-1aOve>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:5574595	Skic2<tm2b(EUCOMM)Wtsi>	MP:0003020,decreased circulating chloride level|MP:0005568,increased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6449032	Skic3<em1(IMPC)Tcp>	MP:0001698,decreased embryo size|MP:0002582,disorganized extraembryonic tissue|MP:0003984,embryonic growth retardation|MP:0005627,increased circulating potassium level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size|MP:0020421,increased freezing behavior
MGI:7482622	Skic8<em1(IMPC)Tcp>	MP:0000220,increased monocyte cell number|MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5548624	Skida1<tm1.1(KOMP)Wtsi>	MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4841167	Skida1<tm1(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004599,abnormal vertebral arch morphology|MP:0005477,increased circulating thyroxine level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6342895	Ski<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity|MP:0001513,limb grasping|MP:0011100,preweaning lethality, complete penetrance
MGI:4398740	Skil<tm1.1Kluo>	MP:0003447,decreased tumor growth/size|MP:0004502,decreased incidence of tumors by chemical induction|MP:0008008,early cellular replicative senescence|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:6150869	Skil<tm1b(EUCOMM)Hmgu>	MP:0010579,increased heart left ventricle size
MGI:2387096	Skil<tm1Sis>	MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0003406,failure of zygotic cell division|MP:0004499,increased incidence of tumors by chemical induction|MP:0005150,cachexia|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2670010	Skil<tm1Spw>	MP:0000691,enlarged spleen|MP:0000716,abnormal immune system cell morphology|MP:0002006,neoplasm|MP:0002722,abnormal immune system organ morphology|MP:0005095,decreased T cell proliferation
MGI:2670012	Skil<tm2Spw>	MP:0001881,abnormal mammary gland physiology|MP:0002006,neoplasm|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0006270,abnormal mammary gland growth during lactation|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009506,abnormal mammary gland alveolus morphology|MP:0012075,impaired mammary gland growth during pregnancy|MP:0013716,hypolactation|MP:0013781,abnormal mammary gland luminal epithelium morphology
MGI:2182130	skimp	MP:0000598,abnormal liver morphology|MP:0002880,opisthotonus|MP:0003458,decreased circulating ketone body level|MP:0005439,decreased glycogen level|MP:0005560,decreased circulating glucose level|MP:0011085,postnatal lethality, complete penetrance
MGI:5588374	Skint1<m1Tac>	MP:0002145,abnormal T cell differentiation|MP:0008037,abnormal T cell morphology
MGI:7545259	Skint2<em2Htaka>	MP:0013410,decreased dendritic epidermal T cell number
MGI:2177555	Ski<tm1Cco>	MP:0000074,abnormal neurocranium morphology|MP:0000088,short mandible|MP:0000108,midline facial cleft|MP:0000454,abnormal jaw morphology|MP:0000562,polydactyly|MP:0000734,muscle hypoplasia|MP:0000759,abnormal skeletal muscle morphology|MP:0000783,abnormal forebrain morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001302,eyelids open at birth|MP:0001914,hemorrhage|MP:0002113,abnormal skeleton development|MP:0002151,abnormal neural tube morphology|MP:0003036,vertebral transformation|MP:0003048,abnormal cervical vertebrae morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004174,abnormal spine curvature|MP:0004200,decreased fetal size|MP:0004376,absent frontal bone|MP:0004383,absent interparietal bone|MP:0004419,absent parietal bone|MP:0004447,small basioccipital bone|MP:0004448,abnormal presphenoid bone morphology|MP:0004462,small basisphenoid bone|MP:0004499,increased incidence of tumors by chemical induction|MP:0004607,abnormal cervical atlas morphology|MP:0004608,abnormal cervical axis morphology|MP:0004819,decreased skeletal muscle mass|MP:0006302,abnormal ectomesenchyme morphology|MP:0008029,abnormal paraxial mesoderm morphology|MP:0009402,decreased skeletal muscle fiber diameter|MP:0011089,perinatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011703,increased fibroblast proliferation|MP:0012175,flat face|MP:0012431,increased lymphoma incidence|MP:0030223,mandibular hyperostosis
MGI:2154320	Skl1<LG/J>	MP:0002758,long tail
MGI:2154953	Skl2<LG/J>	MP:0002758,long tail
MGI:2156454	Skl3<LG/J>	MP:0002758,long tail
MGI:2157907	Skl4<LG/J>	MP:0002758,long tail
MGI:2157911	Skl5<LG/J>	MP:0001260,increased body weight|MP:0002758,long tail
MGI:2157913	Skl6<LG/J>	MP:0002758,long tail
MGI:2157916	Skl7<SM/J>	MP:0002758,long tail
MGI:3583172	Skmw10<C57BL/6J>	MP:0003082,abnormal gastrocnemius morphology|MP:0003397,increased muscle weight
MGI:3583174	Skmw11<C57BL/6J>	MP:0009423,increased extensor digitorum longus weight|MP:0009425,increased soleus weight|MP:0009427,increased tibialis anterior weight
MGI:3640586	Skmw12<C57BL/6J>	MP:0009421,increased gastrocnemius weight
MGI:3640588	Skmw13<C57BL/6J>	MP:0009423,increased extensor digitorum longus weight
MGI:3640590	Skmw14<C57BL/6J>	MP:0009425,increased soleus weight
MGI:3640592	Skmw15<C57BL/6J>	MP:0003082,abnormal gastrocnemius morphology|MP:0003397,increased muscle weight
MGI:3640597	Skmw17<DBA/2J>	MP:0009423,increased extensor digitorum longus weight
MGI:3640598	Skmw18<C57BL/6J>	MP:0009425,increased soleus weight
MGI:3036188	Skmw1<C57BL/6J>	MP:0002108,abnormal muscle morphology|MP:0009421,increased gastrocnemius weight
MGI:3036189	Skmw2<DBA/2J>	MP:0002108,abnormal muscle morphology|MP:0009423,increased extensor digitorum longus weight
MGI:3036191	Skmw3<DBA/2J>	MP:0002108,abnormal muscle morphology
MGI:3036194	Skmw4<C57BL/6J>	MP:0002108,abnormal muscle morphology
MGI:3036196	Skmw5<C57BL/6J>	MP:0002108,abnormal muscle morphology
MGI:3583165	Skmw6<DBA/2J>	MP:0009425,increased soleus weight|MP:0009427,increased tibialis anterior weight
MGI:3583166	Skmw7<C57BL/6J>	MP:0009423,increased extensor digitorum longus weight
MGI:3583168	Skmw8<C57BL/6J>	MP:0009423,increased extensor digitorum longus weight|MP:0009427,increased tibialis anterior weight
MGI:3583170	Skmw9<C57BL/6J>	MP:0009421,increased gastrocnemius weight
MGI:6385903	Skor1<em1(IMPC)J>	MP:0000198,decreased circulating phosphate level|MP:0005559,increased circulating glucose level|MP:0005635,decreased circulating bilirubin level|MP:0011100,preweaning lethality, complete penetrance
MGI:5613907	Skor2<tm1Yono>	MP:0000852,small cerebellum|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008579,abnormal Purkinje cell differentiation|MP:0009719,reduced cerebellar foliation|MP:0010008,abnormal Purkinje cell migration|MP:0011087,neonatal lethality, complete penetrance
MGI:5300465	Skor2<Tn(sb-Tyr)1799B.CA3Ove>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001953,respiratory failure|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5300201	Skor2<Tn(sb-Tyr)1799B.CA7BOve>	MP:0000849,abnormal cerebellum morphology|MP:0000854,abnormal cerebellum development|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001953,respiratory failure|MP:0005449,abnormal food intake|MP:0008579,abnormal Purkinje cell differentiation|MP:0009890,cleft secondary palate|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013551,decreased cerebellar granule cell precursor proliferation
MGI:5300464	Skor2<Tn(sb-Tyr)1799B.CA7Ove>	MP:0000852,small cerebellum|MP:0000854,abnormal cerebellum development|MP:0000857,abnormal cerebellar foliation|MP:0000890,thin cerebellar molecular layer|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001953,respiratory failure|MP:0006097,abnormal cerebellar lobule formation|MP:0008579,abnormal Purkinje cell differentiation|MP:0009719,reduced cerebellar foliation|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013551,decreased cerebellar granule cell precursor proliferation
MGI:4365786	skp	MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0001932,abnormal spermiogenesis|MP:0003644,thymus atrophy|MP:0003871,abnormal myelin sheath morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2179051	Skp2<tm1Kin>	MP:0000350,abnormal cell proliferation|MP:0000607,abnormal hepatocyte morphology|MP:0001146,abnormal testis morphology|MP:0001262,decreased body weight|MP:0002135,abnormal kidney morphology|MP:0002908,delayed wound healing|MP:0008755,abnormal immunoglobulin V(D)J recombination|MP:0013501,increased fibroblast apoptosis
MGI:2157348	Skts10<M. spretus>	MP:0010300,increased skin tumor incidence
MGI:2156467	Skts11<M. spretus>	MP:0010300,increased skin tumor incidence
MGI:2156470	Skts12<M. spretus>	MP:0010300,increased skin tumor incidence
MGI:3055776	Skts13<M. spretus>	MP:0002051,increased skin papilloma incidence
MGI:2156685	Skts16<Car-R>	MP:0002052,decreased tumor incidence
MGI:2156686	Skts16<Car-S>	MP:0010300,increased skin tumor incidence
MGI:2156871	Skts1<M. spretus>	MP:0002052,decreased tumor incidence|MP:0010300,increased skin tumor incidence
MGI:2156873	Skts2<M. spretus>	MP:0010300,increased skin tumor incidence
MGI:2156219	Skts4<SENCARA/Pt>	MP:0010300,increased skin tumor incidence
MGI:2157355	Skts5<NIH/Ola>	MP:0010300,increased skin tumor incidence
MGI:2157347	Skts6<NIH/Ola>	MP:0010300,increased skin tumor incidence
MGI:2155770	Skts7<NIH/Ola>	MP:0010300,increased skin tumor incidence
MGI:2154322	Skts8<NIH/Ola>	MP:0010300,increased skin tumor incidence
MGI:2157352	Skts9<NIH/Ola>	MP:0010300,increased skin tumor incidence
MGI:2156758	Skull10<LG/J>	MP:0000439,enlarged cranium
MGI:2157039	Skull11<LG/J>	MP:0000439,enlarged cranium
MGI:2157392	Skull12<LG/J>	MP:0000439,enlarged cranium
MGI:2157394	Skull13<LG/J>	MP:0000439,enlarged cranium
MGI:2158051	Skull14<LG/J>	MP:0000439,enlarged cranium
MGI:2158054	Skull15<LG/J>	MP:0000439,enlarged cranium
MGI:2158056	Skull16<LG/J>	MP:0000439,enlarged cranium
MGI:2158058	Skull17<LG/J>	MP:0000439,enlarged cranium
MGI:2158060	Skull18<LG/J>	MP:0000439,enlarged cranium
MGI:2158064	Skull19<LG/J>	MP:0000439,enlarged cranium
MGI:2154324	Skull1<LG/J>	MP:0000439,enlarged cranium
MGI:2158069	Skull20<LG/J>	MP:0000439,enlarged cranium
MGI:2158074	Skull21<LG/J>	MP:0000439,enlarged cranium
MGI:2158079	Skull22<LG/J>	MP:0000439,enlarged cranium
MGI:2158084	Skull23<LG/J>	MP:0000439,enlarged cranium
MGI:2158086	Skull24<LG/J>	MP:0000439,enlarged cranium
MGI:2158090	Skull25<LG/J>	MP:0000439,enlarged cranium
MGI:2158093	Skull26<LG/J>	MP:0000439,enlarged cranium
MGI:2154326	Skull2<LG/J>	MP:0000439,enlarged cranium
MGI:2155053	Skull3<LG/J>	MP:0000439,enlarged cranium
MGI:2155358	Skull4<LG/J>	MP:0000439,enlarged cranium
MGI:2155805	Skull5<LG/J>	MP:0000439,enlarged cranium
MGI:2155807	Skull6<LG/J>	MP:0000439,enlarged cranium
MGI:2156522	Skull7<LG/J>	MP:0000439,enlarged cranium
MGI:2156524	Skull8<LG/J>	MP:0000439,enlarged cranium
MGI:2156756	Skull9<LG/J>	MP:0000439,enlarged cranium
MGI:3612272	sky	MP:0000003,abnormal adipose tissue morphology|MP:0000160,kyphosis|MP:0001258,decreased body length|MP:0001302,eyelids open at birth|MP:0002083,premature death|MP:0002108,abnormal muscle morphology|MP:0002161,abnormal fertility/fecundity|MP:0002759,abnormal caudal vertebrae morphology|MP:0002971,abnormal brown adipose tissue morphology|MP:0004173,abnormal intervertebral disk morphology|MP:0004684,intervertebral disk degeneration
MGI:6341873	Sla2<em1(IMPC)Ccpcz>	MP:0000438,abnormal cranium morphology|MP:0001262,decreased body weight|MP:0001556,increased circulating HDL cholesterol level|MP:0002060,abnormal skin morphology|MP:0005178,increased circulating cholesterol level|MP:0005568,increased circulating total protein level|MP:0008045,decreased NK cell number|MP:0009455,enhanced cued conditioning behavior|MP:0020421,increased freezing behavior
MGI:4941869	Sla2<tm1Amch>	MP:0005387,immune system phenotype
MGI:6258620	Slain2<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001399,hyperactivity|MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0005635,decreased circulating bilirubin level|MP:0011100,preweaning lethality, complete penetrance
MGI:3044919	Slamf1<tm1Cpt>	MP:0002451,abnormal macrophage physiology|MP:0003009,abnormal cytokine secretion|MP:0005027,increased susceptibility to parasitic infection
MGI:3776761	Slamf1<tm1Oono>	MP:0020952,increased susceptibility to Paramyxoviridae infection
MGI:3512183	Slamf1<tm1Vei>	MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology
MGI:3581614	Slamf6<tm1Dhow>	MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0005026,decreased susceptibility to parasitic infection|MP:0005074,impaired granulocyte bactericidal activity|MP:0005466,abnormal T-helper 2 physiology|MP:0008553,increased circulating tumor necrosis factor level|MP:0008632,increased circulating interleukin-16 level|MP:0008647,increased circulating interleukin-12b level|MP:0008700,decreased interleukin-4 secretion|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:3529322	Slamf6<tm1Lex>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype
MGI:3836722	Slamf7<tm1Vei>	MP:0005070,impaired natural killer cell mediated cytotoxicity
MGI:5442794	Slamf8<tm1Mill>	MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology
MGI:6364884	Slamf9<em1Isha>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0008524,increased plasmacytoid dendritic cell number|MP:0008769,abnormal plasmacytoid dendritic cell physiology
MGI:2387691	Sla<tm1Weis>	MP:0002408,abnormal double-positive T cell morphology
MGI:5766212	Slbp<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005561,increased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6316122	Slc10a1<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0001157,small seminal vesicle|MP:0001304,cataract|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002699,abnormal vitreous body morphology|MP:0005084,abnormal gallbladder morphology|MP:0009342,enlarged gallbladder
MGI:6356556	Slc10a1<tm1Tac>	MP:0001262,decreased body weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0003868,abnormal feces composition|MP:0004772,abnormal bile secretion|MP:0004789,increased bile salt level|MP:0005344,increased circulating bilirubin level|MP:0005365,abnormal bile salt homeostasis|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0009643,abnormal urine homeostasis|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5692593	Slc10a2<tm1b(KOMP)Mbp>	MP:0010579,increased heart left ventricle size
MGI:2676307	Slc10a2<tm1Pda>	MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0002118,abnormal lipid homeostasis|MP:0002647,decreased intestinal cholesterol absorption|MP:0002791,steatorrhea|MP:0004773,abnormal bile composition|MP:0004774,abnormal bile salt level|MP:0005178,increased circulating cholesterol level|MP:0005342,abnormal intestinal lipid absorption|MP:0005365,abnormal bile salt homeostasis|MP:0014478,increased feces bile salt level
MGI:6383678	Slc10a3<em1(IMPC)J>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0010124,decreased bone mineral content
MGI:6120809	Slc10a4<tm1b(KOMP)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance|MP:0020870,decreased thigmotaxis
MGI:5495143	Slc10a4<tm1Tigm>	MP:0002064,seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0008840,abnormal spike wave discharge
MGI:6510628	Slc10a6<tm1Jmge>	MP:0005178,increased circulating cholesterol level|MP:0005389,reproductive system phenotype
MGI:4455649	Slc10a7<tm1a(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000074,abnormal neurocranium morphology|MP:0000102,abnormal nasal bone morphology|MP:0000131,abnormal long bone epiphysis morphology|MP:0000163,abnormal cartilage morphology|MP:0000435,shortened head|MP:0000559,abnormal femur morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002576,abnormal enamel morphology|MP:0002649,abnormal enamel rod pattern|MP:0002764,short tibia|MP:0002772,brachypodia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003072,abnormal metatarsal bone morphology|MP:0003109,short femur|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003742,narrow head|MP:0004351,short humerus|MP:0004355,short radius|MP:0004380,short frontal bone|MP:0004418,small parietal bone|MP:0004441,small occipital bone|MP:0004471,short nasal bone|MP:0004596,abnormal mandibular angle morphology|MP:0004686,decreased length of long bones|MP:0005104,abnormal tarsal bone morphology|MP:0005306,abnormal phalanx morphology|MP:0005390,skeleton phenotype|MP:0006396,decreased long bone epiphyseal plate size|MP:0006397,disorganized long bone epiphyseal plate|MP:0008151,increased diameter of long bones|MP:0009346,decreased trabecular bone thickness|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0010876,decreased bone volume|MP:0010879,decreased trabecular bone volume|MP:0010965,decreased compact bone volume|MP:0011495,abnormal head shape|MP:0020039,increased bone ossification|MP:0030245,round head
MGI:6277045	Slc11a1<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002060,abnormal skin morphology|MP:0005016,decreased lymphocyte cell number
MGI:1857756	Slc11a1<r>	MP:0002411,decreased susceptibility to bacterial infection
MGI:1857755	Slc11a1<s>	MP:0002412,increased susceptibility to bacterial infection
MGI:2446573	Slc11a1<tm1Mcg>	MP:0002412,increased susceptibility to bacterial infection
MGI:1856400	Slc11a2<mk>	MP:0000208,decreased hematocrit|MP:0001212,skin lesions|MP:0001262,decreased body weight|MP:0001923,reduced female fertility|MP:0002082,postnatal lethality|MP:0002593,high mean erythrocyte cell number|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0003718,maternal effect|MP:0004952,increased spleen weight|MP:0005370,liver/biliary system phenotype|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005637,abnormal iron homeostasis|MP:0008388,hypochromic microcytic anemia|MP:0008807,increased liver iron level|MP:0008956,decreased cellular hemoglobin content|MP:0010035,increased erythrocyte clearance|MP:0010163,hemolysis|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011188,increased erythrocyte protoporphyrin level|MP:0031084,decreased erythrocyte osmotic fragility
MGI:3577914	Slc11a2<tm1Nca>	MP:0000208,decreased hematocrit|MP:0001732,postnatal growth retardation|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002810,microcytic anemia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0005376,homeostasis/metabolism phenotype|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008743,decreased liver iron level|MP:0011085,postnatal lethality, complete penetrance
MGI:3577916	Slc11a2<tm2Nca>	MP:0000240,extramedullary hematopoiesis|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002447,abnormal erythrocyte morphology|MP:0008476,increased spleen red pulp amount|MP:0008743,decreased liver iron level|MP:0008808,decreased spleen iron level|MP:0010376,decreased kidney iron level|MP:0020366,decreased brain iron level|MP:0020368,decreased heart iron level
MGI:3795217	Slc12a1<tm1Haca>	MP:0000192,abnormal mineral level|MP:0002988,decreased urine osmolality|MP:0003353,decreased circulating renin level|MP:0011295,abnormal tubuloglomerular feedback response
MGI:2158359	Slc12a1<tm1Tkh>	MP:0000519,hydronephrosis|MP:0001732,postnatal growth retardation|MP:0001762,polyuria|MP:0001784,abnormal fluid regulation|MP:0002135,abnormal kidney morphology|MP:0002136,abnormal kidney physiology|MP:0002608,increased hematocrit|MP:0002703,abnormal renal tubule morphology|MP:0003019,increased circulating chloride level|MP:0003197,nephrocalcinosis|MP:0003606,kidney failure|MP:0003653,decreased skin turgor|MP:0005441,increased urine calcium level|MP:0005553,increased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005568,increased circulating total protein level|MP:0005582,increased renin activity|MP:0005633,increased circulating sodium level|MP:0009642,abnormal blood homeostasis|MP:0011085,postnatal lethality, complete penetrance|MP:0012551,metabolic acidosis
MGI:3843784	Slc12a1<tm2Haca>	MP:0001771,abnormal circulating magnesium level|MP:0002988,decreased urine osmolality|MP:0003352,increased circulating renin level|MP:0010107,abnormal renal reabsorption|MP:0010108,abnormal renal water reabsorption|MP:0011296,decreased tubuloglomerular feedback response|MP:0031404,increased tubuloglomerular feedback response
MGI:3712283	Slc12a1<urehr3>	MP:0000063,decreased bone mineral density|MP:0000194,increased circulating calcium level|MP:0000519,hydronephrosis|MP:0001263,weight loss|MP:0001426,polydipsia|MP:0001762,polyuria|MP:0002135,abnormal kidney morphology|MP:0002703,abnormal renal tubule morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0002988,decreased urine osmolality|MP:0003020,decreased circulating chloride level|MP:0003028,alkalosis|MP:0003197,nephrocalcinosis|MP:0003353,decreased circulating renin level|MP:0003795,abnormal bone structure|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005441,increased urine calcium level|MP:0005522,increased circulating atrial natriuretic factor|MP:0005553,increased circulating creatinine level|MP:0005554,decreased circulating creatinine level|MP:0005557,increased creatinine clearance|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0005619,increased urine potassium level|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006316,increased urine sodium level|MP:0006317,decreased urine sodium level|MP:0008055,increased urine osmolality|MP:0009643,abnormal urine homeostasis|MP:0010092,increased circulating magnesium level|MP:0011304,kidney papillary atrophy|MP:0011403,pyelonephritis|MP:0011404,pyelitis|MP:0011424,decreased urine uric acid level|MP:0011435,increased urine magnesium level|MP:0011465,abnormal urine urea nitrogen level|MP:0011470,increased urine creatinine level|MP:0011471,decreased urine creatinine level|MP:0011563,increased urine prostaglandin level|MP:0014809,abnormal circulating urea level
MGI:6197529	Slc12a2<em1Dlp>	MP:0000465,gastrointestinal hemorrhage|MP:0000477,abnormal intestine morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0001663,abnormal digestive system physiology|MP:0002083,premature death|MP:0002412,increased susceptibility to bacterial infection|MP:0003304,large intestinal inflammation|MP:0005013,increased lymphocyte cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0006001,abnormal intestinal transit time|MP:0010155,abnormal intestine physiology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013799,abnormal intestinal goblet cell physiology|MP:0014030,abnormal mucous gland physiology|MP:0014219,decreased intestinal mucosa thickness|MP:0014222,decreased colon goblet cell number|MP:0014484,decreased feces water content|MP:0020848,abnormal exocytosis
MGI:5538334	Slc12a2<K842*>	MP:0000026,abnormal inner ear morphology|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001525,impaired balance|MP:0001967,deafness|MP:0004249,abnormal crista ampullaris morphology|MP:0004329,vestibular saccular degeneration|MP:0004332,utricular degeneration|MP:0005307,head tossing|MP:0006024,collapsed Reissner membrane
MGI:5792088	Slc12a2<mpc246H>	MP:0000034,abnormal inner ear vestibule morphology|MP:0001967,deafness
MGI:1857838	Slc12a2<sy-ns>	MP:0000035,abnormal membranous labyrinth morphology|MP:0000046,abnormal sulcus ampullaris morphology|MP:0000048,abnormal stria vascularis morphology|MP:0001394,circling|MP:0001410,head bobbing|MP:0001967,deafness|MP:0002102,abnormal ear morphology|MP:0002428,abnormal semicircular canal morphology|MP:0004300,abnormal organ of Corti supporting cell morphology|MP:0004405,absent cochlear hair cells|MP:0004482,abnormal interdental cell morphology|MP:0006024,collapsed Reissner membrane|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5538339	Slc12a2<tm1.1Jheb>	MP:0000026,abnormal inner ear morphology|MP:0001394,circling|MP:0001399,hyperactivity|MP:0004249,abnormal crista ampullaris morphology|MP:0004329,vestibular saccular degeneration|MP:0004332,utricular degeneration|MP:0005386,behavior/neurological phenotype|MP:0006024,collapsed Reissner membrane
MGI:2181636	Slc12a2<tm1Bhk>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001380,decreased male mating frequency|MP:0001393,ataxia|MP:0001396,unidirectional circling|MP:0001399,hyperactivity|MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001963,abnormal hearing physiology|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005307,head tossing|MP:0006359,absent startle reflex|MP:0006380,abnormal spermatid morphology
MGI:1935225	Slc12a2<tm1Dlp>	MP:0000031,abnormal cochlea morphology|MP:0000042,abnormal organ of Corti morphology|MP:0000746,weakness|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0001516,abnormal motor coordination/balance|MP:0001732,postnatal growth retardation|MP:0001967,deafness|MP:0004301,absent organ of Corti supporting cells|MP:0004405,absent cochlear hair cells|MP:0006024,collapsed Reissner membrane|MP:0006359,absent startle reflex
MGI:1935144	Slc12a2<tm1Ges>	MP:0000035,abnormal membranous labyrinth morphology|MP:0000048,abnormal stria vascularis morphology|MP:0000477,abnormal intestine morphology|MP:0000495,abnormal colon morphology|MP:0000500,small intestinal prolapse|MP:0000510,remittent intestinal hemorrhage|MP:0000623,decreased salivation|MP:0001081,abnormal cranial ganglia morphology|MP:0001265,decreased body size|MP:0001394,circling|MP:0001410,head bobbing|MP:0001411,spinning|MP:0001516,abnormal motor coordination/balance|MP:0001732,postnatal growth retardation|MP:0001967,deafness|MP:0002843,decreased systemic arterial blood pressure|MP:0003149,abnormal tectorial membrane morphology|MP:0003151,absent tunnel of Corti|MP:0003169,abnormal scala media morphology|MP:0003878,abnormal ear physiology|MP:0004366,abnormal strial marginal cell morphology|MP:0004396,decreased cochlear inner hair cell number|MP:0004402,decreased cochlear outer hair cell number|MP:0004738,abnormal auditory brainstem response|MP:0005191,head tilt|MP:0006024,collapsed Reissner membrane|MP:0006358,absent pinna reflex|MP:0009478,coiled cecum|MP:0010025,decreased total body fat amount|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2181638	Slc12a2<tm2Bhk>	MP:0000033,absent scala media|MP:0000035,abnormal membranous labyrinth morphology|MP:0000042,abnormal organ of Corti morphology|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001380,decreased male mating frequency|MP:0001386,abnormal maternal nurturing|MP:0001393,ataxia|MP:0001396,unidirectional circling|MP:0001399,hyperactivity|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001963,abnormal hearing physiology|MP:0003149,abnormal tectorial membrane morphology|MP:0003151,absent tunnel of Corti|MP:0004294,abnormal type II spiral ligament fibrocytes|MP:0004296,abnormal type IV spiral ligament fibrocytes|MP:0004300,abnormal organ of Corti supporting cell morphology|MP:0004366,abnormal strial marginal cell morphology|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004482,abnormal interdental cell morphology|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005307,head tossing|MP:0006021,abnormal Reissner membrane morphology|MP:0006024,collapsed Reissner membrane|MP:0006325,impaired hearing|MP:0006331,abnormal patterning of the organ of Corti|MP:0006359,absent startle reflex|MP:0006380,abnormal spermatid morphology|MP:0011739,abnormal Boettcher cell morphology|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:7495476	Slc12a3<em3Gpt>	MP:0004119,hypokalemia|MP:0005378,growth/size/body region phenotype|MP:0005619,increased urine potassium level|MP:0010093,decreased circulating magnesium level
MGI:7495477	Slc12a3<em4Gpt>	MP:0001762,polyuria|MP:0004119,hypokalemia|MP:0005378,growth/size/body region phenotype|MP:0005619,increased urine potassium level|MP:0010093,decreased circulating magnesium level
MGI:3513101	Slc12a3<tm1Ges>	MP:0002843,decreased systemic arterial blood pressure|MP:0002986,decreased urine calcium level|MP:0004757,abnormal distal convoluted tubule morphology|MP:0006317,decreased urine sodium level|MP:0008872,abnormal physiological response to xenobiotic|MP:0010093,decreased circulating magnesium level|MP:0011442,abnormal renal sodium ion transport|MP:0011460,decreased urine chloride ion level
MGI:5703920	Slc12a4<Rbc10>	MP:0002813,microcytosis|MP:0003656,abnormal erythrocyte physiology|MP:0005397,hematopoietic system phenotype|MP:0008387,hypochromic anemia
MGI:6276849	Slc12a5<em1(IMPC)Mbp>	MP:0000470,abnormal stomach morphology|MP:0000495,abnormal colon morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0001297,microphthalmia|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002060,abnormal skin morphology|MP:0002989,small kidney|MP:0003231,abnormal placenta vasculature|MP:0003271,abnormal duodenum morphology|MP:0003984,embryonic growth retardation|MP:0004002,abnormal jejunum morphology|MP:0005293,impaired glucose tolerance|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:3686895	Slc12a5<tm1Dlp>	MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001732,postnatal growth retardation|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003470,abnormal summary potential|MP:0003997,tonic-clonic seizures|MP:0004101,abnormal brain interneuron morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:3762883	Slc12a5<tm1Hsav>	MP:0002272,abnormal nervous system electrophysiology
MGI:2181025	Slc12a5<tm1Tjj>	MP:0001177,atelectasis|MP:0001512,trunk curl|MP:0001953,respiratory failure|MP:0001968,abnormal touch/nociception|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002272,abnormal nervous system electrophysiology|MP:0002690,akinesia|MP:0003052,omphalocele|MP:0003257,abnormal abdominal wall morphology|MP:0003880,abnormal central pattern generator function|MP:0005402,abnormal action potential|MP:0005423,abnormal somatic nervous system physiology|MP:0011087,neonatal lethality, complete penetrance
MGI:5315721	Slc12a5<tm2.1Tjj>	MP:0000877,abnormal Purkinje cell morphology|MP:0002063,abnormal learning/memory/conditioning|MP:0002578,impaired ability to fire action potentials|MP:0002804,abnormal motor learning|MP:0002882,abnormal neuron morphology|MP:0003631,nervous system phenotype|MP:0004008,abnormal GABA-mediated receptor currents|MP:0004098,abnormal cerebellar granule cell morphology|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0005402,abnormal action potential|MP:0011039,abnormal vestibuloocular dark reflex|MP:0011040,abnormal vestibuloocular light reflex|MP:0014645,decreased optokinetic reflex
MGI:5638435	Slc12a5<tm2Hsav>	MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0009538,abnormal synapse morphology|MP:0009936,abnormal dendritic spine morphology
MGI:6157844	Slc12a6<em1Dlp>	MP:0000921,demyelination|MP:0001405,impaired coordination|MP:0005403,abnormal nerve conduction
MGI:2675598	Slc12a6<gaxp>	MP:0000746,weakness|MP:0000920,abnormal myelination|MP:0001393,ataxia|MP:0002152,abnormal brain morphology|MP:0003225,axonal dystrophy|MP:0005404,abnormal axon morphology|MP:0009434,paraparesis
MGI:3529339	Slc12a6<Gt(OST458419)Lex>	MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0003063,increased coping response|MP:0004262,abnormal physical strength
MGI:5318539	Slc12a6<tm1.1Garo>	MP:0000780,abnormal corpus callosum morphology|MP:0000781,decreased corpus callosum size|MP:0000921,demyelination|MP:0001262,decreased body weight|MP:0001392,abnormal locomotor behavior|MP:0001405,impaired coordination|MP:0001486,abnormal startle reflex|MP:0001513,limb grasping|MP:0001924,infertility|MP:0002176,increased brain weight|MP:0002651,abnormal sciatic nerve morphology|MP:0003632,abnormal nervous system morphology|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0008532,decreased chemical nociceptive threshold|MP:0031391,increased locomotor activity
MGI:5315722	Slc12a6<tm1.1Tjj>	MP:0003631,nervous system phenotype
MGI:2429639	Slc12a6<tm1Dlp>	MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0001524,impaired limb coordination|MP:0001924,infertility|MP:0002651,abnormal sciatic nerve morphology|MP:0003631,nervous system phenotype|MP:0003871,abnormal myelin sheath morphology|MP:0004263,abnormal limb posture|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0009142,decreased prepulse inhibition|MP:0009434,paraparesis
MGI:5318538	Slc12a6<tm1Garo>	MP:0000781,decreased corpus callosum size|MP:0000921,demyelination|MP:0001262,decreased body weight|MP:0001392,abnormal locomotor behavior|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001924,infertility|MP:0002169,no abnormal phenotype detected|MP:0002176,increased brain weight|MP:0002651,abnormal sciatic nerve morphology|MP:0003632,abnormal nervous system morphology|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0008532,decreased chemical nociceptive threshold|MP:0031391,increased locomotor activity
MGI:2680042	Slc12a6<tm1Tjj>	MP:0000043,organ of Corti degeneration|MP:0000231,hypertension|MP:0000811,hippocampal neuron degeneration|MP:0000849,abnormal cerebellum morphology|MP:0000958,peripheral nervous system degeneration|MP:0001506,limp posture|MP:0001513,limb grasping|MP:0001967,deafness|MP:0002229,neurodegeneration|MP:0002651,abnormal sciatic nerve morphology|MP:0002690,akinesia|MP:0002857,cochlear ganglion degeneration|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0004143,muscle hypertonia|MP:0004263,abnormal limb posture|MP:0004268,abnormal optic stalk morphology|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004411,decreased endocochlear potential|MP:0004487,type I spiral ligament fibrocyte degeneration|MP:0004489,type III spiral ligament fibrocyte degeneration|MP:0004740,sensorineural hearing loss|MP:0005405,axon degeneration|MP:0005621,abnormal cell physiology|MP:0012712,spinal cord degeneration
MGI:5688752	Slc12a6<tm2.1Dlp>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0001405,impaired coordination|MP:0002169,no abnormal phenotype detected|MP:0005386,behavior/neurological phenotype
MGI:7425972	Slc12a7<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5792092	Slc12a7<mpc264H>	MP:0001967,deafness
MGI:2383981	Slc12a7<tm1Tjj>	MP:0000026,abnormal inner ear morphology|MP:0000043,organ of Corti degeneration|MP:0000044,absent organ of Corti|MP:0000525,renal tubular acidosis|MP:0001262,decreased body weight|MP:0001967,deafness|MP:0002857,cochlear ganglion degeneration|MP:0004403,absent cochlear outer hair cells|MP:0004404,cochlear outer hair cell degeneration|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0006325,impaired hearing|MP:0006358,absent pinna reflex|MP:0009349,increased urine pH|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6370147	Slc12a8<em1Imai>	MP:0003806,abnormal nucleotide metabolism|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3529818	Slc12a8<Gt(OST428069)Lex>	MP:0002169,no abnormal phenotype detected
MGI:2682798	Slc13a1<tm1Mark>	MP:0000592,short tail|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002853,hyposulfatemia|MP:0002981,increased liver weight|MP:0003109,short femur|MP:0003996,clonic seizures|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004789,increased bile salt level|MP:0005385,cardiovascular system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009472,increased urine sulfate level|MP:0010107,abnormal renal reabsorption|MP:0031434,increased miscarriage rate
MGI:4360396	Slc13a2<tm1Smch>	MP:0002893,ketoaciduria|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0009643,abnormal urine homeostasis
MGI:5548755	Slc13a3<tm1b(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0005553,increased circulating creatinine level|MP:0005575,increased pulmonary ventilation
MGI:6414526	Slc13a4<em1(IMPC)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:4441655	Slc13a4<tm1a(EUCOMM)Wtsi>	MP:0000111,cleft palate|MP:0000192,abnormal mineral level|MP:0000428,abnormal craniofacial morphology|MP:0001303,abnormal lens morphology|MP:0001914,hemorrhage|MP:0003717,pallor|MP:0004265,abnormal placental transport|MP:0004624,abnormal thoracic cage morphology|MP:0005262,coloboma|MP:0005508,abnormal skeleton morphology|MP:0008274,failure of bone ossification|MP:0009577,abnormal developmental vascular remodeling|MP:0009653,abnormal palate development|MP:0010714,iris coloboma|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0013848,subcutaneous edema|MP:0020137,decreased bone mineralization
MGI:5881938	Slc13a4<tm1d(EUCOMM)Wtsi>	MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:6114744	Slc13a5<M1Btlr>	MP:0001262,decreased body weight
MGI:6199951	Slc13a5<m2Btlr>	MP:0001262,decreased body weight
MGI:5293235	Slc13a5<tm1.2Helf>	MP:0000598,abnormal liver morphology|MP:0000609,abnormal liver physiology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002078,abnormal glucose homeostasis|MP:0002106,abnormal muscle physiology|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003213,decreased susceptibility to age related obesity|MP:0003439,abnormal glycerol level|MP:0003960,increased lean body mass|MP:0004889,increased energy expenditure|MP:0005266,abnormal metabolism|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008963,increased carbon dioxide production|MP:0009356,decreased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0010080,abnormal hepatocyte physiology|MP:0011117,abnormal susceptibility to weight gain|MP:0013404,decreased circulating lactate level|MP:0014341,abnormal hepatocyte mitochondrial morphology|MP:0031391,increased locomotor activity|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:5614709	Slc13a5<tm1b(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0002764,short tibia|MP:0010052,increased grip strength
MGI:2182112	Slc14a1<tm1Ask>	MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001762,polyuria|MP:0002988,decreased urine osmolality|MP:0003378,early sexual maturation|MP:0003830,abnormal testis development|MP:0004109,abnormal Sertoli cell development|MP:0004851,increased testis weight|MP:0004884,abnormal testis physiology|MP:0004953,decreased spleen weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005556,abnormal renal filtration rate|MP:0005565,increased blood urea nitrogen level|MP:0009643,abnormal urine homeostasis|MP:0011467,decreased urine urea nitrogen level|MP:0011471,decreased urine creatinine level|MP:0011941,increased fluid intake|MP:0014810,increased circulating urea level
MGI:3043851	Slc14a2<tm1Raf>	MP:0000532,kidney vascular congestion|MP:0001262,decreased body weight|MP:0001762,polyuria|MP:0002988,decreased urine osmolality|MP:0003918,decreased kidney weight|MP:0004851,increased testis weight|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005524,abnormal renal plasma flow rate|MP:0005566,decreased blood urea nitrogen level|MP:0011417,abnormal renal transport|MP:0011431,increased urine flow rate|MP:0011466,increased urine urea nitrogen level|MP:0011741,increased urine nitrite level|MP:0011941,increased fluid intake
MGI:3705080	Slc14a2<tm1Suc>	MP:0002988,decreased urine osmolality|MP:0005389,reproductive system phenotype|MP:0011417,abnormal renal transport
MGI:7425973	Slc15a1<em1(IMPC)Ccpcz>	MP:0000367,abnormal coat/ hair morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002060,abnormal skin morphology|MP:0003961,decreased lean body mass|MP:0005333,decreased heart rate|MP:0010024,increased total body fat amount|MP:0011047,increased lung tissue damping
MGI:4818784	Slc15a1<tm1Dgen>	MP:0001666,abnormal intestinal absorption
MGI:2661036	Slc15a2<tm1Dan>	MP:0005367,renal/urinary system phenotype|MP:0010107,abnormal renal reabsorption|MP:0011445,abnormal renal protein reabsorption
MGI:2451265	Slc15a2<tm1Dsmi>	MP:0005621,abnormal cell physiology
MGI:4363498	Slc15a3<tm1a(KOMP)Wtsi>	MP:0006173,abnormal myeloid dendritic cell morphology
MGI:5637100	Slc15a3<tm1b(KOMP)Wtsi>	MP:0000220,increased monocyte cell number|MP:0002591,decreased mean corpuscular volume|MP:0002965,increased circulating serum albumin level|MP:0010068,decreased red blood cell distribution width
MGI:4835997	Slc15a4<m1Btlr>	MP:0008555,abnormal interferon secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008706,decreased interleukin-6 secretion
MGI:6356820	Slc15a4<tm1Tkyo>	MP:0003009,abnormal cytokine secretion|MP:0008539,decreased susceptibility to induced colitis|MP:0008561,decreased tumor necrosis factor secretion|MP:0008565,decreased interferon-beta secretion|MP:0008597,decreased circulating interleukin-6 level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008658,decreased interleukin-1 beta secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008670,decreased interleukin-12b secretion|MP:0008676,decreased interleukin-15 secretion|MP:0008685,decreased interleukin-18 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0010210,abnormal circulating cytokine level
MGI:6378428	Slc15a5<em1(IMPC)H>	MP:0009342,enlarged gallbladder
MGI:5544305	Slc16a10<m1Ingm>	MP:0001762,polyuria|MP:0003311,aminoaciduria|MP:0005311,abnormal circulating amino acid level|MP:0005332,abnormal amino acid level|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0009349,increased urine pH|MP:0011468,abnormal urine amino acid level|MP:0011470,increased urine creatinine level|MP:0011941,increased fluid intake
MGI:5702668	Slc16a10<Tn(sb-lacZ,GFP)1.4Tcb>	MP:0001759,increased urine glucose level
MGI:6358784	Slc16a11<em1Smoc>	MP:0005376,homeostasis/metabolism phenotype
MGI:6825806	Slc16a13<em1Tac>	MP:0002891,increased insulin sensitivity|MP:0003631,nervous system phenotype|MP:0005292,improved glucose tolerance|MP:0005367,renal/urinary system phenotype|MP:0005369,muscle phenotype|MP:0005370,liver/biliary system phenotype|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0010957,abnormal aerobic respiration|MP:0014143,decreased body fat mass|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5559460	Slc16a1<tm2.1Lupel>	MP:0001258,decreased body length|MP:0001666,abnormal intestinal absorption|MP:0001783,decreased white adipose tissue amount|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0002942,decreased circulating alanine transaminase level|MP:0003402,decreased liver weight|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005378,growth/size/body region phenotype|MP:0005418,abnormal circulating hormone level|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008963,increased carbon dioxide production|MP:0010378,increased respiratory quotient|MP:0010768,mortality/aging|MP:0011091,prenatal lethality, complete penetrance|MP:0011940,decreased food intake|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3687950	Slc16a2<tm1.1Sref>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005135,increased thyroid-stimulating hormone level|MP:0005179,decreased circulating cholesterol level|MP:0005319,abnormal enzyme/coenzyme level|MP:0005418,abnormal circulating hormone level|MP:0005473,decreased triiodothyronine level|MP:0005474,increased triiodothyronine level|MP:0005476,abnormal circulating triiodothyronine level|MP:0005478,decreased circulating thyroxine level|MP:0005584,abnormal enzyme/coenzyme activity
MGI:4364794	Slc16a2<tm1a(KOMP)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005179,decreased circulating cholesterol level|MP:0005554,decreased circulating creatinine level|MP:0008806,increased circulating amylase level|MP:0010088,decreased circulating fructosamine level
MGI:3710233	Slc16a2<tm1Dgen>	MP:0003631,nervous system phenotype|MP:0005469,abnormal thyroxine level|MP:0005472,abnormal triiodothyronine level|MP:0005478,decreased circulating thyroxine level|MP:0005480,increased circulating triiodothyronine level
MGI:6471733	Slc16a3<tm1.1Lupel>	MP:0001458,abnormal object recognition memory|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0012307,impaired spatial learning|MP:0014367,impaired long-term object recognition memory
MGI:6467009	Slc16a3<tm1Tac>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0005369,muscle phenotype|MP:0005402,abnormal action potential|MP:0005404,abnormal axon morphology|MP:0012106,impaired exercise endurance
MGI:4840599	Slc16a4<tm2e(EUCOMM)Wtsi>	MP:0005565,increased blood urea nitrogen level
MGI:6473153	Slc16a7<tm1.1Lupel>	MP:0001458,abnormal object recognition memory|MP:0005386,behavior/neurological phenotype|MP:0011827,impaired neuron differentiation|MP:0012307,impaired spatial learning|MP:0014064,argyrophilic inclusion bodies|MP:0014367,impaired long-term object recognition memory
MGI:3809596	Slc16a8<tm1Njp>	MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology
MGI:6384875	Slc17a1<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0010052,increased grip strength
MGI:6294082	Slc17a2<em1(IMPC)J>	MP:0001312,abnormal cornea morphology|MP:0010053,decreased grip strength
MGI:7704013	Slc17a3<em1Araka>	MP:0008821,increased blood uric acid level|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0010069,increased serotonin level|MP:0011424,decreased urine uric acid level|MP:0031487,increased circulating hypoxanthine level
MGI:3529082	Slc17a5<tm1Lex>	MP:0000358,abnormal cell morphology|MP:0000745,tremors|MP:0000746,weakness|MP:0000780,abnormal corpus callosum morphology|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0000954,decreased oligodendrocyte progenitor number|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001330,abnormal optic nerve morphology|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001417,decreased exploration in new environment|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002573,behavioral despair|MP:0002882,abnormal neuron morphology|MP:0003871,abnormal myelin sheath morphology|MP:0003997,tonic-clonic seizures|MP:0004267,abnormal optic tract morphology|MP:0005277,abnormal brainstem morphology|MP:0005293,impaired glucose tolerance|MP:0006042,increased apoptosis|MP:0006325,impaired hearing|MP:0008025,brain vacuoles|MP:0009358,environmentally induced seizures|MP:0011085,postnatal lethality, complete penetrance
MGI:5469838	Slc17a6<tm1.1Jder>	MP:0001265,decreased body size|MP:0001415,increased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0001475,reduced long-term depression|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0004495,decreased synaptic glutamate release|MP:0008143,abnormal dendrite morphology|MP:0008414,abnormal spatial reference memory|MP:0009936,abnormal dendritic spine morphology|MP:0014254,increased paired-pulse ratio
MGI:3693866	Slc17a6<tm1.1Kldr>	MP:0001505,hunched posture|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0001961,abnormal reflex|MP:0003633,abnormal nervous system physiology|MP:0004769,abnormal synaptic vesicle morphology|MP:0004792,abnormal synaptic vesicle number|MP:0008536,enlarged third ventricle|MP:0009431,decreased fetal weight|MP:0009703,decreased birth body size|MP:0010746,abnormal pre-Botzinger complex physiology|MP:0011001,absence of AMPA-mediated synaptic currents|MP:0011087,neonatal lethality, complete penetrance
MGI:3771178	Slc17a6<tm1.1Lowl>	MP:0011085,postnatal lethality, complete penetrance
MGI:5469841	Slc17a6<tm1.2Jder>	MP:0011087,neonatal lethality, complete penetrance
MGI:5763820	Slc17a6<tm1b(EUCOMM)Hmgu>	MP:0000428,abnormal craniofacial morphology|MP:0004174,abnormal spine curvature|MP:0011100,preweaning lethality, complete penetrance
MGI:3693864	Slc17a6<tm1Kldr>	MP:0001212,skin lesions|MP:0001219,thick epidermis|MP:0001246,mixed cellular infiltration to dermis|MP:0001412,excessive scratching|MP:0001970,abnormal pain threshold|MP:0001973,increased thermal nociceptive threshold|MP:0001982,decreased chemically-elicited antinociception|MP:0002169,no abnormal phenotype detected|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0010072,increased pruritus
MGI:3693887	Slc17a6<tm1Lex>	MP:0001953,respiratory failure|MP:0001970,abnormal pain threshold|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002206,abnormal CNS synaptic transmission|MP:0002805,abnormal conditioned taste aversion behavior|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003313,abnormal locomotor activation|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0011087,neonatal lethality, complete penetrance|MP:0011269,increased excitatory postsynaptic current amplitude|MP:0014372,decreased miniature excitatory postsynaptic current amplitude|MP:0014376,decreased miniature excitatory postsynaptic current frequency
MGI:6153821	Slc17a7<em1(IMPC)H>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5507862	Slc17a7<tm1.1(cre)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5297703	Slc17a7<tm1.1Ehzg>	MP:0003631,nervous system phenotype
MGI:3051945	Slc17a7<tm1Bros>	MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001491,unresponsive to tactile stimuli|MP:0001505,hunched posture|MP:0001732,postnatal growth retardation|MP:0002152,abnormal brain morphology|MP:0002573,behavioral despair|MP:0002801,abnormal long-term object recognition memory|MP:0002910,abnormal excitatory postsynaptic currents|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0011083,lethality at weaning, complete penetrance
MGI:3617803	Slc17a7<tm1Edw>	MP:0001405,impaired coordination|MP:0001488,increased startle reflex|MP:0002001,blindness|MP:0002083,premature death|MP:0002206,abnormal CNS synaptic transmission|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003444,abnormal neurotransmitter uptake|MP:0003463,abnormal single cell response|MP:0004792,abnormal synaptic vesicle number|MP:0005404,abnormal axon morphology|MP:0005449,abnormal food intake|MP:0014376,decreased miniature excitatory postsynaptic current frequency
MGI:3529095	Slc17a7<tm1Lex>	MP:0001265,decreased body size|MP:0001473,reduced long-term potentiation|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002912,abnormal excitatory postsynaptic potential|MP:0020340,abnormal inhibitory learning
MGI:6277038	Slc17a8<em1(IMPC)Mbp>	MP:0000495,abnormal colon morphology|MP:0000639,abnormal adrenal gland morphology|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001304,cataract|MP:0001417,decreased exploration in new environment|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0004738,abnormal auditory brainstem response|MP:0004906,enlarged uterus|MP:0009142,decreased prepulse inhibition
MGI:3777601	Slc17a8<tm1Edw>	MP:0000948,nonconvulsive seizures|MP:0001967,deafness|MP:0002857,cochlear ganglion degeneration|MP:0004495,decreased synaptic glutamate release|MP:0004562,abnormal inner hair cell synaptic ribbon morphology|MP:0004740,sensorineural hearing loss|MP:0006359,absent startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014620,abnormal interictal brain wave pattern
MGI:3794893	Slc17a8<tm1Selm>	MP:0001967,deafness|MP:0002855,abnormal cochlear ganglion morphology|MP:0003444,abnormal neurotransmitter uptake|MP:0004396,decreased cochlear inner hair cell number|MP:0004416,absent cochlear nerve compound action potential|MP:0004433,abnormal cochlear inner hair cell physiology|MP:0004562,abnormal inner hair cell synaptic ribbon morphology|MP:0004633,abnormal cochlear IHC efferent innervation pattern|MP:0004738,abnormal auditory brainstem response|MP:0004836,abnormal synaptic acetylcholine release|MP:0005377,hearing/vestibular/ear phenotype|MP:0009747,impaired behavioral response to xenobiotic|MP:0009754,enhanced behavioral response to cocaine|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0031391,increased locomotor activity
MGI:5695923	Slc17a9<tm1.1(KOMP)Vlcg>	MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology
MGI:4881502	Slc17a9<tm1.1Rpa>	MP:0002169,no abnormal phenotype detected
MGI:6116235	Slc17a9<tm1Nomu>	MP:0000189,hypoglycemia|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0002909,abnormal adrenal gland physiology|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005388,respiratory system phenotype|MP:0011479,abnormal catecholamine level|MP:0013570,abnormal neuroendocrine gland physiology
MGI:3663332	Slc18a1<tm1Dgen>	MP:0001458,abnormal object recognition memory|MP:0002169,no abnormal phenotype detected|MP:0003203,increased neuron apoptosis|MP:0005386,behavior/neurological phenotype|MP:0009967,abnormal neuron proliferation
MGI:5496922	Slc18a2<tm1.1Bgir>	MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002572,abnormal emotion/affect behavior|MP:0003631,nervous system phenotype|MP:0010070,decreased serotonin level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011479,abnormal catecholamine level
MGI:3574768	Slc18a2<tm1Edw>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0003243,abnormal dopaminergic neuron morphology|MP:0003964,abnormal noradrenaline level|MP:0004769,abnormal synaptic vesicle morphology|MP:0005156,bradykinesia|MP:0005322,abnormal serotonin level|MP:0005445,abnormal neurotransmitter secretion|MP:0005643,decreased dopamine level|MP:0009546,absent gastric milk in neonates|MP:0011085,postnatal lethality, complete penetrance
MGI:2182931	Slc18a2<tm1Kmo>	MP:0011087,neonatal lethality, complete penetrance
MGI:2386330	Slc18a2<tm1Mca>	MP:0001402,decreased locomotor activity|MP:0001423,abnormal liquid preference|MP:0001732,postnatal growth retardation|MP:0001905,abnormal dopamine level|MP:0002062,abnormal associative learning|MP:0002204,abnormal synaptic neurotransmitter level|MP:0002757,decreased vertical activity|MP:0003008,enhanced long-term potentiation|MP:0003064,decreased coping response|MP:0003444,abnormal neurotransmitter uptake|MP:0003546,decreased alcohol consumption|MP:0003963,abnormal corticosterone level|MP:0005386,behavior/neurological phenotype|MP:0005445,abnormal neurotransmitter secretion|MP:0005534,decreased body temperature|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005643,decreased dopamine level|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009703,decreased birth body size|MP:0009712,impaired conditioned place preference behavior|MP:0009749,enhanced behavioral response to addictive substance|MP:0009758,impaired behavioral response to cocaine|MP:0011085,postnatal lethality, complete penetrance
MGI:3620458	Slc18a2<tm1Uhl>	MP:0002083,premature death|MP:0003233,prolonged QT interval|MP:0009712,impaired conditioned place preference behavior|MP:0009749,enhanced behavioral response to addictive substance|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011451,increased susceptibility to dopaminergic neuron neurotoxicity
MGI:2182936	Slc18a2<tm2Kmo>	MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001408,stereotypic behavior|MP:0001413,abnormal response to new environment|MP:0001501,abnormal sleep pattern|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002572,abnormal emotion/affect behavior|MP:0003064,decreased coping response|MP:0003107,abnormal response to novelty|MP:0003224,neuron degeneration|MP:0003462,abnormal response to novel odor|MP:0003867,increased defecation amount|MP:0003964,abnormal noradrenaline level|MP:0005369,muscle phenotype|MP:0005391,vision/eye phenotype|MP:0005643,decreased dopamine level|MP:0008493,alpha-synuclein inclusion body|MP:0008544,impaired olfaction|MP:0009854,impaired gastric peristalsis|MP:0010070,decreased serotonin level|MP:0011448,decreased dopaminergic neuron number|MP:0011451,increased susceptibility to dopaminergic neuron neurotoxicity|MP:0014812,abnormal brain physiology|MP:0020467,abnormal circadian behavior
MGI:3798809	Slc18a3<tm1Mca>	MP:0001360,abnormal social investigation|MP:0001405,impaired coordination|MP:0001458,abnormal object recognition memory|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002914,abnormal endplate potential|MP:0004835,abnormal miniature endplate potential|MP:0004836,abnormal synaptic acetylcholine release|MP:0005386,behavior/neurological phenotype|MP:0010053,decreased grip strength|MP:0012106,impaired exercise endurance
MGI:6383711	Slc18b1<tm1.1Ubc>	MP:0002803,abnormal operant conditioning behavior|MP:0005266,abnormal metabolism|MP:0008414,abnormal spatial reference memory|MP:0008428,abnormal spatial working memory|MP:0009750,impaired behavioral response to addictive substance|MP:0012315,impaired learning|MP:0014365,impaired short-term object recognition memory|MP:0014367,impaired long-term object recognition memory|MP:0030585,enhanced behavioral response to amphetamine
MGI:2679677	Slc19a1<tm1Gold>	MP:0000245,abnormal erythropoiesis|MP:0000527,abnormal kidney development|MP:0000603,pale liver|MP:0000692,small spleen|MP:0000706,small thymus|MP:0001262,decreased body weight|MP:0001606,impaired hematopoiesis|MP:0001732,postnatal growth retardation|MP:0002216,abnormal seminiferous tubule morphology|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002401,abnormal lymphopoiesis|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0005016,decreased lymphocyte cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0011092,embryonic lethality, complete penetrance
MGI:3573752	Slc19a1<tm1Rsc>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000495,abnormal colon morphology|MP:0001764,abnormal homeostasis|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0011091,prenatal lethality, complete penetrance
MGI:3605162	Slc19a2<tm1Ejn>	MP:0000245,abnormal erythropoiesis|MP:0001147,small testis|MP:0001925,male infertility|MP:0002875,decreased erythrocyte cell number|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004740,sensorineural hearing loss|MP:0005159,azoospermia|MP:0005505,thrombocytosis|MP:0008261,arrest of male meiosis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2429761	Slc19a2<tm1Gelb>	MP:0000245,abnormal erythropoiesis|MP:0001156,abnormal spermatogenesis|MP:0001393,ataxia|MP:0001601,abnormal myelopoiesis|MP:0001925,male infertility|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002160,abnormal reproductive system morphology|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005293,impaired glucose tolerance|MP:0005381,digestive/alimentary phenotype|MP:0006325,impaired hearing|MP:0008261,arrest of male meiosis|MP:0014633,decreased spermatid number
MGI:6162644	Slc19a3<tm1.1Nwak>	MP:0000753,paralysis|MP:0001392,abnormal locomotor behavior|MP:0002083,premature death|MP:0003354,astrocytosis|MP:0008948,decreased neuron number|MP:0011226,abnormal thiamin level
MGI:4948864	Slc19a3<tm1Said>	MP:0000753,paralysis|MP:0001392,abnormal locomotor behavior|MP:0001654,hepatic necrosis|MP:0001671,abnormal vitamin absorption|MP:0001859,kidney inflammation|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0003354,astrocytosis|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005150,cachexia|MP:0005202,lethargy|MP:0008948,decreased neuron number|MP:0008986,abnormal liver parenchyma morphology|MP:0009860,nephrosclerosis|MP:0011226,abnormal thiamin level|MP:0031301,chronic liver inflammation
MGI:5529617	Slc1a1<tm1b(KOMP)Wtsi>	MP:0001307,fused cornea and lens|MP:0001415,increased exploration in new environment|MP:0002574,increased vertical activity|MP:0005633,increased circulating sodium level|MP:0008810,increased circulating iron level
MGI:2655190	Slc1a1<tm1Wst>	MP:0001402,decreased locomotor activity|MP:0002944,increased lactate dehydrogenase level|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0006219,optic nerve degeneration|MP:0006309,decreased retina ganglion cell number|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0030613,dicarboxylic aciduria
MGI:5576462	Slc1a2<tm1.1Ncd>	MP:0001399,hyperactivity|MP:0002064,seizures|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0008489,slow postnatal weight gain|MP:0008770,decreased survivor rate
MGI:5752263	Slc1a2<tm1.1Pros>	MP:0002064,seizures|MP:0002083,premature death|MP:0003631,nervous system phenotype|MP:0004994,abnormal brain wave pattern|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0008489,slow postnatal weight gain|MP:0010768,mortality/aging|MP:0021009,abnormal synaptic physiology
MGI:2449707	Slc1a2<tm1Kta>	MP:0000787,abnormal telencephalon morphology|MP:0000947,convulsive seizures|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0005621,abnormal cell physiology|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0010014,hippocampus pyramidal cell degeneration|MP:0011085,postnatal lethality, complete penetrance|MP:0011854,cerebral edema
MGI:5443926	Slc1a3<tm1.1(KOMP)Mbp>	MP:0002574,increased vertical activity|MP:0011396,abnormal sleep behavior
MGI:1931872	Slc1a3<tm1Kta>	MP:0000877,abnormal Purkinje cell morphology|MP:0001326,retina degeneration|MP:0001330,abnormal optic nerve morphology|MP:0001499,abnormal kindling response|MP:0001516,abnormal motor coordination/balance|MP:0002064,seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002944,increased lactate dehydrogenase level|MP:0003631,nervous system phenotype|MP:0003633,abnormal nervous system physiology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0004398,cochlear inner hair cell degeneration|MP:0004494,abnormal synaptic glutamate release|MP:0004597,increased susceptibility to noise-induced hearing loss|MP:0004611,increased susceptibility to ototoxicity-induced hearing loss|MP:0005241,abnormal retina ganglion layer morphology|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0005497,optic nerve cupping|MP:0006219,optic nerve degeneration|MP:0006309,decreased retina ganglion cell number|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012029,abnormal electroretinogram waveform feature|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:3056511	Slc1a3<tm1Wst>	MP:0002910,abnormal excitatory postsynaptic currents|MP:0011272,short excitatory postsynaptic current rise time|MP:0011273,prolonged excitatory postsynaptic current decay time
MGI:7574169	Slc1a4<em2Tmg>	MP:0000433,microcephaly|MP:0000780,abnormal corpus callosum morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0002175,decreased brain weight|MP:0003461,abnormal response to novel object|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype
MGI:6256798	Slc1a4<tm1e(KOMP)Wtsi>	MP:0005292,improved glucose tolerance|MP:0005419,decreased circulating serum albumin level|MP:0010067,increased red blood cell distribution width
MGI:6113803	Slc1a5<tm1Tac>	MP:0002444,abnormal T cell physiology|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008087,decreased T helper 1 cell number|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0010220,decreased T-helper 17 cell number|MP:0010221,abnormal T-helper 17 cell differentiation|MP:0010836,decreased CD4-positive, alpha-beta memory T cell number
MGI:3027689	Slc1a6<tm1Dbe>	MP:0005403,abnormal nerve conduction
MGI:6867259	Slc1a7<em1Fmul>	MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology|MP:0012029,abnormal electroretinogram waveform feature
MGI:4421033	Slc20a1<tm1.1Cmg>	MP:0002169,no abnormal phenotype detected
MGI:4438613	Slc20a1<tm1.1Lbek>	MP:0000218,increased leukocyte cell number|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0002123,abnormal definitive hematopoiesis|MP:0002169,no abnormal phenotype detected|MP:0002875,decreased erythrocyte cell number|MP:0008475,intermingled spleen red and white pulp
MGI:4421036	Slc20a1<tm1.2Cmg>	MP:0001577,anemia|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4438614	Slc20a1<tm1.2Lbek>	MP:0000245,abnormal erythropoiesis|MP:0000352,decreased cell proliferation|MP:0000596,abnormal liver development|MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0000602,dilated liver sinusoidal space|MP:0000603,pale liver|MP:0001577,anemia|MP:0003887,increased hepatocyte apoptosis|MP:0003984,embryonic growth retardation|MP:0004001,decreased hepatocyte proliferation|MP:0004266,pale placenta|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4438612	Slc20a1<tm1Lbek>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000256,echinocytosis|MP:0000314,schistocytosis|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001585,hemolytic anemia|MP:0001732,postnatal growth retardation|MP:0002123,abnormal definitive hematopoiesis|MP:0002447,abnormal erythrocyte morphology|MP:0002640,reticulocytosis|MP:0002812,spherocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002896,abnormal bone mineralization|MP:0003717,pallor|MP:0004952,increased spleen weight|MP:0005280,abnormal fatty acids level|MP:0005397,hematopoietic system phenotype|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4431725	Slc20a2<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000160,kyphosis|MP:0000192,abnormal mineral level|MP:0000198,decreased circulating phosphate level|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000832,abnormal thalamus morphology|MP:0001015,small superior cervical ganglion|MP:0001258,decreased body length|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001319,irregularly shaped pupil|MP:0001322,abnormal iris morphology|MP:0002947,increased hemangioma incidence|MP:0002968,increased circulating alkaline phosphatase level|MP:0003869,ectopic cartilage|MP:0004174,abnormal spine curvature|MP:0004613,fusion of vertebral arches|MP:0004738,abnormal auditory brainstem response|MP:0005176,eyelids fail to open|MP:0005287,narrow eye opening|MP:0006007,abnormal basal ganglion morphology|MP:0006062,abnormal vena cava morphology|MP:0006093,arteriovenous malformation|MP:0006358,absent pinna reflex|MP:0008918,microgliosis|MP:0009820,abnormal liver vasculature morphology|MP:0010052,increased grip strength|MP:0010092,increased circulating magnesium level|MP:0010096,abnormal incisor color|MP:0010124,decreased bone mineral content|MP:0010440,anomalous pulmonary venous connection|MP:0013836,abnormal hypoglossal nerve topology|MP:0013848,subcutaneous edema|MP:0013968,multiple persisting craniopharyngeal ducts|MP:0014018,embryo tumor|MP:0014019,embryo cyst|MP:0030014,calcified brain
MGI:5548966	Slc20a2<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001516,abnormal motor coordination/balance|MP:0001529,abnormal vocalization|MP:0005293,impaired glucose tolerance|MP:0010024,increased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3604569	Slc22a12<tm1Dgen>	MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0010768,mortality/aging|MP:0011537,uraturia
MGI:6153680	Slc22a12<tm1Oka>	MP:0009810,increased urine uric acid level|MP:0010107,abnormal renal reabsorption
MGI:6356365	Slc22a14<em1Fjw>	MP:0000242,impaired fertilization|MP:0001765,abnormal ion homeostasis|MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0003666,impaired sperm capacitation|MP:0004043,abnormal pH regulation|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009237,kinked sperm flagellum|MP:0009243,hairpin sperm flagellum|MP:0009647,decreased fertilization frequency|MP:0009834,abnormal sperm annulus morphology|MP:0010771,integument phenotype|MP:0020451,decreased sperm progressive motility|MP:0031012,impaired sperm migration in female genital tract
MGI:6392063	Slc22a15<em1(IMPC)J>	MP:0002626,increased heart rate|MP:0010507,shortened RR interval
MGI:6144258	Slc22a17<em1(IMPC)H>	MP:0002764,short tibia|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:7657433	Slc22a18<tm1Tgot>	MP:0005378,growth/size/body region phenotype|MP:0009356,decreased liver triglyceride level
MGI:2182947	Slc22a1<tm1Ahs>	MP:0000609,abnormal liver physiology|MP:0001663,abnormal digestive system physiology|MP:0002139,abnormal hepatobiliary system physiology|MP:0006273,abnormal urine organic cation level|MP:0008875,abnormal xenobiotic pharmacokinetics
MGI:5636771	Slc22a1<tm1Kmgi>	MP:0008872,abnormal physiological response to xenobiotic|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0013277,abnormal fasting circulating glucose level|MP:0020101,abnormal hepatic glucose production
MGI:4364715	Slc22a21<tm1a(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected|MP:0009199,abnormal external male genitalia morphology
MGI:6158511	Slc22a29<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen
MGI:2680270	Slc22a2<tm1Ahs>	MP:0002169,no abnormal phenotype detected
MGI:6276886	Slc22a3<em1(IMPC)Mbp>	MP:0001293,anophthalmia|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0002092,abnormal eye morphology|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:2388117	Slc22a3<tm1Dpb>	MP:0001905,abnormal dopamine level|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging|MP:0011451,increased susceptibility to dopaminergic neuron neurotoxicity
MGI:6120715	Slc22a4<tm1.1(KOMP)Vlcg>	MP:0009476,enlarged cecum
MGI:5554255	Slc22a4<tm1Atsu>	MP:0001858,intestinal inflammation|MP:0005165,increased susceptibility to injury|MP:0005332,abnormal amino acid level|MP:0008108,abnormal small intestinal villus morphology|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:6257441	Slc22a5<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:1856926	Slc22a5<jvs>	MP:0000189,hypoglycemia|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0001145,abnormal male reproductive system morphology|MP:0001625,cardiac hypertrophy|MP:0001732,postnatal growth retardation|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0002631,abnormal epididymis morphology|MP:0002661,abnormal corpus epididymis morphology|MP:0003311,aminoaciduria|MP:0003978,decreased circulating carnitine level|MP:0004928,increased epididymis weight|MP:0005309,increased circulating ammonia level|MP:0005389,reproductive system phenotype|MP:0010107,abnormal renal reabsorption
MGI:3604571	Slc22a6<tm1Dgen>	MP:0004955,increased thymus weight|MP:0006272,abnormal urine organic anion level|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0011424,decreased urine uric acid level
MGI:8161223	Slc22a7<em1Araka>	MP:0013275,abnormal xenobiotic metabolism
MGI:7435546	Slc22a7<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0002060,abnormal skin morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003179,thrombocytopenia|MP:0010097,abnormal retina blood vessel morphology
MGI:5636960	Slc22a8<tm1b(KOMP)Wtsi>	MP:0005553,increased circulating creatinine level
MGI:2388472	Slc22a8<tm1Ngm>	MP:0006272,abnormal urine organic anion level|MP:0011424,decreased urine uric acid level
MGI:4457389	Slc23a1<tm1Mlev>	MP:0001671,abnormal vitamin absorption|MP:0002082,postnatal lethality|MP:0003311,aminoaciduria|MP:0003718,maternal effect|MP:0004019,abnormal vitamin homeostasis|MP:0005202,lethargy|MP:0005556,abnormal renal filtration rate|MP:0009546,absent gastric milk in neonates|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011229,abnormal vitamin C level
MGI:2180333	Slc23a2<tm1Nbm>	MP:0001176,abnormal lung development|MP:0001739,abnormal adrenal gland secretion|MP:0001905,abnormal dopamine level|MP:0001915,intracranial hemorrhage|MP:0001953,respiratory failure|MP:0002164,abnormal gland physiology|MP:0002665,decreased circulating corticosterone level|MP:0003834,abnormal adrenergic chromaffin cell morphology|MP:0003962,abnormal adrenaline level|MP:0008291,abnormal adrenocortical cell morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011229,abnormal vitamin C level
MGI:5755087	Slc23a3<em1(IMPC)Tcp>	MP:0001175,abnormal lung morphology
MGI:4363429	Slc23a4<tm1a(KOMP)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0001262,decreased body weight
MGI:5766542	Slc24a1<tm1Xen>	MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0008144,nyctalopia|MP:0008451,retina rod cell degeneration|MP:0008515,thin retina outer nuclear layer|MP:0012034,abnormal a-wave shape|MP:0014333,short retina cone cell outer segment|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:3663782	Slc24a2<tm1Jlyt>	MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001898,abnormal long-term depression|MP:0002804,abnormal motor learning|MP:0004231,abnormal calcium ion homeostasis|MP:0005391,vision/eye phenotype
MGI:6336134	Slc24a3<em1(IMPC)Kmpc>	MP:0002075,abnormal coat/hair pigmentation|MP:0002599,increased mean platelet volume|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength
MGI:7610675	Slc24a3<em#Ebje>	MP:0001399,hyperactivity|MP:0002804,abnormal motor learning|MP:0002904,increased circulating parathyroid hormone level|MP:0003064,decreased coping response|MP:0004991,decreased bone strength|MP:0004992,increased bone resorption|MP:0008537,increased susceptibility to induced colitis|MP:0008883,abnormal enterocyte proliferation|MP:0010124,decreased bone mineral content|MP:0013624,decreased femur compact bone thickness|MP:0013631,decreased bone trabecular spacing|MP:0013639,decreased bone stiffness|MP:0014082,decreased small intestinal villus height|MP:0020010,decreased bone mineral density of femur|MP:0020395,abnormal response to social novelty|MP:0021111,decreased social investigation
MGI:6199645	Slc24a4<m1Btlr>	MP:0001262,decreased body weight
MGI:5306364	Slc24a4<tm1.1Hazh>	MP:0001262,decreased body weight|MP:0001983,abnormal olfactory system physiology|MP:0002576,abnormal enamel morphology|MP:0008544,impaired olfaction|MP:0009562,abnormal odor adaptation|MP:0010055,abnormal sensory neuron physiology|MP:0030450,abnormal enamel mineralization
MGI:5306365	Slc24a4<tm1.2Hazh>	MP:0001262,decreased body weight|MP:0001983,abnormal olfactory system physiology|MP:0008544,impaired olfaction|MP:0010055,abnormal sensory neuron physiology
MGI:5637159	Slc24a4<tm1b(KOMP)Wtsi>	MP:0000709,enlarged thymus|MP:0001556,increased circulating HDL cholesterol level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0009142,decreased prepulse inhibition|MP:0010068,decreased red blood cell distribution width|MP:0010087,increased circulating fructosamine level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5554824	Slc24a5<tm1b(KOMP)Mbp>	MP:0001325,abnormal retina morphology|MP:0001523,impaired righting response|MP:0002075,abnormal coat/hair pigmentation|MP:0005633,increased circulating sodium level|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0012122,abnormal iris transillumination|MP:0013278,decreased fasting circulating glucose level
MGI:3776796	Slc24a5<tm1Lex>	MP:0000015,abnormal ear pigmentation|MP:0002864,abnormal ocular fundus morphology|MP:0005075,abnormal melanosome morphology|MP:0005101,abnormal ciliary body pigmentation|MP:0005102,abnormal iris pigmentation|MP:0005103,abnormal retina pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005408,hypopigmentation|MP:0006159,ocular albinism|MP:0006226,iris hypoplasia|MP:0008731,abnormal hair shaft melanin granule morphology|MP:0009273,abnormal hair shaft melanin granule shape|MP:0009385,abnormal dermal pigmentation|MP:0009387,abnormal epidermal pigmentation
MGI:6120716	Slc25a10<tm1b(EUCOMM)Wtsi>	MP:0008806,increased circulating amylase level|MP:0010052,increased grip strength|MP:0010097,abnormal retina blood vessel morphology|MP:0011965,decreased total retina thickness
MGI:7507207	Slc25a11<em1(IMPC)Mbp>	MP:0011100,preweaning lethality, complete penetrance
MGI:6469639	Slc25a11<em1Syki>	MP:0002080,prenatal lethality
MGI:6305719	Slc25a12<em1(IMPC)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:3603462	Slc25a12<Gt(OST123999)Lex>	MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0000947,convulsive seizures|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001400,hyperresponsive|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0001524,impaired limb coordination|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0001905,abnormal dopamine level|MP:0002152,abnormal brain morphology|MP:0002574,increased vertical activity|MP:0002797,increased thigmotaxis|MP:0003245,abnormal GABAergic neuron morphology|MP:0003674,oxidative stress|MP:0004811,abnormal neuron physiology|MP:0008535,enlarged lateral ventricles|MP:0010070,decreased serotonin level|MP:0010149,abnormal synaptic dopamine release|MP:0010954,abnormal cellular respiration|MP:0010957,abnormal aerobic respiration|MP:0011085,postnatal lethality, complete penetrance|MP:0012468,decreased striatum size|MP:0014812,abnormal brain physiology|MP:0030585,enhanced behavioral response to amphetamine|MP:0030635,increased taurine level|MP:0030733,decreased gamma-aminobutyric acid level|MP:0031391,increased locomotor activity
MGI:5514275	Slc25a13<hspn>	MP:0000026,abnormal inner ear morphology|MP:0000031,abnormal cochlea morphology|MP:0000036,absent semicircular canals|MP:0000037,abnormal lateral semicircular canal morphology|MP:0000041,absent endolymphatic duct|MP:0001394,circling|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0002428,abnormal semicircular canal morphology|MP:0002622,abnormal cochlear hair cell morphology|MP:0002730,head shaking|MP:0002858,abnormal posterior semicircular canal morphology|MP:0003069,abnormal superior semicircular canal morphology|MP:0003148,decreased cochlea coiling|MP:0003169,abnormal scala media morphology|MP:0004369,absent utricle|MP:0006013,absent endolymphatic sac|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3028639	Slc25a13<tm1Lct>	MP:0000189,hypoglycemia|MP:0002628,hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0003383,abnormal gluconeogenesis|MP:0005332,abnormal amino acid level|MP:0009355,increased liver triglyceride level|MP:0009643,abnormal urine homeostasis
MGI:5636973	Slc25a15<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment|MP:0002135,abnormal kidney morphology|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:4124412	Slc25a17<Gt(XB686)Byg>	MP:0000599,enlarged liver|MP:0001860,liver inflammation|MP:0002628,hepatic steatosis|MP:0003887,increased hepatocyte apoptosis|MP:0008114,abnormal Kupffer cell morphology|MP:0010768,mortality/aging|MP:0011091,prenatal lethality, complete penetrance
MGI:6152643	Slc25a18<em1(IMPC)Mbp>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology|MP:0002631,abnormal epididymis morphology|MP:0004924,abnormal behavior|MP:0004931,enlarged epididymis|MP:0010024,increased total body fat amount|MP:0010123,increased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:6491207	Slc25a18<tm1b(KOMP)Wtsi>	MP:0002059,abnormal seminal vesicle morphology|MP:0002941,increased circulating alanine transaminase level|MP:0003642,absent seminal vesicle|MP:0005293,impaired glucose tolerance|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior
MGI:3691853	Slc25a19<tm1Mjl>	MP:0000433,microcephaly|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0000930,wavy neural tube|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0001730,embryonic growth arrest|MP:0002893,ketoaciduria|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006036,abnormal mitochondrial physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012172,abnormal amniotic fluid composition|MP:0012677,absent brain ventricles|MP:0013241,embryo tissue necrosis
MGI:6156346	Slc25a1<em1(IMPC)Kmpc>	MP:0001404,no spontaneous movement|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0002111,abnormal tail morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:5692627	Slc25a1<tm1b(EUCOMM)Wtsi>	MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0000783,abnormal forebrain morphology|MP:0000841,abnormal hindbrain morphology|MP:0000914,exencephaly|MP:0001293,anophthalmia|MP:0001415,increased exploration in new environment|MP:0001672,abnormal embryo development|MP:0001697,abnormal embryo size|MP:0002102,abnormal ear morphology|MP:0002109,abnormal limb morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003717,pallor|MP:0003720,abnormal neural tube closure|MP:0003743,abnormal facial morphology|MP:0003984,embryonic growth retardation|MP:0008797,facial cleft|MP:0009908,protruding tongue|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0011496,abnormal head size
MGI:4431570	Slc25a20<tm1a(EUCOMM)Wtsi>	MP:0001785,edema|MP:0003826,abnormal Mullerian duct morphology|MP:0010530,cerebral arteriovenous malformation|MP:0010912,herniated liver|MP:0011100,preweaning lethality, complete penetrance|MP:0011493,double ureter|MP:0012303,umbilical vein stenosis|MP:0013842,ductus venosus stenosis|MP:0013847,retropleural edema|MP:0013851,abnormal Wolffian duct topology|MP:0013865,abnormal dorsal pancreas topology|MP:0013963,jugular vein stenosis|MP:0013968,multiple persisting craniopharyngeal ducts|MP:0013986,abnormal vitelline vein topology|MP:0014019,embryo cyst|MP:0030975,placenta hemorrhage
MGI:4364913	Slc25a21<tm1a(KOMP)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0000458,abnormal mandible morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002100,abnormal tooth morphology|MP:0002932,abnormal joint morphology|MP:0002942,decreased circulating alanine transaminase level|MP:0005358,abnormal incisor morphology|MP:0005628,decreased circulating potassium level|MP:0005632,decreased circulating aspartate transaminase level|MP:0006358,absent pinna reflex|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5629856	Slc25a21<tm1d(KOMP)Wtsi>	MP:0002591,decreased mean corpuscular volume|MP:0003961,decreased lean body mass|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010024,increased total body fat amount|MP:0010093,decreased circulating magnesium level|MP:0010124,decreased bone mineral content
MGI:5500043	Slc25a23<tm1Lex>	MP:0006036,abnormal mitochondrial physiology|MP:0011467,decreased urine urea nitrogen level
MGI:6120741	Slc25a24<tm1b(KOMP)Wtsi>	MP:0002792,abnormal retina vasculature morphology|MP:0010052,increased grip strength|MP:0010097,abnormal retina blood vessel morphology
MGI:6790249	Slc25a24<tm1Sinos>	MP:0001783,decreased white adipose tissue amount|MP:0003402,decreased liver weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009356,decreased liver triglyceride level
MGI:4948968	Slc25a25<tm1.1Kz>	MP:0003060,increased aerobic running capacity|MP:0003061,decreased aerobic running capacity|MP:0003961,decreased lean body mass|MP:0005289,increased oxygen consumption|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005448,abnormal energy homeostasis|MP:0005452,abnormal adipose tissue amount|MP:0005621,abnormal cell physiology|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0010025,decreased total body fat amount|MP:0010182,decreased susceptibility to weight gain|MP:0011939,increased food intake
MGI:3526110	Slc25a26<Tn(sb-T/MPT/eGFP)1.32Dla>	MP:0003984,embryonic growth retardation|MP:0011091,prenatal lethality, complete penetrance
MGI:6514333	Slc25a28<tm1.1Dwrd>	MP:0005380,embryo phenotype|MP:0008743,decreased liver iron level|MP:0010959,abnormal oxidative phosphorylation
MGI:6514336	Slc25a28<tm1.2Dwrd>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005397,hematopoietic system phenotype|MP:0008743,decreased liver iron level|MP:0010959,abnormal oxidative phosphorylation
MGI:5637123	Slc25a28<tm1b(EUCOMM)Wtsi>	MP:0001312,abnormal cornea morphology
MGI:6830922	Slc25a2<em1Osb>	MP:0005389,reproductive system phenotype
MGI:4842343	Slc25a30<tm1a(EUCOMM)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0003960,increased lean body mass|MP:0004599,abnormal vertebral arch morphology|MP:0005419,decreased circulating serum albumin level|MP:0010025,decreased total body fat amount
MGI:3758940	Slc25a31<tm1Nte>	MP:0001147,small testis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:7520348	Slc25a32<em1Liliu>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype
MGI:7520349	Slc25a32<em2Liliu>	MP:0001405,impaired coordination|MP:0001522,impaired swimming|MP:0003978,decreased circulating carnitine level|MP:0003979,increased circulating carnitine level|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0011230,abnormal folic acid level|MP:0030659,decreased glycine level|MP:0030691,increased serine level
MGI:7520351	Slc25a32<em3Liliu>	MP:0000914,exencephaly|MP:0001764,abnormal homeostasis|MP:0003978,decreased circulating carnitine level|MP:0003979,increased circulating carnitine level|MP:0003984,embryonic growth retardation|MP:0008784,craniorachischisis|MP:0011092,embryonic lethality, complete penetrance|MP:0011230,abnormal folic acid level|MP:0030658,increased glycine level|MP:0030691,increased serine level
MGI:4011881	Slc25a32<Gt(IST11480G10)Tigm>	MP:0000428,abnormal craniofacial morphology|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0000929,open neural tube|MP:0003720,abnormal neural tube closure|MP:0008784,craniorachischisis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7572931	Slc25a34<em1Duna>	MP:0001260,increased body weight|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0003983,decreased cholesterol level|MP:0005291,abnormal glucose tolerance|MP:0005293,impaired glucose tolerance|MP:0005318,decreased triglyceride level|MP:0005331,insulin resistance|MP:0005560,decreased circulating glucose level|MP:0013278,decreased fasting circulating glucose level
MGI:7618985	Slc25a34<em2Duna>	MP:0002169,no abnormal phenotype detected
MGI:5505637	Slc25a35<tm1.1(KOMP)Vlcg>	MP:0002833,increased heart weight
MGI:5014803	Slc25a37<tm1.1Kapl>	MP:0005517,impaired liver regeneration|MP:0008743,decreased liver iron level|MP:0010959,abnormal oxidative phosphorylation
MGI:5014804	Slc25a37<tm1.2Kapl>	MP:0003717,pallor|MP:0008956,decreased cellular hemoglobin content|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4431760	Slc25a38<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight
MGI:7425977	Slc25a39<em1(IMPC)Bay>	MP:0000063,decreased bone mineral density|MP:0001513,limb grasping|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6198542	Slc25a3<tm1.1Jmol>	MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0003484,abnormal channel response|MP:0004090,abnormal sarcomere morphology|MP:0004231,abnormal calcium ion homeostasis|MP:0005330,cardiomyopathy|MP:0006038,increased mitochondrial fission|MP:0010630,abnormal cardiac muscle tissue morphology|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5548483	Slc25a3<tm1b(EUCOMM)Wtsi>	MP:0001147,small testis|MP:0001726,abnormal allantois morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3929126	Slc25a40<Gt(IST10006D1)Tigm>	MP:0002169,no abnormal phenotype detected
MGI:6830923	Slc25a41<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6342805	Slc25a42<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0001925,male infertility|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6376222	Slc25a44<em1(IMPC)J>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity
MGI:7596323	Slc25a44<em1Kajim>	MP:0003829,impaired febrile response|MP:0005378,growth/size/body region phenotype|MP:0011698,abnormal brown adipose tissue physiology
MGI:8262722	Slc25a45<em1Brsy>	MP:0003978,decreased circulating carnitine level|MP:0013242,abnormal amino acid metabolism|MP:0021145,abnormal amino acid derivative level
MGI:6118180	Slc25a46<atc>	MP:0000694,spleen hypoplasia|MP:0000851,cerebellum hypoplasia|MP:0000890,thin cerebellar molecular layer|MP:0000956,decreased spinal cord size|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001059,optic nerve atrophy|MP:0001392,abnormal locomotor behavior|MP:0001393,ataxia|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0002083,premature death|MP:0003354,astrocytosis|MP:0003997,tonic-clonic seizures|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight|MP:0008056,abnormal retina ganglion cell morphology|MP:0008106,decreased amacrine cell number|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008918,microgliosis|MP:0009538,abnormal synapse morphology|MP:0010053,decreased grip strength|MP:0010732,abnormal node of Ranvier morphology|MP:0014331,abnormal Purkinje cell mitochondrial morphology|MP:0020339,abnormal retina ganglion cell dendrite morphology
MGI:5790100	Slc25a46<em1(IMPC)J>	MP:0005559,increased circulating glucose level|MP:0010053,decreased grip strength|MP:0013279,increased fasting circulating glucose level
MGI:5692782	Slc25a47<tm1b(EUCOMM)Hmgu>	MP:0003020,decreased circulating chloride level|MP:0005634,decreased circulating sodium level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6280027	Slc25a48<em1(IMPC)J>	MP:0002971,abnormal brown adipose tissue morphology|MP:0003674,oxidative stress|MP:0004777,abnormal phospholipid level|MP:0005266,abnormal metabolism|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011049,impaired adaptive thermogenesis|MP:0011630,increased mitochondrial size|MP:0011634,abnormal mitochondrial inner membrane morphology|MP:0011635,abnormal mitochondrial crista morphology|MP:0011699,abnormal brown adipose tissue thermogenesis|MP:0020582,increased ceramide level|MP:0021128,increased choline level|MP:0021129,abnormal glycerophosphocholine level
MGI:4432177	Slc25a4<tm1a(EUCOMM)Wtsi>	MP:0000194,increased circulating calcium level|MP:0002079,increased circulating insulin level|MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0003020,decreased circulating chloride level|MP:0004613,fusion of vertebral arches|MP:0005292,improved glucose tolerance|MP:0005565,increased blood urea nitrogen level
MGI:3036341	Slc25a4<tm1Dwa>	MP:0002169,no abnormal phenotype detected
MGI:3036342	Slc25a4<tm2Dwa>	MP:0000751,myopathy|MP:0001625,cardiac hypertrophy|MP:0002332,abnormal exercise endurance|MP:0009642,abnormal blood homeostasis|MP:0010957,abnormal aerobic respiration|MP:0013405,increased circulating lactate level|MP:0030673,increased circulating alanine level
MGI:5812587	Slc26a10<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:7507208	Slc26a11<em1(IMPC)Mbp>	MP:0001399,hyperactivity|MP:0001406,abnormal gait
MGI:5888744	Slc26a11<tm1.1Cidz>	MP:0001405,impaired coordination|MP:0003412,abnormal afterhyperpolarization|MP:0004008,abnormal GABA-mediated receptor currents|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential|MP:0012007,abnormal chloride level|MP:0014382,increased miniature inhibitory postsynaptic current frequency
MGI:4440647	Slc26a1<tm1Mark>	MP:0000192,abnormal mineral level|MP:0000194,increased circulating calcium level|MP:0000609,abnormal liver physiology|MP:0001654,hepatic necrosis|MP:0001663,abnormal digestive system physiology|MP:0001859,kidney inflammation|MP:0002708,nephrolithiasis|MP:0002853,hyposulfatemia|MP:0002941,increased circulating alanine transaminase level|MP:0005441,increased urine calcium level|MP:0008546,abnormal vesicle-mediated transport|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009472,increased urine sulfate level
MGI:6257611	Slc26a2<em1(IMPC)Bay>	MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0003743,abnormal facial morphology|MP:0005293,impaired glucose tolerance|MP:0009908,protruding tongue|MP:0011100,preweaning lethality, complete penetrance
MGI:3574926	Slc26a2<tm1Aros>	MP:0000066,osteoporosis|MP:0000131,abnormal long bone epiphysis morphology|MP:0000160,kyphosis|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000352,decreased cell proliferation|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002932,abnormal joint morphology|MP:0003419,delayed endochondral bone ossification|MP:0004358,bowed tibia|MP:0004686,decreased length of long bones|MP:0005621,abnormal cell physiology|MP:0030223,mandibular hyperostosis
MGI:3697318	Slc26a3<tm1Sole>	MP:0000351,increased cell proliferation|MP:0000493,rectal prolapse|MP:0000495,abnormal colon morphology|MP:0001262,decreased body weight|MP:0001663,abnormal digestive system physiology|MP:0002083,premature death|MP:0002666,increased circulating aldosterone level|MP:0003020,decreased circulating chloride level|MP:0003868,abnormal feces composition|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005036,diarrhea|MP:0005565,increased blood urea nitrogen level|MP:0005628,decreased circulating potassium level|MP:0005634,decreased circulating sodium level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014483,increased feces water content
MGI:6500762	Slc26a4<em1Jgao>	MP:0000048,abnormal stria vascularis morphology|MP:0001262,decreased body weight|MP:0001394,circling|MP:0001525,impaired balance|MP:0003143,enlarged otoliths|MP:0003145,detached otolithic membrane|MP:0004362,cochlear hair cell degeneration|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004533,fused inner hair cell stereocilia|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0030126,torticollis
MGI:3574673	Slc26a4<loop>	MP:0000026,abnormal inner ear morphology|MP:0000031,abnormal cochlea morphology|MP:0000034,abnormal inner ear vestibule morphology|MP:0000681,abnormal thyroid gland morphology|MP:0001394,circling|MP:0001406,abnormal gait|MP:0001967,deafness|MP:0002428,abnormal semicircular canal morphology|MP:0002895,abnormal otolithic membrane morphology|MP:0002978,absent otoliths|MP:0003149,abnormal tectorial membrane morphology|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0004249,abnormal crista ampullaris morphology|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004591,enlarged tectorial membrane|MP:0004696,abnormal thyroid follicle morphology|MP:0004742,abnormal vestibular system physiology|MP:0006012,dilated endolymphatic duct|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology|MP:0006358,absent pinna reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5789595	Slc26a4<m1Btlr>	MP:0004742,abnormal vestibular system physiology
MGI:5806435	Slc26a4<m2Btlr>	MP:0001395,bidirectional circling|MP:0005307,head tossing|MP:0008537,increased susceptibility to induced colitis
MGI:3693973	Slc26a4<pdsm>	MP:0000042,abnormal organ of Corti morphology|MP:0001394,circling|MP:0001410,head bobbing|MP:0001967,deafness|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002978,absent otoliths|MP:0003144,decreased otolith number|MP:0003146,absent cochlear ganglion|MP:0003148,decreased cochlea coiling|MP:0003149,abnormal tectorial membrane morphology|MP:0003169,abnormal scala media morphology|MP:0003205,testicular atrophy|MP:0004405,absent cochlear hair cells|MP:0004408,decreased cochlear hair cell number|MP:0005191,head tilt|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0006025,distended Reissner membrane|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5293411	Slc26a4<tm1.1Dontu>	MP:0000045,abnormal hair cell morphology|MP:0001394,circling|MP:0001405,impaired coordination|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0001526,abnormal placing response|MP:0002894,abnormal otolith morphology|MP:0003143,enlarged otoliths|MP:0003144,decreased otolith number|MP:0004324,vestibular hair cell degeneration|MP:0004328,decreased vestibular hair cell number|MP:0004362,cochlear hair cell degeneration|MP:0004363,stria vascularis degeneration|MP:0004366,abnormal strial marginal cell morphology|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004742,abnormal vestibular system physiology|MP:0004924,abnormal behavior|MP:0005191,head tilt|MP:0005367,renal/urinary system phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0006011,abnormal endolymphatic duct morphology|MP:0006012,dilated endolymphatic duct|MP:0006014,dilated endolymphatic sac|MP:0006325,impaired hearing|MP:0008309,dilated scala media|MP:0009821,abnormal vestibular aqueduct morphology|MP:0010053,decreased grip strength|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2385787	Slc26a4<tm1Egr>	MP:0000026,abnormal inner ear morphology|MP:0000043,organ of Corti degeneration|MP:0001394,circling|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0001967,deafness|MP:0002428,abnormal semicircular canal morphology|MP:0002895,abnormal otolithic membrane morphology|MP:0002978,absent otoliths|MP:0003143,enlarged otoliths|MP:0004231,abnormal calcium ion homeostasis|MP:0004287,abnormal spiral limbus morphology|MP:0004316,enlarged vestibular saccule|MP:0004331,vestibular saccular macula degeneration|MP:0004334,utricular macular degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004363,stria vascularis degeneration|MP:0004364,thin stria vascularis|MP:0004365,abnormal strial basal cell morphology|MP:0004366,abnormal strial marginal cell morphology|MP:0004367,abnormal strial intermediate cell morphology|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004410,absent endocochlear potential|MP:0004411,decreased endocochlear potential|MP:0004487,type I spiral ligament fibrocyte degeneration|MP:0004488,type II spiral ligament fibrocyte degeneration|MP:0004493,dilated cochlea|MP:0004533,fused inner hair cell stereocilia|MP:0004740,sensorineural hearing loss|MP:0004742,abnormal vestibular system physiology|MP:0004749,nonsyndromic hearing loss|MP:0004862,small scala tympani|MP:0004863,thin spiral ligament|MP:0005191,head tilt|MP:0005377,hearing/vestibular/ear phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0006012,dilated endolymphatic duct|MP:0006014,dilated endolymphatic sac|MP:0006025,distended Reissner membrane|MP:0006358,absent pinna reflex|MP:0006389,abnormal vestibular endolymph physiology|MP:0006391,abnormal vestibular endolymph ionic homeostasis|MP:0006403,abnormal cochlear endolymph ionic homeostasis|MP:0008309,dilated scala media|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4818636	Slc26a4<tm1Sole>	MP:0003016,increased circulating bicarbonate level|MP:0009350,decreased urine pH|MP:0011735,increased urine ammonia level
MGI:5529273	Slc26a4<tm2.1Dontu>	MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:5792083	Slc26a5<mpc234H>	MP:0001967,deafness
MGI:2387795	Slc26a5<tm1Jnz>	MP:0000043,organ of Corti degeneration|MP:0001262,decreased body weight|MP:0001967,deafness|MP:0002857,cochlear ganglion degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004413,absent cochlear microphonics|MP:0004414,decreased cochlear microphonics|MP:0004417,decreased cochlear nerve compound action potential|MP:0004430,abnormal Claudius cell morphology|MP:0004436,absent cochlear outer hair cell electromotility|MP:0004437,decreased cochlear outer hair cell electromotility|MP:0004465,degeneration of organ of Corti supporting cells|MP:0004466,short cochlear outer hair cells|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004737,absent distortion product otoacoustic emissions|MP:0004767,increased cochlear nerve compound action potential|MP:0006325,impaired hearing|MP:0006336,abnormal otoacoustic response|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3719391	Slc26a5<tm2Jnz>	MP:0004435,abnormal cochlear outer hair cell electromotility
MGI:3834612	Slc26a5<tm3Jnz>	MP:0004402,decreased cochlear outer hair cell number|MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004437,decreased cochlear outer hair cell electromotility|MP:0004767,increased cochlear nerve compound action potential
MGI:5316512	Slc26a5<tm4.1(cre/ERT2)Jnz>	MP:0005377,hearing/vestibular/ear phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5316514	Slc26a5<tm4(cre/ERT2)Jnz>	MP:0005377,hearing/vestibular/ear phenotype
MGI:3623454	Slc26a6<tm1Psar>	MP:0005360,urolithiasis|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis
MGI:3831563	Slc26a6<tm1Smua>	MP:0002693,abnormal pancreas physiology|MP:0002694,abnormal pancreas secretion
MGI:3603678	Slc26a6<tm1Sole>	MP:0001663,abnormal digestive system physiology|MP:0002136,abnormal kidney physiology
MGI:4429559	Slc26a7<tm1Sole>	MP:0000525,renal tubular acidosis|MP:0001663,abnormal digestive system physiology|MP:0002876,abnormal thyroid gland physiology|MP:0003017,decreased circulating bicarbonate level|MP:0003030,acidemia|MP:0003503,decreased activity of thyroid gland|MP:0003620,oliguria|MP:0004696,abnormal thyroid follicle morphology|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005355,enlarged thyroid gland|MP:0005468,abnormal thyroid hormone level|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level|MP:0008055,increased urine osmolality|MP:0009349,increased urine pH
MGI:3759094	Slc26a8<tm1Ggac>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0003666,impaired sperm capacitation|MP:0004542,impaired acrosome reaction|MP:0004543,abnormal sperm physiology|MP:0009237,kinked sperm flagellum|MP:0009242,thin sperm flagellum|MP:0009243,hairpin sperm flagellum|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009834,abnormal sperm annulus morphology|MP:0014465,abnormal sperm mitochondrial morphology
MGI:6276954	Slc26a9<em1(IMPC)Mbp>	MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001404,no spontaneous movement|MP:0001614,abnormal blood vessel morphology|MP:0001914,hemorrhage|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3822918	Slc26a9<tm1Sole>	MP:0000471,abnormal stomach epithelium morphology|MP:0000473,abnormal stomach glandular epithelium morphology|MP:0000505,decreased digestive secretion|MP:0000507,absent digestive secretion|MP:0004137,abnormal gastric surface mucous cell morphology|MP:0004139,abnormal gastric parietal cell morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0008006,increased stomach pH|MP:0013566,dilated gastric gland
MGI:3038701	Slc27a1<tm1Jkk>	MP:0001547,abnormal lipid level|MP:0002078,abnormal glucose homeostasis|MP:0005280,abnormal fatty acids level|MP:0031413,abnormal skeletal muscle triglyceride level|MP:0031617,abnormal skeletal muscle cell glucose uptake
MGI:2663647	Slc27a2<tm1Kds>	MP:0002169,no abnormal phenotype detected|MP:0005621,abnormal cell physiology
MGI:7425980	Slc27a3<em1(IMPC)Tcp>	MP:0002060,abnormal skin morphology|MP:0002591,decreased mean corpuscular volume|MP:0002792,abnormal retina vasculature morphology|MP:0009142,decreased prepulse inhibition|MP:0010097,abnormal retina blood vessel morphology
MGI:3530073	Slc27a4<Gt(OST329034)Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:5475225	Slc27a4<pskn>	MP:0001196,shiny skin|MP:0001198,tight skin|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001220,epidermal necrosis|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001242,hyperkeratosis|MP:0001504,abnormal posture|MP:0002639,micrognathia|MP:0009546,absent gastric milk in neonates|MP:0009583,increased keratinocyte proliferation|MP:0009602,abnormal keratohyalin granule morphology|MP:0009908,protruding tongue|MP:0009931,abnormal skin appearance|MP:0011087,neonatal lethality, complete penetrance
MGI:2667329	Slc27a4<tm1.1Wsr>	MP:0000757,herniated abdominal wall|MP:0001179,thick pulmonary interalveolar septum|MP:0001191,abnormal skin condition|MP:0001192,scaly skin|MP:0001198,tight skin|MP:0001200,thick skin|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0001262,decreased body weight|MP:0001436,abnormal suckling behavior|MP:0001575,cyanosis|MP:0001951,abnormal breathing pattern|MP:0001954,respiratory distress|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002796,impaired skin barrier function|MP:0003313,abnormal locomotor activation|MP:0003427,parakeratosis|MP:0003743,abnormal facial morphology|MP:0005501,abnormal skin physiology|MP:0009607,decreased keratohyalin granule size|MP:0011087,neonatal lethality, complete penetrance|MP:0011159,abnormal epidermal-dermal junction morphology
MGI:2684501	Slc27a4<tm1Asta>	MP:0011092,embryonic lethality, complete penetrance
MGI:2667328	Slc27a4<tm1Wsr>	MP:0001198,tight skin|MP:0001200,thick skin|MP:0001216,abnormal epidermal layer morphology|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001436,abnormal suckling behavior|MP:0001784,abnormal fluid regulation|MP:0001954,respiratory distress|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002796,impaired skin barrier function|MP:0003743,abnormal facial morphology|MP:0009607,decreased keratohyalin granule size|MP:0009908,protruding tongue|MP:0011087,neonatal lethality, complete penetrance|MP:0011159,abnormal epidermal-dermal junction morphology|MP:0030572,abnormal pilosebaceous unit morphology|MP:0030798,joint contracture
MGI:2445864	Slc27a4<wrfr>	MP:0000379,decreased hair follicle number|MP:0000416,sparse hair|MP:0000462,abnormal digestive system morphology|MP:0001196,shiny skin|MP:0001198,tight skin|MP:0001200,thick skin|MP:0001402,decreased locomotor activity|MP:0001435,absent suckling reflex|MP:0002133,abnormal respiratory system physiology|MP:0011087,neonatal lethality, complete penetrance
MGI:3757682	Slc27a5<tm1Asta>	MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0001547,abnormal lipid level|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0003458,decreased circulating ketone body level|MP:0004773,abnormal bile composition|MP:0005179,decreased circulating cholesterol level|MP:0005282,decreased fatty acids level|MP:0005285,decreased unsaturated fatty acids level|MP:0005286,decreased saturated fatty acids level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005533,increased body temperature|MP:0005559,increased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0009289,decreased epididymal fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level|MP:0011940,decreased food intake
MGI:6272674	Slc27a6<em1(IMPC)J>	MP:0010053,decreased grip strength
MGI:7643463	Slc28a1<em1Govr>	MP:0000194,increased circulating calcium level|MP:0000208,decreased hematocrit|MP:0001577,anemia|MP:0002640,reticulocytosis|MP:0002875,decreased erythrocyte cell number|MP:0003020,decreased circulating chloride level|MP:0005178,increased circulating cholesterol level|MP:0005266,abnormal metabolism|MP:0005376,homeostasis/metabolism phenotype|MP:0005553,increased circulating creatinine level|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0010768,mortality/aging|MP:0011477,abnormal urine nucleoside level
MGI:6153822	Slc28a3<em1(IMPC)H>	MP:0000220,increased monocyte cell number|MP:0010090,increased circulating creatine kinase level|MP:0012362,increased large unstained cell number
MGI:3052066	Slc29a1<tm1Msg>	MP:0001262,decreased body weight|MP:0001987,alcohol preference|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003545,increased alcohol consumption|MP:0003656,abnormal erythrocyte physiology|MP:0004685,calcified intervertebral disk|MP:0004703,abnormal vertebral column morphology|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005165,increased susceptibility to injury|MP:0008148,abnormal sternocostal joint morphology|MP:0009755,impaired behavioral response to alcohol|MP:0011584,increased alkaline phosphatase activity|MP:0020080,increased bone mineralization|MP:0030222,hyperostosis
MGI:5513821	Slc29a1<tm2b(NCOM)Mfgc>	MP:0000063,decreased bone mineral density|MP:0000150,abnormal rib morphology|MP:0001258,decreased body length|MP:0002092,abnormal eye morphology|MP:0002590,increased mean corpuscular volume|MP:0002764,short tibia|MP:0002875,decreased erythrocyte cell number|MP:0004122,abnormal sinus arrhythmia|MP:0004609,vertebral fusion|MP:0005292,improved glucose tolerance|MP:0005333,decreased heart rate|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010506,prolonged RR interval
MGI:5317195	Slc29a1<tm2Msg>	MP:0005164,abnormal response to injury|MP:0005166,decreased susceptibility to injury|MP:0008706,decreased interleukin-6 secretion
MGI:3529770	Slc29a2<Gt(OST207791)Lex>	MP:0005166,decreased susceptibility to injury|MP:0005397,hematopoietic system phenotype|MP:0008706,decreased interleukin-6 secretion
MGI:6382397	Slc29a3<em1(IMPC)Mbp>	MP:0000470,abnormal stomach morphology|MP:0000494,abnormal cecum morphology|MP:0000495,abnormal colon morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0001120,abnormal uterus morphology|MP:0001157,small seminal vesicle|MP:0001175,abnormal lung morphology|MP:0001488,increased startle reflex|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002339,abnormal lymph node morphology|MP:0002637,small uterus|MP:0002759,abnormal caudal vertebrae morphology|MP:0002981,increased liver weight|MP:0002989,small kidney|MP:0004952,increased spleen weight|MP:0005333,decreased heart rate|MP:0009476,enlarged cecum|MP:0009483,enlarged ileum|MP:0010506,prolonged RR interval|MP:0011503,distended jejunum|MP:0011882,enlarged duodenum
MGI:6257459	Slc29a3<em1(IMPC)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0002599,increased mean platelet volume|MP:0002644,decreased circulating triglyceride level|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0003019,increased circulating chloride level|MP:0003179,thrombocytopenia|MP:0003960,increased lean body mass|MP:0004151,decreased circulating iron level|MP:0005179,decreased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005567,decreased circulating total protein level|MP:0005633,increased circulating sodium level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008806,increased circulating amylase level|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width
MGI:5007332	Slc29a3<tm1Lex>	MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002083,premature death|MP:0002412,increased susceptibility to bacterial infection|MP:0002446,abnormal macrophage morphology|MP:0002451,abnormal macrophage physiology|MP:0003172,abnormal lysosome physiology|MP:0005387,immune system phenotype|MP:0005425,increased macrophage cell number|MP:0009321,increased histiocytic sarcoma incidence|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010373,myeloid hyperplasia|MP:0011080,increased macrophage apoptosis
MGI:5692811	Slc29a4<tm1b(KOMP)Wtsi>	MP:0000552,abnormal radius morphology|MP:0005108,abnormal ulna morphology|MP:0008259,abnormal optic disk morphology
MGI:5485154	Slc29a4<tm1Jowg>	MP:0000820,abnormal choroid plexus morphology
MGI:3814338	Slc2a10<G128E>	MP:0000689,abnormal spleen morphology|MP:0001614,abnormal blood vessel morphology|MP:0002191,abnormal artery morphology|MP:0002964,aortic elastic tissue lesions|MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0003211,abnormal aorta elastic fiber morphology|MP:0004007,abnormal lung vasculature morphology|MP:0005385,cardiovascular system phenotype|MP:0006083,abnormal blood vessel elastic tissue morphology|MP:0009866,abnormal aorta wall morphology|MP:0009869,abnormal descending aorta morphology|MP:0010903,abnormal pulmonary alveolus wall morphology|MP:0011309,abnormal kidney arterial blood vessel morphology
MGI:3814339	Slc2a10<S150F>	MP:0001614,abnormal blood vessel morphology|MP:0005385,cardiovascular system phenotype
MGI:6257477	Slc2a12<em2(IMPC)Bay>	MP:0000195,decreased circulating calcium level|MP:0002953,thick ventricular wall|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005419,decreased circulating serum albumin level|MP:0010579,increased heart left ventricle size
MGI:6152644	Slc2a13<em1(IMPC)Mbp>	MP:0005293,impaired glucose tolerance|MP:0020420,abnormal freezing behavior|MP:0020421,increased freezing behavior
MGI:7282075	Slc2a1<em1Mase>	MP:0011085,postnatal lethality, complete penetrance
MGI:3811855	Slc2a1<Rgsc200>	MP:0000947,convulsive seizures|MP:0000951,sporadic seizures|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001504,abnormal posture|MP:0001672,abnormal embryo development|MP:0003631,nervous system phenotype|MP:0003926,decreased cellular glucose uptake|MP:0004000,impaired passive avoidance behavior|MP:0004994,abnormal brain wave pattern|MP:0005380,embryo phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008035,behavioral arrest|MP:0009358,environmentally induced seizures|MP:0009454,impaired contextual conditioning behavior|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012289,abnormal non-rapid eye movement sleep pattern|MP:0014134,abnormal embryo morphology|MP:0014620,abnormal interictal brain wave pattern|MP:0014814,increased brain glucose metabolism|MP:0020211,slow movement|MP:0020478,abnormal circadian sleep/wake cycle|MP:0031391,increased locomotor activity|MP:0031648,decreased cerebrospinal fluid glucose level
MGI:3624543	Slc2a1<tm1Dcdv>	MP:0000951,sporadic seizures|MP:0001293,anophthalmia|MP:0001405,impaired coordination|MP:0001698,decreased embryo size|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002175,decreased brain weight|MP:0003926,decreased cellular glucose uptake|MP:0003984,embryonic growth retardation|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0031648,decreased cerebrospinal fluid glucose level
MGI:5575896	Slc2a2<tm1b(KOMP)Wtsi>	MP:0006353,increased glycosylated hemoglobin level|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:2181752	Slc2a2<tm1Thor>	MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002712,increased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0005215,abnormal pancreatic islet morphology|MP:0005281,increased fatty acids level|MP:0005291,abnormal glucose tolerance|MP:0008997,increased blood osmolality|MP:0009109,decreased pancreas weight|MP:0009114,decreased pancreatic beta cell mass|MP:0011085,postnatal lethality, complete penetrance|MP:0030589,increased pancreatic alpha cell mass
MGI:5514187	Slc2a2<tm2Thor>	MP:0000188,abnormal circulating glucose level|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0003059,decreased insulin secretion|MP:0003926,decreased cellular glucose uptake|MP:0004774,abnormal bile salt level|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005438,abnormal glycogen homeostasis|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level|MP:0010400,increased liver glycogen level|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:3822325	Slc2a3<Gt(XG611)Byg>	MP:0001363,increased anxiety-related response|MP:0001488,increased startle reflex|MP:0003631,nervous system phenotype|MP:0004994,abnormal brain wave pattern|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0009142,decreased prepulse inhibition
MGI:3710246	Slc2a3<tm1Dksr>	MP:0001935,decreased litter size|MP:0004265,abnormal placental transport|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance
MGI:5014841	Slc2a3<tm1Stua>	MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:2182083	Slc2a4<tm1Abel>	MP:0000188,abnormal circulating glucose level|MP:0000266,abnormal heart morphology|MP:0000343,abnormal response to cardiac infarction|MP:0001262,decreased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0001547,abnormal lipid level|MP:0001559,hyperglycemia|MP:0001625,cardiac hypertrophy|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002106,abnormal muscle physiology|MP:0002118,abnormal lipid homeostasis|MP:0002833,increased heart weight|MP:0003633,abnormal nervous system physiology|MP:0003822,decreased left ventricle systolic pressure|MP:0005282,decreased fatty acids level|MP:0005291,abnormal glucose tolerance|MP:0005318,decreased triglyceride level|MP:0005329,abnormal myocardium layer morphology|MP:0005331,insulin resistance|MP:0005369,muscle phenotype|MP:0005438,abnormal glycogen homeostasis|MP:0005559,increased circulating glucose level|MP:0010400,increased liver glycogen level|MP:0013759,decreased intestinal glucose absorption|MP:0014071,increased cardiac muscle glycogen level|MP:0030016,increased adipocyte glucose uptake|MP:0030017,decreased adipocyte glucose uptake|MP:0030018,increased cardiac muscle cell glucose uptake|MP:0030020,decreased cardiac muscle cell glucose uptake|MP:0030022,decreased muscle cell glucose uptake|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:3718071	Slc2a4<tm1Jdz>	MP:0001625,cardiac hypertrophy|MP:0002079,increased circulating insulin level|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0005559,increased circulating glucose level|MP:0005608,cardiac interstitial fibrosis|MP:0030016,increased adipocyte glucose uptake|MP:0030017,decreased adipocyte glucose uptake|MP:0030018,increased cardiac muscle cell glucose uptake|MP:0031618,decreased skeletal muscle cell glucose uptake|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:2149725	Slc2a4<tm1Mch>	MP:0000188,abnormal circulating glucose level|MP:0000231,hypertension|MP:0001559,hyperglycemia|MP:0001625,cardiac hypertrophy|MP:0001732,postnatal growth retardation|MP:0001853,heart inflammation|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002628,hepatic steatosis|MP:0002702,decreased circulating free fatty acids level|MP:0002833,increased heart weight|MP:0002837,dystrophic cardiac calcinosis|MP:0002841,impaired skeletal muscle contractility|MP:0002953,thick ventricular wall|MP:0003058,increased insulin secretion|MP:0003458,decreased circulating ketone body level|MP:0003646,increased muscle fatigability|MP:0004819,decreased skeletal muscle mass|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005438,abnormal glycogen homeostasis|MP:0005491,pancreatic islet hyperplasia|MP:0005608,cardiac interstitial fibrosis|MP:0006085,myocardium necrosis|MP:0006086,decreased body mass index|MP:0006094,increased fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0010025,decreased total body fat amount|MP:0010399,decreased skeletal muscle glycogen level|MP:0030022,decreased muscle cell glucose uptake|MP:0031115,macrovesicular hepatic steatosis|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:3797586	Slc2a5<tm1.1Jnz>	MP:0005377,hearing/vestibular/ear phenotype
MGI:5613655	Slc2a5<tm1b(EUCOMM)Wtsi>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001126,abnormal ovary morphology|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001417,decreased exploration in new environment|MP:0002059,abnormal seminal vesicle morphology|MP:0009709,hydrometra
MGI:6356342	Slc2a6<em1Kusu>	MP:0002451,abnormal macrophage physiology|MP:0008553,increased circulating tumor necrosis factor level|MP:0008735,increased susceptibility to endotoxin shock
MGI:6360858	Slc2a6<em1Rbr>	MP:0005376,homeostasis/metabolism phenotype|MP:0010025,decreased total body fat amount|MP:0010379,decreased respiratory quotient
MGI:4450978	Slc2a8<tm1.1Asch>	MP:0002675,asthenozoospermia|MP:0004543,abnormal sperm physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3641337	Slc2a8<tm1.1Thor>	MP:0000812,abnormal dentate gyrus morphology|MP:0004071,prolonged P wave|MP:0005385,cardiovascular system phenotype|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5445581	Slc2a8<tm1Khm>	MP:0000182,increased circulating LDL cholesterol level|MP:0001262,decreased body weight|MP:0001668,abnormal intestinal fructose absorption|MP:0001764,abnormal homeostasis|MP:0001935,decreased litter size|MP:0002079,increased circulating insulin level|MP:0005178,increased circulating cholesterol level|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0009642,abnormal blood homeostasis
MGI:4361276	Slc2a9<tm1.1Thor>	MP:0001762,polyuria|MP:0002901,increased urine phosphate level|MP:0002988,decreased urine osmolality|MP:0005367,renal/urinary system phenotype|MP:0005619,increased urine potassium level|MP:0008821,increased blood uric acid level|MP:0009350,decreased urine pH|MP:0011435,increased urine magnesium level|MP:0011537,uraturia
MGI:4361278	Slc2a9<tm1.2Thor>	MP:0000519,hydronephrosis|MP:0000522,kidney cortex cyst|MP:0001262,decreased body weight|MP:0001426,polydipsia|MP:0001762,polyuria|MP:0001859,kidney inflammation|MP:0002705,dilated renal tubule|MP:0002708,nephrolithiasis|MP:0002988,decreased urine osmolality|MP:0003215,renal interstitial fibrosis|MP:0005553,increased circulating creatinine level|MP:0005619,increased urine potassium level|MP:0006316,increased urine sodium level|MP:0008821,increased blood uric acid level|MP:0009350,decreased urine pH|MP:0010092,increased circulating magnesium level|MP:0010107,abnormal renal reabsorption|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011346,renal tubule atrophy|MP:0011405,tubulointerstitial nephritis|MP:0011423,kidney cortex atrophy|MP:0011435,increased urine magnesium level|MP:0011537,uraturia
MGI:5707492	Slc2a9<tm1Khm>	MP:0000231,hypertension|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002079,increased circulating insulin level|MP:0002169,no abnormal phenotype detected|MP:0002626,increased heart rate|MP:0002628,hepatic steatosis|MP:0003333,liver fibrosis|MP:0003868,abnormal feces composition|MP:0003949,abnormal circulating lipid level|MP:0004889,increased energy expenditure|MP:0005178,increased circulating cholesterol level|MP:0005266,abnormal metabolism|MP:0005289,increased oxygen consumption|MP:0005331,insulin resistance|MP:0005458,increased percent body fat/body weight|MP:0008821,increased blood uric acid level|MP:0008882,abnormal enterocyte physiology|MP:0008965,increased basal metabolism|MP:0009355,increased liver triglyceride level|MP:0009810,increased urine uric acid level|MP:0010359,increased liver free fatty acids level|MP:0010379,decreased respiratory quotient|MP:0011925,abnormal heart echocardiography feature|MP:0014142,increased body fat mass
MGI:6158651	Slc30a10<tm1.1Sommu>	MP:0000607,abnormal hepatocyte morphology|MP:0000681,abnormal thyroid gland morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002083,premature death|MP:0003103,liver degeneration|MP:0003503,decreased activity of thyroid gland|MP:0003631,nervous system phenotype|MP:0004696,abnormal thyroid follicle morphology|MP:0004697,abnormal thyroid follicular cell morphology|MP:0005121,decreased circulating prolactin level|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005478,decreased circulating thyroxine level|MP:0006350,increased circulating copper level|MP:0008489,slow postnatal weight gain|MP:0008810,increased circulating iron level|MP:0010398,decreased liver glycogen level|MP:0020365,increased brain iron level|MP:0030593,abnormal manganese level|MP:0030595,increased brain manganese level|MP:0030598,increased liver manganese level|MP:0030601,increased circulating manganese level
MGI:6158650	Slc30a10<tm1Sommu>	MP:0002169,no abnormal phenotype detected
MGI:3056498	Slc30a1<tm1Gka>	MP:0001730,embryonic growth arrest|MP:0001923,reduced female fertility|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6324180	Slc30a2<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0002060,abnormal skin morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013279,increased fasting circulating glucose level|MP:0013292,embryonic lethality prior to organogenesis
MGI:6202882	Slc30a2<tm1Kgna>	MP:0000628,abnormal mammary gland development|MP:0000662,abnormal branching of the mammary ductal tree|MP:0002451,abnormal macrophage physiology|MP:0003718,maternal effect|MP:0006270,abnormal mammary gland growth during lactation|MP:0009503,abnormal mammary gland duct morphology|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009615,abnormal zinc homeostasis|MP:0010173,increased mammary gland epithelial cell proliferation|MP:0010174,decreased mammary gland epithelial cell proliferation|MP:0013716,hypolactation|MP:0013781,abnormal mammary gland luminal epithelium morphology|MP:0014126,increased mammary gland apoptosis
MGI:1859820	Slc30a3<tm1Rpa>	MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0004769,abnormal synaptic vesicle morphology|MP:0009615,abnormal zinc homeostasis|MP:0009617,decreased brain zinc level
MGI:6156460	Slc30a4<em1(IMPC)Tcp>	MP:0000706,small thymus|MP:0000745,tremors|MP:0001126,abnormal ovary morphology|MP:0002060,abnormal skin morphology|MP:0002764,short tibia|MP:0002768,small adrenal glands|MP:0003068,enlarged kidney|MP:0010052,increased grip strength|MP:0010053,decreased grip strength
MGI:1856938	Slc30a4<lm>	MP:0000414,alopecia|MP:0001194,dermatitis|MP:0001212,skin lesions|MP:0001262,decreased body weight|MP:0001304,cataract|MP:0001314,cornea opacity|MP:0001408,stereotypic behavior|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0001732,postnatal growth retardation|MP:0002075,abnormal coat/hair pigmentation|MP:0002894,abnormal otolith morphology|MP:0003413,hair follicle degeneration|MP:0003718,maternal effect|MP:0003809,abnormal hair shaft morphology|MP:0004047,abnormal milk composition|MP:0004812,abnormal linear vestibular evoked potential|MP:0004813,absent linear vestibular evoked potential|MP:0004924,abnormal behavior|MP:0005376,homeostasis/metabolism phenotype|MP:0006270,abnormal mammary gland growth during lactation|MP:0009599,thick epidermis stratum granulosum|MP:0009615,abnormal zinc homeostasis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013716,hypolactation|MP:0020894,abnormal milk zinc level
MGI:2681466	Slc30a5<tm1Ynak>	MP:0000063,decreased bone mineral density|MP:0000131,abnormal long bone epiphysis morphology|MP:0000135,decreased compact bone thickness|MP:0000160,kyphosis|MP:0000746,weakness|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002114,abnormal axial skeleton morphology|MP:0002115,abnormal limb bone morphology|MP:0004989,decreased osteoblast cell number|MP:0005334,abnormal fat pad morphology|MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009298,increased mesenteric fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0010519,atrioventricular block|MP:0010637,sinus bradycardia
MGI:6279908	Slc30a7<em1(IMPC)Bay>	MP:0000280,thin ventricular wall|MP:0001925,male infertility|MP:0001926,female infertility|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0010024,increased total body fat amount|MP:0011962,increased cornea thickness
MGI:3528432	Slc30a7<Gt(XC827)Byg>	MP:0001670,abnormal intestinal mineral absorption|MP:0005459,decreased percent body fat/body weight|MP:0008489,slow postnatal weight gain|MP:0009615,abnormal zinc homeostasis|MP:0011940,decreased food intake|MP:0031172,decreased circulating zinc level
MGI:4362061	Slc30a8<tm1.1Geno>	MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0009615,abnormal zinc homeostasis
MGI:5558084	Slc30a8<tm1.1Htwt>	MP:0003058,increased insulin secretion|MP:0003839,abnormal insulin clearance|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0009615,abnormal zinc homeostasis
MGI:4363904	Slc30a8<tm1a(KOMP)Wtsi>	MP:0005343,increased circulating aspartate transaminase level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content
MGI:4359863	Slc30a8<tm1Lex>	MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005376,homeostasis/metabolism phenotype|MP:0009615,abnormal zinc homeostasis
MGI:6414508	Slc30a9<em1(IMPC)Bay>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0000928,incomplete rostral neuropore closure|MP:0001672,abnormal embryo development|MP:0001691,abnormal somite shape|MP:0001697,abnormal embryo size|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001726,abnormal allantois morphology|MP:0002151,abnormal neural tube morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0002861,abnormal tail bud morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0004180,failure of initiation of embryo turning|MP:0004258,abnormal placenta size|MP:0005031,abnormal trophoblast layer morphology|MP:0006108,abnormal hindbrain development|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2388121	Slc31a1<tm1Djt>	MP:0001680,abnormal mesoderm development|MP:0001698,decreased embryo size|MP:0002621,delayed neural tube closure|MP:0003952,abnormal copper level|MP:0004180,failure of initiation of embryo turning|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0006301,abnormal mesenchyme morphology|MP:0008743,decreased liver iron level|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2388122	Slc31a1<tm1Jgt>	MP:0001683,absent mesoderm|MP:0001687,thin endoderm|MP:0001914,hemorrhage|MP:0002085,abnormal embryonic tissue morphology|MP:0003087,absent allantois|MP:0003954,abnormal Reichert's membrane morphology|MP:0004272,abnormal basement membrane morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011215,decreased brain copper level|MP:0012096,decreased Reichert's membrane thickness
MGI:3771147	Slc31a1<tm2Djt>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001278,kinked vibrissae|MP:0001393,ataxia|MP:0001732,postnatal growth retardation|MP:0003065,abnormal liver copper level|MP:0003952,abnormal copper level|MP:0004953,decreased spleen weight|MP:0005408,hypopigmentation|MP:0005421,loose skin|MP:0005639,hemosiderosis|MP:0006349,decreased circulating copper level|MP:0011086,postnatal lethality, incomplete penetrance
MGI:7858957	Slc31a2<tm1.1Djt>	MP:0010243,increased kidney copper level|MP:0011214,increased brain copper level|MP:0014539,increased copper level
MGI:4442415	Slc32a1<tm1.1Bgc>	MP:0000013,abnormal adipose tissue distribution|MP:0001505,hunched posture|MP:0001953,respiratory failure|MP:0009886,failure of palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0010146,umbilical hernia|MP:0011089,perinatal lethality, complete penetrance
MGI:3714029	Slc32a1<tm1Bros>	MP:0001404,no spontaneous movement|MP:0001505,hunched posture|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003052,omphalocele|MP:0003990,decreased neurotransmitter release|MP:0004143,muscle hypertonia|MP:0009890,cleft secondary palate|MP:0011089,perinatal lethality, complete penetrance
MGI:3815083	Slc32a1<tm1Lowl>	MP:0001262,decreased body weight|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0005289,increased oxygen consumption|MP:0005449,abnormal food intake|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0010025,decreased total body fat amount|MP:0010379,decreased respiratory quotient|MP:0031391,increased locomotor activity
MGI:3714155	Slc32a1<tm1Yyan>	MP:0000111,cleft palate|MP:0001953,respiratory failure|MP:0002272,abnormal nervous system electrophysiology|MP:0002911,abnormal inhibitory postsynaptic potential|MP:0003052,omphalocele|MP:0003477,abnormal nerve fiber response|MP:0010819,primary atelectasis|MP:0011087,neonatal lethality, complete penetrance
MGI:5141270	Slc32a1<tm2(cre)Lowl>	MP:0002169,no abnormal phenotype detected|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003997,tonic-clonic seizures|MP:0020424,increased kindling response
MGI:5634280	Slc33a1<tm1.1Lpu>	MP:0000219,increased neutrophil cell number|MP:0000780,abnormal corpus callosum morphology|MP:0000781,decreased corpus callosum size|MP:0000921,demyelination|MP:0001194,dermatitis|MP:0001513,limb grasping|MP:0001730,embryonic growth arrest|MP:0001828,abnormal T cell activation|MP:0001846,increased inflammatory response|MP:0001847,brain inflammation|MP:0001852,conjunctivitis|MP:0001870,salivary gland inflammation|MP:0001873,stomach inflammation|MP:0001973,increased thermal nociceptive threshold|MP:0002006,neoplasm|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0002406,increased susceptibility to infection|MP:0003009,abnormal cytokine secretion|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0003608,prostate gland inflammation|MP:0003984,embryonic growth retardation|MP:0005014,increased B cell number|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0005405,axon degeneration|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008027,abnormal spinal cord white matter morphology|MP:0008260,abnormal autophagy|MP:0008566,increased interferon-gamma secretion|MP:0008614,increased circulating interleukin-17 level|MP:0008635,increased circulating interleukin-18 level|MP:0008681,increased interleukin-17 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008770,decreased survivor rate|MP:0008918,microgliosis|MP:0009646,urinary bladder inflammation|MP:0010053,decreased grip strength|MP:0010210,abnormal circulating cytokine level|MP:0012431,increased lymphoma incidence|MP:0012712,spinal cord degeneration|MP:0013905,preputial gland inflammation
MGI:2386786	Slc34a1<tm1Hten>	MP:0000060,delayed bone ossification|MP:0000130,abnormal trabecular bone morphology|MP:0000194,increased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000747,muscle weakness|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001431,abnormal eating behavior|MP:0001921,reduced fertility|MP:0002082,postnatal lethality|MP:0002113,abnormal skeleton development|MP:0002901,increased urine phosphate level|MP:0002905,decreased circulating parathyroid hormone level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003197,nephrocalcinosis|MP:0005202,lethargy|MP:0005367,renal/urinary system phenotype|MP:0005390,skeleton phenotype|MP:0005441,increased urine calcium level|MP:0009643,abnormal urine homeostasis|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0011228,abnormal vitamin D level
MGI:4847567	Slc34a2<tm1.1Scc>	MP:0001666,abnormal intestinal absorption|MP:0002902,decreased urine phosphate level|MP:0002986,decreased urine calcium level|MP:0003868,abnormal feces composition|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010923,calcified pulmonary alveolus
MGI:3841013	Slc34a2<tm1Khan>	MP:0001690,failure of somite differentiation|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003403,absent placental labyrinth|MP:0004076,abnormal vitelline vascular remodeling|MP:0004180,failure of initiation of embryo turning|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance
MGI:5305039	Slc34a2<tm1Sega>	MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0001672,abnormal embryo development|MP:0002902,decreased urine phosphate level|MP:0005166,decreased susceptibility to injury|MP:0005441,increased urine calcium level|MP:0005554,decreased circulating creatinine level|MP:0010155,abnormal intestine physiology|MP:0011092,embryonic lethality, complete penetrance|MP:0011228,abnormal vitamin D level
MGI:5609132	Slc34a3<tm1.1Nhch>	MP:0005376,homeostasis/metabolism phenotype
MGI:4359215	Slc34a3<tm1Kimi>	MP:0000194,increased circulating calcium level|MP:0001666,abnormal intestinal absorption|MP:0005390,skeleton phenotype|MP:0005416,abnormal circulating protein level|MP:0005441,increased urine calcium level|MP:0011228,abnormal vitamin D level
MGI:3604525	Slc35a1<Gt(OST124815)Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:7425982	Slc35a3<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0002111,abnormal tail morphology|MP:0003385,abnormal body wall morphology|MP:0009908,protruding tongue|MP:0011100,preweaning lethality, complete penetrance
MGI:7464255	Slc35a3<em1Tfric>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000153,rib bifurcation|MP:0000157,abnormal sternum morphology|MP:0001265,decreased body size|MP:0003345,decreased rib number|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004621,lumbar vertebral fusion|MP:0004623,thoracic vertebral fusion|MP:0004686,decreased length of long bones|MP:0005352,small cranium|MP:0006395,abnormal epiphyseal plate morphology|MP:0006396,decreased long bone epiphyseal plate size|MP:0011089,perinatal lethality, complete penetrance|MP:0011475,abnormal glycosaminoglycan level
MGI:5548720	Slc35b4<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001399,hyperactivity|MP:0001697,abnormal embryo size|MP:0002833,increased heart weight|MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3709989	Slc35c1<tm1Cknr>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000420,ruffled hair|MP:0001183,overexpanded pulmonary alveolus|MP:0001262,decreased body weight|MP:0001386,abnormal maternal nurturing|MP:0001504,abnormal posture|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002345,abnormal lymph node primary follicle morphology|MP:0003628,abnormal leukocyte adhesion|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005266,abnormal metabolism|MP:0008101,lymph node hypoplasia|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0014474,decreased pulmonary alveolus wall thickness|MP:0020332,impaired leukocyte tethering or rolling
MGI:5755404	Slc35c2<tm1.1(KOMP)Vlcg>	MP:0000367,abnormal coat/ hair morphology|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:7720232	Slc35c2<tm1.1Pst>	MP:0002169,no abnormal phenotype detected
MGI:3774133	Slc35d1<tm1Hko>	MP:0000445,short snout|MP:0000547,short limbs|MP:0001258,decreased body length|MP:0001270,distended abdomen|MP:0002116,abnormal craniofacial bone morphology|MP:0002657,chondrodystrophy|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004134,abnormal chest morphology|MP:0004686,decreased length of long bones|MP:0009908,protruding tongue|MP:0011087,neonatal lethality, complete penetrance|MP:0011175,platyspondylia|MP:0030848,short ilium
MGI:5692775	Slc35d1<tm2b(EUCOMM)Hmgu>	MP:0000111,cleft palate|MP:0001510,abnormal coat appearance|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003385,abnormal body wall morphology|MP:0003743,abnormal facial morphology|MP:0005560,decreased circulating glucose level|MP:0005567,decreased circulating total protein level|MP:0009908,protruding tongue|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape
MGI:3802578	Slc35d3<IAP>	MP:0001186,pigmentation phenotype|MP:0004725,decreased platelet serotonin level
MGI:7586620	Slc35e1<em1Cya>	MP:0001191,abnormal skin condition|MP:0001262,decreased body weight|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009584,decreased keratinocyte proliferation|MP:0020893,abnormal zinc level
MGI:4363454	Slc35f1<tm1a(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected|MP:0005571,decreased lactate dehydrogenase level
MGI:6414495	Slc35f5<em1(IMPC)Hmgu>	MP:0005634,decreased circulating sodium level
MGI:4432047	Slc35f6<tm1a(EUCOMM)Wtsi>	MP:0002644,decreased circulating triglyceride level|MP:0004924,abnormal behavior
MGI:6324175	Slc36a1<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000470,abnormal stomach morphology|MP:0001293,anophthalmia|MP:0001697,abnormal embryo size|MP:0002060,abnormal skin morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder
MGI:6114754	Slc36a2<em1(IMPC)J>	MP:0000572,abnormal autopod morphology|MP:0005655,increased aggression
MGI:6361151	Slc36a3<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6120800	Slc37a1<tm1b(EUCOMM)Hmgu>	MP:0000266,abnormal heart morphology|MP:0000598,abnormal liver morphology|MP:0005344,increased circulating bilirubin level|MP:0010024,increased total body fat amount|MP:0011960,abnormal eye anterior chamber depth
MGI:6857743	Slc37a2<em1(IMPC)Mbp>	MP:0000062,increased bone mineral density|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001304,cataract|MP:0002339,abnormal lymph node morphology|MP:0002699,abnormal vitreous body morphology|MP:0010123,increased bone mineral content
MGI:6771481	Slc37a2<tm1Dgen>	MP:0002451,abnormal macrophage physiology|MP:0008560,increased tumor necrosis factor secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock
MGI:3046091	Slc37a4<tm1Jyc>	MP:0000065,abnormal bone marrow cavity morphology|MP:0000131,abnormal long bone epiphysis morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000189,hypoglycemia|MP:0000222,decreased neutrophil cell number|MP:0000333,decreased bone marrow cell number|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001262,decreased body weight|MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0001601,abnormal myelopoiesis|MP:0001732,postnatal growth retardation|MP:0001764,abnormal homeostasis|MP:0001845,abnormal inflammatory response|MP:0001876,decreased inflammatory response|MP:0002064,seizures|MP:0002078,abnormal glucose homeostasis|MP:0002082,postnatal lethality|MP:0002118,abnormal lipid homeostasis|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002463,abnormal neutrophil physiology|MP:0003068,enlarged kidney|MP:0005016,decreased lymphocyte cell number|MP:0005046,absent spleen white pulp|MP:0005178,increased circulating cholesterol level|MP:0006396,decreased long bone epiphyseal plate size|MP:0008720,impaired neutrophil chemotaxis|MP:0008722,abnormal chemokine secretion|MP:0010400,increased liver glycogen level|MP:0031003,increased kidney glycogen level
MGI:4431702	Slc38a10<tm1a(EUCOMM)Wtsi>	MP:0000061,fragile skeleton|MP:0000063,decreased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0000609,abnormal liver physiology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0004686,decreased length of long bones|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0005567,decreased circulating total protein level|MP:0008805,decreased circulating amylase level|MP:0008810,increased circulating iron level|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content
MGI:4441779	Slc38a10<tm2a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0001552,increased circulating triglyceride level|MP:0002092,abnormal eye morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002896,abnormal bone mineralization|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0003961,decreased lean body mass|MP:0005316,abnormal response to tactile stimuli|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0005627,increased circulating potassium level|MP:0005634,decreased circulating sodium level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008805,decreased circulating amylase level
MGI:6728130	Slc38a11<em1Csz>	MP:0005394,taste/olfaction phenotype
MGI:5696925	Slc38a11<tm2b(KOMP)Mbp>	MP:0001566,increased circulating phosphate level
MGI:6441049	Slc38a1<tm1.1Ttaka>	MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury
MGI:4881203	Slc38a1<tm1(KOMP)Vlcg>	MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7581890	Slc38a2<em1Zhxy>	MP:0001762,polyuria|MP:0002135,abnormal kidney morphology|MP:0008055,increased urine osmolality|MP:0010375,increased kidney iron level|MP:0012605,decreased kidney glutathione level|MP:0012659,decreased superoxide dismutase level|MP:0014359,increased ferroptosis
MGI:5293947	Slc38a2<tm1a(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000218,increased leukocyte cell number|MP:0000559,abnormal femur morphology|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002058,neonatal lethality|MP:0003828,pulmonary edema|MP:0005179,decreased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014525,impaired pulmonary alveolar fluid clearance
MGI:6414493	Slc38a3<em1(IMPC)Bay>	MP:0001258,decreased body length|MP:0003795,abnormal bone structure|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5790979	Slc38a3<m1Ingm>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0002727,decreased circulating insulin level|MP:0005202,lethargy|MP:0005311,abnormal circulating amino acid level|MP:0005332,abnormal amino acid level|MP:0005376,homeostasis/metabolism phenotype|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0008831,abnormal insulin-like growth factor I level|MP:0011085,postnatal lethality, complete penetrance|MP:0011467,decreased urine urea nitrogen level|MP:0011652,increased circulating histidine level|MP:0011736,decreased urine ammonia level|MP:0012335,increased circulating homocysteine level|MP:0013724,decreased circulating tyrosine level|MP:0030625,increased circulating cysteine level|MP:0030674,decreased circulating alanine level|MP:0030698,decreased phenylalanine level|MP:0030703,increased circulating threonine level|MP:0030706,increased glutamine level|MP:0030707,decreased glutamine level|MP:0030733,decreased gamma-aminobutyric acid level|MP:0030737,decreased glutamic acid level|MP:0030748,decreased leucine level|MP:0030750,increased circulating leucine level
MGI:6403486	Slc38a4<em1Smtb>	MP:0001262,decreased body weight|MP:0004921,decreased placenta weight
MGI:6403487	Slc38a4<em2Smtb>	MP:0001262,decreased body weight|MP:0004921,decreased placenta weight
MGI:6403488	Slc38a4<em3Smtb>	MP:0001262,decreased body weight|MP:0004921,decreased placenta weight
MGI:6403492	Slc38a4<em#Smtb>	MP:0001262,decreased body weight|MP:0002082,postnatal lethality|MP:0004200,decreased fetal size|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004921,decreased placenta weight|MP:0005311,abnormal circulating amino acid level|MP:0010039,abnormal trophoblast giant cell proliferation|MP:0011523,thin placenta labyrinth|MP:0011653,decreased circulating histidine level|MP:0012109,decreased trophoblast glycogen cell number|MP:0030656,decreased circulating glycine level|MP:0030695,decreased circulating serine level|MP:0030710,decreased circulating glutamine level|MP:0030716,decreased circulating isoleucine level|MP:0030719,decreased circulating lysine level|MP:0030728,decreased circulating valine level
MGI:4843107	Slc38a5<tm1(KOMP)Vlcg>	MP:0005216,abnormal pancreatic alpha cell morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:7425983	Slc38a7<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001293,anophthalmia|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology
MGI:7543297	Slc38a8<em1Cya>	MP:0002410,decreased susceptibility to viral infection|MP:0005632,decreased circulating aspartate transaminase level|MP:0009790,decreased susceptibility to viral infection induced morbidity/mortality|MP:0030743,decreased aspartic acid level
MGI:7425984	Slc38a8<em1(IMPC)Bay>	MP:0001399,hyperactivity
MGI:7571247	Slc38a8<em1Lmon>	MP:0001186,pigmentation phenotype|MP:0002184,abnormal innervation|MP:0004165,abnormal lateral geniculate nucleus morphology|MP:0005100,abnormal choroid pigmentation|MP:0005102,abnormal iris pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0006149,decreased visual acuity|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:6162488	Slc39a10<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5642299	Slc39a10<tm1.1Tfk>	MP:0000379,decreased hair follicle number|MP:0000416,sparse hair|MP:0001190,reddish skin|MP:0001216,abnormal epidermal layer morphology|MP:0001218,thin epidermis|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0001823,thymus hypoplasia|MP:0002460,decreased immunoglobulin level|MP:0002492,decreased IgE level|MP:0002796,impaired skin barrier function|MP:0003643,spleen atrophy|MP:0003941,abnormal skin development|MP:0005017,decreased B cell number|MP:0008208,decreased pro-B cell number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008897,decreased IgG2c level|MP:0009541,increased thymocyte apoptosis|MP:0009598,thin epidermis stratum granulosum|MP:0011085,postnatal lethality, complete penetrance|MP:0011687,decreased epidermal stem cell number
MGI:3829756	Slc39a13<tm1Thir>	MP:0000063,decreased bone mineral density|MP:0000120,malocclusion|MP:0000126,brittle teeth|MP:0000131,abnormal long bone epiphysis morphology|MP:0000132,thickened long bone epiphysis|MP:0000133,abnormal long bone metaphysis morphology|MP:0000135,decreased compact bone thickness|MP:0000160,kyphosis|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000454,abnormal jaw morphology|MP:0001243,abnormal dermal layer morphology|MP:0001732,postnatal growth retardation|MP:0002100,abnormal tooth morphology|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003671,abnormal eyelid aperture|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0004189,abnormal alveolar process morphology|MP:0004540,small maxilla|MP:0004592,small mandible|MP:0004686,decreased length of long bones|MP:0005006,abnormal osteoblast physiology|MP:0005358,abnormal incisor morphology|MP:0005543,decreased cornea thickness|MP:0006198,enophthalmos|MP:0006395,abnormal epiphyseal plate morphology|MP:0010869,decreased bone trabecula number|MP:0020010,decreased bone mineral density of femur|MP:0030494,abnormal molar root morphology
MGI:5766177	Slc39a14<tm1b(NCOM)Mfgc>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5007337	Slc39a14<tm1Lex>	MP:0002941,increased circulating alanine transaminase level|MP:0003402,decreased liver weight|MP:0004001,decreased hepatocyte proliferation|MP:0005390,skeleton phenotype|MP:0005517,impaired liver regeneration|MP:0011924,abnormal liver zinc level
MGI:4999729	Slc39a14<tm1Thir>	MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000161,scoliosis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002764,short tibia|MP:0003109,short femur|MP:0003383,abnormal gluconeogenesis|MP:0003968,abnormal growth hormone level|MP:0004686,decreased length of long bones|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0011924,abnormal liver zinc level|MP:0013630,increased bone trabecular spacing|MP:0014105,abnormal chondrocyte differentiation|MP:0030126,torticollis
MGI:3625131	Slc39a1<tm1.1Gka>	MP:0001672,abnormal embryo development|MP:0003935,abnormal craniofacial development|MP:0003984,embryonic growth retardation|MP:0006279,abnormal limb development
MGI:5696637	Slc39a1<tm1Gka>	MP:0002169,no abnormal phenotype detected
MGI:3712865	Slc39a2<tm1Gka>	MP:0000420,ruffled hair|MP:0000428,abnormal craniofacial morphology|MP:0001192,scaly skin|MP:0003984,embryonic growth retardation|MP:0004231,abnormal calcium ion homeostasis|MP:0006279,abnormal limb development|MP:0008738,abnormal liver iron level
MGI:3512105	Slc39a3<tm1Gka>	MP:0002436,abnormal CD8-positive, alpha-beta cytotoxic T cell morphology|MP:0003718,maternal effect|MP:0005092,decreased double-positive T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number
MGI:5582434	Slc39a4<tm1.1(KOMP)Wtsi>	MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0006108,abnormal hindbrain development|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3759070	Slc39a4<tm1Gka>	MP:0000432,abnormal head morphology|MP:0000914,exencephaly|MP:0001265,decreased body size|MP:0001293,anophthalmia|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001891,hydrocephaly|MP:0003718,maternal effect|MP:0003921,abnormal heart left ventricle morphology|MP:0003935,abnormal craniofacial development|MP:0003984,embryonic growth retardation|MP:0005508,abnormal skeleton morphology|MP:0010724,thick interventricular septum|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5438020	Slc39a4<tm2Gka>	MP:0000598,abnormal liver morphology|MP:0001263,weight loss|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0003066,increased liver copper level|MP:0003067,decreased liver copper level|MP:0003952,abnormal copper level|MP:0004016,decreased bone mass|MP:0004232,decreased muscle weight|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0004843,abnormal Paneth cell morphology|MP:0005636,abnormal mineral homeostasis|MP:0008108,abnormal small intestinal villus morphology|MP:0008807,increased liver iron level|MP:0009615,abnormal zinc homeostasis|MP:0010157,abnormal small intestinal crypt cell proliferation|MP:0010248,decreased intestine copper level|MP:0011083,lethality at weaning, complete penetrance|MP:0020385,decreased intestine iron level
MGI:5581453	Slc39a5<tm1.1Gka>	MP:0004761,increased susceptibility to induced pancreatitis|MP:0009150,pancreatic acinar cell atrophy|MP:0009615,abnormal zinc homeostasis|MP:0011924,abnormal liver zinc level
MGI:5692713	Slc39a5<tm1b(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0002968,increased circulating alkaline phosphatase level|MP:0005419,decreased circulating serum albumin level
MGI:5566985	Slc39a5<tm1Gka>	MP:0004761,increased susceptibility to induced pancreatitis|MP:0008743,decreased liver iron level|MP:0009150,pancreatic acinar cell atrophy|MP:0009615,abnormal zinc homeostasis
MGI:6112647	Slc39a6<tm1Tfk>	MP:0010771,integument phenotype
MGI:5548942	Slc39a7<tm1.1(KOMP)Mbp>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5888872	Slc39a7<tm1.1Tfk>	MP:0001658,increased mortality induced by gamma-irradiation|MP:0002083,premature death|MP:0005381,digestive/alimentary phenotype|MP:0008882,abnormal enterocyte physiology|MP:0008883,abnormal enterocyte proliferation|MP:0008885,increased enterocyte apoptosis|MP:0010158,abnormal intestine development|MP:0013486,decreased Paneth cell number
MGI:7572529	Slc39a8<em1Xijl>	MP:0001402,decreased locomotor activity|MP:0003631,nervous system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0009617,decreased brain zinc level|MP:0020508,decreased dendritic spine density|MP:0031173,increased circulating zinc level
MGI:7541328	Slc39a8<tm1.1Brvo>	MP:0001566,increased circulating phosphate level|MP:0001596,hypotension|MP:0001759,increased urine glucose level|MP:0001764,abnormal homeostasis|MP:0002079,increased circulating insulin level|MP:0003058,increased insulin secretion|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005390,skeleton phenotype|MP:0005559,increased circulating glucose level|MP:0005560,decreased circulating glucose level
MGI:6147816	Slc39a8<tm1.2Mrl>	MP:0000266,abnormal heart morphology|MP:0001785,edema|MP:0002189,abnormal myocardial trabeculae morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004057,thin myocardium compact layer|MP:0010402,ventricular septal defect|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011394,increased fetal cardiomyocyte proliferation|MP:0020893,abnormal zinc level
MGI:5548544	Slc39a8<tm1b(EUCOMM)Wtsi>	MP:0001325,abnormal retina morphology|MP:0001552,increased circulating triglyceride level|MP:0011100,preweaning lethality, complete penetrance
MGI:5707297	Slc3a1<m1Crl>	MP:0000519,hydronephrosis|MP:0000521,abnormal kidney cortex morphology|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0003311,aminoaciduria|MP:0003587,ureter obstruction|MP:0005553,increased circulating creatinine level|MP:0009552,urinary bladder obstruction|MP:0011625,cystolithiasis|MP:0020400,cystinuria|MP:0020401,argininuria|MP:0020402,ornithinuria|MP:0020403,lysinuria
MGI:2677291	Slc3a1<pbl>	MP:0000063,decreased bone mineral density|MP:0000182,increased circulating LDL cholesterol level|MP:0000519,hydronephrosis|MP:0000521,abnormal kidney cortex morphology|MP:0001262,decreased body weight|MP:0001859,kidney inflammation|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0003311,aminoaciduria|MP:0003918,decreased kidney weight|MP:0005178,increased circulating cholesterol level|MP:0005325,abnormal renal glomerulus morphology|MP:0005360,urolithiasis|MP:0005553,increased circulating creatinine level|MP:0009644,uremia|MP:0009645,crystalluria|MP:0010025,decreased total body fat amount|MP:0011405,tubulointerstitial nephritis|MP:0011422,kidney medulla atrophy|MP:0011423,kidney cortex atrophy|MP:0011468,abnormal urine amino acid level|MP:0020401,argininuria|MP:0020402,ornithinuria|MP:0020403,lysinuria
MGI:5708183	Slc3a1<tm1.1(KOMP)Vlcg>	MP:0000538,abnormal urinary bladder morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001556,increased circulating HDL cholesterol level|MP:0002135,abnormal kidney morphology|MP:0002591,decreased mean corpuscular volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0003917,increased kidney weight|MP:0003960,increased lean body mass|MP:0004952,increased spleen weight|MP:0005011,increased eosinophil cell number|MP:0005178,increased circulating cholesterol level|MP:0005565,increased blood urea nitrogen level|MP:0008528,polycystic kidney|MP:0009552,urinary bladder obstruction|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0011625,cystolithiasis|MP:0011874,enlarged urinary bladder
MGI:6202022	Slc3a1<tm1Jat>	MP:0000741,impaired contractility of urinary bladder detrusor smooth muscle|MP:0001756,abnormal urination|MP:0002708,nephrolithiasis|MP:0003587,ureter obstruction|MP:0010386,abnormal urinary bladder physiology|MP:0011625,cystolithiasis|MP:0011774,abnormal urinary bladder detrusor smooth muscle morphology|MP:0011799,increased urinary bladder weight|MP:0011923,abnormal bladder urine volume|MP:0020400,cystinuria
MGI:5433604	Slc3a2<tm1.1Merl>	MP:0003447,decreased tumor growth/size|MP:0004502,decreased incidence of tumors by chemical induction|MP:0008539,decreased susceptibility to induced colitis|MP:0008883,abnormal enterocyte proliferation|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0010181,decreased susceptibility to weight loss|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3843272	Slc3a2<tm1.1Mgin>	MP:0000358,abnormal cell morphology|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002459,abnormal B cell physiology|MP:0004816,abnormal class switch recombination|MP:0005093,decreased B cell proliferation|MP:0005387,immune system phenotype|MP:0008099,abnormal plasma cell differentiation|MP:0008178,decreased germinal center B cell number|MP:0008217,abnormal B cell activation
MGI:5440713	Slc3a2<tm1.1Yait>	MP:0001798,impaired macrophage phagocytosis|MP:0002446,abnormal macrophage morphology|MP:0002451,abnormal macrophage physiology|MP:0002454,abnormal macrophage antigen presentation|MP:0008113,abnormal macrophage differentiation
MGI:3511126	Slc3a2<tm1Yai>	MP:0011092,embryonic lethality, complete penetrance
MGI:3662903	Slc40a1<ffe>	MP:0001297,microphthalmia|MP:0001577,anemia|MP:0001785,edema|MP:0002447,abnormal erythrocyte morphology|MP:0002451,abnormal macrophage physiology|MP:0002642,anisocytosis|MP:0003232,abnormal forebrain development|MP:0003631,nervous system phenotype|MP:0003720,abnormal neural tube closure|MP:0005376,homeostasis/metabolism phenotype|MP:0005391,vision/eye phenotype|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008807,increased liver iron level|MP:0010175,leptocytosis|MP:0011091,prenatal lethality, complete penetrance|MP:0011890,increased circulating ferritin level|MP:0011896,increased circulating unsaturated transferrin level
MGI:1889622	Slc40a1<Pcm>	MP:0000692,small spleen|MP:0002872,polycythemia|MP:0003717,pallor|MP:0004151,decreased circulating iron level|MP:0008388,hypochromic microcytic anemia|MP:0008737,abnormal spleen physiology|MP:0008743,decreased liver iron level|MP:0008807,increased liver iron level|MP:0008808,decreased spleen iron level|MP:0009322,increased splenocyte apoptosis|MP:0009323,abnormal spleen development
MGI:5607257	Slc40a1<tm1.1Mmfe>	MP:0000609,abnormal liver physiology|MP:0001944,abnormal pancreas morphology|MP:0002083,premature death|MP:0002590,increased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0003674,oxidative stress|MP:0005150,cachexia|MP:0005319,abnormal enzyme/coenzyme level|MP:0005564,increased hemoglobin content|MP:0005637,abnormal iron homeostasis|MP:0005638,hemochromatosis|MP:0008807,increased liver iron level|MP:0008808,decreased spleen iron level|MP:0008810,increased circulating iron level|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0010375,increased kidney iron level|MP:0011886,increased circulating lipase level|MP:0011890,increased circulating ferritin level|MP:0011897,decreased circulating unsaturated transferrin level|MP:0013302,increased pancreas iron level|MP:0014605,dark liver|MP:0020365,increased brain iron level|MP:0020367,increased heart iron level|MP:0020385,decreased intestine iron level
MGI:5548423	Slc40a1<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0001552,increased circulating triglyceride level|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3604568	Slc40a1<tm1Dgen>	MP:0003998,decreased thermal nociceptive threshold|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:3771547	Slc40a1<tm1Nca>	MP:0001698,decreased embryo size|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0005397,hematopoietic system phenotype|MP:0008743,decreased liver iron level|MP:0008809,increased spleen iron level|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance
MGI:3771548	Slc40a1<tm2Nca>	MP:0000208,decreased hematocrit|MP:0001265,decreased body size|MP:0001577,anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002874,decreased hemoglobin content|MP:0003717,pallor|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008738,abnormal liver iron level|MP:0008743,decreased liver iron level|MP:0008808,decreased spleen iron level|MP:0008809,increased spleen iron level|MP:0010768,mortality/aging|MP:0011091,prenatal lethality, complete penetrance|MP:0020369,increased intestine iron level
MGI:7608072	Slc41a1<tm1.1Geno>	MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0010955,abnormal respiratory electron transport chain|MP:0010958,abnormal tricarboxylic acid cycle
MGI:6187996	Slc41a2<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0010392,prolonged QRS complex duration
MGI:4365235	Slc41a3<tm1a(KOMP)Wtsi>	MP:0000519,hydronephrosis|MP:0001513,limb grasping|MP:0003068,enlarged kidney|MP:0003588,ureter stenosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0010093,decreased circulating magnesium level|MP:0011979,abnormal magnesium ion homeostasis
MGI:4968311	Slc43a2<Gt(258C1)Cmhd>	MP:0000188,abnormal circulating glucose level|MP:0000609,abnormal liver physiology|MP:0001666,abnormal intestinal absorption|MP:0001860,liver inflammation|MP:0003979,increased circulating carnitine level|MP:0004201,fetal growth retardation|MP:0004265,abnormal placental transport|MP:0005281,increased fatty acids level|MP:0005311,abnormal circulating amino acid level|MP:0005332,abnormal amino acid level|MP:0008489,slow postnatal weight gain|MP:0009431,decreased fetal weight|MP:0011085,postnatal lethality, complete penetrance|MP:0011653,decreased circulating histidine level|MP:0012172,abnormal amniotic fluid composition|MP:0013278,decreased fasting circulating glucose level|MP:0030668,decreased circulating proline level|MP:0030674,decreased circulating alanine level|MP:0030695,decreased circulating serine level
MGI:5637111	Slc44a1<tm1b(EUCOMM)Hmgu>	MP:0001319,irregularly shaped pupil|MP:0001399,hyperactivity|MP:0001510,abnormal coat appearance|MP:0002574,increased vertical activity|MP:0002626,increased heart rate|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003795,abnormal bone structure|MP:0009142,decreased prepulse inhibition|MP:0010097,abnormal retina blood vessel morphology|MP:0010123,increased bone mineral content|MP:0011959,abnormal eye posterior chamber depth|MP:0011965,decreased total retina thickness
MGI:5796295	Slc44a2<em1(IMPC)J>	MP:0001325,abnormal retina morphology|MP:0001486,abnormal startle reflex
MGI:5828929	Slc44a2<tm1.1Tec>	MP:0002169,no abnormal phenotype detected
MGI:5829833	Slc44a2<tm1.2Tec>	MP:0000042,abnormal organ of Corti morphology|MP:0001265,decreased body size|MP:0002855,abnormal cochlear ganglion morphology|MP:0004396,decreased cochlear inner hair cell number|MP:0004402,decreased cochlear outer hair cell number|MP:0004740,sensorineural hearing loss|MP:0004748,increased susceptibility to age-related hearing loss|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013808,abnormal tunnel of Corti morphology
MGI:5613661	Slc44a3<tm1b(EUCOMM)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001417,decreased exploration in new environment|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0010097,abnormal retina blood vessel morphology
MGI:7703492	Slc44a4<tm1.2Said>	MP:0001262,decreased body weight|MP:0001671,abnormal vitamin absorption|MP:0008537,increased susceptibility to induced colitis|MP:0013956,decreased colon length
MGI:5692698	Slc44a4<tm1b(EUCOMM)Hmgu>	MP:0005344,increased circulating bilirubin level|MP:0009142,decreased prepulse inhibition|MP:0013279,increased fasting circulating glucose level
MGI:4364041	Slc44a5<tm1a(KOMP)Wtsi>	MP:0002590,increased mean corpuscular volume
MGI:5450861	Slc45a2<Ltct>	MP:0000371,diluted coat color|MP:0008480,absent eye pigmentation|MP:0009928,abnormal pinna hair pigmentation
MGI:2681497	Slc45a2<tm1(K14-A)R>	MP:0002075,abnormal coat/hair pigmentation
MGI:1856581	Slc45a2<uw>	MP:0000372,irregular coat pigmentation|MP:0001324,abnormal eye pigmentation|MP:0005376,homeostasis/metabolism phenotype
MGI:6200229	Slc45a2<uw-10Btlr>	MP:0000371,diluted coat color
MGI:3784980	Slc45a2<uw-2Btlr>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation|MP:0005408,hypopigmentation
MGI:3784982	Slc45a2<uw-3Btlr>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation|MP:0005408,hypopigmentation
MGI:3784986	Slc45a2<uw-4Btlr>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation|MP:0005408,hypopigmentation
MGI:3656016	Slc45a2<uw-4J>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0002095,abnormal skin pigmentation|MP:0005408,hypopigmentation
MGI:4420315	Slc45a2<uw-5Btlr>	MP:0000371,diluted coat color
MGI:3656018	Slc45a2<uw-5J>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0002095,abnormal skin pigmentation|MP:0005408,hypopigmentation
MGI:4420306	Slc45a2<uw-6Btlr>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation
MGI:5448550	Slc45a2<uw-6J>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation|MP:0011627,decreased skin pigmentation
MGI:5141321	Slc45a2<uw-7Btlr>	MP:0001324,abnormal eye pigmentation|MP:0002075,abnormal coat/hair pigmentation
MGI:5448551	Slc45a2<uw-7J>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation|MP:0011627,decreased skin pigmentation
MGI:5515378	Slc45a2<uw-8Btlr>	MP:0000371,diluted coat color
MGI:5578029	Slc45a2<uw-9Btlr>	MP:0000371,diluted coat color
MGI:1856226	Slc45a2<uw-bls>	MP:0000372,irregular coat pigmentation|MP:0001265,decreased body size|MP:0001399,hyperactivity|MP:0001924,infertility
MGI:3784977	Slc45a2<uw-Btlr>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation|MP:0005408,hypopigmentation
MGI:1857540	Slc45a2<uw-d>	MP:0000372,irregular coat pigmentation|MP:0001324,abnormal eye pigmentation
MGI:1856227	Slc45a2<Uw-dbr>	MP:0000372,irregular coat pigmentation
MGI:5548649	Slc45a3<tm1.1(KOMP)Vlcg>	MP:0002833,increased heart weight
MGI:7586643	Slc45a4<em1Cya>	MP:0000955,abnormal spinal cord morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001973,increased thermal nociceptive threshold|MP:0002075,abnormal coat/hair pigmentation|MP:0003631,nervous system phenotype|MP:0003663,abnormal thermosensation|MP:0003858,enhanced coordination|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0009642,abnormal blood homeostasis|MP:0010055,abnormal sensory neuron physiology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0020374,abnormal nocifensive behavior|MP:0030733,decreased gamma-aminobutyric acid level
MGI:5577262	Slc46a1<tm1b(KOMP)Mbp>	MP:0001402,decreased locomotor activity|MP:0001510,abnormal coat appearance|MP:0004151,decreased circulating iron level|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005560,decreased circulating glucose level|MP:0005627,increased circulating potassium level|MP:0011435,increased urine magnesium level
MGI:3851364	Slc46a1<tm1Hija>	MP:0005332,abnormal amino acid level|MP:0012335,increased circulating homocysteine level
MGI:3521803	Slc46a2<tm1Moki>	MP:0001823,thymus hypoplasia
MGI:5565613	Slc46a3<tm1.1(KOMP)Vlcg>	MP:0001417,decreased exploration in new environment|MP:0001510,abnormal coat appearance|MP:0001556,increased circulating HDL cholesterol level|MP:0004151,decreased circulating iron level|MP:0005178,increased circulating cholesterol level|MP:0005505,thrombocytosis
MGI:4100843	Slc47a1<Gt(IST12634F2)Tigm>	MP:0000598,abnormal liver morphology|MP:0001260,increased body weight|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0009641,kidney degeneration
MGI:5548541	Slc47a1<tm1b(EUCOMM)Wtsi>	MP:0000198,decreased circulating phosphate level|MP:0001529,abnormal vocalization|MP:0005568,increased circulating total protein level
MGI:4830581	Slc47a1<tm1Kinu>	MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008875,abnormal xenobiotic pharmacokinetics
MGI:5548897	Slc47a2<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0002941,increased circulating alanine transaminase level
MGI:6711492	Slc48a1<em1Ih>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0001770,abnormal iron level|MP:0002397,abnormal bone marrow morphology|MP:0002446,abnormal macrophage morphology|MP:0002451,abnormal macrophage physiology|MP:0003884,decreased macrophage cell number|MP:0003952,abnormal copper level|MP:0008807,increased liver iron level|MP:0008809,increased spleen iron level|MP:0011178,increased erythroblast number|MP:0011890,increased circulating ferritin level|MP:0014605,dark liver|MP:0014606,dark spleen|MP:0020148,abnormal susceptibility to induced morbidity/mortality|MP:0020879,abnormal calcium level|MP:0020891,abnormal sulfate level|MP:0031276,abnormal stress erythropoiesis
MGI:7425985	Slc48a1<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity|MP:0001513,limb grasping|MP:0010124,decreased bone mineral content
MGI:2678417	Slc48a1<Gt(U3Betageo)1Ruiz>	MP:0002169,no abnormal phenotype detected
MGI:6423069	Slc49a4<em1(IMPC)Mbp>	MP:0000494,abnormal cecum morphology|MP:0002060,abnormal skin morphology|MP:0009476,enlarged cecum
MGI:5791987	Slc4a10<mpc96H>	MP:0006325,impaired hearing
MGI:3774019	Slc4a10<tm1.1Cahb>	MP:0000820,abnormal choroid plexus morphology|MP:0000822,abnormal brain ventricle morphology|MP:0001364,decreased anxiety-related response|MP:0001413,abnormal response to new environment|MP:0002083,premature death|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0003461,abnormal response to novel object|MP:0004043,abnormal pH regulation|MP:0004811,abnormal neuron physiology|MP:0008489,slow postnatal weight gain
MGI:5692790	Slc4a10<tm1b(KOMP)Wtsi>	MP:0000692,small spleen|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001488,increased startle reflex|MP:0004738,abnormal auditory brainstem response|MP:0005564,increased hemoglobin content|MP:0010124,decreased bone mineral content
MGI:3529084	Slc4a11<Gt(OST443317)Lex>	MP:0003878,abnormal ear physiology|MP:0004427,abnormal vestibular labyrinth morphology|MP:0004738,abnormal auditory brainstem response|MP:0004814,reduced linear vestibular evoked potential|MP:0006000,abnormal cornea epithelium morphology
MGI:5524270	Slc4a11<tm1.1Jrcy>	MP:0001314,cornea opacity|MP:0001785,edema|MP:0002986,decreased urine calcium level|MP:0002988,decreased urine osmolality|MP:0005301,abnormal cornea endothelium morphology|MP:0005618,decreased urine potassium level|MP:0006317,decreased urine sodium level|MP:0009643,abnormal urine homeostasis|MP:0011436,decreased urine magnesium level|MP:0011460,decreased urine chloride ion level|MP:0011962,increased cornea thickness|MP:0030633,decreased urine creatine level|MP:0031178,increased Descemet membrane thickness
MGI:4820767	Slc4a11<tm1Boet>	MP:0001762,polyuria|MP:0002988,decreased urine osmolality|MP:0004292,abnormal spiral ligament fibrocyte morphology|MP:0004411,decreased endocochlear potential|MP:0004738,abnormal auditory brainstem response|MP:0005300,abnormal cornea stroma morphology|MP:0005301,abnormal cornea endothelium morphology|MP:0005544,cornea deposits|MP:0005619,increased urine potassium level|MP:0006000,abnormal cornea epithelium morphology|MP:0006316,increased urine sodium level|MP:0006325,impaired hearing|MP:0009742,increased cornea stroma thickness|MP:0011435,increased urine magnesium level|MP:0011459,increased urine chloride ion level|MP:0020854,increased cornea epithelium thickness|MP:0031178,increased Descemet membrane thickness
MGI:6342514	Slc4a1ap<em1(IMPC)J>	MP:0001417,decreased exploration in new environment|MP:0002098,abnormal vibrissa morphology
MGI:2671922	Slc4a1<l11Jus51>	MP:0000208,decreased hematocrit|MP:0001577,anemia|MP:0001586,abnormal erythrocyte cell number|MP:0001588,abnormal hemoglobin|MP:0002123,abnormal definitive hematopoiesis|MP:0002447,abnormal erythrocyte morphology|MP:0002811,macrocytic anemia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0009395,increased nucleated erythrocyte cell number|MP:0011085,postnatal lethality, complete penetrance
MGI:2441657	Slc4a1<tm1Ahc>	MP:0000208,decreased hematocrit|MP:0000226,abnormal mean corpuscular volume|MP:0000691,enlarged spleen|MP:0001265,decreased body size|MP:0001588,abnormal hemoglobin|MP:0001732,postnatal growth retardation|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002722,abnormal immune system organ morphology|MP:0002810,microcytic anemia|MP:0002812,spherocytosis|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3834176	Slc4a1<tm1Dmb>	MP:0000172,abnormal bone marrow cell number|MP:0002447,abnormal erythrocyte morphology|MP:0002640,reticulocytosis|MP:0002643,poikilocytosis|MP:0008826,abnormal splenic cell ratio|MP:0010074,stomatocytosis|MP:0031085,increased erythrocyte osmotic fragility
MGI:1857140	Slc4a1<tm1Llp>	MP:0000208,decreased hematocrit|MP:0000216,absent erythroid progenitor cell|MP:0000277,abnormal heart shape|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001429,dehydration|MP:0001566,increased circulating phosphate level|MP:0001585,hemolytic anemia|MP:0001589,abnormal mean corpuscular hemoglobin|MP:0001625,cardiac hypertrophy|MP:0001732,postnatal growth retardation|MP:0001762,polyuria|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002136,abnormal kidney physiology|MP:0002416,abnormal proerythroblast morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002626,increased heart rate|MP:0002640,reticulocytosis|MP:0002643,poikilocytosis|MP:0002753,dilated heart left ventricle|MP:0002810,microcytic anemia|MP:0002812,spherocytosis|MP:0002813,microcytosis|MP:0002814,hyperchromasia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002988,decreased urine osmolality|MP:0003017,decreased circulating bicarbonate level|MP:0003019,increased circulating chloride level|MP:0003030,acidemia|MP:0003197,nephrocalcinosis|MP:0003717,pallor|MP:0005097,polychromatophilia|MP:0005441,increased urine calcium level|MP:0005558,decreased creatinine clearance|MP:0005565,increased blood urea nitrogen level|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0008489,slow postnatal weight gain|MP:0008872,abnormal physiological response to xenobiotic|MP:0008997,increased blood osmolality|MP:0009349,increased urine pH|MP:0009395,increased nucleated erythrocyte cell number|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010163,hemolysis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011422,kidney medulla atrophy|MP:0012551,metabolic acidosis
MGI:4357799	Slc4a1<tm1Phsl>	MP:0000208,decreased hematocrit|MP:0000691,enlarged spleen|MP:0002447,abnormal erythrocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002594,low mean erythrocyte cell number|MP:0002640,reticulocytosis|MP:0002874,decreased hemoglobin content|MP:0003179,thrombocytopenia|MP:0003717,pallor|MP:0008770,decreased survivor rate|MP:0009395,increased nucleated erythrocyte cell number
MGI:1857347	Slc4a1<wan>	MP:0000208,decreased hematocrit|MP:0001577,anemia|MP:0002591,decreased mean corpuscular volume|MP:0002812,spherocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003708,binucleate|MP:0003717,pallor|MP:0008941,reticulocytopenia|MP:0011085,postnatal lethality, complete penetrance|MP:0011176,abnormal erythroblast morphology
MGI:3050237	Slc4a2<tm1Ges>	MP:0000121,failure of tooth eruption|MP:0000468,abnormal esophageal epithelium morphology|MP:0000471,abnormal stomach epithelium morphology|MP:0001393,ataxia|MP:0001438,aphagia|MP:0001541,abnormal osteoclast physiology|MP:0001732,postnatal growth retardation|MP:0001967,deafness|MP:0002083,premature death|MP:0002113,abnormal skeleton development|MP:0004139,abnormal gastric parietal cell morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0004982,abnormal osteoclast morphology|MP:0008003,achlorhydria|MP:0009703,decreased birth body size|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0013566,dilated gastric gland
MGI:3033521	Slc4a2<tm1Jmed>	MP:0001147,small testis|MP:0001648,abnormal apoptosis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0001940,testis hypoplasia|MP:0002169,no abnormal phenotype detected|MP:0002631,abnormal epididymis morphology|MP:0002660,abnormal caput epididymis morphology|MP:0002661,abnormal corpus epididymis morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0005159,azoospermia|MP:0005250,decreased Sertoli cell number|MP:0005376,homeostasis/metabolism phenotype
MGI:5487545	Slc4a2<tm2Ges>	MP:0000065,abnormal bone marrow cavity morphology|MP:0000067,osteopetrosis|MP:0000130,abnormal trabecular bone morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0001541,abnormal osteoclast physiology|MP:0003723,abnormal long bone morphology|MP:0004982,abnormal osteoclast morphology|MP:0005605,increased bone mass|MP:0009347,increased trabecular bone thickness|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume
MGI:3612402	Slc4a3<tm1Cahb>	MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0004043,abnormal pH regulation
MGI:3770133	Slc4a3<tm1Ges>	MP:0001330,abnormal optic nerve morphology|MP:0002001,blindness|MP:0002182,abnormal astrocyte morphology|MP:0002792,abnormal retina vasculature morphology|MP:0005551,abnormal eye electrophysiology|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0030005,increased retina apoptosis
MGI:5433857	Slc4a4<tm1.1Slin>	MP:0000194,increased circulating calcium level|MP:0000477,abnormal intestine morphology|MP:0000525,renal tubular acidosis|MP:0000691,enlarged spleen|MP:0001265,decreased body size|MP:0001314,cornea opacity|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0001785,edema|MP:0002128,abnormal blood circulation|MP:0002640,reticulocytosis|MP:0002666,increased circulating aldosterone level|MP:0002705,dilated renal tubule|MP:0002874,decreased hemoglobin content|MP:0002988,decreased urine osmolality|MP:0003030,acidemia|MP:0003031,acidosis|MP:0003352,increased circulating renin level|MP:0003797,abnormal compact bone morphology|MP:0003918,decreased kidney weight|MP:0004686,decreased length of long bones|MP:0004952,increased spleen weight|MP:0005441,increased urine calcium level|MP:0005508,abnormal skeleton morphology|MP:0006316,increased urine sodium level|MP:0006398,increased long bone epiphyseal plate size|MP:0009350,decreased urine pH|MP:0009422,decreased gastrocnemius weight|MP:0009640,abnormal renal tubule epithelium morphology|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0009644,uremia|MP:0010107,abnormal renal reabsorption|MP:0010155,abnormal intestine physiology|MP:0011085,postnatal lethality, complete penetrance|MP:0011346,renal tubule atrophy|MP:0012551,metabolic acidosis
MGI:3710188	Slc4a4<tm1Ges>	MP:0000126,brittle teeth|MP:0000208,decreased hematocrit|MP:0000438,abnormal cranium morphology|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001765,abnormal ion homeostasis|MP:0002417,abnormal megakaryocyte morphology|MP:0002666,increased circulating aldosterone level|MP:0003017,decreased circulating bicarbonate level|MP:0003031,acidosis|MP:0003267,constipation|MP:0003270,intestinal obstruction|MP:0003631,nervous system phenotype|MP:0003717,pallor|MP:0004860,dilated kidney collecting duct|MP:0005016,decreased lymphocyte cell number|MP:0005150,cachexia|MP:0005376,homeostasis/metabolism phenotype|MP:0005391,vision/eye phenotype|MP:0005634,decreased circulating sodium level|MP:0008476,increased spleen red pulp amount|MP:0008478,increased spleen white pulp amount|MP:0009350,decreased urine pH|MP:0009395,increased nucleated erythrocyte cell number|MP:0009477,small cecum|MP:0009478,coiled cecum|MP:0009703,decreased birth body size|MP:0011085,postnatal lethality, complete penetrance|MP:0011736,decreased urine ammonia level|MP:0012551,metabolic acidosis|MP:0014350,disorganized spleen B cell follicle|MP:0030604,abnormal ammonia homeostasis
MGI:5306980	Slc4a5<tm1.1Boet>	MP:0000525,renal tubular acidosis|MP:0000528,delayed kidney development|MP:0001762,polyuria|MP:0002667,decreased circulating aldosterone level|MP:0002962,increased urine protein level|MP:0003017,decreased circulating bicarbonate level|MP:0003353,decreased circulating renin level|MP:0003631,nervous system phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005522,increased circulating atrial natriuretic factor|MP:0005527,increased renal glomerular filtration rate|MP:0005554,decreased circulating creatinine level|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0011462,increased urine bicarbonate level
MGI:6835638	Slc4a5<tvrm77>	MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0002864,abnormal ocular fundus morphology|MP:0003099,retina detachment|MP:0005201,abnormal retina pigment epithelium morphology|MP:0008515,thin retina outer nuclear layer|MP:0008852,retina neovascularization|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0012671,retina spots|MP:0020962,increased c-wave amplitude|MP:0020977,decreased FO-wave amplitude|MP:0021107,retina fold
MGI:4973507	Slc4a7<Gt(40G1)Cmhd>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000250,abnormal vasoconstriction|MP:0001629,abnormal heart rate|MP:0002626,increased heart rate|MP:0004003,abnormal vascular endothelial cell physiology|MP:0004875,increased mean systemic arterial blood pressure|MP:0005591,decreased vasodilation|MP:0005595,abnormal vascular smooth muscle physiology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3775809	Slc4a7<Gt(RRL021)Byg>	MP:0004043,abnormal pH regulation
MGI:2682641	Slc4a7<tm1Krtz>	MP:0000032,cochlear degeneration|MP:0000043,organ of Corti degeneration|MP:0000048,abnormal stria vascularis morphology|MP:0001327,decreased retina photoreceptor cell number|MP:0002001,blindness|MP:0002792,abnormal retina vasculature morphology|MP:0002857,cochlear ganglion degeneration|MP:0002864,abnormal ocular fundus morphology|MP:0004021,abnormal rod electrophysiology|MP:0004288,abnormal spiral ligament morphology|MP:0004292,abnormal spiral ligament fibrocyte morphology|MP:0004293,abnormal type I spiral ligament fibrocytes|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004430,abnormal Claudius cell morphology|MP:0004465,degeneration of organ of Corti supporting cells|MP:0004488,type II spiral ligament fibrocyte degeneration|MP:0004490,type IV spiral ligament fibrocyte degeneration|MP:0006024,collapsed Reissner membrane|MP:0006072,abnormal retina apoptosis|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008584,photoreceptor outer segment degeneration|MP:0008587,short photoreceptor outer segment|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:7377683	Slc4a8<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0001488,increased startle reflex|MP:0002092,abnormal eye morphology
MGI:4460780	Slc4a8<tm1.1Doel>	MP:0002136,abnormal kidney physiology|MP:0008872,abnormal physiological response to xenobiotic
MGI:5516078	Slc4a9<tm1Doel>	MP:0010107,abnormal renal reabsorption
MGI:3812007	Slc4a9<tm1Ges>	MP:0001663,abnormal digestive system physiology
MGI:5705867	Slc50a1<tm1.1(KOMP)Vlcg>	MP:0002941,increased circulating alanine transaminase level|MP:0013279,increased fasting circulating glucose level
MGI:3762157	Slc51a<tm1Nbal>	MP:0001732,postnatal growth retardation
MGI:3778302	Slc51a<tm1Pda>	MP:0000496,abnormal small intestine morphology|MP:0001732,postnatal growth retardation|MP:0002644,decreased circulating triglyceride level|MP:0003947,abnormal cholesterol level|MP:0004774,abnormal bile salt level|MP:0005179,decreased circulating cholesterol level|MP:0005365,abnormal bile salt homeostasis|MP:0014480,increased feces cholesterol level
MGI:6152645	Slc51b<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0009709,hydrometra|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width
MGI:5548419	Slc52a2<tm1.1(KOMP)Vlcg>	MP:0000702,enlarged lymph nodes|MP:0001284,absent vibrissae|MP:0002768,small adrenal glands|MP:0010025,decreased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:4452914	Slc52a2<tm1(KOMP)Vlcg>	MP:0011092,embryonic lethality, complete penetrance
MGI:6358739	Slc52a3<tm1.1Said>	MP:0000063,decreased bone mineral density|MP:0001262,decreased body weight|MP:0001505,hunched posture|MP:0001732,postnatal growth retardation|MP:0002764,short tibia|MP:0003109,short femur|MP:0004509,abnormal pelvic girdle bone morphology|MP:0005202,lethargy|MP:0005400,abnormal vitamin level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013754,abnormal ocular surface morphology|MP:0020010,decreased bone mineral density of femur
MGI:4363008	Slc52a3<tm2a(KOMP)Wtsi>	MP:0000189,hypoglycemia|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001548,hyperlipidemia|MP:0002083,premature death|MP:0002098,abnormal vibrissa morphology|MP:0002118,abnormal lipid homeostasis|MP:0002931,glutaricadicuria|MP:0003979,increased circulating carnitine level|MP:0004019,abnormal vitamin homeostasis|MP:0004265,abnormal placental transport|MP:0004921,decreased placenta weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005400,abnormal vitamin level|MP:0009431,decreased fetal weight|MP:0009674,decreased birth weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011940,decreased food intake|MP:0014174,decreased fatty acid beta-oxidation
MGI:7425986	Slc5a10<em1(IMPC)Rbrc>	MP:0000137,abnormal vertebrae morphology|MP:0004599,abnormal vertebral arch morphology
MGI:5503305	Slc5a10<tm1Csk>	MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002941,increased circulating alanine transaminase level|MP:0002965,increased circulating serum albumin level|MP:0002981,increased liver weight|MP:0005343,increased circulating aspartate transaminase level|MP:0009289,decreased epididymal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0009643,abnormal urine homeostasis|MP:0010107,abnormal renal reabsorption|MP:0011971,increased circulating lactate dehydrogenase level
MGI:7541410	Slc5a11<em1(IMPC)Tcp>	MP:0002968,increased circulating alkaline phosphatase level|MP:0010053,decreased grip strength
MGI:4277072	Slc5a1<Gt(OST315271)Lex>	MP:0000188,abnormal circulating glucose level|MP:0001262,decreased body weight|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002727,decreased circulating insulin level|MP:0004348,long femur|MP:0005292,improved glucose tolerance|MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype|MP:0008489,slow postnatal weight gain|MP:0009480,distended cecum|MP:0010868,increased bone trabecula number|MP:0011940,decreased food intake
MGI:5433400	Slc5a1<tm1.1Koep>	MP:0000489,abnormal large intestine morphology|MP:0000496,abnormal small intestine morphology|MP:0001759,increased urine glucose level|MP:0002727,decreased circulating insulin level|MP:0005418,abnormal circulating hormone level|MP:0005560,decreased circulating glucose level|MP:0010155,abnormal intestine physiology|MP:0011083,lethality at weaning, complete penetrance|MP:0011447,abnormal renal glucose reabsorption
MGI:6199601	Slc5a2<m2Btlr>	MP:0001260,increased body weight|MP:0008537,increased susceptibility to induced colitis|MP:0008560,increased tumor necrosis factor secretion
MGI:4946611	Slc5a2<tm1Lex>	MP:0000062,increased bone mineral density|MP:0000188,abnormal circulating glucose level|MP:0000198,decreased circulating phosphate level|MP:0001262,decreased body weight|MP:0001759,increased urine glucose level|MP:0001762,polyuria|MP:0002667,decreased circulating aldosterone level|MP:0002727,decreased circulating insulin level|MP:0002901,increased urine phosphate level|MP:0002988,decreased urine osmolality|MP:0003019,increased circulating chloride level|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005292,improved glucose tolerance|MP:0005375,adipose tissue phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005556,abnormal renal filtration rate|MP:0005560,decreased circulating glucose level|MP:0005582,increased renin activity|MP:0005619,increased urine potassium level|MP:0005633,increased circulating sodium level|MP:0006316,increased urine sodium level|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0010025,decreased total body fat amount|MP:0010868,increased bone trabecula number|MP:0011435,increased urine magnesium level|MP:0011447,abnormal renal glucose reabsorption|MP:0011459,increased urine chloride ion level|MP:0011466,increased urine urea nitrogen level|MP:0011470,increased urine creatinine level|MP:0011923,abnormal bladder urine volume|MP:0011939,increased food intake|MP:0011941,increased fluid intake
MGI:2663787	Slc5a3<tm1Gtb>	MP:0001575,cyanosis|MP:0001764,abnormal homeostasis|MP:0001954,respiratory distress|MP:0001957,apnea|MP:0002272,abnormal nervous system electrophysiology|MP:0002321,hypoventilation|MP:0003631,nervous system phenotype|MP:0005388,respiratory system phenotype|MP:0011087,neonatal lethality, complete penetrance|MP:0012172,abnormal amniotic fluid composition
MGI:3609547	Slc5a3<tm1Skc>	MP:0001071,abnormal facial nerve morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001078,abnormal phrenic nerve morphology|MP:0001079,absent phrenic nerve|MP:0001177,atelectasis|MP:0001265,decreased body size|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0003632,abnormal nervous system morphology|MP:0005403,abnormal nerve conduction|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5614611	Slc5a5<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000745,tremors|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001415,increased exploration in new environment|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0001510,abnormal coat appearance|MP:0001556,increased circulating HDL cholesterol level|MP:0002968,increased circulating alkaline phosphatase level|MP:0004738,abnormal auditory brainstem response|MP:0005178,increased circulating cholesterol level|MP:0005544,cornea deposits|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0011396,abnormal sleep behavior|MP:0011471,decreased urine creatinine level
MGI:6147653	Slc5a5<tm1d(KOMP)Wtsi>	MP:0000681,abnormal thyroid gland morphology|MP:0003186,abnormal redox activity|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005355,enlarged thyroid gland|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level
MGI:5493496	Slc5a6<tm1.1Said>	MP:0000488,abnormal intestinal epithelium morphology|MP:0000489,abnormal large intestine morphology|MP:0000491,crypts of Lieberkuhn abscesses|MP:0000496,abnormal small intestine morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000512,intestinal ulcer|MP:0001263,weight loss|MP:0001505,hunched posture|MP:0001671,abnormal vitamin absorption|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002764,short tibia|MP:0003109,short femur|MP:0003306,small intestinal inflammation|MP:0003631,nervous system phenotype|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005036,diarrhea|MP:0005202,lethargy|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0005400,abnormal vitamin level|MP:0008142,decreased small intestinal villus size|MP:0008489,slow postnatal weight gain|MP:0009250,abnormal appendicular skeleton morphology|MP:0009480,distended cecum|MP:0009481,cecum inflammation|MP:0009485,distended ileum|MP:0013956,decreased colon length|MP:0014201,abnormal intestinal epithelium physiology|MP:0020010,decreased bone mineral density of femur|MP:0021184,decreased bone mineral density of humerus|MP:0031154,intestinal hemorrhage
MGI:4942035	Slc5a7<tm1a(KOMP)Wtsi>	MP:0000496,abnormal small intestine morphology|MP:0002073,abnormal hair growth|MP:0002092,abnormal eye morphology|MP:0002169,no abnormal phenotype detected|MP:0009144,dilated pancreatic duct|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010088,decreased circulating fructosamine level|MP:0010420,muscular ventricular septal defect|MP:0010484,bicuspid aortic valve|MP:0010912,herniated liver|MP:0011100,preweaning lethality, complete penetrance|MP:0013971,blood in lymph vessels|MP:0013975,abnormal coronary sinus connection|MP:0014001,abnormal vertebral artery topology|MP:0014087,retrolental blood
MGI:3045463	Slc5a7<tm1Rbl>	MP:0000940,abnormal motor neuron innervation pattern|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0004836,abnormal synaptic acetylcholine release|MP:0005498,hyporesponsive to tactile stimuli|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3811502	Slc5a8<tm1.1Boet>	MP:0002006,neoplasm|MP:0005310,abnormal salivary gland physiology|MP:0005367,renal/urinary system phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0009643,abnormal urine homeostasis
MGI:6423835	Slc5a9<em1(IMPC)Hmgu>	MP:0001399,hyperactivity
MGI:3604491	Slc6a11<tm1Dgen>	MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0011100,preweaning lethality, complete penetrance
MGI:5306247	Slc6a12<tm1.1Ncd>	MP:0005386,behavior/neurological phenotype
MGI:5306260	Slc6a12<tm1.2Ncd>	MP:0005386,behavior/neurological phenotype
MGI:5466690	Slc6a13<tm1.2Ncd>	MP:0030635,increased taurine level|MP:0030636,decreased taurine level
MGI:5555141	Slc6a14<tm1b(KOMP)Wtsi>	MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:5788552	Slc6a14<tm1Gana>	MP:0002169,no abnormal phenotype detected|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0008603,decreased circulating interleukin-4 level|MP:0008639,decreased circulating interleukin-1 alpha level|MP:0010209,abnormal circulating chemokine level|MP:0010210,abnormal circulating cytokine level
MGI:6361241	Slc6a15<em1(IMPC)Hmgu>	MP:0011886,increased circulating lipase level
MGI:3768551	Slc6a15<tm1Uhl>	MP:0002882,abnormal neuron morphology|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype
MGI:3043846	Slc6a18<tm1Mca>	MP:0000231,hypertension|MP:0006144,increased systemic arterial systolic blood pressure|MP:0010107,abnormal renal reabsorption|MP:0011417,abnormal renal transport|MP:0030616,hyperglycinuria
MGI:5816867	Slc6a19<bucp>	MP:0001510,abnormal coat appearance|MP:0001764,abnormal homeostasis|MP:0002075,abnormal coat/hair pigmentation|MP:0009643,abnormal urine homeostasis
MGI:5816868	Slc6a19<bucp-2J>	MP:0001510,abnormal coat appearance|MP:0002075,abnormal coat/hair pigmentation|MP:0005376,homeostasis/metabolism phenotype|MP:0005377,hearing/vestibular/ear phenotype
MGI:5288516	Slc6a19<tm1Dgen>	MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0002727,decreased circulating insulin level|MP:0003311,aminoaciduria|MP:0003961,decreased lean body mass|MP:0005331,insulin resistance|MP:0005381,digestive/alimentary phenotype|MP:0010025,decreased total body fat amount|MP:0010155,abnormal intestine physiology|MP:0011417,abnormal renal transport|MP:0020406,hyperthreoninuria|MP:0030616,hyperglycinuria|MP:0030617,hyperglutaminuria|MP:0031637,methioninuria|MP:0031641,alaninuria|MP:0031642,phenylalaninuria
MGI:3526736	Slc6a1<tm1.1Lst>	MP:0002169,no abnormal phenotype detected
MGI:3526678	Slc6a1<tm1Lst>	MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003444,abnormal neurotransmitter uptake|MP:0005445,abnormal neurotransmitter secretion
MGI:3832387	Slc6a1<tm1Mlit>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001458,abnormal object recognition memory|MP:0001469,abnormal contextual conditioning behavior|MP:0001488,increased startle reflex|MP:0001987,alcohol preference|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002629,hyperactivity elicited by ethanol administration|MP:0002635,reduced sensorimotor gating|MP:0002805,abnormal conditioned taste aversion behavior|MP:0002850,saccharin preference|MP:0003461,abnormal response to novel object|MP:0003545,increased alcohol consumption|MP:0003631,nervous system phenotype|MP:0004008,abnormal GABA-mediated receptor currents|MP:0004210,abnormal bitter taste sensitivity|MP:0006299,abnormal latent inhibition of conditioning behavior|MP:0009142,decreased prepulse inhibition|MP:0009456,impaired cued conditioning behavior|MP:0009745,abnormal behavioral response to xenobiotic|MP:0009746,enhanced behavioral response to xenobiotic|MP:0014370,impaired spatial working memory|MP:0031391,increased locomotor activity
MGI:5689889	Slc6a20b<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001289,persistence of hyaloid vascular system|MP:0002833,increased heart weight|MP:0005344,increased circulating bilirubin level|MP:0005544,cornea deposits|MP:0005561,increased mean corpuscular hemoglobin|MP:0005566,decreased blood urea nitrogen level
MGI:5547831	Slc6a2<tm1.1Hhg>	MP:0009747,impaired behavioral response to xenobiotic|MP:0009758,impaired behavioral response to cocaine
MGI:5516082	Slc6a2<tm1.1Mkh>	MP:0001363,increased anxiety-related response|MP:0001906,increased dopamine level|MP:0002573,behavioral despair|MP:0002626,increased heart rate|MP:0002797,increased thigmotaxis|MP:0003631,nervous system phenotype|MP:0003964,abnormal noradrenaline level|MP:0005385,cardiovascular system phenotype|MP:0005662,increased circulating adrenaline level|MP:0005665,increased circulating noradrenaline level
MGI:5588269	Slc6a2<tm1b(EUCOMM)Hmgu>	MP:0001406,abnormal gait|MP:0002188,small heart|MP:0002874,decreased hemoglobin content|MP:0005293,impaired glucose tolerance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2386278	Slc6a2<tm1Mca>	MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001973,increased thermal nociceptive threshold|MP:0001981,increased chemically-elicited antinociception|MP:0002572,abnormal emotion/affect behavior|MP:0002757,decreased vertical activity|MP:0003008,enhanced long-term potentiation|MP:0003633,abnormal nervous system physiology|MP:0003964,abnormal noradrenaline level|MP:0005534,decreased body temperature|MP:0008872,abnormal physiological response to xenobiotic|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009749,enhanced behavioral response to addictive substance|MP:0009754,enhanced behavioral response to cocaine
MGI:5319237	Slc6a3<tm1.1Asor>	MP:0002169,no abnormal phenotype detected
MGI:3689434	Slc6a3<tm1.1(cre)Bkmn>	MP:0002169,no abnormal phenotype detected|MP:0030586,impaired behavioral response to amphetamine|MP:0031391,increased locomotor activity
MGI:5310749	Slc6a3<tm1.1Jaja>	MP:0005389,reproductive system phenotype|MP:0005643,decreased dopamine level|MP:0010768,mortality/aging|MP:0011452,decreased susceptibility to dopaminergic neuron neurotoxicity
MGI:5488785	Slc6a3<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0002100,abnormal tooth morphology|MP:0002702,decreased circulating free fatty acids level|MP:0002833,increased heart weight|MP:0005633,increased circulating sodium level|MP:0030610,absent teeth
MGI:6467307	Slc6a3<tm1c(KOMP)Wtsi>	MP:0001516,abnormal motor coordination/balance|MP:0005386,behavior/neurological phenotype
MGI:3689433	Slc6a3<tm1(cre)Bkmn>	MP:0002169,no abnormal phenotype detected
MGI:3691571	Slc6a3<tm1(cre)Xz>	MP:0001399,hyperactivity|MP:0002169,no abnormal phenotype detected
MGI:3653596	Slc6a3<tm1Hhg>	MP:0001399,hyperactivity|MP:0001906,increased dopamine level|MP:0002206,abnormal CNS synaptic transmission|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003243,abnormal dopaminergic neuron morphology|MP:0003313,abnormal locomotor activation|MP:0003444,abnormal neurotransmitter uptake|MP:0009712,impaired conditioned place preference behavior|MP:0010149,abnormal synaptic dopamine release|MP:0014381,abnormal miniature inhibitory postsynaptic current frequency|MP:0031391,increased locomotor activity
MGI:2386303	Slc6a3<tm1Mca>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001386,abnormal maternal nurturing|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0001415,increased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0001732,postnatal growth retardation|MP:0001746,abnormal pituitary secretion|MP:0002083,premature death|MP:0002427,disproportionate dwarf|MP:0002757,decreased vertical activity|MP:0002797,increased thigmotaxis|MP:0003008,enhanced long-term potentiation|MP:0003348,hypopituitarism|MP:0003462,abnormal response to novel odor|MP:0003631,nervous system phenotype|MP:0004163,abnormal adenohypophysis morphology|MP:0004686,decreased length of long bones|MP:0005361,small pituitary gland|MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype|MP:0005643,decreased dopamine level|MP:0005646,abnormal pituitary gland physiology|MP:0008329,decreased somatotroph cell number|MP:0008332,decreased lactotroph cell number|MP:0008365,adenohypophysis hypoplasia|MP:0008369,pituitary intermediate lobe hypoplasia|MP:0010249,lactation failure|MP:0011448,decreased dopaminergic neuron number|MP:0031391,increased locomotor activity
MGI:5643943	Slc6a3<tm1Rbl>	MP:0001906,increased dopamine level|MP:0002757,decreased vertical activity|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004811,abnormal neuron physiology|MP:0004924,abnormal behavior|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009745,abnormal behavioral response to xenobiotic|MP:0010069,increased serotonin level|MP:0010149,abnormal synaptic dopamine release|MP:0010831,lethality, incomplete penetrance
MGI:4939491	Slc6a3<tm1Wzh>	MP:0001399,hyperactivity
MGI:5618169	Slc6a3<tm2(HBEGF)Rpa>	MP:0003244,loss of dopaminergic neurons|MP:0005643,decreased dopamine level
MGI:2446518	Slc6a3<tm2Mca>	MP:0001409,increased stereotypic behavior|MP:0001415,increased exploration in new environment|MP:0001440,abnormal grooming behavior|MP:0001906,increased dopamine level|MP:0002574,increased vertical activity|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0003990,decreased neurotransmitter release|MP:0005378,growth/size/body region phenotype|MP:0008872,abnormal physiological response to xenobiotic|MP:0031391,increased locomotor activity
MGI:3628526	Slc6a4<Gt1(IRESBetageo)lLex>	MP:0001417,decreased exploration in new environment|MP:0002573,behavioral despair|MP:0003461,abnormal response to novel object
MGI:4946603	Slc6a4<tm1.1Rbl>	MP:0004811,abnormal neuron physiology|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009747,impaired behavioral response to xenobiotic
MGI:3691577	Slc6a4<tm1(cre)Xz>	MP:0002169,no abnormal phenotype detected|MP:0003141,cardiac fibrosis|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3629666	Slc6a4<tm1Grch>	MP:0001362,abnormal anxiety-related response|MP:0001413,abnormal response to new environment|MP:0002065,abnormal fear/anxiety-related behavior|MP:0002798,abnormal active avoidance behavior|MP:0003877,abnormal serotonergic neuron morphology|MP:0005402,abnormal action potential
MGI:2178613	Slc6a4<tm1Kpl>	MP:0000276,heart right ventricle hypertrophy|MP:0000285,abnormal heart valve morphology|MP:0000434,megacephaly|MP:0000484,abnormal pulmonary artery morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001360,abnormal social investigation|MP:0001361,social withdrawal|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001501,abnormal sleep pattern|MP:0001663,abnormal digestive system physiology|MP:0001777,abnormal body temperature homeostasis|MP:0002152,abnormal brain morphology|MP:0002176,increased brain weight|MP:0002573,behavioral despair|MP:0002733,abnormal thermal nociception|MP:0002795,dilated cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0003289,abnormal intestinal peristalsis|MP:0003461,abnormal response to novel object|MP:0003958,heart valve hyperplasia|MP:0003989,abnormal barrel cortex morphology|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005294,abnormal heart ventricle morphology|MP:0006002,abnormal small intestinal transit time|MP:0008108,abnormal small intestinal villus morphology|MP:0008415,abnormal neurite morphology|MP:0009713,enhanced conditioned place preference behavior|MP:0010070,decreased serotonin level|MP:0010758,increased right ventricle systolic pressure|MP:0011082,abnormal gastrointestinal motility
MGI:4457111	Slc6a4<tm1(SLC6A4)Kres>	MP:0002169,no abnormal phenotype detected
MGI:5521182	Slc6a4<tm2.1Rbl>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001361,social withdrawal|MP:0001409,increased stereotypic behavior|MP:0001488,increased startle reflex|MP:0001663,abnormal digestive system physiology|MP:0002272,abnormal nervous system electrophysiology|MP:0003290,intestinal hypoperistalsis|MP:0003444,abnormal neurotransmitter uptake|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0005378,growth/size/body region phenotype|MP:0006001,abnormal intestinal transit time|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009746,enhanced behavioral response to xenobiotic|MP:0010069,increased serotonin level|MP:0010157,abnormal small intestinal crypt cell proliferation|MP:0010768,mortality/aging|MP:0011082,abnormal gastrointestinal motility|MP:0014082,decreased small intestinal villus height|MP:0020351,decreased vocalization|MP:0020395,abnormal response to social novelty
MGI:4457113	Slc6a4<tm2(SLC6A4)Kres>	MP:0002169,no abnormal phenotype detected
MGI:5086232	Slc6a5<m1J>	MP:0000743,muscle spasm|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001441,increased grooming behavior|MP:0004143,muscle hypertonia|MP:0004811,abnormal neuron physiology|MP:0005386,behavior/neurological phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0011396,abnormal sleep behavior
MGI:5548359	Slc6a5<tm1.1(KOMP)Vlcg>	MP:0003049,abnormal lumbar vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance
MGI:2682554	Slc6a5<tm1Betz>	MP:0000745,tremors|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002206,abnormal CNS synaptic transmission|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0004143,muscle hypertonia|MP:0005604,hyperekplexia|MP:0008489,slow postnatal weight gain|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0011085,postnatal lethality, complete penetrance|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude
MGI:5796925	Slc6a5<trsl>	MP:0000120,malocclusion|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0002826,tonic seizures|MP:0010769,abnormal survival|MP:0010831,lethality, incomplete penetrance|MP:0011084,lethality at weaning, incomplete penetrance
MGI:6276882	Slc6a6<em1(IMPC)Mbp>	MP:0000220,increased monocyte cell number|MP:0000702,enlarged lymph nodes|MP:0001325,abnormal retina morphology|MP:0001566,increased circulating phosphate level|MP:0002339,abnormal lymph node morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005333,decreased heart rate|MP:0005565,increased blood urea nitrogen level|MP:0006243,impaired pupillary reflex|MP:0010506,prolonged RR interval|MP:0013278,decreased fasting circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:6113668	Slc6a6<m1Btlr>	MP:0011965,decreased total retina thickness
MGI:2179132	Slc6a6<tm1Dhau>	MP:0001923,reduced female fertility|MP:0002090,abnormal vision|MP:0008450,retina photoreceptor degeneration|MP:0030636,decreased taurine level|MP:0030639,decreased circulating taurine level|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:3793961	Slc6a6<tm1Jaz>	MP:0000278,abnormal myocardial fiber morphology|MP:0000280,thin ventricular wall|MP:0001262,decreased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0002269,muscular atrophy|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002834,decreased heart weight|MP:0004087,abnormal muscle fiber morphology|MP:0004565,decreased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0009402,decreased skeletal muscle fiber diameter|MP:0010239,decreased skeletal muscle weight|MP:0012106,impaired exercise endurance
MGI:6342437	Slc6a7<em1(IMPC)J>	MP:0001415,increased exploration in new environment|MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6682116	Slc6a7<tm1Veul>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0003461,abnormal response to novel object|MP:0005386,behavior/neurological phenotype|MP:0014812,abnormal brain physiology|MP:0021088,impaired spatial memory extinction
MGI:4941753	Slc6a8<tm1.1Clar>	MP:0001399,hyperactivity|MP:0001463,abnormal spatial learning|MP:0003461,abnormal response to novel object|MP:0005386,behavior/neurological phenotype|MP:0005459,decreased percent body fat/body weight|MP:0008414,abnormal spatial reference memory|MP:0008428,abnormal spatial working memory|MP:0010062,decreased creatine level|MP:0030632,increased urine creatine level
MGI:5825018	Slc6a8<tm1.1Lbar>	MP:0000812,abnormal dentate gyrus morphology|MP:0001458,abnormal object recognition memory|MP:0008428,abnormal spatial working memory|MP:0009967,abnormal neuron proliferation|MP:0010062,decreased creatine level|MP:0014365,impaired short-term object recognition memory|MP:0014367,impaired long-term object recognition memory
MGI:3522510	Slc6a8<tm1.2Clar>	MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001463,abnormal spatial learning|MP:0001522,impaired swimming|MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0010062,decreased creatine level|MP:0010065,decreased circulating creatine level|MP:0010069,increased serotonin level|MP:0014365,impaired short-term object recognition memory
MGI:5825019	Slc6a8<tm1.2Lbar>	MP:0000812,abnormal dentate gyrus morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001441,increased grooming behavior|MP:0001458,abnormal object recognition memory|MP:0001522,impaired swimming|MP:0003245,abnormal GABAergic neuron morphology|MP:0008414,abnormal spatial reference memory|MP:0008428,abnormal spatial working memory|MP:0008842,lipofuscinosis|MP:0008918,microgliosis|MP:0009538,abnormal synapse morphology|MP:0009967,abnormal neuron proliferation|MP:0010062,decreased creatine level|MP:0010065,decreased circulating creatine level|MP:0012307,impaired spatial learning|MP:0014365,impaired short-term object recognition memory|MP:0014367,impaired long-term object recognition memory|MP:0020083,decreased hippocampus volume|MP:0030633,decreased urine creatine level
MGI:4363493	Slc6a8<tm1e(KOMP)Wtsi>	MP:0000069,kyphoscoliosis|MP:0000160,kyphosis|MP:0000747,muscle weakness|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001765,abnormal ion homeostasis|MP:0002106,abnormal muscle physiology|MP:0002108,abnormal muscle morphology|MP:0002804,abnormal motor learning|MP:0003061,decreased aerobic running capacity|MP:0003960,increased lean body mass|MP:0004144,hypotonia|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006086,decreased body mass index|MP:0009413,skeletal muscle fiber atrophy|MP:0010053,decreased grip strength|MP:0010062,decreased creatine level|MP:0013278,decreased fasting circulating glucose level
MGI:3056923	Slc6a9<tm1.1Blt>	MP:0003234,enhanced NMDA-mediated synaptic currents|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0011091,prenatal lethality, complete penetrance
MGI:3622080	Slc6a9<tm1.1Bois>	MP:0001454,abnormal cued conditioning behavior|MP:0002798,abnormal active avoidance behavior|MP:0002805,abnormal conditioned taste aversion behavior|MP:0003234,enhanced NMDA-mediated synaptic currents|MP:0006299,abnormal latent inhibition of conditioning behavior|MP:0009750,impaired behavioral response to addictive substance
MGI:2682493	Slc6a9<tm1Betz>	MP:0001262,decreased body weight|MP:0001429,dehydration|MP:0001436,abnormal suckling behavior|MP:0001951,abnormal breathing pattern|MP:0001954,respiratory distress|MP:0001957,apnea|MP:0002272,abnormal nervous system electrophysiology|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0004144,hypotonia|MP:0004263,abnormal limb posture|MP:0005156,bradykinesia|MP:0005202,lethargy|MP:0005498,hyporesponsive to tactile stimuli|MP:0005574,decreased pulmonary respiratory rate|MP:0009546,absent gastric milk in neonates|MP:0011087,neonatal lethality, complete penetrance|MP:0014812,abnormal brain physiology
MGI:3604567	Slc6a9<tm1Dgen>	MP:0001260,increased body weight|MP:0011100,preweaning lethality, complete penetrance
MGI:3045030	Slc6a9<tm1Jtc>	MP:0001463,abnormal spatial learning|MP:0002634,abnormal sensorimotor gating|MP:0002888,abnormal NMDA-mediated synaptic currents|MP:0003633,abnormal nervous system physiology|MP:0011087,neonatal lethality, complete penetrance|MP:0014812,abnormal brain physiology
MGI:4818447	Slc6a9<tm1Veul>	MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002169,no abnormal phenotype detected|MP:0004144,hypotonia|MP:0004811,abnormal neuron physiology|MP:0005369,muscle phenotype|MP:0005386,behavior/neurological phenotype|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance
MGI:3716074	Slc7a10<tm1Dgen>	MP:0000243,myoclonus|MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001505,hunched posture|MP:0002064,seizures|MP:0002083,premature death|MP:0002206,abnormal CNS synaptic transmission|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003997,tonic-clonic seizures|MP:0005332,abnormal amino acid level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014812,abnormal brain physiology|MP:0021009,abnormal synaptic physiology
MGI:4442905	Slc7a11<m1Mtka>	MP:0002376,abnormal dendritic cell physiology|MP:0002451,abnormal macrophage physiology|MP:0004499,increased incidence of tumors by chemical induction|MP:0005387,immune system phenotype|MP:0011704,decreased fibroblast proliferation
MGI:1857061	Slc7a11<sut>	MP:0000371,diluted coat color|MP:0004725,decreased platelet serotonin level|MP:0005606,increased bleeding time
MGI:5548466	Slc7a11<tm1b(EUCOMM)Wtsi>	MP:0002699,abnormal vitreous body morphology|MP:0004738,abnormal auditory brainstem response|MP:0005559,increased circulating glucose level|MP:0008259,abnormal optic disk morphology
MGI:3608695	Slc7a11<tm1Hsat>	MP:0000313,abnormal cell death|MP:0005311,abnormal circulating amino acid level|MP:0011704,decreased fibroblast proliferation|MP:0030625,increased circulating cysteine level
MGI:5569057	Slc7a13<tm1.1(KOMP)Vlcg>	MP:0001258,decreased body length
MGI:7277696	Slc7a14<em1Jin>	MP:0004397,absent cochlear inner hair cells|MP:0004533,fused inner hair cell stereocilia|MP:0004534,decreased inner hair cell stereocilia number|MP:0004535,absent inner hair cell stereocilia|MP:0004740,sensorineural hearing loss|MP:0005377,hearing/vestibular/ear phenotype|MP:0008587,short photoreceptor outer segment|MP:0011965,decreased total retina thickness|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5705135	Slc7a14<em1Jqu>	MP:0004021,abnormal rod electrophysiology|MP:0004533,fused inner hair cell stereocilia|MP:0004534,decreased inner hair cell stereocilia number|MP:0004535,absent inner hair cell stereocilia|MP:0004740,sensorineural hearing loss|MP:0005377,hearing/vestibular/ear phenotype|MP:0005551,abnormal eye electrophysiology|MP:0008515,thin retina outer nuclear layer|MP:0011965,decreased total retina thickness|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3513834	Slc7a1<tm1Rbmn>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001577,anemia|MP:0002416,abnormal proerythroblast morphology|MP:0002424,abnormal reticulocyte morphology|MP:0002641,anisopoikilocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005621,abnormal cell physiology|MP:0009395,increased nucleated erythrocyte cell number|MP:0011087,neonatal lethality, complete penetrance
MGI:5692923	Slc7a2<tm1b(EUCOMM)Hmgu>	MP:0002590,increased mean corpuscular volume|MP:0004357,long tibia|MP:0005178,increased circulating cholesterol level|MP:0005565,increased blood urea nitrogen level|MP:0008810,increased circulating iron level|MP:0010088,decreased circulating fructosamine level
MGI:2150359	Slc7a2<tm1Clm>	MP:0001790,abnormal immune system physiology
MGI:7442636	Slc7a3<tm1.1Ckq>	MP:0002169,no abnormal phenotype detected
MGI:7425987	Slc7a5<em1(IMPC)H>	MP:0002590,increased mean corpuscular volume|MP:0002606,increased basophil cell number|MP:0005627,increased circulating potassium level|MP:0011100,preweaning lethality, complete penetrance
MGI:5618433	Slc7a5<tm1.1Daca>	MP:0000160,kyphosis|MP:0001360,abnormal social investigation|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0002206,abnormal CNS synaptic transmission|MP:0002757,decreased vertical activity|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004792,abnormal synaptic vesicle number|MP:0004924,abnormal behavior|MP:0005331,insulin resistance|MP:0005332,abnormal amino acid level|MP:0008571,abnormal synaptic bouton morphology|MP:0009285,increased gonadal fat pad weight|MP:0013140,excessive vocalization|MP:0013242,abnormal amino acid metabolism|MP:0013272,abnormal translation|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0020358,abnormal inhibitory synapse morphology|MP:0020361,abnormal symmetric synapse morphology|MP:0030691,increased serine level|MP:0030697,increased phenylalanine level|MP:0031496,motor developmental delay
MGI:5618524	Slc7a5<tm1.2Daca>	MP:0011092,embryonic lethality, complete penetrance
MGI:5007342	Slc7a5<tm1Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:7425989	Slc7a6os<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:6257790	Slc7a7<em1(IMPC)Bay>	MP:0000111,cleft palate|MP:0000445,short snout|MP:0001625,cardiac hypertrophy|MP:0001697,abnormal embryo size|MP:0001891,hydrocephaly|MP:0003960,increased lean body mass|MP:0003984,embryonic growth retardation|MP:0004200,decreased fetal size|MP:0004258,abnormal placenta size|MP:0010402,ventricular septal defect|MP:0011100,preweaning lethality, complete penetrance
MGI:6391169	Slc7a7<em1Lbu>	MP:0000219,increased neutrophil cell number|MP:0000528,delayed kidney development|MP:0000597,delayed hepatic development|MP:0001176,abnormal lung development|MP:0002113,abnormal skeleton development|MP:0002359,abnormal spleen germinal center morphology|MP:0002705,dilated renal tubule|MP:0003311,aminoaciduria|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004953,decreased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0006027,impaired lung alveolus development|MP:0008476,increased spleen red pulp amount|MP:0008489,slow postnatal weight gain|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011423,kidney cortex atrophy|MP:0020137,decreased bone mineralization|MP:0020401,argininuria|MP:0020403,lysinuria
MGI:3530880	Slc7a7<Gt(OST41878)Lex>	MP:0000745,tremors|MP:0001263,weight loss|MP:0001385,pup cannibalization|MP:0001491,unresponsive to tactile stimuli|MP:0001698,decreased embryo size|MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0002083,premature death|MP:0002113,abnormal skeleton development|MP:0003311,aminoaciduria|MP:0003984,embryonic growth retardation|MP:0004144,hypotonia|MP:0004952,increased spleen weight|MP:0005309,increased circulating ammonia level|MP:0009703,decreased birth body size|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3604565	Slc7a8<tm1Dgen>	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002887,decreased susceptibility to pharmacologically induced seizures
MGI:5660917	Slc7a8<tm1Geno>	MP:0001405,impaired coordination|MP:0002857,cochlear ganglion degeneration|MP:0004288,abnormal spiral ligament morphology|MP:0004292,abnormal spiral ligament fibrocyte morphology|MP:0004362,cochlear hair cell degeneration|MP:0004365,abnormal strial basal cell morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0006325,impaired hearing|MP:0009142,decreased prepulse inhibition|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014740,increased auditory brainstem response wave peak latency|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:5636989	Slc7a8<tm2b(EUCOMM)Hmgu>	MP:0002764,short tibia|MP:0010088,decreased circulating fructosamine level
MGI:2677350	Slc7a9<tm1Nune>	MP:0000519,hydronephrosis|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0003311,aminoaciduria|MP:0004154,renal tubular necrosis|MP:0005311,abnormal circulating amino acid level|MP:0005360,urolithiasis|MP:0009645,crystalluria|MP:0011402,renal cast|MP:0011405,tubulointerstitial nephritis|MP:0011799,increased urinary bladder weight|MP:0020400,cystinuria|MP:0020401,argininuria|MP:0020402,ornithinuria|MP:0020403,lysinuria|MP:0030617,hyperglutaminuria
MGI:4849923	Slc8a1<m51207Hubr>	MP:0000270,abnormal heart tube morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001719,absent vitelline blood vessels|MP:0001785,edema|MP:0002884,abnormal pharyngeal arch morphology|MP:0003403,absent placental labyrinth|MP:0004086,absent heartbeat|MP:0006343,enlarged first pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012127,absent placenta hemotrichorial membrane
MGI:5436242	Slc8a1<tm1Herc>	MP:0002078,abnormal glucose homeostasis|MP:0002693,abnormal pancreas physiology|MP:0003058,increased insulin secretion|MP:0009113,increased pancreatic beta cell mass|MP:0010148,abnormal exocrine pancreas physiology|MP:0011092,embryonic lethality, complete penetrance|MP:0011819,increased pancreatic beta cell proliferation
MGI:2384413	Slc8a1<tm1Hssh>	MP:0000267,abnormal heart development|MP:0000280,thin ventricular wall|MP:0000292,distended pericardium|MP:0000295,trabecula carnea hypoplasia|MP:0000298,absent atrioventricular cushions|MP:0001718,abnormal visceral yolk sac morphology|MP:0001730,embryonic growth arrest|MP:0003105,abnormal heart atrium morphology|MP:0003231,abnormal placenta vasculature|MP:0003403,absent placental labyrinth|MP:0003974,abnormal endocardium morphology|MP:0004076,abnormal vitelline vascular remodeling|MP:0005329,abnormal myocardium layer morphology|MP:0005333,decreased heart rate|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013241,embryo tissue necrosis
MGI:3604379	Slc8a1<tm1Kdp>	MP:0000274,enlarged heart|MP:0002083,premature death|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0008028,pregnancy-related premature death
MGI:2384543	Slc8a1<tm1Sjc>	MP:0000266,abnormal heart morphology|MP:0000298,absent atrioventricular cushions|MP:0001544,abnormal cardiovascular system physiology|MP:0001633,poor circulation|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004086,absent heartbeat|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis|MP:0031613,fetal cardiomyocyte disarray
MGI:2384549	Slc8a1<tm1Yin>	MP:0000280,thin ventricular wall|MP:0000291,enlarged pericardium|MP:0000740,impaired smooth muscle contractility|MP:0001544,abnormal cardiovascular system physiology|MP:0001633,poor circulation|MP:0001636,irregular heartbeat|MP:0001698,decreased embryo size|MP:0001719,absent vitelline blood vessels|MP:0002625,heart left ventricle hypertrophy|MP:0003229,abnormal vitelline vasculature morphology|MP:0003819,increased left ventricle diastolic pressure|MP:0003820,increased left ventricle systolic pressure|MP:0004076,abnormal vitelline vascular remodeling|MP:0004084,abnormal cardiac muscle relaxation|MP:0004086,absent heartbeat|MP:0004092,absent Z line|MP:0005608,cardiac interstitial fibrosis|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011392,increased fetal cardiomyocyte apoptosis|MP:0011632,dilated mitochondrion|MP:0011633,abnormal mitochondrial shape|MP:0011635,abnormal mitochondrial crista morphology|MP:0011637,abnormal mitochondrial matrix morphology|MP:0012701,increased embryonic neuroepithelium apoptosis|MP:0031607,abnormal fetal cardiomyocyte mitochondrial morphology|MP:0031611,decreased fetal cardiomyocyte number|MP:0031613,fetal cardiomyocyte disarray|MP:0031635,increased heart left ventricle muscle contractility
MGI:3609617	Slc8a1<tm2Kdp>	MP:0001544,abnormal cardiovascular system physiology|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2667136	Slc8a2<tm1(cre)Hssh>	MP:0001458,abnormal object recognition memory|MP:0001463,abnormal spatial learning|MP:0001898,abnormal long-term depression|MP:0002206,abnormal CNS synaptic transmission|MP:0002919,enhanced paired-pulse facilitation|MP:0002921,abnormal post-tetanic potentiation|MP:0003008,enhanced long-term potentiation|MP:0004811,abnormal neuron physiology|MP:0004859,abnormal synaptic plasticity|MP:0009453,enhanced contextual conditioning behavior
MGI:5554913	Slc8a3<tm1.1(KOMP)Vlcg>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005633,increased circulating sodium level|MP:0011396,abnormal sleep behavior
MGI:3028976	Slc8a3<tm1Sso>	MP:0001405,impaired coordination|MP:0002229,neurodegeneration|MP:0002899,fatigue|MP:0003484,abnormal channel response|MP:0003635,abnormal synaptic transmission|MP:0006060,increased cerebral infarct size|MP:0009414,skeletal muscle fiber necrosis
MGI:5584295	Slc8b1<em1(IMPC)J>	MP:0001417,decreased exploration in new environment|MP:0001510,abnormal coat appearance|MP:0001523,impaired righting response|MP:0011396,abnormal sleep behavior
MGI:5909410	Slc8b1<tm1c(EUCOMM)Wtsi>	MP:0001625,cardiac hypertrophy|MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003896,prolonged PR interval|MP:0004090,abnormal sarcomere morphology|MP:0004564,increased myocardial fiber size|MP:0005333,decreased heart rate|MP:0006138,congestive heart failure|MP:0010392,prolonged QRS complex duration|MP:0011632,dilated mitochondrion|MP:0031633,decreased heart left ventricle muscle contractility
MGI:6276867	Slc9a1<em1(IMPC)Mbp>	MP:0001925,male infertility|MP:0002092,abnormal eye morphology|MP:0002989,small kidney|MP:0008528,polycystic kidney
MGI:1857350	Slc9a1<swe>	MP:0000876,Purkinje cell degeneration|MP:0000889,abnormal cerebellar molecular layer|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0002064,seizures|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002856,abnormal vestibular ganglion morphology|MP:0002857,cochlear ganglion degeneration|MP:0003216,absence seizures|MP:0003224,neuron degeneration|MP:0003312,abnormal locomotor coordination|MP:0003997,tonic-clonic seizures|MP:0005378,growth/size/body region phenotype|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0008035,behavioral arrest|MP:0008571,abnormal synaptic bouton morphology|MP:0009979,abnormal cerebellum deep nucleus morphology|MP:0009980,abnormal cerebellum dentate nucleus morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014329,abnormal Purkinje cell axon morphology
MGI:2429323	Slc9a1<tm1Smb>	MP:0000473,abnormal stomach glandular epithelium morphology|MP:0000623,decreased salivation|MP:0000947,convulsive seizures|MP:0001199,thin skin|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001417,decreased exploration in new environment|MP:0001443,poor grooming|MP:0002161,abnormal fertility/fecundity|MP:0002834,decreased heart weight|MP:0003631,nervous system phenotype|MP:0004486,decreased response of heart to induced stress|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0011084,lethality at weaning, incomplete penetrance|MP:0013532,abnormal parotid gland physiology
MGI:2447441	Slc9a2<tm1Ges>	MP:0000473,abnormal stomach glandular epithelium morphology|MP:0001873,stomach inflammation|MP:0002161,abnormal fertility/fecundity|MP:0004139,abnormal gastric parietal cell morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0008001,hypochlorhydria
MGI:5766165	Slc9a3<tm1b(NCOM)Mfgc>	MP:0009142,decreased prepulse inhibition
MGI:2388341	Slc9a3<tm1Ges>	MP:0000466,esophageal epithelium hyperplasia|MP:0000477,abnormal intestine morphology|MP:0000525,renal tubular acidosis|MP:0001596,hypotension|MP:0001663,abnormal digestive system physiology|MP:0001925,male infertility|MP:0002666,increased circulating aldosterone level|MP:0002731,megacolon|MP:0003027,abnormal blood pH regulation|MP:0005036,diarrhea|MP:0006423,dilated rete testis|MP:0009140,dilated efferent ductule of testis|MP:0009480,distended cecum|MP:0010107,abnormal renal reabsorption|MP:0010108,abnormal renal water reabsorption
MGI:5636898	Slc9a4<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001489,decreased startle reflex|MP:0005178,increased circulating cholesterol level|MP:0009142,decreased prepulse inhibition|MP:0010124,decreased bone mineral content
MGI:3579458	Slc9a4<tm1Ges>	MP:0000473,abnormal stomach glandular epithelium morphology|MP:0001653,gastric necrosis|MP:0001873,stomach inflammation|MP:0004138,abnormal mucous neck cell morphology|MP:0004139,abnormal gastric parietal cell morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0005378,growth/size/body region phenotype|MP:0008001,hypochlorhydria|MP:0010792,abnormal stomach mucosa morphology
MGI:6107624	Slc9a5<em1(IMPC)J>	MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:6507719	Slc9a5<tm1Smoc>	MP:0001458,abnormal object recognition memory|MP:0003999,enhanced passive avoidance behavior|MP:0005386,behavior/neurological phenotype|MP:0008414,abnormal spatial reference memory|MP:0009538,abnormal synapse morphology|MP:0012314,enhanced learning|MP:0014812,abnormal brain physiology
MGI:3604561	Slc9a6<tm1Dgen>	MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000818,abnormal amygdala morphology|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000876,Purkinje cell degeneration|MP:0000880,decreased Purkinje cell number|MP:0000889,abnormal cerebellar molecular layer|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0002152,abnormal brain morphology|MP:0002183,gliosis|MP:0002574,increased vertical activity|MP:0002882,abnormal neuron morphology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003354,astrocytosis|MP:0005386,behavior/neurological phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006254,thin cerebral cortex|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0008269,abnormal hippocampus CA4 region morphology|MP:0008414,abnormal spatial reference memory|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008918,microgliosis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012468,decreased striatum size|MP:0012779,abnormal brain cholesterol level|MP:0014329,abnormal Purkinje cell axon morphology|MP:0031391,increased locomotor activity|MP:0031561,increased ganglioside level
MGI:6209685	Slc9a6<tm1Tigm>	MP:0000880,decreased Purkinje cell number
MGI:3870057	Slc9a8<Gt(YHB273)Byg>	MP:0000494,abnormal cecum morphology|MP:0000496,abnormal small intestine morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0001925,male infertility|MP:0002551,abnormal blood coagulation|MP:0003017,decreased circulating bicarbonate level|MP:0013481,abnormal ileum crypts of Lieberkuhn morphology|MP:0013795,abnormal colon goblet cell morphology
MGI:6268359	Slc9a8<m1Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:4363224	Slc9a8<tm1a(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0002092,abnormal eye morphology|MP:0005103,abnormal retina pigmentation
MGI:5925353	Slc9a8<tm1c(KOMP)Wtsi>	MP:0001925,male infertility|MP:0002686,globozoospermia|MP:0005389,reproductive system phenotype|MP:0008839,absent acrosome|MP:0009230,abnormal sperm head morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009833,absent sperm mitochondrial sheath|MP:0031354,abnormal acrosome assembly|MP:0031355,abnormal proacrosomal vesicle fusion
MGI:5925354	Slc9a8<tm1d(KOMP)Wtsi>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0005389,reproductive system phenotype|MP:0008839,absent acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009833,absent sperm mitochondrial sheath|MP:0031354,abnormal acrosome assembly|MP:0031355,abnormal proacrosomal vesicle fusion
MGI:5905784	Slc9a9<em1(IMPC)J>	MP:0001556,increased circulating HDL cholesterol level|MP:0002941,increased circulating alanine transaminase level|MP:0010052,increased grip strength
MGI:6209388	Slc9a9<tm1.1Yzj>	MP:0001441,increased grooming behavior|MP:0005386,behavior/neurological phenotype|MP:0020351,decreased vocalization|MP:0020395,abnormal response to social novelty
MGI:6201439	Slc9a9<tm2c(KOMP)Wtsi>	MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001409,increased stereotypic behavior|MP:0002557,abnormal social/conspecific interaction behavior|MP:0005386,behavior/neurological phenotype|MP:0011000,abnormal allogrooming behavior|MP:0011617,abnormal habituation|MP:0020396,abnormal social recognition|MP:0020437,abnormal social play behavior|MP:0020852,abnormal olfactory behavior
MGI:6201444	Slc9a9<tm2d(KOMP)Wtsi>	MP:0001360,abnormal social investigation|MP:0001409,increased stereotypic behavior|MP:0002206,abnormal CNS synaptic transmission|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003998,decreased thermal nociceptive threshold|MP:0004043,abnormal pH regulation|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004811,abnormal neuron physiology|MP:0004924,abnormal behavior|MP:0004994,abnormal brain wave pattern|MP:0005378,growth/size/body region phenotype|MP:0005621,abnormal cell physiology|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude|MP:0020396,abnormal social recognition|MP:0020437,abnormal social play behavior|MP:0030950,abnormal synaptic vesicle exocytosis
MGI:6277003	Slc9b1<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002989,small kidney
MGI:3892919	Slc9b2<Gt(D174F03)Wrst>	MP:0003059,decreased insulin secretion|MP:0005390,skeleton phenotype|MP:0005559,increased circulating glucose level
MGI:5521370	Slc9b2<tm1.1Dgfu>	MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005559,increased circulating glucose level
MGI:5695944	Slc9b2<tm1.1(KOMP)Vlcg>	MP:0001566,increased circulating phosphate level
MGI:3530647	Slc9c1<tm1Gar>	MP:0001925,male infertility|MP:0002675,asthenozoospermia
MGI:3840625	slck	MP:0001511,disheveled coat|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype
MGI:5142510	Slco1a1<tm1Dgen>	MP:0005367,renal/urinary system phenotype|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0010080,abnormal hepatocyte physiology
MGI:5142511	Slco1a4<tm1Dgen>	MP:0005367,renal/urinary system phenotype|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0010080,abnormal hepatocyte physiology
MGI:3604411	Slco1a5<tm1Lex>	MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005014,increased B cell number
MGI:7377684	Slco1b2<em1(IMPC)Mbp>	MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0005344,increased circulating bilirubin level
MGI:3785252	Slco1b2<tm1Cdk>	MP:0000199,abnormal circulating serum albumin level|MP:0000609,abnormal liver physiology|MP:0002941,increased circulating alanine transaminase level|MP:0003019,increased circulating chloride level|MP:0005178,increased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0005416,abnormal circulating protein level|MP:0005568,increased circulating total protein level|MP:0005633,increased circulating sodium level|MP:0006357,abnormal circulating mineral level|MP:0008805,decreased circulating amylase level|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008875,abnormal xenobiotic pharmacokinetics|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:5308446	Slco1c1<tm1.1Arte>	MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005471,decreased thyroxine level|MP:0005473,decreased triiodothyronine level
MGI:5308451	Slco1c1<tm1Arte>	MP:0002169,no abnormal phenotype detected
MGI:4888397	Slco2a1<tm1.2Vsch>	MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0003139,patent ductus arteriosus|MP:0005621,abnormal cell physiology|MP:0009643,abnormal urine homeostasis|MP:0009811,abnormal prostaglandin level|MP:0011087,neonatal lethality, complete penetrance
MGI:4888398	Slco2a1<tm1Vsch>	MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0003139,patent ductus arteriosus|MP:0011085,postnatal lethality, complete penetrance
MGI:4363700	Slco2b1<tm1a(KOMP)Wtsi>	MP:0001260,increased body weight
MGI:6489390	Slco2b1<tm1d(KOMP)Wtsi>	MP:0005376,homeostasis/metabolism phenotype|MP:0005565,increased blood urea nitrogen level|MP:0008875,abnormal xenobiotic pharmacokinetics
MGI:6361972	Slco3a1<em1Smoc>	MP:0002941,increased circulating alanine transaminase level|MP:0004789,increased bile salt level|MP:0005343,increased circulating aspartate transaminase level|MP:0005365,abnormal bile salt homeostasis|MP:0008770,decreased survivor rate
MGI:7431382	Slco4c1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0002060,abnormal skin morphology|MP:0002100,abnormal tooth morphology|MP:0002631,abnormal epididymis morphology|MP:0003019,increased circulating chloride level|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0004931,enlarged epididymis|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0010935,increased airway resistance|MP:0011047,increased lung tissue damping
MGI:6257823	Slco6d1<em1(IMPC)Tcp>	MP:0001120,abnormal uterus morphology
MGI:2154333	Sle10<BXSB/J>	MP:0000702,enlarged lymph nodes
MGI:2155328	Sle11<BXSB/J>	MP:0008502,increased IgG3 level
MGI:2158122	Sle12<C57BL/6J>	MP:0002743,glomerulonephritis
MGI:2158123	Sle12<NZM2410/Aeg>	MP:0002743,glomerulonephritis
MGI:3531336	Sle16<129S6/SvEvTac>	MP:0002723,abnormal immune serum protein physiology|MP:0003725,increased autoantibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus
MGI:3531338	Sle17<129S6/SvEvTac>	MP:0002723,abnormal immune serum protein physiology
MGI:3531339	Sle18<C57BL/6>	MP:0002723,abnormal immune serum protein physiology
MGI:2154449	Sle1a<NZM2410/J>	MP:0004829,increased anti-chromatin antibody level
MGI:2154451	Sle1b<NZM2410/J>	MP:0004829,increased anti-chromatin antibody level
MGI:2154453	Sle1c<NZM2410/J>	MP:0004829,increased anti-chromatin antibody level
MGI:2155957	Sle2<NZM2410/Aeg>	MP:0002743,glomerulonephritis
MGI:2156753	Sle3<NZM2410/Aeg>	MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002743,glomerulonephritis
MGI:2156085	Sle6<NZW>	MP:0004801,increased susceptibility to systemic lupus erythematosus
MGI:2154335	Sle7<BXSB/J>	MP:0002743,glomerulonephritis
MGI:2154337	Sle8<BXSB/J>	MP:0002743,glomerulonephritis
MGI:2154339	Sle9<BXSB/J>	MP:0004794,increased anti-nuclear antigen antibody level
MGI:2155790	Sles1<C57BL/6>	MP:0004801,increased susceptibility to systemic lupus erythematosus
MGI:2155791	Sles1<NZW>	MP:0004802,decreased susceptibility to systemic lupus erythematosus
MGI:2155792	Sles2<C57BL/6>	MP:0004801,increased susceptibility to systemic lupus erythematosus
MGI:2155793	Sles2<NZW>	MP:0004802,decreased susceptibility to systemic lupus erythematosus
MGI:2155332	Sles3<C57BL/6>	MP:0004801,increased susceptibility to systemic lupus erythematosus
MGI:2155333	Sles3<NZW>	MP:0004802,decreased susceptibility to systemic lupus erythematosus
MGI:2157367	Sles4<C57BL/6>	MP:0004801,increased susceptibility to systemic lupus erythematosus
MGI:2157368	Sles4<NZW>	MP:0004802,decreased susceptibility to systemic lupus erythematosus
MGI:3579563	Slf1<tm1Brd>	MP:0002169,no abnormal phenotype detected
MGI:7256926	Slfn14<em1(IMPC)Tcp>	MP:0000208,decreased hematocrit|MP:0000470,abnormal stomach morphology|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002591,decreased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010067,increased red blood cell distribution width
MGI:7286186	Slfn14<em1Nvm>	MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000259,abnormal vascular development|MP:0000691,enlarged spleen|MP:0001585,hemolytic anemia|MP:0002416,abnormal proerythroblast morphology|MP:0002599,increased mean platelet volume|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0003131,increased erythrocyte cell number|MP:0004720,abnormal platelet morphology|MP:0004952,increased spleen weight|MP:0005048,abnormal thrombosis|MP:0011085,postnatal lethality, complete penetrance|MP:0013704,increased megakaryocyte-erythroid progenitor cell number
MGI:5766261	Slfn1<tm1.1(KOMP)Vlcg>	MP:0002590,increased mean corpuscular volume|MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval
MGI:4441069	Slfn1<tm1Aki>	MP:0005387,immune system phenotype
MGI:3640337	Slfn1<tm1Hed>	MP:0002169,no abnormal phenotype detected
MGI:3850348	Slfn2<m1Btlr>	MP:0000219,increased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0001828,abnormal T cell activation|MP:0002412,increased susceptibility to bacterial infection|MP:0002442,abnormal leukocyte physiology|MP:0003957,abnormal nitric oxide homeostasis|MP:0005094,abnormal T cell proliferation|MP:0005095,decreased T cell proliferation|MP:0006413,increased T cell apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0020913,increased susceptibility to Riboviria infection|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:5789597	Slfn2<m2Btlr>	MP:0001805,decreased IgG level|MP:0020001,decreased response to antigen|MP:0020154,impaired humoral immune response
MGI:4441068	Slfn3<tm1Aki>	MP:0005387,immune system phenotype
MGI:7493861	Slfn4<tm1c(EUCOMM)Wtsi>	MP:0002411,decreased susceptibility to bacterial infection|MP:0002436,abnormal CD8-positive, alpha-beta cytotoxic T cell morphology|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0010792,abnormal stomach mucosa morphology
MGI:6357190	Slfn5<tm1Aki>	MP:0005387,immune system phenotype
MGI:6151479	Slfn8<tm1Aki>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005387,immune system phenotype|MP:0008567,decreased interferon-gamma secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008706,decreased interleukin-6 secretion
MGI:7711292	Slfn9<em1Liudp>	MP:0002419,abnormal innate immunity|MP:0011075,abnormal macrophage activation involved in immune response
MGI:6717358	Slfnl1<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5538716	Slirp<tm1.2Pjle>	MP:0001922,reduced male fertility|MP:0005389,reproductive system phenotype|MP:0009834,abnormal sperm annulus morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014465,abnormal sperm mitochondrial morphology|MP:0020451,decreased sperm progressive motility
MGI:2179459	Slit1<tm1.1Matl>	MP:0003631,nervous system phenotype
MGI:5636949	Slit1<tm1b(KOMP)Wtsi>	MP:0001402,decreased locomotor activity
MGI:5437102	Slit2<b2b1200.1Clo>	MP:0000284,double outlet right ventricle|MP:0000519,hydronephrosis|MP:0004017,duplex kidney|MP:0004133,heterotaxia|MP:0008528,polycystic kidney|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010422,heart right ventricle hypoplasia|MP:0010466,vascular ring|MP:0010485,aortic arch hypoplasia
MGI:6316121	Slit2<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001711,abnormal placenta morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0003068,enlarged kidney|MP:0003231,abnormal placenta vasculature|MP:0009709,hydrometra|MP:0011100,preweaning lethality, complete penetrance
MGI:5705113	Slit2<tm1.1Ics>	MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:2179460	Slit2<tm1Matl>	MP:0000474,abnormal foregut morphology|MP:0000527,abnormal kidney development|MP:0000534,abnormal ureter morphology|MP:0000536,hydroureter|MP:0003566,abnormal cell adhesion|MP:0006032,abnormal ureteric bud morphology|MP:0009503,abnormal mammary gland duct morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011334,abnormal nephrogenic zone morphology
MGI:5560156	Slit3<b2b2362.1Clo>	MP:0000757,herniated abdominal wall|MP:0003446,renal hypoplasia|MP:0010402,ventricular septal defect|MP:0011660,ectopia cordis|MP:0011667,double outlet right ventricle with atrioventricular septal defect|MP:0011668,double outlet right ventricle, Taussig bing type|MP:0011682,renal glomerulus cyst|MP:0014518,myocardial hypertrabeculation
MGI:2679499	Slit3<Gt(OST106158)Lex>	MP:0000276,heart right ventricle hypertrophy|MP:0000520,absent kidney|MP:0002135,abnormal kidney morphology|MP:0003446,renal hypoplasia|MP:0003924,diaphragmatic hernia
MGI:2662358	Slit3<tm1.1Dor>	MP:0000761,thin diaphragm muscle|MP:0001177,atelectasis|MP:0001182,lung hemorrhage|MP:0001262,decreased body weight|MP:0001614,abnormal blood vessel morphology|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002279,abnormal diaphragm morphology|MP:0003270,intestinal obstruction|MP:0003924,diaphragmatic hernia|MP:0005155,herniated intestine|MP:0010912,herniated liver|MP:0012061,abnormal diaphragm central tendon morphology
MGI:2662346	Slit3<tm1Dor>	MP:0000761,thin diaphragm muscle|MP:0001177,atelectasis|MP:0001182,lung hemorrhage|MP:0001262,decreased body weight|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0003270,intestinal obstruction|MP:0003924,diaphragmatic hernia|MP:0005155,herniated intestine|MP:0010018,pulmonary vascular congestion|MP:0010912,herniated liver|MP:0012061,abnormal diaphragm central tendon morphology|MP:0012251,abnormal diaphragm development|MP:0030786,absent falciform ligament
MGI:5583079	Slitrk1<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001513,limb grasping|MP:0002631,abnormal epididymis morphology|MP:0002941,increased circulating alanine transaminase level|MP:0004931,enlarged epididymis|MP:0005292,improved glucose tolerance|MP:0005343,increased circulating aspartate transaminase level
MGI:3834477	Slitrk1<tm1Jaru>	MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002152,abnormal brain morphology|MP:0003064,decreased coping response|MP:0003459,increased fear-related response|MP:0003631,nervous system phenotype|MP:0003964,abnormal noradrenaline level|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6152646	Slitrk2<em1(IMPC)Mbp>	MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001415,increased exploration in new environment|MP:0002833,increased heart weight|MP:0004832,enlarged ovary|MP:0004906,enlarged uterus|MP:0004931,enlarged epididymis|MP:0020870,decreased thigmotaxis
MGI:7327302	Slitrk2<tm1.1Jaru>	MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0001905,abnormal dopamine level|MP:0002797,increased thigmotaxis|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003063,increased coping response|MP:0003631,nervous system phenotype|MP:0003858,enhanced coordination|MP:0003877,abnormal serotonergic neuron morphology|MP:0004844,abnormal vestibuloocular reflex|MP:0005322,abnormal serotonin level|MP:0009456,impaired cued conditioning behavior|MP:0009538,abnormal synapse morphology|MP:0020379,abnormal sucrose solution preference
MGI:7547409	Slitrk2<tm1.1Jwum>	MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001406,abnormal gait|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008414,abnormal spatial reference memory|MP:0008432,abnormal long-term spatial reference memory|MP:0012307,impaired spatial learning|MP:0020357,abnormal excitatory synapse morphology|MP:0020551,abnormal postsynaptic density morphology
MGI:5781003	Slitrk3<tm1Jaru>	MP:0002064,seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003631,nervous system phenotype|MP:0009538,abnormal synapse morphology|MP:0014383,decreased miniature inhibitory postsynaptic current frequency
MGI:7703964	Slitrk4<tm1.1Jaru>	MP:0000818,abnormal amygdala morphology|MP:0001417,decreased exploration in new environment|MP:0002169,no abnormal phenotype detected|MP:0003008,enhanced long-term potentiation|MP:0003863,decreased aggression towards mice|MP:0004101,abnormal brain interneuron morphology|MP:0004811,abnormal neuron physiology|MP:0004859,abnormal synaptic plasticity|MP:0005386,behavior/neurological phenotype|MP:0009142,decreased prepulse inhibition|MP:0009455,enhanced cued conditioning behavior|MP:0020852,abnormal olfactory behavior|MP:0021111,decreased social investigation
MGI:5548808	Slitrk4<tm1b(KOMP)Wtsi>	MP:0000194,increased circulating calcium level
MGI:6277000	Slitrk5<em1(IMPC)Mbp>	MP:0000538,abnormal urinary bladder morphology|MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology
MGI:4459459	Slitrk5<tm2Vlcg>	MP:0000414,alopecia|MP:0001212,skin lesions|MP:0001363,increased anxiety-related response|MP:0001441,increased grooming behavior|MP:0001914,hemorrhage|MP:0003635,abnormal synaptic transmission|MP:0004077,abnormal striatum morphology|MP:0005386,behavior/neurological phenotype|MP:0008462,abnormal medium spiny neuron morphology|MP:0009746,enhanced behavioral response to xenobiotic
MGI:4417931	Slitrk6<tm1.1Jaru>	MP:0001262,decreased body weight|MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0001967,deafness|MP:0002622,abnormal cochlear hair cell morphology|MP:0003100,myopia|MP:0003986,small cochlear ganglion|MP:0003987,small vestibular ganglion|MP:0004249,abnormal crista ampullaris morphology|MP:0004409,abnormal crista ampullaris neuroepithelium morphology|MP:0004632,abnormal cochlear OHC efferent innervation pattern|MP:0004633,abnormal cochlear IHC efferent innervation pattern|MP:0004746,abnormal cochlear IHC afferent innervation pattern|MP:0004811,abnormal neuron physiology|MP:0004924,abnormal behavior|MP:0005386,behavior/neurological phenotype|MP:0011041,abnormal vertical vestibuloocular reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:7425992	Slk<em1(IMPC)Bay>	MP:0001399,hyperactivity|MP:0001697,abnormal embryo size|MP:0002080,prenatal lethality|MP:0002574,increased vertical activity|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:3858304	Slk<Gt(BC0415)Wtsi>	MP:0000729,abnormal myogenesis|MP:0000913,abnormal brain development|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000962,disorganized dorsal root ganglion|MP:0001286,abnormal eye development|MP:0001614,abnormal blood vessel morphology|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001914,hemorrhage|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0004981,decreased neuronal precursor cell number|MP:0005238,increased brain size|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006279,abnormal limb development|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0008957,abnormal placenta junctional zone morphology|MP:0009658,increased placenta apoptosis|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0013504,increased embryonic tissue cell apoptosis
MGI:1857044	sll1	MP:0011087,neonatal lethality, complete penetrance
MGI:5812880	Slmap<em1(IMPC)J>	MP:0000111,cleft palate|MP:0001697,abnormal embryo size|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0011496,abnormal head size
MGI:7704162	Slmap<tm1.1Tuab>	MP:0000280,thin ventricular wall|MP:0000297,abnormal atrioventricular cushion morphology|MP:0002188,small heart|MP:0005385,cardiovascular system phenotype|MP:0021158,decreased heart left ventricle wall thickness|MP:0031536,decreased heart atrium wall thickness|MP:0031608,decreased fetal cardiomyocyte size
MGI:5287507	Slmap<Tn(sb-rtTA)2426B.SB4Ove>	MP:0000111,cleft palate
MGI:3688609	Slms1<DBA/2J>	MP:0002629,hyperactivity elicited by ethanol administration
MGI:3688611	Slms2<DBA/2J>	MP:0002629,hyperactivity elicited by ethanol administration|MP:0009746,enhanced behavioral response to xenobiotic
MGI:6407424	Sln<em1Cyh>	MP:0005378,growth/size/body region phenotype|MP:0010768,mortality/aging
MGI:3764910	Sln<tm1Peri>	MP:0001552,increased circulating triglyceride level|MP:0002628,hepatic steatosis|MP:0005178,increased circulating cholesterol level|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005385,cardiovascular system phenotype|MP:0005534,decreased body temperature|MP:0005559,increased circulating glucose level|MP:0005599,increased cardiac muscle contractility|MP:0005658,increased susceptibility to diet-induced obesity|MP:0008908,increased total fat pad weight|MP:0009121,increased white fat cell lipid droplet size|MP:0009124,increased brown fat cell lipid droplet size|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011049,impaired adaptive thermogenesis|MP:0011940,decreased food intake|MP:0014142,increased body fat mass
MGI:3767462	Slpd1<NZB/BlNJ>	MP:0005154,increased B cell proliferation
MGI:3778182	Slpi<tm1Ktak>	MP:0002412,increased susceptibility to bacterial infection|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:2652666	Slpi<tm1Nkw>	MP:0002451,abnormal macrophage physiology|MP:0005154,increased B cell proliferation|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock
MGI:2386293	Slpi<tm1Smw>	MP:0001792,impaired wound healing|MP:0002908,delayed wound healing|MP:0005023,abnormal wound healing|MP:0005464,abnormal platelet physiology|MP:0008837,increased transforming growth factor beta level
MGI:3846307	Slpl	MP:0014639,decreased sleep duration
MGI:3045164	Sls	MP:0000519,hydronephrosis|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002731,megacolon|MP:0002938,white spotting|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype
MGI:4363740	Slu7<tm1a(KOMP)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0000609,abnormal liver physiology|MP:0003674,oxidative stress|MP:0005165,increased susceptibility to injury|MP:0005331,insulin resistance|MP:0009642,abnormal blood homeostasis|MP:0010398,decreased liver glycogen level|MP:0011100,preweaning lethality, complete penetrance
MGI:5629843	Slurp1<tm1.1Sgy>	MP:0000572,abnormal autopod morphology|MP:0001219,thick epidermis|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0009596,abnormal stratum corneum lipid matrix formation
MGI:5607538	Slurp1<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0005292,improved glucose tolerance|MP:0010053,decreased grip strength
MGI:5629821	Slurp1<tm1Lex>	MP:0000572,abnormal autopod morphology|MP:0001219,thick epidermis|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001513,limb grasping|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0002796,impaired skin barrier function|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005381,digestive/alimentary phenotype|MP:0005388,respiratory system phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008963,increased carbon dioxide production|MP:0009583,increased keratinocyte proliferation|MP:0009596,abnormal stratum corneum lipid matrix formation|MP:0010025,decreased total body fat amount|MP:0010378,increased respiratory quotient|MP:0011939,increased food intake
MGI:6159751	Slurp2<tm1.1Sgy>	MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001513,limb grasping|MP:0002796,impaired skin barrier function|MP:0005459,decreased percent body fat/body weight|MP:0008489,slow postnatal weight gain|MP:0008907,decreased total fat pad weight
MGI:5006991	Slurp2<tm1Lex>	MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001402,decreased locomotor activity|MP:0001513,limb grasping|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005459,decreased percent body fat/body weight|MP:0008489,slow postnatal weight gain|MP:0008907,decreased total fat pad weight|MP:0009583,increased keratinocyte proliferation|MP:0010771,integument phenotype
MGI:6336095	Slx1b<em1(IMPC)Ics>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005238,increased brain size|MP:0008221,abnormal hippocampal commissure morphology|MP:0012443,increased corpus callosum size|MP:0012459,increased dentate gyrus size
MGI:5559221	Slx1b<tm1.1Jrou>	MP:0004030,induced chromosome breakage|MP:0005389,reproductive system phenotype|MP:0008058,abnormal DNA repair|MP:0008943,increased sensitivity to induced cell death
MGI:5806336	Slx4<m1Btlr>	MP:0001262,decreased body weight
MGI:5559219	Slx4<tm1.2Jrou>	MP:0001147,small testis|MP:0004030,induced chromosome breakage|MP:0008058,abnormal DNA repair|MP:0008943,increased sensitivity to induced cell death|MP:0011100,preweaning lethality, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4432843	Slx4<tm1a(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0000221,decreased leukocyte cell number|MP:0000438,abnormal cranium morphology|MP:0000439,enlarged cranium|MP:0000440,domed cranium|MP:0000788,abnormal cerebral cortex morphology|MP:0000825,dilated lateral ventricle|MP:0000826,abnormal third ventricle morphology|MP:0000917,obstructive hydrocephaly|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001317,abnormal pupil morphology|MP:0001322,abnormal iris morphology|MP:0001333,absent optic nerve|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002092,abnormal eye morphology|MP:0002100,abnormal tooth morphology|MP:0002401,abnormal lymphopoiesis|MP:0002687,oligozoospermia|MP:0002697,abnormal eye size|MP:0002792,abnormal retina vasculature morphology|MP:0003131,increased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0003631,nervous system phenotype|MP:0003671,abnormal eyelid aperture|MP:0004174,abnormal spine curvature|MP:0004609,vertebral fusion|MP:0004805,absent oocytes|MP:0005159,azoospermia|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0006241,abnormal placement of pupils|MP:0006254,thin cerebral cortex|MP:0008008,early cellular replicative senescence|MP:0008280,abnormal male germ cell apoptosis|MP:0008391,abnormal primordial germ cell morphology|MP:0008813,decreased common myeloid progenitor cell number|MP:0008866,chromosomal instability|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008943,increased sensitivity to induced cell death|MP:0010102,increased caudal vertebrae number|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5552807	Slx4<tm1Jrou>	MP:0010207,abnormal telomere morphology
MGI:5780134	Slx9<tm1b(EUCOMM)Hmgu>	MP:0004738,abnormal auditory brainstem response
MGI:6423425	Slx<em1.1Jbmu>	MP:0002169,no abnormal phenotype detected
MGI:6423420	Slxl1<em1.1Jbmu>	MP:0004179,transmission ratio distortion|MP:0005389,reproductive system phenotype
MGI:6423421	Slxl1<em1.2Jbmu>	MP:0005389,reproductive system phenotype
MGI:5425011	SMA010	MP:0000194,increased circulating calcium level|MP:0001265,decreased body size|MP:0002968,increased circulating alkaline phosphatase level
MGI:2386127	Smad1<tm1Abr>	MP:0002169,no abnormal phenotype detected|MP:0010768,mortality/aging
MGI:2157982	Smad1<tm1Rjle>	MP:0000841,abnormal hindbrain morphology|MP:0000897,abnormal midbrain morphology|MP:0001056,abnormal cranial nerve morphology|MP:0001077,abnormal spinal nerve morphology|MP:0001726,abnormal allantois morphology|MP:0002082,postnatal lethality|MP:0002151,abnormal neural tube morphology|MP:0005385,cardiovascular system phenotype|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2155483	Smad1<tm1Rob>	MP:0000292,distended pericardium|MP:0001672,abnormal embryo development|MP:0001680,abnormal mesoderm development|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001711,abnormal placenta morphology|MP:0001726,abnormal allantois morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0002836,abnormal chorion morphology|MP:0003384,abnormal ventral body wall morphology|MP:0003886,abnormal embryonic epiblast morphology|MP:0003988,disorganized embryonic tissue|MP:0008392,decreased primordial germ cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0012134,absent umbilical cord
MGI:3045218	Smad1<tm1Sor>	MP:0000291,enlarged pericardium|MP:0001700,abnormal embryo turning|MP:0001726,abnormal allantois morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0004073,caudal body truncation|MP:0005221,abnormal rostral-caudal axis patterning|MP:0008393,absent primordial germ cells|MP:0010736,abnormal extraembryonic ectoderm morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012157,rostral body truncation
MGI:3805956	Smad1<tm1Tako>	MP:0004558,delayed allantois development|MP:0006301,abnormal mesenchyme morphology|MP:0008392,decreased primordial germ cell number|MP:0008393,absent primordial germ cells|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2155484	Smad1<tm2Rob>	MP:0005389,reproductive system phenotype
MGI:3045219	Smad1<tm2Sor>	MP:0000358,abnormal cell morphology|MP:0000470,abnormal stomach morphology|MP:0001145,abnormal male reproductive system morphology|MP:0001147,small testis|MP:0001921,reduced fertility|MP:0004139,abnormal gastric parietal cell morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0006419,disorganized testis cords|MP:0008393,absent primordial germ cells
MGI:2447199	Smad2<m1Mag>	MP:0000267,abnormal heart development|MP:0000270,abnormal heart tube morphology|MP:0000932,absent notochord|MP:0002085,abnormal embryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0004787,abnormal dorsal aorta morphology|MP:0009657,failure of chorioallantoic fusion|MP:0011092,embryonic lethality, complete penetrance|MP:0012083,absent foregut|MP:0012157,rostral body truncation|MP:0012170,absent optic placodes
MGI:3703160	Smad2<tm1.1Epb>	MP:0000607,abnormal hepatocyte morphology|MP:0003091,abnormal cell migration|MP:0003893,increased hepatocyte proliferation|MP:0005076,abnormal cell differentiation|MP:0005370,liver/biliary system phenotype|MP:0010080,abnormal hepatocyte physiology
MGI:3512448	Smad2<tm1.1Mwst>	MP:0002169,no abnormal phenotype detected
MGI:5085284	Smad2<tm1.1Nomu>	MP:0000745,tremors|MP:0000849,abnormal cerebellum morphology|MP:0000857,abnormal cerebellar foliation|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0001525,impaired balance|MP:0002083,premature death|MP:0003203,increased neuron apoptosis|MP:0003312,abnormal locomotor coordination|MP:0003631,nervous system phenotype|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004998,decreased CNS synapse formation|MP:0008489,slow postnatal weight gain|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0009977,abnormal cerebellar granule cell migration|MP:0009992,abnormal cerebellum vermis lobule IX morphology|MP:0009997,abnormal cerebellum vermis lobule X morphology
MGI:3512449	Smad2<tm1.2Mwst>	MP:0001698,decreased embryo size|MP:0002084,abnormal developmental patterning
MGI:1857694	Smad2<tm1Cxd>	MP:0000458,abnormal mandible morphology|MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001724,abnormal extraembryonic endoderm formation|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002092,abnormal eye morphology|MP:0002583,absent extraembryonic ectoderm|MP:0003085,abnormal egg cylinder morphology|MP:0003087,absent allantois|MP:0005030,absent amnion|MP:0005032,abnormal ectoplacental cone morphology|MP:0005587,abnormal Meckel's cartilage morphology|MP:0009593,absent chorion|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012724,absent head fold|MP:0014586,decreased egg cylinder size
MGI:1857692	Smad2<tm1Enl>	MP:0000087,absent mandible|MP:0000428,abnormal craniofacial morphology|MP:0000458,abnormal mandible morphology|MP:0000460,mandible hypoplasia|MP:0001286,abnormal eye development|MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001698,decreased embryo size|MP:0001705,abnormal proximal-distal axis patterning|MP:0001724,abnormal extraembryonic endoderm formation|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003087,absent allantois|MP:0003886,abnormal embryonic epiblast morphology|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0003984,embryonic growth retardation|MP:0005030,absent amnion|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011092,embryonic lethality, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011197,abnormal proamniotic cavity morphology|MP:0012685,abnormal primitive streak elongation
MGI:2389478	Smad2<tm1Kato>	MP:0002084,abnormal developmental patterning|MP:0002086,abnormal extraembryonic tissue morphology
MGI:3512447	Smad2<tm1Mwst>	MP:0002169,no abnormal phenotype detected
MGI:2179521	Smad2<tm1Rak>	MP:0002085,abnormal embryonic tissue morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:1857691	Smad2<tm1Rob>	MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0002085,abnormal embryonic tissue morphology|MP:0002836,abnormal chorion morphology|MP:0003886,abnormal embryonic epiblast morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0009331,absent primitive node|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013207,absent endoderm|MP:0013216,absent ectoderm
MGI:5305134	Smad2<tm1Xya>	MP:0002724,enhanced wound healing|MP:0005023,abnormal wound healing|MP:0012193,increased keratinocyte migration
MGI:2668416	Smad2<tm2.1Rob>	MP:0002085,abnormal embryonic tissue morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0006207,embryonic lethality during organogenesis
MGI:1857693	Smad2<tm2Enl>	MP:0000428,abnormal craniofacial morphology|MP:0000458,abnormal mandible morphology|MP:0001286,abnormal eye development|MP:0002085,abnormal embryonic tissue morphology|MP:0003984,embryonic growth retardation|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011092,embryonic lethality, complete penetrance
MGI:2389479	Smad2<tm2Kato>	MP:0002084,abnormal developmental patterning|MP:0002086,abnormal extraembryonic tissue morphology
MGI:2668393	Smad2<tm2Rob>	MP:0002169,no abnormal phenotype detected
MGI:3527155	Smad2<tm3Rob>	MP:0002169,no abnormal phenotype detected
MGI:3527156	Smad2<tm4(SMADH3)Rob>	MP:0000433,microcephaly|MP:0000914,exencephaly|MP:0003232,abnormal forebrain development|MP:0005157,holoprosencephaly|MP:0006108,abnormal hindbrain development|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5775197	Smad2<tm5(SMAD2)Rob>	MP:0011092,embryonic lethality, complete penetrance
MGI:6399910	Smad3<em1(IMPC)H>	MP:0001417,decreased exploration in new environment|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005016,decreased lymphocyte cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:1857695	Smad3<tm1Cxd>	MP:0000063,decreased bone mineral density|MP:0000069,kyphoscoliosis|MP:0000150,abnormal rib morphology|MP:0000160,kyphosis|MP:0000163,abnormal cartilage morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000477,abnormal intestine morphology|MP:0000550,abnormal forelimb morphology|MP:0000685,abnormal immune system morphology|MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0000702,enlarged lymph nodes|MP:0000997,abnormal synovial joint capsule morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001392,abnormal locomotor behavior|MP:0001533,abnormal skeleton physiology|MP:0001823,thymus hypoplasia|MP:0001824,abnormal thymus involution|MP:0001828,abnormal T cell activation|MP:0001846,increased inflammatory response|MP:0001869,pancreas inflammation|MP:0001873,stomach inflammation|MP:0001923,reduced female fertility|MP:0002083,premature death|MP:0002442,abnormal leukocyte physiology|MP:0002444,abnormal T cell physiology|MP:0002724,enhanced wound healing|MP:0002816,colitis|MP:0002932,abnormal joint morphology|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0003200,calcified joint|MP:0003215,renal interstitial fibrosis|MP:0003306,small intestinal inflammation|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003453,abnormal keratinocyte physiology|MP:0003560,osteoarthritis|MP:0004041,increased susceptibility to kidney reperfusion injury|MP:0004154,renal tubular necrosis|MP:0004883,abnormal vascular wound healing|MP:0004967,abnormal kidney epithelium morphology|MP:0005104,abnormal tarsal bone morphology|MP:0005166,decreased susceptibility to injury|MP:0005367,renal/urinary system phenotype|MP:0005553,increased circulating creatinine level|MP:0006395,abnormal epiphyseal plate morphology|MP:0006433,abnormal articular cartilage morphology|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008466,enlarged mesenteric lymph nodes|MP:0008720,impaired neutrophil chemotaxis|MP:0008783,decreased B cell apoptosis|MP:0008872,abnormal physiological response to xenobiotic|MP:0011120,increased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0011372,decreased renal tubule apoptosis|MP:0011405,tubulointerstitial nephritis|MP:0031381,decreased secondary ovarian follicle number
MGI:1857592	Smad3<tm1Par>	MP:0000420,ruffled hair|MP:0000493,rectal prolapse|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0001272,increased metastatic potential|MP:0001504,abnormal posture|MP:0001846,increased inflammatory response|MP:0002083,premature death|MP:0002161,abnormal fertility/fecundity|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0003009,abnormal cytokine secretion|MP:0003270,intestinal obstruction|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0005202,lethargy|MP:0005554,decreased circulating creatinine level|MP:0005566,decreased blood urea nitrogen level|MP:0008595,abnormal circulating interleukin-6 level|MP:0008706,decreased interleukin-6 secretion
MGI:3839291	Smad3<tm1Sche>	MP:0001260,increased body weight|MP:0003918,decreased kidney weight|MP:0005554,decreased circulating creatinine level|MP:0005566,decreased blood urea nitrogen level|MP:0008872,abnormal physiological response to xenobiotic|MP:0011338,abnormal mesangial matrix morphology|MP:0011349,abnormal renal glomerulus basement membrane thickness
MGI:1857696	Smad3<tm1Xfw>	MP:0000150,abnormal rib morphology|MP:0000157,abnormal sternum morphology|MP:0000160,kyphosis|MP:0000350,abnormal cell proliferation|MP:0000554,abnormal carpal bone morphology|MP:0001265,decreased body size|MP:0003009,abnormal cytokine secretion|MP:0004624,abnormal thoracic cage morphology|MP:0005094,abnormal T cell proliferation|MP:0005109,abnormal talus morphology|MP:0005153,abnormal B cell proliferation|MP:0005387,immune system phenotype
MGI:2449701	Smad4<E6sad>	MP:0002404,increased intestinal adenoma incidence|MP:0003269,colon polyps|MP:0003299,gastric polyps|MP:0003984,embryonic growth retardation|MP:0005493,stomach epithelial hyperplasia|MP:0008011,intestine polyps|MP:0010301,increased stomach tumor incidence|MP:0011091,prenatal lethality, complete penetrance|MP:0014237,decreased tumor-free survival time
MGI:2447202	Smad4<m1Mag>	MP:0002169,no abnormal phenotype detected
MGI:2447204	Smad4<m2Mag>	MP:0002169,no abnormal phenotype detected
MGI:2447207	Smad4<m3Mag>	MP:0002169,no abnormal phenotype detected
MGI:2447208	Smad4<m4Mag>	MP:0000473,abnormal stomach glandular epithelium morphology|MP:0000489,abnormal large intestine morphology|MP:0000494,abnormal cecum morphology|MP:0000496,abnormal small intestine morphology|MP:0001683,absent mesoderm|MP:0001696,failure to gastrulate|MP:0002020,increased tumor incidence|MP:0003271,abnormal duodenum morphology|MP:0003299,gastric polyps|MP:0003984,embryonic growth retardation|MP:0005210,disorganized stomach mucosa|MP:0008000,increased ovary tumor incidence|MP:0008014,increased lung tumor incidence|MP:0010301,increased stomach tumor incidence|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5792845	Smad4<tm1.1Gsu>	MP:0005379,endocrine/exocrine gland phenotype
MGI:3624263	Smad4<tm1.1Rob>	MP:0001685,abnormal endoderm development|MP:0001705,abnormal proximal-distal axis patterning|MP:0003886,abnormal embryonic epiblast morphology|MP:0010301,increased stomach tumor incidence|MP:0011186,abnormal visceral endoderm morphology
MGI:1857698	Smad4<tm1Cxd>	MP:0000352,decreased cell proliferation|MP:0001683,absent mesoderm|MP:0001685,abnormal endoderm development|MP:0001693,failure of primitive streak formation|MP:0001694,absent egg cylinders|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0002584,small ectoplacental cone|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance|MP:0011192,decreased embryonic epiblast cell proliferation|MP:0012095,increased Reichert's membrane thickness|MP:0012113,decreased inner cell mass proliferation
MGI:1858049	Smad4<tm1Mak>	MP:0000352,decreased cell proliferation|MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0002582,disorganized extraembryonic tissue|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0012157,rostral body truncation
MGI:1857697	Smad4<tm1Mmt>	MP:0003299,gastric polyps|MP:0008012,duodenum polyps|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3693621	Smad4<tm1Rdp>	MP:0005379,endocrine/exocrine gland phenotype|MP:0008012,duodenum polyps
MGI:2386393	Smad4<tm2.1Cxd>	MP:0000060,delayed bone ossification|MP:0000063,decreased bone mineral density|MP:0000120,malocclusion|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000284,double outlet right ventricle|MP:0000298,absent atrioventricular cushions|MP:0000377,abnormal hair follicle morphology|MP:0000381,enlarged hair follicles|MP:0000414,alopecia|MP:0000558,abnormal tibia morphology|MP:0000652,enlarged sebaceous gland|MP:0000706,small thymus|MP:0000880,decreased Purkinje cell number|MP:0000889,abnormal cerebellar molecular layer|MP:0001200,thick skin|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001265,decreased body size|MP:0002006,neoplasm|MP:0002038,increased carcinoma incidence|MP:0002051,increased skin papilloma incidence|MP:0002073,abnormal hair growth|MP:0002083,premature death|MP:0002100,abnormal tooth morphology|MP:0002574,increased vertical activity|MP:0002576,abnormal enamel morphology|MP:0002655,abnormal keratinocyte morphology|MP:0002764,short tibia|MP:0003229,abnormal vitelline vasculature morphology|MP:0003396,abnormal embryonic hematopoiesis|MP:0003413,hair follicle degeneration|MP:0003453,abnormal keratinocyte physiology|MP:0003705,abnormal hypodermis morphology|MP:0003763,abnormal thymus physiology|MP:0003875,abnormal hair follicle regression|MP:0003920,abnormal heart right ventricle morphology|MP:0004067,abnormal trabecula carnea morphology|MP:0004148,increased compact bone thickness|MP:0004214,abnormal long bone diaphysis morphology|MP:0004337,clavicle hypoplasia|MP:0004675,rib fractures|MP:0004734,small thoracic cavity|MP:0004985,decreased osteoclast cell number|MP:0005006,abnormal osteoblast physiology|MP:0005169,abnormal male meiosis|MP:0005381,digestive/alimentary phenotype|MP:0008156,decreased diameter of tibia|MP:0008753,abnormal osteocyte morphology|MP:0009583,increased keratinocyte proliferation|MP:0009715,thick epidermis stratum basale|MP:0009931,abnormal skin appearance|MP:0010224,abnormal heart ventricle outflow tract morphology|MP:0010300,increased skin tumor incidence|MP:0010402,ventricular septal defect|MP:0010556,thin ventricle myocardium compact layer|MP:0010690,thick hair follicle outer root sheath|MP:0010970,abnormal compact bone lamellar structure|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011642,abnormal bone collagen fibril morphology|MP:0014659,increased skin stiffness|MP:0030079,small incisors
MGI:3819836	Smad4<tm2.1Rob>	MP:0002169,no abnormal phenotype detected
MGI:2386394	Smad4<tm2.2Cxd>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2386390	Smad4<tm2Cxd>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3819843	Smad4<tm3Rob>	MP:0002169,no abnormal phenotype detected
MGI:2679443	Smad5<tm1.1Huy>	MP:0000267,abnormal heart development|MP:0000474,abnormal foregut morphology|MP:0000928,incomplete rostral neuropore closure|MP:0001622,abnormal vasculogenesis|MP:0001718,abnormal visceral yolk sac morphology|MP:0001722,pale yolk sac|MP:0001726,abnormal allantois morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002123,abnormal definitive hematopoiesis|MP:0004068,dilated dorsal aorta|MP:0004180,failure of initiation of embryo turning|MP:0005029,abnormal amnion morphology
MGI:1857699	Smad5<tm1Cxd>	MP:0000259,abnormal vascular development|MP:0000955,abnormal spinal cord morphology|MP:0001680,abnormal mesoderm development|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001719,absent vitelline blood vessels|MP:0001722,pale yolk sac|MP:0001723,disorganized yolk sac vascular plexus|MP:0001914,hemorrhage|MP:0002976,vascular smooth muscle hypotrophy|MP:0003229,abnormal vitelline vasculature morphology|MP:0003396,abnormal embryonic hematopoiesis|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004787,abnormal dorsal aorta morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005602,decreased angiogenesis|MP:0006029,abnormal sclerotome morphology|MP:0006042,increased apoptosis|MP:0006055,abnormal vascular endothelial cell morphology|MP:0009656,delayed chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012136,absent forebrain
MGI:2679441	Smad5<tm1Huy>	MP:0002169,no abnormal phenotype detected|MP:0005389,reproductive system phenotype
MGI:1857666	Smad5<tm1Zuk>	MP:0000270,abnormal heart tube morphology|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0001614,abnormal blood vessel morphology|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001706,abnormal left-right axis patterning|MP:0001722,pale yolk sac|MP:0001726,abnormal allantois morphology|MP:0001785,edema|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002085,abnormal embryonic tissue morphology|MP:0002621,delayed neural tube closure|MP:0002884,abnormal pharyngeal arch morphology|MP:0003119,abnormal digestive system development|MP:0003384,abnormal ventral body wall morphology|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004251,failure of heart looping|MP:0005029,abnormal amnion morphology|MP:0008392,decreased primordial germ cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012082,delayed heart development
MGI:5316777	Smad6<b2b390Clo>	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0006123,tricuspid valve atresia|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011665,d-loop transposition of the great arteries
MGI:2181630	Smad6<tm1Glvn>	MP:0000249,abnormal blood vessel physiology|MP:0000266,abnormal heart morphology|MP:0000272,abnormal aorta morphology|MP:0000285,abnormal heart valve morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001633,poor circulation|MP:0002842,increased systemic arterial blood pressure|MP:0003958,heart valve hyperplasia|MP:0003974,abnormal endocardium morphology|MP:0005048,abnormal thrombosis|MP:0005591,decreased vasodilation|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0010454,abnormal truncus arteriosus septation|MP:0010551,abnormal coronary vessel morphology|MP:0010768,mortality/aging|MP:0011110,preweaning lethality, incomplete penetrance|MP:0031524,mitral valve hyperplasia|MP:0031529,pulmonary valve hyperplasia
MGI:3876176	Smad7<Gt(YHC053)Byg>	MP:0000111,cleft palate|MP:0000703,abnormal thymus morphology|MP:0001823,thymus hypoplasia|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0010402,ventricular septal defect
MGI:5426017	Smad7<tm1.1Ink>	MP:0000753,paralysis|MP:0001830,decreased activated T cell number|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008567,decreased interferon-gamma secretion|MP:0008712,decreased interleukin-9 secretion|MP:0008837,increased transforming growth factor beta level
MGI:3839577	Smad7<tm1.1Shou>	MP:0000267,abnormal heart development|MP:0000297,abnormal atrioventricular cushion morphology|MP:0001265,decreased body size|MP:0001636,irregular heartbeat|MP:0001786,skin edema|MP:0002128,abnormal blood circulation|MP:0002925,abnormal cardiovascular development|MP:0003717,pallor|MP:0003898,abnormal QRS complex|MP:0004067,abnormal trabecula carnea morphology|MP:0004110,transposition of great arteries|MP:0005140,decreased cardiac muscle contractility|MP:0005294,abnormal heart ventricle morphology|MP:0010402,ventricular septal defect|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance|MP:0021160,decreased heart right ventricle wall thickness
MGI:5426021	Smad7<tm1.2Ink>	MP:0011100,preweaning lethality, complete penetrance
MGI:5567932	Smad7<tm1Gkg>	MP:0003339,decreased pancreatic beta cell number|MP:0009175,abnormal pancreatic beta cell differentiation|MP:0009177,decreased pancreatic alpha cell number
MGI:5585420	Smad7<tm1Gkh>	MP:0002169,no abnormal phenotype detected|MP:0009278,abnormal bone marrow cell physiology
MGI:3707713	Smad7<tm1Rheu>	MP:0001262,decreased body weight|MP:0001935,decreased litter size|MP:0004816,abnormal class switch recombination|MP:0005093,decreased B cell proliferation|MP:0008782,increased B cell apoptosis|MP:0009703,decreased birth body size|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3839575	Smad7<tm1Shou>	MP:0000267,abnormal heart development|MP:0000297,abnormal atrioventricular cushion morphology|MP:0001265,decreased body size|MP:0001636,irregular heartbeat|MP:0001786,skin edema|MP:0002128,abnormal blood circulation|MP:0002925,abnormal cardiovascular development|MP:0003717,pallor|MP:0003898,abnormal QRS complex|MP:0004067,abnormal trabecula carnea morphology|MP:0004110,transposition of great arteries|MP:0005140,decreased cardiac muscle contractility|MP:0005294,abnormal heart ventricle morphology|MP:0010402,ventricular septal defect|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance|MP:0021160,decreased heart right ventricle wall thickness
MGI:3581767	Smad9<tm1.1Mwst>	MP:0002169,no abnormal phenotype detected
MGI:3769363	Smad9<tm1Jfm>	MP:0005380,embryo phenotype
MGI:3581766	Smad9<tm1Mwst>	MP:0000841,abnormal hindbrain morphology|MP:0000897,abnormal midbrain morphology
MGI:3701868	Smad9<tm1Rob>	MP:0002169,no abnormal phenotype detected
MGI:3701870	Smad9<tm2.1Rob>	MP:0002169,no abnormal phenotype detected
MGI:5514164	Smad9<tm2Rob>	MP:0002169,no abnormal phenotype detected
MGI:3850120	Smad9<tm3Jfm>	MP:0001861,lung inflammation|MP:0002048,increased lung adenoma incidence|MP:0004007,abnormal lung vasculature morphology|MP:0005380,embryo phenotype
MGI:5692839	Smagp<tm1b(KOMP)Mbp>	MP:0003960,increased lean body mass|MP:0005553,increased circulating creatinine level|MP:0005635,decreased circulating bilirubin level
MGI:5503229	Smap1<tm1.1Sata>	MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0000321,increased bone marrow cell number|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000746,weakness|MP:0001402,decreased locomotor activity|MP:0001504,abnormal posture|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0002026,increased leukemia incidence|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002416,abnormal proerythroblast morphology|MP:0002417,abnormal megakaryocyte morphology|MP:0002429,abnormal blood cell morphology/development|MP:0002447,abnormal erythrocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002811,macrocytic anemia|MP:0002874,decreased hemoglobin content|MP:0003131,increased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0003179,thrombocytopenia|MP:0004720,abnormal platelet morphology|MP:0005065,abnormal neutrophil morphology|MP:0005097,polychromatophilia|MP:0010178,increased number of Howell-Jolly bodies|MP:0030951,abnormal endocytosis
MGI:5762694	Smap2<tm1Sata>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0005389,reproductive system phenotype|MP:0008898,abnormal acrosome morphology|MP:0009231,detached acrosome|MP:0009377,ectopic manchette|MP:0009647,decreased fertilization frequency|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0031354,abnormal acrosome assembly|MP:0031355,abnormal proacrosomal vesicle fusion|MP:0031389,abnormal ectoplasmic specialization morphology
MGI:5427348	Smarca1<tm1.1Pick>	MP:0000434,megacephaly|MP:0000788,abnormal cerebral cortex morphology|MP:0000789,thickened cerebral cortex|MP:0000934,abnormal telencephalon development|MP:0002176,increased brain weight|MP:0002833,increased heart weight|MP:0004046,abnormal mitosis|MP:0004948,abnormal neuronal precursor proliferation|MP:0005386,behavior/neurological phenotype|MP:0009937,abnormal neuron differentiation|MP:0014560,increased cortical ventricular zone cell density
MGI:5427347	Smarca1<tm1Pick>	MP:0002169,no abnormal phenotype detected
MGI:6361439	Smarca2<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001566,increased circulating phosphate level|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level
MGI:2387988	Smarca2<tm1Mya>	MP:0001260,increased body weight|MP:0001924,infertility|MP:0002106,abnormal muscle physiology|MP:0005390,skeleton phenotype
MGI:5313991	Smarca4<b2b508.1Clo>	MP:0000284,double outlet right ventricle|MP:0000433,microcephaly|MP:0001293,anophthalmia|MP:0002639,micrognathia|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010413,complete atrioventricular septal defect
MGI:5316781	Smarca4<b2b692Clo>	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0011684,coronary-cameral fistula to heart right ventricle
MGI:5898019	Smarca4<mos6>	MP:0011092,embryonic lethality, complete penetrance
MGI:5578505	Smarca4<tm1.1Axvi>	MP:0002169,no abnormal phenotype detected
MGI:5645479	Smarca4<tm1.1Grc>	MP:0002169,no abnormal phenotype detected
MGI:5009421	Smarca4<tm1.1Pcn>	MP:0001575,cyanosis|MP:0003139,patent ductus arteriosus|MP:0010402,ventricular septal defect
MGI:3605892	Smarca4<tm1.2Pcn>	MP:0000274,enlarged heart|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000556,abnormal hindlimb morphology|MP:0001196,shiny skin|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0002060,abnormal skin morphology|MP:0002081,perinatal lethality|MP:0002110,abnormal digit morphology|MP:0002746,abnormal semilunar valve morphology|MP:0002747,abnormal aortic valve morphology|MP:0002796,impaired skin barrier function|MP:0003800,monodactyly|MP:0003853,dry skin|MP:0003857,abnormal hindlimb zeugopod morphology|MP:0004111,abnormal coronary artery morphology|MP:0005089,decreased double-negative T cell number|MP:0005294,abnormal heart ventricle morphology|MP:0005330,cardiomyopathy|MP:0005385,cardiovascular system phenotype|MP:0006126,abnormal cardiac outflow tract development|MP:0008037,abnormal T cell morphology|MP:0009783,abnormal melanoblast morphology|MP:0010418,perimembraneous ventricular septal defect|MP:0010453,abnormal coronary vein morphology|MP:0010482,abnormal aortic sinus morphology|MP:0010484,bicuspid aortic valve|MP:0010593,thick aortic valve cusps|MP:0010594,thick aortic valve|MP:0010595,abnormal aortic valve cusp morphology|MP:0010601,thick pulmonary valve|MP:0010602,abnormal pulmonary valve cusp morphology|MP:0010656,thick myocardium|MP:0010768,mortality/aging|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011648,thick heart valve cusps
MGI:2386105	Smarca4<tm1Mag>	MP:0000914,exencephaly|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002020,increased tumor incidence|MP:0003789,increased osteosarcoma incidence|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3830390	Smarca4<tm1Tich>	MP:0000715,decreased thymocyte number|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0008083,decreased single-positive T cell number
MGI:3586551	Smarca5<MommeD4>	MP:0011100,preweaning lethality, complete penetrance
MGI:2683166	Smarca5<tm1.1Ais>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2683154	Smarca5<tm1Ais>	MP:0001672,abnormal embryo development|MP:0001730,embryonic growth arrest|MP:0002006,neoplasm|MP:0004965,inner cell mass degeneration|MP:0010380,abnormal inner cell mass apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation|MP:0012119,increased trophectoderm apoptosis|MP:0012120,trophectoderm cell degeneration
MGI:2177962	Smarcad1<Gt(6LSN)6028Gos>	MP:0002169,no abnormal phenotype detected
MGI:5692886	Smarcad1<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0001491,unresponsive to tactile stimuli|MP:0001510,abnormal coat appearance|MP:0001697,abnormal embryo size|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2177964	Smarcad1<tm1Gos>	MP:0000154,rib fusion|MP:0000462,abnormal digestive system morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001625,cardiac hypertrophy|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002114,abnormal axial skeleton morphology|MP:0002161,abnormal fertility/fecundity|MP:0003047,abnormal thoracic vertebrae morphology|MP:0004174,abnormal spine curvature|MP:0004200,decreased fetal size|MP:0004321,short sternum|MP:0004621,lumbar vertebral fusion|MP:0004678,split xiphoid process|MP:0005387,immune system phenotype|MP:0005431,decreased oocyte number|MP:0008146,asymmetric sternocostal joints|MP:0008148,abnormal sternocostal joint morphology|MP:0009703,decreased birth body size|MP:0010103,small thoracic cage|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5425295	Smarcal1<tm1.1Cfbo>	MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002871,albuminuria|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004704,short vertebral column|MP:0005017,decreased B cell number|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011704,decreased fibroblast proliferation
MGI:4433467	Smarcal1<tm1a(EUCOMM)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content
MGI:7520876	Smarcb1<em1Koke>	MP:0000825,dilated lateral ventricle|MP:0000917,obstructive hydrocephaly|MP:0002006,neoplasm|MP:0002958,cerebral aqueductal stenosis|MP:0003631,nervous system phenotype|MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0006254,thin cerebral cortex|MP:0008489,slow postnatal weight gain|MP:0011380,enlarged brain ventricles
MGI:2388033	Smarcb1<Gt(OST32815)Lex>	MP:0001728,failure of embryo implantation|MP:0002020,increased tumor incidence|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011093,embryonic lethality at implantation, complete penetrance|MP:0012114,absent inner cell mass proliferation|MP:0012118,absent trophectoderm cell proliferation
MGI:5609344	Smarcb1<tm1b(EUCOMM)Hmgu>	MP:0000221,decreased leukocyte cell number|MP:0001510,abnormal coat appearance|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005567,decreased circulating total protein level|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration|MP:0013292,embryonic lethality prior to organogenesis
MGI:3603561	Smarcb1<tm1Gvk>	MP:0002020,increased tumor incidence|MP:0008018,increased facial tumor incidence|MP:0008021,increased blastoma incidence|MP:0009277,increased brain tumor incidence|MP:0011091,prenatal lethality, complete penetrance
MGI:2387974	Smarcb1<tm1Mya>	MP:0001728,failure of embryo implantation|MP:0002032,increased sarcoma incidence|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0010380,abnormal inner cell mass apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012119,increased trophectoderm apoptosis
MGI:1931875	Smarcb1<tm1Sho>	MP:0002018,increased malignant tumor incidence|MP:0002020,increased tumor incidence|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0014237,decreased tumor-free survival time
MGI:2447707	Smarcb1<tm2Sho>	MP:0000780,abnormal corpus callosum morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000921,demyelination|MP:0001935,decreased litter size|MP:0002006,neoplasm|MP:0005405,axon degeneration|MP:0006254,thin cerebral cortex|MP:0008026,abnormal brain white matter morphology|MP:0009977,abnormal cerebellar granule cell migration|MP:0011091,prenatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2154523	Smarcc1<tm1Rhs>	MP:0000783,abnormal forebrain morphology|MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0000787,abnormal telencephalon morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000826,abnormal third ventricle morphology|MP:0000830,abnormal diencephalon morphology|MP:0000914,exencephaly|MP:0001694,absent egg cylinders|MP:0002085,abnormal embryonic tissue morphology|MP:0002718,abnormal inner cell mass morphology|MP:0004838,abnormal neural fold elevation formation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0013207,absent endoderm
MGI:5426542	Smarcc1<tm2.1Rhs>	MP:0001802,arrested B cell differentiation|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002403,abnormal pre-B cell morphology|MP:0005017,decreased B cell number|MP:0005022,abnormal immature B cell morphology|MP:0005093,decreased B cell proliferation|MP:0005432,abnormal pro-B cell morphology|MP:0008174,decreased follicular B cell number|MP:0008208,decreased pro-B cell number|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008760,abnormal immunoglobulin heavy chain V(D)J recombination|MP:0008782,increased B cell apoptosis|MP:0014403,decreased early pro-B cell number|MP:0014404,decreased late pro-B cell number
MGI:6362053	Smarcc2<em1(IMPC)J>	MP:0002590,increased mean corpuscular volume|MP:0004738,abnormal auditory brainstem response|MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance|MP:0020870,decreased thigmotaxis
MGI:5431983	Smarcc2<tm1.1Grc>	MP:0002082,postnatal lethality
MGI:5504428	Smarcc2<tm1.1Stoy>	MP:0000789,thickened cerebral cortex|MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0004948,abnormal neuronal precursor proliferation|MP:0004979,abnormal neuronal precursor cell number|MP:0008547,abnormal neocortex morphology|MP:0008877,abnormal DNA methylation|MP:0009937,abnormal neuron differentiation
MGI:5504429	Smarcc2<tm1.2Stoy>	MP:0009430,increased embryo weight|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5912211	Smarcd1<tm1.1Jddl>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0002647,decreased intestinal cholesterol absorption|MP:0002942,decreased circulating alanine transaminase level|MP:0003982,increased cholesterol level|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005632,decreased circulating aspartate transaminase level|MP:0010027,increased liver cholesterol level|MP:0012338,decreased bile salt level|MP:0014480,increased feces cholesterol level
MGI:5558158	Smarcd2<tm1.1(KOMP)Vlcg>	MP:0001785,edema|MP:0002590,increased mean corpuscular volume|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011400,lethality, complete penetrance
MGI:5775819	Smarcd3<em1(IMPC)J>	MP:0001284,absent vibrissae|MP:0002080,prenatal lethality|MP:0002098,abnormal vibrissa morphology|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:6368006	Smarcd3<tm1.1Bbr>	MP:0000274,enlarged heart|MP:0000280,thin ventricular wall|MP:0000281,abnormal interventricular septum morphology|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002652,thin myocardium|MP:0002753,dilated heart left ventricle|MP:0003222,increased cardiomyocyte apoptosis|MP:0003233,prolonged QT interval|MP:0003393,decreased cardiac output|MP:0004090,abnormal sarcomere morphology|MP:0004937,dilated heart|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0005608,cardiac interstitial fibrosis|MP:0006138,congestive heart failure|MP:0006267,abnormal intercalated disk morphology|MP:0010392,prolonged QRS complex duration|MP:0010509,decreased P wave amplitude|MP:0010511,shortened PR interval|MP:0010634,increased QRS amplitude|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011925,abnormal heart echocardiography feature
MGI:6368007	Smarcd3<tm1.2Bbr>	MP:0000267,abnormal heart development|MP:0000280,thin ventricular wall|MP:0000281,abnormal interventricular septum morphology|MP:0000282,abnormal interatrial septum morphology|MP:0000297,abnormal atrioventricular cushion morphology|MP:0001914,hemorrhage|MP:0002189,abnormal myocardial trabeculae morphology|MP:0004057,thin myocardium compact layer|MP:0004084,abnormal cardiac muscle relaxation|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0004094,abnormal M line morphology|MP:0004937,dilated heart|MP:0010402,ventricular septal defect|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0011925,abnormal heart echocardiography feature|MP:0030567,abnormal I band morphology|MP:0031633,decreased heart left ventricle muscle contractility
MGI:6367829	Smarcd3<tm1Jddl>	MP:0002106,abnormal muscle physiology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005378,growth/size/body region phenotype|MP:0005559,increased circulating glucose level
MGI:6363556	Smarce1<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance|MP:0014134,abnormal embryo morphology|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:5474673	Smarce1<tm1Tich>	MP:0011091,prenatal lethality, complete penetrance
MGI:5474671	Smarce1<tm2Tich>	MP:0011091,prenatal lethality, complete penetrance
MGI:5779183	smas	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002066,abnormal motor capabilities/coordination/movement
MGI:1857047	smc	MP:0000131,abnormal long bone epiphysis morphology|MP:0000132,thickened long bone epiphysis|MP:0000133,abnormal long bone metaphysis morphology|MP:0000157,abnormal sternum morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000547,short limbs|MP:0000585,kinked tail|MP:0000588,thick tail|MP:0000592,short tail|MP:0001265,decreased body size|MP:0001926,female infertility|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0002111,abnormal tail morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0004672,short ribs|MP:0006395,abnormal epiphyseal plate morphology|MP:0008272,abnormal endochondral bone ossification|MP:0030876,abnormal costochondral joint morphology
MGI:3612278	Smc1a<tm1Mbk>	MP:0000313,abnormal cell death|MP:0004028,chromosome breakage|MP:0004045,abnormal cell cycle checkpoint function|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0008404,increased cellular sensitivity to methylmethanesulfonate induced cell death
MGI:4836167	Smc1b<m1Ham>	MP:0001925,male infertility|MP:0001926,female infertility|MP:0002682,decreased mature ovarian follicle number|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0008280,abnormal male germ cell apoptosis
MGI:3573932	Smc1b<tm1Jess>	MP:0001924,infertility|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis
MGI:4867229	Smc1b<tm2.1Jess>	MP:0002169,no abnormal phenotype detected|MP:0005389,reproductive system phenotype
MGI:5703880	Smc2<tm1.2Hiran>	MP:0011092,embryonic lethality, complete penetrance
MGI:7384685	Smc3<tm1.1Toshi>	MP:0000111,cleft palate|MP:0001265,decreased body size|MP:0001363,increased anxiety-related response|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0004998,decreased CNS synapse formation|MP:0005352,small cranium|MP:0011380,enlarged brain ventricles|MP:0020337,abnormal pyramidal neuron dendrite morphology
MGI:7384686	Smc3<tm1.2Toshi>	MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0003631,nervous system phenotype|MP:0004998,decreased CNS synapse formation|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0011092,embryonic lethality, complete penetrance|MP:0020337,abnormal pyramidal neuron dendrite morphology|MP:0020508,decreased dendritic spine density|MP:0020510,increased dendritic spine length|MP:0020512,abnormal dendritic mushroom spine morphology|MP:0020514,abnormal dendritic thin spine morphology|MP:0020551,abnormal postsynaptic density morphology
MGI:4434007	Smc3<tm1a(EUCOMM)Wtsi>	MP:0000428,abnormal craniofacial morphology|MP:0001262,decreased body weight|MP:0002075,abnormal coat/hair pigmentation|MP:0003961,decreased lean body mass|MP:0005015,increased T cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:5602831	Smc5<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0000745,tremors|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance
MGI:4340573	Smc6<Gt(RRT274)Byg>	MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5695351	Smc6<tm1.1Arln>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000194,increased circulating calcium level|MP:0000218,increased leukocyte cell number|MP:0000248,macrocytosis|MP:0001516,abnormal motor coordination/balance|MP:0001973,increased thermal nociceptive threshold|MP:0005378,growth/size/body region phenotype|MP:0005505,thrombocytosis|MP:0005559,increased circulating glucose level|MP:0006086,decreased body mass index|MP:0008497,decreased IgG2b level|MP:0010025,decreased total body fat amount|MP:0010768,mortality/aging
MGI:5695349	Smc6<tm1Arln>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001935,decreased litter size|MP:0004200,decreased fetal size|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5613644	Smc6<tm1b(EUCOMM)Hmgu>	MP:0002965,increased circulating serum albumin level|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:6857746	Smchd1<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000470,abnormal stomach morphology|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3821492	Smchd1<Gt(AD0165)Wtsi>	MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3586547	Smchd1<MommeD1>	MP:0003787,abnormal imprinting|MP:0004256,abnormal maternal decidual layer morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0008877,abnormal DNA methylation|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5548583	Smco2<tm1b(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:2387973	Smcp<tm1Wen>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0004542,impaired acrosome reaction|MP:0005389,reproductive system phenotype|MP:0030976,impaired sperm penetration of zona pellucida
MGI:6272384	Smcr8<em1Btlr>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0003172,abnormal lysosome physiology|MP:0005058,abnormal lysosome morphology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008537,increased susceptibility to induced colitis|MP:0008560,increased tumor necrosis factor secretion|MP:0008647,increased circulating interleukin-12b level|MP:0008705,increased interleukin-6 secretion
MGI:6272388	Smcr8<em2Btlr>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008537,increased susceptibility to induced colitis|MP:0008560,increased tumor necrosis factor secretion|MP:0008647,increased circulating interleukin-12b level|MP:0008705,increased interleukin-6 secretion
MGI:6272372	Smcr8<m1Btlr>	MP:0008537,increased susceptibility to induced colitis|MP:0008560,increased tumor necrosis factor secretion
MGI:6272382	Smcr8<m2Btlr>	MP:0008537,increased susceptibility to induced colitis|MP:0008560,increased tumor necrosis factor secretion
MGI:6272383	Smcr8<m3Btlr>	MP:0008537,increased susceptibility to induced colitis|MP:0008560,increased tumor necrosis factor secretion
MGI:5812680	Smcr8<tm1.1(KOMP)Vlcg>	MP:0003172,abnormal lysosome physiology|MP:0008260,abnormal autophagy|MP:0008469,abnormal protein level
MGI:4452950	Smcr8<tm1(KOMP)Vlcg>	MP:0003172,abnormal lysosome physiology|MP:0008260,abnormal autophagy|MP:0008469,abnormal protein level
MGI:2656795	Smdq1<CAST/EiJ>	MP:0006037,abnormal mitochondrial fission
MGI:2656797	Smdq2<CAST/EiJ>	MP:0006037,abnormal mitochondrial fission
MGI:2656801	Smdq3<BALB/c>	MP:0006037,abnormal mitochondrial fission
MGI:6457286	Smdt1<em1Fink>	MP:0002169,no abnormal phenotype detected|MP:0005384,cellular phenotype
MGI:6457287	Smdt1<em2Fink>	MP:0001262,decreased body weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0010025,decreased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020414,abnormal fibroblast physiology
MGI:5548576	Smdt1<tm1b(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0001402,decreased locomotor activity|MP:0001491,unresponsive to tactile stimuli|MP:0011100,preweaning lethality, complete penetrance
MGI:6457374	Smdt1<tm1c(EUCOMM)Wtsi>	MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0006036,abnormal mitochondrial physiology
MGI:3876748	Smg1<Gt(AG0297)Wtsi>	MP:0000116,abnormal tooth development|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001264,increased body size|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002100,abnormal tooth morphology|MP:0002135,abnormal kidney morphology|MP:0002499,chronic inflammation|MP:0002628,hepatic steatosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005384,cellular phenotype|MP:0005390,skeleton phenotype|MP:0005397,hematopoietic system phenotype|MP:0008596,increased circulating interleukin-6 level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0009782,abnormal basicranium angle|MP:0010208,prognathia|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0012431,increased lymphoma incidence|MP:0014237,decreased tumor-free survival time
MGI:4338581	Smg1<Gt(RRT449)Byg>	MP:0000267,abnormal heart development|MP:0000352,decreased cell proliferation|MP:0001286,abnormal eye development|MP:0001634,internal hemorrhage|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0001889,delayed brain development|MP:0002925,abnormal cardiovascular development|MP:0004188,delayed embryo turning|MP:0004251,failure of heart looping|MP:0005621,abnormal cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis|MP:0030241,absent optic pit
MGI:5692718	Smg1<tm1b(EUCOMM)Hmgu>	MP:0005031,abnormal trophoblast layer morphology|MP:0005344,increased circulating bilirubin level|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:6152647	Smg5<em1(IMPC)Mbp>	MP:0001914,hemorrhage|MP:0003054,spina bifida|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:7716509	Smg5<tm1.2Litl>	MP:0011092,embryonic lethality, complete penetrance
MGI:6152648	Smg6<em1(IMPC)Mbp>	MP:0000208,decreased hematocrit|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001192,scaly skin|MP:0001486,abnormal startle reflex|MP:0002060,abnormal skin morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5493450	Smg6<Tg(SMN1*delta5)1Pks>	MP:0002169,no abnormal phenotype detected|MP:0008762,embryonic lethality
MGI:5763144	Smg6<tm1.1Zqw>	MP:0000358,abnormal cell morphology|MP:0005384,cellular phenotype|MP:0005621,abnormal cell physiology|MP:0010207,abnormal telomere morphology
MGI:5763145	Smg6<tm1.2Zqw>	MP:0003984,embryonic growth retardation|MP:0011091,prenatal lethality, complete penetrance|MP:0011103,embryonic lethality at implantation, incomplete penetrance|MP:0012113,decreased inner cell mass proliferation
MGI:6279899	Smg8<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5616624	Smg9<em1(IMPC)J>	MP:0000914,exencephaly|MP:0001297,microphthalmia|MP:0001399,hyperactivity|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002652,thin myocardium|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0004924,abnormal behavior|MP:0005560,decreased circulating glucose level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0009743,preaxial polydactyly|MP:0010412,atrioventricular septal defect|MP:0011085,postnatal lethality, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012089,decreased midbrain size|MP:0012263,decreased hindbrain size|MP:0020870,decreased thigmotaxis
MGI:5692712	Smg9<tm1b(EUCOMM)Wtsi>	MP:0000162,lordosis|MP:0000282,abnormal interatrial septum morphology|MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000520,absent kidney|MP:0000562,polydactyly|MP:0000602,dilated liver sinusoidal space|MP:0000632,abnormal pineal gland morphology|MP:0000914,exencephaly|MP:0001014,absent superior cervical ganglion|MP:0001015,small superior cervical ganglion|MP:0001293,anophthalmia|MP:0001303,abnormal lens morphology|MP:0001711,abnormal placenta morphology|MP:0002237,abnormal nasal cavity morphology|MP:0002725,abnormal vein morphology|MP:0003078,aphakia|MP:0003327,liver cyst|MP:0003387,aorta coarctation|MP:0003686,abnormal eye muscle morphology|MP:0004055,heart atrium hypoplasia|MP:0004164,abnormal neurohypophysis morphology|MP:0004259,small placenta|MP:0004269,abnormal optic cup morphology|MP:0004463,basisphenoid bone foramen|MP:0004612,fusion of vertebral bodies|MP:0005105,abnormal middle ear ossicle morphology|MP:0005262,coloboma|MP:0006011,abnormal endolymphatic duct morphology|MP:0006063,abnormal inferior vena cava morphology|MP:0006065,abnormal heart position or orientation|MP:0008922,abnormal cervical rib|MP:0008923,thoracoschisis|MP:0009770,abnormal optic chiasm morphology|MP:0009771,absent optic chiasm|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010490,abnormal inferior vena cava valve morphology|MP:0010572,persistent right dorsal aorta|MP:0010647,heart left atrium hypoplasia|MP:0011100,preweaning lethality, complete penetrance|MP:0011493,double ureter|MP:0011659,interrupted aortic arch, type b|MP:0013836,abnormal hypoglossal nerve topology|MP:0013840,absent segment of posterior cerebral artery|MP:0013848,subcutaneous edema|MP:0013876,absent ductus venosus valve|MP:0013877,abnormal ductus venosus valve morphology|MP:0013879,duplication of ductus venosus|MP:0013917,persistent right 6th pharyngeal arch artery|MP:0013969,reduced sympathetic cervical ganglion size|MP:0013970,absent connection between subcutaneous lymph vessels and lymph sac|MP:0013971,blood in lymph vessels|MP:0014021,heterochrony|MP:0020486,abnormal lens topology|MP:0020500,persistent trigeminal artery
MGI:2157103	Smgd1<BALB/cAnN>	MP:0002277,abnormal respiratory mucosa morphology
MGI:2157102	Smgd1<C57BL/6N>	MP:0002277,abnormal respiratory mucosa morphology
MGI:6317363	Smim20<em1(IMPC)J>	MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002891,increased insulin sensitivity|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005448,abnormal energy homeostasis|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0010392,prolonged QRS complex duration
MGI:7345511	Smim22<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response
MGI:6276890	Smim23<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology
MGI:6194728	Smim23<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:8278444	Smim26<em1Lenh>	MP:0002925,abnormal cardiovascular development|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6830924	Smim8<em1Ncvc>	MP:0005389,reproductive system phenotype
MGI:5708200	Smim8<tm1.1(KOMP)Vlcg>	MP:0001566,increased circulating phosphate level|MP:0002968,increased circulating alkaline phosphatase level|MP:0009142,decreased prepulse inhibition|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6830925	Smim9<em1Ncvc>	MP:0005389,reproductive system phenotype
MGI:1857048	smk	MP:0000371,diluted coat color|MP:0001144,vagina atresia|MP:0001940,testis hypoplasia
MGI:7748717	Smlr1<em1Jaku>	MP:0011091,prenatal lethality, complete penetrance
MGI:4836979	Smn1<tm1.1Dscd>	MP:0001402,decreased locomotor activity|MP:0002757,decreased vertical activity|MP:0009399,increased skeletal muscle fiber size|MP:0010053,decreased grip strength
MGI:2384155	Smn1<tm1.1Jme>	MP:0002169,no abnormal phenotype detected|MP:0011092,embryonic lethality, complete penetrance
MGI:4836030	Smn1<tm1Cdid>	MP:0001730,embryonic growth arrest|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2383990	Smn1<tm1Hung>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2384151	Smn1<tm1Jme>	MP:0000938,motor neuron degeneration|MP:0001071,abnormal facial nerve morphology|MP:0001078,abnormal phrenic nerve morphology|MP:0001263,weight loss|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0005405,axon degeneration
MGI:2183946	Smn1<tm1Msd>	MP:0001648,abnormal apoptosis|MP:0002085,abnormal embryonic tissue morphology|MP:0002663,absent blastocoele|MP:0003984,embryonic growth retardation|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5290070	Smn1<tm2Cdid>	MP:0000292,distended pericardium|MP:0001730,embryonic growth arrest|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3794065	Smn1<tm2Mrph>	MP:0011091,prenatal lethality, complete penetrance|MP:0011092,embryonic lethality, complete penetrance
MGI:3794199	Smn1<tm3(SMN2/Smn1)Mrph>	MP:0011091,prenatal lethality, complete penetrance
MGI:3794200	Smn1<tm4(SMN2)Mrph>	MP:0011092,embryonic lethality, complete penetrance
MGI:3794202	Smn1<tm5(Smn1/SMN2)Mrph>	MP:0000063,decreased bone mineral density|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001220,epidermal necrosis|MP:0001265,decreased body size|MP:0001614,abnormal blood vessel morphology|MP:0002738,hyperresponsive to tactile stimuli|MP:0002914,abnormal endplate potential|MP:0003635,abnormal synaptic transmission|MP:0003858,enhanced coordination|MP:0003998,decreased thermal nociceptive threshold|MP:0004835,abnormal miniature endplate potential|MP:0005333,decreased heart rate|MP:0005407,hyperalgesia|MP:0009400,decreased skeletal muscle fiber size|MP:0010124,decreased bone mineral content|MP:0013178,tail necrosis
MGI:3846546	Smn1<tm6(SMN2)Mrph>	MP:0002169,no abnormal phenotype detected
MGI:7788963	Smndc1<em1Rkbr>	MP:0001262,decreased body weight|MP:0001265,decreased body size
MGI:7788965	Smndc1<em2Rkbr>	MP:0001262,decreased body weight|MP:0001265,decreased body size
MGI:7788967	Smndc1<em4Rkbr>	MP:0011091,prenatal lethality, complete penetrance
MGI:2137553	Smo<bnb>	MP:0000269,abnormal heart looping|MP:0000955,abnormal spinal cord morphology|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001706,abnormal left-right axis patterning|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0004190,abnormal direction of embryo turning|MP:0004574,broad limb buds|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4431709	Smoc1<tm1a(EUCOMM)Wtsi>	MP:0000111,cleft palate|MP:0000564,syndactyly|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0002075,abnormal coat/hair pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005430,absent fibula|MP:0006221,optic nerve hypoplasia|MP:0010714,iris coloboma|MP:0010715,retina coloboma|MP:0011087,neonatal lethality, complete penetrance
MGI:5548713	Smoc1<tm1b(EUCOMM)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0000455,abnormal maxilla morphology|MP:0000564,syndactyly|MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0001406,abnormal gait|MP:0002110,abnormal digit morphology|MP:0002546,mydriasis|MP:0002606,increased basophil cell number|MP:0002764,short tibia|MP:0002792,abnormal retina vasculature morphology|MP:0002833,increased heart weight|MP:0002875,decreased erythrocyte cell number|MP:0004151,decreased circulating iron level|MP:0004509,abnormal pelvic girdle bone morphology|MP:0005016,decreased lymphocyte cell number|MP:0005287,narrow eye opening|MP:0006243,impaired pupillary reflex|MP:0008259,abnormal optic disk morphology|MP:0010067,increased red blood cell distribution width|MP:0010097,abnormal retina blood vessel morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011496,abnormal head size|MP:0012362,increased large unstained cell number
MGI:4941776	Smoc1<Tn(sb-lacZ,GFP)IR3.PV384Jtak>	MP:0000111,cleft palate|MP:0000556,abnormal hindlimb morphology|MP:0000564,syndactyly|MP:0000566,synostosis|MP:0000571,interdigital webbing|MP:0000576,clubfoot|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0001333,absent optic nerve|MP:0001732,postnatal growth retardation|MP:0002765,short fibula|MP:0002932,abnormal joint morphology|MP:0003757,high palate|MP:0004358,bowed tibia|MP:0004642,fused metatarsal bones|MP:0005201,abnormal retina pigment epithelium morphology|MP:0006221,optic nerve hypoplasia|MP:0006309,decreased retina ganglion cell number|MP:0009874,abnormal interdigital cell death|MP:0010772,abnormal pollex morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0031291,pes valgus
MGI:5529632	Smoc2<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0000441,increased cranium width|MP:0001258,decreased body length|MP:0001510,abnormal coat appearance|MP:0001566,increased circulating phosphate level|MP:0003760,decreased palatal length|MP:0003795,abnormal bone structure|MP:0005166,decreased susceptibility to injury|MP:0005389,reproductive system phenotype|MP:0005633,increased circulating sodium level|MP:0010124,decreased bone mineral content|MP:0010768,mortality/aging|MP:0011862,decreased cranium length
MGI:5770717	Smo<rgsc2073>	MP:0001706,abnormal left-right axis patterning|MP:0003984,embryonic growth retardation|MP:0005157,holoprosencephaly|MP:0011092,embryonic lethality, complete penetrance
MGI:2672132	Smo<tm1.1Pab>	MP:0000292,distended pericardium|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0002084,abnormal developmental patterning|MP:0003425,abnormal optic vesicle formation|MP:0004837,abnormal neural fold formation|MP:0005657,abnormal neural plate morphology|MP:0006337,abnormal first pharyngeal arch morphology|MP:0010335,fused first pharyngeal arch
MGI:2176255	Smo<tm1Amc>	MP:0001672,abnormal embryo development|MP:0001700,abnormal embryo turning|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004949,absent neuronal precursor cells|MP:0005381,digestive/alimentary phenotype
MGI:5573269	Smo<tm1b(KOMP)Wtsi>	MP:0000288,abnormal pericardium morphology|MP:0001672,abnormal embryo development|MP:0001700,abnormal embryo turning|MP:0002060,abnormal skin morphology|MP:0003928,increased heart rate variability|MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2176256	Smo<tm2Amc>	MP:0000265,blood vessel atresia|MP:0000832,abnormal thalamus morphology|MP:0001046,abnormal enteric neuron morphology|MP:0002128,abnormal blood circulation|MP:0002169,no abnormal phenotype detected|MP:0002633,persistent truncus arteriosus|MP:0003354,astrocytosis|MP:0003449,abnormal intestine goblet cell morphology|MP:0003631,nervous system phenotype|MP:0003920,abnormal heart right ventricle morphology|MP:0005385,cardiovascular system phenotype|MP:0008802,abnormal intestinal smooth muscle morphology|MP:0008883,abnormal enterocyte proliferation|MP:0010155,abnormal intestine physiology|MP:0010158,abnormal intestine development|MP:0010802,abnormal intestinal enteroendocrine cell morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:5007344	Smox<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:8260697	Smpd1<em2Mvw>	MP:0003631,nervous system phenotype
MGI:2183206	Smpd1<tm1Esc>	MP:0000716,abnormal immune system cell morphology|MP:0000745,tremors|MP:0000774,decreased brain size|MP:0000876,Purkinje cell degeneration|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001505,hunched posture|MP:0001556,increased circulating HDL cholesterol level|MP:0001648,abnormal apoptosis|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002412,increased susceptibility to bacterial infection|MP:0002462,abnormal granulocyte physiology|MP:0002675,asthenozoospermia|MP:0003360,abnormal depression-related behavior|MP:0003666,impaired sperm capacitation|MP:0004778,increased macrophage derived foam cell number|MP:0005202,lethargy|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006362,abnormal male germ cell morphology|MP:0008872,abnormal physiological response to xenobiotic|MP:0009937,abnormal neuron differentiation|MP:0012232,abnormal ceramide level|MP:0012507,midbrain atrophy|MP:0014185,cerebellum atrophy
MGI:2183207	Smpd1<tm1Wst>	MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000745,tremors|MP:0000788,abnormal cerebral cortex morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000876,Purkinje cell degeneration|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002183,gliosis|MP:0002270,abnormal pulmonary alveolus morphology|MP:0004778,increased macrophage derived foam cell number|MP:0031058,hepatosplenomegaly
MGI:2183203	Smpd2<tm1Wst>	MP:0002169,no abnormal phenotype detected
MGI:1856877	Smpd3<fro>	MP:0000060,delayed bone ossification|MP:0000063,decreased bone mineral density|MP:0000133,abnormal long bone metaphysis morphology|MP:0000149,abnormal scapula morphology|MP:0000150,abnormal rib morphology|MP:0000164,abnormal cartilage development|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0001183,overexpanded pulmonary alveolus|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001547,abnormal lipid level|MP:0001575,cyanosis|MP:0001921,reduced fertility|MP:0001954,respiratory distress|MP:0001958,emphysema|MP:0002109,abnormal limb morphology|MP:0002115,abnormal limb bone morphology|MP:0002187,abnormal fibula morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002896,abnormal bone mineralization|MP:0002904,increased circulating parathyroid hormone level|MP:0003109,short femur|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003723,abnormal long bone morphology|MP:0004189,abnormal alveolar process morphology|MP:0004351,short humerus|MP:0004358,bowed tibia|MP:0004359,short ulna|MP:0004361,bowed ulna|MP:0004373,bowed humerus|MP:0004374,bowed radius|MP:0004506,abnormal pubis morphology|MP:0004507,abnormal ischium morphology|MP:0004672,short ribs|MP:0004675,rib fractures|MP:0004686,decreased length of long bones|MP:0004986,abnormal osteoblast morphology|MP:0005296,abnormal humerus morphology|MP:0005298,abnormal clavicle morphology|MP:0006322,abnormal perichondrium morphology|MP:0006395,abnormal epiphyseal plate morphology|MP:0008271,abnormal bone ossification|MP:0008277,abnormal sternum ossification|MP:0008770,decreased survivor rate|MP:0010869,decreased bone trabecula number|MP:0010895,increased lung compliance|MP:0010971,abnormal periosteum morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0030542,abnormal dentin development|MP:0030856,abnormal olecranon morphology
MGI:3575405	Smpd3<tm1Wst>	MP:0000060,delayed bone ossification|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0001156,abnormal spermatogenesis|MP:0001255,decreased body height|MP:0001938,delayed sexual maturation|MP:0002187,abnormal fibula morphology|MP:0002427,disproportionate dwarf|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003582,abnormal ovary development|MP:0003723,abnormal long bone morphology|MP:0003830,abnormal testis development|MP:0004163,abnormal adenohypophysis morphology|MP:0004201,fetal growth retardation|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005471,decreased thyroxine level|MP:0005473,decreased triiodothyronine level|MP:0008329,decreased somatotroph cell number|MP:0008335,decreased gonadotroph cell number|MP:0008338,decreased thyrotroph cell number|MP:0008341,decreased corticotroph cell number|MP:0011121,decreased primordial ovarian follicle number|MP:0013340,abnormal pituicyte morphology|MP:0014162,decreased circulating cortisol level
MGI:5548688	Smpd4<tm2b(KOMP)Wtsi>	MP:0001925,male infertility|MP:0002092,abnormal eye morphology|MP:0002169,no abnormal phenotype detected|MP:0003586,dilated ureter|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011513,abnormal vertebral artery morphology
MGI:6156507	Smpdl3a<em1(IMPC)Tcp>	MP:0002060,abnormal skin morphology|MP:0010506,prolonged RR interval
MGI:4433288	Smpdl3b<tm1a(EUCOMM)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0001402,decreased locomotor activity|MP:0002446,abnormal macrophage morphology|MP:0008553,increased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level|MP:0008647,increased circulating interleukin-12b level|MP:0008722,abnormal chemokine secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0010209,abnormal circulating chemokine level
MGI:6852752	Smpx<em1Jgao>	MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004597,increased susceptibility to noise-induced hearing loss|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004749,nonsyndromic hearing loss|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6852753	Smpx<em2Jgao>	MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004597,increased susceptibility to noise-induced hearing loss|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004749,nonsyndromic hearing loss|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2387820	Smpx<tm1.1Rph>	MP:0002169,no abnormal phenotype detected
MGI:4431547	Sms<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000162,lordosis|MP:0000747,muscle weakness|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0002161,abnormal fertility/fecundity|MP:0002687,oligozoospermia|MP:0003961,decreased lean body mass|MP:0004174,abnormal spine curvature|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0005628,decreased circulating potassium level|MP:0008039,increased NK T cell number|MP:0008044,increased NK cell number|MP:0010124,decreased bone mineral content|MP:0013600,testis degeneration
MGI:5795735	smsz	MP:0001265,decreased body size|MP:0001304,cataract|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3796616	Smtnl1<tm1Tajh>	MP:0000249,abnormal blood vessel physiology|MP:0003026,decreased vasoconstriction|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005590,increased vasodilation|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0012107,enhanced exercise endurance
MGI:6114749	Smtn<m1Btlr>	MP:0001262,decreased body weight
MGI:3613292	Smtn<tm1Gve>	MP:0000013,abnormal adipose tissue distribution|MP:0000477,abnormal intestine morphology|MP:0000479,abnormal enterocyte morphology|MP:0001732,postnatal growth retardation|MP:0001858,intestinal inflammation|MP:0001924,infertility|MP:0003026,decreased vasoconstriction|MP:0003262,intestinal/bowel diverticulum|MP:0003290,intestinal hypoperistalsis|MP:0004002,abnormal jejunum morphology|MP:0004006,impaired contractility of jejunal smooth muscle|MP:0004857,abnormal heart weight|MP:0004875,increased mean systemic arterial blood pressure|MP:0005044,sepsis|MP:0006001,abnormal intestinal transit time|MP:0008843,absent subcutaneous adipose tissue|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011881,distended duodenum
MGI:3613293	Smtn<tm2Gve>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000249,abnormal blood vessel physiology|MP:0001625,cardiac hypertrophy|MP:0002169,no abnormal phenotype detected|MP:0002953,thick ventricular wall|MP:0003026,decreased vasoconstriction|MP:0003915,increased heart left ventricle weight|MP:0004857,abnormal heart weight|MP:0004875,increased mean systemic arterial blood pressure
MGI:3654131	Smtw1<Smt>	MP:0004852,decreased testis weight
MGI:3654133	Smtw2<Smt>	MP:0004852,decreased testis weight
MGI:4435952	Smug1<tm1a(EUCOMM)Hmgu>	MP:0008944,decreased sensitivity to induced cell death|MP:0010768,mortality/aging|MP:0014762,impaired base-excision repair
MGI:5637086	Smurf1<tm1b(EUCOMM)Wtsi>	MP:0001399,hyperactivity|MP:0001512,trunk curl
MGI:3846785	Smurf1<tm1Wran>	MP:0002169,no abnormal phenotype detected
MGI:3576775	Smurf1<tm1Yez>	MP:0004148,increased compact bone thickness|MP:0005006,abnormal osteoblast physiology|MP:0010872,increased trabecular bone mass|MP:0020011,increased bone mineral density of femur
MGI:4126344	Smurf2<Gt(RRA098)Byg>	MP:0000691,enlarged spleen|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002032,increased sarcoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0008009,delayed cellular replicative senescence|MP:0009309,increased small intestine adenocarcinoma incidence|MP:0012431,increased lymphoma incidence
MGI:5548518	Smurf2<tm1b(EUCOMM)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3846786	Smurf2<tm1Wran>	MP:0002169,no abnormal phenotype detected
MGI:5308952	Smurf2<tm1Yez>	MP:0000137,abnormal vertebrae morphology|MP:0000585,kinked tail|MP:0001891,hydrocephaly|MP:0002111,abnormal tail morphology|MP:0005621,abnormal cell physiology
MGI:2179298	Smyd1<tm1Dsr>	MP:0000274,enlarged heart|MP:0000279,ventricular hypoplasia|MP:0000295,trabecula carnea hypoplasia|MP:0001648,abnormal apoptosis|MP:0003984,embryonic growth retardation|MP:0005385,cardiovascular system phenotype|MP:0010432,common ventricle|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4441342	Smyd2<tm1.1Fben>	MP:0005385,cardiovascular system phenotype
MGI:4362468	Smyd2<tm1a(KOMP)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level
MGI:7310439	Smyd3<em1Yzzh>	MP:0000230,abnormal systemic arterial blood pressure|MP:0001613,abnormal vasodilation|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0009866,abnormal aorta wall morphology
MGI:4363150	Smyd3<tm2a(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:4432884	Smyd4<tm1a(EUCOMM)Wtsi>	MP:0003205,testicular atrophy|MP:0004924,abnormal behavior|MP:0013600,testis degeneration
MGI:4431696	Smyd5<tm1a(EUCOMM)Wtsi>	MP:0000479,abnormal enterocyte morphology|MP:0004924,abnormal behavior|MP:0008539,decreased susceptibility to induced colitis
MGI:3838175	Snai1<tm1.1Stjw>	MP:0000260,abnormal angiogenesis|MP:0000301,decreased atrioventricular cushion size|MP:0001698,decreased embryo size|MP:0002169,no abnormal phenotype detected|MP:0003091,abnormal cell migration|MP:0003227,abnormal vascular branching morphogenesis|MP:0004076,abnormal vitelline vascular remodeling|MP:0004950,abnormal brain vasculature morphology|MP:0005602,decreased angiogenesis|MP:0005621,abnormal cell physiology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009577,abnormal developmental vascular remodeling|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011523,thin placenta labyrinth
MGI:2183156	Snai1<tm1Grid>	MP:0001680,abnormal mesoderm development|MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0005030,absent amnion|MP:0009593,absent chorion|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:3617388	Snai1<tm2.1Grid>	MP:0001680,abnormal mesoderm development|MP:0001730,embryonic growth arrest|MP:0011092,embryonic lethality, complete penetrance
MGI:5582425	Snai2<tm1.1(KOMP)Vlcg>	MP:0000274,enlarged heart|MP:0000367,abnormal coat/ hair morphology|MP:0001914,hemorrhage|MP:0002075,abnormal coat/hair pigmentation|MP:0003054,spina bifida|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2447175	Snai2<tm1Grid>	MP:0000301,decreased atrioventricular cushion size|MP:0001265,decreased body size|MP:0006107,abnormal fetal atrioventricular canal morphology|MP:0008825,abnormal cardiac epithelial to mesenchymal transition
MGI:2447174	Snai2<tm1Look>	MP:0001658,increased mortality induced by gamma-irradiation|MP:0001732,postnatal growth retardation|MP:0002396,abnormal hematopoietic system morphology/development|MP:0005251,blepharitis|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:2447176	Snai2<tm2Grid>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000370,head blaze|MP:0000371,diluted coat color|MP:0000706,small thymus|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001265,decreased body size|MP:0001310,abnormal conjunctiva morphology|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001732,postnatal growth retardation|MP:0001852,conjunctivitis|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002095,abnormal skin pigmentation|MP:0002145,abnormal T cell differentiation|MP:0002590,increased mean corpuscular volume|MP:0002811,macrocytic anemia|MP:0002874,decreased hemoglobin content|MP:0002940,variable body spotting|MP:0003179,thrombocytopenia|MP:0005251,blepharitis|MP:0009889,persistence of medial edge epithelium during palatal shelf fusion|MP:0009890,cleft secondary palate|MP:0011088,neonatal lethality, incomplete penetrance|MP:0030054,decreased forehead pigmentation
MGI:5495406	Snai3<tm1.1Grid>	MP:0002169,no abnormal phenotype detected
MGI:5619843	Snai3<tm1.1Jhws>	MP:0005387,immune system phenotype
MGI:5620192	Snai3<tm1.2Jhws>	MP:0002169,no abnormal phenotype detected
MGI:5495409	Snai3<tm2.1Grid>	MP:0002169,no abnormal phenotype detected
MGI:5495410	Snai3<tm2.2Grid>	MP:0002169,no abnormal phenotype detected
MGI:4439388	Snap23<tm1.1Paro>	MP:0004957,abnormal blastocyst morphology|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5006857	Snap23<tm1.2Paro>	MP:0011100,preweaning lethality, complete penetrance
MGI:5756070	Snap23<tm1b(EUCOMM)Wtsi>	MP:0001488,increased startle reflex|MP:0002075,abnormal coat/hair pigmentation|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:1862014	Snap25<Bdr>	MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002711,decreased glucagon secretion|MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0004495,decreased synaptic glutamate release|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype|MP:0009142,decreased prepulse inhibition
MGI:3821974	Snap25<tm1.1Bark>	MP:0000008,increased white adipose tissue amount|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001463,abnormal spatial learning|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0002064,seizures|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002797,increased thigmotaxis|MP:0002920,decreased paired-pulse facilitation|MP:0003564,abnormal insulin secretion|MP:0005178,increased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005331,insulin resistance|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0006087,increased body mass index|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0009118,increased white fat cell size|MP:0011613,decreased circulating ghrelin level|MP:0011939,increased food intake|MP:0011940,decreased food intake
MGI:5484607	Snap25<tm1.1Hze>	MP:0002169,no abnormal phenotype detected
MGI:3821973	Snap25<tm1Bark>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001290,delayed eyelid opening|MP:0001399,hyperactivity|MP:0002064,seizures|MP:0002920,decreased paired-pulse facilitation|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0006325,impaired hearing
MGI:2180178	Snap25<tm1Mcw>	MP:0000761,thin diaphragm muscle|MP:0000788,abnormal cerebral cortex morphology|MP:0001191,abnormal skin condition|MP:0001404,no spontaneous movement|MP:0001458,abnormal object recognition memory|MP:0001491,unresponsive to tactile stimuli|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001953,respiratory failure|MP:0002152,abnormal brain morphology|MP:0002206,abnormal CNS synaptic transmission|MP:0002280,abnormal intercostal muscle morphology|MP:0002897,blotchy skin|MP:0002913,abnormal PNS synaptic transmission|MP:0002914,abnormal endplate potential|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0011087,neonatal lethality, complete penetrance
MGI:5297219	Snap25<tm1Mtaka>	MP:0000947,convulsive seizures|MP:0001363,increased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001905,abnormal dopamine level|MP:0002757,decreased vertical activity|MP:0002797,increased thigmotaxis|MP:0005322,abnormal serotonin level|MP:0010698,abnormal impulsive behavior control|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031391,increased locomotor activity
MGI:5507846	Snap25<tm2.1(cre)Hze>	MP:0002169,no abnormal phenotype detected
MGI:3511662	Snap25<tm2Mcw>	MP:0000243,myoclonus|MP:0001262,decreased body weight|MP:0001511,disheveled coat|MP:0001924,infertility|MP:0002083,premature death|MP:0002690,akinesia|MP:0002919,enhanced paired-pulse facilitation|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4433565	Snap29<tm1a(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0001260,increased body weight|MP:0003960,increased lean body mass|MP:0010123,increased bone mineral content
MGI:5812298	Snap29<tm1b(EUCOMM)Wtsi>	MP:0001192,scaly skin|MP:0001198,tight skin|MP:0001242,hyperkeratosis|MP:0001874,acanthosis|MP:0005501,abnormal skin physiology|MP:0008260,abnormal autophagy|MP:0009608,abnormal epidermal lamellar body morphology|MP:0009703,decreased birth body size|MP:0009931,abnormal skin appearance|MP:0020352,abnormal endoplasmic reticulum physiology|MP:0020354,increased endoplasmic reticulum stress
MGI:5812297	Snap29<tm1c(EUCOMM)Wtsi>	MP:0000379,decreased hair follicle number|MP:0001192,scaly skin|MP:0001198,tight skin|MP:0001216,abnormal epidermal layer morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001242,hyperkeratosis|MP:0001874,acanthosis|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0005501,abnormal skin physiology|MP:0009546,absent gastric milk in neonates|MP:0009583,increased keratinocyte proliferation|MP:0009605,decreased keratohyalin granule number|MP:0009608,abnormal epidermal lamellar body morphology|MP:0009703,decreased birth body size|MP:0009931,abnormal skin appearance|MP:0011087,neonatal lethality, complete penetrance|MP:0030605,abnormal corneocyte morphology
MGI:4433792	Snap47<tm1a(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0003960,increased lean body mass|MP:0003961,decreased lean body mass|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:7425994	Snap91<em1(IMPC)H>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5788722	Snap91<tm1.1Tmar>	MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001447,abnormal nest building behavior|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002206,abnormal CNS synaptic transmission|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002919,enhanced paired-pulse facilitation|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0003997,tonic-clonic seizures|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004769,abnormal synaptic vesicle morphology|MP:0004770,abnormal synaptic vesicle recycling|MP:0004792,abnormal synaptic vesicle number|MP:0004859,abnormal synaptic plasticity|MP:0004994,abnormal brain wave pattern|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0020357,abnormal excitatory synapse morphology|MP:0020358,abnormal inhibitory synapse morphology|MP:0031391,increased locomotor activity
MGI:5700044	Snapc1<tm1b(KOMP)Mbp>	MP:0001406,abnormal gait|MP:0005627,increased circulating potassium level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5784546	Snapc2<em1(IMPC)J>	MP:0001730,embryonic growth arrest|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012058,abnormal morula morphology|MP:0012129,failure of blastocyst formation|MP:0013292,embryonic lethality prior to organogenesis
MGI:4362491	Snapc4<tm1a(KOMP)Wtsi>	MP:0005296,abnormal humerus morphology
MGI:5571346	Snapin<tm1.1(KOMP)Vlcg>	MP:0002941,increased circulating alanine transaminase level|MP:0005627,increased circulating potassium level|MP:0005633,increased circulating sodium level|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3608768	Snapin<tm1Zhs>	MP:0001739,abnormal adrenal gland secretion|MP:0003631,nervous system phenotype|MP:0005621,abnormal cell physiology|MP:0011087,neonatal lethality, complete penetrance
MGI:5586701	Snapin<tm2Zhs>	MP:0004768,abnormal axonal transport
MGI:6149211	Snca<em1(IMPC)H>	MP:0001392,abnormal locomotor behavior|MP:0002599,increased mean platelet volume|MP:0003896,prolonged PR interval|MP:0004952,increased spleen weight|MP:0005553,increased circulating creatinine level|MP:0008806,increased circulating amylase level|MP:0013279,increased fasting circulating glucose level
MGI:5517595	Snca<tm1.1Koks>	MP:0001405,impaired coordination|MP:0002822,catalepsy|MP:0003313,abnormal locomotor activation|MP:0005643,decreased dopamine level|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010540,long stride length
MGI:5614654	Snca<tm1.1Vlb>	MP:0002169,no abnormal phenotype detected
MGI:2389489	Snca<tm1Nbm>	MP:0010768,mortality/aging
MGI:1888382	Snca<tm1Rosl>	MP:0002411,decreased susceptibility to bacterial infection|MP:0003243,abnormal dopaminergic neuron morphology|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005643,decreased dopamine level|MP:0011448,decreased dopaminergic neuron number|MP:0011452,decreased susceptibility to dopaminergic neuron neurotoxicity
MGI:3487373	Snca<tm1Sud>	MP:0003243,abnormal dopaminergic neuron morphology
MGI:2429773	Snca<tm1Wtd>	MP:0001473,reduced long-term potentiation|MP:0003635,abnormal synaptic transmission|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005384,cellular phenotype|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0010955,abnormal respiratory electron transport chain|MP:0011452,decreased susceptibility to dopaminergic neuron neurotoxicity
MGI:3487297	Sncb<tm1.1Sud>	MP:0002169,no abnormal phenotype detected
MGI:5692645	Sncb<tm1b(EUCOMM)Hmgu>	MP:0003795,abnormal bone structure|MP:0005293,impaired glucose tolerance|MP:0010124,decreased bone mineral content
MGI:2683142	Sncg<tm1Vlb>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0011448,decreased dopaminergic neuron number|MP:0011452,decreased susceptibility to dopaminergic neuron neurotoxicity
MGI:6156505	Snd1<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000219,increased neutrophil cell number|MP:0000706,small thymus|MP:0001258,decreased body length|MP:0001304,cataract|MP:0002059,abnormal seminal vesicle morphology|MP:0002637,small uterus|MP:0002941,increased circulating alanine transaminase level|MP:0004953,decreased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0005278,abnormal cholesterol homeostasis|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011874,enlarged urinary bladder
MGI:7286446	Snd1<tm1.2Elws>	MP:0005387,immune system phenotype
MGI:3032562	Sndy1<Jrt>	MP:0000564,syndactyly
MGI:4433763	Snf8<tm1a(EUCOMM)Wtsi>	MP:0002702,decreased circulating free fatty acids level
MGI:5587826	Snhg14<tm1Alb>	MP:0005386,behavior/neurological phenotype
MGI:6478876	Snhg15<tm1.1Nju>	MP:0031328,delayed skeletal muscle regeneration
MGI:6478873	Snhg15<tm1Nju>	MP:0005367,renal/urinary system phenotype|MP:0005369,muscle phenotype|MP:0005370,liver/biliary system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0009760,abnormal mitotic spindle morphology|MP:0031328,delayed skeletal muscle regeneration
MGI:7738204	Snip1<em1Yiji>	MP:0003631,nervous system phenotype|MP:0011091,prenatal lethality, complete penetrance
MGI:7738205	Snip1<em2Yiji>	MP:0003224,neuron degeneration
MGI:4431749	Snip1<tm1a(EUCOMM)Wtsi>	MP:0004924,abnormal behavior|MP:0005567,decreased circulating total protein level|MP:0006241,abnormal placement of pupils
MGI:1857049	sno	MP:0000160,kyphosis|MP:0000445,short snout|MP:0000755,hindlimb paralysis|MP:0003047,abnormal thoracic vertebrae morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004657,small sacral vertebrae|MP:0004703,abnormal vertebral column morphology|MP:0005297,spina bifida occulta|MP:0013176,abnormal tail position or orientation
MGI:2449570	snol	MP:0000120,malocclusion|MP:0000445,short snout|MP:0000585,kinked tail|MP:0002089,abnormal postnatal growth/weight/body size|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0030071,abnormal face shape
MGI:5006996	Snorc<tm1Lex>	MP:0001402,decreased locomotor activity|MP:0002644,decreased circulating triglyceride level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6714008	Snord115<em1Jcav>	MP:0000005,increased brown adipose tissue amount|MP:0003122,maternal imprinting|MP:0003360,abnormal depression-related behavior|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype
MGI:3773673	Snord116<tm1.1Uta>	MP:0000601,small liver|MP:0001258,decreased body length|MP:0001363,increased anxiety-related response|MP:0001433,polyphagia|MP:0001732,postnatal growth retardation|MP:0001764,abnormal homeostasis|MP:0002175,decreased brain weight|MP:0002636,delayed vaginal opening|MP:0002691,small stomach|MP:0002804,abnormal motor learning|MP:0002891,increased insulin sensitivity|MP:0003122,maternal imprinting|MP:0003402,decreased liver weight|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005289,increased oxygen consumption|MP:0005379,endocrine/exocrine gland phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005449,abnormal food intake|MP:0005459,decreased percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008489,slow postnatal weight gain|MP:0010025,decreased total body fat amount|MP:0010378,increased respiratory quotient|MP:0010768,mortality/aging|MP:0011612,increased circulating ghrelin level
MGI:4356428	Snord116<tm1Jbro>	MP:0005378,growth/size/body region phenotype
MGI:3773671	Snord116<tm1Uta>	MP:0000601,small liver|MP:0001258,decreased body length|MP:0001363,increased anxiety-related response|MP:0001433,polyphagia|MP:0001732,postnatal growth retardation|MP:0001764,abnormal homeostasis|MP:0002169,no abnormal phenotype detected|MP:0002175,decreased brain weight|MP:0002636,delayed vaginal opening|MP:0002691,small stomach|MP:0002804,abnormal motor learning|MP:0002891,increased insulin sensitivity|MP:0003122,maternal imprinting|MP:0003402,decreased liver weight|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005289,increased oxygen consumption|MP:0005379,endocrine/exocrine gland phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005449,abnormal food intake|MP:0005459,decreased percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008489,slow postnatal weight gain|MP:0010025,decreased total body fat amount|MP:0010378,increased respiratory quotient|MP:0010768,mortality/aging|MP:0011612,increased circulating ghrelin level
MGI:7738727	Snord118<em1Jfch>	MP:0000809,absent hippocampus|MP:0000913,abnormal brain development|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002196,absent corpus callosum|MP:0003203,increased neuron apoptosis|MP:0004981,decreased neuronal precursor cell number|MP:0005621,abnormal cell physiology|MP:0006254,thin cerebral cortex|MP:0008547,abnormal neocortex morphology|MP:0009431,decreased fetal weight|MP:0020394,decreased neuronal precursor proliferation
MGI:5552747	Snord50a/Snord50b<tm1.1Soen>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002006,neoplasm|MP:0002834,decreased heart weight|MP:0003402,decreased liver weight|MP:0004852,decreased testis weight|MP:0005630,increased lung weight
MGI:5552981	Snord50a/Snord50b<tm1.1Soen>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002006,neoplasm|MP:0002834,decreased heart weight|MP:0003402,decreased liver weight|MP:0004852,decreased testis weight|MP:0005630,increased lung weight
MGI:5548740	Snph<tm1.1(KOMP)Vlcg>	MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0002175,decreased brain weight|MP:0010124,decreased bone mineral content
MGI:3834635	Snph<tm1Zhs>	MP:0001405,impaired coordination|MP:0002919,enhanced paired-pulse facilitation|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0008571,abnormal synaptic bouton morphology
MGI:6279960	Snrk<tm1.1Hxu>	MP:0000013,abnormal adipose tissue distribution|MP:0001260,increased body weight|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002628,hepatic steatosis|MP:0004890,decreased energy expenditure|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0008553,increased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level|MP:0009269,decreased fat cell size|MP:0010209,abnormal circulating chemokine level|MP:0011014,decreased core body temperature|MP:0031602,white adipose tissue inflammation|MP:0031603,brown adipose tissue inflammation
MGI:6147677	Snrk<tm1Hxu>	MP:0001783,decreased white adipose tissue amount|MP:0002082,postnatal lethality|MP:0005318,decreased triglyceride level|MP:0005559,increased circulating glucose level|MP:0005560,decreased circulating glucose level|MP:0008489,slow postnatal weight gain|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009116,abnormal brown fat cell morphology|MP:0009117,abnormal white fat cell morphology|MP:0009136,decreased brown fat cell size
MGI:5792702	Snrk<tm1Rra>	MP:0000274,enlarged heart|MP:0001547,abnormal lipid level|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0005178,increased circulating cholesterol level|MP:0005385,cardiovascular system phenotype|MP:0010579,increased heart left ventricle size|MP:0011087,neonatal lethality, complete penetrance
MGI:5792703	Snrk<tm2Rra>	MP:0001547,abnormal lipid level|MP:0002083,premature death|MP:0003921,abnormal heart left ventricle morphology|MP:0005385,cardiovascular system phenotype|MP:0010768,mortality/aging|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5286961	Snrnp200<TgTn(sb-cHS4,Tyr)2334FOve>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5548825	Snrnp200<tm1b(KOMP)Mbp>	MP:0000274,enlarged heart|MP:0002750,exophthalmos|MP:0006243,impaired pupillary reflex|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5548525	Snrnp27<tm1b(EUCOMM)Wtsi>	MP:0000467,abnormal esophagus morphology|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6696146	Snrnp40<em1Btlr>	MP:0011100,preweaning lethality, complete penetrance
MGI:7425995	Snrnp40<em1(IMPC)Bay>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0002582,disorganized extraembryonic tissue|MP:0003984,embryonic growth retardation|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0014586,decreased egg cylinder size
MGI:6696147	Snrnp40<em2Btlr>	MP:0011100,preweaning lethality, complete penetrance
MGI:6696145	Snrnp40<swp>	MP:0000373,belly spot|MP:0001262,decreased body weight|MP:0002938,white spotting
MGI:6342907	Snrnp70<em1(IMPC)Bay>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0003984,embryonic growth retardation|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:6414501	Snrpb2<em1(IMPC)Hmgu>	MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:7437928	Snrpb<em1Lajm>	MP:0000018,small ears|MP:0000103,nasal bone hypoplasia|MP:0000111,cleft palate|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000454,abnormal jaw morphology|MP:0000457,maxilla hypoplasia|MP:0000458,abnormal mandible morphology|MP:0000460,mandible hypoplasia|MP:0000705,athymia|MP:0000783,abnormal forebrain morphology|MP:0000964,small dorsal root ganglion|MP:0001065,abnormal trigeminal nerve morphology|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001082,abnormal geniculate ganglion morphology|MP:0001785,edema|MP:0002085,abnormal embryonic tissue morphology|MP:0002233,abnormal nose morphology|MP:0002251,abnormal nasopharynx morphology|MP:0002820,abnormal premaxilla morphology|MP:0002856,abnormal vestibular ganglion morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0003138,absent tympanic ring|MP:0003842,abnormal metopic suture morphology|MP:0003869,ectopic cartilage|MP:0003873,pharyngeal arch hypoplasia|MP:0004205,absent hyoid bone|MP:0004385,interparietal bone hypoplasia|MP:0004420,parietal bone hypoplasia|MP:0004458,absent alisphenoid bone|MP:0004461,basisphenoid bone hypoplasia|MP:0004869,frontal bone hypoplasia|MP:0004872,absent nasal septum|MP:0004900,absent zygomatic arch|MP:0004911,absent mandibular condyloid process|MP:0004912,absent mandibular coronoid process|MP:0004913,absent mandibular angle|MP:0005272,abnormal temporal bone morphology|MP:0006254,thin cerebral cortex|MP:0008535,enlarged lateral ventricles|MP:0009546,absent gastric milk in neonates|MP:0009798,abnormal ophthalmic nerve morphology|MP:0009799,abnormal maxillary nerve morphology|MP:0009800,abnormal mandibular nerve morphology|MP:0009899,hyoid bone hypoplasia|MP:0009901,abnormal frontonasal prominence morphology|MP:0010652,absent aorticopulmonary septum|MP:0011087,neonatal lethality, complete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011495,abnormal head shape|MP:0012090,midbrain hypoplasia|MP:0012176,abnormal head development|MP:0012178,absent frontonasal prominence|MP:0012264,hindbrain hypoplasia|MP:0013267,first pharyngeal arch hypoplasia|MP:0014167,ectopic bone|MP:0020845,abnormal DNA-templated transcription|MP:0030121,small temporal bone squamous part|MP:0030250,frontonasal prominence hypoplasia|MP:0030343,maxillary prominence hypoplasia|MP:0030344,absent maxillary prominence|MP:0030347,mandibular prominence hypoplasia|MP:0030374,Meckel's cartilage hypoplasia
MGI:5306139	Snrpe<M1157Lja>	MP:0001156,abnormal spermatogenesis|MP:0004852,decreased testis weight
MGI:2384038	Snrpn<tm1Alb>	MP:0005384,cellular phenotype
MGI:2155244	Snrpn<tm1Cbr>	MP:0002169,no abnormal phenotype detected
MGI:3617823	Snrpn<tm1Rsnk>	MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001264,increased body size|MP:0001732,postnatal growth retardation|MP:0003122,maternal imprinting|MP:0003787,abnormal imprinting|MP:0005389,reproductive system phenotype|MP:0009546,absent gastric milk in neonates|MP:0010024,increased total body fat amount|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5140864	Snrpn<tm2.1Kaj>	MP:0008877,abnormal DNA methylation|MP:0009546,absent gastric milk in neonates|MP:0009674,decreased birth weight|MP:0011085,postnatal lethality, complete penetrance
MGI:2384039	Snrpn<tm2Alb>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality|MP:0005384,cellular phenotype
MGI:2155245	Snrpn<tm2Cbr>	MP:0000746,weakness|MP:0001265,decreased body size|MP:0001388,abnormal stationary movement|MP:0001429,dehydration|MP:0001436,abnormal suckling behavior|MP:0001732,postnatal growth retardation|MP:0003122,maternal imprinting|MP:0005389,reproductive system phenotype|MP:0005560,decreased circulating glucose level|MP:0009674,decreased birth weight|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2384045	Snrpn<tm3Alb>	MP:0002169,no abnormal phenotype detected
MGI:3617407	Snrpn<tm5Alb>	MP:0003121,genetic imprinting|MP:0008877,abnormal DNA methylation
MGI:2179769	Snta1<tm1Scf>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0001784,abnormal fluid regulation|MP:0002182,abnormal astrocyte morphology|MP:0003957,abnormal nitric oxide homeostasis|MP:0005369,muscle phenotype|MP:0006059,decreased susceptibility to ischemic brain injury
MGI:2179768	Snta1<tm1Stk>	MP:0005369,muscle phenotype
MGI:3574023	Sntb2<tm1Scf>	MP:0002169,no abnormal phenotype detected
MGI:3613602	snthr	MP:0000379,decreased hair follicle number|MP:0000416,sparse hair|MP:0001211,wrinkled skin|MP:0001242,hyperkeratosis|MP:0001382,abnormal nursing|MP:0001732,postnatal growth retardation
MGI:3613603	snthr2	MP:0000379,decreased hair follicle number|MP:0000416,sparse hair|MP:0001211,wrinkled skin|MP:0001242,hyperkeratosis|MP:0001382,abnormal nursing|MP:0001732,postnatal growth retardation
MGI:6111480	Snx10<em1Ael>	MP:0000063,decreased bone mineral density|MP:0000067,osteopetrosis|MP:0000130,abnormal trabecular bone morphology|MP:0000559,abnormal femur morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001541,abnormal osteoclast physiology|MP:0001732,postnatal growth retardation|MP:0004982,abnormal osteoclast morphology|MP:0004985,decreased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0004993,decreased bone resorption|MP:0005190,osteomyelitis|MP:0008770,decreased survivor rate|MP:0009347,increased trabecular bone thickness|MP:0009642,abnormal blood homeostasis|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume|MP:0012336,decreased vitamin D level|MP:0013624,decreased femur compact bone thickness|MP:0013631,decreased bone trabecular spacing|MP:0020010,decreased bone mineral density of femur|MP:0030505,tooth impaction|MP:0030610,absent teeth
MGI:6152650	Snx10<em1(IMPC)Mbp>	MP:0001404,no spontaneous movement|MP:0002092,abnormal eye morphology
MGI:6111481	Snx10<em2Ael>	MP:0000063,decreased bone mineral density|MP:0000067,osteopetrosis|MP:0000130,abnormal trabecular bone morphology|MP:0000559,abnormal femur morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001541,abnormal osteoclast physiology|MP:0001732,postnatal growth retardation|MP:0004982,abnormal osteoclast morphology|MP:0004985,decreased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0004993,decreased bone resorption|MP:0005190,osteomyelitis|MP:0008770,decreased survivor rate|MP:0009347,increased trabecular bone thickness|MP:0009642,abnormal blood homeostasis|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume|MP:0012336,decreased vitamin D level|MP:0013624,decreased femur compact bone thickness|MP:0013631,decreased bone trabecular spacing|MP:0020010,decreased bone mineral density of femur|MP:0030505,tooth impaction|MP:0030610,absent teeth
MGI:5690193	Snx10<tm1a(EUCOMM)Raba>	MP:0000063,decreased bone mineral density|MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000133,abnormal long bone metaphysis morphology|MP:0000135,decreased compact bone thickness|MP:0000195,decreased circulating calcium level|MP:0000470,abnormal stomach morphology|MP:0001541,abnormal osteoclast physiology|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002113,abnormal skeleton development|MP:0002904,increased circulating parathyroid hormone level|MP:0003116,rickets|MP:0003795,abnormal bone structure|MP:0004139,abnormal gastric parietal cell morphology|MP:0004140,abnormal gastric chief cell morphology|MP:0004991,decreased bone strength|MP:0006395,abnormal epiphyseal plate morphology|MP:0008006,increased stomach pH|MP:0009445,osteomalacia|MP:0010124,decreased bone mineral content|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume|MP:0010926,increased osteoid volume|MP:0012336,decreased vitamin D level|MP:0013631,decreased bone trabecular spacing|MP:0013639,decreased bone stiffness
MGI:5690197	Snx10<tm1c(EUCOMM)Raba>	MP:0000062,increased bone mineral density|MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0001541,abnormal osteoclast physiology|MP:0001732,postnatal growth retardation|MP:0005381,digestive/alimentary phenotype|MP:0006395,abnormal epiphyseal plate morphology|MP:0010876,decreased bone volume
MGI:6758755	Snx11<tm1Zhil>	MP:0003453,abnormal keratinocyte physiology|MP:0003663,abnormal thermosensation|MP:0003998,decreased thermal nociceptive threshold
MGI:6376201	Snx12<em1(IMPC)J>	MP:0002644,decreased circulating triglyceride level|MP:0010052,increased grip strength
MGI:3857419	Snx12<Gt(AY0032)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:3696045	Snx13<tm1.1Frq>	MP:0000929,open neural tube|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0001724,abnormal extraembryonic endoderm formation|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003658,abnormal capillary morphology|MP:0004259,small placenta|MP:0005033,abnormal trophoblast giant cell morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6472608	Snx13<tm1b(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0001552,increased circulating triglyceride level|MP:0011100,preweaning lethality, complete penetrance
MGI:6153823	Snx14<em1(IMPC)H>	MP:0001415,increased exploration in new environment|MP:0002599,increased mean platelet volume|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:5585592	Snx15<tm1.1(KOMP)Vlcg>	MP:0000221,decreased leukocyte cell number|MP:0001363,increased anxiety-related response|MP:0001510,abnormal coat appearance|MP:0001556,increased circulating HDL cholesterol level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0005560,decreased circulating glucose level
MGI:5489924	Snx17<b2b1625.1Clo>	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0001293,anophthalmia|MP:0010412,atrioventricular septal defect|MP:0011661,persistent truncus arteriosus type i
MGI:5635292	Snx18<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7425997	Snx19<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3610409	Snx1<tm1Mag>	MP:0002169,no abnormal phenotype detected
MGI:3528973	Snx20<tm1Lex>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype
MGI:6120744	Snx21<tm1b(KOMP)Wtsi>	MP:0001510,abnormal coat appearance
MGI:5605826	Snx22<tm1.1(KOMP)Wtsi>	MP:0001120,abnormal uterus morphology|MP:0001399,hyperactivity|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5707438	Snx25<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0002753,dilated heart left ventricle|MP:0011100,preweaning lethality, complete penetrance
MGI:5548673	Snx27<tm1b(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0000428,abnormal craniofacial morphology|MP:0001785,edema|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4949192	Snx27<tm1Lslo>	MP:0000477,abnormal intestine morphology|MP:0000601,small liver|MP:0000692,small spleen|MP:0001732,postnatal growth retardation|MP:0002188,small heart|MP:0005621,abnormal cell physiology|MP:0008489,slow postnatal weight gain|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5548647	Snx29<tm1b(EUCOMM)Hmgu>	MP:0004738,abnormal auditory brainstem response|MP:0005333,decreased heart rate|MP:0011940,decreased food intake
MGI:3610410	Snx2<tm1Mag>	MP:0002169,no abnormal phenotype detected
MGI:6198594	Snx33<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation
MGI:5634800	Snx3<tm1.1(KOMP)Vlcg>	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0000564,syndactyly|MP:0000783,abnormal forebrain morphology|MP:0000841,abnormal hindbrain morphology|MP:0000897,abnormal midbrain morphology|MP:0000914,exencephaly|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0002590,increased mean corpuscular volume|MP:0003054,spina bifida|MP:0003717,pallor|MP:0003720,abnormal neural tube closure|MP:0003743,abnormal facial morphology|MP:0005565,increased blood urea nitrogen level|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape
MGI:8246795	Snx4<tm1.1Vwj>	MP:0003635,abnormal synaptic transmission|MP:0004769,abnormal synaptic vesicle morphology|MP:0004792,abnormal synaptic vesicle number|MP:0009538,abnormal synapse morphology
MGI:4123839	Snx5<Gt(XA155)Byg>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001575,cyanosis|MP:0001732,postnatal growth retardation|MP:0001953,respiratory failure|MP:0002075,abnormal coat/hair pigmentation|MP:0002270,abnormal pulmonary alveolus morphology|MP:0005631,decreased lung weight|MP:0010816,decreased type I pneumocyte number|MP:0010819,primary atelectasis|MP:0010902,abnormal pulmonary alveolar sac morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:4362512	Snx5<tm1a(KOMP)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001260,increased body weight|MP:0002608,increased hematocrit|MP:0002942,decreased circulating alanine transaminase level|MP:0005179,decreased circulating cholesterol level|MP:0005628,decreased circulating potassium level
MGI:6259581	Snx6<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:6368549	Snx6<tm1.1Nju>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory|MP:0011003,reduced AMPA-mediated synaptic currents|MP:0012307,impaired spatial learning|MP:0020357,abnormal excitatory synapse morphology|MP:0020360,abnormal asymmetric synapse morphology|MP:0020508,decreased dendritic spine density
MGI:6358176	Snx8<tm1Hbsh>	MP:0002376,abnormal dendritic cell physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0005387,immune system phenotype|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008722,abnormal chemokine secretion|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010209,abnormal circulating chemokine level|MP:0011079,decreased macrophage cytokine production|MP:0031219,decreased circulating CXCL10 level|MP:0031222,decreased CXCL10 secretion
MGI:5546671	Snx8<tm2a(EUCOMM)Hmgu>	MP:0000182,increased circulating LDL cholesterol level|MP:0000218,increased leukocyte cell number|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010088,decreased circulating fructosamine level
MGI:6829641	Snx9<em1.1Smoc>	MP:0002169,no abnormal phenotype detected
MGI:3689003	Soa<a>	MP:0001986,abnormal taste sensitivity|MP:0004210,abnormal bitter taste sensitivity
MGI:3689010	Soa<b>	MP:0004210,abnormal bitter taste sensitivity
MGI:3689011	Soa<c>	MP:0004210,abnormal bitter taste sensitivity
MGI:1856648	Soat1<ald>	MP:0000708,thymus hyperplasia|MP:0002026,increased leukemia incidence|MP:0002073,abnormal hair growth|MP:0003809,abnormal hair shaft morphology|MP:0003812,abnormal hair medulla|MP:0008288,abnormal adrenal cortex morphology|MP:0008291,abnormal adrenocortical cell morphology
MGI:5563410	Soat1<m1Anu>	MP:0005387,immune system phenotype
MGI:1857978	Soat1<tm1Far>	MP:0000598,abnormal liver morphology|MP:0000639,abnormal adrenal gland morphology|MP:0001547,abnormal lipid level|MP:0001556,increased circulating HDL cholesterol level|MP:0002446,abnormal macrophage morphology|MP:0005178,increased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis
MGI:1934032	Soat1<tm1Ishi>	MP:0001337,dry eyes|MP:0001345,Meibomian gland atrophy|MP:0002118,abnormal lipid homeostasis|MP:0005287,narrow eye opening
MGI:5426949	Soat2<tm1.1Llr>	MP:0000183,decreased circulating LDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0002647,decreased intestinal cholesterol absorption|MP:0003982,increased cholesterol level|MP:0003983,decreased cholesterol level|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005381,digestive/alimentary phenotype|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level
MGI:2450875	Soat2<tm1Far>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000496,abnormal small intestine morphology|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0002647,decreased intestinal cholesterol absorption|MP:0004773,abnormal bile composition|MP:0005085,abnormal gallbladder physiology|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:1856614	Sobp<jc>	MP:0000031,abnormal cochlea morphology|MP:0001394,circling|MP:0001395,bidirectional circling|MP:0001399,hyperactivity|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0004737,absent distortion product otoacoustic emissions|MP:0004813,absent linear vestibular evoked potential|MP:0008307,short scala media|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0011968,decreased threshold for auditory brainstem response
MGI:3055292	Sobp<jc-2J>	MP:0001394,circling|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856715	soc	MP:0000367,abnormal coat/ hair morphology|MP:0000422,delayed hair appearance|MP:0001216,abnormal epidermal layer morphology|MP:0001511,disheveled coat|MP:0002073,abnormal hair growth|MP:0002074,abnormal hair texture
MGI:5698257	Socs1<tm1.1Ayr>	MP:0002444,abnormal T cell physiology|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0013771,decreased effector memory T-helper cell number
MGI:5584406	Socs1<tm1.1(KOMP)Vlcg>	MP:0011100,preweaning lethality, complete penetrance
MGI:3778686	Socs1<tm1Ayos>	MP:0001194,dermatitis|MP:0001852,conjunctivitis|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004973,increased regulatory T cell number|MP:0005251,blepharitis|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:3051623	Socs1<tm1Jni>	MP:0000598,abnormal liver morphology|MP:0000715,decreased thymocyte number|MP:0002145,abnormal T cell differentiation|MP:0003009,abnormal cytokine secretion|MP:0005017,decreased B cell number|MP:0008713,abnormal cytokine level|MP:0008751,abnormal interleukin level|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010264,increased hepatoma incidence|MP:0011085,postnatal lethality, complete penetrance
MGI:2445448	Socs1<tm1Kish>	MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001829,increased activated T cell number|MP:0001860,liver inflammation|MP:0002357,abnormal spleen white pulp morphology|MP:0003644,thymus atrophy|MP:0003945,abnormal lymphocyte physiology|MP:0005016,decreased lymphocyte cell number|MP:0005165,increased susceptibility to injury|MP:0008039,increased NK T cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0013741,absent thymus corticomedullary boundary
MGI:1934607	Socs1<tm1Wehi>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0000696,abnormal Peyer's patch morphology|MP:0000706,small thymus|MP:0001219,thick epidermis|MP:0001262,decreased body weight|MP:0001654,hepatic necrosis|MP:0001732,postnatal growth retardation|MP:0001845,abnormal inflammatory response|MP:0001846,increased inflammatory response|MP:0001853,heart inflammation|MP:0001860,liver inflammation|MP:0001869,pancreas inflammation|MP:0002344,abnormal lymph node B cell domain morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002451,abnormal macrophage physiology|MP:0002628,hepatic steatosis|MP:0003103,liver degeneration|MP:0003179,thrombocytopenia|MP:0005012,decreased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005397,hematopoietic system phenotype|MP:0008171,abnormal mature B cell morphology|MP:0008172,abnormal follicular B cell morphology|MP:0008209,decreased pre-B cell number|MP:0008476,increased spleen red pulp amount|MP:0010903,abnormal pulmonary alveolus wall morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0013585,thymus cortex atrophy|MP:0031041,decreased susceptibility to Togaviridae infection induced morbidity/mortality
MGI:2177057	Socs1<tm2Wehi>	MP:0000240,extramedullary hematopoiesis|MP:0001262,decreased body weight|MP:0001313,increased incidence of corneal inflammation|MP:0001846,increased inflammatory response|MP:0001856,myocarditis|MP:0001858,intestinal inflammation|MP:0001860,liver inflammation|MP:0001869,pancreas inflammation|MP:0001870,salivary gland inflammation|MP:0002083,premature death|MP:0002743,glomerulonephritis|MP:0003644,thymus atrophy|MP:0004510,myositis|MP:0004947,skin inflammation|MP:0008474,absent spleen germinal center
MGI:2656956	Socs1<tm3.1Wehi>	MP:0001845,abnormal inflammatory response|MP:0008577,increased circulating interferon-gamma level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2656917	Socs1<tm3Wehi>	MP:0002169,no abnormal phenotype detected
MGI:6402019	Socs2<em1(IMPC)H>	MP:0005553,increased circulating creatinine level|MP:0010053,decreased grip strength
MGI:1856899	Socs2<hg>	MP:0001259,abnormal body weight|MP:0001260,increased body weight|MP:0002161,abnormal fertility/fecundity|MP:0004890,decreased energy expenditure|MP:0005450,abnormal energy expenditure
MGI:5640786	Socs2<m1Btlr>	MP:0001260,increased body weight
MGI:5695065	Socs2<tm1Vem>	MP:0000558,abnormal tibia morphology|MP:0001260,increased body weight|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004357,long tibia|MP:0005390,skeleton phenotype|MP:0006398,increased long bone epiphyseal plate size|MP:0008162,increased diameter of tibia|MP:0009347,increased trabecular bone thickness|MP:0010867,abnormal bone trabecula morphology|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0010967,increased compact bone area|MP:0013631,decreased bone trabecular spacing
MGI:1934557	Socs2<tm1Wehi>	MP:0001175,abnormal lung morphology|MP:0001245,thick dermal layer|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001860,liver inflammation|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002138,abnormal hepatobiliary system morphology|MP:0002451,abnormal macrophage physiology|MP:0002865,increased growth rate|MP:0004348,long femur|MP:0004350,long humerus|MP:0004357,long tibia|MP:0004695,increased length of long bones|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005120,decreased circulating growth hormone level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005375,adipose tissue phenotype|MP:0005418,abnormal circulating hormone level|MP:0005559,increased circulating glucose level|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008657,increased interleukin-1 beta secretion|MP:0008831,abnormal insulin-like growth factor I level|MP:0008951,long radius|MP:0009143,abnormal pancreatic duct morphology|MP:0009302,increased renal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0009517,abnormal salivary gland duct morphology|MP:0009643,abnormal urine homeostasis|MP:0010210,abnormal circulating cytokine level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis|MP:0031415,increased skeletal muscle triglyceride level
MGI:3051525	Socs3<tm1Ayos>	MP:0001262,decreased body weight|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005449,abnormal food intake|MP:0008734,decreased susceptibility to endotoxin shock|MP:0014143,decreased body fat mass|MP:0014440,increased response to leptin
MGI:2181439	Socs3<tm1Jni>	MP:0000598,abnormal liver morphology|MP:0001190,reddish skin|MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0002891,increased insulin sensitivity|MP:0003131,increased erythrocyte cell number|MP:0004229,abnormal embryonic erythropoiesis|MP:0005292,improved glucose tolerance|MP:0005397,hematopoietic system phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008687,increased interleukin-2 secretion|MP:0009395,increased nucleated erythrocyte cell number|MP:0010025,decreased total body fat amount|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0014440,increased response to leptin
MGI:3835162	Socs3<tm1Robb>	MP:0000219,increased neutrophil cell number|MP:0000691,enlarged spleen|MP:0002429,abnormal blood cell morphology/development|MP:0003724,increased susceptibility to induced arthritis|MP:0009278,abnormal bone marrow cell physiology
MGI:2180861	Socs3<tm1Wsa>	MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0003231,abnormal placenta vasculature|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009397,increased trophoblast giant cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012099,decreased spongiotrophoblast size|MP:0030989,decreased spongiotrophoblast cell number
MGI:2663925	Socs3<tm2.1Wsa>	MP:0001711,abnormal placenta morphology|MP:0002080,prenatal lethality
MGI:7587716	Socs4<m1Nch>	MP:0001828,abnormal T cell activation|MP:0005015,increased T cell number|MP:0005018,decreased T cell number|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0008566,increased interferon-gamma secretion|MP:0008651,increased interleukin-1 secretion|MP:0008669,increased interleukin-12b secretion|MP:0008672,increased interleukin-13 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0031046,increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:3050577	Socs5<tm1Wsa>	MP:0002169,no abnormal phenotype detected|MP:0006269,abnormal mammary gland growth during pregnancy
MGI:2429394	Socs6<tm1Dlk>	MP:0001262,decreased body weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:5789572	Socs7<M1Btlr>	MP:0001262,decreased body weight
MGI:4432554	Socs7<tm1a(EUCOMM)Wtsi>	MP:0002697,abnormal eye size|MP:0004924,abnormal behavior|MP:0010167,decreased response to stress-induced hyperthermia|MP:0012538,persistent hyaloid artery|MP:0013600,testis degeneration
MGI:5545789	Socs7<tm1c(EUCOMM)Wtsi>	MP:0003631,nervous system phenotype|MP:0008547,abnormal neocortex morphology
MGI:3603205	Socs7<tm1Pbro>	MP:0000189,hypoglycemia|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0002078,abnormal glucose homeostasis|MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0010768,mortality/aging|MP:0011085,postnatal lethality, complete penetrance
MGI:3487375	Socs7<tm1Wsa>	MP:0000434,megacephaly|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001438,aphagia|MP:0001891,hydrocephaly|MP:0001915,intracranial hemorrhage|MP:0002083,premature death|MP:0002835,abnormal cranial suture morphology|MP:0005202,lethargy|MP:0009171,enlarged pancreatic islets|MP:0009716,abnormal subcommissural organ morphology
MGI:5575771	Sod1<m1H>	MP:0000160,kyphosis|MP:0000598,abnormal liver morphology|MP:0000745,tremors|MP:0000748,progressive muscle weakness|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0000940,abnormal motor neuron innervation pattern|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001860,liver inflammation|MP:0001973,increased thermal nociceptive threshold|MP:0002083,premature death|MP:0002878,abnormal corticospinal tract morphology|MP:0003313,abnormal locomotor activation|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003354,astrocytosis|MP:0004087,abnormal muscle fiber morphology|MP:0004811,abnormal neuron physiology|MP:0005356,positive geotaxis|MP:0005498,hyporesponsive to tactile stimuli|MP:0006036,abnormal mitochondrial physiology|MP:0008019,increased liver tumor incidence|MP:0008918,microgliosis|MP:0010053,decreased grip strength|MP:0010831,lethality, incomplete penetrance|MP:0012320,abnormal body fat mass
MGI:1857872	Sod1<tm1Cep>	MP:0000043,organ of Corti degeneration|MP:0002628,hepatic steatosis|MP:0002857,cochlear ganglion degeneration|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004586,pillar cell degeneration|MP:0004597,increased susceptibility to noise-induced hearing loss|MP:0004716,abnormal cochlear nerve morphology|MP:0004748,increased susceptibility to age-related hearing loss|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008813,decreased common myeloid progenitor cell number|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2680903	Sod1<tm1Cje>	MP:0011704,decreased fibroblast proliferation|MP:0013501,increased fibroblast apoptosis
MGI:2387861	Sod1<tm1Dkd>	MP:0001544,abnormal cardiovascular system physiology|MP:0003037,increased myocardial infarct size|MP:0003674,oxidative stress|MP:0005140,decreased cardiac muscle contractility|MP:0005319,abnormal enzyme/coenzyme level|MP:0006085,myocardium necrosis
MGI:1857873	Sod1<tm1Leb>	MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001749,suppressed circulating follicle stimulating hormone level|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0001967,deafness|MP:0002680,decreased corpora lutea number|MP:0002682,decreased mature ovarian follicle number|MP:0002773,decreased circulating luteinizing hormone level|MP:0002857,cochlear ganglion degeneration|MP:0003674,oxidative stress|MP:0004364,thin stria vascularis|MP:0005241,abnormal retina ganglion layer morphology|MP:0005251,blepharitis|MP:0005252,abnormal Meibomian gland morphology|MP:0005551,abnormal eye electrophysiology|MP:0006000,abnormal cornea epithelium morphology|MP:0006035,abnormal mitochondrial morphology|MP:0006303,abnormal retina nerve fiber layer morphology|MP:0006309,decreased retina ganglion cell number|MP:0008511,thin retina inner nuclear layer|MP:0008512,disorganized retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008516,disorganized retina outer nuclear layer|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008596,increased circulating interleukin-6 level|MP:0008705,increased interleukin-6 secretion|MP:0009935,abnormal Meibomian gland acinus morphology|MP:0011632,dilated mitochondrion|MP:0011636,disorganized mitochondrial cristae|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0013391,abnormal Meibomian gland physiology|MP:0013392,Meibomian gland inflammation|MP:0020218,abnormal tear production|MP:0020220,decreased tear production
MGI:5529176	Sod1<tm1Svb>	MP:0000747,muscle weakness|MP:0000750,abnormal muscle regeneration|MP:0002106,abnormal muscle physiology|MP:0003631,nervous system phenotype|MP:0004818,increased skeletal muscle mass|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009421,increased gastrocnemius weight|MP:0009423,increased extensor digitorum longus weight|MP:0009425,increased soleus weight|MP:0009427,increased tibialis anterior weight|MP:0010226,increased quadriceps weight
MGI:3526701	Sod1<tm1Ysh>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0009746,enhanced behavioral response to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:3578627	Sod2<tm1.1Kskk>	MP:0000278,abnormal myocardial fiber morphology|MP:0001732,postnatal growth retardation|MP:0002899,fatigue|MP:0003222,increased cardiomyocyte apoptosis|MP:0003674,oxidative stress|MP:0011085,postnatal lethality, complete penetrance|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:1857344	Sod2<tm1Cje>	MP:0000208,decreased hematocrit|MP:0000274,enlarged heart|MP:0000280,thin ventricular wall|MP:0000609,abnormal liver physiology|MP:0000745,tremors|MP:0000759,abnormal skeletal muscle morphology|MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000798,abnormal frontal lobe morphology|MP:0000807,abnormal hippocampus morphology|MP:0000832,abnormal thalamus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000906,abnormal trigeminal V mesencephalic nucleus morphology|MP:0000911,abnormal trigeminal motor nucleus morphology|MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0001330,abnormal optic nerve morphology|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001523,impaired righting response|MP:0001625,cardiac hypertrophy|MP:0001732,postnatal growth retardation|MP:0002020,increased tumor incidence|MP:0002064,seizures|MP:0002152,abnormal brain morphology|MP:0002319,hyperoxia|MP:0002329,abnormal blood gas level|MP:0002575,increased circulating ketone body level|MP:0002628,hepatic steatosis|MP:0002654,spongiform encephalopathy|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0002899,fatigue|MP:0002968,increased circulating alkaline phosphatase level|MP:0002981,increased liver weight|MP:0003027,abnormal blood pH regulation|MP:0003031,acidosis|MP:0003032,hypocapnia|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003141,cardiac fibrosis|MP:0003195,calcinosis|MP:0003224,neuron degeneration|MP:0003674,oxidative stress|MP:0003717,pallor|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003887,increased hepatocyte apoptosis|MP:0004144,hypotonia|MP:0004200,decreased fetal size|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005277,abnormal brainstem morphology|MP:0005319,abnormal enzyme/coenzyme level|MP:0005343,increased circulating aspartate transaminase level|MP:0005370,liver/biliary system phenotype|MP:0005405,axon degeneration|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0005621,abnormal cell physiology|MP:0006036,abnormal mitochondrial physiology|MP:0008025,brain vacuoles|MP:0008511,thin retina inner nuclear layer|MP:0009400,decreased skeletal muscle fiber size|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0010768,mortality/aging|MP:0010955,abnormal respiratory electron transport chain|MP:0010957,abnormal aerobic respiration|MP:0010958,abnormal tricarboxylic acid cycle|MP:0011015,decreased body surface temperature|MP:0011085,postnatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012431,increased lymphoma incidence|MP:0012551,metabolic acidosis|MP:0013404,decreased circulating lactate level|MP:0030612,organic aciduria
MGI:5774733	Sod2<tm1Kskk>	MP:0001326,retina degeneration|MP:0002792,abnormal retina vasculature morphology|MP:0002864,abnormal ocular fundus morphology|MP:0003674,oxidative stress|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005098,abnormal optic choroid morphology|MP:0005103,abnormal retina pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology|MP:0005548,retina pigment epithelium atrophy|MP:0006185,retina hemorrhage|MP:0008450,retina photoreceptor degeneration|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0008515,thin retina outer nuclear layer|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:1857480	Sod2<tm1Leb>	MP:0000280,thin ventricular wall|MP:0000333,decreased bone marrow cell number|MP:0000607,abnormal hepatocyte morphology|MP:0000746,weakness|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001394,circling|MP:0001577,anemia|MP:0001602,impaired myelopoiesis|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002118,abnormal lipid homeostasis|MP:0002229,neurodegeneration|MP:0002795,dilated cardiomyopathy|MP:0002899,fatigue|MP:0003717,pallor|MP:0004819,decreased skeletal muscle mass|MP:0005377,hearing/vestibular/ear phenotype|MP:0005389,reproductive system phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0010025,decreased total body fat amount|MP:0011085,postnatal lethality, complete penetrance
MGI:5568594	Sod2<tm1(rtTA*M2,tetO)Jsg>	MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0003186,abnormal redox activity|MP:0012556,increased cell death|MP:0014764,impaired double-strand DNA break repair
MGI:2447406	Sod2<tm1Shs>	MP:0000274,enlarged heart|MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0002899,fatigue|MP:0003061,decreased aerobic running capacity|MP:0003083,abnormal tibialis anterior morphology|MP:0003646,increased muscle fatigability|MP:0003674,oxidative stress|MP:0003921,abnormal heart left ventricle morphology|MP:0004566,myocardial fiber degeneration|MP:0004937,dilated heart|MP:0005140,decreased cardiac muscle contractility|MP:0005319,abnormal enzyme/coenzyme level|MP:0005329,abnormal myocardium layer morphology|MP:0005367,renal/urinary system phenotype|MP:0005369,muscle phenotype|MP:0005370,liver/biliary system phenotype|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005608,cardiac interstitial fibrosis|MP:0005620,abnormal muscle contractility|MP:0006036,abnormal mitochondrial physiology|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0009051,dilated distal convoluted tubule|MP:0009640,abnormal renal tubule epithelium morphology|MP:0010630,abnormal cardiac muscle tissue morphology|MP:0010632,cardiac muscle necrosis|MP:0010768,mortality/aging|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0010959,abnormal oxidative phosphorylation|MP:0011089,perinatal lethality, complete penetrance|MP:0011402,renal cast|MP:0011631,decreased mitochondrial size|MP:0011635,abnormal mitochondrial crista morphology|MP:0011925,abnormal heart echocardiography feature|MP:0011940,decreased food intake|MP:0012106,impaired exercise endurance|MP:0014071,increased cardiac muscle glycogen level|MP:0014344,abnormal skeletal muscle fiber mitochondrial morphology|MP:0030021,increased muscle cell glucose uptake|MP:0031131,myocardial fiber disarray
MGI:5788667	Sod2<tm1Smel>	MP:0001212,skin lesions|MP:0001218,thin epidermis|MP:0001219,thick epidermis|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0002656,abnormal keratinocyte differentiation|MP:0002724,enhanced wound healing|MP:0002908,delayed wound healing|MP:0008008,early cellular replicative senescence|MP:0009584,decreased keratinocyte proliferation|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011687,decreased epidermal stem cell number
MGI:4818481	Sod2<tm1(tetO-Sod2)Evbo>	MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001525,impaired balance|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0003674,oxidative stress|MP:0003921,abnormal heart left ventricle morphology|MP:0004564,increased myocardial fiber size|MP:0006085,myocardium necrosis|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0011085,postnatal lethality, complete penetrance|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3811715	Sod3<tm1Dgh>	MP:0002169,no abnormal phenotype detected
MGI:2652386	Sod3<tm1Mrkl>	MP:0002993,autoimmune arthritis|MP:0003724,increased susceptibility to induced arthritis|MP:0008560,increased tumor necrosis factor secretion|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0014600,increased susceptibility to hyperoxia-induced injury|MP:0014708,increased synovial pannus formation
MGI:5621017	Sod3<tm1Svp>	MP:0000276,heart right ventricle hypertrophy|MP:0000484,abnormal pulmonary artery morphology|MP:0004485,increased response of heart to induced stress|MP:0008734,decreased susceptibility to endotoxin shock|MP:0010758,increased right ventricle systolic pressure
MGI:3629211	Sohlh1<tm1Rajk>	MP:0001129,impaired ovarian folliculogenesis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002777,absent ovarian follicles|MP:0004805,absent oocytes|MP:0004833,ovary atrophy|MP:0004852,decreased testis weight|MP:0005431,decreased oocyte number|MP:0011126,absent primary ovarian follicles
MGI:5638449	Sohlh2<tm1Fkh>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0003205,testicular atrophy|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0006378,abnormal spermatogonia morphology|MP:0006379,abnormal spermatocyte morphology
MGI:3829597	Sohlh2<tm1Miya>	MP:0001129,impaired ovarian folliculogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0002777,absent ovarian follicles|MP:0003205,testicular atrophy|MP:0004833,ovary atrophy|MP:0006378,abnormal spermatogonia morphology|MP:0006379,abnormal spermatocyte morphology
MGI:3839324	Sohlh2<tm1Rajk>	MP:0001926,female infertility|MP:0003357,impaired granulosa cell differentiation|MP:0004833,ovary atrophy|MP:0005431,decreased oocyte number|MP:0008871,abnormal ovarian follicle number|MP:0011125,decreased primary ovarian follicle number
MGI:7638800	Son<em1.1Bcgen>	MP:0000069,kyphoscoliosis|MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000245,abnormal erythropoiesis|MP:0000248,macrocytosis|MP:0000333,decreased bone marrow cell number|MP:0000433,microcephaly|MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0001606,impaired hematopoiesis|MP:0001732,postnatal growth retardation|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002144,abnormal B cell differentiation|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002590,increased mean corpuscular volume|MP:0002797,increased thigmotaxis|MP:0003132,increased pre-B cell number|MP:0003179,thrombocytopenia|MP:0003446,renal hypoplasia|MP:0003461,abnormal response to novel object|MP:0003604,single kidney|MP:0004810,decreased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008184,abnormal naive B cell morphology|MP:0008188,abnormal transitional stage B cell morphology|MP:0008489,slow postnatal weight gain|MP:0008973,decreased erythroid progenitor cell number|MP:0009922,increased transitional stage T1 B cell number|MP:0009926,decreased transitional stage T2 B cell number|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011246,abnormal fetal liver hematopoietic progenitor cell morphology|MP:0013630,increased bone trabecular spacing|MP:0013660,abnormal bone marrow hematopoietic cell morphology|MP:0013704,increased megakaryocyte-erythroid progenitor cell number|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance|MP:0014370,impaired spatial working memory|MP:0021182,decreased femoral compact bone area
MGI:6153757	Son<em1(IMPC)Wtsi>	MP:0005561,increased mean corpuscular hemoglobin
MGI:1889611	soo	MP:0001188,hyperpigmentation
MGI:3711721	Sorbs1<tm1Krc>	MP:0000221,decreased leukocyte cell number|MP:0000223,decreased monocyte cell number|MP:0001560,abnormal circulating insulin level|MP:0002078,abnormal glucose homeostasis|MP:0002891,increased insulin sensitivity|MP:0005016,decreased lymphocyte cell number|MP:0005292,improved glucose tolerance|MP:0005318,decreased triglyceride level|MP:0005670,abnormal white adipose tissue physiology|MP:0006094,increased fat cell size
MGI:5775605	Sorbs2<tm1.1Gfng>	MP:0002169,no abnormal phenotype detected
MGI:5494474	Sorbs2<tm1.1(KOMP)Mbp>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001325,abnormal retina morphology|MP:0001417,decreased exploration in new environment|MP:0002626,increased heart rate|MP:0002702,decreased circulating free fatty acids level|MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0005179,decreased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0005633,increased circulating sodium level|MP:0010511,shortened PR interval|MP:0010571,shortened ST segment|MP:0011954,shortened PQ interval
MGI:5776502	Sorbs2<tm1.2Gfng>	MP:0001489,decreased startle reflex|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005386,behavior/neurological phenotype|MP:0008143,abnormal dendrite morphology|MP:0009142,decreased prepulse inhibition|MP:0009454,impaired contextual conditioning behavior|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014367,impaired long-term object recognition memory
MGI:4822403	Sorbs3<tm1Kiok>	MP:0002908,delayed wound healing|MP:0003091,abnormal cell migration
MGI:3611214	Sorbs3<tm1Kmor>	MP:0005389,reproductive system phenotype
MGI:4836913	Sorcs1<tm1.1Gndy>	MP:0003329,amyloid beta deposits
MGI:5649357	Sorcs2<tm1Anyk>	MP:0000788,abnormal cerebral cortex morphology|MP:0002184,abnormal innervation|MP:0003631,nervous system phenotype|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004811,abnormal neuron physiology|MP:0005166,decreased susceptibility to injury|MP:0005643,decreased dopamine level|MP:0008415,abnormal neurite morphology|MP:0009748,abnormal behavioral response to addictive substance|MP:0031391,increased locomotor activity
MGI:5562419	Sorcs3<tm1.1Tew>	MP:0001899,absent long-term depression|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory|MP:0012307,impaired spatial learning|MP:0012312,impaired avoidance learning behavior
MGI:3616090	Sord<C57BL/Lia>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002169,no abnormal phenotype detected
MGI:7425999	Sord<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0005565,increased blood urea nitrogen level
MGI:7314448	Sord<em1Mko>	MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance
MGI:3759785	Sorl1<Gt(Ex255)Byg>	MP:0003329,amyloid beta deposits
MGI:5569945	Sorl1<tm1b(EUCOMM)Wtsi>	MP:0000443,abnormal snout morphology|MP:0001325,abnormal retina morphology|MP:0001406,abnormal gait|MP:0002997,enlarged seminal vesicle
MGI:3815203	Sorl1<tm1Bujo>	MP:0004883,abnormal vascular wound healing|MP:0005595,abnormal vascular smooth muscle physiology
MGI:3604352	Sorl1<tm1Tew>	MP:0001038,abnormal cholinergic neuron morphology|MP:0001458,abnormal object recognition memory|MP:0003224,neuron degeneration|MP:0003329,amyloid beta deposits|MP:0003631,nervous system phenotype|MP:0004250,tau protein deposits|MP:0012307,impaired spatial learning
MGI:5636963	Sort1<tm1b(EUCOMM)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:4397584	Sort1<tm1Camo>	MP:0005058,abnormal lysosome morphology|MP:0005253,abnormal eye physiology|MP:0008752,abnormal tumor necrosis factor level
MGI:3767625	Sort1<tm1Tew>	MP:0000937,abnormal motor neuron morphology|MP:0002882,abnormal neuron morphology|MP:0008056,abnormal retina ganglion cell morphology
MGI:5141757	Sos1<tm1.1Les>	MP:0000715,decreased thymocyte number|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008347,decreased gamma-delta T cell number|MP:0010136,decreased DN4 thymocyte number
MGI:5000290	Sos1<tm1.2Rak>	MP:0000107,abnormal frontal bone morphology|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000266,abnormal heart morphology|MP:0000276,heart right ventricle hypertrophy|MP:0000278,abnormal myocardial fiber morphology|MP:0000428,abnormal craniofacial morphology|MP:0000691,enlarged spleen|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001300,ocular hypertelorism|MP:0001786,skin edema|MP:0001914,hemorrhage|MP:0002083,premature death|MP:0002625,heart left ventricle hypertrophy|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0003921,abnormal heart left ventricle morphology|MP:0004564,increased myocardial fiber size|MP:0004566,myocardial fiber degeneration|MP:0005312,pericardial effusion|MP:0005385,cardiovascular system phenotype|MP:0005608,cardiac interstitial fibrosis|MP:0006117,aortic valve stenosis|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008254,increased megakaryocyte cell number|MP:0008476,increased spleen red pulp amount|MP:0008525,decreased cranium height|MP:0010402,ventricular septal defect|MP:0010405,ostium secundum atrial septal defect|MP:0010593,thick aortic valve cusps|MP:0010724,thick interventricular septum|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011393,decreased fetal cardiomyocyte apoptosis|MP:0011394,increased fetal cardiomyocyte proliferation
MGI:2155441	Sos1<tm1Dlb>	MP:0000111,cleft palate|MP:0000255,blood vessel congestion|MP:0000274,enlarged heart|MP:0000291,enlarged pericardium|MP:0000292,distended pericardium|MP:0000897,abnormal midbrain morphology|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0001914,hemorrhage|MP:0002127,abnormal cardiovascular system morphology|MP:0002189,abnormal myocardial trabeculae morphology|MP:0003105,abnormal heart atrium morphology|MP:0005294,abnormal heart ventricle morphology|MP:0006065,abnormal heart position or orientation|MP:0011091,prenatal lethality, complete penetrance
MGI:2155442	Sos1<tm1Lowy>	MP:0002086,abnormal extraembryonic tissue morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2385790	Sos2<tm1Esn>	MP:0002169,no abnormal phenotype detected
MGI:3694627	Sostdc1<shk>	MP:0000088,short mandible|MP:0003755,abnormal palate morphology|MP:0003756,abnormal hard palate morphology|MP:0006369,supernumerary incisors|MP:0008525,decreased cranium height|MP:0008526,decreased cranium width|MP:0009652,abnormal palatal rugae morphology
MGI:5695910	Sostdc1<tm1.1(KOMP)Vlcg>	MP:0001289,persistence of hyaloid vascular system|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3617495	Sostdc1<tm1Myan>	MP:0004033,supernumerary teeth|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0011372,decreased renal tubule apoptosis|MP:0030473,fused molars
MGI:3604658	Sostdc1<tm1Nit>	MP:0003932,abnormal molar crown morphology|MP:0010773,supernumerary molars|MP:0010864,abnormal enamel knot morphology|MP:0030457,abnormal molar cusp morphology|MP:0030473,fused molars
MGI:3802970	Sostdc1<tm1Noit>	MP:0001092,abnormal trigeminal ganglion morphology|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5617872	Sostdc1<tm1Snd>	MP:0000062,increased bone mineral density|MP:0002896,abnormal bone mineralization|MP:0004985,decreased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0005006,abnormal osteoblast physiology|MP:0005605,increased bone mass|MP:0008271,abnormal bone ossification|MP:0010123,increased bone mineral content|MP:0010768,mortality/aging|MP:0010878,increased trabecular bone volume|MP:0014101,decreased chondrocyte proliferation|MP:0030438,increased osteoblast proliferation
MGI:4360516	Sostdc1<tm2Myan>	MP:0002100,abnormal tooth morphology
MGI:5617945	Sostdc1<tm2Snd>	MP:0000062,increased bone mineral density|MP:0002896,abnormal bone mineralization|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5304482	Sost<tm1Dgen>	MP:0000062,increased bone mineral density|MP:0004148,increased compact bone thickness|MP:0005605,increased bone mass|MP:0008271,abnormal bone ossification|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0021191,increased bone mineral density of lumbar vertebrae
MGI:3797839	Sost<tm1(KOMP)Vlcg>	MP:0000062,increased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0002896,abnormal bone mineralization|MP:0003797,abnormal compact bone morphology|MP:0004148,increased compact bone thickness|MP:0004986,abnormal osteoblast morphology|MP:0005390,skeleton phenotype|MP:0005605,increased bone mass|MP:0008271,abnormal bone ossification|MP:0009347,increased trabecular bone thickness|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume|MP:0010878,increased trabecular bone volume|MP:0010932,increased trabecular bone connectivity density|MP:0010967,increased compact bone area|MP:0020011,increased bone mineral density of femur|MP:0021191,increased bone mineral density of lumbar vertebrae|MP:0030480,decreased osteocyte apoptosis
MGI:5007345	Sost<tm1Lex>	MP:0004148,increased compact bone thickness
MGI:4941817	Sost<tm1Lhe>	MP:0000062,increased bone mineral density|MP:0002998,abnormal bone remodeling|MP:0004986,abnormal osteoblast morphology|MP:0005006,abnormal osteoblast physiology|MP:0005605,increased bone mass|MP:0020011,increased bone mineral density of femur|MP:0030442,decreased osteoblast apoptosis|MP:0030480,decreased osteocyte apoptosis|MP:0030482,increased osteocyte number
MGI:3850014	Sost<tm1Paz>	MP:0000062,increased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0001260,increased body weight|MP:0002896,abnormal bone mineralization|MP:0004149,increased bone strength|MP:0004348,long femur|MP:0005006,abnormal osteoblast physiology|MP:0005605,increased bone mass|MP:0008271,abnormal bone ossification|MP:0009347,increased trabecular bone thickness|MP:0010123,increased bone mineral content|MP:0010868,increased bone trabecula number|MP:0010872,increased trabecular bone mass|MP:0010875,increased bone volume|MP:0010878,increased trabecular bone volume|MP:0010961,increased compact bone mass|MP:0010964,increased compact bone volume|MP:0010967,increased compact bone area|MP:0013617,increased areal bone mineral density|MP:0013640,increased bone stiffness|MP:0020011,increased bone mineral density of femur
MGI:5544793	Sost<tm2.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:6313354	Sowaha<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney
MGI:5296367	Sowahb<m1Tc>	MP:0000914,exencephaly|MP:0000930,wavy neural tube|MP:0003632,abnormal nervous system morphology
MGI:3775949	Sox10<Dal>	MP:0002940,variable body spotting
MGI:3606975	Sox10<df10R>	MP:0000373,belly spot
MGI:3606976	Sox10<df8R>	MP:0000373,belly spot
MGI:1857401	Sox10<Dom>	MP:0000477,abnormal intestine morphology|MP:0000492,abnormal rectum morphology|MP:0000495,abnormal colon morphology|MP:0000938,motor neuron degeneration|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000964,small dorsal root ganglion|MP:0000965,abnormal sensory neuron morphology|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001011,abnormal superior cervical ganglion morphology|MP:0001034,abnormal parasympathetic ganglion morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001077,abnormal spinal nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001087,abnormal nodose ganglion morphology|MP:0001105,abnormal PNS glial cell morphology|MP:0001106,abnormal Schwann cell morphology|MP:0002731,megacolon|MP:0002926,aganglionic megacolon|MP:0002938,white spotting|MP:0002940,variable body spotting|MP:0002950,abnormal neural crest cell migration|MP:0003993,abnormal ventral spinal root morphology|MP:0008492,dorsal root ganglion degeneration|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0012745,abnormal neural crest cell physiology|MP:0013001,abnormal enteric neural crest cell morphology|MP:0013003,absent enteric neural crest cell|MP:0013007,abnormal vagal neural crest cell migration|MP:0030908,abnormal melanocyte differentiation
MGI:1856893	Sox10<gt>	MP:0000370,head blaze|MP:0000371,diluted coat color|MP:0000373,belly spot|MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0000951,sporadic seizures|MP:0001189,absent skin pigmentation|MP:0001663,abnormal digestive system physiology|MP:0002064,seizures|MP:0002083,premature death|MP:0002183,gliosis|MP:0002654,spongiform encephalopathy|MP:0002731,megacolon|MP:0005175,non-pigmented tail tip|MP:0005409,darkened coat color|MP:0008025,brain vacuoles|MP:0011568,decreased foot pigmentation|MP:0013438,dysmyelination
MGI:5509309	Sox10<M2Btlr>	MP:0000373,belly spot|MP:0011568,decreased foot pigmentation
MGI:5300065	Sox10<M2J>	MP:0002940,variable body spotting|MP:0011277,decreased tail pigmentation|MP:0011568,decreased foot pigmentation
MGI:5544794	Sox10<tm1.1Sout>	MP:0002169,no abnormal phenotype detected
MGI:6762161	Sox10<tm1Ngan>	MP:0004493,dilated cochlea
MGI:2151173	Sox10<tm1Weg>	MP:0000373,belly spot|MP:0000819,abnormal olfactory bulb morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001105,abnormal PNS glial cell morphology|MP:0001108,absent Schwann cells|MP:0001491,unresponsive to tactile stimuli|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0002731,megacolon|MP:0002926,aganglionic megacolon|MP:0002961,abnormal axon guidance|MP:0003634,abnormal glial cell morphology|MP:0004263,abnormal limb posture|MP:0005404,abnormal axon morphology|MP:0005408,hypopigmentation|MP:0008025,brain vacuoles|MP:0008917,abnormal oligodendrocyte physiology|MP:0009450,abnormal axon fasciculation|MP:0009783,abnormal melanoblast morphology|MP:0009846,abnormal neural crest morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011266,abnormal frontonasal mesenchyme morphology|MP:0011805,decreased cell migration|MP:0012023,decreased melanocyte number
MGI:3513104	Sox10<tm2(rtTA)Weg>	MP:0000373,belly spot|MP:0002075,abnormal coat/hair pigmentation|MP:0002731,megacolon|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3701358	Sox10<tm3(Sox8)Weg>	MP:0000394,absent hair follicle melanin granules|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001732,postnatal growth retardation|MP:0003631,nervous system phenotype|MP:0005171,absent coat pigmentation|MP:0005381,digestive/alimentary phenotype|MP:0009783,abnormal melanoblast morphology|MP:0009808,decreased oligodendrocyte number|MP:0011085,postnatal lethality, complete penetrance|MP:0013006,abnormal enteric neural crest cell migration|MP:0013009,increased vagal neural crest cell apoptosis
MGI:3723308	Sox10<tm4Weg>	MP:0000373,belly spot|MP:0001046,abnormal enteric neuron morphology|MP:0001106,abnormal Schwann cell morphology|MP:0002926,aganglionic megacolon|MP:0003631,nervous system phenotype|MP:0005381,digestive/alimentary phenotype|MP:0006408,dorsal root ganglion hypoplasia|MP:0009784,abnormal melanoblast migration|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3723291	Sox10<tm5Weg>	MP:0001046,abnormal enteric neuron morphology|MP:0001106,abnormal Schwann cell morphology|MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype|MP:0006408,dorsal root ganglion hypoplasia|MP:0009784,abnormal melanoblast migration|MP:0009808,decreased oligodendrocyte number|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4456384	Sox10<tm6(Sox100B)Weg>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001025,abnormal sympathetic neuron morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0003631,nervous system phenotype|MP:0006408,dorsal root ganglion hypoplasia|MP:0008289,abnormal adrenal medulla morphology|MP:0008948,decreased neuron number|MP:0009783,abnormal melanoblast morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:4820417	Sox10<tm7.1(Sox10)Weg>	MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0001106,abnormal Schwann cell morphology|MP:0001262,decreased body weight|MP:0001392,abnormal locomotor behavior|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002651,abnormal sciatic nerve morphology|MP:0003203,increased neuron apoptosis|MP:0004263,abnormal limb posture|MP:0005402,abnormal action potential|MP:0008814,decreased nerve conduction velocity|MP:0009808,decreased oligodendrocyte number|MP:0009967,abnormal neuron proliferation
MGI:6154154	Sox10<tm8.1Weg>	MP:0000373,belly spot|MP:0001107,decreased Schwann cell number|MP:0002731,megacolon|MP:0003632,abnormal nervous system morphology|MP:0008917,abnormal oligodendrocyte physiology|MP:0011087,neonatal lethality, complete penetrance|MP:0011904,abnormal Schwann cell physiology
MGI:5518640	Sox11<tm1.1Gan>	MP:0000088,short mandible|MP:0000428,abnormal craniofacial morphology|MP:0000458,abnormal mandible morphology|MP:0000460,mandible hypoplasia|MP:0001286,abnormal eye development|MP:0001325,abnormal retina morphology|MP:0005170,cleft upper lip|MP:0005391,vision/eye phenotype|MP:0006073,abnormal retina bipolar cell morphology|MP:0006221,optic nerve hypoplasia|MP:0006309,decreased retina ganglion cell number|MP:0008106,decreased amacrine cell number|MP:0008507,thin retina ganglion layer|MP:0008511,thin retina inner nuclear layer|MP:0009450,abnormal axon fasciculation|MP:0009655,abnormal secondary palate development|MP:0009674,decreased birth weight|MP:0009890,cleft secondary palate|MP:0021166,delayed palatal shelf elevation|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0030005,increased retina apoptosis|MP:0030026,small Meckel's cartilage|MP:0031443,abnormal tongue position|MP:0031462,decreased palatal shelf size
MGI:5510957	Sox11<tm1.1Llei>	MP:0002169,no abnormal phenotype detected|MP:0004948,abnormal neuronal precursor proliferation|MP:0009937,abnormal neuron differentiation
MGI:4454340	Sox11<tm1.1Vlf>	MP:0002169,no abnormal phenotype detected
MGI:5510958	Sox11<tm1.2Llei>	MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0002741,small olfactory bulb|MP:0003203,increased neuron apoptosis|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0006254,thin cerebral cortex|MP:0008265,abnormal hippocampus CA2 region morphology|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0008283,small hippocampus|MP:0009937,abnormal neuron differentiation|MP:0011087,neonatal lethality, complete penetrance|MP:0014558,decreased cortical ventricular zone thickness
MGI:5285292	Sox11<tm1.2Vlf>	MP:0000111,cleft palate|MP:0000137,abnormal vertebrae morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000267,abnormal heart development|MP:0000284,double outlet right ventricle|MP:0000438,abnormal cranium morphology|MP:0000585,kinked tail|MP:0000690,absent spleen|MP:0001297,microphthalmia|MP:0001302,eyelids open at birth|MP:0002633,persistent truncus arteriosus|MP:0002896,abnormal bone mineralization|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003052,omphalocele|MP:0004322,abnormal sternebra morphology|MP:0005170,cleft upper lip|MP:0010082,sternebra fusion|MP:0011089,perinatal lethality, complete penetrance|MP:0030029,wide cranial sutures
MGI:3052744	Sox11<tm1Weg>	MP:0000150,abnormal rib morphology|MP:0000457,maxilla hypoplasia|MP:0000480,increased rib number|MP:0000690,absent spleen|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001178,pulmonary hypoplasia|MP:0001268,barrel chest|MP:0001340,abnormal eyelid morphology|MP:0001575,cyanosis|MP:0001944,abnormal pancreas morphology|MP:0002264,abnormal bronchus morphology|MP:0002633,persistent truncus arteriosus|MP:0002691,small stomach|MP:0002759,abnormal caudal vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003051,curly tail|MP:0003052,omphalocele|MP:0003861,abnormal nervous system development|MP:0004322,abnormal sternebra morphology|MP:0004452,abnormal pterygoid process morphology|MP:0005109,abnormal talus morphology|MP:0005170,cleft upper lip|MP:0005306,abnormal phalanx morphology|MP:0005574,decreased pulmonary respiratory rate|MP:0008146,asymmetric sternocostal joints|MP:0008271,abnormal bone ossification|MP:0008277,abnormal sternum ossification|MP:0009674,decreased birth weight|MP:0009728,abnormal calcaneum morphology|MP:0009888,palatal shelves fail to meet at midline|MP:0010402,ventricular septal defect|MP:0010454,abnormal truncus arteriosus septation|MP:0010785,abnormal stomach pyloric region morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0021208,median cleft palate
MGI:5285296	Sox12<tm1.1Vlf>	MP:0002169,no abnormal phenotype detected
MGI:3804458	Sox12<tm1.1Weg>	MP:0002169,no abnormal phenotype detected|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:4433017	Sox13<tm1a(EUCOMM)Wtsi>	MP:0002590,increased mean corpuscular volume|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:3697320	Sox13<tm1Jskg>	MP:0001732,postnatal growth retardation|MP:0002089,abnormal postnatal growth/weight/body size|MP:0005348,increased T cell proliferation|MP:0008347,decreased gamma-delta T cell number
MGI:6341893	Sox14<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000443,abnormal snout morphology|MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001157,small seminal vesicle|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001489,decreased startle reflex|MP:0001512,trunk curl|MP:0001513,limb grasping|MP:0001529,abnormal vocalization|MP:0001925,male infertility|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002188,small heart|MP:0002339,abnormal lymph node morphology|MP:0002989,small kidney|MP:0004924,abnormal behavior|MP:0005655,increased aggression|MP:0010052,increased grip strength|MP:0010379,decreased respiratory quotient|MP:0010935,increased airway resistance|MP:0020421,increased freezing behavior|MP:0020870,decreased thigmotaxis
MGI:3056078	Sox15<tm1Imad>	MP:0000730,increased satellite cell number|MP:0011808,abnormal myoblast differentiation|MP:0013239,impaired skeletal muscle regeneration
MGI:3590592	Sox15<tm1Yam>	MP:0002169,no abnormal phenotype detected
MGI:5751535	Sox17<SHIVA>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001923,reduced female fertility|MP:0003458,decreased circulating ketone body level|MP:0004833,ovary atrophy|MP:0005266,abnormal metabolism|MP:0009356,decreased liver triglyceride level|MP:0009703,decreased birth body size|MP:0013245,abnormal lipid metabolism|MP:0013278,decreased fasting circulating glucose level|MP:0014010,abnormal peroxisome morphology|MP:0014451,decreased circulating enzyme level
MGI:5638079	Sox17<tm1.1Nat>	MP:0002169,no abnormal phenotype detected
MGI:4356113	Sox17<tm1Jaw>	MP:0002929,abnormal bile duct development|MP:0003250,absent gallbladder|MP:0009495,abnormal common bile duct morphology
MGI:3717118	Sox17<tm1Sjm>	MP:0000600,liver hypoplasia|MP:0001700,abnormal embryo turning|MP:0002929,abnormal bile duct development|MP:0003396,abnormal embryonic hematopoiesis|MP:0003655,absent pancreas|MP:0003984,embryonic growth retardation|MP:0004810,decreased hematopoietic stem cell number|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2179440	Sox17<tm1Ysk>	MP:0000474,abnormal foregut morphology|MP:0000596,abnormal liver development|MP:0000607,abnormal hepatocyte morphology|MP:0000610,cholestasis|MP:0001685,abnormal endoderm development|MP:0001687,thin endoderm|MP:0001860,liver inflammation|MP:0002929,abnormal bile duct development|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003251,gallbladder inflammation|MP:0003402,decreased liver weight|MP:0004180,failure of initiation of embryo turning|MP:0004789,increased bile salt level|MP:0005084,abnormal gallbladder morphology|MP:0005085,abnormal gallbladder physiology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005414,extrahepatic cholestasis|MP:0005675,small gallbladder|MP:0008786,abnormal hindgut morphology|MP:0008987,abnormal liver lobule morphology|MP:0009492,abnormal gallbladder epithelium morphology|MP:0009498,abnormal extrahepatic bile duct morphology|MP:0009705,abnormal midgut morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0031021,abnormal gallbladder smooth muscle morphology|MP:0031315,biliary atresia
MGI:4418897	Sox17<tm2.1(icre)Heli>	MP:0002169,no abnormal phenotype detected
MGI:3717121	Sox17<tm2Sjm>	MP:0000598,abnormal liver morphology|MP:0000610,cholestasis|MP:0001860,liver inflammation|MP:0001914,hemorrhage|MP:0002191,abnormal artery morphology|MP:0003070,increased vascular permeability|MP:0003279,aneurysm|MP:0004044,aortic dissection|MP:0005592,abnormal vascular smooth muscle morphology|MP:0009489,abnormal blood vessel endothelium morphology|MP:0009492,abnormal gallbladder epithelium morphology|MP:0009493,abnormal cystic duct morphology|MP:0009870,abnormal abdominal aorta morphology|MP:0010468,abnormal thoracic aorta morphology|MP:0012201,decreased endothelial cell proliferation|MP:0020134,abnormal gallbladder size|MP:0031315,biliary atresia
MGI:5428890	Sox17<tm3.1Heli>	MP:0002169,no abnormal phenotype detected
MGI:2682755	Sox18<Mhdadcc1>	MP:0000416,sparse hair|MP:0002073,abnormal hair growth|MP:0005409,darkened coat color
MGI:1856135	Sox18<Ra>	MP:0000377,abnormal hair follicle morphology|MP:0000402,abnormal zigzag hair morphology|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000424,retarded hair growth|MP:0001785,edema|MP:0005409,darkened coat color|MP:0006363,absent auchene hairs|MP:0010025,decreased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011748,intestinal fibrosis|MP:0012080,chylous ascites
MGI:1889617	Sox18<Ragl>	MP:0000416,sparse hair|MP:0001511,disheveled coat|MP:0001785,edema|MP:0003815,hairless|MP:0011087,neonatal lethality, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0012080,chylous ascites
MGI:1856385	Sox18<Ra-J>	MP:0000416,sparse hair|MP:0000424,retarded hair growth|MP:0001265,decreased body size|MP:0001282,short vibrissae|MP:0003815,hairless|MP:0005409,darkened coat color|MP:0009003,abnormal vibrissa number|MP:0011088,neonatal lethality, incomplete penetrance
MGI:1856136	Sox18<Ra-Op>	MP:0000377,abnormal hair follicle morphology|MP:0000400,abnormal awl hair morphology|MP:0000402,abnormal zigzag hair morphology|MP:0000416,sparse hair|MP:0000422,delayed hair appearance|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0001282,short vibrissae|MP:0001575,cyanosis|MP:0001614,abnormal blood vessel morphology|MP:0001785,edema|MP:0001786,skin edema|MP:0001879,abnormal lymphatic vessel morphology|MP:0001914,hemorrhage|MP:0002073,abnormal hair growth|MP:0002098,abnormal vibrissa morphology|MP:0003719,abnormal pericyte morphology|MP:0004003,abnormal vascular endothelial cell physiology|MP:0005385,cardiovascular system phenotype|MP:0006056,increased vascular endothelial cell number|MP:0006363,absent auchene hairs|MP:0008538,decreased zigzag hair amount|MP:0008817,hematoma|MP:0009003,abnormal vibrissa number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:5493275	Sox18<tm1.1(KOMP)Vlcg>	MP:0002968,increased circulating alkaline phosphatase level|MP:0004924,abnormal behavior|MP:0005561,increased mean corpuscular hemoglobin|MP:0005633,increased circulating sodium level|MP:0020870,decreased thigmotaxis
MGI:4442184	Sox18<tm1(GFP/cre/ERT2)Pzg>	MP:0002169,no abnormal phenotype detected
MGI:2178809	Sox18<tm1Koop>	MP:0001786,skin edema|MP:0001879,abnormal lymphatic vessel morphology|MP:0002073,abnormal hair growth|MP:0005409,darkened coat color|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2137412	Sox1<tm1Vep>	MP:0001292,abnormal lens vesicle development|MP:0001297,microphthalmia|MP:0001306,small lens|MP:0002064,seizures|MP:0002068,abnormal parental behavior|MP:0002083,premature death|MP:0002566,abnormal sexual interaction|MP:0005545,abnormal lens development
MGI:3701963	Sox1<tm2Vep>	MP:0001292,abnormal lens vesicle development|MP:0001297,microphthalmia|MP:0001306,small lens|MP:0002064,seizures|MP:0002068,abnormal parental behavior|MP:0002083,premature death|MP:0002566,abnormal sexual interaction|MP:0005545,abnormal lens development
MGI:6382403	Sox21<em1(IMPC)Mbp>	MP:0000063,decreased bone mineral density|MP:0000186,decreased circulating HDL cholesterol level|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000367,abnormal coat/ hair morphology|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000702,enlarged lymph nodes|MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0001891,hydrocephaly|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002339,abnormal lymph node morphology|MP:0002590,increased mean corpuscular volume|MP:0003068,enlarged kidney|MP:0003960,increased lean body mass|MP:0005016,decreased lymphocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:3849852	Sox21<tm1.1Ysa>	MP:0000414,alopecia|MP:0000652,enlarged sebaceous gland|MP:0001222,epidermal hyperplasia|MP:0003809,abnormal hair shaft morphology|MP:0003810,abnormal hair cuticle
MGI:6382406	Sox2<em1(IMPC)Mbp>	MP:0001319,irregularly shaped pupil|MP:0001325,abnormal retina morphology|MP:0002152,abnormal brain morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003984,embryonic growth retardation|MP:0008259,abnormal optic disk morphology|MP:0009453,enhanced contextual conditioning behavior|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2447995	Sox2<lcc>	MP:0000026,abnormal inner ear morphology|MP:0000046,abnormal sulcus ampullaris morphology|MP:0000371,diluted coat color|MP:0000397,abnormal guard hair morphology|MP:0000400,abnormal awl hair morphology|MP:0000402,abnormal zigzag hair morphology|MP:0001394,circling|MP:0001410,head bobbing|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002428,abnormal semicircular canal morphology|MP:0003136,yellow coat color|MP:0003148,decreased cochlea coiling|MP:0004317,small vestibular saccule|MP:0004336,small utricle|MP:0004405,absent cochlear hair cells|MP:0004416,absent cochlear nerve compound action potential
MGI:7365204	Sox2ot<em1Dyd>	MP:0005380,embryo phenotype
MGI:5613017	Sox2<tm1.1Knd>	MP:0005380,embryo phenotype
MGI:4366453	Sox2<tm1.1Lan>	MP:0002281,abnormal respiratory mucosa goblet cell morphology|MP:0005391,vision/eye phenotype|MP:0006382,abnormal lung epithelium morphology|MP:0010863,absent respiratory mucosa goblet cells|MP:0010897,abnormal bronchiole epithelium morphology|MP:0011054,absent respiratory motile cilia|MP:0011071,absent club cells
MGI:3701965	Sox2<tm1.1Vep>	MP:0002169,no abnormal phenotype detected
MGI:5464908	Sox2<tm1.1Vlcg>	MP:0002169,no abnormal phenotype detected|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype
MGI:5464909	Sox2<tm1.2Vlcg>	MP:0001694,absent egg cylinders|MP:0002169,no abnormal phenotype detected|MP:0009397,increased trophoblast giant cell number|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011184,absent embryonic epiblast
MGI:3589809	Sox2<tm1Lpev>	MP:0002169,no abnormal phenotype detected
MGI:3809487	Sox2<tm1Okud>	MP:0004948,abnormal neuronal precursor proliferation|MP:0008535,enlarged lateral ventricles|MP:0011087,neonatal lethality, complete penetrance
MGI:2449045	Sox2<tm1Rlb>	MP:0000633,abnormal pituitary gland morphology|MP:0001147,small testis|MP:0001265,decreased body size|MP:0001675,abnormal ectoderm development|MP:0001694,absent egg cylinders|MP:0001717,absent ectoplacental cone|MP:0001922,reduced male fertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0005128,decreased adrenocorticotropin level|MP:0005132,decreased luteinizing hormone level|MP:0005134,decreased thyroid-stimulating hormone level|MP:0005136,decreased growth hormone level|MP:0005138,decreased prolactin level|MP:0005381,digestive/alimentary phenotype|MP:0005391,vision/eye phenotype|MP:0008321,small adenohypophysis|MP:0008329,decreased somatotroph cell number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0013337,abnormal adenohypophysis development|MP:0013342,bifurcated Rathke's pouch
MGI:3701964	Sox2<tm1Vep>	MP:0002169,no abnormal phenotype detected
MGI:3625175	Sox2<tm2Lpev>	MP:0002169,no abnormal phenotype detected|MP:0002697,abnormal eye size|MP:0006071,abnormal retina progenitor cell morphology
MGI:3625177	Sox2<tm3Lpev>	MP:0002169,no abnormal phenotype detected
MGI:5296002	Sox2<tm3(TK)Hoch>	MP:0000470,abnormal stomach morphology|MP:0001147,small testis|MP:0001265,decreased body size|MP:0001785,edema|MP:0001873,stomach inflammation|MP:0002083,premature death|MP:0003300,gastrointestinal ulcer|MP:0004901,decreased male germ cell number|MP:0030129,tongue inflammation
MGI:4397705	Sox2<tm4.1Skn>	MP:0002073,abnormal hair growth|MP:0003648,abnormal radial glial cell morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0009937,abnormal neuron differentiation|MP:0010771,integument phenotype
MGI:3625178	Sox2<tm4Lpev>	MP:0002169,no abnormal phenotype detected
MGI:2447996	Sox2<ysb>	MP:0000026,abnormal inner ear morphology|MP:0000046,abnormal sulcus ampullaris morphology|MP:0000400,abnormal awl hair morphology|MP:0000402,abnormal zigzag hair morphology|MP:0000405,abnormal auchene hair morphology|MP:0001394,circling|MP:0001485,abnormal pinna reflex|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0001526,abnormal placing response|MP:0001967,deafness|MP:0002428,abnormal semicircular canal morphology|MP:0002622,abnormal cochlear hair cell morphology|MP:0003136,yellow coat color|MP:0003148,decreased cochlea coiling|MP:0004325,absent vestibular hair cells|MP:0004417,decreased cochlear nerve compound action potential|MP:0004493,dilated cochlea|MP:0005307,head tossing
MGI:7310078	Sox30<em1Laye>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002631,abnormal epididymis morphology|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0006379,abnormal spermatocyte morphology|MP:0008279,arrest of spermiogenesis|MP:0014052,increased male germ cell apoptosis|MP:0014636,decreased elongated spermatid number|MP:0020550,multinucleated giant male germ cells|MP:0031355,abnormal proacrosomal vesicle fusion
MGI:6258440	Sox30<em2Hncs>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0004930,small epididymis|MP:0014052,increased male germ cell apoptosis
MGI:4451538	Sox30<tm1a(KOMP)Wtsi>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0006380,abnormal spermatid morphology|MP:0008279,arrest of spermiogenesis|MP:0020550,multinucleated giant male germ cells
MGI:5636969	Sox30<tm1b(KOMP)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0013279,increased fasting circulating glucose level
MGI:6114792	Sox30<tm1c(KOMP)Wtsi>	MP:0001925,male infertility|MP:0005159,azoospermia|MP:0008279,arrest of spermiogenesis|MP:0020550,multinucleated giant male germ cells
MGI:2682663	Sox3<tm1.1Lja>	MP:0001119,abnormal female reproductive system morphology|MP:0001125,abnormal oocyte morphology|MP:0001130,abnormal ovarian folliculogenesis|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001923,reduced female fertility|MP:0002100,abnormal tooth morphology|MP:0002209,decreased germ cell number|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0004852,decreased testis weight|MP:0005386,behavior/neurological phenotype|MP:0031239,increased atretic ovarian follicle number
MGI:5504449	Sox3<tm1Pqt>	MP:0001925,male infertility|MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0009463,abnormal pituitary infundibular stalk morphology|MP:0013337,abnormal adenohypophysis development|MP:0014198,absent pituitary infundibular stalk
MGI:3036671	Sox3<tm1Rlb>	MP:0000428,abnormal craniofacial morphology|MP:0000633,abnormal pituitary gland morphology|MP:0000780,abnormal corpus callosum morphology|MP:0000826,abnormal third ventricle morphology|MP:0000830,abnormal diencephalon morphology|MP:0000837,abnormal hypothalamus morphology|MP:0001127,small ovary|MP:0001146,abnormal testis morphology|MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality|MP:0002199,abnormal brain commissure morphology|MP:0005130,decreased follicle stimulating hormone level|MP:0005134,decreased thyroid-stimulating hormone level|MP:0005136,decreased growth hormone level|MP:0005389,reproductive system phenotype|MP:0008221,abnormal hippocampal commissure morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013342,bifurcated Rathke's pouch|MP:0013351,abnormal Rathke's pouch development|MP:0031239,increased atretic ovarian follicle number
MGI:6430658	Sox4<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000774,decreased brain size|MP:0001120,abnormal uterus morphology|MP:0001258,decreased body length|MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0002151,abnormal neural tube morphology|MP:0002152,abnormal brain morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003720,abnormal neural tube closure|MP:0003795,abnormal bone structure|MP:0004906,enlarged uterus|MP:0005084,abnormal gallbladder morphology|MP:0006108,abnormal hindbrain development|MP:0009342,enlarged gallbladder|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0020421,increased freezing behavior
MGI:3819788	Sox4<Igt4>	MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3819793	Sox4<M91Ark>	MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance
MGI:3773013	Sox4<tm1.1Vlf>	MP:0000281,abnormal interventricular septum morphology|MP:0001785,edema|MP:0002633,persistent truncus arteriosus|MP:0010724,thick interventricular septum|MP:0011091,prenatal lethality, complete penetrance|MP:0031553,abnormal semilunar valve development
MGI:2182092	Sox4<tm1Cle>	MP:0000238,absent pre-B cells|MP:0002128,abnormal blood circulation|MP:0002144,abnormal B cell differentiation|MP:0002192,hydrops fetalis|MP:0002626,increased heart rate|MP:0002746,abnormal semilunar valve morphology|MP:0003321,tracheoesophageal fistula|MP:0004111,abnormal coronary artery morphology|MP:0008208,decreased pro-B cell number|MP:0010418,perimembraneous ventricular septal defect|MP:0010572,persistent right dorsal aorta|MP:0010585,abnormal conotruncal ridge morphology|MP:0010645,failure of conotruncal ridge closure|MP:0010650,abnormal aorticopulmonary septum morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3773012	Sox4<tm1Vlf>	MP:0000281,abnormal interventricular septum morphology|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001286,abnormal eye development|MP:0001325,abnormal retina morphology|MP:0001785,edema|MP:0002169,no abnormal phenotype detected|MP:0002633,persistent truncus arteriosus|MP:0003861,abnormal nervous system development|MP:0005391,vision/eye phenotype|MP:0006073,abnormal retina bipolar cell morphology|MP:0006221,optic nerve hypoplasia|MP:0006309,decreased retina ganglion cell number|MP:0008106,decreased amacrine cell number|MP:0008507,thin retina ganglion layer|MP:0008511,thin retina inner nuclear layer|MP:0009450,abnormal axon fasciculation|MP:0011091,prenatal lethality, complete penetrance|MP:0030005,increased retina apoptosis|MP:0031553,abnormal semilunar valve development
MGI:2182108	Sox4<tm2Cle>	MP:0000238,absent pre-B cells|MP:0002128,abnormal blood circulation|MP:0002144,abnormal B cell differentiation|MP:0002192,hydrops fetalis|MP:0002626,increased heart rate|MP:0002746,abnormal semilunar valve morphology|MP:0008208,decreased pro-B cell number|MP:0010402,ventricular septal defect|MP:0010645,failure of conotruncal ridge closure|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5319181	Sox5<tm1.1Tlu>	MP:0002169,no abnormal phenotype detected
MGI:2447147	Sox5<tm1Vlf>	MP:0000074,abnormal neurocranium morphology|MP:0000157,abnormal sternum morphology|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002896,abnormal bone mineralization|MP:0004321,short sternum|MP:0004672,short ribs|MP:0009886,failure of palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0010099,abnormal thoracic cage shape|MP:0011087,neonatal lethality, complete penetrance|MP:0012514,pectus excavatum
MGI:3799355	Sox5<tm2.1Vlf>	MP:0003048,abnormal cervical vertebrae morphology|MP:0008277,abnormal sternum ossification|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0010099,abnormal thoracic cage shape|MP:0011087,neonatal lethality, complete penetrance
MGI:3799354	Sox5<tm2Vlf>	MP:0002169,no abnormal phenotype detected
MGI:4836987	Sox5<Tn(sb-lacZ,GFP)IF2.OR123Jtak>	MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0011087,neonatal lethality, complete penetrance
MGI:2447148	Sox6<tm1Vlf>	MP:0001265,decreased body size|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3641204	Sox6<tm2.1Vlf>	MP:0002169,no abnormal phenotype detected
MGI:3641205	Sox6<tm2.2Vlf>	MP:0000157,abnormal sternum morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5437221	Sox7<tm1.1Dsco>	MP:0000297,abnormal atrioventricular cushion morphology|MP:0001787,pericardial edema|MP:0002279,abnormal diaphragm morphology|MP:0003924,diaphragmatic hernia|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0005084,abnormal gallbladder morphology|MP:0005369,muscle phenotype|MP:0005385,cardiovascular system phenotype|MP:0006107,abnormal fetal atrioventricular canal morphology|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance
MGI:5638074	Sox7<tm1.1Nat>	MP:0000281,abnormal interventricular septum morphology|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0005380,embryo phenotype|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0010403,atrial septal defect|MP:0010414,partial atrioventricular septal defect|MP:0010768,mortality/aging|MP:0030992,atrioventricular cushion hypoplasia
MGI:5437220	Sox7<tm1Dsco>	MP:0010402,ventricular septal defect|MP:0011091,prenatal lethality, complete penetrance|MP:0030992,atrioventricular cushion hypoplasia
MGI:3795214	Sox8<tm1Mkob>	MP:0001145,abnormal male reproductive system morphology|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002161,abnormal fertility/fecundity|MP:0002631,abnormal epididymis morphology|MP:0002673,abnormal sperm number|MP:0002675,asthenozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0004852,decreased testis weight|MP:0008489,slow postnatal weight gain|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014636,decreased elongated spermatid number|MP:0014684,impaired spermiation|MP:0031389,abnormal ectoplasmic specialization morphology
MGI:2154329	Sox8<tm1Weg>	MP:0001262,decreased body weight|MP:0005104,abnormal tarsal bone morphology|MP:0010025,decreased total body fat amount
MGI:5546026	Sox9<Bbfc>	MP:0000097,short maxilla|MP:0000435,shortened head|MP:0000440,domed cranium|MP:0000445,short snout|MP:0001262,decreased body weight|MP:0005377,hearing/vestibular/ear phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0005459,decreased percent body fat/body weight|MP:0010025,decreased total body fat amount|MP:0011092,embryonic lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0011862,decreased cranium length|MP:0013292,embryonic lethality prior to organogenesis
MGI:2385469	Sox9<tm1.1Gsr>	MP:0002113,abnormal skeleton development|MP:0002896,abnormal bone mineralization|MP:0004344,scapular bone hypoplasia|MP:0004354,absent deltoid tuberosity|MP:0005296,abnormal humerus morphology|MP:0005379,endocrine/exocrine gland phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0009114,decreased pancreatic beta cell mass|MP:0009181,decreased pancreatic delta cell number|MP:0009186,decreased PP cell number|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance|MP:0030588,decreased pancreatic alpha cell mass
MGI:7451055	Sox9<tm1.1Ksec>	MP:0001394,circling|MP:0001399,hyperactivity|MP:0001523,impaired righting response|MP:0001526,abnormal placing response|MP:0002894,abnormal otolith morphology|MP:0004411,decreased endocochlear potential|MP:0004493,dilated cochlea|MP:0004862,small scala tympani|MP:0005191,head tilt|MP:0005307,head tossing|MP:0005356,positive geotaxis|MP:0005377,hearing/vestibular/ear phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0006012,dilated endolymphatic duct|MP:0006328,nonsyndromic hearing impairment|MP:0008309,dilated scala media
MGI:7451121	Sox9<tm1.2Ksec>	MP:0000585,kinked tail|MP:0001394,circling|MP:0001522,impaired swimming|MP:0002081,perinatal lethality|MP:0002657,chondrodystrophy|MP:0006011,abnormal endolymphatic duct morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:4867441	Sox9<tm1(cre/ERT2)Haak>	MP:0002169,no abnormal phenotype detected
MGI:2158693	Sox9<tm1Crm>	MP:0000088,short mandible|MP:0000149,abnormal scapula morphology|MP:0000157,abnormal sternum morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000164,abnormal cartilage development|MP:0001954,respiratory distress|MP:0002111,abnormal tail morphology|MP:0002113,abnormal skeleton development|MP:0002256,abnormal laryngeal cartilage morphology|MP:0002639,micrognathia|MP:0002896,abnormal bone mineralization|MP:0003056,abnormal hyoid bone morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003723,abnormal long bone morphology|MP:0004321,short sternum|MP:0004322,abnormal sternebra morphology|MP:0004343,small scapula|MP:0004347,abnormal scapular spine morphology|MP:0004354,absent deltoid tuberosity|MP:0004358,bowed tibia|MP:0004361,bowed ulna|MP:0004374,bowed radius|MP:0004506,abnormal pubis morphology|MP:0004507,abnormal ischium morphology|MP:0004692,small pubis|MP:0005354,abnormal ilium morphology|MP:0005587,abnormal Meckel's cartilage morphology|MP:0009247,meteorism|MP:0009890,cleft secondary palate|MP:0009910,bifurcated tongue|MP:0010103,small thoracic cage|MP:0011087,neonatal lethality, complete penetrance|MP:0021210,bilateral cleft palate
MGI:2385468	Sox9<tm1Gsr>	MP:0000164,abnormal cartilage development|MP:0000282,abnormal interatrial septum morphology|MP:0000285,abnormal heart valve morphology|MP:0000286,abnormal mitral valve morphology|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000352,decreased cell proliferation|MP:0000534,abnormal ureter morphology|MP:0000536,hydroureter|MP:0000539,distended urinary bladder|MP:0000592,short tail|MP:0001787,pericardial edema|MP:0001943,abnormal respiration|MP:0001954,respiratory distress|MP:0002128,abnormal blood circulation|MP:0002624,abnormal tricuspid valve morphology|MP:0002657,chondrodystrophy|MP:0002711,decreased glucagon secretion|MP:0002740,heart hypoplasia|MP:0002745,abnormal atrioventricular valve morphology|MP:0002746,abnormal semilunar valve morphology|MP:0002785,absent Leydig cells|MP:0002995,primary sex reversal|MP:0003059,decreased insulin secretion|MP:0003586,dilated ureter|MP:0003589,abnormal ureter physiology|MP:0003641,small lung|MP:0003830,abnormal testis development|MP:0003885,abnormal rostral-caudal body axis extension|MP:0003934,abnormal pancreas development|MP:0004880,lung cyst|MP:0005076,abnormal cell differentiation|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005388,respiratory system phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0006107,abnormal fetal atrioventricular canal morphology|MP:0006121,calcified mitral valve|MP:0006279,abnormal limb development|MP:0006382,abnormal lung epithelium morphology|MP:0006395,abnormal epiphyseal plate morphology|MP:0006424,absent testis cords|MP:0008272,abnormal endochondral bone ossification|MP:0009114,decreased pancreatic beta cell mass|MP:0009139,failure of Mullerian duct regression|MP:0009181,decreased pancreatic delta cell number|MP:0009186,decreased PP cell number|MP:0009780,abnormal chondrocyte physiology|MP:0010587,conotruncal ridge hypoplasia|MP:0010724,thick interventricular septum|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011085,postnatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011426,abnormal ureter smooth muscle morphology|MP:0011480,impaired ureteric peristalsis|MP:0011648,thick heart valve cusps|MP:0011805,decreased cell migration|MP:0012756,impaired cranial neural crest cell differentiation|MP:0030588,decreased pancreatic alpha cell mass|MP:0031549,abnormal heart valve development|MP:0031550,abnormal atrioventricular valve development
MGI:3844977	Sox9<tm1Haak>	MP:0002169,no abnormal phenotype detected
MGI:3041881	Sox9<tm2.1Crm>	MP:0002211,abnormal primary sex determination|MP:0006138,congestive heart failure|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2429649	Sox9<tm2Crm>	MP:0000088,short mandible|MP:0000137,abnormal vertebrae morphology|MP:0000158,absent sternum|MP:0000160,kyphosis|MP:0000260,abnormal angiogenesis|MP:0000367,abnormal coat/ hair morphology|MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000414,alopecia|MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000547,short limbs|MP:0000561,adactyly|MP:0000592,short tail|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001219,thick epidermis|MP:0001258,decreased body length|MP:0001270,distended abdomen|MP:0001954,respiratory distress|MP:0002113,abnormal skeleton development|MP:0002116,abnormal craniofacial bone morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0002427,disproportionate dwarf|MP:0002657,chondrodystrophy|MP:0002898,absent cartilage|MP:0003056,abnormal hyoid bone morphology|MP:0003413,hair follicle degeneration|MP:0003723,abnormal long bone morphology|MP:0003809,abnormal hair shaft morphology|MP:0003830,abnormal testis development|MP:0003935,abnormal craniofacial development|MP:0004204,absent stapes|MP:0004318,absent incus|MP:0004319,absent malleus|MP:0004344,scapular bone hypoplasia|MP:0004358,bowed tibia|MP:0004361,bowed ulna|MP:0004372,bowed fibula|MP:0004374,bowed radius|MP:0004439,absent Meckel's cartilage|MP:0004449,absent presphenoid bone|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004592,small mandible|MP:0005169,abnormal male meiosis|MP:0005377,hearing/vestibular/ear phenotype|MP:0005650,abnormal limb bud morphology|MP:0008271,abnormal bone ossification|MP:0008384,absent nasal capsule|MP:0008385,absent basisphenoid bone|MP:0008386,absent styloid process|MP:0009759,abnormal hair follicle bulge morphology|MP:0009890,cleft secondary palate|MP:0009915,absent hyoid bone lesser horns|MP:0010116,abnormal primitive urogenital sinus morphology|MP:0010684,abnormal hair follicle outer root sheath morphology|MP:0010686,abnormal hair follicle matrix region morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011195,increased hair follicle apoptosis|MP:0013013,abnormal trunk neural crest cell morphology|MP:0013014,increased trunk neural crest cell apoptosis|MP:0030162,absent hyoid bone body|MP:0030868,absent thyroid cartilage
MGI:3817218	Sox9<tm2Gsr>	MP:0005491,pancreatic islet hyperplasia
MGI:5300544	Sox9<tm3.1Tlu>	MP:0000164,abnormal cartilage development|MP:0001255,decreased body height|MP:0001505,hunched posture|MP:0003416,premature bone ossification|MP:0003854,abnormal forelimb stylopod morphology|MP:0003855,abnormal forelimb zeugopod morphology|MP:0004344,scapular bone hypoplasia
MGI:5293339	Sox9<tm4.1Tlu>	MP:0000141,abnormal vertebral body morphology|MP:0001265,decreased body size|MP:0001505,hunched posture|MP:0002169,no abnormal phenotype detected|MP:0003417,premature endochondral bone ossification|MP:0003854,abnormal forelimb stylopod morphology|MP:0003855,abnormal forelimb zeugopod morphology|MP:0004344,scapular bone hypoplasia|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0005225,abnormal vertebrae development|MP:0005390,skeleton phenotype
MGI:5293340	Sox9<tm4Tlu>	MP:0010768,mortality/aging|MP:0011100,preweaning lethality, complete penetrance
MGI:7386887	Sp110<em1Vnce>	MP:0005387,immune system phenotype
MGI:7386886	Sp140<em1Vnce>	MP:0002412,increased susceptibility to bacterial infection|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:2181866	Sp1<tm1Phi>	MP:0001265,decreased body size|MP:0001293,anophthalmia|MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0008973,decreased erythroid progenitor cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5471237	Sp2<tm1.1Htg>	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002741,small olfactory bulb|MP:0003077,abnormal cell cycle|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004279,abnormal rostral migratory stream morphology|MP:0008439,abnormal cortical plate morphology|MP:0008458,abnormal cortical ventricular zone morphology|MP:0008540,abnormal cerebral hemisphere morphology|MP:0009937,abnormal neuron differentiation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0020083,decreased hippocampus volume|MP:0020394,decreased neuronal precursor proliferation
MGI:4441279	Sp2<tm1.1Sus>	MP:0002169,no abnormal phenotype detected
MGI:4441280	Sp2<tm1.2Sus>	MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011705,absent fibroblast proliferation
MGI:4441277	Sp2<tm1Sus>	MP:0001914,hemorrhage|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0011085,postnatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:2182438	Sp3<tm1Sus>	MP:0000060,delayed bone ossification|MP:0000077,abnormal interparietal bone morphology|MP:0000078,abnormal supraoccipital bone morphology|MP:0000102,abnormal nasal bone morphology|MP:0000106,abnormal basisphenoid bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000109,abnormal parietal bone morphology|MP:0000116,abnormal tooth development|MP:0000141,abnormal vertebral body morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000245,abnormal erythropoiesis|MP:0000438,abnormal cranium morphology|MP:0000600,liver hypoplasia|MP:0000706,small thymus|MP:0001265,decreased body size|MP:0001716,abnormal placenta labyrinth morphology|MP:0001953,respiratory failure|MP:0002144,abnormal B cell differentiation|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002650,abnormal ameloblast morphology|MP:0002896,abnormal bone mineralization|MP:0003072,abnormal metatarsal bone morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0003419,delayed endochondral bone ossification|MP:0003420,delayed intramembranous bone ossification|MP:0003843,abnormal sagittal suture morphology|MP:0004448,abnormal presphenoid bone morphology|MP:0004607,abnormal cervical atlas morphology|MP:0005306,abnormal phalanx morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008277,abnormal sternum ossification|MP:0008395,abnormal osteoblast differentiation|MP:0008801,abnormal erythroid progenitor cell morphology|MP:0008958,abnormal trophoblast glycogen cell morphology|MP:0009703,decreased birth body size|MP:0010029,abnormal basicranium morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0012099,decreased spongiotrophoblast size|MP:0030542,abnormal dentin development|MP:0030544,abnormal enamel development|MP:0030989,decreased spongiotrophoblast cell number
MGI:4887404	Sp3<tm2.1Sus>	MP:0008877,abnormal DNA methylation
MGI:2676622	Sp4<tm1Krc>	MP:0001265,decreased body size|MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0003137,abnormal impulse conducting system conduction|MP:0004085,abnormal heartbeat|MP:0004086,absent heartbeat|MP:0004124,abnormal Purkinje fiber morphology|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0010519,atrioventricular block|MP:0010520,sinoatrial block|MP:0010637,sinus bradycardia|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1857451	Sp4<tm1Ssp>	MP:0001265,decreased body size|MP:0001380,decreased male mating frequency|MP:0001925,male infertility|MP:0003631,nervous system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0008489,slow postnatal weight gain|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2183651	Sp4<tm1Sus>	MP:0000694,spleen hypoplasia|MP:0001147,small testis|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002636,delayed vaginal opening|MP:0002637,small uterus|MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3621971	Sp4<tm2.1Krc>	MP:0001265,decreased body size|MP:0003137,abnormal impulse conducting system conduction|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3621970	Sp4<tm2Krc>	MP:0000266,abnormal heart morphology|MP:0003137,abnormal impulse conducting system conduction|MP:0004123,abnormal impulse conducting system morphology
MGI:3663671	Sp4<tm3(Sp4)Krc>	MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0001473,reduced long-term potentiation|MP:0001486,abnormal startle reflex|MP:0002183,gliosis|MP:0002635,reduced sensorimotor gating|MP:0002757,decreased vertical activity|MP:0004000,impaired passive avoidance behavior|MP:0005385,cardiovascular system phenotype|MP:0008414,abnormal spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0012307,impaired spatial learning
MGI:5635299	Sp5<tm1b(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0001399,hyperactivity|MP:0002098,abnormal vibrissa morphology|MP:0002574,increased vertical activity|MP:0002941,increased circulating alanine transaminase level|MP:0010052,increased grip strength|MP:0013278,decreased fasting circulating glucose level
MGI:1933409	Sp5<tm1Rbe>	MP:0002169,no abnormal phenotype detected
MGI:3778294	Sp6<tm1.1Ibmm>	MP:0000116,abnormal tooth development|MP:0000126,brittle teeth|MP:0000387,disorganized inner root sheath cells|MP:0000564,syndactyly|MP:0000565,oligodactyly|MP:0000652,enlarged sebaceous gland|MP:0001211,wrinkled skin|MP:0001219,thick epidermis|MP:0001262,decreased body weight|MP:0001274,curly vibrissae|MP:0001282,short vibrissae|MP:0001284,absent vibrissae|MP:0002100,abnormal tooth morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002577,reduced enamel thickness|MP:0002650,abnormal ameloblast morphology|MP:0002818,abnormal dentin morphology|MP:0003404,absent enamel|MP:0003809,abnormal hair shaft morphology|MP:0003810,abnormal hair cuticle|MP:0003815,hairless|MP:0003930,abnormal tooth hard tissue morphology|MP:0004033,supernumerary teeth|MP:0005358,abnormal incisor morphology|MP:0010685,abnormal hair follicle inner root sheath morphology|MP:0010747,abnormal enamel organ morphology|MP:0010773,supernumerary molars|MP:0013129,abnormal tooth color|MP:0030079,small incisors|MP:0030088,microdontia|MP:0030457,abnormal molar cusp morphology|MP:0030472,fused teeth|MP:0030473,fused molars|MP:0030497,short tooth root|MP:0030525,abnormal Hertwig epithelial root sheath morphology
MGI:3778292	Sp6<tm1Ibmm>	MP:0002169,no abnormal phenotype detected
MGI:3775913	Sp6<tm1Yoya>	MP:0000116,abnormal tooth development|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002817,abnormal tooth mineralization|MP:0002818,abnormal dentin morphology|MP:0003053,delayed tooth eruption|MP:0003404,absent enamel|MP:0004033,supernumerary teeth|MP:0006369,supernumerary incisors|MP:0008770,decreased survivor rate|MP:0030457,abnormal molar cusp morphology
MGI:7715169	Sp7<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0001404,no spontaneous movement|MP:0002968,increased circulating alkaline phosphatase level|MP:0003743,abnormal facial morphology|MP:0011495,abnormal head shape
MGI:5824213	Sp7<tm1.1Amc>	MP:0002169,no abnormal phenotype detected
MGI:5466596	Sp7<tm1.1Rnis>	MP:0002113,abnormal skeleton development|MP:0008274,failure of bone ossification|MP:0008275,failure of endochondral bone ossification
MGI:2159411	Sp7<tm1Crm>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002109,abnormal limb morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002896,abnormal bone mineralization|MP:0004337,clavicle hypoplasia|MP:0011087,neonatal lethality, complete penetrance
MGI:5466595	Sp7<tm1Rnis>	MP:0002113,abnormal skeleton development|MP:0003116,rickets|MP:0008275,failure of endochondral bone ossification
MGI:2684137	Sp8<tm1Aman>	MP:0000547,short limbs|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000559,abnormal femur morphology|MP:0000585,kinked tail|MP:0000850,absent cerebellum|MP:0000914,exencephaly|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0002233,abnormal nose morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0003054,spina bifida|MP:0003755,abnormal palate morphology|MP:0004073,caudal body truncation|MP:0005296,abnormal humerus morphology|MP:0006279,abnormal limb development|MP:0011089,perinatal lethality, complete penetrance|MP:0013164,abnormal forelimb bud morphology
MGI:2684070	Sp8<tm1Smb>	MP:0000077,abnormal interparietal bone morphology|MP:0000078,abnormal supraoccipital bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000108,midline facial cleft|MP:0000109,abnormal parietal bone morphology|MP:0000111,cleft palate|MP:0000137,abnormal vertebrae morphology|MP:0000428,abnormal craniofacial morphology|MP:0000455,abnormal maxilla morphology|MP:0000550,abnormal forelimb morphology|MP:0000553,absent radius|MP:0000556,abnormal hindlimb morphology|MP:0000561,adactyly|MP:0000565,oligodactyly|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0001300,ocular hypertelorism|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0002728,absent tibia|MP:0002764,short tibia|MP:0002765,short fibula|MP:0002820,abnormal premaxilla morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003054,spina bifida|MP:0003124,hypospadia|MP:0003315,abnormal perineum morphology|MP:0003456,absent tail|MP:0003935,abnormal craniofacial development|MP:0004359,short ulna|MP:0004376,absent frontal bone|MP:0004383,absent interparietal bone|MP:0004419,absent parietal bone|MP:0004444,small supraoccipital bone|MP:0004540,small maxilla|MP:0004653,absent caudal vertebrae|MP:0004656,absent sacral vertebrae|MP:0004870,small premaxilla|MP:0005382,craniofacial phenotype|MP:0005430,absent fibula|MP:0009053,abnormal anal canal morphology|MP:0009885,abnormal palatal shelf elevation|MP:0009888,palatal shelves fail to meet at midline|MP:0009902,abnormal lateral nasal prominence morphology|MP:0009903,abnormal medial nasal prominence morphology|MP:0010940,abnormal maxillary prominence morphology|MP:0011771,abnormal genital tubercle morphology|MP:0011772,genital tubercle hypoplasia|MP:0012707,incomplete caudal neuropore closure|MP:0030313,abnormal face development|MP:0031462,decreased palatal shelf size
MGI:4455192	Sp8<tm2.1Aman>	MP:0000428,abnormal craniofacial morphology|MP:0000784,forebrain hypoplasia|MP:0000785,telencephalon hypoplasia|MP:0000823,abnormal lateral ventricle morphology|MP:0000934,abnormal telencephalon development|MP:0002739,abnormal olfactory bulb development|MP:0003203,increased neuron apoptosis|MP:0003232,abnormal forebrain development|MP:0004948,abnormal neuronal precursor proliferation|MP:0005157,holoprosencephaly|MP:0006007,abnormal basal ganglion morphology|MP:0008128,abnormal brain internal capsule morphology|MP:0008439,abnormal cortical plate morphology|MP:0008441,thin cortical plate|MP:0011087,neonatal lethality, complete penetrance
MGI:4837153	Sp8<tm2Smb>	MP:0002741,small olfactory bulb|MP:0003631,nervous system phenotype|MP:0009946,abnormal olfactory bulb layer morphology|MP:0009947,abnormal olfactory bulb external plexiform layer morphology|MP:0009948,abnormal olfactory bulb glomerular layer morphology|MP:0009950,abnormal olfactory bulb internal plexiform layer morphology
MGI:6152404	Sp9<tm1.1Zyan>	MP:0000746,weakness|MP:0002175,decreased brain weight|MP:0003203,increased neuron apoptosis|MP:0004077,abnormal striatum morphology|MP:0008462,abnormal medium spiny neuron morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0012468,decreased striatum size|MP:0020394,decreased neuronal precursor proliferation
MGI:6152405	Sp9<tm1.2Zyan>	MP:0003203,increased neuron apoptosis|MP:0005389,reproductive system phenotype|MP:0008462,abnormal medium spiny neuron morphology|MP:0031391,increased locomotor activity
MGI:6315580	Spa17<em1(IMPC)J>	MP:0001925,male infertility|MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval
MGI:6343396	Spaar<em1Ppp>	MP:0002106,abnormal muscle physiology|MP:0005378,growth/size/body region phenotype|MP:0013161,enhanced muscle regeneration
MGI:5439282	Spaca1<tm1.1Osb>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009238,coiled sperm flagellum
MGI:6194909	Spaca3<tm1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6766530	Spaca4<em2Pauli>	MP:0031009,abnormal sperm-egg fusion
MGI:6766531	Spaca4<tm1Osb>	MP:0002675,asthenozoospermia|MP:0009647,decreased fertilization frequency
MGI:6467749	Spaca6<em1Nino>	MP:0000242,impaired fertilization
MGI:6437562	Spaca6<em2Osb>	MP:0001925,male infertility|MP:0031010,failure of sperm-egg fusion
MGI:5514186	Spaca6<Tg(Tyr)Bart97bCeb>	MP:0000242,impaired fertilization|MP:0001925,male infertility
MGI:6194729	Spaca7<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6866944	Spaca9<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6152651	Spag11a<em1(IMPC)Mbp>	MP:0000220,increased monocyte cell number|MP:0002574,increased vertical activity|MP:0020421,increased freezing behavior
MGI:8190590	Spag11a<em2Mgef>	MP:0001922,reduced male fertility|MP:0002660,abnormal caput epididymis morphology|MP:0002687,oligozoospermia|MP:0003596,epididymis inflammation|MP:0004499,increased incidence of tumors by chemical induction|MP:0004542,impaired acrosome reaction|MP:0004933,abnormal epididymis epithelium morphology|MP:0009230,abnormal sperm head morphology|MP:0009243,hairpin sperm flagellum|MP:0009824,spermatic granuloma
MGI:3606977	Spag16<tm1Jfs>	MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002674,abnormal sperm motility|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0009237,kinked sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0014052,increased male germ cell apoptosis|MP:0031352,absent sperm axonemal central pair|MP:0031356,abnormal outer dense fiber morphology
MGI:3606979	Spag16<tm2Jfs>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0005578,teratozoospermia
MGI:5635302	Spag17<tm1b(KOMP)Wtsi>	MP:0001155,arrest of spermatogenesis|MP:0001258,decreased body length|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002662,abnormal cauda epididymis morphology|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0008028,pregnancy-related premature death|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009234,absent sperm head|MP:0009239,short sperm flagellum|MP:0009242,thin sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0020869,immotile sperm|MP:0030591,absent sperm fibrous sheath|MP:0031356,abnormal outer dense fiber morphology|MP:0031374,abnormal manchette assembly|MP:0031386,elongated manchette|MP:0031387,abnormal intramanchette transport
MGI:5636738	Spag17<tm1c(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected|MP:0011091,prenatal lethality, complete penetrance
MGI:5636740	Spag17<tm1d(KOMP)Wtsi>	MP:0001177,atelectasis|MP:0001402,decreased locomotor activity|MP:0001436,abnormal suckling behavior|MP:0001575,cyanosis|MP:0001891,hydrocephaly|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002169,no abnormal phenotype detected|MP:0003828,pulmonary edema|MP:0005333,decreased heart rate|MP:0005378,growth/size/body region phenotype|MP:0008535,enlarged lateral ventricles|MP:0009546,absent gastric milk in neonates|MP:0010752,impaired mucociliary clearance|MP:0010898,abnormal pulmonary alveolus epithelium morphology|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011087,neonatal lethality, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0011649,immotile respiratory cilia
MGI:5603354	Spag4<tm1.1(KOMP)Mbp>	MP:0001399,hyperactivity|MP:0013279,increased fasting circulating glucose level
MGI:4456603	Spag4<tm1(KOMP)Mbp>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002631,abnormal epididymis morphology|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009238,coiled sperm flagellum|MP:0009376,abnormal manchette morphology|MP:0009377,ectopic manchette|MP:0009830,abnormal sperm connecting piece morphology|MP:0009836,abnormal sperm principal piece morphology|MP:0014636,decreased elongated spermatid number|MP:0031356,abnormal outer dense fiber morphology|MP:0031374,abnormal manchette assembly|MP:0031388,absent manchette
MGI:2183294	Spag5<tm1Vdh>	MP:0002169,no abnormal phenotype detected
MGI:6316614	Spag6<em1(IMPC)J>	MP:0002169,no abnormal phenotype detected|MP:0005389,reproductive system phenotype
MGI:2662475	Spag6l<tm1Jfs>	MP:0000434,megacephaly|MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0001265,decreased body size|MP:0001891,hydrocephaly|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002083,premature death|MP:0002675,asthenozoospermia|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009234,absent sperm head|MP:0009239,short sperm flagellum|MP:0009831,abnormal sperm midpiece morphology|MP:0009836,abnormal sperm principal piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0031352,absent sperm axonemal central pair|MP:0031356,abnormal outer dense fiber morphology
MGI:7664534	Spag7<em1(IMPC)Mbp>	MP:0001258,decreased body length|MP:0002834,decreased heart weight|MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval
MGI:4442906	Spag9<m1Btlr>	MP:0000371,diluted coat color|MP:0001189,absent skin pigmentation|MP:0009280,decreased activated sperm motility
MGI:3820229	Spag9<tm1Ysok>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype
MGI:2386404	Spam1<tm1Tba>	MP:0000242,impaired fertilization|MP:0004543,abnormal sperm physiology
MGI:6276863	Sparcl1<em1(IMPC)Mbp>	MP:0009709,hydrometra
MGI:2153047	Sparcl1<tm1Pmc>	MP:0000877,abnormal Purkinje cell morphology|MP:0002183,gliosis|MP:0003631,nervous system phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype
MGI:4432869	Sparc<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000558,abnormal tibia morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0002100,abnormal tooth morphology|MP:0002834,decreased heart weight|MP:0003961,decreased lean body mass|MP:0005296,abnormal humerus morphology|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010096,abnormal incisor color|MP:0010124,decreased bone mineral content
MGI:4421677	Sparc<tm1Anjm>	MP:0005397,hematopoietic system phenotype
MGI:2137432	Sparc<tm1Cam>	MP:0003727,abnormal retina layer morphology|MP:0010251,subcapsular cataract
MGI:1888383	Sparc<tm1Hwe>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0001303,abnormal lens morphology|MP:0001326,retina degeneration|MP:0001402,decreased locomotor activity|MP:0001533,abnormal skeleton physiology|MP:0001542,abnormal bone strength|MP:0001851,eye inflammation|MP:0002724,enhanced wound healing|MP:0002840,abnormal lens fiber morphology|MP:0002908,delayed wound healing|MP:0002998,abnormal bone remodeling|MP:0003099,retina detachment|MP:0003236,abnormal lens capsule morphology|MP:0003237,abnormal lens epithelium morphology|MP:0003721,increased tumor growth/size|MP:0004982,abnormal osteoclast morphology|MP:0004985,decreased osteoclast cell number|MP:0004986,abnormal osteoblast morphology|MP:0004989,decreased osteoblast cell number|MP:0005508,abnormal skeleton morphology|MP:0006201,vitreous body inflammation|MP:0008841,ruptured lens capsule|MP:0010253,posterior subcapsular cataract|MP:0010255,cortical cataract
MGI:5430946	Spart<tm1.1Xen>	MP:0000003,abnormal adipose tissue morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000358,abnormal cell morphology|MP:0000754,paresis|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002020,increased tumor incidence|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002644,decreased circulating triglyceride level|MP:0003091,abnormal cell migration|MP:0003631,nervous system phenotype|MP:0003707,increased cell nucleus count|MP:0004046,abnormal mitosis|MP:0005390,skeleton phenotype|MP:0005404,abnormal axon morphology|MP:0008143,abnormal dendrite morphology|MP:0008821,increased blood uric acid level|MP:0009115,abnormal fat cell morphology|MP:0009269,decreased fat cell size|MP:0009434,paraparesis|MP:0010024,increased total body fat amount
MGI:5548741	Spart<tm2b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment|MP:0010574,dilated aorta|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:3813522	Spast<M1Gri>	MP:0001406,abnormal gait|MP:0004768,abnormal axonal transport|MP:0005404,abnormal axon morphology
MGI:6393452	Spast<tm1.1Evre>	MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0005404,abnormal axon morphology|MP:0010540,long stride length
MGI:3698038	Spast<tm1.1Jme>	MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001924,infertility|MP:0005404,abnormal axon morphology
MGI:5014568	Spast<tm1a(KOMP)Wtsi>	MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0004024,aneuploidy|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0008261,arrest of male meiosis|MP:0008898,abnormal acrosome morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009376,abnormal manchette morphology|MP:0009377,ectopic manchette|MP:0009761,abnormal meiotic spindle morphology|MP:0010948,abnormal double-strand DNA break repair|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014052,increased male germ cell apoptosis|MP:0031354,abnormal acrosome assembly|MP:0031374,abnormal manchette assembly|MP:0031375,abnormal manchette disassembly|MP:0031386,elongated manchette
MGI:5605769	Spast<tm1b(KOMP)Wtsi>	MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology
MGI:5490050	Spast<tm1Jfnk>	MP:0001405,impaired coordination
MGI:3698037	Spast<tm1Jme>	MP:0002169,no abnormal phenotype detected
MGI:6153824	Spata13<em1(IMPC)H>	MP:0002557,abnormal social/conspecific interaction behavior|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0004924,abnormal behavior|MP:0005386,behavior/neurological phenotype
MGI:5816603	Spata13<tm1Taki>	MP:0002169,no abnormal phenotype detected
MGI:6147689	Spata16<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6147690	Spata16<em2Osb>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005578,teratozoospermia|MP:0008279,arrest of spermiogenesis|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology
MGI:6510019	Spata19<tm1Lij>	MP:0001925,male infertility|MP:0008892,abnormal sperm flagellum morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0010955,abnormal respiratory electron transport chain|MP:0014465,abnormal sperm mitochondrial morphology|MP:0020451,decreased sperm progressive motility
MGI:6163619	Spata20<Tn(pb-Act-RFP)1.1Zhu>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009376,abnormal manchette morphology|MP:0014633,decreased spermatid number|MP:0020451,decreased sperm progressive motility|MP:0031373,abnormal manchette perinuclear ring morphology
MGI:7426000	Spata21<em1(IMPC)Bay>	MP:0001513,limb grasping|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5314540	Spata22<repro42>	MP:0001127,small ovary|MP:0001131,abnormal ovarian follicle morphology|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002016,ovary cyst|MP:0004805,absent oocytes|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005431,decreased oocyte number|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0014604,hemorrhagic ovary cyst|MP:0014633,decreased spermatid number|MP:0014764,impaired double-strand DNA break repair
MGI:6479012	Spata22<shani>	MP:0001127,small ovary|MP:0001153,small seminiferous tubules|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002777,absent ovarian follicles|MP:0004852,decreased testis weight|MP:0008261,arrest of male meiosis|MP:0009451,abnormal chromosomal synapsis|MP:0010948,abnormal double-strand DNA break repair|MP:0014052,increased male germ cell apoptosis
MGI:4365083	Spata22<tm1a(KOMP)Wtsi>	MP:0001127,small ovary|MP:0001131,abnormal ovarian follicle morphology|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001930,abnormal meiosis|MP:0004805,absent oocytes|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0006379,abnormal spermatocyte morphology|MP:0006380,abnormal spermatid morphology|MP:0008261,arrest of male meiosis|MP:0009451,abnormal chromosomal synapsis|MP:0009452,abnormal synaptonemal complex|MP:0014764,impaired double-strand DNA break repair
MGI:5569960	Spata22<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001944,abnormal pancreas morphology|MP:0003795,abnormal bone structure|MP:0004931,enlarged epididymis|MP:0010124,decreased bone mineral content
MGI:6459763	Spata24<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5637053	Spata24<tm1b(EUCOMM)Wtsi>	MP:0000222,decreased neutrophil cell number|MP:0001304,cataract|MP:0001402,decreased locomotor activity
MGI:6194645	Spata25<tm1b(EUCOMM)Hmgu>	MP:0002169,no abnormal phenotype detected
MGI:6093706	Spata2<em1Jliu>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0006378,abnormal spermatogonia morphology|MP:0009647,decreased fertilization frequency
MGI:5575898	Spata2<tm1.1(KOMP)Vlcg>	MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number
MGI:3800001	Spata2<tm1(KOMP)Vlcg>	MP:0000313,abnormal cell death|MP:0001846,increased inflammatory response|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype
MGI:5692862	Spata31d1c<tm2b(EUCOMM)Hmgu>	MP:0003020,decreased circulating chloride level|MP:0011239,abnormal skin coloration
MGI:7526416	Spata31<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0002834,decreased heart weight|MP:0010124,decreased bone mineral content
MGI:6358061	Spata31f3<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002339,abnormal lymph node morphology|MP:0004357,long tibia|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0013436,increased CD8-positive, naive alpha-beta T cell number
MGI:7544858	Spata31g1<em1Ctu>	MP:0005389,reproductive system phenotype
MGI:6510015	Spata31<tm1Yangy>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0014636,decreased elongated spermatid number|MP:0014686,premature spermiation
MGI:6849782	Spata33<em1Osb>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0002674,abnormal sperm motility|MP:0005389,reproductive system phenotype|MP:0009831,abnormal sperm midpiece morphology
MGI:6849783	Spata33<em2Osb>	MP:0002674,abnormal sperm motility
MGI:6107629	Spata3<em1(IMPC)J>	MP:0005553,increased circulating creatinine level
MGI:6711592	Spata3<em1Sbbx>	MP:0000242,impaired fertilization|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0009231,detached acrosome
MGI:7641860	Spata45<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5829001	Spata46<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000277,abnormal heart shape|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0002092,abnormal eye morphology|MP:0004832,enlarged ovary|MP:0004906,enlarged uterus|MP:0009552,urinary bladder obstruction
MGI:6356373	Spata46<tm1Itl>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009647,decreased fertilization frequency|MP:0030980,abnormal acroplaxome morphology
MGI:6195018	Spata4<tm1.1Osb>	MP:0002169,no abnormal phenotype detected
MGI:4364547	Spata6<tm1a(KOMP)Wtsi>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002662,abnormal cauda epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0008893,detached sperm flagellum|MP:0009234,absent sperm head|MP:0009830,abnormal sperm connecting piece morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0009833,absent sperm mitochondrial sheath|MP:0009834,abnormal sperm annulus morphology|MP:0009837,abnormal sperm end piece morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology
MGI:5548554	Spata6<tm1b(KOMP)Wtsi>	MP:0001925,male infertility|MP:0002764,short tibia|MP:0005576,decreased pulmonary ventilation
MGI:5635367	Spata7<tm1.1(KOMP)Vlcg>	MP:0001325,abnormal retina morphology|MP:0010053,decreased grip strength|MP:0013278,decreased fasting circulating glucose level
MGI:5660490	Spata7<tm1Mrd>	MP:0001005,abnormal retina rod cell morphology|MP:0001006,abnormal retina cone cell morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008515,thin retina outer nuclear layer|MP:0014059,abnormal photoreceptor connecting cilium morphology
MGI:6386673	Spata7<tm2.1Mrd>	MP:0008450,retina photoreceptor degeneration
MGI:6195051	Spata9<tm1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6293902	Spatc1<em1(IMPC)J>	MP:0001566,increased circulating phosphate level|MP:0002098,abnormal vibrissa morphology
MGI:6200789	Spatc1l<em1Choc>	MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008545,absent sperm flagellum|MP:0008893,detached sperm flagellum|MP:0009230,abnormal sperm head morphology|MP:0009234,absent sperm head
MGI:6153862	Spatc1l<em1(IMPC)H>	MP:0001925,male infertility|MP:0005554,decreased circulating creatinine level
MGI:6721057	Spats1<em1Agei>	MP:0005389,reproductive system phenotype
MGI:6260204	Spats2<em1(IMPC)J>	MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1856632	spc	MP:0000416,sparse hair|MP:0000418,focal hair loss|MP:0000420,ruffled hair|MP:0001282,short vibrissae|MP:0001921,reduced fertility|MP:0009703,decreased birth body size
MGI:6259583	Spc25<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5445556	spcy	MP:0002419,abnormal innate immunity|MP:0004514,dystocia
MGI:4398888	Spdef<tm1.1Cle>	MP:0002241,abnormal laryngeal mucosa goblet cell morphology|MP:0010863,absent respiratory mucosa goblet cells
MGI:4410321	Spdef<tm1.2Cle>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0003449,abnormal intestine goblet cell morphology|MP:0004843,abnormal Paneth cell morphology|MP:0013486,decreased Paneth cell number
MGI:4867866	Spdef<tm1Shiv>	MP:0000473,abnormal stomach glandular epithelium morphology|MP:0001663,abnormal digestive system physiology|MP:0001873,stomach inflammation|MP:0003306,small intestinal inflammation|MP:0010790,abnormal stomach pyloric antrum morphology|MP:0010792,abnormal stomach mucosa morphology|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5888863	Spdya<tm1.1Klad>	MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0003205,testicular atrophy|MP:0004833,ovary atrophy|MP:0004901,decreased male germ cell number|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0005431,decreased oocyte number|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0008966,abnormal chiasmata formation|MP:0009451,abnormal chromosomal synapsis|MP:0009452,abnormal synaptonemal complex|MP:0010207,abnormal telomere morphology|MP:0014633,decreased spermatid number|MP:0014634,decreased round spermatid number|MP:0014636,decreased elongated spermatid number|MP:0014764,impaired double-strand DNA break repair
MGI:5888861	Spdya<tm1Kald>	MP:0005389,reproductive system phenotype
MGI:5548903	Spdye4b<tm3b(EUCOMM)Wtsi>	MP:0000689,abnormal spleen morphology
MGI:6357905	Specc1l<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0001399,hyperactivity
MGI:7286333	Specc1l<em2Kumc>	MP:0009652,abnormal palatal rugae morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:7286337	Specc1l<em3Kumc>	MP:0000111,cleft palate|MP:0000914,exencephaly|MP:0003052,omphalocele|MP:0003720,abnormal neural tube closure|MP:0005262,coloboma|MP:0009652,abnormal palatal rugae morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013818,abnormal oral cavity morphology
MGI:7286340	Specc1l<em4Kumc>	MP:0000111,cleft palate|MP:0000914,exencephaly|MP:0003052,omphalocele|MP:0003720,abnormal neural tube closure|MP:0005262,coloboma|MP:0009652,abnormal palatal rugae morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013818,abnormal oral cavity morphology
MGI:4124253	Specc1l<Gt(DTM096)Byg>	MP:0000428,abnormal craniofacial morphology|MP:0002080,prenatal lethality|MP:0003720,abnormal neural tube closure|MP:0006042,increased apoptosis|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0012746,abnormal neural crest cell delamination|MP:0012757,abnormal cranial neural crest cell migration
MGI:4128888	Specc1l<Gt(RRH048)Byg>	MP:0000428,abnormal craniofacial morphology|MP:0002080,prenatal lethality|MP:0003720,abnormal neural tube closure|MP:0006042,increased apoptosis|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0012746,abnormal neural crest cell delamination|MP:0012757,abnormal cranial neural crest cell migration
MGI:6152652	Speer4f1<em1(IMPC)Mbp>	MP:0001404,no spontaneous movement|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5695963	Spef1<tm1.1(KOMP)Vlcg>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5295267	Spef2<bgh>	MP:0000825,dilated lateral ventricle|MP:0001156,abnormal spermatogenesis|MP:0001872,sinus inflammation|MP:0001891,hydrocephaly|MP:0001925,male infertility|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002176,increased brain weight|MP:0002183,gliosis|MP:0002687,oligozoospermia|MP:0003631,nervous system phenotype|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009239,short sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0010768,mortality/aging|MP:0011055,abnormal respiratory motile cilium physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014465,abnormal sperm mitochondrial morphology|MP:0030316,enlarged neurocranium|MP:0030590,abnormal sperm fibrous sheath morphology
MGI:5605745	Speg<tm1b(KOMP)Wtsi>	MP:0002606,increased basophil cell number
MGI:4830540	Speg<tm1Mkap>	MP:0000274,enlarged heart|MP:0000280,thin ventricular wall|MP:0002833,increased heart weight|MP:0003057,abnormal epicardium morphology|MP:0003641,small lung|MP:0004062,dilated heart right atrium|MP:0004063,dilated heart left atrium|MP:0004937,dilated heart|MP:0008022,dilated heart ventricle|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0010551,abnormal coronary vessel morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0031609,increased fetal cardiomyocyte size|MP:0031611,decreased fetal cardiomyocyte number|MP:0031614,fetal cardiomyocyte vacuoles|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3716924	Spem1<tm1Wyan>	MP:0000242,impaired fertilization|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0005578,teratozoospermia|MP:0009230,abnormal sperm head morphology
MGI:7292552	Spem2<em1Smoc>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004542,impaired acrosome reaction|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009647,decreased fertilization frequency|MP:0009831,abnormal sperm midpiece morphology|MP:0009839,multiflagellated sperm|MP:0014465,abnormal sperm mitochondrial morphology|MP:0014468,disorganized sperm mitochondrial sheath|MP:0014684,impaired spermiation|MP:0031009,abnormal sperm-egg fusion|MP:0031012,impaired sperm migration in female genital tract|MP:0031354,abnormal acrosome assembly|MP:0031372,abnormal sperm individualization|MP:0031408,multi-headed sperm
MGI:2667509	Spen<tm1Hon>	MP:0000267,abnormal heart development|MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0001201,translucent skin|MP:0002144,abnormal B cell differentiation|MP:0003934,abnormal pancreas development|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3710413	Spen<tm2.1Hon>	MP:0000771,abnormal brain size|MP:0000787,abnormal telencephalon morphology|MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0001732,postnatal growth retardation|MP:0002063,abnormal learning/memory/conditioning|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0006254,thin cerebral cortex|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008283,small hippocampus|MP:0008535,enlarged lateral ventricles
MGI:3710414	Spen<tm2.2Hon>	MP:0011091,prenatal lethality, complete penetrance
MGI:3710412	Spen<tm2Hon>	MP:0011091,prenatal lethality, complete penetrance
MGI:4838302	Spesp1<tm1Osb>	MP:0004543,abnormal sperm physiology|MP:0005411,delayed fertilization|MP:0008898,abnormal acrosome morphology|MP:0009647,decreased fertilization frequency
MGI:6367562	Spg11<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0005333,decreased heart rate|MP:0005567,decreased circulating total protein level|MP:0010024,increased total body fat amount|MP:0010506,prolonged RR interval
MGI:4377985	Spg11<Gt(EUCE0085f05)Hmgu>	MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000938,motor neuron degeneration|MP:0001263,weight loss|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0002175,decreased brain weight|MP:0002878,abnormal corticospinal tract morphology|MP:0002882,abnormal neuron morphology|MP:0003172,abnormal lysosome physiology|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0005058,abnormal lysosome morphology|MP:0005405,axon degeneration|MP:0008260,abnormal autophagy|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0012506,brain atrophy
MGI:6508399	Spg21<tm1Mchan>	MP:0001392,abnormal locomotor behavior|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002882,abnormal neuron morphology|MP:0005404,abnormal axon morphology|MP:0009937,abnormal neuron differentiation
MGI:3028923	Spg7<tm1Eir>	MP:0000161,scoliosis|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001516,abnormal motor coordination/balance|MP:0001524,impaired limb coordination|MP:0001525,impaired balance|MP:0004768,abnormal axonal transport|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration
MGI:3576619	Spgl	MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0002728,absent tibia|MP:0005371,limbs/digits/tail phenotype|MP:0005389,reproductive system phenotype|MP:0008985,hemimelia
MGI:3040369	Spha1<MSM/Ms>	MP:0009230,abnormal sperm head morphology
MGI:3040371	Spha2<MSM/Ms>	MP:0009230,abnormal sperm head morphology
MGI:3040373	Spha3<MSM/Ms>	MP:0009230,abnormal sperm head morphology
MGI:6336209	Sphk1<em1(IMPC)Mbp>	MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney
MGI:3707992	Sphk1<tm1.1Cgh>	MP:0004215,abnormal myocardial fiber physiology
MGI:3769485	Sphk1<tm1Npa>	MP:0005014,increased B cell number
MGI:3526071	Sphk1<tm1Rlp>	MP:0002169,no abnormal phenotype detected|MP:0008466,enlarged mesenteric lymph nodes|MP:0008713,abnormal cytokine level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:3580701	Sphk2<Gt(NPX039)Byg>	MP:0005387,immune system phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:4362092	Sphk2<tm1.1Stlp>	MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology
MGI:3769486	Sphk2<tm1Npa>	MP:0005014,increased B cell number|MP:0014470,abnormal B cell migration
MGI:3611080	Sphk2<tm1Rlp>	MP:0002169,no abnormal phenotype detected
MGI:6449058	Sphkap<tm1.1Nina>	MP:0002079,increased circulating insulin level|MP:0002727,decreased circulating insulin level|MP:0003058,increased insulin secretion|MP:0003059,decreased insulin secretion|MP:0005560,decreased circulating glucose level
MGI:3045207	Spi1<tm1.1Dgt>	MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0001586,abnormal erythrocyte cell number|MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002397,abnormal bone marrow morphology|MP:0005017,decreased B cell number
MGI:3578013	Spi1<tm1.1Nutt>	MP:0000239,absent common myeloid progenitor cells
MGI:3806995	Spi1<tm1.1Rpd>	MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:3619527	Spi1<tm1.2Dgt>	MP:0002169,no abnormal phenotype detected
MGI:3578011	Spi1<tm1.2Nutt>	MP:0000215,absent erythrocytes|MP:0000239,absent common myeloid progenitor cells|MP:0000240,extramedullary hematopoiesis|MP:0000322,increased granulocyte number|MP:0000689,abnormal spleen morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0005017,decreased B cell number|MP:0008111,abnormal granulocyte differentiation
MGI:3619530	Spi1<tm1.3Dgt>	MP:0000219,increased neutrophil cell number|MP:0000334,decreased granulocyte number|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001802,arrested B cell differentiation|MP:0002024,increased T cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002407,abnormal double-negative T cell morphology|MP:0002416,abnormal proerythroblast morphology|MP:0002494,increased IgM level|MP:0002981,increased liver weight|MP:0003944,abnormal T cell subpopulation ratio|MP:0004023,abnormal chromosome number|MP:0004952,increased spleen weight|MP:0004977,increased B-1 B cell number|MP:0005013,increased lymphocyte cell number|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005141,liver hyperplasia|MP:0008168,decreased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number
MGI:3578012	Spi1<tm1.3Nutt>	MP:0000239,absent common myeloid progenitor cells|MP:0011087,neonatal lethality, complete penetrance
MGI:3044765	Spi1<tm1Kast>	MP:0000245,abnormal erythropoiesis|MP:0000321,increased bone marrow cell number|MP:0001603,failure of myelopoiesis|MP:0004809,increased hematopoietic stem cell number|MP:0008071,absent B cells|MP:0011087,neonatal lethality, complete penetrance|MP:0011241,abnormal fetal derived definitive erythrocyte cell number
MGI:3528071	Spi1<tm1Nutt>	MP:0002169,no abnormal phenotype detected
MGI:1927876	Spi1<tm1Ram>	MP:0000136,abnormal microglial cell morphology|MP:0000222,decreased neutrophil cell number|MP:0000715,decreased thymocyte number|MP:0001286,abnormal eye development|MP:0001289,persistence of hyaloid vascular system|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0002182,abnormal astrocyte morphology|MP:0002415,abnormal neutrophil differentiation|MP:0002458,abnormal B cell number|MP:0003884,decreased macrophage cell number|MP:0005044,sepsis|MP:0005092,decreased double-positive T cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0006387,abnormal T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008113,abnormal macrophage differentiation|MP:0008212,absent mature B cells|MP:0008477,decreased spleen red pulp amount|MP:0011087,neonatal lethality, complete penetrance|MP:0014605,dark liver
MGI:3717917	Spi1<tm1Rpd>	MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000691,enlarged spleen|MP:0001265,decreased body size|MP:0001601,abnormal myelopoiesis|MP:0001602,impaired myelopoiesis|MP:0001802,arrested B cell differentiation|MP:0005141,liver hyperplasia|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1930970	Spi1<tm1Sing>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0001577,anemia|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002441,abnormal granulocyte morphology|MP:0002620,abnormal monocyte morphology|MP:0005460,abnormal leukopoiesis|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3688440	Spi1<tm2.1Dgt>	MP:0001545,abnormal hematopoietic system physiology|MP:0002429,abnormal blood cell morphology/development|MP:0004810,decreased hematopoietic stem cell number|MP:0011091,prenatal lethality, complete penetrance
MGI:5632534	Spi1<tm2b(EUCOMM)Wtsi>	MP:0001914,hemorrhage|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:3688438	Spi1<tm2Dgt>	MP:0002429,abnormal blood cell morphology/development|MP:0005397,hematopoietic system phenotype
MGI:3773989	Spi1<tm3Dgt>	MP:0000322,increased granulocyte number|MP:0005017,decreased B cell number|MP:0005089,decreased double-negative T cell number|MP:0005090,increased double-negative T cell number
MGI:5501529	Spi1<tm4.1Dgt>	MP:0000321,increased bone marrow cell number|MP:0003077,abnormal cell cycle|MP:0004809,increased hematopoietic stem cell number|MP:0005397,hematopoietic system phenotype|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011902,increased hematopoietic stem cell proliferation
MGI:5438102	Spib<tm1Ksho>	MP:0000477,abnormal intestine morphology|MP:0000696,abnormal Peyer's patch morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0005381,digestive/alimentary phenotype
MGI:2448991	Spib<tm1Mcs>	MP:0001800,abnormal humoral immune response|MP:0002357,abnormal spleen white pulp morphology|MP:0002359,abnormal spleen germinal center morphology|MP:0002494,increased IgM level|MP:0005022,abnormal immature B cell morphology|MP:0005093,decreased B cell proliferation|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008782,increased B cell apoptosis
MGI:5692592	Spice1<tm1b(EUCOMM)Hmgu>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005292,improved glucose tolerance|MP:0010067,increased red blood cell distribution width
MGI:3829865	Spic<tm1.1Kmm>	MP:0001798,impaired macrophage phagocytosis|MP:0002446,abnormal macrophage morphology|MP:0004952,increased spleen weight|MP:0008809,increased spleen iron level|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4939280	Spic<tm1Kmm>	MP:0001798,impaired macrophage phagocytosis|MP:0002446,abnormal macrophage morphology|MP:0004952,increased spleen weight|MP:0008809,increased spleen iron level|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5572011	Spic<tm2Kmm>	MP:0002169,no abnormal phenotype detected
MGI:5692750	Spidr<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0001925,male infertility|MP:0001926,female infertility|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011959,abnormal eye posterior chamber depth
MGI:3852674	Spin1<Gt(RRZ449)Byg>	MP:0005389,reproductive system phenotype|MP:0010767,abnormal female meiosis I arrest|MP:0011085,postnatal lethality, complete penetrance
MGI:5581470	Spin1<tm1.1(KOMP)Vlcg>	MP:0001289,persistence of hyaloid vascular system|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0002574,increased vertical activity|MP:0002968,increased circulating alkaline phosphatase level|MP:0008259,abnormal optic disk morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:6511292	Spin1<tm1.1Rosc>	MP:0000161,scoliosis|MP:0000550,abnormal forelimb morphology|MP:0000729,abnormal myogenesis|MP:0000759,abnormal skeletal muscle morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001504,abnormal posture|MP:0002279,abnormal diaphragm morphology|MP:0003081,abnormal soleus morphology|MP:0003083,abnormal tibialis anterior morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004094,abnormal M line morphology|MP:0004819,decreased skeletal muscle mass|MP:0005150,cachexia|MP:0009399,increased skeletal muscle fiber size|MP:0009406,decreased skeletal muscle fiber number|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009412,skeletal muscle fiber degeneration|MP:0009414,skeletal muscle fiber necrosis|MP:0009415,skeletal muscle degeneration|MP:0009419,skeletal muscle fibrosis|MP:0009546,absent gastric milk in neonates|MP:0011088,neonatal lethality, incomplete penetrance
MGI:6511293	Spin1<tm1.2Rosc>	MP:0000550,abnormal forelimb morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:7621834	Spin4<em1Jbn>	MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001264,increased body size|MP:0002176,increased brain weight|MP:0002833,increased heart weight|MP:0002981,increased liver weight|MP:0003917,increased kidney weight|MP:0004357,long tibia|MP:0004952,increased spleen weight|MP:0005630,increased lung weight|MP:0006398,increased long bone epiphyseal plate size|MP:0009780,abnormal chondrocyte physiology|MP:0011692,increased chondrocyte number|MP:0014100,increased chondrocyte proliferation
MGI:7621835	Spin4<em2Jbn>	MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001264,increased body size|MP:0002176,increased brain weight|MP:0002833,increased heart weight|MP:0002981,increased liver weight|MP:0003917,increased kidney weight|MP:0004357,long tibia|MP:0004952,increased spleen weight|MP:0005630,increased lung weight|MP:0006398,increased long bone epiphyseal plate size|MP:0011692,increased chondrocyte number|MP:0014100,increased chondrocyte proliferation
MGI:6864335	Spindoc<em1Mtb>	MP:0001262,decreased body weight|MP:0002879,increased cellular sensitivity to X-ray irradiation induced cell death|MP:0003992,increased mortality induced by ionizing radiation|MP:0005584,abnormal enzyme/coenzyme activity|MP:0010768,mortality/aging
MGI:6864336	Spindoc<em2Mtb>	MP:0001262,decreased body weight|MP:0002879,increased cellular sensitivity to X-ray irradiation induced cell death|MP:0003992,increased mortality induced by ionizing radiation|MP:0005584,abnormal enzyme/coenzyme activity|MP:0010768,mortality/aging
MGI:5649013	Spink12<em1(IMPC)J>	MP:0001325,abnormal retina morphology|MP:0001486,abnormal startle reflex|MP:0002075,abnormal coat/hair pigmentation|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005344,increased circulating bilirubin level|MP:0005566,decreased blood urea nitrogen level|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:6341936	Spink13<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003604,single kidney|MP:0003917,increased kidney weight
MGI:4841420	Spink14<tm1e(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0003884,decreased macrophage cell number|MP:0003960,increased lean body mass|MP:0004794,increased anti-nuclear antigen antibody level|MP:0008045,decreased NK cell number|MP:0013427,increased memory-marker NK cell number|MP:0013666,decreased immature NK cell number|MP:0013672,decreased mature NK cell number
MGI:3613294	Spink1<tm1Kymm>	MP:0000416,sparse hair|MP:0000496,abnormal small intestine morphology|MP:0000692,small spleen|MP:0001199,thin skin|MP:0001262,decreased body weight|MP:0001429,dehydration|MP:0001732,postnatal growth retardation|MP:0001944,abnormal pancreas morphology|MP:0003271,abnormal duodenum morphology|MP:0005520,impaired pancreas regeneration|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:3805845	Spink1<tm2Kymm>	MP:0011085,postnatal lethality, complete penetrance
MGI:4966113	Spink2<Gt(327A6)Cmhd>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008280,abnormal male germ cell apoptosis|MP:0009237,kinked sperm flagellum
MGI:5573273	Spink2<tm1.1(KOMP)Vlcg>	MP:0001925,male infertility|MP:0002606,increased basophil cell number|MP:0002631,abnormal epididymis morphology|MP:0002875,decreased erythrocyte cell number
MGI:6275151	Spink5<em1(IMPC)J>	MP:0001284,absent vibrissae|MP:0011100,preweaning lethality, complete penetrance
MGI:5319218	Spink5<m1Btlr>	MP:0000219,increased neutrophil cell number|MP:0001192,scaly skin|MP:0001195,flaky skin|MP:0001212,skin lesions
MGI:3527214	Spink5<tm1Drh>	MP:0001216,abnormal epidermal layer morphology|MP:0001242,hyperkeratosis|MP:0001429,dehydration|MP:0002796,impaired skin barrier function|MP:0009594,abnormal corneocyte envelope morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3573756	Spink5<tm1Hov>	MP:0000377,abnormal hair follicle morphology|MP:0001190,reddish skin|MP:0001192,scaly skin|MP:0001212,skin lesions|MP:0001216,abnormal epidermal layer morphology|MP:0001230,epidermal desquamation|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001283,sparse vibrissae|MP:0001874,acanthosis|MP:0002098,abnormal vibrissa morphology|MP:0002796,impaired skin barrier function|MP:0003089,decreased skin tensile strength|MP:0003427,parakeratosis|MP:0003809,abnormal hair shaft morphology|MP:0010234,abnormal vibrissa follicle morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:7863868	Spink5<tm2.1Hov>	MP:0000219,increased neutrophil cell number|MP:0000414,alopecia|MP:0000418,focal hair loss|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000694,spleen hypoplasia|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0000711,thymus cortex hypoplasia|MP:0001192,scaly skin|MP:0001212,skin lesions|MP:0001219,thick epidermis|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0001263,weight loss|MP:0001280,loss of vibrissae|MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0002060,abnormal skin morphology|MP:0002083,premature death|MP:0002344,abnormal lymph node B cell domain morphology|MP:0002362,abnormal spleen marginal zone morphology|MP:0002497,increased IgE level|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0003427,parakeratosis|MP:0003644,thymus atrophy|MP:0003941,abnormal skin development|MP:0004947,skin inflammation|MP:0005092,decreased double-positive T cell number|MP:0005150,cachexia|MP:0008102,lymph node hyperplasia|MP:0008478,increased spleen white pulp amount|MP:0008522,abnormal lymph node germinal center morphology|MP:0009583,increased keratinocyte proliferation|MP:0010373,myeloid hyperplasia|MP:0014263,decreased spleen B cell follicle number|MP:0014431,increased chemokine level|MP:0014448,increased enzyme/coenzyme level|MP:0020254,decreased collagen level
MGI:5286986	Spink5<Tn(Pgk2-sb10,sb-Tyr)1498Ove>	MP:0001208,blistering|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001429,dehydration|MP:0002796,impaired skin barrier function|MP:0010771,integument phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:6152706	Spink6<em1(IMPC)Ccpcz>	MP:0000220,increased monocyte cell number|MP:0003884,decreased macrophage cell number|MP:0013669,decreased Ly6C-positive immature NK cell number|MP:0013676,increased Ly6C-positive mature NK cell number
MGI:6764496	Spink7<em1Cya>	MP:0008537,increased susceptibility to induced colitis|MP:0008657,increased interleukin-1 beta secretion|MP:0008705,increased interleukin-6 secretion|MP:0010180,increased susceptibility to weight loss
MGI:6194730	Spink8<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6194731	Spink8<em2Osb>	MP:0002169,no abnormal phenotype detected
MGI:3709554	Spint1<Gt(OST380474)Lex>	MP:0001716,abnormal placenta labyrinth morphology|MP:0004272,abnormal basement membrane morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0005380,embryo phenotype|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5696890	Spint1<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3822295	Spint1<tm1Bug>	MP:0003403,absent placental labyrinth|MP:0003984,embryonic growth retardation|MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3581891	Spint1<tm1Hk>	MP:0000291,enlarged pericardium|MP:0001711,abnormal placenta morphology|MP:0001712,abnormal placenta development|MP:0001730,embryonic growth arrest|MP:0003231,abnormal placenta vasculature|MP:0003403,absent placental labyrinth|MP:0004265,abnormal placental transport|MP:0004560,abnormal chorionic plate morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5304850	Spint1<tm2.1Hk>	MP:0000512,intestinal ulcer|MP:0003866,abnormal defecation|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005036,diarrhea|MP:0008537,increased susceptibility to induced colitis|MP:0008883,abnormal enterocyte proliferation|MP:0008885,increased enterocyte apoptosis|MP:0009477,small cecum|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010155,abnormal intestine physiology|MP:0010180,increased susceptibility to weight loss
MGI:7426003	Spint2<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:2156187	Spint2<Gt(KST272)Byg>	MP:0000914,exencephaly|MP:0001675,abnormal ectoderm development|MP:0001695,abnormal gastrulation|MP:0002151,abnormal neural tube morphology|MP:0003720,abnormal neural tube closure|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011105,embryonic lethality between implantation and placentation, incomplete penetrance
MGI:6693652	Spint3<em1Zuk>	MP:0002169,no abnormal phenotype detected
MGI:3574901	Spir1<BALB/cOlaHsd>	MP:0002411,decreased susceptibility to bacterial infection
MGI:3574902	Spir1<CBA/CaOlaHsd>	MP:0002412,increased susceptibility to bacterial infection
MGI:4310183	Spire1<Gt(OST416113)Lex>	MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype|MP:0005391,vision/eye phenotype|MP:0009453,enhanced contextual conditioning behavior|MP:0009455,enhanced cued conditioning behavior|MP:0009936,abnormal dendritic spine morphology|MP:0010771,integument phenotype
MGI:3042941	Splq1<L6>	MP:0004953,decreased spleen weight
MGI:3042951	Splq2<L6>	MP:0004953,decreased spleen weight
MGI:3042932	Splq3<L6>	MP:0004953,decreased spleen weight
MGI:3043098	Splq4<L6>	MP:0004953,decreased spleen weight
MGI:3042937	Splq5<L6>	MP:0004953,decreased spleen weight
MGI:3042961	Splq6<L6>	MP:0004953,decreased spleen weight
MGI:3042979	Splq7<L6>	MP:0004953,decreased spleen weight
MGI:3043145	Splq8<L6>	MP:0004953,decreased spleen weight
MGI:3043147	Splq9<L6>	MP:0004953,decreased spleen weight
MGI:3525682	Splwt1<LG/J>	MP:0004952,increased spleen weight
MGI:2155767	Spm1<C57BL/6>	MP:0002722,abnormal immune system organ morphology
MGI:5548609	Spmap2l<tm1b(KOMP)Wtsi>	MP:0000745,tremors|MP:0002169,no abnormal phenotype detected|MP:0002833,increased heart weight|MP:0003019,increased circulating chloride level
MGI:2385820	Spmap2<Tg(PDE5A)1Ynk>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008545,absent sperm flagellum|MP:0008892,abnormal sperm flagellum morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009838,abnormal sperm axoneme morphology
MGI:2674963	Spmap2<tm1Wen>	MP:0001147,small testis
MGI:2674964	Spmap2<tm2Wen>	MP:0002169,no abnormal phenotype detected
MGI:3654127	Spmd1<Smt>	MP:0005169,abnormal male meiosis|MP:0020550,multinucleated giant male germ cells
MGI:3654129	Spmd2<Smt>	MP:0002687,oligozoospermia
MGI:3654136	Spmd3<Smt>	MP:0002687,oligozoospermia
MGI:3654138	Spmd4<Smt>	MP:0005169,abnormal male meiosis
MGI:6849777	Spmip10<em1Osb>	MP:0002674,abnormal sperm motility|MP:0005389,reproductive system phenotype
MGI:5568484	Spmip2<tm1b(EUCOMM)Hmgu>	MP:0000689,abnormal spleen morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:6302754	Spmip3<em1(IMPC)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6459756	Spmip4<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6194699	Spmip5<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6194649	Spmip6<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6693634	Spmip7<tm1Itl>	MP:0001147,small testis|MP:0004852,decreased testis weight|MP:0005159,azoospermia
MGI:6195019	Spmip8<tm1.1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6188295	Spmip9<em1Qsh>	MP:0005389,reproductive system phenotype
MGI:5548640	Spmip9<tm1.1(KOMP)Vlcg>	MP:0005343,increased circulating aspartate transaminase level
MGI:6336096	Spn<em1(IMPC)Ics>	MP:0001257,increased body length|MP:0001392,abnormal locomotor behavior|MP:0001417,decreased exploration in new environment|MP:0003961,decreased lean body mass|MP:0004357,long tibia|MP:0004924,abnormal behavior|MP:0010024,increased total body fat amount|MP:0011962,increased cornea thickness|MP:0012443,increased corpus callosum size|MP:0012461,increased brain internal capsule size|MP:0012465,increased hippocampal fimbria size|MP:0020420,abnormal freezing behavior
MGI:3604515	Spns1<Gt(OST214133)Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:4432137	Spns1<tm1a(EUCOMM)Wtsi>	MP:0009141,increased prepulse inhibition
MGI:5426392	Spns2<tm1.1Nmoc>	MP:0002435,abnormal effector T cell morphology|MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0005391,vision/eye phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008211,decreased mature B cell number
MGI:5426395	Spns2<tm1.2Nmoc>	MP:0000221,decreased leukocyte cell number|MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0004978,decreased B-1 B cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0008174,decreased follicular B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0009923,decreased transitional stage T1 B cell number|MP:0013393,symblepharon
MGI:4460276	Spns2<tm1a(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0000150,abnormal rib morphology|MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000322,increased granulocyte number|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001306,small lens|MP:0001312,abnormal cornea morphology|MP:0001313,increased incidence of corneal inflammation|MP:0001314,cornea opacity|MP:0001317,abnormal pupil morphology|MP:0001322,abnormal iris morphology|MP:0001324,abnormal eye pigmentation|MP:0001325,abnormal retina morphology|MP:0001349,excessive tearing|MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0002092,abnormal eye morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002697,abnormal eye size|MP:0003671,abnormal eyelid aperture|MP:0004149,increased bone strength|MP:0004221,abnormal iridocorneal angle|MP:0004647,decreased lumbar vertebrae number|MP:0004738,abnormal auditory brainstem response|MP:0004924,abnormal behavior|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005099,abnormal ciliary body morphology|MP:0005176,eyelids fail to open|MP:0005287,narrow eye opening|MP:0005300,abnormal cornea stroma morphology|MP:0005344,increased circulating bilirubin level|MP:0005387,immune system phenotype|MP:0005542,cornea vascularization|MP:0005560,decreased circulating glucose level|MP:0006358,absent pinna reflex|MP:0008039,increased NK T cell number|MP:0008044,increased NK cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008174,decreased follicular B cell number|MP:0008211,decreased mature B cell number|MP:0008495,decreased IgG1 level|MP:0009859,eye opacity|MP:0010101,increased sacral vertebrae number|MP:0010123,increased bone mineral content
MGI:5442804	Spns2<tm1b(KOMP)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001322,abnormal iris morphology|MP:0001512,trunk curl|MP:0005017,decreased B cell number|MP:0005287,narrow eye opening|MP:0005542,cornea vascularization|MP:0005561,increased mean corpuscular hemoglobin|MP:0006358,absent pinna reflex|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010124,decreased bone mineral content
MGI:5442806	Spns2<tm1c(KOMP)Wtsi>	MP:0005387,immune system phenotype
MGI:5694845	Spns2<tm1Tni>	MP:0000217,abnormal leukocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000223,decreased monocyte cell number|MP:0000703,abnormal thymus morphology|MP:0000715,decreased thymocyte number|MP:0001262,decreased body weight|MP:0001302,eyelids open at birth|MP:0005016,decreased lymphocyte cell number|MP:0005378,growth/size/body region phenotype|MP:0008083,decreased single-positive T cell number|MP:0008770,decreased survivor rate|MP:0013701,abnormal mature B cell number|MP:0020117,decreased sphingosine level
MGI:6257798	Spns3<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0001120,abnormal uterus morphology|MP:0003068,enlarged kidney|MP:0005011,increased eosinophil cell number|MP:0010067,increased red blood cell distribution width|MP:0011874,enlarged urinary bladder
MGI:1857246	Spn<tm1Bam>	MP:0002052,decreased tumor incidence|MP:0002444,abnormal T cell physiology|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:5538688	Spo11<tm1.1Gvpc>	MP:0001127,small ovary|MP:0001132,absent mature ovarian follicles|MP:0003572,abnormal uterus development|MP:0010948,abnormal double-strand DNA break repair
MGI:5432496	Spo11<tm1Bdm>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001930,abnormal meiosis|MP:0001931,abnormal oogenesis|MP:0009452,abnormal synaptonemal complex|MP:0010948,abnormal double-strand DNA break repair|MP:0011751,abnormal X-Y chromosome synapsis during male meiosis
MGI:2178805	Spo11<tm1Mjn>	MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001930,abnormal meiosis|MP:0001931,abnormal oogenesis|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0005387,immune system phenotype|MP:0005431,decreased oocyte number|MP:0008261,arrest of male meiosis|MP:0009451,abnormal chromosomal synapsis|MP:0009452,abnormal synaptonemal complex|MP:0010948,abnormal double-strand DNA break repair|MP:0011121,decreased primordial ovarian follicle number|MP:0014633,decreased spermatid number|MP:0014764,impaired double-strand DNA break repair|MP:0031474,increased female germ cell apoptosis
MGI:4398954	Spo11<tm1Nki>	MP:0001925,male infertility|MP:0001926,female infertility|MP:0001930,abnormal meiosis|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0009452,abnormal synaptonemal complex
MGI:3027823	Spo11<tm1Rdco>	MP:0001119,abnormal female reproductive system morphology|MP:0001126,abnormal ovary morphology|MP:0001145,abnormal male reproductive system morphology|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001929,abnormal gametogenesis|MP:0002160,abnormal reproductive system morphology|MP:0002161,abnormal fertility/fecundity|MP:0002216,abnormal seminiferous tubule morphology|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis
MGI:5490537	Spo11<tm2.1Rdco>	MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis
MGI:5605762	Spo11<tm2b(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0000689,abnormal spleen morphology|MP:0002874,decreased hemoglobin content|MP:0004952,increased spleen weight|MP:0005632,decreased circulating aspartate transaminase level
MGI:5538689	Spo11<tm3Rdco>	MP:0002160,abnormal reproductive system morphology
MGI:6467407	Spocd1<em1Doca>	MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0003205,testicular atrophy|MP:0005159,azoospermia|MP:0008878,abnormal DNA methylation during gametogenesis|MP:0009451,abnormal chromosomal synapsis|MP:0013600,testis degeneration|MP:0013601,increased testis apoptosis
MGI:6153825	Spock1<em1(IMPC)H>	MP:0005333,decreased heart rate|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0010506,prolonged RR interval|MP:0013278,decreased fasting circulating glucose level
MGI:3665280	Spock1<tm1Htmn>	MP:0002169,no abnormal phenotype detected
MGI:6729218	Spock3<Tg(lacZ)78-8Tyama>	MP:0000780,abnormal corpus callosum morphology|MP:0000781,decreased corpus callosum size|MP:0001364,decreased anxiety-related response|MP:0002152,abnormal brain morphology|MP:0005404,abnormal axon morphology|MP:0005603,neuron hypertrophy|MP:0008946,abnormal neuron number|MP:0020067,increased neocortex size|MP:0020395,abnormal response to social novelty
MGI:5502442	Spock3<tm1Htmm>	MP:0002169,no abnormal phenotype detected
MGI:5648858	Spon1<tm1Gdpa>	MP:0000559,abnormal femur morphology|MP:0002998,abnormal bone remodeling|MP:0004992,increased bone resorption|MP:0008838,decreased transforming growth factor beta level|MP:0009780,abnormal chondrocyte physiology|MP:0010872,increased trabecular bone mass|MP:0010878,increased trabecular bone volume|MP:0013623,increased femur compact bone thickness|MP:0013631,decreased bone trabecular spacing
MGI:3026870	Spon2<tm1Mjb>	MP:0001793,abnormal susceptibility to infection|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level
MGI:3853475	Spop<Gt(BGB118)Byg>	MP:0003562,abnormal pancreatic beta cell physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0009113,increased pancreatic beta cell mass|MP:0009488,abnormal pancreatic islet cell apoptosis|MP:0011089,perinatal lethality, complete penetrance
MGI:4455963	Spopl<tm1a(EUCOMM)Wtsi>	MP:0004599,abnormal vertebral arch morphology
MGI:5051359	Spopl<tm1(KOMP)Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:4840778	Spop<tm1a(KOMP)Mbp>	MP:0011087,neonatal lethality, complete penetrance
MGI:5513824	Spop<tm1b(KOMP)Wtsi>	MP:0000702,enlarged lymph nodes|MP:0000706,small thymus|MP:0002768,small adrenal glands|MP:0005343,increased circulating aspartate transaminase level|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0010379,decreased respiratory quotient|MP:0011100,preweaning lethality, complete penetrance|MP:0011940,decreased food intake
MGI:5896728	Spop<tm1c(KOMP)Mbp>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000559,abnormal femur morphology|MP:0002543,brachyphalangia|MP:0002544,brachydactyly|MP:0004016,decreased bone mass|MP:0004634,short metacarpal bones|MP:0004635,short metatarsal bones|MP:0004686,decreased length of long bones|MP:0008271,abnormal bone ossification|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010873,decreased trabecular bone mass|MP:0010876,decreased bone volume|MP:0010933,decreased trabecular bone connectivity density
MGI:5896729	Spop<tm1d(KOMP)Mbp>	MP:0011087,neonatal lethality, complete penetrance
MGI:5776542	Spot	MP:0000373,belly spot|MP:0003051,curly tail
MGI:3514265	Spout1<tm1Mxu>	MP:0008280,abnormal male germ cell apoptosis|MP:0008944,decreased sensitivity to induced cell death|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2663657	Spp1<Ric-r>	MP:0002411,decreased susceptibility to bacterial infection|MP:0005425,increased macrophage cell number|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:2663655	Spp1<Ric-s>	MP:0002412,increased susceptibility to bacterial infection
MGI:5825176	Spp1<tm1.1Dhd>	MP:0000133,abnormal long bone metaphysis morphology|MP:0001541,abnormal osteoclast physiology|MP:0002446,abnormal macrophage morphology|MP:0004985,decreased osteoclast cell number
MGI:5571351	Spp1<tm1.1(KOMP)Vlcg>	MP:0001293,anophthalmia
MGI:1932083	Spp1<tm1Blh>	MP:0000062,increased bone mineral density|MP:0000136,abnormal microglial cell morphology|MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000233,abnormal blood flow velocity|MP:0000249,abnormal blood vessel physiology|MP:0000343,abnormal response to cardiac infarction|MP:0000836,abnormal substantia nigra morphology|MP:0001545,abnormal hematopoietic system physiology|MP:0001613,abnormal vasodilation|MP:0001614,abnormal blood vessel morphology|MP:0001790,abnormal immune system physiology|MP:0001793,abnormal susceptibility to infection|MP:0002442,abnormal leukocyte physiology|MP:0002451,abnormal macrophage physiology|MP:0002500,granulomatous inflammation|MP:0002626,increased heart rate|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0002843,decreased systemic arterial blood pressure|MP:0002874,decreased hemoglobin content|MP:0002891,increased insulin sensitivity|MP:0002896,abnormal bone mineralization|MP:0003156,abnormal leukocyte migration|MP:0003197,nephrocalcinosis|MP:0003799,impaired macrophage chemotaxis|MP:0003884,decreased macrophage cell number|MP:0003961,decreased lean body mass|MP:0004077,abnormal striatum morphology|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004822,decreased susceptibility to experimental autoimmune uveoretinitis|MP:0004880,lung cyst|MP:0004883,abnormal vascular wound healing|MP:0005013,increased lymphocyte cell number|MP:0005023,abnormal wound healing|MP:0005025,abnormal response to infection|MP:0005292,improved glucose tolerance|MP:0005341,decreased susceptibility to atherosclerosis|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005560,decreased circulating glucose level|MP:0005630,increased lung weight|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006317,decreased urine sodium level|MP:0008127,decreased dendritic cell number|MP:0008597,decreased circulating interleukin-6 level|MP:0008721,abnormal chemokine level|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008947,increased neuron number|MP:0009645,crystalluria|MP:0010378,increased respiratory quotient|MP:0010760,abnormal macrophage chemotaxis|MP:0010768,mortality/aging|MP:0011452,decreased susceptibility to dopaminergic neuron neurotoxicity|MP:0011460,decreased urine chloride ion level|MP:0031518,calcified aortic valve cusp
MGI:1932084	Spp1<tm1Rit>	MP:0000062,increased bone mineral density|MP:0000321,increased bone marrow cell number|MP:0000598,abnormal liver morphology|MP:0001541,abnormal osteoclast physiology|MP:0001544,abnormal cardiovascular system physiology|MP:0001845,abnormal inflammatory response|MP:0002429,abnormal blood cell morphology/development|MP:0002705,dilated renal tubule|MP:0002834,decreased heart weight|MP:0002896,abnormal bone mineralization|MP:0002908,delayed wound healing|MP:0003631,nervous system phenotype|MP:0003710,abnormal physiological neovascularization|MP:0004154,renal tubular necrosis|MP:0004809,increased hematopoietic stem cell number|MP:0004984,increased osteoclast cell number|MP:0004985,decreased osteoclast cell number|MP:0004993,decreased bone resorption|MP:0005006,abnormal osteoblast physiology|MP:0005025,abnormal response to infection|MP:0005087,decreased acute inflammation|MP:0005140,decreased cardiac muscle contractility|MP:0005165,increased susceptibility to injury|MP:0005390,skeleton phenotype|MP:0005498,hyporesponsive to tactile stimuli|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008660,increased interleukin-10 secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008944,decreased sensitivity to induced cell death|MP:0009347,increased trabecular bone thickness|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010768,mortality/aging|MP:0020416,decreased fibroblast chemotaxis|MP:0020917,decreased susceptibility to Herpesvirales infection|MP:0021189,increased bone mineral density of presacral vertebrae|MP:0021191,increased bone mineral density of lumbar vertebrae
MGI:5484577	Sppl2a<chompB>	MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0004816,abnormal class switch recombination|MP:0005093,decreased B cell proliferation|MP:0005387,immune system phenotype|MP:0008122,decreased myeloid dendritic cell number|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008211,decreased mature B cell number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0009926,decreased transitional stage T2 B cell number|MP:0010675,decreased activation-induced B cell apoptosis
MGI:5432126	Sppl2a<m1Anu>	MP:0001806,decreased IgM level|MP:0002490,abnormal immunoglobulin level|MP:0005397,hematopoietic system phenotype|MP:0008171,abnormal mature B cell morphology|MP:0008182,decreased marginal zone B cell number|MP:0008188,abnormal transitional stage B cell morphology|MP:0008495,decreased IgG1 level|MP:0009926,decreased transitional stage T2 B cell number|MP:0010228,decreased transitional stage T3 B cell number
MGI:5806432	Sppl2a<m1Btlr>	MP:0001805,decreased IgG level|MP:0020001,decreased response to antigen
MGI:5806433	Sppl2a<m2Btlr>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0020001,decreased response to antigen
MGI:5491887	Sppl2a<tm1Basc>	MP:0000692,small spleen|MP:0001802,arrested B cell differentiation|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002459,abnormal B cell physiology|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008207,decreased B-2 B cell number|MP:0008211,decreased mature B cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0009926,decreased transitional stage T2 B cell number|MP:0014469,abnormal B cell calcium ion homeostasis
MGI:5484576	Sppl2a<tm1Dgen>	MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0008122,decreased myeloid dendritic cell number|MP:0008174,decreased follicular B cell number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0009926,decreased transitional stage T2 B cell number
MGI:7444921	Sppl2b<em1(IMPC)Tcp>	MP:0002792,abnormal retina vasculature morphology|MP:0003961,decreased lean body mass|MP:0010097,abnormal retina blood vessel morphology
MGI:3923485	Sppl2b<Gt(Ayu21-T160)Imeg>	MP:0005387,immune system phenotype
MGI:6717376	Sppl2c<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6358787	Sppl2c<tm1.1(KOMP)Vlcg>	MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype|MP:0014636,decreased elongated spermatid number
MGI:6360035	Sppl3<em1(IMPC)Bay>	MP:0001297,microphthalmia|MP:0001402,decreased locomotor activity|MP:0001697,abnormal embryo size|MP:0003385,abnormal body wall morphology|MP:0003743,abnormal facial morphology|MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance
MGI:6467468	Sppl3<em1Pomz>	MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4261988	Sppl3<Gt(OST279815)Lex>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0003360,abnormal depression-related behavior|MP:0003961,decreased lean body mass
MGI:6467467	Sppl3<tm1Itl>	MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008045,decreased NK cell number|MP:0008053,abnormal NK cell differentiation|MP:0009703,decreased birth body size|MP:0010766,abnormal NK cell physiology|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0013667,increased immature NK cell number|MP:0013672,decreased mature NK cell number
MGI:4888747	sprawl	MP:0009450,abnormal axon fasciculation|MP:0011085,postnatal lethality, complete penetrance
MGI:6341915	Spred1<em1(IMPC)Ccpcz>	MP:0000137,abnormal vertebrae morphology|MP:0000219,increased neutrophil cell number|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000432,abnormal head morphology|MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0000745,tremors|MP:0001126,abnormal ovary morphology|MP:0001157,small seminal vesicle|MP:0001293,anophthalmia|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001486,abnormal startle reflex|MP:0001891,hydrocephaly|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002100,abnormal tooth morphology|MP:0002152,abnormal brain morphology|MP:0002339,abnormal lymph node morphology|MP:0002797,increased thigmotaxis|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0003917,increased kidney weight|MP:0004599,abnormal vertebral arch morphology|MP:0004609,vertebral fusion|MP:0004613,fusion of vertebral arches|MP:0004952,increased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0005270,abnormal zygomatic bone morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0005627,increased circulating potassium level|MP:0008039,increased NK T cell number|MP:0010053,decreased grip strength|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0011239,abnormal skin coloration|MP:0011496,abnormal head size|MP:0013520,increased CD4-positive NK T cell number|MP:0013523,increased memory-marker CD4-positive NK T cell number|MP:0013772,increased effector memory T-helper cell number|MP:0020421,increased freezing behavior
MGI:5436575	Spred1<tm1.1Ayos>	MP:0000324,increased mast cell number|MP:0005382,craniofacial phenotype|MP:0008764,increased mast cell degranulation
MGI:3526452	Spred1<tm1Hiin>	MP:0000585,kinked tail|MP:0001262,decreased body weight|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001522,impaired swimming|MP:0001899,absent long-term depression|MP:0001952,increased airway responsiveness|MP:0002465,abnormal eosinophil physiology|MP:0002797,increased thigmotaxis|MP:0002802,abnormal discrimination learning|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002919,enhanced paired-pulse facilitation|MP:0003009,abnormal cytokine secretion|MP:0003631,nervous system phenotype|MP:0005011,increased eosinophil cell number|MP:0008428,abnormal spatial working memory|MP:0030066,short face
MGI:6293840	Spred2<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001415,increased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002591,decreased mean corpuscular volume|MP:0002699,abnormal vitreous body morphology|MP:0003068,enlarged kidney|MP:0003883,enlarged stomach|MP:0005238,increased brain size|MP:0005344,increased circulating bilirubin level|MP:0010067,increased red blood cell distribution width
MGI:3590299	Spred2<Gt(XB228)Byg>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001935,decreased litter size|MP:0002427,disproportionate dwarf|MP:0002764,short tibia|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0006396,decreased long bone epiphyseal plate size|MP:0008254,increased megakaryocyte cell number
MGI:3044889	Spred2<tm1Taga>	MP:0002123,abnormal definitive hematopoiesis|MP:0008254,increased megakaryocyte cell number
MGI:6156549	Spred3<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001297,microphthalmia|MP:0002989,small kidney|MP:0004832,enlarged ovary|MP:0005553,increased circulating creatinine level|MP:0009142,decreased prepulse inhibition|MP:0020421,increased freezing behavior
MGI:6336216	Spr<em1(IMPC)H>	MP:0000219,increased neutrophil cell number|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:6281933	Spring1<em1(IMPC)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6274678	Spring1<em1Nki>	MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001726,abnormal allantois morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011199,abnormal amniotic cavity morphology
MGI:6694148	Sprn<em1Jvt>	MP:0000628,abnormal mammary gland development|MP:0001732,postnatal growth retardation|MP:0001881,abnormal mammary gland physiology|MP:0001882,abnormal lactation|MP:0003718,maternal effect|MP:0004047,abnormal milk composition|MP:0009674,decreased birth weight|MP:0010174,decreased mammary gland epithelial cell proliferation|MP:0011105,embryonic lethality between implantation and placentation, incomplete penetrance
MGI:5428663	Sprn<tm1Geno>	MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0010768,mortality/aging
MGI:2155780	Sprol1<STS/A>	MP:0005013,increased lymphocyte cell number
MGI:5688853	Sprr1a<em1(IMPC)J>	MP:0001314,cornea opacity|MP:0001399,hyperactivity|MP:0001486,abnormal startle reflex|MP:0010053,decreased grip strength
MGI:5619614	Sprr1b<tm1.1(KOMP)Vlcg>	MP:0011471,decreased urine creatinine level
MGI:6510021	Sprr2f<em1Jadb>	MP:0003985,renal fibrosis|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0020344,abnormal susceptibility to injury induced morbidity/mortality
MGI:5605488	Sprr3<tm1.1(KOMP)Vlcg>	MP:0002833,increased heart weight|MP:0011436,decreased urine magnesium level
MGI:5776399	Sprr3<tm1.1Ppy>	MP:0002169,no abnormal phenotype detected
MGI:3528977	Spr<tm1Lex>	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0005156,bradykinesia|MP:0005320,abnormal biopterin level|MP:0005321,abnormal neopterin level|MP:0005643,decreased dopamine level|MP:0010070,decreased serotonin level|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012574,decreased noradrenaline level|MP:0030698,decreased phenylalanine level
MGI:3757641	Spr<tm1Spo>	MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002204,abnormal synaptic neurotransmitter level|MP:0003243,abnormal dopaminergic neuron morphology|MP:0003313,abnormal locomotor activation|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005319,abnormal enzyme/coenzyme level|MP:0005320,abnormal biopterin level|MP:0005321,abnormal neopterin level|MP:0005643,decreased dopamine level|MP:0010070,decreased serotonin level|MP:0012574,decreased noradrenaline level|MP:0030670,increased circulating phenylalanine level
MGI:5752652	Sprtn<tm1.1Yjm>	MP:0008866,chromosomal instability
MGI:5752656	Sprtn<tm1.2Yjm>	MP:0002663,absent blastocoele|MP:0011092,embryonic lethality, complete penetrance|MP:0012113,decreased inner cell mass proliferation
MGI:5752649	Sprtn<tm1Yjm>	MP:0000160,kyphosis|MP:0000162,lordosis|MP:0001265,decreased body size|MP:0001304,cataract|MP:0003786,premature aging|MP:0005150,cachexia|MP:0005369,muscle phenotype|MP:0005390,skeleton phenotype|MP:0008008,early cellular replicative senescence|MP:0008866,chromosomal instability|MP:0008907,decreased total fat pad weight|MP:0009133,decreased white fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0009293,decreased inguinal fat pad weight|MP:0009295,decreased interscapular fat pad weight|MP:0009303,decreased renal fat pad weight|MP:0012106,impaired exercise endurance
MGI:3574404	Spry1<tm1.1Jdli>	MP:0000534,abnormal ureter morphology|MP:0000536,hydroureter|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0003605,fused kidneys|MP:0003672,abnormal ureter development|MP:0003675,kidney cyst|MP:0006032,abnormal ureteric bud morphology|MP:0010980,ectopic ureteric bud|MP:0010981,abnormal branching involved in ureteric bud morphogenesis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011334,abnormal nephrogenic zone morphology|MP:0011486,ectopic ureter|MP:0011760,abnormal ureteric bud tip morphology|MP:0011761,abnormal ureteric bud trunk morphology|MP:0011797,blind ureter
MGI:3574403	Spry1<tm1Jdli>	MP:0000534,abnormal ureter morphology|MP:0000536,hydroureter|MP:0002135,abnormal kidney morphology|MP:0002169,no abnormal phenotype detected|MP:0011486,ectopic ureter
MGI:3578633	Spry2<tm1.1Mrt>	MP:0000042,abnormal organ of Corti morphology|MP:0000063,decreased bone mineral density|MP:0000074,abnormal neurocranium morphology|MP:0000111,cleft palate|MP:0000116,abnormal tooth development|MP:0000120,malocclusion|MP:0000166,abnormal chondrocyte morphology|MP:0000445,short snout|MP:0000458,abnormal mandible morphology|MP:0001265,decreased body size|MP:0001663,abnormal digestive system physiology|MP:0002100,abnormal tooth morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0003825,abnormal pillar cell morphology|MP:0004033,supernumerary teeth|MP:0004300,abnormal organ of Corti supporting cell morphology|MP:0004375,enlarged frontal bone|MP:0004386,enlarged interparietal bone|MP:0004401,increased cochlear outer hair cell number|MP:0004430,abnormal Claudius cell morphology|MP:0004444,small supraoccipital bone|MP:0004471,short nasal bone|MP:0004538,abnormal maxillary shelf morphology|MP:0004594,abnormal mandibular coronoid process morphology|MP:0004595,abnormal mandibular condyloid process morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004600,abnormal vertebral transverse process morphology|MP:0004601,abnormal vertebral spinous process morphology|MP:0004670,small vertebral body|MP:0004686,decreased length of long bones|MP:0004840,increased Deiters cell number|MP:0005272,abnormal temporal bone morphology|MP:0006398,increased long bone epiphyseal plate size|MP:0010873,decreased trabecular bone mass|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011861,increased cranium height|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013203,abnormal primary cilium morphology|MP:0021170,spinal stenosis|MP:0021213,complete cleft palate|MP:0030315,small neurocranium|MP:0030425,wide intermaxillary suture|MP:0030457,abnormal molar cusp morphology|MP:0030536,abnormal diastema morphology
MGI:3584128	Spry2<tm1Ayos>	MP:0000477,abnormal intestine morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001265,decreased body size|MP:0001663,abnormal digestive system physiology|MP:0002083,premature death|MP:0003270,intestinal obstruction|MP:0004548,dilated esophagus
MGI:3578632	Spry2<tm1Mrt>	MP:0008014,increased lung tumor incidence
MGI:2678385	Spry4<Gt(pT1ATGBetageo)1Ruiz>	MP:0002109,abnormal limb morphology
MGI:3701941	Spry4<tm1.2Mrt>	MP:0004033,supernumerary teeth
MGI:3699499	Spry4<tm1Ayos>	MP:0000120,malocclusion|MP:0000458,abnormal mandible morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0004083,polysyndactyly|MP:0005358,abnormal incisor morphology|MP:0005388,respiratory system phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6306609	Spry4<tm1b(KOMP)Mbp>	MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001399,hyperactivity|MP:0002110,abnormal digit morphology|MP:0002544,brachydactyly|MP:0002764,short tibia|MP:0010053,decreased grip strength|MP:0013278,decreased fasting circulating glucose level
MGI:4434532	Spryd3<tm1a(EUCOMM)Hmgu>	MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0002968,increased circulating alkaline phosphatase level|MP:0004924,abnormal behavior
MGI:5695128	Spryd3<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001488,increased startle reflex|MP:0001556,increased circulating HDL cholesterol level|MP:0002079,increased circulating insulin level|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0005553,increased circulating creatinine level|MP:0010097,abnormal retina blood vessel morphology
MGI:6341853	Spryd4<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus
MGI:7666531	Spryd7<em1(IMPC)Mbp>	MP:0002092,abnormal eye morphology
MGI:1857052	sps	MP:0000947,convulsive seizures|MP:0001262,decreased body weight|MP:0001386,abnormal maternal nurturing|MP:0001921,reduced fertility|MP:0002738,hyperresponsive to tactile stimuli|MP:0004994,abnormal brain wave pattern|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3582298	Spsb2<tm1Nch>	MP:0003179,thrombocytopenia|MP:0005566,decreased blood urea nitrogen level
MGI:6257764	Spta1<em1(IMPC)Bay>	MP:0001488,increased startle reflex|MP:0011100,preweaning lethality, complete penetrance
MGI:3615021	Spta1<ihj>	MP:0000422,delayed hair appearance|MP:0000599,enlarged liver|MP:0000611,jaundice|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001265,decreased body size|MP:0001386,abnormal maternal nurturing|MP:0001585,hemolytic anemia|MP:0001923,reduced female fertility|MP:0002082,postnatal lethality|MP:0002161,abnormal fertility/fecundity|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002812,spherocytosis|MP:0002813,microcytosis|MP:0003717,pallor|MP:0003868,abnormal feces composition|MP:0005097,polychromatophilia|MP:0005344,increased circulating bilirubin level
MGI:1856377	Spta1<sph>	MP:0000172,abnormal bone marrow cell number|MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000248,macrocytosis|MP:0000274,enlarged heart|MP:0000314,schistocytosis|MP:0000321,increased bone marrow cell number|MP:0000599,enlarged liver|MP:0000602,dilated liver sinusoidal space|MP:0000611,jaundice|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001265,decreased body size|MP:0001585,hemolytic anemia|MP:0001625,cardiac hypertrophy|MP:0001656,focal hepatic necrosis|MP:0001924,infertility|MP:0002083,premature death|MP:0002424,abnormal reticulocyte morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002594,low mean erythrocyte cell number|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002643,poikilocytosis|MP:0002704,tubular nephritis|MP:0002743,glomerulonephritis|MP:0002812,spherocytosis|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0003656,abnormal erythrocyte physiology|MP:0003657,abnormal erythrocyte osmotic lysis|MP:0003717,pallor|MP:0004154,renal tubular necrosis|MP:0005026,decreased susceptibility to parasitic infection|MP:0005344,increased circulating bilirubin level|MP:0006085,myocardium necrosis|MP:0008807,increased liver iron level|MP:0008956,decreased cellular hemoglobin content|MP:0009395,increased nucleated erythrocyte cell number|MP:0010019,liver vascular congestion|MP:0010035,increased erythrocyte clearance|MP:0010163,hemolysis|MP:0010375,increased kidney iron level|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011188,increased erythrocyte protoporphyrin level|MP:0014605,dark liver|MP:0020409,abnormal cardiac thrombosis|MP:0021002,brain lesion|MP:0021003,cerebral infarct
MGI:1856180	Spta1<sph-2Bc>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000314,schistocytosis|MP:0000321,increased bone marrow cell number|MP:0000611,jaundice|MP:0000691,enlarged spleen|MP:0001585,hemolytic anemia|MP:0002083,premature death|MP:0002447,abnormal erythrocyte morphology|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002812,spherocytosis|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0003717,pallor|MP:0005096,erythroblastosis|MP:0005344,increased circulating bilirubin level|MP:0009568,abnormal red blood cell deformability|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014606,dark spleen|MP:0020409,abnormal cardiac thrombosis|MP:0031085,increased erythrocyte osmotic fragility
MGI:1858128	Spta1<sph-2J>	MP:0002424,abnormal reticulocyte morphology
MGI:3621484	Spta1<sph-3J>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001585,hemolytic anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002812,spherocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004952,increased spleen weight|MP:0005097,polychromatophilia|MP:0005344,increased circulating bilirubin level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008807,increased liver iron level|MP:0008808,decreased spleen iron level|MP:0008810,increased circulating iron level|MP:0009547,elliptocytosis|MP:0010375,increased kidney iron level
MGI:3798219	Spta1<sph-4J>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001585,hemolytic anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002812,spherocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004952,increased spleen weight|MP:0005097,polychromatophilia|MP:0005344,increased circulating bilirubin level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008807,increased liver iron level|MP:0008810,increased circulating iron level|MP:0010375,increased kidney iron level
MGI:2388936	Spta1<sph-Dem>	MP:0000611,jaundice|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002813,microcytosis|MP:0003103,liver degeneration|MP:0003946,renal necrosis|MP:0009547,elliptocytosis|MP:0020409,abnormal cardiac thrombosis
MGI:1856181	Spta1<sph-ha>	MP:0000172,abnormal bone marrow cell number|MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000248,macrocytosis|MP:0000255,blood vessel congestion|MP:0000314,schistocytosis|MP:0000321,increased bone marrow cell number|MP:0000599,enlarged liver|MP:0000611,jaundice|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001175,abnormal lung morphology|MP:0001265,decreased body size|MP:0001585,hemolytic anemia|MP:0001625,cardiac hypertrophy|MP:0001862,interstitial pneumonia|MP:0001924,infertility|MP:0002083,premature death|MP:0002095,abnormal skin pigmentation|MP:0002397,abnormal bone marrow morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002424,abnormal reticulocyte morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002493,increased IgG level|MP:0002495,increased IgA level|MP:0002590,increased mean corpuscular volume|MP:0002591,decreased mean corpuscular volume|MP:0002594,low mean erythrocyte cell number|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002643,poikilocytosis|MP:0002810,microcytic anemia|MP:0002812,spherocytosis|MP:0002813,microcytosis|MP:0002830,gallstones|MP:0002874,decreased hemoglobin content|MP:0003135,increased erythroid progenitor cell number|MP:0003656,abnormal erythrocyte physiology|MP:0005013,increased lymphocyte cell number|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005048,abnormal thrombosis|MP:0005096,erythroblastosis|MP:0005154,increased B cell proliferation|MP:0005344,increased circulating bilirubin level|MP:0005348,increased T cell proliferation|MP:0005639,hemosiderosis|MP:0006050,pulmonary fibrosis|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008102,lymph node hyperplasia|MP:0008388,hypochromic microcytic anemia|MP:0008826,abnormal splenic cell ratio|MP:0008828,abnormal lymph node cell ratio|MP:0009395,increased nucleated erythrocyte cell number|MP:0009568,abnormal red blood cell deformability|MP:0010035,increased erythrocyte clearance|MP:0010163,hemolysis|MP:0010922,alveolitis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011188,increased erythrocyte protoporphyrin level|MP:0014473,increased pulmonary alveolus wall thickness|MP:0020409,abnormal cardiac thrombosis|MP:0031085,increased erythrocyte osmotic fragility
MGI:6449035	Sptan1<em1(IMPC)Mbp>	MP:0000428,abnormal craniofacial morphology|MP:0000433,microcephaly|MP:0001258,decreased body length|MP:0001289,persistence of hyaloid vascular system|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003068,enlarged kidney|MP:0003232,abnormal forebrain development|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape
MGI:4330132	Sptan1<Gt(RRQ171)Byg>	MP:0000277,abnormal heart shape|MP:0000351,increased cell proliferation|MP:0000428,abnormal craniofacial morphology|MP:0000783,abnormal forebrain morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0001698,decreased embryo size|MP:0002958,cerebral aqueductal stenosis|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0004057,thin myocardium compact layer|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004937,dilated heart|MP:0005621,abnormal cell physiology|MP:0010733,abnormal axon initial segment morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012676,dilated brain ventricle|MP:0014561,decreased cortical ventricular zone cell density
MGI:3714925	Sptan1<tm1.1Gnic>	MP:0002169,no abnormal phenotype detected|MP:0005384,cellular phenotype
MGI:6367831	Sptb<em1(IMPC)J>	MP:0001417,decreased exploration in new environment|MP:0001728,failure of embryo implantation|MP:0002591,decreased mean corpuscular volume|MP:0003131,increased erythrocyte cell number|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012058,abnormal morula morphology|MP:0013292,embryonic lethality prior to organogenesis
MGI:1856378	Sptb<ja>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000274,enlarged heart|MP:0000314,schistocytosis|MP:0000519,hydronephrosis|MP:0000599,enlarged liver|MP:0000611,jaundice|MP:0000691,enlarged spleen|MP:0000774,decreased brain size|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001585,hemolytic anemia|MP:0001625,cardiac hypertrophy|MP:0001655,multifocal hepatic necrosis|MP:0001924,infertility|MP:0002083,premature death|MP:0002424,abnormal reticulocyte morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002594,low mean erythrocyte cell number|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002704,tubular nephritis|MP:0002743,glomerulonephritis|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003656,abnormal erythrocyte physiology|MP:0003657,abnormal erythrocyte osmotic lysis|MP:0004154,renal tubular necrosis|MP:0005329,abnormal myocardium layer morphology|MP:0005344,increased circulating bilirubin level|MP:0005360,urolithiasis|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0008476,increased spleen red pulp amount|MP:0008810,increased circulating iron level|MP:0008956,decreased cellular hemoglobin content|MP:0009395,increased nucleated erythrocyte cell number|MP:0010025,decreased total body fat amount|MP:0010035,increased erythrocyte clearance|MP:0010163,hemolysis|MP:0010375,increased kidney iron level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011188,increased erythrocyte protoporphyrin level|MP:0020409,abnormal cardiac thrombosis|MP:0021002,brain lesion|MP:0021003,cerebral infarct|MP:0031085,increased erythrocyte osmotic fragility
MGI:4452390	Sptb<m1Jus>	MP:0000274,enlarged heart|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002812,spherocytosis|MP:0003068,enlarged kidney|MP:0010163,hemolysis|MP:0010177,acanthocytosis
MGI:5431637	Sptbn1<tm1.1Mnr>	MP:0010733,abnormal axon initial segment morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4432393	Sptbn1<tm1a(EUCOMM)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000267,abnormal heart development|MP:0001262,decreased body weight|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002188,small heart|MP:0002942,decreased circulating alanine transaminase level|MP:0004759,decreased mitotic index|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0005571,decreased lactate dehydrogenase level|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0010402,ventricular septal defect|MP:0010503,myocardial trabeculae hypoplasia|MP:0010561,absent coronary vessels|MP:0011392,increased fetal cardiomyocyte apoptosis|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0020135,abnormal heart ventricle wall thickness|MP:0031525,thin left ventricle myocardium compact layer
MGI:5635107	Sptbn1<tm1c(EUCOMM)Wtsi>	MP:0003077,abnormal cell cycle|MP:0004045,abnormal cell cycle checkpoint function|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0011390,abnormal fetal cardiomyocyte physiology|MP:0011392,increased fetal cardiomyocyte apoptosis|MP:0011395,decreased fetal cardiomyocyte proliferation
MGI:2450327	Sptbn1<tm1Mish>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000414,alopecia|MP:0000428,abnormal craniofacial morphology|MP:0000462,abnormal digestive system morphology|MP:0000598,abnormal liver morphology|MP:0000600,liver hypoplasia|MP:0000913,abnormal brain development|MP:0001148,enlarged testis|MP:0001264,increased body size|MP:0001698,decreased embryo size|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0002038,increased carcinoma incidence|MP:0002083,premature death|MP:0002177,abnormal outer ear morphology|MP:0003068,enlarged kidney|MP:0003229,abnormal vitelline vasculature morphology|MP:0003331,increased hepatocellular carcinoma incidence|MP:0004001,decreased hepatocyte proliferation|MP:0005294,abnormal heart ventricle morphology|MP:0006262,increased testis tumor incidence|MP:0008000,increased ovary tumor incidence|MP:0008019,increased liver tumor incidence|MP:0009906,increased tongue size|MP:0010278,increased glioma incidence|MP:0010346,increased thyroid carcinoma incidence|MP:0010366,increased adrenal cortical tumor incidence|MP:0010383,increased adenoma incidence|MP:0010384,increased renal carcinoma incidence|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012431,increased lymphoma incidence|MP:0013309,adrenal gland cyst|MP:0013328,visceromegaly
MGI:4127354	Sptbn2<Gt(XK442)Byg>	MP:0000877,abnormal Purkinje cell morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0000890,thin cerebellar molecular layer|MP:0001260,increased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0003996,clonic seizures|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:5636946	Sptbn2<tm1b(EUCOMM)Hmgu>	MP:0001566,increased circulating phosphate level|MP:0002764,short tibia|MP:0010090,increased circulating creatine kinase level
MGI:4821979	Sptbn2<tm1Mjac>	MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0002272,abnormal nervous system electrophysiology|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0011269,increased excitatory postsynaptic current amplitude
MGI:2657204	Sptbn4<Gt(ROSABetageo)62Sor>	MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0001380,decreased male mating frequency|MP:0001393,ataxia|MP:0001513,limb grasping|MP:0005404,abnormal axon morphology|MP:0005620,abnormal muscle contractility
MGI:1856132	Sptbn4<qv>	MP:0000745,tremors|MP:0000753,paralysis|MP:0000755,hindlimb paralysis|MP:0001393,ataxia|MP:0001851,eye inflammation|MP:0001925,male infertility|MP:0001967,deafness|MP:0002083,premature death|MP:0003415,priapism|MP:0004738,abnormal auditory brainstem response
MGI:3794968	Sptbn4<qv-10J>	MP:0000745,tremors|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0001925,male infertility|MP:0001967,deafness|MP:0005391,vision/eye phenotype|MP:0010768,mortality/aging|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3794969	Sptbn4<qv-11J>	MP:0000745,tremors|MP:0001406,abnormal gait|MP:0001925,male infertility|MP:0006325,impaired hearing|MP:0010768,mortality/aging|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1856540	Sptbn4<qv-2J>	MP:0004738,abnormal auditory brainstem response
MGI:1856134	Sptbn4<qv-3J>	MP:0000745,tremors|MP:0004738,abnormal auditory brainstem response|MP:0004813,absent linear vestibular evoked potential
MGI:2150646	Sptbn4<qv-4J>	MP:0011966,abnormal auditory brainstem response waveform shape|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:3514297	Sptbn4<qv-7J>	MP:0005369,muscle phenotype|MP:0009434,paraparesis
MGI:3589012	Sptbn4<qv-8J>	MP:0000745,tremors
MGI:3621715	Sptbn4<qv-9J>	MP:0000745,tremors|MP:0001410,head bobbing|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0002574,increased vertical activity
MGI:1856133	Sptbn4<qv-J>	MP:0000745,tremors|MP:0005369,muscle phenotype
MGI:1856939	Sptbn4<qv-lnd>	MP:0000745,tremors|MP:0000754,paresis|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001925,male infertility|MP:0003225,axonal dystrophy
MGI:1857308	Sptbn4<qv-lnd2J>	MP:0002083,premature death|MP:0004631,abnormal auditory cortex morphology|MP:0004813,absent linear vestibular evoked potential|MP:0004814,reduced linear vestibular evoked potential|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014740,increased auditory brainstem response wave peak latency|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:3710201	Sptbn4<tm1Mkom>	MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0005389,reproductive system phenotype|MP:0005404,abnormal axon morphology
MGI:3497744	Sptbn4<tm1Msol>	MP:0000745,tremors|MP:0000849,abnormal cerebellum morphology|MP:0001262,decreased body weight|MP:0001330,abnormal optic nerve morphology|MP:0001406,abnormal gait|MP:0002651,abnormal sciatic nerve morphology|MP:0003314,dysmetria|MP:0004738,abnormal auditory brainstem response
MGI:7596140	Sptbn5<tm1.1Dsna>	MP:0004716,abnormal cochlear nerve morphology|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:6257729	Sptlc1<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:4331285	Sptlc1<Gt(AD0062)Wtsi>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype
MGI:3815115	Sptlc1<tm1Jia>	MP:0001547,abnormal lipid level|MP:0003949,abnormal circulating lipid level|MP:0011091,prenatal lethality, complete penetrance
MGI:6257828	Sptlc2<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3815117	Sptlc2<tm1Jia>	MP:0001547,abnormal lipid level|MP:0003949,abnormal circulating lipid level|MP:0011091,prenatal lethality, complete penetrance
MGI:5523495	Sptlc2<tm1Yhir>	MP:0000219,increased neutrophil cell number|MP:0000316,cellular necrosis|MP:0000333,decreased bone marrow cell number|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000511,abnormal intestinal mucosa morphology|MP:0000649,sebaceous gland atrophy|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0001190,reddish skin|MP:0001192,scaly skin|MP:0001193,psoriasis|MP:0001212,skin lesions|MP:0001222,epidermal hyperplasia|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001429,dehydration|MP:0001732,postnatal growth retardation|MP:0001874,acanthosis|MP:0002083,premature death|MP:0002608,increased hematocrit|MP:0002796,impaired skin barrier function|MP:0002941,increased circulating alanine transaminase level|MP:0002965,increased circulating serum albumin level|MP:0003131,increased erythrocyte cell number|MP:0003853,dry skin|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0004947,skin inflammation|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight|MP:0005016,decreased lymphocyte cell number|MP:0005362,abnormal Langerhans cell physiology|MP:0005416,abnormal circulating protein level|MP:0005564,increased hemoglobin content|MP:0005565,increased blood urea nitrogen level|MP:0008108,abnormal small intestinal villus morphology|MP:0008117,abnormal Langerhans cell morphology|MP:0008126,increased dendritic cell number|MP:0008346,increased gamma-delta T cell number|MP:0008941,reticulocytopenia|MP:0009160,abnormal pancreatic acinar cell zymogen granule morphology|MP:0009441,delayed skin barrier formation|MP:0009560,absent epidermis stratum granulosum|MP:0009608,abnormal epidermal lamellar body morphology|MP:0010219,increased T-helper 17 cell number|MP:0010792,abnormal stomach mucosa morphology|MP:0012232,abnormal ceramide level|MP:0013307,increased adrenal gland weight|MP:0013407,abnormal dendritic epidermal T cell morphology
MGI:4414752	Sptlc2<tm2.1Jia>	MP:0000609,abnormal liver physiology|MP:0001556,increased circulating HDL cholesterol level|MP:0003192,increased cholesterol efflux|MP:0003980,increased circulating phospholipid level|MP:0005178,increased circulating cholesterol level|MP:0009823,abnormal sphingomyelin level
MGI:7858938	Sptlc3<em1Cowl>	MP:0005292,improved glucose tolerance|MP:0005370,liver/biliary system phenotype|MP:0010080,abnormal hepatocyte physiology|MP:0013278,decreased fasting circulating glucose level|MP:0020090,decreased susceptibility to diet-induced non-insulin dependent diabetes|MP:0030973,impaired gluconeogenesis
MGI:6441120	Sptlc3<em1(IMPC)Hmgu>	MP:0000194,increased circulating calcium level|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0008259,abnormal optic disk morphology|MP:0011964,increased total retina thickness
MGI:5471307	Sptssa<tm1b(KOMP)Wtsi>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0005560,decreased circulating glucose level|MP:0005633,increased circulating sodium level|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5502305	Sptssb<tm1b(KOMP)Mbp>	MP:0001510,abnormal coat appearance|MP:0002833,increased heart weight|MP:0004151,decreased circulating iron level|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0013278,decreased fasting circulating glucose level|MP:0013279,increased fasting circulating glucose level
MGI:5689843	Sptssb<Tvrm122>	MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0001393,ataxia|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002864,abnormal ocular fundus morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0003734,abnormal retina inner plexiform layer morphology|MP:0005405,axon degeneration|MP:0006219,optic nerve degeneration|MP:0008025,brain vacuoles|MP:0009978,abnormal cerebellum white matter morphology|MP:0020353,abnormal endoplasmic reticulum stress
MGI:6294149	Spty2d1<em1(IMPC)J>	MP:0000266,abnormal heart morphology|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0001722,pale yolk sac|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0005031,abnormal trophoblast layer morphology|MP:0009698,heart hemorrhage|MP:0010506,prolonged RR interval|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0012099,decreased spongiotrophoblast size|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5755088	Spx<em1(IMPC)Tcp>	MP:0002059,abnormal seminal vesicle morphology
MGI:6313358	Spz1<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000266,abnormal heart morphology|MP:0000277,abnormal heart shape|MP:0001126,abnormal ovary morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002833,increased heart weight|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0004832,enlarged ovary|MP:0009552,urinary bladder obstruction|MP:0010067,increased red blood cell distribution width
MGI:7641915	Spz1<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5489914	Sqle<Sum3-Jus>	MP:0011092,embryonic lethality, complete penetrance
MGI:4431854	Sqle<tm1a(EUCOMM)Wtsi>	MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:6818628	Sqor<em1.1Chji>	MP:0002083,premature death
MGI:6818627	Sqor<em1Chji>	MP:0009747,impaired behavioral response to xenobiotic
MGI:7570167	Sqstm1<em1Kmts>	MP:0000189,hypoglycemia|MP:0000599,enlarged liver|MP:0001242,hyperkeratosis|MP:0001732,postnatal growth retardation|MP:0004546,esophagus hyperplasia|MP:0005178,increased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0010784,abnormal forestomach morphology
MGI:7570168	Sqstm1<em2Kmts>	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype
MGI:5546006	Sqstm1<tm1.1Ewa>	MP:0001260,increased body weight|MP:0011939,increased food intake|MP:0020411,increased abdominal adipose tissue amount
MGI:5056451	Sqstm1<tm1.1Sral>	MP:0000130,abnormal trabecular bone morphology|MP:0002896,abnormal bone mineralization|MP:0003795,abnormal bone structure|MP:0003797,abnormal compact bone morphology|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0008271,abnormal bone ossification|MP:0008396,abnormal osteoclast differentiation
MGI:4364926	Sqstm1<tm1a(KOMP)Wtsi>	MP:0001257,increased body length|MP:0004924,abnormal behavior|MP:0005560,decreased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin
MGI:5313263	Sqstm1<tm1Hwl>	MP:0002083,premature death|MP:0003674,oxidative stress|MP:0003786,premature aging|MP:0005290,decreased oxygen consumption|MP:0006036,abnormal mitochondrial physiology|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0010179,rough coat|MP:0010955,abnormal respiratory electron transport chain|MP:0031253,lordokyphosis
MGI:3817496	Sqstm1<tm1Jjw>	MP:0001541,abnormal osteoclast physiology|MP:0005390,skeleton phenotype|MP:0008396,abnormal osteoclast differentiation
MGI:3043976	Sqstm1<tm1Jmos>	MP:0004985,decreased osteoclast cell number|MP:0008396,abnormal osteoclast differentiation|MP:0008706,decreased interleukin-6 secretion|MP:0010957,abnormal aerobic respiration
MGI:3774352	Sqstm1<tm1Keta>	MP:0000130,abnormal trabecular bone morphology|MP:0001260,increased body weight|MP:0001261,obese|MP:0001541,abnormal osteoclast physiology|MP:0001559,hyperglycemia|MP:0002998,abnormal bone remodeling|MP:0003212,increased susceptibility to age related obesity|MP:0003795,abnormal bone structure|MP:0005006,abnormal osteoblast physiology|MP:0005293,impaired glucose tolerance|MP:0005669,increased circulating leptin level|MP:0008396,abnormal osteoclast differentiation|MP:0008947,increased neuron number|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume|MP:0011939,increased food intake|MP:0013631,decreased bone trabecular spacing|MP:0020011,increased bone mineral density of femur
MGI:5487454	Sqstm1<tm2.1Jmos>	MP:0001260,increased body weight|MP:0001402,decreased locomotor activity|MP:0002628,hepatic steatosis|MP:0003960,increased lean body mass|MP:0004890,decreased energy expenditure|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0009118,increased white fat cell size|MP:0009124,increased brown fat cell lipid droplet size|MP:0010024,increased total body fat amount|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011014,decreased core body temperature|MP:0011635,abnormal mitochondrial crista morphology|MP:0011636,disorganized mitochondrial cristae|MP:0011699,abnormal brown adipose tissue thermogenesis
MGI:4434735	Sra1<tm1a(EUCOMM)Hmgu>	MP:0000598,abnormal liver morphology|MP:0001780,decreased brown adipose tissue amount|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0006319,abnormal epididymal fat pad morphology|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009133,decreased white fat cell size|MP:0009136,decreased brown fat cell size|MP:0009356,decreased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0010360,decreased liver free fatty acids level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5513826	Sra1<tm1b(EUCOMM)Hmgu>	MP:0000438,abnormal cranium morphology|MP:0001120,abnormal uterus morphology|MP:0002989,small kidney|MP:0003795,abnormal bone structure|MP:0008259,abnormal optic disk morphology|MP:0009142,decreased prepulse inhibition|MP:0010124,decreased bone mineral content
MGI:6101175	Srbd1<em1(IMPC)J>	MP:0001415,increased exploration in new environment|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002075,abnormal coat/hair pigmentation|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6153626	Srcap<em1(IMPC)Wtsi>	MP:0002073,abnormal hair growth|MP:0003179,thrombocytopenia
MGI:6694084	Srcap<em2Zfa>	MP:0011092,embryonic lethality, complete penetrance|MP:0012128,abnormal blastocyst formation
MGI:5603577	Srcin1<tm1.1(KOMP)Vlcg>	MP:0002833,increased heart weight|MP:0010123,increased bone mineral content
MGI:5617962	Srcin1<tm1Fdc>	MP:0001458,abnormal object recognition memory|MP:0001473,reduced long-term potentiation|MP:0001475,reduced long-term depression|MP:0001900,impaired synaptic plasticity|MP:0002206,abnormal CNS synaptic transmission|MP:0002804,abnormal motor learning|MP:0002912,abnormal excitatory postsynaptic potential|MP:0009936,abnormal dendritic spine morphology
MGI:5911893	Src<inl>	MP:0000125,absent incisors|MP:0000435,shortened head|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001360,abnormal social investigation|MP:0001405,impaired coordination|MP:0001488,increased startle reflex|MP:0001529,abnormal vocalization|MP:0002063,abnormal learning/memory/conditioning|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002100,abnormal tooth morphology|MP:0002797,increased thigmotaxis|MP:0002804,abnormal motor learning|MP:0003461,abnormal response to novel object|MP:0006400,decreased molar number|MP:0008414,abnormal spatial reference memory|MP:0009456,impaired cued conditioning behavior|MP:0010053,decreased grip strength|MP:0010768,mortality/aging|MP:0014805,impaired tooth eruption|MP:0020395,abnormal response to social novelty|MP:0020396,abnormal social recognition|MP:0030420,short basicranium|MP:0031391,increased locomotor activity
MGI:3045964	Srcr	MP:0002052,decreased tumor incidence|MP:0002419,abnormal innate immunity
MGI:5314758	Src<tm1Mul>	MP:0005389,reproductive system phenotype
MGI:1857247	Src<tm1Sor>	MP:0000065,abnormal bone marrow cavity morphology|MP:0000067,osteopetrosis|MP:0000119,abnormal tooth eruption|MP:0000121,failure of tooth eruption|MP:0000125,absent incisors|MP:0000135,decreased compact bone thickness|MP:0000371,diluted coat color|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001290,delayed eyelid opening|MP:0001846,increased inflammatory response|MP:0001926,female infertility|MP:0002083,premature death|MP:0002109,abnormal limb morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002397,abnormal bone marrow morphology|MP:0003419,delayed endochondral bone ossification|MP:0003631,nervous system phenotype|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0003845,abnormal decidualization|MP:0004214,abnormal long bone diaphysis morphology|MP:0004686,decreased length of long bones|MP:0004993,decreased bone resorption|MP:0005193,abnormal anterior eye segment morphology|MP:0005397,hematopoietic system phenotype|MP:0006398,increased long bone epiphyseal plate size|MP:0010867,abnormal bone trabecula morphology|MP:0010872,increased trabecular bone mass|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011495,abnormal head shape|MP:0030069,broad face|MP:0030132,periodontium inflammation
MGI:4431843	Src<tm2a(EUCOMM)Wtsi>	MP:0000559,abnormal femur morphology|MP:0004924,abnormal behavior
MGI:1857454	Srd5a1<tm1Mahe>	MP:0001935,decreased litter size|MP:0002907,abnormal parturition
MGI:6276851	Srd5a2<em1(IMPC)Mbp>	MP:0000692,small spleen|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001325,abnormal retina morphology|MP:0002060,abnormal skin morphology
MGI:2178039	Srd5a2<tm1Mahe>	MP:0000664,small prostate gland anterior lobe|MP:0001157,small seminal vesicle|MP:0002774,small prostate gland
MGI:3604528	Srd5a3<Gt(OST436695)Lex>	MP:0000929,open neural tube|MP:0003384,abnormal ventral body wall morphology|MP:0004180,failure of initiation of embryo turning|MP:0004937,dilated heart|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:5520177	Srd5a3<tm1b(EUCOMM)Wtsi>	MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0002861,abnormal tail bud morphology|MP:0003984,embryonic growth retardation|MP:0004738,abnormal auditory brainstem response|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:8263020	Srd5a3<tm1d(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected|MP:0011091,prenatal lethality, complete penetrance
MGI:4124835	Srebf1<Gt(XC354)Byg>	MP:0002575,increased circulating ketone body level|MP:0009356,decreased liver triglyceride level
MGI:2177773	Srebf1<tm1Jdh>	MP:0008770,decreased survivor rate|MP:0010027,increased liver cholesterol level|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:2177959	Srebf1<tm1Mbr>	MP:0000187,abnormal triglyceride level|MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0005376,homeostasis/metabolism phenotype|MP:0010027,increased liver cholesterol level
MGI:2177958	Srebf1<tm2Jdh>	MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0010027,increased liver cholesterol level|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3880672	Srebf2<Gt(YTA054)Byg>	MP:0011091,prenatal lethality, complete penetrance
MGI:1856940	Srebf2<lop13>	MP:0001191,abnormal skin condition|MP:0001304,cataract|MP:0002840,abnormal lens fiber morphology|MP:0003983,decreased cholesterol level|MP:0005391,vision/eye phenotype|MP:0010026,decreased liver cholesterol level|MP:0010161,decreased brain cholesterol level|MP:0010254,nuclear cataract
MGI:5907035	Srebf2<tm1Jdh>	MP:0001262,decreased body weight|MP:0002118,abnormal lipid homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level
MGI:6112028	Srek1<em1(IMPC)J>	MP:0000198,decreased circulating phosphate level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7450824	Srfbp1<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0003984,embryonic growth retardation|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012129,failure of blastocyst formation
MGI:5606035	Srf<tm1.1Wtp>	MP:0002169,no abnormal phenotype detected
MGI:2158696	Srf<tm1Nor>	MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3604097	Srf<tm1Rjs>	MP:0001695,abnormal gastrulation|MP:0011092,embryonic lethality, complete penetrance
MGI:3522206	Srf<tm1Rmn>	MP:0000278,abnormal myocardial fiber morphology|MP:0000460,mandible hypoplasia|MP:0000705,athymia|MP:0002633,persistent truncus arteriosus|MP:0002976,vascular smooth muscle hypotrophy|MP:0005314,absent thyroid gland|MP:0005377,hearing/vestibular/ear phenotype|MP:0005382,craniofacial phenotype|MP:0010402,ventricular septal defect|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3046779	Srf<tm1Zli>	MP:0000277,abnormal heart shape|MP:0000278,abnormal myocardial fiber morphology|MP:0000295,trabecula carnea hypoplasia|MP:0001625,cardiac hypertrophy|MP:0001634,internal hemorrhage|MP:0001648,abnormal apoptosis|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002190,disorganized myocardium|MP:0002652,thin myocardium|MP:0002795,dilated cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0003984,embryonic growth retardation|MP:0004084,abnormal cardiac muscle relaxation|MP:0004091,abnormal Z line morphology|MP:0005329,abnormal myocardium layer morphology|MP:0006138,congestive heart failure|MP:0006267,abnormal intercalated disk morphology|MP:0008022,dilated heart ventricle|MP:0010579,increased heart left ventricle size|MP:0010725,thin interventricular septum|MP:0011092,embryonic lethality, complete penetrance|MP:0014730,abnormal myocardial fiber myofibril morphology|MP:0031633,decreased heart left ventricle muscle contractility
MGI:2385465	Srf<tm2.1Nor>	MP:0000160,kyphosis|MP:0001404,no spontaneous movement|MP:0001575,cyanosis|MP:0001732,postnatal growth retardation|MP:0001953,respiratory failure|MP:0002279,abnormal diaphragm morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004819,decreased skeletal muscle mass|MP:0005202,lethargy|MP:0005385,cardiovascular system phenotype|MP:0009674,decreased birth weight|MP:0011085,postnatal lethality, complete penetrance|MP:0011087,neonatal lethality, complete penetrance
MGI:2385464	Srf<tm2Nor>	MP:0000715,decreased thymocyte number|MP:0002169,no abnormal phenotype detected|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008171,abnormal mature B cell morphology|MP:0008183,absent marginal zone B cells
MGI:5432204	Srgap1<tm1a(KOMP)Wtsi>	MP:0002705,dilated renal tubule|MP:0002871,albuminuria|MP:0005165,increased susceptibility to injury|MP:0005264,glomerulosclerosis|MP:0005367,renal/urinary system phenotype|MP:0008061,absent podocyte slit diaphragm|MP:0008140,podocyte foot process effacement|MP:0011353,expanded mesangial matrix|MP:0011402,renal cast|MP:0011427,increased mesangial cell number|MP:0011753,decreased podocyte number|MP:0011856,abnormal glomerular filtration barrier function|MP:0011869,detached podocyte
MGI:4126449	Srgap2<Gt(XH102)Byg>	MP:0008143,abnormal dendrite morphology|MP:0009936,abnormal dendritic spine morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4941459	Srgap3<tm1.1Ssod>	MP:0009936,abnormal dendritic spine morphology
MGI:5465281	Srgap3<tm1.1Zi>	MP:0001360,abnormal social investigation|MP:0001402,decreased locomotor activity|MP:0001891,hydrocephaly|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002780,decreased circulating testosterone level|MP:0003461,abnormal response to novel object|MP:0005386,behavior/neurological phenotype|MP:0008026,abnormal brain white matter morphology|MP:0008428,abnormal spatial working memory|MP:0008911,induced hyperactivity|MP:0009142,decreased prepulse inhibition|MP:0009936,abnormal dendritic spine morphology|MP:0011380,enlarged brain ventricles|MP:0011854,cerebral edema
MGI:4941458	Srgap3<tm1Ssod>	MP:0002063,abnormal learning/memory/conditioning|MP:0002882,abnormal neuron morphology|MP:0004000,impaired passive avoidance behavior|MP:0008432,abnormal long-term spatial reference memory|MP:0009936,abnormal dendritic spine morphology|MP:0014367,impaired long-term object recognition memory
MGI:3057187	Srgn<tm1Mabr>	MP:0000336,decreased mast cell number|MP:0000359,abnormal mast cell morphology
MGI:6160444	Sri<tm1.1Hhv>	MP:0002727,decreased circulating insulin level|MP:0005293,impaired glucose tolerance
MGI:3605474	Srl<tm1Hta>	MP:0001544,abnormal cardiovascular system physiology|MP:0002106,abnormal muscle physiology|MP:0002841,impaired skeletal muscle contractility|MP:0004084,abnormal cardiac muscle relaxation|MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005620,abnormal muscle contractility
MGI:3616183	Srms<tm1Sia>	MP:0002169,no abnormal phenotype detected
MGI:1857054	srn	MP:0000477,abnormal intestine morphology|MP:0000520,absent kidney|MP:0000557,absent hindlimb|MP:0000559,abnormal femur morphology|MP:0000639,abnormal adrenal gland morphology|MP:0002111,abnormal tail morphology|MP:0002639,micrognathia|MP:0003130,anal atresia|MP:0003445,sirenomelia|MP:0003604,single kidney|MP:0004507,abnormal ischium morphology|MP:0004690,ischium hypoplasia|MP:0005313,absent adrenal gland|MP:0009252,absent urinary bladder|MP:0009880,decreased mouth size|MP:0011087,neonatal lethality, complete penetrance
MGI:6715665	Sros1<em1Caox>	MP:0002411,decreased susceptibility to bacterial infection|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0010209,abnormal circulating chemokine level|MP:0031220,increased circulating CXCL10 level
MGI:7708056	Srp14<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0020421,increased freezing behavior
MGI:6361238	Srp72<em1(IMPC)Bay>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0002574,increased vertical activity|MP:0002953,thick ventricular wall|MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0020870,decreased thigmotaxis
MGI:5571347	Srp9<tm1.1(KOMP)Vlcg>	MP:0003019,increased circulating chloride level|MP:0005343,increased circulating aspartate transaminase level|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5636749	Srpk1<tm1.1Xdfu>	MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5636722	Srpk1<tm1Xdfu>	MP:0000352,decreased cell proliferation|MP:0008008,early cellular replicative senescence
MGI:5692649	Srpk3<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000220,increased monocyte cell number|MP:0000494,abnormal cecum morphology|MP:0002731,megacolon|MP:0010053,decreased grip strength
MGI:3613582	Srpk3<tm1Eno>	MP:0000759,abnormal skeletal muscle morphology|MP:0004819,decreased skeletal muscle mass|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:5692540	Srprb<tm2b(EUCOMM)Hmgu>	MP:0002591,decreased mean corpuscular volume|MP:0005554,decreased circulating creatinine level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6195541	Srpx2<em1Gmsa>	MP:0001529,abnormal vocalization|MP:0004998,decreased CNS synapse formation|MP:0020395,abnormal response to social novelty
MGI:6435665	Srpx2<em1(IMPC)Hmgu>	MP:0000198,decreased circulating phosphate level
MGI:3706175	Srpx<tm1Hzi>	MP:0000691,enlarged spleen|MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0002619,abnormal lymphocyte morphology|MP:0010264,increased hepatoma incidence|MP:0012431,increased lymphoma incidence
MGI:6449029	Srr<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002699,abnormal vitreous body morphology
MGI:7708057	Srrm1<em1(IMPC)Mbp>	MP:0000494,abnormal cecum morphology|MP:0000598,abnormal liver morphology|MP:0005084,abnormal gallbladder morphology|MP:0009342,enlarged gallbladder|MP:0009476,enlarged cecum|MP:0010393,shortened QRS complex duration
MGI:6257609	Srrm2<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:4088169	Srrm3<Gt(IST12726F8)Tigm>	MP:0000745,tremors|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000876,Purkinje cell degeneration|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0002083,premature death
MGI:1856676	Srrm4<bv>	MP:0000026,abnormal inner ear morphology|MP:0001394,circling|MP:0001485,abnormal pinna reflex|MP:0001525,impaired balance|MP:0001967,deafness|MP:0002623,abnormal vestibular hair cell morphology|MP:0002857,cochlear ganglion degeneration|MP:0003825,abnormal pillar cell morphology|MP:0004249,abnormal crista ampullaris morphology|MP:0004312,absent pillar cells|MP:0004328,decreased vestibular hair cell number|MP:0004333,abnormal utricular macula morphology|MP:0004334,utricular macular degeneration|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004396,decreased cochlear inner hair cell number|MP:0004397,absent cochlear inner hair cells|MP:0004398,cochlear inner hair cell degeneration|MP:0004518,absent vestibular hair cell stereocilia|MP:0004589,abnormal cochlear hair cell development|MP:0004736,abnormal distortion product otoacoustic emission|MP:0005307,head tossing|MP:0006335,abnormal hearing electrophysiology|MP:0006336,abnormal otoacoustic response|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5752029	Srrm4<tm1b(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0000780,abnormal corpus callosum morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0001394,circling|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002184,abnormal innervation|MP:0002961,abnormal axon guidance|MP:0003424,premature neuronal precursor differentiation|MP:0003651,abnormal axon extension|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004981,decreased neuronal precursor cell number|MP:0005191,head tilt|MP:0008415,abnormal neurite morphology|MP:0008770,decreased survivor rate|MP:0008948,decreased neuron number|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012055,abnormal phrenic nerve innervation pattern to diaphragm
MGI:4451952	Srrm4<tm1e(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4354162	Srr<rgsc1872>	MP:0001360,abnormal social investigation|MP:0008414,abnormal spatial reference memory|MP:0008432,abnormal long-term spatial reference memory|MP:0008911,induced hyperactivity|MP:0009142,decreased prepulse inhibition|MP:0030691,increased serine level|MP:0030692,decreased serine level
MGI:3798495	Srr<Rgsc34>	MP:0002463,abnormal neutrophil physiology
MGI:4438917	Srr<tm1.2Jtc>	MP:0001399,hyperactivity|MP:0001473,reduced long-term potentiation|MP:0001488,increased startle reflex|MP:0002152,abnormal brain morphology|MP:0002574,increased vertical activity|MP:0002797,increased thigmotaxis|MP:0002910,abnormal excitatory postsynaptic currents|MP:0008432,abnormal long-term spatial reference memory|MP:0011269,increased excitatory postsynaptic current amplitude
MGI:3831132	Srr<tm1(cre/PGR)Himo>	MP:0002229,neurodegeneration|MP:0003631,nervous system phenotype|MP:0008236,decreased susceptibility to neuronal excitotoxicity|MP:0030692,decreased serine level
MGI:3777245	Srrt<tm1Bfk>	MP:0001730,embryonic growth arrest|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3848950	Srsf10<tm1Jalm>	MP:0001785,edema|MP:0002190,disorganized myocardium|MP:0002652,thin myocardium|MP:0003103,liver degeneration|MP:0004062,dilated heart right atrium|MP:0004201,fetal growth retardation|MP:0004215,abnormal myocardial fiber physiology|MP:0005329,abnormal myocardium layer morphology|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010413,complete atrioventricular septal defect|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5692694	Srsf11<tm1b(EUCOMM)Wtsi>	MP:0003928,increased heart rate variability|MP:0005385,cardiovascular system phenotype|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3530159	Srsf1<tm1.1Xdfu>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3530151	Srsf1<tm1Xdfu>	MP:0000278,abnormal myocardial fiber morphology|MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0001330,abnormal optic nerve morphology|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002972,abnormal cardiac muscle contractility|MP:0003141,cardiac fibrosis|MP:0005241,abnormal retina ganglion layer morphology|MP:0005333,decreased heart rate|MP:0006068,abnormal retina horizontal cell morphology|MP:0006309,decreased retina ganglion cell number|MP:0008106,decreased amacrine cell number|MP:0010235,abnormal retina inner limiting membrane morphology|MP:0014316,decreased heart left ventricle posterior wall thickness|MP:0030005,increased retina apoptosis
MGI:5694699	Srsf2<tm1.1Oaw>	MP:0000245,abnormal erythropoiesis|MP:0001545,abnormal hematopoietic system physiology|MP:0001601,abnormal myelopoiesis|MP:0001603,failure of myelopoiesis|MP:0001606,impaired hematopoiesis|MP:0002811,macrocytic anemia|MP:0003077,abnormal cell cycle|MP:0004809,increased hematopoietic stem cell number|MP:0005017,decreased B cell number|MP:0005065,abnormal neutrophil morphology|MP:0006042,increased apoptosis|MP:0008801,abnormal erythroid progenitor cell morphology|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:3036849	Srsf2<tm1.1Xdfu>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3036846	Srsf2<tm1Xdfu>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001545,abnormal hematopoietic system physiology|MP:0001606,impaired hematopoiesis|MP:0002145,abnormal T cell differentiation|MP:0002357,abnormal spleen white pulp morphology|MP:0002795,dilated cardiomyopathy|MP:0004956,decreased thymus weight|MP:0005018,decreased T cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005385,cardiovascular system phenotype|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0008028,pregnancy-related premature death|MP:0013741,absent thymus corticomedullary boundary|MP:0013776,bone marrow failure|MP:0031633,decreased heart left ventricle muscle contractility
MGI:2669750	Srsf3<tm1.1Pjln>	MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012129,failure of blastocyst formation
MGI:2669749	Srsf3<tm1Pjln>	MP:0000074,abnormal neurocranium morphology|MP:0000163,abnormal cartilage morphology|MP:0000186,decreased circulating HDL cholesterol level|MP:0000189,hypoglycemia|MP:0000430,absent maxillary shelf|MP:0000431,absent palatine bone horizontal plate|MP:0000433,microcephaly|MP:0000457,maxilla hypoplasia|MP:0000460,mandible hypoplasia|MP:0000527,abnormal kidney development|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0000704,abnormal thymus development|MP:0000783,abnormal forebrain morphology|MP:0000914,exencephaly|MP:0000930,wavy neural tube|MP:0001265,decreased body size|MP:0001634,internal hemorrhage|MP:0001780,decreased brown adipose tissue amount|MP:0002169,no abnormal phenotype detected|MP:0002644,decreased circulating triglyceride level|MP:0002891,increased insulin sensitivity|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003056,abnormal hyoid bone morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0003138,absent tympanic ring|MP:0003743,abnormal facial morphology|MP:0003887,increased hepatocyte apoptosis|MP:0003943,abnormal hepatobiliary system development|MP:0004376,absent frontal bone|MP:0004385,interparietal bone hypoplasia|MP:0004420,parietal bone hypoplasia|MP:0004424,temporal bone hypoplasia|MP:0004444,small supraoccipital bone|MP:0004455,pterygoid bone hypoplasia|MP:0004461,basisphenoid bone hypoplasia|MP:0004473,absent nasal bone|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004871,premaxilla hypoplasia|MP:0005017,decreased B cell number|MP:0005123,increased circulating growth hormone level|MP:0005179,decreased circulating cholesterol level|MP:0005291,abnormal glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005419,decreased circulating serum albumin level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0006208,lethality throughout fetal growth and development|MP:0006306,abnormal nasal pit morphology|MP:0008023,abnormal styloid process morphology|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008535,enlarged lateral ventricles|MP:0008797,facial cleft|MP:0008989,abnormal liver sinusoid morphology|MP:0008991,abnormal bile canaliculus morphology|MP:0009356,decreased liver triglyceride level|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009883,palatal shelf hypoplasia|MP:0009891,abnormal palate bone morphology|MP:0009904,tongue hypoplasia|MP:0009913,abnormal hyoid bone greater horn morphology|MP:0009914,abnormal hyoid bone lesser horn morphology|MP:0010026,decreased liver cholesterol level|MP:0010398,decreased liver glycogen level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0012089,decreased midbrain size|MP:0012090,midbrain hypoplasia|MP:0012139,increased forebrain size|MP:0014172,decreased fatty acid oxidation|MP:0030112,zygomatic bone hypoplasia|MP:0030119,abnormal retrotympanic process morphology|MP:0030261,abnormal temporal bone zygomatic process morphology|MP:0030285,mandibular coronoid process hypoplasia|MP:0030301,abnormal maxillary frontal process morphology|MP:0030313,abnormal face development|MP:0030374,Meckel's cartilage hypoplasia|MP:0030386,facial bone hypoplasia|MP:0030869,thyroid cartilage hypoplasia|MP:0030874,cricoid cartilage hypoplasia|MP:0031459,maxillary zygomatic process hypoplasia
MGI:4431961	Srsf4<tm1a(EUCOMM)Wtsi>	MP:0002075,abnormal coat/hair pigmentation|MP:0005553,increased circulating creatinine level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7580838	Srsf4<tm1c(EUCOMM)Wtsi>	MP:0000274,enlarged heart|MP:0001544,abnormal cardiovascular system physiology|MP:0002625,heart left ventricle hypertrophy|MP:0002626,increased heart rate|MP:0002833,increased heart weight|MP:0003233,prolonged QT interval|MP:0003915,increased heart left ventricle weight|MP:0004485,increased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0005385,cardiovascular system phenotype|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010571,shortened ST segment|MP:0010634,increased QRS amplitude|MP:0011390,abnormal fetal cardiomyocyte physiology|MP:0011925,abnormal heart echocardiography feature|MP:0011928,abnormal mitral valve flow|MP:0021157,increased heart left ventricle wall thickness|MP:0031609,increased fetal cardiomyocyte size
MGI:6164004	Srsf5<em1(IMPC)J>	MP:0001284,absent vibrissae|MP:0001399,hyperactivity|MP:0001529,abnormal vocalization|MP:0001697,abnormal embryo size|MP:0002075,abnormal coat/hair pigmentation|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6782384	Srsf5<em1Nju>	MP:0000692,small spleen|MP:0003233,prolonged QT interval|MP:0003717,pallor|MP:0003822,decreased left ventricle systolic pressure|MP:0003896,prolonged PR interval|MP:0003920,abnormal heart right ventricle morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004067,abnormal trabecula carnea morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0009546,absent gastric milk in neonates|MP:0009703,decreased birth body size|MP:0010394,decreased QRS amplitude|MP:0010499,abnormal ventricle myocardium morphology|MP:0010519,atrioventricular block|MP:0010556,thin ventricle myocardium compact layer|MP:0010819,primary atelectasis|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0021158,decreased heart left ventricle wall thickness
MGI:6111460	Srsf6<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0001697,abnormal embryo size|MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6781649	Srsf7<em1Mmri>	MP:0001262,decreased body weight|MP:0008489,slow postnatal weight gain|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:4433826	Srsf7<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5925314	Srsf9<em1(IMPC)J>	MP:0002574,increased vertical activity|MP:0003179,thrombocytopenia
MGI:2152545	srt	MP:0000152,absent proximal rib|MP:0000162,lordosis|MP:0001258,decreased body length|MP:0001953,respiratory failure|MP:0005225,abnormal vertebrae development|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance
MGI:5501480	Srxn1<tm1Mtol>	MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0008735,increased susceptibility to endotoxin shock|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:5646116	Srxn1<tm1Sgrh>	MP:0001739,abnormal adrenal gland secretion|MP:0001748,increased circulating adrenocorticotropin level|MP:0005345,abnormal circulating corticosterone level|MP:0009078,adrenal gland hyperplasia
MGI:3575651	Sry<AKR/J>	MP:0005389,reproductive system phenotype
MGI:3784808	Sry<CB>	MP:0001939,secondary sex reversal|MP:0002211,abnormal primary sex determination|MP:0002212,abnormal secondary sex determination|MP:0002213,true hermaphroditism|MP:0002995,primary sex reversal|MP:0002996,ovotestis
MGI:1857786	Sry<dl1Rlb>	MP:0002995,primary sex reversal
MGI:5569481	Sry<em1Takas>	MP:0001131,abnormal ovarian follicle morphology|MP:0001926,female infertility|MP:0002995,primary sex reversal|MP:0005180,abnormal circulating testosterone level|MP:0009017,prolonged estrus|MP:0011129,decreased tertiary ovarian follicle number
MGI:3575629	Sry<POS>	MP:0001939,secondary sex reversal|MP:0002211,abnormal primary sex determination|MP:0002212,abnormal secondary sex determination|MP:0002213,true hermaphroditism|MP:0002995,primary sex reversal|MP:0002996,ovotestis|MP:0005652,sex reversal
MGI:6363562	Ss18<em1(IMPC)J>	MP:0001488,increased startle reflex|MP:0005559,increased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance
MGI:6401515	Ss18l1<em1Zqi>	MP:0001052,abnormal innervation pattern to muscle|MP:0001265,decreased body size|MP:0001392,abnormal locomotor behavior|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0020448,increased microglial cell activation
MGI:6401517	Ss18l1<em2Zqi>	MP:0001405,impaired coordination|MP:0020448,increased microglial cell activation
MGI:3028533	Ss18l1<tm1Ghsh>	MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000841,abnormal hindbrain morphology|MP:0000852,small cerebellum|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001924,infertility|MP:0002083,premature death|MP:0008267,abnormal hippocampus CA3 region morphology
MGI:3690630	Ss18<tm1Adg>	MP:0000274,enlarged heart|MP:0000929,open neural tube|MP:0001574,abnormal oxygen level|MP:0001614,abnormal blood vessel morphology|MP:0001701,incomplete embryo turning|MP:0001711,abnormal placenta morphology|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001730,embryonic growth arrest|MP:0001914,hemorrhage|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0003231,abnormal placenta vasculature|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0004560,abnormal chorionic plate morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4938520	Ssbp1<tm1a(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5605777	Ssbp2<tm1b(KOMP)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0002092,abnormal eye morphology|MP:0002175,decreased brain weight|MP:0002631,abnormal epididymis morphology|MP:0002833,increased heart weight|MP:0003960,increased lean body mass|MP:0004931,enlarged epididymis|MP:0006243,impaired pupillary reflex|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength
MGI:4462848	Ssbp2<tm1Lana>	MP:0001577,anemia|MP:0002018,increased malignant tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002032,increased sarcoma incidence|MP:0002038,increased carcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002932,abnormal joint morphology|MP:0003132,increased pre-B cell number|MP:0004207,increased squamous cell carcinoma incidence|MP:0005016,decreased lymphocyte cell number|MP:0005152,pancytopenia|MP:0009312,increased jejunum adenocarcinoma incidence|MP:0010138,arteritis|MP:0010383,increased adenoma incidence|MP:0011090,perinatal lethality, incomplete penetrance|MP:0012431,increased lymphoma incidence
MGI:3663396	Ssbp3<Gt(RRB078)Byg>	MP:0002169,no abnormal phenotype detected
MGI:3663393	Ssbp3<Gt(XB276)Byg>	MP:0000438,abnormal cranium morphology|MP:0000913,abnormal brain development|MP:0001672,abnormal embryo development|MP:0002088,abnormal embryonic growth/weight/body size|MP:0005508,abnormal skeleton morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0012087,absent midbrain|MP:0012089,decreased midbrain size|MP:0012136,absent forebrain|MP:0012176,abnormal head development
MGI:3663636	Ssbp3<Tg(SOD1)1Hssk>	MP:0000141,abnormal vertebral body morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000157,abnormal sternum morphology|MP:0000352,decreased cell proliferation|MP:0000433,microcephaly|MP:0000438,abnormal cranium morphology|MP:0000592,short tail|MP:0000913,abnormal brain development|MP:0000934,abnormal telencephalon development|MP:0001688,abnormal somite development|MP:0001691,abnormal somite shape|MP:0001698,decreased embryo size|MP:0002169,no abnormal phenotype detected|MP:0003232,abnormal forebrain development|MP:0003400,kinked neural tube|MP:0003864,abnormal midbrain development|MP:0004096,abnormal midbrain-hindbrain boundary development|MP:0004388,absent prechordal plate|MP:0005657,abnormal neural plate morphology|MP:0006042,increased apoptosis|MP:0008146,asymmetric sternocostal joints|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011259,abnormal cephalic neural fold morphology|MP:0011732,decreased somite size|MP:0012283,decreased sternebra number|MP:0012517,absent diencephalon|MP:0030324,abnormal anterior head development
MGI:3617648	Ssb<tm1Rjma>	MP:0004965,inner cell mass degeneration|MP:0005033,abnormal trophoblast giant cell morphology|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5569489	Ssb<tm2Rjma>	MP:0011092,embryonic lethality, complete penetrance
MGI:6153627	Ssc5d<em1(IMPC)Wtsi>	MP:0002599,increased mean platelet volume
MGI:5775609	Ssh1<em1(IMPC)J>	MP:0010053,decreased grip strength
MGI:6391206	Ssh2<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0001925,male infertility|MP:0003233,prolonged QT interval|MP:0003960,increased lean body mass|MP:0005635,decreased circulating bilirubin level|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content
MGI:3796064	Ssh3<tm1Taue>	MP:0002169,no abnormal phenotype detected|MP:0005367,renal/urinary system phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0010771,integument phenotype
MGI:2385540	Ssial1<NOD>	MP:0001870,salivary gland inflammation|MP:0005580,periinsulitis
MGI:2385542	Ssial2<NOD>	MP:0001870,salivary gland inflammation
MGI:2385554	Ssial3<NOD>	MP:0001870,salivary gland inflammation
MGI:2385558	Ssial4<NOD>	MP:0001870,salivary gland inflammation
MGI:3611374	Ssic1<C57BL/10J>	MP:0009309,increased small intestine adenocarcinoma incidence
MGI:3761505	ssl	MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001525,impaired balance|MP:0002083,premature death
MGI:6515722	Ssmem1<em1Osb>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0004852,decreased testis weight|MP:0009230,abnormal sperm head morphology
MGI:3771053	Ssnt1<DBA/2J>	MP:0000445,short snout
MGI:3771054	Ssnt2<C57BL/6J>	MP:0000445,short snout
MGI:3771338	Ssnt3<DBA/2J>	MP:0000445,short snout
MGI:5613642	Sspn<tm1b(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0001303,abnormal lens morphology|MP:0002608,increased hematocrit
MGI:2387936	Sspn<tm1Kcam>	MP:0002106,abnormal muscle physiology|MP:0005165,increased susceptibility to injury|MP:0005369,muscle phenotype|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0010226,increased quadriceps weight
MGI:7595634	Sspo<em1Lehm>	MP:0004703,abnormal vertebral column morphology|MP:0005386,behavior/neurological phenotype|MP:0013908,small lateral ventricles|MP:0013909,small third ventricle|MP:0014402,abnormal Reissner's fiber morphology
MGI:6257494	Sspo<em8(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0001120,abnormal uterus morphology|MP:0002092,abnormal eye morphology
MGI:1889614	Ssq	MP:0000367,abnormal coat/ hair morphology|MP:0000556,abnormal hindlimb morphology|MP:0000562,polydactyly|MP:0000574,abnormal foot pad morphology|MP:0000579,abnormal nail morphology|MP:0002109,abnormal limb morphology|MP:0008985,hemimelia
MGI:6362803	Ssr1<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001146,abnormal testis morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0011100,preweaning lethality, complete penetrance
MGI:3691069	Ssr1<Gt(ble-lacZl)16Brr>	MP:0000267,abnormal heart development|MP:0000274,enlarged heart|MP:0000281,abnormal interventricular septum morphology|MP:0000284,double outlet right ventricle|MP:0001785,edema|MP:0002633,persistent truncus arteriosus|MP:0002746,abnormal semilunar valve morphology|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0004200,decreased fetal size|MP:0005294,abnormal heart ventricle morphology|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0010454,abnormal truncus arteriosus septation|MP:0010645,failure of conotruncal ridge closure|MP:0010651,aorticopulmonary septal defect|MP:0011087,neonatal lethality, complete penetrance
MGI:5637009	Ssr2<tm1b(EUCOMM)Wtsi>	MP:0000161,scoliosis|MP:0000282,abnormal interatrial septum morphology|MP:0000284,double outlet right ventricle|MP:0000602,dilated liver sinusoidal space|MP:0000703,abnormal thymus morphology|MP:0000783,abnormal forebrain morphology|MP:0000825,dilated lateral ventricle|MP:0001015,small superior cervical ganglion|MP:0001330,abnormal optic nerve morphology|MP:0001916,intracerebral hemorrhage|MP:0002279,abnormal diaphragm morphology|MP:0002633,persistent truncus arteriosus|MP:0003686,abnormal eye muscle morphology|MP:0003827,abnormal Wolffian duct morphology|MP:0004057,thin myocardium compact layer|MP:0004201,fetal growth retardation|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0004463,basisphenoid bone foramen|MP:0004613,fusion of vertebral arches|MP:0005244,hemopericardium|MP:0008536,enlarged third ventricle|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009770,abnormal optic chiasm morphology|MP:0009913,abnormal hyoid bone greater horn morphology|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010490,abnormal inferior vena cava valve morphology|MP:0010589,common truncal valve|MP:0010592,abnormal atrioventricular septum morphology|MP:0010602,abnormal pulmonary valve cusp morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011659,interrupted aortic arch, type b|MP:0013815,abnormal digastric muscle morphology|MP:0013836,abnormal hypoglossal nerve topology|MP:0013848,subcutaneous edema|MP:0013875,increased trigeminal neuroma incidence|MP:0013876,absent ductus venosus valve|MP:0013877,abnormal ductus venosus valve morphology|MP:0013967,abnormal infrahyoid muscle connection|MP:0013969,reduced sympathetic cervical ganglion size|MP:0013973,abnormal hepatic vein connection|MP:0014021,heterochrony
MGI:4881708	Ssr3<tm1Ryn>	MP:0001711,abnormal placenta morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003231,abnormal placenta vasculature|MP:0004201,fetal growth retardation|MP:0004259,small placenta|MP:0004921,decreased placenta weight|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009431,decreased fetal weight|MP:0009658,increased placenta apoptosis|MP:0010038,abnormal placenta physiology|MP:0011087,neonatal lethality, complete penetrance|MP:0011521,decreased placental labyrinth size
MGI:2669951	Ssrp1<tm1Rul>	MP:0004965,inner cell mass degeneration|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3776399	Ssrq10<A/J>	MP:0010166,increased response to stress-induced hyperthermia
MGI:3776370	Ssrq1<A/J>	MP:0010166,increased response to stress-induced hyperthermia
MGI:3776372	Ssrq2<A/J>	MP:0010166,increased response to stress-induced hyperthermia
MGI:3776384	Ssrq5<A/J>	MP:0010166,increased response to stress-induced hyperthermia
MGI:3776395	Ssrq8<A/J>	MP:0010166,increased response to stress-induced hyperthermia
MGI:2154340	Sst1<C3HeB/FeJ>	MP:0002412,increased susceptibility to bacterial infection|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:2154341	Sst1<C57BL/6J>	MP:0002411,decreased susceptibility to bacterial infection
MGI:6158516	Sstr1<em1(IMPC)Mbp>	MP:0020421,increased freezing behavior
MGI:3604559	Sstr1<tm1Dgen>	MP:0001402,decreased locomotor activity|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3055541	Sstr1<tm1Dric>	MP:0004495,decreased synaptic glutamate release|MP:0004994,abnormal brain wave pattern|MP:0005551,abnormal eye electrophysiology|MP:0006072,abnormal retina apoptosis|MP:0006074,abnormal retina rod bipolar cell morphology
MGI:6276919	Sstr2<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0001200,thick skin|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney
MGI:2181022	Sstr2<tm1Bne>	MP:0005381,digestive/alimentary phenotype
MGI:3045430	Sstr2<tm1Pce>	MP:0001405,impaired coordination|MP:0003038,decreased myocardial infarct size|MP:0004494,abnormal synaptic glutamate release|MP:0004924,abnormal behavior|MP:0004994,abnormal brain wave pattern|MP:0005391,vision/eye phenotype|MP:0005643,decreased dopamine level|MP:0006074,abnormal retina rod bipolar cell morphology
MGI:2388099	Sstr2<tm1Rgs>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001748,increased circulating adrenocorticotropin level|MP:0002757,decreased vertical activity
MGI:5708169	Sstr4<tm1.1(KOMP)Vlcg>	MP:0010053,decreased grip strength
MGI:4355975	Sstr4<tm1Szo>	MP:0001785,edema|MP:0001952,increased airway responsiveness|MP:0002441,abnormal granulocyte morphology|MP:0002463,abnormal neutrophil physiology|MP:0003828,pulmonary edema|MP:0005407,hyperalgesia|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008657,increased interleukin-1 beta secretion
MGI:6276928	Sstr5<em1(IMPC)Mbp>	MP:0001489,decreased startle reflex
MGI:5303078	Sstr5<tm1Fcb>	MP:0003058,increased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0005216,abnormal pancreatic alpha cell morphology|MP:0005376,homeostasis/metabolism phenotype
MGI:3603655	Sstr5<tm1Hawi>	MP:0001262,decreased body weight|MP:0002712,increased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003058,increased insulin secretion|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005669,increased circulating leptin level
MGI:5568485	Sst<tm1b(KOMP)Wtsi>	MP:0002965,increased circulating serum albumin level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0008810,increased circulating iron level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:4355153	Sst<tm1(cre/ERT2)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:2388093	Sst<tm1Low>	MP:0002272,abnormal nervous system electrophysiology|MP:0002911,abnormal inhibitory postsynaptic potential|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003212,increased susceptibility to age related obesity|MP:0004731,increased circulating gastrin level|MP:0005116,abnormal circulating pituitary hormone level|MP:0005136,decreased growth hormone level|MP:0005387,immune system phenotype
MGI:1888381	Sst<tm1Ute>	MP:0001745,increased circulating corticosterone level|MP:0002079,increased circulating insulin level|MP:0002804,abnormal motor learning|MP:0003631,nervous system phenotype|MP:0003883,enlarged stomach|MP:0003892,abnormal gastric gland morphology|MP:0004139,abnormal gastric parietal cell morphology|MP:0005121,decreased circulating prolactin level|MP:0005123,increased circulating growth hormone level|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0008002,hyperchlorhydria|MP:0010778,abnormal stomach fundus morphology|MP:0011612,increased circulating ghrelin level
MGI:4838416	Sst<tm2.1(cre)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:5700394	Sst<tm3.1(flpo)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:7426004	Ssu2<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000538,abnormal urinary bladder morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000759,abnormal skeletal muscle morphology|MP:0001293,anophthalmia|MP:0001529,abnormal vocalization|MP:0002059,abnormal seminal vesicle morphology|MP:0002092,abnormal eye morphology|MP:0002590,increased mean corpuscular volume|MP:0004924,abnormal behavior|MP:0010393,shortened QRS complex duration|MP:0011874,enlarged urinary bladder
MGI:5908700	Ssu2<tm1.1Xmx>	MP:0002100,abnormal tooth morphology|MP:0002818,abnormal dentin morphology|MP:0002819,abnormal dental pulp cavity morphology|MP:0013250,abnormal dental pulp morphology|MP:0030451,abnormal dentin mineralization|MP:0030455,increased odontoblast number|MP:0030459,abnormal tooth attrition|MP:0030543,abnormal predentin morphology
MGI:6267327	Ssu72<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0020870,decreased thigmotaxis
MGI:6759796	Ssu72<tm1Cwl>	MP:0000596,abnormal liver development|MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0001654,hepatic necrosis|MP:0001860,liver inflammation|MP:0002006,neoplasm|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0002981,increased liver weight|MP:0003333,liver fibrosis|MP:0003887,increased hepatocyte apoptosis|MP:0003893,increased hepatocyte proliferation|MP:0005343,increased circulating aspartate transaminase level|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008990,abnormal Ito cell morphology|MP:0010080,abnormal hepatocyte physiology|MP:0020427,increased hepatocyte karyomegaly
MGI:5779850	Ssx2ip<em1(IMPC)J>	MP:0010053,decreased grip strength
MGI:1857055	st	MP:0000438,abnormal cranium morphology|MP:0000592,short tail|MP:0000828,abnormal fourth ventricle morphology|MP:0000854,abnormal cerebellum development|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0001405,impaired coordination|MP:0001525,impaired balance|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0003456,absent tail|MP:0005424,jerky movement|MP:0006030,abnormal otic vesicle development|MP:0006103,abnormal midbrain roof plate morphology|MP:0008770,decreased survivor rate|MP:0008934,absent choroid plexus
MGI:6306895	St13<em1(IMPC)J>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3717153	St14<Gt(RST485)Byg>	MP:0000764,abnormal tongue epithelium morphology|MP:0002796,impaired skin barrier function|MP:0003756,abnormal hard palate morphology
MGI:3717152	St14<Gt(XM184)Byg>	MP:0000764,abnormal tongue epithelium morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0002796,impaired skin barrier function|MP:0003756,abnormal hard palate morphology|MP:0009546,absent gastric milk in neonates|MP:0011087,neonatal lethality, complete penetrance|MP:0030605,abnormal corneocyte morphology
MGI:5695895	St14<tm1.1(KOMP)Vlcg>	MP:0000603,pale liver|MP:0001697,abnormal embryo size|MP:0001722,pale yolk sac|MP:0002092,abnormal eye morphology|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0004848,abnormal liver size|MP:0005650,abnormal limb bud morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:2683707	St14<tm1Bug>	MP:0000379,decreased hair follicle number|MP:0000382,underdeveloped hair follicles|MP:0000414,alopecia|MP:0000443,abnormal snout morphology|MP:0001190,reddish skin|MP:0001192,scaly skin|MP:0001196,shiny skin|MP:0001211,wrinkled skin|MP:0001219,thick epidermis|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001284,absent vibrissae|MP:0001429,dehydration|MP:0001874,acanthosis|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0003809,abnormal hair shaft morphology|MP:0003853,dry skin|MP:0005092,decreased double-positive T cell number|MP:0009541,increased thymocyte apoptosis|MP:0009546,absent gastric milk in neonates|MP:0009595,enlarged corneocyte envelope|MP:0009596,abnormal stratum corneum lipid matrix formation|MP:0009597,impaired stratum corneum desquamation|MP:0009931,abnormal skin appearance|MP:0010234,abnormal vibrissa follicle morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0030570,abnormal piliary canal morphology|MP:0030605,abnormal corneocyte morphology
MGI:2683723	St14<tm2Bug>	MP:0000414,alopecia|MP:0001192,scaly skin|MP:0001219,thick epidermis|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001874,acanthosis|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0009595,enlarged corneocyte envelope|MP:0009596,abnormal stratum corneum lipid matrix formation|MP:0009597,impaired stratum corneum desquamation
MGI:4361197	St14<tm3Bug>	MP:0000623,decreased salivation|MP:0005310,abnormal salivary gland physiology|MP:0005387,immune system phenotype
MGI:4363363	St18<tm1a(KOMP)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0001262,decreased body weight|MP:0002942,decreased circulating alanine transaminase level|MP:0003345,decreased rib number|MP:0005419,decreased circulating serum albumin level|MP:0005632,decreased circulating aspartate transaminase level|MP:0010025,decreased total body fat amount|MP:0010101,increased sacral vertebrae number
MGI:6489608	St18<tm1c(KOMP)Wtsi>	MP:0001846,increased inflammatory response|MP:0003070,increased vascular permeability|MP:0005036,diarrhea|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005387,immune system phenotype|MP:0008489,slow postnatal weight gain|MP:0008641,increased circulating interleukin-1 beta level|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010097,abnormal retina blood vessel morphology|MP:0010180,increased susceptibility to weight loss|MP:0010768,mortality/aging
MGI:3699717	St3gal1<tm2Jxm>	MP:0002169,no abnormal phenotype detected
MGI:2445397	St3gal2<tm1Jxm>	MP:0005015,increased T cell number|MP:0005095,decreased T cell proliferation|MP:0005397,hematopoietic system phenotype|MP:0005606,increased bleeding time|MP:0008483,increased spleen germinal center size
MGI:3699715	St3gal2<tm2Jxm>	MP:0002169,no abnormal phenotype detected
MGI:2445404	St3gal3<tm1Jxm>	MP:0005397,hematopoietic system phenotype
MGI:5695539	St3gal4<tm1.1Bsi>	MP:0001363,increased anxiety-related response|MP:0001500,decreased kindling response|MP:0001501,abnormal sleep pattern|MP:0002573,behavioral despair|MP:0002806,abnormal conditioned emotional response|MP:0003063,increased coping response|MP:0003459,increased fear-related response|MP:0005136,decreased growth hormone level|MP:0008831,abnormal insulin-like growth factor I level|MP:0012286,decreased frequency of paradoxical sleep
MGI:2446673	St3gal4<tm1.1Jxm>	MP:0002599,increased mean platelet volume|MP:0003156,abnormal leukocyte migration|MP:0003179,thrombocytopenia|MP:0003627,abnormal leukocyte tethering or rolling|MP:0005016,decreased lymphocyte cell number|MP:0005025,abnormal response to infection|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time
MGI:2655771	St3gal5<tm1Rlp>	MP:0000189,hypoglycemia|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005379,endocrine/exocrine gland phenotype|MP:0010698,abnormal impulsive behavior control|MP:0014114,abnormal cognition
MGI:5751066	St3gal5<tm1Skoz>	MP:0004494,abnormal synaptic glutamate release|MP:0009765,abnormal xenobiotic induced morbidity/mortality|MP:0020194,abnormal glycosphingolipid level
MGI:5445089	St3gal6<tm1.1Jxm>	MP:0005387,immune system phenotype|MP:0008719,impaired neutrophil recruitment|MP:0020332,impaired leukocyte tethering or rolling
MGI:3814350	St6gal1<tm1Jlau>	MP:0000219,increased neutrophil cell number|MP:0001601,abnormal myelopoiesis|MP:0002412,increased susceptibility to bacterial infection|MP:0002463,abnormal neutrophil physiology|MP:0003303,peritoneal inflammation
MGI:2387745	St6gal1<tm1Jxm>	MP:0000219,increased neutrophil cell number|MP:0002376,abnormal dendritic cell physiology|MP:0003303,peritoneal inflammation|MP:0008182,decreased marginal zone B cell number|MP:0008190,decreased transitional stage B cell number
MGI:3699718	St6gal1<tm2Jxm>	MP:0002169,no abnormal phenotype detected
MGI:6149212	St6gal2<em1(IMPC)H>	MP:0004357,long tibia|MP:0009455,enhanced cued conditioning behavior
MGI:7488215	St6galnac1<em1Len>	MP:0000489,abnormal large intestine morphology|MP:0000495,abnormal colon morphology|MP:0005381,digestive/alimentary phenotype|MP:0013298,increased susceptibility to colitis induced morbidity/mortality|MP:0014030,abnormal mucous gland physiology|MP:0014219,decreased intestinal mucosa thickness
MGI:5052157	St6galnac2<tm1.1Cfg>	MP:0000245,abnormal erythropoiesis|MP:0001262,decreased body weight|MP:0001807,decreased IgA level|MP:0002941,increased circulating alanine transaminase level|MP:0003132,increased pre-B cell number|MP:0005154,increased B cell proliferation|MP:0005554,decreased circulating creatinine level|MP:0008483,increased spleen germinal center size
MGI:5763623	St6galnac3<em1(IMPC)J>	MP:0001304,cataract|MP:0001510,abnormal coat appearance|MP:0002098,abnormal vibrissa morphology|MP:0010053,decreased grip strength
MGI:7540721	St6galnac3<em1Staka>	MP:0002169,no abnormal phenotype detected
MGI:7540720	St6galnac4<em1Staka>	MP:0002169,no abnormal phenotype detected
MGI:6162622	St7<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001399,hyperactivity|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002591,decreased mean corpuscular volume
MGI:2656251	St8sia1<tm1Kfk>	MP:0003631,nervous system phenotype|MP:0004858,abnormal nervous system regeneration|MP:0005348,increased T cell proliferation|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:2158360	St8sia1<tm1Rlp>	MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype
MGI:3051219	St8sia2<tm1Jxm>	MP:0000807,abnormal hippocampus morphology|MP:0001415,increased exploration in new environment|MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0002799,abnormal passive avoidance behavior|MP:0014745,abnormal hippocampal mossy fiber infrapyramidal bundle morphology|MP:0014746,abnormal hippocampal mossy fiber innervation pattern
MGI:6711691	St8sia3<em1Yich>	MP:0001392,abnormal locomotor behavior|MP:0013246,abnormal peptide metabolism
MGI:6711694	St8sia3<em2Yich>	MP:0001392,abnormal locomotor behavior|MP:0013246,abnormal peptide metabolism
MGI:6711696	St8sia3<em3Yich>	MP:0001392,abnormal locomotor behavior|MP:0013246,abnormal peptide metabolism
MGI:3582251	St8sia4<tm1Crem>	MP:0001473,reduced long-term potentiation|MP:0001475,reduced long-term depression
MGI:6423855	St8sia6<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001304,cataract|MP:0002699,abnormal vitreous body morphology
MGI:1861116	Sta	MP:0002075,abnormal coat/hair pigmentation|MP:0002080,prenatal lethality
MGI:3688882	Sta2	MP:0002075,abnormal coat/hair pigmentation
MGI:3688885	Sta3	MP:0002075,abnormal coat/hair pigmentation
MGI:5000470	Stab1<tm1.1Cger>	MP:0002169,no abnormal phenotype detected
MGI:5000471	Stab2<tm1.1Cger>	MP:0002169,no abnormal phenotype detected
MGI:5318244	Stab2<tm1Ami>	MP:0001273,decreased metastatic potential|MP:0010080,abnormal hepatocyte physiology|MP:0014427,increased circulating hyaluronic acid level
MGI:4365152	Stac3<tm1a(KOMP)Wtsi>	MP:0000150,abnormal rib morphology|MP:0000157,abnormal sternum morphology|MP:0000160,kyphosis|MP:0000753,paralysis|MP:0000759,abnormal skeletal muscle morphology|MP:0000761,thin diaphragm muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001404,no spontaneous movement|MP:0001491,unresponsive to tactile stimuli|MP:0001504,abnormal posture|MP:0001506,limp posture|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002113,abnormal skeleton development|MP:0002279,abnormal diaphragm morphology|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0004136,abnormal tongue muscle morphology|MP:0004145,abnormal muscle electrophysiology|MP:0004174,abnormal spine curvature|MP:0004231,abnormal calcium ion homeostasis|MP:0004246,abnormal extensor digitorum longus morphology|MP:0004263,abnormal limb posture|MP:0004353,abnormal deltoid tuberosity morphology|MP:0004627,abnormal trochanter morphology|MP:0004819,decreased skeletal muscle mass|MP:0004835,abnormal miniature endplate potential|MP:0005039,hypoxia|MP:0005162,carpoptosis|MP:0005385,cardiovascular system phenotype|MP:0006432,abnormal costal cartilage morphology|MP:0009401,increased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009406,decreased skeletal muscle fiber number|MP:0009431,decreased fetal weight|MP:0010819,primary atelectasis|MP:0011087,neonatal lethality, complete penetrance|MP:0012055,abnormal phrenic nerve innervation pattern to diaphragm
MGI:6283562	Stac<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior
MGI:6276879	Stag1<em1(IMPC)Mbp>	MP:0000538,abnormal urinary bladder morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0001297,microphthalmia|MP:0001552,increased circulating triglyceride level|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002989,small kidney|MP:0002997,enlarged seminal vesicle|MP:0003068,enlarged kidney|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:3874033	Stag1<Gt(P099A04)Wrst>	MP:0000116,abnormal tooth development|MP:0000160,kyphosis|MP:0000352,decreased cell proliferation|MP:0000379,decreased hair follicle number|MP:0001199,thin skin|MP:0001780,decreased brown adipose tissue amount|MP:0002014,increased papilloma incidence|MP:0002020,increased tumor incidence|MP:0002038,increased carcinoma incidence|MP:0002083,premature death|MP:0002108,abnormal muscle morphology|MP:0002123,abnormal definitive hematopoiesis|MP:0002896,abnormal bone mineralization|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003420,delayed intramembranous bone ossification|MP:0003447,decreased tumor growth/size|MP:0003786,premature aging|MP:0004024,aneuploidy|MP:0004046,abnormal mitosis|MP:0004200,decreased fetal size|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004754,abnormal kidney collecting duct morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0009321,increased histiocytic sarcoma incidence|MP:0010025,decreased total body fat amount|MP:0010207,abnormal telomere morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0012431,increased lymphoma incidence
MGI:6490260	Stag2<tm1.1Alos>	MP:0000267,abnormal heart development|MP:0000316,cellular necrosis|MP:0000352,decreased cell proliferation|MP:0000477,abnormal intestine morphology|MP:0001262,decreased body weight|MP:0001698,decreased embryo size|MP:0002006,neoplasm|MP:0002083,premature death|MP:0003649,decreased heart right ventricle size|MP:0003984,embryonic growth retardation|MP:0004046,abnormal mitosis|MP:0005397,hematopoietic system phenotype|MP:0006126,abnormal cardiac outflow tract development|MP:0008883,abnormal enterocyte proliferation|MP:0010406,common atrium|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0013501,increased fibroblast apoptosis
MGI:6696175	Stag2<tm1.1Soga>	MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000322,increased granulocyte number|MP:0000691,enlarged spleen|MP:0002396,abnormal hematopoietic system morphology/development|MP:0004809,increased hematopoietic stem cell number|MP:0005017,decreased B cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0010067,increased red blood cell distribution width|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0013696,increased granulocyte monocyte progenitor cell number|MP:0013705,decreased megakaryocyte-erythroid progenitor cell number|MP:0013707,abnormal hematopoietic precursor cell morphology|MP:0013891,increased common myeloid progenitor cell number|MP:0013893,decreased common lymphocyte progenitor cell number
MGI:5287255	Stag3<TgTn(sb-cHS4,Tyr)2312COve>	MP:0004805,absent oocytes|MP:0005159,azoospermia
MGI:5565201	Stag3<tm1e.1(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005169,abnormal male meiosis|MP:0005568,increased circulating total protein level|MP:0009451,abnormal chromosomal synapsis|MP:0009452,abnormal synaptonemal complex|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0010948,abnormal double-strand DNA break repair|MP:0014052,increased male germ cell apoptosis
MGI:5307269	Stam2<Gt(pKC199)1Gaj>	MP:0002169,no abnormal phenotype detected
MGI:2446571	Stam2<tm1Sug>	MP:0002169,no abnormal phenotype detected
MGI:6120745	Stambp<tm1b(EUCOMM)Hmgu>	MP:0001488,increased startle reflex|MP:0003900,shortened QT interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2180168	Stambp<tm1Sug>	MP:0000788,abnormal cerebral cortex morphology|MP:0000811,hippocampal neuron degeneration|MP:0001344,blepharoptosis|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0005387,immune system phenotype|MP:0011083,lethality at weaning, complete penetrance
MGI:2388123	Stam<tm1Sug>	MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0002083,premature death|MP:0002183,gliosis|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003415,priapism|MP:0009971,decreased hippocampus pyramidal cell number
MGI:6451099	Stap1<em1Jaku>	MP:0002169,no abnormal phenotype detected
MGI:4458470	Stap1<tm1a(KOMP)Wtsi>	MP:0001925,male infertility
MGI:2667181	Stap2<tm1Ayos>	MP:0002169,no abnormal phenotype detected
MGI:5548497	Stard10<tm1b(KOMP)Wtsi>	MP:0000558,abnormal tibia morphology|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002599,increased mean platelet volume|MP:0009142,decreased prepulse inhibition
MGI:5500937	Stard10<tm1Saaa>	MP:0001663,abnormal digestive system physiology|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0003402,decreased liver weight|MP:0004772,abnormal bile secretion|MP:0004773,abnormal bile composition|MP:0004777,abnormal phospholipid level|MP:0004789,increased bile salt level|MP:0005179,decreased circulating cholesterol level|MP:0005365,abnormal bile salt homeostasis|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5461853	Stard13<tm1.1Fms>	MP:0001732,postnatal growth retardation|MP:0003934,abnormal pancreas development|MP:0005293,impaired glucose tolerance|MP:0009111,pancreas hypoplasia
MGI:5461854	Stard13<tm1.2Fms>	MP:0003934,abnormal pancreas development
MGI:4363733	Stard13<tm1a(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0000688,lymphoid hyperplasia|MP:0002412,increased susceptibility to bacterial infection|MP:0002874,decreased hemoglobin content|MP:0003721,increased tumor growth/size|MP:0005376,homeostasis/metabolism phenotype|MP:0005601,increased angiogenesis|MP:0010144,abnormal tumor vascularization
MGI:4359214	Stard13<tm1Ioln>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002006,neoplasm|MP:0005384,cellular phenotype|MP:0010025,decreased total body fat amount|MP:0010768,mortality/aging
MGI:3042568	Stard3<tm1Jfs>	MP:0010027,increased liver cholesterol level
MGI:4456146	Stard4<tm1.2Bres>	MP:0000183,decreased circulating LDL cholesterol level|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0003402,decreased liver weight|MP:0004773,abnormal bile composition|MP:0005179,decreased circulating cholesterol level|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype
MGI:4363550	Stard5<tm1a(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0001260,increased body weight|MP:0004600,abnormal vertebral transverse process morphology
MGI:4433666	Stard7<tm1a(EUCOMM)Wtsi>	MP:0001194,dermatitis|MP:0001219,thick epidermis|MP:0001861,lung inflammation|MP:0001952,increased airway responsiveness|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0010771,integument phenotype|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013648,increased CD11b-high dendritic cell number|MP:0014026,abnormal respiratory epithelial transmembrane transport|MP:0014032,abnormal mucous gland morphology
MGI:6120770	Stard7<tm1b(EUCOMM)Wtsi>	MP:0005419,decreased circulating serum albumin level
MGI:6111462	Stard9<em1(IMPC)J>	MP:0001566,increased circulating phosphate level|MP:0005553,increased circulating creatinine level
MGI:7543319	Stard9<em#Kvau>	MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0010053,decreased grip strength
MGI:2155798	Start1<C57BL/6By>	MP:0001486,abnormal startle reflex
MGI:2155800	Start2<C57BL/6By>	MP:0001486,abnormal startle reflex
MGI:2388706	Star<tm1Klp>	MP:0000639,abnormal adrenal gland morphology|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001130,abnormal ovarian folliculogenesis|MP:0001134,absent corpus luteum|MP:0001146,abnormal testis morphology|MP:0001152,increased Leydig cell number|MP:0001155,arrest of spermatogenesis|MP:0001157,small seminal vesicle|MP:0001262,decreased body weight|MP:0001575,cyanosis|MP:0001732,postnatal growth retardation|MP:0001754,increased circulating corticotropin-releasing hormone level|MP:0002665,decreased circulating corticosterone level|MP:0002667,decreased circulating aldosterone level|MP:0002774,small prostate gland|MP:0002786,abnormal Leydig cell morphology|MP:0002789,male pseudohermaphroditism|MP:0004832,enlarged ovary|MP:0005129,increased adrenocorticotropin level|MP:0005147,prostate gland hypoplasia|MP:0005148,seminal vesicle hypoplasia|MP:0008288,abnormal adrenal cortex morphology|MP:0008299,adrenal cortical hyperplasia|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3611892	Stat1<fae>	MP:0001828,abnormal T cell activation|MP:0002493,increased IgG level|MP:0005466,abnormal T-helper 2 physiology
MGI:5563415	Stat1<m1Anu>	MP:0005025,abnormal response to infection
MGI:3619019	Stat1<m1Btlr>	MP:0002451,abnormal macrophage physiology|MP:0020913,increased susceptibility to Riboviria infection|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:3785244	Stat1<m2Btlr>	MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0008567,decreased interferon-gamma secretion|MP:0008791,decreased NK cell degranulation|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:6113472	Stat1<m3Btlr>	MP:0005070,impaired natural killer cell mediated cytotoxicity
MGI:6199035	Stat1<m4Btlr>	MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0008039,increased NK T cell number|MP:0008045,decreased NK cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013434,abnormal CD8-positive, naive alpha-beta T cell number
MGI:6305319	Stat1<m5Btlr>	MP:0002145,abnormal T cell differentiation|MP:0005015,increased T cell number|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:5319175	Stat1<tm1.2Mmul>	MP:0002169,no abnormal phenotype detected
MGI:1930947	Stat1<tm1Dlv>	MP:0000477,abnormal intestine morphology|MP:0001265,decreased body size|MP:0001655,multifocal hepatic necrosis|MP:0001841,decreased level of surface class I molecules|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002412,increased susceptibility to bacterial infection|MP:0002442,abnormal leukocyte physiology|MP:0005040,abnormal MHC II cell surface expression on macrophages|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005387,immune system phenotype|MP:0005391,vision/eye phenotype|MP:0008577,increased circulating interferon-gamma level|MP:0008647,increased circulating interleukin-12b level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0010766,abnormal NK cell physiology|MP:0011083,lethality at weaning, complete penetrance|MP:0020913,increased susceptibility to Riboviria infection|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020940,increased susceptibility to Togaviridae infection|MP:0020949,increased susceptibility to Coronaviridae infection
MGI:4821871	Stat1<tm1Mam>	MP:0010771,integument phenotype
MGI:1861949	Stat1<tm1Rds>	MP:0000558,abnormal tibia morphology|MP:0001312,abnormal cornea morphology|MP:0001861,lung inflammation|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0003037,increased myocardial infarct size|MP:0003077,abnormal cell cycle|MP:0003186,abnormal redox activity|MP:0003222,increased cardiomyocyte apoptosis|MP:0003303,peritoneal inflammation|MP:0003828,pulmonary edema|MP:0003957,abnormal nitric oxide homeostasis|MP:0004148,increased compact bone thickness|MP:0004984,increased osteoclast cell number|MP:0004992,increased bone resorption|MP:0005605,increased bone mass|MP:0005621,abnormal cell physiology|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008039,increased NK T cell number|MP:0008236,decreased susceptibility to neuronal excitotoxicity|MP:0008395,abnormal osteoblast differentiation|MP:0008396,abnormal osteoclast differentiation|MP:0008578,decreased circulating interferon-gamma level|MP:0008658,decreased interleukin-1 beta secretion|MP:0008891,decreased hepatocyte apoptosis|MP:0008944,decreased sensitivity to induced cell death|MP:0010537,tumor regression|MP:0010857,pulmonary necrosis|MP:0010878,increased trabecular bone volume|MP:0010964,increased compact bone volume|MP:0020913,increased susceptibility to Riboviria infection|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020940,increased susceptibility to Togaviridae infection|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality|MP:0031053,pleuritis|MP:0031054,bronchiolitis
MGI:3774319	Stat1<tm1Tdec>	MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0005040,abnormal MHC II cell surface expression on macrophages|MP:0008734,decreased susceptibility to endotoxin shock|MP:0020913,increased susceptibility to Riboviria infection
MGI:5284857	Stat1<tm1Uvin>	MP:0011076,increased macrophage nitric oxide production
MGI:5588365	Stat1<tm2.1Uvin>	MP:0002412,increased susceptibility to bacterial infection|MP:0005387,immune system phenotype|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:5766744	Stat1<tm2b(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000702,enlarged lymph nodes|MP:0001406,abnormal gait|MP:0001523,impaired righting response|MP:0002591,decreased mean corpuscular volume|MP:0002606,increased basophil cell number|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010124,decreased bone mineral content|MP:0012362,increased large unstained cell number
MGI:6200395	Stat2<m1Btlr>	MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0010848,decreased central memory CD8 positive, alpha-beta T cell number
MGI:4830698	Stat2<p117>	MP:0001841,decreased level of surface class I molecules|MP:0005042,abnormal level of surface class II molecules|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0008127,decreased dendritic cell number|MP:0031040,increased susceptibility to Picornaviridae infection induced morbidity/mortality
MGI:6156567	Stat2<tm1.1(STAT2)Diam>	MP:0020943,increased susceptibility to Flaviviridae infection|MP:0031044,increased susceptibility to Flaviviridae infection induced morbidity/mortality
MGI:2447829	Stat2<tm1Shnd>	MP:0002145,abnormal T cell differentiation|MP:0020913,increased susceptibility to Riboviria infection
MGI:1926814	Stat3<tm1Aki>	MP:0001683,absent mesoderm|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0008751,abnormal interleukin level|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012113,decreased inner cell mass proliferation
MGI:2673309	Stat3<tm1Desi>	MP:0008735,increased susceptibility to endotoxin shock
MGI:2384272	Stat3<tm1Dlv>	MP:0000322,increased granulocyte number|MP:0000494,abnormal cecum morphology|MP:0000495,abnormal colon morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001845,abnormal inflammatory response|MP:0002038,increased carcinoma incidence|MP:0002378,abnormal gut-associated lymphoid tissue morphology|MP:0002498,abnormal acute inflammation|MP:0002816,colitis|MP:0003269,colon polyps|MP:0005015,increased T cell number|MP:0005036,diarrhea|MP:0005391,vision/eye phenotype|MP:0005425,increased macrophage cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008566,increased interferon-gamma secretion|MP:0008682,decreased interleukin-17 secretion|MP:0010220,decreased T-helper 17 cell number|MP:0010279,increased gastrointestinal tumor incidence
MGI:3028651	Stat3<tm1Dnl>	MP:0002169,no abnormal phenotype detected
MGI:2451328	Stat3<tm1Flv>	MP:0000218,increased leukocyte cell number|MP:0000477,abnormal intestine morphology|MP:0000494,abnormal cecum morphology|MP:0000495,abnormal colon morphology|MP:0000512,intestinal ulcer|MP:0000599,enlarged liver|MP:0000746,weakness|MP:0001134,absent corpus luteum|MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0001258,decreased body length|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001433,polyphagia|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0001745,increased circulating corticosterone level|MP:0001777,abnormal body temperature homeostasis|MP:0001845,abnormal inflammatory response|MP:0001858,intestinal inflammation|MP:0001860,liver inflammation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002419,abnormal innate immunity|MP:0002500,granulomatous inflammation|MP:0002581,abnormal ileum morphology|MP:0002628,hepatic steatosis|MP:0002816,colitis|MP:0002970,abnormal white adipose tissue morphology|MP:0002971,abnormal brown adipose tissue morphology|MP:0003009,abnormal cytokine secretion|MP:0004890,decreased energy expenditure|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005465,abnormal T-helper 1 physiology|MP:0005534,decreased body temperature|MP:0005669,increased circulating leptin level|MP:0008553,increased circulating tumor necrosis factor level|MP:0008577,increased circulating interferon-gamma level|MP:0008735,increased susceptibility to endotoxin shock|MP:0008869,anovulation|MP:0009089,short uterine horn|MP:0009481,cecum inflammation|MP:0009482,ileum inflammation|MP:0010024,increased total body fat amount|MP:0011049,impaired adaptive thermogenesis|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011940,decreased food intake|MP:0020447,decreased NAD(P)H oxidase activity
MGI:3795149	Stat3<tm1Jbha>	MP:0000005,increased brown adipose tissue amount|MP:0001260,increased body weight|MP:0002981,increased liver weight|MP:0005458,increased percent body fat/body weight|MP:0006094,increased fat cell size|MP:0009285,increased gonadal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0010024,increased total body fat amount|MP:0030968,decreased circulating adiponectin level
MGI:2384507	Stat3<tm1Vpo>	MP:0000260,abnormal angiogenesis|MP:0000278,abnormal myocardial fiber morphology|MP:0001855,abnormal atrial thrombosis|MP:0002451,abnormal macrophage physiology|MP:0002753,dilated heart left ventricle|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0003674,oxidative stress|MP:0004499,increased incidence of tumors by chemical induction|MP:0004937,dilated heart|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0006138,congestive heart failure|MP:0008028,pregnancy-related premature death|MP:0008560,increased tumor necrosis factor secretion|MP:0008705,increased interleukin-6 secretion|MP:0011925,abnormal heart echocardiography feature|MP:0013807,generalized edema
MGI:3768531	Stat3<tm1Xyfu>	MP:0003141,cardiac fibrosis|MP:0008560,increased tumor necrosis factor secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:1926816	Stat3<tm2Aki>	MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000495,abnormal colon morphology|MP:0001194,dermatitis|MP:0001209,spontaneous skin ulceration|MP:0001216,abnormal epidermal layer morphology|MP:0001242,hyperkeratosis|MP:0001257,increased body length|MP:0001261,obese|MP:0001431,abnormal eating behavior|MP:0001792,impaired wound healing|MP:0001852,conjunctivitis|MP:0001861,lung inflammation|MP:0001874,acanthosis|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002092,abnormal eye morphology|MP:0002169,no abnormal phenotype detected|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0002314,abnormal respiratory mechanics|MP:0002816,colitis|MP:0004007,abnormal lung vasculature morphology|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004780,abnormal surfactant secretion|MP:0005025,abnormal response to infection|MP:0005095,decreased T cell proliferation|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0005425,increased macrophage cell number|MP:0005559,increased circulating glucose level|MP:0006042,increased apoptosis|MP:0006413,increased T cell apoptosis|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008126,increased dendritic cell number|MP:0008566,increased interferon-gamma secretion|MP:0008663,increased interleukin-12 secretion|MP:0008713,abnormal cytokine level|MP:0008858,abnormal hair cycle anagen phase|MP:0008880,lacrimal gland inflammation|MP:0009932,skin fibrosis|MP:0010768,mortality/aging|MP:0010811,decreased type II pneumocyte number|MP:0010858,pulmonary epithelial necrosis|MP:0010896,decreased lung compliance|MP:0010935,increased airway resistance|MP:0011018,pulmonary hyaline membrane formation|MP:0011044,increased lung elastance|MP:0011047,increased lung tissue damping|MP:0012194,decreased keratinocyte migration|MP:0014600,increased susceptibility to hyperoxia-induced injury
MGI:3040152	Stat3<tm2Vpo>	MP:0011089,perinatal lethality, complete penetrance
MGI:3040161	Stat3<tm3Vpo>	MP:0002451,abnormal macrophage physiology
MGI:4438059	Stat3<tm4Vpo>	MP:0011100,preweaning lethality, complete penetrance
MGI:6382409	Stat4<em1(IMPC)Mbp>	MP:0001304,cataract|MP:0001314,cornea opacity|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney
MGI:5578183	Stat4<ity14>	MP:0002412,increased susceptibility to bacterial infection|MP:0008567,decreased interferon-gamma secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0008617,increased circulating interleukin-12 level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:1857248	Stat4<tm1Gru>	MP:0000188,abnormal circulating glucose level|MP:0001845,abnormal inflammatory response|MP:0002136,abnormal kidney physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0003009,abnormal cytokine secretion|MP:0003564,abnormal insulin secretion|MP:0003945,abnormal lymphocyte physiology|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005094,abnormal T cell proliferation|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008567,decreased interferon-gamma secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0008600,decreased circulating interleukin-2 level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010766,abnormal NK cell physiology
MGI:2388732	Stat4<tm1Jni>	MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0008578,decreased circulating interferon-gamma level|MP:0008699,increased interleukin-4 secretion|MP:0010766,abnormal NK cell physiology
MGI:5437316	Stat5a<tm1.1Wjl>	MP:0002169,no abnormal phenotype detected
MGI:2181607	Stat5a<tm1Jni>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0001881,abnormal mammary gland physiology|MP:0005334,abnormal fat pad morphology
MGI:1857249	Stat5a<tm1Mam>	MP:0000336,decreased mast cell number|MP:0000359,abnormal mast cell morphology|MP:0000628,abnormal mammary gland development|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001168,abnormal prostate gland epithelium morphology|MP:0003607,abnormal prostate gland physiology|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005462,abnormal mast cell differentiation|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0006270,abnormal mammary gland growth during lactation|MP:0008045,decreased NK cell number|MP:0009339,decreased splenocyte number|MP:0009737,prostate gland cyst|MP:0010249,lactation failure
MGI:3055318	Stat5a<tm2Mam>	MP:0009114,decreased pancreatic beta cell mass|MP:0010070,decreased serotonin level|MP:0011820,decreased pancreatic beta cell proliferation
MGI:8204544	Stat5b<em1Mam>	MP:0000692,small spleen|MP:0005397,hematopoietic system phenotype|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0009339,decreased splenocyte number
MGI:8204545	Stat5b<em2Mam>	MP:0000691,enlarged spleen|MP:0001194,dermatitis|MP:0002006,neoplasm|MP:0004973,increased regulatory T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0009338,increased splenocyte number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number
MGI:2181592	Stat5b<tm1Hwd>	MP:0000416,sparse hair|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000609,abnormal liver physiology|MP:0000628,abnormal mammary gland development|MP:0000715,decreased thymocyte number|MP:0000717,abnormal lymphocyte cell number|MP:0001261,obese|MP:0001262,decreased body weight|MP:0002073,abnormal hair growth|MP:0002407,abnormal double-negative T cell morphology|MP:0002619,abnormal lymphocyte morphology|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005095,decreased T cell proliferation|MP:0005123,increased circulating growth hormone level|MP:0008045,decreased NK cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0009339,decreased splenocyte number|MP:0010025,decreased total body fat amount|MP:0011532,decreased urine major urinary protein level|MP:0013716,hypolactation|MP:0031434,increased miscarriage rate
MGI:2181609	Stat5b<tm1Jni>	MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0001881,abnormal mammary gland physiology|MP:0005334,abnormal fat pad morphology
MGI:3055319	Stat5b<tm1Mam>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000352,decreased cell proliferation|MP:0000662,abnormal branching of the mammary ductal tree|MP:0000691,enlarged spleen|MP:0001258,decreased body length|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001433,polyphagia|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001577,anemia|MP:0002079,increased circulating insulin level|MP:0002169,no abnormal phenotype detected|MP:0002415,abnormal neutrophil differentiation|MP:0002416,abnormal proerythroblast morphology|MP:0002463,abnormal neutrophil physiology|MP:0002498,abnormal acute inflammation|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003059,decreased insulin secretion|MP:0003838,abnormal milk ejection|MP:0003944,abnormal T cell subpopulation ratio|MP:0003960,increased lean body mass|MP:0003961,decreased lean body mass|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005016,decreased lymphocyte cell number|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005334,abnormal fat pad morphology|MP:0005458,increased percent body fat/body weight|MP:0005460,abnormal leukopoiesis|MP:0005559,increased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005669,increased circulating leptin level|MP:0006042,increased apoptosis|MP:0006270,abnormal mammary gland growth during lactation|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008388,hypochromic microcytic anemia|MP:0008614,increased circulating interleukin-17 level|MP:0008681,increased interleukin-17 secretion|MP:0008807,increased liver iron level|MP:0008810,increased circulating iron level|MP:0008908,increased total fat pad weight|MP:0008973,decreased erythroid progenitor cell number|MP:0009254,disorganized pancreatic islets|MP:0009506,abnormal mammary gland alveolus morphology|MP:0010024,increased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010249,lactation failure|MP:0011049,impaired adaptive thermogenesis|MP:0014126,increased mammary gland apoptosis
MGI:5437318	Stat5b<tm2.1Wjl>	MP:0002169,no abnormal phenotype detected
MGI:2386746	Stat6<tm1Aki>	MP:0001874,acanthosis|MP:0002492,decreased IgE level|MP:0002493,increased IgG level|MP:0002495,increased IgA level|MP:0004947,skin inflammation|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005466,abnormal T-helper 2 physiology|MP:0008091,decreased T-helper 2 cell number|MP:0008495,decreased IgG1 level
MGI:1888385	Stat6<tm1Gru>	MP:0000627,abnormal mammary gland morphology|MP:0001273,decreased metastatic potential|MP:0001573,abnormal circulating alanine transaminase level|MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002166,abnormal tumor susceptibility|MP:0002334,abnormal airway responsiveness|MP:0002442,abnormal leukocyte physiology|MP:0002451,abnormal macrophage physiology|MP:0002462,abnormal granulocyte physiology|MP:0002490,abnormal immunoglobulin level|MP:0002492,decreased IgE level|MP:0002498,abnormal acute inflammation|MP:0002703,abnormal renal tubule morphology|MP:0002723,abnormal immune serum protein physiology|MP:0003009,abnormal cytokine secretion|MP:0003156,abnormal leukocyte migration|MP:0003964,abnormal noradrenaline level|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005095,decreased T cell proliferation|MP:0005282,decreased fatty acids level|MP:0005370,liver/biliary system phenotype|MP:0005387,immune system phenotype|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008495,decreased IgG1 level|MP:0008498,decreased IgG3 level|MP:0008500,increased IgG2a level|MP:0008553,increased circulating tumor necrosis factor level|MP:0008566,increased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion|MP:0008588,abnormal circulating interleukin level|MP:0008601,abnormal circulating interleukin-4 level|MP:0008625,abnormal circulating interleukin-5 level|MP:0008687,increased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0008720,impaired neutrophil chemotaxis|MP:0008723,impaired eosinophil recruitment|MP:0008724,impaired eosinophil chemotaxis|MP:0009504,abnormal mammary gland epithelium morphology|MP:0010064,increased circulating creatine level|MP:0010174,decreased mammary gland epithelial cell proliferation|MP:0010942,abnormal respiratory epithelium morphology|MP:0011014,decreased core body temperature|MP:0020917,decreased susceptibility to Herpesvirales infection
MGI:2386745	Stat6<tm1Jni>	MP:0000359,abnormal mast cell morphology|MP:0001212,skin lesions|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002459,abnormal B cell physiology|MP:0002492,decreased IgE level|MP:0002497,increased IgE level|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0004816,abnormal class switch recombination|MP:0005027,increased susceptibility to parasitic infection|MP:0005042,abnormal level of surface class II molecules|MP:0005153,abnormal B cell proliferation|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008495,decreased IgG1 level|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008566,increased interferon-gamma secretion|MP:0008663,increased interleukin-12 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008782,increased B cell apoptosis
MGI:3814552	Stau1<tm1Apa>	MP:0001402,decreased locomotor activity|MP:0003631,nervous system phenotype|MP:0004998,decreased CNS synapse formation|MP:0005386,behavior/neurological phenotype|MP:0008143,abnormal dendrite morphology
MGI:6276995	Stau2<em1(IMPC)Mbp>	MP:0000220,increased monocyte cell number|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0005564,increased hemoglobin content
MGI:4128933	Stau2<Gt(RRG396)Byg>	MP:0001405,impaired coordination|MP:0002206,abnormal CNS synaptic transmission|MP:0002804,abnormal motor learning|MP:0004997,increased CNS synapse formation
MGI:4431690	Stau2<tm1a(EUCOMM)Wtsi>	MP:0001258,decreased body length|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5696885	Stbd1<tm1b(KOMP)Wtsi>	MP:0009142,decreased prepulse inhibition
MGI:6356543	Stbd1<tm1Bsn>	MP:0005376,homeostasis/metabolism phenotype
MGI:3626184	Stc1<tm1Rred>	MP:0002169,no abnormal phenotype detected
MGI:5285561	Stc2<tm1Gthi>	MP:0001260,increased body weight|MP:0005621,abnormal cell physiology|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0008943,increased sensitivity to induced cell death
MGI:3799310	Stc2<tm1Rred>	MP:0000202,abnormal circulating alkaline phosphatase level|MP:0001147,small testis|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0005389,reproductive system phenotype
MGI:5660779	Steap2<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0003795,abnormal bone structure
MGI:3758911	Steap3<fred>	MP:0000274,enlarged heart|MP:0000691,enlarged spleen|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002874,decreased hemoglobin content|MP:0003066,increased liver copper level|MP:0003656,abnormal erythrocyte physiology|MP:0005097,polychromatophilia|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005637,abnormal iron homeostasis|MP:0006349,decreased circulating copper level|MP:0008388,hypochromic microcytic anemia|MP:0008807,increased liver iron level|MP:0010175,leptocytosis
MGI:4398911	Steap3<tm1.1Atel>	MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000689,abnormal spleen morphology|MP:0002356,abnormal spleen red pulp morphology|MP:0002424,abnormal reticulocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002641,anisopoikilocytosis|MP:0002810,microcytic anemia|MP:0003131,increased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0004952,increased spleen weight|MP:0005505,thrombocytosis|MP:0005559,increased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008478,increased spleen white pulp amount|MP:0008546,abnormal vesicle-mediated transport|MP:0008996,abnormal blood osmolality|MP:0009341,decreased splenocyte apoptosis
MGI:3609928	Steap3<tm1.1Mdf>	MP:0000208,decreased hematocrit|MP:0002424,abnormal reticulocyte morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002641,anisopoikilocytosis|MP:0002874,decreased hemoglobin content|MP:0003131,increased erythrocyte cell number|MP:0005505,thrombocytosis|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005637,abnormal iron homeostasis|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008807,increased liver iron level
MGI:5644811	Steap3<tm1b(EUCOMM)Hmgu>	MP:0000208,decreased hematocrit|MP:0001399,hyperactivity|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0003131,increased erythrocyte cell number|MP:0005293,impaired glucose tolerance|MP:0005505,thrombocytosis|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:5438093	Steap4<tm1Dgen>	MP:0000180,abnormal circulating cholesterol level|MP:0001402,decreased locomotor activity|MP:0001552,increased circulating triglyceride level|MP:0002628,hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0002970,abnormal white adipose tissue morphology|MP:0002981,increased liver weight|MP:0003383,abnormal gluconeogenesis|MP:0003674,oxidative stress|MP:0005266,abnormal metabolism|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005425,increased macrophage cell number|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0009355,increased liver triglyceride level|MP:0010934,increased subcutaneous adipose tissue amount|MP:0030017,decreased adipocyte glucose uptake|MP:0030022,decreased muscle cell glucose uptake
MGI:3857257	Steep1<Gt(AW0613)Wtsi>	MP:0003984,embryonic growth retardation
MGI:4128982	Steep1<Gt(RRG250)Byg>	MP:0012132,abnormal midbrain-hindbrain boundary morphology|MP:0012138,decreased forebrain size
MGI:3612658	Stheal11<CAST/EiJ>	MP:0002724,enhanced wound healing
MGI:2176952	Stheal1<MRL/MpJ>	MP:0002724,enhanced wound healing
MGI:2176954	Stheal2<MRL/MpJ>	MP:0002724,enhanced wound healing
MGI:2176956	Stheal3<MRL/MpJ>	MP:0002724,enhanced wound healing
MGI:2176975	Stheal4<MRL/MpJ>	MP:0002724,enhanced wound healing
MGI:2176977	Stheal5<MRL/MpJ>	MP:0002724,enhanced wound healing
MGI:2176979	Stheal6<SJL/J>	MP:0002724,enhanced wound healing
MGI:2176981	Stheal7<MRL/MpJ>	MP:0002724,enhanced wound healing
MGI:2176983	Stheal8<MRL/MpJ>	MP:0002724,enhanced wound healing
MGI:2176985	Stheal9<MRL/MpJ>	MP:0002724,enhanced wound healing
MGI:2154343	Stia1<NOD/ShiLtDoi>	MP:0001846,increased inflammatory response
MGI:2154506	Stia2<C57BL/6J>	MP:0001846,increased inflammatory response
MGI:2152962	Stil<tm1Mku>	MP:0000926,absent floor plate|MP:0001648,abnormal apoptosis|MP:0001706,abnormal left-right axis patterning|MP:0002151,abnormal neural tube morphology|MP:0002621,delayed neural tube closure|MP:0003984,embryonic growth retardation|MP:0004712,notochord degeneration|MP:0005157,holoprosencephaly|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6276841	Stim1<em1(IMPC)Mbp>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001417,decreased exploration in new environment|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0005013,increased lymphocyte cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:4124094	Stim1<Gt(GST050)Byg>	MP:0005621,abnormal cell physiology
MGI:3800290	Stim1<Gt(RRS558)Byg>	MP:0001575,cyanosis|MP:0001732,postnatal growth retardation|MP:0004231,abnormal calcium ion homeostasis|MP:0004811,abnormal neuron physiology|MP:0005048,abnormal thrombosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005397,hematopoietic system phenotype|MP:0006298,abnormal platelet activation|MP:0009549,decreased platelet aggregation|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3764828	Stim1<Sax>	MP:0000228,abnormal thrombopoiesis|MP:0000691,enlarged spleen|MP:0001914,hemorrhage|MP:0002397,abnormal bone marrow morphology|MP:0003179,thrombocytopenia|MP:0005048,abnormal thrombosis|MP:0005387,immune system phenotype|MP:0005606,increased bleeding time|MP:0006298,abnormal platelet activation|MP:0008254,increased megakaryocyte cell number|MP:0008476,increased spleen red pulp amount|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance|MP:0011747,myelofibrosis
MGI:4821943	Stim1<tm1.1Kuro>	MP:0001953,respiratory failure|MP:0003009,abnormal cytokine secretion|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0008561,decreased tumor necrosis factor secretion|MP:0008568,abnormal interleukin secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008765,decreased mast cell degranulation|MP:0009703,decreased birth body size|MP:0011089,perinatal lethality, complete penetrance
MGI:7449270	Stim1<tm1.1Pg>	MP:0000274,enlarged heart|MP:0000691,enlarged spleen|MP:0000745,tremors|MP:0000751,myopathy|MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0002106,abnormal muscle physiology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003179,thrombocytopenia|MP:0003852,skeletal muscle necrosis|MP:0004174,abnormal spine curvature|MP:0005606,increased bleeding time|MP:0008045,decreased NK cell number|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009420,skeletal muscle endomysial fibrosis|MP:0009422,decreased gastrocnemius weight|MP:0009425,increased soleus weight|MP:0010053,decreased grip strength|MP:0010089,abnormal circulating creatine kinase level|MP:0010227,decreased quadriceps weight|MP:0010239,decreased skeletal muscle weight|MP:0013022,increased Ly6C high monocyte number|MP:0013026,decreased Ly6C low monocyte number
MGI:3778912	Stim1<tm1.1Rao>	MP:0001732,postnatal growth retardation|MP:0005621,abnormal cell physiology|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:5008476	Stim1<tm1Kuro>	MP:0005093,decreased B cell proliferation|MP:0008661,decreased interleukin-10 secretion|MP:0014469,abnormal B cell calcium ion homeostasis
MGI:3778911	Stim1<tm1Rao>	MP:0005013,increased lymphocyte cell number|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008688,decreased interleukin-2 secretion
MGI:7622053	Stim1<tm3Ics>	MP:0000195,decreased circulating calcium level|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000747,muscle weakness|MP:0000754,paresis|MP:0000759,abnormal skeletal muscle morphology|MP:0001245,thick dermal layer|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001566,increased circulating phosphate level|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002417,abnormal megakaryocyte morphology|MP:0002599,increased mean platelet volume|MP:0002941,increased circulating alanine transaminase level|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003157,impaired muscle relaxation|MP:0003179,thrombocytopenia|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0004233,abnormal muscle weight|MP:0004510,myositis|MP:0004952,increased spleen weight|MP:0004974,decreased regulatory T cell number|MP:0004991,decreased bone strength|MP:0005016,decreased lymphocyte cell number|MP:0005292,improved glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005386,behavior/neurological phenotype|MP:0005560,decreased circulating glucose level|MP:0005606,increased bleeding time|MP:0008040,decreased NK T cell number|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009419,skeletal muscle fibrosis|MP:0009422,decreased gastrocnemius weight|MP:0009425,increased soleus weight|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0010869,decreased bone trabecula number|MP:0010959,abnormal oxidative phosphorylation|MP:0011089,perinatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011585,decreased alkaline phosphatase activity|MP:0011629,decreased mitochondrial number|MP:0013621,decreased internal diameter of femur|MP:0013639,decreased bone stiffness|MP:0014143,decreased body fat mass|MP:0014292,decreased internal diameter of tibia|MP:0014652,increased skeletal muscle fiber mitochondrial size|MP:0020240,increased skeletal muscle cell apoptosis|MP:0020354,increased endoplasmic reticulum stress|MP:0031318,enhanced skeletal muscle regeneration|MP:0031402,decreased muscle fatigability
MGI:5634802	Stim2<tm1.1(KOMP)Vlcg>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0003960,increased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0006243,impaired pupillary reflex|MP:0009142,decreased prepulse inhibition
MGI:5008479	Stim2<tm1.1Kuro>	MP:0005387,immune system phenotype|MP:0014469,abnormal B cell calcium ion homeostasis
MGI:3778914	Stim2<tm1.1Rao>	MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0005621,abnormal cell physiology
MGI:4452038	Stim2<tm1Beni>	MP:0001463,abnormal spatial learning|MP:0002083,premature death|MP:0003204,decreased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology|MP:0005386,behavior/neurological phenotype|MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0010053,decreased grip strength
MGI:3778913	Stim2<tm1Rao>	MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion
MGI:5637076	Stimate<tm2b(KOMP)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level|MP:0010052,increased grip strength
MGI:6287305	Sting1<em1Jmin>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001209,spontaneous skin ulceration|MP:0001212,skin lesions|MP:0001861,lung inflammation|MP:0001954,respiratory distress|MP:0002494,increased IgM level|MP:0005367,renal/urinary system phenotype|MP:0008083,decreased single-positive T cell number|MP:0008553,increased circulating tumor necrosis factor level|MP:0008593,increased circulating interleukin-10 level|MP:0008608,increased circulating interleukin-13 level|MP:0008713,abnormal cytokine level|MP:0010334,pleural effusion|MP:0011091,prenatal lethality, complete penetrance|MP:0013663,increased myeloid cell number|MP:0031167,abnormal lung thrombosis
MGI:7641817	Sting1<em1Osb>	MP:0005389,reproductive system phenotype
MGI:4939597	Sting1<gt>	MP:0001800,abnormal humoral immune response|MP:0001819,abnormal immune cell physiology|MP:0001839,abnormal level of surface class I molecules|MP:0002376,abnormal dendritic cell physiology|MP:0002451,abnormal macrophage physiology|MP:0005025,abnormal response to infection|MP:0005040,abnormal MHC II cell surface expression on macrophages|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008558,abnormal interferon-beta secretion|MP:0008574,decreased circulating interferon-alpha level|MP:0008576,decreased circulating interferon-beta level|MP:0008769,abnormal plasmacytoid dendritic cell physiology|MP:0014234,decreased enterocyte apoptosis|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020934,increased susceptibility to Retroviridae infection|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:5708216	Sting1<tm1.1(KOMP)Mbp>	MP:0001926,female infertility
MGI:5301711	Sting1<tm1Camb>	MP:0005387,immune system phenotype|MP:0008576,decreased circulating interferon-beta level|MP:0008597,decreased circulating interleukin-6 level
MGI:3817418	Sting1<tm1Gnb>	MP:0002419,abnormal innate immunity|MP:0005025,abnormal response to infection|MP:0020913,increased susceptibility to Riboviria infection|MP:0020915,abnormal susceptibility to Herpesvirales infection
MGI:5527074	Stip1<tm1.1Mamp>	MP:0008762,embryonic lethality
MGI:5527075	Stip1<tm1.2Mamp>	MP:0002151,abnormal neural tube morphology|MP:0003076,increased susceptibility to ischemic brain injury|MP:0005088,increased acute inflammation|MP:0005650,abnormal limb bud morphology|MP:0006060,increased cerebral infarct size|MP:0008916,abnormal astrocyte physiology|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010038,abnormal placenta physiology|MP:0010948,abnormal double-strand DNA break repair|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0012556,increased cell death|MP:0013504,increased embryonic tissue cell apoptosis
MGI:7861238	Stk10<em1(IMPC)Ccpcz>	MP:0000220,increased monocyte cell number|MP:0000438,abnormal cranium morphology|MP:0000689,abnormal spleen morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002135,abnormal kidney morphology|MP:0002599,increased mean platelet volume|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0008528,polycystic kidney|MP:0010024,increased total body fat amount|MP:0010935,increased airway resistance
MGI:2386974	Stk10<tm1Hkar>	MP:0002444,abnormal T cell physiology
MGI:5755625	Stk11ip<em1(IMPC)J>	MP:0004486,decreased response of heart to induced stress|MP:0005385,cardiovascular system phenotype|MP:0010768,mortality/aging|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5578333	Stk11<tm1.1Arte>	MP:0002106,abnormal muscle physiology|MP:0002118,abnormal lipid homeostasis|MP:0005376,homeostasis/metabolism phenotype|MP:0005389,reproductive system phenotype|MP:0005621,abnormal cell physiology|MP:0010768,mortality/aging
MGI:5484538	Stk11<tm1.1Gne>	MP:0001176,abnormal lung development|MP:0010906,abnormal lung bud morphology|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2676546	Stk11<tm1.1Jish>	MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0002404,increased intestinal adenoma incidence|MP:0003299,gastric polyps|MP:0003984,embryonic growth retardation|MP:0010383,increased adenoma incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011732,decreased somite size
MGI:3612540	Stk11<tm1.1Mlfr>	MP:0000477,abnormal intestine morphology|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001270,distended abdomen|MP:0002083,premature death|MP:0003299,gastric polyps|MP:0003883,enlarged stomach|MP:0010306,increased hamartoma incidence|MP:0011092,embryonic lethality, complete penetrance|MP:0013328,visceromegaly
MGI:2387402	Stk11<tm1.1Rdp>	MP:0000063,decreased bone mineral density|MP:0000074,abnormal neurocranium morphology|MP:0000085,large anterior fontanelle|MP:0000088,short mandible|MP:0000102,abnormal nasal bone morphology|MP:0000104,abnormal sphenoid bone morphology|MP:0000188,abnormal circulating glucose level|MP:0000377,abnormal hair follicle morphology|MP:0000410,waved hair|MP:0000416,sparse hair|MP:0000422,delayed hair appearance|MP:0000428,abnormal craniofacial morphology|MP:0000445,short snout|MP:0000519,hydronephrosis|MP:0000538,abnormal urinary bladder morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0001190,reddish skin|MP:0001255,decreased body height|MP:0001265,decreased body size|MP:0001272,increased metastatic potential|MP:0001314,cornea opacity|MP:0001436,abnormal suckling behavior|MP:0001869,pancreas inflammation|MP:0002006,neoplasm|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002639,micrognathia|MP:0003270,intestinal obstruction|MP:0003303,peritoneal inflammation|MP:0003334,pancreas fibrosis|MP:0003339,decreased pancreatic beta cell number|MP:0003383,abnormal gluconeogenesis|MP:0003631,nervous system phenotype|MP:0003651,abnormal axon extension|MP:0003809,abnormal hair shaft morphology|MP:0004189,abnormal alveolar process morphology|MP:0004207,increased squamous cell carcinoma incidence|MP:0004247,small pancreas|MP:0004377,small frontal bone|MP:0004418,small parietal bone|MP:0004462,small basisphenoid bone|MP:0004540,small maxilla|MP:0004811,abnormal neuron physiology|MP:0004868,increased endometrial carcinoma incidence|MP:0004870,small premaxilla|MP:0004902,abnormal uterus size|MP:0004904,increased uterus weight|MP:0005044,sepsis|MP:0005215,abnormal pancreatic islet morphology|MP:0005220,abnormal exocrine pancreas morphology|MP:0005249,abnormal palatine bone morphology|MP:0005292,improved glucose tolerance|MP:0005352,small cranium|MP:0005376,homeostasis/metabolism phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0005559,increased circulating glucose level|MP:0006254,thin cerebral cortex|MP:0008256,abnormal myometrium morphology|MP:0009145,abnormal pancreatic acinus morphology|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009172,small pancreatic islets|MP:0009177,decreased pancreatic alpha cell number|MP:0009181,decreased pancreatic delta cell number|MP:0009552,urinary bladder obstruction|MP:0009890,cleft secondary palate|MP:0010029,abnormal basicranium morphology|MP:0010279,increased gastrointestinal tumor incidence|MP:0010352,gastrointestinal tract polyps|MP:0011087,neonatal lethality, complete penetrance|MP:0013220,increased pancreas apoptosis|MP:0014237,decreased tumor-free survival time|MP:0020040,decreased bone ossification|MP:0030121,small temporal bone squamous part|MP:0030266,small vomer bone|MP:0030383,small presphenoid bone
MGI:4440829	Stk11<tm1.1Sjm>	MP:0000221,decreased leukocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0001823,thymus hypoplasia|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0004024,aneuploidy|MP:0004809,increased hematopoietic stem cell number|MP:0004810,decreased hematopoietic stem cell number|MP:0005152,pancytopenia|MP:0005384,cellular phenotype|MP:0006038,increased mitochondrial fission|MP:0009278,abnormal bone marrow cell physiology|MP:0009760,abnormal mitotic spindle morphology
MGI:2387403	Stk11<tm1.2Rdp>	MP:0001622,abnormal vasculogenesis|MP:0001663,abnormal digestive system physiology|MP:0001712,abnormal placenta development|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0003077,abnormal cell cycle|MP:0003269,colon polyps|MP:0003270,intestinal obstruction|MP:0003299,gastric polyps|MP:0004499,increased incidence of tumors by chemical induction|MP:0004868,increased endometrial carcinoma incidence|MP:0005076,abnormal cell differentiation|MP:0005621,abnormal cell physiology|MP:0008011,intestine polyps|MP:0010279,increased gastrointestinal tumor incidence|MP:0010306,increased hamartoma incidence|MP:0010352,gastrointestinal tract polyps|MP:0011092,embryonic lethality, complete penetrance
MGI:3579498	Stk11<tm1Keis>	MP:0001925,male infertility|MP:0003299,gastric polyps|MP:0003383,abnormal gluconeogenesis|MP:0003631,nervous system phenotype|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005438,abnormal glycogen homeostasis|MP:0008593,increased circulating interleukin-10 level|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011942,decreased fluid intake|MP:0030022,decreased muscle cell glucose uptake
MGI:2180012	Stk11<tm1Mmt>	MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0003299,gastric polyps|MP:0003331,increased hepatocellular carcinoma incidence|MP:0010306,increased hamartoma incidence|MP:0011092,embryonic lethality, complete penetrance
MGI:2387401	Stk11<tm1Rdp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0002006,neoplasm|MP:0002216,abnormal seminiferous tubule morphology|MP:0002784,abnormal Sertoli cell morphology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0031407,increased Sertoli cell proliferation
MGI:2387003	Stk11<tm1Tpm>	MP:0001270,distended abdomen|MP:0001688,abnormal somite development|MP:0001700,abnormal embryo turning|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0002052,decreased tumor incidence|MP:0002083,premature death|MP:0002825,abnormal notochord morphology|MP:0002947,increased hemangioma incidence|MP:0003229,abnormal vitelline vasculature morphology|MP:0003270,intestinal obstruction|MP:0003299,gastric polyps|MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003720,abnormal neural tube closure|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004259,small placenta|MP:0004787,abnormal dorsal aorta morphology|MP:0004837,abnormal neural fold formation|MP:0004868,increased endometrial carcinoma incidence|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006342,absent first pharyngeal arch|MP:0008011,intestine polyps|MP:0008012,duodenum polyps|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009656,delayed chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011260,abnormal head mesenchyme morphology|MP:0013267,first pharyngeal arch hypoplasia|MP:0030975,placenta hemorrhage
MGI:5578334	Stk11<tm2.1Arte>	MP:0002169,no abnormal phenotype detected
MGI:2387005	Stk11<tm2.1Tpm>	MP:0001688,abnormal somite development|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0002825,abnormal notochord morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003720,abnormal neural tube closure|MP:0004180,failure of initiation of embryo turning|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004259,small placenta|MP:0004787,abnormal dorsal aorta morphology|MP:0004837,abnormal neural fold formation|MP:0005592,abnormal vascular smooth muscle morphology|MP:0006342,absent first pharyngeal arch|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009656,delayed chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011260,abnormal head mesenchyme morphology|MP:0013267,first pharyngeal arch hypoplasia|MP:0030975,placenta hemorrhage
MGI:5443938	Stk16<tm1.1(KOMP)Vlcg>	MP:0000955,abnormal spinal cord morphology|MP:0002833,increased heart weight|MP:0005564,increased hemoglobin content|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:3522011	Stk17b<tm1Hed>	MP:0003009,abnormal cytokine secretion|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005092,decreased double-positive T cell number|MP:0005348,increased T cell proliferation|MP:0008049,increased memory T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion
MGI:3856801	Stk24<Gt(AM0826)Wtsi>	MP:0002463,abnormal neutrophil physiology|MP:0004154,renal tubular necrosis|MP:0005065,abnormal neutrophil morphology|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005553,increased circulating creatinine level|MP:0010768,mortality/aging
MGI:5559695	Stk25<tm1.1Bwh>	MP:0006009,abnormal neuronal migration
MGI:5559696	Stk25<tm1.2Bwh>	MP:0003631,nervous system phenotype|MP:0010768,mortality/aging
MGI:6695865	Stk26<tm1.1Zzh>	MP:0004499,increased incidence of tumors by chemical induction
MGI:6159329	Stk26<tm1b(EUCOMM)Hmgu>	MP:0000223,decreased monocyte cell number|MP:0000639,abnormal adrenal gland morphology|MP:0000642,enlarged adrenal glands|MP:0000681,abnormal thyroid gland morphology|MP:0001944,abnormal pancreas morphology|MP:0002135,abnormal kidney morphology|MP:0003450,enlarged pancreas|MP:0004599,abnormal vertebral arch morphology|MP:0005355,enlarged thyroid gland|MP:0005554,decreased circulating creatinine level|MP:0008039,increased NK T cell number|MP:0008935,decreased mean platelet volume
MGI:7490341	Stk26<tm2.1Zzh>	MP:0003449,abnormal intestine goblet cell morphology|MP:0004499,increased incidence of tumors by chemical induction|MP:0004502,decreased incidence of tumors by chemical induction|MP:0008883,abnormal enterocyte proliferation|MP:0013486,decreased Paneth cell number|MP:0013958,decreased small intestine length
MGI:5629552	Stk31<tm1.2Jw>	MP:0005389,reproductive system phenotype
MGI:4841276	Stk31<tm2a(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5629553	Stk31<tm2Jw>	MP:0005389,reproductive system phenotype
MGI:7707448	Stk32a<em1Mdea>	MP:0002623,abnormal vestibular hair cell morphology|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0005386,behavior/neurological phenotype
MGI:5634294	Stk32c<tm2b(KOMP)Wtsi>	MP:0001513,limb grasping|MP:0005566,decreased blood urea nitrogen level|MP:0010025,decreased total body fat amount
MGI:6101177	Stk33<em1(IMPC)J>	MP:0001925,male infertility|MP:0003179,thrombocytopenia|MP:0013279,increased fasting circulating glucose level
MGI:6368790	Stk33<tm1.2Csll>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0008892,abnormal sperm flagellum morphology
MGI:5907864	Stk35<em1(IMPC)J>	MP:0001293,anophthalmia|MP:0001314,cornea opacity|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0001529,abnormal vocalization|MP:0002574,increased vertical activity|MP:0002941,increased circulating alanine transaminase level|MP:0003795,abnormal bone structure|MP:0005542,cornea vascularization|MP:0005562,decreased mean corpuscular hemoglobin
MGI:6257038	Stk35<tm1Kll>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001314,cornea opacity|MP:0001325,abnormal retina morphology|MP:0001935,decreased litter size|MP:0002085,abnormal embryonic tissue morphology|MP:0002092,abnormal eye morphology|MP:0002682,decreased mature ovarian follicle number|MP:0002784,abnormal Sertoli cell morphology|MP:0003099,retina detachment|MP:0004221,abnormal iridocorneal angle|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005193,abnormal anterior eye segment morphology|MP:0005261,aniridia|MP:0006200,vitreous body deposition|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011481,anterior iris synechia|MP:0011750,abnormal seminiferous tubule epithelium morphology
MGI:5605978	Stk36<em1(IMPC)J>	MP:0002959,increased urine microalbumin level|MP:0004122,abnormal sinus arrhythmia
MGI:3773685	Stk36<tm1.1Ptch>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3699625	Stk36<tm1Fjs>	MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000527,abnormal kidney development|MP:0001176,abnormal lung development|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001732,postnatal growth retardation|MP:0001867,rhinitis|MP:0001893,non-obstructive hydrocephaly|MP:0001925,male infertility|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0011085,postnatal lethality, complete penetrance
MGI:5429196	Stk36<tm1Lex>	MP:0000428,abnormal craniofacial morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001850,increased susceptibility to otitis media|MP:0001891,hydrocephaly|MP:0001926,female infertility|MP:0002083,premature death|MP:0005378,growth/size/body region phenotype
MGI:3773683	Stk36<tm1Ptch>	MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009234,absent sperm head|MP:0009280,decreased activated sperm motility|MP:0009376,abnormal manchette morphology|MP:0009836,abnormal sperm principal piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0010768,mortality/aging|MP:0020451,decreased sperm progressive motility|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0031386,elongated manchette
MGI:6356402	Stk38<em1Flca>	MP:0001325,abnormal retina morphology|MP:0005240,abnormal amacrine cell morphology|MP:0005253,abnormal eye physiology|MP:0005391,vision/eye phenotype|MP:0008515,thin retina outer nuclear layer|MP:0011996,abnormal retina inner nuclear layer thickness|MP:0030005,increased retina apoptosis
MGI:6356403	Stk38<em2Flca>	MP:0001325,abnormal retina morphology|MP:0005240,abnormal amacrine cell morphology|MP:0005253,abnormal eye physiology|MP:0005391,vision/eye phenotype|MP:0008515,thin retina outer nuclear layer|MP:0011996,abnormal retina inner nuclear layer thickness|MP:0030005,increased retina apoptosis
MGI:4340648	Stk38l<Gt(RRT116)Byg>	MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:6356401	Stk38l<tm1b(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0005240,abnormal amacrine cell morphology|MP:0005253,abnormal eye physiology|MP:0005391,vision/eye phenotype|MP:0030005,increased retina apoptosis
MGI:5635370	Stk38<tm1b(KOMP)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0002833,increased heart weight|MP:0004738,abnormal auditory brainstem response|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:5428694	Stk38<tm1Hem>	MP:0002024,increased T cell derived lymphoma incidence|MP:0002444,abnormal T cell physiology|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0004499,increased incidence of tumors by chemical induction|MP:0008944,decreased sensitivity to induced cell death|MP:0009542,decreased thymocyte apoptosis
MGI:5770366	Stk38<tm1Xen>	MP:0002412,increased susceptibility to bacterial infection|MP:0005165,increased susceptibility to injury|MP:0005387,immune system phenotype|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008596,increased circulating interleukin-6 level|MP:0008705,increased interleukin-6 secretion|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:3844885	Stk39<Rnl5>	MP:0002871,albuminuria
MGI:5462098	Stk39<tm1.1Arte>	MP:0002986,decreased urine calcium level|MP:0004119,hypokalemia|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005376,homeostasis/metabolism phenotype|MP:0005619,increased urine potassium level|MP:0006316,increased urine sodium level|MP:0010093,decreased circulating magnesium level
MGI:6423628	Stk39<tm1.1Pawe>	MP:0011091,prenatal lethality, complete penetrance
MGI:4838422	Stk39<tm1.2Slin>	MP:0001596,hypotension|MP:0002666,increased circulating aldosterone level|MP:0002986,decreased urine calcium level|MP:0005376,homeostasis/metabolism phenotype|MP:0005619,increased urine potassium level|MP:0005628,decreased circulating potassium level|MP:0006317,decreased urine sodium level|MP:0009642,abnormal blood homeostasis|MP:0010093,decreased circulating magnesium level|MP:0011435,increased urine magnesium level|MP:0011460,decreased urine chloride ion level
MGI:3851398	Stk39<tm1Dlp>	MP:0001921,reduced fertility|MP:0004811,abnormal neuron physiology
MGI:6423627	Stk39<tm1Pawe>	MP:0000208,decreased hematocrit|MP:0000231,hypertension|MP:0002136,abnormal kidney physiology|MP:0002608,increased hematocrit|MP:0003019,increased circulating chloride level|MP:0003028,alkalosis|MP:0003881,abnormal nephron morphology|MP:0004119,hypokalemia|MP:0004217,salt-sensitive hypertension|MP:0005565,increased blood urea nitrogen level|MP:0005566,decreased blood urea nitrogen level|MP:0005583,decreased renin activity|MP:0005618,decreased urine potassium level|MP:0012339,hyperkalemia|MP:0012551,metabolic acidosis
MGI:5770425	Stk39<tm2.1Arte>	MP:0002191,abnormal artery morphology|MP:0002986,decreased urine calcium level|MP:0003026,decreased vasoconstriction|MP:0003916,decreased heart left ventricle weight|MP:0004876,decreased mean systemic arterial blood pressure|MP:0004879,decreased systemic vascular resistance|MP:0005333,decreased heart rate|MP:0005367,renal/urinary system phenotype|MP:0005628,decreased circulating potassium level|MP:0006263,decreased systemic arterial diastolic blood pressure|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006316,increased urine sodium level|MP:0010093,decreased circulating magnesium level|MP:0011925,abnormal heart echocardiography feature
MGI:6149213	Stk3<em1(IMPC)H>	MP:0000745,tremors|MP:0001406,abnormal gait|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005553,increased circulating creatinine level
MGI:4410616	Stk3<tm1.1Jav>	MP:0005387,immune system phenotype|MP:0010299,increased mammary gland tumor incidence
MGI:4422170	Stk3<tm1.1Yy>	MP:0002169,no abnormal phenotype detected
MGI:4414809	Stk3<tm1Dlim>	MP:0002169,no abnormal phenotype detected
MGI:5496282	Stk40<tm1Nju>	MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001262,decreased body weight|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002276,abnormal lung interstitium morphology|MP:0003641,small lung|MP:0005631,decreased lung weight|MP:0010825,abnormal lung saccule morphology|MP:0010899,abnormal pulmonary alveolar system morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0030002,increased lung apoptosis|MP:0031006,increased lung glycogen level
MGI:3820519	Stk4<Gt(AJ0315)Wtsi>	MP:0002145,abnormal T cell differentiation|MP:0005348,increased T cell proliferation|MP:0006413,increased T cell apoptosis|MP:0008048,abnormal memory T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008479,decreased spleen white pulp amount|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0009321,increased histiocytic sarcoma incidence|MP:0010768,mortality/aging
MGI:6200285	Stk4<m1Btlr>	MP:0000219,increased neutrophil cell number|MP:0001800,abnormal humoral immune response|MP:0002491,decreased IgD level|MP:0002494,increased IgM level|MP:0002497,increased IgE level|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005425,increased macrophage cell number|MP:0008044,increased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number
MGI:5702919	Stk4<m1Mhda>	MP:0002169,no abnormal phenotype detected
MGI:6200290	Stk4<m2Btlr>	MP:0000219,increased neutrophil cell number|MP:0002491,decreased IgD level|MP:0002497,increased IgE level|MP:0004978,decreased B-1 B cell number|MP:0005018,decreased T cell number|MP:0005425,increased macrophage cell number|MP:0008044,increased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0008126,increased dendritic cell number|MP:0008169,increased B-1b cell number|MP:0008207,decreased B-2 B cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6200295	Stk4<m3Btlr>	MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number
MGI:6285558	Stk4<m4Btlr>	MP:0001805,decreased IgG level|MP:0002491,decreased IgD level|MP:0008126,increased dendritic cell number|MP:0008169,increased B-1b cell number|MP:0013649,decreased CD11b-high dendritic cell number|MP:0020154,impaired humoral immune response
MGI:6285636	Stk4<m5Btlr>	MP:0002145,abnormal T cell differentiation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number
MGI:3847089	Stk4<tm1.1Kina>	MP:0000708,thymus hyperplasia|MP:0002376,abnormal dendritic cell physiology|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002392,abnormal Peyer's patch T cell area morphology|MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0002722,abnormal immune system organ morphology|MP:0003156,abnormal leukocyte migration|MP:0003628,abnormal leukocyte adhesion|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005348,increased T cell proliferation|MP:0008082,increased single-positive T cell number|MP:0008122,decreased myeloid dendritic cell number|MP:0008180,abnormal marginal zone B cell morphology|MP:0008182,decreased marginal zone B cell number|MP:0008470,abnormal spleen B cell follicle morphology|MP:0014348,decreased spleen B cell follicle size
MGI:4422173	Stk4<tm1.1Yy>	MP:0002169,no abnormal phenotype detected
MGI:4358205	Stk4<tm1.2Wtao>	MP:0000714,increased thymocyte number|MP:0002444,abnormal T cell physiology|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number
MGI:4414818	Stk4<tm1Dlim>	MP:0002444,abnormal T cell physiology|MP:0005018,decreased T cell number
MGI:1857057	stm	MP:0000559,abnormal femur morphology|MP:0001731,abnormal postnatal growth|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002113,abnormal skeleton development|MP:0002657,chondrodystrophy|MP:0003109,short femur|MP:0003723,abnormal long bone morphology|MP:0004351,short humerus|MP:0004508,abnormal pectoral girdle bone morphology|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004592,small mandible|MP:0005296,abnormal humerus morphology
MGI:5780143	Stmb	MP:0001393,ataxia
MGI:2655259	Stmn1<tm1Wed>	MP:0000751,myopathy|MP:0000921,demyelination|MP:0002169,no abnormal phenotype detected|MP:0002183,gliosis|MP:0003632,abnormal nervous system morphology|MP:0004883,abnormal vascular wound healing|MP:0005403,abnormal nerve conduction|MP:0005405,axon degeneration|MP:0021002,brain lesion
MGI:6336136	Stmn2<em1(IMPC)Kmpc>	MP:0001399,hyperactivity|MP:0001404,no spontaneous movement|MP:0001491,unresponsive to tactile stimuli
MGI:7494069	Stmn2<em1Jmi>	MP:0000940,abnormal motor neuron innervation pattern|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001078,abnormal phrenic nerve morphology|MP:0001405,impaired coordination|MP:0001924,infertility|MP:0002882,abnormal neuron morphology|MP:0002946,delayed axon extension|MP:0003631,nervous system phenotype|MP:0004792,abnormal synaptic vesicle number|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential|MP:0005404,abnormal axon morphology|MP:0008415,abnormal neurite morphology|MP:0008571,abnormal synaptic bouton morphology|MP:0010053,decreased grip strength|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011633,abnormal mitochondrial shape|MP:0020850,abnormal microtubule cytoskeleton morphology|MP:0020955,increased mechanical nociceptive threshold
MGI:7494070	Stmn2<em2Jmi>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0002882,abnormal neuron morphology|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6295124	Stmn3<em1(IMPC)J>	MP:0002075,abnormal coat/hair pigmentation|MP:0005562,decreased mean corpuscular hemoglobin
MGI:5635383	Stmn4<tm1b(KOMP)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0005292,improved glucose tolerance
MGI:7327130	Stmp1<em1Eno>	MP:0001544,abnormal cardiovascular system physiology|MP:0005385,cardiovascular system phenotype|MP:0010955,abnormal respiratory electron transport chain
MGI:3695132	stn	MP:0000373,belly spot|MP:0000445,short snout|MP:0000449,broad nasal bridge|MP:0030066,short face
MGI:8234909	Stn1<em1Chwh>	MP:0004499,increased incidence of tumors by chemical induction|MP:0005621,abnormal cell physiology|MP:0008058,abnormal DNA repair|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0010639,abnormal tumor pathology|MP:0014040,increased cellular sensitivity to DNA damaging agent induced cell death|MP:0014755,increased tumor cell proliferation|MP:0014758,decreased tumor cell death|MP:0021086,decreased DNA replication
MGI:2157869	Stnn<C57BL/6J>	MP:0008947,increased neuron number
MGI:3029927	Stol<1Jrt>	MP:0000416,sparse hair|MP:0001297,microphthalmia|MP:0002074,abnormal hair texture|MP:0002075,abnormal coat/hair pigmentation|MP:0005382,craniofacial phenotype|MP:0005409,darkened coat color|MP:0006236,absent Meibomian glands
MGI:6266830	Stoml1<em1(IMPC)Tcp>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001325,abnormal retina morphology|MP:0001944,abnormal pancreas morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002092,abnormal eye morphology|MP:0008259,abnormal optic disk morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:4122966	Stoml1<Gt(M038E05)Wrst>	MP:0002272,abnormal nervous system electrophysiology|MP:0005386,behavior/neurological phenotype
MGI:5437980	Stoml2<tm1Jmad>	MP:0005387,immune system phenotype
MGI:4881090	Stoml2<tm1(KOMP)Vlcg>	MP:0001925,male infertility|MP:0002079,increased circulating insulin level|MP:0002590,increased mean corpuscular volume|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0009142,decreased prepulse inhibition
MGI:3699212	Stoml3<tm1Glwn>	MP:0002734,abnormal mechanical nociception|MP:0003477,abnormal nerve fiber response|MP:0005498,hyporesponsive to tactile stimuli
MGI:2182798	Stom<tm1Wcm>	MP:0005397,hematopoietic system phenotype
MGI:5788726	Ston1<tm1.1Tmar>	MP:0000358,abnormal cell morphology|MP:0008546,abnormal vesicle-mediated transport|MP:0011706,abnormal fibroblast migration|MP:0014697,abnormal fibroblast adhesion
MGI:5494671	Ston2<tm1Vha>	MP:0002574,increased vertical activity|MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0002919,enhanced paired-pulse facilitation|MP:0003461,abnormal response to novel object|MP:0003635,abnormal synaptic transmission|MP:0004770,abnormal synaptic vesicle recycling|MP:0004792,abnormal synaptic vesicle number|MP:0005386,behavior/neurological phenotype|MP:0031391,increased locomotor activity
MGI:7328383	Stox1<tm1Rkl>	MP:0001711,abnormal placenta morphology|MP:0003231,abnormal placenta vasculature|MP:0005376,homeostasis/metabolism phenotype|MP:0005380,embryo phenotype|MP:0008059,abnormal podocyte foot process morphology|MP:0009661,abnormal pregnancy|MP:0010038,abnormal placenta physiology|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0012045,increased susceptibility to hypertension
MGI:5661957	Stox2<tm2b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0002833,increased heart weight|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:6717360	Stpg3<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6156160	Stpg4<em1(IMPC)Rbrc>	MP:0003271,abnormal duodenum morphology|MP:0010067,increased red blood cell distribution width
MGI:6342882	Stpg4<em1Ogu>	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0008877,abnormal DNA methylation
MGI:6194651	Stpg4<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:1889616	Stpy	MP:0001262,decreased body weight|MP:0009659,striated fur|MP:0009674,decreased birth weight|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5085884	Stra6<Gt(OST353837)Lex>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0003961,decreased lean body mass
MGI:5548638	Stra6l<tm1b(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0001314,cornea opacity|MP:0002590,increased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002606,increased basophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005561,increased mean corpuscular hemoglobin|MP:0010067,increased red blood cell distribution width
MGI:5648728	Stra6<tm1.1Jvli>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001325,abnormal retina morphology|MP:0002001,blindness|MP:0002698,abnormal sclera morphology|MP:0003631,nervous system phenotype|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005098,abnormal optic choroid morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0006237,abnormal choroid vasculature morphology|MP:0008444,retina cone cell degeneration|MP:0008446,decreased retina cone cell number|MP:0008587,short photoreceptor outer segment|MP:0010192,abnormal retina melanin granule morphology|MP:0011232,abnormal vitamin A level|MP:0011233,abnormal vitamin A metabolism|MP:0011996,abnormal retina inner nuclear layer thickness|MP:0012029,abnormal electroretinogram waveform feature|MP:0014336,short retina rod cell outer segment
MGI:5648726	Stra6<tm1Jvli>	MP:0000438,abnormal cranium morphology|MP:0000439,enlarged cranium|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001891,hydrocephaly|MP:0011085,postnatal lethality, complete penetrance|MP:0012676,dilated brain ventricle
MGI:5587960	Stra6<tm1Jwu>	MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0011233,abnormal vitamin A metabolism
MGI:5490784	Stra6<tm1Nbg>	MP:0001297,microphthalmia|MP:0002891,increased insulin sensitivity|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0004185,abnormal adipocyte glucose uptake|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005292,improved glucose tolerance|MP:0005380,embryo phenotype|MP:0008446,decreased retina cone cell number|MP:0008469,abnormal protein level|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment|MP:0010711,persistent hyperplastic primary vitreous|MP:0010768,mortality/aging|MP:0011234,abnormal retinol level
MGI:6488119	Stra8<em4Keish>	MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis
MGI:3810145	Stra8<tm1.1Nbg>	MP:0001132,absent mature ovarian follicles|MP:0004805,absent oocytes|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis
MGI:3622304	Stra8<tm1Dcp>	MP:0005168,abnormal female meiosis
MGI:5561006	Stra8<tm1Ysa>	MP:0005168,abnormal female meiosis
MGI:6361219	Strada<em1(IMPC)Bay>	MP:0000111,cleft palate|MP:0003385,abnormal body wall morphology|MP:0009908,protruding tongue|MP:0011100,preweaning lethality, complete penetrance
MGI:6758261	Strada<em1Pbcr>	MP:0000120,malocclusion|MP:0000440,domed cranium|MP:0000745,tremors|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001436,abnormal suckling behavior|MP:0001923,reduced female fertility|MP:0004144,hypotonia|MP:0004831,long incisors|MP:0005238,increased brain size|MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype|MP:0006009,abnormal neuronal migration|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011380,enlarged brain ventricles|MP:0011723,ectopic neuron
MGI:6120773	Stradb<tm1b(KOMP)Wtsi>	MP:0002591,decreased mean corpuscular volume|MP:0004738,abnormal auditory brainstem response
MGI:6257855	Strap<em1Pkda>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:3526891	Strap<Gt(ROSA)71Sor>	MP:0000260,abnormal angiogenesis|MP:0000267,abnormal heart development|MP:0001688,abnormal somite development|MP:0001700,abnormal embryo turning|MP:0003720,abnormal neural tube closure|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6302759	Strbp<em1(IMPC)Hmgu>	MP:0001364,decreased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0001512,trunk curl|MP:0002599,increased mean platelet volume|MP:0002757,decreased vertical activity|MP:0003795,abnormal bone structure|MP:0004924,abnormal behavior|MP:0005419,decreased circulating serum albumin level|MP:0008805,decreased circulating amylase level|MP:0009142,decreased prepulse inhibition|MP:0010124,decreased bone mineral content|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake|MP:0020870,decreased thigmotaxis
MGI:3033751	Strbp<Gt(pGT1.8geo)8Pgr>	MP:0000904,abnormal superior colliculus morphology|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001380,decreased male mating frequency|MP:0001513,limb grasping|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011750,abnormal seminiferous tubule epithelium morphology
MGI:6414567	Strc<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance|MP:0020870,decreased thigmotaxis
MGI:3818633	Strc<tm1Ugds>	MP:0004412,abnormal cochlear microphonics|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004737,absent distortion product otoacoustic emissions|MP:0006325,impaired hearing|MP:0006335,abnormal hearing electrophysiology
MGI:1862024	Strg	MP:0001510,abnormal coat appearance|MP:0003849,greasy coat|MP:0009659,striated fur
MGI:6121067	Strip1<cin>	MP:0002231,abnormal primitive streak morphology|MP:0003984,embryonic growth retardation|MP:0011092,embryonic lethality, complete penetrance|MP:0012135,embryonic-extraembryonic boundary constriction|MP:0012173,short rostral-caudal axis
MGI:6121053	Strip1<tm1b(KOMP)Wtsi>	MP:0001680,abnormal mesoderm development|MP:0002231,abnormal primitive streak morphology|MP:0011708,decreased fibroblast cell migration|MP:0012173,short rostral-caudal axis
MGI:6341827	Strip2<em1(IMPC)Ccpcz>	MP:0001325,abnormal retina morphology|MP:0001944,abnormal pancreas morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0003450,enlarged pancreas
MGI:6755525	Strip2<tm1.2Tac>	MP:0003900,shortened QT interval|MP:0005140,decreased cardiac muscle contractility|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5774950	Strit1<em1Eno>	MP:0003157,impaired muscle relaxation
MGI:5468974	Strn3<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002574,increased vertical activity|MP:0004924,abnormal behavior|MP:0005560,decreased circulating glucose level|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013279,increased fasting circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:6317368	Strn4<tm1b(EUCOMM)Hmgu>	MP:0000062,increased bone mineral density|MP:0001325,abnormal retina morphology|MP:0001404,no spontaneous movement|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010097,abnormal retina blood vessel morphology|MP:0010123,increased bone mineral content|MP:0011965,decreased total retina thickness|MP:0020870,decreased thigmotaxis
MGI:4363225	Strn<tm1a(KOMP)Wtsi>	MP:0002666,increased circulating aldosterone level|MP:0002842,increased systemic arterial blood pressure|MP:0011092,embryonic lethality, complete penetrance
MGI:3688891	Strx2	MP:0001192,scaly skin|MP:0001200,thick skin|MP:0001265,decreased body size|MP:0009659,striated fur|MP:0011091,prenatal lethality, complete penetrance
MGI:3688904	Strx3	MP:0001192,scaly skin|MP:0009659,striated fur|MP:0011091,prenatal lethality, complete penetrance
MGI:3688909	Strx4	MP:0001192,scaly skin|MP:0009659,striated fur|MP:0011091,prenatal lethality, complete penetrance
MGI:6188000	Stt3b<em1(IMPC)J>	MP:0000266,abnormal heart morphology|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001787,pericardial edema|MP:0002884,abnormal pharyngeal arch morphology|MP:0002941,increased circulating alanine transaminase level|MP:0003984,embryonic growth retardation|MP:0005031,abnormal trophoblast layer morphology|MP:0005178,increased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0012270,cardiac edema|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:1857058	stu	MP:0000852,small cerebellum|MP:0000873,thin external granule cell layer|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0000890,thin cerebellar molecular layer|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0002082,postnatal lethality|MP:0002862,abnormal righting response|MP:0003631,nervous system phenotype|MP:0004097,abnormal cerebellar cortex morphology|MP:0004098,abnormal cerebellar granule cell morphology|MP:0006099,thin cerebellar granule layer|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008579,abnormal Purkinje cell differentiation|MP:0014330,abnormal Purkinje cell focal axonal swelling|MP:0014331,abnormal Purkinje cell mitochondrial morphology
MGI:5883530	Stub1<em1Schiz>	MP:0005619,increased urine potassium level|MP:0006316,increased urine sodium level|MP:0008055,increased urine osmolality|MP:0011459,increased urine chloride ion level|MP:0011466,increased urine urea nitrogen level|MP:0011470,increased urine creatinine level|MP:0011942,decreased fluid intake
MGI:3623901	Stub1<tm1Atak>	MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0004250,tau protein deposits|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2680005	Stub1<tm1Cpat>	MP:0000849,abnormal cerebellum morphology|MP:0000876,Purkinje cell degeneration|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0001413,abnormal response to new environment|MP:0001489,decreased startle reflex|MP:0001648,abnormal apoptosis|MP:0001823,thymus hypoplasia|MP:0001921,reduced fertility|MP:0003644,thymus atrophy|MP:0004087,abnormal muscle fiber morphology|MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0004852,decreased testis weight|MP:0005130,decreased follicle stimulating hormone level|MP:0005165,increased susceptibility to injury|MP:0005619,increased urine potassium level|MP:0005621,abnormal cell physiology|MP:0006316,increased urine sodium level|MP:0008055,increased urine osmolality|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009541,increased thymocyte apoptosis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011459,increased urine chloride ion level|MP:0011466,increased urine urea nitrogen level|MP:0011470,increased urine creatinine level|MP:0011942,decreased fluid intake|MP:0012307,impaired spatial learning
MGI:3528990	Stub1<tm1Lex>	MP:0001262,decreased body weight|MP:0002083,premature death
MGI:6316115	Stx11<em1(IMPC)Mbp>	MP:0002135,abnormal kidney morphology|MP:0002833,increased heart weight|MP:0002989,small kidney|MP:0005013,increased lymphocyte cell number|MP:0005565,increased blood urea nitrogen level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5476622	Stx11<tm1.2Ics>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0001263,weight loss|MP:0001505,hunched posture|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005152,pancytopenia|MP:0005202,lethargy|MP:0005343,increased circulating aspartate transaminase level|MP:0005534,decreased body temperature|MP:0008553,increased circulating tumor necrosis factor level|MP:0008577,increased circulating interferon-gamma level|MP:0008596,increased circulating interleukin-6 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008791,decreased NK cell degranulation|MP:0011971,increased circulating lactate dehydrogenase level|MP:0020913,increased susceptibility to Riboviria infection
MGI:5461477	Stx11<tm1Bupa>	MP:0002421,abnormal cell-mediated immunity|MP:0002463,abnormal neutrophil physiology|MP:0003009,abnormal cytokine secretion|MP:0003945,abnormal lymphocyte physiology|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion
MGI:5494475	Stx16<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0004924,abnormal behavior|MP:0005292,improved glucose tolerance|MP:0005344,increased circulating bilirubin level|MP:0005419,decreased circulating serum albumin level|MP:0005627,increased circulating potassium level|MP:0010123,increased bone mineral content|MP:0011396,abnormal sleep behavior|MP:0013279,increased fasting circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:3714383	Stx16<tm1Hju>	MP:0002169,no abnormal phenotype detected
MGI:7306965	Stx17<em1Gpt>	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0002972,abnormal cardiac muscle contractility|MP:0005378,growth/size/body region phenotype
MGI:5529067	Stx18<tm2b(KOMP)Wtsi>	MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5603918	Stx19<tm1.1(KOMP)Vlcg>	MP:0001510,abnormal coat appearance|MP:0003020,decreased circulating chloride level|MP:0005560,decreased circulating glucose level|MP:0013279,increased fasting circulating glucose level
MGI:3765939	Stx1a<tm1.1Sud>	MP:0002169,no abnormal phenotype detected
MGI:5636918	Stx1a<tm1b(EUCOMM)Hmgu>	MP:0010053,decreased grip strength|MP:0011965,decreased total retina thickness
MGI:3817409	Stx1a<tm1Gwz>	MP:0001262,decreased body weight|MP:0003984,embryonic growth retardation|MP:0004200,decreased fetal size|MP:0005386,behavior/neurological phenotype|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5563140	Stx1a<tm1Migar>	MP:0001364,decreased anxiety-related response|MP:0001900,impaired synaptic plasticity|MP:0002917,decreased synaptic depression|MP:0002919,enhanced paired-pulse facilitation|MP:0002923,increased post-tetanic potentiation|MP:0003360,abnormal depression-related behavior|MP:0003631,nervous system phenotype|MP:0004770,abnormal synaptic vesicle recycling|MP:0004792,abnormal synaptic vesicle number|MP:0004811,abnormal neuron physiology|MP:0008428,abnormal spatial working memory|MP:0009454,impaired contextual conditioning behavior|MP:0031391,increased locomotor activity
MGI:3629049	Stx1a<tm1Tfuj>	MP:0001360,abnormal social investigation|MP:0001454,abnormal cued conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0001488,increased startle reflex|MP:0001752,abnormal hypothalamus secretion|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003461,abnormal response to novel object|MP:0006299,abnormal latent inhibition of conditioning behavior|MP:0010069,increased serotonin level|MP:0010768,mortality/aging|MP:0014812,abnormal brain physiology
MGI:3809921	Stx1a<tm2.1Sud>	MP:0010768,mortality/aging
MGI:3804480	Stx1b<tm1.1Sud>	MP:0001393,ataxia|MP:0002064,seizures|MP:0002083,premature death|MP:0002206,abnormal CNS synaptic transmission|MP:0002910,abnormal excitatory postsynaptic currents|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004770,abnormal synaptic vesicle recycling|MP:0004811,abnormal neuron physiology|MP:0008504,abnormal adrenal chromaffin cell morphology
MGI:5605503	Stx1b<tm1Tmis>	MP:0001265,decreased body size|MP:0002206,abnormal CNS synaptic transmission|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0004008,abnormal GABA-mediated receptor currents|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004770,abnormal synaptic vesicle recycling|MP:0004792,abnormal synaptic vesicle number|MP:0004807,abnormal paired-pulse inhibition|MP:0009538,abnormal synapse morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0014711,decreased synaptic vesicle readily releasable pool size
MGI:3692880	Stx2<repro34>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0004910,decreased seminal vesicle weight|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0020550,multinucleated giant male germ cells
MGI:5694786	Stx2<tm1b(EUCOMM)Wtsi>	MP:0001304,cataract|MP:0001556,increased circulating HDL cholesterol level|MP:0001925,male infertility|MP:0002591,decreased mean corpuscular volume|MP:0003131,increased erythrocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:3526405	Stx2<tm1Dcru>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002981,increased liver weight|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005397,hematopoietic system phenotype|MP:0008108,abnormal small intestinal villus morphology|MP:0008539,decreased susceptibility to induced colitis|MP:0010157,abnormal small intestinal crypt cell proliferation|MP:0013955,increased colon length|MP:0013957,increased small intestine length|MP:0014052,increased male germ cell apoptosis|MP:0014081,branched small intestinal villi
MGI:6355363	Stx3<Gt(EUCE320f12)1.1Hmgu>	MP:0005387,immune system phenotype|MP:0008763,abnormal mast cell degranulation|MP:0008765,decreased mast cell degranulation|MP:0010768,mortality/aging
MGI:6355364	Stx3<Gt(EUCE320f12)1.2Hmgu>	MP:0005387,immune system phenotype|MP:0008763,abnormal mast cell degranulation|MP:0010768,mortality/aging|MP:0011091,prenatal lethality, complete penetrance
MGI:5529499	Stx3<tm1.1(KOMP)Vlcg>	MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3530844	Stx4a<Gt(OST177143)Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:6355365	Stx4a<tm1.1Radac>	MP:0005387,immune system phenotype|MP:0010768,mortality/aging
MGI:6355366	Stx4a<tm1.2Radac>	MP:0005387,immune system phenotype|MP:0010768,mortality/aging|MP:0011091,prenatal lethality, complete penetrance
MGI:2180164	Stx4a<tm1Jpes>	MP:0002079,increased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5445557	Stx4a<tm2Jpes>	MP:0005397,hematopoietic system phenotype
MGI:5692753	Stx5a<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0008259,abnormal optic disk morphology|MP:0010067,increased red blood cell distribution width|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness
MGI:6266827	Stx6<em1(IMPC)H>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0002098,abnormal vibrissa morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level
MGI:6148324	Stx7<em1(IMPC)Rbrc>	MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0001565,abnormal circulating phosphate level|MP:0012361,decreased large unstained cell number
MGI:4432376	Stx8<tm2a(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected|MP:0004647,decreased lumbar vertebrae number|MP:0005048,abnormal thrombosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology|MP:0009446,abnormal platelet dense granule physiology|MP:0009549,decreased platelet aggregation|MP:0010101,increased sacral vertebrae number
MGI:5645993	Stxbp1<tm1b(EUCOMM)Hmgu>	MP:0000208,decreased hematocrit|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002590,increased mean corpuscular volume|MP:0002797,increased thigmotaxis|MP:0005293,impaired glucose tolerance|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:5509149	Stxbp1<tm1Mver>	MP:0000880,decreased Purkinje cell number|MP:0001393,ataxia
MGI:2183278	Stxbp1<tm1Sud>	MP:0002229,neurodegeneration|MP:0003224,neuron degeneration|MP:0003631,nervous system phenotype|MP:0003635,abnormal synaptic transmission|MP:0005405,axon degeneration|MP:0005445,abnormal neurotransmitter secretion|MP:0011087,neonatal lethality, complete penetrance
MGI:5563406	Stxbp2<m1Anu>	MP:0000358,abnormal cell morphology
MGI:5443995	Stxbp2<tm1Bdic>	MP:0002133,abnormal respiratory system physiology|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0008765,decreased mast cell degranulation|MP:0011100,preweaning lethality, complete penetrance
MGI:3573931	Stxbp3<tm1Jpes>	MP:0001559,hyperglycemia|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3528591	Stxbp3<tm1Yt>	MP:0000788,abnormal cerebral cortex morphology|MP:0001698,decreased embryo size|MP:0009703,decreased birth body size|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4441932	Stxbp4<tm1a(EUCOMM)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0005566,decreased blood urea nitrogen level
MGI:6277010	Stxbp5<em1(IMPC)Hmgu>	MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0002135,abnormal kidney morphology|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:6191659	Stxbp5l<tm1.1Aljg>	MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001634,internal hemorrhage|MP:0002229,neurodegeneration|MP:0002914,abnormal endplate potential|MP:0002920,decreased paired-pulse facilitation|MP:0003717,pallor|MP:0004836,abnormal synaptic acetylcholine release|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012359,increased partial thromboplastin time
MGI:5695954	Stxbp5l<tm1.1(KOMP)Vlcg>	MP:0000367,abnormal coat/ hair morphology|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0002968,increased circulating alkaline phosphatase level|MP:0004924,abnormal behavior|MP:0010123,increased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:3814545	Stxbp5<tm1Ytk>	MP:0002207,abnormal long-term potentiation|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002919,enhanced paired-pulse facilitation|MP:0008770,decreased survivor rate|MP:0011091,prenatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:1857059	sty	MP:0000706,small thymus
MGI:5428590	Styk1<tm1e(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:6467474	Styk1<tm1Twa>	MP:0005387,immune system phenotype
MGI:5905733	Styxl1<em1(IMPC)J>	MP:0001925,male infertility
MGI:7703715	Styxl1<em1Xjg>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009238,coiled sperm flagellum|MP:0009376,abnormal manchette morphology|MP:0009837,abnormal sperm end piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0020451,decreased sperm progressive motility|MP:0031352,absent sperm axonemal central pair|MP:0031356,abnormal outer dense fiber morphology|MP:0031386,elongated manchette
MGI:7703729	Styxl1<em2Xjg>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009238,coiled sperm flagellum|MP:0020451,decreased sperm progressive motility
MGI:6158499	Styxl2<em1(IMPC)Mbp>	MP:0002339,abnormal lymph node morphology
MGI:7736257	Styxl2<tm1.1Nju>	MP:0002192,hydrops fetalis|MP:0004090,abnormal sarcomere morphology|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:7736256	Styxl2<tm1Nju>	MP:0000759,abnormal skeletal muscle morphology|MP:0001575,cyanosis|MP:0002841,impaired skeletal muscle contractility|MP:0004090,abnormal sarcomere morphology|MP:0005369,muscle phenotype|MP:0010819,primary atelectasis|MP:0011087,neonatal lethality, complete penetrance|MP:0013239,impaired skeletal muscle regeneration
MGI:2179184	Styx<tm1.1Jedi>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002208,abnormal germ cell morphology|MP:0002675,asthenozoospermia
MGI:2179177	Styx<tm1Jedi>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0005578,teratozoospermia|MP:0014633,decreased spermatid number
MGI:3529683	Stzid2<NOD>	MP:0002078,abnormal glucose homeostasis
MGI:3528284	Stzid3<NSY>	MP:0001263,weight loss|MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level
MGI:3529681	Stzid<NOD>	MP:0002078,abnormal glucose homeostasis
MGI:6108891	Sub1<tm1.2Ics>	MP:0002080,prenatal lethality|MP:0004179,transmission ratio distortion
MGI:3950803	Sucla2<Gt(IST10208H1)Tigm>	MP:0002080,prenatal lethality|MP:0003979,increased circulating carnitine level|MP:0005384,cellular phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0010959,abnormal oxidative phosphorylation|MP:0011639,decreased mitochondrial DNA content|MP:0014388,decreased hepatocyte mitochondrial DNA content|MP:0014390,decreased myocardial fiber mitochondrial DNA content
MGI:5585619	Sucla2<Gt(SAbetageo)1Bhg>	MP:0001711,abnormal placenta morphology|MP:0004200,decreased fetal size|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0011089,perinatal lethality, complete penetrance|MP:0011639,decreased mitochondrial DNA content|MP:0030937,increased mitochondrial DNA content
MGI:6257584	Suclg1<em2(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6152653	Suclg2<em1(IMPC)Mbp>	MP:0002092,abnormal eye morphology
MGI:3923833	Suclg2<Gt(Ayu21-KBW131)Imeg>	MP:0002080,prenatal lethality|MP:0006036,abnormal mitochondrial physiology
MGI:3828087	Sucnr1<tm1Dgen>	MP:0001828,abnormal T cell activation|MP:0002376,abnormal dendritic cell physiology|MP:0004751,increased length of allograft survival|MP:0005095,decreased T cell proliferation|MP:0005362,abnormal Langerhans cell physiology|MP:0008686,abnormal interleukin-2 secretion
MGI:3528754	Sucnr1<tm1Lex>	MP:0002136,abnormal kidney physiology|MP:0003353,decreased circulating renin level
MGI:7426006	Suco<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:4123936	Suco<Gt(KST050)Byg>	MP:0000060,delayed bone ossification|MP:0000061,fragile skeleton|MP:0000074,abnormal neurocranium morphology|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000189,hypoglycemia|MP:0000438,abnormal cranium morphology|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001523,impaired righting response|MP:0001533,abnormal skeleton physiology|MP:0001541,abnormal osteoclast physiology|MP:0001634,internal hemorrhage|MP:0001732,postnatal growth retardation|MP:0001954,respiratory distress|MP:0002113,abnormal skeleton development|MP:0002932,abnormal joint morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0002998,abnormal bone remodeling|MP:0002999,abnormal bone healing|MP:0003419,delayed endochondral bone ossification|MP:0003420,delayed intramembranous bone ossification|MP:0003723,abnormal long bone morphology|MP:0003797,abnormal compact bone morphology|MP:0004016,decreased bone mass|MP:0004200,decreased fetal size|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004985,decreased osteoclast cell number|MP:0004986,abnormal osteoblast morphology|MP:0005006,abnormal osteoblast physiology|MP:0005325,abnormal renal glomerulus morphology|MP:0006054,spinal hemorrhage|MP:0008271,abnormal bone ossification|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010933,decreased trabecular bone connectivity density|MP:0011085,postnatal lethality, complete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011642,abnormal bone collagen fibril morphology|MP:0011711,impaired osteoblast differentiation|MP:0030029,wide cranial sutures|MP:0030279,thin neurocranium|MP:0030441,increased osteoblast apoptosis|MP:0030482,increased osteocyte number|MP:0030985,decreased circulating osteocalcin level
MGI:3698418	Suds3<tm1.1Rdp>	MP:0002169,no abnormal phenotype detected|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3698417	Suds3<tm1Rdp>	MP:0003077,abnormal cell cycle|MP:0003702,abnormal chromosome morphology|MP:0004024,aneuploidy|MP:0004025,polyploidy
MGI:5313712	Sufu<b2b273Clo>	MP:0000111,cleft palate|MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0000433,microcephaly|MP:0002639,micrognathia|MP:0004111,abnormal coronary artery morphology|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010476,coronary fistula|MP:0011495,abnormal head shape
MGI:3759455	Sufu<Gt(XB699)Byg>	MP:0000266,abnormal heart morphology|MP:0003720,abnormal neural tube closure|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5770710	Sufu<rgsc2062>	MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002109,abnormal limb morphology|MP:0003641,small lung|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5770712	Sufu<rgsc2075>	MP:0000914,exencephaly|MP:0004180,failure of initiation of embryo turning|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4461193	Sufu<tm1.1Blnw>	MP:0002151,abnormal neural tube morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3512046	Sufu<tm1Aeb>	MP:0000929,open neural tube|MP:0001688,abnormal somite development|MP:0001701,incomplete embryo turning|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0001706,abnormal left-right axis patterning|MP:0001915,intracranial hemorrhage|MP:0002084,abnormal developmental patterning|MP:0002169,no abnormal phenotype detected|MP:0003984,embryonic growth retardation|MP:0004066,abnormal primitive node morphology|MP:0004252,abnormal direction of heart looping|MP:0005329,abnormal myocardium layer morphology|MP:0010473,descending aorta dilation|MP:0010479,brain aneurysm|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5569947	Sufu<tm1b(KOMP)Wtsi>	MP:0000470,abnormal stomach morphology|MP:0000603,pale liver|MP:0000702,enlarged lymph nodes|MP:0001488,increased startle reflex|MP:0001697,abnormal embryo size|MP:0001722,pale yolk sac|MP:0002092,abnormal eye morphology|MP:0003232,abnormal forebrain development|MP:0003717,pallor|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0004258,abnormal placenta size|MP:0004848,abnormal liver size|MP:0005385,cardiovascular system phenotype|MP:0005650,abnormal limb bud morphology|MP:0006108,abnormal hindbrain development|MP:0010025,decreased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4840420	Sufu<tm1Hui>	MP:0001783,decreased white adipose tissue amount|MP:0002970,abnormal white adipose tissue morphology|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005670,abnormal white adipose tissue physiology|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009117,abnormal white fat cell morphology|MP:0009131,decreased white fat cell number|MP:0009133,decreased white fat cell size
MGI:3619046	Sufu<tm1Rto>	MP:0000414,alopecia|MP:0000925,abnormal floor plate morphology|MP:0000929,open neural tube|MP:0001231,abnormal epidermis stratum basale morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002151,abnormal neural tube morphology|MP:0003232,abnormal forebrain development|MP:0003864,abnormal midbrain development|MP:0006108,abnormal hindbrain development|MP:0009931,abnormal skin appearance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6456759	Sugct<tm1.2Kald>	MP:0001260,increased body weight|MP:0001859,kidney inflammation|MP:0002135,abnormal kidney morphology|MP:0002136,abnormal kidney physiology|MP:0002628,hepatic steatosis|MP:0002705,dilated renal tubule|MP:0003014,abnormal kidney medulla morphology|MP:0003675,kidney cyst|MP:0005425,increased macrophage cell number|MP:0009115,abnormal fat cell morphology|MP:0009640,abnormal renal tubule epithelium morphology|MP:0010377,abnormal gut flora balance|MP:0010999,proteinosis|MP:0013245,abnormal lipid metabolism|MP:0031602,white adipose tissue inflammation
MGI:6152654	Sugp1<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001126,abnormal ovary morphology|MP:0001399,hyperactivity|MP:0001404,no spontaneous movement|MP:0001785,edema|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0003068,enlarged kidney|MP:0003984,embryonic growth retardation|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation|MP:0020420,abnormal freezing behavior
MGI:4332293	Sugt1<Gt(RRS405)Byg>	MP:0013292,embryonic lethality prior to organogenesis
MGI:5582433	Sugt1<tm1b(KOMP)Wtsi>	MP:0001258,decreased body length|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5780862	sule	MP:0001265,decreased body size|MP:0001406,abnormal gait
MGI:3769469	Sulf1<Gt(OST352220)Lex>	MP:0002411,decreased susceptibility to bacterial infection
MGI:3774126	Sulf1<Gt(XM190)Byg>	MP:0004321,short sternum|MP:0004687,split vertebrae|MP:0010082,sternebra fusion
MGI:3722945	Sulf1<tm1.1Cpe>	MP:0002169,no abnormal phenotype detected
MGI:6160170	Sulf1<tm1b(KOMP)Mbp>	MP:0002753,dilated heart left ventricle|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0011951,increased cardiac stroke volume
MGI:3699620	Sulf1<tm1Clrm>	MP:0002083,premature death|MP:0011703,increased fibroblast proliferation
MGI:5318489	Sulf1<tm1Mmas>	MP:0000358,abnormal cell morphology
MGI:6367980	Sulf2<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001126,abnormal ovary morphology|MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0002060,abnormal skin morphology|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3769472	Sulf2<Gt(OST311938)Lex>	MP:0001262,decreased body weight|MP:0002989,small kidney
MGI:3587954	Sulf2<Gt(PST111)Byg>	MP:0004622,sacral vertebral fusion|MP:0010082,sternebra fusion
MGI:3697687	Sulf2<Gt(XST155)Byg>	MP:0001176,abnormal lung development|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001698,decreased embryo size|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001954,respiratory distress|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3722946	Sulf2<tm1.1Cpe>	MP:0001262,decreased body weight|MP:0004545,enlarged esophagus
MGI:3699621	Sulf2<tm1Clrm>	MP:0001262,decreased body weight|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0011703,increased fibroblast proliferation
MGI:5318490	Sulf2<tm1Mmas>	MP:0000358,abnormal cell morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:7426007	Sult1a1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000627,abnormal mammary gland morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0000759,abnormal skeletal muscle morphology|MP:0001146,abnormal testis morphology|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology|MP:0005084,abnormal gallbladder morphology|MP:0009342,enlarged gallbladder|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5581616	Sult1a1<tm1Glatt>	MP:0000609,abnormal liver physiology|MP:0005621,abnormal cell physiology|MP:0009642,abnormal blood homeostasis
MGI:5636889	Sult1c1<tm1b(KOMP)Wtsi>	MP:0005565,increased blood urea nitrogen level
MGI:5614773	Sult1d1<tm1Glatt>	MP:0005621,abnormal cell physiology|MP:0009642,abnormal blood homeostasis
MGI:3529586	Sult1e1<tm1Song>	MP:0001146,abnormal testis morphology|MP:0001152,increased Leydig cell number|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002674,abnormal sperm motility|MP:0002786,abnormal Leydig cell morphology|MP:0004852,decreased testis weight|MP:0004909,increased seminal vesicle weight|MP:0004929,decreased epididymis weight|MP:0005182,increased circulating estradiol level|MP:0005464,abnormal platelet physiology|MP:0012172,abnormal amniotic fluid composition|MP:0013598,Leydig cell hypertrophy|MP:0020407,abnormal placental thrombosis
MGI:6314734	Sult2a8<em1(IMPC)Hmgu>	MP:0001257,increased body length|MP:0002110,abnormal digit morphology
MGI:5432568	Sult2b1<tm1Rus>	MP:0003947,abnormal cholesterol level
MGI:6370020	Sult4a1<em1Uab>	MP:0000745,tremors|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0003216,absence seizures
MGI:6370021	Sult4a1<em2Uab>	MP:0000745,tremors|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0003216,absence seizures
MGI:3707232	Sumf1<Gt(RST760)Byg>	MP:0000131,abnormal long bone epiphysis morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000136,abnormal microglial cell morphology|MP:0000160,kyphosis|MP:0000428,abnormal craniofacial morphology|MP:0000547,short limbs|MP:0000745,tremors|MP:0000880,decreased Purkinje cell number|MP:0001265,decreased body size|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology|MP:0002446,abnormal macrophage morphology|MP:0002932,abnormal joint morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003203,increased neuron apoptosis|MP:0003887,increased hepatocyte apoptosis|MP:0004097,abnormal cerebellar cortex morphology|MP:0004686,decreased length of long bones|MP:0005425,increased macrophage cell number|MP:0006082,CNS inflammation|MP:0008525,decreased cranium height|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5708195	Sumf1<tm1b(KOMP)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3664241	Sumo1<Gt(RRQ016)Byg>	MP:0002169,no abnormal phenotype detected|MP:0008799,oblique facial cleft|MP:0009890,cleft secondary palate|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3819343	Sumo1<Gt(XA024)Byg>	MP:0002169,no abnormal phenotype detected|MP:0008886,abnormal PML bodies
MGI:5476974	Sumo1<tm1.1Bros>	MP:0002169,no abnormal phenotype detected
MGI:5708184	Sumo1<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001175,abnormal lung morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3810735	Sumo1<tm1Oaj>	MP:0002169,no abnormal phenotype detected
MGI:5641883	Sumo2<tm1Weiy>	MP:0000352,decreased cell proliferation|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002169,no abnormal phenotype detected|MP:0003794,delayed somite formation|MP:0003984,embryonic growth retardation|MP:0005030,absent amnion|MP:0006042,increased apoptosis|MP:0006323,abnormal extraembryonic mesoderm development|MP:0009656,delayed chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012082,delayed heart development
MGI:5641884	Sumo3<tm1Weiy>	MP:0002169,no abnormal phenotype detected
MGI:6362937	Sun1<em1Leim>	MP:0030024,abnormal meiotic attachment of telomere to nuclear envelope
MGI:3838368	Sun1<tm1.1Ktj>	MP:0000852,small cerebellum|MP:0000854,abnormal cerebellum development|MP:0000857,abnormal cerebellar foliation|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0000885,ectopic Purkinje cell|MP:0001147,small testis|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002175,decreased brain weight|MP:0002777,absent ovarian follicles|MP:0004805,absent oocytes|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis|MP:0009268,absent cerebellum fissure|MP:0010008,abnormal Purkinje cell migration
MGI:5793071	Sun1<tm1b(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0001102,small superior vagus ganglion|MP:0001147,small testis|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0001566,increased circulating phosphate level|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002626,increased heart rate|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003961,decreased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005013,increased lymphocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0011965,decreased total retina thickness
MGI:3715140	Sun1<tm1Mhan>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002108,abnormal muscle morphology|MP:0002777,absent ovarian follicles|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004805,absent oocytes|MP:0004901,decreased male germ cell number|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0006358,absent pinna reflex|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0009451,abnormal chromosomal synapsis|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013507,increased ovary apoptosis|MP:0013601,increased testis apoptosis|MP:0030024,abnormal meiotic attachment of telomere to nuclear envelope
MGI:5698817	Sun2<tm1.1Cyh>	MP:0002169,no abnormal phenotype detected
MGI:5637145	Sun2<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment|MP:0003961,decreased lean body mass|MP:0012362,increased large unstained cell number
MGI:3850087	Sun2<tm1Mhan>	MP:0002169,no abnormal phenotype detected|MP:0005377,hearing/vestibular/ear phenotype|MP:0005389,reproductive system phenotype
MGI:7435743	Sun3<em1(IMPC)J>	MP:0000194,increased circulating calcium level|MP:0001925,male infertility
MGI:6693648	Sun3<em1Qsh>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0009376,abnormal manchette morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0014052,increased male germ cell apoptosis
MGI:6158492	Sun5<em1(IMPC)Mbp>	MP:0000195,decreased circulating calcium level|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001146,abnormal testis morphology|MP:0001925,male infertility|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0003179,thrombocytopenia|MP:0003233,prolonged QT interval
MGI:6356352	Sun5<em1Wli>	MP:0001925,male infertility|MP:0002686,globozoospermia|MP:0004182,abnormal spermiation|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0009230,abnormal sperm head morphology|MP:0009234,absent sperm head|MP:0009830,abnormal sperm connecting piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0010768,mortality/aging
MGI:6336137	Suox<em1(IMPC)Kmpc>	MP:0001404,no spontaneous movement
MGI:7620382	Supt16<em1Hguo>	MP:0001458,abnormal object recognition memory|MP:0002272,abnormal nervous system electrophysiology|MP:0002797,increased thigmotaxis|MP:0008143,abnormal dendrite morphology|MP:0008414,abnormal spatial reference memory|MP:0008948,decreased neuron number|MP:0011092,embryonic lethality, complete penetrance|MP:0012204,abnormal neuronal stem cell physiology|MP:0012207,decreased neuronal stem cell self-renewal|MP:0012307,impaired spatial learning|MP:0014416,decreased social novelty preference|MP:0020508,decreased dendritic spine density|MP:0020511,decreased dendritic spine length|MP:0021018,decreased dendritic spine number|MP:0021111,decreased social investigation
MGI:3618352	Supt20<drey>	MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001680,abnormal mesoderm development|MP:0001688,abnormal somite development|MP:0001726,abnormal allantois morphology|MP:0002174,abnormal gastrulation movements|MP:0003054,spina bifida|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0004180,failure of initiation of embryo turning|MP:0005201,abnormal retina pigment epithelium morphology|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3699954	Supt20<Gt(RRK304)Byg>	MP:0000914,exencephaly|MP:0001680,abnormal mesoderm development|MP:0001689,incomplete somite formation|MP:0001718,abnormal visceral yolk sac morphology|MP:0001726,abnormal allantois morphology|MP:0002084,abnormal developmental patterning|MP:0002231,abnormal primitive streak morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0005224,abnormal left-right axis symmetry of the somites|MP:0008029,abnormal paraxial mesoderm morphology|MP:0009657,failure of chorioallantoic fusion|MP:0011257,abnormal head fold morphology|MP:0013241,embryo tissue necrosis
MGI:4435781	Supt3<tm1a(EUCOMM)Hmgu>	MP:0001711,abnormal placenta morphology|MP:0002836,abnormal chorion morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:5605739	Supt4a<tm1b(EUCOMM)Hmgu>	MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5763055	Supt4a<tm1Yty>	MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4840996	Supt5<tm2a(KOMP)Wtsi>	MP:0003036,vertebral transformation|MP:0011100,preweaning lethality, complete penetrance
MGI:5696412	Supt6<Gt(fVET5A)Hiir>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4432224	Supt7l<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0002074,abnormal hair texture|MP:0002966,decreased circulating alkaline phosphatase level|MP:0010025,decreased total body fat amount
MGI:4434293	Supv3l1<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:3818518	Supv3l1<tm1Jkl>	MP:0001672,abnormal embryo development|MP:0003935,abnormal craniofacial development|MP:0004179,transmission ratio distortion|MP:0008770,decreased survivor rate|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5469429	Supv3l1<tm1Whle>	MP:0001694,absent egg cylinders|MP:0001698,decreased embryo size|MP:0003718,maternal effect|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011105,embryonic lethality between implantation and placentation, incomplete penetrance
MGI:3833741	Supv3l1<tm2.1Jkl>	MP:0002169,no abnormal phenotype detected
MGI:3833742	Supv3l1<tm2.2Jkl>	MP:0011091,prenatal lethality, complete penetrance
MGI:3833743	Supv3l1<tm2.3Jkl>	MP:0011091,prenatal lethality, complete penetrance
MGI:3833740	Supv3l1<tm2Jkl>	MP:0000160,kyphosis|MP:0000367,abnormal coat/ hair morphology|MP:0000379,decreased hair follicle number|MP:0000414,alopecia|MP:0000752,dystrophic muscle|MP:0001190,reddish skin|MP:0001192,scaly skin|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0001262,decreased body weight|MP:0001392,abnormal locomotor behavior|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0001861,lung inflammation|MP:0001862,interstitial pneumonia|MP:0001874,acanthosis|MP:0002060,abnormal skin morphology|MP:0002083,premature death|MP:0002102,abnormal ear morphology|MP:0002145,abnormal T cell differentiation|MP:0002169,no abnormal phenotype detected|MP:0002269,muscular atrophy|MP:0002276,abnormal lung interstitium morphology|MP:0003271,abnormal duodenum morphology|MP:0003427,parakeratosis|MP:0003644,thymus atrophy|MP:0004778,increased macrophage derived foam cell number|MP:0004819,decreased skeletal muscle mass|MP:0004938,dilated vasculature|MP:0005089,decreased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005150,cachexia|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008097,increased plasma cell number|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009600,hypergranulosis|MP:0010025,decreased total body fat amount|MP:0010771,integument phenotype|MP:0013192,decreased sebaceous gland number
MGI:2450930	Surf1<tm1Zev>	MP:0000585,kinked tail|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001698,decreased embryo size|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0003631,nervous system phenotype|MP:0010053,decreased grip strength|MP:0010955,abnormal respiratory electron transport chain|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3698400	Surf1<tm2.1Zev>	MP:0001405,impaired coordination|MP:0001661,extended life span|MP:0004198,abnormal fetal size|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006036,abnormal mitochondrial physiology|MP:0008236,decreased susceptibility to neuronal excitotoxicity
MGI:3698399	Surf1<tm2Zev>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6830906	Surf4<em1Bcgen>	MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0005341,decreased susceptibility to atherosclerosis|MP:0010027,increased liver cholesterol level
MGI:6392162	Surf4<em1Dgi>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:6283514	Surf4<em1(IMPC)J>	MP:0000198,decreased circulating phosphate level|MP:0005293,impaired glucose tolerance|MP:0011100,preweaning lethality, complete penetrance
MGI:6149214	Susd1<em1(IMPC)H>	MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010067,increased red blood cell distribution width|MP:0011239,abnormal skin coloration
MGI:5007355	Susd4<tm1Lex>	MP:0000136,abnormal microglial cell morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001363,increased anxiety-related response|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0002757,decreased vertical activity|MP:0005386,behavior/neurological phenotype|MP:0009808,decreased oligodendrocyte number|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0010050,hypermyelination|MP:0011566,abnormal complement protein level|MP:0020357,abnormal excitatory synapse morphology|MP:0020358,abnormal inhibitory synapse morphology|MP:0020448,increased microglial cell activation|MP:0020508,decreased dendritic spine density
MGI:5606033	Susd6<tm1.1Geno>	MP:0002169,no abnormal phenotype detected
MGI:5637151	Susd6<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000691,enlarged spleen|MP:0001488,increased startle reflex|MP:0002941,increased circulating alanine transaminase level|MP:0003179,thrombocytopenia|MP:0005013,increased lymphocyte cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005627,increased circulating potassium level|MP:0008806,increased circulating amylase level|MP:0008810,increased circulating iron level|MP:0010025,decreased total body fat amount|MP:0010088,decreased circulating fructosamine level
MGI:2683703	Susp<ALR/Lt>	MP:0005266,abnormal metabolism
MGI:2445449	Suv39h1<tm1Jnw>	MP:0002023,increased B cell derived lymphoma incidence|MP:0005466,abnormal T-helper 2 physiology|MP:0005597,decreased susceptibility to type I hypersensitivity reaction
MGI:2445450	Suv39h2<tm1Jnw>	MP:0002023,increased B cell derived lymphoma incidence
MGI:3530650	Suz12<Gt(Betageo)1Khe>	MP:0000352,decreased cell proliferation|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002084,abnormal developmental patterning|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002836,abnormal chorion morphology|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005029,abnormal amnion morphology|MP:0009321,increased histiocytic sarcoma incidence|MP:0011092,embryonic lethality, complete penetrance|MP:0011199,abnormal amniotic cavity morphology|MP:0011200,abnormal extraembryonic coelom morphology|MP:0011202,abnormal ectoplacental cavity morphology|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3796426	Suz12<Plt8>	MP:0000218,increased leukocyte cell number|MP:0005013,increased lymphocyte cell number|MP:0005505,thrombocytosis
MGI:3653454	Suz12<tm1Hko>	MP:0001698,decreased embryo size|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003036,vertebral transformation|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0011092,embryonic lethality, complete penetrance|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:3850246	Suz12<tm1Xmir>	MP:0000755,hindlimb paralysis|MP:0000777,increased inferior colliculus size|MP:0000781,decreased corpus callosum size|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000807,abnormal hippocampus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000905,increased superior colliculus size|MP:0001504,abnormal posture|MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology|MP:0003054,spina bifida|MP:0009048,enlarged tectum|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012710,diastematomyelia
MGI:2179735	Sv2a<tm1Baj>	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002083,premature death|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0005621,abnormal cell physiology|MP:0011085,postnatal lethality, complete penetrance
MGI:2179736	Sv2a<tm1Sud>	MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0003631,nervous system phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3511830	Sv2b<tm1Baj>	MP:0001265,decreased body size|MP:0002064,seizures|MP:0004021,abnormal rod electrophysiology|MP:0006069,abnormal retina neuronal layer morphology
MGI:2179737	Sv2b<tm1Sud>	MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype
MGI:5568123	Sv2c<tm1Dda>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0005386,behavior/neurological phenotype
MGI:7287850	Svbp<em1Mjom>	MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0000788,abnormal cerebral cortex morphology|MP:0000837,abnormal hypothalamus morphology|MP:0000852,small cerebellum|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0002741,small olfactory bulb|MP:0005277,abnormal brainstem morphology|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0008143,abnormal dendrite morphology|MP:0008226,decreased anterior commissure size|MP:0008415,abnormal neurite morphology|MP:0012466,decreased hippocampal fimbria size|MP:0012468,decreased striatum size|MP:0020527,small thalamus|MP:0021111,decreased social investigation
MGI:5286317	Svep1<tm1a(EUCOMM)Hmgu>	MP:0001879,abnormal lymphatic vessel morphology|MP:0003390,lymphedema|MP:0008778,abnormal lymphangiogenesis|MP:0012269,nuchal edema
MGI:5509058	Svep1<tm1b(EUCOMM)Hmgu>	MP:0000198,decreased circulating phosphate level|MP:0001219,thick epidermis|MP:0001785,edema|MP:0001874,acanthosis|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0005560,decreased circulating glucose level|MP:0005564,increased hemoglobin content|MP:0005634,decreased circulating sodium level|MP:0009931,abnormal skin appearance|MP:0010392,prolonged QRS complex duration|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration
MGI:6358084	Svil<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3513192	Svil<Gt(RRF043)Byg>	MP:0004720,abnormal platelet morphology|MP:0005464,abnormal platelet physiology|MP:0009586,increased platelet aggregation
MGI:6153863	Svop<em1(IMPC)H>	MP:0001406,abnormal gait|MP:0001523,impaired righting response|MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:5544573	Svop<tm1.1Baj>	MP:0002169,no abnormal phenotype detected
MGI:5544575	Svop<tm1Baj>	MP:0003631,nervous system phenotype|MP:0010768,mortality/aging
MGI:2450881	Swap70<tm1Jess>	MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002492,decreased IgE level|MP:0003725,increased autoantibody level|MP:0004816,abnormal class switch recombination
MGI:7565401	Swhtr<tm1.1Phg>	MP:0020344,abnormal susceptibility to injury induced morbidity/mortality|MP:0031215,abnormal response to myocardial ischemic injury
MGI:3050642	swm2	MP:0000242,impaired fertilization|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008545,absent sperm flagellum|MP:0009232,abnormal sperm nucleus morphology|MP:0009234,absent sperm head|MP:0009239,short sperm flagellum|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009836,abnormal sperm principal piece morphology|MP:0020869,immotile sperm
MGI:3050626	swm6	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0005159,azoospermia
MGI:3698765	Swq6<CAST/EiJ>	MP:0004952,increased spleen weight
MGI:3723195	Swqnd1<NMRI8/Fbn>	MP:0004953,decreased spleen weight
MGI:3723193	Swqnd2<NMRI8/Fbn>	MP:0004953,decreased spleen weight
MGI:3530763	Swrl1<NZB>	MP:0002532,abnormal type II hypersensitivity reaction
MGI:3530765	Swrl1<SWR>	MP:0008502,increased IgG3 level
MGI:3576911	Swrl2<SWR>	MP:0002743,glomerulonephritis|MP:0004771,increased anti-single stranded DNA antibody level
MGI:3576913	Swrl3<SWR>	MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004796,increased anti-histone antibody level
MGI:7507210	Swsap1<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001925,male infertility|MP:0020421,increased freezing behavior
MGI:6287664	Swsap1<em1Mjn>	MP:0001925,male infertility|MP:0001926,female infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002777,absent ovarian follicles|MP:0003702,abnormal chromosome morphology|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0009451,abnormal chromosomal synapsis|MP:0013507,increased ovary apoptosis|MP:0014052,increased male germ cell apoptosis
MGI:6423300	Swt1<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:1856182	sy	MP:0000035,abnormal membranous labyrinth morphology|MP:0000039,abnormal otic capsule morphology|MP:0000063,decreased bone mineral density|MP:0000149,abnormal scapula morphology|MP:0000564,syndactyly|MP:0000566,synostosis|MP:0001394,circling|MP:0001410,head bobbing|MP:0001963,abnormal hearing physiology|MP:0001967,deafness|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002102,abnormal ear morphology|MP:0002110,abnormal digit morphology|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0002428,abnormal semicircular canal morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0008150,decreased diameter of long bones|MP:0011085,postnatal lethality, complete penetrance
MGI:3863900	Syap1<Gt(AF0128)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:4841544	Syap1<tm1a(EUCOMM)Hmgu>	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002169,no abnormal phenotype detected|MP:0005386,behavior/neurological phenotype|MP:0010053,decreased grip strength
MGI:6277002	Sybu<em1(IMPC)Mbp>	MP:0001120,abnormal uterus morphology|MP:0009709,hydrometra
MGI:6760662	Syce1<em1Rrca>	MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001924,infertility|MP:0002777,absent ovarian follicles|MP:0004805,absent oocytes|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0009451,abnormal chromosomal synapsis
MGI:5634805	Syce1l<tm1.1(KOMP)Vlcg>	MP:0001554,increased circulating free fatty acids level|MP:0005633,increased circulating sodium level
MGI:5614613	Syce1<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001303,abnormal lens morphology|MP:0001402,decreased locomotor activity|MP:0001513,limb grasping|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002797,increased thigmotaxis|MP:0002959,increased urine microalbumin level|MP:0005292,improved glucose tolerance|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0013279,increased fasting circulating glucose level
MGI:3840564	Syce1<tm1Hgu>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002682,decreased mature ovarian follicle number|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0009452,abnormal synaptonemal complex|MP:0014052,increased male germ cell apoptosis|MP:0014764,impaired double-strand DNA break repair
MGI:6156487	Syce2<em1(IMPC)Tcp>	MP:0000063,decreased bone mineral density|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002060,abnormal skin morphology|MP:0002989,small kidney|MP:0003961,decreased lean body mass|MP:0004930,small epididymis|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0011874,enlarged urinary bladder
MGI:3708176	Syce2<Gt(FHCRC-GT-S8-7E1)Sor>	MP:0001127,small ovary|MP:0001925,male infertility|MP:0001926,female infertility|MP:0004852,decreased testis weight|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis
MGI:5009455	Syce3<tm1Rben>	MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001132,absent mature ovarian follicles|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001930,abnormal meiosis|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0009451,abnormal chromosomal synapsis|MP:0009452,abnormal synaptonemal complex
MGI:3046204	Sycn<tm1Rja>	MP:0002693,abnormal pancreas physiology|MP:0004761,increased susceptibility to induced pancreatitis|MP:0005379,endocrine/exocrine gland phenotype|MP:0031325,delayed pancreas regeneration
MGI:3580000	Sycp1<tm1Aps>	MP:0001119,abnormal female reproductive system morphology|MP:0001145,abnormal male reproductive system morphology|MP:0001153,small seminiferous tubules|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001929,abnormal gametogenesis|MP:0002777,absent ovarian follicles|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis
MGI:5692068	Sycp2l<tm1Jw>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0005431,decreased oocyte number|MP:0008995,early reproductive senescence|MP:0011121,decreased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number|MP:0031381,decreased secondary ovarian follicle number
MGI:6507385	Sycp2<tm1b(EUCOMM)Hmgu>	MP:0001147,small testis
MGI:3526164	Sycp2<tm1Jw>	MP:0001145,abnormal male reproductive system morphology|MP:0001146,abnormal testis morphology|MP:0001153,small seminiferous tubules|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001929,abnormal gametogenesis|MP:0001935,decreased litter size|MP:0002161,abnormal fertility/fecundity|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:5494477	Sycp3<tm1.1(KOMP)Vlcg>	MP:0011954,shortened PQ interval
MGI:2179041	Sycp3<tm1Hoog>	MP:0001153,small seminiferous tubules|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis
MGI:5905625	Syde1<tm1.1Hwch>	MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0003070,increased vascular permeability|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004921,decreased placenta weight|MP:0005033,abnormal trophoblast giant cell morphology|MP:0005385,cardiovascular system phenotype|MP:0006042,increased apoptosis|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009429,decreased embryo weight
MGI:4841821	Syde1<tm1a(EUCOMM)Hmgu>	MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004792,abnormal synaptic vesicle number
MGI:5704518	Syde1<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0010097,abnormal retina blood vessel morphology
MGI:5614299	Syde1<tm1c(EUCOMM)Hmgu>	MP:0002169,no abnormal phenotype detected
MGI:3904866	Syf2<Gt(PST25562)Mfgc>	MP:0001696,failure to gastrulate|MP:0002085,abnormal embryonic tissue morphology|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0004045,abnormal cell cycle checkpoint function|MP:0011092,embryonic lethality, complete penetrance
MGI:6511001	Syisl<em1Bzuo>	MP:0003084,abnormal skeletal muscle fiber morphology|MP:0005378,growth/size/body region phenotype|MP:0009405,increased skeletal muscle fiber number|MP:0009421,increased gastrocnemius weight|MP:0009427,increased tibialis anterior weight|MP:0010226,increased quadriceps weight|MP:0011808,abnormal myoblast differentiation|MP:0013161,enhanced muscle regeneration|MP:0030948,decreased myoblast proliferation|MP:0030959,abnormal myoblast fusion
MGI:5502198	Syk<m1Btlr>	MP:0000219,increased neutrophil cell number|MP:0005017,decreased B cell number|MP:0008560,increased tumor necrosis factor secretion
MGI:5775011	Syk<M2Btlr>	MP:0001876,decreased inflammatory response|MP:0008053,abnormal NK cell differentiation
MGI:5314125	Syk<tm1.1Nns>	MP:0001614,abnormal blood vessel morphology|MP:0001785,edema|MP:0001879,abnormal lymphatic vessel morphology|MP:0001915,intracranial hemorrhage|MP:0005324,ascites|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0005464,abnormal platelet physiology|MP:0010197,abnormal lymphatic vessel endothelial cell morphology|MP:0010768,mortality/aging
MGI:3690645	Syk<tm1.1Tara>	MP:0001802,arrested B cell differentiation|MP:0005154,increased B cell proliferation|MP:0011090,perinatal lethality, incomplete penetrance
MGI:4415245	Syk<tm1.2Tara>	MP:0004939,abnormal B cell morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0010768,mortality/aging
MGI:5588292	Syk<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:1857421	Syk<tm1Paw>	MP:0000238,absent pre-B cells|MP:0000574,abnormal foot pad morphology|MP:0001614,abnormal blood vessel morphology|MP:0001879,abnormal lymphatic vessel morphology|MP:0001914,hemorrhage|MP:0001916,intracerebral hemorrhage|MP:0002144,abnormal B cell differentiation|MP:0002192,hydrops fetalis|MP:0004106,lymphatic vessel hyperplasia|MP:0004938,dilated vasculature|MP:0008778,abnormal lymphangiogenesis|MP:0010195,abnormal lymphatic vessel endothelium morphology|MP:0010200,enlarged lymphatic vessel|MP:0011085,postnatal lethality, complete penetrance|MP:0014404,decreased late pro-B cell number
MGI:2384078	Syk<tm1Tyb>	MP:0001175,abnormal lung morphology|MP:0001802,arrested B cell differentiation|MP:0001879,abnormal lymphatic vessel morphology|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0002455,abnormal dendritic cell antigen presentation|MP:0002463,abnormal neutrophil physiology|MP:0002467,impaired neutrophil phagocytosis|MP:0004950,abnormal brain vasculature morphology|MP:0004993,decreased bone resorption|MP:0005074,impaired granulocyte bactericidal activity|MP:0006054,spinal hemorrhage|MP:0006387,abnormal T cell number|MP:0008396,abnormal osteoclast differentiation|MP:0008561,decreased tumor necrosis factor secretion|MP:0010198,decreased lymphatic vessel endothelial cell number|MP:0010819,primary atelectasis|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012080,chylous ascites
MGI:5442724	Syk<tm2.1(ZAP70)Fkfr>	MP:0000333,decreased bone marrow cell number|MP:0001802,arrested B cell differentiation|MP:0002459,abnormal B cell physiology|MP:0002463,abnormal neutrophil physiology|MP:0002494,increased IgM level|MP:0002743,glomerulonephritis|MP:0002828,abnormal renal glomerular capsule morphology|MP:0002869,increased anti-insulin autoantibody level|MP:0002962,increased urine protein level|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0005554,decreased circulating creatinine level|MP:0005559,increased circulating glucose level|MP:0005566,decreased blood urea nitrogen level|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008182,decreased marginal zone B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008211,decreased mature B cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008782,increased B cell apoptosis|MP:0009923,decreased transitional stage T1 B cell number|MP:0009926,decreased transitional stage T2 B cell number|MP:0010130,decreased DN1 thymic pro-T cell number|MP:0010133,increased DN3 thymocyte number|MP:0010835,increased CD4-positive, alpha-beta memory T cell number|MP:0010838,increased CD8-positive, alpha-beta memory T cell number|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011353,expanded mesangial matrix|MP:0011427,increased mesangial cell number
MGI:5286672	Sympk<Tg(Tyr)2381AOve>	MP:0001577,anemia|MP:0002192,hydrops fetalis
MGI:4434309	Sympk<tm1a(EUCOMM)Wtsi>	MP:0004924,abnormal behavior
MGI:3032534	Syn1<tm1Noh>	MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004770,abnormal synaptic vesicle recycling|MP:0004793,abnormal synaptic vesicle clustering|MP:0004996,abnormal CNS synapse formation
MGI:2448356	Syn1<tm1Pggd>	MP:0001353,increased aggression towards mice|MP:0001360,abnormal social investigation|MP:0001650,abnormal seizure response to electrical stimulation|MP:0002572,abnormal emotion/affect behavior|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002916,increased synaptic depression|MP:0002924,delayed CNS synapse formation|MP:0002969,impaired social transmission of food preference|MP:0004793,abnormal synaptic vesicle clustering|MP:0005394,taste/olfaction phenotype|MP:0005445,abnormal neurotransmitter secretion|MP:0009940,abnormal hippocampus pyramidal cell morphology
MGI:1857250	Syn1<tm1Sud>	MP:0000947,convulsive seizures|MP:0002919,enhanced paired-pulse facilitation
MGI:3032535	Syn1<tm2Noh>	MP:0004793,abnormal synaptic vesicle clustering|MP:0004996,abnormal CNS synapse formation
MGI:3045984	Syn2<tm1Pggd>	MP:0001353,increased aggression towards mice|MP:0001360,abnormal social investigation|MP:0001441,increased grooming behavior|MP:0002064,seizures|MP:0002152,abnormal brain morphology|MP:0002175,decreased brain weight|MP:0002206,abnormal CNS synaptic transmission|MP:0002572,abnormal emotion/affect behavior|MP:0002882,abnormal neuron morphology|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002917,decreased synaptic depression|MP:0002924,delayed CNS synapse formation|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004792,abnormal synaptic vesicle number|MP:0005394,taste/olfaction phenotype|MP:0012006,abnormal hippocampus physiology|MP:0021111,decreased social investigation
MGI:1857251	Syn2<tm1Sud>	MP:0000947,convulsive seizures|MP:0002206,abnormal CNS synaptic transmission|MP:0002916,increased synaptic depression|MP:0002922,decreased post-tetanic potentiation
MGI:5507835	Syn3<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0000208,decreased hematocrit|MP:0001399,hyperactivity|MP:0001516,abnormal motor coordination/balance|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0003795,abnormal bone structure|MP:0003928,increased heart rate variability|MP:0005633,increased circulating sodium level|MP:0010124,decreased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:2675750	Syn3<tm1Pggd>	MP:0001360,abnormal social investigation|MP:0002916,increased synaptic depression|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0002946,delayed axon extension|MP:0002969,impaired social transmission of food preference|MP:0003863,decreased aggression towards mice|MP:0005394,taste/olfaction phenotype|MP:0011269,increased excitatory postsynaptic current amplitude
MGI:3852417	Syna<tm1.1Ics>	MP:0001716,abnormal placenta labyrinth morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004265,abnormal placental transport|MP:0009397,increased trophoblast giant cell number|MP:0009429,decreased embryo weight|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5308859	Synb<tm1.2Ics>	MP:0001262,decreased body weight|MP:0001716,abnormal placenta labyrinth morphology|MP:0001732,postnatal growth retardation|MP:0004201,fetal growth retardation|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009431,decreased fetal weight|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011531,abnormal syncytiotrophoblast morphology
MGI:6120727	Syncrip<tm1b(EUCOMM)Hmgu>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0002968,increased circulating alkaline phosphatase level|MP:0004738,abnormal auditory brainstem response|MP:0004924,abnormal behavior|MP:0005293,impaired glucose tolerance|MP:0008935,decreased mean platelet volume|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0020870,decreased thigmotaxis
MGI:3813569	Sync<tm1.1Ked>	MP:0002841,impaired skeletal muscle contractility|MP:0005369,muscle phenotype|MP:0010090,increased circulating creatine kinase level
MGI:3797113	Sync<tm1Chen>	MP:0002106,abnormal muscle physiology|MP:0005369,muscle phenotype|MP:0005385,cardiovascular system phenotype
MGI:5440443	Syndig1l<tm1Embr>	MP:0003631,nervous system phenotype|MP:0005389,reproductive system phenotype
MGI:6414551	Syne1<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:4414824	Syne1<tm1.1Chen>	MP:0000746,weakness|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002106,abnormal muscle physiology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0005385,cardiovascular system phenotype|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009546,absent gastric milk in neonates|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012106,impaired exercise endurance
MGI:3834378	Syne1<tm1.1Mcn>	MP:0000069,kyphoscoliosis|MP:0000752,dystrophic muscle|MP:0001177,atelectasis|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001443,poor grooming|MP:0001575,cyanosis|MP:0001852,conjunctivitis|MP:0003233,prolonged QT interval|MP:0003641,small lung|MP:0003896,prolonged PR interval|MP:0005333,decreased heart rate|MP:0008770,decreased survivor rate|MP:0009434,paraparesis|MP:0009703,decreased birth body size|MP:0010392,prolonged QRS complex duration|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4414823	Syne1<tm1Chen>	MP:0003111,abnormal cell nucleus morphology|MP:0014693,abnormal cell nucleus size
MGI:3700735	Syne1<tm1Rexu>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0004087,abnormal muscle fiber morphology
MGI:3689343	Syne2<cpfl8>	MP:0003111,abnormal cell nucleus morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005391,vision/eye phenotype|MP:0005547,abnormal Muller cell morphology|MP:0006068,abnormal retina horizontal cell morphology|MP:0006073,abnormal retina bipolar cell morphology|MP:0008446,decreased retina cone cell number|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008519,thin retina outer plexiform layer|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment|MP:0009538,abnormal synapse morphology|MP:0030005,increased retina apoptosis
MGI:6358246	Syne2<cpfl8-2J>	MP:0002864,abnormal ocular fundus morphology|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0004022,abnormal cone electrophysiology|MP:0008515,thin retina outer nuclear layer|MP:0010097,abnormal retina blood vessel morphology|MP:0011965,decreased total retina thickness
MGI:6358300	Syne2<cpfl8-3J>	MP:0002864,abnormal ocular fundus morphology|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0004022,abnormal cone electrophysiology|MP:0008515,thin retina outer nuclear layer|MP:0010097,abnormal retina blood vessel morphology|MP:0011965,decreased total retina thickness
MGI:6302762	Syne2<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0002591,decreased mean corpuscular volume|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength
MGI:3811076	Syne2<tm1Ngl>	MP:0001219,thick epidermis|MP:0002655,abnormal keratinocyte morphology|MP:0003111,abnormal cell nucleus morphology|MP:0011708,decreased fibroblast cell migration
MGI:3700736	Syne2<tm1Rexu>	MP:0005369,muscle phenotype
MGI:6798091	Syne3<tm1.2Nki>	MP:0002169,no abnormal phenotype detected
MGI:5548806	Syne3<tm1b(KOMP)Wtsi>	MP:0001552,increased circulating triglyceride level|MP:0005560,decreased circulating glucose level
MGI:5494678	Syne4<tm1Kare>	MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3511175	Syngap1<tm1.1Mabk>	MP:0000745,tremors|MP:0000746,weakness|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003203,increased neuron apoptosis|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0014373,increased miniature excitatory postsynaptic current amplitude|MP:0014375,increased miniature excitatory postsynaptic current frequency
MGI:3580631	Syngap1<tm1Grnt>	MP:0001265,decreased body size|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0011085,postnatal lethality, complete penetrance
MGI:3576223	Syngap1<tm1Rlh>	MP:0000774,decreased brain size|MP:0001265,decreased body size|MP:0001361,social withdrawal|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001436,abnormal suckling behavior|MP:0001473,reduced long-term potentiation|MP:0001488,increased startle reflex|MP:0001496,audiogenic seizures|MP:0002206,abnormal CNS synaptic transmission|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002802,abnormal discrimination learning|MP:0002882,abnormal neuron morphology|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005156,bradykinesia|MP:0005386,behavior/neurological phenotype|MP:0008143,abnormal dendrite morphology|MP:0008428,abnormal spatial working memory|MP:0009142,decreased prepulse inhibition|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0009456,impaired cued conditioning behavior|MP:0009848,increased horizontal stereotypic behavior|MP:0009936,abnormal dendritic spine morphology|MP:0011002,enhanced AMPA-mediated synaptic currents|MP:0011085,postnatal lethality, complete penetrance|MP:0014382,increased miniature inhibitory postsynaptic current frequency|MP:0014384,increased miniature inhibitory postsynaptic current amplitude|MP:0031391,increased locomotor activity
MGI:5469866	Syngap1<tm2Geno>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0004924,abnormal behavior|MP:0008428,abnormal spatial working memory
MGI:7426010	Syngr1<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0000759,abnormal skeletal muscle morphology|MP:0001120,abnormal uterus morphology|MP:0002339,abnormal lymph node morphology|MP:0004906,enlarged uterus
MGI:2179744	Syngr1<tm1Sud>	MP:0001900,impaired synaptic plasticity|MP:0002922,decreased post-tetanic potentiation
MGI:7329961	Syngr2<em1(IMPC)J>	MP:0001284,absent vibrissae|MP:0002942,decreased circulating alanine transaminase level|MP:0005505,thrombocytosis|MP:0005559,increased circulating glucose level|MP:0005632,decreased circulating aspartate transaminase level|MP:0005635,decreased circulating bilirubin level
MGI:6257789	Syngr3<em1(IMPC)Bay>	MP:0002764,short tibia|MP:0011960,abnormal eye anterior chamber depth|MP:0011965,decreased total retina thickness
MGI:6690242	Syngr3<em1Pave>	MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:6144029	Syngr4<tm1Osb>	MP:0002169,no abnormal phenotype detected
MGI:2678452	Synj1<Gt(pT1ATGBetageo)1Ruiz>	MP:0011089,perinatal lethality, complete penetrance
MGI:5636987	Synj1<tm1b(EUCOMM)Wtsi>	MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000745,tremors|MP:0001289,persistence of hyaloid vascular system|MP:0005013,increased lymphocyte cell number|MP:0010068,decreased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance
MGI:2179801	Synj1<tm1Pdc>	MP:0000746,weakness|MP:0000947,convulsive seizures|MP:0001393,ataxia|MP:0001732,postnatal growth retardation|MP:0002916,increased synaptic depression|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4999986	Synj2<mozart>	MP:0000043,organ of Corti degeneration|MP:0002857,cochlear ganglion degeneration|MP:0003631,nervous system phenotype|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004528,fused outer hair cell stereocilia|MP:0004533,fused inner hair cell stereocilia|MP:0004740,sensorineural hearing loss|MP:0005386,behavior/neurological phenotype|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4432435	Synj2<tm1a(EUCOMM)Wtsi>	MP:0001260,increased body weight
MGI:6342885	Synm<tm1.1Ics>	MP:0000730,increased satellite cell number|MP:0000751,myopathy|MP:0001257,increased body length|MP:0001399,hyperactivity|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003960,increased lean body mass|MP:0004090,abnormal sarcomere morphology|MP:0004121,abnormal sarcolemma morphology|MP:0004145,abnormal muscle electrophysiology|MP:0004357,long tibia|MP:0004818,increased skeletal muscle mass|MP:0005165,increased susceptibility to injury|MP:0005289,increased oxygen consumption|MP:0008965,increased basal metabolism|MP:0009401,increased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009412,skeletal muscle fiber degeneration|MP:0011941,increased fluid intake|MP:0013237,abnormal skeletal muscle regeneration
MGI:5548847	Synm<tm1.1(KOMP)Vlcg>	MP:0000266,abnormal heart morphology|MP:0000759,abnormal skeletal muscle morphology|MP:0001260,increased body weight|MP:0001529,abnormal vocalization|MP:0001625,cardiac hypertrophy|MP:0002106,abnormal muscle physiology|MP:0002108,abnormal muscle morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002626,increased heart rate|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003393,decreased cardiac output|MP:0003646,increased muscle fatigability|MP:0003852,skeletal muscle necrosis|MP:0004087,abnormal muscle fiber morphology|MP:0004121,abnormal sarcolemma morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0004819,decreased skeletal muscle mass|MP:0005330,cardiomyopathy|MP:0009046,muscle twitch|MP:0010240,decreased skeletal muscle size|MP:0010633,myocardium hypertrophy|MP:0011925,abnormal heart echocardiography feature|MP:0011952,decreased cardiac stroke volume|MP:0014316,decreased heart left ventricle posterior wall thickness|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5548760	Synpo2<tm1b(EUCOMM)Wtsi>	MP:0000208,decreased hematocrit|MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003896,prolonged PR interval|MP:0005016,decreased lymphocyte cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:2675703	Synpo<tm1Mndl>	MP:0000934,abnormal telencephalon development|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0003631,nervous system phenotype|MP:0005367,renal/urinary system phenotype
MGI:5700039	Synrg<tm1b(EUCOMM)Wtsi>	MP:0002626,increased heart rate|MP:0002792,abnormal retina vasculature morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005566,decreased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness|MP:0013278,decreased fasting circulating glucose level
MGI:6384589	Syp<em1(IMPC)Bay>	MP:0002574,increased vertical activity|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5513828	Sypl1<tm1b(KOMP)Wtsi>	MP:0000438,abnormal cranium morphology|MP:0001417,decreased exploration in new environment|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008469,abnormal protein level|MP:0009230,abnormal sperm head morphology|MP:0009237,kinked sperm flagellum|MP:0009830,abnormal sperm connecting piece morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0014239,abnormal intracellular organelle morphology|MP:0020451,decreased sperm progressive motility
MGI:3513758	Sypl2<tm1Hta>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0005386,behavior/neurological phenotype|MP:0009400,decreased skeletal muscle fiber size|MP:0009411,abnormal skeletal muscle fiber triad morphology
MGI:3033781	Syp<tm1Leu>	MP:0002169,no abnormal phenotype detected
MGI:2179741	Syp<tm1Sud>	MP:0002169,no abnormal phenotype detected
MGI:2684031	Sysbp1<BPL/1J>	MP:0002842,increased systemic arterial blood pressure
MGI:2684032	Sysbp2<BPL/1J>	MP:0002842,increased systemic arterial blood pressure
MGI:5286607	Syt10<tm1.1(icre)Geno>	MP:0005386,behavior/neurological phenotype|MP:0020470,shortened circadian behavior period|MP:0020474,advanced circadian behavior phase
MGI:3774591	Syt11<tm1Sud>	MP:0002169,no abnormal phenotype detected
MGI:4940391	Syt12<tm1.1Sud>	MP:0010768,mortality/aging
MGI:7514187	Syt13<tm1c(EUCOMM)Hmgu>	MP:0005379,endocrine/exocrine gland phenotype|MP:0011932,abnormal endocrine pancreas development
MGI:7514188	Syt13<tm1d(EUCOMM)Hmgu>	MP:0011085,postnatal lethality, complete penetrance|MP:0011932,abnormal endocrine pancreas development
MGI:5904336	Syt14<em1(IMPC)J>	MP:0000745,tremors
MGI:5548356	Syt17<tm1b(KOMP)Wtsi>	MP:0000194,increased circulating calcium level|MP:0002590,increased mean corpuscular volume|MP:0002764,short tibia|MP:0002965,increased circulating serum albumin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005565,increased blood urea nitrogen level|MP:0005568,increased circulating total protein level|MP:0005573,increased pulmonary respiratory rate|MP:0005576,decreased pulmonary ventilation
MGI:4433781	Syt1<tm1a(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected|MP:0003253,dilated bile duct|MP:0003266,biliary cyst|MP:0003961,decreased lean body mass|MP:0008923,thoracoschisis|MP:0010124,decreased bone mineral content|MP:0010418,perimembraneous ventricular septal defect|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013309,adrenal gland cyst|MP:0013528,thyroid gland cyst|MP:0013877,abnormal ductus venosus valve morphology|MP:0013967,abnormal infrahyoid muscle connection|MP:0013975,abnormal coronary sinus connection
MGI:1857252	Syt1<tm1Sud>	MP:0001436,abnormal suckling behavior|MP:0002082,postnatal lethality|MP:0002206,abnormal CNS synaptic transmission|MP:0002909,abnormal adrenal gland physiology|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0003635,abnormal synaptic transmission|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004811,abnormal neuron physiology|MP:0005445,abnormal neurotransmitter secretion|MP:0011085,postnatal lethality, complete penetrance|MP:0011270,decreased excitatory postsynaptic current amplitude
MGI:2180146	Syt1<tm2Sud>	MP:0002169,no abnormal phenotype detected
MGI:2180148	Syt1<tm3Sud>	MP:0005445,abnormal neurotransmitter secretion|MP:0011270,decreased excitatory postsynaptic current amplitude
MGI:2180149	Syt1<tm4Sud>	MP:0002169,no abnormal phenotype detected
MGI:2388629	Syt1<tm5Sud>	MP:0002916,increased synaptic depression
MGI:2388630	Syt1<tm6Sud>	MP:0002169,no abnormal phenotype detected
MGI:5688504	Syt2<m1Btlr>	MP:0000745,tremors|MP:0001393,ataxia
MGI:3716868	Syt2<m1Ingm>	MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001924,infertility|MP:0002910,abnormal excitatory postsynaptic currents|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004835,abnormal miniature endplate potential|MP:0011271,prolonged excitatory postsynaptic current rise time
MGI:3696107	Syt2<tm1Sud>	MP:0001262,decreased body weight|MP:0001392,abnormal locomotor behavior|MP:0001732,postnatal growth retardation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002206,abnormal CNS synaptic transmission|MP:0002919,enhanced paired-pulse facilitation|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003990,decreased neurotransmitter release|MP:0004835,abnormal miniature endplate potential|MP:0005445,abnormal neurotransmitter secretion|MP:0011083,lethality at weaning, complete penetrance
MGI:5609531	Syt2<tm2Sud>	MP:0002169,no abnormal phenotype detected
MGI:6153886	Syt4<em2(IMPC)H>	MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0005419,decreased circulating serum albumin level|MP:0005565,increased blood urea nitrogen level|MP:0010088,decreased circulating fructosamine level
MGI:2180158	Syt4<tm1Hahe>	MP:0001405,impaired coordination|MP:0001469,abnormal contextual conditioning behavior|MP:0002969,impaired social transmission of food preference
MGI:3715454	Syt5<tm2.1Sud>	MP:0011101,prenatal lethality, incomplete penetrance
MGI:3715453	Syt5<tm2Sud>	MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003631,nervous system phenotype
MGI:6153890	Syt7<em2(IMPC)H>	MP:0000198,decreased circulating phosphate level|MP:0001402,decreased locomotor activity
MGI:2676220	Syt7<tm1Nan>	MP:0000759,abnormal skeletal muscle morphology|MP:0001846,increased inflammatory response|MP:0002161,abnormal fertility/fecundity|MP:0003851,skeletal muscle interstitial fibrosis|MP:0004510,myositis|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005621,abnormal cell physiology|MP:0009932,skin fibrosis|MP:0010053,decreased grip strength
MGI:3699518	Syt7<tm1Sud>	MP:0002169,no abnormal phenotype detected
MGI:3699592	Syt7<tm2Sud>	MP:0002169,no abnormal phenotype detected
MGI:6272647	Syt8<em1(IMPC)J>	MP:0001513,limb grasping|MP:0008259,abnormal optic disk morphology|MP:0010053,decreased grip strength
MGI:6156504	Syt9<em1(IMPC)Tcp>	MP:0001417,decreased exploration in new environment|MP:0001891,hydrocephaly|MP:0010067,increased red blood cell distribution width
MGI:4363391	Sytl1<tm1a(KOMP)Wtsi>	MP:0002599,increased mean platelet volume|MP:0002608,increased hematocrit|MP:0002874,decreased hemoglobin content|MP:0003036,vertebral transformation|MP:0003312,abnormal locomotor coordination|MP:0003596,epididymis inflammation|MP:0004614,caudal vertebral transformation|MP:0004973,increased regulatory T cell number|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008211,decreased mature B cell number|MP:0008497,decreased IgG2b level|MP:0008805,decreased circulating amylase level|MP:0031110,meningitis
MGI:3805583	Sytl1<tm1Mitf>	MP:0002694,abnormal pancreas secretion|MP:0009161,pancreatic acinar cell zymogen granule accumulation
MGI:5509384	Sytl1<tm1Tiz>	MP:0003059,decreased insulin secretion|MP:0005376,homeostasis/metabolism phenotype
MGI:3693881	Sytl2<tm1Mitf>	MP:0000505,decreased digestive secretion|MP:0004137,abnormal gastric surface mucous cell morphology
MGI:6153629	Sytl3<em1(IMPC)Wtsi>	MP:0005567,decreased circulating total protein level
MGI:6451108	Sytl4<em1(IMPC)Hmgu>	MP:0005292,improved glucose tolerance
MGI:3609563	Sytl4<tm1Tiz>	MP:0001262,decreased body weight|MP:0001747,hypersecretion of adrenocorticotropin|MP:0003058,increased insulin secretion|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005560,decreased circulating glucose level|MP:0008327,abnormal corticotroph morphology
MGI:5575555	Syvn1<tm1.1Dfan>	MP:0002169,no abnormal phenotype detected
MGI:2679656	Syvn1<tm1Tn>	MP:0001648,abnormal apoptosis|MP:0002932,abnormal joint morphology|MP:0003436,decreased susceptibility to induced arthritis|MP:0006042,increased apoptosis|MP:0011091,prenatal lethality, complete penetrance
MGI:2157845	Szs10<C57BL/6J>	MP:0001650,abnormal seizure response to electrical stimulation
MGI:2155997	Szs11<C57BL/6J>	MP:0001650,abnormal seizure response to electrical stimulation
MGI:2155998	Szs11<DBA/2J>	MP:0001650,abnormal seizure response to electrical stimulation
MGI:2157848	Szs12<DBA/2J>	MP:0001650,abnormal seizure response to electrical stimulation
MGI:2157850	Szs13<DBA/2J>	MP:0001650,abnormal seizure response to electrical stimulation
MGI:2154345	Szs1<DBA/2J>	MP:0000950,abnormal seizure response to pharmacological agent|MP:0001650,abnormal seizure response to electrical stimulation|MP:0002064,seizures
MGI:2155930	Szs2<C57BL/6J>	MP:0001650,abnormal seizure response to electrical stimulation
MGI:2154347	Szs5<DBA/2J>	MP:0000950,abnormal seizure response to pharmacological agent
MGI:2156080	Szs6<C57BL/6J>	MP:0000950,abnormal seizure response to pharmacological agent
MGI:2154500	Szs7<DBA/2J>	MP:0001650,abnormal seizure response to electrical stimulation
MGI:2154502	Szs8<DBA/2J>	MP:0001650,abnormal seizure response to electrical stimulation
MGI:2157843	Szs9<DBA/2J>	MP:0001650,abnormal seizure response to electrical stimulation
MGI:2656387	Szt1	MP:0000950,abnormal seizure response to pharmacological agent|MP:0001177,atelectasis|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001650,abnormal seizure response to electrical stimulation|MP:0003631,nervous system phenotype|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0009971,decreased hippocampus pyramidal cell number|MP:0011087,neonatal lethality, complete penetrance
MGI:6433994	Szt2<em1(IMPC)Bay>	MP:0001297,microphthalmia|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0001914,hemorrhage|MP:0011100,preweaning lethality, complete penetrance
MGI:4353996	Szt2<Gt(XH662)Byg>	MP:0000371,diluted coat color|MP:0002193,minimal clonic seizures|MP:0002194,maximal tonic hindlimb extension seizures|MP:0008770,decreased survivor rate|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4353995	Szt2<m1Frk>	MP:0001499,abnormal kindling response|MP:0002193,minimal clonic seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003631,nervous system phenotype|MP:0003997,tonic-clonic seizures|MP:0005386,behavior/neurological phenotype
MGI:2156229	Szv1<C57BL/6J>	MP:0000950,abnormal seizure response to pharmacological agent
MGI:2156837	Szv2<C57BL/6J>	MP:0000950,abnormal seizure response to pharmacological agent
MGI:2157852	Szv3<DBA/2J>	MP:0000950,abnormal seizure response to pharmacological agent
MGI:1856184	T	MP:0000269,abnormal heart looping|MP:0000270,abnormal heart tube morphology|MP:0000461,decreased presacral vertebrae number|MP:0000592,short tail|MP:0000932,absent notochord|MP:0001216,abnormal epidermal layer morphology|MP:0001539,decreased caudal vertebrae number|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001712,abnormal placenta development|MP:0001914,hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0002230,abnormal primitive streak formation|MP:0002825,abnormal notochord morphology|MP:0003400,kinked neural tube|MP:0003861,abnormal nervous system development|MP:0004073,caudal body truncation|MP:0004712,notochord degeneration|MP:0004787,abnormal dorsal aorta morphology|MP:0005244,hemopericardium|MP:0005650,abnormal limb bud morphology|MP:0008854,bleb|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011495,abnormal head shape|MP:0012082,delayed heart development|MP:0012501,abnormal pericardial cavity morphology|MP:0012714,decreased ventral ectodermal ridge size|MP:0013164,abnormal forelimb bud morphology|MP:0013168,absent hindlimb buds
MGI:5436051	T<11J>	MP:0000585,kinked tail|MP:0000592,short tail|MP:0004509,abnormal pelvic girdle bone morphology|MP:0006281,abnormal tail development|MP:0008999,absent anus
MGI:3579549	T(14;15)6Ca	MP:0001921,reduced fertility|MP:0010768,mortality/aging
MGI:3574967	T(16;17)43H	MP:0001463,abnormal spatial learning
MGI:1856196	T<1Or>	MP:0001730,embryonic growth arrest|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2154472	T(2;10)67Gso	MP:0000611,jaundice|MP:0000746,weakness|MP:0001270,distended abdomen|MP:0001921,reduced fertility|MP:0003068,enlarged kidney|MP:0003266,biliary cyst|MP:0003675,kidney cyst|MP:0009703,decreased birth body size|MP:0011087,neonatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5471518	T<24H>	MP:0000592,short tail
MGI:5450859	T<26H>	MP:0003456,absent tail
MGI:1857607	T<29H>	MP:0011090,perinatal lethality, incomplete penetrance
MGI:2675243	T2dm1sa<SM/JNshm>	MP:0001559,hyperglycemia
MGI:2429604	T2dm2<C57BL/6J>	MP:0002727,decreased circulating insulin level
MGI:3622825	T2dm2sa<A/JNshm>	MP:0001260,increased body weight|MP:0002079,increased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0006087,increased body mass index|MP:0010024,increased total body fat amount
MGI:1856190	T<2J>	MP:0000592,short tail
MGI:2662508	T<2Or>	MP:0001730,embryonic growth arrest|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1857754	T2<Tg(H2K)1Art>	MP:0000267,abnormal heart development|MP:0000270,abnormal heart tube morphology|MP:0000585,kinked tail|MP:0000592,short tail|MP:0000932,absent notochord|MP:0003456,absent tail|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2673245	T<31H>	MP:0001922,reduced male fertility|MP:0011090,perinatal lethality, incomplete penetrance
MGI:1857609	T<33H>	MP:0001922,reduced male fertility|MP:0011090,perinatal lethality, incomplete penetrance
MGI:1857610	T<34H>	MP:0000592,short tail|MP:0001785,edema|MP:0011090,perinatal lethality, incomplete penetrance
MGI:2673249	T<36H>	MP:0000592,short tail|MP:0001922,reduced male fertility|MP:0011090,perinatal lethality, incomplete penetrance
MGI:1862032	T<39H>	MP:0002111,abnormal tail morphology
MGI:2662515	T<3Or>	MP:0001730,embryonic growth arrest|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3042262	T<40H>	MP:0000592,short tail|MP:0000932,absent notochord
MGI:3042261	T<41H>	MP:0000592,short tail|MP:0000932,absent notochord
MGI:1860106	T<4J>	MP:0000592,short tail
MGI:1856387	T<4Or>	MP:0001730,embryonic growth arrest|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1856192	T<5J>	MP:0000592,short tail
MGI:2673041	T<5Or>	MP:0001730,embryonic growth arrest|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3578536	t6ga	MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:1858130	T<6J>	MP:0000592,short tail
MGI:2673052	T<6Or>	MP:0001730,embryonic growth arrest|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3029990	T(7;18)50H	MP:0000559,abnormal femur morphology|MP:0000592,short tail|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002673,abnormal sperm number|MP:0002687,oligozoospermia|MP:0002865,increased growth rate|MP:0003109,short femur|MP:0003122,maternal imprinting|MP:0003123,paternal imprinting|MP:0004351,short humerus|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004852,decreased testis weight|MP:0005296,abnormal humerus morphology|MP:0008152,decreased diameter of femur|MP:0008154,decreased diameter of humerus|MP:0008867,uniparental disomy|MP:0009230,abnormal sperm head morphology|MP:0009565,multivalent meiotic configurations|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:3029992	T(7;18)50H	MP:0000559,abnormal femur morphology|MP:0000592,short tail|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002673,abnormal sperm number|MP:0002687,oligozoospermia|MP:0002865,increased growth rate|MP:0003109,short femur|MP:0003122,maternal imprinting|MP:0003123,paternal imprinting|MP:0004351,short humerus|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004852,decreased testis weight|MP:0005296,abnormal humerus morphology|MP:0008152,decreased diameter of femur|MP:0008154,decreased diameter of humerus|MP:0008867,uniparental disomy|MP:0009230,abnormal sperm head morphology|MP:0009565,multivalent meiotic configurations|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5316040	T(7;19)145H	MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0010768,mortality/aging
MGI:5316041	T(7;19)145H	MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0010768,mortality/aging
MGI:2673790	T<7J>	MP:0000592,short tail|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2152905	T<8J>	MP:0000592,short tail|MP:0011091,prenatal lethality, complete penetrance
MGI:3819414	T(9;17)138Ca	MP:0009308,increased adenocarcinoma incidence|MP:0010299,increased mammary gland tumor incidence|MP:0010768,mortality/aging
MGI:2152904	T<9J>	MP:0000592,short tail|MP:0011091,prenatal lethality, complete penetrance
MGI:5288362	Ta33Hl	MP:0000418,focal hair loss|MP:0005382,craniofacial phenotype|MP:0006365,absent guard hair|MP:0009659,striated fur
MGI:6761312	Taar1<em1Ejc>	MP:0012342,high preference for an addictive substance
MGI:6761316	Taar1<em2Ejc>	MP:0012733,abnormal behavioral response to methamphetamine
MGI:5688955	Taar1<m1J>	MP:0008872,abnormal physiological response to xenobiotic|MP:0009749,enhanced behavioral response to addictive substance
MGI:3797798	Taar1<tm1(KOMP)Vlcg>	MP:0005376,homeostasis/metabolism phenotype|MP:0009749,enhanced behavioral response to addictive substance
MGI:5297915	Taar1<tm1Mmil>	MP:0001906,increased dopamine level|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008911,induced hyperactivity|MP:0010069,increased serotonin level|MP:0011016,increased core body temperature
MGI:3818697	Taar1<tm1Tdw>	MP:0001906,increased dopamine level|MP:0003088,abnormal prepulse inhibition|MP:0003964,abnormal noradrenaline level|MP:0005386,behavior/neurological phenotype|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009749,enhanced behavioral response to addictive substance
MGI:6423829	Taar3<em1(IMPC)Mbp>	MP:0000774,decreased brain size|MP:0001304,cataract|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney
MGI:5517413	Taar4<tm3.1Tboz>	MP:0001983,abnormal olfactory system physiology|MP:0008544,impaired olfaction
MGI:3847468	Taar5<tm1(KOMP)Vlcg>	MP:0001983,abnormal olfactory system physiology
MGI:5548865	Taar6<tm1.1(KOMP)Vlcg>	MP:0005573,increased pulmonary respiratory rate|MP:0005576,decreased pulmonary ventilation|MP:0010123,increased bone mineral content|MP:0012125,decreased bronchoconstrictive response
MGI:6430650	Taar8b<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000759,abnormal skeletal muscle morphology|MP:0001304,cataract|MP:0001402,decreased locomotor activity|MP:0002060,abnormal skin morphology|MP:0002699,abnormal vitreous body morphology
MGI:6430653	Taar8c<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001200,thick skin|MP:0001293,anophthalmia|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002699,abnormal vitreous body morphology
MGI:5314079	Tab1<b2b449Clo>	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0004113,abnormal aortic arch morphology|MP:0010402,ventricular septal defect|MP:0011659,interrupted aortic arch, type b|MP:0011662,persistent truncus arteriosus type ii|MP:0011676,aortic arch obstruction
MGI:3814197	Tab1<tm1.1Mis>	MP:0000281,abnormal interventricular septum morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002270,abnormal pulmonary alveolus morphology
MGI:2667182	Tab1<tm1Geny>	MP:0000060,delayed bone ossification|MP:0000157,abnormal sternum morphology|MP:0000272,abnormal aorta morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0000279,ventricular hypoplasia|MP:0000280,thin ventricular wall|MP:0000281,abnormal interventricular septum morphology|MP:0001176,abnormal lung development|MP:0001914,hemorrhage|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002192,hydrops fetalis|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002652,thin myocardium|MP:0002925,abnormal cardiovascular development|MP:0003658,abnormal capillary morphology|MP:0005621,abnormal cell physiology|MP:0006382,abnormal lung epithelium morphology|MP:0009698,heart hemorrhage|MP:0009873,abnormal aorta tunica media morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3814196	Tab1<tm1Mis>	MP:0002169,no abnormal phenotype detected
MGI:2450936	Tab2<tm1Aki>	MP:0000607,abnormal hepatocyte morphology|MP:0003717,pallor|MP:0003888,liver hemorrhage|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011092,embryonic lethality, complete penetrance
MGI:4829863	Tab2<tm1Brs>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5464099	Tab2<tm2.1Aki>	MP:0000259,abnormal vascular development|MP:0003229,abnormal vitelline vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4130227	Tab3<Gt(RRK351)Byg>	MP:0002169,no abnormal phenotype detected
MGI:5780710	Tabl	MP:0000416,sparse hair|MP:0001922,reduced male fertility|MP:0005159,azoospermia|MP:0010231,transverse fur striping
MGI:3603216	Tabw2<TALLYHO/Jng>	MP:0001260,increased body weight|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0008908,increased total fat pad weight
MGI:2156676	Tabw<TALLYHO/Jng>	MP:0001262,decreased body weight
MGI:5484636	Tac1<tm1.1(cre)Hze>	MP:0002169,no abnormal phenotype detected
MGI:2136170	Tac1<tm1Bbm>	MP:0001970,abnormal pain threshold|MP:0003280,urinary incontinence|MP:0010386,abnormal urinary bladder physiology
MGI:2136279	Tac1<tm1Pig>	MP:0001364,decreased anxiety-related response|MP:0003043,hypoalgesia|MP:0003063,increased coping response|MP:0005385,cardiovascular system phenotype
MGI:7643902	Tac2<em1Ysfk>	MP:0003990,decreased neurotransmitter release|MP:0010073,decreased pruritus
MGI:7643915	Tac2<em2Ysfk>	MP:0010073,decreased pruritus
MGI:5484637	Tac2<tm1.1(cre)Hze>	MP:0002169,no abnormal phenotype detected
MGI:5307922	Tac2<tm1.1(cre)Qima>	MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging
MGI:5007356	Tac2<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:5754397	Tac2<tm1Tigm>	MP:0001134,absent corpus luteum|MP:0001260,increased body weight|MP:0001923,reduced female fertility|MP:0001927,abnormal estrous cycle|MP:0001935,decreased litter size|MP:0001938,delayed sexual maturation|MP:0002636,delayed vaginal opening|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003377,late onset of menarche|MP:0003550,short perineum|MP:0004856,decreased ovary weight|MP:0005389,reproductive system phenotype|MP:0009011,prolonged diestrus|MP:0009020,prolonged metestrus
MGI:4847657	Tac4<tm1Albe>	MP:0008186,increased pro-B cell number
MGI:3050542	Tacc2<tm1Jni>	MP:0002006,neoplasm|MP:0002169,no abnormal phenotype detected
MGI:3763220	Tacc3<tm1.1Tno>	MP:0002169,no abnormal phenotype detected
MGI:3763219	Tacc3<tm1.2Tno>	MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2159700	Tacc3<tm1Jni>	MP:0000108,midline facial cleft|MP:0000600,liver hypoplasia|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001698,decreased embryo size|MP:0002123,abnormal definitive hematopoiesis|MP:0004810,decreased hematopoietic stem cell number|MP:0011091,prenatal lethality, complete penetrance
MGI:3763218	Tacc3<tm1Tno>	MP:0000074,abnormal neurocranium morphology|MP:0000163,abnormal cartilage morphology|MP:0000164,abnormal cartilage development|MP:0000592,short tail|MP:0000755,hindlimb paralysis|MP:0001258,decreased body length|MP:0002114,abnormal axial skeleton morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0003743,abnormal facial morphology|MP:0003794,delayed somite formation|MP:0003984,embryonic growth retardation|MP:0004046,abnormal mitosis|MP:0004599,abnormal vertebral arch morphology|MP:0004621,lumbar vertebral fusion|MP:0004653,absent caudal vertebrae|MP:0008271,abnormal bone ossification|MP:0011087,neonatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5911953	Taco1<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0002060,abnormal skin morphology|MP:0002644,decreased circulating triglyceride level|MP:0002833,increased heart weight|MP:0004222,iris synechia|MP:0005554,decreased circulating creatinine level|MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5905291	Taco1<m1Anu>	MP:0000420,ruffled hair|MP:0000876,Purkinje cell degeneration|MP:0001059,optic nerve atrophy|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001625,cardiac hypertrophy|MP:0002090,abnormal vision|MP:0002953,thick ventricular wall|MP:0003786,premature aging|MP:0008511,thin retina inner nuclear layer|MP:0008519,thin retina outer plexiform layer|MP:0010724,thick interventricular septum|MP:0010955,abnormal respiratory electron transport chain|MP:0012017,grizzled coat color|MP:0012065,increased astrocyte number|MP:0020434,increased astrocyte size
MGI:5750980	tacor	MP:0002075,abnormal coat/hair pigmentation
MGI:1934027	Tacr1<tm1Nge>	MP:0001800,abnormal humoral immune response|MP:0002272,abnormal nervous system electrophysiology|MP:0002423,abnormal mast cell physiology|MP:0003071,decreased vascular permeability
MGI:2183231	Tacr1<tm1Rhn>	MP:0001364,decreased anxiety-related response|MP:0001777,abnormal body temperature homeostasis|MP:0002665,decreased circulating corticosterone level|MP:0002736,abnormal nociception after inflammation|MP:0004811,abnormal neuron physiology|MP:0005498,hyporesponsive to tactile stimuli|MP:0008531,increased chemical nociceptive threshold|MP:0008872,abnormal physiological response to xenobiotic|MP:0009747,impaired behavioral response to xenobiotic|MP:0020351,decreased vocalization
MGI:2182395	Tacr1<tm1Sph>	MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001876,decreased inflammatory response|MP:0001905,abnormal dopamine level|MP:0001952,increased airway responsiveness|MP:0001968,abnormal touch/nociception|MP:0001970,abnormal pain threshold|MP:0002281,abnormal respiratory mucosa goblet cell morphology|MP:0002735,abnormal chemical nociception|MP:0002933,joint inflammation|MP:0003481,decreased nerve fiber response intensity|MP:0003633,abnormal nervous system physiology|MP:0003663,abnormal thermosensation|MP:0003964,abnormal noradrenaline level|MP:0005407,hyperalgesia|MP:0005656,decreased aggression|MP:0009712,impaired conditioned place preference behavior|MP:0009750,impaired behavioral response to addictive substance|MP:0009757,impaired behavioral response to morphine|MP:0020844,abnormal pulmonary respiratory rate response|MP:0031391,increased locomotor activity
MGI:4420122	Tacr2<tm1(KOMP)Wtsi>	MP:0002773,decreased circulating luteinizing hormone level|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005559,increased circulating glucose level
MGI:6272656	Tacr3<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001312,abnormal cornea morphology|MP:0001926,female infertility|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:3841488	Tacr3<tm1Jasi>	MP:0001147,small testis|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001463,abnormal spatial learning|MP:0001923,reduced female fertility|MP:0001927,abnormal estrous cycle|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0002798,abnormal active avoidance behavior|MP:0004000,impaired passive avoidance behavior|MP:0004905,decreased uterus weight|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0009011,prolonged diestrus
MGI:6276936	Tacstd2<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001297,microphthalmia|MP:0001417,decreased exploration in new environment|MP:0002092,abnormal eye morphology
MGI:5316861	Tacstd2<tm1Lsm>	MP:0002006,neoplasm|MP:0005380,embryo phenotype|MP:0010768,mortality/aging
MGI:5635385	Tada1<tm1b(KOMP)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5462193	Tada3<tm1.1Viba>	MP:0002169,no abnormal phenotype detected|MP:0004046,abnormal mitosis|MP:0011704,decreased fibroblast proliferation
MGI:5462194	Tada3<tm1.2Viba>	MP:0004964,absent inner cell mass|MP:0010039,abnormal trophoblast giant cell proliferation|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance
MGI:1856563	t<AE5>	MP:0000324,increased mast cell number|MP:0000592,short tail|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000711,thymus cortex hypoplasia|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002111,abnormal tail morphology|MP:0002371,abnormal thymus cortex morphology|MP:0002406,increased susceptibility to infection|MP:0008254,increased megakaryocyte cell number|MP:0008279,arrest of spermiogenesis|MP:0008479,decreased spleen white pulp amount|MP:0008995,early reproductive senescence|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3605460	Taf10<tm1.1Lzt>	MP:0002085,abnormal embryonic tissue morphology|MP:0002718,abnormal inner cell mass morphology|MP:0003886,abnormal embryonic epiblast morphology|MP:0003984,embryonic growth retardation|MP:0005031,abnormal trophoblast layer morphology|MP:0010380,abnormal inner cell mass apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011184,absent embryonic epiblast|MP:0011189,small embryonic epiblast|MP:0012114,absent inner cell mass proliferation
MGI:3606185	Taf10<tm1Lzt>	MP:0001191,abnormal skin condition|MP:0001196,shiny skin|MP:0001216,abnormal epidermal layer morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001241,absent epidermis stratum corneum|MP:0001429,dehydration|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0003853,dry skin|MP:0009608,abnormal epidermal lamellar body morphology|MP:0010771,integument phenotype|MP:0011089,perinatal lethality, complete penetrance
MGI:4842481	Taf11<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6276947	Taf12<em1(IMPC)Mbp>	MP:0001727,abnormal embryo implantation|MP:0001728,failure of embryo implantation|MP:0001730,embryonic growth arrest|MP:0002151,abnormal neural tube morphology|MP:0003720,abnormal neural tube closure|MP:0004964,absent inner cell mass|MP:0006108,abnormal hindbrain development|MP:0009687,empty decidua capsularis|MP:0011093,embryonic lethality at implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:5905737	Taf13<em1(IMPC)J>	MP:0001672,abnormal embryo development|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0003087,absent allantois|MP:0003886,abnormal embryonic epiblast morphology|MP:0003984,embryonic growth retardation|MP:0005030,absent amnion|MP:0009331,absent primitive node|MP:0009593,absent chorion|MP:0009687,empty decidua capsularis|MP:0010052,increased grip strength|MP:0010736,abnormal extraembryonic ectoderm morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011189,small embryonic epiblast|MP:0011208,small proamniotic cavity|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance|MP:0014586,decreased egg cylinder size
MGI:7377685	Taf15<em1(IMPC)Mbp>	MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0005013,increased lymphocyte cell number|MP:0013279,increased fasting circulating glucose level|MP:0020421,increased freezing behavior
MGI:6467480	Taf1a<em1(IMPC)Bay>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012129,failure of blastocyst formation
MGI:4434759	Taf1b<tm1a(EUCOMM)Hmgu>	MP:0011091,prenatal lethality, complete penetrance
MGI:6887478	Taf1b<tm1d(EUCOMM)Hmgu>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:7426012	Taf1c<em1(IMPC)Bay>	MP:0001399,hyperactivity|MP:0001728,failure of embryo implantation|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:7426013	Taf1d<em1(IMPC)Bay>	MP:0001728,failure of embryo implantation|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:8275769	Taf2<em1Dsar>	MP:0000609,abnormal liver physiology|MP:0001860,liver inflammation|MP:0003333,liver fibrosis|MP:0004499,increased incidence of tumors by chemical induction|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:6120788	Taf2<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0001556,increased circulating HDL cholesterol level|MP:0004357,long tibia|MP:0005178,increased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:2152347	Taf4b<tm1Rtj>	MP:0001125,abnormal oocyte morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001132,absent mature ovarian follicles|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0002685,abnormal spermatogonia proliferation|MP:0002687,oligozoospermia|MP:0002777,absent ovarian follicles|MP:0003378,early sexual maturation|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005431,decreased oocyte number|MP:0008995,early reproductive senescence|MP:0009017,prolonged estrus|MP:0009648,abnormal superovulation|MP:0011121,decreased primordial ovarian follicle number|MP:0011127,abnormal tertiary ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0013236,ovary degeneration|MP:0013508,increased granulosa cell apoptosis|MP:0014604,hemorrhagic ovary cyst|MP:0031018,decreased granulosa cell proliferation|MP:0031020,premature ovarian failure|MP:0031239,increased atretic ovarian follicle number|MP:0031354,abnormal acrosome assembly|MP:0031381,decreased secondary ovarian follicle number
MGI:3758059	Taf4<tm1.1Idvd>	MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011703,increased fibroblast proliferation|MP:0013502,decreased fibroblast apoptosis
MGI:3758058	Taf4<tm1Idvd>	MP:0000367,abnormal coat/ hair morphology|MP:0000416,sparse hair|MP:0000427,abnormal hair cycle|MP:0000585,kinked tail|MP:0001191,abnormal skin condition|MP:0001192,scaly skin|MP:0001199,thin skin|MP:0001201,translucent skin|MP:0001222,epidermal hyperplasia|MP:0001247,dermal cyst|MP:0001263,weight loss|MP:0002018,increased malignant tumor incidence|MP:0002060,abnormal skin morphology|MP:0002111,abnormal tail morphology|MP:0002499,chronic inflammation|MP:0002796,impaired skin barrier function|MP:0003809,abnormal hair shaft morphology|MP:0003853,dry skin|MP:0004207,increased squamous cell carcinoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0009583,increased keratinocyte proliferation|MP:0011087,neonatal lethality, complete penetrance
MGI:6324237	Taf5<em1(IMPC)J>	MP:0001727,abnormal embryo implantation|MP:0001728,failure of embryo implantation|MP:0001730,embryonic growth arrest|MP:0002718,abnormal inner cell mass morphology|MP:0003886,abnormal embryonic epiblast morphology|MP:0004964,absent inner cell mass|MP:0005028,abnormal trophectoderm morphology|MP:0009687,empty decidua capsularis|MP:0010024,increased total body fat amount|MP:0010052,increased grip strength|MP:0011093,embryonic lethality at implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011183,abnormal primitive endoderm morphology
MGI:5286639	Taf6<Tg(Tyr)2391A-1cOve>	MP:0006204,embryonic lethality before implantation
MGI:5751154	Taf6<tm1b(EUCOMM)Hmgu>	MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness|MP:0013292,embryonic lethality prior to organogenesis
MGI:3710399	Taf7l<tm1.1Jw>	MP:0000733,abnormal muscle development|MP:0001146,abnormal testis morphology|MP:0001780,decreased brown adipose tissue amount|MP:0001922,reduced male fertility|MP:0001929,abnormal gametogenesis|MP:0001935,decreased litter size|MP:0002106,abnormal muscle physiology|MP:0002216,abnormal seminiferous tubule morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002971,abnormal brown adipose tissue morphology|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006036,abnormal mitochondrial physiology|MP:0009137,decreased brown fat lipid droplet number|MP:0009237,kinked sperm flagellum|MP:0009243,hairpin sperm flagellum|MP:0009295,decreased interscapular fat pad weight|MP:0011170,abnormal brown fat cell differentiation|MP:0011699,abnormal brown adipose tissue thermogenesis
MGI:3526167	Taf7l<tm1Jw>	MP:0005389,reproductive system phenotype
MGI:5430372	Taf7<tm1.1Dss>	MP:0001672,abnormal embryo development|MP:0011092,embryonic lethality, complete penetrance
MGI:3033758	Taf8<Gt(pGT1.8geo)9Pgr>	MP:0004965,inner cell mass degeneration|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5696915	Taf8<tm2b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4128605	Taf9b<Gt(TEA124)Byg>	MP:0002169,no abnormal phenotype detected
MGI:5635076	Tafa1<tm1.1(KOMP)Vlcg>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0010053,decreased grip strength
MGI:5286469	Tafa1<tm1(KOMP)Vlcg>	MP:0001364,decreased anxiety-related response|MP:0001973,increased thermal nociceptive threshold|MP:0003631,nervous system phenotype|MP:0004889,increased energy expenditure|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0008965,increased basal metabolism|MP:0011939,increased food intake|MP:0011940,decreased food intake|MP:0011945,increased eating frequency|MP:0012575,increased noradrenaline level|MP:0020422,decreased freezing behavior|MP:0020874,abnormal nervous system dopamine level|MP:0031391,increased locomotor activity
MGI:6140087	Tafa2<em1Hssh>	MP:0001363,increased anxiety-related response|MP:0020421,increased freezing behavior
MGI:6153792	Tafa2<em1(IMPC)H>	MP:0000745,tremors|MP:0013278,decreased fasting circulating glucose level|MP:0020421,increased freezing behavior
MGI:6355950	Tafa2<tm1Zgwg>	MP:0001363,increased anxiety-related response|MP:0003063,increased coping response|MP:0003240,loss of hippocampal neurons|MP:0003241,loss of cortex neurons|MP:0003927,increased cellular glucose import|MP:0008143,abnormal dendrite morphology|MP:0008414,abnormal spatial reference memory|MP:0009538,abnormal synapse morphology|MP:0012307,impaired spatial learning|MP:0014178,increased brain apoptosis|MP:0014365,impaired short-term object recognition memory|MP:0014367,impaired long-term object recognition memory
MGI:6140086	Tafa3<em1Hssh>	MP:0001363,increased anxiety-related response|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0002557,abnormal social/conspecific interaction behavior|MP:0005386,behavior/neurological phenotype|MP:0020395,abnormal response to social novelty|MP:0031391,increased locomotor activity
MGI:6152486	Tafa3<em1(IMPC)Mbp>	MP:0002092,abnormal eye morphology|MP:0003795,abnormal bone structure|MP:0010123,increased bone mineral content
MGI:6276889	Tafa4<em1(IMPC)Mbp>	MP:0002608,increased hematocrit|MP:0002968,increased circulating alkaline phosphatase level
MGI:6368862	Tafa4<tm1.1Azmo>	MP:0002272,abnormal nervous system electrophysiology|MP:0002734,abnormal mechanical nociception|MP:0002736,abnormal nociception after inflammation|MP:0003631,nervous system phenotype|MP:0005402,abnormal action potential|MP:0008531,increased chemical nociceptive threshold
MGI:8161954	Tafa5<em1Yw>	MP:0000807,abnormal hippocampus morphology|MP:0001262,decreased body weight|MP:0002573,behavioral despair|MP:0004495,decreased synaptic glutamate release|MP:0008432,abnormal long-term spatial reference memory|MP:0009710,anhedonia|MP:0012307,impaired spatial learning|MP:0012775,abnormal brain weight|MP:0014414,increased depression-related behavior|MP:0020508,decreased dendritic spine density|MP:0021001,impaired neuron physiology|MP:0031391,increased locomotor activity
MGI:2155688	Tafat<TALLYHO/Jng>	MP:0001783,decreased white adipose tissue amount
MGI:7520216	Tafazzin<em1Xfa>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003921,abnormal heart left ventricle morphology|MP:0004777,abnormal phospholipid level|MP:0006036,abnormal mitochondrial physiology|MP:0008770,decreased survivor rate|MP:0010954,abnormal cellular respiration|MP:0010955,abnormal respiratory electron transport chain|MP:0011628,increased mitochondrial number|MP:0011631,decreased mitochondrial size|MP:0011633,abnormal mitochondrial shape|MP:0011636,disorganized mitochondrial cristae|MP:0011925,abnormal heart echocardiography feature|MP:0031511,globular heart|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5825473	Tafazzin<tm1Dost>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0005385,cardiovascular system phenotype|MP:0006379,abnormal spermatocyte morphology
MGI:6156489	Tagap1<em1(IMPC)Tcp>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001297,microphthalmia|MP:0002060,abnormal skin morphology|MP:0002644,decreased circulating triglyceride level|MP:0003068,enlarged kidney|MP:0005179,decreased circulating cholesterol level|MP:0005565,increased blood urea nitrogen level
MGI:6156457	Tagln2<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000219,increased neutrophil cell number|MP:0000691,enlarged spleen|MP:0002060,abnormal skin morphology|MP:0002574,increased vertical activity|MP:0002599,increased mean platelet volume|MP:0005016,decreased lymphocyte cell number|MP:0010067,increased red blood cell distribution width|MP:0010393,shortened QRS complex duration
MGI:6118987	Tagln2<tm1Cdj>	MP:0002444,abnormal T cell physiology|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005387,immune system phenotype
MGI:3526077	Tagln<tm1Liw>	MP:0002169,no abnormal phenotype detected
MGI:2183575	Tagln<tm1Msp>	MP:0002169,no abnormal phenotype detected|MP:0005385,cardiovascular system phenotype
MGI:3706313	Tagln<tm2(cre)Yec>	MP:0002169,no abnormal phenotype detected
MGI:3527694	Tailaq1<L6>	MP:0002758,long tail
MGI:3527063	Tailaq2<L6>	MP:0002758,long tail
MGI:3527707	Tailaq3<M16i>	MP:0002758,long tail
MGI:3527711	Tailaq4<M16i>	MP:0002758,long tail
MGI:3527691	Tailq1<M16i>	MP:0002758,long tail
MGI:3526996	Tailq2<M16i>	MP:0002758,long tail
MGI:3527705	Tailq3<M16i>	MP:0002758,long tail
MGI:3526998	Tailq4<M16i>	MP:0002758,long tail
MGI:3527041	Tailq5<M16i>	MP:0002758,long tail
MGI:3527713	Tailq6<M16i>	MP:0002758,long tail
MGI:3698775	Tailq7<CAST/EiJ>	MP:0000592,short tail
MGI:3698807	Tailq8<CAST/EiJ>	MP:0002758,long tail
MGI:1861131	Tal	MP:0000564,syndactyly|MP:0000572,abnormal autopod morphology|MP:0000579,abnormal nail morphology|MP:0000580,deformed nails|MP:0000583,long toenails|MP:0000585,kinked tail|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002082,postnatal lethality|MP:0002110,abnormal digit morphology|MP:0002543,brachyphalangia|MP:0002932,abnormal joint morphology|MP:0003072,abnormal metatarsal bone morphology|MP:0004619,caudal vertebral fusion|MP:0004635,short metatarsal bones|MP:0005306,abnormal phalanx morphology|MP:0008770,decreased survivor rate
MGI:1859843	Tal1<Hpt>	MP:0000221,decreased leukocyte cell number|MP:0000231,hypertension|MP:0000245,abnormal erythropoiesis|MP:0000274,enlarged heart|MP:0000379,decreased hair follicle number|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000418,focal hair loss|MP:0001265,decreased body size|MP:0001510,abnormal coat appearance|MP:0001577,anemia|MP:0001675,abnormal ectoderm development|MP:0002073,abnormal hair growth|MP:0002095,abnormal skin pigmentation|MP:0002135,abnormal kidney morphology|MP:0002625,heart left ventricle hypertrophy|MP:0003606,kidney failure|MP:0003704,abnormal hair follicle development|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0008059,abnormal podocyte foot process morphology|MP:0008139,fused podocyte foot processes|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5527393	Tal1<tm1.1Bgo>	MP:0002398,abnormal bone marrow cell morphology/development|MP:0004809,increased hematopoietic stem cell number|MP:0005397,hematopoietic system phenotype
MGI:3808120	Tal1<tm1Por>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0002591,decreased mean corpuscular volume|MP:0002642,anisocytosis|MP:0002810,microcytic anemia|MP:0002874,decreased hemoglobin content|MP:0004229,abnormal embryonic erythropoiesis|MP:0004952,increased spleen weight|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008770,decreased survivor rate|MP:0008801,abnormal erythroid progenitor cell morphology|MP:0010067,increased red blood cell distribution width|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:1857254	Tal1<tm1Sho>	MP:0000239,absent common myeloid progenitor cells|MP:0000292,distended pericardium|MP:0001577,anemia|MP:0001689,incomplete somite formation|MP:0001698,decreased embryo size|MP:0001721,absent visceral yolk sac blood islands|MP:0003396,abnormal embryonic hematopoiesis|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013241,embryo tissue necrosis
MGI:3806344	Tal1<tm1(tTA)Bock>	MP:0008762,embryonic lethality
MGI:1857566	Tal1<tm1Wehi>	MP:0000292,distended pericardium|MP:0001701,incomplete embryo turning|MP:0001719,absent vitelline blood vessels|MP:0001721,absent visceral yolk sac blood islands|MP:0001722,pale yolk sac|MP:0001730,embryonic growth arrest|MP:0001786,skin edema|MP:0003396,abnormal embryonic hematopoiesis|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2661471	Tal1<tm2Sho>	MP:0001577,anemia|MP:0002083,premature death|MP:0003179,thrombocytopenia
MGI:1858004	Tal1<tm2Wehi>	MP:0000267,abnormal heart development|MP:0000292,distended pericardium|MP:0001577,anemia|MP:0001614,abnormal blood vessel morphology|MP:0001719,absent vitelline blood vessels|MP:0001721,absent visceral yolk sac blood islands|MP:0001723,disorganized yolk sac vascular plexus|MP:0001730,embryonic growth arrest|MP:0001787,pericardial edema|MP:0002725,abnormal vein morphology|MP:0003203,increased neuron apoptosis|MP:0003396,abnormal embryonic hematopoiesis|MP:0004068,dilated dorsal aorta|MP:0005039,hypoxia|MP:0009328,delayed heart looping|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7426014	Tal2<em1(IMPC)H>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:2684532	Tal2<tm1Thr>	MP:0000776,abnormal inferior colliculus morphology|MP:0000825,dilated lateral ventricle|MP:0000832,abnormal thalamus morphology|MP:0000904,abnormal superior colliculus morphology|MP:0000917,obstructive hydrocephaly|MP:0000947,convulsive seizures|MP:0001402,decreased locomotor activity|MP:0001732,postnatal growth retardation|MP:0002892,decreased superior colliculus size|MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0006104,abnormal tectum morphology|MP:0011083,lethality at weaning, complete penetrance
MGI:5510539	Tal44H	MP:0000418,focal hair loss|MP:0000585,kinked tail|MP:0006365,absent guard hair|MP:0009659,striated fur
MGI:3690444	Taldo1<tm1Perl>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0003698,abnormal male reproductive system physiology|MP:0003806,abnormal nucleotide metabolism|MP:0004542,impaired acrosome reaction|MP:0004543,abnormal sperm physiology|MP:0014465,abnormal sperm mitochondrial morphology
MGI:3723519	Tamalin<tm1.1Nak>	MP:0001982,decreased chemically-elicited antinociception|MP:0009712,impaired conditioned place preference behavior|MP:0009757,impaired behavioral response to morphine
MGI:5318549	Tamalin<tm1.1Tes>	MP:0001473,reduced long-term potentiation|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0009937,abnormal neuron differentiation|MP:0009967,abnormal neuron proliferation
MGI:3757981	Tamalin<tm2.1Nak>	MP:0005380,embryo phenotype
MGI:5644833	Tamm41<tm1b(KOMP)Wtsi>	MP:0008762,embryonic lethality
MGI:4839178	Tamm41<tm1(NCOM)Cmhd>	MP:0008810,increased circulating iron level
MGI:6156475	Tanc1<em1(IMPC)Tcp>	MP:0002060,abnormal skin morphology|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0011874,enlarged urinary bladder
MGI:4125076	Tanc1<Gt(XE017)Byg>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory|MP:0009936,abnormal dendritic spine morphology
MGI:6384591	Tanc2<em1(IMPC)Hmgu>	MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001566,increased circulating phosphate level|MP:0002764,short tibia|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0005293,impaired glucose tolerance|MP:0010052,increased grip strength|MP:0010379,decreased respiratory quotient
MGI:4346764	Tanc2<Gt(AS0986)Wtsi>	MP:0011092,embryonic lethality, complete penetrance
MGI:6257625	Tango2<em1(IMPC)Bay>	MP:0000062,increased bone mineral density|MP:0010052,increased grip strength
MGI:5548745	Tango6<tm1b(EUCOMM)Hmgu>	MP:0002092,abnormal eye morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2429609	Tanidd1<TALLYHO/Jng>	MP:0001559,hyperglycemia
MGI:2389324	Tanidd2<TALLYHO/Jng>	MP:0001559,hyperglycemia
MGI:2429607	Tanidd3<TALLYHO/Jng>	MP:0001559,hyperglycemia
MGI:4355741	Tank<tm1Aki>	MP:0000693,spleen hyperplasia|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002083,premature death|MP:0002376,abnormal dendritic cell physiology|MP:0002451,abnormal macrophage physiology|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002743,glomerulonephritis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005154,increased B cell proliferation|MP:0008097,increased plasma cell number|MP:0008102,lymph node hyperplasia|MP:0008210,increased mature B cell number|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008560,increased tumor necrosis factor secretion|MP:0008562,increased interferon-alpha secretion|MP:0008705,increased interleukin-6 secretion|MP:0008769,abnormal plasmacytoid dendritic cell physiology|MP:0020519,renal glomerular immunoglobulin deposits
MGI:7539359	Taok1<em1Bcgen>	MP:0000434,megacephaly|MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001529,abnormal vocalization|MP:0002176,increased brain weight|MP:0004144,hypotonia|MP:0004811,abnormal neuron physiology|MP:0004861,abnormal Raphe nucleus morphology|MP:0005238,increased brain size|MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype|MP:0010053,decreased grip strength|MP:0011400,lethality, complete penetrance|MP:0014416,decreased social novelty preference|MP:0020351,decreased vocalization|MP:0020551,abnormal postsynaptic density morphology|MP:0021111,decreased social investigation
MGI:7539703	Taok1<em1Cya>	MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0021111,decreased social investigation
MGI:7293333	Taok1<em1(IMPC)Tcp>	MP:0000220,increased monocyte cell number|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5287268	Taok2<Tg(Tyr)2276AOve>	MP:0001265,decreased body size
MGI:5554941	Taok2<tm1.1Dkap>	MP:0003545,increased alcohol consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0009751,enhanced behavioral response to alcohol
MGI:5554942	Taok2<tm1.2Dkap>	MP:0003545,increased alcohol consumption|MP:0009642,abnormal blood homeostasis|MP:0009712,impaired conditioned place preference behavior|MP:0009755,impaired behavioral response to alcohol|MP:0011617,abnormal habituation|MP:0011941,increased fluid intake
MGI:6305716	Taok2<tm1b(EUCOMM)Hmgu>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005238,increased brain size|MP:0008221,abnormal hippocampal commissure morphology|MP:0008226,decreased anterior commissure size|MP:0012443,increased corpus callosum size|MP:0012450,decreased primary motor cortex size|MP:0012473,increased cingulate cortex size
MGI:6159644	Taok3<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation
MGI:4329673	Taok3<Gt(RRK451)Byg>	MP:0002863,improved righting response|MP:0005386,behavior/neurological phenotype|MP:0009755,impaired behavioral response to alcohol|MP:0011092,embryonic lethality, complete penetrance
MGI:6113562	Tap1<m1Btlr>	MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010839,decreased CD8-positive, alpha-beta memory T cell number
MGI:5806457	Tap1<m2Btlr>	MP:0001606,impaired hematopoiesis|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:3797750	Tap1<rose>	MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:1857253	Tap1<tm1Arp>	MP:0000727,absent CD8-positive, alpha-beta T cells|MP:0001835,abnormal antigen presentation|MP:0001836,abnormal antigen presentation via MHC class I|MP:0001837,defective assembly of class I molecules|MP:0001838,defective intracellular transport of class I molecules|MP:0001841,decreased level of surface class I molecules|MP:0002411,decreased susceptibility to bacterial infection|MP:0002455,abnormal dendritic cell antigen presentation|MP:0003945,abnormal lymphocyte physiology|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005089,decreased double-negative T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008086,increased T-helper 1 cell number|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:1858161	Tap1<tm1Hpl>	MP:0005387,immune system phenotype
MGI:5692917	Tap1<tm2b(EUCOMM)Hmgu>	MP:0001488,increased startle reflex
MGI:3611893	Tap2<jas>	MP:0000727,absent CD8-positive, alpha-beta T cells|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:4442846	Tap2<m1Btlr>	MP:0000727,absent CD8-positive, alpha-beta T cells|MP:0001837,defective assembly of class I molecules|MP:0001841,decreased level of surface class I molecules|MP:0005078,abnormal cytotoxic T cell physiology|MP:0010766,abnormal NK cell physiology
MGI:5613166	Tap2<m2Btlr>	MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:6113680	Tap2<m3Btlr>	MP:0008040,decreased NK T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010845,decreased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6286077	Tap2<M4Btlr>	MP:0008074,increased CD4-positive, alpha-beta T cell number
MGI:2386113	Tapbp<tm1Gjh>	MP:0001836,abnormal antigen presentation via MHC class I|MP:0001841,decreased level of surface class I molecules|MP:0002455,abnormal dendritic cell antigen presentation|MP:0005018,decreased T cell number|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0010766,abnormal NK cell physiology
MGI:1888941	Tapbp<tm1Luc>	MP:0001836,abnormal antigen presentation via MHC class I|MP:0001837,defective assembly of class I molecules|MP:0001841,decreased level of surface class I molecules|MP:0003945,abnormal lymphocyte physiology|MP:0005078,abnormal cytotoxic T cell physiology|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3033936	Tapr<BALB/c>	MP:0001845,abnormal inflammatory response
MGI:3760260	Tapt1<L5Jcs1>	MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004678,split xiphoid process|MP:0005508,abnormal skeleton morphology|MP:0008148,abnormal sternocostal joint morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:5287259	Tapt1<TgTn(sb-cHS4,Tyr)2508GOve>	MP:0000111,cleft palate|MP:0001577,anemia
MGI:5692872	Tarbp1<tm1b(EUCOMM)Hmgu>	MP:0000195,decreased circulating calcium level|MP:0003020,decreased circulating chloride level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration
MGI:5645258	Tarbp2<tm1.1Dzw>	MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0003140,dilated heart atrium|MP:0003141,cardiac fibrosis|MP:0004937,dilated heart|MP:0008022,dilated heart ventricle|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5645259	Tarbp2<tm1.2Dzw>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0011100,preweaning lethality, complete penetrance
MGI:2445673	Tarbp2<tm1Reb>	MP:0001262,decreased body weight|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0011083,lethality at weaning, complete penetrance
MGI:6405404	Tardbp<em1Koya>	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:6157626	Tardbp<em1Rhbr>	MP:0001260,increased body weight|MP:0001392,abnormal locomotor behavior|MP:0001405,impaired coordination|MP:0001431,abnormal eating behavior|MP:0001433,polyphagia|MP:0001458,abnormal object recognition memory|MP:0002063,abnormal learning/memory/conditioning|MP:0002574,increased vertical activity|MP:0003245,abnormal GABAergic neuron morphology|MP:0003631,nervous system phenotype|MP:0003908,decreased stereotypic behavior|MP:0004101,abnormal brain interneuron morphology|MP:0005386,behavior/neurological phenotype|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014114,abnormal cognition|MP:0014115,cognitive inflexibility
MGI:4126090	Tardbp<Gt(RRB030)Byg>	MP:0010053,decreased grip strength|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5575763	Tardbp<m1H>	MP:0001513,limb grasping|MP:0003157,impaired muscle relaxation|MP:0003631,nervous system phenotype|MP:0004142,abnormal muscle tone|MP:0011092,embryonic lethality, complete penetrance
MGI:6355456	Tardbp<Rgsc2223>	MP:0000939,decreased motor neuron number|MP:0010053,decreased grip strength|MP:0010768,mortality/aging|MP:0011091,prenatal lethality, complete penetrance
MGI:6355454	Tardbp<Rgsc2268>	MP:0011091,prenatal lethality, complete penetrance
MGI:4418700	Tardbp<tm1.1Ckjs>	MP:0011092,embryonic lethality, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:7282115	Tardbp<tm1.1Hiok>	MP:0000788,abnormal cerebral cortex morphology|MP:0000798,abnormal frontal lobe morphology|MP:0001260,increased body weight|MP:0001363,increased anxiety-related response|MP:0004045,abnormal cell cycle checkpoint function|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0012307,impaired spatial learning|MP:0012448,abnormal primary motor cortex morphology
MGI:5643696	Tardbp<tm1.1Jrob>	MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6405194	Tardbp<tm1.1Neas>	MP:0000940,abnormal motor neuron innervation pattern|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0008918,microgliosis
MGI:4834273	Tardbp<tm1.1Pcw>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001922,reduced male fertility|MP:0002687,oligozoospermia|MP:0002970,abnormal white adipose tissue morphology|MP:0003702,abnormal chromosome morphology|MP:0004023,abnormal chromosome number|MP:0004129,abnormal respiratory quotient|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005449,abnormal food intake|MP:0005578,teratozoospermia|MP:0008261,arrest of male meiosis|MP:0008892,abnormal sperm flagellum morphology|MP:0009116,abnormal brown fat cell morphology|MP:0009117,abnormal white fat cell morphology|MP:0009230,abnormal sperm head morphology|MP:0009234,absent sperm head|MP:0009299,decreased mesenteric fat pad weight|MP:0009451,abnormal chromosomal synapsis|MP:0010025,decreased total body fat amount|MP:0010769,abnormal survival|MP:0010951,abnormal lipid oxidation|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014052,increased male germ cell apoptosis|MP:0014764,impaired double-strand DNA break repair
MGI:7311560	Tardbp<tm1.1Sobue>	MP:0000745,tremors|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001263,weight loss|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002269,muscular atrophy|MP:0003354,astrocytosis|MP:0005405,axon degeneration|MP:0010053,decreased grip strength|MP:0030939,abnormal autophagosome formation
MGI:4834280	Tardbp<tm1.2Pcw>	MP:0011091,prenatal lethality, complete penetrance
MGI:5692816	Tardbp<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001486,abnormal startle reflex|MP:0005566,decreased blood urea nitrogen level|MP:0008935,decreased mean platelet volume|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5819107	Tardbp<tm1(TARDBP*G348C/Venus)Okn>	MP:0002066,abnormal motor capabilities/coordination/movement|MP:0008489,slow postnatal weight gain
MGI:6404631	Tardbp<tm2.1Ckjs>	MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging
MGI:6405195	Tardbp<tm2.1Neas>	MP:0000938,motor neuron degeneration|MP:0000940,abnormal motor neuron innervation pattern|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0008918,microgliosis
MGI:5819108	Tardbp<tm2(TARDBP*A382T/Venus)Okn>	MP:0002066,abnormal motor capabilities/coordination/movement|MP:0008489,slow postnatal weight gain
MGI:6404633	Tardbp<tm3.1Ckjs>	MP:0000160,kyphosis|MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001263,weight loss|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0003354,astrocytosis|MP:0004231,abnormal calcium ion homeostasis|MP:0005404,abnormal axon morphology|MP:0009417,skeletal muscle atrophy|MP:0011085,postnatal lethality, complete penetrance|MP:0011975,neuronal cytoplasmic inclusions|MP:0012051,spasticity
MGI:6509631	Tarm1<tm1Yiw>	MP:0002455,abnormal dendritic cell antigen presentation|MP:0003436,decreased susceptibility to induced arthritis|MP:0003945,abnormal lymphocyte physiology|MP:0005017,decreased B cell number|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008115,abnormal dendritic cell differentiation|MP:0008127,decreased dendritic cell number|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008556,abnormal tumor necrosis factor secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008704,abnormal interleukin-6 secretion|MP:0014706,decreased synovial pannus formation
MGI:7539369	Tars1<em1Cya>	MP:0011091,prenatal lethality, complete penetrance
MGI:6404487	Tars2<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6383174	Tars3<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0001399,hyperactivity|MP:0001489,decreased startle reflex|MP:0002757,decreased vertical activity|MP:0003960,increased lean body mass|MP:0005419,decreased circulating serum albumin level|MP:0005565,increased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0010025,decreased total body fat amount
MGI:7539368	Tars3<em1Smoc>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001732,postnatal growth retardation|MP:0002113,abnormal skeleton development|MP:0002644,decreased circulating triglyceride level|MP:0002891,increased insulin sensitivity|MP:0003081,abnormal soleus morphology|MP:0003083,abnormal tibialis anterior morphology|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005605,increased bone mass|MP:0009400,decreased skeletal muscle fiber size|MP:0010868,increased bone trabecula number|MP:0013278,decreased fasting circulating glucose level|MP:0013629,abnormal bone trabecular spacing
MGI:5646390	Tas16	MP:0003051,curly tail
MGI:2681885	Tas1r1<tm1Csz>	MP:0004213,abnormal umami taste sensitivity|MP:0005423,abnormal somatic nervous system physiology
MGI:5430605	Tas1r1<tm1Uboe>	MP:0001156,abnormal spermatogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0013288,premature acrosome reaction|MP:0014052,increased male germ cell apoptosis|MP:0020550,multinucleated giant male germ cells
MGI:2681886	Tas1r2<tm1Csz>	MP:0004209,abnormal sweet taste sensitivity|MP:0005423,abnormal somatic nervous system physiology
MGI:4867646	Tas1r2<tm1Keiw>	MP:0004209,abnormal sweet taste sensitivity
MGI:2681887	Tas1r3<tm1Csz>	MP:0004209,abnormal sweet taste sensitivity|MP:0004213,abnormal umami taste sensitivity|MP:0005423,abnormal somatic nervous system physiology
MGI:4418185	Tas1r3<tm1Jolc>	MP:0001986,abnormal taste sensitivity
MGI:2678581	Tas1r3<tm1Rfm>	MP:0004209,abnormal sweet taste sensitivity|MP:0004213,abnormal umami taste sensitivity|MP:0005423,abnormal somatic nervous system physiology
MGI:5496842	Tas2	MP:0000373,belly spot|MP:0002939,head spot|MP:0010016,variable depigmentation
MGI:6257655	Tas2r102<em1(IMPC)Bay>	MP:0000639,abnormal adrenal gland morphology|MP:0005561,increased mean corpuscular hemoglobin
MGI:6220917	Tas2r103<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:3576385	Tas2r105<tm2Csz>	MP:0004210,abnormal bitter taste sensitivity
MGI:6257476	Tas2r131<em1(IMPC)Bay>	MP:0000689,abnormal spleen morphology|MP:0011239,abnormal skin coloration
MGI:5629321	Tas2r138<tm1.1(KOMP)Vlcg>	MP:0001513,limb grasping
MGI:6152655	Tas2r139<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002059,abnormal seminal vesicle morphology
MGI:5496923	Tas4	MP:0002940,variable body spotting
MGI:5646497	Tas6	MP:0000373,belly spot|MP:0002939,head spot|MP:0011568,decreased foot pigmentation
MGI:8203544	Tasl<em1Bcgen>	MP:0001819,abnormal immune cell physiology|MP:0004802,decreased susceptibility to systemic lupus erythematosus|MP:0014436,decreased interferon level
MGI:6157546	Tasor2<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002574,increased vertical activity|MP:0009141,increased prepulse inhibition
MGI:6341945	Tasor<em1(IMPC)Ccpcz>	MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5659903	Tasor<MommeD20>	MP:0003984,embryonic growth retardation|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:3586553	Tasor<MommeD6>	MP:0001730,embryonic growth arrest|MP:0003984,embryonic growth retardation|MP:0013292,embryonic lethality prior to organogenesis
MGI:3663289	Tasp1<tm1.1Jjdh>	MP:0000137,abnormal vertebrae morphology|MP:0000352,decreased cell proliferation|MP:0000480,increased rib number|MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001265,decreased body size|MP:0001436,abnormal suckling behavior|MP:0001698,decreased embryo size|MP:0001925,male infertility|MP:0003036,vertebral transformation|MP:0003048,abnormal cervical vertebrae morphology|MP:0004322,abnormal sternebra morphology|MP:0004569,glossopharyngeal nerve hypoplasia|MP:0004608,abnormal cervical axis morphology|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0008279,arrest of spermiogenesis|MP:0009879,abnormal arcus anterior morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0014052,increased male germ cell apoptosis|MP:0014633,decreased spermatid number|MP:0014636,decreased elongated spermatid number
MGI:3687251	Tasp1<tm1Jjdh>	MP:0000715,decreased thymocyte number|MP:0004956,decreased thymus weight|MP:0005092,decreased double-positive T cell number
MGI:7573126	Tatdn1<em1(IMPC)Hmgu>	MP:0001392,abnormal locomotor behavior
MGI:8189911	Tatdn1<tm1.2Csaag>	MP:0001260,increased body weight|MP:0001405,impaired coordination|MP:0001516,abnormal motor coordination/balance|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0004565,decreased myocardial fiber size|MP:0004937,dilated heart|MP:0005386,behavior/neurological phenotype|MP:0011925,abnormal heart echocardiography feature|MP:0031392,hypoactivity
MGI:5692861	Tatdn2<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4431994	Tatdn3<tm1a(EUCOMM)Wtsi>	MP:0005566,decreased blood urea nitrogen level
MGI:5548575	Tatdn3<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0010024,increased total body fat amount
MGI:5904323	Tat<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0003960,increased lean body mass|MP:0005333,decreased heart rate|MP:0005561,increased mean corpuscular hemoglobin|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010097,abnormal retina blood vessel morphology|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2664870	Tauph<BALB/cByJ>	MP:0004250,tau protein deposits
MGI:3723593	Tax1bp1<GT(RRJ464)Byg>	MP:0000266,abnormal heart morphology|MP:0001914,hemorrhage|MP:0005621,abnormal cell physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3808042	Tax1bp1<tm1Ktj>	MP:0000285,abnormal heart valve morphology|MP:0002083,premature death|MP:0002148,abnormal hypersensitivity reaction|MP:0002442,abnormal leukocyte physiology|MP:0002444,abnormal T cell physiology|MP:0002463,abnormal neutrophil physiology|MP:0004947,skin inflammation|MP:0008489,slow postnatal weight gain|MP:0008560,increased tumor necrosis factor secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008687,increased interleukin-2 secretion|MP:0010760,abnormal macrophage chemotaxis|MP:0031118,cardiovalvulitis
MGI:5692738	Tax1bp3<tm1b(EUCOMM)Hmgu>	MP:0005344,increased circulating bilirubin level|MP:0009142,decreased prepulse inhibition|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:1856204	tb	MP:0000635,pituitary gland hyperplasia|MP:0001134,absent corpus luteum|MP:0001392,abnormal locomotor behavior|MP:0001732,postnatal growth retardation|MP:0001824,abnormal thymus involution|MP:0001921,reduced fertility|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0008333,absent lactotrophs
MGI:3029245	Tb2r1<DBA/2J>	MP:0002123,abnormal definitive hematopoiesis
MGI:1861472	Tba	MP:0000559,abnormal femur morphology|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0002110,abnormal digit morphology|MP:0002728,absent tibia|MP:0002764,short tibia|MP:0004372,bowed fibula|MP:0008159,increased diameter of fibula|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3583753	tbare	MP:0000416,sparse hair|MP:0000418,focal hair loss
MGI:4840354	Tbata<tm1Faf>	MP:0000708,thymus hyperplasia|MP:0000709,enlarged thymus|MP:0000714,increased thymocyte number|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0005090,increased double-negative T cell number|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0009544,abnormal thymus epithelium morphology
MGI:4432519	Tbc1d10a<tm2a(EUCOMM)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000609,abnormal liver physiology|MP:0002942,decreased circulating alanine transaminase level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0010095,increased chromosomal stability
MGI:5578034	Tbc1d10c<tm1.2Psou>	MP:0001828,abnormal T cell activation|MP:0002459,abnormal B cell physiology|MP:0002493,increased IgG level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0005025,abnormal response to infection|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype
MGI:7411386	Tbc1d12<em1(IMPC)J>	MP:0000194,increased circulating calcium level
MGI:5300733	Tbc1d14<L5Jcs5>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:7626319	Tbc1d15<em1Jren>	MP:0003037,increased myocardial infarct size|MP:0006036,abnormal mitochondrial physiology|MP:0014239,abnormal intracellular organelle morphology|MP:0031217,increased susceptibility to myocardial ischemic injury
MGI:5825264	Tbc1d16<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0002968,increased circulating alkaline phosphatase level|MP:0010124,decreased bone mineral content
MGI:3896754	Tbc1d1<Gt(E140H06)Wrst>	MP:0001262,decreased body weight|MP:0001764,abnormal homeostasis|MP:0003961,decreased lean body mass|MP:0004130,abnormal muscle cell glucose uptake|MP:0005376,homeostasis/metabolism phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008965,increased basal metabolism|MP:0010025,decreased total body fat amount|MP:0010379,decreased respiratory quotient|MP:0010951,abnormal lipid oxidation|MP:0014171,increased fatty acid oxidation
MGI:2156037	Tbc1d1<Nobq1-NZO/HlBom>	MP:0000008,increased white adipose tissue amount|MP:0002079,increased circulating insulin level
MGI:2156036	Tbc1d1<Nobq1-SJL/NBom>	MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0010025,decreased total body fat amount
MGI:5437119	Tbc1d1<tm1.1Schen>	MP:0002169,no abnormal phenotype detected
MGI:1856684	Tbc1d20<bs>	MP:0000358,abnormal cell morphology|MP:0000411,shiny fur|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001306,small lens|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0002840,abnormal lens fiber morphology|MP:0003631,nervous system phenotype|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005578,teratozoospermia|MP:0006362,abnormal male germ cell morphology|MP:0008839,absent acrosome|MP:0008841,ruptured lens capsule|MP:0009230,abnormal sperm head morphology|MP:0011743,abnormal Golgi apparatus morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0020869,immotile sperm|MP:0031345,developmental cataract
MGI:7593975	Tbc1d20<em1Djsi>	MP:0000358,abnormal cell morphology|MP:0001147,small testis|MP:0001303,abnormal lens morphology|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0003631,nervous system phenotype|MP:0003686,abnormal eye muscle morphology|MP:0008841,ruptured lens capsule|MP:0010254,nuclear cataract|MP:0011697,lens vacuoles|MP:0031354,abnormal acrosome assembly
MGI:6276912	Tbc1d20<em1(IMPC)Mbp>	MP:0001404,no spontaneous movement|MP:0001914,hemorrhage|MP:0001925,male infertility|MP:0002060,abnormal skin morphology|MP:0002833,increased heart weight|MP:0010067,increased red blood cell distribution width
MGI:6314798	Tbc1d21<em1(IMPC)J>	MP:0001925,male infertility
MGI:6513081	Tbc1d21<em1Osb>	MP:0001925,male infertility|MP:0006380,abnormal spermatid morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology
MGI:6693639	Tbc1d21<tm1.1Yhln>	MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0011629,decreased mitochondrial number|MP:0011633,abnormal mitochondrial shape|MP:0014465,abnormal sperm mitochondrial morphology|MP:0020451,decreased sperm progressive motility|MP:0031356,abnormal outer dense fiber morphology
MGI:5636942	Tbc1d22a<tm1b(KOMP)Wtsi>	MP:0001554,increased circulating free fatty acids level|MP:0002599,increased mean platelet volume|MP:0002644,decreased circulating triglyceride level|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0005343,increased circulating aspartate transaminase level|MP:0005553,increased circulating creatinine level|MP:0008806,increased circulating amylase level|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level
MGI:3857844	Tbc1d23<Gt(BA0556)Wtsi>	MP:0001846,increased inflammatory response|MP:0008553,increased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level|MP:0008752,abnormal tumor necrosis factor level
MGI:6195493	Tbc1d24<em1Tbf>	MP:0011089,perinatal lethality, complete penetrance
MGI:6195494	Tbc1d24<em2Tbf>	MP:0003631,nervous system phenotype|MP:0003997,tonic-clonic seizures|MP:0005377,hearing/vestibular/ear phenotype|MP:0011085,postnatal lethality, complete penetrance
MGI:6490517	Tbc1d24<em3Tbf>	MP:0005377,hearing/vestibular/ear phenotype
MGI:6490519	Tbc1d24<em4Tbf>	MP:0005377,hearing/vestibular/ear phenotype
MGI:6490521	Tbc1d24<em5Tbf>	MP:0011091,prenatal lethality, complete penetrance
MGI:5692831	Tbc1d24<tm1b(EUCOMM)Hmgu>	MP:0003631,nervous system phenotype|MP:0003635,abnormal synaptic transmission|MP:0003651,abnormal axon extension|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004770,abnormal synaptic vesicle recycling|MP:0005377,hearing/vestibular/ear phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0008143,abnormal dendrite morphology|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0030951,abnormal endocytosis
MGI:7426015	Tbc1d25<em1(IMPC)Tcp>	MP:0001325,abnormal retina morphology|MP:0010053,decreased grip strength
MGI:3957652	Tbc1d25<Gt(IST10205D5)Tigm>	MP:0000274,enlarged heart|MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0004485,increased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0005630,increased lung weight
MGI:4434639	Tbc1d2b<tm1a(EUCOMM)Hmgu>	MP:0002896,abnormal bone mineralization|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level
MGI:4839135	Tbc1d2<tm1(NCOM)Cmhd>	MP:0001262,decreased body weight|MP:0001566,increased circulating phosphate level
MGI:5790099	Tbc1d30<em1(IMPC)J>	MP:0000194,increased circulating calcium level|MP:0000367,abnormal coat/ hair morphology|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:5795760	Tbc1d31<em1(IMPC)J>	MP:0005344,increased circulating bilirubin level|MP:0005553,increased circulating creatinine level
MGI:5491268	Tbc1d32<b2b2284Clo>	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0000562,polydactyly|MP:0000650,mesocardia|MP:0000694,spleen hypoplasia|MP:0001293,anophthalmia|MP:0002633,persistent truncus arteriosus|MP:0003178,left pulmonary isomerism|MP:0003321,tracheoesophageal fistula|MP:0003675,kidney cyst|MP:0004113,abnormal aortic arch morphology|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0004548,dilated esophagus|MP:0005170,cleft upper lip|MP:0006061,right atrial isomerism|MP:0006063,abnormal inferior vena cava morphology|MP:0008461,left atrial isomerism|MP:0008797,facial cleft|MP:0009743,preaxial polydactyly|MP:0010412,atrioventricular septal defect|MP:0010460,pulmonary artery hypoplasia|MP:0010466,vascular ring|MP:0010576,premature closure of the ductus arteriosus|MP:0010808,right-sided stomach
MGI:5560497	Tbc1d32<b2b2596Clo>	MP:0000111,cleft palate|MP:0000273,overriding aortic valve|MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0001178,pulmonary hypoplasia|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002633,persistent truncus arteriosus|MP:0003321,tracheoesophageal fistula|MP:0003675,kidney cyst|MP:0004017,duplex kidney|MP:0005170,cleft upper lip|MP:0006061,right atrial isomerism|MP:0009901,abnormal frontonasal prominence morphology|MP:0010412,atrioventricular septal defect|MP:0011661,persistent truncus arteriosus type i|MP:0011683,dual inferior vena cava
MGI:5648205	Tbc1d32<b2b3260.1Clo>	MP:0000445,short snout|MP:0000914,exencephaly|MP:0002135,abnormal kidney morphology|MP:0002633,persistent truncus arteriosus|MP:0002746,abnormal semilunar valve morphology|MP:0004110,transposition of great arteries|MP:0009743,preaxial polydactyly
MGI:4440463	Tbc1d32<bromi>	MP:0000914,exencephaly|MP:0001286,abnormal eye development|MP:0001306,small lens|MP:0002151,abnormal neural tube morphology|MP:0002984,retina hypoplasia|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0009743,preaxial polydactyly
MGI:6324235	Tbc1d32<em1(IMPC)J>	MP:0000111,cleft palate|MP:0000562,polydactyly|MP:0001293,anophthalmia|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003385,abnormal body wall morphology|MP:0003743,abnormal facial morphology|MP:0008797,facial cleft|MP:0011100,preweaning lethality, complete penetrance
MGI:4127851	Tbc1d32<Gt(RRF165)Byg>	MP:0000914,exencephaly|MP:0001286,abnormal eye development
MGI:4941737	Tbc1d4<tm1.1Arte>	MP:0001265,decreased body size|MP:0002833,increased heart weight|MP:0004851,increased testis weight|MP:0004953,decreased spleen weight|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0030016,increased adipocyte glucose uptake|MP:0030021,increased muscle cell glucose uptake|MP:0030022,decreased muscle cell glucose uptake
MGI:5478502	Tbc1d4<tm1.2Arte>	MP:0001554,increased circulating free fatty acids level|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0003383,abnormal gluconeogenesis|MP:0004890,decreased energy expenditure|MP:0004893,decreased adiponectin level|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005560,decreased circulating glucose level|MP:0020234,decreased basal metabolism|MP:0030016,increased adipocyte glucose uptake|MP:0030017,decreased adipocyte glucose uptake|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:5585586	Tbc1d4<tm1b(EUCOMM)Hmgu>	MP:0000221,decreased leukocyte cell number|MP:0002590,increased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0003020,decreased circulating chloride level|MP:0005633,increased circulating sodium level
MGI:3793866	Tbc1d4<tm1Lex>	MP:0002727,decreased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005438,abnormal glycogen homeostasis|MP:0005560,decreased circulating glucose level|MP:0009118,increased white fat cell size|MP:0009288,increased epididymal fat pad weight|MP:0009300,increased parametrial fat pad weight|MP:0010831,lethality, incomplete penetrance|MP:0030016,increased adipocyte glucose uptake|MP:0030017,decreased adipocyte glucose uptake|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:5750182	Tbc1d5<em1(IMPC)J>	MP:0000572,abnormal autopod morphology|MP:0001289,persistence of hyaloid vascular system|MP:0005178,increased circulating cholesterol level
MGI:7286317	Tbc1d7<em1Hms>	MP:0000789,thickened cerebral cortex|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0002176,increased brain weight|MP:0002882,abnormal neuron morphology|MP:0002948,abnormal neuron specification|MP:0003354,astrocytosis|MP:0003960,increased lean body mass|MP:0005238,increased brain size|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0009399,increased skeletal muscle fiber size|MP:0010053,decreased grip strength|MP:0031392,hypoactivity
MGI:7580970	Tbc1d7<em1(IMPC)Bay>	MP:0000691,enlarged spleen|MP:0001417,decreased exploration in new environment|MP:0002339,abnormal lymph node morphology|MP:0003068,enlarged kidney|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6257679	Tbc1d8b<em1(IMPC)Bay>	MP:0004953,decreased spleen weight
MGI:5823470	Tbc1d8<em1(IMPC)J>	MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001925,male infertility
MGI:6384877	Tbc1d9b<em1(IMPC)J>	MP:0001489,decreased startle reflex|MP:0002591,decreased mean corpuscular volume|MP:0005178,increased circulating cholesterol level|MP:0005562,decreased mean corpuscular hemoglobin
MGI:6414554	Tbcb<em1(IMPC)Bay>	MP:0001727,abnormal embryo implantation|MP:0011100,preweaning lethality, complete penetrance|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:5581733	Tbccd1<tm1b(EUCOMM)Hmgu>	MP:0001925,male infertility|MP:0001926,female infertility|MP:0005293,impaired glucose tolerance|MP:0011239,abnormal skin coloration
MGI:6401486	Tbcc<em1(IMPC)J>	MP:0001727,abnormal embryo implantation|MP:0004964,absent inner cell mass|MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6384595	Tbcd<em1(IMPC)Bay>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:6259594	Tbcel<em1(IMPC)J>	MP:0008259,abnormal optic disk morphology|MP:0010053,decreased grip strength
MGI:1856997	Tbce<pmn>	MP:0000748,progressive muscle weakness|MP:0000753,paralysis|MP:0000938,motor neuron degeneration|MP:0001071,abnormal facial nerve morphology|MP:0001078,abnormal phrenic nerve morphology|MP:0001953,respiratory failure|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0005405,axon degeneration
MGI:5588279	Tbce<tm2b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0011100,preweaning lethality, complete penetrance
MGI:5661955	Tbck<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment|MP:0002757,decreased vertical activity|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008762,embryonic lethality|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3037652	Tbdr1<SS>	MP:0005534,decreased body temperature
MGI:5442100	Tbk1<M1Btlr>	MP:0002451,abnormal macrophage physiology|MP:0008555,abnormal interferon secretion|MP:0011091,prenatal lethality, complete penetrance
MGI:4847640	Tbk1<tm1.1Lex>	MP:0000220,increased monocyte cell number|MP:0000416,sparse hair|MP:0000688,lymphoid hyperplasia|MP:0001214,skin hyperplasia|MP:0001242,hyperkeratosis|MP:0001511,disheveled coat|MP:0001786,skin edema|MP:0001845,abnormal inflammatory response|MP:0002060,abnormal skin morphology|MP:0002495,increased IgA level|MP:0002607,decreased basophil cell number|MP:0003009,abnormal cytokine secretion|MP:0004947,skin inflammation|MP:0004952,increased spleen weight|MP:0004971,dermal hyperplasia|MP:0005012,decreased eosinophil cell number|MP:0008039,increased NK T cell number|MP:0008040,decreased NK T cell number|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008565,decreased interferon-beta secretion|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008705,increased interleukin-6 secretion|MP:0008713,abnormal cytokine level|MP:0008735,increased susceptibility to endotoxin shock|MP:0008858,abnormal hair cycle anagen phase|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3046789	Tbk1<tm1Aki>	MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5446427	Tbk1<tm1Arte>	MP:0002136,abnormal kidney physiology|MP:0002459,abnormal B cell physiology|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002962,increased urine protein level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004816,abnormal class switch recombination|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008210,increased mature B cell number
MGI:3050522	Tbk1<tm1Yeh>	MP:0003103,liver degeneration|MP:0003717,pallor|MP:0003888,liver hemorrhage|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5544313	Tbkbp1<tm1Aki>	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:5548632	Tbkbp1<tm1b(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0005013,increased lymphocyte cell number
MGI:7469825	Tbl1xr1<em2H>	MP:0000063,decreased bone mineral density|MP:0001262,decreased body weight|MP:0003960,increased lean body mass|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0010124,decreased bone mineral content|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014143,decreased body fat mass
MGI:5511131	Tbl1xr1<tm1.1Arte>	MP:0001260,increased body weight|MP:0002970,abnormal white adipose tissue morphology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005666,abnormal adipose tissue physiology|MP:0005669,increased circulating leptin level|MP:0008033,impaired lipolysis|MP:0009118,increased white fat cell size|MP:0009130,increased white fat cell number|MP:0009286,increased abdominal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0010024,increased total body fat amount|MP:0031415,increased skeletal muscle triglyceride level
MGI:7550437	Tbl1xr1<tm1.1Meln>	MP:0000689,abnormal spleen morphology|MP:0002144,abnormal B cell differentiation
MGI:6199116	Tbl1xr1<tm1b(EUCOMM)Hmgu>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0001284,absent vibrissae|MP:0001486,abnormal startle reflex|MP:0001566,increased circulating phosphate level|MP:0002833,increased heart weight|MP:0004738,abnormal auditory brainstem response|MP:0004832,enlarged ovary|MP:0005565,increased blood urea nitrogen level|MP:0009476,enlarged cecum|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7514121	Tbl1xr1<tm1c(EUCOMM)Hmgu>	MP:0000689,abnormal spleen morphology|MP:0002144,abnormal B cell differentiation
MGI:4821368	Tbob	MP:0001394,circling|MP:0001410,head bobbing|MP:0010323,retropulsion
MGI:2181639	Tbpl1<tm1Rgr>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0006380,abnormal spermatid morphology|MP:0008279,arrest of spermiogenesis|MP:0008898,abnormal acrosome morphology|MP:0014052,increased male germ cell apoptosis|MP:0014636,decreased elongated spermatid number|MP:0020550,multinucleated giant male germ cells
MGI:2182539	Tbpl1<tm1Saco>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002209,decreased germ cell number|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0005159,azoospermia|MP:0008279,arrest of spermiogenesis|MP:0014052,increased male germ cell apoptosis
MGI:4360523	Tbpl2<tm1.1Lzt>	MP:0001125,abnormal oocyte morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001132,absent mature ovarian follicles|MP:0001926,female infertility|MP:0003697,absent zona pellucida|MP:0008871,abnormal ovarian follicle number|MP:0009093,oocyte degeneration|MP:0009444,ovarian follicular cyst|MP:0011120,increased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0031015,abnormal granulosa cell apoptosis|MP:0031381,decreased secondary ovarian follicle number|MP:0031422,failure of superovulation
MGI:2183359	Tbp<tm1.1Ees>	MP:0002551,abnormal blood coagulation|MP:0004201,fetal growth retardation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0030975,placenta hemorrhage|MP:0031070,hemophagocytosis
MGI:5693900	Tbp<tm1.1Xjl>	MP:0001393,ataxia|MP:0001407,short stride length|MP:0001513,limb grasping
MGI:2429772	Tbp<tm1Idvd>	MP:0001730,embryonic growth arrest|MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:5644074	Tbp<tm1Xjl>	MP:0000160,kyphosis|MP:0000851,cerebellum hypoplasia|MP:0000876,Purkinje cell degeneration|MP:0000890,thin cerebellar molecular layer|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001447,abnormal nest building behavior|MP:0001505,hunched posture|MP:0001525,impaired balance|MP:0002083,premature death|MP:0008489,slow postnatal weight gain|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:6388548	Tbr1<tm1.1Csbd>	MP:0001363,increased anxiety-related response|MP:0001441,increased grooming behavior|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002574,increased vertical activity|MP:0004101,abnormal brain interneuron morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011620,abnormal habituation to a new environment|MP:0014378,increased excitatory postsynaptic current frequency|MP:0014382,increased miniature inhibitory postsynaptic current frequency|MP:0020870,decreased thigmotaxis|MP:0031391,increased locomotor activity
MGI:5692568	Tbr1<tm1.1(KOMP)Mbp>	MP:0001914,hemorrhage|MP:0003054,spina bifida|MP:0005554,decreased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005566,decreased blood urea nitrogen level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2179766	Tbr1<tm1Jlr>	MP:0000774,decreased brain size|MP:0000783,abnormal forebrain morphology|MP:0000818,abnormal amygdala morphology|MP:0001360,abnormal social investigation|MP:0001438,aphagia|MP:0001454,abnormal cued conditioning behavior|MP:0002184,abnormal innervation|MP:0002739,abnormal olfactory bulb development|MP:0002805,abnormal conditioned taste aversion behavior|MP:0002969,impaired social transmission of food preference|MP:0004811,abnormal neuron physiology|MP:0005237,abnormal olfactory tract morphology|MP:0005267,abnormal olfactory cortex morphology|MP:0008225,abnormal anterior commissure morphology|MP:0009941,abnormal olfactory bulb interneuron morphology|MP:0009947,abnormal olfactory bulb external plexiform layer morphology|MP:0009948,abnormal olfactory bulb glomerular layer morphology|MP:0009951,abnormal olfactory bulb mitral cell layer morphology|MP:0009954,abnormal mitral cell morphology|MP:0009955,abnormal olfactory bulb tufted cell morphology|MP:0010059,olfactory bulb hypoplasia|MP:0011085,postnatal lethality, complete penetrance|MP:0014115,cognitive inflexibility|MP:0020351,decreased vocalization
MGI:4365070	Tbrg1<tm1a(KOMP)Wtsi>	MP:0000691,enlarged spleen|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002947,increased hemangioma incidence|MP:0005397,hematopoietic system phenotype|MP:0008181,increased marginal zone B cell number|MP:0008478,increased spleen white pulp amount|MP:0010769,abnormal survival|MP:0013329,abnormal preputial gland morphology|MP:0013538,increased Harderian gland adenoma incidence
MGI:2154348	Tbrs1<C57BL/6J>	MP:0002411,decreased susceptibility to bacterial infection
MGI:2155292	Tbrs2<C57BL/6J>	MP:0002411,decreased susceptibility to bacterial infection
MGI:2156690	Tbrs3<C57BL/6J>	MP:0002411,decreased susceptibility to bacterial infection
MGI:2664018	Tbrs4<C57BL/6J>	MP:0002411,decreased susceptibility to bacterial infection
MGI:3691650	Tbt1<C57BL/6J>	MP:0003795,abnormal bone structure
MGI:3691651	Tbt1<DBA/2J>	MP:0003795,abnormal bone structure
MGI:3691653	Tbt2<DBA/2J>	MP:0003795,abnormal bone structure
MGI:3691654	Tbt3<C57BL/6J>	MP:0003795,abnormal bone structure
MGI:3691655	Tbt3<DBA/2J>	MP:0003795,abnormal bone structure
MGI:3691656	Tbt4<C57BL/6J>	MP:0003795,abnormal bone structure
MGI:3691657	Tbt4<DBA/2J>	MP:0003795,abnormal bone structure
MGI:1860107	t<btm>	MP:0000592,short tail
MGI:1861236	Tbx10<Dc>	MP:0000034,abnormal inner ear vestibule morphology|MP:0000037,abnormal lateral semicircular canal morphology|MP:0000111,cleft palate|MP:0001265,decreased body size|MP:0001302,eyelids open at birth|MP:0001394,circling|MP:0001395,bidirectional circling|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001522,impaired swimming|MP:0002428,abnormal semicircular canal morphology|MP:0002939,head spot|MP:0002980,abnormal postural reflex|MP:0003069,abnormal superior semicircular canal morphology|MP:0003938,abnormal ear development|MP:0003987,small vestibular ganglion|MP:0004249,abnormal crista ampullaris morphology|MP:0004289,abnormal bony labyrinth|MP:0004317,small vestibular saccule|MP:0004333,abnormal utricular macula morphology|MP:0004336,small utricle|MP:0004427,abnormal vestibular labyrinth morphology|MP:0004718,abnormal vestibular nerve morphology|MP:0005191,head tilt|MP:0005307,head tossing|MP:0005377,hearing/vestibular/ear phenotype|MP:0006089,abnormal vestibular saccule morphology|MP:0006090,abnormal utricle morphology|MP:0006409,vestibular ganglion hypoplasia|MP:0008488,abnormal semicircular canal ampulla morphology|MP:0009265,delayed eyelid fusion|MP:0009886,failure of palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0011087,neonatal lethality, complete penetrance|MP:0031447,unilateral cleft upper lip|MP:0031448,bilateral cleft upper lip
MGI:4459542	Tbx10<tm1.1Miu>	MP:0002169,no abnormal phenotype detected
MGI:1856014	Tbx15<de>	MP:0000372,irregular coat pigmentation|MP:0000435,shortened head|MP:0000449,broad nasal bridge|MP:0001731,abnormal postnatal growth|MP:0002113,abnormal skeleton development|MP:0002115,abnormal limb bone morphology|MP:0004343,small scapula|MP:0011110,preweaning lethality, incomplete penetrance|MP:0030833,small acromion
MGI:1856015	Tbx15<de-H>	MP:0000023,abnormal ear position|MP:0000079,abnormal basioccipital bone morphology|MP:0000088,short mandible|MP:0004342,scapular bone foramen|MP:0004343,small scapula|MP:0004508,abnormal pectoral girdle bone morphology|MP:0004596,abnormal mandibular angle morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004607,abnormal cervical atlas morphology|MP:0004659,abnormal odontoid process morphology|MP:0008525,decreased cranium height|MP:0008526,decreased cranium width|MP:0030833,small acromion
MGI:3574402	Tbx15<tm1Akis>	MP:0000023,abnormal ear position|MP:0000074,abnormal neurocranium morphology|MP:0000078,abnormal supraoccipital bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000149,abnormal scapula morphology|MP:0000167,decreased chondrocyte number|MP:0000552,abnormal radius morphology|MP:0001265,decreased body size|MP:0001300,ocular hypertelorism|MP:0001382,abnormal nursing|MP:0001921,reduced fertility|MP:0002075,abnormal coat/hair pigmentation|MP:0002113,abnormal skeleton development|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003109,short femur|MP:0003419,delayed endochondral bone ossification|MP:0004174,abnormal spine curvature|MP:0004338,small clavicle|MP:0004342,scapular bone foramen|MP:0004343,small scapula|MP:0004345,abnormal acromion morphology|MP:0004347,abnormal scapular spine morphology|MP:0004351,short humerus|MP:0004353,abnormal deltoid tuberosity morphology|MP:0004355,short radius|MP:0004359,short ulna|MP:0004447,small basioccipital bone|MP:0004607,abnormal cervical atlas morphology|MP:0004608,abnormal cervical axis morphology|MP:0004634,short metacarpal bones|MP:0004635,short metatarsal bones|MP:0004659,abnormal odontoid process morphology|MP:0004819,decreased skeletal muscle mass|MP:0005108,abnormal ulna morphology|MP:0005269,abnormal occipital bone morphology|MP:0005272,abnormal temporal bone morphology|MP:0005296,abnormal humerus morphology|MP:0005306,abnormal phalanx morphology|MP:0005508,abnormal skeleton morphology|MP:0005650,abnormal limb bud morphology|MP:0008154,decreased diameter of humerus|MP:0010941,abnormal foramen magnum morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0030189,broad snout|MP:0030833,small acromion
MGI:3767607	Tbx15<tm1Apr>	MP:0000428,abnormal craniofacial morphology|MP:0001265,decreased body size
MGI:3044915	Tbx18<tm1.1Akis>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000963,fused dorsal root ganglion|MP:0001077,abnormal spinal nerve morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004682,small intervertebral disk|MP:0005223,abnormal dorsal-ventral polarity of the somites|MP:0005225,abnormal vertebrae development|MP:0009703,decreased birth body size|MP:0010728,fusion of atlas and occipital bones|MP:0011087,neonatal lethality, complete penetrance
MGI:5553116	Tbx18<tm1.1Mwmy>	MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000534,abnormal ureter morphology|MP:0001258,decreased body length|MP:0001954,respiratory distress|MP:0002114,abnormal axial skeleton morphology|MP:0002135,abnormal kidney morphology|MP:0002925,abnormal cardiovascular development|MP:0003057,abnormal epicardium morphology|MP:0004056,abnormal myocardium compact layer morphology|MP:0004134,abnormal chest morphology|MP:0004682,small intervertebral disk|MP:0004683,absent intervertebral disk|MP:0010551,abnormal coronary vessel morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3044914	Tbx18<tm1Akis>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000266,abnormal heart morphology|MP:0000963,fused dorsal root ganglion|MP:0001077,abnormal spinal nerve morphology|MP:0002725,abnormal vein morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004682,small intervertebral disk|MP:0004786,abnormal common cardinal vein morphology|MP:0005223,abnormal dorsal-ventral polarity of the somites|MP:0005225,abnormal vertebrae development|MP:0009703,decreased birth body size|MP:0010728,fusion of atlas and occipital bones|MP:0011087,neonatal lethality, complete penetrance
MGI:3714981	Tbx18<tm2Akis>	MP:0012496,abnormal pleuropericardial membrane morphology
MGI:2655153	Tbx19<tm1Jdr>	MP:0000189,hypoglycemia|MP:0000640,adrenal gland hypoplasia|MP:0000676,abnormal body water content|MP:0002664,decreased circulating adrenocorticotropin level|MP:0002665,decreased circulating corticosterone level|MP:0005389,reproductive system phenotype|MP:0005408,hypopigmentation|MP:0005559,increased circulating glucose level|MP:0008237,abnormal ventral coat pigmentation|MP:0008341,decreased corticotroph cell number
MGI:6382398	Tbx1<em1(IMPC)Mbp>	MP:0001289,persistence of hyaloid vascular system|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0001944,abnormal pancreas morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:5490246	Tbx1<m1Anu>	MP:0001395,bidirectional circling|MP:0005191,head tilt
MGI:5829802	Tbx1<m1H>	MP:0000026,abnormal inner ear morphology|MP:0000111,cleft palate|MP:0000706,small thymus|MP:0001785,edema|MP:0002633,persistent truncus arteriosus|MP:0010402,ventricular septal defect
MGI:3841191	Tbx1<m1Jlk>	MP:0000111,cleft palate|MP:0000705,athymia|MP:0002169,no abnormal phenotype detected|MP:0002177,abnormal outer ear morphology|MP:0002633,persistent truncus arteriosus|MP:0002672,abnormal pharyngeal arch artery morphology
MGI:3032517	Tbx1<nmf219>	MP:0000031,abnormal cochlea morphology|MP:0000043,organ of Corti degeneration|MP:0000048,abnormal stria vascularis morphology|MP:0001394,circling|MP:0001410,head bobbing|MP:0001967,deafness|MP:0002428,abnormal semicircular canal morphology|MP:0002857,cochlear ganglion degeneration|MP:0002858,abnormal posterior semicircular canal morphology|MP:0004300,abnormal organ of Corti supporting cell morphology|MP:0004366,abnormal strial marginal cell morphology|MP:0004738,abnormal auditory brainstem response|MP:0004758,absent strial marginal cells|MP:0004922,abnormal common crus morphology|MP:0006024,collapsed Reissner membrane|MP:0008304,abnormal organ of Corti supporting cell differentiation|MP:0008308,small scala media|MP:0008488,abnormal semicircular canal ampulla morphology|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3510040	Tbx1<tm1.1Dsr>	MP:0000025,otic hypertelorism|MP:0000026,abnormal inner ear morphology|MP:0000029,abnormal malleus morphology|MP:0000284,double outlet right ventricle|MP:0000705,athymia|MP:0002633,persistent truncus arteriosus|MP:0003056,abnormal hyoid bone morphology|MP:0003138,absent tympanic ring|MP:0003142,anotia|MP:0003756,abnormal hard palate morphology|MP:0004113,abnormal aortic arch morphology|MP:0004158,right aortic arch|MP:0004159,double aortic arch|MP:0004204,absent stapes|MP:0004205,absent hyoid bone|MP:0004385,interparietal bone hypoplasia|MP:0004420,parietal bone hypoplasia|MP:0004424,temporal bone hypoplasia|MP:0004444,small supraoccipital bone|MP:0004469,abnormal zygomatic arch morphology|MP:0004572,fusion of basioccipital and basisphenoid bone|MP:0004608,abnormal cervical axis morphology|MP:0004678,split xiphoid process|MP:0004790,absent upper incisors|MP:0004869,frontal bone hypoplasia|MP:0004900,absent zygomatic arch|MP:0005105,abnormal middle ear ossicle morphology|MP:0005107,abnormal stapes morphology|MP:0005352,small cranium|MP:0006020,decreased tympanic ring size|MP:0008381,absent gonial bone|MP:0008382,gonial bone hypoplasia|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0010402,ventricular septal defect|MP:0010465,aberrant origin of the right subclavian artery|MP:0011087,neonatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011615,submucous cleft palate|MP:0013545,cleft hard palate|MP:0013546,cleft soft palate|MP:0030029,wide cranial sutures|MP:0030084,tympanic ring hypoplasia|MP:0030107,incus hypoplasia|MP:0030137,abnormal upper incisor morphology|MP:0030179,abnormal oral epithelium morphology|MP:0030351,wide coronal suture|MP:0030872,small cricoid cartilage
MGI:2179191	Tbx1<tm1Bem>	MP:0000026,abnormal inner ear morphology|MP:0000049,abnormal middle ear morphology|MP:0000111,cleft palate|MP:0000680,absent parathyroid glands|MP:0000705,athymia|MP:0001823,thymus hypoplasia|MP:0001850,increased susceptibility to otitis media|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002633,persistent truncus arteriosus|MP:0002797,increased thigmotaxis|MP:0002855,abnormal cochlear ganglion morphology|MP:0002925,abnormal cardiovascular development|MP:0003142,anotia|MP:0003461,abnormal response to novel object|MP:0004157,interrupted aortic arch|MP:0004158,right aortic arch|MP:0004160,retroesophageal right subclavian artery|MP:0004161,cervical aortic arch|MP:0004236,absent masseter muscle|MP:0004238,absent pterygoid muscle|MP:0004311,otic vesicle hypoplasia|MP:0004914,absent ultimobranchial body|MP:0006031,abnormal pharyngeal pouch morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0006340,abnormal fourth pharyngeal arch morphology|MP:0006346,small pharyngeal arch|MP:0008428,abnormal spatial working memory|MP:0009888,palatal shelves fail to meet at midline|MP:0009937,abnormal neuron differentiation|MP:0010465,aberrant origin of the right subclavian artery|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0020351,decreased vocalization
MGI:2179136	Tbx1<tm1Bld>	MP:0000026,abnormal inner ear morphology|MP:0000036,absent semicircular canals|MP:0000037,abnormal lateral semicircular canal morphology|MP:0000049,abnormal middle ear morphology|MP:0000111,cleft palate|MP:0000705,athymia|MP:0001056,abnormal cranial nerve morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0001068,abnormal mandibular nerve branching|MP:0001073,abnormal glossopharyngeal nerve morphology|MP:0001074,abnormal vagus nerve morphology|MP:0001075,abnormal accessory nerve morphology|MP:0001096,abnormal glossopharyngeal ganglion morphology|MP:0001100,abnormal vagus ganglion morphology|MP:0001614,abnormal blood vessel morphology|MP:0001786,skin edema|MP:0001879,abnormal lymphatic vessel morphology|MP:0002082,postnatal lethality|MP:0002102,abnormal ear morphology|MP:0002177,abnormal outer ear morphology|MP:0002633,persistent truncus arteriosus|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0002950,abnormal neural crest cell migration|MP:0003147,absent cochlea|MP:0003161,absent lateral semicircular canal|MP:0003410,abnormal artery development|MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0003755,abnormal palate morphology|MP:0003814,vascular smooth muscle hypoplasia|MP:0003874,absent pharyngeal arches|MP:0004038,lymphangiectasis|MP:0004113,abnormal aortic arch morphology|MP:0004160,retroesophageal right subclavian artery|MP:0004310,small otic vesicle|MP:0004314,absent inner ear vestibule|MP:0004555,pharynx hypoplasia|MP:0004568,fusion of glossopharyngeal and vagus nerve|MP:0004569,glossopharyngeal nerve hypoplasia|MP:0004787,abnormal dorsal aorta morphology|MP:0006011,abnormal endolymphatic duct morphology|MP:0006031,abnormal pharyngeal pouch morphology|MP:0006042,increased apoptosis|MP:0006107,abnormal fetal atrioventricular canal morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0006285,absent inner ear|MP:0006340,abnormal fourth pharyngeal arch morphology|MP:0006344,small second pharyngeal arch|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0008778,abnormal lymphangiogenesis|MP:0009142,decreased prepulse inhibition|MP:0009653,abnormal palate development|MP:0009655,abnormal secondary palate development|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009890,cleft secondary palate|MP:0010418,perimembraneous ventricular septal defect|MP:0010454,abnormal truncus arteriosus septation|MP:0010487,abnormal right subclavian artery morphology|MP:0010583,abnormal conotruncus morphology|MP:0010584,abnormal conotruncus septation|MP:0010768,mortality/aging|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0030334,absent sixth pharyngeal arch artery|MP:0030335,absent third pharyngeal arch artery|MP:0030340,absent fourth pharyngeal arch artery|MP:0030341,fourth pharyngeal arch artery hypoplasia|MP:0031461,abnormal palatal shelf size|MP:0031462,decreased palatal shelf size|MP:0031463,increased palatal shelf size|MP:0031510,increased vascular smooth muscle cell proliferation
MGI:3510038	Tbx1<tm1Dsr>	MP:0000018,small ears|MP:0000026,abnormal inner ear morphology|MP:0000284,double outlet right ventricle|MP:0000705,athymia|MP:0002633,persistent truncus arteriosus|MP:0004157,interrupted aortic arch|MP:0004158,right aortic arch|MP:0004159,double aortic arch|MP:0004572,fusion of basioccipital and basisphenoid bone|MP:0005105,abnormal middle ear ossicle morphology|MP:0005107,abnormal stapes morphology|MP:0005382,craniofacial phenotype|MP:0006020,decreased tympanic ring size|MP:0009546,absent gastric milk in neonates|MP:0010402,ventricular septal defect|MP:0010465,aberrant origin of the right subclavian artery|MP:0011087,neonatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0021214,anterior cleft palate|MP:0031460,abnormal palatal shelf morphology
MGI:3641283	Tbx1<tm1(Fgf8)Vite>	MP:0000160,kyphosis|MP:0000281,abnormal interventricular septum morphology|MP:0000585,kinked tail|MP:0002082,postnatal lethality|MP:0002633,persistent truncus arteriosus|MP:0002746,abnormal semilunar valve morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003051,curly tail|MP:0004113,abnormal aortic arch morphology|MP:0004157,interrupted aortic arch|MP:0004159,double aortic arch|MP:0004160,retroesophageal right subclavian artery|MP:0004161,cervical aortic arch|MP:0004599,abnormal vertebral arch morphology|MP:0004607,abnormal cervical atlas morphology|MP:0004608,abnormal cervical axis morphology|MP:0004612,fusion of vertebral bodies|MP:0004668,absent vertebral body|MP:0009879,abnormal arcus anterior morphology|MP:0013270,fourth pharyngeal arch hypoplasia|MP:0030341,fourth pharyngeal arch artery hypoplasia
MGI:2179190	Tbx1<tm1Pa>	MP:0000022,abnormal ear shape|MP:0000024,lowered ear position|MP:0000029,abnormal malleus morphology|MP:0000030,abnormal tympanic ring morphology|MP:0000039,abnormal otic capsule morphology|MP:0000049,abnormal middle ear morphology|MP:0000088,short mandible|MP:0000438,abnormal cranium morphology|MP:0000680,absent parathyroid glands|MP:0000704,abnormal thymus development|MP:0000705,athymia|MP:0000729,abnormal myogenesis|MP:0001065,abnormal trigeminal nerve morphology|MP:0001071,abnormal facial nerve morphology|MP:0001072,abnormal vestibulocochlear nerve morphology|MP:0001698,decreased embryo size|MP:0001953,respiratory failure|MP:0002192,hydrops fetalis|MP:0002253,abnormal pharyngeal muscle morphology|MP:0002260,abnormal thyroid cartilage morphology|MP:0002263,abnormal laryngeal muscle morphology|MP:0002428,abnormal semicircular canal morphology|MP:0002633,persistent truncus arteriosus|MP:0002639,micrognathia|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0002950,abnormal neural crest cell migration|MP:0003056,abnormal hyoid bone morphology|MP:0003147,absent cochlea|MP:0003743,abnormal facial morphology|MP:0004158,right aortic arch|MP:0004159,double aortic arch|MP:0004204,absent stapes|MP:0004310,small otic vesicle|MP:0004314,absent inner ear vestibule|MP:0004469,abnormal zygomatic arch morphology|MP:0004572,fusion of basioccipital and basisphenoid bone|MP:0004607,abnormal cervical atlas morphology|MP:0004790,absent upper incisors|MP:0004912,absent mandibular coronoid process|MP:0005105,abnormal middle ear ossicle morphology|MP:0005106,abnormal incus morphology|MP:0005272,abnormal temporal bone morphology|MP:0005579,absent outer ear|MP:0006012,dilated endolymphatic duct|MP:0006020,decreased tympanic ring size|MP:0006031,abnormal pharyngeal pouch morphology|MP:0006033,abnormal external auditory canal morphology|MP:0006286,inner ear hypoplasia|MP:0006339,abnormal third pharyngeal arch morphology|MP:0006340,abnormal fourth pharyngeal arch morphology|MP:0006345,absent second pharyngeal arch|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009890,cleft secondary palate|MP:0010326,malleus hypoplasia|MP:0010328,thin malleus neck|MP:0010642,absent third pharyngeal arch|MP:0010729,absent arcus anterior|MP:0011087,neonatal lethality, complete penetrance|MP:0012721,short neck|MP:0013174,pharynx stenosis|MP:0030137,abnormal upper incisor morphology|MP:0030535,abnormal hypoglossal cord morphology|MP:0030867,small thyroid cartilage|MP:0030872,small cricoid cartilage
MGI:3619149	Tbx1<tm2.1Bem>	MP:0002169,no abnormal phenotype detected|MP:0030341,fourth pharyngeal arch artery hypoplasia
MGI:3619150	Tbx1<tm2.2Bem>	MP:0000281,abnormal interventricular septum morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0030040,absent facial muscle
MGI:3619531	Tbx1<tm2Bem>	MP:0002116,abnormal craniofacial bone morphology
MGI:3046792	Tbx1<tm2Bld>	MP:0000267,abnormal heart development|MP:0002884,abnormal pharyngeal arch morphology|MP:0004113,abnormal aortic arch morphology|MP:0010402,ventricular septal defect
MGI:3046793	Tbx1<tm3Bld>	MP:0002169,no abnormal phenotype detected
MGI:3046795	Tbx1<tm4(cre/Esr1*)Bld>	MP:0004113,abnormal aortic arch morphology
MGI:3757964	Tbx1<tm6(cre)Bld>	MP:0001614,abnormal blood vessel morphology
MGI:5140345	Tbx1<tm7.1Bld>	MP:0002169,no abnormal phenotype detected
MGI:5140346	Tbx1<tm8.1Bld>	MP:0002169,no abnormal phenotype detected
MGI:6277044	Tbx20<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0001614,abnormal blood vessel morphology|MP:0001691,abnormal somite shape|MP:0001700,abnormal embryo turning|MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001914,hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0003425,abnormal optic vesicle formation|MP:0003720,abnormal neural tube closure|MP:0009806,abnormal otic vesicle morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6438147	Tbx20<em1Ona>	MP:0006126,abnormal cardiac outflow tract development|MP:0010432,common ventricle
MGI:3579836	Tbx20<tm1.1Rph>	MP:0000270,abnormal heart tube morphology|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003385,abnormal body wall morphology|MP:0004063,dilated heart left atrium|MP:0004076,abnormal vitelline vascular remodeling|MP:0004251,failure of heart looping|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0020516,abnormal visceral yolk sac mesenchyme morphology|MP:0021158,decreased heart left ventricle wall thickness|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3579849	Tbx20<tm1.1Sev>	MP:0000270,abnormal heart tube morphology|MP:0001730,embryonic growth arrest|MP:0002740,heart hypoplasia|MP:0004251,failure of heart looping|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation
MGI:5551507	Tbx20<tm1.2Rph>	MP:0002169,no abnormal phenotype detected
MGI:3580099	Tbx20<tm1Akis>	MP:0000259,abnormal vascular development|MP:0000267,abnormal heart development|MP:0000270,abnormal heart tube morphology|MP:0001730,embryonic growth arrest|MP:0001785,edema|MP:0002128,abnormal blood circulation|MP:0003984,embryonic growth retardation|MP:0004251,failure of heart looping|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation
MGI:4367995	Tbx21<duane>	MP:0008041,absent NK T cells|MP:0008044,increased NK cell number|MP:0008045,decreased NK cell number|MP:0008053,abnormal NK cell differentiation
MGI:6268347	Tbx21<m1Btlr>	MP:0002494,increased IgM level|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number
MGI:2180194	Tbx21<tm1Glm>	MP:0001952,increased airway responsiveness|MP:0002132,abnormal respiratory system morphology|MP:0002405,respiratory system inflammation|MP:0002436,abnormal CD8-positive, alpha-beta cytotoxic T cell morphology|MP:0002490,abnormal immunoglobulin level|MP:0003009,abnormal cytokine secretion|MP:0003080,increased natural killer cell mediated cytotoxicity|MP:0003156,abnormal leukocyte migration|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005027,increased susceptibility to parasitic infection|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0006082,CNS inflammation|MP:0008050,decreased memory T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008087,decreased T helper 1 cell number|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008090,increased T-helper 2 cell number|MP:0008537,increased susceptibility to induced colitis|MP:0008567,decreased interferon-gamma secretion|MP:0008681,increased interleukin-17 secretion|MP:0008713,abnormal cytokine level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0010766,abnormal NK cell physiology
MGI:3664621	Tbx21<tm1Srnr>	MP:0002433,abnormal T-helper 1 cell morphology|MP:0008040,decreased NK T cell number|MP:0008041,absent NK T cells|MP:0008045,decreased NK cell number
MGI:5140531	Tbx21<tm2Srnr>	MP:0005387,immune system phenotype|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008560,increased tumor necrosis factor secretion|MP:0008681,increased interleukin-17 secretion|MP:0008687,increased interleukin-2 secretion|MP:0020913,increased susceptibility to Riboviria infection
MGI:5468965	Tbx22<tm1.1(KOMP)Vlcg>	MP:0001415,increased exploration in new environment|MP:0001556,increased circulating HDL cholesterol level|MP:0005561,increased mean corpuscular hemoglobin
MGI:4361267	Tbx22<tm1.1Sta>	MP:0000098,abnormal vomer bone morphology|MP:0001954,respiratory distress|MP:0002896,abnormal bone mineralization|MP:0008273,abnormal intramembranous bone ossification|MP:0008395,abnormal osteoblast differentiation|MP:0008970,choanal atresia|MP:0009652,abnormal palatal rugae morphology|MP:0009890,cleft secondary palate|MP:0009892,palate bone hypoplasia|MP:0009895,decreased palatine bone horizontal plate size|MP:0011090,perinatal lethality, incomplete penetrance|MP:0013264,tongue ankylosis|MP:0030183,persistent oronasal membrane|MP:0030266,small vomer bone
MGI:4361266	Tbx22<tm1Sta>	MP:0002169,no abnormal phenotype detected
MGI:4415614	Tbx2<tm1.1(cre)Vmc>	MP:0000562,polydactyly|MP:0002169,no abnormal phenotype detected|MP:0009890,cleft secondary palate|MP:0021166,delayed palatal shelf elevation|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0031462,decreased palatal shelf size
MGI:3505715	Tbx2<tm1Pa>	MP:0000301,decreased atrioventricular cushion size|MP:0000562,polydactyly|MP:0001787,pericardial edema|MP:0002127,abnormal cardiovascular system morphology|MP:0002192,hydrops fetalis|MP:0002925,abnormal cardiovascular development|MP:0006107,abnormal fetal atrioventricular canal morphology|MP:0008772,increased heart ventricle size|MP:0010454,abnormal truncus arteriosus septation|MP:0010587,conotruncal ridge hypoplasia|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0013917,persistent right 6th pharyngeal arch artery
MGI:4822015	Tbx2<tm2.1Vmc>	MP:0002169,no abnormal phenotype detected
MGI:4822020	Tbx2<tm2.2Vmc>	MP:0006107,abnormal fetal atrioventricular canal morphology|MP:0009744,postaxial polydactyly|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6857755	Tbx3<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0001402,decreased locomotor activity|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0006203,eye hemorrhage|MP:0010097,abnormal retina blood vessel morphology|MP:0013292,embryonic lethality prior to organogenesis
MGI:3710254	Tbx3<tm1.1(cre)Vmc>	MP:0000628,abnormal mammary gland development|MP:0002109,abnormal limb morphology|MP:0002169,no abnormal phenotype detected|MP:0004115,abnormal sinoatrial node morphology|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009890,cleft secondary palate|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0031541,decreased sinoatrial node size
MGI:5538551	Tbx3<tm1.1Moon>	MP:0000267,abnormal heart development|MP:0001636,irregular heartbeat|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0011102,embryonic lethality, incomplete penetrance
MGI:3769504	Tbx3<tm1Jcib>	MP:0000269,abnormal heart looping|MP:0001265,decreased body size|MP:0001787,pericardial edema|MP:0003229,abnormal vitelline vasculature morphology|MP:0004251,failure of heart looping|MP:0006107,abnormal fetal atrioventricular canal morphology|MP:0009328,delayed heart looping|MP:0014322,short hindlimb
MGI:2655214	Tbx3<tm1Pa>	MP:0000550,abnormal forelimb morphology|MP:0000555,absent carpal bone|MP:0000556,abnormal hindlimb morphology|MP:0000601,small liver|MP:0000629,absent mammary gland|MP:0001119,abnormal female reproductive system morphology|MP:0001142,abnormal vagina orifice morphology|MP:0001679,thin apical ectodermal ridge|MP:0001719,absent vitelline blood vessels|MP:0001722,pale yolk sac|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0003074,absent metacarpal bones|MP:0003127,abnormal clitoris morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003857,abnormal hindlimb zeugopod morphology|MP:0004135,abnormal mammary gland embryonic development|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004576,abnormal embryonic autopod plate morphology|MP:0005108,abnormal ulna morphology|MP:0006279,abnormal limb development|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0013169,small hindlimb buds|MP:0013785,abnormal mammary gland bud morphology|MP:0020515,abnormal visceral yolk sac endoderm morphology
MGI:5538563	Tbx3<tm2.1Moon>	MP:0000555,absent carpal bone|MP:0000565,oligodactyly|MP:0001636,irregular heartbeat|MP:0001785,edema|MP:0002083,premature death|MP:0002110,abnormal digit morphology|MP:0002925,abnormal cardiovascular development|MP:0003137,abnormal impulse conducting system conduction|MP:0003898,abnormal QRS complex|MP:0003928,increased heart rate variability|MP:0004070,abnormal P wave|MP:0004122,abnormal sinus arrhythmia|MP:0004360,absent ulna|MP:0005333,decreased heart rate|MP:0005380,embryo phenotype|MP:0005430,absent fibula|MP:0005599,increased cardiac muscle contractility|MP:0006063,abnormal inferior vena cava morphology|MP:0009729,absent tarsus bones|MP:0010392,prolonged QRS complex duration|MP:0010402,ventricular septal defect|MP:0010510,absent P wave|MP:0010511,shortened PR interval|MP:0010512,absent PR interval|MP:0010519,atrioventricular block|MP:0010637,sinus bradycardia|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0031542,sinoatrial node hypoplasia
MGI:5538562	Tbx3<tm2Moon>	MP:0001636,irregular heartbeat
MGI:5538564	Tbx3<tm3.1Moon>	MP:0001636,irregular heartbeat|MP:0004122,abnormal sinus arrhythmia|MP:0010519,atrioventricular block|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5538565	Tbx3<tm3.2Moon>	MP:0001636,irregular heartbeat|MP:0005333,decreased heart rate|MP:0010519,atrioventricular block|MP:0011092,embryonic lethality, complete penetrance
MGI:3808010	Tbx4<tm1.1Kng>	MP:0002187,abnormal fibula morphology|MP:0002544,brachydactyly|MP:0002764,short tibia|MP:0003109,short femur|MP:0004509,abnormal pelvic girdle bone morphology|MP:0005353,abnormal patella morphology|MP:0005371,limbs/digits/tail phenotype|MP:0006279,abnormal limb development|MP:0008919,fused tarsal bones|MP:0030860,patellar dislocation
MGI:2663716	Tbx4<tm1.1Pa>	MP:0000292,distended pericardium|MP:0000364,abnormal vascular regression|MP:0001726,abnormal allantois morphology|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0003230,abnormal umbilical artery morphology|MP:0003891,increased allantois apoptosis|MP:0004558,delayed allantois development|MP:0004559,small allantois|MP:0009656,delayed chorioallantoic fusion|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012134,absent umbilical cord|MP:0013169,small hindlimb buds
MGI:3811603	Tbx4<tm1.2Pa>	MP:0000556,abnormal hindlimb morphology|MP:0000572,abnormal autopod morphology|MP:0002110,abnormal digit morphology|MP:0002169,no abnormal phenotype detected|MP:0002765,short fibula|MP:0003072,abnormal metatarsal bone morphology|MP:0003109,short femur|MP:0004349,absent femur|MP:0004509,abnormal pelvic girdle bone morphology|MP:0005371,limbs/digits/tail phenotype|MP:0005650,abnormal limb bud morphology|MP:0006279,abnormal limb development|MP:0008730,fused phalanges|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0014281,hindlimb oligodactyly|MP:0014322,short hindlimb
MGI:5292375	Tbx4<tm1(cre)Tmj>	MP:0002169,no abnormal phenotype detected
MGI:2663714	Tbx4<tm1Pa>	MP:0000292,distended pericardium|MP:0000364,abnormal vascular regression|MP:0001726,abnormal allantois morphology|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0003230,abnormal umbilical artery morphology|MP:0003891,increased allantois apoptosis|MP:0004558,delayed allantois development|MP:0004559,small allantois|MP:0009656,delayed chorioallantoic fusion|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012134,absent umbilical cord|MP:0013169,small hindlimb buds
MGI:5548329	Tbx4<tm4b(EUCOMM)Wtsi>	MP:0001697,abnormal embryo size|MP:0001722,pale yolk sac|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2387851	Tbx5<tm1.1Jse>	MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000270,abnormal heart tube morphology|MP:0000274,enlarged heart|MP:0000298,absent atrioventricular cushions|MP:0000554,abnormal carpal bone morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001730,embryonic growth arrest|MP:0002110,abnormal digit morphology|MP:0002192,hydrops fetalis|MP:0003137,abnormal impulse conducting system conduction|MP:0003140,dilated heart atrium|MP:0003896,prolonged PR interval|MP:0004071,prolonged P wave|MP:0004117,abnormal atrioventricular bundle morphology|MP:0004122,abnormal sinus arrhythmia|MP:0004123,abnormal impulse conducting system morphology|MP:0004251,failure of heart looping|MP:0005306,abnormal phalanx morphology|MP:0005312,pericardial effusion|MP:0006141,abnormal atrioventricular node conduction|MP:0006142,abnormal sinoatrial node conduction|MP:0008950,ventricular tachycardia|MP:0010392,prolonged QRS complex duration|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010404,ostium primum atrial septal defect|MP:0010406,common atrium|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010519,atrioventricular block|MP:0010520,sinoatrial block|MP:0010566,abnormal left posterior bundle morphology|MP:0010567,abnormal right bundle morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011953,prolonged PQ interval|MP:0031530,abnormal heart ventricle shape
MGI:3692758	Tbx5<tm1.2Jse>	MP:0001636,irregular heartbeat|MP:0001657,abnormal induced morbidity/mortality|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0003137,abnormal impulse conducting system conduction|MP:0004116,abnormal atrioventricular bundle conduction|MP:0005385,cardiovascular system phenotype|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0010519,atrioventricular block
MGI:2387850	Tbx5<tm1Jse>	MP:0000158,absent sternum|MP:0000267,abnormal heart development|MP:0000550,abnormal forelimb morphology|MP:0000551,absent forelimb|MP:0001544,abnormal cardiovascular system physiology|MP:0001677,absent apical ectodermal ridge|MP:0001730,embryonic growth arrest|MP:0002081,perinatal lethality|MP:0003105,abnormal heart atrium morphology|MP:0003140,dilated heart atrium|MP:0003257,abnormal abdominal wall morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004055,heart atrium hypoplasia|MP:0004122,abnormal sinus arrhythmia|MP:0004339,absent clavicle|MP:0004341,absent scapula|MP:0004624,abnormal thoracic cage morphology|MP:0005371,limbs/digits/tail phenotype|MP:0005503,abnormal tendon morphology|MP:0006279,abnormal limb development|MP:0008950,ventricular tachycardia|MP:0010403,atrial septal defect|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011953,prolonged PQ interval|MP:0013164,abnormal forelimb bud morphology|MP:0013165,absent forelimb buds
MGI:3578143	Tbx6<dd1>	MP:0002151,abnormal neural tube morphology|MP:0008029,abnormal paraxial mesoderm morphology
MGI:6368858	Tbx6<em1Fzh>	MP:0005390,skeleton phenotype|MP:0011091,prenatal lethality, complete penetrance
MGI:6368863	Tbx6<em2Fzh>	MP:0005390,skeleton phenotype
MGI:6441961	Tbx6<em3Fzh>	MP:0000137,abnormal vertebrae morphology|MP:0004609,vertebral fusion
MGI:1857025	Tbx6<rv>	MP:0000154,rib fusion|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001258,decreased body length|MP:0001688,abnormal somite development|MP:0001923,reduced female fertility|MP:0002151,abnormal neural tube morphology|MP:0002825,abnormal notochord morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003119,abnormal digestive system development|MP:0003604,single kidney|MP:0003675,kidney cyst|MP:0004600,abnormal vertebral transverse process morphology|MP:0004602,abnormal vertebral articular process morphology|MP:0004607,abnormal cervical atlas morphology|MP:0004612,fusion of vertebral bodies|MP:0004613,fusion of vertebral arches|MP:0004620,cervical vertebral fusion|MP:0004669,enlarged vertebral body|MP:0004670,small vertebral body|MP:0004703,abnormal vertebral column morphology|MP:0005226,abnormal vertebral arch development|MP:0005227,abnormal vertebral body development|MP:0005229,abnormal intervertebral disk development|MP:0006281,abnormal tail development|MP:0011733,fused somites
MGI:2447721	Tbx6<tm1Pa>	MP:0000259,abnormal vascular development|MP:0000789,thickened cerebral cortex|MP:0001680,abnormal mesoderm development|MP:0002151,abnormal neural tube morphology|MP:0003400,kinked neural tube|MP:0003401,enlarged tail bud|MP:0005238,increased brain size|MP:0008029,abnormal paraxial mesoderm morphology|MP:0008817,hematoma|MP:0009768,impaired somite development|MP:0010662,abnormal intersomitic artery morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012452,increased retrosplenial granular cortex size|MP:0012465,increased hippocampal fimbria size|MP:0012475,increased piriform cortex size|MP:0012477,increased secondary somatosensory cortex size
MGI:2445297	Tbxa2r<tm1Cof>	MP:0000249,abnormal blood vessel physiology|MP:0001544,abnormal cardiovascular system physiology|MP:0002328,abnormal airway resistance|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0009548,abnormal platelet aggregation|MP:0009818,abnormal thromboxane level|MP:0010768,mortality/aging
MGI:2667333	Tbxa2r<tm1Sna>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001785,edema|MP:0001790,abnormal immune system physiology|MP:0002339,abnormal lymph node morphology|MP:0002351,abnormal cervical lymph node morphology|MP:0002531,abnormal type I hypersensitivity reaction|MP:0002722,abnormal immune system organ morphology|MP:0002723,abnormal immune serum protein physiology|MP:0005596,increased susceptibility to type I hypersensitivity reaction
MGI:3052866	Tbxas1<tm1Swl>	MP:0001876,decreased inflammatory response|MP:0005606,increased bleeding time|MP:0009549,decreased platelet aggregation
MGI:5776521	tbyl	MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0011083,lethality at weaning, complete penetrance
MGI:1856185	T<c>	MP:0000138,absent vertebrae|MP:0000154,rib fusion|MP:0000292,distended pericardium|MP:0000461,decreased presacral vertebrae number|MP:0000592,short tail|MP:0000955,abnormal spinal cord morphology|MP:0001672,abnormal embryo development|MP:0001726,abnormal allantois morphology|MP:0002082,postnatal lethality|MP:0002111,abnormal tail morphology|MP:0002151,abnormal neural tube morphology|MP:0002861,abnormal tail bud morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003400,kinked neural tube|MP:0003456,absent tail|MP:0004073,caudal body truncation|MP:0004607,abnormal cervical atlas morphology|MP:0004609,vertebral fusion|MP:0004613,fusion of vertebral arches|MP:0004620,cervical vertebral fusion|MP:0004623,thoracic vertebral fusion|MP:0004659,abnormal odontoid process morphology|MP:0004672,short ribs|MP:0004713,split notochord|MP:0004837,abnormal neural fold formation|MP:0005226,abnormal vertebral arch development|MP:0005297,spina bifida occulta|MP:0005650,abnormal limb bud morphology|MP:0006386,absent somites|MP:0006392,abnormal nucleus pulposus morphology|MP:0008271,abnormal bone ossification|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012063,absent tail bud|MP:0013165,absent forelimb buds|MP:0013168,absent hindlimb buds
MGI:1856193	T<c-2H>	MP:0002080,prenatal lethality|MP:0002111,abnormal tail morphology|MP:0002632,vestigial tail|MP:0003456,absent tail|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3042264	T<c-3H>	MP:0000929,open neural tube|MP:0001689,incomplete somite formation|MP:0003456,absent tail|MP:0011092,embryonic lethality, complete penetrance
MGI:6385273	Tcaf2<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0000759,abnormal skeletal muscle morphology|MP:0001293,anophthalmia|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0005564,increased hemoglobin content
MGI:5577263	Tcaim<tm1b(EUCOMM)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005178,increased circulating cholesterol level
MGI:5693866	Tcam1<tm1Zuk>	MP:0003698,abnormal male reproductive system physiology|MP:0005389,reproductive system phenotype
MGI:4457372	Tcap<tm1Mkc>	MP:0000751,myopathy|MP:0001405,impaired coordination|MP:0002106,abnormal muscle physiology|MP:0005369,muscle phenotype|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009413,skeletal muscle fiber atrophy
MGI:5443850	Tcap<tm1Rnk>	MP:0001625,cardiac hypertrophy|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0004090,abnormal sarcomere morphology|MP:0004485,increased response of heart to induced stress|MP:0005385,cardiovascular system phenotype|MP:0006138,congestive heart failure
MGI:3575703	Tcdel1<NOD/ShiLtDoi>	MP:0005089,decreased double-negative T cell number|MP:0005091,increased double-positive T cell number
MGI:3575705	Tcdel2<NOD/ShiLtDoi>	MP:0005089,decreased double-negative T cell number|MP:0005091,increased double-positive T cell number
MGI:3622786	Tcea1<tm1Skmz>	MP:0000245,abnormal erythropoiesis|MP:0000600,liver hypoplasia|MP:0000603,pale liver|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0001787,pericardial edema|MP:0003051,curly tail|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:6362950	Tcea2<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0000221,decreased leukocyte cell number|MP:0001399,hyperactivity|MP:0002075,abnormal coat/hair pigmentation|MP:0010392,prolonged QRS complex duration
MGI:6144038	Tcea3<tm1Skmz>	MP:0002169,no abnormal phenotype detected
MGI:6156561	Tceal1<em1(IMPC)Tcp>	MP:0002092,abnormal eye morphology|MP:0002989,small kidney|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount
MGI:6156471	Tceal3<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0002060,abnormal skin morphology|MP:0011874,enlarged urinary bladder
MGI:4455578	Tceal9<tm1a(KOMP)Wtsi>	MP:0002599,increased mean platelet volume|MP:0010067,increased red blood cell distribution width
MGI:5775646	Tcerg1<em1(IMPC)J>	MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:4820071	Tcerg1l<tm1a(KOMP)Wtsi>	MP:0013278,decreased fasting circulating glucose level
MGI:6268791	Tcf12<m1Btlr>	MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:6269355	Tcf12<M2Btlr>	MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number
MGI:6283517	Tcf12<M3Btlr>	MP:0005017,decreased B cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:6283526	Tcf12<m4Btlr>	MP:0004939,abnormal B cell morphology|MP:0008037,abnormal T cell morphology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:2387400	Tcf12<tm1Zhu>	MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0003631,nervous system phenotype|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008208,decreased pro-B cell number|MP:0011085,postnatal lethality, complete penetrance
MGI:3707160	Tcf12<tm2Zhu>	MP:0000715,decreased thymocyte number|MP:0000914,exencephaly|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0002064,seizures|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005397,hematopoietic system phenotype|MP:0005671,abnormal response to transplant|MP:0008070,absent T cells|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008215,decreased immature B cell number|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3769702	Tcf12<tm3Zhu>	MP:0000715,decreased thymocyte number|MP:0005390,skeleton phenotype|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:1929775	Tcf15<tm1Eno>	MP:0000024,lowered ear position|MP:0000078,abnormal supraoccipital bone morphology|MP:0000079,abnormal basioccipital bone morphology|MP:0000080,abnormal exoccipital bone morphology|MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000592,short tail|MP:0000759,abnormal skeletal muscle morphology|MP:0001438,aphagia|MP:0001954,respiratory distress|MP:0002114,abnormal axial skeleton morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002280,abnormal intercostal muscle morphology|MP:0003051,curly tail|MP:0003257,abnormal abdominal wall morphology|MP:0003345,decreased rib number|MP:0004073,caudal body truncation|MP:0004174,abnormal spine curvature|MP:0004263,abnormal limb posture|MP:0005421,loose skin|MP:0006295,absent sclerotome|MP:0008029,abnormal paraxial mesoderm morphology|MP:0008148,abnormal sternocostal joint morphology|MP:0008149,abnormal costovertebral joint morphology|MP:0008277,abnormal sternum ossification|MP:0009461,skeletal muscle hypertrophy|MP:0009768,impaired somite development|MP:0010728,fusion of atlas and occipital bones|MP:0011087,neonatal lethality, complete penetrance|MP:0012173,short rostral-caudal axis|MP:0012248,absent dermatome|MP:0012249,absent myotome
MGI:6153684	Tcf20<em1(IMPC)Wtsi>	MP:0001258,decreased body length|MP:0002079,increased circulating insulin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0005343,increased circulating aspartate transaminase level|MP:0010024,increased total body fat amount|MP:0010090,increased circulating creatine kinase level|MP:0010124,decreased bone mineral content
MGI:6726263	Tcf20<em1Jwji>	MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000934,abnormal telencephalon development|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001394,circling|MP:0001409,increased stereotypic behavior|MP:0001732,postnatal growth retardation|MP:0008428,abnormal spatial working memory|MP:0010865,prenatal growth retardation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020351,decreased vocalization|MP:0020395,abnormal response to social novelty
MGI:7426017	Tcf21<em1(IMPC)Mbp>	MP:0000194,increased circulating calcium level|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001289,persistence of hyaloid vascular system|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:1888738	Tcf21<tm1Eno>	MP:0000527,abnormal kidney development|MP:0000690,absent spleen|MP:0001178,pulmonary hypoplasia|MP:0001184,absent pulmonary alveoli|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0003446,renal hypoplasia|MP:0003717,pallor|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0009323,abnormal spleen development|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011363,renal glomerulus atrophy
MGI:2148207	Tcf21<tm1Jrt>	MP:0000527,abnormal kidney development|MP:0000528,delayed kidney development|MP:0000530,abnormal kidney vasculature morphology|MP:0001116,small gonad|MP:0001126,abnormal ovary morphology|MP:0001178,pulmonary hypoplasia|MP:0001184,absent pulmonary alveoli|MP:0001939,secondary sex reversal|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002989,small kidney|MP:0002995,primary sex reversal|MP:0003014,abnormal kidney medulla morphology|MP:0003446,renal hypoplasia|MP:0003641,small lung|MP:0004007,abnormal lung vasculature morphology|MP:0004505,decreased renal glomerulus number|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005244,hemopericardium|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005652,sex reversal|MP:0006032,abnormal ureteric bud morphology|MP:0006382,abnormal lung epithelium morphology|MP:0006419,disorganized testis cords|MP:0008059,abnormal podocyte foot process morphology|MP:0010812,absent type II pneumocytes|MP:0010856,dilated respiratory conducting tube|MP:0010902,abnormal pulmonary alveolar sac morphology|MP:0010911,abnormal pulmonary acinus morphology|MP:0010976,small lung lobe|MP:0010981,abnormal branching involved in ureteric bud morphogenesis|MP:0010985,abnormal kidney mesenchyme morphology|MP:0011028,impaired branching involved in bronchus morphogenesis|MP:0011038,impaired branching involved in alveolar sac morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011290,decreased nephron number|MP:0011320,abnormal glomerular capillary morphology|MP:0011321,abnormal peritubular capillary morphology|MP:0011351,absent proximal convoluted tubule brush border|MP:0011727,ectopic ovary|MP:0011760,abnormal ureteric bud tip morphology|MP:0020491,abnormal ovary topology
MGI:2148205	Tcf21<tm2Eno>	MP:0000266,abnormal heart morphology|MP:0000277,abnormal heart shape|MP:0000527,abnormal kidney development|MP:0000690,absent spleen|MP:0001178,pulmonary hypoplasia|MP:0001184,absent pulmonary alveoli|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002652,thin myocardium|MP:0003446,renal hypoplasia|MP:0003717,pallor|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005244,hemopericardium|MP:0008727,increased heart right atrium size|MP:0009323,abnormal spleen development|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011363,renal glomerulus atrophy|MP:0012515,abnormal heart apex morphology
MGI:5442346	Tcf21<tm3.1(cre/Esr1*)Eno>	MP:0002169,no abnormal phenotype detected|MP:0011087,neonatal lethality, complete penetrance
MGI:7738743	Tcf23<em1Hoi>	MP:0001314,cornea opacity|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002907,abnormal parturition|MP:0003566,abnormal cell adhesion|MP:0003845,abnormal decidualization|MP:0004514,dystocia|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0008256,abnormal myometrium morphology|MP:0008257,thin myometrium|MP:0009671,abnormal uterus physiology|MP:0012008,delayed parturition|MP:0012699,decreased maternal body weight gain|MP:0013258,abnormal extracellular matrix morphology|MP:0020253,increased collagen level
MGI:6152656	Tcf25<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0008935,decreased mean platelet volume|MP:0020421,increased freezing behavior
MGI:7628233	Tcf25<em1Xdzg>	MP:0004485,increased response of heart to induced stress
MGI:3803638	Tcf3<tm1.1Mbu>	MP:0002144,abnormal B cell differentiation
MGI:2178119	Tcf3<tm1Cmu>	MP:0002429,abnormal blood cell morphology/development|MP:0003944,abnormal T cell subpopulation ratio|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0008755,abnormal immunoglobulin V(D)J recombination|MP:0008760,abnormal immunoglobulin heavy chain V(D)J recombination|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3803637	Tcf3<tm1Mbu>	MP:0008208,decreased pro-B cell number
MGI:5806089	Tcf3<tm1(PBX1)Mlc>	MP:0000218,increased leukocyte cell number|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001577,anemia|MP:0001802,arrested B cell differentiation|MP:0002459,abnormal B cell physiology|MP:0003179,thrombocytopenia|MP:0005017,decreased B cell number|MP:0005432,abnormal pro-B cell morphology|MP:0008215,decreased immature B cell number|MP:0008233,abnormal pro-B cell differentiation|MP:0014050,increased B cell acute lymphoblastic leukemia incidence
MGI:4458115	Tcf3<tm1(TCF3/HLF)Homy>	MP:0002021,increased incidence of induced tumors|MP:0002144,abnormal B cell differentiation|MP:0005014,increased B cell number|MP:0005048,abnormal thrombosis|MP:0005397,hematopoietic system phenotype|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010768,mortality/aging
MGI:2178112	Tcf3<tm1Wein>	MP:0000709,enlarged thymus|MP:0000717,abnormal lymphocyte cell number|MP:0001732,postnatal growth retardation|MP:0001926,female infertility|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0002458,abnormal B cell number|MP:0003643,spleen atrophy|MP:0005017,decreased B cell number|MP:0008209,decreased pre-B cell number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3776793	Tcf3<tm1Xhsu>	MP:0005014,increased B cell number|MP:0005387,immune system phenotype
MGI:2387348	Tcf3<tm1Zhu>	MP:0001823,thymus hypoplasia|MP:0001926,female infertility|MP:0002083,premature death|MP:0003631,nervous system phenotype|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0005017,decreased B cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008082,increased single-positive T cell number
MGI:2178143	Tcf3<tm2Cmu>	MP:0000238,absent pre-B cells|MP:0000313,abnormal cell death|MP:0000351,increased cell proliferation|MP:0002401,abnormal lymphopoiesis|MP:0008045,decreased NK cell number|MP:0008127,decreased dendritic cell number|MP:0008187,absent pro-B cells
MGI:2178116	Tcf3<tm2Wein>	MP:0000685,abnormal immune system morphology|MP:0001732,postnatal growth retardation|MP:0001926,female infertility|MP:0002024,increased T cell derived lymphoma incidence|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002396,abnormal hematopoietic system morphology/development
MGI:2387351	Tcf3<tm2Zhu>	MP:0001265,decreased body size|MP:0002083,premature death|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0005389,reproductive system phenotype|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0010768,mortality/aging
MGI:4366003	Tcf3<tm3.1Cmu>	MP:0002144,abnormal B cell differentiation|MP:0008209,decreased pre-B cell number|MP:0008761,abnormal immunoglobulin light chain V-J recombination
MGI:2387352	Tcf3<tm3Zhu>	MP:0005017,decreased B cell number|MP:0005387,immune system phenotype
MGI:4366005	Tcf3<tm4.1Cmu>	MP:0001802,arrested B cell differentiation|MP:0008071,absent B cells|MP:0008208,decreased pro-B cell number|MP:0008761,abnormal immunoglobulin light chain V-J recombination
MGI:2387315	Tcf3<tm4Zhu>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype
MGI:5424883	Tcf3<tm5.1Cmu>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype
MGI:3774507	Tcf3<tm5Zhu>	MP:0002169,no abnormal phenotype detected
MGI:4399144	Tcf3<tm6(Esr1*)Zhu>	MP:0001732,postnatal growth retardation|MP:0001802,arrested B cell differentiation|MP:0002083,premature death|MP:0008760,abnormal immunoglobulin heavy chain V(D)J recombination
MGI:6157962	Tcf4<em1Bdph>	MP:0000433,microcephaly|MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001489,decreased startle reflex|MP:0002152,abnormal brain morphology|MP:0002175,decreased brain weight|MP:0003008,enhanced long-term potentiation|MP:0003234,enhanced NMDA-mediated synaptic currents|MP:0005402,abnormal action potential|MP:0009141,increased prepulse inhibition|MP:0012307,impaired spatial learning|MP:0031391,increased locomotor activity
MGI:6157964	Tcf4<em2Bdph>	MP:0000433,microcephaly|MP:0002152,abnormal brain morphology|MP:0002175,decreased brain weight|MP:0003008,enhanced long-term potentiation
MGI:3798811	Tcf4<tm1.1Hmb>	MP:0002145,abnormal T cell differentiation|MP:0002444,abnormal T cell physiology|MP:0005090,increased double-negative T cell number|MP:0005387,immune system phenotype|MP:0011085,postnatal lethality, complete penetrance
MGI:4432303	Tcf4<tm1a(EUCOMM)Wtsi>	MP:0000780,abnormal corpus callosum morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0001325,abnormal retina morphology|MP:0006254,thin cerebral cortex|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020083,decreased hippocampus volume
MGI:3036170	Tcf4<tm1Hmb>	MP:0000433,microcephaly|MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001489,decreased startle reflex|MP:0002152,abnormal brain morphology|MP:0002175,decreased brain weight|MP:0003008,enhanced long-term potentiation|MP:0003234,enhanced NMDA-mediated synaptic currents|MP:0009142,decreased prepulse inhibition|MP:0011620,abnormal habituation to a new environment|MP:0012307,impaired spatial learning|MP:0031391,increased locomotor activity
MGI:2387399	Tcf4<tm1Zhu>	MP:0000913,abnormal brain development|MP:0001361,social withdrawal|MP:0001406,abnormal gait|MP:0001441,increased grooming behavior|MP:0001488,increased startle reflex|MP:0001525,impaired balance|MP:0003008,enhanced long-term potentiation|MP:0008208,decreased pro-B cell number|MP:0008432,abnormal long-term spatial reference memory|MP:0009142,decreased prepulse inhibition|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0010053,decreased grip strength|MP:0011085,postnatal lethality, complete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0012307,impaired spatial learning|MP:0020351,decreased vocalization|MP:0031391,increased locomotor activity
MGI:5430599	Tcf7l1<tm1.1Bjme>	MP:0000914,exencephaly|MP:0001302,eyelids open at birth|MP:0001614,abnormal blood vessel morphology|MP:0001634,internal hemorrhage|MP:0002192,hydrops fetalis|MP:0004938,dilated vasculature|MP:0005650,abnormal limb bud morphology|MP:0006279,abnormal limb development|MP:0009264,failure of eyelid fusion|MP:0009651,abnormal eyelid development|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0014280,forelimb oligodactyly
MGI:5620299	Tcf7l1<tm1.1(cre/ERT2)Hng>	MP:0002169,no abnormal phenotype detected
MGI:4413464	Tcf7l1<tm1.1Efu>	MP:0002169,no abnormal phenotype detected
MGI:4432867	Tcf7l1<tm1a(EUCOMM)Wtsi>	MP:0001314,cornea opacity
MGI:3044615	Tcf7l1<tm1Efu>	MP:0005381,digestive/alimentary phenotype
MGI:3044616	Tcf7l1<tm2Efu>	MP:0000274,enlarged heart|MP:0000291,enlarged pericardium|MP:0000474,abnormal foregut morphology|MP:0000913,abnormal brain development|MP:0001614,abnormal blood vessel morphology|MP:0001698,decreased embryo size|MP:0002230,abnormal primitive streak formation|MP:0002825,abnormal notochord morphology|MP:0004837,abnormal neural fold formation|MP:0005221,abnormal rostral-caudal axis patterning|MP:0006386,absent somites|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011388,absent heart|MP:0012138,decreased forebrain size|MP:0012156,rostral-caudal axis duplication|MP:0012157,rostral body truncation|MP:0012181,increased somite number|MP:0012274,increased axial mesoderm size
MGI:5292672	Tcf7l2<em1Nobr>	MP:0000189,hypoglycemia|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001433,polyphagia|MP:0002727,decreased circulating insulin level|MP:0003961,decreased lean body mass|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005560,decreased circulating glucose level|MP:0009546,absent gastric milk in neonates|MP:0009703,decreased birth body size|MP:0010025,decreased total body fat amount|MP:0011087,neonatal lethality, complete penetrance
MGI:5292673	Tcf7l2<em2Nobr>	MP:0000189,hypoglycemia|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001433,polyphagia|MP:0002727,decreased circulating insulin level|MP:0003961,decreased lean body mass|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005560,decreased circulating glucose level|MP:0009546,absent gastric milk in neonates|MP:0009703,decreased birth body size|MP:0010025,decreased total body fat amount|MP:0011087,neonatal lethality, complete penetrance
MGI:5292674	Tcf7l2<em3Nobr>	MP:0000189,hypoglycemia|MP:0009546,absent gastric milk in neonates|MP:0009703,decreased birth body size|MP:0011087,neonatal lethality, complete penetrance
MGI:6268738	Tcf7l2<m1Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:4946909	Tcf7l2<tm1.1(EGFP/cre)Mrc>	MP:0000477,abnormal intestine morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000495,abnormal colon morphology|MP:0000496,abnormal small intestine morphology|MP:0008883,abnormal enterocyte proliferation|MP:0009546,absent gastric milk in neonates|MP:0009674,decreased birth weight|MP:0010802,abnormal intestinal enteroendocrine cell morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0013241,embryo tissue necrosis|MP:0013792,abnormal small intestine goblet cell morphology|MP:0013795,abnormal colon goblet cell morphology
MGI:4431951	Tcf7l2<tm1a(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0000284,double outlet right ventricle|MP:0000520,absent kidney|MP:0000602,dilated liver sinusoidal space|MP:0000783,abnormal forebrain morphology|MP:0002078,abnormal glucose homeostasis|MP:0002239,abnormal nasal septum morphology|MP:0002599,increased mean platelet volume|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003686,abnormal eye muscle morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0003827,abnormal Wolffian duct morphology|MP:0003960,increased lean body mass|MP:0004160,retroesophageal right subclavian artery|MP:0004164,abnormal neurohypophysis morphology|MP:0004463,basisphenoid bone foramen|MP:0004609,vertebral fusion|MP:0004613,fusion of vertebral arches|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0006063,abnormal inferior vena cava morphology|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010080,abnormal hepatocyte physiology|MP:0010123,increased bone mineral content|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010589,common truncal valve|MP:0010602,abnormal pulmonary valve cusp morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011400,lethality, complete penetrance|MP:0011513,abnormal vertebral artery morphology|MP:0013186,abnormal basilar artery morphology|MP:0013862,abnormal cecum position|MP:0013876,absent ductus venosus valve|MP:0013879,duplication of ductus venosus|MP:0013943,abnormal ureter topology|MP:0013945,abnormal elbow joint morphology|MP:0013977,symmetric azygos veins|MP:0013985,abnormal umbilical vein topology|MP:0014001,abnormal vertebral artery topology|MP:0014021,heterochrony|MP:0020485,abnormal inferior vena cava topology
MGI:1926344	Tcf7l2<tm1Cle>	MP:0000339,decreased enterocyte cell number|MP:0000479,abnormal enterocyte morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000636,enlarged pituitary gland|MP:0003935,abnormal craniofacial development|MP:0005384,cellular phenotype|MP:0008130,abnormal pituitary intermediate lobe morphology|MP:0008366,enlarged adenohypophysis|MP:0011087,neonatal lethality, complete penetrance
MGI:5444885	Tcf7l2<tm1Geno>	MP:0002079,increased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0009114,decreased pancreatic beta cell mass
MGI:5430317	Tcf7l2<tm2.1Cle>	MP:0008883,abnormal enterocyte proliferation|MP:0008885,increased enterocyte apoptosis|MP:0010158,abnormal intestine development|MP:0013486,decreased Paneth cell number|MP:0013792,abnormal small intestine goblet cell morphology|MP:0014076,absent Paneth cells|MP:0014077,ectopic Paneth cells
MGI:4946910	Tcf7l2<tm2.1Mrc>	MP:0000477,abnormal intestine morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000495,abnormal colon morphology|MP:0000496,abnormal small intestine morphology|MP:0001265,decreased body size|MP:0002006,neoplasm|MP:0003449,abnormal intestine goblet cell morphology|MP:0008883,abnormal enterocyte proliferation|MP:0009546,absent gastric milk in neonates|MP:0009674,decreased birth weight|MP:0010802,abnormal intestinal enteroendocrine cell morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0013241,embryo tissue necrosis
MGI:4946911	Tcf7l2<tm2.2Mrc>	MP:0000477,abnormal intestine morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000495,abnormal colon morphology|MP:0000496,abnormal small intestine morphology|MP:0003449,abnormal intestine goblet cell morphology|MP:0008883,abnormal enterocyte proliferation|MP:0009546,absent gastric milk in neonates|MP:0009674,decreased birth weight|MP:0010802,abnormal intestinal enteroendocrine cell morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0013241,embryo tissue necrosis
MGI:4441645	Tcf7<tm1a(EUCOMM)Wtsi>	MP:0000550,abnormal forelimb morphology|MP:0000564,syndactyly|MP:0001304,cataract|MP:0002968,increased circulating alkaline phosphatase level|MP:0005014,increased B cell number|MP:0005018,decreased T cell number|MP:0005316,abnormal response to tactile stimuli|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:1926298	Tcf7<tm1Cle>	MP:0000063,decreased bone mineral density|MP:0000711,thymus cortex hypoplasia|MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0002404,increased intestinal adenoma incidence|MP:0004984,increased osteoclast cell number|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0006422,increased mammary adenoacanthoma incidence|MP:0008051,abnormal memory T cell physiology|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number
MGI:1926299	Tcf7<tm2Cle>	MP:0001823,thymus hypoplasia|MP:0005092,decreased double-positive T cell number|MP:0008083,decreased single-positive T cell number
MGI:7316455	Tcfl5<tm1.1Frem>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0008966,abnormal chiasmata formation|MP:0014052,increased male germ cell apoptosis|MP:0020550,multinucleated giant male germ cells
MGI:7316451	Tcfl5<tm1Frem>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0006380,abnormal spermatid morphology|MP:0008261,arrest of male meiosis|MP:0020550,multinucleated giant male germ cells
MGI:1857064	tch	MP:0000547,short limbs|MP:0000592,short tail|MP:0002427,disproportionate dwarf|MP:0002764,short tibia|MP:0002765,short fibula|MP:0003109,short femur|MP:0004351,short humerus|MP:0004359,short ulna|MP:0004508,abnormal pectoral girdle bone morphology|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004686,decreased length of long bones|MP:0009250,abnormal appendicular skeleton morphology
MGI:6392072	Tchh<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:6257566	Tchhl1<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3038498	Tchol1<KK/Ta>	MP:0005178,increased circulating cholesterol level
MGI:4433203	Tchp<tm1a(EUCOMM)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005358,abnormal incisor morphology
MGI:6711105	Tchp<tm1Inag>	MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0005452,abnormal adipose tissue amount|MP:0005533,increased body temperature|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005670,abnormal white adipose tissue physiology|MP:0009269,decreased fat cell size|MP:0011167,abnormal adipose tissue development|MP:0011168,abnormal fat cell differentiation|MP:0014143,decreased body fat mass|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3814712	Tc(HSA21)1TybEmcf	MP:0000273,overriding aortic valve|MP:0000299,failure of atrioventricular cushion closure|MP:0000458,abnormal mandible morphology|MP:0000644,dextrocardia|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001516,abnormal motor coordination/balance|MP:0001524,impaired limb coordination|MP:0002063,abnormal learning/memory/conditioning|MP:0003461,abnormal response to novel object|MP:0008414,abnormal spatial reference memory|MP:0008948,decreased neuron number|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect
MGI:5702748	Tcim<tm1Icle>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000688,lymphoid hyperplasia|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0003131,increased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0004809,increased hematopoietic stem cell number|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008247,abnormal mononuclear cell morphology|MP:0010067,increased red blood cell distribution width|MP:0010373,myeloid hyperplasia|MP:0013693,abnormal hemopoiesis|MP:0013696,increased granulocyte monocyte progenitor cell number|MP:0013891,increased common myeloid progenitor cell number
MGI:7426019	Tcirg1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001404,no spontaneous movement|MP:0002792,abnormal retina vasculature morphology|MP:0003917,increased kidney weight
MGI:5496553	Tcirg1<M1Jeau>	MP:0000062,increased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0001541,abnormal osteoclast physiology|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0005390,skeleton phenotype|MP:0010123,increased bone mineral content|MP:0010872,increased trabecular bone mass
MGI:1856973	Tcirg1<oc>	MP:0000064,failure of bone resorption|MP:0000067,osteopetrosis|MP:0000133,abnormal long bone metaphysis morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000240,extramedullary hematopoiesis|MP:0000576,clubfoot|MP:0000681,abnormal thyroid gland morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001394,circling|MP:0002083,premature death|MP:0002727,decreased circulating insulin level|MP:0003053,delayed tooth eruption|MP:0003059,decreased insulin secretion|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0004982,abnormal osteoclast morphology|MP:0005358,abnormal incisor morphology|MP:0006398,increased long bone epiphyseal plate size|MP:0008254,increased megakaryocyte cell number|MP:0008271,abnormal bone ossification|MP:0011085,postnatal lethality, complete penetrance|MP:0030543,abnormal predentin morphology|MP:0030610,absent teeth
MGI:3852639	Tcirg1<tm1.1Ywd>	MP:0002169,no abnormal phenotype detected|MP:0005384,cellular phenotype
MGI:3852642	Tcirg1<tm1.2Ywd>	MP:0001265,decreased body size|MP:0002083,premature death|MP:0002451,abnormal macrophage physiology|MP:0030610,absent teeth
MGI:3054898	Tcirg1<tm1Utku>	MP:0000322,increased granulocyte number|MP:0000689,abnormal spleen morphology|MP:0000696,abnormal Peyer's patch morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001790,abnormal immune system physiology|MP:0002356,abnormal spleen red pulp morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002358,abnormal spleen periarteriolar lymphoid sheath morphology|MP:0002360,abnormal spleen B cell corona morphology|MP:0002461,increased immunoglobulin level|MP:0002494,increased IgM level|MP:0002723,abnormal immune serum protein physiology|MP:0003644,thymus atrophy|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005232,abnormal mesenteric lymph node morphology|MP:0008463,abnormal peripheral lymph node morphology|MP:0008481,increased spleen germinal center number|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0014348,decreased spleen B cell follicle size
MGI:1857950	Tcirg1<tm1Ypl>	MP:0000062,increased bone mineral density|MP:0000065,abnormal bone marrow cavity morphology|MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000133,abnormal long bone metaphysis morphology|MP:0000135,decreased compact bone thickness|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000195,decreased circulating calcium level|MP:0000547,short limbs|MP:0001262,decreased body weight|MP:0001541,abnormal osteoclast physiology|MP:0002083,premature death|MP:0002896,abnormal bone mineralization|MP:0003116,rickets|MP:0010969,absent compact bone|MP:0012336,decreased vitamin D level|MP:0030610,absent teeth
MGI:2387964	Tcl1<tm1Rso>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size
MGI:1861626	Tcm	MP:0001286,abnormal eye development|MP:0001292,abnormal lens vesicle development|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001306,small lens|MP:0001320,small pupil|MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0003727,abnormal retina layer morphology|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0010263,total cataract
MGI:2386185	Tcof1<tm1Mjd>	MP:0000024,lowered ear position|MP:0000030,abnormal tympanic ring morphology|MP:0000074,abnormal neurocranium morphology|MP:0000088,short mandible|MP:0000091,short premaxilla|MP:0000097,short maxilla|MP:0000102,abnormal nasal bone morphology|MP:0000103,nasal bone hypoplasia|MP:0000107,abnormal frontal bone morphology|MP:0000111,cleft palate|MP:0000154,rib fusion|MP:0000428,abnormal craniofacial morphology|MP:0000433,microcephaly|MP:0000435,shortened head|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000455,abnormal maxilla morphology|MP:0000457,maxilla hypoplasia|MP:0000460,mandible hypoplasia|MP:0000783,abnormal forebrain morphology|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000962,disorganized dorsal root ganglion|MP:0001065,abnormal trigeminal nerve morphology|MP:0001081,abnormal cranial ganglia morphology|MP:0001093,small trigeminal ganglion|MP:0001270,distended abdomen|MP:0001293,anophthalmia|MP:0001504,abnormal posture|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002092,abnormal eye morphology|MP:0002110,abnormal digit morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002177,abnormal outer ear morphology|MP:0002237,abnormal nasal cavity morphology|MP:0002239,abnormal nasal septum morphology|MP:0002621,delayed neural tube closure|MP:0002750,exophthalmos|MP:0002820,abnormal premaxilla morphology|MP:0002950,abnormal neural crest cell migration|MP:0003104,acrania|MP:0003232,abnormal forebrain development|MP:0003419,delayed endochondral bone ossification|MP:0003631,nervous system phenotype|MP:0003735,cup-shaped ears|MP:0003864,abnormal midbrain development|MP:0003935,abnormal craniofacial development|MP:0003984,embryonic growth retardation|MP:0004188,delayed embryo turning|MP:0004282,retrognathia|MP:0004310,small otic vesicle|MP:0004376,absent frontal bone|MP:0004383,absent interparietal bone|MP:0004419,absent parietal bone|MP:0004424,temporal bone hypoplasia|MP:0004469,abnormal zygomatic arch morphology|MP:0004475,palatine bone hypoplasia|MP:0004570,absent glossopharyngeal nerve|MP:0004592,small mandible|MP:0004609,vertebral fusion|MP:0004726,abnormal nasal capsule morphology|MP:0004837,abnormal neural fold formation|MP:0004869,frontal bone hypoplasia|MP:0004871,premaxilla hypoplasia|MP:0004872,absent nasal septum|MP:0004873,absent turbinates|MP:0005105,abnormal middle ear ossicle morphology|MP:0005249,abnormal palatine bone morphology|MP:0005272,abnormal temporal bone morphology|MP:0005274,abnormal viscerocranium morphology|MP:0005371,limbs/digits/tail phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005382,craniofacial phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype|MP:0005391,vision/eye phenotype|MP:0005657,abnormal neural plate morphology|MP:0006211,small orbits|MP:0006294,absent optic vesicle|MP:0009843,decreased neural crest cell number|MP:0009886,failure of palatal shelf elevation|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009902,abnormal lateral nasal prominence morphology|MP:0009903,abnormal medial nasal prominence morphology|MP:0010768,mortality/aging|MP:0010865,prenatal growth retardation|MP:0010940,abnormal maxillary prominence morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0012505,increased neural tube apoptosis|MP:0012523,abnormal upper lip morphology|MP:0012701,increased embryonic neuroepithelium apoptosis|MP:0012706,decreased embryonic neuroepithelial cell proliferation|MP:0012757,abnormal cranial neural crest cell migration|MP:0012760,decreased cranial neural crest cell proliferation|MP:0013267,first pharyngeal arch hypoplasia|MP:0013351,abnormal Rathke's pouch development|MP:0030060,absent nasal pit|MP:0030084,tympanic ring hypoplasia|MP:0030124,middle ear ossicle hypoplasia|MP:0030250,frontonasal prominence hypoplasia|MP:0030377,zygomatic arch hypoplasia|MP:0030386,facial bone hypoplasia
MGI:6449038	Tcp11x2<em1(IMPC)Hmgu>	MP:0001510,abnormal coat appearance
MGI:3617833	Tcpm1<BALB/c>	MP:0002435,abnormal effector T cell morphology
MGI:3698793	Tcq1<CAST/EiJ>	MP:0005179,decreased circulating cholesterol level
MGI:3698791	Tcq2<CAST/EiJ>	MP:0005179,decreased circulating cholesterol level
MGI:3652545	Tcra-J<tm1Jpdv>	MP:0002145,abnormal T cell differentiation
MGI:3604459	Tcra-J<tm1Slek>	MP:0000714,increased thymocyte number|MP:0002145,abnormal T cell differentiation|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008083,decreased single-positive T cell number
MGI:2180736	Tcra-J<tm1Tgi>	MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0001312,abnormal cornea morphology|MP:0001313,increased incidence of corneal inflammation|MP:0001314,cornea opacity|MP:0001656,focal hepatic necrosis|MP:0001805,decreased IgG level|MP:0001830,decreased activated T cell number|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002334,abnormal airway responsiveness|MP:0002335,decreased airway responsiveness|MP:0002411,decreased susceptibility to bacterial infection|MP:0002492,decreased IgE level|MP:0002602,abnormal eosinophil cell number|MP:0002723,abnormal immune serum protein physiology|MP:0002942,decreased circulating alanine transaminase level|MP:0003434,decreased susceptibility to induced choroidal neovascularization|MP:0003436,decreased susceptibility to induced arthritis|MP:0003699,abnormal female reproductive system physiology|MP:0005017,decreased B cell number|MP:0005385,cardiovascular system phenotype|MP:0005517,impaired liver regeneration|MP:0006050,pulmonary fibrosis|MP:0008040,decreased NK T cell number|MP:0008567,decreased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0008627,decreased circulating interleukin-5 level|MP:0008661,decreased interleukin-10 secretion|MP:0008673,decreased interleukin-13 secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0008712,decreased interleukin-9 secretion|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008891,decreased hepatocyte apoptosis|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:3577336	Tcra-J<tm2.3Krg>	MP:0008756,abnormal T cell receptor alpha chain V-J recombination
MGI:3767247	Tcra-J<tm3.1Krg>	MP:0002145,abnormal T cell differentiation
MGI:3840777	Tcra-J<tm4.1Krg>	MP:0008756,abnormal T cell receptor alpha chain V-J recombination
MGI:3840778	Tcra-J<tm5Krg>	MP:0008756,abnormal T cell receptor alpha chain V-J recombination
MGI:4356137	Tcra<Ln1Ogu>	MP:0000598,abnormal liver morphology|MP:0000715,decreased thymocyte number|MP:0003009,abnormal cytokine secretion|MP:0003944,abnormal T cell subpopulation ratio|MP:0008036,abnormal NK T cell morphology|MP:0008039,increased NK T cell number|MP:0008496,decreased IgG2a level|MP:0008499,increased IgG1 level|MP:0008566,increased interferon-gamma secretion|MP:0008660,increased interleukin-10 secretion|MP:0008687,increased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0009339,decreased splenocyte number
MGI:3834626	Tcra<Ln3Jae>	MP:0001823,thymus hypoplasia|MP:0002407,abnormal double-negative T cell morphology|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:2388328	Tcra<tm1Cgn>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005387,immune system phenotype|MP:0008037,abnormal T cell morphology|MP:0010833,abnormal memory T cell morphology
MGI:5532653	Tcra<tm1Mass>	MP:0000715,decreased thymocyte number|MP:0001825,arrested T cell differentiation|MP:0004919,abnormal positive T cell selection|MP:0005090,increased double-negative T cell number|MP:0008036,abnormal NK T cell morphology|MP:0008039,increased NK T cell number|MP:0008040,decreased NK T cell number|MP:0008045,decreased NK cell number
MGI:2180883	Tcra<tm1Mjo>	MP:0000493,rectal prolapse|MP:0000495,abnormal colon morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0001829,increased activated T cell number|MP:0002135,abnormal kidney morphology|MP:0002371,abnormal thymus cortex morphology|MP:0002444,abnormal T cell physiology|MP:0002461,increased immunoglobulin level|MP:0002497,increased IgE level|MP:0002722,abnormal immune system organ morphology|MP:0002816,colitis|MP:0002962,increased urine protein level|MP:0003725,increased autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005036,diarrhea|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008037,abnormal T cell morphology|MP:0008135,small Peyer's patches|MP:0008346,increased gamma-delta T cell number|MP:0008466,enlarged mesenteric lymph nodes|MP:0008499,increased IgG1 level|MP:0008826,abnormal splenic cell ratio|MP:0009967,abnormal neuron proliferation|MP:0013587,absent thymus medulla|MP:0013593,enlarged thymus cortex
MGI:1857255	Tcra<tm1Mom>	MP:0000489,abnormal large intestine morphology|MP:0000491,crypts of Lieberkuhn abscesses|MP:0000493,rectal prolapse|MP:0000512,intestinal ulcer|MP:0001665,chronic diarrhea|MP:0001805,decreased IgG level|MP:0001825,arrested T cell differentiation|MP:0002083,premature death|MP:0002132,abnormal respiratory system morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002816,colitis|MP:0003449,abnormal intestine goblet cell morphology|MP:0005025,abnormal response to infection|MP:0005671,abnormal response to transplant|MP:0008070,absent T cells|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008350,increased gamma-delta intraepithelial T cell number|MP:0008353,increased mature gamma-delta T cell number
MGI:3610385	Tcra<tm1Slek>	MP:0005387,immune system phenotype
MGI:3834628	Tcrb<Ln3Jae>	MP:0002407,abnormal double-negative T cell morphology|MP:0008348,absent gamma-delta T cells
MGI:3618092	Tcrb<tm1Habu>	MP:0002169,no abnormal phenotype detected
MGI:1857256	Tcrb<tm1Mom>	MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0002133,abnormal respiratory system physiology|MP:0002816,colitis|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3702573	Tcrb<tm1Slek>	MP:0005387,immune system phenotype
MGI:3843491	Tcrb<tm1(Tcrb)Chb>	MP:0002407,abnormal double-negative T cell morphology|MP:0008037,abnormal T cell morphology|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number
MGI:3775389	Tcrb<tm1(Tcrb)Fwa>	MP:0008758,abnormal T cell receptor beta chain V(D)J recombination
MGI:3702574	Tcrb<tm2Slek>	MP:0001825,arrested T cell differentiation|MP:0005018,decreased T cell number
MGI:3712149	Tcrb<tm3.1Che>	MP:0005387,immune system phenotype
MGI:3708170	Tcrb<tm3Che>	MP:0005387,immune system phenotype
MGI:3702579	Tcrb<tm3Slek>	MP:0001825,arrested T cell differentiation|MP:0005018,decreased T cell number
MGI:3702580	Tcrb<tm4Slek>	MP:0005387,immune system phenotype
MGI:3829440	Tcrb<tm5Slek>	MP:0008758,abnormal T cell receptor beta chain V(D)J recombination
MGI:3829441	Tcrb<tm6Slek>	MP:0008758,abnormal T cell receptor beta chain V(D)J recombination
MGI:3829442	Tcrb<tm7Slek>	MP:0008758,abnormal T cell receptor beta chain V(D)J recombination
MGI:5292492	Tcrb<tm8.1Slek>	MP:0005387,immune system phenotype
MGI:5292493	Tcrb<tm9.1Slek>	MP:0005387,immune system phenotype
MGI:1857257	Tcrd<tm1Mom>	MP:0001191,abnormal skin condition|MP:0001194,dermatitis|MP:0002133,abnormal respiratory system physiology|MP:0002796,impaired skin barrier function|MP:0005387,immune system phenotype|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0006042,increased apoptosis|MP:0008348,absent gamma-delta T cells|MP:0008356,abnormal gamma-delta T cell differentiation|MP:0010771,integument phenotype
MGI:2385954	Tcrd-V1<tm1Kjk>	MP:0008344,abnormal mature gamma-delta T cell morphology|MP:0008351,decreased gamma-delta intraepithelial T cell number|MP:0008356,abnormal gamma-delta T cell differentiation|MP:0008759,abnormal T cell receptor delta chain V(D)J recombination
MGI:3849286	Tcrd-V5<tm1Slek>	MP:0002169,no abnormal phenotype detected
MGI:3785563	Tcrg<tm1.1Dhr>	MP:0008757,abnormal T cell receptor gamma chain V-J recombination
MGI:3794897	Tcrg<tm1.1Hish>	MP:0008348,absent gamma-delta T cells
MGI:2385961	Tcrg<tm1Ahay>	MP:0002169,no abnormal phenotype detected|MP:0010771,integument phenotype
MGI:3785561	Tcrg<tm1Dhr>	MP:0008757,abnormal T cell receptor gamma chain V-J recombination
MGI:2429947	Tcrg<tm1Iku>	MP:0005387,immune system phenotype
MGI:3615270	Tcrg<tm1Scar>	MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000708,thymus hyperplasia|MP:0000709,enlarged thymus|MP:0002722,abnormal immune system organ morphology|MP:0005015,increased T cell number|MP:0005074,impaired granulocyte bactericidal activity|MP:0005425,increased macrophage cell number
MGI:2388612	Tcrg<tm2.1Dhr>	MP:0008356,abnormal gamma-delta T cell differentiation|MP:0008757,abnormal T cell receptor gamma chain V-J recombination
MGI:2386729	Tcsz1<LG/J>	MP:0030091,macrodontia
MGI:2386731	Tcsz2<LG/J>	MP:0030091,macrodontia
MGI:2386734	Tcsz3<LG/J>	MP:0030091,macrodontia
MGI:4820083	Tcte1<tm1a(KOMP)Wtsi>	MP:0001124,abnormal gametes|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology
MGI:6152658	Tctn1<em1(IMPC)Mbp>	MP:0001914,hemorrhage|MP:0002092,abnormal eye morphology|MP:0002699,abnormal vitreous body morphology|MP:0003054,spina bifida|MP:0011100,preweaning lethality, complete penetrance
MGI:3716885	Tctn1<Gt(KST296)Byg>	MP:0000926,absent floor plate|MP:0000936,small embryonic telencephalon|MP:0001706,abnormal left-right axis patterning|MP:0004132,absent embryonic cilia|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005157,holoprosencephaly|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0009743,preaxial polydactyly|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5292130	Tctn2<tm1.1Reit>	MP:0000111,cleft palate|MP:0000914,exencephaly|MP:0000926,absent floor plate|MP:0000929,open neural tube|MP:0001297,microphthalmia|MP:0004132,absent embryonic cilia|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005221,abnormal rostral-caudal axis patterning|MP:0009743,preaxial polydactyly|MP:0010402,ventricular septal defect|MP:0010808,right-sided stomach|MP:0011261,abnormal limb mesenchyme morphology
MGI:5812886	Tctn3<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0000562,polydactyly|MP:0001293,anophthalmia|MP:0001303,abnormal lens morphology|MP:0001697,abnormal embryo size|MP:0003385,abnormal body wall morphology|MP:0005278,abnormal cholesterol homeostasis|MP:0005567,decreased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance
MGI:6343517	Tctn3<tm1.2Blnw>	MP:0000562,polydactyly|MP:0000926,absent floor plate|MP:0001785,edema|MP:0004252,abnormal direction of heart looping|MP:0005157,holoprosencephaly|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0013202,abnormal cilium morphology|MP:0013214,decreased embryonic neuroepithelium primary cilium number
MGI:6343518	Tctn3<tm2(Tctn1)Blnw>	MP:0004252,abnormal direction of heart looping|MP:0005157,holoprosencephaly|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013202,abnormal cilium morphology|MP:0013214,decreased embryonic neuroepithelium primary cilium number
MGI:6343519	Tctn3<tm3(Tctn2)Blnw>	MP:0004252,abnormal direction of heart looping|MP:0005157,holoprosencephaly|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013202,abnormal cilium morphology|MP:0013214,decreased embryonic neuroepithelium primary cilium number
MGI:5285105	Tdg<tm1.1Abc>	MP:0000260,abnormal angiogenesis|MP:0000267,abnormal heart development|MP:0000934,abnormal telencephalon development|MP:0001622,abnormal vasculogenesis|MP:0001730,embryonic growth arrest|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0002652,thin myocardium|MP:0003873,pharyngeal arch hypoplasia|MP:0003888,liver hemorrhage|MP:0003920,abnormal heart right ventricle morphology|MP:0004111,abnormal coronary artery morphology|MP:0004181,abnormal carotid artery morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0005244,hemopericardium|MP:0006126,abnormal cardiac outflow tract development|MP:0006279,abnormal limb development|MP:0008877,abnormal DNA methylation|MP:0009797,abnormal mismatch repair|MP:0010500,myocardium hypoplasia|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5487834	Tdg<tm1Psch>	MP:0001634,internal hemorrhage|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5285106	Tdg<tm2.1Abc>	MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0003984,embryonic growth retardation|MP:0005312,pericardial effusion|MP:0008877,abnormal DNA methylation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7450955	Tdg<tm2Psch>	MP:0001634,internal hemorrhage|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3579352	Tdmq1<C57BLKS/J>	MP:0001260,increased body weight|MP:0009300,increased parametrial fat pad weight
MGI:3579353	Tdmq1<DBA/2>	MP:0005559,increased circulating glucose level
MGI:5696916	Tdo2<tm1b(KOMP)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001297,microphthalmia|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0002833,increased heart weight|MP:0009141,increased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5299329	Tdo2<tm1Tnak>	MP:0001364,decreased anxiety-related response|MP:0002739,abnormal olfactory bulb development|MP:0004948,abnormal neuronal precursor proliferation|MP:0005311,abnormal circulating amino acid level|MP:0005332,abnormal amino acid level|MP:0005386,behavior/neurological phenotype|MP:0009937,abnormal neuron differentiation|MP:0010069,increased serotonin level|MP:0013908,small lateral ventricles|MP:0030644,increased circulating methionine level|MP:0030703,increased circulating threonine level
MGI:6414506	Tdp1<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001417,decreased exploration in new environment|MP:0002591,decreased mean corpuscular volume|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010067,increased red blood cell distribution width
MGI:3818340	Tdp1<Gt(XD105)Byg>	MP:0000852,small cerebellum|MP:0004811,abnormal neuron physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005419,decreased circulating serum albumin level|MP:0008058,abnormal DNA repair|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0014768,impaired single-strand DNA break repair
MGI:4332298	Tdp2<Gt(RRS512)Byg>	MP:0002169,no abnormal phenotype detected
MGI:5503302	Tdp2<tm1.1Huy>	MP:0002401,abnormal lymphopoiesis|MP:0002722,abnormal immune system organ morphology|MP:0003111,abnormal cell nucleus morphology|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0003702,abnormal chromosome morphology|MP:0004046,abnormal mitosis|MP:0005022,abnormal immature B cell morphology|MP:0005092,decreased double-positive T cell number|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0010180,increased susceptibility to weight loss|MP:0011176,abnormal erythroblast morphology|MP:0014078,small intestinal villus atrophy|MP:0031678,increased micronucleus incidence
MGI:5503301	Tdp2<tm1Huy>	MP:0002169,no abnormal phenotype detected
MGI:3512943	Tdrd12<repro23>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0004543,abnormal sperm physiology|MP:0004852,decreased testis weight|MP:0004929,decreased epididymis weight|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0006362,abnormal male germ cell morphology|MP:0008261,arrest of male meiosis|MP:0014633,decreased spermatid number
MGI:5556124	Tdrd12<tm1Yam>	MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0003205,testicular atrophy|MP:0004543,abnormal sperm physiology|MP:0005159,azoospermia|MP:0014634,decreased round spermatid number
MGI:3691852	Tdrd1<tm1Chum>	MP:0001125,abnormal oocyte morphology|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0006379,abnormal spermatocyte morphology|MP:0006380,abnormal spermatid morphology|MP:0014052,increased male germ cell apoptosis|MP:0031620,abnormal chromatoid body morphology
MGI:6376192	Tdrd3<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0010124,decreased bone mineral content
MGI:4329489	Tdrd3<Gt(RRK474)Byg>	MP:0002144,abnormal B cell differentiation|MP:0002459,abnormal B cell physiology|MP:0008866,chromosomal instability
MGI:4435844	Tdrd5<tm1a(EUCOMM)Hmgu>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility
MGI:6115347	Tdrd5<tm1c(EUCOMM)Hmgu>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0003205,testicular atrophy|MP:0004852,decreased testis weight
MGI:4946629	Tdrd5<tm1Sait>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002686,globozoospermia|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype|MP:0005621,abnormal cell physiology|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0008280,abnormal male germ cell apoptosis|MP:0008898,abnormal acrosome morphology
MGI:5305938	Tdrd6<tm1Chum>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility
MGI:3847699	Tdrd6<tm1Jess>	MP:0000358,abnormal cell morphology|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0014052,increased male germ cell apoptosis
MGI:4943539	Tdrd7<nmf166>	MP:0001155,arrest of spermatogenesis|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001322,abnormal iris morphology|MP:0001925,male infertility|MP:0002840,abnormal lens fiber morphology|MP:0005258,ocular hypertension|MP:0005515,uveitis|MP:0006222,optic neuropathy|MP:0008841,ruptured lens capsule|MP:0031213,increased eye anterior chamber depth
MGI:5305937	Tdrd7<tm1.1Chum>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0003698,abnormal male reproductive system physiology|MP:0006219,optic nerve degeneration|MP:0014052,increased male germ cell apoptosis
MGI:4421849	Tdrd9<tm1.1Chum>	MP:0001147,small testis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0006362,abnormal male germ cell morphology|MP:0006378,abnormal spermatogonia morphology|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0008878,abnormal DNA methylation during gametogenesis|MP:0009452,abnormal synaptonemal complex|MP:0014052,increased male germ cell apoptosis
MGI:5521576	Tdrkh<tm1.2Hfl>	MP:0001147,small testis|MP:0001925,male infertility|MP:0003205,testicular atrophy|MP:0005159,azoospermia|MP:0005621,abnormal cell physiology|MP:0008261,arrest of male meiosis|MP:0008877,abnormal DNA methylation|MP:0009452,abnormal synaptonemal complex|MP:0010948,abnormal double-strand DNA break repair
MGI:5515780	Tdrkh<tm1b(KOMP)Wtsi>	MP:0001488,increased startle reflex
MGI:5569053	Tdrp<tm1.1(KOMP)Vlcg>	MP:0001120,abnormal uterus morphology|MP:0002135,abnormal kidney morphology|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0008528,polycystic kidney
MGI:6730107	Tdrp<tm1Xwa>	MP:0002674,abnormal sperm motility|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0009230,abnormal sperm head morphology|MP:0020451,decreased sperm progressive motility
MGI:3028949	Tead1<Gt(ROSA5)Sor>	MP:0000266,abnormal heart morphology|MP:0000280,thin ventricular wall|MP:0000295,trabecula carnea hypoplasia|MP:0000828,abnormal fourth ventricle morphology|MP:0001722,pale yolk sac|MP:0005294,abnormal heart ventricle morphology|MP:0005333,decreased heart rate|MP:0008534,enlarged fourth ventricle|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5606037	Tead1<tm1.1Wtp>	MP:0002169,no abnormal phenotype detected
MGI:4364091	Tead1<tm1a(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0005543,decreased cornea thickness|MP:0011100,preweaning lethality, complete penetrance
MGI:5548324	Tead1<tm1b(KOMP)Wtsi>	MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0002100,abnormal tooth morphology|MP:0002833,increased heart weight|MP:0005293,impaired glucose tolerance|MP:0005543,decreased cornea thickness|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0011960,abnormal eye anterior chamber depth|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3773642	Tead1<tm1Hssk>	MP:0002189,abnormal myocardial trabeculae morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:3763367	Tead2<tm1.1Mldp>	MP:0000914,exencephaly|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3773644	Tead2<tm1Hssk>	MP:0002169,no abnormal phenotype detected
MGI:4431809	Tead3<tm1a(EUCOMM)Wtsi>	MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0010092,increased circulating magnesium level|MP:0010869,decreased bone trabecula number|MP:0013630,increased bone trabecular spacing
MGI:3763362	Tead4<tm1.1Bnno>	MP:0001714,absent trophoblast giant cells|MP:0002663,absent blastocoele|MP:0011092,embryonic lethality, complete penetrance|MP:0012058,abnormal morula morphology
MGI:3763361	Tead4<tm1Bnno>	MP:0002169,no abnormal phenotype detected
MGI:3770620	Tead4<tm1Hssk>	MP:0001714,absent trophoblast giant cells|MP:0002663,absent blastocoele|MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012102,absent trophectoderm
MGI:5496539	Tecpr1<tm1Chsa>	MP:0001793,abnormal susceptibility to infection|MP:0008260,abnormal autophagy
MGI:5816118	Tecpr2<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001486,abnormal startle reflex|MP:0001973,increased thermal nociceptive threshold|MP:0002098,abnormal vibrissa morphology|MP:0002574,increased vertical activity|MP:0003043,hypoalgesia|MP:0020954,decreased mechanical nociceptive threshold
MGI:6696317	Tecpr2<em1Wei>	MP:0001406,abnormal gait|MP:0002229,neurodegeneration|MP:0003225,axonal dystrophy|MP:0003998,decreased thermal nociceptive threshold|MP:0005386,behavior/neurological phenotype|MP:0010047,axonal spheroids|MP:0020955,increased mechanical nociceptive threshold|MP:0030940,impaired autophagy
MGI:6156161	Tecr<em1(IMPC)Rbrc>	MP:0000182,increased circulating LDL cholesterol level|MP:0000470,abnormal stomach morphology|MP:0001944,abnormal pancreas morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:7707933	Tecrl<em1Bcgen>	MP:0003674,oxidative stress|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0010954,abnormal cellular respiration|MP:0011925,abnormal heart echocardiography feature|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0031633,decreased heart left ventricle muscle contractility
MGI:6303609	Tecrl<em1(IMPC)J>	MP:0001284,absent vibrissae|MP:0010052,increased grip strength
MGI:7868156	Tecr<tm1.1Migar>	MP:0001056,abnormal cranial nerve morphology|MP:0001076,abnormal hypoglossal nerve morphology|MP:0001889,delayed brain development|MP:0002946,delayed axon extension|MP:0003651,abnormal axon extension|MP:0003861,abnormal nervous system development|MP:0003864,abnormal midbrain development|MP:0005029,abnormal amnion morphology|MP:0005282,decreased fatty acids level|MP:0008415,abnormal neurite morphology|MP:0009768,impaired somite development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011827,impaired neuron differentiation|MP:0013835,absent hypoglossal nerve|MP:0020194,abnormal glycosphingolipid level|MP:0020581,abnormal neuron polarity|MP:0020583,decreased ceramide level|MP:0020866,abnormal lipogenesis|MP:0031560,decreased ganglioside level
MGI:4458424	Tecta<tm1.1Ogha>	MP:0003149,abnormal tectorial membrane morphology|MP:0003150,detached tectorial membrane|MP:0004412,abnormal cochlear microphonics|MP:0004414,decreased cochlear microphonics|MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004737,absent distortion product otoacoustic emissions|MP:0005377,hearing/vestibular/ear phenotype|MP:0006325,impaired hearing|MP:0006336,abnormal otoacoustic response|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014088,abnormal Kimura membrane morphology
MGI:2183148	Tecta<tm1Gpr>	MP:0001963,abnormal hearing physiology|MP:0002895,abnormal otolithic membrane morphology|MP:0003143,enlarged otoliths|MP:0003144,decreased otolith number|MP:0003149,abnormal tectorial membrane morphology|MP:0003150,detached tectorial membrane|MP:0004412,abnormal cochlear microphonics|MP:0004417,decreased cochlear nerve compound action potential|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004737,absent distortion product otoacoustic emissions|MP:0005386,behavior/neurological phenotype|MP:0014091,abnormal tectorial membrane striated-sheet matrix morphology|MP:0014409,decreased distortion product otoacoustic emission amplitude
MGI:3605485	Tecta<tm2Gpr>	MP:0001963,abnormal hearing physiology|MP:0003149,abnormal tectorial membrane morphology|MP:0003150,detached tectorial membrane|MP:0013962,absent Hensen stripe|MP:0014088,abnormal Kimura membrane morphology|MP:0014089,abnormal tectorial membrane marginal band morphology|MP:0014091,abnormal tectorial membrane striated-sheet matrix morphology
MGI:5527094	Tecta<tm3.1Gpr>	MP:0001496,audiogenic seizures|MP:0003149,abnormal tectorial membrane morphology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013961,abnormal Hensen stripe morphology|MP:0014089,abnormal tectorial membrane marginal band morphology|MP:0014090,abnormal tectorial membrane covernet morphology
MGI:5527095	Tecta<tm4.1Gpr>	MP:0001496,audiogenic seizures|MP:0003149,abnormal tectorial membrane morphology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013961,abnormal Hensen stripe morphology|MP:0014088,abnormal Kimura membrane morphology|MP:0014090,abnormal tectorial membrane covernet morphology|MP:0014091,abnormal tectorial membrane striated-sheet matrix morphology
MGI:5527096	Tecta<tm5.1Gpr>	MP:0001496,audiogenic seizures|MP:0003149,abnormal tectorial membrane morphology|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013961,abnormal Hensen stripe morphology|MP:0014088,abnormal Kimura membrane morphology|MP:0014090,abnormal tectorial membrane covernet morphology|MP:0014091,abnormal tectorial membrane striated-sheet matrix morphology
MGI:3711698	Tectb<tm1Gpr>	MP:0003149,abnormal tectorial membrane morphology|MP:0004417,decreased cochlear nerve compound action potential|MP:0004591,enlarged tectorial membrane|MP:0004736,abnormal distortion product otoacoustic emission|MP:0006325,impaired hearing|MP:0006384,enhanced cochlear frequency tuning|MP:0013962,absent Hensen stripe|MP:0014089,abnormal tectorial membrane marginal band morphology|MP:0014091,abnormal tectorial membrane striated-sheet matrix morphology
MGI:2450883	Tec<tm1Welm>	MP:0005387,immune system phenotype|MP:0009549,decreased platelet aggregation
MGI:6156552	Tedc1<em1(IMPC)Tcp>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001697,abnormal embryo size|MP:0002060,abnormal skin morphology|MP:0003984,embryonic growth retardation|MP:0005565,increased blood urea nitrogen level|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6157624	Tedc2<em1(IMPC)J>	MP:0000277,abnormal heart shape|MP:0000925,abnormal floor plate morphology|MP:0000928,incomplete rostral neuropore closure|MP:0000932,absent notochord|MP:0001529,abnormal vocalization|MP:0001700,abnormal embryo turning|MP:0002075,abnormal coat/hair pigmentation|MP:0002151,abnormal neural tube morphology|MP:0003119,abnormal digestive system development|MP:0003400,kinked neural tube|MP:0004180,failure of initiation of embryo turning|MP:0005380,embryo phenotype|MP:0010053,decreased grip strength|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0012270,cardiac edema|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014134,abnormal embryo morphology
MGI:6341948	Teddm1a<em1(IMPC)Tcp>	MP:0000221,decreased leukocyte cell number|MP:0001925,male infertility|MP:0001944,abnormal pancreas morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002966,decreased circulating alkaline phosphatase level
MGI:6360156	Tefm<tm1.1Lrsn>	MP:0000274,enlarged heart|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014395,increased myocardial fiber mitochondrial DNA content
MGI:6360157	Tefm<tm1.2Lrsn>	MP:0001698,decreased embryo size|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0012081,absent heart tube
MGI:3045494	Tef<tm1Schb>	MP:0002064,seizures|MP:0003216,absence seizures
MGI:6367961	Tekt1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002217,small lymph nodes|MP:0002339,abnormal lymph node morphology
MGI:3055308	Tekt2<Gt(OST12401)Lex>	MP:0001925,male infertility|MP:0001947,abnormal mucociliary clearance|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0002675,asthenozoospermia|MP:0009243,hairpin sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011055,abnormal respiratory motile cilium physiology
MGI:3843699	Tekt3<tm1Zuk>	MP:0002675,asthenozoospermia|MP:0005389,reproductive system phenotype|MP:0009243,hairpin sperm flagellum
MGI:3790114	Tekt4<tm1Zuk>	MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0030590,abnormal sperm fibrous sheath morphology
MGI:7641916	Tektl1<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5635996	Tek<tm1.1(icre/Esr1*)Hrr>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5544795	Tek<tm1.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:3581758	Tek<tm1Ber>	MP:0000264,failure of vascular branching|MP:0000267,abnormal heart development|MP:0000293,absent myocardial trabeculae|MP:0002123,abnormal definitive hematopoiesis|MP:0003229,abnormal vitelline vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6324153	Tek<tm1b(EUCOMM)Hmgu>	MP:0000288,abnormal pericardium morphology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2159357	Tek<tm1Dmt>	MP:0000264,failure of vascular branching|MP:0000267,abnormal heart development|MP:0000293,absent myocardial trabeculae|MP:0001915,intracranial hemorrhage|MP:0002123,abnormal definitive hematopoiesis|MP:0003719,abnormal pericyte morphology|MP:0004076,abnormal vitelline vascular remodeling|MP:0005380,embryo phenotype|MP:0006055,abnormal vascular endothelial cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2159358	Tek<tm1Sato>	MP:0000260,abnormal angiogenesis|MP:0000264,failure of vascular branching|MP:0000267,abnormal heart development|MP:0000296,absent trabeculae carneae|MP:0001614,abnormal blood vessel morphology|MP:0003227,abnormal vascular branching morphogenesis|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0006055,abnormal vascular endothelial cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013241,embryo tissue necrosis
MGI:5474349	Tel15q<tm1Rred>	MP:0002169,no abnormal phenotype detected
MGI:5781312	Telo2<em1(IMPC)J>	MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3819391	Telo2<tm1.1Tdl>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6449028	Ten1<em1(IMPC)Hmgu>	MP:0000167,decreased chondrocyte number|MP:0000352,decreased cell proliferation|MP:0000414,alopecia|MP:0000511,abnormal intestinal mucosa morphology|MP:0000711,thymus cortex hypoplasia|MP:0000745,tremors|MP:0000762,abnormal tongue morphology|MP:0000849,abnormal cerebellum morphology|MP:0000851,cerebellum hypoplasia|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0001242,hyperkeratosis|MP:0001244,thin dermal layer|MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0001846,increased inflammatory response|MP:0002060,abnormal skin morphology|MP:0002064,seizures|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002375,abnormal thymus medulla morphology|MP:0003009,abnormal cytokine secretion|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003644,thymus atrophy|MP:0004126,thin hypodermis|MP:0005390,skeleton phenotype|MP:0005543,decreased cornea thickness|MP:0005621,abnormal cell physiology|MP:0006042,increased apoptosis|MP:0008008,early cellular replicative senescence|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008800,increased small intestinal crypt cell apoptosis|MP:0008924,decreased cerebellar granule cell number|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0010207,abnormal telomere morphology|MP:0010948,abnormal double-strand DNA break repair|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011481,anterior iris synechia|MP:0011965,decreased total retina thickness|MP:0012261,increased hindbrain apoptosis|MP:0013660,abnormal bone marrow hematopoietic cell morphology|MP:0013776,bone marrow failure|MP:0014078,small intestinal villus atrophy|MP:0014508,decreased intestinal crypt stem cell number|MP:0030926,increased skin pigmentation|MP:0030927,decreased telomere length
MGI:6414509	Tenm1<em1(IMPC)Tcp>	MP:0000208,decreased hematocrit|MP:0001417,decreased exploration in new environment|MP:0002591,decreased mean corpuscular volume|MP:0002941,increased circulating alanine transaminase level|MP:0004924,abnormal behavior|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0020870,decreased thigmotaxis
MGI:5529622	Tenm2<tm1Cal>	MP:0000805,abnormal visual cortex morphology|MP:0000904,abnormal superior colliculus morphology|MP:0000968,abnormal sensory neuron innervation pattern|MP:0001325,abnormal retina morphology|MP:0002090,abnormal vision|MP:0004165,abnormal lateral geniculate nucleus morphology|MP:0005241,abnormal retina ganglion layer morphology|MP:0010748,abnormal visual evoked potential
MGI:8259778	Tenm3<em1Geof>	MP:0030831,abnormal glenoid fossa morphology|MP:0030838,abnormal acetabular fossa morphology
MGI:3767554	Tenm3<tm1Cal>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002083,premature death|MP:0003631,nervous system phenotype
MGI:6156580	Tenm4<em1(IMPC)Tcp>	MP:0000063,decreased bone mineral density|MP:0000157,abnormal sternum morphology|MP:0001293,anophthalmia|MP:0001314,cornea opacity|MP:0002768,small adrenal glands|MP:0002834,decreased heart weight|MP:0003019,increased circulating chloride level|MP:0003961,decreased lean body mass|MP:0004953,decreased spleen weight|MP:0005633,increased circulating sodium level|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010053,decreased grip strength|MP:0010123,increased bone mineral content|MP:0011874,enlarged urinary bladder|MP:0013278,decreased fasting circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:2449628	Tenm4<l7Rn3-1R>	MP:0001683,absent mesoderm|MP:0001730,embryonic growth arrest|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011091,prenatal lethality, complete penetrance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2449635	Tenm4<l7Rn3-2R>	MP:0001683,absent mesoderm|MP:0001730,embryonic growth arrest|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011091,prenatal lethality, complete penetrance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2449637	Tenm4<l7Rn3-3R>	MP:0000929,open neural tube|MP:0001689,incomplete somite formation|MP:0003984,embryonic growth retardation|MP:0011091,prenatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2449639	Tenm4<l7Rn3-4R>	MP:0001265,decreased body size
MGI:2449641	Tenm4<l7Rn3-5R>	MP:0002085,abnormal embryonic tissue morphology|MP:0003984,embryonic growth retardation|MP:0009657,failure of chorioallantoic fusion|MP:0011091,prenatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2449644	Tenm4<l7Rn3-6R>	MP:0003984,embryonic growth retardation|MP:0009657,failure of chorioallantoic fusion|MP:0011091,prenatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5440486	Tenm4<Tg(Col2a1-Hspg2)2Yoya>	MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000921,demyelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0008027,abnormal spinal cord white matter morphology|MP:0009677,abnormal spinal cord dorsal column morphology|MP:0010205,abnormal oligodendrocyte apoptosis
MGI:7426022	Tent2<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001404,no spontaneous movement|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0004924,abnormal behavior|MP:0008528,polycystic kidney
MGI:3767669	Tent2<tm1Tomo>	MP:0005621,abnormal cell physiology
MGI:6120803	Tent4a<tm1b(EUCOMM)Hmgu>	MP:0000137,abnormal vertebrae morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0002968,increased circulating alkaline phosphatase level|MP:0003036,vertebral transformation|MP:0004599,abnormal vertebral arch morphology|MP:0005084,abnormal gallbladder morphology|MP:0009342,enlarged gallbladder
MGI:7514961	Tent5a<em1Adki>	MP:0001922,reduced male fertility|MP:0001926,female infertility
MGI:6152705	Tent5a<em1(IMPC)Ccpcz>	MP:0000149,abnormal scapula morphology|MP:0000150,abnormal rib morphology|MP:0000161,scoliosis|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0000438,abnormal cranium morphology|MP:0000458,abnormal mandible morphology|MP:0000552,abnormal radius morphology|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001523,impaired righting response|MP:0002100,abnormal tooth morphology|MP:0002187,abnormal fibula morphology|MP:0002764,short tibia|MP:0002932,abnormal joint morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0004174,abnormal spine curvature|MP:0004509,abnormal pelvic girdle bone morphology|MP:0005016,decreased lymphocyte cell number|MP:0005108,abnormal ulna morphology|MP:0005296,abnormal humerus morphology|MP:0005419,decreased circulating serum albumin level|MP:0005505,thrombocytosis|MP:0005560,decreased circulating glucose level|MP:0005627,increased circulating potassium level|MP:0009142,decreased prepulse inhibition|MP:0009455,enhanced cued conditioning behavior|MP:0010379,decreased respiratory quotient|MP:0013675,decreased Ly6C-positive mature NK cell number|MP:0020421,increased freezing behavior
MGI:5424906	Tent5a<m1Mhda>	MP:0000060,delayed bone ossification|MP:0000061,fragile skeleton|MP:0000149,abnormal scapula morphology|MP:0000150,abnormal rib morphology|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0001255,decreased body height|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0002109,abnormal limb morphology|MP:0002932,abnormal joint morphology|MP:0003109,short femur|MP:0004179,transmission ratio distortion|MP:0004343,small scapula|MP:0004351,short humerus|MP:0004353,abnormal deltoid tuberosity morphology|MP:0004507,abnormal ischium morphology|MP:0004624,abnormal thoracic cage morphology|MP:0004672,short ribs|MP:0004689,small ischium|MP:0004703,abnormal vertebral column morphology|MP:0005296,abnormal humerus morphology|MP:0005352,small cranium|MP:0005390,skeleton phenotype|MP:0005508,abnormal skeleton morphology|MP:0006398,increased long bone epiphyseal plate size|MP:0008158,increased diameter of femur|MP:0008160,increased diameter of humerus|MP:0008273,abnormal intramembranous bone ossification|MP:0009728,abnormal calcaneum morphology|MP:0010831,lethality, incomplete penetrance|MP:0010870,absent bone trabeculae|MP:0011584,increased alkaline phosphatase activity|MP:0013624,decreased femur compact bone thickness|MP:0030279,thin neurocranium
MGI:8164230	Tent5b<em1Adki>	MP:0005389,reproductive system phenotype
MGI:8164232	Tent5b<em2Adki>	MP:0005389,reproductive system phenotype
MGI:8164233	Tent5b<em3Adki>	MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0005168,abnormal female meiosis|MP:0008869,anovulation|MP:0009443,parthenogenesis
MGI:6111077	Tent5c<em1Adki>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0003131,increased erythrocyte cell number|MP:0004901,decreased male germ cell number|MP:0005093,decreased B cell proliferation|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008261,arrest of male meiosis|MP:0008388,hypochromic microcytic anemia|MP:0009230,abnormal sperm head morphology|MP:0014052,increased male germ cell apoptosis
MGI:6761747	Tent5c<em1Hncs>	MP:0000208,decreased hematocrit|MP:0001925,male infertility|MP:0002591,decreased mean corpuscular volume|MP:0002687,oligozoospermia|MP:0002874,decreased hemoglobin content|MP:0003131,increased erythrocyte cell number|MP:0005505,thrombocytosis|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0009232,abnormal sperm nucleus morphology|MP:0009234,absent sperm head|MP:0009830,abnormal sperm connecting piece morphology
MGI:6761749	Tent5c<em3Hncs>	MP:0005389,reproductive system phenotype
MGI:5637082	Tent5c<tm1b(KOMP)Wtsi>	MP:0000111,cleft palate|MP:0000497,abnormal small intestine placement|MP:0000783,abnormal forebrain morphology|MP:0001914,hemorrhage|MP:0002928,abnormal bile duct morphology|MP:0002989,small kidney|MP:0003826,abnormal Mullerian duct morphology|MP:0004613,fusion of vertebral arches|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010052,increased grip strength|MP:0010420,muscular ventricular septal defect|MP:0010439,abnormal hepatic vein morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011683,dual inferior vena cava|MP:0013848,subcutaneous edema|MP:0013876,absent ductus venosus valve|MP:0013970,absent connection between subcutaneous lymph vessels and lymph sac|MP:0013971,blood in lymph vessels|MP:0014001,abnormal vertebral artery topology|MP:0014003,additional anastomosis between intracranial vertebral arteries
MGI:8164234	Tent5d<em1Adki>	MP:0001146,abnormal testis morphology|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002780,decreased circulating testosterone level|MP:0014052,increased male germ cell apoptosis
MGI:7514924	Tent5d<em1Fzh>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0014052,increased male germ cell apoptosis|MP:0020550,multinucleated giant male germ cells
MGI:5766168	Tep1<tm1b(NCOM)Mfgc>	MP:0010052,increased grip strength
MGI:2669947	Tep1<tm1Leah>	MP:0002169,no abnormal phenotype detected
MGI:5637095	Tepsin<tm1b(KOMP)Wtsi>	MP:0010052,increased grip strength
MGI:4843634	Terb1<tm1a(KOMP)Mbp>	MP:0001925,male infertility|MP:0001926,female infertility|MP:0002777,absent ovarian follicles|MP:0004805,absent oocytes|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis|MP:0010767,abnormal female meiosis I arrest|MP:0011751,abnormal X-Y chromosome synapsis during male meiosis|MP:0013236,ovary degeneration|MP:0014052,increased male germ cell apoptosis
MGI:5583074	Terb1<tm1b(KOMP)Mbp>	MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001126,abnormal ovary morphology|MP:0002941,increased circulating alanine transaminase level
MGI:6362934	Terb2<em1Leim>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002777,absent ovarian follicles|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0008261,arrest of male meiosis|MP:0009452,abnormal synaptonemal complex|MP:0014052,increased male germ cell apoptosis|MP:0014764,impaired double-strand DNA break repair
MGI:6362936	Terb2<em2Leim>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002777,absent ovarian follicles|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0008261,arrest of male meiosis|MP:0009452,abnormal synaptonemal complex|MP:0014052,increased male germ cell apoptosis|MP:0014764,impaired double-strand DNA break repair
MGI:1857930	Terc<tm1Rdp>	MP:0000013,abnormal adipose tissue distribution|MP:0000066,osteoporosis|MP:0000135,decreased compact bone thickness|MP:0000160,kyphosis|MP:0000260,abnormal angiogenesis|MP:0000278,abnormal myocardial fiber morphology|MP:0000414,alopecia|MP:0000477,abnormal intestine morphology|MP:0000929,open neural tube|MP:0001125,abnormal oocyte morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001533,abnormal skeleton physiology|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0001923,reduced female fertility|MP:0001924,infertility|MP:0001930,abnormal meiosis|MP:0001935,decreased litter size|MP:0002053,decreased incidence of induced tumors|MP:0002083,premature death|MP:0002084,abnormal developmental patterning|MP:0002397,abnormal bone marrow morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002795,dilated cardiomyopathy|MP:0002834,decreased heart weight|MP:0002972,abnormal cardiac muscle contractility|MP:0003155,abnormal telomere length|MP:0003205,testicular atrophy|MP:0003222,increased cardiomyocyte apoptosis|MP:0003567,abnormal fetal cardiomyocyte proliferation|MP:0003702,abnormal chromosome morphology|MP:0003786,premature aging|MP:0003797,abnormal compact bone morphology|MP:0003819,increased left ventricle diastolic pressure|MP:0003824,decreased left ventricle developed pressure|MP:0003916,decreased heart left ventricle weight|MP:0004084,abnormal cardiac muscle relaxation|MP:0004200,decreased fetal size|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004567,decreased myocardial fiber number|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005621,abnormal cell physiology|MP:0006042,increased apoptosis|MP:0006138,congestive heart failure|MP:0006379,abnormal spermatocyte morphology|MP:0008058,abnormal DNA repair|MP:0008271,abnormal bone ossification|MP:0008482,decreased spleen germinal center number|MP:0008782,increased B cell apoptosis|MP:0008866,chromosomal instability|MP:0008883,abnormal enterocyte proliferation|MP:0008885,increased enterocyte apoptosis|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0010924,abnormal osteoid morphology|MP:0010968,decreased compact bone area|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012431,increased lymphoma incidence|MP:0013504,increased embryonic tissue cell apoptosis|MP:0013630,increased bone trabecular spacing|MP:0014052,increased male germ cell apoptosis|MP:0014263,decreased spleen B cell follicle number|MP:0014636,decreased elongated spermatid number|MP:0014718,abnormal binucleate cardiomyocyte morphology|MP:0030927,decreased telomere length
MGI:4357772	Terf1<tm1.1Blas>	MP:0000352,decreased cell proliferation|MP:0000378,absent hair follicles|MP:0000467,abnormal esophagus morphology|MP:0000468,abnormal esophageal epithelium morphology|MP:0000471,abnormal stomach epithelium morphology|MP:0000648,absent sebaceous gland|MP:0000763,abnormal filiform papillae morphology|MP:0000764,abnormal tongue epithelium morphology|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002060,abnormal skin morphology|MP:0002796,impaired skin barrier function|MP:0003155,abnormal telomere length|MP:0003453,abnormal keratinocyte physiology|MP:0003702,abnormal chromosome morphology|MP:0003755,abnormal palate morphology|MP:0003941,abnormal skin development|MP:0004947,skin inflammation|MP:0005501,abnormal skin physiology|MP:0008008,early cellular replicative senescence|MP:0009675,orthokeratosis|MP:0011090,perinatal lethality, incomplete penetrance|MP:0030926,increased skin pigmentation
MGI:2677837	Terf1<tm1Tdl>	MP:0002086,abnormal extraembryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0005032,abnormal ectoplacental cone morphology|MP:0010380,abnormal inner cell mass apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:4431206	Terf1<tm2.1Tdl>	MP:0008008,early cellular replicative senescence
MGI:6277057	Terf2ip<em1(IMPC)Mbp>	MP:0001192,scaly skin|MP:0010068,decreased red blood cell distribution width
MGI:4125012	Terf2ip<Gt(XD108)Byg>	MP:0008734,decreased susceptibility to endotoxin shock|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0011092,embryonic lethality, complete penetrance
MGI:4839729	Terf2ip<tm1.1Blas>	MP:0001188,hyperpigmentation|MP:0001260,increased body weight|MP:0005384,cellular phenotype|MP:0010095,increased chromosomal stability|MP:0010207,abnormal telomere morphology|MP:0030927,decreased telomere length
MGI:4441596	Terf2ip<tm1.2Tdl>	MP:0000010,abnormal abdominal fat pad morphology|MP:0001261,obese|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0003982,increased cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0005458,increased percent body fat/body weight|MP:0005559,increased circulating glucose level|MP:0009286,increased abdominal fat pad weight|MP:0010768,mortality/aging|MP:0010934,increased subcutaneous adipose tissue amount|MP:0011117,abnormal susceptibility to weight gain|MP:0020411,increased abdominal adipose tissue amount
MGI:3619525	Terf2<tm1.1Tdl>	MP:0011092,embryonic lethality, complete penetrance
MGI:5829569	Tert<tm1.1Phan>	MP:0006042,increased apoptosis|MP:0006050,pulmonary fibrosis|MP:0011807,decreased lung fibroblast proliferation
MGI:1859741	Tert<tm1Fish>	MP:0002169,no abnormal phenotype detected
MGI:3044918	Tert<tm1Leah>	MP:0003155,abnormal telomere length|MP:0004024,aneuploidy|MP:0008866,chromosomal instability
MGI:3628579	Tert<tm1Rdp>	MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0003205,testicular atrophy|MP:0003702,abnormal chromosome morphology|MP:0004502,decreased incidence of tumors by chemical induction|MP:0006042,increased apoptosis|MP:0010266,decreased liver tumor incidence|MP:0030927,decreased telomere length
MGI:3764898	Tert<tm1Sear>	MP:0003155,abnormal telomere length|MP:0003345,decreased rib number|MP:0004616,lumbar vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0006042,increased apoptosis
MGI:3052737	Tert<tm1Yjc>	MP:0003155,abnormal telomere length|MP:0005384,cellular phenotype
MGI:4878865	Tert<tm2.1Rdp>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000780,abnormal corpus callosum morphology|MP:0000921,demyelination|MP:0001147,small testis|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0003205,testicular atrophy|MP:0003643,spleen atrophy|MP:0003702,abnormal chromosome morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0004953,decreased spleen weight|MP:0005394,taste/olfaction phenotype|MP:0008008,early cellular replicative senescence|MP:0008280,abnormal male germ cell apoptosis|MP:0008544,impaired olfaction|MP:0009808,decreased oligodendrocyte number|MP:0009937,abnormal neuron differentiation|MP:0030927,decreased telomere length
MGI:4352569	Tert<tm2.1Sear>	MP:0002169,no abnormal phenotype detected
MGI:5431942	Tert<tm3Rdp>	MP:0000352,decreased cell proliferation|MP:0001262,decreased body weight|MP:0003205,testicular atrophy|MP:0004852,decreased testis weight|MP:0006042,increased apoptosis|MP:0008800,increased small intestinal crypt cell apoptosis
MGI:5316034	Tesc<tm1Itl>	MP:0005397,hematopoietic system phenotype
MGI:3760502	Tes<Gt(RRH061)Byg>	MP:0002169,no abnormal phenotype detected
MGI:7386895	Teshl<em1Choc>	MP:0001922,reduced male fertility|MP:0009230,abnormal sperm head morphology
MGI:6200319	Tesk1<em1(IMPC)J>	MP:0002941,increased circulating alanine transaminase level
MGI:6163861	Tesk2<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0004738,abnormal auditory brainstem response
MGI:6437394	Tesmin<em1Osb>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0008261,arrest of male meiosis
MGI:7276184	Tesmin<em1Qsh>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:7276187	Tesmin<em2Qsh>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:5432877	Tespa1<tm1Smoc>	MP:0000703,abnormal thymus morphology|MP:0002145,abnormal T cell differentiation|MP:0004974,decreased regulatory T cell number|MP:0005018,decreased T cell number|MP:0005095,decreased T cell proliferation|MP:0005348,increased T cell proliferation|MP:0008049,increased memory T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion|MP:0013588,small thymus medulla
MGI:3043132	Tesq1<L6>	MP:0004852,decreased testis weight
MGI:3042976	Tesq2<L6>	MP:0004852,decreased testis weight
MGI:3043110	Tesq3<L6>	MP:0004851,increased testis weight
MGI:3587810	Tes<tm1Cro>	MP:0002038,increased carcinoma incidence|MP:0010301,increased stomach tumor incidence|MP:0013575,abnormal forestomach-glandular stomach junction morphology|MP:0013576,small forestomach
MGI:3044635	Tesw1<NZB/BlNJ>	MP:0004851,increased testis weight
MGI:3044637	Tesw2<NZB/BlNJ>	MP:0004851,increased testis weight
MGI:4129024	Tet1<Gt(RRG140)Byg>	MP:0001127,small ovary|MP:0001672,abnormal embryo development|MP:0001935,decreased litter size|MP:0003578,absent ovary|MP:0004856,decreased ovary weight|MP:0005168,abnormal female meiosis|MP:0005389,reproductive system phenotype|MP:0005431,decreased oocyte number|MP:0009452,abnormal synaptonemal complex|MP:0009703,decreased birth body size|MP:0010948,abnormal double-strand DNA break repair|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011205,excessive folding of visceral yolk sac|MP:0011257,abnormal head fold morphology|MP:0013507,increased ovary apoptosis|MP:0031474,increased female germ cell apoptosis
MGI:5523869	Tet1<tm1.1Gxu>	MP:0001468,abnormal temporal memory|MP:0001770,abnormal iron level|MP:0003631,nervous system phenotype|MP:0004948,abnormal neuronal precursor proliferation|MP:0005637,abnormal iron homeostasis|MP:0008807,increased liver iron level|MP:0008808,decreased spleen iron level|MP:0008810,increased circulating iron level|MP:0008877,abnormal DNA methylation|MP:0012307,impaired spatial learning|MP:0013302,increased pancreas iron level|MP:0020385,decreased intestine iron level
MGI:5292563	Tet1<tm1.1Jae>	MP:0000222,decreased neutrophil cell number|MP:0001265,decreased body size|MP:0001935,decreased litter size|MP:0003984,embryonic growth retardation|MP:0009703,decreased birth body size
MGI:5523868	Tet1<tm1Gxu>	MP:0004948,abnormal neuronal precursor proliferation
MGI:5911919	Tet1<tm1Koh>	MP:0000928,incomplete rostral neuropore closure|MP:0003232,abnormal forebrain development
MGI:5906894	Tet1<tuft>	MP:0000108,midline facial cleft|MP:0000372,irregular coat pigmentation|MP:0000823,abnormal lateral ventricle morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001300,ocular hypertelorism|MP:0001890,anencephaly|MP:0003720,abnormal neural tube closure|MP:0008818,abnormal interfrontal bone morphology|MP:0008845,abnormal paraventricular hypothalamic nucleus morphology|MP:0008846,abnormal supraoptic nucleus morphology|MP:0010343,increased lipoma incidence|MP:0012260,encephalomeningocele|MP:0012540,abnormal lamina terminalis morphology|MP:0030117,bifid nose
MGI:4345275	Tet2<Gt(AN0709)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001263,weight loss|MP:0001577,anemia|MP:0001860,liver inflammation|MP:0002083,premature death|MP:0002875,decreased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0003179,thrombocytopenia|MP:0003333,liver fibrosis|MP:0004809,increased hematopoietic stem cell number|MP:0005014,increased B cell number|MP:0005090,increased double-negative T cell number|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008112,abnormal monocyte differentiation|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0010129,increased DN1 thymic pro-T cell number
MGI:3813933	Tet2<Gt(Ayu17-449)Imeg>	MP:0002082,postnatal lethality|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5141120	Tet2<tm1.1Iaai>	MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000322,increased granulocyte number|MP:0000691,enlarged spleen|MP:0001601,abnormal myelopoiesis|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0004809,increased hematopoietic stem cell number|MP:0004952,increased spleen weight|MP:0005017,decreased B cell number|MP:0005481,increased chronic myelocytic leukemia incidence|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008250,abnormal myeloid leukocyte morphology|MP:0010373,myeloid hyperplasia|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011181,increased hematopoietic cell number
MGI:5301343	Tet2<tm1.1Mjxu>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000321,increased bone marrow cell number|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0003131,increased erythrocyte cell number|MP:0004809,increased hematopoietic stem cell number|MP:0005481,increased chronic myelocytic leukemia incidence|MP:0005564,increased hemoglobin content|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0010373,myeloid hyperplasia|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:5285413	Tet2<tm1.2Rao>	MP:0000321,increased bone marrow cell number|MP:0001601,abnormal myelopoiesis|MP:0002123,abnormal definitive hematopoiesis|MP:0004809,increased hematopoietic stem cell number|MP:0009338,increased splenocyte number
MGI:5141225	Tet2<tm1Ics>	MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002416,abnormal proerythroblast morphology|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0004809,increased hematopoietic stem cell number|MP:0005014,increased B cell number|MP:0005090,increased double-negative T cell number|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008476,increased spleen red pulp amount|MP:0008989,abnormal liver sinusoid morphology|MP:0010129,increased DN1 thymic pro-T cell number|MP:0010768,mortality/aging|MP:0011178,increased erythroblast number
MGI:5630072	Tex101<tm1b(KOMP)Wtsi>	MP:0005560,decreased circulating glucose level|MP:0005633,increased circulating sodium level
MGI:5571379	Tex101<tm1Qzh>	MP:0001925,male infertility|MP:0009647,decreased fertilization frequency|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031012,impaired sperm migration in female genital tract
MGI:5312404	Tex10<tm1(KOMP)Vlcg>	MP:0011092,embryonic lethality, complete penetrance|MP:0012113,decreased inner cell mass proliferation
MGI:3797590	Tex11<tm1.1Jpt>	MP:0001156,abnormal spermatogenesis|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype
MGI:3526163	Tex11<tm1Jw>	MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0004218,meiotic nondisjunction during M1 phase|MP:0004852,decreased testis weight|MP:0008261,arrest of male meiosis|MP:0008966,abnormal chiasmata formation|MP:0014052,increased male germ cell apoptosis
MGI:3811722	Tex12<tm1Hoog>	MP:0001127,small ovary|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002777,absent ovarian follicles|MP:0005168,abnormal female meiosis|MP:0005169,abnormal male meiosis|MP:0005431,decreased oocyte number|MP:0008966,abnormal chiasmata formation|MP:0009093,oocyte degeneration|MP:0011122,absent primordial ovarian follicles
MGI:6361173	Tex13a<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6361152	Tex13b<em1Osb>	MP:0005389,reproductive system phenotype
MGI:3623684	Tex14<tm1Zuk>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001929,abnormal gametogenesis|MP:0002784,abnormal Sertoli cell morphology|MP:0004852,decreased testis weight|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis
MGI:3526165	Tex15<tm1Jw>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0014764,impaired double-strand DNA break repair
MGI:5519134	Tex19.1<tm1.2Ics>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001711,abnormal placenta morphology|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004200,decreased fetal size|MP:0004259,small placenta|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008261,arrest of male meiosis|MP:0009431,decreased fetal weight|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0013248,placenta junctional zone necrosis|MP:0014052,increased male germ cell apoptosis
MGI:4453204	Tex19.1<tm1Hjc>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0003698,abnormal male reproductive system physiology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005169,abnormal male meiosis|MP:0011101,prenatal lethality, incomplete penetrance|MP:0014052,increased male germ cell apoptosis
MGI:5140347	Tex19.1<tm1(rtTA2S*M2,lacZ)Jw>	MP:0001147,small testis|MP:0008261,arrest of male meiosis|MP:0008966,abnormal chiasmata formation|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6401351	Tex21<em1(IMPC)J>	MP:0001406,abnormal gait|MP:0002590,increased mean corpuscular volume|MP:0005333,decreased heart rate|MP:0005561,increased mean corpuscular hemoglobin|MP:0010506,prolonged RR interval
MGI:6195020	Tex22<tm1.1Osb>	MP:0002169,no abnormal phenotype detected
MGI:5812916	Tex261<tm1b(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0000218,increased leukocyte cell number|MP:0002874,decreased hemoglobin content|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level|MP:0010123,increased bone mineral content
MGI:5634807	Tex29<tm1.1(KOMP)Vlcg>	MP:0000221,decreased leukocyte cell number|MP:0001513,limb grasping|MP:0010053,decreased grip strength
MGI:5763013	Tex2<em1(IMPC)J>	MP:0005333,decreased heart rate|MP:0005554,decreased circulating creatinine level|MP:0010053,decreased grip strength|MP:0010506,prolonged RR interval
MGI:5763004	Tex2<tm1.1(KOMP)Vlcg>	MP:0000195,decreased circulating calcium level|MP:0000221,decreased leukocyte cell number|MP:0001258,decreased body length|MP:0001303,abnormal lens morphology|MP:0001486,abnormal startle reflex|MP:0002590,increased mean corpuscular volume|MP:0002591,decreased mean corpuscular volume|MP:0002941,increased circulating alanine transaminase level|MP:0003795,abnormal bone structure|MP:0004222,iris synechia|MP:0005344,increased circulating bilirubin level|MP:0005560,decreased circulating glucose level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:6361153	Tex35<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6259893	Tex36<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001417,decreased exploration in new environment
MGI:6717363	Tex36<em1Osb>	MP:0005389,reproductive system phenotype
MGI:4363110	Tex38<tm1a(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001925,male infertility|MP:0010124,decreased bone mineral content
MGI:7738738	Tex44<em1Sbbx>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0004543,abnormal sperm physiology|MP:0005389,reproductive system phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0008892,abnormal sperm flagellum morphology|MP:0009243,hairpin sperm flagellum|MP:0009647,decreased fertilization frequency|MP:0009836,abnormal sperm principal piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0014465,abnormal sperm mitochondrial morphology|MP:0031356,abnormal outer dense fiber morphology
MGI:7764802	Tex46<em1Ncvc>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0004852,decreased testis weight|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009237,kinked sperm flagellum|MP:0030976,impaired sperm penetration of zona pellucida
MGI:7764801	Tex46<em1Osb>	MP:0001925,male infertility
MGI:7539196	Tex47<em1(IMPC)J>	MP:0001488,increased startle reflex
MGI:6336107	Tex55<em2(IMPC)Ics>	MP:0005389,reproductive system phenotype
MGI:6194702	Tex56<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:7443119	Teyorf1<em1Fjw>	MP:0005389,reproductive system phenotype
MGI:7444011	Teyorf1<em2Fjw>	MP:0005389,reproductive system phenotype
MGI:7444012	Teyorf1<em3Fjw>	MP:0005389,reproductive system phenotype
MGI:1860956	Tfam<tm1.1Lrsn>	MP:0000267,abnormal heart development|MP:0001265,decreased body size|MP:0001333,absent optic nerve|MP:0001688,abnormal somite development|MP:0003633,abnormal nervous system physiology|MP:0006042,increased apoptosis|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011630,increased mitochondrial size|MP:0011636,disorganized mitochondrial cristae|MP:0011639,decreased mitochondrial DNA content
MGI:5586702	Tfam<tm1.1Ncdl>	MP:0000379,decreased hair follicle number|MP:0000648,absent sebaceous gland|MP:0001219,thick epidermis|MP:0002083,premature death|MP:0002656,abnormal keratinocyte differentiation|MP:0003186,abnormal redox activity|MP:0003453,abnormal keratinocyte physiology|MP:0006036,abnormal mitochondrial physiology|MP:0008489,slow postnatal weight gain|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008859,abnormal hair cycle catagen phase|MP:0009004,progressive hair loss|MP:0009583,increased keratinocyte proliferation
MGI:1860962	Tfam<tm1Lrsn>	MP:0000233,abnormal blood flow velocity|MP:0000274,enlarged heart|MP:0000495,abnormal colon morphology|MP:0000496,abnormal small intestine morphology|MP:0000743,muscle spasm|MP:0000745,tremors|MP:0001046,abnormal enteric neuron morphology|MP:0001105,abnormal PNS glial cell morphology|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001544,abnormal cardiovascular system physiology|MP:0001560,abnormal circulating insulin level|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0002841,impaired skeletal muscle contractility|MP:0002891,increased insulin sensitivity|MP:0003059,decreased insulin secretion|MP:0003140,dilated heart atrium|MP:0003222,increased cardiomyocyte apoptosis|MP:0003224,neuron degeneration|MP:0003243,abnormal dopaminergic neuron morphology|MP:0003244,loss of dopaminergic neurons|MP:0004191,neuronal intranuclear inclusions|MP:0004263,abnormal limb posture|MP:0005156,bradykinesia|MP:0005405,axon degeneration|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005643,decreased dopamine level|MP:0006035,abnormal mitochondrial morphology|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008948,decreased neuron number|MP:0009174,absent pancreatic beta cells|MP:0009399,increased skeletal muscle fiber size|MP:0010955,abnormal respiratory electron transport chain|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011602,increased glutathione peroxidase activity|MP:0011639,decreased mitochondrial DNA content|MP:0012660,increased superoxide dismutase level|MP:0014387,decreased neuron mitochondrial DNA content
MGI:3045427	Tfap2a<Mhdador>	MP:0000029,abnormal malleus morphology|MP:0000445,short snout|MP:0001303,abnormal lens morphology|MP:0001306,small lens|MP:0001322,abnormal iris morphology|MP:0001485,abnormal pinna reflex|MP:0004417,decreased cochlear nerve compound action potential|MP:0004739,conductive hearing loss|MP:0005105,abnormal middle ear ossicle morphology|MP:0005106,abnormal incus morphology|MP:0005107,abnormal stapes morphology|MP:0006358,absent pinna reflex|MP:0011089,perinatal lethality, complete penetrance|MP:0021107,retina fold|MP:0030191,narrow snout
MGI:5529780	Tfap2a<tm1.1Hsv>	MP:0000284,double outlet right ventricle|MP:0000929,open neural tube|MP:0003384,abnormal ventral body wall morphology|MP:0003935,abnormal craniofacial development|MP:0004160,retroesophageal right subclavian artery|MP:0006128,pulmonary valve stenosis|MP:0006130,pulmonary valve atresia|MP:0010224,abnormal heart ventricle outflow tract morphology|MP:0010241,abnormal aortic arch development|MP:0010402,ventricular septal defect|MP:0010572,persistent right dorsal aorta
MGI:2183192	Tfap2a<tm1Hsv>	MP:0000284,double outlet right ventricle|MP:0000929,open neural tube|MP:0003384,abnormal ventral body wall morphology|MP:0003935,abnormal craniofacial development|MP:0004160,retroesophageal right subclavian artery|MP:0006128,pulmonary valve stenosis|MP:0006130,pulmonary valve atresia|MP:0010224,abnormal heart ventricle outflow tract morphology|MP:0010241,abnormal aortic arch development|MP:0010402,ventricular septal defect|MP:0010572,persistent right dorsal aorta
MGI:1888387	Tfap2a<tm1Jae>	MP:0000074,abnormal neurocranium morphology|MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000108,midline facial cleft|MP:0000158,absent sternum|MP:0000161,scoliosis|MP:0000438,abnormal cranium morphology|MP:0000553,absent radius|MP:0000783,abnormal forebrain morphology|MP:0000914,exencephaly|MP:0000919,cranioschisis|MP:0000928,incomplete rostral neuropore closure|MP:0000929,open neural tube|MP:0001081,abnormal cranial ganglia morphology|MP:0001093,small trigeminal ganglion|MP:0001292,abnormal lens vesicle development|MP:0001293,anophthalmia|MP:0001385,pup cannibalization|MP:0001648,abnormal apoptosis|MP:0002114,abnormal axial skeleton morphology|MP:0003104,acrania|MP:0003384,abnormal ventral body wall morphology|MP:0004377,small frontal bone|MP:0004383,absent interparietal bone|MP:0004419,absent parietal bone|MP:0004468,small zygomatic bone|MP:0004473,absent nasal bone|MP:0004624,abnormal thoracic cage morphology|MP:0004673,splayed ribs|MP:0004838,abnormal neural fold elevation formation|MP:0005105,abnormal middle ear ossicle morphology|MP:0005390,skeleton phenotype|MP:0005579,absent outer ear|MP:0011089,perinatal lethality, complete penetrance
MGI:2176682	Tfap2a<tm1Will>	MP:0000040,decreased middle ear ossicle number|MP:0000074,abnormal neurocranium morphology|MP:0000158,absent sternum|MP:0000161,scoliosis|MP:0000284,double outlet right ventricle|MP:0000313,abnormal cell death|MP:0000432,abnormal head morphology|MP:0000438,abnormal cranium morphology|MP:0000450,absent snout|MP:0000453,absent mouth|MP:0000458,abnormal mandible morphology|MP:0000553,absent radius|MP:0000914,exencephaly|MP:0001056,abnormal cranial nerve morphology|MP:0001062,absent oculomotor nerve|MP:0001071,abnormal facial nerve morphology|MP:0001093,small trigeminal ganglion|MP:0001096,abnormal glossopharyngeal ganglion morphology|MP:0001100,abnormal vagus ganglion morphology|MP:0001265,decreased body size|MP:0001288,abnormal lens induction|MP:0001292,abnormal lens vesicle development|MP:0001293,anophthalmia|MP:0001303,abnormal lens morphology|MP:0001306,small lens|MP:0001312,abnormal cornea morphology|MP:0001341,absent eyelids|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0001739,abnormal adrenal gland secretion|MP:0001890,anencephaly|MP:0002633,persistent truncus arteriosus|MP:0002855,abnormal cochlear ganglion morphology|MP:0002856,abnormal vestibular ganglion morphology|MP:0003138,absent tympanic ring|MP:0003388,absent pericardium|MP:0004113,abnormal aortic arch morphology|MP:0004157,interrupted aortic arch|MP:0004160,retroesophageal right subclavian artery|MP:0004268,abnormal optic stalk morphology|MP:0004339,absent clavicle|MP:0004539,absent maxilla|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005261,aniridia|MP:0005377,hearing/vestibular/ear phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005380,embryo phenotype|MP:0005390,skeleton phenotype|MP:0005579,absent outer ear|MP:0008510,absent retina ganglion layer|MP:0010454,abnormal truncus arteriosus septation|MP:0011089,perinatal lethality, complete penetrance|MP:0011659,interrupted aortic arch, type b|MP:0012535,abnormal optic fissure closure|MP:0030579,thoracoabdominoschisis
MGI:5647993	Tfap2a<tm2.1Will>	MP:0002169,no abnormal phenotype detected
MGI:3038304	Tfap2a<tm2Will>	MP:0000074,abnormal neurocranium morphology|MP:0000102,abnormal nasal bone morphology|MP:0000120,malocclusion|MP:0000445,short snout|MP:0001300,ocular hypertelorism|MP:0001614,abnormal blood vessel morphology|MP:0002169,no abnormal phenotype detected|MP:0004380,short frontal bone|MP:0004471,short nasal bone|MP:0005371,limbs/digits/tail phenotype|MP:0010043,abnormal frontonasal suture morphology|MP:0030200,abnormal nasal septum cartilage morphology
MGI:3769332	Tfap2a<tm3Will>	MP:0000562,polydactyly
MGI:6364882	Tfap2b<em1Fenli>	MP:0000532,kidney vascular congestion|MP:0002135,abnormal kidney morphology|MP:0002705,dilated renal tubule|MP:0003139,patent ductus arteriosus|MP:0003675,kidney cyst|MP:0005371,limbs/digits/tail phenotype|MP:0005382,craniofacial phenotype|MP:0005595,abnormal vascular smooth muscle physiology|MP:0010564,abnormal fetal ductus arteriosus morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:7627101	Tfap2b<em1Sleep>	MP:0005380,embryo phenotype|MP:0010768,mortality/aging|MP:0012289,abnormal non-rapid eye movement sleep pattern|MP:0020478,abnormal circadian sleep/wake cycle
MGI:7627104	Tfap2b<em2Sleep>	MP:0005386,behavior/neurological phenotype|MP:0011091,prenatal lethality, complete penetrance|MP:0012287,increased frequency of paradoxical sleep|MP:0012289,abnormal non-rapid eye movement sleep pattern|MP:0020478,abnormal circadian sleep/wake cycle
MGI:5635165	Tfap2b<tm1b(EUCOMM)Wtsi>	MP:0004222,iris synechia|MP:0005386,behavior/neurological phenotype|MP:0008259,abnormal optic disk morphology|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0012289,abnormal non-rapid eye movement sleep pattern|MP:0020478,abnormal circadian sleep/wake cycle
MGI:2180473	Tfap2b<tm1Rbu>	MP:0000195,decreased circulating calcium level|MP:0000562,polydactyly|MP:0000743,muscle spasm|MP:0000745,tremors|MP:0001192,scaly skin|MP:0001566,increased circulating phosphate level|MP:0001732,postnatal growth retardation|MP:0001765,abnormal ion homeostasis|MP:0002136,abnormal kidney physiology|MP:0002904,increased circulating parathyroid hormone level|MP:0002986,decreased urine calcium level|MP:0002988,decreased urine osmolality|MP:0002989,small kidney|MP:0003139,patent ductus arteriosus|MP:0003675,kidney cyst|MP:0004153,increased renal tubule apoptosis|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0006138,congestive heart failure|MP:0009050,dilated proximal convoluted tubule|MP:0009744,postaxial polydactyly|MP:0010018,pulmonary vascular congestion|MP:0010899,abnormal pulmonary alveolar system morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011368,increased kidney apoptosis
MGI:3040993	Tfap2c<tm1.1Hsc>	MP:0001265,decreased body size|MP:0001683,absent mesoderm|MP:0001698,decreased embryo size|MP:0001713,decreased trophoblast giant cell number|MP:0002584,small ectoplacental cone|MP:0003403,absent placental labyrinth|MP:0005033,abnormal trophoblast giant cell morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2176695	Tfap2c<tm1Hsc>	MP:0002169,no abnormal phenotype detected
MGI:2182570	Tfap2c<tm1Will>	MP:0001680,abnormal mesoderm development|MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0001713,decreased trophoblast giant cell number|MP:0001717,absent ectoplacental cone|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002582,disorganized extraembryonic tissue|MP:0002584,small ectoplacental cone|MP:0003087,absent allantois|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0003954,abnormal Reichert's membrane morphology|MP:0003984,embryonic growth retardation|MP:0003988,disorganized embryonic tissue|MP:0010736,abnormal extraembryonic ectoderm morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0011189,small embryonic epiblast|MP:0011200,abnormal extraembryonic coelom morphology|MP:0011207,absent ectoplacental cavity
MGI:5296818	Tfap2d<tm1Mos>	MP:0003631,nervous system phenotype|MP:0006042,increased apoptosis|MP:0009039,absent inferior colliculus
MGI:4398846	Tfap2e<tm1.1(cre)Will>	MP:0002739,abnormal olfactory bulb development
MGI:4398845	Tfap2e<tm1(cre)Will>	MP:0002739,abnormal olfactory bulb development|MP:0005394,taste/olfaction phenotype
MGI:5692546	Tfap4<tm1.1(KOMP)Vlcg>	MP:0000274,enlarged heart|MP:0001120,abnormal uterus morphology|MP:0002590,increased mean corpuscular volume|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0003960,increased lean body mass|MP:0005333,decreased heart rate|MP:0005560,decreased circulating glucose level|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5296820	Tfap4<tm1.1Litt>	MP:0002145,abnormal T cell differentiation|MP:0005387,immune system phenotype|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3844229	Tfb1m<tm1.1Lrsn>	MP:0002083,premature death|MP:0002833,increased heart weight|MP:0004215,abnormal myocardial fiber physiology|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:3844231	Tfb1m<tm1.2Lrsn>	MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0010955,abnormal respiratory electron transport chain|MP:0011091,prenatal lethality, complete penetrance|MP:0011388,absent heart|MP:0011389,absent optic disk
MGI:4363126	Tfb2m<tm1a(KOMP)Wtsi>	MP:0001559,hyperglycemia|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0009114,decreased pancreatic beta cell mass|MP:0009168,decreased pancreatic islet number|MP:0009488,abnormal pancreatic islet cell apoptosis|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011632,dilated mitochondrion|MP:0011639,decreased mitochondrial DNA content|MP:0014046,abnormal mitophagy|MP:0020354,increased endoplasmic reticulum stress|MP:0030940,impaired autophagy
MGI:3707684	Tfcp2l1<Gt(pLSABetageo)1Sjt>	MP:0000534,abnormal ureter morphology|MP:0001732,postnatal growth retardation|MP:0001762,polyuria|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002163,abnormal gland morphology|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0003446,renal hypoplasia|MP:0003793,abnormal submandibular gland morphology|MP:0004757,abnormal distal convoluted tubule morphology|MP:0005310,abnormal salivary gland physiology|MP:0005619,increased urine potassium level|MP:0006316,increased urine sodium level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011459,increased urine chloride ion level|MP:0011754,abnormal kidney collecting duct intercalated cell morphology|MP:0013580,abnormal nasal gland morphology
MGI:3707688	Tfcp2l1<tm1.1Sjt>	MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality|MP:0003793,abnormal submandibular gland morphology
MGI:2445840	Tfcp2<tm1Jmc>	MP:0002169,no abnormal phenotype detected
MGI:2653309	Tfdp1<tm1Lili>	MP:0001698,decreased embryo size|MP:0001713,decreased trophoblast giant cell number|MP:0002006,neoplasm|MP:0002584,small ectoplacental cone|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012131,small visceral yolk sac
MGI:3044119	Tfe3<tm1Est>	MP:0002169,no abnormal phenotype detected
MGI:7572842	Tfeb<em1Xinli>	MP:0005378,growth/size/body region phenotype|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010768,mortality/aging
MGI:2155472	Tfeb<Gt(PT1-ATG)213Wrst>	MP:0002169,no abnormal phenotype detected
MGI:4431759	Tfeb<tm1a(EUCOMM)Wtsi>	MP:0002874,decreased hemoglobin content|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0011100,preweaning lethality, complete penetrance
MGI:5548342	Tfeb<tm1b(EUCOMM)Wtsi>	MP:0001491,unresponsive to tactile stimuli|MP:0001512,trunk curl|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2155473	Tfeb<tm1Est>	MP:0001711,abnormal placenta morphology|MP:0002080,prenatal lethality
MGI:5548432	Tfec<tm1b(KOMP)Wtsi>	MP:0002075,abnormal coat/hair pigmentation|MP:0002111,abnormal tail morphology|MP:0005178,increased circulating cholesterol level
MGI:3044120	Tfec<tm1Est>	MP:0002169,no abnormal phenotype detected
MGI:4433486	Tff1<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0003960,increased lean body mass|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0010088,decreased circulating fructosamine level
MGI:2179220	Tff1<tm1Mrio>	MP:0000470,abnormal stomach morphology|MP:0000496,abnormal small intestine morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0002038,increased carcinoma incidence|MP:0005211,increased stomach mucosa thickness|MP:0010301,increased stomach tumor incidence|MP:0010383,increased adenoma incidence|MP:0010792,abnormal stomach mucosa morphology
MGI:3617545	Tff2<tm1Blin>	MP:0001663,abnormal digestive system physiology|MP:0002419,abnormal innate immunity|MP:0002420,abnormal adaptive immunity
MGI:2179101	Tff2<tm1Tcw>	MP:0000470,abnormal stomach morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000503,excessive digestive secretion|MP:0005165,increased susceptibility to injury|MP:0010792,abnormal stomach mucosa morphology
MGI:2179219	Tff3<tm1Dkpy>	MP:0000488,abnormal intestinal epithelium morphology|MP:0005165,increased susceptibility to injury|MP:0008537,increased susceptibility to induced colitis
MGI:7662928	Tfg<em1(IMPC)Bay>	MP:0001529,abnormal vocalization|MP:0011100,preweaning lethality, complete penetrance
MGI:6336138	Tfpi2<em1(IMPC)Kmpc>	MP:0001399,hyperactivity|MP:0002764,short tibia|MP:0004357,long tibia|MP:0010052,increased grip strength
MGI:6724439	Tfpi2<tm1Dgen>	MP:0002412,increased susceptibility to bacterial infection|MP:0005387,immune system phenotype|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008660,increased interleukin-10 secretion|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:4836740	Tfpi<tm1.1Rdsi>	MP:0005416,abnormal circulating protein level|MP:0011091,prenatal lethality, complete penetrance|MP:0031121,increased susceptibility to induced thrombosis
MGI:2384068	Tfpi<tm1Gjb>	MP:0000084,abnormal fontanelle morphology|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001633,poor circulation|MP:0001718,abnormal visceral yolk sac morphology|MP:0001721,absent visceral yolk sac blood islands|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0002551,abnormal blood coagulation|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0005048,abnormal thrombosis|MP:0005312,pericardial effusion|MP:0006054,spinal hemorrhage|MP:0010211,abnormal acute phase protein level|MP:0011089,perinatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:6148325	Tfr2<em1(IMPC)Rbrc>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000492,abnormal rectum morphology|MP:0000495,abnormal colon morphology|MP:0000598,abnormal liver morphology|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008810,increased circulating iron level|MP:0010068,decreased red blood cell distribution width
MGI:3847279	Tfr2<m1Btlr>	MP:0005637,abnormal iron homeostasis|MP:0008810,increased circulating iron level|MP:0011890,increased circulating ferritin level
MGI:4458417	Tfr2<tm1.1Anro>	MP:0001262,decreased body weight|MP:0002811,macrocytic anemia|MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0005564,increased hemoglobin content|MP:0008807,increased liver iron level|MP:0008809,increased spleen iron level|MP:0008810,increased circulating iron level|MP:0008955,increased cellular hemoglobin content
MGI:3043773	Tfr2<tm1.1Nsub>	MP:0005638,hemochromatosis|MP:0008807,increased liver iron level|MP:0008808,decreased spleen iron level|MP:0008809,increased spleen iron level|MP:0008810,increased circulating iron level
MGI:2384726	Tfr2<tm1Slu>	MP:0005397,hematopoietic system phenotype|MP:0005637,abnormal iron homeostasis|MP:0008807,increased liver iron level|MP:0008808,decreased spleen iron level|MP:0008810,increased circulating iron level
MGI:6257643	Tfrc<em1(IMPC)H>	MP:0001406,abnormal gait|MP:0001529,abnormal vocalization|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0003131,increased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010067,increased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5436082	Tfrc<Mvd001>	MP:0002591,decreased mean corpuscular volume|MP:0003131,increased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin
MGI:6406247	Tfrc<Rbc6>	MP:0000208,decreased hematocrit|MP:0002396,abnormal hematopoietic system morphology/development|MP:0002591,decreased mean corpuscular volume|MP:0002810,microcytic anemia|MP:0002874,decreased hemoglobin content|MP:0003131,increased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010067,increased red blood cell distribution width
MGI:1859944	Tfrc<tm1Nca>	MP:0000245,abnormal erythropoiesis|MP:0001577,anemia|MP:0001670,abnormal intestinal mineral absorption|MP:0001770,abnormal iron level|MP:0002192,hydrops fetalis|MP:0002591,decreased mean corpuscular volume|MP:0002813,microcytosis|MP:0003131,increased erythrocyte cell number|MP:0003400,kinked neural tube|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0004229,abnormal embryonic erythropoiesis|MP:0004230,abnormal embryonic erythrocyte morphology|MP:0005039,hypoxia|MP:0005312,pericardial effusion|MP:0005397,hematopoietic system phenotype|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005637,abnormal iron homeostasis|MP:0006042,increased apoptosis|MP:0008743,decreased liver iron level|MP:0008808,decreased spleen iron level|MP:0008973,decreased erythroid progenitor cell number|MP:0011092,embryonic lethality, complete penetrance|MP:0013241,embryo tissue necrosis
MGI:3778906	Tfrc<tm2Nca>	MP:0004151,decreased circulating iron level|MP:0008388,hypochromic microcytic anemia
MGI:5689121	Tfrc<tm3.1Nca>	MP:0000030,abnormal tympanic ring morphology|MP:0000088,short mandible|MP:0000458,abnormal mandible morphology|MP:0000477,abnormal intestine morphology|MP:0000479,abnormal enterocyte morphology|MP:0000495,abnormal colon morphology|MP:0000496,abnormal small intestine morphology|MP:0000762,abnormal tongue morphology|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001436,abnormal suckling behavior|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002639,micrognathia|MP:0003056,abnormal hyoid bone morphology|MP:0003271,abnormal duodenum morphology|MP:0003292,melena|MP:0004596,abnormal mandibular angle morphology|MP:0005036,diarrhea|MP:0005587,abnormal Meckel's cartilage morphology|MP:0008380,abnormal gonial bone morphology|MP:0008883,abnormal enterocyte proliferation|MP:0009511,distended stomach|MP:0009655,abnormal secondary palate development|MP:0009886,failure of palatal shelf elevation|MP:0011085,postnatal lethality, complete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0013956,decreased colon length|MP:0014083,blunted small intestinal villi|MP:0021164,oral cleft|MP:0021213,complete cleft palate|MP:0030026,small Meckel's cartilage|MP:0030258,small mandibular condyloid process|MP:0030283,small mandibular coronoid process
MGI:3774625	Tfv1<CAST/EiJ>	MP:0005449,abnormal food intake
MGI:3522332	tga	MP:0000266,abnormal heart morphology|MP:0001823,thymus hypoplasia|MP:0002925,abnormal cardiovascular development|MP:0004110,transposition of great arteries|MP:0004111,abnormal coronary artery morphology|MP:0004158,right aortic arch|MP:0005294,abnormal heart ventricle morphology|MP:0006049,semilunar valve regurgitation|MP:0006061,right atrial isomerism|MP:0010413,complete atrioventricular septal defect
MGI:3852016	Tg(AAVS1)A1Xob	MP:0002169,no abnormal phenotype detected
MGI:3832216	Tg(ABCA1)1Hgc	MP:0003192,increased cholesterol efflux
MGI:4438479	Tg(Abcg1)123Ssf	MP:0004777,abnormal phospholipid level|MP:0010027,increased liver cholesterol level
MGI:4438471	Tg(Abcg1)80-90Ssf	MP:0004777,abnormal phospholipid level|MP:0010027,increased liver cholesterol level
MGI:3057161	Tg(ABCG5/ABCG8)14-2Hobb	MP:0000186,decreased circulating HDL cholesterol level|MP:0001666,abnormal intestinal absorption|MP:0002647,decreased intestinal cholesterol absorption|MP:0002791,steatorrhea|MP:0003982,increased cholesterol level|MP:0004773,abnormal bile composition|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0014476,abnormal feces lipid level|MP:0031205,decreased circulating phytosterol level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:4431035	Tg(Abpa-cre)1Cmal	MP:0005389,reproductive system phenotype
MGI:6401292	Tg(Ace2-ACE2)1Cqin	MP:0000266,abnormal heart morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0001175,abnormal lung morphology|MP:0001182,lung hemorrhage|MP:0001654,hepatic necrosis|MP:0001862,interstitial pneumonia|MP:0001864,vascular inflammation|MP:0001915,intracranial hemorrhage|MP:0001958,emphysema|MP:0002152,abnormal brain morphology|MP:0002267,abnormal bronchiole morphology|MP:0002276,abnormal lung interstitium morphology|MP:0003828,pulmonary edema|MP:0008879,submandibular gland inflammation|MP:0009640,abnormal renal tubule epithelium morphology|MP:0010180,increased susceptibility to weight loss|MP:0010792,abnormal stomach mucosa morphology|MP:0010855,pulmonary hyperemia|MP:0010897,abnormal bronchiole epithelium morphology|MP:0010922,alveolitis|MP:0011320,abnormal glomerular capillary morphology|MP:0011404,pyelitis|MP:0011425,abnormal kidney interstitium morphology|MP:0012562,blood vessel degeneration|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031051,lymph node hemorrhage|MP:0031052,lymph node necrosis
MGI:5009707	Tg(Acp5-Adam8)#Rood	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0004992,increased bone resorption|MP:0008396,abnormal osteoclast differentiation|MP:0010876,decreased bone volume
MGI:3607179	Tg(Acp5-Fhl2)#Rosc	MP:0005390,skeleton phenotype
MGI:6850165	Tg(Acp5-Selenow)#Djeo	MP:0000066,osteoporosis|MP:0001262,decreased body weight|MP:0004984,increased osteoclast cell number|MP:0004992,increased bone resorption|MP:0008396,abnormal osteoclast differentiation
MGI:3794206	Tg(ACTA1-Ar)141Kyjo	MP:0000160,kyphosis|MP:0000747,muscle weakness|MP:0001262,decreased body weight|MP:0001407,short stride length|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002269,muscular atrophy|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0005404,abnormal axon morphology|MP:0008770,decreased survivor rate|MP:0009399,increased skeletal muscle fiber size|MP:0009406,decreased skeletal muscle fiber number|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3794205	Tg(ACTA1-Ar)78Kyjo	MP:0001262,decreased body weight|MP:0002082,postnatal lethality|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008770,decreased survivor rate
MGI:3839624	Tg(ACTA1-Capn3*)10.2Spc	MP:0002169,no abnormal phenotype detected
MGI:3839626	Tg(ACTA1-Capn3*)10.3Spc	MP:0009404,centrally nucleated skeletal muscle fibers
MGI:3839617	Tg(ACTA1-Capn3*)27.10Spc	MP:0000160,kyphosis|MP:0001406,abnormal gait|MP:0004819,decreased skeletal muscle mass|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:3839611	Tg(ACTA1-Capn3*)37.3Spc	MP:0000160,kyphosis|MP:0001406,abnormal gait|MP:0004819,decreased skeletal muscle mass|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:3839605	Tg(ACTA1-Capn3*)37.9Spc	MP:0000160,kyphosis|MP:0001406,abnormal gait|MP:0004819,decreased skeletal muscle mass|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:3839608	Tg(ACTA1-Capn3*)39.1Spc	MP:0000160,kyphosis|MP:0001406,abnormal gait|MP:0004819,decreased skeletal muscle mass|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:3839594	Tg(ACTA1-Capn3*)41.1Spc	MP:0000160,kyphosis|MP:0001406,abnormal gait|MP:0004819,decreased skeletal muscle mass|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:3839622	Tg(ACTA1-Capn3*)42Spc	MP:0000160,kyphosis|MP:0001406,abnormal gait|MP:0004819,decreased skeletal muscle mass|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:3839586	Tg(ACTA1-Capn3)7.2Spc	MP:0005369,muscle phenotype|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:5765989	Tg(ACTA1-Ctss)1Jmol	MP:0000752,dystrophic muscle|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009419,skeletal muscle fibrosis|MP:0012106,impaired exercise endurance
MGI:5316719	Tg(ACTA1*D286G/EGFP)#Kjno	MP:0000747,muscle weakness|MP:0000759,abnormal skeletal muscle morphology|MP:0002841,impaired skeletal muscle contractility|MP:0003061,decreased aerobic running capacity|MP:0004091,abnormal Z line morphology
MGI:5566909	Tg(ACTA1*D286G)#Kjno	MP:0000747,muscle weakness|MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0002841,impaired skeletal muscle contractility|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology
MGI:3817488	Tg(ACTA1-FRG1)highRotu	MP:0000160,kyphosis|MP:0000752,dystrophic muscle|MP:0001262,decreased body weight|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004819,decreased skeletal muscle mass|MP:0005386,behavior/neurological phenotype|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0012106,impaired exercise endurance
MGI:3817486	Tg(ACTA1-FRG1)lowRotu	MP:0005369,muscle phenotype|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype
MGI:3817487	Tg(ACTA1-FRG1)medRotu	MP:0000160,kyphosis|MP:0000752,dystrophic muscle|MP:0001262,decreased body weight|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004819,decreased skeletal muscle mass|MP:0005386,behavior/neurological phenotype|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0012106,impaired exercise endurance
MGI:3630335	Tg(ACTA1-IGF1)1Rjs	MP:0001625,cardiac hypertrophy|MP:0002972,abnormal cardiac muscle contractility|MP:0004564,increased myocardial fiber size|MP:0005378,growth/size/body region phenotype|MP:0005608,cardiac interstitial fibrosis|MP:0009399,increased skeletal muscle fiber size|MP:0031131,myocardial fiber disarray
MGI:4417893	Tg(ACTA1-Il15)10941Lsq	MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype|MP:0005397,hematopoietic system phenotype|MP:0008751,abnormal interleukin level
MGI:4417881	Tg(ACTA1-Il15*)11650Lsq	MP:0001259,abnormal body weight|MP:0001262,decreased body weight|MP:0003960,increased lean body mass|MP:0005397,hematopoietic system phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005668,decreased circulating leptin level|MP:0008611,increased circulating interleukin-15 level|MP:0008751,abnormal interleukin level|MP:0008853,decreased abdominal adipose tissue amount|MP:0009269,decreased fat cell size|MP:0009424,decreased extensor digitorum longus weight|MP:0010123,increased bone mineral content
MGI:3640477	Tg(ACTA1-MYOT)12Mah	MP:0000759,abnormal skeletal muscle morphology|MP:0004121,abnormal sarcolemma morphology
MGI:3640478	Tg(ACTA1-MYOT*T57I)71Mah	MP:0000747,muscle weakness|MP:0000752,dystrophic muscle|MP:0000759,abnormal skeletal muscle morphology|MP:0002841,impaired skeletal muscle contractility|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003851,skeletal muscle interstitial fibrosis|MP:0004093,diffuse Z line
MGI:3693304	Tg(ACTA1-PABPN1*A17)1Drub	MP:0000747,muscle weakness|MP:0000748,progressive muscle weakness|MP:0001515,abnormal grip strength|MP:0001516,abnormal motor coordination/balance|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003313,abnormal locomotor activation|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:6163751	Tg(Acta1-Slmap)#Eno	MP:0009400,decreased skeletal muscle fiber size
MGI:3774939	Tg(ACTA1-SMN)63Ahmb	MP:0002169,no abnormal phenotype detected
MGI:3774944	Tg(ACTA1-SMN)69Ahmb	MP:0002169,no abnormal phenotype detected
MGI:5550399	Tg(ACTA1-STIM1)2Jmol	MP:0003851,skeletal muscle interstitial fibrosis|MP:0004231,abnormal calcium ion homeostasis|MP:0006035,abnormal mitochondrial morphology|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0011633,abnormal mitochondrial shape
MGI:5550401	Tg(ACTA1-STIM1)4Jmol	MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0003851,skeletal muscle interstitial fibrosis|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:5444208	Tg(ACTA1-TPM3*M9R)4Hrd	MP:0000747,muscle weakness|MP:0000751,myopathy|MP:0000759,abnormal skeletal muscle morphology|MP:0002106,abnormal muscle physiology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0009399,increased skeletal muscle fiber size
MGI:2446449	Tg(ACTA1-UCP3)1Clap	MP:0002891,increased insulin sensitivity|MP:0005266,abnormal metabolism|MP:0005290,decreased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0006319,abnormal epididymal fat pad morphology
MGI:3051851	Tg(Acta2/CYSLTR1)31Fun	MP:0002169,no abnormal phenotype detected
MGI:3850849	Tg(Acta2-RAC1*G12V)33Pjgc	MP:0002032,increased sarcoma incidence|MP:0003674,oxidative stress|MP:0004024,aneuploidy|MP:0004025,polyploidy|MP:0008560,increased tumor necrosis factor secretion|MP:0008705,increased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion
MGI:3838984	Tg(ACTB-A)1Jahe	MP:0001260,increased body weight|MP:0002006,neoplasm|MP:0003136,yellow coat color
MGI:4438113	Tg(ACTB-APP)1Colm	MP:0001399,hyperactivity|MP:0001489,decreased startle reflex|MP:0002572,abnormal emotion/affect behavior|MP:0002573,behavioral despair
MGI:4438112	Tg(ACTB-APP*V717F)1Colm	MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0002063,abnormal learning/memory/conditioning|MP:0002573,behavioral despair|MP:0004000,impaired passive avoidance behavior|MP:0005404,abnormal axon morphology|MP:0006042,increased apoptosis|MP:0008911,induced hyperactivity|MP:0009749,enhanced behavioral response to addictive substance
MGI:3045597	Tg(ACTB-Artn)1Wss	MP:0000639,abnormal adrenal gland morphology|MP:0001034,abnormal parasympathetic ganglion morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0002031,increased adrenal gland tumor incidence|MP:0002751,abnormal autonomic nervous system morphology|MP:0008289,abnormal adrenal medulla morphology
MGI:3696379	Tg(ACTB-DDAH1)1Jpck	MP:0001544,abnormal cardiovascular system physiology|MP:0002626,increased heart rate|MP:0002843,decreased systemic arterial blood pressure|MP:0003957,abnormal nitric oxide homeostasis|MP:0004879,decreased systemic vascular resistance|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0011952,decreased cardiac stroke volume
MGI:5538247	Tg(ACTB-Edn1)1398Clou	MP:0000029,abnormal malleus morphology|MP:0000111,cleft palate|MP:0000154,rib fusion|MP:0004475,palatine bone hypoplasia|MP:0004596,abnormal mandibular angle morphology|MP:0004912,absent mandibular coronoid process|MP:0005106,abnormal incus morphology|MP:0005270,abnormal zygomatic bone morphology|MP:0006432,abnormal costal cartilage morphology|MP:0008382,gonial bone hypoplasia|MP:0014166,ectopic cranial bone|MP:0030084,tympanic ring hypoplasia|MP:0030122,temporal bone squamous part hypoplasia|MP:0030300,upper jaw to lower jaw transformation
MGI:5538248	Tg(ACTB-Edn1)1408Clou	MP:0000154,rib fusion|MP:0005382,craniofacial phenotype|MP:0006432,abnormal costal cartilage morphology
MGI:5538249	Tg(ACTB-Edn1)1416Clou	MP:0000108,midline facial cleft|MP:0000154,rib fusion|MP:0003869,ectopic cartilage|MP:0004475,palatine bone hypoplasia|MP:0004596,abnormal mandibular angle morphology|MP:0004912,absent mandibular coronoid process|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006432,abnormal costal cartilage morphology|MP:0010326,malleus hypoplasia|MP:0030084,tympanic ring hypoplasia|MP:0030122,temporal bone squamous part hypoplasia|MP:0030300,upper jaw to lower jaw transformation
MGI:5538246	Tg(ACTB-Edn1)721Clou	MP:0000108,midline facial cleft|MP:0000111,cleft palate|MP:0000458,abnormal mandible morphology|MP:0004423,abnormal temporal bone squamous part morphology|MP:0004461,basisphenoid bone hypoplasia|MP:0004467,absent zygomatic bone|MP:0004476,absent palatine bone|MP:0005587,abnormal Meckel's cartilage morphology|MP:0006432,abnormal costal cartilage morphology|MP:0030300,upper jaw to lower jaw transformation
MGI:6236319	Tg(ACTB-EGFP,-Kcnj8)1Nich	MP:0005385,cardiovascular system phenotype
MGI:6275065	Tg(ACTB-EGFP,-Kcnj8*)1Wco	MP:0000231,hypertension|MP:0000249,abnormal blood vessel physiology|MP:0000278,abnormal myocardial fiber morphology|MP:0002169,no abnormal phenotype detected|MP:0005378,growth/size/body region phenotype|MP:0010768,mortality/aging
MGI:6236320	Tg(ACTB-EGFP,-Kcnj8*G343D)9Nich	MP:0001596,hypotension|MP:0003026,decreased vasoconstriction|MP:0005595,abnormal vascular smooth muscle physiology
MGI:6236321	Tg(ACTB-EGFP,-Kcnj8*Q53R*G343D)1Nich	MP:0001596,hypotension
MGI:5306398	Tg(ACTB-eGFP,-RAMP1)#Afru	MP:0001846,increased inflammatory response|MP:0013787,photophobia
MGI:4438932	Tg(ACTB-Eif4e)#Ppp	MP:0000783,abnormal forebrain morphology|MP:0001360,abnormal social investigation|MP:0001399,hyperactivity|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001898,abnormal long-term depression|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0002152,abnormal brain morphology|MP:0003324,increased liver adenoma incidence|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008008,early cellular replicative senescence|MP:0014384,increased miniature inhibitory postsynaptic current amplitude|MP:0020340,abnormal inhibitory learning|MP:0031391,increased locomotor activity
MGI:4459802	Tg(ACTB-Fpr2)#Jimw	MP:0002376,abnormal dendritic cell physiology|MP:0002405,respiratory system inflammation
MGI:5291512	Tg(Actb-GFP,-Bmp4)1Csk	MP:0002871,albuminuria|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology
MGI:3775630	Tg(ACTB-GLRX)1Dkd	MP:0000343,abnormal response to cardiac infarction
MGI:3044263	Tg(ACTB-HSF1)1Anak	MP:0001145,abnormal male reproductive system morphology|MP:0001153,small seminiferous tubules|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0008261,arrest of male meiosis
MGI:5526090	Tg(ACTB-KRAS*G12V,-luc)#Lche	MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0008014,increased lung tumor incidence
MGI:3707556	Tg(ACTB-MAP2K1*K97M)1Stl	MP:0001454,abnormal cued conditioning behavior|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0002207,abnormal long-term potentiation|MP:0002912,abnormal excitatory postsynaptic potential|MP:0005584,abnormal enzyme/coenzyme activity
MGI:2662357	Tg(ACTB-Mgat3)2Nta	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0002123,abnormal definitive hematopoiesis|MP:0002397,abnormal bone marrow morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0003643,spleen atrophy|MP:0005016,decreased lymphocyte cell number|MP:0005152,pancytopenia|MP:0008973,decreased erythroid progenitor cell number|MP:0014263,decreased spleen B cell follicle number
MGI:3044583	Tg(ACTB-NOTCH1)1Shn	MP:0000774,decreased brain size|MP:0000936,small embryonic telencephalon|MP:0003202,abnormal neuron apoptosis|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0005384,cellular phenotype|MP:0008948,decreased neuron number|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0014558,decreased cortical ventricular zone thickness
MGI:3044584	Tg(Actb-NOTCH1)2Shn	MP:0001648,abnormal apoptosis
MGI:6278014	Tg(Actb-Ptma)T12Clwu	MP:0001431,abnormal eating behavior|MP:0001732,postnatal growth retardation|MP:0001958,emphysema|MP:0002981,increased liver weight|MP:0003675,kidney cyst|MP:0003917,increased kidney weight|MP:0003985,renal fibrosis|MP:0004968,kidney epithelium hyperplasia|MP:0005565,increased blood urea nitrogen level|MP:0006050,pulmonary fibrosis|MP:0008489,slow postnatal weight gain|MP:0008528,polycystic kidney|MP:0009674,decreased birth weight|MP:0011085,postnatal lethality, complete penetrance
MGI:4456414	Tg(ACTB-SLC2A1)224Cwh	MP:0000524,decreased renal tubule number|MP:0002871,albuminuria|MP:0003918,decreased kidney weight|MP:0003927,increased cellular glucose import|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005553,increased circulating creatinine level|MP:0011409,increased renal glomerulus basement membrane thickness
MGI:5445698	Tg(ACTB-Slc2a12)#Khm	MP:0001668,abnormal intestinal fructose absorption
MGI:3783732	Tg(ACTB-SOD2)66Ysh	MP:0002943,abnormal lactate dehydrogenase level|MP:0003038,decreased myocardial infarct size|MP:0005385,cardiovascular system phenotype|MP:0005599,increased cardiac muscle contractility|MP:0006085,myocardium necrosis
MGI:5529515	Tg(ACTB-THRB*)DSyc	MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001409,increased stereotypic behavior|MP:0001410,head bobbing|MP:0001441,increased grooming behavior|MP:0005470,increased thyroxine level
MGI:5529516	Tg(ACTB-THRB*)#Syc	MP:0002574,increased vertical activity|MP:0002757,decreased vertical activity|MP:0011620,abnormal habituation to a new environment|MP:0012298,hypoactivity in response to feed restriction|MP:0012315,impaired learning|MP:0031391,increased locomotor activity
MGI:3843671	Tg(ACTB-TNFRSF6B)754Jwu	MP:0000221,decreased leukocyte cell number|MP:0000609,abnormal liver physiology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001212,skin lesions|MP:0001216,abnormal epidermal layer morphology|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0001577,anemia|MP:0001786,skin edema|MP:0002083,premature death|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002497,increased IgE level|MP:0002534,abnormal type IV hypersensitivity reaction|MP:0002962,increased urine protein level|MP:0003179,thrombocytopenia|MP:0003215,renal interstitial fibrosis|MP:0003725,increased autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005161,hematuria|MP:0005327,abnormal mesangial cell morphology|MP:0008167,increased B-1a cell number|MP:0008499,increased IgG1 level|MP:0008501,increased IgG2b level|MP:0008699,increased interleukin-4 secretion|MP:0011294,renal glomerulus hypertrophy|MP:0011418,leukocyturia|MP:0020518,renal glomerular protein deposits|MP:0020519,renal glomerular immunoglobulin deposits
MGI:2445589	Tg(Actb-Tnfsf4)1Nish	MP:0003009,abnormal cytokine secretion|MP:0005348,increased T cell proliferation|MP:0005617,increased susceptibility to type IV hypersensitivity reaction
MGI:3836898	Tg(ACTB-Twnk*A360T)HSuom	MP:0004087,abnormal muscle fiber morphology|MP:0005369,muscle phenotype|MP:0005386,behavior/neurological phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0010768,mortality/aging
MGI:3836897	Tg(ACTB-Twnk*)DSuom	MP:0000598,abnormal liver morphology|MP:0000751,myopathy|MP:0001764,abnormal homeostasis|MP:0002108,abnormal muscle morphology|MP:0002152,abnormal brain morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003631,nervous system phenotype|MP:0003806,abnormal nucleotide metabolism|MP:0004087,abnormal muscle fiber morphology|MP:0005369,muscle phenotype|MP:0005386,behavior/neurological phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006035,abnormal mitochondrial morphology|MP:0006038,increased mitochondrial fission|MP:0008058,abnormal DNA repair|MP:0008877,abnormal DNA methylation|MP:0010768,mortality/aging|MP:0010954,abnormal cellular respiration|MP:0013242,abnormal amino acid metabolism|MP:0021133,increased amino acid betaine level|MP:0030018,increased cardiac muscle cell glucose uptake|MP:0030658,increased glycine level|MP:0030684,increased cystathionine level|MP:0030691,increased serine level|MP:0030700,increased threonine level|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:3527553	Tg(ACTB-Twnk)#Suom	MP:0005384,cellular phenotype
MGI:5699179	Tg(Actl6b-cre)4092Jiwu	MP:0002169,no abnormal phenotype detected
MGI:7578892	Tg(Adipoq-Apol6)#Hsul	MP:0001260,increased body weight|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0008033,impaired lipolysis|MP:0009118,increased white fat cell size|MP:0009288,increased epididymal fat pad weight|MP:0009302,increased renal fat pad weight|MP:0014145,increased white adipose tissue mass|MP:0031602,white adipose tissue inflammation
MGI:4836360	Tg(Adipoq-cre)1Evdr	MP:0005292,improved glucose tolerance|MP:0013278,decreased fasting circulating glucose level
MGI:5699372	Tg(Adipoq-LPL)1Fnln	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001260,increased body weight|MP:0002891,increased insulin sensitivity|MP:0004889,increased energy expenditure|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009355,increased liver triglyceride level|MP:0009356,decreased liver triglyceride level|MP:0011939,increased food intake|MP:0013278,decreased fasting circulating glucose level|MP:0030969,increased circulating adiponectin level
MGI:6415555	Tg(Adipoq-Zc3h10)#Hsul	MP:0002891,increased insulin sensitivity|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005670,abnormal white adipose tissue physiology|MP:0009116,abnormal brown fat cell morphology|MP:0011628,increased mitochondrial number|MP:0011698,abnormal brown adipose tissue physiology|MP:0011699,abnormal brown adipose tissue thermogenesis|MP:0020523,decreased susceptibility to induced hypothermia
MGI:6415579	Tg(Adipoq-Zc3h10*)#Hsul	MP:0005289,increased oxygen consumption|MP:0009116,abnormal brown fat cell morphology|MP:0011628,increased mitochondrial number|MP:0011699,abnormal brown adipose tissue thermogenesis
MGI:5440979	Tg(Adora2a-Chrm3*,-mCherry)AD6Blr	MP:0001402,decreased locomotor activity|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0009750,impaired behavioral response to addictive substance
MGI:2386502	Tg(ADRB1)1Srr	MP:0000005,increased brown adipose tissue amount|MP:0001262,decreased body weight|MP:0001783,decreased white adipose tissue amount|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008034,enhanced lipolysis|MP:0009115,abnormal fat cell morphology
MGI:3624008	Tg(Afp-IGFBP1)16Csw	MP:0001265,decreased body size|MP:0004200,decreased fetal size|MP:0004260,enlarged placenta
MGI:3624007	Tg(Afp-IGFBP1)2Csw	MP:0001265,decreased body size|MP:0009703,decreased birth body size
MGI:5569820	Tg(AGER)#Eca	MP:0001175,abnormal lung morphology|MP:0001183,overexpanded pulmonary alveolus|MP:0001732,postnatal growth retardation|MP:0001861,lung inflammation|MP:0001953,respiratory failure|MP:0001958,emphysema|MP:0002276,abnormal lung interstitium morphology|MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0004007,abnormal lung vasculature morphology|MP:0010899,abnormal pulmonary alveolar system morphology|MP:0010900,abnormal pulmonary interalveolar septum morphology|MP:0010903,abnormal pulmonary alveolus wall morphology|MP:0010908,dilated pulmonary alveolar duct|MP:0010995,abnormal lung alveolus development|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011140,decreased lung endothelial cell proliferation|MP:0014474,decreased pulmonary alveolus wall thickness
MGI:4453970	Tg(Agt)123Uhg	MP:0005601,increased angiogenesis
MGI:3769588	Tg(AGT)2-5Afu	MP:0000231,hypertension|MP:0000947,convulsive seizures|MP:0001711,abnormal placenta morphology|MP:0001853,heart inflammation|MP:0001914,hemorrhage|MP:0002833,increased heart weight|MP:0002836,abnormal chorion morphology|MP:0002962,increased urine protein level|MP:0003141,cardiac fibrosis|MP:0003718,maternal effect|MP:0004256,abnormal maternal decidual layer morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005325,abnormal renal glomerulus morphology|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008028,pregnancy-related premature death|MP:0008959,abnormal spongiotrophoblast cell morphology|MP:0009661,abnormal pregnancy|MP:0010633,myocardium hypertrophy|MP:0012008,delayed parturition
MGI:4838097	Tg(Alb1-GP33/H2-K<b>)1Hpi	MP:0002941,increased circulating alanine transaminase level|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005079,decreased cytotoxic T cell cytolysis
MGI:3510593	Tg(Alb1HBV)141Bri	MP:0002006,neoplasm
MGI:3510558	Tg(Alb1HBV)43Bri	MP:0000598,abnormal liver morphology|MP:0008019,increased liver tumor incidence
MGI:2678809	Tg(Alb1HBV)44Bri	MP:0000598,abnormal liver morphology|MP:0001860,liver inflammation|MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0008019,increased liver tumor incidence
MGI:3512308	Tg(Alb1-Myc)#Sst	MP:0000607,abnormal hepatocyte morphology|MP:0002981,increased liver weight|MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence
MGI:3039270	Tg(Alb1-Ren)1Unc	MP:0000231,hypertension|MP:0001426,polydipsia|MP:0001762,polyuria|MP:0001859,kidney inflammation|MP:0002871,albuminuria|MP:0002988,decreased urine osmolality|MP:0005553,increased circulating creatinine level
MGI:3039271	Tg(Alb1-Ren)2Unc	MP:0000231,hypertension|MP:0001426,polydipsia|MP:0001625,cardiac hypertrophy|MP:0001762,polyuria|MP:0001859,kidney inflammation|MP:0002083,premature death|MP:0002842,increased systemic arterial blood pressure|MP:0002871,albuminuria|MP:0002988,decreased urine osmolality|MP:0005333,decreased heart rate|MP:0005553,increased circulating creatinine level
MGI:4457120	Tg(Alb1-Ren)3Unc	MP:0001625,cardiac hypertrophy|MP:0002842,increased systemic arterial blood pressure
MGI:5529803	Tg(Alb-Cyr61)#Lfl	MP:0005166,decreased susceptibility to injury
MGI:2429562	Tg(Alb-E2F1)8Sst	MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003893,increased hepatocyte proliferation|MP:0008019,increased liver tumor incidence|MP:0031115,macrovesicular hepatic steatosis
MGI:5755963	Tg(Alb-HBx)A112Tfts	MP:0000598,abnormal liver morphology|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0003331,increased hepatocellular carcinoma incidence|MP:0005141,liver hyperplasia|MP:0005517,impaired liver regeneration
MGI:5661920	Tg(Alb-HRAS*G12V)28Yu	MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003674,oxidative stress|MP:0003887,increased hepatocyte apoptosis|MP:0008019,increased liver tumor incidence|MP:0010080,abnormal hepatocyte physiology
MGI:8260940	Tg(Alb-Igf2bp1)#Tya	MP:0002169,no abnormal phenotype detected
MGI:3056401	Tg(AlbLCAT)1Jdm	MP:0001556,increased circulating HDL cholesterol level|MP:0002644,decreased circulating triglyceride level|MP:0005178,increased circulating cholesterol level|MP:0005339,increased susceptibility to atherosclerosis|MP:0005376,homeostasis/metabolism phenotype
MGI:5706928	Tg(Alb-MYLIP*)1Pton	MP:0000182,increased circulating LDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0002644,decreased circulating triglyceride level|MP:0005178,increased circulating cholesterol level|MP:0005338,atherosclerotic lesions|MP:0005339,increased susceptibility to atherosclerosis|MP:0012320,abnormal body fat mass
MGI:5296937	Tg(Alb-Nos2)1Mkan	MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0003975,increased circulating VLDL triglyceride level|MP:0005317,increased triglyceride level|MP:0005386,behavior/neurological phenotype|MP:0005438,abnormal glycogen homeostasis|MP:0009355,increased liver triglyceride level|MP:0010398,decreased liver glycogen level
MGI:5578131	Tg(Alb-PDGFC)#Jcam	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000609,abnormal liver physiology|MP:0000691,enlarged spleen|MP:0001570,abnormal circulating enzyme level|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0002725,abnormal vein morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003333,liver fibrosis|MP:0003893,increased hepatocyte proliferation|MP:0005343,increased circulating aspartate transaminase level|MP:0005416,abnormal circulating protein level|MP:0005435,hemoperitoneum|MP:0008596,increased circulating interleukin-6 level|MP:0008989,abnormal liver sinusoid morphology|MP:0008990,abnormal Ito cell morphology|MP:0009820,abnormal liver vasculature morphology|MP:0010019,liver vascular congestion|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis|MP:0031301,chronic liver inflammation
MGI:3763545	Tg(Alb-PLG)1Dgi	MP:0002412,increased susceptibility to bacterial infection|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3812483	Tg(Alb-REG3A)24Lchr	MP:0000609,abnormal liver physiology|MP:0003893,increased hepatocyte proliferation|MP:0005166,decreased susceptibility to injury|MP:0005516,enhanced liver regeneration
MGI:6257844	Tg(Alb-SND1)3aDsar	MP:0003331,increased hepatocellular carcinoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0010080,abnormal hepatocyte physiology|MP:0031301,chronic liver inflammation
MGI:6259431	Tg(Alb-SREBF1_ic)#Jkot	MP:0000008,increased white adipose tissue amount|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0001262,decreased body weight|MP:0001554,increased circulating free fatty acids level|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0003960,increased lean body mass|MP:0005281,increased fatty acids level|MP:0005283,increased unsaturated fatty acids level|MP:0005285,decreased unsaturated fatty acids level|MP:0005286,decreased saturated fatty acids level|MP:0005317,increased triglyceride level|MP:0005331,insulin resistance|MP:0005334,abnormal fat pad morphology|MP:0005336,abnormal inguinal fat pad morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0005378,growth/size/body region phenotype|MP:0005455,increased susceptibility to weight gain|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0006319,abnormal epididymal fat pad morphology|MP:0008770,decreased survivor rate|MP:0010378,increased respiratory quotient|MP:0010934,increased subcutaneous adipose tissue amount|MP:0010951,abnormal lipid oxidation|MP:0010954,abnormal cellular respiration|MP:0010957,abnormal aerobic respiration|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011940,decreased food intake|MP:0012232,abnormal ceramide level|MP:0013245,abnormal lipid metabolism|MP:0014142,increased body fat mass
MGI:3796605	Tg(Alb-TAg)1Gjh	MP:0002083,premature death|MP:0003331,increased hepatocellular carcinoma incidence
MGI:5000250	Tg(Alb-TAg)#Arnd	MP:0001790,abnormal immune system physiology|MP:0003331,increased hepatocellular carcinoma incidence
MGI:3584497	Tg(Amelx)42Msnd	MP:0002649,abnormal enamel rod pattern|MP:0030450,abnormal enamel mineralization
MGI:3783594	Tg(Amelx-Ambn)1Mlp	MP:0002576,abnormal enamel morphology|MP:0002649,abnormal enamel rod pattern
MGI:3695684	Tg(Amelx-Dspp)13Mlp	MP:0002576,abnormal enamel morphology|MP:0002577,reduced enamel thickness|MP:0002649,abnormal enamel rod pattern|MP:0030460,enamel pits
MGI:3695683	Tg(Amelx-Dspp)214Mlp	MP:0002576,abnormal enamel morphology
MGI:3716151	Tg(AMELX-LRAP)9Gibs	MP:0002576,abnormal enamel morphology|MP:0002689,abnormal molar morphology
MGI:3716165	Tg(AMELX*M180)87Gibs	MP:0005382,craniofacial phenotype
MGI:3716166	Tg(AMELX*P70T)2Gibs	MP:0002649,abnormal enamel rod pattern|MP:0002689,abnormal molar morphology|MP:0030457,abnormal molar cusp morphology|MP:0030459,abnormal tooth attrition
MGI:4456202	Tg(AMH-Fshr)27Hht	MP:0004834,ovary hemorrhage|MP:0009442,increased ovarian teratoma incidence
MGI:4456199	Tg(AMH-Fshr*D580H)14Hht	MP:0002773,decreased circulating luteinizing hormone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0005124,increased circulating prolactin level|MP:0005182,increased circulating estradiol level
MGI:4456198	Tg(AMH-Fshr*D580H)#Hht	MP:0000351,increased cell proliferation|MP:0000627,abnormal mammary gland morphology|MP:0000635,pituitary gland hyperplasia|MP:0000639,abnormal adrenal gland morphology|MP:0001126,abnormal ovary morphology|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0001928,abnormal ovulation|MP:0001934,increased litter size|MP:0002161,abnormal fertility/fecundity|MP:0003505,increased prolactinoma incidence|MP:0003579,increased ovarian carcinoma incidence|MP:0004834,ovary hemorrhage|MP:0005132,decreased luteinizing hormone level|MP:0005139,increased prolactin level|MP:0008871,abnormal ovarian follicle number|MP:0008939,increased pituitary gland weight|MP:0009009,absent estrous cycle|MP:0009013,abnormal proestrus|MP:0009021,absent estrus|MP:0009442,increased ovarian teratoma incidence|MP:0031019,increased granulosa cell proliferation
MGI:4456201	Tg(AMH-Fshr*D580Y)#Hht	MP:0004834,ovary hemorrhage|MP:0009442,increased ovarian teratoma incidence
MGI:3832594	Tg(Amhr2-Pik3ca*,-GFP)#Lzh	MP:0001126,abnormal ovary morphology|MP:0001923,reduced female fertility|MP:0002006,neoplasm|MP:0008871,abnormal ovarian follicle number
MGI:2667300	Tg(Amhr2-SV40TAg)1Dcco	MP:0001926,female infertility|MP:0003579,increased ovarian carcinoma incidence|MP:0003675,kidney cyst|MP:0006262,increased testis tumor incidence|MP:0008000,increased ovary tumor incidence|MP:0013184,hemorrhagic ascites
MGI:5528705	Tg(Amh-SMAD2*)2Tkw	MP:0001126,abnormal ovary morphology|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002016,ovary cyst|MP:0002680,decreased corpora lutea number|MP:0008976,delayed female fertility|MP:0009433,polyovular ovarian follicle|MP:0013609,abnormal ovarian medulla morphology
MGI:5543909	Tg(Amh-SMAD2*)#Jebu	MP:0002016,ovary cyst|MP:0008000,increased ovary tumor incidence|MP:0009442,increased ovarian teratoma incidence
MGI:2447446	Tg(Amh-Smad4)1Tkw	MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002781,increased circulating testosterone level|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005376,homeostasis/metabolism phenotype|MP:0014052,increased male germ cell apoptosis
MGI:1889519	Tg(AMY1C)9257Mm	MP:0000074,abnormal neurocranium morphology|MP:0000091,short premaxilla|MP:0000097,short maxilla|MP:0000104,abnormal sphenoid bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0001262,decreased body weight|MP:0001286,abnormal eye development|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001306,small lens|MP:0001395,bidirectional circling|MP:0001399,hyperactivity|MP:0001522,impaired swimming|MP:0002092,abnormal eye morphology|MP:0002233,abnormal nose morphology|MP:0002239,abnormal nasal septum morphology|MP:0002244,abnormal turbinate morphology|MP:0002820,abnormal premaxilla morphology|MP:0002840,abnormal lens fiber morphology|MP:0003161,absent lateral semicircular canal|MP:0003162,decreased lateral semicircular canal size|MP:0004249,abnormal crista ampullaris morphology|MP:0004269,abnormal optic cup morphology|MP:0004380,short frontal bone|MP:0004471,short nasal bone|MP:0004539,absent maxilla|MP:0005236,abnormal olfactory nerve morphology|MP:0005249,abnormal palatine bone morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005394,taste/olfaction phenotype|MP:0005545,abnormal lens development|MP:0008789,abnormal olfactory epithelium morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011862,decreased cranium length|MP:0030199,deviated nasal septum
MGI:3056366	Tg(Amy1TAg)354Knw	MP:0002020,increased tumor incidence|MP:0010264,increased hepatoma incidence|MP:0010344,increased hibernoma incidence
MGI:3043029	Tg(Amy1TAg)501Knw	MP:0001272,increased metastatic potential|MP:0003789,increased osteosarcoma incidence|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology
MGI:5645778	Tg(ANPEP)270Mmul	MP:0005387,immune system phenotype
MGI:5645779	Tg(ANPEP)861Mmul	MP:0005387,immune system phenotype
MGI:5582782	Tg(ANPEP)#Mmul	MP:0001885,mammary gland duct hyperplasia|MP:0006269,abnormal mammary gland growth during pregnancy
MGI:3053801	Tg(ANX6)2Agh	MP:0000266,abnormal heart morphology|MP:0000276,heart right ventricle hypertrophy|MP:0000711,thymus cortex hypoplasia|MP:0001544,abnormal cardiovascular system physiology|MP:0001855,abnormal atrial thrombosis|MP:0001856,myocarditis|MP:0002127,abnormal cardiovascular system morphology|MP:0002128,abnormal blood circulation|MP:0002726,abnormal pulmonary vein morphology|MP:0002754,dilated heart right ventricle|MP:0003140,dilated heart atrium|MP:0003141,cardiac fibrosis|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0006085,myocardium necrosis|MP:0011085,postnatal lethality, complete penetrance
MGI:3028848	Tg(aP2-SREBF1c)9884Reh	MP:0000005,increased brown adipose tissue amount|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0000691,enlarged spleen|MP:0000759,abnormal skeletal muscle morphology|MP:0001260,increased body weight|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0001547,abnormal lipid level|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0001783,decreased white adipose tissue amount|MP:0001860,liver inflammation|MP:0002079,increased circulating insulin level|MP:0002082,postnatal lethality|MP:0002108,abnormal muscle morphology|MP:0002628,hepatic steatosis|MP:0002970,abnormal white adipose tissue morphology|MP:0002971,abnormal brown adipose tissue morphology|MP:0002981,increased liver weight|MP:0003450,enlarged pancreas|MP:0003674,oxidative stress|MP:0005178,increased circulating cholesterol level|MP:0005283,increased unsaturated fatty acids level|MP:0005331,insulin resistance|MP:0005375,adipose tissue phenotype|MP:0006319,abnormal epididymal fat pad morphology|MP:0006320,abnormal interscapular fat pad morphology|MP:0008032,abnormal lipolysis|MP:0008561,decreased tumor necrosis factor secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008987,abnormal liver lobule morphology|MP:0009116,abnormal brown fat cell morphology|MP:0009119,increased brown fat cell size|MP:0009124,increased brown fat cell lipid droplet size|MP:0009289,decreased epididymal fat pad weight|MP:0009294,increased interscapular fat pad weight|MP:0009355,increased liver triglyceride level|MP:0009625,abnormal abdominal lymph node morphology|MP:0010378,increased respiratory quotient|MP:0010951,abnormal lipid oxidation|MP:0010954,abnormal cellular respiration|MP:0010957,abnormal aerobic respiration|MP:0013279,increased fasting circulating glucose level|MP:0020102,increased hepatic glucose production|MP:0020582,increased ceramide level|MP:0020583,decreased ceramide level
MGI:3640522	Tg(APCS-Ifng)5Imeg	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0000598,abnormal liver morphology|MP:0001570,abnormal circulating enzyme level|MP:0001856,myocarditis|MP:0001860,liver inflammation|MP:0001869,pancreas inflammation|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002941,increased circulating alanine transaminase level|MP:0003333,liver fibrosis|MP:0005140,decreased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0008617,increased circulating interleukin-12 level|MP:0008713,abnormal cytokine level|MP:0009416,cardiac muscle degeneration|MP:0009418,cardiac muscle atrophy|MP:0010019,liver vascular congestion|MP:0011925,abnormal heart echocardiography feature|MP:0031301,chronic liver inflammation
MGI:3039276	Tg(Apcs-Lep)1Yog	MP:0000601,small liver|MP:0001262,decreased body weight|MP:0001547,abnormal lipid level|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0002078,abnormal glucose homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0004016,decreased bone mass|MP:0005449,abnormal food intake|MP:0005560,decreased circulating glucose level|MP:0008852,retina neovascularization|MP:0009172,small pancreatic islets|MP:0009356,decreased liver triglyceride level|MP:0010398,decreased liver glycogen level
MGI:5550147	Tg(APCS-RARRES2)9Yktk	MP:0003058,increased insulin secretion|MP:0005292,improved glucose tolerance
MGI:6197466	Tg(APCS-Tnfsf11*)#aKhs	MP:0000061,fragile skeleton|MP:0000066,osteoporosis|MP:0001786,skin edema|MP:0002968,increased circulating alkaline phosphatase level|MP:0004982,abnormal osteoclast morphology|MP:0004984,increased osteoclast cell number|MP:0004991,decreased bone strength|MP:0004992,increased bone resorption|MP:0010873,decreased trabecular bone mass|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0013590,enlarged thymus medulla|MP:0013639,decreased bone stiffness|MP:0020010,decreased bone mineral density of femur
MGI:6198355	Tg(APCS-Tnfsf11*)#bKhs	MP:0000066,osteoporosis|MP:0010873,decreased trabecular bone mass
MGI:3052540	Tg(APOA1)1Rub	MP:0000184,abnormal circulating HDL cholesterol level|MP:0001545,abnormal hematopoietic system physiology|MP:0001547,abnormal lipid level|MP:0001556,increased circulating HDL cholesterol level|MP:0002118,abnormal lipid homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0003192,increased cholesterol efflux|MP:0004809,increased hematopoietic stem cell number|MP:0004810,decreased hematopoietic stem cell number|MP:0004951,abnormal spleen weight|MP:0005178,increased circulating cholesterol level|MP:0005341,decreased susceptibility to atherosclerosis|MP:0005376,homeostasis/metabolism phenotype|MP:0008613,abnormal circulating interleukin-17 level
MGI:3614555	Tg(APOA1)427Bres	MP:0005416,abnormal circulating protein level
MGI:3052796	Tg(Apoa2)1Lus	MP:0000182,increased circulating LDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0002118,abnormal lipid homeostasis|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005338,atherosclerotic lesions
MGI:3052677	Tg(APOA2)3Rub	MP:0000186,decreased circulating HDL cholesterol level|MP:0002118,abnormal lipid homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level
MGI:3609254	Tg(APOA5)1Hgc	MP:0002644,decreased circulating triglyceride level|MP:0005146,decreased circulating VLDL cholesterol level
MGI:2448678	Tg(APOB)1102Sgy	MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology|MP:0005278,abnormal cholesterol homeostasis|MP:0006238,abnormal choriocapillaris morphology
MGI:2183814	Tg(APOB)11Rub	MP:0000182,increased circulating LDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:2183816	Tg(APOB)1Rub	MP:0002169,no abnormal phenotype detected
MGI:2447788	Tg(APOC1)1Bres	MP:0000182,increased circulating LDL cholesterol level|MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0002118,abnormal lipid homeostasis|MP:0003975,increased circulating VLDL triglyceride level|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0008033,impaired lipolysis
MGI:1926379	Tg(APOC1)1Lmh	MP:0000010,abnormal abdominal fat pad morphology|MP:0000274,enlarged heart|MP:0000376,folliculitis|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000599,enlarged liver|MP:0000649,sebaceous gland atrophy|MP:0000691,enlarged spleen|MP:0001192,scaly skin|MP:0001194,dermatitis|MP:0001200,thick skin|MP:0001212,skin lesions|MP:0001219,thick epidermis|MP:0001220,epidermal necrosis|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001245,thick dermal layer|MP:0001265,decreased body size|MP:0001345,Meibomian gland atrophy|MP:0001412,excessive scratching|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002092,abnormal eye morphology|MP:0002497,increased IgE level|MP:0002796,impaired skin barrier function|MP:0003427,parakeratosis|MP:0003853,dry skin|MP:0003975,increased circulating VLDL triglyceride level|MP:0004947,skin inflammation|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0008764,increased mast cell degranulation|MP:0008843,absent subcutaneous adipose tissue|MP:0009795,epidermal spongiosis|MP:0010072,increased pruritus|MP:0012328,decreased circulating factor VIII level
MGI:1926380	Tg(APOC1)3Lmh	MP:0000414,alopecia|MP:0000649,sebaceous gland atrophy|MP:0001192,scaly skin|MP:0001200,thick skin|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002092,abnormal eye morphology|MP:0003853,dry skin|MP:0003975,increased circulating VLDL triglyceride level|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0010072,increased pruritus
MGI:3054893	Tg(APOC2)2Bres	MP:0001552,increased circulating triglyceride level|MP:0002118,abnormal lipid homeostasis|MP:0003975,increased circulating VLDL triglyceride level|MP:0003982,increased cholesterol level
MGI:3703623	Tg(APOC3)2674Bres	MP:0001552,increased circulating triglyceride level|MP:0002118,abnormal lipid homeostasis|MP:0003975,increased circulating VLDL triglyceride level
MGI:3703621	Tg(APOC3)2721Bres	MP:0000186,decreased circulating HDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0003975,increased circulating VLDL triglyceride level
MGI:3703618	Tg(APOC3)3707Bres	MP:0001552,increased circulating triglyceride level|MP:0005178,increased circulating cholesterol level|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype
MGI:3696684	Tg(APOE-ABCA1)30Ssf	MP:0001556,increased circulating HDL cholesterol level|MP:0003192,increased cholesterol efflux|MP:0003980,increased circulating phospholipid level|MP:0005178,increased circulating cholesterol level|MP:0005317,increased triglyceride level|MP:0010027,increased liver cholesterol level|MP:0010331,abnormal apolipoprotein level|MP:0010333,abnormal circulating apolipoprotein E level
MGI:4438467	Tg(APOE-ABCG1)1Ssf	MP:0000186,decreased circulating HDL cholesterol level|MP:0004777,abnormal phospholipid level|MP:0010027,increased liver cholesterol level
MGI:5519979	Tg(APOE-Adipoq)#Kry	MP:0004016,decreased bone mass|MP:0004989,decreased osteoblast cell number|MP:0010878,increased trabecular bone volume|MP:0020040,decreased bone ossification|MP:0030969,increased circulating adiponectin level|MP:0030985,decreased circulating osteocalcin level
MGI:3611784	Tg(APOE-ANGPTL4)1Akos	MP:0001552,increased circulating triglyceride level|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005375,adipose tissue phenotype|MP:0011579,decreased lipoprotein lipase activity
MGI:3045598	Tg(APOE-Artn)1Wss	MP:0000639,abnormal adrenal gland morphology|MP:0001034,abnormal parasympathetic ganglion morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0002031,increased adrenal gland tumor incidence|MP:0002751,abnormal autonomic nervous system morphology|MP:0008289,abnormal adrenal medulla morphology
MGI:3775623	Tg(APOE-CYP3A4)A1Nki	MP:0002169,no abnormal phenotype detected
MGI:3701768	Tg(APOE-Cyp7a1)1Road	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0004789,increased bile salt level|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005317,increased triglyceride level|MP:0010331,abnormal apolipoprotein level
MGI:3720375	Tg(APOE-DGAT1)1Far	MP:0001547,abnormal lipid level|MP:0001860,liver inflammation|MP:0005280,abnormal fatty acids level|MP:0005376,homeostasis/metabolism phenotype|MP:0009355,increased liver triglyceride level
MGI:3720367	Tg(APOE-DGAT2)1Far	MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0001547,abnormal lipid level|MP:0001860,liver inflammation|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002941,increased circulating alanine transaminase level|MP:0005280,abnormal fatty acids level|MP:0005317,increased triglyceride level|MP:0005343,increased circulating aspartate transaminase level|MP:0005376,homeostasis/metabolism phenotype
MGI:3720356	Tg(APOE-DGAT2)24Far	MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0001547,abnormal lipid level|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002941,increased circulating alanine transaminase level|MP:0005280,abnormal fatty acids level|MP:0005317,increased triglyceride level|MP:0005343,increased circulating aspartate transaminase level|MP:0005376,homeostasis/metabolism phenotype
MGI:4354167	Tg(Apoe-Fgf21)1Sakl	MP:0003383,abnormal gluconeogenesis|MP:0005289,increased oxygen consumption|MP:0010400,increased liver glycogen level
MGI:5465569	Tg(APOE-FGF23*R176Q)#Ack	MP:0000063,decreased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000445,short snout|MP:0000592,short tail|MP:0001732,postnatal growth retardation|MP:0002896,abnormal bone mineralization|MP:0002904,increased circulating parathyroid hormone level|MP:0002986,decreased urine calcium level|MP:0003112,enlarged parathyroid gland|MP:0003432,increased activity of parathyroid|MP:0004174,abnormal spine curvature|MP:0004985,decreased osteoclast cell number|MP:0004993,decreased bone resorption|MP:0006395,abnormal epiphyseal plate morphology|MP:0006431,abnormal fibrocartilage morphology|MP:0009445,osteomalacia|MP:0010110,abnormal renal phosphate reabsorption|MP:0010111,abnormal renal calcium reabsorption|MP:0010877,abnormal trabecular bone volume|MP:0010924,abnormal osteoid morphology|MP:0011228,abnormal vitamin D level|MP:0011584,increased alkaline phosphatase activity|MP:0013941,abnormal enthesis morphology|MP:0013942,enthesitis
MGI:3768068	Tg(APOE_i3*,APOC1)2Lmh	MP:0000182,increased circulating LDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005338,atherosclerotic lesions|MP:0005339,increased susceptibility to atherosclerosis|MP:0006083,abnormal blood vessel elastic tissue morphology
MGI:3039272	Tg(Apoe-Lep)1Kry	MP:0004016,decreased bone mass|MP:0005449,abnormal food intake|MP:0008271,abnormal bone ossification|MP:0010025,decreased total body fat amount
MGI:3039273	Tg(Apoe-Lepr)1Kry	MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype
MGI:3799059	Tg(APOE-NPC1L1)20Lqyu	MP:0003982,increased cholesterol level|MP:0004773,abnormal bile composition|MP:0005178,increased circulating cholesterol level
MGI:3691618	Tg(APOE-PCSK9)1Jdh	MP:0000182,increased circulating LDL cholesterol level
MGI:4943505	Tg(Apoe-Pcsk9*H229A)#Prat	MP:0005376,homeostasis/metabolism phenotype
MGI:4943504	Tg(Apoe-Pcsk9)#Prat	MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:5004809	Tg(APOE-rtTA*M2,tetO-Rgs16)#Tmw	MP:0001552,increased circulating triglyceride level|MP:0002628,hepatic steatosis|MP:0003458,decreased circulating ketone body level|MP:0005179,decreased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0009355,increased liver triglyceride level|MP:0014172,decreased fatty acid oxidation
MGI:4818467	Tg(APOE-SGMS2)#Jia	MP:0005416,abnormal circulating protein level|MP:0009823,abnormal sphingomyelin level|MP:0010080,abnormal hepatocyte physiology
MGI:3772657	Tg(APOM)HCchr	MP:0001552,increased circulating triglyceride level|MP:0003980,increased circulating phospholipid level|MP:0005178,increased circulating cholesterol level
MGI:3772656	Tg(APOM)NCchr	MP:0005376,homeostasis/metabolism phenotype
MGI:2183639	Tg(App)1874Kha	MP:0001362,abnormal anxiety-related response|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology
MGI:2183649	Tg(APP)6209Kha	MP:0000604,amyloidosis|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology|MP:0003329,amyloid beta deposits|MP:0010768,mortality/aging
MGI:2447334	Tg(APP695)3Dbo	MP:0001392,abnormal locomotor behavior|MP:0001488,increased startle reflex|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003329,amyloid beta deposits|MP:0003631,nervous system phenotype
MGI:2447591	Tg(APP)8.9Btla	MP:0001303,abnormal lens morphology|MP:0001364,decreased anxiety-related response|MP:0001415,increased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0002840,abnormal lens fiber morphology|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0005391,vision/eye phenotype|MP:0014365,impaired short-term object recognition memory
MGI:3720083	Tg(APP-App*R609D*K612E)7Vln	MP:0002882,abnormal neuron morphology|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration
MGI:3510594	Tg(APPSw)40Btla	MP:0003329,amyloid beta deposits|MP:0003631,nervous system phenotype
MGI:2183650	Tg(APPSWE)2123Kha	MP:0001417,decreased exploration in new environment|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology
MGI:2385631	Tg(APPSWE)2576Kha	MP:0000604,amyloidosis|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002128,abnormal blood circulation|MP:0002797,increased thigmotaxis|MP:0002807,abnormal eye blink conditioning behavior|MP:0003329,amyloid beta deposits|MP:0003354,astrocytosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005386,behavior/neurological phenotype|MP:0008432,abnormal long-term spatial reference memory|MP:0008918,microgliosis|MP:0009618,increased brain zinc level
MGI:3524957	Tg(APPswe,PSEN1dE9)85Dbo	MP:0000255,blood vessel congestion|MP:0000604,amyloidosis|MP:0000947,convulsive seizures|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001552,increased circulating triglyceride level|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002206,abnormal CNS synaptic transmission|MP:0003224,neuron degeneration|MP:0003329,amyloid beta deposits|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0003635,abnormal synaptic transmission|MP:0004000,impaired passive avoidance behavior|MP:0004254,cerebral amyloid angiopathy|MP:0004769,abnormal synaptic vesicle morphology|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005394,taste/olfaction phenotype|MP:0005402,abnormal action potential|MP:0005405,axon degeneration|MP:0008414,abnormal spatial reference memory|MP:0008462,abnormal medium spiny neuron morphology|MP:0008918,microgliosis|MP:0008948,decreased neuron number|MP:0009454,impaired contextual conditioning behavior|MP:0009538,abnormal synapse morphology|MP:0009942,abnormal olfactory bulb granule cell morphology|MP:0009947,abnormal olfactory bulb external plexiform layer morphology|MP:0011941,increased fluid intake|MP:0012307,impaired spatial learning|MP:0014370,impaired spatial working memory|MP:0020360,abnormal asymmetric synapse morphology|MP:0020361,abnormal symmetric synapse morphology|MP:0020508,decreased dendritic spine density|MP:0020551,abnormal postsynaptic density morphology|MP:0020852,abnormal olfactory behavior|MP:0031384,impaired blood-brain barrier function
MGI:3693208	Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas	MP:0000754,paresis|MP:0000807,abnormal hippocampus morphology|MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0001364,decreased anxiety-related response|MP:0001385,pup cannibalization|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0001847,brain inflammation|MP:0001898,abnormal long-term depression|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0002882,abnormal neuron morphology|MP:0003224,neuron degeneration|MP:0003329,amyloid beta deposits|MP:0003354,astrocytosis|MP:0003461,abnormal response to novel object|MP:0005103,abnormal retina pigmentation|MP:0005150,cachexia|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology|MP:0008287,abnormal subiculum morphology|MP:0008414,abnormal spatial reference memory|MP:0008916,abnormal astrocyte physiology|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0009974,decreased cerebral cortex pyramidal cell number|MP:0010047,axonal spheroids|MP:0012307,impaired spatial learning|MP:0014370,impaired spatial working memory|MP:0020448,increased microglial cell activation
MGI:3693359	Tg(APPSwLon)96Btla	MP:0003329,amyloid beta deposits|MP:0003631,nervous system phenotype
MGI:2151935	Tg(APPV717F)109Ili	MP:0000604,amyloidosis|MP:0000812,abnormal dentate gyrus morphology|MP:0001463,abnormal spatial learning|MP:0002083,premature death|MP:0002183,gliosis|MP:0003214,neurofibrillary tangles|MP:0003329,amyloid beta deposits|MP:0003631,nervous system phenotype|MP:0008415,abnormal neurite morphology|MP:0031391,increased locomotor activity
MGI:2183645	Tg(APPV717I)1130Kha	MP:0001921,reduced fertility|MP:0002065,abnormal fear/anxiety-related behavior|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology|MP:0010768,mortality/aging
MGI:3712435	Tg(Aqp2-cre)1Dek	MP:0002169,no abnormal phenotype detected
MGI:5000269	Tg(AR*100Q)#Als	MP:0000938,motor neuron degeneration|MP:0003631,nervous system phenotype
MGI:5000265	Tg(AR*100Q)C25Als	MP:0000160,kyphosis|MP:0000598,abnormal liver morphology|MP:0000747,muscle weakness|MP:0000755,hindlimb paralysis|MP:0000938,motor neuron degeneration|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002108,abnormal muscle morphology|MP:0009417,skeletal muscle atrophy
MGI:5000266	Tg(AR*100Q)C32Als	MP:0000755,hindlimb paralysis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0009417,skeletal muscle atrophy
MGI:5000270	Tg(AR*20Q)C3AAls	MP:0002169,no abnormal phenotype detected
MGI:5000267	Tg(AR*20Q)C9BAls	MP:0002169,no abnormal phenotype detected
MGI:2389409	Tg(ARR2/Pbsn-FGF8)3Prb	MP:0000659,prostate gland hyperplasia|MP:0001158,abnormal prostate gland morphology|MP:0001846,increased inflammatory response|MP:0003608,prostate gland inflammation|MP:0009219,increased prostate intraepithelial neoplasia incidence
MGI:3039371	Tg(Arr2/Pbsn-FGFR1K656E)1Wmck	MP:0001922,reduced male fertility|MP:0009219,increased prostate intraepithelial neoplasia incidence
MGI:3785495	Tg(ARR2/Pbsn-MYC)7Key	MP:0004958,enlarged prostate gland|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0010357,increased prostate gland tumor incidence
MGI:5572816	Tg(ASL1/Cryaa-Ralbp1)24Yca	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001306,small lens|MP:0001307,fused cornea and lens|MP:0002092,abnormal eye morphology|MP:0005545,abnormal lens development|MP:0020849,abnormal actin cytoskeleton morphology
MGI:3834571	Tg(ATN1*)Drm21Stsu	MP:0002882,abnormal neuron morphology|MP:0005386,behavior/neurological phenotype|MP:0005621,abnormal cell physiology
MGI:3834570	Tg(ATN1*)Q129Stsu	MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001473,reduced long-term potentiation|MP:0001762,polyuria|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002206,abnormal CNS synaptic transmission|MP:0002272,abnormal nervous system electrophysiology|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002918,abnormal paired-pulse facilitation|MP:0002919,enhanced paired-pulse facilitation|MP:0002988,decreased urine osmolality|MP:0003216,absence seizures|MP:0004008,abnormal GABA-mediated receptor currents|MP:0004191,neuronal intranuclear inclusions|MP:0005424,jerky movement|MP:0005611,decreased circulating antidiuretic hormone level|MP:0008998,decreased blood osmolality|MP:0011941,increased fluid intake
MGI:3849083	Tg(Atoh1-cre)1Mhos	MP:0002169,no abnormal phenotype detected
MGI:3615691	Tg(Atoh1-cre/Esr1*)14Fsh	MP:0002169,no abnormal phenotype detected
MGI:5702608	Tg(Atoh1-ptxA,-mCherry)1Cayo	MP:0004399,abnormal cochlear outer hair cell morphology|MP:0030961,abnormal outer hair cell kinocilium location or orientation
MGI:4356322	Tg(Atp1a3)1Stcl	MP:0004924,abnormal behavior|MP:0020421,increased freezing behavior
MGI:3530509	Tg(Atp4b-TAg)#Jig	MP:0002038,increased carcinoma incidence|MP:0004139,abnormal gastric parietal cell morphology|MP:0005211,increased stomach mucosa thickness|MP:0005213,gastric metaplasia|MP:0010301,increased stomach tumor incidence|MP:0010787,gastric cyst
MGI:5697198	Tg(ATXN2*72Q)#Plt	MP:0000877,abnormal Purkinje cell morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001405,impaired coordination
MGI:3838156	Tg(ATXN3*)67.2Cce	MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002183,gliosis|MP:0004191,neuronal intranuclear inclusions|MP:0008489,slow postnatal weight gain
MGI:3838155	Tg(ATXN3*)84.2Cce	MP:0000745,tremors|MP:0000811,hippocampal neuron degeneration|MP:0000876,Purkinje cell degeneration|MP:0000880,decreased Purkinje cell number|MP:0000921,demyelination|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002183,gliosis|MP:0003224,neuron degeneration|MP:0004191,neuronal intranuclear inclusions|MP:0005356,positive geotaxis|MP:0005498,hyporesponsive to tactile stimuli|MP:0008489,slow postnatal weight gain
MGI:1926807	Tg(Av-E1A)901Gpd	MP:0000383,abnormal hair follicle orientation|MP:0000388,absent hair follicle inner root sheath|MP:0000417,short hair|MP:0001219,thick epidermis
MGI:1926809	Tg(Av-E1A)906Gpd	MP:0000383,abnormal hair follicle orientation|MP:0000388,absent hair follicle inner root sheath|MP:0000417,short hair|MP:0001219,thick epidermis
MGI:5292346	Tg(Avil-cre)1Phep	MP:0005386,behavior/neurological phenotype
MGI:5312922	Tg(Avil-icre/ERT2)AJwo	MP:0005386,behavior/neurological phenotype
MGI:3497939	Tg(AZIP/F)1Vsn	MP:0001175,abnormal lung morphology|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001426,polydipsia|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001559,hyperglycemia|MP:0001732,postnatal growth retardation|MP:0001762,polyuria|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0003058,increased insulin secretion|MP:0005491,pancreatic islet hyperplasia|MP:0005560,decreased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0006086,decreased body mass index|MP:0009113,increased pancreatic beta cell mass|MP:0009355,increased liver triglyceride level|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011819,increased pancreatic beta cell proliferation
MGI:3689387	Tg(B19-RNAi:Il3)241Ckn	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000755,hindlimb paralysis|MP:0001393,ataxia|MP:0001394,circling|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0003132,increased pre-B cell number|MP:0005150,cachexia|MP:0008697,decreased interleukin-3 secretion
MGI:5770329	Tg(B2M,HLA-B*27:05)56-3Trg	MP:0005387,immune system phenotype
MGI:3822832	Tg(B4galt1-Aurkb)1Saco	MP:0002169,no abnormal phenotype detected
MGI:3822833	Tg(B4galt1-Aurkb*K111R*L323I)1Saco	MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0002687,oligozoospermia|MP:0005169,abnormal male meiosis|MP:0006380,abnormal spermatid morphology|MP:0014634,decreased round spermatid number|MP:0014636,decreased elongated spermatid number
MGI:5825056	Tg(BAC144D14)5A2Masu	MP:0000005,increased brown adipose tissue amount|MP:0000189,hypoglycemia|MP:0001262,decreased body weight|MP:0002176,increased brain weight|MP:0002970,abnormal white adipose tissue morphology|MP:0005337,abnormal retroperitoneal fat pad morphology|MP:0005533,increased body temperature|MP:0006320,abnormal interscapular fat pad morphology|MP:0009127,increased brown fat cell number|MP:0009293,decreased inguinal fat pad weight|MP:0009294,increased interscapular fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0009431,decreased fetal weight|MP:0009674,decreased birth weight|MP:0011940,decreased food intake
MGI:5825057	Tg(BAC144D14)5D3Masu	MP:0000005,increased brown adipose tissue amount|MP:0000189,hypoglycemia|MP:0000837,abnormal hypothalamus morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0002635,reduced sensorimotor gating|MP:0002970,abnormal white adipose tissue morphology|MP:0005337,abnormal retroperitoneal fat pad morphology|MP:0005533,increased body temperature|MP:0006320,abnormal interscapular fat pad morphology|MP:0006325,impaired hearing|MP:0009127,increased brown fat cell number|MP:0009142,decreased prepulse inhibition|MP:0009293,decreased inguinal fat pad weight|MP:0009294,increased interscapular fat pad weight|MP:0009299,decreased mesenteric fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0009431,decreased fetal weight|MP:0009674,decreased birth weight|MP:0020325,abnormal beige fat cell morphology|MP:0020379,abnormal sucrose solution preference
MGI:3057169	Tg(BAC54)36Jt	MP:0020470,shortened circadian behavior period
MGI:3697064	Tg(BAT-lacZ)3Picc	MP:0002169,no abnormal phenotype detected
MGI:1891501	Tg(BCL2)1Tsk	MP:0000417,short hair|MP:0000427,abnormal hair cycle|MP:0001224,abnormal keratinocyte apoptosis
MGI:3052827	Tg(BCL2)22Wehi	MP:0002144,abnormal B cell differentiation|MP:0002459,abnormal B cell physiology|MP:0005014,increased B cell number|MP:0005350,increased susceptibility to autoimmune disorder
MGI:3052945	Tg(BCL2)25Wehi	MP:0002144,abnormal B cell differentiation|MP:0002444,abnormal T cell physiology|MP:0005015,increased T cell number|MP:0008099,abnormal plasma cell differentiation
MGI:3052954	Tg(BCL2)36Wehi	MP:0002024,increased T cell derived lymphoma incidence|MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0002461,increased immunoglobulin level|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005153,abnormal B cell proliferation|MP:0005350,increased susceptibility to autoimmune disorder|MP:0008783,decreased B cell apoptosis
MGI:2448738	Tg(BCL2/IGH)1Tjd	MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology|MP:0002445,abnormal mononuclear cell differentiation|MP:0002459,abnormal B cell physiology|MP:0005014,increased B cell number|MP:0008478,increased spleen white pulp amount
MGI:2448740	Tg(BCL2/IGH)M23Tjd	MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology|MP:0002445,abnormal mononuclear cell differentiation|MP:0002459,abnormal B cell physiology|MP:0005014,increased B cell number|MP:0008478,increased spleen white pulp amount
MGI:1926365	Tg(BCL2L1)1Cbt	MP:0001204,decreased sensitivity to skin irradiation|MP:0003453,abnormal keratinocyte physiology
MGI:1926366	Tg(BCL2L1)2Cbt	MP:0001203,increased sensitivity to skin irradiation|MP:0009583,increased keratinocyte proliferation
MGI:3054960	Tg(BCL2OVARY)1Ah	MP:0001156,abnormal spermatogenesis|MP:0001934,increased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002784,abnormal Sertoli cell morphology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0006380,abnormal spermatid morphology|MP:0008872,abnormal physiological response to xenobiotic|MP:0009442,increased ovarian teratoma incidence|MP:0014052,increased male germ cell apoptosis|MP:0031016,decreased granulosa cell apoptosis|MP:0031421,increased superovulation rate
MGI:3582388	Tg(BCR/ABL)623Hkp	MP:0002023,increased B cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0010336,increased acute lymphoblastic leukemia incidence
MGI:1926642	Tg(Bdnf)1Kma	MP:0000973,abnormal cutaneous/subcutaneous mechanoreceptor morphology|MP:0000976,hyperinnervation of hair guard cells|MP:0000978,hyperinnervation of hair-tylotrich cells|MP:0000981,hyperinnervation of hair-down cells|MP:0000983,enlarged Meissner's corpuscles|MP:0000984,hyperinnervation of Meissner's corpuscle|MP:0000986,increased Merkel's receptor number|MP:0000987,hyperinnervation of Merkel's receptor
MGI:1891518	Tg(Bdnf)1Paus	MP:0000417,short hair|MP:0000427,abnormal hair cycle|MP:0000968,abnormal sensory neuron innervation pattern|MP:0000986,increased Merkel's receptor number|MP:0001007,abnormal sympathetic system morphology|MP:0001026,abnormal adrenergic neuron morphology|MP:0001199,thin skin|MP:0001219,thick epidermis|MP:0002184,abnormal innervation|MP:0002655,abnormal keratinocyte morphology
MGI:5758950	Tg(BEST1-HTRA1)44Ybf	MP:0005098,abnormal optic choroid morphology|MP:0005201,abnormal retina pigment epithelium morphology
MGI:5285549	Tg(BEST1-HTRA1)#Ybf	MP:0001004,abnormal retina photoreceptor morphology|MP:0003279,aneurysm|MP:0005098,abnormal optic choroid morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology|MP:0005546,choroidal neovascularization|MP:0006203,eye hemorrhage|MP:0006237,abnormal choroid vasculature morphology|MP:0008450,retina photoreceptor degeneration|MP:0008581,disorganized photoreceptor inner segment|MP:0008586,disorganized photoreceptor outer segment
MGI:3607175	Tg(Bglap2-Fhl2)#Rosc	MP:0005605,increased bone mass
MGI:4431210	Tg(Bglap2-Phex)1Ldq	MP:0002169,no abnormal phenotype detected
MGI:5796023	Tg(Bglap2-TAg)1Rkho	MP:0001272,increased metastatic potential|MP:0002083,premature death|MP:0003789,increased osteosarcoma incidence|MP:0010280,increased skeletal tumor incidence|MP:0014237,decreased tumor-free survival time
MGI:5516352	Tg(Bglap-Omd)1Kieg	MP:0000066,osteoporosis
MGI:2446540	Tg(BGLAP-PTN)1Thg	MP:0003109,short femur|MP:0010123,increased bone mineral content|MP:0014294,abnormal skeletal maturation|MP:0014296,delayed skeletal maturation|MP:0030278,thick neurocranium
MGI:2447712	Tg(BLG-STAT5A)15Itb	MP:0000627,abnormal mammary gland morphology|MP:0000628,abnormal mammary gland development|MP:0001846,increased inflammatory response|MP:0004047,abnormal milk composition|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0006270,abnormal mammary gland growth during lactation|MP:0006271,abnormal involution of the mammary gland|MP:0010173,increased mammary gland epithelial cell proliferation|MP:0010299,increased mammary gland tumor incidence
MGI:2447716	Tg(BLG-STAT5A)6Itb	MP:0000628,abnormal mammary gland development|MP:0004047,abnormal milk composition|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0006270,abnormal mammary gland growth during lactation|MP:0006271,abnormal involution of the mammary gland|MP:0010299,increased mammary gland tumor incidence|MP:0013781,abnormal mammary gland luminal epithelium morphology
MGI:1926357	Tg(BMP4)6Blh	MP:0000372,irregular coat pigmentation|MP:0000377,abnormal hair follicle morphology|MP:0000380,small hair follicles|MP:0000414,alopecia|MP:0000427,abnormal hair cycle|MP:0001244,thin dermal layer|MP:0001510,abnormal coat appearance|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002098,abnormal vibrissa morphology|MP:0005501,abnormal skin physiology|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3039067	Tg(C3-1-TAg)cJeg	MP:0000630,mammary gland hyperplasia|MP:0001167,prostate gland epithelial hyperplasia|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001884,mammary gland alveolar hyperplasia|MP:0001885,mammary gland duct hyperplasia|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0003607,abnormal prostate gland physiology|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0010357,increased prostate gland tumor incidence|MP:0011790,increased urethral gland adenocarcinoma incidence|MP:0011791,increased bulbourethral gland adenocarcinoma incidence
MGI:5776473	Tg(C9orf72*)450BLagi	MP:0001363,increased anxiety-related response|MP:0003240,loss of hippocampal neurons|MP:0008428,abnormal spatial working memory|MP:0011975,neuronal cytoplasmic inclusions|MP:0012307,impaired spatial learning
MGI:5919933	Tg(C9orf72)500Lpwr	MP:0000160,kyphosis|MP:0000753,paralysis|MP:0000811,hippocampal neuron degeneration|MP:0000876,Purkinje cell degeneration|MP:0000890,thin cerebellar molecular layer|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002064,seizures|MP:0002083,premature death|MP:0002108,abnormal muscle morphology|MP:0002229,neurodegeneration|MP:0002797,increased thigmotaxis|MP:0003354,astrocytosis|MP:0003993,abnormal ventral spinal root morphology|MP:0004100,abnormal spinal cord interneuron morphology|MP:0005405,axon degeneration|MP:0008911,induced hyperactivity|MP:0008918,microgliosis|MP:0009417,skeletal muscle atrophy|MP:0009434,paraparesis|MP:0010013,cerebral cortex pyramidal cell degeneration|MP:0014062,nervous system inclusion bodies
MGI:5618290	Tg(C9orf72_i2)8Lutzy	MP:0002169,no abnormal phenotype detected
MGI:5618284	Tg(C9orf72_i3)112Lutzy	MP:0003632,abnormal nervous system morphology|MP:0005386,behavior/neurological phenotype|MP:0005621,abnormal cell physiology
MGI:5566993	Tg(CAG-A4GALT)#Sais	MP:0002169,no abnormal phenotype detected
MGI:6402829	Tg(CAG-ACE2)AC63Ctkt	MP:0020949,increased susceptibility to Coronaviridae infection
MGI:6402828	Tg(CAG-ACE2)AC70Ctkt	MP:0001862,interstitial pneumonia|MP:0001864,vascular inflammation|MP:0001954,respiratory distress|MP:0008713,abnormal cytokine level|MP:0010943,abnormal bronchus epithelium morphology|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:3697400	Tg(CAG-Aes,-ALPP)1Lbe	MP:0002169,no abnormal phenotype detected
MGI:6196043	Tg(CAG-Alk*F1174L,-luc)60Jhsc	MP:0001272,increased metastatic potential|MP:0002039,increased neuroblastoma incidence|MP:0009078,adrenal gland hyperplasia
MGI:3841702	Tg(CAG-ANGPT1*)5Yo	MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003071,decreased vascular permeability|MP:0004007,abnormal lung vasculature morphology|MP:0005288,abnormal oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0010097,abnormal retina blood vessel morphology|MP:0010829,increased bronchioalveolar stem cell number|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012050,decreased susceptilbility to retina ischemic injury|MP:0012065,increased astrocyte number|MP:0012106,impaired exercise endurance
MGI:3579408	Tg(CAG-Angptl6)8.1Yo	MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001614,abnormal blood vessel morphology|MP:0001783,decreased white adipose tissue amount|MP:0002891,increased insulin sensitivity|MP:0002970,abnormal white adipose tissue morphology|MP:0004892,increased adiponectin level|MP:0005289,increased oxygen consumption|MP:0005418,abnormal circulating hormone level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0010025,decreased total body fat amount
MGI:3720041	Tg(CAG-APP)0304Shoj	MP:0003329,amyloid beta deposits|MP:0003631,nervous system phenotype|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0010214,abnormal circulating serum amyloid protein level
MGI:5461701	Tg(CAG-APPL1)#Ymli	MP:0001613,abnormal vasodilation|MP:0003026,decreased vasoconstriction|MP:0005590,increased vasodilation|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:3767715	Tg(CAG-AR*24Q)5-5Sobue	MP:0005386,behavior/neurological phenotype
MGI:3767716	Tg(CAG-AR*97Q)7-8Sobue	MP:0000752,dystrophic muscle|MP:0000937,abnormal motor neuron morphology|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0005150,cachexia
MGI:3697080	Tg(CAG-Bgeo,-Aes,-ALPP)1Lbe	MP:0002169,no abnormal phenotype detected
MGI:3505556	Tg(CAG-Bgeo/ALPP)1Lbe	MP:0011091,prenatal lethality, complete penetrance
MGI:3839915	Tg(CAG-Bgeo,-AlstR,-EGFP)192Gld	MP:0001406,abnormal gait|MP:0002206,abnormal CNS synaptic transmission
MGI:3832033	Tg(CAG-Bgeo,-Fgf4)1Mrt	MP:0001732,postnatal growth retardation|MP:0002160,abnormal reproductive system morphology|MP:0004083,polysyndactyly|MP:0004574,broad limb buds|MP:0006279,abnormal limb development|MP:0006280,abnormal digit development|MP:0008919,fused tarsal bones|MP:0009728,abnormal calcaneum morphology|MP:0013396,eyelid hyperplasia
MGI:4462365	Tg(CAG-Bgeo,-Hras1,-EGFP)#Ichi	MP:0001785,edema|MP:0004106,lymphatic vessel hyperplasia|MP:0005385,cardiovascular system phenotype|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:4453330	Tg(CAG-Bgeo/Lhx2,-GFP)#Lcar	MP:0000427,abnormal hair cycle
MGI:5501130	Tg(CAG-Bgeo,-Nkx6-1,-EGFP)#Msan	MP:0003645,increased pancreatic beta cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0009177,decreased pancreatic alpha cell number|MP:0009181,decreased pancreatic delta cell number|MP:0009191,decreased pancreatic epsilon cell number
MGI:3829033	Tg(CAG-Bgeo,-Spry2,-ALPP)1Mrt	MP:0000088,short mandible|MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0002633,persistent truncus arteriosus|MP:0005385,cardiovascular system phenotype|MP:0006126,abnormal cardiac outflow tract development|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010484,bicuspid aortic valve
MGI:3696852	Tg(CAG-Bgeo,-Tle1,-ALPP)1Lbe	MP:0002027,increased lung adenocarcinoma incidence
MGI:4442215	Tg(CAG-Bgeo,-tsA58T)T26Ichi	MP:0002083,premature death|MP:0009143,abnormal pancreatic duct morphology|MP:0009146,abnormal pancreatic acinar cell morphology
MGI:5825322	Tg(CAG-Bhlha15)1Skz	MP:0005379,endocrine/exocrine gland phenotype
MGI:6110825	Tg(CAG-Bmp4,-EGFP)1Ypc	MP:0000103,nasal bone hypoplasia|MP:0000111,cleft palate|MP:0000445,short snout|MP:0000454,abnormal jaw morphology|MP:0000457,maxilla hypoplasia|MP:0000460,mandible hypoplasia|MP:0001302,eyelids open at birth|MP:0004869,frontal bone hypoplasia|MP:0004911,absent mandibular condyloid process|MP:0004912,absent mandibular coronoid process|MP:0004913,absent mandibular angle|MP:0005579,absent outer ear|MP:0009655,abnormal secondary palate development|MP:0009884,palatal shelf fusion with tongue or mandible|MP:0009888,palatal shelves fail to meet at midline|MP:0011210,abnormal temporomandibular joint morphology|MP:0011710,enhanced osteoblast differentiation|MP:0030085,syngnathia|MP:0030268,agnathia|MP:0031462,decreased palatal shelf size
MGI:5473821	Tg(CAG-Bmpr1a*,-lacZ)1Nobs	MP:0000074,abnormal neurocranium morphology|MP:0000085,large anterior fontanelle|MP:0000102,abnormal nasal bone morphology|MP:0000108,midline facial cleft|MP:0000111,cleft palate|MP:0000373,belly spot|MP:0001300,ocular hypertelorism|MP:0001436,abnormal suckling behavior|MP:0002169,no abnormal phenotype detected|MP:0002239,abnormal nasal septum morphology|MP:0003743,abnormal facial morphology|MP:0003935,abnormal craniofacial development|MP:0004377,small frontal bone|MP:0008271,abnormal bone ossification|MP:0008770,decreased survivor rate|MP:0008797,facial cleft|MP:0010402,ventricular septal defect|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011260,abnormal head mesenchyme morphology|MP:0011266,abnormal frontonasal mesenchyme morphology|MP:0030066,short face
MGI:3640481	Tg(CAG-Btc)2Ewo	MP:0000274,enlarged heart|MP:0000276,heart right ventricle hypertrophy|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000441,increased cranium width|MP:0001175,abnormal lung morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001183,overexpanded pulmonary alveolus|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001575,cyanosis|MP:0001625,cardiac hypertrophy|MP:0001954,respiratory distress|MP:0002092,abnormal eye morphology|MP:0002113,abnormal skeleton development|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002745,abnormal atrioventricular valve morphology|MP:0002833,increased heart weight|MP:0002840,abnormal lens fiber morphology|MP:0002981,increased liver weight|MP:0003727,abnormal retina layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0004471,short nasal bone|MP:0004855,increased ovary weight|MP:0004952,increased spleen weight|MP:0005241,abnormal retina ganglion layer morphology|MP:0005630,increased lung weight|MP:0008489,slow postnatal weight gain|MP:0008511,thin retina inner nuclear layer|MP:0008525,decreased cranium height|MP:0009109,decreased pancreas weight|MP:0010620,thick mitral valve|MP:0010909,pulmonary alveolar hemorrhage|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011965,decreased total retina thickness|MP:0031511,globular heart
MGI:3640482	Tg(CAG-Btc)4Ewo	MP:0000274,enlarged heart|MP:0000276,heart right ventricle hypertrophy|MP:0001175,abnormal lung morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001183,overexpanded pulmonary alveolus|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002092,abnormal eye morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002745,abnormal atrioventricular valve morphology|MP:0002833,increased heart weight|MP:0002981,increased liver weight|MP:0004855,increased ovary weight|MP:0004952,increased spleen weight|MP:0005630,increased lung weight|MP:0009109,decreased pancreas weight|MP:0010620,thick mitral valve|MP:0010909,pulmonary alveolar hemorrhage|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031511,globular heart
MGI:6343247	Tg(CAG-C1qtnf6)#Yiw	MP:0001805,decreased IgG level|MP:0002472,impaired complement alternative pathway|MP:0003436,decreased susceptibility to induced arthritis|MP:0005367,renal/urinary system phenotype|MP:0011566,abnormal complement protein level
MGI:6108898	Tg(CAG-Calr)#Mlk	MP:0000274,enlarged heart|MP:0001262,decreased body weight|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003896,prolonged PR interval|MP:0004070,abnormal P wave|MP:0005140,decreased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006138,congestive heart failure|MP:0010394,decreased QRS amplitude|MP:0010505,abnormal T wave|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0011925,abnormal heart echocardiography feature
MGI:6114990	Tg(CAG-cat,-ALOX15)1868Klv	MP:0009219,increased prostate intraepithelial neoplasia incidence
MGI:6196857	Tg(CAG-cat,-Creg1)#Yal	MP:0001570,abnormal circulating enzyme level|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002727,decreased circulating insulin level|MP:0002942,decreased circulating alanine transaminase level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003402,decreased liver weight|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005560,decreased circulating glucose level|MP:0005632,decreased circulating aspartate transaminase level|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level|MP:0010360,decreased liver free fatty acids level|MP:0010400,increased liver glycogen level
MGI:5298093	Tg(CAG-cat,-Dcn*)#Debi	MP:0001314,cornea opacity|MP:0003094,abnormal cornea posterior stroma morphology|MP:0005300,abnormal cornea stroma morphology
MGI:6197022	Tg(CAG-cat,-Dusp14)4Lyg	MP:0000274,enlarged heart|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0004486,decreased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005630,increased lung weight|MP:0010633,myocardium hypertrophy
MGI:5688534	Tg(CAG-cat,-Il18)#Thos	MP:0001862,interstitial pneumonia|MP:0002270,abnormal pulmonary alveolus morphology|MP:0008566,increased interferon-gamma secretion
MGI:3822131	Tg(CAG-cat,-Map2k1*)243Rbns	MP:0003808,increased atrioventricular cushion size|MP:0011091,prenatal lethality, complete penetrance
MGI:3778826	Tg(CAG-cat,-Nanos2)1Ysa	MP:0005168,abnormal female meiosis|MP:0006361,abnormal female germ cell morphology
MGI:3702441	Tg(CAG-cat,-Notch1)1Ysa	MP:0000267,abnormal heart development|MP:0000274,enlarged heart|MP:0000277,abnormal heart shape|MP:0000278,abnormal myocardial fiber morphology|MP:0000281,abnormal interventricular septum morphology|MP:0000297,abnormal atrioventricular cushion morphology|MP:0002753,dilated heart left ventricle|MP:0003649,decreased heart right ventricle size|MP:0004067,abnormal trabecula carnea morphology|MP:0004090,abnormal sarcomere morphology|MP:0005294,abnormal heart ventricle morphology|MP:0005329,abnormal myocardium layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014730,abnormal myocardial fiber myofibril morphology
MGI:3822130	Tg(CAG-cat,-Ptpn11)1Rbns	MP:0005385,cardiovascular system phenotype
MGI:5828597	Tg(CAG-cat,-Ptpn11*Q510E)#Krnz	MP:0000297,abnormal atrioventricular cushion morphology|MP:0002745,abnormal atrioventricular valve morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3822129	Tg(CAG-cat,-Ptpn11*Q97R)1Rbns	MP:0000024,lowered ear position|MP:0000085,large anterior fontanelle|MP:0000088,short mandible|MP:0000107,abnormal frontal bone morphology|MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000601,small liver|MP:0001255,decreased body height|MP:0001262,decreased body weight|MP:0001300,ocular hypertelorism|MP:0001544,abnormal cardiovascular system physiology|MP:0001654,hepatic necrosis|MP:0001698,decreased embryo size|MP:0001732,postnatal growth retardation|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002082,postnatal lethality|MP:0002233,abnormal nose morphology|MP:0002950,abnormal neural crest cell migration|MP:0002952,ventricular cardiomyopathy|MP:0003808,increased atrioventricular cushion size|MP:0004200,decreased fetal size|MP:0005170,cleft upper lip|MP:0008525,decreased cranium height|MP:0010402,ventricular septal defect|MP:0010588,conotruncal ridge hyperplasia|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012077,webbed neck|MP:0012269,nuchal edema|MP:0030166,increased inner canthal distance|MP:0030189,broad snout|MP:0031449,abnormal nasal cartilage morphology
MGI:3813723	Tg(CAG-cat,-TBX3)1Vmc	MP:0000267,abnormal heart development|MP:0001544,abnormal cardiovascular system physiology|MP:0003140,dilated heart atrium|MP:0003141,cardiac fibrosis|MP:0009732,ventricular premature beat|MP:0010500,myocardium hypoplasia|MP:0010502,ventricle myocardium hypoplasia|MP:0010546,abnormal subendocardium layer morphology
MGI:7628235	Tg(CAG-cat,-Tcf25)1Xdgz	MP:0004486,decreased response of heart to induced stress
MGI:6693494	Tg(CAG-cat,-Trim8)4Holi	MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010768,mortality/aging
MGI:5425605	Tg(CAG-cat,-Twist1)1Dbsp	MP:0000547,short limbs|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0011722,abnormal ossification involved in bone maturation
MGI:2447840	Tg(CAG-CD81)1Uem	MP:0002169,no abnormal phenotype detected
MGI:5484747	Tg(CAG-Cdkal1)#Tkyo	MP:0001260,increased body weight
MGI:5614052	Tg(CAG-CHRM3*,-mCitrine)1Ute	MP:0002169,no abnormal phenotype detected
MGI:5301371	Tg(CAG-COL4A3BP)#Jsau	MP:0000733,abnormal muscle development|MP:0012106,impaired exercise endurance
MGI:6384937	Tg(CAG-COX7A2L)#Sinos	MP:0003060,increased aerobic running capacity|MP:0005289,increased oxygen consumption|MP:0005375,adipose tissue phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008963,increased carbon dioxide production|MP:0011703,increased fibroblast proliferation
MGI:2182767	Tg(CAG-cre/Esr1*)5Amc	MP:0000471,abnormal stomach epithelium morphology|MP:0001663,abnormal digestive system physiology|MP:0002006,neoplasm|MP:0004139,abnormal gastric parietal cell morphology|MP:0006042,increased apoptosis|MP:0013578,abnormal stomach glandular region morphology
MGI:5291515	Tg(CAG-cre/Esr1*)67Csk	MP:0005367,renal/urinary system phenotype
MGI:4410298	Tg(CAG-CYP27A1)23Etl	MP:0000642,enlarged adrenal glands|MP:0003947,abnormal cholesterol level|MP:0004774,abnormal bile salt level|MP:0005376,homeostasis/metabolism phenotype|MP:0014476,abnormal feces lipid level
MGI:5462250	Tg(CAG-Diap3)924Lesp	MP:0002083,premature death|MP:0002127,abnormal cardiovascular system morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004534,decreased inner hair cell stereocilia number|MP:0004562,abnormal inner hair cell synaptic ribbon morphology|MP:0005386,behavior/neurological phenotype|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0031674,long inner hair cell stereocilia
MGI:5468143	Tg(CAG-Diaph3)771Lesp	MP:0002083,premature death|MP:0002127,abnormal cardiovascular system morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004534,decreased inner hair cell stereocilia number|MP:0004562,abnormal inner hair cell synaptic ribbon morphology|MP:0005386,behavior/neurological phenotype|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0031674,long inner hair cell stereocilia
MGI:5426792	Tg(CAG-DMPK*)1323Coop	MP:0000160,kyphosis|MP:0000278,abnormal myocardial fiber morphology|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0001544,abnormal cardiovascular system physiology|MP:0001636,irregular heartbeat|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003157,impaired muscle relaxation|MP:0003896,prolonged PR interval|MP:0004011,decreased diastolic filling velocity|MP:0004084,abnormal cardiac muscle relaxation|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0009415,skeletal muscle degeneration|MP:0009419,skeletal muscle fibrosis|MP:0010240,decreased skeletal muscle size|MP:0010392,prolonged QRS complex duration|MP:0010519,atrioventricular block|MP:0021158,decreased heart left ventricle wall thickness
MGI:6402443	Tg(CAG-DPP4)4Yuzh	MP:0000533,kidney hemorrhage|MP:0000689,abnormal spleen morphology|MP:0000753,paralysis|MP:0001182,lung hemorrhage|MP:0001847,brain inflammation|MP:0001859,kidney inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0008577,increased circulating interferon-gamma level|MP:0008614,increased circulating interleukin-17 level|MP:0010210,abnormal circulating cytokine level|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:6402051	Tg(CAG-DPP4)52Ctkt	MP:0001263,weight loss|MP:0001846,increased inflammatory response|MP:0001847,brain inflammation|MP:0001861,lung inflammation|MP:0001862,interstitial pneumonia|MP:0001954,respiratory distress|MP:0005277,abnormal brainstem morphology|MP:0008247,abnormal mononuclear cell morphology|MP:0020448,increased microglial cell activation|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:4367446	Tg(CAG-dre)1Afst	MP:0002169,no abnormal phenotype detected
MGI:5559582	Tg(CAG-dsRed2/RNAi:Tardbp)6Zxu	MP:0000274,enlarged heart|MP:0000748,progressive muscle weakness|MP:0000749,muscle degeneration|MP:0000753,paralysis|MP:0000755,hindlimb paralysis|MP:0000938,motor neuron degeneration|MP:0001263,weight loss|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0001524,impaired limb coordination|MP:0002083,premature death|MP:0002108,abnormal muscle morphology|MP:0002229,neurodegeneration|MP:0002757,decreased vertical activity|MP:0003354,astrocytosis|MP:0005405,axon degeneration|MP:0008918,microgliosis|MP:0009414,skeletal muscle fiber necrosis
MGI:3809927	Tg(CAG-DsRed,-EGFP)5Gae	MP:0002169,no abnormal phenotype detected
MGI:3663358	Tg(CAG-DsRed*MST)1Nagy	MP:0002169,no abnormal phenotype detected
MGI:3046672	Tg(CAG-DT)3Osb	MP:0001147,small testis|MP:0005159,azoospermia
MGI:6361754	Tg(CAG-Dusp26)#Jhxia	MP:0002941,increased circulating alanine transaminase level|MP:0003402,decreased liver weight|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005343,increased circulating aspartate transaminase level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level|MP:0010360,decreased liver free fatty acids level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:2686773	Tg(CAG-EGFP)1Osb	MP:0002169,no abnormal phenotype detected|MP:0011091,prenatal lethality, complete penetrance
MGI:3760429	Tg(CAG-EGFP)50Osb	MP:0005384,cellular phenotype
MGI:3767445	Tg(CAG-EGFP-CAT-DTA)2Masa	MP:0005386,behavior/neurological phenotype|MP:0006392,abnormal nucleus pulposus morphology|MP:0010770,preweaning lethality
MGI:3793421	Tg(CAG-EGFP/CETN2)3-4Jgg	MP:0002152,abnormal brain morphology|MP:0003631,nervous system phenotype
MGI:5559580	Tg(CAG-EGFP,-dsRed2/RNAi:Tardbp)6Zxu	MP:0000433,microcephaly|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging
MGI:4358071	Tg(CAG-EGFP,-Pax6*5a,-lacZ)1Stoy	MP:0005391,vision/eye phenotype
MGI:4358072	Tg(CAG-EGFP,-Pax6,-lacZ)1Stoy	MP:0001322,abnormal iris morphology|MP:0005099,abnormal ciliary body morphology
MGI:4942191	Tg(CAG-EGFP,-PAX8/PPARG)1Rkoe	MP:0002006,neoplasm|MP:0003498,thyroid gland hyperplasia
MGI:4415346	Tg(CAG-EGFP,RNU6-RNAi:Sly)367Psb	MP:0001922,reduced male fertility|MP:0002674,abnormal sperm motility|MP:0002687,oligozoospermia|MP:0003698,abnormal male reproductive system physiology|MP:0009230,abnormal sperm head morphology|MP:0009647,decreased fertilization frequency
MGI:4867516	Tg(CAG-ELN*)2Zu	MP:0001183,overexpanded pulmonary alveolus|MP:0001265,decreased body size|MP:0001954,respiratory distress|MP:0001958,emphysema|MP:0002083,premature death
MGI:4867517	Tg(CAG-ELN*)60Zu	MP:0001175,abnormal lung morphology|MP:0001183,overexpanded pulmonary alveolus|MP:0002314,abnormal respiratory mechanics|MP:0003211,abnormal aorta elastic fiber morphology|MP:0008418,abnormal cutaneous elastic fiber morphology|MP:0010895,increased lung compliance
MGI:5749814	Tg(CAG-en/Hoxb5,-EGFP)#Vchl	MP:0000495,abnormal colon morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001270,distended abdomen|MP:0001732,postnatal growth retardation|MP:0002581,abnormal ileum morphology|MP:0002926,aganglionic megacolon|MP:0006001,abnormal intestinal transit time|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011503,distended jejunum|MP:0011879,ileum atresia|MP:0011882,enlarged duodenum|MP:0013006,abnormal enteric neural crest cell migration
MGI:6459753	Tg(CAG-EPM2A*C266S)1Bmin	MP:0003631,nervous system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0010401,increased skeletal muscle glycogen level|MP:0014063,Lafora bodies
MGI:3687017	Tg(CAG-EYFP)7AC5Nagy	MP:0002169,no abnormal phenotype detected
MGI:3775946	Tg(CAG-Isx)1Sse	MP:0011090,perinatal lethality, incomplete penetrance
MGI:7386881	Tg(CAG-Jmjd8)#Kaso	MP:0002079,increased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005378,growth/size/body region phenotype|MP:0031602,white adipose tissue inflammation
MGI:3821884	Tg(CAG-LacZ,-ACVR1*,-EGFP)35-1Mis	MP:0003756,abnormal hard palate morphology|MP:0004510,myositis|MP:0005369,muscle phenotype|MP:0005390,skeleton phenotype|MP:0005508,abnormal skeleton morphology|MP:0009546,absent gastric milk in neonates|MP:0009655,abnormal secondary palate development|MP:0009889,persistence of medial edge epithelium during palatal shelf fusion|MP:0011087,neonatal lethality, complete penetrance|MP:0011615,submucous cleft palate|MP:0013550,abnormal secondary palate morphology|MP:0021212,abnormal primary and secondary palatal fusion|MP:0030224,abnormal soft palate muscle morphology|MP:0030292,abnormal tensor veli palatini muscle morphology|MP:0030863,decreased joint mobility
MGI:3811006	Tg(CAG-lacZ,-Akt1*,-EGFP)56Ebm	MP:0000807,abnormal hippocampus morphology|MP:0000913,abnormal brain development|MP:0000952,abnormal CNS glial cell morphology|MP:0002182,abnormal astrocyte morphology|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0010768,mortality/aging
MGI:3829221	Tg(CAG-lacZ,-BMPR1A*,-EGFP)1Mis	MP:0004016,decreased bone mass|MP:0010412,atrioventricular septal defect|MP:0030279,thin neurocranium
MGI:5644690	Tg(CAG-lacZ,-FUS,-EGFP)629Gyu	MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0003354,astrocytosis|MP:0008918,microgliosis|MP:0010053,decreased grip strength|MP:0014603,neuromuscular synapse degeneration
MGI:5644691	Tg(CAG-lacZ,-FUS*R521G,-EGFP)682Gyu	MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0003354,astrocytosis|MP:0005394,taste/olfaction phenotype|MP:0008143,abnormal dendrite morphology|MP:0008918,microgliosis|MP:0009936,abnormal dendritic spine morphology|MP:0010053,decreased grip strength|MP:0014603,neuromuscular synapse degeneration
MGI:6267411	Tg(CAG-lacZ,-Miox)#Ysk	MP:0003674,oxidative stress|MP:0004153,increased renal tubule apoptosis|MP:0005165,increased susceptibility to injury|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level
MGI:4439280	Tg(CAG-lacZ,-SV40)#Bcv	MP:0001272,increased metastatic potential|MP:0002019,abnormal tumor incidence|MP:0002052,decreased tumor incidence|MP:0002083,premature death|MP:0002166,abnormal tumor susceptibility|MP:0002279,abnormal diaphragm morphology|MP:0003448,abnormal tumor morphology|MP:0003579,increased ovarian carcinoma incidence|MP:0005324,ascites|MP:0005649,increased spleen neoplasm incidence|MP:0008000,increased ovary tumor incidence|MP:0008019,increased liver tumor incidence|MP:0009153,increased pancreas tumor incidence
MGI:3052324	Tg(CAG-lacZ-WGA)330Bbm	MP:0002169,no abnormal phenotype detected
MGI:5556056	Tg(CAG-LARGE)126Fmu	MP:0002106,abnormal muscle physiology|MP:0005165,increased susceptibility to injury
MGI:5562450	Tg(CAG-Large)#Kcam	MP:0009402,decreased skeletal muscle fiber diameter
MGI:3851901	Tg(CAG-Lhx,-EGFP)1Eno	MP:0001915,intracranial hemorrhage|MP:0004378,frontal bone foramen|MP:0008276,failure of intramembranous bone ossification|MP:0011087,neonatal lethality, complete penetrance
MGI:5512882	Tg(CAG-Lyn*)#Paau	MP:0001190,reddish skin|MP:0001192,scaly skin|MP:0001193,psoriasis|MP:0001200,thick skin|MP:0001212,skin lesions|MP:0001242,hyperkeratosis|MP:0001265,decreased body size|MP:0001874,acanthosis|MP:0003201,extremity edema|MP:0003427,parakeratosis|MP:0004947,skin inflammation|MP:0009583,increased keratinocyte proliferation|MP:0009598,thin epidermis stratum granulosum|MP:0009795,epidermal spongiosis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011940,decreased food intake|MP:0014659,increased skin stiffness
MGI:4461396	Tg(CAG-Map3k7*K63W)1232Mds	MP:0000266,abnormal heart morphology|MP:0000280,thin ventricular wall|MP:0001402,decreased locomotor activity|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0001732,postnatal growth retardation|MP:0001788,periorbital edema|MP:0001855,abnormal atrial thrombosis|MP:0003898,abnormal QRS complex|MP:0004058,abnormal ventricle papillary muscle morphology|MP:0004564,increased myocardial fiber size|MP:0005330,cardiomyopathy|MP:0008022,dilated heart ventricle|MP:0010392,prolonged QRS complex duration|MP:0010511,shortened PR interval|MP:0011085,postnatal lethality, complete penetrance|MP:0014071,increased cardiac muscle glycogen level
MGI:7545332	Tg(CAG-mCherry)690Biat	MP:0000822,abnormal brain ventricle morphology|MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0011091,prenatal lethality, complete penetrance
MGI:5317720	Tg(CAG-Mir21,-EGFP)#Eno	MP:0002006,neoplasm
MGI:6491446	Tg(CAG-Mmachc,-GFP)1Poche	MP:0002169,no abnormal phenotype detected
MGI:5293615	Tg(CAG-mRFP1,-SOX9,-EGFP)1Haak	MP:0000550,abnormal forelimb morphology|MP:0002896,abnormal bone mineralization|MP:0008272,abnormal endochondral bone ossification|MP:0009780,abnormal chondrocyte physiology
MGI:5490949	Tg(CAG-Msra)#Rlev	MP:0005378,growth/size/body region phenotype
MGI:5634713	Tg(CAG-Mtor*)#Atai	MP:0000788,abnormal cerebral cortex morphology|MP:0003203,increased neuron apoptosis|MP:0004981,decreased neuronal precursor cell number|MP:0008283,small hippocampus
MGI:6198762	Tg(CAG-MYC,-GFP*)#Rugg	MP:0001158,abnormal prostate gland morphology|MP:0002006,neoplasm
MGI:6315314	Tg(CAG-Naa10)10Jprk	MP:0000063,decreased bone mineral density|MP:0000074,abnormal neurocranium morphology|MP:0000084,abnormal fontanelle morphology|MP:0000559,abnormal femur morphology|MP:0005006,abnormal osteoblast physiology|MP:0011711,impaired osteoblast differentiation
MGI:6315315	Tg(CAG-Naa10)15Jprk	MP:0000063,decreased bone mineral density|MP:0000074,abnormal neurocranium morphology|MP:0000084,abnormal fontanelle morphology|MP:0000559,abnormal femur morphology|MP:0005006,abnormal osteoblast physiology|MP:0010876,decreased bone volume|MP:0011711,impaired osteoblast differentiation|MP:0030279,thin neurocranium|MP:0030315,small neurocranium
MGI:6276322	Tg(CAG-Ncoa6)104Hwl	MP:0000633,abnormal pituitary gland morphology|MP:0000639,abnormal adrenal gland morphology|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001625,cardiac hypertrophy|MP:0001855,abnormal atrial thrombosis|MP:0002628,hepatic steatosis|MP:0002795,dilated cardiomyopathy|MP:0003137,abnormal impulse conducting system conduction|MP:0003446,renal hypoplasia|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0009343,dilated gallbladder
MGI:2447467	Tg(CAG-Ncoa6)54Hwl	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001328,disorganized retina layers|MP:0001405,impaired coordination|MP:0002092,abnormal eye morphology|MP:0002794,lenticonus|MP:0003102,sclera thinning|MP:0003236,abnormal lens capsule morphology|MP:0005287,narrow eye opening|MP:0005385,cardiovascular system phenotype|MP:0005545,abnormal lens development|MP:0010711,persistent hyperplastic primary vitreous|MP:0021107,retina fold
MGI:6276318	Tg(CAG-Ncoa6)71Hwl	MP:0000633,abnormal pituitary gland morphology|MP:0000639,abnormal adrenal gland morphology|MP:0001178,pulmonary hypoplasia|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001625,cardiac hypertrophy|MP:0001855,abnormal atrial thrombosis|MP:0001861,lung inflammation|MP:0002628,hepatic steatosis|MP:0002795,dilated cardiomyopathy|MP:0003137,abnormal impulse conducting system conduction|MP:0003446,renal hypoplasia|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0009343,dilated gallbladder|MP:0010018,pulmonary vascular congestion
MGI:6276320	Tg(CAG-Ncoa6)84Hwl	MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001328,disorganized retina layers|MP:0001405,impaired coordination|MP:0002092,abnormal eye morphology|MP:0002794,lenticonus|MP:0002795,dilated cardiomyopathy|MP:0003102,sclera thinning|MP:0003236,abnormal lens capsule morphology|MP:0005287,narrow eye opening|MP:0005545,abnormal lens development|MP:0010402,ventricular septal defect|MP:0010711,persistent hyperplastic primary vitreous|MP:0021107,retina fold
MGI:6276321	Tg(CAG-Ncoa6)87Hwl	MP:0000633,abnormal pituitary gland morphology|MP:0000639,abnormal adrenal gland morphology|MP:0001178,pulmonary hypoplasia|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0001625,cardiac hypertrophy|MP:0001855,abnormal atrial thrombosis|MP:0001861,lung inflammation|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003446,renal hypoplasia|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0005140,decreased cardiac muscle contractility|MP:0005312,pericardial effusion|MP:0006138,congestive heart failure|MP:0008726,increased heart left atrium size|MP:0009343,dilated gallbladder|MP:0010018,pulmonary vascular congestion
MGI:2447471	Tg(CAG-Ncoa6*)#Hwl	MP:0002169,no abnormal phenotype detected
MGI:6476770	Tg(CAG-Ndufab1)#Xiwa	MP:0001399,hyperactivity|MP:0002891,increased insulin sensitivity|MP:0003186,abnormal redox activity|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008963,increased carbon dioxide production|MP:0009125,decreased brown fat cell lipid droplet size|MP:0009136,decreased brown fat cell size|MP:0013278,decreased fasting circulating glucose level
MGI:3714625	Tg(CAG-Ngb,-EGFP)1Dgrn	MP:0003038,decreased myocardial infarct size|MP:0003957,abnormal nitric oxide homeostasis|MP:0006058,decreased cerebral infarct size
MGI:3848915	Tg(CAG-Nog)1Ych	MP:0000111,cleft palate|MP:0000458,abnormal mandible morphology|MP:0009655,abnormal secondary palate development|MP:0009883,palatal shelf hypoplasia|MP:0013546,cleft soft palate|MP:0021202,abnormal palatopharyngeus muscle morphology|MP:0021203,abnormal palatine aponeurosis morphology|MP:0021204,abnormal superior pharyngeal constrictor muscle morphology|MP:0030224,abnormal soft palate muscle morphology|MP:0030292,abnormal tensor veli palatini muscle morphology|MP:0030293,small tensor veli palatini muscle|MP:0030294,abnormal levator veli palatini muscle morphology|MP:0030295,small levator veli palatini muscle
MGI:5294944	Tg(CAG-NRIP1)51Row	MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0001855,abnormal atrial thrombosis|MP:0001861,lung inflammation|MP:0002083,premature death|MP:0003105,abnormal heart atrium morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005324,ascites|MP:0005330,cardiomyopathy|MP:0005608,cardiac interstitial fibrosis|MP:0006050,pulmonary fibrosis|MP:0006138,congestive heart failure|MP:0008028,pregnancy-related premature death|MP:0008725,increased heart atrium size|MP:0010018,pulmonary vascular congestion|MP:0010334,pleural effusion|MP:0010955,abnormal respiratory electron transport chain|MP:0011629,decreased mitochondrial number|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0031131,myocardial fiber disarray|MP:0031530,abnormal heart ventricle shape
MGI:3823244	Tg(CAG-OTC/CAT)#Wcl	MP:0002106,abnormal muscle physiology
MGI:3851902	Tg(CAG-Otx2,-EGFP)1Eno	MP:0001915,intracranial hemorrhage|MP:0004378,frontal bone foramen|MP:0008276,failure of intramembranous bone ossification|MP:0011087,neonatal lethality, complete penetrance
MGI:3050829	Tg(CAG-OVAL)916Jen	MP:0000358,abnormal cell morphology|MP:0002455,abnormal dendritic cell antigen presentation|MP:0004752,decreased length of allograft survival
MGI:3762384	Tg(CAG-p35)1Miur	MP:0001844,autoimmune response|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0006043,decreased apoptosis
MGI:6730133	Tg(CAG-Pgam2)#Hiko	MP:0004499,increased incidence of tumors by chemical induction|MP:0005376,homeostasis/metabolism phenotype|MP:0012572,increased susceptibility to chemically induced skin inflammation
MGI:3624138	Tg(CAG-PGDS)1Groy	MP:0001876,decreased inflammatory response|MP:0002339,abnormal lymph node morphology|MP:0003009,abnormal cytokine secretion
MGI:3844550	Tg(CAG-PKD2)#Hwl	MP:0000522,kidney cortex cyst|MP:0002703,abnormal renal tubule morphology|MP:0002828,abnormal renal glomerular capsule morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0008528,polycystic kidney
MGI:5517570	Tg(CAG-PLA2G3)#aMurm	MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008764,increased mast cell degranulation
MGI:5897172	Tg(CAG-Ppard*E411P)#Als	MP:0000160,kyphosis|MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0003461,abnormal response to novel object|MP:0006007,abnormal basal ganglion morphology|MP:0008462,abnormal medium spiny neuron morphology|MP:0008948,decreased neuron number|MP:0010053,decreased grip strength|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011448,decreased dopaminergic neuron number|MP:0011631,decreased mitochondrial size
MGI:5912198	Tg(CAG-PPARG*,-tdTomato)#Sig	MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0003961,decreased lean body mass|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0010934,increased subcutaneous adipose tissue amount|MP:0014142,increased body fat mass|MP:0014170,increased brown adipose tissue mass
MGI:5912197	Tg(CAG-PPARG,-tdTomato)#Sig	MP:0001260,increased body weight
MGI:6324050	Tg(CAG-Ptafr)1Tksh	MP:0000015,abnormal ear pigmentation|MP:0000324,increased mast cell number|MP:0001262,decreased body weight|MP:0002095,abnormal skin pigmentation|MP:0005075,abnormal melanosome morphology|MP:0005174,abnormal tail pigmentation|MP:0008735,increased susceptibility to endotoxin shock|MP:0009715,thick epidermis stratum basale|MP:0009731,abnormal offspring retrieval|MP:0010322,increased cutaneous melanoma incidence|MP:0011143,thick lung-associated mesenchyme
MGI:5607931	Tg(CAG-RFP,Acr-EGFP)RBGS002Osb	MP:0005389,reproductive system phenotype
MGI:7868141	Tg(CAG-Rnase2a)#Anjm	MP:0000274,enlarged heart|MP:0000706,small thymus|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001861,lung inflammation|MP:0001924,infertility|MP:0002415,abnormal neutrophil differentiation|MP:0002463,abnormal neutrophil physiology|MP:0009342,enlarged gallbladder
MGI:7645346	Tg(CAG-RND2)1Jya	MP:0000920,abnormal myelination|MP:0011730,increased myelin sheath thickness|MP:0011731,decreased myelin sheath thickness
MGI:8210962	Tg(CAG-Romo1)#Xiwa	MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000609,abnormal liver physiology|MP:0002108,abnormal muscle morphology|MP:0002942,decreased circulating alanine transaminase level|MP:0005289,increased oxygen consumption|MP:0005599,increased cardiac muscle contractility|MP:0005632,decreased circulating aspartate transaminase level|MP:0006036,abnormal mitochondrial physiology|MP:0010052,increased grip strength|MP:0010330,abnormal circulating lipoprotein level
MGI:4936750	Tg(CAG-Rpgr)mRDefWrght	MP:0008450,retina photoreceptor degeneration
MGI:4839313	Tg(CAG-RPS19*R62W)#Dmb	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0001265,decreased body size|MP:0001577,anemia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0008941,reticulocytopenia|MP:0008973,decreased erythroid progenitor cell number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:7398506	Tg(CAG-S100a16)#Gpt	MP:0003333,liver fibrosis|MP:0005376,homeostasis/metabolism phenotype
MGI:3772442	Tg(CAG-SAC/EGFP)35Rang	MP:0002052,decreased tumor incidence|MP:0005370,liver/biliary system phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0010266,decreased liver tumor incidence|MP:0010268,decreased lymphoma incidence|MP:0010768,mortality/aging
MGI:3764813	Tg(CAG-SNCA*)1.1Ccs	MP:0000952,abnormal CNS glial cell morphology|MP:0002882,abnormal neuron morphology|MP:0003631,nervous system phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0008025,brain vacuoles|MP:0008916,abnormal astrocyte physiology
MGI:4418352	Tg(CAG-Spltc1)6FAmcc	MP:0001405,impaired coordination|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0030603,increased sperm number
MGI:4418339	Tg(CAG-SPTLC1*C133W)8EAmcc	MP:0001106,abnormal Schwann cell morphology|MP:0001156,abnormal spermatogenesis|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001921,reduced fertility|MP:0001944,abnormal pancreas morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0003224,neuron degeneration|MP:0003866,abnormal defecation|MP:0003871,abnormal myelin sheath morphology|MP:0003993,abnormal ventral spinal root morphology|MP:0003998,decreased thermal nociceptive threshold|MP:0004852,decreased testis weight|MP:0004924,abnormal behavior|MP:0005371,limbs/digits/tail phenotype|MP:0005389,reproductive system phenotype|MP:0005404,abnormal axon morphology|MP:0005407,hyperalgesia|MP:0006001,abnormal intestinal transit time|MP:0008415,abnormal neurite morphology|MP:0008918,microgliosis|MP:0009164,exocrine pancreas atrophy
MGI:3767714	Tg(CAG-STUB1)1Sobue	MP:0003631,nervous system phenotype|MP:0005369,muscle phenotype|MP:0005386,behavior/neurological phenotype|MP:0005449,abnormal food intake
MGI:4421708	Tg(CAG-SYVN1)1Tn	MP:0003561,rheumatoid arthritis|MP:0006043,decreased apoptosis
MGI:5313807	Tg(CAG-Tfb1m)AGsha	MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0004411,decreased endocochlear potential|MP:0004435,abnormal cochlear outer hair cell electromotility|MP:0004748,increased susceptibility to age-related hearing loss|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014740,increased auditory brainstem response wave peak latency|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:3697397	Tg(CAG-Tle1,-ALPP)1Lbe	MP:0002027,increased lung adenocarcinoma incidence
MGI:6368630	Tg(CAG-Tmem135)#Aike	MP:0003674,oxidative stress|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006038,increased mitochondrial fission|MP:0011631,decreased mitochondrial size
MGI:6197464	Tg(CAG-Tnfsf11*)#Khs	MP:0001270,distended abdomen|MP:0011089,perinatal lethality, complete penetrance|MP:0020137,decreased bone mineralization
MGI:5770788	Tg(CAG-TRIM29)ADims	MP:0009550,increased urinary bladder carcinoma incidence|MP:0009552,urinary bladder obstruction
MGI:5496007	Tg(CAG-tTS)1Mlit	MP:0002169,no abnormal phenotype detected
MGI:3762797	Tg(CAG-Ub*G76V/GFP)1Dant	MP:0002169,no abnormal phenotype detected
MGI:3762796	Tg(CAG-Ub*G76V/GFP)2Dant	MP:0002169,no abnormal phenotype detected
MGI:5576803	Tg(CAG-Ubqln1)2Hmw	MP:0003075,abnormal response to CNS ischemic injury|MP:0006058,decreased cerebral infarct size|MP:0008413,decreased cellular sensitivity to oxidative stress|MP:0008891,decreased hepatocyte apoptosis|MP:0010080,abnormal hepatocyte physiology
MGI:4440440	Tg(CAG-VCP*A232E)93Jpat	MP:0000130,abnormal trabecular bone morphology|MP:0000748,progressive muscle weakness|MP:0000751,myopathy|MP:0001263,weight loss|MP:0001363,increased anxiety-related response|MP:0002083,premature death|MP:0002183,gliosis|MP:0002882,abnormal neuron morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003461,abnormal response to novel object|MP:0003795,abnormal bone structure|MP:0003797,abnormal compact bone morphology|MP:0004090,abnormal sarcomere morphology|MP:0004148,increased compact bone thickness|MP:0008770,decreased survivor rate|MP:0009346,decreased trabecular bone thickness|MP:0009415,skeletal muscle degeneration|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume
MGI:4440439	Tg(CAG-VCP*R155H)55Jpat	MP:0000130,abnormal trabecular bone morphology|MP:0000748,progressive muscle weakness|MP:0000751,myopathy|MP:0001263,weight loss|MP:0001363,increased anxiety-related response|MP:0002083,premature death|MP:0002183,gliosis|MP:0002882,abnormal neuron morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003461,abnormal response to novel object|MP:0003795,abnormal bone structure|MP:0003797,abnormal compact bone morphology|MP:0004090,abnormal sarcomere morphology|MP:0004148,increased compact bone thickness|MP:0008770,decreased survivor rate|MP:0009346,decreased trabecular bone thickness|MP:0009415,skeletal muscle degeneration|MP:0010053,decreased grip strength|MP:0010090,increased circulating creatine kinase level|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume
MGI:3525073	Tg(CAG-WRN*K577M)5025Wcl	MP:0005621,abnormal cell physiology
MGI:1858099	Tg(CAMalpha1b)7Wjk	MP:0000276,heart right ventricle hypertrophy|MP:0001625,cardiac hypertrophy|MP:0001855,abnormal atrial thrombosis|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0004937,dilated heart|MP:0005329,abnormal myocardium layer morphology|MP:0005385,cardiovascular system phenotype|MP:0006138,congestive heart failure|MP:0010579,increased heart left ventricle size|MP:0011925,abnormal heart echocardiography feature|MP:0013807,generalized edema|MP:0031131,myocardial fiber disarray|MP:0031530,abnormal heart ventricle shape|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4836192	Tg(Camk2a-AIDPak)21Stl	MP:0001475,reduced long-term depression|MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004792,abnormal synaptic vesicle number|MP:0008432,abnormal long-term spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0009538,abnormal synapse morphology|MP:0009936,abnormal dendritic spine morphology
MGI:4366528	Tg(Camk2a-Apbb1)27Spim	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:4366527	Tg(Camk2a-App*,-Apbb1)25Spim	MP:0002229,neurodegeneration|MP:0004250,tau protein deposits|MP:0005386,behavior/neurological phenotype|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0008428,abnormal spatial working memory
MGI:3709467	Tg(Camk2a-Bdnf)A9Stl	MP:0000805,abnormal visual cortex morphology|MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001473,reduced long-term potentiation|MP:0002064,seizures|MP:0002195,psychomotor seizures|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0004101,abnormal brain interneuron morphology|MP:0004924,abnormal behavior|MP:0005253,abnormal eye physiology|MP:0008547,abnormal neocortex morphology|MP:0009937,abnormal neuron differentiation
MGI:3652380	Tg(CAMK2A-CAST)7Tcs	MP:0008236,decreased susceptibility to neuronal excitotoxicity
MGI:3712116	Tg(Camk2a-Crebbp*)1364Tabe	MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0002797,increased thigmotaxis|MP:0005386,behavior/neurological phenotype
MGI:3802596	Tg(Camk2a-Crem)I15Endo	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0001499,abnormal kindling response|MP:0005386,behavior/neurological phenotype
MGI:3802597	Tg(Camk2a-Crem)IIEndo	MP:0001262,decreased body weight|MP:0001454,abnormal cued conditioning behavior|MP:0001488,increased startle reflex|MP:0001499,abnormal kindling response|MP:0001968,abnormal touch/nociception|MP:0005386,behavior/neurological phenotype
MGI:3758077	Tg(Camk2a-DISC1)10Asaw	MP:0000807,abnormal hippocampus morphology|MP:0000822,abnormal brain ventricle morphology|MP:0000832,abnormal thalamus morphology|MP:0001399,hyperactivity|MP:0001522,impaired swimming|MP:0004924,abnormal behavior|MP:0005643,decreased dopamine level|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009142,decreased prepulse inhibition|MP:0009749,enhanced behavioral response to addictive substance
MGI:5486141	Tg(Camk2a-DISC1)37Asaw	MP:0000798,abnormal frontal lobe morphology|MP:0000822,abnormal brain ventricle morphology|MP:0001399,hyperactivity|MP:0001522,impaired swimming|MP:0004077,abnormal striatum morphology|MP:0004924,abnormal behavior|MP:0005643,decreased dopamine level|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009142,decreased prepulse inhibition|MP:0009749,enhanced behavioral response to addictive substance
MGI:3765913	Tg(Camk2a-EGFP/Fbxl20)31Seto	MP:0002169,no abnormal phenotype detected
MGI:3785794	Tg(Camk2a-ESR1/Disc1*)2698.1Sva	MP:0001360,abnormal social investigation|MP:0001361,social withdrawal|MP:0002206,abnormal CNS synaptic transmission|MP:0002573,behavioral despair|MP:0002882,abnormal neuron morphology|MP:0008143,abnormal dendrite morphology|MP:0008428,abnormal spatial working memory
MGI:2446470	Tg(Camk2a-Fyn-531)1Nko	MP:0001364,decreased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001499,abnormal kindling response|MP:0001650,abnormal seizure response to electrical stimulation|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002570,alcohol aversion|MP:0002826,tonic seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0009755,impaired behavioral response to alcohol|MP:0009776,decreased behavioral withdrawal response
MGI:3789985	Tg(Camk2a-Gpr85)1Mima	MP:0000771,abnormal brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001446,abnormal whisker trimming behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0002175,decreased brain weight|MP:0003203,increased neuron apoptosis|MP:0004807,abnormal paired-pulse inhibition|MP:0008143,abnormal dendrite morphology
MGI:5780419	Tg(Camk2a-Grin2a)1Jzt	MP:0009456,impaired cued conditioning behavior|MP:0014367,impaired long-term object recognition memory
MGI:5780173	Tg(Camk2a-Grin2a/Grin2b)1Jzt	MP:0003008,enhanced long-term potentiation|MP:0009453,enhanced contextual conditioning behavior|MP:0009455,enhanced cued conditioning behavior|MP:0012319,fast extinction of fear memory|MP:0014368,enhanced long-term object recognition memory
MGI:2385435	Tg(Camk2a-Grin2b)1Jzt	MP:0009453,enhanced contextual conditioning behavior|MP:0009455,enhanced cued conditioning behavior|MP:0012319,fast extinction of fear memory|MP:0014368,enhanced long-term object recognition memory
MGI:5780186	Tg(Camk2a-Grin2b/Grin2a)1Jzt	MP:0001475,reduced long-term depression|MP:0003008,enhanced long-term potentiation|MP:0009456,impaired cued conditioning behavior
MGI:5780189	Tg(Camk2a-Grin2d/Grin2b)1Jzt	MP:0003008,enhanced long-term potentiation|MP:0009456,impaired cued conditioning behavior|MP:0014367,impaired long-term object recognition memory
MGI:4360216	Tg(Camk2a-HRAS*G12V)1Sva	MP:0001463,abnormal spatial learning|MP:0002206,abnormal CNS synaptic transmission|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002919,enhanced paired-pulse facilitation|MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004793,abnormal synaptic vesicle clustering|MP:0005386,behavior/neurological phenotype|MP:0009453,enhanced contextual conditioning behavior
MGI:3043428	Tg(Camk2a-IDE)1Selk	MP:0002169,no abnormal phenotype detected
MGI:4418368	Tg(Camk2a-KCNH3)1Akmi	MP:0001473,reduced long-term potentiation|MP:0002801,abnormal long-term object recognition memory|MP:0008414,abnormal spatial reference memory|MP:0008428,abnormal spatial working memory
MGI:5620796	Tg(Camk2a-Magi2)1Shlee	MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001447,abnormal nest building behavior|MP:0001473,reduced long-term potentiation|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002912,abnormal excitatory postsynaptic potential|MP:0004101,abnormal brain interneuron morphology|MP:0004209,abnormal sweet taste sensitivity|MP:0008428,abnormal spatial working memory|MP:0008535,enlarged lateral ventricles|MP:0009142,decreased prepulse inhibition|MP:0009710,anhedonia|MP:0009936,abnormal dendritic spine morphology|MP:0031391,increased locomotor activity
MGI:5749788	Tg(Camk2a-MAPT)601Ymot	MP:0001364,decreased anxiety-related response|MP:0002063,abnormal learning/memory/conditioning|MP:0003926,decreased cellular glucose uptake|MP:0004080,abnormal nucleus accumbens morphology|MP:0005404,abnormal axon morphology|MP:0008428,abnormal spatial working memory|MP:0009538,abnormal synapse morphology|MP:0009936,abnormal dendritic spine morphology|MP:0012307,impaired spatial learning
MGI:6389815	Tg(Camk2a-MAPT)#Atak	MP:0002152,abnormal brain morphology|MP:0004168,abnormal parahippocampal gyrus morphology|MP:0004811,abnormal neuron physiology|MP:0008414,abnormal spatial reference memory|MP:0009538,abnormal synapse morphology|MP:0012307,impaired spatial learning|MP:0020508,decreased dendritic spine density
MGI:6389818	Tg(Camk2a-MAPT*P301L)#Atak	MP:0002152,abnormal brain morphology|MP:0003224,neuron degeneration|MP:0005386,behavior/neurological phenotype
MGI:5646621	Tg(Camk2a-MAPT*P301L)D35Jiri	MP:0003214,neurofibrillary tangles
MGI:3603948	Tg(Camk2a-MAPT*R406W)748Atak	MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0002083,premature death|MP:0004250,tau protein deposits|MP:0009142,decreased prepulse inhibition
MGI:3043425	Tg(Camk2a-MME)3Selk	MP:0002169,no abnormal phenotype detected
MGI:4415723	Tg(Camk2a-Nrd1)1Eiin	MP:0003871,abnormal myelin sheath morphology
MGI:6270168	Tg(Camk2a-Polg*D181A)BTkato	MP:0001262,decreased body weight|MP:0001488,increased startle reflex|MP:0001905,abnormal dopamine level|MP:0003459,increased fear-related response|MP:0003491,abnormal voluntary movement|MP:0005386,behavior/neurological phenotype|MP:0010070,decreased serotonin level|MP:0011638,abnormal mitochondrial chromosome morphology|MP:0011940,decreased food intake|MP:0012574,decreased noradrenaline level|MP:0020480,abnormal ultradian rhythm behavior
MGI:3626071	Tg(Camk2a-Prkaca)426Tabe	MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0001523,impaired righting response|MP:0003546,decreased alcohol consumption|MP:0005584,abnormal enzyme/coenzyme activity
MGI:5298876	Tg(Camk2a-Setdb1)1Akba	MP:0001405,impaired coordination|MP:0002888,abnormal NMDA-mediated synaptic currents|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003360,abnormal depression-related behavior|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging
MGI:4830510	Tg(Camk2a-Tardbp)#Ckjs	MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0002882,abnormal neuron morphology|MP:0003203,increased neuron apoptosis|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008948,decreased neuron number|MP:0009454,impaired contextual conditioning behavior|MP:0014365,impaired short-term object recognition memory|MP:0020083,decreased hippocampus volume
MGI:2179066	Tg(Camk2a-tTA)1Mmay	MP:0000783,abnormal forebrain morphology|MP:0000811,hippocampal neuron degeneration|MP:0000812,abnormal dentate gyrus morphology|MP:0003631,nervous system phenotype|MP:0006099,thin cerebellar granule layer|MP:0008432,abnormal long-term spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0012460,decreased dentate gyrus size
MGI:3843483	Tg(Camk2a-UBB*)3413-1Fwvl	MP:0008414,abnormal spatial reference memory|MP:0009454,impaired contextual conditioning behavior
MGI:3699361	Tg(CASP3)18Fine	MP:0003076,increased susceptibility to ischemic brain injury|MP:0006060,increased cerebral infarct size
MGI:1927810	Tg(Cat)370Rpw	MP:0000585,kinked tail|MP:0002759,abnormal caudal vertebrae morphology|MP:0004174,abnormal spine curvature
MGI:5462465	Tg(CBS)11181Eri	MP:0005376,homeostasis/metabolism phenotype
MGI:5703888	Tg(Cck-EGFP/RNAi:Gad1)2Mirn	MP:0001402,decreased locomotor activity|MP:0003462,abnormal response to novel odor|MP:0013894,abnormal behavioral response to amphetamine
MGI:3054966	Tg(Cd152Ig)1Jbs	MP:0004803,increased susceptibility to autoimmune diabetes
MGI:3814908	Tg(CD19)1Tft	MP:0002494,increased IgM level|MP:0005017,decreased B cell number|MP:0005154,increased B cell proliferation|MP:0008215,decreased immature B cell number|MP:0008495,decreased IgG1 level|MP:0008498,decreased IgG3 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level
MGI:4452498	Tg(CD19-Tnfsf7)#Rvl	MP:0002362,abnormal spleen marginal zone morphology|MP:0005017,decreased B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008211,decreased mature B cell number|MP:0008240,abnormal spleen marginal zone macrophage morphology|MP:0008241,abnormal metallophilic macrophage morphology
MGI:3762048	Tg(CD207-Dta)312Dhka	MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008118,absent Langerhans cell
MGI:4356279	Tg(CD2-Ccdc86)1Hfuj	MP:0006413,increased T cell apoptosis|MP:0008037,abnormal T cell morphology
MGI:3590082	Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell	MP:0001559,hyperglycemia|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype
MGI:3695215	Tg(CD2-Ceacam1*4L)1Rsb	MP:0002444,abnormal T cell physiology|MP:0005018,decreased T cell number|MP:0005095,decreased T cell proliferation|MP:0008688,decreased interleukin-2 secretion
MGI:5449712	Tg(CD2-Fos)#Liux	MP:0003721,increased tumor growth/size|MP:0006043,decreased apoptosis|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3800438	Tg(CD2-Foxj1)#Stlp	MP:0002223,lymphoid hypoplasia|MP:0002444,abnormal T cell physiology|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number
MGI:3785786	Tg(CD2-Ifngr2)1Pbro	MP:0005027,increased susceptibility to parasitic infection|MP:0005387,immune system phenotype|MP:0005465,abnormal T-helper 1 physiology|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008088,abnormal T-helper 1 cell differentiation
MGI:3785869	Tg(CD2-Ifngr2)2Pbro	MP:0001263,weight loss|MP:0001868,ovary inflammation|MP:0004031,insulitis|MP:0004510,myositis|MP:0005027,increased susceptibility to parasitic infection|MP:0005387,immune system phenotype|MP:0005465,abnormal T-helper 1 physiology|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008826,abnormal splenic cell ratio
MGI:3695384	Tg(CD2-LAT2)1Wz	MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology
MGI:4889196	Tg(CD2-Lmo2)#Thr	MP:0000691,enlarged spleen|MP:0000709,enlarged thymus|MP:0002083,premature death|MP:0010336,increased acute lymphoblastic leukemia incidence
MGI:6121483	Tg(CD2-Lrch1)#Liux	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005387,immune system phenotype|MP:0009858,abnormal cellular extravasation
MGI:5588400	Tg(CD2-Mir181d)38Oers	MP:0003644,thymus atrophy|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3761384	Tg(CD2-Myb/en)2Kmw	MP:0000692,small spleen|MP:0000706,small thymus|MP:0001265,decreased body size|MP:0002083,premature death|MP:0005018,decreased T cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0008081,abnormal single-positive T cell number
MGI:2446414	Tg(CD2-Nfat5)1Snh	MP:0000694,spleen hypoplasia|MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0002444,abnormal T cell physiology|MP:0005018,decreased T cell number|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005095,decreased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0009335,decreased splenocyte proliferation
MGI:5310806	Tg(CD2-NPM/ALK)4Sudt	MP:0002023,increased B cell derived lymphoma incidence|MP:0008019,increased liver tumor incidence|MP:0010296,increased hemolymphoid system tumor incidence
MGI:5426510	Tg(CD2-Ppp2ca)#Gct	MP:0000219,increased neutrophil cell number|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002743,glomerulonephritis|MP:0003944,abnormal T cell subpopulation ratio|MP:0005165,increased susceptibility to injury|MP:0008177,increased germinal center B cell number|MP:0008681,increased interleukin-17 secretion
MGI:5805451	Tg(CD2-Rorc)#Staka	MP:0000623,decreased salivation|MP:0000921,demyelination|MP:0001805,decreased IgG level|MP:0001861,lung inflammation|MP:0001870,salivary gland inflammation|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0003725,increased autoantibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005310,abnormal salivary gland physiology|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005386,behavior/neurological phenotype|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008498,decreased IgG3 level|MP:0008566,increased interferon-gamma secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008681,increased interleukin-17 secretion|MP:0008880,lacrimal gland inflammation|MP:0008897,decreased IgG2c level|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010222,abnormal T-helper 17 cell physiology|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0020936,abnormal susceptibility to Picornaviridae infection
MGI:5824062	Tg(CD2-S1PR1)1Ejg	MP:0001800,abnormal humoral immune response|MP:0001829,increased activated T cell number|MP:0001830,decreased activated T cell number|MP:0002497,increased IgE level|MP:0005015,increased T cell number|MP:0005095,decreased T cell proliferation|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0011826,abnormal lymphocyte chemotaxis|MP:0020212,impaired leukocyte migration
MGI:3641449	Tg(CD2-Sh2d1a)#Vei	MP:0003080,increased natural killer cell mediated cytotoxicity
MGI:3641447	Tg(CD2-Sh2d1b1)#Vei	MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0008567,decreased interferon-gamma secretion
MGI:3641448	Tg(CD2-Sh2d1b2)#Vei	MP:0005070,impaired natural killer cell mediated cytotoxicity
MGI:5426209	Tg(Cd2-Smad7)#Chbe	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008566,increased interferon-gamma secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008712,decreased interleukin-9 secretion|MP:0008838,decreased transforming growth factor beta level|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3845883	Tg(CD2-Stat6*V625A*T626A)78Mhk	MP:0000414,alopecia|MP:0001194,dermatitis|MP:0001219,thick epidermis|MP:0001245,thick dermal layer|MP:0001246,mixed cellular infiltration to dermis|MP:0001412,excessive scratching|MP:0002796,impaired skin barrier function
MGI:3706698	Tg(CD2-TcraF5,CD2-TcrbF5)1Kio	MP:0004919,abnormal positive T cell selection|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3614440	Tg(CD2-Tgfbr2)1Grs	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001954,respiratory distress|MP:0002024,increased T cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005150,cachexia|MP:0005202,lethargy|MP:0005348,increased T cell proliferation
MGI:3817775	Tg(CD2-Zbtb7b)C8Rbo	MP:0000727,absent CD8-positive, alpha-beta T cells|MP:0008074,increased CD4-positive, alpha-beta T cell number
MGI:3776897	Tg(CD34)29Dgt	MP:0002169,no abnormal phenotype detected
MGI:3776898	Tg(CD34-tTA,-CD34)1Dgt	MP:0002169,no abnormal phenotype detected
MGI:3767981	Tg(Cd3d-Il5)NJ.1638Nal	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000274,enlarged heart|MP:0000414,alopecia|MP:0000493,rectal prolapse|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0001209,spontaneous skin ulceration|MP:0002083,premature death|MP:0002443,abnormal eosinophil differentiation|MP:0002981,increased liver weight|MP:0003303,peritoneal inflammation|MP:0004952,increased spleen weight|MP:0005011,increased eosinophil cell number|MP:0005096,erythroblastosis|MP:0006387,abnormal T cell number|MP:0008210,increased mature B cell number
MGI:3052629	Tg(CD3E)26Cpt	MP:0000715,decreased thymocyte number|MP:0001120,abnormal uterus morphology|MP:0001262,decreased body weight|MP:0001711,abnormal placenta morphology|MP:0001716,abnormal placenta labyrinth morphology|MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002082,postnatal lethality|MP:0004259,small placenta|MP:0004896,abnormal endometrium morphology|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0008046,absent NK cells|MP:0008770,decreased survivor rate|MP:0008876,decreased uterine NK cell number|MP:0009097,absent endometrial glands|MP:0009543,abnormal thymus corticomedullary boundary morphology|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3688752	Tg(CD46)2Gsv	MP:0000266,abnormal heart morphology|MP:0001800,abnormal humoral immune response|MP:0002083,premature death|MP:0002421,abnormal cell-mediated immunity|MP:0002882,abnormal neuron morphology|MP:0003009,abnormal cytokine secretion|MP:0003203,increased neuron apoptosis|MP:0003354,astrocytosis|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005333,decreased heart rate|MP:0005671,abnormal response to transplant|MP:0008721,abnormal chemokine level|MP:0020952,increased susceptibility to Paramyxoviridae infection
MGI:6501992	Tg(CD46)373Zbz	MP:0005387,immune system phenotype
MGI:5661474	Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt	MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001829,increased activated T cell number|MP:0001859,kidney inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002083,premature death|MP:0002743,glomerulonephritis|MP:0003725,increased autoantibody level|MP:0003944,abnormal T cell subpopulation ratio|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004947,skin inflammation|MP:0004973,increased regulatory T cell number|MP:0005002,abnormal T cell clonal deletion|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005092,decreased double-positive T cell number|MP:0005094,abnormal T cell proliferation|MP:0005232,abnormal mesenteric lymph node morphology|MP:0005350,increased susceptibility to autoimmune disorder|MP:0008073,abnormal CD4-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0008566,increased interferon-gamma secretion|MP:0008826,abnormal splenic cell ratio|MP:0009542,decreased thymocyte apoptosis|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013663,increased myeloid cell number
MGI:3702083	Tg(Cd4-CD4)2362Litt	MP:0005387,immune system phenotype
MGI:4454654	Tg(CD4-CIITA)357Ccum	MP:0000066,osteoporosis|MP:0004984,increased osteoclast cell number|MP:0004992,increased bone resorption|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0013630,increased bone trabecular spacing|MP:0031074,increased circulating type I collagen C-terminal telopeptide level
MGI:3764727	Tg(Cd4-DsRed)4Lt	MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0011100,preweaning lethality, complete penetrance
MGI:4355027	Tg(Cd4-Dtx1)1Mzl	MP:0001828,abnormal T cell activation|MP:0003850,abnormal thymocyte activation|MP:0005095,decreased T cell proliferation|MP:0008688,decreased interleukin-2 secretion
MGI:3720219	Tg(Cd4-EGFP)1Lt	MP:0002169,no abnormal phenotype detected
MGI:2388569	Tg(CD4-HIV)1Pjo	MP:0002082,postnatal lethality
MGI:2388572	Tg(CD4-HIV)F21380Pjo	MP:0000274,enlarged heart|MP:0000746,weakness|MP:0001402,decreased locomotor activity|MP:0001785,edema|MP:0001862,interstitial pneumonia|MP:0002083,premature death|MP:0002704,tubular nephritis|MP:0002837,dystrophic cardiac calcinosis|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0005036,diarrhea|MP:0005150,cachexia|MP:0031071,lymph node atrophy
MGI:2388573	Tg(CD4-HIV)F21388Pjo	MP:0000274,enlarged heart|MP:0000746,weakness|MP:0001402,decreased locomotor activity|MP:0001785,edema|MP:0001862,interstitial pneumonia|MP:0002083,premature death|MP:0002704,tubular nephritis|MP:0002837,dystrophic cardiac calcinosis|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0005036,diarrhea|MP:0005150,cachexia|MP:0031071,lymph node atrophy
MGI:2388592	Tg(CD4-HIV)F21407Pjo	MP:0000746,weakness|MP:0001402,decreased locomotor activity|MP:0001785,edema|MP:0001862,interstitial pneumonia|MP:0002083,premature death|MP:0002704,tubular nephritis|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0005036,diarrhea|MP:0005150,cachexia|MP:0031071,lymph node atrophy
MGI:2388575	Tg(CD4-HIV)F26132Pjo	MP:0002169,no abnormal phenotype detected
MGI:2388577	Tg(CD4-HIV)F26605Pjo	MP:0000746,weakness|MP:0001402,decreased locomotor activity|MP:0001785,edema|MP:0001862,interstitial pneumonia|MP:0002083,premature death|MP:0002704,tubular nephritis|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0005036,diarrhea|MP:0005150,cachexia|MP:0031071,lymph node atrophy
MGI:2450567	Tg(CD4-HIV)F26622Pjo	MP:0000746,weakness|MP:0001402,decreased locomotor activity|MP:0001785,edema|MP:0001862,interstitial pneumonia|MP:0002083,premature death|MP:0002704,tubular nephritis|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0005036,diarrhea|MP:0005150,cachexia|MP:0031071,lymph node atrophy
MGI:2388585	Tg(CD4-HIV)F26985Pjo	MP:0002169,no abnormal phenotype detected
MGI:2450582	Tg(CD4-HIV)F26990Pjo	MP:0000746,weakness|MP:0001402,decreased locomotor activity|MP:0001785,edema|MP:0001862,interstitial pneumonia|MP:0002083,premature death|MP:0002704,tubular nephritis|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0005036,diarrhea|MP:0005150,cachexia|MP:0031071,lymph node atrophy
MGI:2388587	Tg(CD4-HIV)F27011Pjo	MP:0000746,weakness|MP:0001402,decreased locomotor activity|MP:0001785,edema|MP:0001862,interstitial pneumonia|MP:0002083,premature death|MP:0002704,tubular nephritis|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0005036,diarrhea|MP:0005150,cachexia|MP:0031071,lymph node atrophy
MGI:2388588	Tg(CD4-HIV)F27367Pjo	MP:0000746,weakness|MP:0001402,decreased locomotor activity|MP:0001785,edema|MP:0001862,interstitial pneumonia|MP:0002704,tubular nephritis|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0005036,diarrhea|MP:0005150,cachexia|MP:0031071,lymph node atrophy
MGI:2388590	Tg(CD4-HIV)F27372Pjo	MP:0000746,weakness|MP:0001402,decreased locomotor activity|MP:0001785,edema|MP:0005036,diarrhea|MP:0005150,cachexia
MGI:4442428	Tg(Cd4-Il17rb)#Cdon	MP:0001861,lung inflammation|MP:0002145,abnormal T cell differentiation|MP:0005011,increased eosinophil cell number|MP:0005397,hematopoietic system phenotype|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008567,decreased interferon-gamma secretion|MP:0008672,increased interleukin-13 secretion|MP:0008702,increased interleukin-5 secretion|MP:0008711,increased interleukin-9 secretion
MGI:5297501	Tg(CD4-Il17re)#Cdon	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0008568,abnormal interleukin secretion|MP:0008682,decreased interleukin-17 secretion
MGI:3849441	Tg(Cd4-Klra1)6295Dl	MP:0002169,no abnormal phenotype detected
MGI:3833917	Tg(Cd4-NPM/ALK)N1Ingh	MP:0000755,hindlimb paralysis|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001077,abnormal spinal nerve morphology|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0002461,increased immunoglobulin level|MP:0008037,abnormal T cell morphology|MP:0009320,increased lymphoblastic lymphoma incidence|MP:0009440,increased myeloma incidence|MP:0010133,increased DN3 thymocyte number|MP:0010286,increased plasmacytoma incidence|MP:0010296,increased hemolymphoid system tumor incidence|MP:0010365,increased thymus tumor incidence
MGI:3575738	Tg(Cd4-TGFBR2)16Flv	MP:0000693,spleen hyperplasia|MP:0001824,abnormal thymus involution|MP:0001828,abnormal T cell activation|MP:0001846,increased inflammatory response|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001869,pancreas inflammation|MP:0002461,increased immunoglobulin level|MP:0002495,increased IgA level|MP:0002743,glomerulonephritis|MP:0002816,colitis|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005017,decreased B cell number|MP:0005036,diarrhea|MP:0005094,abnormal T cell proliferation|MP:0005150,cachexia|MP:0008049,increased memory T cell number|MP:0008102,lymph node hyperplasia|MP:0008398,abnormal CD8-positive, alpha-beta regulatory T cell morphology|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0020519,renal glomerular immunoglobulin deposits
MGI:4881493	Tg(Cd4-Zbtb16)1797Aben	MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008090,increased T-helper 2 cell number|MP:0010835,increased CD4-positive, alpha-beta memory T cell number
MGI:3817547	Tg(CD4-Zbtb7b*,-GFP)1Itan	MP:0002169,no abnormal phenotype detected
MGI:5575881	Tg(Cd68-BCL2)526Medz	MP:0001819,abnormal immune cell physiology|MP:0001846,increased inflammatory response|MP:0001923,reduced female fertility|MP:0006043,decreased apoptosis
MGI:5576387	Tg(Cd68-BCL2)533Medz	MP:0000128,growth retardation of molars|MP:0000716,abnormal immune system cell morphology|MP:0001923,reduced female fertility|MP:0002075,abnormal coat/hair pigmentation
MGI:5576381	Tg(Cd68-BCL2)535Medz	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001846,increased inflammatory response|MP:0001923,reduced female fertility|MP:0002376,abnormal dendritic cell physiology|MP:0013260,decreased dendritic cell apoptosis
MGI:6150327	Tg(Cd68-Fem1a)1Seno	MP:0000462,abnormal digestive system morphology|MP:0000495,abnormal colon morphology|MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging|MP:0013296,abnormal susceptibility to induced colitis|MP:0013558,abnormal exocrine gland morphology
MGI:3760406	Tg(CD74)AR194Ayr	MP:0002169,no abnormal phenotype detected
MGI:5696384	Tg(Cd74-Nlrc4*)1Kyas	MP:0000219,increased neutrophil cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001194,dermatitis|MP:0001846,increased inflammatory response|MP:0002933,joint inflammation|MP:0002936,joint swelling|MP:0002993,autoimmune arthritis|MP:0004947,skin inflammation|MP:0005015,increased T cell number|MP:0008614,increased circulating interleukin-17 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008657,increased interleukin-1 beta secretion|MP:0009338,increased splenocyte number
MGI:3850366	Tg(Cd79b-TCL1A)BKTeit	MP:0000477,abnormal intestine morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0001175,abnormal lung morphology|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002397,abnormal bone marrow morphology|MP:0005013,increased lymphocyte cell number|MP:0005154,increased B cell proliferation|MP:0005348,increased T cell proliferation|MP:0006414,decreased T cell apoptosis|MP:0008783,decreased B cell apoptosis
MGI:3056809	Tg(Cd8aCd8b)3Erob	MP:0002408,abnormal double-positive T cell morphology|MP:0005089,decreased double-negative T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation
MGI:3055355	Tg(CD8aCD8b)57Scr	MP:0002435,abnormal effector T cell morphology|MP:0005078,abnormal cytotoxic T cell physiology
MGI:3663518	Tg(Cd8b1)46Erob	MP:0000715,decreased thymocyte number|MP:0003944,abnormal T cell subpopulation ratio|MP:0005018,decreased T cell number|MP:0005584,abnormal enzyme/coenzyme activity
MGI:5440883	Tg(Cdh16-Wnk1*)#Cihu	MP:0002666,increased circulating aldosterone level|MP:0005619,increased urine potassium level|MP:0005628,decreased circulating potassium level|MP:0006263,decreased systemic arterial diastolic blood pressure|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006316,increased urine sodium level|MP:0006375,increased circulating angiotensinogen level
MGI:3620560	Tg(Cdh5-cre)7Mlia	MP:0002169,no abnormal phenotype detected
MGI:2652508	Tg(CEACAM5-Tag)L5496Wzm	MP:0008010,increased gastric adenocarcinoma incidence|MP:0009476,enlarged cecum|MP:0011882,enlarged duodenum|MP:0014237,decreased tumor-free survival time
MGI:3848026	Tg(Cela1-cre/ERT)1Lgdn	MP:0002169,no abnormal phenotype detected
MGI:5560472	Tg(Cela1-luc,Cela1-TAg)#Nzh	MP:0001272,increased metastatic potential|MP:0008000,increased ovary tumor incidence|MP:0008780,increased pancreatic acinar cell carcinoma incidence
MGI:5293437	Tg(CEPHY141G6)28Hgc	MP:0005386,behavior/neurological phenotype
MGI:5293441	Tg(CEPHY141G6)4Hgc	MP:0005386,behavior/neurological phenotype
MGI:5293446	Tg(CEPHY152F7)12Hgc	MP:0001402,decreased locomotor activity|MP:0001463,abnormal spatial learning|MP:0001961,abnormal reflex|MP:0002572,abnormal emotion/affect behavior|MP:0003631,nervous system phenotype
MGI:5293456	Tg(CEPHY152F7)57Hgc	MP:0001402,decreased locomotor activity|MP:0001463,abnormal spatial learning|MP:0001961,abnormal reflex|MP:0002572,abnormal emotion/affect behavior|MP:0003631,nervous system phenotype
MGI:5291633	Tg(CEPHY230E8)50Hgc	MP:0000788,abnormal cerebral cortex morphology|MP:0001463,abnormal spatial learning
MGI:5291627	Tg(CEPHY230E8)55Hgc	MP:0001463,abnormal spatial learning
MGI:5293460	Tg(CEPHY285E6)67Hgc	MP:0005386,behavior/neurological phenotype
MGI:5293466	Tg(CEPHY285E6)84Hgc	MP:0005386,behavior/neurological phenotype
MGI:3505595	Tg(CETP)5203Tall	MP:0000186,decreased circulating HDL cholesterol level|MP:0001547,abnormal lipid level|MP:0003983,decreased cholesterol level|MP:0004777,abnormal phospholipid level|MP:0005376,homeostasis/metabolism phenotype|MP:0009356,decreased liver triglyceride level
MGI:3052658	Tg(CETP)UCTP20Pnu	MP:0000180,abnormal circulating cholesterol level|MP:0000182,increased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0005145,increased circulating VLDL cholesterol level|MP:0005339,increased susceptibility to atherosclerosis|MP:0005416,abnormal circulating protein level
MGI:2446075	Tg(Cga-LHB/CGB)94Jhn	MP:0000519,hydronephrosis|MP:0000539,distended urinary bladder|MP:0001133,impaired luteal cell differentiation|MP:0001147,small testis|MP:0001751,increased circulating luteinizing hormone level|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002016,ovary cyst|MP:0003586,dilated ureter|MP:0004832,enlarged ovary|MP:0005186,increased circulating progesterone level|MP:0008000,increased ovary tumor incidence|MP:0008291,abnormal adrenocortical cell morphology|MP:0008869,anovulation|MP:0008975,delayed male fertility|MP:0011403,pyelonephritis|MP:0011405,tubulointerstitial nephritis|MP:0014604,hemorrhagic ovary cyst
MGI:4950478	Tg(Chat-COP4*H134R/EYFP,Slc18a3)6Gfng	MP:0001409,increased stereotypic behavior|MP:0001463,abnormal spatial learning|MP:0002804,abnormal motor learning|MP:0004077,abnormal striatum morphology|MP:0004101,abnormal brain interneuron morphology|MP:0008428,abnormal spatial working memory|MP:0008911,induced hyperactivity|MP:0009456,impaired cued conditioning behavior|MP:0009749,enhanced behavioral response to addictive substance|MP:0011939,increased food intake|MP:0011941,increased fluid intake|MP:0012107,enhanced exercise endurance
MGI:3842784	Tg(Chst4-cre)1Hkwa	MP:0005387,immune system phenotype
MGI:3052237	Tg(Chx10-EGFP/cre,-ALPP)2Clc	MP:0002169,no abnormal phenotype detected
MGI:3720795	Tg(Ckm-APPSw)A2Lfa	MP:0001405,impaired coordination|MP:0003329,amyloid beta deposits|MP:0004510,myositis|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:3720796	Tg(Ckm-APPSw)A6Lfa	MP:0001405,impaired coordination|MP:0003329,amyloid beta deposits|MP:0004510,myositis|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:3652419	Tg(Ckm-Cd36)1Naa	MP:0001262,decreased body weight|MP:0002079,increased circulating insulin level|MP:0002106,abnormal muscle physiology|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0003976,decreased circulating VLDL triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0005559,increased circulating glucose level|MP:0010025,decreased total body fat amount
MGI:5694343	Tg(Ckm-Chrnd*S262T)40Cgz	MP:0002913,abnormal PNS synaptic transmission|MP:0002914,abnormal endplate potential|MP:0004835,abnormal miniature endplate potential|MP:0005369,muscle phenotype|MP:0005402,abnormal action potential
MGI:5468686	Tg(Ckm-Chrne*L269F)5Cgz	MP:0000747,muscle weakness|MP:0001402,decreased locomotor activity|MP:0002913,abnormal PNS synaptic transmission|MP:0002914,abnormal endplate potential|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004835,abnormal miniature endplate potential|MP:0005402,abnormal action potential|MP:0005573,increased pulmonary respiratory rate|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009412,skeletal muscle fiber degeneration|MP:0014603,neuromuscular synapse degeneration
MGI:5427873	Tg(Ckm-CUGBP1)1039Coop	MP:0002081,perinatal lethality|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0009412,skeletal muscle fiber degeneration
MGI:3717406	Tg(Ckm-DGAT2)10Far	MP:0001547,abnormal lipid level|MP:0002078,abnormal glucose homeostasis|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0031415,increased skeletal muscle triglyceride level
MGI:5767288	Tg(Ckm-DNAJB6_ib*F93L)#Ccwe	MP:0000748,progressive muscle weakness|MP:0000751,myopathy|MP:0002083,premature death|MP:0004087,abnormal muscle fiber morphology|MP:0004091,abnormal Z line morphology|MP:0010053,decreased grip strength
MGI:5297551	Tg(Ckm-Fstl1)#Mvdh	MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003915,increased heart left ventricle weight|MP:0004486,decreased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005601,increased angiogenesis|MP:0010551,abnormal coronary vessel morphology
MGI:4353799	Tg(Ckm-GSN*D187N)AJewe	MP:0000604,amyloidosis|MP:0000748,progressive muscle weakness|MP:0000749,muscle degeneration|MP:0001405,impaired coordination|MP:0002269,muscular atrophy|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009413,skeletal muscle fiber atrophy
MGI:3842765	Tg(Ckm-IGF1R*K1003R)1Dlr	MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001559,hyperglycemia|MP:0001732,postnatal growth retardation|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002842,increased systemic arterial blood pressure|MP:0002871,albuminuria|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003917,increased kidney weight|MP:0003926,decreased cellular glucose uptake|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005325,abnormal renal glomerulus morphology|MP:0005331,insulin resistance|MP:0005438,abnormal glycogen homeostasis|MP:0005491,pancreatic islet hyperplasia|MP:0005527,increased renal glomerular filtration rate|MP:0005553,increased circulating creatinine level|MP:0005559,increased circulating glucose level|MP:0008140,podocyte foot process effacement|MP:0008489,slow postnatal weight gain|MP:0009355,increased liver triglyceride level|MP:0011339,abnormal glomerular mesangium morphology|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011753,decreased podocyte number|MP:0030022,decreased muscle cell glucose uptake
MGI:3624978	Tg(Ckm-LPL)HRze	MP:0000013,abnormal adipose tissue distribution|MP:0000751,myopathy|MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0002083,premature death|MP:0002644,decreased circulating triglyceride level|MP:0003249,increased muscle free fatty acids level|MP:0003976,decreased circulating VLDL triglyceride level|MP:0004087,abnormal muscle fiber morphology|MP:0004819,decreased skeletal muscle mass|MP:0010401,increased skeletal muscle glycogen level|MP:0011593,increased catalase activity|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:3624976	Tg(Ckm-LPL)LRze	MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0002083,premature death|MP:0002644,decreased circulating triglyceride level|MP:0003976,decreased circulating VLDL triglyceride level|MP:0011593,increased catalase activity
MGI:3624977	Tg(Ckm-LPL)MRze	MP:0000013,abnormal adipose tissue distribution|MP:0000751,myopathy|MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0002083,premature death|MP:0002644,decreased circulating triglyceride level|MP:0003249,increased muscle free fatty acids level|MP:0003976,decreased circulating VLDL triglyceride level|MP:0004087,abnormal muscle fiber morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0010401,increased skeletal muscle glycogen level|MP:0011593,increased catalase activity|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:2180562	Tg(Ckmm-Cav3)1Ysu	MP:0000160,kyphosis|MP:0000278,abnormal myocardial fiber morphology|MP:0000751,myopathy|MP:0000755,hindlimb paralysis|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002106,abnormal muscle physiology|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0003957,abnormal nitric oxide homeostasis|MP:0004564,increased myocardial fiber size|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009412,skeletal muscle fiber degeneration|MP:0009417,skeletal muscle atrophy|MP:0010580,decreased heart left ventricle size|MP:0010724,thick interventricular septum|MP:0011925,abnormal heart echocardiography feature|MP:0031635,increased heart left ventricle muscle contractility
MGI:4442879	Tg(Ckm-Mir499)#Eno	MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0012107,enhanced exercise endurance
MGI:3530559	Tg(Ckm-Mkl1)1Eno	MP:0000751,myopathy|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0004819,decreased skeletal muscle mass
MGI:3716428	Tg(Ckm*-Mstn)1Nfg	MP:0004819,decreased skeletal muscle mass|MP:0005385,cardiovascular system phenotype
MGI:3716427	Tg(Ckm-Mstn)1Nfg	MP:0001262,decreased body weight|MP:0002834,decreased heart weight|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004819,decreased skeletal muscle mass|MP:0005329,abnormal myocardium layer morphology|MP:0009288,increased epididymal fat pad weight|MP:0009400,decreased skeletal muscle fiber size
MGI:2446436	Tg(Ckmm-Ucp1)1Boud	MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0001433,polyphagia|MP:0004819,decreased skeletal muscle mass|MP:0004889,increased energy expenditure|MP:0005459,decreased percent body fat/body weight|MP:0005554,decreased circulating creatinine level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009422,decreased gastrocnemius weight|MP:0010239,decreased skeletal muscle weight|MP:0010954,abnormal cellular respiration|MP:0014811,decreased circulating urea level
MGI:5554433	Tg(Ckm-Pnpla2)164Eek	MP:0031414,decreased skeletal muscle triglyceride level
MGI:4430733	Tg(Ckm-Ppara)HEDpk	MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008853,decreased abdominal adipose tissue amount|MP:0030022,decreased muscle cell glucose uptake|MP:0031415,increased skeletal muscle triglyceride level
MGI:4429471	Tg(Ckm-Ppard)MEDpk	MP:0004130,abnormal muscle cell glucose uptake|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance
MGI:3845815	Tg(Ckm-Ppargc1a)31Brsp	MP:0000759,abnormal skeletal muscle morphology|MP:0002106,abnormal muscle physiology|MP:0003360,abnormal depression-related behavior|MP:0006038,increased mitochondrial fission|MP:0010957,abnormal aerobic respiration
MGI:4354127	Tg(Ckm-Ppargc1b)T37Brsp	MP:0000759,abnormal skeletal muscle morphology|MP:0002106,abnormal muscle physiology|MP:0006035,abnormal mitochondrial morphology|MP:0009400,decreased skeletal muscle fiber size|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009460,skeletal muscle hypoplasia|MP:0012107,enhanced exercise endurance
MGI:3639284	Tg(Ckm-Prkaa2*K45R)1Mbb	MP:0000188,abnormal circulating glucose level|MP:0000278,abnormal myocardial fiber morphology|MP:0000343,abnormal response to cardiac infarction|MP:0002106,abnormal muscle physiology|MP:0002188,small heart|MP:0012106,impaired exercise endurance|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3717234	Tg(Ckm-PTPN1)45Bbk	MP:0002078,abnormal glucose homeostasis|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005438,abnormal glycogen homeostasis|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:3717241	Tg(Ckm-PTPRF)13Bbk	MP:0002078,abnormal glucose homeostasis|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005438,abnormal glycogen homeostasis|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:5911931	Tg(Ckm-Sgcg)4Mcn	MP:0000752,dystrophic muscle|MP:0000759,abnormal skeletal muscle morphology|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0004819,decreased skeletal muscle mass|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:5911936	Tg(Ckm-Sgcg)5Mcm	MP:0001265,decreased body size|MP:0001406,abnormal gait
MGI:5707033	Tg(Ckm-Slc2a4)1Klip	MP:0005293,impaired glucose tolerance
MGI:4442878	Tg(Ckm-Sox6)#Eno	MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality|MP:0009409,abnormal skeletal muscle fiber type ratio
MGI:3700927	Tg(Ckm-Syne2)1Rexu	MP:0001053,abnormal neuromuscular synapse morphology
MGI:4847575	Tg(CLEC4C-HBEGF)956Cln	MP:0000692,small spleen|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005078,abnormal cytotoxic T cell physiology|MP:0008042,abnormal NK T cell physiology|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0008563,decreased interferon-alpha secretion|MP:0008566,increased interferon-gamma secretion|MP:0008663,increased interleukin-12 secretion|MP:0008722,abnormal chemokine secretion|MP:0009339,decreased splenocyte number|MP:0010766,abnormal NK cell physiology|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:3689050	Tg(CMV-Abcc9)1Ajo	MP:0000343,abnormal response to cardiac infarction|MP:0003038,decreased myocardial infarct size|MP:0004121,abnormal sarcolemma morphology|MP:0004215,abnormal myocardial fiber physiology
MGI:5762688	Tg(CMV-APPL2)1Smoc	MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0031618,decreased skeletal muscle cell glucose uptake
MGI:4360489	Tg(CMV-Atf4)1Kry	MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:5646300	Tg(CMV-ATXN3*135Q)CPama	MP:0000745,tremors|MP:0000774,decreased brain size|MP:0000836,abnormal substantia nigra morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001417,decreased exploration in new environment|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002175,decreased brain weight|MP:0002229,neurodegeneration|MP:0003354,astrocytosis|MP:0004142,abnormal muscle tone|MP:0004191,neuronal intranuclear inclusions|MP:0010053,decreased grip strength|MP:0020560,abnormal pontine nuclei morphology|MP:0020562,decreased pontine nuclei size
MGI:4822568	Tg(CMV-ATXN3*83Q)83Pama	MP:0005386,behavior/neurological phenotype
MGI:4822570	Tg(CMV-ATXN3*94Q)94Pama	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002229,neurodegeneration|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005621,abnormal cell physiology
MGI:4868372	Tg(CMV-BBS1)6Vcs	MP:0002169,no abnormal phenotype detected
MGI:5910536	Tg(CMV-cat,-ROCK2*)3-1Koba	MP:0000272,abnormal aorta morphology|MP:0000280,thin ventricular wall|MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002190,disorganized myocardium|MP:0002833,increased heart weight|MP:0002952,ventricular cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0003896,prolonged PR interval|MP:0003920,abnormal heart right ventricle morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004937,dilated heart|MP:0005294,abnormal heart ventricle morphology|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006267,abnormal intercalated disk morphology|MP:0008022,dilated heart ventricle|MP:0010392,prolonged QRS complex duration|MP:0010535,myocardium steatosis|MP:0010725,thin interventricular septum|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0011925,abnormal heart echocardiography feature|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5000107	Tg(CMV-EGFP,RNU6-RNAi:Rgs16)#Haya	MP:0001402,decreased locomotor activity|MP:0001431,abnormal eating behavior|MP:0020470,shortened circadian behavior period
MGI:3510918	Tg(CMV-EGFP,Rnu6-siAbca1)#Wcyy	MP:0002628,hepatic steatosis|MP:0005179,decreased circulating cholesterol level
MGI:5573173	Tg(CMV-EYFP/DsRed2)1Mklv	MP:0002169,no abnormal phenotype detected
MGI:6393884	Tg(CMV-GFP,-RNAi:Clec16a)KD3Kslr	MP:0008873,increased physiological sensitivity to xenobiotic
MGI:5504430	Tg(CMV-GFP,-Smarcc2,-lacZ)#Stoy	MP:0004979,abnormal neuronal precursor cell number|MP:0006254,thin cerebral cortex|MP:0008547,abnormal neocortex morphology|MP:0008877,abnormal DNA methylation|MP:0008946,abnormal neuron number|MP:0009937,abnormal neuron differentiation
MGI:3620921	Tg(CMV-Gja1)BClo	MP:0000266,abnormal heart morphology|MP:0000277,abnormal heart shape|MP:0000281,abnormal interventricular septum morphology|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0001061,abnormal oculomotor nerve morphology|MP:0001064,absent trochlear nerve|MP:0001071,abnormal facial nerve morphology|MP:0001076,abnormal hypoglossal nerve morphology|MP:0001077,abnormal spinal nerve morphology|MP:0001093,small trigeminal ganglion|MP:0001265,decreased body size|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002151,abnormal neural tube morphology|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002621,delayed neural tube closure|MP:0002752,abnormal somatic nervous system morphology|MP:0002754,dilated heart right ventricle|MP:0004938,dilated vasculature|MP:0005294,abnormal heart ventricle morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005621,abnormal cell physiology|MP:0005657,abnormal neural plate morphology|MP:0008028,pregnancy-related premature death|MP:0010421,ventricular aneurysm|MP:0010428,abnormal heart right ventricle outflow tract morphology|MP:0010449,heart right ventricle outflow tract stenosis|MP:0010551,abnormal coronary vessel morphology|MP:0012681,collapsed brain ventricles|MP:0031526,thin right ventricle myocardium compact layer
MGI:5569528	Tg(CMV-HTT*48Q)BTag	MP:0001396,unidirectional circling|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001513,limb grasping|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002183,gliosis|MP:0002690,akinesia|MP:0003224,neuron degeneration|MP:0003280,urinary incontinence|MP:0003354,astrocytosis|MP:0004191,neuronal intranuclear inclusions|MP:0008489,slow postnatal weight gain
MGI:5569532	Tg(CMV-HTT*89Q)ATag	MP:0001396,unidirectional circling|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0001513,limb grasping|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002183,gliosis|MP:0002690,akinesia|MP:0003224,neuron degeneration|MP:0003280,urinary incontinence|MP:0003354,astrocytosis|MP:0004191,neuronal intranuclear inclusions|MP:0008489,slow postnatal weight gain
MGI:3721910	Tg(CMV-IgkvaD11)BCat	MP:0001015,small superior cervical ganglion|MP:0001038,abnormal cholinergic neuron morphology|MP:0001458,abnormal object recognition memory|MP:0002152,abnormal brain morphology|MP:0002184,abnormal innervation|MP:0002229,neurodegeneration|MP:0003214,neurofibrillary tangles|MP:0003224,neuron degeneration|MP:0003329,amyloid beta deposits|MP:0004250,tau protein deposits|MP:0012307,impaired spatial learning|MP:0031384,impaired blood-brain barrier function
MGI:5318684	Tg(CMV-IGL@AL080)55Dcs	MP:0000471,abnormal stomach epithelium morphology|MP:0000604,amyloidosis|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002757,decreased vertical activity|MP:0003061,decreased aerobic running capacity|MP:0003225,axonal dystrophy|MP:0003299,gastric polyps|MP:0005367,renal/urinary system phenotype|MP:0005385,cardiovascular system phenotype
MGI:5478742	Tg(CMV-LITAF*W116G)#Lli	MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002651,abnormal sciatic nerve morphology|MP:0003871,abnormal myelin sheath morphology|MP:0004924,abnormal behavior|MP:0005402,abnormal action potential|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0005498,hyporesponsive to tactile stimuli|MP:0008814,decreased nerve conduction velocity|MP:0010732,abnormal node of Ranvier morphology|MP:0010734,abnormal paranode morphology|MP:0010737,abnormal juxtaparanode morphology
MGI:3762251	Tg(CMV-Msx2*P7H)1Rem	MP:0000081,premature cranial suture closure|MP:0014166,ectopic cranial bone
MGI:5302242	Tg(CMV-MYOC*Y437H)#Vcs	MP:0002092,abnormal eye morphology|MP:0003224,neuron degeneration|MP:0005203,abnormal trabecular meshwork morphology|MP:0005258,ocular hypertension|MP:0005405,axon degeneration|MP:0005551,abnormal eye electrophysiology|MP:0006219,optic nerve degeneration|MP:0008067,retina ganglion cell degeneration|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0020354,increased endoplasmic reticulum stress
MGI:5613978	Tg(CMV-Plaur*)19Lbh	MP:0005376,homeostasis/metabolism phenotype
MGI:4410523	Tg(CMV-RNAi:Pqbp1)1Hiok	MP:0001364,decreased anxiety-related response|MP:0003461,abnormal response to novel object|MP:0005386,behavior/neurological phenotype
MGI:3038604	Tg(CMV-Rpgr)1Tili	MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0005253,abnormal eye physiology
MGI:5558103	Tg(CMV-SALL4_iB)#Chai	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000321,increased bone marrow cell number|MP:0001406,abnormal gait|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0001891,hydrocephaly|MP:0002026,increased leukemia incidence|MP:0002417,abnormal megakaryocyte morphology|MP:0002447,abnormal erythrocyte morphology|MP:0003135,increased erythroid progenitor cell number|MP:0003708,binucleate|MP:0005065,abnormal neutrophil morphology|MP:0006042,increased apoptosis|MP:0008246,abnormal leukocyte morphology|MP:0008528,polycystic kidney|MP:0009395,increased nucleated erythrocyte cell number|MP:0010373,myeloid hyperplasia|MP:0030025,giant platelets
MGI:5052107	Tg(CMV-SART3)#Hbro	MP:0002123,abnormal definitive hematopoiesis|MP:0003135,increased erythroid progenitor cell number|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008973,decreased erythroid progenitor cell number
MGI:3810927	Tg(CMV-Serpine1)1Dgi	MP:0001175,abnormal lung morphology|MP:0002006,neoplasm|MP:0005385,cardiovascular system phenotype|MP:0006050,pulmonary fibrosis
MGI:5489794	Tg(CMV-TcrAHIII12.2)1Ecol	MP:0002169,no abnormal phenotype detected
MGI:3832958	Tg(CMV-TOR1A)1Nush	MP:0005386,behavior/neurological phenotype
MGI:3832950	Tg(CMV-TOR1A*)1Nush	MP:0001407,short stride length|MP:0002804,abnormal motor learning
MGI:3832953	Tg(CMV-TOR1A*)2Nush	MP:0001407,short stride length|MP:0002804,abnormal motor learning
MGI:5049894	Tg(CMV-Tsc2*)1Arbi	MP:0000849,abnormal cerebellum morphology|MP:0001243,abnormal dermal layer morphology|MP:0001360,abnormal social investigation|MP:0001475,reduced long-term depression|MP:0002804,abnormal motor learning|MP:0009469,increased skin hamartoma incidence|MP:0010306,increased hamartoma incidence|MP:0020395,abnormal response to social novelty
MGI:5463934	Tg(CNN1)#Jomm	MP:0004883,abnormal vascular wound healing
MGI:3850676	Tg(Cnp-EGFP/Rpl10a)JD368Htz	MP:0002169,no abnormal phenotype detected
MGI:5485351	Tg(Cnp-EGFR)10Nrat	MP:0000324,increased mast cell number|MP:0000958,peripheral nervous system degeneration|MP:0001056,abnormal cranial nerve morphology|MP:0001106,abnormal Schwann cell morphology|MP:0002033,increased malignant triton tumor incidence|MP:0002036,increased rhabdomyosarcoma incidence|MP:0002651,abnormal sciatic nerve morphology|MP:0002752,abnormal somatic nervous system morphology|MP:0003632,abnormal nervous system morphology|MP:0003871,abnormal myelin sheath morphology|MP:0008415,abnormal neurite morphology|MP:0010314,increased neurofibroma incidence|MP:0010742,increased Schwann cell number|MP:0011730,increased myelin sheath thickness
MGI:4399724	Tg(Cnp-Gpr17)1Qrlu	MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000920,abnormal myelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0002064,seizures|MP:0002082,postnatal lethality|MP:0002183,gliosis|MP:0003631,nervous system phenotype|MP:0008918,microgliosis
MGI:5573156	Tg(Cnp-MAPT*P301L)6Vle	MP:0003631,nervous system phenotype
MGI:5573154	Tg(Cnp-SNCA)M2Vle	MP:0000921,demyelination|MP:0001405,impaired coordination|MP:0002175,decreased brain weight|MP:0002183,gliosis|MP:0003224,neuron degeneration|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0003871,abnormal myelin sheath morphology|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005405,axon degeneration|MP:0008026,abnormal brain white matter morphology|MP:0008493,alpha-synuclein inclusion body|MP:0008948,decreased neuron number|MP:0009808,decreased oligodendrocyte number|MP:0010053,decreased grip strength|MP:0010768,mortality/aging|MP:0012506,brain atrophy
MGI:5703789	Tg(Cnr1-EGFP/RNAi:Gad1)1Mirn	MP:0001360,abnormal social investigation|MP:0001488,increased startle reflex|MP:0009455,enhanced cued conditioning behavior|MP:0010069,increased serotonin level|MP:0012318,slow extinction of fear memory|MP:0013894,abnormal behavioral response to amphetamine
MGI:2445836	Tg(CNTN2-CNTN1)1Gnn	MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000873,thin external granule cell layer|MP:0000890,thin cerebellar molecular layer|MP:0004098,abnormal cerebellar granule cell morphology|MP:0006099,thin cerebellar granule layer|MP:0008415,abnormal neurite morphology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008579,abnormal Purkinje cell differentiation
MGI:1856829	Tg<cog>	MP:0000208,decreased hematocrit|MP:0000920,abnormal myelination|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0002175,decreased brain weight|MP:0002427,disproportionate dwarf|MP:0002865,increased growth rate|MP:0004696,abnormal thyroid follicle morphology|MP:0004697,abnormal thyroid follicular cell morphology|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005355,enlarged thyroid gland|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level
MGI:4397570	Tg(Col10a1-Tg*L2263P)1Rpbh	MP:0003109,short femur|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004985,decreased osteoclast cell number|MP:0020354,increased endoplasmic reticulum stress
MGI:5448404	Tg(Col11a2-Npr2*)28Keoz	MP:0000074,abnormal neurocranium morphology|MP:0000137,abnormal vertebrae morphology|MP:0000160,kyphosis|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0001257,increased body length|MP:0001392,abnormal locomotor behavior|MP:0002758,long tail|MP:0003723,abnormal long bone morphology|MP:0004348,long femur|MP:0004357,long tibia|MP:0005306,abnormal phalanx morphology|MP:0006397,disorganized long bone epiphyseal plate|MP:0006398,increased long bone epiphyseal plate size
MGI:5317919	Tg(Col11a2-SIK3)#Ntsu	MP:0004686,decreased length of long bones|MP:0006396,decreased long bone epiphyseal plate size|MP:0010873,decreased trabecular bone mass
MGI:3766089	Tg(COL1A1)73Prc	MP:0000061,fragile skeleton|MP:0000126,brittle teeth|MP:0001199,thin skin|MP:0001506,limp posture|MP:0001533,abnormal skeleton physiology|MP:0001732,postnatal growth retardation|MP:0002100,abnormal tooth morphology|MP:0002896,abnormal bone mineralization|MP:0003109,short femur|MP:0003723,abnormal long bone morphology|MP:0004675,rib fractures|MP:0010124,decreased bone mineral content|MP:0011088,neonatal lethality, incomplete penetrance|MP:0030826,decreased femur weight
MGI:4360488	Tg(Col1a1-Atf4)1Kry	MP:0000188,abnormal circulating glucose level|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005559,increased circulating glucose level|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0011820,decreased pancreatic beta cell proliferation
MGI:3830288	Tg(Col1a1-Cthrc1)1Haak	MP:0000130,abnormal trabecular bone morphology|MP:0004988,increased osteoblast cell number|MP:0005006,abnormal osteoblast physiology|MP:0005390,skeleton phenotype|MP:0005605,increased bone mass|MP:0008271,abnormal bone ossification|MP:0010868,increased bone trabecula number|MP:0010872,increased trabecular bone mass|MP:0030438,increased osteoblast proliferation
MGI:5818202	Tg(Col1a1-Dkk1)1Hmk	MP:0000063,decreased bone mineral density|MP:0001533,abnormal skeleton physiology|MP:0001541,abnormal osteoclast physiology|MP:0002123,abnormal definitive hematopoiesis|MP:0002896,abnormal bone mineralization|MP:0003077,abnormal cell cycle|MP:0003497,insensitivity to parathyroid hormone|MP:0004984,increased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0004991,decreased bone strength|MP:0005671,abnormal response to transplant|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0010933,decreased trabecular bone connectivity density|MP:0011711,impaired osteoblast differentiation|MP:0013630,increased bone trabecular spacing|MP:0013892,increased common lymphocyte progenitor cell number|MP:0020040,decreased bone ossification
MGI:6297004	Tg(Col1a1-FGF2*,-Sapphire)203Mmh	MP:0000130,abnormal trabecular bone morphology|MP:0000131,abnormal long bone epiphysis morphology|MP:0000198,decreased circulating phosphate level|MP:0001262,decreased body weight|MP:0002901,increased urine phosphate level|MP:0002904,increased circulating parathyroid hormone level|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003560,osteoarthritis|MP:0004016,decreased bone mass|MP:0004686,decreased length of long bones|MP:0004984,increased osteoclast cell number|MP:0004992,increased bone resorption|MP:0005416,abnormal circulating protein level|MP:0006433,abnormal articular cartilage morphology|MP:0009346,decreased trabecular bone thickness|MP:0009445,osteomalacia|MP:0010124,decreased bone mineral content|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0013304,osteophytes|MP:0013630,increased bone trabecular spacing|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization|MP:0021190,decreased bone mineral density of lumbar vertebrae|MP:0030837,abnormal knee joint morphology|MP:0031074,increased circulating type I collagen C-terminal telopeptide level
MGI:5498524	Tg(Col1a1-FGF2*,-Sapphire)305Mmh	MP:0000062,increased bone mineral density|MP:0001260,increased body weight|MP:0002397,abnormal bone marrow morphology|MP:0003797,abnormal compact bone morphology|MP:0009347,increased trabecular bone thickness|MP:0010123,increased bone mineral content|MP:0010867,abnormal bone trabecula morphology|MP:0010875,increased bone volume|MP:0010971,abnormal periosteum morphology|MP:0013623,increased femur compact bone thickness|MP:0020011,increased bone mineral density of femur|MP:0021183,increased femoral compact bone area
MGI:5498503	Tg(Col1a1-FGF2*,-Sapphire)308Mmh	MP:0000062,increased bone mineral density|MP:0001260,increased body weight|MP:0002397,abnormal bone marrow morphology|MP:0003797,abnormal compact bone morphology|MP:0009347,increased trabecular bone thickness|MP:0010123,increased bone mineral content|MP:0010867,abnormal bone trabecula morphology|MP:0010875,increased bone volume|MP:0010971,abnormal periosteum morphology|MP:0013623,increased femur compact bone thickness|MP:0020011,increased bone mineral density of femur|MP:0021183,increased femoral compact bone area
MGI:5882591	Tg(Col1a1-Ifitm5*)1Brle	MP:0000061,fragile skeleton|MP:0000558,abnormal tibia morphology|MP:0002109,abnormal limb morphology|MP:0002113,abnormal skeleton development|MP:0004624,abnormal thoracic cage morphology|MP:0005508,abnormal skeleton morphology|MP:0006398,increased long bone epiphyseal plate size|MP:0011089,perinatal lethality, complete penetrance|MP:0020137,decreased bone mineralization|MP:0020138,delayed bone mineralization
MGI:5427917	Tg(Col1a1-Mir34c)#Kry	MP:0002113,abnormal skeleton development|MP:0004016,decreased bone mass|MP:0004989,decreased osteoblast cell number|MP:0005006,abnormal osteoblast physiology|MP:0005390,skeleton phenotype|MP:0030439,decreased osteoblast proliferation
MGI:5441468	Tg(Col1a1-Ndgr2)#Xzg	MP:0003047,abnormal thoracic vertebrae morphology|MP:0004607,abnormal cervical atlas morphology|MP:0004616,lumbar vertebral transformation|MP:0004617,sacral vertebral transformation|MP:0010703,split cervical axis
MGI:3763103	Tg(Col1a1-Ptprv)1Kry	MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0004893,decreased adiponectin level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0009114,decreased pancreatic beta cell mass|MP:0011820,decreased pancreatic beta cell proliferation
MGI:4887925	Tg(Col1a1-Runx2)#Pmt	MP:0000061,fragile skeleton|MP:0000135,decreased compact bone thickness|MP:0002896,abnormal bone mineralization|MP:0003797,abnormal compact bone morphology|MP:0004016,decreased bone mass|MP:0004984,increased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0008271,abnormal bone ossification|MP:0008395,abnormal osteoblast differentiation|MP:0030483,decreased osteocyte number
MGI:5706722	Tg(Col1a1-TK*)#Rowe	MP:0000062,increased bone mineral density|MP:0000333,decreased bone marrow cell number|MP:0001542,abnormal bone strength|MP:0002896,abnormal bone mineralization|MP:0004952,increased spleen weight|MP:0004985,decreased osteoclast cell number|MP:0004989,decreased osteoblast cell number|MP:0004993,decreased bone resorption|MP:0008271,abnormal bone ossification|MP:0009347,increased trabecular bone thickness|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0013617,increased areal bone mineral density|MP:0013641,increased vertebra stiffness|MP:0020011,increased bone mineral density of femur
MGI:2176070	Tg(Col2a1-cre)1Bhr	MP:0000438,abnormal cranium morphology
MGI:3665440	Tg(Col2a1-cre/ERT)KA3Smac	MP:0002169,no abnormal phenotype detected
MGI:2181545	Tg(Col2a1-Fgfr3/GH)ADor	MP:0008974,proportional dwarf
MGI:2181547	Tg(Col2a1-Fgfr3/GH)BDor	MP:0000071,axial skeleton hypoplasia|MP:0000137,abnormal vertebrae morphology|MP:0000160,kyphosis|MP:0000440,domed cranium|MP:0002115,abnormal limb bone morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004606,absent vertebral spinous process|MP:0004686,decreased length of long bones|MP:0005225,abnormal vertebrae development|MP:0006322,abnormal perichondrium morphology|MP:0006396,decreased long bone epiphyseal plate size|MP:0006399,abnormal long bone epiphyseal ossification zone morphology|MP:0008396,abnormal osteoclast differentiation|MP:0008974,proportional dwarf|MP:0009250,abnormal appendicular skeleton morphology|MP:0009780,abnormal chondrocyte physiology
MGI:7261448	Tg(Col2a1*G574S)1Waho	MP:0000111,cleft palate|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000438,abnormal cranium morphology|MP:0000445,short snout|MP:0000547,short limbs|MP:0000592,short tail|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003419,delayed endochondral bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004624,abnormal thoracic cage morphology|MP:0004686,decreased length of long bones|MP:0004704,short vertebral column|MP:0006395,abnormal epiphyseal plate morphology|MP:0008272,abnormal endochondral bone ossification|MP:0011090,perinatal lethality, incomplete penetrance|MP:0014105,abnormal chondrocyte differentiation
MGI:4829765	Tg(Col2a1-Glg1)#Brle	MP:0001533,abnormal skeleton physiology|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0009780,abnormal chondrocyte physiology
MGI:3525223	Tg(Col2a1-Hdac4)1Eno	MP:0000130,abnormal trabecular bone morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0004686,decreased length of long bones|MP:0004989,decreased osteoblast cell number
MGI:3718996	Tg(Col2a1-Mef2c/en)1Eno	MP:0000547,short limbs|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004624,abnormal thoracic cage morphology|MP:0004704,short vertebral column|MP:0008275,failure of endochondral bone ossification
MGI:3719002	Tg(Col2a1-Mef2c/VP16)1Eno	MP:0000074,abnormal neurocranium morphology|MP:0000547,short limbs|MP:0000550,abnormal forelimb morphology|MP:0003417,premature endochondral bone ossification|MP:0006395,abnormal epiphyseal plate morphology
MGI:4461001	Tg(Col2a1-Mir140)#Asah	MP:0003436,decreased susceptibility to induced arthritis
MGI:5441471	Tg(Col2a1-Ndgr2)#Xzg	MP:0004616,lumbar vertebral transformation|MP:0004617,sacral vertebral transformation
MGI:3722687	Tg(Col2a1-Npr2*B1)2Gar	MP:0002169,no abnormal phenotype detected
MGI:3722765	Tg(Col2a1-Npr2*B2)25-4Gar	MP:0001258,decreased body length
MGI:2182284	Tg(Col2a1-PTHLH)1Ecw	MP:0000137,abnormal vertebrae morphology|MP:0000547,short limbs|MP:0000592,short tail|MP:0001265,decreased body size|MP:0002113,abnormal skeleton development|MP:0002427,disproportionate dwarf|MP:0002657,chondrodystrophy|MP:0003419,delayed endochondral bone ossification|MP:0004686,decreased length of long bones|MP:0006398,increased long bone epiphyseal plate size|MP:0008271,abnormal bone ossification|MP:0014106,delayed chondrocyte differentiation
MGI:3717404	Tg(Col2a1-PTHLH)2Ecw	MP:0002896,abnormal bone mineralization
MGI:3584013	Tg(Col2a1-PTHR1*H223R)AHju	MP:0000137,abnormal vertebrae morphology|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0002657,chondrodystrophy|MP:0002896,abnormal bone mineralization|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0004686,decreased length of long bones|MP:0008272,abnormal endochondral bone ossification|MP:0009780,abnormal chondrocyte physiology
MGI:3584015	Tg(Col2a1-PTHR1*H223R)BHju	MP:0000133,abnormal long bone metaphysis morphology|MP:0000137,abnormal vertebrae morphology|MP:0000547,short limbs|MP:0000556,abnormal hindlimb morphology|MP:0000592,short tail|MP:0002764,short tibia|MP:0002896,abnormal bone mineralization|MP:0003419,delayed endochondral bone ossification|MP:0008162,increased diameter of tibia|MP:0008271,abnormal bone ossification|MP:0014322,short hindlimb
MGI:7311638	Tg(COL2A1*R519C)#Afe	MP:0000111,cleft palate|MP:0000163,abnormal cartilage morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000445,short snout|MP:0000547,short limbs|MP:0002114,abnormal axial skeleton morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002251,abnormal nasopharynx morphology|MP:0005378,growth/size/body region phenotype|MP:0009703,decreased birth body size|MP:0011087,neonatal lethality, complete penetrance|MP:0030953,abnormal Golgi cisterna morphology
MGI:4941021	Tg(Col2a1*R789C)#Waho	MP:0000060,delayed bone ossification|MP:0000111,cleft palate|MP:0000163,abnormal cartilage morphology|MP:0000445,short snout|MP:0000547,short limbs|MP:0001258,decreased body length|MP:0001270,distended abdomen|MP:0001935,decreased litter size|MP:0001954,respiratory distress|MP:0002115,abnormal limb bone morphology|MP:0002427,disproportionate dwarf|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004134,abnormal chest morphology|MP:0004672,short ribs|MP:0004704,short vertebral column|MP:0006322,abnormal perichondrium morphology|MP:0006395,abnormal epiphyseal plate morphology|MP:0009908,protruding tongue|MP:0011087,neonatal lethality, complete penetrance
MGI:4361027	Tg(Col2a1-rtTA,tetO-COMP)1Jath	MP:0003055,abnormal long bone epiphyseal plate morphology
MGI:4361028	Tg(Col2a1-rtTA,tetO-COMP*)2Jath	MP:0000443,abnormal snout morphology|MP:0000445,short snout|MP:0001846,increased inflammatory response|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0004174,abnormal spine curvature|MP:0005508,abnormal skeleton morphology|MP:0006395,abnormal epiphyseal plate morphology|MP:0006397,disorganized long bone epiphyseal plate|MP:0009780,abnormal chondrocyte physiology|MP:0011862,decreased cranium length|MP:0014103,increased chondrocyte apoptosis|MP:0031277,pectus carinatum
MGI:3055440	Tg(Crh)227.1Pbl	MP:0000414,alopecia|MP:0000642,enlarged adrenal glands|MP:0001199,thin skin|MP:0001201,translucent skin|MP:0001261,obese|MP:0001731,abnormal postnatal growth|MP:0001745,increased circulating corticosterone level|MP:0001747,hypersecretion of adrenocorticotropin|MP:0001748,increased circulating adrenocorticotropin level|MP:0001754,increased circulating corticotropin-releasing hormone level|MP:0001923,reduced female fertility|MP:0002269,muscular atrophy|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight
MGI:3709032	Tg(Crx-GFP,-ALPP)1Clc	MP:0002169,no abnormal phenotype detected
MGI:3783832	Tg(Cryaa-AKR1B1)222Smch	MP:0001304,cataract|MP:0001764,abnormal homeostasis|MP:0005391,vision/eye phenotype
MGI:3783833	Tg(Cryaa-AKR1B1)648Smch	MP:0001304,cataract|MP:0001764,abnormal homeostasis
MGI:5582277	Tg(Cryaa-APEH)KKS4Kksha	MP:0001304,cataract
MGI:4837697	Tg(Cryaa-NCOA6*)AD5Cve	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001306,small lens|MP:0002840,abnormal lens fiber morphology|MP:0005253,abnormal eye physiology|MP:0005545,abnormal lens development
MGI:4837699	Tg(Cryaa-NCOA6*)AD9Cve	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001306,small lens
MGI:3764829	Tg(Cryaa-TAg)7488Lmgd	MP:0001303,abnormal lens morphology|MP:0001312,abnormal cornea morphology|MP:0002019,abnormal tumor incidence|MP:0002092,abnormal eye morphology|MP:0002840,abnormal lens fiber morphology|MP:0003237,abnormal lens epithelium morphology|MP:0005545,abnormal lens development|MP:0010295,increased eye tumor incidence
MGI:3576672	Tg(Cryaa-TAg,Ins2-CALM1)26Ove	MP:0000231,hypertension|MP:0000266,abnormal heart morphology|MP:0000519,hydronephrosis|MP:0000538,abnormal urinary bladder morphology|MP:0000539,distended urinary bladder|MP:0000599,enlarged liver|MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level|MP:0001762,polyuria|MP:0002135,abnormal kidney morphology|MP:0002703,abnormal renal tubule morphology|MP:0002712,increased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0002847,abnormal renal glomerular filtration rate|MP:0002871,albuminuria|MP:0003059,decreased insulin secretion|MP:0003068,enlarged kidney|MP:0003215,renal interstitial fibrosis|MP:0003339,decreased pancreatic beta cell number|MP:0003917,increased kidney weight|MP:0003985,renal fibrosis|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005378,growth/size/body region phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005531,increased renal vascular resistance|MP:0010957,abnormal aerobic respiration|MP:0011294,renal glomerulus hypertrophy|MP:0011339,abnormal glomerular mesangium morphology|MP:0011353,expanded mesangial matrix|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011630,increased mitochondrial size|MP:0014143,decreased body fat mass
MGI:5313507	Tg(CRYBB1-CRYGC*)#Jfhe	MP:0002840,abnormal lens fiber morphology|MP:0010254,nuclear cataract
MGI:6415131	Tg(CRYBB1-Loxl1)1Erta	MP:0001303,abnormal lens morphology|MP:0002840,abnormal lens fiber morphology|MP:0005257,abnormal intraocular pressure
MGI:3053740	Tg(CryHIVPR)72Gjj	MP:0001304,cataract
MGI:3051865	Tg(Csf1r-EGFP-NGFR/FKBP1A/TNFRSF6)2Bck	MP:0002169,no abnormal phenotype detected
MGI:5517795	Tg(Csf1r-HBEGF/mCherry)1Mnz	MP:0002736,abnormal nociception after inflammation|MP:0003998,decreased thermal nociceptive threshold|MP:0020954,decreased mechanical nociceptive threshold
MGI:4943309	Tg(Csf1r-Tnfsf15,-EGFP)#Targ	MP:0001212,skin lesions|MP:0002581,abnormal ileum morphology|MP:0002932,abnormal joint morphology|MP:0002936,joint swelling|MP:0003306,small intestinal inflammation|MP:0003449,abnormal intestine goblet cell morphology|MP:0005245,hemarthrosis|MP:0008566,increased interferon-gamma secretion|MP:0011748,intestinal fibrosis|MP:0013485,increased Paneth cell number|MP:0014083,blunted small intestinal villi
MGI:4888569	Tg(CSN2-fat-1)1Vane	MP:0004047,abnormal milk composition|MP:0005283,increased unsaturated fatty acids level|MP:0005285,decreased unsaturated fatty acids level
MGI:3837569	Tg(CSNK1D*,-EGFP)816Yfu	MP:0020470,shortened circadian behavior period|MP:0020476,abnormal circardian behavior entrainment
MGI:3837566	Tg(CSNK1D*,-EGFP)827Yfu	MP:0020470,shortened circadian behavior period|MP:0020476,abnormal circardian behavior entrainment
MGI:5517400	Tg(CSTG-NPM1/RARA)#Sjch	MP:0000691,enlarged spleen|MP:0002026,increased leukemia incidence|MP:0004049,increased acute promyelocytic leukemia incidence|MP:0005481,increased chronic myelocytic leukemia incidence|MP:0008476,increased spleen red pulp amount
MGI:3054751	Tgct1<MOLF/Ei>	MP:0006262,increased testis tumor incidence
MGI:3054753	Tgct2<MOLF/Ei>	MP:0006262,increased testis tumor incidence
MGI:3054755	Tgct3<MOLF/Ei>	MP:0006262,increased testis tumor incidence
MGI:3054759	Tgct5<MOLF/Ei>	MP:0006262,increased testis tumor incidence
MGI:1891520	Tg(CTNNB1)1Efu	MP:0000383,abnormal hair follicle orientation|MP:0000393,persistent hair follicle morphogenesis|MP:0000573,increased hindlimb autopod size|MP:0001210,skin ridges|MP:0002012,increased trichofolliculoma incidence|MP:0002013,increased pilomatricoma incidence|MP:0002015,epithelioid cyst
MGI:5307058	Tg(CTSG-NUMA1/RARA)#Skr	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000321,increased bone marrow cell number|MP:0000322,increased granulocyte number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002123,abnormal definitive hematopoiesis|MP:0002356,abnormal spleen red pulp morphology|MP:0003179,thrombocytopenia|MP:0004049,increased acute promyelocytic leukemia incidence|MP:0008478,increased spleen white pulp amount|MP:0008483,increased spleen germinal center size|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number
MGI:3620013	Tg(CTSG-PML/RARA)135Ley	MP:0000217,abnormal leukocyte cell number|MP:0000218,increased leukocyte cell number|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0001577,anemia|MP:0002356,abnormal spleen red pulp morphology|MP:0002414,abnormal myeloblast morphology/development|MP:0003179,thrombocytopenia|MP:0004049,increased acute promyelocytic leukemia incidence|MP:0005387,immune system phenotype
MGI:3573865	Tg(CTSG-PML/RARA)6179Ppp	MP:0000218,increased leukocyte cell number|MP:0000322,increased granulocyte number|MP:0001601,abnormal myelopoiesis|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0004049,increased acute promyelocytic leukemia incidence|MP:0008973,decreased erythroid progenitor cell number
MGI:3040508	Tg(CTSG-PML/RARA)#Ppp	MP:0000218,increased leukocyte cell number|MP:0000322,increased granulocyte number|MP:0001601,abnormal myelopoiesis|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0004049,increased acute promyelocytic leukemia incidence|MP:0008973,decreased erythroid progenitor cell number
MGI:4353271	Tg(CTSG-RARA/PML)2544Ley	MP:0002006,neoplasm
MGI:4353264	Tg(CTSG-RARA/PML)#Ley	MP:0002006,neoplasm|MP:0005397,hematopoietic system phenotype
MGI:3527936	Tg(CTSG-RARA/ZBTB16)#Ppp	MP:0000691,enlarged spleen|MP:0001601,abnormal myelopoiesis|MP:0002006,neoplasm|MP:0003179,thrombocytopenia|MP:0006043,decreased apoptosis|MP:0010373,myeloid hyperplasia
MGI:3527937	Tg(CTSG-ZBTB16/RARA)#Ppp	MP:0000218,increased leukocyte cell number|MP:0001601,abnormal myelopoiesis|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0005481,increased chronic myelocytic leukemia incidence
MGI:5517398	Tg(CTSG-ZBTB16/RARA)#Sjch	MP:0000218,increased leukocyte cell number|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001601,abnormal myelopoiesis|MP:0002026,increased leukemia incidence|MP:0002356,abnormal spleen red pulp morphology|MP:0002397,abnormal bone marrow morphology|MP:0005481,increased chronic myelocytic leukemia incidence|MP:0009278,abnormal bone marrow cell physiology|MP:0010373,myeloid hyperplasia
MGI:5662266	Tg(Cyp17a1-NGF)2456Oje	MP:0001129,impaired ovarian folliculogenesis|MP:0001260,increased body weight|MP:0001923,reduced female fertility|MP:0001927,abnormal estrous cycle|MP:0001935,decreased litter size|MP:0001938,delayed sexual maturation|MP:0002079,increased circulating insulin level|MP:0002184,abnormal innervation|MP:0002781,increased circulating testosterone level|MP:0003377,late onset of menarche|MP:0003953,abnormal hormone level|MP:0003960,increased lean body mass|MP:0004183,abnormal sympathetic nervous system physiology|MP:0005182,increased circulating estradiol level|MP:0005185,decreased circulating progesterone level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0009006,prolonged estrous cycle|MP:0009012,short diestrus|MP:0009017,prolonged estrus|MP:0009363,abnormal tertiary ovarian follicle morphology|MP:0009444,ovarian follicular cyst|MP:0009648,abnormal superovulation|MP:0010024,increased total body fat amount|MP:0010123,increased bone mineral content|MP:0013508,increased granulosa cell apoptosis|MP:0020011,increased bone mineral density of femur|MP:0031239,increased atretic ovarian follicle number|MP:0031420,decreased superovulation rate
MGI:2385806	Tg(Cyp19)C2-3Rrte	MP:0000630,mammary gland hyperplasia|MP:0001148,enlarged testis|MP:0001885,mammary gland duct hyperplasia|MP:0001925,male infertility|MP:0004499,increased incidence of tumors by chemical induction|MP:0005182,increased circulating estradiol level|MP:0010299,increased mammary gland tumor incidence|MP:0010364,increased fibroadenoma incidence
MGI:4452377	Tg(CYP1A1-PPARD)#Jfoe	MP:0000414,alopecia|MP:0001192,scaly skin|MP:0001193,psoriasis|MP:0001200,thick skin|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0002060,abnormal skin morphology|MP:0004947,skin inflammation|MP:0005348,increased T cell proliferation|MP:0009583,increased keratinocyte proliferation|MP:0009931,abnormal skin appearance|MP:0010771,integument phenotype
MGI:3822327	Tg(Cyp21a1-Apoe)614Fet	MP:0005178,increased circulating cholesterol level
MGI:3822316	Tg(Cyp21a1-Apoe)619Fet	MP:0005178,increased circulating cholesterol level
MGI:3057122	Tg(DBH-Gal)1923Stei	MP:0000807,abnormal hippocampus morphology|MP:0001038,abnormal cholinergic neuron morphology|MP:0001460,abnormal olfactory discrimination memory|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001973,increased thermal nociceptive threshold|MP:0002064,seizures|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:3835390	Tg(DBH-PTPN11)14Bmas	MP:0003631,nervous system phenotype|MP:0008415,abnormal neurite morphology
MGI:3835396	Tg(DBH-PTPN11)33Bmas	MP:0003631,nervous system phenotype|MP:0008415,abnormal neurite morphology|MP:0009284,abnormal sympathetic neuron innervation pattern
MGI:6852559	Tg(DBH-SNCA)#Dwei	MP:0001363,increased anxiety-related response|MP:0002797,increased thigmotaxis|MP:0003354,astrocytosis|MP:0003459,increased fear-related response|MP:0003661,abnormal locus ceruleus morphology|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0009454,impaired contextual conditioning behavior|MP:0011396,abnormal sleep behavior|MP:0020421,increased freezing behavior|MP:0020874,abnormal nervous system dopamine level
MGI:3830337	Tg(Dct-Birc5)21Gros	MP:0002006,neoplasm|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death
MGI:3525118	Tg(Dct-Grm1)ESzc	MP:0001188,hyperpigmentation|MP:0001326,retina degeneration|MP:0002742,enlarged submandibular lymph nodes|MP:0003099,retina detachment|MP:0005098,abnormal optic choroid morphology|MP:0005099,abnormal ciliary body morphology|MP:0009623,enlarged inguinal lymph nodes|MP:0010276,increased intraocular melanoma incidence|MP:0010322,increased cutaneous melanoma incidence|MP:0010741,abnormal melanocyte proliferation|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation|MP:0011481,anterior iris synechia|MP:0012022,increased melanocyte number
MGI:6267303	Tg(Dct-Hes1)#Nshk	MP:0001186,pigmentation phenotype|MP:0030912,decreased melanoblast apoptosis
MGI:3052468	Tg(Dct-SOX9)aCeb	MP:0000371,diluted coat color|MP:0001297,microphthalmia|MP:0001304,cataract|MP:0002938,white spotting|MP:0005389,reproductive system phenotype|MP:0010714,iris coloboma
MGI:3697304	Tg(Defcr2-Dta)#Jig	MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0013486,decreased Paneth cell number|MP:0014076,absent Paneth cells
MGI:2387572	Tg(Defcr2-TAg)#Jig	MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0013486,decreased Paneth cell number
MGI:5428215	Tg(Disc1/EGFP)M19Sshe	MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0000825,dilated lateral ventricle|MP:0002573,behavioral despair|MP:0003651,abnormal axon extension|MP:0004101,abnormal brain interneuron morphology|MP:0006254,thin cerebral cortex|MP:0006299,abnormal latent inhibition of conditioning behavior|MP:0008415,abnormal neurite morphology|MP:0008535,enlarged lateral ventricles|MP:0008948,decreased neuron number|MP:0009967,abnormal neuron proliferation|MP:0020351,decreased vocalization
MGI:5501066	Tg(Dll1-Dll3)3Gos	MP:0000585,kinked tail|MP:0001258,decreased body length|MP:0004609,vertebral fusion|MP:0004643,abnormal vertebrae number
MGI:3044917	Tg(Dll1-Tbx18)20Akis	MP:0000137,abnormal vertebrae morphology|MP:0000152,absent proximal rib|MP:0000162,lordosis|MP:0001077,abnormal spinal nerve morphology|MP:0001698,decreased embryo size|MP:0004604,abnormal vertebral pedicle morphology|MP:0004674,thin ribs|MP:0005223,abnormal dorsal-ventral polarity of the somites|MP:0005508,abnormal skeleton morphology|MP:0010099,abnormal thoracic cage shape|MP:0010103,small thoracic cage
MGI:3044916	Tg(Dll1-Tbx18)2Akis	MP:0000137,abnormal vertebrae morphology|MP:0004604,abnormal vertebral pedicle morphology|MP:0004674,thin ribs|MP:0005508,abnormal skeleton morphology
MGI:3054417	Tg(DM15)26Bew	MP:0000278,abnormal myocardial fiber morphology|MP:0000751,myopathy|MP:0000752,dystrophic muscle|MP:0001505,hunched posture|MP:0001516,abnormal motor coordination/balance|MP:0001596,hypotension|MP:0001636,irregular heartbeat|MP:0002074,abnormal hair texture|MP:0002625,heart left ventricle hypertrophy|MP:0002953,thick ventricular wall|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003137,abnormal impulse conducting system conduction|MP:0004036,abnormal muscle relaxation|MP:0004070,abnormal P wave|MP:0005330,cardiomyopathy|MP:0005608,cardiac interstitial fibrosis|MP:0008028,pregnancy-related premature death|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010724,thick interventricular septum|MP:0011087,neonatal lethality, complete penetrance|MP:0011940,decreased food intake|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014344,abnormal skeletal muscle fiber mitochondrial morphology|MP:0031131,myocardial fiber disarray
MGI:3720650	Tg(DMD-APP*)18Neve	MP:0000136,abnormal microglial cell morphology|MP:0000604,amyloidosis|MP:0000811,hippocampal neuron degeneration|MP:0002152,abnormal brain morphology|MP:0002229,neurodegeneration|MP:0002882,abnormal neuron morphology|MP:0003329,amyloid beta deposits|MP:0009940,abnormal hippocampus pyramidal cell morphology
MGI:3720652	Tg(DMD-APP*)7Neve	MP:0000136,abnormal microglial cell morphology|MP:0000604,amyloidosis|MP:0000807,abnormal hippocampus morphology|MP:0000811,hippocampal neuron degeneration|MP:0002152,abnormal brain morphology|MP:0002229,neurodegeneration|MP:0002882,abnormal neuron morphology|MP:0003329,amyloid beta deposits|MP:0004254,cerebral amyloid angiopathy|MP:0005404,abnormal axon morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology
MGI:3813454	Tg(DMPK/tetO-EGFP/DMPK)5-313Masm	MP:0000752,dystrophic muscle|MP:0003157,impaired muscle relaxation|MP:0003896,prolonged PR interval|MP:0006141,abnormal atrioventricular node conduction|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009413,skeletal muscle fiber atrophy|MP:0010053,decreased grip strength
MGI:5523466	Tg(DMWD,DMPK*,SIX5)1177Ggo	MP:0001265,decreased body size|MP:0001935,decreased litter size|MP:0002100,abnormal tooth morphology|MP:0002152,abnormal brain morphology|MP:0002269,muscular atrophy|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003157,impaired muscle relaxation|MP:0005382,craniofacial phenotype|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009415,skeletal muscle degeneration|MP:0009419,skeletal muscle fibrosis|MP:0011628,increased mitochondrial number|MP:0011630,increased mitochondrial size
MGI:5523461	Tg(DMWD,DMPK*,SIX5)328Ggo	MP:0000493,rectal prolapse|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001078,abnormal phrenic nerve morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002100,abnormal tooth morphology|MP:0002152,abnormal brain morphology|MP:0002279,abnormal diaphragm morphology|MP:0002327,abnormal respiratory function|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003157,impaired muscle relaxation|MP:0005389,reproductive system phenotype|MP:0005574,decreased pulmonary respiratory rate|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009419,skeletal muscle fibrosis|MP:0010831,lethality, incomplete penetrance|MP:0031068,decreased blood oxygen saturation level
MGI:2664398	Tg(DO11.10)10Dlo	MP:0003763,abnormal thymus physiology|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:6403115	Tg(DPP4)2Nnag	MP:0001861,lung inflammation|MP:0008713,abnormal cytokine level|MP:0020949,increased susceptibility to Coronaviridae infection
MGI:3843500	Tg(Drd1a-cre/ERT2)61.3Gsc	MP:0002169,no abnormal phenotype detected
MGI:3778286	Tg(DRD1-ctxA)7Burt	MP:0000859,abnormal somatosensory cortex morphology|MP:0001363,increased anxiety-related response|MP:0001409,increased stereotypic behavior|MP:0002797,increased thigmotaxis|MP:0003492,abnormal involuntary movement|MP:0003631,nervous system phenotype|MP:0003863,decreased aggression towards mice|MP:0004924,abnormal behavior|MP:0005267,abnormal olfactory cortex morphology|MP:0005386,behavior/neurological phenotype|MP:0031391,increased locomotor activity
MGI:6194345	Tgds<bub>	MP:0000111,cleft palate|MP:0002639,micrognathia
MGI:6430646	Tgds<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0000274,enlarged heart|MP:0000783,abnormal forebrain morphology|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001691,abnormal somite shape|MP:0001700,abnormal embryo turning|MP:0001701,incomplete embryo turning|MP:0001711,abnormal placenta morphology|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001787,pericardial edema|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0002884,abnormal pharyngeal arch morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0002989,small kidney|MP:0003425,abnormal optic vesicle formation|MP:0003984,embryonic growth retardation|MP:0004924,abnormal behavior|MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0012270,cardiac edema|MP:0013294,prenatal lethality prior to heart atrial septation|MP:0014134,abnormal embryo morphology|MP:0020870,decreased thigmotaxis
MGI:3828146	Tg(Dspp-TGFB1)3Kul	MP:0000126,brittle teeth|MP:0000129,ameloblast degeneration|MP:0002577,reduced enamel thickness|MP:0002648,delaminated enamel|MP:0002649,abnormal enamel rod pattern|MP:0002817,abnormal tooth mineralization|MP:0002818,abnormal dentin morphology|MP:0030451,abnormal dentin mineralization|MP:0030460,enamel pits|MP:0030514,absent Tomes' process
MGI:5555034	Tg(DUX4*)1Maar	MP:0001313,increased incidence of corneal inflammation|MP:0002092,abnormal eye morphology|MP:0031328,delayed skeletal muscle regeneration
MGI:1891523	Tg(Dvl2)7Gsb	MP:0000417,short hair
MGI:5430362	Tg(Dyrk1a)189N3Yah	MP:0000435,shortened head|MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000826,abnormal third ventricle morphology|MP:0000832,abnormal thalamus morphology|MP:0000859,abnormal somatosensory cortex morphology|MP:0001155,arrest of spermatogenesis|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0002176,increased brain weight|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0002773,decreased circulating luteinizing hormone level|MP:0002780,decreased circulating testosterone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003363,decreased circulating gonadotropin level|MP:0003953,abnormal hormone level|MP:0004852,decreased testis weight|MP:0005238,increased brain size|MP:0005319,abnormal enzyme/coenzyme level|MP:0006378,abnormal spermatogonia morphology|MP:0008286,abnormal hippocampus molecular cell layer|MP:0009819,abnormal circulating androgen level|MP:0010831,lethality, incomplete penetrance|MP:0011150,abnormal hippocampus stratum oriens morphology
MGI:4867514	Tg(DYRK1A)36Wjs	MP:0001475,reduced long-term depression|MP:0001516,abnormal motor coordination/balance|MP:0001898,abnormal long-term depression|MP:0001900,impaired synaptic plasticity|MP:0002176,increased brain weight|MP:0003008,enhanced long-term potentiation|MP:0004948,abnormal neuronal precursor proliferation|MP:0008414,abnormal spatial reference memory|MP:0009967,abnormal neuron proliferation
MGI:4421668	Tg(Ebf2-EGFP/icre)1Ggc	MP:0002169,no abnormal phenotype detected
MGI:5308012	Tg(ED-L2-IL1RN/IL1B)#Tcw	MP:0000462,abnormal digestive system morphology|MP:0000467,abnormal esophagus morphology|MP:0000691,enlarged spleen|MP:0001263,weight loss|MP:0001663,abnormal digestive system physiology|MP:0001846,increased inflammatory response|MP:0003278,esophageal inflammation|MP:0004499,increased incidence of tumors by chemical induction|MP:0004545,enlarged esophagus|MP:0008596,increased circulating interleukin-6 level|MP:0008751,abnormal interleukin level|MP:0009308,increased adenocarcinoma incidence|MP:0010784,abnormal forestomach morphology
MGI:2448699	Tg(Edn1-NOS3)22Yky	MP:0000249,abnormal blood vessel physiology|MP:0001596,hypotension|MP:0005591,decreased vasodilation|MP:0009642,abnormal blood homeostasis
MGI:5883023	Tg(EEF1A1-Gnas*R201C)184Pabi	MP:0000061,fragile skeleton|MP:0000065,abnormal bone marrow cavity morphology|MP:0002896,abnormal bone mineralization|MP:0002998,abnormal bone remodeling|MP:0003797,abnormal compact bone morphology|MP:0004992,increased bone resorption|MP:0005422,osteosclerosis|MP:0005508,abnormal skeleton morphology|MP:0009877,exostosis|MP:0010867,abnormal bone trabecula morphology|MP:0013620,increased internal diameter of femur|MP:0020039,increased bone ossification
MGI:2384188	Tg(EEF1A1-SHC1*)1Ravi	MP:0000774,decreased brain size|MP:0000860,abnormal primary somatosensory cortex morphology|MP:0001262,decreased body weight|MP:0001823,thymus hypoplasia|MP:0002407,abnormal double-negative T cell morphology|MP:0002741,small olfactory bulb|MP:0003203,increased neuron apoptosis|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004981,decreased neuronal precursor cell number|MP:0005092,decreased double-positive T cell number|MP:0006254,thin cerebral cortex|MP:0008083,decreased single-positive T cell number|MP:0012468,decreased striatum size
MGI:5314513	Tg(EEF1A1-Socs6)1Pwg	MP:0001260,increased body weight|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level
MGI:5314516	Tg(EEF1A1-Socs6)2Pwg	MP:0001260,increased body weight|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level
MGI:1926833	Tg(EGFR)0Jlj	MP:0000377,abnormal hair follicle morphology|MP:0000383,abnormal hair follicle orientation|MP:0000410,waved hair|MP:0000414,alopecia|MP:0000417,short hair|MP:0000422,delayed hair appearance|MP:0001265,decreased body size|MP:0001274,curly vibrissae|MP:0001277,tangled vibrissae
MGI:1926351	Tg(EGFR)1Jlj	MP:0000377,abnormal hair follicle morphology|MP:0000383,abnormal hair follicle orientation|MP:0000410,waved hair|MP:0000414,alopecia|MP:0000417,short hair|MP:0000422,delayed hair appearance|MP:0001265,decreased body size|MP:0001274,curly vibrissae|MP:0001277,tangled vibrissae|MP:0001304,cataract
MGI:1926352	Tg(EGFR)2Jlj	MP:0000410,waved hair|MP:0000414,alopecia|MP:0000422,delayed hair appearance|MP:0001265,decreased body size|MP:0001274,curly vibrissae|MP:0001280,loss of vibrissae
MGI:1926353	Tg(EGFR)3Jlj	MP:0000377,abnormal hair follicle morphology|MP:0000383,abnormal hair follicle orientation|MP:0000410,waved hair|MP:0000414,alopecia|MP:0000417,short hair|MP:0000422,delayed hair appearance|MP:0001265,decreased body size|MP:0001274,curly vibrissae|MP:0001277,tangled vibrissae
MGI:1926355	Tg(EGFR)4Jlj	MP:0000377,abnormal hair follicle morphology|MP:0000383,abnormal hair follicle orientation|MP:0000410,waved hair|MP:0000414,alopecia|MP:0000417,short hair|MP:0000422,delayed hair appearance|MP:0001265,decreased body size|MP:0001274,curly vibrissae|MP:0001277,tangled vibrissae
MGI:1926356	Tg(EGFR)5Jlj	MP:0000377,abnormal hair follicle morphology|MP:0000383,abnormal hair follicle orientation|MP:0000410,waved hair|MP:0000414,alopecia|MP:0000417,short hair|MP:0000422,delayed hair appearance|MP:0001265,decreased body size|MP:0001274,curly vibrissae|MP:0001277,tangled vibrissae
MGI:6281657	Tg(Eif1a-LUM*L199P,-hrGFP)#Fzha	MP:0002697,abnormal eye size|MP:0002698,abnormal sclera morphology
MGI:5699091	Tg(EIF1AX-Aldh2*E487K)101Oht	MP:0000747,muscle weakness|MP:0000807,abnormal hippocampus morphology|MP:0001458,abnormal object recognition memory|MP:0002075,abnormal coat/hair pigmentation|MP:0002083,premature death|MP:0003354,astrocytosis|MP:0003674,oxidative stress|MP:0008943,increased sensitivity to induced cell death|MP:0010014,hippocampus pyramidal cell degeneration|MP:0012307,impaired spatial learning
MGI:3047472	Tg(EIF1AX-Il31ra)1Jagr	MP:0000019,thick ears|MP:0000414,alopecia|MP:0000702,enlarged lymph nodes|MP:0001194,dermatitis|MP:0001242,hyperkeratosis|MP:0001412,excessive scratching|MP:0001492,abnormal pilomotor reflex|MP:0001790,abnormal immune system physiology|MP:0001829,increased activated T cell number|MP:0001852,conjunctivitis|MP:0001874,acanthosis|MP:0005014,increased B cell number|MP:0005018,decreased T cell number|MP:0005460,abnormal leukopoiesis|MP:0008049,increased memory T cell number|MP:0031395,cutaneous mastocytosis
MGI:5634777	Tg(EIF1AX-Lin28a)#Gqda	MP:0000528,delayed kidney development|MP:0002006,neoplasm|MP:0002081,perinatal lethality|MP:0003068,enlarged kidney|MP:0003675,kidney cyst|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0010294,increased kidney tumor incidence|MP:0010985,abnormal kidney mesenchyme morphology
MGI:4357948	Tg(EIF1AX-PMS2*)685Tcar	MP:0005621,abnormal cell physiology|MP:0014766,impaired mismatch repair
MGI:3614384	Tg(Ela1-Bhlhb8)#Skz	MP:0009146,abnormal pancreatic acinar cell morphology
MGI:3511172	Tg(Ela1-Myc)158Bri	MP:0000611,jaundice|MP:0001272,increased metastatic potential|MP:0002083,premature death|MP:0004247,small pancreas|MP:0008780,increased pancreatic acinar cell carcinoma incidence|MP:0009153,increased pancreas tumor incidence|MP:0009164,exocrine pancreas atrophy
MGI:3511167	Tg(Ela1-Myc)159Bri	MP:0000611,jaundice|MP:0001272,increased metastatic potential|MP:0002083,premature death|MP:0004247,small pancreas|MP:0008780,increased pancreatic acinar cell carcinoma incidence|MP:0009153,increased pancreas tumor incidence|MP:0009164,exocrine pancreas atrophy
MGI:3511173	Tg(Ela1-Myc)160Bri	MP:0000611,jaundice|MP:0001272,increased metastatic potential|MP:0002083,premature death|MP:0004247,small pancreas|MP:0008780,increased pancreatic acinar cell carcinoma incidence|MP:0009153,increased pancreas tumor incidence|MP:0009164,exocrine pancreas atrophy
MGI:2385657	Tg(Ela1-TAg)18Bri	MP:0001869,pancreas inflammation|MP:0003364,increased insulinoma incidence|MP:0003430,increased pancreatic islet cell adenoma incidence|MP:0005491,pancreatic islet hyperplasia|MP:0008780,increased pancreatic acinar cell carcinoma incidence|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009153,increased pancreas tumor incidence
MGI:2655223	Tg(Ela1-TAg)19Bri	MP:0003364,increased insulinoma incidence|MP:0005491,pancreatic islet hyperplasia|MP:0008780,increased pancreatic acinar cell carcinoma incidence|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009153,increased pancreas tumor incidence
MGI:3510408	Tg(Ela1-TAg*)289Mjt	MP:0001270,distended abdomen|MP:0001944,abnormal pancreas morphology|MP:0002083,premature death|MP:0008780,increased pancreatic acinar cell carcinoma incidence|MP:0009043,increased pancreas adenoma incidence|MP:0009153,increased pancreas tumor incidence
MGI:3510407	Tg(Ela1-TAg*)79Mjt	MP:0001270,distended abdomen|MP:0001272,increased metastatic potential|MP:0001944,abnormal pancreas morphology|MP:0008780,increased pancreatic acinar cell carcinoma incidence|MP:0009043,increased pancreas adenoma incidence|MP:0009153,increased pancreas tumor incidence|MP:0014237,decreased tumor-free survival time
MGI:2449466	Tg(Ela1-Tgfa)150Bri	MP:0001944,abnormal pancreas morphology|MP:0003334,pancreas fibrosis|MP:0003336,pancreas cyst|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009153,increased pancreas tumor incidence|MP:0013221,pancreatic acinar-to-ductal metaplasia
MGI:3832840	Tg(Ela2a-Prss1*,-GFP)1Dbs	MP:0003334,pancreas fibrosis|MP:0003341,chronic pancreas inflammation|MP:0004761,increased susceptibility to induced pancreatitis|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009147,abnormal pancreatic acinar cell physiology|MP:0009148,pancreas necrosis
MGI:4414765	Tg(Ela-KRAS*G12D)9Eps	MP:0001869,pancreas inflammation|MP:0001944,abnormal pancreas morphology|MP:0004973,increased regulatory T cell number|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009153,increased pancreas tumor incidence|MP:0013221,pancreatic acinar-to-ductal metaplasia|MP:0013584,pancreas degeneration
MGI:6149762	Tg<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001925,male infertility|MP:0002757,decreased vertical activity|MP:0005292,improved glucose tolerance|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content|MP:0010506,prolonged RR interval|MP:0013279,increased fasting circulating glucose level
MGI:4818998	Tg(Emu-FGFR3)A5Wmk	MP:0000688,lymphoid hyperplasia
MGI:4819001	Tg(Emu-FGFR3)D3Wmk	MP:0000688,lymphoid hyperplasia
MGI:4839908	Tg(Emu-Pim1)64aBrn	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0002021,increased incidence of induced tumors|MP:0002024,increased T cell derived lymphoma incidence|MP:0012431,increased lymphoma incidence
MGI:5882421	Tg(EmuSR-HDAC9)1468Kpet	MP:0000691,enlarged spleen|MP:0002023,increased B cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002362,abnormal spleen marginal zone morphology|MP:0003945,abnormal lymphocyte physiology|MP:0005014,increased B cell number|MP:0005154,increased B cell proliferation|MP:0009318,increased splenic marginal zone lymphoma incidence|MP:0009321,increased histiocytic sarcoma incidence
MGI:4430747	Tg(Emu-TXLNA)1Amjr	MP:0000623,decreased salivation|MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0001614,abnormal blood vessel morphology|MP:0001859,kidney inflammation|MP:0001862,interstitial pneumonia|MP:0001870,salivary gland inflammation|MP:0002023,increased B cell derived lymphoma incidence|MP:0002459,abnormal B cell physiology|MP:0002461,increased immunoglobulin level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002962,increased urine protein level|MP:0003725,increased autoantibody level|MP:0004977,increased B-1 B cell number|MP:0005014,increased B cell number|MP:0005325,abnormal renal glomerulus morphology|MP:0005327,abnormal mesangial cell morphology|MP:0005350,increased susceptibility to autoimmune disorder|MP:0008097,increased plasma cell number|MP:0008177,increased germinal center B cell number|MP:0008181,increased marginal zone B cell number|MP:0008206,increased B-2 B cell number|MP:0008500,increased IgG2a level|MP:0008573,increased circulating interferon-alpha level|MP:0008879,submandibular gland inflammation|MP:0008880,lacrimal gland inflammation|MP:0013367,parotid gland inflammation|MP:0020155,enhanced humoral immune response
MGI:4458205	Tg(Emu-Zfp521)1Homy	MP:0002006,neoplasm|MP:0002144,abnormal B cell differentiation|MP:0005014,increased B cell number|MP:0005397,hematopoietic system phenotype
MGI:5634330	Tg(Eno2-APP*Ind)#Kakiz	MP:0001364,decreased anxiety-related response|MP:0003329,amyloid beta deposits|MP:0004254,cerebral amyloid angiopathy|MP:0012307,impaired spatial learning
MGI:5634331	Tg(Eno2-APP*Ind,-PSEN1*P267S)#Kakiz	MP:0012307,impaired spatial learning
MGI:3603946	Tg(Eno2-APPSwe)1223-3Ykk	MP:0001463,abnormal spatial learning|MP:0003203,increased neuron apoptosis|MP:0003240,loss of hippocampal neurons|MP:0003329,amyloid beta deposits
MGI:4360673	Tg(Eno2-ATN1)14Tx	MP:0000745,tremors|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001926,female infertility|MP:0002083,premature death|MP:0004191,neuronal intranuclear inclusions|MP:0009980,abnormal cerebellum dentate nucleus morphology
MGI:4360669	Tg(Eno2-ATN1)3Tx	MP:0000745,tremors|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0004191,neuronal intranuclear inclusions|MP:0009980,abnormal cerebellum dentate nucleus morphology
MGI:8215113	Tg(Eno2-Atxn7)#Cheo	MP:0001399,hyperactivity|MP:0005386,behavior/neurological phenotype|MP:0010698,abnormal impulsive behavior control
MGI:5515418	Tg(Eno2-Bmp4)3Jake	MP:0000069,kyphoscoliosis|MP:0000130,abnormal trabecular bone morphology|MP:0000160,kyphosis|MP:0000161,scoliosis|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002108,abnormal muscle morphology|MP:0003648,abnormal radial glial cell morphology|MP:0004087,abnormal muscle fiber morphology|MP:0009808,decreased oligodendrocyte number|MP:0012065,increased astrocyte number|MP:0014167,ectopic bone
MGI:3505718	Tg(Eno2CDK5R1)1Jdm	MP:0000745,tremors|MP:0001364,decreased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0005404,abnormal axon morphology
MGI:4431225	Tg(Eno2-Hmox1)2Main	MP:0000691,enlarged spleen|MP:0001394,circling|MP:0001417,decreased exploration in new environment
MGI:5476630	Tg(Eno2-MFN2)L916Ugfm	MP:0005386,behavior/neurological phenotype
MGI:4440895	Tg(Eno2-MFN2*R94Q)L51Ugfm	MP:0001392,abnormal locomotor behavior|MP:0001405,impaired coordination|MP:0002272,abnormal nervous system electrophysiology|MP:0003631,nervous system phenotype|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0011628,increased mitochondrial number
MGI:5476535	Tg(Eno2-MFN2*R94Q)L87Ugfm	MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001504,abnormal posture|MP:0003631,nervous system phenotype|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0005507,tail dragging|MP:0011628,increased mitochondrial number
MGI:3590650	Tg(Eno2-PSEN1)1Gae	MP:0003631,nervous system phenotype|MP:0004981,decreased neuronal precursor cell number|MP:0009937,abnormal neuron differentiation
MGI:3590651	Tg(Eno2-PSEN1*P117L)1Gae	MP:0003631,nervous system phenotype|MP:0004981,decreased neuronal precursor cell number|MP:0009937,abnormal neuron differentiation
MGI:5052118	Tg(Eno2-PSEN2*)1480Ykk	MP:0001463,abnormal spatial learning|MP:0001522,impaired swimming|MP:0003329,amyloid beta deposits
MGI:5052116	Tg(Eno2-PSEN2)2348Ykk	MP:0001463,abnormal spatial learning|MP:0001522,impaired swimming|MP:0003329,amyloid beta deposits
MGI:3717604	Tg(Eno2-PTGS2)32Pasi	MP:0002064,seizures|MP:0002083,premature death|MP:0003631,nervous system phenotype|MP:0003997,tonic-clonic seizures|MP:0004811,abnormal neuron physiology|MP:0008235,increased susceptibility to neuronal excitotoxicity
MGI:3793788	Tg(Eno2-Scn2a1*)Q54Mm	MP:0000947,convulsive seizures|MP:0002064,seizures|MP:0002083,premature death|MP:0003631,nervous system phenotype
MGI:6259176	Tg(Eno2-Thrsp)#Cheo	MP:0003461,abnormal response to novel object|MP:0004077,abnormal striatum morphology|MP:0020224,decreased alertness
MGI:4838202	Tg(Eno2-TOR1A*)13Shas	MP:0001382,abnormal nursing|MP:0001395,bidirectional circling|MP:0001399,hyperactivity|MP:0001513,limb grasping|MP:0001906,increased dopamine level|MP:0002730,head shaking|MP:0004924,abnormal behavior|MP:0005191,head tilt|MP:0005323,dystonia|MP:0005377,hearing/vestibular/ear phenotype|MP:0005643,decreased dopamine level
MGI:3722776	Tg(Eno2-YFP/Cox8a)YRwb	MP:0002169,no abnormal phenotype detected
MGI:3722777	Tg(Eno2-YFP/Cox8a)ZRwb	MP:0002169,no abnormal phenotype detected
MGI:3054249	Tg(EPO33)72Ptc	MP:0000691,enlarged spleen|MP:0002608,increased hematocrit|MP:0010768,mortality/aging
MGI:1891491	Tg(Erbb2)1Jek	MP:0000379,decreased hair follicle number|MP:0000466,esophageal epithelium hyperplasia|MP:0001192,scaly skin|MP:0001200,thick skin|MP:0001214,skin hyperplasia|MP:0001222,epidermal hyperplasia|MP:0001237,enlarged spinous cells|MP:0001242,hyperkeratosis|MP:0001732,postnatal growth retardation|MP:0002009,preneoplasia|MP:0002014,increased papilloma incidence|MP:0002656,abnormal keratinocyte differentiation|MP:0003717,pallor|MP:0009004,progressive hair loss|MP:0011090,perinatal lethality, incomplete penetrance|MP:0013396,eyelid hyperplasia
MGI:5824244	Tg(Erbb2-Erbb2)NN60Led	MP:0000627,abnormal mammary gland morphology|MP:0001882,abnormal lactation|MP:0001884,mammary gland alveolar hyperplasia|MP:0006271,abnormal involution of the mammary gland|MP:0009503,abnormal mammary gland duct morphology|MP:0009505,abnormal mammary gland lobule morphology|MP:0013488,increased keratoacanthoma incidence
MGI:5824245	Tg(Erbb2-Erbb2*V664E)#Led	MP:0000630,mammary gland hyperplasia|MP:0001881,abnormal mammary gland physiology|MP:0001882,abnormal lactation|MP:0001883,increased mammary adenocarcinoma incidence|MP:0006271,abnormal involution of the mammary gland|MP:0009505,abnormal mammary gland lobule morphology|MP:0012570,increased mammary gland tumor incidence in breeding females
MGI:6192630	Tg(Erbb2*)#Maed	MP:0001944,abnormal pancreas morphology|MP:0002083,premature death|MP:0005379,endocrine/exocrine gland phenotype|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009153,increased pancreas tumor incidence
MGI:5502923	Tg(Etn2*,Ptf1aos,Ptf1a)#Kymm	MP:0000592,short tail
MGI:3609028	Tg(F2RL1)1Mslb	MP:0001846,increased inflammatory response|MP:0002405,respiratory system inflammation
MGI:3039235	Tg(Fabp1-Ccnd1)2Rdb	MP:0000607,abnormal hepatocyte morphology|MP:0002981,increased liver weight|MP:0003324,increased liver adenoma incidence|MP:0014045,Mallory bodies
MGI:2684226	Tg(Fabp1-Ccnd1)4Rdb	MP:0000607,abnormal hepatocyte morphology|MP:0002981,increased liver weight|MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003887,increased hepatocyte apoptosis|MP:0014045,Mallory bodies
MGI:4887983	Tg(Fabp1-Nr1h3)#Wexi	MP:0000599,enlarged liver|MP:0002628,hepatic steatosis|MP:0009355,increased liver triglyceride level
MGI:4887981	Tg(Fabp1-NR1I2)#Wexi	MP:0000599,enlarged liver|MP:0002628,hepatic steatosis|MP:0009355,increased liver triglyceride level
MGI:2446302	Tg(Fabp2-Arg1)1Wla	MP:0000377,abnormal hair follicle morphology|MP:0000384,distorted hair follicle pattern|MP:0000416,sparse hair|MP:0000422,delayed hair appearance|MP:0000692,small spleen|MP:0000696,abnormal Peyer's patch morphology|MP:0001216,abnormal epidermal layer morphology|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001732,postnatal growth retardation|MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0004953,decreased spleen weight|MP:0005017,decreased B cell number|MP:0005332,abnormal amino acid level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0008190,decreased transitional stage B cell number|MP:0008209,decreased pre-B cell number|MP:0008882,abnormal enterocyte physiology|MP:0009402,decreased skeletal muscle fiber diameter|MP:0014263,decreased spleen B cell follicle number|MP:0030647,increased ornithine level|MP:0030655,increased circulating glycine level|MP:0030662,decreased circulating arginine level|MP:0030665,decreased arginine level
MGI:7657446	Tg(Fabp2-Slc22a18)#Tgot	MP:0001260,increased body weight|MP:0006319,abnormal epididymal fat pad morphology|MP:0009115,abnormal fat cell morphology
MGI:7432549	Tg(Fabp4-Adissp)#Yxw	MP:0002078,abnormal glucose homeostasis|MP:0002970,abnormal white adipose tissue morphology|MP:0005292,improved glucose tolerance|MP:0005336,abnormal inguinal fat pad morphology|MP:0005386,behavior/neurological phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005670,abnormal white adipose tissue physiology|MP:0009115,abnormal fat cell morphology|MP:0009133,decreased white fat cell size|MP:0011019,abnormal adaptive thermogenesis|MP:0014146,decreased white adipose tissue mass|MP:0020521,browned white adipose tissue morphology
MGI:3758185	Tg(Fabp4-Aebp1)1Hsro	MP:0000008,increased white adipose tissue amount|MP:0001260,increased body weight|MP:0001261,obese|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0005338,atherosclerotic lesions|MP:0005455,increased susceptibility to weight gain|MP:0005669,increased circulating leptin level|MP:0009115,abnormal fat cell morphology|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011939,increased food intake
MGI:3608885	Tg(Fabp4-Agt)1Mte	MP:0006144,increased systemic arterial systolic blood pressure
MGI:3608886	Tg(Fabp4-Agt)2Mte	MP:0001260,increased body weight|MP:0001402,decreased locomotor activity|MP:0003353,decreased circulating renin level|MP:0006094,increased fat cell size|MP:0006144,increased systemic arterial systolic blood pressure|MP:0009115,abnormal fat cell morphology|MP:0009288,increased epididymal fat pad weight|MP:0009642,abnormal blood homeostasis|MP:0010024,increased total body fat amount
MGI:4359624	Tg(Fabp4-Angptl2)5Yo	MP:0002499,chronic inflammation|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0010760,abnormal macrophage chemotaxis|MP:0031602,white adipose tissue inflammation
MGI:7578893	Tg(Fabp4-Apol6)#Hsul	MP:0000182,increased circulating LDL cholesterol level|MP:0001260,increased body weight|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0002702,decreased circulating free fatty acids level|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0008033,impaired lipolysis|MP:0009118,increased white fat cell size|MP:0009288,increased epididymal fat pad weight|MP:0009302,increased renal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0011973,abnormal circulating glycerol level|MP:0014142,increased body fat mass|MP:0014145,increased white adipose tissue mass|MP:0031269,increased susceptibility to diet-induced hepatic steatosis|MP:0031602,white adipose tissue inflammation
MGI:4418675	Tg(Fabp4-Ccl2)BYt	MP:0001554,increased circulating free fatty acids level|MP:0002078,abnormal glucose homeostasis|MP:0003383,abnormal gluconeogenesis|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0006319,abnormal epididymal fat pad morphology|MP:0009355,increased liver triglyceride level
MGI:5828148	Tg(Fabp4-ENPP1)#Naba	MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0009269,decreased fat cell size|MP:0009355,increased liver triglyceride level|MP:0011940,decreased food intake
MGI:3815418	Tg(Fabp4-Fabp5)1Hota	MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level
MGI:6150641	Tg(Fabp4-Fam13a)1Iked	MP:0002702,decreased circulating free fatty acids level|MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005670,abnormal white adipose tissue physiology|MP:0008033,impaired lipolysis|MP:0009118,increased white fat cell size
MGI:5427594	Tg(Fabp4-Fcor)1Jnak	MP:0001263,weight loss|MP:0001783,decreased white adipose tissue amount|MP:0002891,increased insulin sensitivity|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009133,decreased white fat cell size|MP:0010025,decreased total body fat amount|MP:0010379,decreased respiratory quotient
MGI:5427595	Tg(Fabp4-Fcor)5Jnak	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0011049,impaired adaptive thermogenesis
MGI:6101512	Tg(Fabp4-FOXC2)ASven	MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003960,increased lean body mass|MP:0005560,decreased circulating glucose level|MP:0009121,increased white fat cell lipid droplet size|MP:0009133,decreased white fat cell size|MP:0010025,decreased total body fat amount|MP:0010182,decreased susceptibility to weight gain|MP:0011049,impaired adaptive thermogenesis|MP:0014146,decreased white adipose tissue mass|MP:0014170,increased brown adipose tissue mass|MP:0020521,browned white adipose tissue morphology
MGI:3622478	Tg(Fabp4-Hsd11b1)7Jesf	MP:0000013,abnormal adipose tissue distribution|MP:0001261,obese|MP:0001433,polyphagia|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0003963,abnormal corticosterone level|MP:0005281,increased fatty acids level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005455,increased susceptibility to weight gain|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size
MGI:5294566	Tg(Fabp4-Il22)#Ychn	MP:0005376,homeostasis/metabolism phenotype|MP:0020410,increased liposarcoma incidence
MGI:4437889	Tg(Fabp4-LEP)F8Ffc	MP:0000601,small liver|MP:0001262,decreased body weight|MP:0001431,abnormal eating behavior|MP:0001783,decreased white adipose tissue amount|MP:0002078,abnormal glucose homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002727,decreased circulating insulin level|MP:0002865,increased growth rate|MP:0003058,increased insulin secretion|MP:0005179,decreased circulating cholesterol level|MP:0005334,abnormal fat pad morphology|MP:0005335,abnormal gonadal fat pad morphology|MP:0005560,decreased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0006320,abnormal interscapular fat pad morphology|MP:0009117,abnormal white fat cell morphology|MP:0009118,increased white fat cell size|MP:0009132,abnormal white fat cell size|MP:0009133,decreased white fat cell size|MP:0009137,decreased brown fat lipid droplet number|MP:0009283,decreased gonadal fat pad weight|MP:0010934,increased subcutaneous adipose tissue amount|MP:0011049,impaired adaptive thermogenesis
MGI:4453883	Tg(Fabp4-LMNA)#Cdl	MP:0005378,growth/size/body region phenotype
MGI:4453886	Tg(Fabp4-LMNA*R482Q)11ACdl	MP:0001780,decreased brown adipose tissue amount|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002715,decreased glycogen catabolism rate|MP:0003960,increased lean body mass|MP:0005331,insulin resistance|MP:0005369,muscle phenotype|MP:0005559,increased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0006319,abnormal epididymal fat pad morphology|MP:0009115,abnormal fat cell morphology|MP:0009124,increased brown fat cell lipid droplet size|MP:0009289,decreased epididymal fat pad weight|MP:0009303,decreased renal fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0010025,decreased total body fat amount|MP:0030017,decreased adipocyte glucose uptake|MP:0030022,decreased muscle cell glucose uptake
MGI:4454324	Tg(Fabp4-LMNA*R482Q)17CCdl	MP:0000003,abnormal adipose tissue morphology|MP:0001764,abnormal homeostasis|MP:0002089,abnormal postnatal growth/weight/body size|MP:0004130,abnormal muscle cell glucose uptake|MP:0005666,abnormal adipose tissue physiology
MGI:6188858	Tg(Fabp4-LMNA*R482Q)#Hjw	MP:0000003,abnormal adipose tissue morphology|MP:0003705,abnormal hypodermis morphology|MP:0008906,abnormal parametrial fat pad morphology|MP:0009115,abnormal fat cell morphology|MP:0020253,increased collagen level
MGI:5763240	Tg(Fabp4-Phb)#Smis	MP:0000005,increased brown adipose tissue amount|MP:0001129,impaired ovarian folliculogenesis|MP:0001261,obese|MP:0001402,decreased locomotor activity|MP:0001554,increased circulating free fatty acids level|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0001935,decreased litter size|MP:0002016,ovary cyst|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002644,decreased circulating triglyceride level|MP:0002680,decreased corpora lutea number|MP:0002970,abnormal white adipose tissue morphology|MP:0003442,decreased circulating glycerol level|MP:0004832,enlarged ovary|MP:0004892,increased adiponectin level|MP:0005179,decreased circulating cholesterol level|MP:0005182,increased circulating estradiol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005452,abnormal adipose tissue amount|MP:0005669,increased circulating leptin level|MP:0005670,abnormal white adipose tissue physiology|MP:0008869,anovulation|MP:0009116,abnormal brown fat cell morphology|MP:0009117,abnormal white fat cell morphology|MP:0009118,increased white fat cell size|MP:0010934,increased subcutaneous adipose tissue amount|MP:0011613,decreased circulating ghrelin level
MGI:5763309	Tg(Fabp4-Phb*Y114F)#Smis	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001261,obese|MP:0002020,increased tumor incidence|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002339,abnormal lymph node morphology|MP:0004702,increased circulating insulin-like growth factor I level|MP:0004892,increased adiponectin level|MP:0005013,increased lymphocyte cell number|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005669,increased circulating leptin level|MP:0010209,abnormal circulating chemokine level|MP:0010210,abnormal circulating cytokine level|MP:0011612,increased circulating ghrelin level|MP:0011613,decreased circulating ghrelin level
MGI:5568549	Tg(Fabp4-Serpina12)1Jwada	MP:0000183,decreased circulating LDL cholesterol level|MP:0001262,decreased body weight|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005668,decreased circulating leptin level|MP:0009289,decreased epididymal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5446499	Tg(Fabp4-SREBF1)#Dajl	MP:0000599,enlarged liver|MP:0001559,hyperglycemia|MP:0001783,decreased white adipose tissue amount|MP:0002079,increased circulating insulin level|MP:0003960,increased lean body mass|MP:0005293,impaired glucose tolerance|MP:0005318,decreased triglyceride level|MP:0005331,insulin resistance|MP:0011174,lipodystrophy|MP:0011939,increased food intake
MGI:5007704	Tg(Fabp4-TLE3)#aPton	MP:0001399,hyperactivity|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0004890,decreased energy expenditure|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0009116,abnormal brown fat cell morphology|MP:0009288,increased epididymal fat pad weight|MP:0011049,impaired adaptive thermogenesis|MP:0011940,decreased food intake|MP:0014573,increased circulating resistin level|MP:0030969,increased circulating adiponectin level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3774274	Tg(Fabp4-Wdct1*)1Jmgr	MP:0002970,abnormal white adipose tissue morphology|MP:0005559,increased circulating glucose level|MP:0006094,increased fat cell size|MP:0010024,increased total body fat amount
MGI:3774273	Tg(Fabp4-Wdtc1)1Jmgr	MP:0001262,decreased body weight|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005560,decreased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0009115,abnormal fat cell morphology|MP:0010025,decreased total body fat amount
MGI:6380548	Tg(Fabp4-Zfp516)#Hsul	MP:0002891,increased insulin sensitivity|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0011016,increased core body temperature|MP:0011019,abnormal adaptive thermogenesis|MP:0020521,browned white adipose tissue morphology
MGI:1856577	Tgfa<tm1Ard>	MP:0000383,abnormal hair follicle orientation|MP:0000396,increased curvature of hairs|MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0001302,eyelids open at birth|MP:0001313,increased incidence of corneal inflammation
MGI:1933208	Tgfa<tm1Unc>	MP:0000013,abnormal adipose tissue distribution|MP:0000377,abnormal hair follicle morphology|MP:0000383,abnormal hair follicle orientation|MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0001278,kinked vibrissae|MP:0001297,microphthalmia|MP:0001302,eyelids open at birth|MP:0001304,cataract|MP:0001316,cornea scarring|MP:0001322,abnormal iris morphology|MP:0001340,abnormal eyelid morphology|MP:0001511,disheveled coat|MP:0002092,abnormal eye morphology|MP:0003671,abnormal eyelid aperture|MP:0003809,abnormal hair shaft morphology|MP:0003812,abnormal hair medulla|MP:0004285,absent Descemet membrane|MP:0005193,abnormal anterior eye segment morphology|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0008841,ruptured lens capsule|MP:0008852,retina neovascularization|MP:0009651,abnormal eyelid development|MP:0010709,absent eye anterior chamber|MP:0013389,Meibomian gland hypoplasia|MP:0013396,eyelid hyperplasia|MP:0030175,orbicularis oculi muscle hypoplasia
MGI:1856388	Tgfa<wa1>	MP:0000367,abnormal coat/ hair morphology|MP:0000396,increased curvature of hairs|MP:0000402,abnormal zigzag hair morphology|MP:0000410,waved hair|MP:0001279,wavy vibrissae|MP:0001297,microphthalmia|MP:0001302,eyelids open at birth|MP:0001314,cornea opacity|MP:0001316,cornea scarring|MP:0001510,abnormal coat appearance|MP:0001852,conjunctivitis|MP:0002074,abnormal hair texture|MP:0002098,abnormal vibrissa morphology|MP:0003095,abnormal cornea stroma development|MP:0003704,abnormal hair follicle development|MP:0003809,abnormal hair shaft morphology|MP:0006194,keratoconjunctivitis|MP:0009264,failure of eyelid fusion|MP:0009272,decreased guard hair length|MP:0009742,increased cornea stroma thickness
MGI:1856268	Tgfa<wa1-5J>	MP:0000410,waved hair|MP:0001265,decreased body size|MP:0001302,eyelids open at birth|MP:0002092,abnormal eye morphology
MGI:5762965	Tgfb1i1<tm1.1Knos>	MP:0004883,abnormal vascular wound healing|MP:0005385,cardiovascular system phenotype|MP:0005595,abnormal vascular smooth muscle physiology
MGI:6093696	Tgfb1i1<tm1.2Cet>	MP:0009503,abnormal mammary gland duct morphology
MGI:5050851	Tgfb1i1<tm1a(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:5636887	Tgfb1i1<tm1b(KOMP)Wtsi>	MP:0005178,increased circulating cholesterol level|MP:0005292,improved glucose tolerance
MGI:5490036	Tgfb1<tm1.1Mki>	MP:0002667,decreased circulating aldosterone level|MP:0003352,increased circulating renin level|MP:0006375,increased circulating angiotensinogen level|MP:0010128,hypovolemia
MGI:1857258	Tgfb1<tm1Doe>	MP:0000218,increased leukocyte cell number|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0001505,hunched posture|MP:0001511,disheveled coat|MP:0001653,gastric necrosis|MP:0001654,hepatic necrosis|MP:0001655,multifocal hepatic necrosis|MP:0001845,abnormal inflammatory response|MP:0001847,brain inflammation|MP:0001851,eye inflammation|MP:0001852,conjunctivitis|MP:0001853,heart inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001869,pancreas inflammation|MP:0001870,salivary gland inflammation|MP:0001873,stomach inflammation|MP:0002279,abnormal diaphragm morphology|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002941,increased circulating alanine transaminase level|MP:0003282,gastric ulcer|MP:0003631,nervous system phenotype|MP:0004041,increased susceptibility to kidney reperfusion injury|MP:0004154,renal tubular necrosis|MP:0004510,myositis|MP:0004947,skin inflammation|MP:0005150,cachexia|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005553,increased circulating creatinine level|MP:0006085,myocardium necrosis|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008086,increased T-helper 1 cell number|MP:0008133,decreased Peyer's patch number|MP:0008566,increased interferon-gamma secretion|MP:0008872,abnormal physiological response to xenobiotic|MP:0008880,lacrimal gland inflammation|MP:0011083,lethality at weaning, complete penetrance|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013467,diaphragmitis
MGI:3513111	Tgfb1<tm1Jmu>	MP:0000598,abnormal liver morphology|MP:0001175,abnormal lung morphology|MP:0001265,decreased body size|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0001722,pale yolk sac|MP:0001790,abnormal immune system physiology|MP:0001853,heart inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001869,pancreas inflammation|MP:0001873,stomach inflammation|MP:0001915,intracranial hemorrhage|MP:0002082,postnatal lethality|MP:0002086,abnormal extraembryonic tissue morphology|MP:0008118,absent Langerhans cell|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011205,excessive folding of visceral yolk sac
MGI:5490035	Tgfb1<tm1Mki>	MP:0000642,enlarged adrenal glands|MP:0001399,hyperactivity|MP:0001745,increased circulating corticosterone level|MP:0001764,abnormal homeostasis|MP:0001784,abnormal fluid regulation|MP:0002666,increased circulating aldosterone level|MP:0002988,decreased urine osmolality|MP:0003353,decreased circulating renin level|MP:0003620,oliguria|MP:0004820,abnormal urine potassium level|MP:0005333,decreased heart rate|MP:0005533,increased body temperature|MP:0005628,decreased circulating potassium level|MP:0006144,increased systemic arterial systolic blood pressure|MP:0006317,decreased urine sodium level|MP:0006376,decreased circulating angiotensinogen level|MP:0008965,increased basal metabolism|MP:0010127,hypervolemia|MP:0011460,decreased urine chloride ion level|MP:0011941,increased fluid intake
MGI:1857671	Tgfb1<tm1N>	MP:0000267,abnormal heart development|MP:0000597,delayed hepatic development|MP:0000598,abnormal liver morphology|MP:0000929,open neural tube|MP:0001175,abnormal lung morphology|MP:0001511,disheveled coat|MP:0001652,colonic necrosis|MP:0001653,gastric necrosis|MP:0001719,absent vitelline blood vessels|MP:0001722,pale yolk sac|MP:0001785,edema|MP:0001790,abnormal immune system physiology|MP:0001846,increased inflammatory response|MP:0001854,atrial endocarditis|MP:0001855,abnormal atrial thrombosis|MP:0001856,myocarditis|MP:0001857,pericarditis|MP:0001862,interstitial pneumonia|MP:0001869,pancreas inflammation|MP:0001870,salivary gland inflammation|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003396,abnormal embryonic hematopoiesis|MP:0003543,abnormal vascular endothelial cell differentiation|MP:0003865,lymph node inflammation|MP:0003984,embryonic growth retardation|MP:0004229,abnormal embryonic erythropoiesis|MP:0005150,cachexia|MP:0008118,absent Langerhans cell|MP:0009657,failure of chorioallantoic fusion|MP:0010140,phlebitis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0013241,embryo tissue necrosis
MGI:3820285	Tgfb1<tm1Rif>	MP:0000479,abnormal enterocyte morphology|MP:0001262,decreased body weight|MP:0001790,abnormal immune system physiology|MP:0001846,increased inflammatory response|MP:0001853,heart inflammation|MP:0001861,lung inflammation|MP:0001873,stomach inflammation|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0003304,large intestinal inflammation|MP:0003305,proctitis|MP:0003306,small intestinal inflammation|MP:0008010,increased gastric adenocarcinoma incidence|MP:0008118,absent Langerhans cell|MP:0009310,increased large intestine adenocarcinoma incidence|MP:0009314,increased colon adenocarcinoma incidence|MP:0009315,increased rectum adenocarcinoma incidence|MP:0009316,increased anal adenocarcinoma incidence|MP:0009481,cecum inflammation|MP:0010301,increased stomach tumor incidence
MGI:5559039	Tgfb1<tm1(Tgfb3)Kul>	MP:0000120,malocclusion|MP:0000129,ameloblast degeneration|MP:0000160,kyphosis|MP:0000220,increased monocyte cell number|MP:0001255,decreased body height|MP:0001262,decreased body weight|MP:0001924,infertility|MP:0002083,premature death|MP:0002100,abnormal tooth morphology|MP:0002576,abnormal enamel morphology|MP:0002727,decreased circulating insulin level|MP:0002817,abnormal tooth mineralization|MP:0004973,increased regulatory T cell number|MP:0004989,decreased osteoblast cell number|MP:0005292,improved glucose tolerance|MP:0005358,abnormal incisor morphology|MP:0005382,craniofacial phenotype|MP:0005387,immune system phenotype|MP:0005668,decreased circulating leptin level|MP:0008037,abnormal T cell morphology|MP:0008271,abnormal bone ossification|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009133,decreased white fat cell size|MP:0010025,decreased total body fat amount|MP:0010096,abnormal incisor color|MP:0010768,mortality/aging|MP:0011939,increased food intake|MP:0030459,abnormal tooth attrition|MP:0030541,misaligned incisors
MGI:3849964	Tgfb1<tm2.1Doe>	MP:0000694,spleen hypoplasia|MP:0001263,weight loss|MP:0001823,thymus hypoplasia|MP:0001828,abnormal T cell activation|MP:0001846,increased inflammatory response|MP:0001861,lung inflammation|MP:0001870,salivary gland inflammation|MP:0002722,abnormal immune system organ morphology|MP:0003944,abnormal T cell subpopulation ratio|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion
MGI:5514235	Tgfb1<tm3.1Flv>	MP:0004973,increased regulatory T cell number|MP:0008086,increased T-helper 1 cell number
MGI:1888389	Tgfb2<tm1Doe>	MP:0000031,abnormal cochlea morphology|MP:0000074,abnormal neurocranium morphology|MP:0000088,short mandible|MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000157,abnormal sternum morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000272,abnormal aorta morphology|MP:0000284,double outlet right ventricle|MP:0000295,trabecula carnea hypoplasia|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000299,failure of atrioventricular cushion closure|MP:0000430,absent maxillary shelf|MP:0000458,abnormal mandible morphology|MP:0000519,hydronephrosis|MP:0000520,absent kidney|MP:0000559,abnormal femur morphology|MP:0001156,abnormal spermatogenesis|MP:0001169,abnormal bulbourethral gland morphology|MP:0001170,bulbourethral gland hyperplasia|MP:0001177,atelectasis|MP:0001262,decreased body weight|MP:0001289,persistence of hyaloid vascular system|MP:0001307,fused cornea and lens|MP:0001329,retina hyperplasia|MP:0001575,cyanosis|MP:0001940,testis hypoplasia|MP:0001954,respiratory distress|MP:0002109,abnormal limb morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002135,abnormal kidney morphology|MP:0002451,abnormal macrophage physiology|MP:0002687,oligozoospermia|MP:0002705,dilated renal tubule|MP:0002745,abnormal atrioventricular valve morphology|MP:0002746,abnormal semilunar valve morphology|MP:0002754,dilated heart right ventricle|MP:0002855,abnormal cochlear ganglion morphology|MP:0002925,abnormal cardiovascular development|MP:0002962,increased urine protein level|MP:0003092,decreased cornea stroma thickness|MP:0003094,abnormal cornea posterior stroma morphology|MP:0003168,abnormal scala vestibuli morphology|MP:0003958,heart valve hyperplasia|MP:0004157,interrupted aortic arch|MP:0004251,failure of heart looping|MP:0004282,retrognathia|MP:0004283,absent cornea endothelium|MP:0004285,absent Descemet membrane|MP:0004304,absent spiral limbus|MP:0004307,absent Rosenthal canal|MP:0004354,absent deltoid tuberosity|MP:0004355,short radius|MP:0004359,short ulna|MP:0004377,small frontal bone|MP:0004384,small interparietal bone|MP:0004418,small parietal bone|MP:0004422,small temporal bone|MP:0004440,absent occipital bone|MP:0004454,absent pterygoid process|MP:0004458,absent alisphenoid bone|MP:0004483,absent interdental cells|MP:0004627,abnormal trochanter morphology|MP:0004913,absent mandibular angle|MP:0005208,abnormal iris stroma morphology|MP:0005296,abnormal humerus morphology|MP:0005297,spina bifida occulta|MP:0005298,abnormal clavicle morphology|MP:0005299,abnormal eye posterior chamber morphology|MP:0005300,abnormal cornea stroma morphology|MP:0005304,bulbourethral gland cyst|MP:0005305,prostate gland anterior lobe hyperplasia|MP:0005329,abnormal myocardium layer morphology|MP:0005371,limbs/digits/tail phenotype|MP:0005543,decreased cornea thickness|MP:0005578,teratozoospermia|MP:0005643,decreased dopamine level|MP:0006069,abnormal retina neuronal layer morphology|MP:0006113,abnormal heart septum morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0006200,vitreous body deposition|MP:0006278,aortic aneurysm|MP:0008108,abnormal small intestinal villus morphology|MP:0009085,abnormal uterine horn morphology|MP:0009621,primary vitreous hyperplasia|MP:0009640,abnormal renal tubule epithelium morphology|MP:0009866,abnormal aorta wall morphology|MP:0009886,failure of palatal shelf elevation|MP:0009890,cleft secondary palate|MP:0010099,abnormal thoracic cage shape|MP:0010224,abnormal heart ventricle outflow tract morphology|MP:0010404,ostium primum atrial septal defect|MP:0010412,atrioventricular septal defect|MP:0010413,complete atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010419,inlet ventricular septal defect|MP:0010433,double inlet heart left ventricle|MP:0010454,abnormal truncus arteriosus septation|MP:0010460,pulmonary artery hypoplasia|MP:0010465,aberrant origin of the right subclavian artery|MP:0010469,ascending aorta hypoplasia|MP:0010485,aortic arch hypoplasia|MP:0010572,persistent right dorsal aorta|MP:0010593,thick aortic valve cusps|MP:0010605,thick pulmonary valve cusps|MP:0010610,patent aortic valve|MP:0010611,patent pulmonary valve|MP:0010620,thick mitral valve|MP:0010629,thick tricuspid valve|MP:0010709,absent eye anterior chamber|MP:0010856,dilated respiratory conducting tube|MP:0011087,neonatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011362,ectopic adrenal gland|MP:0011410,ectopic testis|MP:0011448,decreased dopaminergic neuron number|MP:0011575,dilated aorta bulb|MP:0011659,interrupted aortic arch, type b|MP:0011781,abnormal bulbourethral gland physiology|MP:0014234,decreased enterocyte apoptosis|MP:0030258,small mandibular condyloid process|MP:0030283,small mandibular coronoid process|MP:0030388,large fontanelles|MP:0030858,small olecranon
MGI:5695980	Tgfb3<tm1.1(KOMP)Vlcg>	MP:0000702,enlarged lymph nodes|MP:0001146,abnormal testis morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:3768673	Tgfb3<tm1(cre)Vk>	MP:0000111,cleft palate
MGI:1857259	Tgfb3<tm1Doe>	MP:0000111,cleft palate|MP:0001429,dehydration|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0003204,decreased neuron apoptosis|MP:0003244,loss of dopaminergic neurons|MP:0004391,abnormal respiratory conducting tube morphology|MP:0005388,respiratory system phenotype|MP:0008108,abnormal small intestinal villus morphology|MP:0009546,absent gastric milk in neonates|MP:0009655,abnormal secondary palate development|MP:0009889,persistence of medial edge epithelium during palatal shelf fusion|MP:0011087,neonatal lethality, complete penetrance|MP:0013531,abnormal periderm development|MP:0014234,decreased enterocyte apoptosis|MP:0021213,complete cleft palate|MP:0021214,anterior cleft palate
MGI:2158731	Tgfb3<tm1Jhg>	MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001178,pulmonary hypoplasia|MP:0001182,lung hemorrhage|MP:0001436,abnormal suckling behavior|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002726,abnormal pulmonary vein morphology|MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0004007,abnormal lung vasculature morphology|MP:0005243,hemothorax|MP:0006027,impaired lung alveolus development|MP:0009546,absent gastric milk in neonates|MP:0009889,persistence of medial edge epithelium during palatal shelf fusion|MP:0009890,cleft secondary palate|MP:0010811,decreased type II pneumocyte number|MP:0010825,abnormal lung saccule morphology|MP:0010856,dilated respiratory conducting tube|MP:0010900,abnormal pulmonary interalveolar septum morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011143,thick lung-associated mesenchyme
MGI:5313415	Tgfb3<tm1Moaz>	MP:0002169,no abnormal phenotype detected
MGI:3768675	Tgfb3<tm2(Tgfb1)Vk>	MP:0000111,cleft palate|MP:0001436,abnormal suckling behavior|MP:0002239,abnormal nasal septum morphology|MP:0009887,abnormal palatal shelf fusion at midline|MP:0011085,postnatal lethality, complete penetrance
MGI:6405013	Tgfbi<em1Yaou>	MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0002908,delayed wound healing|MP:0005300,abnormal cornea stroma morphology
MGI:5888672	Tgfbi<tm1.1Nap>	MP:0002006,neoplasm|MP:0005391,vision/eye phenotype|MP:0011996,abnormal retina inner nuclear layer thickness|MP:0030006,decreased retina apoptosis
MGI:5638662	Tgfbi<tm1Jwu>	MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005215,abnormal pancreatic islet morphology|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0014117,increased pancreatic beta cell apoptosis|MP:0020087,increased susceptibility to non-insulin-dependent diabetes
MGI:3830817	Tgfbi<tm1Zhao>	MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002018,increased malignant tumor incidence|MP:0002020,increased tumor incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002083,premature death|MP:0003702,abnormal chromosome morphology|MP:0004499,increased incidence of tumors by chemical induction|MP:0005014,increased B cell number|MP:0012431,increased lymphoma incidence|MP:0031678,increased micronucleus incidence
MGI:5285662	Tgfbr1<R244Q>	MP:0000164,abnormal cartilage development|MP:0002724,enhanced wound healing
MGI:5543795	Tgfbr1<tm1.1Hcd>	MP:0000081,premature cranial suture closure|MP:0000160,kyphosis|MP:0002083,premature death|MP:0003211,abnormal aorta elastic fiber morphology|MP:0004044,aortic dissection|MP:0004111,abnormal coronary artery morphology|MP:0004113,abnormal aortic arch morphology|MP:0005243,hemothorax|MP:0005244,hemopericardium|MP:0010661,ascending aorta aneurysm|MP:0010996,increased aorta wall thickness|MP:0011572,abnormal aorta bulb morphology|MP:0011575,dilated aorta bulb|MP:0030350,premature coronal suture closure|MP:0030356,premature lambdoid suture closure
MGI:2680164	Tgfbr1<tm1.1Karl>	MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002534,abnormal type IV hypersensitivity reaction|MP:0002795,dilated cardiomyopathy|MP:0003229,abnormal vitelline vasculature morphology|MP:0003560,osteoarthritis|MP:0005140,decreased cardiac muscle contractility|MP:0005170,cleft upper lip|MP:0005385,cardiovascular system phenotype|MP:0005397,hematopoietic system phenotype|MP:0006433,abnormal articular cartilage morphology|MP:0008127,decreased dendritic cell number|MP:0009883,palatal shelf hypoplasia|MP:0009903,abnormal medial nasal prominence morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011902,increased hematopoietic stem cell proliferation|MP:0013304,osteophytes|MP:0014103,increased chondrocyte apoptosis|MP:0030343,maxillary prominence hypoplasia|MP:0030804,abnormal synovial joint morphology|MP:0031447,unilateral cleft upper lip|MP:0031448,bilateral cleft upper lip|MP:0031460,abnormal palatal shelf morphology
MGI:5544796	Tgfbr1<tm1.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:3831090	Tgfbr1<tm1Bopa>	MP:0011092,embryonic lethality, complete penetrance
MGI:3604556	Tgfbr1<tm1Dgen>	MP:0011100,preweaning lethality, complete penetrance
MGI:2388050	Tgfbr1<tm1Karl>	MP:0000260,abnormal angiogenesis|MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0002151,abnormal neural tube morphology|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0005312,pericardial effusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3767608	Tgfbr1<tm1Mulm>	MP:0001719,absent vitelline blood vessels|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3613461	Tgfbr1<tm1Spo>	MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0005592,abnormal vascular smooth muscle morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011205,excessive folding of visceral yolk sac
MGI:6156162	Tgfbr2<em1(IMPC)Rbrc>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0011100,preweaning lethality, complete penetrance
MGI:7623146	Tgfbr2<em1Rstot>	MP:0005382,craniofacial phenotype
MGI:5543796	Tgfbr2<tm1.1Hcd>	MP:0000160,kyphosis|MP:0002083,premature death|MP:0003211,abnormal aorta elastic fiber morphology|MP:0004044,aortic dissection|MP:0004111,abnormal coronary artery morphology|MP:0004113,abnormal aortic arch morphology|MP:0005243,hemothorax|MP:0005244,hemopericardium|MP:0010661,ascending aorta aneurysm|MP:0010996,increased aorta wall thickness|MP:0011572,abnormal aorta bulb morphology|MP:0011575,dilated aorta bulb
MGI:2384512	Tgfbr2<tm1.1Hlm>	MP:0011100,preweaning lethality, complete penetrance
MGI:2183504	Tgfbr2<tm1.1Karl>	MP:0000245,abnormal erythropoiesis|MP:0000291,enlarged pericardium|MP:0001698,decreased embryo size|MP:0001719,absent vitelline blood vessels
MGI:2384513	Tgfbr2<tm1.2Hlm>	MP:0000074,abnormal neurocranium morphology|MP:0000109,abnormal parietal bone morphology|MP:0000438,abnormal cranium morphology|MP:0000458,abnormal mandible morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0001828,abnormal T cell activation|MP:0001844,autoimmune response|MP:0001846,increased inflammatory response|MP:0001860,liver inflammation|MP:0002006,neoplasm|MP:0002058,neonatal lethality|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002239,abnormal nasal septum morphology|MP:0002264,abnormal bronchus morphology|MP:0002633,persistent truncus arteriosus|MP:0002792,abnormal retina vasculature morphology|MP:0002795,dilated cardiomyopathy|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003099,retina detachment|MP:0003120,abnormal tracheal cartilage morphology|MP:0003154,abnormal soft palate morphology|MP:0003719,abnormal pericyte morphology|MP:0003727,abnormal retina layer morphology|MP:0003755,abnormal palate morphology|MP:0003756,abnormal hard palate morphology|MP:0003934,abnormal pancreas development|MP:0004113,abnormal aortic arch morphology|MP:0004160,retroesophageal right subclavian artery|MP:0004376,absent frontal bone|MP:0004540,small maxilla|MP:0004551,decreased tracheal cartilage ring number|MP:0004592,small mandible|MP:0004787,abnormal dorsal aorta morphology|MP:0004913,absent mandibular angle|MP:0005039,hypoxia|MP:0005140,decreased cardiac muscle contractility|MP:0005352,small cranium|MP:0005385,cardiovascular system phenotype|MP:0006069,abnormal retina neuronal layer morphology|MP:0006185,retina hemorrhage|MP:0006202,vitreous body hemorrhage|MP:0006309,decreased retina ganglion cell number|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0008119,decreased Langerhans cell number|MP:0008515,thin retina outer nuclear layer|MP:0008852,retina neovascularization|MP:0008918,microgliosis|MP:0009025,abnormal brain dura mater morphology|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009546,absent gastric milk in neonates|MP:0009653,abnormal palate development|MP:0009654,abnormal primary palate development|MP:0009883,palatal shelf hypoplasia|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0010097,abnormal retina blood vessel morphology|MP:0010402,ventricular septal defect|MP:0010452,retina microaneurysm|MP:0010856,dilated respiratory conducting tube|MP:0010975,abnormal lung lobe morphology|MP:0010988,abnormal bronchial cartilage morphology|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011085,postnatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011659,interrupted aortic arch, type b|MP:0012029,abnormal electroretinogram waveform feature|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0012760,decreased cranial neural crest cell proliferation|MP:0013546,cleft soft palate|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0030005,increased retina apoptosis|MP:0030224,abnormal soft palate muscle morphology|MP:0030258,small mandibular condyloid process|MP:0030283,small mandibular coronoid process|MP:0030293,small tensor veli palatini muscle|MP:0030295,small levator veli palatini muscle|MP:0031460,abnormal palatal shelf morphology
MGI:3785874	Tgfbr2<tm1Dgen>	MP:0005281,increased fatty acids level|MP:0005334,abnormal fat pad morphology|MP:0010024,increased total body fat amount
MGI:2384511	Tgfbr2<tm1Hlm>	MP:0011100,preweaning lethality, complete penetrance
MGI:2183502	Tgfbr2<tm1Karl>	MP:0000163,abnormal cartilage morphology|MP:0000249,abnormal blood vessel physiology|MP:0000255,blood vessel congestion|MP:0000678,abnormal parathyroid gland morphology|MP:0000680,absent parathyroid glands|MP:0000706,small thymus|MP:0000753,paralysis|MP:0000841,abnormal hindbrain morphology|MP:0000897,abnormal midbrain morphology|MP:0001263,weight loss|MP:0001388,abnormal stationary movement|MP:0001613,abnormal vasodilation|MP:0001846,increased inflammatory response|MP:0001851,eye inflammation|MP:0001860,liver inflammation|MP:0001869,pancreas inflammation|MP:0001873,stomach inflammation|MP:0002081,perinatal lethality|MP:0002083,premature death|MP:0002116,abnormal craniofacial bone morphology|MP:0002169,no abnormal phenotype detected|MP:0002576,abnormal enamel morphology|MP:0002577,reduced enamel thickness|MP:0002633,persistent truncus arteriosus|MP:0002689,abnormal molar morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003494,parathyroid hypoplasia|MP:0004973,increased regulatory T cell number|MP:0005378,growth/size/body region phenotype|MP:0005387,immune system phenotype|MP:0006138,congestive heart failure|MP:0008049,increased memory T cell number|MP:0009845,abnormal neural crest cell morphology|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0010402,ventricular septal defect|MP:0010464,abnormal aortic arch and aortic arch branch attachment|MP:0011091,prenatal lethality, complete penetrance|MP:0030450,abnormal enamel mineralization|MP:0030459,abnormal tooth attrition
MGI:2158728	Tgfbr2<tm1Mmt>	MP:0001722,pale yolk sac|MP:0003229,abnormal vitelline vasculature morphology|MP:0003396,abnormal embryonic hematopoiesis|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3045693	Tgfbr2<tm1Roes>	MP:0000218,increased leukocyte cell number|MP:0001807,decreased IgA level|MP:0002075,abnormal coat/hair pigmentation|MP:0002459,abnormal B cell physiology|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0004381,abnormal hair follicle melanocyte morphology|MP:0004940,abnormal B-1 B cell morphology|MP:0004976,abnormal B-1 B cell number|MP:0008100,absent plasma cells|MP:0008136,enlarged Peyer's patches|MP:0010037,ectopic melanocytes|MP:0010206,pigment incontinence|MP:0011830,ectopic hair follicle melanin granules
MGI:3512546	Tgfbr2<tm1Sjkm>	MP:0003893,increased hepatocyte proliferation|MP:0004499,increased incidence of tumors by chemical induction
MGI:6276920	Tgfbr3<em1(IMPC)Mbp>	MP:0000603,pale liver|MP:0001297,microphthalmia|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:6460397	Tgfbr3l<em2Djb>	MP:0001750,increased circulating follicle stimulating hormone level|MP:0001934,increased litter size|MP:0002681,increased corpora lutea number|MP:0005389,reproductive system phenotype|MP:0011128,increased tertiary ovarian follicle number|MP:0020152,abnormal oocyte number
MGI:3818438	Tgfbr3<tm1.1Jba>	MP:0001622,abnormal vasculogenesis|MP:0002652,thin myocardium|MP:0003057,abnormal epicardium morphology|MP:0004110,transposition of great arteries|MP:0009653,abnormal palate development|MP:0009886,failure of palatal shelf elevation|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009907,decreased tongue size|MP:0010454,abnormal truncus arteriosus septation|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0021217,abnormal palatal shelf bone ossification|MP:0031462,decreased palatal shelf size
MGI:2664514	Tgfbr3<tm1Stv>	MP:0000154,rib fusion|MP:0000157,abnormal sternum morphology|MP:0000295,trabecula carnea hypoplasia|MP:0000559,abnormal femur morphology|MP:0000596,abnormal liver development|MP:0000689,abnormal spleen morphology|MP:0002113,abnormal skeleton development|MP:0002114,abnormal axial skeleton morphology|MP:0002123,abnormal definitive hematopoiesis|MP:0002161,abnormal fertility/fecundity|MP:0004354,absent deltoid tuberosity|MP:0004567,decreased myocardial fiber number|MP:0004627,abnormal trochanter morphology|MP:0008479,decreased spleen white pulp amount|MP:0010420,muscular ventricular septal defect|MP:0010498,abnormal interventricular septum muscular part morphology|MP:0010502,ventricle myocardium hypoplasia|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation
MGI:6783436	Tgfbrap1<tm1Gsk>	MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:3056729	Tg(FCGR2A)11Mkz	MP:0001862,interstitial pneumonia|MP:0002451,abnormal macrophage physiology|MP:0002743,glomerulonephritis|MP:0002993,autoimmune arthritis|MP:0003724,increased susceptibility to induced arthritis|MP:0004720,abnormal platelet morphology|MP:0004796,increased anti-histone antibody level|MP:0008500,increased IgG2a level|MP:0008560,increased tumor necrosis factor secretion|MP:0014708,increased synovial pannus formation|MP:0020519,renal glomerular immunoglobulin deposits
MGI:5620669	Tg(Fev-cre)FF3Pasq	MP:0002169,no abnormal phenotype detected
MGI:5620670	Tg(Fev-cre)FF9Pasq	MP:0002169,no abnormal phenotype detected
MGI:5620671	Tg(Fev-cre)FM3Pasq	MP:0002169,no abnormal phenotype detected
MGI:3767821	Tg(Fezf2-Fezf1,Venus)1Hibi	MP:0000830,abnormal diencephalon morphology
MGI:3767824	Tg(Fezf2,-Venus)1Hibi	MP:0000830,abnormal diencephalon morphology
MGI:3696864	Tg(Fga,Fgb,Fgg)1Unc	MP:0012331,increased circulating fibrinogen level
MGI:1926458	Tg(FGF7)11Efu	MP:0000414,alopecia|MP:0000622,increased salivation|MP:0001222,epidermal hyperplasia|MP:0001732,postnatal growth retardation
MGI:1926459	Tg(FGF7)29Efu	MP:0000414,alopecia|MP:0000622,increased salivation|MP:0001222,epidermal hyperplasia|MP:0001732,postnatal growth retardation|MP:0001924,infertility
MGI:1926467	Tg(FGF7)2Efu	MP:0001211,wrinkled skin|MP:0001284,absent vibrissae|MP:0001343,pronounced eyelids|MP:0002058,neonatal lethality
MGI:1926364	Tg(FGFR2)1Saw	MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000423,delayed hair regrowth|MP:0001221,epidermal atrophy|MP:0001245,thick dermal layer
MGI:2386939	Tg(FGFR3-G380R)7Aya	MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000439,enlarged cranium|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000547,short limbs|MP:0001953,respiratory failure|MP:0002109,abnormal limb morphology|MP:0002427,disproportionate dwarf|MP:0002657,chondrodystrophy|MP:0002764,short tibia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003109,short femur|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004134,abnormal chest morphology|MP:0004358,bowed tibia|MP:0004361,bowed ulna|MP:0004372,bowed fibula|MP:0004374,bowed radius|MP:0004604,abnormal vertebral pedicle morphology|MP:0005274,abnormal viscerocranium morphology|MP:0006396,decreased long bone epiphyseal plate size|MP:0008736,micromelia|MP:0009908,protruding tongue|MP:0010029,abnormal basicranium morphology|MP:0010103,small thoracic cage|MP:0010941,abnormal foramen magnum morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011175,platyspondylia|MP:0012085,midface hypoplasia|MP:0021170,spinal stenosis|MP:0030852,abnormal ilium wing morphology
MGI:2386171	Tg(Fli1)1Ber	MP:0000714,increased thymocyte number
MGI:3796829	Tg(FLII)1Hdc	MP:0001792,impaired wound healing|MP:0002908,delayed wound healing
MGI:4939366	Tg(FLII)2Hdc	MP:0001792,impaired wound healing
MGI:5812884	Tg(Fos/lacZ)#Jim	MP:0002169,no abnormal phenotype detected
MGI:3848354	Tg(Foxd1-GFP/cre)1Amc	MP:0002169,no abnormal phenotype detected
MGI:6415223	Tg(FOXJ1-ACE2)1Rba	MP:0000278,abnormal myocardial fiber morphology|MP:0001862,interstitial pneumonia|MP:0001954,respiratory distress|MP:0003828,pulmonary edema|MP:0005016,decreased lymphocyte cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0010018,pulmonary vascular congestion|MP:0010857,pulmonary necrosis|MP:0020280,increased creatine kinase level|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality|MP:0031167,abnormal lung thrombosis
MGI:1926454	Tg(Foxn1)1Jlb	MP:0001195,flaky skin|MP:0001196,shiny skin|MP:0001198,tight skin|MP:0001265,decreased body size|MP:0001341,absent eyelids|MP:0002796,impaired skin barrier function|MP:0011087,neonatal lethality, complete penetrance
MGI:1926457	Tg(Foxn1)6Jlb	MP:0000382,underdeveloped hair follicles|MP:0000410,waved hair|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000417,short hair|MP:0000422,delayed hair appearance|MP:0000451,scaly muzzle|MP:0000519,hydronephrosis|MP:0000535,ureter urothelium hyperplasia|MP:0001274,curly vibrissae|MP:0001278,kinked vibrissae|MP:0001280,loss of vibrissae|MP:0002083,premature death|MP:0009703,decreased birth body size
MGI:3849080	Tg(Foxp3-HBEGF/EGFP)23.2Spar	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001222,epidermal hyperplasia|MP:0001846,increased inflammatory response|MP:0001861,lung inflammation|MP:0002270,abnormal pulmonary alveolus morphology|MP:0004031,insulitis|MP:0004947,skin inflammation|MP:0004974,decreased regulatory T cell number|MP:0005387,immune system phenotype|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008102,lymph node hyperplasia|MP:0008476,increased spleen red pulp amount|MP:0008478,increased spleen white pulp amount
MGI:6724276	Tg(Fsip2)#Nali	MP:0005389,reproductive system phenotype|MP:0009240,elongated sperm flagellum|MP:0009831,abnormal sperm midpiece morphology|MP:0009836,abnormal sperm principal piece morphology|MP:0030603,increased sperm number
MGI:1891599	Tg(Fst)10Zuk	MP:0001147,small testis
MGI:1891600	Tg(Fst)4Zuk	MP:0000411,shiny fur|MP:0001121,uterus hypoplasia|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001147,small testis|MP:0001926,female infertility|MP:0002790,decreased circulating follicle stimulating hormone level
MGI:1891601	Tg(Fst)5Zuk	MP:0000411,shiny fur|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility
MGI:1891602	Tg(Fst)7Zuk	MP:0001147,small testis
MGI:1891603	Tg(Fst)9Zuk	MP:0000411,shiny fur|MP:0001121,uterus hypoplasia|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility
MGI:4412181	Tg(FXN)YG22Pook	MP:0003702,abnormal chromosome morphology|MP:0005621,abnormal cell physiology
MGI:3797739	Tg(FXN)YG8Pook	MP:0003702,abnormal chromosome morphology|MP:0005384,cellular phenotype
MGI:3721803	Tg(Gad1-EGFP)3Gfng	MP:0002169,no abnormal phenotype detected
MGI:3697310	Tg(Gad1-EGFP)94Agmo	MP:0002169,no abnormal phenotype detected
MGI:3697311	Tg(Gad1-EGFP)98Agmo	MP:0002169,no abnormal phenotype detected
MGI:4867205	Tg(GART)2Eri	MP:0002169,no abnormal phenotype detected
MGI:4867218	Tg(GART)3Eri	MP:0002169,no abnormal phenotype detected
MGI:2384541	Tg(GAS)2Tcw	MP:0004499,increased incidence of tumors by chemical induction|MP:0005655,increased aggression|MP:0009642,abnormal blood homeostasis
MGI:3847353	Tg(GAS7)63.2Lus	MP:0001262,decreased body weight|MP:0003947,abnormal cholesterol level|MP:0003982,increased cholesterol level|MP:0005318,decreased triglyceride level|MP:0005452,abnormal adipose tissue amount|MP:0005560,decreased circulating glucose level|MP:0008907,decreased total fat pad weight|MP:0009283,decreased gonadal fat pad weight|MP:0009299,decreased mesenteric fat pad weight
MGI:3831657	Tg(Gata1-Dyrk3)FND-IDowo	MP:0000245,abnormal erythropoiesis|MP:0008973,decreased erythroid progenitor cell number
MGI:3531421	Tg(Gcg-TAg)25Ddr	MP:0000489,abnormal large intestine morphology|MP:0001263,weight loss|MP:0001272,increased metastatic potential|MP:0002083,premature death|MP:0005150,cachexia|MP:0005215,abnormal pancreatic islet morphology|MP:0005491,pancreatic islet hyperplasia|MP:0009153,increased pancreas tumor incidence|MP:0009171,enlarged pancreatic islets|MP:0009310,increased large intestine adenocarcinoma incidence|MP:0009480,distended cecum|MP:0010802,abnormal intestinal enteroendocrine cell morphology|MP:0012436,increased colon tumor incidence|MP:0014201,abnormal intestinal epithelium physiology
MGI:3581819	Tg(GFAP)10Mes	MP:0001265,decreased body size|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology
MGI:3581820	Tg(GFAP)7Mes	MP:0002182,abnormal astrocyte morphology
MGI:3717390	Tg(Gfap-APOE_i4)50Hube	MP:0003313,abnormal locomotor activation|MP:0005386,behavior/neurological phenotype
MGI:3717392	Tg(Gfap-APOE_i4*L28P)12Hube	MP:0005386,behavior/neurological phenotype
MGI:6194623	Tg(GFAP-ATXN7*10Q)2791Als	MP:0002169,no abnormal phenotype detected
MGI:6194621	Tg(GFAP-ATXN7*92Q)2521Als	MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0003690,abnormal glial cell physiology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0010387,abnormal Bergmann glial cell morphology
MGI:6194622	Tg(GFAP-ATXN7*92Q)2542Als	MP:0000876,Purkinje cell degeneration|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0010387,abnormal Bergmann glial cell morphology
MGI:6149495	Tg(Gfap-Cyth1*Y382F)1Jya	MP:0011731,decreased myelin sheath thickness|MP:0013438,dysmyelination
MGI:6149499	Tg(Gfap-Cyth1*Y382F)5Jya	MP:0011731,decreased myelin sheath thickness|MP:0013438,dysmyelination
MGI:4398695	Tg(GFAP-EFNA3)181Kln	MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0008143,abnormal dendrite morphology
MGI:4355151	Tg(Gfap-EGFP)3739Sart	MP:0002169,no abnormal phenotype detected
MGI:3809243	Tg(Gfap-GFAP*R239H)60TMIke	MP:0002182,abnormal astrocyte morphology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003631,nervous system phenotype|MP:0004362,cochlear hair cell degeneration|MP:0004597,increased susceptibility to noise-induced hearing loss|MP:0004716,abnormal cochlear nerve morphology|MP:0005386,behavior/neurological phenotype
MGI:4361817	Tg(Gfap-gp120)10Lms	MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0008143,abnormal dendrite morphology|MP:0008918,microgliosis|MP:0009538,abnormal synapse morphology
MGI:4361818	Tg(Gfap-gp120)16Lms	MP:0008143,abnormal dendrite morphology
MGI:4361816	Tg(Gfap-gp120)2Lms	MP:0000136,abnormal microglial cell morphology|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0008143,abnormal dendrite morphology|MP:0008918,microgliosis|MP:0009538,abnormal synapse morphology
MGI:5000435	Tg(Gfap-gp120)#Lms	MP:0000812,abnormal dentate gyrus morphology|MP:0003861,abnormal nervous system development|MP:0004981,decreased neuronal precursor cell number|MP:0008143,abnormal dendrite morphology|MP:0020394,decreased neuronal precursor proliferation
MGI:2445442	Tg(GFAP-Hras1)2Agu	MP:0001393,ataxia|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology|MP:0004027,trisomy|MP:0010277,increased astrocytoma incidence
MGI:4429148	Tg(GFAP-HTT*160Q)1Xjl	MP:0001263,weight loss|MP:0001405,impaired coordination|MP:0001443,poor grooming|MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0004924,abnormal behavior|MP:0005202,lethargy
MGI:4437299	Tg(GFAP-HTT*160Q)31Xjl	MP:0001263,weight loss|MP:0001405,impaired coordination|MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0004924,abnormal behavior
MGI:2447805	Tg(Gfap-Ifna1)12Ilc	MP:0000820,abnormal choroid plexus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001263,weight loss|MP:0001393,ataxia|MP:0002064,seizures|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0003354,astrocytosis|MP:0004950,abnormal brain vasculature morphology|MP:0005405,axon degeneration|MP:0006007,abnormal basal ganglion morphology|MP:0006082,CNS inflammation|MP:0010152,abnormal brain ependyma morphology|MP:0020914,decreased susceptibility to Riboviria infection|MP:0030014,calcified brain|MP:0031023,decreased susceptibility to Riboviria infection induced morbidity/mortality|MP:0031111,meningoencephalitis
MGI:2447806	Tg(Gfap-Ifna1)39Ilc	MP:0000820,abnormal choroid plexus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0002064,seizures|MP:0002083,premature death|MP:0003354,astrocytosis|MP:0004950,abnormal brain vasculature morphology|MP:0005405,axon degeneration|MP:0006007,abnormal basal ganglion morphology|MP:0006082,CNS inflammation|MP:0010152,abnormal brain ependyma morphology|MP:0030014,calcified brain|MP:0031111,meningoencephalitis
MGI:3800175	Tg(Gfap-Il6)G167Lms	MP:0000745,tremors|MP:0000880,decreased Purkinje cell number|MP:0000889,abnormal cerebellar molecular layer|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001492,abnormal pilomotor reflex|MP:0001505,hunched posture|MP:0002064,seizures|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0002654,spongiform encephalopathy|MP:0002882,abnormal neuron morphology|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0003710,abnormal physiological neovascularization|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004924,abnormal behavior|MP:0005404,abnormal axon morphology|MP:0008026,abnormal brain white matter morphology|MP:0008143,abnormal dendrite morphology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008948,decreased neuron number|MP:0009434,paraparesis
MGI:3800176	Tg(Gfap-Il6)G16Lms	MP:0000420,ruffled hair|MP:0000745,tremors|MP:0000889,abnormal cerebellar molecular layer|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001492,abnormal pilomotor reflex|MP:0001505,hunched posture|MP:0001864,vascular inflammation|MP:0002064,seizures|MP:0002083,premature death|MP:0003354,astrocytosis|MP:0005387,immune system phenotype|MP:0009434,paraparesis
MGI:3800178	Tg(Gfap-Il6)G369Lms	MP:0000420,ruffled hair|MP:0000745,tremors|MP:0000880,decreased Purkinje cell number|MP:0000889,abnormal cerebellar molecular layer|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001492,abnormal pilomotor reflex|MP:0001505,hunched posture|MP:0001864,vascular inflammation|MP:0002064,seizures|MP:0002182,abnormal astrocyte morphology|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0002654,spongiform encephalopathy|MP:0002882,abnormal neuron morphology|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0003710,abnormal physiological neovascularization|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004924,abnormal behavior|MP:0005387,immune system phenotype|MP:0005404,abnormal axon morphology|MP:0008026,abnormal brain white matter morphology|MP:0008143,abnormal dendrite morphology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008948,decreased neuron number|MP:0009434,paraparesis
MGI:2445445	Tg(GFAP-lacZ-TAg121)92Tvd	MP:0002169,no abnormal phenotype detected
MGI:5014211	Tg(Gfap-rtTA,tetO-MAOB,-lacZ)1Jkan	MP:0000136,abnormal microglial cell morphology|MP:0001402,decreased locomotor activity|MP:0002229,neurodegeneration|MP:0003243,abnormal dopaminergic neuron morphology|MP:0003244,loss of dopaminergic neurons|MP:0004811,abnormal neuron physiology|MP:0010762,abnormal microglial cell activation
MGI:2445476	Tg(GFAP-SRC)1Aag	MP:0000753,paralysis|MP:0001393,ataxia|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0002182,abnormal astrocyte morphology|MP:0003354,astrocytosis|MP:0010277,increased astrocytoma incidence
MGI:2445477	Tg(GFAP-SRC)2Aag	MP:0000753,paralysis|MP:0001393,ataxia|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0002182,abnormal astrocyte morphology|MP:0003354,astrocytosis|MP:0010277,increased astrocytoma incidence|MP:0010310,increased Schwannoma incidence
MGI:2445478	Tg(GFAP-SRC)3Aag	MP:0002169,no abnormal phenotype detected
MGI:2445447	Tg(GFAP-TAg121)1Tvd	MP:0000438,abnormal cranium morphology|MP:0001263,weight loss|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0010277,increased astrocytoma incidence
MGI:3717676	Tg(Gfap-TGFB1)64Lms	MP:0000604,amyloidosis|MP:0000745,tremors|MP:0000822,abnormal brain ventricle morphology|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001505,hunched posture|MP:0001891,hydrocephaly|MP:0002064,seizures|MP:0003354,astrocytosis|MP:0004254,cerebral amyloid angiopathy|MP:0005387,immune system phenotype|MP:0005623,abnormal meninges morphology|MP:0008534,enlarged fourth ventricle|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0008916,abnormal astrocyte physiology|MP:0012506,brain atrophy|MP:0031442,enlarged cerebral aqueduct
MGI:3664567	Tg(Gfap-TK)7.1Mvs	MP:0000219,increased neutrophil cell number|MP:0000313,abnormal cell death|MP:0000350,abnormal cell proliferation|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000496,abnormal small intestine morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000952,abnormal CNS glial cell morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001577,anemia|MP:0001663,abnormal digestive system physiology|MP:0001785,edema|MP:0001792,impaired wound healing|MP:0001845,abnormal inflammatory response|MP:0001847,brain inflammation|MP:0001925,male infertility|MP:0002184,abnormal innervation|MP:0002581,abnormal ileum morphology|MP:0002875,decreased erythrocyte cell number|MP:0003224,neuron degeneration|MP:0003240,loss of hippocampal neurons|MP:0003292,melena|MP:0003306,small intestinal inflammation|MP:0003354,astrocytosis|MP:0003449,abnormal intestine goblet cell morphology|MP:0003631,nervous system phenotype|MP:0003634,abnormal glial cell morphology|MP:0004002,abnormal jejunum morphology|MP:0005167,abnormal blood-brain barrier function|MP:0005565,increased blood urea nitrogen level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0008916,abnormal astrocyte physiology|MP:0009395,increased nucleated erythrocyte cell number|MP:0009485,distended ileum|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0009937,abnormal neuron differentiation|MP:0011503,distended jejunum|MP:0031126,gangrene|MP:0031155,small intestine hemorrhage
MGI:3766134	Tg(Gfap-TNF*)K21Gkl	MP:0000921,demyelination|MP:0002182,abnormal astrocyte morphology|MP:0003354,astrocytosis|MP:0005405,axon degeneration|MP:0005623,abnormal meninges morphology|MP:0006082,CNS inflammation|MP:0010205,abnormal oligodendrocyte apoptosis
MGI:3619228	Tg(GFAP-TVA)10Ech	MP:0002006,neoplasm
MGI:2663943	Tg(GFAP-TVA)5Hev	MP:0003690,abnormal glial cell physiology|MP:0010278,increased glioma incidence|MP:0010312,increased oligodendroglioma incidence
MGI:2182853	Tg(GFP/KRAS2/ALPP)1Brn	MP:0008014,increased lung tumor incidence|MP:0012431,increased lymphoma incidence|MP:0013488,increased keratoacanthoma incidence
MGI:2387092	Tg(Ggamma-T)15Cps	MP:0002031,increased adrenal gland tumor incidence|MP:0006262,increased testis tumor incidence|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009552,urinary bladder obstruction|MP:0010344,increased hibernoma incidence|MP:0010357,increased prostate gland tumor incidence|MP:0014237,decreased tumor-free survival time
MGI:5298013	Tg(Ggt1-Hif1a*)43Log	MP:0000530,abnormal kidney vasculature morphology|MP:0003675,kidney cyst|MP:0010384,increased renal carcinoma incidence
MGI:2447154	Tg(GH)3Mi	MP:0011091,prenatal lethality, complete penetrance
MGI:2447156	Tg(GH)4Mi	MP:0011091,prenatal lethality, complete penetrance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3524994	Tg(Gh-Gal)4599Vron	MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000635,pituitary gland hyperplasia|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001264,increased body size|MP:0002041,increased pituitary adenoma incidence|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0003982,increased cholesterol level|MP:0005123,increased circulating growth hormone level|MP:0005124,increased circulating prolactin level|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005317,increased triglyceride level|MP:0009286,increased abdominal fat pad weight|MP:0009288,increased epididymal fat pad weight|MP:0020234,decreased basal metabolism
MGI:4360905	Tg(GHRL-TAg)1-5Hiwa	MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0009153,increased pancreas tumor incidence|MP:0010301,increased stomach tumor incidence|MP:0010316,increased thyroid tumor incidence
MGI:4360904	Tg(GHRL-TAg)3-1Hiwa	MP:0001262,decreased body weight|MP:0002727,decreased circulating insulin level|MP:0003285,gastric hypertrophy|MP:0004702,increased circulating insulin-like growth factor I level|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0010025,decreased total body fat amount|MP:0010301,increased stomach tumor incidence|MP:0011940,decreased food intake
MGI:4360906	Tg(GHRL-TAg)4-3Hiwa	MP:0003285,gastric hypertrophy|MP:0009828,increased tumor latency
MGI:5502921	Tg(Gm13344,Etn2*)#Kymm	MP:0002169,no abnormal phenotype detected
MGI:3693959	Tg(GNAT2-Dta)98Wwk	MP:0001004,abnormal retina photoreceptor morphology|MP:0001325,abnormal retina morphology|MP:0002183,gliosis|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0008444,retina cone cell degeneration|MP:0008447,absent retina cone cells|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008453,decreased retina rod cell number|MP:0008454,absent retina rod cells|MP:0008515,thin retina outer nuclear layer|MP:0008519,thin retina outer plexiform layer
MGI:3703643	Tg(GNB1L,TBX1,GP1BB,SEPT5)23Bem	MP:0000267,abnormal heart development|MP:0000704,abnormal thymus development|MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0002367,abnormal thymus lobule morphology|MP:0003139,patent ductus arteriosus|MP:0004113,abnormal aortic arch morphology|MP:0004158,right aortic arch|MP:0004160,retroesophageal right subclavian artery|MP:0006126,abnormal cardiac outflow tract development|MP:0006130,pulmonary valve atresia|MP:0010402,ventricular septal defect|MP:0011087,neonatal lethality, complete penetrance|MP:0011659,interrupted aortic arch, type b
MGI:4437236	Tg(Gnrh1-cre)35Awo	MP:0005389,reproductive system phenotype
MGI:3588566	Tg(Gnrh1-Fgfr1)1Tsai	MP:0001752,abnormal hypothalamus secretion|MP:0001935,decreased litter size|MP:0002636,delayed vaginal opening|MP:0002882,abnormal neuron morphology|MP:0004852,decreased testis weight|MP:0005376,homeostasis/metabolism phenotype|MP:0008995,early reproductive senescence|MP:0014589,abnormal gonadotropin-releasing hormone neuron morphology|MP:0014592,decreased gonadotropin-releasing hormone neuron number
MGI:4437221	Tg(Gnrh1-tetO-cre,CMV-tetR)1Awo	MP:0005389,reproductive system phenotype
MGI:4359293	Tg(Gpbar1)1Auw	MP:0001402,decreased locomotor activity|MP:0002079,increased circulating insulin level|MP:0003058,increased insulin secretion|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0009170,abnormal pancreatic islet size|MP:0010379,decreased respiratory quotient
MGI:3795203	Tg(GPD1)3Bir	MP:0002169,no abnormal phenotype detected
MGI:3795209	Tg(GPD1)A1Bir	MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001921,reduced fertility
MGI:3795211	Tg(GPD1)A2Bir	MP:0002169,no abnormal phenotype detected|MP:0011100,preweaning lethality, complete penetrance
MGI:3783719	Tg(Gpx1)41Dkd	MP:0001544,abnormal cardiovascular system physiology|MP:0003038,decreased myocardial infarct size|MP:0005599,increased cardiac muscle contractility|MP:0006085,myocardium necrosis
MGI:3653636	Tg(Gpx1)41Spec	MP:0011602,increased glutathione peroxidase activity
MGI:3612450	Tg(Gria2*586N)238.2Rsp	MP:0000818,abnormal amygdala morphology|MP:0000938,motor neuron degeneration|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001407,short stride length|MP:0001961,abnormal reflex|MP:0002183,gliosis|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005113,decreased spinal cord ventral horn cell number|MP:0020556,abnormal ventromedial hypothalamic nucleus morphology
MGI:4411993	Tg(Grm6-icre)1Rlbn	MP:0002169,no abnormal phenotype detected
MGI:3720257	Tg(Gt(ROSA)26Sor-BCHE*G117H)837Loc	MP:0005319,abnormal enzyme/coenzyme level
MGI:3720264	Tg(Gt(ROSA)26Sor-BCHE*G117H)844Loc	MP:0000622,increased salivation|MP:0000745,tremors|MP:0005319,abnormal enzyme/coenzyme level|MP:0005376,homeostasis/metabolism phenotype|MP:0005534,decreased body temperature|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:3763223	Tg(Gt(ROSA)26Sor-EGFP)I1Able	MP:0002169,no abnormal phenotype detected
MGI:5780088	Tg(Gt(ROSA)26Sor-Foxe1)#Tme	MP:0000111,cleft palate
MGI:5523963	Tg(Guca1a*L151F/EGFP)#Wbae	MP:0006149,decreased visual acuity|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:5523961	Tg(Guca1a*L151F)#Wbae	MP:0006149,decreased visual acuity|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:3830652	Tg(Gzmb-cre/ERT2)1Dtf	MP:0002169,no abnormal phenotype detected
MGI:4839487	Tg(GZMB-Tax)#Lera	MP:0010280,increased skeletal tumor incidence
MGI:5306998	Tg(H2-D<b>)2Bujf	MP:0020938,decreased susceptibility to Picornaviridae infection
MGI:3623278	Tg(H2-D-Il15)3304Clgr	MP:0000321,increased bone marrow cell number|MP:0000414,alopecia|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001175,abnormal lung morphology|MP:0001194,dermatitis|MP:0001209,spontaneous skin ulceration|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001845,abnormal inflammatory response|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0003413,hair follicle degeneration|MP:0003944,abnormal T cell subpopulation ratio|MP:0003945,abnormal lymphocyte physiology|MP:0005013,increased lymphocyte cell number|MP:0008037,abnormal T cell morphology|MP:0008044,increased NK cell number|MP:0008049,increased memory T cell number|MP:0008478,increased spleen white pulp amount
MGI:3793709	Tg(H2-Ea)16Dim	MP:0002461,increased immunoglobulin level
MGI:3052550	Tg(H2-Ea<d>)12Lt	MP:0001844,autoimmune response|MP:0004031,insulitis|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0008567,decreased interferon-gamma secretion|MP:0008699,increased interleukin-4 secretion
MGI:3052548	Tg(H2-Ea<d>)5Lt	MP:0001844,autoimmune response|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005580,periinsulitis|MP:0008567,decreased interferon-gamma secretion|MP:0008699,increased interleukin-4 secretion
MGI:3790748	Tg(H2-Ea-G6pc2)69Tkay	MP:0002869,increased anti-insulin autoantibody level|MP:0004031,insulitis|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005000,abnormal immune tolerance|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005095,decreased T cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology
MGI:2448707	Tg(H2-Ea-Il7)10Rhdr	MP:0002407,abnormal double-negative T cell morphology|MP:0003132,increased pre-B cell number|MP:0004939,abnormal B cell morphology|MP:0008186,increased pro-B cell number
MGI:3590216	Tg(H2-Ea-Ins2)1Wehi	MP:0001870,salivary gland inflammation|MP:0002870,decreased anti-insulin autoantibody level|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005094,abnormal T cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005379,endocrine/exocrine gland phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:5311331	Tg(H2-Ea-LACK)1Ngkh	MP:0001790,abnormal immune system physiology|MP:0005026,decreased susceptibility to parasitic infection|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0008086,increased T-helper 1 cell number|MP:0008091,decreased T-helper 2 cell number|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality
MGI:3834750	Tg(H2-Ea-Tnfsf9)16Lpc	MP:0000322,increased granulocyte number|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0001805,decreased IgG level|MP:0002344,abnormal lymph node B cell domain morphology|MP:0002459,abnormal B cell physiology|MP:0005013,increased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005425,increased macrophage cell number|MP:0008044,increased NK cell number|MP:0008049,increased memory T cell number|MP:0008995,early reproductive senescence|MP:0014263,decreased spleen B cell follicle number
MGI:5428682	Tg(H2-K1-HLA-A*)28Mpla	MP:0001324,abnormal eye pigmentation|MP:0001325,abnormal retina morphology|MP:0001848,choroid inflammation|MP:0001851,eye inflammation|MP:0001864,vascular inflammation|MP:0003099,retina detachment|MP:0005201,abnormal retina pigment epithelium morphology|MP:0021107,retina fold
MGI:5141611	Tg(H2-K1-Ifnb1)10Seif	MP:0001146,abnormal testis morphology|MP:0001154,seminiferous tubule degeneration|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0003698,abnormal male reproductive system physiology|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype|MP:0008280,abnormal male germ cell apoptosis|MP:0008995,early reproductive senescence
MGI:5633960	Tg(H-2K1-Lrp5/Fkbp1a,-luc*)#Dmps	MP:0000659,prostate gland hyperplasia|MP:0009220,increased prostate gland adenocarcinoma incidence
MGI:3703741	Tg(H2-K-AKR1B1)1Tj	MP:0001304,cataract|MP:0001614,abnormal blood vessel morphology|MP:0002078,abnormal glucose homeostasis|MP:0002828,abnormal renal glomerular capsule morphology|MP:0005584,abnormal enzyme/coenzyme activity
MGI:2447580	Tg(H2-K-BCL2)1Josd	MP:0000218,increased leukocyte cell number|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0002221,abnormal lymph organ size|MP:0002396,abnormal hematopoietic system morphology/development|MP:0003010,decreased mortality induced by ionizing radiation|MP:0004587,decreased cellular sensitivity to X-ray irradiation|MP:0004809,increased hematopoietic stem cell number
MGI:4454683	Tg(H2-K<b>-IL21)5Wjl	MP:0002144,abnormal B cell differentiation|MP:0002494,increased IgM level|MP:0004816,abnormal class switch recombination|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008211,decreased mature B cell number|MP:0008214,increased immature B cell number|MP:0008499,increased IgG1 level|MP:0008782,increased B cell apoptosis|MP:0009922,increased transitional stage T1 B cell number|MP:0009926,decreased transitional stage T2 B cell number
MGI:5444028	Tg(H2-K<b>-Jak2*V617F)2Shmd	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002123,abnormal definitive hematopoiesis|MP:0002417,abnormal megakaryocyte morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004148,increased compact bone thickness|MP:0004952,increased spleen weight|MP:0005097,polychromatophilia|MP:0005505,thrombocytosis|MP:0008254,increased megakaryocyte cell number|MP:0008476,increased spleen red pulp amount|MP:0008973,decreased erythroid progenitor cell number|MP:0010178,increased number of Howell-Jolly bodies|MP:0010373,myeloid hyperplasia|MP:0011179,decreased erythroblast number|MP:0011746,spleen fibrosis|MP:0011747,myelofibrosis|MP:0020399,enhanced megakaryocyte emperipolesis|MP:0030025,giant platelets
MGI:5582295	Tg(H2-K*b-sHEL)LaxmanCcg	MP:0002169,no abnormal phenotype detected
MGI:5582285	Tg(H2-K*b-sHEL)RAMACcg	MP:0002169,no abnormal phenotype detected
MGI:5644514	Tg(H2-K<b>-Tcra,-Tcrb)1640Kurs	MP:0000921,demyelination|MP:0001393,ataxia|MP:0001847,brain inflammation|MP:0003725,increased autoantibody level|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0006082,CNS inflammation|MP:0008086,increased T-helper 1 cell number|MP:0008713,abnormal cytokine level|MP:0010219,increased T-helper 17 cell number|MP:0013147,limb paralysis
MGI:3656476	Tg(H2-K-Cd86)27All	MP:0002144,abnormal B cell differentiation|MP:0005017,decreased B cell number
MGI:3656477	Tg(H2-K-Cd86)31All	MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:3656399	Tg(H2-K-Cd86)7All	MP:0000688,lymphoid hyperplasia|MP:0000693,spleen hyperplasia|MP:0001845,abnormal inflammatory response|MP:0002144,abnormal B cell differentiation|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008102,lymph node hyperplasia|MP:0009338,increased splenocyte number
MGI:3807515	Tg(H2-K-DUSP5)21Wjl	MP:0000414,alopecia|MP:0000523,cortical renal glomerulopathies|MP:0001194,dermatitis|MP:0001214,skin hyperplasia|MP:0002083,premature death|MP:0004947,skin inflammation|MP:0005091,increased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0006387,abnormal T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008082,increased single-positive T cell number|MP:0008083,decreased single-positive T cell number|MP:0008097,increased plasma cell number
MGI:3056679	Tg(H2KePCC)2403Stoe	MP:0005000,abnormal immune tolerance
MGI:3639512	Tg(H2-K-Fosl1)1Wag	MP:0000074,abnormal neurocranium morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000141,abnormal vertebral body morphology|MP:0000150,abnormal rib morphology|MP:0000160,kyphosis|MP:0000240,extramedullary hematopoiesis|MP:0000438,abnormal cranium morphology|MP:0000691,enlarged spleen|MP:0001533,abnormal skeleton physiology|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0002896,abnormal bone mineralization|MP:0003046,liver cirrhosis|MP:0003109,short femur|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0004148,increased compact bone thickness|MP:0005006,abnormal osteoblast physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005422,osteosclerosis|MP:0005605,increased bone mass|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011710,enhanced osteoblast differentiation|MP:0030278,thick neurocranium
MGI:3813493	Tg(H2-K-Fosl2,-EGFP)13Wag	MP:0000484,abnormal pulmonary artery morphology|MP:0001175,abnormal lung morphology|MP:0001505,hunched posture|MP:0001861,lung inflammation|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0003141,cardiac fibrosis|MP:0003333,liver fibrosis|MP:0004007,abnormal lung vasculature morphology|MP:0005367,renal/urinary system phenotype|MP:0005426,tachypnea|MP:0005489,vascular smooth muscle hyperplasia|MP:0005605,increased bone mass|MP:0005630,increased lung weight|MP:0006050,pulmonary fibrosis|MP:0009932,skin fibrosis|MP:0010363,increased fibrosarcoma incidence|MP:0014129,thymus fibrosis|MP:0014158,esophagus fibrosis|MP:0014159,stomach fibrosis
MGI:3806366	Tg(H2-K-HLA-G,B2M)1Alm	MP:0005078,abnormal cytotoxic T cell physiology|MP:0005348,increased T cell proliferation
MGI:6231206	Tg(H2-K-Hmga1)#Lmsr	MP:0000218,increased leukocyte cell number|MP:0000477,abnormal intestine morphology|MP:0000493,rectal prolapse|MP:0001135,abnormal uterine cervix morphology|MP:0001402,decreased locomotor activity|MP:0001926,female infertility|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0003570,increased uterus leiomyoma incidence|MP:0004896,abnormal endometrium morphology|MP:0008011,intestine polyps|MP:0009222,increased uterus tumor incidence|MP:0012431,increased lymphoma incidence|MP:0013328,visceromegaly|MP:0014049,increased T cell acute lymphoblastic leukemia incidence|MP:0014218,increased intestinal mucosa thickness
MGI:5582513	Tg(H2-K-IL6)2Srj	MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002123,abnormal definitive hematopoiesis|MP:0002339,abnormal lymph node morphology|MP:0002356,abnormal spleen red pulp morphology|MP:0002359,abnormal spleen germinal center morphology|MP:0002441,abnormal granulocyte morphology|MP:0002493,increased IgG level|MP:0008097,increased plasma cell number|MP:0008254,increased megakaryocyte cell number|MP:0008522,abnormal lymph node germinal center morphology
MGI:3806951	Tg(H2-K-MC159/EGFP)13Fkmc	MP:0000691,enlarged spleen|MP:0002401,abnormal lymphopoiesis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005015,increased T cell number|MP:0005090,increased double-negative T cell number|MP:0005154,increased B cell proliferation|MP:0005387,immune system phenotype|MP:0006414,decreased T cell apoptosis|MP:0008173,increased follicular B cell number|MP:0008501,increased IgG2b level|MP:0008783,decreased B cell apoptosis|MP:0008944,decreased sensitivity to induced cell death
MGI:3056682	Tg(H2KmPCC)2939Stoe	MP:0005000,abnormal immune tolerance
MGI:3762014	Tg(H2-K-TcrbP14)128Mak	MP:0002145,abnormal T cell differentiation|MP:0005002,abnormal T cell clonal deletion|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation
MGI:6696066	Tg(H2-L<d>)LoxNibl	MP:0005387,immune system phenotype|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality|MP:0020002,increased response to antigen
MGI:3806003	Tg(H2-L-IL6)1Kish	MP:0000130,abnormal trabecular bone morphology|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0002123,abnormal definitive hematopoiesis|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002644,decreased circulating triglyceride level|MP:0002743,glomerulonephritis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002962,increased urine protein level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0004989,decreased osteoblast cell number|MP:0005419,decreased circulating serum albumin level|MP:0005505,thrombocytosis|MP:0005560,decreased circulating glucose level|MP:0005568,increased circulating total protein level|MP:0008097,increased plasma cell number|MP:0008254,increased megakaryocyte cell number|MP:0008499,increased IgG1 level|MP:0010286,increased plasmacytoma incidence
MGI:5556099	Tg(H2-L-IL6)40Csk	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0004952,increased spleen weight
MGI:3806463	Tg(H2-L-IL6)46Kish	MP:0000604,amyloidosis|MP:0000691,enlarged spleen|MP:0001443,poor grooming|MP:0001505,hunched posture|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0002228,abnormal spleen trabecular vein morphology|MP:0002339,abnormal lymph node morphology|MP:0002354,abnormal spleen trabecular artery morphology|MP:0002461,increased immunoglobulin level|MP:0002493,increased IgG level|MP:0002495,increased IgA level|MP:0002722,abnormal immune system organ morphology|MP:0002743,glomerulonephritis|MP:0005324,ascites|MP:0008097,increased plasma cell number|MP:0008466,enlarged mesenteric lymph nodes|MP:0008499,increased IgG1 level|MP:0008501,increased IgG2b level|MP:0009317,increased follicular lymphoma incidence|MP:0009631,enlarged axillary lymph nodes|MP:0010286,increased plasmacytoma incidence
MGI:2447399	Tg(hAGT)2041Sig	MP:0004875,increased mean systemic arterial blood pressure|MP:0005385,cardiovascular system phenotype
MGI:5518842	Tg(Hand2)#Tshir	MP:0004647,decreased lumbar vertebrae number|MP:0008985,hemimelia|MP:0010772,abnormal pollex morphology
MGI:2445993	Tg(Hba-x-v-Ha-ras)TG.ACLed	MP:0002014,increased papilloma incidence|MP:0002021,increased incidence of induced tumors
MGI:3800816	Tg(HBB-cre)12Kpe	MP:0002169,no abnormal phenotype detected
MGI:3579105	Tg(HBB-Gata1)G4Phi	MP:0000245,abnormal erythropoiesis|MP:0001577,anemia|MP:0002169,no abnormal phenotype detected|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3625833	Tg(HBB-GH1)420King	MP:0000137,abnormal vertebrae morphology|MP:0001191,abnormal skin condition|MP:0001510,abnormal coat appearance|MP:0001923,reduced female fertility|MP:0001924,infertility|MP:0004148,increased compact bone thickness|MP:0004149,increased bone strength|MP:0005376,homeostasis/metabolism phenotype|MP:0020138,delayed bone mineralization|MP:0021195,increased bone mineral density of caudal vertebrae
MGI:5524131	Tg(HBB-lacZ)ALey	MP:0005397,hematopoietic system phenotype
MGI:6323000	Tg(HBB-Myc)#Cos	MP:0000208,decreased hematocrit|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001859,kidney inflammation|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0002320,hyperventilation|MP:0002722,abnormal immune system organ morphology|MP:0003068,enlarged kidney|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0005202,lethargy|MP:0005264,glomerulosclerosis|MP:0005385,cardiovascular system phenotype|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008528,polycystic kidney|MP:0010383,increased adenoma incidence
MGI:3054659	Tg(HBV)10Imeg	MP:0002376,abnormal dendritic cell physiology|MP:0003009,abnormal cytokine secretion|MP:0005370,liver/biliary system phenotype
MGI:3513423	Tg(HBV-HCV)21Kko	MP:0002628,hepatic steatosis|MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0011634,abnormal mitochondrial inner membrane morphology
MGI:3513426	Tg(HBV-HCV)49Kko	MP:0002628,hepatic steatosis|MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0011634,abnormal mitochondrial inner membrane morphology
MGI:3794557	Tg(HBV-HCV)Kko	MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0002628,hepatic steatosis|MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003674,oxidative stress|MP:0011593,increased catalase activity|MP:0011634,abnormal mitochondrial inner membrane morphology|MP:0012604,decreased glutathione level
MGI:5544911	Tg(HBVX*,-Myc)#Skp	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0001656,focal hepatic necrosis|MP:0002123,abnormal definitive hematopoiesis|MP:0002981,increased liver weight|MP:0003111,abnormal cell nucleus morphology|MP:0003331,increased hepatocellular carcinoma incidence|MP:0005425,increased macrophage cell number|MP:0008807,increased liver iron level|MP:0008987,abnormal liver lobule morphology|MP:0008989,abnormal liver sinusoid morphology|MP:0010019,liver vascular congestion|MP:0010398,decreased liver glycogen level|MP:0014341,abnormal hepatocyte mitochondrial morphology|MP:0031116,microvesicular hepatic steatosis
MGI:3769132	Tg(HBx)3Yu	MP:0000598,abnormal liver morphology|MP:0003331,increased hepatocellular carcinoma incidence
MGI:5907641	Tg(HBx-HCV)C5Tto	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0002753,dilated heart left ventricle|MP:0002941,increased circulating alanine transaminase level|MP:0003141,cardiac fibrosis|MP:0004091,abnormal Z line morphology|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005164,abnormal response to injury|MP:0005330,cardiomyopathy|MP:0010630,abnormal cardiac muscle tissue morphology|MP:0011633,abnormal mitochondrial shape|MP:0011925,abnormal heart echocardiography feature|MP:0012688,abnormal heart ventricles weight
MGI:3820858	Tg(HBX-HCVE1,HCVE2)1Kko	MP:0002169,no abnormal phenotype detected
MGI:5562295	Tg(Hcn4-cre/ERT2)1Yzhao	MP:0002169,no abnormal phenotype detected
MGI:2387763	Tg(HCRT-MJD)1Stak	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001422,abnormal drinking behavior|MP:0001501,abnormal sleep pattern|MP:0003212,increased susceptibility to age related obesity|MP:0003224,neuron degeneration|MP:0004890,decreased energy expenditure|MP:0004994,abnormal brain wave pattern|MP:0005279,narcolepsy|MP:0005535,abnormal body temperature|MP:0005669,increased circulating leptin level|MP:0009436,fragmentation of sleep/wake states|MP:0011940,decreased food intake|MP:0011943,abnormal circadian feeding behavior|MP:0014622,abnormal brain beta wave pattern|MP:0014623,abnormal brain theta wave pattern
MGI:3057174	Tg(HD)63Aron	MP:0000788,abnormal cerebral cortex morphology|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002882,abnormal neuron morphology|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003234,enhanced NMDA-mediated synaptic currents|MP:0003313,abnormal locomotor activation|MP:0004077,abnormal striatum morphology|MP:0004191,neuronal intranuclear inclusions|MP:0008143,abnormal dendrite morphology|MP:0008462,abnormal medium spiny neuron morphology
MGI:2670626	Tg(HD82Gln)81Gschi	MP:0000745,tremors|MP:0000837,abnormal hypothalamus morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001443,poor grooming|MP:0001513,limb grasping|MP:0001731,abnormal postnatal growth|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0004077,abnormal striatum morphology|MP:0004191,neuronal intranuclear inclusions|MP:0005156,bradykinesia
MGI:2389466	Tg(HDexon1)61Gpb	MP:0001004,abnormal retina photoreceptor morphology|MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0001513,limb grasping|MP:0001629,abnormal heart rate|MP:0001636,irregular heartbeat|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002843,decreased systemic arterial blood pressure|MP:0002882,abnormal neuron morphology|MP:0003137,abnormal impulse conducting system conduction|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0004077,abnormal striatum morphology|MP:0004122,abnormal sinus arrhythmia|MP:0004191,neuronal intranuclear inclusions|MP:0004565,decreased myocardial fiber size|MP:0005551,abnormal eye electrophysiology|MP:0005621,abnormal cell physiology|MP:0005665,increased circulating noradrenaline level|MP:0008431,abnormal short-term spatial reference memory|MP:0008432,abnormal long-term spatial reference memory|MP:0008450,retina photoreceptor degeneration|MP:0008543,atrial fibrillation|MP:0008581,disorganized photoreceptor inner segment|MP:0008586,disorganized photoreceptor outer segment|MP:0008947,increased neuron number|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0010504,abnormal RR interval|MP:0012574,decreased noradrenaline level|MP:0012671,retina spots
MGI:2386951	Tg(HDexon1)62Gpb	MP:0000745,tremors|MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000849,abnormal cerebellum morphology|MP:0001004,abnormal retina photoreceptor morphology|MP:0001119,abnormal female reproductive system morphology|MP:0001127,small ovary|MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001325,abnormal retina morphology|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001408,stereotypic behavior|MP:0001489,decreased startle reflex|MP:0001513,limb grasping|MP:0001525,impaired balance|MP:0001529,abnormal vocalization|MP:0001762,polyuria|MP:0001926,female infertility|MP:0002064,seizures|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002637,small uterus|MP:0002727,decreased circulating insulin level|MP:0002753,dilated heart left ventricle|MP:0002757,decreased vertical activity|MP:0002834,decreased heart weight|MP:0002882,abnormal neuron morphology|MP:0003339,decreased pancreatic beta cell number|MP:0003393,decreased cardiac output|MP:0003491,abnormal voluntary movement|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0003822,decreased left ventricle systolic pressure|MP:0004009,abnormal diastolic filling velocity|MP:0004077,abnormal striatum morphology|MP:0004191,neuronal intranuclear inclusions|MP:0004811,abnormal neuron physiology|MP:0005216,abnormal pancreatic alpha cell morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005218,abnormal pancreatic delta cell morphology|MP:0005293,impaired glucose tolerance|MP:0008450,retina photoreceptor degeneration|MP:0008489,slow postnatal weight gain|MP:0008581,disorganized photoreceptor inner segment|MP:0008586,disorganized photoreceptor outer segment|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0011952,decreased cardiac stroke volume|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014812,abnormal brain physiology|MP:0031633,decreased heart left ventricle muscle contractility
MGI:1926433	Tg(Hgf)1Paus	MP:0000391,premature hair follicle generation|MP:0001200,thick skin|MP:0008859,abnormal hair cycle catagen phase|MP:0012110,increased hair follicle number
MGI:4421552	Tg(Hist1h1t-mm)ADdra	MP:0002169,no abnormal phenotype detected
MGI:5707267	Tg(Hist1h1t-sb100X)8689Izsv	MP:0002169,no abnormal phenotype detected
MGI:3686857	Tg(HIST1H2BB/EGFP)1Pa	MP:0002169,no abnormal phenotype detected
MGI:3771187	Tg(HIV)26Aln	MP:0001265,decreased body size|MP:0001859,kidney inflammation|MP:0002051,increased skin papilloma incidence|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002191,abnormal artery morphology|MP:0002705,dilated renal tubule|MP:0002962,increased urine protein level|MP:0003233,prolonged QT interval|MP:0003675,kidney cyst|MP:0004510,myositis|MP:0005264,glomerulosclerosis|MP:0005265,abnormal blood urea nitrogen level|MP:0005515,uveitis|MP:0005545,abnormal lens development|MP:0005553,increased circulating creatinine level|MP:0008140,podocyte foot process effacement|MP:0008794,increased lens epithelium apoptosis|MP:0008796,increased lens fiber apoptosis|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009415,skeletal muscle degeneration|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010254,nuclear cataract|MP:0010392,prolonged QRS complex duration|MP:0011310,abnormal kidney capillary morphology|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011353,expanded mesangial matrix|MP:0011697,lens vacuoles|MP:0013848,subcutaneous edema|MP:0020081,myocardium degeneration|MP:0031317,spherophakia
MGI:3050815	Tg(HLA-A2/H2-K)1Scr	MP:0005078,abnormal cytotoxic T cell physiology
MGI:3711057	Tg(HLA-A/H2-D/B2M)1Dvs	MP:0004803,increased susceptibility to autoimmune diabetes
MGI:2159102	Tg(HLA-B27)1Trg	MP:0005387,immune system phenotype
MGI:2159095	Tg(HLA-B27)30-4Trg	MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:3809457	Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz	MP:0002444,abnormal T cell physiology|MP:0003724,increased susceptibility to induced arthritis|MP:0003725,increased autoantibody level
MGI:3718047	Tg(Hmgcr-MAPT)23Brio	MP:0003631,nervous system phenotype
MGI:3765440	Tg(Hmgcr-MX1)LStae	MP:0020947,decreased susceptibility to Orthomyxoviridae infection|MP:0031045,decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:5312916	Tg(Hnf1a-RB1*)XMiu	MP:0000607,abnormal hepatocyte morphology|MP:0003324,increased liver adenoma incidence
MGI:4462429	Tg(Hoxb6-Sall1*)#Mrau	MP:0006280,abnormal digit development|MP:0008829,triphalangia|MP:0009743,preaxial polydactyly
MGI:3715437	Tg(Hoxb7-EGFP)33Cos	MP:0002169,no abnormal phenotype detected
MGI:3574566	Tg(Hoxc13)61B1Awg	MP:0000381,enlarged hair follicles|MP:0000414,alopecia|MP:0000424,retarded hair growth|MP:0000592,short tail|MP:0001192,scaly skin|MP:0001195,flaky skin|MP:0001198,tight skin|MP:0001209,spontaneous skin ulceration|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001235,disorganized suprabasal layer|MP:0001278,kinked vibrissae|MP:0001539,decreased caudal vertebrae number|MP:0002098,abnormal vibrissa morphology|MP:0003413,hair follicle degeneration|MP:0003810,abnormal hair cuticle|MP:0009583,increased keratinocyte proliferation|MP:0009703,decreased birth body size|MP:0010690,thick hair follicle outer root sheath|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3574567	Tg(Hoxc13)61U4Awg	MP:0000381,enlarged hair follicles|MP:0000414,alopecia|MP:0000424,retarded hair growth|MP:0000592,short tail|MP:0001192,scaly skin|MP:0001195,flaky skin|MP:0001198,tight skin|MP:0001209,spontaneous skin ulceration|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001235,disorganized suprabasal layer|MP:0001278,kinked vibrissae|MP:0001539,decreased caudal vertebrae number|MP:0002098,abnormal vibrissa morphology|MP:0003413,hair follicle degeneration|MP:0003810,abnormal hair cuticle|MP:0009583,increased keratinocyte proliferation|MP:0009703,decreased birth body size|MP:0010690,thick hair follicle outer root sheath|MP:0011090,perinatal lethality, incomplete penetrance
MGI:2656720	Tg(Hoxd9/lacZ)3Ddu	MP:0000573,increased hindlimb autopod size|MP:0001925,male infertility|MP:0002110,abnormal digit morphology|MP:0002543,brachyphalangia|MP:0002544,brachydactyly|MP:0003072,abnormal metatarsal bone morphology|MP:0005230,ectrodactyly|MP:0005306,abnormal phalanx morphology
MGI:2656719	Tg(Hoxd9/lacZ/neo)2Ddu	MP:0000573,increased hindlimb autopod size|MP:0001925,male infertility|MP:0002110,abnormal digit morphology|MP:0002543,brachyphalangia|MP:0002544,brachydactyly|MP:0003072,abnormal metatarsal bone morphology|MP:0005230,ectrodactyly|MP:0005306,abnormal phalanx morphology
MGI:2656721	Tg(Hoxd9/lacZ/neo)4Ddu	MP:0000573,increased hindlimb autopod size|MP:0001925,male infertility|MP:0002110,abnormal digit morphology|MP:0002543,brachyphalangia|MP:0002544,brachydactyly|MP:0003072,abnormal metatarsal bone morphology|MP:0005230,ectrodactyly|MP:0005306,abnormal phalanx morphology
MGI:2664895	Tg(Hoxd9/lacZ/neo)5Ddu	MP:0000573,increased hindlimb autopod size|MP:0001925,male infertility|MP:0002110,abnormal digit morphology|MP:0002543,brachyphalangia|MP:0002544,brachydactyly|MP:0003072,abnormal metatarsal bone morphology|MP:0005230,ectrodactyly|MP:0005306,abnormal phalanx morphology
MGI:4830474	Tg(HP-MMP1a)34-1Cha	MP:0001958,emphysema
MGI:3039548	Tg(HRAS)2Jic	MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0002006,neoplasm|MP:0002020,increased tumor incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0002051,increased skin papilloma incidence|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003346,abnormal pectoral muscle morphology|MP:0003448,abnormal tumor morphology|MP:0003851,skeletal muscle interstitial fibrosis|MP:0004499,increased incidence of tumors by chemical induction|MP:0008770,decreased survivor rate|MP:0009308,increased adenocarcinoma incidence|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009412,skeletal muscle fiber degeneration|MP:0009414,skeletal muscle fiber necrosis|MP:0010273,increased classified tumor incidence|MP:0012431,increased lymphoma incidence|MP:0021206,abnormal limb muscle morphology
MGI:3039662	Tg(HRAS)7Mok	MP:0002006,neoplasm|MP:0002020,increased tumor incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0009308,increased adenocarcinoma incidence|MP:0012431,increased lymphoma incidence
MGI:3046926	Tg(hREN)9Sig	MP:0005385,cardiovascular system phenotype
MGI:3763906	Tg(HSA*LR)20aCath	MP:0003157,impaired muscle relaxation|MP:0004087,abnormal muscle fiber morphology
MGI:3763907	Tg(HSA*LR)20bCath	MP:0003157,impaired muscle relaxation|MP:0004087,abnormal muscle fiber morphology|MP:0004145,abnormal muscle electrophysiology
MGI:3763908	Tg(HSA*LR)21Cath	MP:0003157,impaired muscle relaxation|MP:0004087,abnormal muscle fiber morphology
MGI:3763909	Tg(HSA*LR)32aCath	MP:0002083,premature death|MP:0003157,impaired muscle relaxation|MP:0004087,abnormal muscle fiber morphology
MGI:3763910	Tg(HSA*LR)32bCath	MP:0003157,impaired muscle relaxation|MP:0004087,abnormal muscle fiber morphology
MGI:3763903	Tg(HSA*LR)41Cath	MP:0003157,impaired muscle relaxation|MP:0004087,abnormal muscle fiber morphology
MGI:3763912	Tg(HSA*SR)29Cath	MP:0005369,muscle phenotype
MGI:5573168	Tg(HSE-EYFP)1Mklv	MP:0002169,no abnormal phenotype detected
MGI:5810681	Tg(Hsf4/EGFP)N7Spbh	MP:0001303,abnormal lens morphology|MP:0002840,abnormal lens fiber morphology|MP:0003237,abnormal lens epithelium morphology|MP:0010262,lamellar cataract
MGI:5575510	Tg(Hspa1b-mPlum)AAmpla	MP:0002169,no abnormal phenotype detected
MGI:3762198	Tg(Htr1a-icre)1Fto	MP:0002169,no abnormal phenotype detected
MGI:4438230	Tg(HTT*)1Xwy	MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0001363,increased anxiety-related response|MP:0001405,impaired coordination|MP:0002882,abnormal neuron morphology|MP:0003224,neuron degeneration|MP:0003360,abnormal depression-related behavior|MP:0012468,decreased striatum size
MGI:3800779	Tg(HTT*97Q)IXwy	MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0001260,increased body weight|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001489,decreased startle reflex|MP:0001902,reduced NMDA-mediated synaptic currents|MP:0002175,decreased brain weight|MP:0002229,neurodegeneration|MP:0002272,abnormal nervous system electrophysiology|MP:0002573,behavioral despair|MP:0002757,decreased vertical activity|MP:0002882,abnormal neuron morphology|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003224,neuron degeneration|MP:0003360,abnormal depression-related behavior|MP:0003631,nervous system phenotype|MP:0004191,neuronal intranuclear inclusions|MP:0005386,behavior/neurological phenotype|MP:0009142,decreased prepulse inhibition|MP:0012138,decreased forebrain size|MP:0012468,decreased striatum size|MP:0012506,brain atrophy|MP:0012508,forebrain atrophy|MP:0014379,decreased excitatory postsynaptic current frequency
MGI:4438228	Tg(HTT*97Q)LXwy	MP:0001260,increased body weight|MP:0001405,impaired coordination|MP:0002152,abnormal brain morphology|MP:0002882,abnormal neuron morphology
MGI:4429385	Tg(Htt-ATXN3*148Q)3746Thsc	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002574,increased vertical activity|MP:0002804,abnormal motor learning|MP:0004191,neuronal intranuclear inclusions
MGI:5635157	Tg(HTT*)AXwy	MP:0000436,abnormal head movements|MP:0001263,weight loss|MP:0004191,neuronal intranuclear inclusions|MP:0005323,dystonia|MP:0012506,brain atrophy
MGI:4438229	Tg(HTT*)BXwy	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:5052379	Tg(HTT*/EGFP)150Nn	MP:0000745,tremors|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0001393,ataxia|MP:0001513,limb grasping|MP:0002083,premature death|MP:0003492,abnormal involuntary movement|MP:0003632,abnormal nervous system morphology|MP:0004077,abnormal striatum morphology|MP:0004191,neuronal intranuclear inclusions
MGI:5052377	Tg(HTT*/EGFP)190Nn	MP:0000745,tremors|MP:0001393,ataxia|MP:0001513,limb grasping|MP:0002083,premature death|MP:0003492,abnormal involuntary movement|MP:0003632,abnormal nervous system morphology
MGI:5635155	Tg(HTT*)LXwy	MP:0000436,abnormal head movements|MP:0000783,abnormal forebrain morphology|MP:0001263,weight loss|MP:0002083,premature death|MP:0004191,neuronal intranuclear inclusions|MP:0005323,dystonia
MGI:5635152	Tg(HTT*)NXwy	MP:0000436,abnormal head movements|MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0001260,increased body weight|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001443,poor grooming|MP:0001925,male infertility|MP:0002229,neurodegeneration|MP:0002272,abnormal nervous system electrophysiology|MP:0002757,decreased vertical activity|MP:0003205,testicular atrophy|MP:0003354,astrocytosis|MP:0003360,abnormal depression-related behavior|MP:0004191,neuronal intranuclear inclusions|MP:0005323,dystonia|MP:0006082,CNS inflammation|MP:0008462,abnormal medium spiny neuron morphology|MP:0009413,skeletal muscle fiber atrophy|MP:0012468,decreased striatum size|MP:0012506,brain atrophy|MP:0020289,astasia
MGI:2386685	Tg(huS100B)5Daoh	MP:0003177,allodynia
MGI:5604232	Tg(ICAM1)4Grom	MP:0000753,paralysis|MP:0000754,paresis|MP:0000938,motor neuron degeneration|MP:0001406,abnormal gait|MP:0020937,increased susceptibility to Picornaviridae infection
MGI:3577049	Tgif1<tm1.1Caw>	MP:0000049,abnormal middle ear morphology|MP:0001265,decreased body size|MP:0001485,abnormal pinna reflex|MP:0001716,abnormal placenta labyrinth morphology|MP:0001784,abnormal fluid regulation|MP:0001850,increased susceptibility to otitis media|MP:0001891,hydrocephaly|MP:0001923,reduced female fertility|MP:0001967,deafness|MP:0002169,no abnormal phenotype detected|MP:0004471,short nasal bone|MP:0004739,conductive hearing loss|MP:0006325,impaired hearing|MP:0008713,abnormal cytokine level|MP:0009661,abnormal pregnancy|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011525,abnormal placenta intervillous maternal lacunae morphology|MP:0011529,increased placenta intervillous maternal lacunae size|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0020903,increased middle ear goblet cell number|MP:0030066,short face|MP:0030226,middle ear polyps|MP:0030410,middle ear effusion
MGI:3577048	Tgif1<tm1Caw>	MP:0002169,no abnormal phenotype detected
MGI:3617788	Tgif1<tm1Dwot>	MP:0000914,exencephaly|MP:0003639,abnormal response to vitamins
MGI:3612977	Tgif1<tm1Jxd>	MP:0002169,no abnormal phenotype detected
MGI:3652354	Tgif1<tm1Pah>	MP:0000352,decreased cell proliferation|MP:0000585,kinked tail|MP:0001265,decreased body size|MP:0002766,situs inversus|MP:0002767,situs ambiguus|MP:0003077,abnormal cell cycle|MP:0003984,embryonic growth retardation
MGI:3698004	Tgif1<tm1Ychn>	MP:0000433,microcephaly|MP:0000443,abnormal snout morphology|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0000935,abnormal folding of telencephalic vesicles|MP:0003232,abnormal forebrain development|MP:0005157,holoprosencephaly|MP:0006108,abnormal hindbrain development|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012258,philtrum hypoplasia|MP:0012523,abnormal upper lip morphology|MP:0013227,small brain ventricles|MP:0030095,abnormal midface morphology
MGI:6361154	Tgif2lx1<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5692682	Tgif2<tm1b(EUCOMM)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0011100,preweaning lethality, complete penetrance
MGI:4437419	Tgif2<tm1Dwot>	MP:0002169,no abnormal phenotype detected
MGI:1926377	Tg(Igf1)1Hys	MP:0001281,increased vibrissae length
MGI:1926378	Tg(IGF1)1Jdg	MP:0000017,big ears|MP:0000052,early ear unfolding|MP:0000053,excessive ear growth|MP:0000391,premature hair follicle generation|MP:0001200,thick skin|MP:0001211,wrinkled skin|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001245,thick dermal layer|MP:0002051,increased skin papilloma incidence|MP:0003809,abnormal hair shaft morphology|MP:0004127,thick hypodermis|MP:0004499,increased incidence of tumors by chemical induction
MGI:3769998	Tg(IGFBP1)2Miel	MP:0001262,decreased body weight|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002080,prenatal lethality|MP:0003026,decreased vasoconstriction|MP:0003845,abnormal decidualization|MP:0003984,embryonic growth retardation|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0004256,abnormal maternal decidual layer morphology|MP:0004920,increased placenta weight|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005559,increased circulating glucose level|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0008957,abnormal placenta junctional zone morphology|MP:0009429,decreased embryo weight|MP:0011520,increased placental labyrinth size
MGI:3769995	Tg(IGFBP2)1Miel	MP:0000010,abnormal abdominal fat pad morphology|MP:0001560,abnormal circulating insulin level|MP:0002078,abnormal glucose homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0008489,slow postnatal weight gain|MP:0009115,abnormal fat cell morphology|MP:0010025,decreased total body fat amount
MGI:3776392	Tg(Igh3H9)41Mwg	MP:0002144,abnormal B cell differentiation|MP:0002491,decreased IgD level|MP:0004771,increased anti-single stranded DNA antibody level
MGI:3793439	Tg(Igh-3/Igh-6VD93)1241Ust	MP:0004939,abnormal B cell morphology|MP:0008209,decreased pre-B cell number
MGI:3798613	Tg(Igh-3VD93)343Ust	MP:0004939,abnormal B cell morphology|MP:0008209,decreased pre-B cell number
MGI:3656398	Tg(Igh-6-Cd80)1Gjf	MP:0000172,abnormal bone marrow cell number|MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0001828,abnormal T cell activation|MP:0002460,decreased immunoglobulin level|MP:0004031,insulitis|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005017,decreased B cell number|MP:0005042,abnormal level of surface class II molecules|MP:0005397,hematopoietic system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0006387,abnormal T cell number|MP:0008174,decreased follicular B cell number|MP:0008207,decreased B-2 B cell number|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008217,abnormal B cell activation|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:3662674	Tg(Igh-6-Cd86)1Akab	MP:0005017,decreased B cell number|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology
MGI:3056939	Tg(Igh-6/Igh-V281)3Jwt	MP:0004031,insulitis|MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:2665029	Tg(Igh-Abl1)40Sco	MP:0000691,enlarged spleen|MP:0005324,ascites|MP:0008463,abnormal peripheral lymph node morphology|MP:0008466,enlarged mesenteric lymph nodes|MP:0010286,increased plasmacytoma incidence
MGI:2384162	Tg(IghelMD4)4Ccg	MP:0002439,abnormal plasma cell morphology|MP:0002494,increased IgM level|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0004939,abnormal B cell morphology|MP:0005022,abnormal immature B cell morphology|MP:0005094,abnormal T cell proliferation|MP:0005432,abnormal pro-B cell morphology|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008166,abnormal B-2 B cell morphology|MP:0008171,abnormal mature B cell morphology|MP:0008176,abnormal germinal center B cell morphology|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008214,increased immature B cell number|MP:0008217,abnormal B cell activation|MP:0008501,increased IgG2b level
MGI:5752045	Tg(IghH280)48Dvs	MP:0004031,insulitis|MP:0004803,increased susceptibility to autoimmune diabetes
MGI:5788539	Tg(Igh-HMGA2)#Cro	MP:0000414,alopecia|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001212,skin lesions|MP:0001243,abnormal dermal layer morphology|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008553,increased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level|MP:0008826,abnormal splenic cell ratio|MP:0014049,increased T cell acute lymphoblastic leukemia incidence|MP:0020001,decreased response to antigen
MGI:2429404	Tg(Igh-HOX11)11Idd	MP:0000218,increased leukocyte cell number|MP:0000693,spleen hyperplasia|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0008755,abnormal immunoglobulin V(D)J recombination|MP:0010373,myeloid hyperplasia
MGI:3772691	Tg(IGH@,IGL@)1Skmr	MP:0002169,no abnormal phenotype detected
MGI:3769767	Tg(Igh-Lmp2a)13FRdni	MP:0001402,decreased locomotor activity|MP:0001429,dehydration|MP:0001943,abnormal respiration|MP:0002082,postnatal lethality|MP:0003122,maternal imprinting
MGI:3769768	Tg(Igh-Lmp2a)ERlon	MP:0005017,decreased B cell number|MP:0005153,abnormal B cell proliferation
MGI:4939021	Tg(Igh-Maf)524Staka	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002461,increased immunoglobulin level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0008097,increased plasma cell number|MP:0011402,renal cast|MP:0012431,increased lymphoma incidence
MGI:4939022	Tg(Igh-Maf)68Staka	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002461,increased immunoglobulin level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0008097,increased plasma cell number|MP:0011402,renal cast|MP:0012431,increased lymphoma incidence
MGI:3711772	Tg(Ighm-Ctla4Ig/Cd80)1Jbs	MP:0002459,abnormal B cell physiology|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005387,immune system phenotype
MGI:5317550	Tg(Igh*-Mir125b-1)116Toki	MP:0000321,increased bone marrow cell number|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002874,decreased hemoglobin content|MP:0005014,increased B cell number|MP:0008783,decreased B cell apoptosis|MP:0012431,increased lymphoma incidence|MP:0014237,decreased tumor-free survival time
MGI:5317552	Tg(Igh*-Mir125b-1)5Toki	MP:0000691,enlarged spleen|MP:0002023,increased B cell derived lymphoma incidence|MP:0002874,decreased hemoglobin content|MP:0012431,increased lymphoma incidence|MP:0014237,decreased tumor-free survival time
MGI:5317461	Tg(Igh-Mir155)10Cro	MP:0000691,enlarged spleen
MGI:5317460	Tg(Igh-Mir155)8Cro	MP:0000221,decreased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000691,enlarged spleen|MP:0002023,increased B cell derived lymphoma incidence|MP:0002401,abnormal lymphopoiesis|MP:0003132,increased pre-B cell number|MP:0005014,increased B cell number|MP:0005154,increased B cell proliferation|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008475,intermingled spleen red and white pulp|MP:0008478,increased spleen white pulp amount|MP:0008479,decreased spleen white pulp amount|MP:0009320,increased lymphoblastic lymphoma incidence
MGI:5555968	Tg(Igh-Mir210)#aKgcs	MP:0001807,decreased IgA level|MP:0002362,abnormal spleen marginal zone morphology|MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype|MP:0008167,increased B-1a cell number|MP:0008182,decreased marginal zone B cell number|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008211,decreased mature B cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:4820820	Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0002401,abnormal lymphopoiesis|MP:0002459,abnormal B cell physiology|MP:0005154,increased B cell proliferation|MP:0008167,increased B-1a cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0010337,increased chronic lymphocytic leukemia incidence
MGI:3039690	Tg(IghMyc)186Brn	MP:0003077,abnormal cell cycle|MP:0003708,binucleate|MP:0004046,abnormal mitosis|MP:0014239,abnormal intracellular organelle morphology
MGI:2447604	Tg(IghMyc)22Bri	MP:0000218,increased leukocyte cell number|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0001272,increased metastatic potential|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002401,abnormal lymphopoiesis|MP:0003132,increased pre-B cell number|MP:0005013,increased lymphocyte cell number|MP:0008782,increased B cell apoptosis|MP:0012431,increased lymphoma incidence
MGI:5005061	Tg(Igh-Nfil3)#Kubo	MP:0008660,increased interleukin-10 secretion|MP:0008672,increased interleukin-13 secretion|MP:0008696,increased interleukin-3 secretion
MGI:2447531	Tg(Igh-Pim1)1Brn	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0002021,increased incidence of induced tumors|MP:0002024,increased T cell derived lymphoma incidence|MP:0012431,increased lymphoma incidence
MGI:5571366	Tg(Igh-ROR1)1Kip	MP:0000691,enlarged spleen|MP:0005013,increased lymphocyte cell number|MP:0008210,increased mature B cell number|MP:0010337,increased chronic lymphocytic leukemia incidence
MGI:3802806	Tg(IGH@*)SALed	MP:0008171,abnormal mature B cell morphology
MGI:4850003	Tg(Igh-TCL1A)1Ypek	MP:0000691,enlarged spleen|MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0003945,abnormal lymphocyte physiology|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008553,increased circulating tumor necrosis factor level|MP:0010209,abnormal circulating chemokine level|MP:0010337,increased chronic lymphocytic leukemia incidence
MGI:3527221	Tg(Igh-V186.2-TCL1A)3Cro	MP:0000599,enlarged liver|MP:0000693,spleen hyperplasia|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0003303,peritoneal inflammation|MP:0004939,abnormal B cell morphology|MP:0008181,increased marginal zone B cell number|MP:0010337,increased chronic lymphocytic leukemia incidence
MGI:4461029	Tg(Igh-V-CD40lg)#Tsub	MP:0000495,abnormal colon morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001263,weight loss|MP:0002393,abnormal bronchus-associated lymphoid tissue morphology|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002731,megacolon|MP:0002743,glomerulonephritis|MP:0002816,colitis|MP:0002962,increased urine protein level|MP:0003725,increased autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004796,increased anti-histone antibody level|MP:0005036,diarrhea|MP:0008566,increased interferon-gamma secretion|MP:0009336,increased splenocyte proliferation|MP:0009338,increased splenocyte number|MP:0013481,abnormal ileum crypts of Lieberkuhn morphology|MP:0013795,abnormal colon goblet cell morphology
MGI:3802657	Tg(IGH@yH1)2BJkbv	MP:0002490,abnormal immunoglobulin level|MP:0004939,abnormal B cell morphology|MP:0008760,abnormal immunoglobulin heavy chain V(D)J recombination
MGI:5752042	Tg(IgkH280)934Dvs	MP:0004031,insulitis|MP:0004803,increased susceptibility to autoimmune diabetes
MGI:3800384	Tg(IgkHyHEL10)1Rbr	MP:0002169,no abnormal phenotype detected
MGI:3702620	Tg(Igk-Lta/Ltb)10Cys	MP:0004939,abnormal B cell morphology
MGI:3577756	Tg(Igk-Lta/Ltb)4Cys	MP:0004939,abnormal B cell morphology
MGI:3046400	Tg(Igk-V21-Bax)1967Bvn	MP:0002135,abnormal kidney morphology|MP:0002439,abnormal plasma cell morphology|MP:0002461,increased immunoglobulin level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0002962,increased urine protein level|MP:0008189,increased transitional stage B cell number|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0011402,renal cast
MGI:6856586	Tg(Igkv3-5*-MYC)24Plbe	MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000137,abnormal vertebrae morphology|MP:0000755,hindlimb paralysis|MP:0001577,anemia|MP:0001588,abnormal hemoglobin|MP:0001800,abnormal humoral immune response|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0002490,abnormal immunoglobulin level|MP:0003795,abnormal bone structure|MP:0005324,ascites|MP:0008097,increased plasma cell number|MP:0008099,abnormal plasma cell differentiation|MP:0008499,increased IgG1 level|MP:0008502,increased IgG3 level|MP:0009440,increased myeloma incidence|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010286,increased plasmacytoma incidence|MP:0010869,decreased bone trabecula number
MGI:5441309	Tg(Igkv3-5-MYC)#Plbe	MP:0002023,increased B cell derived lymphoma incidence
MGI:3802658	Tg(IGK@yK1)9.2CJkbv	MP:0002490,abnormal immunoglobulin level|MP:0004939,abnormal B cell morphology|MP:0008761,abnormal immunoglobulin light chain V-J recombination
MGI:3793466	Tg(Igl-2MOPC315)1275Ust	MP:0001806,decreased IgM level|MP:0004939,abnormal B cell morphology|MP:0008215,decreased immature B cell number
MGI:3619458	Tg(IGL-MYC)3Hm	MP:0000702,enlarged lymph nodes|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death
MGI:1926481	Tg(Il1a)1.1Tsk	MP:0000414,alopecia|MP:0001192,scaly skin|MP:0001212,skin lesions|MP:0001242,hyperkeratosis|MP:0001246,mixed cellular infiltration to dermis
MGI:1926482	Tg(Il1a)1.2Tsk	MP:0000414,alopecia|MP:0001192,scaly skin|MP:0001212,skin lesions|MP:0001242,hyperkeratosis|MP:0001246,mixed cellular infiltration to dermis
MGI:3573755	Tg(Il1rn)1Dih	MP:0000260,abnormal angiogenesis|MP:0001876,decreased inflammatory response|MP:0002412,increased susceptibility to bacterial infection|MP:0008591,increased circulating interleukin-1 level|MP:0008597,decreased circulating interleukin-6 level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0020917,decreased susceptibility to Herpesvirales infection|MP:0031233,decreased circulating serum amyloid protein level
MGI:2447078	Tg(IL2-Il10)1Kro	MP:0002412,increased susceptibility to bacterial infection|MP:0003009,abnormal cytokine secretion|MP:0005026,decreased susceptibility to parasitic infection
MGI:5620606	Tg(IL3,CSF2)C42Pnc	MP:0005387,immune system phenotype
MGI:1926480	Tg(Il6)1Efu	MP:0000414,alopecia|MP:0001192,scaly skin|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight
MGI:3043843	Tg(Ins1-Cat,Tyr)25Pne	MP:0003058,increased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005215,abnormal pancreatic islet morphology|MP:0005560,decreased circulating glucose level|MP:0008872,abnormal physiological response to xenobiotic|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0011593,increased catalase activity
MGI:5569013	Tg(Ins1-Cd80)378Psoh	MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:3704916	Tg(Ins1-Cerulean)24Hara	MP:0002169,no abnormal phenotype detected
MGI:3704922	Tg(Ins1-DsRed*T4)32Hara	MP:0005376,homeostasis/metabolism phenotype
MGI:3704871	Tg(Ins1-EGFP)1Hara	MP:0002169,no abnormal phenotype detected
MGI:3583654	Tg(Ins1-EGFP/GH1)14Hara	MP:0002727,decreased circulating insulin level|MP:0003339,decreased pancreatic beta cell number|MP:0004031,insulitis|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0005351,decreased susceptibility to autoimmune disorder|MP:0010768,mortality/aging
MGI:2388566	Tg(Ins1-GAS)1Sbr	MP:0000470,abnormal stomach morphology|MP:0000477,abnormal intestine morphology|MP:0000503,excessive digestive secretion|MP:0002038,increased carcinoma incidence|MP:0003285,gastric hypertrophy|MP:0003892,abnormal gastric gland morphology|MP:0004139,abnormal gastric parietal cell morphology|MP:0004499,increased incidence of tumors by chemical induction|MP:0004731,increased circulating gastrin level|MP:0005211,increased stomach mucosa thickness|MP:0008001,hypochlorhydria|MP:0012563,increased tumor incidence following infection
MGI:5432220	Tg(Ins1-Kcnj11*)#Nich	MP:0003058,increased insulin secretion
MGI:4821096	Tg(Ins1-Tag,-luc)1Gcr	MP:0002083,premature death|MP:0003364,increased insulinoma incidence
MGI:5829193	Tg(Ins2-Akt1*)3Mbb	MP:0000189,hypoglycemia|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0003334,pancreas fibrosis|MP:0003339,decreased pancreatic beta cell number|MP:0003364,increased insulinoma incidence|MP:0003562,abnormal pancreatic beta cell physiology|MP:0003564,abnormal insulin secretion|MP:0005215,abnormal pancreatic islet morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0009113,increased pancreatic beta cell mass|MP:0009153,increased pancreas tumor incidence|MP:0009167,increased pancreatic islet number|MP:0009171,enlarged pancreatic islets|MP:0010348,increased pancreatic islet cell carcinoma incidence|MP:0020088,decreased susceptibility to non-insulin-dependent diabetes
MGI:3689196	Tg(Ins2-Ccl19)2Cys	MP:0002450,abnormal lymph organ development|MP:0005215,abnormal pancreatic islet morphology
MGI:3689181	Tg(Ins2-Ccl21b)2Cys	MP:0002450,abnormal lymph organ development|MP:0005215,abnormal pancreatic islet morphology
MGI:3701452	Tg(Ins2-Cd274)2Mdos	MP:0004803,increased susceptibility to autoimmune diabetes
MGI:2682826	Tg(Ins2-CD80)3B7Flv	MP:0001759,increased urine glucose level|MP:0004031,insulitis|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005559,increased circulating glucose level
MGI:3764558	Tg(Ins2-CD86)12B70Flv	MP:0003009,abnormal cytokine secretion|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005580,periinsulitis
MGI:3529600	Tg(Ins2-CDKN1B)1Maka	MP:0001559,hyperglycemia|MP:0002727,decreased circulating insulin level|MP:0003339,decreased pancreatic beta cell number|MP:0005215,abnormal pancreatic islet morphology
MGI:4421493	Tg(Ins2-Cebpb)2Maka	MP:0002693,abnormal pancreas physiology|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005559,increased circulating glucose level|MP:0009114,decreased pancreatic beta cell mass|MP:0014121,increased pancreatic islet cell apoptosis
MGI:3770248	Tg(Ins2-Chrm3*)1Jwe	MP:0000189,hypoglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0003058,increased insulin secretion|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype
MGI:2176227	Tg(Ins2-cre)25Mgn	MP:0001560,abnormal circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003564,abnormal insulin secretion|MP:0005293,impaired glucose tolerance
MGI:3721302	Tg(Ins2-cre)3Lt	MP:0011100,preweaning lethality, complete penetrance
MGI:3721303	Tg(Ins2-cre)5Lt	MP:0004031,insulitis|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005351,decreased susceptibility to autoimmune disorder|MP:0010768,mortality/aging
MGI:3762760	Tg(Ins2-cre)6Lt	MP:0002169,no abnormal phenotype detected|MP:0011100,preweaning lethality, complete penetrance
MGI:5308875	Tg(Ins2-crmA)27Ngkh	MP:0002169,no abnormal phenotype detected|MP:0004155,decreased susceptibility to induced pancreatitis|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0008944,decreased sensitivity to induced cell death|MP:0011400,lethality, complete penetrance
MGI:3689201	Tg(Ins2-Cxcl12)2Cys	MP:0005215,abnormal pancreatic islet morphology
MGI:3641325	Tg(Ins2-Cxcl13)1Cys	MP:0002450,abnormal lymph organ development|MP:0005215,abnormal pancreatic islet morphology
MGI:3785598	Tg(Ins2-E3)1Dvs	MP:0002169,no abnormal phenotype detected|MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:3785516	Tg(Ins2-E3*309)5Dvs	MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:3785496	Tg(Ins2-E3*704)2Dvs	MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:3618341	Tg(Ins2-E3*734)3Dvs	MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:3785757	Tg(Ins2-E3*734)4Dvs	MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:3662920	Tg(Ins2-Fas*I246N)1Ach	MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:2385760	Tg(Ins2-Fasl)24Ach	MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005215,abnormal pancreatic islet morphology
MGI:3606176	Tg(Ins2-GAD2)1Lt	MP:0004031,insulitis
MGI:3603349	Tg(Ins2-GAD2)2Lt	MP:0001758,abnormal urine glucose level|MP:0002080,prenatal lethality|MP:0003009,abnormal cytokine secretion|MP:0004031,insulitis|MP:0004804,decreased susceptibility to autoimmune diabetes
MGI:5796770	Tg(Ins2-GLUD1*H454Y)1Csta	MP:0000189,hypoglycemia|MP:0003058,increased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0008770,decreased survivor rate
MGI:5796776	Tg(Ins2-GLUD1*H454Y)2Csta	MP:0000189,hypoglycemia|MP:0003562,abnormal pancreatic beta cell physiology|MP:0003564,abnormal insulin secretion|MP:0008770,decreased survivor rate
MGI:3573699	Tg(Ins2-GP)34-20Olds	MP:0002444,abnormal T cell physiology|MP:0002727,decreased circulating insulin level|MP:0003945,abnormal lymphocyte physiology|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005215,abnormal pancreatic islet morphology|MP:0005559,increased circulating glucose level|MP:0009174,absent pancreatic beta cells
MGI:5568709	Tg(Ins2-GP)#Psoh	MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level|MP:0002083,premature death|MP:0004031,insulitis
MGI:3766019	Tg(Ins2-H2-Ea<d>,Ins2-H2-Eb1<b>)187-7Bri	MP:0001426,polydipsia|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0001762,polyuria|MP:0002893,ketoaciduria|MP:0003059,decreased insulin secretion|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005559,increased circulating glucose level
MGI:2680173	Tg(Ins2-HA)165Bri	MP:0005095,decreased T cell proliferation|MP:0005379,endocrine/exocrine gland phenotype|MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology
MGI:5565217	Tg(Ins2-HBEGF)5Rin	MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level|MP:0002727,decreased circulating insulin level|MP:0002893,ketoaciduria|MP:0003339,decreased pancreatic beta cell number|MP:0005215,abnormal pancreatic islet morphology
MGI:4942165	Tg(Ins2-Hnf1a)#Cbw	MP:0002710,increased glucagon secretion|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0009176,increased pancreatic alpha cell number|MP:0009254,disorganized pancreatic islets
MGI:3771295	Tg(Ins2-Iapp)6Soel	MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005215,abnormal pancreatic islet morphology
MGI:6111355	Tg(Ins2-IAPP)L13Gjsc	MP:0001559,hyperglycemia|MP:0001764,abnormal homeostasis|MP:0002693,abnormal pancreas physiology|MP:0002712,increased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0009114,decreased pancreatic beta cell mass|MP:0014117,increased pancreatic beta cell apoptosis|MP:0014124,increased amylin secretion
MGI:2157065	Tg(Ins2-IAPP)RHFSoel	MP:0001559,hyperglycemia|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005215,abnormal pancreatic islet morphology|MP:0009114,decreased pancreatic beta cell mass|MP:0014117,increased pancreatic beta cell apoptosis
MGI:3054956	Tg(Ins2-Insl3)4Imad	MP:0001923,reduced female fertility|MP:0005149,abnormal gubernaculum morphology|MP:0011727,ectopic ovary
MGI:3510672	Tg(Ins2-Irs2)13Mfw	MP:0002079,increased circulating insulin level|MP:0003058,increased insulin secretion|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005292,improved glucose tolerance
MGI:3764659	Tg(Ins2-Lta)#Flv	MP:0001859,kidney inflammation|MP:0004031,insulitis|MP:0005215,abnormal pancreatic islet morphology|MP:0005580,periinsulitis
MGI:5585172	Tg(Ins2-Mir184)4Mnpy	MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0009114,decreased pancreatic beta cell mass|MP:0011820,decreased pancreatic beta cell proliferation
MGI:5585174	Tg(Ins2-Mir184)96Mnpy	MP:0003059,decreased insulin secretion|MP:0005293,impaired glucose tolerance
MGI:6828985	Tg(Ins2-Mirc13)E4Biat	MP:0001559,hyperglycemia|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0009114,decreased pancreatic beta cell mass|MP:0014117,increased pancreatic beta cell apoptosis|MP:0014143,decreased body fat mass|MP:0030971,ketoacidosis
MGI:3706438	Tg(Ins2-Nos2)31Okam	MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level|MP:0001944,abnormal pancreas morphology|MP:0002727,decreased circulating insulin level|MP:0002893,ketoaciduria|MP:0003957,abnormal nitric oxide homeostasis|MP:0005215,abnormal pancreatic islet morphology|MP:0009114,decreased pancreatic beta cell mass
MGI:3706439	Tg(Ins2-Nos2)40Okam	MP:0001559,hyperglycemia|MP:0001759,increased urine glucose level|MP:0002135,abnormal kidney morphology|MP:0002575,increased circulating ketone body level|MP:0002727,decreased circulating insulin level|MP:0002871,albuminuria|MP:0003917,increased kidney weight|MP:0003957,abnormal nitric oxide homeostasis|MP:0005215,abnormal pancreatic islet morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0005553,increased circulating creatinine level|MP:0009114,decreased pancreatic beta cell mass
MGI:3573697	Tg(Ins2-NP)25-3Olds	MP:0002727,decreased circulating insulin level|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005215,abnormal pancreatic islet morphology|MP:0005559,increased circulating glucose level
MGI:3583231	Tg(Ins2-OVA)307Wehi	MP:0003562,abnormal pancreatic beta cell physiology|MP:0004803,increased susceptibility to autoimmune diabetes
MGI:3583258	Tg(Ins2-OVA)59Wehi	MP:0001828,abnormal T cell activation|MP:0003562,abnormal pancreatic beta cell physiology|MP:0004803,increased susceptibility to autoimmune diabetes
MGI:3763731	Tg(Ins2-rtTA)1Ach	MP:0002169,no abnormal phenotype detected
MGI:3763728	Tg(Ins2-rtTA)2Doi	MP:0002169,no abnormal phenotype detected
MGI:3052662	Tg(Ins2-TAg)1Lt	MP:0003364,increased insulinoma incidence
MGI:5441546	Tg(Ins2-Tag*,-flpe)#Gne	MP:0001634,internal hemorrhage|MP:0001944,abnormal pancreas morphology|MP:0002083,premature death|MP:0003364,increased insulinoma incidence|MP:0009153,increased pancreas tumor incidence|MP:0010348,increased pancreatic islet cell carcinoma incidence
MGI:2386579	Tg(Ins2-TCF1*P291)2Kya	MP:0001559,hyperglycemia|MP:0003059,decreased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005215,abnormal pancreatic islet morphology|MP:0009172,small pancreatic islets|MP:0009254,disorganized pancreatic islets|MP:0011820,decreased pancreatic beta cell proliferation
MGI:3578729	Tg(Ins2-TFRC/OVA)296Wehi	MP:0003156,abnormal leukocyte migration|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0008567,decreased interferon-gamma secretion|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3764663	Tg(Ins2-Tnf)17Flv	MP:0004031,insulitis|MP:0005215,abnormal pancreatic islet morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3763736	Tg(Ins2-tTA)1Doi	MP:0002169,no abnormal phenotype detected
MGI:3576358	Tg(Ins2*Y16A)1Ell	MP:0004803,increased susceptibility to autoimmune diabetes
MGI:3576273	Tg(Ins2*Y16A)3Ell	MP:0004803,increased susceptibility to autoimmune diabetes
MGI:3818739	Tg(Ins-Igf2)1Fbos	MP:0001261,obese|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0003058,increased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005331,insulin resistance|MP:0005491,pancreatic islet hyperplasia|MP:0005559,increased circulating glucose level|MP:0009108,increased pancreas weight|MP:0009113,increased pancreatic beta cell mass|MP:0009254,disorganized pancreatic islets|MP:0010182,decreased susceptibility to weight gain
MGI:3622661	Tg(INS-Il10)#Sar	MP:0001869,pancreas inflammation|MP:0002693,abnormal pancreas physiology|MP:0005220,abnormal exocrine pancreas morphology|MP:0005580,periinsulitis|MP:0006055,abnormal vascular endothelial cell morphology
MGI:3044323	Tg(INS-MT2A,Tyr)1Pne	MP:0001559,hyperglycemia|MP:0002693,abnormal pancreas physiology|MP:0003339,decreased pancreatic beta cell number|MP:0005215,abnormal pancreatic islet morphology|MP:0005319,abnormal enzyme/coenzyme level|MP:0005671,abnormal response to transplant|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:2447354	Tg(Ins-MYC/Er)1Gev	MP:0000351,increased cell proliferation|MP:0006042,increased apoptosis
MGI:3525180	Tg(INS-SOD2)3Pne	MP:0005376,homeostasis/metabolism phenotype
MGI:3056765	Tg(IRS1)1Mhep	MP:0002981,increased liver weight|MP:0003893,increased hepatocyte proliferation
MGI:1926490	Tg(ITGA2)1067Fmw	MP:0002169,no abnormal phenotype detected
MGI:1926491	Tg(ITGA2)1070Fmw	MP:0002169,no abnormal phenotype detected
MGI:1926489	Tg(ITGA2)1075Fmw	MP:0002169,no abnormal phenotype detected
MGI:1926496	Tg(ITGA5)0794Fmw	MP:0000381,enlarged hair follicles|MP:0000383,abnormal hair follicle orientation|MP:0000652,enlarged sebaceous gland|MP:0001274,curly vibrissae|MP:0001302,eyelids open at birth
MGI:1926495	Tg(ITGA5)0844Fmw	MP:0000381,enlarged hair follicles|MP:0000383,abnormal hair follicle orientation|MP:0000652,enlarged sebaceous gland|MP:0001274,curly vibrissae|MP:0001302,eyelids open at birth
MGI:1926497	Tg(ITGA5)0858Fmw	MP:0000381,enlarged hair follicles|MP:0000383,abnormal hair follicle orientation|MP:0000652,enlarged sebaceous gland|MP:0001274,curly vibrissae|MP:0001302,eyelids open at birth
MGI:2448672	Tg(ITGAL-Hhex)2Hro	MP:0000221,decreased leukocyte cell number|MP:0001823,thymus hypoplasia|MP:0002123,abnormal definitive hematopoiesis|MP:0002407,abnormal double-negative T cell morphology|MP:0003135,increased erythroid progenitor cell number|MP:0005016,decreased lymphocyte cell number|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0009543,abnormal thymus corticomedullary boundary morphology
MGI:4442157	Tg(ITGAL-Ptprc<a>)FRasch	MP:0002145,abnormal T cell differentiation
MGI:5705582	Tg(ITGAM-cre/ERT2,U6-RNAi:Cacna1b)17Ttan	MP:0005166,decreased susceptibility to injury|MP:0005386,behavior/neurological phenotype
MGI:6313615	Tg(Itgam-FCAR)83Rcmo	MP:0002495,increased IgA level|MP:0002743,glomerulonephritis|MP:0002871,albuminuria|MP:0005161,hematuria|MP:0011294,renal glomerulus hypertrophy|MP:0011339,abnormal glomerular mesangium morphology|MP:0011353,expanded mesangial matrix|MP:0011425,abnormal kidney interstitium morphology
MGI:3574313	Tg(ITGAM-HBEGF/EGFP)34Lan	MP:0000219,increased neutrophil cell number|MP:0002136,abnormal kidney physiology|MP:0002446,abnormal macrophage morphology|MP:0003333,liver fibrosis|MP:0003884,decreased macrophage cell number|MP:0005166,decreased susceptibility to injury|MP:0005387,immune system phenotype
MGI:5476442	Tg(Itgax-EGFP,-cre,-HBEGF,-luc)2Gjh	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0001793,abnormal susceptibility to infection|MP:0005387,immune system phenotype
MGI:5463655	Tg(Itgax-HBEGF/OVA/EGFP)1Garbi	MP:0000219,increased neutrophil cell number|MP:0001793,abnormal susceptibility to infection|MP:0008127,decreased dendritic cell number
MGI:3795208	Tg(Itgax-TGFBR2)1Flv	MP:0001790,abnormal immune system physiology|MP:0005026,decreased susceptibility to parasitic infection|MP:0005387,immune system phenotype|MP:0008044,increased NK cell number|MP:0008053,abnormal NK cell differentiation|MP:0008750,abnormal interferon level
MGI:1926494	Tg(ITGB1)0840Fmw	MP:0000367,abnormal coat/ hair morphology|MP:0000381,enlarged hair follicles|MP:0000383,abnormal hair follicle orientation|MP:0000410,waved hair|MP:0000652,enlarged sebaceous gland|MP:0001194,dermatitis|MP:0001195,flaky skin|MP:0001242,hyperkeratosis|MP:0001274,curly vibrissae|MP:0001282,short vibrissae|MP:0001302,eyelids open at birth|MP:0001316,cornea scarring|MP:0001851,eye inflammation|MP:0002060,abnormal skin morphology|MP:0002700,increased opacity of vitreous body
MGI:1926492	Tg(ITGB1)0869Fmw	MP:0000367,abnormal coat/ hair morphology|MP:0000381,enlarged hair follicles|MP:0000383,abnormal hair follicle orientation|MP:0000410,waved hair|MP:0000652,enlarged sebaceous gland|MP:0001194,dermatitis|MP:0001195,flaky skin|MP:0001242,hyperkeratosis|MP:0001274,curly vibrissae|MP:0001282,short vibrissae|MP:0001302,eyelids open at birth|MP:0001316,cornea scarring|MP:0001851,eye inflammation|MP:0002060,abnormal skin morphology|MP:0002700,increased opacity of vitreous body
MGI:1926493	Tg(ITGB1)0870Fmw	MP:0000367,abnormal coat/ hair morphology|MP:0000381,enlarged hair follicles|MP:0000383,abnormal hair follicle orientation|MP:0000410,waved hair|MP:0000652,enlarged sebaceous gland|MP:0001194,dermatitis|MP:0001195,flaky skin|MP:0001242,hyperkeratosis|MP:0001274,curly vibrissae|MP:0001282,short vibrissae|MP:0001302,eyelids open at birth|MP:0001316,cornea scarring|MP:0001851,eye inflammation|MP:0002060,abnormal skin morphology|MP:0002700,increased opacity of vitreous body
MGI:5583016	Tg(IVL-KLK5)#Hov	MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000416,sparse hair|MP:0000422,delayed hair appearance|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001192,scaly skin|MP:0001216,abnormal epidermal layer morphology|MP:0001242,hyperkeratosis|MP:0001278,kinked vibrissae|MP:0001282,short vibrissae|MP:0001283,sparse vibrissae|MP:0001412,excessive scratching|MP:0001510,abnormal coat appearance|MP:0001732,postnatal growth retardation|MP:0001829,increased activated T cell number|MP:0001874,acanthosis|MP:0002098,abnormal vibrissa morphology|MP:0002353,abnormal inguinal lymph node morphology|MP:0002497,increased IgE level|MP:0002796,impaired skin barrier function|MP:0003427,parakeratosis|MP:0003454,erythroderma|MP:0003853,dry skin|MP:0003865,lymph node inflammation|MP:0004947,skin inflammation|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009545,abnormal dermis papillary layer morphology|MP:0009703,decreased birth body size|MP:0009931,abnormal skin appearance|MP:0010072,increased pruritus|MP:0010210,abnormal circulating cytokine level
MGI:5553468	Tg(JAK2*V617F)FF1Rsko	MP:0000067,osteopetrosis|MP:0000219,increased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000321,increased bone marrow cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001601,abnormal myelopoiesis|MP:0002397,abnormal bone marrow morphology|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002551,abnormal blood coagulation|MP:0002591,decreased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0003131,increased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005505,thrombocytosis|MP:0005564,increased hemoglobin content|MP:0005606,increased bleeding time|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008254,increased megakaryocyte cell number|MP:0009549,decreased platelet aggregation|MP:0009642,abnormal blood homeostasis|MP:0010067,increased red blood cell distribution width|MP:0011746,spleen fibrosis|MP:0011747,myelofibrosis|MP:0031120,decreased susceptibility to induced thrombosis
MGI:3785734	Tg(Jam2-cre/ERT2)2Jrs	MP:0002169,no abnormal phenotype detected
MGI:5052363	Tg(JPH3*)CXwy	MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000818,abnormal amygdala morphology|MP:0001405,impaired coordination|MP:0002229,neurodegeneration|MP:0004077,abnormal striatum morphology|MP:0004191,neuronal intranuclear inclusions
MGI:5052365	Tg(JPH3-GFP,-JPH3*)GXwy	MP:0000783,abnormal forebrain morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0001405,impaired coordination|MP:0002804,abnormal motor learning|MP:0003631,nervous system phenotype|MP:0004077,abnormal striatum morphology|MP:0004191,neuronal intranuclear inclusions
MGI:1926477	Tg(JUP)21Pac	MP:0000021,prominent ears|MP:0000417,short hair|MP:0000437,taut facial appearance|MP:0002075,abnormal coat/hair pigmentation
MGI:1926474	Tg(JUP)45Pac	MP:0000021,prominent ears|MP:0000417,short hair|MP:0000437,taut facial appearance|MP:0002075,abnormal coat/hair pigmentation
MGI:1926472	Tg(JUP)4Pac	MP:0000021,prominent ears|MP:0000417,short hair|MP:0000437,taut facial appearance|MP:0002075,abnormal coat/hair pigmentation
MGI:1926473	Tg(JUP)9Pac	MP:0000021,prominent ears|MP:0000417,short hair|MP:0000437,taut facial appearance|MP:0002075,abnormal coat/hair pigmentation
MGI:6389235	Tg(K18-ACE2)2Prlmn	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0001175,abnormal lung morphology|MP:0001182,lung hemorrhage|MP:0001505,hunched posture|MP:0001847,brain inflammation|MP:0001852,conjunctivitis|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001862,interstitial pneumonia|MP:0001863,blood vessel inflammation|MP:0001864,vascular inflammation|MP:0001867,rhinitis|MP:0001943,abnormal respiration|MP:0001954,respiratory distress|MP:0002183,gliosis|MP:0002418,increased susceptibility to viral infection|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0003828,pulmonary edema|MP:0005013,increased lymphocyte cell number|MP:0005015,increased T cell number|MP:0005202,lethargy|MP:0005386,behavior/neurological phenotype|MP:0005425,increased macrophage cell number|MP:0006052,cerebellum hemorrhage|MP:0008553,increased circulating tumor necrosis factor level|MP:0008577,increased circulating interferon-gamma level|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008713,abnormal cytokine level|MP:0008721,abnormal chemokine level|MP:0008750,abnormal interferon level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0008918,microgliosis|MP:0009791,increased susceptibility to viral infection induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0010209,abnormal circulating chemokine level|MP:0010210,abnormal circulating cytokine level|MP:0010810,increased type II pneumocyte number|MP:0010897,abnormal bronchiole epithelium morphology|MP:0010900,abnormal pulmonary interalveolar septum morphology|MP:0010909,pulmonary alveolar hemorrhage|MP:0011854,cerebral edema|MP:0011940,decreased food intake|MP:0011942,decreased fluid intake|MP:0014226,abnormal alveolar macrophage physiology|MP:0020155,enhanced humoral immune response|MP:0020946,increased susceptibility to Orthomyxoviridae infection|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0021002,brain lesion|MP:0030002,increased lung apoptosis|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality|MP:0031054,bronchiolitis|MP:0031066,cytokine storm|MP:0031110,meningitis|MP:0031111,meningoencephalitis|MP:0031113,pulmonary parenchymal consolidation|MP:0031168,abnormal brain thrombosis|MP:0031220,increased circulating CXCL10 level|MP:0031226,increased CXCL10 level
MGI:2445978	Tg(K5-Ptgs2)19Kmd	MP:0000379,decreased hair follicle number|MP:0000383,abnormal hair follicle orientation|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000579,abnormal nail morphology|MP:0000583,long toenails|MP:0001199,thin skin|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0001510,abnormal coat appearance|MP:0002051,increased skin papilloma incidence|MP:0002832,coarse hair|MP:0003704,abnormal hair follicle development|MP:0003849,greasy coat|MP:0004207,increased squamous cell carcinoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0009794,sebaceous gland hyperplasia|MP:0009814,increased prostaglandin level|MP:0013383,increased sebaceous gland adenoma incidence
MGI:2651675	Tg(K5-Ptgs2)667Kmd	MP:0000367,abnormal coat/ hair morphology|MP:0000379,decreased hair follicle number|MP:0000383,abnormal hair follicle orientation|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000579,abnormal nail morphology|MP:0000583,long toenails|MP:0001199,thin skin|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0001510,abnormal coat appearance|MP:0002051,increased skin papilloma incidence|MP:0002083,premature death|MP:0002832,coarse hair|MP:0003704,abnormal hair follicle development|MP:0004207,increased squamous cell carcinoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0009794,sebaceous gland hyperplasia|MP:0009814,increased prostaglandin level|MP:0013383,increased sebaceous gland adenoma incidence
MGI:2679341	Tg(K5-Ptgs2)675Kmd	MP:0000367,abnormal coat/ hair morphology|MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000383,abnormal hair follicle orientation|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000427,abnormal hair cycle|MP:0000579,abnormal nail morphology|MP:0000583,long toenails|MP:0001199,thin skin|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0001510,abnormal coat appearance|MP:0002083,premature death|MP:0002832,coarse hair|MP:0003704,abnormal hair follicle development|MP:0003849,greasy coat|MP:0009794,sebaceous gland hyperplasia|MP:0009814,increased prostaglandin level
MGI:1930206	Tg(K6ODCtr)55Tgo	MP:0000377,abnormal hair follicle morphology|MP:0000378,absent hair follicles|MP:0000414,alopecia|MP:0001197,oily skin|MP:0001211,wrinkled skin|MP:0001247,dermal cyst|MP:0001262,decreased body weight|MP:0001284,absent vibrissae|MP:0002051,increased skin papilloma incidence|MP:0003413,hair follicle degeneration|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009580,increased keratinocyte apoptosis|MP:0009794,sebaceous gland hyperplasia|MP:0010300,increased skin tumor incidence|MP:0010683,dilated hair follicle infundibulum|MP:0010700,hair follicle comedo|MP:0012401,long nails|MP:0013488,increased keratoacanthoma incidence
MGI:5319689	Tg(Kap-Ppara/AGT)562Dpo	MP:0002136,abnormal kidney physiology|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:3695585	Tg(KB1430A10)1Ped	MP:0003983,decreased cholesterol level|MP:0004777,abnormal phospholipid level|MP:0005318,decreased triglyceride level|MP:0009356,decreased liver triglyceride level
MGI:3851135	Tg(Kera-PITX2*A)AHjal	MP:0000550,abnormal forelimb morphology|MP:0000552,abnormal radius morphology|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001322,abnormal iris morphology|MP:0004351,short humerus|MP:0004353,abnormal deltoid tuberosity morphology|MP:0005108,abnormal ulna morphology|MP:0005296,abnormal humerus morphology|MP:0005371,limbs/digits/tail phenotype|MP:0006000,abnormal cornea epithelium morphology|MP:0011481,anterior iris synechia|MP:0020855,decreased cornea epithelium thickness|MP:0030855,abnormal olecranon fossa morphology
MGI:3851245	Tg(Kera-PITX2*A)BHjal	MP:0000550,abnormal forelimb morphology|MP:0000552,abnormal radius morphology|MP:0001312,abnormal cornea morphology|MP:0001314,cornea opacity|MP:0001322,abnormal iris morphology|MP:0004351,short humerus|MP:0004353,abnormal deltoid tuberosity morphology|MP:0005108,abnormal ulna morphology|MP:0005296,abnormal humerus morphology|MP:0005371,limbs/digits/tail phenotype|MP:0006000,abnormal cornea epithelium morphology|MP:0011481,anterior iris synechia|MP:0020855,decreased cornea epithelium thickness|MP:0030855,abnormal olecranon fossa morphology
MGI:4942357	Tg(Kit*D814V)1Roer	MP:0000245,abnormal erythropoiesis|MP:0000324,increased mast cell number|MP:0000359,abnormal mast cell morphology|MP:0000489,abnormal large intestine morphology|MP:0000491,crypts of Lieberkuhn abscesses|MP:0000493,rectal prolapse|MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0001263,weight loss|MP:0002026,increased leukemia incidence|MP:0002058,neonatal lethality|MP:0002083,premature death|MP:0002816,colitis|MP:0003304,large intestinal inflammation|MP:0003306,small intestinal inflammation|MP:0003656,abnormal erythrocyte physiology|MP:0003868,abnormal feces composition|MP:0005036,diarrhea|MP:0005481,increased chronic myelocytic leukemia incidence|MP:0008770,decreased survivor rate|MP:0009278,abnormal bone marrow cell physiology|MP:0009395,increased nucleated erythrocyte cell number|MP:0010300,increased skin tumor incidence|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4942358	Tg(Kit*D814V)2Roer	MP:0000324,increased mast cell number|MP:0000359,abnormal mast cell morphology|MP:0000489,abnormal large intestine morphology|MP:0000491,crypts of Lieberkuhn abscesses|MP:0000493,rectal prolapse|MP:0001263,weight loss|MP:0002816,colitis|MP:0003304,large intestinal inflammation|MP:0003306,small intestinal inflammation|MP:0003868,abnormal feces composition|MP:0005036,diarrhea|MP:0009278,abnormal bone marrow cell physiology|MP:0010300,increased skin tumor incidence
MGI:4942359	Tg(Kit*D814V)3Roer	MP:0000245,abnormal erythropoiesis|MP:0000324,increased mast cell number|MP:0000359,abnormal mast cell morphology|MP:0000493,rectal prolapse|MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0001263,weight loss|MP:0002026,increased leukemia incidence|MP:0002058,neonatal lethality|MP:0002083,premature death|MP:0002816,colitis|MP:0003304,large intestinal inflammation|MP:0003656,abnormal erythrocyte physiology|MP:0003868,abnormal feces composition|MP:0005036,diarrhea|MP:0008770,decreased survivor rate|MP:0009278,abnormal bone marrow cell physiology|MP:0009395,increased nucleated erythrocyte cell number|MP:0010300,increased skin tumor incidence|MP:0011088,neonatal lethality, incomplete penetrance
MGI:2384632	Tg(KLK4mHEL)6Ccg	MP:0002169,no abnormal phenotype detected
MGI:2655200	Tg(Krt1-14-GLI)1Oro	MP:0000414,alopecia|MP:0001209,spontaneous skin ulceration|MP:0002012,increased trichofolliculoma incidence|MP:0002020,increased tumor incidence|MP:0002083,premature death
MGI:3775303	Tg(KRT14-Angpt1)1Gdy	MP:0001190,reddish skin|MP:0003658,abnormal capillary morphology|MP:0004125,abnormal venule morphology|MP:0006136,varicose veins|MP:0014273,abnormal skin vasculature morphology|MP:0020327,abnormal capillary branching pattern
MGI:4359454	Tg(Krt14-Angptl2)1Yo	MP:0004947,skin inflammation|MP:0005369,muscle phenotype|MP:0013177,abnormal tail tip morphology
MGI:3057126	Tg(KRT14-Birc5)19Gros	MP:0003453,abnormal keratinocyte physiology|MP:0004502,decreased incidence of tumors by chemical induction
MGI:4455042	Tg(Krt14-Bmp4)#Jake	MP:0005371,limbs/digits/tail phenotype
MGI:2388821	Tg(KRT14-CASP1)1Miz	MP:0000219,increased neutrophil cell number|MP:0000418,focal hair loss|MP:0001193,psoriasis|MP:0001194,dermatitis|MP:0001209,spontaneous skin ulceration|MP:0001212,skin lesions|MP:0001265,decreased body size|MP:0001412,excessive scratching|MP:0001786,skin edema|MP:0001874,acanthosis|MP:0002412,increased susceptibility to bacterial infection|MP:0002444,abnormal T cell physiology|MP:0002497,increased IgE level|MP:0003427,parakeratosis|MP:0005018,decreased T cell number|MP:0008499,increased IgG1 level|MP:0008635,increased circulating interleukin-18 level|MP:0009545,abnormal dermis papillary layer morphology|MP:0009580,increased keratinocyte apoptosis|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0030758,increased circulating histamine level
MGI:7639705	Tg(Krt14-Cpne7)#Parkj	MP:0013250,abnormal dental pulp morphology
MGI:2667375	Tg(Krt14-dnLef1)LFmw	MP:0000383,abnormal hair follicle orientation|MP:0000414,alopecia|MP:0001191,abnormal skin condition|MP:0001200,thick skin|MP:0001283,sparse vibrissae|MP:0002015,epithelioid cyst|MP:0010300,increased skin tumor incidence
MGI:3811075	Tg(KRT14-Edil3)1Gpy	MP:0002073,abnormal hair growth
MGI:3687548	Tg(KRT14-Edn3)1Takk	MP:0002095,abnormal skin pigmentation|MP:0002877,abnormal melanocyte morphology|MP:0005409,darkened coat color|MP:0010316,increased thyroid tumor incidence|MP:0011278,increased ear pigmentation|MP:0012022,increased melanocyte number
MGI:4421514	Tg(KRT14-EGFP/Actb)50Efu	MP:0002169,no abnormal phenotype detected
MGI:3700054	Tg(KRT14-Esr1/HRAS)1Pkha	MP:0001200,thick skin|MP:0001242,hyperkeratosis
MGI:3805117	Tg(KRT14-FIGF)2Ali	MP:0004106,lymphatic vessel hyperplasia|MP:0005385,cardiovascular system phenotype
MGI:5522572	Tg(KRT14-FLT4/IGHG1)#Ali	MP:0001879,abnormal lymphatic vessel morphology|MP:0004875,increased mean systemic arterial blood pressure|MP:0008248,abnormal mononuclear phagocyte morphology|MP:0011977,abnormal sodium ion homeostasis|MP:0012007,abnormal chloride level
MGI:4417888	Tg(Krt14-Fyn)AJsey	MP:0000763,abnormal filiform papillae morphology|MP:0001193,psoriasis|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001265,decreased body size|MP:0002082,postnatal lethality|MP:0002655,abnormal keratinocyte morphology|MP:0011946,decreased eating frequency
MGI:4417930	Tg(KRT14-Fyn*)aJsey	MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0002655,abnormal keratinocyte morphology|MP:0002656,abnormal keratinocyte differentiation|MP:0003427,parakeratosis|MP:0009704,increased skin squamous cell carcinoma incidence
MGI:4418543	Tg(Krt14-HIF1A*)1Dcbe	MP:0003237,abnormal lens epithelium morphology
MGI:4418544	Tg(Krt14-HIF1A*)2Dcbe	MP:0003237,abnormal lens epithelium morphology
MGI:5546373	Tg(KRT14-Hmgn2)#Baam	MP:0002576,abnormal enamel morphology|MP:0004830,short incisors|MP:0030089,short lower incisors|MP:0030090,short upper incisors
MGI:3514313	Tg(KRT14-HPV16E7)2304Plam	MP:0000416,sparse hair|MP:0000469,abnormal esophageal squamous epithelium morphology|MP:0000472,abnormal stomach non-glandular epithelium morphology|MP:0001200,thick skin|MP:0001211,wrinkled skin|MP:0001216,abnormal epidermal layer morphology|MP:0001222,epidermal hyperplasia|MP:0001732,postnatal growth retardation|MP:0002015,epithelioid cyst|MP:0003846,matted coat|MP:0003849,greasy coat|MP:0004045,abnormal cell cycle checkpoint function|MP:0009704,increased skin squamous cell carcinoma incidence|MP:0011195,increased hair follicle apoptosis|MP:0031345,developmental cataract
MGI:3514315	Tg(KRT14-HPV16E7)2326Plam	MP:0000416,sparse hair|MP:0002015,epithelioid cyst|MP:0003846,matted coat|MP:0003849,greasy coat|MP:0009704,increased skin squamous cell carcinoma incidence|MP:0013374,increased sebaceous gland tumor incidence|MP:0031345,developmental cataract
MGI:3514323	Tg(KRT14-HPV16E7)2350Plam	MP:0000416,sparse hair|MP:0000469,abnormal esophageal squamous epithelium morphology|MP:0000472,abnormal stomach non-glandular epithelium morphology|MP:0001200,thick skin|MP:0001211,wrinkled skin|MP:0001216,abnormal epidermal layer morphology|MP:0001222,epidermal hyperplasia|MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality|MP:0003846,matted coat|MP:0003849,greasy coat|MP:0011195,increased hair follicle apoptosis|MP:0031345,developmental cataract
MGI:3047406	Tg(KRT14-HPV16)wt1Dh	MP:0001214,skin hyperplasia|MP:0002006,neoplasm|MP:0002060,abnormal skin morphology|MP:0009583,increased keratinocyte proliferation|MP:0009704,increased skin squamous cell carcinoma incidence|MP:0010367,increased spindle cell carcinoma incidence
MGI:5559370	Tg(KRT14-HPV8)61Vuc	MP:0002051,increased skin papilloma incidence
MGI:5559369	Tg(KRT14-HPV8)85Vuc	MP:0000414,alopecia|MP:0001242,hyperkeratosis|MP:0002051,increased skin papilloma incidence|MP:0009704,increased skin squamous cell carcinoma incidence
MGI:5559368	Tg(KRT14-HPV8)9Vuc	MP:0000414,alopecia|MP:0001209,spontaneous skin ulceration|MP:0001242,hyperkeratosis|MP:0002051,increased skin papilloma incidence|MP:0009704,increased skin squamous cell carcinoma incidence
MGI:5559371	Tg(KRT14-HPV8)#Vuc	MP:0001216,abnormal epidermal layer morphology|MP:0001242,hyperkeratosis|MP:0001874,acanthosis|MP:0002051,increased skin papilloma incidence|MP:0003427,parakeratosis|MP:0009563,dyskeratosis|MP:0009604,increased keratohyalin granule number|MP:0009704,increased skin squamous cell carcinoma incidence|MP:0010300,increased skin tumor incidence
MGI:3715279	Tg(KRT14-Hr)551Cct	MP:0000417,short hair|MP:0000647,abnormal sebaceous gland morphology|MP:0001219,thick epidermis|MP:0030575,decreased hair follicle cell proliferation
MGI:7258010	Tg(Krt14-Ifnk)#Cya	MP:0000691,enlarged spleen|MP:0012572,increased susceptibility to chemically induced skin inflammation
MGI:2388817	Tg(KRT14-Il18)#Knak	MP:0000219,increased neutrophil cell number|MP:0001194,dermatitis|MP:0001212,skin lesions|MP:0001412,excessive scratching|MP:0001874,acanthosis|MP:0002444,abnormal T cell physiology|MP:0002497,increased IgE level|MP:0005018,decreased T cell number|MP:0008499,increased IgG1 level|MP:0008635,increased circulating interleukin-18 level|MP:0030758,increased circulating histamine level
MGI:3762035	Tg(KRT14-Il1f6)1Hblu	MP:0001195,flaky skin|MP:0001212,skin lesions|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001265,decreased body size|MP:0001874,acanthosis|MP:0002111,abnormal tail morphology|MP:0004947,skin inflammation|MP:0008721,abnormal chemokine level
MGI:5564943	Tg(KRT14-Il4)#Lsch	MP:0001194,dermatitis|MP:0001209,spontaneous skin ulceration|MP:0001242,hyperkeratosis|MP:0001310,abnormal conjunctiva morphology|MP:0001316,cornea scarring|MP:0001340,abnormal eyelid morphology|MP:0001412,excessive scratching|MP:0001852,conjunctivitis|MP:0001874,acanthosis|MP:0002412,increased susceptibility to bacterial infection|MP:0002497,increased IgE level|MP:0003427,parakeratosis|MP:0003853,dry skin|MP:0004947,skin inflammation|MP:0005251,blepharitis|MP:0008496,decreased IgG2a level|MP:0008499,increased IgG1 level|MP:0008764,increased mast cell degranulation|MP:0009795,epidermal spongiosis|MP:0010072,increased pruritus
MGI:4454778	Tg(KRT14-Il7)1Tsk	MP:0000019,thick ears|MP:0000414,alopecia|MP:0001190,reddish skin|MP:0001265,decreased body size|MP:0001290,delayed eyelid opening|MP:0001924,infertility|MP:0002083,premature death|MP:0004947,skin inflammation|MP:0005251,blepharitis|MP:0008770,decreased survivor rate
MGI:3700387	Tg(KRT14-MAP2K1/Esr1)12Pkha	MP:0001222,epidermal hyperplasia
MGI:2667449	Tg(Krt14-MYCER)2184C.1Fmw	MP:0000377,abnormal hair follicle morphology|MP:0000652,enlarged sebaceous gland|MP:0001191,abnormal skin condition|MP:0001200,thick skin|MP:0014659,increased skin stiffness
MGI:4455044	Tg(Krt14-Nog)#Jake	MP:0000367,abnormal coat/ hair morphology|MP:0000564,syndactyly|MP:0000571,interdigital webbing|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0002098,abnormal vibrissa morphology|MP:0002544,brachydactyly|MP:0003807,camptodactyly|MP:0004083,polysyndactyly|MP:0008489,slow postnatal weight gain|MP:0009743,preaxial polydactyly|MP:0009744,postaxial polydactyly|MP:0009874,abnormal interdigital cell death
MGI:2450137	Tg(KRT14-Pgf)1Odo	MP:0000260,abnormal angiogenesis|MP:0001190,reddish skin|MP:0001614,abnormal blood vessel morphology|MP:0003070,increased vascular permeability|MP:0003227,abnormal vascular branching morphogenesis|MP:0009489,abnormal blood vessel endothelium morphology
MGI:5444854	Tg(KRT14-Prss8)1Hum	MP:0000416,sparse hair|MP:0001192,scaly skin|MP:0001212,skin lesions|MP:0001243,abnormal dermal layer morphology|MP:0001262,decreased body weight|MP:0001412,excessive scratching|MP:0001874,acanthosis|MP:0002796,impaired skin barrier function|MP:0009596,abnormal stratum corneum lipid matrix formation
MGI:5444856	Tg(KRT14-Prss8)2Hum	MP:0000416,sparse hair|MP:0001192,scaly skin|MP:0001212,skin lesions|MP:0001243,abnormal dermal layer morphology|MP:0001262,decreased body weight|MP:0001412,excessive scratching|MP:0001874,acanthosis|MP:0002796,impaired skin barrier function|MP:0009596,abnormal stratum corneum lipid matrix formation|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1926698	Tg(KRT14-PTHLH)7Wmp	MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000400,abnormal awl hair morphology|MP:0000405,abnormal auchene hair morphology|MP:0000416,sparse hair|MP:0000417,short hair|MP:0001199,thin skin|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0002073,abnormal hair growth|MP:0003704,abnormal hair follicle development|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009351,thin hair shaft|MP:0010203,focal ventral hair loss|MP:0012078,abnormal tail ring morphology
MGI:6274278	Tg(Krt14-Rac1*G12V)#Mrnk	MP:0000579,abnormal nail morphology|MP:0001190,reddish skin|MP:0001193,psoriasis|MP:0001233,abnormal epidermis suprabasal layer morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001265,decreased body size|MP:0001786,skin edema|MP:0002060,abnormal skin morphology|MP:0002932,abnormal joint morphology|MP:0002933,joint inflammation|MP:0003427,parakeratosis|MP:0004924,abnormal behavior|MP:0004947,skin inflammation|MP:0008588,abnormal circulating interleukin level|MP:0011514,skin hemorrhage|MP:0012405,abnormal nail matrix morphology
MGI:3700057	Tg(KRT14-RAF1/ESR1)1Pkha	MP:0001200,thick skin|MP:0001242,hyperkeratosis
MGI:3830534	Tg(Krt14-RNAi:Cdh3)1Efu	MP:0010771,integument phenotype
MGI:3762564	Tg(KRT14-rtTA)F42Efu	MP:0002169,no abnormal phenotype detected
MGI:7332932	Tg(KRT14-Shh)#Cobm	MP:0000039,abnormal otic capsule morphology|MP:0000074,abnormal neurocranium morphology|MP:0000079,abnormal basioccipital bone morphology|MP:0000080,abnormal exoccipital bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000109,abnormal parietal bone morphology|MP:0000111,cleft palate|MP:0000116,abnormal tooth development|MP:0000118,arrest of tooth development|MP:0000120,malocclusion|MP:0000428,abnormal craniofacial morphology|MP:0000431,absent palatine bone horizontal plate|MP:0000455,abnormal maxilla morphology|MP:0000547,short limbs|MP:0000564,syndactyly|MP:0000585,kinked tail|MP:0001196,shiny skin|MP:0001198,tight skin|MP:0001201,translucent skin|MP:0001216,abnormal epidermal layer morphology|MP:0001222,epidermal hyperplasia|MP:0001300,ocular hypertelorism|MP:0002820,abnormal premaxilla morphology|MP:0003054,spina bifida|MP:0004083,polysyndactyly|MP:0004208,increased basal cell carcinoma incidence|MP:0004320,split sternum|MP:0004443,absent supraoccipital bone|MP:0004599,abnormal vertebral arch morphology|MP:0005105,abnormal middle ear ossicle morphology|MP:0005274,abnormal viscerocranium morphology|MP:0008023,abnormal styloid process morphology|MP:0008374,abnormal malleus manubrium morphology|MP:0008382,gonial bone hypoplasia|MP:0009652,abnormal palatal rugae morphology|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009889,persistence of medial edge epithelium during palatal shelf fusion|MP:0009890,cleft secondary palate|MP:0009897,decreased maxillary shelf size|MP:0012523,abnormal upper lip morphology|MP:0013767,decreased palatal rugae number|MP:0014166,ectopic cranial bone|MP:0030084,tympanic ring hypoplasia|MP:0030122,temporal bone squamous part hypoplasia|MP:0030254,abnormal dental arch morphology|MP:0030283,small mandibular coronoid process
MGI:3774670	Tg(KRT14-Snai1)1Efu	MP:0000592,short tail|MP:0001195,flaky skin|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001265,decreased body size|MP:0001272,increased metastatic potential|MP:0004208,increased basal cell carcinoma incidence|MP:0005150,cachexia|MP:0008944,decreased sensitivity to induced cell death|MP:0009583,increased keratinocyte proliferation|MP:0009704,increased skin squamous cell carcinoma incidence|MP:0009794,sebaceous gland hyperplasia|MP:0010300,increased skin tumor incidence|MP:0011159,abnormal epidermal-dermal junction morphology|MP:0011940,decreased food intake|MP:0013374,increased sebaceous gland tumor incidence|MP:0013376,abnormal sebocyte differentiation
MGI:4413466	Tg(Krt14-Tcf7l2)1Efu	MP:0001216,abnormal epidermal layer morphology|MP:0001302,eyelids open at birth
MGI:4413467	Tg(Krt14-Tcf7l2*)2Efu	MP:0001302,eyelids open at birth
MGI:4413469	Tg(Krt14-Tcf7l2*)3Efu	MP:0002169,no abnormal phenotype detected
MGI:3622662	Tg(KRT14-Tslp)1Pcn	MP:0000020,scaly ears|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001246,mixed cellular infiltration to dermis|MP:0002461,increased immunoglobulin level|MP:0003945,abnormal lymphocyte physiology|MP:0008102,lymph node hyperplasia
MGI:3655101	Tg(KRT14-Vegfa)3Dtm	MP:0000260,abnormal angiogenesis|MP:0000324,increased mast cell number|MP:0000702,enlarged lymph nodes|MP:0001193,psoriasis|MP:0001216,abnormal epidermal layer morphology|MP:0001222,epidermal hyperplasia|MP:0001246,mixed cellular infiltration to dermis|MP:0001786,skin edema|MP:0001879,abnormal lymphatic vessel morphology|MP:0002908,delayed wound healing|MP:0003070,increased vascular permeability|MP:0003427,parakeratosis|MP:0003628,abnormal leukocyte adhesion|MP:0003658,abnormal capillary morphology|MP:0005425,increased macrophage cell number|MP:0010200,enlarged lymphatic vessel|MP:0020327,abnormal capillary branching pattern|MP:0020331,increased capillary tortuosity|MP:0020333,enhanced leukocyte tethering or rolling
MGI:3805119	Tg(KRT14-VEGFC*)1Ali	MP:0004106,lymphatic vessel hyperplasia|MP:0005385,cardiovascular system phenotype
MGI:6330734	Tg(KRT14-VP16/NR1I2)13Sdub	MP:0000218,increased leukocyte cell number|MP:0000702,enlarged lymph nodes|MP:0001192,scaly skin|MP:0001194,dermatitis|MP:0001218,thin epidermis|MP:0001222,epidermal hyperplasia|MP:0002419,abnormal innate immunity|MP:0002497,increased IgE level|MP:0002796,impaired skin barrier function|MP:0003853,dry skin|MP:0004043,abnormal pH regulation|MP:0004947,skin inflammation|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0008073,abnormal CD4-positive, alpha-beta T cell number|MP:0008126,increased dendritic cell number|MP:0008346,increased gamma-delta T cell number|MP:0008499,increased IgG1 level|MP:0008658,decreased interleukin-1 beta secretion|MP:0008835,abnormal intercellular signaling peptide or protein level|MP:0009583,increased keratinocyte proliferation|MP:0009596,abnormal stratum corneum lipid matrix formation|MP:0013772,increased effector memory T-helper cell number|MP:0020155,enhanced humoral immune response|MP:0020349,abnormal dendritic cell migration
MGI:1926503	Tg(KRT16)10Cou	MP:0000054,delayed ear emergence|MP:0000367,abnormal coat/ hair morphology|MP:0000379,decreased hair follicle number|MP:0000382,underdeveloped hair follicles|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000417,short hair|MP:0001195,flaky skin|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001732,postnatal growth retardation|MP:0002169,no abnormal phenotype detected
MGI:1926502	Tg(KRT16)13Cou	MP:0002169,no abnormal phenotype detected
MGI:1926506	Tg(KRT16/KRT14)A2Cou	MP:0002169,no abnormal phenotype detected
MGI:6402178	Tg(KRT18-DPP4)3Pbmj	MP:0000488,abnormal intestinal epithelium morphology|MP:0000496,abnormal small intestine morphology|MP:0001177,atelectasis|MP:0001847,brain inflammation|MP:0001861,lung inflammation|MP:0001862,interstitial pneumonia|MP:0002135,abnormal kidney morphology|MP:0002229,neurodegeneration|MP:0003009,abnormal cytokine secretion|MP:0004007,abnormal lung vasculature morphology|MP:0005013,increased lymphocyte cell number|MP:0008108,abnormal small intestinal villus morphology|MP:0008247,abnormal mononuclear cell morphology|MP:0010018,pulmonary vascular congestion|MP:0010894,pulmonary alveolar edema|MP:0011975,neuronal cytoplasmic inclusions|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:5449063	Tg(Krt18-EGFP,-TAg121)36Ysng	MP:0001126,abnormal ovary morphology|MP:0001128,ovary hyperplasia|MP:0003579,increased ovarian carcinoma incidence|MP:0008000,increased ovary tumor incidence
MGI:7262689	Tg(KRT18*R89C)22Rgo	MP:0000607,abnormal hepatocyte morphology|MP:0001654,hepatic necrosis|MP:0002941,increased circulating alanine transaminase level|MP:0003888,liver hemorrhage|MP:0005343,increased circulating aspartate transaminase level|MP:0009820,abnormal liver vasculature morphology|MP:0031301,chronic liver inflammation
MGI:7262690	Tg(KRT18*R89C)30Rgo	MP:0000607,abnormal hepatocyte morphology|MP:0001654,hepatic necrosis|MP:0002941,increased circulating alanine transaminase level|MP:0003888,liver hemorrhage|MP:0005343,increased circulating aspartate transaminase level|MP:0009820,abnormal liver vasculature morphology|MP:0031301,chronic liver inflammation
MGI:7262691	Tg(KRT18*R89C)50Rgo	MP:0000607,abnormal hepatocyte morphology|MP:0001654,hepatic necrosis|MP:0002941,increased circulating alanine transaminase level|MP:0003888,liver hemorrhage|MP:0005343,increased circulating aspartate transaminase level|MP:0009820,abnormal liver vasculature morphology|MP:0031301,chronic liver inflammation
MGI:4361186	Tg(Krt19-Ptgs2,Krt19-Ptges)8Tko	MP:0005213,gastric metaplasia
MGI:5789553	Tg(KRT19-TAg)7Eps	MP:0000420,ruffled hair|MP:0000519,hydronephrosis|MP:0000642,enlarged adrenal glands|MP:0000659,prostate gland hyperplasia|MP:0001272,increased metastatic potential|MP:0002031,increased adrenal gland tumor incidence|MP:0002083,premature death|MP:0003068,enlarged kidney|MP:0004757,abnormal distal convoluted tubule morphology|MP:0005202,lethargy|MP:0005565,increased blood urea nitrogen level|MP:0008489,slow postnatal weight gain|MP:0009551,increased urinary bladder transitional cell carcinoma incidence|MP:0010309,increased mesothelioma incidence|MP:0010357,increased prostate gland tumor incidence|MP:0013899,abnormal seminal vesicle epithelium morphology
MGI:4361187	Tg(Krt19-Wnt1)2Maos	MP:0000473,abnormal stomach glandular epithelium morphology|MP:0013578,abnormal stomach glandular region morphology
MGI:1926921	Tg(Krt2-6a)1Der	MP:0002073,abnormal hair growth
MGI:1926922	Tg(Krt2-6a)2Der	MP:0002169,no abnormal phenotype detected
MGI:1926924	Tg(Krt2-6a)3Der	MP:0002073,abnormal hair growth|MP:0002082,postnatal lethality
MGI:1926925	Tg(Krt2-6a)4Der	MP:0002073,abnormal hair growth
MGI:1926813	Tg(Krt2-9)1Grog	MP:0000410,waved hair|MP:0000414,alopecia|MP:0000417,short hair|MP:0001279,wavy vibrissae|MP:0001282,short vibrissae
MGI:3842829	Tg(KRT5-Akt1*)Jmpa	MP:0000351,increased cell proliferation|MP:0000615,abnormal palatine gland morphology|MP:0002038,increased carcinoma incidence|MP:0002732,increased trichoepithelioma incidence|MP:0003448,abnormal tumor morphology|MP:0003745,abnormal oral mucosa morphology|MP:0003751,oral leukoplakia|MP:0004035,abnormal sublingual gland morphology|MP:0004207,increased squamous cell carcinoma incidence|MP:0009308,increased adenocarcinoma incidence|MP:0009584,decreased keratinocyte proliferation|MP:0013492,oral erythroplakia
MGI:4818964	Tg(KRT5-AR)191Cct	MP:0000423,delayed hair regrowth|MP:0002075,abnormal coat/hair pigmentation
MGI:4818965	Tg(KRT5-AR)335Cct	MP:0000423,delayed hair regrowth|MP:0002075,abnormal coat/hair pigmentation
MGI:3624634	Tg(KRT5-CDK4)2303Mlrp	MP:0000358,abnormal cell morphology|MP:0001219,thick epidermis|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001243,abnormal dermal layer morphology|MP:0001245,thick dermal layer
MGI:5426890	Tg(KRT5-CHUK)#Rche	MP:0005382,craniofacial phenotype
MGI:1926815	Tg(KRT5-cre)1Tak	MP:0000381,enlarged hair follicles|MP:0000410,waved hair|MP:0000414,alopecia|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001274,curly vibrissae|MP:0001510,abnormal coat appearance|MP:0001882,abnormal lactation|MP:0002169,no abnormal phenotype detected|MP:0003704,abnormal hair follicle development|MP:0003718,maternal effect|MP:0005384,cellular phenotype|MP:0009503,abnormal mammary gland duct morphology|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009546,absent gastric milk in neonates|MP:0010172,abnormal mammary gland epithelium physiology
MGI:2384616	Tg(KRT5-E2F1)2Dgj	MP:0001204,decreased sensitivity to skin irradiation
MGI:4456367	Tg(KRT5-IKBKB)1Armz	MP:0000414,alopecia|MP:0001188,hyperpigmentation|MP:0001190,reddish skin|MP:0001191,abnormal skin condition|MP:0001200,thick skin|MP:0001209,spontaneous skin ulceration|MP:0002100,abnormal tooth morphology|MP:0003453,abnormal keratinocyte physiology|MP:0003815,hairless|MP:0005379,endocrine/exocrine gland phenotype|MP:0008560,increased tumor necrosis factor secretion|MP:0008654,increased interleukin-1 alpha secretion|MP:0008705,increased interleukin-6 secretion|MP:0009004,progressive hair loss|MP:0009581,decreased keratinocyte apoptosis|MP:0010072,increased pruritus
MGI:4456368	Tg(KRT5-IKBKB)2Armz	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0001188,hyperpigmentation|MP:0001190,reddish skin|MP:0001191,abnormal skin condition|MP:0001194,dermatitis|MP:0001200,thick skin|MP:0001209,spontaneous skin ulceration|MP:0001220,epidermal necrosis|MP:0001222,epidermal hyperplasia|MP:0001510,abnormal coat appearance|MP:0002060,abnormal skin morphology|MP:0002100,abnormal tooth morphology|MP:0002655,abnormal keratinocyte morphology|MP:0002723,abnormal immune serum protein physiology|MP:0003153,early eyelid opening|MP:0003453,abnormal keratinocyte physiology|MP:0003815,hairless|MP:0005379,endocrine/exocrine gland phenotype|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008599,increased circulating interleukin-2 level|MP:0008602,increased circulating interleukin-4 level|MP:0008626,increased circulating interleukin-5 level|MP:0008638,increased circulating interleukin-1 alpha level|MP:0008654,increased interleukin-1 alpha secretion|MP:0008705,increased interleukin-6 secretion|MP:0008713,abnormal cytokine level|MP:0009004,progressive hair loss|MP:0009545,abnormal dermis papillary layer morphology|MP:0009583,increased keratinocyte proliferation|MP:0009931,abnormal skin appearance|MP:0010072,increased pruritus|MP:0010206,pigment incontinence|MP:0020334,abnormal melanophage morphology
MGI:3690971	Tg(KRT5-Stat3*A661C*N663C)1Jdg	MP:0001190,reddish skin|MP:0001192,scaly skin|MP:0001193,psoriasis|MP:0001200,thick skin|MP:0001242,hyperkeratosis|MP:0001246,mixed cellular infiltration to dermis|MP:0001874,acanthosis|MP:0002060,abnormal skin morphology|MP:0003427,parakeratosis|MP:0009560,absent epidermis stratum granulosum|MP:0009583,increased keratinocyte proliferation
MGI:6258221	Tg(KRT5-Terf2)PMBlas	MP:0000649,sebaceous gland atrophy|MP:0001202,skin photosensitivity|MP:0001203,increased sensitivity to skin irradiation|MP:0001214,skin hyperplasia|MP:0001221,epidermal atrophy|MP:0001222,epidermal hyperplasia|MP:0002060,abnormal skin morphology|MP:0003413,hair follicle degeneration|MP:0003453,abnormal keratinocyte physiology|MP:0003786,premature aging|MP:0003853,dry skin|MP:0004030,induced chromosome breakage|MP:0004501,increased incidence of tumors by UV-induction|MP:0008402,increased cellular sensitivity to alkylating agent induced cell death|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008866,chromosomal instability|MP:0009387,abnormal epidermal pigmentation|MP:0009584,decreased keratinocyte proliferation|MP:0009704,increased skin squamous cell carcinoma incidence|MP:0010202,focal dorsal hair loss|MP:0010207,abnormal telomere morphology|MP:0010300,increased skin tumor incidence|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation|MP:0013488,increased keratoacanthoma incidence|MP:0014760,impaired DNA repair|MP:0030051,increased foot pigmentation|MP:0030926,increased skin pigmentation|MP:0030927,decreased telomere length
MGI:6258223	Tg(KRT5-Terf2)PNBlas	MP:0002006,neoplasm|MP:0010768,mortality/aging|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation|MP:0030051,increased foot pigmentation|MP:0030926,increased skin pigmentation|MP:0030927,decreased telomere length
MGI:6258222	Tg(KRT5-Terf2)POBlas	MP:0001202,skin photosensitivity|MP:0001203,increased sensitivity to skin irradiation|MP:0003453,abnormal keratinocyte physiology|MP:0004030,induced chromosome breakage|MP:0004501,increased incidence of tumors by UV-induction|MP:0008402,increased cellular sensitivity to alkylating agent induced cell death|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008866,chromosomal instability|MP:0009704,increased skin squamous cell carcinoma incidence|MP:0010300,increased skin tumor incidence|MP:0010768,mortality/aging|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation|MP:0013488,increased keratoacanthoma incidence|MP:0014760,impaired DNA repair|MP:0030051,increased foot pigmentation|MP:0030926,increased skin pigmentation|MP:0030927,decreased telomere length
MGI:2429416	Tg(KRT5-Tert)8043Blas	MP:0001214,skin hyperplasia|MP:0002724,enhanced wound healing|MP:0004499,increased incidence of tumors by chemical induction|MP:0005384,cellular phenotype
MGI:3690994	Tg(KRT5-TGFB1)F2020Xjw	MP:0001190,reddish skin|MP:0001192,scaly skin|MP:0001193,psoriasis|MP:0001212,skin lesions|MP:0001233,abnormal epidermis suprabasal layer morphology|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0001874,acanthosis|MP:0002655,abnormal keratinocyte morphology|MP:0003427,parakeratosis|MP:0003711,pathological neovascularization|MP:0004272,abnormal basement membrane morphology|MP:0004947,skin inflammation|MP:0005362,abnormal Langerhans cell physiology|MP:0005501,abnormal skin physiology|MP:0005601,increased angiogenesis|MP:0008117,abnormal Langerhans cell morphology|MP:0008119,decreased Langerhans cell number|MP:0009584,decreased keratinocyte proliferation|MP:0009598,thin epidermis stratum granulosum|MP:0031395,cutaneous mastocytosis
MGI:3038494	Tgl1<KK/Ta>	MP:0005317,increased triglyceride level
MGI:3785742	Tg(Lactb)1Lus	MP:0001260,increased body weight|MP:0010024,increased total body fat amount
MGI:3817516	Tg(Lactb)74.2Lus	MP:0003961,decreased lean body mass
MGI:5522554	Tg(LANA,vFLIP,vCYC)801Dtmr	MP:0000240,extramedullary hematopoiesis|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002144,abnormal B cell differentiation|MP:0005154,increased B cell proliferation|MP:0008097,increased plasma cell number|MP:0008177,increased germinal center B cell number|MP:0008180,abnormal marginal zone B cell morphology|MP:0008181,increased marginal zone B cell number|MP:0008192,abnormal germinal center B cell physiology|MP:0008193,abnormal marginal zone B cell physiology|MP:0008210,increased mature B cell number|MP:0008217,abnormal B cell activation|MP:0008254,increased megakaryocyte cell number|MP:0008499,increased IgG1 level|MP:0008502,increased IgG3 level|MP:0012431,increased lymphoma incidence
MGI:4431394	Tg(Lcat)1Ssf	MP:0001556,increased circulating HDL cholesterol level|MP:0003980,increased circulating phospholipid level|MP:0005178,increased circulating cholesterol level
MGI:3696854	Tg(LCAT)A31Ssf	MP:0001556,increased circulating HDL cholesterol level|MP:0003980,increased circulating phospholipid level|MP:0005178,increased circulating cholesterol level|MP:0010332,abnormal circulating apolipoprotein level|MP:0010333,abnormal circulating apolipoprotein E level
MGI:3696856	Tg(LCAT)T59Ssf	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:3036300	Tg(Lck)4220Rmp	MP:0002024,increased T cell derived lymphoma incidence|MP:0014237,decreased tumor-free survival time
MGI:3803797	Tg(Lck-Akt1*E40K)E-3Pnt	MP:0000691,enlarged spleen|MP:0000715,decreased thymocyte number|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0004045,abnormal cell cycle checkpoint function|MP:0008770,decreased survivor rate
MGI:3803798	Tg(Lck-Akt1*)M-1Pnt	MP:0000691,enlarged spleen|MP:0000715,decreased thymocyte number|MP:0002024,increased T cell derived lymphoma incidence|MP:0004045,abnormal cell cycle checkpoint function|MP:0005090,increased double-negative T cell number|MP:0008082,increased single-positive T cell number|MP:0008770,decreased survivor rate
MGI:5500790	Tg(Lck-Akt2*)#Test	MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0012431,increased lymphoma incidence
MGI:3840209	Tg(Lck-Bcl2l1)1Cant	MP:0005348,increased T cell proliferation|MP:0008049,increased memory T cell number|MP:0008687,increased interleukin-2 secretion
MGI:2448686	Tg(Lck-cre)1Cwi	MP:0000715,decreased thymocyte number
MGI:3588561	Tg(Lck-CrmA)1Hed	MP:0005387,immune system phenotype|MP:0006414,decreased T cell apoptosis|MP:0009542,decreased thymocyte apoptosis
MGI:3686860	Tg(Lck-Cxadr)1Jdgr	MP:0002444,abnormal T cell physiology|MP:0005095,decreased T cell proliferation|MP:0006414,decreased T cell apoptosis
MGI:3850830	Tg(Lck/Emu-Rftn1)1Ayos	MP:0002494,increased IgM level|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005348,increased T cell proliferation|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008502,increased IgG3 level|MP:0008566,increased interferon-gamma secretion|MP:0008681,increased interleukin-17 secretion|MP:0008699,increased interleukin-4 secretion
MGI:3032774	Tg(Lck*F505)2964Rmp	MP:0002006,neoplasm
MGI:3032775	Tg(Lck*F505)3073Rmp	MP:0002006,neoplasm
MGI:3588560	Tg(Lck-FADD)1Hed	MP:0000715,decreased thymocyte number|MP:0001825,arrested T cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002444,abnormal T cell physiology|MP:0005018,decreased T cell number|MP:0005094,abnormal T cell proliferation|MP:0005387,immune system phenotype|MP:0009542,decreased thymocyte apoptosis
MGI:2448671	Tg(Lck-Hhex)1Hro	MP:0000221,decreased leukocyte cell number|MP:0000708,thymus hyperplasia|MP:0002407,abnormal double-negative T cell morphology|MP:0005016,decreased lymphocyte cell number|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:5430381	Tg(Lck-Id1)28Xhsu	MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death
MGI:3047422	Tg(Lck-Il31)1Jagr	MP:0000019,thick ears|MP:0000414,alopecia|MP:0000702,enlarged lymph nodes|MP:0001194,dermatitis|MP:0001242,hyperkeratosis|MP:0001412,excessive scratching|MP:0001492,abnormal pilomotor reflex|MP:0001790,abnormal immune system physiology|MP:0001829,increased activated T cell number|MP:0001852,conjunctivitis|MP:0001874,acanthosis|MP:0005014,increased B cell number|MP:0005018,decreased T cell number|MP:0005460,abnormal leukopoiesis|MP:0008049,increased memory T cell number|MP:0031395,cutaneous mastocytosis
MGI:3052795	Tg(LckIl4)1315Dbl	MP:0000066,osteoporosis|MP:0000135,decreased compact bone thickness|MP:0000160,kyphosis|MP:0000703,abnormal thymus morphology|MP:0000711,thymus cortex hypoplasia|MP:0000727,absent CD8-positive, alpha-beta T cells|MP:0001541,abnormal osteoclast physiology|MP:0001566,increased circulating phosphate level|MP:0001823,thymus hypoplasia|MP:0001828,abnormal T cell activation|MP:0002145,abnormal T cell differentiation|MP:0003850,abnormal thymocyte activation|MP:0004991,decreased bone strength|MP:0005006,abnormal osteoblast physiology|MP:0005027,increased susceptibility to parasitic infection|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0006387,abnormal T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008158,increased diameter of femur|MP:0008500,increased IgG2a level|MP:0008699,increased interleukin-4 secretion|MP:0008827,abnormal thymus cell ratio|MP:0010873,decreased trabecular bone mass
MGI:4819166	Tg(Lck-LMO1)11Sjk	MP:0002006,neoplasm
MGI:2388710	Tg(Lck-Map3k8)3456Ngc	MP:0002024,increased T cell derived lymphoma incidence
MGI:3056807	Tg(LCK-NFKBIA)5Dwb	MP:0005095,decreased T cell proliferation|MP:0005465,abnormal T-helper 1 physiology|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0006413,increased T cell apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion
MGI:3056811	Tg(LckNotch1)9Erob	MP:0002024,increased T cell derived lymphoma incidence|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008827,abnormal thymus cell ratio
MGI:4843437	Tg(Lck-Notch3)#Issc	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000708,thymus hyperplasia|MP:0000714,increased thymocyte number|MP:0001505,hunched posture|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0005090,increased double-negative T cell number|MP:0005202,lethargy|MP:0009320,increased lymphoblastic lymphoma incidence|MP:0010336,increased acute lymphoblastic leukemia incidence
MGI:2447592	Tg(LCKprBCL2)36Sjk	MP:0002024,increased T cell derived lymphoma incidence|MP:0003944,abnormal T cell subpopulation ratio|MP:0004973,increased regulatory T cell number|MP:0005002,abnormal T cell clonal deletion|MP:0005015,increased T cell number|MP:0006387,abnormal T cell number|MP:0006414,decreased T cell apoptosis|MP:0008073,abnormal CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008827,abnormal thymus cell ratio|MP:0009542,decreased thymocyte apoptosis
MGI:3783708	Tg(Lck-Socs3)1Kubo	MP:0000715,decreased thymocyte number|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005018,decreased T cell number|MP:0005095,decreased T cell proliferation|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008688,decreased interleukin-2 secretion
MGI:3697895	Tg(Lck-Sox13)#Jskg	MP:0000715,decreased thymocyte number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0009541,increased thymocyte apoptosis
MGI:3776805	Tg(Lck-Stat5b*)1Mafa	MP:0005154,increased B cell proliferation|MP:0008211,decreased mature B cell number
MGI:4943694	Tg(Lck-Stk17b)26.1Wals	MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000715,decreased thymocyte number|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004952,increased spleen weight|MP:0005091,increased double-positive T cell number|MP:0005348,increased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0008687,increased interleukin-2 secretion|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number
MGI:3528080	Tg(Lck-Tal1)4709Led	MP:0000420,ruffled hair|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0001263,weight loss|MP:0001954,respiratory distress|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0009320,increased lymphoblastic lymphoma incidence
MGI:5636649	Tg(Lck-Tax)53Hall	MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002024,increased T cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0005399,increased susceptibility to fungal infection|MP:0031058,hepatosplenomegaly
MGI:4850020	Tg(Lck-TNFSF13)3919Mhah	MP:0000689,abnormal spleen morphology|MP:0000693,spleen hyperplasia|MP:0002495,increased IgA level|MP:0002722,abnormal immune system organ morphology|MP:0004977,increased B-1 B cell number|MP:0005014,increased B cell number|MP:0005232,abnormal mesenteric lymph node morphology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008136,enlarged Peyer's patches|MP:0008466,enlarged mesenteric lymph nodes|MP:0008475,intermingled spleen red and white pulp|MP:0008783,decreased B cell apoptosis|MP:0010337,increased chronic lymphocytic leukemia incidence
MGI:3849832	Tg(Lck-Tnfsf14)24Yxf	MP:0000240,extramedullary hematopoiesis|MP:0000477,abnormal intestine morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000598,abnormal liver morphology|MP:0000693,spleen hyperplasia|MP:0001209,spontaneous skin ulceration|MP:0001552,increased circulating triglyceride level|MP:0001845,abnormal inflammatory response|MP:0001858,intestinal inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002444,abnormal T cell physiology|MP:0002493,increased IgG level|MP:0002495,increased IgA level|MP:0002743,glomerulonephritis|MP:0002816,colitis|MP:0002962,increased urine protein level|MP:0003306,small intestinal inflammation|MP:0003725,increased autoantibody level|MP:0004510,myositis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004952,increased spleen weight|MP:0005161,hematuria|MP:0005178,increased circulating cholesterol level|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005348,increased T cell proliferation|MP:0008102,lymph node hyperplasia|MP:0008828,abnormal lymph node cell ratio|MP:0008885,increased enterocyte apoptosis|MP:0011339,abnormal glomerular mesangium morphology|MP:0011566,abnormal complement protein level|MP:0020519,renal glomerular immunoglobulin deposits
MGI:4943308	Tg(Lck-Tnfsf15,-EGFP)#Targ	MP:0001212,skin lesions|MP:0002581,abnormal ileum morphology|MP:0002932,abnormal joint morphology|MP:0002936,joint swelling|MP:0003306,small intestinal inflammation|MP:0003449,abnormal intestine goblet cell morphology|MP:0005245,hemarthrosis|MP:0008566,increased interferon-gamma secretion|MP:0008681,increased interleukin-17 secretion|MP:0010835,increased CD4-positive, alpha-beta memory T cell number|MP:0010838,increased CD8-positive, alpha-beta memory T cell number|MP:0011748,intestinal fibrosis|MP:0013485,increased Paneth cell number|MP:0014083,blunted small intestinal villi
MGI:2388725	Tg(Lck-Tnfsf4)1Nish	MP:0000276,heart right ventricle hypertrophy|MP:0000484,abnormal pulmonary artery morphology|MP:0001175,abnormal lung morphology|MP:0001861,lung inflammation|MP:0003009,abnormal cytokine secretion|MP:0003025,increased vasoconstriction|MP:0003944,abnormal T cell subpopulation ratio|MP:0004973,increased regulatory T cell number|MP:0005348,increased T cell proliferation|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008672,increased interleukin-13 secretion|MP:0010758,increased right ventricle systolic pressure
MGI:3850496	Tg(Lck-Tslp)1Chea	MP:0000274,enlarged heart|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001209,spontaneous skin ulceration|MP:0001262,decreased body weight|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002461,increased immunoglobulin level|MP:0002743,glomerulonephritis|MP:0002871,albuminuria|MP:0002981,increased liver weight|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004952,increased spleen weight|MP:0005565,increased blood urea nitrogen level|MP:0005630,increased lung weight|MP:0008140,podocyte foot process effacement|MP:0011320,abnormal glomerular capillary morphology|MP:0011339,abnormal glomerular mesangium morphology|MP:0011353,expanded mesangial matrix|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011454,abnormal glomerular endothelium fenestra morphology|MP:0011508,abnormal glomerular capillary thrombosis|MP:0011512,mesangial cell interposition|MP:0011567,increased renal glomerulus lobularity|MP:0020519,renal glomerular immunoglobulin deposits
MGI:3819792	Tg(Lck-VIPR2)1Ejg	MP:0002497,increased IgE level|MP:0005011,increased eosinophil cell number|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008499,increased IgG1 level|MP:0008567,decreased interferon-gamma secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion
MGI:5509327	Tg(LCR-HBA2,LCR-HBB*)1Cos	MP:0000208,decreased hematocrit|MP:0000691,enlarged spleen|MP:0001265,decreased body size|MP:0001577,anemia|MP:0002447,abnormal erythrocyte morphology|MP:0003656,abnormal erythrocyte physiology|MP:0003717,pallor|MP:0003718,maternal effect|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1926596	Tg(LEF1)1Efu	MP:0000383,abnormal hair follicle orientation|MP:0000416,sparse hair|MP:0000426,ectopic hair growth|MP:0001274,curly vibrissae|MP:0010179,rough coat
MGI:4420245	Tg(Lfng*-LFNG)2Dihz	MP:0002083,premature death
MGI:5307226	Tg(Lgi1)#Mpan	MP:0002918,abnormal paired-pulse facilitation|MP:0003635,abnormal synaptic transmission|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008143,abnormal dendrite morphology|MP:0008960,abnormal axon pruning|MP:0011270,decreased excitatory postsynaptic current amplitude
MGI:5307228	Tg(Lgi1*)#Mpan	MP:0002206,abnormal CNS synaptic transmission|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003635,abnormal synaptic transmission|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004807,abnormal paired-pulse inhibition|MP:0008143,abnormal dendrite morphology|MP:0008960,abnormal axon pruning|MP:0009538,abnormal synapse morphology|MP:0011269,increased excitatory postsynaptic current amplitude
MGI:3606782	Tg(Lim2*G15V)1Rlc	MP:0001297,microphthalmia|MP:0001306,small lens|MP:0002579,disorganized secondary lens fibers|MP:0003237,abnormal lens epithelium morphology|MP:0003847,disorganized lens bow|MP:0010254,nuclear cataract|MP:0010263,total cataract
MGI:3510809	Tg(LIPC)6784His	MP:0000186,decreased circulating HDL cholesterol level|MP:0002644,decreased circulating triglyceride level|MP:0003981,decreased circulating phospholipid level
MGI:2450675	Tg(LIPG)1Tq	MP:0000186,decreased circulating HDL cholesterol level|MP:0004003,abnormal vascular endothelial cell physiology|MP:0005179,decreased circulating cholesterol level|MP:0005318,decreased triglyceride level|MP:0006084,abnormal circulating phospholipid level
MGI:5441745	Tg(LMNA*G608G)HClns	MP:0001926,female infertility|MP:0002080,prenatal lethality|MP:0005592,abnormal vascular smooth muscle morphology|MP:0010695,abnormal blood pressure regulation
MGI:5491077	Tg(Lmnb1)1Yfu	MP:0000743,muscle spasm|MP:0000745,tremors|MP:0000921,demyelination|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0002064,seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003382,straub tail|MP:0003631,nervous system phenotype|MP:0003871,abnormal myelin sheath morphology|MP:0003996,clonic seizures|MP:0005386,behavior/neurological phenotype|MP:0005405,axon degeneration|MP:0008414,abnormal spatial reference memory|MP:0008840,abnormal spike wave discharge|MP:0008917,abnormal oligodendrocyte physiology|MP:0010050,hypermyelination
MGI:5689425	Tg(LONP1-mt-ND4*,-mCherry*)#Jguy	MP:0001059,optic nerve atrophy|MP:0001264,increased body size|MP:0001326,retina degeneration|MP:0001330,abnormal optic nerve morphology|MP:0003631,nervous system phenotype|MP:0003674,oxidative stress|MP:0005241,abnormal retina ganglion layer morphology|MP:0005369,muscle phenotype|MP:0005385,cardiovascular system phenotype|MP:0005551,abnormal eye electrophysiology|MP:0006072,abnormal retina apoptosis|MP:0008067,retina ganglion cell degeneration|MP:0008259,abnormal optic disk morphology|MP:0008507,thin retina ganglion layer|MP:0008513,thin retina inner plexiform layer|MP:0010653,abnormal Wallerian degeneration|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0010959,abnormal oxidative phosphorylation
MGI:2445949	Tg(LPV-TAg121)2Tvd	MP:0000820,abnormal choroid plexus morphology|MP:0002038,increased carcinoma incidence
MGI:3699414	Tglq1<MRL/MpJ>	MP:0001552,increased circulating triglyceride level
MGI:3699417	Tglq2<SJL/J>	MP:0001552,increased circulating triglyceride level
MGI:3720143	Tglq3<RF/J>	MP:0002644,decreased circulating triglyceride level
MGI:3720145	Tglq4<NZB/BlNJ>	MP:0001552,increased circulating triglyceride level
MGI:3847810	Tg(LRRK2)1Cjli	MP:0005378,growth/size/body region phenotype|MP:0008260,abnormal autophagy|MP:0008493,alpha-synuclein inclusion body
MGI:4437427	Tg(Lrrk2)6Yue	MP:0002574,increased vertical activity|MP:0003631,nervous system phenotype|MP:0003858,enhanced coordination|MP:0004250,tau protein deposits|MP:0008921,increased neurotransmitter release|MP:0010540,long stride length|MP:0031391,increased locomotor activity
MGI:4942189	Tg(LRRK2*G2019S)1Cjli	MP:0008260,abnormal autophagy|MP:0008493,alpha-synuclein inclusion body
MGI:4460658	Tg(LRRK2*G2019S)1Mjfa	MP:0003651,abnormal axon extension|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0008415,abnormal neurite morphology|MP:0010768,mortality/aging
MGI:5502368	Tg(LRRK2*G2019S)2AMjff	MP:0004101,abnormal brain interneuron morphology|MP:0004102,abnormal dorsal striatum morphology
MGI:4437428	Tg(Lrrk2*G2019S)2Yue	MP:0001407,short stride length|MP:0003312,abnormal locomotor coordination|MP:0003444,abnormal neurotransmitter uptake|MP:0003631,nervous system phenotype|MP:0003990,decreased neurotransmitter release|MP:0005643,decreased dopamine level
MGI:4460657	Tg(LRRK2)WT1Mjfa	MP:0003631,nervous system phenotype
MGI:5008462	Tg(LRRK2*Y1699C)#aMjfa	MP:0003651,abnormal axon extension|MP:0008415,abnormal neurite morphology
MGI:3038496	Tgls1<KK/Ta>	MP:0002644,decreased circulating triglyceride level
MGI:3834461	Tg(Ly6a-BCR/ABL1)IS1AIsg	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0001175,abnormal lung morphology|MP:0002027,increased lung adenocarcinoma incidence|MP:0002083,premature death|MP:0002339,abnormal lymph node morphology|MP:0003606,kidney failure|MP:0003702,abnormal chromosome morphology|MP:0003789,increased osteosarcoma incidence|MP:0004952,increased spleen weight|MP:0005481,increased chronic myelocytic leukemia incidence|MP:0006262,increased testis tumor incidence|MP:0008476,increased spleen red pulp amount|MP:0010264,increased hepatoma incidence
MGI:3834463	Tg(Ly6a-BCR/ABL1)IS1BIsg	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0001175,abnormal lung morphology|MP:0002027,increased lung adenocarcinoma incidence|MP:0002083,premature death|MP:0002339,abnormal lymph node morphology|MP:0003606,kidney failure|MP:0003702,abnormal chromosome morphology|MP:0003789,increased osteosarcoma incidence|MP:0004952,increased spleen weight|MP:0005481,increased chronic myelocytic leukemia incidence|MP:0006262,increased testis tumor incidence|MP:0008476,increased spleen red pulp amount|MP:0010264,increased hepatoma incidence
MGI:5642051	Tg(Ly6a-GCSAM)102AIsg	MP:0000604,amyloidosis|MP:0000688,lymphoid hyperplasia|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001402,decreased locomotor activity|MP:0001492,abnormal pilomotor reflex|MP:0001846,increased inflammatory response|MP:0002083,premature death|MP:0002493,increased IgG level|MP:0004977,increased B-1 B cell number|MP:0004978,decreased B-1 B cell number|MP:0005154,increased B cell proliferation|MP:0005573,increased pulmonary respiratory rate|MP:0008136,enlarged Peyer's patches|MP:0008478,increased spleen white pulp amount
MGI:3822861	Tg(Ly6a-SET/NUP214)2969Gcg	MP:0000221,decreased leukocyte cell number|MP:0000511,abnormal intestinal mucosa morphology|MP:0002006,neoplasm|MP:0002123,abnormal definitive hematopoiesis|MP:0002144,abnormal B cell differentiation|MP:0005016,decreased lymphocyte cell number|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008782,increased B cell apoptosis|MP:0010792,abnormal stomach mucosa morphology|MP:0010799,stomach mucosa hyperplasia|MP:0013566,dilated gastric gland
MGI:3834479	Tg(Ly6a-TK,-BCR/ABL1)IS9AIsg	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0002083,premature death|MP:0005481,increased chronic myelocytic leukemia incidence
MGI:5432016	Tg(Ly6e-MALT1)#Isg	MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0003132,increased pre-B cell number|MP:0004809,increased hematopoietic stem cell number|MP:0008186,increased pro-B cell number|MP:0008210,increased mature B cell number
MGI:5429340	Tg(LYZ-rtTA2S*M2,tetO-ELAVL1)632Dkon	MP:0003447,decreased tumor growth/size|MP:0004502,decreased incidence of tumors by chemical induction|MP:0008539,decreased susceptibility to induced colitis
MGI:5694939	Tg<m1Anu>	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation
MGI:5806301	Tg<m1Btlr>	MP:0001262,decreased body weight
MGI:2179115	Tgm1<tm1Kfyn>	MP:0001190,reddish skin|MP:0001198,tight skin|MP:0001211,wrinkled skin|MP:0001216,abnormal epidermal layer morphology|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001429,dehydration|MP:0001436,abnormal suckling behavior|MP:0001438,aphagia|MP:0002796,impaired skin barrier function|MP:0011087,neonatal lethality, complete penetrance
MGI:5806302	Tg<m2Btlr>	MP:0001262,decreased body weight
MGI:3527996	Tgm2<tm1.1Rmgr>	MP:0001260,increased body weight|MP:0002444,abnormal T cell physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0014698,decreased fibroblast adhesion
MGI:2180638	Tgm2<tm1Gml>	MP:0000208,decreased hematocrit|MP:0000343,abnormal response to cardiac infarction|MP:0000703,abnormal thymus morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001559,hyperglycemia|MP:0001798,impaired macrophage phagocytosis|MP:0002083,premature death|MP:0002190,disorganized myocardium|MP:0002727,decreased circulating insulin level|MP:0002875,decreased erythrocyte cell number|MP:0002891,increased insulin sensitivity|MP:0003037,increased myocardial infarct size|MP:0003721,increased tumor growth/size|MP:0005293,impaired glucose tolerance|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005425,increased macrophage cell number|MP:0006110,ventricular fibrillation|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport
MGI:4868708	Tgm2<tm1Syki>	MP:0005166,decreased susceptibility to injury
MGI:5521582	Tgm2<tm2.1Rmgr>	MP:0005376,homeostasis/metabolism phenotype
MGI:6200223	Tg<m3Btlr>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002492,decreased IgE level|MP:0002764,short tibia|MP:0003109,short femur|MP:0003961,decreased lean body mass|MP:0004509,abnormal pelvic girdle bone morphology|MP:0005017,decreased B cell number|MP:0008537,increased susceptibility to induced colitis|MP:0014143,decreased body fat mass
MGI:5141395	Tgm3<m1Btlr>	MP:0000410,waved hair
MGI:5617797	Tgm3<tm1b(KOMP)Wtsi>	MP:0002135,abnormal kidney morphology
MGI:5436399	Tgm3<tm1Sjo>	MP:0000396,increased curvature of hairs|MP:0000402,abnormal zigzag hair morphology|MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0001280,loss of vibrissae|MP:0002074,abnormal hair texture|MP:0002098,abnormal vibrissa morphology|MP:0002796,impaired skin barrier function|MP:0003809,abnormal hair shaft morphology|MP:0003810,abnormal hair cuticle|MP:0003848,brittle hair|MP:0005501,abnormal skin physiology|MP:0008538,decreased zigzag hair amount|MP:0009441,delayed skin barrier formation|MP:0009801,abnormal hair cortex keratinization
MGI:1856269	Tgm3<we>	MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0009351,thin hair shaft
MGI:2182248	Tgm3<we-4J>	MP:0000410,waved hair|MP:0001274,curly vibrissae
MGI:6285492	Tg<m4Btlr>	MP:0001262,decreased body weight|MP:0002497,increased IgE level|MP:0005017,decreased B cell number|MP:0005425,increased macrophage cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008167,increased B-1a cell number|MP:0008207,decreased B-2 B cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0012764,increased alpha-beta T cell number|MP:0013279,increased fasting circulating glucose level
MGI:4362984	Tgm4<tm1a(KOMP)Wtsi>	MP:0000242,impaired fertilization|MP:0003698,abnormal male reproductive system physiology|MP:0030983,failure of copulatory plug deposition
MGI:6285496	Tg<M5Btlr>	MP:0010841,increased central memory CD4-positive, alpha-beta T cell number
MGI:4451573	Tgm5<tm2a(KOMP)Wtsi>	MP:0010771,integument phenotype
MGI:6285500	Tg<m6Btlr>	MP:0012764,increased alpha-beta T cell number
MGI:6508555	Tgm6<em1Bge>	MP:0002412,increased susceptibility to bacterial infection
MGI:4841076	Tgm6<tm1a(KOMP)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0003960,increased lean body mass|MP:0005292,improved glucose tolerance|MP:0005419,decreased circulating serum albumin level
MGI:5804114	Tg(Mafg-Nfe2l1)1Mym	MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002981,increased liver weight|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0009171,enlarged pancreatic islets|MP:0009642,abnormal blood homeostasis|MP:0020089,increased susceptibility to diet-induced non-insulin dependent diabetes|MP:0030565,decreased circulating ammonia level
MGI:5804124	Tg(Mafg-Nfe2l1)6Mym	MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0002981,increased liver weight|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0009171,enlarged pancreatic islets|MP:0020089,increased susceptibility to diet-induced non-insulin dependent diabetes
MGI:5052111	Tg(Mapt-MAPT*)#Hanr	MP:0001363,increased anxiety-related response|MP:0001463,abnormal spatial learning|MP:0002152,abnormal brain morphology|MP:0002207,abnormal long-term potentiation|MP:0002920,decreased paired-pulse facilitation|MP:0003214,neurofibrillary tangles|MP:0003354,astrocytosis|MP:0004250,tau protein deposits|MP:0005386,behavior/neurological phenotype|MP:0008432,abnormal long-term spatial reference memory
MGI:5293607	Tg(MAPT*V337M)1Gds	MP:0001364,decreased anxiety-related response|MP:0001441,increased grooming behavior|MP:0001447,abnormal nest building behavior|MP:0002206,abnormal CNS synaptic transmission|MP:0002912,abnormal excitatory postsynaptic potential|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0014372,decreased miniature excitatory postsynaptic current amplitude|MP:0020551,abnormal postsynaptic density morphology
MGI:5528809	Tg(Mbp-Cadm4*)#Pele	MP:0000755,hindlimb paralysis|MP:0000920,abnormal myelination|MP:0001405,impaired coordination|MP:0003871,abnormal myelin sheath morphology|MP:0008814,decreased nerve conduction velocity|MP:0010050,hypermyelination|MP:0010734,abnormal paranode morphology
MGI:3702029	Tg(Mbp-cre,CAG-EGFP)53Masa	MP:0010768,mortality/aging
MGI:4888711	Tg(Mbp-MAPT/lacZ)#aCaw	MP:0002169,no abnormal phenotype detected
MGI:4459094	Tg(Mbp-Pad2)28Fgm	MP:0000745,tremors|MP:0000746,weakness|MP:0000921,demyelination|MP:0000947,convulsive seizures|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0002182,abnormal astrocyte morphology|MP:0002730,head shaking|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0003871,abnormal myelin sheath morphology|MP:0008752,abnormal tumor necrosis factor level
MGI:5634092	Tg(Mbp-SNCA)1Ema	MP:0000745,tremors|MP:0000921,demyelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0001405,impaired coordination|MP:0001516,abnormal motor coordination/balance|MP:0001847,brain inflammation|MP:0002182,abnormal astrocyte morphology|MP:0002229,neurodegeneration|MP:0003354,astrocytosis|MP:0005404,abnormal axon morphology|MP:0008415,abnormal neurite morphology|MP:0008493,alpha-synuclein inclusion body|MP:0008872,abnormal physiological response to xenobiotic
MGI:5634090	Tg(Mbp-SNCA)29Ema	MP:0000745,tremors|MP:0000780,abnormal corpus callosum morphology|MP:0000921,demyelination|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001516,abnormal motor coordination/balance|MP:0002064,seizures|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0002566,abnormal sexual interaction|MP:0003242,loss of basal ganglia neurons|MP:0003354,astrocytosis|MP:0005404,abnormal axon morphology|MP:0006035,abnormal mitochondrial morphology|MP:0008143,abnormal dendrite morphology|MP:0008415,abnormal neurite morphology|MP:0008493,alpha-synuclein inclusion body|MP:0008547,abnormal neocortex morphology|MP:0011630,increased mitochondrial size|MP:0011633,abnormal mitochondrial shape|MP:0011635,abnormal mitochondrial crista morphology
MGI:3837662	Tg(Mc2r-Arntl)1Kyki	MP:0003963,abnormal corticosterone level|MP:0005345,abnormal circulating corticosterone level|MP:0020467,abnormal circadian behavior|MP:0020479,abnormal circadian hormone homeostasis
MGI:3771477	Tg(Mc4r-MAPT/Sapphire)21Rck	MP:0002169,no abnormal phenotype detected
MGI:3505550	Tg(MCL1)8Caig	MP:0000240,extramedullary hematopoiesis|MP:0000693,spleen hyperplasia|MP:0000714,increased thymocyte number|MP:0002024,increased T cell derived lymphoma incidence|MP:0002412,increased susceptibility to bacterial infection|MP:0002442,abnormal leukocyte physiology|MP:0003135,increased erythroid progenitor cell number|MP:0005022,abnormal immature B cell morphology|MP:0005462,abnormal mast cell differentiation|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0006414,decreased T cell apoptosis|MP:0008112,abnormal monocyte differentiation|MP:0008478,increased spleen white pulp amount|MP:0008783,decreased B cell apoptosis|MP:0009317,increased follicular lymphoma incidence|MP:0009341,decreased splenocyte apoptosis|MP:0011073,abnormal macrophage apoptosis|MP:0012431,increased lymphoma incidence
MGI:4834475	Tg(Mcpt8-cre)1Voeh	MP:0001876,decreased inflammatory response|MP:0002607,decreased basophil cell number|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:2182249	Tg(Mdm2)1Snj	MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002036,increased rhabdomyosarcoma incidence|MP:0002041,increased pituitary adenoma incidence|MP:0003667,increased hemangiosarcoma incidence|MP:0009308,increased adenocarcinoma incidence|MP:0012431,increased lymphoma incidence
MGI:3815540	Tg(MECP2)1Hzo	MP:0000160,kyphosis|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001469,abnormal contextual conditioning behavior|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0002083,premature death|MP:0002574,increased vertical activity|MP:0002919,enhanced paired-pulse facilitation|MP:0003008,enhanced long-term potentiation|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0003858,enhanced coordination|MP:0003963,abnormal corticosterone level|MP:0003996,clonic seizures|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004792,abnormal synaptic vesicle number|MP:0004997,increased CNS synapse formation|MP:0005655,increased aggression|MP:0010748,abnormal visual evoked potential|MP:0011269,increased excitatory postsynaptic current amplitude|MP:0011831,abnormal visual contrast sensitivity|MP:0011832,abnormal visual acuity
MGI:3815541	Tg(MECP2)3Hzo	MP:0000160,kyphosis|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001513,limb grasping|MP:0002082,postnatal lethality|MP:0005655,increased aggression
MGI:5491039	Tg(MECP2*G273X/GFP)AHzo	MP:0002169,no abnormal phenotype detected
MGI:5491036	Tg(MECP2*R270X/GFP)AHzo	MP:0002169,no abnormal phenotype detected
MGI:3055098	Tg(MGMT)3Bec	MP:0002051,increased skin papilloma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0004502,decreased incidence of tumors by chemical induction
MGI:5770240	Tg(Mir125a)#Smoc	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0008567,decreased interferon-gamma secretion
MGI:3778684	Tg(Mitf-cre)7114Gsb	MP:0001262,decreased body weight|MP:0001297,microphthalmia
MGI:2384160	Tg(ML5sHEL)5Ccg	MP:0005416,abnormal circulating protein level|MP:0008744,abnormal B cell anergy|MP:0008747,abnormal T cell anergy
MGI:5603751	Tg(MMTV-Akt1)1173Stma	MP:0006271,abnormal involution of the mammary gland
MGI:3836060	Tg(MMTV-AURKA)#Cxd	MP:0000630,mammary gland hyperplasia|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001884,mammary gland alveolar hyperplasia|MP:0001885,mammary gland duct hyperplasia|MP:0002676,uterus hyperplasia|MP:0004025,polyploidy|MP:0008000,increased ovary tumor incidence|MP:0009504,abnormal mammary gland epithelium morphology|MP:0010294,increased kidney tumor incidence
MGI:3621189	Tg(MMTV-CCND1)1Esmp	MP:0001883,increased mammary adenocarcinoma incidence|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0006262,increased testis tumor incidence|MP:0006422,increased mammary adenoacanthoma incidence|MP:0010299,increased mammary gland tumor incidence
MGI:3505709	Tg(MMTV-Cdc37)1Stp	MP:0000628,abnormal mammary gland development|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002020,increased tumor incidence|MP:0006422,increased mammary adenoacanthoma incidence|MP:0012431,increased lymphoma incidence
MGI:3802909	Tg(MMTV-Cdc37)2Stp	MP:0000628,abnormal mammary gland development|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0006422,increased mammary adenoacanthoma incidence|MP:0012431,increased lymphoma incidence
MGI:2176165	Tg(MMTV-cre)1Mam	MP:0003718,maternal effect|MP:0006270,abnormal mammary gland growth during lactation
MGI:2176166	Tg(MMTV-cre)4Mam	MP:0003718,maternal effect|MP:0006270,abnormal mammary gland growth during lactation
MGI:4453858	Tg(MMTV-cre)FMam	MP:0003718,maternal effect|MP:0006270,abnormal mammary gland growth during lactation
MGI:5698356	Tg(MMTV-DMTF1_i2)7Kai	MP:0000630,mammary gland hyperplasia|MP:0012570,increased mammary gland tumor incidence in breeding females
MGI:4835241	Tg(MMTV-ENPP2)20Gbm	MP:0000627,abnormal mammary gland morphology|MP:0001883,increased mammary adenocarcinoma incidence|MP:0012570,increased mammary gland tumor incidence in breeding females
MGI:4835242	Tg(MMTV-ENPP2)21Gbm	MP:0001883,increased mammary adenocarcinoma incidence|MP:0012570,increased mammary gland tumor incidence in breeding females
MGI:4835240	Tg(MMTV-ENPP2)#Gbm	MP:0001883,increased mammary adenocarcinoma incidence|MP:0012570,increased mammary gland tumor incidence in breeding females|MP:0013148,mastitis
MGI:3039039	Tg(MMTV-Erbb2)10Pjo	MP:0000691,enlarged spleen|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001922,reduced male fertility|MP:0002750,exophthalmos|MP:0002997,enlarged seminal vesicle|MP:0004931,enlarged epididymis|MP:0008476,increased spleen red pulp amount|MP:0010318,increased salivary gland tumor incidence|MP:0012437,increased Harderian gland tumor incidence
MGI:3047089	Tg(MMTV-Erbb2)12Pjo	MP:0000691,enlarged spleen|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001922,reduced male fertility|MP:0002997,enlarged seminal vesicle|MP:0004931,enlarged epididymis|MP:0008476,increased spleen red pulp amount|MP:0010318,increased salivary gland tumor incidence
MGI:3039531	Tg(MMTV-Erbb2)17Pjo	MP:0000691,enlarged spleen|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001922,reduced male fertility|MP:0008476,increased spleen red pulp amount
MGI:3039042	Tg(MMTV-Erbb2)1Pv	MP:0001883,increased mammary adenocarcinoma incidence
MGI:5527316	Tg(MMTV-ERBB2)5Erick	MP:0001272,increased metastatic potential|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002750,exophthalmos|MP:0010299,increased mammary gland tumor incidence|MP:0013446,enlarged Harderian gland|MP:0013538,increased Harderian gland adenoma incidence
MGI:3047079	Tg(MMTV-Erbb2)9Pjo	MP:0000691,enlarged spleen|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001922,reduced male fertility|MP:0002997,enlarged seminal vesicle|MP:0004931,enlarged epididymis|MP:0008476,increased spleen red pulp amount
MGI:5883855	Tg(MMTV-ERBB2*)#Arbs	MP:0005379,endocrine/exocrine gland phenotype
MGI:4361017	Tg(MMTV-Erbb2*,-cre)1Mul	MP:0000627,abnormal mammary gland morphology|MP:0010299,increased mammary gland tumor incidence|MP:0010308,decreased tumor latency
MGI:5013830	Tg(MMTV-ERBB2*,-luc)6157Aami	MP:0001883,increased mammary adenocarcinoma incidence|MP:0010299,increased mammary gland tumor incidence
MGI:5013906	Tg(MMTV-ERBB2*,-luc)6177Aami	MP:0010299,increased mammary gland tumor incidence
MGI:5013907	Tg(MMTV-ERBB2*,-luc)6180Aami	MP:0001382,abnormal nursing|MP:0003718,maternal effect|MP:0010299,increased mammary gland tumor incidence|MP:0014237,decreased tumor-free survival time
MGI:3039244	Tg(MMTV-Erbb2)NA1Mul	MP:0001883,increased mammary adenocarcinoma incidence|MP:0001925,male infertility|MP:0004933,abnormal epididymis epithelium morphology|MP:0009531,increased parotid gland size
MGI:3050875	Tg(MMTV-Erbb2)NB1Mul	MP:0001925,male infertility|MP:0004933,abnormal epididymis epithelium morphology
MGI:3793949	Tg(MMTV-Erbb2*)NDL2-5Mul	MP:0010299,increased mammary gland tumor incidence
MGI:3050869	Tg(MMTV-Erbb2)NF1Mul	MP:0001382,abnormal nursing|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001922,reduced male fertility|MP:0003452,abnormal parotid gland morphology|MP:0004933,abnormal epididymis epithelium morphology|MP:0009531,increased parotid gland size
MGI:3050871	Tg(MMTV-Erbb2)NK1Mul	MP:0001883,increased mammary adenocarcinoma incidence|MP:0005389,reproductive system phenotype|MP:0009828,increased tumor latency|MP:0010299,increased mammary gland tumor incidence
MGI:2448360	Tg(MMTV-ERBB3)1Slg	MP:0002027,increased lung adenocarcinoma incidence|MP:0004499,increased incidence of tumors by chemical induction
MGI:5637741	Tg(MMTV-Espl1)1Pati	MP:0000630,mammary gland hyperplasia|MP:0001883,increased mammary adenocarcinoma incidence|MP:0003702,abnormal chromosome morphology|MP:0004024,aneuploidy|MP:0006271,abnormal involution of the mammary gland|MP:0008866,chromosomal instability|MP:0012570,increased mammary gland tumor incidence in breeding females
MGI:3717765	Tg(MMTV-KLF4)1Rup	MP:0001243,abnormal dermal layer morphology|MP:0002060,abnormal skin morphology
MGI:5827748	Tg(MMTV-KRAS*G12V)3025Mrl	MP:0001272,increased metastatic potential|MP:0001326,retina degeneration|MP:0001883,increased mammary adenocarcinoma incidence
MGI:4835232	Tg(MMTV-LPAR1)27Gbm	MP:0001883,increased mammary adenocarcinoma incidence|MP:0012570,increased mammary gland tumor incidence in breeding females
MGI:4835230	Tg(MMTV-LPAR1)2Gbm	MP:0001883,increased mammary adenocarcinoma incidence|MP:0012570,increased mammary gland tumor incidence in breeding females|MP:0013148,mastitis
MGI:4835231	Tg(MMTV-LPAR1)7Gbm	MP:0000627,abnormal mammary gland morphology|MP:0001883,increased mammary adenocarcinoma incidence|MP:0012570,increased mammary gland tumor incidence in breeding females|MP:0013148,mastitis
MGI:4835229	Tg(MMTV-LPAR1)#Gbm	MP:0001272,increased metastatic potential|MP:0001883,increased mammary adenocarcinoma incidence|MP:0012570,increased mammary gland tumor incidence in breeding females|MP:0013148,mastitis
MGI:4835234	Tg(MMTV-LPAR2)3Gbm	MP:0001883,increased mammary adenocarcinoma incidence|MP:0012570,increased mammary gland tumor incidence in breeding females|MP:0013148,mastitis
MGI:4835235	Tg(MMTV-LPAR2)6Gbm	MP:0000627,abnormal mammary gland morphology|MP:0001883,increased mammary adenocarcinoma incidence|MP:0012570,increased mammary gland tumor incidence in breeding females|MP:0013148,mastitis
MGI:4835233	Tg(MMTV-LPAR2)#Gbm	MP:0001272,increased metastatic potential|MP:0001883,increased mammary adenocarcinoma incidence|MP:0012570,increased mammary gland tumor incidence in breeding females|MP:0013148,mastitis
MGI:4835239	Tg(MMTV-LPAR3)22Gbm	MP:0001883,increased mammary adenocarcinoma incidence|MP:0012570,increased mammary gland tumor incidence in breeding females
MGI:4835238	Tg(MMTV-LPAR3)3Gbm	MP:0000627,abnormal mammary gland morphology|MP:0001883,increased mammary adenocarcinoma incidence|MP:0012570,increased mammary gland tumor incidence in breeding females|MP:0013148,mastitis
MGI:4835236	Tg(MMTV-LPAR3)#Gbm	MP:0001272,increased metastatic potential|MP:0001883,increased mammary adenocarcinoma incidence|MP:0012570,increased mammary gland tumor incidence in breeding females|MP:0013148,mastitis
MGI:2447500	Tg(MMTV-Myc)141-3Led	MP:0001152,increased Leydig cell number|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence
MGI:5524082	Tg(MMTV-Myc*T58A)TA14Jrn	MP:0000628,abnormal mammary gland development|MP:0001883,increased mammary adenocarcinoma incidence|MP:0010299,increased mammary gland tumor incidence
MGI:5524144	Tg(MMTV-Myc*T58A)TA39Jrn	MP:0010299,increased mammary gland tumor incidence
MGI:5524083	Tg(MMTV-Myc*T58A)TA41Jrn	MP:0001883,increased mammary adenocarcinoma incidence|MP:0010299,increased mammary gland tumor incidence
MGI:5524080	Tg(MMTV-Myc)WT13Jrn	MP:0000628,abnormal mammary gland development|MP:0001272,increased metastatic potential|MP:0001883,increased mammary adenocarcinoma incidence|MP:0010299,increased mammary gland tumor incidence
MGI:5524081	Tg(MMTV-Myc)WT21Jrn	MP:0001272,increased metastatic potential|MP:0001883,increased mammary adenocarcinoma incidence|MP:0010299,increased mammary gland tumor incidence
MGI:5762986	Tg(MMTV-NCOA3)#Mybr	MP:0000627,abnormal mammary gland morphology|MP:0000630,mammary gland hyperplasia|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001272,increased metastatic potential|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001885,mammary gland duct hyperplasia|MP:0002027,increased lung adenocarcinoma incidence|MP:0002035,increased leiomyosarcoma incidence|MP:0002041,increased pituitary adenoma incidence|MP:0004702,increased circulating insulin-like growth factor I level|MP:0006271,abnormal involution of the mammary gland|MP:0009503,abnormal mammary gland duct morphology|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009506,abnormal mammary gland alveolus morphology|MP:0010172,abnormal mammary gland epithelium physiology|MP:0010174,decreased mammary gland epithelial cell proliferation|MP:0010299,increased mammary gland tumor incidence
MGI:1930204	Tg(MMTVneu)202Mul	MP:0001272,increased metastatic potential|MP:0001883,increased mammary adenocarcinoma incidence|MP:0010299,increased mammary gland tumor incidence
MGI:3761163	Tg(MMTV-neu/OT-I/OT-II)CBnel	MP:0008014,increased lung tumor incidence|MP:0010299,increased mammary gland tumor incidence
MGI:3847925	Tg(MMTV-NFKBIA*S32A*S36A)13Mka	MP:0001882,abnormal lactation|MP:0006269,abnormal mammary gland growth during pregnancy
MGI:1930200	Tg(MMTV-Notch4)3Rnc	MP:0000621,increased salivary adenocarcinoma incidence|MP:0000627,abnormal mammary gland morphology|MP:0000628,abnormal mammary gland development|MP:0001272,increased metastatic potential|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001885,mammary gland duct hyperplasia|MP:0001925,male infertility|MP:0002163,abnormal gland morphology|MP:0002687,oligozoospermia|MP:0003452,abnormal parotid gland morphology|MP:0004035,abnormal sublingual gland morphology|MP:0004931,enlarged epididymis|MP:0004933,abnormal epididymis epithelium morphology|MP:0008969,abnormal nasolacrimal duct morphology|MP:0009517,abnormal salivary gland duct morphology|MP:0009523,submandibular gland hyperplasia|MP:0010249,lactation failure|MP:0013443,Harderian gland hyperplasia
MGI:4834855	Tg(MMTV-PTGS2)#Thla	MP:0000628,abnormal mammary gland development|MP:0000630,mammary gland hyperplasia|MP:0001883,increased mammary adenocarcinoma incidence|MP:0006271,abnormal involution of the mammary gland|MP:0009308,increased adenocarcinoma incidence|MP:0009508,increased mammary gland ductal carcinoma incidence
MGI:2679595	Tg(MMTV-PyVT)634Mul	MP:0000627,abnormal mammary gland morphology|MP:0001272,increased metastatic potential|MP:0001273,decreased metastatic potential|MP:0001883,increased mammary adenocarcinoma incidence|MP:0003448,abnormal tumor morphology|MP:0003721,increased tumor growth/size|MP:0005630,increased lung weight|MP:0010249,lactation failure|MP:0010269,decreased mammary gland tumor incidence|MP:0010299,increased mammary gland tumor incidence
MGI:3525504	Tg(MMTV-PyVT)#Mul	MP:0000691,enlarged spleen|MP:0001272,increased metastatic potential|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002339,abnormal lymph node morphology|MP:0002444,abnormal T cell physiology|MP:0004973,increased regulatory T cell number|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0008553,increased circulating tumor necrosis factor level|MP:0008826,abnormal splenic cell ratio|MP:0008828,abnormal lymph node cell ratio|MP:0009335,decreased splenocyte proliferation|MP:0009338,increased splenocyte number|MP:0010210,abnormal circulating cytokine level|MP:0013663,increased myeloid cell number
MGI:3614339	Tg(MMTV-PyVT*Y250F)250-2Mul	MP:0001883,increased mammary adenocarcinoma incidence|MP:0001884,mammary gland alveolar hyperplasia
MGI:3614340	Tg(MMTV-PyVT*Y315F*Y322F)Db-1Mul	MP:0000630,mammary gland hyperplasia|MP:0001883,increased mammary adenocarcinoma incidence|MP:0014126,increased mammary gland apoptosis
MGI:3511875	Tg(MMTV-rtTA)1Lach	MP:0005389,reproductive system phenotype
MGI:6313626	Tg(MMTV-Scgb1a1)#Abm	MP:0002495,increased IgA level|MP:0005325,abnormal renal glomerulus morphology
MGI:3040319	Tg(MMTVTGFA)254Rjc	MP:0000630,mammary gland hyperplasia|MP:0000652,enlarged sebaceous gland|MP:0001191,abnormal skin condition|MP:0001382,abnormal nursing|MP:0001883,increased mammary adenocarcinoma incidence
MGI:3051514	Tg(MMTVTGFA)257Rjc	MP:0000627,abnormal mammary gland morphology
MGI:3040871	Tg(MMTVTGFA)29Rjc	MP:0000630,mammary gland hyperplasia|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001382,abnormal nursing|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001884,mammary gland alveolar hyperplasia|MP:0001885,mammary gland duct hyperplasia|MP:0004207,increased squamous cell carcinoma incidence|MP:0005379,endocrine/exocrine gland phenotype|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0009506,abnormal mammary gland alveolus morphology|MP:0010299,increased mammary gland tumor incidence
MGI:3043578	Tg(MMTVTGFA)64Rjc	MP:0000627,abnormal mammary gland morphology|MP:0001382,abnormal nursing|MP:0010299,increased mammary gland tumor incidence
MGI:3040376	Tg(MMTVTGFB1)46Hlm	MP:0000627,abnormal mammary gland morphology|MP:0000662,abnormal branching of the mammary ductal tree|MP:0002006,neoplasm|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005379,endocrine/exocrine gland phenotype|MP:0009505,abnormal mammary gland lobule morphology|MP:0013781,abnormal mammary gland luminal epithelium morphology
MGI:2429406	Tg(MMTV-TGFBR2)7Hlm	MP:0001882,abnormal lactation|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001884,mammary gland alveolar hyperplasia|MP:0003344,mammary gland hypoplasia|MP:0006270,abnormal mammary gland growth during lactation|MP:0006271,abnormal involution of the mammary gland|MP:0013716,hypolactation
MGI:2447530	Tg(MMTV-vHaras)SH1Led	MP:0001272,increased metastatic potential|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002038,increased carcinoma incidence|MP:0010299,increased mammary gland tumor incidence
MGI:6198713	Tg(Mnx1-Mfn2*T105M,-EGFP)1Dcc	MP:0000556,abnormal hindlimb morphology|MP:0000572,abnormal autopod morphology|MP:0000585,kinked tail|MP:0000592,short tail|MP:0000747,muscle weakness|MP:0000937,abnormal motor neuron morphology|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0002111,abnormal tail morphology|MP:0004263,abnormal limb posture|MP:0005371,limbs/digits/tail phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0010240,decreased skeletal muscle size
MGI:5006860	Tg(Mov1/Tyr)OVE876BPay	MP:0001354,increased aggression towards male mice|MP:0001360,abnormal social investigation|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001496,audiogenic seizures|MP:0001529,abnormal vocalization|MP:0002175,decreased brain weight|MP:0002635,reduced sensorimotor gating|MP:0002738,hyperresponsive to tactile stimuli|MP:0005366,variegated coat color|MP:0005376,homeostasis/metabolism phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0005394,taste/olfaction phenotype|MP:0005409,darkened coat color|MP:0009142,decreased prepulse inhibition
MGI:5698210	Tg(Mpdz)1Kb	MP:0009776,decreased behavioral withdrawal response
MGI:2447694	Tg(Mpz)80.2Wra	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001924,infertility|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0003861,abnormal nervous system development|MP:0003871,abnormal myelin sheath morphology|MP:0008814,decreased nerve conduction velocity|MP:0010053,decreased grip strength|MP:0013438,dysmyelination|MP:0020253,increased collagen level|MP:0020452,abnormal axon radial sorting
MGI:2447696	Tg(Mpz)80.3Wra	MP:0000745,tremors|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging|MP:0013438,dysmyelination
MGI:2447698	Tg(Mpz)80.4Wra	MP:0000745,tremors|MP:0002083,premature death|MP:0008814,decreased nerve conduction velocity|MP:0013438,dysmyelination
MGI:2384592	Tg(Mpz)88.1Mfel	MP:0000745,tremors|MP:0000747,muscle weakness|MP:0000921,demyelination|MP:0002269,muscular atrophy|MP:0003871,abnormal myelin sheath morphology|MP:0005405,axon degeneration|MP:0008814,decreased nerve conduction velocity|MP:0012674,tomacula|MP:0013438,dysmyelination
MGI:2384593	Tg(Mpz)88.2Mfel	MP:0000745,tremors|MP:0000747,muscle weakness|MP:0000921,demyelination|MP:0002269,muscular atrophy|MP:0003871,abnormal myelin sheath morphology|MP:0004924,abnormal behavior|MP:0005405,axon degeneration|MP:0012674,tomacula|MP:0013438,dysmyelination
MGI:2384594	Tg(Mpz)88.4Mfel	MP:0000745,tremors|MP:0000747,muscle weakness|MP:0003871,abnormal myelin sheath morphology|MP:0008814,decreased nerve conduction velocity|MP:0012674,tomacula|MP:0013438,dysmyelination
MGI:5427464	Tg(Mpz-RAF1/ESR1)A668Ayld	MP:0000219,increased neutrophil cell number|MP:0000249,abnormal blood vessel physiology|MP:0000324,increased mast cell number|MP:0000572,abnormal autopod morphology|MP:0000746,weakness|MP:0000921,demyelination|MP:0001405,impaired coordination|MP:0001524,impaired limb coordination|MP:0001846,increased inflammatory response|MP:0005015,increased T cell number|MP:0005425,increased macrophage cell number|MP:0011904,abnormal Schwann cell physiology|MP:0011906,increased Schwann cell proliferation
MGI:5824059	Tg(Mpz*S63C)32Mes	MP:0000745,tremors|MP:0000746,weakness|MP:0000921,demyelination|MP:0001393,ataxia|MP:0002269,muscular atrophy|MP:0003633,abnormal nervous system physiology|MP:0013438,dysmyelination
MGI:5824061	Tg(Mpz*S63C)33Mes	MP:0000745,tremors|MP:0000746,weakness|MP:0000921,demyelination|MP:0001393,ataxia|MP:0002269,muscular atrophy|MP:0003633,abnormal nervous system physiology|MP:0003871,abnormal myelin sheath morphology|MP:0013438,dysmyelination
MGI:5824055	Tg(Mpz*S63X)30Mes	MP:0000745,tremors|MP:0000746,weakness|MP:0000921,demyelination|MP:0001393,ataxia|MP:0002269,muscular atrophy|MP:0003633,abnormal nervous system physiology|MP:0013438,dysmyelination
MGI:5824056	Tg(Mpz*S63X)31Mes	MP:0000745,tremors|MP:0000746,weakness|MP:0000921,demyelination|MP:0001393,ataxia|MP:0002269,muscular atrophy|MP:0003633,abnormal nervous system physiology|MP:0013438,dysmyelination
MGI:2448148	Tg(Msmb-TAg)183-2Xuan	MP:0000702,enlarged lymph nodes|MP:0001167,prostate gland epithelial hyperplasia|MP:0001272,increased metastatic potential|MP:0002038,increased carcinoma incidence|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0009828,increased tumor latency
MGI:2448149	Tg(Msmb-TAg)186-3Xuan	MP:0001167,prostate gland epithelial hyperplasia|MP:0002020,increased tumor incidence|MP:0002038,increased carcinoma incidence|MP:0009828,increased tumor latency
MGI:5475005	Tg(Msr1-MMP9)#Apar	MP:0001876,decreased inflammatory response|MP:0001958,emphysema|MP:0002451,abnormal macrophage physiology|MP:0005387,immune system phenotype|MP:0010899,abnormal pulmonary alveolar system morphology
MGI:3690133	Tg(MSR1-Plau)1Ddi	MP:0000274,enlarged heart|MP:0001853,heart inflammation|MP:0003141,cardiac fibrosis
MGI:1926388	Tg(Msx2)1Rem	MP:0000081,premature cranial suture closure|MP:0000367,abnormal coat/ hair morphology|MP:0000377,abnormal hair follicle morphology|MP:0000383,abnormal hair follicle orientation|MP:0000384,distorted hair follicle pattern|MP:0000387,disorganized inner root sheath cells|MP:0000389,disorganized outer root sheath cells|MP:0000390,disorganized matrix sheath cells|MP:0000417,short hair|MP:0000418,focal hair loss|MP:0001192,scaly skin|MP:0001195,flaky skin|MP:0001200,thick skin|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001230,epidermal desquamation|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001235,disorganized suprabasal layer|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0001251,dermis papillary layer hypercellularity|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002102,abnormal ear morphology|MP:0003809,abnormal hair shaft morphology|MP:0009612,thick epidermis suprabasal layer|MP:0010681,abnormal hair follicle bulb morphology|MP:0010685,abnormal hair follicle inner root sheath morphology|MP:0010686,abnormal hair follicle matrix region morphology|MP:0010689,thin hair follicle outer root sheath|MP:0014166,ectopic cranial bone
MGI:4834774	Tg(Msx2-En1)86Alj	MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000557,absent hindlimb|MP:0000559,abnormal femur morphology|MP:0000561,adactyly|MP:0000562,polydactyly|MP:0000568,ectopic digits|MP:0000572,abnormal autopod morphology|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0004359,short ulna|MP:0004360,absent ulna|MP:0004374,bowed radius|MP:0005108,abnormal ulna morphology|MP:0005430,absent fibula|MP:0006280,abnormal digit development
MGI:3811642	Tg(Msx2-nog)14Blh	MP:0000377,abnormal hair follicle morphology|MP:0000416,sparse hair|MP:0001284,absent vibrissae|MP:0001923,reduced female fertility|MP:0002109,abnormal limb morphology|MP:0003809,abnormal hair shaft morphology|MP:0003811,abnormal hair cortex morphology|MP:0003812,abnormal hair medulla|MP:0003813,abnormal hair follicle dermal papilla morphology|MP:0008731,abnormal hair shaft melanin granule morphology
MGI:5546503	Tg(Msx2-rtTA)885Lma	MP:0002169,no abnormal phenotype detected
MGI:5546504	Tg(Msx2-rtTA)888Lma	MP:0000410,waved hair|MP:0000571,interdigital webbing|MP:0001274,curly vibrissae|MP:0001282,short vibrissae|MP:0002544,brachydactyly|MP:0005650,abnormal limb bud morphology|MP:0010768,mortality/aging
MGI:3052794	Tg(Mt1)174Bri	MP:0000192,abnormal mineral level|MP:0000343,abnormal response to cardiac infarction|MP:0001670,abnormal intestinal mineral absorption|MP:0003038,decreased myocardial infarct size|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:3814577	Tg(MT1A-Dyrk1a)33Xest	MP:0001463,abnormal spatial learning|MP:0008414,abnormal spatial reference memory
MGI:3814575	Tg(MT1A-Dyrk1a)#Xest	MP:0001364,decreased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0003313,abnormal locomotor activation|MP:0004807,abnormal paired-pulse inhibition|MP:0004924,abnormal behavior|MP:0031391,increased locomotor activity
MGI:3639358	Tg(Mt1a-GPHB5)1Sok	MP:0001262,decreased body weight|MP:0002750,exophthalmos|MP:0004696,abnormal thyroid follicle morphology|MP:0004697,abnormal thyroid follicular cell morphology|MP:0005477,increased circulating thyroxine level|MP:0008288,abnormal adrenal cortex morphology
MGI:3695614	Tg(Mt1-Crry)26Quig	MP:0001845,abnormal inflammatory response|MP:0002136,abnormal kidney physiology
MGI:4941025	Tg(Mt1-GH1)#Jjk	MP:0001260,increased body weight|MP:0001625,cardiac hypertrophy|MP:0002176,increased brain weight|MP:0002191,abnormal artery morphology|MP:0002833,increased heart weight|MP:0002981,increased liver weight|MP:0003917,increased kidney weight|MP:0005449,abnormal food intake|MP:0005459,decreased percent body fat/body weight|MP:0005668,decreased circulating leptin level|MP:0006144,increased systemic arterial systolic blood pressure|MP:0030968,decreased circulating adiponectin level
MGI:3050880	Tg(Mt1-Hgf)19Lmb	MP:0000755,hindlimb paralysis|MP:0001188,hyperpigmentation|MP:0001272,increased metastatic potential|MP:0002006,neoplasm|MP:0002083,premature death|MP:0003270,intestinal obstruction|MP:0003606,kidney failure|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0009389,abnormal extracutaneous pigmentation|MP:0009784,abnormal melanoblast migration|MP:0010037,ectopic melanocytes|MP:0010056,ectopic skeletal muscle|MP:0010275,increased melanoma incidence|MP:0010300,increased skin tumor incidence|MP:0010322,increased cutaneous melanoma incidence
MGI:3050885	Tg(Mt1-Hgf)37Lmb	MP:0001188,hyperpigmentation|MP:0002083,premature death|MP:0003270,intestinal obstruction|MP:0003606,kidney failure
MGI:3579068	Tg(Mt1-Hgf)#Lmb	MP:0001188,hyperpigmentation|MP:0001272,increased metastatic potential|MP:0001923,reduced female fertility|MP:0002340,abnormal axillary lymph node morphology|MP:0002353,abnormal inguinal lymph node morphology|MP:0004499,increased incidence of tumors by chemical induction|MP:0011278,increased ear pigmentation|MP:0014660,increased skin nevi incidence|MP:0030051,increased foot pigmentation
MGI:5302421	Tg(Mt1-IL6)28Gci	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000322,increased granulocyte number|MP:0000599,enlarged liver|MP:0000604,amyloidosis|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001263,weight loss|MP:0001505,hunched posture|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002493,increased IgG level|MP:0002599,increased mean platelet volume|MP:0002705,dilated renal tubule|MP:0002962,increased urine protein level|MP:0003606,kidney failure|MP:0003828,pulmonary edema|MP:0004969,pale kidney|MP:0005264,glomerulosclerosis|MP:0005565,increased blood urea nitrogen level|MP:0008097,increased plasma cell number|MP:0008254,increased megakaryocyte cell number|MP:0008499,increased IgG1 level|MP:0008524,increased plasmacytoid dendritic cell number|MP:0008596,increased circulating interleukin-6 level|MP:0011346,renal tubule atrophy|MP:0011353,expanded mesangial matrix|MP:0011363,renal glomerulus atrophy|MP:0031234,increased circulating serum amyloid protein level
MGI:3848828	Tg(Mt1-LDLR)93-4Reh	MP:0000183,decreased circulating LDL cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:3039777	Tg(Mt1-RET)304Ina	MP:0001188,hyperpigmentation|MP:0001272,increased metastatic potential|MP:0002083,premature death|MP:0010275,increased melanoma incidence|MP:0010322,increased cutaneous melanoma incidence
MGI:4430625	Tg(Mt1-rPRL)Jto	MP:0001346,abnormal lacrimal gland morphology|MP:0005248,abnormal Harderian gland morphology|MP:0013476,abnormal Harderian gland porphyrin secretion
MGI:3040323	Tg(Mt1-Tgfa)147Bri	MP:0000630,mammary gland hyperplasia|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002083,premature death|MP:0006271,abnormal involution of the mammary gland|MP:0010299,increased mammary gland tumor incidence
MGI:3040606	Tg(Mt1-Tgfa)149Bri	MP:0009152,increased pancreatic intraepithelial neoplasia incidence
MGI:5806465	Tg(Mt1-TGFBR2*)AM3Epb	MP:0001869,pancreas inflammation|MP:0001944,abnormal pancreas morphology|MP:0002693,abnormal pancreas physiology|MP:0003334,pancreas fibrosis|MP:0005220,abnormal exocrine pancreas morphology|MP:0009109,decreased pancreas weight|MP:0009143,abnormal pancreatic duct morphology|MP:0009145,abnormal pancreatic acinus morphology|MP:0009147,abnormal pancreatic acinar cell physiology|MP:0009155,pancreatic acinar hyperplasia|MP:0013221,pancreatic acinar-to-ductal metaplasia
MGI:3626317	Tg(Mt1-Tnfsf4)1Pgn	MP:0005339,increased susceptibility to atherosclerosis|MP:0005376,homeostasis/metabolism phenotype
MGI:3653040	Tg(Mt1-Tnfsf4)2Pgn	MP:0005339,increased susceptibility to atherosclerosis|MP:0005376,homeostasis/metabolism phenotype
MGI:3710006	Tg(MT2A-Myc)#Misu	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0004852,decreased testis weight|MP:0005159,azoospermia
MGI:3620964	Tg(MT2A-TGFBR2)4Rser	MP:0000069,kyphoscoliosis|MP:0000137,abnormal vertebrae morphology|MP:0000157,abnormal sternum morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000163,abnormal cartilage morphology|MP:0000556,abnormal hindlimb morphology|MP:0000558,abnormal tibia morphology|MP:0000997,abnormal synovial joint capsule morphology|MP:0002020,increased tumor incidence|MP:0002932,abnormal joint morphology|MP:0003195,calcinosis|MP:0003200,calcified joint|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003560,osteoarthritis|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004320,split sternum|MP:0004609,vertebral fusion|MP:0004678,split xiphoid process|MP:0005508,abnormal skeleton morphology|MP:0006395,abnormal epiphyseal plate morphology|MP:0006433,abnormal articular cartilage morphology|MP:0013304,osteophytes
MGI:3621366	Tg(MT2A-TGFBR2)#Rser	MP:0000266,abnormal heart morphology|MP:0000350,abnormal cell proliferation|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0004485,increased response of heart to induced stress|MP:0005140,decreased cardiac muscle contractility|MP:0011925,abnormal heart echocardiography feature
MGI:3040889	Tg(MtTGFA)100Lmb	MP:0000627,abnormal mammary gland morphology|MP:0001883,increased mammary adenocarcinoma incidence|MP:0003334,pancreas fibrosis|MP:0006271,abnormal involution of the mammary gland|MP:0010299,increased mammary gland tumor incidence
MGI:2388567	Tg(MtTGFA)42Lmb	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0000628,abnormal mammary gland development|MP:0001260,increased body weight|MP:0001944,abnormal pancreas morphology|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003334,pancreas fibrosis|MP:0003675,kidney cyst|MP:0003917,increased kidney weight|MP:0003985,renal fibrosis|MP:0005387,immune system phenotype|MP:0008019,increased liver tumor incidence|MP:0010069,increased serotonin level|MP:0011294,renal glomerulus hypertrophy|MP:0011339,abnormal glomerular mesangium morphology|MP:0011353,expanded mesangial matrix|MP:0011427,increased mesangial cell number|MP:0012575,increased noradrenaline level|MP:0020427,increased hepatocyte karyomegaly
MGI:3800163	Tg(MtTGFA)Lmb	MP:0001944,abnormal pancreas morphology|MP:0003334,pancreas fibrosis|MP:0005215,abnormal pancreatic islet morphology|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009152,increased pancreatic intraepithelial neoplasia incidence|MP:0013221,pancreatic acinar-to-ductal metaplasia
MGI:3054048	Tg(MtTPRMET)243Lng	MP:0001884,mammary gland alveolar hyperplasia|MP:0002032,increased sarcoma incidence|MP:0003789,increased osteosarcoma incidence|MP:0010299,increased mammary gland tumor incidence|MP:0012431,increased lymphoma incidence
MGI:3054636	Tg(MtTPRMET)773Lng	MP:0001884,mammary gland alveolar hyperplasia|MP:0002032,increased sarcoma incidence|MP:0010299,increased mammary gland tumor incidence
MGI:3777621	Tg(MUC1)79.24Gend	MP:0001800,abnormal humoral immune response|MP:0002020,increased tumor incidence|MP:0002493,increased IgG level|MP:0002494,increased IgM level
MGI:5781013	Tg(Mup3-Plau)350-2Eps	MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0001573,abnormal circulating alanine transaminase level|MP:0001654,hepatic necrosis|MP:0001860,liver inflammation|MP:0002628,hepatic steatosis|MP:0002941,increased circulating alanine transaminase level|MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003333,liver fibrosis|MP:0003887,increased hepatocyte apoptosis|MP:0005141,liver hyperplasia|MP:0005385,cardiovascular system phenotype|MP:0008019,increased liver tumor incidence|MP:0008560,increased tumor necrosis factor secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0009355,increased liver triglyceride level|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0010027,increased liver cholesterol level|MP:0010359,increased liver free fatty acids level|MP:0013848,subcutaneous edema
MGI:2447666	Tg(Mx1-IL11)1Tku	MP:0004149,increased bone strength|MP:0005605,increased bone mass|MP:0008271,abnormal bone ossification|MP:0010878,increased trabecular bone volume|MP:0013623,increased femur compact bone thickness|MP:0020011,increased bone mineral density of femur
MGI:3793714	Tg(Myh6*)131Lnwd	MP:0000266,abnormal heart morphology|MP:0001625,cardiac hypertrophy|MP:0002625,heart left ventricle hypertrophy
MGI:3793715	Tg(Myh6*)140Lnwd	MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002625,heart left ventricle hypertrophy|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0004566,myocardial fiber degeneration|MP:0005140,decreased cardiac muscle contractility|MP:0005592,abnormal vascular smooth muscle morphology|MP:0010551,abnormal coronary vessel morphology|MP:0012106,impaired exercise endurance
MGI:7327134	Tg(Myh6-1810058I24Rik)#Eno	MP:0000266,abnormal heart morphology|MP:0001625,cardiac hypertrophy|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0003674,oxidative stress|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0005608,cardiac interstitial fibrosis|MP:0005630,increased lung weight|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006138,congestive heart failure|MP:0011925,abnormal heart echocardiography feature
MGI:3793766	Tg(Myh6*)1Lnwd	MP:0000266,abnormal heart morphology|MP:0002190,disorganized myocardium|MP:0002624,abnormal tricuspid valve morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0004215,abnormal myocardial fiber physiology|MP:0010551,abnormal coronary vessel morphology|MP:0010620,thick mitral valve|MP:0011925,abnormal heart echocardiography feature|MP:0020409,abnormal cardiac thrombosis|MP:0020419,decreased cardiac muscle relaxation
MGI:5569629	Tg(Myh6-2A)#Know	MP:0000278,abnormal myocardial fiber morphology|MP:0001853,heart inflammation|MP:0002795,dilated cardiomyopathy|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0004121,abnormal sarcolemma morphology|MP:0005324,ascites|MP:0005608,cardiac interstitial fibrosis|MP:0006267,abnormal intercalated disk morphology|MP:0008725,increased heart atrium size|MP:0008772,increased heart ventricle size|MP:0010334,pleural effusion|MP:0011925,abnormal heart echocardiography feature|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014730,abnormal myocardial fiber myofibril morphology|MP:0031633,decreased heart left ventricle muscle contractility
MGI:6459902	Tg(Myh6-ACE2)1Rbre	MP:0000278,abnormal myocardial fiber morphology|MP:0000807,abnormal hippocampus morphology|MP:0001656,focal hepatic necrosis|MP:0002083,premature death|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005608,cardiac interstitial fibrosis|MP:0008770,decreased survivor rate|MP:0014730,abnormal myocardial fiber myofibril morphology
MGI:6459903	Tg(Myh6-ACE2)2Rbre	MP:0000278,abnormal myocardial fiber morphology|MP:0000807,abnormal hippocampus morphology|MP:0001656,focal hepatic necrosis|MP:0002083,premature death|MP:0003896,prolonged PR interval|MP:0004116,abnormal atrioventricular bundle conduction|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005608,cardiac interstitial fibrosis|MP:0006110,ventricular fibrillation|MP:0008770,decreased survivor rate|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0010392,prolonged QRS complex duration|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010519,atrioventricular block|MP:0010553,prolonged HV interval|MP:0014730,abnormal myocardial fiber myofibril morphology
MGI:3639514	Tg(Myh6-Acsl1)J3Jesc	MP:0000274,enlarged heart|MP:0002625,heart left ventricle hypertrophy|MP:0002953,thick ventricular wall|MP:0003822,decreased left ventricle systolic pressure|MP:0005598,decreased heart ventricle muscle contractility|MP:0006138,congestive heart failure
MGI:3639516	Tg(Myh6-Acsl1)M13Jesc	MP:0000274,enlarged heart|MP:0002083,premature death|MP:0002625,heart left ventricle hypertrophy|MP:0002953,thick ventricular wall|MP:0003822,decreased left ventricle systolic pressure|MP:0005598,decreased heart ventricle muscle contractility|MP:0006138,congestive heart failure
MGI:3639517	Tg(Myh6-Acsl1)O7Jesc	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001547,abnormal lipid level|MP:0001575,cyanosis|MP:0001625,cardiac hypertrophy|MP:0001951,abnormal breathing pattern|MP:0002083,premature death|MP:0002625,heart left ventricle hypertrophy|MP:0002953,thick ventricular wall|MP:0003222,increased cardiomyocyte apoptosis|MP:0003822,decreased left ventricle systolic pressure|MP:0004777,abnormal phospholipid level|MP:0005202,lethargy|MP:0005330,cardiomyopathy|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006138,congestive heart failure|MP:0031418,increased cardiac muscle triglyceride level
MGI:7642226	Tg(Myh6-Actc1dt)2Kwan	MP:0001625,cardiac hypertrophy|MP:0004564,increased myocardial fiber size|MP:0004567,decreased myocardial fiber number|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0031217,increased susceptibility to myocardial ischemic injury
MGI:5906238	Tg(Myh6-ACTC1*E361G)361.20Sbm	MP:0002795,dilated cardiomyopathy|MP:0004215,abnormal myocardial fiber physiology|MP:0004486,decreased response of heart to induced stress|MP:0005598,decreased heart ventricle muscle contractility|MP:0010394,decreased QRS amplitude|MP:0011925,abnormal heart echocardiography feature|MP:0020419,decreased cardiac muscle relaxation
MGI:5543406	Tg(Myh6-ACTC1*E99K)#Sbm	MP:0000274,enlarged heart|MP:0001263,weight loss|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002625,heart left ventricle hypertrophy|MP:0002795,dilated cardiomyopathy|MP:0003137,abnormal impulse conducting system conduction|MP:0003393,decreased cardiac output|MP:0003819,increased left ventricle diastolic pressure|MP:0004084,abnormal cardiac muscle relaxation|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006065,abnormal heart position or orientation|MP:0006138,congestive heart failure|MP:0008543,atrial fibrillation|MP:0008725,increased heart atrium size|MP:0010334,pleural effusion|MP:0011952,decreased cardiac stroke volume|MP:0031131,myocardial fiber disarray
MGI:5313511	Tg(Myh6-Actc1*R312H)307Iko	MP:0000274,enlarged heart|MP:0001544,abnormal cardiovascular system physiology|MP:0002083,premature death|MP:0002626,increased heart rate|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0004215,abnormal myocardial fiber physiology|MP:0004566,myocardial fiber degeneration|MP:0005140,decreased cardiac muscle contractility|MP:0010394,decreased QRS amplitude|MP:0031645,increased myocardial fiber apoptosis
MGI:3689094	Tg(Myh6-Adra1a)A1A1Rmgr	MP:0002083,premature death|MP:0002626,increased heart rate|MP:0003141,cardiac fibrosis|MP:0003821,decreased left ventricle diastolic pressure|MP:0004084,abnormal cardiac muscle relaxation|MP:0005599,increased cardiac muscle contractility|MP:0010394,decreased QRS amplitude|MP:0031635,increased heart left ventricle muscle contractility
MGI:3689095	Tg(Myh6-Adra1a)A1A4Rmgr	MP:0002083,premature death|MP:0003141,cardiac fibrosis|MP:0004566,myocardial fiber degeneration|MP:0031635,increased heart left ventricle muscle contractility|MP:0031645,increased myocardial fiber apoptosis
MGI:6193703	Tg(Myh6-ADRB1)4Mjlo	MP:0000266,abnormal heart morphology|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002626,increased heart rate|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005324,ascites|MP:0005599,increased cardiac muscle contractility|MP:0006138,congestive heart failure|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0031633,decreased heart left ventricle muscle contractility
MGI:2389028	Tg(Myh6-ADRBK1)12Wjk	MP:0001629,abnormal heart rate|MP:0003819,increased left ventricle diastolic pressure
MGI:2389030	Tg(Myh6-ADRBK1)27Wjk	MP:0003819,increased left ventricle diastolic pressure|MP:0003820,increased left ventricle systolic pressure|MP:0005599,increased cardiac muscle contractility
MGI:3664306	Tg(Myh6-Agtr1a)4-7Vjd	MP:0000275,heart hyperplasia|MP:0002833,increased heart weight|MP:0003137,abnormal impulse conducting system conduction|MP:0003896,prolonged PR interval|MP:0005333,decreased heart rate|MP:0008725,increased heart atrium size|MP:0010392,prolonged QRS complex duration|MP:0010519,atrioventricular block|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3836606	Tg(Myh6-AIP/PLN*)46Jded	MP:0001625,cardiac hypertrophy|MP:0002626,increased heart rate|MP:0002833,increased heart weight|MP:0003105,abnormal heart atrium morphology|MP:0003141,cardiac fibrosis|MP:0003819,increased left ventricle diastolic pressure|MP:0003820,increased left ventricle systolic pressure|MP:0004084,abnormal cardiac muscle relaxation|MP:0005294,abnormal heart ventricle morphology|MP:0005333,decreased heart rate|MP:0005630,increased lung weight|MP:0006138,congestive heart failure|MP:0008726,increased heart left atrium size|MP:0010579,increased heart left ventricle size
MGI:3639137	Tg(Myh6-Akt1)20Anr	MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0002953,thick ventricular wall|MP:0003038,decreased myocardial infarct size
MGI:3639127	Tg(Myh6-Akt1)564Anr	MP:0001625,cardiac hypertrophy|MP:0004564,increased myocardial fiber size
MGI:3639116	Tg(Myh6-Akt1*T308D*S473D)1Siz	MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002953,thick ventricular wall|MP:0004564,increased myocardial fiber size|MP:0005608,cardiac interstitial fibrosis|MP:0031633,decreased heart left ventricle muscle contractility
MGI:7571599	Tg(Myh6-ANKRD1)#Camm	MP:0000267,abnormal heart development|MP:0000278,abnormal myocardial fiber morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002128,abnormal blood circulation|MP:0002972,abnormal cardiac muscle contractility|MP:0003105,abnormal heart atrium morphology|MP:0003141,cardiac fibrosis|MP:0003228,abnormal sinus venosus morphology|MP:0003922,abnormal heart right atrium morphology|MP:0004063,dilated heart left atrium|MP:0004225,patent cardiac foramen ovale|MP:0005140,decreased cardiac muscle contractility|MP:0005294,abnormal heart ventricle morphology|MP:0005385,cardiovascular system phenotype|MP:0008022,dilated heart ventricle|MP:0010425,abnormal heart and great vessel attachment|MP:0010440,anomalous pulmonary venous connection|MP:0011925,abnormal heart echocardiography feature|MP:0012082,delayed heart development|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0031607,abnormal fetal cardiomyocyte mitochondrial morphology|MP:0031613,fetal cardiomyocyte disarray
MGI:5897329	Tg(Myh6-Atp1a1)1Jmol	MP:0005385,cardiovascular system phenotype
MGI:5897332	Tg(Myh6-Atp1a2)1Jmol	MP:0000278,abnormal myocardial fiber morphology|MP:0004486,decreased response of heart to induced stress|MP:0005631,decreased lung weight|MP:0012688,abnormal heart ventricles weight
MGI:6324028	Tg(Myh6-BAG3*P209L)#Mswi	MP:0000266,abnormal heart morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0001853,heart inflammation|MP:0003719,abnormal pericyte morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004564,increased myocardial fiber size|MP:0004937,dilated heart|MP:0005140,decreased cardiac muscle contractility|MP:0011628,increased mitochondrial number|MP:0011631,decreased mitochondrial size|MP:0011925,abnormal heart echocardiography feature|MP:0020419,decreased cardiac muscle relaxation
MGI:6828808	Tg(Myh6-Bclaf1)#Cya	MP:0003037,increased myocardial infarct size|MP:0003222,increased cardiomyocyte apoptosis|MP:0005140,decreased cardiac muscle contractility|MP:0011971,increased circulating lactate dehydrogenase level
MGI:3850088	Tg(Myh6-BRUNOL4*)10Coop	MP:0001175,abnormal lung morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0004007,abnormal lung vasculature morphology|MP:0004011,decreased diastolic filling velocity|MP:0004063,dilated heart left atrium|MP:0004566,myocardial fiber degeneration|MP:0005140,decreased cardiac muscle contractility|MP:0005630,increased lung weight|MP:0008028,pregnancy-related premature death
MGI:5904804	Tg(Myh6-CACNA1C)M1Aschw	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0001785,edema|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0003828,pulmonary edema|MP:0003921,abnormal heart left ventricle morphology|MP:0005324,ascites|MP:0005599,increased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006138,congestive heart failure|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010724,thick interventricular septum|MP:0020135,abnormal heart ventricle wall thickness|MP:0020346,abnormal myocardial fiber calcium currents|MP:0020418,increased cardiac muscle relaxation|MP:0031645,increased myocardial fiber apoptosis
MGI:4399096	Tg(Myh6-Camk2d)1Jhb	MP:0000274,enlarged heart|MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0005140,decreased cardiac muscle contractility|MP:0011915,increased heart left atrium weight|MP:0011925,abnormal heart echocardiography feature|MP:0012557,decreased calcium uptake by cardiac muscle|MP:0020419,decreased cardiac muscle relaxation
MGI:3530237	Tg(Myh6-Camk2d)1Xdfu	MP:0002795,dilated cardiomyopathy|MP:0002972,abnormal cardiac muscle contractility
MGI:6276066	Tg(Myh6-Camk2d_ic)#Jhb	MP:0002626,increased heart rate|MP:0003137,abnormal impulse conducting system conduction|MP:0003233,prolonged QT interval|MP:0005402,abnormal action potential|MP:0006138,congestive heart failure|MP:0008950,ventricular tachycardia|MP:0010392,prolonged QRS complex duration|MP:0010511,shortened PR interval|MP:0020347,abnormal myocardial fiber sodium currents
MGI:6276041	Tg(Myh6-Camk2d_ic)LJhb	MP:0000274,enlarged heart|MP:0001625,cardiac hypertrophy|MP:0001785,edema|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0003140,dilated heart atrium|MP:0003141,cardiac fibrosis|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0010018,pulmonary vascular congestion|MP:0010334,pleural effusion|MP:0011925,abnormal heart echocardiography feature
MGI:6276040	Tg(Myh6-Camk2d_ic)MJhb	MP:0000274,enlarged heart|MP:0001625,cardiac hypertrophy|MP:0001785,edema|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0003140,dilated heart atrium|MP:0003141,cardiac fibrosis|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0010018,pulmonary vascular congestion|MP:0010334,pleural effusion|MP:0011925,abnormal heart echocardiography feature
MGI:3696706	Tg(Myh6-Camta2)1Eno	MP:0000274,enlarged heart|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0006138,congestive heart failure
MGI:7614263	Tg(Myh6-Cand1)1Zpan	MP:0004486,decreased response of heart to induced stress
MGI:2389055	Tg(Myh6-CASQ2)1Mord	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0001784,abnormal fluid regulation|MP:0001943,abnormal respiration|MP:0002083,premature death|MP:0002626,increased heart rate|MP:0002795,dilated cardiomyopathy|MP:0002953,thick ventricular wall|MP:0003141,cardiac fibrosis|MP:0003822,decreased left ventricle systolic pressure|MP:0003921,abnormal heart left ventricle morphology|MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004231,abnormal calcium ion homeostasis|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0005598,decreased heart ventricle muscle contractility|MP:0011925,abnormal heart echocardiography feature|MP:0020419,decreased cardiac muscle relaxation|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4437429	Tg(Myh6-Cast)1Gwd	MP:0000278,abnormal myocardial fiber morphology|MP:0001629,abnormal heart rate|MP:0002795,dilated cardiomyopathy|MP:0003921,abnormal heart left ventricle morphology|MP:0005333,decreased heart rate|MP:0005598,decreased heart ventricle muscle contractility|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3710498	Tg(Myh6-Ccna2)58Djw	MP:0000274,enlarged heart|MP:0000275,heart hyperplasia|MP:0000278,abnormal myocardial fiber morphology|MP:0002833,increased heart weight|MP:0004565,decreased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0006321,increased myocardial fiber number
MGI:3710407	Tg(Myh6-Ccnd1)#Ljf	MP:0000278,abnormal myocardial fiber morphology|MP:0002833,increased heart weight|MP:0004215,abnormal myocardial fiber physiology|MP:0006321,increased myocardial fiber number
MGI:3710481	Tg(Myh6-Ccnd2)1Ljf	MP:0000343,abnormal response to cardiac infarction|MP:0002833,increased heart weight|MP:0003038,decreased myocardial infarct size|MP:0004215,abnormal myocardial fiber physiology
MGI:3710483	Tg(Myh6-Ccnd3)1Ljf	MP:0002833,increased heart weight|MP:0004215,abnormal myocardial fiber physiology
MGI:7529395	Tg(Myh6-Cirpil)1Zpan	MP:0031216,decreased susceptibility to myocardial ischemic injury
MGI:2386742	Tg(Myh6-cre)2182Mds	MP:0005385,cardiovascular system phenotype
MGI:4360273	Tg(Myh6-CREB1*S133A)1Jml	MP:0000275,heart hyperplasia|MP:0000278,abnormal myocardial fiber morphology|MP:0001654,hepatic necrosis|MP:0001785,edema|MP:0001855,abnormal atrial thrombosis|MP:0001954,respiratory distress|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002972,abnormal cardiac muscle contractility|MP:0003140,dilated heart atrium|MP:0003821,decreased left ventricle diastolic pressure|MP:0003822,decreased left ventricle systolic pressure|MP:0003921,abnormal heart left ventricle morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005048,abnormal thrombosis|MP:0005202,lethargy|MP:0005324,ascites|MP:0006263,decreased systemic arterial diastolic blood pressure|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0008022,dilated heart ventricle|MP:0008772,increased heart ventricle size|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009418,cardiac muscle atrophy|MP:0010019,liver vascular congestion|MP:0010563,increased heart right ventricle size|MP:0010579,increased heart left ventricle size|MP:0010754,abnormal heart left ventricle pressure|MP:0014605,dark liver|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5496902	Tg(Myh6-cre)TG9Pjay	MP:0001785,edema|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0005140,decreased cardiac muscle contractility|MP:0005324,ascites|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0010018,pulmonary vascular congestion|MP:0010334,pleural effusion|MP:0031645,increased myocardial fiber apoptosis
MGI:3795718	Tg(Myh6-Cryab*R120G)708Rbns	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002837,dystrophic cardiac calcinosis|MP:0004091,abnormal Z line morphology|MP:0004564,increased myocardial fiber size|MP:0004937,dilated heart|MP:0005140,decreased cardiac muscle contractility|MP:0005324,ascites|MP:0006138,congestive heart failure|MP:0010018,pulmonary vascular congestion|MP:0010019,liver vascular congestion|MP:0010334,pleural effusion|MP:0013848,subcutaneous edema|MP:0020419,decreased cardiac muscle relaxation
MGI:6103872	Tg(Myh6-CRYAB*R120G)7302Ijb	MP:0001625,cardiac hypertrophy|MP:0001785,edema|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0004215,abnormal myocardial fiber physiology|MP:0005202,lethargy|MP:0005329,abnormal myocardium layer morphology|MP:0005330,cardiomyopathy|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0011593,increased catalase activity|MP:0011602,increased glutathione peroxidase activity|MP:0012606,increased glutathione level|MP:0020044,increased glucose-6-phosphate dehydrogenase activity
MGI:3851346	Tg(Myh6-CYP2J2)#Dcz	MP:0000343,abnormal response to cardiac infarction
MGI:3795722	Tg(Myh6-Des)520Rbns	MP:0002169,no abnormal phenotype detected
MGI:3795721	Tg(Myh6-Des*)641Rbns	MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0003819,increased left ventricle diastolic pressure|MP:0004084,abnormal cardiac muscle relaxation|MP:0004091,abnormal Z line morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0011925,abnormal heart echocardiography feature|MP:0014730,abnormal myocardial fiber myofibril morphology|MP:0031633,decreased heart left ventricle muscle contractility
MGI:6315918	Tg(Myh6-DFFB)1Khu	MP:0004485,increased response of heart to induced stress
MGI:7642197	Tg(Myh6-Dyrk1b)#Yax	MP:0000274,enlarged heart|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0004484,abnormal response of heart to induced stress|MP:0005140,decreased cardiac muscle contractility|MP:0006036,abnormal mitochondrial physiology|MP:0010579,increased heart left ventricle size|MP:0010831,lethality, incomplete penetrance|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0021158,decreased heart left ventricle wall thickness|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5502606	Tg(Myh6-EGFP/AC3I)#Mean	MP:0000343,abnormal response to cardiac infarction|MP:0006043,decreased apoptosis|MP:0006142,abnormal sinoatrial node conduction|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:5908353	Tg(Myh6-EGFR*)9-12Iko	MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0004937,dilated heart|MP:0005136,decreased growth hormone level|MP:0005140,decreased cardiac muscle contractility|MP:0006138,congestive heart failure|MP:0009642,abnormal blood homeostasis|MP:0011925,abnormal heart echocardiography feature
MGI:3640671	Tg(Myh6-EP300)21Csk	MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0004564,increased myocardial fiber size|MP:0006138,congestive heart failure|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3640673	Tg(Myh6-EP300)39Csk	MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0004564,increased myocardial fiber size|MP:0006138,congestive heart failure|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5461578	Tg(Myh6-Erbb2)6Kaga	MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0002843,decreased systemic arterial blood pressure|MP:0003141,cardiac fibrosis|MP:0003393,decreased cardiac output|MP:0003921,abnormal heart left ventricle morphology|MP:0004070,abnormal P wave|MP:0004071,prolonged P wave|MP:0004485,increased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005329,abnormal myocardium layer morphology|MP:0005330,cardiomyopathy|MP:0005608,cardiac interstitial fibrosis|MP:0010392,prolonged QRS complex duration|MP:0010511,shortened PR interval|MP:0010546,abnormal subendocardium layer morphology|MP:0010633,myocardium hypertrophy
MGI:3826819	Tg(Myh6-F2r)18Nmk	MP:0000274,enlarged heart|MP:0001544,abnormal cardiovascular system physiology|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight
MGI:3826845	Tg(Myh6-F3)4Nmk	MP:0005385,cardiovascular system phenotype
MGI:5319192	Tg(Myh6-FKBP1A)4Shou	MP:0001636,irregular heartbeat|MP:0003137,abnormal impulse conducting system conduction|MP:0004071,prolonged P wave|MP:0004215,abnormal myocardial fiber physiology|MP:0005333,decreased heart rate|MP:0008726,increased heart left atrium size|MP:0008727,increased heart right atrium size|MP:0010392,prolonged QRS complex duration|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010519,atrioventricular block|MP:0010831,lethality, incomplete penetrance|MP:0011953,prolonged PQ interval
MGI:7382964	Tg(Myh6-GAL4)G#2Vmc	MP:0000274,enlarged heart|MP:0000676,abnormal body water content|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0008986,abnormal liver parenchyma morphology|MP:0010018,pulmonary vascular congestion|MP:0010334,pleural effusion
MGI:3581033	Tg(Myh6-GFP,MAP2K3)58Ywa	MP:0000278,abnormal myocardial fiber morphology|MP:0000280,thin ventricular wall|MP:0001544,abnormal cardiovascular system physiology|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002833,increased heart weight|MP:0003828,pulmonary edema|MP:0005608,cardiac interstitial fibrosis|MP:0008725,increased heart atrium size
MGI:3581034	Tg(Myh6-GFP,MAP2K6)8Ywa	MP:0001544,abnormal cardiovascular system physiology|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002833,increased heart weight|MP:0003828,pulmonary edema|MP:0004564,increased myocardial fiber size|MP:0005608,cardiac interstitial fibrosis|MP:0008725,increased heart atrium size
MGI:3688513	Tg(Myh6-Gja7)927Kaya	MP:0001636,irregular heartbeat|MP:0004215,abnormal myocardial fiber physiology
MGI:2654360	Tg(Myh6-Gnaq)25Gwd	MP:0001625,cardiac hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0003819,increased left ventricle diastolic pressure|MP:0003921,abnormal heart left ventricle morphology|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0010724,thick interventricular septum|MP:0031633,decreased heart left ventricle muscle contractility
MGI:2654383	Tg(Myh6-Gnaq)40Gwd	MP:0002083,premature death
MGI:4430394	Tg(Myh6-Gnaq)#Gwd	MP:0000274,enlarged heart|MP:0002082,postnatal lethality|MP:0003222,increased cardiomyocyte apoptosis|MP:0003921,abnormal heart left ventricle morphology|MP:0004937,dilated heart|MP:0005140,decreased cardiac muscle contractility|MP:0005294,abnormal heart ventricle morphology|MP:0006138,congestive heart failure
MGI:5905048	Tg(Myh6-Gnaq*Q209L)44Ejne	MP:0000278,abnormal myocardial fiber morphology|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0005608,cardiac interstitial fibrosis|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0008726,increased heart left atrium size|MP:0011917,increased heart right atrium weight|MP:0011925,abnormal heart echocardiography feature|MP:0012688,abnormal heart ventricles weight
MGI:5559165	Tg(Myh6-Gnaq*Q209L)52Ejne	MP:0001625,cardiac hypertrophy|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0003140,dilated heart atrium|MP:0003141,cardiac fibrosis|MP:0003393,decreased cardiac output|MP:0004564,increased myocardial fiber size|MP:0004566,myocardial fiber degeneration|MP:0005140,decreased cardiac muscle contractility|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005608,cardiac interstitial fibrosis|MP:0005630,increased lung weight|MP:0008022,dilated heart ventricle|MP:0010018,pulmonary vascular congestion|MP:0010019,liver vascular congestion|MP:0010581,abnormal atrium myocardial trabeculae morphology|MP:0010633,myocardium hypertrophy|MP:0011925,abnormal heart echocardiography feature|MP:0012687,abnormal heart atria weight|MP:0012688,abnormal heart ventricles weight
MGI:6105945	Tg(Myh6-Gnaq*Q209L/Esr1*)7Rzl	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001260,increased body weight|MP:0001263,weight loss|MP:0001270,distended abdomen|MP:0001511,disheveled coat|MP:0001785,edema|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0004084,abnormal cardiac muscle relaxation|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0011925,abnormal heart echocardiography feature|MP:0020346,abnormal myocardial fiber calcium currents
MGI:6343528	Tg(Myh6-Grem2)1Akh	MP:0001876,decreased inflammatory response|MP:0005385,cardiovascular system phenotype|MP:0005599,increased cardiac muscle contractility|MP:0008661,decreased interleukin-10 secretion|MP:0008838,decreased transforming growth factor beta level|MP:0031215,abnormal response to myocardial ischemic injury
MGI:5471797	Tg(Myh6-Gsk3b*)19Jusa	MP:0003037,increased myocardial infarct size|MP:0003038,decreased myocardial infarct size
MGI:5907885	Tg(Myh6-HBEGF)#Iko	MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0004564,increased myocardial fiber size|MP:0004566,myocardial fiber degeneration|MP:0004937,dilated heart|MP:0005140,decreased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0011925,abnormal heart echocardiography feature
MGI:3712794	Tg(Myh6-Hod)3Joe	MP:0000230,abnormal systemic arterial blood pressure|MP:0000274,enlarged heart|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002953,thick ventricular wall|MP:0003141,cardiac fibrosis|MP:0003819,increased left ventricle diastolic pressure|MP:0004564,increased myocardial fiber size|MP:0005294,abnormal heart ventricle morphology|MP:0006138,congestive heart failure
MGI:3664272	Tg(Myh6-Hoxb7)18Ssp	MP:0000078,abnormal supraoccipital bone morphology|MP:0000111,cleft palate|MP:0000150,abnormal rib morphology|MP:0004322,abnormal sternebra morphology|MP:0004608,abnormal cervical axis morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3664274	Tg(Myh6-Hoxb7)25Ssp	MP:0000078,abnormal supraoccipital bone morphology|MP:0000080,abnormal exoccipital bone morphology|MP:0002135,abnormal kidney morphology|MP:0004194,abnormal kidney pelvis morphology|MP:0010402,ventricular septal defect|MP:0011493,double ureter
MGI:5645783	Tg(Myh6-Htr2b)1Lum	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0002626,increased heart rate|MP:0002953,thick ventricular wall|MP:0003915,increased heart left ventricle weight|MP:0004564,increased myocardial fiber size|MP:0006035,abnormal mitochondrial morphology|MP:0006038,increased mitochondrial fission|MP:0006321,increased myocardial fiber number|MP:0010955,abnormal respiratory electron transport chain|MP:0010959,abnormal oxidative phosphorylation|MP:0011628,increased mitochondrial number|MP:0011633,abnormal mitochondrial shape|MP:0011925,abnormal heart echocardiography feature
MGI:3630343	Tg(Myh6-IGF1)34Pia	MP:0000274,enlarged heart|MP:0000275,heart hyperplasia|MP:0001260,increased body weight|MP:0002176,increased brain weight|MP:0002833,increased heart weight|MP:0002981,increased liver weight|MP:0003917,increased kidney weight|MP:0004952,increased spleen weight
MGI:3630255	Tg(Myh6-IGF1R)7Jmcm	MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0003820,increased left ventricle systolic pressure|MP:0004564,increased myocardial fiber size|MP:0005600,increased heart ventricle muscle contractility
MGI:4946230	Tg(Myh6-INPP5F)#Joe	MP:0004486,decreased response of heart to induced stress
MGI:3639589	Tg(Myh6-Jund1)9Wag	MP:0005140,decreased cardiac muscle contractility|MP:0005294,abnormal heart ventricle morphology
MGI:5660496	Tg(Myh6-Jup*)1Ajm	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0004857,abnormal heart weight|MP:0005608,cardiac interstitial fibrosis|MP:0008950,ventricular tachycardia|MP:0009115,abnormal fat cell morphology|MP:0010519,atrioventricular block|MP:0011168,abnormal fat cell differentiation|MP:0011925,abnormal heart echocardiography feature|MP:0031633,decreased heart left ventricle muscle contractility
MGI:6501730	Tg(Myh6-JUP*)1Dpju	MP:0001853,heart inflammation|MP:0002083,premature death|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat
MGI:5660502	Tg(Myh6-Jup)2Ajm	MP:0000266,abnormal heart morphology|MP:0002083,premature death|MP:0005608,cardiac interstitial fibrosis|MP:0009115,abnormal fat cell morphology|MP:0011925,abnormal heart echocardiography feature
MGI:6275012	Tg(Myh6-Kcnj11*)1Wco	MP:0002083,premature death|MP:0003137,abnormal impulse conducting system conduction|MP:0004215,abnormal myocardial fiber physiology|MP:0010394,decreased QRS amplitude|MP:0020345,abnormal myocardial fiber currents
MGI:6275008	Tg(Myh6-Kcnj8*/EGFP)1Wco	MP:0002083,premature death|MP:0002626,increased heart rate|MP:0003061,decreased aerobic running capacity|MP:0003137,abnormal impulse conducting system conduction|MP:0004215,abnormal myocardial fiber physiology|MP:0010507,shortened RR interval|MP:0020345,abnormal myocardial fiber currents
MGI:5575890	Tg(Myh6-KCNQ1_i2)H02Desc	MP:0003233,prolonged QT interval|MP:0003896,prolonged PR interval|MP:0004070,abnormal P wave|MP:0004071,prolonged P wave|MP:0005333,decreased heart rate|MP:0006141,abnormal atrioventricular node conduction|MP:0006142,abnormal sinoatrial node conduction|MP:0010505,abnormal T wave|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010519,atrioventricular block|MP:0011938,prolonged PP interval
MGI:5575891	Tg(Myh6-KCNQ1_i2)H05Desc	MP:0000266,abnormal heart morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0003137,abnormal impulse conducting system conduction|MP:0003233,prolonged QT interval|MP:0004071,prolonged P wave|MP:0006142,abnormal sinoatrial node conduction|MP:0008770,decreased survivor rate|MP:0010505,abnormal T wave
MGI:5575892	Tg(Myh6-KCNQ1_i2)H08Desc	MP:0003233,prolonged QT interval|MP:0003896,prolonged PR interval|MP:0004071,prolonged P wave|MP:0005333,decreased heart rate|MP:0006142,abnormal sinoatrial node conduction|MP:0010505,abnormal T wave|MP:0010519,atrioventricular block
MGI:5056132	Tg(Myh6-KDM4A)BZpl	MP:0002833,increased heart weight|MP:0003921,abnormal heart left ventricle morphology|MP:0004485,increased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility
MGI:5910333	Tg(Myh6-LDB3*S196L)93Mva	MP:0003141,cardiac fibrosis|MP:0003896,prolonged PR interval|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004937,dilated heart|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0010392,prolonged QRS complex duration|MP:0010519,atrioventricular block|MP:0011925,abnormal heart echocardiography feature|MP:0020346,abnormal myocardial fiber calcium currents|MP:0020347,abnormal myocardial fiber sodium currents
MGI:3664022	Tg(Myh6-Lef1)2Tfo	MP:0002626,increased heart rate|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0004215,abnormal myocardial fiber physiology|MP:0005598,decreased heart ventricle muscle contractility|MP:0011089,perinatal lethality, complete penetrance|MP:0014316,decreased heart left ventricle posterior wall thickness
MGI:5907285	Tg(Myh6-LMNA*E82K)35Lizh	MP:0000278,abnormal myocardial fiber morphology|MP:0000280,thin ventricular wall|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003222,increased cardiomyocyte apoptosis|MP:0004090,abnormal sarcomere morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006036,abnormal mitochondrial physiology|MP:0008022,dilated heart ventricle|MP:0010392,prolonged QRS complex duration|MP:0010630,abnormal cardiac muscle tissue morphology|MP:0011630,increased mitochondrial size|MP:0011925,abnormal heart echocardiography feature|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3766499	Tg(Myh6-Map2k1*)1Jmol	MP:0001627,abnormal cardiac output|MP:0002625,heart left ventricle hypertrophy|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0003038,decreased myocardial infarct size|MP:0003223,decreased cardiomyocyte apoptosis|MP:0003820,increased left ventricle systolic pressure|MP:0003821,decreased left ventricle diastolic pressure|MP:0004564,increased myocardial fiber size
MGI:3851571	Tg(Myh6-Map2k3*)1Jmol	MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002625,heart left ventricle hypertrophy|MP:0003921,abnormal heart left ventricle morphology|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0005608,cardiac interstitial fibrosis|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3851605	Tg(Myh6-Map2k6*)1Jmol	MP:0001625,cardiac hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0003921,abnormal heart left ventricle morphology|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005598,decreased heart ventricle muscle contractility
MGI:3851578	Tg(Myh6-Map2k7)1Jmol	MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0002972,abnormal cardiac muscle contractility|MP:0003038,decreased myocardial infarct size|MP:0003223,decreased cardiomyocyte apoptosis
MGI:3851580	Tg(Myh6-Mapk1)1Jmol	MP:0002169,no abnormal phenotype detected
MGI:3851575	Tg(Myh6-Mapk14*)1Jmol	MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002625,heart left ventricle hypertrophy|MP:0003921,abnormal heart left ventricle morphology|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3851796	Tg(Myh6-Mapk8*,Myh6-Mapk9*)22.4Jmol	MP:0003223,decreased cardiomyocyte apoptosis|MP:0005329,abnormal myocardium layer morphology
MGI:5431514	Tg(Myh6-Med13)1Eno	MP:0000180,abnormal circulating cholesterol level|MP:0001262,decreased body weight|MP:0001783,decreased white adipose tissue amount|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0006320,abnormal interscapular fat pad morphology|MP:0008963,increased carbon dioxide production|MP:0009295,decreased interscapular fat pad weight|MP:0010025,decreased total body fat amount|MP:0012778,abnormal liver triglyceride level
MGI:3851584	Tg(Myh6-MEF2A)1Jmol	MP:0000274,enlarged heart|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0003921,abnormal heart left ventricle morphology|MP:0004564,increased myocardial fiber size|MP:0005598,decreased heart ventricle muscle contractility|MP:0010018,pulmonary vascular congestion
MGI:3851582	Tg(Myh6-Mef2c)2Jmol	MP:0001625,cardiac hypertrophy|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003105,abnormal heart atrium morphology|MP:0005140,decreased cardiac muscle contractility|MP:0008022,dilated heart ventricle|MP:0008772,increased heart ventricle size
MGI:4418154	Tg(Myh6-Mef2c/VP16)1Eno	MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0012107,enhanced exercise endurance
MGI:3776912	Tg(Myh6-Mef2d)2Eno	MP:0003141,cardiac fibrosis|MP:0005048,abnormal thrombosis|MP:0005330,cardiomyopathy|MP:0008725,increased heart atrium size|MP:0010018,pulmonary vascular congestion|MP:0010019,liver vascular congestion
MGI:6192033	Tg(Myh6-Mir30c-1)AEec	MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0005608,cardiac interstitial fibrosis|MP:0008022,dilated heart ventricle|MP:0008727,increased heart right atrium size
MGI:6192034	Tg(Myh6-Mir30c-1)BEec	MP:0000280,thin ventricular wall|MP:0002795,dilated cardiomyopathy|MP:0005140,decreased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006036,abnormal mitochondrial physiology|MP:0008727,increased heart right atrium size|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011925,abnormal heart echocardiography feature|MP:0021160,decreased heart right ventricle wall thickness
MGI:3689961	Tg(Myh6-Mmp2*V107G)712Ajb	MP:0002189,abnormal myocardial trabeculae morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005329,abnormal myocardium layer morphology
MGI:3763353	Tg(Myh6-MT2A)15Pne	MP:0000266,abnormal heart morphology|MP:0001260,increased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0002079,increased circulating insulin level|MP:0003916,decreased heart left ventricle weight|MP:0003921,abnormal heart left ventricle morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0005266,abnormal metabolism|MP:0005385,cardiovascular system phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:6362670	Tg(Myh6-Mtg1)3Ywxu	MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0004486,decreased response of heart to induced stress|MP:0005599,increased cardiac muscle contractility|MP:0005630,increased lung weight|MP:0006321,increased myocardial fiber number|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport
MGI:5284885	Tg(Myh6-Mtpn)4Ssen	MP:0001625,cardiac hypertrophy|MP:0001785,edema|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0002837,dystrophic cardiac calcinosis|MP:0002953,thick ventricular wall|MP:0003141,cardiac fibrosis|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005202,lethargy|MP:0006138,congestive heart failure|MP:0008725,increased heart atrium size|MP:0008772,increased heart ventricle size|MP:0010334,pleural effusion|MP:0010724,thick interventricular septum|MP:0011925,abnormal heart echocardiography feature|MP:0031131,myocardial fiber disarray
MGI:5607307	Tg(Myh6-Murc)#Tue	MP:0000266,abnormal heart morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001636,irregular heartbeat|MP:0001855,abnormal atrial thrombosis|MP:0003822,decreased left ventricle systolic pressure|MP:0003896,prolonged PR interval|MP:0004564,increased myocardial fiber size|MP:0005333,decreased heart rate|MP:0005608,cardiac interstitial fibrosis|MP:0008543,atrial fibrillation|MP:0008725,increased heart atrium size|MP:0010519,atrioventricular block|MP:0014316,decreased heart left ventricle posterior wall thickness
MGI:5908461	Tg(Myh6-Mybpc3*)24Rbns	MP:0000266,abnormal heart morphology|MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0005333,decreased heart rate|MP:0012106,impaired exercise endurance|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:5908459	Tg(Myh6-Mybpc3*)32Rbns	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0004090,abnormal sarcomere morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004485,increased response of heart to induced stress|MP:0004566,myocardial fiber degeneration|MP:0005333,decreased heart rate|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010637,sinus bradycardia|MP:0012106,impaired exercise endurance|MP:0014730,abnormal myocardial fiber myofibril morphology
MGI:3769140	Tg(Myh6-Myh7)102Rbns	MP:0000343,abnormal response to cardiac infarction|MP:0001544,abnormal cardiovascular system physiology|MP:0003105,abnormal heart atrium morphology|MP:0003822,decreased left ventricle systolic pressure|MP:0003913,increased heart right ventricle weight|MP:0003915,increased heart left ventricle weight|MP:0003921,abnormal heart left ventricle morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005385,cardiovascular system phenotype|MP:0005630,increased lung weight|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0008872,abnormal physiological response to xenobiotic
MGI:4839805	Tg(Myh6-Myh7)137Rbns	MP:0000343,abnormal response to cardiac infarction|MP:0003105,abnormal heart atrium morphology|MP:0003822,decreased left ventricle systolic pressure|MP:0003913,increased heart right ventricle weight|MP:0003915,increased heart left ventricle weight|MP:0003921,abnormal heart left ventricle morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005630,increased lung weight|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0008726,increased heart left atrium size|MP:0008872,abnormal physiological response to xenobiotic
MGI:6712703	Tg(Myh6-MYH7B)#Lnwd	MP:0002753,dilated heart left ventricle|MP:0003913,increased heart right ventricle weight|MP:0003915,increased heart left ventricle weight|MP:0005140,decreased cardiac muscle contractility|MP:0005384,cellular phenotype|MP:0011915,increased heart left atrium weight|MP:0011917,increased heart right atrium weight
MGI:3688749	Tg(Myh6-Myl2*)21Rbns	MP:0000278,abnormal myocardial fiber morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002754,dilated heart right ventricle|MP:0002972,abnormal cardiac muscle contractility|MP:0003140,dilated heart atrium|MP:0003824,decreased left ventricle developed pressure|MP:0004084,abnormal cardiac muscle relaxation|MP:0004090,abnormal sarcomere morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004566,myocardial fiber degeneration|MP:0005140,decreased cardiac muscle contractility|MP:0006044,tricuspid valve regurgitation|MP:0006113,abnormal heart septum morphology|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006267,abnormal intercalated disk morphology|MP:0008725,increased heart atrium size|MP:0014731,disorganized myocardial fiber myofibrils
MGI:5315427	Tg(Myh6-MYL2*A13T)L1Dsc	MP:0000281,abnormal interventricular septum morphology|MP:0001625,cardiac hypertrophy|MP:0003141,cardiac fibrosis|MP:0004215,abnormal myocardial fiber physiology|MP:0005330,cardiomyopathy
MGI:3838172	Tg(Myh6-MYL2*D166V)1Dsc	MP:0003141,cardiac fibrosis|MP:0004215,abnormal myocardial fiber physiology|MP:0005385,cardiovascular system phenotype
MGI:6193897	Tg(Myh6-MYL2*D94A)1Dsc	MP:0001544,abnormal cardiovascular system physiology|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0003393,decreased cardiac output|MP:0004090,abnormal sarcomere morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005329,abnormal myocardium layer morphology|MP:0008022,dilated heart ventricle|MP:0011925,abnormal heart echocardiography feature
MGI:5908892	Tg(Myh6-MYL2*E22K)4Dsc	MP:0004215,abnormal myocardial fiber physiology|MP:0010498,abnormal interventricular septum muscular part morphology|MP:0010569,papillary muscle hypertrophy
MGI:6193977	Tg(Myh6-MYL2*K104E)2Dsc	MP:0000266,abnormal heart morphology|MP:0001625,cardiac hypertrophy|MP:0003141,cardiac fibrosis|MP:0004215,abnormal myocardial fiber physiology|MP:0005330,cardiomyopathy|MP:0005599,increased cardiac muscle contractility|MP:0011628,increased mitochondrial number|MP:0011925,abnormal heart echocardiography feature|MP:0020419,decreased cardiac muscle relaxation
MGI:4820519	Tg(Myh6-MYL2*N47K)#Dsc	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0003393,decreased cardiac output|MP:0004009,abnormal diastolic filling velocity|MP:0004215,abnormal myocardial fiber physiology|MP:0031131,myocardial fiber disarray
MGI:4820518	Tg(Myh6-MYL2*R58Q)#Dsc	MP:0000278,abnormal myocardial fiber morphology|MP:0000343,abnormal response to cardiac infarction|MP:0001544,abnormal cardiovascular system physiology|MP:0002972,abnormal cardiac muscle contractility|MP:0003393,decreased cardiac output|MP:0004009,abnormal diastolic filling velocity|MP:0004215,abnormal myocardial fiber physiology|MP:0020419,decreased cardiac muscle relaxation|MP:0031131,myocardial fiber disarray
MGI:5909257	Tg(Myh6-MYL3*A57G)#Dsc	MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002128,abnormal blood circulation|MP:0002833,increased heart weight|MP:0003394,increased cardiac output|MP:0003820,increased left ventricle systolic pressure|MP:0003921,abnormal heart left ventricle morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0005608,cardiac interstitial fibrosis|MP:0010630,abnormal cardiac muscle tissue morphology|MP:0011925,abnormal heart echocardiography feature|MP:0011951,increased cardiac stroke volume|MP:0031635,increased heart left ventricle muscle contractility
MGI:5909252	Tg(Myh6-MYL3*)#Dsc	MP:0000274,enlarged heart|MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0004215,abnormal myocardial fiber physiology|MP:0005329,abnormal myocardium layer morphology|MP:0010630,abnormal cardiac muscle tissue morphology|MP:0010724,thick interventricular septum
MGI:6315994	Tg(Myh6-MYL3*E143K)2Dsc	MP:0001544,abnormal cardiovascular system physiology|MP:0002188,small heart|MP:0002834,decreased heart weight|MP:0003141,cardiac fibrosis|MP:0003393,decreased cardiac output|MP:0004084,abnormal cardiac muscle relaxation|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0004146,absent M line|MP:0004215,abnormal myocardial fiber physiology|MP:0005330,cardiomyopathy|MP:0011925,abnormal heart echocardiography feature|MP:0011952,decreased cardiac stroke volume|MP:0030678,increased hydroxyproline level
MGI:5569925	Tg(Myh6-Mylk3)3Hkas	MP:0004486,decreased response of heart to induced stress
MGI:5581489	Tg(Myh6-MYOZ2*I246M)#Ajm	MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0004564,increased myocardial fiber size|MP:0005608,cardiac interstitial fibrosis|MP:0010724,thick interventricular septum
MGI:5581488	Tg(Myh6-MYOZ2*S48P)114Ajm	MP:0001625,cardiac hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0002953,thick ventricular wall|MP:0004564,increased myocardial fiber size|MP:0005608,cardiac interstitial fibrosis|MP:0010724,thick interventricular septum
MGI:5319508	Tg(Myh6-MYPN*Y20C)#Jato	MP:0000274,enlarged heart|MP:0001625,cardiac hypertrophy|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0006267,abnormal intercalated disk morphology|MP:0008022,dilated heart ventricle|MP:0010724,thick interventricular septum|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3783599	Tg(Myh6-Ncor2*)1Kjep	MP:0004057,thin myocardium compact layer|MP:0010402,ventricular septal defect|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5907160	Tg(Myh6-NEBL*A592E)#Jato	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0004091,abnormal Z line morphology|MP:0005140,decreased cardiac muscle contractility|MP:0010630,abnormal cardiac muscle tissue morphology|MP:0012106,impaired exercise endurance
MGI:5907159	Tg(Myh6-NEBL*G202R)#Jato	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0005140,decreased cardiac muscle contractility|MP:0006267,abnormal intercalated disk morphology|MP:0010630,abnormal cardiac muscle tissue morphology|MP:0012106,impaired exercise endurance|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:3056187	Tg(Myh6-NFATC4)#Eno	MP:0001625,cardiac hypertrophy|MP:0003141,cardiac fibrosis|MP:0031131,myocardial fiber disarray
MGI:3851596	Tg(Myh6/NFAT-luc)1Jmol	MP:0002169,no abnormal phenotype detected
MGI:3664113	Tg(Myh6-Ngfb)4Fed	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001012,superior cervical ganglion hypertrophy|MP:0001013,enlarged superior cervical ganglion|MP:0001017,abnormal stellate ganglion morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0002184,abnormal innervation|MP:0003632,abnormal nervous system morphology
MGI:4834488	Tg(Myh6-Nox4)13Jusa	MP:0001625,cardiac hypertrophy
MGI:4838552	Tg(Myh6-Nox4)1Ams	MP:0001544,abnormal cardiovascular system physiology|MP:0002833,increased heart weight|MP:0003915,increased heart left ventricle weight|MP:0004486,decreased response of heart to induced stress|MP:0010724,thick interventricular septum
MGI:4834487	Tg(Myh6-Nox4)3Jusa	MP:0001625,cardiac hypertrophy
MGI:4834504	Tg(Myh6-Nox4)#Jusa	MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0003674,oxidative stress|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006036,abnormal mitochondrial physiology|MP:0010499,abnormal ventricle myocardium morphology
MGI:3640602	Tg(Myh6-Pfkfb3)7Pne	MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002078,abnormal glucose homeostasis|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0005140,decreased cardiac muscle contractility|MP:0014071,increased cardiac muscle glycogen level|MP:0030020,decreased cardiac muscle cell glucose uptake
MGI:3619921	Tg(Myh6-Pik3ca)1Siz	MP:0002188,small heart|MP:0002834,decreased heart weight|MP:0004485,increased response of heart to induced stress|MP:0004565,decreased myocardial fiber size
MGI:3619920	Tg(Myh6-Pik3r1/PIK3CA)BSiz	MP:0000274,enlarged heart|MP:0001625,cardiac hypertrophy|MP:0003921,abnormal heart left ventricle morphology|MP:0004486,decreased response of heart to induced stress|MP:0004564,increased myocardial fiber size
MGI:6188930	Tg(Myh6-Pkp2*/mRuby)4Rbrug	MP:0002754,dilated heart right ventricle|MP:0003137,abnormal impulse conducting system conduction|MP:0003896,prolonged PR interval|MP:0003920,abnormal heart right ventricle morphology|MP:0005330,cardiomyopathy|MP:0008950,ventricular tachycardia|MP:0010428,abnormal heart right ventricle outflow tract morphology|MP:0011925,abnormal heart echocardiography feature|MP:0012735,abnormal response to exercise
MGI:6188931	Tg(Myh6-Pkp2*/mRuby)5Rbrug	MP:0002754,dilated heart right ventricle|MP:0003896,prolonged PR interval|MP:0003920,abnormal heart right ventricle morphology|MP:0005330,cardiomyopathy|MP:0008950,ventricular tachycardia|MP:0010428,abnormal heart right ventricle outflow tract morphology|MP:0011925,abnormal heart echocardiography feature|MP:0012735,abnormal response to exercise
MGI:3834110	Tg(Myh6-Pln)416Egk	MP:0002972,abnormal cardiac muscle contractility|MP:0004215,abnormal myocardial fiber physiology
MGI:5905137	Tg(Myh6-Pln*)#Egk	MP:0000274,enlarged heart|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0005608,cardiac interstitial fibrosis|MP:0008022,dilated heart ventricle|MP:0010630,abnormal cardiac muscle tissue morphology|MP:0012557,decreased calcium uptake by cardiac muscle
MGI:5789526	Tg(Myh6-Pln*R9C)#Ces	MP:0000274,enlarged heart|MP:0000599,enlarged liver|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0005202,lethargy|MP:0005312,pericardial effusion|MP:0005608,cardiac interstitial fibrosis|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0008726,increased heart left atrium size|MP:0010334,pleural effusion|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5908193	Tg(Myh6-POLG*Y955C)DWcc	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0002083,premature death|MP:0002953,thick ventricular wall|MP:0003674,oxidative stress|MP:0004564,increased myocardial fiber size|MP:0005330,cardiomyopathy|MP:0006138,congestive heart failure|MP:0008725,increased heart atrium size|MP:0008772,increased heart ventricle size|MP:0010724,thick interventricular septum|MP:0011635,abnormal mitochondrial crista morphology|MP:0011925,abnormal heart echocardiography feature|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014390,decreased myocardial fiber mitochondrial DNA content
MGI:3641546	Tg(Myh6-Ppara)402-2Dpk	MP:0000278,abnormal myocardial fiber morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001547,abnormal lipid level|MP:0001625,cardiac hypertrophy|MP:0005281,increased fatty acids level|MP:0005330,cardiomyopathy|MP:0005598,decreased heart ventricle muscle contractility
MGI:3641575	Tg(Myh6-Ppara)404-3Dpk	MP:0000278,abnormal myocardial fiber morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001547,abnormal lipid level|MP:0001625,cardiac hypertrophy|MP:0004564,increased myocardial fiber size|MP:0005281,increased fatty acids level|MP:0005330,cardiomyopathy|MP:0005598,decreased heart ventricle muscle contractility|MP:0030020,decreased cardiac muscle cell glucose uptake
MGI:4429461	Tg(Myh6-Ppara)404-4Dpk	MP:0000278,abnormal myocardial fiber morphology|MP:0001547,abnormal lipid level|MP:0001625,cardiac hypertrophy|MP:0005281,increased fatty acids level
MGI:4429481	Tg(Myh6-Ppard)HEDpk	MP:0000343,abnormal response to cardiac infarction|MP:0003038,decreased myocardial infarct size|MP:0005140,decreased cardiac muscle contractility|MP:0005385,cardiovascular system phenotype|MP:0014071,increased cardiac muscle glycogen level|MP:0030018,increased cardiac muscle cell glucose uptake
MGI:3577401	Tg(Myh6-Ppif)26.2Jmol	MP:0006042,increased apoptosis|MP:0011632,dilated mitochondrion|MP:0011635,abnormal mitochondrial crista morphology|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:3056186	Tg(Myh6-Ppp3ca)37Eno	MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002833,increased heart weight|MP:0003828,pulmonary edema|MP:0004564,increased myocardial fiber size|MP:0005608,cardiac interstitial fibrosis|MP:0031131,myocardial fiber disarray
MGI:3639282	Tg(Myh6-Prkaa2*D157A)1Rti	MP:0000343,abnormal response to cardiac infarction
MGI:6193913	Tg(Myh6-Prkaca)2Eno	MP:0000274,enlarged heart|MP:0001625,cardiac hypertrophy|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002953,thick ventricular wall|MP:0003141,cardiac fibrosis|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0006138,congestive heart failure|MP:0008543,atrial fibrillation|MP:0009732,ventricular premature beat|MP:0010520,sinoatrial block|MP:0011738,anasarca|MP:0011925,abnormal heart echocardiography feature
MGI:6193912	Tg(Myh6-Prkaca)33Eno	MP:0000274,enlarged heart|MP:0001625,cardiac hypertrophy|MP:0001785,edema|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002953,thick ventricular wall|MP:0003141,cardiac fibrosis|MP:0004564,increased myocardial fiber size|MP:0006138,congestive heart failure
MGI:3688832	Tg(Myh6-PRKAG2)2Dca	MP:0002833,increased heart weight|MP:0014071,increased cardiac muscle glycogen level
MGI:3841167	Tg(Myh6-PRKAG2*N488I)4623Jse	MP:0000266,abnormal heart morphology|MP:0001629,abnormal heart rate|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0003137,abnormal impulse conducting system conduction|MP:0003915,increased heart left ventricle weight|MP:0004485,increased response of heart to induced stress|MP:0004564,increased myocardial fiber size|MP:0005333,decreased heart rate|MP:0008543,atrial fibrillation|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010511,shortened PR interval|MP:0010637,sinus bradycardia|MP:0014071,increased cardiac muscle glycogen level|MP:0031302,syncope|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3688892	Tg(Myh6-PRKAG2*R302Q)#Rro	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002626,increased heart rate|MP:0002833,increased heart weight|MP:0003137,abnormal impulse conducting system conduction|MP:0005598,decreased heart ventricle muscle contractility|MP:0010392,prolonged QRS complex duration|MP:0010511,shortened PR interval|MP:0014071,increased cardiac muscle glycogen level
MGI:3688831	Tg(Myh6-PRKAG2*R531G)22Dca	MP:0000274,enlarged heart|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0003137,abnormal impulse conducting system conduction|MP:0003393,decreased cardiac output|MP:0005438,abnormal glycogen homeostasis|MP:0010392,prolonged QRS complex duration|MP:0010511,shortened PR interval|MP:0011952,decreased cardiac stroke volume|MP:0014071,increased cardiac muscle glycogen level|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3688893	Tg(Myh6-PRKAG2)#Rro	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0002626,increased heart rate|MP:0002833,increased heart weight|MP:0005598,decreased heart ventricle muscle contractility
MGI:4818807	Tg(Myh6-PRKAG2*T400N)1Feah	MP:0000278,abnormal myocardial fiber morphology|MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0003037,increased myocardial infarct size|MP:0003137,abnormal impulse conducting system conduction|MP:0003921,abnormal heart left ventricle morphology|MP:0004485,increased response of heart to induced stress|MP:0005598,decreased heart ventricle muscle contractility|MP:0010392,prolonged QRS complex duration|MP:0010511,shortened PR interval|MP:0014071,increased cardiac muscle glycogen level
MGI:3037092	Tg(Myh6-Prkca)1Jmk	MP:0001625,cardiac hypertrophy|MP:0005140,decreased cardiac muscle contractility
MGI:5559996	Tg(Myh6-PRKCE*A159E)344Robo	MP:0001544,abnormal cardiovascular system physiology|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003393,decreased cardiac output|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0006138,congestive heart failure|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0010534,calcified myocardium|MP:0011952,decreased cardiac stroke volume
MGI:5559989	Tg(Myh6-PRKCE*A159E)388Robo	MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0004215,abnormal myocardial fiber physiology
MGI:3848193	Tg(Myh6-PROKR1)13Cagn	MP:0000259,abnormal vascular development|MP:0000266,abnormal heart morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0002972,abnormal cardiac muscle contractility|MP:0004112,abnormal arteriole morphology
MGI:3822134	Tg(Myh6-Ptpn11)75Rbns	MP:0005385,cardiovascular system phenotype
MGI:5909086	Tg(Myh6-Ptpn11*Q510E)#Krnz	MP:0005385,cardiovascular system phenotype
MGI:3822133	Tg(Myh6-Ptpn11*Q79R)197Rbns	MP:0005385,cardiovascular system phenotype
MGI:5904946	Tg(Myh6-Rab1a)highGwd	MP:0000274,enlarged heart|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0006138,congestive heart failure|MP:0011925,abnormal heart echocardiography feature|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5904948	Tg(Myh6-Rab1a)lowGwd	MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0011925,abnormal heart echocardiography feature|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5904947	Tg(Myh6-Rab1a)medGwd	MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0002795,dilated cardiomyopathy|MP:0004564,increased myocardial fiber size|MP:0005598,decreased heart ventricle muscle contractility|MP:0012557,decreased calcium uptake by cardiac muscle|MP:0020346,abnormal myocardial fiber calcium currents|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3838148	Tg(Myh6-RARA/lacZ)1Mcco	MP:0002169,no abnormal phenotype detected
MGI:5905765	Tg(Myh6-Rest*)474Ysai	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0003822,decreased left ventricle systolic pressure|MP:0004091,abnormal Z line morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006110,ventricular fibrillation|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0010519,atrioventricular block|MP:0010579,increased heart left ventricle size|MP:0011953,prolonged PQ interval|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014730,abnormal myocardial fiber myofibril morphology|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3757939	Tg(Myh6-rtTA2S*M2)216Rbns	MP:0001625,cardiac hypertrophy|MP:0002083,premature death
MGI:5906918	Tg(Myh6-Rxra)41Pcn	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0004094,abnormal M line morphology|MP:0004566,myocardial fiber degeneration|MP:0010334,pleural effusion|MP:0010955,abnormal respiratory electron transport chain|MP:0014730,abnormal myocardial fiber myofibril morphology|MP:0020409,abnormal cardiac thrombosis
MGI:5911918	Tg(Myh6-Sgcd*S151A)5Mcn	MP:0000278,abnormal myocardial fiber morphology|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight
MGI:3623457	Tg(Myh6-SLC2A1)54Rti	MP:0004484,abnormal response of heart to induced stress|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0014071,increased cardiac muscle glycogen level|MP:0030018,increased cardiac muscle cell glucose uptake
MGI:3655879	Tg(Myh6-Sln)26Peri	MP:0004084,abnormal cardiac muscle relaxation|MP:0004231,abnormal calcium ion homeostasis|MP:0005140,decreased cardiac muscle contractility
MGI:5906252	Tg(Myh6-Snai1)B10Jcc	MP:0000274,enlarged heart|MP:0000280,thin ventricular wall|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003137,abnormal impulse conducting system conduction|MP:0003896,prolonged PR interval|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005150,cachexia|MP:0005324,ascites|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0010392,prolonged QRS complex duration|MP:0010768,mortality/aging|MP:0011925,abnormal heart echocardiography feature|MP:0020347,abnormal myocardial fiber sodium currents|MP:0021158,decreased heart left ventricle wall thickness
MGI:4360100	Tg(Myh6-SOD2,Tyr)3Pne	MP:0005385,cardiovascular system phenotype|MP:0005621,abnormal cell physiology
MGI:4452338	Tg(Myh6-STK4)28Jusa	MP:0000278,abnormal myocardial fiber morphology|MP:0000280,thin ventricular wall|MP:0001544,abnormal cardiovascular system physiology|MP:0001785,edema|MP:0001855,abnormal atrial thrombosis|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002127,abnormal cardiovascular system morphology|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0002981,increased liver weight|MP:0003222,increased cardiomyocyte apoptosis|MP:0003921,abnormal heart left ventricle morphology|MP:0004062,dilated heart right atrium|MP:0004063,dilated heart left atrium|MP:0004565,decreased myocardial fiber size|MP:0004567,decreased myocardial fiber number|MP:0005630,increased lung weight|MP:0006138,congestive heart failure|MP:0010018,pulmonary vascular congestion|MP:0010019,liver vascular congestion|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4452341	Tg(Myh6-STK4*K59R)10Jusa	MP:0003038,decreased myocardial infarct size|MP:0003223,decreased cardiomyocyte apoptosis|MP:0004486,decreased response of heart to induced stress
MGI:5776137	Tg(Myh6-Strit1)#Eno	MP:0004215,abnormal myocardial fiber physiology
MGI:6194343	Tg(Myh6-Sumo2*)9592Jwang	MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002953,thick ventricular wall|MP:0011925,abnormal heart echocardiography feature
MGI:6194340	Tg(Myh6-Sumo2*)9606Jwang	MP:0000274,enlarged heart|MP:0002833,increased heart weight|MP:0003222,increased cardiomyocyte apoptosis|MP:0004564,increased myocardial fiber size|MP:0005330,cardiomyopathy|MP:0011085,postnatal lethality, complete penetrance
MGI:6194341	Tg(Myh6-Sumo2*)9608Jwang	MP:0002083,premature death|MP:0005330,cardiomyopathy
MGI:6194342	Tg(Myh6-Sumo2*)9610Jwang	MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0003921,abnormal heart left ventricle morphology|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0011925,abnormal heart echocardiography feature
MGI:5443851	Tg(Myh6-Tcap)#Rnk	MP:0003223,decreased cardiomyocyte apoptosis|MP:0004486,decreased response of heart to induced stress|MP:0005385,cardiovascular system phenotype
MGI:3663410	Tg(Myh6-TEAD4)2Afrs	MP:0002083,premature death|MP:0003137,abnormal impulse conducting system conduction|MP:0003140,dilated heart atrium|MP:0003896,prolonged PR interval|MP:0008543,atrial fibrillation|MP:0010392,prolonged QRS complex duration
MGI:3663411	Tg(Myh6-TEAD4)3Afrs	MP:0001636,irregular heartbeat|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002626,increased heart rate|MP:0003137,abnormal impulse conducting system conduction|MP:0003140,dilated heart atrium|MP:0003896,prolonged PR interval|MP:0008543,atrial fibrillation|MP:0010392,prolonged QRS complex duration
MGI:6294697	Tg(Myh6*/tetO-BAG3)69Atsa	MP:0000266,abnormal heart morphology|MP:0005140,decreased cardiac muscle contractility|MP:0008260,abnormal autophagy
MGI:3764670	Tg(Myh6/tetO-BNIP3)1Gwd	MP:0002753,dilated heart left ventricle|MP:0002833,increased heart weight|MP:0003037,increased myocardial infarct size|MP:0003222,increased cardiomyocyte apoptosis|MP:0003822,decreased left ventricle systolic pressure
MGI:4437471	Tg(Myh6*/tetO-Capn1)L1Gwd	MP:0010768,mortality/aging
MGI:4437466	Tg(Myh6*/tetO-Capn1)L2Gwd	MP:0002083,premature death|MP:0002833,increased heart weight|MP:0003921,abnormal heart left ventricle morphology|MP:0005598,decreased heart ventricle muscle contractility
MGI:4437470	Tg(Myh6*/tetO-Capn1)L3Gwd	MP:0001853,heart inflammation|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0003921,abnormal heart left ventricle morphology|MP:0005598,decreased heart ventricle muscle contractility|MP:0006085,myocardium necrosis|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle
MGI:5752796	Tg(Myh6*/tetO-FXYD1*S68E)39Jych	MP:0001265,decreased body size|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002972,abnormal cardiac muscle contractility|MP:0003393,decreased cardiac output|MP:0004122,abnormal sinus arrhythmia|MP:0004215,abnormal myocardial fiber physiology|MP:0005333,decreased heart rate|MP:0005402,abnormal action potential|MP:0005600,increased heart ventricle muscle contractility|MP:0006110,ventricular fibrillation|MP:0008950,ventricular tachycardia|MP:0010579,increased heart left ventricle size|MP:0011951,increased cardiac stroke volume
MGI:3757978	Tg(Myh6*/tetO-GCaMP2)1Mik	MP:0000274,enlarged heart
MGI:3757954	Tg(Myh6/tetO-Gsk3b*S9A)1Rbns	MP:0004486,decreased response of heart to induced stress
MGI:6294491	Tg(Myh6*/tetO-Hspb8*K141N)#Atsa	MP:0000266,abnormal heart morphology|MP:0001625,cardiac hypertrophy|MP:0003141,cardiac fibrosis|MP:0003329,amyloid beta deposits|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0010959,abnormal oxidative phosphorylation
MGI:5909970	Tg(Myh6/tetO-Mybpc3*)#Rbns	MP:0000266,abnormal heart morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003921,abnormal heart left ventricle morphology|MP:0004087,abnormal muscle fiber morphology|MP:0004090,abnormal sarcomere morphology|MP:0005140,decreased cardiac muscle contractility|MP:0006138,congestive heart failure|MP:0008725,increased heart atrium size|MP:0008772,increased heart ventricle size
MGI:3819377	Tg(Myh6/tetO-POSTN)22.1Jmol	MP:0000343,abnormal response to cardiac infarction|MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0005165,increased susceptibility to injury|MP:0005385,cardiovascular system phenotype
MGI:3841177	Tg(Myh6/tetO-PRKAG2*N488I)1Chib	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002626,increased heart rate|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0003137,abnormal impulse conducting system conduction|MP:0003898,abnormal QRS complex|MP:0003920,abnormal heart right ventricle morphology|MP:0005333,decreased heart rate|MP:0006113,abnormal heart septum morphology|MP:0010392,prolonged QRS complex duration|MP:0010511,shortened PR interval|MP:0010519,atrioventricular block|MP:0010520,sinoatrial block|MP:0014071,increased cardiac muscle glycogen level|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3851565	Tg(Myh6/tetO-PRKCA*)1Jmk	MP:0002833,increased heart weight|MP:0002972,abnormal cardiac muscle contractility|MP:0005329,abnormal myocardium layer morphology|MP:0005600,increased heart ventricle muscle contractility
MGI:5800483	Tg(Myh6*/tetO-SCN5A*F1759A)#Marx	MP:0003105,abnormal heart atrium morphology|MP:0003141,cardiac fibrosis|MP:0003233,prolonged QT interval|MP:0005294,abnormal heart ventricle morphology|MP:0005330,cardiomyopathy|MP:0008543,atrial fibrillation|MP:0008725,increased heart atrium size|MP:0008726,increased heart left atrium size|MP:0008772,increased heart ventricle size|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0014071,increased cardiac muscle glycogen level|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0020345,abnormal myocardial fiber currents|MP:0020347,abnormal myocardial fiber sodium currents|MP:0031131,myocardial fiber disarray|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5752791	Tg(Myh6*/tetO-Slc8a1)BJych	MP:0000278,abnormal myocardial fiber morphology|MP:0002972,abnormal cardiac muscle contractility|MP:0004215,abnormal myocardial fiber physiology|MP:0005402,abnormal action potential
MGI:5897311	Tg(Myh6/tetO-Tnnc1*I61Q)1Jmol	MP:0002083,premature death|MP:0002833,increased heart weight|MP:0004090,abnormal sarcomere morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0010579,increased heart left ventricle size|MP:0010725,thin interventricular septum|MP:0020418,increased cardiac muscle relaxation
MGI:5897318	Tg(Myh6/tetO-Tnnc1*L48Q)2Jmol	MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0002972,abnormal cardiac muscle contractility|MP:0004215,abnormal myocardial fiber physiology|MP:0004486,decreased response of heart to induced stress|MP:0005385,cardiovascular system phenotype|MP:0005599,increased cardiac muscle contractility|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010579,increased heart left ventricle size|MP:0010724,thick interventricular septum|MP:0020419,decreased cardiac muscle relaxation
MGI:7595946	Tg(Myh6-Tmem11)#Kwan	MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0031217,increased susceptibility to myocardial ischemic injury
MGI:3622294	Tg(Myh6-Tmod1)65Msus	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002652,thin myocardium|MP:0002750,exophthalmos|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003393,decreased cardiac output|MP:0004084,abnormal cardiac muscle relaxation|MP:0004566,myocardial fiber degeneration|MP:0005140,decreased cardiac muscle contractility|MP:0005294,abnormal heart ventricle morphology|MP:0005333,decreased heart rate|MP:0005388,respiratory system phenotype|MP:0006138,congestive heart failure|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010725,thin interventricular septum|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011738,anasarca|MP:0014730,abnormal myocardial fiber myofibril morphology|MP:0014731,disorganized myocardial fiber myofibrils|MP:0014733,decreased myocardial fiber myofibril length|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4450947	Tg(Myh6-Tnf)1.6Amf	MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0001636,irregular heartbeat|MP:0002127,abnormal cardiovascular system morphology|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003137,abnormal impulse conducting system conduction|MP:0003140,dilated heart atrium|MP:0003141,cardiac fibrosis|MP:0003233,prolonged QT interval|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0006141,abnormal atrioventricular node conduction|MP:0008022,dilated heart ventricle|MP:0008543,atrial fibrillation|MP:0008726,increased heart left atrium size|MP:0008772,increased heart ventricle size|MP:0010392,prolonged QRS complex duration|MP:0010553,prolonged HV interval
MGI:3586566	Tg(Myh6-Tnf)1Brgi	MP:0001402,decreased locomotor activity|MP:0001443,poor grooming|MP:0001505,hunched posture|MP:0001855,abnormal atrial thrombosis|MP:0001856,myocarditis|MP:0001943,abnormal respiration|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0003140,dilated heart atrium|MP:0003141,cardiac fibrosis|MP:0005294,abnormal heart ventricle morphology|MP:0005426,tachypnea|MP:0005598,decreased heart ventricle muscle contractility|MP:0031511,globular heart
MGI:3586567	Tg(Myh6-Tnf)2Brgi	MP:0001402,decreased locomotor activity|MP:0001443,poor grooming|MP:0001505,hunched posture|MP:0001855,abnormal atrial thrombosis|MP:0001856,myocarditis|MP:0001943,abnormal respiration|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0003140,dilated heart atrium|MP:0003141,cardiac fibrosis|MP:0005294,abnormal heart ventricle morphology|MP:0005426,tachypnea|MP:0005598,decreased heart ventricle muscle contractility|MP:0031511,globular heart
MGI:5906192	Tg(Myh6-Tnni3*)1Ammu	MP:0000274,enlarged heart|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0004084,abnormal cardiac muscle relaxation|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005329,abnormal myocardium layer morphology|MP:0005333,decreased heart rate|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008022,dilated heart ventricle|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010768,mortality/aging|MP:0011925,abnormal heart echocardiography feature
MGI:3690009	Tg(Myh6-TNNI3*G203S)1Chs	MP:0001625,cardiac hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0003137,abnormal impulse conducting system conduction|MP:0003896,prolonged PR interval|MP:0003898,abnormal QRS complex|MP:0004215,abnormal myocardial fiber physiology|MP:0005330,cardiomyopathy|MP:0005608,cardiac interstitial fibrosis|MP:0031131,myocardial fiber disarray
MGI:3690014	Tg(Myh6-TNNI3*G203S)4Chs	MP:0001625,cardiac hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0003137,abnormal impulse conducting system conduction|MP:0003896,prolonged PR interval|MP:0003898,abnormal QRS complex|MP:0004215,abnormal myocardial fiber physiology|MP:0005330,cardiomyopathy|MP:0005608,cardiac interstitial fibrosis|MP:0031131,myocardial fiber disarray
MGI:5614261	Tg(Myh6-TNNI3K*K490R)#Tfo	MP:0005384,cellular phenotype|MP:0005385,cardiovascular system phenotype
MGI:5614260	Tg(Myh6-TNNI3K)#Tfo	MP:0000343,abnormal response to cardiac infarction|MP:0003037,increased myocardial infarct size|MP:0003674,oxidative stress|MP:0004215,abnormal myocardial fiber physiology|MP:0005385,cardiovascular system phenotype
MGI:5910501	Tg(Myh6-Tnni3*L184)#Rste	MP:0002834,decreased heart weight|MP:0004215,abnormal myocardial fiber physiology
MGI:5909328	Tg(Myh6-Tnni3*R146G)121Rbns	MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0004215,abnormal myocardial fiber physiology|MP:0004485,increased response of heart to induced stress|MP:0005599,increased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0020419,decreased cardiac muscle relaxation
MGI:5909327	Tg(Myh6-Tnni3*R146G)133Rbns	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0005294,abnormal heart ventricle morphology|MP:0005608,cardiac interstitial fibrosis|MP:0011085,postnatal lethality, complete penetrance|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0030567,abnormal I band morphology
MGI:5909303	Tg(Myh6-Tnni3*R193H)42Xhu	MP:0003140,dilated heart atrium|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0020419,decreased cardiac muscle relaxation
MGI:5912298	Tg(Myh6-Tnni3*R193H)594Jmme	MP:0002188,small heart|MP:0002834,decreased heart weight|MP:0003819,increased left ventricle diastolic pressure|MP:0004215,abnormal myocardial fiber physiology|MP:0005330,cardiomyopathy|MP:0005599,increased cardiac muscle contractility|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0011925,abnormal heart echocardiography feature|MP:0012106,impaired exercise endurance|MP:0020419,decreased cardiac muscle relaxation
MGI:3692598	Tg(Myh6-Tnnt2)117Lnwd	MP:0000278,abnormal myocardial fiber morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0002190,disorganized myocardium|MP:0002834,decreased heart weight|MP:0003105,abnormal heart atrium morphology|MP:0003916,decreased heart left ventricle weight|MP:0004084,abnormal cardiac muscle relaxation|MP:0004091,abnormal Z line morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004565,decreased myocardial fiber size|MP:0004566,myocardial fiber degeneration|MP:0004567,decreased myocardial fiber number|MP:0005140,decreased cardiac muscle contractility|MP:0011089,perinatal lethality, complete penetrance|MP:0014731,disorganized myocardial fiber myofibrils
MGI:3692603	Tg(Myh6-Tnnt2)191Lnwd	MP:0000278,abnormal myocardial fiber morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0002083,premature death|MP:0002190,disorganized myocardium|MP:0002834,decreased heart weight|MP:0003105,abnormal heart atrium morphology|MP:0003140,dilated heart atrium|MP:0004084,abnormal cardiac muscle relaxation|MP:0004215,abnormal myocardial fiber physiology|MP:0004565,decreased myocardial fiber size|MP:0004566,myocardial fiber degeneration|MP:0004567,decreased myocardial fiber number|MP:0005140,decreased cardiac muscle contractility
MGI:3805021	Tg(Myh6-Tnnt2*)1Feah	MP:0002795,dilated cardiomyopathy
MGI:3793475	Tg(Myh6-TNNT2)3Jdp	MP:0005385,cardiovascular system phenotype
MGI:3793476	Tg(Myh6-TNNT2*I79N)8Jdp	MP:0000266,abnormal heart morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0002834,decreased heart weight|MP:0004215,abnormal myocardial fiber physiology|MP:0008950,ventricular tachycardia|MP:0009732,ventricular premature beat|MP:0010392,prolonged QRS complex duration|MP:0010768,mortality/aging
MGI:3793478	Tg(Myh6-TNNT2*I79N)9Jdp	MP:0002834,decreased heart weight|MP:0004215,abnormal myocardial fiber physiology|MP:0010768,mortality/aging
MGI:4819721	Tg(Myh6-TNNT2*R141W)#Ajm	MP:0000274,enlarged heart|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0003915,increased heart left ventricle weight|MP:0003921,abnormal heart left ventricle morphology|MP:0005608,cardiac interstitial fibrosis
MGI:5576170	Tg(Myh6-TNNT2*R141W)#Lian	MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0003921,abnormal heart left ventricle morphology|MP:0005048,abnormal thrombosis|MP:0005140,decreased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0008022,dilated heart ventricle|MP:0021158,decreased heart left ventricle wall thickness
MGI:3693255	Tg(Myh6-Tnnt2*R92L)1Jcf	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0003822,decreased left ventricle systolic pressure|MP:0004566,myocardial fiber degeneration|MP:0005140,decreased cardiac muscle contractility|MP:0005294,abnormal heart ventricle morphology|MP:0005330,cardiomyopathy|MP:0008725,increased heart atrium size|MP:0020419,decreased cardiac muscle relaxation
MGI:3692448	Tg(Myh6-Tnnt2*R92Q)1Lnwd	MP:0001625,cardiac hypertrophy|MP:0003105,abnormal heart atrium morphology|MP:0004090,abnormal sarcomere morphology|MP:0005294,abnormal heart ventricle morphology|MP:0010580,decreased heart left ventricle size
MGI:3692450	Tg(Myh6-Tnnt2*R92Q)2Lnwd	MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0001853,heart inflammation|MP:0002626,increased heart rate|MP:0002972,abnormal cardiac muscle contractility|MP:0003105,abnormal heart atrium morphology|MP:0004084,abnormal cardiac muscle relaxation|MP:0004090,abnormal sarcomere morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004565,decreased myocardial fiber size|MP:0004566,myocardial fiber degeneration|MP:0005294,abnormal heart ventricle morphology|MP:0005599,increased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0010580,decreased heart left ventricle size|MP:0011749,perivascular fibrosis
MGI:3692451	Tg(Myh6-Tnnt2*R92Q)3Lnwd	MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0001853,heart inflammation|MP:0003105,abnormal heart atrium morphology|MP:0004090,abnormal sarcomere morphology|MP:0004566,myocardial fiber degeneration|MP:0005294,abnormal heart ventricle morphology|MP:0005608,cardiac interstitial fibrosis|MP:0010580,decreased heart left ventricle size|MP:0011749,perivascular fibrosis|MP:0031131,myocardial fiber disarray
MGI:4819720	Tg(Myh6-TNNT2*R92Q)#Ajm	MP:0001544,abnormal cardiovascular system physiology|MP:0003921,abnormal heart left ventricle morphology|MP:0005385,cardiovascular system phenotype|MP:0005608,cardiac interstitial fibrosis|MP:0010768,mortality/aging|MP:0031131,myocardial fiber disarray
MGI:3693250	Tg(Myh6-Tnnt2*R92W)1Jcf	MP:0000266,abnormal heart morphology|MP:0000278,abnormal myocardial fiber morphology|MP:0002188,small heart|MP:0002834,decreased heart weight|MP:0003822,decreased left ventricle systolic pressure|MP:0003824,decreased left ventricle developed pressure|MP:0003921,abnormal heart left ventricle morphology|MP:0004089,dilated sarcoplasmic reticulum|MP:0004565,decreased myocardial fiber size|MP:0004566,myocardial fiber degeneration|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0020419,decreased cardiac muscle relaxation
MGI:5462246	Tg(Myh6-Tpm1*D175N)#Dfw	MP:0000281,abnormal interventricular septum morphology|MP:0001855,abnormal atrial thrombosis|MP:0002190,disorganized myocardium|MP:0003141,cardiac fibrosis|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0008775,abnormal heart ventricle pressure|MP:0010633,myocardium hypertrophy|MP:0012735,abnormal response to exercise|MP:0020419,decreased cardiac muscle relaxation
MGI:6256754	Tg(Myh6-Tpm1*D230N)HJcf	MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0006267,abnormal intercalated disk morphology|MP:0011925,abnormal heart echocardiography feature|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5007645	Tg(Myh6-Tpm1*E180G)57Dfw	MP:0001625,cardiac hypertrophy|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002625,heart left ventricle hypertrophy|MP:0002972,abnormal cardiac muscle contractility|MP:0003141,cardiac fibrosis|MP:0003819,increased left ventricle diastolic pressure|MP:0003921,abnormal heart left ventricle morphology|MP:0004009,abnormal diastolic filling velocity|MP:0004084,abnormal cardiac muscle relaxation|MP:0004215,abnormal myocardial fiber physiology|MP:0004231,abnormal calcium ion homeostasis|MP:0005140,decreased cardiac muscle contractility|MP:0005202,lethargy|MP:0005294,abnormal heart ventricle morphology|MP:0005333,decreased heart rate|MP:0005599,increased cardiac muscle contractility|MP:0005630,increased lung weight|MP:0006113,abnormal heart septum morphology|MP:0008725,increased heart atrium size|MP:0031131,myocardial fiber disarray
MGI:5906016	Tg(Myh6-Tpm1*E54K)30Dfw	MP:0000278,abnormal myocardial fiber morphology|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003393,decreased cardiac output|MP:0003821,decreased left ventricle diastolic pressure|MP:0003822,decreased left ventricle systolic pressure|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0020419,decreased cardiac muscle relaxation|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5906017	Tg(Myh6-Tpm1*E54K)67Dfw	MP:0000278,abnormal myocardial fiber morphology|MP:0001260,increased body weight|MP:0001785,edema|MP:0002083,premature death|MP:0002267,abnormal bronchiole morphology|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003393,decreased cardiac output|MP:0003821,decreased left ventricle diastolic pressure|MP:0003822,decreased left ventricle systolic pressure|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0020419,decreased cardiac muscle relaxation|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5792805	Tg(Myh6-Trim72)1Rpx	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003921,abnormal heart left ventricle morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0008022,dilated heart ventricle|MP:0010633,myocardium hypertrophy
MGI:5544294	Tg(Myh6-Yap1*S112A)#Eno	MP:0001544,abnormal cardiovascular system physiology|MP:0002833,increased heart weight|MP:0003038,decreased myocardial infarct size|MP:0003223,decreased cardiomyocyte apoptosis|MP:0004215,abnormal myocardial fiber physiology|MP:0010656,thick myocardium|MP:0031321,enhanced cardiac muscle regeneration
MGI:3615481	Tg(Myh7-BVp35-EGFP)#Ksa	MP:0003221,abnormal cardiomyocyte apoptosis
MGI:5906059	Tg(Myh7-Phc1)#Yota	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0001785,edema|MP:0001855,abnormal atrial thrombosis|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002652,thin myocardium|MP:0002795,dilated cardiomyopathy|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0004094,abnormal M line morphology|MP:0005324,ascites|MP:0006138,congestive heart failure|MP:0010334,pleural effusion|MP:0011633,abnormal mitochondrial shape|MP:0011635,abnormal mitochondrial crista morphology|MP:0031633,decreased heart left ventricle muscle contractility|MP:0031645,increased myocardial fiber apoptosis
MGI:3834218	Tg(Myh7-Pln)2Egk	MP:0000747,muscle weakness|MP:0000751,myopathy|MP:0002106,abnormal muscle physiology|MP:0002841,impaired skeletal muscle contractility|MP:0003081,abnormal soleus morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003157,impaired muscle relaxation|MP:0003674,oxidative stress|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009417,skeletal muscle atrophy|MP:0009419,skeletal muscle fibrosis|MP:0009420,skeletal muscle endomysial fibrosis|MP:0009426,decreased soleus weight|MP:0012106,impaired exercise endurance|MP:0020309,increased creatine kinase activity
MGI:3822135	Tg(Myh7-Ptpn11)294Rbns	MP:0005385,cardiovascular system phenotype
MGI:5909085	Tg(Myh7-Ptpn11*Q510E)#Krnz	MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0004032,abnormal interventricular groove morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0005330,cardiomyopathy|MP:0005599,increased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0008725,increased heart atrium size|MP:0008726,increased heart left atrium size|MP:0010402,ventricular septal defect|MP:0010724,thick interventricular septum|MP:0011925,abnormal heart echocardiography feature|MP:0031131,myocardial fiber disarray|MP:0031530,abnormal heart ventricle shape|MP:0031609,increased fetal cardiomyocyte size|MP:0031613,fetal cardiomyocyte disarray|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3822132	Tg(Myh7-Ptpn11*Q79R)11Rbns	MP:0001544,abnormal cardiovascular system physiology|MP:0001855,abnormal atrial thrombosis|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0002952,ventricular cardiomyopathy|MP:0002953,thick ventricular wall|MP:0003140,dilated heart atrium|MP:0004032,abnormal interventricular groove morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005630,increased lung weight|MP:0008022,dilated heart ventricle|MP:0010402,ventricular septal defect
MGI:3838149	Tg(Myh7-RARA/lacZ)30Mcco	MP:0000274,enlarged heart|MP:0001544,abnormal cardiovascular system physiology|MP:0001855,abnormal atrial thrombosis|MP:0001922,reduced male fertility|MP:0002652,thin myocardium|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003915,increased heart left ventricle weight|MP:0003921,abnormal heart left ventricle morphology|MP:0004061,papillary muscle hypoplasia|MP:0004084,abnormal cardiac muscle relaxation|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0008028,pregnancy-related premature death|MP:0010563,increased heart right ventricle size|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3838151	Tg(Myh7-RARA/lacZ)32Mcco	MP:0000274,enlarged heart|MP:0001544,abnormal cardiovascular system physiology|MP:0001855,abnormal atrial thrombosis|MP:0004084,abnormal cardiac muscle relaxation|MP:0004564,increased myocardial fiber size|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5446508	Tg(MYH7-Yap1*S112A)#Eno	MP:0002189,abnormal myocardial trabeculae morphology|MP:0005329,abnormal myocardium layer morphology|MP:0010656,thick myocardium
MGI:3699603	Tg(Myhca-Casq2)418Egk	MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0004084,abnormal cardiac muscle relaxation|MP:0004215,abnormal myocardial fiber physiology|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3813966	Tg(Myl1-cre)13Nros	MP:0005369,muscle phenotype|MP:0005378,growth/size/body region phenotype
MGI:5441720	Tg(Myl1-FST)F66Sjl	MP:0004818,increased skeletal muscle mass|MP:0009399,increased skeletal muscle fiber size|MP:0009401,increased skeletal muscle fiber diameter|MP:0010238,increased skeletal muscle weight
MGI:3055157	Tg(Myl1-Prkag3*R225Q)1Sson	MP:0000187,abnormal triglyceride level|MP:0002078,abnormal glucose homeostasis|MP:0010401,increased skeletal muscle glycogen level
MGI:5499110	Tg(Myl1-SOD1*G93A)#Amu	MP:0002106,abnormal muscle physiology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003674,oxidative stress|MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0004090,abnormal sarcomere morphology|MP:0004091,abnormal Z line morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006035,abnormal mitochondrial morphology|MP:0009417,skeletal muscle atrophy|MP:0011593,increased catalase activity|MP:0011630,increased mitochondrial size|MP:0011633,abnormal mitochondrial shape|MP:0011635,abnormal mitochondrial crista morphology|MP:0020448,increased microglial cell activation
MGI:6379619	Tg(Myl1-Trp53inp2)1Azo	MP:0000759,abnormal skeletal muscle morphology|MP:0003961,decreased lean body mass|MP:0004819,decreased skeletal muscle mass|MP:0005376,homeostasis/metabolism phenotype|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009402,decreased skeletal muscle fiber diameter|MP:0010239,decreased skeletal muscle weight|MP:0030941,enhanced autophagy
MGI:6379620	Tg(Myl1-Trp53inp2)2Azo	MP:0003961,decreased lean body mass|MP:0010239,decreased skeletal muscle weight|MP:0030941,enhanced autophagy
MGI:3510921	Tg(Myl2-FGF19)1Dfre	MP:0000005,increased brown adipose tissue amount|MP:0000598,abnormal liver morphology|MP:0001262,decreased body weight|MP:0002696,decreased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003893,increased hepatocyte proliferation|MP:0004499,increased incidence of tumors by chemical induction|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005448,abnormal energy homeostasis|MP:0005533,increased body temperature|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005668,decreased circulating leptin level|MP:0008019,increased liver tumor incidence|MP:0008965,increased basal metabolism|MP:0009289,decreased epididymal fat pad weight|MP:0009305,decreased retroperitoneal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0010025,decreased total body fat amount|MP:0011939,increased food intake|MP:0031414,decreased skeletal muscle triglyceride level
MGI:3505739	Tg(Myl2SLC2A1)2Mue	MP:0005560,decreased circulating glucose level|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:3761931	Tg(Mylpf-cre)3Kraj	MP:0002169,no abnormal phenotype detected
MGI:6286495	Tg(Myoc*Y423H)#Sit	MP:0003354,astrocytosis|MP:0003734,abnormal retina inner plexiform layer morphology|MP:0005203,abnormal trabecular meshwork morphology|MP:0005204,abnormal canal of Schlemm morphology|MP:0005258,ocular hypertension|MP:0005405,axon degeneration|MP:0006069,abnormal retina neuronal layer morphology|MP:0006219,optic nerve degeneration|MP:0008067,retina ganglion cell degeneration
MGI:5641919	Tg(MYOC*Y437H)#Sit	MP:0001330,abnormal optic nerve morphology|MP:0005258,ocular hypertension|MP:0005405,axon degeneration|MP:0006303,abnormal retina nerve fiber layer morphology|MP:0008067,retina ganglion cell degeneration|MP:0009450,abnormal axon fasciculation
MGI:7545567	Tg(Myog-Myhas)#Bcgen	MP:0002106,abnormal muscle physiology|MP:0005166,decreased susceptibility to injury|MP:0009401,increased skeletal muscle fiber diameter|MP:0009421,increased gastrocnemius weight|MP:0009423,increased extensor digitorum longus weight|MP:0009427,increased tibialis anterior weight|MP:0009461,skeletal muscle hypertrophy
MGI:3052131	Tg(Myog-Ntf3)5160Wds	MP:0000961,abnormal dorsal root ganglion morphology|MP:0004069,abnormal muscle spindle morphology|MP:0004297,abnormal proprioceptive neuron morphology
MGI:6106868	Tg(Myog-Ppargc1a_i4)#Brsp	MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009289,decreased epididymal fat pad weight|MP:0014143,decreased body fat mass
MGI:2182068	Tg(NEFH)200Jpj	MP:0000745,tremors|MP:0000748,progressive muscle weakness|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0001513,limb grasping|MP:0005404,abnormal axon morphology
MGI:4947051	Tg(NEFH)398Jpj	MP:0000745,tremors|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0001513,limb grasping
MGI:2665289	Tg(NEFL)29Jpj	MP:0000794,abnormal parietal lobe morphology|MP:0000804,abnormal occipital lobe morphology|MP:0000832,abnormal thalamus morphology|MP:0005386,behavior/neurological phenotype|MP:0008535,enlarged lateral ventricles|MP:0008948,decreased neuron number
MGI:2446543	Tg(NEFL-APP)#Nalb	MP:0000811,hippocampal neuron degeneration|MP:0001473,reduced long-term potentiation|MP:0002183,gliosis|MP:0003240,loss of hippocampal neurons|MP:0003329,amyloid beta deposits|MP:0012307,impaired spatial learning
MGI:5141088	Tg(NEFL*E397K)1Milg	MP:0000937,abnormal motor neuron morphology|MP:0001402,decreased locomotor activity|MP:0001513,limb grasping|MP:0002110,abnormal digit morphology|MP:0002269,muscular atrophy|MP:0004263,abnormal limb posture|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005404,abnormal axon morphology|MP:0008814,decreased nerve conduction velocity|MP:0009434,paraparesis
MGI:2389416	Tg(Nell1)1Ting	MP:0000081,premature cranial suture closure|MP:0011710,enhanced osteoblast differentiation
MGI:2654006	Tg(Neph1-Vegfa)1Seq	MP:0000523,cortical renal glomerulopathies|MP:0000533,kidney hemorrhage|MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality|MP:0002871,albuminuria|MP:0003606,kidney failure|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005327,abnormal mesangial cell morphology|MP:0009050,dilated proximal convoluted tubule|MP:0011320,abnormal glomerular capillary morphology|MP:0011402,renal cast|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011501,increased glomerular capsule space|MP:0011509,dilated glomerular capillary|MP:0011869,detached podocyte
MGI:2176173	Tg(Nes-cre)1Kln	MP:0001262,decreased body weight|MP:0002891,increased insulin sensitivity|MP:0005386,behavior/neurological phenotype|MP:0009299,decreased mesenteric fat pad weight|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0011940,decreased food intake
MGI:2386545	Tg(Nes-cre)1Wme	MP:0000745,tremors|MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000852,small cerebellum|MP:0001392,abnormal locomotor behavior|MP:0001525,impaired balance|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0001893,non-obstructive hydrocephaly|MP:0002083,premature death|MP:0003203,increased neuron apoptosis|MP:0004024,aneuploidy|MP:0005404,abnormal axon morphology|MP:0006254,thin cerebral cortex|MP:0008948,decreased neuron number|MP:0009703,decreased birth body size|MP:0011380,enlarged brain ventricles|MP:0012051,spasticity|MP:0012460,decreased dentate gyrus size|MP:0020394,decreased neuronal precursor proliferation|MP:0030956,abnormal neuronal precursor cell migration
MGI:4398673	Tg(Nes-cre/ERT2)1Imayo	MP:0000774,decreased brain size|MP:0000852,small cerebellum|MP:0001891,hydrocephaly|MP:0010152,abnormal brain ependyma morphology|MP:0012676,dilated brain ventricle|MP:0020394,decreased neuronal precursor proliferation
MGI:3817325	Tg(Nes-cre/ERT2)4Imayo	MP:0000774,decreased brain size|MP:0001891,hydrocephaly|MP:0020394,decreased neuronal precursor proliferation|MP:0031434,increased miscarriage rate
MGI:4355234	Tg(Nes-cre/ERT2)7Vtlr	MP:0002169,no abnormal phenotype detected
MGI:4420448	Tg(Nes-cre/Esr1*)1Kuan	MP:0002169,no abnormal phenotype detected
MGI:5448202	Tg(NES/TK-PDGFB,-lacZ)310Kfn	MP:0000249,abnormal blood vessel physiology|MP:0001004,abnormal retina photoreceptor morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001415,increased exploration in new environment|MP:0002792,abnormal retina vasculature morphology|MP:0003312,abnormal locomotor coordination|MP:0003690,abnormal glial cell physiology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005260,ocular hypotension|MP:0006042,increased apoptosis|MP:0006068,abnormal retina horizontal cell morphology|MP:0006069,abnormal retina neuronal layer morphology|MP:0006203,eye hemorrhage|MP:0006226,iris hypoplasia|MP:0008509,disorganized retina ganglion layer|MP:0008512,disorganized retina inner nuclear layer|MP:0008535,enlarged lateral ventricles|MP:0010098,abnormal retina blood vessel pattern|MP:0021107,retina fold|MP:0030005,increased retina apoptosis|MP:0031391,increased locomotor activity|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:2663944	Tg(NES-TVA)J12Ech	MP:0002006,neoplasm|MP:0002083,premature death|MP:0010278,increased glioma incidence|MP:0010312,increased oligodendroglioma incidence
MGI:3830738	Tg(Neurod2-Smo*A1)199Jols	MP:0000438,abnormal cranium morphology|MP:0000849,abnormal cerebellum morphology|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0001263,weight loss|MP:0001393,ataxia|MP:0001505,hunched posture|MP:0003631,nervous system phenotype|MP:0005191,head tilt|MP:0006283,increased medulloblastoma incidence|MP:0008925,increased cerebellar granule cell number|MP:0009027,abnormal subarachnoid space morphology|MP:0014237,decreased tumor-free survival time
MGI:5447065	Tg(Neurod2-Smo*A2)#Jols	MP:0000849,abnormal cerebellum morphology|MP:0000853,absent cerebellar foliation|MP:0000854,abnormal cerebellum development|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000885,ectopic Purkinje cell|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001505,hunched posture|MP:0001891,hydrocephaly|MP:0002006,neoplasm|MP:0003648,abnormal radial glial cell morphology|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004980,increased neuronal precursor cell number|MP:0005191,head tilt|MP:0005202,lethargy|MP:0005386,behavior/neurological phenotype|MP:0006009,abnormal neuronal migration|MP:0006283,increased medulloblastoma incidence|MP:0009967,abnormal neuron proliferation|MP:0011495,abnormal head shape
MGI:2182067	Tg(NFH)120Jpj	MP:0000745,tremors|MP:0000748,progressive muscle weakness|MP:0000937,abnormal motor neuron morphology|MP:0001513,limb grasping|MP:0005404,abnormal axon morphology
MGI:2182128	Tg(Nfh/lacZ)44AApt	MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000939,decreased motor neuron number|MP:0002882,abnormal neuron morphology|MP:0003224,neuron degeneration|MP:0003993,abnormal ventral spinal root morphology|MP:0004100,abnormal spinal cord interneuron morphology|MP:0005404,abnormal axon morphology|MP:0006069,abnormal retina neuronal layer morphology|MP:0010050,hypermyelination
MGI:1926645	Tg(Ngf)47Kma	MP:0000968,abnormal sensory neuron innervation pattern|MP:0001012,superior cervical ganglion hypertrophy|MP:0001094,trigeminal ganglion hypertrophy|MP:0002184,abnormal innervation
MGI:1926649	Tg(Ngf)56Kma	MP:0000968,abnormal sensory neuron innervation pattern|MP:0001012,superior cervical ganglion hypertrophy|MP:0001094,trigeminal ganglion hypertrophy|MP:0001265,decreased body size|MP:0002184,abnormal innervation|MP:0008489,slow postnatal weight gain
MGI:3695919	Tg(Nlrp1b)1Die	MP:0002451,abnormal macrophage physiology
MGI:2447657	Tg(NOS3)2Crom	MP:0004876,decreased mean systemic arterial blood pressure|MP:0004879,decreased systemic vascular resistance
MGI:2447660	Tg(NOS3)3Crom	MP:0004876,decreased mean systemic arterial blood pressure|MP:0004879,decreased systemic vascular resistance
MGI:1926638	Tg(Notch1)1Anc	MP:0000410,waved hair|MP:0000418,focal hair loss|MP:0001274,curly vibrissae|MP:0001282,short vibrissae
MGI:1926625	Tg(Notch1)A3Rko	MP:0002169,no abnormal phenotype detected
MGI:1926629	Tg(Notch1)A4Rko	MP:0002169,no abnormal phenotype detected
MGI:1926630	Tg(Notch1)A5Rko	MP:0000404,decreased curvature of zigzag hairs|MP:0000410,waved hair|MP:0000414,alopecia|MP:0000580,deformed nails|MP:0001274,curly vibrissae
MGI:1926633	Tg(Notch1)A7Rko	MP:0000404,decreased curvature of zigzag hairs|MP:0000410,waved hair|MP:0000414,alopecia|MP:0000580,deformed nails|MP:0001274,curly vibrissae
MGI:4429538	Tg(Notch3*R169C)88Bbb	MP:0000233,abnormal blood flow velocity|MP:0000249,abnormal blood vessel physiology|MP:0000920,abnormal myelination|MP:0003026,decreased vasoconstriction|MP:0003354,astrocytosis|MP:0003658,abnormal capillary morphology|MP:0004950,abnormal brain vasculature morphology|MP:0005595,abnormal vascular smooth muscle physiology|MP:0008025,brain vacuoles|MP:0008026,abnormal brain white matter morphology|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0013821,abnormal cerebral artery morphology
MGI:4942404	Tg(NPEPPS)1Skar	MP:0002169,no abnormal phenotype detected
MGI:6470404	Tg(Nphs1-ACE2)#Kdbu	MP:0001262,decreased body weight|MP:0002644,decreased circulating triglyceride level|MP:0011753,decreased podocyte number|MP:0020086,abnormal susceptibility to non-insulin-dependent diabetes
MGI:3762500	Tg(Nphs1-IL2RA)18Mska	MP:0001785,edema|MP:0002842,increased systemic arterial blood pressure|MP:0002962,increased urine protein level|MP:0003606,kidney failure|MP:0005264,glomerulosclerosis|MP:0005324,ascites|MP:0005567,decreased circulating total protein level|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5301702	Tg(Nphs1-Ptgs2)14Rhrs	MP:0002871,albuminuria|MP:0005165,increased susceptibility to injury|MP:0005326,abnormal podocyte morphology|MP:0008140,podocyte foot process effacement|MP:0011339,abnormal glomerular mesangium morphology|MP:0011409,increased renal glomerulus basement membrane thickness
MGI:2450359	Tg(NPHS2-cre)295Lbh	MP:0008140,podocyte foot process effacement|MP:0011409,increased renal glomerulus basement membrane thickness
MGI:4442436	Tg(NPHS2-cre/ERT2)#Mkas	MP:0002169,no abnormal phenotype detected
MGI:5004938	Tg(Nphs2-RNAi:Gpc5)#Enoi	MP:0005166,decreased susceptibility to injury|MP:0005389,reproductive system phenotype
MGI:3767326	Tg(NPHS2-rtTA,tetO-cre)1Holt	MP:0002169,no abnormal phenotype detected
MGI:5319640	Tg(NPHS2-Trpc6*E896K)F75aWalz	MP:0002871,albuminuria|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0008140,podocyte foot process effacement|MP:0011337,abnormal perihilar interstitium morphology|MP:0011339,abnormal glomerular mesangium morphology|MP:0011409,increased renal glomerulus basement membrane thickness
MGI:5319631	Tg(NPHS2-Trpc6)F419Walz	MP:0002871,albuminuria|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0008140,podocyte foot process effacement|MP:0011337,abnormal perihilar interstitium morphology|MP:0011339,abnormal glomerular mesangium morphology|MP:0011409,increased renal glomerulus basement membrane thickness
MGI:5319638	Tg(NPHS2-Trpc6*P111Q)F615Walz	MP:0002871,albuminuria|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0008140,podocyte foot process effacement|MP:0011337,abnormal perihilar interstitium morphology|MP:0011339,abnormal glomerular mesangium morphology|MP:0011409,increased renal glomerulus basement membrane thickness
MGI:3043003	Tg(NPPA-Bmp10)1Krc	MP:0000280,thin ventricular wall|MP:0001785,edema|MP:0010725,thin interventricular septum|MP:0014518,myocardial hypertrabeculation
MGI:5703795	Tg(Npy-EGFP/RNAi:Gad1)1Mirn	MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0013894,abnormal behavioral response to amphetamine
MGI:3709190	Tg(Npy-hrGFP)1Lowl	MP:0002169,no abnormal phenotype detected
MGI:3785480	Tg(Npy-MAPT/Sapphire)1Rck	MP:0002169,no abnormal phenotype detected
MGI:5007644	Tg(Nr4a1-EGFP/cre)820Khog	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype
MGI:5634784	Tg(Nrp2-cre/ERT2,-Kikume)1Qsch	MP:0002169,no abnormal phenotype detected
MGI:1926654	Tg(Ntf3)1Kma	MP:0000972,abnormal mechanoreceptor morphology|MP:0000976,hyperinnervation of hair guard cells|MP:0000978,hyperinnervation of hair-tylotrich cells|MP:0000986,increased Merkel's receptor number|MP:0000987,hyperinnervation of Merkel's receptor|MP:0001008,abnormal sympathetic ganglion morphology|MP:0001012,superior cervical ganglion hypertrophy|MP:0001020,L4 dorsal root ganglion hypertrophy|MP:0001023,L5 dorsal root ganglion hypertrophy|MP:0001081,abnormal cranial ganglia morphology|MP:0001094,trigeminal ganglion hypertrophy|MP:0001219,thick epidermis|MP:0002655,abnormal keratinocyte morphology
MGI:7510160	Tgoln1<em1(IMPC)J>	MP:0000063,decreased bone mineral density
MGI:5495671	Tg(Omp-Hist2h2be)14Dlc	MP:0003203,increased neuron apoptosis|MP:0006092,abnormal olfactory sensory neuron morphology
MGI:3040254	Tg(OMP-SV40T)13Bse	MP:0001272,increased metastatic potential|MP:0002031,increased adrenal gland tumor incidence|MP:0002039,increased neuroblastoma incidence|MP:0005000,abnormal immune tolerance|MP:0014237,decreased tumor-free survival time
MGI:3767977	Tg(OPN1LW-DT)1Mame	MP:0003732,abnormal retina outer plexiform layer morphology|MP:0004022,abnormal cone electrophysiology|MP:0008447,absent retina cone cells|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5705748	Tg(OPTN*E50K,-EGFP)1Mde	MP:0001330,abnormal optic nerve morphology|MP:0005405,axon degeneration|MP:0006149,decreased visual acuity|MP:0008067,retina ganglion cell degeneration|MP:0011831,abnormal visual contrast sensitivity
MGI:3766291	Tg(Or10j5-Or6a2*,-EYFP)1Hsak	MP:0001983,abnormal olfactory system physiology|MP:0006092,abnormal olfactory sensory neuron morphology
MGI:1926799	Tg(Otc)94Mori	MP:0002169,no abnormal phenotype detected
MGI:3767826	Tg(Otx2-Fezf2,Venus)1Hibi	MP:0000830,abnormal diencephalon morphology
MGI:2665339	Tg(PAH-INSR)1Rjv	MP:0000189,hypoglycemia|MP:0005292,improved glucose tolerance
MGI:5316840	Tg(PAX6)77Ndha	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001312,abnormal cornea morphology|MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0002699,abnormal vitreous body morphology|MP:0005099,abnormal ciliary body morphology|MP:0005193,abnormal anterior eye segment morphology|MP:0005195,abnormal posterior eye segment morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005391,vision/eye phenotype|MP:0006069,abnormal retina neuronal layer morphology|MP:0008509,disorganized retina ganglion layer|MP:0009770,abnormal optic chiasm morphology|MP:0021107,retina fold
MGI:5538391	Tg(Pax6-GFP/cre)1Rilm	MP:0005391,vision/eye phenotype
MGI:5430364	Tg(Pax6-HRAS*G12V)2044Ove	MP:0001286,abnormal eye development|MP:0001307,fused cornea and lens|MP:0005300,abnormal cornea stroma morphology|MP:0005545,abnormal lens development|MP:0006000,abnormal cornea epithelium morphology|MP:0009264,failure of eyelid fusion|MP:0011697,lens vacuoles
MGI:5517702	Tg(Pax6-TAg)1796Hur	MP:0006310,increased retinoblastoma incidence|MP:0009772,abnormal retina development|MP:0010295,increased eye tumor incidence
MGI:3831171	Tg(Pbsn-Ar*E231G)7353Ng	MP:0001168,abnormal prostate gland epithelium morphology|MP:0001272,increased metastatic potential|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0009380,abnormal prostate gland ventral lobe morphology|MP:0010357,increased prostate gland tumor incidence|MP:0031365,prostate gland ventral lobe hyperplasia
MGI:3505712	Tg(Pbsn-Cdc37)1Stp	MP:0001158,abnormal prostate gland morphology|MP:0001167,prostate gland epithelial hyperplasia
MGI:4358243	Tg(Pbsn-ERG*)1Vv	MP:0001168,abnormal prostate gland epithelium morphology|MP:0002083,premature death|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0010357,increased prostate gland tumor incidence
MGI:2448654	Tg(Pbsn-FGF7)3293Ng	MP:0000659,prostate gland hyperplasia|MP:0001158,abnormal prostate gland morphology|MP:0001167,prostate gland epithelial hyperplasia|MP:0001168,abnormal prostate gland epithelium morphology|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009734,abnormal prostate gland duct morphology
MGI:5009680	Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp	MP:0000659,prostate gland hyperplasia|MP:0001272,increased metastatic potential|MP:0002032,increased sarcoma incidence|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0009737,prostate gland cyst|MP:0010357,increased prostate gland tumor incidence
MGI:5565702	Tg(Pbsn-FGFR1*K656E)#Wmck	MP:0000659,prostate gland hyperplasia|MP:0001922,reduced male fertility|MP:0002083,premature death|MP:0003607,abnormal prostate gland physiology|MP:0004958,enlarged prostate gland|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0011801,urethra obstruction
MGI:5009681	Tg(Pbsn-Fgfr2/Fkbp1a)#Dmsp	MP:0005379,endocrine/exocrine gland phenotype
MGI:2448655	Tg(Pbsn-FGFR2_iiib*)#Ng	MP:0001158,abnormal prostate gland morphology|MP:0001168,abnormal prostate gland epithelium morphology|MP:0002774,small prostate gland|MP:0009734,abnormal prostate gland duct morphology
MGI:4358581	Tg(Pbsn-Hpn,-GFP)DVv	MP:0001158,abnormal prostate gland morphology
MGI:3831172	Tg(Pbsn-IGF1*)5305Ng	MP:0001158,abnormal prostate gland morphology|MP:0001168,abnormal prostate gland epithelium morphology|MP:0002006,neoplasm|MP:0009219,increased prostate intraepithelial neoplasia incidence
MGI:5633983	Tg(Pbsn-Lrp5/Fkbp1a,-luc*)#Dmps	MP:0000659,prostate gland hyperplasia
MGI:3619445	Tg(Pbsn-MYC)6Key	MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0010357,increased prostate gland tumor incidence
MGI:5566832	Tg(Pbsn-MYC)#Tt	MP:0001158,abnormal prostate gland morphology|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence
MGI:3808599	Tg(Pbsn-SFRP1)1Pcma	MP:0001158,abnormal prostate gland morphology
MGI:3040284	Tg(Pbsn-Tag)12T10Rjm	MP:0001272,increased metastatic potential|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0010357,increased prostate gland tumor incidence
MGI:3706555	Tg(Pbsn-Tag)12T7fRjm	MP:0000659,prostate gland hyperplasia|MP:0001158,abnormal prostate gland morphology|MP:0004958,enlarged prostate gland|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0010357,increased prostate gland tumor incidence
MGI:3794201	Tg(Pbsn-TAg)15Tvd	MP:0001167,prostate gland epithelial hyperplasia|MP:0001168,abnormal prostate gland epithelium morphology|MP:0001925,male infertility|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence
MGI:2447853	Tg(Pcp2-ATXN1*30Q)2Horr	MP:0000890,thin cerebellar molecular layer|MP:0003894,abnormal Purkinje cell innervation|MP:0005386,behavior/neurological phenotype|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:5518614	Tg(Pcp2-ATXN1*30Q*S776D)2Horr	MP:0000890,thin cerebellar molecular layer|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0003894,abnormal Purkinje cell innervation|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:2447854	Tg(Pcp2-ATXN1*82Q)5Horr	MP:0000849,abnormal cerebellum morphology|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000885,ectopic Purkinje cell|MP:0000889,abnormal cerebellar molecular layer|MP:0000890,thin cerebellar molecular layer|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0002183,gliosis|MP:0003894,abnormal Purkinje cell innervation|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0010387,abnormal Bergmann glial cell morphology
MGI:5518615	Tg(Pcp2-ATXN1*82Q*S776D)5Horr	MP:0000890,thin cerebellar molecular layer|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:5467321	Tg(Pcp2-ATXN2*127Q)#Plt	MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000890,thin cerebellar molecular layer|MP:0001405,impaired coordination|MP:0002272,abnormal nervous system electrophysiology
MGI:5523235	Tg(Pcp2-ATXN3*69Q)bHirai	MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000877,abnormal Purkinje cell morphology|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0004191,neuronal intranuclear inclusions|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0014185,cerebellum atrophy
MGI:2137515	Tg(Pcp2-cre)2Mpin	MP:0002169,no abnormal phenotype detected
MGI:3848942	Tg(Pcp2-EGFP*)1Dln	MP:0000880,decreased Purkinje cell number|MP:0004191,neuronal intranuclear inclusions
MGI:3848937	Tg(Pcp2-FMR1*)1Dln	MP:0000880,decreased Purkinje cell number|MP:0001405,impaired coordination|MP:0004191,neuronal intranuclear inclusions
MGI:3505741	Tg(Pcp2-SCA2)11Plt	MP:0000880,decreased Purkinje cell number|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:2447846	Tg(Pcp2-SCA7)P7EJman	MP:0000876,Purkinje cell degeneration|MP:0001405,impaired coordination|MP:0004191,neuronal intranuclear inclusions|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:5142235	Tg(Pcp2-TBP*)69Hmhl	MP:0000788,abnormal cerebral cortex morphology|MP:0000811,hippocampal neuron degeneration|MP:0000835,abnormal subthalamic nucleus morphology|MP:0000852,small cerebellum|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0001847,brain inflammation|MP:0002183,gliosis|MP:0002574,increased vertical activity|MP:0003224,neuron degeneration|MP:0004080,abnormal nucleus accumbens morphology|MP:0004081,abnormal globus pallidus morphology|MP:0004102,abnormal dorsal striatum morphology|MP:0005277,abnormal brainstem morphology|MP:0006007,abnormal basal ganglion morphology|MP:0009980,abnormal cerebellum dentate nucleus morphology|MP:0014185,cerebellum atrophy|MP:0031391,increased locomotor activity
MGI:4440595	Tg(PDGFB-Adra2b)13Hag	MP:0006144,increased systemic arterial systolic blood pressure
MGI:3057135	Tg(PDGFB-APP)5Lms	MP:0002229,neurodegeneration|MP:0003329,amyloid beta deposits|MP:0003631,nervous system phenotype
MGI:5550581	Tg(PDGFB-APPInd)F17Plhn	MP:0000794,abnormal parietal lobe morphology|MP:0000798,abnormal frontal lobe morphology|MP:0001363,increased anxiety-related response|MP:0002063,abnormal learning/memory/conditioning|MP:0002083,premature death|MP:0003224,neuron degeneration|MP:0008143,abnormal dendrite morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0012307,impaired spatial learning
MGI:5003453	Tg(PDGFB-APPSwDutLon)46Lpr	MP:0003329,amyloid beta deposits
MGI:3603941	Tg(PDGFB-APPSweIndArc)48Lms	MP:0000604,amyloidosis|MP:0002882,abnormal neuron morphology|MP:0003329,amyloid beta deposits
MGI:3603942	Tg(PDGFB-APPSweIndArc)6Lms	MP:0002882,abnormal neuron morphology|MP:0003329,amyloid beta deposits
MGI:3717718	Tg(PDGFB-APPSwInd)J9Lms	MP:0002229,neurodegeneration|MP:0003329,amyloid beta deposits
MGI:3768633	Tg(PDGFB-GPR37)20Ryot	MP:0001399,hyperactivity|MP:0001906,increased dopamine level|MP:0003631,nervous system phenotype
MGI:3050236	Tg(PDGFB-Hyou1)#Tam	MP:0003075,abnormal response to CNS ischemic injury|MP:0008236,decreased susceptibility to neuronal excitotoxicity
MGI:5559903	Tg(PDGFB-LRRK2*G2019S)32Hlw	MP:0001402,decreased locomotor activity|MP:0003224,neuron degeneration|MP:0003243,abnormal dopaminergic neuron morphology|MP:0004250,tau protein deposits|MP:0005156,bradykinesia|MP:0013219,abnormal substantia nigra pars compacta morphology
MGI:4950671	Tg(PDGFB-LRRK2*G2019S)340Djmo	MP:0001764,abnormal homeostasis|MP:0002882,abnormal neuron morphology|MP:0005404,abnormal axon morphology|MP:0008260,abnormal autophagy|MP:0008415,abnormal neurite morphology|MP:0010069,increased serotonin level|MP:0011448,decreased dopaminergic neuron number
MGI:5800408	Tg(PDGFB-LRRK2*R1441C)31Hlw	MP:0002757,decreased vertical activity|MP:0003244,loss of dopaminergic neurons|MP:0003631,nervous system phenotype|MP:0005156,bradykinesia|MP:0008571,abnormal synaptic bouton morphology|MP:0010149,abnormal synaptic dopamine release
MGI:4950673	Tg(PDGFB-LRRK2*R1441C)574Djmo	MP:0001402,decreased locomotor activity|MP:0002757,decreased vertical activity|MP:0002882,abnormal neuron morphology|MP:0005643,decreased dopamine level|MP:0005664,decreased circulating noradrenaline level|MP:0008260,abnormal autophagy
MGI:3604147	Tg(PDGFB-MAPT*V337M)1Atak	MP:0000811,hippocampal neuron degeneration|MP:0002272,abnormal nervous system electrophysiology|MP:0002882,abnormal neuron morphology|MP:0003240,loss of hippocampal neurons|MP:0004250,tau protein deposits
MGI:3528873	Tg(PDGFB-SNCA)4Ema	MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001516,abnormal motor coordination/balance|MP:0002797,increased thigmotaxis|MP:0003244,loss of dopaminergic neurons|MP:0004191,neuronal intranuclear inclusions|MP:0005643,decreased dopamine level|MP:0008493,alpha-synuclein inclusion body
MGI:5699838	Tg(PDGFB-SNCA*A53T)8Ema	MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002184,abnormal innervation|MP:0002229,neurodegeneration|MP:0003632,abnormal nervous system morphology|MP:0008493,alpha-synuclein inclusion body|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010070,decreased serotonin level
MGI:5824305	Tg(PDGFB-SNCA/EGFP)78Ema	MP:0005058,abnormal lysosome morphology|MP:0008143,abnormal dendrite morphology|MP:0008493,alpha-synuclein inclusion body|MP:0008571,abnormal synaptic bouton morphology
MGI:5008738	Tg(PDGFB-UCHL1*I93M)HWada	MP:0001402,decreased locomotor activity|MP:0003632,abnormal nervous system morphology|MP:0004077,abnormal striatum morphology|MP:0011448,decreased dopaminergic neuron number|MP:0020875,decreased nervous system dopamine level|MP:0031391,increased locomotor activity
MGI:5008736	Tg(PDGFB-UCHL1*I93M)LWada	MP:0003631,nervous system phenotype|MP:0011451,increased susceptibility to dopaminergic neuron neurotoxicity
MGI:3763193	Tg(Pdgfrb-cre)9Rha	MP:0002169,no abnormal phenotype detected
MGI:5049965	Tg(PDGF-S100B)36Cqin	MP:0001405,impaired coordination|MP:0001906,increased dopamine level
MGI:3774305	Tg(Pdx1-cre)1Heed	MP:0002169,no abnormal phenotype detected
MGI:3774306	Tg(Pdx1-EGFP)1Heed	MP:0002169,no abnormal phenotype detected
MGI:3774304	Tg(Pdx1-Ffar1)AHeed	MP:0003059,decreased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005293,impaired glucose tolerance|MP:0009254,disorganized pancreatic islets
MGI:3809539	Tg(Pdx1-Myt1)2Ggu	MP:0005215,abnormal pancreatic islet morphology
MGI:3693631	Tg(Pdx1-Neurog3)1Heed	MP:0003934,abnormal pancreas development
MGI:3693633	Tg(Pdx1-Notch3)1Heed	MP:0003934,abnormal pancreas development
MGI:3837438	Tg(PER2*S662D)382Ljp	MP:0020469,prolonged circadian behavior period
MGI:3837437	Tg(PER2*S662G)867Ljp	MP:0020469,prolonged circadian behavior period
MGI:5751206	Tg(PER3)L474Ljp	MP:0005386,behavior/neurological phenotype
MGI:5751250	Tg(PER3*P415A*H417R)1Ljp	MP:0001501,abnormal sleep pattern|MP:0002573,behavioral despair|MP:0012286,decreased frequency of paradoxical sleep|MP:0012289,abnormal non-rapid eye movement sleep pattern|MP:0020469,prolonged circadian behavior period|MP:0020475,delayed circadian behavior phase
MGI:3054406	Tg(PF4MER)6Kra	MP:0000229,abnormal megakaryocyte differentiation|MP:0000691,enlarged spleen|MP:0002417,abnormal megakaryocyte morphology|MP:0008254,increased megakaryocyte cell number
MGI:3789607	Tg(Pfkl)224Yg	MP:0005584,abnormal enzyme/coenzyme activity
MGI:3722189	Tg(Pgk1-FGF2)15Cofn	MP:0000074,abnormal neurocranium morphology|MP:0000343,abnormal response to cardiac infarction|MP:0000434,megacephaly|MP:0002657,chondrodystrophy|MP:0002823,abnormal rib development|MP:0002975,vascular smooth muscle hypertrophy|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003109,short femur|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004686,decreased length of long bones|MP:0005108,abnormal ulna morphology|MP:0008489,slow postnatal weight gain
MGI:3722245	Tg(Pgk1-FGF2)16Cofn	MP:0000434,megacephaly|MP:0002657,chondrodystrophy|MP:0002975,vascular smooth muscle hypertrophy|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004686,decreased length of long bones|MP:0006395,abnormal epiphyseal plate morphology
MGI:3722188	Tg(Pgk1-FGF2)48Cofn	MP:0000434,megacephaly|MP:0002657,chondrodystrophy|MP:0002975,vascular smooth muscle hypertrophy|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004686,decreased length of long bones|MP:0006395,abnormal epiphyseal plate morphology
MGI:4415609	Tg(Pgk1-flpo)10Sykr	MP:0002169,no abnormal phenotype detected
MGI:5700531	Tg(PGK1-FTL*)#Sle	MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0003674,oxidative stress|MP:0004191,neuronal intranuclear inclusions|MP:0005386,behavior/neurological phenotype|MP:0005637,abnormal iron homeostasis|MP:0008842,lipofuscinosis|MP:0009745,abnormal behavioral response to xenobiotic|MP:0011891,decreased circulating ferritin level|MP:0020365,increased brain iron level
MGI:5883014	Tg(PGK1-Gnas*R201C)60Pabi	MP:0000061,fragile skeleton|MP:0005508,abnormal skeleton morphology
MGI:3817558	Tg(PGK1-KITLG*220)441Daw	MP:0000370,head blaze|MP:0000373,belly spot|MP:0000703,abnormal thymus morphology|MP:0002940,variable body spotting
MGI:5300514	Tg(PGK2-sb10)1780Ove	MP:0002169,no abnormal phenotype detected
MGI:7516772	Tg(Pgk-tetR,tetO-RNAi:Pum3)#Yuj	MP:0002982,abnormal primordial germ cell migration|MP:0008391,abnormal primordial germ cell morphology|MP:0008392,decreased primordial germ cell number|MP:0030934,decreased primordial germ cell proliferation
MGI:3590500	Tg(Pim1-Il9)5Jcrd	MP:0002024,increased T cell derived lymphoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008702,increased interleukin-5 secretion
MGI:4437719	Tg(Pkd1)18Mtru	MP:0000208,decreased hematocrit|MP:0000231,hypertension|MP:0000522,kidney cortex cyst|MP:0002083,premature death|MP:0002708,nephrolithiasis|MP:0002962,increased urine protein level|MP:0003141,cardiac fibrosis|MP:0003197,nephrocalcinosis|MP:0003675,kidney cyst|MP:0004969,pale kidney|MP:0005264,glomerulosclerosis|MP:0011307,kidney medulla cyst
MGI:4437718	Tg(Pkd1)26Mtru	MP:0000208,decreased hematocrit|MP:0000231,hypertension|MP:0000522,kidney cortex cyst|MP:0000852,small cerebellum|MP:0000854,abnormal cerebellum development|MP:0001566,increased circulating phosphate level|MP:0001625,cardiac hypertrophy|MP:0001762,polyuria|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002625,heart left ventricle hypertrophy|MP:0002705,dilated renal tubule|MP:0002708,nephrolithiasis|MP:0002833,increased heart weight|MP:0002837,dystrophic cardiac calcinosis|MP:0002953,thick ventricular wall|MP:0002962,increased urine protein level|MP:0002963,decreased urine protein level|MP:0003141,cardiac fibrosis|MP:0003197,nephrocalcinosis|MP:0003215,renal interstitial fibrosis|MP:0003279,aneurysm|MP:0003327,liver cyst|MP:0003333,liver fibrosis|MP:0003394,increased cardiac output|MP:0003675,kidney cyst|MP:0003843,abnormal sagittal suture morphology|MP:0003893,increased hepatocyte proliferation|MP:0004937,dilated heart|MP:0004968,kidney epithelium hyperplasia|MP:0004969,pale kidney|MP:0005161,hematuria|MP:0005264,glomerulosclerosis|MP:0005329,abnormal myocardium layer morphology|MP:0005633,increased circulating sodium level|MP:0006116,calcified aortic valve|MP:0006117,aortic valve stenosis|MP:0008997,increased blood osmolality|MP:0009640,abnormal renal tubule epithelium morphology|MP:0010595,abnormal aortic valve cusp morphology|MP:0010724,thick interventricular septum|MP:0011307,kidney medulla cyst|MP:0011402,renal cast|MP:0011440,increased kidney cell proliferation|MP:0011951,increased cardiac stroke volume|MP:0012676,dilated brain ventricle|MP:0031109,subarachnoid hemorrhage
MGI:5519083	Tg(Pkd1*)39Mtru	MP:0000208,decreased hematocrit|MP:0001762,polyuria|MP:0001765,abnormal ion homeostasis|MP:0002083,premature death|MP:0002705,dilated renal tubule|MP:0002962,increased urine protein level|MP:0002988,decreased urine osmolality|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0004969,pale kidney|MP:0005325,abnormal renal glomerulus morphology|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008528,polycystic kidney|MP:0011346,renal tubule atrophy|MP:0011467,decreased urine urea nitrogen level|MP:0011471,decreased urine creatinine level|MP:0011682,renal glomerulus cyst
MGI:4437717	Tg(Pkd1)6Mtru	MP:0000208,decreased hematocrit|MP:0000522,kidney cortex cyst|MP:0001625,cardiac hypertrophy|MP:0001762,polyuria|MP:0002083,premature death|MP:0002625,heart left ventricle hypertrophy|MP:0002705,dilated renal tubule|MP:0002708,nephrolithiasis|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0002962,increased urine protein level|MP:0003197,nephrocalcinosis|MP:0003215,renal interstitial fibrosis|MP:0003327,liver cyst|MP:0003333,liver fibrosis|MP:0003675,kidney cyst|MP:0003893,increased hepatocyte proliferation|MP:0004937,dilated heart|MP:0004968,kidney epithelium hyperplasia|MP:0004969,pale kidney|MP:0005161,hematuria|MP:0005264,glomerulosclerosis|MP:0005599,increased cardiac muscle contractility|MP:0005633,increased circulating sodium level|MP:0008055,increased urine osmolality|MP:0008997,increased blood osmolality|MP:0009640,abnormal renal tubule epithelium morphology|MP:0010595,abnormal aortic valve cusp morphology|MP:0010724,thick interventricular septum|MP:0011307,kidney medulla cyst|MP:0011402,renal cast|MP:0011440,increased kidney cell proliferation|MP:0011467,decreased urine urea nitrogen level|MP:0011471,decreased urine creatinine level
MGI:5428762	Tg(Pklr-HRAS*G12V)21Ak	MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001925,male infertility|MP:0002083,premature death|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0008528,polycystic kidney
MGI:5428752	Tg(Pklr-HRAS*G12V)23Ak	MP:0002703,abnormal renal tubule morphology|MP:0003331,increased hepatocellular carcinoma incidence|MP:0010264,increased hepatoma incidence|MP:0010294,increased kidney tumor incidence
MGI:5428913	Tg(Pklr-Myc)73Ak	MP:0003331,increased hepatocellular carcinoma incidence|MP:0005491,pancreatic islet hyperplasia|MP:0008040,decreased NK T cell number|MP:0010264,increased hepatoma incidence
MGI:5429578	Tg(Pklr-SV40)1Ak	MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003364,increased insulinoma incidence|MP:0003789,increased osteosarcoma incidence|MP:0005491,pancreatic islet hyperplasia|MP:0009153,increased pancreas tumor incidence|MP:0009308,increased adenocarcinoma incidence|MP:0010264,increased hepatoma incidence
MGI:3766007	Tg(PLA2G2A)703Dsg	MP:0000381,enlarged hair follicles|MP:0000414,alopecia|MP:0000652,enlarged sebaceous gland|MP:0001200,thick skin|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0005387,immune system phenotype
MGI:4459455	Tg(PLP1*)4Rsj	MP:0000745,tremors|MP:0000746,weakness|MP:0000755,hindlimb paralysis|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0003354,astrocytosis|MP:0003871,abnormal myelin sheath morphology|MP:0005202,lethargy|MP:0006082,CNS inflammation|MP:0009358,environmentally induced seizures|MP:0009434,paraparesis|MP:0012029,abnormal electroretinogram waveform feature
MGI:2450391	Tg(Plp1-cre/ERT)3Pop	MP:0002169,no abnormal phenotype detected
MGI:6116281	Tg(Plp1-Eif2ak3*)18Pop	MP:0000745,tremors|MP:0000953,abnormal oligodendrocyte morphology|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0003631,nervous system phenotype|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005404,abnormal axon morphology|MP:0008026,abnormal brain white matter morphology|MP:0011731,decreased myelin sheath thickness|MP:0013272,abnormal translation|MP:0013438,dysmyelination
MGI:5700344	Tg(Plp1-HTT*150Q)4aXjl	MP:0000745,tremors|MP:0000921,demyelination|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0005405,axon degeneration
MGI:5697874	Tg(Plp1-LMNB1)1108Qsp	MP:0000160,kyphosis|MP:0000756,forelimb paralysis|MP:0000921,demyelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0001393,ataxia|MP:0001547,abnormal lipid level|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0003354,astrocytosis|MP:0003983,decreased cholesterol level|MP:0004777,abnormal phospholipid level|MP:0005113,decreased spinal cord ventral horn cell number|MP:0005405,axon degeneration|MP:0008027,abnormal spinal cord white matter morphology|MP:0008918,microgliosis|MP:0009823,abnormal sphingomyelin level|MP:0010160,increased oligodendrocyte number
MGI:5491149	Tg(Plp1-Lmnb1)#Yfu	MP:0000921,demyelination|MP:0001405,impaired coordination|MP:0002064,seizures|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0003871,abnormal myelin sheath morphology|MP:0005405,axon degeneration
MGI:3604008	Tg(Plp1-SNCA)1Haa	MP:0000852,small cerebellum|MP:0000880,decreased Purkinje cell number|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0002757,decreased vertical activity|MP:0003224,neuron degeneration|MP:0003244,loss of dopaminergic neurons|MP:0003354,astrocytosis|MP:0004077,abnormal striatum morphology|MP:0008918,microgliosis|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:2388028	Tg(Plp)66Kan	MP:0000160,kyphosis|MP:0000745,tremors|MP:0000921,demyelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0001263,weight loss|MP:0001393,ataxia|MP:0002064,seizures|MP:0002083,premature death|MP:0003354,astrocytosis|MP:0003871,abnormal myelin sheath morphology|MP:0005405,axon degeneration|MP:0010205,abnormal oligodendrocyte apoptosis
MGI:5447029	Tg(Plp)72Kan	MP:0000921,demyelination|MP:0001330,abnormal optic nerve morphology|MP:0002083,premature death|MP:0003354,astrocytosis|MP:0004267,abnormal optic tract morphology|MP:0004768,abnormal axonal transport|MP:0008814,decreased nerve conduction velocity|MP:0011731,decreased myelin sheath thickness|MP:0013438,dysmyelination|MP:0020378,abnormal cell cytoskeleton morphology
MGI:3054872	Tg(PLTP)1Pgn	MP:0000180,abnormal circulating cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0020125,increased circulating HDL phospholipid level|MP:0021043,decreased circulating LDL phospholipid level|MP:0021045,decreased circulating VLDL phospholipid level
MGI:3785576	Tg(Pmch-ATXN3*)3Rck	MP:0000837,abnormal hypothalamus morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002727,decreased circulating insulin level|MP:0003961,decreased lean body mass|MP:0004889,increased energy expenditure|MP:0005376,homeostasis/metabolism phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0010025,decreased total body fat amount|MP:0011940,decreased food intake
MGI:3033300	Tg(PML-RARA)556Kog	MP:0000218,increased leukocyte cell number|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001914,hemorrhage|MP:0002051,increased skin papilloma incidence|MP:0002415,abnormal neutrophil differentiation|MP:0002551,abnormal blood coagulation|MP:0003179,thrombocytopenia|MP:0004049,increased acute promyelocytic leukemia incidence|MP:0005505,thrombocytosis|MP:0031167,abnormal lung thrombosis
MGI:2183755	Tg(Pmp22)247Ueli	MP:0000920,abnormal myelination|MP:0001106,abnormal Schwann cell morphology
MGI:2183770	Tg(PMP22)C22Clh	MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000920,abnormal myelination|MP:0001406,abnormal gait|MP:0001922,reduced male fertility|MP:0002083,premature death|MP:0008912,nervous|MP:0010742,increased Schwann cell number|MP:0010800,abnormal submucous nerve plexus morphology|MP:0011731,decreased myelin sheath thickness|MP:0013438,dysmyelination
MGI:5817407	Tg(PMP22)C22Fbas	MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001106,abnormal Schwann cell morphology|MP:0001402,decreased locomotor activity|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0005402,abnormal action potential|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0008814,decreased nerve conduction velocity|MP:0010050,hypermyelination|MP:0010800,abnormal submucous nerve plexus morphology|MP:0013438,dysmyelination
MGI:5817396	Tg(PMP22)C3Fbas	MP:0000920,abnormal myelination|MP:0001106,abnormal Schwann cell morphology|MP:0001402,decreased locomotor activity|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0005402,abnormal action potential|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0008814,decreased nerve conduction velocity|MP:0010050,hypermyelination|MP:0010800,abnormal submucous nerve plexus morphology|MP:0013438,dysmyelination
MGI:4819405	Tg(PMP22)C61Clh	MP:0000921,demyelination|MP:0005402,abnormal action potential|MP:0005425,increased macrophage cell number|MP:0008814,decreased nerve conduction velocity|MP:0010053,decreased grip strength
MGI:2183742	Tg(Pmp22)My41Clh	MP:0000746,weakness|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001406,abnormal gait|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002083,premature death|MP:0005405,axon degeneration|MP:0010742,increased Schwann cell number|MP:0010800,abnormal submucous nerve plexus morphology|MP:0011731,decreased myelin sheath thickness|MP:0013438,dysmyelination
MGI:5006974	Tg(Pnkd*A7V*A9V,-DsRed)671Ljp	MP:0001905,abnormal dopamine level|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003635,abnormal synaptic transmission|MP:0005643,decreased dopamine level|MP:0009745,abnormal behavioral response to xenobiotic|MP:0010149,abnormal synaptic dopamine release
MGI:5466584	Tg(Pnkd*A7V*A9V,-DsRed)704Ljp	MP:0001905,abnormal dopamine level|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003635,abnormal synaptic transmission|MP:0005643,decreased dopamine level|MP:0009745,abnormal behavioral response to xenobiotic|MP:0010149,abnormal synaptic dopamine release
MGI:5466586	Tg(Pnkd,-DsRed)445Ljp	MP:0002169,no abnormal phenotype detected
MGI:3640616	Tg(Pomc1-cre)16Lowl	MP:0002169,no abnormal phenotype detected
MGI:3709191	Tg(Pomc1-hrGFP)1Lowl	MP:0002169,no abnormal phenotype detected
MGI:4353096	Tg(Pomc-FLP)1aBrn	MP:0002169,no abnormal phenotype detected
MGI:4353097	Tg(Pomc-FLP)1bBrn	MP:0002169,no abnormal phenotype detected
MGI:4833830	Tg(Pomc)#Low	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype
MGI:3785478	Tg(Pomc-MAPT/Topaz)1Rck	MP:0002169,no abnormal phenotype detected
MGI:3785562	Tg(Pomc-rtTA)1Rck	MP:0002169,no abnormal phenotype detected
MGI:4356000	Tg(Ppp1r1b-cre)1Meeh	MP:0002169,no abnormal phenotype detected
MGI:3813481	Tg(Ppp1r1b-HTT*)1Meeh	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002175,decreased brain weight|MP:0004191,neuronal intranuclear inclusions|MP:0008489,slow postnatal weight gain|MP:0013908,small lateral ventricles
MGI:3604080	Tg(Prdx6)153Pgn	MP:0002451,abnormal macrophage physiology|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0014599,decreased susceptibility to hyperoxia-induced injury
MGI:3055287	Tg(PRG1)18Wlad	MP:0020937,increased susceptibility to Picornaviridae infection|MP:0020938,decreased susceptibility to Picornaviridae infection|MP:0031040,increased susceptibility to Picornaviridae infection induced morbidity/mortality
MGI:3055289	Tg(PRG3)9Wlad	MP:0020937,increased susceptibility to Picornaviridae infection
MGI:5696741	Tg(Prl-EGFR)#Sme	MP:0003505,increased prolactinoma incidence|MP:0005124,increased circulating prolactin level
MGI:3702329	Tg(Prm1-cre)1Mrc	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0005389,reproductive system phenotype
MGI:4367777	Tg(Prm1-Mir124a)1Min	MP:0002865,increased growth rate|MP:0003378,early sexual maturation
MGI:3525701	Tg(Prm1-Tfam)4Lrsn	MP:0005384,cellular phenotype
MGI:2447139	Tg(Prnp)1D4Lnq	MP:0000849,abnormal cerebellum morphology|MP:0001263,weight loss|MP:0001393,ataxia|MP:0001412,excessive scratching|MP:0001511,disheveled coat|MP:0002183,gliosis|MP:0003224,neuron degeneration|MP:0014185,cerebellum atrophy
MGI:2447138	Tg(Prnp)2D1Lnq	MP:0001391,abnormal tail movements|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002183,gliosis|MP:0003224,neuron degeneration|MP:0003632,abnormal nervous system morphology|MP:0014185,cerebellum atrophy
MGI:5491029	Tg(Prnp)4053Sbp	MP:0003633,abnormal nervous system physiology|MP:0005364,increased susceptibility to prion infection
MGI:2447133	Tg(Prnp)a20Cwe	MP:0005364,increased susceptibility to prion infection|MP:0005405,axon degeneration
MGI:3800823	Tg(Prnp-Abca1)EHol	MP:0001146,abnormal testis morphology|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0003205,testicular atrophy|MP:0003329,amyloid beta deposits|MP:0003690,abnormal glial cell physiology|MP:0003830,abnormal testis development|MP:0004852,decreased testis weight|MP:0005376,homeostasis/metabolism phenotype|MP:0008469,abnormal protein level|MP:0020550,multinucleated giant male germ cells
MGI:3835599	Tg(Prnp-APOE4)3R1Dbo	MP:0003631,nervous system phenotype
MGI:4818971	Tg(Prnp-APP*)1Hmor	MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0002882,abnormal neuron morphology|MP:0002920,decreased paired-pulse facilitation|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0008918,microgliosis|MP:0008948,decreased neuron number
MGI:4818980	Tg(Prnp-APP*)3Hmor	MP:0001473,reduced long-term potentiation|MP:0002920,decreased paired-pulse facilitation
MGI:3696803	Tg(Prnp-APP)A-2Dbo	MP:0002169,no abnormal phenotype detected
MGI:3696473	Tg(Prnp-App/APPswe)E1-2Dbo	MP:0001363,increased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001458,abnormal object recognition memory|MP:0001463,abnormal spatial learning|MP:0002757,decreased vertical activity|MP:0003329,amyloid beta deposits
MGI:4818979	Tg(Prnp-APP)#Hmor	MP:0001473,reduced long-term potentiation|MP:0002920,decreased paired-pulse facilitation|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype
MGI:3589474	Tg(PRNP-APPSwe)6Dwst	MP:0003631,nervous system phenotype
MGI:5553464	Tg(Prnp-APPSweArc)#Rmni	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001613,abnormal vasodilation|MP:0002063,abnormal learning/memory/conditioning|MP:0003329,amyloid beta deposits|MP:0003957,abnormal nitric oxide homeostasis|MP:0003998,decreased thermal nociceptive threshold|MP:0004254,cerebral amyloid angiopathy|MP:0008428,abnormal spatial working memory|MP:0012293,impaired active avoidance behavior|MP:0031391,increased locomotor activity
MGI:4367784	Tg(PRNP-APPSweInd)19959Dwst	MP:0000604,amyloidosis|MP:0001262,decreased body weight|MP:0003329,amyloid beta deposits
MGI:3589475	Tg(PRNP-APPSweInd)8Dwst	MP:0000604,amyloidosis|MP:0001463,abnormal spatial learning|MP:0001552,increased circulating triglyceride level|MP:0002083,premature death|MP:0003329,amyloid beta deposits|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0003952,abnormal copper level|MP:0003975,increased circulating VLDL triglyceride level|MP:0004254,cerebral amyloid angiopathy|MP:0008414,abnormal spatial reference memory|MP:0008415,abnormal neurite morphology|MP:0010061,increased creatine level
MGI:5308126	Tg(Prnp-AR*112Q)#Deme	MP:0000937,abnormal motor neuron morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0001922,reduced male fertility|MP:0002757,decreased vertical activity|MP:0004191,neuronal intranuclear inclusions|MP:0009434,paraparesis|MP:0010053,decreased grip strength
MGI:3831350	Tg(Prnp-ATN1)124Dbo	MP:0000745,tremors|MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0001524,impaired limb coordination|MP:0005655,increased aggression
MGI:3831358	Tg(Prnp-ATN1)150Dbo	MP:0000745,tremors|MP:0001377,abnormal mating frequency|MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0001524,impaired limb coordination|MP:0002064,seizures|MP:0002083,premature death|MP:0004191,neuronal intranuclear inclusions|MP:0005655,increased aggression
MGI:3831325	Tg(Prnp-ATN1)84Dbo	MP:0002169,no abnormal phenotype detected
MGI:5516452	Tg(Prnp-ATXN3*148Q)148.19Olri	MP:0000745,tremors|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001442,decreased grooming behavior|MP:0002083,premature death|MP:0004191,neuronal intranuclear inclusions|MP:0004924,abnormal behavior
MGI:5516458	Tg(Prnp-ATXN3*148Q)NES.24Olri	MP:0001407,short stride length|MP:0003631,nervous system phenotype
MGI:5516462	Tg(Prnp-ATXN3*148Q)NLS.28Olri	MP:0000877,abnormal Purkinje cell morphology|MP:0002083,premature death|MP:0004191,neuronal intranuclear inclusions|MP:0004924,abnormal behavior
MGI:5516451	Tg(Prnp-ATXN3*70Q)70.61Olri	MP:0000160,kyphosis|MP:0000745,tremors|MP:0000849,abnormal cerebellum morphology|MP:0000877,abnormal Purkinje cell morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001442,decreased grooming behavior|MP:0001513,limb grasping|MP:0002083,premature death|MP:0003633,abnormal nervous system physiology|MP:0004191,neuronal intranuclear inclusions|MP:0004924,abnormal behavior|MP:0005377,hearing/vestibular/ear phenotype
MGI:4940057	Tg(Prnp-ATXN3*79Q)#Hlw	MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001505,hunched posture|MP:0001523,impaired righting response|MP:0003631,nervous system phenotype|MP:0004191,neuronal intranuclear inclusions
MGI:3798041	Tg(Prnp-ATXN3)AVcg	MP:0002169,no abnormal phenotype detected|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype
MGI:3798042	Tg(Prnp-ATXN3)BVcg	MP:0000160,kyphosis|MP:0000745,tremors|MP:0001263,weight loss|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001441,increased grooming behavior|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002064,seizures|MP:0002773,decreased circulating luteinizing hormone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003205,testicular atrophy|MP:0004191,neuronal intranuclear inclusions|MP:0005119,decreased circulating thyroid-stimulating hormone level|MP:0005121,decreased circulating prolactin level|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0010053,decreased grip strength|MP:0014052,increased male germ cell apoptosis
MGI:3798044	Tg(Prnp-ATXN3)CVcg	MP:0000160,kyphosis|MP:0000745,tremors|MP:0001146,abnormal testis morphology|MP:0001263,weight loss|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001441,increased grooming behavior|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001922,reduced male fertility|MP:0002064,seizures|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0004191,neuronal intranuclear inclusions|MP:0005389,reproductive system phenotype|MP:0010053,decreased grip strength|MP:0011448,decreased dopaminergic neuron number
MGI:2183506	Tg(Prnp-ATXN7*24Q)6129Als	MP:0002169,no abnormal phenotype detected
MGI:5705123	Tg(Prnp-ATXN7*92Q)1963Als	MP:0000160,kyphosis|MP:0001327,decreased retina photoreceptor cell number|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002083,premature death|MP:0008444,retina cone cell degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0012029,abnormal electroretinogram waveform feature|MP:0021009,abnormal synaptic physiology
MGI:2183508	Tg(Prnp-ATXN7*92Q)6076Als	MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0001004,abnormal retina photoreceptor morphology|MP:0001265,decreased body size|MP:0001327,decreased retina photoreceptor cell number|MP:0001392,abnormal locomotor behavior|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0002001,blindness|MP:0002083,premature death|MP:0003690,abnormal glial cell physiology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005253,abnormal eye physiology|MP:0008447,absent retina cone cells|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0010387,abnormal Bergmann glial cell morphology
MGI:5704405	Tg(Prnp-ATXN7*92Q)6529Als	MP:0001046,abnormal enteric neuron morphology|MP:0001270,distended abdomen|MP:0002083,premature death|MP:0002090,abnormal vision|MP:0002816,colitis|MP:0003270,intestinal obstruction|MP:0004191,neuronal intranuclear inclusions|MP:0005202,lethargy|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0010768,mortality/aging|MP:0011082,abnormal gastrointestinal motility
MGI:5705125	Tg(Prnp-ATXN7*92Q*D266N)1239Als	MP:0002083,premature death|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype
MGI:5492387	Tg(Prnp-CCS)17Jlel	MP:0002169,no abnormal phenotype detected
MGI:3836986	Tg(Prnp*D177N*M128V)A21Rchi	MP:0000160,kyphosis|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001501,abnormal sleep pattern|MP:0001513,limb grasping|MP:0001525,impaired balance|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0003354,astrocytosis|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004994,abnormal brain wave pattern|MP:0008428,abnormal spatial working memory
MGI:3848965	Tg(Prnp-FTL*)4Ruvi	MP:0000162,lordosis|MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001440,abnormal grooming behavior|MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0002083,premature death|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004191,neuronal intranuclear inclusions|MP:0005637,abnormal iron homeostasis|MP:0008770,decreased survivor rate
MGI:5618414	Tg(Prnp-FUS*R521C)3313Ejh	MP:0000749,muscle degeneration|MP:0000755,hindlimb paralysis|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0002804,abnormal motor learning|MP:0005621,abnormal cell physiology|MP:0008143,abnormal dendrite morphology|MP:0009936,abnormal dendritic spine morphology|MP:0012051,spasticity
MGI:5445385	Tg(Prnp-FUS)WT3Cshw	MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000938,motor neuron degeneration|MP:0000955,abnormal spinal cord morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002269,muscular atrophy|MP:0002841,impaired skeletal muscle contractility|MP:0002882,abnormal neuron morphology|MP:0003157,impaired muscle relaxation|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0005369,muscle phenotype|MP:0008489,slow postnatal weight gain|MP:0008918,microgliosis|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0010768,mortality/aging
MGI:5440458	Tg(Prnp-HSPB1*R136W)1Kolb	MP:0002272,abnormal nervous system electrophysiology|MP:0003225,axonal dystrophy|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype
MGI:5790704	Tg(Prnp-HTRA2)1Olri	MP:0000849,abnormal cerebellum morphology|MP:0001405,impaired coordination|MP:0001525,impaired balance|MP:0002804,abnormal motor learning|MP:0003244,loss of dopaminergic neurons|MP:0005621,abnormal cell physiology|MP:0006036,abnormal mitochondrial physiology
MGI:5790703	Tg(Prnp-HTRA2*G399S)1Olri	MP:0005386,behavior/neurological phenotype|MP:0006036,abnormal mitochondrial physiology
MGI:5304797	Tg(Prnp-HTT*82Q)52Caro	MP:0000774,decreased brain size|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001443,poor grooming|MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0002062,abnormal associative learning|MP:0002083,premature death|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior
MGI:6294292	Tg(Prnp-HTT*82Q)61Gschi	MP:0001263,weight loss|MP:0001443,poor grooming|MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0002083,premature death|MP:0004191,neuronal intranuclear inclusions
MGI:6294291	Tg(Prnp-HTT*82Q)8AGschi	MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001443,poor grooming|MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0002083,premature death|MP:0004191,neuronal intranuclear inclusions
MGI:5286114	Tg(Prnp-HTT*82Q,KRT14-EGFP)C63Dbo	MP:0000774,decreased brain size|MP:0000807,abnormal hippocampus morphology|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001429,dehydration|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0003354,astrocytosis|MP:0004077,abnormal striatum morphology|MP:0004098,abnormal cerebellar granule cell morphology|MP:0008924,decreased cerebellar granule cell number
MGI:5575877	Tg(Prnp-Immt/SOD1)1Gmnf	MP:0002169,no abnormal phenotype detected
MGI:5575878	Tg(Prnp-Immt/SOD1*G93A)7Gmnf	MP:0000160,kyphosis|MP:0000774,decreased brain size|MP:0000938,motor neuron degeneration|MP:0001194,dermatitis|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0002175,decreased brain weight|MP:0002183,gliosis|MP:0002188,small heart|MP:0002269,muscular atrophy|MP:0003241,loss of cortex neurons|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0009105,penis prolapse|MP:0009417,skeletal muscle atrophy|MP:0010053,decreased grip strength|MP:0010239,decreased skeletal muscle weight|MP:0010240,decreased skeletal muscle size|MP:0011636,disorganized mitochondrial cristae|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4415606	Tg(Prnp-ITM2B*)1Ruvi	MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0001263,weight loss|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001440,abnormal grooming behavior|MP:0001504,abnormal posture|MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0002182,abnormal astrocyte morphology|MP:0002183,gliosis|MP:0003329,amyloid beta deposits|MP:0003631,nervous system phenotype|MP:0004250,tau protein deposits|MP:0004254,cerebral amyloid angiopathy|MP:0004950,abnormal brain vasculature morphology|MP:0008415,abnormal neurite morphology|MP:0009538,abnormal synapse morphology
MGI:4452484	Tg(Prnp-ITM2B*)6Jckr	MP:0000604,amyloidosis
MGI:4452483	Tg(Prnp-ITM2B*)7Jckr	MP:0000160,kyphosis|MP:0000414,alopecia|MP:0000604,amyloidosis|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001463,abnormal spatial learning|MP:0001522,impaired swimming|MP:0001916,intracerebral hemorrhage|MP:0002573,behavioral despair|MP:0002757,decreased vertical activity|MP:0002797,increased thigmotaxis|MP:0003354,astrocytosis|MP:0004950,abnormal brain vasculature morphology|MP:0005386,behavior/neurological phenotype|MP:0008415,abnormal neurite morphology|MP:0008489,slow postnatal weight gain|MP:0008571,abnormal synaptic bouton morphology|MP:0008918,microgliosis|MP:0009939,abnormal hippocampus neuron morphology
MGI:3710691	Tg(Prnp-ITM2B/APP695*40)1Emcg	MP:0000604,amyloidosis|MP:0003631,nervous system phenotype
MGI:3710689	Tg(Prnp-ITM2B/APP695*42)A12Emcg	MP:0000604,amyloidosis|MP:0000783,abnormal forebrain morphology|MP:0002183,gliosis|MP:0003329,amyloid beta deposits
MGI:5644279	Tg(Prnp-lacZ/ATXN10*)#Teas	MP:0000811,hippocampal neuron degeneration|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001417,decreased exploration in new environment|MP:0001443,poor grooming|MP:0001490,abnormal vibrissae reflex|MP:0001513,limb grasping|MP:0002152,abnormal brain morphology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003224,neuron degeneration|MP:0004924,abnormal behavior|MP:0008025,brain vacuoles
MGI:3604150	Tg(Prnp-MAPT)25Hlmc	MP:0002152,abnormal brain morphology|MP:0005386,behavior/neurological phenotype
MGI:5578354	Tg(Prnp-MAPT*)2652Gds	MP:0001262,decreased body weight|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001921,reduced fertility|MP:0002064,seizures|MP:0002083,premature death|MP:0002757,decreased vertical activity|MP:0004250,tau protein deposits|MP:0004924,abnormal behavior|MP:0008414,abnormal spatial reference memory|MP:0008415,abnormal neurite morphology|MP:0009413,skeletal muscle fiber atrophy|MP:0010047,axonal spheroids|MP:0010053,decreased grip strength
MGI:2385566	Tg(Prnp-MAPT)43Vle	MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0001262,decreased body weight|MP:0001513,limb grasping|MP:0001525,impaired balance|MP:0002083,premature death|MP:0003354,astrocytosis|MP:0004250,tau protein deposits|MP:0004768,abnormal axonal transport|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0010768,mortality/aging
MGI:3604149	Tg(Prnp-MAPT)4Hlmc	MP:0005386,behavior/neurological phenotype
MGI:2385580	Tg(Prnp-MAPT)7Vle	MP:0000746,weakness|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0001262,decreased body weight|MP:0001513,limb grasping|MP:0001525,impaired balance|MP:0003214,neurofibrillary tangles|MP:0003354,astrocytosis|MP:0004250,tau protein deposits|MP:0004768,abnormal axonal transport|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration
MGI:5708387	Tg(Prnp-MAPT*K274Q*K281Q)1Lgn	MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0003354,astrocytosis|MP:0004250,tau protein deposits
MGI:5708388	Tg(Prnp-MAPT*K274Q*K281Q)286Lgn	MP:0000812,abnormal dentate gyrus morphology|MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003354,astrocytosis|MP:0004250,tau protein deposits|MP:0008432,abnormal long-term spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0012296,impaired discrimination learning
MGI:5708386	Tg(Prnp-MAPT)#Lgn	MP:0003354,astrocytosis
MGI:3604148	Tg(Prnp-MAPT*P301L)JNPL3Hlmc	MP:0000746,weakness|MP:0000939,decreased motor neuron number|MP:0000955,abnormal spinal cord morphology|MP:0001056,abnormal cranial nerve morphology|MP:0001263,weight loss|MP:0001392,abnormal locomotor behavior|MP:0001442,decreased grooming behavior|MP:0001504,abnormal posture|MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0001851,eye inflammation|MP:0002083,premature death|MP:0002183,gliosis|MP:0002882,abnormal neuron morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003214,neurofibrillary tangles|MP:0003224,neuron degeneration|MP:0004090,abnormal sarcomere morphology|MP:0004250,tau protein deposits|MP:0005150,cachexia|MP:0005253,abnormal eye physiology|MP:0009434,paraparesis|MP:0010053,decreased grip strength|MP:0020351,decreased vocalization
MGI:5525087	Tg(Prnp-MAPT*P301L)#Ruvi	MP:0001263,weight loss|MP:0001440,abnormal grooming behavior|MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0004250,tau protein deposits|MP:0005323,dystonia|MP:0009538,abnormal synapse morphology
MGI:6286246	Tg(Prnp-MAPT*P301S)50Hiw	MP:0001262,decreased body weight|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0003461,abnormal response to novel object|MP:0004250,tau protein deposits|MP:0004768,abnormal axonal transport|MP:0005621,abnormal cell physiology|MP:0014370,impaired spatial working memory
MGI:3768407	Tg(Prnp-MAPT*P301S)PS19Vle	MP:0000746,weakness|MP:0000748,progressive muscle weakness|MP:0000752,dystrophic muscle|MP:0000753,paralysis|MP:0000754,paresis|MP:0000788,abnormal cerebral cortex morphology|MP:0000811,hippocampal neuron degeneration|MP:0000812,abnormal dentate gyrus morphology|MP:0000818,abnormal amygdala morphology|MP:0001263,weight loss|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002206,abnormal CNS synaptic transmission|MP:0002229,neurodegeneration|MP:0002566,abnormal sexual interaction|MP:0002572,abnormal emotion/affect behavior|MP:0002574,increased vertical activity|MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002920,decreased paired-pulse facilitation|MP:0003214,neurofibrillary tangles|MP:0003240,loss of hippocampal neurons|MP:0003354,astrocytosis|MP:0003998,decreased thermal nociceptive threshold|MP:0004250,tau protein deposits|MP:0004924,abnormal behavior|MP:0006300,abnormal entorhinal cortex morphology|MP:0008027,abnormal spinal cord white matter morphology|MP:0009141,increased prepulse inhibition|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0012506,brain atrophy|MP:0012676,dilated brain ventricle|MP:0020083,decreased hippocampus volume|MP:0030003,hippocampus atrophy|MP:0031391,increased locomotor activity
MGI:5703730	Tg(Prnp-MAPT*R406W)21807Dwst	MP:0001405,impaired coordination|MP:0001462,abnormal avoidance learning behavior|MP:0003214,neurofibrillary tangles|MP:0003354,astrocytosis|MP:0004250,tau protein deposits|MP:0005369,muscle phenotype|MP:0008918,microgliosis
MGI:5487544	Tg(Prnp*P101L)174Sbp	MP:0001393,ataxia|MP:0002083,premature death|MP:0002183,gliosis|MP:0002654,spongiform encephalopathy|MP:0003354,astrocytosis|MP:0003632,abnormal nervous system morphology|MP:0005202,lethargy
MGI:5491023	Tg(Prnp*P101L)2247Sbp	MP:0001393,ataxia|MP:0002152,abnormal brain morphology|MP:0002229,neurodegeneration|MP:0002654,spongiform encephalopathy|MP:0003354,astrocytosis|MP:0003633,abnormal nervous system physiology|MP:0005202,lethargy
MGI:5491026	Tg(Prnp*P101L)2862Sbp	MP:0001393,ataxia|MP:0002152,abnormal brain morphology|MP:0002654,spongiform encephalopathy|MP:0003354,astrocytosis|MP:0003633,abnormal nervous system physiology|MP:0005202,lethargy
MGI:5491025	Tg(Prnp*P101L)2866Sbp	MP:0000751,myopathy|MP:0000759,abnormal skeletal muscle morphology|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002229,neurodegeneration|MP:0002651,abnormal sciatic nerve morphology|MP:0002654,spongiform encephalopathy|MP:0003354,astrocytosis|MP:0003633,abnormal nervous system physiology|MP:0004087,abnormal muscle fiber morphology|MP:0005405,axon degeneration|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009412,skeletal muscle fiber degeneration|MP:0010653,abnormal Wallerian degeneration
MGI:5796265	Tg(Prnp-PFN1)34Zxu	MP:0005386,behavior/neurological phenotype
MGI:5906305	Tg(Prnp-PFN1)850Kiaei	MP:0002169,no abnormal phenotype detected
MGI:5796267	Tg(Prnp-PFN1*C71G)22Zxu	MP:0000748,progressive muscle weakness|MP:0002080,prenatal lethality
MGI:5428331	Tg(Prnp*)#Rgab	MP:0000160,kyphosis|MP:0000243,myoclonus|MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002111,abnormal tail morphology|MP:0002269,muscular atrophy|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0009434,paraparesis
MGI:4359884	Tg(Prnp-RTN3)2Yanr	MP:0000807,abnormal hippocampus morphology|MP:0001473,reduced long-term potentiation|MP:0002912,abnormal excitatory postsynaptic potential|MP:0004097,abnormal cerebellar cortex morphology|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008414,abnormal spatial reference memory|MP:0008415,abnormal neurite morphology
MGI:6881754	Tg(Prnp-SETX*R2136H)1920Als	MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0004811,abnormal neuron physiology|MP:0008235,increased susceptibility to neuronal excitotoxicity
MGI:3774945	Tg(Prnp-SMN)92Ahmb	MP:0002169,no abnormal phenotype detected
MGI:5575507	Tg(Prnp-SNAP25/HTT*150Q)8Xjl	MP:0000160,kyphosis|MP:0001263,weight loss|MP:0001363,increased anxiety-related response|MP:0001405,impaired coordination|MP:0001473,reduced long-term potentiation|MP:0001489,decreased startle reflex|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002920,decreased paired-pulse facilitation|MP:0003354,astrocytosis|MP:0004495,decreased synaptic glutamate release
MGI:3530000	Tg(Prnp-SNCA)20Vle	MP:0002169,no abnormal phenotype detected
MGI:3530087	Tg(Prnp-SNCA)22Dpr	MP:0003631,nervous system phenotype
MGI:3530128	Tg(Prnp-SNCA*A30P)2Dpr	MP:0003631,nervous system phenotype
MGI:4942281	Tg(Prnp-SNCA*A30P)3Dpr	MP:0003631,nervous system phenotype
MGI:4942280	Tg(Prnp-SNCA*A53T)25Mkle	MP:0000753,paralysis|MP:0000955,abnormal spinal cord morphology|MP:0001393,ataxia|MP:0001523,impaired righting response|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0002882,abnormal neuron morphology|MP:0003354,astrocytosis|MP:0003632,abnormal nervous system morphology|MP:0004191,neuronal intranuclear inclusions|MP:0005156,bradykinesia|MP:0005323,dystonia
MGI:3057167	Tg(Prnp-SNCA*A53T)83Vle	MP:0000745,tremors|MP:0000746,weakness|MP:0000754,paresis|MP:0000920,abnormal myelination|MP:0001077,abnormal spinal nerve morphology|MP:0001263,weight loss|MP:0001406,abnormal gait|MP:0001438,aphagia|MP:0001442,decreased grooming behavior|MP:0001505,hunched posture|MP:0001523,impaired righting response|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0002690,akinesia|MP:0003082,abnormal gastrocnemius morphology|MP:0003632,abnormal nervous system morphology|MP:0004250,tau protein deposits|MP:0005405,axon degeneration|MP:0008493,alpha-synuclein inclusion body|MP:0008544,impaired olfaction|MP:0008948,decreased neuron number|MP:0009948,abnormal olfactory bulb glomerular layer morphology|MP:0009951,abnormal olfactory bulb mitral cell layer morphology|MP:0011449,increased dopaminergic neuron number|MP:0011622,abnormal habituation to a novel odor|MP:0012624,decreased acetylcholinesterase activity
MGI:3723258	Tg(Prnp-SNCA*A53T)AAub	MP:0000746,weakness|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0001664,abnormal digestion|MP:0001899,absent long-term depression|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0002272,abnormal nervous system electrophysiology|MP:0002757,decreased vertical activity|MP:0003484,abnormal channel response|MP:0003866,abnormal defecation|MP:0004811,abnormal neuron physiology|MP:0008415,abnormal neurite morphology|MP:0008493,alpha-synuclein inclusion body|MP:0010053,decreased grip strength
MGI:4849838	Tg(Prnp-SOD1*G37R,-PSEN1)110Dbo	MP:0000755,hindlimb paralysis|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0001406,abnormal gait|MP:0003354,astrocytosis
MGI:4839644	Tg(Prnp-TARDBP)21Jlel	MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging
MGI:5002476	Tg(Prnp-TARDBP)3cPtrc	MP:0000745,tremors|MP:0000921,demyelination|MP:0000937,abnormal motor neuron morphology|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002183,gliosis|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0005277,abnormal brainstem morphology|MP:0005405,axon degeneration|MP:0008027,abnormal spinal cord white matter morphology|MP:0012267,abnormal red nucleus morphology
MGI:4839645	Tg(Prnp-TARDBP)4Jlel	MP:0000747,muscle weakness|MP:0000751,myopathy|MP:0001407,short stride length|MP:0001516,abnormal motor coordination/balance|MP:0002083,premature death|MP:0004144,hypotonia|MP:0009403,increased variability of skeletal muscle fiber size|MP:0010053,decreased grip strength
MGI:5463113	Tg(Prnp-TARDBP)96Dwc	MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype
MGI:4839643	Tg(Prnp-TARDBP*A315T)23Jlel	MP:0000747,muscle weakness|MP:0001407,short stride length|MP:0001516,abnormal motor coordination/balance|MP:0002083,premature death|MP:0003354,astrocytosis|MP:0004191,neuronal intranuclear inclusions|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005277,abnormal brainstem morphology|MP:0009417,skeletal muscle atrophy|MP:0010053,decreased grip strength|MP:0010225,abnormal quadriceps morphology
MGI:4358722	Tg(Prnp-TARDBP*A315T)95Balo	MP:0000160,kyphosis|MP:0000747,muscle weakness|MP:0000759,abnormal skeletal muscle morphology|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0000955,abnormal spinal cord morphology|MP:0001040,deficient enteric cholinergic innervation|MP:0001045,abnormal enteric ganglia morphology|MP:0001263,weight loss|MP:0001270,distended abdomen|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001429,dehydration|MP:0001511,disheveled coat|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001657,abnormal induced morbidity/mortality|MP:0001661,extended life span|MP:0002083,premature death|MP:0002882,abnormal neuron morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003224,neuron degeneration|MP:0003288,intestinal edema|MP:0003354,astrocytosis|MP:0004145,abnormal muscle electrophysiology|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005404,abnormal axon morphology|MP:0005507,tail dragging|MP:0006001,abnormal intestinal transit time|MP:0010155,abnormal intestine physiology|MP:0010801,abnormal myenteric nerve plexus morphology|MP:0011975,neuronal cytoplasmic inclusions|MP:0012311,decreased defecation amount
MGI:5463124	Tg(Prnp-TARDBP*M337V)106Dwc	MP:0000939,decreased motor neuron number|MP:0001405,impaired coordination|MP:0008027,abnormal spinal cord white matter morphology|MP:0009677,abnormal spinal cord dorsal column morphology|MP:0009678,abnormal spinal cord lateral column morphology|MP:0010053,decreased grip strength
MGI:5463119	Tg(Prnp-TARDBP*Q331K)103Dwc	MP:0000745,tremors|MP:0000750,abnormal muscle regeneration|MP:0000939,decreased motor neuron number|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002106,abnormal muscle physiology|MP:0002152,abnormal brain morphology|MP:0002272,abnormal nervous system electrophysiology|MP:0003632,abnormal nervous system morphology|MP:0003674,oxidative stress|MP:0004145,abnormal muscle electrophysiology|MP:0008027,abnormal spinal cord white matter morphology|MP:0009415,skeletal muscle degeneration|MP:0009677,abnormal spinal cord dorsal column morphology|MP:0009678,abnormal spinal cord lateral column morphology|MP:0010053,decreased grip strength
MGI:5463115	Tg(Prnp-TARDBP*Q331K)109Dwc	MP:0000939,decreased motor neuron number|MP:0001405,impaired coordination|MP:0008027,abnormal spinal cord white matter morphology|MP:0009677,abnormal spinal cord dorsal column morphology|MP:0009678,abnormal spinal cord lateral column morphology|MP:0010053,decreased grip strength
MGI:5825215	Tg(Prnp-TARDBP*Q331K)31Dwc	MP:0000745,tremors|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003354,astrocytosis|MP:0004191,neuronal intranuclear inclusions|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0008547,abnormal neocortex morphology|MP:0008918,microgliosis|MP:0009974,decreased cerebral cortex pyramidal cell number|MP:0011975,neuronal cytoplasmic inclusions
MGI:3772700	Tg(Prnp-TBP*)105Xjl	MP:0000160,kyphosis|MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0000951,sporadic seizures|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001443,poor grooming|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0002083,premature death|MP:0002183,gliosis|MP:0003224,neuron degeneration|MP:0004191,neuronal intranuclear inclusions|MP:0005405,axon degeneration|MP:0008415,abnormal neurite morphology
MGI:3772701	Tg(Prnp-TBP*)13Xjl	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging
MGI:3772866	Tg(Prnp-TBP*)71-16Xjl	MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0000951,sporadic seizures|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001443,poor grooming|MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0002083,premature death|MP:0002183,gliosis|MP:0002882,abnormal neuron morphology|MP:0005405,axon degeneration|MP:0008415,abnormal neurite morphology|MP:0008489,slow postnatal weight gain
MGI:3772868	Tg(Prnp-TBP*)71-27Xjl	MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0000951,sporadic seizures|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001443,poor grooming|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002183,gliosis|MP:0002882,abnormal neuron morphology|MP:0005405,axon degeneration|MP:0008415,abnormal neurite morphology
MGI:6784048	Tg(Prnp-UBQLN2*P506T)#Hlp	MP:0003631,nervous system phenotype|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0008515,thin retina outer nuclear layer
MGI:6784070	Tg(Prnp-UBQLN2)WT-hiHlp	MP:0001004,abnormal retina photoreceptor morphology|MP:0003631,nervous system phenotype|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0006149,decreased visual acuity|MP:0008511,thin retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0011965,decreased total retina thickness
MGI:6784047	Tg(Prnp-UBQLN2)WT-lowHlp	MP:0003631,nervous system phenotype|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype
MGI:4847348	Tg(Prox1-EGFP)KY221Gsat	MP:0008778,abnormal lymphangiogenesis|MP:0010197,abnormal lymphatic vessel endothelial cell morphology
MGI:3768632	Tg(Prp-GPR37)1Ryot	MP:0001399,hyperactivity|MP:0001516,abnormal motor coordination/balance|MP:0001906,increased dopamine level|MP:0003224,neuron degeneration|MP:0003244,loss of dopaminergic neurons|MP:0003674,oxidative stress|MP:0004811,abnormal neuron physiology|MP:0008489,slow postnatal weight gain|MP:0011451,increased susceptibility to dopaminergic neuron neurotoxicity
MGI:4355342	Tg(Prrx1-cre/ERT2,-EGFP)1Smkm	MP:0002169,no abnormal phenotype detected
MGI:5428676	Tg(Prrx1-FUS/DDIT3)1Mete	MP:0002169,no abnormal phenotype detected
MGI:2446334	Tg(Prrx1-Hand2)1Eno	MP:0000562,polydactyly
MGI:2446336	Tg(Prrx1-Hand2)2Eno	MP:0000547,short limbs|MP:0000562,polydactyly|MP:0002115,abnormal limb bone morphology|MP:0003855,abnormal forelimb zeugopod morphology|MP:0003857,abnormal hindlimb zeugopod morphology
MGI:2446339	Tg(Prrx1-Hand2)3Eno	MP:0000547,short limbs|MP:0000562,polydactyly|MP:0000565,oligodactyly
MGI:2446340	Tg(Prrx1-Hand2)4Eno	MP:0005371,limbs/digits/tail phenotype
MGI:2446342	Tg(Prrx1-Hand2)5Eno	MP:0000562,polydactyly|MP:0002115,abnormal limb bone morphology|MP:0003855,abnormal forelimb zeugopod morphology|MP:0003857,abnormal hindlimb zeugopod morphology
MGI:2446344	Tg(Prrx1-Hand2)6Eno	MP:0000562,polydactyly|MP:0002115,abnormal limb bone morphology|MP:0003855,abnormal forelimb zeugopod morphology|MP:0003857,abnormal hindlimb zeugopod morphology
MGI:2446345	Tg(Prrx1-Hand2)7Eno	MP:0005371,limbs/digits/tail phenotype
MGI:2446350	Tg(Prrx1-Hand2)8Eno	MP:0005371,limbs/digits/tail phenotype
MGI:2446351	Tg(Prrx1-Hand2/VP16)1Eno	MP:0000562,polydactyly
MGI:3840957	Tg(Prrx1-Sox9,-lacZ)1Haak	MP:0000164,abnormal cartilage development|MP:0000547,short limbs|MP:0000550,abnormal forelimb morphology|MP:0000562,polydactyly|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0002544,brachydactyly|MP:0003419,delayed endochondral bone ossification|MP:0005385,cardiovascular system phenotype|MP:0005650,abnormal limb bud morphology
MGI:5439541	Tg(Prrxl1-cre/ERT2)1Yqd	MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype
MGI:7625683	Tg(PRSS1/lacZ)#Gwzh	MP:0004761,increased susceptibility to induced pancreatitis|MP:0009145,abnormal pancreatic acinus morphology|MP:0009147,abnormal pancreatic acinar cell physiology|MP:0013245,abnormal lipid metabolism
MGI:2664249	Tg(PSEN1)1098Citr	MP:0001473,reduced long-term potentiation|MP:0001902,reduced NMDA-mediated synaptic currents|MP:0003234,enhanced NMDA-mediated synaptic currents|MP:0003631,nervous system phenotype|MP:0008143,abnormal dendrite morphology
MGI:2447335	Tg(PSEN1)5Dbo	MP:0003631,nervous system phenotype
MGI:3618599	Tg(PSEN1dE9)S9Dbo	MP:0002152,abnormal brain morphology
MGI:3693364	Tg(PSEN1H163R)G9Btla	MP:0003329,amyloid beta deposits
MGI:2664251	Tg(PSEN1*L286V)1274Citr	MP:0001473,reduced long-term potentiation|MP:0001902,reduced NMDA-mediated synaptic currents|MP:0003008,enhanced long-term potentiation|MP:0003234,enhanced NMDA-mediated synaptic currents|MP:0003631,nervous system phenotype|MP:0008143,abnormal dendrite morphology
MGI:3818761	Tg(Psp-Rbbp4)1Yoha	MP:0000623,decreased salivation|MP:0001348,abnormal lacrimal gland physiology|MP:0001828,abnormal T cell activation|MP:0001835,abnormal antigen presentation|MP:0001870,salivary gland inflammation|MP:0003725,increased autoantibody level|MP:0005310,abnormal salivary gland physiology|MP:0005350,increased susceptibility to autoimmune disorder|MP:0008181,increased marginal zone B cell number|MP:0008566,increased interferon-gamma secretion|MP:0008684,increased interleukin-18 secretion|MP:0008687,increased interleukin-2 secretion|MP:0008880,lacrimal gland inflammation|MP:0020220,decreased tear production
MGI:5645732	Tg(Pten)1Srn	MP:0000003,abnormal adipose tissue morphology|MP:0000352,decreased cell proliferation|MP:0001262,decreased body weight|MP:0001433,polyphagia|MP:0001661,extended life span|MP:0001698,decreased embryo size|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002971,abnormal brown adipose tissue morphology|MP:0003858,enhanced coordination|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004889,increased energy expenditure|MP:0005179,decreased circulating cholesterol level|MP:0005621,abnormal cell physiology|MP:0005668,decreased circulating leptin level|MP:0008965,increased basal metabolism|MP:0009125,decreased brown fat cell lipid droplet size|MP:0009133,decreased white fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011698,abnormal brown adipose tissue physiology|MP:0013278,decreased fasting circulating glucose level|MP:0014143,decreased body fat mass|MP:0030016,increased adipocyte glucose uptake|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3844257	Tg(PTH-CCND1)PC2Anar	MP:0000194,increased circulating calcium level|MP:0000678,abnormal parathyroid gland morphology|MP:0002904,increased circulating parathyroid hormone level|MP:0002998,abnormal bone remodeling|MP:0003112,enlarged parathyroid gland|MP:0003431,abnormal parathyroid gland physiology|MP:0003493,parathyroid gland hyperplasia|MP:0003495,increased parathyroid adenoma incidence|MP:0003795,abnormal bone structure|MP:0004984,increased osteoclast cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0006357,abnormal circulating mineral level|MP:0008271,abnormal bone ossification|MP:0010876,decreased bone volume
MGI:4454793	Tg(Pvalb-COP4*H134R/EYFP)15Gfng	MP:0002169,no abnormal phenotype detected
MGI:3837553	Tg(Pvalb-cre)1Tama	MP:0002169,no abnormal phenotype detected
MGI:5703933	Tg(Pvalb-tdTomato/RNAi:Gad1)3Mirn	MP:0001360,abnormal social investigation|MP:0001488,increased startle reflex|MP:0002574,increased vertical activity|MP:0002757,decreased vertical activity|MP:0003461,abnormal response to novel object|MP:0004008,abnormal GABA-mediated receptor currents|MP:0009142,decreased prepulse inhibition|MP:0012318,slow extinction of fear memory
MGI:5558897	Tg(PVR)1Kkst	MP:0020937,increased susceptibility to Picornaviridae infection
MGI:5805518	Tg(PyLT)1Vb	MP:0000642,enlarged adrenal glands|MP:0001150,enlarged scrotum|MP:0001260,increased body weight|MP:0001263,weight loss|MP:0001393,ataxia|MP:0001748,increased circulating adrenocorticotropin level|MP:0002041,increased pituitary adenoma incidence|MP:0002073,abnormal hair growth|MP:0002083,premature death|MP:0003599,large penis|MP:0004174,abnormal spine curvature|MP:0008288,abnormal adrenal cortex morphology|MP:0008301,adrenal medulla hyperplasia|MP:0008302,thin adrenal cortex|MP:0010320,increased pituitary gland tumor incidence|MP:0013307,increased adrenal gland weight
MGI:3828107	Tgq10<DBA/2J>	MP:0001552,increased circulating triglyceride level
MGI:3828109	Tgq11<DBA/2J>	MP:0001552,increased circulating triglyceride level
MGI:3828175	Tgq13<DBA/2J>	MP:0001552,increased circulating triglyceride level
MGI:3828178	Tgq14<DBA/2J>	MP:0001552,increased circulating triglyceride level
MGI:3828181	Tgq15<DBA/2J>	MP:0001552,increased circulating triglyceride level
MGI:3828320	Tgq17<DBA/2J>	MP:0001552,increased circulating triglyceride level
MGI:3828322	Tgq18<DBA/2J>	MP:0001552,increased circulating triglyceride level
MGI:3828324	Tgq19<DBA/2J>	MP:0001552,increased circulating triglyceride level
MGI:3828442	Tgq20<DBA/2J>	MP:0001552,increased circulating triglyceride level
MGI:3828444	Tgq21<DBA/2J>	MP:0001552,increased circulating triglyceride level
MGI:3828446	Tgq22<DBA/2J>	MP:0001552,increased circulating triglyceride level
MGI:3828448	Tgq23<DBA/2J>	MP:0001552,increased circulating triglyceride level
MGI:3828450	Tgq24<DBA/2J>	MP:0001552,increased circulating triglyceride level
MGI:3828454	Tgq25<DBA/2J>	MP:0001552,increased circulating triglyceride level
MGI:3828456	Tgq26<DBA/2J>	MP:0001552,increased circulating triglyceride level
MGI:3828458	Tgq27<DBA/2J>	MP:0001552,increased circulating triglyceride level
MGI:3828461	Tgq28<DBA/2J>	MP:0001552,increased circulating triglyceride level
MGI:3828465	Tgq29<DBA/2J>	MP:0001552,increased circulating triglyceride level
MGI:3812493	Tgq4<NZW/LacJ>	MP:0005317,increased triglyceride level
MGI:3812495	Tgq5<NZW/LacJ>	MP:0005317,increased triglyceride level
MGI:3812498	Tgq6<NZB/BlNJ>	MP:0005317,increased triglyceride level
MGI:3828105	Tgq9<DBA/2J>	MP:0001552,increased circulating triglyceride level
MGI:5702681	Tg(RasE)290Biat	MP:0002006,neoplasm|MP:0002027,increased lung adenocarcinoma incidence|MP:0008014,increased lung tumor incidence|MP:0009151,increased pancreatic ductal adenocarcinoma incidence|MP:0009152,increased pancreatic intraepithelial neoplasia incidence|MP:0009153,increased pancreas tumor incidence|MP:0013374,increased sebaceous gland tumor incidence
MGI:4360790	Tg(RBP3-ELOVL4*)1Kzh	MP:0001325,abnormal retina morphology|MP:0002864,abnormal ocular fundus morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005548,retina pigment epithelium atrophy|MP:0006187,retina deposits|MP:0008450,retina photoreceptor degeneration|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:4360792	Tg(RBP3-ELOVL4*)2Kzh	MP:0001325,abnormal retina morphology|MP:0002864,abnormal ocular fundus morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005548,retina pigment epithelium atrophy|MP:0008450,retina photoreceptor degeneration|MP:0008516,disorganized retina outer nuclear layer|MP:0008581,disorganized photoreceptor inner segment|MP:0008582,short photoreceptor inner segment|MP:0008583,absent photoreceptor inner segment|MP:0008585,absent photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0008842,lipofuscinosis|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:4360793	Tg(RBP3-ELOVL4*)3Kzh	MP:0001325,abnormal retina morphology|MP:0002864,abnormal ocular fundus morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005548,retina pigment epithelium atrophy|MP:0008450,retina photoreceptor degeneration|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:5492042	Tg(RBP3-ELOVL4*)#Kzh	MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology
MGI:2385652	Tg(Rbp3-SV40)IT-2Jjw	MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002750,exophthalmos|MP:0006310,increased retinoblastoma incidence|MP:0013364,enlarged pineal gland|MP:0013365,increased pineal gland tumor incidence
MGI:3522638	Tg(RBP3-TAg)#Ove	MP:0002020,increased tumor incidence|MP:0003099,retina detachment|MP:0009277,increased brain tumor incidence|MP:0010303,increased retina tumor incidence
MGI:3809545	Tg(RCAN1)M9Mapr	MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0001363,increased anxiety-related response|MP:0001458,abnormal object recognition memory|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0001739,abnormal adrenal gland secretion|MP:0002272,abnormal nervous system electrophysiology|MP:0002574,increased vertical activity|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008431,abnormal short-term spatial reference memory|MP:0008432,abnormal long-term spatial reference memory|MP:0008948,decreased neuron number|MP:0009936,abnormal dendritic spine morphology|MP:0009937,abnormal neuron differentiation
MGI:2389118	Tg(Ren2-TAg)4Kwg	MP:0000530,abnormal kidney vasculature morphology|MP:0002009,preneoplasia|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence
MGI:3830171	Tg(REN-cre)1Haca	MP:0002169,no abnormal phenotype detected
MGI:3767843	Tg(Rgs4-EGFP)4Lvt	MP:0002169,no abnormal phenotype detected
MGI:5607413	Tg(Rgs4-EGFP)#Surm	MP:0002136,abnormal kidney physiology|MP:0002703,abnormal renal tubule morphology|MP:0005265,abnormal blood urea nitrogen level|MP:0005328,abnormal circulating creatinine level|MP:0005524,abnormal renal plasma flow rate
MGI:2686794	Tg(Rho)1Wbae	MP:0001325,abnormal retina morphology|MP:0001327,decreased retina photoreceptor cell number|MP:0005551,abnormal eye electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment
MGI:5806092	Tg(Rho-Arl3*Q71L)#Visu	MP:0001005,abnormal retina rod cell morphology|MP:0001325,abnormal retina morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0008451,retina rod cell degeneration|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0012034,abnormal a-wave shape|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:5441362	Tg(Rho*G90D*A337V)202Sie	MP:0004021,abnormal rod electrophysiology|MP:0005391,vision/eye phenotype
MGI:6160441	Tg(Rho-GRK1)1Cjch	MP:0005391,vision/eye phenotype
MGI:4430086	Tg(Rho-GUCA1A*Y99C)L53Amd	MP:0001326,retina degeneration|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005253,abnormal eye physiology|MP:0008450,retina photoreceptor degeneration|MP:0008585,absent photoreceptor outer segment|MP:0008587,short photoreceptor outer segment
MGI:5908882	Tg(Rho-GUCY2D*R838S)362Amd	MP:0001326,retina degeneration|MP:0002001,blindness|MP:0004021,abnormal rod electrophysiology|MP:0008451,retina rod cell degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:5908875	Tg(Rho-GUCY2D*R838S)379Amd	MP:0002001,blindness|MP:0004021,abnormal rod electrophysiology|MP:0008450,retina photoreceptor degeneration|MP:0008451,retina rod cell degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:5490881	Tg(Rho-Mirc35*)SP1128Kpal	MP:0001326,retina degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration
MGI:5490880	Tg(Rho-Mirc35*)SP1135Kpal	MP:0001326,retina degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration
MGI:5490651	Tg(Rho-Mirc35*)SP1231Kpal	MP:0001326,retina degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration
MGI:2181671	Tg(RHO-P23H)DTpd	MP:0005103,abnormal retina pigmentation|MP:0005551,abnormal eye electrophysiology|MP:0008584,photoreceptor outer segment degeneration|MP:0010098,abnormal retina blood vessel pattern
MGI:6187993	Tg(RHO*P347S)A1Tili	MP:0008515,thin retina outer nuclear layer
MGI:6386387	Tg(Rho-Pdcl*)#Msok	MP:0003729,abnormal photoreceptor outer segment morphology|MP:0008450,retina photoreceptor degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0012029,abnormal electroretinogram waveform feature|MP:0020813,abnormal photoreceptor outer segment disc membrane morphology
MGI:2447845	Tg(RHO-SCA7)R7EJman	MP:0001004,abnormal retina photoreceptor morphology|MP:0001005,abnormal retina rod cell morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004191,neuronal intranuclear inclusions|MP:0005551,abnormal eye electrophysiology|MP:0006068,abnormal retina horizontal cell morphology|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0008516,disorganized retina outer nuclear layer|MP:0008520,disorganized retina outer plexiform layer|MP:0008584,photoreceptor outer segment degeneration|MP:0012671,retina spots|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:2447847	Tg(RHO-SCA7)R7NJman	MP:0005391,vision/eye phenotype
MGI:3806312	Tg(RHO-VEGFA)V-24Camp	MP:0008450,retina photoreceptor degeneration
MGI:3806310	Tg(RHO-VEGFA)V-6Camp	MP:0003070,increased vascular permeability|MP:0005201,abnormal retina pigment epithelium morphology|MP:0008852,retina neovascularization
MGI:3487269	Tg(RIP1-Neurod1)1Jle	MP:0002169,no abnormal phenotype detected
MGI:2429941	Tg(RIP1-Tag)2Dh	MP:0000189,hypoglycemia|MP:0002083,premature death|MP:0003364,increased insulinoma incidence|MP:0003645,increased pancreatic beta cell number|MP:0005215,abnormal pancreatic islet morphology|MP:0009153,increased pancreas tumor incidence|MP:0009177,decreased pancreatic alpha cell number|MP:0009181,decreased pancreatic delta cell number|MP:0010348,increased pancreatic islet cell carcinoma incidence
MGI:2447333	Tg(RIP1-Tag)5Dh	MP:0000189,hypoglycemia|MP:0001869,pancreas inflammation|MP:0002009,preneoplasia|MP:0002083,premature death|MP:0003364,increased insulinoma incidence|MP:0005215,abnormal pancreatic islet morphology
MGI:3040264	Tg(RIR-Tag)87Dh	MP:0000189,hypoglycemia|MP:0002083,premature death|MP:0003645,increased pancreatic beta cell number|MP:0005215,abnormal pancreatic islet morphology|MP:0009153,increased pancreas tumor incidence|MP:0009177,decreased pancreatic alpha cell number|MP:0009181,decreased pancreatic delta cell number
MGI:6193754	Tg(RNU6-1-RNAi:Cdk5)#Chad	MP:0000371,diluted coat color|MP:0000414,alopecia|MP:0001191,abnormal skin condition|MP:0001212,skin lesions|MP:0001219,thick epidermis|MP:0001237,enlarged spinous cells|MP:0003813,abnormal hair follicle dermal papilla morphology|MP:0005077,abnormal melanogenesis|MP:0008834,abnormal melanosome transport|MP:0009474,thick epidermis stratum spinosum|MP:0009555,abnormal hair follicle melanin granule distribution
MGI:4438942	Tg(RNU6-EGFP,-RNAi:Dpp7)#Bhub	MP:0001431,abnormal eating behavior|MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005379,endocrine/exocrine gland phenotype|MP:0005458,increased percent body fat/body weight|MP:0005559,increased circulating glucose level|MP:0009286,increased abdominal fat pad weight|MP:0009288,increased epididymal fat pad weight
MGI:5288517	Tg(Rnu6-RNAi:Bccip)4Zshn	MP:0000352,decreased cell proliferation|MP:0000932,absent notochord|MP:0001672,abnormal embryo development|MP:0001680,abnormal mesoderm development|MP:0001730,embryonic growth arrest|MP:0001935,decreased litter size|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002169,no abnormal phenotype detected|MP:0003984,embryonic growth retardation|MP:0006207,embryonic lethality during organogenesis|MP:0008866,chromosomal instability|MP:0012113,decreased inner cell mass proliferation|MP:0012142,absent amniotic cavity|MP:0012166,absent neural plate|MP:0013504,increased embryonic tissue cell apoptosis|MP:0014764,impaired double-strand DNA break repair
MGI:3822350	Tg(RNU6-RNAi:Cldn16)551Dago	MP:0000063,decreased bone mineral density|MP:0001596,hypotension|MP:0002666,increased circulating aldosterone level|MP:0003197,nephrocalcinosis|MP:0004119,hypokalemia|MP:0005441,increased urine calcium level|MP:0005619,increased urine potassium level|MP:0010093,decreased circulating magnesium level|MP:0010124,decreased bone mineral content|MP:0011435,increased urine magnesium level
MGI:5297927	Tg(RNU6-RNAi:Mpp5)13Wij	MP:0001004,abnormal retina photoreceptor morphology|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0001328,disorganized retina layers|MP:0002183,gliosis|MP:0002864,abnormal ocular fundus morphology|MP:0003070,increased vascular permeability|MP:0003203,increased neuron apoptosis|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005551,abnormal eye electrophysiology|MP:0006069,abnormal retina neuronal layer morphology|MP:0006073,abnormal retina bipolar cell morphology|MP:0008450,retina photoreceptor degeneration|MP:0008511,thin retina inner nuclear layer|MP:0008512,disorganized retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008516,disorganized retina outer nuclear layer|MP:0008520,disorganized retina outer plexiform layer|MP:0008587,short photoreceptor outer segment|MP:0010236,abnormal retina outer limiting membrane morphology
MGI:5763202	Tg(RNU6-RNAi:Rhox3)2Wilk	MP:0001153,small seminiferous tubules|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005169,abnormal male meiosis|MP:0006380,abnormal spermatid morphology|MP:0014052,increased male germ cell apoptosis
MGI:5428311	Tg(RP11-111A8)1Zim	MP:0001405,impaired coordination|MP:0001441,increased grooming behavior|MP:0005386,behavior/neurological phenotype|MP:0008544,impaired olfaction|MP:0009142,decreased prepulse inhibition|MP:0009749,enhanced behavioral response to addictive substance
MGI:5014749	Tg(RP11-12907)13Jwth	MP:0002169,no abnormal phenotype detected
MGI:5014750	Tg(RP11-12907)9Jwth	MP:0002169,no abnormal phenotype detected
MGI:5304449	Tg(RP11-209M4)AGglo	MP:0000063,decreased bone mineral density|MP:0000135,decreased compact bone thickness|MP:0005306,abnormal phalanx morphology|MP:0005390,skeleton phenotype|MP:0006280,abnormal digit development|MP:0008271,abnormal bone ossification|MP:0008730,fused phalanges|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009346,decreased trabecular bone thickness|MP:0010868,increased bone trabecula number|MP:0010876,decreased bone volume
MGI:5304447	Tg(RP11-209M4*)#Gglo	MP:0005306,abnormal phalanx morphology|MP:0005390,skeleton phenotype|MP:0006280,abnormal digit development|MP:0008730,fused phalanges
MGI:5292675	Tg(RP11-466I19/Tcf7l2)1Nobr	MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0011940,decreased food intake
MGI:6273999	Tg(RP11-578M14)1Mkru	MP:0005378,growth/size/body region phenotype
MGI:6273991	Tg(RP11-578M14)5Mkru	MP:0000005,increased brown adipose tissue amount|MP:0000008,increased white adipose tissue amount|MP:0001260,increased body weight|MP:0002079,increased circulating insulin level|MP:0002702,decreased circulating free fatty acids level|MP:0002773,decreased circulating luteinizing hormone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003980,increased circulating phospholipid level|MP:0003982,increased cholesterol level|MP:0005119,decreased circulating thyroid-stimulating hormone level|MP:0005136,decreased growth hormone level|MP:0005138,decreased prolactin level|MP:0005293,impaired glucose tolerance|MP:0005317,increased triglyceride level|MP:0005418,abnormal circulating hormone level|MP:0005669,increased circulating leptin level|MP:0009118,increased white fat cell size|MP:0011049,impaired adaptive thermogenesis|MP:0011613,decreased circulating ghrelin level|MP:0013279,increased fasting circulating glucose level|MP:0014142,increased body fat mass|MP:0014570,increased circulating peptide YY level|MP:0014573,increased circulating resistin level|MP:0031514,increased circulating C-peptide level
MGI:5463931	Tg(Rp1)L2Eap	MP:0005391,vision/eye phenotype
MGI:5463932	Tg(Rp1)T1Eap	MP:0005391,vision/eye phenotype
MGI:2386569	Tg(RP23-291P1)1Flp	MP:0002830,gallstones|MP:0004773,abnormal bile composition
MGI:4461458	Tg(RP23-326M22)760She	MP:0000607,abnormal hepatocyte morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001363,increased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001504,abnormal posture|MP:0001523,impaired righting response|MP:0001732,postnatal growth retardation|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002738,hyperresponsive to tactile stimuli|MP:0002757,decreased vertical activity|MP:0010053,decreased grip strength|MP:0031391,increased locomotor activity
MGI:5696226	Tg(RP23-352G18)1Coppa	MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0020090,decreased susceptibility to diet-induced non-insulin dependent diabetes
MGI:3842797	Tg(RP23-65I14)1Jno	MP:0002206,abnormal CNS synaptic transmission|MP:0003216,absence seizures|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype
MGI:3842799	Tg(RP23-65I14)2Jno	MP:0002206,abnormal CNS synaptic transmission|MP:0003216,absence seizures|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype
MGI:3801155	Tg(RP24-173I23)1Sun	MP:0002169,no abnormal phenotype detected
MGI:4821955	Tg(RP24-180N9)2Kjn	MP:0004738,abnormal auditory brainstem response
MGI:5308378	Tg(RP3-340H11)29Kel	MP:0001559,hyperglycemia|MP:0002891,increased insulin sensitivity|MP:0003058,increased insulin secretion|MP:0003123,paternal imprinting|MP:0003339,decreased pancreatic beta cell number|MP:0003562,abnormal pancreatic beta cell physiology|MP:0003645,increased pancreatic beta cell number|MP:0003934,abnormal pancreas development|MP:0005293,impaired glucose tolerance|MP:0005378,growth/size/body region phenotype|MP:0005381,digestive/alimentary phenotype|MP:0009114,decreased pancreatic beta cell mass|MP:0009176,increased pancreatic alpha cell number|MP:0009177,decreased pancreatic alpha cell number|MP:0009181,decreased pancreatic delta cell number|MP:0009186,decreased PP cell number
MGI:2680523	Tg(rPEPCKSREBF2)788Reh	MP:0000603,pale liver|MP:0001547,abnormal lipid level|MP:0005178,increased circulating cholesterol level|MP:0005281,increased fatty acids level|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level
MGI:4430325	Tg(Rr505-ECFP)1Rlb	MP:0002169,no abnormal phenotype detected
MGI:3769677	Tg(RSV-BDKRB2)8905Chao	MP:0000740,impaired smooth muscle contractility|MP:0002843,decreased systemic arterial blood pressure
MGI:3040267	Tg(rTH-Tag)20Dmc	MP:0002031,increased adrenal gland tumor incidence|MP:0002039,increased neuroblastoma incidence|MP:0009277,increased brain tumor incidence
MGI:1926798	Tg(rv-CYCLIN)29Dlh	MP:0000414,alopecia|MP:0000582,toenail hyperkeratosis|MP:0000655,dilated sex gland|MP:0000688,lymphoid hyperplasia|MP:0000693,spleen hyperplasia|MP:0001209,spontaneous skin ulceration|MP:0001216,abnormal epidermal layer morphology|MP:0001222,epidermal hyperplasia|MP:0001732,postnatal growth retardation|MP:0001882,abnormal lactation
MGI:4454421	Tg(S100a4-TK)M31Egn	MP:0002135,abnormal kidney morphology|MP:0005164,abnormal response to injury|MP:0008872,abnormal physiological response to xenobiotic|MP:0008943,increased sensitivity to induced cell death|MP:0008944,decreased sensitivity to induced cell death
MGI:3588512	Tg(S100B-EGFP)1Wjt	MP:0003631,nervous system phenotype
MGI:3588511	Tg(S100B-EYFP)1Wjt	MP:0003631,nervous system phenotype
MGI:3033302	Tg(S100b-v-erbB)4496Waw	MP:0002083,premature death|MP:0010312,increased oligodendroglioma incidence
MGI:5444605	Tgs1<tm1.1Jkr>	MP:0003077,abnormal cell cycle|MP:0011707,impaired fibroblast cell migration
MGI:5444606	Tgs1<tm1.2Jkr>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002718,abnormal inner cell mass morphology|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0004957,abnormal blastocyst morphology|MP:0008932,abnormal embryonic tissue physiology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3616405	Tg(SBE/TK-luc)7Twc	MP:0002169,no abnormal phenotype detected
MGI:3819980	Tg(Scgb1a1-cre)1Vart	MP:0002169,no abnormal phenotype detected
MGI:3709263	Tg(Scgb1a1-GH1)4-5Gtn	MP:0000422,delayed hair appearance|MP:0001265,decreased body size|MP:0001290,delayed eyelid opening|MP:0001732,postnatal growth retardation
MGI:3625098	Tg(Scgb1a1-Has2)1Nbl	MP:0006043,decreased apoptosis|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:3832264	Tg(Scgb1a1-Il13)2Eli	MP:0001952,increased airway responsiveness|MP:0002132,abnormal respiratory system morphology|MP:0002133,abnormal respiratory system physiology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002405,respiratory system inflammation|MP:0002442,abnormal leukocyte physiology|MP:0010903,abnormal pulmonary alveolus wall morphology|MP:0010935,increased airway resistance
MGI:3851444	Tg(Scgb1a1-Il17a)3Cdon	MP:0001179,thick pulmonary interalveolar septum|MP:0001861,lung inflammation|MP:0002267,abnormal bronchiole morphology|MP:0006382,abnormal lung epithelium morphology|MP:0008721,abnormal chemokine level
MGI:3803108	Tg(Scgb1a1-Il17f,GFP)1Cdon	MP:0001861,lung inflammation|MP:0002277,abnormal respiratory mucosa morphology
MGI:3835842	Tg(Scgb1a1-IL6)9Flv	MP:0000276,heart right ventricle hypertrophy|MP:0000484,abnormal pulmonary artery morphology|MP:0001262,decreased body weight|MP:0001861,lung inflammation|MP:0002314,abnormal respiratory mechanics|MP:0004007,abnormal lung vasculature morphology|MP:0006134,artery occlusion|MP:0010758,increased right ventricle systolic pressure
MGI:5576314	Tg(Scgb1a1-Muc5b,-AcGFP)#Evns	MP:0002411,decreased susceptibility to bacterial infection|MP:0010768,mortality/aging
MGI:5000230	Tg(Scgb1a1-PLUNC)#Chuh	MP:0002411,decreased susceptibility to bacterial infection
MGI:3819982	Tg(Scgb1a1-rtTA)2Vart	MP:0002169,no abnormal phenotype detected
MGI:3836020	Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli	MP:0000219,increased neutrophil cell number|MP:0001942,abnormal lung volume|MP:0001958,emphysema|MP:0005013,increased lymphocyte cell number|MP:0005425,increased macrophage cell number|MP:0006042,increased apoptosis|MP:0010895,increased lung compliance
MGI:3835944	Tg(Scgb1a1-rtTA,tetO-Il13)1Eli	MP:0005466,abnormal T-helper 2 physiology|MP:0006050,pulmonary fibrosis|MP:0008090,increased T-helper 2 cell number
MGI:3846185	Tg(Scgb1a1-rtTA,-tTS,tetO-CHI3L1)1Eli	MP:0002446,abnormal macrophage morphology|MP:0006043,decreased apoptosis|MP:0006414,decreased T cell apoptosis|MP:0008090,increased T-helper 2 cell number
MGI:3836057	Tg(Scgb1a1-rtTA,-tTS,tetO-TGFB1*)1Eli	MP:0001861,lung inflammation|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003426,pulmonary interstitial fibrosis|MP:0006050,pulmonary fibrosis|MP:0006382,abnormal lung epithelium morphology
MGI:3605471	Tg(Scgb1a1-Scnn1b)6608Bouc	MP:0001947,abnormal mucociliary clearance|MP:0001954,respiratory distress|MP:0001958,emphysema|MP:0002082,postnatal lethality|MP:0002133,abnormal respiratory system physiology|MP:0002281,abnormal respiratory mucosa goblet cell morphology|MP:0002405,respiratory system inflammation|MP:0010858,pulmonary epithelial necrosis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031055,bronchitis
MGI:3851210	Tg(Scn1a*)RH9Aesc	MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0004811,abnormal neuron physiology
MGI:3717419	Tg(Scx-GFP)1Stzr	MP:0002169,no abnormal phenotype detected
MGI:3847801	Tg(SERPINA1*E342K)#Slcw	MP:0000607,abnormal hepatocyte morphology|MP:0001654,hepatic necrosis|MP:0001860,liver inflammation|MP:0003333,liver fibrosis|MP:0005319,abnormal enzyme/coenzyme level
MGI:3528241	Tg(SERPINA1-HBVX)1655Jtsb	MP:0000598,abnormal liver morphology|MP:0001860,liver inflammation
MGI:3044038	Tg(SERPINA1-IGHG1/Il1rl1)423Zbz	MP:0002465,abnormal eosinophil physiology|MP:0005011,increased eosinophil cell number|MP:0005025,abnormal response to infection|MP:0008703,decreased interleukin-5 secretion
MGI:6467540	Tg(SERPINA1-TAg)1812Jtsb	MP:0003331,increased hepatocellular carcinoma incidence|MP:0004839,bile duct hyperplasia|MP:0014237,decreased tumor-free survival time
MGI:3607126	Tg(SERPINA1-Tnfsf12)1Biib	MP:0000609,abnormal liver physiology|MP:0003887,increased hepatocyte apoptosis|MP:0010040,abnormal oval cell morphology|MP:0010042,abnormal oval cell physiology
MGI:5437686	Tg(SERPINC1-SV40)A1Pbr	MP:0000598,abnormal liver morphology|MP:0001272,increased metastatic potential|MP:0002083,premature death|MP:0002642,anisocytosis|MP:0003331,increased hepatocellular carcinoma incidence|MP:0010080,abnormal hepatocyte physiology|MP:0014694,anisokaryosis
MGI:5437709	Tg(SERPINC1-SV40)BPbr	MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0005425,increased macrophage cell number|MP:0010144,abnormal tumor vascularization
MGI:5433102	Tg(SFTPC-Agr2)#Eem	MP:0003115,abnormal respiratory system development
MGI:3760413	Tg(SFTPC-CCNE1)1Edm	MP:0001272,increased metastatic potential|MP:0002027,increased lung adenocarcinoma incidence
MGI:3760419	Tg(SFTPC-CCNE1*T62A*T380A)3Edm	MP:0001272,increased metastatic potential|MP:0002027,increased lung adenocarcinoma incidence
MGI:3760420	Tg(SFTPC-CCNE1*T62A*T380A)4Edm	MP:0001272,increased metastatic potential|MP:0002027,increased lung adenocarcinoma incidence
MGI:5806502	Tg(SFTPC-CD74/ROS1)125Tno	MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002083,premature death|MP:0008014,increased lung tumor incidence|MP:0008716,increased lung non-small cell carcinoma incidence
MGI:3574949	Tg(Sftpc-cre)1Blh	MP:0001175,abnormal lung morphology|MP:0004880,lung cyst|MP:0014200,abnormal respiratory epithelium physiology
MGI:6402180	Tg(SFTPC-DPP4)3Pbmj	MP:0020948,abnormal susceptibility to Coronaviridae infection
MGI:5789333	Tg(SFTPC-EGFR*L858R)4-3Kkiu	MP:0002027,increased lung adenocarcinoma incidence|MP:0002083,premature death|MP:0008014,increased lung tumor incidence|MP:0008714,increased lung carcinoma incidence
MGI:3834680	Tg(SFTPC-EML4/ALK)502-4Hima	MP:0002027,increased lung adenocarcinoma incidence
MGI:4366152	Tg(SFTPC-env)1Yhch	MP:0001272,increased metastatic potential|MP:0002027,increased lung adenocarcinoma incidence|MP:0008014,increased lung tumor incidence
MGI:5523925	Tg(SFTPC-EZR/ROS1)AShiba	MP:0002027,increased lung adenocarcinoma incidence|MP:0002083,premature death
MGI:5707177	Tg(Sftpc-Grem1)105Mmyl	MP:0001179,thick pulmonary interalveolar septum|MP:0001861,lung inflammation|MP:0002169,no abnormal phenotype detected|MP:0006050,pulmonary fibrosis|MP:0010899,abnormal pulmonary alveolar system morphology
MGI:5688493	Tg(SFTPC-Il18)AThos	MP:0000063,decreased bone mineral density|MP:0000274,enlarged heart|MP:0000276,heart right ventricle hypertrophy|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001183,overexpanded pulmonary alveolus|MP:0001263,weight loss|MP:0001544,abnormal cardiovascular system physiology|MP:0001861,lung inflammation|MP:0001942,abnormal lung volume|MP:0001958,emphysema|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002333,abnormal lung compliance|MP:0002754,dilated heart right ventricle|MP:0003548,pulmonary hypertension|MP:0005293,impaired glucose tolerance|MP:0008566,increased interferon-gamma secretion|MP:0008672,increased interleukin-13 secretion|MP:0008777,increased right ventricle diastolic pressure|MP:0010239,decreased skeletal muscle weight|MP:0010758,increased right ventricle systolic pressure|MP:0014473,increased pulmonary alveolus wall thickness
MGI:3832271	Tg(SFTPC-ITGB6)1Des	MP:0002169,no abnormal phenotype detected
MGI:5661918	Tg(SFTPC-KIF5B/RET)1Tkoh	MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0008014,increased lung tumor incidence
MGI:3811265	Tg(Sftpc-Mirn17-92)1Blh	MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0002270,abnormal pulmonary alveolus morphology|MP:0004202,pulmonary hyperplasia|MP:0011090,perinatal lethality, incomplete penetrance
MGI:2446031	Tg(SFTPC-MST1R)71Mhw	MP:0001954,respiratory distress|MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence
MGI:3574950	Tg(Sftpc-Nmyc1/EGFP)1Blh	MP:0001176,abnormal lung development|MP:0001184,absent pulmonary alveoli
MGI:2447566	Tg(SFTPC-RAF1)87Urr	MP:0002048,increased lung adenoma incidence
MGI:2447567	Tg(SFTPC-RAF1-BxB)1Urr	MP:0002048,increased lung adenoma incidence
MGI:4437863	Tg(SFTPC-rtTA,tetO-Tnf)320-1Gwho	MP:0000219,increased neutrophil cell number|MP:0001861,lung inflammation|MP:0001958,emphysema|MP:0002393,abnormal bronchus-associated lymphoid tissue morphology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0004939,abnormal B cell morphology|MP:0005013,increased lymphocyte cell number|MP:0005461,abnormal dendritic cell morphology|MP:0006050,pulmonary fibrosis|MP:0008037,abnormal T cell morphology|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:5806503	Tg(SFTPC-SDC4/ROS1)141Tno	MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002083,premature death|MP:0008014,increased lung tumor incidence|MP:0008716,increased lung non-small cell carcinoma incidence
MGI:5644302	Tg(SFTPC-Tnf)2Pva	MP:0001175,abnormal lung morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001182,lung hemorrhage|MP:0001575,cyanosis|MP:0001862,interstitial pneumonia|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0001958,emphysema|MP:0002083,premature death|MP:0002132,abnormal respiratory system morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0002551,abnormal blood coagulation|MP:0004007,abnormal lung vasculature morphology|MP:0006050,pulmonary fibrosis|MP:0010898,abnormal pulmonary alveolus epithelium morphology|MP:0010899,abnormal pulmonary alveolar system morphology|MP:0010900,abnormal pulmonary interalveolar septum morphology|MP:0010903,abnormal pulmonary alveolus wall morphology|MP:0010922,alveolitis|MP:0011898,abnormal platelet cell number|MP:0014429,increased hyaluronic acid level|MP:0014473,increased pulmonary alveolus wall thickness|MP:0020253,increased collagen level
MGI:5647890	Tg(SFTPC*)#Twv	MP:0001178,pulmonary hypoplasia|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0004391,abnormal respiratory conducting tube morphology|MP:0010825,abnormal lung saccule morphology|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011087,neonatal lethality, complete penetrance
MGI:5515936	Tg(Shank3-EGFP)1Hzo	MP:0001260,increased body weight|MP:0001399,hyperactivity|MP:0001433,polyphagia|MP:0001488,increased startle reflex|MP:0002064,seizures|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002572,abnormal emotion/affect behavior|MP:0009142,decreased prepulse inhibition|MP:0009538,abnormal synapse morphology|MP:0009936,abnormal dendritic spine morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0011269,increased excitatory postsynaptic current amplitude|MP:0011620,abnormal habituation to a new environment|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0020351,decreased vocalization|MP:0020467,abnormal circadian behavior|MP:0020469,prolonged circadian behavior period|MP:0031391,increased locomotor activity
MGI:5828513	Tg(SHBG)4-aGlha	MP:0002781,increased circulating testosterone level|MP:0005389,reproductive system phenotype
MGI:5692334	Tg(Shh-cre/ERT2)#aYjg	MP:0002169,no abnormal phenotype detected
MGI:3665473	Tg(Shh)#Dje	MP:0000034,abnormal inner ear vestibule morphology|MP:0000036,absent semicircular canals|MP:0000350,abnormal cell proliferation|MP:0000849,abnormal cerebellum morphology|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0003169,abnormal scala media morphology|MP:0003308,abnormal cochlear sensory epithelium morphology|MP:0003703,abnormal vestibulocochlear ganglion morphology|MP:0004097,abnormal cerebellar cortex morphology|MP:0004315,absent vestibular saccule|MP:0004369,absent utricle
MGI:5529482	Tg(Sirt1)ASrn	MP:0004889,increased energy expenditure|MP:0005292,improved glucose tolerance|MP:0008735,increased susceptibility to endotoxin shock|MP:0011939,increased food intake|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3848345	Tg(Six2-GFP/cre)1Amc	MP:0002169,no abnormal phenotype detected
MGI:3057133	Tg(SKP2)4Paga	MP:0002169,no abnormal phenotype detected
MGI:4456190	Tg(Slc1a3-cre)#Tdan	MP:0002169,no abnormal phenotype detected
MGI:3055948	Tg(SLC2A4-OGT)15Jaha	MP:0002079,increased circulating insulin level|MP:0005331,insulin resistance|MP:0005669,increased circulating leptin level
MGI:5708106	Tg(Slc5a7)1Rbl	MP:0001363,increased anxiety-related response|MP:0012107,enhanced exercise endurance|MP:0030676,increased acetylcholine level|MP:0031391,increased locomotor activity
MGI:3852083	Tg(Slc6a3-icre)1Fto	MP:0005386,behavior/neurological phenotype
MGI:3845880	Tg(Slc6a3-PARK2*Q311X)AXwy	MP:0000836,abnormal substantia nigra morphology|MP:0001402,decreased locomotor activity|MP:0001525,impaired balance|MP:0001968,abnormal touch/nociception|MP:0002757,decreased vertical activity|MP:0003244,loss of dopaminergic neurons|MP:0003313,abnormal locomotor activation|MP:0005643,decreased dopamine level
MGI:3845881	Tg(Slc6a3-PARK2*Q311X)DXwy	MP:0001402,decreased locomotor activity|MP:0001968,abnormal touch/nociception|MP:0003244,loss of dopaminergic neurons|MP:0005386,behavior/neurological phenotype
MGI:3696870	Tg(Smgb-TAg)8Mir	MP:0000621,increased salivary adenocarcinoma incidence|MP:0009523,submandibular gland hyperplasia|MP:0009525,abnormal submandibular duct morphology
MGI:3832059	Tg(SMN2)11Tro	MP:0003631,nervous system phenotype
MGI:3832058	Tg(SMN2)46Tro	MP:0002169,no abnormal phenotype detected
MGI:4847444	Tg(Smoc2-EGFP)HY194Gsat	MP:0003985,renal fibrosis|MP:0005165,increased susceptibility to injury|MP:0011425,abnormal kidney interstitium morphology
MGI:5429214	Tg(SNCA)ARyot	MP:0001364,decreased anxiety-related response|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0031391,increased locomotor activity
MGI:5431984	Tg(SNCA*E46K)3Elan	MP:0001405,impaired coordination|MP:0002229,neurodegeneration|MP:0003243,abnormal dopaminergic neuron morphology|MP:0003354,astrocytosis|MP:0008493,alpha-synuclein inclusion body|MP:0009538,abnormal synapse morphology
MGI:5526031	Tg(Snca-SNCA)#Galt	MP:0001460,abnormal olfactory discrimination memory|MP:0002063,abnormal learning/memory/conditioning|MP:0005386,behavior/neurological phenotype|MP:0008544,impaired olfaction
MGI:5544077	Tg(Snca-SNCA/GFP)#Jyl	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0003462,abnormal response to novel odor|MP:0008493,alpha-synuclein inclusion body|MP:0008544,impaired olfaction|MP:0010149,abnormal synaptic dopamine release
MGI:3695897	Tg(SOD1*)125Dbo	MP:0000755,hindlimb paralysis|MP:0000939,decreased motor neuron number|MP:0004191,neuronal intranuclear inclusions
MGI:2448770	Tg(SOD1)2Gur	MP:0000953,abnormal oligodendrocyte morphology|MP:0000955,abnormal spinal cord morphology|MP:0005404,abnormal axon morphology
MGI:2387864	Tg(SOD1)3Cje	MP:0006085,myocardium necrosis|MP:0011968,decreased threshold for auditory brainstem response
MGI:3718455	Tg(SOD1)51Yg	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001364,decreased anxiety-related response|MP:0001473,reduced long-term potentiation|MP:0001970,abnormal pain threshold|MP:0003313,abnormal locomotor activation|MP:0004262,abnormal physical strength
MGI:3718456	Tg(SOD1)69Yg	MP:0003313,abnormal locomotor activation
MGI:3695886	Tg(SOD1)76Dpr	MP:0002169,no abnormal phenotype detected|MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury
MGI:5449884	Tg(SOD1*A4V)A1073Gur	MP:0002169,no abnormal phenotype detected
MGI:5621172	Tg(SOD1*)D-14Dbo	MP:0000753,paralysis|MP:0000955,abnormal spinal cord morphology
MGI:5449420	Tg(SOD1*)DF7Yaw	MP:0000160,kyphosis|MP:0000746,weakness|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002183,gliosis|MP:0002269,muscular atrophy|MP:0005113,decreased spinal cord ventral horn cell number|MP:0009434,paraparesis
MGI:5286585	Tg(SOD1*G127X)716Mrkl	MP:0000753,paralysis|MP:0000755,hindlimb paralysis|MP:0000756,forelimb paralysis|MP:0000937,abnormal motor neuron morphology|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology|MP:0003354,astrocytosis
MGI:5286589	Tg(SOD1*G127X)832Mrkl	MP:0002083,premature death
MGI:2182087	Tg(SOD1*G37R)106Dpr	MP:0000745,tremors|MP:0000746,weakness|MP:0000755,hindlimb paralysis|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0002269,muscular atrophy|MP:0004145,abnormal muscle electrophysiology|MP:0010179,rough coat|MP:0014346,abnormal motor neuron mitochondrial morphology
MGI:3629226	Tg(SOD1*G37R)1Dwc	MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0001263,weight loss|MP:0002083,premature death|MP:0005405,axon degeneration
MGI:3574016	Tg(SOD1*G37R)29Dpr	MP:0000745,tremors|MP:0000746,weakness|MP:0000755,hindlimb paralysis|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0000966,decreased sensory neuron number|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001770,abnormal iron level|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0002882,abnormal neuron morphology|MP:0004145,abnormal muscle electrophysiology|MP:0005637,abnormal iron homeostasis|MP:0010179,rough coat|MP:0014346,abnormal motor neuron mitochondrial morphology
MGI:3574014	Tg(SOD1*G37R)42Dpr	MP:0000745,tremors|MP:0000746,weakness|MP:0000755,hindlimb paralysis|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0000955,abnormal spinal cord morphology|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0002269,muscular atrophy|MP:0004145,abnormal muscle electrophysiology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0008025,brain vacuoles|MP:0010179,rough coat|MP:0014346,abnormal motor neuron mitochondrial morphology
MGI:3574015	Tg(SOD1*G37R)9Dpr	MP:0000745,tremors|MP:0000746,weakness|MP:0000755,hindlimb paralysis|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0002269,muscular atrophy|MP:0004145,abnormal muscle electrophysiology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0008025,brain vacuoles|MP:0010179,rough coat|MP:0014346,abnormal motor neuron mitochondrial morphology
MGI:2182171	Tg(SOD1*G85R)148Dwc	MP:0000748,progressive muscle weakness|MP:0000753,paralysis|MP:0000755,hindlimb paralysis|MP:0000937,abnormal motor neuron morphology|MP:0000939,decreased motor neuron number|MP:0002182,abnormal astrocyte morphology|MP:0002269,muscular atrophy|MP:0002882,abnormal neuron morphology|MP:0003354,astrocytosis|MP:0005405,axon degeneration|MP:0010053,decreased grip strength
MGI:2182172	Tg(SOD1*G85R)74Dwc	MP:0000748,progressive muscle weakness|MP:0000753,paralysis|MP:0000755,hindlimb paralysis|MP:0002269,muscular atrophy|MP:0010053,decreased grip strength
MGI:5621057	Tg(SOD1*G85R/EYFP)641Alho	MP:0000753,paralysis|MP:0000937,abnormal motor neuron morphology|MP:0002183,gliosis|MP:0003633,abnormal nervous system physiology
MGI:5630056	Tg(SOD1*G85R/EYFP)737Alho	MP:0000753,paralysis|MP:0000937,abnormal motor neuron morphology|MP:0003633,abnormal nervous system physiology|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0008260,abnormal autophagy
MGI:5448547	Tg(SOD1*G85R)#Roos	MP:0000755,hindlimb paralysis|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0001263,weight loss|MP:0002083,premature death|MP:0003354,astrocytosis
MGI:2183736	Tg(Sod1*G86R)M1Jwg	MP:0000003,abnormal adipose tissue morphology|MP:0000746,weakness|MP:0000749,muscle degeneration|MP:0000753,paralysis|MP:0000909,abnormal facial motor nucleus morphology|MP:0000911,abnormal trigeminal motor nucleus morphology|MP:0000938,motor neuron degeneration|MP:0001056,abnormal cranial nerve morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001405,impaired coordination|MP:0001438,aphagia|MP:0001525,impaired balance|MP:0001745,increased circulating corticosterone level|MP:0001783,decreased white adipose tissue amount|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002118,abnormal lipid homeostasis|MP:0002229,neurodegeneration|MP:0002575,increased circulating ketone body level|MP:0002727,decreased circulating insulin level|MP:0003439,abnormal glycerol level|MP:0003948,abnormal gas homeostasis|MP:0004280,abnormal oculomotor nucleus morphology|MP:0004281,abnormal hypoglossal nucleus morphology|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005289,increased oxygen consumption|MP:0005334,abnormal fat pad morphology|MP:0005418,abnormal circulating hormone level|MP:0005450,abnormal energy expenditure|MP:0005479,decreased circulating triiodothyronine level|MP:0005551,abnormal eye electrophysiology|MP:0005559,increased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0006282,abnormal spinal cord dorsal horn morphology|MP:0008034,enhanced lipolysis|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0010053,decreased grip strength|MP:0010379,decreased respiratory quotient|MP:0011049,impaired adaptive thermogenesis|MP:0014336,short retina rod cell outer segment
MGI:2183738	Tg(SOD1*G86R)M3Jwg	MP:0000746,weakness|MP:0000755,hindlimb paralysis|MP:0000938,motor neuron degeneration|MP:0001438,aphagia|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0005112,abnormal spinal cord ventral horn morphology
MGI:2183719	Tg(SOD1*G93A)1Gur	MP:0000003,abnormal adipose tissue morphology|MP:0000136,abnormal microglial cell morphology|MP:0000221,decreased leukocyte cell number|MP:0000223,decreased monocyte cell number|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000745,tremors|MP:0000747,muscle weakness|MP:0000748,progressive muscle weakness|MP:0000753,paralysis|MP:0000755,hindlimb paralysis|MP:0000788,abnormal cerebral cortex morphology|MP:0000832,abnormal thalamus morphology|MP:0000836,abnormal substantia nigra morphology|MP:0000837,abnormal hypothalamus morphology|MP:0000897,abnormal midbrain morphology|MP:0000904,abnormal superior colliculus morphology|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0000955,abnormal spinal cord morphology|MP:0000966,decreased sensory neuron number|MP:0001038,abnormal cholinergic neuron morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001363,increased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001422,abnormal drinking behavior|MP:0001475,reduced long-term depression|MP:0001745,increased circulating corticosterone level|MP:0001785,edema|MP:0001900,impaired synaptic plasticity|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002152,abnormal brain morphology|MP:0002182,abnormal astrocyte morphology|MP:0002183,gliosis|MP:0002206,abnormal CNS synaptic transmission|MP:0002207,abnormal long-term potentiation|MP:0002444,abnormal T cell physiology|MP:0002606,increased basophil cell number|MP:0002619,abnormal lymphocyte morphology|MP:0002727,decreased circulating insulin level|MP:0002757,decreased vertical activity|MP:0002798,abnormal active avoidance behavior|MP:0002878,abnormal corticospinal tract morphology|MP:0002882,abnormal neuron morphology|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003106,abnormal fear-related response|MP:0003354,astrocytosis|MP:0003633,abnormal nervous system physiology|MP:0003658,abnormal capillary morphology|MP:0003926,decreased cellular glucose uptake|MP:0003957,abnormal nitric oxide homeostasis|MP:0004081,abnormal globus pallidus morphology|MP:0004100,abnormal spinal cord interneuron morphology|MP:0004231,abnormal calcium ion homeostasis|MP:0004280,abnormal oculomotor nucleus morphology|MP:0004768,abnormal axonal transport|MP:0004807,abnormal paired-pulse inhibition|MP:0004811,abnormal neuron physiology|MP:0004953,decreased spleen weight|MP:0005012,decreased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005113,decreased spinal cord ventral horn cell number|MP:0005277,abnormal brainstem morphology|MP:0005289,increased oxygen consumption|MP:0005334,abnormal fat pad morphology|MP:0005418,abnormal circulating hormone level|MP:0005450,abnormal energy expenditure|MP:0005621,abnormal cell physiology|MP:0005668,decreased circulating leptin level|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006055,abnormal vascular endothelial cell morphology|MP:0006060,increased cerebral infarct size|MP:0006082,CNS inflammation|MP:0006100,abnormal tegmentum morphology|MP:0008025,brain vacuoles|MP:0008027,abnormal spinal cord white matter morphology|MP:0008143,abnormal dendrite morphology|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0008489,slow postnatal weight gain|MP:0008571,abnormal synaptic bouton morphology|MP:0008826,abnormal splenic cell ratio|MP:0008918,microgliosis|MP:0008948,decreased neuron number|MP:0009332,abnormal splenocyte morphology|MP:0009339,decreased splenocyte number|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009417,skeletal muscle atrophy|MP:0009936,abnormal dendritic spine morphology|MP:0010053,decreased grip strength|MP:0010240,decreased skeletal muscle size|MP:0010540,long stride length|MP:0010955,abnormal respiratory electron transport chain|MP:0011630,increased mitochondrial size|MP:0011632,dilated mitochondrion|MP:0011633,abnormal mitochondrial shape|MP:0011635,abnormal mitochondrial crista morphology|MP:0012267,abnormal red nucleus morphology|MP:0014812,abnormal brain physiology|MP:0014815,decreased brain gluscose metabolism|MP:0020543,decreased substantia nigra size|MP:0021103,abnormal ventral interneuron 1 morphology
MGI:2183718	Tg(SOD1*G93A)2Gur	MP:0000745,tremors|MP:0000748,progressive muscle weakness|MP:0000753,paralysis|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0000955,abnormal spinal cord morphology|MP:0001263,weight loss|MP:0001405,impaired coordination|MP:0001440,abnormal grooming behavior|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002832,coarse hair|MP:0003993,abnormal ventral spinal root morphology|MP:0004263,abnormal limb posture|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005277,abnormal brainstem morphology|MP:0005333,decreased heart rate|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006035,abnormal mitochondrial morphology|MP:0006277,abnormal parasympathetic nervous system physiology|MP:0008025,brain vacuoles|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009677,abnormal spinal cord dorsal column morphology|MP:0009678,abnormal spinal cord lateral column morphology|MP:0009679,abnormal spinal cord ventral column morphology|MP:0009732,ventricular premature beat|MP:0010047,axonal spheroids
MGI:2671112	Tg(SOD1*G93A)<dl>1Gur	MP:0000747,muscle weakness|MP:0000748,progressive muscle weakness|MP:0000753,paralysis|MP:0000755,hindlimb paralysis|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002882,abnormal neuron morphology|MP:0003354,astrocytosis|MP:0004768,abnormal axonal transport|MP:0006035,abnormal mitochondrial morphology|MP:0008918,microgliosis
MGI:4820848	Tg(SOD1*G93A)G20Gur	MP:0000938,motor neuron degeneration|MP:0001077,abnormal spinal nerve morphology|MP:0002083,premature death|MP:0002651,abnormal sciatic nerve morphology|MP:0003993,abnormal ventral spinal root morphology
MGI:5699338	Tg(SOD1*H46R*C111S)PAra	MP:0000753,paralysis|MP:0000938,motor neuron degeneration|MP:0002083,premature death|MP:0003354,astrocytosis|MP:0005378,growth/size/body region phenotype|MP:0008918,microgliosis
MGI:5699327	Tg(SOD1*H46R*C111S)QAra	MP:0000753,paralysis|MP:0002083,premature death|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0008918,microgliosis
MGI:3695885	Tg(SOD1*H46R*H48Q)139Dbo	MP:0000755,hindlimb paralysis|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0002882,abnormal neuron morphology|MP:0003354,astrocytosis
MGI:3695884	Tg(SOD1*H46R*H48Q)58Dbo	MP:0000755,hindlimb paralysis|MP:0000939,decreased motor neuron number|MP:0003354,astrocytosis
MGI:5699320	Tg(SOD1*H46R)IAra	MP:0000753,paralysis|MP:0001263,weight loss|MP:0001405,impaired coordination|MP:0002083,premature death
MGI:5699326	Tg(SOD1*H46R)LAra	MP:0000753,paralysis|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0000955,abnormal spinal cord morphology|MP:0001263,weight loss|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0003083,abnormal tibialis anterior morphology|MP:0003354,astrocytosis|MP:0008918,microgliosis|MP:0009428,decreased tibialis anterior weight
MGI:5297587	Tg(SOD1*H46R)#Maw	MP:0000748,progressive muscle weakness|MP:0000749,muscle degeneration|MP:0001405,impaired coordination|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0004191,neuronal intranuclear inclusions|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005113,decreased spinal cord ventral horn cell number|MP:0008916,abnormal astrocyte physiology
MGI:5621061	Tg(SOD1*L126Z)45Dbo	MP:0000753,paralysis|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0000955,abnormal spinal cord morphology|MP:0002083,premature death|MP:0003354,astrocytosis|MP:0003633,abnormal nervous system physiology|MP:0008918,microgliosis
MGI:5449894	Tg(SOD1*L126Z)#Deng	MP:0002083,premature death|MP:0003633,abnormal nervous system physiology|MP:0008503,abnormal spinal cord grey matter morphology
MGI:4839388	Tg(Sox3)1Pqt	MP:0000351,increased cell proliferation|MP:0000440,domed cranium|MP:0000830,abnormal diencephalon morphology|MP:0000923,abnormal roof plate morphology|MP:0001891,hydrocephaly|MP:0003631,nervous system phenotype|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0009716,abnormal subcommissural organ morphology|MP:0010893,abnormal posterior commissure morphology|MP:0013361,absent pineal recess|MP:0013362,absent pineal gland
MGI:5428449	Tg(Sox3-EGFP)NrPqt	MP:0001891,hydrocephaly|MP:0009716,abnormal subcommissural organ morphology
MGI:5763034	Tg(Sp7-Mir188)1Xhl	MP:0000135,decreased compact bone thickness|MP:0004989,decreased osteoblast cell number|MP:0004991,decreased bone strength|MP:0008271,abnormal bone ossification|MP:0009115,abnormal fat cell morphology|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume
MGI:3689350	Tg(Sp7-tTA,tetO-EGFP/cre)1Amc	MP:0002764,short tibia|MP:0004148,increased compact bone thickness|MP:0008156,decreased diameter of tibia|MP:0010879,decreased trabecular bone volume
MGI:3054654	Tg(SREBP1a)7343Reh	MP:0000186,decreased circulating HDL cholesterol level|MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002965,increased circulating serum albumin level|MP:0002981,increased liver weight|MP:0003983,decreased cholesterol level|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005325,abnormal renal glomerulus morphology|MP:0005331,insulin resistance|MP:0005334,abnormal fat pad morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0005517,impaired liver regeneration|MP:0005559,increased circulating glucose level|MP:0005568,increased circulating total protein level|MP:0005668,decreased circulating leptin level|MP:0009113,increased pancreatic beta cell mass|MP:0009289,decreased epididymal fat pad weight|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0011174,lipodystrophy|MP:0011353,expanded mesangial matrix|MP:0011427,increased mesangial cell number
MGI:3041981	Tg(Sry)1Ei	MP:0001924,infertility|MP:0002995,primary sex reversal
MGI:3043687	Tg(Sry)1Rlb	MP:0001156,abnormal spermatogenesis|MP:0001924,infertility|MP:0002995,primary sex reversal
MGI:3041982	Tg(Sry)2Ei	MP:0001924,infertility|MP:0002995,primary sex reversal
MGI:3710215	Tg(Sry)3Ei	MP:0001924,infertility|MP:0002995,primary sex reversal
MGI:3042867	Tg(Sry)4Ei	MP:0002995,primary sex reversal
MGI:3703730	Tg(Sry-EGFP)92Ei	MP:0002169,no abnormal phenotype detected
MGI:5574060	Tg(Stat3*)9199Alau	MP:0000219,increased neutrophil cell number|MP:0001846,increased inflammatory response|MP:0001858,intestinal inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0002497,increased IgE level|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008495,decreased IgG1 level|MP:0008498,decreased IgG3 level|MP:0008735,increased susceptibility to endotoxin shock|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010221,abnormal T-helper 17 cell differentiation
MGI:4819165	Tg(STIL-TAL1)A5.3Alpa	MP:0002006,neoplasm
MGI:3779079	Tg(Stra8-icre)1Reb	MP:0002169,no abnormal phenotype detected
MGI:5581619	Tg(SULT1A1,SULT1A2)1Glatt	MP:0000609,abnormal liver physiology|MP:0005621,abnormal cell physiology|MP:0009642,abnormal blood homeostasis
MGI:2654022	Tg(SV40-Ahr)1Poe	MP:0000473,abnormal stomach glandular epithelium morphology|MP:0000494,abnormal cecum morphology|MP:0002083,premature death|MP:0002581,abnormal ileum morphology|MP:0002981,increased liver weight|MP:0003132,increased pre-B cell number|MP:0004956,decreased thymus weight|MP:0004978,decreased B-1 B cell number|MP:0005213,gastric metaplasia|MP:0008186,increased pro-B cell number|MP:0008203,absent B-1a cells|MP:0008206,increased B-2 B cell number|MP:0008210,increased mature B cell number|MP:0010301,increased stomach tumor incidence|MP:0010783,abnormal stomach wall morphology
MGI:3703557	Tg(SV40/HTLV-FCER1A)1Bhk	MP:0005387,immune system phenotype
MGI:5563691	Tg(SV40-KLK7)1010Teg	MP:0000416,sparse hair|MP:0001192,scaly skin|MP:0001194,dermatitis|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001412,excessive scratching|MP:0001510,abnormal coat appearance|MP:0001874,acanthosis|MP:0013116,focal hair loss in head/neck region
MGI:3757990	Tg(SV40-NRAS*G12D)1Sco	MP:0002024,increased T cell derived lymphoma incidence|MP:0002032,increased sarcoma incidence
MGI:3056380	Tg(SV)419Bri	MP:0002006,neoplasm|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0008528,polycystic kidney|MP:0009277,increased brain tumor incidence|MP:0010294,increased kidney tumor incidence
MGI:3056377	Tg(SV)427Bri	MP:0000438,abnormal cranium morphology|MP:0000709,enlarged thymus|MP:0001915,intracranial hemorrhage|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0002083,premature death|MP:0009277,increased brain tumor incidence
MGI:3040283	Tg(SV)7Bri	MP:0009277,increased brain tumor incidence
MGI:6510603	Tg(Syn1-ACE2)#Lazar	MP:0005385,cardiovascular system phenotype|MP:0012046,decreased susceptibility to hypertension
MGI:3695128	Tg(Syn1-ADCY7)11004Btab	MP:0001981,increased chemically-elicited antinociception|MP:0002573,behavioral despair|MP:0009745,abnormal behavioral response to xenobiotic
MGI:7510166	Tg(Syn1-Cabp7/mCherry)1Mrkr	MP:0003631,nervous system phenotype
MGI:3783748	Tg(T)118.9Bgh	MP:0005371,limbs/digits/tail phenotype
MGI:3802950	Tg(TACSTD1)02Leij	MP:0002169,no abnormal phenotype detected
MGI:3699001	Tg(Tagln-Ager)#Yon	MP:0004883,abnormal vascular wound healing|MP:0005595,abnormal vascular smooth muscle physiology|MP:0031509,decreased vascular smooth muscle cell proliferation
MGI:5474459	Tg(Tagln-SLC6A4)#Edd	MP:0000276,heart right ventricle hypertrophy|MP:0003548,pulmonary hypertension|MP:0004007,abnormal lung vasculature morphology|MP:0005592,abnormal vascular smooth muscle morphology|MP:0010758,increased right ventricle systolic pressure
MGI:2447082	Tg(Tagln-tTA)1Mrab	MP:0002169,no abnormal phenotype detected
MGI:3040285	Tg(TagRb)1Plm	MP:0001004,abnormal retina photoreceptor morphology|MP:0001325,abnormal retina morphology|MP:0006310,increased retinoblastoma incidence
MGI:5476824	Tg(TARDBP*A315T)#Jpj	MP:0000937,abnormal motor neuron morphology|MP:0001405,impaired coordination|MP:0003354,astrocytosis|MP:0004000,impaired passive avoidance behavior|MP:0008918,microgliosis|MP:0011975,neuronal cytoplasmic inclusions
MGI:5476825	Tg(TARDBP*G348C)#Jpj	MP:0000937,abnormal motor neuron morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0004000,impaired passive avoidance behavior|MP:0008713,abnormal cytokine level|MP:0008918,microgliosis|MP:0011975,neuronal cytoplasmic inclusions
MGI:5476821	Tg(TARDBP)#Jpj	MP:0000937,abnormal motor neuron morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0003354,astrocytosis|MP:0004000,impaired passive avoidance behavior|MP:0008918,microgliosis
MGI:6278978	Tg(TBK1)#Andm	MP:0008067,retina ganglion cell degeneration
MGI:1889853	Tg(TCF3/HLF)1Mlc	MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0001824,abnormal thymus involution|MP:0001825,arrested T cell differentiation|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0014237,decreased tumor-free survival time
MGI:3057160	Tg(TCF/Lef1-lacZ)34Efu	MP:0000417,short hair|MP:0000648,absent sebaceous gland|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0002656,abnormal keratinocyte differentiation
MGI:3688270	Tg(Tcra2B4)1Mmd	MP:0000715,decreased thymocyte number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008827,abnormal thymus cell ratio|MP:0012431,increased lymphoma incidence
MGI:3621454	Tg(Tcra2C,Tcrb2C)1Dlo	MP:0000715,decreased thymocyte number|MP:0001219,thick epidermis|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005016,decreased lymphocyte cell number|MP:0008051,abnormal memory T cell physiology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0009545,abnormal dermis papillary layer morphology|MP:0009792,seborrheic dermatitis
MGI:3700794	Tg(Tcra2D2,Tcrb2D2)1Kuch	MP:0000351,increased cell proliferation|MP:0000921,demyelination|MP:0001330,abnormal optic nerve morphology|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0003009,abnormal cytokine secretion|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005095,decreased T cell proliferation|MP:0005251,blepharitis|MP:0005348,increased T cell proliferation|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005405,axon degeneration|MP:0006082,CNS inflammation|MP:0006167,eyelid edema|MP:0006413,increased T cell apoptosis|MP:0008085,abnormal T-helper 1 cell number|MP:0008091,decreased T-helper 2 cell number|MP:0008566,increased interferon-gamma secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008681,increased interleukin-17 secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008705,increased interleukin-6 secretion|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010220,decreased T-helper 17 cell number
MGI:3760401	Tg(Tcra51-11.5,Tcrb51-11.5)AR206Ayr	MP:0004919,abnormal positive T cell selection
MGI:3761187	Tg(Tcra5CC7,Tcrb5CC7)IWep	MP:0001828,abnormal T cell activation
MGI:3057179	Tg(TcraAI4)1Dvs	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0004803,increased susceptibility to autoimmune diabetes
MGI:3814864	Tg(TcraAV19AJ33)1Shima	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0008036,abnormal NK T cell morphology|MP:0008042,abnormal NK T cell physiology
MGI:2181203	Tg(TcraBDC2.5,TcrbBDC2.5)1Doi	MP:0001829,increased activated T cell number|MP:0004031,insulitis|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype|MP:0008127,decreased dendritic cell number
MGI:3617607	Tg(TcraCl1,TcrbCl1)1Shrm	MP:0000746,weakness|MP:0002020,increased tumor incidence|MP:0002161,abnormal fertility/fecundity|MP:0003944,abnormal T cell subpopulation ratio
MGI:3586582	Tg(TcraCl4,TcrbCl4)1Shrm	MP:0003944,abnormal T cell subpopulation ratio|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation
MGI:3800484	Tg(TcraDN32D3)#Alhn	MP:0000715,decreased thymocyte number|MP:0005090,increased double-negative T cell number|MP:0008045,decreased NK cell number
MGI:3044562	Tg(TcraH-Y,TcrbH-Y)71Vbo	MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0002145,abnormal T cell differentiation|MP:0002407,abnormal double-negative T cell morphology|MP:0005078,abnormal cytotoxic T cell physiology
MGI:3053044	Tg(TcrAND)53Hed	MP:0002145,abnormal T cell differentiation|MP:0003850,abnormal thymocyte activation|MP:0003944,abnormal T cell subpopulation ratio|MP:0004919,abnormal positive T cell selection|MP:0005092,decreased double-positive T cell number|MP:0005094,abnormal T cell proliferation|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008828,abnormal lymph node cell ratio
MGI:3767242	Tg(TcraR28,TcrbR28)KRNDim	MP:0000691,enlarged spleen|MP:0000717,abnormal lymphocyte cell number|MP:0001828,abnormal T cell activation|MP:0001859,kidney inflammation|MP:0002743,glomerulonephritis|MP:0002935,chronic joint inflammation|MP:0003072,abnormal metatarsal bone morphology|MP:0003561,rheumatoid arthritis|MP:0004173,abnormal intervertebral disk morphology|MP:0005002,abnormal T cell clonal deletion|MP:0005014,increased B cell number|MP:0005094,abnormal T cell proliferation|MP:0005306,abnormal phalanx morphology|MP:0006253,clinodactyly|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008499,increased IgG1 level|MP:0008719,impaired neutrophil recruitment|MP:0008747,abnormal T cell anergy|MP:0010760,abnormal macrophage chemotaxis|MP:0020519,renal glomerular immunoglobulin deposits|MP:0030863,decreased joint mobility
MGI:3054907	Tg(TcraTcrb)1100Mjb	MP:0000603,pale liver|MP:0001860,liver inflammation|MP:0003887,increased hepatocyte apoptosis|MP:0003944,abnormal T cell subpopulation ratio|MP:0004919,abnormal positive T cell selection|MP:0005002,abnormal T cell clonal deletion|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005348,increased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0009828,increased tumor latency
MGI:3707414	Tg(Tcra,Tcrb)24Efro	MP:0001844,autoimmune response|MP:0002145,abnormal T cell differentiation|MP:0003009,abnormal cytokine secretion|MP:0003725,increased autoantibody level|MP:0005095,decreased T cell proliferation|MP:0005348,increased T cell proliferation|MP:0005350,increased susceptibility to autoimmune disorder|MP:0008049,increased memory T cell number
MGI:2665469	Tg(Tcra,Tcrb)3Ayr	MP:0004919,abnormal positive T cell selection|MP:0005004,abnormal lymphocyte anergy|MP:0005095,decreased T cell proliferation
MGI:3046083	Tg(TcraTcrb)425Cbn	MP:0004919,abnormal positive T cell selection|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008713,abnormal cytokine level
MGI:3051150	Tg(TcraTcrb)8Rest	MP:0002166,abnormal tumor susceptibility|MP:0002436,abnormal CD8-positive, alpha-beta cytotoxic T cell morphology|MP:0005078,abnormal cytotoxic T cell physiology|MP:0008566,increased interferon-gamma secretion
MGI:3773741	Tg(Tcra,Tcrb)HRCAll	MP:0003944,abnormal T cell subpopulation ratio|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008567,decreased interferon-gamma secretion
MGI:3773740	Tg(Tcra,Tcrb)HRVAll	MP:0003944,abnormal T cell subpopulation ratio|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:3849006	Tg(TcraTcrbNY4.1)1Pesa	MP:0004031,insulitis|MP:0004803,increased susceptibility to autoimmune diabetes
MGI:3584121	Tg(TcraTcrbNY8.3)1Pesa	MP:0001869,pancreas inflammation|MP:0005559,increased circulating glucose level
MGI:3700739	Tg(TcraY1,TcrbY1)416Tev	MP:0005000,abnormal immune tolerance
MGI:3056727	Tg(Tcrb)93Vbo	MP:0005002,abnormal T cell clonal deletion|MP:0005078,abnormal cytotoxic T cell physiology|MP:0008037,abnormal T cell morphology|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008758,abnormal T cell receptor beta chain V(D)J recombination
MGI:3057181	Tg(TcrbAI4)1Dvs	MP:0000188,abnormal circulating glucose level|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology
MGI:3790483	Tg(TcrbBL17)1Lmor	MP:0003724,increased susceptibility to induced arthritis
MGI:3773739	Tg(Tcrb)HRBAll	MP:0005387,immune system phenotype
MGI:5638109	Tg(Tcrb-TCF3/PBX1)19Gusa	MP:0000715,decreased thymocyte number|MP:0002026,increased leukemia incidence|MP:0010336,increased acute lymphoblastic leukemia incidence
MGI:5638104	Tg(Tcrb-TCF3/PBX1)23Gusa	MP:0000715,decreased thymocyte number|MP:0002026,increased leukemia incidence|MP:0010336,increased acute lymphoblastic leukemia incidence
MGI:5509185	Tg(T-cre/ERT2)1Lwd	MP:0002169,no abnormal phenotype detected
MGI:2385683	Tg(TcrHEL3A9)1Mmd	MP:0001828,abnormal T cell activation|MP:0002408,abnormal double-positive T cell morphology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0005094,abnormal T cell proliferation|MP:0005348,increased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008568,abnormal interleukin secretion|MP:0008827,abnormal thymus cell ratio
MGI:3052138	Tg(TcrLCMV)1Aox	MP:0002493,increased IgG level|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3758830	Tg(TcrLCMV)2Aox	MP:0005078,abnormal cytotoxic T cell physiology|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:2665105	Tg(TcrLCMV)327Sdz	MP:0001823,thymus hypoplasia|MP:0001844,autoimmune response|MP:0002145,abnormal T cell differentiation|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:2136412	Tg(Tek-cre)12Flv	MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance
MGI:2450311	Tg(Tek-cre)1Ywa	MP:0001262,decreased body weight|MP:0001967,deafness|MP:0004333,abnormal utricular macula morphology|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0004531,short outer hair cell stereocilia|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004589,abnormal cochlear hair cell development|MP:0031674,long inner hair cell stereocilia
MGI:3810530	Tg(Tek-cre)2352Rwng	MP:0002169,no abnormal phenotype detected
MGI:3775831	Tg(Tek-CYSLTR2)4Fun	MP:0000343,abnormal response to cardiac infarction|MP:0003037,increased myocardial infarct size
MGI:3767832	Tg(Tek-Jam3)1Maal	MP:0001861,lung inflammation|MP:0002442,abnormal leukocyte physiology|MP:0003303,peritoneal inflammation|MP:0003628,abnormal leukocyte adhesion|MP:0008720,impaired neutrophil chemotaxis|MP:0009858,abnormal cellular extravasation
MGI:5575645	Tg(Tek-Nfkbia*S32A*S36A)1Gkl	MP:0002169,no abnormal phenotype detected
MGI:5750460	Tg(Tek-Npr1)#Kkan	MP:0001273,decreased metastatic potential|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:3579665	Tg(Tek-Nr2f2)1Tsa	MP:0001700,abnormal embryo turning|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0005312,pericardial effusion|MP:0006093,arteriovenous malformation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3703326	Tg(Tek-Procr)1Cte	MP:0001790,abnormal immune system physiology|MP:0001845,abnormal inflammatory response|MP:0002551,abnormal blood coagulation|MP:0005319,abnormal enzyme/coenzyme level|MP:0005464,abnormal platelet physiology|MP:0010211,abnormal acute phase protein level
MGI:5588000	Tg(Tek-Tnf*)5382Mcla	MP:0001859,kidney inflammation|MP:0001861,lung inflammation|MP:0001876,decreased inflammatory response|MP:0002499,chronic inflammation|MP:0031301,chronic liver inflammation
MGI:3700152	Tg(TERT)C10Hode	MP:0003155,abnormal telomere length
MGI:5585175	Tg(tetO-Ago2)30Mnpy	MP:0003059,decreased insulin secretion|MP:0003645,increased pancreatic beta cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005559,increased circulating glucose level|MP:0009113,increased pancreatic beta cell mass|MP:0011819,increased pancreatic beta cell proliferation
MGI:5587972	Tg(tetO-Aimp1)29872Mcla	MP:0001183,overexpanded pulmonary alveolus|MP:0001958,emphysema|MP:0005425,increased macrophage cell number|MP:0010908,dilated pulmonary alveolar duct|MP:0010911,abnormal pulmonary acinus morphology|MP:0011141,increased lung endothelial cell apoptosis
MGI:3708167	Tg(tetO-APPSwInd)102Dbo	MP:0003633,abnormal nervous system physiology
MGI:3708462	Tg(tetO-APPSwInd)107Dbo	MP:0000811,hippocampal neuron degeneration|MP:0000812,abnormal dentate gyrus morphology|MP:0002182,abnormal astrocyte morphology|MP:0003214,neurofibrillary tangles|MP:0003313,abnormal locomotor activation|MP:0003329,amyloid beta deposits|MP:0003633,abnormal nervous system physiology|MP:0005386,behavior/neurological phenotype|MP:0006082,CNS inflammation|MP:0008432,abnormal long-term spatial reference memory|MP:0014370,impaired spatial working memory|MP:0020467,abnormal circadian behavior|MP:0031391,increased locomotor activity
MGI:3709065	Tg(tetO-APPSwInd)18Dbo	MP:0003329,amyloid beta deposits|MP:0003633,abnormal nervous system physiology
MGI:3639702	Tg(tetO-APPSwInd)885Dbo	MP:0000811,hippocampal neuron degeneration|MP:0000812,abnormal dentate gyrus morphology|MP:0003329,amyloid beta deposits|MP:0003633,abnormal nervous system physiology
MGI:5295154	Tg(tetO-APPSwInd)Dbo	MP:0002182,abnormal astrocyte morphology|MP:0002229,neurodegeneration|MP:0003329,amyloid beta deposits|MP:0004768,abnormal axonal transport|MP:0005405,axon degeneration|MP:0008789,abnormal olfactory epithelium morphology|MP:0008918,microgliosis|MP:0010733,abnormal axon initial segment morphology|MP:0011677,abnormal olfactory sensory neuron physiology|MP:0020348,decreased olfactory sensory neuron number
MGI:5317077	Tg(tetO-ATXN1*82Q)#Horr	MP:0000877,abnormal Purkinje cell morphology|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:3656025	Tg(tetO-Aurkb,lacZ)41Kra	MP:0000228,abnormal thrombopoiesis|MP:0005464,abnormal platelet physiology
MGI:2387679	Tg(tetO-BCR/ABL1)27Dgt	MP:0000218,increased leukocyte cell number|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001577,anemia|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002397,abnormal bone marrow morphology|MP:0003179,thrombocytopenia|MP:0006042,increased apoptosis
MGI:2387680	Tg(tetO-BCR/ABL1)2Dgt	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000321,increased bone marrow cell number|MP:0000496,abnormal small intestine morphology|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001175,abnormal lung morphology|MP:0001577,anemia|MP:0002026,increased leukemia incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002339,abnormal lymph node morphology|MP:0002356,abnormal spleen red pulp morphology|MP:0002397,abnormal bone marrow morphology|MP:0002401,abnormal lymphopoiesis|MP:0002414,abnormal myeloblast morphology/development|MP:0003179,thrombocytopenia|MP:0004809,increased hematopoietic stem cell number|MP:0006042,increased apoptosis|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008254,increased megakaryocyte cell number|MP:0008826,abnormal splenic cell ratio|MP:0012431,increased lymphoma incidence
MGI:4838675	Tg(tetO-Bmpr2*R899X)#Jwst	MP:0000276,heart right ventricle hypertrophy|MP:0001260,increased body weight|MP:0004007,abnormal lung vasculature morphology|MP:0010758,increased right ventricle systolic pressure
MGI:3703793	Tg(tetO-BMPR2*T504)1Jwst	MP:0000231,hypertension|MP:0002608,increased hematocrit|MP:0003913,increased heart right ventricle weight|MP:0005294,abnormal heart ventricle morphology|MP:0005592,abnormal vascular smooth muscle morphology|MP:0010758,increased right ventricle systolic pressure
MGI:4430395	Tg(tetO-Bnip3l)1Gwd	MP:0003222,increased cardiomyocyte apoptosis|MP:0005140,decreased cardiac muscle contractility|MP:0005385,cardiovascular system phenotype
MGI:5524276	Tg(tetO-BRAF*V600E)26Jaf	MP:0003503,decreased activity of thyroid gland|MP:0005119,decreased circulating thyroid-stimulating hormone level|MP:0005355,enlarged thyroid gland|MP:0005478,decreased circulating thyroxine level|MP:0010316,increased thyroid tumor incidence|MP:0010346,increased thyroid carcinoma incidence
MGI:5429526	Tg(tetO-CALY)5Cber	MP:0001364,decreased anxiety-related response
MGI:3653679	Tg(tetO-CDK5R1/GFP)337Lht	MP:0000783,abnormal forebrain morphology|MP:0000807,abnormal hippocampus morphology|MP:0000811,hippocampal neuron degeneration|MP:0001262,decreased body weight|MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002169,no abnormal phenotype detected|MP:0002175,decreased brain weight|MP:0002183,gliosis|MP:0003214,neurofibrillary tangles|MP:0003329,amyloid beta deposits|MP:0003354,astrocytosis|MP:0006254,thin cerebral cortex|MP:0009454,impaired contextual conditioning behavior|MP:0009538,abnormal synapse morphology|MP:0012508,forebrain atrophy
MGI:6278302	Tg(tetO-CHMP2B*)3Fbga	MP:0000788,abnormal cerebral cortex morphology|MP:0001360,abnormal social investigation|MP:0001441,increased grooming behavior|MP:0002206,abnormal CNS synaptic transmission|MP:0002797,increased thigmotaxis|MP:0003354,astrocytosis|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0020507,increased dendritic spine density
MGI:3843695	Tg(tetO-Chrnb2*V287L)H3Gica	MP:0002064,seizures|MP:0004994,abnormal brain wave pattern|MP:0014624,abnormal brain delta wave pattern
MGI:3772938	Tg(tetO-Clock)1Jt	MP:0020470,shortened circadian behavior period
MGI:3772924	Tg(tetO-Clock<m1Jt>)CL57Jt	MP:0020469,prolonged circadian behavior period|MP:0020473,abnormal circadian behavior phase|MP:0020475,delayed circadian behavior phase|MP:0020477,abnormal locomotor circadian rhythm
MGI:3804805	Tg(tetO/CMV-CD200)1Rmgo	MP:0002376,abnormal dendritic cell physiology
MGI:6200913	Tg(tetO/CMV-Dek,-luc)317Siwe	MP:0000765,abnormal tongue squamous epithelium morphology|MP:0002083,premature death|MP:0004207,increased squamous cell carcinoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0004546,esophagus hyperplasia
MGI:5705532	Tg(tetO/CMV-Hgf)#Agoc	MP:0004042,decreased susceptibility to kidney reperfusion injury
MGI:3693226	Tg(tetO/CMV-KRAS*G12C)9.1Msmi	MP:0001175,abnormal lung morphology|MP:0002020,increased tumor incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002133,abnormal respiratory system physiology|MP:0004782,abnormal surfactant physiology|MP:0010898,abnormal pulmonary alveolus epithelium morphology
MGI:5779548	Tg(tetO/CMV-Pmp22)JP18Clh	MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001406,abnormal gait|MP:0008814,decreased nerve conduction velocity|MP:0010742,increased Schwann cell number|MP:0011731,decreased myelin sheath thickness
MGI:4365814	Tg(tetO/CMV-Prnp*,-lacZ)33Mjy	MP:0000358,abnormal cell morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0001265,decreased body size|MP:0001353,increased aggression towards mice|MP:0001394,circling|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0002175,decreased brain weight|MP:0002229,neurodegeneration|MP:0002738,hyperresponsive to tactile stimuli|MP:0003354,astrocytosis|MP:0003950,abnormal plasma membrane morphology|MP:0006254,thin cerebral cortex|MP:0031391,increased locomotor activity
MGI:5705531	Tg(tetO/CMV-PTHLH)#Agoc	MP:0000198,decreased circulating phosphate level|MP:0005367,renal/urinary system phenotype
MGI:5317863	Tg(tetO/CMV-Tslp)#Sfz	MP:0000208,decreased hematocrit|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001190,reddish skin|MP:0001194,dermatitis|MP:0001212,skin lesions|MP:0001242,hyperkeratosis|MP:0001852,conjunctivitis|MP:0001874,acanthosis|MP:0002339,abnormal lymph node morphology|MP:0002497,increased IgE level|MP:0003725,increased autoantibody level|MP:0003853,dry skin|MP:0004827,increased susceptibility to autoimmune hemolytic anemia|MP:0005154,increased B cell proliferation|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008217,abnormal B cell activation|MP:0008496,decreased IgG2a level|MP:0008499,increased IgG1 level|MP:0008602,increased circulating interleukin-4 level|MP:0008713,abnormal cytokine level|MP:0009795,epidermal spongiosis
MGI:5693612	Tg(tetO-Comt)1Kndl	MP:0001468,abnormal temporal memory|MP:0002062,abnormal associative learning|MP:0004924,abnormal behavior|MP:0010149,abnormal synaptic dopamine release|MP:0010698,abnormal impulsive behavior control
MGI:3693934	Tg(tetO-COX8A/EYFP)1Ksn	MP:0002169,no abnormal phenotype detected
MGI:5316004	Tg(tetO-COX8A/PstI*)1Ctm	MP:0001402,decreased locomotor activity|MP:0001513,limb grasping|MP:0002083,premature death
MGI:3776900	Tg(tetO-cre)1Dgt	MP:0002169,no abnormal phenotype detected
MGI:4460238	Tg(tetO-Creb1)5397Nes	MP:0002169,no abnormal phenotype detected
MGI:4460244	Tg(tetO-Creb1*)7922Nes	MP:0002169,no abnormal phenotype detected
MGI:4460255	Tg(tetO-Creb1*)7941Nes	MP:0002169,no abnormal phenotype detected
MGI:4452236	Tg(tetO-Csnk1d)#Mfla	MP:0001364,decreased anxiety-related response|MP:0001447,abnormal nest building behavior|MP:0002574,increased vertical activity|MP:0003313,abnormal locomotor activation|MP:0004077,abnormal striatum morphology|MP:0005386,behavior/neurological phenotype|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009745,abnormal behavioral response to xenobiotic|MP:0031391,increased locomotor activity
MGI:5473718	Tg(tetO-CTGF)#Swu	MP:0000276,heart right ventricle hypertrophy|MP:0001861,lung inflammation|MP:0003548,pulmonary hypertension|MP:0004007,abnormal lung vasculature morphology|MP:0006027,impaired lung alveolus development|MP:0006050,pulmonary fibrosis|MP:0010758,increased right ventricle systolic pressure|MP:0010900,abnormal pulmonary interalveolar septum morphology
MGI:4438033	Tg(tetO-CUGBP1)3413Coop	MP:0000274,enlarged heart|MP:0002080,prenatal lethality|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003896,prolonged PR interval|MP:0003921,abnormal heart left ventricle morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005202,lethargy|MP:0006085,myocardium necrosis|MP:0009416,cardiac muscle degeneration|MP:0010392,prolonged QRS complex duration
MGI:6270427	Tg(tetO-DDR2)#Yeli	MP:0003560,osteoarthritis|MP:0005165,increased susceptibility to injury
MGI:3838645	Tg(tetO-DISC1*)1001Plet	MP:0000823,abnormal lateral ventricle morphology|MP:0001353,increased aggression towards mice|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002882,abnormal neuron morphology|MP:0008414,abnormal spatial reference memory|MP:0031391,increased locomotor activity
MGI:6287123	Tg(tetO-DISC1*)1302BPlet	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0009142,decreased prepulse inhibition|MP:0009746,enhanced behavioral response to xenobiotic|MP:0030690,abnormal serine level|MP:0030692,decreased serine level|MP:0031391,increased locomotor activity
MGI:6287122	Tg(tetO-DISC1*)70Plet	MP:0001354,increased aggression towards male mice|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002882,abnormal neuron morphology|MP:0008414,abnormal spatial reference memory|MP:0008535,enlarged lateral ventricles|MP:0031391,increased locomotor activity
MGI:5532849	Tg(tetO-Dkk1)1Smr	MP:0000377,abnormal hair follicle morphology|MP:0000392,accelerated hair follicle regression|MP:0002073,abnormal hair growth|MP:0008858,abnormal hair cycle anagen phase
MGI:5693386	Tg(tetO-DRD2)2-5Kndl	MP:0001906,increased dopamine level|MP:0002063,abnormal learning/memory/conditioning|MP:0005266,abnormal metabolism|MP:0008414,abnormal spatial reference memory
MGI:5693547	Tg(tetO-DRD3)3-10Kndl	MP:0002572,abnormal emotion/affect behavior
MGI:3767624	Tg(tetO-DTA)1Gfi	MP:0001260,increased body weight|MP:0001402,decreased locomotor activity|MP:0001501,abnormal sleep pattern|MP:0001559,hyperglycemia|MP:0001636,irregular heartbeat|MP:0001855,abnormal atrial thrombosis|MP:0001944,abnormal pancreas morphology|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0003105,abnormal heart atrium morphology|MP:0003137,abnormal impulse conducting system conduction|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0003224,neuron degeneration|MP:0003339,decreased pancreatic beta cell number|MP:0003645,increased pancreatic beta cell number|MP:0004567,decreased myocardial fiber number|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005279,narcolepsy|MP:0005292,improved glucose tolerance|MP:0005294,abnormal heart ventricle morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0006042,increased apoptosis|MP:0008022,dilated heart ventricle|MP:0008543,atrial fibrillation|MP:0008950,ventricular tachycardia|MP:0009254,disorganized pancreatic islets|MP:0009436,fragmentation of sleep/wake states|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011941,increased fluid intake|MP:0012286,decreased frequency of paradoxical sleep|MP:0020448,increased microglial cell activation
MGI:3851561	Tg(tetO-Dusp6)1Jmol	MP:0001625,cardiac hypertrophy|MP:0002133,abnormal respiratory system physiology|MP:0003141,cardiac fibrosis|MP:0003222,increased cardiomyocyte apoptosis|MP:0004564,increased myocardial fiber size|MP:0005140,decreased cardiac muscle contractility
MGI:3713107	Tg(tetO-Eda*A1)1Dsch	MP:0000397,abnormal guard hair morphology|MP:0001340,abnormal eyelid morphology|MP:0005371,limbs/digits/tail phenotype|MP:0008538,decreased zigzag hair amount|MP:0009793,sebaceous gland hypertrophy|MP:0010771,integument phenotype|MP:0013386,enlarged Meibomian gland
MGI:4837732	Tg(tetO-EDN1,-lacZ)9Mhus	MP:0000278,abnormal myocardial fiber morphology|MP:0001186,pigmentation phenotype|MP:0001402,decreased locomotor activity|MP:0001505,hunched posture|MP:0001853,heart inflammation|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003822,decreased left ventricle systolic pressure|MP:0004071,prolonged P wave|MP:0004564,increased myocardial fiber size|MP:0005385,cardiovascular system phenotype|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0009388,abnormal epidermal melanocyte morphology|MP:0010018,pulmonary vascular congestion|MP:0010019,liver vascular congestion|MP:0010392,prolonged QRS complex duration|MP:0010494,abnormal ventricle endocardium morphology|MP:0010632,cardiac muscle necrosis|MP:0010741,abnormal melanocyte proliferation|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011830,ectopic hair follicle melanin granules|MP:0030908,abnormal melanocyte differentiation
MGI:3850383	Tg(tetO-Egfr*)2-9Jek	MP:0001265,decreased body size|MP:0001290,delayed eyelid opening|MP:0001732,postnatal growth retardation|MP:0001919,abnormal reproductive system physiology|MP:0002082,postnatal lethality|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0008321,small adenohypophysis|MP:0008325,abnormal gonadotroph morphology|MP:0008329,decreased somatotroph cell number|MP:0008332,decreased lactotroph cell number|MP:0008489,slow postnatal weight gain
MGI:3690457	Tg(tetO-EGFR*delta19)11Hev	MP:0002027,increased lung adenocarcinoma incidence|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0004390,abnormal bronchoalveolar duct junction morphology
MGI:6256806	Tg(tetO-EGFR*)#Kkw	MP:0008014,increased lung tumor incidence
MGI:3690078	Tg(tetO-EGFR*L858R)56Hev	MP:0001179,thick pulmonary interalveolar septum|MP:0002020,increased tumor incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002275,abnormal type II pneumocyte morphology|MP:0005388,respiratory system phenotype
MGI:3690075	Tg(tetO-EGFR*L858R)57Hev	MP:0001179,thick pulmonary interalveolar septum|MP:0002027,increased lung adenocarcinoma incidence|MP:0002275,abnormal type II pneumocyte morphology
MGI:5449268	Tg(tetO-EGFR*L858R)#Hev	MP:0002027,increased lung adenocarcinoma incidence
MGI:5705250	Tg(tetO-EGFR*T790M)8Paow	MP:0002027,increased lung adenocarcinoma incidence
MGI:5781130	Tg(tetO-EGFR*T790M*L858R)19Kkw	MP:0001272,increased metastatic potential|MP:0001862,interstitial pneumonia|MP:0002027,increased lung adenocarcinoma incidence|MP:0008014,increased lung tumor incidence|MP:0008714,increased lung carcinoma incidence
MGI:5705251	Tg(tetO-EGFR*T790M*L858R)51Paow	MP:0002027,increased lung adenocarcinoma incidence|MP:0005426,tachypnea
MGI:3511877	Tg(TetO-Erbb2)1Lach	MP:0001272,increased metastatic potential|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001885,mammary gland duct hyperplasia|MP:0002083,premature death
MGI:5912483	Tg(tetO-ERBB2*)26Kkw	MP:0002083,premature death|MP:0008014,increased lung tumor incidence|MP:0008714,increased lung carcinoma incidence|MP:0008716,increased lung non-small cell carcinoma incidence
MGI:5912484	Tg(tetO-ERBB2*)5BKkw	MP:0002083,premature death|MP:0008014,increased lung tumor incidence|MP:0008714,increased lung carcinoma incidence|MP:0008716,increased lung non-small cell carcinoma incidence
MGI:5775596	Tg(tetO-ERBB2)#Jjz	MP:0000662,abnormal branching of the mammary ductal tree|MP:0001272,increased metastatic potential|MP:0001883,increased mammary adenocarcinoma incidence
MGI:5296756	Tg(tetO-Esr1)#Paf	MP:0000627,abnormal mammary gland morphology|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001884,mammary gland alveolar hyperplasia|MP:0001885,mammary gland duct hyperplasia|MP:0001935,decreased litter size|MP:0002059,abnormal seminal vesicle morphology|MP:0002769,abnormal vas deferens morphology|MP:0004929,decreased epididymis weight|MP:0009018,short estrus|MP:0009503,abnormal mammary gland duct morphology|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009505,abnormal mammary gland lobule morphology|MP:0009508,increased mammary gland ductal carcinoma incidence
MGI:5484569	Tg(tetO-Fbxl21*)11Jt	MP:0020470,shortened circadian behavior period
MGI:5538516	Tg(tetO-Fgf9,-EGFP)#Dor	MP:0001176,abnormal lung development|MP:0001953,respiratory failure|MP:0002018,increased malignant tumor incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002083,premature death|MP:0004007,abnormal lung vasculature morphology|MP:0004882,enlarged lung|MP:0005324,ascites|MP:0006382,abnormal lung epithelium morphology|MP:0008014,increased lung tumor incidence|MP:0008021,increased blastoma incidence|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011142,abnormal lung-associated mesenchyme development|MP:0011147,increased mesenchymal cell proliferation involved in lung development
MGI:5604241	Tg(tetO-Fgfr3*R248C/Fgfr1)#Dor	MP:0000274,enlarged heart|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0002953,thick ventricular wall|MP:0004084,abnormal cardiac muscle relaxation|MP:0004564,increased myocardial fiber size|MP:0005330,cardiomyopathy|MP:0005386,behavior/neurological phenotype|MP:0005599,increased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0010448,heart left ventricle outflow tract stenosis|MP:0031131,myocardial fiber disarray|MP:0031635,increased heart left ventricle muscle contractility
MGI:5751860	Tg(tetO-FMR1*,-EGFP)#Rkhu	MP:0000598,abnormal liver morphology|MP:0000603,pale liver|MP:0001263,weight loss|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0003631,nervous system phenotype|MP:0004191,neuronal intranuclear inclusions|MP:0004844,abnormal vestibuloocular reflex|MP:0014645,decreased optokinetic reflex
MGI:6331299	Tg(tetO-GFP,-APOL1*S342G*I384M)#Susz	MP:0002871,albuminuria|MP:0005264,glomerulosclerosis|MP:0005326,abnormal podocyte morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0008140,podocyte foot process effacement|MP:0011753,decreased podocyte number|MP:0011863,abnormal podocyte physiology|MP:0011899,podocyte vacuoles
MGI:6331297	Tg(tetO-GFP,-APOL1)#Susz	MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype
MGI:6331300	Tg(tetO-GFP,-APOL1*)#Susz	MP:0002083,premature death|MP:0002871,albuminuria|MP:0005264,glomerulosclerosis|MP:0005326,abnormal podocyte morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008140,podocyte foot process effacement|MP:0009644,uremia|MP:0011753,decreased podocyte number|MP:0011863,abnormal podocyte physiology|MP:0011899,podocyte vacuoles
MGI:5635524	Tg(tetO-GJB2*G45E,-EGFP)#Tww	MP:0000377,abnormal hair follicle morphology|MP:0000649,sebaceous gland atrophy|MP:0001190,reddish skin|MP:0001192,scaly skin|MP:0001211,wrinkled skin|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0001265,decreased body size|MP:0001874,acanthosis|MP:0002060,abnormal skin morphology|MP:0002655,abnormal keratinocyte morphology|MP:0003453,abnormal keratinocyte physiology|MP:0009675,orthokeratosis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011195,increased hair follicle apoptosis
MGI:4455195	Tg(tetO-Gnaq*R183C)1Conk	MP:0002169,no abnormal phenotype detected
MGI:4843269	Tg(tetO-Gnas)1593Mpke	MP:0001399,hyperactivity|MP:0001463,abnormal spatial learning|MP:0002919,enhanced paired-pulse facilitation|MP:0003008,enhanced long-term potentiation|MP:0004102,abnormal dorsal striatum morphology|MP:0004103,abnormal ventral striatum morphology|MP:0005386,behavior/neurological phenotype|MP:0008535,enlarged lateral ventricles|MP:0009142,decreased prepulse inhibition|MP:0009454,impaired contextual conditioning behavior|MP:0014370,impaired spatial working memory
MGI:5547617	Tg(tetO-H2-K1)#Papl	MP:0000747,muscle weakness|MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001570,abnormal circulating enzyme level|MP:0003725,increased autoantibody level|MP:0004174,abnormal spine curvature|MP:0004510,myositis|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005150,cachexia|MP:0008713,abnormal cytokine level|MP:0009412,skeletal muscle fiber degeneration|MP:0009413,skeletal muscle fiber atrophy|MP:0010090,increased circulating creatine kinase level|MP:0010768,mortality/aging|MP:0011089,perinatal lethality, complete penetrance
MGI:4417969	Tg(tetO-HDAC5*)1Eno	MP:0000266,abnormal heart morphology|MP:0001442,decreased grooming behavior|MP:0001544,abnormal cardiovascular system physiology|MP:0001547,abnormal lipid level|MP:0001856,myocarditis|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0005202,lethargy|MP:0005266,abnormal metabolism|MP:0005333,decreased heart rate|MP:0005498,hyporesponsive to tactile stimuli|MP:0006085,myocardium necrosis
MGI:5648118	Tg(tetO-Hgf,-EGFP)24Tcre	MP:0000730,increased satellite cell number|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0009400,decreased skeletal muscle fiber size
MGI:5462364	Tg(tetO-HMOX1)6Hyms	MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000836,abnormal substantia nigra morphology|MP:0001906,increased dopamine level|MP:0002182,abnormal astrocyte morphology|MP:0003674,oxidative stress|MP:0004077,abnormal striatum morphology|MP:0006035,abnormal mitochondrial morphology|MP:0008260,abnormal autophagy|MP:0008415,abnormal neurite morphology|MP:0009142,decreased prepulse inhibition|MP:0010069,increased serotonin level|MP:0011634,abnormal mitochondrial inner membrane morphology|MP:0011635,abnormal mitochondrial crista morphology|MP:0011636,disorganized mitochondrial cristae|MP:0014812,abnormal brain physiology|MP:0020365,increased brain iron level|MP:0031391,increased locomotor activity
MGI:4367596	Tg(tetO-HTR4*D100A)2Niss	MP:0000026,abnormal inner ear morphology|MP:0000031,abnormal cochlea morphology|MP:0000039,abnormal otic capsule morphology|MP:0000062,increased bone mineral density|MP:0001255,decreased body height|MP:0002998,abnormal bone remodeling|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004739,conductive hearing loss|MP:0005105,abnormal middle ear ossicle morphology|MP:0005422,osteosclerosis|MP:0005508,abnormal skeleton morphology|MP:0008753,abnormal osteocyte morphology|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4367585	Tg(tetO-HTR4*D100A)7Niss	MP:0000062,increased bone mineral density|MP:0000065,abnormal bone marrow cavity morphology|MP:0000130,abnormal trabecular bone morphology|MP:0000438,abnormal cranium morphology|MP:0000559,abnormal femur morphology|MP:0001255,decreased body height|MP:0002083,premature death|MP:0002113,abnormal skeleton development|MP:0002397,abnormal bone marrow morphology|MP:0004984,increased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0005422,osteosclerosis|MP:0005508,abnormal skeleton morphology|MP:0008158,increased diameter of femur|MP:0010875,increased bone volume|MP:0010878,increased trabecular bone volume|MP:0010962,decreased compact bone mass|MP:0013617,increased areal bone mineral density|MP:0021170,spinal stenosis|MP:0030823,increased femur size|MP:0030824,increased femur weight
MGI:3851440	Tg(tetO-HTT*94Q,-lacZ)1Rhn	MP:0000745,tremors|MP:0000774,decreased brain size|MP:0001402,decreased locomotor activity|MP:0001442,decreased grooming behavior|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002183,gliosis|MP:0003354,astrocytosis|MP:0004102,abnormal dorsal striatum morphology|MP:0004191,neuronal intranuclear inclusions|MP:0005323,dystonia|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011380,enlarged brain ventricles|MP:0012468,decreased striatum size
MGI:4355871	Tg(tetO-Ifng)184Pop	MP:0000745,tremors|MP:0000849,abnormal cerebellum morphology|MP:0000854,abnormal cerebellum development|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001732,postnatal growth retardation|MP:0006082,CNS inflammation|MP:0006283,increased medulloblastoma incidence|MP:0008559,abnormal interferon-gamma secretion|MP:0008914,enlarged cerebellum|MP:0010768,mortality/aging|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5432255	Tg(tetO-IGF1R)1Ramo	MP:0000628,abnormal mammary gland development|MP:0000630,mammary gland hyperplasia|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0008014,increased lung tumor incidence|MP:0009504,abnormal mammary gland epithelium morphology|MP:0010299,increased mammary gland tumor incidence
MGI:3850185	Tg(tetO-Il13)1Tazh	MP:0000414,alopecia|MP:0001190,reddish skin|MP:0001191,abnormal skin condition|MP:0001194,dermatitis|MP:0001212,skin lesions|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001245,thick dermal layer|MP:0002497,increased IgE level|MP:0005601,increased angiogenesis|MP:0008499,increased IgG1 level|MP:0008672,increased interleukin-13 secretion|MP:0008699,increased interleukin-4 secretion|MP:0009795,epidermal spongiosis|MP:0009932,skin fibrosis|MP:0010072,increased pruritus|MP:0031395,cutaneous mastocytosis
MGI:5444502	Tg(tetO-IL1B)KBry	MP:0001179,thick pulmonary interalveolar septum|MP:0001183,overexpanded pulmonary alveolus|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001861,lung inflammation|MP:0001942,abnormal lung volume|MP:0001953,respiratory failure|MP:0001958,emphysema|MP:0002267,abnormal bronchiole morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0004007,abnormal lung vasculature morphology|MP:0006050,pulmonary fibrosis|MP:0006382,abnormal lung epithelium morphology|MP:0008721,abnormal chemokine level|MP:0010861,increased respiratory mucosa goblet cell number|MP:0010995,abnormal lung alveolus development|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014473,increased pulmonary alveolus wall thickness
MGI:4437720	Tg(tetO-Jag1)1Rha	MP:0001914,hemorrhage|MP:0003227,abnormal vascular branching morphogenesis|MP:0004201,fetal growth retardation|MP:0005601,increased angiogenesis|MP:0011091,prenatal lethality, complete penetrance
MGI:3810550	Tg(tetO-Kdr*)4377.5Rwng	MP:0000598,abnormal liver morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0000611,jaundice|MP:0001614,abnormal blood vessel morphology|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0011090,perinatal lethality, incomplete penetrance|MP:0014605,dark liver
MGI:3717763	Tg(tetO-KLF4)32831Rup	MP:0000649,sebaceous gland atrophy|MP:0001212,skin lesions|MP:0001216,abnormal epidermal layer morphology|MP:0001222,epidermal hyperplasia|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001242,hyperkeratosis|MP:0001510,abnormal coat appearance|MP:0002060,abnormal skin morphology|MP:0003413,hair follicle degeneration
MGI:2179992	Tg(tetO-Kras2)12Hev	MP:0000630,mammary gland hyperplasia|MP:0002006,neoplasm|MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002133,abnormal respiratory system physiology|MP:0008014,increased lung tumor incidence|MP:0010299,increased mammary gland tumor incidence
MGI:8187930	Tg(tetO-LACTB)#Susz	MP:0002136,abnormal kidney physiology|MP:0005166,decreased susceptibility to injury|MP:0005566,decreased blood urea nitrogen level|MP:0013242,abnormal amino acid metabolism
MGI:3834665	Tg(tetO-LMNA,-EGFP)SF1-04Maer	MP:0010771,integument phenotype
MGI:3834666	Tg(tetO-LMNA*G608G,-EGFP)VF1-07Maer	MP:0000377,abnormal hair follicle morphology|MP:0000416,sparse hair|MP:0000452,abnormal mouth morphology|MP:0000652,enlarged sebaceous gland|MP:0001212,skin lesions|MP:0001222,epidermal hyperplasia|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0003705,abnormal hypodermis morphology|MP:0004947,skin inflammation|MP:0009794,sebaceous gland hyperplasia|MP:0009932,skin fibrosis|MP:0010788,stomach hypoplasia|MP:0013193,sebaceous gland hypoplasia|MP:0013376,abnormal sebocyte differentiation|MP:0030132,periodontium inflammation|MP:0030136,abnormal lower incisor morphology
MGI:5491150	Tg(tetO-LMNB1)AF1Yfu	MP:0005386,behavior/neurological phenotype
MGI:4414667	Tg(tetO-LRRK2)1Cai	MP:0003631,nervous system phenotype
MGI:4420821	Tg(tetO-LRRK2)C77Cai	MP:0003631,nervous system phenotype
MGI:4420758	Tg(tetO-LRRK2)C7874Cai	MP:0002882,abnormal neuron morphology|MP:0003631,nervous system phenotype
MGI:4420818	Tg(tetO-LRRK2*)D10Cai	MP:0002882,abnormal neuron morphology
MGI:4414665	Tg(tetO-LRRK2*G2019S)1Cai	MP:0005404,abnormal axon morphology|MP:0008415,abnormal neurite morphology
MGI:4420755	Tg(tetO-LRRK2*G2019S)E3Cai	MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0002882,abnormal neuron morphology|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0014812,abnormal brain physiology
MGI:5056483	Tg(tetO-MAP2K1)#Ahsa	MP:0004762,increased anti-double stranded DNA antibody level|MP:0005387,immune system phenotype
MGI:5788166	Tg(tetO-MAPT)32Lms	MP:0001262,decreased body weight|MP:0002152,abnormal brain morphology|MP:0002206,abnormal CNS synaptic transmission|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002920,decreased paired-pulse facilitation|MP:0004994,abnormal brain wave pattern|MP:0010768,mortality/aging
MGI:5788163	Tg(tetO-MAPT*A152T)L1Lms	MP:0000811,hippocampal neuron degeneration|MP:0001262,decreased body weight|MP:0001447,abnormal nest building behavior|MP:0002152,abnormal brain morphology|MP:0002206,abnormal CNS synaptic transmission|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0002920,decreased paired-pulse facilitation|MP:0003354,astrocytosis|MP:0004994,abnormal brain wave pattern|MP:0010768,mortality/aging|MP:0012307,impaired spatial learning
MGI:5554188	Tg(tetO-MAPT*K280*I277P*I308P,-luc)#Eman	MP:0001900,impaired synaptic plasticity|MP:0002918,abnormal paired-pulse facilitation|MP:0002922,decreased post-tetanic potentiation|MP:0003631,nervous system phenotype
MGI:5554185	Tg(tetO-MAPT*K280,-luc)#Eman	MP:0001405,impaired coordination|MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002922,decreased post-tetanic potentiation|MP:0003214,neurofibrillary tangles|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0004000,impaired passive avoidance behavior|MP:0004250,tau protein deposits|MP:0008415,abnormal neurite morphology|MP:0009538,abnormal synapse morphology|MP:0012307,impaired spatial learning
MGI:3772577	Tg(tetO-Mcpt1)1Mrab	MP:0000250,abnormal vasoconstriction|MP:0000351,increased cell proliferation|MP:0002169,no abnormal phenotype detected|MP:0002191,abnormal artery morphology|MP:0003025,increased vasoconstriction|MP:0003915,increased heart left ventricle weight|MP:0004875,increased mean systemic arterial blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0009873,abnormal aorta tunica media morphology
MGI:7666556	Tg(tetO-Met)1Sqiu	MP:0005386,behavior/neurological phenotype
MGI:3810467	Tg(tetO-MET)23Rwng	MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0000611,jaundice|MP:0001656,focal hepatic necrosis|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0003331,increased hepatocellular carcinoma incidence|MP:0005150,cachexia
MGI:5585169	Tg(tetO-Mir184)#Mnpy	MP:0002727,decreased circulating insulin level|MP:0003339,decreased pancreatic beta cell number|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0009114,decreased pancreatic beta cell mass|MP:0011820,decreased pancreatic beta cell proliferation
MGI:4359827	Tg(tetO-Mir208a)#Dzw	MP:0000274,enlarged heart|MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0003896,prolonged PR interval|MP:0003921,abnormal heart left ventricle morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006321,increased myocardial fiber number|MP:0010519,atrioventricular block
MGI:6725805	Tg(tetO-Mir24-1)#Smoc	MP:0001218,thin epidermis|MP:0001265,decreased body size|MP:0002073,abnormal hair growth|MP:0003941,abnormal skin development|MP:0008858,abnormal hair cycle anagen phase|MP:0009584,decreased keratinocyte proliferation|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6358212	Tg(tetO-Mir31)#Zhyu	MP:0000627,abnormal mammary gland morphology|MP:0000628,abnormal mammary gland development|MP:0000630,mammary gland hyperplasia|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001382,abnormal nursing|MP:0001885,mammary gland duct hyperplasia|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0009503,abnormal mammary gland duct morphology|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009506,abnormal mammary gland alveolus morphology|MP:0010173,increased mammary gland epithelial cell proliferation
MGI:5634714	Tg(tetO-Mtor*)#Atai	MP:0000434,megacephaly|MP:0000788,abnormal cerebral cortex morphology|MP:0000789,thickened cerebral cortex|MP:0001402,decreased locomotor activity|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0002882,abnormal neuron morphology|MP:0008918,microgliosis|MP:0011975,neuronal cytoplasmic inclusions
MGI:3531157	Tg(tetO-MYC)1Lach	MP:0000627,abnormal mammary gland morphology|MP:0000630,mammary gland hyperplasia|MP:0001883,increased mammary adenocarcinoma incidence|MP:0009504,abnormal mammary gland epithelium morphology|MP:0010173,increased mammary gland epithelial cell proliferation|MP:0010299,increased mammary gland tumor incidence|MP:0014126,increased mammary gland apoptosis
MGI:3039697	Tg(tetO-MYC)36aBop	MP:0002083,premature death|MP:0003068,enlarged kidney|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003447,decreased tumor growth/size|MP:0003606,kidney failure|MP:0003675,kidney cyst|MP:0008019,increased liver tumor incidence|MP:0008528,polycystic kidney|MP:0010054,increased hepatoblastoma incidence|MP:0010383,increased adenoma incidence|MP:0010384,increased renal carcinoma incidence|MP:0014237,decreased tumor-free survival time
MGI:4459898	Tg(tetO-MYC)36Bop	MP:0001272,increased metastatic potential|MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002052,decreased tumor incidence|MP:0002083,premature death|MP:0008014,increased lung tumor incidence|MP:0009151,increased pancreatic ductal adenocarcinoma incidence|MP:0009152,increased pancreatic intraepithelial neoplasia incidence|MP:0009153,increased pancreas tumor incidence|MP:0010899,abnormal pulmonary alveolar system morphology|MP:0014237,decreased tumor-free survival time
MGI:5570746	Tg(tetO-MYCN,-luc)#Waw	MP:0001272,increased metastatic potential|MP:0002018,increased malignant tumor incidence|MP:0002083,premature death|MP:0006283,increased medulloblastoma incidence|MP:0014237,decreased tumor-free survival time
MGI:5811153	Tg(tetO-MYC,-OVAL)#Gtgm	MP:0002083,premature death|MP:0003331,increased hepatocellular carcinoma incidence|MP:0005000,abnormal immune tolerance
MGI:4819012	Tg(tetO-NEFL)173.2Jpj	MP:0000937,abnormal motor neuron morphology|MP:0001052,abnormal innervation pattern to muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002882,abnormal neuron morphology|MP:0004263,abnormal limb posture|MP:0004768,abnormal axonal transport|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0009399,increased skeletal muscle fiber size|MP:0010768,mortality/aging
MGI:4412273	Tg(TetO-Nfkbia*S32A*S36A)1Wcg	MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001463,abnormal spatial learning|MP:0002574,increased vertical activity|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003008,enhanced long-term potentiation|MP:0008414,abnormal spatial reference memory|MP:0009358,environmentally induced seizures
MGI:4837700	Tg(tetO-NOS2,-lacZ)240iMhus	MP:0000274,enlarged heart|MP:0001260,increased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0001785,edema|MP:0001853,heart inflammation|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002833,increased heart weight|MP:0003896,prolonged PR interval|MP:0003921,abnormal heart left ventricle morphology|MP:0004070,abnormal P wave|MP:0004071,prolonged P wave|MP:0004086,absent heartbeat|MP:0004114,abnormal atrioventricular node morphology|MP:0005202,lethargy|MP:0005608,cardiac interstitial fibrosis|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0008772,increased heart ventricle size|MP:0008950,ventricular tachycardia|MP:0010519,atrioventricular block|MP:0010559,heart block|MP:0010632,cardiac muscle necrosis
MGI:4431198	Tg(tetO-Notch4*)1Rwng	MP:0000249,abnormal blood vessel physiology|MP:0000849,abnormal cerebellum morphology|MP:0000897,abnormal midbrain morphology|MP:0001393,ataxia|MP:0001914,hemorrhage|MP:0001917,intraventricular hemorrhage|MP:0002064,seizures|MP:0002083,premature death|MP:0003203,increased neuron apoptosis|MP:0003633,abnormal nervous system physiology|MP:0004950,abnormal brain vasculature morphology|MP:0005048,abnormal thrombosis|MP:0006052,cerebellum hemorrhage|MP:0006093,arteriovenous malformation|MP:0008547,abnormal neocortex morphology|MP:0010530,cerebral arteriovenous malformation|MP:0020487,abnormal middle cerebral artery morphology|MP:0030014,calcified brain
MGI:5766488	Tg(tetO-NPM1/ALK,-luc)2Gde	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001222,epidermal hyperplasia|MP:0001243,abnormal dermal layer morphology|MP:0001732,postnatal growth retardation|MP:0002023,increased B cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002060,abnormal skin morphology|MP:0002083,premature death|MP:0011092,embryonic lethality, complete penetrance
MGI:5784536	Tg(tetO-NRG1_i4)6Ajla	MP:0001360,abnormal social investigation|MP:0002206,abnormal CNS synaptic transmission|MP:0002635,reduced sensorimotor gating|MP:0002802,abnormal discrimination learning|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008143,abnormal dendrite morphology|MP:0008414,abnormal spatial reference memory|MP:0008415,abnormal neurite morphology|MP:0009142,decreased prepulse inhibition|MP:0009936,abnormal dendritic spine morphology|MP:0014378,increased excitatory postsynaptic current frequency
MGI:3834439	Tg(tetO-PIK3CA*H1047R)13Lca	MP:0002027,increased lung adenocarcinoma incidence
MGI:5526971	Tg(tetO-PIK3CA*H1047R,-luc)2239Jjz	MP:0001883,increased mammary adenocarcinoma incidence|MP:0010299,increased mammary gland tumor incidence
MGI:4360887	Tg(tetO-PLAGL2)P3Ysy	MP:0001958,emphysema|MP:0002327,abnormal respiratory function|MP:0006042,increased apoptosis
MGI:2445698	Tg(tetO-Plau)1Ths	MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:4429485	Tg(tetO-Ppargc1a)1Dpk	MP:0001625,cardiac hypertrophy|MP:0002626,increased heart rate|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0003921,abnormal heart left ventricle morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0005333,decreased heart rate|MP:0006035,abnormal mitochondrial morphology|MP:0006038,increased mitochondrial fission|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:3695686	Tg(TetOp-Polb/tTA)2Sbl	MP:0002006,neoplasm|MP:0002111,abnormal tail morphology|MP:0002404,increased intestinal adenoma incidence|MP:0002580,duodenal lesions|MP:0002743,glomerulonephritis|MP:0002840,abnormal lens fiber morphology|MP:0003237,abnormal lens epithelium morphology|MP:0003789,increased osteosarcoma incidence|MP:0010280,increased skeletal tumor incidence|MP:0010313,increased osteoma incidence|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011427,increased mesangial cell number|MP:0011697,lens vacuoles|MP:0012518,abnormal Brunner's gland morphology|MP:0013482,abnormal duodenum crypts of Lieberkuhn morphology|MP:0013732,mature cataract|MP:0014218,increased intestinal mucosa thickness
MGI:3773697	Tg(tetO-Prkar1a*x2as)1Stra	MP:0000003,abnormal adipose tissue morphology|MP:0000639,abnormal adrenal gland morphology|MP:0001262,decreased body weight|MP:0001272,increased metastatic potential|MP:0001745,increased circulating corticosterone level|MP:0001869,pancreas inflammation|MP:0002014,increased papilloma incidence|MP:0002051,increased skin papilloma incidence|MP:0002083,premature death|MP:0002339,abnormal lymph node morphology|MP:0003324,increased liver adenoma incidence|MP:0003496,increased thyroid adenoma incidence|MP:0003498,thyroid gland hyperplasia|MP:0004696,abnormal thyroid follicle morphology|MP:0005455,increased susceptibility to weight gain|MP:0006077,inguinal hernia|MP:0008019,increased liver tumor incidence|MP:0008288,abnormal adrenal cortex morphology|MP:0008291,abnormal adrenocortical cell morphology|MP:0008296,abnormal adrenal gland x-zone morphology|MP:0008297,retention of the adrenal gland x-zone|MP:0008299,adrenal cortical hyperplasia|MP:0009078,adrenal gland hyperplasia|MP:0009321,increased histiocytic sarcoma incidence|MP:0010310,increased Schwannoma incidence|MP:0010367,increased spindle cell carcinoma incidence|MP:0012431,increased lymphoma incidence|MP:0013528,thyroid gland cyst
MGI:5660027	Tg(tetO-PRKCG*S361G,-GFP)3Jpka	MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000876,Purkinje cell degeneration|MP:0000880,decreased Purkinje cell number|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:5803807	Tg(tetO/Prnp-APP*Swe*Lon)9191Krz	MP:0000783,abnormal forebrain morphology|MP:0001262,decreased body weight|MP:0002183,gliosis|MP:0003329,amyloid beta deposits|MP:0005404,abnormal axon morphology|MP:0012460,decreased dentate gyrus size
MGI:7428915	Tg(tetO/Prnp-SNCA*A53T)4360Tmd	MP:0003244,loss of dopaminergic neurons|MP:0003354,astrocytosis|MP:0005643,decreased dopamine level
MGI:5792270	Tg(tetO/Prnp-TARDBP*)2Vle	MP:0000811,hippocampal neuron degeneration|MP:0003240,loss of hippocampal neurons|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0011975,neuronal cytoplasmic inclusions
MGI:5688299	Tg(tetO-PTPN11*E76K)#Jiwu	MP:0002048,increased lung adenoma incidence|MP:0008716,increased lung non-small cell carcinoma incidence
MGI:4455185	Tg(tetO-ptxA)1Conk	MP:0002169,no abnormal phenotype detected
MGI:5805223	Tg(tetO-PyVT,-cre)1Mul	MP:0001272,increased metastatic potential|MP:0001883,increased mammary adenocarcinoma incidence|MP:0012571,increased mammary gland tumor incidence in virgin females
MGI:5555964	Tg(tetO-Rai1,-EGFP)463Walz	MP:0001262,decreased body weight|MP:0009287,decreased abdominal fat pad weight|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0020351,decreased vocalization|MP:0031391,increased locomotor activity
MGI:5555965	Tg(tetO-Rai1,-EGFP)479Walz	MP:0001262,decreased body weight|MP:0009287,decreased abdominal fat pad weight|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0020351,decreased vocalization|MP:0031391,increased locomotor activity
MGI:5521542	Tg(tetO-RNAi:Trp53)ASlowe	MP:0001272,increased metastatic potential|MP:0002083,premature death|MP:0003789,increased osteosarcoma incidence
MGI:5446890	Tg(tetO-RNAi:Vegfa)#Atuf	MP:0002962,increased urine protein level|MP:0003606,kidney failure|MP:0005325,abnormal renal glomerulus morphology|MP:0005553,increased circulating creatinine level|MP:0008140,podocyte foot process effacement|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011430,mesangiolysis|MP:0011471,decreased urine creatinine level|MP:0011855,abnormal glomerular filtration barrier morphology
MGI:3775798	Tg(tetO-Rnf5)1Zron	MP:0000160,kyphosis|MP:0000746,weakness|MP:0000749,muscle degeneration|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0002083,premature death|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010090,increased circulating creatine kinase level|MP:0010239,decreased skeletal muscle weight
MGI:3524978	Tg(tetORo1-lacZ)3Conk	MP:0000280,thin ventricular wall|MP:0001429,dehydration|MP:0001636,irregular heartbeat|MP:0001785,edema|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0004084,abnormal cardiac muscle relaxation|MP:0005140,decreased cardiac muscle contractility|MP:0005150,cachexia|MP:0005324,ascites|MP:0005329,abnormal myocardium layer morphology|MP:0005598,decreased heart ventricle muscle contractility|MP:0008772,increased heart ventricle size|MP:0010334,pleural effusion|MP:0010392,prolonged QRS complex duration|MP:0031131,myocardial fiber disarray|MP:0031633,decreased heart left ventricle muscle contractility|MP:0031634,decreased heart right ventricle muscle contractility
MGI:3776629	Tg(tetO-S100a10)1Pggd	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0003360,abnormal depression-related behavior
MGI:4936851	Tg(tetO-S100a7a)#Yus	MP:0001193,psoriasis|MP:0002060,abnormal skin morphology|MP:0008560,increased tumor necrosis factor secretion|MP:0008654,increased interleukin-1 alpha secretion|MP:0008722,abnormal chemokine secretion
MGI:5512701	Tg(tetO-SNCA)0Olri	MP:0000811,hippocampal neuron degeneration|MP:0000836,abnormal substantia nigra morphology|MP:0001405,impaired coordination|MP:0001516,abnormal motor coordination/balance|MP:0002804,abnormal motor learning|MP:0003224,neuron degeneration|MP:0004981,decreased neuronal precursor cell number|MP:0005643,decreased dopamine level|MP:0008432,abnormal long-term spatial reference memory|MP:0008493,alpha-synuclein inclusion body|MP:0008571,abnormal synaptic bouton morphology|MP:0009937,abnormal neuron differentiation|MP:0010014,hippocampus pyramidal cell degeneration|MP:0011448,decreased dopaminergic neuron number|MP:0013218,abnormal substantia nigra pars reticulata morphology
MGI:4420977	Tg(tetO-SNCA)1Cai	MP:0003631,nervous system phenotype
MGI:5289965	Tg(tetO-SNCA)7Vle	MP:0000812,abnormal dentate gyrus morphology|MP:0005386,behavior/neurological phenotype|MP:0008493,alpha-synuclein inclusion body
MGI:5289968	Tg(tetO-SNCA*A53T)33Vle	MP:0000811,hippocampal neuron degeneration|MP:0000812,abnormal dentate gyrus morphology|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0003203,increased neuron apoptosis|MP:0003354,astrocytosis|MP:0006254,thin cerebral cortex|MP:0008493,alpha-synuclein inclusion body|MP:0008571,abnormal synaptic bouton morphology|MP:0009454,impaired contextual conditioning behavior|MP:0009971,decreased hippocampus pyramidal cell number
MGI:4420801	Tg(tetO-SNCA*A53T)E2Cai	MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0002229,neurodegeneration|MP:0002574,increased vertical activity|MP:0002882,abnormal neuron morphology|MP:0003313,abnormal locomotor activation|MP:0003354,astrocytosis|MP:0003632,abnormal nervous system morphology|MP:0003633,abnormal nervous system physiology|MP:0004077,abnormal striatum morphology|MP:0008493,alpha-synuclein inclusion body|MP:0008918,microgliosis|MP:0014345,abnormal neuron mitochondrial morphology|MP:0031391,increased locomotor activity
MGI:4399759	Tg(tetO-Spdef)1Jaw	MP:0002281,abnormal respiratory mucosa goblet cell morphology|MP:0010861,increased respiratory mucosa goblet cell number
MGI:5475548	Tg(tetO-Spp1)5Gad	MP:0000266,abnormal heart morphology|MP:0001853,heart inflammation|MP:0001856,myocarditis|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003137,abnormal impulse conducting system conduction|MP:0010392,prolonged QRS complex duration|MP:0010505,abnormal T wave|MP:0010519,atrioventricular block|MP:0011953,prolonged PQ interval|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5662095	Tg(tetO-SPTBN2*)#Lpwr	MP:0000849,abnormal cerebellum morphology|MP:0000890,thin cerebellar molecular layer|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001473,reduced long-term potentiation|MP:0003633,abnormal nervous system physiology|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:6160741	Tg(tetO-Sri)10Hhv	MP:0002079,increased circulating insulin level|MP:0002693,abnormal pancreas physiology|MP:0005215,abnormal pancreatic islet morphology|MP:0005292,improved glucose tolerance|MP:0005378,growth/size/body region phenotype|MP:0013278,decreased fasting circulating glucose level
MGI:6160738	Tg(tetO-Sri)1Hhv	MP:0002079,increased circulating insulin level|MP:0002693,abnormal pancreas physiology|MP:0005292,improved glucose tolerance|MP:0005378,growth/size/body region phenotype
MGI:3770670	Tg(tetO-TAg)1Efr	MP:0000189,hypoglycemia|MP:0003364,increased insulinoma incidence|MP:0005376,homeostasis/metabolism phenotype
MGI:5292658	Tg(tetO-TAg)2-5Hiwa	MP:0002031,increased adrenal gland tumor incidence|MP:0002039,increased neuroblastoma incidence|MP:0002083,premature death|MP:0005385,cardiovascular system phenotype|MP:0008301,adrenal medulla hyperplasia
MGI:3819437	Tg(tetO-TAg,CMV-rtTA)123Yihu	MP:0000438,abnormal cranium morphology|MP:0002083,premature death|MP:0006283,increased medulloblastoma incidence
MGI:5000260	Tg(tetO-TARDBP)12Vle	MP:0000812,abnormal dentate gyrus morphology|MP:0001513,limb grasping|MP:0002175,decreased brain weight|MP:0002229,neurodegeneration|MP:0003354,astrocytosis|MP:0004191,neuronal intranuclear inclusions|MP:0008918,microgliosis
MGI:5000261	Tg(tetO-TARDBP*)4Vle	MP:0000745,tremors|MP:0000774,decreased brain size|MP:0000812,abnormal dentate gyrus morphology|MP:0000939,decreased motor neuron number|MP:0001052,abnormal innervation pattern to muscle|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001263,weight loss|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001525,impaired balance|MP:0002083,premature death|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0002878,abnormal corticospinal tract morphology|MP:0002882,abnormal neuron morphology|MP:0003354,astrocytosis|MP:0004819,decreased skeletal muscle mass|MP:0006254,thin cerebral cortex|MP:0010053,decreased grip strength|MP:0011975,neuronal cytoplasmic inclusions|MP:0012506,brain atrophy
MGI:5922010	Tg(tetO-TARDBP*A315T)13Lmit	MP:0000811,hippocampal neuron degeneration|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0002152,abnormal brain morphology|MP:0002229,neurodegeneration|MP:0003241,loss of cortex neurons|MP:0003354,astrocytosis|MP:0006254,thin cerebral cortex|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008283,small hippocampus|MP:0008414,abnormal spatial reference memory|MP:0009417,skeletal muscle atrophy|MP:0010053,decreased grip strength|MP:0010698,abnormal impulsive behavior control|MP:0011975,neuronal cytoplasmic inclusions|MP:0012448,abnormal primary motor cortex morphology|MP:0012508,forebrain atrophy|MP:0031391,increased locomotor activity
MGI:5922009	Tg(tetO-TARDBP*A315T)6Lmit	MP:0000811,hippocampal neuron degeneration
MGI:3762570	Tg(tetO-Tcf3)1Efu	MP:0000427,abnormal hair cycle|MP:0000764,abnormal tongue epithelium morphology|MP:0001216,abnormal epidermal layer morphology|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0003704,abnormal hair follicle development|MP:0003941,abnormal skin development|MP:0013376,abnormal sebocyte differentiation|MP:0013379,decreased sebocyte cell number|MP:0013380,absent sebocyte
MGI:3691068	Tg(tetO-Tek)1Dmt	MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000691,enlarged spleen|MP:0001190,reddish skin|MP:0001192,scaly skin|MP:0001193,psoriasis|MP:0001200,thick skin|MP:0001212,skin lesions|MP:0001219,thick epidermis|MP:0001242,hyperkeratosis|MP:0001265,decreased body size|MP:0001304,cataract|MP:0001510,abnormal coat appearance|MP:0001874,acanthosis|MP:0002060,abnormal skin morphology|MP:0002356,abnormal spleen red pulp morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0003227,abnormal vascular branching morphogenesis|MP:0003427,parakeratosis|MP:0003658,abnormal capillary morphology|MP:0004947,skin inflammation|MP:0005011,increased eosinophil cell number|MP:0005015,increased T cell number|MP:0005601,increased angiogenesis|MP:0008566,increased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion|MP:0008663,increased interleukin-12 secretion|MP:0008681,increased interleukin-17 secretion|MP:0008690,increased interleukin-23 secretion|MP:0012404,abnormal nail color|MP:0014273,abnormal skin vasculature morphology
MGI:5503055	Tg(tetO-Tfrc/EGFP/Ova)#Sfz	MP:0005387,immune system phenotype|MP:0010771,integument phenotype
MGI:6275554	Tg(tetO-TGFA)22.1Kor	MP:0001263,weight loss|MP:0003426,pulmonary interstitial fibrosis|MP:0006050,pulmonary fibrosis|MP:0010911,abnormal pulmonary acinus morphology|MP:0030678,increased hydroxyproline level
MGI:3815091	Tg(tetO-TGFB1*C223S*C225S)1Glk	MP:0000350,abnormal cell proliferation|MP:0000352,decreased cell proliferation|MP:0000367,abnormal coat/ hair morphology|MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000427,abnormal hair cycle|MP:0001190,reddish skin|MP:0001194,dermatitis|MP:0001196,shiny skin|MP:0001198,tight skin|MP:0001216,abnormal epidermal layer morphology|MP:0001218,thin epidermis|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0001245,thick dermal layer|MP:0001265,decreased body size|MP:0001874,acanthosis|MP:0002060,abnormal skin morphology|MP:0003985,renal fibrosis|MP:0004947,skin inflammation|MP:0004971,dermal hyperplasia|MP:0005501,abnormal skin physiology|MP:0009004,progressive hair loss|MP:0009580,increased keratinocyte apoptosis|MP:0010768,mortality/aging|MP:0011089,perinatal lethality, complete penetrance|MP:0011091,prenatal lethality, complete penetrance
MGI:5766489	Tg(tetO-TPM3/ALK,-luc)2Gde	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001222,epidermal hyperplasia|MP:0001243,abnormal dermal layer morphology|MP:0002023,increased B cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002060,abnormal skin morphology|MP:0002083,premature death|MP:0011092,embryonic lethality, complete penetrance
MGI:4949465	Tg(tetO-TPR/MET,-EGFP)12Tcre	MP:0000414,alopecia|MP:0001262,decreased body weight|MP:0001575,cyanosis|MP:0001625,cardiac hypertrophy|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0003828,pulmonary edema|MP:0005150,cachexia|MP:0005202,lethargy|MP:0005324,ascites|MP:0006138,congestive heart failure|MP:0010018,pulmonary vascular congestion|MP:0010239,decreased skeletal muscle weight|MP:0011925,abnormal heart echocardiography feature|MP:0011940,decreased food intake
MGI:2388011	Tg(tetO-Vegfa)1Kesh	MP:0000267,abnormal heart development|MP:0003974,abnormal endocardium morphology|MP:0006126,abnormal cardiac outflow tract development|MP:0008825,abnormal cardiac epithelial to mesenchymal transition
MGI:3586336	Tg(tetO-Vegfa)90Ala	MP:0001176,abnormal lung development
MGI:6376136	Tg(tetO-Xbp1_is)#Pesch	MP:0001263,weight loss|MP:0002970,abnormal white adipose tissue morphology|MP:0003806,abnormal nucleotide metabolism|MP:0005289,increased oxygen consumption|MP:0005534,decreased body temperature|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008963,increased carbon dioxide production|MP:0008965,increased basal metabolism|MP:0009269,decreased fat cell size|MP:0014143,decreased body fat mass|MP:0014146,decreased white adipose tissue mass|MP:0014169,decreased brown adipose tissue mass|MP:0014171,increased fatty acid oxidation
MGI:4887924	Tg(tetO-Zfp521)#Rbar	MP:0000130,abnormal trabecular bone morphology|MP:0004337,clavicle hypoplasia|MP:0005605,increased bone mass|MP:0009912,decreased hyoid bone size|MP:0010875,increased bone volume|MP:0020039,increased bone ossification
MGI:3056737	Tg(TF-CAT)48Gsa	MP:0002169,no abnormal phenotype detected
MGI:5647918	Tg(Tff3-Tmem207)1Tamo	MP:0002038,increased carcinoma incidence|MP:0002732,increased trichoepithelioma incidence|MP:0010300,increased skin tumor incidence
MGI:5524234	Tg(TG-BRAF*V600E)2Jaf	MP:0002083,premature death|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005355,enlarged thyroid gland|MP:0005479,decreased circulating triiodothyronine level|MP:0008489,slow postnatal weight gain|MP:0010316,increased thyroid tumor incidence|MP:0010346,increased thyroid carcinoma incidence
MGI:5524235	Tg(TG-BRAF*V600E)3Jaf	MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005355,enlarged thyroid gland|MP:0010346,increased thyroid carcinoma incidence
MGI:5575412	Tg(Tg-cre/ERT2)1Kero	MP:0002169,no abnormal phenotype detected
MGI:1926812	Tg(Tgfa)1Efu	MP:0000019,thick ears|MP:0000020,scaly ears|MP:0000122,premature tooth eruption|MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000424,retarded hair growth|MP:0000492,abnormal rectum morphology|MP:0000574,abnormal foot pad morphology|MP:0000583,long toenails|MP:0000764,abnormal tongue epithelium morphology|MP:0001141,thickened vaginal epithelium|MP:0001150,enlarged scrotum|MP:0001151,enlarged foreskin|MP:0001191,abnormal skin condition|MP:0001192,scaly skin|MP:0001195,flaky skin|MP:0001211,wrinkled skin|MP:0001219,thick epidermis|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001237,enlarged spinous cells|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001244,thin dermal layer|MP:0001265,decreased body size|MP:0001849,ear inflammation|MP:0002051,increased skin papilloma incidence|MP:0002060,abnormal skin morphology|MP:0002111,abnormal tail morphology|MP:0003153,early eyelid opening|MP:0003453,abnormal keratinocyte physiology
MGI:1926811	Tg(Tgfb1)1Der	MP:0000379,decreased hair follicle number|MP:0001196,shiny skin|MP:0001198,tight skin|MP:0001402,decreased locomotor activity|MP:0002058,neonatal lethality|MP:0005574,decreased pulmonary respiratory rate
MGI:5570240	Tg(TG-NRAS*Q61K)#Msnt	MP:0001272,increased metastatic potential|MP:0003496,increased thyroid adenoma incidence|MP:0004696,abnormal thyroid follicle morphology|MP:0005135,increased thyroid-stimulating hormone level|MP:0010346,increased thyroid carcinoma incidence
MGI:5569664	Tg(TG-RET/CCDC6)1Cled	MP:0010346,increased thyroid carcinoma incidence
MGI:5569727	Tg(TG-RET/CCDC6)42Cled	MP:0001265,decreased body size|MP:0002876,abnormal thyroid gland physiology|MP:0003503,decreased activity of thyroid gland|MP:0004696,abnormal thyroid follicle morphology|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005135,increased thyroid-stimulating hormone level|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level|MP:0008337,increased thyrotroph cell number|MP:0008420,increased thyrotroph cell size|MP:0010033,paraphimosis|MP:0010346,increased thyroid carcinoma incidence
MGI:5569734	Tg(TG-RET/NCOA4)3209Rstn	MP:0000681,abnormal thyroid gland morphology|MP:0001272,increased metastatic potential|MP:0004697,abnormal thyroid follicular cell morphology|MP:0005355,enlarged thyroid gland|MP:0010346,increased thyroid carcinoma incidence
MGI:5569755	Tg(TG-SV40)#Cled	MP:0000694,spleen hypoplasia|MP:0001272,increased metastatic potential|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0003501,iodide oxidation defect|MP:0003503,decreased activity of thyroid gland|MP:0005150,cachexia|MP:0005355,enlarged thyroid gland|MP:0005478,decreased circulating thyroxine level|MP:0010346,increased thyroid carcinoma incidence|MP:0013528,thyroid gland cyst|MP:0030044,short forehead|MP:0030049,prominent forehead
MGI:5569747	Tg(TG-TPR/NTRK1)5215Rstn	MP:0003498,thyroid gland hyperplasia|MP:0004696,abnormal thyroid follicle morphology|MP:0010346,increased thyroid carcinoma incidence
MGI:5569754	Tg(TG-TPR/NTRK1)#Rstn	MP:0010346,increased thyroid carcinoma incidence
MGI:3701769	Tg(TG-TSHR)51.9Smcl	MP:0005387,immune system phenotype
MGI:3846686	Tg(Th-EGFP)DJ76Gsat	MP:0005386,behavior/neurological phenotype
MGI:3039395	Tg(Th-MYCN)41Waw	MP:0002039,increased neuroblastoma incidence
MGI:4354389	Tg(Th-Oprm1)4Jtw	MP:0003631,nervous system phenotype
MGI:3764815	Tg(Th-SNCA*)1.2Ccs	MP:0000952,abnormal CNS glial cell morphology|MP:0002882,abnormal neuron morphology|MP:0003631,nervous system phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0008025,brain vacuoles|MP:0008916,abnormal astrocyte physiology
MGI:3757756	Tg(Th-SNCA*)1702Yosh	MP:0001957,apnea|MP:0003244,loss of dopaminergic neurons|MP:0005156,bradykinesia|MP:0005643,decreased dopamine level|MP:0008415,abnormal neurite morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011448,decreased dopaminergic neuron number
MGI:3530029	Tg(Th-SNCA)5Eric	MP:0001402,decreased locomotor activity|MP:0003244,loss of dopaminergic neurons|MP:0003691,abnormal microglial cell physiology|MP:0005643,decreased dopamine level|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0011449,increased dopaminergic neuron number
MGI:3530031	Tg(Th-SNCA*A30P*A53T)39Eric	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0002862,abnormal righting response|MP:0003243,abnormal dopaminergic neuron morphology|MP:0003244,loss of dopaminergic neurons|MP:0003313,abnormal locomotor activation|MP:0005643,decreased dopamine level|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:3057175	Tg(Th-TAg)17Dmc	MP:0002031,increased adrenal gland tumor incidence|MP:0014237,decreased tumor-free survival time
MGI:5447072	Tg(Th-Twnk*,-EGFP)2Gcor	MP:0001405,impaired coordination|MP:0003244,loss of dopaminergic neurons|MP:0005621,abnormal cell physiology|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0008260,abnormal autophagy|MP:0011448,decreased dopaminergic neuron number
MGI:3829246	Tg(THY1-APOD1)1Era	MP:0002118,abnormal lipid homeostasis|MP:0002574,increased vertical activity|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:4438891	Tg(Thy1-APP)16Ppa	MP:0000604,amyloidosis|MP:0003329,amyloid beta deposits
MGI:2447144	Tg(THY1-APP)1Somm	MP:0003631,nervous system phenotype
MGI:2447145	Tg(THY1-APP)2Somm	MP:0001847,brain inflammation|MP:0003329,amyloid beta deposits
MGI:6343355	Tg(Thy1-APP*)2Tbay	MP:0003240,loss of hippocampal neurons|MP:0008414,abnormal spatial reference memory
MGI:2447146	Tg(Thy1-APP)3Somm	MP:0001038,abnormal cholinergic neuron morphology|MP:0001262,decreased body weight|MP:0001353,increased aggression towards mice|MP:0001399,hyperactivity|MP:0001401,jumpy|MP:0001415,increased exploration in new environment|MP:0001458,abnormal object recognition memory|MP:0001463,abnormal spatial learning|MP:0001847,brain inflammation|MP:0001864,vascular inflammation|MP:0001916,intracerebral hemorrhage|MP:0002063,abnormal learning/memory/conditioning|MP:0002083,premature death|MP:0002128,abnormal blood circulation|MP:0003224,neuron degeneration|MP:0003313,abnormal locomotor activation|MP:0003329,amyloid beta deposits|MP:0003814,vascular smooth muscle hypoplasia|MP:0004254,cerebral amyloid angiopathy|MP:0004950,abnormal brain vasculature morphology|MP:0004994,abnormal brain wave pattern|MP:0005164,abnormal response to injury|MP:0005404,abnormal axon morphology|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008918,microgliosis|MP:0008948,decreased neuron number|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0011620,abnormal habituation to a new environment|MP:0020477,abnormal locomotor circadian rhythm|MP:0031384,impaired blood-brain barrier function
MGI:3717568	Tg(Thy1-APP)4Vln	MP:0001399,hyperactivity|MP:0001413,abnormal response to new environment|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0002064,seizures|MP:0002083,premature death|MP:0003631,nervous system phenotype
MGI:5463435	Tg(Thy1-APPArc)M8Cagr	MP:0001463,abnormal spatial learning|MP:0003329,amyloid beta deposits|MP:0005386,behavior/neurological phenotype|MP:0008428,abnormal spatial working memory|MP:0008432,abnormal long-term spatial reference memory
MGI:4438890	Tg(Thy1-APPDutch)#Jckr	MP:0000604,amyloidosis|MP:0001914,hemorrhage|MP:0003329,amyloid beta deposits|MP:0003354,astrocytosis|MP:0003814,vascular smooth muscle hypoplasia|MP:0004254,cerebral amyloid angiopathy|MP:0004272,abnormal basement membrane morphology|MP:0006080,brain ischemia|MP:0008918,microgliosis
MGI:3717572	Tg(Thy1-APPLon)2Vln	MP:0000604,amyloidosis|MP:0001399,hyperactivity|MP:0001413,abnormal response to new environment|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0002064,seizures|MP:0002083,premature death|MP:0003329,amyloid beta deposits|MP:0004254,cerebral amyloid angiopathy|MP:0005386,behavior/neurological phenotype|MP:0008287,abnormal subiculum morphology|MP:0008415,abnormal neurite morphology
MGI:3720072	Tg(Thy1-App*R609D*K612E)2Vln	MP:0000136,abnormal microglial cell morphology|MP:0002064,seizures|MP:0002083,premature death|MP:0002183,gliosis|MP:0002882,abnormal neuron morphology|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration|MP:0003354,astrocytosis
MGI:3720070	Tg(Thy1-App*R609D*K612E)4Vln	MP:0000136,abnormal microglial cell morphology|MP:0000243,myoclonus|MP:0001353,increased aggression towards mice|MP:0001413,abnormal response to new environment|MP:0001943,abnormal respiration|MP:0002064,seizures|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology|MP:0002183,gliosis|MP:0002797,increased thigmotaxis|MP:0002882,abnormal neuron morphology|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration|MP:0003313,abnormal locomotor activation|MP:0003354,astrocytosis|MP:0003996,clonic seizures|MP:0003997,tonic-clonic seizures|MP:0005202,lethargy|MP:0008035,behavioral arrest|MP:0030143,facial muscle spasm
MGI:3720071	Tg(Thy1-App*R609D*K612E)6Vln	MP:0000136,abnormal microglial cell morphology|MP:0000243,myoclonus|MP:0001353,increased aggression towards mice|MP:0001413,abnormal response to new environment|MP:0001943,abnormal respiration|MP:0002064,seizures|MP:0002083,premature death|MP:0002182,abnormal astrocyte morphology|MP:0002183,gliosis|MP:0002797,increased thigmotaxis|MP:0002882,abnormal neuron morphology|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003224,neuron degeneration|MP:0003313,abnormal locomotor activation|MP:0003354,astrocytosis|MP:0003996,clonic seizures|MP:0003997,tonic-clonic seizures|MP:0005202,lethargy|MP:0008035,behavioral arrest|MP:0030143,facial muscle spasm
MGI:3510606	Tg(Thy1-APP<SL>)28Lpr	MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0003329,amyloid beta deposits|MP:0004811,abnormal neuron physiology|MP:0005238,increased brain size|MP:0008286,abnormal hippocampus molecular cell layer|MP:0008415,abnormal neurite morphology|MP:0008571,abnormal synaptic bouton morphology|MP:0010053,decreased grip strength|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011151,abnormal hippocampus stratum radiatum morphology|MP:0014812,abnormal brain physiology
MGI:4843212	Tg(Thy1-APPSw)10Jiri	MP:0000812,abnormal dentate gyrus morphology|MP:0001463,abnormal spatial learning|MP:0003329,amyloid beta deposits|MP:0004924,abnormal behavior|MP:0008415,abnormal neurite morphology|MP:0008918,microgliosis|MP:0009538,abnormal synapse morphology
MGI:3717574	Tg(Thy1-APPSw)1Vln	MP:0000604,amyloidosis|MP:0001399,hyperactivity|MP:0001413,abnormal response to new environment|MP:0002064,seizures|MP:0002083,premature death
MGI:3721992	Tg(Thy1-APPSwDutIowa)BWevn	MP:0000604,amyloidosis|MP:0002128,abnormal blood circulation|MP:0002182,abnormal astrocyte morphology|MP:0003329,amyloid beta deposits|MP:0003691,abnormal microglial cell physiology|MP:0004254,cerebral amyloid angiopathy
MGI:4420244	Tg(Thy1-APPSwe)1Lngn	MP:0003329,amyloid beta deposits
MGI:4420229	Tg(Thy1-APPSweArc)BLngn	MP:0001262,decreased body weight|MP:0001408,stereotypic behavior|MP:0001417,decreased exploration in new environment|MP:0001458,abnormal object recognition memory|MP:0003329,amyloid beta deposits|MP:0003354,astrocytosis|MP:0004000,impaired passive avoidance behavior|MP:0010698,abnormal impulsive behavior control|MP:0011617,abnormal habituation|MP:0011942,decreased fluid intake|MP:0012317,impaired conditioning behavior
MGI:5559448	Tg(Thy1-APPSweAut)A7Tiwa	MP:0003329,amyloid beta deposits
MGI:6324681	Tg(Thy1-APP*Swe*Ind)fAccu	MP:0001458,abnormal object recognition memory|MP:0003329,amyloid beta deposits|MP:0008414,abnormal spatial reference memory|MP:0008571,abnormal synaptic bouton morphology|MP:0012307,impaired spatial learning|MP:0014062,nervous system inclusion bodies|MP:0014779,decreased brain enzyme/coenzyme level
MGI:5491622	Tg(Thy1-APPSweLon)41Ema	MP:0003329,amyloid beta deposits|MP:0003354,astrocytosis|MP:0008571,abnormal synaptic bouton morphology|MP:0008918,microgliosis
MGI:4412048	Tg(Thy1-APPSwe,Prnp-PSEN2*N141I)152HLaoz	MP:0001260,increased body weight|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0002923,increased post-tetanic potentiation|MP:0003008,enhanced long-term potentiation|MP:0003329,amyloid beta deposits|MP:0009937,abnormal neuron differentiation
MGI:3765351	Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr	MP:0001399,hyperactivity|MP:0002062,abnormal associative learning|MP:0003329,amyloid beta deposits|MP:0005621,abnormal cell physiology|MP:0008414,abnormal spatial reference memory
MGI:5295199	Tg(Thy1-BSCL2*N88S)1Dit	MP:0000753,paralysis|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002183,gliosis|MP:0002269,muscular atrophy|MP:0003354,astrocytosis|MP:0003632,abnormal nervous system morphology|MP:0004768,abnormal axonal transport|MP:0005405,axon degeneration|MP:0008770,decreased survivor rate|MP:0010053,decreased grip strength|MP:0020354,increased endoplasmic reticulum stress
MGI:3715524	Tg(Thy1-CFP/COX8A)C1Lich	MP:0002169,no abnormal phenotype detected
MGI:3715464	Tg(Thy1-CFP/COX8A)S2Lich	MP:0002169,no abnormal phenotype detected
MGI:4847925	Tg(Thy1-Clomeleon)12Gjau	MP:0001921,reduced fertility
MGI:4847926	Tg(Thy1-Clomeleon)13Gjau	MP:0001921,reduced fertility
MGI:4847924	Tg(Thy1-Clomeleon)1Gjau	MP:0001921,reduced fertility
MGI:3770122	Tg(Thy1-cmyc)1Kio	MP:0011085,postnatal lethality, complete penetrance
MGI:3770124	Tg(Thy1-cmyc)6Kio	MP:0001954,respiratory distress|MP:0002024,increased T cell derived lymphoma incidence
MGI:3770123	Tg(Thy1-cmyc)6LKio	MP:0002024,increased T cell derived lymphoma incidence
MGI:4454790	Tg(Thy1-COP3/EYFP)1Gfng	MP:0002169,no abnormal phenotype detected
MGI:4454808	Tg(Thy1-COP3/EYFP)4Gfng	MP:0002169,no abnormal phenotype detected
MGI:4454791	Tg(Thy1-COP3/EYFP)8Gfng	MP:0002169,no abnormal phenotype detected
MGI:3719486	Tg(Thy1-COP4/EYFP)18Gfng	MP:0002169,no abnormal phenotype detected
MGI:3719563	Tg(Thy1-COP4/EYFP)9Gfng	MP:0002169,no abnormal phenotype detected
MGI:4454792	Tg(Thy1-COP4*H134R/EYFP)20Gfng	MP:0002169,no abnormal phenotype detected
MGI:5308396	Tg(Thy1-DCTN1*G59S)M2Pcw	MP:0000745,tremors|MP:0000748,progressive muscle weakness|MP:0000753,paralysis|MP:0000937,abnormal motor neuron morphology|MP:0000939,decreased motor neuron number|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001263,weight loss|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002269,muscular atrophy|MP:0002883,chromatolysis|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003354,astrocytosis|MP:0003993,abnormal ventral spinal root morphology|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0010053,decreased grip strength|MP:0011975,neuronal cytoplasmic inclusions
MGI:6331092	Tg(Thy1-DCTN1*G71A)#Ytsu	MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0002757,decreased vertical activity|MP:0003631,nervous system phenotype
MGI:3773655	Tg(Thy1-ECFP/VAMP2)1Sud	MP:0002169,no abnormal phenotype detected
MGI:6150882	Tg(Thy1-EGFP/RNAi:Sumo3/RNAi:Sumo2/RNAi:Sumo1)27Weiy	MP:0001363,increased anxiety-related response|MP:0003106,abnormal fear-related response|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0011621,abnormal habituation to a novel object|MP:0020508,decreased dendritic spine density
MGI:5634106	Tg(Thy1-EGFP/SQSTM1)02Mcwo	MP:0001364,decreased anxiety-related response|MP:0003360,abnormal depression-related behavior|MP:0008432,abnormal long-term spatial reference memory
MGI:5634938	Tg(Thy1-EGFP/SQSTM1*P392L)#Mcwo	MP:0001363,increased anxiety-related response|MP:0003360,abnormal depression-related behavior
MGI:3769459	Tg(Thy1-Fcer2a)2431Putt	MP:0001790,abnormal immune system physiology|MP:0002492,decreased IgE level|MP:0005011,increased eosinophil cell number|MP:0008495,decreased IgG1 level
MGI:3769460	Tg(Thy1-Fcer2a)2733Putt	MP:0005387,immune system phenotype
MGI:5577178	Tg(Thy1-FUS*)19Vlb	MP:0000753,paralysis|MP:0000938,motor neuron degeneration|MP:0000958,peripheral nervous system degeneration|MP:0001406,abnormal gait|MP:0001429,dehydration|MP:0001523,impaired righting response|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0003354,astrocytosis|MP:0004191,neuronal intranuclear inclusions|MP:0008918,microgliosis|MP:0011975,neuronal cytoplasmic inclusions
MGI:6476958	Tg(Thy1-FUS*)1Dit	MP:0000745,tremors|MP:0000746,weakness|MP:0000938,motor neuron degeneration|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002882,abnormal neuron morphology|MP:0003354,astrocytosis|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008918,microgliosis|MP:0009456,impaired cued conditioning behavior|MP:0011975,neuronal cytoplasmic inclusions|MP:0020508,decreased dendritic spine density|MP:0020512,abnormal dendritic mushroom spine morphology|MP:0020551,abnormal postsynaptic density morphology|MP:0021112,impaired social recognition
MGI:5086269	Tg(Thy1-GLRA1)783Wha	MP:0001524,impaired limb coordination|MP:0002229,neurodegeneration|MP:0005386,behavior/neurological phenotype
MGI:5086276	Tg(Thy1-GLRA1)803Wha	MP:0001524,impaired limb coordination|MP:0002229,neurodegeneration
MGI:5086230	Tg(Thy1-GLRA1*R271Q)300Wha	MP:0000745,tremors|MP:0001406,abnormal gait|MP:0001501,abnormal sleep pattern|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001921,reduced fertility|MP:0002106,abnormal muscle physiology|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004142,abnormal muscle tone|MP:0004994,abnormal brain wave pattern|MP:0005604,hyperekplexia|MP:0009436,fragmentation of sleep/wake states|MP:0011100,preweaning lethality, complete penetrance|MP:0011396,abnormal sleep behavior
MGI:5306914	Tg(Thy1-GLRA1*R271Q)382Wha	MP:0000745,tremors|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002169,no abnormal phenotype detected|MP:0005604,hyperekplexia
MGI:4454787	Tg(Thy1-hop/EYFP)2Gfng	MP:0002169,no abnormal phenotype detected
MGI:4454789	Tg(Thy1-hop/EYFP)4Gfng	MP:0002169,no abnormal phenotype detected
MGI:5285201	Tg(Thy1-HSPB1*P182L)#Lvdb	MP:0000937,abnormal motor neuron morphology|MP:0000965,abnormal sensory neuron morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0002651,abnormal sciatic nerve morphology|MP:0003082,abnormal gastrocnemius morphology|MP:0003632,abnormal nervous system morphology|MP:0005402,abnormal action potential|MP:0009413,skeletal muscle fiber atrophy|MP:0010053,decreased grip strength
MGI:5285200	Tg(Thy1-HSPB1*S135F)#Lvdb	MP:0000937,abnormal motor neuron morphology|MP:0000965,abnormal sensory neuron morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0001973,increased thermal nociceptive threshold|MP:0002651,abnormal sciatic nerve morphology|MP:0003082,abnormal gastrocnemius morphology|MP:0003632,abnormal nervous system morphology|MP:0004768,abnormal axonal transport|MP:0005402,abnormal action potential|MP:0009413,skeletal muscle fiber atrophy|MP:0010053,decreased grip strength
MGI:2672839	Tg(Thy1-MAPT)183Gotz	MP:0001463,abnormal spatial learning|MP:0003858,enhanced coordination|MP:0004250,tau protein deposits
MGI:3813500	Tg(Thy1-MAPT*)1Avil	MP:0000243,myoclonus|MP:0000811,hippocampal neuron degeneration|MP:0000812,abnormal dentate gyrus morphology|MP:0000948,nonconvulsive seizures|MP:0002064,seizures|MP:0002183,gliosis|MP:0002184,abnormal innervation|MP:0002573,behavioral despair|MP:0002882,abnormal neuron morphology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003354,astrocytosis|MP:0003997,tonic-clonic seizures|MP:0004250,tau protein deposits|MP:0008285,abnormal hippocampus granule cell layer|MP:0008918,microgliosis
MGI:3720113	Tg(Thy1-MAPT)1Vln	MP:0000747,muscle weakness|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0002269,muscular atrophy|MP:0002882,abnormal neuron morphology|MP:0002980,abnormal postural reflex|MP:0003313,abnormal locomotor activation|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0004250,tau protein deposits|MP:0004819,decreased skeletal muscle mass|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0009413,skeletal muscle fiber atrophy|MP:0020378,abnormal cell cytoskeleton morphology
MGI:3717232	Tg(Thy1-MAPT)22Schd	MP:0000807,abnormal hippocampus morphology|MP:0001262,decreased body weight|MP:0001353,increased aggression towards mice|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001413,abnormal response to new environment|MP:0001463,abnormal spatial learning|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002183,gliosis|MP:0002206,abnormal CNS synaptic transmission|MP:0002573,behavioral despair|MP:0002882,abnormal neuron morphology|MP:0003214,neurofibrillary tangles|MP:0003631,nervous system phenotype|MP:0004250,tau protein deposits|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0009710,anhedonia|MP:0010070,decreased serotonin level|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0020477,abnormal locomotor circadian rhythm
MGI:3720114	Tg(Thy1-MAPT)2Vln	MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002269,muscular atrophy|MP:0005404,abnormal axon morphology|MP:0020378,abnormal cell cytoskeleton morphology
MGI:4940070	Tg(Thy1-MAPT*)30Schd	MP:0000755,hindlimb paralysis|MP:0000955,abnormal spinal cord morphology|MP:0001405,impaired coordination|MP:0001504,abnormal posture|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002651,abnormal sciatic nerve morphology|MP:0003214,neurofibrillary tangles|MP:0005386,behavior/neurological phenotype
MGI:3720115	Tg(Thy1-MAPT)5Vln	MP:0001405,impaired coordination|MP:0005404,abnormal axon morphology
MGI:3833383	Tg(Thy1-MAPT*K369I)K3Gotz	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001458,abnormal object recognition memory|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002269,muscular atrophy|MP:0002882,abnormal neuron morphology|MP:0003244,loss of dopaminergic neurons|MP:0003631,nervous system phenotype|MP:0004768,abnormal axonal transport|MP:0005156,bradykinesia|MP:0005404,abnormal axon morphology|MP:0005643,decreased dopamine level|MP:0009746,enhanced behavioral response to xenobiotic
MGI:5774860	Tg(Thy1-MAPT*L266V*G272V)13Ema	MP:0000812,abnormal dentate gyrus morphology|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0002229,neurodegeneration|MP:0002574,increased vertical activity|MP:0002797,increased thigmotaxis|MP:0003225,axonal dystrophy|MP:0004191,neuronal intranuclear inclusions|MP:0004250,tau protein deposits|MP:0008143,abnormal dendrite morphology|MP:0008414,abnormal spatial reference memory|MP:0008948,decreased neuron number|MP:0011620,abnormal habituation to a new environment|MP:0012307,impaired spatial learning|MP:0020070,decreased neocortex volume
MGI:3768525	Tg(Thy1-MAPT*P301L)2Vln	MP:0000753,paralysis|MP:0000755,hindlimb paralysis|MP:0001263,weight loss|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0002083,premature death|MP:0003214,neurofibrillary tangles|MP:0003631,nervous system phenotype|MP:0004250,tau protein deposits
MGI:3778191	Tg(Thy1-MAPT*P301S)2541Godt	MP:0000745,tremors|MP:0000747,muscle weakness|MP:0000939,decreased motor neuron number|MP:0001513,limb grasping|MP:0001851,eye inflammation|MP:0002229,neurodegeneration|MP:0003354,astrocytosis|MP:0003634,abnormal glial cell morphology|MP:0004250,tau protein deposits|MP:0009413,skeletal muscle fiber atrophy|MP:0009434,paraparesis
MGI:3832877	Tg(Thy1-MAPT*V337M)1Godt	MP:0005386,behavior/neurological phenotype|MP:0010698,abnormal impulsive behavior control
MGI:3844457	Tg(Thy1-Nlgn1)6Hnes	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:3844455	Tg(Thy1-Nlgn2)6Hnes	MP:0000160,kyphosis|MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001409,increased stereotypic behavior|MP:0001488,increased startle reflex|MP:0001513,limb grasping|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002574,increased vertical activity|MP:0002797,increased thigmotaxis|MP:0003107,abnormal response to novelty|MP:0003382,straub tail|MP:0003631,nervous system phenotype|MP:0004994,abnormal brain wave pattern|MP:0005386,behavior/neurological phenotype|MP:0008489,slow postnatal weight gain|MP:0014382,increased miniature inhibitory postsynaptic current frequency
MGI:3530750	Tg(Thy1-Nrg1*I)1Kan	MP:0004069,abnormal muscle spindle morphology|MP:0004297,abnormal proprioceptive neuron morphology|MP:0008485,increased muscle spindle number|MP:0010050,hypermyelination
MGI:3530751	Tg(Thy1-Nrg1*III)1Kan	MP:0000920,abnormal myelination|MP:0003631,nervous system phenotype
MGI:3619918	Tg(Thy1-Ntrk2/EGFP)817Cnl	MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0009969,abnormal cerebral cortex pyramidal cell morphology
MGI:5796269	Tg(Thy1-PFN1*C71G)67Zxu	MP:0000748,progressive muscle weakness|MP:0000753,paralysis|MP:0002083,premature death
MGI:4417910	Tg(Thy1-PSEN1*M146V,-APP*Swe)10Arte	MP:0000604,amyloidosis|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001458,abnormal object recognition memory|MP:0001463,abnormal spatial learning|MP:0002083,premature death|MP:0003329,amyloid beta deposits|MP:0003354,astrocytosis|MP:0003461,abnormal response to novel object|MP:0004254,cerebral amyloid angiopathy|MP:0008415,abnormal neurite morphology|MP:0008428,abnormal spatial working memory|MP:0008770,decreased survivor rate|MP:0008918,microgliosis
MGI:4941713	Tg(Thy1-QPCT)#Tbay	MP:0005386,behavior/neurological phenotype
MGI:3833391	Tg(Thy1-SERPINI1)183Icka	MP:0005376,homeostasis/metabolism phenotype
MGI:3833390	Tg(Thy1-SERPINI1*G392E)333Icka	MP:0002882,abnormal neuron morphology|MP:0002906,increased susceptibility to pharmacologically induced seizures
MGI:5573194	Tg(Thy1-Snca)1S13Putt	MP:0000921,demyelination|MP:0000937,abnormal motor neuron morphology|MP:0000955,abnormal spinal cord morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002882,abnormal neuron morphology|MP:0003354,astrocytosis|MP:0004087,abnormal muscle fiber morphology|MP:0005277,abnormal brainstem morphology|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0008143,abnormal dendrite morphology|MP:0008493,alpha-synuclein inclusion body|MP:0008918,microgliosis|MP:0011630,increased mitochondrial size
MGI:3767987	Tg(THY1-SNCA)1Sud	MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number
MGI:5435401	Tg(Thy1-SNCA)61Ema	MP:0000136,abnormal microglial cell morphology|MP:0001262,decreased body weight|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0003214,neurofibrillary tangles|MP:0003267,constipation|MP:0003868,abnormal feces composition|MP:0008493,alpha-synuclein inclusion body|MP:0010053,decreased grip strength|MP:0010762,abnormal microglial cell activation
MGI:2445720	Tg(Thy1-SNCA*A30P)18Pjk	MP:0000748,progressive muscle weakness|MP:0000755,hindlimb paralysis|MP:0001391,abnormal tail movements|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0001505,hunched posture|MP:0002183,gliosis
MGI:3810438	Tg(THY1-SNCA*A30P)M30Sud	MP:0000745,tremors|MP:0000754,paresis|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0008493,alpha-synuclein inclusion body|MP:0010768,mortality/aging
MGI:3767582	Tg(THY1-SNCA*A30P)TS2Sud	MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0008493,alpha-synuclein inclusion body
MGI:3528894	Tg(Thy1-SNCA*A53T)9813Putt	MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001405,impaired coordination|MP:0002269,muscular atrophy|MP:0003354,astrocytosis|MP:0005405,axon degeneration|MP:0008415,abnormal neurite morphology|MP:0008493,alpha-synuclein inclusion body
MGI:3811331	Tg(THY1-SNCA*A53T)F53Sud	MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000938,motor neuron degeneration|MP:0003203,increased neuron apoptosis
MGI:3768388	Tg(THY1-SNCA*A53T)M53Sud	MP:0000745,tremors|MP:0000788,abnormal cerebral cortex morphology|MP:0000813,abnormal hippocampus layer morphology|MP:0000832,abnormal thalamus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000897,abnormal midbrain morphology|MP:0000938,motor neuron degeneration|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0002083,premature death|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration|MP:0003632,abnormal nervous system morphology|MP:0004101,abnormal brain interneuron morphology|MP:0005156,bradykinesia|MP:0005405,axon degeneration|MP:0005424,jerky movement|MP:0008493,alpha-synuclein inclusion body|MP:0009512,abnormal cerebellar Golgi cell morphology|MP:0009956,abnormal cerebellar layer morphology|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0009978,abnormal cerebellum white matter morphology|MP:0009984,abnormal cerebellum interpositus nucleus morphology|MP:0009987,abnormal superior cerebellar peduncle morphology|MP:0010369,abnormal thalamus neuron morphology|MP:0011975,neuronal cytoplasmic inclusions|MP:0012051,spasticity|MP:0012267,abnormal red nucleus morphology|MP:0013219,abnormal substantia nigra pars compacta morphology
MGI:5806788	Tg(Thy1-SNCA*E57K)16Ema	MP:0002229,neurodegeneration|MP:0003354,astrocytosis|MP:0004792,abnormal synaptic vesicle number|MP:0008143,abnormal dendrite morphology|MP:0008493,alpha-synuclein inclusion body|MP:0009538,abnormal synapse morphology|MP:0011620,abnormal habituation to a new environment
MGI:3767580	Tg(THY1-Snca)M1mSud	MP:0003631,nervous system phenotype
MGI:3783986	Tg(THY1-Snca)M2mSud	MP:0002169,no abnormal phenotype detected
MGI:6810775	Tg(Thy1-SNCA*)#Ztzh	MP:0000747,muscle weakness|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002797,increased thigmotaxis|MP:0003224,neuron degeneration|MP:0003244,loss of dopaminergic neurons|MP:0003267,constipation|MP:0004792,abnormal synaptic vesicle number|MP:0004924,abnormal behavior|MP:0008493,alpha-synuclein inclusion body|MP:0009538,abnormal synapse morphology|MP:0014484,decreased feces water content|MP:0020167,abnormal vertical activity|MP:0020875,decreased nervous system dopamine level|MP:0031391,increased locomotor activity
MGI:4440514	Tg(Thy1-Sncg)HvP36Putt	MP:0000604,amyloidosis|MP:0000753,paralysis|MP:0000754,paresis|MP:0000939,decreased motor neuron number|MP:0001065,abnormal trigeminal nerve morphology|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0001525,impaired balance|MP:0002083,premature death|MP:0002183,gliosis|MP:0002651,abnormal sciatic nerve morphology|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0003632,abnormal nervous system morphology|MP:0003871,abnormal myelin sheath morphology|MP:0003993,abnormal ventral spinal root morphology|MP:0003994,abnormal dorsal spinal root morphology|MP:0008918,microgliosis
MGI:3785266	Tg(Thy1-SOD1*G93A)T1Hgrd	MP:0005386,behavior/neurological phenotype
MGI:3785090	Tg(Thy1-SOD1*G93A)T3Hgrd	MP:0000748,progressive muscle weakness|MP:0000939,decreased motor neuron number|MP:0000955,abnormal spinal cord morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001263,weight loss|MP:0001405,impaired coordination|MP:0001515,abnormal grip strength|MP:0001516,abnormal motor coordination/balance|MP:0002152,abnormal brain morphology|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0008415,abnormal neurite morphology
MGI:4438490	Tg(Thy1-TARDBP)4Singh	MP:0000753,paralysis|MP:0000807,abnormal hippocampus morphology|MP:0000859,abnormal somatosensory cortex morphology|MP:0000876,Purkinje cell degeneration|MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0000955,abnormal spinal cord morphology|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0002083,premature death|MP:0003354,astrocytosis|MP:0004191,neuronal intranuclear inclusions|MP:0004263,abnormal limb posture|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0008287,abnormal subiculum morphology|MP:0008547,abnormal neocortex morphology|MP:0008918,microgliosis|MP:0008948,decreased neuron number|MP:0030143,facial muscle spasm|MP:0030215,facial muscle fasciculation
MGI:4438491	Tg(Thy1-TARDBP)6Singh	MP:0000807,abnormal hippocampus morphology|MP:0000859,abnormal somatosensory cortex morphology|MP:0000876,Purkinje cell degeneration|MP:0000939,decreased motor neuron number|MP:0000955,abnormal spinal cord morphology|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002083,premature death|MP:0003203,increased neuron apoptosis|MP:0003354,astrocytosis|MP:0004191,neuronal intranuclear inclusions|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0008287,abnormal subiculum morphology|MP:0008547,abnormal neocortex morphology|MP:0008918,microgliosis|MP:0008948,decreased neuron number
MGI:5310969	Tg(Thy1-TARDBP*)BOddo	MP:0001405,impaired coordination|MP:0002152,abnormal brain morphology|MP:0003461,abnormal response to novel object|MP:0005386,behavior/neurological phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008260,abnormal autophagy|MP:0008428,abnormal spatial working memory|MP:0008432,abnormal long-term spatial reference memory|MP:0012307,impaired spatial learning
MGI:5521185	Tg(Thy1-Tcf4)1Mjro	MP:0002062,abnormal associative learning|MP:0002635,reduced sensorimotor gating|MP:0002797,increased thigmotaxis|MP:0003088,abnormal prepulse inhibition|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0012307,impaired spatial learning
MGI:6458481	Tg(Thy1/THY1)hT10Gsv	MP:0002083,premature death|MP:0009640,abnormal renal tubule epithelium morphology|MP:0010294,increased kidney tumor incidence
MGI:6458479	Tg(Thy1/THY1)hT13Gsv	MP:0002014,increased papilloma incidence|MP:0002083,premature death|MP:0009640,abnormal renal tubule epithelium morphology|MP:0010294,increased kidney tumor incidence
MGI:6458476	Tg(Thy1/THY1)mhT4Gsv	MP:0002962,increased urine protein level|MP:0011534,granular kidney
MGI:6458466	Tg(Thy1/THY1)T12Gsv	MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002703,abnormal renal tubule morphology|MP:0002962,increased urine protein level|MP:0003606,kidney failure|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0008059,abnormal podocyte foot process morphology|MP:0011339,abnormal glomerular mesangium morphology|MP:0011534,granular kidney|MP:0011899,podocyte vacuoles
MGI:6458475	Tg(Thy1/THY1)T6Gsv	MP:0000219,increased neutrophil cell number|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002871,albuminuria|MP:0003620,oliguria|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004778,increased macrophage derived foam cell number|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0008059,abnormal podocyte foot process morphology|MP:0008062,abnormal podocyte slit junction morphology|MP:0008140,podocyte foot process effacement|MP:0008247,abnormal mononuclear cell morphology|MP:0011339,abnormal glomerular mesangium morphology|MP:0011483,renal glomerular synechia|MP:0011498,abnormal glomerular capsule parietal layer morphology|MP:0011499,abnormal glomerular capsule space morphology|MP:0011501,increased glomerular capsule space|MP:0011758,renal ischemia|MP:0011871,podocyte hypertrophy|MP:0011899,podocyte vacuoles
MGI:3843489	Tg(Thy1-UBB*)8630Fwvl	MP:0003631,nervous system phenotype|MP:0010768,mortality/aging
MGI:5829042	Tg(Thy1-UBQLN2)356Mont	MP:0000939,decreased motor neuron number|MP:0003240,loss of hippocampal neurons|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0010768,mortality/aging
MGI:5829037	Tg(Thy1-UBQLN2*P497S)3Mont	MP:0000749,muscle degeneration|MP:0000755,hindlimb paralysis|MP:0000939,decreased motor neuron number|MP:0001052,abnormal innervation pattern to muscle|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003240,loss of hippocampal neurons|MP:0003354,astrocytosis|MP:0003461,abnormal response to novel object|MP:0005404,abnormal axon morphology|MP:0009402,decreased skeletal muscle fiber diameter|MP:0010053,decreased grip strength|MP:0014062,nervous system inclusion bodies|MP:0020448,increased microglial cell activation
MGI:5896606	Tg(Thy1-UBQLN2*P506T)6Mont	MP:0000749,muscle degeneration|MP:0000755,hindlimb paralysis|MP:0000939,decreased motor neuron number|MP:0001052,abnormal innervation pattern to muscle|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003240,loss of hippocampal neurons|MP:0003354,astrocytosis|MP:0003461,abnormal response to novel object|MP:0005404,abnormal axon morphology|MP:0009402,decreased skeletal muscle fiber diameter|MP:0010053,decreased grip strength|MP:0014062,nervous system inclusion bodies|MP:0020449,decreased microglial cell activation
MGI:5544194	Tg(Thy1-VAPB*P56S,-EGFP)D3Cai	MP:0000938,motor neuron degeneration|MP:0000939,decreased motor neuron number|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0002574,increased vertical activity|MP:0002878,abnormal corticospinal tract morphology|MP:0002882,abnormal neuron morphology|MP:0003633,abnormal nervous system physiology|MP:0008571,abnormal synaptic bouton morphology|MP:0031391,increased locomotor activity
MGI:5508556	Tg(Thy1-VCP*A232E)BMaki	MP:0001458,abnormal object recognition memory|MP:0001463,abnormal spatial learning|MP:0002882,abnormal neuron morphology|MP:0009454,impaired contextual conditioning behavior|MP:0011975,neuronal cytoplasmic inclusions
MGI:3696682	Tg(Thy1-YFP/Syp)10Jrs	MP:0002169,no abnormal phenotype detected
MGI:6358307	Tg(Tie1-RHOA*T19N)#Jiao	MP:0000297,abnormal atrioventricular cushion morphology
MGI:3056937	Tg(TIE2GFP)287Sato	MP:0002169,no abnormal phenotype detected
MGI:6162535	Tg(Tie2-Gja5*,-EGFP)#Dach	MP:0001614,abnormal blood vessel morphology|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype
MGI:6162534	Tg(Tie2-Gja5,-EGFP)#Dach	MP:0001614,abnormal blood vessel morphology|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype
MGI:3762250	Tg(Timp1-Msx2*P7H)1Rem	MP:0000081,premature cranial suture closure
MGI:6443611	Tg(Tk1-DPP4)27Ysj	MP:0000420,ruffled hair|MP:0000947,convulsive seizures|MP:0001175,abnormal lung morphology|MP:0001182,lung hemorrhage|MP:0001402,decreased locomotor activity|MP:0001861,lung inflammation|MP:0002419,abnormal innate immunity|MP:0006050,pulmonary fibrosis|MP:0008721,abnormal chemokine level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0008837,increased transforming growth factor beta level|MP:0010180,increased susceptibility to weight loss|MP:0010946,hyperpnea|MP:0011075,abnormal macrophage activation involved in immune response|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality
MGI:5444399	Tg(Tlr7)1Boll	MP:0000240,extramedullary hematopoiesis|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001844,autoimmune response|MP:0001860,liver inflammation|MP:0002083,premature death|MP:0002743,glomerulonephritis|MP:0003179,thrombocytopenia|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005461,abnormal dendritic cell morphology|MP:0008479,decreased spleen white pulp amount|MP:0008553,increased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level|MP:0010209,abnormal circulating chemokine level
MGI:5488498	Tg(Tlr7)6Boll	MP:0000691,enlarged spleen|MP:0001828,abnormal T cell activation|MP:0001844,autoimmune response|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002083,premature death|MP:0002743,glomerulonephritis|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004939,abnormal B cell morphology|MP:0005461,abnormal dendritic cell morphology|MP:0008182,decreased marginal zone B cell number|MP:0008210,increased mature B cell number|MP:0008217,abnormal B cell activation|MP:0009336,increased splenocyte proliferation
MGI:3053711	Tg(TNF)197Gkl	MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0002936,joint swelling|MP:0002993,autoimmune arthritis|MP:0004016,decreased bone mass|MP:0004984,increased osteoclast cell number|MP:0004992,increased bone resorption|MP:0008396,abnormal osteoclast differentiation|MP:0010053,decreased grip strength|MP:0010879,decreased trabecular bone volume
MGI:4818266	Tg(TNF)3647Gkl	MP:0000066,osteoporosis|MP:0002896,abnormal bone mineralization|MP:0002993,autoimmune arthritis|MP:0008271,abnormal bone ossification|MP:0011711,impaired osteoblast differentiation
MGI:3766101	Tg(Tnf)6074Gkl	MP:0000136,abnormal microglial cell morphology|MP:0000921,demyelination|MP:0001847,brain inflammation|MP:0002182,abnormal astrocyte morphology|MP:0005405,axon degeneration|MP:0005623,abnormal meninges morphology|MP:0006042,increased apoptosis|MP:0010205,abnormal oligodendrocyte apoptosis|MP:0031384,impaired blood-brain barrier function
MGI:5575757	Tg(Tnfrsf19-cre/ERT2)1Kori	MP:0002169,no abnormal phenotype detected
MGI:5788418	Tg(TNFSF11)5516Edou	MP:0000066,osteoporosis|MP:0000130,abnormal trabecular bone morphology|MP:0004991,decreased bone strength|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0010933,decreased trabecular bone connectivity density|MP:0013630,increased bone trabecular spacing|MP:0013638,decreased femur stiffness
MGI:5788420	Tg(TNFSF11)5519Edou	MP:0000066,osteoporosis|MP:0000135,decreased compact bone thickness|MP:0000163,abnormal cartilage morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0002998,abnormal bone remodeling|MP:0003109,short femur|MP:0003797,abnormal compact bone morphology|MP:0004984,increased osteoclast cell number|MP:0004991,decreased bone strength|MP:0004992,increased bone resorption|MP:0006395,abnormal epiphyseal plate morphology|MP:0008158,increased diameter of femur|MP:0010867,abnormal bone trabecula morphology|MP:0010869,decreased bone trabecula number|MP:0010965,decreased compact bone volume|MP:0013638,decreased femur stiffness|MP:0030009,increased bone marrow adipose tissue amount
MGI:2386944	Tg(Tnfsf13b)1Fma	MP:0000623,decreased salivation|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001859,kidney inflammation|MP:0001870,salivary gland inflammation|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002136,abnormal kidney physiology|MP:0002144,abnormal B cell differentiation|MP:0002358,abnormal spleen periarteriolar lymphoid sheath morphology|MP:0002359,abnormal spleen germinal center morphology|MP:0002362,abnormal spleen marginal zone morphology|MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0002461,increased immunoglobulin level|MP:0002490,abnormal immunoglobulin level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002743,glomerulonephritis|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0003725,increased autoantibody level|MP:0003944,abnormal T cell subpopulation ratio|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004939,abnormal B cell morphology|MP:0004940,abnormal B-1 B cell morphology|MP:0005013,increased lymphocyte cell number|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005325,abnormal renal glomerulus morphology|MP:0005327,abnormal mesangial cell morphology|MP:0005397,hematopoietic system phenotype|MP:0006387,abnormal T cell number|MP:0008097,increased plasma cell number|MP:0008136,enlarged Peyer's patches|MP:0008167,increased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0008181,increased marginal zone B cell number|MP:0008189,increased transitional stage B cell number|MP:0008193,abnormal marginal zone B cell physiology|MP:0008210,increased mature B cell number|MP:0008217,abnormal B cell activation|MP:0008473,abnormal spleen follicular dendritic cell network|MP:0008483,increased spleen germinal center size|MP:0009516,enlarged salivary gland|MP:0009925,increased transitional stage T2 B cell number|MP:0010319,increased submandibular gland tumor incidence|MP:0011294,renal glomerulus hypertrophy|MP:0011339,abnormal glomerular mesangium morphology|MP:0011353,expanded mesangial matrix|MP:0011363,renal glomerulus atrophy|MP:0014347,increased spleen B cell follicle size|MP:0020519,renal glomerular immunoglobulin deposits
MGI:4421555	TgTn(mm-DTT)1Ddra	MP:0002169,no abnormal phenotype detected
MGI:4421556	TgTn(mm-DTT-3XSstop)ADdra	MP:0002169,no abnormal phenotype detected
MGI:4421557	TgTn(mm-DTT-3XSstop)LDdra	MP:0002169,no abnormal phenotype detected
MGI:4421553	TgTn(mm-STT)ADdra	MP:0002169,no abnormal phenotype detected
MGI:4421554	TgTn(mm-STT)BDdra	MP:0002169,no abnormal phenotype detected
MGI:4819718	Tg(Tnnt2-TNNT2*R92Q)#Ajm	MP:0000233,abnormal blood flow velocity|MP:0001544,abnormal cardiovascular system physiology|MP:0005608,cardiac interstitial fibrosis|MP:0031131,myocardial fiber disarray
MGI:4819719	Tg(Tnnt2-TNNT2*R92Q)M-2Ajm	MP:0000233,abnormal blood flow velocity|MP:0001544,abnormal cardiovascular system physiology|MP:0005608,cardiac interstitial fibrosis|MP:0031131,myocardial fiber disarray
MGI:6794092	TgTn(pb-CAG-Gm40600)#Rew	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002492,decreased IgE level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0005014,increased B cell number|MP:0005017,decreased B cell number|MP:0008097,increased plasma cell number|MP:0008098,decreased plasma cell number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008499,increased IgG1 level|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level|MP:0008896,increased IgG2c level|MP:0008897,decreased IgG2c level|MP:0013940,abnormal plasmablast number
MGI:6727902	TgTn(pb-CAG-Gm614)#Cya	MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0005387,immune system phenotype|MP:0008783,decreased B cell apoptosis
MGI:7545506	TgTn(sb-CAG-Ing3,-EGFP)774.1Biat	MP:0010768,mortality/aging
MGI:4836982	TgTn(sb-lacZ,GFP)IF2Jtak	MP:0002169,no abnormal phenotype detected
MGI:4836983	TgTn(sb-lacZ,GFP)IR3Jtak	MP:0002169,no abnormal phenotype detected
MGI:5300386	TgTn(sb-Tyr)1799BOve	MP:0002169,no abnormal phenotype detected
MGI:5306361	TgTn(sb-Tyr)2161BOve	MP:0000111,cleft palate
MGI:2384595	Tg(TRAMP)8247Ng	MP:0000659,prostate gland hyperplasia|MP:0004961,increased prostate gland weight|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0009220,increased prostate gland adenocarcinoma incidence|MP:0010357,increased prostate gland tumor incidence
MGI:4360913	Tg(Trp53)1Srn	MP:0002052,decreased tumor incidence|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005389,reproductive system phenotype|MP:0009541,increased thymocyte apoptosis|MP:0010768,mortality/aging
MGI:2447408	Tg(Trp53A135V)L3Ber	MP:0000066,osteoporosis|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000420,ruffled hair|MP:0000423,delayed hair regrowth|MP:0001263,weight loss|MP:0002027,increased lung adenocarcinoma incidence|MP:0002052,decreased tumor incidence|MP:0002083,premature death|MP:0002908,delayed wound healing|MP:0003402,decreased liver weight|MP:0003786,premature aging|MP:0003918,decreased kidney weight|MP:0004819,decreased skeletal muscle mass|MP:0004852,decreased testis weight|MP:0004953,decreased spleen weight|MP:0005202,lethargy|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0031253,lordokyphosis
MGI:4948957	Tg(Trp53)bSrn	MP:0009541,increased thymocyte apoptosis
MGI:1929642	Tg(Trp53R172H)8512Jmr	MP:0001883,increased mammary adenocarcinoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0005379,endocrine/exocrine gland phenotype|MP:0008866,chromosomal instability
MGI:1929643	Tg(Trp53R172L)4491Jmr	MP:0000377,abnormal hair follicle morphology|MP:0001212,skin lesions|MP:0001881,abnormal mammary gland physiology|MP:0002006,neoplasm|MP:0004502,decreased incidence of tumors by chemical induction|MP:0006270,abnormal mammary gland growth during lactation|MP:0010249,lactation failure|MP:0010699,dilated hair follicle|MP:0010700,hair follicle comedo
MGI:4943525	Tg(TSPY1-Figla)#Dean	MP:0000242,impaired fertilization|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001925,male infertility|MP:0002674,abnormal sperm motility|MP:0002687,oligozoospermia|MP:0004901,decreased male germ cell number|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0009237,kinked sperm flagellum|MP:0031620,abnormal chromatoid body morphology
MGI:2429747	Tg(Ttr-Cdkn1a)36Tvd	MP:0001265,decreased body size|MP:0001559,hyperglycemia|MP:0002083,premature death|MP:0004001,decreased hepatocyte proliferation|MP:0010040,abnormal oval cell morphology
MGI:3521642	Tg(Ttr-Foxo1)305Dac	MP:0001559,hyperglycemia|MP:0002727,decreased circulating insulin level|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance
MGI:3521643	Tg(Ttr-Foxo1)307Dac	MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0001559,hyperglycemia|MP:0002079,increased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0005178,increased circulating cholesterol level|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005293,impaired glucose tolerance
MGI:4455320	Tg(Ttr-IGF1)1Sykr	MP:0000662,abnormal branching of the mammary ductal tree|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0002727,decreased circulating insulin level|MP:0002981,increased liver weight|MP:0003917,increased kidney weight|MP:0004702,increased circulating insulin-like growth factor I level|MP:0004952,increased spleen weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005459,decreased percent body fat/body weight|MP:0009283,decreased gonadal fat pad weight|MP:0010025,decreased total body fat amount|MP:0031421,increased superovulation rate
MGI:6110833	Tg(TTR)#Jbux	MP:0000604,amyloidosis|MP:0008469,abnormal protein level
MGI:3716726	Tg(Ttr-KLF6)1Fdmn	MP:0000606,decreased hepatocyte number|MP:0001262,decreased body weight|MP:0003402,decreased liver weight|MP:0004001,decreased hepatocyte proliferation|MP:0005419,decreased circulating serum albumin level
MGI:6110834	Tg(TTR*L55P)#Jbux	MP:0005376,homeostasis/metabolism phenotype
MGI:3835332	Tg(TTR-p19Cdkn2a)2Tvd	MP:0001426,polydipsia|MP:0001762,polyuria|MP:0001923,reduced female fertility|MP:0005559,increased circulating glucose level
MGI:4462407	Tg(Ttr-Retn)1Laz	MP:0001559,hyperglycemia|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005559,increased circulating glucose level
MGI:5749481	Tg(Ttr-SMYD3)1Ital	MP:0000603,pale liver|MP:0002628,hepatic steatosis
MGI:3047080	Tg(TTR-V30M)15Imeg	MP:0000266,abnormal heart morphology|MP:0000496,abnormal small intestine morphology|MP:0000604,amyloidosis|MP:0002135,abnormal kidney morphology
MGI:2385585	Tg(Tuba1-MAPT)14Vle	MP:0000746,weakness|MP:0001106,abnormal Schwann cell morphology|MP:0002182,abnormal astrocyte morphology|MP:0003871,abnormal myelin sheath morphology|MP:0004250,tau protein deposits|MP:0005323,dystonia|MP:0005405,axon degeneration|MP:0005424,jerky movement|MP:0008948,decreased neuron number|MP:0009808,decreased oligodendrocyte number
MGI:5496879	Tg(Twnk)1Lrsn	MP:0002169,no abnormal phenotype detected
MGI:4358257	Tg(TXNRD2,COMT,ARVCF)1Nhir	MP:0002802,abnormal discrimination learning|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0012588,increased brain catechol O-methyltransferase activity|MP:0014370,impaired spatial working memory
MGI:3706799	Tg(Tyr)3412ARpw	MP:0002075,abnormal coat/hair pigmentation|MP:0005366,variegated coat color
MGI:4354192	Tg(Tyr-BRAF*V600E)470Fgh	MP:0000371,diluted coat color|MP:0000588,thick tail|MP:0001188,hyperpigmentation|MP:0001297,microphthalmia|MP:0002018,increased malignant tumor incidence|MP:0002083,premature death|MP:0002877,abnormal melanocyte morphology
MGI:4354193	Tg(Tyr-BRAF*V600E)476Fgh	MP:0002018,increased malignant tumor incidence|MP:0002083,premature death|MP:0002877,abnormal melanocyte morphology
MGI:5788285	Tg(Tyr,Col1a1-Trps1)1Brle	MP:0000126,brittle teeth|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002818,abnormal dentin morphology|MP:0002819,abnormal dental pulp cavity morphology|MP:0005358,abnormal incisor morphology|MP:0008819,abnormal mastication|MP:0030451,abnormal dentin mineralization
MGI:5788532	Tg(Tyr,Col2a1-Trpv4*R594H)#Dhco	MP:0000132,thickened long bone epiphysis|MP:0000445,short snout|MP:0000547,short limbs|MP:0000554,abnormal carpal bone morphology|MP:0000592,short tail|MP:0001784,abnormal fluid regulation|MP:0002896,abnormal bone mineralization|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003073,abnormal metacarpal bone morphology|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004200,decreased fetal size|MP:0004214,abnormal long bone diaphysis morphology|MP:0004686,decreased length of long bones|MP:0005306,abnormal phalanx morphology|MP:0005508,abnormal skeleton morphology|MP:0006395,abnormal epiphyseal plate morphology|MP:0008275,failure of endochondral bone ossification|MP:0008915,fused carpal bones|MP:0011089,perinatal lethality, complete penetrance|MP:0012085,midface hypoplasia|MP:0020137,decreased bone mineralization
MGI:4354013	Tg(Tyr-cre/ERT,-Hras1*,-Trap1a)10BJvde	MP:0002020,increased tumor incidence
MGI:6272337	Tg(Tyr-Ctnnb1/EGFP)#Lru	MP:0000371,diluted coat color|MP:0004382,abnormal hair follicle melanogenesis|MP:0008732,reduced hair shaft melanin granule number|MP:0009783,abnormal melanoblast morphology|MP:0009928,abnormal pinna hair pigmentation|MP:0009933,abnormal tail hair pigmentation|MP:0030906,decreased melanoblast proliferation
MGI:3768646	Tg(Tyr-DT)3Bee	MP:0005100,abnormal choroid pigmentation|MP:0005408,hypopigmentation
MGI:8215438	Tg(Tyr)GwNpln	MP:0000013,abnormal adipose tissue distribution|MP:0001260,increased body weight|MP:0001923,reduced female fertility|MP:0002079,increased circulating insulin level|MP:0002636,delayed vaginal opening|MP:0002680,decreased corpora lutea number|MP:0005189,abnormal anogenital distance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0006094,increased fat cell size|MP:0009011,prolonged diestrus|MP:0009015,short proestrus|MP:0009016,abnormal estrus|MP:0009018,short estrus|MP:0009093,oocyte degeneration|MP:0010024,increased total body fat amount|MP:0010378,increased respiratory quotient|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011939,increased food intake|MP:0020354,increased endoplasmic reticulum stress|MP:0031239,increased atretic ovarian follicle number|MP:0031434,increased miscarriage rate
MGI:5774447	Tg(Tyr)HolNpln	MP:0000420,ruffled hair|MP:0001044,abnormal enteric nervous system morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001270,distended abdomen|MP:0001505,hunched posture|MP:0001732,postnatal growth retardation|MP:0002075,abnormal coat/hair pigmentation|MP:0002926,aganglionic megacolon|MP:0011085,postnatal lethality, complete penetrance|MP:0013006,abnormal enteric neural crest cell migration
MGI:6266855	Tg(Tyr-HRAS*G12V)#Acc	MP:0000026,abnormal inner ear morphology|MP:0000031,abnormal cochlea morphology|MP:0000049,abnormal middle ear morphology|MP:0000371,diluted coat color|MP:0001188,hyperpigmentation|MP:0001212,skin lesions|MP:0001265,decreased body size|MP:0001304,cataract|MP:0001340,abnormal eyelid morphology|MP:0001394,circling|MP:0001395,bidirectional circling|MP:0001396,unidirectional circling|MP:0001967,deafness|MP:0002006,neoplasm|MP:0005100,abnormal choroid pigmentation|MP:0005205,abnormal eye anterior chamber morphology|MP:0005287,narrow eye opening|MP:0009022,abnormal brain meninges morphology|MP:0009389,abnormal extracutaneous pigmentation|MP:0009390,abnormal otic pigmentation|MP:0010191,abnormal choroid melanocyte morphology|MP:0010206,pigment incontinence|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation|MP:0012022,increased melanocyte number|MP:0030051,increased foot pigmentation|MP:0030926,increased skin pigmentation
MGI:3768645	Tg(Tyr-NRAS*Q61K)1Bee	MP:0000377,abnormal hair follicle morphology|MP:0001188,hyperpigmentation|MP:0001212,skin lesions|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0002877,abnormal melanocyte morphology|MP:0004947,skin inflammation|MP:0005081,abnormal dermis reticular layer morphology|MP:0005098,abnormal optic choroid morphology|MP:0009545,abnormal dermis papillary layer morphology|MP:0010741,abnormal melanocyte proliferation
MGI:3522144	Tg(Tyrp1-TAg)3434Bee	MP:0010295,increased eye tumor incidence|MP:0014237,decreased tumor-free survival time
MGI:8211391	Tg(Tyr)SpotNpln	MP:0000550,abnormal forelimb morphology|MP:0001076,abnormal hypoglossal nerve morphology|MP:0001077,abnormal spinal nerve morphology|MP:0001394,circling|MP:0002926,aganglionic megacolon|MP:0003690,abnormal glial cell physiology|MP:0004174,abnormal spine curvature|MP:0005171,absent coat pigmentation|MP:0005377,hearing/vestibular/ear phenotype|MP:0008066,small endolymphatic duct|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012023,decreased melanocyte number
MGI:4437002	Tg(Tyr-TAg)BJjw	MP:0010303,increased retina tumor incidence|MP:0010304,increased choroid tumor incidence|MP:0010305,increased iris tumor incidence
MGI:5755287	Tg(Tyr)TashTNpln	MP:0001045,abnormal enteric ganglia morphology|MP:0001265,decreased body size|MP:0002926,aganglionic megacolon|MP:0003270,intestinal obstruction|MP:0005076,abnormal cell differentiation|MP:0005366,variegated coat color|MP:0010158,abnormal intestine development|MP:0012745,abnormal neural crest cell physiology|MP:0013006,abnormal enteric neural crest cell migration
MGI:5013582	Tg(UBB-EmGFP/RNAi:Sarm1)#Yph	MP:0000774,decreased brain size|MP:0002175,decreased brain weight|MP:0008143,abnormal dendrite morphology|MP:0008283,small hippocampus
MGI:3616231	Tg(UBC-Adk)1Bois	MP:0000948,nonconvulsive seizures|MP:0000950,abnormal seizure response to pharmacological agent|MP:0001399,hyperactivity|MP:0002183,gliosis|MP:0004994,abnormal brain wave pattern
MGI:6724445	Tg(Ubc-Fto)#Pzg	MP:0000780,abnormal corpus callosum morphology|MP:0000954,decreased oligodendrocyte progenitor number|MP:0001405,impaired coordination|MP:0008535,enlarged lateral ventricles|MP:0009808,decreased oligodendrocyte number|MP:0010053,decreased grip strength|MP:0012307,impaired spatial learning|MP:0013438,dysmyelination
MGI:5565690	Tg(UBC-GFP/HTT*84Q)22Shya	MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001513,limb grasping|MP:0002083,premature death|MP:0004191,neuronal intranuclear inclusions|MP:0008770,decreased survivor rate|MP:0010053,decreased grip strength
MGI:5438390	Tg(UBC-HPV11E2)613Josc	MP:0002169,no abnormal phenotype detected
MGI:3760426	Tg(UBC-scFv)2Nemz	MP:0000694,spleen hypoplasia|MP:0002144,abnormal B cell differentiation|MP:0002490,abnormal immunoglobulin level|MP:0004939,abnormal B cell morphology|MP:0004940,abnormal B-1 B cell morphology|MP:0005000,abnormal immune tolerance|MP:0008171,abnormal mature B cell morphology|MP:0008211,decreased mature B cell number|MP:0008766,abnormal B cell receptor editing|MP:0009339,decreased splenocyte number
MGI:3689922	Tg(UCP3,UCP2)1Ful	MP:0001392,abnormal locomotor behavior|MP:0001783,decreased white adipose tissue amount|MP:0002863,improved righting response|MP:0003960,increased lean body mass|MP:0003998,decreased thermal nociceptive threshold|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0006319,abnormal epididymal fat pad morphology
MGI:2183746	Tg(UcpDta)1Kz	MP:0001260,increased body weight|MP:0001261,obese|MP:0001433,polyphagia|MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0001780,decreased brown adipose tissue amount|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002118,abnormal lipid homeostasis|MP:0003631,nervous system phenotype|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005376,homeostasis/metabolism phenotype|MP:0005458,increased percent body fat/body weight
MGI:4819095	Tg(Umod)416Lura	MP:0002169,no abnormal phenotype detected
MGI:4819096	Tg(Umod*C147W)958Lura	MP:0001426,polydipsia|MP:0001762,polyuria|MP:0001859,kidney inflammation|MP:0002135,abnormal kidney morphology|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002988,decreased urine osmolality|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0004154,renal tubular necrosis|MP:0005441,increased urine calcium level|MP:0005502,abnormal renal/urinary system physiology|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005610,increased circulating antidiuretic hormone level|MP:0008997,increased blood osmolality|MP:0009350,decreased urine pH|MP:0011308,kidney corticomedullary cyst|MP:0011346,renal tubule atrophy|MP:0011402,renal cast|MP:0011440,increased kidney cell proliferation|MP:0013305,isosthenuria
MGI:6758566	Tg(Umod*C217G)1Xrw	MP:0001762,polyuria|MP:0002083,premature death|MP:0002987,abnormal urine osmolality|MP:0002988,decreased urine osmolality|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0003620,oliguria|MP:0004153,increased renal tubule apoptosis|MP:0005264,glomerulosclerosis|MP:0005528,decreased renal glomerular filtration rate|MP:0005558,decreased creatinine clearance|MP:0008055,increased urine osmolality|MP:0009810,increased urine uric acid level|MP:0011346,renal tubule atrophy
MGI:2384606	Tg(UPII-SV40T)29Xrw	MP:0001272,increased metastatic potential|MP:0009550,increased urinary bladder carcinoma incidence|MP:0009551,increased urinary bladder transitional cell carcinoma incidence
MGI:2384608	Tg(UPII-SV40T)2Xrw	MP:0009550,increased urinary bladder carcinoma incidence|MP:0009551,increased urinary bladder transitional cell carcinoma incidence
MGI:2384609	Tg(UPII-SV40T)9Xrw	MP:0009550,increased urinary bladder carcinoma incidence
MGI:3522718	Tg(Upk2-HRAS*Q61L)12Xrw	MP:0000519,hydronephrosis|MP:0000540,abnormal urinary bladder urothelium morphology|MP:0002083,premature death|MP:0003068,enlarged kidney|MP:0003585,large ureter|MP:0003606,kidney failure|MP:0010289,increased urinary system tumor incidence|MP:0011304,kidney papillary atrophy|MP:0011874,enlarged urinary bladder
MGI:3522719	Tg(Upk2-HRAS*Q61L)5Xrw	MP:0000540,abnormal urinary bladder urothelium morphology|MP:0010289,increased urinary system tumor incidence
MGI:5014305	Tg(Upk2-TAg)1Rkl	MP:0000858,abnormal metastatic potential|MP:0005039,hypoxia|MP:0009550,increased urinary bladder carcinoma incidence|MP:0009551,increased urinary bladder transitional cell carcinoma incidence|MP:0010144,abnormal tumor vascularization|MP:0011799,increased urinary bladder weight
MGI:3040905	Tg(Utg-TAg)7593Fjd	MP:0002027,increased lung adenocarcinoma incidence|MP:0002083,premature death
MGI:3040305	Tg(Utg-TAg)7736Fjd	MP:0002027,increased lung adenocarcinoma incidence|MP:0002083,premature death|MP:0010910,bronchiolar epithelial hyperplasia
MGI:4452494	Tg(Utg-TAg)#Fjd	MP:0002027,increased lung adenocarcinoma incidence
MGI:6315194	Tg(Vav1-Asxl1*Y588X)#Fcy	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000221,decreased leukocyte cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004809,increased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0005065,abnormal neutrophil morphology|MP:0005505,thrombocytosis|MP:0008254,increased megakaryocyte cell number|MP:0009439,increased myeloid sarcoma incidence|MP:0010178,increased number of Howell-Jolly bodies|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0013658,abnormal myeloid cell morphology|MP:0013663,increased myeloid cell number|MP:0013696,increased granulocyte monocyte progenitor cell number|MP:0013705,decreased megakaryocyte-erythroid progenitor cell number|MP:0020838,increased acute myeloid leukemia incidence|MP:0031058,hepatosplenomegaly
MGI:5141633	Tg(Vav1-ERG)#Jpim	MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0010336,increased acute lymphoblastic leukemia incidence
MGI:5441310	Tg(Vav1-JAK2*V617F)AZjz	MP:0000218,increased leukocyte cell number|MP:0000322,increased granulocyte number|MP:0000691,enlarged spleen|MP:0002123,abnormal definitive hematopoiesis|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002429,abnormal blood cell morphology/development|MP:0002608,increased hematocrit|MP:0002813,microcytosis|MP:0003131,increased erythrocyte cell number|MP:0004952,increased spleen weight|MP:0005505,thrombocytosis|MP:0005564,increased hemoglobin content|MP:0008254,increased megakaryocyte cell number|MP:0009642,abnormal blood homeostasis|MP:0011286,decreased circulating erythropoietin level|MP:0011746,spleen fibrosis|MP:0011747,myelofibrosis|MP:0030025,giant platelets
MGI:5446657	Tg(Vav1-Lin28b)C3Apla	MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0000420,ruffled hair|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000715,decreased thymocyte number|MP:0001505,hunched posture|MP:0001577,anemia|MP:0001845,abnormal inflammatory response|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0002371,abnormal thymus cortex morphology|MP:0002493,increased IgG level|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005092,decreased double-positive T cell number|MP:0005202,lethargy|MP:0005324,ascites|MP:0005348,increased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008713,abnormal cytokine level|MP:0008827,abnormal thymus cell ratio|MP:0009543,abnormal thymus corticomedullary boundary morphology|MP:0010334,pleural effusion|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013590,enlarged thymus medulla
MGI:4357688	Tg(Vav1-NUP98/HOXD13)C1Apla	MP:0000221,decreased leukocyte cell number|MP:0000321,increased bone marrow cell number|MP:0001577,anemia|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002417,abnormal megakaryocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0005065,abnormal neutrophil morphology|MP:0005097,polychromatophilia|MP:0008801,abnormal erythroid progenitor cell morphology|MP:0009395,increased nucleated erythrocyte cell number|MP:0011178,increased erythroblast number|MP:0030025,giant platelets
MGI:4357686	Tg(Vav1-NUP98/HOXD13)G2Apla	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0005016,decreased lymphocyte cell number|MP:0005065,abnormal neutrophil morphology|MP:0005097,polychromatophilia|MP:0009395,increased nucleated erythrocyte cell number
MGI:6164041	Tg(Vav1-STAT5B)731Biat	MP:0002006,neoplasm
MGI:6164037	Tg(Vav1-STAT5B*N642H)726Biat	MP:0000218,increased leukocyte cell number|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002133,abnormal respiratory system physiology|MP:0002339,abnormal lymph node morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0004809,increased hematopoietic stem cell number|MP:0005348,increased T cell proliferation|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0012431,increased lymphoma incidence|MP:0013762,abnormal effector T cell number|MP:0013891,increased common myeloid progenitor cell number|MP:0013892,increased common lymphocyte progenitor cell number
MGI:2429387	Tg(Vav-BCL2)69Jad	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000717,abnormal lymphocyte cell number|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0002359,abnormal spleen germinal center morphology|MP:0002743,glomerulonephritis|MP:0004815,abnormal somatic hypermutation frequency|MP:0004816,abnormal class switch recombination|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005325,abnormal renal glomerulus morphology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008481,increased spleen germinal center number|MP:0008483,increased spleen germinal center size|MP:0009317,increased follicular lymphoma incidence|MP:0009321,increased histiocytic sarcoma incidence|MP:0011320,abnormal glomerular capillary morphology|MP:0011506,glomerular crescent|MP:0012431,increased lymphoma incidence
MGI:5806870	Tg(Venus/SOX10*)55Kein	MP:0000489,abnormal large intestine morphology|MP:0000953,abnormal oligodendrocyte morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0001394,circling|MP:0001967,deafness|MP:0002082,postnatal lethality|MP:0003871,abnormal myelin sheath morphology|MP:0005408,hypopigmentation|MP:0010800,abnormal submucous nerve plexus morphology|MP:0011731,decreased myelin sheath thickness|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3846679	Tg(Vil1-Ascl2)1Cle	MP:0008108,abnormal small intestinal villus morphology|MP:0013481,abnormal ileum crypts of Lieberkuhn morphology|MP:0014081,branched small intestinal villi|MP:0014082,decreased small intestinal villus height
MGI:3053826	Tg(Vil1-cre/ERT2)23Syr	MP:0010180,increased susceptibility to weight loss|MP:0012734,abnormal response to radiation|MP:0014201,abnormal intestinal epithelium physiology|MP:0031331,delayed intestine regeneration
MGI:3775624	Tg(Vil1-CYP3A4)1Nki	MP:0000511,abnormal intestinal mucosa morphology
MGI:5584102	Tg(Vil1-EGFP/Ocln)#Tjr	MP:0005381,digestive/alimentary phenotype
MGI:5560200	Tg(Vil1-Lin28b,-tdTomato)HiAru	MP:0002404,increased intestinal adenoma incidence|MP:0003449,abnormal intestine goblet cell morphology|MP:0009309,increased small intestine adenocarcinoma incidence|MP:0013483,abnormal jejunum crypts of Lieberkuhn morphology|MP:0013486,decreased Paneth cell number
MGI:5560202	Tg(Vil1-Lin28b,-tdTomato)LoAru	MP:0000496,abnormal small intestine morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0005381,digestive/alimentary phenotype|MP:0013486,decreased Paneth cell number
MGI:5560201	Tg(Vil1-Lin28b,-tdTomato)MedAru	MP:0000496,abnormal small intestine morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0002404,increased intestinal adenoma incidence|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0009309,increased small intestine adenocarcinoma incidence|MP:0013486,decreased Paneth cell number
MGI:5584023	Tg(Vil1-mRFP1/TJP1)#Tjr	MP:0005381,digestive/alimentary phenotype
MGI:4950744	Tg(Vil1-PPARGC1A)#Amos	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0003447,decreased tumor growth/size|MP:0004502,decreased incidence of tumors by chemical induction|MP:0008885,increased enterocyte apoptosis|MP:0011628,increased mitochondrial number|MP:0014082,decreased small intestinal villus height
MGI:5433607	Tg(Vil-SLC3A2)HEMerl	MP:0000479,abnormal enterocyte morphology|MP:0000494,abnormal cecum morphology|MP:0000496,abnormal small intestine morphology|MP:0001265,decreased body size|MP:0002044,increased colon adenoma incidence|MP:0002816,colitis|MP:0003293,rectal hemorrhage|MP:0003721,increased tumor growth/size|MP:0004499,increased incidence of tumors by chemical induction|MP:0005036,diarrhea|MP:0008141,decreased small intestinal microvillus size|MP:0008537,increased susceptibility to induced colitis|MP:0008553,increased circulating tumor necrosis factor level|MP:0008882,abnormal enterocyte physiology|MP:0008883,abnormal enterocyte proliferation|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010155,abnormal intestine physiology|MP:0010180,increased susceptibility to weight loss
MGI:4365636	Tg(Vim*R113C)1Tmm	MP:0000358,abnormal cell morphology|MP:0001304,cataract|MP:0002579,disorganized secondary lens fibers|MP:0002840,abnormal lens fiber morphology|MP:0008841,ruptured lens capsule
MGI:3052038	Tg(VIM-Tag)3Pau	MP:0000708,thymus hyperplasia|MP:0000709,enlarged thymus|MP:0000788,abnormal cerebral cortex morphology|MP:0002083,premature death|MP:0002705,dilated renal tubule|MP:0002743,glomerulonephritis|MP:0005090,increased double-negative T cell number|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3036575	Tg(Wap-Hgf)402Mig	MP:0000627,abnormal mammary gland morphology|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001272,increased metastatic potential|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001885,mammary gland duct hyperplasia|MP:0012570,increased mammary gland tumor incidence in breeding females|MP:0012571,increased mammary gland tumor incidence in virgin females
MGI:3039648	Tg(Wap-HRAS)69Lln	MP:0000621,increased salivary adenocarcinoma incidence|MP:0000858,abnormal metastatic potential|MP:0009308,increased adenocarcinoma incidence|MP:0010299,increased mammary gland tumor incidence
MGI:3053848	Tg(WapIgf1)39Dlr	MP:0001885,mammary gland duct hyperplasia|MP:0006271,abnormal involution of the mammary gland|MP:0009506,abnormal mammary gland alveolus morphology
MGI:3053842	Tg(WapIGFBP3)67Dlr	MP:0001885,mammary gland duct hyperplasia|MP:0006271,abnormal involution of the mammary gland|MP:0009506,abnormal mammary gland alveolus morphology
MGI:3054251	Tg(WapMyc)212Bri	MP:0000627,abnormal mammary gland morphology|MP:0000630,mammary gland hyperplasia|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001884,mammary gland alveolar hyperplasia|MP:0001885,mammary gland duct hyperplasia|MP:0002083,premature death|MP:0009505,abnormal mammary gland lobule morphology|MP:0010249,lactation failure|MP:0010299,increased mammary gland tumor incidence
MGI:1930202	Tg(WapNotch4)10Rnc	MP:0001883,increased mammary adenocarcinoma incidence|MP:0002006,neoplasm|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0008014,increased lung tumor incidence|MP:0010249,lactation failure
MGI:5312328	Tg(Wap-TAg)12Gmn	MP:0006269,abnormal mammary gland growth during pregnancy|MP:0006270,abnormal mammary gland growth during lactation|MP:0009504,abnormal mammary gland epithelium morphology|MP:0010249,lactation failure|MP:0010299,increased mammary gland tumor incidence
MGI:5428742	Tg(Wap-TAg)1Depp	MP:0009508,increased mammary gland ductal carcinoma incidence
MGI:5313806	Tg(Wap-tAg)1Gmn	MP:0001883,increased mammary adenocarcinoma incidence|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0008904,abnormal mammary fat pad morphology|MP:0009503,abnormal mammary gland duct morphology|MP:0009504,abnormal mammary gland epithelium morphology|MP:0009506,abnormal mammary gland alveolus morphology|MP:0010249,lactation failure
MGI:3040314	Tg(WapTAg)1Knw	MP:0001883,increased mammary adenocarcinoma incidence|MP:0002032,increased sarcoma incidence
MGI:3040884	Tg(WapTAg)3Knw	MP:0000630,mammary gland hyperplasia|MP:0001382,abnormal nursing|MP:0001393,ataxia|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0003789,increased osteosarcoma incidence|MP:0009308,increased adenocarcinoma incidence
MGI:5428741	Tg(Wap-TAg)NP8Depp	MP:0009508,increased mammary gland ductal carcinoma incidence
MGI:3054253	Tg(WapTgfa)215Bri	MP:0000627,abnormal mammary gland morphology|MP:0000630,mammary gland hyperplasia|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001885,mammary gland duct hyperplasia|MP:0002083,premature death|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0006271,abnormal involution of the mammary gland|MP:0009505,abnormal mammary gland lobule morphology|MP:0010249,lactation failure|MP:0010299,increased mammary gland tumor incidence|MP:0012431,increased lymphoma incidence
MGI:3710126	Tg(Wap-Tsg101)4389Kuw	MP:0000628,abnormal mammary gland development|MP:0001883,increased mammary adenocarcinoma incidence|MP:0005379,endocrine/exocrine gland phenotype
MGI:5525135	Tg(Wnk4*Q562E)#Rpl	MP:0002083,premature death|MP:0002136,abnormal kidney physiology|MP:0003017,decreased circulating bicarbonate level|MP:0003019,increased circulating chloride level|MP:0004757,abnormal distal convoluted tubule morphology|MP:0005385,cardiovascular system phenotype|MP:0005441,increased urine calcium level|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0010092,increased circulating magnesium level|MP:0012339,hyperkalemia
MGI:5525134	Tg(Wnk4)#Rpl	MP:0002986,decreased urine calcium level|MP:0003020,decreased circulating chloride level|MP:0004757,abnormal distal convoluted tubule morphology|MP:0005385,cardiovascular system phenotype|MP:0005628,decreased circulating potassium level|MP:0006263,decreased systemic arterial diastolic blood pressure|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0010093,decreased circulating magnesium level
MGI:1890080	Tg(Wnt1)1Hev	MP:0000627,abnormal mammary gland morphology|MP:0000630,mammary gland hyperplasia|MP:0000662,abnormal branching of the mammary ductal tree|MP:0001883,increased mammary adenocarcinoma incidence|MP:0001884,mammary gland alveolar hyperplasia|MP:0001885,mammary gland duct hyperplasia|MP:0009505,abnormal mammary gland lobule morphology|MP:0010299,increased mammary gland tumor incidence|MP:0014237,decreased tumor-free survival time
MGI:1891524	Tg(Wnt3)7Gsb	MP:0000414,alopecia|MP:0000417,short hair|MP:0001247,dermal cyst|MP:0003809,abnormal hair shaft morphology|MP:0010699,dilated hair follicle
MGI:3037368	Tg(WTbeta2)4Wjk	MP:0000278,abnormal myocardial fiber morphology|MP:0001575,cyanosis|MP:0001855,abnormal atrial thrombosis|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002625,heart left ventricle hypertrophy|MP:0002626,increased heart rate|MP:0002753,dilated heart left ventricle|MP:0002899,fatigue|MP:0002972,abnormal cardiac muscle contractility|MP:0003060,increased aerobic running capacity|MP:0003141,cardiac fibrosis|MP:0003921,abnormal heart left ventricle morphology|MP:0004084,abnormal cardiac muscle relaxation|MP:0004564,increased myocardial fiber size|MP:0004566,myocardial fiber degeneration|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0005599,increased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006138,congestive heart failure|MP:0009732,ventricular premature beat|MP:0010018,pulmonary vascular congestion|MP:0010182,decreased susceptibility to weight gain|MP:0010334,pleural effusion|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010571,shortened ST segment|MP:0011925,abnormal heart echocardiography feature|MP:0020253,increased collagen level|MP:0031635,increased heart left ventricle muscle contractility
MGI:3613515	Tg(YAC128)53Hay	MP:0000788,abnormal cerebral cortex morphology|MP:0001260,increased body weight|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002063,abnormal learning/memory/conditioning|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002175,decreased brain weight|MP:0002574,increased vertical activity|MP:0002757,decreased vertical activity|MP:0002804,abnormal motor learning|MP:0003242,loss of basal ganglia neurons|MP:0003631,nervous system phenotype|MP:0004077,abnormal striatum morphology|MP:0004191,neuronal intranuclear inclusions|MP:0005156,bradykinesia|MP:0005386,behavior/neurological phenotype|MP:0006007,abnormal basal ganglion morphology|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0008462,abnormal medium spiny neuron morphology|MP:0009142,decreased prepulse inhibition
MGI:5432153	Tg(YAC128)54Hay	MP:0003631,nervous system phenotype|MP:0012468,decreased striatum size
MGI:5432147	Tg(YAC128)55Hay	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0004077,abnormal striatum morphology|MP:0004191,neuronal intranuclear inclusions|MP:0008235,increased susceptibility to neuronal excitotoxicity
MGI:5432149	Tg(YAC128)#Hay	MP:0001405,impaired coordination|MP:0001486,abnormal startle reflex|MP:0001522,impaired swimming|MP:0002063,abnormal learning/memory/conditioning|MP:0002635,reduced sensorimotor gating|MP:0002804,abnormal motor learning|MP:0009142,decreased prepulse inhibition|MP:0011617,abnormal habituation|MP:0011620,abnormal habituation to a new environment|MP:0012307,impaired spatial learning
MGI:3829789	Tg(YAC18)18Hay	MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008236,decreased susceptibility to neuronal excitotoxicity
MGI:3710982	Tg(YAC353G6)W7Hay	MP:0002176,increased brain weight|MP:0003631,nervous system phenotype|MP:0004077,abnormal striatum morphology|MP:0008236,decreased susceptibility to neuronal excitotoxicity
MGI:3829794	Tg(YAC46)668Hay	MP:0002207,abnormal long-term potentiation|MP:0002922,decreased post-tetanic potentiation|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:2429756	Tg(YAC72)2511Hay	MP:0001396,unidirectional circling|MP:0001399,hyperactivity|MP:0001473,reduced long-term potentiation|MP:0002207,abnormal long-term potentiation|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration|MP:0003234,enhanced NMDA-mediated synaptic currents|MP:0004077,abnormal striatum morphology|MP:0005389,reproductive system phenotype|MP:0008235,increased susceptibility to neuronal excitotoxicity
MGI:3655816	Tg(YACW408A5)1952Ricc	MP:0003787,abnormal imprinting|MP:0004201,fetal growth retardation
MGI:3525681	Tgyl1<SM/J>	MP:0005317,increased triglyceride level
MGI:7329776	Tg(Zfhx2*R1907K)#Jcox	MP:0001973,increased thermal nociceptive threshold|MP:0004811,abnormal neuron physiology|MP:0008531,increased chemical nociceptive threshold
MGI:1926802	Tg(Zfp38)A4Htz	MP:0000414,alopecia|MP:0009004,progressive hair loss
MGI:1926806	Tg(Zfp38)D1Htz	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000855,accelerated formation of intralobular fissures|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001243,abnormal dermal layer morphology|MP:0002015,epithelioid cyst|MP:0003809,abnormal hair shaft morphology|MP:0003941,abnormal skin development|MP:0008914,enlarged cerebellum|MP:0008925,increased cerebellar granule cell number|MP:0009004,progressive hair loss|MP:0009267,abnormal cerebellum fissure morphology
MGI:1926804	Tg(Zfp38-lacZ)Y7Htz	MP:0002169,no abnormal phenotype detected
MGI:3785900	Tg(ZFP90)1Eesc	MP:0001260,increased body weight|MP:0001924,infertility|MP:0005334,abnormal fat pad morphology|MP:0005452,abnormal adipose tissue amount|MP:0008908,increased total fat pad weight|MP:0009298,increased mesenteric fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0010024,increased total body fat amount
MGI:3721278	Tg(Zfy1-lacZ)218Bri	MP:0002169,no abnormal phenotype detected
MGI:3057275	Tg(ZP2)2Dean	MP:0005389,reproductive system phenotype
MGI:3056745	Tg(ZP3)7812Dean	MP:0005389,reproductive system phenotype
MGI:2176052	Tg(Zp3-cre)3Mrt	MP:0001923,reduced female fertility
MGI:2176187	Tg(Zp3-cre)93Knw	MP:0005389,reproductive system phenotype
MGI:3603681	Tg(Zp3-siH1foo)1Eya	MP:0002169,no abnormal phenotype detected
MGI:3603682	Tg(Zp3-siH1foo)2Eya	MP:0002169,no abnormal phenotype detected
MGI:1856186	T<h>	MP:0000592,short tail|MP:0001672,abnormal embryo development|MP:0011092,embryonic lethality, complete penetrance
MGI:1856739	t<h20>	MP:0008762,embryonic lethality
MGI:1856741	t<h45>	MP:0010768,mortality/aging
MGI:5465007	t<h7m>	MP:0002169,no abnormal phenotype detected|MP:0005389,reproductive system phenotype
MGI:5465008	t<h7m2>	MP:0004179,transmission ratio distortion|MP:0011400,lethality, complete penetrance
MGI:7275233	Thada<em1Zsg>	MP:0002169,no abnormal phenotype detected|MP:0005389,reproductive system phenotype
MGI:6860325	Thap11<em1Poche>	MP:0000208,decreased hematocrit|MP:0000428,abnormal craniofacial morphology|MP:0000585,kinked tail|MP:0000914,exencephaly|MP:0001575,cyanosis|MP:0001698,decreased embryo size|MP:0001953,respiratory failure|MP:0002182,abnormal astrocyte morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003036,vertebral transformation|MP:0003179,thrombocytopenia|MP:0003935,abnormal craniofacial development|MP:0004067,abnormal trabecula carnea morphology|MP:0005319,abnormal enzyme/coenzyme level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006254,thin cerebral cortex|MP:0008535,enlarged lateral ventricles|MP:0010499,abnormal ventricle myocardium morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3797583	Thap11<tm1.1Tpz>	MP:0005621,abnormal cell physiology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:3797582	Thap11<tm1Tpz>	MP:0003935,abnormal craniofacial development|MP:0005621,abnormal cell physiology
MGI:6460295	Thap12<em1(IMPC)J>	MP:0005559,increased circulating glucose level|MP:0005635,decreased circulating bilirubin level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5909270	Thap1<em1(IMPC)J>	MP:0001312,abnormal cornea morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6107687	Thap1<tm1.1Meeh>	MP:0000774,decreased brain size|MP:0001406,abnormal gait|MP:0009980,abnormal cerebellum dentate nucleus morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:6107688	Thap1<tm1.2Meeh>	MP:0000774,decreased brain size|MP:0001293,anophthalmia|MP:0001406,abnormal gait|MP:0003651,abnormal axon extension|MP:0009980,abnormal cerebellum dentate nucleus morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0011877,absent liver
MGI:7665254	Thap4<em1Nvl>	MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001265,decreased body size|MP:0004955,increased thymus weight
MGI:5445362	Thbd<tm1.1Hlwu>	MP:0002411,decreased susceptibility to bacterial infection|MP:0005166,decreased susceptibility to injury|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008597,decreased circulating interleukin-6 level|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:5603359	Thbd<tm1.1(KOMP)Vlcg>	MP:0005630,increased lung weight|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5462218	Thbd<tm1.1(THBD)Sltz>	MP:0005164,abnormal response to injury|MP:0005584,abnormal enzyme/coenzyme activity|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance
MGI:1857982	Thbd<tm1Emc>	MP:0005376,homeostasis/metabolism phenotype|MP:0005416,abnormal circulating protein level
MGI:1857983	Thbd<tm1Rdr>	MP:0000267,abnormal heart development|MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0003974,abnormal endocardium morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5462220	Thbd<tm1(THBD)Sltz>	MP:0005584,abnormal enzyme/coenzyme activity|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance
MGI:2158812	Thbd<tm1Wlr>	MP:0000266,abnormal heart morphology|MP:0000689,abnormal spleen morphology|MP:0001175,abnormal lung morphology|MP:0002135,abnormal kidney morphology|MP:0002551,abnormal blood coagulation|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008735,increased susceptibility to endotoxin shock|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0031083,increased circulating D-dimer level|MP:0031121,increased susceptibility to induced thrombosis
MGI:3698840	Thbd<tm2.1Emc>	MP:0002442,abnormal leukocyte physiology|MP:0003037,increased myocardial infarct size|MP:0003628,abnormal leukocyte adhesion|MP:0008553,increased circulating tumor necrosis factor level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008735,increased susceptibility to endotoxin shock
MGI:3712468	Thbd<tm2Emc>	MP:0002442,abnormal leukocyte physiology|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:2158818	Thbd<tm2Rdr>	MP:0001712,abnormal placenta development|MP:0001713,decreased trophoblast giant cell number|MP:0001730,embryonic growth arrest|MP:0002584,small ectoplacental cone|MP:0005031,abnormal trophoblast layer morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:5582449	Thbs1<tm1.1(KOMP)Vlcg>	MP:0000598,abnormal liver morphology|MP:0001175,abnormal lung morphology|MP:0002941,increased circulating alanine transaminase level|MP:0010123,increased bone mineral content
MGI:2154534	Thbs1<tm1Hyn>	MP:0000160,kyphosis|MP:0000162,lordosis|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000230,abnormal systemic arterial blood pressure|MP:0000281,abnormal interventricular septum morphology|MP:0000556,abnormal hindlimb morphology|MP:0001175,abnormal lung morphology|MP:0001204,decreased sensitivity to skin irradiation|MP:0001243,abnormal dermal layer morphology|MP:0001297,microphthalmia|MP:0001312,abnormal cornea morphology|MP:0001348,abnormal lacrimal gland physiology|MP:0001861,lung inflammation|MP:0001869,pancreas inflammation|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0001944,abnormal pancreas morphology|MP:0003710,abnormal physiological neovascularization|MP:0004007,abnormal lung vasculature morphology|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0004087,abnormal muscle fiber morphology|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004875,increased mean systemic arterial blood pressure|MP:0004974,decreased regulatory T cell number|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005287,narrow eye opening|MP:0005294,abnormal heart ventricle morphology|MP:0005333,decreased heart rate|MP:0005369,muscle phenotype|MP:0005384,cellular phenotype|MP:0005488,bronchial epithelial hyperplasia|MP:0005489,vascular smooth muscle hyperplasia|MP:0005490,increased club cell number|MP:0005491,pancreatic islet hyperplasia|MP:0005492,exocrine pancreas hypoplasia|MP:0005493,stomach epithelial hyperplasia|MP:0005494,esophagogastric junction metaplasia|MP:0005501,abnormal skin physiology|MP:0006000,abnormal cornea epithelium morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006266,decreased pulse pressure|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008567,decreased interferon-gamma secretion|MP:0008681,increased interleukin-17 secretion|MP:0008880,lacrimal gland inflammation|MP:0009343,dilated gallbladder|MP:0009493,abnormal cystic duct morphology|MP:0010771,integument phenotype|MP:0010909,pulmonary alveolar hemorrhage|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011372,decreased renal tubule apoptosis|MP:0011376,abnormal kidney corticomedullary boundary morphology|MP:0013452,increased lacrimal gland apoptosis|MP:0013462,abnormal conjunctiva goblet cell number|MP:0013464,decreased conjunctiva goblet cell number
MGI:6449024	Thbs2<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001158,abnormal prostate gland morphology|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0004958,enlarged prostate gland
MGI:2153006	Thbs2<tm1Bst>	MP:0000062,increased bone mineral density|MP:0000160,kyphosis|MP:0000260,abnormal angiogenesis|MP:0001391,abnormal tail movements|MP:0001614,abnormal blood vessel morphology|MP:0001914,hemorrhage|MP:0002083,premature death|MP:0002111,abnormal tail morphology|MP:0002724,enhanced wound healing|MP:0003089,decreased skin tensile strength|MP:0004148,increased compact bone thickness|MP:0004499,increased incidence of tumors by chemical induction|MP:0005503,abnormal tendon morphology|MP:0005504,abnormal ligament morphology|MP:0005505,thrombocytosis|MP:0005507,tail dragging|MP:0005606,increased bleeding time|MP:0006043,decreased apoptosis|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0011643,abnormal tendon collagen fibril morphology
MGI:3581964	Thbs3<tm1Bst>	MP:0000559,abnormal femur morphology|MP:0001260,increased body weight|MP:0003416,premature bone ossification
MGI:3604558	Thbs4<tm1Dgen>	MP:0000266,abnormal heart morphology|MP:0001262,decreased body weight|MP:0001625,cardiac hypertrophy|MP:0001792,impaired wound healing|MP:0002792,abnormal retina vasculature morphology|MP:0002833,increased heart weight|MP:0003141,cardiac fibrosis|MP:0003915,increased heart left ventricle weight|MP:0004485,increased response of heart to induced stress|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005425,increased macrophage cell number|MP:0005598,decreased heart ventricle muscle contractility|MP:0010551,abnormal coronary vessel morphology
MGI:7628361	Thbs4<tm1Olsa>	MP:0002724,enhanced wound healing|MP:0002792,abnormal retina vasculature morphology|MP:0003884,decreased macrophage cell number|MP:0005397,hematopoietic system phenotype
MGI:3036491	Thcr<BALB/cJ>	MP:0008567,decreased interferon-gamma secretion|MP:0008699,increased interleukin-4 secretion
MGI:3036492	Thcr<C57BL/10Sn>	MP:0008566,increased interferon-gamma secretion|MP:0008700,decreased interleukin-4 secretion
MGI:1856212	thd	MP:0001522,impaired swimming|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002894,abnormal otolith morphology|MP:0005191,head tilt
MGI:1856213	thd<ub>	MP:0001504,abnormal posture|MP:0001522,impaired swimming|MP:0002894,abnormal otolith morphology|MP:0002978,absent otoliths
MGI:6153826	Th<em1(IMPC)H>	MP:0001406,abnormal gait|MP:0011100,preweaning lethality, complete penetrance
MGI:3848835	Them4<tm1Hem>	MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0014341,abnormal hepatocyte mitochondrial morphology
MGI:5433219	Them5<tm1Hem>	MP:0001554,increased circulating free fatty acids level|MP:0002628,hepatic steatosis|MP:0005282,decreased fatty acids level|MP:0006035,abnormal mitochondrial morphology|MP:0010954,abnormal cellular respiration|MP:0010955,abnormal respiratory electron transport chain|MP:0011630,increased mitochondrial size|MP:0011633,abnormal mitochondrial shape
MGI:4364708	Themis2<tm1a(KOMP)Wtsi>	MP:0001262,decreased body weight|MP:0005627,increased circulating potassium level|MP:0005628,decreased circulating potassium level
MGI:5779207	Themis2<tm1d(KOMP)Wtsi>	MP:0005387,immune system phenotype
MGI:4353412	Themis<5AT161>	MP:0004974,decreased regulatory T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number
MGI:5575394	Themis<m1Btlr>	MP:0002619,abnormal lymphocyte morphology|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008168,decreased B-1a cell number|MP:0020154,impaired humoral immune response
MGI:5806438	Themis<m2Btlr>	MP:0001606,impaired hematopoiesis|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number
MGI:6113462	Themis<m3Btlr>	MP:0002436,abnormal CD8-positive, alpha-beta cytotoxic T cell morphology|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010838,increased CD8-positive, alpha-beta memory T cell number|MP:0010839,decreased CD8-positive, alpha-beta memory T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6286098	Themis<M4Btlr>	MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:6304287	Themis<m5Btlr>	MP:0002145,abnormal T cell differentiation|MP:0008039,increased NK T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0010838,increased CD8-positive, alpha-beta memory T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0012765,decreased alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:4359649	Themis<Spotr>	MP:0002145,abnormal T cell differentiation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0013588,small thymus medulla
MGI:4359650	Themis<tm1.1Hko>	MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number
MGI:4353091	Themis<tm1Gasc>	MP:0000715,decreased thymocyte number|MP:0002375,abnormal thymus medulla morphology|MP:0004919,abnormal positive T cell selection|MP:0004941,abnormal regulatory T cell morphology|MP:0005091,increased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010833,abnormal memory T cell morphology
MGI:4365409	Themis<tm1Hasu>	MP:0000715,decreased thymocyte number|MP:0002145,abnormal T cell differentiation|MP:0005348,increased T cell proliferation|MP:0008049,increased memory T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0009339,decreased splenocyte number
MGI:4353254	Themis<tm1Lov>	MP:0002145,abnormal T cell differentiation|MP:0004918,abnormal negative T cell selection|MP:0004974,decreased regulatory T cell number|MP:0008049,increased memory T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number
MGI:1857071	thf	MP:0000407,abnormal duvet hair morphology|MP:0000416,sparse hair|MP:0000427,abnormal hair cycle|MP:0001510,abnormal coat appearance|MP:0002073,abnormal hair growth
MGI:6120731	Thg1l<tm1b(EUCOMM)Wtsi>	MP:0009476,enlarged cecum|MP:0010511,shortened PR interval|MP:0011100,preweaning lethality, complete penetrance
MGI:2152519	Thim<Tg(Myh6-TGFB1)1Ljf>	MP:0000598,abnormal liver morphology|MP:0001954,respiratory distress|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0002750,exophthalmos|MP:0003201,extremity edema|MP:0006062,abnormal vena cava morphology
MGI:3815520	thnh	MP:0000376,folliculitis|MP:0000377,abnormal hair follicle morphology|MP:0000416,sparse hair|MP:0008538,decreased zigzag hair amount
MGI:7435547	Thnsl2<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0002060,abnormal skin morphology|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:6367976	Thoc1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002135,abnormal kidney morphology|MP:0002590,increased mean corpuscular volume|MP:0003917,increased kidney weight|MP:0003961,decreased lean body mass|MP:0005561,increased mean corpuscular hemoglobin|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3512076	Thoc1<tm1Dwg>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0004964,absent inner cell mass|MP:0011093,embryonic lethality at implantation, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3698314	Thoc1<tm2.1Dwg>	MP:0002085,abnormal embryonic tissue morphology|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3698313	Thoc1<tm2Dwg>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001698,decreased embryo size
MGI:7711300	Thoc2<em1Gecz>	MP:0000445,short snout|MP:0000447,flattened snout|MP:0000601,small liver|MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001364,decreased anxiety-related response|MP:0001407,short stride length|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002175,decreased brain weight|MP:0002188,small heart|MP:0002272,abnormal nervous system electrophysiology|MP:0002834,decreased heart weight|MP:0002882,abnormal neuron morphology|MP:0002989,small kidney|MP:0003402,decreased liver weight|MP:0003424,premature neuronal precursor differentiation|MP:0003641,small lung|MP:0003918,decreased kidney weight|MP:0004046,abnormal mitosis|MP:0005404,abnormal axon morphology|MP:0005631,decreased lung weight|MP:0006009,abnormal neuronal migration|MP:0006042,increased apoptosis|MP:0008441,thin cortical plate|MP:0009431,decreased fetal weight|MP:0009538,abnormal synapse morphology|MP:0009936,abnormal dendritic spine morphology|MP:0011104,embryonic lethality before implantation, incomplete penetrance|MP:0012205,abnormal neuronal stem cell self-renewal|MP:0012307,impaired spatial learning|MP:0014241,abnormal intracellular organelle physiology|MP:0014370,impaired spatial working memory|MP:0014558,decreased cortical ventricular zone thickness|MP:0014587,impaired fine motor coordination|MP:0014812,abnormal brain physiology|MP:0031391,increased locomotor activity
MGI:6388620	Thoc3<em1(IMPC)J>	MP:0001727,abnormal embryo implantation|MP:0002718,abnormal inner cell mass morphology|MP:0004738,abnormal auditory brainstem response|MP:0005028,abnormal trophectoderm morphology|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0012111,failure of morula compaction|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:4946268	Thoc5<tm1.1Tate>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4946267	Thoc5<tm1Tate>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0000603,pale liver|MP:0001577,anemia|MP:0002083,premature death|MP:0002401,abnormal lymphopoiesis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0004810,decreased hematopoietic stem cell number|MP:0004953,decreased spleen weight|MP:0008813,decreased common myeloid progenitor cell number|MP:0009278,abnormal bone marrow cell physiology
MGI:7610212	Thoc6<em1Schaf>	MP:0000934,abnormal telencephalon development|MP:0001698,decreased embryo size|MP:0002169,no abnormal phenotype detected|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012705,increased embryonic neuroepithelial cell proliferation|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5755089	Thoc6<em5(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001175,abnormal lung morphology|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001697,abnormal embryo size|MP:0002757,decreased vertical activity|MP:0003984,embryonic growth retardation|MP:0004832,enlarged ovary|MP:0010393,shortened QRS complex duration|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6260024	Thoc7<em1(IMPC)J>	MP:0001727,abnormal embryo implantation|MP:0005344,increased circulating bilirubin level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6449023	Thop1<em1(IMPC)Mbp>	MP:0000221,decreased leukocyte cell number|MP:0001146,abnormal testis morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002989,small kidney
MGI:3877959	Thop1<Gt(CSG163)Byg>	MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0002409,decreased susceptibility to infection|MP:0003179,thrombocytopenia|MP:0003360,abnormal depression-related behavior|MP:0003998,decreased thermal nociceptive threshold|MP:0004000,impaired passive avoidance behavior|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005016,decreased lymphocyte cell number|MP:0005386,behavior/neurological phenotype|MP:0005606,increased bleeding time|MP:0009142,decreased prepulse inhibition|MP:0009786,decreased susceptibility to infection induced morbidity/mortality|MP:0014812,abnormal brain physiology
MGI:5548323	Thpo<tm1.1(KOMP)Vlcg>	MP:0000438,abnormal cranium morphology|MP:0001314,cornea opacity|MP:0002599,increased mean platelet volume|MP:0003179,thrombocytopenia|MP:0005573,increased pulmonary respiratory rate|MP:0005576,decreased pulmonary ventilation|MP:0012125,decreased bronchoconstrictive response
MGI:2662551	Thpo<tm1Mwm>	MP:0002599,increased mean platelet volume|MP:0003179,thrombocytopenia|MP:0005387,immune system phenotype|MP:0008255,decreased megakaryocyte cell number
MGI:5496141	Thpr	MP:0000116,abnormal tooth development|MP:0000120,malocclusion|MP:0000454,abnormal jaw morphology|MP:0001265,decreased body size|MP:0001386,abnormal maternal nurturing|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001516,abnormal motor coordination/balance|MP:0001935,decreased litter size|MP:0003312,abnormal locomotor coordination|MP:0004033,supernumerary teeth|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0009393,abnormal resting posture|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5465006	t<hr4>	MP:0011100,preweaning lethality, complete penetrance
MGI:6272829	Thra<em1Ffla>	MP:0002874,decreased hemoglobin content|MP:0003109,short femur|MP:0003419,delayed endochondral bone ossification|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0005474,increased triiodothyronine level|MP:0008883,abnormal enterocyte proliferation|MP:0009346,decreased trabecular bone thickness
MGI:6272834	Thra<em2Ffla>	MP:0002874,decreased hemoglobin content|MP:0003109,short femur|MP:0003419,delayed endochondral bone ossification|MP:0005390,skeleton phenotype|MP:0005474,increased triiodothyronine level|MP:0008883,abnormal enterocyte proliferation|MP:0009346,decreased trabecular bone thickness
MGI:6272835	Thra<em3Ffla>	MP:0003419,delayed endochondral bone ossification|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype
MGI:6272836	Thra<em4Ffla>	MP:0003419,delayed endochondral bone ossification|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype
MGI:6272837	Thra<em5Ffla>	MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0009346,decreased trabecular bone thickness
MGI:6317007	Thra<em6Ffla>	MP:0000849,abnormal cerebellum morphology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:7522740	Thrap3<tm1c(KOMP)Wtsi>	MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0002942,decreased circulating alanine transaminase level|MP:0004889,increased energy expenditure|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005632,decreased circulating aspartate transaminase level|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level|MP:0010080,abnormal hepatocyte physiology|MP:0010955,abnormal respiratory electron transport chain|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011630,increased mitochondrial size|MP:0011635,abnormal mitochondrial crista morphology|MP:0014046,abnormal mitophagy|MP:0014391,increased hepatocyte mitochondrial DNA content|MP:0030939,abnormal autophagosome formation|MP:0030941,enhanced autophagy|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5304668	Thra<tm1.1Fcas>	MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002710,increased glucagon secretion|MP:0002712,increased circulating glucagon level|MP:0002891,increased insulin sensitivity|MP:0003058,increased insulin secretion|MP:0003564,abnormal insulin secretion|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005477,increased circulating thyroxine level|MP:0005480,increased circulating triiodothyronine level|MP:0005534,decreased body temperature|MP:0005559,increased circulating glucose level|MP:0009172,small pancreatic islets|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011940,decreased food intake
MGI:5614615	Thra<tm1b(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0001469,abnormal contextual conditioning behavior|MP:0001488,increased startle reflex|MP:0001489,decreased startle reflex|MP:0001513,limb grasping|MP:0002574,increased vertical activity|MP:0002608,increased hematocrit|MP:0002764,short tibia|MP:0002968,increased circulating alkaline phosphatase level|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003795,abnormal bone structure|MP:0003921,abnormal heart left ventricle morphology|MP:0005292,improved glucose tolerance|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:2679056	Thra<tm1Brnt>	MP:0000422,delayed hair appearance|MP:0001260,increased body weight|MP:0001921,reduced fertility|MP:0002079,increased circulating insulin level|MP:0003620,oliguria|MP:0003866,abnormal defecation|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005331,insulin resistance|MP:0005333,decreased heart rate|MP:0005477,increased circulating thyroxine level|MP:0005480,increased circulating triiodothyronine level|MP:0005559,increased circulating glucose level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005669,increased circulating leptin level|MP:0008033,impaired lipolysis|MP:0009288,increased epididymal fat pad weight|MP:0010024,increased total body fat amount|MP:0011014,decreased core body temperature|MP:0011049,impaired adaptive thermogenesis|MP:0011091,prenatal lethality, complete penetrance|MP:0011940,decreased food intake
MGI:3758914	Thra<tm1Ffla>	MP:0000060,delayed bone ossification|MP:0000849,abnormal cerebellum morphology|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0001290,delayed eyelid opening|MP:0001393,ataxia|MP:0001629,abnormal heart rate|MP:0001636,irregular heartbeat|MP:0001731,abnormal postnatal growth|MP:0001732,postnatal growth retardation|MP:0001926,female infertility|MP:0002427,disproportionate dwarf|MP:0002626,increased heart rate|MP:0003419,delayed endochondral bone ossification|MP:0004953,decreased spleen weight|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0011049,impaired adaptive thermogenesis|MP:0011086,postnatal lethality, incomplete penetrance
MGI:1860442	Thra<tm1Jas>	MP:0000479,abnormal enterocyte morphology|MP:0000496,abnormal small intestine morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003449,abnormal intestine goblet cell morphology|MP:0003499,thyroid gland hypoplasia|MP:0004696,abnormal thyroid follicle morphology|MP:0005333,decreased heart rate|MP:0005478,decreased circulating thyroxine level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005598,decreased heart ventricle muscle contractility|MP:0008882,abnormal enterocyte physiology|MP:0008883,abnormal enterocyte proliferation|MP:0010392,prolonged QRS complex duration|MP:0013958,decreased small intestine length|MP:0014082,decreased small intestinal villus height
MGI:2387580	Thra<tm1Syc>	MP:0000130,abnormal trabecular bone morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001541,abnormal osteoclast physiology|MP:0001542,abnormal bone strength|MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002188,small heart|MP:0002764,short tibia|MP:0002896,abnormal bone mineralization|MP:0002932,abnormal joint morphology|MP:0002998,abnormal bone remodeling|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003420,delayed intramembranous bone ossification|MP:0003503,decreased activity of thyroid gland|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003795,abnormal bone structure|MP:0003797,abnormal compact bone morphology|MP:0003953,abnormal hormone level|MP:0004148,increased compact bone thickness|MP:0004214,abnormal long bone diaphysis morphology|MP:0004359,short ulna|MP:0004686,decreased length of long bones|MP:0004876,decreased mean systemic arterial blood pressure|MP:0004985,decreased osteoclast cell number|MP:0004993,decreased bone resorption|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005135,increased thyroid-stimulating hormone level|MP:0005474,increased triiodothyronine level|MP:0005480,increased circulating triiodothyronine level|MP:0006398,increased long bone epiphyseal plate size|MP:0006399,abnormal long bone epiphyseal ossification zone morphology|MP:0008151,increased diameter of long bones|MP:0009347,increased trabecular bone thickness|MP:0010122,abnormal bone mineral content|MP:0010123,increased bone mineral content|MP:0010124,decreased bone mineral content|MP:0010743,delayed cranial suture closure|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0010964,increased compact bone volume|MP:0030020,decreased cardiac muscle cell glucose uptake|MP:0030029,wide cranial sutures|MP:0030388,large fontanelles
MGI:1860441	Thra<tm1Ven>	MP:0003233,prolonged QT interval|MP:0003503,decreased activity of thyroid gland|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0005333,decreased heart rate|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0005534,decreased body temperature
MGI:2183135	Thra<tm2Jas>	MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000511,abnormal intestinal mucosa morphology|MP:0000547,short limbs|MP:0000592,short tail|MP:0001262,decreased body weight|MP:0001541,abnormal osteoclast physiology|MP:0001732,postnatal growth retardation|MP:0002764,short tibia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003449,abnormal intestine goblet cell morphology|MP:0003503,decreased activity of thyroid gland|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003795,abnormal bone structure|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004985,decreased osteoclast cell number|MP:0005333,decreased heart rate|MP:0005390,skeleton phenotype|MP:0005422,osteosclerosis|MP:0005478,decreased circulating thyroxine level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005598,decreased heart ventricle muscle contractility|MP:0005605,increased bone mass|MP:0006398,increased long bone epiphyseal plate size|MP:0008882,abnormal enterocyte physiology|MP:0008883,abnormal enterocyte proliferation|MP:0009347,increased trabecular bone thickness|MP:0009780,abnormal chondrocyte physiology|MP:0010392,prolonged QRS complex duration|MP:0014082,decreased small intestinal villus height
MGI:2654864	Thra<tm2Ven>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001384,abnormal pup retrieval|MP:0001541,abnormal osteoclast physiology|MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0002626,increased heart rate|MP:0002876,abnormal thyroid gland physiology|MP:0003502,increased activity of thyroid gland|MP:0003503,decreased activity of thyroid gland|MP:0003797,abnormal compact bone morphology|MP:0003971,abnormal thyroid-stimulating hormone level|MP:0004696,abnormal thyroid follicle morphology|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005377,hearing/vestibular/ear phenotype|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level|MP:0005533,increased body temperature|MP:0009006,prolonged estrous cycle|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010968,decreased compact bone area|MP:0011090,perinatal lethality, incomplete penetrance|MP:0013618,decreased areal bone mineral density
MGI:2670368	Thra<tm3Jas>	MP:0003449,abnormal intestine goblet cell morphology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008882,abnormal enterocyte physiology|MP:0008883,abnormal enterocyte proliferation
MGI:3603303	Thra<tm3Ven>	MP:0000807,abnormal hippocampus morphology|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0001262,decreased body weight|MP:0001363,increased anxiety-related response|MP:0001458,abnormal object recognition memory|MP:0001731,abnormal postnatal growth|MP:0003312,abnormal locomotor coordination|MP:0011085,postnatal lethality, complete penetrance
MGI:4847930	Thra<tm4.1Ven>	MP:0003402,decreased liver weight|MP:0005480,increased circulating triiodothyronine level
MGI:2137592	Thrb<tm1.1Syc>	MP:0000031,abnormal cochlea morphology|MP:0000042,abnormal organ of Corti morphology|MP:0000043,organ of Corti degeneration|MP:0000081,premature cranial suture closure|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000438,abnormal cranium morphology|MP:0000636,enlarged pituitary gland|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001399,hyperactivity|MP:0001732,postnatal growth retardation|MP:0002041,increased pituitary adenoma incidence|MP:0002083,premature death|MP:0002109,abnormal limb morphology|MP:0002113,abnormal skeleton development|MP:0002757,decreased vertical activity|MP:0002764,short tibia|MP:0002896,abnormal bone mineralization|MP:0003109,short femur|MP:0003149,abnormal tectorial membrane morphology|MP:0003150,detached tectorial membrane|MP:0003417,premature endochondral bone ossification|MP:0003418,premature intramembranous bone ossification|MP:0003498,thyroid gland hyperplasia|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003965,abnormal pituitary hormone level|MP:0004197,abnormal fetal growth/weight/body size|MP:0004362,cochlear hair cell degeneration|MP:0004591,enlarged tectorial membrane|MP:0004696,abnormal thyroid follicle morphology|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005355,enlarged thyroid gland|MP:0005377,hearing/vestibular/ear phenotype|MP:0005418,abnormal circulating hormone level|MP:0005468,abnormal thyroid hormone level|MP:0005477,increased circulating thyroxine level|MP:0005480,increased circulating triiodothyronine level|MP:0005646,abnormal pituitary gland physiology|MP:0006325,impaired hearing|MP:0006395,abnormal epiphyseal plate morphology|MP:0008337,increased thyrotroph cell number|MP:0010346,increased thyroid carcinoma incidence|MP:0011617,abnormal habituation|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012315,impaired learning|MP:0020169,increased thyroid gland weight|MP:0030018,increased cardiac muscle cell glucose uptake|MP:0030389,small fontanelles
MGI:1860434	Thrb<tm1Df>	MP:0000042,abnormal organ of Corti morphology|MP:0001496,audiogenic seizures|MP:0001967,deafness|MP:0003498,thyroid gland hyperplasia|MP:0003502,increased activity of thyroid gland|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004414,decreased cochlear microphonics|MP:0004415,abnormal cochlear nerve compound action potential|MP:0004433,abnormal cochlear inner hair cell physiology|MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004437,decreased cochlear outer hair cell electromotility|MP:0004466,short cochlear outer hair cells|MP:0004591,enlarged tectorial membrane|MP:0004664,delayed inner ear development|MP:0004696,abnormal thyroid follicle morphology|MP:0005135,increased thyroid-stimulating hormone level|MP:0005355,enlarged thyroid gland|MP:0005386,behavior/neurological phenotype|MP:0005477,increased circulating thyroxine level|MP:0005478,decreased circulating thyroxine level|MP:0005480,increased circulating triiodothyronine level|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014091,abnormal tectorial membrane striated-sheet matrix morphology|MP:0014406,increased or absent distortion product otoacoustic emission threshold
MGI:5784668	Thrb<tm1Ehs>	MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0005376,homeostasis/metabolism phenotype|MP:0011270,decreased excitatory postsynaptic current amplitude
MGI:1860353	Thrb<tm1Few>	MP:0002876,abnormal thyroid gland physiology|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005377,hearing/vestibular/ear phenotype|MP:0005470,increased thyroxine level|MP:0005474,increased triiodothyronine level
MGI:3836780	Thrb<tm1Mkni>	MP:0003350,increased circulating levels of thyroid hormone|MP:0005119,decreased circulating thyroid-stimulating hormone level|MP:0005378,growth/size/body region phenotype|MP:0005468,abnormal thyroid hormone level|MP:0005470,increased thyroxine level|MP:0005477,increased circulating thyroxine level|MP:0020168,decreased thyroid gland weight
MGI:1860407	Thrb<tm1Olc>	MP:0000066,osteoporosis|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000547,short limbs|MP:0000592,short tail|MP:0001262,decreased body weight|MP:0001541,abnormal osteoclast physiology|MP:0002626,increased heart rate|MP:0002764,short tibia|MP:0002896,abnormal bone mineralization|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003417,premature endochondral bone ossification|MP:0003498,thyroid gland hyperplasia|MP:0003502,increased activity of thyroid gland|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003795,abnormal bone structure|MP:0004148,increased compact bone thickness|MP:0004696,abnormal thyroid follicle morphology|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004984,increased osteoclast cell number|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0005477,increased circulating thyroxine level|MP:0005480,increased circulating triiodothyronine level|MP:0006396,decreased long bone epiphyseal plate size|MP:0009346,decreased trabecular bone thickness|MP:0009780,abnormal chondrocyte physiology|MP:0030389,small fontanelles
MGI:4432802	Thrb<tm2a(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0002874,decreased hemoglobin content|MP:0003442,decreased circulating glycerol level
MGI:2657173	Thrb<tm2Df>	MP:0001006,abnormal retina cone cell morphology|MP:0004022,abnormal cone electrophysiology|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005377,hearing/vestibular/ear phenotype|MP:0005480,increased circulating triiodothyronine level
MGI:2183367	Thrb<tm2Few>	MP:0000852,small cerebellum|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0000890,thin cerebellar molecular layer|MP:0001463,abnormal spatial learning|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005470,increased thyroxine level|MP:0005474,increased triiodothyronine level
MGI:5701356	Thrb<tm3.1Df>	MP:0003638,abnormal response/metabolism to endogenous compounds
MGI:2676923	Thrb<tm3Few>	MP:0000031,abnormal cochlea morphology|MP:0001006,abnormal retina cone cell morphology|MP:0003502,increased activity of thyroid gland|MP:0003825,abnormal pillar cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004591,enlarged tectorial membrane|MP:0004740,sensorineural hearing loss|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005355,enlarged thyroid gland|MP:0005477,increased circulating thyroxine level|MP:0005480,increased circulating triiodothyronine level|MP:0005646,abnormal pituitary gland physiology|MP:0008337,increased thyrotroph cell number|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014406,increased or absent distortion product otoacoustic emission threshold
MGI:2676951	Thrb<tm4Few>	MP:0000031,abnormal cochlea morphology|MP:0001006,abnormal retina cone cell morphology|MP:0003149,abnormal tectorial membrane morphology|MP:0003825,abnormal pillar cell morphology|MP:0004402,decreased cochlear outer hair cell number|MP:0004465,degeneration of organ of Corti supporting cells|MP:0004591,enlarged tectorial membrane|MP:0004737,absent distortion product otoacoustic emissions|MP:0004740,sensorineural hearing loss|MP:0004864,spiral ligament degeneration|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005355,enlarged thyroid gland|MP:0005646,abnormal pituitary gland physiology|MP:0008337,increased thyrotroph cell number|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014406,increased or absent distortion product otoacoustic emission threshold
MGI:3603187	Thrb<tm5Few>	MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005477,increased circulating thyroxine level|MP:0005480,increased circulating triiodothyronine level|MP:0020169,increased thyroid gland weight
MGI:3849878	Thrb<tm6.1Few>	MP:0001262,decreased body weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005477,increased circulating thyroxine level|MP:0005480,increased circulating triiodothyronine level
MGI:2387689	Thrsp<tm1Cnm>	MP:0001882,abnormal lactation|MP:0002118,abnormal lipid homeostasis|MP:0004047,abnormal milk composition|MP:0005318,decreased triglyceride level
MGI:5505900	Thsd1<tm1.1(KOMP)Vlcg>	MP:0001489,decreased startle reflex|MP:0002590,increased mean corpuscular volume|MP:0005561,increased mean corpuscular hemoglobin
MGI:6164038	Thsd4<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0005655,increased aggression
MGI:7618765	Thsd4<tm1.2Lysa>	MP:0000272,abnormal aorta morphology|MP:0009865,abnormal aorta smooth muscle morphology|MP:0010470,dilated ascending aorta|MP:0010473,descending aorta dilation|MP:0010482,abnormal aortic sinus morphology|MP:0010574,dilated aorta|MP:0010575,aortic arch dilation|MP:0010768,mortality/aging
MGI:5635392	Thsd7a<tm1b(KOMP)Mbp>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0003961,decreased lean body mass|MP:0010124,decreased bone mineral content
MGI:6336139	Thsd7b<em1(IMPC)Kmpc>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0001552,increased circulating triglyceride level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1861169	Tht	MP:0000585,kinked tail|MP:0000588,thick tail|MP:0000592,short tail
MGI:8252972	Th<tm1.1Ehess>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0003491,abnormal voluntary movement|MP:0003631,nervous system phenotype|MP:0005156,bradykinesia|MP:0005323,dystonia|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009538,abnormal synapse morphology|MP:0010069,increased serotonin level|MP:0012574,decreased noradrenaline level|MP:0020875,decreased nervous system dopamine level
MGI:5305343	Th<tm1.1Ich>	MP:0005643,decreased dopamine level
MGI:3795871	Th<tm1(cre/Esr1)Nat>	MP:0002169,no abnormal phenotype detected
MGI:3056580	Th<tm1(cre)Te>	MP:0002169,no abnormal phenotype detected
MGI:3665325	Th<tm1Gfng>	MP:0002169,no abnormal phenotype detected|MP:0011091,prenatal lethality, complete penetrance
MGI:1860450	Th<tm1Rpa>	MP:0000255,blood vessel congestion|MP:0000746,weakness|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001516,abnormal motor coordination/balance|MP:0003105,abnormal heart atrium morphology|MP:0003140,dilated heart atrium|MP:0005333,decreased heart rate|MP:0010019,liver vascular congestion|MP:0011085,postnatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0031613,fetal cardiomyocyte disarray|MP:0031614,fetal cardiomyocyte vacuoles
MGI:1860480	Th<tm1Srt>	MP:0000267,abnormal heart development|MP:0000279,ventricular hypoplasia|MP:0001265,decreased body size|MP:0003105,abnormal heart atrium morphology|MP:0003140,dilated heart atrium|MP:0003962,abnormal adrenaline level|MP:0003964,abnormal noradrenaline level|MP:0005643,decreased dopamine level|MP:0010017,visceral vascular congestion|MP:0010021,heart vascular congestion|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:1860453	Th<tm1Tna>	MP:0001177,atelectasis|MP:0001454,abnormal cued conditioning behavior|MP:0001953,respiratory failure|MP:0002062,abnormal associative learning|MP:0002063,abnormal learning/memory/conditioning|MP:0002316,anoxia|MP:0002798,abnormal active avoidance behavior|MP:0002805,abnormal conditioned taste aversion behavior|MP:0003897,abnormal ST segment|MP:0003962,abnormal adrenaline level|MP:0003964,abnormal noradrenaline level|MP:0005333,decreased heart rate|MP:0005643,decreased dopamine level|MP:0011087,neonatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:2181959	Th<tm2Rpa>	MP:0000255,blood vessel congestion|MP:0000746,weakness|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001516,abnormal motor coordination/balance|MP:0003105,abnormal heart atrium morphology|MP:0003140,dilated heart atrium|MP:0005333,decreased heart rate|MP:0010019,liver vascular congestion|MP:0011085,postnatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0031613,fetal cardiomyocyte disarray|MP:0031614,fetal cardiomyocyte vacuoles
MGI:3487230	Th<tm2Te>	MP:0001265,decreased body size|MP:0005156,bradykinesia|MP:0005643,decreased dopamine level|MP:0010069,increased serotonin level|MP:0012574,decreased noradrenaline level
MGI:5431878	Th<tm4.1Rpa>	MP:0002090,abnormal vision|MP:0005253,abnormal eye physiology|MP:0005551,abnormal eye electrophysiology|MP:0005643,decreased dopamine level
MGI:3527166	Th<tm5Rpa>	MP:0011091,prenatal lethality, complete penetrance
MGI:7435548	Thtpa<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0002792,abnormal retina vasculature morphology|MP:0009142,decreased prepulse inhibition|MP:0010097,abnormal retina blood vessel morphology
MGI:8209553	Thumpd1<em1Meij>	MP:0001125,abnormal oocyte morphology|MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001265,decreased body size|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002680,decreased corpora lutea number|MP:0003205,testicular atrophy|MP:0003631,nervous system phenotype|MP:0004833,ovary atrophy|MP:0005431,decreased oocyte number|MP:0006362,abnormal male germ cell morphology|MP:0008871,abnormal ovarian follicle number|MP:0011101,prenatal lethality, incomplete penetrance|MP:0014052,increased male germ cell apoptosis
MGI:3526563	Thy1<tm1Kak>	MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype
MGI:3586862	Thy1<tm1Rjmo>	MP:0001473,reduced long-term potentiation|MP:0006050,pulmonary fibrosis
MGI:3042406	Thyls2<BALB/c>	MP:0004503,decreased incidence of tumors by ionizing radiation induction
MGI:3042407	Thyls2<MSM>	MP:0002024,increased T cell derived lymphoma incidence
MGI:6343245	Thyn1<tm1.2Osb>	MP:0002169,no abnormal phenotype detected
MGI:2447032	Thypr1<DBA/2J>	MP:0005348,increased T cell proliferation
MGI:2447028	Thypr2<DBA/2J>	MP:0005348,increased T cell proliferation
MGI:1856635	ti	MP:0001406,abnormal gait|MP:0001516,abnormal motor coordination/balance|MP:0001523,impaired righting response|MP:0001524,impaired limb coordination|MP:0001525,impaired balance|MP:0005377,hearing/vestibular/ear phenotype|MP:0005389,reproductive system phenotype|MP:0008913,weaving
MGI:3037091	Tia1<tm1Andp>	MP:0002451,abnormal macrophage physiology|MP:0002993,autoimmune arthritis|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008735,increased susceptibility to endotoxin shock|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5708174	Tial1<tm1b(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0002644,decreased circulating triglyceride level|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005505,thrombocytosis|MP:0010025,decreased total body fat amount
MGI:2660803	Tial1<tm1Mst>	MP:0001127,small ovary|MP:0001128,ovary hyperplasia|MP:0001147,small testis|MP:0001698,decreased embryo size|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002777,absent ovarian follicles|MP:0008392,decreased primordial germ cell number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3880733	Tiam1<Gt(CSJ260)Byg>	MP:0000783,abnormal forebrain morphology|MP:0000830,abnormal diencephalon morphology|MP:0000914,exencephaly|MP:0001890,anencephaly
MGI:5790637	Tiam1<tm1b(EUCOMM)Hmgu>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0011962,increased cornea thickness
MGI:2183309	Tiam1<tm1Jgc>	MP:0000352,decreased cell proliferation|MP:0001648,abnormal apoptosis|MP:0002018,increased malignant tumor incidence|MP:0004207,increased squamous cell carcinoma incidence|MP:0004502,decreased incidence of tumors by chemical induction
MGI:2679794	Ticam1<Lps2>	MP:0000219,increased neutrophil cell number|MP:0001182,lung hemorrhage|MP:0001952,increased airway responsiveness|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002297,abnormal forced expiratory flow rates|MP:0002327,abnormal respiratory function|MP:0002411,decreased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0003009,abnormal cytokine secretion|MP:0003631,nervous system phenotype|MP:0005166,decreased susceptibility to injury|MP:0005387,immune system phenotype|MP:0005425,increased macrophage cell number|MP:0006071,abnormal retina progenitor cell morphology|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008524,increased plasmacytoid dendritic cell number|MP:0008539,decreased susceptibility to induced colitis|MP:0008552,abnormal circulating tumor necrosis factor level|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008564,increased interferon-beta secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008721,abnormal chemokine level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008882,abnormal enterocyte physiology|MP:0011077,decreased macrophage nitric oxide production|MP:0011079,decreased macrophage cytokine production|MP:0011081,decreased macrophage apoptosis|MP:0013022,increased Ly6C high monocyte number|MP:0013026,decreased Ly6C low monocyte number|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031048,increased susceptibility to Coronaviridae infection induced morbidity/mortality|MP:0031266,decreased susceptibility to alcohol-induced hepatic steatosis
MGI:5789548	Ticam1<M2Btlr>	MP:0002451,abnormal macrophage physiology|MP:0003009,abnormal cytokine secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0011079,decreased macrophage cytokine production
MGI:6114756	Ticam1<M3Btlr>	MP:0008561,decreased tumor necrosis factor secretion
MGI:3029019	Ticam1<tm1Aki>	MP:0001798,impaired macrophage phagocytosis|MP:0001805,decreased IgG level|MP:0001856,myocarditis|MP:0002376,abnormal dendritic cell physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002459,abnormal B cell physiology|MP:0003009,abnormal cytokine secretion|MP:0003691,abnormal microglial cell physiology|MP:0005025,abnormal response to infection|MP:0005166,decreased susceptibility to injury|MP:0005387,immune system phenotype|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0008042,abnormal NK T cell physiology|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008217,abnormal B cell activation|MP:0008496,decreased IgG2a level|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008565,decreased interferon-beta secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0008597,decreased circulating interleukin-6 level|MP:0008648,decreased circulating interleukin-12b level|MP:0008670,decreased interleukin-12b secretion|MP:0008713,abnormal cytokine level|MP:0008719,impaired neutrophil recruitment|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008751,abnormal interleukin level|MP:0009335,decreased splenocyte proliferation|MP:0010181,decreased susceptibility to weight loss|MP:0010766,abnormal NK cell physiology|MP:0011079,decreased macrophage cytokine production|MP:0020927,abnormal susceptibility to Poxviridae infection|MP:0020937,increased susceptibility to Picornaviridae infection|MP:0020947,decreased susceptibility to Orthomyxoviridae infection|MP:0031040,increased susceptibility to Picornaviridae infection induced morbidity/mortality
MGI:3701472	Ticam1<tm1Tsse>	MP:0003721,increased tumor growth/size|MP:0005070,impaired natural killer cell mediated cytotoxicity
MGI:5604364	Ticam2<M1Btlr>	MP:0008561,decreased tumor necrosis factor secretion
MGI:6113627	Ticam2<M2Btlr>	MP:0008658,decreased interleukin-1 beta secretion
MGI:6113633	Ticam2<M3Btlr>	MP:0008561,decreased tumor necrosis factor secretion
MGI:3040182	Ticam2<tm1Aki>	MP:0001790,abnormal immune system physiology|MP:0008706,decreased interleukin-6 secretion|MP:0020949,increased susceptibility to Coronaviridae infection
MGI:3722129	Ticam2<tm1Btlr>	MP:0008555,abnormal interferon secretion|MP:0008561,decreased tumor necrosis factor secretion
MGI:6467486	Ticrr<em1(IMPC)Bay>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012129,failure of blastocyst formation
MGI:5563404	Ticrr<m1Anu>	MP:0003815,hairless
MGI:5440921	tictac	MP:0001410,head bobbing
MGI:4441288	Tie1<tm1.1Scba>	MP:0001785,edema|MP:0001879,abnormal lymphatic vessel morphology|MP:0001914,hemorrhage|MP:0004106,lymphatic vessel hyperplasia|MP:0004938,dilated vasculature|MP:0008778,abnormal lymphangiogenesis|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5544797	Tie1<tm1.1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:4454546	Tie1<tm1Geno>	MP:0001785,edema|MP:0005385,cardiovascular system phenotype|MP:0008778,abnormal lymphangiogenesis
MGI:2159370	Tie1<tm1Jpa>	MP:0001785,edema|MP:0001914,hemorrhage|MP:0005385,cardiovascular system phenotype|MP:0008778,abnormal lymphangiogenesis|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2159359	Tie1<tm1Sato>	MP:0000496,abnormal small intestine morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001786,skin edema|MP:0001914,hemorrhage|MP:0001953,respiratory failure|MP:0002188,small heart|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003105,abnormal heart atrium morphology|MP:0003227,abnormal vascular branching morphogenesis|MP:0003288,intestinal edema|MP:0003542,abnormal vascular endothelial cell development|MP:0003828,pulmonary edema|MP:0003974,abnormal endocardium morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0006055,abnormal vascular endothelial cell morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4441286	Tie1<tm1Scba>	MP:0001785,edema|MP:0001879,abnormal lymphatic vessel morphology|MP:0001914,hemorrhage|MP:0002082,postnatal lethality|MP:0003659,abnormal lymph circulation|MP:0004106,lymphatic vessel hyperplasia|MP:0005385,cardiovascular system phenotype|MP:0008778,abnormal lymphangiogenesis|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5546198	Tie1<tm2Vlcg>	MP:0001785,edema
MGI:6404191	Tifab<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0003960,increased lean body mass
MGI:5911664	Tifab<tm1.1Dsta>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000691,enlarged spleen|MP:0002083,premature death|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0005016,decreased lymphocyte cell number|MP:0005065,abnormal neutrophil morphology|MP:0011182,decreased hematopoietic cell number|MP:0011903,decreased hematopoietic stem cell proliferation
MGI:4391656	Tigar<Gt(EUCE0047g05)Hmgu>	MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0003674,oxidative stress|MP:0008402,increased cellular sensitivity to alkylating agent induced cell death|MP:0008537,increased susceptibility to induced colitis|MP:0008800,increased small intestinal crypt cell apoptosis|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010156,abnormal small intestinal crypt cell physiology|MP:0010157,abnormal small intestinal crypt cell proliferation
MGI:5522697	Tigar<tm1.1Khv>	MP:0008537,increased susceptibility to induced colitis
MGI:6393533	Tigd3<em1(IMPC)J>	MP:0002941,increased circulating alanine transaminase level|MP:0005293,impaired glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0010052,increased grip strength
MGI:6406775	Tigit<tm1.1(IMPC)Wtsi>	MP:0001554,increased circulating free fatty acids level|MP:0005628,decreased circulating potassium level
MGI:4939784	Tigit<tm1Sdl>	MP:0002006,neoplasm|MP:0002452,abnormal professional antigen presenting cell physiology|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0008661,decreased interleukin-10 secretion|MP:0010768,mortality/aging
MGI:3713355	Tilss1<DBA/2NCrl>	MP:0003638,abnormal response/metabolism to endogenous compounds
MGI:3713357	Tilss3<DBA/2NCrl>	MP:0003638,abnormal response/metabolism to endogenous compounds
MGI:3723608	Timd2<tm1(GAL4)Pdre>	MP:0001845,abnormal inflammatory response|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion
MGI:4459812	Timd4<tm1Kuch>	MP:0002451,abnormal macrophage physiology|MP:0002459,abnormal B cell physiology|MP:0002495,increased IgA level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008566,increased interferon-gamma secretion|MP:0008681,increased interleukin-17 secretion|MP:0009336,increased splenocyte proliferation
MGI:5438219	Timd4<tm1Osa>	MP:0001798,impaired macrophage phagocytosis|MP:0005387,immune system phenotype
MGI:4459454	Timd4<tm1Wouy>	MP:0000218,increased leukocyte cell number|MP:0001798,impaired macrophage phagocytosis|MP:0002451,abnormal macrophage physiology|MP:0005013,increased lymphocyte cell number|MP:0008500,increased IgG2a level|MP:0008560,increased tumor necrosis factor secretion|MP:0008561,decreased tumor necrosis factor secretion
MGI:5637177	Timd6<tm1b(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0001512,trunk curl|MP:0004952,increased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:5692606	Timeless<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance
MGI:3051143	Timeless<tm1Rep>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5705871	Timm10b<tm1.1(KOMP)Vlcg>	MP:0002968,increased circulating alkaline phosphatase level
MGI:6257582	Timm13<em1(IMPC)Tcp>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000709,enlarged thymus|MP:0002059,abnormal seminal vesicle morphology|MP:0002637,small uterus|MP:0003068,enlarged kidney|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0020420,abnormal freezing behavior
MGI:7343917	Timm17b<em1(IMPC)J>	MP:0000198,decreased circulating phosphate level|MP:0005505,thrombocytosis|MP:0005635,decreased circulating bilirubin level
MGI:5529629	Timm22<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0005633,increased circulating sodium level|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014586,decreased egg cylinder size
MGI:3848025	Timm23<Gt(W023C08)Wrst>	MP:0000160,kyphosis|MP:0000414,alopecia|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0003786,premature aging|MP:0010053,decreased grip strength|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:7708059	Timm44<em1(IMPC)Mbp>	MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level|MP:0020421,increased freezing behavior
MGI:6369400	Timm50<em1Ywxu>	MP:0004485,increased response of heart to induced stress
MGI:5548523	Timm50<tm1b(EUCOMM)Wtsi>	MP:0000062,increased bone mineral density|MP:0001258,decreased body length|MP:0002941,increased circulating alanine transaminase level|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6156465	Timm8a1<em1(IMPC)Tcp>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005344,increased circulating bilirubin level|MP:0005565,increased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0010067,increased red blood cell distribution width
MGI:8172653	Timm8a1<em1Yfhu>	MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001973,increased thermal nociceptive threshold|MP:0003631,nervous system phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0006325,impaired hearing|MP:0008432,abnormal long-term spatial reference memory|MP:0008489,slow postnatal weight gain|MP:0011635,abnormal mitochondrial crista morphology|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012307,impaired spatial learning
MGI:7608260	Timm8a2<em1(IMPC)Bay>	MP:0000745,tremors|MP:0001392,abnormal locomotor behavior|MP:0001410,head bobbing
MGI:4307855	Timmdc1<Gt(OST407011)Lex>	MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:5637083	Timmdc1<tm1b(EUCOMM)Wtsi>	MP:0001510,abnormal coat appearance|MP:0002836,abnormal chorion morphology|MP:0002941,increased circulating alanine transaminase level|MP:0005031,abnormal trophoblast layer morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:3766100	Timo	MP:0000182,increased circulating LDL cholesterol level|MP:0001257,increased body length|MP:0001261,obese|MP:0001353,increased aggression towards mice|MP:0001433,polyphagia|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0003960,increased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005334,abnormal fat pad morphology|MP:0005458,increased percent body fat/body weight|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0009298,increased mesenteric fat pad weight|MP:0009302,increased renal fat pad weight|MP:0009306,increased uterine fat pad weight|MP:0010024,increased total body fat amount
MGI:5637221	Timp1<tm1b(EUCOMM)Hmgu>	MP:0000559,abnormal femur morphology|MP:0005296,abnormal humerus morphology
MGI:3512125	Timp1<tm1Pds>	MP:0000219,increased neutrophil cell number|MP:0000230,abnormal systemic arterial blood pressure|MP:0000333,decreased bone marrow cell number|MP:0000343,abnormal response to cardiac infarction|MP:0001182,lung hemorrhage|MP:0001263,weight loss|MP:0001861,lung inflammation|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002006,neoplasm|MP:0002411,decreased susceptibility to bacterial infection|MP:0002781,increased circulating testosterone level|MP:0003070,increased vascular permeability|MP:0003572,abnormal uterus development|MP:0003819,increased left ventricle diastolic pressure|MP:0004851,increased testis weight|MP:0004904,increased uterus weight|MP:0005182,increased circulating estradiol level|MP:0005185,decreased circulating progesterone level|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0006278,aortic aneurysm|MP:0009009,absent estrous cycle|MP:0009014,prolonged proestrus|MP:0009016,abnormal estrus|MP:0009018,short estrus|MP:0009021,absent estrus|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0013400,abnormal endometrial gland development
MGI:6276911	Timp2<em1(IMPC)Hmgu>	MP:0000556,abnormal hindlimb morphology|MP:0001486,abnormal startle reflex|MP:0003604,single kidney|MP:0008173,increased follicular B cell number|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:1888709	Timp2<tm1Jjc>	MP:0001454,abnormal cued conditioning behavior|MP:0002169,no abnormal phenotype detected|MP:0003088,abnormal prepulse inhibition|MP:0005319,abnormal enzyme/coenzyme level
MGI:1888708	Timp2<tm1Pds>	MP:0000219,increased neutrophil cell number|MP:0001454,abnormal cued conditioning behavior|MP:0005385,cardiovascular system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009142,decreased prepulse inhibition
MGI:5445932	Timp3<tm1.1(KOMP)Vlcg>	MP:0001325,abnormal retina morphology|MP:0002590,increased mean corpuscular volume|MP:0010097,abnormal retina blood vessel morphology
MGI:3797605	Timp3<tm1Hest>	MP:0003227,abnormal vascular branching morphogenesis|MP:0006237,abnormal choroid vasculature morphology
MGI:4398972	Timp3<tm1Osya>	MP:0000230,abnormal systemic arterial blood pressure|MP:0000249,abnormal blood vessel physiology|MP:0000272,abnormal aorta morphology|MP:0000519,hydronephrosis|MP:0001463,abnormal spatial learning|MP:0002063,abnormal learning/memory/conditioning|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002191,abnormal artery morphology|MP:0002843,decreased systemic arterial blood pressure|MP:0003068,enlarged kidney|MP:0005165,increased susceptibility to injury|MP:0005289,increased oxygen consumption|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005533,increased body temperature|MP:0005591,decreased vasodilation|MP:0006083,abnormal blood vessel elastic tissue morphology|MP:0008963,increased carbon dioxide production|MP:0009866,abnormal aorta wall morphology|MP:0009870,abnormal abdominal aorta morphology|MP:0010139,aortitis|MP:0010659,abdominal aorta aneurysm|MP:0020523,decreased susceptibility to induced hypothermia
MGI:2387409	Timp3<tm1Rkho>	MP:0000266,abnormal heart morphology|MP:0000420,ruffled hair|MP:0001183,overexpanded pulmonary alveolus|MP:0001262,decreased body weight|MP:0001505,hunched posture|MP:0001625,cardiac hypertrophy|MP:0001648,abnormal apoptosis|MP:0001654,hepatic necrosis|MP:0001860,liver inflammation|MP:0001882,abnormal lactation|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002133,abnormal respiratory system physiology|MP:0002267,abnormal bronchiole morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0003822,decreased left ventricle systolic pressure|MP:0003824,decreased left ventricle developed pressure|MP:0003828,pulmonary edema|MP:0003887,increased hepatocyte apoptosis|MP:0003921,abnormal heart left ventricle morphology|MP:0004084,abnormal cardiac muscle relaxation|MP:0004485,increased response of heart to induced stress|MP:0005140,decreased cardiac muscle contractility|MP:0005202,lethargy|MP:0005367,renal/urinary system phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005384,cellular phenotype|MP:0005388,respiratory system phenotype|MP:0005517,impaired liver regeneration|MP:0005598,decreased heart ventricle muscle contractility|MP:0006026,dilated terminal bronchiole tube|MP:0006027,impaired lung alveolus development|MP:0006138,congestive heart failure|MP:0006271,abnormal involution of the mammary gland|MP:0008560,increased tumor necrosis factor secretion|MP:0008987,abnormal liver lobule morphology|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010768,mortality/aging|MP:0011031,abnormal branching involved in terminal bronchiole morphogenesis|MP:0014474,decreased pulmonary alveolus wall thickness
MGI:2183790	Timp3<tm1Web>	MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology
MGI:6276973	Timp4<em1(IMPC)Mbp>	MP:0000692,small spleen|MP:0001333,absent optic nerve|MP:0001488,increased startle reflex|MP:0002060,abnormal skin morphology|MP:0002989,small kidney|MP:0020421,increased freezing behavior
MGI:5576463	Timp4<tm1Lex>	MP:0005385,cardiovascular system phenotype
MGI:3663251	Timp4<tm1Vuo>	MP:0000343,abnormal response to cardiac infarction|MP:0003023,decreased coronary flow rate|MP:0003915,increased heart left ventricle weight|MP:0003920,abnormal heart right ventricle morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:1856636	Tim<T(4;17)3Lws>	MP:0001314,cornea opacity|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001522,impaired swimming|MP:0001524,impaired limb coordination|MP:0001921,reduced fertility|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003237,abnormal lens epithelium morphology|MP:0005307,head tossing|MP:0006226,iris hypoplasia|MP:0006325,impaired hearing|MP:0010252,anterior subcapsular cataract|MP:0010768,mortality/aging|MP:0013743,ciliary body hypoplasia
MGI:6153214	Tinagl1<tm1.1Maru>	MP:0001923,reduced female fertility|MP:0005389,reproductive system phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:7426027	Tincr<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002339,abnormal lymph node morphology|MP:0005599,increased cardiac muscle contractility
MGI:7548522	Tincr<em1Kei>	MP:0001792,impaired wound healing|MP:0005501,abnormal skin physiology|MP:0009584,decreased keratinocyte proliferation
MGI:3052712	Tinf2<tm1Yjc>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5556226	Tinf2<tm2.1Tdl>	MP:0001262,decreased body weight|MP:0002169,no abnormal phenotype detected|MP:0009703,decreased birth body size|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5556393	Tinf2<tm2.2Tdl>	MP:0000688,lymphoid hyperplasia|MP:0001154,seminiferous tubule degeneration|MP:0001194,dermatitis|MP:0001891,hydrocephaly|MP:0001921,reduced fertility|MP:0002064,seizures|MP:0002183,gliosis|MP:0003205,testicular atrophy|MP:0005152,pancytopenia|MP:0010373,myeloid hyperplasia|MP:0011092,embryonic lethality, complete penetrance|MP:0030927,decreased telomere length
MGI:1856637	tip	MP:0000852,small cerebellum|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0001523,impaired righting response|MP:0003631,nervous system phenotype|MP:0003684,abnormal inferior olivary complex morphology|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0006219,optic nerve degeneration|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008911,induced hyperactivity|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013159,Purkinje cell axonal dystrophy|MP:0014329,abnormal Purkinje cell axon morphology|MP:0014331,abnormal Purkinje cell mitochondrial morphology
MGI:3526866	Tiparp<Gt(ROSA)79Sor>	MP:0000074,abnormal neurocranium morphology|MP:0000091,short premaxilla|MP:0000097,short maxilla|MP:0000107,abnormal frontal bone morphology|MP:0000157,abnormal sternum morphology|MP:0000208,decreased hematocrit|MP:0000445,short snout|MP:0000599,enlarged liver|MP:0000767,abnormal smooth muscle morphology|MP:0001577,anemia|MP:0001614,abnormal blood vessel morphology|MP:0001824,abnormal thymus involution|MP:0001859,kidney inflammation|MP:0001914,hemorrhage|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002082,postnatal lethality|MP:0002135,abnormal kidney morphology|MP:0002293,long gestation period|MP:0002628,hepatic steatosis|MP:0002640,reticulocytosis|MP:0002681,increased corpora lutea number|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0002989,small kidney|MP:0003103,liver degeneration|MP:0003755,abnormal palate morphology|MP:0004471,short nasal bone|MP:0004832,enlarged ovary|MP:0004906,enlarged uterus|MP:0004969,pale kidney|MP:0005097,polychromatophilia|MP:0005181,decreased circulating estradiol level|MP:0005325,abnormal renal glomerulus morphology|MP:0005508,abnormal skeleton morphology|MP:0005565,increased blood urea nitrogen level|MP:0008146,asymmetric sternocostal joints|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009006,prolonged estrous cycle|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0009895,decreased palatine bone horizontal plate size|MP:0010180,increased susceptibility to weight loss|MP:0011128,increased tertiary ovarian follicle number|MP:0013278,decreased fasting circulating glucose level|MP:0014604,hemorrhagic ovary cyst|MP:0030189,broad snout|MP:0030383,small presphenoid bone
MGI:5696921	Tiparp<tm1b(EUCOMM)Wtsi>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001192,scaly skin|MP:0002060,abnormal skin morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5698469	Tiprl<tm1.1(KOMP)Vlcg>	MP:0001486,abnormal startle reflex|MP:0003232,abnormal forebrain development|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0020870,decreased thigmotaxis
MGI:2680961	Tir10<C57BL/6>	MP:0005027,increased susceptibility to parasitic infection
MGI:3042256	Tir2<C57BL/6JOlaHsd>	MP:0005026,decreased susceptibility to parasitic infection
MGI:3036509	Tir3<C57BL/6JOlaHsd>	MP:0005026,decreased susceptibility to parasitic infection
MGI:2445530	Tir4<C57BL/6JOlaHsd>	MP:0005026,decreased susceptibility to parasitic infection
MGI:2680959	Tir9<C57BL/6>	MP:0005027,increased susceptibility to parasitic infection
MGI:3774113	Tirap<m1Btlr>	MP:0008555,abnormal interferon secretion|MP:0008561,decreased tumor necrosis factor secretion
MGI:3654146	Tirap<tm1Aki>	MP:0002376,abnormal dendritic cell physiology|MP:0003009,abnormal cytokine secretion|MP:0005042,abnormal level of surface class II molecules|MP:0008498,decreased IgG3 level|MP:0008670,decreased interleukin-12b secretion|MP:0008706,decreased interleukin-6 secretion
MGI:3573942	Tirap<tm1Medz>	MP:0000343,abnormal response to cardiac infarction|MP:0002376,abnormal dendritic cell physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0005093,decreased B cell proliferation|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:2684153	tirs	MP:0001293,anophthalmia|MP:0001297,microphthalmia
MGI:3522300	titanm	MP:0000371,diluted coat color
MGI:1859973	T<Jic>	MP:0000592,short tail|MP:0001935,decreased litter size
MGI:5749399	Tjp1<tm1.1Whun>	MP:0001732,postnatal growth retardation|MP:0002135,abnormal kidney morphology|MP:0002169,no abnormal phenotype detected|MP:0002705,dilated renal tubule|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0004194,abnormal kidney pelvis morphology|MP:0004969,pale kidney|MP:0005264,glomerulosclerosis|MP:0005370,liver/biliary system phenotype|MP:0008059,abnormal podocyte foot process morphology|MP:0008060,abnormal podocyte slit diaphragm morphology|MP:0008061,absent podocyte slit diaphragm|MP:0008139,fused podocyte foot processes|MP:0008140,podocyte foot process effacement|MP:0011304,kidney papillary atrophy|MP:0011402,renal cast|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011534,granular kidney|MP:0011855,abnormal glomerular filtration barrier morphology|MP:0011869,detached podocyte
MGI:5692184	Tjp1<tm1Sats>	MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0002825,abnormal notochord morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003891,increased allantois apoptosis|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004180,failure of initiation of embryo turning|MP:0004557,dilated allantois|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009577,abnormal developmental vascular remodeling|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012505,increased neural tube apoptosis|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5558017	Tjp1<tm1Tlch>	MP:0002169,no abnormal phenotype detected
MGI:3776874	Tjp2<tm1Whun>	MP:0000352,decreased cell proliferation|MP:0001683,absent mesoderm|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0003950,abnormal plasma membrane morphology|MP:0003988,disorganized embryonic tissue|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:6363120	Tjp2<tm2Whun>	MP:0000182,increased circulating LDL cholesterol level|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005370,liver/biliary system phenotype
MGI:3697319	Tjp3<tm1Mada>	MP:0002169,no abnormal phenotype detected
MGI:3776875	Tjp3<tm1Whun>	MP:0002169,no abnormal phenotype detected
MGI:1857073	tk	MP:0000464,increased presacral vertebrae number|MP:0000585,kinked tail|MP:0000592,short tail|MP:0002082,postnatal lethality|MP:0002111,abnormal tail morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0005225,abnormal vertebrae development|MP:0008770,decreased survivor rate
MGI:1860251	Tk1<tm1Vnd>	MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0001156,abnormal spermatogenesis|MP:0001392,abnormal locomotor behavior|MP:0001505,hunched posture|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002267,abnormal bronchiole morphology|MP:0002631,abnormal epididymis morphology|MP:0003504,thyroid gland inflammation|MP:0003881,abnormal nephron morphology|MP:0003991,arteriosclerosis|MP:0004035,abnormal sublingual gland morphology|MP:0004247,small pancreas|MP:0005264,glomerulosclerosis|MP:0005639,hemosiderosis|MP:0009161,pancreatic acinar cell zymogen granule accumulation|MP:0009168,decreased pancreatic islet number|MP:0010138,arteritis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0031071,lymph node atrophy
MGI:3802583	Tk2<tm1Anka>	MP:0000607,abnormal hepatocyte morphology|MP:0001732,postnatal growth retardation|MP:0002971,abnormal brown adipose tissue morphology|MP:0005534,decreased body temperature|MP:0008843,absent subcutaneous adipose tissue|MP:0011019,abnormal adaptive thermogenesis|MP:0011085,postnatal lethality, complete penetrance|MP:0011635,abnormal mitochondrial crista morphology|MP:0011639,decreased mitochondrial DNA content|MP:0031131,myocardial fiber disarray
MGI:3808750	Tk2<tm1Mihi>	MP:0000266,abnormal heart morphology|MP:0000745,tremors|MP:0000746,weakness|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0002152,abnormal brain morphology|MP:0002182,abnormal astrocyte morphology|MP:0003632,abnormal nervous system morphology|MP:0004100,abnormal spinal cord interneuron morphology|MP:0005369,muscle phenotype|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011085,postnatal lethality, complete penetrance|MP:0011639,decreased mitochondrial DNA content|MP:0014386,decreased muscle fiber mitochondrial DNA content|MP:0014390,decreased myocardial fiber mitochondrial DNA content
MGI:6147791	tkb	MP:0000585,kinked tail|MP:0002111,abnormal tail morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0013179,wavy tail
MGI:7426028	Tkfc<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001330,abnormal optic nerve morphology|MP:0001333,absent optic nerve
MGI:1861458	Tks	MP:0000585,kinked tail|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002940,variable body spotting|MP:0008770,decreased survivor rate|MP:0009674,decreased birth weight
MGI:1858139	t<ks1>	MP:0008762,embryonic lethality
MGI:6356816	Tkt<em1(IMPC)H>	MP:0010067,increased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6194752	Tktl1<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:4949665	Tktl1<tm1Arte>	MP:0008537,increased susceptibility to induced colitis|MP:0010180,increased susceptibility to weight loss
MGI:6361155	Tktl2<em1Osb>	MP:0005389,reproductive system phenotype
MGI:2671068	Tkt<tm1Jpi>	MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001732,postnatal growth retardation|MP:0001783,decreased white adipose tissue amount|MP:0001921,reduced fertility|MP:0002175,decreased brain weight|MP:0002566,abnormal sexual interaction|MP:0002834,decreased heart weight|MP:0003402,decreased liver weight|MP:0003918,decreased kidney weight|MP:0004852,decreased testis weight|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:1932330	Tl	MP:0000592,short tail|MP:0002114,abnormal axial skeleton morphology|MP:0011091,prenatal lethality, complete penetrance
MGI:5527564	Tl5	MP:0000585,kinked tail|MP:0000592,short tail|MP:0001539,decreased caudal vertebrae number|MP:0002111,abnormal tail morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype
MGI:6257762	Tlcd3b<em1(IMPC)Bay>	MP:0001258,decreased body length|MP:0001325,abnormal retina morphology|MP:0001489,decreased startle reflex|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004022,abnormal cone electrophysiology|MP:0005389,reproductive system phenotype|MP:0008446,decreased retina cone cell number|MP:0008515,thin retina outer nuclear layer|MP:0009142,decreased prepulse inhibition|MP:0011965,decreased total retina thickness|MP:0012144,decreased b-wave amplitude
MGI:4462642	Tlcd3b<tm1a(EUCOMM)Hmgu>	MP:0000774,decreased brain size|MP:0006254,thin cerebral cortex|MP:0012450,decreased primary motor cortex size|MP:0012453,decreased retrosplenial granular cortex size|MP:0012474,decreased cingulate cortex size|MP:0012476,decreased piriform cortex size
MGI:5468987	Tlcd5<tm1.1(KOMP)Vlcg>	MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011396,abnormal sleep behavior
MGI:5904784	Tldc2<em1(IMPC)J>	MP:0000195,decreased circulating calcium level
MGI:6384610	Tle1<em1(IMPC)Hmgu>	MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:4415479	Tle2<tm1(KOMP)Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:6430671	Tle3<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000774,decreased brain size|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0002152,abnormal brain morphology|MP:0002699,abnormal vitreous body morphology
MGI:3864554	Tle3<Gt(XP0165)Wtsi>	MP:0005076,abnormal cell differentiation|MP:0011092,embryonic lethality, complete penetrance|MP:0011167,abnormal adipose tissue development
MGI:5505553	Tle3<tm1.1Pton>	MP:0001559,hyperglycemia|MP:0002971,abnormal brown adipose tissue morphology|MP:0003059,decreased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0004889,increased energy expenditure|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005336,abnormal inguinal fat pad morphology|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0009116,abnormal brown fat cell morphology|MP:0010147,abnormal endocrine pancreas physiology|MP:0011016,increased core body temperature|MP:0020523,decreased susceptibility to induced hypothermia
MGI:5319211	Tle3<tm1Jcc>	MP:0001698,decreased embryo size|MP:0001711,abnormal placenta morphology|MP:0003934,abnormal pancreas development|MP:0004247,small pancreas|MP:0005216,abnormal pancreatic alpha cell morphology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0009175,abnormal pancreatic beta cell differentiation|MP:0009179,abnormal pancreatic alpha cell differentiation|MP:0009183,abnormal pancreatic delta cell differentiation|MP:0009188,abnormal PP cell differentiation|MP:0009189,abnormal pancreatic epsilon cell morphology|MP:0009193,abnormal pancreatic epsilon cell differentiation|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:6152659	Tle4<em1(IMPC)Mbp>	MP:0000492,abnormal rectum morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000702,enlarged lymph nodes|MP:0001402,decreased locomotor activity|MP:0001925,male infertility|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002834,decreased heart weight|MP:0002989,small kidney|MP:0003961,decreased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005278,abnormal cholesterol homeostasis|MP:0005293,impaired glucose tolerance|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:5707932	Tle4<tm1.2Dasw>	MP:0000135,decreased compact bone thickness|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000221,decreased leukocyte cell number|MP:0000333,decreased bone marrow cell number|MP:0000694,spleen hypoplasia|MP:0000703,abnormal thymus morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0002083,premature death|MP:0002401,abnormal lymphopoiesis|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003644,thymus atrophy|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004810,decreased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0006396,decreased long bone epiphyseal plate size|MP:0008039,increased NK T cell number|MP:0008174,decreased follicular B cell number|MP:0008813,decreased common myeloid progenitor cell number|MP:0009541,increased thymocyte apoptosis|MP:0010124,decreased bone mineral content|MP:0010132,decreased DN2 thymocyte number|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0010873,decreased trabecular bone mass|MP:0011816,decreased pre-pro B cell number|MP:0014263,decreased spleen B cell follicle number
MGI:2180116	Tle5<tm1Grid>	MP:0000633,abnormal pituitary gland morphology|MP:0000636,enlarged pituitary gland|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0003817,abnormal pituitary diverticulum morphology|MP:0005379,endocrine/exocrine gland phenotype|MP:0013342,bifurcated Rathke's pouch|MP:0014602,decreased female mating frequency
MGI:6402939	Tle6<tm1Lil>	MP:0001926,female infertility|MP:0003406,failure of zygotic cell division|MP:0009760,abnormal mitotic spindle morphology|MP:0020850,abnormal microtubule cytoskeleton morphology
MGI:2157569	Tlf2<NOD/Smrf>	MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:2157567	Tlf<NOD/Smrf>	MP:0008074,increased CD4-positive, alpha-beta T cell number
MGI:3909296	Tlk1<Gt(E067A02)Wrst>	MP:0002169,no abnormal phenotype detected
MGI:5635402	Tlk1<tm1b(EUCOMM)Hmgu>	MP:0001566,increased circulating phosphate level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0005293,impaired glucose tolerance|MP:0005344,increased circulating bilirubin level|MP:0005562,decreased mean corpuscular hemoglobin
MGI:6414564	Tlk2<em1(IMPC)Bay>	MP:0001700,abnormal embryo turning|MP:0003795,abnormal bone structure|MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6274362	Tlk2<tm1.2Strc>	MP:0001713,decreased trophoblast giant cell number|MP:0001716,abnormal placenta labyrinth morphology|MP:0003231,abnormal placenta vasculature|MP:0004259,small placenta|MP:0005031,abnormal trophoblast layer morphology|MP:0011527,disorganized placental labyrinth|MP:0011531,abnormal syncytiotrophoblast morphology|MP:0030989,decreased spongiotrophoblast cell number
MGI:6274360	Tlk2<tm1Strc>	MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0004259,small placenta|MP:0004266,pale placenta|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5560905	Tll1<b2b2476Clo>	MP:0000273,overriding aortic valve|MP:0000284,double outlet right ventricle|MP:0001823,thymus hypoplasia|MP:0003755,abnormal palate morphology|MP:0004056,abnormal myocardium compact layer morphology|MP:0010402,ventricular septal defect|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect
MGI:2449853	Tll1<tm1Dgr>	MP:0000284,double outlet right ventricle|MP:0000286,abnormal mitral valve morphology|MP:0000299,failure of atrioventricular cushion closure|MP:0001785,edema|MP:0002746,abnormal semilunar valve morphology|MP:0003717,pallor|MP:0003888,liver hemorrhage|MP:0004068,dilated dorsal aorta|MP:0004783,abnormal cardinal vein morphology|MP:0006065,abnormal heart position or orientation|MP:0006138,congestive heart failure|MP:0009868,abnormal descending thoracic aorta morphology|MP:0010402,ventricular septal defect|MP:0010404,ostium primum atrial septal defect|MP:0010412,atrioventricular septal defect|MP:0010433,double inlet heart left ventricle|MP:0010585,abnormal conotruncal ridge morphology|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3778379	Tll2<tm1.1Sjl>	MP:0003397,increased muscle weight
MGI:2154360	Tlln<C57BL/6J>	MP:0002758,long tail
MGI:2429594	Tln1<tm1Crit>	MP:0001672,abnormal embryo development|MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002174,abnormal gastrulation movements|MP:0002582,disorganized extraembryonic tissue|MP:0005031,abnormal trophoblast layer morphology|MP:0006323,abnormal extraembryonic mesoderm development|MP:0011092,embryonic lethality, complete penetrance|MP:0011199,abnormal amniotic cavity morphology|MP:0011207,absent ectoplacental cavity|MP:0011208,small proamniotic cavity|MP:0011209,absent extraembryonic coelom|MP:0012104,small amniotic cavity|MP:0012135,embryonic-extraembryonic boundary constriction
MGI:2429596	Tln1<tm3Crit>	MP:0001672,abnormal embryo development|MP:0001675,abnormal ectoderm development|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002086,abnormal extraembryonic tissue morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011197,abnormal proamniotic cavity morphology|MP:0011208,small proamniotic cavity
MGI:3770513	Tln1<tm4.1Crit>	MP:0000208,decreased hematocrit|MP:0000465,gastrointestinal hemorrhage|MP:0002083,premature death|MP:0002417,abnormal megakaryocyte morphology|MP:0002594,low mean erythrocyte cell number|MP:0002874,decreased hemoglobin content|MP:0003179,thrombocytopenia|MP:0003292,melena|MP:0003405,abnormal platelet shape|MP:0003423,reduced thrombolysis|MP:0004720,abnormal platelet morphology|MP:0005048,abnormal thrombosis|MP:0005387,immune system phenotype|MP:0005435,hemoperitoneum|MP:0005606,increased bleeding time|MP:0006298,abnormal platelet activation|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3770448	Tln1<tm4Crit>	MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:3587955	Tln2<Gt(RRI434)Byg>	MP:0002169,no abnormal phenotype detected
MGI:3844953	Tln2<Gt(S1-6D1)Sor>	MP:0002169,no abnormal phenotype detected
MGI:4358355	Tln2<tm1.1Crit>	MP:0000759,abnormal skeletal muscle morphology|MP:0005369,muscle phenotype|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:4358352	Tln2<tm1Crit>	MP:0002169,no abnormal phenotype detected
MGI:4358373	Tln2<tm2Crit>	MP:0000752,dystrophic muscle|MP:0005384,cellular phenotype|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0011704,decreased fibroblast proliferation
MGI:5465003	t<low2H>	MP:0004179,transmission ratio distortion|MP:0010768,mortality/aging
MGI:2155124	Tlq1<BALB/c>	MP:0030928,increased telomere length
MGI:2155122	Tlq1<M. spretus>	MP:0030927,decreased telomere length
MGI:3045751	Tlr12<tm1Gho>	MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology
MGI:4422095	Tlr13<m1Btlr>	MP:0005387,immune system phenotype
MGI:5692860	Tlr13<tm1.1(KOMP)Vlcg>	MP:0001417,decreased exploration in new environment
MGI:3609369	Tlr1<tm1Aki>	MP:0003009,abnormal cytokine secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008706,decreased interleukin-6 secretion
MGI:3526882	Tlr1<tm1Flv>	MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002460,decreased immunoglobulin level
MGI:3717224	Tlr2<lngd>	MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology
MGI:2178675	Tlr2<tm1Aki>	MP:0000180,abnormal circulating cholesterol level|MP:0000181,abnormal circulating LDL cholesterol level|MP:0000188,abnormal circulating glucose level|MP:0000266,abnormal heart morphology|MP:0000343,abnormal response to cardiac infarction|MP:0000607,abnormal hepatocyte morphology|MP:0001262,decreased body weight|MP:0001392,abnormal locomotor behavior|MP:0001541,abnormal osteoclast physiology|MP:0001554,increased circulating free fatty acids level|MP:0001560,abnormal circulating insulin level|MP:0001876,decreased inflammatory response|MP:0002078,abnormal glucose homeostasis|MP:0002133,abnormal respiratory system physiology|MP:0002182,abnormal astrocyte morphology|MP:0002334,abnormal airway responsiveness|MP:0002376,abnormal dendritic cell physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002460,decreased immunoglobulin level|MP:0002628,hepatic steatosis|MP:0002738,hyperresponsive to tactile stimuli|MP:0002834,decreased heart weight|MP:0002942,decreased circulating alanine transaminase level|MP:0003009,abnormal cytokine secretion|MP:0003156,abnormal leukocyte migration|MP:0003313,abnormal locomotor activation|MP:0003631,nervous system phenotype|MP:0003690,abnormal glial cell physiology|MP:0003916,decreased heart left ventricle weight|MP:0003949,abnormal circulating lipid level|MP:0003998,decreased thermal nociceptive threshold|MP:0004031,insulitis|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0005015,increased T cell number|MP:0005026,decreased susceptibility to parasitic infection|MP:0005146,decreased circulating VLDL cholesterol level|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005294,abnormal heart ventricle morphology|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005608,cardiac interstitial fibrosis|MP:0005631,decreased lung weight|MP:0006058,decreased cerebral infarct size|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008664,decreased interleukin-12 secretion|MP:0008670,decreased interleukin-12b secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008721,abnormal chemokine level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0008782,increased B cell apoptosis|MP:0008916,abnormal astrocyte physiology|MP:0009132,abnormal white fat cell size|MP:0009172,small pancreatic islets|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0009937,abnormal neuron differentiation|MP:0010266,decreased liver tumor incidence|MP:0010267,decreased lung tumor incidence|MP:0012320,abnormal body fat mass|MP:0020449,decreased microglial cell activation|MP:0020467,abnormal circadian behavior|MP:0020477,abnormal locomotor circadian rhythm|MP:0020917,decreased susceptibility to Herpesvirales infection|MP:0031025,decreased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:3604557	Tlr2<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:2674036	Tlr2<tm1Kir>	MP:0000479,abnormal enterocyte morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000639,abnormal adrenal gland morphology|MP:0000642,enlarged adrenal glands|MP:0000920,abnormal myelination|MP:0001263,weight loss|MP:0001652,colonic necrosis|MP:0001739,abnormal adrenal gland secretion|MP:0001748,increased circulating adrenocorticotropin level|MP:0002006,neoplasm|MP:0002038,increased carcinoma incidence|MP:0002044,increased colon adenoma incidence|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002310,decreased susceptibility to hepatic steatosis|MP:0002412,increased susceptibility to bacterial infection|MP:0002419,abnormal innate immunity|MP:0002451,abnormal macrophage physiology|MP:0002665,decreased circulating corticosterone level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003009,abnormal cytokine secretion|MP:0003058,increased insulin secretion|MP:0003204,decreased neuron apoptosis|MP:0003293,rectal hemorrhage|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0004889,increased energy expenditure|MP:0005116,abnormal circulating pituitary hormone level|MP:0005292,improved glucose tolerance|MP:0005345,abnormal circulating corticosterone level|MP:0005602,decreased angiogenesis|MP:0005668,decreased circulating leptin level|MP:0006035,abnormal mitochondrial morphology|MP:0006058,decreased cerebral infarct size|MP:0006080,brain ischemia|MP:0008288,abnormal adrenal cortex morphology|MP:0008537,increased susceptibility to induced colitis|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008568,abnormal interleukin secretion|MP:0008652,decreased interleukin-1 secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0009269,decreased fat cell size|MP:0009283,decreased gonadal fat pad weight|MP:0009335,decreased splenocyte proliferation|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0009858,abnormal cellular extravasation|MP:0010279,increased gastrointestinal tumor incidence|MP:0011077,decreased macrophage nitric oxide production|MP:0011079,decreased macrophage cytokine production|MP:0011629,decreased mitochondrial number|MP:0011633,abnormal mitochondrial shape|MP:0011939,increased food intake|MP:0030016,increased adipocyte glucose uptake
MGI:5688601	Tlr3<M1Btlr>	MP:0008561,decreased tumor necrosis factor secretion|MP:0011079,decreased macrophage cytokine production
MGI:6113649	Tlr3<M2Btlr>	MP:0008561,decreased tumor necrosis factor secretion
MGI:3690535	Tlr3<tm1Aki>	MP:0002376,abnormal dendritic cell physiology|MP:0005387,immune system phenotype|MP:0005595,abnormal vascular smooth muscle physiology
MGI:2653138	Tlr3<tm1Flv>	MP:0000808,abnormal hippocampus development|MP:0000812,abnormal dentate gyrus morphology|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001559,hyperglycemia|MP:0001853,heart inflammation|MP:0001876,decreased inflammatory response|MP:0002020,increased tumor incidence|MP:0002063,abnormal learning/memory/conditioning|MP:0002133,abnormal respiratory system physiology|MP:0002327,abnormal respiratory function|MP:0002451,abnormal macrophage physiology|MP:0002459,abnormal B cell physiology|MP:0002572,abnormal emotion/affect behavior|MP:0002862,abnormal righting response|MP:0002908,delayed wound healing|MP:0003009,abnormal cytokine secretion|MP:0003106,abnormal fear-related response|MP:0003459,increased fear-related response|MP:0003460,decreased fear-related response|MP:0003461,abnormal response to novel object|MP:0003562,abnormal pancreatic beta cell physiology|MP:0004811,abnormal neuron physiology|MP:0004883,abnormal vascular wound healing|MP:0005215,abnormal pancreatic islet morphology|MP:0005387,immune system phenotype|MP:0005404,abnormal axon morphology|MP:0008042,abnormal NK T cell physiology|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008428,abnormal spatial working memory|MP:0008432,abnormal long-term spatial reference memory|MP:0008565,decreased interferon-beta secretion|MP:0008713,abnormal cytokine level|MP:0008750,abnormal interferon level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0009114,decreased pancreatic beta cell mass|MP:0009167,increased pancreatic islet number|MP:0009661,abnormal pregnancy|MP:0009669,abnormal postimplantation uterine environment|MP:0010766,abnormal NK cell physiology|MP:0020914,decreased susceptibility to Riboviria infection|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0020949,increased susceptibility to Coronaviridae infection|MP:0031023,decreased susceptibility to Riboviria infection induced morbidity/mortality|MP:0031040,increased susceptibility to Picornaviridae infection induced morbidity/mortality|MP:0031079,increased circulating troponin I level
MGI:3842324	Tlr4<Lps-2Btlr>	MP:0008561,decreased tumor necrosis factor secretion|MP:0008658,decreased interleukin-1 beta secretion
MGI:3626283	Tlr4<lps-2J>	MP:0001845,abnormal inflammatory response
MGI:5613596	Tlr4<Lps-3Btlr>	MP:0008561,decreased tumor necrosis factor secretion|MP:0008565,decreased interferon-beta secretion
MGI:5688512	Tlr4<lps-4Btlr>	MP:0008561,decreased tumor necrosis factor secretion|MP:0011079,decreased macrophage cytokine production|MP:0011081,decreased macrophage apoptosis
MGI:5688583	Tlr4<lps-5Btlr>	MP:0005017,decreased B cell number|MP:0008561,decreased tumor necrosis factor secretion|MP:0008729,decreased memory B cell number|MP:0011079,decreased macrophage cytokine production
MGI:5688584	Tlr4<Lps-6Btlr>	MP:0008561,decreased tumor necrosis factor secretion|MP:0011079,decreased macrophage cytokine production
MGI:5789540	Tlr4<lps-7Btlr>	MP:0000316,cellular necrosis|MP:0008561,decreased tumor necrosis factor secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0011079,decreased macrophage cytokine production|MP:0012556,increased cell death
MGI:5789549	Tlr4<Lps-8Btlr>	MP:0000316,cellular necrosis|MP:0008561,decreased tumor necrosis factor secretion|MP:0008658,decreased interleukin-1 beta secretion|MP:0011079,decreased macrophage cytokine production|MP:0012556,increased cell death
MGI:3767575	Tlr4<lps-Btlr>	MP:0002451,abnormal macrophage physiology
MGI:1857718	Tlr4<Lps-d>	MP:0000062,increased bone mineral density|MP:0000188,abnormal circulating glucose level|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001392,abnormal locomotor behavior|MP:0001516,abnormal motor coordination/balance|MP:0001547,abnormal lipid level|MP:0001570,abnormal circulating enzyme level|MP:0001656,focal hepatic necrosis|MP:0001793,abnormal susceptibility to infection|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001973,increased thermal nociceptive threshold|MP:0002078,abnormal glucose homeostasis|MP:0002132,abnormal respiratory system morphology|MP:0002133,abnormal respiratory system physiology|MP:0002191,abnormal artery morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002727,decreased circulating insulin level|MP:0002942,decreased circulating alanine transaminase level|MP:0003204,decreased neuron apoptosis|MP:0003293,rectal hemorrhage|MP:0003632,abnormal nervous system morphology|MP:0003691,abnormal microglial cell physiology|MP:0003724,increased susceptibility to induced arthritis|MP:0003795,abnormal bone structure|MP:0003828,pulmonary edema|MP:0003871,abnormal myelin sheath morphology|MP:0003948,abnormal gas homeostasis|MP:0004486,decreased response of heart to induced stress|MP:0004882,enlarged lung|MP:0004883,abnormal vascular wound healing|MP:0004892,increased adiponectin level|MP:0004951,abnormal spleen weight|MP:0005280,abnormal fatty acids level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005338,atherosclerotic lesions|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005466,abnormal T-helper 2 physiology|MP:0005498,hyporesponsive to tactile stimuli|MP:0005534,decreased body temperature|MP:0005602,decreased angiogenesis|MP:0005605,increased bone mass|MP:0005667,abnormal circulating leptin level|MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0008251,abnormal phagocyte morphology|MP:0008396,abnormal osteoclast differentiation|MP:0008596,increased circulating interleukin-6 level|MP:0008713,abnormal cytokine level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0008891,decreased hepatocyte apoptosis|MP:0009269,decreased fat cell size|MP:0009289,decreased epididymal fat pad weight|MP:0009356,decreased liver triglyceride level|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0009878,decreased susceptibility to bone fracture|MP:0010123,increased bone mineral content|MP:0010170,abnormal glial cell apoptosis|MP:0010181,decreased susceptibility to weight loss|MP:0010379,decreased respiratory quotient|MP:0010760,abnormal macrophage chemotaxis|MP:0010908,dilated pulmonary alveolar duct|MP:0031034,increased susceptibility to Poxviridae infection induced morbidity/mortality|MP:0031617,abnormal skeletal muscle cell glucose uptake
MGI:1860755	Tlr4<lps-del>	MP:0001005,abnormal retina rod cell morphology|MP:0001570,abnormal circulating enzyme level|MP:0001973,increased thermal nociceptive threshold|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002271,abnormal pulmonary alveolar duct morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002942,decreased circulating alanine transaminase level|MP:0003009,abnormal cytokine secretion|MP:0003293,rectal hemorrhage|MP:0003690,abnormal glial cell physiology|MP:0003727,abnormal retina layer morphology|MP:0004486,decreased response of heart to induced stress|MP:0004882,enlarged lung|MP:0004952,increased spleen weight|MP:0005166,decreased susceptibility to injury|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005459,decreased percent body fat/body weight|MP:0005498,hyporesponsive to tactile stimuli|MP:0005605,increased bone mass|MP:0006071,abnormal retina progenitor cell morphology|MP:0006074,abnormal retina rod bipolar cell morphology|MP:0006080,brain ischemia|MP:0008661,decreased interleukin-10 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008752,abnormal tumor necrosis factor level|MP:0009937,abnormal neuron differentiation|MP:0010123,increased bone mineral content
MGI:3695275	Tlr4<lps-hypo>	MP:0002411,decreased susceptibility to bacterial infection
MGI:1857731	Tlr4<lps-n>	MP:0004952,increased spleen weight|MP:0005087,decreased acute inflammation|MP:0005387,immune system phenotype
MGI:5465308	Tlr4<tm1.1Djh>	MP:0003449,abnormal intestine goblet cell morphology|MP:0004774,abnormal bile salt level|MP:0005166,decreased susceptibility to injury|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008883,abnormal enterocyte proliferation|MP:0010159,abnormal enterocyte differentiation|MP:0011702,abnormal fibroblast proliferation
MGI:5568597	Tlr4<tm1.1Karp>	MP:0002169,no abnormal phenotype detected
MGI:5708281	Tlr4<tm1.1(KOMP)Vlcg>	MP:0000494,abnormal cecum morphology|MP:0001120,abnormal uterus morphology|MP:0004906,enlarged uterus|MP:0009476,enlarged cecum
MGI:1860885	Tlr4<tm1Aki>	MP:0002132,abnormal respiratory system morphology|MP:0002133,abnormal respiratory system physiology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002271,abnormal pulmonary alveolar duct morphology|MP:0002334,abnormal airway responsiveness|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002498,abnormal acute inflammation|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002874,decreased hemoglobin content|MP:0003209,abnormal pulmonary elastic fiber morphology|MP:0003436,decreased susceptibility to induced arthritis|MP:0003881,abnormal nephron morphology|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0004154,renal tubular necrosis|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004882,enlarged lung|MP:0005042,abnormal level of surface class II molecules|MP:0005093,decreased B cell proliferation|MP:0005166,decreased susceptibility to injury|MP:0005377,hearing/vestibular/ear phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005388,respiratory system phenotype|MP:0008466,enlarged mesenteric lymph nodes|MP:0008561,decreased tumor necrosis factor secretion|MP:0008597,decreased circulating interleukin-6 level|MP:0008706,decreased interleukin-6 secretion|MP:0008720,impaired neutrophil chemotaxis|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009640,abnormal renal tubule epithelium morphology|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010895,increased lung compliance|MP:0011350,abnormal proximal convoluted tubule brush border morphology|MP:0011402,renal cast|MP:0020947,decreased susceptibility to Orthomyxoviridae infection
MGI:5469002	Tlr4<tm1Djh>	MP:0003449,abnormal intestine goblet cell morphology|MP:0004774,abnormal bile salt level|MP:0005166,decreased susceptibility to injury
MGI:5750875	Tlr5<tm1.1Gewr>	MP:0000495,abnormal colon morphology|MP:0000691,enlarged spleen|MP:0001260,increased body weight|MP:0001433,polyphagia|MP:0001552,increased circulating triglyceride level|MP:0003304,large intestinal inflammation|MP:0005178,increased circulating cholesterol level|MP:0005387,immune system phenotype|MP:0008657,increased interleukin-1 beta secretion|MP:0008907,decreased total fat pad weight|MP:0008908,increased total fat pad weight|MP:0010377,abnormal gut flora balance|MP:0013279,increased fasting circulating glucose level|MP:0013298,increased susceptibility to colitis induced morbidity/mortality|MP:0013956,decreased colon length
MGI:3664436	Tlr5<tm1Aki>	MP:0000691,enlarged spleen|MP:0002411,decreased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0005387,immune system phenotype|MP:0008657,increased interleukin-1 beta secretion|MP:0008670,decreased interleukin-12b secretion|MP:0008706,decreased interleukin-6 secretion|MP:0010377,abnormal gut flora balance|MP:0013298,increased susceptibility to colitis induced morbidity/mortality|MP:0013956,decreased colon length
MGI:3665162	Tlr5<tm1Flv>	MP:0000222,decreased neutrophil cell number|MP:0000231,hypertension|MP:0001260,increased body weight|MP:0001261,obese|MP:0001431,abnormal eating behavior|MP:0001433,polyphagia|MP:0001552,increased circulating triglyceride level|MP:0001861,lung inflammation|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002376,abnormal dendritic cell physiology|MP:0002412,increased susceptibility to bacterial infection|MP:0002628,hepatic steatosis|MP:0002842,increased systemic arterial blood pressure|MP:0003009,abnormal cytokine secretion|MP:0003156,abnormal leukocyte migration|MP:0004761,increased susceptibility to induced pancreatitis|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005178,increased circulating cholesterol level|MP:0005331,insulin resistance|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005666,abnormal adipose tissue physiology|MP:0005671,abnormal response to transplant|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008537,increased susceptibility to induced colitis|MP:0008872,abnormal physiological response to xenobiotic|MP:0009288,increased epididymal fat pad weight|MP:0010024,increased total body fat amount|MP:0010377,abnormal gut flora balance|MP:0031342,increased circulating lipocalin 2 level
MGI:3641228	Tlr6<int>	MP:0002419,abnormal innate immunity|MP:0002420,abnormal adaptive immunity|MP:0002421,abnormal cell-mediated immunity|MP:0002451,abnormal macrophage physiology
MGI:3831304	Tlr6<m2Btlr>	MP:0002451,abnormal macrophage physiology|MP:0008561,decreased tumor necrosis factor secretion
MGI:3831305	Tlr6<m3Btlr>	MP:0002451,abnormal macrophage physiology|MP:0008561,decreased tumor necrosis factor secretion
MGI:3831306	Tlr6<m4Btlr>	MP:0001925,male infertility|MP:0002451,abnormal macrophage physiology|MP:0008561,decreased tumor necrosis factor secretion
MGI:3034062	Tlr6<tm1Aki>	MP:0002451,abnormal macrophage physiology|MP:0003009,abnormal cytokine secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008706,decreased interleukin-6 secretion
MGI:7279260	Tlr7<em2Anu>	MP:0000221,decreased leukocyte cell number|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000696,abnormal Peyer's patch morphology|MP:0001846,increased inflammatory response|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001869,pancreas inflammation|MP:0001870,salivary gland inflammation|MP:0002083,premature death|MP:0002108,abnormal muscle morphology|MP:0002451,abnormal macrophage physiology|MP:0002459,abnormal B cell physiology|MP:0002743,glomerulonephritis|MP:0003141,cardiac fibrosis|MP:0003179,thrombocytopenia|MP:0003725,increased autoantibody level|MP:0003865,lymph node inflammation|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0005014,increased B cell number|MP:0005093,decreased B cell proliferation|MP:0005220,abnormal exocrine pancreas morphology|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008097,increased plasma cell number|MP:0008171,abnormal mature B cell morphology|MP:0008177,increased germinal center B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008481,increased spleen germinal center number|MP:0008553,increased circulating tumor necrosis factor level|MP:0008577,increased circulating interferon-gamma level|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008769,abnormal plasmacytoid dendritic cell physiology|MP:0008783,decreased B cell apoptosis|MP:0009318,increased splenic marginal zone lymphoma incidence|MP:0010186,increased T follicular helper cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0011353,expanded mesangial matrix|MP:0020519,renal glomerular immunoglobulin deposits
MGI:3767244	Tlr7<rsq1>	MP:0002451,abnormal macrophage physiology|MP:0008561,decreased tumor necrosis factor secretion
MGI:3811335	Tlr7<rsq2>	MP:0002451,abnormal macrophage physiology|MP:0008561,decreased tumor necrosis factor secretion
MGI:3045662	Tlr7<tm1Aki>	MP:0002376,abnormal dendritic cell physiology|MP:0005397,hematopoietic system phenotype|MP:0008563,decreased interferon-alpha secretion|MP:0008670,decreased interleukin-12b secretion
MGI:3040902	Tlr7<tm1Flv>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002870,decreased anti-insulin autoantibody level|MP:0008181,increased marginal zone B cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008574,decreased circulating interferon-alpha level|MP:0009335,decreased splenocyte proliferation
MGI:4837832	Tlr8/Tlr7<tm1Vlcg>	MP:0002870,decreased anti-insulin autoantibody level|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number
MGI:4837833	Tlr8/Tlr7<tm1Vlcg>	MP:0002870,decreased anti-insulin autoantibody level|MP:0008174,decreased follicular B cell number|MP:0008181,increased marginal zone B cell number
MGI:4837530	Tlr8<tm1Vlcg>	MP:0000691,enlarged spleen|MP:0002362,abnormal spleen marginal zone morphology|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002743,glomerulonephritis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004952,increased spleen weight|MP:0008127,decreased dendritic cell number|MP:0008168,decreased B-1a cell number|MP:0008170,decreased B-1b cell number|MP:0008182,decreased marginal zone B cell number|MP:0008206,increased B-2 B cell number|MP:0008495,decreased IgG1 level|MP:0008500,increased IgG2a level|MP:0008617,increased circulating interleukin-12 level|MP:0008705,increased interleukin-6 secretion|MP:0020519,renal glomerular immunoglobulin deposits
MGI:3038816	Tlr9<M1Btlr>	MP:0002451,abnormal macrophage physiology|MP:0003009,abnormal cytokine secretion|MP:0008042,abnormal NK T cell physiology|MP:0010766,abnormal NK cell physiology|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:3767565	Tlr9<M2Btlr>	MP:0002451,abnormal macrophage physiology|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:3767571	Tlr9<m3Btlr>	MP:0002451,abnormal macrophage physiology|MP:0005093,decreased B cell proliferation
MGI:3774140	Tlr9<m4Btlr>	MP:0002451,abnormal macrophage physiology|MP:0005093,decreased B cell proliferation|MP:0008769,abnormal plasmacytoid dendritic cell physiology
MGI:3843064	Tlr9<M5Btlr>	MP:0002451,abnormal macrophage physiology|MP:0008561,decreased tumor necrosis factor secretion|MP:0008563,decreased interferon-alpha secretion|MP:0008565,decreased interferon-beta secretion
MGI:4415350	Tlr9<m6Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:4838258	Tlr9<M7Btlr>	MP:0008561,decreased tumor necrosis factor secretion
MGI:4887254	Tlr9<M8Btlr>	MP:0008567,decreased interferon-gamma secretion
MGI:5632141	Tlr9<M9Btlr>	MP:0008561,decreased tumor necrosis factor secretion
MGI:2660562	Tlr9<tm1Aki>	MP:0001790,abnormal immune system physiology|MP:0001876,decreased inflammatory response|MP:0002376,abnormal dendritic cell physiology|MP:0002451,abnormal macrophage physiology|MP:0002459,abnormal B cell physiology|MP:0003156,abnormal leukocyte migration|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005025,abnormal response to infection|MP:0005026,decreased susceptibility to parasitic infection|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005387,immune system phenotype|MP:0005465,abnormal T-helper 1 physiology|MP:0008561,decreased tumor necrosis factor secretion|MP:0008563,decreased interferon-alpha secretion|MP:0008565,decreased interferon-beta secretion|MP:0008670,decreased interleukin-12b secretion
MGI:2156830	Tlsm1<AKR/JMs>	MP:0002024,increased T cell derived lymphoma incidence
MGI:5438100	tlss	MP:0000477,abnormal intestine morphology|MP:0000691,enlarged spleen|MP:0000709,enlarged thymus|MP:0002083,premature death|MP:0003290,intestinal hypoperistalsis|MP:0008466,enlarged mesenteric lymph nodes
MGI:5692287	Tlx1<tm1.1(cre/ERT2)Rygo>	MP:0000690,absent spleen
MGI:1857260	Tlx1<tm1Sjk>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000690,absent spleen|MP:0003631,nervous system phenotype|MP:0005013,increased lymphocyte cell number|MP:0005380,embryo phenotype|MP:0009323,abnormal spleen development|MP:0010178,increased number of Howell-Jolly bodies|MP:0011263,abnormal spleen mesenchyme morphology
MGI:3581680	Tlx1<tm1Thr>	MP:0000690,absent spleen|MP:0009322,increased splenocyte apoptosis|MP:0009323,abnormal spleen development
MGI:3846678	Tlx2<tm1.1(cre)Rpk>	MP:0000496,abnormal small intestine morphology|MP:0001270,distended abdomen|MP:0002083,premature death|MP:0002731,megacolon|MP:0009480,distended cecum
MGI:2448951	Tlx2<tm1Htno>	MP:0000489,abnormal large intestine morphology|MP:0000495,abnormal colon morphology|MP:0000496,abnormal small intestine morphology|MP:0001044,abnormal enteric nervous system morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001270,distended abdomen|MP:0002083,premature death|MP:0002184,abnormal innervation|MP:0002731,megacolon|MP:0008770,decreased survivor rate
MGI:2655186	Tlx2<tm1Sjk>	MP:0000489,abnormal large intestine morphology|MP:0000496,abnormal small intestine morphology|MP:0001045,abnormal enteric ganglia morphology|MP:0001046,abnormal enteric neuron morphology|MP:0001270,distended abdomen|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002731,megacolon|MP:0003631,nervous system phenotype|MP:0009480,distended cecum|MP:0009485,distended ileum
MGI:1857514	Tlx2<tm1Ut>	MP:0001675,abnormal ectoderm development|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002230,abnormal primitive streak formation|MP:0005029,abnormal amnion morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2180105	Tlx3<tm1Sjk>	MP:0001575,cyanosis|MP:0001951,abnormal breathing pattern|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0001957,apnea|MP:0003247,abnormal glutaminergic neuron morphology|MP:0003631,nervous system phenotype|MP:0003633,abnormal nervous system physiology|MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype|MP:0005426,tachypnea|MP:0009546,absent gastric milk in neonates|MP:0011087,neonatal lethality, complete penetrance|MP:0021093,abnormal dorsal interneuron 2 morphology|MP:0021095,abnormal dorsal interneuron 4 morphology
MGI:5433363	Tlx3<tm2.1Qima>	MP:0004811,abnormal neuron physiology
MGI:3033597	Tlyr1<C57BL/6J>	MP:0002052,decreased tumor incidence
MGI:1857075	tm	MP:0000192,abnormal mineral level|MP:0000745,tremors|MP:0001924,infertility|MP:0002965,increased circulating serum albumin level|MP:0005416,abnormal circulating protein level|MP:0014812,abnormal brain physiology
MGI:5646519	Tm13	MP:0001410,head bobbing
MGI:4867537	T<M1Shao>	MP:0000592,short tail|MP:0003051,curly tail|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5752830	Tm26	MP:0000373,belly spot|MP:0000745,tremors|MP:0006325,impaired hearing
MGI:6257640	Tm2d1<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0002080,prenatal lethality|MP:0002608,increased hematocrit|MP:0003984,embryonic growth retardation|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance
MGI:6257594	Tm2d2<em1(IMPC)Bay>	MP:0000428,abnormal craniofacial morphology|MP:0001489,decreased startle reflex|MP:0001785,edema|MP:0002080,prenatal lethality|MP:0011100,preweaning lethality, complete penetrance
MGI:5907977	Tm2d3<em1(IMPC)J>	MP:0001363,increased anxiety-related response|MP:0001785,edema|MP:0001914,hemorrhage|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:5646499	Tm4	MP:0005293,impaired glucose tolerance
MGI:5646550	Tm45	MP:0005291,abnormal glucose tolerance
MGI:5646570	Tm47	MP:0001364,decreased anxiety-related response
MGI:7426029	Tm4sf19<em1(IMPC)Bay>	MP:0011960,abnormal eye anterior chamber depth|MP:0011962,increased cornea thickness
MGI:7567663	Tm4sf19<em1Sjkm>	MP:0000062,increased bone mineral density|MP:0001541,abnormal osteoclast physiology|MP:0005605,increased bone mass|MP:0008396,abnormal osteoclast differentiation|MP:0010868,increased bone trabecula number|MP:0010872,increased trabecular bone mass|MP:0010875,increased bone volume|MP:0013631,decreased bone trabecular spacing|MP:0020011,increased bone mineral density of femur|MP:0021191,increased bone mineral density of lumbar vertebrae
MGI:7567667	Tm4sf19<em2Sjkm>	MP:0000062,increased bone mineral density|MP:0001541,abnormal osteoclast physiology|MP:0005605,increased bone mass|MP:0008396,abnormal osteoclast differentiation|MP:0010868,increased bone trabecula number|MP:0010872,increased trabecular bone mass|MP:0010875,increased bone volume|MP:0013631,decreased bone trabecular spacing|MP:0020011,increased bone mineral density of femur|MP:0021191,increased bone mineral density of lumbar vertebrae
MGI:6257612	Tm4sf20<em1(IMPC)Bay>	MP:0001417,decreased exploration in new environment|MP:0004953,decreased spleen weight
MGI:5548789	Tm4sf4<tm1.1(KOMP)Vlcg>	MP:0000062,increased bone mineral density|MP:0001293,anophthalmia|MP:0001529,abnormal vocalization|MP:0003795,abnormal bone structure
MGI:6156347	Tm4sf5<em1(IMPC)Kmpc>	MP:0010052,increased grip strength|MP:0011239,abnormal skin coloration|MP:0011942,decreased fluid intake
MGI:6831152	Tm4sf5<em1Jwnl>	MP:0005584,abnormal enzyme/coenzyme activity
MGI:5646529	Tm58	MP:0001504,abnormal posture
MGI:5646555	Tm59	MP:0001260,increased body weight|MP:0002079,increased circulating insulin level|MP:0005291,abnormal glucose tolerance
MGI:5646558	Tm60	MP:0001260,increased body weight|MP:0002079,increased circulating insulin level|MP:0005291,abnormal glucose tolerance
MGI:5896993	Tm6sf2<em1Yech>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype
MGI:4362886	Tm6sf2<tm1a(KOMP)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000479,abnormal enterocyte morphology|MP:0001552,increased circulating triglyceride level|MP:0002628,hepatic steatosis|MP:0002647,decreased intestinal cholesterol absorption|MP:0002941,increased circulating alanine transaminase level|MP:0003976,decreased circulating VLDL triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005317,increased triglyceride level|MP:0005342,abnormal intestinal lipid absorption|MP:0009355,increased liver triglyceride level|MP:0010332,abnormal circulating apolipoprotein level
MGI:6120765	Tm6sf2<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0002941,increased circulating alanine transaminase level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0005179,decreased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0008810,increased circulating iron level
MGI:6120749	Tm7sf2<tm1b(KOMP)Wtsi>	MP:0002574,increased vertical activity|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005419,decreased circulating serum albumin level
MGI:3829354	Tm7sf2<tm1Fdp>	MP:0001764,abnormal homeostasis|MP:0003055,abnormal long bone epiphyseal plate morphology
MGI:3826687	Tm7sf2<tm1Riro>	MP:0005376,homeostasis/metabolism phenotype
MGI:7426030	Tm9sf1<em1(IMPC)Bay>	MP:0010024,increased total body fat amount
MGI:6369354	Tm9sf2<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001697,abnormal embryo size|MP:0002161,abnormal fertility/fecundity|MP:0003984,embryonic growth retardation|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6152661	Tm9sf3<em1(IMPC)Mbp>	MP:0001552,increased circulating triglyceride level|MP:0001566,increased circulating phosphate level|MP:0001785,edema|MP:0002075,abnormal coat/hair pigmentation|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:4363779	Tm9sf4<tm1a(KOMP)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0000377,abnormal hair follicle morphology|MP:0000647,abnormal sebaceous gland morphology|MP:0001556,increased circulating HDL cholesterol level|MP:0003036,vertebral transformation|MP:0005178,increased circulating cholesterol level|MP:0005568,increased circulating total protein level|MP:0010099,abnormal thoracic cage shape|MP:0012725,small sebaceous gland
MGI:7294424	Tm9sf5<em1Dzha>	MP:0001125,abnormal oocyte morphology|MP:0001923,reduced female fertility|MP:0003355,decreased ovulation rate|MP:0003674,oxidative stress|MP:0003718,maternal effect|MP:0004024,aneuploidy|MP:0006036,abnormal mitochondrial physiology|MP:0008871,abnormal ovarian follicle number|MP:0009363,abnormal tertiary ovarian follicle morphology|MP:0011121,decreased primordial ovarian follicle number|MP:0011129,decreased tertiary ovarian follicle number|MP:0030941,enhanced autophagy|MP:0031381,decreased secondary ovarian follicle number
MGI:5576384	Tmbim1<tm1Noj>	MP:0001570,abnormal circulating enzyme level|MP:0005385,cardiovascular system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009873,abnormal aorta tunica media morphology|MP:0010574,dilated aorta
MGI:3052422	Tmbim6<Gt1Jcre>	MP:0003076,increased susceptibility to ischemic brain injury|MP:0008873,increased physiological sensitivity to xenobiotic
MGI:5695928	Tmbim7<tm1.1(KOMP)Vlcg>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5314997	Tmc1<baringo>	MP:0000032,cochlear degeneration|MP:0000043,organ of Corti degeneration|MP:0004300,abnormal organ of Corti supporting cell morphology|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0005386,behavior/neurological phenotype|MP:0006325,impaired hearing
MGI:1856845	Tmc1<dn>	MP:0000043,organ of Corti degeneration|MP:0000048,abnormal stria vascularis morphology|MP:0001963,abnormal hearing physiology|MP:0001967,deafness|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002102,abnormal ear morphology|MP:0002857,cochlear ganglion degeneration|MP:0002894,abnormal otolith morphology|MP:0003149,abnormal tectorial membrane morphology|MP:0003169,abnormal scala media morphology|MP:0003631,nervous system phenotype|MP:0004331,vestibular saccular macula degeneration|MP:0004628,Deiters cell degeneration|MP:0005307,head tossing|MP:0005377,hearing/vestibular/ear phenotype
MGI:2177263	Tmc1<Mhdabth>	MP:0001406,abnormal gait|MP:0001967,deafness
MGI:5314995	Tmc1<nice>	MP:0000032,cochlear degeneration|MP:0004302,abnormal Deiters cell morphology|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0005386,behavior/neurological phenotype|MP:0006325,impaired hearing
MGI:5314996	Tmc1<stitch>	MP:0000032,cochlear degeneration|MP:0000043,organ of Corti degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0006325,impaired hearing
MGI:5427097	Tmc1<tm1.1Ajg>	MP:0001967,deafness|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0005386,behavior/neurological phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5427099	Tmc2<tm1.1Ajg>	MP:0004432,abnormal cochlear hair cell physiology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype
MGI:7259873	Tmc4<em1Abek>	MP:0001985,abnormal gustatory system physiology|MP:0004212,abnormal salty taste sensitivity|MP:0005376,homeostasis/metabolism phenotype
MGI:6162500	Tmc4<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0005655,increased aggression
MGI:6423085	Tmc5<em1(IMPC)J>	MP:0001925,male infertility
MGI:6690848	Tmc6<tm1.1Les>	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008469,abnormal protein level|MP:0010771,integument phenotype
MGI:4434247	Tmc6<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0004609,vertebral fusion|MP:0005632,decreased circulating aspartate transaminase level
MGI:6152662	Tmc7<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001126,abnormal ovary morphology|MP:0001297,microphthalmia|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0005178,increased circulating cholesterol level
MGI:7787153	Tmc7<em1Zjl>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0014052,increased male germ cell apoptosis|MP:0020362,abnormal male germ cell physiology|MP:0031354,abnormal acrosome assembly|MP:0031355,abnormal proacrosomal vesicle fusion
MGI:6690849	Tmc8<tm1.1Les>	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008469,abnormal protein level|MP:0010771,integument phenotype
MGI:6423822	Tmcc2<em1(IMPC)Mbp>	MP:0000494,abnormal cecum morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001289,persistence of hyaloid vascular system|MP:0001404,no spontaneous movement|MP:0001711,abnormal placenta morphology|MP:0002060,abnormal skin morphology|MP:0002591,decreased mean corpuscular volume|MP:0003231,abnormal placenta vasculature|MP:0005084,abnormal gallbladder morphology|MP:0009342,enlarged gallbladder|MP:0009476,enlarged cecum|MP:0009931,abnormal skin appearance|MP:0010097,abnormal retina blood vessel morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7294527	Tmcc2<em1Tar>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001577,anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0002811,macrocytic anemia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003131,increased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0003717,pallor|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0005564,increased hemoglobin content|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008801,abnormal erythroid progenitor cell morphology|MP:0009395,increased nucleated erythrocyte cell number
MGI:5642374	Tmco1<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0001314,cornea opacity|MP:0001926,female infertility|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5823562	Tmco1<em1Smoc>	MP:0000060,delayed bone ossification|MP:0000434,megacephaly|MP:0000438,abnormal cranium morphology|MP:0000445,short snout|MP:0001131,abnormal ovarian follicle morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001732,postnatal growth retardation|MP:0004231,abnormal calcium ion homeostasis|MP:0004380,short frontal bone|MP:0004471,short nasal bone|MP:0005006,abnormal osteoblast physiology|MP:0008770,decreased survivor rate|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011380,enlarged brain ventricles|MP:0012175,flat face|MP:0012307,impaired spatial learning|MP:0030029,wide cranial sutures
MGI:7294562	Tmco1<tm1Tsta>	MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001134,absent corpus luteum|MP:0001262,decreased body weight|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002777,absent ovarian follicles|MP:0003674,oxidative stress|MP:0004231,abnormal calcium ion homeostasis|MP:0004856,decreased ovary weight|MP:0005181,decreased circulating estradiol level|MP:0005376,homeostasis/metabolism phenotype|MP:0009093,oocyte degeneration|MP:0011121,decreased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number|MP:0013508,increased granulosa cell apoptosis|MP:0020354,increased endoplasmic reticulum stress|MP:0031020,premature ovarian failure|MP:0031239,increased atretic ovarian follicle number|MP:0031381,decreased secondary ovarian follicle number|MP:0031420,decreased superovulation rate
MGI:4419673	Tmco2<tm1a(KOMP)Wtsi>	MP:0010088,decreased circulating fructosamine level
MGI:5635417	Tmco3<tm1b(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0001488,increased startle reflex|MP:0003795,abnormal bone structure
MGI:6194763	Tmco5<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:5692673	Tmco5<tm1b(KOMP)Wtsi>	MP:0003896,prolonged PR interval
MGI:5698471	Tmco6<tm1.1(KOMP)Vlcg>	MP:0000195,decreased circulating calcium level|MP:0001402,decreased locomotor activity|MP:0001489,decreased startle reflex|MP:0002574,increased vertical activity|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3522311	Tmcrs	MP:0020470,shortened circadian behavior period
MGI:5695918	Tmed10<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001891,hydrocephaly|MP:0002135,abnormal kidney morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:3640663	Tmed10<tm1Mjo>	MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011743,abnormal Golgi apparatus morphology
MGI:4456438	Tmed2<99J>	MP:0000267,abnormal heart development|MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001726,abnormal allantois morphology|MP:0002861,abnormal tail bud morphology|MP:0003403,absent placental labyrinth|MP:0003794,delayed somite formation|MP:0003984,embryonic growth retardation|MP:0004073,caudal body truncation|MP:0004086,absent heartbeat|MP:0004251,failure of heart looping|MP:0004252,abnormal direction of heart looping|MP:0009656,delayed chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012062,small tail bud
MGI:5692654	Tmed3<tm2b(EUCOMM)Hmgu>	MP:0008810,increased circulating iron level
MGI:6156163	Tmed6<em1(IMPC)Rbrc>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0001417,decreased exploration in new environment|MP:0001944,abnormal pancreas morphology|MP:0004247,small pancreas
MGI:7548809	Tmeff1<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0002834,decreased heart weight|MP:0010124,decreased bone mineral content
MGI:7426031	Tmeff2<em1(IMPC)Hmgu>	MP:0001325,abnormal retina morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0005554,decreased circulating creatinine level|MP:0008259,abnormal optic disk morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5438565	Tmeff2<tm1Fawa>	MP:0001265,decreased body size|MP:0001783,decreased white adipose tissue amount|MP:0002006,neoplasm|MP:0003631,nervous system phenotype|MP:0005389,reproductive system phenotype|MP:0008489,slow postnatal weight gain|MP:0011083,lethality at weaning, complete penetrance
MGI:4881484	Tmem100<tm1.1Yjl>	MP:0002169,no abnormal phenotype detected
MGI:5432904	Tmem100<tm1.1Ysai>	MP:0000262,poor arterial differentiation|MP:0000266,abnormal heart morphology|MP:0000272,abnormal aorta morphology|MP:0000274,enlarged heart|MP:0001718,abnormal visceral yolk sac morphology|MP:0002128,abnormal blood circulation|MP:0002652,thin myocardium|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004067,abnormal trabecula carnea morphology|MP:0004076,abnormal vitelline vascular remodeling|MP:0004787,abnormal dorsal aorta morphology|MP:0005312,pericardial effusion|MP:0006093,arteriovenous malformation|MP:0009577,abnormal developmental vascular remodeling|MP:0010545,abnormal heart layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4881485	Tmem100<tm1.2Yjl>	MP:0011091,prenatal lethality, complete penetrance
MGI:5548552	Tmem100<tm1e.1(KOMP)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0000218,increased leukocyte cell number|MP:0000288,abnormal pericardium morphology|MP:0001175,abnormal lung morphology|MP:0001697,abnormal embryo size|MP:0001722,pale yolk sac|MP:0001785,edema|MP:0005013,increased lymphocyte cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:6274402	Tmem102<tm1.1Jyen>	MP:0003628,abnormal leukocyte adhesion|MP:0011825,decreased cell chemotaxis|MP:0020212,impaired leukocyte migration
MGI:5698480	Tmem104<tm1.1(KOMP)Vlcg>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0002941,increased circulating alanine transaminase level
MGI:7738707	Tmem106a<em1Cheyy>	MP:0005165,increased susceptibility to injury|MP:0005387,immune system phenotype|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008575,increased circulating interferon-beta level|MP:0008596,increased circulating interleukin-6 level|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011075,abnormal macrophage activation involved in immune response|MP:0020344,abnormal susceptibility to injury induced morbidity/mortality
MGI:7564553	Tmem106a<em1(IMPC)Bay>	MP:0001529,abnormal vocalization
MGI:6512073	Tmem106b<em1Damme>	MP:0000937,abnormal motor neuron morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001405,impaired coordination|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002098,abnormal vibrissa morphology|MP:0002654,spongiform encephalopathy|MP:0003631,nervous system phenotype|MP:0005058,abnormal lysosome morphology|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005404,abnormal axon morphology|MP:0010733,abnormal axon initial segment morphology|MP:0030173,abnormal orbicularis oculi muscle morphology|MP:0030940,impaired autophagy
MGI:7426032	Tmem106b<em1(IMPC)Bay>	MP:0003733,abnormal retina inner nuclear layer morphology|MP:0011965,decreased total retina thickness
MGI:5548613	Tmem106b<tm2b(KOMP)Wtsi>	MP:0001258,decreased body length|MP:0002631,abnormal epididymis morphology|MP:0002654,spongiform encephalopathy|MP:0002968,increased circulating alkaline phosphatase level|MP:0004931,enlarged epididymis|MP:0010123,increased bone mineral content
MGI:5433051	Tmem107<schlei>	MP:0000079,abnormal basioccipital bone morphology|MP:0000080,abnormal exoccipital bone morphology|MP:0000111,cleft palate|MP:0000153,rib bifurcation|MP:0000568,ectopic digits|MP:0000914,exencephaly|MP:0000926,absent floor plate|MP:0001297,microphthalmia|MP:0002151,abnormal neural tube morphology|MP:0003420,delayed intramembranous bone ossification|MP:0004320,split sternum|MP:0004321,short sternum|MP:0004449,absent presphenoid bone|MP:0004451,short presphenoid bone|MP:0004462,small basisphenoid bone|MP:0004463,basisphenoid bone foramen|MP:0004574,broad limb buds|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005380,embryo phenotype|MP:0006279,abnormal limb development|MP:0009743,preaxial polydactyly|MP:0009883,palatal shelf hypoplasia|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011505,camptomelia|MP:0013202,abnormal cilium morphology
MGI:5007367	Tmem107<tm1Lex>	MP:0000088,short mandible|MP:0000105,impaired ossification of basisphenoid bone|MP:0000106,abnormal basisphenoid bone morphology|MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0000445,short snout|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0000762,abnormal tongue morphology|MP:0000914,exencephaly|MP:0000926,absent floor plate|MP:0001286,abnormal eye development|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002151,abnormal neural tube morphology|MP:0002243,abnormal vomeronasal organ morphology|MP:0002820,abnormal premaxilla morphology|MP:0003420,delayed intramembranous bone ossification|MP:0003743,abnormal facial morphology|MP:0004377,small frontal bone|MP:0004418,small parietal bone|MP:0004468,small zygomatic bone|MP:0004470,small nasal bone|MP:0004473,absent nasal bone|MP:0004540,small maxilla|MP:0005170,cleft upper lip|MP:0005249,abnormal palatine bone morphology|MP:0006221,optic nerve hypoplasia|MP:0008273,abnormal intramembranous bone ossification|MP:0009652,abnormal palatal rugae morphology|MP:0009743,preaxial polydactyly|MP:0009885,abnormal palatal shelf elevation|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0009897,decreased maxillary shelf size|MP:0009907,decreased tongue size|MP:0011091,prenatal lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0013203,abnormal primary cilium morphology|MP:0013933,short Meckel's cartilage|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0021217,abnormal palatal shelf bone ossification|MP:0030189,broad snout|MP:0030200,abnormal nasal septum cartilage morphology|MP:0030204,large nasal septum|MP:0030205,thick nasal septum|MP:0030467,abnormal cranial cartilage development|MP:0031443,abnormal tongue position|MP:0031447,unilateral cleft upper lip|MP:0031457,abnormal vomeronasal cartilage morphology|MP:0031460,abnormal palatal shelf morphology
MGI:5548724	Tmem108<tm1b(EUCOMM)Wtsi>	MP:0001312,abnormal cornea morphology|MP:0001513,limb grasping|MP:0003961,decreased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005343,increased circulating aspartate transaminase level|MP:0010024,increased total body fat amount|MP:0010123,increased bone mineral content
MGI:5007368	Tmem108<tm1Lex>	MP:0002206,abnormal CNS synaptic transmission|MP:0002635,reduced sensorimotor gating|MP:0002910,abnormal excitatory postsynaptic currents|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008428,abnormal spatial working memory|MP:0009142,decreased prepulse inhibition|MP:0009454,impaired contextual conditioning behavior|MP:0009936,abnormal dendritic spine morphology|MP:0009938,abnormal hippocampus granule cell morphology|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0020335,abnormal dentate gyrus neuron dendrite morphology
MGI:4453832	Tmem109<tm1Yamt>	MP:0009542,decreased thymocyte apoptosis
MGI:6459767	Tmem114<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5695939	Tmem115<tm1.1(KOMP)Vlcg>	MP:0001785,edema
MGI:4951149	Tmem115<tm1(KOMP)Vlcg>	MP:0000222,decreased neutrophil cell number|MP:0003917,increased kidney weight|MP:0003960,increased lean body mass|MP:0005344,increased circulating bilirubin level|MP:0011100,preweaning lethality, complete penetrance
MGI:5695121	Tmem116<tm1b(EUCOMM)Hmgu>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001175,abnormal lung morphology|MP:0001262,decreased body weight|MP:0001303,abnormal lens morphology|MP:0001486,abnormal startle reflex|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005292,improved glucose tolerance|MP:0005567,decreased circulating total protein level|MP:0010052,increased grip strength
MGI:7616761	Tmem117<tm1.1Thor>	MP:0002710,increased glucagon secretion|MP:0003674,oxidative stress|MP:0005610,increased circulating antidiuretic hormone level|MP:0008948,decreased neuron number|MP:0020879,abnormal calcium level
MGI:5583072	Tmem119<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis
MGI:5544075	Tmem119<tm1Tfur>	MP:0000135,decreased compact bone thickness|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0003419,delayed endochondral bone ossification|MP:0005390,skeleton phenotype|MP:0010867,abnormal bone trabecula morphology|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0010933,decreased trabecular bone connectivity density|MP:0011711,impaired osteoblast differentiation
MGI:6156551	Tmem11<em1(IMPC)Tcp>	MP:0002060,abnormal skin morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0010067,increased red blood cell distribution width
MGI:7307591	Tmem11<em4Gpt>	MP:0003038,decreased myocardial infarct size|MP:0004215,abnormal myocardial fiber physiology|MP:0004565,decreased myocardial fiber size|MP:0006321,increased myocardial fiber number|MP:0031216,decreased susceptibility to myocardial ischemic injury
MGI:6492190	Tmem120a<tm1c(EUCOMM)Wtsi>	MP:0020374,abnormal nocifensive behavior|MP:0020955,increased mechanical nociceptive threshold
MGI:6156511	Tmem121b<em1(IMPC)Tcp>	MP:0000219,increased neutrophil cell number|MP:0002060,abnormal skin morphology|MP:0002941,increased circulating alanine transaminase level|MP:0005016,decreased lymphocyte cell number
MGI:4456136	Tmem123<tm1Shr>	MP:0002169,no abnormal phenotype detected
MGI:7426034	Tmem125<em1(IMPC)Kmpc>	MP:0000538,abnormal urinary bladder morphology|MP:0001399,hyperactivity|MP:0002135,abnormal kidney morphology|MP:0002764,short tibia|MP:0003068,enlarged kidney|MP:0003960,increased lean body mass|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content|MP:0011874,enlarged urinary bladder
MGI:4432149	Tmem126a<tm1a(EUCOMM)Wtsi>	MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0012765,decreased alpha-beta T cell number|MP:0013764,decreased T-helper cell number
MGI:6478924	Tmem126b<em1Cya>	MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:5581337	Tmem127<tm1.1Pdah>	MP:0000358,abnormal cell morphology|MP:0003172,abnormal lysosome physiology
MGI:4419725	Tmem127<tm1(KOMP)Wtsi>	MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0000579,abnormal nail morphology|MP:0000745,tremors|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005344,increased circulating bilirubin level|MP:0005553,increased circulating creatinine level|MP:0008045,decreased NK cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0008207,decreased B-2 B cell number|MP:0008806,increased circulating amylase level|MP:0010123,increased bone mineral content|MP:0010851,decreased effector memory CD8-positive, alpha-beta T cell number|MP:0012764,increased alpha-beta T cell number|MP:0012767,increased KLRG1-positive NK cell number|MP:0012768,decreased KLRG1-positive NK cell number|MP:0013023,decreased Ly6C high monocyte number|MP:0013025,increased Ly6C low monocyte number|MP:0013426,decreased memory-marker NK cell number|MP:0013427,increased memory-marker NK cell number|MP:0013436,increased CD8-positive, naive alpha-beta T cell number|MP:0013774,decreased KLRG1-positive T-helper cell number
MGI:5698484	Tmem129<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001556,increased circulating HDL cholesterol level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010024,increased total body fat amount
MGI:6208805	Tmem131<em1(IMPC)J>	MP:0000428,abnormal craniofacial morphology|MP:0001529,abnormal vocalization|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002075,abnormal coat/hair pigmentation|MP:0002968,increased circulating alkaline phosphatase level|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:5804137	Tmem131l<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4362366	Tmem132a<tm1a(KOMP)Wtsi>	MP:0000519,hydronephrosis|MP:0000929,open neural tube|MP:0001178,pulmonary hypoplasia|MP:0001672,abnormal embryo development|MP:0002114,abnormal axial skeleton morphology|MP:0002151,abnormal neural tube morphology|MP:0003054,spina bifida|MP:0003446,renal hypoplasia|MP:0003675,kidney cyst|MP:0004007,abnormal lung vasculature morphology|MP:0004073,caudal body truncation|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0005034,abnormal anus morphology|MP:0006027,impaired lung alveolus development|MP:0006279,abnormal limb development|MP:0008469,abnormal protein level|MP:0011089,perinatal lethality, complete penetrance|MP:0012707,incomplete caudal neuropore closure|MP:0013166,small forelimb buds|MP:0013169,small hindlimb buds|MP:0013956,decreased colon length|MP:0014282,forelimb syndactyly
MGI:5548753	Tmem132a<tm1b(KOMP)Wtsi>	MP:0000428,abnormal craniofacial morphology|MP:0000438,abnormal cranium morphology|MP:0000564,syndactyly|MP:0001491,unresponsive to tactile stimuli|MP:0001697,abnormal embryo size|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0002833,increased heart weight|MP:0003054,spina bifida|MP:0003720,abnormal neural tube closure|MP:0003743,abnormal facial morphology|MP:0003795,abnormal bone structure|MP:0005650,abnormal limb bud morphology|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape
MGI:6152707	Tmem132b<em1(IMPC)Ccpcz>	MP:0000598,abnormal liver morphology|MP:0001260,increased body weight|MP:0001399,hyperactivity|MP:0005278,abnormal cholesterol homeostasis|MP:0010896,decreased lung compliance
MGI:6336141	Tmem132e<em1(IMPC)Kmpc>	MP:0001404,no spontaneous movement|MP:0001491,unresponsive to tactile stimuli|MP:0009455,enhanced cued conditioning behavior|MP:0011100,preweaning lethality, complete penetrance
MGI:5811600	Tmem135<fun025>	MP:0001325,abnormal retina morphology|MP:0003674,oxidative stress|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005165,increased susceptibility to injury|MP:0005549,retina pigment epithelium hyperplasia|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006039,decreased mitochondrial fission|MP:0006073,abnormal retina bipolar cell morphology|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008842,lipofuscinosis|MP:0009392,retina gliosis|MP:0010955,abnormal respiratory electron transport chain|MP:0011629,decreased mitochondrial number|MP:0011630,increased mitochondrial size
MGI:5692725	Tmem138<tm1b(EUCOMM)Wtsi>	MP:0001258,decreased body length|MP:0002953,thick ventricular wall|MP:0004952,increased spleen weight|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:6336210	Tmem145<em1(IMPC)Mbp>	MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001489,decreased startle reflex|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002989,small kidney|MP:0004738,abnormal auditory brainstem response|MP:0006203,eye hemorrhage|MP:0009142,decreased prepulse inhibition
MGI:5792097	Tmem145<mpc269H>	MP:0006325,impaired hearing
MGI:6313402	Tmem147<em1(IMPC)J>	MP:0000579,abnormal nail morphology|MP:0003385,abnormal body wall morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5635437	Tmem14a<tm2b(KOMP)Wtsi>	MP:0001415,increased exploration in new environment
MGI:4351741	Tmem14c<Gt(E295C12)Wrst>	MP:0000245,abnormal erythropoiesis|MP:0000603,pale liver|MP:0001577,anemia|MP:0001588,abnormal hemoglobin|MP:0006207,embryonic lethality during organogenesis|MP:0008956,decreased cellular hemoglobin content|MP:0011091,prenatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:6693644	Tmem150b<em1Cya>	MP:0005389,reproductive system phenotype
MGI:6152708	Tmem150b<em1(IMPC)Ccpcz>	MP:0000598,abnormal liver morphology|MP:0001284,absent vibrissae|MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0002098,abnormal vibrissa morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0005012,decreased eosinophil cell number|MP:0013522,decreased memory-marker CD4-positive NK T cell number
MGI:7713407	Tmem151a<em#Zyw>	MP:0002066,abnormal motor capabilities/coordination/movement
MGI:7868163	Tmem151b<nmf389>	MP:0001650,abnormal seizure response to electrical stimulation|MP:0002064,seizures|MP:0002194,maximal tonic hindlimb extension seizures|MP:0003997,tonic-clonic seizures|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0020424,increased kindling response
MGI:5494963	Tmem151b<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0001650,abnormal seizure response to electrical stimulation|MP:0004924,abnormal behavior|MP:0005633,increased circulating sodium level|MP:0011396,abnormal sleep behavior|MP:0020424,increased kindling response|MP:0020870,decreased thigmotaxis
MGI:3711170	Tmem158<tm1Srn>	MP:0002006,neoplasm
MGI:7336126	Tmem160<em1.1Bros>	MP:0001442,decreased grooming behavior|MP:0004811,abnormal neuron physiology|MP:0005316,abnormal response to tactile stimuli|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0008713,abnormal cytokine level
MGI:7336125	Tmem160<em1Bros>	MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype
MGI:5755091	Tmem160<em1(IMPC)Tcp>	MP:0001120,abnormal uterus morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0009709,hydrometra
MGI:7519190	Tmem161b<em1Jgg>	MP:0000790,abnormal stratification in cerebral cortex|MP:0003631,nervous system phenotype|MP:0003648,abnormal radial glial cell morphology|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype|MP:0005391,vision/eye phenotype
MGI:7520066	Tmem161b<em2Jgg>	MP:0000790,abnormal stratification in cerebral cortex|MP:0003631,nervous system phenotype|MP:0003648,abnormal radial glial cell morphology|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype|MP:0005391,vision/eye phenotype
MGI:7520092	Tmem161b<em3Jgg>	MP:0000433,microcephaly|MP:0000454,abnormal jaw morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0003104,acrania|MP:0005371,limbs/digits/tail phenotype|MP:0005548,retina pigment epithelium atrophy|MP:0006254,thin cerebral cortex|MP:0009268,absent cerebellum fissure|MP:0030192,downturned snout
MGI:4302644	Tmem161b<Gt(OST389140)Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:5692723	Tmem161b<tm2b(EUCOMM)Hmgu>	MP:0000428,abnormal craniofacial morphology|MP:0001697,abnormal embryo size|MP:0003961,decreased lean body mass|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:6341959	Tmem163<em1(IMPC)Kmpc>	MP:0000063,decreased bone mineral density|MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0002075,abnormal coat/hair pigmentation|MP:0002941,increased circulating alanine transaminase level|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011239,abnormal skin coloration
MGI:6382394	Tmem163<em1(IMPC)Mbp>	MP:0002060,abnormal skin morphology|MP:0002079,increased circulating insulin level|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0006203,eye hemorrhage
MGI:7310327	Tmem163<em1Lwbch>	MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0009549,decreased platelet aggregation|MP:0020432,decreased platelet dense granule number
MGI:4432756	Tmem165<tm1e(EUCOMM)Wtsi>	MP:0001322,abnormal iris morphology|MP:0002590,increased mean corpuscular volume
MGI:4435969	Tmem167<tm1a(EUCOMM)Hmgu>	MP:0002644,decreased circulating triglyceride level|MP:0002965,increased circulating serum albumin level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level
MGI:7587147	Tmem169<em2Cya>	MP:0001409,increased stereotypic behavior|MP:0001441,increased grooming behavior|MP:0002797,increased thigmotaxis|MP:0002882,abnormal neuron morphology|MP:0003631,nervous system phenotype|MP:0004996,abnormal CNS synapse formation|MP:0005386,behavior/neurological phenotype|MP:0008143,abnormal dendrite morphology|MP:0008415,abnormal neurite morphology|MP:0011269,increased excitatory postsynaptic current amplitude|MP:0014254,increased paired-pulse ratio|MP:0014378,increased excitatory postsynaptic current frequency|MP:0014379,decreased excitatory postsynaptic current frequency|MP:0014416,decreased social novelty preference|MP:0020508,decreased dendritic spine density|MP:0020551,abnormal postsynaptic density morphology|MP:0021111,decreased social investigation
MGI:7426038	Tmem170b<em1(IMPC)Kmpc>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5692686	Tmem174<tm1.1(KOMP)Vlcg>	MP:0002135,abnormal kidney morphology|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis
MGI:7336005	Tmem174<tm1Myz>	MP:0001566,increased circulating phosphate level|MP:0002136,abnormal kidney physiology|MP:0002902,decreased urine phosphate level|MP:0002904,increased circulating parathyroid hormone level|MP:0005378,growth/size/body region phenotype|MP:0005418,abnormal circulating hormone level|MP:0006133,calcified artery
MGI:6695089	Tmem175<em1Dren>	MP:0000778,abnormal nervous system tract morphology|MP:0001405,impaired coordination|MP:0003172,abnormal lysosome physiology|MP:0003244,loss of dopaminergic neurons|MP:0004811,abnormal neuron physiology|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0008260,abnormal autophagy|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death
MGI:6695106	Tmem175<em2Dren>	MP:0003172,abnormal lysosome physiology|MP:0008236,decreased susceptibility to neuronal excitotoxicity|MP:0008407,decreased cellular sensitivity to hydrogen peroxide
MGI:6695108	Tmem175<em3Dren>	MP:0003172,abnormal lysosome physiology|MP:0008235,increased susceptibility to neuronal excitotoxicity|MP:0008493,alpha-synuclein inclusion body
MGI:6386298	Tmem175<tm1b(KOMP)Wtsi>	MP:0002059,abnormal seminal vesicle morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002833,increased heart weight|MP:0005343,increased circulating aspartate transaminase level|MP:0009141,increased prepulse inhibition|MP:0010053,decreased grip strength
MGI:7461559	Tmem176a<em1(IMPC)Kmpc>	MP:0000182,increased circulating LDL cholesterol level|MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment|MP:0002942,decreased circulating alanine transaminase level|MP:0005178,increased circulating cholesterol level|MP:0010123,increased bone mineral content
MGI:3664609	Tmem176b<tm1Tto>	MP:0000852,small cerebellum|MP:0000854,abnormal cerebellum development|MP:0000857,abnormal cerebellar foliation|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001393,ataxia
MGI:4419645	Tmem178b<tm1a(KOMP)Wtsi>	MP:0001258,decreased body length|MP:0002073,abnormal hair growth|MP:0010088,decreased circulating fructosamine level
MGI:5007374	Tmem178<tm1Lex>	MP:0000063,decreased bone mineral density|MP:0001541,abnormal osteoclast physiology|MP:0003724,increased susceptibility to induced arthritis|MP:0004016,decreased bone mass|MP:0004984,increased osteoclast cell number|MP:0004992,increased bone resorption|MP:0008396,abnormal osteoclast differentiation|MP:0009346,decreased trabecular bone thickness|MP:0010873,decreased trabecular bone mass|MP:0010879,decreased trabecular bone volume
MGI:6336143	Tmem17<em1(IMPC)Kmpc>	MP:0001404,no spontaneous movement|MP:0001491,unresponsive to tactile stimuli|MP:0001614,abnormal blood vessel morphology|MP:0001914,hemorrhage|MP:0002092,abnormal eye morphology|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:5585726	Tmem181a<tm1b(EUCOMM)Wtsi>	MP:0002833,increased heart weight
MGI:7587150	Tmem182<em1Cya>	MP:0001260,increased body weight|MP:0001264,increased body size|MP:0004818,increased skeletal muscle mass|MP:0009399,increased skeletal muscle fiber size|MP:0009401,increased skeletal muscle fiber diameter|MP:0009405,increased skeletal muscle fiber number|MP:0009421,increased gastrocnemius weight|MP:0009427,increased tibialis anterior weight|MP:0010226,increased quadriceps weight|MP:0010238,increased skeletal muscle weight|MP:0011808,abnormal myoblast differentiation|MP:0014695,increased cell adhesion|MP:0030945,abnormal myoblast migration|MP:0030959,abnormal myoblast fusion|MP:0031318,enhanced skeletal muscle regeneration
MGI:3941678	Tmem184b<Gt(IST10294F4)Tigm>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0002229,neurodegeneration|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003632,abnormal nervous system morphology|MP:0003633,abnormal nervous system physiology|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0008260,abnormal autophagy|MP:0008571,abnormal synaptic bouton morphology|MP:0010053,decreased grip strength
MGI:5583076	Tmem184b<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0002060,abnormal skin morphology|MP:0002339,abnormal lymph node morphology|MP:0002574,increased vertical activity|MP:0004924,abnormal behavior|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020870,decreased thigmotaxis
MGI:7577007	Tmem185b<em1(IMPC)J>	MP:0001304,cataract
MGI:4842746	Tmem18<tm1a(EUCOMM)Wtsi>	MP:0001260,increased body weight|MP:0003960,increased lean body mass|MP:0004889,increased energy expenditure|MP:0005658,increased susceptibility to diet-induced obesity|MP:0009285,increased gonadal fat pad weight|MP:0011939,increased food intake|MP:0014142,increased body fat mass|MP:0014170,increased brown adipose tissue mass
MGI:5637133	Tmem18<tm1b(EUCOMM)Wtsi>	MP:0005560,decreased circulating glucose level|MP:0013630,increased bone trabecular spacing
MGI:5308734	Tmem190<tm1Pmkf>	MP:0002169,no abnormal phenotype detected
MGI:6115602	Tmem192<tm2d(EUCOMM)Hmgu>	MP:0002169,no abnormal phenotype detected
MGI:5006987	Tmem198b<tm1Lex>	MP:0002635,reduced sensorimotor gating
MGI:6361174	Tmem19<em1Osb>	MP:0005389,reproductive system phenotype
MGI:7547167	Tmem201<em2Smoc>	MP:0002792,abnormal retina vasculature morphology|MP:0005602,decreased angiogenesis
MGI:6144256	Tmem203<em1(IMPC)H>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000194,increased circulating calcium level|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0001925,male infertility|MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0005179,decreased circulating cholesterol level|MP:0005333,decreased heart rate|MP:0009142,decreased prepulse inhibition|MP:0010506,prolonged RR interval
MGI:5770432	Tmem203<tm1.1Roml>	MP:0001146,abnormal testis morphology|MP:0001154,seminiferous tubule degeneration|MP:0001262,decreased body weight|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0004182,abnormal spermiation|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0009230,abnormal sperm head morphology|MP:0020352,abnormal endoplasmic reticulum physiology
MGI:4454669	Tmem204<tm1.1Ali>	MP:0010196,abnormal lymphatic vessel smooth muscle morphology|MP:0010200,enlarged lymphatic vessel
MGI:4454668	Tmem204<tm1Ali>	MP:0010200,enlarged lymphatic vessel
MGI:6156490	Tmem209<em1(IMPC)Tcp>	MP:0000470,abnormal stomach morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000914,exencephaly|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001697,abnormal embryo size|MP:0001711,abnormal placenta morphology|MP:0001925,male infertility|MP:0002059,abnormal seminal vesicle morphology|MP:0003717,pallor|MP:0009263,abnormal eyelid fusion|MP:0009908,protruding tongue|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011495,abnormal head shape|MP:0011496,abnormal head size
MGI:6830926	Tmem210<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6740211	Tmem212<em1(IMPC)J>	MP:0003131,increased erythrocyte cell number|MP:0005278,abnormal cholesterol homeostasis|MP:0005505,thrombocytosis|MP:0005632,decreased circulating aspartate transaminase level|MP:0009142,decreased prepulse inhibition
MGI:7587156	Tmem216<em1Cya>	MP:0000111,cleft palate|MP:0001293,anophthalmia|MP:0001614,abnormal blood vessel morphology|MP:0002639,micrognathia|MP:0003052,omphalocele|MP:0003077,abnormal cell cycle|MP:0004320,split sternum|MP:0005545,abnormal lens development|MP:0008528,polycystic kidney|MP:0009744,postaxial polydactyly|MP:0010865,prenatal growth retardation|MP:0011065,abnormal kidney epithelial cell primary cilium morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0013202,abnormal cilium morphology|MP:0020383,decreased kidney epithelial cell primary cilium length
MGI:4156922	Tmem218<Gt(OST40451)Lex>	MP:0000194,increased circulating calcium level|MP:0000522,kidney cortex cyst|MP:0001262,decreased body weight|MP:0002090,abnormal vision|MP:0002703,abnormal renal tubule morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003019,increased circulating chloride level|MP:0003215,renal interstitial fibrosis|MP:0003675,kidney cyst|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008515,thin retina outer nuclear layer|MP:0011346,renal tubule atrophy|MP:0012029,abnormal electroretinogram waveform feature|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:4399704	Tmem219<tm1(KOMP)Vlcg>	MP:0001273,decreased metastatic potential|MP:0002497,increased IgE level|MP:0005011,increased eosinophil cell number|MP:0005165,increased susceptibility to injury|MP:0005387,immune system phenotype|MP:0008672,increased interleukin-13 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008838,decreased transforming growth factor beta level|MP:0020344,abnormal susceptibility to injury induced morbidity/mortality|MP:0030002,increased lung apoptosis
MGI:5635439	Tmem222<tm1b(KOMP)Mbp>	MP:0006243,impaired pupillary reflex|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6276842	Tmem225<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000692,small spleen|MP:0001304,cataract|MP:0001925,male infertility|MP:0002188,small heart|MP:0002699,abnormal vitreous body morphology|MP:0009142,decreased prepulse inhibition|MP:0009453,enhanced contextual conditioning behavior|MP:0020420,abnormal freezing behavior
MGI:7738841	Tmem225<em1Jliu>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0003674,oxidative stress|MP:0004543,abnormal sperm physiology|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0008892,abnormal sperm flagellum morphology|MP:0009237,kinked sperm flagellum|MP:0009243,hairpin sperm flagellum|MP:0009831,abnormal sperm midpiece morphology|MP:0014246,decreased cellular ATP level|MP:0014537,increased calcium level|MP:0020451,decreased sperm progressive motility
MGI:4284576	Tmem231<Gt(OST335874)Lex>	MP:0000562,polydactyly|MP:0001297,microphthalmia|MP:0001614,abnormal blood vessel morphology|MP:0003861,abnormal nervous system development|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:7511695	Tmem232<em1Shliu>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009243,hairpin sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0020451,decreased sperm progressive motility|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0031356,abnormal outer dense fiber morphology
MGI:5006992	Tmem234<tm1Lex>	MP:0008500,increased IgG2a level
MGI:6150875	Tmem237<tm1b(EUCOMM)Hmgu>	MP:0000194,increased circulating calcium level|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000627,abnormal mammary gland morphology|MP:0000639,abnormal adrenal gland morphology|MP:0000702,enlarged lymph nodes|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001325,abnormal retina morphology|MP:0001552,increased circulating triglyceride level|MP:0002152,abnormal brain morphology|MP:0002339,abnormal lymph node morphology|MP:0002768,small adrenal glands|MP:0002968,increased circulating alkaline phosphatase level|MP:0003019,increased circulating chloride level|MP:0004357,long tibia|MP:0005238,increased brain size|MP:0005343,increased circulating aspartate transaminase level|MP:0005627,increased circulating potassium level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0020421,increased freezing behavior
MGI:6341826	Tmem240<em1(IMPC)Ccpcz>	MP:0000598,abnormal liver morphology|MP:0000745,tremors|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001364,decreased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002968,increased circulating alkaline phosphatase level|MP:0008935,decreased mean platelet volume|MP:0010053,decreased grip strength|MP:0013279,increased fasting circulating glucose level
MGI:7645535	Tmem241<em1Blsg>	MP:0001861,lung inflammation|MP:0003061,decreased aerobic running capacity|MP:0014473,increased pulmonary alveolus wall thickness|MP:0031632,increased lung cholesterol level
MGI:5637138	Tmem241<tm1b(EUCOMM)Wtsi>	MP:0002966,decreased circulating alkaline phosphatase level
MGI:6194765	Tmem247<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:5569952	Tmem248<tm1.1(KOMP)Vlcg>	MP:0000208,decreased hematocrit|MP:0000220,increased monocyte cell number|MP:0000494,abnormal cecum morphology|MP:0000495,abnormal colon morphology|MP:0000642,enlarged adrenal glands|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0001157,small seminal vesicle|MP:0001258,decreased body length|MP:0001926,female infertility|MP:0001944,abnormal pancreas morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002135,abnormal kidney morphology|MP:0002731,megacolon|MP:0002834,decreased heart weight|MP:0002875,decreased erythrocyte cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0003271,abnormal duodenum morphology|MP:0003402,decreased liver weight|MP:0003655,absent pancreas|MP:0003960,increased lean body mass|MP:0004002,abnormal jejunum morphology|MP:0004609,vertebral fusion|MP:0004956,decreased thymus weight|MP:0005179,decreased circulating cholesterol level|MP:0009476,enlarged cecum|MP:0009483,enlarged ileum|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0011503,distended jejunum|MP:0011882,enlarged duodenum
MGI:7495499	Tmem249<em1Osb>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002675,asthenozoospermia|MP:0004543,abnormal sperm physiology|MP:0004884,abnormal testis physiology|MP:0005389,reproductive system phenotype|MP:0009279,abnormal activated sperm motility|MP:0009282,decreased hyperactivated sperm motility|MP:0020451,decreased sperm progressive motility
MGI:4944325	Tmem254<tm2a(KOMP)Wtsi>	MP:0000195,decreased circulating calcium level
MGI:6152663	Tmem255a<em1(IMPC)Mbp>	MP:0020421,increased freezing behavior
MGI:4436032	Tmem255b<tm1a(EUCOMM)Hmgu>	MP:0000745,tremors|MP:0002833,increased heart weight
MGI:5573272	Tmem256<tm1.1(KOMP)Vlcg>	MP:0000208,decreased hematocrit|MP:0000220,increased monocyte cell number|MP:0001513,limb grasping|MP:0001529,abnormal vocalization|MP:0002764,short tibia|MP:0002874,decreased hemoglobin content|MP:0003795,abnormal bone structure|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010511,shortened PR interval|MP:0010571,shortened ST segment
MGI:5892142	Tmem258<tm1.1(KOMP)Vlcg>	MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0008537,increased susceptibility to induced colitis|MP:0008883,abnormal enterocyte proliferation|MP:0008885,increased enterocyte apoptosis|MP:0010180,increased susceptibility to weight loss|MP:0011092,embryonic lethality, complete penetrance|MP:0013298,increased susceptibility to colitis induced morbidity/mortality|MP:0013956,decreased colon length|MP:0020354,increased endoplasmic reticulum stress
MGI:5317185	Tmem259<tm1.1Itl>	MP:0002169,no abnormal phenotype detected
MGI:4365196	Tmem260<tm1a(KOMP)Wtsi>	MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount|MP:0013278,decreased fasting circulating glucose level
MGI:7612228	Tmem263<em1Gww>	MP:0000195,decreased circulating calcium level|MP:0001732,postnatal growth retardation|MP:0001935,decreased litter size|MP:0002176,increased brain weight|MP:0002727,decreased circulating insulin level|MP:0003109,short femur|MP:0003402,decreased liver weight|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003917,increased kidney weight|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004953,decreased spleen weight|MP:0005508,abnormal skeleton morphology|MP:0005560,decreased circulating glucose level|MP:0006396,decreased long bone epiphyseal plate size|MP:0008974,proportional dwarf|MP:0009346,decreased trabecular bone thickness|MP:0009642,abnormal blood homeostasis|MP:0010239,decreased skeletal muscle weight|MP:0010879,decreased trabecular bone volume
MGI:7312059	Tmem266<tm1Nig>	MP:0001409,increased stereotypic behavior
MGI:7709327	Tmem268<em1Cheyy>	MP:0001798,impaired macrophage phagocytosis|MP:0002412,increased susceptibility to bacterial infection|MP:0002442,abnormal leukocyte physiology|MP:0002451,abnormal macrophage physiology|MP:0002467,impaired neutrophil phagocytosis|MP:0003628,abnormal leukocyte adhesion|MP:0003884,decreased macrophage cell number|MP:0005387,immune system phenotype|MP:0008546,abnormal vesicle-mediated transport|MP:0008553,increased circulating tumor necrosis factor level|MP:0008575,increased circulating interferon-beta level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0012440,abnormal neutrophil cell number|MP:0012441,abnormal monocyte cell number|MP:0014431,increased chemokine level|MP:0020212,impaired leukocyte migration
MGI:6514815	Tmem26<tm1.1Uqah>	MP:0002169,no abnormal phenotype detected
MGI:6361177	Tmem270<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6341882	Tmem273<em1(IMPC)Ccpcz>	MP:0000137,abnormal vertebrae morphology|MP:0002100,abnormal tooth morphology|MP:0002135,abnormal kidney morphology|MP:0003036,vertebral transformation|MP:0003795,abnormal bone structure|MP:0005293,impaired glucose tolerance
MGI:6423830	Tmem278<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002060,abnormal skin morphology
MGI:6110574	Tmem30a<tm1.1Xjz>	MP:0000598,abnormal liver morphology|MP:0000611,jaundice|MP:0001006,abnormal retina cone cell morphology|MP:0001326,retina degeneration|MP:0001860,liver inflammation|MP:0002941,increased circulating alanine transaminase level|MP:0003255,bile duct proliferation|MP:0003333,liver fibrosis|MP:0003402,decreased liver weight|MP:0004022,abnormal cone electrophysiology|MP:0004174,abnormal spine curvature|MP:0004789,increased bile salt level|MP:0005150,cachexia|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005415,intrahepatic cholestasis|MP:0006309,decreased retina ganglion cell number|MP:0008444,retina cone cell degeneration|MP:0008447,absent retina cone cells|MP:0008515,thin retina outer nuclear layer|MP:0008584,photoreceptor outer segment degeneration|MP:0008585,absent photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0009773,absent retina|MP:0011092,embryonic lethality, complete penetrance|MP:0011584,increased alkaline phosphatase activity|MP:0020211,slow movement
MGI:5286179	Tmem30a<tm1a(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6110573	Tmem30a<tm1Xjz>	MP:0011092,embryonic lethality, complete penetrance
MGI:5692820	Tmem30b<tm1b(EUCOMM)Wtsi>	MP:0000538,abnormal urinary bladder morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0004738,abnormal auditory brainstem response
MGI:6307033	Tmem33<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0002574,increased vertical activity
MGI:6113597	Tmem35a<tm1.1(KOMP)Vlcg>	MP:0000693,spleen hyperplasia|MP:0001363,increased anxiety-related response|MP:0001473,reduced long-term potentiation|MP:0001745,increased circulating corticosterone level|MP:0002806,abnormal conditioned emotional response|MP:0003460,decreased fear-related response|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0008432,abnormal long-term spatial reference memory|MP:0009078,adrenal gland hyperplasia|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0031391,increased locomotor activity
MGI:7426043	Tmem35b<em1(IMPC)Bay>	MP:0001513,limb grasping
MGI:4441685	Tmem37<tm1a(EUCOMM)Wtsi>	MP:0005344,increased circulating bilirubin level
MGI:3716063	Tmem38a<tm1Hta>	MP:0005389,reproductive system phenotype
MGI:7465003	Tmem38b<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:3716065	Tmem38b<tm1Hta>	MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001179,thick pulmonary interalveolar septum|MP:0001575,cyanosis|MP:0001953,respiratory failure|MP:0001954,respiratory distress|MP:0002058,neonatal lethality|MP:0002133,abnormal respiratory system physiology|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0002275,abnormal type II pneumocyte morphology|MP:0003031,acidosis|MP:0004231,abnormal calcium ion homeostasis|MP:0004780,abnormal surfactant secretion|MP:0004781,abnormal surfactant composition|MP:0005039,hypoxia|MP:0006027,impaired lung alveolus development|MP:0010018,pulmonary vascular congestion|MP:0010813,abnormal alveolar lamellar body morphology|MP:0010825,abnormal lung saccule morphology|MP:0010889,small alveolar lamellar bodies|MP:0010890,decreased alveolar lamellar body number|MP:0011087,neonatal lethality, complete penetrance
MGI:4191483	Tmem41a<Gt(OST118933)Lex>	MP:0002169,no abnormal phenotype detected
MGI:6838393	Tmem41b<em1Cya>	MP:0000183,decreased circulating LDL cholesterol level|MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0011091,prenatal lethality, complete penetrance|MP:0020950,decreased susceptibility to Coronaviridae infection|MP:0030940,impaired autophagy
MGI:4232785	Tmem41b<Gt(OST208407)Lex>	MP:0001730,embryonic growth arrest|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0014134,abnormal embryo morphology
MGI:6256794	Tmem41b<tm1b(KOMP)Wtsi>	MP:0010090,increased circulating creatine kinase level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5636939	Tmem42<tm1b(KOMP)Wtsi>	MP:0000062,increased bone mineral density|MP:0000186,decreased circulating HDL cholesterol level|MP:0003960,increased lean body mass|MP:0010123,increased bone mineral content
MGI:6888277	Tmem43<em1Cby>	MP:0004300,abnormal organ of Corti supporting cell morphology|MP:0004396,decreased cochlear inner hair cell number|MP:0004739,conductive hearing loss|MP:0005377,hearing/vestibular/ear phenotype|MP:0005385,cardiovascular system phenotype|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:6358294	Tmem43<em1Chen>	MP:0005380,embryo phenotype|MP:0005385,cardiovascular system phenotype|MP:0010768,mortality/aging
MGI:4168877	Tmem43<Gt(OST62799)Lex>	MP:0001363,increased anxiety-related response
MGI:5550594	Tmem43<tm1b(EUCOMM)Wtsi>	MP:0005380,embryo phenotype|MP:0005385,cardiovascular system phenotype|MP:0010768,mortality/aging
MGI:6277067	Tmem45a<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0010053,decreased grip strength
MGI:6370168	Tmem45a<tm1.1Urfm>	MP:0010771,integument phenotype
MGI:7388444	Tmem45b<em1Tkwa>	MP:0002736,abnormal nociception after inflammation|MP:0002882,abnormal neuron morphology
MGI:6120758	Tmem50b<tm1b(EUCOMM)Wtsi>	MP:0002699,abnormal vitreous body morphology|MP:0010053,decreased grip strength|MP:0011962,increased cornea thickness
MGI:5792558	Tmem51<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0001406,abnormal gait|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0001556,increased circulating HDL cholesterol level|MP:0004738,abnormal auditory brainstem response|MP:0009142,decreased prepulse inhibition|MP:0010088,decreased circulating fructosamine level
MGI:6723864	Tmem53<em1Ikeg>	MP:0000547,short limbs|MP:0001255,decreased body height|MP:0001300,ocular hypertelorism|MP:0003109,short femur|MP:0003795,abnormal bone structure|MP:0003840,abnormal coronal suture morphology|MP:0004214,abnormal long bone diaphysis morphology|MP:0004635,short metatarsal bones|MP:0005006,abnormal osteoblast physiology|MP:0006398,increased long bone epiphyseal plate size|MP:0010029,abnormal basicranium morphology|MP:0011175,platyspondylia|MP:0011710,enhanced osteoblast differentiation|MP:0020039,increased bone ossification|MP:0030032,high forehead|MP:0030278,thick neurocranium|MP:0030417,craniofacial hyperostosis|MP:0030469,optic canal stenosis
MGI:6723866	Tmem53<em2Ikeg>	MP:0001255,decreased body height
MGI:6723867	Tmem53<em3Ikeg>	MP:0001255,decreased body height
MGI:6158675	Tmem59<tm1.1Tqw>	MP:0001417,decreased exploration in new environment|MP:0003107,abnormal response to novelty|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0004811,abnormal neuron physiology|MP:0008143,abnormal dendrite morphology|MP:0009538,abnormal synapse morphology|MP:0009936,abnormal dendritic spine morphology|MP:0020340,abnormal inhibitory learning|MP:0020508,decreased dendritic spine density|MP:0020551,abnormal postsynaptic density morphology
MGI:6152710	Tmem60<em1(IMPC)Ccpcz>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001925,male infertility|MP:0002135,abnormal kidney morphology|MP:0003233,prolonged QT interval|MP:0005333,decreased heart rate|MP:0005568,increased circulating total protein level|MP:0008935,decreased mean platelet volume|MP:0010506,prolonged RR interval|MP:0013771,decreased effector memory T-helper cell number
MGI:6341890	Tmem62<em1(IMPC)Ccpcz>	MP:0002764,short tibia|MP:0005333,decreased heart rate|MP:0008935,decreased mean platelet volume
MGI:5051187	Tmem63a<tm1(KOMP)Vlcg>	MP:0001406,abnormal gait
MGI:6693364	Tmem63b<em1Yss>	MP:0001967,deafness|MP:0004404,cochlear outer hair cell degeneration|MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004736,abnormal distortion product otoacoustic emission|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6693365	Tmem63b<em2Yss>	MP:0004404,cochlear outer hair cell degeneration|MP:0004736,abnormal distortion product otoacoustic emission|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5548796	Tmem63b<tm1b(EUCOMM)Wtsi>	MP:0001312,abnormal cornea morphology|MP:0001399,hyperactivity|MP:0001513,limb grasping|MP:0002764,short tibia|MP:0005344,increased circulating bilirubin level|MP:0011100,preweaning lethality, complete penetrance
MGI:6257549	Tmem63c<em1(IMPC)Rbrc>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology|MP:0010024,increased total body fat amount
MGI:3880885	Tmem64<Gt(SYA242)Byg>	MP:0000062,increased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0003795,abnormal bone structure|MP:0004985,decreased osteoclast cell number|MP:0004986,abnormal osteoblast morphology|MP:0004993,decreased bone resorption|MP:0005605,increased bone mass|MP:0008396,abnormal osteoclast differentiation|MP:0009347,increased trabecular bone thickness|MP:0010123,increased bone mineral content|MP:0010867,abnormal bone trabecula morphology|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0011710,enhanced osteoblast differentiation|MP:0020039,increased bone ossification|MP:0030984,increased circulating osteocalcin level
MGI:6316224	Tmem65<em1(IMPC)Tcp>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5433409	Tmem67<b2b1163.1Clo>	MP:0000284,double outlet right ventricle|MP:0004133,heterotaxia|MP:0004157,interrupted aortic arch|MP:0008528,polycystic kidney|MP:0010412,atrioventricular septal defect|MP:0010422,heart right ventricle hypoplasia
MGI:5437086	Tmem67<b2b1291.1Clo>	MP:0004133,heterotaxia|MP:0008528,polycystic kidney|MP:0010808,right-sided stomach|MP:0011253,situs inversus with levocardia
MGI:6342424	Tmem67<em1(IMPC)J>	MP:0001415,increased exploration in new environment|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:5292220	Tmem67<tm1Dgen>	MP:0000433,microcephaly|MP:0000460,mandible hypoplasia|MP:0000780,abnormal corpus callosum morphology|MP:0000829,dilated fourth ventricle|MP:0000852,small cerebellum|MP:0000866,cerebellum vermis hypoplasia|MP:0000914,exencephaly|MP:0000923,abnormal roof plate morphology|MP:0000928,incomplete rostral neuropore closure|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0001732,postnatal growth retardation|MP:0002081,perinatal lethality|MP:0002082,postnatal lethality|MP:0002151,abnormal neural tube morphology|MP:0003232,abnormal forebrain development|MP:0003632,abnormal nervous system morphology|MP:0003675,kidney cyst|MP:0003864,abnormal midbrain development|MP:0003943,abnormal hepatobiliary system development|MP:0004132,absent embryonic cilia|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005371,limbs/digits/tail phenotype|MP:0005384,cellular phenotype|MP:0006007,abnormal basal ganglion morphology|MP:0006100,abnormal tegmentum morphology|MP:0008227,absent anterior commissure|MP:0008282,enlarged hippocampus|MP:0009689,abnormal neural tube ventricular layer morphology|MP:0011056,abnormal brain ependyma motile cilium morphology|MP:0011066,abnormal renal tubule epithelial cell primary cilium morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011256,abnormal neural fold morphology|MP:0012138,decreased forebrain size|MP:0012139,increased forebrain size|MP:0012259,meningocele|MP:0012260,encephalomeningocele|MP:0012263,decreased hindbrain size|MP:0013202,abnormal cilium morphology|MP:0014278,semilobar holoprosencephaly|MP:0030309,abnormal posterior cranial fossa morphology|MP:0030943,abnormal centrosome morphology
MGI:4431978	Tmem68<tm1a(EUCOMM)Wtsi>	MP:0000194,increased circulating calcium level|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002644,decreased circulating triglyceride level|MP:0005316,abnormal response to tactile stimuli|MP:0005318,decreased triglyceride level|MP:0005628,decreased circulating potassium level|MP:0009356,decreased liver triglyceride level|MP:0010378,increased respiratory quotient|MP:0010768,mortality/aging|MP:0010951,abnormal lipid oxidation|MP:0011940,decreased food intake|MP:0014143,decreased body fat mass
MGI:6257555	Tmem70<em2(IMPC)Bay>	MP:0001672,abnormal embryo development|MP:0001691,abnormal somite shape|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0002151,abnormal neural tube morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4455478	Tmem70<tm1a(KOMP)Wtsi>	MP:0001698,decreased embryo size|MP:0002188,small heart|MP:0003674,oxidative stress|MP:0003794,delayed somite formation|MP:0003984,embryonic growth retardation|MP:0004188,delayed embryo turning|MP:0005319,abnormal enzyme/coenzyme level|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0010959,abnormal oxidative phosphorylation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011633,abnormal mitochondrial shape|MP:0011635,abnormal mitochondrial crista morphology|MP:0011636,disorganized mitochondrial cristae|MP:0012082,delayed heart development|MP:0012708,delayed rostral neuropore closure|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5897275	Tmem70<tm1b(KOMP)Wtsi>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6256796	Tmem72<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001488,increased startle reflex|MP:0001566,increased circulating phosphate level|MP:0002075,abnormal coat/hair pigmentation|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0003960,increased lean body mass|MP:0005564,increased hemoglobin content|MP:0005566,decreased blood urea nitrogen level|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength
MGI:6690870	Tmem74<em1Fehan>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002272,abnormal nervous system electrophysiology|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype
MGI:6156573	Tmem74<em1(IMPC)Tcp>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000706,small thymus|MP:0001126,abnormal ovary morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002631,abnormal epididymis morphology|MP:0011874,enlarged urinary bladder
MGI:5299918	Tmem79<m1J>	MP:0000402,abnormal zigzag hair morphology|MP:0000403,increased curvature of zigzag hairs|MP:0000411,shiny fur|MP:0000416,sparse hair|MP:0001191,abnormal skin condition|MP:0002075,abnormal coat/hair pigmentation
MGI:1856947	Tmem79<ma>	MP:0000414,alopecia|MP:0000427,abnormal hair cycle|MP:0001194,dermatitis|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001412,excessive scratching|MP:0001510,abnormal coat appearance|MP:0001874,acanthosis|MP:0002073,abnormal hair growth|MP:0002497,increased IgE level|MP:0002796,impaired skin barrier function|MP:0003704,abnormal hair follicle development|MP:0003809,abnormal hair shaft morphology|MP:0003810,abnormal hair cuticle|MP:0003846,matted coat|MP:0003848,brittle hair|MP:0004947,skin inflammation|MP:0005251,blepharitis|MP:0005409,darkened coat color|MP:0009594,abnormal corneocyte envelope morphology|MP:0009675,orthokeratosis|MP:0009801,abnormal hair cortex keratinization
MGI:5632528	Tmem79<tm1.1(KOMP)Wtsi>	MP:0000367,abnormal coat/ hair morphology|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001510,abnormal coat appearance|MP:0002833,increased heart weight|MP:0005561,increased mean corpuscular hemoglobin|MP:0011396,abnormal sleep behavior|MP:0013278,decreased fasting circulating glucose level
MGI:8193005	Tmem81<em1Osb>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0031010,failure of sperm-egg fusion
MGI:6194941	Tmem86a<tm1b(KOMP)Mbp>	MP:0002059,abnormal seminal vesicle morphology|MP:0002339,abnormal lymph node morphology|MP:0002764,short tibia|MP:0005565,increased blood urea nitrogen level
MGI:5692683	Tmem86b<tm2b(EUCOMM)Hmgu>	MP:0001566,increased circulating phosphate level
MGI:7614451	Tmem87a<em1Glwn>	MP:0003463,abnormal single cell response|MP:0003477,abnormal nerve fiber response|MP:0005386,behavior/neurological phenotype|MP:0005498,hyporesponsive to tactile stimuli|MP:0010055,abnormal sensory neuron physiology
MGI:7461568	Tmem87a<em1(IMPC)Kmpc>	MP:0002965,increased circulating serum albumin level|MP:0005278,abnormal cholesterol homeostasis|MP:0005292,improved glucose tolerance|MP:0005542,cornea vascularization
MGI:5805532	Tmem87b<em1(IMPC)J>	MP:0001556,increased circulating HDL cholesterol level
MGI:6257826	Tmem8b<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0001126,abnormal ovary morphology|MP:0001258,decreased body length|MP:0002059,abnormal seminal vesicle morphology|MP:0002092,abnormal eye morphology|MP:0002606,increased basophil cell number|MP:0003883,enlarged stomach|MP:0009142,decreased prepulse inhibition|MP:0011874,enlarged urinary bladder
MGI:6358488	Tmem94<em1Mcvm>	MP:0000267,abnormal heart development|MP:0001634,internal hemorrhage|MP:0002116,abnormal craniofacial bone morphology|MP:0002188,small heart|MP:0003743,abnormal facial morphology|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0004471,short nasal bone|MP:0005294,abnormal heart ventricle morphology|MP:0006009,abnormal neuronal migration|MP:0008439,abnormal cortical plate morphology|MP:0008443,absent subplate|MP:0008547,abnormal neocortex morphology|MP:0010489,abnormal heart atrium auricular region morphology|MP:0010630,abnormal cardiac muscle tissue morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0030245,round head|MP:0031511,globular heart
MGI:4432189	Tmem94<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:6460450	Tmem95<em1Beal>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0031010,failure of sperm-egg fusion
MGI:7327523	Tmem95<em1Nino>	MP:0001922,reduced male fertility|MP:0009647,decreased fertilization frequency|MP:0031010,failure of sperm-egg fusion
MGI:6437561	Tmem95<em1Osb>	MP:0001925,male infertility|MP:0031010,failure of sperm-egg fusion
MGI:6459765	Tmem97<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5548577	Tmem97<tm1.1(KOMP)Vlcg>	MP:0000208,decreased hematocrit|MP:0001147,small testis|MP:0001529,abnormal vocalization|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0010067,increased red blood cell distribution width
MGI:6355418	Tmem98<em1Jkn>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005102,abnormal iris pigmentation|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0010768,mortality/aging
MGI:7520866	Tmem98<em1Siggs>	MP:0005380,embryo phenotype|MP:0005391,vision/eye phenotype|MP:0012671,retina spots|MP:0021107,retina fold
MGI:6355419	Tmem98<em2Jkn>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005102,abnormal iris pigmentation|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0010768,mortality/aging
MGI:2178433	Tmem98<Rwhs>	MP:0001328,disorganized retina layers|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005102,abnormal iris pigmentation|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0010768,mortality/aging|MP:0011089,perinatal lethality, complete penetrance|MP:0012671,retina spots
MGI:4432615	Tmem98<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0011100,preweaning lethality, complete penetrance
MGI:5784648	Tmem9b<em1(IMPC)J>	MP:0001556,increased circulating HDL cholesterol level|MP:0002591,decreased mean corpuscular volume|MP:0005178,increased circulating cholesterol level|MP:0010024,increased total body fat amount|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6273211	Tmem9<tm1d(EUCOMM)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:2678008	Tmevd5<C57BL/6J>	MP:0000921,demyelination
MGI:2669661	Tmevd6<BALB/cByJ>	MP:0000921,demyelination
MGI:2669662	Tmevd6<DBA/2J>	MP:0000921,demyelination
MGI:2669664	Tmevd7<DBA/2J>	MP:0000921,demyelination
MGI:2669667	Tmevd8<DBA/2J>	MP:0000921,demyelination
MGI:2669669	Tmevd9<DBA/2J>	MP:0000921,demyelination
MGI:3620800	Tmevp2<C57BL/10SnSg>	MP:0020938,decreased susceptibility to Picornaviridae infection
MGI:3620798	Tmevp3<C57BL/10SnSg>	MP:0020938,decreased susceptibility to Picornaviridae infection
MGI:4867392	Tmf1<tm1.1Unir>	MP:0001919,abnormal reproductive system physiology|MP:0002160,abnormal reproductive system morphology
MGI:4867389	Tmf1<tm1Unir>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0004852,decreased testis weight|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0008839,absent acrosome|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology
MGI:2448277	tmgc10	MP:0001360,abnormal social investigation|MP:0001362,abnormal anxiety-related response|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002573,behavioral despair
MGI:2448595	tmgc11	MP:0001486,abnormal startle reflex|MP:0001488,increased startle reflex|MP:0003088,abnormal prepulse inhibition
MGI:2448638	tmgc12	MP:0002629,hyperactivity elicited by ethanol administration
MGI:2671110	tmgc14	MP:0000371,diluted coat color
MGI:2671106	Tmgc15	MP:0000592,short tail
MGI:2670736	Tmgc16	MP:0000585,kinked tail|MP:0000592,short tail
MGI:2670719	tmgc17	MP:0000373,belly spot|MP:0000564,syndactyly|MP:0000585,kinked tail
MGI:2670675	Tmgc18	MP:0000371,diluted coat color
MGI:2669904	Tmgc19	MP:0000373,belly spot|MP:0002082,postnatal lethality|MP:0002940,variable body spotting
MGI:2448637	tmgc2	MP:0001402,decreased locomotor activity
MGI:2669975	tmgc20	MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0002629,hyperactivity elicited by ethanol administration|MP:0004738,abnormal auditory brainstem response|MP:0006325,impaired hearing
MGI:2669969	Tmgc21	MP:0000373,belly spot|MP:0002940,variable body spotting|MP:0009379,abnormal foot pigmentation
MGI:2670296	tmgc22	MP:0002864,abnormal ocular fundus morphology|MP:0005098,abnormal optic choroid morphology|MP:0005100,abnormal choroid pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology
MGI:2670298	tmgc23	MP:0002792,abnormal retina vasculature morphology|MP:0005098,abnormal optic choroid morphology|MP:0005201,abnormal retina pigment epithelium morphology
MGI:2670422	tmgc24	MP:0001330,abnormal optic nerve morphology|MP:0005098,abnormal optic choroid morphology|MP:0008259,abnormal optic disk morphology
MGI:2670435	tmgc25	MP:0002864,abnormal ocular fundus morphology|MP:0005098,abnormal optic choroid morphology|MP:0005100,abnormal choroid pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology
MGI:2670866	tmgc27	MP:0000022,abnormal ear shape|MP:0001891,hydrocephaly
MGI:2670877	tmgc28	MP:0000585,kinked tail|MP:0001265,decreased body size|MP:0001410,head bobbing|MP:0001924,infertility
MGI:2670277	tmgc29	MP:0002864,abnormal ocular fundus morphology|MP:0005098,abnormal optic choroid morphology|MP:0005100,abnormal choroid pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005239,abnormal Bruch membrane morphology
MGI:2671047	tmgc30	MP:0001362,abnormal anxiety-related response|MP:0002573,behavioral despair
MGI:2669998	tmgc31	MP:0001454,abnormal cued conditioning behavior
MGI:2670252	tmgc32	MP:0000857,abnormal cerebellar foliation|MP:0001525,impaired balance|MP:0002082,postnatal lethality
MGI:2448786	tmgc33	MP:0001265,decreased body size|MP:0003051,curly tail|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2448971	tmgc34	MP:0001265,decreased body size
MGI:3053004	tmgc35	MP:0009758,impaired behavioral response to cocaine
MGI:3053560	tmgc36	MP:0001297,microphthalmia|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3053561	tmgc37	MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3053563	tmgc38	MP:0001973,increased thermal nociceptive threshold|MP:0002734,abnormal mechanical nociception|MP:0003043,hypoalgesia|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3053566	tmgc39	MP:0002073,abnormal hair growth
MGI:2448644	tmgc4	MP:0000849,abnormal cerebellum morphology|MP:0000887,delaminated cerebellar granule layer|MP:0000889,abnormal cerebellar molecular layer
MGI:3053565	tmgc40	MP:0003088,abnormal prepulse inhibition
MGI:3053564	tmgc41	MP:0002557,abnormal social/conspecific interaction behavior
MGI:3511452	tmgc42	MP:0006009,abnormal neuronal migration|MP:0006325,impaired hearing|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3511453	tmgc43	MP:0009758,impaired behavioral response to cocaine
MGI:3589238	tmgc44	MP:0001394,circling|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3589243	tmgc46	MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3589246	tmgc47	MP:0005189,abnormal anogenital distance|MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3589248	tmgc49	MP:0001987,alcohol preference|MP:0003545,increased alcohol consumption
MGI:2448646	tmgc5	MP:0000813,abnormal hippocampus layer morphology|MP:0009940,abnormal hippocampus pyramidal cell morphology
MGI:3589249	tmgc50	MP:0002119,dipsosis|MP:0003545,increased alcohol consumption|MP:0011941,increased fluid intake
MGI:3589250	tmgc52	MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3589252	tmgc53	MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3589253	tmgc54	MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3589254	tmgc55	MP:0001987,alcohol preference|MP:0003546,decreased alcohol consumption
MGI:3589256	tmgc56	MP:0001516,abnormal motor coordination/balance|MP:0002066,abnormal motor capabilities/coordination/movement
MGI:3589257	tmgc57	MP:0002573,behavioral despair|MP:0003360,abnormal depression-related behavior
MGI:3589258	tmgc58	MP:0001364,decreased anxiety-related response
MGI:3614273	tmgc59	MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2448653	tmgc6	MP:0000781,decreased corpus callosum size|MP:0002175,decreased brain weight
MGI:3614275	tmgc60	MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3614276	tmgc61	MP:0002887,decreased susceptibility to pharmacologically induced seizures
MGI:3614277	tmgc62	MP:0001486,abnormal startle reflex|MP:0003088,abnormal prepulse inhibition
MGI:3614278	tmgc63	MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3614280	tmgc64	MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3664658	tmgc65	MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3664653	tmgc66	MP:0006325,impaired hearing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3052999	tmgc7	MP:0001423,abnormal liquid preference|MP:0001426,polydipsia
MGI:2448272	tmgc8	MP:0001362,abnormal anxiety-related response|MP:0002573,behavioral despair|MP:0002574,increased vertical activity
MGI:2448266	Tmgc9	MP:0001405,impaired coordination
MGI:6196082	Tmie<em1(IMPC)J>	MP:0001410,head bobbing|MP:0001486,abnormal startle reflex|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0004924,abnormal behavior|MP:0005655,increased aggression|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1857053	Tmie<sr>	MP:0001265,decreased body size|MP:0001382,abnormal nursing|MP:0001394,circling|MP:0001395,bidirectional circling|MP:0001522,impaired swimming|MP:0001525,impaired balance|MP:0001961,abnormal reflex|MP:0001967,deafness|MP:0002730,head shaking|MP:0002857,cochlear ganglion degeneration|MP:0003150,detached tectorial membrane|MP:0004331,vestibular saccular macula degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004813,absent linear vestibular evoked potential|MP:0004924,abnormal behavior
MGI:3819109	Tmie<sr-2J>	MP:0001394,circling|MP:0001967,deafness|MP:0005191,head tilt
MGI:2182706	Tmie<sr-J>	MP:0001394,circling|MP:0001486,abnormal startle reflex|MP:0002730,head shaking|MP:0004924,abnormal behavior
MGI:6506201	Tmigd1<em1Gpt>	MP:0000488,abnormal intestinal epithelium morphology|MP:0002404,increased intestinal adenoma incidence
MGI:5909983	Tmigd3<Tg(H2-K-CALR*)del52Shmd>	MP:0000229,abnormal megakaryocyte differentiation|MP:0002417,abnormal megakaryocyte morphology|MP:0005505,thrombocytosis|MP:0008254,increased megakaryocyte cell number|MP:0013704,increased megakaryocyte-erythroid progenitor cell number|MP:0013891,increased common myeloid progenitor cell number
MGI:7426046	Tmlhe<em1(IMPC)Bay>	MP:0000443,abnormal snout morphology|MP:0000556,abnormal hindlimb morphology|MP:0001406,abnormal gait
MGI:7564264	Tmlhe<em1Plaa>	MP:0000266,abnormal heart morphology|MP:0000343,abnormal response to cardiac infarction|MP:0003038,decreased myocardial infarct size|MP:0003978,decreased circulating carnitine level|MP:0004215,abnormal myocardial fiber physiology|MP:0005280,abnormal fatty acids level|MP:0005281,increased fatty acids level|MP:0005283,increased unsaturated fatty acids level|MP:0005386,behavior/neurological phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0013404,decreased circulating lactate level|MP:0014172,decreased fatty acid oxidation|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:5320501	tmm	MP:0000781,decreased corpus callosum size|MP:0001963,abnormal hearing physiology|MP:0005238,increased brain size|MP:0005386,behavior/neurological phenotype|MP:0008232,abnormal cingulum morphology|MP:0011723,ectopic neuron
MGI:3522307	Tmmch	MP:0020470,shortened circadian behavior period
MGI:4461475	Tmod1<tm1a(KOMP)Wtsi>	MP:0001260,increased body weight|MP:0002968,increased circulating alkaline phosphatase level
MGI:3043840	Tmod1<tm1Sung>	MP:0000259,abnormal vascular development|MP:0000269,abnormal heart looping|MP:0000270,abnormal heart tube morphology|MP:0001577,anemia|MP:0001636,irregular heartbeat|MP:0002085,abnormal embryonic tissue morphology|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002447,abnormal erythrocyte morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004230,abnormal embryonic erythrocyte morphology|MP:0005312,pericardial effusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0014730,abnormal myocardial fiber myofibril morphology
MGI:2687078	Tmod1<tm1Vmf>	MP:0000267,abnormal heart development|MP:0000292,distended pericardium|MP:0000293,absent myocardial trabeculae|MP:0001627,abnormal cardiac output|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002652,thin myocardium|MP:0002972,abnormal cardiac muscle contractility|MP:0003984,embryonic growth retardation|MP:0004086,absent heartbeat|MP:0004090,abnormal sarcomere morphology|MP:0006107,abnormal fetal atrioventricular canal morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011205,excessive folding of visceral yolk sac|MP:0012176,abnormal head development|MP:0014729,abnormal myocardial fiber myofibril maturation
MGI:5609348	Tmod2<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003795,abnormal bone structure|MP:0004924,abnormal behavior|MP:0010124,decreased bone mineral content|MP:0011396,abnormal sleep behavior|MP:0020870,decreased thigmotaxis
MGI:2664500	Tmod2<tm1Hzo>	MP:0001405,impaired coordination|MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0002574,increased vertical activity|MP:0003008,enhanced long-term potentiation|MP:0031391,increased locomotor activity
MGI:2664502	Tmod2<tm2Hzo>	MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001489,decreased startle reflex|MP:0003008,enhanced long-term potentiation|MP:0009142,decreased prepulse inhibition
MGI:4127953	Tmod3<Gt(RRF004)Byg>	MP:0000245,abnormal erythropoiesis|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001577,anemia|MP:0002875,decreased erythrocyte cell number|MP:0003077,abnormal cell cycle|MP:0003717,pallor|MP:0008973,decreased erythroid progenitor cell number|MP:0009395,increased nucleated erythrocyte cell number|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011176,abnormal erythroblast morphology
MGI:4419118	Tmod4<tm1(KOMP)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:3835992	Tmpo<tm1.1Foi>	MP:0000572,abnormal autopod morphology|MP:0001219,thick epidermis|MP:0002608,increased hematocrit|MP:0003077,abnormal cell cycle|MP:0003135,increased erythroid progenitor cell number|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0008883,abnormal enterocyte proliferation
MGI:3604454	Tmprss11a<tm1Dgen>	MP:0000659,prostate gland hyperplasia|MP:0002169,no abnormal phenotype detected
MGI:5293641	Tmprss11d<tm1Bug>	MP:0012431,increased lymphoma incidence
MGI:6364120	Tmprss11f<em1Bug>	MP:0002796,impaired skin barrier function
MGI:6360461	Tmprss11f<em1Nju>	MP:0002796,impaired skin barrier function|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:7280668	Tmprss12<em1Huizh>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0003666,impaired sperm capacitation|MP:0004542,impaired acrosome reaction|MP:0004543,abnormal sperm physiology|MP:0004901,decreased male germ cell number|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0009647,decreased fertilization frequency|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011635,abnormal mitochondrial crista morphology|MP:0011751,abnormal X-Y chromosome synapsis during male meiosis|MP:0014052,increased male germ cell apoptosis|MP:0014764,impaired double-strand DNA break repair|MP:0020451,decreased sperm progressive motility
MGI:7507211	Tmprss12<em1(IMPC)Mbp>	MP:0001925,male infertility|MP:0002092,abnormal eye morphology
MGI:6455010	Tmprss12<em4Osb>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0030978,impaired binding of sperm to zona pellucida|MP:0031012,impaired sperm migration in female genital tract
MGI:3663353	Tmprss13<tm1Dgen>	MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001282,short vibrissae|MP:0002169,no abnormal phenotype detected|MP:0002796,impaired skin barrier function|MP:0005376,homeostasis/metabolism phenotype|MP:0010771,integument phenotype
MGI:4364308	Tmprss15<tm1a(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000218,increased leukocyte cell number|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002942,decreased circulating alanine transaminase level|MP:0003019,increased circulating chloride level|MP:0005179,decreased circulating cholesterol level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0005633,increased circulating sodium level|MP:0008806,increased circulating amylase level|MP:0010025,decreased total body fat amount
MGI:7426047	Tmprss2<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002631,abnormal epididymis morphology|MP:0002941,increased circulating alanine transaminase level|MP:0004931,enlarged epididymis
MGI:5578606	Tmprss2<tm1.1(ERG)Sho>	MP:0002006,neoplasm|MP:0005389,reproductive system phenotype
MGI:4399580	Tmprss2<tm1(KOMP)Vlcg>	MP:0001861,lung inflammation|MP:0003009,abnormal cytokine secretion|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0020950,decreased susceptibility to Coronaviridae infection|MP:0031045,decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:3526414	Tmprss2<tm1Psn>	MP:0002169,no abnormal phenotype detected|MP:0020947,decreased susceptibility to Orthomyxoviridae infection|MP:0031045,decreased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:5578607	Tmprss2<tm2.1(ETV1)Sho>	MP:0002006,neoplasm|MP:0003608,prostate gland inflammation|MP:0005389,reproductive system phenotype|MP:0011385,abnormal testosterone level
MGI:5812917	Tmprss2<tm2b(EUCOMM)Hmgu>	MP:0001469,abnormal contextual conditioning behavior|MP:0004738,abnormal auditory brainstem response|MP:0005140,decreased cardiac muscle contractility|MP:0005292,improved glucose tolerance|MP:0005568,increased circulating total protein level|MP:0013279,increased fasting circulating glucose level
MGI:5009322	Tmprss3<m1Ingm>	MP:0000031,abnormal cochlea morphology|MP:0000042,abnormal organ of Corti morphology|MP:0000043,organ of Corti degeneration|MP:0000048,abnormal stria vascularis morphology|MP:0001405,impaired coordination|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0002857,cochlear ganglion degeneration|MP:0004324,vestibular hair cell degeneration|MP:0004325,absent vestibular hair cells|MP:0004362,cochlear hair cell degeneration|MP:0004397,absent cochlear inner hair cells|MP:0004398,cochlear inner hair cell degeneration|MP:0004403,absent cochlear outer hair cells|MP:0004404,cochlear outer hair cell degeneration|MP:0004405,absent cochlear hair cells|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004737,absent distortion product otoacoustic emissions|MP:0004742,abnormal vestibular system physiology|MP:0005377,hearing/vestibular/ear phenotype|MP:0006089,abnormal vestibular saccule morphology|MP:0011060,abnormal kinocilium morphology|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5806232	Tmprss4<tm1.2Hum>	MP:0002169,no abnormal phenotype detected
MGI:5822806	Tmprss6<hem8>	MP:0000414,alopecia|MP:0002591,decreased mean corpuscular volume|MP:0004151,decreased circulating iron level|MP:0005397,hematopoietic system phenotype|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005637,abnormal iron homeostasis|MP:0008743,decreased liver iron level|MP:0011896,increased circulating unsaturated transferrin level
MGI:3812005	Tmprss6<m2Btlr>	MP:0000414,alopecia|MP:0004151,decreased circulating iron level|MP:0009004,progressive hair loss
MGI:3829007	Tmprss6<m3Btlr>	MP:0000414,alopecia|MP:0000416,sparse hair|MP:0001923,reduced female fertility|MP:0004151,decreased circulating iron level
MGI:5806439	Tmprss6<m5Btlr>	MP:0000418,focal hair loss
MGI:3776631	Tmprss6<msk>	MP:0000414,alopecia|MP:0001265,decreased body size|MP:0001670,abnormal intestinal mineral absorption|MP:0001926,female infertility|MP:0002591,decreased mean corpuscular volume|MP:0002810,microcytic anemia|MP:0002874,decreased hemoglobin content|MP:0004151,decreased circulating iron level|MP:0005637,abnormal iron homeostasis|MP:0008808,decreased spleen iron level|MP:0009004,progressive hair loss
MGI:6120748	Tmprss6<tm1b(EUCOMM)Wtsi>	MP:0000194,increased circulating calcium level|MP:0000208,decreased hematocrit|MP:0000367,abnormal coat/ hair morphology|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001510,abnormal coat appearance|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002591,decreased mean corpuscular volume|MP:0002764,short tibia|MP:0002833,increased heart weight|MP:0002874,decreased hemoglobin content|MP:0005387,immune system phenotype|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008045,decreased NK cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0009142,decreased prepulse inhibition|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013279,increased fasting circulating glucose level|MP:0013648,increased CD11b-high dendritic cell number|MP:0013676,increased Ly6C-positive mature NK cell number
MGI:4457116	Tmprss6<tm1Dgen>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000414,alopecia|MP:0001265,decreased body size|MP:0001770,abnormal iron level|MP:0002447,abnormal erythrocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0002810,microcytic anemia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003718,maternal effect|MP:0004151,decreased circulating iron level|MP:0004952,increased spleen weight|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005637,abnormal iron homeostasis|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008743,decreased liver iron level|MP:0008808,decreased spleen iron level|MP:0010067,increased red blood cell distribution width|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011896,increased circulating unsaturated transferrin level|MP:0013303,decreased pancreas iron level|MP:0020368,decreased heart iron level
MGI:3809291	Tmprss6<tm1Otin>	MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0001770,abnormal iron level|MP:0001926,female infertility|MP:0002447,abnormal erythrocyte morphology|MP:0002641,anisopoikilocytosis|MP:0002813,microcytosis|MP:0002874,decreased hemoglobin content|MP:0003582,abnormal ovary development|MP:0003717,pallor|MP:0004151,decreased circulating iron level|MP:0010682,abnormal hair follicle infundibulum morphology|MP:0010689,thin hair follicle outer root sheath
MGI:6393876	Tmprss9<tm1.3Hzo>	MP:0001260,increased body weight|MP:0001360,abnormal social investigation|MP:0001458,abnormal object recognition memory|MP:0001973,increased thermal nociceptive threshold|MP:0003631,nervous system phenotype|MP:0020396,abnormal social recognition
MGI:5646574	Tmr10	MP:0001364,decreased anxiety-related response
MGI:3794752	Tmrb1<C57BL/6J>	MP:0003951,abnormal copper homeostasis|MP:0008811,abnormal brain iron level
MGI:3794757	Tmrb2<C57BL/6J>	MP:0000192,abnormal mineral level|MP:0003952,abnormal copper level
MGI:7485946	Tmsb10<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001289,persistence of hyaloid vascular system|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010392,prolonged QRS complex duration
MGI:7377687	Tmsb4x<em1(IMPC)Mbp>	MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0002060,abnormal skin morphology|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:5427989	Tmsb4x<tm1.1Chen>	MP:0002169,no abnormal phenotype detected|MP:0005385,cardiovascular system phenotype
MGI:5427990	Tmsb4x<tm1.2Chen>	MP:0002169,no abnormal phenotype detected
MGI:5427987	Tmsb4x<tm1Chen>	MP:0002169,no abnormal phenotype detected
MGI:5487444	Tmsb4x<tm1Prri>	MP:0001614,abnormal blood vessel morphology|MP:0001634,internal hemorrhage|MP:0001915,intracranial hemorrhage|MP:0002652,thin myocardium|MP:0004112,abnormal arteriole morphology|MP:0005244,hemopericardium|MP:0005391,vision/eye phenotype|MP:0009698,heart hemorrhage|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011401,abnormal vascular smooth muscle development
MGI:3522306	Tmshr	MP:0020470,shortened circadian behavior period
MGI:5574603	Tmt1b<tm1.1(KOMP)Vlcg>	MP:0002075,abnormal coat/hair pigmentation|MP:0003020,decreased circulating chloride level|MP:0005560,decreased circulating glucose level
MGI:7426050	Tmtc2<em2(IMPC)Kmpc>	MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0009453,enhanced contextual conditioning behavior|MP:0010025,decreased total body fat amount
MGI:4124060	Tmtc3<Gt(JST185)Byg>	MP:0001176,abnormal lung development|MP:0001183,overexpanded pulmonary alveolus|MP:0001575,cyanosis|MP:0001732,postnatal growth retardation|MP:0001953,respiratory failure|MP:0005076,abnormal cell differentiation|MP:0006027,impaired lung alveolus development|MP:0010906,abnormal lung bud morphology|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5694185	Tmtc3<tm1b(EUCOMM)Wtsi>	MP:0003928,increased heart rate variability|MP:0004122,abnormal sinus arrhythmia|MP:0011110,preweaning lethality, incomplete penetrance
MGI:8210905	Tmtc4<em1Dkc>	MP:0004362,cochlear hair cell degeneration|MP:0004749,nonsyndromic hearing loss|MP:0005377,hearing/vestibular/ear phenotype|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014406,increased or absent distortion product otoacoustic emission threshold
MGI:5708220	Tmtc4<tm1.1(KOMP)Vlcg>	MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0004738,abnormal auditory brainstem response|MP:0009142,decreased prepulse inhibition|MP:0013278,decreased fasting circulating glucose level
MGI:5008116	Tmtc4<tm1(KOMP)Vlcg>	MP:0000032,cochlear degeneration|MP:0000043,organ of Corti degeneration|MP:0002857,cochlear ganglion degeneration|MP:0004231,abnormal calcium ion homeostasis|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004465,degeneration of organ of Corti supporting cells|MP:0004737,absent distortion product otoacoustic emissions|MP:0004740,sensorineural hearing loss|MP:0006325,impaired hearing|MP:0008943,increased sensitivity to induced cell death|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0020352,abnormal endoplasmic reticulum physiology|MP:0020354,increased endoplasmic reticulum stress
MGI:3522309	Tmtrav	MP:0020469,prolonged circadian behavior period
MGI:3522310	Tmtri	MP:0020470,shortened circadian behavior period
MGI:4842927	Tmub1<tm1(KOMP)Vlcg>	MP:0001648,abnormal apoptosis|MP:0001921,reduced fertility|MP:0005621,abnormal cell physiology|MP:0006036,abnormal mitochondrial physiology|MP:0008944,decreased sensitivity to induced cell death|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5007386	Tmub1<tm1Lex>	MP:0000220,increased monocyte cell number|MP:0001399,hyperactivity|MP:0001501,abnormal sleep pattern|MP:0008853,decreased abdominal adipose tissue amount|MP:0010025,decreased total body fat amount|MP:0014639,decreased sleep duration|MP:0031391,increased locomotor activity
MGI:5696911	Tmub2<tm1b(KOMP)Wtsi>	MP:0001488,increased startle reflex|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0010123,increased bone mineral content
MGI:5007388	Tmx1<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:5779820	Tmx2<tm1.1(KOMP)Vlcg>	MP:0001730,embryonic growth arrest|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012058,abnormal morula morphology|MP:0012129,failure of blastocyst formation|MP:0013292,embryonic lethality prior to organogenesis
MGI:3033599	Tnbs1<SJL/J>	MP:0008537,increased susceptibility to induced colitis
MGI:3033601	Tnbs2<SJL/J>	MP:0008537,increased susceptibility to induced colitis|MP:0008669,increased interleukin-12b secretion
MGI:2388370	Tnc<tm1Msch>	MP:0001364,decreased anxiety-related response|MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0003461,abnormal response to novel object|MP:0004000,impaired passive avoidance behavior|MP:0010053,decreased grip strength|MP:0020476,abnormal circardian behavior entrainment
MGI:2148541	Tnc<tm1Ref>	MP:0002169,no abnormal phenotype detected
MGI:2148540	Tnc<tm1Sia>	MP:0001409,increased stereotypic behavior|MP:0001522,impaired swimming|MP:0002169,no abnormal phenotype detected|MP:0002206,abnormal CNS synaptic transmission|MP:0005322,abnormal serotonin level|MP:0005377,hearing/vestibular/ear phenotype|MP:0005643,decreased dopamine level|MP:0020467,abnormal circadian behavior|MP:0031391,increased locomotor activity
MGI:2154363	Tne1<NZB/BlNJ>	MP:0001405,impaired coordination
MGI:4433727	Tnfaip1<tm1a(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001391,abnormal tail movements|MP:0001552,increased circulating triglyceride level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005559,increased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0010053,decreased grip strength
MGI:7564565	Tnfaip2<tm1.1Ohno>	MP:0002136,abnormal kidney physiology|MP:0002871,albuminuria|MP:0005264,glomerulosclerosis|MP:0005326,abnormal podocyte morphology|MP:0005558,decreased creatinine clearance|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008140,podocyte foot process effacement|MP:0011282,increased podocyte apoptosis|MP:0011293,dilated nephron|MP:0011402,renal cast|MP:0011498,abnormal glomerular capsule parietal layer morphology|MP:0011753,decreased podocyte number|MP:0011863,abnormal podocyte physiology
MGI:7266848	Tnfaip3<m1Apb>	MP:0000628,abnormal mammary gland development|MP:0000662,abnormal branching of the mammary ductal tree|MP:0000702,enlarged lymph nodes|MP:0001923,reduced female fertility|MP:0001927,abnormal estrous cycle|MP:0002079,increased circulating insulin level|MP:0002680,decreased corpora lutea number|MP:0002773,decreased circulating luteinizing hormone level|MP:0005186,increased circulating progesterone level|MP:0005331,insulin resistance|MP:0005425,increased macrophage cell number|MP:0006082,CNS inflammation|MP:0008976,delayed female fertility|MP:0009011,prolonged diestrus|MP:0009018,short estrus|MP:0009080,uterus inflammation|MP:0009505,abnormal mammary gland lobule morphology|MP:0012075,impaired mammary gland growth during pregnancy|MP:0013278,decreased fasting circulating glucose level|MP:0013772,increased effector memory T-helper cell number|MP:0020448,increased microglial cell activation|MP:0021029,increased tumor necrosis factor (ligand) superfamily member 11 level|MP:0021032,increased tumor necrosis factor receptor superfamily member 11b level|MP:0031381,decreased secondary ovarian follicle number
MGI:5291646	Tnfaip3<tm1.1Awai>	MP:0000691,enlarged spleen|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005154,increased B cell proliferation|MP:0008168,decreased B-1a cell number|MP:0008170,decreased B-1b cell number|MP:0008173,increased follicular B cell number|MP:0008177,increased germinal center B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008211,decreased mature B cell number|MP:0008500,increased IgG2a level|MP:0009338,increased splenocyte number
MGI:5695623	Tnfaip3<tm1.1Gho>	MP:0000691,enlarged spleen|MP:0005387,immune system phenotype|MP:0013415,increased myeloid cell number in bone marrow|MP:0013663,increased myeloid cell number
MGI:4829650	Tnfaip3<tm1.1Gvl>	MP:0002941,increased circulating alanine transaminase level|MP:0003103,liver degeneration|MP:0003293,rectal hemorrhage|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004841,abnormal small intestine crypts of Lieberkuhn morphology|MP:0005036,diarrhea|MP:0005343,increased circulating aspartate transaminase level|MP:0008537,increased susceptibility to induced colitis|MP:0008596,increased circulating interleukin-6 level|MP:0008885,increased enterocyte apoptosis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0011049,impaired adaptive thermogenesis|MP:0013956,decreased colon length
MGI:3055173	Tnfaip3<tm1Ama>	MP:0000322,increased granulocyte number|MP:0001219,thick epidermis|MP:0001245,thick dermal layer|MP:0001265,decreased body size|MP:0001845,abnormal inflammatory response|MP:0001846,increased inflammatory response|MP:0001858,intestinal inflammation|MP:0001859,kidney inflammation|MP:0001860,liver inflammation|MP:0002083,premature death|MP:0002933,joint inflammation|MP:0003009,abnormal cytokine secretion|MP:0005013,increased lymphocyte cell number|MP:0005425,increased macrophage cell number|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5621002	Tnfaip3<tm1Homy>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002083,premature death|MP:0002429,abnormal blood cell morphology/development|MP:0002458,abnormal B cell number|MP:0003644,thymus atrophy|MP:0005150,cachexia|MP:0005397,hematopoietic system phenotype|MP:0006042,increased apoptosis|MP:0008553,increased circulating tumor necrosis factor level|MP:0008577,increased circulating interferon-gamma level|MP:0008588,abnormal circulating interleukin level|MP:0008596,increased circulating interleukin-6 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0009246,pale spleen|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010210,abnormal circulating cytokine level
MGI:4831001	Tnfaip3<tm2Ama>	MP:0002461,increased immunoglobulin level|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0003725,increased autoantibody level|MP:0004939,abnormal B cell morphology|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005154,increased B cell proliferation|MP:0005350,increased susceptibility to autoimmune disorder|MP:0008097,increased plasma cell number|MP:0008164,abnormal B-1a B cell morphology|MP:0008177,increased germinal center B cell number|MP:0008214,increased immature B cell number|MP:0008217,abnormal B cell activation|MP:0008705,increased interleukin-6 secretion|MP:0008783,decreased B cell apoptosis
MGI:5528684	Tnfaip3<tm3.1Ama>	MP:0000691,enlarged spleen|MP:0005014,increased B cell number|MP:0005378,growth/size/body region phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008537,increased susceptibility to induced colitis|MP:0008706,decreased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0010373,myeloid hyperplasia
MGI:5528685	Tnfaip3<tm4.1Ama>	MP:0000691,enlarged spleen|MP:0005014,increased B cell number|MP:0005378,growth/size/body region phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008537,increased susceptibility to induced colitis|MP:0008706,decreased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0010373,myeloid hyperplasia
MGI:2654926	Tnfaip6<tm1Cful>	MP:0000242,impaired fertilization|MP:0001876,decreased inflammatory response|MP:0001926,female infertility|MP:0002335,decreased airway responsiveness|MP:0009374,absent cumulus expansion|MP:0031420,decreased superovulation rate
MGI:5178061	Tnfaip8<Gt(IST13629C1)Tigm>	MP:0000219,increased neutrophil cell number|MP:0000495,abnormal colon morphology|MP:0000692,small spleen|MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0008596,increased circulating interleukin-6 level|MP:0008614,increased circulating interleukin-17 level|MP:0008657,increased interleukin-1 beta secretion|MP:0008681,increased interleukin-17 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008885,increased enterocyte apoptosis|MP:0010180,increased susceptibility to weight loss
MGI:7567994	Tnfaip8l1<em1Huwa>	MP:0002006,neoplasm|MP:0005378,growth/size/body region phenotype|MP:0005397,hematopoietic system phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0013298,increased susceptibility to colitis induced morbidity/mortality
MGI:6276897	Tnfaip8l1<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000538,abnormal urinary bladder morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0001486,abnormal startle reflex|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney
MGI:3810526	Tnfaip8l2<tm1Yhcn>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0001263,weight loss|MP:0001845,abnormal inflammatory response|MP:0001858,intestinal inflammation|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002459,abnormal B cell physiology|MP:0002499,chronic inflammation|MP:0003865,lymph node inflammation|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0006173,abnormal myeloid dendritic cell morphology|MP:0006412,abnormal T cell apoptosis|MP:0008217,abnormal B cell activation|MP:0008246,abnormal leukocyte morphology|MP:0008478,increased spleen white pulp amount|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008617,increased circulating interleukin-12 level|MP:0008641,increased circulating interleukin-1 beta level|MP:0008657,increased interleukin-1 beta secretion|MP:0008663,increased interleukin-12 secretion|MP:0008681,increased interleukin-17 secretion|MP:0008687,increased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0008770,decreased survivor rate|MP:0011075,abnormal macrophage activation involved in immune response
MGI:4462563	Tnfaip8l3<tm1a(KOMP)Mbp>	MP:0004502,decreased incidence of tumors by chemical induction|MP:0010308,decreased tumor latency
MGI:5795894	Tnf<Bpsm1>	MP:0000160,kyphosis|MP:0000755,hindlimb paralysis|MP:0002083,premature death|MP:0002109,abnormal limb morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003141,cardiac fibrosis|MP:0003561,rheumatoid arthritis|MP:0004174,abnormal spine curvature|MP:0004625,abnormal rib joint morphology|MP:0006278,aortic aneurysm|MP:0008553,increased circulating tumor necrosis factor level|MP:0009384,cardiac valve regurgitation|MP:0010053,decreased grip strength|MP:0010594,thick aortic valve|MP:0010620,thick mitral valve|MP:0010768,mortality/aging|MP:0013147,limb paralysis|MP:0014708,increased synovial pannus formation|MP:0030332,accelerated temporomandibular joint osteoarthritis|MP:0030795,joint dislocation|MP:0030814,abnormal wrist joint morphology|MP:0031118,cardiovalvulitis|MP:0031124,aortic valve inflammation|MP:0031516,mitral valve inflammation
MGI:6729295	Tnf<em4Boui>	MP:0001698,decreased embryo size|MP:0002083,premature death|MP:0002816,colitis|MP:0002993,autoimmune arthritis|MP:0003278,esophageal inflammation|MP:0009482,ileum inflammation|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0014134,abnormal embryo morphology|MP:0031118,cardiovalvulitis
MGI:6729296	Tnf<em5Boui>	MP:0011091,prenatal lethality, complete penetrance
MGI:3616888	Tnf<M1Btlr>	MP:0002412,increased susceptibility to bacterial infection|MP:0005387,immune system phenotype|MP:0008200,decreased follicular dendritic cell number
MGI:5582740	Tnf<M2Btlr>	MP:0008561,decreased tumor necrosis factor secretion|MP:0011079,decreased macrophage cytokine production
MGI:3036746	Tnfp<DBA/2J>	MP:0003638,abnormal response/metabolism to endogenous compounds
MGI:3689190	Tnf<R8H>	MP:0002412,increased susceptibility to bacterial infection|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3774334	Tnfrsf10b<tm1.1Cjk>	MP:0001272,increased metastatic potential
MGI:3522001	Tnfrsf10b<tm1Wnt>	MP:0002419,abnormal innate immunity|MP:0008044,increased NK cell number|MP:0008560,increased tumor necrosis factor secretion|MP:0008577,increased circulating interferon-gamma level|MP:0008647,increased circulating interleukin-12b level|MP:0008663,increased interleukin-12 secretion|MP:0008750,abnormal interferon level|MP:0020917,decreased susceptibility to Herpesvirales infection|MP:0031025,decreased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:3574360	Tnfrsf10b<tm1Wsed>	MP:0000709,enlarged thymus|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3664109	Tnfrsf11a<del8>	MP:0000062,increased bone mineral density|MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000130,abnormal trabecular bone morphology|MP:0000160,kyphosis|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000240,extramedullary hematopoiesis|MP:0000445,short snout|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001265,decreased body size|MP:0001577,anemia|MP:0002083,premature death|MP:0002396,abnormal hematopoietic system morphology/development|MP:0004985,decreased osteoclast cell number|MP:0005232,abnormal mesenteric lymph node morphology|MP:0006398,increased long bone epiphyseal plate size
MGI:5629957	Tnfrsf11a<tm1.1Irw>	MP:0000696,abnormal Peyer's patch morphology|MP:0001807,decreased IgA level|MP:0002388,abnormal Peyer's patch epithelium morphology|MP:0002389,abnormal Peyer's patch follicle morphology|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002392,abnormal Peyer's patch T cell area morphology|MP:0008098,decreased plasma cell number
MGI:7427368	Tnfrsf11a<tm1.1Sral>	MP:0000067,osteopetrosis|MP:0000125,absent incisors|MP:0000130,abnormal trabecular bone morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000135,decreased compact bone thickness|MP:0000558,abnormal tibia morphology|MP:0001265,decreased body size|MP:0001541,abnormal osteoclast physiology|MP:0002083,premature death|MP:0003795,abnormal bone structure|MP:0004984,increased osteoclast cell number|MP:0004985,decreased osteoclast cell number|MP:0004988,increased osteoblast cell number|MP:0005378,growth/size/body region phenotype|MP:0005422,osteosclerosis|MP:0006398,increased long bone epiphyseal plate size|MP:0008396,abnormal osteoclast differentiation|MP:0009347,increased trabecular bone thickness|MP:0010768,mortality/aging|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0013631,decreased bone trabecular spacing|MP:0021030,decreased tumor necrosis factor (ligand) superfamily member 11 level
MGI:4415802	Tnfrsf11a<tm1.2Pngr>	MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0004985,decreased osteoclast cell number|MP:0008024,absent lymph nodes
MGI:1860238	Tnfrsf11a<tm1Imx>	MP:0000062,increased bone mineral density|MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000135,decreased compact bone thickness|MP:0000219,increased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000322,increased granulocyte number|MP:0000333,decreased bone marrow cell number|MP:0000440,domed cranium|MP:0000547,short limbs|MP:0000693,spleen hyperplasia|MP:0001265,decreased body size|MP:0002238,abnormal nasal mucosa morphology|MP:0004918,abnormal negative T cell selection|MP:0004985,decreased osteoclast cell number|MP:0005017,decreased B cell number|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008024,absent lymph nodes|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0008151,increased diameter of long bones|MP:0008211,decreased mature B cell number|MP:0008396,abnormal osteoclast differentiation|MP:0008484,decreased spleen germinal center size|MP:0009544,abnormal thymus epithelium morphology|MP:0030505,tooth impaction
MGI:2183226	Tnfrsf11a<tm1Wjb>	MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0010249,lactation failure
MGI:6276873	Tnfrsf11b<em1(IMPC)Mbp>	MP:0000063,decreased bone mineral density|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0000774,decreased brain size|MP:0001258,decreased body length|MP:0001293,anophthalmia|MP:0001314,cornea opacity|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001566,increased circulating phosphate level|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002699,abnormal vitreous body morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003068,enlarged kidney|MP:0003795,abnormal bone structure|MP:0004738,abnormal auditory brainstem response|MP:0009084,blind uterus|MP:0009552,urinary bladder obstruction|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2179712	Tnfrsf11b<tm1Eac>	MP:0000063,decreased bone mineral density|MP:0000458,abnormal mandible morphology|MP:0000685,abnormal immune system morphology|MP:0001790,abnormal immune system physiology|MP:0002455,abnormal dendritic cell antigen presentation|MP:0002490,abnormal immunoglobulin level|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0003797,abnormal compact bone morphology|MP:0005014,increased B cell number|MP:0008151,increased diameter of long bones|MP:0008186,increased pro-B cell number|MP:0008214,increased immature B cell number|MP:0008233,abnormal pro-B cell differentiation|MP:0030793,short femur neck
MGI:2181227	Tnfrsf11b<tm1Khs>	MP:0000026,abnormal inner ear morphology|MP:0000029,abnormal malleus morphology|MP:0000039,abnormal otic capsule morphology|MP:0000049,abnormal middle ear morphology|MP:0000061,fragile skeleton|MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000130,abnormal trabecular bone morphology|MP:0001533,abnormal skeleton physiology|MP:0001541,abnormal osteoclast physiology|MP:0001732,postnatal growth retardation|MP:0001967,deafness|MP:0002113,abnormal skeleton development|MP:0002998,abnormal bone remodeling|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003795,abnormal bone structure|MP:0004290,abnormal stapes footplate morphology|MP:0004737,absent distortion product otoacoustic emissions|MP:0004748,increased susceptibility to age-related hearing loss|MP:0004897,otosclerosis|MP:0004984,increased osteoclast cell number|MP:0005105,abnormal middle ear ossicle morphology|MP:0005107,abnormal stapes morphology|MP:0008396,abnormal osteoclast differentiation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014406,increased or absent distortion product otoacoustic emission threshold|MP:0030399,abnormal incus body morphology|MP:0030400,abnormal stapes annular ligament morphology
MGI:2183229	Tnfrsf11b<tm1Wss>	MP:0000061,fragile skeleton|MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000109,abnormal parietal bone morphology|MP:0000131,abnormal long bone epiphysis morphology|MP:0001265,decreased body size|MP:0003797,abnormal compact bone morphology|MP:0004982,abnormal osteoclast morphology|MP:0004986,abnormal osteoblast morphology|MP:0006133,calcified artery|MP:0010870,absent bone trabeculae|MP:0010873,decreased trabecular bone mass|MP:0011086,postnatal lethality, incomplete penetrance|MP:0030281,thin parietal bone
MGI:3603146	Tnfrsf12a<tm1Biib>	MP:0008722,abnormal chemokine secretion|MP:0010042,abnormal oval cell physiology
MGI:3052983	Tnfrsf13b<tm1Cmac>	MP:0000691,enlarged spleen|MP:0005014,increased B cell number|MP:0005387,immune system phenotype
MGI:2388136	Tnfrsf13b<tm1Rjb>	MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002492,decreased IgE level|MP:0004816,abnormal class switch recombination|MP:0004952,increased spleen weight|MP:0005014,increased B cell number|MP:0005154,increased B cell proliferation|MP:0008217,abnormal B cell activation|MP:0008495,decreased IgG1 level
MGI:2182823	Tnfrsf13b<tm1Vmd>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001859,kidney inflammation|MP:0001860,liver inflammation|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0002345,abnormal lymph node primary follicle morphology|MP:0002358,abnormal spleen periarteriolar lymphoid sheath morphology|MP:0002389,abnormal Peyer's patch follicle morphology|MP:0002490,abnormal immunoglobulin level|MP:0002743,glomerulonephritis|MP:0002962,increased urine protein level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005014,increased B cell number|MP:0005154,increased B cell proliferation|MP:0005264,glomerulosclerosis|MP:0008173,increased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008189,increased transitional stage B cell number|MP:0008210,increased mature B cell number|MP:0008471,abnormal spleen primary B follicle morphology|MP:0008478,increased spleen white pulp amount|MP:0008483,increased spleen germinal center size|MP:0008499,increased IgG1 level|MP:0011377,renal glomerulus fibrosis|MP:0011427,increased mesangial cell number|MP:0011506,glomerular crescent|MP:0020519,renal glomerular immunoglobulin deposits
MGI:2389403	Tnfrsf13c<Bcmd1>	MP:0001805,decreased IgG level|MP:0003945,abnormal lymphocyte physiology|MP:0004751,increased length of allograft survival|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0008567,decreased interferon-gamma secretion
MGI:6200301	Tnfrsf13c<m1Btlr>	MP:0005017,decreased B cell number
MGI:6200306	Tnfrsf13c<M2Btlr>	MP:0005017,decreased B cell number
MGI:3054891	Tnfrsf13c<tm1Mass>	MP:0001802,arrested B cell differentiation|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002459,abnormal B cell physiology|MP:0005016,decreased lymphocyte cell number|MP:0008183,absent marginal zone B cells|MP:0008207,decreased B-2 B cell number|MP:0008211,decreased mature B cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level
MGI:3054873	Tnfrsf13c<tm1Msc>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002491,decreased IgD level|MP:0005017,decreased B cell number|MP:0008183,absent marginal zone B cells|MP:0008207,decreased B-2 B cell number|MP:0008216,absent transitional stage B cells|MP:0008495,decreased IgG1 level
MGI:4949656	Tnfrsf13c<tm2.1Mass>	MP:0002398,abnormal bone marrow cell morphology/development|MP:0003132,increased pre-B cell number|MP:0008186,increased pro-B cell number|MP:0008214,increased immature B cell number|MP:0009278,abnormal bone marrow cell physiology
MGI:5907516	Tnfrsf14<tm1.1Kro>	MP:0001993,abnormal blinking|MP:0020917,decreased susceptibility to Herpesvirales infection
MGI:4940320	Tnfrsf14<tm1Csj>	MP:0008539,decreased susceptibility to induced colitis|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality
MGI:3582550	Tnfrsf14<tm1Kpf>	MP:0002444,abnormal T cell physiology|MP:0005348,increased T cell proliferation
MGI:5908456	Tnfrsf14<tm1Kro>	MP:0001993,abnormal blinking|MP:0020917,decreased susceptibility to Herpesvirales infection
MGI:3702279	Tnfrsf14<tm1Wwhk>	MP:0004752,decreased length of allograft survival
MGI:5605758	Tnfrsf17<tm1.1(KOMP)Vlcg>	MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval
MGI:2387797	Tnfrsf17<tm1Kplm>	MP:0008098,decreased plasma cell number
MGI:2387427	Tnfrsf17<tm1Msc>	MP:0002169,no abnormal phenotype detected
MGI:5583084	Tnfrsf18<tm1.1(KOMP)Vlcg>	MP:0002092,abnormal eye morphology
MGI:2676557	Tnfrsf18<tm1Ppp>	MP:0001828,abnormal T cell activation|MP:0003077,abnormal cell cycle|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0006413,increased T cell apoptosis|MP:0008687,increased interleukin-2 secretion
MGI:3813972	Tnfrsf19<Gt(OST294987)Lex>	MP:0005382,craniofacial phenotype|MP:0005389,reproductive system phenotype|MP:0010771,integument phenotype|MP:0031384,impaired blood-brain barrier function
MGI:3579138	Tnfrsf19<tm1Shmi>	MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004811,abnormal neuron physiology
MGI:7426125	Tnfrsf1a<em1(IMPC)Ccpcz>	MP:0000219,increased neutrophil cell number|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0002060,abnormal skin morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0008044,increased NK cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number
MGI:3053140	Tnfrsf1a<tm1.1Gkl>	MP:0001860,liver inflammation|MP:0002411,decreased susceptibility to bacterial infection|MP:0003009,abnormal cytokine secretion|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:1861040	Tnfrsf1a<tm1Blt>	MP:0000696,abnormal Peyer's patch morphology|MP:0001501,abnormal sleep pattern|MP:0001790,abnormal immune system physiology|MP:0002344,abnormal lymph node B cell domain morphology|MP:0002389,abnormal Peyer's patch follicle morphology|MP:0002411,decreased susceptibility to bacterial infection|MP:0002412,increased susceptibility to bacterial infection|MP:0002942,decreased circulating alanine transaminase level|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005027,increased susceptibility to parasitic infection|MP:0005596,increased susceptibility to type I hypersensitivity reaction|MP:0008133,decreased Peyer's patch number|MP:0008201,absent follicular dendritic cells|MP:0008495,decreased IgG1 level|MP:0008597,decreased circulating interleukin-6 level|MP:0008706,decreased interleukin-6 secretion|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0008943,increased sensitivity to induced cell death|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0020154,impaired humoral immune response|MP:0030012,impaired central nervous system regeneration
MGI:1857468	Tnfrsf1a<tm1Imx>	MP:0001790,abnormal immune system physiology|MP:0001861,lung inflammation|MP:0001876,decreased inflammatory response|MP:0002051,increased skin papilloma incidence|MP:0002052,decreased tumor incidence|MP:0002314,abnormal respiratory mechanics|MP:0002334,abnormal airway responsiveness|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0003633,abnormal nervous system physiology|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0008196,abnormal follicular dendritic cell morphology|MP:0008553,increased circulating tumor necrosis factor level|MP:0008597,decreased circulating interleukin-6 level|MP:0008706,decreased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008943,increased sensitivity to induced cell death|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0009967,abnormal neuron proliferation|MP:0010042,abnormal oval cell physiology|MP:0011452,decreased susceptibility to dopaminergic neuron neurotoxicity|MP:0011982,decreased microglial cell number|MP:0020154,impaired humoral immune response
MGI:1857261	Tnfrsf1a<tm1Mak>	MP:0000062,increased bone mineral density|MP:0001805,decreased IgG level|MP:0002359,abnormal spleen germinal center morphology|MP:0002411,decreased susceptibility to bacterial infection|MP:0002500,granulomatous inflammation|MP:0002796,impaired skin barrier function|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0008553,increased circulating tumor necrosis factor level|MP:0008597,decreased circulating interleukin-6 level|MP:0008943,increased sensitivity to induced cell death|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0020154,impaired humoral immune response
MGI:3808000	Tnfrsf1a<tm1Rsie>	MP:0002451,abnormal macrophage physiology|MP:0008196,abnormal follicular dendritic cell morphology|MP:0008553,increased circulating tumor necrosis factor level|MP:0008597,decreased circulating interleukin-6 level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008705,increased interleukin-6 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008735,increased susceptibility to endotoxin shock|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0011049,impaired adaptive thermogenesis
MGI:4461135	Tnfrsf1a<tm2.1Rsie>	MP:0002451,abnormal macrophage physiology|MP:0008553,increased circulating tumor necrosis factor level|MP:0008597,decreased circulating interleukin-6 level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008705,increased interleukin-6 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008735,increased susceptibility to endotoxin shock|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:5780574	Tnfrsf1a<tm2b(EUCOMM)Wtsi>	MP:0000195,decreased circulating calcium level|MP:0000218,increased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0002606,increased basophil cell number|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0010052,increased grip strength|MP:0012362,increased large unstained cell number
MGI:3686874	Tnfrsf1a<tm2Gkl>	MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010155,abnormal intestine physiology
MGI:5572949	Tnfrsf1a<tm3.1Gkl>	MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:5572951	Tnfrsf1a<tm4.1(TNFRSF1A)Gkl>	MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010537,tumor regression
MGI:6195552	Tnfrsf1b<tm1.1Gkl>	MP:0002169,no abnormal phenotype detected
MGI:6195556	Tnfrsf1b<tm1.2Gkl>	MP:0002169,no abnormal phenotype detected
MGI:4433096	Tnfrsf1b<tm1a(EUCOMM)Wtsi>	MP:0001402,decreased locomotor activity|MP:0005018,decreased T cell number|MP:0005554,decreased circulating creatinine level|MP:0010053,decreased grip strength
MGI:1860087	Tnfrsf1b<tm1Imx>	MP:0001846,increased inflammatory response|MP:0001861,lung inflammation|MP:0002051,increased skin papilloma incidence|MP:0002329,abnormal blood gas level|MP:0002333,abnormal lung compliance|MP:0002843,decreased systemic arterial blood pressure|MP:0002886,abnormal glutamate-mediated receptor currents|MP:0005376,homeostasis/metabolism phenotype|MP:0005388,respiratory system phenotype|MP:0005390,skeleton phenotype|MP:0008553,increased circulating tumor necrosis factor level|MP:0008918,microgliosis|MP:0011452,decreased susceptibility to dopaminergic neuron neurotoxicity
MGI:1857262	Tnfrsf1b<tm1Mwm>	MP:0001501,abnormal sleep pattern|MP:0001790,abnormal immune system physiology|MP:0002411,decreased susceptibility to bacterial infection|MP:0002412,increased susceptibility to bacterial infection|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005027,increased susceptibility to parasitic infection|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0005580,periinsulitis|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion|MP:0030012,impaired central nervous system regeneration
MGI:5546637	Tnfrsf21<tm1Arte>	MP:0000920,abnormal myelination|MP:0010160,increased oligodendrocyte number|MP:0010205,abnormal oligodendrocyte apoptosis
MGI:2182829	Tnfrsf21<tm1Ddy>	MP:0002494,increased IgM level|MP:0005154,increased B cell proliferation|MP:0005348,increased T cell proliferation|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0008483,increased spleen germinal center size|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level|MP:0008660,increased interleukin-10 secretion|MP:0008672,increased interleukin-13 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion
MGI:2657184	Tnfrsf21<tm1Vmd>	MP:0001915,intracranial hemorrhage|MP:0002421,abnormal cell-mediated immunity|MP:0002494,increased IgM level|MP:0002497,increased IgE level|MP:0004950,abnormal brain vasculature morphology|MP:0005015,increased T cell number|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0005466,abnormal T-helper 2 physiology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion|MP:0008699,increased interleukin-4 secretion|MP:0031384,impaired blood-brain barrier function
MGI:5312063	Tnfrsf21<tm2Gne>	MP:0001915,intracranial hemorrhage|MP:0004950,abnormal brain vasculature morphology
MGI:2670362	Tnfrsf25<tm1Mjo>	MP:0000709,enlarged thymus|MP:0000714,increased thymocyte number|MP:0004918,abnormal negative T cell selection|MP:0006414,decreased T cell apoptosis
MGI:3575088	Tnfrsf4<tm1Mfb>	MP:0002169,no abnormal phenotype detected|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology
MGI:1859871	Tnfrsf4<tm1Nik>	MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0005597,decreased susceptibility to type I hypersensitivity reaction
MGI:1860056	Tnfrsf8<tm1Mak>	MP:0000709,enlarged thymus|MP:0000714,increased thymocyte number|MP:0005387,immune system phenotype|MP:0005673,decreased susceptibility to graft versus host disease
MGI:5568599	Tnfrsf9<em1Ygch>	MP:0002078,abnormal glucose homeostasis|MP:0002444,abnormal T cell physiology|MP:0004031,insulitis|MP:0005387,immune system phenotype
MGI:5568601	Tnfrsf9<em2Ygch>	MP:0002078,abnormal glucose homeostasis|MP:0002444,abnormal T cell physiology|MP:0004031,insulitis|MP:0005387,immune system phenotype
MGI:6200374	Tnfrsf9<m1Btlr>	MP:0005014,increased B cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:5548402	Tnfrsf9<tm1b(EUCOMM)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:2664914	Tnfrsf9<tm1Byk>	MP:0002490,abnormal immunoglobulin level|MP:0002495,increased IgA level|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005348,increased T cell proliferation|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008496,decreased IgG2a level|MP:0008498,decreased IgG3 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008567,decreased interferon-gamma secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0009336,increased splenocyte proliferation
MGI:3834749	Tnfrsf9<tm1Lpc>	MP:0005387,immune system phenotype|MP:0008051,abnormal memory T cell physiology
MGI:5692569	Tnfsf10<tm1b(KOMP)Wtsi>	MP:0002941,increased circulating alanine transaminase level
MGI:2179709	Tnfsf10<tm1Mjs>	MP:0000708,thymus hyperplasia|MP:0001860,liver inflammation|MP:0002021,increased incidence of induced tumors|MP:0002411,decreased susceptibility to bacterial infection|MP:0003724,increased susceptibility to induced arthritis|MP:0004499,increased incidence of tumors by chemical induction|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0004918,abnormal negative T cell selection|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0014708,increased synovial pannus formation
MGI:2388390	Tnfsf10<tm1Sdg>	MP:0002006,neoplasm|MP:0003721,increased tumor growth/size|MP:0005387,immune system phenotype|MP:0005390,skeleton phenotype|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:5614816	Tnfsf11<gum>	MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000460,mandible hypoplasia|MP:0000752,dystrophic muscle|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001386,abnormal maternal nurturing|MP:0001921,reduced fertility|MP:0002116,abnormal craniofacial bone morphology|MP:0002835,abnormal cranial suture morphology|MP:0003961,decreased lean body mass|MP:0004033,supernumerary teeth|MP:0005270,abnormal zygomatic bone morphology|MP:0005352,small cranium|MP:0009917,abnormal hyoid bone body morphology|MP:0010123,increased bone mineral content|MP:0011999,abnormal tail length|MP:0013614,abnormal areal bone mineral density|MP:0013617,increased areal bone mineral density|MP:0013619,abnormal long bone internal diameter|MP:0013621,decreased internal diameter of femur
MGI:5307891	Tnfsf11<tles>	MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000130,abnormal trabecular bone morphology|MP:0000691,enlarged spleen|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0002083,premature death|MP:0004985,decreased osteoclast cell number|MP:0005006,abnormal osteoblast physiology|MP:0005390,skeleton phenotype|MP:0008024,absent lymph nodes|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume
MGI:5297355	Tnfsf11<tm1.1Caob>	MP:0000062,increased bone mineral density|MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000135,decreased compact bone thickness|MP:0000163,abnormal cartilage morphology|MP:0003795,abnormal bone structure|MP:0004983,abnormal osteoclast cell number|MP:0004985,decreased osteoclast cell number|MP:0005390,skeleton phenotype|MP:0006398,increased long bone epiphyseal plate size|MP:0010878,increased trabecular bone volume|MP:0013630,increased bone trabecular spacing|MP:0020011,increased bone mineral density of femur|MP:0021187,increased bone mineral density of vertebrae
MGI:5297060	Tnfsf11<tm1.1Htaka>	MP:0005390,skeleton phenotype
MGI:5297062	Tnfsf11<tm1.2Htaka>	MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000130,abnormal trabecular bone morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000160,kyphosis|MP:0000163,abnormal cartilage morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0004686,decreased length of long bones|MP:0004952,increased spleen weight|MP:0004985,decreased osteoclast cell number|MP:0004993,decreased bone resorption|MP:0010875,increased bone volume
MGI:1859962	Tnfsf11<tm1Pngr>	MP:0000062,increased bone mineral density|MP:0000067,osteopetrosis|MP:0000074,abnormal neurocranium morphology|MP:0000121,failure of tooth eruption|MP:0000240,extramedullary hematopoiesis|MP:0000685,abnormal immune system morphology|MP:0001732,postnatal growth retardation|MP:0001790,abnormal immune system physiology|MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0002811,macrocytic anemia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0004686,decreased length of long bones|MP:0004952,increased spleen weight|MP:0004956,decreased thymus weight|MP:0004985,decreased osteoclast cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0008135,small Peyer's patches|MP:0008151,increased diameter of long bones|MP:0008211,decreased mature B cell number|MP:0008215,decreased immature B cell number|MP:0008233,abnormal pro-B cell differentiation|MP:0008464,absent peripheral lymph nodes|MP:0008465,absent mesenteric lymph nodes|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008703,decreased interleukin-5 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0009544,abnormal thymus epithelium morphology|MP:0010249,lactation failure|MP:0030072,round face|MP:0030279,thin neurocranium
MGI:4840355	Tnfsf11<tm1(TNFSF11)Kost>	MP:0000062,increased bone mineral density|MP:0001262,decreased body weight|MP:0001533,abnormal skeleton physiology|MP:0002896,abnormal bone mineralization|MP:0002998,abnormal bone remodeling|MP:0003795,abnormal bone structure|MP:0004982,abnormal osteoclast morphology|MP:0004986,abnormal osteoblast morphology|MP:0009347,increased trabecular bone thickness|MP:0010868,increased bone trabecula number|MP:0010875,increased bone volume|MP:0010878,increased trabecular bone volume|MP:0021183,increased femoral compact bone area
MGI:2386263	Tnfsf11<tm1Ywc>	MP:0000062,increased bone mineral density|MP:0000063,decreased bone mineral density|MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000166,abnormal chondrocyte morphology|MP:0000195,decreased circulating calcium level|MP:0000240,extramedullary hematopoiesis|MP:0000333,decreased bone marrow cell number|MP:0000689,abnormal spleen morphology|MP:0001175,abnormal lung morphology|MP:0001262,decreased body weight|MP:0002351,abnormal cervical lymph node morphology|MP:0002362,abnormal spleen marginal zone morphology|MP:0002397,abnormal bone marrow morphology|MP:0002764,short tibia|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004686,decreased length of long bones|MP:0004704,short vertebral column|MP:0004985,decreased osteoclast cell number|MP:0006398,increased long bone epiphyseal plate size|MP:0008119,decreased Langerhans cell number|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0008162,increased diameter of tibia|MP:0008464,absent peripheral lymph nodes|MP:0008465,absent mesenteric lymph nodes|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008476,increased spleen red pulp amount|MP:0008479,decreased spleen white pulp amount|MP:0008525,decreased cranium height|MP:0008826,abnormal splenic cell ratio|MP:0008827,abnormal thymus cell ratio|MP:0009347,increased trabecular bone thickness|MP:0009633,absent cervical lymph nodes|MP:0010869,decreased bone trabecula number|MP:0010875,increased bone volume|MP:0013588,small thymus medulla|MP:0013619,abnormal long bone internal diameter|MP:0014105,abnormal chondrocyte differentiation|MP:0020080,increased bone mineralization|MP:0030469,optic canal stenosis
MGI:3613442	Tnfsf12<tm1Ash>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002412,increased susceptibility to bacterial infection|MP:0002722,abnormal immune system organ morphology|MP:0003009,abnormal cytokine secretion|MP:0005091,increased double-positive T cell number|MP:0008044,increased NK cell number|MP:0008049,increased memory T cell number|MP:0008086,increased T-helper 1 cell number|MP:0008246,abnormal leukocyte morphology|MP:0008566,increased interferon-gamma secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008663,increased interleukin-12 secretion
MGI:5009047	Tnfsf13b<m1Anu>	MP:0002144,abnormal B cell differentiation|MP:0008211,decreased mature B cell number|MP:0008214,increased immature B cell number
MGI:5632166	Tnfsf13b<M1Btlr>	MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0008082,increased single-positive T cell number|MP:0020154,impaired humoral immune response
MGI:5632172	Tnfsf13b<m2Btlr>	MP:0001805,decreased IgG level|MP:0005017,decreased B cell number|MP:0020154,impaired humoral immune response
MGI:6286111	Tnfsf13b<m3Btlr>	MP:0002619,abnormal lymphocyte morphology|MP:0005017,decreased B cell number
MGI:3047300	Tnfsf13b<tm1Cleg>	MP:0000694,spleen hypoplasia|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0002221,abnormal lymph organ size|MP:0002459,abnormal B cell physiology|MP:0005015,increased T cell number|MP:0008050,decreased memory T cell number|MP:0008101,lymph node hypoplasia|MP:0008174,decreased follicular B cell number|MP:0008211,decreased mature B cell number|MP:0008246,abnormal leukocyte morphology
MGI:2387426	Tnfsf13b<tm1Msc>	MP:0001800,abnormal humoral immune response|MP:0001802,arrested B cell differentiation|MP:0002144,abnormal B cell differentiation|MP:0002344,abnormal lymph node B cell domain morphology|MP:0002460,decreased immunoglobulin level|MP:0004751,increased length of allograft survival|MP:0004953,decreased spleen weight|MP:0005017,decreased B cell number|MP:0005095,decreased T cell proliferation|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008190,decreased transitional stage B cell number
MGI:3028906	Tnfsf13<tm1Ash>	MP:0002169,no abnormal phenotype detected
MGI:3038886	Tnfsf13<tm1Geha>	MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002493,increased IgG level|MP:0004816,abnormal class switch recombination|MP:0005387,immune system phenotype|MP:0008049,increased memory T cell number|MP:0008481,increased spleen germinal center number|MP:0008483,increased spleen germinal center size
MGI:3818634	Tnfsf13<tm1Pod>	MP:0001807,decreased IgA level|MP:0003436,decreased susceptibility to induced arthritis|MP:0005348,increased T cell proliferation|MP:0008496,decreased IgG2a level|MP:0008499,increased IgG1 level|MP:0008566,increased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008672,increased interleukin-13 secretion|MP:0008681,increased interleukin-17 secretion|MP:0008682,decreased interleukin-17 secretion|MP:0008699,increased interleukin-4 secretion|MP:0008702,increased interleukin-5 secretion
MGI:2668383	Tnfsf14<tm1Ddy>	MP:0001828,abnormal T cell activation|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype
MGI:2671122	Tnfsf14<tm1Kpf>	MP:0000130,abnormal trabecular bone morphology|MP:0000166,abnormal chondrocyte morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003797,abnormal compact bone morphology|MP:0003944,abnormal T cell subpopulation ratio|MP:0004174,abnormal spine curvature|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005095,decreased T cell proliferation|MP:0008343,abnormal gamma-delta T cell morphology|MP:0008396,abnormal osteoclast differentiation|MP:0008567,decreased interferon-gamma secretion|MP:0008661,decreased interleukin-10 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0009335,decreased splenocyte proliferation|MP:0010879,decreased trabecular bone volume|MP:0013630,increased bone trabecular spacing
MGI:2180198	Tnfsf14<tm1Lpc>	MP:0001876,decreased inflammatory response|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005387,immune system phenotype|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion
MGI:2446076	Tnfsf14<tm1Wwh>	MP:0004751,increased length of allograft survival
MGI:3797013	Tnfsf15<tm1Cdon>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0008115,abnormal dendritic cell differentiation
MGI:5563219	Tnfsf15<tm1Hluo>	MP:0001805,decreased IgG level|MP:0003436,decreased susceptibility to induced arthritis|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005387,immune system phenotype|MP:0008098,decreased plasma cell number|MP:0008101,lymph node hypoplasia|MP:0008178,decreased germinal center B cell number|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0010187,decreased T follicular helper cell number
MGI:5431588	Tnfsf15<tm1Lex>	MP:0008044,increased NK cell number
MGI:7621394	Tnfsf18<em1Pwan>	MP:0001828,abnormal T cell activation|MP:0001876,decreased inflammatory response|MP:0002942,decreased circulating alanine transaminase level|MP:0005164,abnormal response to injury|MP:0005632,decreased circulating aspartate transaminase level|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0012243,decreased hepatoblast number
MGI:5614617	Tnfsf18<tm1.1(KOMP)Vlcg>	MP:0002608,increased hematocrit|MP:0003961,decreased lean body mass
MGI:3044349	Tnfsf4<Ath1-BALB/cJ>	MP:0001556,increased circulating HDL cholesterol level|MP:0005341,decreased susceptibility to atherosclerosis
MGI:3044315	Tnfsf4<Ath1-C3H/HeJ>	MP:0001556,increased circulating HDL cholesterol level
MGI:3044290	Tnfsf4<Ath1-C57BL/6J>	MP:0000186,decreased circulating HDL cholesterol level|MP:0002118,abnormal lipid homeostasis|MP:0002127,abnormal cardiovascular system morphology|MP:0005339,increased susceptibility to atherosclerosis
MGI:3576370	Tnfsf4<Ath1-PERA/EiJ>	MP:0001556,increased circulating HDL cholesterol level|MP:0001614,abnormal blood vessel morphology
MGI:3044286	Tnfsf4<Ath1-SPRET/EiJ>	MP:0005341,decreased susceptibility to atherosclerosis
MGI:2683777	Tnfsf4<tm1Shr>	MP:0002421,abnormal cell-mediated immunity|MP:0002455,abnormal dendritic cell antigen presentation|MP:0003009,abnormal cytokine secretion|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008567,decreased interferon-gamma secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion
MGI:2388724	Tnfsf4<tm1Sug>	MP:0003009,abnormal cytokine secretion|MP:0005095,decreased T cell proliferation|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction
MGI:6382395	Tnfsf8<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney
MGI:3054968	Tnfsf8<tm1Pod>	MP:0005673,decreased susceptibility to graft versus host disease
MGI:2179297	Tnfsf9<tm1Thw>	MP:0005078,abnormal cytotoxic T cell physiology|MP:0005387,immune system phenotype
MGI:3527143	Tnf<tm1.1Sned>	MP:0001654,hepatic necrosis|MP:0002412,increased susceptibility to bacterial infection|MP:0005351,decreased susceptibility to autoimmune disorder|MP:0005387,immune system phenotype|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008722,abnormal chemokine secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:3576929	Tnf<tm1.2Sned>	MP:0000218,increased leukocyte cell number|MP:0002411,decreased susceptibility to bacterial infection|MP:0002831,absent Peyer's patches|MP:0005027,increased susceptibility to parasitic infection
MGI:2149024	Tnf<tm1Gkl>	MP:0000062,increased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000696,abnormal Peyer's patch morphology|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001845,abnormal inflammatory response|MP:0001876,decreased inflammatory response|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002344,abnormal lymph node B cell domain morphology|MP:0002363,abnormal spleen marginal sinus morphology|MP:0002389,abnormal Peyer's patch follicle morphology|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002392,abnormal Peyer's patch T cell area morphology|MP:0002411,decreased susceptibility to bacterial infection|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002644,decreased circulating triglyceride level|MP:0002687,oligozoospermia|MP:0002727,decreased circulating insulin level|MP:0003945,abnormal lymphocyte physiology|MP:0004502,decreased incidence of tumors by chemical induction|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004852,decreased testis weight|MP:0004884,abnormal testis physiology|MP:0004988,increased osteoblast cell number|MP:0005013,increased lymphocyte cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005232,abnormal mesenteric lymph node morphology|MP:0005334,abnormal fat pad morphology|MP:0005351,decreased susceptibility to autoimmune disorder|MP:0005387,immune system phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005560,decreased circulating glucose level|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0005668,decreased circulating leptin level|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0008201,absent follicular dendritic cells|MP:0008241,abnormal metallophilic macrophage morphology|MP:0008471,abnormal spleen primary B follicle morphology|MP:0008473,abnormal spleen follicular dendritic cell network|MP:0008474,absent spleen germinal center|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008722,abnormal chemokine secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0009584,decreased keratinocyte proliferation|MP:0014269,decreased testes secretion|MP:0014684,impaired spermiation|MP:0030466,alveolar process atrophy
MGI:1860953	Tnf<tm1Jods>	MP:0000218,increased leukocyte cell number|MP:0000696,abnormal Peyer's patch morphology|MP:0001790,abnormal immune system physiology|MP:0002345,abnormal lymph node primary follicle morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002363,abnormal spleen marginal sinus morphology|MP:0002389,abnormal Peyer's patch follicle morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0008200,decreased follicular dendritic cell number|MP:0008241,abnormal metallophilic macrophage morphology|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008471,abnormal spleen primary B follicle morphology|MP:0008474,absent spleen germinal center|MP:0008713,abnormal cytokine level|MP:0008734,decreased susceptibility to endotoxin shock
MGI:1860250	Tnf<tm1Ljo>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000788,abnormal cerebral cortex morphology|MP:0001175,abnormal lung morphology|MP:0001212,skin lesions|MP:0001405,impaired coordination|MP:0001516,abnormal motor coordination/balance|MP:0001793,abnormal susceptibility to infection|MP:0001805,decreased IgG level|MP:0001861,lung inflammation|MP:0002389,abnormal Peyer's patch follicle morphology|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002392,abnormal Peyer's patch T cell area morphology|MP:0002411,decreased susceptibility to bacterial infection|MP:0002412,increased susceptibility to bacterial infection|MP:0002460,decreased immunoglobulin level|MP:0002463,abnormal neutrophil physiology|MP:0003009,abnormal cytokine secretion|MP:0004947,skin inflammation|MP:0005013,increased lymphocyte cell number|MP:0005027,increased susceptibility to parasitic infection|MP:0005351,decreased susceptibility to autoimmune disorder|MP:0005370,liver/biliary system phenotype|MP:0005399,increased susceptibility to fungal infection|MP:0006043,decreased apoptosis|MP:0008101,lymph node hypoplasia|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0008197,abnormal follicular dendritic cell physiology|MP:0008201,absent follicular dendritic cells|MP:0008432,abnormal long-term spatial reference memory|MP:0008474,absent spleen germinal center|MP:0008479,decreased spleen white pulp amount|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008566,increased interferon-gamma secretion|MP:0008722,abnormal chemokine secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008828,abnormal lymph node cell ratio|MP:0014263,decreased spleen B cell follicle number
MGI:2653694	Tnf<tm1Sek>	MP:0000609,abnormal liver physiology|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001441,increased grooming behavior|MP:0002391,abnormal Peyer's patch germinal center morphology|MP:0002451,abnormal macrophage physiology|MP:0002757,decreased vertical activity|MP:0003009,abnormal cytokine secretion|MP:0003064,decreased coping response|MP:0003699,abnormal female reproductive system physiology|MP:0005232,abnormal mesenteric lymph node morphology|MP:0005387,immune system phenotype|MP:0008474,absent spleen germinal center|MP:0008523,absent lymph node germinal center|MP:0008578,decreased circulating interferon-gamma level|MP:0008597,decreased circulating interleukin-6 level|MP:0008639,decreased circulating interleukin-1 alpha level|MP:0008642,decreased circulating interleukin-1 beta level|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008978,abnormal vagina weight|MP:0009017,prolonged estrus|MP:0010069,increased serotonin level
MGI:3625620	Tnf<tm2.1Gkl>	MP:0000511,abnormal intestinal mucosa morphology|MP:0001263,weight loss|MP:0003304,large intestinal inflammation|MP:0003306,small intestinal inflammation|MP:0005387,immune system phenotype|MP:0008108,abnormal small intestinal villus morphology|MP:0008553,increased circulating tumor necrosis factor level|MP:0009482,ileum inflammation|MP:0014079,decreased small intestinal villus number
MGI:2388715	Tnf<tm2Gkl>	MP:0000351,increased cell proliferation|MP:0000414,alopecia|MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001601,abnormal myelopoiesis|MP:0001823,thymus hypoplasia|MP:0001858,intestinal inflammation|MP:0001876,decreased inflammatory response|MP:0002078,abnormal glucose homeostasis|MP:0002083,premature death|MP:0002444,abnormal T cell physiology|MP:0002724,enhanced wound healing|MP:0002747,abnormal aortic valve morphology|MP:0002791,steatorrhea|MP:0002932,abnormal joint morphology|MP:0002993,autoimmune arthritis|MP:0003141,cardiac fibrosis|MP:0003233,prolonged QT interval|MP:0003306,small intestinal inflammation|MP:0003393,decreased cardiac output|MP:0003561,rheumatoid arthritis|MP:0003944,abnormal T cell subpopulation ratio|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005333,decreased heart rate|MP:0005449,abnormal food intake|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0005667,abnormal circulating leptin level|MP:0005671,abnormal response to transplant|MP:0006042,increased apoptosis|MP:0006117,aortic valve stenosis|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008126,increased dendritic cell number|MP:0008399,abnormal alpha-beta intraepithelial T cell morphology|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion|MP:0009482,ileum inflammation|MP:0010155,abnormal intestine physiology|MP:0010209,abnormal circulating chemokine level|MP:0010222,abnormal T-helper 17 cell physiology|MP:0010593,thick aortic valve cusps|MP:0010835,increased CD4-positive, alpha-beta memory T cell number|MP:0011572,abnormal aorta bulb morphology|MP:0011703,increased fibroblast proliferation|MP:0011709,increased fibroblast cell migration|MP:0011804,increased cell migration|MP:0011929,abnormal aortic valve flow|MP:0031118,cardiovalvulitis|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3578747	Tnf<tm2Jods>	MP:0001790,abnormal immune system physiology|MP:0002345,abnormal lymph node primary follicle morphology|MP:0002357,abnormal spleen white pulp morphology|MP:0002389,abnormal Peyer's patch follicle morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002460,decreased immunoglobulin level|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005387,immune system phenotype|MP:0008241,abnormal metallophilic macrophage morphology|MP:0008471,abnormal spleen primary B follicle morphology|MP:0008473,abnormal spleen follicular dendritic cell network|MP:0008482,decreased spleen germinal center number|MP:0008484,decreased spleen germinal center size|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008828,abnormal lymph node cell ratio|MP:0010360,decreased liver free fatty acids level
MGI:3692522	Tnf<tm3Gkl>	MP:0001844,autoimmune response|MP:0002344,abnormal lymph node B cell domain morphology|MP:0002411,decreased susceptibility to bacterial infection|MP:0003945,abnormal lymphocyte physiology|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005232,abnormal mesenteric lymph node morphology|MP:0008201,absent follicular dendritic cells|MP:0008471,abnormal spleen primary B follicle morphology|MP:0008474,absent spleen germinal center|MP:0008495,decreased IgG1 level|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008561,decreased tumor necrosis factor secretion|MP:0008734,decreased susceptibility to endotoxin shock
MGI:5571275	Tnik<m1Anu>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype
MGI:5461352	Tnik<tm1Grnt>	MP:0001458,abnormal object recognition memory|MP:0002802,abnormal discrimination learning|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002919,enhanced paired-pulse facilitation|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008924,decreased cerebellar granule cell number|MP:0009937,abnormal neuron differentiation|MP:0031391,increased locomotor activity
MGI:6113591	Tnik<tm1Teya>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001262,decreased body weight|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005179,decreased circulating cholesterol level|MP:0005560,decreased circulating glucose level
MGI:5002995	Tnik<tm3a(EUCOMM)Wtsi>	MP:0001258,decreased body length|MP:0004509,abnormal pelvic girdle bone morphology|MP:0010025,decreased total body fat amount
MGI:3894752	Tnip1<Gt(E059E05)Wrst>	MP:0000219,increased neutrophil cell number|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001577,anemia|MP:0002083,premature death|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002743,glomerulonephritis|MP:0002874,decreased hemoglobin content|MP:0002962,increased urine protein level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0005150,cachexia|MP:0008102,lymph node hyperplasia|MP:0008499,increased IgG1 level|MP:0008501,increased IgG2b level|MP:0008664,decreased interleukin-12 secretion|MP:0008670,decreased interleukin-12b secretion|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6200058	Tnip1<m1Btlr>	MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005017,decreased B cell number|MP:0005425,increased macrophage cell number|MP:0008126,increased dendritic cell number|MP:0008167,increased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0008207,decreased B-2 B cell number|MP:0008537,increased susceptibility to induced colitis
MGI:3835790	Tnip1<tm1.1Ama>	MP:0000208,decreased hematocrit|MP:0000600,liver hypoplasia|MP:0001577,anemia|MP:0003717,pallor|MP:0003887,increased hepatocyte apoptosis|MP:0004200,decreased fetal size|MP:0009431,decreased fetal weight|MP:0011090,perinatal lethality, incomplete penetrance|MP:0013501,increased fibroblast apoptosis
MGI:5296045	Tnip1<tm1.1Pcoh>	MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0000477,abnormal intestine morphology|MP:0000685,abnormal immune system morphology|MP:0000691,enlarged spleen|MP:0000696,abnormal Peyer's patch morphology|MP:0000702,enlarged lymph nodes|MP:0001614,abnormal blood vessel morphology|MP:0001864,vascular inflammation|MP:0002083,premature death|MP:0002359,abnormal spleen germinal center morphology|MP:0002435,abnormal effector T cell morphology|MP:0002439,abnormal plasma cell morphology|MP:0002461,increased immunoglobulin level|MP:0002471,abnormal complement pathway|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0002743,glomerulonephritis|MP:0003333,liver fibrosis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004839,bile duct hyperplasia|MP:0004952,increased spleen weight|MP:0005014,increased B cell number|MP:0005154,increased B cell proliferation|MP:0005387,immune system phenotype|MP:0008097,increased plasma cell number|MP:0008177,increased germinal center B cell number|MP:0008476,increased spleen red pulp amount|MP:0008478,increased spleen white pulp amount|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level|MP:0008560,increased tumor necrosis factor secretion|MP:0008669,increased interleukin-12b secretion|MP:0008705,increased interleukin-6 secretion|MP:0010186,increased T follicular helper cell number|MP:0013501,increased fibroblast apoptosis
MGI:5547505	Tnip1<tm1.2Ama>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0008049,increased memory T cell number|MP:0008246,abnormal leukocyte morphology|MP:0008524,increased plasmacytoid dendritic cell number|MP:0008560,increased tumor necrosis factor secretion|MP:0008663,increased interleukin-12 secretion|MP:0008690,increased interleukin-23 secretion|MP:0008705,increased interleukin-6 secretion|MP:0010763,abnormal hematopoietic stem cell physiology
MGI:5296230	Tnip1<tm1.2Pcoh>	MP:0000685,abnormal immune system morphology|MP:0002083,premature death
MGI:6195689	Tnip1<tm1b(EUCOMM)Hmgu>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000208,decreased hematocrit|MP:0000220,increased monocyte cell number|MP:0002599,increased mean platelet volume|MP:0002606,increased basophil cell number|MP:0002644,decreased circulating triglyceride level|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0004151,decreased circulating iron level|MP:0004952,increased spleen weight|MP:0005012,decreased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005627,increased circulating potassium level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level|MP:0010506,prolonged RR interval|MP:0012362,increased large unstained cell number|MP:0020421,increased freezing behavior
MGI:3664444	Tnip2<tm1.1Sley>	MP:0002451,abnormal macrophage physiology|MP:0005387,immune system phenotype
MGI:3716211	Tnip3<tm1Rds>	MP:0005387,immune system phenotype
MGI:5635448	Tnk1<tm1b(EUCOMM)Hmgu>	MP:0010025,decreased total body fat amount
MGI:3814727	Tnk1<tm1Sksuf>	MP:0002018,increased malignant tumor incidence|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002038,increased carcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002404,increased intestinal adenoma incidence|MP:0002732,increased trichoepithelioma incidence|MP:0002957,increased intestinal adenocarcinoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003667,increased hemangiosarcoma incidence|MP:0005491,pancreatic islet hyperplasia|MP:0009153,increased pancreas tumor incidence|MP:0010264,increased hepatoma incidence|MP:0010279,increased gastrointestinal tumor incidence|MP:0010300,increased skin tumor incidence|MP:0012431,increased lymphoma incidence
MGI:6257705	Tnk2<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes
MGI:7543727	Tnk2<tm1.2Npma>	MP:0001829,increased activated T cell number|MP:0002444,abnormal T cell physiology|MP:0003447,decreased tumor growth/size|MP:0004972,abnormal regulatory T cell number|MP:0008577,increased circulating interferon-gamma level|MP:0008599,increased circulating interleukin-2 level|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0014435,increased interferon level|MP:0014437,increased interleukin level
MGI:5795838	Tnks1bp1<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0005419,decreased circulating serum albumin level
MGI:3621820	Tnks2<tm1.1Susm>	MP:0001262,decreased body weight|MP:0005384,cellular phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3621924	Tnks2<tm1.1Yjc>	MP:0001262,decreased body weight|MP:0005384,cellular phenotype|MP:0010768,mortality/aging|MP:0030017,decreased adipocyte glucose uptake
MGI:5473325	Tnks2<tm1b(KOMP)Wtsi>	MP:0001488,increased startle reflex|MP:0002075,abnormal coat/hair pigmentation|MP:0010052,increased grip strength
MGI:3621819	Tnks2<tm1Susm>	MP:0001262,decreased body weight|MP:0005384,cellular phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6273966	Tnks<em1(IMPC)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000137,abnormal vertebrae morphology|MP:0000186,decreased circulating HDL cholesterol level|MP:0001325,abnormal retina morphology|MP:0001891,hydrocephaly|MP:0002599,increased mean platelet volume|MP:0002644,decreased circulating triglyceride level|MP:0002757,decreased vertical activity|MP:0002833,increased heart weight|MP:0002875,decreased erythrocyte cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005560,decreased circulating glucose level|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010067,increased red blood cell distribution width|MP:0010124,decreased bone mineral content|MP:0011965,decreased total retina thickness|MP:0013279,increased fasting circulating glucose level
MGI:4127087	Tnks<Gt(RRC239)Byg>	MP:0000189,hypoglycemia|MP:0002079,increased circulating insulin level|MP:0002575,increased circulating ketone body level|MP:0004892,increased adiponectin level|MP:0005289,increased oxygen consumption|MP:0005533,increased body temperature|MP:0005668,decreased circulating leptin level|MP:0009289,decreased epididymal fat pad weight|MP:0009303,decreased renal fat pad weight|MP:0011939,increased food intake|MP:0030021,increased muscle cell glucose uptake
MGI:3804704	Tnks<tm1.1Yjc>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype
MGI:3530136	Tnmd<tm1Ref>	MP:0005390,skeleton phenotype|MP:0005391,vision/eye phenotype|MP:0005503,abnormal tendon morphology
MGI:5911233	Tnnc1<em1(IMPC)J>	MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6304486	Tnnc1<tm1.1Jrpi>	MP:0000266,abnormal heart morphology|MP:0000276,heart right ventricle hypertrophy|MP:0000639,abnormal adrenal gland morphology|MP:0000783,abnormal forebrain morphology|MP:0001363,increased anxiety-related response|MP:0001544,abnormal cardiovascular system physiology|MP:0002573,behavioral despair|MP:0002625,heart left ventricle hypertrophy|MP:0002834,decreased heart weight|MP:0002953,thick ventricular wall|MP:0002972,abnormal cardiac muscle contractility|MP:0004084,abnormal cardiac muscle relaxation|MP:0004183,abnormal sympathetic nervous system physiology|MP:0004215,abnormal myocardial fiber physiology|MP:0005330,cardiomyopathy|MP:0005333,decreased heart rate|MP:0005599,increased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0008725,increased heart atrium size|MP:0010569,papillary muscle hypertrophy|MP:0010754,abnormal heart left ventricle pressure|MP:0011915,increased heart left atrium weight|MP:0011925,abnormal heart echocardiography feature|MP:0011951,increased cardiac stroke volume|MP:0020419,decreased cardiac muscle relaxation|MP:0031131,myocardial fiber disarray
MGI:7426051	Tnn<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver
MGI:5791872	Tnni1<tm3b(EUCOMM)Hmgu>	MP:0004357,long tibia|MP:0011100,preweaning lethality, complete penetrance
MGI:5569035	Tnni2<tm1.1(KOMP)Vlcg>	MP:0002060,abnormal skin morphology|MP:0005560,decreased circulating glucose level|MP:0010025,decreased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:6270415	Tnni2<tm1Sgao>	MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000550,abnormal forelimb morphology|MP:0001265,decreased body size|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0004343,small scapula|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004704,short vertebral column|MP:0004989,decreased osteoblast cell number|MP:0005602,decreased angiogenesis|MP:0006395,abnormal epiphyseal plate morphology|MP:0008273,abnormal intramembranous bone ossification|MP:0008489,slow postnatal weight gain|MP:0009674,decreased birth weight|MP:0010873,decreased trabecular bone mass|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014321,short forelimb|MP:0014322,short hindlimb|MP:0020137,decreased bone mineralization|MP:0020254,decreased collagen level|MP:0030439,decreased osteoblast proliferation
MGI:7539710	Tnni3k<B>	MP:0001559,hyperglycemia|MP:0002727,decreased circulating insulin level|MP:0002753,dilated heart left ventricle|MP:0005140,decreased cardiac muscle contractility|MP:0005331,insulin resistance|MP:0005333,decreased heart rate|MP:0014316,decreased heart left ventricle posterior wall thickness
MGI:6098722	Tnni3k<tm1.1Tfo>	MP:0000350,abnormal cell proliferation|MP:0004215,abnormal myocardial fiber physiology|MP:0005369,muscle phenotype|MP:0006321,increased myocardial fiber number
MGI:5613890	Tnni3k<tm1Tfo>	MP:0000343,abnormal response to cardiac infarction|MP:0003038,decreased myocardial infarct size|MP:0004215,abnormal myocardial fiber physiology|MP:0005385,cardiovascular system phenotype|MP:0006321,increased myocardial fiber number
MGI:5308372	Tnni3<tm1.1Jdp>	MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0005385,cardiovascular system phenotype|MP:0005608,cardiac interstitial fibrosis|MP:0010724,thick interventricular septum|MP:0010768,mortality/aging
MGI:5308371	Tnni3<tm1Jdp>	MP:0001544,abnormal cardiovascular system physiology|MP:0011100,preweaning lethality, complete penetrance
MGI:2387868	Tnni3<tm1Jww>	MP:0001544,abnormal cardiovascular system physiology|MP:0001954,respiratory distress|MP:0004007,abnormal lung vasculature morphology|MP:0004090,abnormal sarcomere morphology|MP:0005202,lethargy|MP:0005329,abnormal myocardium layer morphology|MP:0006138,congestive heart failure|MP:0011085,postnatal lethality, complete penetrance|MP:0014733,decreased myocardial fiber myofibril length
MGI:5635256	Tnnt1<tm1.2Jin>	MP:0002106,abnormal muscle physiology|MP:0004036,abnormal muscle relaxation|MP:0004087,abnormal muscle fiber morphology|MP:0005620,abnormal muscle contractility|MP:0009400,decreased skeletal muscle fiber size|MP:0009401,increased skeletal muscle fiber diameter|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009413,skeletal muscle fiber atrophy|MP:0009458,abnormal skeletal muscle size
MGI:5635254	Tnnt1<tm1Jin>	MP:0002106,abnormal muscle physiology|MP:0004036,abnormal muscle relaxation|MP:0004087,abnormal muscle fiber morphology|MP:0005620,abnormal muscle contractility|MP:0009400,decreased skeletal muscle fiber size|MP:0009401,increased skeletal muscle fiber diameter|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009413,skeletal muscle fiber atrophy
MGI:3805012	Tnnt2<tm1Feah>	MP:0000267,abnormal heart development|MP:0000278,abnormal myocardial fiber morphology|MP:0003984,embryonic growth retardation|MP:0005140,decreased cardiac muscle contractility|MP:0005312,pericardial effusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance
MGI:3055296	Tnnt2<tm1Mmto>	MP:0000298,absent atrioventricular cushions|MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0004086,absent heartbeat|MP:0004090,abnormal sarcomere morphology|MP:0004251,failure of heart looping|MP:0004937,dilated heart|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5910771	Tnnt2<tm2.1Feah>	MP:0001544,abnormal cardiovascular system physiology|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0004215,abnormal myocardial fiber physiology|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0005402,abnormal action potential|MP:0008770,decreased survivor rate|MP:0008950,ventricular tachycardia|MP:0011925,abnormal heart echocardiography feature
MGI:3803301	Tnnt2<tm2Mmto>	MP:0000274,enlarged heart|MP:0001544,abnormal cardiovascular system physiology|MP:0002083,premature death|MP:0002972,abnormal cardiac muscle contractility|MP:0003233,prolonged QT interval|MP:0003822,decreased left ventricle systolic pressure|MP:0003921,abnormal heart left ventricle morphology|MP:0004215,abnormal myocardial fiber physiology|MP:0005608,cardiac interstitial fibrosis|MP:0031633,decreased heart left ventricle muscle contractility
MGI:4363809	Tnnt3<tm2a(KOMP)Wtsi>	MP:0000533,kidney hemorrhage|MP:0000547,short limbs|MP:0000761,thin diaphragm muscle|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002896,abnormal bone mineralization|MP:0003888,liver hemorrhage|MP:0004200,decreased fetal size|MP:0005390,skeleton phenotype|MP:0006396,decreased long bone epiphyseal plate size|MP:0011087,neonatal lethality, complete penetrance
MGI:6507894	Tnn<tm1b(KOMP)Wtsi>	MP:0000116,abnormal tooth development|MP:0000119,abnormal tooth eruption|MP:0000458,abnormal mandible morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0002083,premature death|MP:0002576,abnormal enamel morphology|MP:0002818,abnormal dentin morphology|MP:0003668,abnormal periodontal ligament morphology|MP:0004189,abnormal alveolar process morphology|MP:0005335,abnormal gonadal fat pad morphology|MP:0011584,increased alkaline phosphatase activity|MP:0011940,decreased food intake|MP:0013250,abnormal dental pulp morphology|MP:0030131,abnormal periodontium morphology|MP:0030136,abnormal lower incisor morphology|MP:0030137,abnormal upper incisor morphology|MP:0030450,abnormal enamel mineralization|MP:0030456,abnormal odontoblast differentiation|MP:0030471,abnormal ameloblast differentiation|MP:0030508,abnormal dental epithelium morphology|MP:0030542,abnormal dentin development|MP:0030544,abnormal enamel development
MGI:1859961	Tnp1<tm1Mlm>	MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009238,coiled sperm flagellum
MGI:2180358	Tnp2<tm1Mzh>	MP:0001935,decreased litter size|MP:0002169,no abnormal phenotype detected|MP:0002675,asthenozoospermia|MP:0005578,teratozoospermia|MP:0009232,abnormal sperm nucleus morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0031356,abnormal outer dense fiber morphology
MGI:2180779	Tnp2<tm1Wen>	MP:0001925,male infertility|MP:0002169,no abnormal phenotype detected|MP:0002675,asthenozoospermia|MP:0005578,teratozoospermia|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0030976,impaired sperm penetration of zona pellucida
MGI:5756072	Tnpo2<tm1b(EUCOMM)Hmgu>	MP:0010097,abnormal retina blood vessel morphology|MP:0011959,abnormal eye posterior chamber depth
MGI:5563403	Tnpo3<m1Anu>	MP:0008762,embryonic lethality
MGI:7578774	Tnrc18<em1Ggw>	MP:0001265,decreased body size|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4052360	Tnrc6a<Gt(IST12137A2)Tigm>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4124681	Tnrc6a<Gt(XE786)Byg>	MP:0000352,decreased cell proliferation|MP:0001606,impaired hematopoiesis|MP:0001724,abnormal extraembryonic endoderm formation|MP:0002875,decreased erythrocyte cell number|MP:0003717,pallor|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011182,decreased hematopoietic cell number|MP:0011204,abnormal visceral yolk sac blood island morphology
MGI:6361216	Tnrc6b<em1(IMPC)Bay>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0001925,male infertility|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0020870,decreased thigmotaxis
MGI:4041902	Tnrc6b<Gt(IST12075C8)Tigm>	MP:0001262,decreased body weight|MP:0001924,infertility|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6195001	Tnrc6c<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation
MGI:4001992	Tnrc6c<Gt(IST11346C2)Tigm>	MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0011087,neonatal lethality, complete penetrance|MP:0011142,abnormal lung-associated mesenchyme development
MGI:6156164	Tnr<em1(IMPC)Rbrc>	MP:0001565,abnormal circulating phosphate level|MP:0003313,abnormal locomotor activation|MP:0004952,increased spleen weight
MGI:2154583	Tnr<tm1Msch>	MP:0003632,abnormal nervous system morphology|MP:0004792,abnormal synaptic vesicle number|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008814,decreased nerve conduction velocity|MP:0009538,abnormal synapse morphology
MGI:2447792	Tns1<tm1Efu>	MP:0000286,abnormal mitral valve morphology|MP:0000521,abnormal kidney cortex morphology|MP:0000522,kidney cortex cyst|MP:0000746,weakness|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003566,abnormal cell adhesion|MP:0003606,kidney failure|MP:0003675,kidney cyst|MP:0004194,abnormal kidney pelvis morphology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004969,pale kidney|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005385,cardiovascular system phenotype|MP:0005526,decreased renal plasma flow rate|MP:0009050,dilated proximal convoluted tubule|MP:0009641,kidney degeneration|MP:0010614,abnormal mitral valve cusp morphology|MP:0011402,renal cast|MP:0011405,tubulointerstitial nephritis|MP:0011501,increased glomerular capsule space|MP:0011534,granular kidney
MGI:2447990	Tns2<nph>	MP:0000208,decreased hematocrit|MP:0000477,abnormal intestine morphology|MP:0000516,abnormal renal/urinary system morphology|MP:0000521,abnormal kidney cortex morphology|MP:0000702,enlarged lymph nodes|MP:0001785,edema|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002160,abnormal reproductive system morphology|MP:0002705,dilated renal tubule|MP:0002743,glomerulonephritis|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0002989,small kidney|MP:0005178,increased circulating cholesterol level|MP:0005325,abnormal renal glomerulus morphology|MP:0005565,increased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0008853,decreased abdominal adipose tissue amount|MP:0020518,renal glomerular protein deposits|MP:0020519,renal glomerular immunoglobulin deposits
MGI:6257504	Tns3<em1(IMPC)Bay>	MP:0000432,abnormal head morphology|MP:0005140,decreased cardiac muscle contractility|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013279,increased fasting circulating glucose level
MGI:3574415	Tns3<Gt(XK294)Byg>	MP:0000462,abnormal digestive system morphology|MP:0000692,small spleen|MP:0001175,abnormal lung morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002082,postnatal lethality|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002397,abnormal bone marrow morphology|MP:0002691,small stomach|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003091,abnormal cell migration|MP:0008108,abnormal small intestinal villus morphology|MP:0014101,decreased chondrocyte proliferation
MGI:5300463	Tn(sb-Tyr)1799B.CA1Ove	MP:0002169,no abnormal phenotype detected
MGI:5300461	Tn(sb-Tyr)1799B.CA6Ove	MP:0002169,no abnormal phenotype detected
MGI:5692761	Tnxb<tm1b(EUCOMM)Hmgu>	MP:0000274,enlarged heart|MP:0000691,enlarged spleen|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005566,decreased blood urea nitrogen level|MP:0010124,decreased bone mineral content
MGI:2181283	Tnxb<tm1Jbrs>	MP:0005275,abnormal skin tensile strength
MGI:3053791	Tnxb<tm1Kmat>	MP:0002166,abnormal tumor susceptibility|MP:0008438,abnormal cutaneous collagen fibril morphology|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:1933294	Tob1<tm1Tya>	MP:0000351,increased cell proliferation|MP:0004988,increased osteoblast cell number|MP:0005605,increased bone mass|MP:0008271,abnormal bone ossification|MP:0008395,abnormal osteoblast differentiation|MP:0010872,increased trabecular bone mass
MGI:3789484	Tob2<tm1Tya>	MP:0000066,osteoporosis|MP:0000130,abnormal trabecular bone morphology|MP:0001541,abnormal osteoclast physiology|MP:0004016,decreased bone mass|MP:0004984,increased osteoclast cell number|MP:0004992,increased bone resorption|MP:0008396,abnormal osteoclast differentiation
MGI:6369003	Toe1<em1Jgg>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5635449	Toe1<tm1.1(KOMP)Vlcg>	MP:0001513,limb grasping|MP:0011100,preweaning lethality, complete penetrance|MP:0011436,decreased urine magnesium level|MP:0013292,embryonic lethality prior to organogenesis
MGI:6203652	Togaram1<em1(IMPC)J>	MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0000783,abnormal forebrain morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001914,hemorrhage|MP:0005650,abnormal limb bud morphology|MP:0008797,facial cleft|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:7426052	Togaram2<em1(IMPC)Hmgu>	MP:0003019,increased circulating chloride level
MGI:3619521	Tollip<tm1Kbns>	MP:0008561,decreased tumor necrosis factor secretion|MP:0008597,decreased circulating interleukin-6 level|MP:0008706,decreased interleukin-6 secretion
MGI:6283556	Tom1l1<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior
MGI:3784979	Tom1l2<Gt(XG909)Byg>	MP:0000120,malocclusion|MP:0000160,kyphosis|MP:0000218,increased leukocyte cell number|MP:0000418,focal hair loss|MP:0000688,lymphoid hyperplasia|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001194,dermatitis|MP:0001209,spontaneous skin ulceration|MP:0001212,skin lesions|MP:0001272,increased metastatic potential|MP:0001299,abnormal eye distance/ position|MP:0001312,abnormal cornea morphology|MP:0001790,abnormal immune system physiology|MP:0001800,abnormal humoral immune response|MP:0001845,abnormal inflammatory response|MP:0001846,increased inflammatory response|MP:0001852,conjunctivitis|MP:0001891,hydrocephaly|MP:0001914,hemorrhage|MP:0001958,emphysema|MP:0002016,ovary cyst|MP:0002020,increased tumor incidence|MP:0002065,abnormal fear/anxiety-related behavior|MP:0002358,abnormal spleen periarteriolar lymphoid sheath morphology|MP:0002406,increased susceptibility to infection|MP:0002412,increased susceptibility to bacterial infection|MP:0002574,increased vertical activity|MP:0002750,exophthalmos|MP:0003179,thrombocytopenia|MP:0003675,kidney cyst|MP:0004208,increased basal cell carcinoma incidence|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0008000,increased ovary tumor incidence|MP:0008014,increased lung tumor incidence|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008478,increased spleen white pulp amount|MP:0008826,abnormal splenic cell ratio|MP:0008828,abnormal lymph node cell ratio|MP:0010024,increased total body fat amount|MP:0010299,increased mammary gland tumor incidence|MP:0010300,increased skin tumor incidence|MP:0010357,increased prostate gland tumor incidence|MP:0010383,increased adenoma incidence|MP:0014606,dark spleen|MP:0031391,increased locomotor activity
MGI:6120515	Tomm20<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0001529,abnormal vocalization|MP:0001728,failure of embryo implantation|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6830927	Tomm20l<em1Kzt>	MP:0005389,reproductive system phenotype
MGI:5763625	Tomm22<em1(IMPC)J>	MP:0005562,decreased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3055553	Tomm34<tm1Kate>	MP:0002169,no abnormal phenotype detected
MGI:5774456	Tomm40<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0001399,hyperactivity|MP:0001486,abnormal startle reflex|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:4159168	Tomm5<Gt(OST44663)Lex>	MP:0000321,increased bone marrow cell number|MP:0001861,lung inflammation|MP:0003644,thymus atrophy|MP:0004007,abnormal lung vasculature morphology|MP:0005011,increased eosinophil cell number|MP:0005388,respiratory system phenotype|MP:0006050,pulmonary fibrosis|MP:0008770,decreased survivor rate|MP:0010904,abnormal alveolar pore morphology|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4940754	Tomm6<tm1a(KOMP)Wtsi>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000613,abnormal salivary gland morphology|MP:0000702,enlarged lymph nodes|MP:0001404,no spontaneous movement|MP:0002339,abnormal lymph node morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011971,increased circulating lactate dehydrogenase level
MGI:6302770	Tomm70a<em1(IMPC)J>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:6695994	Tomm7<em1Yihc>	MP:0000774,decreased brain size|MP:0001622,abnormal vasculogenesis|MP:0001732,postnatal growth retardation|MP:0003674,oxidative stress|MP:0005380,embryo phenotype|MP:0008489,slow postnatal weight gain|MP:0011100,preweaning lethality, complete penetrance
MGI:7490176	Tomt<em1(IMPC)Tcp>	MP:0001120,abnormal uterus morphology|MP:0001293,anophthalmia|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0001417,decreased exploration in new environment|MP:0001486,abnormal startle reflex|MP:0002590,increased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002966,decreased circulating alkaline phosphatase level|MP:0004738,abnormal auditory brainstem response|MP:0004924,abnormal behavior|MP:0005565,increased blood urea nitrogen level|MP:0005628,decreased circulating potassium level|MP:0020870,decreased thigmotaxis
MGI:3800574	Tomt<m1Btlr>	MP:0000043,organ of Corti degeneration|MP:0001262,decreased body weight|MP:0001354,increased aggression towards male mice|MP:0001395,bidirectional circling|MP:0001399,hyperactivity|MP:0001525,impaired balance|MP:0001967,deafness|MP:0002857,cochlear ganglion degeneration|MP:0003631,nervous system phenotype|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0004737,absent distortion product otoacoustic emissions|MP:0005307,head tossing|MP:0006359,absent startle reflex|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6257573	Tonsl<em1(IMPC)Bay>	MP:0002792,abnormal retina vasculature morphology|MP:0002953,thick ventricular wall|MP:0010579,increased heart left ventricle size|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6389087	Tonsl<em1Tjch>	MP:0001634,internal hemorrhage|MP:0001719,absent vitelline blood vessels|MP:0002169,no abnormal phenotype detected|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012131,small visceral yolk sac
MGI:7426053	Tonsl<em2(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:5448057	Top1mt<tm1.1Hlzh>	MP:0000609,abnormal liver physiology|MP:0003186,abnormal redox activity|MP:0003674,oxidative stress|MP:0003925,abnormal cellular glucose uptake|MP:0005621,abnormal cell physiology|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0008260,abnormal autophagy|MP:0009642,abnormal blood homeostasis|MP:0010954,abnormal cellular respiration|MP:0011628,increased mitochondrial number|MP:0011704,decreased fibroblast proliferation
MGI:2678314	Top1<tm1Unc>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:6157267	Top2a<em2(IMPC)Tcp>	MP:0000598,abnormal liver morphology|MP:0000692,small spleen|MP:0000706,small thymus|MP:0001297,microphthalmia|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002590,increased mean corpuscular volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0005343,increased circulating aspartate transaminase level|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6449041	Top2b<em1(IMPC)Mbp>	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001289,persistence of hyaloid vascular system|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002092,abnormal eye morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape
MGI:2179201	Top2b<tm1Jcw>	MP:0000160,kyphosis|MP:0000753,paralysis|MP:0000940,abnormal motor neuron innervation pattern|MP:0001052,abnormal innervation pattern to muscle|MP:0001698,decreased embryo size|MP:0001953,respiratory failure|MP:0011087,neonatal lethality, complete penetrance
MGI:3521923	Top2b<tm2.1Jcw>	MP:0000774,decreased brain size|MP:0000790,abnormal stratification in cerebral cortex|MP:0000934,abnormal telencephalon development|MP:0001265,decreased body size|MP:0001953,respiratory failure|MP:0002741,small olfactory bulb|MP:0004174,abnormal spine curvature|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0008442,disorganized cortical plate|MP:0008443,absent subplate|MP:0011087,neonatal lethality, complete penetrance|MP:0014551,impaired neuronal migration
MGI:3521850	Top2b<tm2Jcw>	MP:0001005,abnormal retina rod cell morphology|MP:0001006,abnormal retina cone cell morphology|MP:0002169,no abnormal phenotype detected|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0008444,retina cone cell degeneration|MP:0008449,abnormal retina cone cell outer segment morphology|MP:0008450,retina photoreceptor degeneration|MP:0008456,abnormal retina rod cell outer segment morphology|MP:0008515,thin retina outer nuclear layer|MP:0008584,photoreceptor outer segment degeneration|MP:0010236,abnormal retina outer limiting membrane morphology
MGI:5660780	Top3a<tm1b(EUCOMM)Hmgu>	MP:0001488,increased startle reflex|MP:0006243,impaired pupillary reflex|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:2388159	Top3a<tm1Jcw>	MP:0004966,abnormal inner cell mass proliferation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2388157	Top3b<tm1Jcw>	MP:0000613,abnormal salivary gland morphology|MP:0000691,enlarged spleen|MP:0001175,abnormal lung morphology|MP:0001194,dermatitis|MP:0001846,increased inflammatory response|MP:0001869,pancreas inflammation|MP:0001873,stomach inflammation|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002742,enlarged submandibular lymph nodes|MP:0002743,glomerulonephritis|MP:0004024,aneuploidy|MP:0005169,abnormal male meiosis|MP:0005491,pancreatic islet hyperplasia|MP:0008995,early reproductive senescence|MP:0009631,enlarged axillary lymph nodes
MGI:5796830	Top6bl<em2Arte>	MP:0001147,small testis|MP:0001930,abnormal meiosis|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0009452,abnormal synaptonemal complex|MP:0011121,decreased primordial ovarian follicle number|MP:0011125,decreased primary ovarian follicle number
MGI:5700076	Topaz1<tm1Ics>	MP:0001147,small testis|MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0006362,abnormal male germ cell morphology|MP:0008261,arrest of male meiosis|MP:0008280,abnormal male germ cell apoptosis
MGI:4947431	Topbp1<tm1.1Dsh>	MP:0002169,no abnormal phenotype detected|MP:0003077,abnormal cell cycle|MP:0005621,abnormal cell physiology
MGI:5544423	Topbp1<tm1.1Zqw>	MP:0001730,embryonic growth arrest|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4947432	Topbp1<tm1.2Dsh>	MP:0000352,decreased cell proliferation|MP:0001730,embryonic growth arrest|MP:0011093,embryonic lethality at implantation, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5316209	Topbp1<tm1Pmc>	MP:0000788,abnormal cerebral cortex morphology
MGI:6363569	Topors<em1(IMPC)J>	MP:0000208,decreased hematocrit|MP:0001304,cataract|MP:0001314,cornea opacity|MP:0001399,hyperactivity|MP:0001926,female infertility|MP:0002574,increased vertical activity|MP:0002834,decreased heart weight|MP:0002875,decreased erythrocyte cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0003233,prolonged QT interval|MP:0003961,decreased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005333,decreased heart rate|MP:0005419,decreased circulating serum albumin level|MP:0005559,increased circulating glucose level|MP:0005567,decreased circulating total protein level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010506,prolonged RR interval
MGI:4124300	Topors<Gt(DTM034)Byg>	MP:0000160,kyphosis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002006,neoplasm|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0004024,aneuploidy|MP:0004046,abnormal mitosis|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011704,decreased fibroblast proliferation|MP:0020414,abnormal fibroblast physiology
MGI:1857077	tor	MP:0001504,abnormal posture|MP:0001524,impaired limb coordination|MP:0002566,abnormal sexual interaction|MP:0008492,dorsal root ganglion degeneration|MP:0012712,spinal cord degeneration|MP:0013173,trigeminal ganglion degeneration
MGI:6153827	Tor1a<em1(IMPC)H>	MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance
MGI:4460952	Tor1aip1<Gt(GST004691)Lex>	MP:0003111,abnormal cell nucleus morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:7610707	Tor1aip1<tm1.1Wtd>	MP:0000607,abnormal hepatocyte morphology
MGI:5792560	Tor1aip1<tm1b(EUCOMM)Hmgu>	MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance
MGI:7610710	Tor1aip2<tm1.1Wtd>	MP:0002169,no abnormal phenotype detected|MP:0005370,liver/biliary system phenotype
MGI:6119725	Tor1a<tm1Calak>	MP:0000745,tremors|MP:0000848,abnormal pons morphology|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001413,abnormal response to new environment|MP:0001475,reduced long-term depression|MP:0001512,trunk curl|MP:0002152,abnormal brain morphology|MP:0005323,dystonia|MP:0008026,abnormal brain white matter morphology|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020421,increased freezing behavior
MGI:3623421	Tor1a<tm1Wtd>	MP:0000955,abnormal spinal cord morphology|MP:0001436,abnormal suckling behavior|MP:0003111,abnormal cell nucleus morphology|MP:0003894,abnormal Purkinje cell innervation|MP:0004996,abnormal CNS synapse formation|MP:0011087,neonatal lethality, complete penetrance|MP:0020351,decreased vocalization
MGI:3613019	Tor1a<tm1Yql>	MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0005643,decreased dopamine level|MP:0011089,perinatal lethality, complete penetrance|MP:0020560,abnormal pontine nuclei morphology|MP:0031391,increased locomotor activity
MGI:3772565	Tor1a<tm2.1Yql>	MP:0009546,absent gastric milk in neonates|MP:0011085,postnatal lethality, complete penetrance
MGI:3623422	Tor1a<tm2Wtd>	MP:0000745,tremors|MP:0000778,abnormal nervous system tract morphology|MP:0000864,abnormal cerebellum vermis morphology|MP:0000885,ectopic Purkinje cell|MP:0001406,abnormal gait|MP:0001431,abnormal eating behavior|MP:0001436,abnormal suckling behavior|MP:0003111,abnormal cell nucleus morphology|MP:0004102,abnormal dorsal striatum morphology|MP:0004811,abnormal neuron physiology|MP:0005386,behavior/neurological phenotype|MP:0008026,abnormal brain white matter morphology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008914,enlarged cerebellum|MP:0011085,postnatal lethality, complete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0020351,decreased vocalization
MGI:3772564	Tor1a<tm2Yql>	MP:0001394,circling|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001409,increased stereotypic behavior|MP:0001516,abnormal motor coordination/balance|MP:0003631,nervous system phenotype
MGI:5605367	Tor1a<tm3.1Wtd>	MP:0002628,hepatic steatosis
MGI:5693628	Tor1a<tm4.1Wtd>	MP:0002169,no abnormal phenotype detected
MGI:5693835	Tor1a<tm4.2Wtd>	MP:0000745,tremors|MP:0000746,weakness|MP:0001262,decreased body weight|MP:0001290,delayed eyelid opening|MP:0001405,impaired coordination|MP:0001505,hunched posture|MP:0001513,limb grasping|MP:0001525,impaired balance|MP:0001961,abnormal reflex|MP:0002083,premature death|MP:0002183,gliosis|MP:0002882,abnormal neuron morphology|MP:0003111,abnormal cell nucleus morphology|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7507212	Tor1b<em1(IMPC)Mbp>	MP:0002606,increased basophil cell number
MGI:6705131	Tor1b<tm1.1Wtd>	MP:0002169,no abnormal phenotype detected
MGI:7738442	Tox2<em1Cdon>	MP:0008178,decreased germinal center B cell number|MP:0010188,abnormal T follicular helper cell differentiation
MGI:5749959	Tox2<em1(IMPC)H>	MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0002764,short tibia|MP:0008935,decreased mean platelet volume|MP:0010024,increased total body fat amount
MGI:5755092	Tox3<em1(IMPC)Tcp>	MP:0001417,decreased exploration in new environment
MGI:5548886	Tox3<tm1b(KOMP)Mbp>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5635451	Tox4<tm1b(KOMP)Mbp>	MP:0003984,embryonic growth retardation|MP:0005553,increased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance
MGI:3773716	Tox<tm1.1Kay>	MP:0000496,abnormal small intestine morphology|MP:0000689,abnormal spleen morphology|MP:0004919,abnormal positive T cell selection|MP:0005010,abnormal CD8-positive, alpha beta T cell morphology|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0008040,decreased NK T cell number|MP:0008045,decreased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008133,decreased Peyer's patch number|MP:0008135,small Peyer's patches|MP:0008397,abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology|MP:0008465,absent mesenteric lymph nodes|MP:0009622,absent inguinal lymph nodes|MP:0009630,absent axillary lymph nodes|MP:0009634,absent popliteal lymph nodes
MGI:5605811	Tox<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001486,abnormal startle reflex|MP:0002968,increased circulating alkaline phosphatase level|MP:0003402,decreased liver weight|MP:0004738,abnormal auditory brainstem response|MP:0004952,increased spleen weight|MP:0005179,decreased circulating cholesterol level|MP:0009142,decreased prepulse inhibition|MP:0010124,decreased bone mineral content|MP:0010506,prolonged RR interval
MGI:4839072	Tox<tm1Kay>	MP:0008076,abnormal CD4-positive T cell differentiation
MGI:1856214	tp	MP:0000371,diluted coat color|MP:0001265,decreased body size|MP:0002907,abnormal parturition|MP:0004014,abnormal uterine environment|MP:0009722,abnormal nipple development|MP:0009733,absent nipple|MP:0011088,neonatal lethality, incomplete penetrance
MGI:1856215	tp<3J>	MP:0000371,diluted coat color|MP:0002075,abnormal coat/hair pigmentation|MP:0005376,homeostasis/metabolism phenotype
MGI:1856556	tp<4J>	MP:0000371,diluted coat color|MP:0002075,abnormal coat/hair pigmentation
MGI:1856557	tp<5J>	MP:0000371,diluted coat color|MP:0002075,abnormal coat/hair pigmentation
MGI:1856558	tp<6J>	MP:0000371,diluted coat color|MP:0002075,abnormal coat/hair pigmentation
MGI:4459319	Tpbg<tm1Plst>	MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0003091,abnormal cell migration|MP:0005076,abnormal cell differentiation
MGI:3529820	Tpcn1<Gt(OST359423)Lex>	MP:0002169,no abnormal phenotype detected
MGI:5614621	Tpcn1<tm1.1(KOMP)Vlcg>	MP:0002591,decreased mean corpuscular volume|MP:0002959,increased urine microalbumin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011436,decreased urine magnesium level
MGI:5427695	Tpcn1<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:7450918	Tpcn2<em1Lwbch>	MP:0000371,diluted coat color|MP:0003172,abnormal lysosome physiology|MP:0005058,abnormal lysosome morphology|MP:0005172,decreased eye pigmentation|MP:0005391,vision/eye phenotype|MP:0010190,abnormal retina melanocyte morphology|MP:0011277,decreased tail pigmentation
MGI:3848998	Tpcn2<Gt(YHD437)Byg>	MP:0003562,abnormal pancreatic beta cell physiology
MGI:5548791	Tpcn2<tm1b(EUCOMM)Hmgu>	MP:0001552,increased circulating triglyceride level|MP:0005011,increased eosinophil cell number
MGI:5692810	Tpcn2<tm1c(EUCOMM)Hmgu>	MP:0002169,no abnormal phenotype detected
MGI:3528890	Tpcn2<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:5755683	Tpd52l1<em1(IMPC)J>	MP:0002968,increased circulating alkaline phosphatase level
MGI:4363000	Tpd52l2<tm1a(KOMP)Wtsi>	MP:0000609,abnormal liver physiology|MP:0001258,decreased body length
MGI:2388468	Tpgs1<Gt(ROSA22)Sor>	MP:0001355,submission towards male mice|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0005578,teratozoospermia|MP:0008545,absent sperm flagellum|MP:0009838,abnormal sperm axoneme morphology|MP:0010025,decreased total body fat amount|MP:0031352,absent sperm axonemal central pair
MGI:5468968	Tpgs2<tm1.1(KOMP)Vlcg>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001925,male infertility|MP:0002702,decreased circulating free fatty acids level|MP:0002797,increased thigmotaxis|MP:0003131,increased erythrocyte cell number|MP:0003795,abnormal bone structure|MP:0005554,decreased circulating creatinine level|MP:0011396,abnormal sleep behavior|MP:0020870,decreased thigmotaxis
MGI:2450301	Tph1<tm1Bdr>	MP:0005386,behavior/neurological phenotype|MP:0005390,skeleton phenotype
MGI:6271993	Tph1<tm1c(KOMP)Wtsi>	MP:0005293,impaired glucose tolerance|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009114,decreased pancreatic beta cell mass|MP:0011820,decreased pancreatic beta cell proliferation
MGI:3837399	Tph1<tm1Kry>	MP:0004988,increased osteoblast cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0005605,increased bone mass|MP:0010070,decreased serotonin level|MP:0020039,increased bone ossification|MP:0030438,increased osteoblast proliferation
MGI:3583821	Tph1<tm1Mlt>	MP:0000274,enlarged heart|MP:0001954,respiratory distress|MP:0002626,increased heart rate|MP:0002899,fatigue|MP:0003393,decreased cardiac output|MP:0003717,pallor|MP:0005140,decreased cardiac muscle contractility|MP:0010070,decreased serotonin level|MP:0010754,abnormal heart left ventricle pressure|MP:0011952,decreased cardiac stroke volume
MGI:3831653	Tph1<tm2Lex>	MP:0005322,abnormal serotonin level|MP:0005386,behavior/neurological phenotype
MGI:3521924	Tph2<Arg447>	MP:0005322,abnormal serotonin level
MGI:6386305	Tph2<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001289,persistence of hyaloid vascular system|MP:0001402,decreased locomotor activity|MP:0001404,no spontaneous movement|MP:0001417,decreased exploration in new environment|MP:0001711,abnormal placenta morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003068,enlarged kidney|MP:0003231,abnormal placenta vasculature|MP:0004832,enlarged ovary|MP:0005011,increased eosinophil cell number|MP:0005238,increased brain size|MP:0009141,increased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3521925	Tph2<Pro447>	MP:0005322,abnormal serotonin level
MGI:5007662	Tph2<tm1.1Zfc>	MP:0001375,abnormal mating preference|MP:0010070,decreased serotonin level
MGI:3851254	Tph2<tm1.2Kpl>	MP:0003631,nervous system phenotype|MP:0003877,abnormal serotonergic neuron morphology|MP:0010768,mortality/aging
MGI:3849838	Tph2<tm1Bdr>	MP:0000746,weakness|MP:0001191,abnormal skin condition|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001356,increased aggression towards female mice|MP:0001384,abnormal pup retrieval|MP:0001385,pup cannibalization|MP:0001386,abnormal maternal nurturing|MP:0001501,abnormal sleep pattern|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005394,taste/olfaction phenotype|MP:0005574,decreased pulmonary respiratory rate|MP:0005655,increased aggression|MP:0006276,abnormal autonomic nervous system physiology|MP:0008911,induced hyperactivity|MP:0010070,decreased serotonin level|MP:0011021,abnormal circadian regulation of heart rate|MP:0011022,abnormal circadian regulation of systemic arterial blood pressure|MP:0011049,impaired adaptive thermogenesis
MGI:5487385	Tph2<tm1Dmkh>	MP:0003631,nervous system phenotype|MP:0010070,decreased serotonin level|MP:0011016,increased core body temperature
MGI:3831654	Tph2<tm1Lex>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0002572,abnormal emotion/affect behavior|MP:0003461,abnormal response to novel object|MP:0010070,decreased serotonin level
MGI:3774541	Tph2<tm1Mca>	MP:0001354,increased aggression towards male mice|MP:0001363,increased anxiety-related response|MP:0002272,abnormal nervous system electrophysiology|MP:0003064,decreased coping response|MP:0010070,decreased serotonin level
MGI:5442736	Tph2<tm1Pasq>	MP:0001732,postnatal growth retardation|MP:0005386,behavior/neurological phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5823172	Tph2<tm2.1Pasq>	MP:0002169,no abnormal phenotype detected
MGI:5823173	Tph2<tm2.2Pasq>	MP:0001262,decreased body weight|MP:0010070,decreased serotonin level|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2183489	Tpi1<a-M1Neu>	MP:0002169,no abnormal phenotype detected|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2183490	Tpi1<a-M2Neu>	MP:0002169,no abnormal phenotype detected|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2183492	Tpi1<a-M3Neu>	MP:0002169,no abnormal phenotype detected|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2183493	Tpi1<a-M4Neu>	MP:0002169,no abnormal phenotype detected|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2384551	Tpi1<a-M5Neu>	MP:0002169,no abnormal phenotype detected
MGI:4821798	Tpi1<a-m6Neu>	MP:0000208,decreased hematocrit|MP:0001585,hemolytic anemia|MP:0002590,increased mean corpuscular volume|MP:0002874,decreased hemoglobin content|MP:0004952,increased spleen weight|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:6188634	Tpi1<rbc19>	MP:0000208,decreased hematocrit|MP:0000245,abnormal erythropoiesis|MP:0000248,macrocytosis|MP:0000691,enlarged spleen|MP:0001585,hemolytic anemia|MP:0001764,abnormal homeostasis|MP:0002356,abnormal spleen red pulp morphology|MP:0002640,reticulocytosis|MP:0002811,macrocytic anemia|MP:0002875,decreased erythrocyte cell number|MP:0003631,nervous system phenotype|MP:0003656,abnormal erythrocyte physiology|MP:0005097,polychromatophilia|MP:0005344,increased circulating bilirubin level|MP:0005561,increased mean corpuscular hemoglobin
MGI:4432885	Tpi1<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight
MGI:5905734	Tpk1<em1(IMPC)J>	MP:0001304,cataract|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:6879497	Tpm1<em1Clo>	MP:0000269,abnormal heart looping|MP:0002192,hydrops fetalis|MP:0004086,absent heartbeat|MP:0005312,pericardial effusion|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0012700,abnormal endocardial heart tube morphology
MGI:2387893	Tpm1<tm1Dfw>	MP:0002169,no abnormal phenotype detected|MP:0011092,embryonic lethality, complete penetrance
MGI:2385810	Tpm1<tm1Jse>	MP:0001698,decreased embryo size|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6368153	Tpm2<em1Eku>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001792,impaired wound healing|MP:0002840,abnormal lens fiber morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:3040795	Tpm3<tm1Pgun>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3574955	Tpm3<tm2Pgun>	MP:0003631,nervous system phenotype
MGI:5509478	Tpm3<tm3Pgun>	MP:0002108,abnormal muscle morphology|MP:0005620,abnormal muscle contractility
MGI:5509479	Tpm3<tm4.1Pgun>	MP:0005620,abnormal muscle contractility
MGI:8192458	Tpm4<em1Hrd>	MP:0003179,thrombocytopenia
MGI:8192457	Tpm4<Plt53>	MP:0000228,abnormal thrombopoiesis|MP:0002417,abnormal megakaryocyte morphology|MP:0002599,increased mean platelet volume|MP:0003179,thrombocytopenia|MP:0004720,abnormal platelet morphology|MP:0005013,increased lymphocyte cell number|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0008254,increased megakaryocyte cell number
MGI:3712056	Tpmt<tm1Rlng>	MP:0001263,weight loss|MP:0002429,abnormal blood cell morphology/development|MP:0003806,abnormal nucleotide metabolism|MP:0005389,reproductive system phenotype|MP:0005505,thrombocytosis|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:2155914	Tpnr1<C57BL/6J>	MP:0001970,abnormal pain threshold
MGI:2155915	Tpnr1<DBA/2J>	MP:0001970,abnormal pain threshold
MGI:6257652	Tpo<em1(IMPC)H>	MP:0002599,increased mean platelet volume|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3665236	Tpo<R479C>	MP:0000208,decreased hematocrit|MP:0000692,small spleen|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002427,disproportionate dwarf|MP:0002750,exophthalmos|MP:0002875,decreased erythrocyte cell number|MP:0004696,abnormal thyroid follicle morphology|MP:0004697,abnormal thyroid follicular cell morphology|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005355,enlarged thyroid gland|MP:0005584,abnormal enzyme/coenzyme activity|MP:0030049,prominent forehead
MGI:3625284	Tpo<tee>	MP:0000031,abnormal cochlea morphology|MP:0000559,abnormal femur morphology|MP:0000681,abnormal thyroid gland morphology|MP:0002876,abnormal thyroid gland physiology|MP:0002951,small thyroid gland|MP:0003149,abnormal tectorial membrane morphology|MP:0003421,abnormal thyroid gland development|MP:0003503,decreased activity of thyroid gland|MP:0004664,delayed inner ear development|MP:0004696,abnormal thyroid follicle morphology|MP:0005391,vision/eye phenotype|MP:0008974,proportional dwarf|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3721538	Tpo<tee-2J>	MP:0000031,abnormal cochlea morphology|MP:0000681,abnormal thyroid gland morphology|MP:0002876,abnormal thyroid gland physiology|MP:0002951,small thyroid gland|MP:0003149,abnormal tectorial membrane morphology|MP:0003421,abnormal thyroid gland development|MP:0003503,decreased activity of thyroid gland|MP:0004664,delayed inner ear development|MP:0004696,abnormal thyroid follicle morphology|MP:0008974,proportional dwarf|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:7519115	Tpp1<em1(IMPC)Hmgu>	MP:0002626,increased heart rate
MGI:5512906	Tpp1<m1J>	MP:0000745,tremors|MP:0000751,myopathy|MP:0001505,hunched posture|MP:0002083,premature death|MP:0011975,neuronal cytoplasmic inclusions
MGI:3795216	Tpp1<tm1.1Plob>	MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0003172,abnormal lysosome physiology
MGI:3604537	Tpp1<tm1Dgen>	MP:0000745,tremors|MP:0000746,weakness|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001429,dehydration|MP:0001505,hunched posture|MP:0001954,respiratory distress|MP:0001973,increased thermal nociceptive threshold|MP:0002064,seizures|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0003313,abnormal locomotor activation|MP:0005426,tachypnea
MGI:3521972	Tpp1<tm1Plob>	MP:0000745,tremors|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000921,demyelination|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001496,audiogenic seizures|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002229,neurodegeneration|MP:0002757,decreased vertical activity|MP:0003172,abnormal lysosome physiology|MP:0005058,abnormal lysosome morphology
MGI:4315077	Tpp2<Gt(OST432061)Lex>	MP:0001835,abnormal antigen presentation|MP:0001839,abnormal level of surface class I molecules|MP:0005397,hematopoietic system phenotype
MGI:3783750	Tpp2<tm1.1Gnie>	MP:0000221,decreased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000418,focal hair loss|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000716,abnormal immune system cell morphology|MP:0001263,weight loss|MP:0001511,disheveled coat|MP:0002083,premature death|MP:0002722,abnormal immune system organ morphology|MP:0003077,abnormal cell cycle|MP:0003644,thymus atrophy|MP:0003725,increased autoantibody level|MP:0003786,premature aging|MP:0003945,abnormal lymphocyte physiology|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005018,decreased T cell number|MP:0005078,abnormal cytotoxic T cell physiology|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0006413,increased T cell apoptosis|MP:0008008,early cellular replicative senescence|MP:0008049,increased memory T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008082,increased single-positive T cell number|MP:0008476,increased spleen red pulp amount|MP:0008826,abnormal splenic cell ratio
MGI:6368880	Tppp2<em1Nju>	MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0006035,abnormal mitochondrial morphology|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0014052,increased male germ cell apoptosis
MGI:7426054	Tppp3<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002100,abnormal tooth morphology|MP:0002339,abnormal lymph node morphology|MP:0008039,increased NK T cell number|MP:0011100,preweaning lethality, complete penetrance|MP:0013129,abnormal tooth color|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0013520,increased CD4-positive NK T cell number|MP:0013523,increased memory-marker CD4-positive NK T cell number
MGI:5554931	Tppp<tm1.1(KOMP)Vlcg>	MP:0000947,convulsive seizures|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002608,increased hematocrit|MP:0002968,increased circulating alkaline phosphatase level|MP:0003019,increased circulating chloride level|MP:0003131,increased erythrocyte cell number|MP:0004924,abnormal behavior|MP:0005564,increased hemoglobin content|MP:0008810,increased circulating iron level|MP:0010052,increased grip strength|MP:0011396,abnormal sleep behavior|MP:0020870,decreased thigmotaxis
MGI:6423072	Tprg1<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0005084,abnormal gallbladder morphology|MP:0009342,enlarged gallbladder|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6414546	Tprkb<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:5897817	Tprn<em1Pghu>	MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004529,decreased outer hair cell stereocilia number|MP:0004534,decreased inner hair cell stereocilia number|MP:0004749,nonsyndromic hearing loss|MP:0005377,hearing/vestibular/ear phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5445918	Tprn<tm1.1(KOMP)Vlcg>	MP:0001486,abnormal startle reflex|MP:0004738,abnormal auditory brainstem response
MGI:5609352	Tpr<tm2b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:3823092	Tpsab1<m1>	MP:0005462,abnormal mast cell differentiation
MGI:3783331	Tpsb2<tm1.1Mfg>	MP:0003436,decreased susceptibility to induced arthritis|MP:0005027,increased susceptibility to parasitic infection|MP:0005462,abnormal mast cell differentiation|MP:0008720,impaired neutrophil chemotaxis|MP:0008723,impaired eosinophil recruitment
MGI:3722523	Tpsb2<tm1(cre)Adch>	MP:0002412,increased susceptibility to bacterial infection
MGI:6508397	Tpsg1<tm1.2Rls>	MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010768,mortality/aging|MP:0010896,decreased lung compliance|MP:0010935,increased airway resistance|MP:0010950,abnormal lung hysteresivity|MP:0011044,increased lung elastance|MP:0011047,increased lung tissue damping|MP:0013299,decreased susceptibility to colitis induced morbidity/mortality
MGI:2183366	Tpst1<tm1Klm>	MP:0001262,decreased body weight|MP:0001386,abnormal maternal nurturing|MP:0001923,reduced female fertility|MP:0001935,decreased litter size
MGI:1856891	Tpst2<grt>	MP:0001153,small seminiferous tubules|MP:0001732,postnatal growth retardation|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002216,abnormal seminiferous tubule morphology|MP:0003503,decreased activity of thyroid gland|MP:0003968,abnormal growth hormone level|MP:0004163,abnormal adenohypophysis morphology|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005478,decreased circulating thyroxine level|MP:0008366,enlarged adenohypophysis
MGI:3512111	Tpst2<tm1Klm>	MP:0001259,abnormal body weight|MP:0001925,male infertility
MGI:4353107	Tpt1<tm1.1Atel>	MP:0000352,decreased cell proliferation|MP:0003984,embryonic growth retardation|MP:0011092,embryonic lethality, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3764984	Tpt1<tm1.1Yen>	MP:0001680,abnormal mesoderm development|MP:0001685,abnormal endoderm development|MP:0001698,decreased embryo size|MP:0002230,abnormal primitive streak formation|MP:0009657,failure of chorioallantoic fusion|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011191,increased embryonic epiblast cell apoptosis|MP:0011192,decreased embryonic epiblast cell proliferation
MGI:3846761	Tpt1<tm1Kefu>	MP:0002083,premature death|MP:0004957,abnormal blastocyst morphology|MP:0008943,increased sensitivity to induced cell death|MP:0011089,perinatal lethality, complete penetrance|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance
MGI:3764981	Tpt1<tm1Yen>	MP:0002169,no abnormal phenotype detected
MGI:6336146	Tpte<em1(IMPC)Kmpc>	MP:0000160,kyphosis|MP:0001399,hyperactivity|MP:0004174,abnormal spine curvature
MGI:6458829	Tpte<tm1Osb>	MP:0000242,impaired fertilization|MP:0002675,asthenozoospermia|MP:0004543,abnormal sperm physiology|MP:0009831,abnormal sperm midpiece morphology
MGI:6367835	Tpx2<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5426862	Tpx2<Gt(D028B03)1.1Wrst>	MP:0000352,decreased cell proliferation|MP:0003111,abnormal cell nucleus morphology|MP:0004025,polyploidy|MP:0004046,abnormal mitosis|MP:0009762,abnormal mitotic spindle assembly checkpoint|MP:0031678,increased micronucleus incidence
MGI:5426857	Tpx2<Gt(D028B03)1.2Wrst>	MP:0001672,abnormal embryo development
MGI:3873923	Tpx2<Gt(D028B03)Wrst>	MP:0001272,increased metastatic potential|MP:0001672,abnormal embryo development|MP:0001730,embryonic growth arrest|MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002404,increased intestinal adenoma incidence|MP:0002500,granulomatous inflammation|MP:0003331,increased hepatocellular carcinoma incidence|MP:0004024,aneuploidy|MP:0004025,polyploidy|MP:0008371,pituitary intermediate lobe hyperplasia|MP:0009332,abnormal splenocyte morphology|MP:0009760,abnormal mitotic spindle morphology|MP:0010301,increased stomach tumor incidence|MP:0011092,embryonic lethality, complete penetrance|MP:0012431,increased lymphoma incidence
MGI:2136323	Tp(Y)1Ct<Sxr-a>	MP:0001147,small testis|MP:0001929,abnormal gametogenesis|MP:0002211,abnormal primary sex determination|MP:0002995,primary sex reversal|MP:0004806,absent germ cells|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0008392,decreased primordial germ cell number
MGI:2136318	Tp(Y)1Ct<Sxr-b>	MP:0002211,abnormal primary sex determination|MP:0002995,primary sex reversal
MGI:5637105	Tra2a<tm2b(EUCOMM)Hmgu>	MP:0002606,increased basophil cell number|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6451746	Tra2b<em1H>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis|MP:0014633,decreased spermatid number
MGI:3872436	Tra2b<Gt(P142D08)Wrst>	MP:0001552,increased circulating triglyceride level|MP:0003975,increased circulating VLDL triglyceride level|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0010768,mortality/aging|MP:0011092,embryonic lethality, complete penetrance
MGI:4450919	Tra2b<tm1.1Bwir>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002169,no abnormal phenotype detected|MP:0002216,abnormal seminiferous tubule morphology|MP:0002685,abnormal spermatogonia proliferation|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0006378,abnormal spermatogonia morphology|MP:0014617,decreased spermatogonia number
MGI:4450921	Tra2b<tm1.2Bwir>	MP:0001622,abnormal vasculogenesis|MP:0001698,decreased embryo size|MP:0001726,abnormal allantois morphology|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4450920	Tra2b<tm1Bwir>	MP:0011091,prenatal lethality, complete penetrance
MGI:6152711	Trabd2b<em2(IMPC)Ccpcz>	MP:0000137,abnormal vertebrae morphology|MP:0000432,abnormal head morphology|MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0000639,abnormal adrenal gland morphology|MP:0000642,enlarged adrenal glands|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001552,increased circulating triglyceride level|MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology|MP:0002932,abnormal joint morphology|MP:0002953,thick ventricular wall|MP:0004599,abnormal vertebral arch morphology|MP:0005565,increased blood urea nitrogen level|MP:0008935,decreased mean platelet volume
MGI:6152664	Trabd<em1(IMPC)Mbp>	MP:0000639,abnormal adrenal gland morphology
MGI:3809708	Tradd<tm1.1Mak>	MP:0001876,decreased inflammatory response|MP:0005087,decreased acute inflammation|MP:0008473,abnormal spleen follicular dendritic cell network|MP:0008474,absent spleen germinal center|MP:0008597,decreased circulating interleukin-6 level|MP:0008706,decreased interleukin-6 secretion|MP:0008944,decreased sensitivity to induced cell death
MGI:3799300	Tradd<tm1.1Mpa>	MP:0001805,decreased IgG level|MP:0002359,abnormal spleen germinal center morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008565,decreased interferon-beta secretion|MP:0008751,abnormal interleukin level|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3810080	Tradd<tm1.1Zgl>	MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:2386957	Traf1<tm1Tsi>	MP:0005013,increased lymphocyte cell number|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0008828,abnormal lymph node cell ratio|MP:0008943,increased sensitivity to induced cell death
MGI:3511496	Traf2<tm1.1Rbr>	MP:0011091,prenatal lethality, complete penetrance
MGI:4452008	Traf2<tm1a(EUCOMM)Wtsi>	MP:0001711,abnormal placenta morphology|MP:0003019,increased circulating chloride level|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012765,decreased alpha-beta T cell number|MP:0013247,placenta necrosis|MP:0030975,placenta hemorrhage
MGI:2179513	Traf2<tm1Mak>	MP:0000322,increased granulocyte number|MP:0000715,decreased thymocyte number|MP:0001265,decreased body size|MP:0002223,lymphoid hypoplasia|MP:0003643,spleen atrophy|MP:0003644,thymus atrophy|MP:0004819,decreased skeletal muscle mass|MP:0005016,decreased lymphocyte cell number|MP:0005092,decreased double-positive T cell number|MP:0005150,cachexia|MP:0005621,abnormal cell physiology|MP:0008215,decreased immature B cell number|MP:0008474,absent spleen germinal center|MP:0008523,absent lymph node germinal center|MP:0008553,increased circulating tumor necrosis factor level|MP:0008943,increased sensitivity to induced cell death|MP:0009541,increased thymocyte apoptosis|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0014143,decreased body fat mass
MGI:3511494	Traf2<tm1Rbr>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002362,abnormal spleen marginal zone morphology|MP:0002459,abnormal B cell physiology|MP:0005014,increased B cell number|MP:0008102,lymph node hyperplasia|MP:0008173,increased follicular B cell number|MP:0008175,absent follicular B cells|MP:0008181,increased marginal zone B cell number|MP:0008183,absent marginal zone B cells|MP:0008211,decreased mature B cell number
MGI:6358077	Traf3ip1<em1(IMPC)Bay>	MP:0000266,abnormal heart morphology|MP:0000288,abnormal pericardium morphology|MP:0001691,abnormal somite shape|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001785,edema|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011962,increased cornea thickness|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4129326	Traf3ip1<Gt(RRJ005)Byg>	MP:0000562,polydactyly|MP:0001297,microphthalmia|MP:0002151,abnormal neural tube morphology|MP:0003051,curly tail|MP:0003861,abnormal nervous system development|MP:0004132,absent embryonic cilia|MP:0011092,embryonic lethality, complete penetrance|MP:0012270,cardiac edema
MGI:4820827	Traf3ip2<adjm>	MP:0001194,dermatitis|MP:0001219,thick epidermis|MP:0001926,female infertility|MP:0002083,premature death|MP:0002497,increased IgE level|MP:0010072,increased pruritus
MGI:4011845	Traf3ip2<Gt(IST11484G7)Tigm>	MP:0005387,immune system phenotype
MGI:3510784	Traf3ip2<tm1.1Lix>	MP:0000624,xerostomia|MP:0000685,abnormal immune system morphology|MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0001337,dry eyes|MP:0001790,abnormal immune system physiology|MP:0001846,increased inflammatory response|MP:0001859,kidney inflammation|MP:0002083,premature death|MP:0002360,abnormal spleen B cell corona morphology|MP:0002405,respiratory system inflammation|MP:0002461,increased immunoglobulin level|MP:0002493,increased IgG level|MP:0002497,increased IgE level|MP:0002742,enlarged submandibular lymph nodes|MP:0002743,glomerulonephritis|MP:0003725,increased autoantibody level|MP:0003746,stomatitis|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004796,increased anti-histone antibody level|MP:0004829,increased anti-chromatin antibody level|MP:0004952,increased spleen weight|MP:0005014,increased B cell number|MP:0005251,blepharitis|MP:0005325,abnormal renal glomerulus morphology|MP:0005387,immune system phenotype|MP:0008102,lymph node hyperplasia|MP:0008126,increased dendritic cell number|MP:0008173,increased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008188,abnormal transitional stage B cell morphology|MP:0008189,increased transitional stage B cell number|MP:0008214,increased immature B cell number|MP:0008499,increased IgG1 level|MP:0008542,enlarged cervical lymph nodes|MP:0008879,submandibular gland inflammation|MP:0008880,lacrimal gland inflammation|MP:0008896,increased IgG2c level|MP:0009521,increased submandibular gland size|MP:0011320,abnormal glomerular capillary morphology|MP:0011427,increased mesangial cell number|MP:0013367,parotid gland inflammation|MP:0013558,abnormal exocrine gland morphology|MP:0020519,renal glomerular immunoglobulin deposits
MGI:3831153	Traf3ip2<tm1Sbn>	MP:0001876,decreased inflammatory response|MP:0003009,abnormal cytokine secretion|MP:0003799,impaired macrophage chemotaxis|MP:0005351,decreased susceptibility to autoimmune disorder|MP:0008706,decreased interleukin-6 secretion|MP:0008719,impaired neutrophil recruitment|MP:0008723,impaired eosinophil recruitment
MGI:4363678	Traf3ip3<tm1a(KOMP)Wtsi>	MP:0000221,decreased leukocyte cell number
MGI:5795737	Traf3ip3<tm1b(KOMP)Wtsi>	MP:0000715,decreased thymocyte number|MP:0002145,abnormal T cell differentiation|MP:0004974,decreased regulatory T cell number|MP:0005018,decreased T cell number|MP:0005091,increased double-positive T cell number|MP:0005387,immune system phenotype|MP:0008346,increased gamma-delta T cell number|MP:0010836,decreased CD4-positive, alpha-beta memory T cell number|MP:0010839,decreased CD8-positive, alpha-beta memory T cell number
MGI:5578024	Traf3<m1Btlr>	MP:0008211,decreased mature B cell number|MP:0020154,impaired humoral immune response
MGI:5615721	Traf3<m2Btlr>	MP:0001805,decreased IgG level|MP:0020001,decreased response to antigen
MGI:2135257	Traf3<tm1Bal>	MP:0000189,hypoglycemia|MP:0000221,decreased leukocyte cell number|MP:0000694,spleen hypoplasia|MP:0000715,decreased thymocyte number|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001745,increased circulating corticosterone level|MP:0002144,abnormal B cell differentiation|MP:0002444,abnormal T cell physiology|MP:0005092,decreased double-positive T cell number|MP:0011085,postnatal lethality, complete penetrance
MGI:3722126	Traf3<tm1Bshp>	MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001790,abnormal immune system physiology|MP:0001844,autoimmune response|MP:0002135,abnormal kidney morphology|MP:0002344,abnormal lymph node B cell domain morphology|MP:0002359,abnormal spleen germinal center morphology|MP:0002420,abnormal adaptive immunity|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002722,abnormal immune system organ morphology|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005014,increased B cell number|MP:0005018,decreased T cell number|MP:0008173,increased follicular B cell number|MP:0008181,increased marginal zone B cell number|MP:0008189,increased transitional stage B cell number|MP:0008246,abnormal leukocyte morphology|MP:0008478,increased spleen white pulp amount|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level|MP:0008783,decreased B cell apoptosis|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3777324	Traf3<tm1Rbr>	MP:0002444,abnormal T cell physiology|MP:0002459,abnormal B cell physiology|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008102,lymph node hyperplasia|MP:0008173,increased follicular B cell number|MP:0008181,increased marginal zone B cell number
MGI:2158361	Traf4<tm1Lind>	MP:0001262,decreased body weight|MP:0001861,lung inflammation|MP:0003120,abnormal tracheal cartilage morphology|MP:0005387,immune system phenotype|MP:0010883,trachea stenosis|MP:0013752,stridor
MGI:2182705	Traf4<tm1Mrio>	MP:0000069,kyphoscoliosis|MP:0000141,abnormal vertebral body morphology|MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001698,decreased embryo size|MP:0001935,decreased litter size|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002264,abnormal bronchus morphology|MP:0002282,abnormal trachea morphology|MP:0002376,abnormal dendritic cell physiology|MP:0003051,curly tail|MP:0003091,abnormal cell migration|MP:0003120,abnormal tracheal cartilage morphology|MP:0004173,abnormal intervertebral disk morphology|MP:0004549,small trachea|MP:0004552,fused tracheal cartilage rings|MP:0004703,abnormal vertebral column morphology|MP:0005297,spina bifida occulta|MP:0005387,immune system phenotype|MP:0008146,asymmetric sternocostal joints|MP:0008148,abnormal sternocostal joint morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012547,spina bifida cystica|MP:0031086,wheezing
MGI:2158362	Traf4<tm2Lind>	MP:0001262,decreased body weight|MP:0001861,lung inflammation|MP:0003120,abnormal tracheal cartilage morphology|MP:0005387,immune system phenotype|MP:0010883,trachea stenosis|MP:0013752,stridor
MGI:1859960	Traf5<tm1Hna>	MP:0001800,abnormal humoral immune response|MP:0001806,decreased IgM level|MP:0005094,abnormal T cell proliferation|MP:0005153,abnormal B cell proliferation|MP:0008495,decreased IgG1 level
MGI:3836555	Traf6<tm1.1Mpa>	MP:0005166,decreased susceptibility to injury|MP:0008597,decreased circulating interleukin-6 level
MGI:2675469	Traf6<tm1Jino>	MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000367,abnormal coat/ hair morphology|MP:0000414,alopecia|MP:0000577,absent eccrine glands|MP:0000585,kinked tail|MP:0000647,abnormal sebaceous gland morphology|MP:0001201,translucent skin|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002095,abnormal skin pigmentation|MP:0002219,decreased lymph node number|MP:0002717,abnormal male preputial gland morphology|MP:0003704,abnormal hair follicle development|MP:0006365,absent guard hair|MP:0008215,decreased immature B cell number|MP:0008396,abnormal osteoclast differentiation|MP:0011085,postnatal lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013382,small perianal sebaceous gland|MP:0013385,abnormal Meibomian gland development
MGI:1859953	Traf6<tm1Mak>	MP:0000062,increased bone mineral density|MP:0000067,osteopetrosis|MP:0000121,failure of tooth eruption|MP:0000125,absent incisors|MP:0000133,abnormal long bone metaphysis morphology|MP:0000198,decreased circulating phosphate level|MP:0000274,enlarged heart|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001541,abnormal osteoclast physiology|MP:0002451,abnormal macrophage physiology|MP:0003109,short femur|MP:0003723,abnormal long bone morphology|MP:0003931,absent molars|MP:0004686,decreased length of long bones|MP:0004982,abnormal osteoclast morphology|MP:0004993,decreased bone resorption|MP:0005093,decreased B cell proliferation|MP:0008387,hypochromic anemia|MP:0008561,decreased tumor necrosis factor secretion|MP:0008770,decreased survivor rate|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:2678775	Traf6<tm1Ywc>	MP:0000067,osteopetrosis|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001265,decreased body size|MP:0002339,abnormal lymph node morphology|MP:0002376,abnormal dendritic cell physiology|MP:0003644,thymus atrophy|MP:0005046,absent spleen white pulp|MP:0008115,abnormal dendritic cell differentiation|MP:0008127,decreased dendritic cell number|MP:0008664,decreased interleukin-12 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0011085,postnatal lethality, complete penetrance
MGI:4840586	Traf6<tm2a(EUCOMM)Wtsi>	MP:0000783,abnormal forebrain morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000914,exencephaly|MP:0002135,abnormal kidney morphology|MP:0002152,abnormal brain morphology|MP:0002199,abnormal brain commissure morphology|MP:0003253,dilated bile duct|MP:0003262,intestinal/bowel diverticulum|MP:0003584,bifid ureter|MP:0003686,abnormal eye muscle morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0003827,abnormal Wolffian duct morphology|MP:0004056,abnormal myocardium compact layer morphology|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0004666,absent stapedial artery|MP:0005107,abnormal stapes morphology|MP:0010052,increased grip strength|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010572,persistent right dorsal aorta|MP:0010912,herniated liver|MP:0011100,preweaning lethality, complete penetrance|MP:0012303,umbilical vein stenosis|MP:0013834,thin hypoglossal nerve|MP:0013842,ductus venosus stenosis|MP:0013848,subcutaneous edema|MP:0013876,absent ductus venosus valve|MP:0013878,abnormal ductus venosus valve topology|MP:0013917,persistent right 6th pharyngeal arch artery|MP:0013918,abnormal endolymphatic sac topology|MP:0013968,multiple persisting craniopharyngeal ducts|MP:0013971,blood in lymph vessels|MP:0013975,abnormal coronary sinus connection|MP:0013986,abnormal vitelline vein topology|MP:0014001,abnormal vertebral artery topology
MGI:3773273	Traf6<tm2Ywc>	MP:0001829,increased activated T cell number|MP:0005004,abnormal lymphocyte anergy|MP:0008049,increased memory T cell number
MGI:6388361	Traf7<em1(IMPC)Tcp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000702,enlarged lymph nodes|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001672,abnormal embryo development|MP:0001701,incomplete embryo turning|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001722,pale yolk sac|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0003984,embryonic growth retardation|MP:0005031,abnormal trophoblast layer morphology|MP:0005244,hemopericardium|MP:0006051,brainstem hemorrhage|MP:0010395,abnormal pharyngeal arch development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0012176,abnormal head development|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:4432441	Trafd1<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0010025,decreased total body fat amount
MGI:3831676	Trafd1<tm1Ayos>	MP:0002941,increased circulating alanine transaminase level|MP:0008560,increased tumor necrosis factor secretion|MP:0008596,increased circulating interleukin-6 level|MP:0008663,increased interleukin-12 secretion|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0020914,decreased susceptibility to Riboviria infection
MGI:3764469	Traip<tm1Jarh>	MP:0000352,decreased cell proliferation|MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0003984,embryonic growth retardation|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011198,absent proamniotic cavity|MP:0013504,increased embryonic tissue cell apoptosis
MGI:6220718	Traj18<em1Hwata>	MP:0000598,abnormal liver morphology|MP:0002891,increased insulin sensitivity|MP:0003009,abnormal cytokine secretion|MP:0005292,improved glucose tolerance|MP:0005334,abnormal fat pad morphology|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008041,absent NK T cells|MP:0009269,decreased fat cell size|MP:0013278,decreased fasting circulating glucose level
MGI:5788003	Traj18<tm1.1Kro>	MP:0001876,decreased inflammatory response|MP:0008041,absent NK T cells|MP:0008559,abnormal interferon-gamma secretion|MP:0008601,abnormal circulating interleukin-4 level|MP:0010936,decreased airway resistance
MGI:6360151	Traj33<em#Dig>	MP:0005018,decreased T cell number|MP:0005387,immune system phenotype
MGI:7443054	Trak1<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002135,abnormal kidney morphology|MP:0003917,increased kidney weight|MP:0005634,decreased circulating sodium level|MP:0008528,polycystic kidney
MGI:3044768	Trak1<hyrt>	MP:0000745,tremors|MP:0000746,weakness|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001505,hunched posture|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002882,abnormal neuron morphology|MP:0005424,jerky movement
MGI:6158494	Trak2<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001297,microphthalmia|MP:0001364,decreased anxiety-related response|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:6415735	Tram1<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0002834,decreased heart weight|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005565,increased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0005635,decreased circulating bilirubin level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:4949327	Tram2<tm1a(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000149,abnormal scapula morphology|MP:0000160,kyphosis|MP:0000552,abnormal radius morphology|MP:0002932,abnormal joint morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0004174,abnormal spine curvature|MP:0004599,abnormal vertebral arch morphology|MP:0005108,abnormal ulna morphology|MP:0005296,abnormal humerus morphology|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0006358,absent pinna reflex|MP:0008806,increased circulating amylase level|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content
MGI:6161422	Trank1<em1(IMPC)J>	MP:0000208,decreased hematocrit|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005554,decreased circulating creatinine level
MGI:7624132	Trank1<em1Xwy>	MP:0001364,decreased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0005386,behavior/neurological phenotype
MGI:8163545	Trap1<em1Iimcb>	MP:0001360,abnormal social investigation|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002912,abnormal excitatory postsynaptic potential|MP:0008571,abnormal synaptic bouton morphology|MP:0009936,abnormal dendritic spine morphology|MP:0014253,decreased paired-pulse ratio|MP:0014345,abnormal neuron mitochondrial morphology|MP:0020507,increased dendritic spine density|MP:0020508,decreased dendritic spine density|MP:0020510,increased dendritic spine length|MP:0020511,decreased dendritic spine length|MP:0021009,abnormal synaptic physiology
MGI:6277031	Trap1<em1(IMPC)Mbp>	MP:0000198,decreased circulating phosphate level|MP:0000223,decreased monocyte cell number|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology|MP:0003179,thrombocytopenia|MP:0005554,decreased circulating creatinine level
MGI:3916086	Trap1<Gt(E150H04)Wrst>	MP:0000598,abnormal liver morphology|MP:0000693,spleen hyperplasia|MP:0001262,decreased body weight|MP:0001876,decreased inflammatory response|MP:0001944,abnormal pancreas morphology|MP:0002052,decreased tumor incidence|MP:0003674,oxidative stress|MP:0005141,liver hyperplasia|MP:0005554,decreased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0010959,abnormal oxidative phosphorylation|MP:0011704,decreased fibroblast proliferation
MGI:5560902	Trappc10<b2b2416Clo>	MP:0000276,heart right ventricle hypertrophy|MP:0001293,anophthalmia|MP:0001823,thymus hypoplasia|MP:0001890,anencephaly|MP:0002625,heart left ventricle hypertrophy|MP:0005157,holoprosencephaly|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect
MGI:5615094	Trappc10<b2b2613Clo>	MP:0000111,cleft palate|MP:0001297,microphthalmia|MP:0001625,cardiac hypertrophy|MP:0002639,micrognathia|MP:0010402,ventricular septal defect|MP:0010412,atrioventricular septal defect|MP:0010420,muscular ventricular septal defect
MGI:5636961	Trappc10<tm1b(KOMP)Wtsi>	MP:0002079,increased circulating insulin level|MP:0002599,increased mean platelet volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:6304268	Trappc11<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7574683	Trappc12<em1(IMPC)Bay>	MP:0001392,abnormal locomotor behavior|MP:0011100,preweaning lethality, complete penetrance
MGI:6152665	Trappc1<em1(IMPC)Mbp>	MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001148,enlarged testis|MP:0002060,abnormal skin morphology|MP:0002188,small heart|MP:0002989,small kidney|MP:0009552,urinary bladder obstruction|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5694170	Trappc2b<tm1b(EUCOMM)Hmgu>	MP:0003733,abnormal retina inner nuclear layer morphology|MP:0009142,decreased prepulse inhibition|MP:0011962,increased cornea thickness
MGI:6276946	Trappc2l<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001258,decreased body length|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002590,increased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002833,increased heart weight|MP:0002875,decreased erythrocyte cell number|MP:0003795,abnormal bone structure|MP:0005561,increased mean corpuscular hemoglobin|MP:0009142,decreased prepulse inhibition|MP:0010124,decreased bone mineral content|MP:0020420,abnormal freezing behavior
MGI:5548516	Trappc2<tm1.1(KOMP)Vlcg>	MP:0001258,decreased body length|MP:0005575,increased pulmonary ventilation|MP:0005576,decreased pulmonary ventilation|MP:0009709,hydrometra|MP:0012125,decreased bronchoconstrictive response
MGI:6414544	Trappc4<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity|MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:3688725	Trappc6a<mhyp>	MP:0000372,irregular coat pigmentation|MP:0005075,abnormal melanosome morphology|MP:0005103,abnormal retina pigmentation
MGI:7465004	Trappc8<em1(IMPC)Tcp>	MP:0000220,increased monocyte cell number|MP:0001944,abnormal pancreas morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002941,increased circulating alanine transaminase level|MP:0005011,increased eosinophil cell number|MP:0010097,abnormal retina blood vessel morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6696138	Trappc9<em1Xyli>	MP:0000774,decreased brain size|MP:0000780,abnormal corpus callosum morphology|MP:0000846,abnormal medulla oblongata morphology|MP:0000848,abnormal pons morphology|MP:0000849,abnormal cerebellum morphology|MP:0001260,increased body weight|MP:0001402,decreased locomotor activity|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002797,increased thigmotaxis|MP:0002804,abnormal motor learning|MP:0003243,abnormal dopaminergic neuron morphology|MP:0003354,astrocytosis|MP:0003461,abnormal response to novel object|MP:0005655,increased aggression|MP:0012307,impaired spatial learning|MP:0012467,increased striatum size|MP:0020083,decreased hippocampus volume|MP:0020395,abnormal response to social novelty|MP:0030003,hippocampus atrophy
MGI:4461737	Trappc9<tm1a(EUCOMM)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0000220,increased monocyte cell number|MP:0000282,abnormal interatrial septum morphology|MP:0000433,microcephaly|MP:0000537,abnormal urethra morphology|MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0000788,abnormal cerebral cortex morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001260,increased body weight|MP:0001261,obese|MP:0001417,decreased exploration in new environment|MP:0001552,increased circulating triglyceride level|MP:0001556,increased circulating HDL cholesterol level|MP:0001634,internal hemorrhage|MP:0001914,hemorrhage|MP:0002079,increased circulating insulin level|MP:0002098,abnormal vibrissa morphology|MP:0002175,decreased brain weight|MP:0002599,increased mean platelet volume|MP:0002947,increased hemangioma incidence|MP:0003123,paternal imprinting|MP:0003443,increased circulating glycerol level|MP:0003960,increased lean body mass|MP:0003961,decreased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005633,increased circulating sodium level|MP:0008347,decreased gamma-delta T cell number|MP:0008923,thoracoschisis|MP:0009493,abnormal cystic duct morphology|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010067,increased red blood cell distribution width|MP:0010124,decreased bone mineral content|MP:0010490,abnormal inferior vena cava valve morphology|MP:0010602,abnormal pulmonary valve cusp morphology|MP:0011683,dual inferior vena cava|MP:0012450,decreased primary motor cortex size|MP:0012466,decreased hippocampal fimbria size|MP:0012474,decreased cingulate cortex size|MP:0012768,decreased KLRG1-positive NK cell number|MP:0013022,increased Ly6C high monocyte number|MP:0013025,increased Ly6C low monocyte number|MP:0013279,increased fasting circulating glucose level|MP:0013648,increased CD11b-high dendritic cell number|MP:0013652,decreased CD11b-low dendritic cell number|MP:0013840,absent segment of posterior cerebral artery|MP:0013876,absent ductus venosus valve|MP:0013967,abnormal infrahyoid muscle connection|MP:0013968,multiple persisting craniopharyngeal ducts|MP:0013971,blood in lymph vessels|MP:0014021,heterochrony|MP:0014142,increased body fat mass|MP:0020396,abnormal social recognition|MP:0020527,small thalamus|MP:0020543,decreased substantia nigra size
MGI:6157331	Trarg1<em2(IMPC)Tcp>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment
MGI:4944413	Trarg1<tm1a(KOMP)Wtsi>	MP:0001260,increased body weight|MP:0001559,hyperglycemia|MP:0001560,abnormal circulating insulin level|MP:0002079,increased circulating insulin level|MP:0005331,insulin resistance|MP:0013277,abnormal fasting circulating glucose level|MP:0030017,decreased adipocyte glucose uptake
MGI:3625134	Trat1<tm1Lsmn>	MP:0000333,decreased bone marrow cell number|MP:0000694,spleen hypoplasia|MP:0001262,decreased body weight|MP:0001823,thymus hypoplasia|MP:0008101,lymph node hypoplasia
MGI:5775635	Trav1<em1(IMPC)J>	MP:0001304,cataract
MGI:3711047	Trbv13-2<tm1(CD2)Zhu>	MP:0002145,abnormal T cell differentiation|MP:0005387,immune system phenotype
MGI:3052832	Trbv14<tm1Che>	MP:0005018,decreased T cell number
MGI:3052833	Trbv14<tm2Che>	MP:0005018,decreased T cell number
MGI:3581023	Trbv15<tm1Krg>	MP:0005387,immune system phenotype
MGI:6153687	Trbv19<em1(IMPC)Wtsi>	MP:0005419,decreased circulating serum albumin level
MGI:3665255	Trdc<tm1Mal>	MP:0002169,no abnormal phenotype detected
MGI:3529438	Trdmt1<Gt(OST19279)Lex>	MP:0008045,decreased NK cell number
MGI:3695409	Trdmt1<tm1Bes>	MP:0002169,no abnormal phenotype detected
MGI:6195686	Trdmt1<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0008935,decreased mean platelet volume|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength
MGI:3769415	Trdn<tm1.1Cfp>	MP:0009411,abnormal skeletal muscle fiber triad morphology
MGI:4437311	Trdn<tm1.2Isma>	MP:0002106,abnormal muscle physiology|MP:0004088,abnormal sarcoplasmic reticulum morphology|MP:0004145,abnormal muscle electrophysiology|MP:0005378,growth/size/body region phenotype|MP:0009411,abnormal skeletal muscle fiber triad morphology|MP:0009461,skeletal muscle hypertrophy|MP:0010053,decreased grip strength
MGI:6302751	Treh<em1(IMPC)H>	MP:0005011,increased eosinophil cell number
MGI:3586558	Treh<tm1Tkam>	MP:0001666,abnormal intestinal absorption|MP:0002078,abnormal glucose homeostasis|MP:0005367,renal/urinary system phenotype|MP:0005381,digestive/alimentary phenotype
MGI:5461334	Trem1<tm1.1Ahoru>	MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005166,decreased susceptibility to injury|MP:0009828,increased tumor latency
MGI:4415423	Trem1<tm1(KOMP)Vlcg>	MP:0004794,increased anti-nuclear antigen antibody level
MGI:6197715	Trem2<em2Bwef>	MP:0001599,abnormal blood volume|MP:0001798,impaired macrophage phagocytosis|MP:0002078,abnormal glucose homeostasis|MP:0003884,decreased macrophage cell number|MP:0008553,increased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level|MP:0008735,increased susceptibility to endotoxin shock|MP:0011080,increased macrophage apoptosis|MP:0011986,decreased macrophage proliferation|MP:0020449,decreased microglial cell activation
MGI:3806795	Trem2<tm1Cln>	MP:0008750,abnormal interferon level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level
MGI:3797897	Trem2<tm1(KOMP)Vlcg>	MP:0003691,abnormal microglial cell physiology|MP:0004045,abnormal cell cycle checkpoint function|MP:0010170,abnormal glial cell apoptosis|MP:0020449,decreased microglial cell activation
MGI:3851246	Treml1<tm1Mcvic>	MP:0001914,hemorrhage|MP:0003179,thrombocytopenia|MP:0005606,increased bleeding time|MP:0008560,increased tumor necrosis factor secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0009549,decreased platelet aggregation|MP:0011514,skin hemorrhage|MP:0031083,increased circulating D-dimer level
MGI:5313376	Treml4<tm1Ji>	MP:0005387,immune system phenotype
MGI:7431384	Trex1<em1(IMPC)Ccpcz>	MP:0000160,kyphosis|MP:0000161,scoliosis|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000438,abnormal cranium morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001303,abnormal lens morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002599,increased mean platelet volume|MP:0002631,abnormal epididymis morphology|MP:0002764,short tibia|MP:0002833,increased heart weight|MP:0002997,enlarged seminal vesicle|MP:0003068,enlarged kidney|MP:0003179,thrombocytopenia|MP:0003795,abnormal bone structure|MP:0003917,increased kidney weight|MP:0003960,increased lean body mass|MP:0004174,abnormal spine curvature|MP:0004931,enlarged epididymis|MP:0004952,increased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0005292,improved glucose tolerance|MP:0008045,decreased NK cell number|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0013129,abnormal tooth color|MP:0013772,increased effector memory T-helper cell number
MGI:7408568	Trex1<em3Gpt>	MP:0000691,enlarged spleen|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0002083,premature death|MP:0004952,increased spleen weight|MP:0005350,increased susceptibility to autoimmune disorder|MP:0008553,increased circulating tumor necrosis factor level
MGI:5751220	Trex1<tm1.1Fwpe>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001177,atelectasis|MP:0001828,abnormal T cell activation|MP:0001846,increased inflammatory response|MP:0001853,heart inflammation|MP:0001855,abnormal atrial thrombosis|MP:0001864,vascular inflammation|MP:0001869,pancreas inflammation|MP:0001870,salivary gland inflammation|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002493,increased IgG level|MP:0002722,abnormal immune system organ morphology|MP:0002743,glomerulonephritis|MP:0003140,dilated heart atrium|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004952,increased spleen weight|MP:0004973,increased regulatory T cell number|MP:0005014,increased B cell number|MP:0006138,congestive heart failure|MP:0008022,dilated heart ventricle|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008097,increased plasma cell number|MP:0008880,lacrimal gland inflammation|MP:0009338,increased splenocyte number|MP:0010019,liver vascular congestion|MP:0011405,tubulointerstitial nephritis|MP:0020519,renal glomerular immunoglobulin deposits|MP:0031054,bronchiolitis
MGI:3052754	Trex1<tm1Tld>	MP:0000278,abnormal myocardial fiber morphology|MP:0000376,folliculitis|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000711,thymus cortex hypoplasia|MP:0001194,dermatitis|MP:0001212,skin lesions|MP:0001654,hepatic necrosis|MP:0001846,increased inflammatory response|MP:0001853,heart inflammation|MP:0001855,abnormal atrial thrombosis|MP:0001856,myocarditis|MP:0001859,kidney inflammation|MP:0001873,stomach inflammation|MP:0002083,premature death|MP:0002362,abnormal spleen marginal zone morphology|MP:0002493,increased IgG level|MP:0002743,glomerulonephritis|MP:0003141,cardiac fibrosis|MP:0003725,increased autoantibody level|MP:0003946,renal necrosis|MP:0004510,myositis|MP:0004566,myocardial fiber degeneration|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004801,increased susceptibility to systemic lupus erythematosus|MP:0004947,skin inflammation|MP:0005330,cardiomyopathy|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005387,immune system phenotype|MP:0008555,abnormal interferon secretion|MP:0014347,increased spleen B cell follicle size
MGI:4355746	Trex2<tm1.2Coso>	MP:0003453,abnormal keratinocyte physiology|MP:0004499,increased incidence of tumors by chemical induction|MP:0005501,abnormal skin physiology|MP:0009581,decreased keratinocyte apoptosis
MGI:6094268	Trf<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001417,decreased exploration in new environment|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0001697,abnormal embryo size|MP:0002590,increased mean corpuscular volume|MP:0003717,pallor|MP:0005561,increased mean corpuscular hemoglobin|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:6156165	Trf<em1(IMPC)Rbrc>	MP:0001565,abnormal circulating phosphate level|MP:0004151,decreased circulating iron level|MP:0011100,preweaning lethality, complete penetrance|MP:0012362,increased large unstained cell number
MGI:1856905	Trf<hpx>	MP:0000208,decreased hematocrit|MP:0001732,postnatal growth retardation|MP:0002424,abnormal reticulocyte morphology|MP:0002591,decreased mean corpuscular volume|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002812,spherocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005397,hematopoietic system phenotype|MP:0005637,abnormal iron homeostasis|MP:0005638,hemochromatosis|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008387,hypochromic anemia|MP:0008810,increased circulating iron level|MP:0011085,postnatal lethality, complete penetrance
MGI:3046956	Trgc1<tm1.2Dhr>	MP:0008347,decreased gamma-delta T cell number
MGI:3522044	Trglyd<RR>	MP:0005317,increased triglyceride level
MGI:5755093	Trh<em1(IMPC)Tcp>	MP:0000062,increased bone mineral density|MP:0000470,abnormal stomach morphology|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001556,increased circulating HDL cholesterol level|MP:0002188,small heart|MP:0002834,decreased heart weight|MP:0002989,small kidney|MP:0005178,increased circulating cholesterol level|MP:0005333,decreased heart rate|MP:0005553,increased circulating creatinine level|MP:0010123,increased bone mineral content
MGI:7614548	Trhr2<tm1Gemc>	MP:0001364,decreased anxiety-related response|MP:0003360,abnormal depression-related behavior
MGI:3044170	Trhr<tm1Bau>	MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0003351,decreased circulating levels of thyroid hormone|MP:0003503,decreased activity of thyroid gland|MP:0005121,decreased circulating prolactin level|MP:0005289,increased oxygen consumption|MP:0005389,reproductive system phenotype|MP:0005471,decreased thyroxine level|MP:0005473,decreased triiodothyronine level|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level|MP:0011611,abnormal circulating ghrelin level|MP:0011612,increased circulating ghrelin level|MP:0011613,decreased circulating ghrelin level
MGI:3763533	Trhr<tm1Hzg>	MP:0001363,increased anxiety-related response|MP:0002573,behavioral despair|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005478,decreased circulating thyroxine level|MP:0005559,increased circulating glucose level
MGI:3620126	Trh<tm1Mmt>	MP:0001559,hyperglycemia|MP:0001732,postnatal growth retardation|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003816,abnormal pituitary gland development|MP:0005119,decreased circulating thyroid-stimulating hormone level|MP:0005135,increased thyroid-stimulating hormone level|MP:0005478,decreased circulating thyroxine level
MGI:2156740	Tria4<STS/A>	MP:0002442,abnormal leukocyte physiology
MGI:2157374	Tria5<STS/A>	MP:0002442,abnormal leukocyte physiology
MGI:5000311	Trib1<tm1Aki>	MP:0000219,increased neutrophil cell number|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002356,abnormal spleen red pulp morphology|MP:0003884,decreased macrophage cell number|MP:0005012,decreased eosinophil cell number|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0006319,abnormal epididymal fat pad morphology|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008664,decreased interleukin-12 secretion|MP:0008807,increased liver iron level|MP:0008808,decreased spleen iron level|MP:0009133,decreased white fat cell size|MP:0011174,lipodystrophy
MGI:5637148	Trib1<tm1b(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001491,unresponsive to tactile stimuli|MP:0001510,abnormal coat appearance|MP:0001697,abnormal embryo size|MP:0005419,decreased circulating serum albumin level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration
MGI:5294354	Trib2<Tg(Thy1-Trh/APP*)2.1Ingm>	MP:0000745,tremors|MP:0000807,abnormal hippocampus morphology|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001473,reduced long-term potentiation|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002083,premature death|MP:0002183,gliosis|MP:0002206,abnormal CNS synaptic transmission|MP:0002757,decreased vertical activity|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003329,amyloid beta deposits|MP:0003354,astrocytosis|MP:0004924,abnormal behavior|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008489,slow postnatal weight gain|MP:0008918,microgliosis|MP:0009142,decreased prepulse inhibition|MP:0009971,decreased hippocampus pyramidal cell number|MP:0010014,hippocampus pyramidal cell degeneration|MP:0011940,decreased food intake|MP:0011942,decreased fluid intake
MGI:5692783	Trib2<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0002764,short tibia|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0005179,decreased circulating cholesterol level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:5430770	Trib2<tm1Lex>	MP:0001417,decreased exploration in new environment|MP:0005017,decreased B cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:5512770	Trib2<tm1Myam>	MP:0005397,hematopoietic system phenotype
MGI:3806571	Trib2<tm1Ryn>	MP:0002169,no abnormal phenotype detected
MGI:4280770	Trib3<Gt(OST324148)Lex>	MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging|MP:0014118,decreased pancreatic beta cell apoptosis
MGI:3713755	Trib3<tm1Mws>	MP:0005376,homeostasis/metabolism phenotype
MGI:5512771	Trib3<tm1Myam>	MP:0005397,hematopoietic system phenotype
MGI:5474051	Trib3<tm1Tord>	MP:0002423,abnormal mast cell physiology|MP:0008765,decreased mast cell degranulation
MGI:2155750	Triglq1<SM/J>	MP:0001552,increased circulating triglyceride level
MGI:2157904	Triglq2<SM/J>	MP:0001552,increased circulating triglyceride level
MGI:3029265	Trigq2<KK>	MP:0005317,increased triglyceride level
MGI:6508377	Tril<tm1.1Kaf>	MP:0003009,abnormal cytokine secretion|MP:0005386,behavior/neurological phenotype|MP:0008561,decreased tumor necrosis factor secretion|MP:0008565,decreased interferon-beta secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion
MGI:7427727	Trim10<em1(IMPC)J>	MP:0002834,decreased heart weight|MP:0004738,abnormal auditory brainstem response|MP:0005561,increased mean corpuscular hemoglobin|MP:0010024,increased total body fat amount
MGI:6717383	Trim10<em2Cya>	MP:0004486,decreased response of heart to induced stress
MGI:7354926	Trim11<em1Bcgen>	MP:0005378,growth/size/body region phenotype
MGI:6156472	Trim13<em1(IMPC)Tcp>	MP:0000627,abnormal mammary gland morphology|MP:0000709,enlarged thymus|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001552,increased circulating triglyceride level|MP:0002059,abnormal seminal vesicle morphology|MP:0002637,small uterus|MP:0002768,small adrenal glands|MP:0011874,enlarged urinary bladder
MGI:6270360	Trim13<tm1.1Jskg>	MP:0008548,abnormal circulating interferon level|MP:0008564,increased interferon-beta secretion|MP:0008576,decreased circulating interferon-beta level|MP:0031039,decreased susceptibility to Picornaviridae infection induced morbidity/mortality
MGI:6152723	Trim14<em1(IMPC)Mbp>	MP:0003998,decreased thermal nociceptive threshold
MGI:6358730	Trim14<em1Rfw>	MP:0008565,decreased interferon-beta secretion|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:5588277	Trim15<tm1b(EUCOMM)Hmgu>	MP:0001529,abnormal vocalization
MGI:6156546	Trim16<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0002060,abnormal skin morphology|MP:0002941,increased circulating alanine transaminase level|MP:0010067,increased red blood cell distribution width
MGI:6479657	Trim16<tm1Gmma>	MP:0001272,increased metastatic potential|MP:0002006,neoplasm|MP:0003721,increased tumor growth/size|MP:0004499,increased incidence of tumors by chemical induction|MP:0005386,behavior/neurological phenotype|MP:0010308,decreased tumor latency
MGI:6361133	Trim17<em1Osb>	MP:0005389,reproductive system phenotype
MGI:4452788	Trim17<tm1e(EUCOMM)Wtsi>	MP:0004509,abnormal pelvic girdle bone morphology
MGI:3849316	Trim21<tm1Hm>	MP:0000622,increased salivation|MP:0002398,abnormal bone marrow cell morphology/development|MP:0005385,cardiovascular system phenotype
MGI:4365543	Trim21<tm1Mwah>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001194,dermatitis|MP:0001828,abnormal T cell activation|MP:0001844,autoimmune response|MP:0001846,increased inflammatory response|MP:0002962,increased urine protein level|MP:0003725,increased autoantibody level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0008770,decreased survivor rate
MGI:6719577	Trim23<em1Phua>	MP:0002626,increased heart rate|MP:0005381,digestive/alimentary phenotype|MP:0008531,increased chemical nociceptive threshold
MGI:7614463	Trim24<em1Schen>	MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:7614464	Trim24<em2Schen>	MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5792079	Trim24<mpc232H>	MP:0001573,abnormal circulating alanine transaminase level
MGI:3772051	Trim24<tm1.1Los>	MP:0003324,increased liver adenoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0003893,increased hepatocyte proliferation|MP:0004025,polyploidy|MP:0008019,increased liver tumor incidence
MGI:2673138	Trim25<tm1Mura>	MP:0002637,small uterus|MP:0005026,decreased susceptibility to parasitic infection|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality
MGI:5692539	Trim25<tm2b(EUCOMM)Hmgu>	MP:0005293,impaired glucose tolerance
MGI:4966301	Trim27<Gt(345D11)Cmhd>	MP:0005387,immune system phenotype|MP:0005465,abnormal T-helper 1 physiology|MP:0005466,abnormal T-helper 2 physiology|MP:0008560,increased tumor necrosis factor secretion|MP:0008566,increased interferon-gamma secretion
MGI:3858633	Trim27<Gt(XP0484)Wtsi>	MP:0003447,decreased tumor growth/size|MP:0004502,decreased incidence of tumors by chemical induction|MP:0008008,early cellular replicative senescence
MGI:5494137	Trim27<tm1Sis>	MP:0002942,decreased circulating alanine transaminase level|MP:0005632,decreased circulating aspartate transaminase level|MP:0008891,decreased hepatocyte apoptosis|MP:0008944,decreased sensitivity to induced cell death|MP:0009764,decreased susceptibility to induced morbidity/mortality
MGI:5620610	Trim28<chatwo>	MP:0000929,open neural tube|MP:0001685,abnormal endoderm development|MP:0001730,embryonic growth arrest|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003119,abnormal digestive system development|MP:0004558,delayed allantois development|MP:0005028,abnormal trophectoderm morphology|MP:0010117,abnormal lateral plate mesoderm morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011200,abnormal extraembryonic coelom morphology|MP:0011202,abnormal ectoplacental cavity morphology|MP:0011203,abnormal parietal yolk sac morphology|MP:0012173,short rostral-caudal axis|MP:0012180,abnormal somatic mesoderm morphology
MGI:3821600	Trim28<MommeD9>	MP:0001730,embryonic growth arrest|MP:0001935,decreased litter size|MP:0002210,abnormal sex determination|MP:0011092,embryonic lethality, complete penetrance
MGI:7471137	Trim28<tm1.1Ics>	MP:0011091,prenatal lethality, complete penetrance
MGI:1928907	Trim28<tm1.1Ipc>	MP:0001131,abnormal ovarian follicle morphology|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002687,oligozoospermia|MP:0004182,abnormal spermiation|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0013600,testis degeneration|MP:0014636,decreased elongated spermatid number
MGI:1859550	Trim28<tm1.2Ipc>	MP:0001683,absent mesoderm|MP:0001685,abnormal endoderm development|MP:0001724,abnormal extraembryonic endoderm formation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4948085	Trim28<tm1Fca>	MP:0001700,abnormal embryo turning|MP:0003077,abnormal cell cycle|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1928908	Trim28<tm1Ipc>	MP:0002169,no abnormal phenotype detected
MGI:4434517	Trim29<tm1a(EUCOMM)Wtsi>	MP:0003186,abnormal redox activity|MP:0008555,abnormal interferon secretion|MP:0008562,increased interferon-alpha secretion|MP:0008564,increased interferon-beta secretion|MP:0008752,abnormal tumor necrosis factor level|MP:0010052,increased grip strength|MP:0010091,decreased circulating creatine kinase level|MP:0011393,decreased fetal cardiomyocyte apoptosis|MP:0014435,increased interferon level|MP:0014438,decreased interleukin level|MP:0020938,decreased susceptibility to Picornaviridae infection|MP:0031039,decreased susceptibility to Picornaviridae infection induced morbidity/mortality|MP:0031601,decreased endoplasmic reticulum stress
MGI:5548617	Trim29<tm1b(EUCOMM)Wtsi>	MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount
MGI:7608151	Trim29<tm1c(EUCOMM)Wtsi>	MP:0001876,decreased inflammatory response|MP:0005348,increased T cell proliferation|MP:0005379,endocrine/exocrine gland phenotype|MP:0008566,increased interferon-gamma secretion|MP:0008752,abnormal tumor necrosis factor level|MP:0010091,decreased circulating creatine kinase level|MP:0010768,mortality/aging|MP:0011393,decreased fetal cardiomyocyte apoptosis|MP:0013662,decreased myeloid cell number|MP:0014435,increased interferon level|MP:0014438,decreased interleukin level|MP:0020938,decreased susceptibility to Picornaviridae infection|MP:0031039,decreased susceptibility to Picornaviridae infection induced morbidity/mortality|MP:0031601,decreased endoplasmic reticulum stress
MGI:6279898	Trim2<em1(IMPC)Bay>	MP:0001314,cornea opacity|MP:0003043,hypoalgesia
MGI:3814237	Trim2<Gt(IRESBetageo)11Pgr>	MP:0000745,tremors|MP:0000880,decreased Purkinje cell number|MP:0001393,ataxia|MP:0002064,seizures|MP:0002229,neurodegeneration|MP:0005404,abnormal axon morphology|MP:0006309,decreased retina ganglion cell number|MP:0008067,retina ganglion cell degeneration|MP:0008511,thin retina inner nuclear layer|MP:0008519,thin retina outer plexiform layer|MP:0009979,abnormal cerebellum deep nucleus morphology
MGI:5606169	Trim30a<tm1Yjk>	MP:0003944,abnormal T cell subpopulation ratio|MP:0005348,increased T cell proliferation|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0008074,increased CD4-positive, alpha-beta T cell number
MGI:5692871	Trim30b<tm1b(KOMP)Wtsi>	MP:0004357,long tibia
MGI:6356828	Trim31<em1Cya>	MP:0000219,increased neutrophil cell number|MP:0000495,abnormal colon morphology|MP:0001259,abnormal body weight|MP:0001663,abnormal digestive system physiology|MP:0008539,decreased susceptibility to induced colitis|MP:0008641,increased circulating interleukin-1 beta level|MP:0010210,abnormal circulating cytokine level|MP:0013022,increased Ly6C high monocyte number
MGI:5692807	Trim31<tm2b(EUCOMM)Hmgu>	MP:0010097,abnormal retina blood vessel morphology
MGI:3837468	Trim32<Gt(BGA355)Byg>	MP:0000751,myopathy|MP:0001260,increased body weight|MP:0001405,impaired coordination|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0004232,decreased muscle weight|MP:0005369,muscle phenotype|MP:0005404,abnormal axon morphology|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0010053,decreased grip strength
MGI:4453461	Trim32<tm1Hdin>	MP:0000730,increased satellite cell number|MP:0000751,myopathy|MP:0000759,abnormal skeletal muscle morphology|MP:0002106,abnormal muscle physiology|MP:0008872,abnormal physiological response to xenobiotic|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0031328,delayed skeletal muscle regeneration
MGI:5287715	Trim32<tm1Spc>	MP:0000746,weakness|MP:0000752,dystrophic muscle|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010053,decreased grip strength
MGI:6358622	Trim33<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001314,cornea opacity|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3799365	Trim33<tm1.1Vk>	MP:0003984,embryonic growth retardation|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:4830323	Trim33<tm1.2Los>	MP:0001680,abnormal mesoderm development|MP:0001693,failure of primitive streak formation|MP:0001698,decreased embryo size|MP:0002084,abnormal developmental patterning|MP:0002583,absent extraembryonic ectoderm|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0008533,abnormal anterior visceral endoderm morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011197,abnormal proamniotic cavity morphology
MGI:4355864	Trim33<tm1Los>	MP:0005379,endocrine/exocrine gland phenotype|MP:0005387,immune system phenotype
MGI:3799363	Trim33<tm1Vk>	MP:0002169,no abnormal phenotype detected
MGI:6388663	Trim35<em1(IMPC)J>	MP:0001364,decreased anxiety-related response|MP:0004738,abnormal auditory brainstem response|MP:0010024,increased total body fat amount
MGI:6512427	Trim35<em1Smoc>	MP:0008576,decreased circulating interferon-beta level|MP:0011079,decreased macrophage cytokine production|MP:0020946,increased susceptibility to Orthomyxoviridae infection|MP:0031046,increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:7641861	Trim36<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6378209	Trim36<tm1Htan>	MP:0001925,male infertility|MP:0020451,decreased sperm progressive motility
MGI:4329141	Trim37<Gt(RRO307)Byg>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000602,dilated liver sinusoidal space|MP:0000691,enlarged spleen|MP:0001116,small gonad|MP:0001126,abnormal ovary morphology|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001944,abnormal pancreas morphology|MP:0002016,ovary cyst|MP:0002020,increased tumor incidence|MP:0002038,increased carcinoma incidence|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0002727,decreased circulating insulin level|MP:0002786,abnormal Leydig cell morphology|MP:0003450,enlarged pancreas|MP:0004067,abnormal trabecula carnea morphology|MP:0004805,absent oocytes|MP:0004806,absent germ cells|MP:0005324,ascites|MP:0005330,cardiomyopathy|MP:0005352,small cranium|MP:0005384,cellular phenotype|MP:0005431,decreased oocyte number|MP:0006283,increased medulloblastoma incidence|MP:0006362,abnormal male germ cell morphology|MP:0008000,increased ovary tumor incidence|MP:0008526,decreased cranium width|MP:0009355,increased liver triglyceride level|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake|MP:0011942,decreased fluid intake|MP:0012431,increased lymphoma incidence|MP:0013279,increased fasting circulating glucose level|MP:0013600,testis degeneration
MGI:4415381	Trim38<tm1(KOMP)Vlcg>	MP:0002412,increased susceptibility to bacterial infection|MP:0008553,increased circulating tumor necrosis factor level|MP:0008573,increased circulating interferon-alpha level|MP:0008575,increased circulating interferon-beta level|MP:0008596,increased circulating interleukin-6 level|MP:0009787,increased susceptibility to infection induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:5775770	Trim39<tm1b(EUCOMM)Hmgu>	MP:0000223,decreased monocyte cell number|MP:0001284,absent vibrissae|MP:0001314,cornea opacity|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0002098,abnormal vibrissa morphology|MP:0003960,increased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0005013,increased lymphocyte cell number|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content|MP:0013278,decreased fasting circulating glucose level|MP:0013279,increased fasting circulating glucose level
MGI:5562431	Trim3<tm1.2Kstrn>	MP:0002169,no abnormal phenotype detected
MGI:5695119	Trim3<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0010097,abnormal retina blood vessel morphology|MP:0011965,decreased total retina thickness
MGI:4459821	Trim3<tm1Mak>	MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0014385,decreased miniature inhibitory postsynaptic current amplitude
MGI:6368568	Trim40<em1Caox>	MP:0001790,abnormal immune system physiology|MP:0002451,abnormal macrophage physiology|MP:0020414,abnormal fibroblast physiology|MP:0031023,decreased susceptibility to Riboviria infection induced morbidity/mortality
MGI:7713327	Trim41<em1Osb>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0005169,abnormal male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:7709890	Trim41<tm1Caox>	MP:0002412,increased susceptibility to bacterial infection|MP:0002419,abnormal innate immunity|MP:0008576,decreased circulating interferon-beta level|MP:0008597,decreased circulating interleukin-6 level|MP:0008752,abnormal tumor necrosis factor level|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0014436,decreased interferon level|MP:0014438,decreased interleukin level|MP:0020913,increased susceptibility to Riboviria infection|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:7713326	Trim41<tm1Osb>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005169,abnormal male meiosis|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009239,short sperm flagellum|MP:0014052,increased male germ cell apoptosis
MGI:7610749	Trim44<em1(IMPC)Bay>	MP:0000745,tremors|MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0001529,abnormal vocalization|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4363243	Trim45<tm1a(KOMP)Wtsi>	MP:0000282,abnormal interatrial septum morphology|MP:0000783,abnormal forebrain morphology|MP:0003078,aphakia|MP:0003827,abnormal Wolffian duct morphology|MP:0004269,abnormal optic cup morphology|MP:0004613,fusion of vertebral arches|MP:0006063,abnormal inferior vena cava morphology|MP:0010484,bicuspid aortic valve|MP:0011100,preweaning lethality, complete penetrance|MP:0013840,absent segment of posterior cerebral artery|MP:0013848,subcutaneous edema|MP:0013859,abnormal vitelline vein connection|MP:0013877,abnormal ductus venosus valve morphology|MP:0013971,blood in lymph vessels|MP:0014001,abnormal vertebral artery topology|MP:0014003,additional anastomosis between intracranial vertebral arteries
MGI:6415696	Trim46<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0002797,increased thigmotaxis|MP:0010124,decreased bone mineral content
MGI:6257581	Trim47<em1(IMPC)Bay>	MP:0020870,decreased thigmotaxis
MGI:5698073	Trim50<tm1b(KOMP)Wtsi>	MP:0004953,decreased spleen weight
MGI:5466680	Trim50<tm1Hta>	MP:0004139,abnormal gastric parietal cell morphology|MP:0008001,hypochlorhydria|MP:0008006,increased stomach pH
MGI:3706252	Trim54<tm1Eno>	MP:0000266,abnormal heart morphology|MP:0001625,cardiac hypertrophy|MP:0001914,hemorrhage|MP:0002083,premature death|MP:0002795,dilated cardiomyopathy|MP:0002972,abnormal cardiac muscle contractility|MP:0003222,increased cardiomyocyte apoptosis|MP:0003921,abnormal heart left ventricle morphology|MP:0004090,abnormal sarcomere morphology|MP:0004566,myocardial fiber degeneration|MP:0005202,lethargy|MP:0014316,decreased heart left ventricle posterior wall thickness
MGI:3785406	Trim55<tm1Cpat>	MP:0005385,cardiovascular system phenotype
MGI:3773035	Trim55<tm1Slbt>	MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0009399,increased skeletal muscle fiber size|MP:0009461,skeletal muscle hypertrophy|MP:0010226,increased quadriceps weight|MP:0020950,decreased susceptibility to Coronaviridae infection
MGI:5692855	Trim55<tm2b(EUCOMM)Hmgu>	MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval|MP:0013278,decreased fasting circulating glucose level
MGI:5527611	Trim56<tm1a(EUCOMM)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001258,decreased body length|MP:0004151,decreased circulating iron level|MP:0004974,decreased regulatory T cell number|MP:0005179,decreased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0008810,increased circulating iron level|MP:0010052,increased grip strength
MGI:6277009	Trim58<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002590,increased mean corpuscular volume|MP:0003068,enlarged kidney
MGI:6362941	Trim58<tm2313.1Arte>	MP:0008537,increased susceptibility to induced colitis
MGI:6362942	Trim58<tm2313.2Arte>	MP:0008537,increased susceptibility to induced colitis|MP:0010768,mortality/aging
MGI:5694172	Trim59<tm1b(EUCOMM)Hmgu>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:6287110	Trim59<tm1Ryag>	MP:0001672,abnormal embryo development|MP:0001674,abnormal germ layer development|MP:0001683,absent mesoderm|MP:0001685,abnormal endoderm development|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0002583,absent extraembryonic ectoderm|MP:0002718,abnormal inner cell mass morphology|MP:0003984,embryonic growth retardation|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005030,absent amnion|MP:0009687,empty decidua capsularis|MP:0011092,embryonic lethality, complete penetrance|MP:0011189,small embryonic epiblast|MP:0011209,absent extraembryonic coelom|MP:0012142,absent amniotic cavity
MGI:6362809	Trim61<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0002135,abnormal kidney morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0002989,small kidney
MGI:5538538	Trim62<tm1Akil>	MP:0001883,increased mammary adenocarcinoma incidence|MP:0002020,increased tumor incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0003331,increased hepatocellular carcinoma incidence|MP:0004207,increased squamous cell carcinoma incidence|MP:0009308,increased adenocarcinoma incidence|MP:0009591,increased liver adenocarcinoma incidence|MP:0010367,increased spindle cell carcinoma incidence|MP:0010768,mortality/aging|MP:0012431,increased lymphoma incidence
MGI:3851099	Trim63<tm1.1Vlcg>	MP:0005369,muscle phenotype
MGI:2676048	Trim63<tm1Glas>	MP:0001625,cardiac hypertrophy|MP:0002625,heart left ventricle hypertrophy|MP:0004064,decreased susceptibility to induced muscular atrophy
MGI:3773034	Trim63<tm1Slbt>	MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0009399,increased skeletal muscle fiber size|MP:0010226,increased quadriceps weight
MGI:3851102	Trim63<tm2.1Vlcg>	MP:0004064,decreased susceptibility to induced muscular atrophy
MGI:6356825	Trim65<em1Cya>	MP:0008563,decreased interferon-alpha secretion|MP:0008565,decreased interferon-beta secretion|MP:0008574,decreased circulating interferon-alpha level|MP:0008576,decreased circulating interferon-beta level|MP:0020937,increased susceptibility to Picornaviridae infection|MP:0031040,increased susceptibility to Picornaviridae infection induced morbidity/mortality
MGI:6356826	Trim65<em2Cya>	MP:0008565,decreased interferon-beta secretion
MGI:6356827	Trim65<em3Cya>	MP:0008565,decreased interferon-beta secretion
MGI:7657542	Trim66<em1Emr>	MP:0001935,decreased litter size|MP:0005389,reproductive system phenotype|MP:0010723,paternal effect|MP:0011101,prenatal lethality, incomplete penetrance
MGI:7657543	Trim66<em2Emr>	MP:0005389,reproductive system phenotype|MP:0010723,paternal effect
MGI:4431799	Trim66<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0001415,increased exploration in new environment|MP:0005561,increased mean corpuscular hemoglobin|MP:0010025,decreased total body fat amount
MGI:6259600	Trim67<tm1.2Slgu>	MP:0000781,decreased corpus callosum size|MP:0000783,abnormal forebrain morphology|MP:0000807,abnormal hippocampus morphology|MP:0001405,impaired coordination|MP:0001489,decreased startle reflex|MP:0002175,decreased brain weight|MP:0003631,nervous system phenotype|MP:0004102,abnormal dorsal striatum morphology|MP:0008222,decreased hippocampal commissure size|MP:0008283,small hippocampus|MP:0008414,abnormal spatial reference memory|MP:0009142,decreased prepulse inhibition|MP:0010053,decreased grip strength|MP:0012307,impaired spatial learning|MP:0012462,decreased brain internal capsule size|MP:0012480,decreased amygdala size|MP:0013908,small lateral ventricles|MP:0014114,abnormal cognition|MP:0014115,cognitive inflexibility|MP:0020395,abnormal response to social novelty|MP:0020527,small thalamus|MP:0020554,decreased stria medullaris size
MGI:6294128	Trim68<em1(IMPC)J>	MP:0010097,abnormal retina blood vessel morphology
MGI:6385121	Trim69<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response
MGI:7284271	Trim69<em1Jsha>	MP:0002169,no abnormal phenotype detected
MGI:7327325	Trim6<em1Raj>	MP:0005025,abnormal response to infection
MGI:7661051	Trim71<em1Ktka>	MP:0000434,megacephaly|MP:0000438,abnormal cranium morphology|MP:0000440,domed cranium|MP:0000788,abnormal cerebral cortex morphology|MP:0000914,exencephaly|MP:0001891,hydrocephaly|MP:0002958,cerebral aqueductal stenosis|MP:0003424,premature neuronal precursor differentiation|MP:0003633,abnormal nervous system physiology|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0006254,thin cerebral cortex|MP:0008948,decreased neuron number|MP:0009967,abnormal neuron proliferation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0012207,decreased neuronal stem cell self-renewal|MP:0012706,decreased embryonic neuroepithelial cell proliferation|MP:0013907,abnormal cerebrospinal fluid flow
MGI:3875666	Trim71<Gt(H004C06)Wrst>	MP:0000928,incomplete rostral neuropore closure|MP:0001730,embryonic growth arrest|MP:0002169,no abnormal phenotype detected|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4123844	Trim71<Gt(XA144)Byg>	MP:0000774,decreased brain size|MP:0000822,abnormal brain ventricle morphology|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0001914,hemorrhage|MP:0002233,abnormal nose morphology|MP:0003717,pallor|MP:0004200,decreased fetal size|MP:0008797,facial cleft|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012680,absent lateral ventricles|MP:0012686,everted embryonic neuroepithelium
MGI:4125025	Trim71<Gt(XD089)Byg>	MP:0000914,exencephaly
MGI:5708258	Trim71<tm1.1(KOMP)Vlcg>	MP:0002581,abnormal ileum morphology|MP:0004002,abnormal jejunum morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:7661049	Trim71<tm1695Arte>	MP:0001891,hydrocephaly|MP:0002958,cerebral aqueductal stenosis|MP:0006254,thin cerebral cortex|MP:0008948,decreased neuron number|MP:0009967,abnormal neuron proliferation|MP:0011380,enlarged brain ventricles
MGI:3839863	Trim72<tm1Hta>	MP:0000750,abnormal muscle regeneration|MP:0000759,abnormal skeletal muscle morphology|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002106,abnormal muscle physiology|MP:0002841,impaired skeletal muscle contractility|MP:0009402,decreased skeletal muscle fiber diameter|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:7568835	Trim72<tm1Rpx>	MP:0002323,decreased susceptibility to hyperlipidemia|MP:0005369,muscle phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0020090,decreased susceptibility to diet-induced non-insulin dependent diabetes|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5432128	Trim72<tm1Ygko>	MP:0000729,abnormal myogenesis|MP:0009404,centrally nucleated skeletal muscle fibers
MGI:6856766	Trim7<em1(IMPC)Bay>	MP:0001399,hyperactivity
MGI:6478305	Trim7<em1Jiew>	MP:0002410,decreased susceptibility to viral infection|MP:0020917,decreased susceptibility to Herpesvirales infection
MGI:6690866	Trim8<em1Holi>	MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0010768,mortality/aging
MGI:6153692	Trim8<em1(IMPC)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001257,increased body length|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005561,increased mean corpuscular hemoglobin
MGI:6164179	Trim8<tm1Hbsh>	MP:0002412,increased susceptibility to bacterial infection|MP:0005387,immune system phenotype|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008564,increased interferon-beta secretion|MP:0008596,increased circulating interleukin-6 level|MP:0008705,increased interleukin-6 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010209,abnormal circulating chemokine level|MP:0011078,increased macrophage cytokine production
MGI:6147539	Trim9<em1(IMPC)Ccpcz>	MP:0001158,abnormal prostate gland morphology|MP:0001175,abnormal lung morphology|MP:0001325,abnormal retina morphology|MP:0002135,abnormal kidney morphology|MP:0002774,small prostate gland|MP:0003068,enlarged kidney|MP:0004599,abnormal vertebral arch morphology|MP:0004953,decreased spleen weight|MP:0005634,decreased circulating sodium level|MP:0008935,decreased mean platelet volume|MP:0010068,decreased red blood cell distribution width|MP:0013771,decreased effector memory T-helper cell number
MGI:5660333	Trim9<tm1.1Slgu>	MP:0000780,abnormal corpus callosum morphology|MP:0004811,abnormal neuron physiology|MP:0009937,abnormal neuron differentiation|MP:0012443,increased corpus callosum size
MGI:6274369	Triobp<em1(IMPC)J>	MP:0001284,absent vibrissae|MP:0001489,decreased startle reflex|MP:0004738,abnormal auditory brainstem response|MP:0005559,increased circulating glucose level|MP:0009142,decreased prepulse inhibition
MGI:4128049	Triobp<Gt(RRE310)Byg>	MP:0008762,embryonic lethality
MGI:3870075	Triobp<Gt(YHB226)Byg>	MP:0008762,embryonic lethality
MGI:4881773	Triobp<tm1Tbf>	MP:0001967,deafness|MP:0004432,abnormal cochlear hair cell physiology|MP:0004523,decreased cochlear hair cell stereocilia number|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004528,fused outer hair cell stereocilia|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004533,fused inner hair cell stereocilia|MP:0004589,abnormal cochlear hair cell development|MP:0005377,hearing/vestibular/ear phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6382414	Trio<em1(IMPC)H>	MP:0000219,increased neutrophil cell number|MP:0001697,abnormal embryo size|MP:0005293,impaired glucose tolerance|MP:0011100,preweaning lethality, complete penetrance
MGI:2158695	Trio<tm1Mst>	MP:0000729,abnormal myogenesis|MP:0000759,abnormal skeletal muscle morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0006009,abnormal neuronal migration|MP:0011089,perinatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:4839231	Trio<tm1Mzhu>	MP:0000774,decreased brain size|MP:0000812,abnormal dentate gyrus morphology|MP:0000852,small cerebellum|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0002741,small olfactory bulb|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004279,abnormal rostral migratory stream morphology|MP:0005386,behavior/neurological phenotype|MP:0009546,absent gastric milk in neonates|MP:0009937,abnormal neuron differentiation|MP:0009951,abnormal olfactory bulb mitral cell layer morphology|MP:0009964,abnormal cerebellum lobule morphology|MP:0009977,abnormal cerebellar granule cell migration|MP:0010387,abnormal Bergmann glial cell morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4834223	Trip10<tm1.1Geha>	MP:0001805,decreased IgG level|MP:0002359,abnormal spleen germinal center morphology|MP:0002444,abnormal T cell physiology|MP:0002492,decreased IgE level|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008482,decreased spleen germinal center number|MP:0008484,decreased spleen germinal center size
MGI:4453577	Trip10<tm1Sejc>	MP:0005560,decreased circulating glucose level|MP:0030016,increased adipocyte glucose uptake
MGI:3836913	Trip11<Gt(AJ0490)Wtsi>	MP:0000273,overriding aortic valve|MP:0000358,abnormal cell morphology|MP:0000428,abnormal craniofacial morphology|MP:0001402,decreased locomotor activity|MP:0001575,cyanosis|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0002274,abnormal type I pneumocyte morphology|MP:0002953,thick ventricular wall|MP:0003052,omphalocele|MP:0004007,abnormal lung vasculature morphology|MP:0009431,decreased fetal weight|MP:0010420,muscular ventricular septal defect|MP:0010449,heart right ventricle outflow tract stenosis|MP:0010825,abnormal lung saccule morphology|MP:0010827,small lung saccule|MP:0011087,neonatal lethality, complete penetrance
MGI:4829605	Trip11<m1Mawa>	MP:0000131,abnormal long bone epiphysis morphology|MP:0000166,abnormal chondrocyte morphology|MP:0000440,domed cranium|MP:0000445,short snout|MP:0000547,short limbs|MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002741,small olfactory bulb|MP:0002896,abnormal bone mineralization|MP:0003052,omphalocele|MP:0003631,nervous system phenotype|MP:0004986,abnormal osteoblast morphology|MP:0005621,abnormal cell physiology|MP:0008274,failure of bone ossification|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009780,abnormal chondrocyte physiology|MP:0010103,small thoracic cage|MP:0011085,postnatal lethality, complete penetrance|MP:0011087,neonatal lethality, complete penetrance
MGI:6154012	Trip11<tm1.1Psmi>	MP:0002169,no abnormal phenotype detected
MGI:5307150	Trip12<tm1Jyan>	MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5523320	Trip12<tm1Wgu>	MP:0002169,no abnormal phenotype detected|MP:0008943,increased sensitivity to induced cell death
MGI:5639079	Trip13<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001925,male infertility|MP:0001926,female infertility|MP:0010124,decreased bone mineral content|MP:0011396,abnormal sleep behavior
MGI:3870635	Trip13<Gt(CH0621)Wtsi>	MP:0001129,impaired ovarian folliculogenesis|MP:0001147,small testis|MP:0001924,infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0005168,abnormal female meiosis|MP:0008261,arrest of male meiosis|MP:0008966,abnormal chiasmata formation|MP:0009451,abnormal chromosomal synapsis|MP:0009452,abnormal synaptonemal complex
MGI:3719273	Trip13<Gt(RRB047)Byg>	MP:0000585,kinked tail|MP:0000592,short tail|MP:0001116,small gonad|MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001147,small testis|MP:0001265,decreased body size|MP:0001924,infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002777,absent ovarian follicles|MP:0005168,abnormal female meiosis|MP:0005431,decreased oocyte number|MP:0008058,abnormal DNA repair|MP:0008261,arrest of male meiosis|MP:0008966,abnormal chiasmata formation|MP:0009451,abnormal chromosomal synapsis|MP:0009452,abnormal synaptonemal complex|MP:0010948,abnormal double-strand DNA break repair|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014764,impaired double-strand DNA break repair|MP:0020869,immotile sperm
MGI:5443928	Trip13<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000367,abnormal coat/ hair morphology|MP:0001303,abnormal lens morphology|MP:0001325,abnormal retina morphology|MP:0001363,increased anxiety-related response|MP:0001399,hyperactivity|MP:0001556,increased circulating HDL cholesterol level|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002075,abnormal coat/hair pigmentation|MP:0002110,abnormal digit morphology|MP:0002111,abnormal tail morphology|MP:0002574,increased vertical activity|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005102,abnormal iris pigmentation|MP:0005178,increased circulating cholesterol level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content|MP:0010506,prolonged RR interval|MP:0013279,increased fasting circulating glucose level
MGI:7331652	Trip6<tm1.2Pher>	MP:0000820,abnormal choroid plexus morphology|MP:0001891,hydrocephaly|MP:0008535,enlarged lateral ventricles|MP:0010152,abnormal brain ependyma morphology|MP:0030964,decreased brain ependyma motile cilium length|MP:0030966,decreased brain ependyma motile cilium number
MGI:5695898	Trip6<tm1b(EUCOMM)Hmgu>	MP:0000438,abnormal cranium morphology|MP:0000691,enlarged spleen|MP:0001891,hydrocephaly|MP:0010378,increased respiratory quotient
MGI:5704516	Trit1<tm1.1(KOMP)Vlcg>	MP:0001696,failure to gastrulate|MP:0009331,absent primitive node|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:3814701	Trl	MP:0000745,tremors|MP:0001406,abnormal gait|MP:0001925,male infertility
MGI:1857078	trm	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0003631,nervous system phenotype
MGI:4432566	Trmo<tm1a(EUCOMM)Wtsi>	MP:0004924,abnormal behavior|MP:0005343,increased circulating aspartate transaminase level
MGI:2664290	Trmq1<DBA/2J>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology
MGI:2664291	Trmq2<C57BL/6J>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology
MGI:3528157	Trmq3<FVB/N>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0005094,abnormal T cell proliferation
MGI:5552892	Trms	MP:0000745,tremors|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0003312,abnormal locomotor coordination|MP:0005150,cachexia|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype
MGI:7785269	Trmt10a<em1Tomik>	MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001900,impaired synaptic plasticity|MP:0002175,decreased brain weight|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0008414,abnormal spatial reference memory|MP:0012307,impaired spatial learning|MP:0020551,abnormal postsynaptic density morphology
MGI:4432852	Trmt10a<tm1a(EUCOMM)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001262,decreased body weight|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001554,increased circulating free fatty acids level|MP:0002942,decreased circulating alanine transaminase level|MP:0003443,increased circulating glycerol level|MP:0005179,decreased circulating cholesterol level|MP:0005632,decreased circulating aspartate transaminase level|MP:0010092,increased circulating magnesium level|MP:0010101,increased sacral vertebrae number
MGI:6304418	Trmt10b<em1(IMPC)J>	MP:0001284,absent vibrissae|MP:0001566,increased circulating phosphate level|MP:0010053,decreased grip strength
MGI:3702935	Trmt1l<Gt(W027A02)Wrst>	MP:0001405,impaired coordination|MP:0001417,decreased exploration in new environment|MP:0002757,decreased vertical activity|MP:0005389,reproductive system phenotype|MP:0010053,decreased grip strength
MGI:5634291	Trmt1<tm1b(EUCOMM)Hmgu>	MP:0000598,abnormal liver morphology|MP:0002135,abnormal kidney morphology|MP:0002590,increased mean corpuscular volume|MP:0002792,abnormal retina vasculature morphology|MP:0005179,decreased circulating cholesterol level|MP:0010097,abnormal retina blood vessel morphology|MP:0010392,prolonged QRS complex duration|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5811627	Trmt2a<tm1.1(KOMP)Vlcg>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001402,decreased locomotor activity|MP:0002590,increased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002626,increased heart rate|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0005293,impaired glucose tolerance|MP:0005561,increased mean corpuscular hemoglobin|MP:0013279,increased fasting circulating glucose level
MGI:5548943	Trmt2a<tm2b(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number
MGI:6314212	Trmt2b<em1(IMPC)J>	MP:0010052,increased grip strength
MGI:7426055	Trmt44<em1(IMPC)Bay>	MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:6414539	Trmt5<em1(IMPC)Bay>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:7543515	Trmt61a<em1Hbgl>	MP:0001828,abnormal T cell activation|MP:0002816,colitis|MP:0005095,decreased T cell proliferation|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:7543517	Trmt6<em1Hbgl>	MP:0005095,decreased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:6140147	Trmt9b<em1(IMPC)H>	MP:0001304,cataract
MGI:6108879	Trmu<tm1.1Tomik>	MP:0002127,abnormal cardiovascular system morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6108878	Trmu<tm1Tomik>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0001654,hepatic necrosis|MP:0001764,abnormal homeostasis|MP:0001845,abnormal inflammatory response|MP:0002941,increased circulating alanine transaminase level|MP:0003707,increased cell nucleus count|MP:0003806,abnormal nucleotide metabolism|MP:0005179,decreased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005376,homeostasis/metabolism phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005554,decreased circulating creatinine level|MP:0006036,abnormal mitochondrial physiology|MP:0008805,decreased circulating amylase level|MP:0010958,abnormal tricarboxylic acid cycle|MP:0011630,increased mitochondrial size|MP:0011635,abnormal mitochondrial crista morphology|MP:0011971,increased circulating lactate dehydrogenase level|MP:0013405,increased circulating lactate level|MP:0014341,abnormal hepatocyte mitochondrial morphology|MP:0020427,increased hepatocyte karyomegaly|MP:0030937,increased mitochondrial DNA content
MGI:5825365	Trnau1ap<tm1.1Usch>	MP:0002169,no abnormal phenotype detected
MGI:5825366	Trnau1ap<tm2.1Usch>	MP:0001405,impaired coordination|MP:0003631,nervous system phenotype|MP:0005376,homeostasis/metabolism phenotype
MGI:5825369	Trnau1ap<tm2.2Usch>	MP:0011091,prenatal lethality, complete penetrance
MGI:4435001	Trnt1<tm1a(EUCOMM)Hmgu>	MP:0001260,increased body weight|MP:0002965,increased circulating serum albumin level|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:4829800	Tro<tm1Mfu>	MP:0002169,no abnormal phenotype detected|MP:0011102,embryonic lethality, incomplete penetrance
MGI:3611496	Trp53<Bbl>	MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002627,increased teratoma incidence|MP:0003667,increased hemangiosarcoma incidence|MP:0003789,increased osteosarcoma incidence|MP:0009277,increased brain tumor incidence|MP:0010363,increased fibrosarcoma incidence|MP:0012431,increased lymphoma incidence
MGI:3611889	Trp53<bhy>	MP:0001914,hemorrhage|MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002083,premature death|MP:0003667,increased hemangiosarcoma incidence|MP:0003789,increased osteosarcoma incidence|MP:0009277,increased brain tumor incidence|MP:0010349,increased teratocarcinoma incidence|MP:0010363,increased fibrosarcoma incidence|MP:0012431,increased lymphoma incidence
MGI:2661096	Trp53bp1<Gt(OST94324)Lex>	MP:0000352,decreased cell proliferation|MP:0000706,small thymus|MP:0001262,decreased body weight|MP:0001658,increased mortality induced by gamma-irradiation|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0001935,decreased litter size|MP:0002145,abnormal T cell differentiation|MP:0004029,spontaneous chromosome breakage|MP:0004030,induced chromosome breakage|MP:0005018,decreased T cell number|MP:0008211,decreased mature B cell number|MP:0008866,chromosomal instability
MGI:6113484	Trp53bp1<m2Btlr>	MP:0001805,decreased IgG level|MP:0002491,decreased IgD level|MP:0005017,decreased B cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0020154,impaired humoral immune response
MGI:6113492	Trp53bp1<m3Btlr>	MP:0002491,decreased IgD level
MGI:6113496	Trp53bp1<m4Btlr>	MP:0002491,decreased IgD level
MGI:6286091	Trp53bp1<m5Btlr>	MP:0002491,decreased IgD level
MGI:2654201	Trp53bp1<tm1Jc>	MP:0000352,decreased cell proliferation|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0001935,decreased litter size|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0003992,increased mortality induced by ionizing radiation|MP:0004024,aneuploidy|MP:0004045,abnormal cell cycle checkpoint function|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0004816,abnormal class switch recombination|MP:0005090,increased double-negative T cell number|MP:0005389,reproductive system phenotype|MP:0005621,abnormal cell physiology|MP:0008058,abnormal DNA repair|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008409,increased cellular sensitivity to hydroxyurea induced cell death|MP:0008866,chromosomal instability|MP:0010948,abnormal double-strand DNA break repair|MP:0012431,increased lymphoma incidence
MGI:5694181	Trp53bp2<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0005343,increased circulating aspartate transaminase level|MP:0005564,increased hemoglobin content|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3839864	Trp53bp2<tm1Cdlo>	MP:0002020,increased tumor incidence|MP:0002444,abnormal T cell physiology|MP:0004045,abnormal cell cycle checkpoint function|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0011092,embryonic lethality, complete penetrance
MGI:3625686	Trp53bp2<tm1Xlu>	MP:0000111,cleft palate|MP:0000440,domed cranium|MP:0000537,abnormal urethra morphology|MP:0000632,abnormal pineal gland morphology|MP:0000653,abnormal sex gland morphology|MP:0000706,small thymus|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000819,abnormal olfactory bulb morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000914,exencephaly|MP:0000930,wavy neural tube|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0001265,decreased body size|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001328,disorganized retina layers|MP:0001406,abnormal gait|MP:0001891,hydrocephaly|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0001917,intraventricular hemorrhage|MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002036,increased rhabdomyosarcoma incidence|MP:0002151,abnormal neural tube morphology|MP:0002152,abnormal brain morphology|MP:0002639,micrognathia|MP:0003054,spina bifida|MP:0003203,increased neuron apoptosis|MP:0003667,increased hemangiosarcoma incidence|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003742,narrow head|MP:0004207,increased squamous cell carcinoma incidence|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0004948,abnormal neuronal precursor proliferation|MP:0004980,increased neuronal precursor cell number|MP:0005262,coloboma|MP:0006009,abnormal neuronal migration|MP:0006065,abnormal heart position or orientation|MP:0006071,abnormal retina progenitor cell morphology|MP:0008439,abnormal cortical plate morphology|MP:0008458,abnormal cortical ventricular zone morphology|MP:0008784,craniorachischisis|MP:0009688,abnormal spinal cord central canal morphology|MP:0009937,abnormal neuron differentiation|MP:0010402,ventricular septal defect|MP:0010768,mortality/aging|MP:0011085,postnatal lethality, complete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011380,enlarged brain ventricles|MP:0012303,umbilical vein stenosis|MP:0012431,increased lymphoma incidence|MP:0012676,dilated brain ventricle|MP:0012704,abnormal embryonic neuroepithelial cell proliferation|MP:0012705,increased embryonic neuroepithelial cell proliferation|MP:0013362,absent pineal gland|MP:0013842,ductus venosus stenosis|MP:0013849,absent abducens nerve
MGI:4819167	Trp53bp2<tm2Xlu>	MP:0002136,abnormal kidney physiology
MGI:5565172	Trp53cor1<tm1Vlcg>	MP:0001513,limb grasping
MGI:5905785	Trp53i11<em1(IMPC)J>	MP:0005553,increased circulating creatinine level
MGI:3700974	Trp53inp1<tm1Acar>	MP:0000358,abnormal cell morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0001260,increased body weight|MP:0001559,hyperglycemia|MP:0002006,neoplasm|MP:0002044,increased colon adenoma incidence|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0003304,large intestinal inflammation|MP:0003674,oxidative stress|MP:0004499,increased incidence of tumors by chemical induction|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005455,increased susceptibility to weight gain|MP:0005658,increased susceptibility to diet-induced obesity|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006319,abnormal epididymal fat pad morphology|MP:0008537,increased susceptibility to induced colitis|MP:0008902,abnormal renal fat pad morphology|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010955,abnormal respiratory electron transport chain|MP:0010959,abnormal oxidative phosphorylation|MP:0011628,increased mitochondrial number|MP:0014046,abnormal mitophagy|MP:0014142,increased body fat mass|MP:0020089,increased susceptibility to diet-induced non-insulin dependent diabetes
MGI:6362806	Trp53inp2<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000702,enlarged lymph nodes|MP:0001146,abnormal testis morphology|MP:0001148,enlarged testis|MP:0001258,decreased body length|MP:0001304,cataract|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0009142,decreased prepulse inhibition
MGI:5637673	Trp53inp2<tm1Azo>	MP:0000759,abnormal skeletal muscle morphology|MP:0003960,increased lean body mass|MP:0005376,homeostasis/metabolism phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009401,increased skeletal muscle fiber diameter|MP:0009461,skeletal muscle hypertrophy|MP:0010238,increased skeletal muscle weight|MP:0030940,impaired autophagy
MGI:6342457	Trp53inp2<tm1c(KOMP)Mbp>	MP:0000966,decreased sensory neuron number|MP:0001011,abnormal superior cervical ganglion morphology|MP:0001025,abnormal sympathetic neuron morphology|MP:0003651,abnormal axon extension|MP:0009284,abnormal sympathetic neuron innervation pattern
MGI:3575501	Trp53<tm1.1Att>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4941040	Trp53<tm1.1Awbr>	MP:0001658,increased mortality induced by gamma-irradiation|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0003789,increased osteosarcoma incidence|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0008186,increased pro-B cell number|MP:0008944,decreased sensitivity to induced cell death|MP:0009317,increased follicular lymphoma incidence|MP:0009321,increased histiocytic sarcoma incidence|MP:0009542,decreased thymocyte apoptosis|MP:0010363,increased fibrosarcoma incidence
MGI:2156651	Trp53<tm1.1Brn>	MP:0002020,increased tumor incidence|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0010300,increased skin tumor incidence|MP:0010308,decreased tumor latency
MGI:4819616	Trp53<tm1.1Dgj>	MP:0002006,neoplasm|MP:0004228,decreased cellular sensitivity to ionizing radiation induced cell death|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death
MGI:6202103	Trp53<tm1.1Hwan>	MP:0004499,increased incidence of tumors by chemical induction|MP:0010831,lethality, incomplete penetrance|MP:0014040,increased cellular sensitivity to DNA damaging agent induced cell death
MGI:5550216	Trp53<tm1.1Manf>	MP:0000222,decreased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000274,enlarged heart|MP:0000333,decreased bone marrow cell number|MP:0000558,abnormal tibia morphology|MP:0000569,abnormal digit pigmentation|MP:0000585,kinked tail|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0000774,decreased brain size|MP:0000857,abnormal cerebellar foliation|MP:0000865,absent cerebellum vermis|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0001393,ataxia|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0002109,abnormal limb morphology|MP:0002123,abnormal definitive hematopoiesis|MP:0002357,abnormal spleen white pulp morphology|MP:0003179,thrombocytopenia|MP:0004097,abnormal cerebellar cortex morphology|MP:0006099,thin cerebellar granule layer|MP:0009625,abnormal abdominal lymph node morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011903,decreased hematopoietic stem cell proliferation|MP:0013177,abnormal tail tip morphology
MGI:3852473	Trp53<tm1.1Mcba>	MP:0002169,no abnormal phenotype detected
MGI:5431904	Trp53<tm1.1Rfo>	MP:0002006,neoplasm
MGI:5518934	Trp53<tm1.1Thst>	MP:0000693,spleen hyperplasia|MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002035,increased leiomyosarcoma incidence|MP:0002038,increased carcinoma incidence|MP:0002083,premature death|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0003667,increased hemangiosarcoma incidence|MP:0005387,immune system phenotype|MP:0005621,abnormal cell physiology|MP:0009542,decreased thymocyte apoptosis
MGI:5523909	Trp53<tm1.1Tldo>	MP:0000333,decreased bone marrow cell number|MP:0000575,increased foot pad pigmentation|MP:0000762,abnormal tongue morphology|MP:0000851,cerebellum hypoplasia|MP:0001116,small gonad|MP:0001265,decreased body size|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0003751,oral leukoplakia|MP:0005152,pancytopenia|MP:0005378,growth/size/body region phenotype|MP:0006050,pulmonary fibrosis|MP:0009541,increased thymocyte apoptosis|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011276,increased tail pigmentation|MP:0012400,nail dystrophy|MP:0030927,decreased telomere length
MGI:5708402	Trp53<tm1.1Umol>	MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0010308,decreased tumor latency
MGI:5431727	Trp53<tm1.1Wgu>	MP:0002006,neoplasm|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0005384,cellular phenotype|MP:0009542,decreased thymocyte apoptosis|MP:0011703,increased fibroblast proliferation
MGI:4840439	Trp53<tm1.1Xlu>	MP:0002006,neoplasm|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0005141,liver hyperplasia|MP:0008019,increased liver tumor incidence|MP:0010768,mortality/aging|MP:0012431,increased lymphoma incidence
MGI:5014809	Trp53<tm1.2Awbr>	MP:0000240,extramedullary hematopoiesis|MP:0000351,increased cell proliferation|MP:0000367,abnormal coat/ hair morphology|MP:0000691,enlarged spleen|MP:0000696,abnormal Peyer's patch morphology|MP:0000914,exencephaly|MP:0001333,absent optic nerve|MP:0001846,increased inflammatory response|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001864,vascular inflammation|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002083,premature death|MP:0002404,increased intestinal adenoma incidence|MP:0002619,abnormal lymphocyte morphology|MP:0002628,hepatic steatosis|MP:0003046,liver cirrhosis|MP:0003077,abnormal cell cycle|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0003789,increased osteosarcoma incidence|MP:0005238,increased brain size|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008000,increased ovary tumor incidence|MP:0008553,increased circulating tumor necrosis factor level|MP:0008577,increased circulating interferon-gamma level|MP:0008596,increased circulating interleukin-6 level|MP:0008623,increased circulating interleukin-3 level|MP:0008626,increased circulating interleukin-5 level|MP:0009321,increased histiocytic sarcoma incidence|MP:0009336,increased splenocyte proliferation|MP:0009542,decreased thymocyte apoptosis|MP:0010306,increased hamartoma incidence|MP:0010344,increased hibernoma incidence|MP:0020386,adipose tissue inflammation
MGI:3057305	Trp53<tm1Adv>	MP:0002051,increased skin papilloma incidence|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0010300,increased skin tumor incidence
MGI:3573778	Trp53<tm1Att>	MP:0000313,abnormal cell death|MP:0000575,increased foot pad pigmentation|MP:0003077,abnormal cell cycle|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0004045,abnormal cell cycle checkpoint function|MP:0005409,darkened coat color|MP:0006043,decreased apoptosis|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0011276,increased tail pigmentation|MP:0011278,increased ear pigmentation
MGI:6120822	Trp53<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0001488,increased startle reflex|MP:0010091,decreased circulating creatine kinase level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1857590	Trp53<tm1Brd>	MP:0000343,abnormal response to cardiac infarction|MP:0000351,increased cell proliferation|MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002032,increased sarcoma incidence|MP:0002036,increased rhabdomyosarcoma incidence|MP:0002038,increased carcinoma incidence|MP:0002083,premature death|MP:0003077,abnormal cell cycle|MP:0003204,decreased neuron apoptosis|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0003447,decreased tumor growth/size|MP:0003667,increased hemangiosarcoma incidence|MP:0003674,oxidative stress|MP:0003763,abnormal thymus physiology|MP:0003789,increased osteosarcoma incidence|MP:0003927,increased cellular glucose import|MP:0004023,abnormal chromosome number|MP:0004045,abnormal cell cycle checkpoint function|MP:0004228,decreased cellular sensitivity to ionizing radiation induced cell death|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005621,abnormal cell physiology|MP:0006043,decreased apoptosis|MP:0008009,delayed cellular replicative senescence|MP:0008944,decreased sensitivity to induced cell death|MP:0009542,decreased thymocyte apoptosis|MP:0009764,decreased susceptibility to induced morbidity/mortality|MP:0011703,increased fibroblast proliferation|MP:0012431,increased lymphoma incidence|MP:0014237,decreased tumor-free survival time
MGI:1931011	Trp53<tm1Brn>	MP:0000313,abnormal cell death|MP:0001272,increased metastatic potential|MP:0001658,increased mortality induced by gamma-irradiation|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002006,neoplasm|MP:0002013,increased pilomatricoma incidence|MP:0002016,ovary cyst|MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002038,increased carcinoma incidence|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002661,abnormal corpus epididymis morphology|MP:0002724,enhanced wound healing|MP:0003091,abnormal cell migration|MP:0003448,abnormal tumor morphology|MP:0003789,increased osteosarcoma incidence|MP:0004207,increased squamous cell carcinoma incidence|MP:0004868,increased endometrial carcinoma incidence|MP:0004896,abnormal endometrium morphology|MP:0005367,renal/urinary system phenotype|MP:0005384,cellular phenotype|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0005621,abnormal cell physiology|MP:0006283,increased medulloblastoma incidence|MP:0008014,increased lung tumor incidence|MP:0009277,increased brain tumor incidence|MP:0009704,increased skin squamous cell carcinoma incidence|MP:0010277,increased astrocytoma incidence|MP:0010299,increased mammary gland tumor incidence|MP:0010300,increased skin tumor incidence|MP:0010308,decreased tumor latency|MP:0010367,increased spindle cell carcinoma incidence|MP:0010771,integument phenotype|MP:0012043,increased myoepithelioma incidence|MP:0012431,increased lymphoma incidence|MP:0013236,ovary degeneration|MP:0014237,decreased tumor-free survival time
MGI:3043426	Trp53<tm1Elee>	MP:0000745,tremors|MP:0001393,ataxia|MP:0001525,impaired balance|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002064,seizures|MP:0002083,premature death|MP:0003631,nervous system phenotype|MP:0005238,increased brain size|MP:0006283,increased medulloblastoma incidence|MP:0009828,increased tumor latency|MP:0010278,increased glioma incidence|MP:0010299,increased mammary gland tumor incidence|MP:0012431,increased lymphoma incidence
MGI:3582594	Trp53<tm1Gev>	MP:0002024,increased T cell derived lymphoma incidence|MP:0003207,decreased cellular sensitivity to gamma-irradiation
MGI:2386273	Trp53<tm1Glo>	MP:0001272,increased metastatic potential|MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002032,increased sarcoma incidence|MP:0002038,increased carcinoma incidence|MP:0003667,increased hemangiosarcoma incidence|MP:0003789,increased osteosarcoma incidence|MP:0004207,increased squamous cell carcinoma incidence|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0009542,decreased thymocyte apoptosis|MP:0010363,increased fibrosarcoma incidence|MP:0012431,increased lymphoma incidence|MP:0014237,decreased tumor-free survival time
MGI:2157167	Trp53<tm1Holl>	MP:0002006,neoplasm|MP:0005384,cellular phenotype
MGI:2159430	Trp53<tm1Ldo>	MP:0000063,decreased bone mineral density|MP:0000416,sparse hair|MP:0000423,delayed hair regrowth|MP:0000600,liver hypoplasia|MP:0000628,abnormal mammary gland development|MP:0000694,spleen hypoplasia|MP:0001244,thin dermal layer|MP:0001263,weight loss|MP:0001940,testis hypoplasia|MP:0002048,increased lung adenoma incidence|MP:0002052,decreased tumor incidence|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0002908,delayed wound healing|MP:0003402,decreased liver weight|MP:0003446,renal hypoplasia|MP:0003786,premature aging|MP:0003918,decreased kidney weight|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0004819,decreased skeletal muscle mass|MP:0004852,decreased testis weight|MP:0004953,decreased spleen weight|MP:0005202,lethargy|MP:0005621,abnormal cell physiology|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008872,abnormal physiological response to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0031253,lordokyphosis
MGI:5550149	Trp53<tm1Manf>	MP:0002169,no abnormal phenotype detected
MGI:1857989	Trp53<tm1Mlh>	MP:0003077,abnormal cell cycle|MP:0005384,cellular phenotype|MP:0014234,decreased enterocyte apoptosis
MGI:1926340	Trp53<tm1Sia>	MP:0000218,increased leukocyte cell number|MP:0000350,abnormal cell proliferation|MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0003179,thrombocytopenia|MP:0004952,increased spleen weight|MP:0004955,increased thymus weight|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008943,increased sensitivity to induced cell death
MGI:3028920	Trp53<tm1Snj>	MP:0002052,decreased tumor incidence|MP:0004228,decreased cellular sensitivity to ionizing radiation induced cell death
MGI:3589921	Trp53<tm1Thl>	MP:0002006,neoplasm
MGI:5518935	Trp53<tm1Thst>	MP:0000693,spleen hyperplasia|MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002038,increased carcinoma incidence|MP:0002083,premature death|MP:0002627,increased teratoma incidence|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0003674,oxidative stress|MP:0005621,abnormal cell physiology|MP:0009542,decreased thymocyte apoptosis
MGI:1857263	Trp53<tm1Tyj>	MP:0000352,decreased cell proliferation|MP:0000512,intestinal ulcer|MP:0001204,decreased sensitivity to skin irradiation|MP:0001263,weight loss|MP:0001330,abnormal optic nerve morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001545,abnormal hematopoietic system physiology|MP:0001625,cardiac hypertrophy|MP:0001648,abnormal apoptosis|MP:0001770,abnormal iron level|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002006,neoplasm|MP:0002019,abnormal tumor incidence|MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002026,increased leukemia incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0002035,increased leiomyosarcoma incidence|MP:0002036,increased rhabdomyosarcoma incidence|MP:0002038,increased carcinoma incidence|MP:0002052,decreased tumor incidence|MP:0002083,premature death|MP:0002627,increased teratoma incidence|MP:0002700,increased opacity of vitreous body|MP:0002792,abnormal retina vasculature morphology|MP:0002864,abnormal ocular fundus morphology|MP:0002947,increased hemangioma incidence|MP:0003010,decreased mortality induced by ionizing radiation|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0003269,colon polyps|MP:0003299,gastric polyps|MP:0003448,abnormal tumor morphology|MP:0003667,increased hemangiosarcoma incidence|MP:0003789,increased osteosarcoma incidence|MP:0004024,aneuploidy|MP:0004025,polyploidy|MP:0004045,abnormal cell cycle checkpoint function|MP:0004207,increased squamous cell carcinoma incidence|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0004228,decreased cellular sensitivity to ionizing radiation induced cell death|MP:0004478,increased testicular teratoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0005195,abnormal posterior eye segment morphology|MP:0005601,increased angiogenesis|MP:0005637,abnormal iron homeostasis|MP:0006035,abnormal mitochondrial morphology|MP:0006219,optic nerve degeneration|MP:0006221,optic nerve hypoplasia|MP:0006283,increased medulloblastoma incidence|MP:0006414,decreased T cell apoptosis|MP:0008011,intestine polyps|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008469,abnormal protein level|MP:0008770,decreased survivor rate|MP:0009153,increased pancreas tumor incidence|MP:0009308,increased adenocarcinoma incidence|MP:0009321,increased histiocytic sarcoma incidence|MP:0009341,decreased splenocyte apoptosis|MP:0009542,decreased thymocyte apoptosis|MP:0009937,abnormal neuron differentiation|MP:0010289,increased urinary system tumor incidence|MP:0010307,abnormal tumor latency|MP:0010363,increased fibrosarcoma incidence|MP:0010383,increased adenoma incidence|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011703,increased fibroblast proliferation|MP:0012431,increased lymphoma incidence|MP:0014237,decreased tumor-free survival time|MP:0021107,retina fold
MGI:1927802	Trp53<tm1Wahl>	MP:0002020,increased tumor incidence|MP:0003077,abnormal cell cycle|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0011703,increased fibroblast proliferation|MP:0013502,decreased fibroblast apoptosis
MGI:2680218	Trp53<tm1Xu>	MP:0002006,neoplasm|MP:0004228,decreased cellular sensitivity to ionizing radiation induced cell death|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0009258,abnormal thymocyte apoptosis
MGI:5476675	Trp53<tm1Yjc>	MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001212,skin lesions|MP:0002006,neoplasm|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002357,abnormal spleen white pulp morphology|MP:0002362,abnormal spleen marginal zone morphology|MP:0005387,immune system phenotype|MP:0009318,increased splenic marginal zone lymphoma incidence|MP:0009341,decreased splenocyte apoptosis
MGI:4819617	Trp53<tm2.1Dgj>	MP:0002006,neoplasm|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death
MGI:5432141	Trp53<tm2.1Kasa>	MP:0002006,neoplasm|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:5142476	Trp53<tm2.1Snj>	MP:0000914,exencephaly|MP:0003077,abnormal cell cycle|MP:0003763,abnormal thymus physiology|MP:0004228,decreased cellular sensitivity to ionizing radiation induced cell death|MP:0008009,delayed cellular replicative senescence|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011703,increased fibroblast proliferation
MGI:6479078	Trp53<tm2.1Thst>	MP:0002019,abnormal tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002032,increased sarcoma incidence|MP:0002038,increased carcinoma incidence|MP:0002083,premature death|MP:0006262,increased testis tumor incidence|MP:0014237,decreased tumor-free survival time
MGI:5523990	Trp53<tm2.1Tldo>	MP:0010768,mortality/aging
MGI:3039264	Trp53<tm2.1Tyj>	MP:0000067,osteopetrosis|MP:0000351,increased cell proliferation|MP:0001272,increased metastatic potential|MP:0002083,premature death|MP:0003207,decreased cellular sensitivity to gamma-irradiation
MGI:5708410	Trp53<tm2.1Umol>	MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death
MGI:5431730	Trp53<tm2.1Wgu>	MP:0002006,neoplasm|MP:0003077,abnormal cell cycle|MP:0005384,cellular phenotype|MP:0008009,delayed cellular replicative senescence|MP:0009542,decreased thymocyte apoptosis|MP:0011703,increased fibroblast proliferation
MGI:3775090	Trp53<tm2Att>	MP:0003077,abnormal cell cycle|MP:0008008,early cellular replicative senescence|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0011091,prenatal lethality, complete penetrance
MGI:2450287	Trp53<tm2Brd>	MP:0002020,increased tumor incidence|MP:0005409,darkened coat color
MGI:3032598	Trp53<tm2Glo>	MP:0001648,abnormal apoptosis|MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0012431,increased lymphoma incidence|MP:0014237,decreased tumor-free survival time
MGI:3794646	Trp53<tm2Holl>	MP:0002169,no abnormal phenotype detected
MGI:2388703	Trp53<tm2Mok>	MP:0002020,increased tumor incidence|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death
MGI:6479073	Trp53<tm2Thst>	MP:0002083,premature death
MGI:3039263	Trp53<tm2Tyj>	MP:0002006,neoplasm|MP:0008008,early cellular replicative senescence
MGI:3623943	Trp53<tm2Wahl>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000274,enlarged heart|MP:0000333,decreased bone marrow cell number|MP:0002123,abnormal definitive hematopoiesis|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002833,increased heart weight|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0003717,pallor|MP:0003992,increased mortality induced by ionizing radiation|MP:0008477,decreased spleen red pulp amount|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0010768,mortality/aging
MGI:3629221	Trp53<tm2Xu>	MP:0002020,increased tumor incidence|MP:0005095,decreased T cell proliferation|MP:0006414,decreased T cell apoptosis|MP:0009828,increased tumor latency
MGI:3528279	Trp53<tm3.1Glo>	MP:0000218,increased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0001262,decreased body weight|MP:0001272,increased metastatic potential|MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002032,increased sarcoma incidence|MP:0002038,increased carcinoma incidence|MP:0002083,premature death|MP:0002811,macrocytic anemia|MP:0003077,abnormal cell cycle|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0003789,increased osteosarcoma incidence|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011703,increased fibroblast proliferation|MP:0012431,increased lymphoma incidence|MP:0021085,increased DNA replication|MP:0031058,hepatosplenomegaly
MGI:5465276	Trp53<tm3.1Holl>	MP:0005621,abnormal cell physiology|MP:0009541,increased thymocyte apoptosis
MGI:3039266	Trp53<tm3.1Tyj>	MP:0000351,increased cell proliferation|MP:0001272,increased metastatic potential|MP:0001883,increased mammary adenocarcinoma incidence|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002038,increased carcinoma incidence|MP:0002083,premature death|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0003331,increased hepatocellular carcinoma incidence|MP:0004207,increased squamous cell carcinoma incidence|MP:0010300,increased skin tumor incidence
MGI:5140077	Trp53<tm3Att>	MP:0005384,cellular phenotype
MGI:3039265	Trp53<tm3Tyj>	MP:0001883,increased mammary adenocarcinoma incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0002947,increased hemangioma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0008008,early cellular replicative senescence|MP:0008014,increased lung tumor incidence|MP:0008411,decreased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0010299,increased mammary gland tumor incidence|MP:0010300,increased skin tumor incidence|MP:0012431,increased lymphoma incidence
MGI:3624429	Trp53<tm3Wahl>	MP:0000351,increased cell proliferation|MP:0003077,abnormal cell cycle|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0006043,decreased apoptosis|MP:0009828,increased tumor latency|MP:0010768,mortality/aging
MGI:3687352	Trp53<tm3Xu>	MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0010768,mortality/aging
MGI:5000495	Trp53<tm4.1Glo>	MP:0002006,neoplasm|MP:0010768,mortality/aging
MGI:5140078	Trp53<tm4Att>	MP:0000026,abnormal inner ear morphology|MP:0000063,decreased bone mineral density|MP:0000088,short mandible|MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000352,decreased cell proliferation|MP:0000428,abnormal craniofacial morphology|MP:0000527,abnormal kidney development|MP:0000706,small thymus|MP:0000914,exencephaly|MP:0002113,abnormal skeleton development|MP:0002177,abnormal outer ear morphology|MP:0002633,persistent truncus arteriosus|MP:0002989,small kidney|MP:0003207,decreased cellular sensitivity to gamma-irradiation|MP:0003720,abnormal neural tube closure|MP:0004351,short humerus|MP:0005170,cleft upper lip|MP:0006042,increased apoptosis|MP:0006043,decreased apoptosis|MP:0006126,abnormal cardiac outflow tract development|MP:0009908,protruding tongue|MP:0010402,ventricular septal defect|MP:0010715,retina coloboma|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0020010,decreased bone mineral density of femur|MP:0021184,decreased bone mineral density of humerus|MP:0030073,square face
MGI:5000493	Trp53<tm4Glo>	MP:0002024,increased T cell derived lymphoma incidence|MP:0002032,increased sarcoma incidence|MP:0009308,increased adenocarcinoma incidence|MP:0010367,increased spindle cell carcinoma incidence|MP:0012431,increased lymphoma incidence|MP:0014237,decreased tumor-free survival time
MGI:3056071	Trp53<tm4Tyj>	MP:0002023,increased B cell derived lymphoma incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0003207,decreased cellular sensitivity to gamma-irradiation
MGI:3762530	Trp53<tm4Xu>	MP:0002006,neoplasm|MP:0002019,abnormal tumor incidence|MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002032,increased sarcoma incidence|MP:0004029,spontaneous chromosome breakage|MP:0004045,abnormal cell cycle checkpoint function|MP:0005384,cellular phenotype|MP:0006043,decreased apoptosis|MP:0012431,increased lymphoma incidence|MP:0014237,decreased tumor-free survival time
MGI:3702077	Trp53<tm5Tyj>	MP:0000313,abnormal cell death|MP:0003077,abnormal cell cycle|MP:0004023,abnormal chromosome number|MP:0005384,cellular phenotype|MP:0010537,tumor regression
MGI:3699248	Trp53<tm5Wahl>	MP:0005384,cellular phenotype|MP:0010768,mortality/aging
MGI:3762531	Trp53<tm5Xu>	MP:0004029,spontaneous chromosome breakage|MP:0006043,decreased apoptosis
MGI:3699247	Trp53<tm6Wahl>	MP:0005384,cellular phenotype|MP:0010768,mortality/aging
MGI:4430743	Trp53<tm6Xu>	MP:0001272,increased metastatic potential|MP:0002024,increased T cell derived lymphoma incidence|MP:0012431,increased lymphoma incidence|MP:0014237,decreased tumor-free survival time
MGI:4456121	Trp53<tm7.1Xu>	MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002083,premature death|MP:0003763,abnormal thymus physiology|MP:0004045,abnormal cell cycle checkpoint function|MP:0008866,chromosomal instability|MP:0009542,decreased thymocyte apoptosis|MP:0012431,increased lymphoma incidence
MGI:4946291	Trp53<tm8Xu>	MP:0011100,preweaning lethality, complete penetrance
MGI:5702898	Trp63<m1Mhda>	MP:0000428,abnormal craniofacial morphology|MP:0000549,decreased limb number|MP:0002169,no abnormal phenotype detected|MP:0011091,prenatal lethality, complete penetrance
MGI:5502576	Trp63<tm1.1(cre)Ssig>	MP:0000428,abnormal craniofacial morphology|MP:0000468,abnormal esophageal epithelium morphology|MP:0000549,decreased limb number|MP:0001217,absent epidermis|MP:0002169,no abnormal phenotype detected
MGI:4355528	Trp63<tm1.1Elrf>	MP:0000160,kyphosis|MP:0000379,decreased hair follicle number|MP:0000468,abnormal esophageal epithelium morphology|MP:0000540,abnormal urinary bladder urothelium morphology|MP:0001208,blistering|MP:0001209,spontaneous skin ulceration|MP:0001792,impaired wound healing|MP:0002083,premature death|MP:0003675,kidney cyst|MP:0003786,premature aging|MP:0004024,aneuploidy|MP:0005501,abnormal skin physiology|MP:0008008,early cellular replicative senescence|MP:0008866,chromosomal instability|MP:0010768,mortality/aging|MP:0010787,gastric cyst|MP:0011102,embryonic lethality, incomplete penetrance
MGI:3795257	Trp63<tm1Aam>	MP:0000428,abnormal craniofacial morphology|MP:0000557,absent hindlimb|MP:0001675,abnormal ectoderm development|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0004575,small limb buds|MP:0005230,ectrodactyly|MP:0005306,abnormal phalanx morphology|MP:0014321,short forelimb
MGI:1861713	Trp63<tm1Brd>	MP:0000378,absent hair follicles|MP:0000553,absent radius|MP:0000555,absent carpal bone|MP:0000557,absent hindlimb|MP:0001191,abnormal skin condition|MP:0001196,shiny skin|MP:0001201,translucent skin|MP:0001216,abnormal epidermal layer morphology|MP:0001241,absent epidermis stratum corneum|MP:0001677,absent apical ectodermal ridge|MP:0002115,abnormal limb bone morphology|MP:0002796,impaired skin barrier function|MP:0003743,abnormal facial morphology|MP:0004360,absent ulna|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004575,small limb buds|MP:0005296,abnormal humerus morphology|MP:0005306,abnormal phalanx morphology|MP:0005501,abnormal skin physiology|MP:0009560,absent epidermis stratum granulosum|MP:0009614,absent epidermis stratum spinosum|MP:0011087,neonatal lethality, complete penetrance|MP:0014321,short forelimb|MP:0030610,absent teeth
MGI:5468661	Trp63<tm1Cmis>	MP:0000111,cleft palate|MP:0001208,blistering|MP:0001216,abnormal epidermal layer morphology|MP:0003453,abnormal keratinocyte physiology|MP:0011087,neonatal lethality, complete penetrance
MGI:4355527	Trp63<tm1Elrf>	MP:0005376,homeostasis/metabolism phenotype|MP:0010771,integument phenotype
MGI:1934269	Trp63<tm1Fmc>	MP:0000117,absent tooth placode|MP:0000378,absent hair follicles|MP:0000428,abnormal craniofacial morphology|MP:0000468,abnormal esophageal epithelium morphology|MP:0000469,abnormal esophageal squamous epithelium morphology|MP:0000471,abnormal stomach epithelium morphology|MP:0000472,abnormal stomach non-glandular epithelium morphology|MP:0000540,abnormal urinary bladder urothelium morphology|MP:0000543,absent urinary bladder urothelium|MP:0000544,thin urinary bladder urothelium|MP:0000549,decreased limb number|MP:0000550,abnormal forelimb morphology|MP:0000553,absent radius|MP:0000555,absent carpal bone|MP:0000557,absent hindlimb|MP:0000561,adactyly|MP:0000614,absent salivary gland|MP:0000629,absent mammary gland|MP:0000648,absent sebaceous gland|MP:0000766,absent tongue squamous epithelium|MP:0001119,abnormal female reproductive system morphology|MP:0001137,abnormal uterine cervix epithelium morphology|MP:0001140,abnormal vagina epithelium morphology|MP:0001159,absent prostate gland|MP:0001217,absent epidermis|MP:0001284,absent vibrissae|MP:0001341,absent eyelids|MP:0001347,absent lacrimal glands|MP:0001677,absent apical ectodermal ridge|MP:0002018,increased malignant tumor incidence|MP:0002020,increased tumor incidence|MP:0002048,increased lung adenoma incidence|MP:0002083,premature death|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0002637,small uterus|MP:0003125,abnormal septation of the cloaca|MP:0003160,abnormal esophagus development|MP:0003320,rectovaginal fistula|MP:0003384,abnormal ventral body wall morphology|MP:0003575,absent oviduct|MP:0003578,absent ovary|MP:0003786,premature aging|MP:0003809,abnormal hair shaft morphology|MP:0004207,increased squamous cell carcinoma incidence|MP:0004540,small maxilla|MP:0004575,small limb buds|MP:0004592,small mandible|MP:0004684,intervertebral disk degeneration|MP:0005213,gastric metaplasia|MP:0005389,reproductive system phenotype|MP:0005494,esophagogastric junction metaplasia|MP:0005650,abnormal limb bud morphology|MP:0006042,increased apoptosis|MP:0006043,decreased apoptosis|MP:0006279,abnormal limb development|MP:0009101,clitoris hypoplasia|MP:0009321,increased histiocytic sarcoma incidence|MP:0009655,abnormal secondary palate development|MP:0009736,abnormal prostate gland branching morphogenesis|MP:0010942,abnormal respiratory epithelium morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0012062,small tail bud
MGI:5140823	Trp63<tm1Sin>	MP:0000111,cleft palate|MP:0000378,absent hair follicles|MP:0000648,absent sebaceous gland|MP:0001217,absent epidermis|MP:0001429,dehydration|MP:0001672,abnormal embryo development|MP:0002060,abnormal skin morphology|MP:0002109,abnormal limb morphology|MP:0002655,abnormal keratinocyte morphology|MP:0002656,abnormal keratinocyte differentiation|MP:0003453,abnormal keratinocyte physiology|MP:0003935,abnormal craniofacial development|MP:0003941,abnormal skin development|MP:0004200,decreased fetal size|MP:0006279,abnormal limb development|MP:0008789,abnormal olfactory epithelium morphology|MP:0009584,decreased keratinocyte proliferation|MP:0009655,abnormal secondary palate development|MP:0011087,neonatal lethality, complete penetrance|MP:0013530,abnormal periderm morphology
MGI:5616190	Trp63<tm2.1Aam>	MP:0002006,neoplasm|MP:0005380,embryo phenotype|MP:0008007,abnormal cellular replicative senescence
MGI:5576519	Trp63<tm2.2Elrf>	MP:0001211,wrinkled skin|MP:0001216,abnormal epidermal layer morphology|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001236,abnormal epidermis stratum spinosum morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011160,dermal-epidermal separation
MGI:5616188	Trp63<tm2Aam>	MP:0008007,abnormal cellular replicative senescence
MGI:1934580	Trp63<tm2Brd>	MP:0000352,decreased cell proliferation|MP:0000414,alopecia|MP:0000428,abnormal craniofacial morphology|MP:0000492,abnormal rectum morphology|MP:0000493,rectal prolapse|MP:0000539,distended urinary bladder|MP:0000540,abnormal urinary bladder urothelium morphology|MP:0000543,absent urinary bladder urothelium|MP:0000553,absent radius|MP:0000555,absent carpal bone|MP:0000557,absent hindlimb|MP:0000702,enlarged lymph nodes|MP:0000746,weakness|MP:0000764,abnormal tongue epithelium morphology|MP:0001137,abnormal uterine cervix epithelium morphology|MP:0001191,abnormal skin condition|MP:0001196,shiny skin|MP:0001201,translucent skin|MP:0001209,spontaneous skin ulceration|MP:0001212,skin lesions|MP:0001216,abnormal epidermal layer morphology|MP:0001241,absent epidermis stratum corneum|MP:0001270,distended abdomen|MP:0001394,circling|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0001677,absent apical ectodermal ridge|MP:0001859,kidney inflammation|MP:0001874,acanthosis|MP:0001914,hemorrhage|MP:0002060,abnormal skin morphology|MP:0002083,premature death|MP:0002109,abnormal limb morphology|MP:0002115,abnormal limb bone morphology|MP:0002160,abnormal reproductive system morphology|MP:0002406,increased susceptibility to infection|MP:0002796,impaired skin barrier function|MP:0003257,abnormal abdominal wall morphology|MP:0003704,abnormal hair follicle development|MP:0003743,abnormal facial morphology|MP:0003786,premature aging|MP:0004360,absent ulna|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004575,small limb buds|MP:0005034,abnormal anus morphology|MP:0005296,abnormal humerus morphology|MP:0005306,abnormal phalanx morphology|MP:0005369,muscle phenotype|MP:0005501,abnormal skin physiology|MP:0006000,abnormal cornea epithelium morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006042,increased apoptosis|MP:0008008,early cellular replicative senescence|MP:0008789,abnormal olfactory epithelium morphology|MP:0009228,uterine cervix inflammation|MP:0009560,absent epidermis stratum granulosum|MP:0009614,absent epidermis stratum spinosum|MP:0010116,abnormal primitive urogenital sinus morphology|MP:0010146,umbilical hernia|MP:0011087,neonatal lethality, complete penetrance|MP:0011774,abnormal urinary bladder detrusor smooth muscle morphology|MP:0012067,abnormal olfactory gland morphology|MP:0012069,abnormal horizontal basal cell of olfactory epithelium morphology|MP:0013282,urinary bladder exstrophy|MP:0014321,short forelimb|MP:0020823,absent pubic symphysis|MP:0030610,absent teeth
MGI:3693853	Trp63<tm2Fmc>	MP:0004228,decreased cellular sensitivity to ionizing radiation induced cell death
MGI:6477383	Trp63<tm3.1Aam>	MP:0000111,cleft palate|MP:0000547,short limbs|MP:0001672,abnormal embryo development|MP:0002109,abnormal limb morphology|MP:0003453,abnormal keratinocyte physiology|MP:0003941,abnormal skin development|MP:0009584,decreased keratinocyte proliferation|MP:0011089,perinatal lethality, complete penetrance
MGI:2385473	Trp63<tm3.1Brd>	MP:0000352,decreased cell proliferation|MP:0008008,early cellular replicative senescence
MGI:6477385	Trp63<tm3.2Aam>	MP:0000547,short limbs|MP:0001672,abnormal embryo development|MP:0002109,abnormal limb morphology|MP:0003941,abnormal skin development|MP:0005382,craniofacial phenotype|MP:0011089,perinatal lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2385474	Trp63<tm3.2Brd>	MP:0000378,absent hair follicles|MP:0000557,absent hindlimb|MP:0014321,short forelimb
MGI:6477377	Trp63<tm3Aam>	MP:0000111,cleft palate|MP:0000116,abnormal tooth development|MP:0000414,alopecia|MP:0000420,ruffled hair|MP:0000547,short limbs|MP:0001672,abnormal embryo development|MP:0002092,abnormal eye morphology|MP:0002109,abnormal limb morphology|MP:0003453,abnormal keratinocyte physiology|MP:0003941,abnormal skin development|MP:0004033,supernumerary teeth|MP:0009546,absent gastric milk in neonates|MP:0009584,decreased keratinocyte proliferation|MP:0009887,abnormal palatal shelf fusion at midline|MP:0011089,perinatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0012400,nail dystrophy|MP:0030493,abnormal tooth root morphology
MGI:2385472	Trp63<tm3Brd>	MP:0002169,no abnormal phenotype detected
MGI:6149215	Trp73<em1(IMPC)H>	MP:0004953,decreased spleen weight|MP:0005505,thrombocytosis|MP:0005565,increased blood urea nitrogen level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4365581	Trp73<tm1(cre)Agof>	MP:0000792,abnormal cortical marginal zone morphology|MP:0000820,abnormal choroid plexus morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001921,reduced fertility|MP:0002243,abnormal vomeronasal organ morphology|MP:0003203,increased neuron apoptosis|MP:0003232,abnormal forebrain development|MP:0008031,decreased Cajal-Retzius cell number|MP:0014592,decreased gonadotropin-releasing hormone neuron number
MGI:1859911	Trp73<tm1Fmc>	MP:0000344,absent Cajal-Retzius cell|MP:0000440,domed cranium|MP:0000465,gastrointestinal hemorrhage|MP:0000487,absent enterocytes|MP:0000503,excessive digestive secretion|MP:0000807,abnormal hippocampus morphology|MP:0000808,abnormal hippocampus development|MP:0000812,abnormal dentate gyrus morphology|MP:0000825,dilated lateral ventricle|MP:0001265,decreased body size|MP:0001355,submission towards male mice|MP:0001380,decreased male mating frequency|MP:0001788,periorbital edema|MP:0001850,increased susceptibility to otitis media|MP:0001852,conjunctivitis|MP:0001867,rhinitis|MP:0001872,sinus inflammation|MP:0001891,hydrocephaly|MP:0001893,non-obstructive hydrocephaly|MP:0001911,abnormal cerebrospinal fluid production|MP:0001915,intracranial hemorrhage|MP:0001917,intraventricular hemorrhage|MP:0001926,female infertility|MP:0002006,neoplasm|MP:0002018,increased malignant tumor incidence|MP:0002020,increased tumor incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002083,premature death|MP:0002243,abnormal vomeronasal organ morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002499,chronic inflammation|MP:0003667,increased hemangiosarcoma incidence|MP:0005150,cachexia|MP:0008143,abnormal dendrite morphology|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0009485,distended ileum|MP:0009939,abnormal hippocampus neuron morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014746,abnormal hippocampal mossy fiber innervation pattern
MGI:3822523	Trp73<tm1Mak>	MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0001672,abnormal embryo development|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001928,abnormal ovulation|MP:0002024,increased T cell derived lymphoma incidence|MP:0002027,increased lung adenocarcinoma incidence|MP:0002038,increased carcinoma incidence|MP:0002083,premature death|MP:0003077,abnormal cell cycle|MP:0003667,increased hemangiosarcoma incidence|MP:0003718,maternal effect|MP:0004023,abnormal chromosome number|MP:0004025,polyploidy|MP:0004499,increased incidence of tumors by chemical induction|MP:0005431,decreased oocyte number|MP:0008143,abnormal dendrite morphology|MP:0008871,abnormal ovarian follicle number|MP:0009648,abnormal superovulation|MP:0009761,abnormal meiotic spindle morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011121,decreased primordial ovarian follicle number|MP:0012431,increased lymphoma incidence|MP:0014445,abnormal spindle assembly in female meiosis|MP:0031422,failure of superovulation
MGI:4442798	Trp73<tm2Mak>	MP:0000788,abnormal cerebral cortex morphology|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002229,neurodegeneration|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008943,increased sensitivity to induced cell death|MP:0008948,decreased neuron number|MP:0009541,increased thymocyte apoptosis|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6161425	Trpa1<em1(IMPC)J>	MP:0001312,abnormal cornea morphology|MP:0001529,abnormal vocalization|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount
MGI:6199997	Trpa1<m1Btlr>	MP:0003460,decreased fear-related response
MGI:6200002	Trpa1<m2Btlr>	MP:0003460,decreased fear-related response
MGI:4458079	Trpa1<tm1.1Bju>	MP:0002330,abnormal bronchial provocation|MP:0004811,abnormal neuron physiology|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010055,abnormal sensory neuron physiology
MGI:3692770	Trpa1<tm1Jul>	MP:0002498,abnormal acute inflammation|MP:0002733,abnormal thermal nociception|MP:0002734,abnormal mechanical nociception|MP:0004811,abnormal neuron physiology|MP:0005407,hyperalgesia|MP:0008531,increased chemical nociceptive threshold
MGI:3624810	Trpa1<tm1Kykw>	MP:0001973,increased thermal nociceptive threshold|MP:0001986,abnormal taste sensitivity|MP:0003663,abnormal thermosensation|MP:0005498,hyporesponsive to tactile stimuli|MP:0011968,decreased threshold for auditory brainstem response
MGI:3814429	Trpa1<tm2.1Kykw>	MP:0003043,hypoalgesia
MGI:3814427	Trpa1<tm2Kykw>	MP:0002169,no abnormal phenotype detected
MGI:6257428	Trpc1<em1(IMPC)H>	MP:0001417,decreased exploration in new environment|MP:0002968,increased circulating alkaline phosphatase level|MP:0004952,increased spleen weight
MGI:6283669	Trpc1<m1Btlr>	MP:0001260,increased body weight
MGI:6283673	Trpc1<M2Btlr>	MP:0001260,increased body weight
MGI:6283882	Trpc1<m3Btlr>	MP:0001260,increased body weight
MGI:3764882	Trpc1<tm1Lbi>	MP:0000623,decreased salivation|MP:0001260,increased body weight|MP:0001264,increased body size|MP:0003463,abnormal single cell response|MP:0003631,nervous system phenotype|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0013300,abnormal submandibular gland physiology
MGI:6156166	Trpc2<em1(IMPC)Rbrc>	MP:0002152,abnormal brain morphology
MGI:3529779	Trpc2<Gt(OST448844)Lex>	MP:0001552,increased circulating triglyceride level|MP:0005178,increased circulating cholesterol level
MGI:2657154	Trpc2<tm1Dlc>	MP:0000968,abnormal sensory neuron innervation pattern|MP:0001355,submission towards male mice|MP:0001375,abnormal mating preference|MP:0002243,abnormal vomeronasal organ morphology|MP:0002272,abnormal nervous system electrophysiology|MP:0002590,increased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0003656,abnormal erythrocyte physiology|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0009945,abnormal accessory olfactory bulb morphology|MP:0011176,abnormal erythroblast morphology
MGI:3694003	Trpc2<tm1Mom>	MP:0004924,abnormal behavior|MP:0011678,abnormal vomeronasal sensory neuron physiology
MGI:2179812	Trpc2<tm1Rax>	MP:0001355,submission towards male mice|MP:0001375,abnormal mating preference|MP:0002272,abnormal nervous system electrophysiology|MP:0002566,abnormal sexual interaction|MP:0003862,decreased aggression towards male mice
MGI:3689326	Trpc3<Mwk>	MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0002083,premature death|MP:0002272,abnormal nervous system electrophysiology|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:3810122	Trpc3<tm1.1Akon>	MP:0001406,abnormal gait|MP:0001524,impaired limb coordination|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003631,nervous system phenotype|MP:0005253,abnormal eye physiology
MGI:5461709	Trpc3<tm1.1Bmil>	MP:0005397,hematopoietic system phenotype
MGI:5451202	Trpc3<tm1.2Akon>	MP:0005387,immune system phenotype
MGI:5550592	Trpc3<tm1b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:6765363	Trpc4ap<em1Cya>	MP:0001363,increased anxiety-related response|MP:0002079,increased circulating insulin level|MP:0005166,decreased susceptibility to injury|MP:0005331,insulin resistance|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008428,abnormal spatial working memory|MP:0013279,increased fasting circulating glucose level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:4362238	Trpc4ap<tm1a(KOMP)Wtsi>	MP:0008858,abnormal hair cycle anagen phase
MGI:5615468	Trpc4<tm1.1Clph>	MP:0001364,decreased anxiety-related response|MP:0003463,abnormal single cell response|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0011270,decreased excitatory postsynaptic current amplitude
MGI:2387666	Trpc4<tm1Bni>	MP:0005591,decreased vasodilation
MGI:5427696	Trpc4<tm1Dgen>	MP:0002169,no abnormal phenotype detected
MGI:3849324	Trpc5<tm1.1Clph>	MP:0001364,decreased anxiety-related response|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003459,increased fear-related response|MP:0003460,decreased fear-related response|MP:0005121,decreased circulating prolactin level|MP:0005402,abnormal action potential|MP:0009006,prolonged estrous cycle
MGI:5474572	Trpc5<tm1.1Lbi>	MP:0001473,reduced long-term potentiation|MP:0002887,decreased susceptibility to pharmacologically induced seizures|MP:0005386,behavior/neurological phenotype|MP:0008236,decreased susceptibility to neuronal excitotoxicity
MGI:6383454	Trpc5<tm1.1Mfre>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002773,decreased circulating luteinizing hormone level|MP:0003355,decreased ovulation rate|MP:0005121,decreased circulating prolactin level|MP:0005402,abnormal action potential|MP:0009006,prolonged estrous cycle|MP:0009011,prolonged diestrus|MP:0009016,abnormal estrus
MGI:6383455	Trpc5<tm1.2Mfre>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0005121,decreased circulating prolactin level|MP:0005402,abnormal action potential|MP:0009006,prolonged estrous cycle
MGI:5427697	Trpc6<tm1Dgen>	MP:0001973,increased thermal nociceptive threshold
MGI:3623135	Trpc6<tm1Lbi>	MP:0000250,abnormal vasoconstriction|MP:0002842,increased systemic arterial blood pressure|MP:0003025,increased vasoconstriction|MP:0005253,abnormal eye physiology|MP:0005595,abnormal vascular smooth muscle physiology
MGI:5296004	Trpc7<tm1.1Lbi>	MP:0005253,abnormal eye physiology
MGI:6361179	Trpd52l3<em1Osb>	MP:0005389,reproductive system phenotype
MGI:7620516	Trpm1<nob11>	MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005551,abnormal eye electrophysiology|MP:0012029,abnormal electroretinogram waveform feature|MP:0012671,retina spots|MP:0020439,absent b-wave
MGI:4867502	Trpm1<rd15>	MP:0001326,retina degeneration|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008519,thin retina outer plexiform layer|MP:0020439,absent b-wave
MGI:5636954	Trpm1<tm1b(KOMP)Wtsi>	MP:0001513,limb grasping|MP:0001556,increased circulating HDL cholesterol level|MP:0002546,mydriasis|MP:0005293,impaired glucose tolerance|MP:0006243,impaired pupillary reflex|MP:0010090,increased circulating creatine kinase level
MGI:3528857	Trpm1<tm1Lex>	MP:0002090,abnormal vision|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005253,abnormal eye physiology|MP:0005551,abnormal eye electrophysiology
MGI:4421441	Trpm1<tm1Tfur>	MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology
MGI:4867880	Trpm1<tvrm27>	MP:0003484,abnormal channel response|MP:0004021,abnormal rod electrophysiology|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology
MGI:6257752	Trpm2<em1(IMPC)H>	MP:0002941,increased circulating alanine transaminase level
MGI:5284866	Trpm2<tm1.1Alp>	MP:0002412,increased susceptibility to bacterial infection|MP:0003332,liver abscess|MP:0008567,decreased interferon-gamma secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0008618,decreased circulating interleukin-12 level|MP:0008648,decreased circulating interleukin-12b level|MP:0008664,decreased interleukin-12 secretion|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:5500054	Trpm2<tm1.1Jych>	MP:0000278,abnormal myocardial fiber morphology|MP:0003674,oxidative stress|MP:0004215,abnormal myocardial fiber physiology|MP:0004485,increased response of heart to induced stress|MP:0005140,decreased cardiac muscle contractility|MP:0010579,increased heart left ventricle size
MGI:5007395	Trpm2<tm1Lex>	MP:0002169,no abnormal phenotype detected
MGI:5522800	Trpm2<tm1Lhj>	MP:0002446,abnormal macrophage morphology|MP:0002451,abnormal macrophage physiology
MGI:3803341	Trpm2<tm1Yamo>	MP:0001360,abnormal social investigation|MP:0001363,increased anxiety-related response|MP:0001876,decreased inflammatory response|MP:0002442,abnormal leukocyte physiology|MP:0002451,abnormal macrophage physiology|MP:0004994,abnormal brain wave pattern|MP:0008719,impaired neutrophil recruitment|MP:0008750,abnormal interferon level|MP:0008751,abnormal interleukin level|MP:0009745,abnormal behavioral response to xenobiotic
MGI:6727113	Trpm3<em1Alsh>	MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001306,small lens|MP:0003236,abnormal lens capsule morphology|MP:0003237,abnormal lens epithelium morphology|MP:0005199,abnormal iris pigment epithelium|MP:0005389,reproductive system phenotype|MP:0010259,anterior polar cataract|MP:0010768,mortality/aging|MP:0020486,abnormal lens topology
MGI:6200254	Trpm3<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:3528836	Trpm3<tm1Lex>	MP:0001297,microphthalmia|MP:0001306,small lens|MP:0001973,increased thermal nociceptive threshold|MP:0002736,abnormal nociception after inflammation|MP:0003663,abnormal thermosensation|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0008531,increased chemical nociceptive threshold|MP:0010055,abnormal sensory neuron physiology|MP:0010768,mortality/aging
MGI:3817408	Trpm4<tm1.1Knt>	MP:0002376,abnormal dendritic cell physiology|MP:0008127,decreased dendritic cell number
MGI:3700529	Trpm4<tm1.1Mfre>	MP:0003070,increased vascular permeability|MP:0004231,abnormal calcium ion homeostasis|MP:0005596,increased susceptibility to type I hypersensitivity reaction
MGI:2653340	Trpm5<tm1Csz>	MP:0001985,abnormal gustatory system physiology|MP:0001986,abnormal taste sensitivity|MP:0004209,abnormal sweet taste sensitivity|MP:0004210,abnormal bitter taste sensitivity
MGI:3604455	Trpm5<tm1Dgen>	MP:0001986,abnormal taste sensitivity|MP:0002169,no abnormal phenotype detected
MGI:3612408	Trpm5<tm1Sdmk>	MP:0001986,abnormal taste sensitivity|MP:0004209,abnormal sweet taste sensitivity|MP:0004210,abnormal bitter taste sensitivity|MP:0004211,abnormal sour taste sensitivity|MP:0004212,abnormal salty taste sensitivity|MP:0004213,abnormal umami taste sensitivity
MGI:4366769	Trpm6<tm1.1Rws>	MP:0000445,short snout|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0001919,abnormal reproductive system physiology|MP:0002083,premature death|MP:0003720,abnormal neural tube closure|MP:0003743,abnormal facial morphology|MP:0003935,abnormal craniofacial development|MP:0004200,decreased fetal size|MP:0005297,spina bifida occulta|MP:0009431,decreased fetal weight|MP:0010093,decreased circulating magnesium level|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5812927	Trpm6<tm1b(KOMP)Wtsi>	MP:0000198,decreased circulating phosphate level|MP:0001257,increased body length|MP:0002591,decreased mean corpuscular volume|MP:0010052,increased grip strength|MP:0011960,abnormal eye anterior chamber depth
MGI:3814707	Trpm7<Gt(XC765)Byg>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3814706	Trpm7<tm1.1Clph>	MP:0011092,embryonic lethality, complete penetrance
MGI:5707246	Trpm7<tm1.1Mkma>	MP:0002169,no abnormal phenotype detected
MGI:5546500	Trpm7<tm1Agry>	MP:0000745,tremors|MP:0001513,limb grasping|MP:0001664,abnormal digestion|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002064,seizures|MP:0003484,abnormal channel response|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0005621,abnormal cell physiology|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010093,decreased circulating magnesium level|MP:0011091,prenatal lethality, complete penetrance|MP:0011436,decreased urine magnesium level|MP:0011979,abnormal magnesium ion homeostasis|MP:0012367,decreased erythrocyte magnesium level
MGI:6120763	Trpm7<tm1b(KOMP)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005505,thrombocytosis|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3814705	Trpm7<tm1Clph>	MP:0000394,absent hair follicle melanin granules|MP:0000522,kidney cortex cyst|MP:0000527,abnormal kidney development|MP:0000754,paresis|MP:0000755,hindlimb paralysis|MP:0000964,small dorsal root ganglion|MP:0000966,decreased sensory neuron number|MP:0001524,impaired limb coordination|MP:0002084,abnormal developmental patterning|MP:0002169,no abnormal phenotype detected|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002989,small kidney|MP:0003606,kidney failure|MP:0003675,kidney cyst|MP:0004381,abnormal hair follicle melanocyte morphology|MP:0004505,decreased renal glomerulus number|MP:0005367,renal/urinary system phenotype|MP:0005408,hypopigmentation|MP:0008812,abnormal rostrocaudal coat patterning|MP:0011092,embryonic lethality, complete penetrance|MP:0012023,decreased melanocyte number|MP:0012024,abnormal nephron morphogenesis|MP:0012025,abnormal comma shaped body morphology|MP:0012026,abnormal S-shaped body morphology|MP:0014134,abnormal embryo morphology
MGI:3716558	Trpm8<tm1Apat>	MP:0001973,increased thermal nociceptive threshold|MP:0002736,abnormal nociception after inflammation|MP:0003663,abnormal thermosensation|MP:0004811,abnormal neuron physiology
MGI:3716518	Trpm8<tm1Jul>	MP:0001973,increased thermal nociceptive threshold|MP:0003663,abnormal thermosensation
MGI:3716553	Trpm8<tm1Lex>	MP:0001970,abnormal pain threshold|MP:0001973,increased thermal nociceptive threshold|MP:0002736,abnormal nociception after inflammation|MP:0003663,abnormal thermosensation|MP:0004811,abnormal neuron physiology
MGI:6153694	Trps1<em1(IMPC)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level
MGI:5563401	Trps1<m1Anu>	MP:0005387,immune system phenotype
MGI:2446570	Trps1<tm1.1Shiv>	MP:0000063,decreased bone mineral density|MP:0000069,kyphoscoliosis|MP:0000088,short mandible|MP:0000111,cleft palate|MP:0000150,abnormal rib morphology|MP:0000161,scoliosis|MP:0000379,decreased hair follicle number|MP:0000445,short snout|MP:0001177,atelectasis|MP:0001179,thick pulmonary interalveolar septum|MP:0001284,absent vibrissae|MP:0001505,hunched posture|MP:0001953,respiratory failure|MP:0002233,abnormal nose morphology|MP:0002239,abnormal nasal septum morphology|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002273,abnormal pulmonary alveolus epithelial cell morphology|MP:0002639,micrognathia|MP:0003053,delayed tooth eruption|MP:0003419,delayed endochondral bone ossification|MP:0003761,arched palate|MP:0004449,absent presphenoid bone|MP:0004462,small basisphenoid bone|MP:0004596,abnormal mandibular angle morphology|MP:0004674,thin ribs|MP:0008272,abnormal endochondral bone ossification|MP:0009655,abnormal secondary palate development|MP:0009888,palatal shelves fail to meet at midline|MP:0009900,vomer bone hypoplasia|MP:0010029,abnormal basicranium morphology|MP:0010099,abnormal thoracic cage shape|MP:0010103,small thoracic cage|MP:0011087,neonatal lethality, complete penetrance|MP:0021166,delayed palatal shelf elevation|MP:0030192,downturned snout|MP:0030259,mandibular condyloid process hypoplasia|MP:0030285,mandibular coronoid process hypoplasia|MP:0030377,zygomatic arch hypoplasia|MP:0030467,abnormal cranial cartilage development|MP:0031459,maxillary zygomatic process hypoplasia
MGI:2446569	Trps1<tm1Shiv>	MP:0011087,neonatal lethality, complete penetrance
MGI:3772098	Trps1<tm1Ymur>	MP:0000088,short mandible|MP:0000097,short maxilla|MP:0000166,abnormal chondrocyte morphology|MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000416,sparse hair|MP:0000480,increased rib number|MP:0000527,abnormal kidney development|MP:0001175,abnormal lung morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001216,abnormal epidermal layer morphology|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002282,abnormal trachea morphology|MP:0002427,disproportionate dwarf|MP:0003641,small lung|MP:0003704,abnormal hair follicle development|MP:0004320,split sternum|MP:0004321,short sternum|MP:0004505,decreased renal glomerulus number|MP:0004553,absent tracheal cartilage rings|MP:0004624,abnormal thoracic cage morphology|MP:0004686,decreased length of long bones|MP:0008271,abnormal bone ossification|MP:0008277,abnormal sternum ossification|MP:0010981,abnormal branching involved in ureteric bud morphogenesis|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0011290,decreased nephron number|MP:0011425,abnormal kidney interstitium morphology
MGI:5445769	Trpt1<tm1Dron>	MP:0005376,homeostasis/metabolism phenotype|MP:0005384,cellular phenotype
MGI:3029186	Trpv1<tm1Jbd>	MP:0002272,abnormal nervous system electrophysiology|MP:0002733,abnormal thermal nociception|MP:0002736,abnormal nociception after inflammation|MP:0010055,abnormal sensory neuron physiology
MGI:1934023	Trpv1<tm1Jul>	MP:0000427,abnormal hair cycle|MP:0001260,increased body weight|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001473,reduced long-term potentiation|MP:0001475,reduced long-term depression|MP:0001756,abnormal urination|MP:0001859,kidney inflammation|MP:0001973,increased thermal nociceptive threshold|MP:0001986,abnormal taste sensitivity|MP:0001987,alcohol preference|MP:0002272,abnormal nervous system electrophysiology|MP:0002578,impaired ability to fire action potentials|MP:0002703,abnormal renal tubule morphology|MP:0002734,abnormal mechanical nociception|MP:0002736,abnormal nociception after inflammation|MP:0002862,abnormal righting response|MP:0002917,decreased synaptic depression|MP:0002962,increased urine protein level|MP:0003022,increased coronary flow rate|MP:0003043,hypoalgesia|MP:0003545,increased alcohol consumption|MP:0003631,nervous system phenotype|MP:0003821,decreased left ventricle diastolic pressure|MP:0003823,increased left ventricle developed pressure|MP:0003829,impaired febrile response|MP:0004484,abnormal response of heart to induced stress|MP:0004499,increased incidence of tumors by chemical induction|MP:0004811,abnormal neuron physiology|MP:0004924,abnormal behavior|MP:0004948,abnormal neuronal precursor proliferation|MP:0005165,increased susceptibility to injury|MP:0005264,glomerulosclerosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005402,abnormal action potential|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008531,increased chemical nociceptive threshold|MP:0008560,increased tumor necrosis factor secretion|MP:0008705,increased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0008734,decreased susceptibility to endotoxin shock|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0008859,abnormal hair cycle catagen phase|MP:0008860,abnormal hair cycle telogen phase|MP:0008872,abnormal physiological response to xenobiotic|MP:0008997,increased blood osmolality|MP:0009269,decreased fat cell size|MP:0009287,decreased abdominal fat pad weight|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0009643,abnormal urine homeostasis|MP:0009755,impaired behavioral response to alcohol|MP:0010055,abnormal sensory neuron physiology|MP:0010073,decreased pruritus|MP:0011942,decreased fluid intake|MP:0020523,decreased susceptibility to induced hypothermia|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:4439393	Trpv2<tm1Mijc>	MP:0001262,decreased body weight|MP:0001798,impaired macrophage phagocytosis|MP:0002412,increased susceptibility to bacterial infection|MP:0003799,impaired macrophage chemotaxis|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:2384170	Trpv3<Nh>	MP:0001194,dermatitis|MP:0002073,abnormal hair growth|MP:0002412,increased susceptibility to bacterial infection
MGI:4836895	Trpv3<tm1.1Clph>	MP:0000383,abnormal hair follicle orientation|MP:0000410,waved hair|MP:0001192,scaly skin|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001274,curly vibrissae|MP:0003454,erythroderma|MP:0003853,dry skin|MP:0009594,abnormal corneocyte envelope morphology
MGI:4836903	Trpv3<tm1.2Clph>	MP:0000383,abnormal hair follicle orientation|MP:0000410,waved hair|MP:0001192,scaly skin|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001274,curly vibrissae|MP:0003453,abnormal keratinocyte physiology|MP:0003454,erythroderma|MP:0003853,dry skin|MP:0009594,abnormal corneocyte envelope morphology
MGI:3574024	Trpv3<tm1Apat>	MP:0000367,abnormal coat/ hair morphology|MP:0001973,increased thermal nociceptive threshold|MP:0003453,abnormal keratinocyte physiology|MP:0003663,abnormal thermosensation
MGI:5544606	Trpv4<tm1.1Ldtk>	MP:0001973,increased thermal nociceptive threshold|MP:0002734,abnormal mechanical nociception|MP:0005386,behavior/neurological phenotype|MP:0005501,abnormal skin physiology
MGI:6256763	Trpv4<tm1c(KOMP)Wtsi>	MP:0005164,abnormal response to injury
MGI:6256768	Trpv4<tm1d(KOMP)Wtsi>	MP:0005164,abnormal response to injury
MGI:2667379	Trpv4<tm1Msz>	MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0004597,increased susceptibility to noise-induced hearing loss|MP:0005316,abnormal response to tactile stimuli|MP:0006325,impaired hearing|MP:0008531,increased chemical nociceptive threshold|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2682656	Trpv4<tm1Rck>	MP:0001422,abnormal drinking behavior|MP:0001613,abnormal vasodilation|MP:0001784,abnormal fluid regulation|MP:0001970,abnormal pain threshold|MP:0001973,increased thermal nociceptive threshold|MP:0002133,abnormal respiratory system physiology|MP:0002734,abnormal mechanical nociception|MP:0002736,abnormal nociception after inflammation|MP:0003280,urinary incontinence|MP:0003453,abnormal keratinocyte physiology|MP:0004003,abnormal vascular endothelial cell physiology|MP:0004811,abnormal neuron physiology|MP:0005166,decreased susceptibility to injury|MP:0005203,abnormal trabecular meshwork morphology|MP:0005258,ocular hypertension|MP:0005376,homeostasis/metabolism phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0005611,decreased circulating antidiuretic hormone level|MP:0008997,increased blood osmolality|MP:0008998,decreased blood osmolality|MP:0010386,abnormal urinary bladder physiology|MP:0011942,decreased fluid intake
MGI:5501482	Trpv5<Hcalc1>	MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0001426,polydipsia|MP:0001762,polyuria|MP:0001859,kidney inflammation|MP:0002135,abnormal kidney morphology|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002901,increased urine phosphate level|MP:0002989,small kidney|MP:0003215,renal interstitial fibrosis|MP:0003795,abnormal bone structure|MP:0004153,increased renal tubule apoptosis|MP:0005376,homeostasis/metabolism phenotype|MP:0005441,increased urine calcium level|MP:0009346,decreased trabecular bone thickness|MP:0009350,decreased urine pH|MP:0009640,abnormal renal tubule epithelium morphology|MP:0011228,abnormal vitamin D level
MGI:5304494	Trpv5<m1Btlr>	MP:0001263,weight loss|MP:0001426,polydipsia|MP:0001762,polyuria|MP:0001858,intestinal inflammation|MP:0005036,diarrhea|MP:0008537,increased susceptibility to induced colitis
MGI:2684536	Trpv5<tm1Bind>	MP:0000135,decreased compact bone thickness|MP:0001762,polyuria|MP:0002901,increased urine phosphate level|MP:0003795,abnormal bone structure|MP:0004214,abnormal long bone diaphysis morphology|MP:0004231,abnormal calcium ion homeostasis|MP:0004984,increased osteoclast cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005441,increased urine calcium level|MP:0009346,decreased trabecular bone thickness|MP:0009350,decreased urine pH|MP:0010111,abnormal renal calcium reabsorption|MP:0011228,abnormal vitamin D level
MGI:2446468	Trrap<tm1.1Zqw>	MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0004964,absent inner cell mass|MP:0005031,abnormal trophoblast layer morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4433230	Trrap<tm1a(EUCOMM)Wtsi>	MP:0001312,abnormal cornea morphology|MP:0002590,increased mean corpuscular volume|MP:0010092,increased circulating magnesium level|MP:0011100,preweaning lethality, complete penetrance
MGI:2446467	Trrap<tm1Zqw>	MP:0011092,embryonic lethality, complete penetrance
MGI:5692714	Trub1<tm1b(EUCOMM)Hmgu>	MP:0002591,decreased mean corpuscular volume|MP:0005343,increased circulating aspartate transaminase level|MP:0005505,thrombocytosis|MP:0005554,decreased circulating creatinine level|MP:0010090,increased circulating creatine kinase level
MGI:4840623	Trub2<tm2a(EUCOMM)Wtsi>	MP:0005031,abnormal trophoblast layer morphology|MP:0005178,increased circulating cholesterol level|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:6361031	Try10<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0005333,decreased heart rate|MP:0005553,increased circulating creatinine level|MP:0010506,prolonged RR interval|MP:0020870,decreased thigmotaxis
MGI:3698134	Ts(10<16>)232Dn	MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0006362,abnormal male germ cell morphology|MP:0008261,arrest of male meiosis|MP:0020451,decreased sperm progressive motility
MGI:3698133	Ts(12<17>)4Rk	MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0006362,abnormal male germ cell morphology|MP:0008261,arrest of male meiosis|MP:0020451,decreased sperm progressive motility
MGI:3623022	Ts(16C-tel)1Cje	MP:0000435,shortened head|MP:0000825,dilated lateral ventricle|MP:0000852,small cerebellum|MP:0001262,decreased body weight|MP:0001463,abnormal spatial learning|MP:0001922,reduced male fertility|MP:0002272,abnormal nervous system electrophysiology|MP:0002356,abnormal spleen red pulp morphology|MP:0002687,oligozoospermia|MP:0002689,abnormal molar morphology|MP:0003631,nervous system phenotype|MP:0003908,decreased stereotypic behavior|MP:0004008,abnormal GABA-mediated receptor currents|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004592,small mandible|MP:0004596,abnormal mandibular angle morphology|MP:0004852,decreased testis weight|MP:0008432,abnormal long-term spatial reference memory|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008525,decreased cranium height|MP:0009317,increased follicular lymphoma incidence|MP:0009937,abnormal neuron differentiation|MP:0012431,increased lymphoma incidence|MP:0014347,increased spleen B cell follicle size|MP:0014351,abnormal spleen B cell follicle shape|MP:0030283,small mandibular coronoid process|MP:0030315,small neurocranium|MP:0031391,increased locomotor activity
MGI:3512067	Ts(17<16>)65Dn	MP:0000266,abnormal heart morphology|MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000852,small cerebellum|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0001146,abnormal testis morphology|MP:0001156,abnormal spermatogenesis|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001399,hyperactivity|MP:0001409,increased stereotypic behavior|MP:0001447,abnormal nest building behavior|MP:0001463,abnormal spatial learning|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0002018,increased malignant tumor incidence|MP:0002063,abnormal learning/memory/conditioning|MP:0002152,abnormal brain morphology|MP:0002356,abnormal spleen red pulp morphology|MP:0002574,increased vertical activity|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0002797,increased thigmotaxis|MP:0002882,abnormal neuron morphology|MP:0003109,short femur|MP:0003233,prolonged QT interval|MP:0003447,decreased tumor growth/size|MP:0003461,abnormal response to novel object|MP:0003861,abnormal nervous system development|MP:0003896,prolonged PR interval|MP:0003898,abnormal QRS complex|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004160,retroesophageal right subclavian artery|MP:0004592,small mandible|MP:0004596,abnormal mandibular angle morphology|MP:0004852,decreased testis weight|MP:0004996,abnormal CNS synapse formation|MP:0005238,increased brain size|MP:0005333,decreased heart rate|MP:0005352,small cranium|MP:0005358,abnormal incisor morphology|MP:0006362,abnormal male germ cell morphology|MP:0008143,abnormal dendrite morphology|MP:0008261,arrest of male meiosis|MP:0008285,abnormal hippocampus granule cell layer|MP:0008428,abnormal spatial working memory|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008525,decreased cranium height|MP:0009317,increased follicular lymphoma incidence|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0010053,decreased grip strength|MP:0010392,prolonged QRS complex duration|MP:0010394,decreased QRS amplitude|MP:0010402,ventricular septal defect|MP:0010506,prolonged RR interval|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010509,decreased P wave amplitude|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012307,impaired spatial learning|MP:0012431,increased lymphoma incidence|MP:0014347,increased spleen B cell follicle size|MP:0014351,abnormal spleen B cell follicle shape|MP:0020451,decreased sperm progressive motility|MP:0030283,small mandibular coronoid process|MP:0030316,enlarged neurocranium
MGI:6459295	Ts(17<16>)66Yah	MP:0001447,abnormal nest building behavior|MP:0001922,reduced male fertility|MP:0002152,abnormal brain morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0003461,abnormal response to novel object|MP:0005386,behavior/neurological phenotype|MP:0012307,impaired spatial learning
MGI:3698135	Ts(4<17>)2Lws	MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0006362,abnormal male germ cell morphology|MP:0008261,arrest of male meiosis|MP:0020451,decreased sperm progressive motility
MGI:6194703	Tsbp1<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:7426056	Tsc1<em1(IMPC)Ccpcz>	MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001488,increased startle reflex|MP:0002792,abnormal retina vasculature morphology|MP:0004174,abnormal spine curvature|MP:0011100,preweaning lethality, complete penetrance
MGI:2183900	Tsc1<tm1.1Djk>	MP:0000274,enlarged heart|MP:0000600,liver hypoplasia|MP:0002045,increased renal cystadenoma incidence|MP:0002047,increased hepatic hemangioma incidence|MP:0002083,premature death|MP:0002192,hydrops fetalis|MP:0003667,increased hemangiosarcoma incidence|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0005312,pericardial effusion|MP:0010384,increased renal carcinoma incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3584174	Tsc1<tm1Chdl>	MP:0000914,exencephaly|MP:0001698,decreased embryo size|MP:0002045,increased renal cystadenoma incidence|MP:0002047,increased hepatic hemangioma incidence|MP:0003675,kidney cyst|MP:0010384,increased renal carcinoma incidence|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis|MP:0031614,fetal cardiomyocyte vacuoles
MGI:2656240	Tsc1<tm1Djk>	MP:0000130,abnormal trabecular bone morphology|MP:0000134,abnormal compact bone thickness|MP:0000150,abnormal rib morphology|MP:0000160,kyphosis|MP:0000278,abnormal myocardial fiber morphology|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0000609,abnormal liver physiology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0001125,abnormal oocyte morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001131,abnormal ovarian follicle morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001272,increased metastatic potential|MP:0001286,abnormal eye development|MP:0001312,abnormal cornea morphology|MP:0001322,abnormal iris morphology|MP:0001325,abnormal retina morphology|MP:0001360,abnormal social investigation|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0001441,increased grooming behavior|MP:0001454,abnormal cued conditioning behavior|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0001513,limb grasping|MP:0001522,impaired swimming|MP:0001728,failure of embryo implantation|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001764,abnormal homeostasis|MP:0001785,edema|MP:0001855,abnormal atrial thrombosis|MP:0001923,reduced female fertility|MP:0001926,female infertility|MP:0002006,neoplasm|MP:0002049,increased extremity angiosarcoma incidence|MP:0002062,abnormal associative learning|MP:0002063,abnormal learning/memory/conditioning|MP:0002064,seizures|MP:0002083,premature death|MP:0002176,increased brain weight|MP:0002216,abnormal seminiferous tubule morphology|MP:0002546,mydriasis|MP:0002566,abnormal sexual interaction|MP:0002644,decreased circulating triglyceride level|MP:0002784,abnormal Sertoli cell morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002795,dilated cardiomyopathy|MP:0003203,increased neuron apoptosis|MP:0003354,astrocytosis|MP:0003458,decreased circulating ketone body level|MP:0003462,abnormal response to novel odor|MP:0003463,abnormal single cell response|MP:0003507,abnormal ovary physiology|MP:0003574,abnormal oviduct morphology|MP:0003631,nervous system phenotype|MP:0003632,abnormal nervous system morphology|MP:0003633,abnormal nervous system physiology|MP:0003667,increased hemangiosarcoma incidence|MP:0003956,abnormal body size|MP:0004134,abnormal chest morphology|MP:0004173,abnormal intervertebral disk morphology|MP:0004269,abnormal optic cup morphology|MP:0004564,increased myocardial fiber size|MP:0004610,small vertebrae|MP:0004682,small intervertebral disk|MP:0004811,abnormal neuron physiology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0004924,abnormal behavior|MP:0004968,kidney epithelium hyperplasia|MP:0005099,abnormal ciliary body morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005193,abnormal anterior eye segment morphology|MP:0005195,abnormal posterior eye segment morphology|MP:0005199,abnormal iris pigment epithelium|MP:0005205,abnormal eye anterior chamber morphology|MP:0005229,abnormal intervertebral disk development|MP:0005238,increased brain size|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005370,liver/biliary system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005534,decreased body temperature|MP:0005601,increased angiogenesis|MP:0005603,neuron hypertrophy|MP:0006226,iris hypoplasia|MP:0006393,absent nucleus pulposus|MP:0006432,abnormal costal cartilage morphology|MP:0008019,increased liver tumor incidence|MP:0008256,abnormal myometrium morphology|MP:0008489,slow postnatal weight gain|MP:0008528,polycystic kidney|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008916,abnormal astrocyte physiology|MP:0009012,short diestrus|MP:0009017,prolonged estrus|MP:0009069,dilated oviduct|MP:0009092,endometrium hyperplasia|MP:0009093,oocyte degeneration|MP:0009781,abnormal preimplantation embryo development|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0010018,pulmonary vascular congestion|MP:0010080,abnormal hepatocyte physiology|MP:0011085,postnatal lethality, complete penetrance|MP:0011121,decreased primordial ovarian follicle number|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0013140,excessive vocalization|MP:0014175,abnormal ciliary epithelium morphology|MP:0014329,abnormal Purkinje cell axon morphology|MP:0014657,decreased cornea curvature|MP:0021135,abnormal annulus fibrosus morphology|MP:0021170,spinal stenosis|MP:0031020,premature ovarian failure|MP:0031239,increased atretic ovarian follicle number|MP:0031407,increased Sertoli cell proliferation
MGI:2183146	Tsc1<tm1Hin>	MP:0000600,liver hypoplasia|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001698,decreased embryo size|MP:0002020,increased tumor incidence|MP:0002035,increased leiomyosarcoma incidence|MP:0002045,increased renal cystadenoma incidence|MP:0002047,increased hepatic hemangioma incidence|MP:0002083,premature death|MP:0002574,increased vertical activity|MP:0002947,increased hemangioma incidence|MP:0003448,abnormal tumor morphology|MP:0003570,increased uterus leiomyoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0005498,hyporesponsive to tactile stimuli|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0010384,increased renal carcinoma incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3847243	Tsc22d1<tm1Clgr>	MP:0002834,decreased heart weight|MP:0003918,decreased kidney weight|MP:0009278,abnormal bone marrow cell physiology
MGI:7859713	Tsc22d2<em1(IMPC)Tcp>	MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5698172	Tsc22d3<tm1.1Hum>	MP:0001147,small testis|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0011750,abnormal seminiferous tubule epithelium morphology
MGI:5308358	Tsc22d3<tm1.1Ric>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002685,abnormal spermatogonia proliferation|MP:0004849,abnormal testis size|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0014634,decreased round spermatid number
MGI:5515630	Tsc22d3<tm1.2Efmd>	MP:0001925,male infertility|MP:0002425,abnormal susceptibility to autoimmune disorder|MP:0003944,abnormal T cell subpopulation ratio|MP:0005387,immune system phenotype|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008566,increased interferon-gamma secretion|MP:0008681,increased interleukin-17 secretion
MGI:5698178	Tsc22d3<tm1.2Hum>	MP:0001152,increased Leydig cell number|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001765,abnormal ion homeostasis|MP:0001776,abnormal circulating sodium level|MP:0001925,male infertility|MP:0002078,abnormal glucose homeostasis|MP:0002079,increased circulating insulin level|MP:0002665,decreased circulating corticosterone level|MP:0002776,increased Sertoli cell number|MP:0002781,increased circulating testosterone level|MP:0004852,decreased testis weight|MP:0004956,decreased thymus weight|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0005418,abnormal circulating hormone level|MP:0005459,decreased percent body fat/body weight|MP:0005627,increased circulating potassium level|MP:0005666,abnormal adipose tissue physiology|MP:0008261,arrest of male meiosis|MP:0008827,abnormal thymus cell ratio|MP:0009176,increased pancreatic alpha cell number|MP:0010134,decreased DN3 thymocyte number|MP:0010135,increased DN4 thymocyte number|MP:0011178,increased erythroblast number|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014052,increased male germ cell apoptosis|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5308356	Tsc22d3<tm1Ric>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0004849,abnormal testis size|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0006380,abnormal spermatid morphology|MP:0008261,arrest of male meiosis
MGI:5496783	Tsc2<tm1.1Kcess>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002169,no abnormal phenotype detected|MP:0009358,environmentally induced seizures|MP:0011085,postnatal lethality, complete penetrance
MGI:3795271	Tsc2<tm1.1Kido>	MP:0010294,increased kidney tumor incidence
MGI:3712063	Tsc2<tm1.1Mjg>	MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001272,increased metastatic potential|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001634,internal hemorrhage|MP:0002006,neoplasm|MP:0002064,seizures|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002176,increased brain weight|MP:0002216,abnormal seminiferous tubule morphology|MP:0002784,abnormal Sertoli cell morphology|MP:0003354,astrocytosis|MP:0003570,increased uterus leiomyoma incidence|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0004904,increased uterus weight|MP:0004906,enlarged uterus|MP:0005238,increased brain size|MP:0008014,increased lung tumor incidence|MP:0008256,abnormal myometrium morphology|MP:0008489,slow postnatal weight gain|MP:0009092,endometrium hyperplasia|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0013401,increased endometrial gland number|MP:0031407,increased Sertoli cell proliferation
MGI:3712064	Tsc2<tm1.2Mjg>	MP:0003675,kidney cyst|MP:0003984,embryonic growth retardation|MP:0010383,increased adenoma incidence|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:1857938	Tsc2<tm1Djk>	MP:0000600,liver hypoplasia|MP:0001360,abnormal social investigation|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0002020,increased tumor incidence|MP:0002045,increased renal cystadenoma incidence|MP:0002047,increased hepatic hemangioma incidence|MP:0002048,increased lung adenoma incidence|MP:0002049,increased extremity angiosarcoma incidence|MP:0003008,enhanced long-term potentiation|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0008260,abnormal autophagy|MP:0009936,abnormal dendritic spine morphology|MP:0010384,increased renal carcinoma incidence|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0020395,abnormal response to social novelty
MGI:5471751	Tsc2<tm1Jusa>	MP:0003037,increased myocardial infarct size|MP:0003038,decreased myocardial infarct size
MGI:5496784	Tsc2<tm1Kcess>	MP:0011100,preweaning lethality, complete penetrance
MGI:3795269	Tsc2<tm1Kido>	MP:0000189,hypoglycemia|MP:0001262,decreased body weight|MP:0002079,increased circulating insulin level|MP:0002169,no abnormal phenotype detected|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003339,decreased pancreatic beta cell number|MP:0005215,abnormal pancreatic islet morphology|MP:0005292,improved glucose tolerance|MP:0005491,pancreatic islet hyperplasia|MP:0005559,increased circulating glucose level|MP:0009113,increased pancreatic beta cell mass
MGI:3712062	Tsc2<tm1Mjg>	MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0003675,kidney cyst|MP:0003717,pallor|MP:0011091,prenatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:1926345	Tsc2<tm1Tno>	MP:0000275,heart hyperplasia|MP:0000928,incomplete rostral neuropore closure|MP:0001360,abnormal social investigation|MP:0001698,decreased embryo size|MP:0002047,increased hepatic hemangioma incidence|MP:0002574,increased vertical activity|MP:0003064,decreased coping response|MP:0003631,nervous system phenotype|MP:0003974,abnormal endocardium morphology|MP:0003984,embryonic growth retardation|MP:0005294,abnormal heart ventricle morphology|MP:0008143,abnormal dendrite morphology|MP:0009936,abnormal dendritic spine morphology|MP:0010384,increased renal carcinoma incidence|MP:0010656,thick myocardium|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4354599	Tsc2<tm2.1Djk>	MP:0002169,no abnormal phenotype detected
MGI:4354601	Tsc2<tm2.2Djk>	MP:0000259,abnormal vascular development|MP:0000600,liver hypoplasia|MP:0001634,internal hemorrhage|MP:0002045,increased renal cystadenoma incidence|MP:0003396,abnormal embryonic hematopoiesis|MP:0003631,nervous system phenotype|MP:0003984,embryonic growth retardation|MP:0004938,dilated vasculature|MP:0006042,increased apoptosis|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3845084	Tsed	MP:0000556,abnormal hindlimb morphology|MP:0000562,polydactyly|MP:0006279,abnormal limb development|MP:0006280,abnormal digit development
MGI:7620421	Tsen15<em1(IMPC)Bay>	MP:0001529,abnormal vocalization
MGI:6377433	Tsen54<em1(IMPC)J>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6402621	Tsen54<tm1b(EUCOMM)Wtsi>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:4432572	Tsfm<tm1a(EUCOMM)Wtsi>	MP:0001325,abnormal retina morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:2447444	Tsg101<tm1.1Kuw>	MP:0002006,neoplasm|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5605737	Tsg101<tm1b(EUCOMM)Hmgu>	MP:0001402,decreased locomotor activity|MP:0002135,abnormal kidney morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:2447442	Tsg101<tm1Kuw>	MP:0000628,abnormal mammary gland development|MP:0001882,abnormal lactation|MP:0002006,neoplasm|MP:0002169,no abnormal phenotype detected|MP:0006270,abnormal mammary gland growth during lactation
MGI:2385839	Tsg101<tm1Mak>	MP:0000352,decreased cell proliferation|MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002582,disorganized extraembryonic tissue|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0004759,decreased mitotic index|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology|MP:0011187,abnormal parietal endoderm morphology|MP:0012114,absent inner cell mass proliferation
MGI:6725804	Tsga10<em1Smoc>	MP:0000242,impaired fertilization|MP:0001925,male infertility|MP:0002673,abnormal sperm number|MP:0002674,abnormal sperm motility|MP:0006378,abnormal spermatogonia morphology
MGI:6725810	Tsga10<em2Smoc>	MP:0001925,male infertility
MGI:6104246	Tsga13<em1(IMPC)J>	MP:0001552,increased circulating triglyceride level|MP:0003961,decreased lean body mass
MGI:6195022	Tsga13<tm1.1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6726553	Tsga8<em1Ohbo>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0009852,increased Sertoli cell phagocytosis|MP:0013601,increased testis apoptosis
MGI:6726554	Tsga8<em2Ohbo>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0009852,increased Sertoli cell phagocytosis|MP:0013601,increased testis apoptosis
MGI:5613811	Tshb<tm1Hru>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001926,female infertility
MGI:1856914	Tshr<hyt>	MP:0000042,abnormal organ of Corti morphology|MP:0000060,delayed bone ossification|MP:0000135,decreased compact bone thickness|MP:0000547,short limbs|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001394,circling|MP:0001396,unidirectional circling|MP:0001409,increased stereotypic behavior|MP:0001577,anemia|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001967,deafness|MP:0002896,abnormal bone mineralization|MP:0002998,abnormal bone remodeling|MP:0003149,abnormal tectorial membrane morphology|MP:0003194,abnormal frequency of paradoxical sleep|MP:0003356,impaired luteinization|MP:0003419,delayed endochondral bone ossification|MP:0003503,decreased activity of thyroid gland|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004014,abnormal uterine environment|MP:0004402,decreased cochlear outer hair cell number|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0004696,abnormal thyroid follicle morphology|MP:0005017,decreased B cell number|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005135,increased thyroid-stimulating hormone level|MP:0005178,increased circulating cholesterol level|MP:0005185,decreased circulating progesterone level|MP:0005471,decreased thyroxine level|MP:0005478,decreased circulating thyroxine level|MP:0006395,abnormal epiphyseal plate morphology|MP:0008186,increased pro-B cell number|MP:0009009,absent estrous cycle|MP:0010867,abnormal bone trabecula morphology|MP:0010876,decreased bone volume|MP:0011049,impaired adaptive thermogenesis|MP:0011448,decreased dopaminergic neuron number|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0013624,decreased femur compact bone thickness|MP:0014406,increased or absent distortion product otoacoustic emission threshold|MP:0014409,decreased distortion product otoacoustic emission amplitude|MP:0020010,decreased bone mineral density of femur|MP:0021194,decreased bone mineral density of caudal vertebrae|MP:0031420,decreased superovulation rate
MGI:4453218	Tshr<hyt-2J>	MP:0001262,decreased body weight|MP:0003718,maternal effect|MP:0004022,abnormal cone electrophysiology|MP:0004696,abnormal thyroid follicle morphology|MP:0005389,reproductive system phenotype|MP:0005478,decreased circulating thyroxine level|MP:0008337,increased thyrotroph cell number|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012144,decreased b-wave amplitude
MGI:5554389	Tshr<hyt-3J>	MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002083,premature death|MP:0003503,decreased activity of thyroid gland|MP:0008974,proportional dwarf|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5640754	Tshr<m1Btlr>	MP:0001262,decreased body weight
MGI:2447142	Tshr<tm1Rmar>	MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0002876,abnormal thyroid gland physiology|MP:0002951,small thyroid gland|MP:0003351,decreased circulating levels of thyroid hormone|MP:0003501,iodide oxidation defect|MP:0003503,decreased activity of thyroid gland|MP:0004696,abnormal thyroid follicle morphology|MP:0005122,increased circulating thyroid-stimulating hormone level|MP:0005468,abnormal thyroid hormone level|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level|MP:0011083,lethality at weaning, complete penetrance
MGI:3613765	Tsht	MP:0020470,shortened circadian behavior period
MGI:3721421	Tshz1<tm1Core>	MP:0000029,abnormal malleus morphology|MP:0000030,abnormal tympanic ring morphology|MP:0000049,abnormal middle ear morphology|MP:0001438,aphagia|MP:0001954,respiratory distress|MP:0002114,abnormal axial skeleton morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0003110,absent malleus processus brevis|MP:0003755,abnormal palate morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004613,fusion of vertebral arches|MP:0004618,thoracic vertebral transformation|MP:0004620,cervical vertebral fusion|MP:0006033,abnormal external auditory canal morphology|MP:0008148,abnormal sternocostal joint morphology|MP:0008377,absent malleus manubrium|MP:0008382,gonial bone hypoplasia|MP:0009879,abnormal arcus anterior morphology|MP:0009887,abnormal palatal shelf fusion at midline|MP:0010371,abnormal epiglottis morphology|MP:0010728,fusion of atlas and occipital bones|MP:0011087,neonatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0012284,increased sternebra number|MP:0030291,short soft palate
MGI:5588813	Tshz1<tm1Garr>	MP:0001438,aphagia|MP:0010994,aerophagia|MP:0011087,neonatal lethality, complete penetrance
MGI:7426057	Tshz2<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3613189	Tshz2<Tn(sb-lacZ,GFP)T1.67Jtak>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3810527	Tshz3<tm1Lafa>	MP:0000519,hydronephrosis|MP:0000534,abnormal ureter morphology|MP:0000536,hydroureter|MP:0001177,atelectasis|MP:0001404,no spontaneous movement|MP:0001954,respiratory distress|MP:0003586,dilated ureter|MP:0003672,abnormal ureter development|MP:0004194,abnormal kidney pelvis morphology|MP:0005367,renal/urinary system phenotype|MP:0005498,hyporesponsive to tactile stimuli|MP:0011087,neonatal lethality, complete penetrance|MP:0011426,abnormal ureter smooth muscle morphology|MP:0011480,impaired ureteric peristalsis
MGI:7261361	Tshz3<tm2.1Lafa>	MP:0001360,abnormal social investigation|MP:0001409,increased stereotypic behavior|MP:0001899,absent long-term depression|MP:0002797,increased thigmotaxis|MP:0002910,abnormal excitatory postsynaptic currents|MP:0003635,abnormal synaptic transmission|MP:0004924,abnormal behavior|MP:0005402,abnormal action potential|MP:0020395,abnormal response to social novelty|MP:0020508,decreased dendritic spine density
MGI:2447997	Tsil<Tg(Myc)12ALvn>	MP:0002083,premature death|MP:0005091,increased double-positive T cell number|MP:0012431,increased lymphoma incidence
MGI:3590293	Tsiq1<BALB/cOla>	MP:0008699,increased interleukin-4 secretion
MGI:3590295	Tsiq2<BALB/cOla>	MP:0008699,increased interleukin-4 secretion
MGI:2679786	Tsix<tm1Enl>	MP:0001663,abnormal digestive system physiology|MP:0001674,abnormal germ layer development|MP:0001680,abnormal mesoderm development|MP:0001694,absent egg cylinders|MP:0001695,abnormal gastrulation|MP:0001718,abnormal visceral yolk sac morphology|MP:0001726,abnormal allantois morphology|MP:0002084,abnormal developmental patterning|MP:0002836,abnormal chorion morphology|MP:0005032,abnormal ectoplacental cone morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011200,abnormal extraembryonic coelom morphology|MP:0011202,abnormal ectoplacental cavity morphology|MP:0012104,small amniotic cavity
MGI:2387816	Tsix<tm1Jtl>	MP:0005384,cellular phenotype
MGI:2387818	Tsix<tm2Jtl>	MP:0002080,prenatal lethality|MP:0003787,abnormal imprinting|MP:0010382,abnormal dosage compensation, by inactivation of X chromosome
MGI:3698272	Tsix<tm3Jtl>	MP:0001935,decreased litter size|MP:0003787,abnormal imprinting|MP:0008770,decreased survivor rate|MP:0011091,prenatal lethality, complete penetrance|MP:0011103,embryonic lethality at implantation, incomplete penetrance
MGI:3772862	Tsix/Xist<tm3Sado>	MP:0001672,abnormal embryo development|MP:0008877,abnormal DNA methylation|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3772875	Tsix/Xist<tm3Sado>	MP:0001672,abnormal embryo development|MP:0008877,abnormal DNA methylation|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6152743	Tsks<em1(IMPC)Wtsi>	MP:0001925,male infertility|MP:0003795,abnormal bone structure
MGI:7509242	Tsks<em1Osb>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0004182,abnormal spermiation|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0009230,abnormal sperm head morphology|MP:0009647,decreased fertilization frequency|MP:0009831,abnormal sperm midpiece morphology|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0014052,increased male germ cell apoptosis|MP:0020451,decreased sperm progressive motility
MGI:4867728	Tsku<tm1Koth>	MP:0000780,abnormal corpus callosum morphology|MP:0008225,abnormal anterior commissure morphology|MP:0008535,enlarged lateral ventricles
MGI:6314192	tsl	MP:0000745,tremors|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0002064,seizures|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003717,pallor|MP:0013438,dysmyelination|MP:0013693,abnormal hemopoiesis|MP:0020851,abnormal vacuole morphology
MGI:3837749	Tslp<tm1.1Pcn>	MP:0002492,decreased IgE level|MP:0005012,decreased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3837753	Tslp<tm1.2Pcn>	MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:5292857	Tslp<tm1(KOMP)Vlcg>	MP:0001790,abnormal immune system physiology|MP:0002334,abnormal airway responsiveness|MP:0002405,respiratory system inflammation|MP:0002490,abnormal immunoglobulin level|MP:0005087,decreased acute inflammation|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008566,increased interferon-gamma secretion|MP:0008603,decreased circulating interleukin-4 level
MGI:5294911	Tslp<tm1Mak>	MP:0001263,weight loss|MP:0002816,colitis|MP:0005381,digestive/alimentary phenotype|MP:0005387,immune system phenotype|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:5503051	Tslp<tm1Sfz>	MP:0005387,immune system phenotype|MP:0005466,abnormal T-helper 2 physiology|MP:0008568,abnormal interleukin secretion|MP:0008672,increased interleukin-13 secretion|MP:0008702,increased interleukin-5 secretion|MP:0010771,integument phenotype
MGI:6343407	Tslrn1<em1Cwr>	MP:0002687,oligozoospermia|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype
MGI:6343408	Tslrn1<em2Cwr>	MP:0002687,oligozoospermia|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype
MGI:7507213	Tsnax<em1(IMPC)Mbp>	MP:0001258,decreased body length|MP:0001944,abnormal pancreas morphology|MP:0002060,abnormal skin morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0002834,decreased heart weight|MP:0010053,decreased grip strength
MGI:4973633	Tsnax<Gt(S21-6D1)Sor>	MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0008058,abnormal DNA repair|MP:0013501,increased fibroblast apoptosis
MGI:7531504	Tsnaxip1<em1Osb>	MP:0001922,reduced male fertility|MP:0009282,decreased hyperactivated sperm motility|MP:0020451,decreased sperm progressive motility
MGI:2677496	Tsn<Gt(OST63223)Lex>	MP:0000352,decreased cell proliferation|MP:0001146,abnormal testis morphology|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001405,impaired coordination|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002687,oligozoospermia|MP:0003961,decreased lean body mass|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005458,increased percent body fat/body weight|MP:0005656,decreased aggression|MP:0008261,arrest of male meiosis|MP:0008489,slow postnatal weight gain|MP:0009286,increased abdominal fat pad weight|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0014052,increased male germ cell apoptosis
MGI:5691814	Tsn<tm1Jmat>	MP:0002123,abnormal definitive hematopoiesis|MP:0012734,abnormal response to radiation
MGI:5692687	Tspan11<tm2b(EUCOMM)Wtsi>	MP:0000367,abnormal coat/ hair morphology|MP:0001529,abnormal vocalization
MGI:4414643	Tspan12<tm1Wye>	MP:0000255,blood vessel congestion|MP:0001289,persistence of hyaloid vascular system|MP:0002792,abnormal retina vasculature morphology|MP:0004368,abnormal stria vascularis vasculature morphology|MP:0005385,cardiovascular system phenotype|MP:0006185,retina hemorrhage|MP:0006303,abnormal retina nerve fiber layer morphology|MP:0008515,thin retina outer nuclear layer|MP:0009392,retina gliosis|MP:0010452,retina microaneurysm
MGI:6336148	Tspan13<em1(IMPC)Kmpc>	MP:0000063,decreased bone mineral density|MP:0002098,abnormal vibrissa morphology|MP:0003795,abnormal bone structure|MP:0004924,abnormal behavior|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0013278,decreased fasting circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:6149216	Tspan14<em1(IMPC)H>	MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:7426059	Tspan15<em1(IMPC)Hmgu>	MP:0002059,abnormal seminal vesicle morphology|MP:0002098,abnormal vibrissa morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7594194	Tspan15<em1Psf>	MP:0003631,nervous system phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:6153828	Tspan17<em1(IMPC)H>	MP:0005178,increased circulating cholesterol level|MP:0008810,increased circulating iron level
MGI:5471282	Tspan18<tm1.1(KOMP)Vlcg>	MP:0002941,increased circulating alanine transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0005561,increased mean corpuscular hemoglobin|MP:0013279,increased fasting circulating glucose level
MGI:5007398	Tspan18<tm1Lex>	MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0009676,abnormal hemostasis|MP:0031120,decreased susceptibility to induced thrombosis|MP:0031164,decreased circulating von Willebrand factor level
MGI:5556057	Tspan2<tm1Hbw>	MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0008918,microgliosis
MGI:6293843	Tspan32<em1(IMPC)Mbp>	MP:0000274,enlarged heart|MP:0000470,abnormal stomach morphology|MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001200,thick skin|MP:0001304,cataract|MP:0001944,abnormal pancreas morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002591,decreased mean corpuscular volume|MP:0002699,abnormal vitreous body morphology|MP:0002989,small kidney|MP:0003883,enlarged stomach
MGI:2183564	Tspan32<Gt(pMS-1)1Jmt>	MP:0005348,increased T cell proliferation
MGI:3826388	Tspan33<tm1Stsa>	MP:0000208,decreased hematocrit|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000248,macrocytosis|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002447,abnormal erythrocyte morphology|MP:0002640,reticulocytosis|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0008019,increased liver tumor incidence|MP:0008826,abnormal splenic cell ratio|MP:0010175,leptocytosis
MGI:4125242	Tspan3<Gt(NPX312)Byg>	MP:0004810,decreased hematopoietic stem cell number|MP:0011995,decreased leukemia incidence
MGI:7641818	Tspan4<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6336149	Tspan5<em1(IMPC)Kmpc>	MP:0001399,hyperactivity
MGI:6509072	Tspan6<tm2Vlcg>	MP:0001473,reduced long-term potentiation|MP:0002206,abnormal CNS synaptic transmission|MP:0002804,abnormal motor learning|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:6400549	Tspan7<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0002574,increased vertical activity
MGI:6095166	Tspan7<tm1Mpass>	MP:0001473,reduced long-term potentiation|MP:0003461,abnormal response to novel object|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005402,abnormal action potential|MP:0008428,abnormal spatial working memory|MP:0009454,impaired contextual conditioning behavior|MP:0009939,abnormal hippocampus neuron morphology|MP:0012307,impaired spatial learning|MP:0020508,decreased dendritic spine density
MGI:6277054	Tspan8<em1(IMPC)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0002699,abnormal vitreous body morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:6147563	Tspan9<em1(IMPC)J>	MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010052,increased grip strength
MGI:6719497	Tspan9<em1Tshu>	MP:0000222,decreased neutrophil cell number|MP:0002446,abnormal macrophage morphology|MP:0005065,abnormal neutrophil morphology
MGI:6478279	Tspo2<em1Muti>	MP:0000208,decreased hematocrit|MP:0002640,reticulocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0011176,abnormal erythroblast morphology|MP:0012393,increased erythrocyte sodium:potassium-exchanging ATPase activity
MGI:6153864	Tspoap1<em1(IMPC)H>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005565,increased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount|MP:0010052,increased grip strength
MGI:5509342	Tspoap1<tm1Sud>	MP:0002169,no abnormal phenotype detected
MGI:5603424	Tspo<tm1.1Guwu>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005379,endocrine/exocrine gland phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008044,increased NK cell number|MP:0010768,mortality/aging|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport
MGI:5560329	Tspo<tm1.1Maf>	MP:0002169,no abnormal phenotype detected|MP:0005370,liver/biliary system phenotype|MP:0005385,cardiovascular system phenotype
MGI:5569290	Tspo<tm1.1Wbd>	MP:0005389,reproductive system phenotype
MGI:5614711	Tspo<tm1b(EUCOMM)Wtsi>	MP:0002792,abnormal retina vasculature morphology
MGI:6200424	Tspyl1<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0003385,abnormal body wall morphology|MP:0005655,increased aggression|MP:0011100,preweaning lethality, complete penetrance
MGI:5548366	Tspyl2<tm1b(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0009142,decreased prepulse inhibition
MGI:5141121	Tspyl2<tm1Sich>	MP:0002006,neoplasm|MP:0003631,nervous system phenotype|MP:0004045,abnormal cell cycle checkpoint function|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:6260179	Tspyl4<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001513,limb grasping|MP:0005655,increased aggression
MGI:7465005	Tspyl5<em1(IMPC)Tcp>	MP:0001322,abnormal iris morphology|MP:0002792,abnormal retina vasculature morphology|MP:0006243,impaired pupillary reflex|MP:0010097,abnormal retina blood vessel morphology
MGI:7665244	Tspyl5<em1Yuya>	MP:0001146,abnormal testis morphology|MP:0001922,reduced male fertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002685,abnormal spermatogonia proliferation|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0014617,decreased spermatogonia number|MP:0020362,abnormal male germ cell physiology
MGI:3582264	Tspy-ps<tm1(Mlc3-Gdf8)Mgs>	MP:0003397,increased muscle weight|MP:0009399,increased skeletal muscle fiber size
MGI:3582561	Tspy-ps<tm2(Mlc3-Gdf8)Mgs>	MP:0003397,increased muscle weight|MP:0009399,increased skeletal muscle fiber size
MGI:7461809	Tsr1<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:7507214	Tssk2<em1(IMPC)Mbp>	MP:0001925,male infertility
MGI:7451036	Tssk3<em1Amsa>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009838,abnormal sperm axoneme morphology|MP:0020869,immotile sperm|MP:0031356,abnormal outer dense fiber morphology
MGI:7495884	Tssk3<em1Osb>	MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0006362,abnormal male germ cell morphology|MP:0008898,abnormal acrosome morphology|MP:0009230,abnormal sperm head morphology|MP:0009231,detached acrosome|MP:0009376,abnormal manchette morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014684,impaired spermiation|MP:0020362,abnormal male germ cell physiology
MGI:7451037	Tssk3<em2Amsa>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0020869,immotile sperm
MGI:7451038	Tssk3<em3Amsa>	MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0020869,immotile sperm
MGI:5907824	Tssk4<em1(IMPC)J>	MP:0004222,iris synechia
MGI:6191661	Tssk4<tm1.1Lgyu>	MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0005389,reproductive system phenotype|MP:0009280,decreased activated sperm motility|MP:0009831,abnormal sperm midpiece morphology|MP:0009836,abnormal sperm principal piece morphology|MP:0009838,abnormal sperm axoneme morphology
MGI:5585594	Tssk5<tm1.1(KOMP)Vlcg>	MP:0000221,decreased leukocyte cell number
MGI:3580646	Tssk6<tm1Grj>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0009230,abnormal sperm head morphology
MGI:6342466	Tstd1<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number
MGI:5569084	Tst<tm1.1(KOMP)Vlcg>	MP:0002590,increased mean corpuscular volume|MP:0002631,abnormal epididymis morphology|MP:0010052,increased grip strength
MGI:4452974	Tst<tm1(KOMP)Vlcg>	MP:0000218,increased leukocyte cell number|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0005013,increased lymphocyte cell number
MGI:1861632	Tsv	MP:0000585,kinked tail|MP:0000592,short tail|MP:0002081,perinatal lethality|MP:0011090,perinatal lethality, incomplete penetrance
MGI:3044639	Tsvw1<NZB/BlNJ>	MP:0004851,increased testis weight|MP:0004909,increased seminal vesicle weight
MGI:3040367	Tswt<MSM/Ms>	MP:0004852,decreased testis weight
MGI:5050138	Tsx<tm1.2Jtl>	MP:0001147,small testis|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0001940,testis hypoplasia|MP:0009453,enhanced contextual conditioning behavior
MGI:6784017	Ttbk1<em1(IMPC)J>	MP:0000745,tremors|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0002797,increased thigmotaxis|MP:0003960,increased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0004924,abnormal behavior|MP:0005179,decreased circulating cholesterol level|MP:0005559,increased circulating glucose level|MP:0010052,increased grip strength|MP:0013279,increased fasting circulating glucose level
MGI:5496675	Ttbk2<bby>	MP:0002085,abnormal embryonic tissue morphology|MP:0002151,abnormal neural tube morphology|MP:0004252,abnormal direction of heart looping|MP:0005157,holoprosencephaly|MP:0006279,abnormal limb development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013202,abnormal cilium morphology
MGI:6314594	Ttbk2<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5296197	Ttbk2<tm1a(EUCOMM)Hmgu>	MP:0001891,hydrocephaly|MP:0008528,polycystic kidney|MP:0013202,abnormal cilium morphology
MGI:5056320	Ttbk2<tm1Dral>	MP:0000913,abnormal brain development|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0003631,nervous system phenotype|MP:0003861,abnormal nervous system development|MP:0003984,embryonic growth retardation|MP:0004132,absent embryonic cilia|MP:0004203,abnormal cranial flexure morphology|MP:0004252,abnormal direction of heart looping|MP:0005157,holoprosencephaly|MP:0005621,abnormal cell physiology|MP:0011100,preweaning lethality, complete penetrance
MGI:7450833	Ttc12<em1(IMPC)J>	MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity
MGI:6759775	Ttc17<em1(IMPC)J>	MP:0001488,increased startle reflex|MP:0005178,increased circulating cholesterol level|MP:0010097,abnormal retina blood vessel morphology
MGI:6276545	Ttc19<em1Bds>	MP:0001402,decreased locomotor activity|MP:0003631,nervous system phenotype
MGI:6386313	Ttc1<em1(IMPC)Mbp>	MP:0001711,abnormal placenta morphology|MP:0001727,abnormal embryo implantation|MP:0002718,abnormal inner cell mass morphology|MP:0009552,urinary bladder obstruction|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6368822	Ttc21a<em1Fzh>	MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0008893,detached sperm flagellum|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009239,short sperm flagellum|MP:0009830,abnormal sperm connecting piece morphology|MP:0009831,abnormal sperm midpiece morphology|MP:0009834,abnormal sperm annulus morphology|MP:0009836,abnormal sperm principal piece morphology|MP:0009837,abnormal sperm end piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0020451,decreased sperm progressive motility|MP:0031352,absent sperm axonemal central pair
MGI:2152544	Ttc21b<aln>	MP:0000137,abnormal vertebrae morphology|MP:0000154,rib fusion|MP:0000428,abnormal craniofacial morphology|MP:0000433,microcephaly|MP:0000562,polydactyly|MP:0000784,forebrain hypoplasia|MP:0002115,abnormal limb bone morphology|MP:0002151,abnormal neural tube morphology|MP:0002152,abnormal brain morphology|MP:0003451,absent olfactory bulb|MP:0004677,truncated ribs|MP:0008528,polycystic kidney
MGI:6200040	Ttc21b<m1Btlr>	MP:0001260,increased body weight
MGI:7608147	Ttc27<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:5513829	Ttc28<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000137,abnormal vertebrae morphology|MP:0000186,decreased circulating HDL cholesterol level|MP:0000218,increased leukocyte cell number|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0001258,decreased body length|MP:0002764,short tibia|MP:0002968,increased circulating alkaline phosphatase level|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004609,vertebral fusion|MP:0005013,increased lymphocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0005270,abnormal zygomatic bone morphology|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0010067,increased red blood cell distribution width|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6391112	Ttc29<em1Fzh>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0005389,reproductive system phenotype|MP:0009243,hairpin sperm flagellum|MP:0009831,abnormal sperm midpiece morphology|MP:0009836,abnormal sperm principal piece morphology|MP:0009837,abnormal sperm end piece morphology|MP:0020451,decreased sperm progressive motility
MGI:6317331	Ttc29<em1(IMPC)J>	MP:0010393,shortened QRS complex duration
MGI:5763010	Ttc32<em1(IMPC)J>	MP:0005344,increased circulating bilirubin level
MGI:5588394	Ttc36<em1Qz>	MP:0005389,reproductive system phenotype
MGI:6259151	Ttc38<em1Llp>	MP:0005293,impaired glucose tolerance
MGI:7627138	Ttc39aos1<em1Bcgen>	MP:0004761,increased susceptibility to induced pancreatitis|MP:0014433,increased cytokine level
MGI:7610578	Ttc39aos1<tm1Kaf>	MP:0005397,hematopoietic system phenotype|MP:0008735,increased susceptibility to endotoxin shock
MGI:5816879	Ttc39a<tm1b(KOMP)Mbp>	MP:0000194,increased circulating calcium level|MP:0001566,increased circulating phosphate level|MP:0002833,increased heart weight|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:4431723	Ttc39b<tm1e(EUCOMM)Wtsi>	MP:0002644,decreased circulating triglyceride level|MP:0005505,thrombocytosis|MP:0005554,decreased circulating creatinine level
MGI:7343914	Ttc39c<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001319,irregularly shaped pupil|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number
MGI:7426060	Ttc4<em1(IMPC)Bay>	MP:0001513,limb grasping|MP:0001728,failure of embryo implantation|MP:0001730,embryonic growth arrest|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012058,abnormal morula morphology
MGI:6452192	Ttc5<em1(IMPC)Rbrc>	MP:0000137,abnormal vertebrae morphology|MP:0004599,abnormal vertebral arch morphology
MGI:7541253	Ttc6<em1Cya>	MP:0001922,reduced male fertility|MP:0005389,reproductive system phenotype|MP:0008892,abnormal sperm flagellum morphology|MP:0009243,hairpin sperm flagellum|MP:0020451,decreased sperm progressive motility|MP:0030978,impaired binding of sperm to zona pellucida
MGI:6189597	Ttc7b<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002080,prenatal lethality|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6149967	Ttc7<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:1856879	Ttc7<fsn>	MP:0000192,abnormal mineral level|MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000274,enlarged heart|MP:0000414,alopecia|MP:0000471,abnormal stomach epithelium morphology|MP:0000472,abnormal stomach non-glandular epithelium morphology|MP:0000579,abnormal nail morphology|MP:0000580,deformed nails|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0000706,small thymus|MP:0000711,thymus cortex hypoplasia|MP:0001192,scaly skin|MP:0001195,flaky skin|MP:0001212,skin lesions|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0001246,mixed cellular infiltration to dermis|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0001770,abnormal iron level|MP:0001873,stomach inflammation|MP:0001874,acanthosis|MP:0002014,increased papilloma incidence|MP:0002083,premature death|MP:0002591,decreased mean corpuscular volume|MP:0002594,low mean erythrocyte cell number|MP:0002655,abnormal keratinocyte morphology|MP:0002874,decreased hemoglobin content|MP:0003427,parakeratosis|MP:0003717,pallor|MP:0003809,abnormal hair shaft morphology|MP:0003810,abnormal hair cuticle|MP:0004152,abnormal circulating iron level|MP:0009600,hypergranulosis|MP:0009602,abnormal keratohyalin granule morphology|MP:0009675,orthokeratosis|MP:0010784,abnormal forestomach morphology|MP:0010792,abnormal stomach mucosa morphology|MP:0013409,increased dendritic epidermal T cell number|MP:0013412,increased Langerhans cell number
MGI:3692528	Ttc7<fsn-Jic>	MP:0000208,decreased hematocrit|MP:0000240,extramedullary hematopoiesis|MP:0000416,sparse hair|MP:0000600,liver hypoplasia|MP:0000603,pale liver|MP:0001191,abnormal skin condition|MP:0001192,scaly skin|MP:0001242,hyperkeratosis|MP:0001246,mixed cellular infiltration to dermis|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0001860,liver inflammation|MP:0001874,acanthosis|MP:0002447,abnormal erythrocyte morphology|MP:0002594,low mean erythrocyte cell number|MP:0002834,decreased heart weight|MP:0003427,parakeratosis|MP:0003717,pallor|MP:0004952,increased spleen weight|MP:0004956,decreased thymus weight|MP:0004969,pale kidney|MP:0005174,abnormal tail pigmentation|MP:0005505,thrombocytosis|MP:0008476,increased spleen red pulp amount|MP:0008479,decreased spleen white pulp amount|MP:0009395,increased nucleated erythrocyte cell number|MP:0010176,dacryocytosis|MP:0010177,acanthocytosis|MP:0010771,integument phenotype|MP:0011085,postnatal lethality, complete penetrance|MP:0011242,increased fetal derived definitive erythrocyte cell number
MGI:1856896	Ttc7<hea>	MP:0000192,abnormal mineral level|MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000607,abnormal hepatocyte morphology|MP:0000691,enlarged spleen|MP:0001220,epidermal necrosis|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0001586,abnormal erythrocyte cell number|MP:0002082,postnatal lethality|MP:0002095,abnormal skin pigmentation|MP:0002123,abnormal definitive hematopoiesis|MP:0002447,abnormal erythrocyte morphology|MP:0002594,low mean erythrocyte cell number|MP:0002640,reticulocytosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002874,decreased hemoglobin content|MP:0003717,pallor|MP:0005096,erythroblastosis|MP:0005097,polychromatophilia|MP:0008255,decreased megakaryocyte cell number|MP:0008810,increased circulating iron level|MP:0011085,postnatal lethality, complete penetrance|MP:0011413,colorless urine
MGI:5140723	Ttc8<tm1Reed>	MP:0001261,obese|MP:0001265,decreased body size|MP:0001326,retina degeneration|MP:0002705,dilated renal tubule|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0008489,slow postnatal weight gain|MP:0008544,impaired olfaction|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011281,abnormal olfactory epithelium cilium morphology
MGI:5904133	Ttc9<tm1Vcl>	MP:0000662,abnormal branching of the mammary ductal tree|MP:0000708,thymus hyperplasia|MP:0001260,increased body weight|MP:0004952,increased spleen weight|MP:0004955,increased thymus weight
MGI:3710000	T<Tg(MT2A-Myc)137Misu>	MP:0000292,distended pericardium|MP:0000585,kinked tail|MP:0001265,decreased body size|MP:0001688,abnormal somite development|MP:0001701,incomplete embryo turning|MP:0002151,abnormal neural tube morphology|MP:0002825,abnormal notochord morphology|MP:0003984,embryonic growth retardation|MP:0004251,failure of heart looping|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3047560	tth	MP:0000745,tremors|MP:0001399,hyperactivity|MP:0001504,abnormal posture|MP:0001925,male infertility|MP:0005191,head tilt|MP:0005377,hearing/vestibular/ear phenotype
MGI:4415267	tth<2J>	MP:0000745,tremors|MP:0001394,circling|MP:0001522,impaired swimming|MP:0005191,head tilt|MP:0005377,hearing/vestibular/ear phenotype
MGI:7428768	Tti1<em1(IMPC)J>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000221,decreased leukocyte cell number|MP:0004738,abnormal auditory brainstem response|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:5699602	Tti2<tm1b(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0001417,decreased exploration in new environment|MP:0005016,decreased lymphocyte cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:6367822	Ttk<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0001727,abnormal embryo implantation|MP:0002718,abnormal inner cell mass morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5056148	Ttk<tm1Katj>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0004024,aneuploidy|MP:0005168,abnormal female meiosis|MP:0009769,abnormal meiotic spindle assembly checkpoint|MP:0014444,enhanced polar body extrusion
MGI:5607785	Ttll10<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0005560,decreased circulating glucose level
MGI:5775002	Ttll10<tm1b(EUCOMM)Hmgu>	MP:0005293,impaired glucose tolerance
MGI:7426061	Ttll11<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0002060,abnormal skin morphology
MGI:4297933	Ttll1<Gt(OST372941)Lex>	MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001850,increased susceptibility to otitis media|MP:0001867,rhinitis|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0003631,nervous system phenotype|MP:0003961,decreased lean body mass|MP:0005378,growth/size/body region phenotype|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0008545,absent sperm flagellum|MP:0008893,detached sperm flagellum|MP:0009234,absent sperm head|MP:0009831,abnormal sperm midpiece morphology|MP:0020869,immotile sperm
MGI:4432051	Ttll1<tm1a(EUCOMM)Wtsi>	MP:0001391,abnormal tail movements
MGI:4461777	Ttll1<tm1Seto>	MP:0000788,abnormal cerebral cortex morphology|MP:0001947,abnormal mucociliary clearance|MP:0001950,abnormal respiratory sounds|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0003631,nervous system phenotype|MP:0003633,abnormal nervous system physiology|MP:0009239,short sperm flagellum|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011055,abnormal respiratory motile cilium physiology|MP:0030118,rhinosinusitis|MP:0031088,coughing|MP:0031089,sneezing
MGI:4433856	Ttll3<tm1a(EUCOMM)Wtsi>	MP:0000488,abnormal intestinal epithelium morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000495,abnormal colon morphology|MP:0002169,no abnormal phenotype detected|MP:0004499,increased incidence of tumors by chemical induction|MP:0005628,decreased circulating potassium level|MP:0010155,abnormal intestine physiology
MGI:6401419	Ttll3<tm1d(EUCOMM)Wtsi>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0008450,retina photoreceptor degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0014059,abnormal photoreceptor connecting cilium morphology
MGI:4433211	Ttll4<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0001325,abnormal retina morphology|MP:0001413,abnormal response to new environment|MP:0002896,abnormal bone mineralization
MGI:5467943	Ttll5<tm1.1N>	MP:0001006,abnormal retina cone cell morphology|MP:0001326,retina degeneration|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002675,asthenozoospermia|MP:0002864,abnormal ocular fundus morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0005578,teratozoospermia|MP:0005621,abnormal cell physiology|MP:0008515,thin retina outer nuclear layer|MP:0009238,coiled sperm flagellum|MP:0009647,decreased fertilization frequency|MP:0009838,abnormal sperm axoneme morphology|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:5605489	Ttll6<tm1.1(KOMP)Vlcg>	MP:0005560,decreased circulating glucose level|MP:0005627,increased circulating potassium level
MGI:6101191	Ttll7<em1(IMPC)J>	MP:0010052,increased grip strength
MGI:6476783	Ttll7<tm1Seto>	MP:0001260,increased body weight|MP:0001405,impaired coordination|MP:0002573,behavioral despair|MP:0003631,nervous system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0014812,abnormal brain physiology|MP:0031391,increased locomotor activity
MGI:6343411	Ttll9<tm1Seto>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0003631,nervous system phenotype|MP:0004543,abnormal sperm physiology|MP:0004884,abnormal testis physiology|MP:0005367,renal/urinary system phenotype|MP:0005371,limbs/digits/tail phenotype|MP:0005388,respiratory system phenotype|MP:0005578,teratozoospermia|MP:0008893,detached sperm flagellum|MP:0009836,abnormal sperm principal piece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0020451,decreased sperm progressive motility|MP:0030590,abnormal sperm fibrous sheath morphology
MGI:5696909	Ttl<tm1b(EUCOMM)Wtsi>	MP:0001417,decreased exploration in new environment|MP:0001785,edema|MP:0011100,preweaning lethality, complete penetrance
MGI:3584264	Ttl<tm1Wehl>	MP:0000790,abnormal stratification in cerebral cortex|MP:0000934,abnormal telencephalon development|MP:0001393,ataxia|MP:0001951,abnormal breathing pattern|MP:0003232,abnormal forebrain development|MP:0008129,absent brain internal capsule|MP:0009937,abnormal neuron differentiation|MP:0011087,neonatal lethality, complete penetrance
MGI:5490031	T<tm1(cre/ERT2)Hssk>	MP:0000592,short tail|MP:0002111,abnormal tail morphology|MP:0003051,curly tail|MP:0003456,absent tail|MP:0011092,embryonic lethality, complete penetrance
MGI:6511815	Ttn<em1Kage>	MP:0000266,abnormal heart morphology|MP:0002753,dilated heart left ventricle|MP:0005329,abnormal myocardium layer morphology|MP:0005369,muscle phenotype|MP:0005385,cardiovascular system phenotype|MP:0031633,decreased heart left ventricle muscle contractility
MGI:1856953	Ttn<mdm>	MP:0000160,kyphosis|MP:0000749,muscle degeneration|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0004510,myositis|MP:0005369,muscle phenotype
MGI:2159020	Ttn<shru>	MP:0000260,abnormal angiogenesis|MP:0000263,absent organized vascular network|MP:0000267,abnormal heart development|MP:0000295,trabecula carnea hypoplasia|MP:0000316,cellular necrosis|MP:0000433,microcephaly|MP:0001614,abnormal blood vessel morphology|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0002127,abnormal cardiovascular system morphology|MP:0002128,abnormal blood circulation|MP:0002925,abnormal cardiovascular development|MP:0004076,abnormal vitelline vascular remodeling|MP:0004787,abnormal dorsal aorta morphology|MP:0005039,hypoxia|MP:0005140,decreased cardiac muscle contractility|MP:0006042,increased apoptosis|MP:0006337,abnormal first pharyngeal arch morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011266,abnormal frontonasal mesenchyme morphology
MGI:3654306	Ttn<tm1.1Her>	MP:0001698,decreased embryo size|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002652,thin myocardium|MP:0003984,embryonic growth retardation|MP:0005294,abnormal heart ventricle morphology|MP:0005312,pericardial effusion|MP:0005329,abnormal myocardium layer morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis|MP:0014730,abnormal myocardial fiber myofibril morphology
MGI:5551762	Ttn<tm1.1Hgra>	MP:0000160,kyphosis|MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0002279,abnormal diaphragm morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0003923,abnormal heart left atrium morphology|MP:0005620,abnormal muscle contractility|MP:0009413,skeletal muscle fiber atrophy|MP:0009426,decreased soleus weight|MP:0011915,increased heart left atrium weight|MP:0012106,impaired exercise endurance
MGI:4838322	Ttn<tm1.1Isrd>	MP:0000752,dystrophic muscle|MP:0000759,abnormal skeletal muscle morphology|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002841,impaired skeletal muscle contractility|MP:0003081,abnormal soleus morphology|MP:0003082,abnormal gastrocnemius morphology|MP:0003083,abnormal tibialis anterior morphology|MP:0003819,increased left ventricle diastolic pressure|MP:0003820,increased left ventricle systolic pressure|MP:0004094,abnormal M line morphology|MP:0004510,myositis|MP:0005598,decreased heart ventricle muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009414,skeletal muscle fiber necrosis|MP:0010225,abnormal quadriceps morphology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0021206,abnormal limb muscle morphology
MGI:4359790	Ttn<tm1Brge>	MP:0000267,abnormal heart development|MP:0001698,decreased embryo size|MP:0001787,pericardial edema|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0003921,abnormal heart left ventricle morphology|MP:0003984,embryonic growth retardation|MP:0004086,absent heartbeat|MP:0005140,decreased cardiac muscle contractility|MP:0005329,abnormal myocardium layer morphology|MP:0005385,cardiovascular system phenotype|MP:0005608,cardiac interstitial fibrosis|MP:0011092,embryonic lethality, complete penetrance
MGI:2651645	Ttn<tm1Her>	MP:0000748,progressive muscle weakness|MP:0001265,decreased body size|MP:0001344,blepharoptosis|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0004090,abnormal sarcomere morphology|MP:0004094,abnormal M line morphology|MP:0005385,cardiovascular system phenotype|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3763610	Ttn<tm1Mgot>	MP:0000279,ventricular hypoplasia|MP:0002834,decreased heart weight|MP:0004011,decreased diastolic filling velocity|MP:0004090,abnormal sarcomere morphology|MP:0004215,abnormal myocardial fiber physiology
MGI:5662236	Ttn<tm2.1Hgra>	MP:0000278,abnormal myocardial fiber morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002953,thick ventricular wall|MP:0003921,abnormal heart left ventricle morphology|MP:0004090,abnormal sarcomere morphology|MP:0004564,increased myocardial fiber size|MP:0011915,increased heart left atrium weight|MP:0012106,impaired exercise endurance
MGI:4946083	Ttn<tm2.1Mgot>	MP:0001625,cardiac hypertrophy|MP:0002106,abnormal muscle physiology|MP:0002625,heart left ventricle hypertrophy|MP:0002972,abnormal cardiac muscle contractility|MP:0003915,increased heart left ventricle weight|MP:0004090,abnormal sarcomere morphology|MP:0004564,increased myocardial fiber size|MP:0010579,increased heart left ventricle size
MGI:5013398	Ttn<tm3.1Mgot>	MP:0002169,no abnormal phenotype detected
MGI:1932559	Ttpa<tm1Far>	MP:0001926,female infertility|MP:0005385,cardiovascular system phenotype|MP:0011231,abnormal vitamin E level
MGI:2386172	Ttpa<tm1Hsz>	MP:0000745,tremors|MP:0000754,paresis|MP:0001328,disorganized retina layers|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001713,decreased trophoblast giant cell number|MP:0001715,placental labyrinth hypoplasia|MP:0001908,abnormal somatosensory cortex physiology|MP:0001926,female infertility|MP:0002118,abnormal lipid homeostasis|MP:0002229,neurodegeneration|MP:0002730,head shaking|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005323,dystonia|MP:0005551,abnormal eye electrophysiology|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009413,skeletal muscle fiber atrophy|MP:0011231,abnormal vitamin E level|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:6386310	Ttr<em1(IMPC)H>	MP:0001402,decreased locomotor activity
MGI:6194707	Ttr<tm1.1Smoc>	MP:0000604,amyloidosis|MP:0002700,increased opacity of vitreous body|MP:0006200,vitreous body deposition
MGI:3838181	Ttr<tm1Kymm>	MP:0005416,abnormal circulating protein level|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level|MP:0011234,abnormal retinol level
MGI:1857264	Ttr<tm1Wsb>	MP:0003351,decreased circulating levels of thyroid hormone|MP:0005391,vision/eye phenotype|MP:0005416,abnormal circulating protein level|MP:0005444,abnormal retinol metabolism|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level|MP:0009642,abnormal blood homeostasis|MP:0011234,abnormal retinol level
MGI:3838182	Ttr<tm2(TTR)Kymm>	MP:0005416,abnormal circulating protein level|MP:0005478,decreased circulating thyroxine level|MP:0005479,decreased circulating triiodothyronine level|MP:0011234,abnormal retinol level
MGI:3838183	Ttr<tm3(TTR*)Kymm>	MP:0005416,abnormal circulating protein level
MGI:1856772	t<Tu3>	MP:0005371,limbs/digits/tail phenotype
MGI:7447414	Ttyh1<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:4818475	Ttyh1<tm1Tohe>	MP:0001730,embryonic growth arrest|MP:0003111,abnormal cell nucleus morphology|MP:0003707,increased cell nucleus count|MP:0004046,abnormal mitosis|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:6414563	Ttyh3<em1(IMPC)Tcp>	MP:0002591,decreased mean corpuscular volume|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:1857080	tu	MP:0000562,polydactyly|MP:0000568,ectopic digits
MGI:7426063	Tuba1a<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0001914,hemorrhage|MP:0003743,abnormal facial morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6506267	Tuba1a<em1Rstot>	MP:0000111,cleft palate|MP:0000826,abnormal third ventricle morphology|MP:0000934,abnormal telencephalon development|MP:0001785,edema|MP:0001914,hemorrhage|MP:0004174,abnormal spine curvature|MP:0004811,abnormal neuron physiology|MP:0006007,abnormal basal ganglion morphology|MP:0008439,abnormal cortical plate morphology|MP:0008457,abnormal cortical intermediate zone morphology|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0011100,preweaning lethality, complete penetrance|MP:0014557,increased cortical ventricular zone thickness|MP:0020393,increased neuronal precursor proliferation
MGI:6506268	Tuba1a<em2Rstot>	MP:0000111,cleft palate|MP:0000826,abnormal third ventricle morphology|MP:0000934,abnormal telencephalon development|MP:0001785,edema|MP:0001914,hemorrhage|MP:0004174,abnormal spine curvature|MP:0006007,abnormal basal ganglion morphology|MP:0008439,abnormal cortical plate morphology|MP:0008457,abnormal cortical intermediate zone morphology|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0011100,preweaning lethality, complete penetrance|MP:0014557,increased cortical ventricular zone thickness
MGI:3617352	Tuba1a<Jna>	MP:0000788,abnormal cerebral cortex morphology|MP:0000805,abnormal visual cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000812,abnormal dentate gyrus morphology|MP:0000815,abnormal Ammon gyrus morphology|MP:0000859,abnormal somatosensory cortex morphology|MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001447,abnormal nest building behavior|MP:0002761,abnormal hippocampal mossy fiber morphology|MP:0004631,abnormal auditory cortex morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008428,abnormal spatial working memory|MP:0009971,decreased hippocampus pyramidal cell number|MP:0014551,impaired neuronal migration
MGI:6506270	Tuba1a<quas>	MP:0000788,abnormal cerebral cortex morphology|MP:0003203,increased neuron apoptosis|MP:0004174,abnormal spine curvature|MP:0004811,abnormal neuron physiology|MP:0004979,abnormal neuronal precursor cell number|MP:0006009,abnormal neuronal migration|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0020393,increased neuronal precursor proliferation|MP:0020394,decreased neuronal precursor proliferation
MGI:5308811	Tuba1a<Rgsc1736>	MP:0001364,decreased anxiety-related response|MP:0002882,abnormal neuron morphology|MP:0003461,abnormal response to novel object|MP:0008143,abnormal dendrite morphology|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0031391,increased locomotor activity
MGI:6314751	Tuba1c<em1(IMPC)J>	MP:0002968,increased circulating alkaline phosphatase level
MGI:6764562	Tuba3a<em1Smtb>	MP:0005389,reproductive system phenotype
MGI:5636920	Tuba3a<tm1b(KOMP)Wtsi>	MP:0011939,increased food intake
MGI:6764561	Tuba3b<em1Smtb>	MP:0005389,reproductive system phenotype
MGI:6441799	Tuba4a<m1Frla>	MP:0000229,abnormal megakaryocyte differentiation|MP:0002599,increased mean platelet volume|MP:0003179,thrombocytopenia|MP:0003405,abnormal platelet shape|MP:0004720,abnormal platelet morphology
MGI:5779854	Tuba8<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001284,absent vibrissae|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation
MGI:6094271	Tuba8<tm1.2Ctpd>	MP:0002169,no abnormal phenotype detected
MGI:6342821	Tubal3<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0000221,decreased leukocyte cell number|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0005562,decreased mean corpuscular hemoglobin
MGI:7641819	Tubal3<em1Kzt>	MP:0005389,reproductive system phenotype
MGI:3513083	Tubb1<tm1Shiv>	MP:0003179,thrombocytopenia|MP:0003405,abnormal platelet shape|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time
MGI:5795759	Tubb2a<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0010053,decreased grip strength
MGI:6506264	Tubb2a<em1Rstot>	MP:0000788,abnormal cerebral cortex morphology|MP:0000859,abnormal somatosensory cortex morphology|MP:0005404,abnormal axon morphology|MP:0012448,abnormal primary motor cortex morphology
MGI:6506265	Tubb2a<em2Rstot>	MP:0000788,abnormal cerebral cortex morphology|MP:0000859,abnormal somatosensory cortex morphology|MP:0005404,abnormal axon morphology|MP:0012448,abnormal primary motor cortex morphology
MGI:5056364	Tubb2b<brdp>	MP:0000445,short snout|MP:0000787,abnormal telencephalon morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000852,small cerebellum|MP:0001399,hyperactivity|MP:0001891,hydrocephaly|MP:0001921,reduced fertility|MP:0001954,respiratory distress|MP:0002196,absent corpus callosum|MP:0002741,small olfactory bulb|MP:0003203,increased neuron apoptosis|MP:0004101,abnormal brain interneuron morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0005389,reproductive system phenotype|MP:0006007,abnormal basal ganglion morphology|MP:0006254,thin cerebral cortex|MP:0008128,abnormal brain internal capsule morphology|MP:0008227,absent anterior commissure|MP:0008439,abnormal cortical plate morphology|MP:0011091,prenatal lethality, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0012089,decreased midbrain size
MGI:6199642	Tubb2b<em1(IMPC)J>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6506266	Tubb2b<em1Rstot>	MP:0000788,abnormal cerebral cortex morphology|MP:0000859,abnormal somatosensory cortex morphology|MP:0012448,abnormal primary motor cortex morphology
MGI:4441058	Tubb3<tm1.1Ece>	MP:0000780,abnormal corpus callosum morphology|MP:0001056,abnormal cranial nerve morphology|MP:0001061,abnormal oculomotor nerve morphology|MP:0001063,abnormal trochlear nerve morphology|MP:0001065,abnormal trigeminal nerve morphology|MP:0001954,respiratory distress|MP:0002196,absent corpus callosum|MP:0002199,abnormal brain commissure morphology|MP:0002961,abnormal axon guidance|MP:0006007,abnormal basal ganglion morphology|MP:0008225,abnormal anterior commissure morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:6444834	Tubb4a<em1Avan>	MP:0000745,tremors|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000913,abnormal brain development|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0001263,weight loss|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001523,impaired righting response|MP:0002083,premature death|MP:0003224,neuron degeneration|MP:0003354,astrocytosis|MP:0005323,dystonia|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0009808,decreased oligodendrocyte number|MP:0010053,decreased grip strength|MP:0011731,decreased myelin sheath thickness|MP:0013438,dysmyelination|MP:0031496,motor developmental delay
MGI:6887964	Tubb4a<Jit>	MP:0000778,abnormal nervous system tract morphology|MP:0000849,abnormal cerebellum morphology|MP:0000890,thin cerebellar molecular layer|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0003203,increased neuron apoptosis|MP:0003224,neuron degeneration|MP:0004098,abnormal cerebellar granule cell morphology|MP:0006099,thin cerebellar granule layer|MP:0008917,abnormal oligodendrocyte physiology|MP:0013438,dysmyelination|MP:0014185,cerebellum atrophy
MGI:5634810	Tubb4a<tm1.1(KOMP)Wtsi>	MP:0013278,decreased fasting circulating glucose level
MGI:4419785	Tubb4a<tm1(KOMP)Wtsi>	MP:0005386,behavior/neurological phenotype|MP:0010768,mortality/aging
MGI:6120520	Tubb4b<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001510,abnormal coat appearance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7593955	Tubb4b<tm2b(EUCOMM)Wtsi>	MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0005391,vision/eye phenotype|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011644,abnormal oviduct epithelium motile cilium morphology
MGI:6119463	Tubb5<tm1.1Dak>	MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0000852,small cerebellum|MP:0002741,small olfactory bulb|MP:0002882,abnormal neuron morphology|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0004046,abnormal mitosis|MP:0004079,abnormal putamen morphology|MP:0006254,thin cerebral cortex|MP:0008283,small hippocampus|MP:0009760,abnormal mitotic spindle morphology|MP:0009956,abnormal cerebellar layer morphology|MP:0020527,small thalamus
MGI:6119464	Tubb5<tm2.1Dak>	MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0000852,small cerebellum|MP:0002741,small olfactory bulb|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0004046,abnormal mitosis|MP:0004079,abnormal putamen morphology|MP:0006254,thin cerebral cortex|MP:0008283,small hippocampus|MP:0009956,abnormal cerebellar layer morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0020527,small thalamus
MGI:7426064	Tube1<em1(IMPC)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001325,abnormal retina morphology|MP:0001364,decreased anxiety-related response|MP:0001417,decreased exploration in new environment|MP:0002792,abnormal retina vasculature morphology|MP:0004924,abnormal behavior|MP:0008259,abnormal optic disk morphology|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0020870,decreased thigmotaxis
MGI:7432911	Tubg1<tm1dIcs>	MP:0001402,decreased locomotor activity
MGI:3583648	Tubg1<tm1Sts>	MP:0001730,embryonic growth arrest|MP:0009760,abnormal mitotic spindle morphology|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:7616511	Tubg1<tm2.1Ics>	MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000790,abnormal stratification in cerebral cortex|MP:0000852,small cerebellum|MP:0002574,increased vertical activity|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0006254,thin cerebral cortex|MP:0008026,abnormal brain white matter morphology|MP:0008225,abnormal anterior commissure morphology|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0020570,decreased premotor cortex size|MP:0020596,decreased cerebral cortex total cell area|MP:0031391,increased locomotor activity
MGI:3583649	Tubg2<tm1Sts>	MP:0002169,no abnormal phenotype detected
MGI:6404499	Tubgcp2<em1(IMPC)Bay>	MP:0003795,abnormal bone structure|MP:0011100,preweaning lethality, complete penetrance
MGI:6381351	Tubgcp2<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0001727,abnormal embryo implantation|MP:0004964,absent inner cell mass|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:5792574	Tubgcp4<em1(IMPC)J>	MP:0001284,absent vibrissae|MP:0001399,hyperactivity|MP:0002098,abnormal vibrissa morphology|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7329950	Tubgcp4<tm1Rzh>	MP:0000352,decreased cell proliferation|MP:0000433,microcephaly|MP:0003984,embryonic growth retardation|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008586,disorganized photoreceptor outer segment|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude|MP:0030941,enhanced autophagy
MGI:5640758	Tub<m1Btlr>	MP:0001260,increased body weight
MGI:1857081	Tub<tm1Rok>	MP:0001326,retina degeneration|MP:0001327,decreased retina photoreceptor cell number|MP:0003212,increased susceptibility to age related obesity|MP:0005455,increased susceptibility to weight gain|MP:0008515,thin retina outer nuclear layer|MP:0030005,increased retina apoptosis
MGI:1861349	Tub<tub>	MP:0000043,organ of Corti degeneration|MP:0000837,abnormal hypothalamus morphology|MP:0001261,obese|MP:0001327,decreased retina photoreceptor cell number|MP:0001552,increased circulating triglyceride level|MP:0001963,abnormal hearing physiology|MP:0002079,increased circulating insulin level|MP:0002102,abnormal ear morphology|MP:0002628,hepatic steatosis|MP:0002792,abnormal retina vasculature morphology|MP:0002857,cochlear ganglion degeneration|MP:0003151,absent tunnel of Corti|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0004289,abnormal bony labyrinth|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004465,degeneration of organ of Corti supporting cells|MP:0005178,increased circulating cholesterol level|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005362,abnormal Langerhans cell physiology|MP:0005377,hearing/vestibular/ear phenotype|MP:0006069,abnormal retina neuronal layer morphology|MP:0006187,retina deposits|MP:0006325,impaired hearing|MP:0008450,retina photoreceptor degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0008584,photoreceptor outer segment degeneration|MP:0009171,enlarged pancreatic islets|MP:0010024,increased total body fat amount|MP:0010400,increased liver glycogen level|MP:0011939,increased food intake|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012029,abnormal electroretinogram waveform feature|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:4419443	Tuft1<tm1a(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000410,waved hair|MP:0001208,blistering|MP:0001212,skin lesions|MP:0001233,abnormal epidermis suprabasal layer morphology|MP:0001340,abnormal eyelid morphology|MP:0001510,abnormal coat appearance|MP:0001874,acanthosis|MP:0002098,abnormal vibrissa morphology|MP:0002655,abnormal keratinocyte morphology|MP:0002656,abnormal keratinocyte differentiation|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003089,decreased skin tensile strength|MP:0003809,abnormal hair shaft morphology|MP:0004241,acantholysis|MP:0005292,improved glucose tolerance|MP:0005385,cardiovascular system phenotype|MP:0010072,increased pruritus|MP:0013027,wounding|MP:0030578,decreased keratinocyte adhesion
MGI:5563546	Tug1<tm1Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:6842317	Tulp1<rd18>	MP:0005551,abnormal eye electrophysiology|MP:0010097,abnormal retina blood vessel morphology|MP:0010749,absent visual evoked potential|MP:0012671,retina spots|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:1859921	Tulp1<tm1Pjn>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001325,abnormal retina morphology|MP:0001327,decreased retina photoreceptor cell number|MP:0002792,abnormal retina vasculature morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005378,growth/size/body region phenotype|MP:0006069,abnormal retina neuronal layer morphology|MP:0008450,retina photoreceptor degeneration|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008582,short photoreceptor inner segment|MP:0008583,absent photoreceptor inner segment|MP:0008585,absent photoreceptor outer segment|MP:0008587,short photoreceptor outer segment|MP:0030005,increased retina apoptosis|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:4867883	Tulp1<tvrm124>	MP:0001326,retina degeneration|MP:0008518,retina outer nuclear layer degeneration|MP:0008584,photoreceptor outer segment degeneration
MGI:6724546	Tulp2<em1Huizh>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005389,reproductive system phenotype|MP:0006380,abnormal spermatid morphology|MP:0009237,kinked sperm flagellum|MP:0009831,abnormal sperm midpiece morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0011635,abnormal mitochondrial crista morphology|MP:0013601,increased testis apoptosis|MP:0020451,decreased sperm progressive motility
MGI:6430648	Tulp2<em1(IMPC)Mbp>	MP:0001304,cataract|MP:0001925,male infertility|MP:0002699,abnormal vitreous body morphology
MGI:7783441	Tulp2<em1Zfhu>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0031356,abnormal outer dense fiber morphology
MGI:3664273	Tulp3<hhkr>	MP:0000153,rib bifurcation|MP:0000432,abnormal head morphology|MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0001785,edema|MP:0002110,abnormal digit morphology|MP:0002151,abnormal neural tube morphology|MP:0003861,abnormal nervous system development|MP:0005225,abnormal vertebrae development|MP:0005297,spina bifida occulta|MP:0006253,clinodactyly|MP:0012544,abnormal caudal neuropore morphology|MP:0012547,spina bifida cystica|MP:0012703,decreased embryonic neuroepithelium thickness|MP:0012707,incomplete caudal neuropore closure
MGI:6392262	Tulp3<m1Kflj>	MP:0000111,cleft palate|MP:0000480,increased rib number|MP:0002082,postnatal lethality|MP:0003068,enlarged kidney|MP:0005508,abnormal skeleton morphology|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008528,polycystic kidney|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011440,increased kidney cell proliferation
MGI:5548429	Tulp3<tm1b(EUCOMM)Hmgu>	MP:0000428,abnormal craniofacial morphology|MP:0000562,polydactyly|MP:0000929,open neural tube|MP:0001785,edema|MP:0002113,abnormal skeleton development|MP:0002941,increased circulating alanine transaminase level|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0013278,decreased fasting circulating glucose level|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5752546	Tulp3<tm1c(EUCOMM)Hmgu>	MP:0002705,dilated renal tubule|MP:0003675,kidney cyst
MGI:2388066	Tulp3<tm1Jng>	MP:0000137,abnormal vertebrae morphology|MP:0000783,abnormal forebrain morphology|MP:0000784,forebrain hypoplasia|MP:0000841,abnormal hindbrain morphology|MP:0000897,abnormal midbrain morphology|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001577,anemia|MP:0001634,internal hemorrhage|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0002151,abnormal neural tube morphology|MP:0002152,abnormal brain morphology|MP:0002948,abnormal neuron specification|MP:0003054,spina bifida|MP:0003717,pallor|MP:0003935,abnormal craniofacial development|MP:0006042,increased apoptosis|MP:0006108,abnormal hindbrain development|MP:0008797,facial cleft|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0012701,increased embryonic neuroepithelium apoptosis
MGI:6152667	Tulp4<em1(IMPC)Mbp>	MP:0000538,abnormal urinary bladder morphology|MP:0001404,no spontaneous movement|MP:0009455,enhanced cued conditioning behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4365109	Tulp4<tm1a(KOMP)Wtsi>	MP:0000157,abnormal sternum morphology|MP:0000284,double outlet right ventricle|MP:0000681,abnormal thyroid gland morphology|MP:0001260,increased body weight|MP:0002127,abnormal cardiovascular system morphology|MP:0002191,abnormal artery morphology|MP:0002823,abnormal rib development|MP:0004158,right aortic arch|MP:0004175,telangiectasia|MP:0004665,abnormal stapedial artery morphology|MP:0004880,lung cyst|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0009820,abnormal liver vasculature morphology|MP:0010418,perimembraneous ventricular septal defect|MP:0010420,muscular ventricular septal defect|MP:0010484,bicuspid aortic valve|MP:0010768,mortality/aging|MP:0011089,perinatal lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011513,abnormal vertebral artery morphology|MP:0011683,dual inferior vena cava|MP:0013162,abnormal thyroid gland isthmus morphology|MP:0013814,abnormal hepatic portal vein connection|MP:0013834,thin hypoglossal nerve|MP:0013840,absent segment of posterior cerebral artery|MP:0013848,subcutaneous edema|MP:0013876,absent ductus venosus valve|MP:0013936,abnormal thymus topology|MP:0013952,retroesophageal left subclavian artery|MP:0013966,abnormal infrahyoid muscle morphology|MP:0013970,absent connection between subcutaneous lymph vessels and lymph sac|MP:0013973,abnormal hepatic vein connection|MP:0013995,abnormal external carotid artery origin|MP:0020824,abnormal testis tissue architecture
MGI:5784541	Tusc1<em1(IMPC)J>	MP:0010024,increased total body fat amount
MGI:3706236	Tusc2<tm1Avi>	MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0000715,decreased thymocyte number|MP:0000746,weakness|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001382,abnormal nursing|MP:0001864,vascular inflammation|MP:0002019,abnormal tumor incidence|MP:0002026,increased leukemia incidence|MP:0002073,abnormal hair growth|MP:0002083,premature death|MP:0002499,chronic inflammation|MP:0002662,abnormal cauda epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002743,glomerulonephritis|MP:0002875,decreased erythrocyte cell number|MP:0002947,increased hemangioma incidence|MP:0002997,enlarged seminal vesicle|MP:0003107,abnormal response to novelty|MP:0003667,increased hemangiosarcoma incidence|MP:0003786,premature aging|MP:0004154,renal tubular necrosis|MP:0004207,increased squamous cell carcinoma incidence|MP:0004231,abnormal calcium ion homeostasis|MP:0004794,increased anti-nuclear antigen antibody level|MP:0005095,decreased T cell proliferation|MP:0005325,abnormal renal glomerulus morphology|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005425,increased macrophage cell number|MP:0008045,decreased NK cell number|MP:0008053,abnormal NK cell differentiation|MP:0008676,decreased interleukin-15 secretion|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009661,abnormal pregnancy|MP:0010138,arteritis|MP:0010959,abnormal oxidative phosphorylation|MP:0011117,abnormal susceptibility to weight gain|MP:0011402,renal cast|MP:0011508,abnormal glomerular capillary thrombosis|MP:0012431,increased lymphoma incidence|MP:0013249,adipose tissue necrosis|MP:0013600,testis degeneration|MP:0013663,increased myeloid cell number|MP:0031210,small cauda epididymis|MP:0031253,lordokyphosis
MGI:5659636	Tusc3<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system|MP:0001697,abnormal embryo size|MP:0003385,abnormal body wall morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4330742	Tut4<Gt(RRR277)Byg>	MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005376,homeostasis/metabolism phenotype|MP:0005621,abnormal cell physiology|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5296547	Tut4<tm1a(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0001258,decreased body length|MP:0008935,decreased mean platelet volume
MGI:7331509	Tvp23b<em1(IMPC)J>	MP:0010052,increased grip strength
MGI:7541044	Tvp23b<em3Eetr>	MP:0005036,diarrhea|MP:0008537,increased susceptibility to induced colitis|MP:0010180,increased susceptibility to weight loss|MP:0013486,decreased Paneth cell number|MP:0013799,abnormal intestinal goblet cell physiology|MP:0014222,decreased colon goblet cell number
MGI:7541038	Tvp23b<m1Btlr>	MP:0008537,increased susceptibility to induced colitis|MP:0010180,increased susceptibility to weight loss
MGI:1857112	t<w18>	MP:0002230,abnormal primitive streak formation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1856569	t<w2>	MP:0001154,seminiferous tubule degeneration|MP:0001925,male infertility|MP:0005578,teratozoospermia|MP:0009376,abnormal manchette morphology
MGI:2665549	t<w3>	MP:0002081,perinatal lethality
MGI:1858134	t<w71Jr1>	MP:0000592,short tail
MGI:1856571	t<w73>	MP:0005028,abnormal trophectoderm morphology|MP:0005032,abnormal ectoplacental cone morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011192,decreased embryonic epiblast cell proliferation
MGI:3047782	t<w73lab>	MP:0011087,neonatal lethality, complete penetrance
MGI:1856721	t<w8>	MP:0001154,seminiferous tubule degeneration|MP:0001925,male infertility|MP:0005578,teratozoospermia|MP:0009230,abnormal sperm head morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0031374,abnormal manchette assembly
MGI:4434218	Twf1<tm1a(EUCOMM)Wtsi>	MP:0001191,abnormal skin condition|MP:0001262,decreased body weight|MP:0002966,decreased circulating alkaline phosphatase level
MGI:5293453	Twf2<tm1Pla>	MP:0002169,no abnormal phenotype detected
MGI:1857760	T<Wis>	MP:0000141,abnormal vertebral body morphology|MP:0000589,thin tail|MP:0000592,short tail|MP:0000932,absent notochord|MP:0000955,abnormal spinal cord morphology|MP:0001680,abnormal mesoderm development|MP:0001684,abnormal axial mesoderm morphology|MP:0002151,abnormal neural tube morphology|MP:0002230,abnormal primitive streak formation|MP:0002825,abnormal notochord morphology|MP:0002861,abnormal tail bud morphology|MP:0003050,abnormal sacral vertebrae morphology|MP:0003087,absent allantois|MP:0003345,decreased rib number|MP:0003456,absent tail|MP:0004387,abnormal prechordal plate morphology|MP:0004613,fusion of vertebral arches|MP:0004668,absent vertebral body|MP:0005221,abnormal rostral-caudal axis patterning|MP:0006386,absent somites|MP:0008762,embryonic lethality|MP:0009331,absent primitive node|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0012707,incomplete caudal neuropore closure|MP:0012740,abnormal posterior primitive streak morphology
MGI:6379556	Twist1<em1(IMPC)Rbrc>	MP:0000137,abnormal vertebrae morphology|MP:0000186,decreased circulating HDL cholesterol level|MP:0000438,abnormal cranium morphology|MP:0000572,abnormal autopod morphology|MP:0000579,abnormal nail morphology|MP:0001489,decreased startle reflex|MP:0002060,abnormal skin morphology|MP:0002110,abnormal digit morphology|MP:0002152,abnormal brain morphology|MP:0002644,decreased circulating triglyceride level|MP:0003960,increased lean body mass|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004599,abnormal vertebral arch morphology|MP:0005179,decreased circulating cholesterol level|MP:0005270,abnormal zygomatic bone morphology|MP:0008805,decreased circulating amylase level|MP:0009142,decreased prepulse inhibition
MGI:2684436	Twist1<Pas>	MP:0000111,cleft palate|MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2157489	Twist1<Pde>	MP:0000562,polydactyly|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0011092,embryonic lethality, complete penetrance
MGI:3038818	Twist1<Ska10>	MP:0000081,premature cranial suture closure|MP:0000150,abnormal rib morphology|MP:0000547,short limbs|MP:0000562,polydactyly|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0002115,abnormal limb bone morphology|MP:0003417,premature endochondral bone ossification|MP:0003631,nervous system phenotype|MP:0005298,abnormal clavicle morphology|MP:0008271,abnormal bone ossification|MP:0008395,abnormal osteoblast differentiation|MP:0011087,neonatal lethality, complete penetrance|MP:0030350,premature coronal suture closure|MP:0030356,premature lambdoid suture closure
MGI:1857265	Twist1<tm1Bhr>	MP:0000081,premature cranial suture closure|MP:0000550,abnormal forelimb morphology|MP:0000562,polydactyly|MP:0000733,abnormal muscle development|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001634,internal hemorrhage|MP:0002109,abnormal limb morphology|MP:0004386,enlarged interparietal bone|MP:0004424,temporal bone hypoplasia|MP:0005382,craniofacial phenotype|MP:0008395,abnormal osteoblast differentiation|MP:0008430,short temporal bone squamous part|MP:0011092,embryonic lethality, complete penetrance|MP:0030350,premature coronal suture closure
MGI:3768516	Twist1<tm2Bhr>	MP:0005390,skeleton phenotype
MGI:3830850	Twist2<tm1.1(cre)Dor>	MP:0002169,no abnormal phenotype detected
MGI:5548349	Twist2<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001175,abnormal lung morphology|MP:0004882,enlarged lung|MP:0005630,increased lung weight|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3044412	Twist2<tm1(cre)Dor>	MP:0000024,lowered ear position|MP:0000189,hypoglycemia|MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000425,loss of eyelid cilia|MP:0000428,abnormal craniofacial morphology|MP:0000432,abnormal head morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000759,abnormal skeletal muscle morphology|MP:0001199,thin skin|MP:0001212,skin lesions|MP:0001221,epidermal atrophy|MP:0001242,hyperkeratosis|MP:0001243,abnormal dermal layer morphology|MP:0001244,thin dermal layer|MP:0002073,abnormal hair growth|MP:0002092,abnormal eye morphology|MP:0002169,no abnormal phenotype detected|MP:0002357,abnormal spleen white pulp morphology|MP:0002371,abnormal thymus cortex morphology|MP:0002375,abnormal thymus medulla morphology|MP:0003644,thymus atrophy|MP:0005150,cachexia|MP:0005323,dystonia|MP:0006236,absent Meibomian glands|MP:0006320,abnormal interscapular fat pad morphology|MP:0008395,abnormal osteoblast differentiation|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0008843,absent subcutaneous adipose tissue|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009116,abnormal brown fat cell morphology|MP:0010025,decreased total body fat amount|MP:0010398,decreased liver glycogen level|MP:0010399,decreased skeletal muscle glycogen level|MP:0010678,abnormal skin adnexa morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013389,Meibomian gland hypoplasia|MP:0030191,narrow snout
MGI:2675504	twit	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001529,abnormal vocalization|MP:0002161,abnormal fertility/fecundity|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2176974	twl	MP:0002187,abnormal fibula morphology|MP:0004358,bowed tibia
MGI:1857098	t<wN10>	MP:0004179,transmission ratio distortion|MP:0011091,prenatal lethality, complete penetrance
MGI:1856757	t<wN11>	MP:0004179,transmission ratio distortion|MP:0011091,prenatal lethality, complete penetrance
MGI:1857099	t<wN13>	MP:0004179,transmission ratio distortion|MP:0011091,prenatal lethality, complete penetrance
MGI:1856758	t<wN15>	MP:0004179,transmission ratio distortion|MP:0011091,prenatal lethality, complete penetrance
MGI:1856759	t<wN19>	MP:0004179,transmission ratio distortion|MP:0011091,prenatal lethality, complete penetrance
MGI:1856760	t<wN20>	MP:0004179,transmission ratio distortion|MP:0011091,prenatal lethality, complete penetrance
MGI:1856761	t<wN25>	MP:0004179,transmission ratio distortion|MP:0011091,prenatal lethality, complete penetrance
MGI:1856763	t<wN29>	MP:0004179,transmission ratio distortion|MP:0011091,prenatal lethality, complete penetrance
MGI:1857097	t<wN5>	MP:0004179,transmission ratio distortion|MP:0011091,prenatal lethality, complete penetrance
MGI:1856756	t<wN8>	MP:0004179,transmission ratio distortion|MP:0011091,prenatal lethality, complete penetrance
MGI:5496874	Twnk<tm1.1Lrsn>	MP:0000274,enlarged heart|MP:0002083,premature death|MP:0006035,abnormal mitochondrial morphology|MP:0010955,abnormal respiratory electron transport chain
MGI:8226835	Twnk<tm1.1Suom>	MP:0000607,abnormal hepatocyte morphology|MP:0000880,decreased Purkinje cell number|MP:0001263,weight loss|MP:0001764,abnormal homeostasis|MP:0002083,premature death|MP:0002108,abnormal muscle morphology|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0002654,spongiform encephalopathy|MP:0003631,nervous system phenotype|MP:0003806,abnormal nucleotide metabolism|MP:0005289,increased oxygen consumption|MP:0005319,abnormal enzyme/coenzyme level|MP:0005384,cellular phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008963,increased carbon dioxide production|MP:0009358,environmentally induced seizures|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011639,decreased mitochondrial DNA content|MP:0013245,abnormal lipid metabolism|MP:0020237,increased proline level|MP:0020338,abnormal hippocampal pyramidal neuron dendrite morphology|MP:0030658,increased glycine level|MP:0030691,increased serine level|MP:0030743,decreased aspartic acid level
MGI:5496876	Twnk<tm1.2Lrsn>	MP:0001672,abnormal embryo development|MP:0011091,prenatal lethality, complete penetrance|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:1856793	t<wPas1>	MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0003954,abnormal Reichert's membrane morphology|MP:0003988,disorganized embryonic tissue|MP:0011092,embryonic lethality, complete penetrance
MGI:1856794	t<wPas2>	MP:0001925,male infertility
MGI:1856795	t<wPas3>	MP:0001925,male infertility
MGI:3830633	Twsg1<tm1.1Mboc>	MP:0000024,lowered ear position|MP:0000060,delayed bone ossification|MP:0000137,abnormal vertebrae morphology|MP:0000428,abnormal craniofacial morphology|MP:0000432,abnormal head morphology|MP:0000454,abnormal jaw morphology|MP:0000474,abnormal foregut morphology|MP:0000585,kinked tail|MP:0000592,short tail|MP:0000755,hindlimb paralysis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0001406,abnormal gait|MP:0001539,decreased caudal vertebrae number|MP:0002083,premature death|MP:0002252,abnormal oropharynx morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003935,abnormal craniofacial development|MP:0004599,abnormal vertebral arch morphology|MP:0004601,abnormal vertebral spinous process morphology|MP:0004605,abnormal vertebral lamina morphology|MP:0005163,cyclopia|MP:0009524,absent submandibular gland|MP:0009880,decreased mouth size|MP:0010335,fused first pharyngeal arch|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0013541,abnormal submandibular gland development|MP:0013790,single external naris|MP:0014277,alobar holoprosencephaly|MP:0030268,agnathia
MGI:5056109	Twsg1<tm1Aptr>	MP:0000934,abnormal telencephalon development|MP:0006341,small first pharyngeal arch|MP:0009901,abnormal frontonasal prominence morphology|MP:0010335,fused first pharyngeal arch
MGI:3604453	Twsg1<tm1Dgen>	MP:0000585,kinked tail|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0006086,decreased body mass index
MGI:3802605	Twsg1<tm1Ecan>	MP:0000585,kinked tail|MP:0000592,short tail|MP:0001265,decreased body size|MP:0002111,abnormal tail morphology|MP:0002113,abnormal skeleton development|MP:0003109,short femur|MP:0005508,abnormal skeleton morphology|MP:0010124,decreased bone mineral content|MP:0010869,decreased bone trabecula number|MP:0010876,decreased bone volume|MP:0010879,decreased trabecular bone volume|MP:0011101,prenatal lethality, incomplete penetrance|MP:0030985,decreased circulating osteocalcin level
MGI:3044357	Twsg1<tm1Emdr>	MP:0000585,kinked tail|MP:0000592,short tail|MP:0001262,decreased body weight|MP:0002111,abnormal tail morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0004711,persistence of notochord tissue|MP:0005226,abnormal vertebral arch development|MP:0005229,abnormal intervertebral disk development|MP:0011101,prenatal lethality, incomplete penetrance
MGI:2655736	Twsg1<tm1Nosa>	MP:0000220,increased monocyte cell number|MP:0000322,increased granulocyte number|MP:0000527,abnormal kidney development|MP:0000585,kinked tail|MP:0000704,abnormal thymus development|MP:0000715,decreased thymocyte number|MP:0000745,tremors|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001634,internal hemorrhage|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002113,abnormal skeleton development|MP:0002115,abnormal limb bone morphology|MP:0002144,abnormal B cell differentiation|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002427,disproportionate dwarf|MP:0002875,decreased erythrocyte cell number|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003179,thrombocytopenia|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003419,delayed endochondral bone ossification|MP:0003644,thymus atrophy|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0004173,abnormal intervertebral disk morphology|MP:0004874,abnormal timing of postnatal eyelid opening|MP:0005016,decreased lymphocyte cell number|MP:0005092,decreased double-positive T cell number|MP:0005150,cachexia|MP:0006050,pulmonary fibrosis|MP:0008082,increased single-positive T cell number|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number|MP:0008215,decreased immature B cell number|MP:0008273,abnormal intramembranous bone ossification|MP:0008479,decreased spleen white pulp amount|MP:0009323,abnormal spleen development|MP:0009339,decreased splenocyte number|MP:0009541,increased thymocyte apoptosis|MP:0011088,neonatal lethality, incomplete penetrance|MP:0020010,decreased bone mineral density of femur|MP:0021190,decreased bone mineral density of lumbar vertebrae|MP:0030279,thin neurocranium|MP:0031109,subarachnoid hemorrhage
MGI:2652126	Txk<tm1Pls>	MP:0003009,abnormal cytokine secretion|MP:0005027,increased susceptibility to parasitic infection
MGI:5817709	Txlna<tm1b(EUCOMM)Hmgu>	MP:0001147,small testis|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0002874,decreased hemoglobin content|MP:0005013,increased lymphocyte cell number|MP:0005627,increased circulating potassium level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012362,increased large unstained cell number
MGI:4130037	Txlng<Gt(RRJ292)Byg>	MP:0002169,no abnormal phenotype detected
MGI:5605561	Txlng<tm1.2Star>	MP:0002169,no abnormal phenotype detected
MGI:2669963	Txn1<tm1Mmt>	MP:0001730,embryonic growth arrest|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0005031,abnormal trophoblast layer morphology|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:2450237	Txn2<Gt(OST69169)Lex>	MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0001698,decreased embryo size|MP:0010954,abnormal cellular respiration|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:6294714	Txndc11<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0002797,increased thigmotaxis|MP:0003795,abnormal bone structure|MP:0005178,increased circulating cholesterol level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010124,decreased bone mineral content
MGI:4173257	Txndc12<Gt(OST69558)Lex>	MP:0002169,no abnormal phenotype detected
MGI:5550543	Txndc2<tm1.1Arte>	MP:0005379,endocrine/exocrine gland phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:3604412	Txndc2<tm1Lex>	MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001264,increased body size|MP:0001565,abnormal circulating phosphate level|MP:0008597,decreased circulating interleukin-6 level
MGI:6728079	Txndc5<em1Ntuh>	MP:0003141,cardiac fibrosis|MP:0004215,abnormal myocardial fiber physiology|MP:0004486,decreased response of heart to induced stress
MGI:5695945	Txndc5<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0001399,hyperactivity|MP:0002059,abnormal seminal vesicle morphology|MP:0002079,increased circulating insulin level|MP:0002574,increased vertical activity|MP:0002644,decreased circulating triglyceride level|MP:0005179,decreased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level
MGI:3526865	Txnip<Gt(ROSA)83Sor>	MP:0002169,no abnormal phenotype detected
MGI:2687368	Txnip<Hyplip1>	MP:0001552,increased circulating triglyceride level|MP:0002118,abnormal lipid homeostasis|MP:0002981,increased liver weight|MP:0003331,increased hepatocellular carcinoma incidence|MP:0005145,increased circulating VLDL cholesterol level|MP:0005178,increased circulating cholesterol level|MP:0005281,increased fatty acids level
MGI:3818744	Txnip<tm1.1Rlee>	MP:0003921,abnormal heart left ventricle morphology|MP:0004484,abnormal response of heart to induced stress|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005560,decreased circulating glucose level|MP:0030018,increased cardiac muscle cell glucose uptake|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3778277	Txnip<tm1.1Road>	MP:0000189,hypoglycemia|MP:0001552,increased circulating triglyceride level|MP:0002078,abnormal glucose homeostasis|MP:0002575,increased circulating ketone body level|MP:0002891,increased insulin sensitivity|MP:0003383,abnormal gluconeogenesis|MP:0003926,decreased cellular glucose uptake|MP:0005292,improved glucose tolerance|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0010768,mortality/aging|MP:0010954,abnormal cellular respiration|MP:0013405,increased circulating lactate level|MP:0031619,increased skeletal muscle cell glucose uptake
MGI:5637001	Txnip<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000194,increased circulating calcium level|MP:0001325,abnormal retina morphology|MP:0001552,increased circulating triglyceride level|MP:0001566,increased circulating phosphate level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:3613036	Txnip<tm1Jjy>	MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001560,abnormal circulating insulin level|MP:0002078,abnormal glucose homeostasis|MP:0002118,abnormal lipid homeostasis|MP:0002575,increased circulating ketone body level|MP:0002628,hepatic steatosis|MP:0003103,liver degeneration|MP:0003606,kidney failure|MP:0005161,hematuria|MP:0005178,increased circulating cholesterol level|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0005606,increased bleeding time|MP:0005627,increased circulating potassium level|MP:0005634,decreased circulating sodium level|MP:0006084,abnormal circulating phospholipid level|MP:0009642,abnormal blood homeostasis|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0012325,decreased circulating antithrombin level|MP:0012356,increased prothrombin time|MP:0012359,increased partial thromboplastin time|MP:0031115,macrovesicular hepatic steatosis|MP:0031116,microvesicular hepatic steatosis
MGI:3818743	Txnip<tm1Rlee>	MP:0004484,abnormal response of heart to induced stress|MP:0030018,increased cardiac muscle cell glucose uptake
MGI:3778275	Txnip<tm1Road>	MP:0000189,hypoglycemia|MP:0001552,increased circulating triglyceride level|MP:0002575,increased circulating ketone body level|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:3574362	Txnip<tm1Yu>	MP:0002581,abnormal ileum morphology|MP:0004973,increased regulatory T cell number|MP:0005013,increased lymphocyte cell number|MP:0005068,abnormal NK cell morphology|MP:0005232,abnormal mesenteric lymph node morphology|MP:0005348,increased T cell proliferation|MP:0008040,decreased NK T cell number|MP:0008045,decreased NK cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010766,abnormal NK cell physiology
MGI:7256942	Txnl1<em1(IMPC)Tcp>	MP:0000208,decreased hematocrit|MP:0000220,increased monocyte cell number|MP:0001289,persistence of hyaloid vascular system|MP:0001340,abnormal eyelid morphology|MP:0002591,decreased mean corpuscular volume|MP:0003131,increased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010123,increased bone mineral content
MGI:4126539	Txnl1<Gt(XH718)Byg>	MP:0002169,no abnormal phenotype detected
MGI:6285590	Txnl4a<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:3722092	Txnrd1<tm1.1Ees>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0009397,increased trophoblast giant cell number|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011184,absent embryonic epiblast|MP:0011186,abnormal visceral endoderm morphology
MGI:3574773	Txnrd1<tm1.1Marc>	MP:0000352,decreased cell proliferation|MP:0001698,decreased embryo size|MP:0001718,abnormal visceral yolk sac morphology|MP:0001730,embryonic growth arrest|MP:0002151,abnormal neural tube morphology|MP:0004180,failure of initiation of embryo turning|MP:0009768,impaired somite development|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011705,absent fibroblast proliferation|MP:0012173,short rostral-caudal axis
MGI:3722091	Txnrd1<tm1Ees>	MP:0002169,no abnormal phenotype detected
MGI:3574358	Txnrd1<tm1Marc>	MP:0000745,tremors|MP:0000849,abnormal cerebellum morphology|MP:0000851,cerebellum hypoplasia|MP:0000854,abnormal cerebellum development|MP:0000873,thin external granule cell layer|MP:0000885,ectopic Purkinje cell|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001525,impaired balance|MP:0002182,abnormal astrocyte morphology|MP:0003631,nervous system phenotype|MP:0003634,abnormal glial cell morphology|MP:0004097,abnormal cerebellar cortex morphology|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0006097,abnormal cerebellar lobule formation|MP:0008489,slow postnatal weight gain|MP:0008572,abnormal Purkinje cell dendrite morphology
MGI:3512409	Txnrd2<tm1.1Marc>	MP:0000233,abnormal blood flow velocity|MP:0000266,abnormal heart morphology|MP:0000280,thin ventricular wall|MP:0000295,trabecula carnea hypoplasia|MP:0000598,abnormal liver morphology|MP:0001577,anemia|MP:0002123,abnormal definitive hematopoiesis|MP:0010725,thin interventricular septum|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0011704,decreased fibroblast proliferation
MGI:3512408	Txnrd2<tm1Marc>	MP:0002169,no abnormal phenotype detected|MP:0003631,nervous system phenotype
MGI:7384954	Txnrd3<tm1Vgla>	MP:0001922,reduced male fertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0009647,decreased fertilization frequency
MGI:1856639	Ty	MP:0000745,tremors|MP:0001405,impaired coordination|MP:0001926,female infertility|MP:0002064,seizures|MP:0003631,nervous system phenotype|MP:0011085,postnatal lethality, complete penetrance
MGI:3706656	Tyk2<E775K>	MP:0001805,decreased IgG level|MP:0003436,decreased susceptibility to induced arthritis|MP:0005027,increased susceptibility to parasitic infection|MP:0005465,abnormal T-helper 1 physiology|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008567,decreased interferon-gamma secretion|MP:0008617,increased circulating interleukin-12 level
MGI:5438711	Tyk2<tm1Biat>	MP:0003957,abnormal nitric oxide homeostasis|MP:0005025,abnormal response to infection|MP:0008567,decreased interferon-gamma secretion|MP:0009791,increased susceptibility to viral infection induced morbidity/mortality|MP:0011077,decreased macrophage nitric oxide production|MP:0020913,increased susceptibility to Riboviria infection|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality|MP:0031040,increased susceptibility to Picornaviridae infection induced morbidity/mortality
MGI:2389582	Tyk2<tm1Shmd>	MP:0001260,increased body weight|MP:0001261,obese|MP:0001554,increased circulating free fatty acids level|MP:0001777,abnormal body temperature homeostasis|MP:0002079,increased circulating insulin level|MP:0002145,abnormal T cell differentiation|MP:0002444,abnormal T cell physiology|MP:0002971,abnormal brown adipose tissue morphology|MP:0003077,abnormal cell cycle|MP:0003982,increased cholesterol level|MP:0004890,decreased energy expenditure|MP:0005293,impaired glucose tolerance|MP:0006036,abnormal mitochondrial physiology|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008567,decreased interferon-gamma secretion|MP:0009333,abnormal splenocyte physiology|MP:0011049,impaired adaptive thermogenesis|MP:0011168,abnormal fat cell differentiation|MP:0011636,disorganized mitochondrial cristae
MGI:6120762	Tyk2<tm2b(EUCOMM)Hmgu>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000691,enlarged spleen|MP:0000709,enlarged thymus|MP:0001126,abnormal ovary morphology|MP:0001944,abnormal pancreas morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0003179,thrombocytopenia|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0010580,decreased heart left ventricle size|MP:0011971,increased circulating lactate dehydrogenase level
MGI:5438771	Tyk2<tm3.1Biat>	MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality|MP:0031040,increased susceptibility to Picornaviridae infection induced morbidity/mortality
MGI:1856641	Tyl	MP:0000160,kyphosis|MP:0000745,tremors|MP:0000754,paresis|MP:0002064,seizures|MP:0002083,premature death|MP:0003631,nervous system phenotype
MGI:2183547	Tymp<tm1Akiy>	MP:0003806,abnormal nucleotide metabolism|MP:0005584,abnormal enzyme/coenzyme activity
MGI:3830837	Tymp<tm1Mihi>	MP:0003806,abnormal nucleotide metabolism
MGI:2153519	Tyr<c-10FR60L>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:1855988	Tyr<c-10J>	MP:0002075,abnormal coat/hair pigmentation|MP:0005171,absent coat pigmentation|MP:0006159,ocular albinism
MGI:2153484	Tyr<c-10R75M>	MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance
MGI:1856308	Tyr<c-112K>	MP:0008480,absent eye pigmentation|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance
MGI:2153485	Tyr<c-11DSD>	MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:1855989	Tyr<c-11J>	MP:0002075,abnormal coat/hair pigmentation|MP:0005171,absent coat pigmentation|MP:0006159,ocular albinism
MGI:2153521	Tyr<c-12FR60Hb>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2153523	Tyr<c-12HATh>	MP:0005171,absent coat pigmentation
MGI:2153526	Tyr<c-146G>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:1856580	Tyr<c-14CoS>	MP:0011087,neonatal lethality, complete penetrance
MGI:2153587	Tyr<c-14FR60Hb>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2153627	Tyr<c-15DSD>	MP:0005171,absent coat pigmentation
MGI:2153637	Tyr<c-15R145M>	MP:0005171,absent coat pigmentation
MGI:2153643	Tyr<c-15R60L>	MP:0011087,neonatal lethality, complete penetrance
MGI:2153663	Tyr<c-16DFiOD>	MP:0005171,absent coat pigmentation
MGI:2153707	Tyr<c-16HATh>	MP:0011087,neonatal lethality, complete penetrance
MGI:2153721	Tyr<c-177G>	MP:0005171,absent coat pigmentation
MGI:1856578	Tyr<c-17J>	MP:0005171,absent coat pigmentation|MP:0008480,absent eye pigmentation
MGI:2153722	Tyr<c-17UThc>	MP:0005171,absent coat pigmentation
MGI:1856405	Tyr<c-18J>	MP:0001189,absent skin pigmentation|MP:0005171,absent coat pigmentation
MGI:2153723	Tyr<c-19DTR>	MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:2388603	Tyr<c-19J>	MP:0001189,absent skin pigmentation|MP:0005171,absent coat pigmentation
MGI:1857547	Tyr<c-1DThWb>	MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:2153724	Tyr<c-1FAFyh>	MP:0011087,neonatal lethality, complete penetrance
MGI:2153725	Tyr<c-1FATw>	MP:0005171,absent coat pigmentation
MGI:2153726	Tyr<c-1FDFoHrc>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2153727	Tyr<c-1FR60Hb>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2153729	Tyr<c-202G>	MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:2153730	Tyr<c-20FATw>	MP:0002083,premature death
MGI:2672967	Tyr<c-20J>	MP:0001189,absent skin pigmentation|MP:0005171,absent coat pigmentation|MP:0005172,decreased eye pigmentation
MGI:2153731	Tyr<c-222THO-I>	MP:0005171,absent coat pigmentation
MGI:2153732	Tyr<c-23DVT>	MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:2153733	Tyr<c-24R145L>	MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:2153739	Tyr<c-24R75M>	MP:0005171,absent coat pigmentation
MGI:1856306	Tyr<c-25H>	MP:0000358,abnormal cell morphology|MP:0003111,abnormal cell nucleus morphology|MP:0003406,failure of zygotic cell division|MP:0003702,abnormal chromosome morphology|MP:0004028,chromosome breakage|MP:0004030,induced chromosome breakage|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2153742	Tyr<c-26DVT>	MP:0002169,no abnormal phenotype detected|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2153743	Tyr<c-27FrThc>	MP:0005171,absent coat pigmentation
MGI:4442899	Tyr<c-2Btlr>	MP:0005171,absent coat pigmentation|MP:0008480,absent eye pigmentation
MGI:2153744	Tyr<c-2CHLb>	MP:0011091,prenatal lethality, complete penetrance
MGI:1855985	Tyr<c-2J>	MP:0000394,absent hair follicle melanin granules|MP:0001004,abnormal retina photoreceptor morphology|MP:0001189,absent skin pigmentation|MP:0001224,abnormal keratinocyte apoptosis|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0001327,decreased retina photoreceptor cell number|MP:0002090,abnormal vision|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0005075,abnormal melanosome morphology|MP:0005171,absent coat pigmentation|MP:0005198,abnormal aqueous drainage system morphology|MP:0005241,abnormal retina ganglion layer morphology|MP:0005253,abnormal eye physiology|MP:0005257,abnormal intraocular pressure|MP:0006159,ocular albinism|MP:0012143,decreased a-wave amplitude|MP:0012144,decreased b-wave amplitude
MGI:2153745	Tyr<c-2MLPm>	MP:0005171,absent coat pigmentation|MP:0008770,decreased survivor rate
MGI:2153748	Tyr<c-2R145L>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2153486	Tyr<c-2YPSj>	MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:2153770	Tyr<c-31HATh>	MP:0005171,absent coat pigmentation
MGI:2153771	Tyr<c-32DSD>	MP:0005171,absent coat pigmentation
MGI:2153772	Tyr<c-36FrS>	MP:0000371,diluted coat color
MGI:2153773	Tyr<c-38R145L>	MP:0005171,absent coat pigmentation
MGI:2153774	Tyr<c-39SAS>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2153775	Tyr<c-3DENb>	MP:0011091,prenatal lethality, complete penetrance
MGI:2153776	Tyr<c-3FAFyh>	MP:0005171,absent coat pigmentation
MGI:2153777	Tyr<c-3FDFoHrd>	MP:0005171,absent coat pigmentation
MGI:2153778	Tyr<c-3FR60Hb>	MP:0005171,absent coat pigmentation
MGI:2153779	Tyr<c-3R145L>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2153780	Tyr<c-3R60L>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:2153781	Tyr<c-3YPSd>	MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:5304151	Tyr<c-40H>	MP:0002169,no abnormal phenotype detected
MGI:5304153	Tyr<c-42H>	MP:0010769,abnormal survival
MGI:1856307	Tyr<c-44H>	MP:0001324,abnormal eye pigmentation|MP:0002075,abnormal coat/hair pigmentation|MP:0005171,absent coat pigmentation|MP:0005172,decreased eye pigmentation
MGI:2153841	Tyr<c-45DSD>	MP:0005171,absent coat pigmentation
MGI:1858165	Tyr<c-45H>	MP:0005171,absent coat pigmentation
MGI:1858166	Tyr<c-46H>	MP:0005171,absent coat pigmentation
MGI:5304155	Tyr<c-47H>	MP:0001925,male infertility|MP:0003604,single kidney|MP:0003642,absent seminal vesicle|MP:0005389,reproductive system phenotype|MP:0031434,increased miscarriage rate
MGI:2153842	Tyr<c-4CFO>	MP:0005171,absent coat pigmentation
MGI:2153844	Tyr<c-4FR60Hd>	MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:1855986	Tyr<c-4J>	MP:0005171,absent coat pigmentation
MGI:2153846	Tyr<c-4PB>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5304157	Tyr<c-50H>	MP:0005171,absent coat pigmentation
MGI:2153848	Tyr<c-51DTD>	MP:0005171,absent coat pigmentation
MGI:5304158	Tyr<c-51H>	MP:0005171,absent coat pigmentation|MP:0005389,reproductive system phenotype
MGI:5304160	Tyr<c-55H>	MP:0011089,perinatal lethality, complete penetrance
MGI:2153850	Tyr<c-5FR60Hg>	MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:2153851	Tyr<c-62DSD>	MP:0005171,absent coat pigmentation
MGI:2153852	Tyr<c-65G>	MP:0005171,absent coat pigmentation
MGI:1856309	Tyr<c-65K>	MP:0011087,neonatal lethality, complete penetrance
MGI:2153853	Tyr<c-68G>	MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:2153854	Tyr<c-6THO-IV>	MP:0005171,absent coat pigmentation
MGI:2153855	Tyr<c-76UT>	MP:0005171,absent coat pigmentation
MGI:2153857	Tyr<c-77HATh>	MP:0005171,absent coat pigmentation
MGI:2153859	Tyr<c-7R250H>	MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:2153861	Tyr<c-7THO-II>	MP:0005171,absent coat pigmentation
MGI:2153862	Tyr<c-8FrS>	MP:0000371,diluted coat color
MGI:2153863	Tyr<c-9FR60Hb>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:1855987	Tyr<c-9J>	MP:0002075,abnormal coat/hair pigmentation|MP:0005171,absent coat pigmentation|MP:0006159,ocular albinism
MGI:2153864	Tyr<c-9Pub>	MP:0005171,absent coat pigmentation
MGI:1855983	Tyr<c-a>	MP:0002075,abnormal coat/hair pigmentation|MP:0005376,homeostasis/metabolism phenotype
MGI:2153865	Tyr<c-AL>	MP:0011093,embryonic lethality at implantation, complete penetrance
MGI:1856301	Tyr<c-Bc>	MP:0011092,embryonic lethality, complete penetrance
MGI:1856302	Tyr<c-Bc2>	MP:0002075,abnormal coat/hair pigmentation|MP:0005171,absent coat pigmentation|MP:0005389,reproductive system phenotype|MP:0008480,absent eye pigmentation|MP:0010768,mortality/aging
MGI:1856303	Tyr<c-Bc3>	MP:0002075,abnormal coat/hair pigmentation|MP:0005171,absent coat pigmentation|MP:0005389,reproductive system phenotype|MP:0008480,absent eye pigmentation|MP:0010768,mortality/aging
MGI:3640303	Tyr<c-Brd>	MP:0001189,absent skin pigmentation|MP:0005171,absent coat pigmentation|MP:0005172,decreased eye pigmentation
MGI:3777840	Tyr<c-Btlr>	MP:0005171,absent coat pigmentation|MP:0008480,absent eye pigmentation
MGI:1855977	Tyr<c-ch>	MP:0000371,diluted coat color
MGI:5303088	Tyr<c-ch37H>	MP:0000371,diluted coat color
MGI:5304150	Tyr<c-ch38H>	MP:0000371,diluted coat color|MP:0010768,mortality/aging
MGI:5304156	Tyr<c-ch49H>	MP:0000421,mottled coat
MGI:5304159	Tyr<c-ch54H>	MP:0000371,diluted coat color|MP:0005389,reproductive system phenotype
MGI:5288227	Tyr<c-ch62H>	MP:0000371,diluted coat color
MGI:5293353	Tyr<c-ch83R>	MP:0000371,diluted coat color|MP:0002169,no abnormal phenotype detected
MGI:2683485	Tyr<c-em>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0005366,variegated coat color
MGI:1855979	Tyr<c-h>	MP:0000371,diluted coat color|MP:0001510,abnormal coat appearance|MP:0002075,abnormal coat/hair pigmentation|MP:0005102,abnormal iris pigmentation|MP:0005172,decreased eye pigmentation|MP:0006159,ocular albinism|MP:0008480,absent eye pigmentation
MGI:2663091	Tyr<c-i>	MP:0000371,diluted coat color|MP:0005391,vision/eye phenotype|MP:0010771,integument phenotype
MGI:2153866	Tyr<c-LA>	MP:0011087,neonatal lethality, complete penetrance
MGI:1855980	Tyr<c-m>	MP:0000372,irregular coat pigmentation|MP:0002075,abnormal coat/hair pigmentation|MP:0010231,transverse fur striping
MGI:2153728	Tyr<cm1OR>	MP:0000394,absent hair follicle melanin granules|MP:0000421,mottled coat|MP:0002075,abnormal coat/hair pigmentation|MP:0002095,abnormal skin pigmentation|MP:0006159,ocular albinism|MP:0008480,absent eye pigmentation
MGI:2153879	Tyr<c-OR15Q>	MP:0002080,prenatal lethality
MGI:1855981	Tyr<c-p>	MP:0000371,diluted coat color|MP:0000411,shiny fur|MP:0002075,abnormal coat/hair pigmentation|MP:0004382,abnormal hair follicle melanogenesis|MP:0005408,hypopigmentation|MP:0008480,absent eye pigmentation
MGI:5442732	Tyr<c-Wtsi>	MP:0005171,absent coat pigmentation|MP:0006159,ocular albinism
MGI:5818884	Tyr<em11Ove>	MP:0005171,absent coat pigmentation|MP:0008480,absent eye pigmentation
MGI:5582798	Tyr<em2Utr>	MP:0005171,absent coat pigmentation
MGI:5470270	Tyr<em3J>	MP:0001189,absent skin pigmentation|MP:0005171,absent coat pigmentation|MP:0008480,absent eye pigmentation
MGI:5817585	Tyr<em3Ove>	MP:0000371,diluted coat color|MP:0011551,variegated eye pigmentation pattern
MGI:5817676	Tyr<em5Ove>	MP:0000371,diluted coat color|MP:0011279,decreased ear pigmentation|MP:0011551,variegated eye pigmentation pattern
MGI:5817685	Tyr<em6Ove>	MP:0000371,diluted coat color|MP:0011551,variegated eye pigmentation pattern
MGI:4868367	Tyr<m3Btlr>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation
MGI:5512995	Tyr<m4Btlr>	MP:0000371,diluted coat color|MP:0001186,pigmentation phenotype
MGI:5607743	Tyr<m5Btlr>	MP:0000371,diluted coat color
MGI:6399920	Tyro3<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001175,abnormal lung morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002100,abnormal tooth morphology|MP:0002110,abnormal digit morphology|MP:0002339,abnormal lymph node morphology|MP:0004083,polysyndactyly|MP:0005011,increased eosinophil cell number|MP:0010090,increased circulating creatine kinase level
MGI:2387762	Tyro3<tm1Grl>	MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0005391,vision/eye phenotype|MP:0009357,abnormal seizure response to inducing agent
MGI:2386271	Tyrobp<tm1.1Viv>	MP:0000062,increased bone mineral density|MP:0000067,osteopetrosis|MP:0000136,abnormal microglial cell morphology|MP:0000920,abnormal myelination|MP:0001541,abnormal osteoclast physiology|MP:0001601,abnormal myelopoiesis|MP:0001728,failure of embryo implantation|MP:0001921,reduced fertility|MP:0002910,abnormal excitatory postsynaptic currents|MP:0002998,abnormal bone remodeling|MP:0003008,enhanced long-term potentiation|MP:0003631,nervous system phenotype|MP:0004256,abnormal maternal decidual layer morphology|MP:0004260,enlarged placenta|MP:0004993,decreased bone resorption|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005404,abnormal axon morphology|MP:0005605,increased bone mass|MP:0005616,decreased susceptibility to type IV hypersensitivity reaction|MP:0008126,increased dendritic cell number|MP:0008271,abnormal bone ossification|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0008876,decreased uterine NK cell number|MP:0010123,increased bone mineral content|MP:0010868,increased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0012529,abnormal decidua basalis morphology|MP:0012726,abnormal uterine spiral artery morphology|MP:0012727,abnormal uterine spiral artery remodeling
MGI:2386277	Tyrobp<tm1Lll>	MP:0000067,osteopetrosis|MP:0003080,increased natural killer cell mediated cytotoxicity|MP:0003436,decreased susceptibility to induced arthritis|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0004993,decreased bone resorption|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008042,abnormal NK T cell physiology|MP:0008126,increased dendritic cell number|MP:0008396,abnormal osteoclast differentiation|MP:0008567,decreased interferon-gamma secretion
MGI:2450834	Tyrobp<tm1Ttk>	MP:0000062,increased bone mineral density|MP:0000067,osteopetrosis|MP:0000920,abnormal myelination|MP:0000953,abnormal oligodendrocyte morphology|MP:0001489,decreased startle reflex|MP:0001541,abnormal osteoclast physiology|MP:0002376,abnormal dendritic cell physiology|MP:0002635,reduced sensorimotor gating|MP:0002882,abnormal neuron morphology|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003725,increased autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004982,abnormal osteoclast morphology|MP:0005154,increased B cell proliferation|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0008177,increased germinal center B cell number|MP:0008481,increased spleen germinal center number|MP:0008483,increased spleen germinal center size|MP:0008500,increased IgG2a level|MP:0008502,increased IgG3 level|MP:0008705,increased interleukin-6 secretion|MP:0009142,decreased prepulse inhibition|MP:0010872,increased trabecular bone mass|MP:0020011,increased bone mineral density of femur|MP:0021195,increased bone mineral density of caudal vertebrae
MGI:2386270	Tyrobp<tm1Viv>	MP:0020916,increased susceptibility to Herpesvirales infection
MGI:1855960	Tyrp1<b>	MP:0001322,abnormal iris morphology|MP:0006228,iris atrophy
MGI:1857374	Tyrp1<b-11PU>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857353	Tyrp1<b-11R30M>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857375	Tyrp1<b-12PU>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857359	Tyrp1<b-13DT>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857354	Tyrp1<b-13R75M>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857366	Tyrp1<b-173G>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857367	Tyrp1<b-1DFiOD>	MP:0011091,prenatal lethality, complete penetrance
MGI:2155307	Tyrp1<b-1ETOPc>	MP:0011091,prenatal lethality, complete penetrance
MGI:2155308	Tyrp1<b-1FBleo>	MP:0011091,prenatal lethality, complete penetrance
MGI:2155309	Tyrp1<b-1FCHLc>	MP:0001265,decreased body size|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002075,abnormal coat/hair pigmentation|MP:0004924,abnormal behavior|MP:0005172,decreased eye pigmentation
MGI:2155310	Tyrp1<b-1MLP5>	MP:0002075,abnormal coat/hair pigmentation|MP:0005172,decreased eye pigmentation
MGI:1857368	Tyrp1<b-1OZ>	MP:0011089,perinatal lethality, complete penetrance
MGI:1857381	Tyrp1<b-1THO-IV>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857355	Tyrp1<b-26R60L>	MP:0011091,prenatal lethality, complete penetrance
MGI:5582741	Tyrp1<b-2Btlr>	MP:0000371,diluted coat color
MGI:2155311	Tyrp1<b-2MLP10>	MP:0002075,abnormal coat/hair pigmentation|MP:0005172,decreased eye pigmentation
MGI:2155312	Tyrp1<b-2MLP7.5>	MP:0002075,abnormal coat/hair pigmentation|MP:0005172,decreased eye pigmentation
MGI:1857362	Tyrp1<b-331K>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857369	Tyrp1<b-33G>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857360	Tyrp1<b-37DTD>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857370	Tyrp1<b-37FrThc>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857377	Tyrp1<b-37Pub>	MP:0011091,prenatal lethality, complete penetrance
MGI:5806329	Tyrp1<b-3Btlr>	MP:0000371,diluted coat color
MGI:1857378	Tyrp1<b-3CHLe>	MP:0011091,prenatal lethality, complete penetrance
MGI:2155313	Tyrp1<b-3MLPc>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857363	Tyrp1<b-3YPSc>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857364	Tyrp1<b-3YPSh>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857371	Tyrp1<b-46UThc>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857357	Tyrp1<b-47DThWb>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857361	Tyrp1<b-49HATh>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857380	Tyrp1<b-4ACRg>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857358	Tyrp1<b-51DThWb>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857372	Tyrp1<b-55CoS>	MP:0011091,prenatal lethality, complete penetrance
MGI:5308095	Tyrp1<b-55H>	MP:0000371,diluted coat color|MP:0002075,abnormal coat/hair pigmentation
MGI:1857379	Tyrp1<b-5CHLe>	MP:0011091,prenatal lethality, complete penetrance
MGI:2155315	Tyrp1<b-5CHLo>	MP:0002075,abnormal coat/hair pigmentation|MP:0005172,decreased eye pigmentation
MGI:2155316	Tyrp1<b-5MLPm>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857376	Tyrp1<b-8PUb>	MP:0011091,prenatal lethality, complete penetrance
MGI:2155317	Tyrp1<b-9Bleo>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857373	Tyrp1<b-9PU>	MP:0011091,prenatal lethality, complete penetrance
MGI:1857356	Tyrp1<b-9R75VH>	MP:0011091,prenatal lethality, complete penetrance
MGI:5515343	Tyrp1<b-Btlr>	MP:0000371,diluted coat color
MGI:1855961	Tyrp1<b-c>	MP:0002075,abnormal coat/hair pigmentation
MGI:3795448	Tyrp1<b-cH>	MP:0002075,abnormal coat/hair pigmentation
MGI:1856390	Tyrp1<b-cJ>	MP:0002075,abnormal coat/hair pigmentation
MGI:1855965	Tyrp1<b-J>	MP:0005607,decreased bleeding time
MGI:1855962	Tyrp1<B-lt>	MP:0000026,abnormal inner ear morphology|MP:0000048,abnormal stria vascularis morphology|MP:0000371,diluted coat color|MP:0001963,abnormal hearing physiology|MP:0002075,abnormal coat/hair pigmentation|MP:0002102,abnormal ear morphology|MP:0002630,abnormal endocochlear potential|MP:0003878,abnormal ear physiology|MP:0004367,abnormal strial intermediate cell morphology|MP:0004411,decreased endocochlear potential|MP:0005102,abnormal iris pigmentation|MP:0005606,increased bleeding time
MGI:1855963	Tyrp1<B-w>	MP:0000371,diluted coat color|MP:0005172,decreased eye pigmentation
MGI:2178126	Tyrp1<isa>	MP:0005208,abnormal iris stroma morphology
MGI:3798840	Tyrp1<rgsc101>	MP:0002075,abnormal coat/hair pigmentation
MGI:3799001	Tyrp1<rgsc220>	MP:0002075,abnormal coat/hair pigmentation
MGI:3806983	Tyrp1<rgsc671>	MP:0002075,abnormal coat/hair pigmentation
MGI:3807951	Tyrp1<rgsc799>	MP:0002075,abnormal coat/hair pigmentation
MGI:3807968	Tyrp1<rgsc849>	MP:0002075,abnormal coat/hair pigmentation
MGI:3807981	Tyrp1<rgsc892>	MP:0002075,abnormal coat/hair pigmentation
MGI:3798832	Tyrp1<rgsc96>	MP:0002075,abnormal coat/hair pigmentation
MGI:2676946	Tyr<skc35>	MP:0002075,abnormal coat/hair pigmentation
MGI:5585631	Tyr<tm1Arte>	MP:0005171,absent coat pigmentation|MP:0008480,absent eye pigmentation
MGI:5695314	Tysnd1<tm1.1Arte>	MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0001402,decreased locomotor activity|MP:0001925,male infertility|MP:0002628,hepatic steatosis|MP:0002686,globozoospermia|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005389,reproductive system phenotype|MP:0008898,abnormal acrosome morphology|MP:0009647,decreased fertilization frequency|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0009838,abnormal sperm axoneme morphology|MP:0011971,increased circulating lactate dehydrogenase level|MP:0012216,decreased plasmalogen level
MGI:5635453	Tyw1<tm1b(KOMP)Wtsi>	MP:0000208,decreased hematocrit|MP:0001417,decreased exploration in new environment|MP:0002757,decreased vertical activity|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005419,decreased circulating serum albumin level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0006243,impaired pupillary reflex
MGI:1861588	Tz	MP:0000585,kinked tail|MP:0000592,short tail|MP:0011091,prenatal lethality, complete penetrance
MGI:6294123	U2af1<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system|MP:0001314,cornea opacity|MP:0001319,irregularly shaped pupil|MP:0002075,abnormal coat/hair pigmentation|MP:0004738,abnormal auditory brainstem response|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5659888	U2af1l4<tm1.2Tmo>	MP:0020476,abnormal circardian behavior entrainment
MGI:6202047	U2af1<tm1.1Hev>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0002006,neoplasm|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002590,increased mean corpuscular volume|MP:0002811,macrocytic anemia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0004810,decreased hematopoietic stem cell number|MP:0010768,mortality/aging
MGI:6783443	U2af1<tm1Mohi>	MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000333,decreased bone marrow cell number|MP:0001577,anemia|MP:0002083,premature death|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0004810,decreased hematopoietic stem cell number|MP:0005152,pancytopenia|MP:0008813,decreased common myeloid progenitor cell number|MP:0008973,decreased erythroid progenitor cell number|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0013776,bone marrow failure|MP:0020464,decreased megakaryocyte progenitor cell number
MGI:6379288	U2af2<em1(IMPC)J>	MP:0000062,increased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0000218,increased leukocyte cell number|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0004738,abnormal auditory brainstem response|MP:0005278,abnormal cholesterol homeostasis|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6306472	U2surp<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001402,decreased locomotor activity|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7541071	U90926<em1Dnkv>	MP:0008596,increased circulating interleukin-6 level|MP:0008735,increased susceptibility to endotoxin shock|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:3622180	Ua1<KK/Ta>	MP:0002871,albuminuria
MGI:3043446	Uaca<tm1Kiy>	MP:0000599,enlarged liver|MP:0001648,abnormal apoptosis|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0002717,abnormal male preputial gland morphology|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003331,increased hepatocellular carcinoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0005166,decreased susceptibility to injury|MP:0005178,increased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0008114,abnormal Kupffer cell morphology|MP:0008127,decreased dendritic cell number|MP:0008560,increased tumor necrosis factor secretion|MP:0011971,increased circulating lactate dehydrogenase level
MGI:6414487	Uap1<em1(IMPC)Tcp>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7287390	Uba1<em1Imat>	MP:0011093,embryonic lethality at implantation, complete penetrance|MP:0014134,abnormal embryo morphology
MGI:4362341	Uba2<tm1a(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5287495	Uba3<Tg(Tyr)2295C-2Ove>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:2154503	Uba3<tm1Tchi>	MP:0002085,abnormal embryonic tissue morphology|MP:0002718,abnormal inner cell mass morphology|MP:0003077,abnormal cell cycle|MP:0003693,abnormal blastocyst hatching|MP:0003988,disorganized embryonic tissue|MP:0010380,abnormal inner cell mass apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance|MP:0011184,absent embryonic epiblast|MP:0012128,abnormal blastocyst formation
MGI:4441283	Uba5<tm1Kmts>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5509054	Uba6<tm1Whpr>	MP:0000774,decreased brain size|MP:0000807,abnormal hippocampus morphology|MP:0000818,abnormal amygdala morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001360,abnormal social investigation|MP:0001399,hyperactivity|MP:0001438,aphagia|MP:0001447,abnormal nest building behavior|MP:0001488,increased startle reflex|MP:0001492,abnormal pilomotor reflex|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002797,increased thigmotaxis|MP:0003360,abnormal depression-related behavior|MP:0003631,nervous system phenotype|MP:0003858,enhanced coordination|MP:0004889,increased energy expenditure|MP:0005266,abnormal metabolism|MP:0005289,increased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0008428,abnormal spatial working memory|MP:0008948,decreased neuron number|MP:0008963,increased carbon dioxide production|MP:0009142,decreased prepulse inhibition|MP:0009454,impaired contextual conditioning behavior|MP:0009674,decreased birth weight|MP:0009936,abnormal dendritic spine morphology|MP:0010053,decreased grip strength|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011620,abnormal habituation to a new environment
MGI:3813907	Uba6<tm1Zjc>	MP:0011092,embryonic lethality, complete penetrance
MGI:3521787	Uba7<tm1Dez>	MP:0002169,no abnormal phenotype detected
MGI:6283518	Ubac1<em1(IMPC)J>	MP:0002591,decreased mean corpuscular volume|MP:0002965,increased circulating serum albumin level|MP:0003131,increased erythrocyte cell number|MP:0005287,narrow eye opening|MP:0005542,cornea vascularization|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:6260243	Ubac2<tm1e.1(EUCOMM)Hmgu>	MP:0009476,enlarged cecum
MGI:7414300	Ubap1<em1Yta>	MP:0001406,abnormal gait|MP:0002882,abnormal neuron morphology|MP:0003224,neuron degeneration|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005405,axon degeneration|MP:0011091,prenatal lethality, complete penetrance|MP:0012051,spasticity|MP:0030940,impaired autophagy|MP:0031204,hindlimb paresis
MGI:4433059	Ubap1<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5910359	Ubap2<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0005566,decreased blood urea nitrogen level
MGI:6257745	Ubap2l<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0002764,short tibia|MP:0003385,abnormal body wall morphology|MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval|MP:0011100,preweaning lethality, complete penetrance
MGI:5287115	Ubap2l<TgTn(sb-cHS4,Tyr)2326F-3b2Ove>	MP:0001265,decreased body size|MP:0001923,reduced female fertility
MGI:4940752	Ubash3a<tm1a(KOMP)Wtsi>	MP:0010053,decreased grip strength
MGI:5605803	Ubash3a<tm1b(KOMP)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002644,decreased circulating triglyceride level|MP:0010097,abnormal retina blood vessel morphology
MGI:3051962	Ubash3a<tm1Jni>	MP:0002169,no abnormal phenotype detected
MGI:2670555	Ubash3b<tm1Jni>	MP:0002169,no abnormal phenotype detected
MGI:3774112	Ubb<tm1Rrk>	MP:0000837,abnormal hypothalamus morphology|MP:0001125,abnormal oocyte morphology|MP:0001127,small ovary|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001326,retina degeneration|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001929,abnormal gametogenesis|MP:0002680,decreased corpora lutea number|MP:0002682,decreased mature ovarian follicle number|MP:0003205,testicular atrophy|MP:0003212,increased susceptibility to age related obesity|MP:0003224,neuron degeneration|MP:0004856,decreased ovary weight|MP:0004901,decreased male germ cell number|MP:0005168,abnormal female meiosis|MP:0005431,decreased oocyte number|MP:0005448,abnormal energy homeostasis|MP:0005669,increased circulating leptin level|MP:0008261,arrest of male meiosis|MP:0008451,retina rod cell degeneration|MP:0008453,decreased retina rod cell number|MP:0008515,thin retina outer nuclear layer|MP:0009363,abnormal tertiary ovarian follicle morphology|MP:0009375,thin zona pellucida|MP:0010024,increased total body fat amount|MP:0011957,decreased compensatory feeding amount|MP:0013600,testis degeneration|MP:0014447,impaired spindle assembly in female meiosis|MP:0031422,failure of superovulation
MGI:6277029	Ubc<em1(IMPC)Mbp>	MP:0002151,abnormal neural tube morphology|MP:0003720,abnormal neural tube closure|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:3715099	Ubc<tm1Rrk>	MP:0000313,abnormal cell death|MP:0000352,decreased cell proliferation|MP:0000596,abnormal liver development|MP:0001698,decreased embryo size|MP:0003077,abnormal cell cycle|MP:0003396,abnormal embryonic hematopoiesis|MP:0008008,early cellular replicative senescence|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5810734	Ubd<tm1b(EUCOMM)Wtsi>	MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0002059,abnormal seminal vesicle morphology|MP:0013522,decreased memory-marker CD4-positive NK T cell number|MP:0013883,increased CD4-positive, CD25-positive NK T cell number
MGI:3654319	Ubd<tm1Smwe>	MP:0002412,increased susceptibility to bacterial infection|MP:0003945,abnormal lymphocyte physiology|MP:0006042,increased apoptosis
MGI:5488492	Ube2a<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001488,increased startle reflex|MP:0001926,female infertility|MP:0002833,increased heart weight|MP:0005419,decreased circulating serum albumin level|MP:0010053,decreased grip strength|MP:0010097,abnormal retina blood vessel morphology
MGI:2450874	Ube2a<tm1Agr>	MP:0001262,decreased body weight|MP:0001475,reduced long-term depression|MP:0001926,female infertility|MP:0009454,impaired contextual conditioning behavior|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012307,impaired spatial learning
MGI:4431903	Ube2b<tm1a(EUCOMM)Wtsi>	MP:0001552,increased circulating triglyceride level|MP:0002644,decreased circulating triglyceride level|MP:0004924,abnormal behavior
MGI:5548336	Ube2b<tm1b(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000274,enlarged heart|MP:0001406,abnormal gait|MP:0001510,abnormal coat appearance|MP:0001513,limb grasping|MP:0002607,decreased basophil cell number|MP:0005013,increased lymphocyte cell number|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2183933	Ube2b<tm1Jhjh>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006379,abnormal spermatocyte morphology|MP:0006380,abnormal spermatid morphology|MP:0008892,abnormal sperm flagellum morphology|MP:0008966,abnormal chiasmata formation|MP:0009230,abnormal sperm head morphology|MP:0009376,abnormal manchette morphology|MP:0009377,ectopic manchette|MP:0009452,abnormal synaptonemal complex|MP:0009831,abnormal sperm midpiece morphology|MP:0010207,abnormal telomere morphology|MP:0014052,increased male germ cell apoptosis|MP:0014764,impaired double-strand DNA break repair|MP:0030590,abnormal sperm fibrous sheath morphology|MP:0031356,abnormal outer dense fiber morphology
MGI:7308166	Ube2c<em1Gpt>	MP:0000352,decreased cell proliferation|MP:0002006,neoplasm|MP:0005388,respiratory system phenotype
MGI:5490487	Ube2c<tm1.1(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:6324191	Ube2d1<tm3e(EUCOMM)Wtsi>	MP:0002599,increased mean platelet volume|MP:0005179,decreased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0005561,increased mean corpuscular hemoglobin
MGI:3586923	Ube2d2a<tm1Ssw>	MP:0001938,delayed sexual maturation
MGI:6361156	Ube2d2b<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5605774	Ube2d3<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0003961,decreased lean body mass|MP:0010124,decreased bone mineral content
MGI:5548787	Ube2e2<tm1b(KOMP)Wtsi>	MP:0002590,increased mean corpuscular volume
MGI:6152668	Ube2f<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000277,abnormal heart shape|MP:0000288,abnormal pericardium morphology|MP:0000598,abnormal liver morphology|MP:0002151,abnormal neural tube morphology|MP:0002833,increased heart weight|MP:0002884,abnormal pharyngeal arch morphology|MP:0003425,abnormal optic vesicle formation|MP:0005650,abnormal limb bud morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:7738243	Ube2f<tm1c(EUCOMM)Hmgu>	MP:0005379,endocrine/exocrine gland phenotype
MGI:5577267	Ube2g1<tm1b(EUCOMM)Hmgu>	MP:0000601,small liver|MP:0001925,male infertility|MP:0002764,short tibia|MP:0002932,abnormal joint morphology|MP:0004509,abnormal pelvic girdle bone morphology|MP:0004609,vertebral fusion|MP:0004613,fusion of vertebral arches|MP:0004738,abnormal auditory brainstem response
MGI:5692550	Ube2h<tm1b(EUCOMM)Hmgu>	MP:0001488,increased startle reflex
MGI:6108121	Ube2i<em1(IMPC)J>	MP:0000194,increased circulating calcium level|MP:0000218,increased leukocyte cell number|MP:0001392,abnormal locomotor behavior|MP:0001529,abnormal vocalization|MP:0001566,increased circulating phosphate level|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0005561,increased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3614394	Ube2i<tm1.1Adej>	MP:0002429,abnormal blood cell morphology/development|MP:0002718,abnormal inner cell mass morphology|MP:0010380,abnormal inner cell mass apoptosis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:5766208	Ube2j1<tm1.1(NCOM)Mfgc>	MP:0000063,decreased bone mineral density|MP:0001925,male infertility|MP:0002764,short tibia|MP:0003961,decreased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0008806,increased circulating amylase level|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011941,increased fluid intake
MGI:5707498	Ube2j1<tm1.2Hpl>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001925,male infertility|MP:0002673,abnormal sperm number|MP:0002675,asthenozoospermia|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0005410,abnormal fertilization|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008898,abnormal acrosome morphology|MP:0009234,absent sperm head|MP:0011086,postnatal lethality, incomplete penetrance
MGI:7796935	Ube2j2<em1Cya>	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0008261,arrest of male meiosis
MGI:6156167	Ube2j2<em1(IMPC)Rbrc>	MP:0000063,decreased bone mineral density|MP:0000221,decreased leukocyte cell number|MP:0000598,abnormal liver morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002590,increased mean corpuscular volume|MP:0002631,abnormal epididymis morphology|MP:0002764,short tibia|MP:0002875,decreased erythrocyte cell number|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0004930,small epididymis|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005265,abnormal blood urea nitrogen level|MP:0005561,increased mean corpuscular hemoglobin|MP:0008428,abnormal spatial working memory|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:3809822	Ube2k<Gt(XK109)Byg>	MP:0003204,decreased neuron apoptosis
MGI:2153819	Ube2l3<m1Hrb>	MP:0001711,abnormal placenta morphology|MP:0001712,abnormal placenta development|MP:0003984,embryonic growth retardation|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:4392054	Ube2m<Gt(EUCE0082h09)Hmgu>	MP:0011092,embryonic lethality, complete penetrance
MGI:5515621	Ube2m<tm1.1(KOMP)Wtsi>	MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0003886,abnormal embryonic epiblast morphology|MP:0005633,increased circulating sodium level|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis
MGI:6341889	Ube2n<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001399,hyperactivity|MP:0002059,abnormal seminal vesicle morphology|MP:0002932,abnormal joint morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3712183	Ube2n<Gt(OST374154)Lex>	MP:0002442,abnormal leukocyte physiology|MP:0002451,abnormal macrophage physiology|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0008734,decreased susceptibility to endotoxin shock|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3655236	Ube2n<tm1Aki>	MP:0001800,abnormal humoral immune response|MP:0002169,no abnormal phenotype detected|MP:0002362,abnormal spleen marginal zone morphology|MP:0002451,abnormal macrophage physiology|MP:0002459,abnormal B cell physiology|MP:0002460,decreased immunoglobulin level|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0008182,decreased marginal zone B cell number|MP:0008782,increased B cell apoptosis
MGI:3655238	Ube2n<tm2Aki>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5477804	Ube2o<tm1.1(KOMP)Mbp>	MP:0002941,increased circulating alanine transaminase level|MP:0003091,abnormal cell migration|MP:0005178,increased circulating cholesterol level|MP:0005621,abnormal cell physiology|MP:0010052,increased grip strength|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:5486217	Ube2q1<tm1Grz>	MP:0001377,abnormal mating frequency|MP:0001382,abnormal nursing|MP:0001935,decreased litter size|MP:0003718,maternal effect|MP:0005121,decreased circulating prolactin level|MP:0008976,delayed female fertility|MP:0009011,prolonged diestrus|MP:0011103,embryonic lethality at implantation, incomplete penetrance
MGI:6376261	Ube2q2l<em1(IMPC)J>	MP:0000062,increased bone mineral density
MGI:7621220	Ube2s<tm1.1Smoc>	MP:0001926,female infertility|MP:0002451,abnormal macrophage physiology|MP:0005168,abnormal female meiosis|MP:0005389,reproductive system phenotype|MP:0008553,increased circulating tumor necrosis factor level|MP:0008564,increased interferon-beta secretion|MP:0008573,increased circulating interferon-alpha level|MP:0008575,increased circulating interferon-beta level|MP:0008596,increased circulating interleukin-6 level|MP:0010767,abnormal female meiosis I arrest|MP:0014435,increased interferon level|MP:0020914,decreased susceptibility to Riboviria infection|MP:0020917,decreased susceptibility to Herpesvirales infection|MP:0020938,decreased susceptibility to Picornaviridae infection|MP:0031039,decreased susceptibility to Picornaviridae infection induced morbidity/mortality
MGI:6194766	Ube2u<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:5637184	Ube2u<tm1e.1(KOMP)Wtsi>	MP:0002606,increased basophil cell number
MGI:5605776	Ube2w<tm1b(EUCOMM)Wtsi>	MP:0004738,abnormal auditory brainstem response|MP:0010052,increased grip strength|MP:0013279,increased fasting circulating glucose level
MGI:5897638	Ube2w<tm1d(EUCOMM)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0001146,abnormal testis morphology|MP:0001154,seminiferous tubule degeneration|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001922,reduced male fertility|MP:0005159,azoospermia|MP:0005384,cellular phenotype|MP:0009605,decreased keratohyalin granule number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6273955	Ube3a<em1(IMPC)Hmgu>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002059,abnormal seminal vesicle morphology|MP:0002608,increased hematocrit|MP:0002757,decreased vertical activity|MP:0010124,decreased bone mineral content|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake
MGI:7520304	Ube3a<em1Mjz>	MP:0002574,increased vertical activity|MP:0002804,abnormal motor learning|MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0020870,decreased thigmotaxis|MP:0021111,decreased social investigation|MP:0031391,increased locomotor activity
MGI:5882092	Ube3a<tm1.1Bdph>	MP:0002803,abnormal operant conditioning behavior|MP:0004008,abnormal GABA-mediated receptor currents
MGI:2181811	Ube3a<tm1Alb>	MP:0000788,abnormal cerebral cortex morphology|MP:0000852,small cerebellum|MP:0001130,abnormal ovarian folliculogenesis|MP:0001260,increased body weight|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0001496,audiogenic seizures|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0001732,postnatal growth retardation|MP:0001906,increased dopamine level|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0002082,postnatal lethality|MP:0002207,abnormal long-term potentiation|MP:0002272,abnormal nervous system electrophysiology|MP:0002572,abnormal emotion/affect behavior|MP:0002687,oligozoospermia|MP:0002804,abnormal motor learning|MP:0003123,paternal imprinting|MP:0003216,absence seizures|MP:0003356,impaired luteinization|MP:0003666,impaired sperm capacitation|MP:0003962,abnormal adrenaline level|MP:0003997,tonic-clonic seizures|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0004905,decreased uterus weight|MP:0004962,decreased prostate gland weight|MP:0004994,abnormal brain wave pattern|MP:0005156,bradykinesia|MP:0005431,decreased oocyte number|MP:0006269,abnormal mammary gland growth during pregnancy|MP:0008143,abnormal dendrite morphology|MP:0009454,impaired contextual conditioning behavior|MP:0010069,increased serotonin level|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2182454	Ube3a<tm1Jwf>	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0001501,abnormal sleep pattern|MP:0001504,abnormal posture|MP:0002063,abnormal learning/memory/conditioning|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002175,decreased brain weight|MP:0002272,abnormal nervous system electrophysiology|MP:0004994,abnormal brain wave pattern|MP:0008840,abnormal spike wave discharge|MP:0009454,impaired contextual conditioning behavior|MP:0014623,abnormal brain theta wave pattern
MGI:5704099	Ube3a<tm1Yelg>	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001447,abnormal nest building behavior|MP:0001496,audiogenic seizures|MP:0002207,abnormal long-term potentiation|MP:0002572,abnormal emotion/affect behavior|MP:0003123,paternal imprinting|MP:0003360,abnormal depression-related behavior|MP:0005386,behavior/neurological phenotype
MGI:6257474	Ube3b<em1(IMPC)Bay>	MP:0001303,abnormal lens morphology|MP:0001307,fused cornea and lens|MP:0001312,abnormal cornea morphology|MP:0001322,abnormal iris morphology|MP:0001697,abnormal embryo size|MP:0002792,abnormal retina vasculature morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003743,abnormal facial morphology|MP:0004222,iris synechia|MP:0006203,eye hemorrhage|MP:0011100,preweaning lethality, complete penetrance|MP:0011960,abnormal eye anterior chamber depth|MP:0011962,increased cornea thickness
MGI:4129255	Ube3b<Gt(RRJ142)Byg>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000774,decreased brain size|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001851,eye inflammation|MP:0001921,reduced fertility|MP:0003631,nervous system phenotype|MP:0004038,lymphangiectasis|MP:0005179,decreased circulating cholesterol level|MP:0005377,hearing/vestibular/ear phenotype|MP:0006188,calcified retina|MP:0006325,impaired hearing|MP:0008283,small hippocampus|MP:0010053,decreased grip strength|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012460,decreased dentate gyrus size
MGI:4434627	Ube3b<tm1a(EUCOMM)Hmgu>	MP:0000780,abnormal corpus callosum morphology|MP:0000860,abnormal primary somatosensory cortex morphology|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001443,poor grooming|MP:0001447,abnormal nest building behavior|MP:0001732,postnatal growth retardation|MP:0004924,abnormal behavior|MP:0006036,abnormal mitochondrial physiology|MP:0008143,abnormal dendrite morphology|MP:0009538,abnormal synapse morphology|MP:0010053,decreased grip strength|MP:0011380,enlarged brain ventricles|MP:0020351,decreased vocalization|MP:0020508,decreased dendritic spine density
MGI:5565262	Ube3c<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0001258,decreased body length|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0002626,increased heart rate|MP:0002757,decreased vertical activity|MP:0002764,short tibia|MP:0002834,decreased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0003921,abnormal heart left ventricle morphology|MP:0004151,decreased circulating iron level|MP:0005013,increased lymphocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0005387,immune system phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005599,increased cardiac muscle contractility|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010379,decreased respiratory quotient|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0011965,decreased total retina thickness|MP:0011971,increased circulating lactate dehydrogenase level|MP:0013510,decreased CD4-negative NK T cell number|MP:0013669,decreased Ly6C-positive immature NK cell number|MP:0013678,decreased Ly6C-positive NK T cell number|MP:0013691,decreased CD5-positive Ly6C-positive T cell number
MGI:5825270	Ube3d<em1Xxl>	MP:0005201,abnormal retina pigment epithelium morphology|MP:0005551,abnormal eye electrophysiology|MP:0011091,prenatal lethality, complete penetrance
MGI:6388370	Ube4a<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0002764,short tibia|MP:0003900,shortened QT interval|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:7647232	Ube4b<em1Bcgen>	MP:0001262,decreased body weight|MP:0002152,abnormal brain morphology|MP:0003997,tonic-clonic seizures|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020394,decreased neuronal precursor proliferation|MP:0021090,abnormal dendrite arborization pattern
MGI:3611069	Ube4b<tm1Kei>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000846,abnormal medulla oblongata morphology|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0001917,intraventricular hemorrhage|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002725,abnormal vein morphology|MP:0003222,increased cardiomyocyte apoptosis|MP:0003225,axonal dystrophy|MP:0005312,pericardial effusion|MP:0005329,abnormal myocardium layer morphology|MP:0005621,abnormal cell physiology|MP:0006138,congestive heart failure|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:7574684	Ubfd1<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5896808	Ubiad1<em1(IMPC)J>	MP:0001312,abnormal cornea morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6273244	Ubiad1<em1Wwk>	MP:0001312,abnormal cornea morphology|MP:0004777,abnormal phospholipid level|MP:0005544,cornea deposits|MP:0006035,abnormal mitochondrial morphology|MP:0011635,abnormal mitochondrial crista morphology|MP:0030937,increased mitochondrial DNA content
MGI:5707728	Ubiad1<tm1.1Thka>	MP:0001556,increased circulating HDL cholesterol level|MP:0001675,abnormal ectoderm development|MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0004019,abnormal vitamin homeostasis|MP:0005178,increased circulating cholesterol level|MP:0005376,homeostasis/metabolism phenotype|MP:0011092,embryonic lethality, complete penetrance
MGI:5439599	Ubl4a<tm1.1Xya>	MP:0002169,no abnormal phenotype detected
MGI:5795865	Ubl4a<tm1.2Arte>	MP:0001262,decreased body weight|MP:0001575,cyanosis|MP:0005438,abnormal glycogen homeostasis|MP:0011088,neonatal lethality, incomplete penetrance
MGI:5439608	Ubl4a<tm1Xya>	MP:0002169,no abnormal phenotype detected
MGI:6341871	Ubl4b<em1(IMPC)Ccpcz>	MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001325,abnormal retina morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002965,increased circulating serum albumin level|MP:0009141,increased prepulse inhibition
MGI:6864284	Ubl4b<em1Qsh>	MP:0005389,reproductive system phenotype
MGI:7710910	Ubl7<em1Fanm>	MP:0010180,increased susceptibility to weight loss|MP:0020913,increased susceptibility to Riboviria infection|MP:0020946,increased susceptibility to Orthomyxoviridae infection|MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality|MP:0031046,increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:6274930	Ubl7<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0001297,microphthalmia|MP:0001312,abnormal cornea morphology|MP:0001319,irregularly shaped pupil|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0001925,male infertility|MP:0001944,abnormal pancreas morphology|MP:0002590,increased mean corpuscular volume|MP:0002608,increased hematocrit|MP:0005287,narrow eye opening|MP:0005333,decreased heart rate|MP:0005561,increased mean corpuscular hemoglobin|MP:0005564,increased hemoglobin content|MP:0005565,increased blood urea nitrogen level|MP:0009454,impaired contextual conditioning behavior|MP:0010506,prolonged RR interval
MGI:5548725	Ublcp1<tm1b(KOMP)Wtsi>	MP:0000745,tremors|MP:0001491,unresponsive to tactile stimuli|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5629302	Ubn1<em1(IMPC)J>	MP:0001488,increased startle reflex|MP:0001513,limb grasping|MP:0002941,increased circulating alanine transaminase level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6358626	Ubn2<em1(IMPC)Tcp>	MP:0000914,exencephaly|MP:0001293,anophthalmia|MP:0001417,decreased exploration in new environment|MP:0001697,abnormal embryo size|MP:0001925,male infertility|MP:0003717,pallor|MP:0003743,abnormal facial morphology|MP:0005562,decreased mean corpuscular hemoglobin|MP:0009263,abnormal eyelid fusion|MP:0009908,protruding tongue|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011495,abnormal head shape|MP:0011496,abnormal head size
MGI:5513832	Ubox5<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0002092,abnormal eye morphology|MP:0009142,decreased prepulse inhibition
MGI:5692554	Ubp1<tm1b(KOMP)Mbp>	MP:0000195,decreased circulating calcium level|MP:0001697,abnormal embryo size|MP:0001722,pale yolk sac|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003717,pallor|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3052819	Ubp1<tm1Jmc>	MP:0000260,abnormal angiogenesis|MP:0000266,abnormal heart morphology|MP:0000292,distended pericardium|MP:0000295,trabecula carnea hypoplasia|MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001719,absent vitelline blood vessels|MP:0001723,disorganized yolk sac vascular plexus|MP:0001914,hemorrhage|MP:0002652,thin myocardium|MP:0003984,embryonic growth retardation|MP:0004937,dilated heart|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5576876	Ubqln1<tm1.1Hmw>	MP:0002152,abnormal brain morphology|MP:0003075,abnormal response to CNS ischemic injury|MP:0006060,increased cerebral infarct size
MGI:6784046	Ubqln2<em1Hlp>	MP:0005391,vision/eye phenotype
MGI:6194767	Ubqln3<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:4951160	Ubqln3<tm1(KOMP)Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:6386300	Ubqln4<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0000774,decreased brain size|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001258,decreased body length|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002152,abnormal brain morphology|MP:0002175,decreased brain weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0005343,increased circulating aspartate transaminase level|MP:0009142,decreased prepulse inhibition|MP:0009453,enhanced contextual conditioning behavior|MP:0009455,enhanced cued conditioning behavior|MP:0020420,abnormal freezing behavior|MP:0020421,increased freezing behavior
MGI:6361180	Ubqln5<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6194768	Ubqlnl<em1Osb>	MP:0002169,no abnormal phenotype detected
MGI:3808576	Ubqlnl<tm1(KOMP)Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:2178612	Ubr1<tm1Avar>	MP:0000189,hypoglycemia|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001463,abnormal spatial learning|MP:0002063,abnormal learning/memory/conditioning|MP:0002644,decreased circulating triglyceride level|MP:0002693,abnormal pancreas physiology|MP:0002757,decreased vertical activity|MP:0002802,abnormal discrimination learning|MP:0003335,exocrine pancreatic insufficiency|MP:0003999,enhanced passive avoidance behavior|MP:0004819,decreased skeletal muscle mass|MP:0005419,decreased circulating serum albumin level|MP:0005566,decreased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0010025,decreased total body fat amount
MGI:5766159	Ubr2<tm1e.1(KOMP)Mbp>	MP:0000598,abnormal liver morphology|MP:0001914,hemorrhage|MP:0003054,spina bifida|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2682037	Ubr2<tm1Ytkw>	MP:0001732,postnatal growth retardation|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001929,abnormal gametogenesis|MP:0002085,abnormal embryonic tissue morphology|MP:0002161,abnormal fertility/fecundity|MP:0002687,oligozoospermia|MP:0008261,arrest of male meiosis|MP:0008932,abnormal embryonic tissue physiology|MP:0011101,prenatal lethality, incomplete penetrance|MP:0013504,increased embryonic tissue cell apoptosis|MP:0013600,testis degeneration
MGI:3718505	Ubr3<tm1Ytkw>	MP:0001262,decreased body weight|MP:0001436,abnormal suckling behavior|MP:0003964,abnormal noradrenaline level|MP:0004512,anosmia|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5286698	Ubr4<Tg(Tyr)2393A-1Ove>	MP:0009703,decreased birth body size|MP:0011087,neonatal lethality, complete penetrance
MGI:5532331	Ubr4<tm1.1Nkt>	MP:0001698,decreased embryo size|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011523,thin placenta labyrinth
MGI:5487648	Ubr4<tm1.1Ytkw>	MP:0001722,pale yolk sac|MP:0001730,embryonic growth arrest|MP:0003229,abnormal vitelline vasculature morphology|MP:0004076,abnormal vitelline vascular remodeling|MP:0008260,abnormal autophagy|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5532332	Ubr4<tm1.2Nkt>	MP:0000267,abnormal heart development|MP:0000280,thin ventricular wall|MP:0000281,abnormal interventricular septum morphology|MP:0000297,abnormal atrioventricular cushion morphology|MP:0000313,abnormal cell death|MP:0000351,increased cell proliferation|MP:0000432,abnormal head morphology|MP:0000600,liver hypoplasia|MP:0000602,dilated liver sinusoidal space|MP:0000774,decreased brain size|MP:0000828,abnormal fourth ventricle morphology|MP:0002152,abnormal brain morphology|MP:0003984,embryonic growth retardation|MP:0004276,abnormal medial ganglionic eminence morphology|MP:0004277,abnormal lateral ganglionic eminence morphology|MP:0005380,embryo phenotype|MP:0008986,abnormal liver parenchyma morphology|MP:0009820,abnormal liver vasculature morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5692693	Ubr4<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6489293	Ubr5<em1Mem>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6489299	Ubr5<em2Mem>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:3052764	Ubr5<tm1Ckww>	MP:0000260,abnormal angiogenesis|MP:0000352,decreased cell proliferation|MP:0000913,abnormal brain development|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001718,abnormal visceral yolk sac morphology|MP:0001722,pale yolk sac|MP:0001726,abnormal allantois morphology|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0005312,pericardial effusion|MP:0006346,small pharyngeal arch|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:7426069	Ubr7<em1(IMPC)Tcp>	MP:0000218,increased leukocyte cell number|MP:0001325,abnormal retina morphology|MP:0001488,increased startle reflex|MP:0002626,increased heart rate|MP:0002764,short tibia|MP:0002792,abnormal retina vasculature morphology|MP:0002874,decreased hemoglobin content|MP:0003795,abnormal bone structure|MP:0005292,improved glucose tolerance|MP:0005419,decreased circulating serum albumin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010097,abnormal retina blood vessel morphology|MP:0010507,shortened RR interval
MGI:6152669	Ubtf<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000538,abnormal urinary bladder morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000639,abnormal adrenal gland morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001325,abnormal retina morphology|MP:0001700,abnormal embryo turning|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0002339,abnormal lymph node morphology|MP:0003068,enlarged kidney|MP:0004931,enlarged epididymis|MP:0005419,decreased circulating serum albumin level|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5708602	Ubtf<tm1.1Tmss>	MP:0002169,no abnormal phenotype detected
MGI:5708604	Ubtf<tm1.2Tmss>	MP:0001730,embryonic growth arrest|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5708606	Ubtf<tm1Tmss>	MP:0011100,preweaning lethality, complete penetrance
MGI:5637146	Ubxn10<tm1b(EUCOMM)Wtsi>	MP:0002941,increased circulating alanine transaminase level|MP:0010090,increased circulating creatine kinase level
MGI:7437469	Ubxn11<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number
MGI:6307027	Ubxn1<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior|MP:0002590,increased mean corpuscular volume|MP:0005567,decreased circulating total protein level
MGI:5708247	Ubxn2a<tm1b(EUCOMM)Hmgu>	MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0003984,embryonic growth retardation|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6120776	Ubxn7<tm1b(EUCOMM)Wtsi>	MP:0000428,abnormal craniofacial morphology|MP:0001697,abnormal embryo size|MP:0003984,embryonic growth retardation|MP:0009931,abnormal skin appearance|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration
MGI:1856882	Uchl1<gad>	MP:0000556,abnormal hindlimb morphology|MP:0000745,tremors|MP:0000753,paralysis|MP:0000846,abnormal medulla oblongata morphology|MP:0000938,motor neuron degeneration|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001388,abnormal stationary movement|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0003225,axonal dystrophy|MP:0005367,renal/urinary system phenotype|MP:0005370,liver/biliary system phenotype|MP:0005381,digestive/alimentary phenotype|MP:0005385,cardiovascular system phenotype|MP:0005388,respiratory system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005405,axon degeneration|MP:0009677,abnormal spinal cord dorsal column morphology
MGI:4458326	Uchl1<gad-2J>	MP:0000753,paralysis|MP:0001263,weight loss|MP:0001393,ataxia|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0003312,abnormal locomotor coordination
MGI:3832097	Uchl1<gad-J>	MP:0001263,weight loss|MP:0001405,impaired coordination|MP:0002083,premature death
MGI:5692544	Uchl1<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0002599,increased mean platelet volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0004174,abnormal spine curvature|MP:0005565,increased blood urea nitrogen level|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content
MGI:3604452	Uchl1<tm1Dgen>	MP:0000160,kyphosis|MP:0000755,hindlimb paralysis|MP:0000756,forelimb paralysis|MP:0000938,motor neuron degeneration|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001125,abnormal oocyte morphology|MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001131,abnormal ovarian follicle morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001926,female infertility|MP:0001973,increased thermal nociceptive threshold|MP:0002083,premature death|MP:0002913,abnormal PNS synaptic transmission|MP:0002914,abnormal endplate potential|MP:0002916,increased synaptic depression|MP:0002920,decreased paired-pulse facilitation|MP:0003063,increased coping response|MP:0003507,abnormal ovary physiology|MP:0003718,maternal effect|MP:0003990,decreased neurotransmitter release|MP:0004835,abnormal miniature endplate potential|MP:0004859,abnormal synaptic plasticity|MP:0005181,decreased circulating estradiol level|MP:0005405,axon degeneration|MP:0005431,decreased oocyte number|MP:0006036,abnormal mitochondrial physiology|MP:0009011,prolonged diestrus|MP:0009017,prolonged estrus|MP:0010053,decreased grip strength|MP:0011129,decreased tertiary ovarian follicle number
MGI:1930988	Uchl3<tm1Tilg>	MP:0000961,abnormal dorsal root ganglion morphology|MP:0001262,decreased body weight|MP:0002792,abnormal retina vasculature morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003225,axonal dystrophy|MP:0003727,abnormal retina layer morphology|MP:0003729,abnormal photoreceptor outer segment morphology|MP:0003730,abnormal photoreceptor inner segment morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0008515,thin retina outer nuclear layer|MP:0008519,thin retina outer plexiform layer|MP:0030005,increased retina apoptosis|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:6152712	Uchl4<em1(IMPC)Ccpcz>	MP:0000150,abnormal rib morphology|MP:0008935,decreased mean platelet volume|MP:0013279,increased fasting circulating glucose level
MGI:3529781	Uchl5<Gt(OST447189)Lex>	MP:0000788,abnormal cerebral cortex morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000826,abnormal third ventricle morphology|MP:0000828,abnormal fourth ventricle morphology|MP:0000897,abnormal midbrain morphology|MP:0000913,abnormal brain development|MP:0003984,embryonic growth retardation|MP:0005537,abnormal cerebral aqueduct morphology|MP:0009937,abnormal neuron differentiation|MP:0011091,prenatal lethality, complete penetrance
MGI:4880413	Uchl5<tm1(NCOM)Mfgc>	MP:0001402,decreased locomotor activity|MP:0011100,preweaning lethality, complete penetrance
MGI:6111455	Uck2<em1(IMPC)J>	MP:0002060,abnormal skin morphology|MP:0002590,increased mean corpuscular volume|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:6284338	Uckl1<em1(IMPC)J>	MP:0002968,increased circulating alkaline phosphatase level|MP:0003131,increased erythrocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin
MGI:5314628	Ucma<tm1Msto>	MP:0005390,skeleton phenotype
MGI:4818656	Ucn2<tm1.1Jde>	MP:0005386,behavior/neurological phenotype
MGI:3625732	Ucn2<tm1Pbl>	MP:0001422,abnormal drinking behavior|MP:0001745,increased circulating corticosterone level|MP:0001748,increased circulating adrenocorticotropin level|MP:0003313,abnormal locomotor activation|MP:0011940,decreased food intake
MGI:4818652	Ucn3<tm1.1Jde>	MP:0001360,abnormal social investigation|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype
MGI:5695941	Ucn3<tm1.1(KOMP)Vlcg>	MP:0005553,increased circulating creatinine level
MGI:3702546	Ucn3<tm1Pbl>	MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0005292,improved glucose tolerance|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3716279	Ucn<tm1Abas>	MP:0001745,increased circulating corticosterone level|MP:0002572,abnormal emotion/affect behavior|MP:0005345,abnormal circulating corticosterone level
MGI:2386958	Ucn<tm1Brd>	MP:0001488,increased startle reflex|MP:0001489,decreased startle reflex|MP:0003631,nervous system phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype
MGI:2384136	Ucn<tm1Klee>	MP:0001363,increased anxiety-related response|MP:0002797,increased thigmotaxis|MP:0003631,nervous system phenotype|MP:0004466,short cochlear outer hair cells|MP:0004736,abnormal distortion product otoacoustic emission|MP:0005376,homeostasis/metabolism phenotype|MP:0005377,hearing/vestibular/ear phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6515577	Ucp1<em1Yqiu>	MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:3847238	Ucp1<m1H>	MP:0001777,abnormal body temperature homeostasis
MGI:5692920	Ucp1<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0002608,increased hematocrit|MP:0002644,decreased circulating triglyceride level|MP:0002953,thick ventricular wall|MP:0003131,increased erythrocyte cell number
MGI:1857471	Ucp1<tm1Kz>	MP:0000005,increased brown adipose tissue amount|MP:0001262,decreased body weight|MP:0001783,decreased white adipose tissue amount|MP:0002118,abnormal lipid homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0003829,impaired febrile response|MP:0005288,abnormal oxygen consumption|MP:0005290,decreased oxygen consumption|MP:0005376,homeostasis/metabolism phenotype|MP:0005478,decreased circulating thyroxine level|MP:0005480,increased circulating triiodothyronine level|MP:0005533,increased body temperature|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0006036,abnormal mitochondrial physiology|MP:0008872,abnormal physiological response to xenobiotic|MP:0010379,decreased respiratory quotient|MP:0011049,impaired adaptive thermogenesis
MGI:3687318	Ucp2<Gt(S20-3G1)Sor>	MP:0000837,abnormal hypothalamus morphology|MP:0001392,abnormal locomotor behavior|MP:0001523,impaired righting response|MP:0001973,increased thermal nociceptive threshold|MP:0004859,abnormal synaptic plasticity|MP:0005449,abnormal food intake|MP:0005645,abnormal hypothalamus physiology
MGI:2176058	Ucp2<tm1Lowl>	MP:0003327,liver cyst|MP:0003336,pancreas cyst|MP:0003675,kidney cyst|MP:0005376,homeostasis/metabolism phenotype|MP:0005643,decreased dopamine level|MP:0006039,decreased mitochondrial fission|MP:0008489,slow postnatal weight gain|MP:0010954,abnormal cellular respiration|MP:0011451,increased susceptibility to dopaminergic neuron neurotoxicity|MP:0013139,moribund
MGI:2176053	Ucp2<tm1Rcq>	MP:0002411,decreased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0003204,decreased neuron apoptosis|MP:0004893,decreased adiponectin level|MP:0005026,decreased susceptibility to parasitic infection|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0005388,respiratory system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005560,decreased circulating glucose level|MP:0006036,abnormal mitochondrial physiology|MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0008413,decreased cellular sensitivity to oxidative stress|MP:0009786,decreased susceptibility to infection induced morbidity/mortality|MP:0013404,decreased circulating lactate level
MGI:2183204	Ucp3<tm1Brnd>	MP:0006036,abnormal mitochondrial physiology|MP:0031414,decreased skeletal muscle triglyceride level
MGI:2183166	Ucp3<tm1Lowl>	MP:0005281,increased fatty acids level|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0010954,abnormal cellular respiration|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport
MGI:2183202	Ucp3<tm1Rei>	MP:0002702,decreased circulating free fatty acids level|MP:0002891,increased insulin sensitivity|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0006036,abnormal mitochondrial physiology|MP:0006319,abnormal epididymal fat pad morphology
MGI:4434449	Uevld<tm1a(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number
MGI:3640091	Ufd1<tm1Bld>	MP:0002169,no abnormal phenotype detected
MGI:5311849	Ufde	MP:0000024,lowered ear position|MP:0000564,syndactyly|MP:0001923,reduced female fertility|MP:0009703,decreased birth body size|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4432479	Ufl1<tm1a(EUCOMM)Wtsi>	MP:0000601,small liver|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0001698,decreased embryo size|MP:0002942,decreased circulating alanine transaminase level|MP:0005632,decreased circulating aspartate transaminase level|MP:0008973,decreased erythroid progenitor cell number|MP:0009395,increased nucleated erythrocyte cell number|MP:0010025,decreased total body fat amount|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5825300	Ufl1<tm1c(EUCOMM)Wtsi>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000223,decreased monocyte cell number|MP:0000334,decreased granulocyte number|MP:0001263,weight loss|MP:0001577,anemia|MP:0002083,premature death|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0005016,decreased lymphocyte cell number|MP:0005152,pancytopenia|MP:0008260,abnormal autophagy|MP:0008973,decreased erythroid progenitor cell number|MP:0009278,abnormal bone marrow cell physiology
MGI:5903257	Ufm1<tm1.1Kmts>	MP:0000433,microcephaly|MP:0000913,abnormal brain development|MP:0003203,increased neuron apoptosis|MP:0011087,neonatal lethality, complete penetrance|MP:0012089,decreased midbrain size|MP:0014178,increased brain apoptosis|MP:0020069,decreased neocortex size|MP:0020527,small thalamus
MGI:8255238	Ufsp1<em1Dpmi>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0005369,muscle phenotype
MGI:8255237	Ufsp1<em1Ics>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0005369,muscle phenotype
MGI:6152670	Ufsp2<em1(IMPC)Mbp>	MP:0001914,hemorrhage|MP:0003054,spina bifida|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6751640	Ugcg<em1(IMPC)H>	MP:0000219,increased neutrophil cell number|MP:0002941,increased circulating alanine transaminase level|MP:0005016,decreased lymphocyte cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:3603453	Ugcg<tm1Hjg>	MP:0005367,renal/urinary system phenotype|MP:0009350,decreased urine pH|MP:0010768,mortality/aging
MGI:2180226	Ugcg<tm1Rlp>	MP:0001698,decreased embryo size|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002582,disorganized extraembryonic tissue|MP:0003895,increased ectoderm apoptosis|MP:0003954,abnormal Reichert's membrane morphology|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:4442647	Ugcg<tm4Rlp>	MP:0000876,Purkinje cell degeneration|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0002169,no abnormal phenotype detected
MGI:2678264	Ugdh<lzme>	MP:0001680,abnormal mesoderm development|MP:0001730,embryonic growth arrest|MP:0002231,abnormal primitive streak morphology|MP:0003984,embryonic growth retardation|MP:0006323,abnormal extraembryonic mesoderm development|MP:0011091,prenatal lethality, complete penetrance|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011183,abnormal primitive endoderm morphology
MGI:5430380	Ugdh<tm1.1Xzh>	MP:0000111,cleft palate|MP:0001347,absent lacrimal glands|MP:0002169,no abnormal phenotype detected|MP:0008932,abnormal embryonic tissue physiology|MP:0011087,neonatal lethality, complete penetrance|MP:0013331,abnormal lacrimal gland development
MGI:6316116	Uggt1<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000428,abnormal craniofacial morphology|MP:0000598,abnormal liver morphology|MP:0001293,anophthalmia|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001614,abnormal blood vessel morphology|MP:0001700,abnormal embryo turning|MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001726,abnormal allantois morphology|MP:0001785,edema|MP:0002135,abnormal kidney morphology|MP:0002151,abnormal neural tube morphology|MP:0002699,abnormal vitreous body morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0002989,small kidney|MP:0003229,abnormal vitelline vasculature morphology|MP:0003720,abnormal neural tube closure|MP:0003743,abnormal facial morphology|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape
MGI:4128266	Uggt1<Gt(RST539)Byg>	MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0020352,abnormal endoplasmic reticulum physiology
MGI:4841374	Uggt1<tm1a(KOMP)Wtsi>	MP:0020936,abnormal susceptibility to Picornaviridae infection|MP:0020938,decreased susceptibility to Picornaviridae infection|MP:0031039,decreased susceptibility to Picornaviridae infection induced morbidity/mortality
MGI:6472606	Uggt2<tm1b(KOMP)Wtsi>	MP:0000598,abnormal liver morphology|MP:0002581,abnormal ileum morphology|MP:0005293,impaired glucose tolerance|MP:0010025,decreased total body fat amount
MGI:7426070	Ugp2<em1(IMPC)Bay>	MP:0001914,hemorrhage|MP:0011100,preweaning lethality, complete penetrance
MGI:6355938	Ugt1a6b<em1(IMPC)Bay>	MP:0001293,anophthalmia|MP:0001297,microphthalmia
MGI:5320594	Ugt1<tm1.1Afmu>	MP:0000611,jaundice|MP:0000849,abnormal cerebellum morphology|MP:0000873,thin external granule cell layer|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000880,decreased Purkinje cell number|MP:0000886,abnormal cerebellar granule layer morphology|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001436,abnormal suckling behavior|MP:0001527,athetotic walking movements|MP:0002064,seizures|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003203,increased neuron apoptosis|MP:0003313,abnormal locomotor activation|MP:0004263,abnormal limb posture|MP:0005084,abnormal gallbladder morphology|MP:0005202,lethargy|MP:0005323,dystonia|MP:0005344,increased circulating bilirubin level|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0009267,abnormal cerebellum fissure morphology|MP:0009956,abnormal cerebellar layer morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0013806,encephalopathy
MGI:3784509	Ugt1<tm1Rhtu>	MP:0000611,jaundice|MP:0005344,increased circulating bilirubin level|MP:0011085,postnatal lethality, complete penetrance
MGI:6257701	Ugt2a1<em1(IMPC)Bay>	MP:0002574,increased vertical activity
MGI:7482623	Ugt2b38<em1(IMPC)Tcp>	MP:0001289,persistence of hyaloid vascular system|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:2183312	Ugt8a<tm1Pop>	MP:0000436,abnormal head movements|MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000877,abnormal Purkinje cell morphology|MP:0000920,abnormal myelination|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001547,abnormal lipid level|MP:0002083,premature death|MP:0003631,nervous system phenotype|MP:0005387,immune system phenotype|MP:0005403,abnormal nerve conduction|MP:0014329,abnormal Purkinje cell axon morphology
MGI:2384084	Ugt8a<tm1Wst>	MP:0000745,tremors|MP:0000755,hindlimb paralysis|MP:0000756,forelimb paralysis|MP:0000921,demyelination|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001547,abnormal lipid level|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0005403,abnormal nerve conduction
MGI:3832867	Uhmk1<tm1Enbl>	MP:0003077,abnormal cell cycle|MP:0003091,abnormal cell migration|MP:0004883,abnormal vascular wound healing|MP:0005178,increased circulating cholesterol level
MGI:4434100	Uhrf1<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0008044,increased NK cell number
MGI:4440836	Uhrf1<tm1Hko>	MP:0001680,abnormal mesoderm development|MP:0001726,abnormal allantois morphology|MP:0001730,embryonic growth arrest|MP:0003632,abnormal nervous system morphology|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0006029,abnormal sclerotome morphology|MP:0006346,small pharyngeal arch|MP:0008877,abnormal DNA methylation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6729206	Uhrf1<tm1Smoc>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001154,seminiferous tubule degeneration|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0002784,abnormal Sertoli cell morphology|MP:0003077,abnormal cell cycle|MP:0004109,abnormal Sertoli cell development|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0004930,small epididymis|MP:0005250,decreased Sertoli cell number|MP:0006428,ectopic Sertoli cells|MP:0008877,abnormal DNA methylation|MP:0014052,increased male germ cell apoptosis|MP:0020355,abnormal Sertoli cell barrier morphology|MP:0020356,abnormal Sertoli cell barrier function|MP:0031406,decreased Sertoli cell proliferation
MGI:5907901	Uhrf2<em1Yoz>	MP:0008414,abnormal spatial reference memory|MP:0008877,abnormal DNA methylation|MP:0009454,impaired contextual conditioning behavior
MGI:5605797	Uhrf2<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000218,increased leukocyte cell number|MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0001926,female infertility|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005013,increased lymphocyte cell number|MP:0005333,decreased heart rate|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:4329579	Uimc1<Gt(RRN158)Byg>	MP:0001658,increased mortality induced by gamma-irradiation|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0004028,chromosome breakage|MP:0008058,abnormal DNA repair|MP:0014237,decreased tumor-free survival time
MGI:5463917	Uimc1<tm1.2Amj>	MP:0002023,increased B cell derived lymphoma incidence|MP:0002024,increased T cell derived lymphoma incidence|MP:0004045,abnormal cell cycle checkpoint function|MP:0004499,increased incidence of tumors by chemical induction|MP:0004500,increased incidence of tumors by ionizing radiation induction|MP:0008008,early cellular replicative senescence|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011704,decreased fibroblast proliferation|MP:0012431,increased lymphoma incidence
MGI:3808004	Ulk1<tm1.1Thsn>	MP:0000245,abnormal erythropoiesis|MP:0002424,abnormal reticulocyte morphology|MP:0002447,abnormal erythrocyte morphology|MP:0002590,increased mean corpuscular volume|MP:0002640,reticulocytosis|MP:0004952,increased spleen weight|MP:0005391,vision/eye phenotype|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0006035,abnormal mitochondrial morphology|MP:0008260,abnormal autophagy|MP:0010067,increased red blood cell distribution width
MGI:5141011	Ulk2<tm1.1Thsn>	MP:0002169,no abnormal phenotype detected
MGI:3604447	Ulk2<tm1Lex>	MP:0001363,increased anxiety-related response|MP:0010166,increased response to stress-induced hyperthermia
MGI:5309111	Ulk2<tm1Thsn>	MP:0002169,no abnormal phenotype detected
MGI:6157270	Ulk3<em2(IMPC)Tcp>	MP:0000689,abnormal spleen morphology|MP:0000702,enlarged lymph nodes|MP:0001120,abnormal uterus morphology|MP:0001147,small testis|MP:0002059,abnormal seminal vesicle morphology|MP:0002339,abnormal lymph node morphology|MP:0002631,abnormal epididymis morphology|MP:0004958,enlarged prostate gland|MP:0005178,increased circulating cholesterol level|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0005633,increased circulating sodium level|MP:0011874,enlarged urinary bladder
MGI:4362969	Ulk4<tm1a(KOMP)Wtsi>	MP:0000440,domed cranium|MP:0000470,abnormal stomach morphology|MP:0000781,decreased corpus callosum size|MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0000917,obstructive hydrocephaly|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002691,small stomach|MP:0002958,cerebral aqueductal stenosis|MP:0011056,abnormal brain ependyma motile cilium morphology|MP:0011057,absent brain ependyma motile cilia|MP:0011069,abnormal brain ependyma motile cilium physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011380,enlarged brain ventricles|MP:0011940,decreased food intake|MP:0012676,dilated brain ventricle|MP:0013907,abnormal cerebrospinal fluid flow|MP:0014402,abnormal Reissner's fiber morphology
MGI:5429194	Ulk4<tm1Lex>	MP:0000440,domed cranium|MP:0000820,abnormal choroid plexus morphology|MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0001265,decreased body size|MP:0001850,increased susceptibility to otitis media|MP:0001866,nasal inflammation|MP:0001891,hydrocephaly|MP:0001917,intraventricular hemorrhage|MP:0002083,premature death|MP:0010152,abnormal brain ependyma morphology|MP:0011050,abnormal respiratory motile cilium morphology|MP:0030113,maxillary sinus inflammation|MP:0030964,decreased brain ependyma motile cilium length
MGI:3844548	Uml	MP:0002075,abnormal coat/hair pigmentation|MP:0005409,darkened coat color
MGI:6162681	Umod<em1Duf>	MP:0001262,decreased body weight|MP:0001859,kidney inflammation|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0003918,decreased kidney weight|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008260,abnormal autophagy|MP:0011368,increased kidney apoptosis|MP:0013305,isosthenuria|MP:0020354,increased endoplasmic reticulum stress
MGI:5289814	Umodl1<tm1a(KOMP)Wtsi>	MP:0005561,increased mean corpuscular hemoglobin
MGI:6116661	Umod<tm1.1Rvt>	MP:0000194,increased circulating calcium level|MP:0001762,polyuria|MP:0001859,kidney inflammation|MP:0002703,abnormal renal tubule morphology|MP:0002963,decreased urine protein level|MP:0002988,decreased urine osmolality|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0005264,glomerulosclerosis|MP:0005441,increased urine calcium level|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008997,increased blood osmolality|MP:0009350,decreased urine pH|MP:0011424,decreased urine uric acid level|MP:0011584,increased alkaline phosphatase activity
MGI:3574985	Umod<tm1Kuma>	MP:0001263,weight loss|MP:0001762,polyuria|MP:0002135,abnormal kidney morphology|MP:0002829,abnormal juxtaglomerular apparatus morphology|MP:0002987,abnormal urine osmolality|MP:0005527,increased renal glomerular filtration rate|MP:0005528,decreased renal glomerular filtration rate|MP:0005557,increased creatinine clearance|MP:0005558,decreased creatinine clearance|MP:0005619,increased urine potassium level|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006316,increased urine sodium level|MP:0009643,abnormal urine homeostasis|MP:0011344,abnormal loop of Henle ascending limb thick segment morphology|MP:0011459,increased urine chloride ion level|MP:0011941,increased fluid intake|MP:0012046,decreased susceptibility to hypertension
MGI:3526897	Umod<tm1Xrw>	MP:0000519,hydronephrosis|MP:0002412,increased susceptibility to bacterial infection|MP:0002901,increased urine phosphate level|MP:0003197,nephrocalcinosis|MP:0003985,renal fibrosis|MP:0004193,abnormal kidney papilla morphology|MP:0004860,dilated kidney collecting duct|MP:0005360,urolithiasis|MP:0005441,increased urine calcium level|MP:0005619,increased urine potassium level|MP:0006272,abnormal urine organic anion level|MP:0006316,increased urine sodium level|MP:0009350,decreased urine pH|MP:0009643,abnormal urine homeostasis|MP:0009645,crystalluria|MP:0009810,increased urine uric acid level|MP:0011331,abnormal papillary duct morphology|MP:0011432,decreased urine flow rate|MP:0011435,increased urine magnesium level|MP:0011459,increased urine chloride ion level|MP:0011470,increased urine creatinine level|MP:0011735,increased urine ammonia level|MP:0030779,decreased urine citrate level
MGI:3712279	Umod<Urehd1>	MP:0000063,decreased bone mineral density|MP:0000194,increased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000519,hydronephrosis|MP:0001262,decreased body weight|MP:0001762,polyuria|MP:0002644,decreased circulating triglyceride level|MP:0002968,increased circulating alkaline phosphatase level|MP:0002988,decreased urine osmolality|MP:0003215,renal interstitial fibrosis|MP:0003670,dilated renal glomerular capsule|MP:0004151,decreased circulating iron level|MP:0004154,renal tubular necrosis|MP:0005179,decreased circulating cholesterol level|MP:0005376,homeostasis/metabolism phenotype|MP:0005441,increased urine calcium level|MP:0005528,decreased renal glomerular filtration rate|MP:0005553,increased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0005619,increased urine potassium level|MP:0005627,increased circulating potassium level|MP:0006316,increased urine sodium level|MP:0006317,decreased urine sodium level|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011344,abnormal loop of Henle ascending limb thick segment morphology|MP:0011424,decreased urine uric acid level|MP:0011431,increased urine flow rate|MP:0011435,increased urine magnesium level|MP:0011459,increased urine chloride ion level|MP:0011465,abnormal urine urea nitrogen level|MP:0011471,decreased urine creatinine level|MP:0011682,renal glomerulus cyst|MP:0011891,decreased circulating ferritin level|MP:0011894,decreased circulating transferrin level|MP:0011939,increased food intake|MP:0011941,increased fluid intake
MGI:3712284	Umod<urehr4>	MP:0000063,decreased bone mineral density|MP:0000194,increased circulating calcium level|MP:0001262,decreased body weight|MP:0001762,polyuria|MP:0002644,decreased circulating triglyceride level|MP:0002988,decreased urine osmolality|MP:0003215,renal interstitial fibrosis|MP:0003795,abnormal bone structure|MP:0003949,abnormal circulating lipid level|MP:0003960,increased lean body mass|MP:0004154,renal tubular necrosis|MP:0005179,decreased circulating cholesterol level|MP:0005367,renal/urinary system phenotype|MP:0005459,decreased percent body fat/body weight|MP:0005534,decreased body temperature|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005619,increased urine potassium level|MP:0006316,increased urine sodium level|MP:0006317,decreased urine sodium level|MP:0008821,increased blood uric acid level|MP:0009643,abnormal urine homeostasis|MP:0009644,uremia|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0014810,increased circulating urea level|MP:0020010,decreased bone mineral density of femur|MP:0020234,decreased basal metabolism
MGI:5695949	Unc119b<tm1.1(KOMP)Vlcg>	MP:0005278,abnormal cholesterol homeostasis|MP:0005586,decreased tidal volume
MGI:5548428	Unc119<tm1.1(KOMP)Vlcg>	MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology
MGI:3718005	Unc119<tm1Gina>	MP:0001325,abnormal retina morphology|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005551,abnormal eye electrophysiology|MP:0008515,thin retina outer nuclear layer|MP:0011965,decreased total retina thickness|MP:0031606,increased susceptibility to age-related retinal degeneration
MGI:2449468	Unc13a<tm1Bros>	MP:0000746,weakness|MP:0002206,abnormal CNS synaptic transmission|MP:0003059,decreased insulin secretion|MP:0003631,nervous system phenotype|MP:0003990,decreased neurotransmitter release|MP:0004792,abnormal synaptic vesicle number|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0005574,decreased pulmonary respiratory rate|MP:0009546,absent gastric milk in neonates|MP:0011085,postnatal lethality, complete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0014711,decreased synaptic vesicle readily releasable pool size
MGI:3051217	Unc13a<tm2Bros>	MP:0002910,abnormal excitatory postsynaptic currents|MP:0004769,abnormal synaptic vesicle morphology|MP:0004770,abnormal synaptic vesicle recycling|MP:0004792,abnormal synaptic vesicle number|MP:0005215,abnormal pancreatic islet morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0011087,neonatal lethality, complete penetrance
MGI:3695486	Unc13a<tm3Bros>	MP:0003631,nervous system phenotype|MP:0005389,reproductive system phenotype
MGI:5523890	Unc13a<tm4.1Bros>	MP:0002206,abnormal CNS synaptic transmission|MP:0002917,decreased synaptic depression|MP:0004811,abnormal neuron physiology
MGI:5548450	Unc13b<tm1b(KOMP)Wtsi>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2449706	Unc13b<tm2Bros>	MP:0000951,sporadic seizures|MP:0003631,nervous system phenotype|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology|MP:0009538,abnormal synapse morphology
MGI:6153829	Unc13c<em1(IMPC)H>	MP:0001566,increased circulating phosphate level|MP:0005553,increased circulating creatinine level
MGI:2449467	Unc13c<tm1Bros>	MP:0002206,abnormal CNS synaptic transmission|MP:0002804,abnormal motor learning|MP:0002919,enhanced paired-pulse facilitation|MP:0003631,nervous system phenotype
MGI:3628822	Unc13d<Jinx>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0002397,abnormal bone marrow morphology|MP:0002451,abnormal macrophage physiology|MP:0003009,abnormal cytokine secretion|MP:0003179,thrombocytopenia|MP:0005079,decreased cytotoxic T cell cytolysis|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008523,absent lymph node germinal center|MP:0010766,abnormal NK cell physiology|MP:0020913,increased susceptibility to Riboviria infection|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0031070,hemophagocytosis
MGI:4399208	Unc13d<tm1(KOMP)Vlcg>	MP:0005397,hematopoietic system phenotype|MP:0005606,increased bleeding time|MP:0006058,decreased cerebral infarct size|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0009446,abnormal platelet dense granule physiology|MP:0009549,decreased platelet aggregation|MP:0020215,impaired blood coagulation
MGI:5759982	Unc45a<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment|MP:0011100,preweaning lethality, complete penetrance
MGI:6257596	Unc45b<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:5287450	Unc45b<Tg(Tyr)2280FOve>	MP:0005380,embryo phenotype|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:3665134	Unc5a<tm1Lhck>	MP:0000955,abnormal spinal cord morphology|MP:0003204,decreased neuron apoptosis|MP:0005192,increased motor neuron number
MGI:3654305	Unc5b<tm1.1Dyl>	MP:0005385,cardiovascular system phenotype
MGI:3760978	Unc5b<tm1Matl>	MP:0000928,incomplete rostral neuropore closure|MP:0001622,abnormal vasculogenesis|MP:0001648,abnormal apoptosis|MP:0001730,embryonic growth arrest|MP:0003658,abnormal capillary morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0020327,abnormal capillary branching pattern
MGI:6156168	Unc5c<em2(IMPC)Rbrc>	MP:0001402,decreased locomotor activity|MP:0011100,preweaning lethality, complete penetrance
MGI:6152672	Unc5cl<em1(IMPC)Mbp>	MP:0001126,abnormal ovary morphology|MP:0001293,anophthalmia|MP:0001402,decreased locomotor activity|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0005178,increased circulating cholesterol level
MGI:1857013	Unc5c<rcm>	MP:0000745,tremors|MP:0000776,abnormal inferior colliculus morphology|MP:0000777,increased inferior colliculus size|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000854,abnormal cerebellum development|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000877,abnormal Purkinje cell morphology|MP:0000885,ectopic Purkinje cell|MP:0000886,abnormal cerebellar granule layer morphology|MP:0000889,abnormal cerebellar molecular layer|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0001504,abnormal posture|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0002762,ectopic cerebellar granule cells|MP:0005389,reproductive system phenotype|MP:0006009,abnormal neuronal migration|MP:0006097,abnormal cerebellar lobule formation|MP:0009719,reduced cerebellar foliation|MP:0009956,abnormal cerebellar layer morphology|MP:0009957,abnormal cerebellum vermis lobule morphology|MP:0009960,abnormal cerebellum anterior lobe morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2678074	Unc5c<rcmTg(Tert)5Hwl>	MP:0000852,small cerebellum|MP:0000854,abnormal cerebellum development|MP:0000899,abnormal corpora quadrigemina morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0005334,abnormal fat pad morphology|MP:0006319,abnormal epididymal fat pad morphology|MP:0011939,increased food intake|MP:0011941,increased fluid intake|MP:0031391,increased locomotor activity
MGI:1857852	Unc5c<rcmTg(Ucp)1.23Kz>	MP:0000776,abnormal inferior colliculus morphology|MP:0000852,small cerebellum|MP:0000854,abnormal cerebellum development|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000885,ectopic Purkinje cell|MP:0001052,abnormal innervation pattern to muscle|MP:0001063,abnormal trochlear nerve morphology|MP:0001078,abnormal phrenic nerve morphology|MP:0001393,ataxia|MP:0002762,ectopic cerebellar granule cells|MP:0002878,abnormal corticospinal tract morphology|MP:0006097,abnormal cerebellar lobule formation|MP:0009677,abnormal spinal cord dorsal column morphology|MP:0009681,abnormal pyramidal decussation morphology|MP:0009719,reduced cerebellar foliation|MP:0010768,mortality/aging|MP:0011100,preweaning lethality, complete penetrance|MP:0012055,abnormal phrenic nerve innervation pattern to diaphragm
MGI:5495472	Unc5d<tm1Kln>	MP:0003651,abnormal axon extension|MP:0005386,behavior/neurological phenotype|MP:0006009,abnormal neuronal migration
MGI:3701691	Unc79<Lwt>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001987,alcohol preference|MP:0002081,perinatal lethality|MP:0002849,abnormal saccharin consumption|MP:0002850,saccharin preference|MP:0003545,increased alcohol consumption|MP:0009751,enhanced behavioral response to alcohol|MP:0009778,impaired behavioral response to anesthetic|MP:0010025,decreased total body fat amount|MP:0011941,increased fluid intake|MP:0031391,increased locomotor activity
MGI:3663686	Unc79<tm1Mnkm>	MP:0000746,weakness|MP:0001262,decreased body weight|MP:0005156,bradykinesia|MP:0009546,absent gastric milk in neonates|MP:0011085,postnatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance
MGI:6451179	Unc80<em1Dren>	MP:0001957,apnea|MP:0002272,abnormal nervous system electrophysiology|MP:0003484,abnormal channel response|MP:0011087,neonatal lethality, complete penetrance
MGI:6257629	Unc80<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001258,decreased body length|MP:0001325,abnormal retina morphology|MP:0001417,decreased exploration in new environment|MP:0002792,abnormal retina vasculature morphology|MP:0003020,decreased circulating chloride level|MP:0005634,decreased circulating sodium level|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:6451181	Unc80<em2Dren>	MP:0001957,apnea|MP:0002272,abnormal nervous system electrophysiology|MP:0003484,abnormal channel response|MP:0011087,neonatal lethality, complete penetrance
MGI:3619211	Unc93b1<3d>	MP:0001836,abnormal antigen presentation via MHC class I|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002455,abnormal dendritic cell antigen presentation|MP:0005041,abnormal antigen presentation via MHC class II|MP:0005461,abnormal dendritic cell morphology|MP:0008548,abnormal circulating interferon level|MP:0008553,increased circulating tumor necrosis factor level|MP:0008556,abnormal tumor necrosis factor secretion|MP:0008670,decreased interleukin-12b secretion|MP:0008706,decreased interleukin-6 secretion|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:8269013	Unc93b1<em1Yuxz>	MP:0000240,extramedullary hematopoiesis|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0001263,weight loss|MP:0001861,lung inflammation|MP:0001869,pancreas inflammation|MP:0002989,small kidney|MP:0004762,increased anti-double stranded DNA antibody level|MP:0008577,increased circulating interferon-gamma level|MP:0008593,increased circulating interleukin-10 level|MP:0008596,increased circulating interleukin-6 level|MP:0008617,increased circulating interleukin-12 level|MP:0008826,abnormal splenic cell ratio|MP:0009338,increased splenocyte number|MP:0011353,expanded mesangial matrix|MP:0013660,abnormal bone marrow hematopoietic cell morphology
MGI:5140947	Unc93b1<tm1.1Kmiy>	MP:0000598,abnormal liver morphology|MP:0000691,enlarged spleen|MP:0001577,anemia|MP:0001655,multifocal hepatic necrosis|MP:0001860,liver inflammation|MP:0002083,premature death|MP:0002397,abnormal bone marrow morphology|MP:0002743,glomerulonephritis|MP:0002941,increased circulating alanine transaminase level|MP:0003009,abnormal cytokine secretion|MP:0003179,thrombocytopenia|MP:0003326,liver failure|MP:0003656,abnormal erythrocyte physiology|MP:0003725,increased autoantibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004952,increased spleen weight|MP:0005014,increased B cell number|MP:0005093,decreased B cell proliferation|MP:0005154,increased B cell proliferation|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005553,increased circulating creatinine level|MP:0008049,increased memory T cell number|MP:0008086,increased T-helper 1 cell number|MP:0008088,abnormal T-helper 1 cell differentiation|MP:0008182,decreased marginal zone B cell number|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008560,increased tumor necrosis factor secretion|MP:0008561,decreased tumor necrosis factor secretion|MP:0008562,increased interferon-alpha secretion|MP:0008563,decreased interferon-alpha secretion|MP:0008669,increased interleukin-12b secretion|MP:0008670,decreased interleukin-12b secretion|MP:0010219,increased T-helper 17 cell number|MP:0010221,abnormal T-helper 17 cell differentiation|MP:0010835,increased CD4-positive, alpha-beta memory T cell number|MP:0011178,increased erythroblast number|MP:0011971,increased circulating lactate dehydrogenase level
MGI:3797728	Unc93b1<tm1(KOMP)Vlcg>	MP:0002376,abnormal dendritic cell physiology|MP:0002455,abnormal dendritic cell antigen presentation|MP:0005461,abnormal dendritic cell morphology|MP:0008597,decreased circulating interleukin-6 level|MP:0008648,decreased circulating interleukin-12b level|MP:0008752,abnormal tumor necrosis factor level
MGI:1859373	Uncx<tm1Akis>	MP:0000137,abnormal vertebrae morphology|MP:0000139,absent vertebral transverse processes|MP:0000140,absent vertebral pedicles|MP:0000141,abnormal vertebral body morphology|MP:0000152,absent proximal rib|MP:0000154,rib fusion|MP:0000157,abnormal sternum morphology|MP:0000161,scoliosis|MP:0000162,lordosis|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000963,fused dorsal root ganglion|MP:0001953,respiratory failure|MP:0002114,abnormal axial skeleton morphology|MP:0003345,decreased rib number|MP:0004624,abnormal thoracic cage morphology|MP:0004734,small thoracic cavity|MP:0005367,renal/urinary system phenotype|MP:0006029,abnormal sclerotome morphology|MP:0008147,asymmetric costovertebral joints|MP:0011089,perinatal lethality, complete penetrance
MGI:1928812	Uncx<tm1Pgr>	MP:0000140,absent vertebral pedicles|MP:0000152,absent proximal rib|MP:0000154,rib fusion|MP:0000160,kyphosis|MP:0000961,abnormal dorsal root ganglion morphology|MP:0000962,disorganized dorsal root ganglion|MP:0000963,fused dorsal root ganglion|MP:0001077,abnormal spinal nerve morphology|MP:0001953,respiratory failure|MP:0002114,abnormal axial skeleton morphology|MP:0003345,decreased rib number|MP:0004612,fusion of vertebral bodies|MP:0004624,abnormal thoracic cage morphology|MP:0005367,renal/urinary system phenotype|MP:0006029,abnormal sclerotome morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:3046503	Ung<tm1Mend>	MP:0003076,increased susceptibility to ischemic brain injury|MP:0008412,increased cellular sensitivity to oxidative stress
MGI:2182610	Ung<tm1Tld>	MP:0000688,lymphoid hyperplasia|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0000709,enlarged thymus|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002494,increased IgM level|MP:0004815,abnormal somatic hypermutation frequency|MP:0004816,abnormal class switch recombination|MP:0008498,decreased IgG3 level|MP:0008943,increased sensitivity to induced cell death|MP:0009796,abnormal base-excision repair
MGI:6394011	Unkl<em1(IMPC)J>	MP:0010052,increased grip strength
MGI:4880910	Unk<tm1a(KOMP)Wtsi>	MP:0000520,absent kidney|MP:0001015,small superior cervical ganglion|MP:0001258,decreased body length|MP:0002947,increased hemangioma incidence|MP:0003131,increased erythrocyte cell number|MP:0003722,absent ureter|MP:0005562,decreased mean corpuscular hemoglobin|MP:0009532,decreased parotid gland size|MP:0010052,increased grip strength|MP:0010123,increased bone mineral content|MP:0010977,fused right lung lobes|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013835,absent hypoglossal nerve|MP:0013840,absent segment of posterior cerebral artery|MP:0013848,subcutaneous edema
MGI:6761879	Unk<tm1c(KOMP)Wtsi>	MP:0001262,decreased body weight|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0014114,abnormal cognition
MGI:1857082	uns	MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001505,hunched posture|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002083,premature death|MP:0004145,abnormal muscle electrophysiology|MP:0005405,axon degeneration|MP:0005620,abnormal muscle contractility|MP:0009417,skeletal muscle atrophy
MGI:6506271	Uox<em1Cli>	MP:0000182,increased circulating LDL cholesterol level|MP:0001552,increased circulating triglyceride level|MP:0001859,kidney inflammation|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002644,decreased circulating triglyceride level|MP:0002705,dilated renal tubule|MP:0002842,increased systemic arterial blood pressure|MP:0003059,decreased insulin secretion|MP:0003215,renal interstitial fibrosis|MP:0003881,abnormal nephron morphology|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008713,abnormal cytokine level|MP:0008770,decreased survivor rate|MP:0008821,increased blood uric acid level|MP:0009114,decreased pancreatic beta cell mass|MP:0011291,nephron necrosis|MP:0011425,abnormal kidney interstitium morphology|MP:0011501,increased glomerular capsule space|MP:0014117,increased pancreatic beta cell apoptosis|MP:0020087,increased susceptibility to non-insulin-dependent diabetes
MGI:7426072	Uox<em1(IMPC)Ccpcz>	MP:0001944,abnormal pancreas morphology|MP:0003450,enlarged pancreas|MP:0004247,small pancreas|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2157909	Uox<in>	MP:0000519,hydronephrosis|MP:0001762,polyuria|MP:0002082,postnatal lethality|MP:0002135,abnormal kidney morphology|MP:0002499,chronic inflammation|MP:0002705,dilated renal tubule|MP:0005325,abnormal renal glomerulus morphology|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0009643,abnormal urine homeostasis
MGI:1857266	Uox<tm1Bay>	MP:0000519,hydronephrosis|MP:0000522,kidney cortex cyst|MP:0000539,distended urinary bladder|MP:0001426,polydipsia|MP:0001762,polyuria|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002988,decreased urine osmolality|MP:0002989,small kidney|MP:0003619,abnormal urine color|MP:0003675,kidney cyst|MP:0003881,abnormal nephron morphology|MP:0003985,renal fibrosis|MP:0004860,dilated kidney collecting duct|MP:0004969,pale kidney|MP:0005325,abnormal renal glomerulus morphology|MP:0005565,increased blood urea nitrogen level|MP:0008821,increased blood uric acid level|MP:0009644,uremia|MP:0009645,crystalluria|MP:0009810,increased urine uric acid level|MP:0011346,renal tubule atrophy|MP:0011363,renal glomerulus atrophy|MP:0011402,renal cast|MP:0011405,tubulointerstitial nephritis|MP:0011501,increased glomerular capsule space|MP:0011625,cystolithiasis
MGI:4441733	Upb1<tm1a(EUCOMM)Wtsi>	MP:0001258,decreased body length|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount
MGI:2386175	Upf1<tm1Hcd>	MP:0001672,abnormal embryo development|MP:0006042,increased apoptosis|MP:0009687,empty decidua capsularis|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3790199	Upf2<tm1.1Btp>	MP:0011092,embryonic lethality, complete penetrance
MGI:3790198	Upf2<tm1Btp>	MP:0000208,decreased hematocrit|MP:0000334,decreased granulocyte number|MP:0000851,cerebellum hypoplasia|MP:0000872,abnormal cerebellum external granule cell layer morphology|MP:0001577,anemia|MP:0001823,thymus hypoplasia|MP:0002083,premature death|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002458,abnormal B cell number|MP:0002594,low mean erythrocyte cell number|MP:0002874,decreased hemoglobin content|MP:0002892,decreased superior colliculus size|MP:0003203,increased neuron apoptosis|MP:0003246,loss of GABAergic neurons|MP:0004810,decreased hematopoietic stem cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0008758,abnormal T cell receptor beta chain V(D)J recombination|MP:0008924,decreased cerebellar granule cell number|MP:0009038,decreased inferior colliculus size|MP:0009960,abnormal cerebellum anterior lobe morphology|MP:0020393,increased neuronal precursor proliferation
MGI:6152673	Upf3a<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001925,male infertility|MP:0002092,abnormal eye morphology
MGI:6117429	Upf3a<tm1.1Wilk>	MP:0002687,oligozoospermia|MP:0004901,decreased male germ cell number|MP:0005169,abnormal male meiosis|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0005621,abnormal cell physiology|MP:0006378,abnormal spermatogonia morphology|MP:0006379,abnormal spermatocyte morphology|MP:0014052,increased male germ cell apoptosis|MP:0014633,decreased spermatid number
MGI:6117430	Upf3a<tm1.2Wilk>	MP:0006205,embryonic lethality between implantation and somite formation|MP:0010768,mortality/aging|MP:0011092,embryonic lethality, complete penetrance|MP:0014134,abnormal embryo morphology
MGI:6156436	Upf3b<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0000470,abnormal stomach morphology|MP:0000706,small thymus|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0002989,small kidney|MP:0005016,decreased lymphocyte cell number|MP:0013279,increased fasting circulating glucose level|MP:0020422,decreased freezing behavior
MGI:5248632	Upf3b<Gt(IST14619B5)Tigm>	MP:0001489,decreased startle reflex|MP:0001501,abnormal sleep pattern|MP:0001513,limb grasping|MP:0005377,hearing/vestibular/ear phenotype|MP:0009142,decreased prepulse inhibition|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0011827,impaired neuron differentiation|MP:0012286,decreased frequency of paradoxical sleep|MP:0012292,decreased slow-wave sleep duration|MP:0014639,decreased sleep duration|MP:0020393,increased neuronal precursor proliferation|MP:0020508,decreased dendritic spine density
MGI:7748716	Upk1a<em2Mgef>	MP:0000540,abnormal urinary bladder urothelium morphology|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001158,abnormal prostate gland morphology|MP:0001168,abnormal prostate gland epithelium morphology|MP:0001860,liver inflammation|MP:0001861,lung inflammation|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002152,abnormal brain morphology|MP:0002216,abnormal seminiferous tubule morphology|MP:0002412,increased susceptibility to bacterial infection|MP:0002660,abnormal caput epididymis morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0002687,oligozoospermia|MP:0002703,abnormal renal tubule morphology|MP:0003068,enlarged kidney|MP:0003203,increased neuron apoptosis|MP:0003215,renal interstitial fibrosis|MP:0003426,pulmonary interstitial fibrosis|MP:0003596,epididymis inflammation|MP:0003828,pulmonary edema|MP:0003917,increased kidney weight|MP:0004852,decreased testis weight|MP:0004929,decreased epididymis weight|MP:0004958,enlarged prostate gland|MP:0004961,increased prostate gland weight|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0009172,small pancreatic islets|MP:0009248,small caput epididymis|MP:0009641,kidney degeneration|MP:0009646,urinary bladder inflammation|MP:0010894,pulmonary alveolar edema|MP:0011363,renal glomerulus atrophy|MP:0011405,tubulointerstitial nephritis|MP:0011769,urinary bladder fibrosis|MP:0011799,increased urinary bladder weight|MP:0011874,enlarged urinary bladder|MP:0013600,testis degeneration|MP:0013900,seminal vesicle epithelium degeneration|MP:0014117,increased pancreatic beta cell apoptosis
MGI:4441453	Upk1b<tm1Pzg>	MP:0002169,no abnormal phenotype detected
MGI:3527893	Upk2<tm1Tsun>	MP:0000519,hydronephrosis|MP:0001732,postnatal growth retardation|MP:0001762,polyuria|MP:0003587,ureter obstruction|MP:0003630,abnormal urothelium morphology|MP:0005565,increased blood urea nitrogen level|MP:0005618,decreased urine potassium level|MP:0006317,decreased urine sodium level|MP:0009643,abnormal urine homeostasis|MP:0010386,abnormal urinary bladder physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011424,decreased urine uric acid level|MP:0011460,decreased urine chloride ion level|MP:0011471,decreased urine creatinine level
MGI:2183244	Upk3a<tm1Tsun>	MP:0000519,hydronephrosis|MP:0001948,vesicoureteral reflux|MP:0003630,abnormal urothelium morphology|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0009349,increased urine pH|MP:0010386,abnormal urinary bladder physiology|MP:0011535,increased urination frequency|MP:0011783,abnormal ureteral orifice morphology
MGI:5695209	Upk3b<tm1.1Akis>	MP:0005367,renal/urinary system phenotype|MP:0005385,cardiovascular system phenotype
MGI:3699164	Upp1<tm1Akiy>	MP:0003806,abnormal nucleotide metabolism|MP:0005584,abnormal enzyme/coenzyme activity
MGI:3586525	Upp1<tm1Gp>	MP:0003806,abnormal nucleotide metabolism|MP:0005319,abnormal enzyme/coenzyme level|MP:0005584,abnormal enzyme/coenzyme activity|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009642,abnormal blood homeostasis|MP:0009747,impaired behavioral response to xenobiotic|MP:0011477,abnormal urine nucleoside level
MGI:6718325	Uqcc3<em1Hya>	MP:0002053,decreased incidence of induced tumors|MP:0005370,liver/biliary system phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0031252,abnormal physiological response to hypoxia
MGI:7426073	Uqcc3<em1(IMPC)Bay>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0000288,abnormal pericardium morphology|MP:0001672,abnormal embryo development|MP:0001697,abnormal embryo size|MP:0001700,abnormal embryo turning|MP:0001718,abnormal visceral yolk sac morphology|MP:0001722,pale yolk sac|MP:0002151,abnormal neural tube morphology|MP:0002861,abnormal tail bud morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003232,abnormal forebrain development|MP:0003425,abnormal optic vesicle formation|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003984,embryonic growth retardation|MP:0005650,abnormal limb bud morphology|MP:0006108,abnormal hindbrain development|MP:0009806,abnormal otic vesicle morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:7413183	Uqcc6<em1Lenh>	MP:0010955,abnormal respiratory electron transport chain|MP:0012735,abnormal response to exercise|MP:0013405,increased circulating lactate level
MGI:6257426	Uqcr10<em1(IMPC)Bay>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0002582,disorganized extraembryonic tissue|MP:0003984,embryonic growth retardation|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0014586,decreased egg cylinder size
MGI:6257639	Uqcr10<em2(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:5548543	Uqcrb<tm1b(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0011100,preweaning lethality, complete penetrance
MGI:6285593	Uqcrc1<em1(IMPC)Bay>	MP:0001417,decreased exploration in new environment|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6403206	Uqcrc1<tm1Zzuo>	MP:0003076,increased susceptibility to ischemic brain injury|MP:0003461,abnormal response to novel object|MP:0004924,abnormal behavior|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005389,reproductive system phenotype|MP:0011092,embryonic lethality, complete penetrance|MP:0012307,impaired spatial learning
MGI:5307154	Uqcrfs1<tm1.1Hek>	MP:0001661,extended life span|MP:0002083,premature death|MP:0005386,behavior/neurological phenotype|MP:0010769,abnormal survival|MP:0010955,abnormal respiratory electron transport chain|MP:0011100,preweaning lethality, complete penetrance|MP:0020234,decreased basal metabolism
MGI:3819772	Uqcrfs1<tm1Ctm>	MP:0000811,hippocampal neuron degeneration|MP:0000859,abnormal somatosensory cortex morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0002229,neurodegeneration|MP:0003224,neuron degeneration|MP:0003690,abnormal glial cell physiology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006036,abnormal mitochondrial physiology|MP:0006038,increased mitochondrial fission|MP:0008238,abnormal dorsoventral coat patterning|MP:0010009,abnormal piriform cortex morphology
MGI:5692661	Uqcrh<tm1b(EUCOMM)Wtsi>	MP:0001944,abnormal pancreas morphology|MP:0002059,abnormal seminal vesicle morphology|MP:0002135,abnormal kidney morphology|MP:0002966,decreased circulating alkaline phosphatase level|MP:0002997,enlarged seminal vesicle|MP:0009476,enlarged cecum
MGI:6201258	Uqcrq<tm1b(EUCOMM)Hmgu>	MP:0008935,decreased mean platelet volume|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:1857083	ur	MP:0000111,cleft palate|MP:0000154,rib fusion|MP:0000480,increased rib number|MP:0000519,hydronephrosis|MP:0000592,short tail|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002135,abnormal kidney morphology|MP:0004645,decreased vertebrae number|MP:0005508,abnormal skeleton morphology|MP:0008148,abnormal sternocostal joint morphology|MP:0008525,decreased cranium height|MP:0008528,polycystic kidney|MP:0008770,decreased survivor rate|MP:0009703,decreased birth body size|MP:0011090,perinatal lethality, incomplete penetrance
MGI:4836355	Urah<plt2>	MP:0000609,abnormal liver physiology|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002981,increased liver weight|MP:0003331,increased hepatocellular carcinoma incidence|MP:0005068,abnormal NK cell morphology|MP:0005348,increased T cell proliferation|MP:0005505,thrombocytosis|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008254,increased megakaryocyte cell number|MP:0008821,increased blood uric acid level|MP:0008874,decreased physiological sensitivity to xenobiotic
MGI:6257618	Urb1<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7660773	Urb1<em1Jil>	MP:0001730,embryonic growth arrest|MP:0002663,absent blastocoele|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3712281	urehr1	MP:0001762,polyuria|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002844,aortic hypertrophy|MP:0002871,albuminuria|MP:0005178,increased circulating cholesterol level|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005553,increased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0006317,decreased urine sodium level|MP:0008140,podocyte foot process effacement|MP:0011294,renal glomerulus hypertrophy|MP:0011309,abnormal kidney arterial blood vessel morphology|MP:0011320,abnormal glomerular capillary morphology|MP:0011346,renal tubule atrophy|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011402,renal cast|MP:0011430,mesangiolysis|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011471,decreased urine creatinine level|MP:0011483,renal glomerular synechia|MP:0011508,abnormal glomerular capillary thrombosis|MP:0011509,dilated glomerular capillary|MP:0011512,mesangial cell interposition|MP:0011868,podocyte microvillus transformation|MP:0011941,increased fluid intake|MP:0020519,renal glomerular immunoglobulin deposits
MGI:5706757	Uri1<tm1.1Ndj>	MP:0000598,abnormal liver morphology|MP:0001654,hepatic necrosis|MP:0001860,liver inflammation|MP:0002082,postnatal lethality|MP:0002941,increased circulating alanine transaminase level|MP:0003326,liver failure|MP:0003887,increased hepatocyte apoptosis|MP:0003888,liver hemorrhage|MP:0004502,decreased incidence of tumors by chemical induction|MP:0005166,decreased susceptibility to injury|MP:0014782,increased liver enzyme/coenzyme level
MGI:4942141	Uri1<tm1a(EUCOMM)Wtsi>	MP:0013279,increased fasting circulating glucose level
MGI:6385665	Urm1<em1(IMPC)J>	MP:0000267,abnormal heart development|MP:0000783,abnormal forebrain morphology|MP:0000928,incomplete rostral neuropore closure|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001914,hemorrhage|MP:0002824,abnormal chorioallantoic fusion|MP:0002884,abnormal pharyngeal arch morphology|MP:0003400,kinked neural tube|MP:0003984,embryonic growth retardation|MP:0005031,abnormal trophoblast layer morphology|MP:0005293,impaired glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0012099,decreased spongiotrophoblast size|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0014134,abnormal embryo morphology
MGI:6257735	Uroc1<em1(IMPC)Bay>	MP:0001417,decreased exploration in new environment|MP:0010097,abnormal retina blood vessel morphology
MGI:2687172	Urod<tm1Kush>	MP:0002169,no abnormal phenotype detected|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:3619379	Uros<tm1Cged>	MP:0000061,fragile skeleton|MP:0000321,increased bone marrow cell number|MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001202,skin photosensitivity|MP:0001585,hemolytic anemia|MP:0002628,hepatic steatosis|MP:0002642,anisocytosis|MP:0002643,poikilocytosis|MP:0002703,abnormal renal tubule morphology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005325,abnormal renal glomerulus morphology|MP:0005508,abnormal skeleton morphology|MP:0005654,porphyria|MP:0008388,hypochromic microcytic anemia|MP:0008476,increased spleen red pulp amount|MP:0009703,decreased birth body size|MP:0011414,erythruria|MP:0030058,erythrodontia
MGI:3776882	Uros<tm1Rjde>	MP:0011100,preweaning lethality, complete penetrance
MGI:3620007	Uros<tm2Cged>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:3776884	Uros<tm2Rjde>	MP:0011100,preweaning lethality, complete penetrance
MGI:3776889	Uros<tm3Rjde>	MP:0001202,skin photosensitivity|MP:0001219,thick epidermis|MP:0004147,increased porphyrin level|MP:0005397,hematopoietic system phenotype|MP:0005584,abnormal enzyme/coenzyme activity
MGI:3776890	Uros<tm4Rjde>	MP:0011100,preweaning lethality, complete penetrance
MGI:1857084	us	MP:0000154,rib fusion|MP:0000400,abnormal awl hair morphology|MP:0000536,hydroureter|MP:0000585,kinked tail|MP:0001144,vagina atresia|MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002016,ovary cyst|MP:0002083,premature death|MP:0002286,cryptorchism|MP:0002730,head shaking|MP:0002759,abnormal caudal vertebrae morphology|MP:0002989,small kidney|MP:0003675,kidney cyst|MP:0004620,cervical vertebral fusion|MP:0004621,lumbar vertebral fusion|MP:0004622,sacral vertebral fusion|MP:0004687,split vertebrae|MP:0008538,decreased zigzag hair amount|MP:0009703,decreased birth body size|MP:0031286,unilateral cryptorchism|MP:0031287,bilateral cryptorchism
MGI:6257807	Usb1<em1(IMPC)Bay>	MP:0000783,abnormal forebrain morphology|MP:0001701,incomplete embryo turning|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002111,abnormal tail morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003984,embryonic growth retardation|MP:0005031,abnormal trophoblast layer morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3842569	Use1<tm1.1Aha>	MP:0002058,neonatal lethality|MP:0002169,no abnormal phenotype detected|MP:0002882,abnormal neuron morphology|MP:0006042,increased apoptosis|MP:0006254,thin cerebral cortex|MP:0012676,dilated brain ventricle|MP:0014812,abnormal brain physiology
MGI:3842571	Use1<tm1.2Aha>	MP:0011092,embryonic lethality, complete penetrance
MGI:3842567	Use1<tm1Aha>	MP:0011092,embryonic lethality, complete penetrance
MGI:3860046	Usf1<Gt(P116C05)Wrst>	MP:0020467,abnormal circadian behavior
MGI:4336768	Usf1<Gt(W233A07)Wrst>	MP:0020467,abnormal circadian behavior
MGI:2181678	Usf1<tm1Msw>	MP:0000951,sporadic seizures|MP:0001446,abnormal whisker trimming behavior|MP:0002808,abnormal barbering behavior|MP:0009358,environmentally induced seizures
MGI:3640336	Usf1<tm1Svl>	MP:0002169,no abnormal phenotype detected
MGI:2181680	Usf2<tm1Msw>	MP:0000585,kinked tail|MP:0000951,sporadic seizures|MP:0001265,decreased body size|MP:0001922,reduced male fertility|MP:0002083,premature death|MP:0008237,abnormal ventral coat pigmentation|MP:0009546,absent gastric milk in neonates|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5766209	Usf3<tm2b(EUCOMM)Wtsi>	MP:0001491,unresponsive to tactile stimuli|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2651858	Ush1c<dfcr>	MP:0000043,organ of Corti degeneration|MP:0001326,retina degeneration|MP:0001394,circling|MP:0001525,impaired balance|MP:0001967,deafness|MP:0002857,cochlear ganglion degeneration|MP:0004324,vestibular hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004578,abnormal cochlear hair bundle tip links morphology|MP:0005307,head tossing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2651859	Ush1c<dfcr-2J>	MP:0001394,circling|MP:0001525,impaired balance|MP:0001967,deafness|MP:0004324,vestibular hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004404,cochlear outer hair cell degeneration|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0005307,head tossing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3842842	Ush1c<dfcr-3J>	MP:0001394,circling|MP:0001410,head bobbing|MP:0001967,deafness|MP:0005391,vision/eye phenotype
MGI:6359826	Ush1c<dfcr-4J>	MP:0001394,circling|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0005307,head tossing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4436726	Ush1c<tm1.1Mull>	MP:0001394,circling|MP:0001967,deafness|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0005307,head tossing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3757683	Ush1c<tm1.1Ugds>	MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004577,abnormal cochlear hair cell inter-stereocilial links morphology
MGI:4363497	Ush1c<tm1a(KOMP)Wtsi>	MP:0001408,stereotypic behavior|MP:0001512,trunk curl|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0003019,increased circulating chloride level|MP:0003960,increased lean body mass|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005633,increased circulating sodium level|MP:0006358,absent pinna reflex|MP:0008805,decreased circulating amylase level|MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength|MP:0010067,increased red blood cell distribution width|MP:0010123,increased bone mineral content|MP:0011939,increased food intake
MGI:3699259	Ush1c<tm1Bkts>	MP:0001394,circling|MP:0001399,hyperactivity|MP:0005307,head tossing|MP:0005389,reproductive system phenotype|MP:0006358,absent pinna reflex
MGI:4437562	Ush1c<tm1Xzl>	MP:0000479,abnormal enterocyte morphology|MP:0000488,abnormal intestinal epithelium morphology|MP:0000495,abnormal colon morphology|MP:0000496,abnormal small intestine morphology|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001522,impaired swimming|MP:0001967,deafness|MP:0002622,abnormal cochlear hair cell morphology|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004492,abnormal orientation of inner hair cell stereociliary bundles|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0005307,head tossing|MP:0005391,vision/eye phenotype|MP:0008141,decreased small intestinal microvillus size|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012029,abnormal electroretinogram waveform feature
MGI:1856575	Ush1g<js>	MP:0001394,circling|MP:0001399,hyperactivity|MP:0001485,abnormal pinna reflex|MP:0001522,impaired swimming|MP:0001961,abnormal reflex|MP:0001967,deafness|MP:0002730,head shaking|MP:0004404,cochlear outer hair cell degeneration|MP:0004466,short cochlear outer hair cells|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004577,abnormal cochlear hair cell inter-stereocilial links morphology|MP:0004813,absent linear vestibular evoked potential|MP:0004814,reduced linear vestibular evoked potential|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3640130	Ush1g<js-2J>	MP:0001395,bidirectional circling|MP:0001967,deafness|MP:0004405,absent cochlear hair cells|MP:0005307,head tossing|MP:0005391,vision/eye phenotype
MGI:5317822	Ush1g<js-3J>	MP:0001394,circling|MP:0001967,deafness|MP:0005307,head tossing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:2450561	Ush1g<js-seal>	MP:0001394,circling|MP:0001399,hyperactivity|MP:0001967,deafness|MP:0004324,vestibular hair cell degeneration|MP:0004331,vestibular saccular macula degeneration|MP:0004333,abnormal utricular macula morphology|MP:0005307,head tossing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4361359	Ush1g<tm1.1Ugds>	MP:0001394,circling|MP:0001967,deafness|MP:0003879,abnormal hair cell physiology|MP:0004413,absent cochlear microphonics|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0004531,short outer hair cell stereocilia|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004534,decreased inner hair cell stereocilia number|MP:0004536,short inner hair cell stereocilia|MP:0004578,abnormal cochlear hair bundle tip links morphology|MP:0004737,absent distortion product otoacoustic emissions|MP:0004742,abnormal vestibular system physiology|MP:0006335,abnormal hearing electrophysiology|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4950014	Ush1g<tm1.2Ugds>	MP:0004413,absent cochlear microphonics|MP:0004431,abnormal hair cell mechanoelectric transduction|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004737,absent distortion product otoacoustic emissions|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0030961,abnormal outer hair cell kinocilium location or orientation
MGI:3702040	Ush2a<tm1Tili>	MP:0001004,abnormal retina photoreceptor morphology|MP:0003728,abnormal retina photoreceptor layer morphology|MP:0004402,decreased cochlear outer hair cell number|MP:0004736,abnormal distortion product otoacoustic emission|MP:0005551,abnormal eye electrophysiology|MP:0008444,retina cone cell degeneration|MP:0008450,retina photoreceptor degeneration|MP:0008582,short photoreceptor inner segment|MP:0008587,short photoreceptor outer segment
MGI:4460519	Ushbp1<tm1a(EUCOMM)Wtsi>	MP:0004609,vertebral fusion
MGI:6467488	Uso1<em1(IMPC)Bay>	MP:0001257,increased body length|MP:0011100,preweaning lethality, complete penetrance|MP:0011964,increased total retina thickness
MGI:3857238	Uso1<Gt(AW0562)Wtsi>	MP:0011092,embryonic lethality, complete penetrance|MP:0011743,abnormal Golgi apparatus morphology
MGI:3880692	Uso1<Gt(YTA025)Byg>	MP:0011092,embryonic lethality, complete penetrance|MP:0011743,abnormal Golgi apparatus morphology
MGI:5498660	Usp10<tm1Fuj>	MP:0000358,abnormal cell morphology|MP:0003674,oxidative stress|MP:0006042,increased apoptosis
MGI:4880482	Usp10<tm1(NCOM)Mfgc>	MP:0011100,preweaning lethality, complete penetrance
MGI:4419682	Usp11<tm1(KOMP)Wtsi>	MP:0000182,increased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0005561,increased mean corpuscular hemoglobin
MGI:6363163	Usp11<tm1Tac>	MP:0001167,prostate gland epithelial hyperplasia|MP:0004958,enlarged prostate gland|MP:0010768,mortality/aging|MP:0011703,increased fibroblast proliferation|MP:0020414,abnormal fibroblast physiology
MGI:4434551	Usp12<tm1a(EUCOMM)Hmgu>	MP:0000565,oligodactyly|MP:0001262,decreased body weight|MP:0001807,decreased IgA level|MP:0002833,increased heart weight|MP:0002834,decreased heart weight|MP:0002942,decreased circulating alanine transaminase level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:5548414	Usp12<tm1b(EUCOMM)Hmgu>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance
MGI:6406217	Usp13<em1Nmw>	MP:0001861,lung inflammation|MP:0002412,increased susceptibility to bacterial infection|MP:0008560,increased tumor necrosis factor secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008705,increased interleukin-6 secretion
MGI:5701723	Usp13<tm1b(EUCOMM)Hmgu>	MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount
MGI:1855959	Usp14<ax-J>	MP:0000745,tremors|MP:0000746,weakness|MP:0000748,progressive muscle weakness|MP:0000753,paralysis|MP:0000781,decreased corpus callosum size|MP:0000812,abnormal dentate gyrus morphology|MP:0000841,abnormal hindbrain morphology|MP:0000848,abnormal pons morphology|MP:0000852,small cerebellum|MP:0000876,Purkinje cell degeneration|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001077,abnormal spinal nerve morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001473,reduced long-term potentiation|MP:0001732,postnatal growth retardation|MP:0001900,impaired synaptic plasticity|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002152,abnormal brain morphology|MP:0002199,abnormal brain commissure morphology|MP:0002269,muscular atrophy|MP:0002916,increased synaptic depression|MP:0002920,decreased paired-pulse facilitation|MP:0002922,decreased post-tetanic potentiation|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003203,increased neuron apoptosis|MP:0003415,priapism|MP:0003635,abnormal synaptic transmission|MP:0004098,abnormal cerebellar granule cell morphology|MP:0004166,abnormal limbic system morphology|MP:0004708,short lumbar vertebrae|MP:0004835,abnormal miniature endplate potential|MP:0005376,homeostasis/metabolism phenotype|MP:0005445,abnormal neurotransmitter secretion|MP:0008027,abnormal spinal cord white matter morphology|MP:0008222,decreased hippocampal commissure size|MP:0008232,abnormal cingulum morphology|MP:0008283,small hippocampus|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0012089,decreased midbrain size|MP:0020560,abnormal pontine nuclei morphology
MGI:3622127	Usp14<nmf375>	MP:0000743,muscle spasm|MP:0000747,muscle weakness|MP:0000749,muscle degeneration|MP:0000955,abnormal spinal cord morphology|MP:0001053,abnormal neuromuscular synapse morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002083,premature death|MP:0003225,axonal dystrophy|MP:0003631,nervous system phenotype|MP:0005277,abnormal brainstem morphology|MP:0005369,muscle phenotype|MP:0005386,behavior/neurological phenotype|MP:0009434,paraparesis|MP:0011089,perinatal lethality, complete penetrance|MP:0020955,increased mechanical nociceptive threshold
MGI:5637099	Usp14<tm2b(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:7621223	Usp15<em1Peih>	MP:0002451,abnormal macrophage physiology
MGI:6149704	Usp15<L749R>	MP:0002411,decreased susceptibility to bacterial infection|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005026,decreased susceptibility to parasitic infection|MP:0005387,immune system phenotype|MP:0005465,abnormal T-helper 1 physiology|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality
MGI:5708164	Usp15<tm1b(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0002599,increased mean platelet volume|MP:0003960,increased lean body mass|MP:0005560,decreased circulating glucose level|MP:0005633,increased circulating sodium level|MP:0010025,decreased total body fat amount|MP:0010088,decreased circulating fructosamine level|MP:0010123,increased bone mineral content|MP:0013278,decreased fasting circulating glucose level
MGI:6149705	Usp15<tm1Pgrs>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0010751,decreased susceptibility to parasitic infection induced morbidity/mortality
MGI:5286645	Usp16<Tg(Tyr)2414FOve>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:5618768	Usp16<tm1b(EUCOMM)Hmgu>	MP:0002606,increased basophil cell number|MP:0005011,increased eosinophil cell number|MP:0008935,decreased mean platelet volume
MGI:5466162	Usp17lc<tm1Khb>	MP:0000352,decreased cell proliferation|MP:0001260,increased body weight|MP:0002675,asthenozoospermia|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0004852,decreased testis weight|MP:0004955,increased thymus weight|MP:0004974,decreased regulatory T cell number|MP:0005014,increased B cell number|MP:0005389,reproductive system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012119,increased trophectoderm apoptosis|MP:0013504,increased embryonic tissue cell apoptosis
MGI:4830352	Usp18<ity9>	MP:0000221,decreased leukocyte cell number|MP:0001577,anemia|MP:0002412,increased susceptibility to bacterial infection|MP:0002619,abnormal lymphocyte morphology|MP:0003179,thrombocytopenia|MP:0008567,decreased interferon-gamma secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0008596,increased circulating interleukin-6 level|MP:0008705,increased interleukin-6 secretion|MP:0008735,increased susceptibility to endotoxin shock|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality
MGI:2387336	Usp18<tm1Dez>	MP:0000745,tremors|MP:0000788,abnormal cerebral cortex morphology|MP:0000947,convulsive seizures|MP:0001394,circling|MP:0001411,spinning|MP:0001570,abnormal circulating enzyme level|MP:0001891,hydrocephaly|MP:0001916,intracerebral hemorrhage|MP:0002083,premature death|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0008574,decreased circulating interferon-alpha level|MP:0008576,decreased circulating interferon-beta level|MP:0008578,decreased circulating interferon-gamma level|MP:0008713,abnormal cytokine level|MP:0020950,decreased susceptibility to Coronaviridae infection
MGI:4125720	Usp19<Gt(XG128)Byg>	MP:0001262,decreased body weight|MP:0001922,reduced male fertility|MP:0004064,decreased susceptibility to induced muscular atrophy|MP:0008260,abnormal autophagy|MP:0008469,abnormal protein level|MP:0009402,decreased skeletal muscle fiber diameter|MP:0010052,increased grip strength
MGI:5796934	Usp19<tm1b(EUCOMM)Hmgu>	MP:0001510,abnormal coat appearance|MP:0001925,male infertility|MP:0003960,increased lean body mass|MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3838373	Usp1<tm1.1Ada>	MP:0000333,decreased bone marrow cell number|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001262,decreased body weight|MP:0001575,cyanosis|MP:0001658,increased mortality induced by gamma-irradiation|MP:0001785,edema|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0004030,induced chromosome breakage|MP:0005431,decreased oocyte number|MP:0006362,abnormal male germ cell morphology|MP:0006379,abnormal spermatocyte morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014619,absent spermatogonia|MP:0014633,decreased spermatid number
MGI:5823224	Usp1<tm1b(KOMP)Wtsi>	MP:0000443,abnormal snout morphology|MP:0001258,decreased body length|MP:0002079,increased circulating insulin level|MP:0002875,decreased erythrocyte cell number|MP:0003671,abnormal eyelid aperture|MP:0005553,increased circulating creatinine level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level
MGI:5556385	Usp1<tm1d(KOMP)Wtsi>	MP:0000060,delayed bone ossification|MP:0000063,decreased bone mineral density|MP:0002966,decreased circulating alkaline phosphatase level|MP:0004992,increased bone resorption|MP:0005390,skeleton phenotype|MP:0010876,decreased bone volume|MP:0010924,abnormal osteoid morphology
MGI:6515595	Usp20<em1Cya>	MP:0001262,decreased body weight|MP:0002644,decreased circulating triglyceride level|MP:0002891,increased insulin sensitivity|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0014143,decreased body fat mass
MGI:6713512	Usp20<em1Dalin>	MP:0008561,decreased tumor necrosis factor secretion|MP:0008565,decreased interferon-beta secretion|MP:0008576,decreased circulating interferon-beta level|MP:0008597,decreased circulating interleukin-6 level|MP:0010209,abnormal circulating chemokine level|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:6515593	Usp20<em1Gpt>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0000598,abnormal liver morphology|MP:0001262,decreased body weight|MP:0001570,abnormal circulating enzyme level|MP:0002644,decreased circulating triglyceride level|MP:0002702,decreased circulating free fatty acids level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0003402,decreased liver weight|MP:0003976,decreased circulating VLDL triglyceride level|MP:0004889,increased energy expenditure|MP:0005179,decreased circulating cholesterol level|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005560,decreased circulating glucose level|MP:0009269,decreased fat cell size|MP:0009356,decreased liver triglyceride level|MP:0010026,decreased liver cholesterol level|MP:0011017,increased body surface temperature|MP:0013278,decreased fasting circulating glucose level|MP:0014143,decreased body fat mass|MP:0014146,decreased white adipose tissue mass|MP:0014782,increased liver enzyme/coenzyme level|MP:0014783,decreased liver enzyme/coenzyme level
MGI:4434938	Usp20<tm1a(EUCOMM)Hmgu>	MP:0002968,increased circulating alkaline phosphatase level|MP:0003019,increased circulating chloride level
MGI:5568976	Usp21<tm1.1Jhy>	MP:0000219,increased neutrophil cell number|MP:0000691,enlarged spleen|MP:0004952,increased spleen weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0005425,increased macrophage cell number|MP:0008573,increased circulating interferon-alpha level|MP:0008575,increased circulating interferon-beta level|MP:0008750,abnormal interferon level|MP:0009338,increased splenocyte number|MP:0020914,decreased susceptibility to Riboviria infection|MP:0031023,decreased susceptibility to Riboviria infection induced morbidity/mortality
MGI:4887724	Usp21<tm1a(EUCOMM)Wtsi>	MP:0000218,increased leukocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005566,decreased blood urea nitrogen level|MP:0010088,decreased circulating fructosamine level
MGI:5888903	Usp21<tm1c(EUCOMM)Wtsi>	MP:0002085,abnormal embryonic tissue morphology|MP:0002399,abnormal pluripotent precursor cell morphology
MGI:7593830	Usp22<em14Dent>	MP:0011092,embryonic lethality, complete penetrance
MGI:7593831	Usp22<em25Dent>	MP:0011092,embryonic lethality, complete penetrance
MGI:4330216	Usp22<Gt(RRS377)Byg>	MP:0001715,placental labyrinth hypoplasia|MP:0005039,hypoxia|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011525,abnormal placenta intervillous maternal lacunae morphology
MGI:3858606	Usp22<Gt(XP0208)Wtsi>	MP:0010865,prenatal growth retardation|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4364127	Usp22<tm1a(KOMP)Wtsi>	MP:0000488,abnormal intestinal epithelium morphology|MP:0000496,abnormal small intestine morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0003960,increased lean body mass|MP:0005076,abnormal cell differentiation|MP:0005561,increased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0008439,abnormal cortical plate morphology|MP:0010067,increased red blood cell distribution width|MP:0010768,mortality/aging|MP:0010802,abnormal intestinal enteroendocrine cell morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011827,impaired neuron differentiation|MP:0013485,increased Paneth cell number|MP:0013794,abnormal intestinal villus goblet cell morphology
MGI:5548748	Usp22<tm1b(KOMP)Wtsi>	MP:0000220,increased monocyte cell number|MP:0001406,abnormal gait|MP:0011100,preweaning lethality, complete penetrance
MGI:5441074	Usp22<tm1Dfan>	MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013501,increased fibroblast apoptosis
MGI:4124438	Usp24<Gt(XB614)Byg>	MP:0002020,increased tumor incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0008014,increased lung tumor incidence|MP:0008019,increased liver tumor incidence|MP:0008866,chromosomal instability|MP:0010343,increased lipoma incidence|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance
MGI:4847688	Usp24<tm1a(KOMP)Wtsi>	MP:0001552,increased circulating triglyceride level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:4332130	Usp25<Gt(RRS805)Byg>	MP:0000219,increased neutrophil cell number|MP:0001861,lung inflammation|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0008567,decreased interferon-gamma secretion|MP:0008705,increased interleukin-6 secretion
MGI:6361181	Usp26<em1Osb>	MP:0005389,reproductive system phenotype
MGI:6758249	Usp26<tm1Smoc>	MP:0001146,abnormal testis morphology|MP:0001156,abnormal spermatogenesis|MP:0001751,increased circulating luteinizing hormone level|MP:0001922,reduced male fertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0002780,decreased circulating testosterone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0004901,decreased male germ cell number
MGI:4383143	Usp28<Gt(EUCE0037g10)Hmgu>	MP:0002006,neoplasm|MP:0004030,induced chromosome breakage|MP:0004953,decreased spleen weight|MP:0005384,cellular phenotype|MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0009339,decreased splenocyte number
MGI:6156467	Usp29<em1(IMPC)Tcp>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0009142,decreased prepulse inhibition
MGI:6258721	Usp29<tm1Jkim>	MP:0001935,decreased litter size|MP:0008877,abnormal DNA methylation|MP:0009674,decreased birth weight|MP:0010723,paternal effect
MGI:5302030	Usp2<tm1.1Bjc>	MP:0001399,hyperactivity|MP:0020468,abnormal circadian behavior period|MP:0020475,delayed circadian behavior phase
MGI:5295262	Usp2<tm1.1Ssw>	MP:0000242,impaired fertilization|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002674,abnormal sperm motility|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0006362,abnormal male germ cell morphology
MGI:5636991	Usp2<tm1b(EUCOMM)Wtsi>	MP:0002591,decreased mean corpuscular volume
MGI:5514236	Usp2<tm1Dgen>	MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype
MGI:6403637	Usp30<tm1.1Tac>	MP:0010768,mortality/aging|MP:0010954,abnormal cellular respiration|MP:0014046,abnormal mitophagy
MGI:5692776	Usp30<tm2b(EUCOMM)Hmgu>	MP:0002968,increased circulating alkaline phosphatase level|MP:0003179,thrombocytopenia|MP:0005293,impaired glucose tolerance
MGI:6257795	Usp31<em1(IMPC)H>	MP:0000745,tremors|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0003960,increased lean body mass|MP:0005627,increased circulating potassium level|MP:0006243,impaired pupillary reflex|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount
MGI:7426074	Usp32<em1(IMPC)Mhzh>	MP:0000218,increased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0002590,increased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0005013,increased lymphocyte cell number|MP:0005419,decreased circulating serum albumin level|MP:0005505,thrombocytosis|MP:0005560,decreased circulating glucose level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0010067,increased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance
MGI:4433766	Usp33<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0003961,decreased lean body mass|MP:0005344,increased circulating bilirubin level|MP:0005505,thrombocytosis|MP:0005561,increased mean corpuscular hemoglobin|MP:0010025,decreased total body fat amount
MGI:6256462	Usp34<em1Qyn>	MP:0002999,abnormal bone healing|MP:0004989,decreased osteoblast cell number|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0013616,decreased volumetric bone mineral density|MP:0013630,increased bone trabecular spacing|MP:0020010,decreased bone mineral density of femur|MP:0020040,decreased bone ossification|MP:0020137,decreased bone mineralization
MGI:6272660	Usp35<em1(IMPC)J>	MP:0003900,shortened QT interval|MP:0010392,prolonged QRS complex duration
MGI:4378382	Usp36<Gt(EUCE00141e03)Hmgu>	MP:0001730,embryonic growth arrest|MP:0005621,abnormal cell physiology|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012129,failure of blastocyst formation|MP:0013504,increased embryonic tissue cell apoptosis
MGI:5605789	Usp36<tm1b(EUCOMM)Hmgu>	MP:0005559,increased circulating glucose level
MGI:6153697	Usp37<em1(IMPC)Wtsi>	MP:0005561,increased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance
MGI:5648437	Usp37<m1Anu>	MP:0011092,embryonic lethality, complete penetrance
MGI:7256446	Usp38<em1Cya>	MP:0001861,lung inflammation|MP:0006050,pulmonary fibrosis|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:5548650	Usp38<tm1b(EUCOMM)Hmgu>	MP:0001289,persistence of hyaloid vascular system|MP:0001417,decreased exploration in new environment|MP:0002590,increased mean corpuscular volume|MP:0003179,thrombocytopenia|MP:0003795,abnormal bone structure|MP:0003961,decreased lean body mass|MP:0005554,decreased circulating creatinine level|MP:0009142,decreased prepulse inhibition|MP:0010024,increased total body fat amount|MP:0010506,prolonged RR interval
MGI:7287389	Usp39<em1Imat>	MP:0001680,abnormal mesoderm development|MP:0001693,failure of primitive streak formation|MP:0002084,abnormal developmental patterning|MP:0003886,abnormal embryonic epiblast morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0014134,abnormal embryo morphology
MGI:5605740	Usp39<tm1b(EUCOMM)Hmgu>	MP:0002075,abnormal coat/hair pigmentation|MP:0004738,abnormal auditory brainstem response
MGI:4432395	Usp3<tm1a(EUCOMM)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5548759	Usp3<tm1b(EUCOMM)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:4432706	Usp42<tm2a(EUCOMM)Wtsi>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001399,hyperactivity|MP:0001925,male infertility|MP:0002161,abnormal fertility/fecundity|MP:0002687,oligozoospermia|MP:0003179,thrombocytopenia|MP:0003961,decreased lean body mass|MP:0004647,decreased lumbar vertebrae number|MP:0004924,abnormal behavior|MP:0005015,increased T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0010101,increased sacral vertebrae number|MP:0013600,testis degeneration
MGI:5478528	Usp44<tm1.2Pjgl>	MP:0002020,increased tumor incidence|MP:0002032,increased sarcoma incidence|MP:0002048,increased lung adenoma incidence|MP:0004024,aneuploidy|MP:0008866,chromosomal instability|MP:0009760,abnormal mitotic spindle morphology|MP:0010264,increased hepatoma incidence|MP:0012431,increased lymphoma incidence
MGI:5693168	Usp45<em1(IMPC)H>	MP:0000222,decreased neutrophil cell number
MGI:7329914	Usp45<em1Qzha>	MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0008446,decreased retina cone cell number
MGI:5438646	Usp46<CS>	MP:0001362,abnormal anxiety-related response|MP:0001447,abnormal nest building behavior|MP:0002863,improved righting response|MP:0003360,abnormal depression-related behavior
MGI:5438668	Usp46<Gt(pU17)1Imeg>	MP:0003360,abnormal depression-related behavior
MGI:4130032	Usp47<Gt(RRJ301)Byg>	MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death
MGI:5605792	Usp47<tm1b(EUCOMM)Wtsi>	MP:0001556,increased circulating HDL cholesterol level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0005559,increased circulating glucose level
MGI:6403288	Usp49<em1Gpt>	MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008564,increased interferon-beta secretion|MP:0008575,increased circulating interferon-beta level|MP:0008596,increased circulating interleukin-6 level|MP:0008705,increased interleukin-6 secretion|MP:0010768,mortality/aging|MP:0020917,decreased susceptibility to Herpesvirales infection|MP:0031025,decreased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:7627086	Usp4<em1Pwa>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:5013819	Usp4<tm1Xilu>	MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0005621,abnormal cell physiology|MP:0008008,early cellular replicative senescence|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0009322,increased splenocyte apoptosis|MP:0009541,increased thymocyte apoptosis
MGI:5293035	Usp50<tm1(KOMP)Vlcg>	MP:0001319,irregularly shaped pupil|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:6153699	Usp51<em1(IMPC)Wtsi>	MP:0000063,decreased bone mineral density
MGI:6156547	Usp53<em1(IMPC)Tcp>	MP:0000063,decreased bone mineral density|MP:0000367,abnormal coat/ hair morphology|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0002968,increased circulating alkaline phosphatase level|MP:0003896,prolonged PR interval|MP:0004738,abnormal auditory brainstem response|MP:0005178,increased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0005568,increased circulating total protein level|MP:0009142,decreased prepulse inhibition|MP:0010124,decreased bone mineral content
MGI:3708452	Usp53<mbo>	MP:0000043,organ of Corti degeneration|MP:0001489,decreased startle reflex|MP:0001967,deafness|MP:0002857,cochlear ganglion degeneration|MP:0004362,cochlear hair cell degeneration|MP:0004398,cochlear inner hair cell degeneration|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004411,decreased endocochlear potential|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004528,fused outer hair cell stereocilia|MP:0004597,increased susceptibility to noise-induced hearing loss|MP:0004628,Deiters cell degeneration|MP:0004737,absent distortion product otoacoustic emissions|MP:0004749,nonsyndromic hearing loss|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5694179	Usp54<tm1b(KOMP)Wtsi>	MP:0000219,increased neutrophil cell number|MP:0000274,enlarged heart|MP:0001417,decreased exploration in new environment|MP:0002874,decreased hemoglobin content|MP:0002941,increased circulating alanine transaminase level|MP:0005016,decreased lymphocyte cell number|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0008805,decreased circulating amylase level|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level
MGI:5286654	Usp5<Tg(Tyr)2395D-2aOve>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:4942058	Usp5<tm1a(EUCOMM)Hmgu>	MP:0000221,decreased leukocyte cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:6102918	Usp6nl<tm1.1Ppdf>	MP:0005389,reproductive system phenotype|MP:0011709,increased fibroblast cell migration|MP:0020417,increased fibroblast chemotaxis
MGI:4941831	Usp7<tm1Wgu>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011198,absent proamniotic cavity
MGI:5526105	Usp7<tm2.1Wgu>	MP:0001672,abnormal embryo development|MP:0011092,embryonic lethality, complete penetrance
MGI:5526104	Usp7<tm2Wgu>	MP:0000774,decreased brain size|MP:0000783,abnormal forebrain morphology|MP:0000789,thickened cerebral cortex|MP:0000850,absent cerebellum|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0008536,enlarged third ventricle|MP:0008948,decreased neuron number|MP:0009546,absent gastric milk in neonates|MP:0010768,mortality/aging|MP:0011087,neonatal lethality, complete penetrance|MP:0012138,decreased forebrain size
MGI:3716283	Usp8<tm1.1Kpk>	MP:0000607,abnormal hepatocyte morphology|MP:0000611,jaundice|MP:0001654,hepatic necrosis|MP:0002083,premature death|MP:0003326,liver failure|MP:0003887,increased hepatocyte apoptosis|MP:0005344,increased circulating bilirubin level
MGI:3716285	Usp8<tm1.2Kpk>	MP:0000267,abnormal heart development|MP:0001672,abnormal embryo development|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0003984,embryonic growth retardation|MP:0011092,embryonic lethality, complete penetrance
MGI:4334222	Usp9x<Gt(W059E04)Wrst>	MP:0002169,no abnormal phenotype detected
MGI:4457785	Usp9x<Gt(XK141)Byg>	MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0004180,failure of initiation of embryo turning|MP:0004251,failure of heart looping|MP:0009657,failure of chorioallantoic fusion|MP:0012105,delayed gastrulation
MGI:5438072	Usp9x<tm1Tuv>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0006379,abnormal spermatocyte morphology|MP:0006380,abnormal spermatid morphology|MP:0014052,increased male germ cell apoptosis|MP:0014685,spermiation failure
MGI:5749738	Ust<em1(IMPC)J>	MP:0001486,abnormal startle reflex|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5543270	Utf1<tm1Okud>	MP:0000060,delayed bone ossification|MP:0000352,decreased cell proliferation|MP:0001262,decreased body weight|MP:0001712,abnormal placenta development|MP:0002652,thin myocardium|MP:0004201,fetal growth retardation|MP:0004259,small placenta|MP:0004921,decreased placenta weight|MP:0005389,reproductive system phenotype|MP:0009674,decreased birth weight|MP:0010768,mortality/aging|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:1856924	Utp14b<jsd>	MP:0001055,failure of neuromuscular synapse postsynaptic differentiation|MP:0001156,abnormal spermatogenesis|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001925,male infertility|MP:0001940,testis hypoplasia|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype
MGI:7539038	Utp18<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:6188020	Utp20<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002080,prenatal lethality|MP:0011100,preweaning lethality, complete penetrance
MGI:6355374	Utp25<em1Glo>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:6355371	Utp25<em2Glo>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:4415557	Utp3<tm1(KOMP)Vlcg>	MP:0001698,decreased embryo size|MP:0002084,abnormal developmental patterning|MP:0011091,prenatal lethality, complete penetrance
MGI:5907896	Utp4<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0000367,abnormal coat/ hair morphology|MP:0001284,absent vibrissae|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002968,increased circulating alkaline phosphatase level|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0003720,abnormal neural tube closure|MP:0011100,preweaning lethality, complete penetrance|MP:0012058,abnormal morula morphology|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6384606	Utp6<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:2148539	Utrn<tm1Jrs>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0003633,abnormal nervous system physiology|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:2148589	Utrn<tm1Ked>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0004835,abnormal miniature endplate potential|MP:0005367,renal/urinary system phenotype|MP:0005369,muscle phenotype|MP:0005388,respiratory system phenotype
MGI:3608769	Uts2r<tm1Djbe>	MP:0000250,abnormal vasoconstriction
MGI:5588699	Uts2<tm1Ags>	MP:0000183,decreased circulating LDL cholesterol level|MP:0001556,increased circulating HDL cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005584,abnormal enzyme/coenzyme activity|MP:0010331,abnormal apolipoprotein level|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:3877328	Uty<Gt(XS0378)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:7708061	Uvrag<em1(IMPC)Mbp>	MP:0011100,preweaning lethality, complete penetrance|MP:0020421,increased freezing behavior
MGI:5635118	Uvrag<Tn(pb-Act-RFP)1.100107015-HRAZhu>	MP:0000274,enlarged heart|MP:0001544,abnormal cardiovascular system physiology|MP:0001853,heart inflammation|MP:0003222,increased cardiomyocyte apoptosis|MP:0004564,increased myocardial fiber size|MP:0005058,abnormal lysosome morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005330,cardiomyopathy|MP:0005608,cardiac interstitial fibrosis|MP:0008260,abnormal autophagy|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0011925,abnormal heart echocardiography feature
MGI:3606749	uwl	MP:0002075,abnormal coat/hair pigmentation|MP:0002095,abnormal skin pigmentation|MP:0005172,decreased eye pigmentation|MP:0011277,decreased tail pigmentation|MP:0011279,decreased ear pigmentation
MGI:6761388	Uxs1<m1Btlr>	MP:0002764,short tibia|MP:0003109,short femur
MGI:5007401	Uxs1<tm1Lex>	MP:0001800,abnormal humoral immune response|MP:0008499,increased IgG1 level|MP:0011091,prenatal lethality, complete penetrance
MGI:6159372	Uxt<tm1.1Sklo>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014052,increased male germ cell apoptosis
MGI:6159373	Uxt<tm1.2Sklo>	MP:0011091,prenatal lethality, complete penetrance
MGI:7620422	Vac14<em1(IMPC)Bay>	MP:0001364,decreased anxiety-related response|MP:0001410,head bobbing|MP:0011100,preweaning lethality, complete penetrance
MGI:3766320	Vac14<Gt(RRP155)Byg>	MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000832,abnormal thalamus morphology|MP:0000837,abnormal hypothalamus morphology|MP:0000846,abnormal medulla oblongata morphology|MP:0000848,abnormal pons morphology|MP:0000849,abnormal cerebellum morphology|MP:0000897,abnormal midbrain morphology|MP:0000904,abnormal superior colliculus morphology|MP:0000960,abnormal sensory ganglion morphology|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0003105,abnormal heart atrium morphology|MP:0008535,enlarged lateral ventricles|MP:0011085,postnatal lethality, complete penetrance|MP:0012261,increased hindbrain apoptosis|MP:0012503,increased midbrain apoptosis|MP:0012504,increased forebrain apoptosis|MP:0020851,abnormal vacuole morphology|MP:0021002,brain lesion
MGI:2675671	Vac14<ingls>	MP:0000371,diluted coat color|MP:0000745,tremors|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001516,abnormal motor coordination/balance|MP:0001891,hydrocephaly|MP:0002183,gliosis|MP:0002654,spongiform encephalopathy|MP:0003354,astrocytosis|MP:0011085,postnatal lethality, complete penetrance|MP:0011380,enlarged brain ventricles
MGI:3590259	Vacq1<C57BL/6J>	MP:0001987,alcohol preference|MP:0003545,increased alcohol consumption
MGI:3590263	Vacq3<C57BL/6J>	MP:0001987,alcohol preference|MP:0003545,increased alcohol consumption
MGI:3590264	Vacq4<A/J>	MP:0001987,alcohol preference|MP:0003545,increased alcohol consumption
MGI:3590267	Vacq5<C57BL/6J>	MP:0001987,alcohol preference|MP:0003545,increased alcohol consumption
MGI:3590268	Vacq6<A/J>	MP:0001987,alcohol preference|MP:0003545,increased alcohol consumption
MGI:3590270	Vacq7<A/J>	MP:0001987,alcohol preference|MP:0003545,increased alcohol consumption
MGI:3785419	Vactq1<C57L/J>	MP:0001392,abnormal locomotor behavior
MGI:3785421	Vactq2<C57L/J>	MP:0001392,abnormal locomotor behavior
MGI:2449158	Vamp1<lew>	MP:0001265,decreased body size|MP:0001504,abnormal posture|MP:0001523,impaired righting response|MP:0001524,impaired limb coordination|MP:0002082,postnatal lethality|MP:0002690,akinesia|MP:0011085,postnatal lethality, complete penetrance
MGI:5792085	Vamp2<rlss>	MP:0002066,abnormal motor capabilities/coordination/movement|MP:0014639,decreased sleep duration
MGI:5548222	Vamp2<tm1.1Jret>	MP:0002169,no abnormal phenotype detected
MGI:3795865	Vamp2<tm1(cre/ERT)Nat>	MP:0002082,postnatal lethality|MP:0002169,no abnormal phenotype detected
MGI:2179745	Vamp2<tm1Sud>	MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001732,postnatal growth retardation|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002206,abnormal CNS synaptic transmission|MP:0002912,abnormal excitatory postsynaptic potential|MP:0002919,enhanced paired-pulse facilitation|MP:0003990,decreased neurotransmitter release|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008504,abnormal adrenal chromaffin cell morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:2385941	Vamp3<tm1Jpes>	MP:0002169,no abnormal phenotype detected|MP:0005387,immune system phenotype|MP:0005464,abnormal platelet physiology
MGI:5692605	Vamp3<tm2b(EUCOMM)Wtsi>	MP:0002098,abnormal vibrissa morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6367952	Vamp4<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0000759,abnormal skeletal muscle morphology|MP:0001175,abnormal lung morphology|MP:0001417,decreased exploration in new environment|MP:0002059,abnormal seminal vesicle morphology|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002997,enlarged seminal vesicle|MP:0003068,enlarged kidney|MP:0003271,abnormal duodenum morphology|MP:0004882,enlarged lung
MGI:7708019	Vamp4<em1Tax>	MP:0003058,increased insulin secretion|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005217,abnormal pancreatic beta cell morphology|MP:0005292,improved glucose tolerance|MP:0005379,endocrine/exocrine gland phenotype
MGI:4399506	Vamp5<tm1(KOMP)Vlcg>	MP:0000519,hydronephrosis|MP:0000536,hydroureter|MP:0001177,atelectasis|MP:0001953,respiratory failure|MP:0003068,enlarged kidney|MP:0003586,dilated ureter|MP:0003675,kidney cyst|MP:0009674,decreased birth weight|MP:0009703,decreased birth body size|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011493,double ureter
MGI:5494246	Vamp7<tm1.1Aha>	MP:0003651,abnormal axon extension
MGI:5313432	Vamp7<tm1.1Ics>	MP:0001363,increased anxiety-related response|MP:0002175,decreased brain weight|MP:0003443,increased circulating glycerol level|MP:0005385,cardiovascular system phenotype|MP:0005534,decreased body temperature
MGI:1861709	Vamp8<Gt(OST20346)Lex>	MP:0002423,abnormal mast cell physiology
MGI:4421511	Vamp8<tm1.1Hong>	MP:0000519,hydronephrosis|MP:0002083,premature death|MP:0002988,decreased urine osmolality|MP:0003352,increased circulating renin level|MP:0004860,dilated kidney collecting duct|MP:0004970,kidney atrophy|MP:0008997,increased blood osmolality|MP:0009641,kidney degeneration|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011413,colorless urine|MP:0011422,kidney medulla atrophy|MP:0011941,increased fluid intake
MGI:3056083	Vamp8<tm1Hong>	MP:0001732,postnatal growth retardation|MP:0002376,abnormal dendritic cell physiology|MP:0002531,abnormal type I hypersensitivity reaction|MP:0002694,abnormal pancreas secretion|MP:0004155,decreased susceptibility to induced pancreatitis|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology|MP:0005584,abnormal enzyme/coenzyme activity|MP:0006298,abnormal platelet activation|MP:0008765,decreased mast cell degranulation|MP:0008804,abnormal circulating amylase level|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009160,abnormal pancreatic acinar cell zymogen granule morphology|MP:0009161,pancreatic acinar cell zymogen granule accumulation|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011885,abnormal circulating lipase level
MGI:3778822	Vangl1<Gt(XL802)Byg>	MP:0003631,nervous system phenotype|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0005385,cardiovascular system phenotype
MGI:5440498	Vangl1<tm1.1Nat>	MP:0002169,no abnormal phenotype detected
MGI:4365105	Vangl1<tm1e(KOMP)Wtsi>	MP:0000574,abnormal foot pad morphology|MP:0000575,increased foot pad pigmentation|MP:0003849,greasy coat|MP:0005561,increased mean corpuscular hemoglobin|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6430659	Vangl2<em1(IMPC)Mbp>	MP:0000111,cleft palate|MP:0000198,decreased circulating phosphate level|MP:0000428,abnormal craniofacial morphology|MP:0000914,exencephaly|MP:0001289,persistence of hyaloid vascular system|MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001711,abnormal placenta morphology|MP:0002111,abnormal tail morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape
MGI:1857642	Vangl2<Lp>	MP:0000026,abnormal inner ear morphology|MP:0000031,abnormal cochlea morphology|MP:0000042,abnormal organ of Corti morphology|MP:0000137,abnormal vertebrae morphology|MP:0000141,abnormal vertebral body morphology|MP:0000150,abnormal rib morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000157,abnormal sternum morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0000284,double outlet right ventricle|MP:0000436,abnormal head movements|MP:0000585,kinked tail|MP:0000592,short tail|MP:0000780,abnormal corpus callosum morphology|MP:0000783,abnormal forebrain morphology|MP:0000807,abnormal hippocampus morphology|MP:0000822,abnormal brain ventricle morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000841,abnormal hindbrain morphology|MP:0000847,abnormal metencephalon morphology|MP:0000897,abnormal midbrain morphology|MP:0000913,abnormal brain development|MP:0000929,open neural tube|MP:0001144,vagina atresia|MP:0001175,abnormal lung morphology|MP:0001178,pulmonary hypoplasia|MP:0001391,abnormal tail movements|MP:0001392,abnormal locomotor behavior|MP:0001525,impaired balance|MP:0001672,abnormal embryo development|MP:0001688,abnormal somite development|MP:0001691,abnormal somite shape|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001701,incomplete embryo turning|MP:0001914,hemorrhage|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002085,abnormal embryonic tissue morphology|MP:0002151,abnormal neural tube morphology|MP:0002152,abnormal brain morphology|MP:0002200,abnormal brain ventricular system morphology|MP:0002231,abnormal primitive streak morphology|MP:0002428,abnormal semicircular canal morphology|MP:0002621,delayed neural tube closure|MP:0002730,head shaking|MP:0002757,decreased vertical activity|MP:0002823,abnormal rib development|MP:0002825,abnormal notochord morphology|MP:0003051,curly tail|MP:0003052,omphalocele|MP:0003054,spina bifida|MP:0003119,abnormal digestive system development|MP:0003345,decreased rib number|MP:0003384,abnormal ventral body wall morphology|MP:0003385,abnormal body wall morphology|MP:0003631,nervous system phenotype|MP:0003641,small lung|MP:0003720,abnormal neural tube closure|MP:0003864,abnormal midbrain development|MP:0003938,abnormal ear development|MP:0004102,abnormal dorsal striatum morphology|MP:0004113,abnormal aortic arch morphology|MP:0004158,right aortic arch|MP:0004159,double aortic arch|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004322,abnormal sternebra morphology|MP:0004391,abnormal respiratory conducting tube morphology|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004407,increased cochlear hair cell number|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004492,abnormal orientation of inner hair cell stereociliary bundles|MP:0004522,abnormal orientation of cochlear hair cell stereociliary bundles|MP:0004599,abnormal vertebral arch morphology|MP:0004609,vertebral fusion|MP:0004613,fusion of vertebral arches|MP:0005222,abnormal somite size|MP:0005226,abnormal vertebral arch development|MP:0005377,hearing/vestibular/ear phenotype|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0005657,abnormal neural plate morphology|MP:0006014,dilated endolymphatic sac|MP:0006026,dilated terminal bronchiole tube|MP:0006382,abnormal lung epithelium morphology|MP:0006394,abnormal vertebral epiphyseal plate morphology|MP:0008148,abnormal sternocostal joint morphology|MP:0008149,abnormal costovertebral joint morphology|MP:0008277,abnormal sternum ossification|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008784,craniorachischisis|MP:0010402,ventricular septal defect|MP:0010465,aberrant origin of the right subclavian artery|MP:0010466,vascular ring|MP:0010488,abnormal left subclavian artery morphology|MP:0010589,common truncal valve|MP:0010744,abnormal cervical flexure morphology|MP:0010825,abnormal lung saccule morphology|MP:0010975,abnormal lung lobe morphology|MP:0010976,small lung lobe|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011032,impaired branching involved in terminal bronchiole morphogenesis|MP:0011089,perinatal lethality, complete penetrance|MP:0011143,thick lung-associated mesenchyme|MP:0011172,abnormal otic pit morphology|MP:0011733,fused somites|MP:0012304,short umbilical cord
MGI:4462051	Vangl2<Lp-2J>	MP:0000592,short tail|MP:0001144,vagina atresia|MP:0002111,abnormal tail morphology|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1934175	Vangl2<Lp-m1Jus>	MP:0000445,short snout|MP:0000585,kinked tail|MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0003051,curly tail|MP:0003232,abnormal forebrain development|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0006030,abnormal otic vesicle development|MP:0008784,craniorachischisis|MP:0012675,enlarged floor plate|MP:0031462,decreased palatal shelf size
MGI:5468724	Vangl2<M1Yzcm>	MP:0000929,open neural tube|MP:0002151,abnormal neural tube morphology|MP:0003051,curly tail|MP:0004200,decreased fetal size|MP:0004201,fetal growth retardation|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0005390,skeleton phenotype|MP:0009264,failure of eyelid fusion|MP:0012675,enlarged floor plate
MGI:3038827	Vangl2<ska17>	MP:0000585,kinked tail|MP:0001925,male infertility|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0003540,imperforate hymen|MP:0005391,vision/eye phenotype
MGI:5430220	Vangl2<tm1.1Mdea>	MP:0011400,lethality, complete penetrance
MGI:5430219	Vangl2<tm1.2Mdea>	MP:0000585,kinked tail|MP:0001302,eyelids open at birth|MP:0002622,abnormal cochlear hair cell morphology|MP:0002623,abnormal vestibular hair cell morphology|MP:0003054,spina bifida|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0005371,limbs/digits/tail phenotype|MP:0008784,craniorachischisis
MGI:4819590	Vangl2<tm1.2Yy>	MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0008784,craniorachischisis
MGI:5551989	Vangl2<tm2.1Mdea>	MP:0010768,mortality/aging
MGI:5551990	Vangl2<tm2.2Mdea>	MP:0000031,abnormal cochlea morphology|MP:0002151,abnormal neural tube morphology|MP:0003148,decreased cochlea coiling|MP:0004491,abnormal orientation of outer hair cell stereociliary bundles|MP:0004492,abnormal orientation of inner hair cell stereociliary bundles|MP:0006286,inner ear hypoplasia|MP:0008307,short scala media|MP:0011091,prenatal lethality, complete penetrance
MGI:6285602	Vapb<em1(IMPC)H>	MP:0005292,improved glucose tolerance|MP:0005655,increased aggression
MGI:5085882	Vapb<Gt(OST284921)Lex>	MP:0003858,enhanced coordination
MGI:5697413	Vapb<tm1.1Tsud>	MP:0001053,abnormal neuromuscular synapse morphology|MP:0001405,impaired coordination|MP:0005405,axon degeneration|MP:0008571,abnormal synaptic bouton morphology|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009413,skeletal muscle fiber atrophy|MP:0011975,neuronal cytoplasmic inclusions
MGI:5521564	Vapb<tm1.2Ics>	MP:0000745,tremors|MP:0001405,impaired coordination|MP:0003631,nervous system phenotype|MP:0004144,hypotonia|MP:0005384,cellular phenotype
MGI:3764556	Varc	MP:0001394,circling|MP:0001522,impaired swimming|MP:0001850,increased susceptibility to otitis media|MP:0005307,head tossing|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:6257493	Vars2<em1(IMPC)Bay>	MP:0003385,abnormal body wall morphology|MP:0003394,increased cardiac output|MP:0011100,preweaning lethality, complete penetrance|MP:0011960,abnormal eye anterior chamber depth
MGI:3846783	Vash1<tm1Ysat>	MP:0005601,increased angiogenesis
MGI:3846784	Vash2<tm1Ysat>	MP:0005602,decreased angiogenesis
MGI:5140849	Vasn<tm1Zgl>	MP:0001922,reduced male fertility|MP:0003674,oxidative stress|MP:0003887,increased hepatocyte apoptosis|MP:0006042,increased apoptosis|MP:0008280,abnormal male germ cell apoptosis|MP:0008406,increased cellular sensitivity to hydrogen peroxide induced cell death|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0008943,increased sensitivity to induced cell death|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:1858032	Vasp<tm1Mzim>	MP:0005397,hematopoietic system phenotype|MP:0006298,abnormal platelet activation|MP:0008254,increased megakaryocyte cell number
MGI:3764987	Vasp<tm1Ref>	MP:0005397,hematopoietic system phenotype|MP:0005464,abnormal platelet physiology|MP:0009586,increased platelet aggregation
MGI:4436304	Vat1l<tm1a(EUCOMM)Hmgu>	MP:0004924,abnormal behavior
MGI:7786417	Vaultrc5<em1.1Vdgl>	MP:0000208,decreased hematocrit|MP:0011898,abnormal platelet cell number
MGI:5563399	Vav1<m1Anu>	MP:0005015,increased T cell number
MGI:6199670	Vav1<m1Btlr>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0002491,decreased IgD level|MP:0002494,increased IgM level|MP:0004978,decreased B-1 B cell number|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6199674	Vav1<m2Btlr>	MP:0004978,decreased B-1 B cell number
MGI:6285507	Vav1<M3Btlr>	MP:0001805,decreased IgG level|MP:0020154,impaired humoral immune response
MGI:6285514	Vav1<M4Btlr>	MP:0002145,abnormal T cell differentiation|MP:0004978,decreased B-1 B cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6285528	Vav1<M5Btlr>	MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:2387839	Vav1<tm1Bbd>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0004179,transmission ratio distortion|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:2387838	Vav1<tm1Tyb>	MP:0000715,decreased thymocyte number|MP:0000717,abnormal lymphocyte cell number|MP:0001790,abnormal immune system physiology|MP:0001823,thymus hypoplasia|MP:0002407,abnormal double-negative T cell morphology|MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002444,abnormal T cell physiology|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0004918,abnormal negative T cell selection|MP:0005089,decreased double-negative T cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005095,decreased T cell proliferation|MP:0006387,abnormal T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008083,decreased single-positive T cell number|MP:0008211,decreased mature B cell number|MP:0008561,decreased tumor necrosis factor secretion|MP:0008567,decreased interferon-gamma secretion|MP:0008686,abnormal interleukin-2 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0010131,increased DN2 thymocyte number|MP:0010133,increased DN3 thymocyte number
MGI:2387840	Vav1<tm2Bbd>	MP:0001805,decreased IgG level|MP:0001823,thymus hypoplasia|MP:0001828,abnormal T cell activation|MP:0002145,abnormal T cell differentiation|MP:0002444,abnormal T cell physiology|MP:0002458,abnormal B cell number|MP:0004919,abnormal positive T cell selection|MP:0004978,decreased B-1 B cell number|MP:0005018,decreased T cell number|MP:0005025,abnormal response to infection|MP:0005070,impaired natural killer cell mediated cytotoxicity|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005093,decreased B cell proliferation|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0006387,abnormal T cell number|MP:0008040,decreased NK T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008189,increased transitional stage B cell number|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008498,decreased IgG3 level|MP:0008688,decreased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0008826,abnormal splenic cell ratio|MP:0008828,abnormal lymph node cell ratio
MGI:3686972	Vav1<tm2Tyb>	MP:0002432,abnormal CD4-positive, alpha beta T cell morphology|MP:0002444,abnormal T cell physiology|MP:0004918,abnormal negative T cell selection|MP:0005089,decreased double-negative T cell number|MP:0005095,decreased T cell proliferation|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:3686975	Vav1<tm3Tyb>	MP:0002169,no abnormal phenotype detected
MGI:5447927	Vav1<tm4Tyb>	MP:0000717,abnormal lymphocyte cell number|MP:0001790,abnormal immune system physiology|MP:0002444,abnormal T cell physiology|MP:0002723,abnormal immune serum protein physiology|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0006387,abnormal T cell number|MP:0008577,increased circulating interferon-gamma level|MP:0008686,abnormal interleukin-2 secretion|MP:0010131,increased DN2 thymocyte number|MP:0010133,increased DN3 thymocyte number
MGI:2387822	Vav2<tm1Kdf>	MP:0004221,abnormal iridocorneal angle|MP:0005093,decreased B cell proliferation|MP:0005258,ocular hypertension|MP:0008211,decreased mature B cell number|MP:0008498,decreased IgG3 level|MP:0011481,anterior iris synechia
MGI:2387845	Vav2<tm1Tnr>	MP:0000231,hypertension|MP:0000266,abnormal heart morphology|MP:0001739,abnormal adrenal gland secretion|MP:0001806,decreased IgM level|MP:0001891,hydrocephaly|MP:0002625,heart left ventricle hypertrophy|MP:0002626,increased heart rate|MP:0002666,increased circulating aldosterone level|MP:0003141,cardiac fibrosis|MP:0003352,increased circulating renin level|MP:0003620,oliguria|MP:0003985,renal fibrosis|MP:0004564,increased myocardial fiber size|MP:0004816,abnormal class switch recombination|MP:0004875,increased mean systemic arterial blood pressure|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0005489,vascular smooth muscle hyperplasia|MP:0005558,decreased creatinine clearance|MP:0005582,increased renin activity|MP:0005610,increased circulating antidiuretic hormone level|MP:0005662,increased circulating adrenaline level|MP:0005665,increased circulating noradrenaline level|MP:0006317,decreased urine sodium level|MP:0008300,enlarged adrenal medulla|MP:0008301,adrenal medulla hyperplasia|MP:0008482,decreased spleen germinal center number|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0008872,abnormal physiological response to xenobiotic|MP:0009812,abnormal bradykinin level|MP:0009873,abnormal aorta tunica media morphology
MGI:2683642	Vav3<tm1Swat>	MP:0002169,no abnormal phenotype detected|MP:0005391,vision/eye phenotype
MGI:3514154	Vav3<tm1Xrb>	MP:0000231,hypertension|MP:0000260,abnormal angiogenesis|MP:0001544,abnormal cardiovascular system physiology|MP:0001756,abnormal urination|MP:0001906,increased dopamine level|MP:0002127,abnormal cardiovascular system morphology|MP:0002625,heart left ventricle hypertrophy|MP:0002626,increased heart rate|MP:0002666,increased circulating aldosterone level|MP:0003141,cardiac fibrosis|MP:0003184,increased angiotensin I-converting enzyme activity|MP:0003352,increased circulating renin level|MP:0003985,renal fibrosis|MP:0004183,abnormal sympathetic nervous system physiology|MP:0004564,increased myocardial fiber size|MP:0004875,increased mean systemic arterial blood pressure|MP:0005558,decreased creatinine clearance|MP:0005582,increased renin activity|MP:0005598,decreased heart ventricle muscle contractility|MP:0005610,increased circulating antidiuretic hormone level|MP:0005618,decreased urine potassium level|MP:0005662,increased circulating adrenaline level|MP:0005665,increased circulating noradrenaline level|MP:0006317,decreased urine sodium level|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0009812,abnormal bradykinin level|MP:0009873,abnormal aorta tunica media morphology|MP:0031232,increased circulating angiotensin II level
MGI:5490505	Vax1<tm1b(KOMP)Mbp>	MP:0002968,increased circulating alkaline phosphatase level|MP:0004122,abnormal sinus arrhythmia|MP:0005560,decreased circulating glucose level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1859863	Vax1<tm1Grl>	MP:0000111,cleft palate|MP:0000819,abnormal olfactory bulb morphology|MP:0001286,abnormal eye development|MP:0001330,abnormal optic nerve morphology|MP:0001332,abnormal optic nerve innervation|MP:0002196,absent corpus callosum|MP:0002653,abnormal ependyma morphology|MP:0002739,abnormal olfactory bulb development|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004277,abnormal lateral ganglionic eminence morphology|MP:0004279,abnormal rostral migratory stream morphology|MP:0005262,coloboma|MP:0009937,abnormal neuron differentiation|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014750,abnormal retinal ganglion cell axon guidance
MGI:1859922	Vax1<tm1Pgr>	MP:0000111,cleft palate|MP:0000431,absent palatine bone horizontal plate|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0000633,abnormal pituitary gland morphology|MP:0000780,abnormal corpus callosum morphology|MP:0000823,abnormal lateral ventricle morphology|MP:0000837,abnormal hypothalamus morphology|MP:0000934,abnormal telencephalon development|MP:0001330,abnormal optic nerve morphology|MP:0001332,abnormal optic nerve innervation|MP:0002083,premature death|MP:0002237,abnormal nasal cavity morphology|MP:0002820,abnormal premaxilla morphology|MP:0003232,abnormal forebrain development|MP:0004448,abnormal presphenoid bone morphology|MP:0004449,absent presphenoid bone|MP:0004450,presphenoid bone hypoplasia|MP:0004475,palatine bone hypoplasia|MP:0004592,small mandible|MP:0004872,absent nasal septum|MP:0005157,holoprosencephaly|MP:0005262,coloboma|MP:0005352,small cranium|MP:0008225,abnormal anterior commissure morphology|MP:0009771,absent optic chiasm|MP:0009888,palatal shelves fail to meet at midline|MP:0009898,maxillary shelf hypoplasia|MP:0009900,vomer bone hypoplasia|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011266,abnormal frontonasal mesenchyme morphology|MP:0012085,midface hypoplasia|MP:0012138,decreased forebrain size|MP:0014276,lobar holoprosencephaly|MP:0030095,abnormal midface morphology|MP:0030137,abnormal upper incisor morphology|MP:0030274,maxillary retrognathia|MP:0030476,fused upper incisors|MP:0031457,abnormal vomeronasal cartilage morphology
MGI:2388160	Vax2<tm1Grl>	MP:0000745,tremors|MP:0001265,decreased body size|MP:0001297,microphthalmia|MP:0001332,abnormal optic nerve innervation|MP:0002961,abnormal axon guidance|MP:0005262,coloboma|MP:0014750,abnormal retinal ganglion cell axon guidance
MGI:2159246	Vax2<tm1Sba>	MP:0005262,coloboma|MP:0008056,abnormal retina ganglion cell morphology
MGI:3857765	Vbp1<Gt(BA0243)Wtsi>	MP:0002169,no abnormal phenotype detected
MGI:1857085	vc	MP:0000745,tremors|MP:0000747,muscle weakness|MP:0001265,decreased body size|MP:0001386,abnormal maternal nurturing|MP:0001406,abnormal gait|MP:0001967,deafness|MP:0003863,decreased aggression towards mice|MP:0008770,decreased survivor rate|MP:0008975,delayed male fertility|MP:0011086,postnatal lethality, incomplete penetrance
MGI:2153831	Vcam1<tm1Dmil>	MP:0000218,increased leukocyte cell number|MP:0000220,increased monocyte cell number|MP:0002824,abnormal chorioallantoic fusion|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011825,decreased cell chemotaxis
MGI:1857452	Vcam1<tm1Roml>	MP:0000281,abnormal interventricular septum morphology|MP:0001698,decreased embryo size|MP:0001726,abnormal allantois morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002127,abnormal cardiovascular system morphology|MP:0002190,disorganized myocardium|MP:0002824,abnormal chorioallantoic fusion|MP:0003057,abnormal epicardium morphology|MP:0004557,dilated allantois|MP:0005312,pericardial effusion|MP:0005329,abnormal myocardium layer morphology|MP:0009657,failure of chorioallantoic fusion|MP:0010555,absent epicardium|MP:0010556,thin ventricle myocardium compact layer|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012299,hydropic allantois
MGI:2387554	Vcam1<tm2.1Roml>	MP:0011100,preweaning lethality, complete penetrance
MGI:5700541	Vcam1<tm2Dmil>	MP:0011825,decreased cell chemotaxis
MGI:2386556	Vcam1<tm2Flv>	MP:0000333,decreased bone marrow cell number|MP:0002429,abnormal blood cell morphology/development
MGI:2387553	Vcam1<tm2Roml>	MP:0001800,abnormal humoral immune response|MP:0002082,postnatal lethality|MP:0005014,increased B cell number|MP:0005017,decreased B cell number|MP:0005389,reproductive system phenotype|MP:0008189,increased transitional stage B cell number|MP:0008190,decreased transitional stage B cell number|MP:0008210,increased mature B cell number|MP:0008211,decreased mature B cell number|MP:0008214,increased immature B cell number
MGI:7548796	Vcan<em1Hwat>	MP:0001217,absent epidermis|MP:0001243,abnormal dermal layer morphology|MP:0001698,decreased embryo size|MP:0001914,hemorrhage|MP:0002724,enhanced wound healing|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0014283,hindlimb syndactyly
MGI:7426078	Vcan<em2(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001289,persistence of hyaloid vascular system|MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001691,abnormal somite shape|MP:0001700,abnormal embryo turning|MP:0001711,abnormal placenta morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0002092,abnormal eye morphology|MP:0002151,abnormal neural tube morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003425,abnormal optic vesicle formation|MP:0003984,embryonic growth retardation|MP:0006203,eye hemorrhage|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:1857689	Vcan<Tg(Hoxa1)1Chm>	MP:0000267,abnormal heart development|MP:0000298,absent atrioventricular cushions|MP:0001698,decreased embryo size|MP:0002753,dilated heart left ventricle|MP:0003140,dilated heart atrium|MP:0003920,abnormal heart right ventricle morphology|MP:0004937,dilated heart|MP:0010586,absent conotruncal ridges|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3850559	Vcan<tm1.1Dzim>	MP:0003631,nervous system phenotype|MP:0005404,abnormal axon morphology
MGI:4840040	Vcan<tm1.1Hwat>	MP:0000547,short limbs|MP:0000572,abnormal autopod morphology|MP:0002110,abnormal digit morphology|MP:0002169,no abnormal phenotype detected|MP:0005306,abnormal phalanx morphology|MP:0009780,abnormal chondrocyte physiology
MGI:5694701	Vcan<tm2Hwat>	MP:0000281,abnormal interventricular septum morphology|MP:0000301,decreased atrioventricular cushion size|MP:0001544,abnormal cardiovascular system physiology|MP:0001575,cyanosis|MP:0004200,decreased fetal size|MP:0010402,ventricular septal defect|MP:0011087,neonatal lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4433549	Vcf1<tm2a(EUCOMM)Wtsi>	MP:0004924,abnormal behavior|MP:0005343,increased circulating aspartate transaminase level
MGI:4822196	Vcl<tm1.1Whz>	MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0004938,dilated vasculature|MP:0006042,increased apoptosis|MP:0008932,abnormal embryonic tissue physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011260,abnormal head mesenchyme morphology|MP:0012176,abnormal head development|MP:0012677,absent brain ventricles|MP:0012701,increased embryonic neuroepithelium apoptosis|MP:0014699,increased fibroblast adhesion
MGI:1857730	Vcl<tm1Eda>	MP:0000267,abnormal heart development|MP:0000278,abnormal myocardial fiber morphology|MP:0000298,absent atrioventricular cushions|MP:0000474,abnormal foregut morphology|MP:0000774,decreased brain size|MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0000928,incomplete rostral neuropore closure|MP:0000930,wavy neural tube|MP:0000964,small dorsal root ganglion|MP:0001056,abnormal cranial nerve morphology|MP:0001077,abnormal spinal nerve morphology|MP:0001675,abnormal ectoderm development|MP:0001680,abnormal mesoderm development|MP:0001690,failure of somite differentiation|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002188,small heart|MP:0002652,thin myocardium|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0004567,decreased myocardial fiber number|MP:0004837,abnormal neural fold formation|MP:0005140,decreased cardiac muscle contractility|MP:0006065,abnormal heart position or orientation|MP:0006267,abnormal intercalated disk morphology|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010392,prolonged QRS complex duration|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011495,abnormal head shape|MP:0011703,increased fibroblast proliferation|MP:0011732,decreased somite size|MP:0012082,delayed heart development|MP:0012173,short rostral-caudal axis|MP:0012250,absent heart valves|MP:0012501,abnormal pericardial cavity morphology|MP:0012677,absent brain ventricles|MP:0012703,decreased embryonic neuroepithelium thickness|MP:0013164,abnormal forelimb bud morphology|MP:0013166,small forelimb buds|MP:0013227,small brain ventricles|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014698,decreased fibroblast adhesion|MP:0014730,abnormal myocardial fiber myofibril morphology|MP:0031633,decreased heart left ventricle muscle contractility
MGI:3769142	Vcl<tm1Ross>	MP:0000278,abnormal myocardial fiber morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0001625,cardiac hypertrophy|MP:0001636,irregular heartbeat|MP:0002083,premature death|MP:0002127,abnormal cardiovascular system morphology|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0003137,abnormal impulse conducting system conduction|MP:0003141,cardiac fibrosis|MP:0004084,abnormal cardiac muscle relaxation|MP:0005140,decreased cardiac muscle contractility|MP:0006138,congestive heart failure|MP:0006267,abnormal intercalated disk morphology|MP:0008950,ventricular tachycardia|MP:0010559,heart block
MGI:7284311	Vcp<em1Kene>	MP:0001262,decreased body weight|MP:0001552,increased circulating triglyceride level|MP:0002891,increased insulin sensitivity|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0005658,increased susceptibility to diet-induced obesity|MP:0005659,decreased susceptibility to diet-induced obesity
MGI:3529784	Vcp<Gt(OST196720)Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:6515598	Vcpip1<em1Zlou>	MP:0000160,kyphosis|MP:0000162,lordosis|MP:0001262,decreased body weight|MP:0001304,cataract|MP:0002083,premature death|MP:0003702,abnormal chromosome morphology|MP:0005336,abnormal inguinal fat pad morphology|MP:0008866,chromosomal instability|MP:0014040,increased cellular sensitivity to DNA damaging agent induced cell death|MP:0014760,impaired DNA repair
MGI:6116233	Vcpkmt<tm1.1Klng>	MP:0002169,no abnormal phenotype detected
MGI:5575900	Vcpkmt<tm1.1(KOMP)Vlcg>	MP:0001510,abnormal coat appearance|MP:0002833,increased heart weight|MP:0005278,abnormal cholesterol homeostasis|MP:0005344,increased circulating bilirubin level|MP:0005560,decreased circulating glucose level
MGI:3700224	Vcp<tm1.1Dts>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:7282107	Vcp<tm1.1Hiok>	MP:0000316,cellular necrosis|MP:0000433,microcephaly|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000798,abnormal frontal lobe morphology|MP:0001260,increased body weight|MP:0001363,increased anxiety-related response|MP:0002175,decreased brain weight|MP:0004045,abnormal cell cycle checkpoint function|MP:0005384,cellular phenotype|MP:0006254,thin cerebral cortex|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0012207,decreased neuronal stem cell self-renewal|MP:0012307,impaired spatial learning|MP:0012319,fast extinction of fear memory|MP:0012448,abnormal primary motor cortex morphology|MP:0014760,impaired DNA repair|MP:0021018,decreased dendritic spine number
MGI:3699223	Vcp<tm1Dts>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4849540	Vcp<tm1Itl>	MP:0000160,kyphosis|MP:0000266,abnormal heart morphology|MP:0000418,focal hair loss|MP:0000747,muscle weakness|MP:0000748,progressive muscle weakness|MP:0000751,myopathy|MP:0000759,abnormal skeletal muscle morphology|MP:0000938,motor neuron degeneration|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001405,impaired coordination|MP:0001732,postnatal growth retardation|MP:0002064,seizures|MP:0002115,abnormal limb bone morphology|MP:0002152,abnormal brain morphology|MP:0002183,gliosis|MP:0002882,abnormal neuron morphology|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003997,tonic-clonic seizures|MP:0004016,decreased bone mass|MP:0004090,abnormal sarcomere morphology|MP:0004148,increased compact bone thickness|MP:0004819,decreased skeletal muscle mass|MP:0004984,increased osteoclast cell number|MP:0005386,behavior/neurological phenotype|MP:0006038,increased mitochondrial fission|MP:0008260,abnormal autophagy|MP:0008396,abnormal osteoclast differentiation|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009414,skeletal muscle fiber necrosis|MP:0009420,skeletal muscle endomysial fibrosis|MP:0010053,decreased grip strength|MP:0010933,decreased trabecular bone connectivity density|MP:0011085,postnatal lethality, complete penetrance|MP:0011635,abnormal mitochondrial crista morphology
MGI:5701719	Vdac1<tm1b(EUCOMM)Wtsi>	MP:0001488,increased startle reflex|MP:0005293,impaired glucose tolerance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2182154	Vdac1<tm1Wjc>	MP:0001454,abnormal cued conditioning behavior|MP:0001463,abnormal spatial learning|MP:0001473,reduced long-term potentiation|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:5638533	Vdac2<tm1.1Ehyc>	MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0009258,abnormal thymocyte apoptosis
MGI:6273947	Vdac3<em1(IMPC)Hmgu>	MP:0000598,abnormal liver morphology|MP:0001510,abnormal coat appearance
MGI:7432761	Vdac3<em1Kei>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0004852,decreased testis weight|MP:0009237,kinked sperm flagellum|MP:0009647,decreased fertilization frequency|MP:0009832,abnormal sperm mitochondrial sheath morphology|MP:0014464,decreased sperm mitochondrial sheath size
MGI:2182182	Vdac3<tm1Wjc>	MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0001925,male infertility|MP:0002106,abnormal muscle physiology|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0002675,asthenozoospermia|MP:0002920,decreased paired-pulse facilitation|MP:0009838,abnormal sperm axoneme morphology|MP:0010955,abnormal respiratory electron transport chain|MP:0014465,abnormal sperm mitochondrial morphology|MP:0014654,abnormal skeletal muscle fiber mitochondrial shape|MP:0020451,decreased sperm progressive motility
MGI:7426079	Vdr<em1(IMPC)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000367,abnormal coat/ hair morphology|MP:0000432,abnormal head morphology|MP:0000745,tremors|MP:0001392,abnormal locomotor behavior|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001489,decreased startle reflex|MP:0002075,abnormal coat/hair pigmentation|MP:0002757,decreased vertical activity|MP:0002764,short tibia|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:2183409	Vdr<tm1.1Gcm>	MP:0000063,decreased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0001262,decreased body weight|MP:0002896,abnormal bone mineralization|MP:0002904,increased circulating parathyroid hormone level|MP:0003116,rickets|MP:0004905,decreased uterus weight|MP:0009643,abnormal urine homeostasis|MP:0011221,decreased intestinal calcium absorption|MP:0011228,abnormal vitamin D level
MGI:5461525	Vdr<tm1.2Sgcg>	MP:0000195,decreased circulating calcium level|MP:0000414,alopecia|MP:0001262,decreased body weight|MP:0003432,increased activity of parathyroid|MP:0003915,increased heart left ventricle weight|MP:0005522,increased circulating atrial natriuretic factor
MGI:2183407	Vdr<tm1Gcm>	MP:0000130,abnormal trabecular bone morphology|MP:0001566,increased circulating phosphate level|MP:0003419,delayed endochondral bone ossification|MP:0004985,decreased osteoclast cell number|MP:0005602,decreased angiogenesis|MP:0005636,abnormal mineral homeostasis|MP:0011228,abnormal vitamin D level
MGI:2183404	Vdr<tm1Mbd>	MP:0000062,increased bone mineral density|MP:0000166,abnormal chondrocyte morphology|MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000231,hypertension|MP:0000414,alopecia|MP:0000488,abnormal intestinal epithelium morphology|MP:0000511,abnormal intestinal mucosa morphology|MP:0000512,intestinal ulcer|MP:0000558,abnormal tibia morphology|MP:0000708,thymus hyperplasia|MP:0001247,dermal cyst|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001625,cardiac hypertrophy|MP:0001732,postnatal growth retardation|MP:0001762,polyuria|MP:0001858,intestinal inflammation|MP:0002764,short tibia|MP:0002833,increased heart weight|MP:0002896,abnormal bone mineralization|MP:0002904,increased circulating parathyroid hormone level|MP:0003109,short femur|MP:0003112,enlarged parathyroid gland|MP:0003116,rickets|MP:0003141,cardiac fibrosis|MP:0003352,increased circulating renin level|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0004215,abnormal myocardial fiber physiology|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0004955,increased thymus weight|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005581,abnormal renin activity|MP:0005582,increased renin activity|MP:0005584,abnormal enzyme/coenzyme activity|MP:0005605,increased bone mass|MP:0005619,increased urine potassium level|MP:0005636,abnormal mineral homeostasis|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006316,increased urine sodium level|MP:0006375,increased circulating angiotensinogen level|MP:0006397,disorganized long bone epiphyseal plate|MP:0008537,increased susceptibility to induced colitis|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010699,dilated hair follicle|MP:0010878,increased trabecular bone volume|MP:0011941,increased fluid intake|MP:0031232,increased circulating angiotensin II level
MGI:2183400	Vdr<tm1Rge>	MP:0000063,decreased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000414,alopecia|MP:0002451,abnormal macrophage physiology|MP:0002904,increased circulating parathyroid hormone level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003116,rickets|MP:0003414,epidermal cyst|MP:0003432,increased activity of parathyroid|MP:0003639,abnormal response to vitamins|MP:0003957,abnormal nitric oxide homeostasis|MP:0005026,decreased susceptibility to parasitic infection|MP:0005441,increased urine calcium level|MP:0008489,slow postnatal weight gain|MP:0011228,abnormal vitamin D level
MGI:1859929	Vdr<tm1Ska>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000133,abnormal long bone metaphysis morphology|MP:0000135,decreased compact bone thickness|MP:0000165,abnormal long bone hypertrophic chondrocyte zone|MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000367,abnormal coat/ hair morphology|MP:0000414,alopecia|MP:0000445,short snout|MP:0000495,abnormal colon morphology|MP:0000558,abnormal tibia morphology|MP:0001119,abnormal female reproductive system morphology|MP:0001121,uterus hypoplasia|MP:0001132,absent mature ovarian follicles|MP:0001145,abnormal male reproductive system morphology|MP:0001156,abnormal spermatogenesis|MP:0001194,dermatitis|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001247,dermal cyst|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001283,sparse vibrissae|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001407,short stride length|MP:0001413,abnormal response to new environment|MP:0001486,abnormal startle reflex|MP:0001732,postnatal growth retardation|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001927,abnormal estrous cycle|MP:0001929,abnormal gametogenesis|MP:0002083,premature death|MP:0002115,abnormal limb bone morphology|MP:0002161,abnormal fertility/fecundity|MP:0002187,abnormal fibula morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0002757,decreased vertical activity|MP:0002896,abnormal bone mineralization|MP:0002968,increased circulating alkaline phosphatase level|MP:0003116,rickets|MP:0003313,abnormal locomotor activation|MP:0003795,abnormal bone structure|MP:0003941,abnormal skin development|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0004804,decreased susceptibility to autoimmune diabetes|MP:0004842,abnormal large intestine crypts of Lieberkuhn morphology|MP:0004851,increased testis weight|MP:0004974,decreased regulatory T cell number|MP:0004988,increased osteoblast cell number|MP:0005291,abnormal glucose tolerance|MP:0005401,abnormal fat-soluble vitamin level|MP:0006387,abnormal T cell number|MP:0006398,increased long bone epiphyseal plate size|MP:0008115,abnormal dendritic cell differentiation|MP:0008271,abnormal bone ossification|MP:0008650,abnormal interleukin-1 secretion|MP:0008706,decreased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0009142,decreased prepulse inhibition|MP:0009257,dilated seminiferous tubule|MP:0009335,decreased splenocyte proliferation|MP:0009642,abnormal blood homeostasis|MP:0010699,dilated hair follicle|MP:0010760,abnormal macrophage chemotaxis|MP:0010771,integument phenotype|MP:0011221,decreased intestinal calcium absorption|MP:0011228,abnormal vitamin D level|MP:0012175,flat face|MP:0030575,decreased hair follicle cell proliferation
MGI:3604810	Vdr<tm1Tyam>	MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000559,abnormal femur morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002904,increased circulating parathyroid hormone level|MP:0003109,short femur|MP:0003408,increased width of hypertrophic chondrocyte zone|MP:0011228,abnormal vitamin D level|MP:0020010,decreased bone mineral density of femur
MGI:5501514	Vdr<tm2.1Ska>	MP:0000062,increased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0000198,decreased circulating phosphate level|MP:0000414,alopecia|MP:0001263,weight loss|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0003432,increased activity of parathyroid|MP:0005605,increased bone mass|MP:0006397,disorganized long bone epiphyseal plate|MP:0008271,abnormal bone ossification|MP:0010878,increased trabecular bone volume|MP:0010926,increased osteoid volume|MP:0011228,abnormal vitamin D level
MGI:3663379	Vdr<tm2Ska>	MP:0000062,increased bone mineral density|MP:0001246,mixed cellular infiltration to dermis|MP:0001849,ear inflammation|MP:0004985,decreased osteoclast cell number|MP:0004993,decreased bone resorption|MP:0005376,homeostasis/metabolism phenotype|MP:0005390,skeleton phenotype|MP:0005605,increased bone mass|MP:0008396,abnormal osteoclast differentiation|MP:0010771,integument phenotype|MP:0010878,increased trabecular bone volume
MGI:1861629	Ve	MP:0000377,abnormal hair follicle morphology|MP:0001216,abnormal epidermal layer morphology|MP:0001274,curly vibrissae|MP:0001510,abnormal coat appearance|MP:0001511,disheveled coat|MP:0002080,prenatal lethality|MP:0002098,abnormal vibrissa morphology|MP:0003809,abnormal hair shaft morphology
MGI:1889787	Vegfa<tm1.1Nagy>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000280,thin ventricular wall|MP:0000281,abnormal interventricular septum morphology|MP:0001785,edema|MP:0001879,abnormal lymphatic vessel morphology|MP:0002189,abnormal myocardial trabeculae morphology|MP:0010454,abnormal truncus arteriosus septation|MP:0010551,abnormal coronary vessel morphology|MP:0010556,thin ventricle myocardium compact layer|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:1931046	Vegfa<tm1Dco>	MP:0000259,abnormal vascular development|MP:0003229,abnormal vitelline vasculature morphology|MP:0003543,abnormal vascular endothelial cell differentiation|MP:0004787,abnormal dorsal aorta morphology|MP:0005602,decreased angiogenesis|MP:0011089,perinatal lethality, complete penetrance
MGI:1931041	Vegfa<tm1Gne>	MP:0000280,thin ventricular wall|MP:0001614,abnormal blood vessel morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0003232,abnormal forebrain development|MP:0004787,abnormal dorsal aorta morphology|MP:0010666,abnormal vitelline vein morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011204,abnormal visceral yolk sac blood island morphology|MP:0012082,delayed heart development|MP:0012701,increased embryonic neuroepithelium apoptosis|MP:0013164,abnormal forelimb bud morphology|MP:0013504,increased embryonic tissue cell apoptosis
MGI:1931047	Vegfa<tm1Pec>	MP:0000088,short mandible|MP:0000111,cleft palate|MP:0000125,absent incisors|MP:0000266,abnormal heart morphology|MP:0000273,overriding aortic valve|MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000364,abnormal vascular regression|MP:0000458,abnormal mandible morphology|MP:0000530,abnormal kidney vasculature morphology|MP:0000680,absent parathyroid glands|MP:0000703,abnormal thymus morphology|MP:0000705,athymia|MP:0000909,abnormal facial motor nucleus morphology|MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001179,thick pulmonary interalveolar septum|MP:0001262,decreased body weight|MP:0001289,persistence of hyaloid vascular system|MP:0001544,abnormal cardiovascular system physiology|MP:0001575,cyanosis|MP:0001614,abnormal blood vessel morphology|MP:0001636,irregular heartbeat|MP:0001823,thymus hypoplasia|MP:0001914,hemorrhage|MP:0001954,respiratory distress|MP:0002191,abnormal artery morphology|MP:0002633,persistent truncus arteriosus|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0002792,abnormal retina vasculature morphology|MP:0002989,small kidney|MP:0003007,ectopic thymus|MP:0003137,abnormal impulse conducting system conduction|MP:0003203,increased neuron apoptosis|MP:0003233,prolonged QT interval|MP:0003658,abnormal capillary morphology|MP:0003719,abnormal pericyte morphology|MP:0003822,decreased left ventricle systolic pressure|MP:0003840,abnormal coronal suture morphology|MP:0003897,abnormal ST segment|MP:0004084,abnormal cardiac muscle relaxation|MP:0004090,abnormal sarcomere morphology|MP:0004111,abnormal coronary artery morphology|MP:0004112,abnormal arteriole morphology|MP:0004120,cardiac ischemia|MP:0004125,abnormal venule morphology|MP:0004158,right aortic arch|MP:0004159,double aortic arch|MP:0004160,retroesophageal right subclavian artery|MP:0004161,cervical aortic arch|MP:0004181,abnormal carotid artery morphology|MP:0004505,decreased renal glomerulus number|MP:0004564,increased myocardial fiber size|MP:0004566,myocardial fiber degeneration|MP:0004755,abnormal loop of Henle morphology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004969,pale kidney|MP:0005016,decreased lymphocyte cell number|MP:0005140,decreased cardiac muscle contractility|MP:0005202,lethargy|MP:0005264,glomerulosclerosis|MP:0005327,abnormal mesangial cell morphology|MP:0005333,decreased heart rate|MP:0005528,decreased renal glomerular filtration rate|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005602,decreased angiogenesis|MP:0006009,abnormal neuronal migration|MP:0006185,retina hemorrhage|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0006355,abnormal sixth pharyngeal arch artery morphology|MP:0006356,abnormal third pharyngeal arch artery morphology|MP:0009050,dilated proximal convoluted tubule|MP:0010392,prolonged QRS complex duration|MP:0010402,ventricular septal defect|MP:0010458,pulmonary trunk hypoplasia|MP:0010505,abnormal T wave|MP:0010551,abnormal coronary vessel morphology|MP:0010572,persistent right dorsal aorta|MP:0010635,aorta pulmonary collateral arteries|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011294,renal glomerulus hypertrophy|MP:0011309,abnormal kidney arterial blood vessel morphology|MP:0011312,abnormal kidney afferent arteriole morphology|MP:0011313,abnormal kidney efferent arteriole morphology|MP:0011316,abnormal kidney interlobular artery morphology|MP:0011320,abnormal glomerular capillary morphology|MP:0011321,abnormal peritubular capillary morphology|MP:0011334,abnormal nephrogenic zone morphology|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011349,abnormal renal glomerulus basement membrane thickness|MP:0011353,expanded mesangial matrix|MP:0011359,decreased glomerular capillary number|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011659,interrupted aortic arch, type b|MP:0011758,renal ischemia|MP:0012310,persistent ductus caroticus|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0014592,decreased gonadotropin-releasing hormone neuron number|MP:0014730,abnormal myocardial fiber myofibril morphology|MP:0020326,dilated capillary|MP:0020329,decreased capillary density|MP:0020331,increased capillary tortuosity|MP:0031633,decreased heart left ventricle muscle contractility
MGI:2383985	Vegfa<tm2.1Nagy>	MP:0003227,abnormal vascular branching morphogenesis|MP:0003229,abnormal vitelline vasculature morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0004950,abnormal brain vasculature morphology|MP:0005152,pancytopenia|MP:0006057,decreased vascular endothelial cell number|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0012082,delayed heart development
MGI:1931048	Vegfa<tm2Gne>	MP:0000240,extramedullary hematopoiesis|MP:0000259,abnormal vascular development|MP:0000260,abnormal angiogenesis|MP:0000262,poor arterial differentiation|MP:0000280,thin ventricular wall|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0000523,cortical renal glomerulopathies|MP:0000596,abnormal liver development|MP:0000774,decreased brain size|MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001265,decreased body size|MP:0001273,decreased metastatic potential|MP:0001325,abnormal retina morphology|MP:0001326,retina degeneration|MP:0001577,anemia|MP:0001657,abnormal induced morbidity/mortality|MP:0001732,postnatal growth retardation|MP:0001785,edema|MP:0001861,lung inflammation|MP:0001876,decreased inflammatory response|MP:0001954,respiratory distress|MP:0001958,emphysema|MP:0002133,abnormal respiratory system physiology|MP:0002135,abnormal kidney morphology|MP:0002295,abnormal pulmonary circulation|MP:0002333,abnormal lung compliance|MP:0002705,dilated renal tubule|MP:0002792,abnormal retina vasculature morphology|MP:0002871,albuminuria|MP:0002962,increased urine protein level|MP:0003182,decreased pulmonary endothelial cell surface|MP:0003227,abnormal vascular branching morphogenesis|MP:0003606,kidney failure|MP:0003653,decreased skin turgor|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003732,abnormal retina outer plexiform layer morphology|MP:0003828,pulmonary edema|MP:0004007,abnormal lung vasculature morphology|MP:0004111,abnormal coronary artery morphology|MP:0004950,abnormal brain vasculature morphology|MP:0004969,pale kidney|MP:0004970,kidney atrophy|MP:0005023,abnormal wound healing|MP:0005202,lethargy|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005327,abnormal mesangial cell morphology|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005602,decreased angiogenesis|MP:0006085,myocardium necrosis|MP:0006113,abnormal heart septum morphology|MP:0006382,abnormal lung epithelium morphology|MP:0008060,abnormal podocyte slit diaphragm morphology|MP:0008140,podocyte foot process effacement|MP:0008273,abnormal intramembranous bone ossification|MP:0008948,decreased neuron number|MP:0009392,retina gliosis|MP:0009655,abnormal secondary palate development|MP:0009698,heart hemorrhage|MP:0009883,palatal shelf hypoplasia|MP:0009885,abnormal palatal shelf elevation|MP:0009888,palatal shelves fail to meet at midline|MP:0010453,abnormal coronary vein morphology|MP:0010551,abnormal coronary vessel morphology|MP:0010768,mortality/aging|MP:0010825,abnormal lung saccule morphology|MP:0010887,pale lung|MP:0010911,abnormal pulmonary acinus morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011148,decreased mesenchymal cell proliferation involved in lung development|MP:0011320,abnormal glomerular capillary morphology|MP:0011353,expanded mesangial matrix|MP:0011363,renal glomerulus atrophy|MP:0011402,renal cast|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011453,abnormal glomerular capillary endothelium morphology|MP:0011455,absent glomerular endothelium fenestra|MP:0011855,abnormal glomerular filtration barrier morphology|MP:0021215,abnormal palatal mesenchymal cell proliferation|MP:0021217,abnormal palatal shelf bone ossification|MP:0031462,decreased palatal shelf size
MGI:2136623	Vegfa<tm2Pec>	MP:0000161,scoliosis|MP:0000748,progressive muscle weakness|MP:0000754,paresis|MP:0000755,hindlimb paralysis|MP:0000938,motor neuron degeneration|MP:0001056,abnormal cranial nerve morphology|MP:0001078,abnormal phrenic nerve morphology|MP:0001176,abnormal lung development|MP:0001177,atelectasis|MP:0001179,thick pulmonary interalveolar septum|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001440,abnormal grooming behavior|MP:0001513,limb grasping|MP:0001515,abnormal grip strength|MP:0001523,impaired righting response|MP:0001926,female infertility|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002106,abnormal muscle physiology|MP:0002128,abnormal blood circulation|MP:0002229,neurodegeneration|MP:0002566,abnormal sexual interaction|MP:0002651,abnormal sciatic nerve morphology|MP:0002752,abnormal somatic nervous system morphology|MP:0002832,coarse hair|MP:0003354,astrocytosis|MP:0003658,abnormal capillary morphology|MP:0005112,abnormal spinal cord ventral horn morphology|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0008489,slow postnatal weight gain|MP:0008770,decreased survivor rate|MP:0009413,skeletal muscle fiber atrophy|MP:0011090,perinatal lethality, incomplete penetrance
MGI:2386593	Vegfa<tm3.1Pec>	MP:0002169,no abnormal phenotype detected
MGI:3761357	Vegfa<tm3Gne>	MP:0002169,no abnormal phenotype detected
MGI:2386595	Vegfa<tm4Pec>	MP:0000364,abnormal vascular regression|MP:0001262,decreased body weight|MP:0001614,abnormal blood vessel morphology|MP:0001921,reduced fertility|MP:0001935,decreased litter size|MP:0002633,persistent truncus arteriosus|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003873,pharyngeal arch hypoplasia|MP:0004112,abnormal arteriole morphology|MP:0004158,right aortic arch|MP:0004159,double aortic arch|MP:0004160,retroesophageal right subclavian artery|MP:0005388,respiratory system phenotype|MP:0006354,abnormal fourth pharyngeal arch artery morphology|MP:0006355,abnormal sixth pharyngeal arch artery morphology|MP:0006356,abnormal third pharyngeal arch artery morphology|MP:0010402,ventricular septal defect|MP:0010458,pulmonary trunk hypoplasia|MP:0010572,persistent right dorsal aorta|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011659,interrupted aortic arch, type b
MGI:6115297	Vegfb<em1Ywz>	MP:0000008,increased white adipose tissue amount|MP:0001260,increased body weight|MP:0020520,whitened brown adipose tissue morphology
MGI:5529627	Vegfb<tm1b(EUCOMM)Hmgu>	MP:0000198,decreased circulating phosphate level|MP:0001402,decreased locomotor activity|MP:0001523,impaired righting response|MP:0003131,increased erythrocyte cell number|MP:0005564,increased hemoglobin content|MP:0013278,decreased fasting circulating glucose level
MGI:2178819	Vegfb<tm1Gfk>	MP:0000276,heart right ventricle hypertrophy|MP:0000484,abnormal pulmonary artery morphology|MP:0001544,abnormal cardiovascular system physiology|MP:0002188,small heart|MP:0002834,decreased heart weight|MP:0003039,increased time of peak ischemic contracture|MP:0003547,abnormal pulmonary pressure|MP:0003913,increased heart right ventricle weight|MP:0005542,cornea vascularization|MP:0010755,abnormal heart right ventricle pressure
MGI:3609979	Vegfb<tm1Ueks>	MP:0002067,abnormal sensory capabilities/reflexes/nociception|MP:0003137,abnormal impulse conducting system conduction|MP:0003224,neuron degeneration|MP:0003631,nervous system phenotype|MP:0003896,prolonged PR interval|MP:0005385,cardiovascular system phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:3026650	Vegfc<tm1Ali>	MP:0001879,abnormal lymphatic vessel morphology|MP:0002080,prenatal lethality|MP:0002192,hydrops fetalis|MP:0003390,lymphedema|MP:0003659,abnormal lymph circulation|MP:0008778,abnormal lymphangiogenesis|MP:0010194,absent lymphatic vessels|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0012080,chylous ascites|MP:0031440,lymphatic vessel hypoplasia
MGI:6414537	Vegfd<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus
MGI:3826978	Vegfd<tm1Hrl>	MP:0001273,decreased metastatic potential|MP:0005375,adipose tissue phenotype|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005387,immune system phenotype|MP:0011939,increased food intake
MGI:3576785	Vegfd<tm1Mach>	MP:0002169,no abnormal phenotype detected
MGI:2664103	Vent1<C57BL/6J>	MP:0011380,enlarged brain ventricles
MGI:3613370	Veph1<tm1Wtnb>	MP:0002169,no abnormal phenotype detected
MGI:2154364	Vertcling<C57BL/6By>	MP:0002066,abnormal motor capabilities/coordination/movement
MGI:3777574	Vesp	MP:0000940,abnormal motor neuron innervation pattern
MGI:3583268	Vezf1<tm1Stmn>	MP:0000260,abnormal angiogenesis|MP:0000265,blood vessel atresia|MP:0001614,abnormal blood vessel morphology|MP:0001634,internal hemorrhage|MP:0001698,decreased embryo size|MP:0001699,increased embryo size|MP:0001879,abnormal lymphatic vessel morphology|MP:0001914,hemorrhage|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0003658,abnormal capillary morphology|MP:0005380,embryo phenotype|MP:0006055,abnormal vascular endothelial cell morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3618234	Vezt<tm1.1Smc>	MP:0001728,failure of embryo implantation|MP:0002169,no abnormal phenotype detected|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0003695,delayed blastocyst hatching from the zona pellucida|MP:0011093,embryonic lethality at implantation, complete penetrance|MP:0014134,abnormal embryo morphology|MP:0014696,decreased cell adhesion
MGI:5585593	Vezt<tm1b(EUCOMM)Hmgu>	MP:0001402,decreased locomotor activity|MP:0001510,abnormal coat appearance|MP:0002590,increased mean corpuscular volume|MP:0002757,decreased vertical activity|MP:0002959,increased urine microalbumin level|MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:3618233	Vezt<tm1Smc>	MP:0002169,no abnormal phenotype detected
MGI:6144255	Vgf<em1(IMPC)H>	MP:0000745,tremors|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001513,limb grasping|MP:0001925,male infertility|MP:0002764,short tibia|MP:0002941,increased circulating alanine transaminase level|MP:0005343,increased circulating aspartate transaminase level|MP:0005560,decreased circulating glucose level|MP:0009142,decreased prepulse inhibition|MP:0010052,increased grip strength|MP:0010088,decreased circulating fructosamine level
MGI:2179681	Vgf<tm1Srjs>	MP:0001131,abnormal ovarian follicle morphology|MP:0001132,absent mature ovarian follicles|MP:0001134,absent corpus luteum|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001399,hyperactivity|MP:0001463,abnormal spatial learning|MP:0001469,abnormal contextual conditioning behavior|MP:0001475,reduced long-term depression|MP:0001745,increased circulating corticosterone level|MP:0001783,decreased white adipose tissue amount|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0001938,delayed sexual maturation|MP:0002636,delayed vaginal opening|MP:0002727,decreased circulating insulin level|MP:0003631,nervous system phenotype|MP:0003960,increased lean body mass|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0004905,decreased uterus weight|MP:0004910,decreased seminal vesicle weight|MP:0005119,decreased circulating thyroid-stimulating hormone level|MP:0005266,abnormal metabolism|MP:0005289,increased oxygen consumption|MP:0005386,behavior/neurological phenotype|MP:0005478,decreased circulating thyroxine level|MP:0005560,decreased circulating glucose level|MP:0006319,abnormal epididymal fat pad morphology|MP:0008965,increased basal metabolism|MP:0009006,prolonged estrous cycle|MP:0009009,absent estrous cycle|MP:0009066,decreased oviduct weight|MP:0010025,decreased total body fat amount|MP:0010249,lactation failure|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020470,shortened circadian behavior period|MP:0031239,increased atretic ovarian follicle number
MGI:3828156	Vgf<tm1Vlcg>	MP:0000231,hypertension|MP:0001265,decreased body size|MP:0003960,increased lean body mass|MP:0003962,abnormal adrenaline level|MP:0004875,increased mean systemic arterial blood pressure|MP:0005266,abnormal metabolism|MP:0005386,behavior/neurological phenotype|MP:0005662,increased circulating adrenaline level|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0006144,increased systemic arterial systolic blood pressure|MP:0008289,abnormal adrenal medulla morphology|MP:0008506,abnormal noradrenergic chromaffin cell morphology|MP:0010025,decreased total body fat amount|MP:0012575,increased noradrenaline level
MGI:5619978	Vgf<tm2(VGF*)Srjs>	MP:0005385,cardiovascular system phenotype
MGI:5619977	Vgf<tm3(VGF)Srjs>	MP:0005385,cardiovascular system phenotype
MGI:6343554	Vgll2<tm1Tm>	MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0012106,impaired exercise endurance
MGI:6149156	Vgll3<em1(IMPC)H>	MP:0001489,decreased startle reflex|MP:0002169,no abnormal phenotype detected|MP:0004174,abnormal spine curvature
MGI:7524740	Vgll3<em1Nakm>	MP:0031216,decreased susceptibility to myocardial ischemic injury
MGI:6120802	Vgll4<tm1b(EUCOMM)Hmgu>	MP:0000233,abnormal blood flow velocity|MP:0000267,abnormal heart development|MP:0000351,increased cell proliferation|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002833,increased heart weight|MP:0005385,cardiovascular system phenotype|MP:0005599,increased cardiac muscle contractility|MP:0006117,aortic valve stenosis|MP:0010593,thick aortic valve cusps|MP:0010605,thick pulmonary valve cusps|MP:0011100,preweaning lethality, complete penetrance|MP:0011886,increased circulating lipase level
MGI:3510188	Vgot1<A/J>	MP:0008994,early vaginal opening
MGI:3510190	Vgot2<A/J>	MP:0008994,early vaginal opening
MGI:2136646	Vhl<tm1.1Jae>	MP:0001614,abnormal blood vessel morphology|MP:0002047,increased hepatic hemangioma incidence|MP:0002628,hepatic steatosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2677579	Vhl<tm1.1Lss>	MP:0000598,abnormal liver morphology|MP:0002047,increased hepatic hemangioma incidence
MGI:5529337	Vhl<tm1.1Whkr>	MP:0005370,liver/biliary system phenotype|MP:0014241,abnormal intracellular organelle physiology
MGI:4436910	Vhl<tm1.1Wkr>	MP:0000522,kidney cortex cyst|MP:0001614,abnormal blood vessel morphology|MP:0002009,preneoplasia|MP:0004499,increased incidence of tumors by chemical induction|MP:0005370,liver/biliary system phenotype|MP:0009308,increased adenocarcinoma incidence|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:2658719	Vhl<tm1Bjg>	MP:0002884,abnormal pharyngeal arch morphology|MP:0003984,embryonic growth retardation|MP:0005650,abnormal limb bud morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2136645	Vhl<tm1Jae>	MP:0000240,extramedullary hematopoiesis|MP:0000260,abnormal angiogenesis|MP:0000333,decreased bone marrow cell number|MP:0000352,decreased cell proliferation|MP:0000414,alopecia|MP:0000519,hydronephrosis|MP:0000530,abnormal kidney vasculature morphology|MP:0000574,abnormal foot pad morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000607,abnormal hepatocyte morphology|MP:0000691,enlarged spleen|MP:0001190,reddish skin|MP:0001222,epidermal hyperplasia|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001613,abnormal vasodilation|MP:0001614,abnormal blood vessel morphology|MP:0001636,irregular heartbeat|MP:0001663,abnormal digestive system physiology|MP:0001785,edema|MP:0001846,increased inflammatory response|MP:0001859,kidney inflammation|MP:0002047,increased hepatic hemangioma incidence|MP:0002083,premature death|MP:0002135,abnormal kidney morphology|MP:0002169,no abnormal phenotype detected|MP:0002429,abnormal blood cell morphology/development|MP:0002608,increased hematocrit|MP:0002628,hepatic steatosis|MP:0002631,abnormal epididymis morphology|MP:0002640,reticulocytosis|MP:0002705,dilated renal tubule|MP:0002792,abnormal retina vasculature morphology|MP:0002833,increased heart weight|MP:0002871,albuminuria|MP:0002872,polycythemia|MP:0002981,increased liver weight|MP:0003070,increased vascular permeability|MP:0003131,increased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0003215,renal interstitial fibrosis|MP:0003233,prolonged QT interval|MP:0003606,kidney failure|MP:0003675,kidney cyst|MP:0003893,increased hepatocyte proliferation|MP:0003921,abnormal heart left ventricle morphology|MP:0004809,increased hematopoietic stem cell number|MP:0004860,dilated kidney collecting duct|MP:0004938,dilated vasculature|MP:0004988,increased osteoblast cell number|MP:0005016,decreased lymphocyte cell number|MP:0005150,cachexia|MP:0005330,cardiomyopathy|MP:0005333,decreased heart rate|MP:0005367,renal/urinary system phenotype|MP:0005564,increased hemoglobin content|MP:0005565,increased blood urea nitrogen level|MP:0005598,decreased heart ventricle muscle contractility|MP:0005601,increased angiogenesis|MP:0006056,increased vascular endothelial cell number|MP:0008140,podocyte foot process effacement|MP:0008539,decreased susceptibility to induced colitis|MP:0009583,increased keratinocyte proliferation|MP:0010392,prolonged QRS complex duration|MP:0010868,increased bone trabecula number|MP:0010872,increased trabecular bone mass|MP:0010878,increased trabecular bone volume|MP:0011085,postnatal lethality, complete penetrance|MP:0011285,increased circulating erythropoietin level|MP:0011348,abnormal renal glomerulus basement membrane morphology|MP:0011353,expanded mesangial matrix|MP:0011377,renal glomerulus fibrosis|MP:0011402,renal cast|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011427,increased mesangial cell number|MP:0011506,glomerular crescent|MP:0011509,dilated glomerular capillary|MP:0011629,decreased mitochondrial number|MP:0011753,decreased podocyte number
MGI:2677574	Vhl<tm1Lss>	MP:0003336,pancreas cyst|MP:0005215,abnormal pancreatic islet morphology|MP:0005220,abnormal exocrine pancreas morphology|MP:0005379,endocrine/exocrine gland phenotype|MP:0009043,increased pancreas adenoma incidence|MP:0010768,mortality/aging|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3776030	Vhl<tm1Mcs>	MP:0000218,increased leukocyte cell number|MP:0000245,abnormal erythropoiesis|MP:0000598,abnormal liver morphology|MP:0002006,neoplasm|MP:0002608,increased hematocrit|MP:0002872,polycythemia|MP:0003131,increased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0003548,pulmonary hypertension|MP:0004952,increased spleen weight|MP:0005397,hematopoietic system phenotype|MP:0005564,increased hemoglobin content|MP:0005601,increased angiogenesis|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008254,increased megakaryocyte cell number|MP:0008476,increased spleen red pulp amount|MP:0008479,decreased spleen white pulp amount|MP:0011101,prenatal lethality, incomplete penetrance|MP:0014606,dark spleen
MGI:1857702	Vhl<tm1Wml>	MP:0001712,abnormal placenta development|MP:0004499,increased incidence of tumors by chemical induction|MP:0005031,abnormal trophoblast layer morphology|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0030975,placenta hemorrhage
MGI:6153700	Vil1<em1(IMPC)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0010025,decreased total body fat amount|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level
MGI:2676462	Vil1<tm1Gum>	MP:0002169,no abnormal phenotype detected
MGI:1859841	Vil1<tm1Syr>	MP:0001792,impaired wound healing
MGI:1931877	Vim<tm1Cba>	MP:0000250,abnormal vasoconstriction|MP:0000358,abnormal cell morphology|MP:0000849,abnormal cerebellum morphology|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0000876,Purkinje cell degeneration|MP:0000877,abnormal Purkinje cell morphology|MP:0000880,decreased Purkinje cell number|MP:0001363,increased anxiety-related response|MP:0001392,abnormal locomotor behavior|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001525,impaired balance|MP:0001613,abnormal vasodilation|MP:0001614,abnormal blood vessel morphology|MP:0002182,abnormal astrocyte morphology|MP:0002804,abnormal motor learning|MP:0003091,abnormal cell migration|MP:0003156,abnormal leukocyte migration|MP:0003627,abnormal leukocyte tethering or rolling|MP:0003628,abnormal leukocyte adhesion|MP:0003631,nervous system phenotype|MP:0004876,decreased mean systemic arterial blood pressure|MP:0005376,homeostasis/metabolism phenotype|MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0005385,cardiovascular system phenotype|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0005389,reproductive system phenotype|MP:0005553,increased circulating creatinine level|MP:0005621,abnormal cell physiology|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0009858,abnormal cellular extravasation
MGI:1931879	Vim<tm2Cba>	MP:0000260,abnormal angiogenesis|MP:0000358,abnormal cell morphology|MP:0003091,abnormal cell migration|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0005621,abnormal cell physiology
MGI:5816979	Vipas39<tm1c(KOMP)Mbp>	MP:0000414,alopecia|MP:0001192,scaly skin|MP:0003853,dry skin|MP:0005378,growth/size/body region phenotype|MP:0011643,abnormal tendon collagen fibril morphology
MGI:5427698	Vipr1<tm1Dgen>	MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001505,hunched posture|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5296326	Vipr1<tm1Msod>	MP:0000189,hypoglycemia|MP:0000477,abnormal intestine morphology|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002078,abnormal glucose homeostasis|MP:0002891,increased insulin sensitivity|MP:0003270,intestinal obstruction|MP:0005220,abnormal exocrine pancreas morphology|MP:0005293,impaired glucose tolerance|MP:0008883,abnormal enterocyte proliferation|MP:0009254,disorganized pancreatic islets|MP:0009476,enlarged cecum|MP:0011084,lethality at weaning, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0031155,small intestine hemorrhage
MGI:3574664	Vipr2<tm1Ajh>	MP:0001402,decreased locomotor activity|MP:0002492,decreased IgE level|MP:0003009,abnormal cytokine secretion|MP:0005597,decreased susceptibility to type I hypersensitivity reaction|MP:0005617,increased susceptibility to type IV hypersensitivity reaction|MP:0008566,increased interferon-gamma secretion|MP:0008687,increased interleukin-2 secretion|MP:0008700,decreased interleukin-4 secretion|MP:0020467,abnormal circadian behavior|MP:0020471,abnormal circadian behavior persistence|MP:0020472,arrhythmic circadian behavior persistence|MP:0020476,abnormal circardian behavior entrainment
MGI:3621886	Vipr2<tm1Hmh>	MP:0001154,seminiferous tubule degeneration|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001922,reduced male fertility|MP:0002891,increased insulin sensitivity|MP:0003960,increased lean body mass|MP:0005480,increased circulating triiodothyronine level|MP:0010025,decreased total body fat amount|MP:0011940,decreased food intake
MGI:3053090	Vip<tm1Clw>	MP:0000276,heart right ventricle hypertrophy|MP:0000484,abnormal pulmonary artery morphology|MP:0001154,seminiferous tubule degeneration|MP:0001861,lung inflammation|MP:0002083,premature death|MP:0002780,decreased circulating testosterone level|MP:0002790,decreased circulating follicle stimulating hormone level|MP:0003548,pulmonary hypertension|MP:0004007,abnormal lung vasculature morphology|MP:0004910,decreased seminal vesicle weight|MP:0005389,reproductive system phenotype|MP:0010758,increased right ventricle systolic pressure|MP:0014269,decreased testes secretion|MP:0020470,shortened circadian behavior period|MP:0020472,arrhythmic circadian behavior persistence|MP:0020473,abnormal circadian behavior phase
MGI:4431361	Vip<tm1(cre)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:5700390	Vip<tm2.1(flpo)Zjh>	MP:0002169,no abnormal phenotype detected
MGI:4880937	Virma<tm1a(KOMP)Wtsi>	MP:0005031,abnormal trophoblast layer morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:2157989	Vispl<NZB/BlNJ>	MP:0005391,vision/eye phenotype
MGI:5823247	Vit<tm1Koth>	MP:0000939,decreased motor neuron number|MP:0000956,decreased spinal cord size|MP:0002151,abnormal neural tube morphology|MP:0004100,abnormal spinal cord interneuron morphology|MP:0004981,decreased neuronal precursor cell number|MP:0009688,abnormal spinal cord central canal morphology|MP:0009937,abnormal neuron differentiation|MP:0010151,abnormal spinal cord ependymal layer morphology|MP:0012203,abnormal neuronal stem cell morphology
MGI:6358066	Vkorc1<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance
MGI:3605979	Vkorc1<L128S>	MP:0002551,abnormal blood coagulation
MGI:6269386	Vkorc1l1<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0000221,decreased leukocyte cell number|MP:0001399,hyperactivity|MP:0002590,increased mean corpuscular volume|MP:0002875,decreased erythrocyte cell number|MP:0003795,abnormal bone structure|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0005278,abnormal cholesterol homeostasis|MP:0005419,decreased circulating serum albumin level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005567,decreased circulating total protein level|MP:0010124,decreased bone mineral content|MP:0013279,increased fasting circulating glucose level
MGI:6198559	Vkorc1l1<tm1.1Kry>	MP:0005376,homeostasis/metabolism phenotype
MGI:6198561	Vkorc1l1<tm1.2Kry>	MP:0005397,hematopoietic system phenotype|MP:0010768,mortality/aging
MGI:5560512	Vkorc1<tm1.1Jobg>	MP:0001916,intracerebral hemorrhage|MP:0002083,premature death|MP:0002551,abnormal blood coagulation|MP:0002764,short tibia|MP:0002765,short fibula|MP:0003109,short femur|MP:0004351,short humerus|MP:0004355,short radius|MP:0011085,postnatal lethality, complete penetrance|MP:0031117,subdural hemorrhage|MP:0031136,muscle hemorrhage|MP:0031152,subcutaneous hemorrhage
MGI:6198560	Vkorc1<tm1.1Kry>	MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0011922,abnormal circulating osteocalcin level
MGI:6198562	Vkorc1<tm1.2Kry>	MP:0001634,internal hemorrhage|MP:0011085,postnatal lethality, complete penetrance
MGI:3605985	Vkorc1<Y139C>	MP:0002551,abnormal blood coagulation
MGI:6277005	Vldlr<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:5290092	Vldlr<m1Btlr>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001325,abnormal retina morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0005103,abnormal retina pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0008450,retina photoreceptor degeneration
MGI:6197824	Vldlr<m2Btlr>	MP:0008515,thin retina outer nuclear layer|MP:0011965,decreased total retina thickness|MP:0013146,eye lesions
MGI:6295987	Vldlr<rnv4>	MP:0000414,alopecia|MP:0001265,decreased body size|MP:0002792,abnormal retina vasculature morphology|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0010098,abnormal retina blood vessel pattern
MGI:1857267	Vldlr<tm1Her>	MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000913,abnormal brain development|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001325,abnormal retina morphology|MP:0001327,decreased retina photoreceptor cell number|MP:0001399,hyperactivity|MP:0001454,abnormal cued conditioning behavior|MP:0001469,abnormal contextual conditioning behavior|MP:0001473,reduced long-term potentiation|MP:0001552,increased circulating triglyceride level|MP:0001900,impaired synaptic plasticity|MP:0002152,abnormal brain morphology|MP:0002207,abnormal long-term potentiation|MP:0002864,abnormal ocular fundus morphology|MP:0003711,pathological neovascularization|MP:0005178,increased circulating cholesterol level|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005546,choroidal neovascularization|MP:0006069,abnormal retina neuronal layer morphology|MP:0008450,retina photoreceptor degeneration|MP:0008512,disorganized retina inner nuclear layer|MP:0008515,thin retina outer nuclear layer|MP:0008518,retina outer nuclear layer degeneration|MP:0008852,retina neovascularization|MP:0009289,decreased epididymal fat pad weight|MP:0009719,reduced cerebellar foliation
MGI:5312686	Vldlr<tm1Lex>	MP:0003070,increased vascular permeability|MP:0008852,retina neovascularization
MGI:5320605	Vm	MP:0000477,abnormal intestine morphology|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0002020,increased tumor incidence|MP:0002075,abnormal coat/hair pigmentation|MP:0002135,abnormal kidney morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3036618	Vmbic3<C57BL/6J>	MP:0020365,increased brain iron level
MGI:3036628	Vmbic8<C57BL/6J>	MP:0008807,increased liver iron level
MGI:3036631	Vmbic9<DBA/2J>	MP:0000192,abnormal mineral level|MP:0003952,abnormal copper level|MP:0005637,abnormal iron homeostasis
MGI:3697354	Vmmt10<C3H/HeJ>	MP:0000137,abnormal vertebrae morphology
MGI:3697356	Vmmt11<C3H/HeJ>	MP:0000137,abnormal vertebrae morphology
MGI:3697358	Vmmt12<C3H/HeJ>	MP:0000137,abnormal vertebrae morphology
MGI:3697363	Vmmt13<C3H/HeJ>	MP:0000137,abnormal vertebrae morphology
MGI:3697366	Vmmt14<C57BL/6J>	MP:0000137,abnormal vertebrae morphology
MGI:3697653	Vmmt15<C3H/HeJ>	MP:0000137,abnormal vertebrae morphology
MGI:3697655	Vmmt16<C3H/HeJ>	MP:0000137,abnormal vertebrae morphology
MGI:3697657	Vmmt17<C57BL/6J>	MP:0000137,abnormal vertebrae morphology
MGI:3697660	Vmmt18<DBA/2J>	MP:0000137,abnormal vertebrae morphology
MGI:3697662	Vmmt19<DBA/2J>	MP:0000137,abnormal vertebrae morphology
MGI:3697224	Vmmt1<C3H/HeJ>	MP:0000137,abnormal vertebrae morphology
MGI:3697222	Vmmt1<C57BL/6J>	MP:0000137,abnormal vertebrae morphology
MGI:3697232	Vmmt20<C3H/HeJ>	MP:0000137,abnormal vertebrae morphology
MGI:3697226	Vmmt2<DBA/2J>	MP:0000137,abnormal vertebrae morphology
MGI:3697228	Vmmt3<C57BL/6J>	MP:0000137,abnormal vertebrae morphology
MGI:3697230	Vmmt4<BALB/cJ>	MP:0000137,abnormal vertebrae morphology
MGI:3697344	Vmmt5<DBA/2J>	MP:0000137,abnormal vertebrae morphology
MGI:3697346	Vmmt6<BALB/cJ>	MP:0000137,abnormal vertebrae morphology
MGI:3697348	Vmmt7<BALB/cJ>	MP:0000137,abnormal vertebrae morphology
MGI:3697350	Vmmt8<DBA/2J>	MP:0000137,abnormal vertebrae morphology
MGI:3697352	Vmmt9<DBA/2J>	MP:0000137,abnormal vertebrae morphology
MGI:3640469	Vmn1r49<tm3Mom>	MP:0009945,abnormal accessory olfactory bulb morphology|MP:0012014,abnormal olfactory neuron innervation pattern
MGI:3640470	Vmn1r49<tm4(Or8a1)Mom>	MP:0009945,abnormal accessory olfactory bulb morphology
MGI:6506252	Vmn2r115<em1Ktou>	MP:0001376,abnormal mating receptivity
MGI:4819730	Vmn2r116<tm1.1Ktou>	MP:0002243,abnormal vomeronasal organ morphology|MP:0002566,abnormal sexual interaction|MP:0013596,abnormal vomeronasal organ physiology
MGI:6506255	Vmn2r117<em1Ktou>	MP:0002243,abnormal vomeronasal organ morphology
MGI:5605388	Vmn2r1<tm1Mom>	MP:0002243,abnormal vomeronasal organ morphology|MP:0011679,abnormal vomeronasal sensory neuron morphology
MGI:6159872	Vmn2r1<tm2Mom>	MP:0002243,abnormal vomeronasal organ morphology|MP:0011679,abnormal vomeronasal sensory neuron morphology
MGI:3722386	Vmn2r26<tm2Mom>	MP:0004513,avnosmia|MP:0011678,abnormal vomeronasal sensory neuron physiology
MGI:7334897	Vmn2r53<em1Ktou>	MP:0003862,decreased aggression towards male mice|MP:0021115,abnormal aggression towards conspecific
MGI:6315488	Vmn2r65<tm1.1Dlc>	MP:0003863,decreased aggression towards mice|MP:0005386,behavior/neurological phenotype|MP:0021118,abnormal paternal behavior
MGI:3722385	Vmn2r81<tm2Mom>	MP:0002169,no abnormal phenotype detected
MGI:4438781	Vmn2r81<tm4Mom>	MP:0002243,abnormal vomeronasal organ morphology
MGI:6315489	Vmn2r88<tm1.1Dlc>	MP:0005386,behavior/neurological phenotype
MGI:6386774	Vmp1<tm1.1Arte>	MP:0000479,abnormal enterocyte morphology|MP:0001262,decreased body weight|MP:0001547,abnormal lipid level
MGI:4887606	Vmp1<tm1a(KOMP)Wtsi>	MP:0001547,abnormal lipid level|MP:0001698,decreased embryo size|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011186,abnormal visceral endoderm morphology
MGI:3712475	Vms1<A/J>	MP:0001856,myocarditis|MP:0004121,abnormal sarcolemma morphology
MGI:3712478	Vms2<C57BL/10SnSg>	MP:0004121,abnormal sarcolemma morphology
MGI:3712480	Vms3<C57BL/10SnSg>	MP:0004121,abnormal sarcolemma morphology
MGI:1862013	Vng	MP:0000024,lowered ear position|MP:0001265,decreased body size
MGI:3027932	Vnn1<tm1Pna>	MP:0005319,abnormal enzyme/coenzyme level|MP:0005378,growth/size/body region phenotype|MP:0005387,immune system phenotype
MGI:7426080	Vnn3<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0000759,abnormal skeletal muscle morphology|MP:0001120,abnormal uterus morphology|MP:0001157,small seminal vesicle|MP:0002059,abnormal seminal vesicle morphology|MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0004122,abnormal sinus arrhythmia|MP:0004906,enlarged uterus|MP:0010025,decreased total body fat amount
MGI:5659670	Vopp1<em1(IMPC)J>	MP:0001486,abnormal startle reflex|MP:0002546,mydriasis|MP:0006243,impaired pupillary reflex|MP:0010053,decreased grip strength
MGI:2448884	vos	MP:0000564,syndactyly|MP:0001732,postnatal growth retardation
MGI:3043722	Vpantd<SWV/Fnn>	MP:0000914,exencephaly|MP:0011102,embryonic lethality, incomplete penetrance
MGI:1859923	Vpreb1a<tm1Ilm>	MP:0001802,arrested B cell differentiation|MP:0002403,abnormal pre-B cell morphology|MP:0003132,increased pre-B cell number|MP:0005387,immune system phenotype|MP:0008209,decreased pre-B cell number
MGI:3842838	Vpreb1b<tm3Ilm>	MP:0005387,immune system phenotype
MGI:6153702	Vpreb3<em1(IMPC)Wtsi>	MP:0005567,decreased circulating total protein level
MGI:6156169	Vps11<em1(IMPC)Rbrc>	MP:0011100,preweaning lethality, complete penetrance
MGI:3531502	Vps13a<tm1Asan>	MP:0001360,abnormal social investigation|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0001925,male infertility|MP:0002183,gliosis|MP:0002204,abnormal synaptic neurotransmitter level|MP:0002641,anisopoikilocytosis|MP:0002675,asthenozoospermia|MP:0003242,loss of basal ganglia neurons|MP:0005389,reproductive system phenotype|MP:0010177,acanthocytosis|MP:0012468,decreased striatum size|MP:0014465,abnormal sperm mitochondrial morphology|MP:0031085,increased erythrocyte osmotic fragility
MGI:5637150	Vps13a<tm1b(EUCOMM)Wtsi>	MP:0001925,male infertility|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0013764,decreased T-helper cell number
MGI:6156483	Vps13b<em1(IMPC)Tcp>	MP:0000221,decreased leukocyte cell number|MP:0000598,abnormal liver morphology|MP:0000692,small spleen|MP:0000702,enlarged lymph nodes|MP:0001258,decreased body length|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0001925,male infertility|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002188,small heart|MP:0002590,increased mean corpuscular volume|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003961,decreased lean body mass|MP:0005016,decreased lymphocyte cell number|MP:0005293,impaired glucose tolerance|MP:0010024,increased total body fat amount|MP:0010052,increased grip strength
MGI:6695987	Vps13b<em1Yosl>	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0005386,behavior/neurological phenotype|MP:0012307,impaired spatial learning
MGI:6467991	Vps13b<tm1.2Ics>	MP:0001147,small testis|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001851,eye inflammation|MP:0001925,male infertility|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0002699,abnormal vitreous body morphology|MP:0003381,vitreal fibroplasia|MP:0005384,cellular phenotype|MP:0005578,teratozoospermia|MP:0008839,absent acrosome|MP:0009232,abnormal sperm nucleus morphology|MP:0009325,necrospermia|MP:0010255,cortical cataract|MP:0011743,abnormal Golgi apparatus morphology|MP:0013732,mature cataract|MP:0014052,increased male germ cell apoptosis|MP:0020550,multinucleated giant male germ cells|MP:0020849,abnormal actin cytoskeleton morphology|MP:0021107,retina fold|MP:0030949,abnormal Golgi vesicle transport|MP:0030952,abnormal Golgi stack morphology|MP:0030980,abnormal acroplaxome morphology
MGI:5907128	Vps13c<tm1.1Geno>	MP:0002727,decreased circulating insulin level|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005293,impaired glucose tolerance
MGI:5548822	Vps13c<tm1b(EUCOMM)Hmgu>	MP:0000208,decreased hematocrit|MP:0001402,decreased locomotor activity|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0004924,abnormal behavior|MP:0005343,increased circulating aspartate transaminase level|MP:0008806,increased circulating amylase level|MP:0010067,increased red blood cell distribution width|MP:0010088,decreased circulating fructosamine level|MP:0011886,increased circulating lipase level|MP:0020870,decreased thigmotaxis
MGI:5287025	Vps13d<TgTn(sb-cHS4,Tyr)2320F-2Ove>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:6316281	Vps13d<tm1e.1(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6116463	Vps16<em1Weli>	MP:0001392,abnormal locomotor behavior|MP:0005323,dystonia|MP:0005378,growth/size/body region phenotype
MGI:5431976	Vps18<tm1.1Wtao>	MP:0000774,decreased brain size|MP:0000807,abnormal hippocampus morphology|MP:0000849,abnormal cerebellum morphology|MP:0000852,small cerebellum|MP:0000880,decreased Purkinje cell number|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002229,neurodegeneration|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0004811,abnormal neuron physiology|MP:0006009,abnormal neuronal migration|MP:0008260,abnormal autophagy|MP:0008267,abnormal hippocampus CA3 region morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:5431830	Vps18<tm1Wtao>	MP:0011100,preweaning lethality, complete penetrance
MGI:5751483	Vps25<m1Lis>	MP:0000149,abnormal scapula morphology|MP:0000351,increased cell proliferation|MP:0000358,abnormal cell morphology|MP:0000445,short snout|MP:0000460,mandible hypoplasia|MP:0000547,short limbs|MP:0000562,polydactyly|MP:0002177,abnormal outer ear morphology|MP:0003857,abnormal hindlimb zeugopod morphology|MP:0004342,scapular bone foramen|MP:0006042,increased apoptosis|MP:0009743,preaxial polydactyly|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5695878	Vps25<tm1.1(KOMP)Vlcg>	MP:0001697,abnormal embryo size|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4951319	Vps25<tm1(KOMP)Vlcg>	MP:0011092,embryonic lethality, complete penetrance
MGI:1858010	Vps26a<Tg(HB58)Cos>	MP:0001675,abnormal ectoderm development|MP:0001689,incomplete somite formation|MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002824,abnormal chorioallantoic fusion|MP:0003984,embryonic growth retardation|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4867701	Vps26b<tm1Ktch>	MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype
MGI:6258602	Vps26c<em1(IMPC)J>	MP:0000603,pale liver|MP:0001284,absent vibrissae|MP:0001297,microphthalmia|MP:0001312,abnormal cornea morphology|MP:0001392,abnormal locomotor behavior|MP:0002075,abnormal coat/hair pigmentation|MP:0002080,prenatal lethality|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6467487	Vps29<em1(IMPC)Bay>	MP:0003232,abnormal forebrain development|MP:0011100,preweaning lethality, complete penetrance
MGI:1856687	Vps33a<bf>	MP:0000371,diluted coat color|MP:0001324,abnormal eye pigmentation|MP:0002136,abnormal kidney physiology|MP:0002551,abnormal blood coagulation|MP:0005075,abnormal melanosome morphology|MP:0005100,abnormal choroid pigmentation|MP:0005102,abnormal iris pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005408,hypopigmentation|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0009549,decreased platelet aggregation|MP:0030918,small melanosome
MGI:6157271	Vps33a<em2(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0000219,increased neutrophil cell number|MP:0002764,short tibia|MP:0002833,increased heart weight|MP:0003068,enlarged kidney|MP:0004952,increased spleen weight|MP:0005016,decreased lymphocyte cell number|MP:0010067,increased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:5770088	Vps33b<tm1.1Arte>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000414,alopecia|MP:0000691,enlarged spleen|MP:0001192,scaly skin|MP:0001212,skin lesions|MP:0002417,abnormal megakaryocyte morphology|MP:0003853,dry skin|MP:0005016,decreased lymphocyte cell number|MP:0005378,growth/size/body region phenotype|MP:0005425,increased macrophage cell number|MP:0005505,thrombocytosis|MP:0005606,increased bleeding time|MP:0008127,decreased dendritic cell number|MP:0008254,increased megakaryocyte cell number|MP:0008935,decreased mean platelet volume|MP:0009549,decreased platelet aggregation|MP:0011643,abnormal tendon collagen fibril morphology|MP:0020431,decreased platelet alpha-granule number
MGI:4431968	Vps33b<tm1a(EUCOMM)Wtsi>	MP:0001556,increased circulating HDL cholesterol level|MP:0001711,abnormal placenta morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0010099,abnormal thoracic cage shape|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:6153830	Vps35<em1(IMPC)H>	MP:0001325,abnormal retina morphology|MP:0001406,abnormal gait|MP:0011100,preweaning lethality, complete penetrance
MGI:4130266	Vps35<Gt(RRK261)Byg>	MP:0001402,decreased locomotor activity|MP:0002757,decreased vertical activity|MP:0003243,abnormal dopaminergic neuron morphology|MP:0003244,loss of dopaminergic neurons|MP:0005058,abnormal lysosome morphology|MP:0005643,decreased dopamine level|MP:0008493,alpha-synuclein inclusion body|MP:0011092,embryonic lethality, complete penetrance
MGI:6507962	Vps35l<em1Shis>	MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:6507963	Vps35l<em2Shis>	MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:5704327	Vps35<tm1.1Hckn>	MP:0005381,digestive/alimentary phenotype|MP:0010157,abnormal small intestinal crypt cell proliferation
MGI:7465211	Vps35<tm1.1Hlw>	MP:0001402,decreased locomotor activity|MP:0003631,nervous system phenotype|MP:0003674,oxidative stress|MP:0005156,bradykinesia|MP:0011631,decreased mitochondrial size|MP:0011633,abnormal mitochondrial shape|MP:0013219,abnormal substantia nigra pars compacta morphology|MP:0020211,slow movement
MGI:5607779	Vps35<tm1.1Mjff>	MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0002229,neurodegeneration|MP:0003243,abnormal dopaminergic neuron morphology|MP:0003354,astrocytosis|MP:0005386,behavior/neurological phenotype|MP:0005404,abnormal axon morphology|MP:0006036,abnormal mitochondrial physiology|MP:0008493,alpha-synuclein inclusion body|MP:0008842,lipofuscinosis|MP:0008918,microgliosis|MP:0011448,decreased dopaminergic neuron number|MP:0011633,abnormal mitochondrial shape|MP:0020874,abnormal nervous system dopamine level
MGI:5466855	Vps35<tm1.2Mjff>	MP:0002169,no abnormal phenotype detected
MGI:6383171	Vps36<em1(IMPC)J>	MP:0001325,abnormal retina morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0002080,prenatal lethality|MP:0011100,preweaning lethality, complete penetrance
MGI:6316230	Vps37a<em1(IMPC)Tcp>	MP:0000367,abnormal coat/ hair morphology|MP:0001258,decreased body length|MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance|MP:0020421,increased freezing behavior
MGI:6379561	Vps37b<em1(IMPC)H>	MP:0001392,abnormal locomotor behavior|MP:0002965,increased circulating serum albumin level|MP:0005568,increased circulating total protein level
MGI:5548767	Vps37d<tm2b(EUCOMM)Wtsi>	MP:0001402,decreased locomotor activity|MP:0001491,unresponsive to tactile stimuli|MP:0003385,abnormal body wall morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness
MGI:6783440	Vps39<tm1Gsk>	MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:5425109	Vps41<tm1.1Ywd>	MP:0001674,abnormal germ layer development|MP:0001680,abnormal mesoderm development|MP:0001685,abnormal endoderm development|MP:0002085,abnormal embryonic tissue morphology|MP:0003085,abnormal egg cylinder morphology|MP:0003895,increased ectoderm apoptosis|MP:0005380,embryo phenotype|MP:0010117,abnormal lateral plate mesoderm morphology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0030951,abnormal endocytosis
MGI:5425108	Vps41<tm1Ywd>	MP:0002169,no abnormal phenotype detected
MGI:5296588	Vps45<tm1a(EUCOMM)Hmgu>	MP:0001674,abnormal germ layer development|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:5561562	Vps4a<tm1b(EUCOMM)Hmgu>	MP:0000691,enlarged spleen|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001491,unresponsive to tactile stimuli|MP:0001697,abnormal embryo size|MP:0002060,abnormal skin morphology|MP:0003385,abnormal body wall morphology|MP:0004952,increased spleen weight|MP:0009908,protruding tongue|MP:0011100,preweaning lethality, complete penetrance
MGI:6694861	Vps4b<em1.1Nju>	MP:0001711,abnormal placenta morphology|MP:0001714,absent trophoblast giant cells|MP:0001914,hemorrhage|MP:0002169,no abnormal phenotype detected|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0004259,small placenta|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0030975,placenta hemorrhage
MGI:4458528	Vps51<tm1a(KOMP)Wtsi>	MP:0005344,increased circulating bilirubin level|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:5463589	Vps52<tm1.1Kab>	MP:0002169,no abnormal phenotype detected
MGI:5463590	Vps52<tm1.2Kab>	MP:0011092,embryonic lethality, complete penetrance
MGI:4451513	Vps53<tm1a(KOMP)Wtsi>	MP:0004599,abnormal vertebral arch morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:4398894	Vps53<tm1Xtz>	MP:0001698,decreased embryo size|MP:0001716,abnormal placenta labyrinth morphology|MP:0003984,embryonic growth retardation|MP:0009397,increased trophoblast giant cell number|MP:0011092,embryonic lethality, complete penetrance
MGI:6414475	Vps54<em1(IMPC)Bay>	MP:0001700,abnormal embryo turning|MP:0001718,abnormal visceral yolk sac morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3613397	Vps54<Gt(RRI497)Byg>	MP:0000278,abnormal myocardial fiber morphology|MP:0000956,decreased spinal cord size|MP:0003984,embryonic growth retardation|MP:0008460,absent dorsal root ganglion|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:1857091	Vps54<wr>	MP:0000358,abnormal cell morphology|MP:0000607,abnormal hepatocyte morphology|MP:0000745,tremors|MP:0000747,muscle weakness|MP:0000748,progressive muscle weakness|MP:0000756,forelimb paralysis|MP:0000920,abnormal myelination|MP:0000921,demyelination|MP:0000937,abnormal motor neuron morphology|MP:0000938,motor neuron degeneration|MP:0001077,abnormal spinal nerve morphology|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001513,limb grasping|MP:0001515,abnormal grip strength|MP:0001924,infertility|MP:0001929,abnormal gametogenesis|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002182,abnormal astrocyte morphology|MP:0002183,gliosis|MP:0002206,abnormal CNS synaptic transmission|MP:0002269,muscular atrophy|MP:0002651,abnormal sciatic nerve morphology|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002687,oligozoospermia|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0003084,abnormal skeletal muscle fiber morphology|MP:0003245,abnormal GABAergic neuron morphology|MP:0003371,decreased circulating estrogen level|MP:0003632,abnormal nervous system morphology|MP:0003633,abnormal nervous system physiology|MP:0003806,abnormal nucleotide metabolism|MP:0004008,abnormal GABA-mediated receptor currents|MP:0004768,abnormal axonal transport|MP:0004852,decreased testis weight|MP:0005058,abnormal lysosome morphology|MP:0006411,upturned snout|MP:0008571,abnormal synaptic bouton morphology|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0011987,abnormal GABAergic neuron physiology|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0020448,increased microglial cell activation|MP:0030140,facial muscle atrophy
MGI:5008033	Vps72<tm1a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:5767329	Vps9d1<tm1b(KOMP)Wtsi>	MP:0010052,increased grip strength|MP:0011959,abnormal eye posterior chamber depth|MP:0011960,abnormal eye anterior chamber depth
MGI:6158464	Vrk1<em1(IMPC)Mbp>	MP:0002941,increased circulating alanine transaminase level|MP:0004924,abnormal behavior|MP:0005343,increased circulating aspartate transaminase level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0020870,decreased thigmotaxis
MGI:4330710	Vrk1<Gt(RRR178)Byg>	MP:0000242,impaired fertilization|MP:0001125,abnormal oocyte morphology|MP:0001129,impaired ovarian folliculogenesis|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001931,abnormal oogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0002631,abnormal epididymis morphology|MP:0002685,abnormal spermatogonia proliferation|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0008995,early reproductive senescence|MP:0011129,decreased tertiary ovarian follicle number|MP:0014011,abnormal ovary tissue architecture|MP:0014443,impaired polar body extrusion|MP:0014633,decreased spermatid number|MP:0031381,decreased secondary ovarian follicle number
MGI:4126457	Vrk1<Gt(XH078)Byg>	MP:0002169,no abnormal phenotype detected
MGI:7308529	Vrk2<em9Gpt>	MP:0002573,behavioral despair|MP:0005386,behavior/neurological phenotype|MP:0020338,abnormal hippocampal pyramidal neuron dendrite morphology|MP:0020512,abnormal dendritic mushroom spine morphology|MP:0020514,abnormal dendritic thin spine morphology|MP:0021010,impaired synaptic physiology
MGI:6152674	Vrk3<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001192,scaly skin|MP:0001944,abnormal pancreas morphology|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney
MGI:3880442	Vrk3<Gt(YTA189)Byg>	MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001384,abnormal pup retrieval|MP:0001441,increased grooming behavior|MP:0001447,abnormal nest building behavior|MP:0002065,abnormal fear/anxiety-related behavior|MP:0002557,abnormal social/conspecific interaction behavior|MP:0002885,abnormal AMPA-mediated synaptic currents|MP:0003461,abnormal response to novel object|MP:0004000,impaired passive avoidance behavior|MP:0008432,abnormal long-term spatial reference memory|MP:0020338,abnormal hippocampal pyramidal neuron dendrite morphology|MP:0020395,abnormal response to social novelty|MP:0020508,decreased dendritic spine density|MP:0020510,increased dendritic spine length|MP:0020551,abnormal postsynaptic density morphology|MP:0031391,increased locomotor activity
MGI:6202694	Vrtn<em#Lhhg>	MP:0000160,kyphosis|MP:0000270,abnormal heart tube morphology|MP:0002151,abnormal neural tube morphology|MP:0003345,decreased rib number|MP:0003984,embryonic growth retardation|MP:0004180,failure of initiation of embryo turning|MP:0004648,decreased thoracic vertebrae number|MP:0009768,impaired somite development|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3522333	vsd	MP:0000266,abnormal heart morphology|MP:0000550,abnormal forelimb morphology|MP:0000576,clubfoot|MP:0001625,cardiac hypertrophy|MP:0003105,abnormal heart atrium morphology|MP:0003984,embryonic growth retardation|MP:0006049,semilunar valve regurgitation|MP:0006138,congestive heart failure|MP:0010420,muscular ventricular septal defect|MP:0010453,abnormal coronary vein morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0014280,forelimb oligodactyly
MGI:6153703	Vsig10<em1(IMPC)Wtsi>	MP:0000218,increased leukocyte cell number
MGI:5297726	Vsig1<tm1Imad>	MP:0000473,abnormal stomach glandular epithelium morphology
MGI:7354911	Vsig4<em#Tvg>	MP:0002006,neoplasm
MGI:5529618	Vsig4<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0002574,increased vertical activity|MP:0002833,increased heart weight|MP:0002941,increased circulating alanine transaminase level|MP:0002959,increased urine microalbumin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0005278,abnormal cholesterol homeostasis|MP:0005343,increased circulating aspartate transaminase level|MP:0005560,decreased circulating glucose level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level|MP:0005633,increased circulating sodium level|MP:0010025,decreased total body fat amount|MP:0011396,abnormal sleep behavior
MGI:3806036	Vsig4<tm1Gne>	MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0008086,increased T-helper 1 cell number|MP:0008539,decreased susceptibility to induced colitis|MP:0008641,increased circulating interleukin-1 beta level|MP:0008657,increased interleukin-1 beta secretion|MP:0008883,abnormal enterocyte proliferation|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010219,increased T-helper 17 cell number
MGI:5493273	Vsig8<tm1.1(KOMP)Mbp>	MP:0002833,increased heart weight|MP:0005560,decreased circulating glucose level|MP:0005566,decreased blood urea nitrogen level|MP:0005627,increased circulating potassium level|MP:0010571,shortened ST segment
MGI:5006997	Vsir<tm1Lex>	MP:0001654,hepatic necrosis|MP:0001828,abnormal T cell activation|MP:0001846,increased inflammatory response|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0008566,increased interferon-gamma secretion|MP:0008681,increased interleukin-17 secretion|MP:0009148,pancreas necrosis|MP:0010857,pulmonary necrosis
MGI:3689342	Vss	MP:0000373,belly spot|MP:0001265,decreased body size|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype
MGI:6857758	Vstm2a<em1(IMPC)Mbp>	MP:0002060,abnormal skin morphology|MP:0002135,abnormal kidney morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0002989,small kidney|MP:0003068,enlarged kidney|MP:0003604,single kidney|MP:0006203,eye hemorrhage
MGI:7490177	Vstm2l<em1(IMPC)Tcp>	MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:6393534	Vstm4<em1Gypk>	MP:0002792,abnormal retina vasculature morphology|MP:0005165,increased susceptibility to injury|MP:0009660,abnormal induced retina neovascularization
MGI:6283592	Vstm4<em1(IMPC)J>	MP:0001510,abnormal coat appearance
MGI:6367659	Vstm5<em1Cdj>	MP:0005387,immune system phenotype|MP:0008688,decreased interleukin-2 secretion
MGI:7429091	Vstm5<em1(IMPC)Hmgu>	MP:0002135,abnormal kidney morphology
MGI:7426081	Vsx1<em1(IMPC)Ccpcz>	MP:0003020,decreased circulating chloride level
MGI:3040317	Vsx1<tm1Bhr>	MP:0004022,abnormal cone electrophysiology|MP:0005391,vision/eye phenotype
MGI:3033929	Vsx1<tm1Mci>	MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology|MP:0006075,abnormal retina cone bipolar cell morphology
MGI:3033931	Vsx1<tm2Mci>	MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0005551,abnormal eye electrophysiology|MP:0006075,abnormal retina cone bipolar cell morphology
MGI:1856111	Vsx2<or>	MP:0001286,abnormal eye development|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001330,abnormal optic nerve morphology|MP:0001333,absent optic nerve|MP:0004045,abnormal cell cycle checkpoint function|MP:0004268,abnormal optic stalk morphology|MP:0009771,absent optic chiasm|MP:0013447,Harderian gland hypertrophy|MP:0013454,lacrimal gland hypertrophy
MGI:1856113	Vsx2<or-2J>	MP:0001286,abnormal eye development|MP:0001297,microphthalmia|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001929,abnormal gametogenesis|MP:0005545,abnormal lens development
MGI:1856112	Vsx2<or-J>	MP:0000313,abnormal cell death|MP:0001286,abnormal eye development|MP:0001297,microphthalmia|MP:0001306,small lens|MP:0001325,abnormal retina morphology|MP:0001328,disorganized retina layers|MP:0001333,absent optic nerve|MP:0004268,abnormal optic stalk morphology|MP:0004269,abnormal optic cup morphology|MP:0005103,abnormal retina pigmentation|MP:0005172,decreased eye pigmentation|MP:0005176,eyelids fail to open|MP:0005201,abnormal retina pigment epithelium morphology|MP:0005545,abnormal lens development|MP:0006071,abnormal retina progenitor cell morphology|MP:0008056,abnormal retina ganglion cell morphology|MP:0009772,abnormal retina development|MP:0011965,decreased total retina thickness|MP:0012534,abnormal optic fissure morphology|MP:0012537,abnormal hyaloid artery morphology
MGI:3836012	Vsx2<tm1.1(DTA)Kash>	MP:0003633,abnormal nervous system physiology|MP:0004100,abnormal spinal cord interneuron morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0021104,abnormal ventral interneuron 2 morphology
MGI:5449356	Vsx2<tm1.1Eml>	MP:0001297,microphthalmia|MP:0001306,small lens|MP:0002092,abnormal eye morphology|MP:0002699,abnormal vitreous body morphology|MP:0005103,abnormal retina pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0009772,abnormal retina development|MP:0011965,decreased total retina thickness
MGI:5449355	Vsx2<tm1.1Itl>	MP:0001297,microphthalmia|MP:0001306,small lens|MP:0005103,abnormal retina pigmentation|MP:0005201,abnormal retina pigment epithelium morphology|MP:0009772,abnormal retina development|MP:0011965,decreased total retina thickness
MGI:5812896	vtab	MP:0000585,kinked tail|MP:0001154,seminiferous tubule degeneration|MP:0001932,abnormal spermiogenesis|MP:0002216,abnormal seminiferous tubule morphology|MP:0004901,decreased male germ cell number|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3045103	Vtbt10<C3H/HeJ>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3045111	Vtbt11<C3H/HeJ>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3045116	Vtbt12<C57BL/6J>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3045118	Vtbt13<C57BL/6J>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3045121	Vtbt14<C3H/HeJ>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3045122	Vtbt15<C57BL/6J>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3045125	Vtbt16<C3H/HeJ>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3045127	Vtbt17<C3H/HeJ>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3045128	Vtbt18<C57BL/6J>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3045131	Vtbt19<C3H/HeJ>	MP:0002114,abnormal axial skeleton morphology
MGI:3045083	Vtbt1<C57BL/6J>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3045087	Vtbt2<C3H/HeJ>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3045086	Vtbt2<C57BL/6J>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3045089	Vtbt3<C3H/HeJ>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3045090	Vtbt4<C57BL/6J>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3045092	Vtbt5<C57BL/6J>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3045094	Vtbt6<C57BL/6J>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3045096	Vtbt7<C57BL/6J>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3045099	Vtbt8<C3H/HeJ>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3045098	Vtbt8<C57BL/6J>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3045100	Vtbt9<C57BL/6J>	MP:0003049,abnormal lumbar vertebrae morphology
MGI:3836401	Vtcn1<tm1Lpc>	MP:0000219,increased neutrophil cell number|MP:0001601,abnormal myelopoiesis|MP:0002411,decreased susceptibility to bacterial infection|MP:0009789,decreased susceptibility to bacterial infection induced morbidity/mortality
MGI:3663315	Vtcn1<tm1Mak>	MP:0002169,no abnormal phenotype detected|MP:0005026,decreased susceptibility to parasitic infection|MP:0008566,increased interferon-gamma secretion|MP:0008700,decreased interleukin-4 secretion
MGI:5463743	Vtcn1<tm1Xxz>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0004803,increased susceptibility to autoimmune diabetes|MP:0005559,increased circulating glucose level|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008086,increased T-helper 1 cell number|MP:0008681,increased interleukin-17 secretion|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0010219,increased T-helper 17 cell number
MGI:5468843	vtd	MP:0000585,kinked tail|MP:0002111,abnormal tail morphology|MP:0003051,curly tail|MP:0006281,abnormal tail development
MGI:5548487	Vti1a<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0001513,limb grasping|MP:0002574,increased vertical activity|MP:0002631,abnormal epididymis morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0004738,abnormal auditory brainstem response|MP:0004924,abnormal behavior|MP:0004931,enlarged epididymis|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013278,decreased fasting circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:4940029	Vti1a<tm1Gfvm>	MP:0002169,no abnormal phenotype detected
MGI:2670119	Vti1b<tm1Gfvm>	MP:0000607,abnormal hepatocyte morphology|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0002830,gallstones|MP:0003172,abnormal lysosome physiology|MP:0003327,liver cyst|MP:0009342,enlarged gallbladder
MGI:3043041	Vtl	MP:0000585,kinked tail|MP:0000592,short tail
MGI:3047776	Vtl2	MP:0000585,kinked tail|MP:0000592,short tail
MGI:1931522	Vtn<tm1Dgi>	MP:0002169,no abnormal phenotype detected|MP:0002551,abnormal blood coagulation|MP:0005164,abnormal response to injury|MP:0009548,abnormal platelet aggregation
MGI:3809230	Vwa1<tm1Jfba>	MP:0001516,abnormal motor coordination/balance|MP:0001973,increased thermal nociceptive threshold|MP:0003632,abnormal nervous system morphology|MP:0005369,muscle phenotype|MP:0005390,skeleton phenotype
MGI:6152675	Vwa2<em1(IMPC)Mbp>	MP:0002092,abnormal eye morphology
MGI:6361183	Vwa3b<em1Osb>	MP:0005389,reproductive system phenotype
MGI:5696234	Vwa5a<em1(IMPC)J>	MP:0001314,cornea opacity|MP:0001486,abnormal startle reflex|MP:0002098,abnormal vibrissa morphology
MGI:7426083	Vwa7<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5614704	Vwa8<tm1b(EUCOMM)Wtsi>	MP:0001325,abnormal retina morphology|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0005627,increased circulating potassium level|MP:0010097,abnormal retina blood vessel morphology|MP:0013279,increased fasting circulating glucose level
MGI:6152676	Vwc2l<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology
MGI:6467485	Vwce<em1(IMPC)Bay>	MP:0003795,abnormal bone structure|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7286448	Vwde<em1Iwto>	MP:0002576,abnormal enamel morphology|MP:0002689,abnormal molar morphology|MP:0013129,abnormal tooth color
MGI:5312914	Vwf<tm1.1Diac>	MP:0005606,increased bleeding time|MP:0006298,abnormal platelet activation|MP:0020215,impaired blood coagulation
MGI:6258653	Vwf<tm1.1Geno>	MP:0002599,increased mean platelet volume|MP:0003179,thrombocytopenia|MP:0005088,increased acute inflammation|MP:0005164,abnormal response to injury|MP:0005464,abnormal platelet physiology|MP:0005564,increased hemoglobin content|MP:0005606,increased bleeding time|MP:0009548,abnormal platelet aggregation|MP:0009549,decreased platelet aggregation|MP:0031120,decreased susceptibility to induced thrombosis
MGI:6473963	Vwf<tm1.1Vhf>	MP:0002551,abnormal blood coagulation|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0031120,decreased susceptibility to induced thrombosis
MGI:2153009	Vwf<tm1Wgr>	MP:0001634,internal hemorrhage|MP:0002412,increased susceptibility to bacterial infection|MP:0002551,abnormal blood coagulation|MP:0003038,decreased myocardial infarct size|MP:0003292,melena|MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005464,abnormal platelet physiology|MP:0005606,increased bleeding time|MP:0006059,decreased susceptibility to ischemic brain injury|MP:0012359,increased partial thromboplastin time|MP:0031120,decreased susceptibility to induced thrombosis|MP:0031384,impaired blood-brain barrier function
MGI:5637366	Vwf<tm2.1Diac>	MP:0005376,homeostasis/metabolism phenotype|MP:0005606,increased bleeding time|MP:0020215,impaired blood coagulation
MGI:5637368	Vwf<tm3.1(VWF)Diac>	MP:0005606,increased bleeding time|MP:0020215,impaired blood coagulation
MGI:3527020	W10q10<M16i>	MP:0001260,increased body weight
MGI:3527034	W10q11<M16i>	MP:0001260,increased body weight
MGI:3527721	W10q12<M16i>	MP:0001260,increased body weight
MGI:3527062	W10q13<M16i>	MP:0001260,increased body weight
MGI:3527056	W10q14<M16i>	MP:0001260,increased body weight
MGI:3527727	W10q15<M16i>	MP:0001260,increased body weight
MGI:3527026	W10q16<M16i>	MP:0001260,increased body weight
MGI:3527709	W10q17<M16i>	MP:0001260,increased body weight
MGI:3527045	W10q18<M16i>	MP:0001260,increased body weight
MGI:3526990	W10q1<M16i>	MP:0001260,increased body weight
MGI:3527685	W10q2<M16i>	MP:0001260,increased body weight
MGI:3527004	W10q3<M16i>	MP:0001260,increased body weight
MGI:3527012	W10q4<M16i>	MP:0001260,increased body weight
MGI:3527671	W10q5<M16i>	MP:0001260,increased body weight
MGI:3526966	W10q6<M16i>	MP:0001260,increased body weight
MGI:3526970	W10q7<M16i>	MP:0001260,increased body weight
MGI:3527673	W10q8<M16i>	MP:0001260,increased body weight
MGI:3526980	W10q9<M16i>	MP:0001260,increased body weight
MGI:3578533	w3ga	MP:0001730,embryonic growth arrest|MP:0002085,abnormal embryonic tissue morphology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:3527047	W3q10<M16i>	MP:0001260,increased body weight
MGI:3527664	W3q11<M16i>	MP:0001260,increased body weight
MGI:3526962	W3q12<M16i>	MP:0001260,increased body weight
MGI:3526960	W3q13<M16i>	MP:0001260,increased body weight
MGI:3587872	W3q14<M16i>	MP:0001260,increased body weight
MGI:3587866	W3q15<M16i>	MP:0001260,increased body weight
MGI:3587864	W3q16<M16i>	MP:0001260,increased body weight
MGI:3527022	W3q17<M16i>	MP:0001260,increased body weight
MGI:3526982	W3q1<M16i>	MP:0001260,increased body weight
MGI:3526984	W3q2<M16i>	MP:0001260,increased body weight
MGI:3527032	W3q3<M16i>	MP:0001260,increased body weight
MGI:3527681	W3q4<M16i>	MP:0001260,increased body weight
MGI:3527060	W3q5<M16i>	MP:0001260,increased body weight
MGI:3527717	W3q6<M16i>	MP:0001260,increased body weight
MGI:3527715	W3q7<M16i>	MP:0001260,increased body weight
MGI:3527049	W3q8<M16i>	MP:0001260,increased body weight
MGI:3527014	W3q9<M16i>	MP:0001260,increased body weight
MGI:3527697	W6q10<M16i>	MP:0001260,increased body weight
MGI:3527719	W6q11<M16i>	MP:0001260,increased body weight
MGI:3527731	W6q12<M16i>	MP:0001260,increased body weight
MGI:3527018	W6q13<M16i>	MP:0001260,increased body weight
MGI:3526968	W6q14<M16i>	MP:0001260,increased body weight
MGI:3527016	W6q15<M16i>	MP:0001260,increased body weight
MGI:3527703	W6q16<M16i>	MP:0001260,increased body weight
MGI:3527043	W6q17<M16i>	MP:0001260,increased body weight
MGI:3526978	W6q1<M16i>	MP:0001260,increased body weight
MGI:3526986	W6q2<M16i>	MP:0001260,increased body weight
MGI:3527689	W6q3<M16i>	MP:0001260,increased body weight
MGI:3527030	W6q4<M16i>	MP:0001260,increased body weight
MGI:3527036	W6q5<M16i>	MP:0001260,increased body weight
MGI:3527669	W6q6<M16i>	MP:0001260,increased body weight
MGI:3527010	W6q7<M16i>	MP:0001260,increased body weight
MGI:3527677	W6q8<M16i>	MP:0001260,increased body weight
MGI:3527058	W6q9<M16i>	MP:0001260,increased body weight
MGI:3776123	wa1l	MP:0000410,waved hair|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0010771,integument phenotype
MGI:7587544	Wac<em2Cya>	MP:0001806,decreased IgM level|MP:0005093,decreased B cell proliferation|MP:0005397,hematopoietic system phenotype|MP:0008098,decreased plasma cell number|MP:0008099,abnormal plasma cell differentiation|MP:0008495,decreased IgG1 level|MP:0008497,decreased IgG2b level|MP:0008498,decreased IgG3 level|MP:0012167,abnormal epigenetic regulation of gene expression|MP:0020154,impaired humoral immune response
MGI:5637134	Wac<tm2b(EUCOMM)Wtsi>	MP:0000220,increased monocyte cell number|MP:0000438,abnormal cranium morphology|MP:0002599,increased mean platelet volume|MP:0002644,decreased circulating triglyceride level|MP:0002968,increased circulating alkaline phosphatase level|MP:0004613,fusion of vertebral arches|MP:0005012,decreased eosinophil cell number|MP:0008805,decreased circulating amylase level|MP:0011100,preweaning lethality, complete penetrance|MP:0013025,increased Ly6C low monocyte number
MGI:4818895	wad	MP:0000371,diluted coat color|MP:0001186,pigmentation phenotype
MGI:1856644	wal	MP:0000410,waved hair|MP:0000416,sparse hair|MP:0001200,thick skin|MP:0001247,dermal cyst
MGI:1889562	wam	MP:0000397,abnormal guard hair morphology|MP:0000583,long toenails|MP:0001212,skin lesions|MP:0001274,curly vibrissae|MP:0001278,kinked vibrissae|MP:0001511,disheveled coat|MP:0002075,abnormal coat/hair pigmentation|MP:0002098,abnormal vibrissa morphology
MGI:5551807	Wapl<tm1.2Jmpt>	MP:0011091,prenatal lethality, complete penetrance
MGI:7414361	Wapl<tm1.2Kpfe>	MP:0006204,embryonic lethality before implantation
MGI:2177210	Wap<tm1(cre)Arge>	MP:0002169,no abnormal phenotype detected
MGI:3584430	Wap<tm1Kuw>	MP:0004047,abnormal milk composition|MP:0005379,endocrine/exocrine gland phenotype
MGI:5548346	Wars1<tm1b(EUCOMM)Hmgu>	MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001406,abnormal gait|MP:0001417,decreased exploration in new environment|MP:0001523,impaired righting response|MP:0002135,abnormal kidney morphology|MP:0002591,decreased mean corpuscular volume|MP:0002753,dilated heart left ventricle|MP:0002941,increased circulating alanine transaminase level|MP:0002968,increased circulating alkaline phosphatase level|MP:0002981,increased liver weight|MP:0003131,increased erythrocyte cell number|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0005562,decreased mean corpuscular hemoglobin|MP:0008528,polycystic kidney|MP:0010067,increased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance|MP:0011897,decreased circulating unsaturated transferrin level
MGI:5791998	Wars2<mpc151H>	MP:0005330,cardiomyopathy|MP:0006325,impaired hearing|MP:0014143,decreased body fat mass
MGI:5468955	Wars2<tm1.1(KOMP)Vlcg>	MP:0000955,abnormal spinal cord morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2663235	Wasf1<Gt(VICTR37)1Kwak>	MP:0000607,abnormal hepatocyte morphology|MP:0000745,tremors|MP:0000746,weakness|MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0000788,abnormal cerebral cortex morphology|MP:0000913,abnormal brain development|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0003631,nervous system phenotype|MP:0005449,abnormal food intake|MP:0006254,thin cerebral cortex|MP:0008109,abnormal small intestinal microvillus morphology|MP:0008535,enlarged lateral ventricles|MP:0009413,skeletal muscle fiber atrophy|MP:0012468,decreased striatum size|MP:0012489,abnormal retrosplenial region morphology
MGI:2451310	Wasf1<tm1Jsco>	MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001405,impaired coordination|MP:0001458,abnormal object recognition memory|MP:0001463,abnormal spatial learning|MP:0001475,reduced long-term depression|MP:0001525,impaired balance|MP:0002082,postnatal lethality|MP:0002206,abnormal CNS synaptic transmission|MP:0002882,abnormal neuron morphology|MP:0002888,abnormal NMDA-mediated synaptic currents|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003008,enhanced long-term potentiation|MP:0004811,abnormal neuron physiology
MGI:3714530	Wasf1<tm2Jsco>	MP:0001463,abnormal spatial learning|MP:0002882,abnormal neuron morphology|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003008,enhanced long-term potentiation|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype
MGI:6148327	Wasf2<em1(IMPC)Rbrc>	MP:0000470,abnormal stomach morphology|MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance
MGI:3530906	Wasf2<Gt(OST91942)Lex>	MP:0011100,preweaning lethality, complete penetrance
MGI:2670152	Wasf2<tm1.1Fwa>	MP:0011091,prenatal lethality, complete penetrance
MGI:2670143	Wasf2<tm1Fwa>	MP:0000822,abnormal brain ventricle morphology|MP:0001688,abnormal somite development|MP:0001698,decreased embryo size|MP:0001914,hemorrhage|MP:0002085,abnormal embryonic tissue morphology|MP:0005370,liver/biliary system phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2670134	Wasf2<tm1Tta>	MP:0000260,abnormal angiogenesis|MP:0000295,trabecula carnea hypoplasia|MP:0001689,incomplete somite formation|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0001785,edema|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0002188,small heart|MP:0002925,abnormal cardiovascular development|MP:0003542,abnormal vascular endothelial cell development|MP:0003658,abnormal capillary morphology|MP:0003974,abnormal endocardium morphology|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004251,failure of heart looping|MP:0004784,abnormal anterior cardinal vein morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0005244,hemopericardium|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012253,abnormal intersomitic vessel morphology|MP:0012501,abnormal pericardial cavity morphology|MP:0020327,abnormal capillary branching pattern|MP:0020329,decreased capillary density
MGI:3848363	Wasf3<tm1Tta>	MP:0005397,hematopoietic system phenotype
MGI:5551785	Washc1<tm1.1Xya>	MP:0001672,abnormal embryo development|MP:0008260,abnormal autophagy|MP:0011092,embryonic lethality, complete penetrance|MP:0011199,abnormal amniotic cavity morphology|MP:0011200,abnormal extraembryonic coelom morphology|MP:0011202,abnormal ectoplacental cavity morphology|MP:0012556,increased cell death
MGI:5504472	Washc1<tm1.2Ddb>	MP:0011092,embryonic lethality, complete penetrance
MGI:5551786	Washc1<tm1Xya>	MP:0008260,abnormal autophagy
MGI:5692563	Washc2<tm2b(KOMP)Wtsi>	MP:0001711,abnormal placenta morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011100,preweaning lethality, complete penetrance
MGI:5707433	Washc3<tm1.1(KOMP)Vlcg>	MP:0002092,abnormal eye morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5910317	Washc4<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013279,increased fasting circulating glucose level|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:6783463	Washc4<em1Ssod>	MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001524,impaired limb coordination|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0003203,increased neuron apoptosis|MP:0005058,abnormal lysosome morphology|MP:0005059,lysosomal protein accumulation|MP:0008469,abnormal protein level|MP:0009456,impaired cued conditioning behavior|MP:0010540,long stride length|MP:0012319,fast extinction of fear memory|MP:0020357,abnormal excitatory synapse morphology
MGI:6256428	Washc5<tm1.2Cbee>	MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0005386,behavior/neurological phenotype|MP:0011092,embryonic lethality, complete penetrance
MGI:4435153	Washc5<tm1a(EUCOMM)Hmgu>	MP:0001262,decreased body weight|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:5910638	Washc5<tm1c(EUCOMM)Hmgu>	MP:0001186,pigmentation phenotype|MP:0002877,abnormal melanocyte morphology
MGI:2159338	Wasl<tm1.1Cgn>	MP:0001680,abnormal mesoderm development|MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0001726,abnormal allantois morphology|MP:0004180,failure of initiation of embryo turning|MP:0006323,abnormal extraembryonic mesoderm development|MP:0011091,prenatal lethality, complete penetrance|MP:0011202,abnormal ectoplacental cavity morphology
MGI:2651838	Wasl<tm1.1Sbs>	MP:0011091,prenatal lethality, complete penetrance
MGI:5620949	Wasl<tm1.1Ttha>	MP:0000160,kyphosis|MP:0000414,alopecia|MP:0000439,enlarged cranium|MP:0000440,domed cranium|MP:0000467,abnormal esophagus morphology|MP:0000781,decreased corpus callosum size|MP:0000788,abnormal cerebral cortex morphology|MP:0000809,absent hippocampus|MP:0000820,abnormal choroid plexus morphology|MP:0000825,dilated lateral ventricle|MP:0000829,dilated fourth ventricle|MP:0000917,obstructive hydrocephaly|MP:0001192,scaly skin|MP:0001194,dermatitis|MP:0001211,wrinkled skin|MP:0001219,thick epidermis|MP:0001222,epidermal hyperplasia|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001406,abnormal gait|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002412,increased susceptibility to bacterial infection|MP:0002796,impaired skin barrier function|MP:0002958,cerebral aqueductal stenosis|MP:0003354,astrocytosis|MP:0003853,dry skin|MP:0004102,abnormal dorsal striatum morphology|MP:0004174,abnormal spine curvature|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004548,dilated esophagus|MP:0004947,skin inflammation|MP:0004950,abnormal brain vasculature morphology|MP:0005202,lethargy|MP:0005238,increased brain size|MP:0005537,abnormal cerebral aqueduct morphology|MP:0006254,thin cerebral cortex|MP:0008553,increased circulating tumor necrosis factor level|MP:0008596,increased circulating interleukin-6 level|MP:0008614,increased circulating interleukin-17 level|MP:0008638,increased circulating interleukin-1 alpha level|MP:0009583,increased keratinocyte proliferation|MP:0009931,abnormal skin appearance|MP:0010152,abnormal brain ependyma morphology|MP:0010209,abnormal circulating chemokine level|MP:0011057,absent brain ependyma motile cilia|MP:0011085,postnatal lethality, complete penetrance|MP:0011380,enlarged brain ventricles|MP:0012003,abnormal septum of telencephalon morphology
MGI:2159337	Wasl<tm1Cgn>	MP:0002169,no abnormal phenotype detected
MGI:2651836	Wasl<tm1Sbs>	MP:0000930,wavy neural tube|MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0004086,absent heartbeat|MP:0004188,delayed embryo turning|MP:0004937,dilated heart|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011518,abnormal cell chemotaxis|MP:0011704,decreased fibroblast proliferation
MGI:3760279	Wasl<tm2Sbs>	MP:0000524,decreased renal tubule number|MP:0003446,renal hypoplasia|MP:0004505,decreased renal glomerulus number
MGI:5319483	Was<tm1.1Ldn>	MP:0002458,abnormal B cell number|MP:0002459,abnormal B cell physiology|MP:0002494,increased IgM level|MP:0002827,abnormal renal corpuscle morphology|MP:0003725,increased autoantibody level|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004829,increased anti-chromatin antibody level|MP:0005017,decreased B cell number|MP:0005153,abnormal B cell proliferation|MP:0008097,increased plasma cell number|MP:0008174,decreased follicular B cell number|MP:0008177,increased germinal center B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008211,decreased mature B cell number
MGI:4362083	Was<tm1Itl>	MP:0000218,increased leukocyte cell number|MP:0000693,spleen hyperplasia|MP:0002376,abnormal dendritic cell physiology|MP:0002619,abnormal lymphocyte morphology|MP:0003179,thrombocytopenia|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005014,increased B cell number|MP:0005018,decreased T cell number|MP:0005095,decreased T cell proliferation|MP:0005461,abnormal dendritic cell morphology|MP:0008045,decreased NK cell number|MP:0008173,increased follicular B cell number|MP:0009338,increased splenocyte number
MGI:3028420	Was<tm1Kas>	MP:0001823,thymus hypoplasia|MP:0002223,lymphoid hypoplasia|MP:0003179,thrombocytopenia|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number
MGI:1861707	Was<tm1Sbs>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000359,abnormal mast cell morphology|MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0000491,crypts of Lieberkuhn abscesses|MP:0000693,spleen hyperplasia|MP:0001541,abnormal osteoclast physiology|MP:0002006,neoplasm|MP:0002135,abnormal kidney morphology|MP:0002376,abnormal dendritic cell physiology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002407,abnormal double-negative T cell morphology|MP:0002408,abnormal double-positive T cell morphology|MP:0002417,abnormal megakaryocyte morphology|MP:0002423,abnormal mast cell physiology|MP:0002455,abnormal dendritic cell antigen presentation|MP:0002459,abnormal B cell physiology|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0002619,abnormal lymphocyte morphology|MP:0002743,glomerulonephritis|MP:0002816,colitis|MP:0002827,abnormal renal corpuscle morphology|MP:0002962,increased urine protein level|MP:0003009,abnormal cytokine secretion|MP:0003091,abnormal cell migration|MP:0003179,thrombocytopenia|MP:0003725,increased autoantibody level|MP:0003850,abnormal thymocyte activation|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004771,increased anti-single stranded DNA antibody level|MP:0004829,increased anti-chromatin antibody level|MP:0005014,increased B cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0005461,abnormal dendritic cell morphology|MP:0008045,decreased NK cell number|MP:0008097,increased plasma cell number|MP:0008173,increased follicular B cell number|MP:0008177,increased germinal center B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008211,decreased mature B cell number|MP:0008396,abnormal osteoclast differentiation|MP:0009338,increased splenocyte number|MP:0011339,abnormal glomerular mesangium morphology|MP:0011353,expanded mesangial matrix|MP:0011427,increased mesangial cell number|MP:0020519,renal glomerular immunoglobulin deposits
MGI:4362085	Was<tm2Itl>	MP:0000218,increased leukocyte cell number|MP:0002376,abnormal dendritic cell physiology|MP:0002619,abnormal lymphocyte morphology|MP:0003179,thrombocytopenia|MP:0004762,increased anti-double stranded DNA antibody level|MP:0005014,increased B cell number|MP:0005018,decreased T cell number|MP:0005095,decreased T cell proliferation|MP:0005461,abnormal dendritic cell morphology|MP:0008045,decreased NK cell number|MP:0008173,increased follicular B cell number|MP:0009338,increased splenocyte number
MGI:3609349	Wbcq1<C57BLKS/J>	MP:0000218,increased leukocyte cell number
MGI:3609358	Wbcq2<SM/J>	MP:0000218,increased leukocyte cell number
MGI:3609368	Wbcq3<SM/J>	MP:0000218,increased leukocyte cell number
MGI:3609351	Wbcq4<NZW/LacJ>	MP:0000218,increased leukocyte cell number
MGI:3609353	Wbcq5<NZW/LacJ>	MP:0000218,increased leukocyte cell number
MGI:3609376	Wbcq6<NZW/LacJ>	MP:0000218,increased leukocyte cell number
MGI:3609375	Wbcq6<SM/J>	MP:0000218,increased leukocyte cell number
MGI:3036211	Wbct	MP:0002940,variable body spotting
MGI:6509996	Wbp11<em1Gcha>	MP:0000111,cleft palate|MP:0000150,abnormal rib morphology|MP:0000467,abnormal esophagus morphology|MP:0000601,small liver|MP:0000774,decreased brain size|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney|MP:0003007,ectopic thymus|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003345,decreased rib number|MP:0003641,small lung|MP:0003984,embryonic growth retardation|MP:0004600,abnormal vertebral transverse process morphology|MP:0004620,cervical vertebral fusion|MP:0004623,thoracic vertebral fusion|MP:0004647,decreased lumbar vertebrae number|MP:0004921,decreased placenta weight|MP:0005385,cardiovascular system phenotype|MP:0008832,hemivertebra|MP:0008922,abnormal cervical rib|MP:0008970,choanal atresia|MP:0009431,decreased fetal weight|MP:0010082,sternebra fusion|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011854,cerebral edema|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:7541412	Wbp1<em1(IMPC)Tcp>	MP:0000220,increased monocyte cell number|MP:0002092,abnormal eye morphology|MP:0002792,abnormal retina vasculature morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:5511627	Wbp1l<tm2a(EUCOMM)Hmgu>	MP:0002403,abnormal pre-B cell morphology|MP:0003396,abnormal embryonic hematopoiesis|MP:0004809,increased hematopoietic stem cell number|MP:0004978,decreased B-1 B cell number|MP:0005017,decreased B cell number|MP:0005387,immune system phenotype|MP:0008126,increased dendritic cell number|MP:0008181,increased marginal zone B cell number|MP:0008208,decreased pro-B cell number|MP:0008209,decreased pre-B cell number
MGI:5692573	Wbp1l<tm2b(EUCOMM)Hmgu>	MP:0000195,decreased circulating calcium level|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0002966,decreased circulating alkaline phosphatase level|MP:0005333,decreased heart rate|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level|MP:0009142,decreased prepulse inhibition|MP:0010506,prolonged RR interval|MP:0010570,prolonged ST segment|MP:0011239,abnormal skin coloration|MP:0011960,abnormal eye anterior chamber depth
MGI:6458551	Wbp1l<tm2c(EUCOMM)Hmgu>	MP:0009278,abnormal bone marrow cell physiology
MGI:5882390	Wbp2nl<tm1.1Osb>	MP:0005389,reproductive system phenotype
MGI:4847848	Wbp2<tm2a(EUCOMM)Wtsi>	MP:0000042,abnormal organ of Corti morphology|MP:0000218,increased leukocyte cell number|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004740,sensorineural hearing loss|MP:0004746,abnormal cochlear IHC afferent innervation pattern|MP:0004747,abnormal cochlear OHC afferent innervation pattern|MP:0004924,abnormal behavior|MP:0005377,hearing/vestibular/ear phenotype|MP:0005419,decreased circulating serum albumin level|MP:0006358,absent pinna reflex|MP:0006388,abnormal auditory summating potential|MP:0008805,decreased circulating amylase level|MP:0010088,decreased circulating fructosamine level|MP:0011966,abnormal auditory brainstem response waveform shape|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014740,increased auditory brainstem response wave peak latency|MP:0031671,decreased auditory brainstem response wave amplitude
MGI:1860129	Wc	MP:0000367,abnormal coat/ hair morphology|MP:0000371,diluted coat color|MP:0000410,waved hair|MP:0000420,ruffled hair|MP:0001192,scaly skin|MP:0001279,wavy vibrissae|MP:0001675,abnormal ectoderm development|MP:0003815,hairless|MP:0003853,dry skin|MP:0009931,abnormal skin appearance|MP:0011092,embryonic lethality, complete penetrance
MGI:4834171	Wc2	MP:0000410,waved hair
MGI:5308100	wccw	MP:0000410,waved hair|MP:0001274,curly vibrissae|MP:0005389,reproductive system phenotype
MGI:1857089	wd	MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0008770,decreased survivor rate|MP:0008913,weaving
MGI:7426084	Wdcp<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0001914,hemorrhage|MP:0004258,abnormal placenta size|MP:0011100,preweaning lethality, complete penetrance
MGI:6283594	Wdfy1<em1(IMPC)J>	MP:0002626,increased heart rate|MP:0004738,abnormal auditory brainstem response|MP:0010053,decreased grip strength|MP:0010507,shortened RR interval
MGI:6695933	Wdfy2<tm1.1Wgz>	MP:0001552,increased circulating triglyceride level|MP:0002079,increased circulating insulin level|MP:0002628,hepatic steatosis|MP:0002981,increased liver weight|MP:0005178,increased circulating cholesterol level|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0009355,increased liver triglyceride level|MP:0010027,increased liver cholesterol level|MP:0010398,decreased liver glycogen level|MP:0020102,increased hepatic glucose production
MGI:5795594	Wdfy3<disc>	MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0000859,abnormal somatosensory cortex morphology|MP:0002169,no abnormal phenotype detected|MP:0002741,small olfactory bulb|MP:0003077,abnormal cell cycle|MP:0003232,abnormal forebrain development|MP:0003424,premature neuronal precursor differentiation|MP:0004274,abnormal embryonic/fetal subventricular zone morphology|MP:0004276,abnormal medial ganglionic eminence morphology|MP:0004277,abnormal lateral ganglionic eminence morphology|MP:0004948,abnormal neuronal precursor proliferation|MP:0004981,decreased neuronal precursor cell number|MP:0005384,cellular phenotype|MP:0006009,abnormal neuronal migration|MP:0006254,thin cerebral cortex|MP:0008443,absent subplate|MP:0008457,abnormal cortical intermediate zone morphology|MP:0008535,enlarged lateral ventricles|MP:0008536,enlarged third ventricle|MP:0008547,abnormal neocortex morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011724,ectopic cortical neuron|MP:0012139,increased forebrain size|MP:0014558,decreased cortical ventricular zone thickness|MP:0020067,increased neocortex size|MP:0020389,increased radial glial cell number
MGI:6276846	Wdfy3<em1(IMPC)Mbp>	MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002989,small kidney|MP:0003743,abnormal facial morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:4455365	Wdfy3<tm1a(KOMP)Mbp>	MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0003232,abnormal forebrain development|MP:0006009,abnormal neuronal migration|MP:0006254,thin cerebral cortex|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008547,abnormal neocortex morphology|MP:0011089,perinatal lethality, complete penetrance|MP:0011724,ectopic cortical neuron
MGI:5795593	Wdfy3<tm1c(KOMP)Mbp>	MP:0002169,no abnormal phenotype detected
MGI:6433103	Wdfy3<Tn(pb-Act-RFP)1.1Zhu>	MP:0000266,abnormal heart morphology|MP:0000267,abnormal heart development|MP:0000273,overriding aortic valve|MP:0000280,thin ventricular wall|MP:0000284,double outlet right ventricle|MP:0001575,cyanosis|MP:0001785,edema|MP:0003717,pallor|MP:0004067,abnormal trabecula carnea morphology|MP:0005384,cellular phenotype|MP:0008022,dilated heart ventricle|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0009431,decreased fetal weight|MP:0009703,decreased birth body size|MP:0010418,perimembraneous ventricular septal defect|MP:0011089,perinatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5775775	Wdfy4<em1(IMPC)J>	MP:0000208,decreased hematocrit|MP:0002875,decreased erythrocyte cell number
MGI:7545162	Wdfy4<em1Jkln>	MP:0003721,increased tumor growth/size|MP:0005387,immune system phenotype|MP:0008127,decreased dendritic cell number
MGI:6257543	Wdhd1<em1(IMPC)Bay>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6266825	Wdhd1<em1(IMPC)Rbrc>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000681,abnormal thyroid gland morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003917,increased kidney weight|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005355,enlarged thyroid gland|MP:0011100,preweaning lethality, complete penetrance
MGI:6726123	Wdhd1<em1Isyu>	MP:0000352,decreased cell proliferation|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0006042,increased apoptosis|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:8270932	Wdhd1<em1Wezhu>	MP:0004501,increased incidence of tumors by UV-induction|MP:0014762,impaired base-excision repair
MGI:5558098	Wdpcp<cys40>	MP:0000111,cleft palate|MP:0000267,abnormal heart development|MP:0000477,abnormal intestine morphology|MP:0000562,polydactyly|MP:0001293,anophthalmia|MP:0002622,abnormal cochlear hair cell morphology|MP:0002633,persistent truncus arteriosus|MP:0003125,abnormal septation of the cloaca|MP:0003321,tracheoesophageal fistula|MP:0003675,kidney cyst|MP:0004017,duplex kidney|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004754,abnormal kidney collecting duct morphology|MP:0005380,embryo phenotype|MP:0005388,respiratory system phenotype|MP:0005621,abnormal cell physiology|MP:0006130,pulmonary valve atresia|MP:0008797,facial cleft|MP:0010412,atrioventricular septal defect|MP:0010454,abnormal truncus arteriosus septation|MP:0011060,abnormal kinocilium morphology|MP:0011682,renal glomerulus cyst|MP:0011707,impaired fibroblast cell migration|MP:0011865,abnormal podocyte motility|MP:0013202,abnormal cilium morphology
MGI:5558100	Wdpcp<tm1.1Clo>	MP:0000111,cleft palate|MP:0000477,abnormal intestine morphology|MP:0000562,polydactyly|MP:0001293,anophthalmia|MP:0003675,kidney cyst|MP:0004017,duplex kidney|MP:0006126,abnormal cardiac outflow tract development|MP:0011089,perinatal lethality, complete penetrance
MGI:6152678	Wdr11<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000955,abnormal spinal cord morphology|MP:0001293,anophthalmia|MP:0001404,no spontaneous movement|MP:0001417,decreased exploration in new environment|MP:0001925,male infertility|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0002135,abnormal kidney morphology|MP:0002188,small heart|MP:0003068,enlarged kidney|MP:0005292,improved glucose tolerance|MP:0005313,absent adrenal gland|MP:0010067,increased red blood cell distribution width|MP:0011999,abnormal tail length
MGI:4946808	Wdr11<Gt(Ayu21-KBW205)Imeg>	MP:0000266,abnormal heart morphology|MP:0000284,double outlet right ventricle|MP:0000428,abnormal craniofacial morphology|MP:0000433,microcephaly|MP:0000547,short limbs|MP:0000564,syndactyly|MP:0000783,abnormal forebrain morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000914,exencephaly|MP:0001120,abnormal uterus morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001134,absent corpus luteum|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001261,obese|MP:0001286,abnormal eye development|MP:0001293,anophthalmia|MP:0001732,postnatal growth retardation|MP:0001891,hydrocephaly|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0001927,abnormal estrous cycle|MP:0001938,delayed sexual maturation|MP:0002233,abnormal nose morphology|MP:0002637,small uterus|MP:0002739,abnormal olfactory bulb development|MP:0002981,increased liver weight|MP:0003550,short perineum|MP:0003743,abnormal facial morphology|MP:0003816,abnormal pituitary gland development|MP:0003817,abnormal pituitary diverticulum morphology|MP:0003984,embryonic growth retardation|MP:0004163,abnormal adenohypophysis morphology|MP:0004261,abnormal embryonic neuroepithelium morphology|MP:0004391,abnormal respiratory conducting tube morphology|MP:0004592,small mandible|MP:0004624,abnormal thoracic cage morphology|MP:0005157,holoprosencephaly|MP:0005163,cyclopia|MP:0005188,small penis|MP:0005458,increased percent body fat/body weight|MP:0005508,abnormal skeleton morphology|MP:0005536,decreased Leydig cell number|MP:0005578,teratozoospermia|MP:0005645,abnormal hypothalamus physiology|MP:0006009,abnormal neuronal migration|MP:0006087,increased body mass index|MP:0006197,ocular hypotelorism|MP:0006305,abnormal optic eminence morphology|MP:0006306,abnormal nasal pit morphology|MP:0008770,decreased survivor rate|MP:0008940,delayed balanopreputial separation|MP:0009203,external male genitalia hypoplasia|MP:0009229,abnormal neurohypophysis median eminence morphology|MP:0009903,abnormal medial nasal prominence morphology|MP:0009908,protruding tongue|MP:0010059,olfactory bulb hypoplasia|MP:0010402,ventricular septal defect|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011130,absent tertiary ovarian follicles|MP:0011281,abnormal olfactory epithelium cilium morphology|MP:0011380,enlarged brain ventricles|MP:0013203,abnormal primary cilium morphology|MP:0013350,Rathke's pouch hypoplasia|MP:0014592,decreased gonadotropin-releasing hormone neuron number|MP:0014604,hemorrhagic ovary cyst|MP:0020137,decreased bone mineralization|MP:0030095,abnormal midface morphology|MP:0030198,nasal septum hypoplasia|MP:0031116,microvesicular hepatic steatosis|MP:0031239,increased atretic ovarian follicle number
MGI:5445742	Wdr12<tm1.1(KOMP)Vlcg>	MP:0002075,abnormal coat/hair pigmentation|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5694710	Wdr13<tm1Kuma>	MP:0001260,increased body weight|MP:0002079,increased circulating insulin level|MP:0005292,improved glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005491,pancreatic islet hyperplasia|MP:0005560,decreased circulating glucose level|MP:0005658,increased susceptibility to diet-induced obesity|MP:0009108,increased pancreas weight|MP:0009118,increased white fat cell size|MP:0009285,increased gonadal fat pad weight|MP:0009288,increased epididymal fat pad weight|MP:0011819,increased pancreatic beta cell proliferation
MGI:6259989	Wdr18<em1(IMPC)J>	MP:0001513,limb grasping|MP:0011100,preweaning lethality, complete penetrance
MGI:5315748	Wdr19<dmhd>	MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011685,abnormal limb paddle morphology|MP:0013202,abnormal cilium morphology
MGI:5287037	Wdr19<TgTn(sb-cHS4,Tyr)2315A-2Ove>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5315747	Wdr19<twto>	MP:0000030,abnormal tympanic ring morphology|MP:0000088,short mandible|MP:0000091,short premaxilla|MP:0000097,short maxilla|MP:0000111,cleft palate|MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000153,rib bifurcation|MP:0000154,rib fusion|MP:0000413,polyphalangy|MP:0000438,abnormal cranium morphology|MP:0000455,abnormal maxilla morphology|MP:0000562,polydactyly|MP:0000568,ectopic digits|MP:0000737,abnormal myotome development|MP:0000914,exencephaly|MP:0001293,anophthalmia|MP:0001688,abnormal somite development|MP:0002728,absent tibia|MP:0002820,abnormal premaxilla morphology|MP:0003935,abnormal craniofacial development|MP:0004174,abnormal spine curvature|MP:0004206,abnormal dermomyotome development|MP:0004320,split sternum|MP:0004376,absent frontal bone|MP:0004385,interparietal bone hypoplasia|MP:0004420,parietal bone hypoplasia|MP:0004443,absent supraoccipital bone|MP:0004596,abnormal mandibular angle morphology|MP:0004672,short ribs|MP:0005249,abnormal palatine bone morphology|MP:0006279,abnormal limb development|MP:0008277,abnormal sternum ossification|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009890,cleft secondary palate|MP:0009895,decreased palatine bone horizontal plate size|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011261,abnormal limb mesenchyme morphology|MP:0011685,abnormal limb paddle morphology|MP:0013202,abnormal cilium morphology|MP:0030066,short face|MP:0031448,bilateral cleft upper lip
MGI:3784953	Wdr1<Gt(XN462)Byg>	MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance
MGI:2671870	Wdr1<rede>	MP:0000219,increased neutrophil cell number|MP:0000228,abnormal thrombopoiesis|MP:0000245,abnormal erythropoiesis|MP:0001222,epidermal hyperplasia|MP:0001541,abnormal osteoclast physiology|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0001846,increased inflammatory response|MP:0001849,ear inflammation|MP:0002417,abnormal megakaryocyte morphology|MP:0002599,increased mean platelet volume|MP:0003179,thrombocytopenia|MP:0003405,abnormal platelet shape|MP:0004720,abnormal platelet morphology|MP:0004721,abnormal platelet dense granule morphology|MP:0004947,skin inflammation|MP:0004984,increased osteoclast cell number|MP:0005606,increased bleeding time|MP:0008254,increased megakaryocyte cell number|MP:0008720,impaired neutrophil chemotaxis|MP:0014060,abnormal platelet alpha-granule morphology
MGI:5636587	Wdr1<tm1.1Zzy>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0000281,abnormal interventricular septum morphology|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002833,increased heart weight|MP:0003233,prolonged QT interval|MP:0003921,abnormal heart left ventricle morphology|MP:0004071,prolonged P wave|MP:0004564,increased myocardial fiber size|MP:0005329,abnormal myocardium layer morphology|MP:0005333,decreased heart rate|MP:0010505,abnormal T wave|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010570,prolonged ST segment|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014730,abnormal myocardial fiber myofibril morphology|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5692617	Wdr1<tm1b(EUCOMM)Hmgu>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7520408	Wdr24<em1Jiguo>	MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0013243,abnormal carbohydrate metabolism
MGI:7520409	Wdr24<em2Jiguo>	MP:0001698,decreased embryo size|MP:0014257,embryonic lethality prior to tooth bud stage, complete penetrance
MGI:5635475	Wdr24<tm1b(KOMP)Mbp>	MP:0000208,decreased hematocrit|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6376207	Wdr25<em1(IMPC)J>	MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0009331,absent primitive node|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:7426085	Wdr27<em1(IMPC)Ccpcz>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001325,abnormal retina morphology|MP:0002953,thick ventricular wall|MP:0003394,increased cardiac output|MP:0005179,decreased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0008810,increased circulating iron level|MP:0010067,increased red blood cell distribution width|MP:0010574,dilated aorta
MGI:6857759	Wdr33<em1(IMPC)Tcp>	MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:7494200	Wdr35<em1(IMPC)Hmgu>	MP:0002135,abnormal kidney morphology
MGI:5500169	Wdr35<yeti>	MP:0000151,absent ribs|MP:0000270,abnormal heart tube morphology|MP:0001178,pulmonary hypoplasia|MP:0001785,edema|MP:0003321,tracheoesophageal fistula|MP:0003924,diaphragmatic hernia|MP:0004083,polysyndactyly|MP:0004132,absent embryonic cilia|MP:0004188,delayed embryo turning|MP:0004190,abnormal direction of embryo turning|MP:0004252,abnormal direction of heart looping|MP:0009768,impaired somite development|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5603579	Wdr36<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0004151,decreased circulating iron level|MP:0005560,decreased circulating glucose level|MP:0011100,preweaning lethality, complete penetrance|MP:0013279,increased fasting circulating glucose level|MP:0013292,embryonic lethality prior to organogenesis
MGI:4868240	Wdr36<tm1Erta>	MP:0002663,absent blastocoele|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:4452651	Wdr37<tm1a(KOMP)Wtsi>	MP:0000160,kyphosis|MP:0000194,increased circulating calcium level|MP:0000221,decreased leukocyte cell number|MP:0001262,decreased body weight|MP:0002079,increased circulating insulin level|MP:0002968,increased circulating alkaline phosphatase level|MP:0004174,abnormal spine curvature|MP:0004609,vertebral fusion|MP:0004613,fusion of vertebral arches|MP:0010053,decreased grip strength|MP:0010123,increased bone mineral content
MGI:7435756	Wdr38<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0000745,tremors|MP:0001488,increased startle reflex|MP:0002098,abnormal vibrissa morphology|MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin
MGI:4362309	Wdr3<tm1a(KOMP)Wtsi>	MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype|MP:0005391,vision/eye phenotype|MP:0011091,prenatal lethality, complete penetrance|MP:0031391,increased locomotor activity
MGI:6109968	Wdr41<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001556,increased circulating HDL cholesterol level|MP:0002591,decreased mean corpuscular volume|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010053,decreased grip strength
MGI:6272389	Wdr41<m1Btlr>	MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008537,increased susceptibility to induced colitis|MP:0008560,increased tumor necrosis factor secretion|MP:0008647,increased circulating interleukin-12b level
MGI:6272390	Wdr41<m2Btlr>	MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008560,increased tumor necrosis factor secretion
MGI:4127278	Wdr44<Gt(RRE018)Byg>	MP:0002169,no abnormal phenotype detected
MGI:6257775	Wdr45b<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6479738	Wdr45b<tm1c(EUCOMM)Hmgu>	MP:0000876,Purkinje cell degeneration|MP:0000880,decreased Purkinje cell number|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0001524,impaired limb coordination|MP:0001732,postnatal growth retardation|MP:0002152,abnormal brain morphology|MP:0005384,cellular phenotype|MP:0005404,abnormal axon morphology|MP:0011632,dilated mitochondrion|MP:0011743,abnormal Golgi apparatus morphology|MP:0014185,cerebellum atrophy|MP:0020365,increased brain iron level
MGI:5779851	Wdr45<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0001486,abnormal startle reflex|MP:0001513,limb grasping|MP:0001556,increased circulating HDL cholesterol level|MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0003795,abnormal bone structure|MP:0004738,abnormal auditory brainstem response|MP:0010124,decreased bone mineral content
MGI:6720362	Wdr45<em1Wrst>	MP:0000218,increased leukocyte cell number|MP:0000745,tremors|MP:0000875,abnormal cerebellar Purkinje cell layer|MP:0001260,increased body weight|MP:0001326,retina degeneration|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002229,neurodegeneration|MP:0002642,anisocytosis|MP:0002644,decreased circulating triglyceride level|MP:0003131,increased erythrocyte cell number|MP:0003354,astrocytosis|MP:0005293,impaired glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005376,homeostasis/metabolism phenotype|MP:0005397,hematopoietic system phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005543,decreased cornea thickness|MP:0005559,increased circulating glucose level|MP:0005564,increased hemoglobin content|MP:0005567,decreased circulating total protein level|MP:0006325,impaired hearing|MP:0008805,decreased circulating amylase level|MP:0008810,increased circulating iron level|MP:0008842,lipofuscinosis|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011448,decreased dopaminergic neuron number|MP:0011584,increased alkaline phosphatase activity|MP:0011897,decreased circulating unsaturated transferrin level|MP:0011965,decreased total retina thickness|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0011971,increased circulating lactate dehydrogenase level|MP:0013404,decreased circulating lactate level|MP:0020396,abnormal social recognition|MP:0031213,increased eye anterior chamber depth|MP:0031391,increased locomotor activity
MGI:6385188	Wdr45<tm1Beij>	MP:0000921,demyelination|MP:0001405,impaired coordination|MP:0001473,reduced long-term potentiation|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003354,astrocytosis|MP:0005386,behavior/neurological phenotype|MP:0005405,axon degeneration|MP:0008025,brain vacuoles|MP:0008428,abnormal spatial working memory|MP:0009454,impaired contextual conditioning behavior|MP:0010047,axonal spheroids|MP:0012307,impaired spatial learning|MP:0030940,impaired autophagy
MGI:4433065	Wdr47<tm1a(EUCOMM)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001513,limb grasping|MP:0002874,decreased hemoglobin content|MP:0002968,increased circulating alkaline phosphatase level|MP:0004924,abnormal behavior|MP:0006358,absent pinna reflex|MP:0010053,decreased grip strength
MGI:3877670	Wdr48<Gt(CSD197)Byg>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0001923,reduced female fertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0003205,testicular atrophy|MP:0003984,embryonic growth retardation|MP:0004901,decreased male germ cell number|MP:0005431,decreased oocyte number|MP:0005501,abnormal skin physiology|MP:0005508,abnormal skeleton morphology|MP:0009674,decreased birth weight|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:6341828	Wdr49<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0002060,abnormal skin morphology|MP:0002981,increased liver weight
MGI:7859739	Wdr4<em1Bcgen>	MP:0000547,short limbs|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0003109,short femur|MP:0004016,decreased bone mass|MP:0004351,short humerus|MP:0004924,abnormal behavior|MP:0004989,decreased osteoblast cell number|MP:0009346,decreased trabecular bone thickness|MP:0010879,decreased trabecular bone volume|MP:0010962,decreased compact bone mass|MP:0014101,decreased chondrocyte proliferation|MP:0020010,decreased bone mineral density of femur|MP:0020040,decreased bone ossification
MGI:6114160	Wdr4<tm1.1Hsi>	MP:0000913,abnormal brain development|MP:0001634,internal hemorrhage|MP:0008932,abnormal embryonic tissue physiology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:6394015	Wdr53<em1(IMPC)J>	MP:0001556,increased circulating HDL cholesterol level|MP:0002608,increased hematocrit|MP:0003131,increased erythrocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0005560,decreased circulating glucose level|MP:0005568,increased circulating total protein level
MGI:3580272	Wdr55<tm1Matn>	MP:0011092,embryonic lethality, complete penetrance
MGI:5548803	Wdr59<tm1b(EUCOMM)Wtsi>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0001697,abnormal embryo size|MP:0002080,prenatal lethality|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:6156494	Wdr62<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001147,small testis|MP:0001157,small seminal vesicle|MP:0001297,microphthalmia|MP:0001925,male infertility|MP:0002989,small kidney|MP:0005633,increased circulating sodium level|MP:0009142,decreased prepulse inhibition
MGI:3876681	Wdr62<Gt(AF0003)Wtsi>	MP:0000433,microcephaly|MP:0001921,reduced fertility|MP:0003241,loss of cortex neurons|MP:0003633,abnormal nervous system physiology|MP:0004046,abnormal mitosis|MP:0004201,fetal growth retardation|MP:0004981,decreased neuronal precursor cell number|MP:0006254,thin cerebral cortex|MP:0008974,proportional dwarf|MP:0009760,abnormal mitotic spindle morphology|MP:0009762,abnormal mitotic spindle assembly checkpoint|MP:0012556,increased cell death
MGI:6388423	Wdr62<tm1.1Jfch>	MP:0000352,decreased cell proliferation|MP:0000774,decreased brain size|MP:0002175,decreased brain weight|MP:0003077,abnormal cell cycle|MP:0003424,premature neuronal precursor differentiation|MP:0004981,decreased neuronal precursor cell number|MP:0012504,increased forebrain apoptosis|MP:0013203,abnormal primary cilium morphology|MP:0020066,abnormal neocortex size
MGI:5511671	Wdr62<tm3a(EUCOMM)Hmgu>	MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004805,absent oocytes|MP:0004852,decreased testis weight|MP:0005169,abnormal male meiosis|MP:0005378,growth/size/body region phenotype|MP:0005578,teratozoospermia|MP:0006254,thin cerebral cortex|MP:0008458,abnormal cortical ventricular zone morphology|MP:0008547,abnormal neocortex morphology|MP:0009230,abnormal sperm head morphology|MP:0020451,decreased sperm progressive motility|MP:0031375,abnormal manchette disassembly
MGI:7426086	Wdr64<em1(IMPC)Bay>	MP:0020870,decreased thigmotaxis
MGI:6195848	Wdr6<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001513,limb grasping|MP:0002075,abnormal coat/hair pigmentation|MP:0005292,improved glucose tolerance|MP:0010507,shortened RR interval|MP:0013279,increased fasting circulating glucose level
MGI:6259591	Wdr70<em1(IMPC)J>	MP:0005655,increased aggression
MGI:4363147	Wdr72<tm1a(KOMP)Wtsi>	MP:0001262,decreased body weight|MP:0002576,abnormal enamel morphology|MP:0002577,reduced enamel thickness|MP:0002650,abnormal ameloblast morphology|MP:0003631,nervous system phenotype|MP:0005367,renal/urinary system phenotype|MP:0030450,abnormal enamel mineralization
MGI:6294116	Wdr73<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0001727,abnormal embryo implantation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6268399	Wdr74<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:4001984	Wdr76<Gt(IST11346A1)Tigm>	MP:0002169,no abnormal phenotype detected
MGI:3798419	Wdr77<tm1Zwan>	MP:0000659,prostate gland hyperplasia|MP:0001167,prostate gland epithelial hyperplasia|MP:0001168,abnormal prostate gland epithelium morphology|MP:0002006,neoplasm|MP:0011092,embryonic lethality, complete penetrance
MGI:4821121	Wdr77<tm2Zwan>	MP:0000666,decreased prostate gland duct number|MP:0001163,abnormal prostate gland anterior lobe morphology|MP:0001167,prostate gland epithelial hyperplasia|MP:0001168,abnormal prostate gland epithelium morphology|MP:0002169,no abnormal phenotype detected|MP:0002774,small prostate gland|MP:0003607,abnormal prostate gland physiology|MP:0009380,abnormal prostate gland ventral lobe morphology|MP:0009381,abnormal prostate gland dorsolateral lobe morphology|MP:0009734,abnormal prostate gland duct morphology|MP:0009735,abnormal prostate gland development|MP:0009736,abnormal prostate gland branching morphogenesis
MGI:5788768	Wdr81<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001486,abnormal startle reflex|MP:0001529,abnormal vocalization|MP:0005565,increased blood urea nitrogen level|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:6269421	Wdr81<m1Btlr>	MP:0001262,decreased body weight|MP:0001393,ataxia
MGI:2671731	Wdr81<nur5>	MP:0000745,tremors|MP:0000880,decreased Purkinje cell number|MP:0001263,weight loss|MP:0001327,decreased retina photoreceptor cell number|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001407,short stride length|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008924,decreased cerebellar granule cell number|MP:0011630,increased mitochondrial size|MP:0011636,disorganized mitochondrial cristae|MP:0011965,decreased total retina thickness|MP:0014345,abnormal neuron mitochondrial morphology
MGI:4367006	Wdr83<tm1Guwo>	MP:0000259,abnormal vascular development|MP:0001712,abnormal placenta development|MP:0001859,kidney inflammation|MP:0004042,decreased susceptibility to kidney reperfusion injury|MP:0005554,decreased circulating creatinine level|MP:0005566,decreased blood urea nitrogen level|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011372,decreased renal tubule apoptosis
MGI:5563398	Wdr89<m1Anu>	MP:0005387,immune system phenotype
MGI:4944354	Wdr89<tm1a(KOMP)Wtsi>	MP:0005553,increased circulating creatinine level
MGI:6393542	Wdr91<em1(IMPC)J>	MP:0001697,abnormal embryo size|MP:0011100,preweaning lethality, complete penetrance
MGI:6368012	Wdr91<tm1.1Bcgen>	MP:0001634,internal hemorrhage|MP:0011087,neonatal lethality, complete penetrance
MGI:6368014	Wdr91<tm2Bcgen>	MP:0000774,decreased brain size|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002175,decreased brain weight|MP:0003203,increased neuron apoptosis|MP:0006254,thin cerebral cortex|MP:0008143,abnormal dendrite morphology|MP:0008415,abnormal neurite morphology|MP:0009937,abnormal neuron differentiation
MGI:5588281	Wdsub1<tm1b(EUCOMM)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001489,decreased startle reflex|MP:0004357,long tibia|MP:0005419,decreased circulating serum albumin level|MP:0005553,increased circulating creatinine level|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:3774270	Wdtc1<Gt(RRF015)Byg>	MP:0001261,obese|MP:0002079,increased circulating insulin level|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0005669,increased circulating leptin level|MP:0006094,increased fat cell size|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4362336	Wdtc1<tm1a(KOMP)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0004599,abnormal vertebral arch morphology|MP:0013278,decreased fasting circulating glucose level
MGI:3611814	Wdup	MP:0001364,decreased anxiety-related response|MP:0001415,increased exploration in new environment
MGI:5286657	Wee1<Tg(Tyr)2416BOve>	MP:0006205,embryonic lethality between implantation and somite formation
MGI:5707453	Wee1<tm1.1Cxd>	MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0004045,abnormal cell cycle checkpoint function|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0011104,embryonic lethality before implantation, incomplete penetrance|MP:0011191,increased embryonic epiblast cell apoptosis|MP:0011192,decreased embryonic epiblast cell proliferation
MGI:5513834	Wee1<tm1b(EUCOMM)Wtsi>	MP:0002941,increased circulating alanine transaminase level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:5707451	Wee1<tm1Cxd>	MP:0000358,abnormal cell morphology|MP:0004045,abnormal cell cycle checkpoint function|MP:0006042,increased apoptosis
MGI:5576529	Wee2<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0004151,decreased circulating iron level
MGI:7541486	Wee2<em1Osb>	MP:0005389,reproductive system phenotype
MGI:7541487	Wee2<em2Osb>	MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0005389,reproductive system phenotype
MGI:1861591	Wf	MP:0000410,waved hair|MP:0001510,abnormal coat appearance
MGI:7868144	Wfdc15a<em1Ohbo>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001875,testis inflammation|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002660,abnormal caput epididymis morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0002784,abnormal Sertoli cell morphology|MP:0004852,decreased testis weight|MP:0004884,abnormal testis physiology|MP:0005159,azoospermia|MP:0005378,growth/size/body region phenotype|MP:0014052,increased male germ cell apoptosis|MP:0014631,abnormal elongated spermatid morphology|MP:0014636,decreased elongated spermatid number|MP:0031389,abnormal ectoplasmic specialization morphology
MGI:7868145	Wfdc15a<em2Ohbo>	MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0005378,growth/size/body region phenotype
MGI:4363398	Wfdc18<tm1a(KOMP)Wtsi>	MP:0001510,abnormal coat appearance|MP:0003020,decreased circulating chloride level
MGI:5692680	Wfdc1<tm1.1(KOMP)Vlcg>	MP:0002092,abnormal eye morphology
MGI:5609943	Wfdc1<tm1Drow>	MP:0002724,enhanced wound healing|MP:0005391,vision/eye phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0014695,increased cell adhesion|MP:0020947,decreased susceptibility to Orthomyxoviridae infection
MGI:6476955	Wfdc2<em1Fcw>	MP:0001175,abnormal lung morphology|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0002276,abnormal lung interstitium morphology|MP:0003182,decreased pulmonary endothelial cell surface|MP:0005378,growth/size/body region phenotype|MP:0005385,cardiovascular system phenotype|MP:0005397,hematopoietic system phenotype|MP:0010816,decreased type I pneumocyte number|MP:0010899,abnormal pulmonary alveolar system morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0031068,decreased blood oxygen saturation level
MGI:6149155	Wfdc2<em1(IMPC)H>	MP:0000274,enlarged heart|MP:0005012,decreased eosinophil cell number|MP:0008806,increased circulating amylase level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6728533	Wfdc2<tm1.1Ohbo>	MP:0001175,abnormal lung morphology|MP:0001177,atelectasis|MP:0001575,cyanosis|MP:0001861,lung inflammation|MP:0001954,respiratory distress|MP:0004777,abnormal phospholipid level|MP:0005385,cardiovascular system phenotype|MP:0008713,abnormal cytokine level|MP:0010813,abnormal alveolar lamellar body morphology|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011053,decreased respiratory motile cilia number|MP:0011085,postnatal lethality, complete penetrance|MP:0014200,abnormal respiratory epithelium physiology
MGI:5546193	Wfikkn1<tm1.1Sjl>	MP:0000480,increased rib number|MP:0002114,abnormal axial skeleton morphology|MP:0003048,abnormal cervical vertebrae morphology|MP:0003345,decreased rib number|MP:0004618,thoracic vertebral transformation|MP:0008922,abnormal cervical rib|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0010227,decreased quadriceps weight|MP:0010239,decreased skeletal muscle weight|MP:0013239,impaired skeletal muscle regeneration|MP:0021206,abnormal limb muscle morphology
MGI:5546173	Wfikkn2<tm1.1Sjl>	MP:0005390,skeleton phenotype|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0010227,decreased quadriceps weight|MP:0010239,decreased skeletal muscle weight|MP:0013239,impaired skeletal muscle regeneration|MP:0021206,abnormal limb muscle morphology
MGI:7571399	Wfs1<tm1.1Bedel>	MP:0000034,abnormal inner ear vestibule morphology|MP:0001394,circling|MP:0001405,impaired coordination|MP:0001410,head bobbing|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0001967,deafness|MP:0002980,abnormal postural reflex|MP:0003631,nervous system phenotype|MP:0004324,vestibular hair cell degeneration|MP:0004363,stria vascularis degeneration|MP:0004411,decreased endocochlear potential|MP:0004516,fused vestibular hair cell stereocilia|MP:0004530,absent outer hair cell stereocilia|MP:0004533,fused inner hair cell stereocilia|MP:0004737,absent distortion product otoacoustic emissions|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:3835761	Wfs1<tm1Koks>	MP:0000681,abnormal thyroid gland morphology|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001363,increased anxiety-related response|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001431,abnormal eating behavior|MP:0001454,abnormal cued conditioning behavior|MP:0001463,abnormal spatial learning|MP:0001522,impaired swimming|MP:0001529,abnormal vocalization|MP:0001559,hyperglycemia|MP:0001745,increased circulating corticosterone level|MP:0001922,reduced male fertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002574,increased vertical activity|MP:0002727,decreased circulating insulin level|MP:0002757,decreased vertical activity|MP:0002797,increased thigmotaxis|MP:0004270,analgesia|MP:0004404,cochlear outer hair cell degeneration|MP:0004532,abnormal inner hair cell stereociliary bundle morphology|MP:0004696,abnormal thyroid follicle morphology|MP:0004702,increased circulating insulin-like growth factor I level|MP:0004901,decreased male germ cell number|MP:0005250,decreased Sertoli cell number|MP:0005289,increased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005560,decreased circulating glucose level|MP:0005668,decreased circulating leptin level|MP:0006325,impaired hearing|MP:0008489,slow postnatal weight gain|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0009642,abnormal blood homeostasis|MP:0009748,abnormal behavioral response to addictive substance|MP:0009750,impaired behavioral response to addictive substance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0011940,decreased food intake|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0014617,decreased spermatogonia number|MP:0031391,increased locomotor activity|MP:0031426,increased sperm motility|MP:0031436,decreased copulatory plug deposition
MGI:3613056	Wfs1<tm1Perm>	MP:0001262,decreased body weight|MP:0001559,hyperglycemia|MP:0002078,abnormal glucose homeostasis|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003339,decreased pancreatic beta cell number|MP:0003562,abnormal pancreatic beta cell physiology|MP:0005215,abnormal pancreatic islet morphology|MP:0005293,impaired glucose tolerance|MP:0009114,decreased pancreatic beta cell mass|MP:0009254,disorganized pancreatic islets
MGI:3044175	Wfs1<tm1Yoka>	MP:0001360,abnormal social investigation|MP:0001463,abnormal spatial learning|MP:0002062,abnormal associative learning|MP:0002694,abnormal pancreas secretion|MP:0002710,increased glucagon secretion|MP:0002727,decreased circulating insulin level|MP:0003063,increased coping response|MP:0003339,decreased pancreatic beta cell number|MP:0003866,abnormal defecation|MP:0003999,enhanced passive avoidance behavior|MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0012294,enhanced active avoidance behavior
MGI:2154524	Wg1<C57BL/6J>	MP:0001260,increased body weight
MGI:3762232	Wg2a<CAST/EiJ>	MP:0001260,increased body weight
MGI:3762234	Wg2b<CAST/EiJ>	MP:0001262,decreased body weight|MP:0008907,decreased total fat pad weight
MGI:2154526	Wg2<C57BL/6J>	MP:0001260,increased body weight
MGI:3762236	Wg2c<CAST/EiJ>	MP:0008908,increased total fat pad weight|MP:0009285,increased gonadal fat pad weight|MP:0009304,increased retroperitoneal fat pad weight
MGI:2157007	Wg3<C57BL/6J>	MP:0001260,increased body weight
MGI:3698755	Wg5<CAST/EiJ>	MP:0001262,decreased body weight|MP:0005384,cellular phenotype
MGI:3698757	Wg6<CAST/EiJ>	MP:0001262,decreased body weight
MGI:3698759	Wg7<CAST/EiJ>	MP:0001260,increased body weight|MP:0001262,decreased body weight
MGI:5635487	Whamm<tm1b(KOMP)Wtsi>	MP:0001759,increased urine glucose level|MP:0002871,albuminuria|MP:0002901,increased urine phosphate level|MP:0003311,aminoaciduria|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005619,increased urine potassium level|MP:0008260,abnormal autophagy|MP:0010107,abnormal renal reabsorption|MP:0011350,abnormal proximal convoluted tubule brush border morphology|MP:0020400,cystinuria|MP:0020404,prolinuria|MP:0020849,abnormal actin cytoskeleton morphology|MP:0020992,increased urine HAVCR1 level|MP:0030617,hyperglutaminuria|MP:0030939,abnormal autophagosome formation|MP:0031637,methioninuria
MGI:1861580	Whl	MP:0000026,abnormal inner ear morphology|MP:0000037,abnormal lateral semicircular canal morphology|MP:0000259,abnormal vascular development|MP:0000933,abnormal rhombomere morphology|MP:0001265,decreased body size|MP:0001395,bidirectional circling|MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0001411,spinning|MP:0001488,increased startle reflex|MP:0002428,abnormal semicircular canal morphology|MP:0002858,abnormal posterior semicircular canal morphology|MP:0003232,abnormal forebrain development|MP:0006108,abnormal hindbrain development|MP:0011092,embryonic lethality, complete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011275,abnormal behavioral response to light|MP:0020467,abnormal circadian behavior|MP:0020468,abnormal circadian behavior period|MP:0020469,prolonged circadian behavior period
MGI:2656704	Whll	MP:0001394,circling|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5503986	Whrn<hb>	MP:0001399,hyperactivity|MP:0006325,impaired hearing
MGI:4432119	Whrn<tm1a(EUCOMM)Wtsi>	MP:0001973,increased thermal nociceptive threshold|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:5796356	Whrn<tm1b(EUCOMM)Wtsi>	MP:0004434,abnormal cochlear outer hair cell physiology|MP:0004515,abnormal vestibular hair cell stereociliary bundle morphology|MP:0004520,short vestibular hair cell stereocilia|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004580,abnormal cochlear hair bundle transient lateral links morphology|MP:0004736,abnormal distortion product otoacoustic emission|MP:0004737,absent distortion product otoacoustic emissions|MP:0005377,hearing/vestibular/ear phenotype|MP:0005386,behavior/neurological phenotype|MP:0006325,impaired hearing|MP:0006383,abnormal cochlear frequency tuning|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4462398	Whrn<tm1Tili>	MP:0001004,abnormal retina photoreceptor morphology|MP:0001326,retina degeneration|MP:0004021,abnormal rod electrophysiology|MP:0004022,abnormal cone electrophysiology|MP:0004408,decreased cochlear hair cell number|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0004737,absent distortion product otoacoustic emissions|MP:0006325,impaired hearing|MP:0008515,thin retina outer nuclear layer|MP:0008587,short photoreceptor outer segment
MGI:1857090	Whrn<wi>	MP:0000221,decreased leukocyte cell number|MP:0000642,enlarged adrenal glands|MP:0001262,decreased body weight|MP:0001386,abnormal maternal nurturing|MP:0001394,circling|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0001410,head bobbing|MP:0001522,impaired swimming|MP:0001523,impaired righting response|MP:0001745,increased circulating corticosterone level|MP:0001967,deafness|MP:0002833,increased heart weight|MP:0002981,increased liver weight|MP:0003917,increased kidney weight|MP:0004362,cochlear hair cell degeneration|MP:0004393,abnormal cochlear inner hair cell morphology|MP:0004398,cochlear inner hair cell degeneration|MP:0004399,abnormal cochlear outer hair cell morphology|MP:0004404,cochlear outer hair cell degeneration|MP:0004413,absent cochlear microphonics|MP:0004416,absent cochlear nerve compound action potential|MP:0004520,short vestibular hair cell stereocilia|MP:0004521,abnormal cochlear hair cell stereociliary bundle morphology|MP:0004524,short cochlear hair cell stereocilia|MP:0004527,abnormal outer hair cell stereociliary bundle morphology|MP:0004529,decreased outer hair cell stereocilia number|MP:0004531,short outer hair cell stereocilia|MP:0004536,short inner hair cell stereocilia|MP:0004905,decreased uterus weight|MP:0004910,decreased seminal vesicle weight|MP:0004956,decreased thymus weight|MP:0005289,increased oxygen consumption|MP:0005307,head tossing|MP:0005560,decreased circulating glucose level|MP:0006388,abnormal auditory summating potential|MP:0010025,decreased total body fat amount|MP:0010398,decreased liver glycogen level|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:1862008	Whto	MP:0000373,belly spot|MP:0001891,hydrocephaly|MP:0001935,decreased litter size|MP:0030930,decreased digit pigmentation
MGI:3773873	Why1<MOLF/EiJ>	MP:0008705,increased interleukin-6 secretion
MGI:3773875	Why2<MOLF/EiJ>	MP:0008706,decreased interleukin-6 secretion
MGI:3849075	Wif1<tm1Dmth>	MP:0002021,increased incidence of induced tumors|MP:0002032,increased sarcoma incidence|MP:0003789,increased osteosarcoma incidence|MP:0009763,increased susceptibility to induced morbidity/mortality
MGI:2178802	Wipf1<tm1Geha>	MP:0000220,increased monocyte cell number|MP:0000245,abnormal erythropoiesis|MP:0000322,increased granulocyte number|MP:0000473,abnormal stomach glandular epithelium morphology|MP:0000491,crypts of Lieberkuhn abscesses|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0001861,lung inflammation|MP:0001862,interstitial pneumonia|MP:0002083,premature death|MP:0002344,abnormal lymph node B cell domain morphology|MP:0002392,abnormal Peyer's patch T cell area morphology|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002401,abnormal lymphopoiesis|MP:0002444,abnormal T cell physiology|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002497,increased IgE level|MP:0002743,glomerulonephritis|MP:0002816,colitis|MP:0002933,joint inflammation|MP:0003725,increased autoantibody level|MP:0004137,abnormal gastric surface mucous cell morphology|MP:0004956,decreased thymus weight|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005095,decreased T cell proliferation|MP:0005154,increased B cell proliferation|MP:0005264,glomerulosclerosis|MP:0008174,decreased follicular B cell number|MP:0008182,decreased marginal zone B cell number|MP:0008476,increased spleen red pulp amount|MP:0008479,decreased spleen white pulp amount|MP:0011339,abnormal glomerular mesangium morphology|MP:0012762,abnormal alpha-beta T cell morphology|MP:0013693,abnormal hemopoiesis
MGI:3777008	Wipf3<tm1Tta>	MP:0000242,impaired fertilization|MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility|MP:0001935,decreased litter size|MP:0005376,homeostasis/metabolism phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0009230,abnormal sperm head morphology|MP:0009235,small sperm head
MGI:6404517	Wipi1<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001325,abnormal retina morphology|MP:0002135,abnormal kidney morphology|MP:0002989,small kidney
MGI:7426089	Wipi2<em1(IMPC)Bay>	MP:0003731,abnormal retina outer nuclear layer morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011964,increased total retina thickness
MGI:7310064	Wiz<em1Ccpcz>	MP:0000111,cleft palate|MP:0000445,short snout|MP:0004200,decreased fetal size|MP:0009651,abnormal eyelid development|MP:0011089,perinatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0021166,delayed palatal shelf elevation
MGI:6316145	Wiz<em1(IMPC)Ccpcz>	MP:0001325,abnormal retina morphology|MP:0001404,no spontaneous movement|MP:0001697,abnormal embryo size|MP:0002100,abnormal tooth morphology|MP:0003984,embryonic growth retardation|MP:0005565,increased blood urea nitrogen level|MP:0009263,abnormal eyelid fusion|MP:0010099,abnormal thoracic cage shape|MP:0010935,increased airway resistance|MP:0011100,preweaning lethality, complete penetrance|MP:0020421,increased freezing behavior
MGI:5515384	Wiz<MommeD30>	MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012167,abnormal epigenetic regulation of gene expression
MGI:1857538	Wld<s>	MP:0004220,abnormal peripheral nervous system regeneration|MP:0008067,retina ganglion cell degeneration|MP:0010654,slow Wallerian degeneration|MP:0031330,delayed peripheral nervous system regeneration
MGI:7541264	Wls<em1Jgg>	MP:0000519,hydronephrosis|MP:0000561,adactyly|MP:0000774,decreased brain size|MP:0000812,abnormal dentate gyrus morphology|MP:0001539,decreased caudal vertebrae number|MP:0002861,abnormal tail bud morphology|MP:0003720,abnormal neural tube closure|MP:0003861,abnormal nervous system development|MP:0008948,decreased neuron number|MP:0009937,abnormal neuron differentiation|MP:0011089,perinatal lethality, complete penetrance
MGI:7541266	Wls<em2Jgg>	MP:0000519,hydronephrosis|MP:0000561,adactyly|MP:0000774,decreased brain size|MP:0000812,abnormal dentate gyrus morphology|MP:0001539,decreased caudal vertebrae number|MP:0002861,abnormal tail bud morphology|MP:0003720,abnormal neural tube closure|MP:0003861,abnormal nervous system development|MP:0008948,decreased neuron number|MP:0009937,abnormal neuron differentiation|MP:0011089,perinatal lethality, complete penetrance
MGI:4129920	Wls<Gt(RRJ545)Byg>	MP:0001674,abnormal germ layer development|MP:0001675,abnormal ectoderm development|MP:0001683,absent mesoderm|MP:0001685,abnormal endoderm development|MP:0001693,failure of primitive streak formation|MP:0002084,abnormal developmental patterning|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5547720	Wls<tm1.1Arte>	MP:0000219,increased neutrophil cell number|MP:0000379,decreased hair follicle number|MP:0000416,sparse hair|MP:0001190,reddish skin|MP:0001192,scaly skin|MP:0001195,flaky skin|MP:0001199,thin skin|MP:0001244,thin dermal layer|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0002073,abnormal hair growth|MP:0002083,premature death|MP:0002092,abnormal eye morphology|MP:0002102,abnormal ear morphology|MP:0002145,abnormal T cell differentiation|MP:0002233,abnormal nose morphology|MP:0002444,abnormal T cell physiology|MP:0002796,impaired skin barrier function|MP:0003413,hair follicle degeneration|MP:0003644,thymus atrophy|MP:0003944,abnormal T cell subpopulation ratio|MP:0004126,thin hypodermis|MP:0004947,skin inflammation|MP:0004956,decreased thymus weight|MP:0005018,decreased T cell number|MP:0005090,increased double-negative T cell number|MP:0005092,decreased double-positive T cell number|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0005425,increased macrophage cell number|MP:0005501,abnormal skin physiology|MP:0005666,abnormal adipose tissue physiology|MP:0008347,decreased gamma-delta T cell number|MP:0009583,increased keratinocyte proliferation|MP:0009795,epidermal spongiosis|MP:0009931,abnormal skin appearance|MP:0010771,integument phenotype|MP:0011015,decreased body surface temperature|MP:0011092,embryonic lethality, complete penetrance|MP:0013588,small thymus medulla|MP:0031395,cutaneous mastocytosis
MGI:4452362	Wls<tm1.1Lan>	MP:0000377,abnormal hair follicle morphology|MP:0000847,abnormal metencephalon morphology|MP:0000850,absent cerebellum|MP:0001216,abnormal epidermal layer morphology|MP:0001693,failure of primitive streak formation|MP:0001730,embryonic growth arrest|MP:0002081,perinatal lethality|MP:0002151,abnormal neural tube morphology|MP:0002655,abnormal keratinocyte morphology|MP:0008859,abnormal hair cycle catagen phase|MP:0008934,absent choroid plexus|MP:0009111,pancreas hypoplasia|MP:0010771,integument phenotype|MP:0011106,embryonic lethality between implantation and somite formation, incomplete penetrance|MP:0012087,absent midbrain|MP:0012133,absent midbrain-hindbrain boundary|MP:0012138,decreased forebrain size|MP:0012173,short rostral-caudal axis|MP:0031395,cutaneous mastocytosis
MGI:4881718	Wls<tm1.1Whsu>	MP:0000074,abnormal neurocranium morphology|MP:0000111,cleft palate|MP:0000428,abnormal craniofacial morphology|MP:0000613,abnormal salivary gland morphology|MP:0000850,absent cerebellum|MP:0001056,abnormal cranial nerve morphology|MP:0002100,abnormal tooth morphology|MP:0002152,abnormal brain morphology|MP:0003864,abnormal midbrain development|MP:0003935,abnormal craniofacial development|MP:0004096,abnormal midbrain-hindbrain boundary development|MP:0005274,abnormal viscerocranium morphology|MP:0006101,absent tegmentum|MP:0006106,absent tectum|MP:0006108,abnormal hindbrain development|MP:0008052,abnormal serous gland morphology|MP:0008934,absent choroid plexus
MGI:4881719	Wls<tm1.2Whsu>	MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001730,embryonic growth arrest|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5426917	Wls<tm1Xzg>	MP:0000060,delayed bone ossification|MP:0000352,decreased cell proliferation|MP:0000547,short limbs|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000565,oligodactyly|MP:0000733,abnormal muscle development|MP:0001243,abnormal dermal layer morphology|MP:0001428,adipsia|MP:0001676,abnormal apical ectodermal ridge morphology|MP:0001679,thin apical ectodermal ridge|MP:0002657,chondrodystrophy|MP:0002764,short tibia|MP:0002765,short fibula|MP:0003704,abnormal hair follicle development|MP:0003854,abnormal forelimb stylopod morphology|MP:0003857,abnormal hindlimb zeugopod morphology|MP:0005503,abnormal tendon morphology|MP:0005504,abnormal ligament morphology|MP:0005508,abnormal skeleton morphology|MP:0006042,increased apoptosis|MP:0006279,abnormal limb development|MP:0006280,abnormal digit development|MP:0010743,delayed cranial suture closure|MP:0011084,lethality at weaning, incomplete penetrance|MP:0014291,decreased autopod size
MGI:1858016	wn	MP:0000372,irregular coat pigmentation|MP:0002877,abnormal melanocyte morphology|MP:0005408,hypopigmentation
MGI:1858017	wn<J>	MP:0000372,irregular coat pigmentation|MP:0002075,abnormal coat/hair pigmentation|MP:0005174,abnormal tail pigmentation|MP:0010016,variable depigmentation
MGI:2683145	Wnk1<Gt(OST38262)Lex>	MP:0000260,abnormal angiogenesis|MP:0000292,distended pericardium|MP:0000295,trabecula carnea hypoplasia|MP:0001614,abnormal blood vessel morphology|MP:0001634,internal hemorrhage|MP:0001716,abnormal placenta labyrinth morphology|MP:0001718,abnormal visceral yolk sac morphology|MP:0001722,pale yolk sac|MP:0001787,pericardial edema|MP:0001914,hemorrhage|MP:0001915,intracranial hemorrhage|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002652,thin myocardium|MP:0002740,heart hypoplasia|MP:0002843,decreased systemic arterial blood pressure|MP:0003227,abnormal vascular branching morphogenesis|MP:0003229,abnormal vitelline vasculature morphology|MP:0003984,embryonic growth retardation|MP:0004076,abnormal vitelline vascular remodeling|MP:0004783,abnormal cardinal vein morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0004950,abnormal brain vasculature morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0008803,abnormal placental labyrinth vasculature morphology|MP:0009698,heart hemorrhage|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4838243	Wnk1<tm1.1Juha>	MP:0003620,oliguria|MP:0004875,increased mean systemic arterial blood pressure|MP:0006143,increased systemic arterial diastolic blood pressure|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009643,abnormal urine homeostasis
MGI:4360972	Wnk1<tm1Clhu>	MP:0001698,decreased embryo size|MP:0001787,pericardial edema|MP:0002189,abnormal myocardial trabeculae morphology|MP:0002652,thin myocardium|MP:0002740,heart hypoplasia|MP:0003227,abnormal vascular branching morphogenesis|MP:0003229,abnormal vitelline vasculature morphology|MP:0004076,abnormal vitelline vascular remodeling|MP:0004783,abnormal cardinal vein morphology|MP:0004787,abnormal dorsal aorta morphology|MP:0004950,abnormal brain vasculature morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5544571	Wnk1<tm2.1Juha>	MP:0000208,decreased hematocrit|MP:0002136,abnormal kidney physiology|MP:0003019,increased circulating chloride level|MP:0004757,abnormal distal convoluted tubule morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005441,increased urine calcium level|MP:0006144,increased systemic arterial systolic blood pressure|MP:0011540,increased urine aldosterone level|MP:0012339,hyperkalemia|MP:0012551,metabolic acidosis
MGI:5440881	Wnk1<tm2Cihu>	MP:0005633,increased circulating sodium level|MP:0006144,increased systemic arterial systolic blood pressure|MP:0006317,decreased urine sodium level
MGI:5911092	Wnk2<em1Murr>	MP:0001399,hyperactivity|MP:0002574,increased vertical activity
MGI:4340788	Wnk3<Gt(RRU456)Byg>	MP:0002169,no abnormal phenotype detected
MGI:5318041	Wnk3<tm1.1Esoh>	MP:0002843,decreased systemic arterial blood pressure|MP:0005367,renal/urinary system phenotype|MP:0005376,homeostasis/metabolism phenotype
MGI:6414871	Wnk4<em1Cjc>	MP:0000231,hypertension|MP:0003017,decreased circulating bicarbonate level|MP:0003019,increased circulating chloride level|MP:0003860,abnormal carbon dioxide level|MP:0005618,decreased urine potassium level|MP:0005619,increased urine potassium level|MP:0005627,increased circulating potassium level|MP:0006274,abnormal urine sodium level|MP:0006316,increased urine sodium level|MP:0012339,hyperkalemia|MP:0012551,metabolic acidosis
MGI:5427702	Wnk4<tm1Pfi>	MP:0001762,polyuria|MP:0002667,decreased circulating aldosterone level|MP:0003020,decreased circulating chloride level|MP:0003028,alkalosis|MP:0003352,increased circulating renin level|MP:0004119,hypokalemia|MP:0005376,homeostasis/metabolism phenotype|MP:0005385,cardiovascular system phenotype|MP:0005502,abnormal renal/urinary system physiology|MP:0005619,increased urine potassium level|MP:0006316,increased urine sodium level|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009642,abnormal blood homeostasis|MP:0009643,abnormal urine homeostasis|MP:0010093,decreased circulating magnesium level|MP:0011459,increased urine chloride ion level
MGI:3771073	Wnk4<tm1Suc>	MP:0000231,hypertension|MP:0003017,decreased circulating bicarbonate level|MP:0003031,acidosis|MP:0005618,decreased urine potassium level|MP:0005627,increased circulating potassium level
MGI:4360633	Wnk4<tm2.1Suc>	MP:0005619,increased urine potassium level|MP:0006264,decreased systemic arterial systolic blood pressure|MP:0006316,increased urine sodium level
MGI:6214838	Wnk4<tm3.1Suc>	MP:0003020,decreased circulating chloride level|MP:0003029,alkalemia|MP:0005634,decreased circulating sodium level|MP:0006264,decreased systemic arterial systolic blood pressure
MGI:5548381	Wnt10a<tm1.1(KOMP)Vlcg>	MP:0000367,abnormal coat/ hair morphology|MP:0002075,abnormal coat/hair pigmentation|MP:0002764,short tibia|MP:0002818,abnormal dentin morphology|MP:0003932,abnormal molar crown morphology|MP:0005358,abnormal incisor morphology|MP:0006402,small molars|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0010773,supernumerary molars|MP:0030451,abnormal dentin mineralization|MP:0030457,abnormal molar cusp morphology|MP:0030491,dental pulp stones|MP:0030496,taurodontia|MP:0030524,abnormal tooth root resorption
MGI:5904667	Wnt10a<tm1.1Smr>	MP:0000579,abnormal nail morphology|MP:0000674,abnormal sweat gland morphology|MP:0000762,abnormal tongue morphology|MP:0000763,abnormal filiform papillae morphology|MP:0002689,abnormal molar morphology|MP:0003931,absent molars|MP:0004189,abnormal alveolar process morphology|MP:0005394,taste/olfaction phenotype|MP:0006257,abnormal fungiform papillae morphology|MP:0006260,abnormal gustatory papilla taste bud morphology|MP:0006402,small molars|MP:0010773,supernumerary molars|MP:0011941,increased fluid intake|MP:0030457,abnormal molar cusp morphology|MP:0030494,abnormal molar root morphology
MGI:5904666	Wnt10a<tm1Smr>	MP:0000352,decreased cell proliferation|MP:0000380,small hair follicles|MP:0000392,accelerated hair follicle regression|MP:0000652,enlarged sebaceous gland|MP:0000674,abnormal sweat gland morphology|MP:0000762,abnormal tongue morphology|MP:0000763,abnormal filiform papillae morphology|MP:0002992,abnormal sebaceous lipid secretion|MP:0005390,skeleton phenotype|MP:0006257,abnormal fungiform papillae morphology|MP:0006260,abnormal gustatory papilla taste bud morphology|MP:0008858,abnormal hair cycle anagen phase|MP:0010773,supernumerary molars|MP:0011194,abnormal hair follicle physiology|MP:0013371,hypohidrosis|MP:0030457,abnormal molar cusp morphology|MP:0030494,abnormal molar root morphology
MGI:5582422	Wnt10b<tm1e.1(KOMP)Wtsi>	MP:0000063,decreased bone mineral density|MP:0000494,abnormal cecum morphology|MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology|MP:0010124,decreased bone mineral content
MGI:3582610	Wnt10b<tm1Ptr>	MP:0000733,abnormal muscle development|MP:0000750,abnormal muscle regeneration
MGI:5583056	Wnt11<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001258,decreased body length|MP:0002135,abnormal kidney morphology|MP:0005565,increased blood urea nitrogen level
MGI:2665014	Wnt11<tm1Amc>	MP:0000528,delayed kidney development|MP:0002989,small kidney|MP:0003446,renal hypoplasia|MP:0004505,decreased renal glomerulus number|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011760,abnormal ureteric bud tip morphology
MGI:5467557	Wnt16<tm1Lex>	MP:0000135,decreased compact bone thickness|MP:0004991,decreased bone strength|MP:0005390,skeleton phenotype|MP:0021182,decreased femoral compact bone area
MGI:1856382	Wnt1<sw>	MP:0000776,abnormal inferior colliculus morphology|MP:0000854,abnormal cerebellum development|MP:0000867,abnormal cerebellum anterior vermis morphology|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001522,impaired swimming|MP:0003312,abnormal locomotor coordination|MP:0004097,abnormal cerebellar cortex morphology|MP:0004143,muscle hypertonia|MP:0004814,reduced linear vestibular evoked potential|MP:0008026,abnormal brain white matter morphology|MP:0008913,weaving|MP:0012133,absent midbrain-hindbrain boundary
MGI:5495278	Wnt1<tm1.1Mze>	MP:0000897,abnormal midbrain morphology|MP:0012089,decreased midbrain size|MP:0012785,decreased rhombomere 1 size
MGI:3700020	Wnt1<tm1Amc>	MP:0006108,abnormal hindbrain development|MP:0011091,prenatal lethality, complete penetrance|MP:0012087,absent midbrain|MP:0012516,absent metencephalon
MGI:5630075	Wnt1<tm1b(EUCOMM)Wtsi>	MP:0005178,increased circulating cholesterol level|MP:0005553,increased circulating creatinine level|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1857490	Wnt1<tm1Brd>	MP:0000109,abnormal parietal bone morphology|MP:0000715,decreased thymocyte number|MP:0000783,abnormal forebrain morphology|MP:0000847,abnormal metencephalon morphology|MP:0000850,absent cerebellum|MP:0003864,abnormal midbrain development|MP:0004096,abnormal midbrain-hindbrain boundary development|MP:0004203,abnormal cranial flexure morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0012087,absent midbrain|MP:0012785,decreased rhombomere 1 size
MGI:2153126	Wnt1<tm1Mrc>	MP:0000798,abnormal frontal lobe morphology|MP:0000847,abnormal metencephalon morphology|MP:0000850,absent cerebellum|MP:0000897,abnormal midbrain morphology|MP:0001393,ataxia|MP:0001516,abnormal motor coordination/balance|MP:0001891,hydrocephaly|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:4361157	Wnt2b<tm1.1Tpy>	MP:0002169,no abnormal phenotype detected
MGI:5548412	Wnt2b<tm1b(EUCOMM)Wtsi>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000692,small spleen|MP:0001289,persistence of hyaloid vascular system|MP:0001319,irregularly shaped pupil|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney
MGI:4361155	Wnt2<tm1.1(rtTA)Eem>	MP:0001178,pulmonary hypoplasia|MP:0001575,cyanosis|MP:0002133,abnormal respiratory system physiology|MP:0004007,abnormal lung vasculature morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011142,abnormal lung-associated mesenchyme development|MP:0011148,decreased mesenchymal cell proliferation involved in lung development
MGI:2177935	Wnt2<tm1Bjw>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001711,abnormal placenta morphology|MP:0001712,abnormal placenta development|MP:0001716,abnormal placenta labyrinth morphology|MP:0003231,abnormal placenta vasculature|MP:0004197,abnormal fetal growth/weight/body size|MP:0011090,perinatal lethality, incomplete penetrance
MGI:6367974	Wnt3a<em1(IMPC)Ccpcz>	MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000367,abnormal coat/ hair morphology|MP:0000689,abnormal spleen morphology|MP:0001510,abnormal coat appearance|MP:0001552,increased circulating triglyceride level|MP:0002792,abnormal retina vasculature morphology|MP:0003036,vertebral transformation|MP:0004599,abnormal vertebral arch morphology|MP:0004609,vertebral fusion|MP:0005011,increased eosinophil cell number|MP:0011100,preweaning lethality, complete penetrance
MGI:4849924	Wnt3a<strtls>	MP:0000137,abnormal vertebrae morphology|MP:0000557,absent hindlimb|MP:0001690,failure of somite differentiation|MP:0003445,sirenomelia|MP:0003456,absent tail|MP:0004073,caudal body truncation
MGI:1857489	Wnt3a<tm1Amc>	MP:0000160,kyphosis|MP:0000955,abnormal spinal cord morphology|MP:0001258,decreased body length|MP:0001680,abnormal mesoderm development|MP:0001688,abnormal somite development|MP:0001689,incomplete somite formation|MP:0001695,abnormal gastrulation|MP:0003048,abnormal cervical vertebrae morphology|MP:0003400,kinked neural tube|MP:0003445,sirenomelia|MP:0003456,absent tail|MP:0003632,abnormal nervous system morphology|MP:0004073,caudal body truncation|MP:0004608,abnormal cervical axis morphology|MP:0004615,cervical vertebral transformation|MP:0004714,truncated notochord|MP:0005221,abnormal rostral-caudal axis patterning|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0012063,absent tail bud
MGI:3612795	Wnt3a<tm1(cre)Eag>	MP:0003631,nervous system phenotype
MGI:3612796	Wnt3a<tm2Eag>	MP:0000088,short mandible|MP:0000344,absent Cajal-Retzius cell|MP:0000788,abnormal cerebral cortex morphology|MP:0000792,abnormal cortical marginal zone morphology|MP:0001436,abnormal suckling behavior|MP:0002082,postnatal lethality|MP:0008031,decreased Cajal-Retzius cell number|MP:0008934,absent choroid plexus
MGI:1857088	Wnt3a<vt>	MP:0001539,decreased caudal vertebrae number|MP:0001688,abnormal somite development|MP:0001923,reduced female fertility|MP:0002111,abnormal tail morphology|MP:0002151,abnormal neural tube morphology|MP:0002632,vestigial tail|MP:0002759,abnormal caudal vertebrae morphology|MP:0002861,abnormal tail bud morphology|MP:0004615,cervical vertebral transformation|MP:0004616,lumbar vertebral transformation|MP:0004617,sacral vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0008271,abnormal bone ossification|MP:0008787,abnormal tailgut morphology|MP:0012714,decreased ventral ectodermal ridge size
MGI:2450902	Wnt3<tm1Amc>	MP:0000549,decreased limb number|MP:0001696,failure to gastrulate|MP:0006207,embryonic lethality during organogenesis
MGI:2178826	Wnt3<tm1Brd>	MP:0000549,decreased limb number|MP:0001674,abnormal germ layer development|MP:0001675,abnormal ectoderm development|MP:0001683,absent mesoderm|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001697,abnormal embryo size|MP:0001710,absent amniotic folds|MP:0001724,abnormal extraembryonic endoderm formation|MP:0002086,abnormal extraembryonic tissue morphology|MP:0003087,absent allantois|MP:0003886,abnormal embryonic epiblast morphology|MP:0003988,disorganized embryonic tissue|MP:0005030,absent amnion|MP:0005221,abnormal rostral-caudal axis patterning|MP:0009331,absent primitive node|MP:0009593,absent chorion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011206,absent visceral yolk sac
MGI:4455951	Wnt3<tm2a(EUCOMM)Wtsi>	MP:0011100,preweaning lethality, complete penetrance
MGI:2450289	Wnt3<tm2Brd>	MP:0011091,prenatal lethality, complete penetrance
MGI:7519116	Wnt4<em1(IMPC)Hmgu>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0003179,thrombocytopenia|MP:0005016,decreased lymphocyte cell number|MP:0005179,decreased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level
MGI:3773442	Wnt4<tm1.1Bhr>	MP:0010869,decreased bone trabecula number|MP:0010873,decreased trabecular bone mass|MP:0013618,decreased areal bone mineral density|MP:0020010,decreased bone mineral density of femur|MP:0021182,decreased femoral compact bone area
MGI:4838176	Wnt4<tm1.1Boer>	MP:0002169,no abnormal phenotype detected
MGI:4399114	Wnt4<tm1.1Svo>	MP:0000527,abnormal kidney development|MP:0002169,no abnormal phenotype detected
MGI:5006677	Wnt4<tm1.2Bhr>	MP:0011087,neonatal lethality, complete penetrance
MGI:4838181	Wnt4<tm1.2Boer>	MP:0000527,abnormal kidney development|MP:0003936,abnormal reproductive system development|MP:0011085,postnatal lethality, complete penetrance
MGI:1857453	Wnt4<tm1Amc>	MP:0000520,absent kidney|MP:0000528,delayed kidney development|MP:0000715,decreased thymocyte number|MP:0001126,abnormal ovary morphology|MP:0001931,abnormal oogenesis|MP:0001939,secondary sex reversal|MP:0002212,abnormal secondary sex determination|MP:0002909,abnormal adrenal gland physiology|MP:0003606,kidney failure|MP:0003631,nervous system phenotype|MP:0004163,abnormal adenohypophysis morphology|MP:0004505,decreased renal glomerulus number|MP:0005431,decreased oocyte number|MP:0006361,abnormal female germ cell morphology|MP:0006425,absent Mullerian ducts|MP:0008329,decreased somatotroph cell number|MP:0008335,decreased gonadotroph cell number|MP:0008338,decreased thyrotroph cell number|MP:0009093,oocyte degeneration|MP:0010984,abnormal metanephric mesenchyme morphology|MP:0010987,abnormal nephrogenic mesenchyme morphogenesis|MP:0011087,neonatal lethality, complete penetrance|MP:0011365,small metanephros
MGI:4399122	Wnt4<tm1Svo>	MP:0000520,absent kidney|MP:0000527,abnormal kidney development|MP:0002989,small kidney|MP:0002995,primary sex reversal|MP:0003582,abnormal ovary development|MP:0010985,abnormal kidney mesenchyme morphology|MP:0013312,absent ovary capsule
MGI:3845544	Wnt4<tm2(EGFP/cre/ERT2)Amc>	MP:0005385,cardiovascular system phenotype|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance|MP:0030992,atrioventricular cushion hypoplasia
MGI:5646613	Wnt5a<b2b3077.1Clo>	MP:0000111,cleft palate|MP:0000284,double outlet right ventricle|MP:0000445,short snout|MP:0000477,abnormal intestine morphology|MP:0000564,syndactyly|MP:0000572,abnormal autopod morphology|MP:0001178,pulmonary hypoplasia|MP:0001823,thymus hypoplasia|MP:0002109,abnormal limb morphology|MP:0002111,abnormal tail morphology|MP:0002135,abnormal kidney morphology|MP:0002633,persistent truncus arteriosus|MP:0002639,micrognathia|MP:0004733,abnormal thoracic cavity morphology|MP:0005170,cleft upper lip|MP:0010412,atrioventricular septal defect|MP:0010446,heart left ventricle hypoplasia|MP:0010460,pulmonary artery hypoplasia
MGI:5605689	Wnt5a<tm1.1Krvl>	MP:0001011,abnormal superior cervical ganglion morphology|MP:0002169,no abnormal phenotype detected|MP:0008948,decreased neuron number|MP:0009284,abnormal sympathetic neuron innervation pattern
MGI:5440733	Wnt5a<tm1.1Tpy>	MP:0001120,abnormal uterus morphology|MP:0001672,abnormal embryo development|MP:0001711,abnormal placenta morphology|MP:0001729,impaired embryo implantation|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0003380,abnormal intestine regeneration|MP:0004256,abnormal maternal decidual layer morphology|MP:0005023,abnormal wound healing|MP:0005389,reproductive system phenotype|MP:0009352,impaired spacing of implantation sites|MP:0009353,twin decidual capsule|MP:0009663,abnormal uterine-embryonic axis|MP:0009666,abnormal embryo attachment|MP:0010039,abnormal trophoblast giant cell proliferation|MP:0011521,decreased placental labyrinth size
MGI:1857617	Wnt5a<tm1Amc>	MP:0000018,small ears|MP:0000060,delayed bone ossification|MP:0000088,short mandible|MP:0000137,abnormal vertebrae morphology|MP:0000154,rib fusion|MP:0000445,short snout|MP:0000492,abnormal rectum morphology|MP:0000495,abnormal colon morphology|MP:0000538,abnormal urinary bladder morphology|MP:0000547,short limbs|MP:0000561,adactyly|MP:0000592,short tail|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0001176,abnormal lung development|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001953,respiratory failure|MP:0002085,abnormal embryonic tissue morphology|MP:0002160,abnormal reproductive system morphology|MP:0002230,abnormal primitive streak formation|MP:0002276,abnormal lung interstitium morphology|MP:0002632,vestigial tail|MP:0002982,abnormal primordial germ cell migration|MP:0003119,abnormal digestive system development|MP:0003130,anal atresia|MP:0003631,nervous system phenotype|MP:0004351,short humerus|MP:0004355,short radius|MP:0004359,short ulna|MP:0004550,short trachea|MP:0004551,decreased tracheal cartilage ring number|MP:0004609,vertebral fusion|MP:0004610,small vertebrae|MP:0004653,absent caudal vertebrae|MP:0004704,short vertebral column|MP:0005034,abnormal anus morphology|MP:0006301,abnormal mesenchyme morphology|MP:0008392,decreased primordial germ cell number|MP:0008999,absent anus|MP:0009204,absent external male genitalia|MP:0009211,absent external female genitalia|MP:0009509,absent rectum|MP:0009705,abnormal midgut morphology|MP:0009907,decreased tongue size|MP:0011087,neonatal lethality, complete penetrance|MP:0011732,decreased somite size|MP:0011772,genital tubercle hypoplasia|MP:0012182,abnormal presomitic mesoderm morphology|MP:0013956,decreased colon length|MP:0014291,decreased autopod size|MP:0030935,increased primordial germ cell apoptosis
MGI:5548972	Wnt5b<tm1.1(KOMP)Vlcg>	MP:0000062,increased bone mineral density|MP:0010123,increased bone mineral content
MGI:4412383	Wnt5b<tm1Tmj>	MP:0003631,nervous system phenotype
MGI:3778772	Wnt6<tm1Akis>	MP:0000352,decreased cell proliferation|MP:0001727,abnormal embryo implantation|MP:0001935,decreased litter size|MP:0003077,abnormal cell cycle|MP:0003845,abnormal decidualization|MP:0004256,abnormal maternal decidual layer morphology|MP:0005379,endocrine/exocrine gland phenotype
MGI:5766185	Wnt6<tm1b(NCOM)Mfgc>	MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance
MGI:3777583	Wnt7a<m1Btlr>	MP:0000562,polydactyly|MP:0001924,infertility|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology
MGI:1857009	Wnt7a<px>	MP:0000461,decreased presacral vertebrae number|MP:0000480,increased rib number|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000565,oligodactyly|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002765,short fibula|MP:0003826,abnormal Mullerian duct morphology|MP:0004342,scapular bone foramen|MP:0005108,abnormal ulna morphology
MGI:5315309	Wnt7a<px-2J>	MP:0000550,abnormal forelimb morphology|MP:0000565,oligodactyly|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002110,abnormal digit morphology|MP:0004351,short humerus|MP:0005296,abnormal humerus morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0008730,fused phalanges|MP:0008985,hemimelia|MP:0009931,abnormal skin appearance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5315307	Wnt7a<px-J>	MP:0000550,abnormal forelimb morphology|MP:0000565,oligodactyly|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002674,abnormal sperm motility|MP:0005377,hearing/vestibular/ear phenotype|MP:0005391,vision/eye phenotype|MP:0006279,abnormal limb development|MP:0008985,hemimelia|MP:0014321,short forelimb
MGI:1857703	Wnt7a<px-r>	MP:0000565,oligodactyly|MP:0001926,female infertility|MP:0005108,abnormal ulna morphology|MP:0005389,reproductive system phenotype|MP:0005390,skeleton phenotype|MP:0008985,hemimelia
MGI:5285199	Wnt7a<tm1.1Tesp>	MP:0001926,female infertility|MP:0009097,absent endometrial glands|MP:0009669,abnormal postimplantation uterine environment
MGI:1857704	Wnt7a<tm1Amc>	MP:0000565,oligodactyly|MP:0001120,abnormal uterus morphology|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002109,abnormal limb morphology|MP:0002637,small uterus|MP:0003572,abnormal uterus development|MP:0003574,abnormal oviduct morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0004360,absent ulna|MP:0008257,thin myometrium|MP:0009071,short oviduct|MP:0009081,thin uterus|MP:0009097,absent endometrial glands|MP:0009139,failure of Mullerian duct regression|MP:0031336,abnormal uterine epithelium development
MGI:5285198	Wnt7a<tm1Tesp>	MP:0002169,no abnormal phenotype detected
MGI:3793960	Wnt7b<tm1.1Amc>	MP:0001289,persistence of hyaloid vascular system|MP:0008770,decreased survivor rate|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3641208	Wnt7b<tm1Eem>	MP:0001175,abnormal lung morphology|MP:0001178,pulmonary hypoplasia|MP:0001182,lung hemorrhage|MP:0001953,respiratory failure|MP:0004007,abnormal lung vasculature morphology|MP:0010816,decreased type I pneumocyte number|MP:0011087,neonatal lethality, complete penetrance|MP:0011144,thin lung-associated mesenchyme|MP:0011146,abnormal mesenchymal cell proliferation involved in lung development
MGI:2387443	Wnt7b<tm1Parr>	MP:0001712,abnormal placenta development|MP:0002824,abnormal chorioallantoic fusion|MP:0002836,abnormal chorion morphology|MP:0011092,embryonic lethality, complete penetrance
MGI:3793280	Wnt7b<tm2.1Amc>	MP:0011092,embryonic lethality, complete penetrance
MGI:4399164	Wnt8a<tm1(KOMP)Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:4414945	Wnt8b<tm1Jmas>	MP:0003631,nervous system phenotype
MGI:3701349	Wnt9a<tm1.1Chha>	MP:0000078,abnormal supraoccipital bone morphology|MP:0000079,abnormal basioccipital bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000438,abnormal cranium morphology|MP:0002113,abnormal skeleton development|MP:0002932,abnormal joint morphology|MP:0003189,fused joints|MP:0003843,abnormal sagittal suture morphology|MP:0003869,ectopic cartilage|MP:0004447,small basioccipital bone|MP:0004607,abnormal cervical atlas morphology|MP:0004686,decreased length of long bones|MP:0008818,abnormal interfrontal bone morphology|MP:0009780,abnormal chondrocyte physiology|MP:0009899,hyoid bone hypoplasia|MP:0011087,neonatal lethality, complete penetrance
MGI:3701350	Wnt9a<tm2Chha>	MP:0000078,abnormal supraoccipital bone morphology|MP:0000079,abnormal basioccipital bone morphology|MP:0000107,abnormal frontal bone morphology|MP:0000438,abnormal cranium morphology|MP:0002113,abnormal skeleton development|MP:0002932,abnormal joint morphology|MP:0003189,fused joints|MP:0003843,abnormal sagittal suture morphology|MP:0003869,ectopic cartilage|MP:0004447,small basioccipital bone|MP:0004607,abnormal cervical atlas morphology|MP:0004686,decreased length of long bones|MP:0008818,abnormal interfrontal bone morphology|MP:0009780,abnormal chondrocyte physiology|MP:0009899,hyoid bone hypoplasia|MP:0011087,neonatal lethality, complete penetrance
MGI:1856821	Wnt9b<clf1>	MP:0005170,cleft upper lip
MGI:3526437	Wnt9b<tm1.1Amc>	MP:0000111,cleft palate|MP:0000527,abnormal kidney development|MP:0000528,delayed kidney development|MP:0002058,neonatal lethality|MP:0003557,absent vas deferens|MP:0003558,absent uterus|MP:0003576,oviduct hypoplasia|MP:0003826,abnormal Mullerian duct morphology|MP:0004727,absent epididymis|MP:0004754,abnormal kidney collecting duct morphology|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005170,cleft upper lip|MP:0006032,abnormal ureteric bud morphology|MP:0009072,absent cranial vagina|MP:0009073,absent Wolffian ducts
MGI:3526436	Wnt9b<tm1Amc>	MP:0000111,cleft palate|MP:0002083,premature death|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002989,small kidney|MP:0003675,kidney cyst|MP:0011682,renal glomerulus cyst|MP:0011843,abnormal kidney collecting duct epithelium morphology|MP:0031448,bilateral cleft upper lip
MGI:5637129	Wrap53<tm1b(EUCOMM)Wtsi>	MP:0000183,decreased circulating LDL cholesterol level|MP:0000186,decreased circulating HDL cholesterol level|MP:0001711,abnormal placenta morphology|MP:0002833,increased heart weight|MP:0002836,abnormal chorion morphology|MP:0003960,increased lean body mass|MP:0005031,abnormal trophoblast layer morphology|MP:0005179,decreased circulating cholesterol level|MP:0010088,decreased circulating fructosamine level|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:3575922	wrmod1<CAST/Ei>	MP:0000938,motor neuron degeneration|MP:0002183,gliosis
MGI:5648002	Wrn<b2b3121.1Clo>	MP:0000111,cleft palate|MP:0000642,enlarged adrenal glands|MP:0001823,thymus hypoplasia|MP:0002925,abnormal cardiovascular development|MP:0010484,bicuspid aortic valve|MP:0010527,bicuspid pulmonary valve
MGI:7426091	Wrn<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0001126,abnormal ovary morphology|MP:0002060,abnormal skin morphology|MP:0004832,enlarged ovary|MP:0020421,increased freezing behavior
MGI:4432335	Wrnip1<tm1a(EUCOMM)Wtsi>	MP:0002644,decreased circulating triglyceride level|MP:0004924,abnormal behavior|MP:0005018,decreased T cell number|MP:0005316,abnormal response to tactile stimuli
MGI:6164779	Wrnip1<tm1b(EUCOMM)Wtsi>	MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0002059,abnormal seminal vesicle morphology|MP:0009476,enlarged cecum|MP:0011965,decreased total retina thickness
MGI:2156622	Wrn<tm1Led>	MP:0001548,hyperlipidemia|MP:0001552,increased circulating triglyceride level|MP:0001559,hyperglycemia|MP:0001853,heart inflammation|MP:0002020,increased tumor incidence|MP:0002079,increased circulating insulin level|MP:0002406,increased susceptibility to infection|MP:0003212,increased susceptibility to age related obesity|MP:0003674,oxidative stress|MP:0003820,increased left ventricle systolic pressure|MP:0005048,abnormal thrombosis|MP:0005178,increased circulating cholesterol level|MP:0005331,insulin resistance|MP:0005608,cardiac interstitial fibrosis|MP:0006117,aortic valve stenosis|MP:0006263,decreased systemic arterial diastolic blood pressure|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0009292,increased inguinal fat pad weight|MP:0009304,increased retroperitoneal fat pad weight|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014427,increased circulating hyaluronic acid level|MP:0020411,increased abdominal adipose tissue amount
MGI:2386438	Wrn<tm1Lgu>	MP:0004984,increased osteoclast cell number|MP:0005621,abnormal cell physiology|MP:0010876,decreased bone volume
MGI:5795754	wrpl	MP:0001395,bidirectional circling|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7782525	Wsb1<tm1.1Jszh>	MP:0001876,decreased inflammatory response|MP:0002275,abnormal type II pneumocyte morphology|MP:0005166,decreased susceptibility to injury|MP:0006043,decreased apoptosis|MP:0012196,abnormal myofibroblast differentiation
MGI:5548747	Wsb2<tm1b(EUCOMM)Hmgu>	MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002100,abnormal tooth morphology|MP:0002757,decreased vertical activity|MP:0002792,abnormal retina vasculature morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0010052,increased grip strength|MP:0010097,abnormal retina blood vessel morphology|MP:0010379,decreased respiratory quotient|MP:0011940,decreased food intake|MP:0011965,decreased total retina thickness
MGI:5763626	Wscd2<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0005554,decreased circulating creatinine level|MP:0020870,decreased thigmotaxis
MGI:1861234	Wt	MP:0000036,absent semicircular canals|MP:0000037,abnormal lateral semicircular canal morphology|MP:0000041,absent endolymphatic duct|MP:0000828,abnormal fourth ventricle morphology|MP:0001082,abnormal geniculate ganglion morphology|MP:0001363,increased anxiety-related response|MP:0001386,abnormal maternal nurturing|MP:0001394,circling|MP:0001395,bidirectional circling|MP:0001410,head bobbing|MP:0001522,impaired swimming|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0002151,abnormal neural tube morphology|MP:0002152,abnormal brain morphology|MP:0002428,abnormal semicircular canal morphology|MP:0002572,abnormal emotion/affect behavior|MP:0002855,abnormal cochlear ganglion morphology|MP:0002858,abnormal posterior semicircular canal morphology|MP:0003162,decreased lateral semicircular canal size|MP:0003984,embryonic growth retardation|MP:0004046,abnormal mitosis|MP:0004427,abnormal vestibular labyrinth morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005389,reproductive system phenotype|MP:0006030,abnormal otic vesicle development|MP:0006292,abnormal nasal placode morphology|MP:0010323,retropulsion|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011238,abnormal inner ear development|MP:0012168,abnormal optic placode morphology|MP:0012170,absent optic placodes|MP:0012712,spinal cord degeneration
MGI:2154366	Wt10q1<MH>	MP:0001262,decreased body weight
MGI:2155593	Wt10q2<MH>	MP:0001260,increased body weight
MGI:3036512	Wt10q3<MH>	MP:0001260,increased body weight
MGI:5512658	Wt1<tm1.1Ceng>	MP:0002871,albuminuria|MP:0005264,glomerulosclerosis
MGI:2183548	Wt1<tm1.1Jak>	MP:0002169,no abnormal phenotype detected
MGI:4413579	Wt1<tm1.1Lahe>	MP:0002083,premature death|MP:0002962,increased urine protein level|MP:0005264,glomerulosclerosis|MP:0005325,abnormal renal glomerulus morphology|MP:0005326,abnormal podocyte morphology|MP:0005327,abnormal mesangial cell morphology|MP:0005367,renal/urinary system phenotype|MP:0011353,expanded mesangial matrix|MP:0011409,increased renal glomerulus basement membrane thickness|MP:0011430,mesangiolysis|MP:0011498,abnormal glomerular capsule parietal layer morphology|MP:0011871,podocyte hypertrophy
MGI:4849364	Wt1<tm1.1Ndha>	MP:0003924,diaphragmatic hernia|MP:0006301,abnormal mesenchyme morphology|MP:0010118,abnormal intermediate mesoderm morphology|MP:0010551,abnormal coronary vessel morphology|MP:0010556,thin ventricle myocardium compact layer|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0012251,abnormal diaphragm development|MP:0014808,abnormal pleuroperitoneal fold morphology
MGI:2183640	Wt1<tm1Asc>	MP:0002209,decreased germ cell number|MP:0002989,small kidney|MP:0002995,primary sex reversal|MP:0005325,abnormal renal glomerulus morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:2654351	Wt1<tm1Hst>	MP:0002169,no abnormal phenotype detected
MGI:1857268	Wt1<tm1Jae>	MP:0000527,abnormal kidney development|MP:0000690,absent spleen|MP:0001176,abnormal lung development|MP:0001178,pulmonary hypoplasia|MP:0001785,edema|MP:0002085,abnormal embryonic tissue morphology|MP:0002188,small heart|MP:0003924,diaphragmatic hernia|MP:0005244,hemopericardium|MP:0005313,absent adrenal gland|MP:0005385,cardiovascular system phenotype|MP:0006301,abnormal mesenchyme morphology|MP:0009322,increased splenocyte apoptosis|MP:0009323,abnormal spleen development|MP:0010819,primary atelectasis|MP:0011087,neonatal lethality, complete penetrance|MP:0011089,perinatal lethality, complete penetrance|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011386,increased metanephric mesenchyme apoptosis|MP:0011411,abnormal gonadal ridge morphology|MP:0012251,abnormal diaphragm development|MP:0012496,abnormal pleuropericardial membrane morphology|MP:0012515,abnormal heart apex morphology
MGI:2180792	Wt1<tm1Jak>	MP:0011092,embryonic lethality, complete penetrance
MGI:3794650	Wt1<tm1Mlh>	MP:0000267,abnormal heart development|MP:0000277,abnormal heart shape|MP:0000522,kidney cortex cyst|MP:0000527,abnormal kidney development|MP:0000596,abnormal liver development|MP:0000600,liver hypoplasia|MP:0001698,decreased embryo size|MP:0002743,glomerulonephritis|MP:0002962,increased urine protein level|MP:0003578,absent ovary|MP:0005244,hemopericardium|MP:0005264,glomerulosclerosis|MP:0005327,abnormal mesangial cell morphology|MP:0005644,agonadal|MP:0006415,absent testes|MP:0010500,myocardium hypoplasia|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0011301,juxtaglomerular cell hyperplasia|MP:0011353,expanded mesangial matrix|MP:0011366,absent metanephros|MP:0011402,renal cast|MP:0011427,increased mesangial cell number|MP:0011871,podocyte hypertrophy|MP:0012251,abnormal diaphragm development|MP:0012515,abnormal heart apex morphology|MP:0013310,abnormal adrenal gland development
MGI:3721102	Wt1<tm1Nhsn>	MP:0002169,no abnormal phenotype detected|MP:0011089,perinatal lethality, complete penetrance
MGI:3512766	Wt1<tm1Vih>	MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001923,reduced female fertility|MP:0002080,prenatal lethality|MP:0002083,premature death|MP:0002962,increased urine protein level|MP:0003355,decreased ovulation rate|MP:0003357,impaired granulosa cell differentiation|MP:0005264,glomerulosclerosis|MP:0005367,renal/urinary system phenotype|MP:0008140,podocyte foot process effacement|MP:0008868,abnormal granulosa cell morphology|MP:0009362,abnormal primary ovarian follicle morphology|MP:0031420,decreased superovulation rate
MGI:3665321	Wt1<tm2.1Vih>	MP:0002169,no abnormal phenotype detected|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:2183642	Wt1<tm2Asc>	MP:0002212,abnormal secondary sex determination|MP:0002214,streak gonad|MP:0002989,small kidney|MP:0005325,abnormal renal glomerulus morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:3610301	Wt1<tm2Hst>	MP:0000530,abnormal kidney vasculature morphology|MP:0001147,small testis|MP:0001919,abnormal reproductive system physiology|MP:0001925,male infertility|MP:0002705,dilated renal tubule|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0003675,kidney cyst|MP:0005159,azoospermia|MP:0005264,glomerulosclerosis|MP:0005327,abnormal mesangial cell morphology|MP:0008138,absent podocyte foot process|MP:0011316,abnormal kidney interlobular artery morphology|MP:0011320,abnormal glomerular capillary morphology|MP:0011353,expanded mesangial matrix|MP:0011427,increased mesangial cell number|MP:0011500,decreased glomerular capsule space|MP:0011506,glomerular crescent|MP:0011868,podocyte microvillus transformation|MP:0011871,podocyte hypertrophy
MGI:2154370	Wt3q1<MH>	MP:0001260,increased body weight
MGI:2154372	Wt3q2<MH>	MP:0001260,increased body weight
MGI:2445537	Wt3q3<MH>	MP:0001260,increased body weight
MGI:2154374	Wt6q1<MH>	MP:0001260,increased body weight
MGI:2154378	Wt6q2<MH>	MP:0001260,increased body weight
MGI:3036515	Wt6q3<MH>	MP:0001260,increased body weight
MGI:2155756	Wta1<LG/J>	MP:0001260,increased body weight
MGI:2156450	Wta2<LG/J>	MP:0001260,increased body weight
MGI:2157917	Wta3<LG/J>	MP:0001260,increased body weight
MGI:2157919	Wta4<LG/J>	MP:0001260,increased body weight
MGI:3762751	Wtap<Gt(ROSANBetageo)5B4Masn>	MP:0001672,abnormal embryo development|MP:0011092,embryonic lethality, complete penetrance
MGI:4126568	Wtip<Gt(XH617)Byg>	MP:0002962,increased urine protein level|MP:0005165,increased susceptibility to injury|MP:0005367,renal/urinary system phenotype|MP:0008140,podocyte foot process effacement|MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5569955	Wtip<tm1b(KOMP)Wtsi>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:1857094	wuf	MP:0000372,irregular coat pigmentation|MP:0001324,abnormal eye pigmentation
MGI:2671866	ww1	MP:0001116,small gonad|MP:0002286,cryptorchism|MP:0002780,decreased circulating testosterone level
MGI:2671867	ww2	MP:0001116,small gonad
MGI:5562434	Wwc1<tm1.1Arsc>	MP:0008428,abnormal spatial working memory|MP:0012293,impaired active avoidance behavior|MP:0012307,impaired spatial learning
MGI:5301655	Wwc1<tm1.1Rlh>	MP:0001473,reduced long-term potentiation|MP:0001475,reduced long-term depression|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior
MGI:7426092	Wwc2<em1(IMPC)Bay>	MP:0001925,male infertility|MP:0003795,abnormal bone structure|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6711442	Wwc2<tm1.1Arte>	MP:0005370,liver/biliary system phenotype
MGI:7541100	Wwox<em1Mald>	MP:0000610,cholestasis|MP:0000851,cerebellum hypoplasia|MP:0000876,Purkinje cell degeneration|MP:0000890,thin cerebellar molecular layer|MP:0000947,convulsive seizures|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001513,limb grasping|MP:0002065,abnormal fear/anxiety-related behavior|MP:0002066,abnormal motor capabilities/coordination/movement|MP:0002083,premature death|MP:0002797,increased thigmotaxis|MP:0003103,liver degeneration|MP:0003354,astrocytosis|MP:0003997,tonic-clonic seizures|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0006099,thin cerebellar granule layer|MP:0008918,microgliosis|MP:0009268,absent cerebellum fissure|MP:0009342,enlarged gallbladder|MP:0009808,decreased oligodendrocyte number|MP:0009957,abnormal cerebellum vermis lobule morphology|MP:0014185,cerebellum atrophy|MP:0020395,abnormal response to social novelty|MP:0021111,decreased social investigation
MGI:3775954	Wwox<Gt(XG218)Byg>	MP:0001152,increased Leydig cell number|MP:0001154,seminiferous tubule degeneration|MP:0001922,reduced male fertility|MP:0002018,increased malignant tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0003205,testicular atrophy|MP:0008770,decreased survivor rate
MGI:4415792	Wwox<tm1.1Mald>	MP:0000063,decreased bone mineral density|MP:0000195,decreased circulating calcium level|MP:0000221,decreased leukocyte cell number|MP:0000692,small spleen|MP:0001262,decreased body weight|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0002006,neoplasm|MP:0002176,increased brain weight|MP:0002371,abnormal thymus cortex morphology|MP:0003017,decreased circulating bicarbonate level|MP:0003019,increased circulating chloride level|MP:0003402,decreased liver weight|MP:0003643,spleen atrophy|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight|MP:0004989,decreased osteoblast cell number|MP:0005150,cachexia|MP:0005560,decreased circulating glucose level|MP:0005565,increased blood urea nitrogen level|MP:0009346,decreased trabecular bone thickness|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0011085,postnatal lethality, complete penetrance
MGI:4415791	Wwox<tm1Mald>	MP:0005378,growth/size/body region phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:3704944	Wwox<tm1Ria>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000189,hypoglycemia|MP:0000195,decreased circulating calcium level|MP:0000691,enlarged spleen|MP:0001127,small ovary|MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001265,decreased body size|MP:0001541,abnormal osteoclast physiology|MP:0001566,increased circulating phosphate level|MP:0001570,abnormal circulating enzyme level|MP:0001732,postnatal growth retardation|MP:0001764,abnormal homeostasis|MP:0001940,testis hypoplasia|MP:0002020,increased tumor incidence|MP:0002083,premature death|MP:0002113,abnormal skeleton development|MP:0002176,increased brain weight|MP:0002644,decreased circulating triglyceride level|MP:0002780,decreased circulating testosterone level|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003020,decreased circulating chloride level|MP:0003789,increased osteosarcoma incidence|MP:0004499,increased incidence of tumors by chemical induction|MP:0004992,increased bone resorption|MP:0005150,cachexia|MP:0005179,decreased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0005419,decreased circulating serum albumin level|MP:0005508,abnormal skeleton morphology|MP:0005536,decreased Leydig cell number|MP:0005567,decreased circulating total protein level|MP:0005627,increased circulating potassium level|MP:0005632,decreased circulating aspartate transaminase level|MP:0005634,decreased circulating sodium level|MP:0005646,abnormal pituitary gland physiology|MP:0008014,increased lung tumor incidence|MP:0008395,abnormal osteoblast differentiation|MP:0008821,increased blood uric acid level|MP:0008939,increased pituitary gland weight|MP:0009088,thin uterine horn|MP:0009362,abnormal primary ovarian follicle morphology|MP:0009370,decreased theca cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0013307,increased adrenal gland weight
MGI:5499852	Wwox<tm2.1Ria>	MP:0000063,decreased bone mineral density|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000189,hypoglycemia|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0003797,abnormal compact bone morphology|MP:0010280,increased skeletal tumor incidence|MP:0010869,decreased bone trabecula number|MP:0010879,decreased trabecular bone volume|MP:0010933,decreased trabecular bone connectivity density|MP:0010968,decreased compact bone area|MP:0011085,postnatal lethality, complete penetrance
MGI:6149154	Wwp1<em1(IMPC)H>	MP:0001402,decreased locomotor activity|MP:0001566,increased circulating phosphate level|MP:0002764,short tibia|MP:0013278,decreased fasting circulating glucose level
MGI:5449071	Wwp1<tm1Lmat>	MP:0011710,enhanced osteoblast differentiation
MGI:6359819	Wwp2<em1Asah>	MP:0005382,craniofacial phenotype
MGI:3868073	Wwp2<Gt(HMA140)Byg>	MP:0000440,domed cranium|MP:0000443,abnormal snout morphology|MP:0000445,short snout|MP:0000454,abnormal jaw morphology|MP:0001265,decreased body size|MP:0004471,short nasal bone|MP:0030082,long lower incisors
MGI:5774713	Wwp2<tm1.1Yyiw>	MP:0005387,immune system phenotype|MP:0008553,increased circulating tumor necrosis factor level|MP:0008575,increased circulating interferon-beta level|MP:0008596,increased circulating interleukin-6 level|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality
MGI:3877650	Wwtr1<Gt(CSD245)Byg>	MP:0003675,kidney cyst
MGI:5544289	Wwtr1<tm1.1Eno>	MP:0005385,cardiovascular system phenotype
MGI:5544290	Wwtr1<tm1.2Eno>	MP:0008528,polycystic kidney
MGI:3759999	Wwtr1<tm1Benj>	MP:0000519,hydronephrosis|MP:0000522,kidney cortex cyst|MP:0001183,overexpanded pulmonary alveolus|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001858,intestinal inflammation|MP:0001861,lung inflammation|MP:0001923,reduced female fertility|MP:0001958,emphysema|MP:0002083,premature death|MP:0003068,enlarged kidney|MP:0008528,polycystic kidney|MP:0009269,decreased fat cell size|MP:0010903,abnormal pulmonary alveolus wall morphology|MP:0011101,prenatal lethality, incomplete penetrance
MGI:3775483	Wwtr1<tm1Hku>	MP:0000519,hydronephrosis|MP:0001176,abnormal lung development|MP:0001183,overexpanded pulmonary alveolus|MP:0001762,polyuria|MP:0001861,lung inflammation|MP:0001958,emphysema|MP:0002314,abnormal respiratory mechanics|MP:0002988,decreased urine osmolality|MP:0003068,enlarged kidney|MP:0003215,renal interstitial fibrosis|MP:0004007,abnormal lung vasculature morphology|MP:0004882,enlarged lung|MP:0004969,pale kidney|MP:0005166,decreased susceptibility to injury|MP:0006027,impaired lung alveolus development|MP:0006050,pulmonary fibrosis|MP:0008528,polycystic kidney|MP:0010887,pale lung|MP:0010922,alveolitis|MP:0011045,decreased lung elastance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0014474,decreased pulmonary alveolus wall thickness
MGI:5486299	Wwtr1<tm1Hmc>	MP:0000533,kidney hemorrhage|MP:0003675,kidney cyst
MGI:3702742	Wwtr1<tm1Whun>	MP:0001255,decreased body height|MP:0001262,decreased body weight|MP:0001935,decreased litter size|MP:0002083,premature death|MP:0002703,abnormal renal tubule morphology|MP:0002704,tubular nephritis|MP:0002705,dilated renal tubule|MP:0003068,enlarged kidney|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0003675,kidney cyst|MP:0004969,pale kidney|MP:0005508,abnormal skeleton morphology|MP:0005565,increased blood urea nitrogen level|MP:0008271,abnormal bone ossification|MP:0009050,dilated proximal convoluted tubule|MP:0009051,dilated distal convoluted tubule|MP:0011066,abnormal renal tubule epithelial cell primary cilium morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011308,kidney corticomedullary cyst|MP:0011363,renal glomerulus atrophy|MP:0011501,increased glomerular capsule space
MGI:3574459	Xab2<tm1Tnka>	MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012111,failure of morula compaction
MGI:3574460	Xab2<tm2Tnka>	MP:0009781,abnormal preimplantation embryo development|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0012111,failure of morula compaction
MGI:7645252	Xaf1<em1Gaod>	MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0004890,decreased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005560,decreased circulating glucose level|MP:0005659,decreased susceptibility to diet-induced obesity
MGI:6386307	Xaf1<em1(IMPC)Mbp>	MP:0000470,abnormal stomach morphology|MP:0002060,abnormal skin morphology|MP:0002759,abnormal caudal vertebrae morphology|MP:0003883,enlarged stomach
MGI:8164282	Xaf1<em2.1Cya>	MP:0005387,immune system phenotype|MP:0005416,abnormal circulating protein level|MP:0008576,decreased circulating interferon-beta level|MP:0008752,abnormal tumor necrosis factor level|MP:0011079,decreased macrophage cytokine production|MP:0020913,increased susceptibility to Riboviria infection|MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality|MP:0031219,decreased circulating CXCL10 level
MGI:5576515	Xbp1<tm1.1Geno>	MP:0000233,abnormal blood flow velocity|MP:0003710,abnormal physiological neovascularization|MP:0005164,abnormal response to injury|MP:0005602,decreased angiogenesis|MP:0010097,abnormal retina blood vessel morphology
MGI:5576516	Xbp1<tm1.2Geno>	MP:0000352,decreased cell proliferation|MP:0001614,abnormal blood vessel morphology|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0009429,decreased embryo weight|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:4432347	Xbp1<tm1a(EUCOMM)Wtsi>	MP:0002644,decreased circulating triglyceride level|MP:0002896,abnormal bone mineralization|MP:0003795,abnormal bone structure|MP:0004609,vertebral fusion|MP:0005018,decreased T cell number|MP:0005179,decreased circulating cholesterol level|MP:0008495,decreased IgG1 level|MP:0010052,increased grip strength
MGI:5548973	Xbp1<tm1b(EUCOMM)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0001289,persistence of hyaloid vascular system|MP:0002590,increased mean corpuscular volume|MP:0005016,decreased lymphocyte cell number|MP:0005561,increased mean corpuscular hemoglobin|MP:0010068,decreased red blood cell distribution width|MP:0011100,preweaning lethality, complete penetrance|MP:0012361,decreased large unstained cell number
MGI:2386788	Xbp1<tm1Glm>	MP:0000596,abnormal liver development|MP:0000600,liver hypoplasia|MP:0000601,small liver|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0003717,pallor|MP:0003887,increased hepatocyte apoptosis|MP:0003984,embryonic growth retardation|MP:0004001,decreased hepatocyte proliferation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2445686	Xbp1<tm1Nogu>	MP:0000267,abnormal heart development|MP:0000280,thin ventricular wall|MP:0000291,enlarged pericardium|MP:0000296,absent trabeculae carneae|MP:0000930,wavy neural tube|MP:0002316,anoxia|MP:0003984,embryonic growth retardation|MP:0006085,myocardium necrosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013241,embryo tissue necrosis
MGI:4365400	Xbp1<tm1Tiw>	MP:0001698,decreased embryo size|MP:0004264,abnormal extraembryonic tissue physiology
MGI:3774017	Xbp1<tm2Glm>	MP:0000491,crypts of Lieberkuhn abscesses|MP:0000512,intestinal ulcer|MP:0002118,abnormal lipid homeostasis|MP:0002412,increased susceptibility to bacterial infection|MP:0002644,decreased circulating triglyceride level|MP:0003091,abnormal cell migration|MP:0003293,rectal hemorrhage|MP:0003306,small intestinal inflammation|MP:0003631,nervous system phenotype|MP:0003806,abnormal nucleotide metabolism|MP:0003983,decreased cholesterol level|MP:0004843,abnormal Paneth cell morphology|MP:0005150,cachexia|MP:0005282,decreased fatty acids level|MP:0005363,decreased susceptibility to prion infection|MP:0005386,behavior/neurological phenotype|MP:0008260,abnormal autophagy|MP:0008537,increased susceptibility to induced colitis|MP:0008882,abnormal enterocyte physiology|MP:0009378,abnormal endoplasmic reticulum morphology|MP:0010155,abnormal intestine physiology|MP:0010768,mortality/aging|MP:0013792,abnormal small intestine goblet cell morphology|MP:0014076,absent Paneth cells|MP:0014142,increased body fat mass
MGI:5441521	Xbp1<tm3Glm>	MP:0003306,small intestinal inflammation|MP:0006042,increased apoptosis|MP:0008142,decreased small intestinal villus size|MP:0010155,abnormal intestine physiology|MP:0013486,decreased Paneth cell number
MGI:5296620	Xcl1<tm1.1Dnax>	MP:0000685,abnormal immune system morphology|MP:0001844,autoimmune response|MP:0001846,increased inflammatory response|MP:0001853,heart inflammation|MP:0001860,liver inflammation|MP:0001870,salivary gland inflammation|MP:0001873,stomach inflammation|MP:0004974,decreased regulatory T cell number|MP:0008126,increased dendritic cell number|MP:0008127,decreased dendritic cell number|MP:0008880,lacrimal gland inflammation
MGI:4415308	Xcl1<tm1Rakr>	MP:0005079,decreased cytotoxic T cell cytolysis|MP:0005387,immune system phenotype
MGI:3604538	Xcr1<tm1Dgen>	MP:0002169,no abnormal phenotype detected|MP:0002376,abnormal dendritic cell physiology|MP:0005387,immune system phenotype
MGI:5544057	Xcr1<tm1Ksho>	MP:0002169,no abnormal phenotype detected
MGI:5544058	Xcr1<tm2(HBEGF/Venus)Ksho>	MP:0001835,abnormal antigen presentation|MP:0002411,decreased susceptibility to bacterial infection|MP:0004392,abnormal CD8-positive, alpha-beta T cell physiology|MP:0005387,immune system phenotype|MP:0008127,decreased dendritic cell number|MP:0008567,decreased interferon-gamma secretion
MGI:6430665	Xdh<em1(IMPC)Mbp>	MP:0001175,abnormal lung morphology|MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0001925,male infertility|MP:0002060,abnormal skin morphology|MP:0002699,abnormal vitreous body morphology
MGI:5435289	Xdh<renf>	MP:0000194,increased circulating calcium level|MP:0000521,abnormal kidney cortex morphology|MP:0002083,premature death|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002968,increased circulating alkaline phosphatase level|MP:0002989,small kidney|MP:0003215,renal interstitial fibrosis|MP:0003432,increased activity of parathyroid|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0008489,slow postnatal weight gain|MP:0008822,decreased blood uric acid level|MP:0009640,abnormal renal tubule epithelium morphology
MGI:7624113	Xdh<tm1.1Takni>	MP:0003674,oxidative stress|MP:0005378,growth/size/body region phenotype|MP:0005397,hematopoietic system phenotype|MP:0008244,abnormal peritoneal macrophage morphology|MP:0010768,mortality/aging
MGI:3611749	Xdh<tm1Fink>	MP:0000527,abnormal kidney development|MP:0001265,decreased body size|MP:0002083,premature death|MP:0002118,abnormal lipid homeostasis|MP:0002135,abnormal kidney morphology|MP:0002703,abnormal renal tubule morphology|MP:0002705,dilated renal tubule|MP:0002989,small kidney|MP:0003215,renal interstitial fibrosis|MP:0003606,kidney failure|MP:0003674,oxidative stress|MP:0004969,pale kidney|MP:0005039,hypoxia|MP:0005317,increased triglyceride level|MP:0005325,abnormal renal glomerulus morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005565,increased blood urea nitrogen level|MP:0008489,slow postnatal weight gain|MP:0008806,increased circulating amylase level|MP:0008822,decreased blood uric acid level|MP:0008853,decreased abdominal adipose tissue amount|MP:0009640,abnormal renal tubule epithelium morphology|MP:0009645,crystalluria|MP:0011085,postnatal lethality, complete penetrance|MP:0011405,tubulointerstitial nephritis|MP:0031479,increased urine xanthine level|MP:0031484,increased urine hypoxanthine level|MP:0031487,increased circulating hypoxanthine level|MP:0031490,increased circulating xanthine level
MGI:2448161	Xdh<tm1Mrc>	MP:0000759,abnormal skeletal muscle morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001882,abnormal lactation|MP:0002083,premature death|MP:0004047,abnormal milk composition|MP:0006270,abnormal mammary gland growth during lactation|MP:0006271,abnormal involution of the mammary gland|MP:0010025,decreased total body fat amount
MGI:7624143	Xdh<tm2.1Takni>	MP:0005378,growth/size/body region phenotype|MP:0005384,cellular phenotype|MP:0005397,hematopoietic system phenotype|MP:0010768,mortality/aging
MGI:3809790	Xiap<tm1Hs>	MP:0005387,immune system phenotype|MP:0005389,reproductive system phenotype|MP:0008943,increased sensitivity to induced cell death
MGI:2158344	Xiap<tm1Thsn>	MP:0002169,no abnormal phenotype detected
MGI:3629213	Xiap<tm1Vdr>	MP:0000291,enlarged pericardium|MP:0000628,abnormal mammary gland development|MP:0001914,hemorrhage|MP:0003105,abnormal heart atrium morphology|MP:0004047,abnormal milk composition|MP:0005140,decreased cardiac muscle contractility|MP:0005244,hemopericardium|MP:0006138,congestive heart failure|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0013716,hypolactation
MGI:4442410	Xirp1<tm1Dofr>	MP:0001262,decreased body weight|MP:0001544,abnormal cardiovascular system physiology|MP:0002127,abnormal cardiovascular system morphology|MP:0002972,abnormal cardiac muscle contractility|MP:0003141,cardiac fibrosis|MP:0004090,abnormal sarcomere morphology|MP:0005140,decreased cardiac muscle contractility|MP:0005329,abnormal myocardium layer morphology|MP:0005385,cardiovascular system phenotype|MP:0010393,shortened QRS complex duration|MP:0010554,shortened HV interval
MGI:3521795	Xirp1<tm1Jl>	MP:0000274,enlarged heart|MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0003233,prolonged QT interval|MP:0004067,abnormal trabecula carnea morphology|MP:0004071,prolonged P wave|MP:0004090,abnormal sarcomere morphology|MP:0004093,diffuse Z line|MP:0004564,increased myocardial fiber size|MP:0005330,cardiomyopathy|MP:0005608,cardiac interstitial fibrosis|MP:0006267,abnormal intercalated disk morphology|MP:0010499,abnormal ventricle myocardium morphology|MP:0014731,disorganized myocardial fiber myofibrils|MP:0020345,abnormal myocardial fiber currents|MP:0020346,abnormal myocardial fiber calcium currents|MP:0020347,abnormal myocardial fiber sodium currents|MP:0030566,abnormal A band morphology|MP:0030567,abnormal I band morphology
MGI:4947972	Xirp2<tm1.1Itl>	MP:0002169,no abnormal phenotype detected
MGI:4947971	Xirp2<tm1Itl>	MP:0001625,cardiac hypertrophy|MP:0002833,increased heart weight|MP:0003638,abnormal response/metabolism to endogenous compounds|MP:0004564,increased myocardial fiber size|MP:0005385,cardiovascular system phenotype
MGI:4453315	Xirp2<tm1Jl>	MP:0000277,abnormal heart shape|MP:0000278,abnormal myocardial fiber morphology|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001544,abnormal cardiovascular system physiology|MP:0001732,postnatal growth retardation|MP:0002190,disorganized myocardium|MP:0002834,decreased heart weight|MP:0003137,abnormal impulse conducting system conduction|MP:0003222,increased cardiomyocyte apoptosis|MP:0003233,prolonged QT interval|MP:0003402,decreased liver weight|MP:0003717,pallor|MP:0003896,prolonged PR interval|MP:0003920,abnormal heart right ventricle morphology|MP:0003921,abnormal heart left ventricle morphology|MP:0004011,decreased diastolic filling velocity|MP:0004067,abnormal trabecula carnea morphology|MP:0004117,abnormal atrioventricular bundle morphology|MP:0004124,abnormal Purkinje fiber morphology|MP:0004565,decreased myocardial fiber size|MP:0006267,abnormal intercalated disk morphology|MP:0008489,slow postnatal weight gain|MP:0009674,decreased birth weight|MP:0010420,muscular ventricular septal defect|MP:0010508,abnormal heart electrocardiography waveform feature|MP:0010519,atrioventricular block|MP:0010640,ventricular myocardium compact layer hypoplasia|MP:0011085,postnatal lethality, complete penetrance|MP:0012624,decreased acetylcholinesterase activity|MP:0020345,abnormal myocardial fiber currents
MGI:2386405	Xist<tm1.1Nbd>	MP:0005384,cellular phenotype
MGI:2386399	Xist<tm1Jae>	MP:0005389,reproductive system phenotype|MP:0010382,abnormal dosage compensation, by inactivation of X chromosome
MGI:2386402	Xist<tm1Nbd>	MP:0003787,abnormal imprinting
MGI:2445460	Xist<tm2.1Jae>	MP:0003984,embryonic growth retardation|MP:0005389,reproductive system phenotype|MP:0010382,abnormal dosage compensation, by inactivation of X chromosome
MGI:3047785	Xist<tm2.1Nbd>	MP:0010382,abnormal dosage compensation, by inactivation of X chromosome
MGI:3047784	Xist<tm2Nbd>	MP:0010382,abnormal dosage compensation, by inactivation of X chromosome
MGI:3583750	Xist<tm2Sado>	MP:0005384,cellular phenotype
MGI:3047786	Xist<tm3Nbd>	MP:0010382,abnormal dosage compensation, by inactivation of X chromosome
MGI:3639360	Xist<tm4.1Nbd>	MP:0002169,no abnormal phenotype detected
MGI:3772876	Xist<tm4Sado>	MP:0011091,prenatal lethality, complete penetrance
MGI:4950442	Xist<tm5.1Nbd>	MP:0002169,no abnormal phenotype detected
MGI:4950441	Xist<tm5.2Nbd>	MP:0000929,open neural tube|MP:0001698,decreased embryo size|MP:0003403,absent placental labyrinth|MP:0003984,embryonic growth retardation|MP:0004179,transmission ratio distortion|MP:0010382,abnormal dosage compensation, by inactivation of X chromosome|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3829654	Xist<tm5Sado>	MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0003787,abnormal imprinting|MP:0010736,abnormal extraembryonic ectoderm morphology|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5825311	Xkr4<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0003795,abnormal bone structure|MP:0010124,decreased bone mineral content
MGI:5613662	Xkr5<tm1b(KOMP)Mbp>	MP:0009142,decreased prepulse inhibition|MP:0013279,increased fasting circulating glucose level
MGI:7435549	Xkr7<em1(IMPC)Tcp>	MP:0002060,abnormal skin morphology
MGI:5528895	Xkr8<tm1.2Osa>	MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001935,decreased litter size|MP:0002216,abnormal seminiferous tubule morphology|MP:0002662,abnormal cauda epididymis morphology|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0006428,ectopic Sertoli cells|MP:0008280,abnormal male germ cell apoptosis|MP:0009851,abnormal Sertoli cell phagocytosis|MP:0014052,increased male germ cell apoptosis
MGI:5637183	Xkrx<tm1b(EUCOMM)Wtsi>	MP:0004794,increased anti-nuclear antigen antibody level
MGI:5581658	Xk<tm1Ariv>	MP:0003084,abnormal skeletal muscle fiber morphology|MP:0005369,muscle phenotype|MP:0005404,abnormal axon morphology|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0010738,abnormal internode morphology|MP:0011730,increased myelin sheath thickness|MP:0011731,decreased myelin sheath thickness|MP:0012368,increased erythrocyte magnesium level|MP:0012372,abnormal erythrocyte ion content
MGI:5558150	Xk<tm1b(KOMP)Mbp>	MP:0002060,abnormal skin morphology|MP:0002631,abnormal epididymis morphology|MP:0002941,increased circulating alanine transaminase level|MP:0004931,enlarged epididymis|MP:0005343,increased circulating aspartate transaminase level
MGI:3797607	Xlch	MP:0000278,abnormal myocardial fiber morphology|MP:0001625,cardiac hypertrophy|MP:0002083,premature death|MP:0002190,disorganized myocardium|MP:0002625,heart left ventricle hypertrophy|MP:0002833,increased heart weight|MP:0002953,thick ventricular wall|MP:0004058,abnormal ventricle papillary muscle morphology|MP:0004089,dilated sarcoplasmic reticulum|MP:0005599,increased cardiac muscle contractility|MP:0005608,cardiac interstitial fibrosis|MP:0006117,aortic valve stenosis|MP:0010593,thick aortic valve cusps|MP:0011088,neonatal lethality, incomplete penetrance|MP:0014343,abnormal myocardial fiber mitochondrial morphology
MGI:5585403	Xlhl	MP:0000377,abnormal hair follicle morphology|MP:0000416,sparse hair|MP:0000418,focal hair loss
MGI:3052638	Xls	MP:0000421,mottled coat|MP:0002938,white spotting
MGI:3689057	Xmo2<1R>	MP:0000421,mottled coat|MP:0001274,curly vibrissae|MP:0011091,prenatal lethality, complete penetrance
MGI:3689059	Xmo3<1R>	MP:0000421,mottled coat|MP:0001274,curly vibrissae|MP:0011091,prenatal lethality, complete penetrance
MGI:3689060	Xmo4<1R>	MP:0000371,diluted coat color|MP:0000421,mottled coat|MP:0001274,curly vibrissae|MP:0002109,abnormal limb morphology|MP:0011085,postnatal lethality, complete penetrance
MGI:3689061	Xmo5<1R>	MP:0000421,mottled coat|MP:0001274,curly vibrissae|MP:0011091,prenatal lethality, complete penetrance
MGI:3689062	Xmo6<1R>	MP:0000421,mottled coat|MP:0001274,curly vibrissae|MP:0011091,prenatal lethality, complete penetrance
MGI:4441710	Xndc1<tm1a(EUCOMM)Wtsi>	MP:0004613,fusion of vertebral arches
MGI:1857939	Xpa<tm1Hvs>	MP:0000601,small liver|MP:0001190,reddish skin|MP:0001192,scaly skin|MP:0001216,abnormal epidermal layer morphology|MP:0001314,cornea opacity|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0001786,skin edema|MP:0001874,acanthosis|MP:0002021,increased incidence of induced tumors|MP:0003717,pallor|MP:0004201,fetal growth retardation|MP:0004501,increased incidence of tumors by UV-induction|MP:0005621,abnormal cell physiology|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:2183931	Xpa<tm1Tnka>	MP:0001146,abnormal testis morphology|MP:0001152,increased Leydig cell number|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001790,abnormal immune system physiology|MP:0001922,reduced male fertility|MP:0002014,increased papilloma incidence|MP:0002020,increased tumor incidence|MP:0002021,increased incidence of induced tumors|MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0002631,abnormal epididymis morphology|MP:0003324,increased liver adenoma incidence|MP:0003945,abnormal lymphocyte physiology|MP:0004499,increased incidence of tumors by chemical induction|MP:0004501,increased incidence of tumors by UV-induction|MP:0004852,decreased testis weight|MP:0005362,abnormal Langerhans cell physiology|MP:0008019,increased liver tumor incidence|MP:0008044,increased NK cell number|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death|MP:0009704,increased skin squamous cell carcinoma incidence|MP:0009814,increased prostaglandin level|MP:0010766,abnormal NK cell physiology|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0014762,impaired base-excision repair
MGI:1931883	Xpc<tm1Brd>	MP:0001203,increased sensitivity to skin irradiation|MP:0001999,photosensitivity|MP:0004501,increased incidence of tumors by UV-induction|MP:0005621,abnormal cell physiology
MGI:1859840	Xpc<tm1Ecf>	MP:0000377,abnormal hair follicle morphology|MP:0001203,increased sensitivity to skin irradiation|MP:0001222,epidermal hyperplasia|MP:0002027,increased lung adenocarcinoma incidence|MP:0002048,increased lung adenoma incidence|MP:0003674,oxidative stress|MP:0008014,increased lung tumor incidence|MP:0008410,increased cellular sensitivity to ultraviolet irradiation induced cell death
MGI:1861233	Xpl	MP:0000519,hydronephrosis|MP:0000520,absent kidney|MP:0000536,hydroureter|MP:0000562,polydactyly|MP:0001925,male infertility|MP:0002286,cryptorchism|MP:0003675,kidney cyst|MP:0008985,hemimelia|MP:0012528,abnormal zone of polarizing activity morphology
MGI:5318196	Xpna	MP:0001577,anemia|MP:0009703,decreased birth body size|MP:0011091,prenatal lethality, complete penetrance
MGI:4973607	Xpnpep1<Gt(S22-1B1)Sor>	MP:0000433,microcephaly|MP:0000774,decreased brain size|MP:0000784,forebrain hypoplasia|MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0002962,increased urine protein level|MP:0003619,abnormal urine color|MP:0009703,decreased birth body size|MP:0010769,abnormal survival|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:4419636	Xpnpep1<tm1a(KOMP)Wtsi>	MP:0000286,abnormal mitral valve morphology|MP:0000438,abnormal cranium morphology|MP:0000602,dilated liver sinusoidal space|MP:0000703,abnormal thymus morphology|MP:0002747,abnormal aortic valve morphology|MP:0002928,abnormal bile duct morphology|MP:0002947,increased hemangioma incidence|MP:0003686,abnormal eye muscle morphology|MP:0003826,abnormal Mullerian duct morphology|MP:0006063,abnormal inferior vena cava morphology|MP:0006064,abnormal superior vena cava morphology|MP:0008044,increased NK cell number|MP:0008346,increased gamma-delta T cell number|MP:0010420,muscular ventricular septal defect|MP:0010490,abnormal inferior vena cava valve morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0013836,abnormal hypoglossal nerve topology|MP:0013848,subcutaneous edema|MP:0013875,increased trigeminal neuroma incidence|MP:0013966,abnormal infrahyoid muscle morphology|MP:0013967,abnormal infrahyoid muscle connection|MP:0013971,blood in lymph vessels|MP:0013985,abnormal umbilical vein topology|MP:0013986,abnormal vitelline vein topology|MP:0014001,abnormal vertebral artery topology|MP:0014018,embryo tumor|MP:0014023,abnormal intestine placement
MGI:5749455	Xpnpep3<tm1.1(KOMP)Vlcg>	MP:0010053,decreased grip strength
MGI:6152680	Xpo1<em1(IMPC)Mbp>	MP:0001914,hemorrhage|MP:0002833,increased heart weight|MP:0003054,spina bifida|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:7356624	Xpo4<em1Gshan>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004884,abnormal testis physiology|MP:0005578,teratozoospermia|MP:0008414,abnormal spatial reference memory|MP:0008428,abnormal spatial working memory|MP:0008948,decreased neuron number|MP:0009234,absent sperm head|MP:0009238,coiled sperm flagellum|MP:0009939,abnormal hippocampus neuron morphology|MP:0012006,abnormal hippocampus physiology|MP:0012556,increased cell death|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0020451,decreased sperm progressive motility
MGI:6402024	Xpo4<em1(IMPC)Tcp>	MP:0001297,microphthalmia|MP:0001325,abnormal retina morphology|MP:0001785,edema|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5490885	Xpo4<Gt(PT1-ATG)3EVal>	MP:0002169,no abnormal phenotype detected
MGI:6152681	Xpo5<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0001126,abnormal ovary morphology|MP:0001297,microphthalmia|MP:0001914,hemorrhage|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0003054,spina bifida|MP:0004832,enlarged ovary|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:7388268	Xpo7<em1.1Gmkf>	MP:0000208,decreased hematocrit|MP:0001545,abnormal hematopoietic system physiology|MP:0001577,anemia|MP:0002640,reticulocytosis|MP:0002875,decreased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0005397,hematopoietic system phenotype|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010067,increased red blood cell distribution width|MP:0031276,abnormal stress erythropoiesis
MGI:7388266	Xpo7<tm1.1Dglh>	MP:0002169,no abnormal phenotype detected
MGI:7388252	Xpo7<tm1c(KOMP)Wtsi>	MP:0000208,decreased hematocrit
MGI:7388255	Xpo7<tm1d(KOMP)Wtsi>	MP:0001577,anemia|MP:0002640,reticulocytosis|MP:0005397,hematopoietic system phenotype|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010067,increased red blood cell distribution width|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0013659,abnormal erythroid lineage cell morphology|MP:0031276,abnormal stress erythropoiesis
MGI:5576684	Xpot<tm3b(EUCOMM)Hmgu>	MP:0001491,unresponsive to tactile stimuli|MP:0001697,abnormal embryo size|MP:0003743,abnormal facial morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:1856706	Xpr1<Sxv>	MP:0020934,increased susceptibility to Retroviridae infection
MGI:3836442	Xrcc1<tm1Pmc>	MP:0000774,decreased brain size|MP:0000852,small cerebellum|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001732,postnatal growth retardation|MP:0001925,male infertility|MP:0002064,seizures|MP:0002083,premature death|MP:0002085,abnormal embryonic tissue morphology|MP:0002169,no abnormal phenotype detected|MP:0002216,abnormal seminiferous tubule morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0003203,increased neuron apoptosis|MP:0003246,loss of GABAergic neurons|MP:0003674,oxidative stress|MP:0004101,abnormal brain interneuron morphology|MP:0004852,decreased testis weight|MP:0005384,cellular phenotype|MP:0006035,abnormal mitochondrial morphology|MP:0006036,abnormal mitochondrial physiology|MP:0006378,abnormal spermatogonia morphology|MP:0006379,abnormal spermatocyte morphology|MP:0008026,abnormal brain white matter morphology|MP:0008058,abnormal DNA repair|MP:0009937,abnormal neuron differentiation|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011594,decreased catalase activity|MP:0011750,abnormal seminiferous tubule epithelium morphology|MP:0013504,increased embryonic tissue cell apoptosis|MP:0013601,increased testis apoptosis
MGI:1932097	Xrcc1<tm1Rpe>	MP:0001683,absent mesoderm|MP:0001685,abnormal endoderm development|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0005380,embryo phenotype|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance
MGI:2662686	Xrcc2<tm1Jtk>	MP:0000428,abnormal craniofacial morphology|MP:0000592,short tail|MP:0000914,exencephaly|MP:0001575,cyanosis|MP:0001698,decreased embryo size|MP:0001953,respiratory failure|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002084,abnormal developmental patterning|MP:0002270,abnormal pulmonary alveolus morphology|MP:0003203,increased neuron apoptosis|MP:0003720,abnormal neural tube closure|MP:0003984,embryonic growth retardation|MP:0006042,increased apoptosis|MP:0008441,thin cortical plate|MP:0008866,chromosomal instability|MP:0011087,neonatal lethality, complete penetrance|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3654106	Xrcc2<tm1Pmc>	MP:0006042,increased apoptosis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:3831320	Xrcc2<tm2Pmc>	MP:0003631,nervous system phenotype
MGI:7310058	Xrcc3<em2Mjn>	MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7310062	Xrcc3<em4Mjn>	MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5529638	Xrcc3<tm1b(KOMP)Mbp>	MP:0001730,embryonic growth arrest|MP:0002591,decreased mean corpuscular volume|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:1926771	Xrcc4<tm1Fwa>	MP:0000788,abnormal cerebral cortex morphology|MP:0001823,thymus hypoplasia|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0003203,increased neuron apoptosis|MP:0004029,spontaneous chromosome breakage|MP:0004201,fetal growth retardation|MP:0005621,abnormal cell physiology|MP:0006254,thin cerebral cortex|MP:0008058,abnormal DNA repair|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:6388354	Xrcc5<em1(IMPC)Ccpcz>	MP:0000137,abnormal vertebrae morphology|MP:0000160,kyphosis|MP:0000161,scoliosis|MP:0000221,decreased leukocyte cell number|MP:0000280,thin ventricular wall|MP:0000438,abnormal cranium morphology|MP:0000443,abnormal snout morphology|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000572,abnormal autopod morphology|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000703,abnormal thymus morphology|MP:0000706,small thymus|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001552,increased circulating triglyceride level|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002590,increased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002764,short tibia|MP:0002797,increased thigmotaxis|MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0002981,increased liver weight|MP:0003393,decreased cardiac output|MP:0003917,increased kidney weight|MP:0003921,abnormal heart left ventricle morphology|MP:0003961,decreased lean body mass|MP:0004174,abnormal spine curvature|MP:0004599,abnormal vertebral arch morphology|MP:0005270,abnormal zygomatic bone morphology|MP:0005387,immune system phenotype|MP:0005419,decreased circulating serum albumin level|MP:0005561,increased mean corpuscular hemoglobin|MP:0008040,decreased NK T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010052,increased grip strength|MP:0010053,decreased grip strength|MP:0010067,increased red blood cell distribution width|MP:0010097,abnormal retina blood vessel morphology|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010463,aorta stenosis|MP:0010580,decreased heart left ventricle size|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0011496,abnormal head size|MP:0011952,decreased cardiac stroke volume|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number|MP:0013519,decreased CD4-positive NK T cell number|MP:0013522,decreased memory-marker CD4-positive NK T cell number|MP:0013764,decreased T-helper cell number|MP:0013771,decreased effector memory T-helper cell number|MP:0013772,increased effector memory T-helper cell number
MGI:6304305	Xrcc5<m1Btlr>	MP:0000219,increased neutrophil cell number|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0005018,decreased T cell number|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008126,increased dendritic cell number|MP:0008167,increased B-1a cell number|MP:0008169,increased B-1b cell number|MP:0008207,decreased B-2 B cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:2179987	Xrcc5<tm1Dbr>	MP:0001325,abnormal retina morphology|MP:0001802,arrested B cell differentiation|MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0002144,abnormal B cell differentiation|MP:0003203,increased neuron apoptosis|MP:0004028,chromosome breakage|MP:0005090,increased double-negative T cell number|MP:0008070,absent T cells|MP:0008101,lymph node hypoplasia|MP:0010768,mortality/aging|MP:0011101,prenatal lethality, incomplete penetrance|MP:0030005,increased retina apoptosis
MGI:2152542	Xrcc5<tm1Nus>	MP:0000694,spleen hypoplasia|MP:0001265,decreased body size|MP:0001386,abnormal maternal nurturing|MP:0001800,abnormal humoral immune response|MP:0001823,thymus hypoplasia|MP:0001935,decreased litter size|MP:0002398,abnormal bone marrow cell morphology/development|MP:0004201,fetal growth retardation|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0004816,abnormal class switch recombination|MP:0008974,proportional dwarf|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014764,impaired double-strand DNA break repair
MGI:4458398	Xrcc6<avon>	MP:0005017,decreased B cell number|MP:0005018,decreased T cell number
MGI:2179954	Xrcc6<tm1Fwa>	MP:0000238,absent pre-B cells|MP:0000352,decreased cell proliferation|MP:0000715,decreased thymocyte number|MP:0000830,abnormal diencephalon morphology|MP:0001265,decreased body size|MP:0001382,abnormal nursing|MP:0001802,arrested B cell differentiation|MP:0001806,decreased IgM level|MP:0002007,increased cellular sensitivity to gamma-irradiation induced cell death|MP:0002024,increased T cell derived lymphoma incidence|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0003203,increased neuron apoptosis|MP:0003631,nervous system phenotype|MP:0004077,abnormal striatum morphology|MP:0004939,abnormal B cell morphology|MP:0005091,increased double-positive T cell number|MP:0005277,abnormal brainstem morphology|MP:0005621,abnormal cell physiology|MP:0008008,early cellular replicative senescence|MP:0008037,abnormal T cell morphology|MP:0008083,decreased single-positive T cell number|MP:0008212,absent mature B cells|MP:0008213,absent immature B cells|MP:0008489,slow postnatal weight gain
MGI:3625858	Xrcc6<tm1Gcl>	MP:0000692,small spleen|MP:0000694,spleen hypoplasia|MP:0000706,small thymus|MP:0001823,thymus hypoplasia|MP:0001935,decreased litter size|MP:0002144,abnormal B cell differentiation|MP:0002217,small lymph nodes|MP:0002398,abnormal bone marrow cell morphology/development|MP:0002722,abnormal immune system organ morphology|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0005621,abnormal cell physiology|MP:0008212,absent mature B cells|MP:0008479,decreased spleen white pulp amount|MP:0008974,proportional dwarf
MGI:7621400	Xrn1<em1.1Tya>	MP:0000929,open neural tube|MP:0003984,embryonic growth retardation|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:7621399	Xrn1<em1Tya>	MP:0000005,increased brown adipose tissue amount|MP:0000008,increased white adipose tissue amount|MP:0000598,abnormal liver morphology|MP:0001257,increased body length|MP:0001260,increased body weight|MP:0001261,obese|MP:0001262,decreased body weight|MP:0001392,abnormal locomotor behavior|MP:0002079,increased circulating insulin level|MP:0002175,decreased brain weight|MP:0002981,increased liver weight|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005559,increased circulating glucose level|MP:0005645,abnormal hypothalamus physiology|MP:0005669,increased circulating leptin level|MP:0009118,increased white fat cell size|MP:0009288,increased epididymal fat pad weight|MP:0009292,increased inguinal fat pad weight|MP:0010378,increased respiratory quotient|MP:0011699,abnormal brown adipose tissue thermogenesis|MP:0011939,increased food intake|MP:0013245,abnormal lipid metabolism|MP:0014441,decreased response to leptin
MGI:5792938	Xtol	MP:0000556,abnormal hindlimb morphology|MP:0000562,polydactyly|MP:0000564,syndactyly|MP:0000567,truncated digits|MP:0002109,abnormal limb morphology|MP:0002110,abnormal digit morphology|MP:0006279,abnormal limb development|MP:0011101,prenatal lethality, incomplete penetrance|MP:0012000,abnormal limb position
MGI:4456689	Xxylt1<tm1a(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0002098,abnormal vibrissa morphology|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount
MGI:3512504	Xydsq<M. macedonius>	MP:0005169,abnormal male meiosis
MGI:4435322	Xylb<tm1a(EUCOMM)Hmgu>	MP:0000062,increased bone mineral density|MP:0001486,abnormal startle reflex|MP:0002896,abnormal bone mineralization|MP:0002966,decreased circulating alkaline phosphatase level|MP:0003960,increased lean body mass|MP:0005316,abnormal response to tactile stimuli
MGI:6189558	Xylt1<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002109,abnormal limb morphology|MP:0003743,abnormal facial morphology|MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0020870,decreased thigmotaxis
MGI:6761397	Xylt1<m1Btlr>	MP:0002764,short tibia|MP:0003109,short femur
MGI:6761399	Xylt1<m2Btlr>	MP:0002764,short tibia|MP:0003109,short femur
MGI:5563785	Xylt1<npo>	MP:0000088,short mandible|MP:0000167,decreased chondrocyte number|MP:0000445,short snout|MP:0001265,decreased body size|MP:0002427,disproportionate dwarf|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003416,premature bone ossification|MP:0003795,abnormal bone structure|MP:0003854,abnormal forelimb stylopod morphology|MP:0003855,abnormal forelimb zeugopod morphology|MP:0003856,abnormal hindlimb stylopod morphology|MP:0003857,abnormal hindlimb zeugopod morphology|MP:0004351,short humerus|MP:0004359,short ulna|MP:0004672,short ribs|MP:0005378,growth/size/body region phenotype|MP:0005390,skeleton phenotype|MP:0008272,abnormal endochondral bone ossification|MP:0008396,abnormal osteoclast differentiation|MP:0009347,increased trabecular bone thickness|MP:0010103,small thoracic cage|MP:0010869,decreased bone trabecula number|MP:0010878,increased trabecular bone volume|MP:0010932,increased trabecular bone connectivity density|MP:0010971,abnormal periosteum morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0014288,rhizomelic limb
MGI:3714171	Xylt2<tm1Meh>	MP:0000519,hydronephrosis|MP:0000609,abnormal liver physiology|MP:0002705,dilated renal tubule|MP:0002981,increased liver weight|MP:0003327,liver cyst|MP:0003333,liver fibrosis|MP:0003675,kidney cyst|MP:0003917,increased kidney weight|MP:0005083,abnormal biliary tract morphology|MP:0005141,liver hyperplasia|MP:0005565,increased blood urea nitrogen level
MGI:1856277	Yaa	MP:0000220,increased monocyte cell number|MP:0000702,enlarged lymph nodes|MP:0001819,abnormal immune cell physiology|MP:0002083,premature death|MP:0002144,abnormal B cell differentiation|MP:0002339,abnormal lymph node morphology|MP:0002493,increased IgG level|MP:0002723,abnormal immune serum protein physiology|MP:0002743,glomerulonephritis|MP:0002875,decreased erythrocyte cell number|MP:0002962,increased urine protein level|MP:0003725,increased autoantibody level|MP:0003944,abnormal T cell subpopulation ratio|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004797,increased anti-erythrocyte antigen antibody level|MP:0004952,increased spleen weight|MP:0005350,increased susceptibility to autoimmune disorder|MP:0005654,porphyria|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008097,increased plasma cell number|MP:0008182,decreased marginal zone B cell number|MP:0008470,abnormal spleen B cell follicle morphology|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level|MP:0009060,increased circulating interleukin-21 level|MP:0009336,increased splenocyte proliferation|MP:0009338,increased splenocyte number|MP:0020519,renal glomerular immunoglobulin deposits
MGI:2154381	Yaa2<BXSB/J>	MP:0001859,kidney inflammation
MGI:2154383	Yaa3<BXSB/J>	MP:0001859,kidney inflammation
MGI:2154385	Yaa4<BXSB/J>	MP:0001859,kidney inflammation
MGI:2156782	Yaail<NZW/Ola>	MP:0002743,glomerulonephritis|MP:0004762,increased anti-double stranded DNA antibody level
MGI:5548529	Yae1d1<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0001556,increased circulating HDL cholesterol level|MP:0002968,increased circulating alkaline phosphatase level|MP:0005178,increased circulating cholesterol level|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0011886,increased circulating lipase level
MGI:5760324	yahsmts	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility
MGI:5760314	yahsmts2	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility
MGI:5760299	yahsmts3	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility
MGI:5760343	yahsmts4	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility
MGI:5760337	yahsmts5	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility
MGI:5760332	yahsmts6	MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility
MGI:6268758	Yap1<M1Btlr>	MP:0008537,increased susceptibility to induced colitis
MGI:4819826	Yap1<tm1.1Dupa>	MP:0000599,enlarged liver|MP:0000603,pale liver|MP:0000607,abnormal hepatocyte morphology|MP:0002928,abnormal bile duct morphology|MP:0002929,abnormal bile duct development|MP:0002941,increased circulating alanine transaminase level|MP:0003046,liver cirrhosis|MP:0003333,liver fibrosis|MP:0003887,increased hepatocyte apoptosis|MP:0003893,increased hepatocyte proliferation|MP:0005344,increased circulating bilirubin level|MP:0005381,digestive/alimentary phenotype|MP:0008537,increased susceptibility to induced colitis|MP:0008883,abnormal enterocyte proliferation|MP:0008885,increased enterocyte apoptosis|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0031115,macrovesicular hepatic steatosis
MGI:5446483	Yap1<tm1.1Eno>	MP:0000280,thin ventricular wall|MP:0001544,abnormal cardiovascular system physiology|MP:0001855,abnormal atrial thrombosis|MP:0001954,respiratory distress|MP:0002083,premature death|MP:0002652,thin myocardium|MP:0002795,dilated cardiomyopathy|MP:0003037,increased myocardial infarct size|MP:0003141,cardiac fibrosis|MP:0005140,decreased cardiac muscle contractility|MP:0005202,lethargy|MP:0005329,abnormal myocardium layer morphology|MP:0005333,decreased heart rate|MP:0008022,dilated heart ventricle|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5316446	Yap1<tm1.1Fcam>	MP:0000351,increased cell proliferation|MP:0000352,decreased cell proliferation|MP:0001191,abnormal skin condition|MP:0001199,thin skin|MP:0001216,abnormal epidermal layer morphology|MP:0001218,thin epidermis|MP:0001231,abnormal epidermis stratum basale morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0002796,impaired skin barrier function|MP:0009714,thin epidermis stratum basale|MP:0011004,abnormal epidermal stem cell morphology
MGI:6716871	Yap1<tm1.1Hmc>	MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0003690,abnormal glial cell physiology|MP:0006071,abnormal retina progenitor cell morphology|MP:0008444,retina cone cell degeneration|MP:0008446,decreased retina cone cell number|MP:0009392,retina gliosis|MP:0012029,abnormal electroretinogram waveform feature|MP:0012144,decreased b-wave amplitude|MP:0020359,abnormal ribbon synapse morphology
MGI:4819827	Yap1<tm1.2Dupa>	MP:0011100,preweaning lethality, complete penetrance
MGI:5548341	Yap1<tm1b(KOMP)Mbp>	MP:0011100,preweaning lethality, complete penetrance
MGI:5486298	Yap1<tm1Hmc>	MP:0000521,abnormal kidney cortex morphology|MP:0000524,decreased renal tubule number|MP:0000527,abnormal kidney development|MP:0001325,abnormal retina morphology|MP:0002703,abnormal renal tubule morphology|MP:0003014,abnormal kidney medulla morphology|MP:0003446,renal hypoplasia|MP:0003624,anuria|MP:0003690,abnormal glial cell physiology|MP:0004193,abnormal kidney papilla morphology|MP:0004505,decreased renal glomerulus number|MP:0004755,abnormal loop of Henle morphology|MP:0004756,abnormal proximal convoluted tubule morphology|MP:0004936,impaired branching involved in ureteric bud morphogenesis|MP:0005325,abnormal renal glomerulus morphology|MP:0008140,podocyte foot process effacement|MP:0009392,retina gliosis|MP:0011085,postnatal lethality, complete penetrance|MP:0011334,abnormal nephrogenic zone morphology|MP:0011364,abnormal metanephros morphology
MGI:3608880	Yap1<tm1Smil>	MP:0001614,abnormal blood vessel morphology|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0001701,incomplete embryo turning|MP:0001704,abnormal dorsal-ventral axis patterning|MP:0001718,abnormal visceral yolk sac morphology|MP:0001721,absent visceral yolk sac blood islands|MP:0001723,disorganized yolk sac vascular plexus|MP:0002085,abnormal embryonic tissue morphology|MP:0003384,abnormal ventral body wall morphology|MP:0003632,abnormal nervous system morphology|MP:0003885,abnormal rostral-caudal body axis extension|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011205,excessive folding of visceral yolk sac|MP:0012135,embryonic-extraembryonic boundary constriction|MP:0012740,abnormal posterior primitive streak morphology
MGI:5660284	Yap1<tm2.1Dupa>	MP:0004499,increased incidence of tumors by chemical induction
MGI:7257843	Yars1<tm1.1Rwb>	MP:0020845,abnormal DNA-templated transcription
MGI:5513836	Yars1<tm1b(KOMP)Wtsi>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:4334333	Ybx1<Gt(W094B04)Wrst>	MP:0011092,embryonic lethality, complete penetrance
MGI:3581780	Ybx1<tm1Ley>	MP:0000428,abnormal craniofacial morphology|MP:0000600,liver hypoplasia|MP:0000914,exencephaly|MP:0001575,cyanosis|MP:0001698,decreased embryo size|MP:0001916,intracerebral hemorrhage|MP:0001953,respiratory failure|MP:0003186,abnormal redox activity|MP:0003717,pallor|MP:0003720,abnormal neural tube closure|MP:0004200,decreased fetal size|MP:0008008,early cellular replicative senescence|MP:0011087,neonatal lethality, complete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011111,lethality during fetal growth through weaning, complete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:3698273	Ybx1<tm1Tuch>	MP:0000358,abnormal cell morphology|MP:0000455,abnormal maxilla morphology|MP:0000458,abnormal mandible morphology|MP:0000601,small liver|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0001785,edema|MP:0002123,abnormal definitive hematopoiesis|MP:0003984,embryonic growth retardation|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0011704,decreased fibroblast proliferation
MGI:3576937	Ybx2<tm1Nbh>	MP:0001126,abnormal ovary morphology|MP:0001127,small ovary|MP:0001129,impaired ovarian folliculogenesis|MP:0001147,small testis|MP:0001155,arrest of spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002016,ovary cyst|MP:0002679,abnormal corpus luteum morphology|MP:0003696,abnormal zona pellucida morphology|MP:0005159,azoospermia|MP:0005431,decreased oocyte number|MP:0014052,increased male germ cell apoptosis|MP:0014604,hemorrhagic ovary cyst|MP:0031422,failure of superovulation
MGI:6156170	Ybx3<em1(IMPC)Rbrc>	MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0004002,abnormal jejunum morphology
MGI:3693011	Ybx3<tm1Ley>	MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002687,oligozoospermia
MGI:5523231	Ydjc<tm1.1(KOMP)Vlcg>	MP:0000063,decreased bone mineral density|MP:0001523,impaired righting response|MP:0001556,increased circulating HDL cholesterol level|MP:0002608,increased hematocrit|MP:0002968,increased circulating alkaline phosphatase level|MP:0003131,increased erythrocyte cell number|MP:0005560,decreased circulating glucose level|MP:0005564,increased hemoglobin content|MP:0005633,increased circulating sodium level
MGI:4419362	Ydjc<tm1(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0003960,increased lean body mass|MP:0008177,increased germinal center B cell number|MP:0010025,decreased total body fat amount|MP:0013772,increased effector memory T-helper cell number
MGI:5910402	Yeats2<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002075,abnormal coat/hair pigmentation|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6384942	Yeats4<em1Zfa>	MP:0002378,abnormal gut-associated lymphoid tissue morphology|MP:0002401,abnormal lymphopoiesis|MP:0002412,increased susceptibility to bacterial infection|MP:0002498,abnormal acute inflammation|MP:0003945,abnormal lymphocyte physiology|MP:0005016,decreased lymphocyte cell number|MP:0008133,decreased Peyer's patch number|MP:0008567,decreased interferon-gamma secretion|MP:0008568,abnormal interleukin secretion|MP:0008664,decreased interleukin-12 secretion|MP:0008703,decreased interleukin-5 secretion
MGI:6384943	Yeats4<em2Zfa>	MP:0011092,embryonic lethality, complete penetrance
MGI:1857269	Yes1<tm1Sor>	MP:0002169,no abnormal phenotype detected
MGI:1929675	Yes1<tm2Sor>	MP:0002169,no abnormal phenotype detected
MGI:6379294	Yif1a<em1(IMPC)J>	MP:0002968,increased circulating alkaline phosphatase level
MGI:6393258	Yif1b<tm1.2Ics>	MP:0011743,abnormal Golgi apparatus morphology|MP:0030949,abnormal Golgi vesicle transport|MP:0030953,abnormal Golgi cisterna morphology
MGI:4432914	Yipf1<tm1a(EUCOMM)Wtsi>	MP:0001391,abnormal tail movements|MP:0002169,no abnormal phenotype detected
MGI:5574599	Yipf5<tm1b(EUCOMM)Hmgu>	MP:0002875,decreased erythrocyte cell number|MP:0002953,thick ventricular wall|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0009141,increased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6276902	Yipf6<em1(IMPC)Mbp>	MP:0000220,increased monocyte cell number|MP:0000689,abnormal spleen morphology|MP:0001293,anophthalmia|MP:0002092,abnormal eye morphology
MGI:4839074	Yipf6<M1Btlr>	MP:0000495,abnormal colon morphology|MP:0000496,abnormal small intestine morphology|MP:0002816,colitis|MP:0003449,abnormal intestine goblet cell morphology|MP:0004843,abnormal Paneth cell morphology|MP:0008537,increased susceptibility to induced colitis|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0010180,increased susceptibility to weight loss|MP:0013486,decreased Paneth cell number
MGI:5300493	Y(IsXPAR;Y)Ei	MP:0009451,abnormal chromosomal synapsis
MGI:5563210	Yju2<tm1b(KOMP)Wtsi>	MP:0001325,abnormal retina morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6360693	Ykt6<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0001415,increased exploration in new environment|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:5661980	Ylpm1<tm1b(KOMP)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0001486,abnormal startle reflex|MP:0001693,failure of primitive streak formation|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0009331,absent primitive node|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content|MP:0011095,embryonic lethality between implantation and placentation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012724,absent head fold|MP:0013279,increased fasting circulating glucose level|MP:0013292,embryonic lethality prior to organogenesis|MP:0014586,decreased egg cylinder size
MGI:1857324	Ym	MP:0000421,mottled coat|MP:0001510,abnormal coat appearance|MP:0010771,integument phenotype|MP:0011091,prenatal lethality, complete penetrance
MGI:5911072	Yme1l1<tm1.1Tlan>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5629742	Yme1l1<tm1Tlan>	MP:0000266,abnormal heart morphology|MP:0001263,weight loss|MP:0001544,abnormal cardiovascular system physiology|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002727,decreased circulating insulin level|MP:0002753,dilated heart left ventricle|MP:0002795,dilated cardiomyopathy|MP:0003141,cardiac fibrosis|MP:0005293,impaired glucose tolerance|MP:0005385,cardiovascular system phenotype|MP:0006036,abnormal mitochondrial physiology|MP:0006138,congestive heart failure|MP:0010632,cardiac muscle necrosis|MP:0010768,mortality/aging|MP:0011631,decreased mitochondrial size|MP:0014343,abnormal myocardial fiber mitochondrial morphology|MP:0030018,increased cardiac muscle cell glucose uptake|MP:0031078,increased circulating troponin T level|MP:0031633,decreased heart left ventricle muscle contractility
MGI:7738762	Yod1<em1Smoc>	MP:0001846,increased inflammatory response|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0002551,abnormal blood coagulation|MP:0003179,thrombocytopenia|MP:0008641,increased circulating interleukin-1 beta level|MP:0008657,increased interleukin-1 beta secretion|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0011078,increased macrophage cytokine production|MP:0012330,decreased circulating fibrinogen level|MP:0012359,increased partial thromboplastin time|MP:0031083,increased circulating D-dimer level|MP:0031121,increased susceptibility to induced thrombosis
MGI:6473481	Yod1<tm1bNarl>	MP:0000219,increased neutrophil cell number|MP:0002941,increased circulating alanine transaminase level|MP:0005016,decreased lymphocyte cell number|MP:0005343,increased circulating aspartate transaminase level
MGI:6156500	Ypel2<em1(IMPC)Tcp>	MP:0000157,abnormal sternum morphology|MP:0001258,decreased body length|MP:0002092,abnormal eye morphology|MP:0002100,abnormal tooth morphology|MP:0003233,prolonged QT interval|MP:0009142,decreased prepulse inhibition|MP:0011874,enlarged urinary bladder
MGI:5548509	Ypel3<tm1.1(KOMP)Vlcg>	MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0002574,increased vertical activity|MP:0002590,increased mean corpuscular volume|MP:0002764,short tibia|MP:0002968,increased circulating alkaline phosphatase level|MP:0004738,abnormal auditory brainstem response|MP:0006203,eye hemorrhage
MGI:4456736	Ypel4<tm1a(EUCOMM)Wtsi>	MP:0001554,increased circulating free fatty acids level|MP:0010024,increased total body fat amount
MGI:6194737	Ythdc1<tm1.2Jw>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5911671	Ythdc2<em1Chhe>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002209,decreased germ cell number|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:5911567	Ythdc2<em1Embrp>	MP:0001131,abnormal ovarian follicle morphology|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002777,absent ovarian follicles|MP:0003205,testicular atrophy|MP:0004833,ovary atrophy|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005431,decreased oocyte number|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:6257552	Ythdc2<em1(IMPC)Bay>	MP:0000063,decreased bone mineral density|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002834,decreased heart weight|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5911553	Ythdc2<em1Sky>	MP:0001127,small ovary|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0004852,decreased testis weight|MP:0005266,abnormal metabolism|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:5911672	Ythdc2<em2Chhe>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002209,decreased germ cell number|MP:0005159,azoospermia
MGI:5911568	Ythdc2<em2Embrp>	MP:0001131,abnormal ovarian follicle morphology|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002777,absent ovarian follicles|MP:0003205,testicular atrophy|MP:0004833,ovary atrophy|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005431,decreased oocyte number|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:8250765	Ythdc2<em2Sky>	MP:0002169,no abnormal phenotype detected|MP:0005389,reproductive system phenotype
MGI:8253161	Ythdc2<em3Sky>	MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0003205,testicular atrophy|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0005389,reproductive system phenotype|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis|MP:0014634,decreased round spermatid number|MP:0014636,decreased elongated spermatid number
MGI:5911552	Ythdc2<ketu>	MP:0001127,small ovary|MP:0001153,small seminiferous tubules|MP:0001925,male infertility|MP:0001926,female infertility|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:6356299	Ythdf1<em1Chhe>	MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002912,abnormal excitatory postsynaptic potential|MP:0003631,nervous system phenotype|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0005386,behavior/neurological phenotype|MP:0008414,abnormal spatial reference memory|MP:0009454,impaired contextual conditioning behavior|MP:0009940,abnormal hippocampus pyramidal cell morphology|MP:0012307,impaired spatial learning|MP:0013272,abnormal translation|MP:0014252,abnormal paired-pulse ratio|MP:0020508,decreased dendritic spine density
MGI:6491616	Ythdf1<em2Jhha>	MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:6356298	Ythdf1<tm1.1Sjj>	MP:0002961,abnormal axon guidance|MP:0008469,abnormal protein level
MGI:6491617	Ythdf2<em2Jhha>	MP:0001154,seminiferous tubule degeneration|MP:0001922,reduced male fertility|MP:0001926,female infertility|MP:0002687,oligozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0005389,reproductive system phenotype|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5911733	Ythdf2<tm1.1Doca>	MP:0001926,female infertility|MP:0002169,no abnormal phenotype detected|MP:0003718,maternal effect
MGI:5911734	Ythdf2<tm1.2Doca>	MP:0001926,female infertility|MP:0005389,reproductive system phenotype|MP:0011110,preweaning lethality, incomplete penetrance
MGI:7444511	Ythdf2<tm1c(KOMP)Wtsi>	MP:0000242,impaired fertilization|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0005266,abnormal metabolism|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0014052,increased male germ cell apoptosis|MP:0020451,decreased sperm progressive motility
MGI:6343198	Ythdf3<em1Caox>	MP:0002451,abnormal macrophage physiology|MP:0005387,immune system phenotype|MP:0020914,decreased susceptibility to Riboviria infection|MP:0031023,decreased susceptibility to Riboviria infection induced morbidity/mortality
MGI:6276848	Ythdf3<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002941,increased circulating alanine transaminase level
MGI:6491619	Ythdf3<em2Jhha>	MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0010768,mortality/aging
MGI:7308745	Ywhab<em1Gpt>	MP:0005293,impaired glucose tolerance|MP:0005559,increased circulating glucose level|MP:0010398,decreased liver glycogen level|MP:0030974,enhanced gluconeogenesis
MGI:6161255	Ywhab<tm1b(EUCOMM)Hmgu>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001325,abnormal retina morphology|MP:0003179,thrombocytopenia|MP:0004151,decreased circulating iron level|MP:0004924,abnormal behavior|MP:0005179,decreased circulating cholesterol level|MP:0005344,increased circulating bilirubin level|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0005566,decreased blood urea nitrogen level|MP:0005567,decreased circulating total protein level|MP:0011965,decreased total retina thickness
MGI:2667341	Ywhae<tm1Awb>	MP:0000266,abnormal heart morphology|MP:0000280,thin ventricular wall|MP:0000788,abnormal cerebral cortex morphology|MP:0001575,cyanosis|MP:0001935,decreased litter size|MP:0002152,abnormal brain morphology|MP:0002189,abnormal myocardial trabeculae morphology|MP:0003077,abnormal cell cycle|MP:0003921,abnormal heart left ventricle morphology|MP:0004057,thin myocardium compact layer|MP:0004759,decreased mitotic index|MP:0005294,abnormal heart ventricle morphology|MP:0008022,dilated heart ventricle|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0010402,ventricular septal defect|MP:0010556,thin ventricle myocardium compact layer|MP:0011089,perinatal lethality, complete penetrance|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011390,abnormal fetal cardiomyocyte physiology|MP:0011395,decreased fetal cardiomyocyte proliferation|MP:0014553,decreased neuronal migration
MGI:5762859	Ywhae<tm2.1Awb>	MP:0005389,reproductive system phenotype
MGI:6380689	Ywhae<tm2.2Awb>	MP:0001926,female infertility
MGI:3530054	Ywhag<tm1Bros>	MP:0002169,no abnormal phenotype detected
MGI:6380691	Ywhah<tm1.1Cya>	MP:0005389,reproductive system phenotype
MGI:6380693	Ywhah<tm1.2Cya>	MP:0005389,reproductive system phenotype
MGI:5907862	Ywhaq<em1(IMPC)J>	MP:0001325,abnormal retina morphology
MGI:3700919	Ywhaq<Gt(RRR746)Byg>	MP:0001544,abnormal cardiovascular system physiology|MP:0001698,decreased embryo size|MP:0001730,embryonic growth arrest|MP:0002753,dilated heart left ventricle|MP:0003037,increased myocardial infarct size|MP:0003222,increased cardiomyocyte apoptosis|MP:0003984,embryonic growth retardation|MP:0005294,abnormal heart ventricle morphology|MP:0005385,cardiovascular system phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0009763,increased susceptibility to induced morbidity/mortality|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4307338	Ywhaz<Gt(OST405390)Lex>	MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0005386,behavior/neurological phenotype|MP:0011086,postnatal lethality, incomplete penetrance
MGI:4315078	Ywhaz<Gt(OST432062)Lex>	MP:0000813,abnormal hippocampus layer morphology|MP:0001265,decreased body size|MP:0001364,decreased anxiety-related response|MP:0001489,decreased startle reflex|MP:0001732,postnatal growth retardation|MP:0003461,abnormal response to novel object|MP:0003631,nervous system phenotype|MP:0005386,behavior/neurological phenotype|MP:0006009,abnormal neuronal migration|MP:0008143,abnormal dendrite morphology|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008428,abnormal spatial working memory|MP:0009142,decreased prepulse inhibition|MP:0009938,abnormal hippocampus granule cell morphology|MP:0010011,ectopic hippocampus pyramidal cells|MP:0011086,postnatal lethality, incomplete penetrance|MP:0014367,impaired long-term object recognition memory|MP:0014745,abnormal hippocampal mossy fiber infrapyramidal bundle morphology|MP:0031391,increased locomotor activity
MGI:5605747	Ywhaz<tm1b(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0000702,enlarged lymph nodes|MP:0001325,abnormal retina morphology|MP:0001785,edema|MP:0002060,abnormal skin morphology|MP:0002764,short tibia|MP:0004122,abnormal sinus arrhythmia|MP:0005013,increased lymphocyte cell number|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2445451	Yy1<tm1Yshi>	MP:0000914,exencephaly|MP:0001694,absent egg cylinders|MP:0001698,decreased embryo size|MP:0011092,embryonic lethality, complete penetrance
MGI:3624790	Yy1<tm2.1Yshi>	MP:0000394,absent hair follicle melanin granules|MP:0001175,abnormal lung morphology|MP:0001176,abnormal lung development|MP:0001953,respiratory failure|MP:0002075,abnormal coat/hair pigmentation|MP:0002169,no abnormal phenotype detected|MP:0002282,abnormal trachea morphology|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0003120,abnormal tracheal cartilage morphology|MP:0003178,left pulmonary isomerism|MP:0004381,abnormal hair follicle melanocyte morphology|MP:0004880,lung cyst|MP:0005072,abnormal hair follicle melanin granule morphology|MP:0006382,abnormal lung epithelium morphology|MP:0008021,increased blastoma incidence|MP:0008238,abnormal dorsoventral coat patterning|MP:0009783,abnormal melanoblast morphology|MP:0010862,decreased respiratory mucosa goblet cell number|MP:0010883,trachea stenosis|MP:0010949,decreased club cell number|MP:0011024,abnormal branching involved in lung morphogenesis|MP:0011083,lethality at weaning, complete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011113,abnormal airway basal cell morphology|MP:0011142,abnormal lung-associated mesenchyme development|MP:0011627,decreased skin pigmentation|MP:0012023,decreased melanocyte number|MP:0012197,impaired myofibroblast differentiation|MP:0014200,abnormal respiratory epithelium physiology|MP:0030002,increased lung apoptosis
MGI:3625967	Yy1<tm2Yshi>	MP:0009703,decreased birth body size|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5562922	Yy1<tm3.1Yshi>	MP:0005387,immune system phenotype
MGI:6152682	Yy2<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001293,anophthalmia|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology
MGI:4839099	Zan<tm1Dmh>	MP:0005389,reproductive system phenotype|MP:0030978,impaired binding of sperm to zona pellucida
MGI:4867219	Zap70<m1Btlr>	MP:0000727,absent CD8-positive, alpha-beta T cells|MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0003790,absent CD4-positive, alpha-beta T cells|MP:0004816,abnormal class switch recombination|MP:0005018,decreased T cell number|MP:0005387,immune system phenotype
MGI:2683318	Zap70<m1Saka>	MP:0000066,osteoporosis|MP:0001246,mixed cellular infiltration to dermis|MP:0001829,increased activated T cell number|MP:0001861,lung inflammation|MP:0002145,abnormal T cell differentiation|MP:0002169,no abnormal phenotype detected|MP:0002461,increased immunoglobulin level|MP:0002935,chronic joint inflammation|MP:0002936,joint swelling|MP:0003189,fused joints|MP:0003561,rheumatoid arthritis|MP:0003724,increased susceptibility to induced arthritis|MP:0003725,increased autoantibody level|MP:0003850,abnormal thymocyte activation|MP:0004917,abnormal T cell selection|MP:0004919,abnormal positive T cell selection|MP:0004974,decreased regulatory T cell number|MP:0005002,abnormal T cell clonal deletion|MP:0005014,increased B cell number|MP:0005095,decreased T cell proliferation|MP:0008049,increased memory T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008681,increased interleukin-17 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008826,abnormal splenic cell ratio|MP:0008827,abnormal thymus cell ratio|MP:0008828,abnormal lymph node cell ratio|MP:0030795,joint dislocation
MGI:5141315	Zap70<m2Btlr>	MP:0005018,decreased T cell number
MGI:5690199	Zap70<m3Btlr>	MP:0001805,decreased IgG level|MP:0020154,impaired humoral immune response
MGI:5806458	Zap70<m4Btlr>	MP:0001606,impaired hematopoiesis|MP:0005018,decreased T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:6113444	Zap70<m5Btlr>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0005014,increased B cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:6113448	Zap70<m6Btlr>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0005014,increased B cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0010169,decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010841,increased central memory CD4-positive, alpha-beta T cell number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:3800788	Zap70<m6Hefl>	MP:0001800,abnormal humoral immune response|MP:0002145,abnormal T cell differentiation|MP:0002497,increased IgE level|MP:0005018,decreased T cell number|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008499,increased IgG1 level
MGI:6113455	Zap70<m7Btlr>	MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number
MGI:6286299	Zap70<m8Btlr>	MP:0010847,increased central memory CD8 positive, alpha-beta T cell number|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:3614790	Zap70<mrtle>	MP:0001825,arrested T cell differentiation|MP:0002408,abnormal double-positive T cell morphology|MP:0003944,abnormal T cell subpopulation ratio|MP:0004919,abnormal positive T cell selection|MP:0004972,abnormal regulatory T cell number|MP:0005018,decreased T cell number|MP:0005091,increased double-positive T cell number|MP:0008070,absent T cells|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:3614796	Zap70<mur>	MP:0001828,abnormal T cell activation|MP:0002444,abnormal T cell physiology|MP:0005018,decreased T cell number|MP:0008501,increased IgG2b level
MGI:3526403	Zap70<st>	MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0002444,abnormal T cell physiology|MP:0005018,decreased T cell number
MGI:2388913	Zap70<tm1.1Mmal>	MP:0005387,immune system phenotype
MGI:2677447	Zap70<tm1Dlo>	MP:0005091,increased double-positive T cell number
MGI:2176252	Zap70<tm1Weis>	MP:0001825,arrested T cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0002217,small lymph nodes|MP:0008826,abnormal splenic cell ratio|MP:0008828,abnormal lymph node cell ratio
MGI:2388918	Zap70<tm2.1Mmal>	MP:0005387,immune system phenotype
MGI:4399123	Zap70<tm2.1Weis>	MP:0001829,increased activated T cell number|MP:0003850,abnormal thymocyte activation|MP:0004919,abnormal positive T cell selection|MP:0004946,abnormal regulatory T cell physiology|MP:0004974,decreased regulatory T cell number|MP:0005002,abnormal T cell clonal deletion|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008049,increased memory T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008681,increased interleukin-17 secretion|MP:0008688,decreased interleukin-2 secretion|MP:0008826,abnormal splenic cell ratio|MP:0008827,abnormal thymus cell ratio|MP:0008828,abnormal lymph node cell ratio
MGI:6696065	Zar1<em1Hyfn>	MP:0001926,female infertility|MP:0003718,maternal effect|MP:0005168,abnormal female meiosis|MP:0014443,impaired polar body extrusion
MGI:6696064	Zar1l<em1Hyfn>	MP:0005168,abnormal female meiosis|MP:0005389,reproductive system phenotype|MP:0014443,impaired polar body extrusion
MGI:7641820	Zar1l<em1Kzt>	MP:0005389,reproductive system phenotype
MGI:2449829	Zar1<tm1Zuk>	MP:0001926,female infertility|MP:0003718,maternal effect
MGI:7507216	Zbed3<em1(IMPC)Mbp>	MP:0001297,microphthalmia|MP:0002092,abnormal eye morphology|MP:0009709,hydrometra
MGI:6469491	Zbed3<tm1.1Lil>	MP:0001935,decreased litter size|MP:0002161,abnormal fertility/fecundity|MP:0003718,maternal effect
MGI:5548859	Zbed4<tm1.1(KOMP)Mbp>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001417,decreased exploration in new environment|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5637059	Zbed5<tm1b(EUCOMM)Wtsi>	MP:0002098,abnormal vibrissa morphology
MGI:6393538	Zbed6<em1(IMPC)J>	MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6201365	Zbed6<tm1.2Sson>	MP:0001260,increased body weight|MP:0002891,increased insulin sensitivity|MP:0002981,increased liver weight|MP:0003398,increased skeletal muscle size|MP:0003917,increased kidney weight|MP:0003960,increased lean body mass|MP:0010378,increased respiratory quotient
MGI:5775152	Zbp1<tm1.1Jreh>	MP:0012555,decreased cell death|MP:0020916,increased susceptibility to Herpesvirales infection
MGI:3776827	Zbp1<tm1Aki>	MP:0005387,immune system phenotype
MGI:8213606	Zbtb11<tm1.1Lieg>	MP:0000598,abnormal liver morphology|MP:0001577,anemia|MP:0001601,abnormal myelopoiesis|MP:0001606,impaired hematopoiesis|MP:0002123,abnormal definitive hematopoiesis|MP:0002401,abnormal lymphopoiesis|MP:0004046,abnormal mitosis|MP:0004201,fetal growth retardation|MP:0004809,increased hematopoietic stem cell number|MP:0008813,decreased common myeloid progenitor cell number|MP:0011091,prenatal lethality, complete penetrance|MP:0011246,abnormal fetal liver hematopoietic progenitor cell morphology|MP:0011695,absent hematopoietic stem cells|MP:0011805,decreased cell migration|MP:0011903,decreased hematopoietic stem cell proliferation|MP:0013697,decreased granulocyte monocyte progenitor cell number|MP:0013893,decreased common lymphocyte progenitor cell number
MGI:6360699	Zbtb12<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system|MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0001488,increased startle reflex|MP:0020870,decreased thigmotaxis
MGI:5476175	Zbtb14<b2b1982Clo>	MP:0000284,double outlet right ventricle|MP:0000285,abnormal heart valve morphology|MP:0000519,hydronephrosis|MP:0000914,exencephaly|MP:0003675,kidney cyst|MP:0004017,duplex kidney|MP:0010412,atrioventricular septal defect|MP:0010418,perimembraneous ventricular septal defect
MGI:4457499	Zbtb16<7t>	MP:0000159,abnormal xiphoid process morphology|MP:0000480,increased rib number|MP:0000558,abnormal tibia morphology|MP:0000562,polydactyly|MP:0000565,oligodactyly|MP:0000568,ectopic digits|MP:0000571,interdigital webbing|MP:0002110,abnormal digit morphology|MP:0002187,abnormal fibula morphology|MP:0003072,abnormal metatarsal bone morphology|MP:0003723,abnormal long bone morphology|MP:0003857,abnormal hindlimb zeugopod morphology|MP:0004617,sacral vertebral transformation|MP:0004642,fused metatarsal bones|MP:0005109,abnormal talus morphology|MP:0005389,reproductive system phenotype|MP:0005430,absent fibula|MP:0008159,increased diameter of fibula
MGI:6404507	Zbtb16<em1(IMPC)Mbp>	MP:0000556,abnormal hindlimb morphology|MP:0000572,abnormal autopod morphology|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0000774,decreased brain size|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001258,decreased body length|MP:0001304,cataract|MP:0001314,cornea opacity|MP:0001399,hyperactivity|MP:0001406,abnormal gait|MP:0002110,abnormal digit morphology|MP:0002152,abnormal brain morphology|MP:0002699,abnormal vitreous body morphology|MP:0003960,increased lean body mass|MP:0004738,abnormal auditory brainstem response|MP:0008259,abnormal optic disk morphology|MP:0009142,decreased prepulse inhibition|MP:0010025,decreased total body fat amount|MP:0020421,increased freezing behavior
MGI:1856943	Zbtb16<lu>	MP:0000413,polyphalangy|MP:0000464,increased presacral vertebrae number|MP:0000480,increased rib number|MP:0000482,long fibula|MP:0000562,polydactyly|MP:0000585,kinked tail|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001925,male infertility|MP:0002543,brachyphalangia|MP:0002764,short tibia|MP:0004372,bowed fibula|MP:0004901,decreased male germ cell number|MP:0005104,abnormal tarsal bone morphology|MP:0005159,azoospermia|MP:0008040,decreased NK T cell number|MP:0012284,increased sternebra number
MGI:3850654	Zbtb16<lu-3J>	MP:0002109,abnormal limb morphology|MP:0008985,hemimelia
MGI:3762657	Zbtb16<lu-Sfd>	MP:0000413,polyphalangy|MP:0000562,polydactyly|MP:0000565,oligodactyly|MP:0000585,kinked tail|MP:0001925,male infertility|MP:0002110,abnormal digit morphology|MP:0002764,short tibia|MP:0008159,increased diameter of fibula
MGI:4462277	Zbtb16<pnky>	MP:0000556,abnormal hindlimb morphology|MP:0000562,polydactyly|MP:0001922,reduced male fertility|MP:0014322,short hindlimb
MGI:5522866	Zbtb16<tm1Geno>	MP:0001146,abnormal testis morphology|MP:0008280,abnormal male germ cell apoptosis|MP:0008877,abnormal DNA methylation|MP:0009278,abnormal bone marrow cell physiology|MP:0012167,abnormal epigenetic regulation of gene expression
MGI:2182708	Zbtb16<tm1Ppp>	MP:0000480,increased rib number|MP:0000550,abnormal forelimb morphology|MP:0000556,abnormal hindlimb morphology|MP:0000558,abnormal tibia morphology|MP:0000562,polydactyly|MP:0000568,ectopic digits|MP:0000585,kinked tail|MP:0000592,short tail|MP:0001147,small testis|MP:0001152,increased Leydig cell number|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001539,decreased caudal vertebrae number|MP:0002114,abnormal axial skeleton morphology|MP:0002187,abnormal fibula morphology|MP:0002675,asthenozoospermia|MP:0002685,abnormal spermatogonia proliferation|MP:0002687,oligozoospermia|MP:0002781,increased circulating testosterone level|MP:0003036,vertebral transformation|MP:0003072,abnormal metatarsal bone morphology|MP:0003205,testicular atrophy|MP:0004616,lumbar vertebral transformation|MP:0004617,sacral vertebral transformation|MP:0004618,thoracic vertebral transformation|MP:0004642,fused metatarsal bones|MP:0004651,increased thoracic vertebrae number|MP:0004679,xiphoid process foramen|MP:0004694,absent patella|MP:0005104,abnormal tarsal bone morphology|MP:0005109,abnormal talus morphology|MP:0005353,abnormal patella morphology|MP:0005397,hematopoietic system phenotype|MP:0005430,absent fibula|MP:0008159,increased diameter of fibula|MP:0014052,increased male germ cell apoptosis|MP:0014281,hindlimb oligodactyly|MP:0014322,short hindlimb|MP:0014617,decreased spermatogonia number
MGI:5522868	Zbtb16<tm2Geno>	MP:0005389,reproductive system phenotype|MP:0008877,abnormal DNA methylation|MP:0009278,abnormal bone marrow cell physiology
MGI:3721142	Zbtb17<tm1Cksn>	MP:0000367,abnormal coat/ hair morphology|MP:0000377,abnormal hair follicle morphology|MP:0000383,abnormal hair follicle orientation|MP:0000404,decreased curvature of zigzag hairs|MP:0000416,sparse hair|MP:0000715,decreased thymocyte number|MP:0001216,abnormal epidermal layer morphology|MP:0001242,hyperkeratosis|MP:0001823,thymus hypoplasia|MP:0001825,arrested T cell differentiation|MP:0004381,abnormal hair follicle melanocyte morphology|MP:0005018,decreased T cell number|MP:0005089,decreased double-negative T cell number|MP:0005387,immune system phenotype|MP:0005409,darkened coat color|MP:0006413,increased T cell apoptosis|MP:0008347,decreased gamma-delta T cell number|MP:0008538,decreased zigzag hair amount|MP:0009583,increased keratinocyte proliferation|MP:0010130,decreased DN1 thymic pro-T cell number|MP:0010132,decreased DN2 thymocyte number|MP:0010134,decreased DN3 thymocyte number|MP:0010179,rough coat|MP:0010202,focal dorsal hair loss
MGI:2679766	Zbtb17<tm1Elr>	MP:0000352,decreased cell proliferation|MP:0001675,abnormal ectoderm development|MP:0001696,failure to gastrulate|MP:0001698,decreased embryo size|MP:0002084,abnormal developmental patterning|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002231,abnormal primitive streak morphology|MP:0003984,embryonic growth retardation|MP:0006042,increased apoptosis|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011198,absent proamniotic cavity
MGI:5425228	Zbtb18<tm1.1Nda>	MP:0000774,decreased brain size|MP:0000788,abnormal cerebral cortex morphology|MP:0000790,abnormal stratification in cerebral cortex|MP:0001265,decreased body size|MP:0002082,postnatal lethality|MP:0002196,absent corpus callosum|MP:0003203,increased neuron apoptosis|MP:0003648,abnormal radial glial cell morphology|MP:0003861,abnormal nervous system development|MP:0004097,abnormal cerebellar cortex morphology|MP:0006009,abnormal neuronal migration|MP:0006254,thin cerebral cortex|MP:0009937,abnormal neuron differentiation|MP:0011380,enlarged brain ventricles
MGI:3851929	Zbtb18<tm1Haok>	MP:0000807,abnormal hippocampus morphology|MP:0000857,abnormal cerebellar foliation|MP:0003203,increased neuron apoptosis|MP:0003651,abnormal axon extension|MP:0004275,abnormal postnatal subventricular zone morphology|MP:0004811,abnormal neuron physiology|MP:0004948,abnormal neuronal precursor proliferation|MP:0004980,increased neuronal precursor cell number|MP:0005404,abnormal axon morphology|MP:0006009,abnormal neuronal migration|MP:0008283,small hippocampus|MP:0008284,abnormal hippocampus pyramidal cell layer|MP:0008285,abnormal hippocampus granule cell layer|MP:0008440,abnormal subplate morphology|MP:0008458,abnormal cortical ventricular zone morphology|MP:0008547,abnormal neocortex morphology|MP:0008948,decreased neuron number|MP:0009937,abnormal neuron differentiation|MP:0011087,neonatal lethality, complete penetrance
MGI:5502199	Zbtb18<tm2.1Haok>	MP:0006009,abnormal neuronal migration|MP:0009937,abnormal neuron differentiation
MGI:5300200	Zbtb1<m1Btlr>	MP:0000703,abnormal thymus morphology|MP:0001790,abnormal immune system physiology|MP:0001823,thymus hypoplasia|MP:0002144,abnormal B cell differentiation|MP:0002145,abnormal T cell differentiation|MP:0005014,increased B cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0005387,immune system phenotype|MP:0005397,hematopoietic system phenotype|MP:0008045,decreased NK cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008174,decreased follicular B cell number|MP:0008190,decreased transitional stage B cell number|MP:0010132,decreased DN2 thymocyte number|MP:0010134,decreased DN3 thymocyte number|MP:0010136,decreased DN4 thymocyte number
MGI:6286068	Zbtb1<m2Btlr>	MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0010847,increased central memory CD8 positive, alpha-beta T cell number
MGI:3057148	Zbtb20<Tg(PDGFB-APPSwInd)20Lms>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001463,abnormal spatial learning|MP:0002083,premature death|MP:0002229,neurodegeneration|MP:0002801,abnormal long-term object recognition memory|MP:0002882,abnormal neuron morphology|MP:0002906,increased susceptibility to pharmacologically induced seizures|MP:0003329,amyloid beta deposits|MP:0008415,abnormal neurite morphology|MP:0009937,abnormal neuron differentiation|MP:0009969,abnormal cerebral cortex pyramidal cell morphology|MP:0014367,impaired long-term object recognition memory
MGI:3848219	Zbtb20<tm1.1Wpjz>	MP:0000189,hypoglycemia|MP:0000808,abnormal hippocampus development|MP:0001262,decreased body weight|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002575,increased circulating ketone body level|MP:0002712,increased circulating glucagon level|MP:0002727,decreased circulating insulin level|MP:0002891,increased insulin sensitivity|MP:0002968,increased circulating alkaline phosphatase level|MP:0005292,improved glucose tolerance|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005438,abnormal glycogen homeostasis|MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level|MP:0005668,decreased circulating leptin level|MP:0010398,decreased liver glycogen level|MP:0011084,lethality at weaning, incomplete penetrance|MP:0014573,increased circulating resistin level
MGI:5637567	Zbtb20<tm1Stoy>	MP:0000812,abnormal dentate gyrus morphology|MP:0000815,abnormal Ammon gyrus morphology|MP:0001258,decreased body length|MP:0001265,decreased body size|MP:0001399,hyperactivity|MP:0001511,disheveled coat|MP:0002083,premature death|MP:0006203,eye hemorrhage|MP:0008263,abnormal hippocampus CA1 region morphology|MP:0008283,small hippocampus|MP:0008287,abnormal subiculum morphology|MP:0011090,perinatal lethality, incomplete penetrance|MP:0012460,decreased dentate gyrus size
MGI:3812013	Zbtb20<tm1Wpjz>	MP:0005370,liver/biliary system phenotype
MGI:7705190	Zbtb21<em1Jhan>	MP:0003631,nervous system phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype
MGI:7619075	Zbtb22<em1Yga>	MP:0001764,abnormal homeostasis|MP:0002644,decreased circulating triglyceride level|MP:0002891,increased insulin sensitivity|MP:0002971,abnormal brown adipose tissue morphology|MP:0003402,decreased liver weight|MP:0004889,increased energy expenditure|MP:0005292,improved glucose tolerance|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0009122,decreased white fat cell lipid droplet size|MP:0009133,decreased white fat cell size|MP:0009356,decreased liver triglyceride level|MP:0013278,decreased fasting circulating glucose level|MP:0014143,decreased body fat mass|MP:0031268,decreased susceptibility to diet-induced hepatic steatosis
MGI:5548888	Zbtb24<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001488,increased startle reflex|MP:0001556,increased circulating HDL cholesterol level|MP:0002699,abnormal vitreous body morphology|MP:0002792,abnormal retina vasculature morphology|MP:0003020,decreased circulating chloride level|MP:0010068,decreased red blood cell distribution width|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance
MGI:5824824	Zbtb24<tm1Ldax>	MP:0011095,embryonic lethality between implantation and placentation, complete penetrance
MGI:4080005	Zbtb32<Gt(IST12443F7)Tigm>	MP:0005621,abnormal cell physiology
MGI:5505908	Zbtb32<tm1b(KOMP)Mbp>	MP:0002079,increased circulating insulin level|MP:0002702,decreased circulating free fatty acids level|MP:0002833,increased heart weight|MP:0004924,abnormal behavior|MP:0005633,increased circulating sodium level|MP:0020870,decreased thigmotaxis
MGI:3522354	Zbtb32<tm1Iho>	MP:0003009,abnormal cytokine secretion|MP:0005348,increased T cell proliferation
MGI:3527274	Zbtb32<tm1Ppp>	MP:0002169,no abnormal phenotype detected
MGI:3527275	Zbtb32<tm2Ppp>	MP:0002123,abnormal definitive hematopoiesis|MP:0003009,abnormal cytokine secretion|MP:0005348,increased T cell proliferation
MGI:3612463	Zbtb33<tm1.1Bird>	MP:0002169,no abnormal phenotype detected
MGI:6382793	Zbtb34<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6696060	Zbtb38<em1.1Dbhat>	MP:0005378,growth/size/body region phenotype|MP:0010768,mortality/aging
MGI:6416527	Zbtb38<em1Dbhat>	MP:0005387,immune system phenotype
MGI:6454063	Zbtb40<em1Clab>	MP:0005390,skeleton phenotype|MP:0010869,decreased bone trabecula number|MP:0010873,decreased trabecular bone mass|MP:0010879,decreased trabecular bone volume|MP:0010933,decreased trabecular bone connectivity density|MP:0011585,decreased alkaline phosphatase activity|MP:0011711,impaired osteoblast differentiation|MP:0013618,decreased areal bone mineral density|MP:0021190,decreased bone mineral density of lumbar vertebrae
MGI:6152683	Zbtb42<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0009142,decreased prepulse inhibition
MGI:5635489	Zbtb43<tm1b(KOMP)Mbp>	MP:0001289,persistence of hyaloid vascular system|MP:0001399,hyperactivity|MP:0001566,increased circulating phosphate level|MP:0002590,increased mean corpuscular volume|MP:0002941,increased circulating alanine transaminase level|MP:0003960,increased lean body mass|MP:0004924,abnormal behavior|MP:0005343,increased circulating aspartate transaminase level|MP:0005419,decreased circulating serum albumin level|MP:0005560,decreased circulating glucose level|MP:0006243,impaired pupillary reflex|MP:0020870,decreased thigmotaxis
MGI:6260061	Zbtb44<em1(IMPC)J>	MP:0001566,increased circulating phosphate level
MGI:4839210	Zbtb45<tm1(NCOM)Cmhd>	MP:0000063,decreased bone mineral density|MP:0003961,decreased lean body mass
MGI:5695925	Zbtb46<tm1.1(KOMP)Vlcg>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5444842	Zbtb46<tm1(HBEGF)Mnz>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0005025,abnormal response to infection|MP:0005027,increased susceptibility to parasitic infection|MP:0005387,immune system phenotype|MP:0005465,abnormal T-helper 1 physiology|MP:0008051,abnormal memory T cell physiology|MP:0008127,decreased dendritic cell number
MGI:5320483	Zbtb46<tm1Kmm>	MP:0002376,abnormal dendritic cell physiology|MP:0005387,immune system phenotype
MGI:5462199	Zbtb46<tm2.1Mnz>	MP:0000702,enlarged lymph nodes|MP:0005461,abnormal dendritic cell morphology|MP:0008102,lymph node hyperplasia|MP:0008126,increased dendritic cell number|MP:0008127,decreased dendritic cell number|MP:0008778,abnormal lymphangiogenesis
MGI:5697173	Zbtb46<tm2Mnz>	MP:0002169,no abnormal phenotype detected
MGI:6152684	Zbtb48<em1(IMPC)Mbp>	MP:0002092,abnormal eye morphology|MP:0003795,abnormal bone structure|MP:0010024,increased total body fat amount|MP:0010123,increased bone mineral content
MGI:5507825	Zbtb4<tm1.1(KOMP)Vlcg>	MP:0001289,persistence of hyaloid vascular system|MP:0001303,abnormal lens morphology|MP:0001307,fused cornea and lens|MP:0001399,hyperactivity|MP:0003019,increased circulating chloride level|MP:0005633,increased circulating sodium level|MP:0011396,abnormal sleep behavior
MGI:5692747	Zbtb5<tm2b(EUCOMM)Hmgu>	MP:0001293,anophthalmia|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001488,increased startle reflex|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0004924,abnormal behavior|MP:0005287,narrow eye opening|MP:0011965,decreased total retina thickness|MP:0020870,decreased thigmotaxis
MGI:3711162	Zbtb7a<tm1Ppp>	MP:0002401,abnormal lymphopoiesis|MP:0005017,decreased B cell number|MP:0005397,hematopoietic system phenotype|MP:0005671,abnormal response to transplant|MP:0008208,decreased pro-B cell number|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:3530739	Zbtb7b<hd>	MP:0001923,reduced female fertility|MP:0003790,absent CD4-positive, alpha-beta T cells|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:3838356	Zbtb7b<hpls>	MP:0001800,abnormal humoral immune response|MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:3817628	Zbtb7b<tm1.1Rbo>	MP:0002145,abnormal T cell differentiation|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008077,abnormal CD8-positive, alpha-beta T cell number
MGI:4943529	Zbtb7b<tm1.1Skok>	MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:3774002	Zbtb7b<tm1.1Tani>	MP:0005090,increased double-negative T cell number
MGI:3817518	Zbtb7b<tm2Itan>	MP:0002169,no abnormal phenotype detected
MGI:3818473	Zbtb7b<tm2Litt>	MP:0003790,absent CD4-positive, alpha-beta T cells
MGI:3817542	Zbtb7b<tm3Itan>	MP:0002169,no abnormal phenotype detected
MGI:5486334	Zbtb7b<tm4.1Itan>	MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008078,increased CD8-positive, alpha-beta T cell number
MGI:5506929	Zbtb7b<tm6.1Itan>	MP:0005387,immune system phenotype|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:5506942	Zbtb7b<tm7Itan>	MP:0008075,decreased CD4-positive, alpha-beta T cell number
MGI:5313397	Zbtb7c<tm1Mwhu>	MP:0000352,decreased cell proliferation
MGI:7519009	Zbtb8os<em1(IMPC)J>	MP:0009141,increased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance
MGI:6341946	Zc2hc1a<em1(IMPC)Ccpcz>	MP:0001417,decreased exploration in new environment|MP:0002060,abnormal skin morphology|MP:0002092,abnormal eye morphology|MP:0020420,abnormal freezing behavior|MP:0020421,increased freezing behavior
MGI:6442539	Zc2hc1b<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0002060,abnormal skin morphology|MP:0002100,abnormal tooth morphology|MP:0002110,abnormal digit morphology|MP:0003795,abnormal bone structure|MP:0004083,polysyndactyly
MGI:6341958	Zc2hc1c<em1(IMPC)Ccpcz>	MP:0000160,kyphosis|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001148,enlarged testis|MP:0002092,abnormal eye morphology|MP:0004174,abnormal spine curvature|MP:0009709,hydrometra
MGI:6415552	Zc3h10<tm1c(EUCOMM)Wtsi>	MP:0001260,increased body weight|MP:0005290,decreased oxygen consumption|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0011049,impaired adaptive thermogenesis|MP:0011699,abnormal brown adipose tissue thermogenesis|MP:0014142,increased body fat mass
MGI:6152685	Zc3h11a<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000277,abnormal heart shape|MP:0000703,abnormal thymus morphology|MP:0001304,cataract|MP:0001914,hemorrhage|MP:0002075,abnormal coat/hair pigmentation|MP:0002699,abnormal vitreous body morphology|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0003054,spina bifida|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:3843029	Zc3h12a<tm1Aki>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001577,anemia|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002416,abnormal proerythroblast morphology|MP:0002461,increased immunoglobulin level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0002498,abnormal acute inflammation|MP:0002500,granulomatous inflammation|MP:0002874,decreased hemoglobin content|MP:0004762,increased anti-double stranded DNA antibody level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004816,abnormal class switch recombination|MP:0005505,thrombocytosis|MP:0005621,abnormal cell physiology|MP:0008049,increased memory T cell number|MP:0008097,increased plasma cell number|MP:0008499,increased IgG1 level|MP:0008500,increased IgG2a level|MP:0008501,increased IgG2b level|MP:0008502,increased IgG3 level|MP:0008566,increased interferon-gamma secretion|MP:0008669,increased interleukin-12b secretion|MP:0008705,increased interleukin-6 secretion
MGI:6220866	Zc3h12a<tm1b(EUCOMM)Hmgu>	MP:0011110,preweaning lethality, incomplete penetrance|MP:0011886,increased circulating lipase level
MGI:6115370	Zc3h12a<tm1c(EUCOMM)Hmgu>	MP:0000599,enlarged liver|MP:0000691,enlarged spleen|MP:0001846,increased inflammatory response|MP:0001860,liver inflammation|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002500,granulomatous inflammation|MP:0002968,increased circulating alkaline phosphatase level|MP:0003252,abnormal bile duct physiology|MP:0003254,bile duct inflammation|MP:0003333,liver fibrosis|MP:0003725,increased autoantibody level|MP:0004789,increased bile salt level|MP:0004794,increased anti-nuclear antigen antibody level|MP:0004839,bile duct hyperplasia|MP:0005370,liver/biliary system phenotype|MP:0005415,intrahepatic cholestasis|MP:0008986,abnormal liver parenchyma morphology|MP:0013611,abnormal bile duct epithelium morphology
MGI:5295981	Zc3h12a<tm1Fum>	MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0008553,increased circulating tumor necrosis factor level|MP:0008560,increased tumor necrosis factor secretion|MP:0008657,increased interleukin-1 beta secretion|MP:0008705,increased interleukin-6 secretion|MP:0008722,abnormal chemokine secretion|MP:0010209,abnormal circulating chemokine level
MGI:6156569	Zc3h12b<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001126,abnormal ovary morphology|MP:0001297,microphthalmia|MP:0002637,small uterus|MP:0005568,increased circulating total protein level|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0009456,impaired cued conditioning behavior
MGI:6156592	Zc3h12c<em1(IMPC)Tcp>	MP:0000063,decreased bone mineral density|MP:0000219,increased neutrophil cell number|MP:0000702,enlarged lymph nodes|MP:0001552,increased circulating triglyceride level|MP:0005016,decreased lymphocyte cell number|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content
MGI:6359731	Zc3h12c<tm2c(EUCOMM)Hmgu>	MP:0000702,enlarged lymph nodes|MP:0005014,increased B cell number|MP:0005387,immune system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008181,increased marginal zone B cell number|MP:0008214,increased immature B cell number|MP:0010850,increased effector memory CD8-positive, alpha-beta T cell number
MGI:6359732	Zc3h12c<tm2d(EUCOMM)Hmgu>	MP:0000240,extramedullary hematopoiesis|MP:0000702,enlarged lymph nodes|MP:0002343,abnormal lymph node cortex morphology|MP:0002345,abnormal lymph node primary follicle morphology|MP:0002493,increased IgG level|MP:0002494,increased IgM level|MP:0002495,increased IgA level|MP:0003884,decreased macrophage cell number|MP:0005014,increased B cell number|MP:0005015,increased T cell number|MP:0005387,immune system phenotype|MP:0008074,increased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008178,decreased germinal center B cell number|MP:0008181,increased marginal zone B cell number|MP:0008214,increased immature B cell number|MP:0008577,increased circulating interferon-gamma level|MP:0009338,increased splenocyte number|MP:0010844,increased effector memory CD4-positive, alpha-beta T cell number|MP:0013663,increased myeloid cell number
MGI:6120807	Zc3h12d<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0002941,increased circulating alanine transaminase level|MP:0005016,decreased lymphocyte cell number
MGI:5588370	Zc3h12d<tm1Tom>	MP:0004799,increased susceptibility to experimental autoimmune encephalomyelitis|MP:0005348,increased T cell proliferation|MP:0005387,immune system phenotype|MP:0008660,increased interleukin-10 secretion|MP:0008705,increased interleukin-6 secretion|MP:0010219,increased T-helper 17 cell number
MGI:6189585	Zc3h13<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001312,abnormal cornea morphology|MP:0001529,abnormal vocalization|MP:0001556,increased circulating HDL cholesterol level|MP:0001697,abnormal embryo size|MP:0002075,abnormal coat/hair pigmentation|MP:0002874,decreased hemoglobin content|MP:0003984,embryonic growth retardation|MP:0005178,increased circulating cholesterol level|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:4419828	Zc3h14<tm1a(KOMP)Wtsi>	MP:0001258,decreased body length|MP:0001312,abnormal cornea morphology
MGI:6107561	Zc3h14<tm1d(KOMP)Wtsi>	MP:0001147,small testis|MP:0001935,decreased litter size|MP:0008428,abnormal spatial working memory|MP:0008535,enlarged lateral ventricles
MGI:6152686	Zc3h4<em1(IMPC)Mbp>	MP:0000352,decreased cell proliferation|MP:0001289,persistence of hyaloid vascular system|MP:0001728,failure of embryo implantation|MP:0001730,embryonic growth arrest|MP:0001914,hemorrhage|MP:0002075,abnormal coat/hair pigmentation|MP:0002092,abnormal eye morphology|MP:0002631,abnormal epididymis morphology|MP:0002718,abnormal inner cell mass morphology|MP:0002965,increased circulating serum albumin level|MP:0003054,spina bifida|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0003886,abnormal embryonic epiblast morphology|MP:0004931,enlarged epididymis|MP:0004957,abnormal blastocyst morphology|MP:0005028,abnormal trophectoderm morphology|MP:0005384,cellular phenotype|MP:0008932,abnormal embryonic tissue physiology|MP:0009687,empty decidua capsularis|MP:0011093,embryonic lethality at implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011183,abnormal primitive endoderm morphology|MP:0012114,absent inner cell mass proliferation|MP:0013292,embryonic lethality prior to organogenesis|MP:0013294,prenatal lethality prior to heart atrial septation|MP:0013504,increased embryonic tissue cell apoptosis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:2155864	Zc3h4<KK>	MP:0001260,increased body weight|MP:0005455,increased susceptibility to weight gain
MGI:6189599	Zc3h7a<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0002591,decreased mean corpuscular volume|MP:0004738,abnormal auditory brainstem response|MP:0005562,decreased mean corpuscular hemoglobin|MP:0020870,decreased thigmotaxis
MGI:6690238	Zc3h7ait<em1Caox>	MP:0005387,immune system phenotype|MP:0008555,abnormal interferon secretion|MP:0008563,decreased interferon-alpha secretion|MP:0008565,decreased interferon-beta secretion|MP:0008574,decreased circulating interferon-alpha level|MP:0008576,decreased circulating interferon-beta level|MP:0008597,decreased circulating interleukin-6 level|MP:0008706,decreased interleukin-6 secretion|MP:0011075,abnormal macrophage activation involved in immune response|MP:0020913,increased susceptibility to Riboviria infection|MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality
MGI:6314204	Zc3h7b<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number|MP:0010393,shortened QRS complex duration
MGI:6341865	Zc3h8<em1(IMPC)Ccpcz>	MP:0000162,lordosis|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000599,enlarged liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002060,abnormal skin morphology|MP:0002110,abnormal digit morphology|MP:0002135,abnormal kidney morphology|MP:0003068,enlarged kidney|MP:0003604,single kidney|MP:0005568,increased circulating total protein level|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage|MP:0013435,decreased CD8-positive, naive alpha-beta T cell number
MGI:5696926	Zc3hav1l<tm1b(EUCOMM)Wtsi>	MP:0000598,abnormal liver morphology|MP:0002092,abnormal eye morphology|MP:0005011,increased eosinophil cell number
MGI:5767101	Zc3hav1<tm1Aki>	MP:0005621,abnormal cell physiology
MGI:5431129	Zc3hc1<tm1.2Jduy>	MP:0001126,abnormal ovary morphology|MP:0001146,abnormal testis morphology|MP:0001153,small seminiferous tubules|MP:0001155,arrest of spermatogenesis|MP:0001156,abnormal spermatogenesis|MP:0001265,decreased body size|MP:0001648,abnormal apoptosis|MP:0001923,reduced female fertility|MP:0001925,male infertility|MP:0001930,abnormal meiosis|MP:0002016,ovary cyst|MP:0002680,decreased corpora lutea number|MP:0003205,testicular atrophy|MP:0004852,decreased testis weight|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0005431,decreased oocyte number|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0009451,abnormal chromosomal synapsis|MP:0009452,abnormal synaptonemal complex|MP:0010831,lethality, incomplete penetrance|MP:0011121,decreased primordial ovarian follicle number|MP:0014052,increased male germ cell apoptosis|MP:0014633,decreased spermatid number|MP:0014764,impaired double-strand DNA break repair|MP:0031474,increased female germ cell apoptosis
MGI:4362278	Zc3hc1<tm1a(KOMP)Wtsi>	MP:0000443,abnormal snout morphology|MP:0001262,decreased body weight|MP:0001312,abnormal cornea morphology|MP:0001925,male infertility|MP:0003345,decreased rib number|MP:0003961,decreased lean body mass|MP:0004648,decreased thoracic vertebrae number
MGI:6455141	Zc4h2<em1.1Yqd>	MP:0000939,decreased motor neuron number|MP:0000955,abnormal spinal cord morphology|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0004100,abnormal spinal cord interneuron morphology|MP:0005390,skeleton phenotype|MP:0008770,decreased survivor rate|MP:0011087,neonatal lethality, complete penetrance|MP:0021101,abnormal ventral interneuron morphology|MP:0021102,abnormal ventral interneuron 0 morphology|MP:0021103,abnormal ventral interneuron 1 morphology|MP:0021104,abnormal ventral interneuron 2 morphology|MP:0021105,abnormal ventral interneuron 3 morphology
MGI:6194915	Zcchc13<tm1Osb>	MP:0002169,no abnormal phenotype detected
MGI:6435661	Zcchc17<em1(IMPC)Hmgu>	MP:0002098,abnormal vibrissa morphology|MP:0002599,increased mean platelet volume|MP:0004952,increased spleen weight
MGI:6147733	Zcchc17<tm1Pou>	MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype
MGI:6147734	Zcchc17<tm2Pou>	MP:0003674,oxidative stress|MP:0005076,abnormal cell differentiation|MP:0005380,embryo phenotype|MP:0005389,reproductive system phenotype|MP:0008008,early cellular replicative senescence
MGI:6147770	Zcchc17<tm3Pou>	MP:0005380,embryo phenotype|MP:0005384,cellular phenotype|MP:0005389,reproductive system phenotype
MGI:6794045	Zcchc2<em1(IMPC)J>	MP:0002591,decreased mean corpuscular volume|MP:0003961,decreased lean body mass|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010024,increased total body fat amount
MGI:6356330	Zcchc3<em1Hbsh>	MP:0002419,abnormal innate immunity|MP:0008576,decreased circulating interferon-beta level|MP:0008597,decreased circulating interleukin-6 level|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality|MP:0031034,increased susceptibility to Poxviridae infection induced morbidity/mortality|MP:0031219,decreased circulating CXCL10 level
MGI:6731053	Zcchc3<em1(IMPC)J>	MP:0002965,increased circulating serum albumin level|MP:0005344,increased circulating bilirubin level
MGI:7594049	Zcchc4<em1(IMPC)Bay>	MP:0001529,abnormal vocalization|MP:0002339,abnormal lymph node morphology
MGI:6711985	Zcchc8<em1Sgao>	MP:0000352,decreased cell proliferation|MP:0001125,abnormal oocyte morphology|MP:0001127,small ovary|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001924,infertility|MP:0002682,decreased mature ovarian follicle number|MP:0002687,oligozoospermia|MP:0003718,maternal effect|MP:0004046,abnormal mitosis|MP:0005076,abnormal cell differentiation|MP:0005168,abnormal female meiosis|MP:0008770,decreased survivor rate|MP:0011112,lethality during fetal growth through weaning, incomplete penetrance
MGI:7426095	Zcrb1<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0001312,abnormal cornea morphology|MP:0001529,abnormal vocalization|MP:0004924,abnormal behavior|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6257662	Zcwpw1<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001147,small testis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0001944,abnormal pancreas morphology|MP:0004852,decreased testis weight|MP:0005159,azoospermia|MP:0008261,arrest of male meiosis|MP:0008967,absent chiasmata formation|MP:0009451,abnormal chromosomal synapsis|MP:0010948,abnormal double-strand DNA break repair
MGI:6358521	Zcwpw1<em1Kliu>	MP:0001130,abnormal ovarian folliculogenesis|MP:0001132,absent mature ovarian follicles|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002682,decreased mature ovarian follicle number|MP:0004805,absent oocytes|MP:0005159,azoospermia|MP:0005168,abnormal female meiosis|MP:0008261,arrest of male meiosis|MP:0009451,abnormal chromosomal synapsis|MP:0010948,abnormal double-strand DNA break repair
MGI:6161219	Zdbf2<em1Dhbh>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0008877,abnormal DNA methylation
MGI:6361129	Zdbf2<em1(IMPC)J>	MP:0000221,decreased leukocyte cell number
MGI:7327510	Zdhhc11<em1Mngx>	MP:0005389,reproductive system phenotype
MGI:5445927	Zdhhc11<tm1.1(KOMP)Vlcg>	MP:0002410,decreased susceptibility to viral infection|MP:0004738,abnormal auditory brainstem response|MP:0008597,decreased circulating interleukin-6 level|MP:0008734,decreased susceptibility to endotoxin shock
MGI:7431133	Zdhhc12<em1Cya>	MP:0000219,increased neutrophil cell number|MP:0008641,increased circulating interleukin-1 beta level|MP:0008735,increased susceptibility to endotoxin shock|MP:0014437,increased interleukin level|MP:0014787,increased protein level
MGI:4338023	Zdhhc13<Gt(AC0492)Wtsi>	MP:0000377,abnormal hair follicle morphology|MP:0000379,decreased hair follicle number|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000780,abnormal corpus callosum morphology|MP:0000788,abnormal cerebral cortex morphology|MP:0000849,abnormal cerebellum morphology|MP:0001219,thick epidermis|MP:0001262,decreased body weight|MP:0001402,decreased locomotor activity|MP:0001516,abnormal motor coordination/balance|MP:0002175,decreased brain weight|MP:0002804,abnormal motor learning|MP:0003203,increased neuron apoptosis|MP:0004081,abnormal globus pallidus morphology|MP:0008948,decreased neuron number|MP:0010768,mortality/aging|MP:0012468,decreased striatum size|MP:0020527,small thalamus
MGI:2671845	Zdhhc13<skc4>	MP:0000063,decreased bone mineral density|MP:0000066,osteoporosis|MP:0000130,abnormal trabecular bone morphology|MP:0000160,kyphosis|MP:0000219,increased neutrophil cell number|MP:0000221,decreased leukocyte cell number|MP:0000414,alopecia|MP:0000416,sparse hair|MP:0000427,abnormal hair cycle|MP:0000599,enlarged liver|MP:0000604,amyloidosis|MP:0000691,enlarged spleen|MP:0001211,wrinkled skin|MP:0001222,epidermal hyperplasia|MP:0001242,hyperkeratosis|MP:0001244,thin dermal layer|MP:0001265,decreased body size|MP:0001780,decreased brown adipose tissue amount|MP:0001783,decreased white adipose tissue amount|MP:0002073,abnormal hair growth|MP:0002083,premature death|MP:0002269,muscular atrophy|MP:0002941,increased circulating alanine transaminase level|MP:0003809,abnormal hair shaft morphology|MP:0005150,cachexia|MP:0005325,abnormal renal glomerulus morphology|MP:0005343,increased circulating aspartate transaminase level|MP:0005344,increased circulating bilirubin level|MP:0005565,increased blood urea nitrogen level|MP:0008114,abnormal Kupffer cell morphology|MP:0008489,slow postnatal weight gain|MP:0010090,increased circulating creatine kinase level|MP:0010179,rough coat
MGI:6449022	Zdhhc14<em1(IMPC)Mbp>	MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001304,cataract|MP:0001325,abnormal retina morphology|MP:0002092,abnormal eye morphology|MP:0002699,abnormal vitreous body morphology
MGI:3856578	Zdhhc15<Gt(AH0619)Wtsi>	MP:0002151,abnormal neural tube morphology|MP:0003984,embryonic growth retardation
MGI:6446933	Zdhhc16<tm1b(EUCOMM)Hmgu>	MP:0000062,increased bone mineral density|MP:0000428,abnormal craniofacial morphology|MP:0001529,abnormal vocalization|MP:0001697,abnormal embryo size|MP:0003961,decreased lean body mass|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:5907020	Zdhhc16<tm1Goff>	MP:0000280,thin ventricular wall|MP:0001286,abnormal eye development|MP:0001312,abnormal cornea morphology|MP:0001325,abnormal retina morphology|MP:0001402,decreased locomotor activity|MP:0001436,abnormal suckling behavior|MP:0001698,decreased embryo size|MP:0002058,neonatal lethality|MP:0003393,decreased cardiac output|MP:0004090,abnormal sarcomere morphology|MP:0005330,cardiomyopathy|MP:0005333,decreased heart rate|MP:0008772,increased heart ventricle size|MP:0008788,abnormal fetal cardiomyocyte morphology|MP:0009703,decreased birth body size|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011952,decreased cardiac stroke volume
MGI:4129208	Zdhhc17<Gt(RRJ233)Byg>	MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001522,impaired swimming|MP:0002175,decreased brain weight|MP:0002574,increased vertical activity|MP:0003203,increased neuron apoptosis|MP:0004077,abnormal striatum morphology|MP:0008026,abnormal brain white matter morphology|MP:0008948,decreased neuron number|MP:0009142,decreased prepulse inhibition|MP:0009538,abnormal synapse morphology|MP:0009848,increased horizontal stereotypic behavior|MP:0009849,increased vertical stereotypic behavior|MP:0012468,decreased striatum size|MP:0020083,decreased hippocampus volume
MGI:6838376	Zdhhc19<em1Cya>	MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0004542,impaired acrosome reaction|MP:0009230,abnormal sperm head morphology|MP:0009237,kinked sperm flagellum|MP:0009238,coiled sperm flagellum|MP:0009647,decreased fertilization frequency
MGI:6302782	Zdhhc19<em1(IMPC)J>	MP:0001925,male infertility|MP:0010024,increased total body fat amount
MGI:7327515	Zdhhc19<em1Mngx>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001932,abnormal spermiogenesis|MP:0002662,abnormal cauda epididymis morphology|MP:0002675,asthenozoospermia|MP:0002687,oligozoospermia|MP:0004852,decreased testis weight|MP:0005578,teratozoospermia|MP:0008892,abnormal sperm flagellum morphology|MP:0009230,abnormal sperm head morphology|MP:0014052,increased male germ cell apoptosis|MP:0020451,decreased sperm progressive motility
MGI:6393261	Zdhhc1<tm1Yyiw>	MP:0005387,immune system phenotype|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008574,decreased circulating interferon-alpha level|MP:0008576,decreased circulating interferon-beta level|MP:0008597,decreased circulating interleukin-6 level|MP:0010210,abnormal circulating cytokine level|MP:0020916,increased susceptibility to Herpesvirales infection|MP:0031026,increased susceptibility to Herpesvirales infection induced morbidity/mortality
MGI:7711280	Zdhhc20<em1.1Jdo>	MP:0002169,no abnormal phenotype detected
MGI:6277052	Zdhhc20<em1(IMPC)Hmgu>	MP:0000063,decreased bone mineral density|MP:0000194,increased circulating calcium level|MP:0002100,abnormal tooth morphology|MP:0002111,abnormal tail morphology|MP:0010124,decreased bone mineral content
MGI:1856841	Zdhhc21<dep>	MP:0000377,abnormal hair follicle morphology|MP:0000382,underdeveloped hair follicles|MP:0000383,abnormal hair follicle orientation|MP:0000416,sparse hair|MP:0000417,short hair|MP:0000427,abnormal hair cycle|MP:0000652,enlarged sebaceous gland|MP:0001216,abnormal epidermal layer morphology|MP:0001219,thick epidermis|MP:0001510,abnormal coat appearance|MP:0002073,abnormal hair growth|MP:0002991,abnormal sebaceous gland physiology|MP:0003414,epidermal cyst|MP:0003846,matted coat|MP:0003849,greasy coat|MP:0005114,premature hair loss|MP:0005382,craniofacial phenotype|MP:0005501,abnormal skin physiology|MP:0008731,abnormal hair shaft melanin granule morphology|MP:0008767,abnormal hair medullary septa cells|MP:0009794,sebaceous gland hyperplasia|MP:0010683,dilated hair follicle infundibulum|MP:0011194,abnormal hair follicle physiology|MP:0013373,increased sebum secretion
MGI:6401345	Zdhhc22<em1(IMPC)J>	MP:0010052,increased grip strength|MP:0010506,prolonged RR interval
MGI:5548874	Zdhhc23<tm1.1(KOMP)Vlcg>	MP:0001314,cornea opacity|MP:0001399,hyperactivity|MP:0005505,thrombocytosis
MGI:4223339	Zdhhc24<Gt(OST190401)Lex>	MP:0002169,no abnormal phenotype detected
MGI:5548600	Zdhhc24<tm1b(EUCOMM)Hmgu>	MP:0009142,decreased prepulse inhibition
MGI:6693324	Zdhhc2<em1Eko>	MP:0000221,decreased leukocyte cell number|MP:0001828,abnormal T cell activation|MP:0008124,decreased plasmacytoid dendritic cell number|MP:0008346,increased gamma-delta T cell number|MP:0008713,abnormal cytokine level|MP:0008750,abnormal interferon level|MP:0008751,abnormal interleukin level|MP:0008752,abnormal tumor necrosis factor level|MP:0008769,abnormal plasmacytoid dendritic cell physiology|MP:0012573,decreased susceptibility to chemically induced skin inflammation|MP:0012764,increased alpha-beta T cell number|MP:0013410,decreased dendritic epidermal T cell number
MGI:5605795	Zdhhc2<tm1b(KOMP)Wtsi>	MP:0002753,dilated heart left ventricle|MP:0003769,abnormal lip morphology|MP:0013279,increased fasting circulating glucose level
MGI:5708230	Zdhhc3<tm1.1(KOMP)Vlcg>	MP:0001399,hyperactivity|MP:0001891,hydrocephaly|MP:0002152,abnormal brain morphology
MGI:5818156	Zdhhc3<tm1.2Lusc>	MP:0001262,decreased body weight|MP:0002184,abnormal innervation|MP:0005376,homeostasis/metabolism phenotype|MP:0005386,behavior/neurological phenotype|MP:0005584,abnormal enzyme/coenzyme activity|MP:0011987,abnormal GABAergic neuron physiology|MP:0020358,abnormal inhibitory synapse morphology
MGI:6363130	Zdhhc4<em1Smoc>	MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002118,abnormal lipid homeostasis|MP:0005375,adipose tissue phenotype|MP:0005378,growth/size/body region phenotype|MP:0005560,decreased circulating glucose level|MP:0011049,impaired adaptive thermogenesis
MGI:7639940	Zdhhc5<em1Eko>	MP:0004793,abnormal synaptic vesicle clustering|MP:0009939,abnormal hippocampus neuron morphology
MGI:4126703	Zdhhc5<Gt(RRD153)Byg>	MP:0005386,behavior/neurological phenotype|MP:0009454,impaired contextual conditioning behavior|MP:0011101,prenatal lethality, incomplete penetrance
MGI:6363129	Zdhhc5<tm1.1Smoc>	MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0002118,abnormal lipid homeostasis|MP:0005375,adipose tissue phenotype|MP:0005378,growth/size/body region phenotype|MP:0005560,decreased circulating glucose level
MGI:6317366	Zdhhc5<tm1e.1(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0001489,decreased startle reflex|MP:0002599,increased mean platelet volume|MP:0002792,abnormal retina vasculature morphology|MP:0004738,abnormal auditory brainstem response|MP:0008528,polycystic kidney|MP:0010511,shortened PR interval|MP:0011965,decreased total retina thickness
MGI:6452490	Zdhhc7<tm1.1Wqz>	MP:0000807,abnormal hippocampus morphology|MP:0001364,decreased anxiety-related response|MP:0001473,reduced long-term potentiation|MP:0001900,impaired synaptic plasticity|MP:0002206,abnormal CNS synaptic transmission|MP:0002945,abnormal inhibitory postsynaptic currents|MP:0004753,abnormal miniature excitatory postsynaptic currents|MP:0008428,abnormal spatial working memory|MP:0009435,abnormal miniature inhibitory postsynaptic currents|MP:0011270,decreased excitatory postsynaptic current amplitude|MP:0014383,decreased miniature inhibitory postsynaptic current frequency|MP:0014384,increased miniature inhibitory postsynaptic current amplitude|MP:0020870,decreased thigmotaxis|MP:0031391,increased locomotor activity
MGI:5818178	Zdhhc7<tm1.2Lusc>	MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005386,behavior/neurological phenotype
MGI:5233886	Zdhhc8<Gt(IST14452C2)Tigm>	MP:0003631,nervous system phenotype
MGI:3047084	Zdhhc8<tm1Kara>	MP:0001417,decreased exploration in new environment|MP:0008143,abnormal dendrite morphology|MP:0009142,decreased prepulse inhibition|MP:0009538,abnormal synapse morphology|MP:0009936,abnormal dendritic spine morphology
MGI:5007410	Zdhhc9<tm1Lex>	MP:0000781,decreased corpus callosum size|MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001489,decreased startle reflex|MP:0002442,abnormal leukocyte physiology|MP:0004144,hypotonia|MP:0005397,hematopoietic system phenotype|MP:0008874,decreased physiological sensitivity to xenobiotic|MP:0009278,abnormal bone marrow cell physiology|MP:0009767,decreased susceptibility to xenobiotic induced morbidity/mortality|MP:0012307,impaired spatial learning
MGI:5428990	Zeb1<m1Btlr>	MP:0000714,increased thymocyte number|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0002144,abnormal B cell differentiation|MP:0004816,abnormal class switch recombination|MP:0004978,decreased B-1 B cell number|MP:0005092,decreased double-positive T cell number|MP:0005093,decreased B cell proliferation|MP:0005387,immune system phenotype|MP:0008045,decreased NK cell number|MP:0008082,increased single-positive T cell number|MP:0008168,decreased B-1a cell number|MP:0008170,decreased B-1b cell number|MP:0008178,decreased germinal center B cell number|MP:0008183,absent marginal zone B cells|MP:0008194,abnormal memory B cell physiology|MP:0008495,decreased IgG1 level
MGI:5640753	Zeb1<m2Btlr>	MP:0020154,impaired humoral immune response
MGI:5295192	Zeb1<tm1.1Ajg>	MP:0000111,cleft palate|MP:0002428,abnormal semicircular canal morphology|MP:0003148,decreased cochlea coiling|MP:0003161,absent lateral semicircular canal|MP:0003164,decreased posterior semicircular canal size
MGI:5901939	Zeb1<tm1.1Mpst>	MP:0002169,no abnormal phenotype detected
MGI:5901940	Zeb1<tm1.2Mpst>	MP:0000556,abnormal hindlimb morphology|MP:0001785,edema|MP:0001914,hemorrhage|MP:0001953,respiratory failure|MP:0002192,hydrops fetalis|MP:0003051,curly tail|MP:0004201,fetal growth retardation|MP:0005163,cyclopia|MP:0011089,perinatal lethality, complete penetrance|MP:0014012,abnormal cranial blood vasculature morphology
MGI:1857515	Zeb1<tm1Yhi>	MP:0000704,abnormal thymus development|MP:0000706,small thymus|MP:0000715,decreased thymocyte number|MP:0001823,thymus hypoplasia|MP:0002024,increased T cell derived lymphoma incidence|MP:0002083,premature death|MP:0002145,abnormal T cell differentiation|MP:0003944,abnormal T cell subpopulation ratio|MP:0004105,cornea abrasion|MP:0004221,abnormal iridocorneal angle|MP:0005016,decreased lymphocyte cell number|MP:0005018,decreased T cell number|MP:0005092,decreased double-positive T cell number|MP:0005300,abnormal cornea stroma morphology|MP:0005301,abnormal cornea endothelium morphology|MP:0005324,ascites|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008101,lymph node hypoplasia|MP:0009339,decreased splenocyte number|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011087,neonatal lethality, complete penetrance|MP:0011481,anterior iris synechia|MP:0011962,increased cornea thickness|MP:0020858,cornea epithelium hypoplasia
MGI:1857799	Zeb1<tm2Yhi>	MP:0000037,abnormal lateral semicircular canal morphology|MP:0000088,short mandible|MP:0000091,short premaxilla|MP:0000097,short maxilla|MP:0000106,abnormal basisphenoid bone morphology|MP:0000150,abnormal rib morphology|MP:0000154,rib fusion|MP:0000157,abnormal sternum morphology|MP:0000159,abnormal xiphoid process morphology|MP:0000454,abnormal jaw morphology|MP:0000460,mandible hypoplasia|MP:0000547,short limbs|MP:0000564,syndactyly|MP:0000715,decreased thymocyte number|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001575,cyanosis|MP:0001823,thymus hypoplasia|MP:0001914,hemorrhage|MP:0001953,respiratory failure|MP:0002116,abnormal craniofacial bone morphology|MP:0002192,hydrops fetalis|MP:0002239,abnormal nasal septum morphology|MP:0002543,brachyphalangia|MP:0003051,curly tail|MP:0003419,delayed endochondral bone ossification|MP:0004201,fetal growth retardation|MP:0004321,short sternum|MP:0004322,abnormal sternebra morphology|MP:0004340,short scapula|MP:0004358,bowed tibia|MP:0004374,bowed radius|MP:0004453,abnormal pterygoid bone morphology|MP:0004596,abnormal mandibular angle morphology|MP:0004642,fused metatarsal bones|MP:0004681,intervertebral disk hypoplasia|MP:0004686,decreased length of long bones|MP:0004883,abnormal vascular wound healing|MP:0005104,abnormal tarsal bone morphology|MP:0005306,abnormal phalanx morphology|MP:0005595,abnormal vascular smooth muscle physiology|MP:0008052,abnormal serous gland morphology|MP:0008915,fused carpal bones|MP:0009727,abnormal navicular morphology|MP:0009890,cleft secondary palate|MP:0009892,palate bone hypoplasia|MP:0011087,neonatal lethality, complete penetrance|MP:0013945,abnormal elbow joint morphology|MP:0014806,humeroradial synostosis|MP:0030259,mandibular condyloid process hypoplasia|MP:0030285,mandibular coronoid process hypoplasia|MP:0030373,Meckel's cartilage hyperplasia|MP:0030829,abnormal hip joint morphology|MP:0030860,patellar dislocation|MP:0030897,abnormal humeroulnar joint morphology
MGI:1861230	Zeb1<Tw>	MP:0000010,abnormal abdominal fat pad morphology|MP:0000026,abnormal inner ear morphology|MP:0000031,abnormal cochlea morphology|MP:0000037,abnormal lateral semicircular canal morphology|MP:0000100,abnormal ethmoid bone morphology|MP:0000108,midline facial cleft|MP:0000111,cleft palate|MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000371,diluted coat color|MP:0000416,sparse hair|MP:0000692,small spleen|MP:0000706,small thymus|MP:0000819,abnormal olfactory bulb morphology|MP:0001260,increased body weight|MP:0001261,obese|MP:0001265,decreased body size|MP:0001270,distended abdomen|MP:0001354,increased aggression towards male mice|MP:0001394,circling|MP:0001395,bidirectional circling|MP:0001399,hyperactivity|MP:0001410,head bobbing|MP:0001436,abnormal suckling behavior|MP:0001552,increased circulating triglyceride level|MP:0001554,increased circulating free fatty acids level|MP:0001732,postnatal growth retardation|MP:0001745,increased circulating corticosterone level|MP:0001922,reduced male fertility|MP:0001924,infertility|MP:0001926,female infertility|MP:0001954,respiratory distress|MP:0002068,abnormal parental behavior|MP:0002079,increased circulating insulin level|MP:0002237,abnormal nasal cavity morphology|MP:0002239,abnormal nasal septum morphology|MP:0002244,abnormal turbinate morphology|MP:0002428,abnormal semicircular canal morphology|MP:0002729,abnormal inner ear canal morphology|MP:0002730,head shaking|MP:0002820,abnormal premaxilla morphology|MP:0002858,abnormal posterior semicircular canal morphology|MP:0002894,abnormal otolith morphology|MP:0002978,absent otoliths|MP:0002980,abnormal postural reflex|MP:0003069,abnormal superior semicircular canal morphology|MP:0003143,enlarged otoliths|MP:0003144,decreased otolith number|MP:0003148,decreased cochlea coiling|MP:0003161,absent lateral semicircular canal|MP:0003162,decreased lateral semicircular canal size|MP:0003164,decreased posterior semicircular canal size|MP:0003169,abnormal scala media morphology|MP:0003212,increased susceptibility to age related obesity|MP:0003949,abnormal circulating lipid level|MP:0004179,transmission ratio distortion|MP:0004249,abnormal crista ampullaris morphology|MP:0004409,abnormal crista ampullaris neuroepithelium morphology|MP:0004477,turbinate hypoplasia|MP:0004538,abnormal maxillary shelf morphology|MP:0005016,decreased lymphocyte cell number|MP:0005170,cleft upper lip|MP:0005236,abnormal olfactory nerve morphology|MP:0005293,impaired glucose tolerance|MP:0005331,insulin resistance|MP:0005336,abnormal inguinal fat pad morphology|MP:0005377,hearing/vestibular/ear phenotype|MP:0005418,abnormal circulating hormone level|MP:0005458,increased percent body fat/body weight|MP:0005669,increased circulating leptin level|MP:0006012,dilated endolymphatic duct|MP:0006092,abnormal olfactory sensory neuron morphology|MP:0008488,abnormal semicircular canal ampulla morphology|MP:0008789,abnormal olfactory epithelium morphology|MP:0009247,meteorism|MP:0009888,palatal shelves fail to meet at midline|MP:0009890,cleft secondary palate|MP:0009946,abnormal olfactory bulb layer morphology|MP:0009948,abnormal olfactory bulb glomerular layer morphology|MP:0009951,abnormal olfactory bulb mitral cell layer morphology|MP:0010024,increased total body fat amount|MP:0011087,neonatal lethality, complete penetrance|MP:0011939,increased food intake|MP:0011967,increased or absent threshold for auditory brainstem response|MP:0012014,abnormal olfactory neuron innervation pattern|MP:0021208,median cleft palate|MP:0021210,bilateral cleft palate|MP:0021211,unilateral cleft palate|MP:0030304,abnormal cribriform plate morphology|MP:0030969,increased circulating adiponectin level|MP:0031447,unilateral cleft upper lip|MP:0031448,bilateral cleft upper lip|MP:0031460,abnormal palatal shelf morphology|MP:0031462,decreased palatal shelf size
MGI:2387499	Zeb2<tm1.1Yhi>	MP:0000394,absent hair follicle melanin granules|MP:0001303,abnormal lens morphology|MP:0001306,small lens|MP:0002840,abnormal lens fiber morphology|MP:0004381,abnormal hair follicle melanocyte morphology|MP:0005075,abnormal melanosome morphology|MP:0005408,hypopigmentation|MP:0008732,reduced hair shaft melanin granule number|MP:0009759,abnormal hair follicle bulge morphology|MP:0009783,abnormal melanoblast morphology|MP:0009784,abnormal melanoblast migration
MGI:2387501	Zeb2<tm1.2Yhi>	MP:0000929,open neural tube|MP:0001672,abnormal embryo development|MP:0001688,abnormal somite development|MP:0001691,abnormal somite shape|MP:0001701,incomplete embryo turning|MP:0001730,embryonic growth arrest|MP:0003631,nervous system phenotype|MP:0005657,abnormal neural plate morphology|MP:0006342,absent first pharyngeal arch|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011732,decreased somite size|MP:0012746,abnormal neural crest cell delamination|MP:0012757,abnormal cranial neural crest cell migration|MP:0013011,absent vagal neural crest cells
MGI:6189603	Zer1<em1(IMPC)J>	MP:0001529,abnormal vocalization|MP:0002833,increased heart weight|MP:0005292,improved glucose tolerance
MGI:3664591	Zfand2a<Gt(XM071)Byg>	MP:0005621,abnormal cell physiology
MGI:6119758	Zfand2b<tm1Otin>	MP:0000218,increased leukocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000321,increased bone marrow cell number|MP:0000322,increased granulocyte number|MP:0000333,decreased bone marrow cell number|MP:0000691,enlarged spleen|MP:0001263,weight loss|MP:0001270,distended abdomen|MP:0002083,premature death|MP:0002123,abnormal definitive hematopoiesis|MP:0002608,increased hematocrit|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0004809,increased hematopoietic stem cell number|MP:0004952,increased spleen weight|MP:0005013,increased lymphocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0005150,cachexia|MP:0005397,hematopoietic system phenotype|MP:0005481,increased chronic myelocytic leukemia incidence|MP:0005505,thrombocytosis|MP:0008250,abnormal myeloid leukocyte morphology|MP:0008469,abnormal protein level|MP:0009395,increased nucleated erythrocyte cell number|MP:0010763,abnormal hematopoietic stem cell physiology|MP:0011747,myelofibrosis|MP:0013414,decreased myeloid cell number in bone marrow|MP:0013658,abnormal myeloid cell morphology|MP:0013660,abnormal bone marrow hematopoietic cell morphology|MP:0013663,increased myeloid cell number|MP:0013696,increased granulocyte monocyte progenitor cell number|MP:0013704,increased megakaryocyte-erythroid progenitor cell number|MP:0013891,increased common myeloid progenitor cell number
MGI:6361035	Zfand3<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0000221,decreased leukocyte cell number|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0002875,decreased erythrocyte cell number|MP:0005553,increased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005567,decreased circulating total protein level
MGI:3530039	Zfand5<Gt(OST223460)Lex>	MP:0001262,decreased body weight|MP:0003213,decreased susceptibility to age related obesity|MP:0010025,decreased total body fat amount
MGI:3526860	Zfand5<Gt(ROSA)72Sor>	MP:0000074,abnormal neurocranium morphology|MP:0000107,abnormal frontal bone morphology|MP:0000157,abnormal sternum morphology|MP:0001614,abnormal blood vessel morphology|MP:0001634,internal hemorrhage|MP:0001914,hemorrhage|MP:0001954,respiratory distress|MP:0003814,vascular smooth muscle hypoplasia|MP:0003828,pulmonary edema|MP:0005508,abnormal skeleton morphology|MP:0008146,asymmetric sternocostal joints|MP:0011087,neonatal lethality, complete penetrance|MP:0011708,decreased fibroblast cell migration
MGI:6276871	Zfand6<em1(IMPC)Mbp>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002590,increased mean corpuscular volume|MP:0003068,enlarged kidney|MP:0005179,decreased circulating cholesterol level|MP:0005292,improved glucose tolerance|MP:0005344,increased circulating bilirubin level|MP:0005419,decreased circulating serum albumin level|MP:0005567,decreased circulating total protein level
MGI:2384333	Zfa-ps<tm1Ems>	MP:0005389,reproductive system phenotype
MGI:6399888	Zfat<em1(IMPC)Ccpcz>	MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000703,abnormal thymus morphology|MP:0000709,enlarged thymus|MP:0001697,abnormal embryo size|MP:0002100,abnormal tooth morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance|MP:0013294,prenatal lethality prior to heart atrial septation
MGI:4829941	Zfat<tm1Sawa>	MP:0001722,pale yolk sac|MP:0003396,abnormal embryonic hematopoiesis|MP:0004180,failure of initiation of embryo turning|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0011092,embryonic lethality, complete penetrance|MP:0011204,abnormal visceral yolk sac blood island morphology
MGI:5439020	Zfat<tm2.1Sawa>	MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0005463,abnormal CD4-positive, alpha-beta T cell physiology|MP:0006413,increased T cell apoptosis|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008688,decreased interleukin-2 secretion
MGI:6279957	Zfat<tm3.1Sawa>	MP:0011091,prenatal lethality, complete penetrance
MGI:6430662	Zfc3h1<em1(IMPC)Mbp>	MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001257,increased body length|MP:0001289,persistence of hyaloid vascular system|MP:0002792,abnormal retina vasculature morphology|MP:0003984,embryonic growth retardation|MP:0011100,preweaning lethality, complete penetrance
MGI:6379557	Zfhx2<em1(IMPC)Rbrc>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0002631,abnormal epididymis morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:6476743	Zfhx2<tm3Ymri>	MP:0002272,abnormal nervous system electrophysiology|MP:0003998,decreased thermal nociceptive threshold|MP:0020955,increased mechanical nociceptive threshold
MGI:3830369	Zfhx3<Gt(RRJ548)Byg>	MP:0005134,decreased thyroid-stimulating hormone level|MP:0005136,decreased growth hormone level|MP:0005379,endocrine/exocrine gland phenotype
MGI:2679554	Zfhx3<Sci>	MP:0011091,prenatal lethality, complete penetrance|MP:0020467,abnormal circadian behavior|MP:0020470,shortened circadian behavior period|MP:0020472,arrhythmic circadian behavior persistence|MP:0020473,abnormal circadian behavior phase|MP:0020474,advanced circadian behavior phase|MP:0020476,abnormal circardian behavior entrainment
MGI:5446504	Zfhx3<tm1.1Jtd>	MP:0002169,no abnormal phenotype detected|MP:0009219,increased prostate intraepithelial neoplasia incidence|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020469,prolonged circadian behavior period
MGI:5446506	Zfhx3<tm1.2Jtd>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001402,decreased locomotor activity|MP:0001431,abnormal eating behavior|MP:0002083,premature death|MP:0002161,abnormal fertility/fecundity|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance
MGI:6400544	Zfhx4<em1(IMPC)J>	MP:0000208,decreased hematocrit|MP:0001417,decreased exploration in new environment
MGI:6834794	Zfhx4<tm1.1Rnis>	MP:0000060,delayed bone ossification|MP:0000167,decreased chondrocyte number|MP:0000460,mandible hypoplasia|MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0003109,short femur|MP:0003120,abnormal tracheal cartilage morphology|MP:0004351,short humerus|MP:0004911,absent mandibular condyloid process|MP:0005352,small cranium|MP:0008272,abnormal endochondral bone ossification|MP:0009655,abnormal secondary palate development|MP:0009886,failure of palatal shelf elevation|MP:0011087,neonatal lethality, complete penetrance|MP:0021213,complete cleft palate
MGI:4128645	Zfp105<Gt(TEA059)Byg>	MP:0001156,abnormal spermatogenesis|MP:0001922,reduced male fertility
MGI:6149784	Zfp106<em1Blk>	MP:0000759,abnormal skeletal muscle morphology|MP:0000939,decreased motor neuron number|MP:0004262,abnormal physical strength|MP:0005150,cachexia|MP:0009412,skeletal muscle fiber degeneration|MP:0009413,skeletal muscle fiber atrophy|MP:0010053,decreased grip strength
MGI:4362535	Zfp106<tm1a(KOMP)Wtsi>	MP:0000160,kyphosis|MP:0000194,increased circulating calcium level|MP:0000745,tremors|MP:0000938,motor neuron degeneration|MP:0000955,abnormal spinal cord morphology|MP:0000964,small dorsal root ganglion|MP:0001021,small L4 dorsal root ganglion|MP:0001024,small L5 dorsal root ganglion|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001513,limb grasping|MP:0001524,impaired limb coordination|MP:0001973,increased thermal nociceptive threshold|MP:0002083,premature death|MP:0002106,abnormal muscle physiology|MP:0002183,gliosis|MP:0002229,neurodegeneration|MP:0002883,chromatolysis|MP:0003081,abnormal soleus morphology|MP:0003082,abnormal gastrocnemius morphology|MP:0003186,abnormal redox activity|MP:0003354,astrocytosis|MP:0003631,nervous system phenotype|MP:0004145,abnormal muscle electrophysiology|MP:0005356,positive geotaxis|MP:0005404,abnormal axon morphology|MP:0005405,axon degeneration|MP:0005562,decreased mean corpuscular hemoglobin|MP:0006036,abnormal mitochondrial physiology|MP:0006404,abnormal lumbar dorsal root ganglion morphology|MP:0008918,microgliosis|MP:0009199,abnormal external male genitalia morphology|MP:0009403,increased variability of skeletal muscle fiber size|MP:0009404,centrally nucleated skeletal muscle fibers|MP:0009406,decreased skeletal muscle fiber number|MP:0009409,abnormal skeletal muscle fiber type ratio|MP:0009413,skeletal muscle fiber atrophy|MP:0009417,skeletal muscle atrophy|MP:0009419,skeletal muscle fibrosis|MP:0009422,decreased gastrocnemius weight|MP:0009426,decreased soleus weight|MP:0009428,decreased tibialis anterior weight|MP:0010053,decreased grip strength|MP:0010956,abnormal mitochondrial ATP synthesis coupled electron transport|MP:0013182,increased spinal cord apoptosis
MGI:6149962	Zfp106<tm1b(KOMP)Wtsi>	MP:0000759,abnormal skeletal muscle morphology|MP:0000939,decreased motor neuron number|MP:0004262,abnormal physical strength|MP:0005150,cachexia|MP:0009412,skeletal muscle fiber degeneration|MP:0009413,skeletal muscle fiber atrophy|MP:0010053,decreased grip strength
MGI:2156881	Zfp110<tm1Mpin>	MP:0001698,decreased embryo size|MP:0002169,no abnormal phenotype detected|MP:0004852,decreased testis weight|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0030006,decreased retina apoptosis
MGI:5605805	Zfp111<tm1b(KOMP)Wtsi>	MP:0002060,abnormal skin morphology
MGI:5548456	Zfp119a<tm1b(EUCOMM)Hmgu>	MP:0000218,increased leukocyte cell number|MP:0001488,increased startle reflex
MGI:6356577	Zfp131<tm1.1Mytk>	MP:0003850,abnormal thymocyte activation|MP:0003944,abnormal T cell subpopulation ratio|MP:0005018,decreased T cell number|MP:0005095,decreased T cell proliferation|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008079,decreased CD8-positive, alpha-beta T cell number
MGI:4435325	Zfp13<tm1a(EUCOMM)Hmgu>	MP:0002874,decreased hemoglobin content|MP:0005554,decreased circulating creatinine level
MGI:2678386	Zfp141<Gt(pT1ATGBetageo)1Ruiz>	MP:0002095,abnormal skin pigmentation
MGI:5548684	Zfp142<tm1b(EUCOMM)Wtsi>	MP:0001399,hyperactivity
MGI:2678408	Zfp143<Gt(U3Betageo)1Ruiz>	MP:0001924,infertility
MGI:6758799	Zfp146<em1(IMPC)J>	MP:0002098,abnormal vibrissa morphology|MP:0010052,increased grip strength
MGI:3784952	Zfp148<Gt(XB878)Byg>	MP:0000929,open neural tube|MP:0001176,abnormal lung development|MP:0001575,cyanosis|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0003229,abnormal vitelline vasculature morphology|MP:0003717,pallor|MP:0003984,embryonic growth retardation|MP:0008489,slow postnatal weight gain|MP:0010825,abnormal lung saccule morphology|MP:0011088,neonatal lethality, incomplete penetrance|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:5502212	Zfp148<tm1.1Jmer>	MP:0001846,increased inflammatory response|MP:0002412,increased susceptibility to bacterial infection|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0010070,decreased serotonin level|MP:0010180,increased susceptibility to weight loss
MGI:5636955	Zfp148<tm1b(EUCOMM)Hmgu>	MP:0000062,increased bone mineral density|MP:0001491,unresponsive to tactile stimuli|MP:0001697,abnormal embryo size|MP:0002135,abnormal kidney morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration
MGI:3623378	Zfp148<tm1Djl>	MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0008537,increased susceptibility to induced colitis|MP:0009766,increased susceptibility to xenobiotic induced morbidity/mortality|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3040891	Zfp148<tm1Kii>	MP:0001147,small testis|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0008280,abnormal male germ cell apoptosis
MGI:5612830	Zfp14<tm1b(KOMP)Wtsi>	MP:0000947,convulsive seizures|MP:0002833,increased heart weight
MGI:7429175	Zfp14<tm1Xch>	MP:0000693,spleen hyperplasia|MP:0000708,thymus hyperplasia|MP:0001214,skin hyperplasia|MP:0001846,increased inflammatory response|MP:0002020,increased tumor incidence|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0003341,chronic pancreas inflammation|MP:0008102,lymph node hyperplasia
MGI:4124834	Zfp157<Gt(XC356)Byg>	MP:0000627,abnormal mammary gland morphology|MP:0000628,abnormal mammary gland development|MP:0001881,abnormal mammary gland physiology|MP:0001884,mammary gland alveolar hyperplasia|MP:0006269,abnormal mammary gland growth during pregnancy
MGI:5638563	Zfp160<tm1b(EUCOMM)Wtsi>	MP:0000063,decreased bone mineral density|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0004953,decreased spleen weight|MP:0010124,decreased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5689892	Zfp174<em1(IMPC)J>	MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0001486,abnormal startle reflex|MP:0002111,abnormal tail morphology|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:5637160	Zfp175<tm1b(EUCOMM)Wtsi>	MP:0001556,increased circulating HDL cholesterol level|MP:0005178,increased circulating cholesterol level
MGI:4841252	Zfp182<tm1a(KOMP)Wtsi>	MP:0001303,abnormal lens morphology|MP:0001304,cataract
MGI:5552020	Zfp182<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level
MGI:4362182	Zfp184<tm1a(KOMP)Wtsi>	MP:0004924,abnormal behavior
MGI:7587661	Zfp185<em1Cya>	MP:0003070,increased vascular permeability
MGI:5906318	Zfp202<em1(IMPC)J>	MP:0003961,decreased lean body mass|MP:0005178,increased circulating cholesterol level|MP:0010024,increased total body fat amount|MP:0010052,increased grip strength|MP:0010124,decreased bone mineral content
MGI:4839011	Zfp202<tm1(NCOM)Cmhd>	MP:0001258,decreased body length|MP:0001262,decreased body weight|MP:0001399,hyperactivity|MP:0003961,decreased lean body mass
MGI:5548446	Zfp207<tm1b(EUCOMM)Hmgu>	MP:0000219,increased neutrophil cell number|MP:0002591,decreased mean corpuscular volume|MP:0005016,decreased lymphocyte cell number|MP:0005419,decreased circulating serum albumin level|MP:0011100,preweaning lethality, complete penetrance
MGI:6830528	Zfp212<em1Jhsn>	MP:0000876,Purkinje cell degeneration|MP:0000880,decreased Purkinje cell number|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0002083,premature death|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0020870,decreased thigmotaxis
MGI:6730372	Zfp217<em1Sjia>	MP:0002891,increased insulin sensitivity|MP:0004889,increased energy expenditure|MP:0005289,increased oxygen consumption|MP:0005292,improved glucose tolerance|MP:0005459,decreased percent body fat/body weight|MP:0005659,decreased susceptibility to diet-induced obesity|MP:0008907,decreased total fat pad weight|MP:0008963,increased carbon dioxide production|MP:0009269,decreased fat cell size|MP:0011091,prenatal lethality, complete penetrance|MP:0011167,abnormal adipose tissue development
MGI:5607861	Zfp219<em1(IMPC)J>	MP:0001759,increased urine glucose level|MP:0005560,decreased circulating glucose level
MGI:5796933	Zfp219<tm1b(EUCOMM)Hmgu>	MP:0005505,thrombocytosis
MGI:5638566	Zfp235<tm1b(KOMP)Wtsi>	MP:0002953,thick ventricular wall|MP:0005599,increased cardiac muscle contractility|MP:0010052,increased grip strength
MGI:6152687	Zfp236<em1(IMPC)Mbp>	MP:0000266,abnormal heart morphology|MP:0000277,abnormal heart shape|MP:0000538,abnormal urinary bladder morphology|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0002059,abnormal seminal vesicle morphology|MP:0002135,abnormal kidney morphology|MP:0002188,small heart|MP:0002631,abnormal epididymis morphology|MP:0003068,enlarged kidney|MP:0004931,enlarged epididymis|MP:0011100,preweaning lethality, complete penetrance|MP:0011874,enlarged urinary bladder|MP:0013292,embryonic lethality prior to organogenesis
MGI:4412036	Zfp24<hmcns>	MP:0000745,tremors|MP:0000774,decreased brain size|MP:0000956,decreased spinal cord size|MP:0002083,premature death|MP:0002826,tonic seizures|MP:0003871,abnormal myelin sheath morphology|MP:0008027,abnormal spinal cord white matter morphology|MP:0009808,decreased oligodendrocyte number
MGI:5472018	Zfp24<hmcns-2J>	MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0002083,premature death|MP:0002826,tonic seizures|MP:0005391,vision/eye phenotype|MP:0011731,decreased myelin sheath thickness|MP:0011967,increased or absent threshold for auditory brainstem response
MGI:4429676	Zfp24<tm1.1Pop>	MP:0000745,tremors|MP:0002826,tonic seizures|MP:0003871,abnormal myelin sheath morphology
MGI:4429673	Zfp24<tm1.2Pop>	MP:0000745,tremors|MP:0000920,abnormal myelination|MP:0002083,premature death|MP:0002826,tonic seizures|MP:0003871,abnormal myelin sheath morphology|MP:0009808,decreased oligodendrocyte number
MGI:4430080	Zfp24<tm1Jifu>	MP:0004264,abnormal extraembryonic tissue physiology|MP:0004965,inner cell mass degeneration|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance|MP:0012114,absent inner cell mass proliferation
MGI:7539479	Zfp251<em1Hgseo>	MP:0001262,decreased body weight|MP:0002891,increased insulin sensitivity|MP:0005293,impaired glucose tolerance|MP:0006094,increased fat cell size|MP:0013279,increased fasting circulating glucose level
MGI:5513839	Zfp260<tm1b(NCOM)Mfgc>	MP:0000063,decreased bone mineral density|MP:0000219,increased neutrophil cell number|MP:0001785,edema|MP:0002764,short tibia|MP:0005016,decreased lymphocyte cell number|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5637091	Zfp266<tm1b(EUCOMM)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5766136	Zfp275<tm1.1(NCOM)Mfgc>	MP:0001175,abnormal lung morphology|MP:0005642,decreased mean corpuscular hemoglobin concentration
MGI:7513907	Zfp276<em1(IMPC)J>	MP:0001489,decreased startle reflex|MP:0009141,increased prepulse inhibition
MGI:7510125	Zfp276<tm1c(EUCOMM)Hmgu>	MP:0000920,abnormal myelination|MP:0013438,dysmyelination|MP:0014318,abnormal oligodendrocyte differentiation|MP:0020868,decreased lipogenesis
MGI:5496522	Zfp277<tm1Aiwa>	MP:0008008,early cellular replicative senescence
MGI:7429092	Zfp280c<em1(IMPC)Hmgu>	MP:0001325,abnormal retina morphology|MP:0001392,abnormal locomotor behavior|MP:0001415,increased exploration in new environment|MP:0002699,abnormal vitreous body morphology|MP:0010097,abnormal retina blood vessel morphology
MGI:7662826	Zfp280c<em1Xss>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:6382407	Zfp280d<em1(IMPC)Hmgu>	MP:0001486,abnormal startle reflex|MP:0001489,decreased startle reflex|MP:0002753,dilated heart left ventricle|MP:0002968,increased circulating alkaline phosphatase level|MP:0005140,decreased cardiac muscle contractility|MP:0005333,decreased heart rate|MP:0005343,increased circulating aspartate transaminase level|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0009142,decreased prepulse inhibition|MP:0010392,prolonged QRS complex duration|MP:0010506,prolonged RR interval
MGI:6277070	Zfp281<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000692,small spleen|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0002968,increased circulating alkaline phosphatase level|MP:0003068,enlarged kidney|MP:0004924,abnormal behavior|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0020870,decreased thigmotaxis
MGI:5449148	Zfp281<tm1.1Jlwa>	MP:0005076,abnormal cell differentiation|MP:0011096,embryonic lethality between implantation and somite formation, complete penetrance
MGI:7707397	Zfp282<em1Bbw>	MP:0002169,no abnormal phenotype detected
MGI:7426097	Zfp282<em1(IMPC)Bay>	MP:0001399,hyperactivity|MP:0001417,decreased exploration in new environment
MGI:5548771	Zfp287<tm1b(EUCOMM)Wtsi>	MP:0001406,abnormal gait
MGI:7356590	Zfp28<em1(IMPC)J>	MP:0000208,decreased hematocrit|MP:0002875,decreased erythrocyte cell number
MGI:7311695	Zfp292<em1Zfa>	MP:0002412,increased susceptibility to bacterial infection|MP:0009788,increased susceptibility to bacterial infection induced morbidity/mortality|MP:0013893,decreased common lymphocyte progenitor cell number
MGI:6283680	Zfp296<tm1Miya>	MP:0001127,small ovary|MP:0001147,small testis|MP:0001154,seminiferous tubule degeneration|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002006,neoplasm|MP:0002209,decreased germ cell number|MP:0002687,oligozoospermia|MP:0003984,embryonic growth retardation|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0004901,decreased male germ cell number|MP:0005431,decreased oocyte number|MP:0008391,abnormal primordial germ cell morphology|MP:0008392,decreased primordial germ cell number|MP:0008877,abnormal DNA methylation|MP:0008995,early reproductive senescence|MP:0009429,decreased embryo weight|MP:0011102,embryonic lethality, incomplete penetrance|MP:0030934,decreased primordial germ cell proliferation
MGI:6257683	Zfp300<em1(IMPC)Bay>	MP:0003394,increased cardiac output|MP:0011959,abnormal eye posterior chamber depth
MGI:6506190	Zfp30<em1Snpk>	MP:0001262,decreased body weight|MP:0003961,decreased lean body mass|MP:0005375,adipose tissue phenotype|MP:0005387,immune system phenotype|MP:0005388,respiratory system phenotype|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5563395	Zfp318<m1Anu>	MP:0001922,reduced male fertility|MP:0002458,abnormal B cell number|MP:0002491,decreased IgD level|MP:0002494,increased IgM level|MP:0005397,hematopoietic system phenotype|MP:0008191,abnormal follicular B cell physiology|MP:0008193,abnormal marginal zone B cell physiology|MP:0008210,increased mature B cell number
MGI:5619130	Zfp318<M1Btlr>	MP:0002491,decreased IgD level
MGI:5606279	Zfp318<tm1.1Jhws>	MP:0002491,decreased IgD level|MP:0002494,increased IgM level|MP:0009926,decreased transitional stage T2 B cell number
MGI:5578603	Zfp318<tm1Hhag>	MP:0002491,decreased IgD level|MP:0002494,increased IgM level|MP:0005397,hematopoietic system phenotype
MGI:5695254	Zfp329<em1(IMPC)J>	MP:0001325,abnormal retina morphology|MP:0002546,mydriasis|MP:0008259,abnormal optic disk morphology|MP:0010053,decreased grip strength
MGI:5752554	Zfp334<tm1.1(KOMP)Vlcg>	MP:0001304,cataract|MP:0001399,hyperactivity|MP:0002574,increased vertical activity|MP:0005344,increased circulating bilirubin level
MGI:5576210	Zfp335<blt>	MP:0002145,abnormal T cell differentiation|MP:0004974,decreased regulatory T cell number|MP:0005017,decreased B cell number|MP:0008040,decreased NK T cell number|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008076,abnormal CD4-positive T cell differentiation|MP:0008079,decreased CD8-positive, alpha-beta T cell number|MP:0008080,abnormal CD8-positive, alpha-beta T cell differentiation|MP:0008083,decreased single-positive T cell number|MP:0010836,decreased CD4-positive, alpha-beta memory T cell number|MP:0010839,decreased CD8-positive, alpha-beta memory T cell number
MGI:3857418	Zfp335<Gt(AY0030)Wtsi>	MP:0011092,embryonic lethality, complete penetrance
MGI:4125700	Zfp335<Gt(XG241)Byg>	MP:0011092,embryonic lethality, complete penetrance
MGI:5286608	Zfp335<Tg(Tyr)2359A-4d2Ove>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5470136	Zfp335<tm1.1Caw>	MP:0000774,decreased brain size|MP:0003241,loss of cortex neurons|MP:0006254,thin cerebral cortex
MGI:4362726	Zfp341<tm1a(KOMP)Wtsi>	MP:0003019,increased circulating chloride level|MP:0005633,increased circulating sodium level|MP:0008806,increased circulating amylase level|MP:0010123,increased bone mineral content
MGI:5521539	Zfp346<tm1.1(KOMP)Vlcg>	MP:0001554,increased circulating free fatty acids level|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6430652	Zfp354a<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0003068,enlarged kidney|MP:0005553,increased circulating creatinine level
MGI:4398896	Zfp35<tm1Naka>	MP:0001952,increased airway responsiveness|MP:0005011,increased eosinophil cell number|MP:0008092,abnormal T-helper 2 cell differentiation|MP:0008602,increased circulating interleukin-4 level|MP:0008608,increased circulating interleukin-13 level|MP:0008626,increased circulating interleukin-5 level
MGI:5561003	Zfp365<tm1That>	MP:0000920,abnormal myelination|MP:0003631,nervous system phenotype|MP:0004101,abnormal brain interneuron morphology|MP:0010160,increased oligodendrocyte number
MGI:5645262	Zfp366<b2b2834Clo>	MP:0000273,overriding aortic valve|MP:0000445,short snout|MP:0000519,hydronephrosis|MP:0000564,syndactyly|MP:0001297,microphthalmia|MP:0001823,thymus hypoplasia|MP:0002639,micrognathia|MP:0010402,ventricular septal defect
MGI:4363813	Zfp367<tm1a(KOMP)Wtsi>	MP:0005553,increased circulating creatinine level
MGI:3050540	Zfp36l1<tm1Pjb>	MP:0000267,abnormal heart development|MP:0000352,decreased cell proliferation|MP:0000929,open neural tube|MP:0001648,abnormal apoptosis|MP:0001698,decreased embryo size|MP:0001715,placental labyrinth hypoplasia|MP:0004255,abnormal spongiotrophoblast layer morphology|MP:0009657,failure of chorioallantoic fusion|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance|MP:0031590,abnormal epicardium development
MGI:3686982	Zfp36l1<tm1Seb>	MP:0000260,abnormal angiogenesis|MP:0000295,trabecula carnea hypoplasia|MP:0001577,anemia|MP:0001711,abnormal placenta morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003231,abnormal placenta vasculature|MP:0003403,absent placental labyrinth|MP:0003984,embryonic growth retardation|MP:0004229,abnormal embryonic erythropoiesis|MP:0004787,abnormal dorsal aorta morphology|MP:0005031,abnormal trophoblast layer morphology|MP:0009657,failure of chorioallantoic fusion|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011204,abnormal visceral yolk sac blood island morphology|MP:0012253,abnormal intersomitic vessel morphology
MGI:3578661	Zfp36l2<tm1Pjb>	MP:0001926,female infertility
MGI:4360890	Zfp36l2<tm2Pjb>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000240,extramedullary hematopoiesis|MP:0000333,decreased bone marrow cell number|MP:0000598,abnormal liver morphology|MP:0000603,pale liver|MP:0001265,decreased body size|MP:0001577,anemia|MP:0001914,hemorrhage|MP:0002123,abnormal definitive hematopoiesis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0003396,abnormal embryonic hematopoiesis|MP:0003717,pallor|MP:0004969,pale kidney|MP:0005152,pancytopenia|MP:0009278,abnormal bone marrow cell physiology|MP:0009339,decreased splenocyte number|MP:0009395,increased nucleated erythrocyte cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0031152,subcutaneous hemorrhage|MP:0031154,intestinal hemorrhage
MGI:5816709	Zfp36l3<tm1Pjb>	MP:0001770,abnormal iron level|MP:0003123,paternal imprinting|MP:0005380,embryo phenotype|MP:0008770,decreased survivor rate|MP:0009615,abnormal zinc homeostasis|MP:0010382,abnormal dosage compensation, by inactivation of X chromosome|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3847518	Zfp36<tm1(KOMP)Vlcg>	MP:0000218,increased leukocyte cell number|MP:0002591,decreased mean corpuscular volume|MP:0013279,increased fasting circulating glucose level
MGI:2652418	Zfp36<tm1Pjb>	MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000322,increased granulocyte number|MP:0000414,alopecia|MP:0000691,enlarged spleen|MP:0000693,spleen hyperplasia|MP:0000702,enlarged lymph nodes|MP:0001194,dermatitis|MP:0001262,decreased body weight|MP:0001613,abnormal vasodilation|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0001852,conjunctivitis|MP:0001853,heart inflammation|MP:0001860,liver inflammation|MP:0001863,blood vessel inflammation|MP:0002083,premature death|MP:0002371,abnormal thymus cortex morphology|MP:0002375,abnormal thymus medulla morphology|MP:0002451,abnormal macrophage physiology|MP:0002843,decreased systemic arterial blood pressure|MP:0002993,autoimmune arthritis|MP:0003674,oxidative stress|MP:0003957,abnormal nitric oxide homeostasis|MP:0005016,decreased lymphocyte cell number|MP:0005325,abnormal renal glomerulus morphology|MP:0005376,homeostasis/metabolism phenotype|MP:0005505,thrombocytosis|MP:0008412,increased cellular sensitivity to oxidative stress|MP:0008843,absent subcutaneous adipose tissue|MP:0014708,increased synovial pannus formation
MGI:5750624	Zfp36<tm2.1Pjb>	MP:0001876,decreased inflammatory response|MP:0003436,decreased susceptibility to induced arthritis|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis
MGI:5441582	Zfp36<tm4.1Pjb>	MP:0000496,abnormal small intestine morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001262,decreased body weight|MP:0001492,abnormal pilomotor reflex|MP:0001656,focal hepatic necrosis|MP:0001846,increased inflammatory response|MP:0002941,increased circulating alanine transaminase level|MP:0002993,autoimmune arthritis|MP:0004952,increased spleen weight|MP:0005202,lethargy|MP:0005325,abnormal renal glomerulus morphology|MP:0005329,abnormal myocardium layer morphology|MP:0005426,tachypnea|MP:0005534,decreased body temperature|MP:0005565,increased blood urea nitrogen level|MP:0008553,increased circulating tumor necrosis factor level|MP:0008735,increased susceptibility to endotoxin shock|MP:0010768,mortality/aging|MP:0010922,alveolitis|MP:0011971,increased circulating lactate dehydrogenase level
MGI:5441583	Zfp36<tm4.2Pjb>	MP:0001262,decreased body weight|MP:0002083,premature death
MGI:6153705	Zfp383<em1(IMPC)Wtsi>	MP:0001258,decreased body length|MP:0002941,increased circulating alanine transaminase level
MGI:3573930	Zfp384<tm1Tnk>	MP:0001154,seminiferous tubule degeneration|MP:0001265,decreased body size|MP:0001925,male infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0004852,decreased testis weight|MP:0005390,skeleton phenotype
MGI:3530044	Zfp385a<Gt(PT1-ATG)1Ber>	MP:0002169,no abnormal phenotype detected
MGI:3510440	Zfp385a<tm1Ber>	MP:0000465,gastrointestinal hemorrhage|MP:0001265,decreased body size|MP:0001915,intracranial hemorrhage|MP:0002417,abnormal megakaryocyte morphology|MP:0002551,abnormal blood coagulation|MP:0004720,abnormal platelet morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020431,decreased platelet alpha-granule number
MGI:7388258	Zfp385c<em1(IMPC)J>	MP:0002102,abnormal ear morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5692849	Zfp395<tm1b(EUCOMM)Wtsi>	MP:0001510,abnormal coat appearance|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0010571,shortened ST segment|MP:0011239,abnormal skin coloration
MGI:6152688	Zfp398<em1(IMPC)Mbp>	MP:0000494,abnormal cecum morphology|MP:0002606,increased basophil cell number|MP:0002631,abnormal epididymis morphology|MP:0002833,increased heart weight|MP:0004931,enlarged epididymis|MP:0009477,small cecum
MGI:7574685	Zfp39<em1(IMPC)Bay>	MP:0000745,tremors|MP:0001392,abnormal locomotor behavior|MP:0001406,abnormal gait
MGI:5907859	Zfp407<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001730,embryonic growth arrest|MP:0002574,increased vertical activity|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012129,failure of blastocyst formation|MP:0013292,embryonic lethality prior to organogenesis
MGI:5286302	Zfp410<tm1a(EUCOMM)Hmgu>	MP:0001262,decreased body weight|MP:0005397,hematopoietic system phenotype|MP:0010768,mortality/aging
MGI:6279929	Zfp414<em1(IMPC)Bay>	MP:0000433,microcephaly|MP:0001293,anophthalmia|MP:0003743,abnormal facial morphology|MP:0011495,abnormal head shape|MP:0011496,abnormal head size
MGI:6369036	Zfp418<em#Juli>	MP:0001625,cardiac hypertrophy|MP:0002625,heart left ventricle hypertrophy
MGI:5637152	Zfp420<tm1b(EUCOMM)Hmgu>	MP:0005013,increased lymphocyte cell number
MGI:5688574	Zfp422<em1(IMPC)J>	MP:0001325,abnormal retina morphology|MP:0001399,hyperactivity|MP:0001486,abnormal startle reflex|MP:0001488,increased startle reflex|MP:0002574,increased vertical activity|MP:0005292,improved glucose tolerance
MGI:6477290	Zfp422<em1Mode>	MP:0003084,abnormal skeletal muscle fiber morphology|MP:0009400,decreased skeletal muscle fiber size|MP:0009431,decreased fetal weight|MP:0011808,abnormal myoblast differentiation|MP:0013239,impaired skeletal muscle regeneration
MGI:6280645	Zfp423<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system|MP:0001402,decreased locomotor activity|MP:0002968,increased circulating alkaline phosphatase level|MP:0011100,preweaning lethality, complete penetrance
MGI:2678434	Zfp423<Gt(pT1Betageo)1Ruiz>	MP:0002169,no abnormal phenotype detected
MGI:3714339	Zfp423<Gt(XB409)Byg>	MP:0000783,abnormal forebrain morphology|MP:0000846,abnormal medulla oblongata morphology|MP:0000856,abnormal cerebellar plate morphology|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0008534,enlarged fourth ventricle|MP:0008535,enlarged lateral ventricles|MP:0009804,abnormal brain interventricular foramen morphology|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3653507	Zfp423<Gt(XH542)Byg>	MP:0005386,behavior/neurological phenotype
MGI:2671784	Zfp423<nur12>	MP:0000745,tremors|MP:0000787,abnormal telencephalon morphology|MP:0000807,abnormal hippocampus morphology|MP:0000820,abnormal choroid plexus morphology|MP:0000825,dilated lateral ventricle|MP:0000829,dilated fourth ventricle|MP:0000849,abnormal cerebellum morphology|MP:0000866,cerebellum vermis hypoplasia|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0002196,absent corpus callosum|MP:0004097,abnormal cerebellar cortex morphology|MP:0011083,lethality at weaning, complete penetrance
MGI:3653505	Zfp423<tm1.1Ngc>	MP:0002169,no abnormal phenotype detected
MGI:3653506	Zfp423<tm1.2Ngc>	MP:0000774,decreased brain size|MP:0000849,abnormal cerebellum morphology|MP:0000864,abnormal cerebellum vermis morphology|MP:0000885,ectopic Purkinje cell|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0001406,abnormal gait|MP:0001429,dehydration|MP:0001516,abnormal motor coordination/balance|MP:0002083,premature death|MP:0005449,abnormal food intake|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0009719,reduced cerebellar foliation|MP:0011084,lethality at weaning, incomplete penetrance|MP:0012263,decreased hindbrain size
MGI:3714340	Zfp423<tm1Reed>	MP:0000780,abnormal corpus callosum morphology|MP:0000783,abnormal forebrain morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000849,abnormal cerebellum morphology|MP:0000850,absent cerebellum|MP:0000854,abnormal cerebellum development|MP:0000865,absent cerebellum vermis|MP:0000866,cerebellum vermis hypoplasia|MP:0000880,decreased Purkinje cell number|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001393,ataxia|MP:0002083,premature death|MP:0002237,abnormal nasal cavity morphology|MP:0002741,small olfactory bulb|MP:0004097,abnormal cerebellar cortex morphology|MP:0005236,abnormal olfactory nerve morphology|MP:0008221,abnormal hippocampal commissure morphology|MP:0008535,enlarged lateral ventricles|MP:0008572,abnormal Purkinje cell dendrite morphology|MP:0008789,abnormal olfactory epithelium morphology|MP:0009719,reduced cerebellar foliation|MP:0009965,abnormal cerebellum lateral hemisphere morphology|MP:0009968,abnormal cerebellar granule cell precursor proliferation|MP:0011083,lethality at weaning, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0020527,small thalamus
MGI:4125334	Zfp42<Gt(XB238)Byg>	MP:0001935,decreased litter size|MP:0003787,abnormal imprinting|MP:0008877,abnormal DNA methylation|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011102,embryonic lethality, incomplete penetrance
MGI:5289943	Zfp42<tm1.1Log>	MP:0002687,oligozoospermia|MP:0003205,testicular atrophy|MP:0004901,decreased male germ cell number|MP:0005389,reproductive system phenotype|MP:0009230,abnormal sperm head morphology|MP:0009237,kinked sperm flagellum
MGI:5493322	Zfp42<tm1b(KOMP)Mbp>	MP:0001399,hyperactivity|MP:0002833,increased heart weight|MP:0005419,decreased circulating serum albumin level|MP:0020870,decreased thigmotaxis
MGI:3797379	Zfp42<tm1Hini>	MP:0008770,decreased survivor rate
MGI:6198633	Zfp438<em1(IMPC)J>	MP:0002075,abnormal coat/hair pigmentation|MP:0004738,abnormal auditory brainstem response
MGI:5613658	Zfp445<tm1b(EUCOMM)Hmgu>	MP:0000194,increased circulating calcium level|MP:0002152,abnormal brain morphology|MP:0004738,abnormal auditory brainstem response|MP:0010053,decreased grip strength|MP:0010067,increased red blood cell distribution width|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:5753058	Zfp449<tm1Taks>	MP:0005390,skeleton phenotype
MGI:7797788	Zfp451<em1Ssli>	MP:0002133,abnormal respiratory system physiology|MP:0006050,pulmonary fibrosis|MP:0008873,increased physiological sensitivity to xenobiotic|MP:0011709,increased fibroblast cell migration|MP:0020414,abnormal fibroblast physiology|MP:0030678,increased hydroxyproline level
MGI:5692773	Zfp451<tm1b(EUCOMM)Hmgu>	MP:0001417,decreased exploration in new environment|MP:0001944,abnormal pancreas morphology|MP:0002060,abnormal skin morphology
MGI:5605827	Zfp459<tm1b(EUCOMM)Wtsi>	MP:0010097,abnormal retina blood vessel morphology
MGI:6857761	Zfp462<em1(IMPC)Tcp>	MP:0001488,increased startle reflex|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0003179,thrombocytopenia|MP:0003961,decreased lean body mass|MP:0005293,impaired glucose tolerance|MP:0010024,increased total body fat amount|MP:0011100,preweaning lethality, complete penetrance
MGI:6198748	Zfp462<Tn(pb-Act-RFP)1.090115023-HRAZhu>	MP:0000414,alopecia|MP:0001262,decreased body weight|MP:0001302,eyelids open at birth|MP:0001363,increased anxiety-related response|MP:0001441,increased grooming behavior|MP:0001732,postnatal growth retardation|MP:0002175,decreased brain weight|MP:0005386,behavior/neurological phenotype|MP:0009703,decreased birth body size|MP:0011091,prenatal lethality, complete penetrance
MGI:6711762	Zfp467<tm1.1(KOMP)Vlcg>	MP:0000130,abnormal trabecular bone morphology|MP:0001265,decreased body size|MP:0001541,abnormal osteoclast physiology|MP:0002397,abnormal bone marrow morphology|MP:0003797,abnormal compact bone morphology|MP:0003961,decreased lean body mass|MP:0004148,increased compact bone thickness|MP:0004984,increased osteoclast cell number|MP:0005292,improved glucose tolerance|MP:0009269,decreased fat cell size|MP:0009293,decreased inguinal fat pad weight|MP:0009346,decreased trabecular bone thickness|MP:0009347,increased trabecular bone thickness|MP:0010025,decreased total body fat amount|MP:0010124,decreased bone mineral content|MP:0010868,increased bone trabecula number|MP:0010872,increased trabecular bone mass|MP:0010875,increased bone volume|MP:0010878,increased trabecular bone volume|MP:0010932,increased trabecular bone connectivity density|MP:0010961,increased compact bone mass|MP:0010968,decreased compact bone area|MP:0011167,abnormal adipose tissue development|MP:0011710,enhanced osteoblast differentiation|MP:0013618,decreased areal bone mineral density|MP:0013631,decreased bone trabecular spacing|MP:0020039,increased bone ossification|MP:0031008,decreased bone marrow adipose tissue amount
MGI:6765940	Zfp469<em1Chms>	MP:0001243,abnormal dermal layer morphology|MP:0001244,thin dermal layer|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001312,abnormal cornea morphology|MP:0002750,exophthalmos|MP:0003092,decreased cornea stroma thickness|MP:0005300,abnormal cornea stroma morphology|MP:0005543,decreased cornea thickness|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009827,skin detachment|MP:0011650,abnormal cornea stroma collagen fibril morphology|MP:0020860,abnormal cornea physiology|MP:0031213,increased eye anterior chamber depth
MGI:6336211	Zfp469<em1(IMPC)Mbp>	MP:0000218,increased leukocyte cell number|MP:0001258,decreased body length|MP:0001304,cataract|MP:0002059,abnormal seminal vesicle morphology|MP:0002135,abnormal kidney morphology|MP:0002699,abnormal vitreous body morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003068,enlarged kidney|MP:0004738,abnormal auditory brainstem response|MP:0005013,increased lymphocyte cell number|MP:0010053,decreased grip strength
MGI:6341851	Zfp474<em1(IMPC)Ccpcz>	MP:0000219,increased neutrophil cell number|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0002060,abnormal skin morphology|MP:0002110,abnormal digit morphology|MP:0005011,increased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0010067,increased red blood cell distribution width
MGI:6257496	Zfp488<em1(IMPC)Bay>	MP:0000689,abnormal spleen morphology
MGI:8242623	Zfp488<tm1Qrlu>	MP:0000920,abnormal myelination|MP:0009808,decreased oligodendrocyte number|MP:0014318,abnormal oligodendrocyte differentiation
MGI:6158506	Zfp503<em1(IMPC)Mbp>	MP:0000433,microcephaly|MP:0000702,enlarged lymph nodes|MP:0001293,anophthalmia|MP:0001415,increased exploration in new environment|MP:0001697,abnormal embryo size|MP:0001711,abnormal placenta morphology|MP:0001785,edema|MP:0002135,abnormal kidney morphology|MP:0002339,abnormal lymph node morphology|MP:0002606,increased basophil cell number|MP:0003068,enlarged kidney|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0005554,decreased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0008259,abnormal optic disk morphology|MP:0009198,abnormal male genitalia morphology|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape
MGI:7606867	Zfp503<tm1.1Lif>	MP:0004077,abnormal striatum morphology|MP:0004102,abnormal dorsal striatum morphology|MP:0004103,abnormal ventral striatum morphology|MP:0006009,abnormal neuronal migration|MP:0009953,abnormal olfactory tubercle morphology|MP:0011087,neonatal lethality, complete penetrance
MGI:6304310	Zfp512b<em1(IMPC)J>	MP:0001399,hyperactivity
MGI:6194251	Zfp512<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0001529,abnormal vocalization|MP:0002075,abnormal coat/hair pigmentation|MP:0004924,abnormal behavior|MP:0010053,decreased grip strength|MP:0020870,decreased thigmotaxis
MGI:6402263	Zfp513<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0002591,decreased mean corpuscular volume|MP:0002968,increased circulating alkaline phosphatase level|MP:0005559,increased circulating glucose level|MP:0005635,decreased circulating bilirubin level
MGI:4337894	Zfp516<Gt(A044B05)Wrst>	MP:0009116,abnormal brown fat cell morphology|MP:0009133,decreased white fat cell size|MP:0011087,neonatal lethality, complete penetrance|MP:0011170,abnormal brown fat cell differentiation|MP:0011636,disorganized mitochondrial cristae
MGI:4840366	Zfp521<tm1Ngc>	MP:0001732,postnatal growth retardation|MP:0002896,abnormal bone mineralization|MP:0003055,abnormal long bone epiphyseal plate morphology|MP:0003409,decreased width of hypertrophic chondrocyte zone|MP:0003662,abnormal long bone epiphyseal plate proliferative zone|MP:0003795,abnormal bone structure|MP:0004610,small vertebrae|MP:0004686,decreased length of long bones|MP:0006396,decreased long bone epiphyseal plate size|MP:0008974,proportional dwarf|MP:0009780,abnormal chondrocyte physiology|MP:0010103,small thoracic cage
MGI:5635813	Zfp521<tm1Nohk>	MP:0000774,decreased brain size|MP:0000807,abnormal hippocampus morphology|MP:0000808,abnormal hippocampus development|MP:0000812,abnormal dentate gyrus morphology|MP:0000849,abnormal cerebellum morphology|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001360,abnormal social investigation|MP:0001364,decreased anxiety-related response|MP:0001732,postnatal growth retardation|MP:0002063,abnormal learning/memory/conditioning|MP:0002083,premature death|MP:0002169,no abnormal phenotype detected|MP:0002175,decreased brain weight|MP:0002834,decreased heart weight|MP:0003063,increased coping response|MP:0003402,decreased liver weight|MP:0003918,decreased kidney weight|MP:0004953,decreased spleen weight|MP:0004956,decreased thymus weight|MP:0004981,decreased neuronal precursor cell number|MP:0005631,decreased lung weight|MP:0006396,decreased long bone epiphyseal plate size|MP:0008938,decreased pituitary gland weight|MP:0009142,decreased prepulse inhibition|MP:0009393,abnormal resting posture|MP:0009938,abnormal hippocampus granule cell morphology|MP:0009939,abnormal hippocampus neuron morphology|MP:0010698,abnormal impulsive behavior control|MP:0011827,impaired neuron differentiation|MP:0012204,abnormal neuronal stem cell physiology|MP:0013308,decreased adrenal gland weight|MP:0031391,increased locomotor activity
MGI:4887921	Zfp521<tm2Ngc>	MP:0005298,abnormal clavicle morphology|MP:0009911,increased hyoid bone size
MGI:7466984	Zfp524<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0001488,increased startle reflex
MGI:6314226	Zfp52<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0002833,increased heart weight|MP:0003960,increased lean body mass|MP:0010025,decreased total body fat amount
MGI:6794038	Zfp532<em1(IMPC)J>	MP:0001556,increased circulating HDL cholesterol level|MP:0002591,decreased mean corpuscular volume|MP:0002942,decreased circulating alanine transaminase level|MP:0003131,increased erythrocyte cell number|MP:0005178,increased circulating cholesterol level|MP:0005505,thrombocytosis|MP:0005632,decreased circulating aspartate transaminase level|MP:0011100,preweaning lethality, complete penetrance
MGI:5548695	Zfp536<tm1.1(KOMP)Wtsi>	MP:0001399,hyperactivity|MP:0001575,cyanosis|MP:0003019,increased circulating chloride level|MP:0005388,respiratory system phenotype|MP:0005564,increased hemoglobin content|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0011100,preweaning lethality, complete penetrance
MGI:7511804	Zfp541<em1Fcw>	MP:0001147,small testis|MP:0001153,small seminiferous tubules|MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0005159,azoospermia|MP:0005169,abnormal male meiosis|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0010948,abnormal double-strand DNA break repair|MP:0011751,abnormal X-Y chromosome synapsis during male meiosis|MP:0014052,increased male germ cell apoptosis
MGI:6342250	Zfp541<em1(IMPC)J>	MP:0001925,male infertility|MP:0005333,decreased heart rate|MP:0010506,prolonged RR interval
MGI:6153708	Zfp54<em1(IMPC)Wtsi>	MP:0002965,increased circulating serum albumin level
MGI:7330383	Zfp551<em1(IMPC)J>	MP:0005554,decreased circulating creatinine level|MP:0005632,decreased circulating aspartate transaminase level|MP:0005635,decreased circulating bilirubin level
MGI:5286668	Zfp553<Tg(Tyr)2412B-1Ove>	MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:6140091	Zfp558<em1(IMPC)Mbp>	MP:0002631,abnormal epididymis morphology|MP:0004931,enlarged epididymis|MP:0005419,decreased circulating serum albumin level|MP:0005554,decreased circulating creatinine level|MP:0005560,decreased circulating glucose level|MP:0005567,decreased circulating total protein level
MGI:3578538	Zfp568<chato>	MP:0000928,incomplete rostral neuropore closure|MP:0000929,open neural tube|MP:0001672,abnormal embryo development|MP:0001674,abnormal germ layer development|MP:0001688,abnormal somite development|MP:0001711,abnormal placenta morphology|MP:0001724,abnormal extraembryonic endoderm formation|MP:0001730,embryonic growth arrest|MP:0002080,prenatal lethality|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002151,abnormal neural tube morphology|MP:0002825,abnormal notochord morphology|MP:0002836,abnormal chorion morphology|MP:0003119,abnormal digestive system development|MP:0003229,abnormal vitelline vasculature morphology|MP:0003403,absent placental labyrinth|MP:0004180,failure of initiation of embryo turning|MP:0004187,cardia bifida|MP:0004264,abnormal extraembryonic tissue physiology|MP:0004559,small allantois|MP:0006323,abnormal extraembryonic mesoderm development|MP:0008029,abnormal paraxial mesoderm morphology|MP:0008926,abnormal anterior definitive endoderm morphology|MP:0009657,failure of chorioallantoic fusion|MP:0010117,abnormal lateral plate mesoderm morphology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011205,excessive folding of visceral yolk sac|MP:0012173,short rostral-caudal axis
MGI:3808700	Zfp568<Gt(RRU161)Byg>	MP:0001730,embryonic growth arrest|MP:0012173,short rostral-caudal axis
MGI:5466413	Zfp568<tm1Ckjs>	MP:0001385,pup cannibalization|MP:0002175,decreased brain weight|MP:0003631,nervous system phenotype|MP:0004948,abnormal neuronal precursor proliferation|MP:0005386,behavior/neurological phenotype|MP:0005655,increased aggression
MGI:7790452	Zfp574<em1Btlr>	MP:0000208,decreased hematocrit|MP:0000221,decreased leukocyte cell number|MP:0000222,decreased neutrophil cell number|MP:0000223,decreased monocyte cell number|MP:0001800,abnormal humoral immune response|MP:0001805,decreased IgG level|MP:0001806,decreased IgM level|MP:0001807,decreased IgA level|MP:0002459,abnormal B cell physiology|MP:0002460,decreased immunoglobulin level|MP:0002590,increased mean corpuscular volume|MP:0002811,macrocytic anemia|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0003179,thrombocytopenia|MP:0004816,abnormal class switch recombination|MP:0004978,decreased B-1 B cell number|MP:0005016,decreased lymphocyte cell number|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005093,decreased B cell proliferation|MP:0005152,pancytopenia|MP:0005561,increased mean corpuscular hemoglobin|MP:0005642,decreased mean corpuscular hemoglobin concentration|MP:0008495,decreased IgG1 level|MP:0008496,decreased IgG2a level|MP:0008497,decreased IgG2b level|MP:0008782,increased B cell apoptosis|MP:0010067,increased red blood cell distribution width
MGI:7790453	Zfp574<em2Btlr>	MP:0011091,prenatal lethality, complete penetrance
MGI:7790454	Zfp574<em3Btlr>	MP:0002811,macrocytic anemia|MP:0004808,abnormal hematopoietic stem cell morphology|MP:0005017,decreased B cell number|MP:0005152,pancytopenia
MGI:7790451	Zfp574<m1Btlr>	MP:0001800,abnormal humoral immune response|MP:0002444,abnormal T cell physiology|MP:0005017,decreased B cell number
MGI:5696236	Zfp579<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0002965,increased circulating serum albumin level|MP:0005568,increased circulating total protein level
MGI:3826984	Zfp57<tm1.1Xjli>	MP:0003718,maternal effect|MP:0003787,abnormal imprinting|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:3826983	Zfp57<tm1Xjli>	MP:0003718,maternal effect|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance
MGI:5694173	Zfp580<tm1b(EUCOMM)Hmgu>	MP:0003733,abnormal retina inner nuclear layer morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:7537202	Zfp592<em1(IMPC)Bay>	MP:0001697,abnormal embryo size|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011965,decreased total retina thickness
MGI:6342852	Zfp593<em1(IMPC)J>	MP:0000063,decreased bone mineral density|MP:0000221,decreased leukocyte cell number|MP:0001566,increased circulating phosphate level|MP:0002834,decreased heart weight|MP:0003961,decreased lean body mass|MP:0005333,decreased heart rate|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:5692858	Zfp595<tm1b(KOMP)Wtsi>	MP:0000221,decreased leukocyte cell number|MP:0002953,thick ventricular wall|MP:0005012,decreased eosinophil cell number|MP:0005016,decreased lymphocyte cell number|MP:0005560,decreased circulating glucose level
MGI:6115009	Zfp597<em1(IMPC)J>	MP:0004222,iris synechia
MGI:6356881	Zfp597<tm1Hnawa>	MP:0000953,abnormal oligodendrocyte morphology|MP:0001393,ataxia|MP:0001730,embryonic growth arrest|MP:0002064,seizures|MP:0002229,neurodegeneration|MP:0002654,spongiform encephalopathy|MP:0004102,abnormal dorsal striatum morphology|MP:0008025,brain vacuoles|MP:0011092,embryonic lethality, complete penetrance|MP:0020749,abnormal cingulate cortex morphology
MGI:7486743	Zfp605<em1(IMPC)J>	MP:0001304,cataract|MP:0001402,decreased locomotor activity|MP:0002834,decreased heart weight
MGI:5616367	Zfp609<tm1b(EUCOMM)Hmgu>	MP:0001697,abnormal embryo size|MP:0009142,decreased prepulse inhibition|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration
MGI:5635493	Zfp60<tm1b(KOMP)Mbp>	MP:0000745,tremors|MP:0001399,hyperactivity|MP:0002968,increased circulating alkaline phosphatase level|MP:0004924,abnormal behavior|MP:0020870,decreased thigmotaxis
MGI:5787575	Zfp612<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0002591,decreased mean corpuscular volume|MP:0005554,decreased circulating creatinine level
MGI:5548908	Zfp616<tm1b(KOMP)Wtsi>	MP:0013279,increased fasting circulating glucose level|MP:0013775,increased KLRG1-positive T-helper cell number
MGI:6120826	Zfp61<tm1b(EUCOMM)Hmgu>	MP:0000194,increased circulating calcium level|MP:0005553,increased circulating creatinine level|MP:0009476,enlarged cecum
MGI:6731067	Zfp622<em1(IMPC)J>	MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0011094,embryonic lethality before implantation, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0012058,abnormal morula morphology|MP:0012129,failure of blastocyst formation|MP:0013292,embryonic lethality prior to organogenesis
MGI:6460369	Zfp628<em1Frei>	MP:0001147,small testis|MP:0001925,male infertility|MP:0004901,decreased male germ cell number|MP:0005159,azoospermia|MP:0005389,reproductive system phenotype|MP:0008279,arrest of spermiogenesis|MP:0008898,abnormal acrosome morphology|MP:0014052,increased male germ cell apoptosis|MP:0020550,multinucleated giant male germ cells
MGI:6810759	Zfp628<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:6156578	Zfp629<em1(IMPC)Tcp>	MP:0000692,small spleen|MP:0001399,hyperactivity|MP:0001488,increased startle reflex|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount
MGI:6153711	Zfp637<em1(IMPC)Wtsi>	MP:0001554,increased circulating free fatty acids level|MP:0002169,no abnormal phenotype detected|MP:0002599,increased mean platelet volume
MGI:6304325	Zfp638<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0005278,abnormal cholesterol homeostasis|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6713584	Zfp639<tm1.2Jaty>	MP:0002006,neoplasm|MP:0005378,growth/size/body region phenotype|MP:0005380,embryo phenotype|MP:0005386,behavior/neurological phenotype|MP:0005387,immune system phenotype|MP:0010768,mortality/aging|MP:0013891,increased common myeloid progenitor cell number|MP:0020935,decreased susceptibility to Retroviridae infection
MGI:3526867	Zfp640<Gt(ROSA)81Sor>	MP:0000137,abnormal vertebrae morphology|MP:0000157,abnormal sternum morphology|MP:0000480,increased rib number|MP:0001260,increased body weight|MP:0004599,abnormal vertebral arch morphology|MP:0005508,abnormal skeleton morphology|MP:0008146,asymmetric sternocostal joints|MP:0009887,abnormal palatal shelf fusion at midline|MP:0009895,decreased palatine bone horizontal plate size|MP:0011708,decreased fibroblast cell migration|MP:0030383,small presphenoid bone
MGI:5689903	Zfp641<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0002591,decreased mean corpuscular volume|MP:0005564,increased hemoglobin content|MP:0005641,increased mean corpuscular hemoglobin concentration
MGI:6341848	Zfp644<em1(IMPC)Ccpcz>	MP:0001120,abnormal uterus morphology|MP:0001146,abnormal testis morphology|MP:0001147,small testis|MP:0001262,decreased body weight|MP:0001556,increased circulating HDL cholesterol level|MP:0002060,abnormal skin morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003020,decreased circulating chloride level|MP:0004906,enlarged uterus|MP:0005565,increased blood urea nitrogen level|MP:0005627,increased circulating potassium level
MGI:5563394	Zfp644<m1Anu>	MP:0005387,immune system phenotype
MGI:6293897	Zfp652<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6279912	Zfp654<em1(IMPC)Bay>	MP:0010123,increased bone mineral content|MP:0011100,preweaning lethality, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5708248	Zfp664<tm1b(EUCOMM)Wtsi>	MP:0002968,increased circulating alkaline phosphatase level|MP:0005293,impaired glucose tolerance
MGI:4276801	Zfp683<Gt(OST314703)Lex>	MP:0001793,abnormal susceptibility to infection|MP:0005387,immune system phenotype|MP:0008036,abnormal NK T cell morphology|MP:0008040,decreased NK T cell number|MP:0008566,increased interferon-gamma secretion
MGI:6355936	Zfp687<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5603580	Zfp689<tm1.1(KOMP)Vlcg>	MP:0000208,decreased hematocrit|MP:0001523,impaired righting response|MP:0005505,thrombocytosis|MP:0005564,increased hemoglobin content|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011396,abnormal sleep behavior
MGI:7280909	Zfp691<em1(IMPC)J>	MP:0002965,increased circulating serum albumin level
MGI:5775599	Zfp692<em1(IMPC)J>	MP:0005554,decreased circulating creatinine level
MGI:8187614	Zfp697<em1Bcgen>	MP:0001406,abnormal gait|MP:0002106,abnormal muscle physiology|MP:0003961,decreased lean body mass|MP:0005369,muscle phenotype|MP:0005386,behavior/neurological phenotype|MP:0010053,decreased grip strength|MP:0010239,decreased skeletal muscle weight|MP:0013239,impaired skeletal muscle regeneration
MGI:6357937	Zfp697<em1(IMPC)J>	MP:0002644,decreased circulating triglyceride level|MP:0005632,decreased circulating aspartate transaminase level
MGI:5692574	Zfp69<tm1b(EUCOMM)Hmgu>	MP:0001303,abnormal lens morphology|MP:0001488,increased startle reflex|MP:0004151,decreased circulating iron level|MP:0008259,abnormal optic disk morphology
MGI:4431765	Zfp704<tm1a(EUCOMM)Wtsi>	MP:0002644,decreased circulating triglyceride level
MGI:3759307	Zfp704<tm1Glh>	MP:0002169,no abnormal phenotype detected
MGI:5907827	Zfp706<em1(IMPC)J>	MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0002075,abnormal coat/hair pigmentation|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6444753	Zfp708<em1Dame>	MP:0003122,maternal imprinting
MGI:5807188	Zfp711<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001392,abnormal locomotor behavior|MP:0002075,abnormal coat/hair pigmentation|MP:0010052,increased grip strength
MGI:4435328	Zfp715<tm1a(EUCOMM)Hmgu>	MP:0003062,abnormal coping response|MP:0005178,increased circulating cholesterol level|MP:0005179,decreased circulating cholesterol level
MGI:4431958	Zfp719<tm1a(EUCOMM)Wtsi>	MP:0004738,abnormal auditory brainstem response|MP:0006358,absent pinna reflex
MGI:5548829	Zfp719<tm1b(EUCOMM)Wtsi>	MP:0004738,abnormal auditory brainstem response|MP:0006358,absent pinna reflex
MGI:6401338	Zfp729b<em1(IMPC)J>	MP:0001325,abnormal retina morphology|MP:0005562,decreased mean corpuscular hemoglobin
MGI:7607238	Zfp746<em1Jhsn>	MP:0004502,decreased incidence of tumors by chemical induction
MGI:7428903	Zfp746<tm1.1Tmd>	MP:0002169,no abnormal phenotype detected
MGI:6729666	Zfp746<tm1b(EUCOMM)Hmgu>	MP:0000063,decreased bone mineral density|MP:0002075,abnormal coat/hair pigmentation|MP:0002997,enlarged seminal vesicle|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010053,decreased grip strength|MP:0010124,decreased bone mineral content
MGI:6361131	Zfp74<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response|MP:0010052,increased grip strength
MGI:6712815	Zfp750<em1(IMPC)J>	MP:0011100,preweaning lethality, complete penetrance
MGI:7470773	Zfp750<tm1b(EUCOMM)Wtsi>	MP:0001196,shiny skin|MP:0001211,wrinkled skin|MP:0001218,thin epidermis|MP:0001239,abnormal epidermis stratum granulosum morphology|MP:0001240,abnormal epidermis stratum corneum morphology|MP:0001263,weight loss|MP:0001302,eyelids open at birth|MP:0001341,absent eyelids|MP:0001429,dehydration|MP:0002656,abnormal keratinocyte differentiation|MP:0002796,impaired skin barrier function|MP:0003941,abnormal skin development|MP:0004777,abnormal phospholipid level|MP:0005278,abnormal cholesterol homeostasis|MP:0005318,decreased triglyceride level|MP:0005319,abnormal enzyme/coenzyme level|MP:0009546,absent gastric milk in neonates|MP:0009594,abnormal corneocyte envelope morphology|MP:0009596,abnormal stratum corneum lipid matrix formation|MP:0009607,decreased keratohyalin granule size|MP:0009608,abnormal epidermal lamellar body morphology|MP:0009674,decreased birth weight|MP:0009823,abnormal sphingomyelin level|MP:0009931,abnormal skin appearance|MP:0011006,abnormal epidermal stem cell proliferation|MP:0011087,neonatal lethality, complete penetrance|MP:0012232,abnormal ceramide level|MP:0013245,abnormal lipid metabolism
MGI:4436640	Zfp760<tm1a(EUCOMM)Hmgu>	MP:0001262,decreased body weight|MP:0002492,decreased IgE level|MP:0002608,increased hematocrit|MP:0002965,increased circulating serum albumin level|MP:0003131,increased erythrocyte cell number|MP:0003179,thrombocytopenia
MGI:6153715	Zfp763<em1(IMPC)Wtsi>	MP:0003443,increased circulating glycerol level
MGI:8164214	Zfp768<em1Mala>	MP:0001265,decreased body size|MP:0002006,neoplasm|MP:0002834,decreased heart weight|MP:0004227,increased cellular sensitivity to ionizing radiation induced cell death|MP:0008008,early cellular replicative senescence|MP:0008489,slow postnatal weight gain|MP:0010768,mortality/aging|MP:0011704,decreased fibroblast proliferation|MP:0012734,abnormal response to radiation|MP:0020414,abnormal fibroblast physiology
MGI:6294143	Zfp786<em1(IMPC)J>	MP:0001392,abnormal locomotor behavior
MGI:6198582	Zfp787<em1(IMPC)J>	MP:0000186,decreased circulating HDL cholesterol level|MP:0001392,abnormal locomotor behavior|MP:0002833,increased heart weight|MP:0003179,thrombocytopenia|MP:0005278,abnormal cholesterol homeostasis|MP:0005293,impaired glucose tolerance|MP:0009142,decreased prepulse inhibition|MP:0013279,increased fasting circulating glucose level
MGI:5819276	Zfp7<em1(IMPC)J>	MP:0005562,decreased mean corpuscular hemoglobin
MGI:6716236	Zfp800<em1Mgn>	MP:0003339,decreased pancreatic beta cell number|MP:0009146,abnormal pancreatic acinar cell morphology|MP:0009177,decreased pancreatic alpha cell number|MP:0009181,decreased pancreatic delta cell number|MP:0009186,decreased PP cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0011932,abnormal endocrine pancreas development
MGI:6257708	Zfp804a<em1(IMPC)Tcp>	MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0002590,increased mean corpuscular volume|MP:0003179,thrombocytopenia|MP:0003233,prolonged QT interval|MP:0009709,hydrometra
MGI:6828598	Zfp804a<em1Yqd>	MP:0003631,nervous system phenotype|MP:0008414,abnormal spatial reference memory|MP:0009142,decreased prepulse inhibition|MP:0009454,impaired contextual conditioning behavior|MP:0012307,impaired spatial learning|MP:0020508,decreased dendritic spine density
MGI:4333341	Zfp809<Gt(F065A07)Wrst>	MP:0005621,abnormal cell physiology
MGI:4944342	Zfp809<tm1a(KOMP)Wtsi>	MP:0005621,abnormal cell physiology
MGI:5749229	Zfp809<tm1c(KOMP)Wtsi>	MP:0005621,abnormal cell physiology
MGI:5829404	Zfp827<em1(IMPC)J>	MP:0001513,limb grasping|MP:0001523,impaired righting response|MP:0010097,abnormal retina blood vessel morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6849761	Zfp82<tm1.1Cya>	MP:0002021,increased incidence of induced tumors
MGI:5637021	Zfp830<tm1b(EUCOMM)Hmgu>	MP:0001325,abnormal retina morphology|MP:0001406,abnormal gait|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:3583779	Zfp830<tm1Cota>	MP:0001728,failure of embryo implantation|MP:0002718,abnormal inner cell mass morphology|MP:0003077,abnormal cell cycle|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0005028,abnormal trophectoderm morphology|MP:0011093,embryonic lethality at implantation, complete penetrance|MP:0012113,decreased inner cell mass proliferation|MP:0012114,absent inner cell mass proliferation|MP:0012118,absent trophectoderm cell proliferation
MGI:4950703	Zfp830<tm2.2Cota>	MP:0011094,embryonic lethality before implantation, complete penetrance
MGI:5617795	Zfp831<tm1b(KOMP)Wtsi>	MP:0001510,abnormal coat appearance|MP:0001566,increased circulating phosphate level|MP:0002764,short tibia|MP:0011239,abnormal skin coloration
MGI:5636909	Zfp84<tm1b(KOMP)Wtsi>	MP:0000186,decreased circulating HDL cholesterol level|MP:0003960,increased lean body mass|MP:0005179,decreased circulating cholesterol level|MP:0010052,increased grip strength
MGI:5014690	Zfp871<tm1a(EUCOMM)Wtsi>	MP:0000693,spleen hyperplasia|MP:0000708,thymus hyperplasia|MP:0001265,decreased body size|MP:0001860,liver inflammation|MP:0002006,neoplasm|MP:0002023,increased B cell derived lymphoma incidence|MP:0002083,premature death|MP:0002628,hepatic steatosis|MP:0009703,decreased birth body size|MP:0010268,decreased lymphoma incidence|MP:0011085,postnatal lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance
MGI:5700369	Zfp871<tm1b(EUCOMM)Wtsi>	MP:0001697,abnormal embryo size|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0003984,embryonic growth retardation|MP:0010052,increased grip strength|MP:0010097,abnormal retina blood vessel morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011965,decreased total retina thickness
MGI:7426101	Zfp90<em1(IMPC)Bay>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:6156443	Zfp91<em1(IMPC)Tcp>	MP:0000702,enlarged lymph nodes|MP:0001258,decreased body length|MP:0001488,increased startle reflex|MP:0001697,abnormal embryo size|MP:0001785,edema|MP:0003717,pallor|MP:0011100,preweaning lethality, complete penetrance|MP:0011239,abnormal skin coloration
MGI:6715549	Zfp91<tm1Smoc>	MP:0004499,increased incidence of tumors by chemical induction|MP:0004946,abnormal regulatory T cell physiology|MP:0004974,decreased regulatory T cell number|MP:0005350,increased susceptibility to autoimmune disorder|MP:0008078,increased CD8-positive, alpha-beta T cell number|MP:0008537,increased susceptibility to induced colitis
MGI:5816145	Zfp92<em1(IMPC)J>	MP:0001304,cataract|MP:0003961,decreased lean body mass|MP:0010024,increased total body fat amount|MP:0010124,decreased bone mineral content
MGI:6716238	Zfp92<em1Mgn>	MP:0010768,mortality/aging
MGI:5692845	Zfp930<tm1b(KOMP)Wtsi>	MP:0001289,persistence of hyaloid vascular system|MP:0008259,abnormal optic disk morphology|MP:0011960,abnormal eye anterior chamber depth
MGI:6149131	Zfp949<tm1Htno>	MP:0000352,decreased cell proliferation|MP:0001672,abnormal embryo development|MP:0001698,decreased embryo size|MP:0003984,embryonic growth retardation|MP:0004180,failure of initiation of embryo turning|MP:0005657,abnormal neural plate morphology|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011102,embryonic lethality, incomplete penetrance|MP:0011107,embryonic lethality between somite formation and embryo turning, incomplete penetrance|MP:0013504,increased embryonic tissue cell apoptosis
MGI:3526859	Zfp950<Gt(ROSA)76Sor>	MP:0000137,abnormal vertebrae morphology|MP:0000157,abnormal sternum morphology|MP:0000208,decreased hematocrit|MP:0000480,increased rib number|MP:0000767,abnormal smooth muscle morphology|MP:0001577,anemia|MP:0001614,abnormal blood vessel morphology|MP:0001859,kidney inflammation|MP:0001914,hemorrhage|MP:0002135,abnormal kidney morphology|MP:0002136,abnormal kidney physiology|MP:0002640,reticulocytosis|MP:0002874,decreased hemoglobin content|MP:0002875,decreased erythrocyte cell number|MP:0002989,small kidney|MP:0003091,abnormal cell migration|MP:0003755,abnormal palate morphology|MP:0004599,abnormal vertebral arch morphology|MP:0004969,pale kidney|MP:0005097,polychromatophilia|MP:0005325,abnormal renal glomerulus morphology|MP:0005508,abnormal skeleton morphology|MP:0005565,increased blood urea nitrogen level|MP:0008146,asymmetric sternocostal joints|MP:0009895,decreased palatine bone horizontal plate size|MP:0011086,postnatal lethality, incomplete penetrance|MP:0030383,small presphenoid bone
MGI:5516079	Zfp961<tm1.1(KOMP)Mbp>	MP:0002833,increased heart weight|MP:0002968,increased circulating alkaline phosphatase level|MP:0004151,decreased circulating iron level|MP:0005560,decreased circulating glucose level
MGI:5572028	Zfpl1<tm2b(EUCOMM)Wtsi>	MP:0000745,tremors|MP:0003731,abnormal retina outer nuclear layer morphology
MGI:4421436	Zfpm1<tm1.1Esv>	MP:0000172,abnormal bone marrow cell number|MP:0000219,increased neutrophil cell number|MP:0000229,abnormal megakaryocyte differentiation|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000322,increased granulocyte number|MP:0000689,abnormal spleen morphology|MP:0001722,pale yolk sac|MP:0001787,pericardial edema|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002599,increased mean platelet volume|MP:0003131,increased erythrocyte cell number|MP:0003135,increased erythroid progenitor cell number|MP:0003179,thrombocytopenia|MP:0004952,increased spleen weight|MP:0006410,abnormal common myeloid progenitor cell morphology|MP:0008255,decreased megakaryocyte cell number|MP:0008476,increased spleen red pulp amount|MP:0008850,increased hemoglobin concentration distribution width|MP:0011108,embryonic lethality during organogenesis, incomplete penetrance
MGI:4421151	Zfpm1<tm1.1Geab>	MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000240,extramedullary hematopoiesis|MP:0000245,abnormal erythropoiesis|MP:0000691,enlarged spleen|MP:0000694,spleen hypoplasia|MP:0001577,anemia|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0002417,abnormal megakaryocyte morphology|MP:0002599,increased mean platelet volume|MP:0002640,reticulocytosis|MP:0002833,increased heart weight|MP:0003179,thrombocytopenia|MP:0004720,abnormal platelet morphology|MP:0004952,increased spleen weight|MP:0005397,hematopoietic system phenotype|MP:0008479,decreased spleen white pulp amount|MP:0008850,increased hemoglobin concentration distribution width|MP:0008973,decreased erythroid progenitor cell number|MP:0010067,increased red blood cell distribution width|MP:0010209,abnormal circulating chemokine level|MP:0011090,perinatal lethality, incomplete penetrance|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0020431,decreased platelet alpha-granule number
MGI:1857554	Zfpm1<tm1Sho>	MP:0000229,abnormal megakaryocyte differentiation|MP:0000245,abnormal erythropoiesis|MP:0000601,small liver|MP:0000603,pale liver|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0002413,abnormal megakaryocyte progenitor cell morphology|MP:0003229,abnormal vitelline vasculature morphology|MP:0003717,pallor|MP:0004229,abnormal embryonic erythropoiesis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2183293	Zfpm1<tm2Sho>	MP:0000229,abnormal megakaryocyte differentiation|MP:0000245,abnormal erythropoiesis|MP:0000601,small liver|MP:0000603,pale liver|MP:0001577,anemia|MP:0001606,impaired hematopoiesis|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0003229,abnormal vitelline vasculature morphology|MP:0003717,pallor|MP:0004229,abnormal embryonic erythropoiesis|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2669966	Zfpm1<tm3Sho>	MP:0002169,no abnormal phenotype detected
MGI:3583784	Zfpm1<tm4Sho>	MP:0005385,cardiovascular system phenotype
MGI:3587413	Zfpm2<lil>	MP:0000284,double outlet right ventricle|MP:0000761,thin diaphragm muscle|MP:0001178,pulmonary hypoplasia|MP:0002279,abnormal diaphragm morphology|MP:0002652,thin myocardium|MP:0003808,increased atrioventricular cushion size|MP:0004057,thin myocardium compact layer|MP:0008725,increased heart atrium size|MP:0009573,abnormal right lung middle lobe morphology|MP:0010402,ventricular septal defect|MP:0010404,ostium primum atrial septal defect|MP:0010413,complete atrioventricular septal defect|MP:0010551,abnormal coronary vessel morphology|MP:0010824,absent right lung accessory lobe|MP:0011099,lethality throughout fetal growth and development, complete penetrance
MGI:5661400	Zfpm2<tm1.1Esv>	MP:0002169,no abnormal phenotype detected|MP:0004057,thin myocardium compact layer|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0011925,abnormal heart echocardiography feature|MP:0031633,decreased heart left ventricle muscle contractility
MGI:5606032	Zfpm2<tm1.1Wtp>	MP:0002169,no abnormal phenotype detected
MGI:2182616	Zfpm2<tm1Jml>	MP:0000267,abnormal heart development|MP:0000285,abnormal heart valve morphology|MP:0001786,skin edema|MP:0001787,pericardial edema|MP:0002747,abnormal aortic valve morphology|MP:0002748,abnormal pulmonary valve morphology|MP:0003105,abnormal heart atrium morphology|MP:0003140,dilated heart atrium|MP:0003920,abnormal heart right ventricle morphology|MP:0005294,abnormal heart ventricle morphology|MP:0006123,tricuspid valve atresia|MP:0006138,congestive heart failure|MP:0010224,abnormal heart ventricle outflow tract morphology|MP:0010402,ventricular septal defect|MP:0010413,complete atrioventricular septal defect|MP:0010449,heart right ventricle outflow tract stenosis|MP:0010601,thick pulmonary valve|MP:0010607,common atrioventricular valve|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0031525,thin left ventricle myocardium compact layer|MP:0031529,pulmonary valve hyperplasia
MGI:2386183	Zfpm2<tm1Sho>	MP:0000273,overriding aortic valve|MP:0000280,thin ventricular wall|MP:0000601,small liver|MP:0001176,abnormal lung development|MP:0001178,pulmonary hypoplasia|MP:0001914,hemorrhage|MP:0002192,hydrops fetalis|MP:0002213,true hermaphroditism|MP:0002995,primary sex reversal|MP:0002996,ovotestis|MP:0003105,abnormal heart atrium morphology|MP:0003140,dilated heart atrium|MP:0003717,pallor|MP:0005333,decreased heart rate|MP:0006138,congestive heart failure|MP:0008825,abnormal cardiac epithelial to mesenchymal transition|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010449,heart right ventricle outflow tract stenosis|MP:0010459,supravalvar pulmonary trunk stenosis|MP:0010556,thin ventricle myocardium compact layer|MP:0010561,absent coronary vessels|MP:0010607,common atrioventricular valve|MP:0010640,ventricular myocardium compact layer hypoplasia|MP:0010824,absent right lung accessory lobe|MP:0011099,lethality throughout fetal growth and development, complete penetrance|MP:0031511,globular heart
MGI:3802480	Zfpm2<tm2Sho>	MP:0002169,no abnormal phenotype detected|MP:0004215,abnormal myocardial fiber physiology
MGI:7426102	Zfr2<em1(IMPC)Bay>	MP:0001402,decreased locomotor activity
MGI:7311766	Zfr2<em1Marp>	MP:0005389,reproductive system phenotype
MGI:2387996	Zfr<tm1Reb>	MP:0001695,abnormal gastrulation|MP:0001698,decreased embryo size|MP:0002085,abnormal embryonic tissue morphology|MP:0011097,embryonic lethality between somite formation and embryo turning, complete penetrance|MP:0011186,abnormal visceral endoderm morphology
MGI:6867026	Zfta<tm1.1(KOMP)Vlcg>	MP:0002169,no abnormal phenotype detected
MGI:7425625	Zftraf1<em1(IMPC)H>	MP:0005012,decreased eosinophil cell number|MP:0010052,increased grip strength|MP:0010068,decreased red blood cell distribution width
MGI:3848796	Zfx<tm1.1Reiz>	MP:0001545,abnormal hematopoietic system physiology|MP:0001606,impaired hematopoiesis|MP:0003631,nervous system phenotype|MP:0004810,decreased hematopoietic stem cell number|MP:0005016,decreased lymphocyte cell number|MP:0005018,decreased T cell number|MP:0008211,decreased mature B cell number|MP:0008249,abnormal common lymphocyte progenitor cell morphology|MP:0010768,mortality/aging|MP:0011087,neonatal lethality, complete penetrance
MGI:3848798	Zfx<tm1.2Reiz>	MP:0002086,abnormal extraembryonic tissue morphology|MP:0004810,decreased hematopoietic stem cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance
MGI:2450147	Zfx<tm1Dcp>	MP:0001262,decreased body weight|MP:0001698,decreased embryo size|MP:0001923,reduced female fertility|MP:0002088,abnormal embryonic growth/weight/body size|MP:0002089,abnormal postnatal growth/weight/body size|MP:0002161,abnormal fertility/fecundity|MP:0002209,decreased germ cell number|MP:0002682,decreased mature ovarian follicle number|MP:0002687,oligozoospermia|MP:0005431,decreased oocyte number|MP:0008392,decreased primordial germ cell number|MP:0011085,postnatal lethality, complete penetrance|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:4451610	Zfyve16<tm2a(KOMP)Wtsi>	MP:0005015,increased T cell number|MP:0005017,decreased B cell number|MP:0005093,decreased B cell proliferation|MP:0005378,growth/size/body region phenotype|MP:0013892,increased common lymphocyte progenitor cell number
MGI:6403734	Zfyve19<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0004924,abnormal behavior|MP:0005559,increased circulating glucose level|MP:0020870,decreased thigmotaxis
MGI:6452968	Zfyve1<em1Hbsh>	MP:0002410,decreased susceptibility to viral infection|MP:0009790,decreased susceptibility to viral infection induced morbidity/mortality
MGI:5585269	Zfyve26<em1(IMPC)J>	MP:0000195,decreased circulating calcium level|MP:0002574,increased vertical activity|MP:0002804,abnormal motor learning|MP:0005562,decreased mean corpuscular hemoglobin|MP:0011396,abnormal sleep behavior
MGI:5792091	Zfyve26<mpc264H>	MP:0000745,tremors|MP:0006325,impaired hearing
MGI:5707975	Zfyve26<tm1.1Cahb>	MP:0000160,kyphosis|MP:0000876,Purkinje cell degeneration|MP:0000938,motor neuron degeneration|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001405,impaired coordination|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0002175,decreased brain weight|MP:0002946,delayed axon extension|MP:0003172,abnormal lysosome physiology|MP:0003354,astrocytosis|MP:0005058,abnormal lysosome morphology|MP:0005386,behavior/neurological phenotype|MP:0005405,axon degeneration|MP:0010386,abnormal urinary bladder physiology|MP:0011874,enlarged urinary bladder|MP:0012506,brain atrophy
MGI:6473985	Zfyve27<tm1Kei>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001399,hyperactivity|MP:0001489,decreased startle reflex|MP:0002573,behavioral despair|MP:0003631,nervous system phenotype|MP:0004924,abnormal behavior|MP:0005386,behavior/neurological phenotype|MP:0009456,impaired cued conditioning behavior
MGI:5637169	Zfyve28<tm1b(EUCOMM)Wtsi>	MP:0005367,renal/urinary system phenotype|MP:0008810,increased circulating iron level
MGI:6336099	Zg16<em1(IMPC)Ics>	MP:0005238,increased brain size|MP:0008221,abnormal hippocampal commissure morphology|MP:0008228,increased anterior commissure size|MP:0012465,increased hippocampal fimbria size|MP:0012475,increased piriform cortex size|MP:0012481,increased habenula size|MP:0020873,abnormal arcuate nucleus of hypothalamus morphology
MGI:3529206	Zg16<tm1Lex>	MP:0000477,abnormal intestine morphology|MP:0001260,increased body weight|MP:0002412,increased susceptibility to bacterial infection|MP:0008577,increased circulating interferon-gamma level|MP:0008596,increased circulating interleukin-6 level|MP:0009286,increased abdominal fat pad weight
MGI:3696745	Zglp1<tm1Eem>	MP:0001127,small ovary|MP:0001130,abnormal ovarian folliculogenesis|MP:0001131,abnormal ovarian follicle morphology|MP:0001132,absent mature ovarian follicles|MP:0001147,small testis|MP:0001156,abnormal spermatogenesis|MP:0001750,increased circulating follicle stimulating hormone level|MP:0001751,increased circulating luteinizing hormone level|MP:0001924,infertility|MP:0001925,male infertility|MP:0001926,female infertility|MP:0002682,decreased mature ovarian follicle number|MP:0002685,abnormal spermatogonia proliferation|MP:0002687,oligozoospermia|MP:0002777,absent ovarian follicles|MP:0004901,decreased male germ cell number|MP:0013601,increased testis apoptosis
MGI:5605819	Zgpat<tm1b(EUCOMM)Hmgu>	MP:0009142,decreased prepulse inhibition|MP:0013279,increased fasting circulating glucose level
MGI:6314753	Zgrf1<em1(IMPC)J>	MP:0001417,decreased exploration in new environment|MP:0005343,increased circulating aspartate transaminase level
MGI:3623885	Zhx2<BALB/cJ>	MP:0005416,abnormal circulating protein level
MGI:5548830	Zhx3<tm1.1(KOMP)Vlcg>	MP:0000062,increased bone mineral density|MP:0001257,increased body length|MP:0001399,hyperactivity|MP:0001415,increased exploration in new environment|MP:0003960,increased lean body mass|MP:0004357,long tibia|MP:0004924,abnormal behavior|MP:0005343,increased circulating aspartate transaminase level|MP:0006203,eye hemorrhage|MP:0010025,decreased total body fat amount|MP:0010123,increased bone mineral content|MP:0011110,preweaning lethality, incomplete penetrance|MP:0020870,decreased thigmotaxis
MGI:2156822	Zic1<tm1Jaru>	MP:0000160,kyphosis|MP:0000851,cerebellum hypoplasia|MP:0000854,abnormal cerebellum development|MP:0000857,abnormal cerebellar foliation|MP:0000864,abnormal cerebellum vermis morphology|MP:0001393,ataxia|MP:0001402,decreased locomotor activity|MP:0001406,abnormal gait|MP:0001436,abnormal suckling behavior|MP:0001523,impaired righting response|MP:0001524,impaired limb coordination|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0004144,hypotonia|MP:0009719,reduced cerebellar foliation|MP:0011085,postnatal lethality, complete penetrance|MP:0011088,neonatal lethality, incomplete penetrance
MGI:3510680	Zic1/Zic4<tm1Kjmi>	MP:0000857,abnormal cerebellar foliation|MP:0000864,abnormal cerebellum vermis morphology|MP:0000866,cerebellum vermis hypoplasia|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001523,impaired righting response|MP:0011086,postnatal lethality, incomplete penetrance
MGI:3510681	Zic1/Zic4<tm1Kjmi>	MP:0000857,abnormal cerebellar foliation|MP:0000864,abnormal cerebellum vermis morphology|MP:0000866,cerebellum vermis hypoplasia|MP:0001262,decreased body weight|MP:0001393,ataxia|MP:0001523,impaired righting response|MP:0011086,postnatal lethality, incomplete penetrance
MGI:5566852	Zic2<em1Bend>	MP:0003051,curly tail
MGI:5566853	Zic2<em2Bend>	MP:0003051,curly tail
MGI:5566854	Zic2<em3Bend>	MP:0003051,curly tail
MGI:5566855	Zic2<em4Bend>	MP:0003051,curly tail
MGI:5566856	Zic2<em5Bend>	MP:0003051,curly tail
MGI:6355448	Zic2<iso>	MP:0000284,double outlet right ventricle|MP:0000508,right-sided isomerism|MP:0000531,right pulmonary isomerism|MP:0000644,dextrocardia|MP:0000650,mesocardia|MP:0000689,abnormal spleen morphology|MP:0000690,absent spleen|MP:0000914,exencephaly|MP:0001293,anophthalmia|MP:0001944,abnormal pancreas morphology|MP:0002224,abnormal spleen size|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0004133,heterotaxia|MP:0004158,right aortic arch|MP:0005163,cyclopia|MP:0006061,right atrial isomerism|MP:0006197,ocular hypotelorism|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010808,right-sided stomach|MP:0013973,abnormal hepatic vein connection|MP:0014277,alobar holoprosencephaly|MP:0014804,ventricular situs inversus|MP:0020494,left sided inferior vena cava
MGI:1862004	Zic2<Ku>	MP:0000373,belly spot|MP:0000585,kinked tail|MP:0000914,exencephaly|MP:0000928,incomplete rostral neuropore closure|MP:0001299,abnormal eye distance/ position|MP:0002825,abnormal notochord morphology|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0003232,abnormal forebrain development|MP:0003895,increased ectoderm apoptosis|MP:0004066,abnormal primitive node morphology|MP:0004387,abnormal prechordal plate morphology|MP:0005157,holoprosencephaly|MP:0005163,cyclopia|MP:0006197,ocular hypotelorism|MP:0006290,proboscis|MP:0008817,hematoma|MP:0009843,decreased neural crest cell number|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0012157,rostral body truncation|MP:0012709,delayed caudal neuropore closure|MP:0012793,decreased rhombomere 3 size|MP:0012801,decreased rhombomere 5 size
MGI:4943187	Zic2<m1Nisw>	MP:0000477,abnormal intestine morphology|MP:0000914,exencephaly|MP:0001044,abnormal enteric nervous system morphology|MP:0001046,abnormal enteric neuron morphology|MP:0003054,spina bifida|MP:0008415,abnormal neurite morphology|MP:0010155,abnormal intestine physiology|MP:0011089,perinatal lethality, complete penetrance|MP:0013001,abnormal enteric neural crest cell morphology
MGI:2156825	Zic2<tm1Jaru>	MP:0000433,microcephaly|MP:0000755,hindlimb paralysis|MP:0000774,decreased brain size|MP:0000781,decreased corpus callosum size|MP:0000788,abnormal cerebral cortex morphology|MP:0000818,abnormal amygdala morphology|MP:0000819,abnormal olfactory bulb morphology|MP:0000913,abnormal brain development|MP:0000914,exencephaly|MP:0000923,abnormal roof plate morphology|MP:0000934,abnormal telencephalon development|MP:0000961,abnormal dorsal root ganglion morphology|MP:0001399,hyperactivity|MP:0001402,decreased locomotor activity|MP:0001463,abnormal spatial learning|MP:0001488,increased startle reflex|MP:0001890,anencephaly|MP:0002115,abnormal limb bone morphology|MP:0002151,abnormal neural tube morphology|MP:0003051,curly tail|MP:0003054,spina bifida|MP:0003232,abnormal forebrain development|MP:0003861,abnormal nervous system development|MP:0003863,decreased aggression towards mice|MP:0004599,abnormal vertebral arch morphology|MP:0004613,fusion of vertebral arches|MP:0004639,fused metacarpal bones|MP:0004642,fused metatarsal bones|MP:0004837,abnormal neural fold formation|MP:0005157,holoprosencephaly|MP:0005386,behavior/neurological phenotype|MP:0005657,abnormal neural plate morphology|MP:0006254,thin cerebral cortex|MP:0006282,abnormal spinal cord dorsal horn morphology|MP:0008428,abnormal spatial working memory|MP:0008535,enlarged lateral ventricles|MP:0008540,abnormal cerebral hemisphere morphology|MP:0008915,fused carpal bones|MP:0008919,fused tarsal bones|MP:0008948,decreased neuron number|MP:0009142,decreased prepulse inhibition|MP:0009454,impaired contextual conditioning behavior|MP:0009456,impaired cued conditioning behavior|MP:0011085,postnatal lethality, complete penetrance|MP:0014320,abnormal autopod rotation
MGI:1856679	Zic3<Bn>	MP:0000074,abnormal neurocranium morphology|MP:0000441,increased cranium width|MP:0000585,kinked tail|MP:0000592,short tail|MP:0000866,cerebellum vermis hypoplasia|MP:0000914,exencephaly|MP:0000919,cranioschisis|MP:0000929,open neural tube|MP:0001405,impaired coordination|MP:0001539,decreased caudal vertebrae number|MP:0001732,postnatal growth retardation|MP:0001921,reduced fertility|MP:0002083,premature death|MP:0002767,situs ambiguus|MP:0005386,behavior/neurological phenotype|MP:0008818,abnormal interfrontal bone morphology|MP:0009959,abnormal cerebellar hemisphere morphology|MP:0009990,abnormal cerebellum vermis lobule III morphology|MP:0009993,abnormal cerebellum vermis lobule V morphology|MP:0011042,abnormal horizontal vestibuloocular reflex|MP:0011101,prenatal lethality, incomplete penetrance|MP:0031392,hypoactivity
MGI:3043028	Zic3<Ka>	MP:0000269,abnormal heart looping|MP:0000585,kinked tail|MP:0001706,abnormal left-right axis patterning|MP:0003085,abnormal egg cylinder morphology|MP:0003890,abnormal embryonic-extraembryonic boundary morphology|MP:0004252,abnormal direction of heart looping
MGI:5476827	Zic3<tm1.1Smwa>	MP:0000266,abnormal heart morphology|MP:0000269,abnormal heart looping|MP:0001695,abnormal gastrulation|MP:0001706,abnormal left-right axis patterning|MP:0002151,abnormal neural tube morphology|MP:0002169,no abnormal phenotype detected|MP:0004066,abnormal primitive node morphology
MGI:2180720	Zic3<tm1Bca>	MP:0000111,cleft palate|MP:0000137,abnormal vertebrae morphology|MP:0000150,abnormal rib morphology|MP:0000267,abnormal heart development|MP:0000269,abnormal heart looping|MP:0000284,double outlet right ventricle|MP:0000432,abnormal head morphology|MP:0000531,right pulmonary isomerism|MP:0000585,kinked tail|MP:0000598,abnormal liver morphology|MP:0000644,dextrocardia|MP:0000694,spleen hypoplasia|MP:0000783,abnormal forebrain morphology|MP:0000786,abnormal embryonic neuroepithelial layer differentiation|MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000830,abnormal diencephalon morphology|MP:0000850,absent cerebellum|MP:0000897,abnormal midbrain morphology|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001672,abnormal embryo development|MP:0001680,abnormal mesoderm development|MP:0001685,abnormal endoderm development|MP:0001688,abnormal somite development|MP:0001695,abnormal gastrulation|MP:0001700,abnormal embryo turning|MP:0001706,abnormal left-right axis patterning|MP:0001730,embryonic growth arrest|MP:0001890,anencephaly|MP:0002085,abnormal embryonic tissue morphology|MP:0002086,abnormal extraembryonic tissue morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002127,abnormal cardiovascular system morphology|MP:0002151,abnormal neural tube morphology|MP:0002231,abnormal primitive streak morphology|MP:0002621,delayed neural tube closure|MP:0002766,situs inversus|MP:0003036,vertebral transformation|MP:0003178,left pulmonary isomerism|MP:0003886,abnormal embryonic epiblast morphology|MP:0003984,embryonic growth retardation|MP:0004066,abnormal primitive node morphology|MP:0004073,caudal body truncation|MP:0004131,abnormal motile primary cilium morphology|MP:0004133,heterotaxia|MP:0004157,interrupted aortic arch|MP:0004158,right aortic arch|MP:0004252,abnormal direction of heart looping|MP:0004559,small allantois|MP:0004713,split notochord|MP:0005221,abnormal rostral-caudal axis patterning|MP:0005224,abnormal left-right axis symmetry of the somites|MP:0005236,abnormal olfactory nerve morphology|MP:0005657,abnormal neural plate morphology|MP:0006007,abnormal basal ganglion morphology|MP:0006063,abnormal inferior vena cava morphology|MP:0006065,abnormal heart position or orientation|MP:0008533,abnormal anterior visceral endoderm morphology|MP:0009331,absent primitive node|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010807,abnormal stomach position or orientation|MP:0010808,right-sided stomach|MP:0010853,abnormal lung position or orientation|MP:0010854,lung situs inversus|MP:0011086,postnatal lethality, incomplete penetrance|MP:0011091,prenatal lethality, complete penetrance|MP:0011092,embryonic lethality, complete penetrance|MP:0011101,prenatal lethality, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011665,d-loop transposition of the great arteries|MP:0012156,rostral-caudal axis duplication|MP:0012685,abnormal primitive streak elongation|MP:0012739,abnormal anterior primitive streak morphology|MP:0020530,disorganized thalamus
MGI:3698161	Zic3<tm1Jwb>	MP:0000023,abnormal ear position|MP:0000024,lowered ear position|MP:0000120,malocclusion|MP:0000160,kyphosis|MP:0000161,scoliosis|MP:0000454,abnormal jaw morphology|MP:0000457,maxilla hypoplasia|MP:0000458,abnormal mandible morphology|MP:0000585,kinked tail|MP:0000644,dextrocardia|MP:0001706,abnormal left-right axis patterning|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002258,abnormal cricoid cartilage morphology|MP:0003056,abnormal hyoid bone morphology|MP:0003345,decreased rib number|MP:0004871,premaxilla hypoplasia|MP:0005270,abnormal zygomatic bone morphology|MP:0009916,absent hyoid bone greater horns|MP:0011660,ectopia cordis|MP:0030100,hemifacial hypoplasia|MP:0030285,mandibular coronoid process hypoplasia|MP:0031345,developmental cataract
MGI:5470150	Zic3<tm2.1Jwb>	MP:0000111,cleft palate|MP:0000269,abnormal heart looping|MP:0000585,kinked tail|MP:0000644,dextrocardia|MP:0000755,hindlimb paralysis|MP:0000914,exencephaly|MP:0001672,abnormal embryo development|MP:0002092,abnormal eye morphology|MP:0002114,abnormal axial skeleton morphology|MP:0002151,abnormal neural tube morphology|MP:0002169,no abnormal phenotype detected|MP:0003984,embryonic growth retardation|MP:0004133,heterotaxia|MP:0004252,abnormal direction of heart looping|MP:0005034,abnormal anus morphology|MP:0006063,abnormal inferior vena cava morphology|MP:0006065,abnormal heart position or orientation|MP:0010402,ventricular septal defect|MP:0010403,atrial septal defect|MP:0010807,abnormal stomach position or orientation|MP:0010808,right-sided stomach|MP:0010853,abnormal lung position or orientation|MP:0011109,lethality throughout fetal growth and development, incomplete penetrance|MP:0011110,preweaning lethality, incomplete penetrance
MGI:3510678	Zic4<tm2Kjmi>	MP:0000851,cerebellum hypoplasia|MP:0000857,abnormal cerebellar foliation
MGI:3052154	Zic5<tm1Jaru>	MP:0000788,abnormal cerebral cortex morphology|MP:0000807,abnormal hippocampus morphology|MP:0000830,abnormal diencephalon morphology|MP:0000914,exencephaly|MP:0000929,open neural tube|MP:0001262,decreased body weight|MP:0001406,abnormal gait|MP:0001504,abnormal posture|MP:0001891,hydrocephaly|MP:0002082,postnatal lethality|MP:0002083,premature death|MP:0004592,small mandible|MP:0004870,small premaxilla|MP:0005358,abnormal incisor morphology|MP:0006007,abnormal basal ganglion morphology
MGI:3574814	Zic5<tm1Sia>	MP:0000087,absent mandible|MP:0000433,microcephaly|MP:0000788,abnormal cerebral cortex morphology|MP:0000808,abnormal hippocampus development|MP:0000820,abnormal choroid plexus morphology|MP:0000825,dilated lateral ventricle|MP:0000827,dilated third ventricle|MP:0000837,abnormal hypothalamus morphology|MP:0000914,exencephaly|MP:0000934,abnormal telencephalon development|MP:0000935,abnormal folding of telencephalic vesicles|MP:0001081,abnormal cranial ganglia morphology|MP:0001092,abnormal trigeminal ganglion morphology|MP:0001096,abnormal glossopharyngeal ganglion morphology|MP:0001293,anophthalmia|MP:0001297,microphthalmia|MP:0002639,micrognathia|MP:0003232,abnormal forebrain development|MP:0003425,abnormal optic vesicle formation|MP:0004077,abnormal striatum morphology|MP:0004081,abnormal globus pallidus morphology|MP:0005404,abnormal axon morphology|MP:0011087,neonatal lethality, complete penetrance|MP:0020527,small thalamus
MGI:7426103	Zim1<em1(IMPC)Ccpcz>	MP:0002311,abnormal inspiratory capacity|MP:0010896,decreased lung compliance|MP:0010935,increased airway resistance|MP:0011044,increased lung elastance|MP:0011047,increased lung tissue damping
MGI:3588724	Zit1<DBA/2J>	MP:0008873,increased physiological sensitivity to xenobiotic
MGI:4432778	Zkscan14<tm1a(EUCOMM)Wtsi>	MP:0002942,decreased circulating alanine transaminase level|MP:0005632,decreased circulating aspartate transaminase level
MGI:5548856	Zkscan17<tm1b(EUCOMM)Wtsi>	MP:0002833,increased heart weight|MP:0003179,thrombocytopenia|MP:0011100,preweaning lethality, complete penetrance
MGI:6370004	Zkscan3<em1Fink>	MP:0002169,no abnormal phenotype detected
MGI:6863904	Zkscan3<tm1.2Itl>	MP:0005025,abnormal response to infection
MGI:6158493	Zkscan7<em1(IMPC)Mbp>	MP:0000689,abnormal spleen morphology|MP:0000691,enlarged spleen|MP:0000702,enlarged lymph nodes|MP:0001293,anophthalmia|MP:0002092,abnormal eye morphology|MP:0002339,abnormal lymph node morphology
MGI:6512875	Zmat3<em1Ast>	MP:0005384,cellular phenotype
MGI:6313415	Zmat4<em1(IMPC)J>	MP:0004738,abnormal auditory brainstem response
MGI:7426104	Zmat5<em1(IMPC)Hmgu>	MP:0005343,increased circulating aspartate transaminase level|MP:0005544,cornea deposits|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance
MGI:5795595	Zmiz1<tm1c(EUCOMM)Hmgu>	MP:0001823,thymus hypoplasia|MP:0002053,decreased incidence of induced tumors|MP:0005017,decreased B cell number|MP:0005018,decreased T cell number|MP:0005381,digestive/alimentary phenotype|MP:0008045,decreased NK cell number|MP:0014224,increased ileal goblet cell number
MGI:3769389	Zmiz1<tm1Zsu>	MP:0000259,abnormal vascular development|MP:0000285,abnormal heart valve morphology|MP:0000352,decreased cell proliferation|MP:0001698,decreased embryo size|MP:0001722,pale yolk sac|MP:0002672,abnormal pharyngeal arch artery morphology|MP:0003105,abnormal heart atrium morphology|MP:0003227,abnormal vascular branching morphogenesis|MP:0003229,abnormal vitelline vasculature morphology|MP:0003658,abnormal capillary morphology|MP:0003717,pallor|MP:0004068,dilated dorsal aorta|MP:0004076,abnormal vitelline vascular remodeling|MP:0004787,abnormal dorsal aorta morphology|MP:0005397,hematopoietic system phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011110,preweaning lethality, incomplete penetrance|MP:0012732,abnormal perineural vascular plexus morphology
MGI:5445796	Zmiz2<tm1.1(KOMP)Vlcg>	MP:0001417,decreased exploration in new environment|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:2180033	Zmpste24<tm1Otin>	MP:0000160,kyphosis|MP:0000161,scoliosis|MP:0000280,thin ventricular wall|MP:0000377,abnormal hair follicle morphology|MP:0000414,alopecia|MP:0000558,abnormal tibia morphology|MP:0000559,abnormal femur morphology|MP:0000745,tremors|MP:0000752,dystrophic muscle|MP:0001221,epidermal atrophy|MP:0001259,abnormal body weight|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001265,decreased body size|MP:0001392,abnormal locomotor behavior|MP:0001505,hunched posture|MP:0001732,postnatal growth retardation|MP:0001823,thymus hypoplasia|MP:0002083,premature death|MP:0002753,dilated heart left ventricle|MP:0002754,dilated heart right ventricle|MP:0002795,dilated cardiomyopathy|MP:0002833,increased heart weight|MP:0002980,abnormal postural reflex|MP:0003786,premature aging|MP:0003917,increased kidney weight|MP:0004701,decreased circulating insulin-like growth factor I level|MP:0005114,premature hair loss|MP:0005123,increased circulating growth hormone level|MP:0005343,increased circulating aspartate transaminase level|MP:0005608,cardiac interstitial fibrosis|MP:0008843,absent subcutaneous adipose tissue|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0009543,abnormal thymus corticomedullary boundary morphology|MP:0010090,increased circulating creatine kinase level|MP:0011009,increased circulating glutamate dehydrogenase level|MP:0011195,increased hair follicle apoptosis
MGI:2158363	Zmpste24<tm1Sgy>	MP:0000061,fragile skeleton|MP:0000130,abnormal trabecular bone morphology|MP:0000135,decreased compact bone thickness|MP:0000150,abnormal rib morphology|MP:0000160,kyphosis|MP:0000414,alopecia|MP:0000458,abnormal mandible morphology|MP:0000558,abnormal tibia morphology|MP:0000746,weakness|MP:0000748,progressive muscle weakness|MP:0001262,decreased body weight|MP:0001263,weight loss|MP:0001406,abnormal gait|MP:0001438,aphagia|MP:0001515,abnormal grip strength|MP:0001533,abnormal skeleton physiology|MP:0001661,extended life span|MP:0001732,postnatal growth retardation|MP:0002083,premature death|MP:0002114,abnormal axial skeleton morphology|MP:0002116,abnormal craniofacial bone morphology|MP:0002187,abnormal fibula morphology|MP:0002639,micrognathia|MP:0002835,abnormal cranial suture morphology|MP:0003047,abnormal thoracic vertebrae morphology|MP:0003049,abnormal lumbar vertebrae morphology|MP:0003111,abnormal cell nucleus morphology|MP:0003723,abnormal long bone morphology|MP:0003795,abnormal bone structure|MP:0004469,abnormal zygomatic arch morphology|MP:0004675,rib fractures|MP:0005150,cachexia|MP:0005270,abnormal zygomatic bone morphology|MP:0005358,abnormal incisor morphology|MP:0005370,liver/biliary system phenotype|MP:0005385,cardiovascular system phenotype|MP:0005455,increased susceptibility to weight gain|MP:0005508,abnormal skeleton morphology|MP:0005560,decreased circulating glucose level|MP:0005567,decreased circulating total protein level|MP:0005621,abnormal cell physiology|MP:0008770,decreased survivor rate|MP:0008844,decreased subcutaneous adipose tissue amount|MP:0010053,decreased grip strength|MP:0011085,postnatal lethality, complete penetrance|MP:0021188,decreased bone mineral density of presacral vertebrae|MP:0030082,long lower incisors|MP:0030136,abnormal lower incisor morphology
MGI:6360032	Zmym2<em1(IMPC)Bay>	MP:0000266,abnormal heart morphology|MP:0000288,abnormal pericardium morphology|MP:0001691,abnormal somite shape|MP:0001700,abnormal embryo turning|MP:0001785,edema|MP:0002151,abnormal neural tube morphology|MP:0003720,abnormal neural tube closure|MP:0003731,abnormal retina outer nuclear layer morphology|MP:0006108,abnormal hindbrain development|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013293,embryonic lethality prior to tooth bud stage
MGI:6324365	Zmym2<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0000277,abnormal heart shape|MP:0000928,incomplete rostral neuropore closure|MP:0001488,increased startle reflex|MP:0001698,decreased embryo size|MP:0001700,abnormal embryo turning|MP:0001701,incomplete embryo turning|MP:0002111,abnormal tail morphology|MP:0002884,abnormal pharyngeal arch morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003229,abnormal vitelline vasculature morphology|MP:0003232,abnormal forebrain development|MP:0003984,embryonic growth retardation|MP:0006031,abnormal pharyngeal pouch morphology|MP:0010024,increased total body fat amount|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011100,preweaning lethality, complete penetrance|MP:0011495,abnormal head shape|MP:0012098,increased spongiotrophoblast size
MGI:5648435	Zmym2<m1Anu>	MP:0002080,prenatal lethality
MGI:8215475	Zmym2<Tn(pb-Act-RFP)1Xwu>	MP:0000516,abnormal renal/urinary system morphology|MP:0000519,hydronephrosis|MP:0000524,decreased renal tubule number|MP:0000527,abnormal kidney development|MP:0001146,abnormal testis morphology|MP:0001354,increased aggression towards male mice|MP:0001363,increased anxiety-related response|MP:0001559,hyperglycemia|MP:0001698,decreased embryo size|MP:0001948,vesicoureteral reflux|MP:0002083,premature death|MP:0002675,asthenozoospermia|MP:0002727,decreased circulating insulin level|MP:0003059,decreased insulin secretion|MP:0003604,single kidney|MP:0003623,hydrocele|MP:0003631,nervous system phenotype|MP:0003984,embryonic growth retardation|MP:0004017,duplex kidney|MP:0004505,decreased renal glomerulus number|MP:0004910,decreased seminal vesicle weight|MP:0005376,homeostasis/metabolism phenotype|MP:0005378,growth/size/body region phenotype|MP:0005382,craniofacial phenotype|MP:0005386,behavior/neurological phenotype|MP:0005389,reproductive system phenotype|MP:0005559,increased circulating glucose level|MP:0010771,integument phenotype|MP:0011098,embryonic lethality during organogenesis, complete penetrance|MP:0011334,abnormal nephrogenic zone morphology|MP:0011368,increased kidney apoptosis|MP:0011493,double ureter|MP:0011803,double kidney pelvis|MP:0013319,seminal vesicle atrophy|MP:0020343,abnormal ureteric bud number|MP:0031286,unilateral cryptorchism|MP:0031287,bilateral cryptorchism|MP:0031310,abnormal cyst
MGI:7287466	Zmym3<em1Hncs>	MP:0001147,small testis|MP:0001922,reduced male fertility|MP:0001925,male infertility|MP:0002687,oligozoospermia|MP:0004929,decreased epididymis weight|MP:0008261,arrest of male meiosis|MP:0014052,increased male germ cell apoptosis|MP:0014633,decreased spermatid number|MP:0014634,decreased round spermatid number|MP:0014636,decreased elongated spermatid number
MGI:6153718	Zmym4<em1(IMPC)Wtsi>	MP:0000194,increased circulating calcium level|MP:0001258,decreased body length|MP:0001556,increased circulating HDL cholesterol level|MP:0003443,increased circulating glycerol level|MP:0005178,increased circulating cholesterol level|MP:0008806,increased circulating amylase level|MP:0010088,decreased circulating fructosamine level|MP:0010124,decreased bone mineral content|MP:0011100,preweaning lethality, complete penetrance
MGI:6157344	Zmym6<em1(IMPC)Hmgu>	MP:0000280,thin ventricular wall
MGI:4419323	Zmynd10<tm1(KOMP)Wtsi>	MP:0000432,abnormal head morphology|MP:0001179,thick pulmonary interalveolar septum|MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0001732,postnatal growth retardation|MP:0001861,lung inflammation|MP:0001891,hydrocephaly|MP:0002083,premature death|MP:0002270,abnormal pulmonary alveolus morphology|MP:0002276,abnormal lung interstitium morphology|MP:0002285,abnormal tracheal ciliated epithelium morphology|MP:0002766,situs inversus|MP:0003828,pulmonary edema|MP:0004133,heterotaxia|MP:0006254,thin cerebral cortex|MP:0010752,impaired mucociliary clearance|MP:0011050,abnormal respiratory motile cilium morphology|MP:0011056,abnormal brain ependyma motile cilium morphology|MP:0011069,abnormal brain ependyma motile cilium physiology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012676,dilated brain ventricle
MGI:6119402	Zmynd11<em1(IMPC)Wtsi>	MP:0000111,cleft palate|MP:0000150,abnormal rib morphology|MP:0000602,dilated liver sinusoidal space|MP:0000783,abnormal forebrain morphology|MP:0001127,small ovary|MP:0001146,abnormal testis morphology|MP:0002279,abnormal diaphragm morphology|MP:0002652,thin myocardium|MP:0003105,abnormal heart atrium morphology|MP:0003641,small lung|MP:0003686,abnormal eye muscle morphology|MP:0005477,increased circulating thyroxine level|MP:0006063,abnormal inferior vena cava morphology|MP:0009493,abnormal cystic duct morphology|MP:0009494,abnormal biliary ductule morphology|MP:0010418,perimembraneous ventricular septal defect|MP:0010439,abnormal hepatic vein morphology|MP:0010912,herniated liver|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011513,abnormal vertebral artery morphology|MP:0012303,umbilical vein stenosis|MP:0013163,absent thyroid gland isthmus|MP:0013836,abnormal hypoglossal nerve topology|MP:0013852,abnormal Mullerian duct topology|MP:0013878,abnormal ductus venosus valve topology|MP:0013967,abnormal infrahyoid muscle connection|MP:0013971,blood in lymph vessels|MP:0013975,abnormal coronary sinus connection|MP:0013986,abnormal vitelline vein topology|MP:0014001,abnormal vertebral artery topology|MP:0014021,heterochrony
MGI:7344362	Zmynd12<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0002942,decreased circulating alanine transaminase level|MP:0005505,thrombocytosis|MP:0005632,decreased circulating aspartate transaminase level|MP:0005635,decreased circulating bilirubin level
MGI:4433147	Zmynd8<tm1a(EUCOMM)Wtsi>	MP:0001262,decreased body weight|MP:0001539,decreased caudal vertebrae number|MP:0005419,decreased circulating serum albumin level|MP:0005562,decreased mean corpuscular hemoglobin|MP:0010025,decreased total body fat amount|MP:0010093,decreased circulating magnesium level|MP:0011100,preweaning lethality, complete penetrance
MGI:6305162	Znfx1<em1(IMPC)J>	MP:0010025,decreased total body fat amount|MP:0010053,decreased grip strength
MGI:8187911	Znfx1<em1Xua>	MP:0001798,impaired macrophage phagocytosis|MP:0002412,increased susceptibility to bacterial infection|MP:0002451,abnormal macrophage physiology|MP:0005025,abnormal response to infection|MP:0008554,decreased circulating tumor necrosis factor level|MP:0008563,decreased interferon-alpha secretion|MP:0008565,decreased interferon-beta secretion|MP:0008578,decreased circulating interferon-gamma level|MP:0008618,decreased circulating interleukin-12 level|MP:0011079,decreased macrophage cytokine production|MP:0020913,increased susceptibility to Riboviria infection|MP:0030940,impaired autophagy
MGI:7309144	Zng1<em1Skan>	MP:0000516,abnormal renal/urinary system morphology|MP:0000519,hydronephrosis|MP:0000536,hydroureter|MP:0011493,double ureter
MGI:7309151	Zng1<em2Skan>	MP:0000516,abnormal renal/urinary system morphology|MP:0000519,hydronephrosis|MP:0000536,hydroureter|MP:0002703,abnormal renal tubule morphology|MP:0011425,abnormal kidney interstitium morphology|MP:0011493,double ureter
MGI:6317369	Znhit1<em1(IMPC)J>	MP:0000367,abnormal coat/ hair morphology|MP:0001510,abnormal coat appearance|MP:0001566,increased circulating phosphate level|MP:0001698,decreased embryo size|MP:0001713,decreased trophoblast giant cell number|MP:0001729,impaired embryo implantation|MP:0002718,abnormal inner cell mass morphology|MP:0005028,abnormal trophectoderm morphology|MP:0008527,embryonic lethality at implantation|MP:0009687,empty decidua capsularis|MP:0010053,decreased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0011183,abnormal primitive endoderm morphology|MP:0011187,abnormal parietal endoderm morphology|MP:0013292,embryonic lethality prior to organogenesis
MGI:6360223	Znhit1<tm1.1Nju>	MP:0000490,abnormal crypts of Lieberkuhn morphology|MP:0001262,decreased body weight|MP:0002083,premature death|MP:0008108,abnormal small intestinal villus morphology|MP:0010158,abnormal intestine development|MP:0011086,postnatal lethality, incomplete penetrance|MP:0013485,increased Paneth cell number
MGI:6385698	Znhit2<em1(IMPC)J>	MP:0000218,increased leukocyte cell number|MP:0002399,abnormal pluripotent precursor cell morphology|MP:0002718,abnormal inner cell mass morphology|MP:0003694,failure of blastocyst to hatch from the zona pellucida|MP:0004957,abnormal blastocyst morphology|MP:0005028,abnormal trophectoderm morphology|MP:0005559,increased circulating glucose level|MP:0005635,decreased circulating bilirubin level|MP:0008527,embryonic lethality at implantation|MP:0009687,empty decidua capsularis|MP:0009781,abnormal preimplantation embryo development|MP:0010052,increased grip strength|MP:0011100,preweaning lethality, complete penetrance|MP:0011183,abnormal primitive endoderm morphology|MP:0013292,embryonic lethality prior to organogenesis
MGI:6276844	Znhit6<em1(IMPC)Mbp>	MP:0000702,enlarged lymph nodes|MP:0001614,abnormal blood vessel morphology|MP:0001711,abnormal placenta morphology|MP:0001914,hemorrhage|MP:0002339,abnormal lymph node morphology|MP:0003231,abnormal placenta vasculature|MP:0009142,decreased prepulse inhibition|MP:0011100,preweaning lethality, complete penetrance|MP:0013292,embryonic lethality prior to organogenesis
MGI:6369072	Znrf1<tm1Lchs>	MP:0001545,abnormal hematopoietic system physiology|MP:0008734,decreased susceptibility to endotoxin shock
MGI:7426106	Znrf2<em1(IMPC)Bay>	MP:0001417,decreased exploration in new environment
MGI:5427833	Znrf3<tm1.1Fcon>	MP:0003078,aphakia|MP:0003720,abnormal neural tube closure|MP:0011089,perinatal lethality, complete penetrance|MP:0012168,abnormal optic placode morphology
MGI:5049948	zoef	MP:0012269,nuchal edema|MP:0012270,cardiac edema
MGI:3580127	Zolw1<DBA/1J>	MP:0009775,increased behavioral withdrawal response
MGI:1857997	Zp1<tm1Dean>	MP:0001130,abnormal ovarian folliculogenesis|MP:0001919,abnormal reproductive system physiology|MP:0001923,reduced female fertility|MP:0001935,decreased litter size|MP:0003696,abnormal zona pellucida morphology|MP:0008868,abnormal granulosa cell morphology|MP:0009375,thin zona pellucida
MGI:1932591	Zp2<tm1Dean>	MP:0001926,female infertility|MP:0009372,abnormal cumulus oophorus morphology|MP:0009375,thin zona pellucida|MP:0011129,decreased tertiary ovarian follicle number|MP:0031420,decreased superovulation rate
MGI:7426107	Zp3r<em1(IMPC)Ccpcz>	MP:0000689,abnormal spleen morphology|MP:0002792,abnormal retina vasculature morphology|MP:0010935,increased airway resistance
MGI:5430162	Zp3r<tm1Osb>	MP:0005389,reproductive system phenotype
MGI:1857971	Zp3<tm1Dean>	MP:0001130,abnormal ovarian folliculogenesis|MP:0001926,female infertility|MP:0003697,absent zona pellucida|MP:0031420,decreased superovulation rate
MGI:1932681	Zp3<tm1Pmw>	MP:0001125,abnormal oocyte morphology|MP:0001127,small ovary|MP:0001130,abnormal ovarian folliculogenesis|MP:0001926,female infertility|MP:0003697,absent zona pellucida|MP:0004856,decreased ovary weight|MP:0005389,reproductive system phenotype|MP:0009372,abnormal cumulus oophorus morphology|MP:0009375,thin zona pellucida|MP:0011129,decreased tertiary ovarian follicle number|MP:0031420,decreased superovulation rate
MGI:3762590	Zpbp2<tm1Zuk>	MP:0001922,reduced male fertility|MP:0005389,reproductive system phenotype|MP:0005411,delayed fertilization|MP:0005578,teratozoospermia
MGI:3762589	Zpbp<tm1Zuk>	MP:0001156,abnormal spermatogenesis|MP:0001925,male infertility|MP:0002675,asthenozoospermia|MP:0002686,globozoospermia|MP:0002784,abnormal Sertoli cell morphology|MP:0005389,reproductive system phenotype|MP:0005578,teratozoospermia|MP:0006380,abnormal spermatid morphology|MP:0008839,absent acrosome|MP:0008892,abnormal sperm flagellum morphology|MP:0008893,detached sperm flagellum|MP:0008898,abnormal acrosome morphology|MP:0009232,abnormal sperm nucleus morphology|MP:0009238,coiled sperm flagellum
MGI:6356634	Zpld1<cwh>	MP:0001394,circling|MP:0001399,hyperactivity|MP:0001522,impaired swimming|MP:0004742,abnormal vestibular system physiology|MP:0004844,abnormal vestibuloocular reflex|MP:0005377,hearing/vestibular/ear phenotype
MGI:6108892	Zpld1<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0004924,abnormal behavior|MP:0005377,hearing/vestibular/ear phenotype|MP:0020870,decreased thigmotaxis
MGI:6356635	Zpld1<sprl>	MP:0001394,circling|MP:0001399,hyperactivity|MP:0004742,abnormal vestibular system physiology|MP:0004844,abnormal vestibuloocular reflex|MP:0005377,hearing/vestibular/ear phenotype
MGI:3526216	Zpr1<tm1Rjd>	MP:0002718,abnormal inner cell mass morphology|MP:0005028,abnormal trophectoderm morphology|MP:0005033,abnormal trophoblast giant cell morphology|MP:0008888,abnormal Cajal body morphology|MP:0010380,abnormal inner cell mass apoptosis|MP:0011092,embryonic lethality, complete penetrance|MP:0012113,decreased inner cell mass proliferation
MGI:7449310	Zranb1<em1Shios>	MP:0001262,decreased body weight|MP:0001265,decreased body size|MP:0005380,embryo phenotype|MP:0005381,digestive/alimentary phenotype|MP:0013298,increased susceptibility to colitis induced morbidity/mortality|MP:0013795,abnormal colon goblet cell morphology|MP:0014219,decreased intestinal mucosa thickness
MGI:4435532	Zranb1<tm1a(EUCOMM)Hmgu>	MP:0003960,increased lean body mass|MP:0005505,thrombocytosis
MGI:5548368	Zranb1<tm1b(EUCOMM)Hmgu>	MP:0011110,preweaning lethality, incomplete penetrance
MGI:5806462	Zranb1<tm1c(EUCOMM)Hmgu>	MP:0002376,abnormal dendritic cell physiology|MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005387,immune system phenotype|MP:0008087,decreased T helper 1 cell number|MP:0010220,decreased T-helper 17 cell number
MGI:5806463	Zranb1<tm1d(EUCOMM)Hmgu>	MP:0004800,decreased susceptibility to experimental autoimmune encephalomyelitis|MP:0005387,immune system phenotype|MP:0008075,decreased CD4-positive, alpha-beta T cell number|MP:0008087,decreased T helper 1 cell number|MP:0008578,decreased circulating interferon-gamma level|MP:0008615,decreased circulating interleukin-17 level|MP:0010220,decreased T-helper 17 cell number
MGI:4432383	Zranb2<tm1a(EUCOMM)Wtsi>	MP:0004924,abnormal behavior|MP:0010088,decreased circulating fructosamine level
MGI:6276976	Zranb3<em1(IMPC)Mbp>	MP:0001552,increased circulating triglyceride level
MGI:6313361	Zrsr2<em1(IMPC)Mbp>	MP:0000219,increased neutrophil cell number|MP:0000266,abnormal heart morphology|MP:0000274,enlarged heart|MP:0000598,abnormal liver morphology|MP:0000601,small liver|MP:0001926,female infertility|MP:0005016,decreased lymphocyte cell number
MGI:2388701	Zrsr2-ps1<tm1Mok>	MP:0002169,no abnormal phenotype detected
MGI:5707638	Zscan10<Gt(285B6)1.1Cmhd>	MP:0000195,decreased circulating calcium level|MP:0001262,decreased body weight|MP:0001297,microphthalmia|MP:0001303,abnormal lens morphology|MP:0001304,cataract|MP:0001402,decreased locomotor activity|MP:0001405,impaired coordination|MP:0001488,increased startle reflex|MP:0001923,reduced female fertility|MP:0002090,abnormal vision|MP:0002599,increased mean platelet volume|MP:0002665,decreased circulating corticosterone level|MP:0002764,short tibia|MP:0002834,decreased heart weight|MP:0002981,increased liver weight|MP:0003020,decreased circulating chloride level|MP:0003179,thrombocytopenia|MP:0003718,maternal effect|MP:0003921,abnormal heart left ventricle morphology|MP:0003944,abnormal T cell subpopulation ratio|MP:0004016,decreased bone mass|MP:0004953,decreased spleen weight|MP:0005014,increased B cell number|MP:0005018,decreased T cell number|MP:0005333,decreased heart rate|MP:0005419,decreased circulating serum albumin level|MP:0005534,decreased body temperature|MP:0005553,increased circulating creatinine level|MP:0005565,increased blood urea nitrogen level|MP:0005574,decreased pulmonary respiratory rate|MP:0005586,decreased tidal volume|MP:0008499,increased IgG1 level|MP:0008501,increased IgG2b level|MP:0009141,increased prepulse inhibition|MP:0010124,decreased bone mineral content|MP:0010168,increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number|MP:0010896,decreased lung compliance|MP:0011535,increased urination frequency|MP:0011971,increased circulating lactate dehydrogenase level|MP:0013673,increased mature NK cell number|MP:0020174,abnormal IgG level|MP:0031391,increased locomotor activity
MGI:4431612	Zscan10<tm2a(EUCOMM)Wtsi>	MP:0001325,abnormal retina morphology|MP:0011110,preweaning lethality, incomplete penetrance
MGI:5775626	Zscan12<em1(IMPC)J>	MP:0010053,decreased grip strength
MGI:5904160	Zscan21<tm1.1Jiwa>	MP:0001925,male infertility|MP:0004852,decreased testis weight|MP:0006379,abnormal spermatocyte morphology|MP:0008261,arrest of male meiosis|MP:0011751,abnormal X-Y chromosome synapsis during male meiosis|MP:0014634,decreased round spermatid number|MP:0014764,impaired double-strand DNA break repair
MGI:1926800	Zscan21<tm1Htz>	MP:0002169,no abnormal phenotype detected
MGI:5792561	Zscan21<tm2b(EUCOMM)Wtsi>	MP:0001925,male infertility|MP:0001926,female infertility|MP:0003733,abnormal retina inner nuclear layer morphology|MP:0010379,decreased respiratory quotient|MP:0011110,preweaning lethality, incomplete penetrance|MP:0011239,abnormal skin coloration|MP:0011965,decreased total retina thickness
MGI:4363795	Zscan2<tm1a(KOMP)Wtsi>	MP:0004609,vertebral fusion
MGI:5905771	Zscan5b<em1(IMPC)J>	MP:0001304,cataract|MP:0001406,abnormal gait
MGI:6455748	Zscan5b<tm1Thama>	MP:0010095,increased chromosomal stability
MGI:5700042	Zswim1<tm1b(KOMP)Mbp>	MP:0000208,decreased hematocrit|MP:0000218,increased leukocyte cell number|MP:0000219,increased neutrophil cell number|MP:0000220,increased monocyte cell number|MP:0000223,decreased monocyte cell number|MP:0002591,decreased mean corpuscular volume|MP:0002599,increased mean platelet volume|MP:0002606,increased basophil cell number|MP:0003131,increased erythrocyte cell number|MP:0003960,increased lean body mass|MP:0005011,increased eosinophil cell number|MP:0005013,increased lymphocyte cell number|MP:0005016,decreased lymphocyte cell number|MP:0005562,decreased mean corpuscular hemoglobin|MP:0005641,increased mean corpuscular hemoglobin concentration|MP:0010067,increased red blood cell distribution width
MGI:7378669	Zswim2<em1Zuk>	MP:0005389,reproductive system phenotype
MGI:5582436	Zswim5<tm1.1(KOMP)Wtsi>	MP:0002075,abnormal coat/hair pigmentation
MGI:5823481	Zswim6<em1(IMPC)J>	MP:0001289,persistence of hyaloid vascular system|MP:0001304,cataract|MP:0005561,increased mean corpuscular hemoglobin|MP:0005655,increased aggression|MP:0011110,preweaning lethality, incomplete penetrance
MGI:6149981	Zswim6<tm1.2Itl>	MP:0000788,abnormal cerebral cortex morphology|MP:0001262,decreased body weight|MP:0001364,decreased anxiety-related response|MP:0001399,hyperactivity|MP:0001405,impaired coordination|MP:0001409,increased stereotypic behavior|MP:0001440,abnormal grooming behavior|MP:0002574,increased vertical activity|MP:0008462,abnormal medium spiny neuron morphology|MP:0011086,postnatal lethality, incomplete penetrance|MP:0012468,decreased striatum size|MP:0013894,abnormal behavioral response to amphetamine|MP:0031391,increased locomotor activity
MGI:6287662	Zswim7<em1Mjn>	MP:0001925,male infertility|MP:0001926,female infertility|MP:0002216,abnormal seminiferous tubule morphology|MP:0002777,absent ovarian follicles|MP:0004852,decreased testis weight|MP:0004856,decreased ovary weight|MP:0009451,abnormal chromosomal synapsis|MP:0013507,increased ovary apoptosis
MGI:7537043	Zswim8<em1Jtm>	MP:0000280,thin ventricular wall|MP:0001176,abnormal lung development|MP:0001179,thick pulmonary interalveolar septum|MP:0001953,respiratory failure|MP:0002188,small heart|MP:0008022,dilated heart ventricle|MP:0009674,decreased birth weight|MP:0010402,ventricular septal defect|MP:0010827,small lung saccule|MP:0011087,neonatal lethality, complete penetrance|MP:0031511,globular heart
MGI:7537044	Zswim8<em2Jtm>	MP:0008022,dilated heart ventricle|MP:0010768,mortality/aging|MP:0031511,globular heart
MGI:7539525	Zswim8<em#Dpbl>	MP:0001575,cyanosis|MP:0001954,respiratory distress|MP:0004200,decreased fetal size|MP:0009703,decreased birth body size|MP:0010402,ventricular septal defect|MP:0010825,abnormal lung saccule morphology|MP:0011089,perinatal lethality, complete penetrance
MGI:7709433	Zup1<em1Lisi>	MP:0002451,abnormal macrophage physiology|MP:0031024,increased susceptibility to Riboviria infection induced morbidity/mortality|MP:0031046,increased susceptibility to Orthomyxoviridae infection induced morbidity/mortality
MGI:5576065	Zwilch<tm1.1(KOMP)Vlcg>	MP:0001697,abnormal embryo size|MP:0001711,abnormal placenta morphology|MP:0003231,abnormal placenta vasculature|MP:0003984,embryonic growth retardation|MP:0004151,decreased circulating iron level|MP:0004258,abnormal placenta size|MP:0005561,increased mean corpuscular hemoglobin|MP:0011100,preweaning lethality, complete penetrance
MGI:5749807	Zwint<em1(IMPC)J>	MP:0001399,hyperactivity|MP:0002718,abnormal inner cell mass morphology|MP:0011100,preweaning lethality, complete penetrance|MP:0011189,small embryonic epiblast|MP:0013292,embryonic lethality prior to organogenesis|MP:0014259,embryonic lethality prior to organogenesis, complete penetrance
MGI:6305141	Zyg11b<em1(IMPC)J>	MP:0001402,decreased locomotor activity|MP:0001417,decreased exploration in new environment|MP:0011110,preweaning lethality, incomplete penetrance
MGI:2448217	Zyx<tm1Mbk>	MP:0000358,abnormal cell morphology|MP:0002169,no abnormal phenotype detected|MP:0011707,impaired fibroblast cell migration|MP:0011709,increased fibroblast cell migration|MP:0014699,increased fibroblast adhesion
MGI:5474781	Zzef1<tm2.1(KOMP)Vlcg>	MP:0000186,decreased circulating HDL cholesterol level|MP:0000195,decreased circulating calcium level|MP:0001258,decreased body length|MP:0001399,hyperactivity|MP:0002075,abnormal coat/hair pigmentation|MP:0002135,abnormal kidney morphology|MP:0002968,increased circulating alkaline phosphatase level|MP:0003063,increased coping response|MP:0003917,increased kidney weight|MP:0005179,decreased circulating cholesterol level|MP:0005343,increased circulating aspartate transaminase level|MP:0005561,increased mean corpuscular hemoglobin|MP:0005627,increased circulating potassium level|MP:0011396,abnormal sleep behavior|MP:0030610,absent teeth
